"sample_ID"	"cell"	"UMAP_1"	"UMAP_2"	"orig.ident"	"samples"	"Broad_cell_identity"	"Cell_type_identity"	"clusters_res.2"	"CNV_pos"	"malignant"	"aml"	"ap_aml_age"	"age_group"	"sex.x"	"inflammation_group"	"occupancy_score"	"GSM"	"date"	"cell_ID"	"cell_type_original"	"Sample.ID"	"sex.y"	"Age"	"Sequencing"	"Institution"	"Manuscript.ID"	"Dx"	"DxELN_Cytogenetic"	"Cytogenetics"	"Overall.survival"	"Flow.report.summary"	"RAS.pathway"	"NPM1"	"IDH"	"TET2"	"TP53"	"RUNX1"	"CBF"	"MLL.rearranged"	"IDH1"	"IDH2"	"ASXL1"	"BCOR"	"CBL"	"CEBPAdm"	"CSF3R"	"DNMT3A"	"ETV6"	"FLT3.TKD"	"FLT3.ITD"	"GATA2"	"JAK2"	"KIT"	"NPM1.1"	"NRAS"	"KRAS"	"PTPN11"	"PHF6"	"RAD21"	"RUNX1.1"	"SETBP1"	"SMC1A"	"STAG2"	"SRSF2"	"SF3B1"	"TET2.1"	"U2AF1"	"WT1"	"TP53.1"	"ZRSR2"	"health_status"	"case_or_control"	"cell_type"	"cell_subtype"	"total_counts_raw"	"mito_counts"	"frac_mito"	"nr_genes"	"counts_upper_threshold"	"counts_lower_threshold"	"genes_lower_threshold"	"counts_upper_filter"	"counts_lower_filter"	"genes_lower_filter"	"cell_filter"	"threshold_celltype_size"	"celltype_size_cf"	"celltype_size_filter"	"cell_type_ID"	"total_counts_raw_cf_ctf_gf"	"total_counts_raw_cf_ctf_gf_sf"
"AML-0024"	"2020-09-15-AML0024:CATCAAGGTTAGCGGA"	-0.731073121458846	-15.7979812852112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCAAGGTTAGCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.86667501992	31.4851247380216	0.012152352354364	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.36224730057	2584.36224730057
"AML-0024"	"2020-09-15-AML0024:CATCAAGTCCGAGAAG"	-2.19977102699931	-16.6848325959411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCAAGTCCGAGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.75184813479	37.5290967143779	0.0144467597015951	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.81471141968	2593.81471141968
"AML-0024"	"2020-09-15-AML0024:CATCCACAGGGACCAT"	-2.86679397049602	-16.1065244904724	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACAGGGACCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.67109087177	40.7509450979409	0.0152930488260031	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.50749567696	2655.50749567696
"AML-0024"	"2020-09-15-AML0024:CCTCAACAGAGCAAGA"	-1.6662965816563	-16.1348085633484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACAGAGCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.25586743214	37.0796455029937	0.0134773526308193	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.62302818943	2742.62302818943
"AML-0024"	"2020-09-15-AML0024:CCTCAACAGTTCCATG"	-0.971509675413925	-17.4919233552185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACAGTTCCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.24060407425	44.333479741988	0.015581627676234	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.28312483307	2843.28312483307
"AML-0024"	"2020-09-15-AML0024:CCTCAACGTAGAATAC"	-1.68747160854991	-16.5901346436706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACGTAGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2799.51198222764	37.586538690875	0.0134261038814938	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.53997379135	2790.53997379135
"AML-0024"	"2020-09-15-AML0024:CCTCAACGTTCTCCCA"	-2.17314062538798	-15.7897520295349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACGTTCTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.40894672938	34.3361902397073	0.0118916962831332	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.7216940925	2881.7216940925
"AML-0024"	"2020-09-15-AML0024:CCTCAACTCCGAACGC"	-0.437048713595229	-16.3216066590515	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACTCCGAACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2855.78952070043	36.0423051714003	0.0126207848688233	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.0261098145	2843.0261098145
"AML-0024"	"2020-09-15-AML0024:CCTCAACTCTAGTCAG"	-1.84361002865489	-16.8637342683044	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACTCTAGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.18964793485	44.5974543293323	0.0160238646915147	2691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.6267178729	2769.6267178729
"AML-0024"	"2020-09-15-AML0024:CCTCACAAGACAGTCG"	0.0609723861211955	-15.8800859681335	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACAAGACAGTCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2873.10003345831	42.1753834133949	0.0146793995761536	2659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2865.74389764341	2865.74389764341
"AML-0024"	"2020-09-15-AML0024:CCTCACACAATTGCCA"	-1.24722407284434	-16.4106073609558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACACAATTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.44214598372	35.5238549023089	0.0133878384935124	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.14106815322	2644.14106815322
"AML-0024"	"2020-09-15-AML0024:CCTCACACAGAACTAA"	-1.39071498337443	-16.3034601441589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACACAGAACTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.68587163282	48.2911634573866	0.0181226477655303	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.43844523224	2653.43844523224
"AML-0024"	"2020-09-15-AML0024:CCTCACACAGCTGAAG"	-1.61071179333385	-16.2866010895935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACACAGCTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.91399378918	24.3340313504642	0.00925630561058802	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.82383858312	2624.82383858312
"AML-0024"	"2020-09-15-AML0024:CCTCACAGTAATCAGA"	-1.83609602871593	-15.5623178712097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACAGTAATCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3204.67381894785	37.2591430658277	0.0116265009079959	3258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3195.91063733891	3195.91063733891
"AML-0024"	"2020-09-15-AML0024:CCTCACAGTACTCCGG"	-2.24520001831706	-16.5423040620056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCACAGTACTCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.10362824049	36.1424359606102	0.0148483554854795	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2424.71173654577	2424.71173654577
"AML-0024"	"2020-09-15-AML0024:CCTCAACAGAACGCGT"	-0.982909778982955	-16.7870455018249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAACAGAACGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.60138266943	33.7259805000699	0.0138414025125116	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2431.19519390225	2431.19519390225
"AML-0024"	"2020-09-15-AML0024:CATACTTAGGCGTTAG"	-1.77501748028453	-15.5331220856872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACTTAGGCGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.55504492291	36.0377146814342	0.0138737058727099	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.56821715035	2592.56821715035
"AML-0024"	"2020-09-15-AML0024:CATACTTAGTTGCATC"	-2.22889337959941	-16.2171087495056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACTTAGTTGCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.65202820892	36.9506631514959	0.0141918592619747	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2597.27415447917	2597.27415447917
"AML-0024"	"2020-09-15-AML0024:CATACTTCAACTTGGT"	-1.4220920604771	-15.5619926682678	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACTTCAACTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.67253752367	36.5927107157184	0.01250745264427	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.60312855427	2920.60312855427
"AML-0024"	"2020-09-15-AML0024:CATACTTTCCTTGACC"	-0.718505005270797	-15.7273502579895	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACTTTCCTTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.44852069776	29.7767085882329	0.0104831009508732	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.36703229299	2834.36703229299
"AML-0024"	"2020-09-15-AML0024:CATAGACAGCACTAAA"	-2.60847030106242	-16.3838243714538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAGACAGCACTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2266.28338059132	43.03634700038	0.018989834796896	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.75009315729	2257.75009315729
"AML-0024"	"2020-09-15-AML0024:CATAGACAGGATCACG"	-2.06863103333171	-16.5518141022888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAGACAGGATCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.89222967734	37.7839541087632	0.0170206254175929	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2218.81722953976	2218.81722953976
"AML-0024"	"2020-09-15-AML0024:CATAGACAGGGAGTGG"	-0.971275429159957	-15.6029272309509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAGACAGGGAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.99990079092	38.3948167398249	0.0134955423826732	2674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.91276730342	2838.91276730342
"AML-0024"	"2020-09-15-AML0024:CATAGACCACACAGCC"	-2.95925627175029	-15.7792406312195	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAGACCACACAGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.53805332823	35.3701939865367	0.0129725656839306	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.52579231601	2721.52579231601
"AML-0024"	"2020-09-15-AML0024:CATAGACTCCATTGGA"	-2.32394657555278	-15.8536777726379	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAGACTCCATTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.66929543359	31.9485142033464	0.0126445175318695	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.87372546409	2520.87372546409
"AML-0024"	"2020-09-15-AML0024:CATCAAGAGAGTTCGG"	-1.85360322418864	-16.6168489686218	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCAAGAGAGTTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.10245880018	29.3112127849489	0.0123932105672152	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2362.15765354571	2362.15765354571
"AML-0024"	"2020-09-15-AML0024:CATCAAGAGAGTTGCG"	-0.981900910765487	-15.6679573289123	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCAAGAGAGTTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.67155348578	39.5262658104702	0.0136926786016721	2659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.16364261815	2876.16364261815
"AML-0024"	"2020-09-15-AML0024:CCTAAGATCGAGAGCA"	-2.8695584339207	-15.9751978150574	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAAGATCGAGAGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.29991300247	39.8895559733657	0.0176245117777823	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2260.06215932481	2260.06215932481
"AML-0024"	"2020-09-15-AML0024:CCTACGTAGCCGTAAG"	-2.63673291626628	-16.0785093537536	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTACGTAGCCGTAAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2330.75505707554	48.8031877507605	0.020938788742561	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2324.15540710152	2324.15540710152
"AML-0024"	"2020-09-15-AML0024:CCTACGTCATCCTTCG"	-2.50771365585979	-16.2183389893738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTACGTCATCCTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2876.76017762027	36.7384461489416	0.0127707712428544	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.12201136454	2868.12201136454
"AML-0024"	"2020-09-15-AML0024:CCTACGTGTATTTCTC"	0.801649590104264	-16.2473669282165	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTACGTGTATTTCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2944.57142614001	36.913013195671	0.0125359544237851	3783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2935.08360463114	2935.08360463114
"AML-0024"	"2020-09-15-AML0024:CCTACGTGTCTCAGAT"	-1.39135513725932	-16.9779405823913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTACGTGTCTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.22525999198	39.7504644816009	0.0135471754754471	3005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.23867830183	2924.23867830183
"AML-0024"	"2020-09-15-AML0024:CCTACGTTCCACAAGT"	-1.70293031159099	-15.4765701523987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTACGTTCCACAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.014629851	33.8080382736894	0.0117756412392242	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.39279445909	2863.39279445909
"AML-0024"	"2020-09-15-AML0024:CCTATCGAGAATCCCT"	-1.60268817368205	11.1378316649231	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGAGAATCCCT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1976.82937822526	41.1500469975439	0.0208161854790358	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1971.97116951557	1971.97116951557
"AML-0024"	"2020-09-15-AML0024:CCTATCGAGGAGACCT"	-2.20887313309367	-16.2117967835632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGAGGAGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.37107614571	38.849222273665	0.0146194194037863	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.90041966107	2647.90041966107
"AML-0024"	"2020-09-15-AML0024:CCTATCGAGTCGAGGT"	-1.35455320301707	-15.6675625077453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGAGTCGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.2683027901	37.5250859023472	0.0139744270110205	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.49030759916	2678.49030759916
"AML-0024"	"2020-09-15-AML0024:CCTATCGCAGAACGCA"	-1.09063396874126	-16.6452665559021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGCAGAACGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.65364305772	35.3601114981541	0.0133906662053601	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.77978757496	2631.77978757496
"AML-0024"	"2020-09-15-AML0024:CCTATCGCAGCTCGGT"	-1.75385485115703	-16.8804540864197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGCAGCTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.33833047777	36.550275164134	0.0136517207213074	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.82364215469	2662.82364215469
"AML-0024"	"2020-09-15-AML0024:CCTATCGGTAAGTTGA"	-0.396858463913757	-16.6301374665466	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGGTAAGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.22111649295	38.4135407829444	0.0148934655262037	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.57541657971	2575.57541657971
"AML-0024"	"2020-09-15-AML0024:CCTATCGGTCAGTCCG"	-1.00520883026775	-17.4398546448913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGGTCAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.14734574986	41.1469907032076	0.0146266745555909	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.59715887662	2807.59715887662
"AML-0024"	"2020-09-15-AML0024:CCTATCGTCCGTGTAA"	-1.97036395493205	-16.5955229035583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGTCCGTGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.00603412464	34.0670554860769	0.0133595979892539	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.13815486851	2546.13815486851
"AML-0024"	"2020-09-15-AML0024:CCTATCGTCGTAGCCG"	-1.49004373970683	-15.5980577698913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGTCGTAGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.69355258063	36.0937957301274	0.0152249942599445	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.9849682511	2368.9849682511
"AML-0024"	"2020-09-15-AML0024:CCTATCGTCTACCACC"	-0.702351431280929	-15.7140894166199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTATCGTCTACCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.55009621321	39.0573492804461	0.0133458673169423	2810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.88298381425	2920.88298381425
"AML-0024"	"2020-09-15-AML0024:AAACCCACAACATACC"	-1.82896707478221	-16.6609678498474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACCCACAACATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.09917005058	39.1049923229937	0.0154011283939787	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.30657000085	2524.30657000085
"AML-0024"	"2020-09-15-AML0024:AAACCCAGTACAACGG"	-1.42228005352672	-15.8741941682068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACCCAGTACAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2644.5067766454	34.8381662029879	0.0131737859440015	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.43797709054	2640.43797709054
"AML-0024"	"2020-09-15-AML0024:AAACCCAGTTGTAGCT"	-1.8574677509373	-16.0671167603699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACCCAGTTGTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.3758368294	34.3939640734643	0.0119035964913467	2873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.08893047792	2877.08893047792
"AML-0024"	"2020-09-15-AML0024:AAACCCATCATCTGTT"	-2.83788762512859	-16.0580969086853	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACCCATCATCTGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2835.96226889598	41.7571037703574	0.0147241393964713	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.1183901002	2817.1183901002
"AML-0024"	"2020-09-15-AML0024:AAACCCATCTCAGAAC"	-1.01996527138408	-16.7516374818054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACCCATCTCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.95726195998	42.6694778271563	0.0159813336472035	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.93754234625	2664.93754234625
"AML-0024"	"2020-09-15-AML0024:AAACGAACAAGTTCGT"	-1.691389421851	-16.0838690034119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGAACAAGTTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.12834336915	33.922286362253	0.0123482714028023	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.39430417791	2737.39430417791
"AML-0024"	"2020-09-15-AML0024:AAACGAACAGCAGTTT"	0.955607553094071	-16.2237425080505	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGAACAGCAGTTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2789.86272964961	41.0043368088117	0.0146976180487423	2896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2779.26322329103	2779.26322329103
"AML-0024"	"2020-09-15-AML0024:AAACGAAGTAACAGTA"	-1.36463401737865	-16.7441950074402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGAAGTAACAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.19653966751	37.3139908185124	0.0148886929767538	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.33658092529	2498.33658092529
"AML-0024"	"2020-09-15-AML0024:AAACGAATCTTTGGAG"	-2.01756487312968	-16.506615661737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGAATCTTTGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.43148525164	39.1951214082201	0.0136833859039839	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.66145479139	2857.66145479139
"AML-0024"	"2020-09-15-AML0024:AAACGCTAGATTAGTG"	-1.31201217594798	-16.2439928284851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGCTAGATTAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.05997136996	35.3176590981429	0.0123962497992489	3115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.20185829207	2839.20185829207
"AML-0024"	"2020-09-15-AML0024:AAACGCTAGCGAATGC"	-0.392360906035262	-16.1969309083191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGCTAGCGAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.08982764622	39.6144033214736	0.0154436709757742	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.92015524311	2557.92015524311
"AML-0024"	"2020-09-15-AML0024:AAACGCTAGTTCCTGA"	-3.21433458748515	13.5516624220642	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGCTAGTTCCTGA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2026.26516501235	30.2669175064396	0.0149372935137317	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2020.88086375065	2020.88086375065
"AML-0024"	"2020-09-15-AML0024:AAACGCTGTCTACAAC"	-0.713947097689468	-15.8556261292663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAACGCTGTCTACAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2947.40782807373	37.9376806877091	0.0128715409948895	3108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.87342462397	2939.87342462397
"AML-0024"	"2020-09-15-AML0024:AAAGAACAGCACCCAC"	-0.191900934011298	-16.456271194574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACAGCACCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.92762443226	47.0545580465296	0.0169022203140521	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.85317671259	2774.85317671259
"AML-0024"	"2020-09-15-AML0024:AAAGAACAGCGGACAT"	-0.919022182852584	-16.1407919160095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACAGCGGACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.72559595688	38.6702847163033	0.0146827310998789	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.77799988231	2626.77799988231
"AML-0024"	"2020-09-15-AML0024:AAAGAACAGCTGACTT"	-1.01850436154063	-15.7688369981018	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACAGCTGACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.25403266635	37.4397126239517	0.014932556548383	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.01354479477	2500.01354479477
"AML-0024"	"2020-09-15-AML0024:AAAGAACAGGGCTTCC"	-1.98882089081462	-16.2222891083923	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACAGGGCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.69304307288	35.0213196788321	0.0135547524783284	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.87719503425	2574.87719503425
"AML-0024"	"2020-09-15-AML0024:AAAGAACAGTAAGCAT"	9.39665951308553	7.75706575000612	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACAGTAAGCAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1791.21712974771	28.7417168567338	0.0160459144675453	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1789.39681468458	1789.39681468458
"AML-0024"	"2020-09-15-AML0024:AAAGAACCAACAAAGT"	-1.82180200043376	-16.6125269166199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACCAACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.0297937881	42.0820835363806	0.0173460703756123	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2417.99472920046	2417.99472920046
"AML-0024"	"2020-09-15-AML0024:AAAGAACGTACTCGCG"	-1.53386233273204	-16.1499338380066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACGTACTCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.24618906212	29.4441440949578	0.0110974037073302	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.37312470961	2646.37312470961
"AML-0024"	"2020-09-15-AML0024:AAAGAACGTCATCGCG"	-2.57481584969218	-15.674119972345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACGTCATCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2428.8243345484	32.5096392577235	0.0133849281709244	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2426.36321115723	2426.36321115723
"AML-0024"	"2020-09-15-AML0024:AAAGAACGTGCATACT"	-2.52786026421245	-16.3383760682312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACGTGCATACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.75793717751	39.4416035698898	0.015259302622728	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.03332889157	2571.03332889157
"AML-0024"	"2020-09-15-AML0024:AAAGAACGTTTCCAAG"	-1.85039172592815	-16.9135122529236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACGTTTCCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.44813629533	39.4032300399528	0.0161790470725814	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.39708218999	2434.39708218999
"AML-0024"	"2020-09-15-AML0024:AAAGAACTCCAAATGC"	-0.384694944054443	-16.0115614167419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACTCCAAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.90256402458	32.34924245095	0.0107297804038374	3048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3004.15528890622	3004.15528890622
"AML-0024"	"2020-09-15-AML0024:AAAGAACTCTGGGTCG"	-1.48404477062877	-15.1735964051453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGAACTCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3225.93209053162	37.5471591627971	0.0116391660174748	3642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3218.97148982042	3218.97148982042
"AML-0024"	"2020-09-15-AML0024:AAAGGATAGCCAGACA"	-1.21255050125774	-15.8606424561706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATAGCCAGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.66356340758	39.2002734110757	0.013756105778396	3337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.6060668773	2843.6060668773
"AML-0024"	"2020-09-15-AML0024:AAAGGATAGCTAGCCC"	-2.23409567299541	-16.4379549256531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATAGCTAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.06341877701	40.9235691589854	0.0174064080246177	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.99829410149	2345.99829410149
"AML-0024"	"2020-09-15-AML0024:AAAGGATAGGCTGGAT"	-0.936931352049667	-15.8874788514343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATAGGCTGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3007.36647024719	37.0195698592721	0.0123096304442834	3455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2997.57110195091	2997.57110195091
"AML-0024"	"2020-09-15-AML0024:AAAGGATAGTTGGCTT"	-1.78336797180827	-16.0694551697937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATAGTTGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2949.24066548261	34.7640777813823	0.011787467258354	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.08045461714	2935.08045461714
"AML-0024"	"2020-09-15-AML0024:AAAGGATCAGACCCGT"	1.10211743888203	-16.2128381959167	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATCAGACCCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3056.90455479749	39.3555567404872	0.0128743164972956	4475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3046.65558939054	3046.65558939054
"AML-0024"	"2020-09-15-AML0024:AAAGGATCATCGCTGG"	1.26681747016255	-16.1777849427429	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATCATCGCTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2919.64968685351	35.0017959683272	0.0119883546734843	4030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2909.6184746925	2909.6184746925
"AML-0024"	"2020-09-15-AML0024:AAAGGATCATTGGGAG"	-1.715523938567	-16.7391653290954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATCATTGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.97617503525	32.6350179264716	0.013513598297091	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2407.68408333466	2407.68408333466
"AML-0024"	"2020-09-15-AML0024:AAAGGATTCCCATACC"	0.931167800992173	-16.2130251160828	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGATTCCCATACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3228.92082642617	31.689120144919	0.00981415211099898	5025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3219.76306434369	3219.76306434369
"AML-0024"	"2020-09-15-AML0024:AAAGGGCCAATTAGGA"	-0.25807366791423	-15.9969320527283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGGCCAATTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2944.35982736391	35.0693927193128	0.011910702079749	3010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2936.89893065661	2936.89893065661
"AML-0024"	"2020-09-15-AML0024:AAAGGGCGTGGTCTCG"	-1.73207817497905	-16.7475519410339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGGCGTGGTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.7646576738	41.6542651077908	0.0165375772527556	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.52253049403	2513.52253049403
"AML-0024"	"2020-09-15-AML0024:AAAGGGCGTTGGGCCT"	-2.34537802162822	-15.8073396912781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGGCGTTGGGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.92476524268	34.2121051757112	0.0126434059125228	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.44430093882	2698.44430093882
"AML-0024"	"2020-09-15-AML0024:AAAGGGCTCATGCCCT"	-0.183791707188445	-16.0265703431335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGGCTCATGCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.28515452063	38.3292054912029	0.0133120560952513	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.06875102904	2872.06875102904
"AML-0024"	"2020-09-15-AML0024:AAAGGTAAGGACTGGT"	8.83714642104451	7.57027766788331	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTAAGGACTGGT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1898.75491154138	40.3529441786582	0.0212523185237742	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1891.41415125923	1891.41415125923
"AML-0024"	"2020-09-15-AML0024:AAAGGTAAGGGAGGTG"	-2.27462587776836	-15.3545208207336	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTAAGGGAGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.47557527864	37.543664401139	0.014218523644998	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.3763592415	2638.3763592415
"AML-0024"	"2020-09-15-AML0024:AAAGGTACATCTCAAG"	-2.46357665482219	-15.868944191095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTACATCTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.30243912118	34.4702559060222	0.0131903048763135	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.13021552202	2605.13021552202
"AML-0024"	"2020-09-15-AML0024:AAAGGTATCCTAAGTG"	-1.0720239681309	-16.2091131440369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTATCCTAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.07520253455	37.2061829706247	0.0134024405883009	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.82207325012	2766.82207325012
"AML-0024"	"2020-09-15-AML0024:AAAGGTATCTCAGAAC"	-1.76947496357616	-16.3963842622009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTATCTCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.12075144471	36.9219796775073	0.0139585233140458	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.37968304887	2634.37968304887
"AML-0024"	"2020-09-15-AML0024:AAAGGTATCTGATTCT"	-1.72225914421733	-16.0365019074646	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGGTATCTGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.32204001987	34.6948314673708	0.0123807438873531	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.39555376338	2795.39555376338
"AML-0024"	"2020-09-15-AML0024:AAAGTCCCACCAGTTA"	-1.18318937245067	-15.7256250611511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTCCCACCAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.22400119887	41.508763130839	0.0147496301336199	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.3967233618	2807.3967233618
"AML-0024"	"2020-09-15-AML0024:AAAGTCCCAGAACGCA"	-1.55777869644817	-15.6789312592712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTCCCAGAACGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.22275884795	35.9379553634759	0.0136014101169673	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.56663275771	2636.56663275771
"AML-0024"	"2020-09-15-AML0024:AAAGTGAAGATCCGAG"	-0.719767252833206	-15.8936624757019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAAGATCCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.2042584602	37.0189860404782	0.0134019726915904	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.60199137395	2754.60199137395
"AML-0024"	"2020-09-15-AML0024:AAAGTGAAGCGTGTCC"	-1.77299330654796	-15.8055124512878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAAGCGTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2823.55159375269	36.2516458982789	0.0128390237240532	2529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.30710195946	2816.30710195946
"AML-0024"	"2020-09-15-AML0024:AAAGTGAAGGTGGTTG"	-1.04301402989085	-15.5383806458679	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAAGGTGGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.50971456296	36.0078801559726	0.0128118682420466	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.09629497779	2807.09629497779
"AML-0024"	"2020-09-15-AML0024:AAAGTGAAGTCAGGGT"	-0.654177348048049	-16.2787790528503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.52695936482	38.8103256114548	0.0147258313839477	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.72891865891	2627.72891865891
"AML-0024"	"2020-09-15-AML0024:AAAGTGAAGTGAATAC"	-1.31195280972179	-16.1775083771911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAAGTGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.97047676389	35.6243888400213	0.0142727605040463	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.26409491156	2487.26409491156
"AML-0024"	"2020-09-15-AML0024:AAAGTGACAACCGCCA"	-2.58990202370341	-15.6765651932922	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGACAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3036.11688272479	37.2936856255612	0.0122833497741008	3554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3028.11131436888	3028.11131436888
"AML-0024"	"2020-09-15-AML0024:AAAGTGAGTCAACCTA"	-1.10761521282848	-16.0649729005066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAGTCAACCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.18926453331	36.9892739251972	0.0131158835296532	2645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.72723163395	2811.72723163395
"AML-0024"	"2020-09-15-AML0024:AAAGTGAGTCGTTGCG"	-2.24555836144145	-16.3431310883728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAGTCGTTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.69120944067	36.5616735597457	0.014691124966027	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2482.6855154447	2482.6855154447
"AML-0024"	"2020-09-15-AML0024:AAAGTGAGTTACACAC"	-1.82190154019054	-16.6112356415954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGAGTTACACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.94971521134	35.6386604988333	0.013373108053563	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.83299632276	2654.83299632276
"AML-0024"	"2020-09-15-AML0024:AAAGTGATCATTCGTT"	-1.15414820137675	-15.7376518479553	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAAGTGATCATTCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.41260204151	38.7480406291611	0.0149524782732921	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.66986926391	2586.66986926391
"AML-0024"	"2020-09-15-AML0024:AAATGGAAGCTGTGCC"	-1.81853208962138	-16.8310308686462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAAGCTGTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.90576973983	44.0385453969133	0.0159276840024307	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.28525971271	2754.28525971271
"AML-0024"	"2020-09-15-AML0024:AAATGGAAGTATGAAC"	-1.93793342533763	-16.1087408295837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAAGTATGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.22549401496	32.1207741177428	0.0116581289580534	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.05006607112	2749.05006607112
"AML-0024"	"2020-09-15-AML0024:AAATGGAGTCATCCCT"	-0.918212036520797	-17.3645715943542	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAGTCATCCCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2890.84963601526	39.9189556950294	0.0138087277863589	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2880.73273726452	2880.73273726452
"AML-0024"	"2020-09-15-AML0024:AAATGGAGTCGCGTCA"	-1.67397616329845	-15.9440756074158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAGTCGCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.24704949271	31.5839433605118	0.012169917837566	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.04918883907	2587.04918883907
"AML-0024"	"2020-09-15-AML0024:AAATGGAGTCTCGACG"	-1.81485054913219	-15.7543869248596	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAGTCTCGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3011.39924853165	39.2275504314238	0.0130263532643674	3309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.25328177553	3000.25328177553
"AML-0024"	"2020-09-15-AML0024:AAATGGAGTCTGTGGC"	-1.48411999169047	-16.9052324525085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAATGGAGTCTGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.62874922982	38.791662755558	0.0149969966765074	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.54934414775	2576.54934414775
"AML-0024"	"2020-09-15-AML0024:AACAAAGAGAAACCAT"	-0.520855526358444	-16.0651903382507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGAGAAACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.63060407615	34.5147120510119	0.0127660605701739	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.06343552487	2692.06343552487
"AML-0024"	"2020-09-15-AML0024:AACAAAGAGTCACGCC"	-0.536077598959762	-16.0073671570984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGAGTCACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.79713584534	36.6067585541403	0.0129499064824803	3203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.84169185677	2820.84169185677
"AML-0024"	"2020-09-15-AML0024:AACAAAGGTGTATACC"	-1.37145946446117	-16.2690916291443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGGTGTATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.13303266612	38.9160267749604	0.015466601435507	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.61344654614	2510.61344654614
"AML-0024"	"2020-09-15-AML0024:AACAAAGGTTAAGTCC"	-0.0725320306723893	-16.0680017701355	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGGTTAAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2873.87096900878	41.5118770049745	0.0144445862227741	3136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.41775494723	2867.41775494723
"AML-0024"	"2020-09-15-AML0024:AACAAAGGTTACTCAG"	0.0494559724697888	-16.425416015741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGGTTACTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.77413130861	35.7033483511737	0.012389363886392	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2871.96252831244	2871.96252831244
"AML-0024"	"2020-09-15-AML0024:AACAAAGTCATTCGGA"	-2.18364367905315	-15.5514812699524	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGTCATTCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2997.00250971392	33.6398736503594	0.0112245063330195	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2992.02899378952	2992.02899378952
"AML-0024"	"2020-09-15-AML0024:AACAAAGTCTTCCTAA"	-2.19317923012431	-15.5861997834411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAAGTCTTCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.0923414609	33.8755285257346	0.0121719024629821	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.38597921675	2775.38597921675
"AML-0024"	"2020-09-15-AML0024:AACAACCAGAAGTATC"	-0.0330625650590241	-16.4705000153747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCAGAAGTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.34308241132	39.473037068256	0.0134888616804732	2782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.95119103847	2915.95119103847
"AML-0024"	"2020-09-15-AML0024:AACAACCAGAGTTGCG"	9.11552300032918	7.52362010562745	"2020-09-15-AML0024"	"AML0024"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCAGAGTTGCG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1599.46839789245	38.1395262175528	0.0238451264606463	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1597.90031603124	1597.90031603124
"AML-0024"	"2020-09-15-AML0024:AACAACCCAGGCGAAT"	0.550190885632676	-16.3405962220398	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCCAGGCGAAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2989.32135855708	43.2756442652708	0.014476745412932	3050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2977.18605568535	2977.18605568535
"AML-0024"	"2020-09-15-AML0024:AACAACCCATGGCGCT"	-1.98517070236858	-16.3983640900818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCCATGGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.51748127572	32.9521601410388	0.0122748912498717	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.30554029242	2675.30554029242
"AML-0024"	"2020-09-15-AML0024:AACAACCGTATAATGG"	-1.74555478516276	-15.9159050217834	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCGTATAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.53700780849	32.4145990259949	0.0117251456335868	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.08644773367	2757.08644773367
"AML-0024"	"2020-09-15-AML0024:AACAACCGTGTGAGCA"	-2.53031597557719	-16.1031027070251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCGTGTGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.2772640501	31.9036412791133	0.0116552465101428	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.61084349916	2732.61084349916
"AML-0024"	"2020-09-15-AML0024:AACAACCTCCCTCGAT"	-2.4727922481602	-16.307740234491	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCTCCCTCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.94083084365	41.1427185683691	0.0145950983143041	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.23850923716	2802.23850923716
"AML-0024"	"2020-09-15-AML0024:AACAACCTCCGCCTAT"	-1.77033136311229	-15.7175398102966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCTCCGCCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2978.02719548571	39.7378622235851	0.0133436868151582	3182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2966.41838660387	2966.41838660387
"AML-0024"	"2020-09-15-AML0024:AACAACCTCGTGGGTC"	-0.119702081114608	-16.5375242463318	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCTCGTGGGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2841.50107536558	36.8401782296544	0.0129650411006495	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2837.14894188272	2837.14894188272
"AML-0024"	"2020-09-15-AML0024:AACAACCTCTTCACGC"	-2.09692058983501	-16.2974634400574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAACCTCTTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.32292702456	35.1665437250105	0.0140648007283041	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2492.28699850827	2492.28699850827
"AML-0024"	"2020-09-15-AML0024:AACAAGAAGTTCTCTT"	-0.0385016453569711	-16.3348360291687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGAAGTTCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.95750985312	38.390879070739	0.0137014494101845	2674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.87358151399	2795.87358151399
"AML-0024"	"2020-09-15-AML0024:AACAAGAGTAGTCTTG"	-2.02094445648845	-16.8005190125671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGAGTAGTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.33160730835	36.7567579734745	0.0148073520335709	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.11601835394	2468.11601835394
"AML-0024"	"2020-09-15-AML0024:AACAAGAGTGACACGA"	-0.357157717377502	-15.8717537156311	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGAGTGACACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2825.6632113894	36.0905654276584	0.0127724228712708	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.57307441973	2817.57307441973
"AML-0024"	"2020-09-15-AML0024:AACAAGAGTGACTGTT"	0.755423744290513	-16.2550077668396	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGAGTGACTGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2800.92172698267	45.6521572765776	0.0162989764536394	2853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2790.20067725072	2790.20067725072
"AML-0024"	"2020-09-15-AML0024:AACAAGAGTTCTTGTT"	-1.62275252762492	-15.7062607041565	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGAGTTCTTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.59197689436	35.3820610080257	0.0134298067094753	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.14823916528	2631.14823916528
"AML-0024"	"2020-09-15-AML0024:AACAAGATCTCGGTCT"	-1.62524066391643	-16.5557394257751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGATCTCGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3047.91293670404	38.9316827908807	0.0127732266634167	3474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3037.40164477195	3037.40164477195
"AML-0024"	"2020-09-15-AML0024:AACAAGATCTTCTAAC"	-1.98066149178203	-16.0013113251892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAAGATCTTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.89125752868	35.7791043961501	0.0131304705453089	2444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.59813376116	2719.59813376116
"AML-0024"	"2020-09-15-AML0024:AACACACGTCGCATCG"	-0.76933048191722	-15.7518882981506	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACACACGTCGCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2013.66193902652	47.1929568269557	0.0234363851808068	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2008.75601564788	2008.75601564788
"AML-0024"	"2020-09-15-AML0024:AACACACGTCTACAAC"	-1.94794164124187	-16.0077448121277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACACACGTCTACAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.9890360839	42.4294081916023	0.015312008686821	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.3072599153	2764.3072599153
"AML-0024"	"2020-09-15-AML0024:AACACACGTGTGTTTG"	-2.85223064842876	-16.1403055421081	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACACACGTGTGTTTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.93307499415	45.2104798159444	0.0191900526784092	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.86461196892	2351.86461196892
"AML-0024"	"2020-09-15-AML0024:AACACACTCGAGATGG"	-1.76002667370494	-15.6119384995666	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACACACTCGAGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.78222403014	47.3505020798561	0.0178426479954138	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.31943866973	2650.31943866973
"AML-0024"	"2020-09-15-AML0024:AACAGGGAGACTCCGC"	-0.632809082896072	-16.6146898499695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGAGACTCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.58859509983	41.3457685429371	0.0142542684656436	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.4594380759	2894.4594380759
"AML-0024"	"2020-09-15-AML0024:AACAGGGAGATACTGA"	-2.06465087357219	-16.1176462403503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGAGATACTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.40376831301	37.3453629997704	0.013778523862891	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.37654580296	2701.37654580296
"AML-0024"	"2020-09-15-AML0024:AACAGGGAGCAAACAT"	-0.625580589205581	-16.2075109711853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGAGCAAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.01448718365	40.8081262706506	0.0152781373768134	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.13574396617	2663.13574396617
"AML-0024"	"2020-09-15-AML0024:AACAGGGGTACGCGTC"	-1.53064523163493	-15.8609018555847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGGTACGCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2846.73385271669	46.9448834444241	0.0164907876441009	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.17036431177	2835.17036431177
"AML-0024"	"2020-09-15-AML0024:AACAGGGGTAGTAAGT"	1.02961363372151	-16.2682104340759	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGGTAGTAAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2805.04582913307	44.4361942631921	0.0158415216613148	3441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2789.51083011868	2789.51083011868
"AML-0024"	"2020-09-15-AML0024:AACAGGGGTCATAAAG"	-2.45474110069926	-16.3516588441101	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGGTCATAAAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.82072290438	38.2126924054513	0.0146982028679125	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.008917567	2589.008917567
"AML-0024"	"2020-09-15-AML0024:AACAGGGTCGCCTAGG"	-0.736799876124221	-16.2038011780945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGTCGCCTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.40288690883	35.4795255668501	0.0141895235174329	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.71161762292	2495.71161762292
"AML-0024"	"2020-09-15-AML0024:AACAGGGTCTATCGTT"	-1.30820427361186	-15.0751066437927	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGTCTATCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1824.95867244441	34.144722665476	0.0187098607661846	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1820.58209249259	1820.58209249259
"AML-0024"	"2020-09-15-AML0024:AACAGGGTCTGGCTGG"	-1.73572192612346	-15.5399084321228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACAGGGTCTGGCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.11656447581	33.7846612932257	0.0130235710129134	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.96413469629	2589.96413469629
"AML-0024"	"2020-09-15-AML0024:AACCAACCACTCTGCT"	-0.0332004902070344	-16.1363706818786	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCAACCACTCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.4676089302	37.5683609305038	0.0138095233360552	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.21815186933	2714.21815186933
"AML-0024"	"2020-09-15-AML0024:AACCAACCACTGTTCC"	-2.61298904839213	-16.1521978608337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCAACCACTGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2103.30806474632	42.5570583712871	0.0202333928560389	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2093.35059193785	2093.35059193785
"AML-0024"	"2020-09-15-AML0024:AACCAACGTATCGATC"	-0.609588663012344	-15.7260103455749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCAACGTATCGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.63241884182	36.0936538174691	0.0128235763845572	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.56162211405	2803.56162211405
"AML-0024"	"2020-09-15-AML0024:AACCAACGTTAAGGGC"	-0.476695577532607	-16.3718881837097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCAACGTTAAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2421.72617468697	41.9121602588932	0.0173067296777724	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.54637715952	2415.54637715952
"AML-0024"	"2020-09-15-AML0024:AACCACAAGCCGATCC"	-2.09148440781291	-15.7997884980408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAAGCCGATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.1664062238	28.9904677415195	0.0102979588266708	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.76704915514	2809.76704915514
"AML-0024"	"2020-09-15-AML0024:AACCACAAGTAAACTG"	-0.341205070645171	-16.5837316743103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAAGTAAACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.93153272916	33.9866484022203	0.0121470622153034	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.21168403564	2792.21168403564
"AML-0024"	"2020-09-15-AML0024:AACCACAAGTCGCCAC"	-1.30802712860759	-16.4950952759949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAAGTCGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.15941846437	32.649426132351	0.0124846790990367	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.95239123599	2603.95239123599
"AML-0024"	"2020-09-15-AML0024:AACCACACACCTATCC"	-0.934444884688217	-16.1569662324158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACACACCTATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.73572668316	30.5084844481383	0.010858133082912	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.74250339653	2798.74250339653
"AML-0024"	"2020-09-15-AML0024:AACCACACAGTCGGTC"	-1.98902593079265	-16.0127954713074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACACAGTCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.47886789601	43.3261867248795	0.0160557813664336	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.96174888859	2691.96174888859
"AML-0024"	"2020-09-15-AML0024:AACCACACATCTCGTC"	-2.17956767502483	-16.3890142670837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACACATCTCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.53981529762	37.7193400450018	0.0156023655975892	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2416.63092790061	2416.63092790061
"AML-0024"	"2020-09-15-AML0024:AACCACAGTCTCGACG"	-1.61982868138011	-15.7097940674988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAGTCTCGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3066.52633322183	35.2592927132082	0.0114981216144207	3019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3058.24904859587	3058.24904859587
"AML-0024"	"2020-09-15-AML0024:AACCACAGTCTGTAGT"	-0.588616709143478	-16.4081316224304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAGTCTGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.40213023202	38.2148188941571	0.015090343843083	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2525.96839171408	2525.96839171408
"AML-0024"	"2020-09-15-AML0024:AACCACAGTGTTCGTA"	-0.617521147162277	-16.1768350831238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAGTGTTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2906.68461358505	39.054528351472	0.013436107986722	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.10154584686	2894.10154584686
"AML-0024"	"2020-09-15-AML0024:AACCACAGTTCAGCGC"	-1.37243411961253	-16.5823908082214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACAGTTCAGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.21028252163	33.8132430155318	0.0117643594907281	2937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2861.70167853506	2861.70167853506
"AML-0024"	"2020-09-15-AML0024:AACCACATCGGTAGAG"	-2.07608972016032	-15.5195360413757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCACATCGGTAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.33931571284	29.2212626011673	0.0107457213714822	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.07920749601	2712.07920749601
"AML-0024"	"2020-09-15-AML0024:AACCATGAGAACAGGA"	-2.49403868141826	-15.7957487336365	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGAGAACAGGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.60685213347	48.9737743044223	0.0222445593576184	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2198.68986336061	2198.68986336061
"AML-0024"	"2020-09-15-AML0024:AACCATGAGCAGGTCA"	-2.60200939598735	-15.8699302903381	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGAGCAGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.68108168925	33.3415205154097	0.0118036406770107	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.81538654588	2811.81538654588
"AML-0024"	"2020-09-15-AML0024:AACCATGCAACGGTAG"	-2.30939898911174	-16.6747961274353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGCAACGGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2316.32452198798	36.7035788446318	0.0158456116559743	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2307.69565510959	2307.69565510959
"AML-0024"	"2020-09-15-AML0024:AACCATGCAATAAGGT"	-1.64155815067943	-16.236207031366	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGCAATAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.4071901132	41.9277511919099	0.0159033670326584	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.15090817149	2624.15090817149
"AML-0024"	"2020-09-15-AML0024:AACCATGGTGGTAATA"	-2.64110265198405	-16.0009126893249	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGGTGGTAATA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.18228745953	33.4248439481441	0.0110891912832239	3106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3006.06209625954	3006.06209625954
"AML-0024"	"2020-09-15-AML0024:AACCATGTCAACTGGT"	-1.41189299050029	-15.0772981873718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGTCAACTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.37933784658	36.7214568047421	0.014236547632191	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.56798403223	2564.56798403223
"AML-0024"	"2020-09-15-AML0024:AACCATGTCAAGAATG"	-1.86827931824382	-15.8062696686951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGTCAAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.20283029546	37.1625386751521	0.013581792352411	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.80958795439	2733.80958795439
"AML-0024"	"2020-09-15-AML0024:AACCATGTCTGTAACG"	-0.826612750918228	-16.4478159180847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCATGTCTGTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.61937392712	31.1430638547979	0.0111399513629246	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.41896954622	2790.41896954622
"AML-0024"	"2020-09-15-AML0024:AACCCAAAGAGCCTGA"	-0.422209302813369	-16.4688768616882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCCAAAGAGCCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.22770487298	33.6756028049833	0.0133303908986607	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.93529902809	2515.93529902809
"AML-0024"	"2020-09-15-AML0024:AACCCAACAGTCACGC"	-1.67469177666362	-16.4374208680359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCCAACAGTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.18373909247	38.0732105294735	0.0136552014114629	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.07257339956	2779.07257339956
"AML-0024"	"2020-09-15-AML0024:AACCCAAGTTAAGACA"	-0.533172051340896	-15.8141327134338	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCCAAGTTAAGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.46798138017	33.3500762058698	0.0124187204752037	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.66697165784	2678.66697165784
"AML-0024"	"2020-09-15-AML0024:AACCCAATCGCCTCTA"	-2.8762403530186	-16.0917330018249	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCCAATCGCCTCTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.39705530392	33.4939473796526	0.0142442754634323	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2342.48713597417	2342.48713597417
"AML-0024"	"2020-09-15-AML0024:AACCTGAAGATGGTCG"	-0.471389214426833	-16.2608633271423	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGAAGATGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.61935221544	39.6172192876133	0.0149973232344727	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.72268566448	2636.72268566448
"AML-0024"	"2020-09-15-AML0024:AACCTGAAGCCTGTCG"	1.33404030379598	-16.1808939210144	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGAAGCCTGTCG"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2995.38279438277	40.4516328942203	0.0135046622321792	4208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	2982.52816375941	2982.52816375941
"AML-0024"	"2020-09-15-AML0024:AACCTGAAGGACGGAG"	-0.25712881508525	-15.9598531953064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGAAGGACGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2885.83220170253	38.2113775402631	0.013241025419884	2886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.4171895678	2878.4171895678
"AML-0024"	"2020-09-15-AML0024:AACCTGACACCGTGGT"	-1.23532758179362	-16.354500793573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGACACCGTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.17995268138	38.1368759192207	0.0152475538108868	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2496.34513592993	2496.34513592993
"AML-0024"	"2020-09-15-AML0024:AACCTGAGTTAGGAGC"	-0.716860811144668	-16.1104784241882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGAGTTAGGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.07182866614	36.013603893449	0.0135845447505543	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.03585837915	2643.03585837915
"AML-0024"	"2020-09-15-AML0024:AACCTGAGTTATGACC"	1.07196058806722	-16.2491598359314	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGAGTTATGACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3056.03687560352	36.9294742953809	0.0120841062456381	3754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3044.04678680991	3044.04678680991
"AML-0024"	"2020-09-15-AML0024:AACCTGATCGTGCTCT"	-0.15608192506488	-16.258101486322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTGATCGTGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.67744065328	39.1186991600515	0.0159169378832942	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.55116968476	2449.55116968476
"AML-0024"	"2020-09-15-AML0024:AACCTTTAGGTTGGAC"	-1.96887026253398	-15.9632177582947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTAGGTTGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.38464436711	37.4413204887894	0.0140577969344291	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.48110568371	2658.48110568371
"AML-0024"	"2020-09-15-AML0024:AACCTTTAGGTTTACC"	-0.362884561449844	-16.2020960084167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTAGGTTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2332.74044489467	37.5172521538353	0.0160829089391166	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2326.5983696769	2326.5983696769
"AML-0024"	"2020-09-15-AML0024:AACCTTTGTAGAGATT"	-2.49109492722209	-15.5267648926941	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTGTAGAGATT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.35795615609	39.1525892397126	0.0132390430310311	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.05453681751	2947.05453681751
"AML-0024"	"2020-09-15-AML0024:AACCTTTGTCAAAGAT"	-1.48864791813548	-15.8242798081604	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTGTCAAAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.90892900589	41.1177479930497	0.0148176927765987	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.36776039703	2765.36776039703
"AML-0024"	"2020-09-15-AML0024:AACCTTTGTGTTCAGT"	-2.10509310188945	-16.6499586335388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTGTGTTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.7874514405	32.6799315435582	0.0130887919693379	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.0556430836	2490.0556430836
"AML-0024"	"2020-09-15-AML0024:AACCTTTGTTAAGCAA"	-1.78493843498881	-15.990242981073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTGTTAAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.26051368238	35.5226485199392	0.0135207941256463	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.50640913043	2619.50640913043
"AML-0024"	"2020-09-15-AML0024:AACCTTTGTTAGTTCG"	-1.87875614586528	-16.3618002167908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTGTTAGTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.47479586965	39.3893616546944	0.0167794609441598	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2342.41025029733	2342.41025029733
"AML-0024"	"2020-09-15-AML0024:AACCTTTTCTGGGCGT"	-0.72038839283641	-15.677589439508	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACCTTTTCTGGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.52194619541	36.7379642012616	0.013212614362397	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.33169554925	2773.33169554925
"AML-0024"	"2020-09-15-AML0024:AACGAAACAAATACAG"	-1.69105730477031	-16.1977663270203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAACAAATACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.8025858803	38.8665103083174	0.0139867835541131	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.92333776364	2774.92333776364
"AML-0024"	"2020-09-15-AML0024:AACGAAACAAGAATAC"	-1.04110215130504	-16.8914575806824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAACAAGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.66506713167	37.2871980731713	0.0143984635489835	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.02360707087	2578.02360707087
"AML-0024"	"2020-09-15-AML0024:AACGAAAGTACTCGTA"	-1.72680876675304	-15.4941950074402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAAGTACTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.0555461192	37.2149194389298	0.013896246286922	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.02365124816	2671.02365124816
"AML-0024"	"2020-09-15-AML0024:AACGAAAGTATGGAGC"	-2.60655413094218	-15.8275575867859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAAGTATGGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1909.83934402823	49.061145548983	0.0256886243873809	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1906.59117519843	1906.59117519843
"AML-0024"	"2020-09-15-AML0024:AACGAAATCACTCCGT"	-2.52465329590495	-16.1767626038757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCACTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2854.02378093288	39.0306408396174	0.0136756536859898	3006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.67052946479	2843.67052946479
"AML-0024"	"2020-09-15-AML0024:AACGAAATCAGCACCG"	-2.45215712013896	-15.9681101075378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCAGCACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.6747964107	41.6296755010564	0.0149120791413743	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.14671971125	2781.14671971125
"AML-0024"	"2020-09-15-AML0024:AACGAAATCCGATAAC"	-1.07240353050883	-17.3637914887634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCCGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.4592954775	31.5349607335826	0.0107172122251789	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.39674218749	2935.39674218749
"AML-0024"	"2020-09-15-AML0024:AACGAAATCGCTCATC"	-2.43435678902324	-15.8418379059997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCGCTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.57210789015	36.6431372518604	0.0130376079478593	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.75853008939	2797.75853008939
"AML-0024"	"2020-09-15-AML0024:AACGAAATCGGTCGAC"	-1.64781008186992	-16.6975507966247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCGGTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2297.590372313	49.6709412008922	0.02161871054103	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2289.12576217297	2289.12576217297
"AML-0024"	"2020-09-15-AML0024:AACGAAATCTTTGCTA"	-1.22975061360057	-16.2074880830017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGAAATCTTTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.05044976341	35.4033669487433	0.0135954996386341	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.04142802315	2598.04142802315
"AML-0024"	"2020-09-15-AML0024:AACGGGAAGTTACTCG"	-0.730245749384719	-15.8084812394348	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGAAGTTACTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.49964260354	34.8833062961371	0.0143464163781598	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2418.32651265598	2418.32651265598
"AML-0024"	"2020-09-15-AML0024:AACGGGACAATCCTAG"	-1.22715721550639	-16.024666809198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGACAATCCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.79873915615	36.4677395822314	0.0140002139259502	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.48318708556	2601.48318708556
"AML-0024"	"2020-09-15-AML0024:AACGGGAGTACTAGCT"	-1.32924507084544	-15.5992794266907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGAGTACTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.02773362244	34.2663962361587	0.0130388259597727	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.25704669279	2625.25704669279
"AML-0024"	"2020-09-15-AML0024:AACGGGAGTCCATAGT"	-1.72888372364696	-16.4700403443542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGAGTCCATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.45706325338	34.6624942708722	0.0126116193461075	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.90412023923	2738.90412023923
"AML-0024"	"2020-09-15-AML0024:AACGGGATCGATAACC"	-0.913540641695815	-16.2462454072204	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGATCGATAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.47054364029	39.3712774572754	0.0148600547953934	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.29099203969	2639.29099203969
"AML-0024"	"2020-09-15-AML0024:AACGGGATCGCCGAGT"	-0.791884343058425	-16.0071001282898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGGGATCGCCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.31563648108	43.0027478248065	0.0155732822632358	2551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.96297605001	2753.96297605001
"AML-0024"	"2020-09-15-AML0024:AACGTCAAGGCTTTCA"	0.158467819064301	-16.1993246308533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGTCAAGGCTTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.99165336721	40.7171218235402	0.0147793993400215	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.02502848433	2746.02502848433
"AML-0024"	"2020-09-15-AML0024:AACGTCAAGGGTTAAT"	-1.57204709473308	-16.6178903809753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGTCAAGGGTTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.2050696142	41.4721136805716	0.0174677892029397	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2367.39540377691	2367.39540377691
"AML-0024"	"2020-09-15-AML0024:AACGTCAGTGCATTAC"	0.227779959409875	-16.4098215333191	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGTCAGTGCATTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2974.96851755037	40.0964629954882	0.0134779453157051	2982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2968.33500121431	2968.33500121431
"AML-0024"	"2020-09-15-AML0024:AACGTCAGTGCTTCAA"	-1.60013995590861	-16.3502779236999	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGTCAGTGCTTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.65605056007	25.7921774540312	0.010338971357691	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.21295039642	2490.21295039642
"AML-0024"	"2020-09-15-AML0024:AACGTCATCGCTGTCT"	-1.49329457703288	-16.5678568116394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACGTCATCGCTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.6548525424	40.054625642871	0.0149031880358377	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.51637971944	2683.51637971944
"AML-0024"	"2020-09-15-AML0024:AACTTCTTCGTGACTA"	-0.590091328055221	-16.3971815339294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AACTTCTTCGTGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.70386703832	37.6623281558937	0.0131149762996754	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2860.828050733	2860.828050733
"AML-0024"	"2020-09-15-AML0024:AAGAACAAGTACGAGC"	-1.153925160796	-17.3461885682312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACAAGTACGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2939.22270882513	43.9393943125359	0.0149493245886425	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2931.38222715871	2931.38222715871
"AML-0024"	"2020-09-15-AML0024:AAGAACACAAACACCT"	-1.21249030056651	-16.244845413324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACACAAACACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.48947629498	45.024673135878	0.0182323810520664	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.04075064312	2462.04075064312
"AML-0024"	"2020-09-15-AML0024:AAGAACACACCTGCAG"	-1.17758152905162	-16.0309324494568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACACACCTGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.63708247356	41.0800874336348	0.0147949070092511	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.92210104297	2775.92210104297
"AML-0024"	"2020-09-15-AML0024:AAGAACACATCTATCT"	-1.31997356835063	-16.2914686433044	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACACATCTATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.75047447051	34.4857700627984	0.0125688434074726	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.83350150864	2740.83350150864
"AML-0024"	"2020-09-15-AML0024:AAGAACACATGGCTAT"	-1.73007486286815	-15.4940223923889	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACACATGGCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.04274913225	33.3512005243095	0.0127731346165793	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.19945244807	2604.19945244807
"AML-0024"	"2020-09-15-AML0024:AAGAACAGTAACTGCT"	-2.72783837738689	-15.7046804658142	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACAGTAACTGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.17587667473	36.1801870282822	0.0124665728631639	2886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2895.7793188801	2895.7793188801
"AML-0024"	"2020-09-15-AML0024:AAGAACAGTCACCACG"	-0.623792509466964	-15.8841600648132	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACAGTCACCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.22278663928	37.8315271522614	0.0140992866267527	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.851106314	2679.851106314
"AML-0024"	"2020-09-15-AML0024:AAGAACAGTGACACGA"	-1.79006276550944	-16.0386114350525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACAGTGACACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3035.19020832743	36.2184730261871	0.0119328511692009	3652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3024.96693640764	3024.96693640764
"AML-0024"	"2020-09-15-AML0024:AAGAACAGTGGACCAA"	-1.54097841206248	-16.3388223878113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACAGTGGACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.9598891554	35.7271386463744	0.0132422793941384	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.53929671891	2691.53929671891
"AML-0024"	"2020-09-15-AML0024:AAGAACATCACTCTTA"	-1.12291965904887	-16.0405302277771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACATCACTCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.65209893223	36.3977164820824	0.0142867687850069	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.16238496642	2540.16238496642
"AML-0024"	"2020-09-15-AML0024:AAGAACATCATCACTT"	-2.09104714813884	-16.1206064454285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACATCATCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.56796254134	35.0094186775007	0.0119667083881686	2712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.92198022962	2912.92198022962
"AML-0024"	"2020-09-15-AML0024:AAGAACATCGATACAC"	-2.38260040703471	-15.5097046128479	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACATCGATACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.60465910138	37.9168691850879	0.0141607421604252	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.39859259788	2667.39859259788
"AML-0024"	"2020-09-15-AML0024:AAGAACATCTACCCAC"	-0.680193821818191	-16.369788192865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACATCTACCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.00032465927	39.7251859239104	0.0141019458095786	2838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.59304363479	2804.59304363479
"AML-0024"	"2020-09-15-AML0024:AAGAACATCTAGTTCT"	-2.28409538689311	-15.8985777131286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGAACATCTAGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.08132783058	39.4386129948205	0.0162628001552844	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2421.10350118998	2421.10350118998
"AML-0024"	"2020-09-15-AML0024:AAGACAAAGAAATTCG"	-0.0306574356859506	-16.0788622132507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAAAGAAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.29899730599	37.7834827320524	0.0137981581884318	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.61800659378	2730.61800659378
"AML-0024"	"2020-09-15-AML0024:AAGACAAAGACATATG"	-1.02196560326274	-15.7206506959167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAAAGACATATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.96598707936	38.6364167163132	0.0139232037063553	2714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.54544245246	2768.54544245246
"AML-0024"	"2020-09-15-AML0024:AAGACAAAGCACCAGA"	-0.593560735613662	-16.3639478913513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAAAGCACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.43720638876	34.7574762253085	0.0144135937412028	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.3807595977	2409.3807595977
"AML-0024"	"2020-09-15-AML0024:AAGACAAAGCTGAGTG"	-1.68359599533733	-16.4754095307556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAAAGCTGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.96791991426	38.1814760957451	0.0166225552236578	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.87530056179	2294.87530056179
"AML-0024"	"2020-09-15-AML0024:AAGACAAAGTGAGCCA"	-0.12706052783187	-16.4013815156189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAAAGTGAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.66650964797	40.9837534024646	0.0150749469480799	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.96973243407	2710.96973243407
"AML-0024"	"2020-09-15-AML0024:AAGACAACACAATGCT"	-2.22537146034892	-16.1597185364929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAACACAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.36251584664	32.7893490480334	0.0123344159619218	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.91868566541	2650.91868566541
"AML-0024"	"2020-09-15-AML0024:AAGACAACAGAGTGTG"	-2.5576323074406	-15.4433059922424	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAACAGAGTGTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.90214217472	41.1355360797771	0.0149806999484688	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.18579623088	2740.18579623088
"AML-0024"	"2020-09-15-AML0024:AAGACAACAGCGCGTT"	-0.722372869879562	-15.9097481003967	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACAACAGCGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3057.02261931823	42.6474156475869	0.0139506379109155	3732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3049.49825772396	3049.49825772396
"AML-0024"	"2020-09-15-AML0024:AAGACTCAGGCAGGGA"	-0.580054263502914	-16.3609953156677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCAGGCAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.9828248116	34.051169893665	0.0138083564699063	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2454.54064170479	2454.54064170479
"AML-0024"	"2020-09-15-AML0024:AAGACTCCAGAACTCT"	-0.735748271376449	-16.626078628656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCCAGAACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.8629991594	37.7829836407944	0.0139995930332745	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.31859792588	2691.31859792588
"AML-0024"	"2020-09-15-AML0024:AAGACTCCATGCCGCA"	-0.779134373099166	-16.2522382966247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCCATGCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.6087474063	38.1440969018411	0.0136589477266618	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.54203370023	2783.54203370023
"AML-0024"	"2020-09-15-AML0024:AAGACTCTCAAGTGGG"	-1.54557547989543	-15.8014402619568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCTCAAGTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.79608846526	34.2840114918346	0.0131366629152992	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.50745853444	2602.50745853444
"AML-0024"	"2020-09-15-AML0024:AAGACTCTCATCGCTC"	1.07014729556386	-16.2294874421326	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCTCATCGCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2978.4223906323	48.2912832165339	0.0162137121210273	3810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2965.59921928811	2965.59921928811
"AML-0024"	"2020-09-15-AML0024:AAGACTCTCCAAATGC"	-1.29231105271037	-16.8188276520935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCTCCAAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.58517436411	35.2245159420261	0.0136128913903993	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.19176904424	2581.19176904424
"AML-0024"	"2020-09-15-AML0024:AAGACTCTCCGCAGTG"	-1.83614001694377	-17.0147180787292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGACTCTCCGCAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1720.81503305334	49.1305885501128	0.0285507667043899	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1714.47292531665	1714.47292531665
"AML-0024"	"2020-09-15-AML0024:AAGATAGCAACGTAAA"	-1.82184813442882	-15.3645115128723	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGATAGCAACGTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.07375547793	39.619006130909	0.015261125015154	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.6862843105	2590.6862843105
"AML-0024"	"2020-09-15-AML0024:AAGATAGCAACTTGGT"	-0.900274435908157	-16.0230341187683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGATAGCAACTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.87850701329	47.2258858776165	0.0179437940435972	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.83328147183	2619.83328147183
"AML-0024"	"2020-09-15-AML0024:AAGATAGCATCGGCCA"	-2.15113959732707	-16.7400026551453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGATAGCATCGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2259.51254158089	41.6731231682182	0.0184434130819478	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2251.29597183637	2251.29597183637
"AML-0024"	"2020-09-15-AML0024:AAGATAGTCCCTCGTA"	-1.85967395725902	-16.4446916810242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGATAGTCCCTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.12384074802	31.0045497060011	0.0130703756580534	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2360.2447666135	2360.2447666135
"AML-0024"	"2020-09-15-AML0024:AAGATAGTCGGTCTGG"	-0.630203287035781	-16.729760192987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGATAGTCGGTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.62302458471	42.4049899112606	0.0154671118279231	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.70165132329	2729.70165132329
"AML-0024"	"2020-09-15-AML0024:AAGCATCCATAATGCC"	0.876768131821793	-16.2594804993835	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCATCCATAATGCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3014.44791229996	33.4540326326273	0.0110978970630488	3506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3001.95394311368	3001.95394311368
"AML-0024"	"2020-09-15-AML0024:AAGCATCGTGACTATC"	-1.15771136704143	-16.5086298218933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCATCGTGACTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2344.37704364822	33.5867499588939	0.0143265137533627	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2339.68714049884	2339.68714049884
"AML-0024"	"2020-09-15-AML0024:AAGCATCGTTGTGGAG"	-0.520861784846145	-16.5917463532654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCATCGTTGTGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3064.58964113565	38.1945148470606	0.0124631742972631	3588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3060.58132130452	3060.58132130452
"AML-0024"	"2020-09-15-AML0024:AAGCATCGTTGTTGAC"	-1.79248044911082	-16.7090826264587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCATCGTTGTTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.91233779682	44.0974864471678	0.0198198759106323	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2217.2469765787	2217.2469765787
"AML-0024"	"2020-09-15-AML0024:AAGCATCGTTTCCCAC"	-2.21369920197185	-15.7692690125671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCATCGTTTCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.96736259268	36.1162207500579	0.0136753756451583	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.6252422279	2634.6252422279
"AML-0024"	"2020-09-15-AML0024:AAGCCATGTACAGAGC"	-1.15427360954936	-15.9707994691101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCCATGTACAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2297.91406842402	35.1282267624758	0.0152870062658905	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.14936177274	2294.14936177274
"AML-0024"	"2020-09-15-AML0024:AAGCCATGTCCACATA"	-2.22665892067607	-15.6349468461243	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCCATGTCCACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.60923606229	29.2275865714002	0.0124023898931319	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2348.74886305898	2348.74886305898
"AML-0024"	"2020-09-15-AML0024:AAGCGAGAGACAACAT"	-2.48672662201579	-15.7101860276428	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGAGACAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.2414049772	37.648537631086	0.0145403737012376	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.35594154324	2581.35594154324
"AML-0024"	"2020-09-15-AML0024:AAGCGAGAGATGGTAT"	-0.906210343272048	-16.8312616578308	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGAGATGGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2428.21223600529	44.3452655217423	0.0182625162925197	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2420.62953372502	2420.62953372502
"AML-0024"	"2020-09-15-AML0024:AAGCGAGCACTCATAG"	1.0057855444843	-16.2274198762146	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGCACTCATAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2775.54213908704	41.1857178398887	0.0148388011336178	3217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2769.29349030413	2769.29349030413
"AML-0024"	"2020-09-15-AML0024:AAGCGAGCATCGCTCT"	-2.02800307694133	-16.6892843476501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGCATCGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.35030102512	40.1651605106781	0.0165469155785695	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.10583381845	2423.10583381845
"AML-0024"	"2020-09-15-AML0024:AAGCGAGGTACGGATG"	-0.955368856818038	-17.3887548676697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGGTACGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.89439967394	46.2614262007041	0.0164228471631947	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.15891856087	2809.15891856087
"AML-0024"	"2020-09-15-AML0024:AAGCGAGGTGATGAAT"	-0.520923177630264	-16.5338640443054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGAGGTGATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.00517897269	35.5032322794891	0.0127297118510789	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.58863186338	2781.58863186338
"AML-0024"	"2020-09-15-AML0024:AAGCGTTAGAAAGCGA"	-2.83003077927287	-15.8886327973572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGTTAGAAAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2963.27759120022	39.0418678458269	0.013175231359278	3280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2959.29481617396	2959.29481617396
"AML-0024"	"2020-09-15-AML0024:AAGCGTTCAGACGCTC"	-1.66923747482951	-16.3727998963562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGTTCAGACGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.05672295038	42.6321021751938	0.0161665472737713	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.94996710926	2629.94996710926
"AML-0024"	"2020-09-15-AML0024:AAGCGTTCATAGCACT"	0.488147904246491	-16.2272291413513	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGTTCATAGCACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3073.33213046689	39.8748165633217	0.0129744573220806	4169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3064.38193989542	3064.38193989542
"AML-0024"	"2020-09-15-AML0024:AAGCGTTGTATGTCAC"	-1.93852935257609	-16.473361038324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGTTGTATGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.43050524386	38.93183760852	0.0138084047597948	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.53986566956	2811.53986566956
"AML-0024"	"2020-09-15-AML0024:AAGCGTTTCCCAAGCG"	-2.8472560447758	-15.7036476365295	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGCGTTTCCCAAGCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.10528906247	30.3800889735545	0.0133181441116384	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2277.90022735639	2277.90022735639
"AML-0024"	"2020-09-15-AML0024:AAGGAATGTACTGAGG"	-1.77899215641673	13.6252136000427	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGAATGTACTGAGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1687.47201111182	45.3520778871441	0.0268757511760228	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1687.47201111182	1687.47201111182
"AML-0024"	"2020-09-15-AML0024:AAGGTAAAGCCTGTGC"	1.9808929162914	-10.3175335160461	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00099304865938431	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAAAGCCTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.19124048949	46.8090437028463	0.0203500660635874	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2292.76212104699	2292.76212104699
"AML-0024"	"2020-09-15-AML0024:AAGGTAAAGCTCGTGC"	-0.133152718574363	-16.3574381104675	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAAAGCTCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.74351782428	47.6763682993281	0.0166540830509199	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.64042429068	2849.64042429068
"AML-0024"	"2020-09-15-AML0024:AAGGTAAAGTATAACG"	-1.74691448631938	-15.521061920282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAAAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.6898829834	41.6078205749459	0.0153608653527802	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.90927613679	2701.90927613679
"AML-0024"	"2020-09-15-AML0024:AAGGTAACAAGTGTCT"	-2.3126839202946	-16.5407839051453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAACAAGTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.52529637587	36.2372912278051	0.0140862720684829	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.31763514741	2565.31763514741
"AML-0024"	"2020-09-15-AML0024:AAGGTAACACGGCGTT"	-0.72185061398204	-16.3091287842956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAACACGGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.29584157586	35.1804632006139	0.0123992932584268	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.60576292507	2829.60576292507
"AML-0024"	"2020-09-15-AML0024:AAGGTAACAGCTACCG"	-0.937322060496169	-17.4814481965271	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAACAGCTACCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3033.05343422824	46.6746341741735	0.0153886620154616	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3015.71419859182	3015.71419859182
"AML-0024"	"2020-09-15-AML0024:AAGGTAACAGCTTTGA"	-0.864513258368331	-15.7256784669128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAACAGCTTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1980.64334310621	40.9638816792426	0.0206821090843138	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1978.89296654203	1978.89296654203
"AML-0024"	"2020-09-15-AML0024:AAGGTAAGTGAAGCGT"	-2.20854936066325	-15.4233112565246	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAAGTGAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.10637861473	34.5174038937908	0.0135516145629392	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.11089303975	2539.11089303975
"AML-0024"	"2020-09-15-AML0024:AAGGTAAGTGTAACGG"	-0.651372651488143	-15.8008156052795	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAAGTGTAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.36318551668	36.9514605377433	0.0140855298807838	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.90122762524	2614.90122762524
"AML-0024"	"2020-09-15-AML0024:AAGGTAATCCGACATA"	-2.2118857902592	-15.8386621705261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGGTAATCCGACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.09172680596	33.8548424479419	0.0121995399722905	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2767.15348016299	2767.15348016299
"AML-0024"	"2020-09-15-AML0024:AAGTACCAGCAGATAT"	-1.32969532433208	-16.5817327729431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCAGCAGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.28496200129	34.1810047754738	0.0116886709809845	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.06303810862	2916.06303810862
"AML-0024"	"2020-09-15-AML0024:AAGTACCAGTATAGAC"	-2.25524506989177	13.6554803618225	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCAGTATAGAC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2080.23163894286	36.8096949623957	0.0176949981306417	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2075.33865206576	2075.33865206576
"AML-0024"	"2020-09-15-AML0024:AAGTACCAGTATAGGT"	-1.74975262108501	-16.3171491852966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCAGTATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.76815513727	37.1009570989809	0.0153514754901567	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.18700252714	2409.18700252714
"AML-0024"	"2020-09-15-AML0024:AAGTACCCATAGAATG"	-0.980225424200851	-16.1390352479187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCCATAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.81912307992	43.6182912682433	0.0173790576648078	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.91185053484	2501.91185053484
"AML-0024"	"2020-09-15-AML0024:AAGTACCTCCGATTAG"	0.956947227090043	-16.2378626099792	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCTCCGATTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2989.83611209545	35.4856305241975	0.0118687544045105	3613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2973.12101586092	2973.12101586092
"AML-0024"	"2020-09-15-AML0024:AAGTACCTCCGTGTAA"	0.681279798119706	10.9963598021301	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCTCCGTGTAA"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1552.76320916926	47.1457182690581	0.0303624647922212	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1551.13199834298	1551.13199834298
"AML-0024"	"2020-09-15-AML0024:AAGTACCTCGATACTG"	-2.65523586693462	-16.1497507325378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTACCTCGATACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.75582892824	42.320801311337	0.0154808270963719	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.80730650017	2723.80730650017
"AML-0024"	"2020-09-15-AML0024:AAGTCGTAGCCTCAAT"	-2.8902419609135	13.26792810047	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTAGCCTCAAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1969.77189576854	25.8795441066005	0.0131383456948467	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1964.36575392434	1964.36575392434
"AML-0024"	"2020-09-15-AML0024:AAGTCGTAGGGTCAAC"	-2.69703517380412	-15.7649641267029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTAGGGTCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.03162899325	36.9781115196506	0.0141568391091432	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.80972404231	2603.80972404231
"AML-0024"	"2020-09-15-AML0024:AAGTCGTAGGTAAACT"	-1.57464478436168	-16.909935974237	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTAGGTAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.93997156781	36.587410509591	0.0128244585845543	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.802986394	2844.802986394
"AML-0024"	"2020-09-15-AML0024:AAGTCGTCATATGCGT"	-0.441788147122222	-15.8252439728943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTCATATGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.38133217837	34.6474524996138	0.013033289122303	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.78251471785	2653.78251471785
"AML-0024"	"2020-09-15-AML0024:AAGTCGTGTGGTCTCG"	-2.45645080033	-15.5149898759094	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTGTGGTCTCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.94905635944	35.7320504398214	0.0135711134833835	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.85654790901	2625.85654790901
"AML-0024"	"2020-09-15-AML0024:AAGTCGTTCATTGTGG"	-2.04815779152568	-15.6501817933288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTTCATTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.86559414116	36.3503880885717	0.0143798737451948	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2521.99723525608	2521.99723525608
"AML-0024"	"2020-09-15-AML0024:AAGTCGTTCGTCGATA"	-0.225047062069732	-16.1034364930359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTTCGTCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.13985492983	38.2528755182856	0.0148316406515018	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.13038243191	2577.13038243191
"AML-0024"	"2020-09-15-AML0024:AAGTCGTTCTTAGCTT"	-1.09848771515544	-16.0683355561462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTCGTTCTTAGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2872.21514853622	36.6606495977127	0.0127638939640006	2520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2862.85199798636	2862.85199798636
"AML-0024"	"2020-09-15-AML0024:AAGTGAAAGCTGACAG"	-0.363041381270248	-16.2219000092712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAAGCTGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.9466873002	35.2043078631737	0.0126727802315702	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.9369705921	2771.9369705921
"AML-0024"	"2020-09-15-AML0024:AAGTGAAAGGCACGAT"	-0.679358105093795	-15.7475910416809	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAAGGCACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.25465244831	35.2010356936775	0.0125125664194825	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.01761153861	2810.01761153861
"AML-0024"	"2020-09-15-AML0024:AAGTGAAAGTGGATAT"	-1.30329070511516	-16.2939729920593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAAGTGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.94388419845	42.2716713663805	0.0160002154546918	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.89360557974	2629.89360557974
"AML-0024"	"2020-09-15-AML0024:AAGTGAACAAGCGCAA"	-1.76284585419353	-16.1021185151306	"2020-09-15-AML0024"	"AML0024"	"CD11c+"	"CD11c+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAACAAGCGCAA"	"CD11c+"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.79480478664	39.5121029511198	0.0146081702320619	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.64066166446	2689.64066166446
"AML-0024"	"2020-09-15-AML0024:AAGTGAACAGGACGAT"	-1.65995262089427	-16.5835676423279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAACAGGACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.80526647844	37.4195016309523	0.0131397683933722	2951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2837.93094662298	2837.93094662298
"AML-0024"	"2020-09-15-AML0024:AAGTGAAGTACCTATG"	-2.66516695442851	-16.0176973572937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAGTACCTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.71285824985	41.4228738258083	0.0150261837034802	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.26502878478	2746.26502878478
"AML-0024"	"2020-09-15-AML0024:AAGTGAAGTATCAGGG"	-0.85875109854396	-16.6510992280212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAGTATCAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.8040609667	37.9728964257636	0.0129388182777884	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2926.71284728485	2926.71284728485
"AML-0024"	"2020-09-15-AML0024:AAGTGAAGTCTGTGTA"	-0.987230281264144	-16.4000940552917	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAAGTCTGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3133.4377174632	36.6770285155582	0.0117050446897829	3271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3123.76310152574	3123.76310152574
"AML-0024"	"2020-09-15-AML0024:AAGTGAATCCGTTGGG"	-1.14476321163829	-16.7292909852234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAATCCGTTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.66086955009	33.2124681013081	0.0118672714020714	3276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.41136308292	2793.41136308292
"AML-0024"	"2020-09-15-AML0024:AAGTGAATCTTCGGAA"	-2.27473102036174	-16.1026735535828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTGAATCTTCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.23869442196	42.4268509915886	0.0161488375919811	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.46012770591	2619.46012770591
"AML-0024"	"2020-09-15-AML0024:AAGTTCGAGGAACTAT"	-1.89680478993114	-16.6145868531433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGAGGAACTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.66024600851	39.8179516303548	0.0153816831280778	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.97264584046	2583.97264584046
"AML-0024"	"2020-09-15-AML0024:AAGTTCGAGGTAATCA"	-2.320628742606	-15.4221554032532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGAGGTAATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.88133635284	35.0035567633947	0.0157257065737156	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2220.3450204805	2220.3450204805
"AML-0024"	"2020-09-15-AML0024:AAGTTCGAGTTGTCAC"	-2.09031567993816	-16.7960329285828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGAGTTGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1808.48258320279	48.3546769542421	0.026737706740093	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1797.30421583475	1797.30421583475
"AML-0024"	"2020-09-15-AML0024:AAGTTCGCAAGTGCAG"	0.187820662825745	-16.0493688813415	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGCAAGTGCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2835.6603390549	36.3140421558412	0.0128062030757691	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2826.2532521236	2826.2532521236
"AML-0024"	"2020-09-15-AML0024:AAGTTCGCATGTGCCG"	-1.81975112381633	-16.3395815125671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGCATGTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.35644662757	42.5490159206563	0.016775645228111	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.42580969917	2524.42580969917
"AML-0024"	"2020-09-15-AML0024:AAGTTCGCATTAAAGG"	-0.803398291498977	-16.3597040406433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGCATTAAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.42845613216	38.6892470490832	0.0134738676725374	3442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.05421307261	2864.05421307261
"AML-0024"	"2020-09-15-AML0024:AAGTTCGGTAACTAAG"	-1.16745768013652	-15.930054687616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGGTAACTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.42681436726	33.9205419839838	0.0139738680413422	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2424.73342047107	2424.73342047107
"AML-0024"	"2020-09-15-AML0024:AAGTTCGGTAGCACGA"	-1.96236072006877	-16.898970626947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGGTAGCACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.79293414806	41.0397813584245	0.0161079736144835	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.13883193052	2538.13883193052
"AML-0024"	"2020-09-15-AML0024:AAGTTCGGTCTCAAGT"	-2.7205904525822	-16.2585916749206	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGGTCTCAAGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.67843490852	36.1246481327891	0.0151804746401283	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2373.74873977035	2373.74873977035
"AML-0024"	"2020-09-15-AML0024:AAGTTCGTCCTATTGT"	-0.74836758795436	-16.0104379883972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGTCCTATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2892.02020399634	36.8457583621697	0.0127404913393255	2637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.16419855764	2886.16419855764
"AML-0024"	"2020-09-15-AML0024:AAGTTCGTCGATACGT"	1.26781811293904	-16.1715517274109	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGTCGATACGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2215.78767661565	47.8132582301303	0.0215784475808438	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2212.1232824547	2212.1232824547
"AML-0024"	"2020-09-15-AML0024:AAGTTCGTCGTCAAAC"	-2.64216981354411	-15.5779113999573	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGTCGTCAAAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.94354370339	38.820435873518	0.0142150268770749	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.3972853704	2719.3972853704
"AML-0024"	"2020-09-15-AML0024:AAGTTCGTCTTGGATG"	-0.0757217359846414	-16.428059600946	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AAGTTCGTCTTGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.90186046108	45.1228351857623	0.0175172959336601	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.07878927904	2566.07878927904
"AML-0024"	"2020-09-15-AML0024:AATAGAGTCACGGACC"	0.245280628173989	-16.2440119019714	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATAGAGTCACGGACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2825.47973506138	38.9861408304023	0.0137980606785542	3117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2817.63502367322	2817.63502367322
"AML-0024"	"2020-09-15-AML0024:AATAGAGTCTCCTGTG"	-0.962023119360763	-15.7220192185608	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATAGAGTCTCCTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.85080824911	40.4580280391106	0.0145070607288996	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.30463885601	2781.30463885601
"AML-0024"	"2020-09-15-AML0024:AATCACGAGAGAGTGA"	-1.98406086388286	-16.437134765741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGAGAGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1969.49995746065	48.251082305037	0.0244991537685784	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1969.49995746065	1969.49995746065
"AML-0024"	"2020-09-15-AML0024:AATCACGAGCGGCTCT"	-0.826614956290084	-16.3761625519958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGAGCGGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.8470212067	41.363608358888	0.0170864197516577	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2414.43138533001	2414.43138533001
"AML-0024"	"2020-09-15-AML0024:AATCACGAGTCTTCGA"	0.0424682200769007	-15.9561186066833	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGAGTCTTCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2594.58926457113	34.7991783623132	0.0134122108795765	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2588.43076583338	2588.43076583338
"AML-0024"	"2020-09-15-AML0024:AATCACGCAGGTACGA"	-0.590982894331771	-16.3546438447204	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGCAGGTACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.37491172374	34.4305322113285	0.0120286591635175	2944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.22139043978	2852.22139043978
"AML-0024"	"2020-09-15-AML0024:AATCACGGTAGCCAGA"	-2.14774833145793	-15.8999691239563	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGGTAGCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.89700493875	39.0696718915372	0.018957605255338	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2053.41308058973	2053.41308058973
"AML-0024"	"2020-09-15-AML0024:AATCACGGTTGTAAAG"	-1.53431842747386	-16.7094221345154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCACGGTTGTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2953.37040560515	33.5700068330114	0.0113666767870699	3100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.61559246571	2939.61559246571
"AML-0024"	"2020-09-15-AML0024:AATCGACAGGATACCG"	-0.94946668568309	-17.3507585755554	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	52	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.2	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACAGGATACCG"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2844.92563014635	40.2383102816702	0.0141438882813961	3456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	2840.52791351745	2840.52791351745
"AML-0024"	"2020-09-15-AML0024:AATCGACCAAGACCGA"	0.243878443806809	-16.1466760865417	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACCAAGACCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2936.50772434253	41.2853754733547	0.014059345095916	3164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2925.76387792542	2925.76387792542
"AML-0024"	"2020-09-15-AML0024:AATCGACCACCCGTAG"	-0.226884464651901	-16.6575918427673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACCACCCGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.94748756825	39.610202865254	0.0151187010629816	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.64295586747	2604.64295586747
"AML-0024"	"2020-09-15-AML0024:AATCGACCAGCTCTGG"	-2.08120809021648	-16.5670271149841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACCAGCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.75345332972	33.7877557067234	0.0133667133011789	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.28494090311	2524.28494090311
"AML-0024"	"2020-09-15-AML0024:AATCGACGTAACTAAG"	-0.974920253187972	-16.9721975556579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACGTAACTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.20728303622	37.0082626446401	0.0132541243873548	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.99411541663	2785.99411541663
"AML-0024"	"2020-09-15-AML0024:AATCGACGTCGTACTA"	-0.616171757609207	-16.0221224061218	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACGTCGTACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.77474313955	33.618357000303	0.0144609094276817	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2315.68850695414	2315.68850695414
"AML-0024"	"2020-09-15-AML0024:AATCGACTCGTGCTCT"	-1.62842414799388	-15.9522543183533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACTCGTGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.47055713661	32.1373685040609	0.0125562563767151	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.1169894274	2553.1169894274
"AML-0024"	"2020-09-15-AML0024:AATCGACTCTTCCGTG"	-2.72675810280498	-16.346573852655	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGACTCTTCCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.34199217214	37.9195829421094	0.0145211094738945	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.51852557837	2599.51852557837
"AML-0024"	"2020-09-15-AML0024:AATCGTGCAAAGCTCT"	-2.87379203262981	-15.4813375703064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGCAAAGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2799.08682196791	41.2928293802293	0.0147522502896849	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.78194934406	2794.78194934406
"AML-0024"	"2020-09-15-AML0024:AATCGTGCACGACAAG"	-2.33327899399455	-16.317219757196	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGCACGACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.41640449197	37.5170746120141	0.0140966571592075	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.55167984487	2657.55167984487
"AML-0024"	"2020-09-15-AML0024:AATCGTGCACTTCCTG"	-0.71186206761058	-16.1662569276062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGCACTTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.68866716501	36.4001252639998	0.0139748468685965	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.59417602172	2595.59417602172
"AML-0024"	"2020-09-15-AML0024:AATCGTGGTCAGTCGC"	-0.306013713509399	-16.6246023408142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGGTCAGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.62897169308	35.5260735022052	0.0134638381838921	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.75602446745	2628.75602446745
"AML-0024"	"2020-09-15-AML0024:AATCGTGGTCCTGAAT"	-1.54843626442607	-15.8389673463074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGGTCCTGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.53022191644	38.9397423670142	0.0140803893800987	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.80484236535	2758.80484236535
"AML-0024"	"2020-09-15-AML0024:AATCGTGGTCGTGGTC"	-2.12289724770244	13.9033622511658	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGGTCGTGGTC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1902.07126727758	40.8397067781207	0.0214711759126535	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1898.604347992	1898.604347992
"AML-0024"	"2020-09-15-AML0024:AATCGTGGTTCCATTT"	0.89696623858754	-16.2176428071228	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGGTTCCATTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2816.35712102949	39.2535363763944	0.0139376984840778	3253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2807.2998831065	2807.2998831065
"AML-0024"	"2020-09-15-AML0024:AATCGTGTCGGAATGG"	-1.59621200981792	-16.0228719941345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGTCGGAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.25223357834	37.7953588243104	0.0143422167877224	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.2209355284	2630.2209355284
"AML-0024"	"2020-09-15-AML0024:AATCGTGTCTCTATGT"	-1.69501684132274	-16.3938589326111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATCGTGTCTCTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.77332809327	40.6956687274348	0.0170576425883507	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2377.21973843709	2377.21973843709
"AML-0024"	"2020-09-15-AML0024:AATGAAGAGACCTCAT"	-1.06797526302989	-16.3960581055847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGAGACCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2561.842964401	37.7849895770862	0.0147491435275858	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.0841104121	2556.0841104121
"AML-0024"	"2020-09-15-AML0024:AATGAAGAGCCAGACA"	-2.65115318718608	-16.1656828156677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGAGCCAGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.3637054417	35.9714935148324	0.0132620464735847	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.43852519782	2704.43852519782
"AML-0024"	"2020-09-15-AML0024:AATGAAGAGGCCTTCG"	-1.10521254959758	-16.1865835419861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGAGGCCTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.52659471902	34.6971006562349	0.0121978471639715	2742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.29453167912	2838.29453167912
"AML-0024"	"2020-09-15-AML0024:AATGAAGGTCCAGAAG"	-0.321007589728194	-15.8263616791931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGGTCCAGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2884.37425844231	43.1910255281207	0.0149741405442461	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.3193666959	2875.3193666959
"AML-0024"	"2020-09-15-AML0024:AATGAAGGTTACCCTC"	-2.14040909233745	-16.0038061372009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGGTTACCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.55541168677	37.2071985296952	0.0140960096404714	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.56153911194	2633.56153911194
"AML-0024"	"2020-09-15-AML0024:AATGAAGTCACGTCCT"	-1.64039955559428	-16.864338897821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGTCACGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.57338398111	35.540886568889	0.0147010580131233	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2410.99037750216	2410.99037750216
"AML-0024"	"2020-09-15-AML0024:AATGAAGTCCGTGACG"	-2.78405843201335	-16.2109136811462	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGTCCGTGACG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.34616214902	39.5763361450525	0.0153853072838335	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.91854232378	2565.91854232378
"AML-0024"	"2020-09-15-AML0024:AATGAAGTCTGGACTA"	-2.37724075737651	-15.56450083172	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGAAGTCTGGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.99100982998	33.6239281780386	0.0125182578999648	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.74289382829	2676.74289382829
"AML-0024"	"2020-09-15-AML0024:AATGACCAGAACTCCT"	-2.50238476219829	-15.4772062531677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCAGAACTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2823.94770086254	38.7813142841359	0.0137330143445258	2869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.84127581254	2815.84127581254
"AML-0024"	"2020-09-15-AML0024:AATGACCAGACCTGGA"	-0.728188256651717	-16.0739507905212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCAGACCTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.68994889748	34.5116935075021	0.012793054117137	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.48540116409	2689.48540116409
"AML-0024"	"2020-09-15-AML0024:AATGACCCAACAGCCC"	-2.60873566094096	-16.1345682374206	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCCAACAGCCC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.79881307325	28.4429505895596	0.0118275801014765	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2394.98727018049	2394.98727018049
"AML-0024"	"2020-09-15-AML0024:AATGACCGTCACAATC"	-1.91651175442393	-16.7772703400818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.166666666666667	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCGTCACAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1216.6507206381	49.5886423478428	0.0407583224229177	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1216.6507206381	1216.6507206381
"AML-0024"	"2020-09-15-AML0024:AATGACCGTGAATTGA"	-0.387166420847732	-16.4823122254578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCGTGAATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.60222215874	47.2520438248322	0.0176011341400276	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.97181518766	2675.97181518766
"AML-0024"	"2020-09-15-AML0024:AATGACCGTGCACAAG"	-2.62536487999614	-16.1713915101257	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCGTGCACAAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.73092099489	29.5136043939036	0.0111551799012144	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.23053838231	2641.23053838231
"AML-0024"	"2020-09-15-AML0024:AATGACCTCACGACTA"	0.326808055012864	10.5291795500549	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCTCACGACTA"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2194.3377187975	34.5358139441731	0.0157386047044293	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2189.19362787433	2189.19362787433
"AML-0024"	"2020-09-15-AML0024:AATGACCTCTAGCCAA"	-1.43058572235759	-16.3177194825378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGACCTCTAGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.18102138352	40.5201799217875	0.016619020313264	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2429.98905181846	2429.98905181846
"AML-0024"	"2020-09-15-AML0024:AATGCCAAGAAGAGCA"	-2.06120953980144	-15.9552335969177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCAAGAAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.47985541706	29.299957457303	0.0104587428678623	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.99198326046	2785.99198326046
"AML-0024"	"2020-09-15-AML0024:AATGCCAAGCTGTACT"	-2.64322958412822	-15.7220487824646	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCAAGCTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3010.61071797487	32.9047156766392	0.0109295816560346	3295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3007.63125652016	3007.63125652016
"AML-0024"	"2020-09-15-AML0024:AATGCCAAGTAAAGCT"	-0.611065904528457	-16.3896894684997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCAAGTAAAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.22151376494	45.2910879860627	0.0165524201013038	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.29158631348	2727.29158631348
"AML-0024"	"2020-09-15-AML0024:AATGCCACACGGTGCT"	-0.206415424973327	-15.9646291962829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCACACGGTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.29671156682	32.1850449564381	0.0136071913511088	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2356.64545338474	2356.64545338474
"AML-0024"	"2020-09-15-AML0024:AATGCCAGTGACCTGC"	-0.357172946364242	-15.7993355027405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCAGTGACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.21645917367	33.0943437926483	0.012761890229246	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.11177961024	2587.11177961024
"AML-0024"	"2020-09-15-AML0024:AATGCCAGTTAAGAAC"	-0.731296877295333	-15.695601486322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCAGTTAAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.95933896057	37.8510226658216	0.0135087694312734	2847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.08139224567	2794.08139224567
"AML-0024"	"2020-09-15-AML0024:AATGCCATCAGTAGGG"	-0.153820524842101	-15.8871278992859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGCCATCAGTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2952.05906451823	37.4555430028158	0.012687938209979	3180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2937.77742444195	2937.77742444195
"AML-0024"	"2020-09-15-AML0024:AATGGAAAGACGCAGT"	-2.2149535221165	-15.6936292878357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGAAAGACGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.21625473965	36.4892193719448	0.0127932863825838	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.98884235315	2842.98884235315
"AML-0024"	"2020-09-15-AML0024:AATGGAAAGTATCCTG"	0.0682225516879975	-16.395308517572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGAAAGTATCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.60093280798	30.7013054487531	0.0120890274736225	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.86573854295	2534.86573854295
"AML-0024"	"2020-09-15-AML0024:AATGGAAGTGCCTTTC"	-1.7806525034016	-15.6657562485901	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGAAGTGCCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.25563022028	33.5790451005806	0.0135823515538272	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.52840857895	2468.52840857895
"AML-0024"	"2020-09-15-AML0024:AATGGAATCAAGCCCG"	-1.17335770550426	-16.3013048402038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGAATCAAGCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.95768400913	38.003238651915	0.0140235542702987	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.69508484186	2704.69508484186
"AML-0024"	"2020-09-15-AML0024:AATGGAATCCATTTCA"	-2.17499504509624	-16.1668100587097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGAATCCATTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2297.73103804632	34.9029953243954	0.0151902005702426	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2291.7367658357	2291.7367658357
"AML-0024"	"2020-09-15-AML0024:AATGGCTAGGTTCTTG"	-1.79486201229747	-16.8516149750915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.18301178827	43.0026408279288	0.0155852803689372	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.46007720493	2745.46007720493
"AML-0024"	"2020-09-15-AML0024:AATGGCTCAACCGCCA"	-1.47067521038707	-15.5009145966736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTCAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.48833235652	33.1213659753807	0.0121036021179956	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.21532174545	2732.21532174545
"AML-0024"	"2020-09-15-AML0024:AATGGCTCACTCATAG"	-1.96566949310954	-16.1542253724304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTCACTCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.99007970129	39.5325142993299	0.0148451601831593	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.54224340649	2654.54224340649
"AML-0024"	"2020-09-15-AML0024:AATGGCTCAGTAGATA"	-0.253602067858535	-16.3355703583923	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTCAGTAGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.8550037768	36.2329911936357	0.0133167666572974	2419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.69914843446	2713.69914843446
"AML-0024"	"2020-09-15-AML0024:AATGGCTCATGGACAG"	-2.72704396668132	-15.4827995530334	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTCATGGACAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2987.00721008852	36.030890359495	0.0120625387972958	2911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.09758871347	2973.09758871347
"AML-0024"	"2020-09-15-AML0024:AATGGCTGTACCCGCA"	-0.326605777174789	-16.3890810242859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTGTACCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.72560439203	37.0022537339677	0.012912001650562	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.5825703556	2855.5825703556
"AML-0024"	"2020-09-15-AML0024:AATGGCTGTGTTGAGG"	-0.218017945916015	-16.1730642548767	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTGTGTTGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3093.05113671529	39.9067985094932	0.0129020817133572	3507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3089.12733942569	3089.12733942569
"AML-0024"	"2020-09-15-AML0024:AATGGCTGTTGTATGC"	-2.15928516808208	-16.8672418824402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTGTTGTATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.47370351666	41.3355679242072	0.0192305529751678	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2137.75098407618	2137.75098407618
"AML-0024"	"2020-09-15-AML0024:AATGGCTTCTGAGTCA"	-1.65927503529246	-16.0047312012878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTTCTGAGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.00589489778	37.2952194568525	0.0127243754513681	2515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.21874813935	2921.21874813935
"AML-0024"	"2020-09-15-AML0024:AATGGCTTCTGATTCT"	-1.95311532440837	-16.5290994874206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATGGCTTCTGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3001.3699893258	32.8615033176231	0.0109488345104046	3109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.32642142373	2988.32642142373
"AML-0024"	"2020-09-15-AML0024:AATTCCTAGTCGGCCT"	0.868714531033677	-16.2438249818054	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTCCTAGTCGGCCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2925.00719908197	38.7728318725574	0.0132556363911605	3594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2914.42802024248	2914.42802024248
"AML-0024"	"2020-09-15-AML0024:AATTCCTTCGTTGTTT"	-1.56988404217418	-16.4767675629822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTCCTTCGTTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.2251048254	32.3233488573021	0.0123219882265702	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.74159836047	2615.74159836047
"AML-0024"	"2020-09-15-AML0024:AATTTCCAGACACACG"	-1.07255039635356	-16.6643076173035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCAGACACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3048.29897471368	33.9491560088562	0.01113708212038	2864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3037.02833796552	3037.02833796552
"AML-0024"	"2020-09-15-AML0024:AATTTCCAGGCTCTCG"	-1.32768891277965	-15.5947618714538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCAGGCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.05776612637	35.9386965759837	0.0127439575911061	2579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.17607850941	2815.17607850941
"AML-0024"	"2020-09-15-AML0024:AATTTCCAGTAAACAC"	-1.76914368096049	-15.6761780015198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCAGTAAACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3211.79675905109	38.6398754088412	0.012030610374069	4670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3200.82046036928	3200.82046036928
"AML-0024"	"2020-09-15-AML0024:AATTTCCAGTCCTACA"	-0.659498373896438	-16.6107607117859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCAGTCCTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.20500904169	41.922442776351	0.0170263818903803	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.52012150201	2453.52012150201
"AML-0024"	"2020-09-15-AML0024:AATTTCCCAAGTAGTA"	-1.87950406494792	-16.6037092438904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCCAAGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2963.32676234994	35.2888907569571	0.0119085384728118	2985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.67005378231	2957.67005378231
"AML-0024"	"2020-09-15-AML0024:AATTTCCCAGGTTCGC"	-2.78017578545268	-16.2242422333923	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCCAGGTTCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.40140857938	44.0138030847403	0.0173734027839755	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.09638252853	2518.09638252853
"AML-0024"	"2020-09-15-AML0024:AATTTCCCATCTAACG"	-1.77496288242992	-15.86989977276	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCCATCTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2993.82884349824	34.6805513613457	0.0115840127055567	2895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2982.79039941468	2982.79039941468
"AML-0024"	"2020-09-15-AML0024:AATTTCCGTTACAGCT"	-2.01966748657878	-16.3304376832214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCGTTACAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.74550611277	41.7203608405499	0.0157094724417387	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.30702430279	2649.30702430279
"AML-0024"	"2020-09-15-AML0024:AATTTCCTCATGAGGG"	0.175518629222554	-16.2222872010437	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AATTTCCTCATGAGGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2803.9051667507	38.4739202624869	0.0137215483314909	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2799.64537016417	2799.64537016417
"AML-0024"	"2020-09-15-AML0024:ACAAAGAGTTACACTG"	0.05682918111552	-15.9583444825378	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAAGAGTTACACTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2714.69239372344	36.6845039507209	0.0135133188701372	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2706.7669173887	2706.7669173887
"AML-0024"	"2020-09-15-AML0024:ACAAAGATCCCTTTGG"	-1.7417942089146	-15.7509412995544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAAGATCCCTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.12396081363	32.9960208043746	0.011737661257323	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.26968528743	2801.26968528743
"AML-0024"	"2020-09-15-AML0024:ACAACCAAGAATTGCA"	-0.462435523897964	-16.6939554444519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCAAGAATTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.28422374409	43.0632137204923	0.0160846627110326	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.01787376172	2668.01787376172
"AML-0024"	"2020-09-15-AML0024:ACAACCAAGATGCGAC"	-0.927934924990493	-15.8146238557068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCAAGATGCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.53982377217	35.2137183298593	0.0135774735390963	2410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.82755817966	2588.82755817966
"AML-0024"	"2020-09-15-AML0024:ACAACCAAGCATTGTC"	-1.89036081257518	-15.3870325318542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCAAGCATTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.31847692118	39.6429461173937	0.0144349413407568	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.18164741802	2738.18164741802
"AML-0024"	"2020-09-15-AML0024:ACAACCACATCGAACT"	-0.0487368431990922	-15.9835386506286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCACATCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.77764611032	35.5716181697567	0.0128196283473816	3811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.86536983603	2762.86536983603
"AML-0024"	"2020-09-15-AML0024:ACAACCAGTCACTAGT"	-1.30766592446025	-16.3903436890808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCAGTCACTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.69922921673	41.2159980360971	0.015329344981478	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.77423870205	2683.77423870205
"AML-0024"	"2020-09-15-AML0024:ACAACCAGTGTATACC"	-0.169271836907226	-16.2495908967224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAACCAGTGTATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2893.17921023119	39.5358380139161	0.013665188065124	3064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.20652883057	2887.20652883057
"AML-0024"	"2020-09-15-AML0024:ACAAGCTAGATAGGGA"	-1.48025093498881	-16.7305898896423	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTAGATAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.889373511	36.9588681190524	0.0134060033290287	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.03332244802	2753.03332244802
"AML-0024"	"2020-09-15-AML0024:ACAAGCTAGATGGCGT"	0.859804649918717	-16.2358255616394	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTAGATGGCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3045.4024879702	36.4964159526335	0.0119841026257777	3301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3032.44565283565	3032.44565283565
"AML-0024"	"2020-09-15-AML0024:ACAAGCTAGCTCCGAC"	-2.18761477890666	-16.3436918488708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTAGCTCCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.02990962238	35.6968830804069	0.012896133440002	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.791997483	2763.791997483
"AML-0024"	"2020-09-15-AML0024:ACAAGCTCACAGAGAC"	-0.558731178671676	-16.6015959016052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTCACAGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.67713248661	43.1638516194172	0.0160778557306211	2527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.21024095818	2674.21024095818
"AML-0024"	"2020-09-15-AML0024:ACAAGCTCAGAGACTG"	-0.579789678484756	-15.8451938859192	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTCAGAGACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.87685811037	39.2996430484896	0.0143383468440767	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.37314136144	2735.37314136144
"AML-0024"	"2020-09-15-AML0024:ACAAGCTCATTCGATG"	1.17418076571767	-16.1984529725281	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTCATTCGATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3151.6151434472	40.2437067658837	0.0127692325789074	3989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3141.48261414861	3141.48261414861
"AML-0024"	"2020-09-15-AML0024:ACAAGCTCATTGGCAT"	-0.925231317908126	-16.4059095612732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTCATTGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.1025322122	30.1222032586061	0.0113879151722008	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.33677750472	2637.33677750472
"AML-0024"	"2020-09-15-AML0024:ACAAGCTGTGAGACGT"	-1.74883757057841	-16.3122358552185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTGTGAGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.98582896504	42.6121290424623	0.0157241150809767	2414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.04125847709	2698.04125847709
"AML-0024"	"2020-09-15-AML0024:ACAAGCTTCCTACCAC"	-2.09623179855998	-16.0534258118835	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAAGCTTCCTACCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.13006318652	32.0495153275727	0.0120300115112394	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.16492016366	2654.16492016366
"AML-0024"	"2020-09-15-AML0024:ACACAGTAGGACAGCT"	-1.89546952667888	-15.9897928467956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTAGGACAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2890.60348833335	35.0699448057777	0.012132395517864	2780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.71389377163	2881.71389377163
"AML-0024"	"2020-09-15-AML0024:ACACAGTAGGCACTAG"	-2.10651193085368	-15.9065847626892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTAGGCACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.542380588	39.2562242847106	0.0147107366816714	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.37233977759	2658.37233977759
"AML-0024"	"2020-09-15-AML0024:ACACAGTCAACGTATC"	-1.65043805065807	-16.1062708131042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTCAACGTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.60311545609	30.0471038786028	0.0120303757200895	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2494.90474836493	2494.90474836493
"AML-0024"	"2020-09-15-AML0024:ACACAGTCATTAAAGG"	-0.215378652245361	-16.2012472382751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTCATTAAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.33388080053	35.3134549256313	0.0122008919426615	2852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.98757020574	2887.98757020574
"AML-0024"	"2020-09-15-AML0024:ACACAGTGTAGCCCTG"	-1.55350981178935	-15.7533855668274	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTGTAGCCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.8697131544	34.4641651450187	0.0132205169177082	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.09489205476	2601.09489205476
"AML-0024"	"2020-09-15-AML0024:ACACAGTGTCTAACGT"	-1.42129061642345	-16.6585016480652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTGTCTAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.46628465638	36.718425807135	0.0154964964240712	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2362.414154071	2362.414154071
"AML-0024"	"2020-09-15-AML0024:ACACAGTGTTGCAACT"	9.1367002921993	7.80979249561159	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTGTTGCAACT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1627.0355221039	34.8361437924497	0.0214108071515264	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1623.39798807951	1623.39798807951
"AML-0024"	"2020-09-15-AML0024:ACACAGTTCCAGCAAT"	-1.29989741268809	-15.5412531129089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTTCCAGCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.45904446923	39.9133490812716	0.0145751126575668	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.96054576657	2731.96054576657
"AML-0024"	"2020-09-15-AML0024:ACACAGTTCCGCGATG"	-2.45635376396831	-15.9583406678406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACAGTTCCGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.86993093088	51.4200324691832	0.0202451439906363	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.21751008016	2534.21751008016
"AML-0024"	"2020-09-15-AML0024:ACACCAAAGCAAACAT"	-2.96346388283427	-15.7588672867981	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAAAGCAAACAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.6089289282	31.672076070491	0.0113739763388181	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.1607376349	2778.1607376349
"AML-0024"	"2020-09-15-AML0024:ACACCAACAATTGGTC"	-0.843682627112228	-16.0675363770691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAACAATTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.99764694654	32.9992226951596	0.0120084610450183	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.33244659765	2746.33244659765
"AML-0024"	"2020-09-15-AML0024:ACACCAACACTATGTG"	-2.29310737076457	-16.1129923096863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAACACTATGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.26062458781	34.982521015944	0.0124525722924255	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.12986471323	2801.12986471323
"AML-0024"	"2020-09-15-AML0024:ACACCAACATAGCTGT"	-0.51099662008937	-16.3567037812439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAACATAGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.92568716904	35.6973248889514	0.0123523331577153	3026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.64635578066	2877.64635578066
"AML-0024"	"2020-09-15-AML0024:ACACCAAGTCCCTGTT"	-2.91250691834148	-16.1330366364685	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAAGTCCCTGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2958.78824930739	37.5088769946223	0.0126771075974776	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.38577585481	2947.38577585481
"AML-0024"	"2020-09-15-AML0024:ACACCAATCTAGATCG"	-0.23705236139949	-16.5746526948181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACCAATCTAGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3137.72301773198	34.1555620526614	0.0108854611639206	3381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3128.55187691459	3128.55187691459
"AML-0024"	"2020-09-15-AML0024:ACACGCGAGAGTACCG"	0.00552537020985481	-16.3072118989197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGAGAGTACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2990.36466980116	31.8909809838999	0.0106645792421098	3037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2981.73358272961	2981.73358272961
"AML-0024"	"2020-09-15-AML0024:ACACGCGAGGTGCCTC"	-1.01384649697002	-15.8893146744934	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGAGGTGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3100.07637437484	34.1509411284347	0.0110161612180673	3558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3094.46294853982	3094.46294853982
"AML-0024"	"2020-09-15-AML0024:ACACGCGCACTAGTAC"	-0.867345790297347	-16.1144666901794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGCACTAGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2978.01770843816	40.9607486823721	0.0137543670631342	3536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2967.05019194878	2967.05019194878
"AML-0024"	"2020-09-15-AML0024:ACACGCGCACTCTGCT"	-0.670788804919082	-16.4389353028503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGCACTCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.6786115427	36.8987242247068	0.0137955730701508	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.4020583475	2670.4020583475
"AML-0024"	"2020-09-15-AML0024:ACACGCGCATGGTACT"	-0.117437790066558	-16.1918916932312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGCATGGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.94561014208	37.0719019500322	0.013160318685799	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.56903283359	2809.56903283359
"AML-0024"	"2020-09-15-AML0024:ACACGCGGTCTAATCG"	-1.50512013855632	-15.1043014756409	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGGTCTAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.86772158995	37.2428265205896	0.0124772117207095	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2979.87296483842	2979.87296483842
"AML-0024"	"2020-09-15-AML0024:ACACGCGGTTCCGTTC"	-2.98426065865214	13.4752664335999	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACGCGGTTCCGTTC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2156.85564728812	39.208983950258	0.0181787705633229	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2151.99678765212	2151.99678765212
"AML-0024"	"2020-09-15-AML0024:ACACTGAAGTTGAAAC"	-0.512479047209579	-16.1177225342956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACTGAAGTTGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.14499672875	35.2030961301108	0.0130374836065321	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.31313416997	2693.31313416997
"AML-0024"	"2020-09-15-AML0024:ACACTGACAAGCCTGC"	-0.756946782500106	-16.3158388367859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACTGACAAGCCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.11117392678	42.2414554162304	0.0156211977612183	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.05453403745	2697.05453403745
"AML-0024"	"2020-09-15-AML0024:ACACTGACACAACGTT"	-0.475381891161758	-16.6254339448181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACTGACACAACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.5343560658	42.1200350358541	0.0152634573812314	2640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.64829269739	2753.64829269739
"AML-0024"	"2020-09-15-AML0024:ACACTGAGTGTCGATT"	-0.947556595236617	-17.508366607782	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACTGAGTGTCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.71978575819	45.3340052982182	0.0186504448451172	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.22106739063	2423.22106739063
"AML-0024"	"2020-09-15-AML0024:ACACTGATCTGCTGAA"	-0.597952048212844	-16.5863867036072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACACTGATCTGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.69803493566	35.2509035892567	0.0128667112724649	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.53588484446	2725.53588484446
"AML-0024"	"2020-09-15-AML0024:ACAGAAAAGACGGTCA"	-1.28023157540019	-15.6202965012756	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAAAGACGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.58993744669	38.9833498736142	0.014188197933874	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.41395516641	2742.41395516641
"AML-0024"	"2020-09-15-AML0024:ACAGAAACACTTCAGA"	-1.08179519596751	-16.8740701905456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAACACTTCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.43492968722	37.6940721506254	0.0131593396519367	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.33851435872	2858.33851435872
"AML-0024"	"2020-09-15-AML0024:ACAGAAAGTACTCGTA"	-0.412871251732665	-15.9473238221374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAAGTACTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.16879238629	40.0541565903532	0.0153278107051694	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.71480699174	2602.71480699174
"AML-0024"	"2020-09-15-AML0024:ACAGAAAGTCTAACTG"	-2.19499001923259	-15.5612240067688	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAAGTCTAACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.24114279711	35.350044185867	0.0120556401961354	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2927.18804537593	2927.18804537593
"AML-0024"	"2020-09-15-AML0024:ACAGAAATCTCGGTCT"	-3.0024450820988	-15.5987129441467	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAATCTCGGTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.16479675831	38.568141392307	0.0143902126611601	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.91792749542	2674.91792749542
"AML-0024"	"2020-09-15-AML0024:ACAGAAATCTGGGCGT"	-1.92633209648784	-16.7813196412292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGAAATCTGGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.22424003323	39.8875773092427	0.0165493221114948	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2408.22501799326	2408.22501799326
"AML-0024"	"2020-09-15-AML0024:ACAGCCGCACTGGCGT"	-1.56702564182933	-16.2610655060974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGCCGCACTGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.52832886841	31.1463994847721	0.0119861689167482	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.67179067512	2586.67179067512
"AML-0024"	"2020-09-15-AML0024:ACAGCCGCACTTTAGG"	-2.42489347878154	-16.5798616639343	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGCCGCACTTTAGG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1805.48886591176	50.6810901866542	0.0280705636814108	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1797.12577894856	1797.12577894856
"AML-0024"	"2020-09-15-AML0024:ACAGCCGCAGGTGAGT"	-0.403081576258498	-15.8740530244079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGCCGCAGGTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.21673876429	38.7169844704983	0.0140573484742777	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.90607220663	2748.90607220663
"AML-0024"	"2020-09-15-AML0024:ACAGCCGTCGATTGGT"	-0.590071420103866	-16.7080755463806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGCCGTCGATTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.37522667586	33.7125987504279	0.0127971894091061	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.87545645564	2627.87545645564
"AML-0024"	"2020-09-15-AML0024:ACAGGGACAAGACCGA"	-0.864866356283981	-16.3044195405212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGGGACAAGACCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2132.78380099981	40.8205959324401	0.0191395845717245	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2129.01913352508	2129.01913352508
"AML-0024"	"2020-09-15-AML0024:ACAGGGACATCCGTGG"	0.0944910432094752	-16.3970098725525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGGGACATCCGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.28398921374	35.8418105959428	0.0130843719516028	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.42395864335	2731.42395864335
"AML-0024"	"2020-09-15-AML0024:ACAGGGAGTTCCAAAC"	-2.51260481301005	-16.1195974580017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGGGAGTTCCAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.43550800824	37.0845522125754	0.0144893481771825	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.9078486413	2552.9078486413
"AML-0024"	"2020-09-15-AML0024:ACAGGGATCTCTGCCA"	-2.16952429238017	13.9205245741638	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACAGGGATCTCTGCCA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2266.81220130119	33.9184126604607	0.0149630448614097	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2265.22896175306	2265.22896175306
"AML-0024"	"2020-09-15-AML0024:ACATCCCAGCGTGAGT"	-0.37517405572589	-16.2468424073425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCAGCGTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.90460060626	31.7711633889147	0.0121129694848875	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.85335212202	2615.85335212202
"AML-0024"	"2020-09-15-AML0024:ACATCCCAGGTTCATC"	-0.792475561529952	-16.3962049714294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCAGGTTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.67395629282	33.4355601656813	0.0123667131119341	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.92856751977	2699.92856751977
"AML-0024"	"2020-09-15-AML0024:ACATCCCCAAATGCTC"	3.50253333625142	-10.384677909967	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00427350427350427	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCCAAATGCTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1983.43907754683	33.9580195310682	0.01712077770146	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1978.6093225143	1978.6093225143
"AML-0024"	"2020-09-15-AML0024:ACATCCCCAATAACCC"	-1.39905665341075	-15.5522651902405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCCAATAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.6627267788	36.3383016273438	0.0133662411557756	2831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.44860448839	2710.44860448839
"AML-0024"	"2020-09-15-AML0024:ACATCCCGTACCGGAA"	-0.486797551543075	-16.0573301545349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCGTACCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.5416729063	38.7351346067836	0.0146916451216511	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.00842529944	2632.00842529944
"AML-0024"	"2020-09-15-AML0024:ACATCCCGTAGAATAC"	-0.794266859919387	-15.6485166779724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCGTAGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.56435650834	34.7390480211611	0.0123866111114708	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.2701913721	2797.2701913721
"AML-0024"	"2020-09-15-AML0024:ACATCCCTCACGGTCG"	-2.06417284432109	-15.6832494965759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCCCTCACGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.59364798675	44.1940653901488	0.0157017569558435	2792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.8179015705	2797.8179015705
"AML-0024"	"2020-09-15-AML0024:ACATCGAAGTAGCTCT"	-0.860320608050186	-15.9895963898865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCGAAGTAGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.95491813825	29.2734971842536	0.0103845212266066	2775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.18698724518	2812.18698724518
"AML-0024"	"2020-09-15-AML0024:ACATCGACAGTCAGTT"	-1.32272193852122	-15.4463739625183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCGACAGTCAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.62989580132	35.8404639532762	0.012811009779051	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.59414734925	2784.59414734925
"AML-0024"	"2020-09-15-AML0024:ACATCGAGTTCTGAGT"	-1.45977876606639	-16.3197946778503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATCGAGTTCTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.8549256546	40.4393627802488	0.0152609723606884	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.33290401764	2646.33290401764
"AML-0024"	"2020-09-15-AML0024:ACATGCAAGAGAATCT"	-2.55092463913615	-16.1790418854919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATGCAAGAGAATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.08902378929	37.3010455524419	0.013779024341146	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.17374418064	2695.17374418064
"AML-0024"	"2020-09-15-AML0024:ACATGCAAGATACCAA"	-2.57157860222514	-16.2775621644226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATGCAAGATACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.95133841071	41.6159951542164	0.015482421336847	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.0092074168	2681.0092074168
"AML-0024"	"2020-09-15-AML0024:ACATGCAAGCGTGTCC"	-1.6127282184666	-16.5009184113708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATGCAAGCGTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.59153245825	37.6255879075145	0.0147923074233351	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.42120494769	2536.42120494769
"AML-0024"	"2020-09-15-AML0024:ACATGCACAAACGAGC"	-0.624550024897415	-16.5035009614197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATGCACAAACGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.27331804862	37.64171318096	0.0141071429700794	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.38111219439	2659.38111219439
"AML-0024"	"2020-09-15-AML0024:ACATTTCAGGCTCTAT"	-0.730434576899368	-16.0163870087829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCAGGCTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.65314950862	42.1957848552573	0.0172392828059517	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.44230008252	2445.44230008252
"AML-0024"	"2020-09-15-AML0024:ACATTTCAGTTTGCTG"	-1.86250744286235	-16.2416525117126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCAGTTTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.05777473773	43.0939232867704	0.0154788178886949	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.20658283509	2772.20658283509
"AML-0024"	"2020-09-15-AML0024:ACATTTCCAGAACTCT"	-1.7119622034138	-16.9105558625427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCCAGAACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.03844944746	43.5000658512359	0.0173650292117596	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2493.97222062692	2493.97222062692
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTAAGGTCG"	-1.00023291531261	-16.3648195496765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTAAGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.93081906339	35.837751939923	0.0135855541324042	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.2851433895	2635.2851433895
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTCCCGCAA"	-0.129573757678825	-16.1600847474304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTCCCGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.18840048553	35.7451236619185	0.0125457213204389	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.41465233556	2842.41465233556
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTGGTCTGC"	-0.415372709662277	-16.2340708008972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTGGTCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.49079318593	31.7334995650897	0.0126807657600569	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2492.03749802213	2492.03749802213
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTTAATCGC"	-2.16632876816447	-16.2160425416199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTTAATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.26176634986	28.6932429963075	0.0108758135232372	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.15557692491	2632.15557692491
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTTGGGACA"	-1.99871955338176	-16.3288030854431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTTGGGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.30398797614	35.6149812890145	0.0132579862325435	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.83177904578	2679.83177904578
"AML-0024"	"2020-09-15-AML0024:ACATTTCGTTTAGTCG"	-1.32535229149516	-16.5711641541687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCGTTTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1936.3687852702	50.8028151339406	0.0262361258456516	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1925.94685334876	1925.94685334876
"AML-0024"	"2020-09-15-AML0024:ACATTTCTCATAAGGA"	-1.01275048676189	-16.0995092622009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACATTTCTCATAAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.56546487103	31.8518722236145	0.0124393899162499	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.37179336997	2551.37179336997
"AML-0024"	"2020-09-15-AML0024:ACCAAACTCCAACTAG"	-1.8522279066151	-15.8768072358337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAAACTCCAACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.16079308962	46.4579616013982	0.0196592469447069	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2354.92098135595	2354.92098135595
"AML-0024"	"2020-09-15-AML0024:ACCAACAAGCACACAG"	-2.28454456749614	-16.3958196870056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAACAAGCACACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.46290249648	38.8257940276205	0.0146985952333178	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.85878052177	2631.85878052177
"AML-0024"	"2020-09-15-AML0024:ACCAACAAGTTGCCCG"	-0.573714534670669	-16.7897653809753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAACAAGTTGCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.64761466729	32.8604082919257	0.0125678152985472	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.16080424183	2605.16080424183
"AML-0024"	"2020-09-15-AML0024:ACCAACACAGGTCTCG"	-1.62781892243083	-16.3778486481872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAACACAGGTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.03233724861	37.0215687429157	0.0140550927258497	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.46346967473	2624.46346967473
"AML-0024"	"2020-09-15-AML0024:ACCAACATCAAACTGC"	-2.79280267182048	-15.7369089356628	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAACATCAAACTGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2888.33084140224	27.6426492342445	0.00957045807841887	2898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.01473172091	2881.01473172091
"AML-0024"	"2020-09-15-AML0024:ACCAACATCCCTTCCC"	-1.25382886353191	-16.3783712617126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCAACATCCCTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.17300256528	38.5423423831067	0.0136376443862858	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.45387941839	2821.45387941839
"AML-0024"	"2020-09-15-AML0024:ACCACAACATCATCTT"	-1.61053786698039	-17.0693865052429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAACATCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1615.79325102913	50.3744853597565	0.0311763187076515	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1602.86750506597	1602.86750506597
"AML-0024"	"2020-09-15-AML0024:ACCACAAGTCACTCTC"	-1.51433120194133	-16.0986871949402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAAGTCACTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.83698887478	28.8278855286057	0.0108016659124467	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.10762921838	2661.10762921838
"AML-0024"	"2020-09-15-AML0024:ACCACAAGTCCCAAAT"	-2.8883880180424	-16.03187658703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAAGTCCCAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.64983057237	36.1570183739788	0.0138977267229019	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.50433335882	2595.50433335882
"AML-0024"	"2020-09-15-AML0024:ACCACAAGTGAGAGGG"	0.0133292200857818	-16.4008760682312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAAGTGAGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.63371670677	38.1234284235669	0.0136270263672843	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2789.47425528732	2789.47425528732
"AML-0024"	"2020-09-15-AML0024:ACCACAAGTTTCCCAC"	-1.37785361233409	-16.0619459382263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAAGTTTCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.42772566047	39.9106177696505	0.0151899964287763	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.27866935411	2618.27866935411
"AML-0024"	"2020-09-15-AML0024:ACCACAATCACCCTTG"	-1.88275788250621	-15.6645717850891	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCACAATCACCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.53970113507	34.092417605794	0.0122478646853472	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.12917069619	2777.12917069619
"AML-0024"	"2020-09-15-AML0024:ACCATTTAGGGAGAAT"	-1.07084379616435	-16.4794569245544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTAGGGAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.03245105169	34.5318497880897	0.0129282778928774	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.48795484519	2663.48795484519
"AML-0024"	"2020-09-15-AML0024:ACCATTTAGTACAACA"	-2.21245871010478	-16.2777586213318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTAGTACAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.62407884914	34.5265664097237	0.012279936947992	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.42419528099	2809.42419528099
"AML-0024"	"2020-09-15-AML0024:ACCATTTAGTCCCAAT"	-1.41949675503429	-15.0349169007507	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Ery-3"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTAGTCCCAAT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1654.28800223448	52.2738267087851	0.0315989879864799	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1644.34687517591	1644.34687517591
"AML-0024"	"2020-09-15-AML0024:ACCATTTCAGCGTATT"	-0.144133756787139	-16.1890936127869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTCAGCGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.03467266371	39.7116336299901	0.0145568654342706	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.97297574295	2719.97297574295
"AML-0024"	"2020-09-15-AML0024:ACCATTTCATCAACCA"	-1.75999031487163	-16.8786821595398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.166666666666667	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTCATCAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1601.24151611652	50.6967162849151	0.0316608804946985	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1584.66737199872	1584.66737199872
"AML-0024"	"2020-09-15-AML0024:ACCATTTCATCACGGC"	-2.51823506775554	-15.9336920014587	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTCATCACGGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.52171922589	39.5172693998108	0.0149600395530314	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.33887283831	2629.33887283831
"AML-0024"	"2020-09-15-AML0024:ACCATTTGTACCTAAC"	-1.84749863568004	-16.6883993378845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTGTACCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.70707580549	31.26781889062	0.0119401742865808	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.26714145762	2616.26714145762
"AML-0024"	"2020-09-15-AML0024:ACCATTTGTCGAGCAA"	-0.900876144797164	-17.4311437836853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTGTCGAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3250.11012538759	44.2033760760596	0.0136005779406592	3432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3238.26930254902	3238.26930254902
"AML-0024"	"2020-09-15-AML0024:ACCATTTTCAAAGAAC"	-1.80310521546062	-16.5737924805847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCATTTTCAAAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2306.70364334556	47.1767357250854	0.0204520142243595	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2292.58171937582	2292.58171937582
"AML-0024"	"2020-09-15-AML0024:ACCCAAAAGCCACCGT"	-1.63370023194011	-16.0154848328796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCAAAAGCCACCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.50840151404	37.159525115999	0.0153139898847302	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2418.5915078425	2418.5915078425
"AML-0024"	"2020-09-15-AML0024:ACCCAAAAGCTACTGT"	-0.980604271323043	-16.3151293030945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCAAAAGCTACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.56253988352	41.8557362647412	0.0166984607799518	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2496.56168235414	2496.56168235414
"AML-0024"	"2020-09-15-AML0024:ACCCAAAGTGCATTTG"	-1.41225383701976	-15.5604915848938	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCAAAGTGCATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.36550279432	38.6275113666556	0.0139481449190004	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.48864221252	2763.48864221252
"AML-0024"	"2020-09-15-AML0024:ACCCAAATCAACCCGG"	-0.985871891409713	-15.7340660325256	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCAAATCAACCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.7069412819	32.1395636956009	0.0115788749949078	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.25374213758	2771.25374213758
"AML-0024"	"2020-09-15-AML0024:ACCCAAATCGTCACCT"	-1.97054801407512	-15.2977123490539	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCAAATCGTCACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.93297542091	33.5045794088072	0.0120609747266241	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.51925065456	2769.51925065456
"AML-0024"	"2020-09-15-AML0024:ACCCTCAAGCATGAAT"	-0.311693052679855	-15.8902645341125	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTCAAGCATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3037.26416578926	38.996564581229	0.0128393720310776	4071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3031.7521878999	3031.7521878999
"AML-0024"	"2020-09-15-AML0024:ACCCTCAGTCTGTAAC"	-1.48881862583812	-15.7306146851745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTCAGTCTGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.14115137992	34.8619001509557	0.0130708868306122	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.13806750326	2660.13806750326
"AML-0024"	"2020-09-15-AML0024:ACCCTCATCATTCCTA"	-1.92298684540446	-15.5456676713196	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTCATCATTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.77707806207	33.0450562712545	0.0114589496263911	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.36517700888	2877.36517700888
"AML-0024"	"2020-09-15-AML0024:ACCCTCATCCGAGGCT"	-2.33704815331157	-15.6349926224914	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTCATCCGAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.70851607901	31.4284798568071	0.012306995751051	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.90939679016	2548.90939679016
"AML-0024"	"2020-09-15-AML0024:ACCCTTGAGACATCCT"	-1.26321063461955	-16.5016794434753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGAGACATCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.55012687589	39.8450271873009	0.0161019276815399	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.95365536893	2470.95365536893
"AML-0024"	"2020-09-15-AML0024:ACCCTTGAGCTGAAGC"	-1.80070589008983	-16.6825018159119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGAGCTGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.24723494986	37.422425103758	0.0145996159065359	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.78445770653	2557.78445770653
"AML-0024"	"2020-09-15-AML0024:ACCCTTGAGGCTCTCG"	-1.2505091232365	-16.5697946778503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGAGGCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.78003854819	38.0029609124118	0.0137652983511125	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.4077764388	2753.4077764388
"AML-0024"	"2020-09-15-AML0024:ACCCTTGCAAAGGGTC"	-2.27069220963176	-16.2356233826843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGCAAAGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.53899942433	31.0664172582459	0.0131718904227696	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.18570629258	2351.18570629258
"AML-0024"	"2020-09-15-AML0024:ACCCTTGCACGATAGG"	-1.30087480965312	-16.2016344300476	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGCACGATAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.84361733018	44.3349431665093	0.0163607017331094	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.67161119877	2700.67161119877
"AML-0024"	"2020-09-15-AML0024:ACCCTTGCAGTTAAAG"	-1.30344269695933	-15.9060106507507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCCTTGCAGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.72591599093	42.8680535426094	0.0170807709596781	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.43251583264	2502.43251583264
"AML-0024"	"2020-09-15-AML0024:ACCGTTCAGCAACTCT"	-0.049696328968364	-15.9968862763611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCAGCAACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.67224304566	27.7492292148486	0.00970024765413355	2712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.19044500021	2856.19044500021
"AML-0024"	"2020-09-15-AML0024:ACCGTTCAGTGTTCCA"	-0.781612078577834	-15.9517736664978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCAGTGTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.44322421826	39.0223459189595	0.013914471714733	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.45819312052	2798.45819312052
"AML-0024"	"2020-09-15-AML0024:ACCGTTCCAGGTCTCG"	-1.62663326683696	-16.1323099366394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCCAGGTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.05023124222	46.822503408775	0.0184482177824583	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.44782675909	2531.44782675909
"AML-0024"	"2020-09-15-AML0024:ACCGTTCGTAGCTAAA"	-0.111524383456069	-16.3856516114441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCGTAGCTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.13287769694	31.8547015215901	0.0116209986683878	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.87896833619	2735.87896833619
"AML-0024"	"2020-09-15-AML0024:ACCGTTCGTTTCGACA"	-1.05755875530894	-16.0286588898865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCGTTTCGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.77152055103	37.8373198277406	0.013952989601444	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.28384964769	2703.28384964769
"AML-0024"	"2020-09-15-AML0024:ACCGTTCTCACTGTTT"	-1.80626414242442	-16.4485750428406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCTCACTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.05222475268	35.3609172600799	0.012985765362356	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.12629690803	2714.12629690803
"AML-0024"	"2020-09-15-AML0024:ACCGTTCTCCGATGTA"	-0.863967697054702	-16.4996652833191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCGTTCTCCGATGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.04672669436	27.0023059230734	0.0105640893185057	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.54888131512	2547.54888131512
"AML-0024"	"2020-09-15-AML0024:ACCTACCAGCATCGAG"	-2.02756963196452	-16.1994981995788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCAGCATCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.86768636607	36.1734540386686	0.0139189287043886	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.60318690925	2592.60318690925
"AML-0024"	"2020-09-15-AML0024:ACCTACCCAATCGCGC"	-0.0301860001986802	-16.1143999329773	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCCAATCGCGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2680.45045880208	41.0391359781677	0.015310537019404	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2669.82610244124	2669.82610244124
"AML-0024"	"2020-09-15-AML0024:ACCTACCCAGTATTCG"	-1.16834507408794	-16.2270822755066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCCAGTATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.11872939813	35.1849306058989	0.0128500383230763	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.6107472812	2728.6107472812
"AML-0024"	"2020-09-15-AML0024:ACCTACCGTGACGCCT"	-0.176606531173545	-16.2463751069275	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCGTGACGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.60891065456	30.7798390091078	0.0115210871195839	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.62841931802	2656.62841931802
"AML-0024"	"2020-09-15-AML0024:ACCTACCTCGGTATGT"	-2.32677207413371	-16.5851660004822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCTCGGTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.33709602223	36.1591024832018	0.0137417218561101	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.24011272781	2619.24011272781
"AML-0024"	"2020-09-15-AML0024:ACCTACCTCTGGGAGA"	-1.34845040264781	-15.9437866440979	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTACCTCTGGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.08517303906	29.4588735500074	0.0115657198517859	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.08250132691	2540.08250132691
"AML-0024"	"2020-09-15-AML0024:ACCTGAAAGCTGGAGT"	10.2168957191402	-1.47415759479674	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Ery-3"	72	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0434782608695652	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAAAGCTGGAGT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1840.47997756359	43.0547212039329	0.0233932027127665	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1836.12567076847	1836.12567076847
"AML-0024"	"2020-09-15-AML0024:ACCTGAAAGGAGAGGC"	-2.3091016811436	-15.4394598237244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAAAGGAGAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.64646711715	39.6175097866972	0.0144134614111538	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.21638978424	2741.21638978424
"AML-0024"	"2020-09-15-AML0024:ACCTGAACAATAAGGT"	-2.08701668205913	-15.9256096116272	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAACAATAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.90150383854	26.6557253765712	0.0105487789437298	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.90150383854	2526.90150383854
"AML-0024"	"2020-09-15-AML0024:ACCTGAATCCAAGCTA"	-2.59490857544597	-15.9120159379211	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAATCCAAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.62066329488	39.8270578225426	0.0140899903335872	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.94088890994	2815.94088890994
"AML-0024"	"2020-09-15-AML0024:ACCTGAATCGACCACG"	-2.31592307511027	-16.2405328980652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAATCGACCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.89124126141	41.3778949434781	0.017615926279012	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.35808904013	2345.35808904013
"AML-0024"	"2020-09-15-AML0024:ACCTGAATCTAGAGCT"	-1.2142290872639	-16.5503301850525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAATCTAGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.83946766469	41.7358645471665	0.0160841797988867	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.41505743526	2587.41505743526
"AML-0024"	"2020-09-15-AML0024:ACCTGAATCTGGGTCG"	-1.9464250606602	-16.2792444459167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGAATCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.26785522674	37.8519430509278	0.0135657022962951	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.74034209503	2781.74034209503
"AML-0024"	"2020-09-15-AML0024:ACCTGTCAGAATCGTA"	-0.411786089569885	-16.2156515351501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCAGAATCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.39062867058	45.2761703462467	0.0183572585055804	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2459.30921333463	2459.30921333463
"AML-0024"	"2020-09-15-AML0024:ACCTGTCCAATTGCAC"	1.3290454345638	-16.1773424378601	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCCAATTGCAC"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3061.79660503774	32.6710745249646	0.0106705567806853	4314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	3051.5809741783	3051.5809741783
"AML-0024"	"2020-09-15-AML0024:ACCTGTCCATTGTACG"	-0.856285194784957	-16.482918762323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCCATTGTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.56364582137	41.470725381696	0.0160641886357605	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.68522502835	2572.68522502835
"AML-0024"	"2020-09-15-AML0024:ACCTGTCGTGTATTCG"	-2.62300548973735	-15.5652055970398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCGTGTATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.71910564223	36.0265104231644	0.0144933956300168	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.67493762443	2481.67493762443
"AML-0024"	"2020-09-15-AML0024:ACCTGTCGTTTCGATG"	-1.77398059788402	-16.3483438721863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCGTTTCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.42110273338	37.7353999155334	0.0139480688893156	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.3086758005	2699.3086758005
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCACCTACC"	-2.10478315773662	-16.5938406220642	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCACCTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.0601519456	32.1645458003201	0.0119479298325018	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.10730579663	2680.10730579663
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCCGAGGCT"	-0.983077387244064	-17.4921694031921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCCGAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3212.74408419786	41.9051065099101	0.0130434001002519	3590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3197.58077562845	3197.58077562845
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCCGCTAGG"	-1.09889755669292	-16.5881128541199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCCGCTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.71192875033	37.8132376950224	0.015181698557165	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.12707924951	2488.12707924951
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCTCATTGT"	-1.74244854870494	-15.7970295182434	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCTCATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.25946434755	38.1754841322184	0.0135457663196587	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.18096577702	2813.18096577702
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCTCTTCAA"	-1.30905697766002	-16.1206350556579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCTCTTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.40010254024	35.9448160913893	0.0124747743500462	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.04471059338	2877.04471059338
"AML-0024"	"2020-09-15-AML0024:ACCTGTCTCTTCGTAT"	-0.666773180395919	-15.7811660996643	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACCTGTCTCTTCGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.56096010218	34.3963124814917	0.0123747285903121	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.72951661468	2771.72951661468
"AML-0024"	"2020-09-15-AML0024:ACGATCAAGAAGCTCG"	-0.598280350596267	-15.6543112031189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCAAGAAGCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.84768733595	36.7710331896264	0.0141109679465643	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.18227383536	2600.18227383536
"AML-0024"	"2020-09-15-AML0024:ACGATCAAGAGAGCGG"	-2.52815614166911	-16.1853895417419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCAAGAGAGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.72273832932	40.0203958424486	0.0163034281703384	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.5882364364	2449.5882364364
"AML-0024"	"2020-09-15-AML0024:ACGATCAAGGCACTAG"	-1.00123713436778	-17.4259863129822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCAAGGCACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3110.78834845025	45.429046702557	0.0146037086467773	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3102.93341687938	3102.93341687938
"AML-0024"	"2020-09-15-AML0024:ACGATCACATGTTCGA"	-1.58253977719005	-15.6879902116028	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCACATGTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.88849899783	32.1245453192058	0.0114981486665373	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.31475058419	2787.31475058419
"AML-0024"	"2020-09-15-AML0024:ACGATCAGTCGAACGA"	-0.958927492529708	-15.940043472406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCAGTCGAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.66337613126	33.780589958815	0.0131459203071467	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.08911910374	2563.08911910374
"AML-0024"	"2020-09-15-AML0024:ACGATCAGTGGCAACA"	-2.85351071777995	-15.9787225953308	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCAGTGGCAACA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.71303398101	36.2958627394871	0.0148163732796502	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.30926271976	2445.30926271976
"AML-0024"	"2020-09-15-AML0024:ACGATCATCCCAGCGA"	-1.08775756779369	-16.9538927308288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCATCCCAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.31809970342	38.628657440181	0.0153940855265606	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2494.60957655394	2494.60957655394
"AML-0024"	"2020-09-15-AML0024:ACGATCATCCCTCTCC"	-1.38775620880778	-15.9436817399231	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCATCCCTCTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2861.97864418308	33.8678702879604	0.0118337257186723	3083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.50129147207	2852.50129147207
"AML-0024"	"2020-09-15-AML0024:ACGATCATCGGAAGGT"	0.922241051762742	-16.2352228394714	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCATCGGAAGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2666.23335603551	37.7254473266526	0.0141493418950948	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2655.27915536746	2655.27915536746
"AML-0024"	"2020-09-15-AML0024:ACGATCATCTCGGTCT"	-2.71790466728862	-16.0353021851745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATCATCTCGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.91761011856	34.0255244800202	0.0124411515557667	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.1170645582	2726.1170645582
"AML-0024"	"2020-09-15-AML0024:ACGATGTTCAGACCCG"	-1.57284377041515	-16.0953874818054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATGTTCAGACCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.67913408569	31.2242902797559	0.0111727639495084	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.00911365183	2784.00911365183
"AML-0024"	"2020-09-15-AML0024:ACGATGTTCAGTGTCA"	-1.01291904869731	-16.2132654420105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATGTTCAGTGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3125.65464168676	37.603752165938	0.0120306804419202	3680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3114.53300574986	3114.53300574986
"AML-0024"	"2020-09-15-AML0024:ACGATGTTCGTTCATT"	-0.985373358160812	-17.4182996979919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATGTTCGTTCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3084.45013144889	36.9834718448335	0.0119902965743398	2904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3074.44675385811	3074.44675385811
"AML-0024"	"2020-09-15-AML0024:ACGATGTTCTAGGCCG"	-0.41693208637889	-16.0133447877136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATGTTCTAGGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3041.59298278813	34.6618520262067	0.011395953443591	4082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3036.34288950894	3036.34288950894
"AML-0024"	"2020-09-15-AML0024:ACGATGTTCTCAGTCC"	-2.51970444145854	-15.8961248627869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGATGTTCTCAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.92966173595	34.3683359597531	0.0131682996916068	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.19171289621	2599.19171289621
"AML-0024"	"2020-09-15-AML0024:ACGCACGGTCCAGCGT"	-1.86945043030437	-16.7406664124695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGCACGGTCCAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.06932321893	33.8997636795928	0.0141954688458954	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.96689458905	2380.96689458905
"AML-0024"	"2020-09-15-AML0024:ACGCACGGTCCGACGT"	-2.55187116089519	-15.7047157517639	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGCACGGTCCGACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2969.50881131161	38.3600167604139	0.0129179669763197	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2962.23834778395	2962.23834778395
"AML-0024"	"2020-09-15-AML0024:ACGCACGTCCCGTGAG"	-1.98729954186137	-15.5703163377014	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGCACGTCCCGTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.4055148858	35.1253741891384	0.0126105064420319	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.58917751344	2777.58917751344
"AML-0024"	"2020-09-15-AML0024:ACGCACGTCGCCGTGA"	-1.89372513714488	-16.5725298157898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGCACGTCGCCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.69181474318	33.3248242504155	0.0119929903969921	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.37137941248	2772.37137941248
"AML-0024"	"2020-09-15-AML0024:ACGGAAGAGGAGAGTA"	-1.11190460148509	-17.3019399872986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.12616746692	44.9680848252863	0.0160135557106574	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.58619508155	2804.58619508155
"AML-0024"	"2020-09-15-AML0024:ACGGAAGAGTAATACG"	-1.63348982754405	-16.4042368165222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGAGTAATACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.22633949402	35.5067708966042	0.0147807766124498	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.8085138833	2397.8085138833
"AML-0024"	"2020-09-15-AML0024:ACGGAAGAGTCAGAGC"	-1.30854199352916	-16.1492948762146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGAGTCAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.06721848435	37.0104109234248	0.0149171335011366	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2477.09641347329	2477.09641347329
"AML-0024"	"2020-09-15-AML0024:ACGGAAGCACTACAGT"	-1.86652086201366	-16.4870882264343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGCACTACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.2951848433	36.5303154729599	0.0143860058850205	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.21752373636	2534.21752373636
"AML-0024"	"2020-09-15-AML0024:ACGGAAGCAGTTGCGC"	-1.17395291748698	-15.5269565812317	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGCAGTTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.54555476331	34.5852686108724	0.0128543702037095	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.20883559434	2684.20883559434
"AML-0024"	"2020-09-15-AML0024:ACGGAAGTCGACCTAA"	-1.77282951298411	-16.5446520081726	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGAAGTCGACCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.32053206283	38.9794823345365	0.014542843614505	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.38562661054	2676.38562661054
"AML-0024"	"2020-09-15-AML0024:ACGGGTCAGACAAGCC"	-1.57174442234691	-16.9114046326843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGGTCAGACAAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.61557304704	40.6794560213911	0.0172252658246596	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2352.31353243207	2352.31353243207
"AML-0024"	"2020-09-15-AML0024:ACGGGTCAGCGGGTTA"	-1.09644113007243	-15.8402567139831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGGTCAGCGGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.64321761303	36.0080372826635	0.0135692835584178	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.44263605028	2648.44263605028
"AML-0024"	"2020-09-15-AML0024:ACGGGTCCACCGCTAG"	-1.37069962444957	-16.1565351716247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGGTCCACCGCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.83841374193	38.3977014663591	0.0166668379333049	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2297.56673447405	2297.56673447405
"AML-0024"	"2020-09-15-AML0024:ACGGGTCGTGCAATGG"	-2.43802915039714	-15.7311620942322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGGTCGTGCAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1940.63576296446	49.2635128250815	0.0253852442406957	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1938.86635737217	1938.86635737217
"AML-0024"	"2020-09-15-AML0024:ACGGGTCGTGGAACCA"	-0.683452169329482	-16.5003309479919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGGTCGTGGAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.57391693092	30.6896298728985	0.0115566844806063	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.30174959095	2650.30174959095
"AML-0024"	"2020-09-15-AML0024:ACGGTCGCAACCGGAA"	-2.71876678887065	-15.4615593186584	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTCGCAACCGGAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.38866891851	34.5338569819741	0.0128455596399558	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.15947489157	2682.15947489157
"AML-0024"	"2020-09-15-AML0024:ACGGTCGGTACGCTTA"	-2.72221432152446	-15.6106186143127	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTCGGTACGCTTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.36123517256	39.5450804774466	0.0149093871351478	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.14413193018	2644.14413193018
"AML-0024"	"2020-09-15-AML0024:ACGGTCGGTATGCTAC"	-0.040693293244201	-16.032494567987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTCGGTATGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2923.91085161356	42.0270342200071	0.0143735689468147	3182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.11074884819	2915.11074884819
"AML-0024"	"2020-09-15-AML0024:ACGGTCGTCCGTGACG"	-1.51801476898845	-15.5999937287536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTCGTCCGTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.03082468649	43.9102182919565	0.0159846106921526	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.49593081646	2742.49593081646
"AML-0024"	"2020-09-15-AML0024:ACGGTCGTCGATCCAA"	-2.69786034050639	-15.6497316590515	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTCGTCGATCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.39191909507	37.3721013975782	0.0133835444595075	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.54732948317	2785.54732948317
"AML-0024"	"2020-09-15-AML0024:ACGGTTAAGTGAGTTA"	-2.58844862404521	-16.2750349274841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTAAGTGAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2371.1500073547	33.8540550309456	0.0142774834683335	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.43123269644	2368.43123269644
"AML-0024"	"2020-09-15-AML0024:ACGGTTACATAATGAG"	-1.71345625343974	-15.979105972406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTACATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2170.72594047489	41.8980886362986	0.0193014179519744	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2159.85439751991	2159.85439751991
"AML-0024"	"2020-09-15-AML0024:ACGGTTACATCGTGGC"	-0.740962664515334	-15.7991600266662	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTACATCGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2045.3530341182	42.9431709148162	0.020995481072699	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2040.27623125067	2040.27623125067
"AML-0024"	"2020-09-15-AML0024:ACGGTTAGTCACTCTC"	-1.20452521267589	-16.3603410950867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTAGTCACTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.2768326171	38.1899931695306	0.0141220723813885	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.70142924121	2697.70142924121
"AML-0024"	"2020-09-15-AML0024:ACGGTTAGTCGCCACA"	-2.38141785088237	-15.7817573777405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTAGTCGCCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.42506603885	30.6928557792362	0.0113659350023211	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.19507958045	2691.19507958045
"AML-0024"	"2020-09-15-AML0024:ACGGTTAGTTCAGCGC"	-1.02667210522349	-15.526975654718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTAGTTCAGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.72279203783	33.4229207825055	0.0118155518372401	2981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.42124443048	2817.42124443048
"AML-0024"	"2020-09-15-AML0024:ACGGTTATCAGTGTGT"	-1.17406354370769	-15.6773834458557	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGGTTATCAGTGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.36689059324	40.1943660179099	0.0152634887912846	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.12070669971	2628.12070669971
"AML-0024"	"2020-09-15-AML0024:ACGTAACAGAAGTCCG"	-0.950529794127303	-17.4837961426941	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACAGAAGTCCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2894.46254849368	46.2595787617647	0.0159820961531663	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2885.61163445436	2885.61163445436
"AML-0024"	"2020-09-15-AML0024:ACGTAACAGTGGTTAA"	-0.872255424887496	-16.0135450593201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACAGTGGTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.50413181555	34.5221911421666	0.0129709327629776	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.07530845969	2655.07530845969
"AML-0024"	"2020-09-15-AML0024:ACGTAACAGTGTACAA"	-0.85250018063243	-16.1889944306579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACAGTGTACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.4977181026	37.9193802937863	0.0150743051845773	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.36961219217	2509.36961219217
"AML-0024"	"2020-09-15-AML0024:ACGTAACCACCTCTGT"	-1.03195105019267	-15.8416834107605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACCACCTCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2537.8291898	35.2173711853724	0.0138769667111236	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.08742047283	2533.08742047283
"AML-0024"	"2020-09-15-AML0024:ACGTAACTCAGCTAGT"	-2.11731110039409	-16.3801489106384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACTCAGCTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.73826749766	37.454750427396	0.0144739330471836	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.05126319818	2573.05126319818
"AML-0024"	"2020-09-15-AML0024:ACGTAACTCATTACTC"	-1.47358832779582	-15.1273546448913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAACTCATTACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.64360847299	36.8387839746585	0.0140678876100059	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.61149162993	2610.61149162993
"AML-0024"	"2020-09-15-AML0024:ACGTACAAGAGCATTA"	-0.360245714814025	-16.6109705201355	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTACAAGAGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.04853831631	43.8566207033797	0.017479383134138	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2503.85829321001	2503.85829321001
"AML-0024"	"2020-09-15-AML0024:ACGTACAGTCGCATTA"	-1.54426966133769	-15.9080124131409	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTACAGTCGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.57612746434	37.1117935404612	0.014043793537207	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.22330546583	2636.22330546583
"AML-0024"	"2020-09-15-AML0024:ACGTACAGTTAAGTCC"	-2.58780799332317	-16.2534742585388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTACAGTTAAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.51452897727	35.9572942989337	0.0137634810831119	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.03713333783	2604.03713333783
"AML-0024"	"2020-09-15-AML0024:ACGTACATCCGATAAC"	-1.2635067504948	-16.435124420282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTACATCCGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.11688993393	45.6906365720514	0.018474919951427	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2467.83198927265	2467.83198927265
"AML-0024"	"2020-09-15-AML0024:ACGTACATCTTCGACC"	0.0330223507130563	-16.167941116449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTACATCTTCGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3042.23911961955	35.1645198798667	0.0115587626406777	3602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3028.21277052189	3028.21277052189
"AML-0024"	"2020-09-15-AML0024:ACGTAGTCACTGGACC"	-1.29344139519389	-16.4419336549011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTCACTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.16972418095	47.2139616096442	0.0185650061656226	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.52715273288	2534.52715273288
"AML-0024"	"2020-09-15-AML0024:ACGTAGTCATACTGAC"	-2.28693137589152	-16.3095045319763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTCATACTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.75319351872	27.9663504976381	0.0104283834042698	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.65269776917	2672.65269776917
"AML-0024"	"2020-09-15-AML0024:ACGTAGTCATCTCGTC"	0.935534198849839	-16.2183199158874	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTCATCTCGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2978.13056197456	40.0125788042148	0.0134354683152929	3570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2966.49074482888	2966.49074482888
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTCATAACC"	0.0840393687481105	-16.3011865845886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTCATAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2962.58505457656	39.6228476300541	0.0133744169028481	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2953.39959539129	2953.39959539129
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTCGGCTAC"	-0.122776518494445	-16.0199213257995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTCGGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.75376095066	36.0295324644449	0.0136747247497789	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.72721584367	2629.72721584367
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTCGTTGGC"	0.738572497933549	-16.23744299328	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTCGTTGGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2800.57684350704	43.6848175672537	0.0155985070249132	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2795.11202835383	2795.11202835383
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTGACAGGT"	-1.17364070835765	-15.6767740479675	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTGACAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.50265063838	33.1525225463404	0.0133383573490962	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2480.9465038721	2480.9465038721
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTGTTGCCG"	-2.34323034706767	-16.4056215516296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTGTTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.66453147568	38.7678467766361	0.0142914268708142	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.81387832108	2704.81387832108
"AML-0024"	"2020-09-15-AML0024:ACGTAGTGTTTACTGG"	-0.837964217097122	-16.2858553162781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTGTTTACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.70868382515	36.3205483040706	0.0133693202073219	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.37599782346	2710.37599782346
"AML-0024"	"2020-09-15-AML0024:ACGTAGTTCATTTGGG"	-0.247858474881011	-16.1529226533142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTTCATTTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.86883956828	33.6746752768966	0.0130934652493979	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.52082325681	2564.52082325681
"AML-0024"	"2020-09-15-AML0024:ACGTAGTTCCCTAGGG"	-0.965520362288314	-16.4573011628357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTTCCCTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2986.26738856335	33.8974881098083	0.0113511228899419	4105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2974.68081876328	2974.68081876328
"AML-0024"	"2020-09-15-AML0024:ACGTAGTTCTCCAAGA"	-0.406570355326492	-15.8145447007385	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTTCTCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.59318594379	38.5163491795571	0.0138071563171409	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.51090885797	2785.51090885797
"AML-0024"	"2020-09-15-AML0024:ACGTAGTTCTGCTTAT"	-0.842460612685043	-16.0231180421081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTAGTTCTGCTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.90690143439	32.9149634008243	0.0124118095484502	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.99006771929	2643.99006771929
"AML-0024"	"2020-09-15-AML0024:ACGTCCTAGACGACGT"	-2.96329317513164	-15.6652012101379	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTCCTAGACGACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.22025923106	35.2121275486544	0.013261471407593	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.96075661208	2649.96075661208
"AML-0024"	"2020-09-15-AML0024:ACGTCCTCAGGTGACA"	-2.49541101875957	-16.4878969422546	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTCCTCAGGTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.50674179644	41.7719698676776	0.0168333090392644	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.77176551456	2475.77176551456
"AML-0024"	"2020-09-15-AML0024:ACGTCCTTCATTACCT"	-1.75124130669292	-16.6237039796081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTCCTTCATTACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.25786057176	28.5505634675761	0.0107161412151934	2631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.10361850705	2653.10361850705
"AML-0024"	"2020-09-15-AML0024:ACGTTCCAGGTCGTGA"	-1.17763946476634	-15.1474142304626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCAGGTCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.10666749276	36.4676930036882	0.013362501890478	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.60110688014	2723.60110688014
"AML-0024"	"2020-09-15-AML0024:ACGTTCCAGTCAGCGA"	-0.415083567530471	-16.2006273499695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCAGTCAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2969.44697511817	32.2703353151024	0.0108674563262131	3246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2958.05501487896	2958.05501487896
"AML-0024"	"2020-09-15-AML0024:ACGTTCCAGTTTAGGA"	-1.71143458309825	-15.6181183091369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCAGTTTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.29492753129	37.0948339722815	0.0130235228149048	2635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.97011982282	2840.97011982282
"AML-0024"	"2020-09-15-AML0024:ACGTTCCCAAGGTTGG"	1.06071641024892	-16.2229891053406	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCCAAGGTTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2934.16369756909	40.8489189212264	0.0139218268411776	3427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2925.478012012	2925.478012012
"AML-0024"	"2020-09-15-AML0024:ACGTTCCGTAACGCGA"	-2.32777677002605	-16.1476297608581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCGTAACGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.37287562005	34.2029769669778	0.0122093625110179	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.77078824726	2795.77078824726
"AML-0024"	"2020-09-15-AML0024:ACGTTCCGTGCTGATT"	-0.235210756689864	-16.5129137269226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCGTGCTGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.09843880909	33.6390941180758	0.0118694162691862	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.14992197681	2826.14992197681
"AML-0024"	"2020-09-15-AML0024:ACGTTCCTCTCCAAGA"	-0.895058373839217	-15.952006363031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCTCTCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.2838102352	36.3873727822567	0.0131872526658122	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.84680937504	2752.84680937504
"AML-0024"	"2020-09-15-AML0024:ACGTTCCTCTTACGGA"	-2.30292258682902	13.7994880446228	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACGTTCCTCTTACGGA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1887.22876681739	34.2325031034853	0.0181390320587444	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1885.39961398828	1885.39961398828
"AML-0024"	"2020-09-15-AML0024:ACTACGAAGGGTACAC"	-1.76487658444102	-16.455252670404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGAAGGGTACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.8783475611	34.4673062239977	0.0130762128138005	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.53863190269	2626.53863190269
"AML-0024"	"2020-09-15-AML0024:ACTACGACACTACAGT"	-1.72860632363017	-15.7365064851013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGACACTACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.79200923052	33.3869496244167	0.0120757545279903	2602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.27493530493	2757.27493530493
"AML-0024"	"2020-09-15-AML0024:ACTACGAGTAGTCACT"	-1.78217945519145	-16.3848695985046	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGAGTAGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.02555552254	35.7335211012037	0.0137647031344463	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.41397585614	2589.41397585614
"AML-0024"	"2020-09-15-AML0024:ACTACGAGTATGCTAC"	-1.66559861126598	-15.914707206842	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGAGTATGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.78284520458	40.5692407562706	0.0139807983300041	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2897.3413773105	2897.3413773105
"AML-0024"	"2020-09-15-AML0024:ACTACGAGTGGCAACA"	-1.20513937893565	-16.0158853760925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGAGTGGCAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.58761527191	35.7685922424519	0.0130944334505234	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.90058029163	2718.90058029163
"AML-0024"	"2020-09-15-AML0024:ACTACGATCAGACAAA"	-0.813184480101425	-15.7887058488098	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGATCAGACAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.37966090588	43.4825141478707	0.0165876445889735	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.93224492069	2613.93224492069
"AML-0024"	"2020-09-15-AML0024:ACTACGATCCCTGGTT"	-1.96948848190959	-16.1985941163269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGATCCCTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.51279617488	36.3944442665662	0.0124830336242446	3241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.55538757678	2908.55538757678
"AML-0024"	"2020-09-15-AML0024:ACTACGATCGTGTGGC"	-0.855635742575485	-16.2258272401062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTACGATCGTGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.59203928234	36.982830752387	0.0130700221936469	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.09260478107	2824.09260478107
"AML-0024"	"2020-09-15-AML0024:ACTATCTAGATGTAGT"	-1.59205077114757	-16.2310762635437	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTAGATGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2949.06468366398	36.2718814509835	0.0122994526542289	3081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2941.2850620108	2941.2850620108
"AML-0024"	"2020-09-15-AML0024:ACTATCTAGGATATGT"	-0.448704997927505	-16.6066560975281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTAGGATATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.43025913982	35.1974817092083	0.0136190487573548	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.03923935308	2582.03923935308
"AML-0024"	"2020-09-15-AML0024:ACTATCTAGTTGTAAG"	-2.98099289360698	-15.6219358674255	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTAGTTGTAAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.49118161571	36.7809770930424	0.0138352827150206	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.64845175595	2649.64845175595
"AML-0024"	"2020-09-15-AML0024:ACTATCTCATGTTCAG"	-0.567796210676986	-15.8258362046448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTCATGTTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.90848042366	31.3914620885105	0.0106559529249178	3288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.40721479074	2939.40721479074
"AML-0024"	"2020-09-15-AML0024:ACTATCTGTATTTCCT"	-2.0588244003361	-16.1021776429382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTGTATTTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.91825340278	34.3752851302744	0.0125874456650037	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.97707757258	2721.97707757258
"AML-0024"	"2020-09-15-AML0024:ACTATCTGTCTCCTGT"	-0.937541226775009	-17.4655981293884	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTGTCTCCTGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3084.97831356133	37.2220039781372	0.0120655642260149	3155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3073.58280741343	3073.58280741343
"AML-0024"	"2020-09-15-AML0024:ACTATCTGTGGGTATG"	-1.8039120239323	-15.4841585389343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTGTGGGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.97402983438	39.3465910833495	0.0147976590376102	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.49091373077	2654.49091373077
"AML-0024"	"2020-09-15-AML0024:ACTATCTGTGTCTAAC"	-1.9355619949406	-15.6786880723205	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTGTGTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.09785670285	25.7290198602853	0.0101571361691391	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.49959290904	2527.49959290904
"AML-0024"	"2020-09-15-AML0024:ACTATCTGTTGGATCT"	-2.0376287502354	-16.8024511567322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTGTTGGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1991.78826024885	45.9353877555029	0.0230623850297038	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1988.46828021165	1988.46828021165
"AML-0024"	"2020-09-15-AML0024:ACTATCTTCCATCCGT"	1.22648789462392	-16.1989698640076	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTTCCATCCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3304.24924301974	41.5416936885127	0.0125722034366112	4070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3292.57820381204	3292.57820381204
"AML-0024"	"2020-09-15-AML0024:ACTATCTTCTCAGAAC"	-1.04768345776256	-16.0426798096863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATCTTCTCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.12881576107	38.3240250353779	0.013455860852676	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.0564687209	2840.0564687209
"AML-0024"	"2020-09-15-AML0024:ACTATGGAGAGTGAAG"	-1.54300699654277	-16.0081835023132	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGAGAGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.48225424697	39.5029774182689	0.0145580378705043	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.36933217684	2705.36933217684
"AML-0024"	"2020-09-15-AML0024:ACTATGGAGCGTTACT"	-1.65025339546855	-15.4922905198303	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGAGCGTTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.93543810024	33.3001221721746	0.012585387267077	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.77433189092	2642.77433189092
"AML-0024"	"2020-09-15-AML0024:ACTATGGAGCTCCGAC"	-0.452153722674209	-16.3758840790954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGAGCTCCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.35843685688	37.8418703108885	0.014586215140239	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.56040010094	2582.56040010094
"AML-0024"	"2020-09-15-AML0024:ACTATGGAGGGTGGGA"	-0.939323703677017	-16.5407743684021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGAGGGTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.53159087295	33.9698662478824	0.012611645752732	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.63370179791	2689.63370179791
"AML-0024"	"2020-09-15-AML0024:ACTATGGAGGTTCTAC"	-1.41757331314738	-16.9621362916199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGAGGTTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2524.48903881434	38.3467948911266	0.0151899233078614	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.59289826728	2511.59289826728
"AML-0024"	"2020-09-15-AML0024:ACTATGGCAACAAAGT"	-0.0973828685587228	-16.1049623719421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGCAACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.18134265772	35.5220007376773	0.0140448611329506	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2523.51836501184	2523.51836501184
"AML-0024"	"2020-09-15-AML0024:ACTATGGCAAGGACAC"	-1.63719294491466	-15.6106958619324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGCAAGGACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.07144328417	31.0599710651868	0.012359366522663	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2508.51183326943	2508.51183326943
"AML-0024"	"2020-09-15-AML0024:ACTATGGCAATTCTCT"	-0.964857081801254	-17.4925604096619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGCAATTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3175.23907964616	34.8903028918943	0.0109882443547471	2725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3165.24487793729	3165.24487793729
"AML-0024"	"2020-09-15-AML0024:ACTATGGGTACACTCA"	-1.59608815136607	-15.1379699937073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGGTACACTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.54602154188	33.8079574451049	0.0131061656441767	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.33344057211	2569.33344057211
"AML-0024"	"2020-09-15-AML0024:ACTATGGGTGGAACCA"	-1.61196015301402	-16.935669921991	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATGGGTGGAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.39358229869	45.0723585661778	0.0202627623658219	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2220.25219244093	2220.25219244093
"AML-0024"	"2020-09-15-AML0024:ACTATTCAGACCATGG"	-2.52598486366923	-16.0202570191589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCAGACCATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2857.71438817326	46.967927184298	0.0164354868277517	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.22572395166	2847.22572395166
"AML-0024"	"2020-09-15-AML0024:ACTATTCAGCAAACAT"	-0.808223168284255	-15.7234459153381	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCAGCAAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.34120783266	32.4192921066033	0.0112514588756356	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.49682649835	2875.49682649835
"AML-0024"	"2020-09-15-AML0024:ACTATTCAGCGTACAG"	0.252474506467026	-15.999484085199	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCAGCGTACAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2921.8882181765	38.6578360493214	0.0132304294903681	2776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2914.12919240441	2914.12919240441
"AML-0024"	"2020-09-15-AML0024:ACTATTCCAACAGCTT"	-1.69472966614421	-17.0052957764831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCCAACAGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.96467292986	39.3538921993693	0.0148844243655343	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.41486503615	2634.41486503615
"AML-0024"	"2020-09-15-AML0024:ACTATTCCACTCCTTG"	-2.29655681076701	-15.6095657578674	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCCACTCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.33966554816	30.9684484649791	0.0119461384156349	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.59374420982	2588.59374420982
"AML-0024"	"2020-09-15-AML0024:ACTATTCGTAACCAGG"	-0.984193066984969	-17.2326841584411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCGTAACCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3070.68007584673	42.1810136827374	0.0137367008743515	2606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3060.63216849694	3060.63216849694
"AML-0024"	"2020-09-15-AML0024:ACTATTCGTCGGCCTA"	-0.560163597494918	-16.5845041505066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCGTCGGCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.06590501433	31.8642153315627	0.0121569683809185	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.44319051752	2611.44319051752
"AML-0024"	"2020-09-15-AML0024:ACTATTCGTTTCAGAC"	-0.474486808211166	-16.0055570832458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCGTTTCAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.17969642688	36.3967824035797	0.0138539371528645	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.63328059524	2624.63328059524
"AML-0024"	"2020-09-15-AML0024:ACTATTCTCACACCCT"	-1.78465996208842	-16.7586088410583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCTCACACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.3245701805	38.0798936758597	0.0144607672396607	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.69024818848	2622.69024818848
"AML-0024"	"2020-09-15-AML0024:ACTATTCTCACTGCTC"	-1.10267637196239	-16.3813734284607	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCTCACTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.27687601102	33.9656345348406	0.0122430586609935	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.3176052197	2768.3176052197
"AML-0024"	"2020-09-15-AML0024:ACTATTCTCGAATCCA"	-1.55418906632121	-16.494357132074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCTCGAATCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.05140994239	39.2443135618899	0.0148368812093314	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.86185241945	2630.86185241945
"AML-0024"	"2020-09-15-AML0024:ACTATTCTCGGTATGT"	-1.71007833901103	-16.1713533631531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTATTCTCGGTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.23877835583	36.0171768346599	0.0136935008072439	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.19686119022	2623.19686119022
"AML-0024"	"2020-09-15-AML0024:ACTCCCAAGAAGGATG"	-1.82117531719859	-16.46671202099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCCCAAGAAGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.92403861856	39.0804106275129	0.0148938803305022	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.038076394	2609.038076394
"AML-0024"	"2020-09-15-AML0024:ACTCCCAAGGGTTAAT"	-0.90167991343196	-17.1205473176208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCCCAAGGGTTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2916.58980005651	38.333046547933	0.013143105193329	2763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2907.17463196375	2907.17463196375
"AML-0024"	"2020-09-15-AML0024:ACTCCCAGTGGGATTG"	-0.962571005255538	-17.4478101960388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCCCAGTGGGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.28438830546	42.5291826893345	0.0150424141502173	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.28319784693	2817.28319784693
"AML-0024"	"2020-09-15-AML0024:ACTCCCATCGGCATTA"	-2.01845894280131	-15.6812124482361	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCCCATCGGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3003.380249653	39.3206770249238	0.013092140773539	3268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2993.82207450032	2993.82207450032
"AML-0024"	"2020-09-15-AML0024:ACTCCCATCGTGGACC"	-1.30313322964366	-15.9413633576599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCCCATCGTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.89881428227	39.7809383368029	0.0137655125294353	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2883.63128089182	2883.63128089182
"AML-0024"	"2020-09-15-AML0024:ACTCTCGAGCCTCCAG"	-2.5053313774174	-16.5339384309021	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGAGCCTCCAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.5035259797	45.9879891108564	0.0195901682795828	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2343.58443120633	2343.58443120633
"AML-0024"	"2020-09-15-AML0024:ACTCTCGAGGCATCTT"	-1.99320326271709	-15.662922882196	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGAGGCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.59766313297	35.2567773226448	0.0129544413563535	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.90903358113	2718.90903358113
"AML-0024"	"2020-09-15-AML0024:ACTCTCGAGGTCTTTG"	-2.61420283737834	-16.4221678010193	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGAGGTCTTTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2345.45408387855	39.3925079401801	0.0167952586285717	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2336.08119056401	2336.08119056401
"AML-0024"	"2020-09-15-AML0024:ACTCTCGAGTGATTCC"	-2.12565598908122	-16.3390302888122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGAGTGATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.96442055593	42.504443531666	0.0166035290140617	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.02274207194	2543.02274207194
"AML-0024"	"2020-09-15-AML0024:ACTCTCGCACGTCGTG"	-1.8842890066212	-16.490242981073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGCACGTCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2275.39879061013	40.3645030919639	0.017739529113989	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2265.54286981883	2265.54286981883
"AML-0024"	"2020-09-15-AML0024:ACTCTCGCAGCAGATG"	-0.728312293917495	-15.7589884034363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGCAGCAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.66585701874	36.3126024187353	0.0136376865775388	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.81947354237	2656.81947354237
"AML-0024"	"2020-09-15-AML0024:ACTCTCGTCAACACGT"	-0.974812607199508	-17.4865560761658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGTCAACACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3095.93771747537	41.1325283363197	0.0132859676420951	3023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3086.42160811764	3086.42160811764
"AML-0024"	"2020-09-15-AML0024:ACTCTCGTCGTAGTGT"	-1.78627441349681	-15.4857454529968	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTCTCGTCGTAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.23077271472	36.5168757895147	0.0135991573463896	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.54406111665	2681.54406111665
"AML-0024"	"2020-09-15-AML0024:ACTGATGGTCTGCATA"	-2.9611636203831	-15.9306097260681	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGATGGTCTGCATA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.54806417514	34.7833655060888	0.0126367876945729	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.20383705608	2746.20383705608
"AML-0024"	"2020-09-15-AML0024:ACTGATGTCCGTGCGA"	-1.38000498238261	-16.8544054261413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGATGTCCGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.22571050759	38.2965856687533	0.0154283252754328	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.10910126801	2474.10910126801
"AML-0024"	"2020-09-15-AML0024:ACTGCAAAGACTTCAC"	-1.97450051727946	-16.2876959077087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAAAGACTTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.54113312186	35.7022035243871	0.0135773512247746	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.83736718529	2620.83736718529
"AML-0024"	"2020-09-15-AML0024:ACTGCAAAGTCTAGAA"	11.854529996484	-2.31135966694029	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAAAGTCTAGAA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1487.27787172128	38.4003207133319	0.0258191972350733	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1484.47936458437	1484.47936458437
"AML-0024"	"2020-09-15-AML0024:ACTGCAACAAGTACCT"	-1.48944232884105	-16.9939718476501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAACAAGTACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2011.71760612161	42.279666928347	0.021016700753471	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2005.40681260182	2005.40681260182
"AML-0024"	"2020-09-15-AML0024:ACTGCAAGTGCAACGA"	-1.06259665909465	-16.4332533112732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAAGTGCAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.56220582911	42.5359455879273	0.0175582470021114	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.9887780798	2415.9887780798
"AML-0024"	"2020-09-15-AML0024:ACTGCAAGTGGCCTCA"	-1.42246578159984	-16.7118463746277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAAGTGGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.64858833221	36.8451362614332	0.013926693221438	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.05898723304	2633.05898723304
"AML-0024"	"2020-09-15-AML0024:ACTGCAAGTTGTCTAG"	-0.059658813208896	-16.3841543427673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGCAAGTTGTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.42628658009	32.5583951152607	0.011972523497302	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.76849629119	2711.76849629119
"AML-0024"	"2020-09-15-AML0024:ACTGTCCAGGGTACGT"	-2.67815623703654	-16.0734434357849	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCAGGGTACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.0060478537	33.8643402464659	0.0142167314297876	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2374.81523448818	2374.81523448818
"AML-0024"	"2020-09-15-AML0024:ACTGTCCAGTTCATCG"	1.56537725505177	-10.6861276856628	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCAGTTCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2026.91290585458	46.3113363401675	0.0228482122771042	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2023.86131794699	2023.86131794699
"AML-0024"	"2020-09-15-AML0024:ACTGTCCCAACCGTGC"	-2.4329870742863	-16.0921125642029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCCAACCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.14142895465	33.8913680185588	0.0133739055095039	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.52777713169	2528.52777713169
"AML-0024"	"2020-09-15-AML0024:ACTGTCCCACAATGCT"	-1.48074827614482	-15.9462118378845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCCACAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.0446603265	34.5907363234365	0.0123536373592709	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.61381955406	2791.61381955406
"AML-0024"	"2020-09-15-AML0024:ACTGTCCCACTAAACC"	-1.73922357979472	-16.3772764435974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCCACTAAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.35359323231	43.3974561296939	0.0166762334843941	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.41872495934	2595.41872495934
"AML-0024"	"2020-09-15-AML0024:ACTGTCCCACTCCTGT"	-0.787471930414993	-16.2350263825622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCCACTCCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.03820550636	38.0822052975839	0.0130238398478754	2918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2913.04624470335	2913.04624470335
"AML-0024"	"2020-09-15-AML0024:ACTGTCCGTCAAGTTC"	0.077479419379872	-15.9724607697693	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCGTCAAGTTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2944.32774627943	34.9527431568282	0.0118712134547507	2862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2936.24319676196	2936.24319676196
"AML-0024"	"2020-09-15-AML0024:ACTGTCCTCAATCAGC"	-0.19220175865348	-16.5648317567078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCTCAATCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.3585364991	43.7021877026128	0.0155117593790239	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.87652320186	2805.87652320186
"AML-0024"	"2020-09-15-AML0024:ACTGTCCTCAGAGTTC"	-2.46939287605937	-16.2685613862244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCTCAGAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.76640521819	42.5235614671651	0.0171967563848446	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.59897605183	2462.59897605183
"AML-0024"	"2020-09-15-AML0024:ACTGTCCTCTGCGGCA"	-1.22759697857555	-15.4974613419739	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTCCTCTGCGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2920.90279202962	34.5550012519152	0.0118302469175649	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2914.63939756907	2914.63939756907
"AML-0024"	"2020-09-15-AML0024:ACTGTGAAGAGAGTTT"	-1.39124558392223	-16.0315695039001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGAAGAGAGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.14556933557	40.7969361475783	0.0148398602833674	2643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.17381326687	2738.17381326687
"AML-0024"	"2020-09-15-AML0024:ACTGTGAAGCTAGAGC"	-1.3608537715977	-15.5823936692444	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGAAGCTAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.81694448652	38.3687522122496	0.0148038048342381	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.13018194202	2584.13018194202
"AML-0024"	"2020-09-15-AML0024:ACTGTGAAGTTCCTGA"	-0.976587037474471	-17.4620752564636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGAAGTTCCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3213.34057557603	41.2066286326885	0.0128236107140002	3355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3206.05042084255	3206.05042084255
"AML-0024"	"2020-09-15-AML0024:ACTGTGACAACTCCAA"	-1.53969428959544	14.1333541640076	"2020-09-15-AML0024"	"AML0024"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGACAACTCCAA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2252.30072473941	36.2993326183998	0.0161165568255099	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2252.30072473941	2252.30072473941
"AML-0024"	"2020-09-15-AML0024:ACTGTGACAGAACTTC"	-2.09993229332622	-16.4588461152283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGACAGAACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.54084659357	45.3168394238815	0.0183800805760293	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.28886087182	2458.28886087182
"AML-0024"	"2020-09-15-AML0024:ACTGTGACAGACACAG"	0.0183345909113109	-16.3264723054138	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGACAGACACAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2733.53905457093	41.0632729939057	0.0150220180411329	2789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2724.15396793074	2724.15396793074
"AML-0024"	"2020-09-15-AML0024:ACTGTGAGTAATGATG"	-0.52059636536296	-16.5503607026306	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGAGTAATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.89632814248	33.2602429425038	0.0129020870930328	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.91351425397	2568.91351425397
"AML-0024"	"2020-09-15-AML0024:ACTGTGAGTCTGATCA"	-0.999533752829391	-16.0978269807068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGAGTCTGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.6129805688	35.8534594543066	0.0128894492888709	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.28152182519	2778.28152182519
"AML-0024"	"2020-09-15-AML0024:ACTGTGATCCGGGACT"	-0.443860541016418	-16.5899572602478	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGATCCGGGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.56268553484	38.0657818689959	0.0133490952389343	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.32741398717	2842.32741398717
"AML-0024"	"2020-09-15-AML0024:ACTGTGATCGTTCGCT"	-2.15456281128581	-16.2135153046814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTGTGATCGTTCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.4591726182	40.8413260030014	0.0159507819690165	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.42383148756	2552.42383148756
"AML-0024"	"2020-09-15-AML0024:ACTTAGGCAAGACCGA"	-1.42957971516307	-16.3887262574402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGCAAGACCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.07684564205	35.2447746044829	0.0144145876917124	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.36644520349	2442.36644520349
"AML-0024"	"2020-09-15-AML0024:ACTTAGGCACGTCGTG"	-1.49568245831187	10.5637435683045	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGCACGTCGTG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1673.12101328573	40.88763754169	0.0244379439484736	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1667.15479340269	1667.15479340269
"AML-0024"	"2020-09-15-AML0024:ACTTAGGGTACAAGCG"	-1.96850238266643	-15.767472290155	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGGTACAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.6899501153	34.5578076377726	0.0124054752167743	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.06913319187	2779.06913319187
"AML-0024"	"2020-09-15-AML0024:ACTTAGGGTATACCTG"	-1.11218808117564	-16.4729128113953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGGTATACCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.9073848697	34.6536347600143	0.0125424525446583	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.74574746667	2752.74574746667
"AML-0024"	"2020-09-15-AML0024:ACTTAGGTCAGCTGAT"	-0.424073914915878	-16.0923071137634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGTCAGCTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.56828751297	37.2459068659484	0.0137816709527898	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.17519302446	2693.17519302446
"AML-0024"	"2020-09-15-AML0024:ACTTAGGTCCACCTGT"	-0.445779095322448	-15.8532352677551	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTAGGTCCACCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.55385671069	33.8290792953193	0.0130940097135771	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.83690508203	2579.83690508203
"AML-0024"	"2020-09-15-AML0024:ACTTATCAGAGATTCA"	1.29713608798329	-16.1880750886169	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCAGAGATTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2932.56104392004	40.5789865686085	0.0138373885354371	3824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2921.66789967932	2921.66789967932
"AML-0024"	"2020-09-15-AML0024:ACTTATCAGCTCTTCC"	-1.72931037369426	-17.020739578363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCAGCTCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1745.77861971603	49.3155632461682	0.0282484632869372	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1739.31434085453	1739.31434085453
"AML-0024"	"2020-09-15-AML0024:ACTTATCCAAGCGAAC"	-1.48510907116588	-16.2045107117859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCCAAGCGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.77072367524	33.4302084474386	0.013064948781117	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.15052751514	2556.15052751514
"AML-0024"	"2020-09-15-AML0024:ACTTATCCAAGGTTGG"	-0.415272424847442	-16.4801988831726	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCCAAGGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.31218479702	32.4614806068483	0.0127835721819463	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.17124154319	2529.17124154319
"AML-0024"	"2020-09-15-AML0024:ACTTATCGTCAACATC"	-0.503903607756454	-16.1649923554626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCGTCAACATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.68399399742	35.2195752389791	0.0125663739880806	2551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.75018757371	2795.75018757371
"AML-0024"	"2020-09-15-AML0024:ACTTATCGTCGATTCA"	-1.63070700588878	-15.7574224702087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCGTCGATTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.68214188387	38.3043769639146	0.0143964498280105	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.00425820424	2653.00425820424
"AML-0024"	"2020-09-15-AML0024:ACTTATCTCACGGACC"	-0.790382007986862	-16.5361166230408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCTCACGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2983.53777861053	35.8141230795038	0.0120039113753682	3822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2972.88833363861	2972.88833363861
"AML-0024"	"2020-09-15-AML0024:ACTTATCTCCTTATGT"	-1.13422356072124	-16.9191274872986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTATCTCCTTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.37903261477	43.89275632172	0.01575827052899	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.4357133035	2777.4357133035
"AML-0024"	"2020-09-15-AML0024:ACTTCCGAGAGTAACT"	-1.81123421612437	-16.7120027772156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGAGAGTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.62901389233	37.4350417134952	0.0137698235111154	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.73267056524	2712.73267056524
"AML-0024"	"2020-09-15-AML0024:ACTTCCGAGTACAGAT"	-1.75012598457988	-15.5387945405212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGAGTACAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.52536482522	32.0453677176204	0.0121590056181249	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.34803312514	2622.34803312514
"AML-0024"	"2020-09-15-AML0024:ACTTCCGCACGGCACT"	-1.67131541195567	-15.8097028962341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGCACGGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.49054883969	37.5904425574156	0.0130954768593857	2812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.57853848183	2863.57853848183
"AML-0024"	"2020-09-15-AML0024:ACTTCCGCACTCAGAT"	-1.91130385819133	-16.4578542939392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGCACTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.10358607559	38.2624764818183	0.0140717244748449	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.02060043298	2711.02060043298
"AML-0024"	"2020-09-15-AML0024:ACTTCCGGTAGAGCTG"	-0.479567090899307	-16.2934789887634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGGTAGAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.91223334428	34.5703101017614	0.012211720905569	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2823.90983738243	2823.90983738243
"AML-0024"	"2020-09-15-AML0024:ACTTCCGTCCACTAGA"	-2.17481360855754	-16.2807569733826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCCGTCCACTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.48733190046	35.6676263435987	0.013326282519063	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.53280693338	2667.53280693338
"AML-0024"	"2020-09-15-AML0024:ACTTCGCAGACGGAAA"	-1.05810127678569	-16.0020818940369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCGCAGACGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.10155137558	35.180700046457	0.0133812632791039	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.10258879586	2620.10258879586
"AML-0024"	"2020-09-15-AML0024:ACTTCGCAGCAAACAT"	-0.584910849959213	-15.91362192547	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCGCAGCAAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3009.34514075062	35.1813440096898	0.0116906975983866	3430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3003.09740945176	3003.09740945176
"AML-0024"	"2020-09-15-AML0024:ACTTCGCTCCGCGAGT"	-2.16813192787822	-16.2818098298279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCGCTCCGCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.98963024549	35.4273025373666	0.0135116104688978	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.92632602342	2613.92632602342
"AML-0024"	"2020-09-15-AML0024:ACTTCGCTCTCGCTCA"	-1.30398331108745	-16.2714014283386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTCGCTCTCGCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.72575522368	35.2517090354938	0.0125062571164169	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.67218554837	2810.67218554837
"AML-0024"	"2020-09-15-AML0024:ACTTTCAAGGGTACGT"	-1.68328521671947	-16.5786295167175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTCAAGGGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.77210935826	34.8778085942104	0.01266546657063	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.39814479565	2746.39814479565
"AML-0024"	"2020-09-15-AML0024:ACTTTCAAGGTTGACG"	-2.72997198525127	-15.6494627228943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTCAAGGTTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3000.71523613091	38.1564916033363	0.0127157989348349	2858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2995.73300818484	2995.73300818484
"AML-0024"	"2020-09-15-AML0024:ACTTTCAAGTTACGAA"	-1.0746125978535	-16.2049818268982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTCAAGTTACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.16311379778	38.61702409491	0.0142964428536917	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.86473558571	2693.86473558571
"AML-0024"	"2020-09-15-AML0024:ACTTTCATCGCATTAG"	-2.33125791969951	-16.1358919373718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTCATCGCATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.59440201347	33.3225278407804	0.0127545736969732	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.37072851106	2602.37072851106
"AML-0024"	"2020-09-15-AML0024:ACTTTGTCAGGCCCTA"	-1.3139388364857	-16.5073843232361	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTGTCAGGCCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.19705267969	31.864263935167	0.0121842688307242	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.84480507359	2609.84480507359
"AML-0024"	"2020-09-15-AML0024:ACTTTGTGTTTCAGAC"	-1.08645234528239	-16.711771988031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTGTGTTTCAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.97935941342	40.188024775514	0.0169714421773799	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2364.51401028395	2364.51401028395
"AML-0024"	"2020-09-15-AML0024:CATCCACAGGGCGAGA"	-1.68045518818553	-16.683264755365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACAGGGCGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.27645443166	38.4104842630259	0.0146982092912093	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.07852252766	2604.07852252766
"AML-0024"	"2020-09-15-AML0024:CATCCACGTCCGAAGA"	-1.82836435261424	-16.6206312409607	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACGTCCGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.49359365624	42.461865409332	0.0178900273937213	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2365.90828054433	2365.90828054433
"AML-0024"	"2020-09-15-AML0024:CATCCACTCATTGTGG"	-1.32674417915996	-16.376774810907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACTCATTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.98264315353	40.7819469721478	0.0150432342586703	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.29114811573	2695.29114811573
"AML-0024"	"2020-09-15-AML0024:CATCCACTCCATTTAC"	-1.3737065595692	-16.2758245698181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACTCCATTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3080.02754388032	36.2669563648084	0.0117748805321131	4507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3071.87008363573	3071.87008363573
"AML-0024"	"2020-09-15-AML0024:CATCCACTCTGCTAGA"	-2.3355589908665	-15.6527128449646	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCACTCTGCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2825.69514661323	31.8923643327842	0.0112865552290767	2454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.80523867495	2816.80523867495
"AML-0024"	"2020-09-15-AML0024:CATCCCAAGTATAACG"	-2.1080084842747	-15.7957782975403	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCCAAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.1802709585	33.4599867594982	0.0119321810748141	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.66266560802	2795.66266560802
"AML-0024"	"2020-09-15-AML0024:CATCCCAAGTCGCCAC"	-0.410072247416335	-15.8405761948791	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCCAAGTCGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2904.09701783735	37.8629537367021	0.0130377716392196	2847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2896.96551212696	2896.96551212696
"AML-0024"	"2020-09-15-AML0024:CATCCCACACTCATAG"	-2.09189758721049	-15.6017704240051	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCCACACTCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.10797775966	37.5892299659798	0.0134146257975516	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.00709371435	2794.00709371435
"AML-0024"	"2020-09-15-AML0024:CATCCCAGTTCCGTTC"	-2.28258071366008	-15.6382236710754	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCCAGTTCCGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.07227139446	41.3185674906455	0.0146153205592671	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.93251244187	2819.93251244187
"AML-0024"	"2020-09-15-AML0024:CATCCCATCCTGTTAT"	-0.940931360155898	-16.6458978882995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCCATCCTGTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2884.01934530962	33.0502653416483	0.0114597932206658	2728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2874.61172288866	2874.61172288866
"AML-0024"	"2020-09-15-AML0024:CATCCGTCAGCGTGAA"	-1.66361508789714	-16.2495184174744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCGTCAGCGTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.3446277611	39.1470156175681	0.0153979972620953	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.45327436838	2533.45327436838
"AML-0024"	"2020-09-15-AML0024:CATCCGTGTGCCTGCA"	-1.94669578495677	-16.7251310578552	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCGTGTGCCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.85588263799	31.959957908126	0.0124510137574535	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.68784276212	2557.68784276212
"AML-0024"	"2020-09-15-AML0024:CATCCGTTCCGATAGT"	-0.961755494505721	-15.9904146424499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCCGTTCCGATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3084.96213902933	35.6847157938066	0.0115673107758252	3459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3071.06501740943	3071.06501740943
"AML-0024"	"2020-09-15-AML0024:CATCGCTCAAGGTCTT"	-1.27965281429942	-16.3067560425964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGCTCAAGGTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.54568677888	35.0615843732627	0.0145089681379034	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.59773520597	2413.59773520597
"AML-0024"	"2020-09-15-AML0024:CATCGCTCAGTACTAC"	-2.48023806038554	-15.6865778199402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGCTCAGTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.99243222761	44.8681018411881	0.0172238895154179	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.72098412625	2599.72098412625
"AML-0024"	"2020-09-15-AML0024:CATCGGGAGCATTTCG"	-2.12082348290141	-15.7763319245544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGAGCATTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.49266713457	41.7369534438887	0.0153079280010507	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.12674467413	2720.12674467413
"AML-0024"	"2020-09-15-AML0024:CATCGGGAGGGCAGAG"	-1.50243459168132	-15.0903597108093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGAGGGCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.31583836595	38.2218883513823	0.0149636500613149	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.48426435682	2551.48426435682
"AML-0024"	"2020-09-15-AML0024:CATCGGGGTCTAACGT"	-2.58820090714152	-15.4487304917541	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGGTCTAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.84212222661	36.7010190505919	0.0130615947281439	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.72792983416	2802.72792983416
"AML-0024"	"2020-09-15-AML0024:CATCGGGTCACCTTGC"	-1.26161692562755	-16.3473940125671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGTCACCTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.174577839	29.4934231756794	0.0106892196719132	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.96271067145	2751.96271067145
"AML-0024"	"2020-09-15-AML0024:CATCGGGTCCACAAGT"	-2.58799229088481	-16.2599096528259	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGTCCACAAGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1431.89594652096	47.7322311099952	0.0333349858458422	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1429.88532363054	1429.88532363054
"AML-0024"	"2020-09-15-AML0024:CATCGGGTCTCGTTTA"	-2.0399583381718	-15.8733844987121	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGGGTCTCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.47375212017	34.7499988222707	0.0126479820946259	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.37313475143	2741.37313475143
"AML-0024"	"2020-09-15-AML0024:CATCGTCAGAAGGCTC"	-1.21659384194072	-16.6672849885193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGTCAGAAGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.01061941409	40.7461494716197	0.0168163313627872	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.03083867332	2413.03083867332
"AML-0024"	"2020-09-15-AML0024:CATCGTCAGTAGAGTT"	0.842673678963822	-16.2213182679382	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGTCAGTAGAGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2796.61628545339	39.9849417008131	0.0142976145525558	3105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2785.69360981233	2785.69360981233
"AML-0024"	"2020-09-15-AML0024:CATCGTCGTTGTCCCT"	-0.196919376880485	-16.3138056031433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGTCGTTGTCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.43632380957	28.0179135211368	0.00987089732685387	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.55314213356	2827.55314213356
"AML-0024"	"2020-09-15-AML0024:CATCGTCTCCCGAGGT"	-1.56685171547588	-16.4080267182556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATCGTCTCCCGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.86069847248	35.3804499658586	0.0132667034262884	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.58300509945	2654.58300509945
"AML-0024"	"2020-09-15-AML0024:CATGAGTAGCGCCTAC"	-1.80750844898875	-16.8915834656921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGAGTAGCGCCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2264.7508853595	40.0245870153898	0.0176728430813866	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2263.81644825226	2263.81644825226
"AML-0024"	"2020-09-15-AML0024:CATGAGTCAAATCCCA"	-0.678697447211105	-16.0262403718201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGAGTCAAATCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.85302121206	42.7734008680086	0.0158899466393411	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.46823584689	2680.46823584689
"AML-0024"	"2020-09-15-AML0024:CATGAGTCAGAACTTC"	-2.39703784409221	-15.9792242280212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGAGTCAGAACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.99050544346	37.274919308356	0.0132840504043206	2597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.30792049444	2795.30792049444
"AML-0024"	"2020-09-15-AML0024:CATGAGTCATGCAGGA"	-2.04003296318706	-15.6834573975769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGAGTCATGCAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.24451869256	40.7225773625053	0.0147639475349373	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.09920270492	2752.09920270492
"AML-0024"	"2020-09-15-AML0024:CATGAGTTCTCATTAC"	-1.46235893192943	-15.7097187272278	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGAGTTCTCATTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3020.16279075251	38.7654702707948	0.0128355565433398	3188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3012.33147866841	3012.33147866841
"AML-0024"	"2020-09-15-AML0024:CATGCAAAGGTTTACC"	-1.02291617813762	-17.4431638947693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAAAGGTTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.27615027551	40.1673871179754	0.0144680806028569	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.65167590246	2765.65167590246
"AML-0024"	"2020-09-15-AML0024:CATGCAACAACCAACT"	-0.910726825625259	-16.4674291840759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAACAACCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.79633051247	35.0059849219214	0.0134545446587767	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.12924509688	2594.12924509688
"AML-0024"	"2020-09-15-AML0024:CATGCAACAACGTAAA"	-0.68877867880519	-15.9916792145935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAACAACGTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.48335464338	36.6448049942529	0.0131887797466961	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.01217297749	2769.01217297749
"AML-0024"	"2020-09-15-AML0024:CATGCAACATAACAGA"	-1.4767064851826	-16.0026407471863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAACATAACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.00420105863	35.1742108692116	0.0126753721150379	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2767.1562860234	2767.1562860234
"AML-0024"	"2020-09-15-AML0024:CATGCAAGTATCGAGG"	-0.619330565363723	-16.6893358460632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAAGTATCGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.36689746356	36.376610077036	0.0144617511320982	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.27579529756	2504.27579529756
"AML-0024"	"2020-09-15-AML0024:CATGCAAGTGGCTGAA"	-1.28218982639964	-16.0037222138611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAAGTGGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.23251890189	32.9229347758791	0.0138609313041486	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.6361705556	2370.6361705556
"AML-0024"	"2020-09-15-AML0024:CATGCAAGTGGGATTG"	-2.49785480919536	-15.8818025819031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCAAGTGGGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.29172773883	34.9919628611157	0.0132832527592346	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.41149155332	2629.41149155332
"AML-0024"	"2020-09-15-AML0024:CATGCCTAGAGAATCT"	-2.19117865982707	-16.0950689545837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTAGAGAATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.68592779988	35.0100821670342	0.0133235413702381	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.87083966964	2620.87083966964
"AML-0024"	"2020-09-15-AML0024:CATGCCTAGGCCATAG"	-2.21343121948894	-16.4249887696472	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTAGGCCATAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.23727038075	33.8212579730503	0.0128978633455772	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.12665163257	2617.12665163257
"AML-0024"	"2020-09-15-AML0024:CATGCCTCAGCATACT"	-1.20736024799998	-16.6112375489441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTCAGCATACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3046.9612909693	33.3777016022085	0.0109544225918244	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3037.21461315001	3037.21461315001
"AML-0024"	"2020-09-15-AML0024:CATGCCTCAGCGTACC"	0.145638582378072	-16.4733305207458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTCAGCGTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3063.60051451872	39.7497815073243	0.012974857955189	3105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3050.85023544191	3050.85023544191
"AML-0024"	"2020-09-15-AML0024:CATGCCTGTACAAACA"	-1.973869184882	-16.3328237763611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTGTACAAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.86065208475	43.5158540256525	0.0183081216761633	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.19597825001	2368.19597825001
"AML-0024"	"2020-09-15-AML0024:CATGCCTGTATGAGCG"	1.05885555323903	-16.2461786500183	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTGTATGAGCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2845.44776508187	45.2198315754825	0.0158919914575137	3204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2834.46773316818	2834.46773316818
"AML-0024"	"2020-09-15-AML0024:CATGCCTGTGCCTATA"	-1.1808411878651	-16.1265554658142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTGTGCCTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.65214077633	39.7056900186049	0.0146102915170234	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.69096151036	2711.69096151036
"AML-0024"	"2020-09-15-AML0024:CATGCCTTCACGGAGA"	-2.7895167869633	-16.12123205578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCCTTCACGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.49955904291	43.4885296424215	0.019541019213288	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2217.56560638705	2217.56560638705
"AML-0024"	"2020-09-15-AML0024:CATGCGGGTAGCTTGT"	-0.186100940138656	-15.9578180543152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCGGGTAGCTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3146.48361881457	39.1910261732981	0.0124554998281107	3718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3137.11520898457	3137.11520898457
"AML-0024"	"2020-09-15-AML0024:CATGCGGTCAAAGGAT"	-1.59808383408244	-16.927233718988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCGGTCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.68087431467	33.7455397338983	0.0125044572906265	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.88030003406	2691.88030003406
"AML-0024"	"2020-09-15-AML0024:CATGCGGTCACTTCTA"	-1.0936760706013	-16.3446150056091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCGGTCACTTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.80375108146	29.6879762791556	0.0114457295648437	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.03252307609	2587.03252307609
"AML-0024"	"2020-09-15-AML0024:CATGCGGTCGGCATCG"	-0.919923822314102	-16.1827478638855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCGGTCGGCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.4531554561	45.9107352843091	0.019007089903857	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2400.67046701478	2400.67046701478
"AML-0024"	"2020-09-15-AML0024:CATGCGGTCTGATGGT"	-2.38653145256694	-15.9160337678161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCGGTCTGATGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.24083927587	43.9847558433853	0.0201005095298106	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2184.31059548899	2184.31059548899
"AML-0024"	"2020-09-15-AML0024:CATGCTCCAAGTCATC"	-0.629564563662368	-16.3646307221619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCTCCAAGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2999.68250823429	38.3326107945061	0.012778889328881	3204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2993.39410325507	2993.39410325507
"AML-0024"	"2020-09-15-AML0024:CATGCTCCAAGTGGTG"	-1.59156511250194	-15.600009941217	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCTCCAAGTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.62610194549	39.6277797147512	0.0137138087478069	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2882.07240441221	2882.07240441221
"AML-0024"	"2020-09-15-AML0024:CATGCTCCATATAGCC"	-2.24418960037883	-16.0453520051208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCTCCATATAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.52127288087	38.1089741980778	0.014007967729553	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.0652056035	2714.0652056035
"AML-0024"	"2020-09-15-AML0024:CATGCTCGTTTACCTT"	-1.60620770874675	-16.7950926057068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGCTCGTTTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.04913363088	36.00380384917	0.0138420314263388	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.04848350759	2594.04848350759
"AML-0024"	"2020-09-15-AML0024:CATGGATCAAAGGCGT"	-1.62520394745525	-16.7399187318054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGATCAAAGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.386371557	44.8454106430011	0.0171205787469774	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.064931007	2604.064931007
"AML-0024"	"2020-09-15-AML0024:CATGGATCAGCAAGAC"	9.62525906142537	7.85220954501954	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGATCAGCAAGAC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1981.32184193681	35.5917837260011	0.0179636558648185	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1979.75303725623	1979.75303725623
"AML-0024"	"2020-09-15-AML0024:CATGGATGTCCACTTC"	-0.219019274145919	-15.9455175629822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGATGTCCACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.83827623766	33.8861306038209	0.0123050546926513	2786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.69984562918	2747.69984562918
"AML-0024"	"2020-09-15-AML0024:CATGGATGTCTACGAT"	-0.456054965884048	-16.5866308442322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGATGTCTACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.58728181442	35.694165858751	0.0136623821555013	2378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2606.26197853877	2606.26197853877
"AML-0024"	"2020-09-15-AML0024:CATGGATGTTATCCAG"	-0.502418915659744	-16.5761003724304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGATGTTATCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.74022038947	35.1759563541607	0.0127046792238286	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.17240863683	2759.17240863683
"AML-0024"	"2020-09-15-AML0024:CATGGTACACAGAAGC"	-2.82445846024211	-16.0049810639587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGTACACAGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2042.58099261898	36.4232477124848	0.017831972315469	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2034.51413734358	2034.51413734358
"AML-0024"	"2020-09-15-AML0024:CATGGTACACATAGCT"	-2.77987537804301	10.1726283797058	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGTACACATAGCT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2001.06798368389	39.9936234869242	0.0199861393081196	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2001.06798368389	2001.06798368389
"AML-0024"	"2020-09-15-AML0024:CATGGTACACTGCACG"	-2.11236439171489	-16.379834198114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGTACACTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.61036729257	37.0087305677105	0.0126111224100439	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2925.19970451242	2925.19970451242
"AML-0024"	"2020-09-15-AML0024:CATGGTAGTTGCTAGT"	-0.996441583067733	-16.4310903779236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGTAGTTGCTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.3550106956	41.3311964796559	0.0157972432298732	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.41876040677	2608.41876040677
"AML-0024"	"2020-09-15-AML0024:CATGGTATCAAAGGAT"	-0.399481306702453	-16.645329498407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATGGTATCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3051.35102706616	41.8027661344345	0.0136997565221552	3486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3036.16133624118	3036.16133624118
"AML-0024"	"2020-09-15-AML0024:CATTCATCAGTGCGCT"	-2.7737811607426	-16.0800028077331	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCATCAGTGCGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.88390342071	36.744993710411	0.0129800426170815	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2823.30017938634	2823.30017938634
"AML-0024"	"2020-09-15-AML0024:CATTCATGTCGTGGAA"	-1.44563661041911	-15.907084488031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCATGTCGTGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.03005744434	38.7695908625836	0.0147467278865085	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.56998701102	2621.56998701102
"AML-0024"	"2020-09-15-AML0024:CATTCATGTCTGATCA"	-1.52423129501994	-15.6478758088318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCATGTCTGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.78320725028	45.2348630176824	0.0166256770834007	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.34624996596	2715.34624996596
"AML-0024"	"2020-09-15-AML0024:CATTCATGTGCTGTCG"	1.0429775911266	-16.2563886872497	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCATGTGCTGTCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3049.96103404319	50.3990888802493	0.0165245025486236	3125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3035.47515335684	3035.47515335684
"AML-0024"	"2020-09-15-AML0024:CATTCATGTTCAGTAC"	-2.2046037715977	-15.9311533204285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCATGTTCAGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1735.46763602856	50.1555220146167	0.0289002923323839	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1735.46763602856	1735.46763602856
"AML-0024"	"2020-09-15-AML0024:CATTCCGAGCGAGTCA"	-2.0098012489384	-15.4340934983459	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCCGAGCGAGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2929.68488237552	35.8968097085343	0.0122527886614985	2724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.8947668215	2924.8947668215
"AML-0024"	"2020-09-15-AML0024:CATTCCGCACTGCGTG"	0.113180236040992	-16.3466196290222	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCCGCACTGCGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2831.00677518147	40.5704199944839	0.0143307392798039	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2819.36381271851	2819.36381271851
"AML-0024"	"2020-09-15-AML0024:CATTCCGTCACAGTGT"	-1.16045413437541	-16.3900327912536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCCGTCACAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.94182661999	37.4846777030919	0.0135571306933843	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.72177390159	2758.72177390159
"AML-0024"	"2020-09-15-AML0024:CATTCCGTCGATACGT"	-1.94491026821788	-16.6346903077331	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCCGTCGATACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.6495172013	47.6208039762572	0.01626032876128	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2919.13962372503	2919.13962372503
"AML-0024"	"2020-09-15-AML0024:CATTCTAAGTTATGGA"	-2.57323823395427	-15.7778568497864	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTAAGTTATGGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.91741933401	38.3697569546465	0.0166903589628557	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2293.71158875275	2293.71158875275
"AML-0024"	"2020-09-15-AML0024:CATTCTACATGGAGAC"	-1.33729479733165	-16.1848707429138	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTACATGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.94106620427	36.0759242059436	0.0134413995374956	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.15676802818	2678.15676802818
"AML-0024"	"2020-09-15-AML0024:CATTCTACATTGAAAG"	-1.09111843529399	-15.8076210252014	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTACATTGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2937.62194419523	39.2179238488939	0.0133502283799278	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2927.43046696772	2927.43046696772
"AML-0024"	"2020-09-15-AML0024:CATTCTAGTAGGTAGC"	-0.0138825726812661	-16.305443786737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTAGTAGGTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.51451529755	34.2499822350171	0.0120449472125987	2719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2836.0518388595	2836.0518388595
"AML-0024"	"2020-09-15-AML0024:CATTCTAGTCGAGCTC"	-2.31755099716838	-16.272095703241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTAGTCGAGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2190.5999150289	43.1586105714625	0.0197017311446819	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2185.07194511745	2185.07194511745
"AML-0024"	"2020-09-15-AML0024:CATTCTAGTTTCCATT"	-2.42112217369731	-16.203284286615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTCTAGTTTCCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.96433780468	35.6755836056714	0.0123789122362448	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.06625407582	2873.06625407582
"AML-0024"	"2020-09-15-AML0024:CATTGAGAGATCCCGC"	-3.41390881958659	11.1584672697815	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGAGAGATCCCGC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.1141312024	36.7767835239898	0.0164393863554128	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2237.1141312024	2237.1141312024
"AML-0024"	"2020-09-15-AML0024:CATTGAGAGATGGCAC"	-0.214031944901305	-16.2038831940857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGAGAGATGGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2856.76882677242	38.6456784038536	0.0135277583687146	3232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.48774343764	2844.48774343764
"AML-0024"	"2020-09-15-AML0024:CATTGAGAGCTTTGTG"	-2.78962312164958	-15.550560974237	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGAGAGCTTTGTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2985.59347064156	33.1730050111089	0.0111110254417794	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2981.4172196897	2981.4172196897
"AML-0024"	"2020-09-15-AML0024:CATTGAGGTCTACAAC"	-0.295707623392898	-16.4516973725525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGAGGTCTACAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2275.19713387329	44.535020702537	0.019574137132777	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2269.29924648985	2269.29924648985
"AML-0024"	"2020-09-15-AML0024:CATTGAGTCTATCGTT"	1.29963972148244	-16.17250158703	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGAGTCTATCGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3230.17854640513	43.6127139090942	0.0135016418698065	4856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3217.13758164669	3217.13758164669
"AML-0024"	"2020-09-15-AML0024:CATTGCCAGAGGTGCT"	-1.58131382885631	-16.5110349885193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGCCAGAGGTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.27167807121	32.2230504164456	0.0124592674039863	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.02192043939	2583.02192043939
"AML-0024"	"2020-09-15-AML0024:CATTGCCGTCAAAGAT"	-2.14317760887797	-16.739869140741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGCCGTCAAAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.36200307725	41.1256475142988	0.0172480720046797	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.07044654835	2382.07044654835
"AML-0024"	"2020-09-15-AML0024:CATTGCCTCAAGAGGC"	-1.57928345623668	-15.7458820573059	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGCCTCAAGAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.62926980209	32.9521185225892	0.0116659976850335	3020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.5693306946	2819.5693306946
"AML-0024"	"2020-09-15-AML0024:CATTGTTCAAGTACCT"	-2.84221802178081	-15.6870165101257	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGTTCAAGTACCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.72846142828	34.0961992398378	0.0122704322185955	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.74012032804	2768.74012032804
"AML-0024"	"2020-09-15-AML0024:CATTGTTCATGGGATG"	1.31830002841298	-16.1623811951843	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGTTCATGGGATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3005.89264860436	40.3668459242796	0.0134292373824534	4481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2997.61185351627	2997.61185351627
"AML-0024"	"2020-09-15-AML0024:CATTGTTGTAGGACTG"	-1.81997559490855	-16.667016052362	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGTTGTAGGACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.77042293344	34.626849507137	0.013087624386074	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.23380066872	2635.23380066872
"AML-0024"	"2020-09-15-AML0024:CATTGTTTCCGAAATC"	-1.8303566974705	-16.9134054414001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTGTTTCCGAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.98903348919	32.5657806858139	0.0125013120082868	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.8620728943	2589.8620728943
"AML-0024"	"2020-09-15-AML0024:CATTTCAAGCTACTGT"	-1.4388669532841	-15.755753540155	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTTCAAGCTACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.75574154507	35.3937401642273	0.0128528974557376	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.71019698087	2742.71019698087
"AML-0024"	"2020-09-15-AML0024:CATTTCACATCCGTGG"	-0.673383812338668	-16.6584367982117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTTCACATCCGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.44019771334	35.3550812286313	0.014265053181937	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2471.0792725746	2471.0792725746
"AML-0024"	"2020-09-15-AML0024:CATTTCAGTGAGTCAG"	-2.13559351387675	-16.7228288880554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTTCAGTGAGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.42656172304	43.1432131373949	0.0181699505189528	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.04453465299	2368.04453465299
"AML-0024"	"2020-09-15-AML0024:CATTTCAGTGTTCCTC"	-1.93221102181132	-15.5968895188537	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTTCAGTGTTCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.38997448857	35.9770489322498	0.013009756043143	2629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.8297913898	2759.8297913898
"AML-0024"	"2020-09-15-AML0024:CATTTCATCTAAGCGT"	-0.726361493498641	-16.5876665345398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATTTCATCTAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.57641554162	43.9611203527601	0.0147294336723432	3419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2976.26626572567	2976.26626572567
"AML-0024"	"2020-09-15-AML0024:CCAAGCGAGTAAGCAT"	-2.59820232811626	-15.7447386018005	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAAGCGAGTAAGCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.73935466011	33.1773027787085	0.0119828190843848	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.94798976234	2762.94798976234
"AML-0024"	"2020-09-15-AML0024:CCAAGCGAGTCATTGC"	-2.00183997574504	-16.3429060212341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAAGCGAGTCATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.89507800185	35.7291198308686	0.0134476969477241	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.30407870417	2649.30407870417
"AML-0024"	"2020-09-15-AML0024:CCAAGCGCACATGGTT"	-1.32075927677806	-16.5688181153503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAAGCGCACATGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.11741959449	35.5522327001463	0.0129605216481772	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.8965937605	2734.8965937605
"AML-0024"	"2020-09-15-AML0024:CCAATGACAAATGATG"	-1.05206082287486	-15.7570553055969	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGACAAATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.41020321675	31.5530478575832	0.0127569004997826	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.45464632648	2468.45464632648
"AML-0024"	"2020-09-15-AML0024:CCAATGACATACATCG"	0.885544438927811	-16.2288389435974	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGACATACATCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2911.13288244905	39.3684016363803	0.0135233956078504	3507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2893.55489362478	2893.55489362478
"AML-0024"	"2020-09-15-AML0024:CCAATGAGTAACATGA"	-2.5949412387913	-15.4840708008972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGAGTAACATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.23977011094	34.9115678503119	0.0130498836928042	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.12008482518	2668.12008482518
"AML-0024"	"2020-09-15-AML0024:CCAATGAGTCGAATGG"	-2.98490844193156	-15.9866304627624	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGAGTCGAATGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.16525213278	35.9225077658961	0.0139985169450956	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.50666493213	2559.50666493213
"AML-0024"	"2020-09-15-AML0024:CCAATGAGTTGCGTAT"	-2.01034341278728	-16.5598974457947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGAGTTGCGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.06131902816	37.0982944552438	0.0142517942946862	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.57351831217	2596.57351831217
"AML-0024"	"2020-09-15-AML0024:CCAATGATCACCATAG"	-1.92290375652965	-16.200858139154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGATCACCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.26235097211	32.5922464502424	0.0116348425697908	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.89512590398	2795.89512590398
"AML-0024"	"2020-09-15-AML0024:CCAATGATCGACGCTG"	-2.45769176903422	-16.5048399201599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGATCGACGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.62762395977	43.4962381425605	0.0188244257497537	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.53020166801	2305.53020166801
"AML-0024"	"2020-09-15-AML0024:CCAATGATCGGAAACG"	-2.63623772087749	-15.9959383240906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATGATCGGAAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.3611402857	33.7559123306043	0.0128723354735674	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.8749365775	2613.8749365775
"AML-0024"	"2020-09-15-AML0024:CCAATTTAGACCAAGC"	-0.804815034300643	-16.90052893078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATTTAGACCAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.36526409143	32.7867090264313	0.0120302072747528	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.3803203885	2718.3803203885
"AML-0024"	"2020-09-15-AML0024:CCAATTTAGAGGGTAA"	1.12370087680165	-16.2153597108093	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATTTAGAGGGTAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2437.46556486896	47.3793634433043	0.0194379621711092	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2425.63239933855	2425.63239933855
"AML-0024"	"2020-09-15-AML0024:CCAATTTAGCGGCTCT"	-2.45975432816203	-15.730926536676	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATTTAGCGGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.13373773023	37.2352555249039	0.0138157357475932	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.14739960407	2689.14739960407
"AML-0024"	"2020-09-15-AML0024:CCAATTTGTGGCAACA"	-2.386457781226	-15.6354170075622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATTTGTGGCAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.28255901988	36.902541412215	0.0128121254272957	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.16292836736	2873.16292836736
"AML-0024"	"2020-09-15-AML0024:CCAATTTGTGGTCCGT"	-1.49103961411174	-16.66664221203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCAATTTGTGGTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.92392700855	39.4855265108516	0.0167033829048885	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2356.50620929193	2356.50620929193
"AML-0024"	"2020-09-15-AML0024:CCACAAACAGGAATCG"	-2.70237074318584	-15.4816828004089	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACAAACAGGAATCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.39028412589	42.3830284638882	0.0157126051477652	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.11154572298	2695.11154572298
"AML-0024"	"2020-09-15-AML0024:CCACAAATCCTGGGAC"	-2.13515863838847	-15.5000066987244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACAAATCCTGGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.23894347976	30.4556893094936	0.011487342317596	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.50786788975	2645.50786788975
"AML-0024"	"2020-09-15-AML0024:CCACAAATCTACACTT"	-1.14817891541179	-15.9806108704773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACAAATCTACACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.42360201187	35.4415508977058	0.013956533628193	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2532.73270661325	2532.73270661325
"AML-0024"	"2020-09-15-AML0024:CCACACTAGAGAGAAC"	-0.89707992497142	-16.066472076532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTAGAGAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.81352686735	27.9262046582852	0.00999215310424918	2656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.94264834349	2785.94264834349
"AML-0024"	"2020-09-15-AML0024:CCACACTAGTGCCCGT"	-1.34056530419047	-16.2243948212829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTAGTGCCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.64974962597	35.5301075767129	0.0126863802163973	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.67488077254	2796.67488077254
"AML-0024"	"2020-09-15-AML0024:CCACACTCAACCCGCA"	-0.979985455900985	-16.0870599976745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTCAACCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.65590792782	33.5318275092448	0.0119814041498487	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.7675577741	2791.7675577741
"AML-0024"	"2020-09-15-AML0024:CCACACTCAAGACGGT"	-2.61837158623393	-16.1899709931579	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTCAAGACGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1680.68521327684	48.3741591697762	0.0287824030268351	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1675.3131826686	1675.3131826686
"AML-0024"	"2020-09-15-AML0024:CCACACTCACCTGTCT"	-1.47824309292491	-16.0182180634704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTCACCTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.71873570352	29.7580693416116	0.0107247156112443	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.79228755302	2768.79228755302
"AML-0024"	"2020-09-15-AML0024:CCACACTCAGGTGACA"	-1.86056421223338	-15.8387031785217	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTCAGGTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.56293685922	38.608936421373	0.0142386281714314	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.6354753864	2706.6354753864
"AML-0024"	"2020-09-15-AML0024:CCACACTCAGTCGGAA"	-2.18222175064738	-16.5982446900574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTCAGTCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.26081767301	50.123598382589	0.0202253120515592	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.64354659377	2462.64354659377
"AML-0024"	"2020-09-15-AML0024:CCACACTGTTACAGCT"	-0.490869562060195	-16.2342825165954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACACTGTTACAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.88938266422	30.1972923368259	0.0115085996141211	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.85116634265	2617.85116634265
"AML-0024"	"2020-09-15-AML0024:CCACCATAGCGGGTAT"	-0.577757279307205	-16.3519277802673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATAGCGGGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.32963644756	33.9416018430355	0.0124222207270586	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.13717887298	2726.13717887298
"AML-0024"	"2020-09-15-AML0024:CCACCATAGGGATCTG"	-1.81599448147472	-16.9503374329773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATAGGGATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1443.55975164967	51.4649360678444	0.0356514068842881	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1439.69176613631	1439.69176613631
"AML-0024"	"2020-09-15-AML0024:CCACCATAGTCCGTCG"	-0.203406671912032	-15.9687986603943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATAGTCCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.80690565698	29.899228075196	0.0107985963246872	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.83370633348	2757.83370633348
"AML-0024"	"2020-09-15-AML0024:CCACCATCAGTCAGCC"	-1.80792568150218	-16.8621721497742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATCAGTCAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.34595376726	45.2790680873547	0.0183587659380033	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.26054186827	2455.26054186827
"AML-0024"	"2020-09-15-AML0024:CCACCATGTACGGTTT"	-1.79096577587779	-16.4892778626648	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATGTACGGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.19397302502	35.6184266380302	0.015200801575999	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2338.48786580075	2338.48786580075
"AML-0024"	"2020-09-15-AML0024:CCACCATTCGCGTGAC"	11.221868177026	-2.38929011737975	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATTCGCGTGAC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1408.84441132203	40.698433631691	0.0288878128092941	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1408.84441132203	1408.84441132203
"AML-0024"	"2020-09-15-AML0024:CCACCATTCGTACCTC"	-0.199564735323745	-16.0465994111267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACCATTCGTACCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.14395777058	36.2825445713596	0.0153795381803012	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.78015724921	2351.78015724921
"AML-0024"	"2020-09-15-AML0024:CCACGAGAGGAGGGTG"	-2.68091092529948	-16.3811521760193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGAGGAGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.44035520416	50.6386987906338	0.0228262611035912	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2204.70692188662	2204.70692188662
"AML-0024"	"2020-09-15-AML0024:CCACGAGCAAGGCTTT"	-1.40537391129192	-15.9925718537536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGCAAGGCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.17574484119	36.6798087015975	0.0148310562959822	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2467.22665080116	2467.22665080116
"AML-0024"	"2020-09-15-AML0024:CCACGAGCACTTTAGG"	-2.54752049866374	-15.538320564386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGCACTTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.05907137643	30.7128135262509	0.0110714345787207	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.50753379378	2765.50753379378
"AML-0024"	"2020-09-15-AML0024:CCACGAGCAGGCATGA"	-1.76146183434184	-16.4763937226501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGCAGGCATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.23143212068	38.5883697151932	0.0146990353852427	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.3194154375	2608.3194154375
"AML-0024"	"2020-09-15-AML0024:CCACGAGGTTCATCGA"	-1.1840617460316	-16.7292280427185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGGTTCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.48097499706	33.4210312522925	0.0123302954570005	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.93503277052	2703.93503277052
"AML-0024"	"2020-09-15-AML0024:CCACGAGGTTCGAAGG"	-0.318624178797561	-15.8688516846863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGGTTCGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3020.17918800327	41.4466545144831	0.013723243534396	3375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3015.14114538434	3015.14114538434
"AML-0024"	"2020-09-15-AML0024:CCACGAGTCTCTCGAC"	-0.932593683630782	-17.474072479364	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGAGTCTCTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3132.2603707123	34.0208532470149	0.010861438456752	2993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3123.87311706864	3123.87311706864
"AML-0024"	"2020-09-15-AML0024:CCACGTTAGACCTTTG"	-1.09123216095622	-15.557680153009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTAGACCTTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.36722045744	35.6774506562512	0.0129813259271492	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.43996188851	2745.43996188851
"AML-0024"	"2020-09-15-AML0024:CCACGTTAGCTGAAGC"	-0.794438938528854	-16.5050192109314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTAGCTGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.8943649692	34.7916920134622	0.0126935545047367	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.78332933654	2735.78332933654
"AML-0024"	"2020-09-15-AML0024:CCACGTTAGTTTGCTG"	-1.74420772019084	-16.6281423798767	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTAGTTTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.54028244776	37.8673684654449	0.0153027892631383	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.25440878579	2462.25440878579
"AML-0024"	"2020-09-15-AML0024:CCACGTTCACACGGAA"	-2.35361085358318	-15.6109504929748	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTCACACGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.14432476207	35.7392375507252	0.0126369921215856	2715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.92985770226	2819.92985770226
"AML-0024"	"2020-09-15-AML0024:CCACGTTCAGAAACCG"	-0.0250552100246728	-16.0028410187927	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTCAGAAACCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2168.62346028265	39.6459812824812	0.0182816344139862	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2164.04809614134	2164.04809614134
"AML-0024"	"2020-09-15-AML0024:CCACGTTCAGCGTAGA"	-0.735516826540786	-15.9685392609802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTCAGCGTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.93615980744	32.1800670530929	0.0121850984294294	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.62734042381	2635.62734042381
"AML-0024"	"2020-09-15-AML0024:CCACGTTGTGTTTACG"	-1.64785657349284	-15.3697805634704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTGTGTTTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.60229550088	39.6123662518258	0.0144644464502579	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.315240214	2732.315240214
"AML-0024"	"2020-09-15-AML0024:CCACGTTGTTATCTGG"	-0.714055756956893	-15.5649519196716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTGTTATCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.10950207938	32.4148889015183	0.0129085923471981	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.1819170728	2505.1819170728
"AML-0024"	"2020-09-15-AML0024:CCACGTTGTTCTCACC"	-1.53493879261668	-16.2718858948913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTGTTCTCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2878.96143571974	37.1254913381258	0.0128954458637423	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2871.5243406307	2871.5243406307
"AML-0024"	"2020-09-15-AML0024:CCACGTTGTTGCGTAT"	-1.0051762861317	-15.5845184556213	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACGTTGTTGCGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.35570972648	39.6824252633007	0.0137482795795329	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.52788949672	2878.52788949672
"AML-0024"	"2020-09-15-AML0024:CCACTTGAGACGAAGA"	-2.0102256340092	-15.4926624528137	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGAGACGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.83725443533	37.6692086778538	0.0142587165861984	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.20802777941	2640.20802777941
"AML-0024"	"2020-09-15-AML0024:CCACTTGAGCTCGAAG"	-1.0445308488911	-16.3671655884949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGAGCTCGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.1877142445	43.5195918148946	0.0178931879147383	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2425.50179966681	2425.50179966681
"AML-0024"	"2020-09-15-AML0024:CCACTTGAGTAGAGTT"	-2.39253888550456	-15.5944147340027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGAGTAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2991.88614058707	36.7746600903707	0.0122914637664503	2736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2981.84448171118	2981.84448171118
"AML-0024"	"2020-09-15-AML0024:CCACTTGCAGGAACCA"	-0.740152220160323	-16.4958677521911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGCAGGAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.04212666817	32.4449245245616	0.0125219594813314	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.65886095447	2585.65886095447
"AML-0024"	"2020-09-15-AML0024:CCACTTGCATGAAGCG"	-0.740771035582382	-16.587374710199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGCATGAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.5950003394	38.892027040339	0.0143640489199691	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.28037154305	2696.28037154305
"AML-0024"	"2020-09-15-AML0024:CCACTTGCATTGCTTT"	-1.57670209828075	-16.5244817963806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGCATTGCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.77889704014	37.4916556963668	0.0147385669957365	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.72107455108	2534.72107455108
"AML-0024"	"2020-09-15-AML0024:CCACTTGGTCAGTCGC"	-1.14080176773723	-16.6446314088074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGGTCAGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.29772828698	37.5120413857173	0.0139434535409591	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.88082399587	2682.88082399587
"AML-0024"	"2020-09-15-AML0024:CCACTTGGTCTGGTTA"	-1.14509628239329	-16.7631311646667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGGTCTGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.05971894988	29.7916656468006	0.0114890009779125	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.62436600919	2586.62436600919
"AML-0024"	"2020-09-15-AML0024:CCACTTGGTGTGTCGC"	-1.01633117619212	-17.4242754212585	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGGTGTGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.00258695074	40.1155349167836	0.0139000342890089	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2880.32109642648	2880.32109642648
"AML-0024"	"2020-09-15-AML0024:CCACTTGTCACTGTCC"	-0.0886195552652657	-16.1091280213562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGTCACTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2941.74877169677	39.6553016516002	0.013480179556165	2560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2938.63624453881	2938.63624453881
"AML-0024"	"2020-09-15-AML0024:CCACTTGTCAGCCCAG"	-0.969948391348678	-15.8248615494934	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCACTTGTCAGCCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.09461433126	30.500027795426	0.0113505596835922	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.69165629559	2681.69165629559
"AML-0024"	"2020-09-15-AML0024:CCATAAGAGAGTGACC"	-0.884495357901412	-15.9361276856628	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGAGAGTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.79886271095	37.4080769639562	0.0138558755174797	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.48515138692	2688.48515138692
"AML-0024"	"2020-09-15-AML0024:CCATAAGAGTCCTACA"	-1.5048579973286	-15.739549659845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGAGTCCTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.37676985899	37.8008577535426	0.0136102736091732	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.01308057862	2770.01308057862
"AML-0024"	"2020-09-15-AML0024:CCATAAGCAATCGTCA"	-1.99632201615031	-16.0653524628845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGCAATCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.61714013615	34.4350262807794	0.012966863995694	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.2483090048	2652.2483090048
"AML-0024"	"2020-09-15-AML0024:CCATAAGCAATTCTCT"	-2.47685466232951	-16.2496919861999	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGCAATTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.03189933821	38.7652373253429	0.0148694909852017	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.60459728961	2602.60459728961
"AML-0024"	"2020-09-15-AML0024:CCATAAGCAGTTCTAG"	-1.04385719719585	-16.2085256806579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGCAGTTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.46234890905	49.4856075625402	0.018163439690167	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.94709817985	2715.94709817985
"AML-0024"	"2020-09-15-AML0024:CCATAAGCATGAAAGT"	-1.01662252369578	-16.3861761323181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGCATGAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.37229697717	34.3279391564871	0.0129864185970863	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.22581543878	2637.22581543878
"AML-0024"	"2020-09-15-AML0024:CCATAAGGTACTGGGA"	0.0457557999411642	-16.1078596345154	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGGTACTGGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2698.44699733308	41.1776571441298	0.0152597613311754	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2691.65183919478	2691.65183919478
"AML-0024"	"2020-09-15-AML0024:CCATAAGGTATCGTTG"	-2.46679292145427	-16.0088167420593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGGTATCGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.76553774455	40.4710284807536	0.0159789873470852	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.16703815483	2522.16703815483
"AML-0024"	"2020-09-15-AML0024:CCATAAGGTGAGCAGT"	-2.12310777130778	-16.3329839936462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGGTGAGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.56272459559	37.6625309203155	0.0141718314197257	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.98584047031	2646.98584047031
"AML-0024"	"2020-09-15-AML0024:CCATAAGGTTCTTAGG"	-2.24672279778178	-16.5539827576843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGGTTCTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.95388868646	47.0916701542327	0.0181613989973761	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.98936974585	2578.98936974585
"AML-0024"	"2020-09-15-AML0024:CCATAAGTCGCTATTT"	-2.30149827423747	-15.5314398041931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATAAGTCGCTATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.29197078482	31.8439653378063	0.0116418889383387	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.57260855979	2720.57260855979
"AML-0024"	"2020-09-15-AML0024:CCATCACAGGTGATAT"	-0.785655419260818	-16.0057039490906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACAGGTGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2985.24267753922	37.0991633302637	0.0124275200838429	4567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2978.36081663168	2978.36081663168
"AML-0024"	"2020-09-15-AML0024:CCATCACAGTGCGACA"	-0.797407667071182	-16.1496038666931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACAGTGCGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.46957159897	33.2427495178857	0.0120642774866845	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.79560257294	2748.79560257294
"AML-0024"	"2020-09-15-AML0024:CCATCACCATCTTCGC"	-1.18258021298106	-16.2295503846374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACCATCTTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.40551866013	26.0206020226808	0.00975868143108111	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.05417777908	2656.05417777908
"AML-0024"	"2020-09-15-AML0024:CCATCACTCAAAGGAT"	-0.176459113985854	-16.0761652222839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACTCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.88158773007	33.9637460320314	0.0122529570463523	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.4072850427	2766.4072850427
"AML-0024"	"2020-09-15-AML0024:CCATCACTCGAGCCAC"	-2.50138340416606	-15.7249336472717	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACTCGAGCCAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.78032976102	32.9833696810568	0.011852667394659	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.65288354972	2774.65288354972
"AML-0024"	"2020-09-15-AML0024:CCATCACTCTGAATCG"	-0.0468773719971955	-16.4584341279236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCATCACTCTGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.03957293759	33.7376198539292	0.01326665153502	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.76472786973	2535.76472786973
"AML-0024"	"2020-09-15-AML0024:CCCAACTAGACGGAAA"	-0.986795286566573	-17.4196634522644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTAGACGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.18737934392	43.0374900115502	0.0156148636098155	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.39068624607	2744.39068624607
"AML-0024"	"2020-09-15-AML0024:CCCAACTAGATGACAT"	1.15237106856648	-16.2131967774597	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTAGATGACAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2864.4341644882	37.6425393295093	0.0131413525910919	3548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2852.69206953814	2852.69206953814
"AML-0024"	"2020-09-15-AML0024:CCCAACTAGGCACTAG"	-0.561629931361038	-16.4341325989929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTAGGCACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.61150333485	32.0988744632862	0.0120690087341846	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.95356522604	2651.95356522604
"AML-0024"	"2020-09-15-AML0024:CCCAACTAGGTAAGTT"	-1.09237621250804	-16.1986761323181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTAGGTAAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.12120649325	29.8575159482936	0.0121316722920918	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.95180477226	2453.95180477226
"AML-0024"	"2020-09-15-AML0024:CCCAACTCACATTCGA"	-1.69034753266032	-15.8071174851623	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTCACATTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.20838977715	35.2833822696001	0.0124711146754302	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.88677049125	2817.88677049125
"AML-0024"	"2020-09-15-AML0024:CCCAACTGTAAGTCAA"	-0.743218581110793	-16.4475279084411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTGTAAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.0260255276	35.1777739132131	0.0127871468996614	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.60624150784	2740.60624150784
"AML-0024"	"2020-09-15-AML0024:CCCAACTGTCAGGTAG"	-1.09583220902141	-16.8504553071228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTGTCAGGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.13862270393	40.161235906093	0.0159551148847541	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.59881623524	2511.59881623524
"AML-0024"	"2020-09-15-AML0024:CCCAACTTCATGGCCG"	-0.787773291498977	-16.6075754395691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTTCATGGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.5533796211	30.2274715049361	0.0113570788158452	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.69347175411	2652.69347175411
"AML-0024"	"2020-09-15-AML0024:CCCAACTTCCTGTTGC"	-0.585598568350631	-15.8553028336731	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTTCCTGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.60947809298	42.398463579542	0.0146070161692567	2944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2895.04872991033	2895.04872991033
"AML-0024"	"2020-09-15-AML0024:CCCAACTTCGCTGTCT"	-1.54914913597758	-16.0974703065124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCAACTTCGCTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.36058144244	34.0793504596118	0.0126484000301724	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.01209671453	2689.01209671453
"AML-0024"	"2020-09-15-AML0024:CCCATTGAGCATAGGC"	-1.4871018928593	-16.3080377808777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGAGCATAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3018.75643759129	41.6391752788269	0.0137934862052175	3169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3010.57879998726	3010.57879998726
"AML-0024"	"2020-09-15-AML0024:CCCATTGAGCCGTCGT"	-1.81405196610149	-16.8194208375183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGAGCCGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2222.10518814775	43.4047456696553	0.0195331642719558	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2212.39763701731	2212.39763701731
"AML-0024"	"2020-09-15-AML0024:CCCATTGAGGCGCTCT"	-2.39056501808818	-15.9867086640564	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGAGGCGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.14282511916	36.6204988279458	0.0134183152640049	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.75466935933	2722.75466935933
"AML-0024"	"2020-09-15-AML0024:CCCATTGAGTTCTCTT"	-0.077417011291343	-16.0522566071716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGAGTTCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.60154861056	25.7429083083197	0.00971576587499325	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.30248249174	2645.30248249174
"AML-0024"	"2020-09-15-AML0024:CCCATTGCAATACCTG"	-1.91542802277263	-15.9830370179382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGCAATACCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.35543503389	44.5992747238933	0.0158922402227196	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.78659831079	2797.78659831079
"AML-0024"	"2020-09-15-AML0024:CCCATTGGTCAGCTTA"	-2.18392000618632	-16.1770620576111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCATTGGTCAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.29297780421	34.2626887350662	0.0126510274242357	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.94708336548	2705.94708336548
"AML-0024"	"2020-09-15-AML0024:CCCGAAGAGGCCGCTT"	-1.73804471913036	-16.4183473817078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGAAGAGGCCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.25256733271	48.6284590522533	0.0226047186605089	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2149.72698041093	2149.72698041093
"AML-0024"	"2020-09-15-AML0024:CCCGAAGGTAAGTTAG"	-1.39099011841472	-16.122733139154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGAAGGTAAGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.73669722467	39.458237299648	0.0151894675629766	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.19760008264	2592.19760008264
"AML-0024"	"2020-09-15-AML0024:CCCGAAGTCGACGACC"	1.20851816710774	-16.1990881196228	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGAAGTCGACGACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2866.5051678398	43.0942386537432	0.0150337209007088	3499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2849.60994089139	2849.60994089139
"AML-0024"	"2020-09-15-AML0024:CCCGAAGTCTAGTGTG"	-0.996801475912887	-15.9673853150574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGAAGTCTAGTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.95284265453	31.138572702333	0.0116625927637637	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.38227143733	2664.38227143733
"AML-0024"	"2020-09-15-AML0024:CCCGGAACAAGTGACG"	-1.72042129460033	-16.927592300531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGGAACAAGTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1994.36339752968	52.5044804081977	0.0263264360312832	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1989.74531456415	1989.74531456415
"AML-0024"	"2020-09-15-AML0024:CCCGGAAGTACTGGGA"	-1.70434353771861	-16.2130575410095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGGAAGTACTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.84366994893	51.2276818264545	0.021204882776019	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2404.70197041579	2404.70197041579
"AML-0024"	"2020-09-15-AML0024:CCCGGAAGTTGCACGC"	-1.66430638256724	-16.4095888367859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGGAAGTTGCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.29706546744	34.2650684613836	0.0133727930782033	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.21490401998	2556.21490401998
"AML-0024"	"2020-09-15-AML0024:CCCGGAATCGGTAGAG"	8.67105736312215	6.50465772235719	"2020-09-15-AML0024"	"AML0024"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGGAATCGGTAGAG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1394.33677356705	36.4838515018603	0.0261657385744234	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1392.26277242717	1392.26277242717
"AML-0024"	"2020-09-15-AML0024:CCCGGAATCTGCGGCA"	-0.726954380900222	-16.1963777772156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCGGAATCTGCGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2294.90127692664	30.5967088139166	0.0133324727828345	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2290.83862566801	2290.83862566801
"AML-0024"	"2020-09-15-AML0024:CCCTAACCATTGAGCT"	-2.79235706749614	-15.8542938462463	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTAACCATTGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.63967837879	41.44213018365	0.0159292351389238	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.47899233289	2589.47899233289
"AML-0024"	"2020-09-15-AML0024:CCCTAACTCACCTTGC"	-1.62741873684581	-16.202473663446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTAACTCACCTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.66357298511	33.9535514326972	0.0132183723044894	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.54359804258	2563.54359804258
"AML-0024"	"2020-09-15-AML0024:CCCTAACTCTGGTGCG"	-0.853650073439437	-16.2630090943542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTAACTCTGGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.5882568772	35.1829831199845	0.0131989563764069	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.32320135251	2658.32320135251
"AML-0024"	"2020-09-15-AML0024:CCCTCAACAACAGAGC"	-2.56835256043132	-16.0178385010925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCAACAACAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.29228505242	41.1164744271113	0.0164974528363741	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.55496021575	2487.55496021575
"AML-0024"	"2020-09-15-AML0024:CCCTCAAGTTCTAAGC"	-2.0419114631718	-16.4562101594177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCAAGTTCTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.49983509997	34.544747294119	0.0121872461823236	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.61606603084	2824.61606603084
"AML-0024"	"2020-09-15-AML0024:CCCTCAAGTTTGCAGT"	-1.18539951267894	-16.1689748994079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCAAGTTTGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.48913254546	37.2763318373053	0.01431783654148	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.22281244624	2596.22281244624
"AML-0024"	"2020-09-15-AML0024:CCCTCTCCACTATCGA"	-2.03066692772563	-15.8388643494812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCCACTATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.59069042607	37.3573390090189	0.0148621409011849	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.61288084608	2504.61288084608
"AML-0024"	"2020-09-15-AML0024:CCCTCTCCATGTGTCA"	-0.518716852099258	-16.5507974854675	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCCATGTGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.8456081164	34.640148235856	0.0131919973241323	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.62890804796	2617.62890804796
"AML-0024"	"2020-09-15-AML0024:CCCTCTCGTAGTATAG"	0.030032285570544	-16.133891128656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCGTAGTATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2854.42313488331	32.0361857456478	0.0112233485477819	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.54520129309	2845.54520129309
"AML-0024"	"2020-09-15-AML0024:CCCTCTCTCATGGGAG"	1.24730612811391	-16.1874113312927	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCTCATGGGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2964.88556159539	43.1671226862593	0.0145594566095264	4266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2952.82877864955	2952.82877864955
"AML-0024"	"2020-09-15-AML0024:CCCTCTCTCGAATGCT"	-0.477415482432204	-16.4267873994079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCTCGAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.14163922032	33.0651404681206	0.0127411698723522	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.9032834144	2587.9032834144
"AML-0024"	"2020-09-15-AML0024:CCCTCTCTCTTAGCAG"	-2.46282206001933	-16.148783706781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTCTCTCTTAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.98460349107	32.3130159733141	0.0123663246733802	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.67376200819	2602.67376200819
"AML-0024"	"2020-09-15-AML0024:CCCTGATCACCATATG"	-0.446192721754867	-16.3138742676941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTGATCACCATATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.66498217953	42.1708509435578	0.0166969298149616	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.40737097197	2518.40737097197
"AML-0024"	"2020-09-15-AML0024:CCCTGATTCCGTCACT"	-2.41212401810344	-16.096573852655	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTGATTCCGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.48296459816	36.9183122472012	0.0140776175653282	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.7923046565	2615.7923046565
"AML-0024"	"2020-09-15-AML0024:CCCTTAGAGAGTCAGC"	-2.28986201706584	-16.4252348176208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGAGAGTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.28690918634	50.5313592746867	0.0224156734747332	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2245.82784322281	2245.82784322281
"AML-0024"	"2020-09-15-AML0024:CCCTTAGAGCTGCCAC"	-2.71198497238811	-15.8263635865417	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGAGCTGCCAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.14301694959	30.9682421280553	0.0118736748432894	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.97090584107	2602.97090584107
"AML-0024"	"2020-09-15-AML0024:CCCTTAGAGGATAATC"	-1.34268842163737	-16.7763929597107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGAGGATAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.68135721	32.7400847061878	0.0114971025895484	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.64421890711	2835.64421890711
"AML-0024"	"2020-09-15-AML0024:CCCTTAGAGTTTCTTC"	-2.86631331864055	-16.1436090699402	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGAGTTTCTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.23941710375	36.5523977150174	0.0154279037614951	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2362.32418436716	2362.32418436716
"AML-0024"	"2020-09-15-AML0024:CCCTTAGCACGCTGAC"	-2.11924658241923	-16.6283235779968	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGCACGCTGAC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.74081202374	38.3068586539081	0.0144568323362357	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.80652393888	2640.80652393888
"AML-0024"	"2020-09-15-AML0024:CCCTTAGCAGGCTTGC"	-2.01212344589885	-15.9819650880066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGCAGGCTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.70030745212	35.2249246040353	0.013374689786976	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.51591663561	2623.51591663561
"AML-0024"	"2020-09-15-AML0024:CCCTTAGGTCGCTTAA"	-2.05438409271892	-16.2929811707703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGGTCGCTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.65824616811	33.5250037599203	0.012376978087711	2419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.96829517023	2699.96829517023
"AML-0024"	"2020-09-15-AML0024:CCCTTAGGTCTGTAAC"	-0.619861702353317	-16.6241884461609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGGTCTGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2972.51311840621	36.4336179886287	0.0122568401003941	3062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2963.36317588947	2963.36317588947
"AML-0024"	"2020-09-15-AML0024:CCCTTAGTCAGACCCG"	-1.92286560955699	-15.7535047761169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCCTTAGTCAGACCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2896.33224605763	32.9565382283366	0.0113787146737726	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2888.94399857339	2888.94399857339
"AML-0024"	"2020-09-15-AML0024:CCGAACGGTAACGTTC"	-1.65606973591502	-15.6673231354919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGAACGGTAACGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3079.34772344835	35.8858108786224	0.0116537052978338	2815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3066.53748548859	3066.53748548859
"AML-0024"	"2020-09-15-AML0024:CCGATCTAGGTCACTT"	-1.02472470226939	-17.2235574952331	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATCTAGGTCACTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.3793095706	30.2213202616438	0.0109561872643064	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2751.11543118919	2751.11543118919
"AML-0024"	"2020-09-15-AML0024:CCGATCTCAGCTCGGT"	-2.80849800530131	-15.7008390656677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATCTCAGCTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.70988059462	35.1995313073306	0.013370076044756	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.50362045029	2627.50362045029
"AML-0024"	"2020-09-15-AML0024:CCGATCTGTACCTAAC"	-1.87157378616984	-16.6153784028259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATCTGTACCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.07231265878	43.2612671891	0.0170718361007267	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.42980931416	2522.42980931416
"AML-0024"	"2020-09-15-AML0024:CCGATCTTCCTGATAG"	-1.35944877091106	-15.5620308152405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATCTTCCTGATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.15362358368	30.4574580874542	0.0113810574322218	2506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.57286517519	2671.57286517519
"AML-0024"	"2020-09-15-AML0024:CCGATCTTCGCCTATC"	-0.908531526953536	-17.3755769959656	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATCTTCGCCTATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3000.13750663427	36.0709335577177	0.012023093434202	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2990.48311127926	2990.48311127926
"AML-0024"	"2020-09-15-AML0024:CCGATGGAGCACCAGA"	-0.0249442857807458	-16.1994428864685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGAGCACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2133.80328801298	42.4003444257794	0.0198707840895976	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2130.93026007904	2130.93026007904
"AML-0024"	"2020-09-15-AML0024:CCGATGGAGGCTCAAG"	-1.26013420048411	12.3347778090271	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGAGGCTCAAG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1900.14790546989	36.1677719369122	0.0190341877244384	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1898.5361667051	1898.5361667051
"AML-0024"	"2020-09-15-AML0024:CCGATGGCAAGACCTT"	-1.06025026264842	-16.4104795685974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGCAAGACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.94432332234	37.9288978841666	0.0133885080521757	2819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2825.54909383377	2825.54909383377
"AML-0024"	"2020-09-15-AML0024:CCGATGGCAAGTTCGT"	-0.519880692393142	-16.1482324830261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGCAAGTTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.50917229364	34.1530209202309	0.0123540993325391	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.08639934749	2756.08639934749
"AML-0024"	"2020-09-15-AML0024:CCGATGGCAGAAGTGC"	-2.07653222504314	-16.5926618806091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGCAGAAGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.55719139475	38.2685086763364	0.0136646053128012	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.87242904598	2791.87242904598
"AML-0024"	"2020-09-15-AML0024:CCGATGGGTCGTAATC"	0.336114783852738	-16.082585357782	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGGTCGTAATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2873.02993765569	28.8483620945172	0.0100410934520427	2692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2867.20981337351	2867.20981337351
"AML-0024"	"2020-09-15-AML0024:CCGATGGGTGCCTACG"	-2.69415483895	-15.9055204621521	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGATGGGTGCCTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.68899870669	35.1267350199043	0.0139077831981259	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.5333306676	2519.5333306676
"AML-0024"	"2020-09-15-AML0024:CCGCAAGGTCGACTGC"	-1.40701852265056	-16.2210073701111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGCAAGGTCGACTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.4526920639	34.9504844942615	0.0125791180803944	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.40529977646	2772.40529977646
"AML-0024"	"2020-09-15-AML0024:CCGCAAGTCCGGTAGC"	-1.17316053333934	-15.6167297593323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGCAAGTCCGGTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3118.52758515465	39.0587226682978	0.0125247321377665	3857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3106.66329326789	3106.66329326789
"AML-0024"	"2020-09-15-AML0024:CCGGACAAGCGTATGG"	0.103280906646889	-16.1765127412048	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGACAAGCGTATGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2723.58916723151	40.2091075289054	0.0147632792833353	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2713.91883366338	2713.91883366338
"AML-0024"	"2020-09-15-AML0024:CCGGGTAAGCGACTAG"	-1.29458759251292	-15.9661131135193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTAAGCGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.41276957262	33.0067820962812	0.0133933659587412	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2461.66809728802	2461.66809728802
"AML-0024"	"2020-09-15-AML0024:CCGGGTAAGGAGAGTA"	-0.994611005217391	-16.0540838471619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTAAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.54006818718	35.393577029522	0.0135216944564422	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.41588834003	2610.41588834003
"AML-0024"	"2020-09-15-AML0024:CCGGGTAAGGTTGGAC"	-2.15382991257365	-16.5014009705749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTAAGGTTGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2245.97333649806	37.8878031501996	0.0168692132424308	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2242.48905098337	2242.48905098337
"AML-0024"	"2020-09-15-AML0024:CCGGGTACATCTGGGC"	-0.547642688185531	-16.2356233826843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTACATCTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.46159561573	34.0015084866318	0.0133158487854339	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.86116595064	2548.86116595064
"AML-0024"	"2020-09-15-AML0024:CCGGGTAGTAGATGTA"	-2.10539565506633	-16.2762518159119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTAGTAGATGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2279.638360303	37.9700255622337	0.0166561618822676	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2271.06864280485	2271.06864280485
"AML-0024"	"2020-09-15-AML0024:CCGGGTATCCGAGCTG"	-1.95968470993693	-15.6119594804016	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTATCCGAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.73936303024	33.9971486847657	0.0123323768437055	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.5876889778	2747.5876889778
"AML-0024"	"2020-09-15-AML0024:CCGGGTATCGGACGTC"	-0.305015335709411	-16.1280279389587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTATCGGACGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.47704456057	33.4722260131549	0.0130066153432002	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.81822552847	2562.81822552847
"AML-0024"	"2020-09-15-AML0024:CCGGGTATCGTTGTAG"	-0.452166656882125	-15.8134174576965	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGGTATCGTTGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3011.8043853376	39.9893983466751	0.0132775549904091	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3002.67903510865	3002.67903510865
"AML-0024"	"2020-09-15-AML0024:CCGGTAGCAACTGCTA"	-2.20382938805278	-15.9253492585388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTAGCAACTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.41648467925	32.8556555191894	0.0114622755258352	2761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.89149586623	2859.89149586623
"AML-0024"	"2020-09-15-AML0024:CCGGTAGGTTCCTTGC"	-2.47837219658549	-16.3575563660828	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTAGGTTCCTTGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1562.96475596573	51.2746238350478	0.0328060013121447	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1552.72814879241	1552.72814879241
"AML-0024"	"2020-09-15-AML0024:CCGGTAGTCCATCACC"	-2.09421787682231	-16.226643585321	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTAGTCCATCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.09481203651	35.3086241634676	0.0147790803385362	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2385.0629047578	2385.0629047578
"AML-0024"	"2020-09-15-AML0024:CCGGTAGTCGTCACCT"	-0.574074963957626	-16.1123647919861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTAGTCGTCACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.89760913974	39.9740804068077	0.014871876172248	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.55477781017	2680.55477781017
"AML-0024"	"2020-09-15-AML0024:CCGGTGAAGAGAATCT"	-2.58707962456401	-16.1724786988464	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAAGAGAATCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.85581144461	34.0243502428711	0.012382145417224	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.85690360025	2740.85690360025
"AML-0024"	"2020-09-15-AML0024:CCGGTGAAGTCACGAG"	-1.95622930947002	-15.9110002747742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAAGTCACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.0598525283	38.3250759932294	0.0144075991210509	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.80543988901	2651.80543988901
"AML-0024"	"2020-09-15-AML0024:CCGGTGAGTAGATCCT"	-0.618345240980941	-15.8579540482727	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAGTAGATCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.13142076122	40.0194785301776	0.014514896979096	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.57286480559	2750.57286480559
"AML-0024"	"2020-09-15-AML0024:CCGGTGAGTCCCTCAT"	-0.920405427843887	-15.615258239862	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAGTCCCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.06692194217	40.7968942469143	0.013947337047532	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.65212166608	2915.65212166608
"AML-0024"	"2020-09-15-AML0024:CCGGTGAGTGAGTAAT"	-0.591588596731979	-15.7614126435486	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAGTGAGTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.97999009041	37.2580534104679	0.0127771979015922	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.13741810729	2908.13741810729
"AML-0024"	"2020-09-15-AML0024:CCGGTGAGTTGGGAAC"	-2.58718953552898	-16.0611410371033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGAGTTGGGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.25067991459	31.7468135567861	0.011752635100786	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.40263732673	2694.40263732673
"AML-0024"	"2020-09-15-AML0024:CCGGTGATCCATTGGA"	-0.453127126128036	-15.9149141541687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGATCCATTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.12267938233	34.0760606019002	0.0118314615019136	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.37161531948	2875.37161531948
"AML-0024"	"2020-09-15-AML0024:CCGGTGATCCTATTGT"	-2.08182368698772	-16.6373205414978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGATCCTATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.79991536618	32.3963413403333	0.0112183469387716	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2883.85793881375	2883.85793881375
"AML-0024"	"2020-09-15-AML0024:CCGGTGATCTCGACCT"	-1.85461924496349	-16.6302709809509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGGTGATCTCGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.08389226567	48.4254667607666	0.0209717225619082	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2301.45146710667	2301.45146710667
"AML-0024"	"2020-09-15-AML0024:CCGTAGGAGTGAGGTC"	-0.35798285427745	-15.9625292054382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTAGGAGTGAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.97608976078	32.9722776772695	0.0122030234842636	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.85365295139	2698.85365295139
"AML-0024"	"2020-09-15-AML0024:CCGTAGGCAAGAGCTG"	-1.45730100098308	-15.6580229035583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTAGGCAAGAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.11180532157	37.339200542121	0.0134841794651859	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.27119115346	2762.27119115346
"AML-0024"	"2020-09-15-AML0024:CCGTGAGCAGCTGAAG"	-1.13658414307292	-16.0303030244079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTGAGCAGCTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.59643053016	35.8289552326044	0.0131453632794915	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.56986012627	2718.56986012627
"AML-0024"	"2020-09-15-AML0024:CCGTGAGCATTCTTCA"	-0.438195894390899	-16.4292326203552	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTGAGCATTCTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2799.98239914857	34.9414825353648	0.012479179349838	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.8444136703	2794.8444136703
"AML-0024"	"2020-09-15-AML0024:CCGTGAGGTGCAACGA"	0.947502990334672	-16.221272491571	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTGAGGTGCAACGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3097.63736104981	38.4494406753923	0.0124125054658953	3561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3090.55157830409	3090.55157830409
"AML-0024"	"2020-09-15-AML0024:CCGTTCAAGGAGAATG"	-2.16270981255229	-15.4665565720764	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTTCAAGGAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.90536651532	31.0701380190837	0.0112740221041661	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.59169030498	2750.59169030498
"AML-0024"	"2020-09-15-AML0024:CCGTTCAAGGAGAGTA"	-0.849843124777633	-16.6530523530212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTTCAAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.97218215171	34.2860254269538	0.0117822519532134	3089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.29910816407	2901.29910816407
"AML-0024"	"2020-09-15-AML0024:CCGTTCAGTCAAAGTA"	-0.663597683340865	-15.6765737763611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTTCAGTCAAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3056.06174571112	38.91659666841	0.0127342311466794	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3046.92236567915	3046.92236567915
"AML-0024"	"2020-09-15-AML0024:CCGTTCATCGTAGTGT"	-1.28800497475322	-15.8336277238098	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCGTTCATCGTAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.59006193924	36.2132685237256	0.013605877569794	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.25084554711	2655.25084554711
"AML-0024"	"2020-09-15-AML0024:CCTAACCAGGCTAAAT"	-1.52507660809215	-15.6570415726868	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAACCAGGCTAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.87615064031	38.8857000859095	0.0135401730597747	2378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2866.14247720178	2866.14247720178
"AML-0024"	"2020-09-15-AML0024:CCTAACCAGGGACTGT"	-1.93298862400706	-16.9415235749451	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAACCAGGGACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1718.83816214304	45.6293592570512	0.0265466291487039	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1699.84275845857	1699.84275845857
"AML-0024"	"2020-09-15-AML0024:CCTAACCGTCAAAGCG"	-1.98291335526164	-15.9017725220886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAACCGTCAAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.2429085467	32.0310772418924	0.0123803903901257	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.75863576331	2579.75863576331
"AML-0024"	"2020-09-15-AML0024:CCTAACCGTGAGTGAC"	-1.78697715225871	-16.3375864258972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAACCGTGAGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.61685474274	43.3286048823815	0.0185433075150662	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2332.85507763336	2332.85507763336
"AML-0024"	"2020-09-15-AML0024:CCTAAGAAGCAGTACG"	-0.82159117880519	-16.8771906129089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAAGAAGCAGTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.83219110805	35.8705217889526	0.0144068029632909	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2478.95672547444	2478.95672547444
"AML-0024"	"2020-09-15-AML0024:CCTAAGAAGTCGCCAC"	-0.700781564146835	-15.999686264154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAAGAAGTCGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.4989017281	37.0242740854961	0.0138330989269568	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.17013574312	2673.17013574312
"AML-0024"	"2020-09-15-AML0024:CCTAAGACACTTGGCG"	-2.17724738541301	-16.3814764252869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAAGACACTTGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.58132980838	41.3099217417868	0.0175594021844726	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.41076413112	2345.41076413112
"AML-0024"	"2020-09-15-AML0024:CCTAAGAGTCGGAACA"	-1.90859411183055	-16.1614942780701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTAAGAGTCGGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.90691907562	36.1443412972928	0.0135783640811319	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.85012437551	2647.85012437551
"AML-0024"	"2020-09-15-AML0024:AGGTCATTCACATTGG"	-0.0949689698522866	-16.4686479798523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATTCACATTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.97654772158	42.2445228967007	0.0155197967932756	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.89607986021	2708.89607986021
"AML-0024"	"2020-09-15-AML0024:AGGTCTAAGGTACCTT"	-0.45453510704692	-16.0824575654236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTAAGGTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.34103922552	25.5647825767279	0.00911614608178618	2750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.10801111796	2798.10801111796
"AML-0024"	"2020-09-15-AML0024:AGGTCTAAGTCTCGTA"	-2.01346168938335	-16.1077871552673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTAAGTCTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.44818209554	34.0779552601706	0.0129502665080157	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.73958418254	2625.73958418254
"AML-0024"	"2020-09-15-AML0024:AGGTCTACACAAGTTC"	-1.67567441883739	-15.905489944574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTACACAAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.93591305627	35.0742194914712	0.0127452893525119	2454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.91147589444	2743.91147589444
"AML-0024"	"2020-09-15-AML0024:AGGTCTACATGTTACG"	-1.78293798390086	-16.9240045777527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTACATGTTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2199.29575427342	35.9994192413328	0.0163686121665914	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2192.08778463449	2192.08778463449
"AML-0024"	"2020-09-15-AML0024:AGGTCTAGTGCATACT"	-0.240248600870925	-16.1619959107605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTAGTGCATACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.43586115952	36.6031315680467	0.0133664374204288	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.40171384842	2730.40171384842
"AML-0024"	"2020-09-15-AML0024:AGGTCTATCACGATCA"	-2.29753838005717	-15.4436655274597	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTATCACGATCA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.04634907228	37.3536915945258	0.0143389738949667	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.4648419098	2596.4648419098
"AML-0024"	"2020-09-15-AML0024:AGGTCTATCCAAGCAT"	-0.858565072447616	-17.0892420045105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTATCCAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2978.80717226646	39.9565288681103	0.0134136003297282	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2972.10498634096	2972.10498634096
"AML-0024"	"2020-09-15-AML0024:AGGTCTATCTCTTAAC"	-1.63554320755656	-16.9304399720398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTATCTCTTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.68182185049	40.9500410011078	0.0168471416674077	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.37442438062	2423.37442438062
"AML-0024"	"2020-09-15-AML0024:AGGTCTATCTTGGTCC"	-1.94337044182475	-15.8942909470764	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCTATCTTGGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3157.09698147486	35.0282205062384	0.0110950726923424	4079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3150.3130313075	3150.3130313075
"AML-0024"	"2020-09-15-AML0024:AGGTGTTAGCTGACAG"	-1.2551740211552	-15.8452205888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTAGCTGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.27816852483	34.6877104160057	0.0142204816423144	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2432.75939427325	2432.75939427325
"AML-0024"	"2020-09-15-AML0024:AGGTGTTAGGATCACG"	-0.288733403117019	-16.2356939545837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTAGGATCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.88339216733	35.2697370270354	0.013269858689427	2598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.2617813564	2643.2617813564
"AML-0024"	"2020-09-15-AML0024:AGGTGTTCAGGCTATT"	-0.134803320199806	-15.9022913209167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTCAGGCTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2831.07427923679	39.1572472595902	0.013831232739731	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.1024032771	2822.1024032771
"AML-0024"	"2020-09-15-AML0024:AGGTGTTCATAATCCG"	-2.86528740349467	-15.9412355653015	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTCATAATCCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2551.05685264204	43.6837337991734	0.0171237790149332	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.82362933133	2546.82362933133
"AML-0024"	"2020-09-15-AML0024:AGGTGTTCATCGTGGC"	-1.27385065975841	-16.083842300531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTCATCGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.97844367139	34.8751814123796	0.0123191264456084	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.26594876675	2824.26594876675
"AML-0024"	"2020-09-15-AML0024:AGGTGTTGTCAACCTA"	-2.12611661377605	-16.7337370148865	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTGTCAACCTA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2255.90829698499	37.0793329049755	0.0164365426354129	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2247.25529370235	2247.25529370235
"AML-0024"	"2020-09-15-AML0024:AGGTGTTTCAGGTAAA"	-1.35783956471141	-16.1129713288513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTGTTTCAGGTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.90517763336	39.1712491218647	0.0146879047108175	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.90191267475	2661.90191267475
"AML-0024"	"2020-09-15-AML0024:AGGTTACAGCCTCTGG"	-0.448123971850234	-16.2936487427917	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACAGCCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.68955630102	33.9345205061007	0.0129982978727586	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.40952984513	2600.40952984513
"AML-0024"	"2020-09-15-AML0024:AGGTTACAGCTGAGCA"	0.795245190232438	-16.2343511811462	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACAGCTGAGCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3034.5134061163	38.3630409330597	0.0126422380786771	3289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3022.472775372	3022.472775372
"AML-0024"	"2020-09-15-AML0024:AGGTTACAGTAAGACT"	-2.567854265601	-16.1937475434509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACAGTAAGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2267.06771276046	31.7721751511076	0.0140146564534769	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2259.47505947577	2259.47505947577
"AML-0024"	"2020-09-15-AML0024:AGGTTACCACCCTAGG"	0.139542494981927	-16.0595236054626	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACCACCCTAGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2817.20386162142	39.8992547295084	0.0141627147658901	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2808.9277352458	2808.9277352458
"AML-0024"	"2020-09-15-AML0024:AGGTTACGTACCGGAA"	-0.900580088526565	-15.5505810013977	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACGTACCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.43712215891	36.3492932770791	0.0136834758759649	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.63880996059	2651.63880996059
"AML-0024"	"2020-09-15-AML0024:AGGTTACTCGTGGCGT"	0.145822149782819	-16.3990202180115	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACTCGTGGCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2805.53127768787	39.2606734239271	0.013994024495882	2703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2799.20253927026	2799.20253927026
"AML-0024"	"2020-09-15-AML0024:AGGTTACTCTGTGCGG"	-0.699270944029647	-16.0719423524109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTACTCTGTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.73267949751	37.212425661062	0.0131877927102892	2838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.7486500711	2811.7486500711
"AML-0024"	"2020-09-15-AML0024:AGGTTGTAGCATCCTA"	-0.324834505945998	-16.6987142792908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTAGCATCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.77375230952	43.1189932645299	0.016217624093466	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.34865568809	2650.34865568809
"AML-0024"	"2020-09-15-AML0024:AGGTTGTAGGTGAGAA"	-1.32051954689677	-16.0538397065369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTAGGTGAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.96274612963	33.6863109198464	0.0132208804744167	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2541.37101475099	2541.37101475099
"AML-0024"	"2020-09-15-AML0024:AGGTTGTAGGTTGCCC"	-1.54210482063945	-15.8523416749206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTAGGTTGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.22287488839	35.2559463013587	0.0132430483690577	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.19678385456	2652.19678385456
"AML-0024"	"2020-09-15-AML0024:AGGTTGTCACGCACCA"	-1.00611184063609	-16.4145040742126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTCACGCACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.03326012869	38.0050865072108	0.0162273897447222	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2337.00491712887	2337.00491712887
"AML-0024"	"2020-09-15-AML0024:AGGTTGTCACGCCAGT"	-0.800331036478835	-16.6658468476501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTCACGCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.79171895299	36.2809758583507	0.013912528211002	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.59016115291	2598.59016115291
"AML-0024"	"2020-09-15-AML0024:AGGTTGTCACTACACA"	-2.27334008637126	-15.5336647263733	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTCACTACACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.6950983746	33.7853364617231	0.012990887122	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.30594298507	2596.30594298507
"AML-0024"	"2020-09-15-AML0024:AGGTTGTTCTAAGCCA"	-1.63578627529796	-15.8876686326233	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTTGTTCTAAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.85395479849	34.447102337872	0.0129022421904242	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.49009942864	2664.49009942864
"AML-0024"	"2020-09-15-AML0024:AGTAACCAGACATAGT"	-1.5172235769337	-15.2856416932312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCAGACATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.71520157776	33.6649840558245	0.0133288915689285	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.41056263706	2513.41056263706
"AML-0024"	"2020-09-15-AML0024:AGTAACCAGCATCCCG"	-1.83028636398967	-16.6927271119324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCAGCATCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.99709167652	35.0067651463816	0.013422854365178	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.5008353368	2599.5008353368
"AML-0024"	"2020-09-15-AML0024:AGTAACCCAGTTTGGT"	-1.0639707845753	-15.9488210908142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCCAGTTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3078.71217029526	29.8757229055329	0.00970396752050637	2881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3071.58094446591	3071.58094446591
"AML-0024"	"2020-09-15-AML0024:AGTAACCGTCGAGATG"	-2.07243881645854	-15.9900408021179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCGTCGAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.82993877975	30.3880861277697	0.0124652198434237	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2428.49175235304	2428.49175235304
"AML-0024"	"2020-09-15-AML0024:AGTAACCTCCAACCAA"	-0.0701221701806367	-16.2546816102234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCTCCAACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2948.77315296756	36.1746323099265	0.0122676891145463	3182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.7905197597	2939.7905197597
"AML-0024"	"2020-09-15-AML0024:AGTAACCTCGGTGAAG"	-0.387391636998016	-16.5245027772156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCTCGGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.53689958197	38.2947341113791	0.0139989828385174	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.78909390171	2723.78909390171
"AML-0024"	"2020-09-15-AML0024:AGTAACCTCGTTGTGA"	-2.03724227371867	-16.238440536615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAACCTCGTTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.84953450536	32.873372970881	0.0119415800096709	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.32739681208	2743.32739681208
"AML-0024"	"2020-09-15-AML0024:AGTACCAAGGATAATC"	-0.352465311915237	-15.9587526551453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAAGGATAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.01245543348	36.3249932071518	0.0123344107221458	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2938.89170817376	2938.89170817376
"AML-0024"	"2020-09-15-AML0024:AGTACCAAGGTCGCCT"	-2.32333813133891	-16.3567018738953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAAGGTCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.30421304696	37.4359768318174	0.0139566484106186	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.44111347384	2676.44111347384
"AML-0024"	"2020-09-15-AML0024:AGTACCACAAATAGCA"	-1.65360722962077	13.9575624235901	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCACAAATAGCA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2665.76802961213	40.6550542900577	0.0152507847038638	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2655.60603942422	2655.60603942422
"AML-0024"	"2020-09-15-AML0024:AGTACCAGTATTGAGA"	-2.31989703598674	-15.761932396051	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAGTATTGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.68236967978	36.3501145148513	0.0148690541420367	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2435.93337034356	2435.93337034356
"AML-0024"	"2020-09-15-AML0024:AGTACCAGTGGCAGAT"	-1.77192292633708	-16.8560419312683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAGTGGCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.36951148111	32.7358819988918	0.0130871835802893	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.97142573396	2497.97142573396
"AML-0024"	"2020-09-15-AML0024:AGTACCAGTGTCTTGA"	-2.5477114719456	-16.1815214387146	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAGTGTCTTGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.28046116967	42.2802984902959	0.0172201502675397	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2451.107485079	2451.107485079
"AML-0024"	"2020-09-15-AML0024:AGTACCAGTTCAGCTA"	9.60960640487019	6.96272513950197	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCAGTTCAGCTA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1502.12260307508	44.352564785246	0.0295265943635022	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1499.98679785908	1499.98679785908
"AML-0024"	"2020-09-15-AML0024:AGTACCATCAGGACAG"	-2.38921437683757	-16.1195135346619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCATCAGGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.60862593081	40.1916486496647	0.0166866664085505	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2400.90668537972	2400.90668537972
"AML-0024"	"2020-09-15-AML0024:AGTACCATCGGACGTC"	-0.472611765295821	-16.08070471203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACCATCGGACGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.08475124728	31.6193156257137	0.0122172643729983	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.87430234074	2580.87430234074
"AML-0024"	"2020-09-15-AML0024:AGTACTGAGGTTCAGG"	-2.13878021660503	-16.6331548920837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGAGGTTCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2084.59209668776	41.3563369350617	0.0198390548447216	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2077.25281944265	2077.25281944265
"AML-0024"	"2020-09-15-AML0024:AGTACTGAGGTTGACG"	-1.54617665234264	-15.9451990357605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGAGGTTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.35459130503	38.1216882497946	0.0150479085638606	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.11348261251	2524.11348261251
"AML-0024"	"2020-09-15-AML0024:AGTACTGCATTCACCC"	0.225586851208848	-16.1896620026794	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGCATTCACCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2871.8150976886	40.3115119819093	0.0140369454894064	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2860.76873043226	2860.76873043226
"AML-0024"	"2020-09-15-AML0024:AGTACTGCATTGGATC"	-0.617767433554488	-15.9036903611389	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGCATTGGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.69069578223	33.3439390481681	0.012885596838338	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.79367006256	2583.79367006256
"AML-0024"	"2020-09-15-AML0024:AGTACTGGTACCACGC"	-0.611987451941329	-16.4081964722839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGGTACCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.23442034379	42.434798807585	0.0155425477356049	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.63358829576	2722.63358829576
"AML-0024"	"2020-09-15-AML0024:AGTACTGGTGTTAGCT"	-0.324150691658813	-16.6859426728454	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGGTGTTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.64673032361	41.2395924327573	0.0148256038350203	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.09137776093	2771.09137776093
"AML-0024"	"2020-09-15-AML0024:AGTACTGTCATTACGG"	-2.24681435051616	-15.500252746698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGTCATTACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.75053580039	36.9440111874089	0.0132760772883233	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.97445355696	2777.97445355696
"AML-0024"	"2020-09-15-AML0024:AGTACTGTCGTACCTC"	0.978406389325303	-16.2236318818298	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGTCGTACCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2854.52353030003	33.53556029392	0.0117482164494175	4260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2842.76889442884	2842.76889442884
"AML-0024"	"2020-09-15-AML0024:AGTACTGTCTGTCGTC"	-0.913559059531051	-15.6067762604919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTACTGTCTGTCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.2880321556	37.1259944330609	0.0127963835446827	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.47717916805	2890.47717916805
"AML-0024"	"2020-09-15-AML0024:AGTAGCTAGACACACG"	-1.95661316338237	-15.6457386246887	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGCTAGACACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.73695842466	37.0534753879544	0.014247298354386	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.35654638219	2595.35654638219
"AML-0024"	"2020-09-15-AML0024:AGTAGCTGTCCTCCAT"	-1.78289483013805	-15.7787847748962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGCTGTCCTCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2922.53858231588	31.388915044482	0.0107402910724309	2806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.84492132668	2916.84492132668
"AML-0024"	"2020-09-15-AML0024:AGTAGCTTCTCTGACC"	-0.791494588286239	-15.8644638291565	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGCTTCTCTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2107.99290707558	49.4952177050381	0.0234797837976138	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2104.3444147518	2104.3444147518
"AML-0024"	"2020-09-15-AML0024:AGTAGTCCACACGGTC"	-1.13112113896068	-16.8681249848572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCCACACGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2115.56034387331	49.1973041624106	0.0232549755930559	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2106.15987435064	2106.15987435064
"AML-0024"	"2020-09-15-AML0024:AGTAGTCCAGCATCTA"	-0.807391683489639	-15.6248655549255	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCCAGCATCTA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1697.44552874105	34.9526650010763	0.0205913323339452	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1697.44552874105	1697.44552874105
"AML-0024"	"2020-09-15-AML0024:AGTAGTCCAGTTTCGA"	-1.44839094105418	-15.8268804780212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCCAGTTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.42892258541	40.8749957164252	0.0143550539197696	2657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.02096418949	2838.02096418949
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTCCTGTCT"	9.27958454665486	7.35767791354982	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTCCTGTCT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1855.75668440436	33.6834957710014	0.0181508147345366	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1848.63732202182	1848.63732202182
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTGCTGCAC"	1.25435151633565	-16.1925115815369	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTGCTGCAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3063.96408510066	40.1376940515237	0.0130999231507653	3598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3055.46650736486	3055.46650736486
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTGGATCAG"	-0.932797471911269	-17.5518503419128	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes (cycling)"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTGGATCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2800.94241327934	43.562002681776	0.0155526234581787	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2789.05659251144	2789.05659251144
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTTCTATCT"	-0.440426240593749	-15.644594215509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTTCTATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.41363270775	37.7802533001584	0.013300968867743	2868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.56133567612	2832.56133567612
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTTGGCCGT"	0.033298890187782	-16.0358915559021	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTTGGCCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2478.91981885788	46.867247948246	0.0189063186278608	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2476.6718005575	2476.6718005575
"AML-0024"	"2020-09-15-AML0024:AGTAGTCGTTTACACG"	0.0323380279237449	-16.142773651239	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCGTTTACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.06931448844	42.1197137514991	0.0151179705158315	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.37532678578	2783.37532678578
"AML-0024"	"2020-09-15-AML0024:AGTAGTCTCGACACCG"	-1.13795397701915	-17.2620249024597	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCTCGACACCG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.32668135272	40.7717106286613	0.0150430982763717	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.57944361657	2706.57944361657
"AML-0024"	"2020-09-15-AML0024:AGTAGTCTCGATTGGT"	-3.19446812096294	11.8336982497009	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTAGTCTCGATTGGT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1957.61118869014	31.7311930678604	0.0162091396142316	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1950.44620959621	1950.44620959621
"AML-0024"	"2020-09-15-AML0024:AGTCAACAGACTCTAC"	-2.06770692291911	-16.6475954285828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACAGACTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.90752625564	38.4635548307587	0.0154291943947601	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2483.90409419439	2483.90409419439
"AML-0024"	"2020-09-15-AML0024:AGTCAACCATCCGAAT"	-1.27150140228923	-16.2695570222107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACCATCCGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.35409047098	39.8854756880128	0.0155416884350097	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.69014577086	2557.69014577086
"AML-0024"	"2020-09-15-AML0024:AGTCAACGTCCGGCAT"	-0.828539709479171	-16.6884603730408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACGTCCGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.92933134017	30.5183831459413	0.0114820145088483	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.0305957083	2650.0305957083
"AML-0024"	"2020-09-15-AML0024:AGTCAACGTCGTTTCC"	-2.7998288673466	-15.6276722184387	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACGTCGTTTCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.86743718167	36.475020269424	0.0144006826942392	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.07524343609	2531.07524343609
"AML-0024"	"2020-09-15-AML0024:AGTCAACGTTGGCCGT"	-2.87485776367839	-15.8754425278869	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACGTTGGCCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.34644100774	43.222728164927	0.0167507461316111	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.41049487453	2575.41049487453
"AML-0024"	"2020-09-15-AML0024:AGTCAACTCACCGCTT"	-1.51742492142375	-16.2840528718201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACTCACCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.12537421608	37.8171622338691	0.0126727792875672	3166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2969.3939510491	2969.3939510491
"AML-0024"	"2020-09-15-AML0024:AGTCAACTCTTACGTT"	-2.44857607308086	-16.3440294495788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACTCTTACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.23308211077	36.412036682695	0.013534900349276	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.44500374453	2684.44500374453
"AML-0024"	"2020-09-15-AML0024:AGTCAACTCTTTGGAG"	-1.96043048325236	-15.9475279084411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCAACTCTTTGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.54921828661	39.5174880294335	0.0158606090296738	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2483.59958336299	2483.59958336299
"AML-0024"	"2020-09-15-AML0024:AGTCACAAGCAGTACG"	-2.21591625633891	-16.1008615723816	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAAGCAGTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.04025618887	33.0872911491934	0.0129245198661252	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.49708556379	2552.49708556379
"AML-0024"	"2020-09-15-AML0024:AGTCACAAGCGTATGG"	-2.12668261948283	-16.1866712800232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAAGCGTATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.13852433016	36.3237404139948	0.0139217370313138	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.37824793291	2600.37824793291
"AML-0024"	"2020-09-15-AML0024:AGTCACAAGGTGGGTT"	-0.275645027787048	-16.0878343812195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAAGGTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.37020145019	31.1632929289046	0.0121334895223862	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.20221566028	2562.20221566028
"AML-0024"	"2020-09-15-AML0024:AGTCACAGTCAGACTT"	0.115796958177727	-16.0159979096619	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAGTCAGACTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2874.2453839172	41.0801120787461	0.0142924860586397	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2861.6349993042	2861.6349993042
"AML-0024"	"2020-09-15-AML0024:AGTCACAGTCTTGTCC"	-1.75291929665263	-16.265482925531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAGTCTTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1925.40762803393	41.2340890254137	0.0214157710944142	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1924.02760066614	1924.02760066614
"AML-0024"	"2020-09-15-AML0024:AGTCACAGTTGTGTTG"	-1.78786383095439	-15.2040243378845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACAGTTGTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.27922140859	43.2812256499442	0.0148820736782562	2848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.15705327533	2901.15705327533
"AML-0024"	"2020-09-15-AML0024:AGTCACATCTACCACC"	-1.46804819527324	-15.8473386994568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCACATCTACCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.21748563238	39.5246481160788	0.0148520924462086	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.15776233735	2655.15776233735
"AML-0024"	"2020-09-15-AML0024:AGTCATGAGATCGCTT"	-1.69618425789531	-15.5209284058777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGAGATCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.27671804861	36.7460248622559	0.0131787582718737	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.26718049283	2779.26718049283
"AML-0024"	"2020-09-15-AML0024:AGTCATGCAAAGGAGA"	-2.06406817856486	-15.7669353715149	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGCAAAGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.33322303278	35.2875845579413	0.01313107889096	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.28186138618	2678.28186138618
"AML-0024"	"2020-09-15-AML0024:AGTCATGCAGCGTTTA"	-1.13430295410808	-15.8965025178161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGCAGCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.73770340791	31.991693191857	0.0124348833343874	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.16564516695	2566.16564516695
"AML-0024"	"2020-09-15-AML0024:AGTCATGCATCGCTCT"	-0.861459593207198	11.9975185164246	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGCATCGCTCT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1907.1917093604	40.8517255736215	0.0214198317731371	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1907.1917093604	1907.1917093604
"AML-0024"	"2020-09-15-AML0024:AGTCATGGTACGAAAT"	-1.97223315659221	-16.67787268078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGGTACGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.84785680977	37.4821412059942	0.014214753084519	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.26547171381	2624.26547171381
"AML-0024"	"2020-09-15-AML0024:AGTCATGGTGACTAAA"	-0.556060890585738	-15.7222852936951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGGTGACTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.9667800868	33.9175180766813	0.0120063422748069	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.98738103547	2817.98738103547
"AML-0024"	"2020-09-15-AML0024:AGTCATGGTGCCGGTT"	-0.921913186938125	-16.2240457764831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGGTGCCGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3011.96768536308	38.9100846553435	0.0129184933970011	3217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.87583724831	3000.87583724831
"AML-0024"	"2020-09-15-AML0024:AGTCATGGTTAATCGC"	0.961520453065079	-16.3025026551453	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGGTTAATCGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2675.57293614865	49.2847170430709	0.0184202480064004	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2663.33314066613	2663.33314066613
"AML-0024"	"2020-09-15-AML0024:AGTCATGTCCAAAGGG"	-2.78714213791545	-16.2191610566345	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCATGTCCAAAGGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.54857762533	37.9649201320181	0.0135176298656433	2860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.95976200516	2799.95976200516
"AML-0024"	"2020-09-15-AML0024:AGTCTCCAGAGTCAAT"	-0.692821542651016	-15.9196329346863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCTCCAGAGTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.52647931353	33.1346716358722	0.0121082956391433	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.03274783206	2730.03274783206
"AML-0024"	"2020-09-15-AML0024:AGTCTCCAGCTAATCC"	8.72882809218709	7.55899570072023	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCTCCAGCTAATCC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1533.05711716224	39.4801787696129	0.0257525817711819	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1533.05711716224	1533.05711716224
"AML-0024"	"2020-09-15-AML0024:AGTCTCCAGGAGAGTA"	-1.4798518222874	-15.8933305970398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCTCCAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.58265366019	36.0836407872916	0.0133219640680083	2484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.37763897866	2702.37763897866
"AML-0024"	"2020-09-15-AML0024:AGTCTCCAGGTAGGCT"	-2.52578626099284	-16.1944036713806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCTCCAGGTAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.11211522594	29.8569370171268	0.0115317281324148	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.67769023368	2582.67769023368
"AML-0024"	"2020-09-15-AML0024:AGTCTCCAGTGAGCCA"	-0.703549365431625	-15.9740629426208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTCTCCAGTGAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.39111795065	31.075755651546	0.0114190699920222	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.50593406077	2711.50593406077
"AML-0024"	"2020-09-15-AML0024:AGTGACTAGAGAGAAC"	-1.5068133873051	-16.018879913446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTAGAGAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.35797321816	31.1398671408415	0.0126360973037438	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.38998211687	2455.38998211687
"AML-0024"	"2020-09-15-AML0024:AGTGACTAGGATTTGA"	0.693974514573258	-16.2495088807312	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTAGGATTTGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3015.2310880008	36.8086555889144	0.0122075736534409	3886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3005.90483895731	3005.90483895731
"AML-0024"	"2020-09-15-AML0024:AGTGACTCAGCTATAC"	-0.475609759718734	-16.1371488801208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTCAGCTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.99294212502	26.7972171908963	0.00991390572031205	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.07677123612	2697.07677123612
"AML-0024"	"2020-09-15-AML0024:AGTGACTCAGGTGTTT"	-1.05965135517772	-15.9549665681091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTCAGGTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.57747024498	36.6208469367385	0.0126297184029522	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.23183354379	2890.23183354379
"AML-0024"	"2020-09-15-AML0024:AGTGACTCAGTAGGAC"	-0.848230759531814	-15.6804971924988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTCAGTAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.42486346783	33.6994517514712	0.0118101766697706	2789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.20166925717	2850.20166925717
"AML-0024"	"2020-09-15-AML0024:AGTGACTCATTAAAGG"	-1.97611127319987	-15.6112957230774	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTCATTAAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1881.12518153494	47.4752115999072	0.025237667363088	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1877.76826059734	1877.76826059734
"AML-0024"	"2020-09-15-AML0024:AGTGACTGTGGGTCAA"	-2.05089793625529	-16.4126863709656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTGTGGGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.93135444736	40.8364163310151	0.0154804696726349	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.39036744282	2626.39036744282
"AML-0024"	"2020-09-15-AML0024:AGTGACTGTTACCCTC"	-2.36116013947185	-16.5177793732849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTGTTACCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.31501468968	40.5597140835065	0.0157310933118808	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.84451477614	2564.84451477614
"AML-0024"	"2020-09-15-AML0024:AGTGACTGTTGTAGCT"	-1.30202553692515	-16.0861158601013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTGTTGTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.03804376427	33.6061427559473	0.0124603888453286	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.79273872894	2689.79273872894
"AML-0024"	"2020-09-15-AML0024:AGTGACTTCTACGGGC"	-0.88348619166072	-15.886142753717	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGACTTCTACGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3003.86388928837	42.1655068203721	0.0140370896866307	2848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2999.68380832453	2999.68380832453
"AML-0024"	"2020-09-15-AML0024:AGTGATCAGCTCATAC"	-0.83976117792781	-16.1602697602478	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCAGCTCATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.65380667045	35.4447526836333	0.0127103452564996	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.88450609641	2780.88450609641
"AML-0024"	"2020-09-15-AML0024:AGTGATCAGGTGCCAA"	-1.89344916763957	-16.0085878602234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCAGGTGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.33732674725	34.3870519623361	0.0138026479165038	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.16386434764	2481.16386434764
"AML-0024"	"2020-09-15-AML0024:AGTGATCAGTGTAGTA"	-0.391323487192947	-16.3409052125183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCAGTGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.9910344854	35.7739310003084	0.0143096237173795	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.4515513096	2497.4515513096
"AML-0024"	"2020-09-15-AML0024:AGTGATCCACGCCAGT"	-0.947346667677718	-17.5430059663025	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCCACGCCAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2979.58474343134	41.315467569026	0.0138661830847766	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2964.20001143996	2964.20001143996
"AML-0024"	"2020-09-15-AML0024:AGTGATCCAGCCTACG"	-1.03652487221416	-16.3588094941345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCCAGCCTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.00362878494	39.4934061807527	0.0150279115858803	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.02306024903	2619.02306024903
"AML-0024"	"2020-09-15-AML0024:AGTGATCGTACTGAGG"	-0.895672301680404	-15.6896906129089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCGTACTGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.14742029622	37.4765605119404	0.0131720979533772	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.23523231933	2839.23523231933
"AML-0024"	"2020-09-15-AML0024:AGTGATCGTCCACTCT"	-1.8919771713322	-16.5814638367859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCGTCCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.49189041496	37.4922443275513	0.016630019600847	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2244.45351447486	2244.45351447486
"AML-0024"	"2020-09-15-AML0024:AGTGATCGTGTGTGTT"	-1.49024806442912	-16.5654325715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCGTGTGTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.64968512465	33.257476991447	0.0133529324457295	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.1107138254	2486.1107138254
"AML-0024"	"2020-09-15-AML0024:AGTGATCTCGCAATGT"	-2.30388174477275	-16.3183698884216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCTCGCAATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.11429831411	46.1606193766405	0.0187179561824028	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2457.39041506943	2457.39041506943
"AML-0024"	"2020-09-15-AML0024:AGTGATCTCTTCGGTC"	9.68360390242879	7.65261409366456	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGATCTCTTCGGTC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2066.99100463674	30.1827485393291	0.0146022640986933	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	2066.99100463674	2066.99100463674
"AML-0024"	"2020-09-15-AML0024:AGTGCCGAGGGTGGGA"	-0.519414941698867	-15.8833379975525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGAGGGTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.73047368082	41.0228698809825	0.0155700441812828	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.23444687178	2625.23444687178
"AML-0024"	"2020-09-15-AML0024:AGTGCCGAGTATCTGC"	-1.45436726036723	-16.4021368256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGAGTATCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.0995535667	31.999586038577	0.0125582165711641	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.38595734543	2543.38595734543
"AML-0024"	"2020-09-15-AML0024:AGTGCCGAGTTGGAAT"	-1.9355608028477	-15.9764509431091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGAGTTGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.68148274757	37.1366515900873	0.0140261023964067	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.63549924176	2642.63549924176
"AML-0024"	"2020-09-15-AML0024:AGTGCCGCAAATGGCG"	-1.75712917271312	13.9872474440369	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGCAAATGGCG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1966.37936891056	34.4206654035562	0.0175045903897102	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1960.79443065324	1960.79443065324
"AML-0024"	"2020-09-15-AML0024:AGTGCCGCAGGTGGAT"	1.0702107149059	-16.2184152833191	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGCAGGTGGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2840.67376881139	40.1649929667325	0.0141392487260297	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2828.25452913201	2828.25452913201
"AML-0024"	"2020-09-15-AML0024:AGTGCCGCAGTTAAAG"	-1.29849145832713	-15.8973598710266	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGCAGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2888.74259931051	38.2573775061081	0.0132436090066451	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.52963243246	2878.52963243246
"AML-0024"	"2020-09-15-AML0024:AGTGCCGGTCCATACA"	-1.11285005036052	-15.7291374436584	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGGTCCATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.12957494503	33.4000273610848	0.0147910145332992	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2252.1745470214	2252.1745470214
"AML-0024"	"2020-09-15-AML0024:AGTGCCGGTGCCAAGA"	-0.582395712763625	-16.3042841187683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGGTGCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.72421295454	38.9150768420293	0.0146202512839725	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.29729948039	2654.29729948039
"AML-0024"	"2020-09-15-AML0024:AGTGCCGGTTTACGAC"	-0.513233224779922	-16.2351064912048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGGTTTACGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.4068894323	49.8832621492605	0.0214606411536853	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2314.78215943387	2314.78215943387
"AML-0024"	"2020-09-15-AML0024:AGTGCCGTCCGCACTT"	-1.86398444595988	-15.4091005555359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGCCGTCCGCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.26100069071	43.3886209924306	0.0155947342760651	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.76632371044	2774.76632371044
"AML-0024"	"2020-09-15-AML0024:AGTGTTGAGCATAGGC"	-1.71818111363109	-16.9222765198913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGAGCATAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.42164798126	39.1205865361911	0.0163998622923952	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2371.57234392469	2371.57234392469
"AML-0024"	"2020-09-15-AML0024:AGTGTTGAGCCTCCAG"	-2.78573570671733	-15.4827776185242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGAGCCTCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.25124414542	34.5470638942654	0.0128320356316639	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.68394802618	2685.68394802618
"AML-0024"	"2020-09-15-AML0024:AGTGTTGAGCTGACTT"	-1.68943784657176	-16.6137037507263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGAGCTGACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.76196128971	41.5889484270824	0.0163751363556777	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.71406847714	2535.71406847714
"AML-0024"	"2020-09-15-AML0024:AGTGTTGCAAGTGGAC"	-2.2583421272343	-15.7851000062195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGCAAGTGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.62878304789	35.842261702422	0.0142705251446143	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.65053920962	2509.65053920962
"AML-0024"	"2020-09-15-AML0024:AGTGTTGCATACACCA"	-1.96048412743266	-15.5298137894836	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGCATACACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.84597172361	31.098992084532	0.011548745235	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.91893460725	2687.91893460725
"AML-0024"	"2020-09-15-AML0024:AGTGTTGCATCGTGCG"	-1.48851356926616	-15.5959902039734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGCATCGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.78175425354	40.2362904356362	0.0162914356162604	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2465.50539765138	2465.50539765138
"AML-0024"	"2020-09-15-AML0024:AGTGTTGGTGTTGACT"	-1.6386823457783	-15.6372432938782	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGGTGTTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.96685452843	39.7274763184354	0.0153449149991809	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.7697894239	2585.7697894239
"AML-0024"	"2020-09-15-AML0024:AGTGTTGGTGTTTCTT"	-1.60535893860515	-15.5749349824158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGGTGTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2443.42629587282	41.5921618907728	0.0170220652699964	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.11464377157	2441.11464377157
"AML-0024"	"2020-09-15-AML0024:AGTGTTGGTTGCTCAA"	-2.17926011505778	-15.7991161576477	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGGTTGCTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.57929965409	39.9346212344441	0.0154930718289844	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.53464517463	2575.53464517463
"AML-0024"	"2020-09-15-AML0024:AGTGTTGTCACTGATG"	-2.16358337822612	-16.5947771302429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGTCACTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2035.48004753705	44.5259800172034	0.0218749282613113	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2032.44190813494	2032.44190813494
"AML-0024"	"2020-09-15-AML0024:AGTGTTGTCATCCCGT"	1.35699393328969	-16.1732301942078	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTGTTGTCATCCCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3010.7323025418	36.9037709677608	0.0122574069227626	4411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2999.74731075137	2999.74731075137
"AML-0024"	"2020-09-15-AML0024:AGTTAGCAGAATTCAG"	-1.68382630768474	-15.713706993219	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCAGAATTCAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.57655796706	36.9215461903149	0.0142742908871538	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.19886298204	2579.19886298204
"AML-0024"	"2020-09-15-AML0024:AGTTAGCAGGATACCG"	-1.90510437908824	-16.0696382752624	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCAGGATACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.93953429043	39.8923777265041	0.016066592510842	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2479.03519272823	2479.03519272823
"AML-0024"	"2020-09-15-AML0024:AGTTAGCAGGCAGGTT"	-0.723721782595474	-16.077473663446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCAGGCAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.95746488952	40.5674259748043	0.0148166750196177	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.04522130086	2729.04522130086
"AML-0024"	"2020-09-15-AML0024:AGTTAGCAGTCATAGA"	-2.54602108421977	11.4765290983948	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCAGTCATAGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1925.94868601378	37.5715576232169	0.0195080782245452	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1922.37803637111	1922.37803637111
"AML-0024"	"2020-09-15-AML0024:AGTTAGCCACCTTCCA"	-0.765946130186874	-16.5880213013855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCCACCTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.04985469928	32.5648086073026	0.01176453110193	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.70694327433	2763.70694327433
"AML-0024"	"2020-09-15-AML0024:AGTTAGCCAGAGAAAG"	-1.42402408543285	-15.7957887879578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCCAGAGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2913.11896215502	38.636776651731	0.013263027412773	2940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.951297398	2908.951297398
"AML-0024"	"2020-09-15-AML0024:AGTTAGCCAGCGTAGA"	-2.04347072067912	-16.8040685883728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCCAGCGTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.33624836941	38.2324766410629	0.0141846779466541	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.54928333935	2684.54928333935
"AML-0024"	"2020-09-15-AML0024:AGTTAGCCAGGTTCGC"	0.889647861092728	-16.2295694581238	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCCAGGTTCGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2809.29293554636	33.9295472728126	0.0120776110043554	2844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2804.66476178704	2804.66476178704
"AML-0024"	"2020-09-15-AML0024:AGTTAGCCAGTATGAA"	0.2285309183294	-16.305895828363	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCCAGTATGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2593.51296759827	49.0591732734038	0.018916108724467	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2583.79245153786	2583.79245153786
"AML-0024"	"2020-09-15-AML0024:AGTTAGCGTACGTTCA"	-2.09553585472758	-16.56556799328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCGTACGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.91773653328	38.1384461263334	0.0135007280506287	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.15223282575	2817.15223282575
"AML-0024"	"2020-09-15-AML0024:AGTTAGCGTCTCGGGT"	-2.43651280823405	-16.3195181122986	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCGTCTCGGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2244.27100016614	39.9463581789769	0.0177992578329532	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2237.27429126561	2237.27429126561
"AML-0024"	"2020-09-15-AML0024:AGTTAGCGTGAAGCTG"	-1.7238703769749	-15.4818506470886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTAGCGTGAAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.91619517149	34.6173890816895	0.0136025654390387	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.49666415198	2539.49666415198
"AML-0024"	"2020-09-15-AML0024:AGTTCCCAGCATCAGG"	-1.06227622452434	-15.6812114945618	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCAGCATCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.98571024529	39.6057856317586	0.0139457693356978	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.49176557654	2832.49176557654
"AML-0024"	"2020-09-15-AML0024:AGTTCCCAGGGTGAAA"	-0.909626702696639	-15.8451528779236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCAGGGTGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.68218640706	26.3005560001143	0.00915858869223287	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.28935152535	2865.28935152535
"AML-0024"	"2020-09-15-AML0024:AGTTCCCAGTCACGCC"	-0.670434693724471	-15.8272438279358	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCAGTCACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.14791657424	39.1630883055865	0.0148505467059508	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.28152853718	2630.28152853718
"AML-0024"	"2020-09-15-AML0024:AGTTCCCAGTGATAAC"	-0.0456204068964303	-16.243432067987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCAGTGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.50224400065	41.1958481200025	0.0153172759799313	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.64178256083	2682.64178256083
"AML-0024"	"2020-09-15-AML0024:AGTTCCCCACGCTTAA"	-0.548829535872299	-16.5630865327087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCCACGCTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3046.43296289037	39.2909404537918	0.0128973592829411	3797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3041.67048328326	3041.67048328326
"AML-0024"	"2020-09-15-AML0024:AGTTCCCGTCCAAGAG"	-0.0922953439062417	-16.3436823121277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCGTCCAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.2763254042	38.4763390629391	0.0131981790980326	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2905.24888504732	2905.24888504732
"AML-0024"	"2020-09-15-AML0024:AGTTCCCGTCTACAGT"	-0.518867353827316	-16.4425440064636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCGTCTACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.6342941394	38.2143587098873	0.0136351570341509	2607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.14830481867	2795.14830481867
"AML-0024"	"2020-09-15-AML0024:AGTTCCCGTCTCAGAT"	-2.07307372513469	-15.8291778794494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCGTCTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.18262107383	38.0596260733942	0.0142963994175735	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.84565277738	2658.84565277738
"AML-0024"	"2020-09-15-AML0024:AGTTCCCGTTGCTCGG"	-2.65939317169841	-16.1618204346863	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCGTTGCTCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.55589601288	33.1355785515621	0.0137175788837078	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2408.58023756507	2408.58023756507
"AML-0024"	"2020-09-15-AML0024:AGTTCCCTCTTCGACC"	-2.06739364090617	-16.4595785371033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCCCTCTTCGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.67960617937	34.0326971403846	0.0134056684654283	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.05902475264	2536.05902475264
"AML-0024"	"2020-09-15-AML0024:AGTTCGAAGGTGAGAA"	-0.414649675518829	-16.581530593988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGAAGGTGAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.72918141112	42.2404851781914	0.0180227670983552	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2337.78524666637	2337.78524666637
"AML-0024"	"2020-09-15-AML0024:AGTTCGAAGTGATCGG"	-0.788549463183242	-16.5246763459411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGAAGTGATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.92620048159	46.8887293876496	0.0190378133857528	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.37752044858	2458.37752044858
"AML-0024"	"2020-09-15-AML0024:AGTTCGACACACCTTC"	-2.27432070198711	-16.0550317994324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGACACACCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.24287199903	30.9118838839029	0.0110587470568509	2912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2789.8126252994	2789.8126252994
"AML-0024"	"2020-09-15-AML0024:AGTTCGAGTACGAGTG"	-2.09987960282024	-15.4028387299744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGAGTACGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.02199728509	43.2134766171776	0.0163500253352286	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.76377004472	2638.76377004472
"AML-0024"	"2020-09-15-AML0024:AGTTCGATCAATCTTC"	-0.214541475207168	-16.0775556794372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGATCAATCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.77521729578	34.8519793023928	0.0121191597635248	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.64077030535	2868.64077030535
"AML-0024"	"2020-09-15-AML0024:AGTTCGATCACCCATC"	-0.536040107638198	-15.8878936997619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGTTCGATCACCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.76425864947	34.530712908471	0.0122720703421845	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.18658057566	2807.18658057566
"AML-0024"	"2020-09-15-AML0024:ATACCGACACAATGTC"	-1.84203026714976	-15.6815843812195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCGACACAATGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.81281399068	33.8098419448576	0.0123582438725184	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.68227171094	2731.68227171094
"AML-0024"	"2020-09-15-AML0024:ATACCGACACTGAGGA"	1.18858899649922	-16.2129087678161	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCGACACTGAGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3007.5640889917	40.1700218951469	0.013356331139269	3983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2995.44243088687	2995.44243088687
"AML-0024"	"2020-09-15-AML0024:ATACCGACATTCCTAT"	8.87833656844441	5.86370704257814	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCGACATTCCTAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1608.72357665435	41.9238593342226	0.026060325056845	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1606.87128490434	1606.87128490434
"AML-0024"	"2020-09-15-AML0024:ATACCGAGTCTCTCTG"	-2.76651463928874	-15.901656173822	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCGAGTCTCTCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.23675779255	32.0491666081702	0.01164477093674	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.72637870486	2743.72637870486
"AML-0024"	"2020-09-15-AML0024:ATACCGAGTTGCCGAC"	-0.565747181803542	-16.2794218293396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCGAGTTGCCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.85853729211	37.0328040324007	0.0143323651422539	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.67481494552	2577.67481494552
"AML-0024"	"2020-09-15-AML0024:ATACCTTAGAGCTTTC"	-0.639809648424941	-16.7015276185242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCTTAGAGCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.14924071333	33.1281590945848	0.0135874205489129	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2432.05843704355	2432.05843704355
"AML-0024"	"2020-09-15-AML0024:ATACCTTAGATGTTCC"	-1.48372564736064	-16.8715086213318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCTTAGATGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.89601343813	37.6823191496382	0.013713153250836	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.71085817074	2731.71085817074
"AML-0024"	"2020-09-15-AML0024:ATACCTTAGGATTTAG"	-1.98330936852153	-16.2171697846619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCTTAGGATTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.35661493872	32.2942012033322	0.0118713116603867	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.25963027878	2714.25963027878
"AML-0024"	"2020-09-15-AML0024:ATACCTTTCCGATAAC"	-2.68725595894511	-16.3178091279236	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCTTTCCGATAAC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.43050658225	32.9308850683455	0.0133192358615034	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2466.39901858636	2466.39901858636
"AML-0024"	"2020-09-15-AML0024:ATACCTTTCGGCCAAC"	-0.524103860289413	-15.8873348466125	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACCTTTCGGCCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3164.43854940465	36.2607590483173	0.0114588286301655	3536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3154.76711100453	3154.76711100453
"AML-0024"	"2020-09-15-AML0024:ATACTTCAGAGAACCC"	-1.22769389572795	-16.1067877045837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACTTCAGAGAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.77412750483	28.4626697900019	0.0118556216779892	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2391.16550432039	2391.16550432039
"AML-0024"	"2020-09-15-AML0024:ATACTTCCAAGTGGAC"	-1.8192962211674	-16.6777982941833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACTTCCAAGTGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.38393980786	34.754124994364	0.01269147269276	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.97261089723	2731.97261089723
"AML-0024"	"2020-09-15-AML0024:ATACTTCGTACCGTCG"	-0.895681480795699	-16.1101904145447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATACTTCGTACCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2993.88061241757	36.8687376209408	0.0123146986783715	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2989.79504614563	2989.79504614563
"AML-0024"	"2020-09-15-AML0024:ATAGACCAGAGCTTTC"	0.0773846852475822	-16.5427866212097	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGACCAGAGCTTTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2689.11004307125	36.8204014171879	0.0136924115515686	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2678.52666429786	2678.52666429786
"AML-0024"	"2020-09-15-AML0024:ATAGACCAGGATATGT"	-2.1326941055363	-16.941508316156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGACCAGGATATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1938.84945749593	46.0235624934361	0.0237375636955726	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1930.05583988931	1930.05583988931
"AML-0024"	"2020-09-15-AML0024:ATAGACCAGTCAGGGT"	-1.08912835541423	-16.8066416016785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGACCAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.40322878313	33.0175072464722	0.0125809581715008	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.35237014351	2614.35237014351
"AML-0024"	"2020-09-15-AML0024:ATAGACCGTACTAAGA"	-2.41620192948039	-15.978467010614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGACCGTACTAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.46068818025	39.0296175749513	0.0136159612221052	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2861.09608057939	2861.09608057939
"AML-0024"	"2020-09-15-AML0024:ATAGACCGTCATGCAT"	-2.49264893952068	-16.464234375116	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGACCGTCATGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1858.71588347455	45.7603633869007	0.0246193427375031	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1838.4301342744	1838.4301342744
"AML-0024"	"2020-09-15-AML0024:ATAGAGAAGAATAGTC"	-2.6259814304417	-16.2507181397644	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAAGAATAGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.44980420535	38.0799316905945	0.0164744791867483	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2303.09594464829	2303.09594464829
"AML-0024"	"2020-09-15-AML0024:ATAGAGAAGCCACAAG"	-1.01008663597758	-15.6312303773132	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAAGCCACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.01373215976	33.6218415486471	0.0122976125368936	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.57038888393	2724.57038888393
"AML-0024"	"2020-09-15-AML0024:ATAGAGAAGGAACATT"	-1.41907296600993	-15.8847017518249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAAGGAACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.76921064393	32.853881776497	0.0123151139331752	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.95292411147	2658.95292411147
"AML-0024"	"2020-09-15-AML0024:ATAGAGAAGGTTGGTG"	-1.78512726250346	-16.1377821198669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAAGGTTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.92421212326	29.7581783400112	0.0108018137882189	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.80617156973	2746.80617156973
"AML-0024"	"2020-09-15-AML0024:ATAGAGAAGTGACCTT"	-1.59931776943858	-15.9213228455749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAAGTGACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.05853398636	35.8121499964837	0.0131950543984339	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.44785190492	2708.44785190492
"AML-0024"	"2020-09-15-AML0024:ATAGAGACACCTCGTT"	-1.58742437782939	-15.6087465516296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGACACCTCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.45771596907	33.4342695305784	0.0123352854145613	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.29401350592	2703.29401350592
"AML-0024"	"2020-09-15-AML0024:ATAGAGACATAGCTGT"	-0.594815711409408	-16.3087702027527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGACATAGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.1284835137	32.9181421693384	0.0126116941664974	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.89426904123	2600.89426904123
"AML-0024"	"2020-09-15-AML0024:ATAGAGAGTATCTTCT"	1.22569908675496	-16.1989107361999	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAGTATCTTCT"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3037.96923143773	36.5267513478328	0.0120234105631631	4076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	3021.80607771189	3021.80607771189
"AML-0024"	"2020-09-15-AML0024:ATAGAGAGTTGCATTG"	-0.607839505106765	-16.1698236695495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGAGTTGCATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.11246007817	32.333660027423	0.0134549092331581	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2390.06175382354	2390.06175382354
"AML-0024"	"2020-09-15-AML0024:ATAGAGATCGCTTTAT"	-0.730791489512283	-15.5124454728332	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGAGATCGCTTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.55975702114	29.4235270099937	0.0115045315868842	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.26136735794	2552.26136735794
"AML-0024"	"2020-09-15-AML0024:ATAGGCTAGACCCTTA"	-2.36565170708354	-16.4628114930359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGGCTAGACCCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.29558869045	40.1402246009353	0.0170425422582536	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2350.12999418243	2350.12999418243
"AML-0024"	"2020-09-15-AML0024:ATAGGCTAGGAGACCT"	-0.176094124943572	-16.082642578241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGGCTAGGAGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.67091965962	36.8216385207688	0.0131850975571647	2798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.06887150664	2784.06887150664
"AML-0024"	"2020-09-15-AML0024:ATAGGCTGTGCGAACA"	-0.809372643858749	-16.2690820924011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGGCTGTGCGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.75992865714	41.1512850493916	0.0153563327107488	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.5521752845	2673.5521752845
"AML-0024"	"2020-09-15-AML0024:ATAGGCTTCCTCTTTC"	-1.19998059693034	-16.3591413727966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATAGGCTTCCTCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.57495047	35.4891991368247	0.0129071582975973	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.42056221432	2743.42056221432
"AML-0024"	"2020-09-15-AML0024:ATATCCTCATAGAGGC"	-1.87376115742381	-16.4066362611023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTCATAGAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.50359334635	41.2259229427813	0.016278722388033	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.06890783366	2527.06890783366
"AML-0024"	"2020-09-15-AML0024:ATATCCTGTACAGAGC"	-1.97555742684062	-16.0354490510193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTGTACAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.4079142199	36.0431808005279	0.0128203312718244	2816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.00800381162	2805.00800381162
"AML-0024"	"2020-09-15-AML0024:ATATCCTGTGGGTCAA"	-1.8193863433903	-16.07999327099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTGTGGGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.93946001407	36.0783564387021	0.0131579697381491	2524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.995034971	2732.995034971
"AML-0024"	"2020-09-15-AML0024:ATATCCTTCACTACGA"	-2.88112125816997	-15.9721842042175	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTTCACTACGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.31154368272	34.8780639282024	0.0126907242406245	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.16528426924	2739.16528426924
"AML-0024"	"2020-09-15-AML0024:ATATCCTTCTACGGTA"	0.259836499660653	-16.2907610169617	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTTCTACGGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2877.04476180383	33.1622110256591	0.0115264842125248	2612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2871.25636108327	2871.25636108327
"AML-0024"	"2020-09-15-AML0024:ATATCCTTCTGTCCGT"	-1.93684051457103	-15.9911394349304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATATCCTTCTGTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.6230014279	37.673008175133	0.0137011539965912	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.14576540419	2739.14576540419
"AML-0024"	"2020-09-15-AML0024:ATCACAGAGTCTGCAT"	-0.0457280975883782	-16.1967611542908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACAGAGTCTGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.76133247195	37.6039753445352	0.0134407373881711	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.21801475318	2786.21801475318
"AML-0024"	"2020-09-15-AML0024:ATCACAGTCCGTTGGG"	0.355940570204896	-16.2801065674988	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACAGTCCGTTGGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2607.74235380325	43.053855380263	0.0165100111663529	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2594.5807466337	2594.5807466337
"AML-0024"	"2020-09-15-AML0024:ATCACAGTCGTGGCTG"	-2.60473666611369	-15.7590885392395	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACAGTCGTGGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.68611598356	38.8022480768047	0.0142671787927159	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.30436038833	2717.30436038833
"AML-0024"	"2020-09-15-AML0024:ATCACAGTCTGCGATA"	-1.12995765629466	-15.5901136628357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACAGTCTGCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.60402195714	37.4005292893911	0.0140255279679437	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.4488940904	2663.4488940904
"AML-0024"	"2020-09-15-AML0024:ATCACGAAGAGAGCCT"	-0.628077129751998	-16.0925073853699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAAGAGAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.8328508448	31.8213664513746	0.011847858082965	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.79382516588	2679.79382516588
"AML-0024"	"2020-09-15-AML0024:ATCACGAAGCAATAAC"	-0.044392074376899	-16.0984659424988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAAGCAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.99358080672	37.8198699314106	0.013692960836051	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.9114818587	2752.9114818587
"AML-0024"	"2020-09-15-AML0024:ATCACGAAGCCGGAAT"	-2.26525745812114	-16.3932714692322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAAGCCGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.47306110632	36.1815451884086	0.0157278717147892	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.22833511794	2294.22833511794
"AML-0024"	"2020-09-15-AML0024:ATCACGAAGCTTTGTG"	-1.94127426567729	-16.4462328187195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAAGCTTTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2329.14433558657	50.9075976371475	0.021856780990057	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2319.1265326013	2319.1265326013
"AML-0024"	"2020-09-15-AML0024:ATCACGAAGGTCTACT"	-1.59484062615092	-16.490523361322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAAGGTCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.72699883447	30.2140119396607	0.0109960021328454	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.61984301267	2739.61984301267
"AML-0024"	"2020-09-15-AML0024:ATCACGAGTGGCACTC"	-1.38624284687694	-15.9535513154236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAGTGGCACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.69478477735	38.2689230354825	0.0161153017561668	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2372.32753272153	2372.32753272153
"AML-0024"	"2020-09-15-AML0024:ATCACGAGTTACCCAA"	-1.24340806427653	-16.6196508637634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGAGTTACCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.1143574642	33.9785488114568	0.013366255027705	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.59634847397	2536.59634847397
"AML-0024"	"2020-09-15-AML0024:ATCACGATCTCTCGCA"	-1.38687167587932	-15.8604459992615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACGATCTCTCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.56685940066	37.1369861434059	0.0149651362415337	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.50932533989	2474.50932533989
"AML-0024"	"2020-09-15-AML0024:ATCACTTTCACAGTGT"	0.160331619053525	-16.2325391999451	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACTTTCACAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2971.9652998431	41.1230748724219	0.0138369969779233	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2963.5960725417	2963.5960725417
"AML-0024"	"2020-09-15-AML0024:ATCACTTTCCATGCAA"	-1.9888256591862	-16.1402349702087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACTTTCCATGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.98472343289	35.5004969422289	0.0129422875158413	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.61674571678	2730.61674571678
"AML-0024"	"2020-09-15-AML0024:ATCACTTTCTAACACG"	-0.922250966460067	-16.2115335694519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCACTTTCTAACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.02462187646	35.9510901437059	0.0133447518822842	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.39010390961	2682.39010390961
"AML-0024"	"2020-09-15-AML0024:ATCAGGTAGGTCGCCT"	-1.99992714348491	-15.8519077531067	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTAGGTCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.60893579768	33.4634728474796	0.0115926589267044	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.89960970003	2876.89960970003
"AML-0024"	"2020-09-15-AML0024:ATCAGGTAGTAGGTTA"	-1.3429961008137	-16.5734415284363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTAGTAGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.61329390408	35.7661406503677	0.0136427980181261	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.71252756864	2615.71252756864
"AML-0024"	"2020-09-15-AML0024:ATCAGGTCACACGGAA"	-1.12254617634471	-16.026598953363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTCACACGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.07270141298	38.4676304835429	0.0135350620919789	2780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.32106086513	2830.32106086513
"AML-0024"	"2020-09-15-AML0024:ATCAGGTCATAACAGA"	-0.454556505114394	-16.1340532532898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTCATAACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.6798135225	38.7290606854143	0.013643335363475	2952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.50486446002	2829.50486446002
"AML-0024"	"2020-09-15-AML0024:ATCAGGTCATACCATG"	-0.152257735759574	-16.1205282441345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTCATACCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.56672328623	36.6714036566551	0.0124454686082101	3570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.32305535121	2935.32305535121
"AML-0024"	"2020-09-15-AML0024:ATCAGGTTCACTGATG"	-1.7363306087559	-15.7447977296081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCAGGTTCACTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.81558836223	40.4087865319328	0.0144378167321766	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.98944427711	2786.98944427711
"AML-0024"	"2020-09-15-AML0024:ATCATTCAGACATCAA"	-0.886196653277236	-16.3390436402527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCAGACATCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.68130436526	33.694265204314	0.0124623657196255	2459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.16321526912	2696.16321526912
"AML-0024"	"2020-09-15-AML0024:ATCATTCAGATAGCAT"	1.11150135573689	-16.2191210023132	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCAGATAGCAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2875.77234594961	37.2388478828476	0.0129491640516318	3983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2864.47167937814	2864.47167937814
"AML-0024"	"2020-09-15-AML0024:ATCATTCAGCTGACCC"	-1.11763010445293	-15.9400282136169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCAGCTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.75202031498	31.0734755801554	0.0112026869570795	2845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.91258328089	2765.91258328089
"AML-0024"	"2020-09-15-AML0024:ATCATTCCATCTCAAG"	-0.845705787569839	-15.6878767243591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCCATCTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2964.81676096595	28.3845610593099	0.00957379944454378	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.04325958012	2957.04325958012
"AML-0024"	"2020-09-15-AML0024:ATCATTCCATGGGATG"	-2.06616101685222	-16.4302263489929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCCATGGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2041.13640909852	51.1360066578037	0.0250527139831816	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2038.32419896461	2038.32419896461
"AML-0024"	"2020-09-15-AML0024:ATCATTCCATGTGGCC"	-2.60493312302287	-15.453190826532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCCATGTGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.79958608165	36.1726809374563	0.0137288168438081	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.70335397554	2630.70335397554
"AML-0024"	"2020-09-15-AML0024:ATCATTCGTAGCTGCC"	-2.20470843735393	-16.7372999421326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCATTCGTAGCTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1794.34702431047	45.6113876712515	0.0254194907970932	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1790.72828045707	1790.72828045707
"AML-0024"	"2020-09-15-AML0024:ATCCACCAGATGCAGC"	-1.54230187359508	-16.2155618897644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCACCAGATGCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.53271137259	35.2464860789702	0.0135692174056762	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.64718390748	2590.64718390748
"AML-0024"	"2020-09-15-AML0024:ATCCACCCAGGTGTGA"	-1.7203211587971	-15.7687912217346	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCACCCAGGTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.315856885	40.8523548055901	0.0154666677592164	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.25176895476	2631.25176895476
"AML-0024"	"2020-09-15-AML0024:ATCCACCGTGGCTACC"	-1.27851686897929	-16.2194643250671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCACCGTGGCTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.96050385459	34.6955541415221	0.0127371722506349	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.62747101664	2715.62747101664
"AML-0024"	"2020-09-15-AML0024:ATCCACCTCTTCGCTG"	-2.12229977074321	-16.1547041169372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCACCTCTTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.48938238955	32.783671817174	0.0127192267177375	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.89638309677	2569.89638309677
"AML-0024"	"2020-09-15-AML0024:ATCCATTCACTTACAG"	-3.4990385574406	12.5086183317932	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTCACTTACAG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2068.59747846323	42.9139815937261	0.0207454480828272	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2066.80726174264	2066.80726174264
"AML-0024"	"2020-09-15-AML0024:ATCCATTGTTACGATC"	-1.75388262692149	-16.6287698975769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTGTTACGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.1847808065	35.5704833585337	0.0127988911007966	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.14976424067	2769.14976424067
"AML-0024"	"2020-09-15-AML0024:ATCCATTGTTCTCTCG"	-0.86037246409114	-15.9648218384949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTGTTCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.34275464254	35.2925136175474	0.0147646246752697	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.9305630641	2382.9305630641
"AML-0024"	"2020-09-15-AML0024:ATCCATTTCCTATTTG"	-0.536975602537948	-16.5855264893738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTTCCTATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.83638580071	30.0855700745601	0.0112856026104256	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.21242947906	2655.21242947906
"AML-0024"	"2020-09-15-AML0024:ATCCATTTCTCATTGT"	-1.89343796196635	-16.0227194062439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTTCTCATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.96760183053	31.3374820241406	0.0107690140620217	2816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.50177597128	2902.50177597128
"AML-0024"	"2020-09-15-AML0024:ATCCATTTCTGCTTAT"	-0.0541094643181146	-16.1335287324158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCATTTCTGCTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.10958957545	36.1764066478048	0.0135689871073775	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.72970712048	2661.72970712048
"AML-0024"	"2020-09-15-AML0024:ATCCCTGAGTCAGGGT"	-1.48976085606273	-16.9061765900818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2132.31235477421	44.5337193894603	0.0208851762687347	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2122.80536947949	2122.80536947949
"AML-0024"	"2020-09-15-AML0024:ATCCCTGAGTGTCATC"	-0.341694633395034	-15.8434152833191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGAGTGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.49175113392	37.9430084600235	0.0132506086127185	2845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.68251498406	2856.68251498406
"AML-0024"	"2020-09-15-AML0024:ATCCCTGCATACTTTC"	-2.19893894615825	-16.4147234193054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGCATACTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2950.52190127517	31.5726136340701	0.0107006877733817	2712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2940.92579977648	2940.92579977648
"AML-0024"	"2020-09-15-AML0024:ATCCCTGGTGCACATT"	-2.72324476662334	-15.7407932511536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGGTGCACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.54454239772	31.3955912785652	0.0112265657859492	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.7777196517	2791.7777196517
"AML-0024"	"2020-09-15-AML0024:ATCCCTGGTGCTATTG"	-1.82576475563701	-15.4798240891662	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGGTGCTATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2024.95251292362	44.0581153569448	0.0217576042281277	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2023.32567026752	2023.32567026752
"AML-0024"	"2020-09-15-AML0024:ATCCCTGTCACCTGGG"	-2.20264134827312	-15.6792907944885	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCCTGTCACCTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.75063715756	33.7973909751163	0.0127887173689105	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.77372367818	2637.77372367818
"AML-0024"	"2020-09-15-AML0024:ATCCGTCAGTAACCGG"	-1.20886633816417	-15.917037033197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCAGTAACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.67222642033	39.8670846603662	0.014189229720635	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.35240892858	2802.35240892858
"AML-0024"	"2020-09-15-AML0024:ATCCGTCAGTCAGAGC"	-0.898923258215743	-16.1963224641052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCAGTCAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.13316290487	35.2964751720799	0.0127787014927837	2818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.76006900034	2756.76006900034
"AML-0024"	"2020-09-15-AML0024:ATCCGTCCAAATCAGA"	-0.447608332068282	-15.9130125275818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCCAAATCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.85586349033	32.5568972716821	0.0116572064091394	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.13216630908	2786.13216630908
"AML-0024"	"2020-09-15-AML0024:ATCCGTCCACAGCTTA"	-1.23873804035838	-16.0760889283386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCCACAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.24262820302	44.4434627904149	0.0184470680827875	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2403.39450838354	2403.39450838354
"AML-0024"	"2020-09-15-AML0024:ATCCGTCCACTGCGTG"	-0.166456635028678	-16.3230886689392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCCACTGCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.17380405668	30.5609246062499	0.0110480854678876	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.09482211157	2755.09482211157
"AML-0024"	"2020-09-15-AML0024:ATCCGTCTCAGAATAG"	-0.982264022261459	-15.8383798829285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCTCAGAATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.54684195091	34.1588519008635	0.0132268082599653	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.82564730367	2576.82564730367
"AML-0024"	"2020-09-15-AML0024:ATCCGTCTCCATTGGA"	-3.00081167641338	-15.8946285477844	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCTCCATTGGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.990724771	32.479680143134	0.0118669310236159	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.89336306889	2731.89336306889
"AML-0024"	"2020-09-15-AML0024:ATCCGTCTCCTATTGT"	11.4344507652218	-1.94095327770384	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCTCCTATTGT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1217.24676176006	51.0822293295469	0.0419653852729788	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1217.24676176006	1217.24676176006
"AML-0024"	"2020-09-15-AML0024:ATCCGTCTCGTGTGGC"	-1.60213838043864	13.8576831587586	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCGTCTCGTGTGGC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2040.89401552761	33.4399006606723	0.0163849275887202	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2035.36819545551	2035.36819545551
"AML-0024"	"2020-09-15-AML0024:ATCCTATAGACTCGAG"	-1.95695314827617	-16.7539911500183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCTATAGACTCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.52476583501	42.5005986187119	0.0157030148606823	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.38014613384	2699.38014613384
"AML-0024"	"2020-09-15-AML0024:ATCCTATAGCCAAGTG"	-1.672226647765	-15.8468065491882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCTATAGCCAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3084.84065198377	39.5325302690795	0.0128150963790163	3019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3078.65886423801	3078.65886423801
"AML-0024"	"2020-09-15-AML0024:ATCCTATGTACCAGAG"	-0.376687715679961	-15.9313888779846	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCTATGTACCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.96383838999	38.1993527429617	0.0134128643868444	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.79323078688	2842.79323078688
"AML-0024"	"2020-09-15-AML0024:ATCCTATGTATGGTAA"	-0.919159094721633	-16.2665510407654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCTATGTATGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.33698481697	38.7020277366653	0.0147193105943243	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.52879730986	2621.52879730986
"AML-0024"	"2020-09-15-AML0024:ATCCTATGTTAAGCAA"	-0.816130558878738	-15.9476804963318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCCTATGTTAAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.78651403382	30.4223502883606	0.0114637519361412	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.32217667877	2648.32217667877
"AML-0024"	"2020-09-15-AML0024:ATCGATGCACCACTGG"	-2.43853722038921	-16.5020132294861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGATGCACCACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2197.74048221976	43.5396193234029	0.0198110830990504	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2192.43800704045	2192.43800704045
"AML-0024"	"2020-09-15-AML0024:ATCGATGCAGAACATA"	-1.79440377178844	-16.7380323640076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGATGCAGAACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.69115286986	36.1008637575197	0.0137700673544256	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.03386725923	2617.03386725923
"AML-0024"	"2020-09-15-AML0024:ATCGATGTCAGAGCAG"	-1.29218016091045	-15.997136139032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGATGTCAGAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2644.87170365178	29.9497528930966	0.0113237072526977	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.85067002246	2640.85067002246
"AML-0024"	"2020-09-15-AML0024:ATCGATGTCTGAATCG"	-1.39901338043864	-15.6933889619079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGATGTCTGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.19846795571	35.025641541661	0.0124019759726781	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.27373988804	2819.27373988804
"AML-0024"	"2020-09-15-AML0024:ATCGCCTAGATTTGCC"	-1.83639703217204	-16.900284790155	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTAGATTTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.32323037947	41.9410197148401	0.0165950358904203	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2521.46332789761	2521.46332789761
"AML-0024"	"2020-09-15-AML0024:ATCGCCTAGCGTTCCG"	-1.50648222389873	-16.6209631196228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTAGCGTTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.37428776295	37.4344397253911	0.0136703152277888	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.96810454913	2729.96810454913
"AML-0024"	"2020-09-15-AML0024:ATCGCCTAGGAGGGTG"	-0.605768124491531	-15.7881803742615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTAGGAGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3098.69162182899	41.9498161984569	0.0135379125508773	4342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3088.0899289965	3088.0899289965
"AML-0024"	"2020-09-15-AML0024:ATCGCCTAGTTTAGGA"	-1.13554547253307	-16.0142698518005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTAGTTTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.9548826515	39.5019266845522	0.0158645150399221	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2480.95326112024	2480.95326112024
"AML-0024"	"2020-09-15-AML0024:ATCGCCTCACTACTTT"	-2.52530608597453	-16.09681799328	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTCACTACTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.431376522	23.0452840631627	0.00839404847640274	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.31214389654	2733.31214389654
"AML-0024"	"2020-09-15-AML0024:ATCGCCTGTAGACTGG"	-1.32003376904185	-16.7875261536804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTGTAGACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.96727351651	39.4256909794546	0.0168560250610861	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2329.50128223632	2329.50128223632
"AML-0024"	"2020-09-15-AML0024:ATCGCCTTCAAATGAG"	-1.87025175514873	-16.5799112549988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTTCAAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.89522185473	49.4469973240699	0.0227667508204395	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2167.91584822742	2167.91584822742
"AML-0024"	"2020-09-15-AML0024:ATCGCCTTCCAAGCCG"	-0.144950727850753	-16.3451853028503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGCCTTCCAAGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.5912505242	43.1330681241477	0.0150625785423293	3254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2853.46550175516	2853.46550175516
"AML-0024"	"2020-09-15-AML0024:ATCGGATAGGCAGGGA"	-0.155253316194373	-16.4873152009216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATAGGCAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.93465785609	40.0550277238644	0.0141390581010355	2893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.34385693265	2820.34385693265
"AML-0024"	"2020-09-15-AML0024:ATCGGATAGGTTTGAA"	-1.64601133289989	-16.4503526917663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATAGGTTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2479.63226828452	35.6038120992966	0.014358504910056	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2472.5735701434	2472.5735701434
"AML-0024"	"2020-09-15-AML0024:ATCGGATCAACCGATT"	-2.1210449737614	-16.2714548341003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATCAACCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.17906520397	40.9937018594644	0.015729426426137	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.31461709959	2600.31461709959
"AML-0024"	"2020-09-15-AML0024:ATCGGATCACTAGTAC"	-0.238279263407546	-16.1683035126892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATCACTAGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.45614960913	38.4528763919554	0.0139907185339027	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.21331569992	2742.21331569992
"AML-0024"	"2020-09-15-AML0024:ATCGGATGTCGCGGTT"	-0.486805061728317	-16.3204088441101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATGTCGCGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.55814488733	41.4653309638807	0.0149448412318512	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.40224191018	2768.40224191018
"AML-0024"	"2020-09-15-AML0024:ATCGGATTCGACTCCT"	-2.12529335442241	-15.9673032990661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATTCGACTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.02632662845	42.2243604317321	0.0150531066432037	2629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.25557285206	2799.25557285206
"AML-0024"	"2020-09-15-AML0024:ATCGGATTCTCCGATC"	-0.927044312388259	-16.4055433503357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGATTCTCCGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.58999529813	36.9609673118912	0.0138451849823342	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.09095954484	2666.09095954484
"AML-0024"	"2020-09-15-AML0024:ATCGGCGAGTAGGATT"	-1.3299677175587	-15.6227598420349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGCGAGTAGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3071.58936933704	40.1303321340423	0.0130650055422948	3274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3060.33764605157	3060.33764605157
"AML-0024"	"2020-09-15-AML0024:ATCGGCGCAGCATCTA"	-1.06925759735759	-16.5746546021667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGCGCAGCATCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.2322575198	39.1137692675724	0.0148482614454046	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.40091017457	2627.40091017457
"AML-0024"	"2020-09-15-AML0024:ATCGGCGGTGCCAAGA"	-0.65008787337001	-16.6921301118103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGGCGGTGCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2857.68486326333	36.1280053565212	0.0126424035837405	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.6974442093	2849.6974442093
"AML-0024"	"2020-09-15-AML0024:ATCGTAGAGAAATGGG"	1.10351230677907	-16.2285528413025	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGAGAAATGGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2826.55389434644	42.3186513152345	0.0149718182978497	3431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2817.59056887979	2817.59056887979
"AML-0024"	"2020-09-15-AML0024:ATCGTAGAGATTGTGA"	-0.598437587649185	-16.3179483643738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGAGATTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.72752172176	34.129914549277	0.0125860412876611	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.44145006308	2707.44145006308
"AML-0024"	"2020-09-15-AML0024:ATCGTAGAGCTTTCTT"	-1.64473531666453	-16.0734873048035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGAGCTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.32594399602	43.938756830113	0.0162535919605622	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.66967874156	2693.66967874156
"AML-0024"	"2020-09-15-AML0024:ATCGTAGCACGCTTAA"	-1.36929068985637	-15.8955335847107	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGCACGCTTAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.09224232199	41.7785657493306	0.015197222234363	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.96958480551	2739.96958480551
"AML-0024"	"2020-09-15-AML0024:ATCGTAGCATTCTTCA"	-1.13917956772502	-16.3691702119079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGCATTCTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.26161428312	41.1132651565849	0.0148516545345487	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.51822527849	2763.51822527849
"AML-0024"	"2020-09-15-AML0024:ATCGTAGGTTCTCTAT"	-1.6492922109669	-16.7972231141296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGGTTCTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.95131252273	39.7646165233261	0.0156989265157734	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2525.04790845009	2525.04790845009
"AML-0024"	"2020-09-15-AML0024:ATCGTAGGTTCTTGTT"	-0.633226911455947	-15.9118213883606	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTAGGTTCTTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.27414893429	28.8698911661217	0.0111930293172016	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.76519537485	2577.76519537485
"AML-0024"	"2020-09-15-AML0024:ATCGTCCAGACGGTCA"	-2.11417565766032	-16.8473978272644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCAGACGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1607.55571540091	49.9673189867793	0.0310827914131225	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1600.66152766347	1600.66152766347
"AML-0024"	"2020-09-15-AML0024:ATCGTCCGTATCGTAC"	-1.51825390282329	-15.716371559259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCGTATCGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.41706375408	39.3261206862625	0.0151463034330094	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.86524245409	2593.86524245409
"AML-0024"	"2020-09-15-AML0024:ATCGTCCGTTGCATGT"	-1.02713880959209	-16.1941194764343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCGTTGCATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.43782684627	35.2029886711656	0.0137327257569867	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.12993803762	2557.12993803762
"AML-0024"	"2020-09-15-AML0024:ATCGTCCTCAGATTGC"	-2.55729542198833	-15.9127035371033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCTCAGATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.92149853677	37.1418828069136	0.0148512789500368	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.47833922229	2498.47833922229
"AML-0024"	"2020-09-15-AML0024:ATCGTCCTCAGCGGAA"	-2.412824968726	-16.2161340943542	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCTCAGCGGAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.97248762577	37.381045886853	0.0153454302446932	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2426.41059682591	2426.41059682591
"AML-0024"	"2020-09-15-AML0024:ATCGTCCTCGAACCAT"	-2.40832934799846	-16.420289062616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTCCTCGAACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.80374635599	39.3073225474748	0.0146461240322976	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.11108168241	2675.11108168241
"AML-0024"	"2020-09-15-AML0024:ATCGTGAAGAGTAACT"	-0.587725202471572	-16.1216364136902	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGAAGAGTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.2127796117	38.1680768885358	0.0166584601954797	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2282.45989428402	2282.45989428402
"AML-0024"	"2020-09-15-AML0024:ATCGTGAAGTCGCTAT"	8.90703548964803	7.32074449146119	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGAAGTCGCTAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1391.65035260616	19.5743277843996	0.0140655501202171	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1391.65035260616	1391.65035260616
"AML-0024"	"2020-09-15-AML0024:ATCGTGAGTATTAAGG"	-1.02808926525767	-15.5358448258606	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGAGTATTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2512.72379219361	40.2974357132113	0.0160373519120586	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2506.9777680407	2506.9777680407
"AML-0024"	"2020-09-15-AML0024:ATCGTGAGTCTCGGGT"	-0.857637683779556	-16.7322111359802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGAGTCTCGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.4004879212	43.3373202019645	0.0183290945943202	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.84521280795	2351.84521280795
"AML-0024"	"2020-09-15-AML0024:ATCGTGATCAGTGCGC"	-0.529050688177902	-16.2895803681579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGATCAGTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.47251756502	41.5834857613083	0.0154443491957775	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.37356604598	2685.37356604598
"AML-0024"	"2020-09-15-AML0024:ATCGTGATCATCGCCT"	-1.56744883480724	-16.7960348359314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGATCATCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.70016337	41.1619416241417	0.0152130462131007	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.46644417523	2699.46644417523
"AML-0024"	"2020-09-15-AML0024:ATCGTGATCCCGAGGT"	-1.98189983788188	-16.8131761780945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGATCCCGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.28740110166	31.3946975882631	0.0135072356255869	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2319.44078359228	2319.44078359228
"AML-0024"	"2020-09-15-AML0024:ATCGTGATCTCAGAAC"	-0.75334076109584	-16.0278444520203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCGTGATCTCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.27179590474	33.2316579833694	0.0131492220335062	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2521.12877957223	2521.12877957223
"AML-0024"	"2020-09-15-AML0024:ATCTCTAAGTACAGAT"	-0.656331459910232	-16.4861002198425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTAAGTACAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.29956183223	33.8895309598629	0.0134787164880094	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2508.40244127125	2508.40244127125
"AML-0024"	"2020-09-15-AML0024:ATCTCTACACGGATCC"	-2.18766532364543	-15.9318409196106	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTACACGGATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.99725767933	36.2333515823275	0.0128669697683539	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2808.87520350208	2808.87520350208
"AML-0024"	"2020-09-15-AML0024:ATCTCTAGTGATGAAT"	-0.612821440131027	-16.2957868806091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTAGTGATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.97744298164	39.8969173717778	0.0148870347682442	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.71767730401	2669.71767730401
"AML-0024"	"2020-09-15-AML0024:ATCTCTAGTGCAATAA"	-0.625283698469955	13.8899497755798	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTAGTGCAATAA"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2278.45697547951	47.9136379020691	0.0210289851499107	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2267.79754623628	2267.79754623628
"AML-0024"	"2020-09-15-AML0024:ATCTCTAGTGCTCTCT"	-1.78249094906505	-16.6130037537781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTAGTGCTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.52555431449	36.5166253835866	0.0127434303730445	3021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.8954079921	2857.8954079921
"AML-0024"	"2020-09-15-AML0024:ATCTCTATCGGCTGAC"	-2.5707417530125	-15.7827902070251	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTCTATCGGCTGAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.2635293668	34.0654573880794	0.0138575286909349	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.32441324774	2450.32441324774
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAAATTGGA"	-2.1117356819218	-15.9091758958069	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAAATTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.31910605994	32.8203810697235	0.0119073227035164	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.19340721599	2748.19340721599
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAGAAGCGT"	-1.50786099854167	-15.0294018021789	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAGAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2386.60579776489	42.7171227186351	0.0178986922593755	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.66254443938	2382.66254443938
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAGAATTCC"	-1.45132444325145	-16.9271478882995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAGAATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.85350076208	44.6700847760363	0.0174502504782941	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.44506931491	2551.44506931491
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAGCACAGA"	-1.93628762188609	-16.5831022492615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAGCACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.04975841029	33.653953084039	0.0127378195573002	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.75235370649	2638.75235370649
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAGGAGGAG"	-1.91073725643809	-15.7145176163879	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAGGAGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.07151463233	30.9911197432179	0.0124209344547724	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.75953092226	2490.75953092226
"AML-0024"	"2020-09-15-AML0024:ATCTTCACAGGTCAGA"	-0.935075859457809	-17.4719419709411	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCACAGGTCAGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2837.11035429439	49.2419356446487	0.0173563695081912	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2825.20400983823	2825.20400983823
"AML-0024"	"2020-09-15-AML0024:ATCTTCAGTTCTCCTG"	-1.52651153031047	-16.1620092622009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCAGTTCTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.87887229911	27.7057837110699	0.0102277676548731	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.34062263548	2699.34062263548
"AML-0024"	"2020-09-15-AML0024:ATCTTCATCATTCACT"	-1.7403189939564	-16.4744634858337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCATCATTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.68482942739	35.2805003268494	0.0125210953185346	2498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.54364729198	2806.54364729198
"AML-0024"	"2020-09-15-AML0024:ATCTTCATCCGATAAC"	-1.4105021757191	-16.5956144562927	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATCTTCATCCGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.34450786618	33.8397906110272	0.0131859890623819	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.26534695642	2559.26534695642
"AML-0024"	"2020-09-15-AML0024:ATGAAAGAGACCAAGC"	-1.6967193883961	-15.6772423020569	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGAGACCAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1947.88709086943	44.2006068986225	0.0226915651866114	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1939.02972248899	1939.02972248899
"AML-0024"	"2020-09-15-AML0024:ATGAAAGAGACCATGG"	-2.46179542961772	-16.3706159821716	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGAGACCATGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.0819581813	34.4399655008553	0.0134737328709757	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.30708717872	2549.30708717872
"AML-0024"	"2020-09-15-AML0024:ATGAAAGAGCGGTAAC"	-2.62746487084087	-15.9511461487976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGAGCGGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.53516408706	33.2241266864714	0.0128748978695764	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.5991031536	2576.5991031536
"AML-0024"	"2020-09-15-AML0024:ATGAAAGGTACAAAGT"	-2.73614941063579	-15.7664871445862	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGGTACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2468.50691884757	37.6462069409082	0.0152505981058718	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.87483645305	2464.87483645305
"AML-0024"	"2020-09-15-AML0024:ATGAAAGGTGCTGATT"	-1.70541117611583	-16.5869684449402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGGTGCTGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.18354412539	33.369899612795	0.0130750390933308	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.1875693742	2544.1875693742
"AML-0024"	"2020-09-15-AML0024:ATGAAAGTCGAGAGCA"	-1.97079716149028	-16.362744354364	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGTCGAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.663365048	40.061925982872	0.0167436533563794	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2387.36041060823	2387.36041060823
"AML-0024"	"2020-09-15-AML0024:ATGAAAGTCTACGCAA"	-2.75747023049052	-16.1853857270447	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAAAGTCTACGCAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.65959551664	35.3347651389504	0.0128975020096565	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.5355257244	2728.5355257244
"AML-0024"	"2020-09-15-AML0024:ATGACCAAGAGGCGTT"	-0.345357279211837	-16.3516016236511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGACCAAGAGGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.03579392059	34.3600781568262	0.0133851184460302	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.48710956112	2560.48710956112
"AML-0024"	"2020-09-15-AML0024:ATGACCAAGCTCGTGC"	-2.31582532349284	-15.7610655060974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGACCAAGCTCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.83674880369	34.7200026649	0.0127514081335044	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.95853034596	2721.95853034596
"AML-0024"	"2020-09-15-AML0024:ATGACCACAAATGAAC"	0.684928615658921	-16.3058824769226	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGACCACAAATGAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2796.19755788003	43.5282242426058	0.0155669345035861	2576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2787.76420160115	2787.76420160115
"AML-0024"	"2020-09-15-AML0024:ATGACCAGTGGAAGTC"	-1.38158724728282	-16.7849169007507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGACCAGTGGAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.45502641272	31.5815689571348	0.0111263235327875	2924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2825.65350834393	2825.65350834393
"AML-0024"	"2020-09-15-AML0024:ATGAGGGAGACGCATG"	-2.8425546688145	-15.4569311372009	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGAGACGCATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.25041558193	39.4870395491456	0.0145910516343162	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.08820840371	2699.08820840371
"AML-0024"	"2020-09-15-AML0024:ATGAGGGAGACGGTCA"	-0.992711882025558	-17.4840231171814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGAGACGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2807.96247883862	39.3233621720901	0.0140042334854682	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.53049334097	2800.53049334097
"AML-0024"	"2020-09-15-AML0024:ATGAGGGAGCTGGAGT"	0.606918593018693	-16.1878366700378	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGAGCTGGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2923.81781592021	39.2526427979727	0.0134251329149996	2838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2917.53877167811	2917.53877167811
"AML-0024"	"2020-09-15-AML0024:ATGAGGGCATACCGTA"	-1.58367810669597	-15.9520101777283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGCATACCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.35562785544	41.6835552520151	0.0159807791571301	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.528786531	2599.528786531
"AML-0024"	"2020-09-15-AML0024:ATGAGGGTCGAAGCCC"	-1.67035756531413	-16.0404157868591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGTCGAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.43228898675	36.4560076875154	0.012560502384792	2891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2893.34345732407	2893.34345732407
"AML-0024"	"2020-09-15-AML0024:ATGAGGGTCTAACACG"	-1.45525131645854	-16.3105058900085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGTCTAACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3222.64352362077	38.7421243240145	0.0120218460527977	3246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3217.6893181561	3217.6893181561
"AML-0024"	"2020-09-15-AML0024:ATGAGGGTCTCGTGAA"	-1.94829068604167	-16.5531358948913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGGGTCTCGTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2230.97567961476	32.5012947651283	0.0145681977002728	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2224.84585127177	2224.84585127177
"AML-0024"	"2020-09-15-AML0024:ATGAGTCAGATCACTC"	-0.224041561514694	-15.9469080201355	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.285714285714286	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCAGATCACTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2040.88503216058	49.5016039372628	0.0242549693673132	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2036.95331121727	2036.95331121727
"AML-0024"	"2020-09-15-AML0024:ATGAGTCCAGTCAGAG"	-1.42514918270763	-16.3754987946716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCCAGTCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.92378873574	38.441463123536	0.0133899281041049	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2862.14950240734	2862.14950240734
"AML-0024"	"2020-09-15-AML0024:ATGAGTCCAGTCGGTC"	-2.51538072052653	-15.8441524735657	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCCAGTCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.48621206127	32.6840657554955	0.0120317436585459	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.29299584481	2712.29299584481
"AML-0024"	"2020-09-15-AML0024:ATGAGTCCATACAGAA"	-1.92091451111491	-16.2879324189392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCCATACAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3239.35906225678	36.5917475365185	0.0112959838144729	4048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3222.48316585974	3222.48316585974
"AML-0024"	"2020-09-15-AML0024:ATGAGTCGTCCTACAA"	-2.19521341744121	-16.2438249818054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCGTCCTACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.65076011545	35.2971118546071	0.0143446247743629	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2456.85065855883	2456.85065855883
"AML-0024"	"2020-09-15-AML0024:ATGAGTCGTTCCAAAC"	-1.10161350193675	11.6489333876404	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCGTTCCAAAC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1792.42018203154	41.1908009335076	0.0229805496202468	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1792.42018203154	1792.42018203154
"AML-0024"	"2020-09-15-AML0024:ATGAGTCTCAAGTTGC"	-1.98384533348735	-15.6852283707825	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCTCAAGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.63074453168	33.6479692530372	0.0123495520707048	2560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.20056465055	2721.20056465055
"AML-0024"	"2020-09-15-AML0024:ATGAGTCTCCTTTAGT"	-0.637678305537063	-15.9709692231384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGAGTCTCCTTTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.53683696212	34.871703640627	0.0130092238091186	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.07118141561	2673.07118141561
"AML-0024"	"2020-09-15-AML0024:ATGATCGAGTCATGCT"	-2.39679060402568	-16.5815649262634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGATCGAGTCATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1758.87946643013	43.2384955115612	0.0245829781612717	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1753.32580680434	1753.32580680434
"AML-0024"	"2020-09-15-AML0024:ATGATCGAGTGAATAC"	-0.435018281370956	-16.2033262482849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGATCGAGTGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.2586487632	41.2188022343934	0.0147565289926317	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2782.76297632101	2782.76297632101
"AML-0024"	"2020-09-15-AML0024:ATGATCGGTAGGGAGG"	-1.14161620560344	-16.0010709992615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGATCGGTAGGGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.37484547548	37.017167025447	0.0139090391901685	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.46143559851	2654.46143559851
"AML-0024"	"2020-09-15-AML0024:ATGATCGTCTAGCATG"	-2.43083439293559	-15.4817295304504	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGATCGTCTAGCATG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.76442402788	34.1942132597346	0.0126328737573885	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.7933556769	2700.7933556769
"AML-0024"	"2020-09-15-AML0024:ATGATCGTCTGAGTCA"	-2.12964425507243	-16.2565183869568	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGATCGTCTGAGTCA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.23144245416	33.6888272551449	0.0120522496790344	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.94202764604	2786.94202764604
"AML-0024"	"2020-09-15-AML0024:ATGCATGCAATTGCCA"	-0.619872967631179	-16.3787508240906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCATGCAATTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.95258270439	38.2108067681957	0.0139866288346668	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.13120411371	2727.13120411371
"AML-0024"	"2020-09-15-AML0024:ATGCATGCAGAGCTAG"	-0.918041507632095	-17.3344087830749	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCATGCAGAGCTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2810.27914493208	46.0055365530798	0.0163704508272938	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2803.55913979601	2803.55913979601
"AML-0024"	"2020-09-15-AML0024:ATGCATGCAGCATTGT"	-1.48369095745738	-16.7663355103699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCATGCAGCATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2986.62662851653	36.880713243316	0.0123486186358805	3739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2979.03084732937	2979.03084732937
"AML-0024"	"2020-09-15-AML0024:ATGCCTCTCTAACACG"	-0.955943922430831	-15.6429119340149	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCCTCTCTAACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.80078170139	37.6095696446913	0.0136722258823227	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.49360269809	2742.49360269809
"AML-0024"	"2020-09-15-AML0024:ATGCCTCTCTTCACAT"	-1.51302895966228	-15.5906009904114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCCTCTCTTCACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.14487653669	34.1447113475599	0.012845316163522	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.25350969054	2654.25350969054
"AML-0024"	"2020-09-15-AML0024:ATGCGATAGAACGCGT"	8.85130371627156	6.74494741046754	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATAGAACGCGT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1553.54843856423	37.0197400514505	0.0238291508217559	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1549.90428832045	1549.90428832045
"AML-0024"	"2020-09-15-AML0024:ATGCGATAGCTCACTA"	-2.49338994446452	-15.5546760789123	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATAGCTCACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.53547847854	30.2981619197735	0.0110233839646651	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.52156047717	2742.52156047717
"AML-0024"	"2020-09-15-AML0024:ATGCGATAGTAAAGCT"	-2.18319378319438	-16.7035608521667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATAGTAAAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.79561874575	39.4476704669272	0.0154466826465546	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.42182494803	2544.42182494803
"AML-0024"	"2020-09-15-AML0024:ATGCGATCACTCCTTG"	-0.906269113451797	-16.6016359559265	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATCACTCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.07709827031	30.6988284152255	0.0108129604630774	2714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.21585271741	2830.21585271741
"AML-0024"	"2020-09-15-AML0024:ATGCGATCAGACGCTC"	-2.02673087540324	-15.8627729645935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATCAGACGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.44210261585	39.788580113162	0.0142793493092174	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.38504836172	2780.38504836172
"AML-0024"	"2020-09-15-AML0024:ATGCGATGTGAGACCA"	-1.87298820439036	-15.404175781366	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATGTGAGACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.11662925998	48.4670648847149	0.0189389824326725	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.07513357283	2553.07513357283
"AML-0024"	"2020-09-15-AML0024:ATGCGATGTTGGTACT"	-2.3905066055363	-15.5606231919494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATGTTGGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.46040556762	36.1312812503247	0.014649041666659	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2457.24057619563	2457.24057619563
"AML-0024"	"2020-09-15-AML0024:ATGCGATTCATTTGTC"	-2.09013019028361	-15.9409151307312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGCGATTCATTTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.20247484487	31.6128977232575	0.011755491830373	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.61302199857	2685.61302199857
"AML-0024"	"2020-09-15-AML0024:ATGGAGGTCATTGTGG"	-1.85780451718028	-15.716862701532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGAGGTCATTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2936.44959779783	40.9372597960172	0.0139410735422524	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2928.21577041628	2928.21577041628
"AML-0024"	"2020-09-15-AML0024:ATGGAGGTCTCTTGCG"	-2.06576667252238	-16.2594862214294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGAGGTCTCTTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.04257587017	36.7774050794192	0.014293352711811	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.37809400204	2570.37809400204
"AML-0024"	"2020-09-15-AML0024:ATGGAGGTCTTACCGC"	-1.54715488377269	-15.9216289750305	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGAGGTCTTACCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.82569433828	33.8439933203374	0.0123706687126949	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.98750352511	2727.98750352511
"AML-0024"	"2020-09-15-AML0024:ATGGATCCAATTCACG"	-1.89920006218608	-16.9298029175964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGATCCAATTCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1649.77187485673	51.2636820208422	0.0310731943016631	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1646.40876481248	1646.40876481248
"AML-0024"	"2020-09-15-AML0024:ATGGATCCAGTCTACA"	-0.548503975302535	-16.1299410096374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGATCCAGTCTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.25344606299	31.5183449799026	0.0113405796166415	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.91641127996	2774.91641127996
"AML-0024"	"2020-09-15-AML0024:ATGGATCGTACCGCGT"	-1.48621032658275	-16.1204290620056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGATCGTACCGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.38268377624	40.0554300010565	0.0143240158914751	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.22319003304	2790.22319003304
"AML-0024"	"2020-09-15-AML0024:ATGGATCGTTGTTTGG"	-0.951639632613021	-17.5152425996033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGATCGTTGTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3052.63414624552	41.8260384903483	0.0137016217753414	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3046.7918884901	3046.7918884901
"AML-0024"	"2020-09-15-AML0024:ATGGATCTCAGTCACA"	-0.952687243849593	-17.451928161737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGATCTCAGTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2859.82804511598	33.5379704104946	0.0117272681718647	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2848.93792605155	2848.93792605155
"AML-0024"	"2020-09-15-AML0024:ATGGGAGAGACGACTG"	-1.04634902897533	-16.0884275666443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGAGAGACGACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.69561341835	38.8394186453396	0.0144293502027947	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.77981551708	2684.77981551708
"AML-0024"	"2020-09-15-AML0024:ATGGGAGAGACTTCAC"	-1.3257841867512	-16.7845564118591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGAGAGACTTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.61855283405	36.298483752206	0.014006105841661	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.72333903232	2585.72333903232
"AML-0024"	"2020-09-15-AML0024:ATGGGAGCAGACTGCC"	-1.14672885361369	-16.1372213593689	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGAGCAGACTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.67526783933	38.9999015661863	0.0147969296681065	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.18801422314	2627.18801422314
"AML-0024"	"2020-09-15-AML0024:ATGGGAGGTATGAGCG"	-2.14358625832255	-16.133610748407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGAGGTATGAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2197.4270605599	30.8545195518531	0.0140412030531705	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2193.86966987345	2193.86966987345
"AML-0024"	"2020-09-15-AML0024:ATGGGAGTCTTCGCTG"	-0.187868933111984	-16.5620184174744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGAGTCTTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.32828582802	46.467101628301	0.0173557728703897	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.01494494707	2665.01494494707
"AML-0024"	"2020-09-15-AML0024:ATGGGTTAGCCGTTAT"	-1.95249686661418	-16.4858541718689	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGTTAGCCGTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.84269933017	39.5236810573991	0.01456373321385	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.23659667995	2705.23659667995
"AML-0024"	"2020-09-15-AML0024:ATGGGTTCAGCTCTGG"	-0.415176520973998	-15.9228906861511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGTTCAGCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.51238869391	35.7292289690677	0.0131914585726879	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.98728654115	2700.98728654115
"AML-0024"	"2020-09-15-AML0024:ATGGGTTGTGGTCTCG"	-0.411593238741714	-16.0120401612488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGGTTGTGGTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3046.8463451458	34.8129465600878	0.0114258950457254	2843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3031.15780315732	3031.15780315732
"AML-0024"	"2020-09-15-AML0024:ATGGTTGAGACCATGG"	-2.69187627258952	-16.1773424378601	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGAGACCATGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.74383545176	40.2462672442242	0.0148196110100087	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.06246564214	2703.06246564214
"AML-0024"	"2020-09-15-AML0024:ATGGTTGAGGGCAGTT"	-2.93776712837871	-15.5697069398132	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGAGGGCAGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3024.52709927808	38.7869962172369	0.012824152320042	3070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3015.38790305872	3015.38790305872
"AML-0024"	"2020-09-15-AML0024:ATGGTTGCAGTGGGTA"	-0.709358612925369	-17.1915941468445	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGCAGTGGGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2869.09003829655	48.5543643181093	0.0169232626616825	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2856.15563884459	2856.15563884459
"AML-0024"	"2020-09-15-AML0024:ATGGTTGGTCCATACA"	0.109798641025466	-16.002902053949	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGGTCCATACA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2891.91694671335	34.91755609242	0.0120741904888049	2905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2885.17206888111	2885.17206888111
"AML-0024"	"2020-09-15-AML0024:ATGGTTGGTGCATGAG"	0.710738380520981	-16.2567396393982	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGGTGCATGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2686.36110417481	47.1055708701175	0.0175350852113336	2686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2677.42134983089	2677.42134983089
"AML-0024"	"2020-09-15-AML0024:ATGGTTGTCAATGCAC"	-1.59714053097423	-16.5586290589538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGTCAATGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.9721543614	41.7128898652552	0.0170258628413382	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2440.9791737905	2440.9791737905
"AML-0024"	"2020-09-15-AML0024:ATGGTTGTCCTGTTAT"	-0.932735959917861	-15.9679956666199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGGTTGTCCTGTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.63004173493	35.3472899975641	0.0127670687180054	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.4445096022	2760.4445096022
"AML-0024"	"2020-09-15-AML0024:ATGTCCCAGAAGAGCA"	-0.339764009148437	-16.668538116571	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCCCAGAAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.04290714827	36.7940989894472	0.0145141918054703	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2525.15078624788	2525.15078624788
"AML-0024"	"2020-09-15-AML0024:ATGTCCCCATCGAACT"	-0.770539800555068	-15.5334758988586	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCCCCATCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.71343119318	36.1326544917844	0.0123500319978531	2855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2914.52219578872	2914.52219578872
"AML-0024"	"2020-09-15-AML0024:ATGTCCCTCCGTGGTG"	-2.54717264595683	-15.9755621186462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCCCTCCGTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.98950439741	34.7235705550861	0.0123703955788536	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.79236713613	2796.79236713613
"AML-0024"	"2020-09-15-AML0024:ATGTCTTAGAGGGTGG"	-1.44820831242259	-15.8251657716003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCTTAGAGGGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.25364118892	36.0938104271085	0.0138489247004537	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.13536793971	2599.13536793971
"AML-0024"	"2020-09-15-AML0024:ATGTCTTAGTCAGGGT"	-1.05058095875438	-16.6374044648376	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCTTAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.32749343647	42.8309096222522	0.0170550872931522	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.1932615669	2505.1932615669
"AML-0024"	"2020-09-15-AML0024:ATGTCTTCATCCAATG"	0.959659476845902	-16.2146349183288	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATGTCTTCATCCAATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3080.46654004106	41.0546743128504	0.0133274209536791	4341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3065.61915302393	3065.61915302393
"AML-0024"	"2020-09-15-AML0024:ATTACCTAGCGTACAG"	-2.10907040062602	-16.8725290528503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTAGCGTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1626.77116358223	52.4875884372566	0.0322648874115007	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1618.94396695892	1618.94396695892
"AML-0024"	"2020-09-15-AML0024:ATTACCTAGTGTCATC"	-0.845855812460738	-16.2027902833191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTAGTGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.51856485346	37.2237221640589	0.0138557472302781	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.40525392784	2680.40525392784
"AML-0024"	"2020-09-15-AML0024:ATTACCTCACACTGGC"	-1.19026313248332	-16.5526991120544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTCACACTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2971.18378582968	38.7740715765703	0.0130500414553598	3375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2965.8519381211	2965.8519381211
"AML-0024"	"2020-09-15-AML0024:ATTACCTGTCGAGTGA"	-1.15812335434611	-15.8615856400696	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTGTCGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.25232548006	40.3322122286339	0.0143161518987339	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.11492367384	2810.11492367384
"AML-0024"	"2020-09-15-AML0024:ATTACCTGTTCTGACA"	-2.14548263970073	-16.1702413789001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTGTTCTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.33521823133	42.8708905155036	0.0170505866539389	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.34232076038	2507.34232076038
"AML-0024"	"2020-09-15-AML0024:ATTACCTTCGCTCCTA"	-1.59390149536784	-15.6730547181335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACCTTCGCTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.7554107113	41.1974143770711	0.0153793116804687	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.80043994545	2673.80043994545
"AML-0024"	"2020-09-15-AML0024:ATTACTCCAGCTACTA"	-1.56714055958446	-16.228150390741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACTCCAGCTACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.19225150411	36.6879603001673	0.0139275940392045	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.15887378606	2626.15887378606
"AML-0024"	"2020-09-15-AML0024:ATTACTCGTCGCTTAA"	0.0748187816584527	-16.4083090058533	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACTCGTCGCTTAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2691.57564177476	34.6026296014329	0.0128559008576169	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2685.41824534064	2685.41824534064
"AML-0024"	"2020-09-15-AML0024:ATTACTCTCCCGTAAA"	-0.703593949705917	-16.7100229493347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTACTCTCCCGTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.83815822685	36.0007753912611	0.0132412351512455	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.2593215584	2711.2593215584
"AML-0024"	"2020-09-15-AML0024:ATTATCCAGCTTTCTT"	-0.563758890063125	-16.5298013917175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCAGCTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2825.6831323807	41.9243136061805	0.0148368771875912	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.8602526466	2815.8602526466
"AML-0024"	"2020-09-15-AML0024:ATTATCCAGTTACGTC"	9.35938801345174	7.44659993732301	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCAGTTACGTC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1774.91603944812	35.8833873407801	0.020216949164501	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1767.71813627339	1767.71813627339
"AML-0024"	"2020-09-15-AML0024:ATTATCCCATGAGGGT"	-1.53578207913097	-15.7267828217712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCCATGAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.59086697363	35.384136654775	0.0136481760795831	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.98388357962	2588.98388357962
"AML-0024"	"2020-09-15-AML0024:ATTATCCGTAGAGGAA"	-1.28604565087016	-16.3188238373962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCGTAGAGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.40762858176	34.6324829077192	0.0127026063691491	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.80780516063	2716.80780516063
"AML-0024"	"2020-09-15-AML0024:ATTATCCGTGAACGGT"	-1.73756835880931	-15.9316587678161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCGTGAACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.48210119438	38.5787130707418	0.0150846463608582	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.48350886568	2548.48350886568
"AML-0024"	"2020-09-15-AML0024:ATTATCCGTGTTGCCG"	-1.97822914543803	13.8864669569763	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCGTGTTGCCG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2088.52407063981	31.9673399655785	0.0153061869934712	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2085.05518209022	2085.05518209022
"AML-0024"	"2020-09-15-AML0024:ATTATCCGTTAAAGTG"	-2.14693246308025	-16.7466936341492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCGTTAAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.57302036606	40.6230575661008	0.0163501161902321	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.36871910983	2476.36871910983
"AML-0024"	"2020-09-15-AML0024:ATTATCCTCAAACTGC"	-0.154605190188247	-15.9118442765442	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCTCAAACTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.48338596006	37.0117009831708	0.0127254297417806	2493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2899.95951961004	2899.95951961004
"AML-0024"	"2020-09-15-AML0024:ATTATCCTCTGAATGC"	-1.01044736328776	-17.4427747956482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTATCCTCTGAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3220.5264165379	35.436686567207	0.0110033832932511	3231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3212.88933155829	3212.88933155829
"AML-0024"	"2020-09-15-AML0024:ATTCACTAGCCTGGAA"	-1.28142652931865	-16.7459116212097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTAGCCTGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.71762647058	44.0927412225115	0.0165593004621208	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.92952345393	2649.92952345393
"AML-0024"	"2020-09-15-AML0024:ATTCACTAGGAAAGGT"	-0.952009419829208	-16.6282911530701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTAGGAAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.38514342684	40.912808430514	0.0142932576786411	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2854.09538659595	2854.09538659595
"AML-0024"	"2020-09-15-AML0024:ATTCACTGTAACGTTC"	-1.44441674175914	-16.5504045716492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTGTAACGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.26772486992	35.5520113923472	0.0126327751543221	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.12783271352	2807.12783271352
"AML-0024"	"2020-09-15-AML0024:ATTCACTGTTCGATTG"	-1.74397216263469	-16.0244989625183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTGTTCGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.02286349765	36.481661500819	0.0127557237273984	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2846.95374297588	2846.95374297588
"AML-0024"	"2020-09-15-AML0024:ATTCACTTCAGACATC"	-2.2094181579655	-16.2962599030701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTTCAGACATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.89165361726	37.2561220749333	0.0134358376485184	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2767.33648850853	2767.33648850853
"AML-0024"	"2020-09-15-AML0024:ATTCACTTCTACTGCC"	-1.09569356861766	-16.0325269929138	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTTCTACTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.61586344377	29.548747057194	0.0106000067816697	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.86019222072	2777.86019222072
"AML-0024"	"2020-09-15-AML0024:ATTCACTTCTATTGTC"	0.926329989998978	-16.2854337922302	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCACTTCTATTGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2261.5651369264	49.1698582198089	0.0217415175963641	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2244.58263455042	2244.58263455042
"AML-0024"	"2020-09-15-AML0024:ATTCAGGAGGAAGTAG"	-2.35507140579875	13.892834640387	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCAGGAGGAAGTAG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1778.26136557907	41.2812147521907	0.0232143685687891	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1776.3004519443	1776.3004519443
"AML-0024"	"2020-09-15-AML0024:ATTCAGGCATGAATCC"	-1.92312775078471	10.933738685492	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCAGGCATGAATCC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2033.87620003009	39.604988411592	0.0194726642708175	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2032.35409535272	2032.35409535272
"AML-0024"	"2020-09-15-AML0024:ATTCATCAGGATACGC"	-1.98806105080302	-15.771080040094	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCATCAGGATACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.81991951569	36.3216964338724	0.0138800901670738	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.71770390642	2613.71770390642
"AML-0024"	"2020-09-15-AML0024:ATTCATCCAACCTATG"	-2.2629762691563	-16.068253540155	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCATCCAACCTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2873.38415558638	33.4007400061748	0.0116241818697433	3130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.07188054949	2864.07188054949
"AML-0024"	"2020-09-15-AML0024:ATTCATCCAGAGGCTA"	-1.50351999226268	-15.8201284638611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCATCCAGAGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.13933959042	39.5251606544546	0.0136948206596511	2979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.64096619529	2881.64096619529
"AML-0024"	"2020-09-15-AML0024:ATTCATCGTGCGAACA"	-0.755839864641982	-15.9873953095642	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCATCGTGCGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.68844511005	40.997605906023	0.0156737343786745	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.08910856952	2613.08910856952
"AML-0024"	"2020-09-15-AML0024:ATTCATCGTGGCGTAA"	-0.096605415374595	-16.0880174866882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCATCGTGGCGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.93919302754	34.6535273998492	0.0130968721772468	2875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.21434657935	2634.21434657935
"AML-0024"	"2020-09-15-AML0024:ATTCCATAGATGTTGA"	-0.64632080021556	-16.6459017029968	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATAGATGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.27557532991	35.5903237026478	0.0143032082360608	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2482.19855584347	2482.19855584347
"AML-0024"	"2020-09-15-AML0024:ATTCCATCACTCGATA"	-0.299450169236022	-15.9123172990051	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATCACTCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2976.10873223284	40.5276596389215	0.0136176676611259	3038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2967.99172807245	2967.99172807245
"AML-0024"	"2020-09-15-AML0024:ATTCCATCAGAACATA"	0.117025119333905	-16.0492182007995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATCAGAACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2991.75055454533	39.4185989111936	0.0131757638855637	2997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2986.51155426512	2986.51155426512
"AML-0024"	"2020-09-15-AML0024:ATTCCATGTCTTGCGG"	0.407603730528992	-16.3207788697449	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATGTCTTGCGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2882.52363608141	37.0316197350813	0.0128469440012722	3078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2873.22070624085	2873.22070624085
"AML-0024"	"2020-09-15-AML0024:ATTCCATGTGACTCGC"	-2.68704376640971	-15.9825391999451	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATGTGACTCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.32374450105	39.3935683177083	0.0156738933469667	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.98741825919	2509.98741825919
"AML-0024"	"2020-09-15-AML0024:ATTCCATTCAAGAATG"	-1.98077354851421	-16.5136919251648	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATTCAAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.83841781509	37.5783759760397	0.0162407088095305	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2306.08144557204	2306.08144557204
"AML-0024"	"2020-09-15-AML0024:ATTCCATTCCCACAGG"	-0.527606467634994	-16.0619802705017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCATTCCCACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.76548655153	30.0244326758445	0.0112418828336036	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.26452322327	2666.26452322327
"AML-0024"	"2020-09-15-AML0024:ATTCCCGAGCGTGAGT"	-2.45824561539348	-15.4634189835754	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCCGAGCGTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.34357003166	38.8364967841694	0.0146147819281444	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.00326235557	2648.00326235557
"AML-0024"	"2020-09-15-AML0024:ATTCCCGAGTTTGTCG"	-1.22238061848338	-16.514994644281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCCGAGTTTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.19918184841	32.8609829887047	0.0134334862150817	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2435.04459443846	2435.04459443846
"AML-0024"	"2020-09-15-AML0024:ATTCCCGCATTGGATC"	-2.9597831768101	-15.9059467545715	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCCGCATTGGATC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.07926505134	29.7056081189897	0.0124652203368274	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2377.51462133999	2377.51462133999
"AML-0024"	"2020-09-15-AML0024:ATTCCCGTCGGATAAA"	-1.30218038979228	-15.6820917359558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCCGTCGGATAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.81372278346	37.5291484104979	0.0132620561234623	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.90730646164	2826.90730646164
"AML-0024"	"2020-09-15-AML0024:ATTCCTAAGCGCCATC"	-0.130188818008262	-16.540852569696	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTAAGCGCCATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2761.46996647433	52.6992254040082	0.0190837583040207	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2747.42186125186	2747.42186125186
"AML-0024"	"2020-09-15-AML0024:ATTCCTAAGGTTCAGG"	-0.88870600882228	-15.6306848756042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTAAGGTTCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.42290404805	38.0694572735176	0.0142346437490851	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.9154958324	2666.9154958324
"AML-0024"	"2020-09-15-AML0024:ATTCCTAAGTAAATGC"	-2.66927991333659	-16.2376470795837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTAAGTAAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.63319675362	45.7133801615435	0.0202753069667229	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2246.25174675167	2246.25174675167
"AML-0024"	"2020-09-15-AML0024:ATTCCTACACATCATG"	-2.84382043305095	-15.8727674714294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTACACATCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.23075707899	34.9701560690132	0.0132652105568182	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.33499013167	2628.33499013167
"AML-0024"	"2020-09-15-AML0024:ATTCCTACACCAGTAT"	-1.10989795151408	-16.7648515931335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTACACCAGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.63012539563	48.7418105958322	0.0197045670229443	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2467.15671711961	2467.15671711961
"AML-0024"	"2020-09-15-AML0024:ATTCCTACATGGATCT"	-1.86666093292888	-16.402445816156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTACATGGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2323.66841018591	31.306215151714	0.0134727549828029	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2317.52528181724	2317.52528181724
"AML-0024"	"2020-09-15-AML0024:ATTCCTAGTAGCTGAG"	-0.670861701399642	-15.8332567445007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTAGTAGCTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.71162952409	31.771180232804	0.0114833724967098	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.60262410713	2757.60262410713
"AML-0024"	"2020-09-15-AML0024:ATTCCTAGTGCCGGTT"	-2.47596011582072	-15.8841152421203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTAGTGCCGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2905.68626263244	33.9729871936037	0.011691897928039	3357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2898.28815370759	2898.28815370759
"AML-0024"	"2020-09-15-AML0024:ATTCCTATCAAGCGTT"	0.215173442929429	-15.9070558778015	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTATCAAGCGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2352.23365276873	41.4801302793166	0.0176343579773598	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2348.74738431376	2348.74738431376
"AML-0024"	"2020-09-15-AML0024:ATTCCTATCCCTCATG"	-1.35772357407268	-16.2238188019958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTATCCCTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2935.97045908225	32.0068846528337	0.010901637158447	3013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2925.79039361759	2925.79039361759
"AML-0024"	"2020-09-15-AML0024:ATTCCTATCCTGATAG"	-1.19773612442668	-16.2270784608093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCCTATCCTGATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2974.0828670876	38.812208903764	0.0130501437378479	3342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2961.50621254643	2961.50621254643
"AML-0024"	"2020-09-15-AML0024:ATTCGTTAGACCTCCG"	-0.99416540089305	-15.8929519883362	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTAGACCTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.34754187184	37.989967476481	0.0146095730915777	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.58607482871	2594.58607482871
"AML-0024"	"2020-09-15-AML0024:ATTCGTTAGCCATGCC"	-1.87489400330241	-16.5428896180359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTAGCCATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.27363085531	40.5797241894775	0.0150558829073692	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.20704972853	2683.20704972853
"AML-0024"	"2020-09-15-AML0024:ATTCGTTCAACCTAAC"	-1.98587499085124	-16.8100900880066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTCAACCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.70229985108	35.7969258829317	0.0144944295047586	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.77705497341	2458.77705497341
"AML-0024"	"2020-09-15-AML0024:ATTCGTTCACTTCAAG"	-0.789480845362502	-16.691903137323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTCACTTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2967.51090097005	35.3160275312905	0.0119008922662242	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2955.49977078527	2955.49977078527
"AML-0024"	"2020-09-15-AML0024:ATTCGTTGTCCGTTTC"	-0.58504037085231	-16.2128839722839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTGTCCGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.19902029139	42.322426068557	0.0161154679221002	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.7883414862	2613.7883414862
"AML-0024"	"2020-09-15-AML0024:ATTCGTTGTCTGTAAC"	-0.732087115675765	-16.1555242768494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTGTCTGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.89744083424	33.7513374900224	0.0122336325339505	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.89506878785	2752.89506878785
"AML-0024"	"2020-09-15-AML0024:ATTCGTTTCGCTTTAT"	-1.13285932961162	-16.5969057313171	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCGTTTCGCTTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.91133434298	40.1124181780498	0.0170842985385879	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2340.35782209328	2340.35782209328
"AML-0024"	"2020-09-15-AML0024:ATTCTACCACAATTCG"	-1.20604000511821	-16.4134054414001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACCACAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.46325580104	35.3263835985542	0.0138076572014296	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.0902262469	2556.0902262469
"AML-0024"	"2020-09-15-AML0024:ATTCTACCAGTTTGGT"	-2.24696312370952	-16.5671224824158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACCAGTTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.04361998013	42.4935828251999	0.015680036480561	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.53247601505	2702.53247601505
"AML-0024"	"2020-09-15-AML0024:ATTCTACGTACCCGCA"	-2.42616281929668	-16.2406511536804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACGTACCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.32062025766	53.6666140275596	0.0227081393728578	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2356.52342248105	2356.52342248105
"AML-0024"	"2020-09-15-AML0024:ATTCTACGTGAGACGT"	-0.941048721701461	-17.4899854890076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACGTGAGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.31838989561	45.4173037219806	0.0164715485481892	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.62431384825	2753.62431384825
"AML-0024"	"2020-09-15-AML0024:ATTCTACGTTGCTTGA"	-0.820542673498946	-16.4717664948669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACGTTGCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.13522318344	41.2549197359845	0.0159400171082408	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.99806860285	2580.99806860285
"AML-0024"	"2020-09-15-AML0024:ATTCTACGTTTAAGGA"	-2.73081598702129	-15.7106800309387	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACGTTTAAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.96845417463	42.8376257822867	0.0160502555641985	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.57272355585	2659.57272355585
"AML-0024"	"2020-09-15-AML0024:ATTCTACTCCTCAGGG"	-2.01807032051738	-16.5485544434753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTACTCCTCAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.77920782678	35.7563916097399	0.0140508817031225	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.12686059633	2538.12686059633
"AML-0024"	"2020-09-15-AML0024:ATTCTTGCATACTGAC"	-0.124383862048942	-16.0061903229919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGCATACTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.78525690679	32.3540671023346	0.0118176058625171	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.33730568975	2733.33730568975
"AML-0024"	"2020-09-15-AML0024:ATTCTTGCATGTGTCA"	-1.25488028946574	-16.2168531647888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGCATGTGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.36375698696	41.0518560520491	0.0177455257211762	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2306.88900019498	2306.88900019498
"AML-0024"	"2020-09-15-AML0024:ATTCTTGGTGACAGCA"	-1.06734226170238	-15.657759689447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGGTGACAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.98718931825	39.8061755470905	0.0136090085086385	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.34258284857	2920.34258284857
"AML-0024"	"2020-09-15-AML0024:ATTCTTGGTTCTCAGA"	-0.486263374716598	-16.4987592927185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGGTTCTCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.42182555785	34.7466305014223	0.0120005417499842	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.20799343519	2886.20799343519
"AML-0024"	"2020-09-15-AML0024:ATTCTTGTCATGGATC"	-2.13292608681377	-15.6494646302429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGTCATGGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.61993094582	33.5903302011917	0.0129162780771949	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.86762894834	2593.86762894834
"AML-0024"	"2020-09-15-AML0024:ATTCTTGTCATTCATC"	-0.995848993689376	-16.1170187226501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGTCATTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.36857765201	35.4374621878087	0.0132063341886552	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.78666089697	2679.78666089697
"AML-0024"	"2020-09-15-AML0024:ATTCTTGTCCTAGCGG"	-1.79012451592143	-15.8574619523254	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGTCCTAGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.24350853825	36.0596361312496	0.0134739742539143	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.34989078105	2668.34989078105
"AML-0024"	"2020-09-15-AML0024:ATTCTTGTCGGAGCAA"	-2.07695231857951	-16.4177141419617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTCTTGTCGGAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.19465727018	42.9544576451512	0.0147498579938388	2704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2900.71916571574	2900.71916571574
"AML-0024"	"2020-09-15-AML0024:ATTGGGTAGAATACAC"	-1.67597482624705	-16.4788236848083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTAGAATACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.3335217185	37.2817478157834	0.0137604866720639	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.98161978343	2691.98161978343
"AML-0024"	"2020-09-15-AML0024:ATTGGGTAGAGCCCAA"	-0.106313536793548	-16.4854936829773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTAGAGCCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.37004794499	36.275757161402	0.0139021129601649	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.38107056725	2598.38107056725
"AML-0024"	"2020-09-15-AML0024:ATTGGGTAGGTTCATC"	-2.58103046837505	-15.7200384370056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTAGGTTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.77910146273	34.2827728198157	0.0131918764471053	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.69325460623	2584.69325460623
"AML-0024"	"2020-09-15-AML0024:ATTGGGTCACATGTTG"	-0.732349137694198	-16.2629556885925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTCACATGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.14846331512	51.0056633733048	0.0207159170672548	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2454.72136875089	2454.72136875089
"AML-0024"	"2020-09-15-AML0024:ATTGGGTGTTGAGGAC"	-2.41272888603862	-15.8983202210632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTGTTGAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2229.26430404081	37.3037138422807	0.0167336433704443	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2222.89015983542	2222.89015983542
"AML-0024"	"2020-09-15-AML0024:ATTGGGTTCATTGGTG"	-1.24870357933696	-15.4476137391296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTTCATTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.90266240523	30.2470358102266	0.0111864366387068	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.30626798338	2696.30626798338
"AML-0024"	"2020-09-15-AML0024:ATTGGGTTCGGACAAG"	-0.953644613653976	-16.3806944123474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGGGTTCGGACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.43336878617	41.08790025197	0.0145010998686628	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2823.10158134737	2823.10158134737
"AML-0024"	"2020-09-15-AML0024:ATTGTTCAGCCTTTCC"	-1.06675086441692	-16.5427618256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGTTCAGCCTTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3009.71410138556	37.5725761862173	0.012483769195526	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.46658825397	3000.46658825397
"AML-0024"	"2020-09-15-AML0024:ATTGTTCGTTTACGAC"	-0.248594800860244	-16.0440206757751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGTTCGTTTACGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.12733240371	36.9433495298562	0.0127473175925695	3215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2891.31032211453	2891.31032211453
"AML-0024"	"2020-09-15-AML0024:ATTGTTCTCTTCCCAG"	-1.04629848423656	-16.8020868531433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTGTTCTCTTCCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.54761212099	40.3406847984011	0.0151114310961287	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.19565185116	2657.19565185116
"AML-0024"	"2020-09-15-AML0024:ATTTACCAGGGCTGAT"	-0.244430909783202	-16.5369596711365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTACCAGGGCTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2841.84250690255	36.9566891051862	0.0130044817808947	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.66735681376	2834.66735681376
"AML-0024"	"2020-09-15-AML0024:ATTTACCCAGTTTCGA"	-3.05114493790324	-15.7272806397644	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTACCCAGTTTCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.16298230011	44.5948875953971	0.0163761360907345	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.98684562779	2716.98684562779
"AML-0024"	"2020-09-15-AML0024:ATTTACCTCATTCTTG"	-1.63845322552379	-15.6955328217712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTACCTCATTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.09100005529	34.4409903213364	0.0124963182712927	2511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.16728640651	2751.16728640651
"AML-0024"	"2020-09-15-AML0024:ATTTACCTCTCGGTCT"	-1.83103118363078	-16.5023889771667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTACCTCTCGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.00155934659	39.6077735419543	0.017087034899631	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2308.4447751584	2308.4447751584
"AML-0024"	"2020-09-15-AML0024:ATTTCACAGATCGCTT"	-1.83650122109111	-16.0227060548035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACAGATCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3081.00936422902	33.7334339697328	0.0109488255249669	3086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3072.65112113288	3072.65112113288
"AML-0024"	"2020-09-15-AML0024:ATTTCACAGCCTGCCA"	-2.4926966232365	-15.6722059479919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACAGCCTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.74855924947	34.1992692493187	0.0126769669219407	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.09576632987	2694.09576632987
"AML-0024"	"2020-09-15-AML0024:ATTTCACCAGGGACTA"	-0.73029069128688	-16.6051912537781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACCAGGGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.26656324889	33.0588947373189	0.0125543289838957	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.00450988554	2623.00450988554
"AML-0024"	"2020-09-15-AML0024:ATTTCACGTAGGATAT"	-1.16129897061046	-15.5160656205383	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACGTAGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.53674216315	39.7756446526711	0.0157120550494889	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.58706725549	2519.58706725549
"AML-0024"	"2020-09-15-AML0024:ATTTCACTCAAGCCGC"	-1.91883347454723	-15.4371586075989	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACTCAAGCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.46762805633	38.9552453838763	0.0133022625931267	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.15074369602	2922.15074369602
"AML-0024"	"2020-09-15-AML0024:ATTTCACTCGAGTACT"	-0.816079358488876	-16.7544908753601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCACTCGAGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.93173577912	40.6176210512566	0.0155567533592126	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.55354110495	2600.55354110495
"AML-0024"	"2020-09-15-AML0024:ATTTCTGAGACCAAGC"	-0.198637585074264	-16.0964193574158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCTGAGACCAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.67827592637	34.6844535719052	0.0121628214040512	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.45419963866	2844.45419963866
"AML-0024"	"2020-09-15-AML0024:ATTTCTGAGCATGTTC"	-1.01092598858531	-16.8329134217468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCTGAGCATGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2479.58227812801	35.8476803943871	0.0144571449435632	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.4639173163	2468.4639173163
"AML-0024"	"2020-09-15-AML0024:ATTTCTGCATGAAGCG"	-0.712990264326888	-16.1370744935242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCTGCATGAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.34104492108	33.9886900860493	0.01237599028311	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.61059661971	2738.61059661971
"AML-0024"	"2020-09-15-AML0024:ATTTCTGTCCTGTTGC"	-1.95499573174174	-15.9324007264343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ATTTCTGTCCTGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.06895668083	40.8477242015334	0.016658472874607	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2447.91457970971	2447.91457970971
"AML-0024"	"2020-09-15-AML0024:CAAAGAAAGAAGGGAT"	-2.50353870812114	-16.4261160126892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAAGAAAGAAGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.03519377919	38.7224820722434	0.0159546438269598	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2421.2219593163	2421.2219593163
"AML-0024"	"2020-09-15-AML0024:CAAAGAACAGCACACC"	-0.449700037867385	-16.6198015443054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAAGAACAGCACACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2985.07023168826	44.0611477526608	0.0147605062302809	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.05920873276	2973.05920873276
"AML-0024"	"2020-09-15-AML0024:CAAAGAAGTTCCGCAG"	-1.40153537216838	-16.7680883637634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAAGAAGTTCCGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.94182825642	38.7369966831947	0.0169828954878721	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2275.24879871161	2275.24879871161
"AML-0024"	"2020-09-15-AML0024:CAAAGAATCAATCCGA"	8.97814335402791	6.40948340976564	"2020-09-15-AML0024"	"AML0024"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAAGAATCAATCCGA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1298.67235078547	45.8957401058557	0.0353405076177196	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1294.10965812956	1294.10965812956
"AML-0024"	"2020-09-15-AML0024:CAAAGAATCCGAAATC"	-0.193762401968795	-16.1454305878845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAAGAATCCGAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.30674798532	33.5153383599403	0.0121068008031739	2765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.55922499401	2760.55922499401
"AML-0024"	"2020-09-15-AML0024:CAACAACAGTATGGAT"	-1.88708732548411	-15.4018593064514	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACAGTATGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.43970801343	38.7781708536394	0.0137538571026803	2500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.39557279661	2817.39557279661
"AML-0024"	"2020-09-15-AML0024:CAACAACCAATTTCTC"	-0.311573157936889	-16.3598604432312	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACCAATTTCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2471.22777192348	42.3048655642362	0.0171189665496953	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2466.64520448621	2466.64520448621
"AML-0024"	"2020-09-15-AML0024:CAACAACCACTTTAGG"	-1.09214232388194	-15.6471796265808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACCACTTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.74498005141	39.9277440301492	0.0152004645800704	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.4280886208	2623.4280886208
"AML-0024"	"2020-09-15-AML0024:CAACAACGTCAAGTTC"	-0.863062779337722	-16.4919557801453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACGTCAAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.57991337205	44.9821213166797	0.0181630001413656	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.12281700966	2470.12281700966
"AML-0024"	"2020-09-15-AML0024:CAACAACGTTTACCAG"	0.105206561356229	-16.1286440125671	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACGTTTACCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2686.08349818526	39.7713783030272	0.0148064564373733	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2683.18880784223	2683.18880784223
"AML-0024"	"2020-09-15-AML0024:CAACAACTCACTACGA"	-2.04357896271403	-15.6241531602112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACTCACTACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.93969756565	33.3284704796884	0.0128386920971016	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.5193664331	2593.5193664331
"AML-0024"	"2020-09-15-AML0024:CAACAACTCGTGGACC"	-1.15850792351421	-16.5114679566589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAACTCGTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.96528268468	42.2850537406003	0.0154722249889184	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.13099019187	2726.13099019187
"AML-0024"	"2020-09-15-AML0024:CAACAGTAGCAACCAG"	-0.785160462290603	-16.2044954529968	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTAGCAACCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.64548676162	37.6847296114617	0.0134078558782885	2997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.49235810498	2797.49235810498
"AML-0024"	"2020-09-15-AML0024:CAACAGTCAGTCCCGA"	-3.20859132233318	11.2613811262879	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTCAGTCCCGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2051.99723998093	42.3286127630837	0.0206280066748418	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2042.18218239115	2042.18218239115
"AML-0024"	"2020-09-15-AML0024:CAACAGTGTTGCTCCT"	-2.14049611511882	-15.9256162873474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTGTTGCTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.40253908107	31.4084819378198	0.0115285760776062	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.0925026912	2717.0925026912
"AML-0024"	"2020-09-15-AML0024:CAACAGTTCAAAGGAT"	-0.650097946554977	-16.2124815217224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTTCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.50715889105	40.5474282916468	0.0164525504198137	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2461.52923378741	2461.52923378741
"AML-0024"	"2020-09-15-AML0024:CAACAGTTCCGACGGT"	-2.23769531670268	-15.9905119172302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTTCCGACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2195.25641930158	45.0584832961618	0.0205253850529667	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2185.24188734185	2185.24188734185
"AML-0024"	"2020-09-15-AML0024:CAACAGTTCGCAAGAG"	-1.02001533928569	-17.4275408021179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACAGTTCGCAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3004.87259556062	47.5147716414366	0.0158125744537837	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2993.58305536567	2993.58305536567
"AML-0024"	"2020-09-15-AML0024:CAACCAACAAAGCACG"	-1.85834501209911	-15.9473848572937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACCAACAAAGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.71884588404	35.3296193460273	0.0128953448632527	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.08661736448	2734.08661736448
"AML-0024"	"2020-09-15-AML0024:CAACCTCGTTAGAGAT"	-2.86614857140239	-15.835569404718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACCTCGTTAGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.25208185968	40.1794252169335	0.0156324842611788	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.07831769629	2565.07831769629
"AML-0024"	"2020-09-15-AML0024:CAACCTCTCGTGTCAA"	-1.97245297852214	-16.0577707520691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACCTCTCGTGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.96427802664	37.2056530030159	0.0139140426477474	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.89982880232	2664.89982880232
"AML-0024"	"2020-09-15-AML0024:CAACGATCAAGAAACT"	-1.21817515316661	-16.3041486970154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGATCAAGAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.85312764015	38.6228133684656	0.0142685293760793	2904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.95063027647	2694.95063027647
"AML-0024"	"2020-09-15-AML0024:CAACGATCATCCAATG"	-0.684426645666915	-16.5689802399841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGATCATCCAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.23219948055	34.9905781031964	0.0126720882473335	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.10694225993	2750.10694225993
"AML-0024"	"2020-09-15-AML0024:CAACGATGTAGACAGC"	-1.14137456837352	-16.2132196656433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGATGTAGACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.31345800638	40.1447632041603	0.0153089109471605	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.33629653328	2610.33629653328
"AML-0024"	"2020-09-15-AML0024:CAACGATGTGGGTTGA"	-2.17218885842021	-16.001322769281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGATGTGGGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.75159908619	38.7360014397203	0.0149056190877732	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.32855185575	2594.32855185575
"AML-0024"	"2020-09-15-AML0024:CAACGGCAGTGCTCAT"	-1.8706605238026	-15.4348888627258	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGGCAGTGCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.48434936878	37.7017745718572	0.0144479788050759	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.51536132618	2600.51536132618
"AML-0024"	"2020-09-15-AML0024:CAACGGCAGTGCTCGC"	-2.96424613419231	-15.8524160615173	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGGCAGTGCTCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.29401151937	32.109944316442	0.0125464070059615	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.08242856038	2552.08242856038
"AML-0024"	"2020-09-15-AML0024:CAACGGCGTAGGATAT"	-2.53671226921733	-15.4413357011047	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGGCGTAGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.25079561024	35.1954742589764	0.0120192827444078	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.07323412524	2915.07323412524
"AML-0024"	"2020-09-15-AML0024:CAACGGCGTTAGAGAT"	-2.3819776577061	-16.2086820832458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAACGGCGTTAGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.07513126728	40.485353127628	0.016350615785599	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2471.16637036862	2471.16637036862
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGAAGATCT"	-1.55526874485667	-16.5343199006286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGAAGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.45033121197	35.5209159406483	0.0160332711775201	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2206.56789766304	2206.56789766304
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGACGCCCT"	-2.53280220452006	-16.3568907014099	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGACGCCCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.22664282669	32.814933718038	0.0130309691589965	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.75856053462	2513.75856053462
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGATGACAT"	-1.9797707599705	-15.8722524872986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGATGACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.4257232487	36.5463873080558	0.0131017603385016	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.86523979042	2779.86523979042
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGCTAAGTA"	-1.24833999100383	-15.7610969773498	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGCTAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.30733277338	32.2552493107154	0.0123144195059244	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.81180521932	2609.81180521932
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGGGTTTCT"	-1.4995987218922	-15.7822962037292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGGGTTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.21586295909	39.2079122067141	0.0148502676454534	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.76808714382	2633.76808714382
"AML-0024"	"2020-09-15-AML0024:CAAGACTAGTCTTCCC"	-2.45815358582194	-15.5199270478454	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTAGTCTTCCC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.21274360077	35.6480600718648	0.0130187328048833	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.99778998456	2727.99778998456
"AML-0024"	"2020-09-15-AML0024:CAAGACTCAACCGGAA"	0.002615318715018	-16.0979910126892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTCAACCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.92623311687	39.2346729447345	0.0138495215604563	2793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.35559795292	2826.35559795292
"AML-0024"	"2020-09-15-AML0024:CAAGACTCAGGTTCCG"	-2.5114143890446	-15.7561712495056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTCAGGTTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.50422044097	33.1104506766141	0.0123018386615011	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.12307961425	2683.12307961425
"AML-0024"	"2020-09-15-AML0024:CAAGACTTCCCTTGTG"	-1.6760005754536	-16.1694269410339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTTCCCTTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.01785463232	33.9205499272041	0.011906050315568	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.13503649238	2845.13503649238
"AML-0024"	"2020-09-15-AML0024:CAAGACTTCTAGTGAC"	-2.84145937386211	-16.1478491059509	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTTCTAGTGAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.52080443894	37.8716488378954	0.014003090224241	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.70078612202	2698.70078612202
"AML-0024"	"2020-09-15-AML0024:CAAGACTTCTTCGGTC"	-2.14321623268779	-16.7252035371033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGACTTCTTCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.77640558726	36.067016075847	0.0135398061189357	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.92335901633	2655.92335901633
"AML-0024"	"2020-09-15-AML0024:CAAGAGGAGTGGAATT"	-0.483204702765304	-16.1622934571472	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGAGGAGTGGAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2964.59498104153	36.0962549173456	0.0121757795409423	3007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2956.62977303912	2956.62977303912
"AML-0024"	"2020-09-15-AML0024:CAAGAGGCACTGCACG"	-1.99810610237773	-16.6439543000427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGAGGCACTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2904.71703415741	30.7586301117198	0.0105892001699374	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2895.34310158471	2895.34310158471
"AML-0024"	"2020-09-15-AML0024:CAAGAGGCATCTGTTT"	-0.265182326466399	11.2389974364075	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGAGGCATCTGTTT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1807.42451899281	40.0955858043043	0.0221838231046282	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1804.03968710597	1804.03968710597
"AML-0024"	"2020-09-15-AML0024:CAAGAGGGTTTGGGTT"	-2.15054879608806	-15.58301355755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGAGGGTTTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.57380404063	38.3536979670636	0.0133284845425018	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.76304637013	2873.76304637013
"AML-0024"	"2020-09-15-AML0024:CAAGAGGTCGGCATTA"	-2.13035474243816	-15.9926977387634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGAGGTCGGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3108.34685507208	35.119761634197	0.011298533680979	3453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3100.18251640687	3100.18251640687
"AML-0024"	"2020-09-15-AML0024:CAAGCTAAGAATCGTA"	-1.92783544483836	-16.6765680543152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAAGAATCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.37685579476	39.9306030822942	0.0156199986679507	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.15325977327	2543.15325977327
"AML-0024"	"2020-09-15-AML0024:CAAGCTAAGAATTGCA"	12.1442686515743	-2.95947697078856	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAAGAATTGCA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1879.83963388375	49.4704002419313	0.0263162874908246	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1878.21164003699	1878.21164003699
"AML-0024"	"2020-09-15-AML0024:CAAGCTAAGACCTGGA"	-2.47659955444987	-15.8205394974914	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAAGACCTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.11180907568	36.0765263139192	0.0131373115234016	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.69126776386	2737.69126776386
"AML-0024"	"2020-09-15-AML0024:CAAGCTAAGATGTTAG"	-1.6669958633488	-15.565980934259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAAGATGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.04321888353	37.4195785783254	0.0138281526019988	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.47159416367	2697.47159416367
"AML-0024"	"2020-09-15-AML0024:CAAGCTAAGCGATTCT"	-0.258582482964355	-16.2128381959167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAAGCGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.78300740278	37.2910782826334	0.0138691289627922	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.53205487651	2681.53205487651
"AML-0024"	"2020-09-15-AML0024:CAAGCTACACCCATAA"	-0.083639289171058	-16.0686426392761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTACACCCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.10447692703	38.2539886396435	0.0135743684994096	2849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.63542179334	2811.63542179334
"AML-0024"	"2020-09-15-AML0024:CAAGCTAGTTCTCTAT"	-2.82817326012309	-15.9604025117126	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTAGTTCTCTAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.53195982763	44.5652998726778	0.0189758115431176	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2342.68997088656	2342.68997088656
"AML-0024"	"2020-09-15-AML0024:CAAGCTATCAGCTTGA"	-0.604382614523727	-16.7474642029968	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTATCAGCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.99838925102	39.4565886649488	0.01703653545187	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2309.47472595065	2309.47472595065
"AML-0024"	"2020-09-15-AML0024:CAAGCTATCCGACATA"	-0.630025307566482	-16.1017523041931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGCTATCCGACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.1264902224	39.337086866985	0.0144190846751311	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.20559908957	2721.20559908957
"AML-0024"	"2020-09-15-AML0024:CAAGGGAAGATTGCGG"	-2.97698507729228	-15.6359396210876	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGAAGATTGCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.01387387494	35.8372805938749	0.0134020548449671	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.76881743566	2671.76881743566
"AML-0024"	"2020-09-15-AML0024:CAAGGGAAGTATAACG"	-0.728597919375259	-16.4621763459411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGAAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.6835003758	30.1997287131576	0.0112238130976533	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.18392364035	2681.18392364035
"AML-0024"	"2020-09-15-AML0024:CAAGGGACACAGTCGC"	-2.72577176514323	-15.9402618638244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGACACAGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.78666893914	35.0149957736899	0.0125421459179742	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2782.60548165802	2782.60548165802
"AML-0024"	"2020-09-15-AML0024:CAAGGGACACTTACAG"	-2.42762861672099	-15.4741773835388	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGACACTTACAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3064.59388467416	41.3646159869967	0.0134975848492874	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3052.03088356561	3052.03088356561
"AML-0024"	"2020-09-15-AML0024:CAAGGGAGTACAGCGA"	-1.54012535038646	-15.738741897699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGAGTACAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.59263410715	39.2298515383085	0.0139330708082878	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.15107763458	2809.15107763458
"AML-0024"	"2020-09-15-AML0024:CAAGGGAGTAGTCGTT"	-1.80539808693584	-16.2198324433533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGAGTAGTCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.91137332087	38.2581955363159	0.01365919532504	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.41035556417	2796.41035556417
"AML-0024"	"2020-09-15-AML0024:CAAGGGAGTGCCTGAC"	-1.66284726086314	-16.4109258881775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGAGTGCCTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.66248056476	46.4277676021211	0.0170523404694991	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.64583197604	2713.64583197604
"AML-0024"	"2020-09-15-AML0024:CAAGGGATCTGGTCAA"	-1.91475246372874	-15.6090841523376	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGATCTGGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.16285429708	35.548400289177	0.0127634907360376	2489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.08122485332	2781.08122485332
"AML-0024"	"2020-09-15-AML0024:CAAGGGATCTTCTGTA"	-0.730033258826095	-15.9024162522522	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAAGGGATCTTCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.6666397349	36.1000540085386	0.0139239088648242	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.14979198166	2583.14979198166
"AML-0024"	"2020-09-15-AML0024:CAATACGAGGTGCATG"	-1.4136748117512	-16.1490888825622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATACGAGGTGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.72160578605	38.4122184331034	0.0170061765623106	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2256.53021527216	2256.53021527216
"AML-0024"	"2020-09-15-AML0024:CAATACGCAGTTGTCA"	0.0109503540093124	-15.8472051850525	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATACGCAGTTGTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2659.13039195829	45.080863095797	0.0169532352501893	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2654.82528580756	2654.82528580756
"AML-0024"	"2020-09-15-AML0024:CAATACGGTAGCTTTG"	-2.12021480026897	-16.2398596039978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATACGGTAGCTTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.98098171247	32.5913110364314	0.0123312696012343	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.05581504829	2637.05581504829
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGAGAACCC"	-1.54202828827556	-16.8852968445984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGAGAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.97543316411	34.9658724266475	0.0133153844415506	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.90993528249	2617.90993528249
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGCGATCGA"	-2.08564720574077	-15.898596786615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGCGATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.40943251633	35.8961835364719	0.01330765107579	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.16224105642	2692.16224105642
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGCGCTGAA"	-1.1139397424763	-16.37220861828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGCGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.66234768738	43.4922722292056	0.0160212456132	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.78843813229	2705.78843813229
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGCTAAATG"	-0.5921667617863	-16.016158126947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGCTAAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.69664105571	37.0861994978085	0.0134824752916319	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.94949676365	2741.94949676365
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGGAGGCAG"	0.258803327649277	-16.262927078363	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGGAGGCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3015.02737550449	38.3048889065892	0.0127046570846408	4077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3003.61130868236	3003.61130868236
"AML-0024"	"2020-09-15-AML0024:CAATCGAAGTAGAATC"	-2.15459070625957	-15.964608215448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAAGTAGAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.24617879446	42.1534567959456	0.0163053937151944	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.58588832511	2581.58588832511
"AML-0024"	"2020-09-15-AML0024:CAATCGACAGGGAATC"	-0.784897844225723	-16.5681410065857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGACAGGGAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.87454343622	39.7594752204828	0.0161500817848287	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.96454909295	2453.96454909295
"AML-0024"	"2020-09-15-AML0024:CAATCGAGTCAAGTTC"	-1.41533289375957	-15.9804582825867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAGTCAAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.94465075268	35.5714355660531	0.0131748758464869	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.49460409076	2695.49460409076
"AML-0024"	"2020-09-15-AML0024:CAATCGAGTGGACCTC"	-2.80895004692729	-16.0739069215027	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAGTGGACCTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.24095237824	34.1878859691217	0.0139699713409494	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2435.14077236008	2435.14077236008
"AML-0024"	"2020-09-15-AML0024:CAATCGAGTGTGGACA"	-1.86802444878276	-16.5792513123718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAGTGTGGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.53170757062	42.4502569699999	0.0172314636095598	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.7189716718	2455.7189716718
"AML-0024"	"2020-09-15-AML0024:CAATCGAGTTCGGGTC"	-1.66155920448955	-15.7212743989197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGAGTTCGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.3884838355	32.0098487480377	0.0139757289970449	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2285.95715696962	2285.95715696962
"AML-0024"	"2020-09-15-AML0024:CAATCGATCACAAGGG"	-2.10928068581279	-16.7692938080994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGATCACAAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1938.10810465635	40.9627302064334	0.0211354207270582	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1934.99537319304	1934.99537319304
"AML-0024"	"2020-09-15-AML0024:CAATCGATCATTTGCT"	-0.539346973330337	-16.379626297113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGATCATTTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.20388489158	33.099165238566	0.0123173256129396	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.03849241332	2678.03849241332
"AML-0024"	"2020-09-15-AML0024:CAATCGATCCTCACTG"	-0.739919464022476	-16.7843675843445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGATCCTCACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2654.03915744386	32.3041588188815	0.0121716963852161	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.92066238952	2643.92066238952
"AML-0024"	"2020-09-15-AML0024:CAATCGATCTAACACG"	-1.50005207482036	-16.9032736054626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATCGATCTAACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.74700064258	38.6674970299756	0.01518905728661	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.45921213724	2538.45921213724
"AML-0024"	"2020-09-15-AML0024:CAATGACAGAGCCTGA"	-2.26218805733379	10.9158696898255	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACAGAGCCTGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1961.94560336131	37.6328552802773	0.019181395863271	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1961.94560336131	1961.94560336131
"AML-0024"	"2020-09-15-AML0024:CAATGACAGAGCTGCA"	-1.7267396253651	-16.0228891602722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACAGAGCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.26225557508	33.8084624326519	0.0125669764583695	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.87928850699	2683.87928850699
"AML-0024"	"2020-09-15-AML0024:CAATGACAGCCACTCG"	-1.96340475502666	-15.5223388901916	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACAGCCACTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.20511499848	39.402813171594	0.0139914571427143	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.95188564854	2810.95188564854
"AML-0024"	"2020-09-15-AML0024:CAATGACAGTGTAGTA"	-2.74153147164043	-16.1702203980652	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACAGTGTAGTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.23642124247	43.955245219474	0.0169892650159762	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.02417472556	2573.02417472556
"AML-0024"	"2020-09-15-AML0024:CAATGACCAAGGTCAG"	-2.31623754921611	12.987503982428	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACCAAGGTCAG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2001.69348509818	42.976109574259	0.0214698753301638	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1997.52480931114	1997.52480931114
"AML-0024"	"2020-09-15-AML0024:CAATGACCACCAGCGT"	-0.802113632590133	-15.7234773865906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACCACCAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3027.78364361558	36.9036488116596	0.0121883374624455	2833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3021.89064948739	3021.89064948739
"AML-0024"	"2020-09-15-AML0024:CAATGACGTCAGGTAG"	-1.83858809891399	-16.0343218079773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACGTCAGGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.72055513127	36.8297349408764	0.0146631498737532	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.80298772291	2507.80298772291
"AML-0024"	"2020-09-15-AML0024:CAATGACGTCGTACAT"	-2.0304003757542	-16.6512155762878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACGTCGTACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2905.31613275635	44.8029705956715	0.0154210311540747	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2896.54508417166	2896.54508417166
"AML-0024"	"2020-09-15-AML0024:CAATGACGTGTGTCCG"	-1.00173078003581	-15.5809641114441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACGTGTGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.45218965225	44.6362257973412	0.0162110044856012	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.03200543053	2747.03200543053
"AML-0024"	"2020-09-15-AML0024:CAATGACTCGCTTGCT"	9.75269379195515	7.72506282413331	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATGACTCGCTTGCT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1837.60125614756	36.0074009646388	0.0195947846923693	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1833.25556573091	1833.25556573091
"AML-0024"	"2020-09-15-AML0024:CAATTTCCAAACGTGG"	-1.0513359111851	-17.4631929627624	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCCAAACGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.039088298	42.9938497274902	0.0153000895633559	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.13563090856	2805.13563090856
"AML-0024"	"2020-09-15-AML0024:CAATTTCCACTTCAAG"	-2.49621687355693	-16.4007692567078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCCACTTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.29829226967	42.8859919993334	0.0173466090776458	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.04870468481	2464.04870468481
"AML-0024"	"2020-09-15-AML0024:CAATTTCCAGCTCCTT"	-2.0944598716801	-16.5815477601257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCCAGCTCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.83950895378	39.0764687469256	0.0139966744584001	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.61856385918	2781.61856385918
"AML-0024"	"2020-09-15-AML0024:CAATTTCCAGCTGTCG"	-1.21894071522411	-16.083354019281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCCAGCTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.88810338821	38.9940992828076	0.0145073372785324	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.47055052363	2680.47055052363
"AML-0024"	"2020-09-15-AML0024:CAATTTCCATCCAACA"	-0.297812621027786	-16.673270248529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCCATCCAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.04964233627	44.5591560512278	0.0162266389377135	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.12077481246	2738.12077481246
"AML-0024"	"2020-09-15-AML0024:CAATTTCGTACAAGCG"	-1.0894824070042	-17.1982450715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCGTACAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.78538740812	44.287505845138	0.0157115564891801	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.99899406218	2807.99899406218
"AML-0024"	"2020-09-15-AML0024:CAATTTCTCAGTAGGG"	-2.4240337413853	-15.8566847077576	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCTCAGTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.94188293363	38.1905122832995	0.0138174078547427	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.74724078276	2756.74724078276
"AML-0024"	"2020-09-15-AML0024:CAATTTCTCGCGTTTC"	-0.0684264552896798	-16.2879591218201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAATTTCTCGCGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.83273027755	38.0356594580533	0.0131710050444638	2762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.32956861425	2881.32956861425
"AML-0024"	"2020-09-15-AML0024:CACAACAAGGTCCGAA"	-0.540397684008437	-15.937002205011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAACAAGGTCCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2831.4698431838	37.1358244917454	0.0131153876073031	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.67390461909	2824.67390461909
"AML-0024"	"2020-09-15-AML0024:CACAACATCAAGCTGT"	-0.656174580485183	-16.5410146943298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAACATCAAGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.3214178569	35.1340815556692	0.0122404694251635	3603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.69304178811	2859.69304178811
"AML-0024"	"2020-09-15-AML0024:CACACAAAGTCACACT"	-1.34568915787395	-16.4212637177673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACACAAAGTCACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.40738073827	34.8636759857409	0.0124052036813903	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.74473004696	2801.74473004696
"AML-0024"	"2020-09-15-AML0024:CACACAACAGCTGTAT"	-0.814016799361068	-16.4972963563171	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACACAACAGCTGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.54102297439	36.9443376142599	0.0138133374275836	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.16187579834	2669.16187579834
"AML-0024"	"2020-09-15-AML0024:CACACAAGTGTGTTTG"	-0.839792887598831	-16.0812769166199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACACAAGTGTGTTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.69808460624	31.7093199738515	0.0119671445430221	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.19443928662	2642.19443928662
"AML-0024"	"2020-09-15-AML0024:CACACAATCATGAGGG"	-1.38441012325938	-16.6713991395203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACACAATCATGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.27403224922	39.8364284613949	0.0145692889562446	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.02623951367	2721.02623951367
"AML-0024"	"2020-09-15-AML0024:CACAGATAGATGGCAC"	-1.25853226605113	-16.0788851014343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATAGATGGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.28486036975	35.9106252328542	0.0138689356982245	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.15437978908	2582.15437978908
"AML-0024"	"2020-09-15-AML0024:CACAGATCACAGAGCA"	-2.96616468849834	-15.846911453363	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATCACAGAGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.71057888781	39.7069233892932	0.0163019874912331	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2428.65787808956	2428.65787808956
"AML-0024"	"2020-09-15-AML0024:CACAGATCACTGGACC"	-1.97206149521526	-16.9046526185242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATCACTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1381.74905748711	45.3007101874857	0.0327850487337194	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1379.78935831603	1379.78935831603
"AML-0024"	"2020-09-15-AML0024:CACAGATCAGTCTGGC"	-1.22215888920482	-16.0685835114685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATCAGTCTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.38752246794	37.2996966544719	0.0136659585153907	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.44960064396	2719.44960064396
"AML-0024"	"2020-09-15-AML0024:CACAGATCATATCTCT"	-0.174061383039314	-15.790123008844	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATCATATCTCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2930.0571294244	44.6861322056043	0.0152509422962626	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2916.75094242171	2916.75094242171
"AML-0024"	"2020-09-15-AML0024:CACAGATCATGCACTA"	-1.51796505871471	-16.1456423035828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATCATGCACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.69792504865	31.315619874875	0.0117785550512671	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.76085095039	2652.76085095039
"AML-0024"	"2020-09-15-AML0024:CACAGATTCCATCTGC"	-0.153387705714065	-16.5331163636413	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGATTCCATCTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2386.3355948039	43.8181145550459	0.0183620923437831	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2378.80757378702	2378.80757378702
"AML-0024"	"2020-09-15-AML0024:CACAGGCAGGTACCTT"	-1.45540795746501	-15.0897474518982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCAGGTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.92658011512	33.1772456412937	0.0119517734651029	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.74294385304	2768.74294385304
"AML-0024"	"2020-09-15-AML0024:CACAGGCAGTCCCTAA"	-2.2233239215916	-16.4228315583435	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCAGTCCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.88276677513	38.5105835787629	0.0149678734204561	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.72303227303	2562.72303227303
"AML-0024"	"2020-09-15-AML0024:CACAGGCCAAGCGAAC"	-1.40532646599467	-16.0023393861023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCCAAGCGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.63157157697	32.3785804538573	0.0121375758177568	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.80222101512	2659.80222101512
"AML-0024"	"2020-09-15-AML0024:CACAGGCCAATCGCGC"	-0.538360099226791	-15.5987940064636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCCAATCGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.07497407621	32.3928918651987	0.0117960697253344	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.08462088022	2742.08462088022
"AML-0024"	"2020-09-15-AML0024:CACAGGCCAGCATGCC"	-1.66303680363353	-15.8658590546814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCCAGCATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.26007409539	45.2934088713084	0.0154465864987374	3377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.21941513405	2924.21941513405
"AML-0024"	"2020-09-15-AML0024:CACAGGCTCTACACAG"	-1.10287938538249	-16.6254053345886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACAGGCTCTACACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.19446611662	30.3717169694972	0.0116850498742692	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.22065981643	2591.22065981643
"AML-0024"	"2020-09-15-AML0024:CACATGAAGGAACGAA"	-0.758381049067336	-16.0266390076843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAAGGAACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.39750481993	35.7938290080298	0.0128367024235812	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.32740787744	2779.32740787744
"AML-0024"	"2020-09-15-AML0024:CACATGAAGGTCATAA"	-2.22147021713908	-16.2266893616882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAAGGTCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.03068321076	38.3039003352518	0.0145198843133363	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.11221910791	2629.11221910791
"AML-0024"	"2020-09-15-AML0024:CACATGACAAGTTCCA"	-0.612578193575698	-15.5920210114685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGACAAGTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3021.02588288835	39.0513321826498	0.0129265136071305	2867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3013.25527125528	3013.25527125528
"AML-0024"	"2020-09-15-AML0024:CACATGACACTCCACT"	-2.29111347618755	-16.7023992768494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGACACTCCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.84267580097	35.0580470441138	0.0138632772135616	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.09014714533	2524.09014714533
"AML-0024"	"2020-09-15-AML0024:CACATGAGTAATGCGG"	-1.02064404907878	-17.3580427399841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAGTAATGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2974.16144770294	48.2683788232045	0.01622923962668	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2967.50886379752	2967.50886379752
"AML-0024"	"2020-09-15-AML0024:CACATGAGTCTTGGTA"	-1.43365023556407	-15.5423097840515	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAGTCTTGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.54603022101	36.7812376299872	0.0134456657733577	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.63963364469	2730.63963364469
"AML-0024"	"2020-09-15-AML0024:CACATGAGTGAATTGA"	-2.33517513695415	-16.6027193299499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAGTGAATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.00361273554	43.1539474232101	0.0186732496588911	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2304.32977050011	2304.32977050011
"AML-0024"	"2020-09-15-AML0024:CACATGAGTTCACGAT"	-1.5933041376179	-16.7103929749695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACATGAGTTCACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.37089459203	39.8515754221496	0.0140601131271092	2821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.12830240357	2826.12830240357
"AML-0024"	"2020-09-15-AML0024:CACCAAAAGGCCCGTT"	-0.964769939810592	-16.1991243592468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAAAGGCCCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.58303112797	34.1643912658431	0.0122077461650559	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.32466428337	2790.32466428337
"AML-0024"	"2020-09-15-AML0024:CACCAAACACCAATTG"	-1.37813351574596	-15.814232849237	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAACACCAATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.39764142366	40.9185320175447	0.0172259714769359	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2372.66333280862	2372.66333280862
"AML-0024"	"2020-09-15-AML0024:CACCAAACACTTTATC"	-1.7895978492802	-15.7920828095642	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAACACTTTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.27412299642	36.4171615325871	0.0135466696722117	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.48403305899	2680.48403305899
"AML-0024"	"2020-09-15-AML0024:CACCAAATCCCGAGTG"	-1.10341260853465	-15.8373518220154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAATCCCGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.02036431746	33.8108478842127	0.0128606260883759	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.44961769959	2620.44961769959
"AML-0024"	"2020-09-15-AML0024:CACCAAATCCTTATAC"	-2.47937117043193	-15.6976490250793	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAATCCTTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2387.45065066783	28.6585086218829	0.0120038119380044	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.90431536456	2380.90431536456
"AML-0024"	"2020-09-15-AML0024:CACCAAATCTCCAAGA"	-2.8908625644749	-15.6941147080627	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAATCTCCAAGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.90046914648	34.6064990800752	0.0126351795072201	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.72110456285	2728.72110456285
"AML-0024"	"2020-09-15-AML0024:CACCAAATCTCTAGGA"	-2.12697015228923	-16.4748716584411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCAAATCTCTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.25269706749	37.6734986502057	0.0139570106537764	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.08388138858	2693.08388138858
"AML-0024"	"2020-09-15-AML0024:CACCGTTAGTGTACCT"	1.14919998225514	-16.2188749543396	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCGTTAGTGTACCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3096.44569327403	39.1395993628385	0.0126401698075493	4447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3080.83398887028	3080.83398887028
"AML-0024"	"2020-09-15-AML0024:CACCGTTTCAATCTCT"	-0.386295984417754	-16.2770090333191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCGTTTCAATCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2979.93619684691	37.8399602854162	0.0126982451253336	3341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2969.63110740696	2969.63110740696
"AML-0024"	"2020-09-15-AML0024:CACCGTTTCCAATCTT"	-1.30427632752116	-16.5178232423035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACCGTTTCCAATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.3926619587	32.0816118088181	0.0119023889400607	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.91332599133	2691.91332599133
"AML-0024"	"2020-09-15-AML0024:CACGAATCAACCAACT"	-2.73643145981486	-16.017550491449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATCAACCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.68614578861	49.6621757601154	0.022474764506609	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2200.52553487612	2200.52553487612
"AML-0024"	"2020-09-15-AML0024:CACGAATCAAGAGCTG"	-2.17593179169353	-15.6759004822937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATCAAGAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.07879062405	34.8417920011917	0.0127017102535597	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.21047012196	2741.21047012196
"AML-0024"	"2020-09-15-AML0024:CACGAATCACCCTAAA"	-1.64531848850902	-16.0598478547302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATCACCCTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.78118665285	33.5889521230039	0.0132616873103802	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.67099124148	2522.67099124148
"AML-0024"	"2020-09-15-AML0024:CACGAATCAGATCCTA"	-0.79144642773326	-16.185534500238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATCAGATCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.91844589028	35.5570924959949	0.0124198761396913	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2853.6682228903	2853.6682228903
"AML-0024"	"2020-09-15-AML0024:CACGAATTCTCCGCAT"	-2.26699004593547	-16.492699646112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATTCTCCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.59166410568	34.0462081951774	0.0125604341834389	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.01876399137	2709.01876399137
"AML-0024"	"2020-09-15-AML0024:CACGAATTCTTCGTGC"	-2.00077162209209	-16.3944845429626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGAATTCTTCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.32596753672	34.2967992250924	0.0147682968302124	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.01337324083	2316.01337324083
"AML-0024"	"2020-09-15-AML0024:CACGGGTAGCACTAAA"	-1.35281167450603	-15.8450222245422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGGGTAGCACTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.29130982213	29.6630484339143	0.0112390202337738	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.10754266549	2636.10754266549
"AML-0024"	"2020-09-15-AML0024:CACGGGTAGTACGAGC"	-0.887908737093765	-16.2023706666199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGGGTAGTACGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.90531545494	36.9291232271893	0.0136324894844054	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.91338393033	2700.91338393033
"AML-0024"	"2020-09-15-AML0024:CACGGGTCACCACATA"	-1.79445336285289	-15.6596632233826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGGGTCACCACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2835.27298618358	37.1597282039897	0.0131062258855041	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.50301394496	2829.50301394496
"AML-0024"	"2020-09-15-AML0024:CACGGGTCACTTGACA"	-1.26297579231914	-15.652710937616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGGGTCACTTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.32240062337	40.0041921791792	0.0150091381702352	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.18052829075	2662.18052829075
"AML-0024"	"2020-09-15-AML0024:CACGGGTCAGCACAGA"	-2.11343727532085	-16.3146429291931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGGGTCAGCACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.03656702803	39.2650041118424	0.0147389133459403	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.1105061699	2657.1105061699
"AML-0024"	"2020-09-15-AML0024:CACGTGGCAGTACTAC"	-1.02718470516856	-16.7228174439636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTGGCAGTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.8242570702	33.0010072663581	0.0125201849773701	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.08664686451	2631.08664686451
"AML-0024"	"2020-09-15-AML0024:CACGTGGGTGGGTCAA"	-0.6031890315121	-16.1558790436951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTGGGTGGGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.2573313146	31.4592376348814	0.0133400359736588	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2355.45669579277	2355.45669579277
"AML-0024"	"2020-09-15-AML0024:CACGTGGTCGATACTG"	-1.62034843388255	-16.8745298615661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTGGTCGATACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1942.31366785332	46.8241281701993	0.0241073977623553	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1935.11895800133	1935.11895800133
"AML-0024"	"2020-09-15-AML0024:CACGTGGTCGCATTGA"	-1.28118787232097	-16.3036546937195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTGGTCGCATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2116.15742891446	37.7309105914355	0.0178299166573777	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2111.88659489165	2111.88659489165
"AML-0024"	"2020-09-15-AML0024:CACGTGGTCTCATTTG"	-2.84227500382121	-16.1659250489441	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTGGTCTCATTTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2387.07743345477	36.9488325839643	0.0154786904128573	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2383.21849368189	2383.21849368189
"AML-0024"	"2020-09-15-AML0024:CACGTTCCAAACTGCT"	-2.73607955399211	-16.0108213654724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTTCCAAACTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.48655491612	34.5372508720621	0.0126256335678174	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.539746977	2730.539746977
"AML-0024"	"2020-09-15-AML0024:CACGTTCCAGCAAGAC"	-0.200250874192077	-16.5011492005554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTTCCAGCAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.72182622553	32.0946637449392	0.0118617750848804	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.95501607947	2701.95501607947
"AML-0024"	"2020-09-15-AML0024:CACGTTCGTACGAGTG"	-1.49290166321452	-16.656575225946	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTTCGTACGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.68923736031	36.3290861370683	0.0137678532290567	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.57215297285	2629.57215297285
"AML-0024"	"2020-09-15-AML0024:CACGTTCGTGTCCTAA"	-2.75863657417949	-15.6220274201599	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTTCGTGTCCTAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.92981265915	38.6804830318272	0.0149407229360527	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.30490340625	2580.30490340625
"AML-0024"	"2020-09-15-AML0024:CACGTTCTCGATCCCT"	-2.25568781319316	-16.07657530224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACGTTCTCGATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.71963472266	38.2497672981884	0.0161138521747356	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2360.46634467544	2360.46634467544
"AML-0024"	"2020-09-15-AML0024:CACTAAGAGGCTCTAT"	1.02164252576177	-16.2682752839294	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGAGGCTCTAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2947.16166589897	41.9930284778792	0.0142486341905747	4168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2939.89175372539	2939.89175372539
"AML-0024"	"2020-09-15-AML0024:CACTAAGAGTATGTAG"	-4.28514800491984	10.6179933317932	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGAGTATGTAG"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1920.18797164377	39.1543846038777	0.0203909123388372	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1920.18797164377	1920.18797164377
"AML-0024"	"2020-09-15-AML0024:CACTAAGCACGGTGAA"	-1.94848046723064	-16.7224416962829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGCACGGTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.8095817992	33.8846768146098	0.0128799427556579	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.08712830453	2623.08712830453
"AML-0024"	"2020-09-15-AML0024:CACTAAGCATTACTCT"	-2.51414022865947	-16.6081705323425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGCATTACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2231.01945538371	42.096281036984	0.0188686301840178	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2213.48934839793	2213.48934839793
"AML-0024"	"2020-09-15-AML0024:CACTAAGGTCTCGCGA"	-2.15428624573405	-16.0255766144958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGGTCTCGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2418.51046149028	41.2586630838337	0.0170595346767325	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2407.91078167792	2407.91078167792
"AML-0024"	"2020-09-15-AML0024:CACTAAGTCTTCGACC"	-1.34103784981425	-16.6650514832703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTAAGTCTTCGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.65873583337	35.6461669011774	0.0146591980099382	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.94050519178	2423.94050519178
"AML-0024"	"2020-09-15-AML0024:CACTGAAAGCCAGAGT"	0.0730143013292968	-16.3840017548767	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAAAGCCAGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2924.60920275687	41.914330902609	0.0143316005649913	3028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2910.53598216451	2910.53598216451
"AML-0024"	"2020-09-15-AML0024:CACTGAAAGTGGCGAT"	-1.47834644737895	-16.1226778260437	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAAAGTGGCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.60589844417	34.7850939517557	0.0133963702279958	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.31690139413	2593.31690139413
"AML-0024"	"2020-09-15-AML0024:CACTGAACAACCGATT"	-2.94482598725017	-16.0266485444275	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAACAACCGATT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.04065597209	33.7466040111713	0.0124985540260398	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.30750966747	2691.30750966747
"AML-0024"	"2020-09-15-AML0024:CACTGAACATGGTACT"	-1.87720559063609	-16.2570944062439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAACATGGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.33698684613	31.5278891802918	0.0113111149922226	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.45230628934	2778.45230628934
"AML-0024"	"2020-09-15-AML0024:CACTGAACATTGTCGA"	-2.09673200073894	-15.5173912278381	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAACATTGTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.76202351716	36.8141224353645	0.0136816716281895	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.13568709255	2683.13568709255
"AML-0024"	"2020-09-15-AML0024:CACTGAAGTCGTTCAA"	-1.86099312725719	-15.8673525086609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGAAGTCGTTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.65656504996	29.7587360907589	0.0106828445631543	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.35611726266	2780.35611726266
"AML-0024"	"2020-09-15-AML0024:CACTGGGAGCCTATCA"	-2.29199276390727	-16.7400465241638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGAGCCTATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2200.52466536491	46.5878155686135	0.0211712307986731	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2190.59932773988	2190.59932773988
"AML-0024"	"2020-09-15-AML0024:CACTGGGAGGGCAGTT"	-0.946284632117111	-16.5582418671814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGAGGGCAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.72226470224	39.9661641306476	0.014518778244768	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.61747781929	2741.61747781929
"AML-0024"	"2020-09-15-AML0024:CACTGGGCAGTCTACA"	-1.9312575859135	-16.6590795747009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGCAGTCTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.90715209749	35.01908165965	0.0131063991621713	2670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.39219054723	2666.39219054723
"AML-0024"	"2020-09-15-AML0024:CACTGGGGTTATGTCG"	-2.57881794396098	13.8024825819763	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGGTTATGTCG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1897.41601469804	30.3353198996695	0.0159877009916021	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1897.41601469804	1897.41601469804
"AML-0024"	"2020-09-15-AML0024:CACTGGGGTTCGTTCC"	-0.767164031893569	-16.808337234613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGGTTCGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.07368727875	47.3875875989741	0.0171565254820053	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.58668306666	2746.58668306666
"AML-0024"	"2020-09-15-AML0024:CACTGGGTCTCTCTAA"	-0.431745360524017	-16.0261202088562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGGGTCTCTCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3109.54411343985	39.6488341271565	0.0127506903522575	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3092.89680100145	3092.89680100145
"AML-0024"	"2020-09-15-AML0024:CACTGTCAGCAGGGAG"	9.15043797072713	7.59981105411378	"2020-09-15-AML0024"	"AML0024"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCAGCAGGGAG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1519.62562633489	28.6928932870675	0.018881553976074	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1517.85281764169	1517.85281764169
"AML-0024"	"2020-09-15-AML0024:CACTGTCCAGATTAAG"	-2.24792681160625	-16.3865690461365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCCAGATTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.78961319317	39.4177221713999	0.0150346625728644	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.95136751319	2614.95136751319
"AML-0024"	"2020-09-15-AML0024:CACTGTCGTACAAGCG"	-0.700759987265426	-16.6757192841736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCGTACAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.58020017698	47.9954796871391	0.0172671685041083	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.45169927935	2766.45169927935
"AML-0024"	"2020-09-15-AML0024:CACTGTCTCAGGAGAC"	-0.85729287090953	-15.7196159592834	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCTCAGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.82393580044	38.0479665682049	0.0131935816524264	2674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.96852967278	2876.96852967278
"AML-0024"	"2020-09-15-AML0024:CACTGTCTCGGAGATG"	-1.89268849316295	-15.7353430024353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCTCGGAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.30685352653	29.6284103292795	0.0114780659605819	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.97140269844	2573.97140269844
"AML-0024"	"2020-09-15-AML0024:CACTGTCTCGTAATGC"	-2.09712729874309	-16.7359361878601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCTCGTAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.61848140291	37.288926601923	0.0147002503038218	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.77435230629	2529.77435230629
"AML-0024"	"2020-09-15-AML0024:CACTGTCTCTACTGCC"	-1.70276067677196	10.3281049498352	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTGTCTCTACTGCC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2000.43228116263	31.9081319834765	0.0159506184158015	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1995.6132851828	1995.6132851828
"AML-0024"	"2020-09-15-AML0024:CACTTCGCATAGAATG"	-1.95154104653056	-16.6737184754578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTTCGCATAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.31264406305	35.3072880622301	0.0140146512364928	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.45408552513	2512.45408552513
"AML-0024"	"2020-09-15-AML0024:CACTTCGGTATGATCC"	-0.71275762739833	-15.7261715165344	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTTCGGTATGATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2872.91892450942	37.1423423285434	0.0129284338697047	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2870.64716802082	2870.64716802082
"AML-0024"	"2020-09-15-AML0024:CACTTCGGTGAACTAA"	-2.33559141579326	-15.5772066346374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTTCGGTGAACTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2930.30801951453	29.2028114832894	0.00996578219382119	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.76367012117	2924.76367012117
"AML-0024"	"2020-09-15-AML0024:CACTTCGTCTACGCAA"	-2.28909764710124	-15.8523073426453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CACTTCGTCTACGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.74854528383	38.9632163429474	0.0140218575765255	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.41499938201	2774.41499938201
"AML-0024"	"2020-09-15-AML0024:CAGAGCCAGAGTACCG"	-0.526372293860275	-16.3669061890808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGAGCCAGAGTACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2561.11656919209	35.6423683714219	0.0139167302262487	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.08850259505	2551.08850259505
"AML-0024"	"2020-09-15-AML0024:CAGAGCCTCCGATTAG"	-0.96362934532817	-17.3172636262146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGAGCCTCCGATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3053.74717372966	42.1927974967179	0.0138167291187981	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3046.78379384408	3046.78379384408
"AML-0024"	"2020-09-15-AML0024:CAGAGCCTCCTAGCCT"	-1.6627017063206	-16.394331955072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGAGCCTCCTAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.3066784388	32.2894535596643	0.0133631437796327	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2406.28105550462	2406.28105550462
"AML-0024"	"2020-09-15-AML0024:CAGATACAGAGATGCC"	-0.185352290899116	-16.0039568177429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACAGAGATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.80812079781	41.1338998772741	0.0151349536277047	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.0360953558	2711.0360953558
"AML-0024"	"2020-09-15-AML0024:CAGATACAGCTCGGCT"	-1.68529019776042	-16.5389795533386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACAGCTCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2846.07083092401	36.9408649004136	0.0129796013855426	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.71791990214	2838.71791990214
"AML-0024"	"2020-09-15-AML0024:CAGATACAGGTTCACT"	-1.87099681320842	-16.5645990601745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACAGGTTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.29311854559	39.6941121984228	0.013950798931645	2735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2836.4060260381	2836.4060260381
"AML-0024"	"2020-09-15-AML0024:CAGATACCAAATGCGG"	-1.7665390771931	-16.5291662446228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACCAAATGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.26436104603	35.9289588564541	0.0138227413090045	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.72878062954	2596.72878062954
"AML-0024"	"2020-09-15-AML0024:CAGATACCAACCGTGC"	-0.47830561819728	-16.4730921021667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACCAACCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.59592553972	33.8343399520909	0.0124914682301123	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.4845069427	2700.4845069427
"AML-0024"	"2020-09-15-AML0024:CAGATACCAGCGAGTA"	-2.85848794403728	-15.7374534836975	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACCAGCGAGTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.59067252449	34.4456475854617	0.0136332520973984	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.09821732282	2519.09821732282
"AML-0024"	"2020-09-15-AML0024:CAGATACCATCGAGCC"	-0.593300144106704	-16.0017194977966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACCATCGAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.16985021652	36.2884640477292	0.0130667067572047	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.93568052797	2764.93568052797
"AML-0024"	"2020-09-15-AML0024:CAGATACTCCGTGACG"	-0.610683481127578	-16.1895628205505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACTCCGTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.25233793243	38.059587733212	0.014773237532996	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.97055033937	2569.97055033937
"AML-0024"	"2020-09-15-AML0024:CAGATACTCTCGAGTA"	-1.25890038433726	-16.4783849946228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATACTCTCGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.4926541844	29.2897790680018	0.0109556235444145	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.45474283738	2667.45474283738
"AML-0024"	"2020-09-15-AML0024:CAGATCAAGCCACCGT"	-1.60230241242107	-15.4920253983703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCAAGCCACCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.4936559712	34.4151132564429	0.0118652606550588	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2897.47596754649	2897.47596754649
"AML-0024"	"2020-09-15-AML0024:CAGATCAAGGCTTCCG"	-0.243929515511352	-16.3463068238464	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCAAGGCTTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.80057714066	33.2101111330815	0.0131120118310196	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.38017703716	2528.38017703716
"AML-0024"	"2020-09-15-AML0024:CAGATCAAGTGGTTAA"	-1.78822300854381	-16.5055418244568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCAAGTGGTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.88770598567	34.6028257821736	0.0131625347493493	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.86475757551	2623.86475757551
"AML-0024"	"2020-09-15-AML0024:CAGATCACATGGAACG"	-2.00204787674602	-15.5164947739807	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCACATGGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.33750349984	38.4358619795042	0.0144858548634714	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.94972252933	2649.94972252933
"AML-0024"	"2020-09-15-AML0024:CAGATCAGTCACTTAG"	-0.932237367064315	-17.4947653046814	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCAGTCACTTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3043.97251934386	38.2804666173152	0.012575825298701	2604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3034.82716426023	3034.82716426023
"AML-0024"	"2020-09-15-AML0024:CAGATCATCGAATGCT"	-1.93036482754405	-15.7980232468811	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCATCGAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.46346950423	37.4733592569264	0.0121965190567336	3884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3062.06912757726	3062.06912757726
"AML-0024"	"2020-09-15-AML0024:CAGATCATCGTGCATA"	-1.34741423550304	-16.0243120423523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCATCGTGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.77466130004	31.7298713620702	0.0123665853594458	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.45547425067	2557.45547425067
"AML-0024"	"2020-09-15-AML0024:CAGATCATCTTAATCC"	-1.63847146454509	-16.5429888001648	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATCATCTTAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.79658086453	37.1777205491895	0.0135943275669289	2693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.81942113744	2721.81942113744
"AML-0024"	"2020-09-15-AML0024:CAGATTGCAACTGGTT"	-1.11151001873668	-15.8924923173157	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGCAACTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.27114051099	37.8904272973973	0.0139545648801271	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.27920152525	2706.27920152525
"AML-0024"	"2020-09-15-AML0024:CAGATTGCACTGGATT"	-2.61878691139873	-16.2649698487488	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGCACTGGATT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.54743726004	34.9804310232282	0.0135501794459974	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.34099615577	2576.34099615577
"AML-0024"	"2020-09-15-AML0024:CAGATTGGTAGACAGC"	-0.940278987318832	-16.8016557923523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGGTAGACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.31356256583	43.1518915614729	0.016795105194704	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.81230401623	2560.81230401623
"AML-0024"	"2020-09-15-AML0024:CAGATTGGTGAGAGGG"	-0.321505348116714	-15.8145418397156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGGTGAGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.59345691838	37.6606638594909	0.013544110076857	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.85164383509	2772.85164383509
"AML-0024"	"2020-09-15-AML0024:CAGATTGTCCCAGTGG"	-2.53893814507182	-15.943178199884	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGTCCCAGTGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.46416974588	38.6145012607661	0.0147357486152962	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.54039591265	2612.54039591265
"AML-0024"	"2020-09-15-AML0024:CAGATTGTCCGTCCTA"	-0.563522140414077	-16.4684839478699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGTCCGTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.71819730398	33.0502696254587	0.0128016565324489	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.57238523047	2573.57238523047
"AML-0024"	"2020-09-15-AML0024:CAGATTGTCCTGGGTG"	-2.81500158730205	-15.6896200410095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGTCCTGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.96671448594	36.2250691722891	0.0133574903330462	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.1907732043	2707.1907732043
"AML-0024"	"2020-09-15-AML0024:CAGATTGTCGCTATTT"	0.975225587456864	-16.2236337891785	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGTCGCTATTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2705.84544784139	43.1889964842123	0.0159613685691718	3219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2695.70719579933	2695.70719579933
"AML-0024"	"2020-09-15-AML0024:CAGATTGTCGTCTAAG"	-1.86308346214946	-16.9047308198181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGATTGTCGTCTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.63228856036	50.0352824045844	0.0216825196339229	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2296.99164772758	2296.99164772758
"AML-0024"	"2020-09-15-AML0024:CAGCAATAGGTTACCT"	0.0366229853475511	-16.2004804841247	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATAGGTTACCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2528.2475368614	29.6435355854084	0.0117249340316606	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2517.30776883234	2517.30776883234
"AML-0024"	"2020-09-15-AML0024:CAGCAATAGTATAACG"	-1.49759111824687	-15.5686235657898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2884.60625588309	37.2064105397293	0.0128982631386338	3300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.06447133186	2872.06447133186
"AML-0024"	"2020-09-15-AML0024:CAGCAATAGTCGCCAC"	-2.65069995346721	-15.3931446305481	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATAGTCGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.32773158324	32.2982234195833	0.0116292445620638	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.54873354036	2773.54873354036
"AML-0024"	"2020-09-15-AML0024:CAGCAATGTAACATCC"	-0.317157099873382	-16.1759519807068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATGTAACATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2846.16684965716	37.9727555823633	0.0133417180327771	2895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.40976970029	2840.40976970029
"AML-0024"	"2020-09-15-AML0024:CAGCAATTCATCTATC"	-0.527382890612441	-16.3640527955261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATTCATCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.02715427407	30.3333401562092	0.0116486266690507	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.11437410604	2591.11437410604
"AML-0024"	"2020-09-15-AML0024:CAGCAATTCCGCAACG"	-0.939719120890457	-16.0952730408874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATTCCGCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.2052692318	38.0338549827269	0.0132975962920809	2785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2851.31789770389	2851.31789770389
"AML-0024"	"2020-09-15-AML0024:CAGCAATTCTTGGGCG"	-2.81718836250957	-15.9886789551941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAATTCTTGGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.98467276792	31.5706142817497	0.0122795808999362	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.69482218926	2564.69482218926
"AML-0024"	"2020-09-15-AML0024:CAGCACGCACCGGCTA"	-2.71271191063579	-16.1377821198669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGCACCGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.76388091557	38.825181409598	0.0143120386122563	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.486956501	2709.486956501
"AML-0024"	"2020-09-15-AML0024:CAGCACGGTAACATAG"	-0.463812331587631	-15.7250948182312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGGTAACATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2897.34795624046	39.9503469879087	0.0137885913570931	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.86964829496	2879.86964829496
"AML-0024"	"2020-09-15-AML0024:CAGCACGGTACGATGG"	-1.85868666592296	-15.8111839524475	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGGTACGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3039.79557005406	35.9059136649552	0.0118119501254213	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3033.72230628759	3033.72230628759
"AML-0024"	"2020-09-15-AML0024:CAGCACGGTACTCCGG"	-0.949317435652572	-16.2486791840759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGGTACTCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2767.46732608082	40.5804987589269	0.01466340663772	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.94734324992	2760.94734324992
"AML-0024"	"2020-09-15-AML0024:CAGCACGTCACTGATG"	-1.71013746681865	-15.9645624390808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGTCACTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.97309297265	38.97605910859	0.0135759053973695	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.96251332356	2864.96251332356
"AML-0024"	"2020-09-15-AML0024:CAGCACGTCCATTCAT"	-0.823757748038131	-16.4689417115417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGTCCATTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.88254504516	28.2935100159997	0.0105302370094946	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.12792644572	2677.12792644572
"AML-0024"	"2020-09-15-AML0024:CAGCACGTCGTAGAGG"	-2.17988477173503	-16.2920618287292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGTCGTAGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.94213340231	31.5489122138389	0.012143808673876	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.18965420808	2595.18965420808
"AML-0024"	"2020-09-15-AML0024:CAGCACGTCTTCCCGA"	-0.54510329189952	-16.034260772821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCACGTCTTCCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.55027272923	34.1430386605162	0.0125224313675829	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.60837663345	2718.60837663345
"AML-0024"	"2020-09-15-AML0024:CAGCAGCAGTTGGAAT"	-1.56772027435954	-16.3158521882263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCAGTTGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3091.75746360612	33.3328743036968	0.0107812060603287	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3074.71587223577	3074.71587223577
"AML-0024"	"2020-09-15-AML0024:CAGCAGCCAATGGGTG"	-0.413136522204238	-15.8643284074036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCCAATGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.27360979586	40.736911551382	0.0143932768232681	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.17343837186	2824.17343837186
"AML-0024"	"2020-09-15-AML0024:CAGCAGCCAGCTGTAT"	-1.90054068985637	-15.663863205072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCCAGCTGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.57147949701	44.3730078791111	0.015409587223326	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.71909015723	2867.71909015723
"AML-0024"	"2020-09-15-AML0024:CAGCAGCCAGTCTCTC"	-2.54960809174235	-16.0485735169617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCCAGTCTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.70094516807	35.3091492423984	0.0126027545171422	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.65587981943	2793.65587981943
"AML-0024"	"2020-09-15-AML0024:CAGCAGCGTAGCTCGC"	0.0369557562166869	-16.2064905396667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCGTAGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2974.36665827871	38.0604119054358	0.0127961399108278	3403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2962.00874784436	2962.00874784436
"AML-0024"	"2020-09-15-AML0024:CAGCAGCTCATTGCGA"	-0.974152545363265	-17.4399557343689	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCTCATTGCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2682.28305109932	39.2471604234053	0.014631998068705	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2672.49291116061	2672.49291116061
"AML-0024"	"2020-09-15-AML0024:CAGCAGCTCTGGACCG"	-0.172785709530669	-16.486071609613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCAGCTCTGGACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.87929151163	40.1719470227541	0.0142510348505245	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.92168080974	2812.92168080974
"AML-0024"	"2020-09-15-AML0024:CAGCCAGCAAATAAGC"	0.130282309919041	-16.2799043885437	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCCAGCAAATAAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2797.67520335235	39.1089971701225	0.0139791056242911	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2792.03382229376	2792.03382229376
"AML-0024"	"2020-09-15-AML0024:CAGCCAGGTGTCCAAT"	-1.34489200535472	-16.0926218262878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCCAGGTGTCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.93298636865	38.1754930183988	0.013600429081774	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.52160357437	2795.52160357437
"AML-0024"	"2020-09-15-AML0024:CAGCCAGTCATTTGCT"	-1.69212553921397	-15.9872827759949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCCAGTCATTTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.87691016498	38.8557611048214	0.0144237329323416	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.88077934667	2687.88077934667
"AML-0024"	"2020-09-15-AML0024:CAGCCAGTCCCGTTGT"	-2.46662769737895	-15.6782169572082	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCCAGTCCCGTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.62595631665	48.0340399520725	0.0198027399183232	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.6787310444	2415.6787310444
"AML-0024"	"2020-09-15-AML0024:CAGCGTGAGACGCTCC"	-2.48621068421062	-15.9673834077087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCGTGAGACGCTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.84875839243	40.6866124361987	0.0144133164468114	2774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.46013532025	2813.46013532025
"AML-0024"	"2020-09-15-AML0024:CAGCGTGCAATACAGA"	-1.31805799427684	-16.9423418275085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGCGTGCAATACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.76186587346	37.1211052578686	0.013867914711104	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.13547397061	2669.13547397061
"AML-0024"	"2020-09-15-AML0024:CAGGCCAAGGATATAC"	-2.20072422447856	-16.6772527924744	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGCCAAGGATATAC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.81757848536	42.172421034019	0.017179452112299	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.5214687441	2444.5214687441
"AML-0024"	"2020-09-15-AML0024:CAGGCCAAGGTAAGTT"	-2.0731876892155	-16.2226495972839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGCCAAGGTAAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.02539878551	42.1713536096323	0.0180371665900371	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2329.70410637852	2329.70410637852
"AML-0024"	"2020-09-15-AML0024:CAGGCCAAGGTGAGCT"	-2.69291196289714	-16.0437574616638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGCCAAGGTGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.82689916529	43.4423821826393	0.0158848745402858	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.11166009933	2726.11166009933
"AML-0024"	"2020-09-15-AML0024:CAGGCCAAGTCCCGAC"	-1.72215209427531	-16.0613756409851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGCCAAGTCCCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.6623155729	33.5376487424969	0.0129706220880069	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.38347322222	2582.38347322222
"AML-0024"	"2020-09-15-AML0024:CAGGCCATCGGAGCAA"	-2.63319693031963	-16.4661398164001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGCCATCGGAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2002.7876858816	49.8950634505099	0.0249128071848249	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1990.04858840926	1990.04858840926
"AML-0024"	"2020-09-15-AML0024:CAGGGCTAGCGATTCT"	-1.58531413498576	-15.881636642572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTAGCGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.93513034339	36.8879400515345	0.0138005369575862	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.29819910588	2669.29819910588
"AML-0024"	"2020-09-15-AML0024:CAGGGCTAGTAGCAAT"	-1.34903262081798	-16.146492981073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTAGTAGCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.02972291123	40.1737034859344	0.0135858301236089	3272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.0144909646	2947.0144909646
"AML-0024"	"2020-09-15-AML0024:CAGGGCTCAGAGGGTT"	-0.403089771897155	-16.6371526948181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTCAGAGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2997.18764903037	35.9637036429704	0.0119991498212016	2936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2991.63072756524	2991.63072756524
"AML-0024"	"2020-09-15-AML0024:CAGGGCTGTACCGGCT"	-0.785888115794021	-16.0309992066589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTGTACCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3056.96143563039	38.2360885903696	0.0125078740427371	3517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3048.62785132885	3048.62785132885
"AML-0024"	"2020-09-15-AML0024:CAGGGCTGTGGATTTC"	-0.333732257515746	-15.9487257233826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTGTGGATTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.77430040618	41.7852164508666	0.0151353250588862	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.52953358004	2756.52953358004
"AML-0024"	"2020-09-15-AML0024:CAGGGCTGTTGTATGC"	-0.712291280657607	-16.2448415986267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTGTTGTATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.88662402987	31.1545228042067	0.0118824828345636	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.01416277935	2616.01416277935
"AML-0024"	"2020-09-15-AML0024:CAGGGCTTCCATCGTC"	1.58525468882863	-4.7824654809204	"2020-09-15-AML0024"	"AML0024"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00337078651685393	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTTCCATCGTC"	"cDC2"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2357.91362067677	48.2164368907471	0.0204487715189956	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"DC_AML-0024"	2354.37224829973	2354.37224829973
"AML-0024"	"2020-09-15-AML0024:CAGGGCTTCCGACAGC"	-1.56011913242992	-16.6154260865417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTTCCGACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.06247507986	30.4059762502633	0.0113494838336523	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.18147659613	2671.18147659613
"AML-0024"	"2020-09-15-AML0024:CAGGGCTTCCGTGGTG"	-0.80859480324443	-16.2212381592956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGGCTTCCGTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.11472921029	37.4130775233151	0.014494930078045	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.07728465665	2575.07728465665
"AML-0024"	"2020-09-15-AML0024:CAGGTATAGCAGGCTA"	-1.39409039440807	-16.2213316193786	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATAGCAGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.5023741451	40.9394068831536	0.0148951688265823	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.01048132052	2738.01048132052
"AML-0024"	"2020-09-15-AML0024:CAGGTATCAAAGCTAA"	-1.8030004304951	-15.8526449433533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATCAAAGCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.82445634318	35.4953565321336	0.0130314405722707	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.10602362359	2717.10602362359
"AML-0024"	"2020-09-15-AML0024:CAGGTATCAAGTGATA"	-2.62724719467815	-16.4030161133972	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATCAAGTGATA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.94030302202	44.7429775564032	0.0173763164543627	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.18303840229	2569.18303840229
"AML-0024"	"2020-09-15-AML0024:CAGGTATCACTGATTG"	-0.623011450201827	-16.7413473359314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATCACTGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.53888646089	36.9573260502453	0.0148331323468691	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.13962841695	2486.13962841695
"AML-0024"	"2020-09-15-AML0024:CAGGTATGTAATGATG"	-1.08904216709788	-16.8273248902527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATGTAATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.67855793043	33.9412345068156	0.0124295971813466	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.59919141082	2721.59919141082
"AML-0024"	"2020-09-15-AML0024:CAGGTATGTCCTCCAT"	0.442468841641587	-16.258761428949	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATGTCCTCCAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2727.7421349851	42.9603486128154	0.0157494170954873	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2719.66760129749	2719.66760129749
"AML-0024"	"2020-09-15-AML0024:CAGGTATTCATTGCCC"	-2.31522212448772	-15.897674583551	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATTCATTGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3066.16596734	36.7067372347183	0.0119715428407036	3598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3058.01022968603	3058.01022968603
"AML-0024"	"2020-09-15-AML0024:CAGGTATTCTGGGCAC"	0.318398107855958	-16.329670929071	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGGTATTCTGGGCAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2869.66831083355	38.0837936921062	0.0132711482885783	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2861.41916044837	2861.41916044837
"AML-0024"	"2020-09-15-AML0024:CAGTGCGCAACACTAC"	-1.97677860680278	-16.8470545045105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGCAACACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.018602551	41.8854699654623	0.0178996311908804	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2326.76477713877	2326.76477713877
"AML-0024"	"2020-09-15-AML0024:CAGTGCGCACCGCTGA"	-2.06063304367717	-15.6947565308777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGCACCGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.37952895918	35.431264260224	0.0128589415315893	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.53328006816	2747.53328006816
"AML-0024"	"2020-09-15-AML0024:CAGTGCGGTACAGTTC"	-1.07296655598338	-15.9608812562195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGGTACAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.17939106183	33.9065575166109	0.0126650300797224	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.32170714079	2669.32170714079
"AML-0024"	"2020-09-15-AML0024:CAGTGCGGTAGAAACT"	-0.664201895624954	-15.8958378068176	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGGTAGAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.35580597344	36.411961833606	0.0137126488855823	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.99885527799	2648.99885527799
"AML-0024"	"2020-09-15-AML0024:CAGTGCGGTGAGCCAA"	-1.43519411507304	-15.1387520066467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGGTGAGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.82034752533	32.3707336801569	0.0133387433120733	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2419.81331223952	2419.81331223952
"AML-0024"	"2020-09-15-AML0024:CAGTGCGGTTGGCTAT"	-1.45477328720744	-16.8439321747986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTGCGGTTGGCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.62628611149	43.3730323928271	0.0171731790373489	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.71081435284	2513.71081435284
"AML-0024"	"2020-09-15-AML0024:CAGTTAGAGTTTGTCG"	-0.122108350426513	-16.1888818970886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGAGTTTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.80317871743	35.2530398387298	0.0134154034534413	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.96107950866	2619.96107950866
"AML-0024"	"2020-09-15-AML0024:CAGTTAGCAACACGTT"	-0.823772351176101	-16.2702036133972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGCAACACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.16619864924	36.4939416330638	0.014243393598863	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.48553295905	2553.48553295905
"AML-0024"	"2020-09-15-AML0024:CAGTTAGCACGCGCTA"	-2.10602174225505	-15.4877224198547	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGCACGCGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.76957476448	32.755085392421	0.0124792232077592	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.83946937925	2618.83946937925
"AML-0024"	"2020-09-15-AML0024:CAGTTAGGTCCGAAGA"	-1.78216133537944	-16.7179460755554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGGTCCGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.62797797031	37.5284489077444	0.0146330965855894	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.43214909721	2559.43214909721
"AML-0024"	"2020-09-15-AML0024:CAGTTAGGTGCCCTTT"	-0.835626165301162	-16.8317537537781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGGTGCCCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.48610118033	46.6132823356113	0.019265778097618	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2405.13622468459	2405.13622468459
"AML-0024"	"2020-09-15-AML0024:CAGTTAGTCCCACAGG"	-1.81916342201884	-15.7224540940491	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTAGTCCCACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.6909127922	31.7853718809994	0.0108679422300574	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.84549071739	2915.84549071739
"AML-0024"	"2020-09-15-AML0024:CAGTTCCAGGACACTG"	-1.18069730225261	-16.6109457246033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTCCAGGACACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.52421398432	42.8626185618749	0.0166229265288317	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.3491189477	2569.3491189477
"AML-0024"	"2020-09-15-AML0024:CAGTTCCGTTAATGAG"	-1.72726605358775	-16.7840433350769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CAGTTCCGTTAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.78034250437	35.807684258491	0.0147309420075363	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2425.86962550875	2425.86962550875
"AML-0024"	"2020-09-15-AML0024:CATAAGCCACTATGTG"	0.290771876543206	-16.1159010163513	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCCACTATGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3020.6180789718	39.1934520532092	0.0129753087045517	3231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3007.10206034091	3007.10206034091
"AML-0024"	"2020-09-15-AML0024:CATAAGCCATACCGTA"	-2.82239375534709	-15.4940862885681	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCCATACCGTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.52998673876	32.812078671008	0.0119685280955253	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.43936055446	2735.43936055446
"AML-0024"	"2020-09-15-AML0024:CATAAGCCATCTTTCA"	-2.02097974243816	-16.5085458985535	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCCATCTTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.20523794048	36.4090658981747	0.0129514079608248	2597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.12596240234	2800.12596240234
"AML-0024"	"2020-09-15-AML0024:CATAAGCGTAAGTCAA"	-0.419348160654861	-15.9220361939636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCGTAAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.11346752881	34.4206547661355	0.0127525779039032	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.03209834201	2691.03209834201
"AML-0024"	"2020-09-15-AML0024:CATAAGCGTCTGTGGC"	-0.923336724669296	-16.2840662232605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCGTCTGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.71162049083	41.3887487948135	0.0161001134724365	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.91746521238	2560.91746521238
"AML-0024"	"2020-09-15-AML0024:CATAAGCGTGGACCAA"	-1.99286184731181	-16.0252866975036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCGTGGACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.47178357256	32.062726002521	0.0131003455147986	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2437.4536111734	2437.4536111734
"AML-0024"	"2020-09-15-AML0024:CATAAGCGTGTCATGT"	-0.673520366579849	-16.4527120820251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATAAGCGTGTCATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.09519484363	38.6031335286846	0.0142758041959085	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.25113407219	2696.25113407219
"AML-0024"	"2020-09-15-AML0024:CATACAGAGGCTGTAG"	-1.31619618359264	-16.4478426209656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGAGGCTGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.62428226406	38.4000158936886	0.0153072009089508	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.64339182279	2502.64339182279
"AML-0024"	"2020-09-15-AML0024:CATACAGCACTCAGAT"	-1.83141515675243	-16.1713419190613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGCACTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.59888232344	34.4781495770641	0.0143563314551963	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2396.94409226386	2396.94409226386
"AML-0024"	"2020-09-15-AML0024:CATACAGGTATGGTAA"	-1.64226410809215	-15.5989094010559	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGGTATGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.74937431657	35.8443702803352	0.0129788642712032	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.89051247423	2752.89051247423
"AML-0024"	"2020-09-15-AML0024:CATACAGGTGGTTTGT"	-2.33389196816142	-16.4413118592468	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGGTGGTTTGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.92473858212	36.6447277459697	0.0134282661694105	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.49509745366	2717.49509745366
"AML-0024"	"2020-09-15-AML0024:CATACAGTCTCGACCT"	-0.482347826392013	-16.5213365784851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGTCTCGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.71953939732	30.9500004396655	0.011914296355043	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.07677289272	2590.07677289272
"AML-0024"	"2020-09-15-AML0024:CATACAGTCTCGCAGG"	-0.548173169524032	-16.3506403199402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGTCTCGCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.59098975665	35.4176114981003	0.0122189062283236	3406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2889.09903089517	2889.09903089517
"AML-0024"	"2020-09-15-AML0024:CATACAGTCTGGGCCA"	-0.854179005057174	-16.1219721070495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACAGTCTGGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.13316661807	35.1806826376397	0.0123782668070765	2708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.20600465373	2832.20600465373
"AML-0024"	"2020-09-15-AML0024:CATACCCAGCATGAAT"	-1.93213341656383	-16.7347917786804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCAGCATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.38377823929	41.7103044442581	0.0179911129622961	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2312.5363929787	2312.5363929787
"AML-0024"	"2020-09-15-AML0024:CATACCCAGGGTAGCT"	1.03551330146138	-16.2197084656921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCAGGGTAGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3035.03008128232	43.9235642049672	0.0144722006137116	4258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3024.44581986194	3024.44581986194
"AML-0024"	"2020-09-15-AML0024:CATACCCAGTGGTCAG"	-0.482343117625076	-15.8853626481262	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCAGTGGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.43863764607	38.451905464892	0.0134238887017984	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.17705161057	2858.17705161057
"AML-0024"	"2020-09-15-AML0024:CATACCCCAGCGTATT"	0.18494146045987	-16.3331690064636	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCCAGCGTATT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2668.83024838338	39.362670925066	0.0147490350684198	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2660.25021096423	2660.25021096423
"AML-0024"	"2020-09-15-AML0024:CATACCCGTCTGCAAT"	-1.2118378681248	-16.7879610291687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCGTCTGCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.84439427324	36.3599659260556	0.0148175515981829	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.87119301897	2450.87119301897
"AML-0024"	"2020-09-15-AML0024:CATACCCGTCTTCATT"	-0.739922503859359	-16.6448831788269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCGTCTTCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.24373009288	33.7572772283246	0.0112590170337082	3153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2978.84361044963	2978.84361044963
"AML-0024"	"2020-09-15-AML0024:CATACCCGTTATGTGC"	-0.107754538685638	-15.9641180268494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCGTTATGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.92495431981	35.7516418758803	0.0130866119947214	2721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.37078297295	2725.37078297295
"AML-0024"	"2020-09-15-AML0024:CATACCCTCAGAGTGG"	-0.418455730110961	-16.2188844910828	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCTCAGAGTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1750.27088124299	42.4379253439617	0.0242464899569281	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	1744.84355480771	1744.84355480771
"AML-0024"	"2020-09-15-AML0024:CATACCCTCAGCTTCC"	-2.96173129501994	-15.6009912720886	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACCCTCAGCTTCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3077.53147975203	31.084658831711	0.0101005169358058	2757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3068.62051413936	3068.62051413936
"AML-0024"	"2020-09-15-AML0024:CATACTTAGGCCTGAA"	-0.979695896536666	-17.4512014619079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CATACTTAGGCCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3096.98826126738	32.726163579909	0.0105670931947661	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3089.26545591211	3089.26545591211
"AML-0024"	"2020-09-15-AML0024:TCGCAGGGTGCTATTG"	-2.08612499657329	-16.768843673822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGGTGCTATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1559.00830729189	48.8245257821055	0.0313176816016569	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1553.2827017181	1553.2827017181
"AML-0024"	"2020-09-15-AML0024:TCGCAGGGTGGCACTC"	-2.15804157677348	-16.6840219727722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGGTGGCACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2443.22131446115	47.5431223875455	0.0194591959828376	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2436.70021537975	2436.70021537975
"AML-0024"	"2020-09-15-AML0024:TCGCAGGGTTCTGAGT"	-1.23044214668925	-16.7243337861267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGGTTCTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.94959090071	41.2792834011232	0.0143732618190478	2883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.66952001399	2863.66952001399
"AML-0024"	"2020-09-15-AML0024:TCGCAGGTCAAGATAG"	-0.646530012518722	-16.1932363740173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGTCAAGATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.06118434728	38.5842996406109	0.0144669720616304	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.88704710192	2657.88704710192
"AML-0024"	"2020-09-15-AML0024:TCGCAGGTCAGTCACA"	-1.14956996861156	-15.9757299653259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGTCAGTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.62872983346	33.1557653133329	0.0123871364540707	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.07286863627	2668.07286863627
"AML-0024"	"2020-09-15-AML0024:TCGCAGGTCGCATAGT"	-2.87916479530986	-15.6753273240295	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGTCGCATAGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.18420780558	36.6241059974555	0.0139616981104401	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.44514562333	2620.44514562333
"AML-0024"	"2020-09-15-AML0024:TCGCTCAAGACGACGT"	-1.26691518250163	-16.3836565247742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCAAGACGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.48567059936	33.8491764040483	0.0125437673332281	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.02123132772	2692.02123132772
"AML-0024"	"2020-09-15-AML0024:TCGCTCAAGTTGTCGT"	-1.75540481033977	-16.6730375519958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCAAGTTGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.4933573835	43.1584852125487	0.0161009483920814	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.20422733384	2661.20422733384
"AML-0024"	"2020-09-15-AML0024:TCGCTCAAGTTTCGGT"	-2.64681134644206	-15.7641544572082	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCAAGTTTCGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2807.00797314963	35.7266742047121	0.0127276710812562	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.19856697678	2797.19856697678
"AML-0024"	"2020-09-15-AML0024:TCGCTCACAGGATCTT"	-1.55403397503551	-15.6977653733459	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCACAGGATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.47783834163	32.1318335413236	0.0125491551069759	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.97157649738	2556.97157649738
"AML-0024"	"2020-09-15-AML0024:TCGCTCAGTAACCCTA"	-0.213924298912841	-16.191716217157	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCAGTAACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.00618638664	41.4601600686202	0.0153954938084452	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.00426735941	2680.00426735941
"AML-0024"	"2020-09-15-AML0024:TCGCTCAGTATGCAAA"	-0.0825779688661874	-16.0994711152283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCAGTATGCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.9724552971	36.8730752562835	0.013566390337923	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.46770529317	2716.46770529317
"AML-0024"	"2020-09-15-AML0024:TCGCTCATCATTACTC"	-1.7142815393513	-15.8083753815857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTCATCATTACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.49085153544	36.6898759035032	0.0142457799380766	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.04636253928	2567.04636253928
"AML-0024"	"2020-09-15-AML0024:ACTTTGTGTTTGCCGG"	-1.38266191902812	-15.5674906007019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTGTGTTTGCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.17950472762	30.6190223837927	0.0125581493587419	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2431.315800312	2431.315800312
"AML-0024"	"2020-09-15-AML0024:ACTTTGTTCTAAGGAA"	-2.20730576935466	-16.3499937287536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.ACTTTGTTCTAAGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.10536888516	39.832562395584	0.0185431138400145	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2145.33450049837	2145.33450049837
"AML-0024"	"2020-09-15-AML0024:AGAAATGAGTGCGTCC"	-0.54525206509288	-16.0093183747497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAATGAGTGCGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.39697203772	38.9060591617662	0.0143226706413903	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.15936267236	2709.15936267236
"AML-0024"	"2020-09-15-AML0024:AGAAATGCACGACGAA"	-1.97574840012248	-16.8410406342712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAATGCACGACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.75714752053	36.4897486202647	0.014390080160454	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2524.32505272749	2524.32505272749
"AML-0024"	"2020-09-15-AML0024:AGAAATGCAGAATGTA"	-1.58164833012279	-16.3569708100525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAATGCAGAATGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.37196583095	38.1472826360484	0.0164118666017429	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.11971988069	2316.11971988069
"AML-0024"	"2020-09-15-AML0024:AGAAATGTCAAGGCTT"	-0.698323468596298	-16.6450395814148	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAATGTCAAGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2927.4898275196	43.1781326129412	0.0147491998800642	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.09998187283	2915.09998187283
"AML-0024"	"2020-09-15-AML0024:AGAACAAAGCAGTAAT"	-1.39006636562999	-16.4356832734314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAAAGCAGTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2000.76930283404	38.6093136064477	0.0192972340947847	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1995.27131410638	1995.27131410638
"AML-0024"	"2020-09-15-AML0024:AGAACAAAGTGGATAT"	-0.604453842074233	-16.5283365479675	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAAAGTGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.73442211904	39.2551376456197	0.0155359175471629	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.35316614512	2517.35316614512
"AML-0024"	"2020-09-15-AML0024:AGAACAAGTAGGATAT"	-0.869625071913558	-15.8003845444885	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAAGTAGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.76056539591	41.8289365156201	0.0145961030452805	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.86391886797	2856.86391886797
"AML-0024"	"2020-09-15-AML0024:AGAACAAGTGTAACGG"	-2.18505964699443	-15.5137148133484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAAGTGTAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.96832745655	33.8699142637396	0.0131178658946232	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.78043242378	2579.78043242378
"AML-0024"	"2020-09-15-AML0024:AGAACAATCCCATTCG"	-0.658081750304061	-16.6114378205505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAATCCCATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.68837848851	50.7170233795683	0.0212677781453836	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2379.40143550079	2379.40143550079
"AML-0024"	"2020-09-15-AML0024:AGAACAATCCGATAAC"	-1.51533649388011	-16.0696802369324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACAATCCGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.47393227529	37.4954426757644	0.0153514197962537	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.07551579767	2434.07551579767
"AML-0024"	"2020-09-15-AML0024:AGAACCTAGCAAACAT"	0.230741326778573	-16.0716676942078	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTAGCAAACAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3062.58067015869	36.6523919701566	0.011967812742793	3383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3052.27370758192	3052.27370758192
"AML-0024"	"2020-09-15-AML0024:AGAACCTAGGACCCAA"	-1.0493315261906	-16.3966627351013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTAGGACCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.23241690998	28.6140076844148	0.011012874559715	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.53459721427	2590.53459721427
"AML-0024"	"2020-09-15-AML0024:AGAACCTAGGGAGGTG"	-0.726178447634536	-15.8440876237121	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTAGGGAGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.83715614313	34.6472417813992	0.0125042504589575	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.25969760441	2762.25969760441
"AML-0024"	"2020-09-15-AML0024:AGAACCTCATGTGCCG"	-1.6965151828831	-16.5184278718201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTCATGTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.55470299112	37.0053221695085	0.0126102001546572	2897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.85222690128	2924.85222690128
"AML-0024"	"2020-09-15-AML0024:AGAACCTTCCAGCTCT"	-2.89780078354533	-15.8616733781067	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTTCCAGCTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.3206060203	42.6599448235956	0.0163993414440599	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.57013007696	2593.57013007696
"AML-0024"	"2020-09-15-AML0024:AGAACCTTCCATAAGC"	-2.27976570549663	-16.1031027070251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAACCTTCCATAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2112.82684967893	37.2144673673572	0.0176135907081134	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2111.46853333323	2111.46853333323
"AML-0024"	"2020-09-15-AML0024:AGAAGCGCAAGGTTGG"	-1.9495099586552	-16.7319498292175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGCGCAAGGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.05485115749	43.7730971266365	0.0173217835404668	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.5585423905	2513.5585423905
"AML-0024"	"2020-09-15-AML0024:AGAAGCGCACAATGTC"	-0.77430901947673	-15.8950748673645	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGCGCACAATGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.7989491405	38.4559403887014	0.0147070352775467	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.05407083798	2607.05407083798
"AML-0024"	"2020-09-15-AML0024:AGAAGCGCAGTCGAGA"	-0.908402304083663	-16.1795892945495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGCGCAGTCGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.63352585732	34.1918986524161	0.0142428647622112	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.6509427147	2397.6509427147
"AML-0024"	"2020-09-15-AML0024:AGAAGCGGTAGCGCCT"	-2.77095494690593	-15.9795255891052	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGCGGTAGCGCCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.00032777636	39.2237483362439	0.0151560059383553	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.10461679183	2582.10461679183
"AML-0024"	"2020-09-15-AML0024:AGAAGCGGTTGTACGT"	-0.816955189139205	-16.7606916657654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGCGGTTGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.26228880079	39.5892855298345	0.0154268274535314	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.03863485967	2559.03863485967
"AML-0024"	"2020-09-15-AML0024:AGAAGTAAGGAACTAT"	-0.91955546560939	-15.8250494233337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTAAGGAACTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.07539435151	33.4863453911763	0.0132092108446906	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.54680197662	2531.54680197662
"AML-0024"	"2020-09-15-AML0024:AGAAGTACAACTCGAT"	-2.22284374657329	-15.4533682099548	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTACAACTCGAT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.10908390753	34.5104138356525	0.0126964786071207	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.84188293376	2712.84188293376
"AML-0024"	"2020-09-15-AML0024:AGAAGTACAGTCTGGC"	-0.255645881325561	-16.3673544160095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTACAGTCTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.05193539411	44.5146220886819	0.0165972259900108	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.12958175177	2673.12958175177
"AML-0024"	"2020-09-15-AML0024:AGAAGTATCACACCGG"	-0.991719583899337	-16.4369135132995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTATCACACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.48687896979	37.7026401428617	0.0138435181876564	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.67290805564	2714.67290805564
"AML-0024"	"2020-09-15-AML0024:AGAAGTATCCGAGTGC"	-2.58046565476115	-16.0108881226745	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTATCCGAGTGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.52185312064	44.7899115081032	0.0157128812954263	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2846.24307167207	2846.24307167207
"AML-0024"	"2020-09-15-AML0024:AGAAGTATCTGCGGGT"	-0.441570858389694	-16.4458837739197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAAGTATCTGCGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.18886694211	26.4626815695409	0.0100649603009762	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.8799202428	2622.8799202428
"AML-0024"	"2020-09-15-AML0024:AGACAAAAGTGAGCCA"	-2.22300801697429	-16.514449142572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAAAGTGAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2953.43778915381	32.6213394454751	0.0110452096080282	3070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2942.67364732159	2942.67364732159
"AML-0024"	"2020-09-15-AML0024:AGACAAAAGTTGCGAG"	-0.486423830420333	-16.2798929444519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAAAGTTGCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.17814216495	33.9838815282148	0.0140709626900448	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2408.95092146514	2408.95092146514
"AML-0024"	"2020-09-15-AML0024:AGACAAACACTCAAGT"	-0.30480001393016	-15.9461279145447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAACACTCAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.38488568191	34.1192121783144	0.0122449746098032	2454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.61234273654	2776.61234273654
"AML-0024"	"2020-09-15-AML0024:AGACAAACAGTGACCC"	-0.299955199391204	-16.4596815339294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAACAGTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.56032859241	34.3890153429833	0.0120639493218389	2691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.1123678797	2839.1123678797
"AML-0024"	"2020-09-15-AML0024:AGACAAACATTGAGCT"	-1.33604107323344	-16.1227274171081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAACATTGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2910.90159932058	33.495403290903	0.011506882712463	3252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.49689402087	2908.49689402087
"AML-0024"	"2020-09-15-AML0024:AGACAAATCTACGGTA"	-1.41656778279002	-16.1470575562683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAAATCTACGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2906.6119072361	33.7179198010835	0.0116004203096883	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2900.49361400299	2900.49361400299
"AML-0024"	"2020-09-15-AML0024:AGACACTCAGTTGGTT"	-2.10516844216045	-16.0341806641785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTCAGTTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.98437925799	30.5725657482386	0.0111012124754592	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.93804982903	2749.93804982903
"AML-0024"	"2020-09-15-AML0024:AGACACTCATCGCTGG"	0.416350592940491	-16.2265615693298	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTCATCGCTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2844.01186913152	32.0912815960427	0.0112838071965721	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2836.33625016493	2836.33625016493
"AML-0024"	"2020-09-15-AML0024:AGACACTCATGTGACT"	-2.0904212993687	-15.8195972672668	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTCATGTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.07700237953	29.4875587322527	0.010730251993201	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.16405704717	2744.16405704717
"AML-0024"	"2020-09-15-AML0024:AGACACTGTAACAGTA"	-0.970126370817977	-15.9648790589538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTGTAACAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.53758020894	31.0828046153818	0.0111187217927003	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.46086308242	2785.46086308242
"AML-0024"	"2020-09-15-AML0024:AGACACTGTGCTAGCC"	-2.57500110092815	-15.8677788010803	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTGTGCTAGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.55391926702	28.1438278664487	0.00955468093194915	2658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2938.30377758084	2938.30377758084
"AML-0024"	"2020-09-15-AML0024:AGACACTTCACCCTTG"	-2.38725362244304	-15.9380254975525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTTCACCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.32671029779	30.7014121545457	0.0112322511754187	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.36699660061	2728.36699660061
"AML-0024"	"2020-09-15-AML0024:AGACACTTCCTTTGAT"	-1.96591077271159	-15.9162235490051	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTTCCTTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.67792810486	31.6294323862029	0.0110954071922219	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.15723692496	2839.15723692496
"AML-0024"	"2020-09-15-AML0024:AGACACTTCTCTGAGA"	-1.73951886120494	-16.5114450684753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTTCTCTGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.46216407253	49.3914347520424	0.0199282585257965	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2465.26521716233	2465.26521716233
"AML-0024"	"2020-09-15-AML0024:AGACACTTCTGTCGTC"	-3.03794608536418	12.3716344603333	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACACTTCTGTCGTC"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1918.98770744518	39.3077503601815	0.0204835863240174	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1918.98770744518	1918.98770744518
"AML-0024"	"2020-09-15-AML0024:AGACAGGAGTACAACA"	-2.6849185031956	-16.0278730622497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAGGAGTACAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.27560583842	35.9006291374343	0.0135204907010391	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.32800786722	2649.32800786722
"AML-0024"	"2020-09-15-AML0024:AGACAGGCATAGCACT"	-2.05610189858134	-15.5401849976745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAGGCATAGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.40620832133	30.2719326199321	0.0112811591946302	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.71041713181	2678.71041713181
"AML-0024"	"2020-09-15-AML0024:AGACAGGGTGACAGCA"	-1.69170210781749	-16.3824491730896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAGGGTGACAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.37530866679	41.0571077353199	0.0180045396822525	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2274.58287446006	2274.58287446006
"AML-0024"	"2020-09-15-AML0024:AGACAGGGTGTCTAAC"	-2.39194164696391	-15.553550743219	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAGGGTGTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.05890167763	39.5077654309885	0.0149760740390839	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.61189768829	2632.61189768829
"AML-0024"	"2020-09-15-AML0024:AGACAGGTCAACCTTT"	-0.957807759672958	-16.5431394807068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACAGGTCAACCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.25511586321	33.7242839867373	0.0132238864170741	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.15439231397	2544.15439231397
"AML-0024"	"2020-09-15-AML0024:AGACCATAGAAGTCTA"	-1.08485339108165	-15.9200020066467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCATAGAAGTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.67485478296	38.6585241965125	0.0135043363838271	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.16897975166	2855.16897975166
"AML-0024"	"2020-09-15-AML0024:AGACCATAGTAACCGG"	-2.21410260620769	-15.7561435929504	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCATAGTAACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.92041281724	47.9849873875728	0.0196103588560634	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.11659136886	2445.11659136886
"AML-0024"	"2020-09-15-AML0024:AGACCATCAGAATGTA"	0.021382081403774	-16.3690538636413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCATCAGAATGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3198.24393377301	38.1141802168042	0.0119172211394896	3442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3190.18882358814	3190.18882358814
"AML-0024"	"2020-09-15-AML0024:AGACCATGTTGGACCC"	-1.50634894791301	-15.2812261811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCATGTTGGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2807.19707664171	39.6083649688894	0.014109577591992	2792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.49131732661	2802.49131732661
"AML-0024"	"2020-09-15-AML0024:AGACCCGAGATAACGT"	1.07193269309346	-16.2106161347595	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCCGAGATAACGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2833.32032471921	41.0500998651116	0.0144883370605756	3672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2821.14274197076	2821.14274197076
"AML-0024"	"2020-09-15-AML0024:AGACCCGAGTTGAAAC"	-1.96326647225078	-15.4727277985779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCCGAGTTGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.89842069464	33.4262042499644	0.0115946521077598	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.70624955178	2876.70624955178
"AML-0024"	"2020-09-15-AML0024:AGACCCGCAATCGCCG"	-2.68788919869121	-15.7782411805359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCCGCAATCGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2910.23797139078	43.2021505275797	0.0148448858657884	2661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.96565306444	2901.96565306444
"AML-0024"	"2020-09-15-AML0024:AGACCCGCAGTCAACT"	-0.351607422262985	-16.0693636170593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCCGCAGTCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.30965057218	39.465557883221	0.0140681645875248	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.74802263431	2796.74802263431
"AML-0024"	"2020-09-15-AML0024:AGACCCGGTAGTCGTT"	-1.51637766781505	-16.2958593598572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACCCGGTAGTCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.2819145706	38.522837093993	0.0140170616739702	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.89228680669	2738.89228680669
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGACAGTCG"	-1.42359183254893	-16.1411276093689	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGACAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.05597995354	36.2847385985357	0.0140908542886086	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.97273262037	2567.97273262037
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGACATATG"	-0.7312128347462	-16.6207380524841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGACATATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.33557882426	33.5141352066513	0.0138354633848536	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.80231709376	2413.80231709376
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGAGGACTC"	-1.89225063744243	-15.7708873978821	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGAGGACTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.35838631826	31.8234532368979	0.0115748653923265	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.73643879368	2740.73643879368
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGAGTCAGC"	-0.685826877981979	-16.7317304841247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGAGTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.04779405379	34.7941271589184	0.0138840636804597	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.68390318128	2502.68390318128
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGATGATTG"	-0.45772890272792	-16.021119140741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGATGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.36937283406	36.9087118753747	0.0135327147994707	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.7507172549	2721.7507172549
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGCGGTATG"	-2.04027376595195	-15.5808811417786	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGCGGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.96438884945	30.4851527836196	0.0114220904973413	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.10363472335	2662.10363472335
"AML-0024"	"2020-09-15-AML0024:AGACTCAAGTATAGGT"	-1.40084789219554	-16.8720636597839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAAGTATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.36686769124	36.9567256452586	0.0151625617526611	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2429.80223874254	2429.80223874254
"AML-0024"	"2020-09-15-AML0024:AGACTCACAGCGCGTT"	-0.614497701556045	-15.8204612961975	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCACAGCGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.33022763994	41.7060111080411	0.016869110219088	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.57821309913	2468.57821309913
"AML-0024"	"2020-09-15-AML0024:AGACTCACAGGCTACC"	-0.765224913985092	-17.2112894288269	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCACAGGCTACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2679.80636919002	41.1751972937198	0.0153649897123594	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2672.12309535462	2672.12309535462
"AML-0024"	"2020-09-15-AML0024:AGACTCAGTGACCTGC"	0.948660333722275	-16.2597284547058	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCAGTGACCTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3049.14998032317	44.2692357906843	0.0145185497848132	3366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3033.69640119423	3033.69640119423
"AML-0024"	"2020-09-15-AML0024:AGACTCATCATAGGCT"	-2.55938206139262	-16.3565664521423	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCATCATAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.92354051915	41.7834911172362	0.015905864968182	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.77815952686	2615.77815952686
"AML-0024"	"2020-09-15-AML0024:AGACTCATCATTGGTG"	-1.50028071823772	-16.9722089997497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCATCATTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1750.92360698343	50.8086020165346	0.0290181717888138	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1742.66138459378	1742.66138459378
"AML-0024"	"2020-09-15-AML0024:AGACTCATCTTCGGTC"	-0.490995923907119	-15.8723297349182	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGACTCATCTTCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.81023257869	33.4381907610734	0.0118038936659145	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.01562079877	2826.01562079877
"AML-0024"	"2020-09-15-AML0024:AGAGAATCACCGGCTA"	-0.555746654898483	-16.098376297113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAATCACCGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1399.78468509267	50.4446711863349	0.0360374504190231	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1397.40053641421	1397.40053641421
"AML-0024"	"2020-09-15-AML0024:AGAGAATTCGAGAGCA"	-0.492658893496352	-16.4791403046814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAATTCGAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.75911051103	35.8077211495293	0.0154626277780798	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2306.73650587926	2306.73650587926
"AML-0024"	"2020-09-15-AML0024:AGAGAATTCTGGCCGA"	-2.65818653526958	-15.4885463944641	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAATTCTGGCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.89675549279	35.0339358390387	0.0122930543962744	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.54568579241	2844.54568579241
"AML-0024"	"2020-09-15-AML0024:AGAGAGCAGAAACTCA"	-0.430584321648437	-16.5625524750915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCAGAAACTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.47029889851	37.4044808597007	0.0149949594012875	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.61061859305	2490.61061859305
"AML-0024"	"2020-09-15-AML0024:AGAGAGCAGAACCCGA"	-2.46087656441386	-15.7625761262146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCAGAACCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.46715074859	34.0447928372643	0.0139787526293672	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2430.20278715875	2430.20278715875
"AML-0024"	"2020-09-15-AML0024:AGAGAGCAGCAAATCA"	-2.02439628067668	-16.2767210236755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCAGCAAATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2092.93207251393	38.8586836073618	0.0185666243628665	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2088.70836484347	2088.70836484347
"AML-0024"	"2020-09-15-AML0024:AGAGAGCCAAAGCACG"	-0.932349304587203	-16.2415304414001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCCAAAGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.51230362469	34.1344454528684	0.0140153040500216	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2429.2018888994	2429.2018888994
"AML-0024"	"2020-09-15-AML0024:AGAGAGCCATCTGGGC"	-2.2877713245457	-15.9887438050476	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCCATCTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.33879398931	35.8619310590907	0.0132953009607116	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.49674652546	2688.49674652546
"AML-0024"	"2020-09-15-AML0024:AGAGAGCGTGAACGGT"	-2.67480407181438	-15.9170131913391	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCGTGAACGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.30127064771	38.9047019488938	0.0152131868057298	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.06349938874	2546.06349938874
"AML-0024"	"2020-09-15-AML0024:AGAGAGCGTTAGTTCG"	-0.704006711870986	-16.0110121003357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCGTTAGTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.88190198676	38.5926266961204	0.0142099797004754	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.70480258657	2708.70480258657
"AML-0024"	"2020-09-15-AML0024:AGAGAGCTCGAGTACT"	-2.92433295670207	13.3887796171936	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCTCGAGTACT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2012.78436804333	33.2547542553829	0.016521766952965	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2011.08678924016	2011.08678924016
"AML-0024"	"2020-09-15-AML0024:AGAGAGCTCGTAGTCA"	-1.63271663609203	-15.6394052735535	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCTCGTAGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.46581855176	35.1016281028579	0.0136133773231763	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.46352954091	2576.46352954091
"AML-0024"	"2020-09-15-AML0024:AGAGAGCTCTCATTTG"	-1.60278211060222	-15.5636196366516	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGAGCTCTCATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.05939914305	31.5349336192092	0.011546776913422	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.5973740049	2726.5973740049
"AML-0024"	"2020-09-15-AML0024:AGAGCCCAGAGGCGGA"	-1.30191276493724	-16.8000612488953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGCCCAGAGGCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.80042495343	39.5326278095854	0.0147851827087184	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.59799303297	2668.59799303297
"AML-0024"	"2020-09-15-AML0024:AGAGCCCAGCGCACAA"	-2.67809186402019	-16.0855951539245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGCCCAGCGCACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.02498019905	36.1287147364345	0.0134057068123228	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.18511128355	2686.18511128355
"AML-0024"	"2020-09-15-AML0024:AGAGCCCAGGAACGTC"	-2.15175996246989	-16.7146482697693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGCCCAGGAACGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2228.4510078049	46.479980387156	0.0208575284914791	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2219.8655493271	2219.8655493271
"AML-0024"	"2020-09-15-AML0024:AGAGCCCAGGTCCTGC"	-1.89870629730876	-16.5175562134949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGCCCAGGTCCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.38535173933	38.1662161781764	0.0141022844930962	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.33487910927	2699.33487910927
"AML-0024"	"2020-09-15-AML0024:AGAGCCCTCTATACTC"	0.5124574798042	-16.1336698762146	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGAGCCCTCTATACTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.71012438038	39.0909609947737	0.0132479841621116	3286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2945.00269547494	2945.00269547494
"AML-0024"	"2020-09-15-AML0024:AGATAGAGTCAAAGCG"	-0.995084862143356	-16.495427154657	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATAGAGTCAAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.62444380105	39.9710522653077	0.0146006339020738	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.46041558543	2729.46041558543
"AML-0024"	"2020-09-15-AML0024:AGATAGAGTGTCGATT"	-0.52693478289302	-15.7406120530334	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATAGAGTGTCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.24290265161	32.294275512331	0.0139184890838043	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2309.44241863319	2309.44241863319
"AML-0024"	"2020-09-15-AML0024:AGATAGATCCTCCACA"	-2.9045766395634	-16.1435690156189	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATAGATCCTCCACA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.99408516442	40.2633181882531	0.01452503755464	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.51009556136	2765.51009556136
"AML-0024"	"2020-09-15-AML0024:AGATCCAAGGTAGTCG"	-1.72698066654857	-16.6227274171081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCAAGGTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.25011339391	39.4267069149449	0.0151743308743455	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.80041999557	2591.80041999557
"AML-0024"	"2020-09-15-AML0024:AGATCCACAAACGTGG"	-1.49175558510478	-16.4729604951111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCACAAACGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.10402125034	34.159500053154	0.0116780462523697	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2917.56598808909	2917.56598808909
"AML-0024"	"2020-09-15-AML0024:AGATCCACACGTGTGC"	-1.5044404071873	-16.2479238740173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCACACGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.09286470634	37.023752921312	0.014467530050169	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.25660146668	2555.25660146668
"AML-0024"	"2020-09-15-AML0024:AGATCCACAGAGGGTT"	-2.0800601047581	-16.2461614838806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCACAGAGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.91851516875	37.8266585926173	0.0161107203458032	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2344.42457114034	2344.42457114034
"AML-0024"	"2020-09-15-AML0024:AGATCCAGTAAGATTG"	-0.819989721209365	-16.8152227631775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCAGTAAGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.17130420873	37.1817884925503	0.0145345186350025	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.87271275576	2546.87271275576
"AML-0024"	"2020-09-15-AML0024:AGATCCAGTAGTGCGA"	-0.473483065993148	-15.8500108948913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCAGTAGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.99736052058	28.6993543268563	0.012063634370984	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2371.03179613317	2371.03179613317
"AML-0024"	"2020-09-15-AML0024:AGATCCATCGTACCTC"	-3.01906357231792	13.3703326948914	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCCATCGTACCTC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2100.12150851557	34.4550900148246	0.016406236436852	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2093.42659853614	2093.42659853614
"AML-0024"	"2020-09-15-AML0024:AGATCGTAGCATCGAG"	-0.525570611388046	-16.756564163324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTAGCATCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.21176524895	38.7153037483055	0.0147869260470703	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.31097122058	2611.31097122058
"AML-0024"	"2020-09-15-AML0024:AGATCGTAGTCTAACC"	-1.81291447106059	-16.3202619782654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTAGTCTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.73024445171	48.9980719644861	0.0199932538782734	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2430.8330062587	2430.8330062587
"AML-0024"	"2020-09-15-AML0024:AGATCGTCAATAGTCC"	-0.398293952376205	-16.2686586610046	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTCAATAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.12928440755	42.639927575476	0.0154261697584146	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.64632150057	2754.64632150057
"AML-0024"	"2020-09-15-AML0024:AGATCGTCAGCGGTTC"	-1.93620799008067	-15.3906326523987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTCAGCGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.388721455	35.5151708696338	0.012856688341432	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.17012246969	2756.17012246969
"AML-0024"	"2020-09-15-AML0024:AGATCGTGTGCAAGAC"	-1.73000727120097	-16.1203718415466	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTGTGCAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.98142057507	31.9551443136524	0.0126958204984888	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.32719397917	2513.32719397917
"AML-0024"	"2020-09-15-AML0024:AGATCGTGTGGAAATT"	-1.99797449532207	-15.7483501664368	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTGTGGAAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.02597202095	34.0422899311251	0.0134446843386658	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.59985076799	2527.59985076799
"AML-0024"	"2020-09-15-AML0024:AGATCGTTCAGCTTCC"	-0.457102040678817	-16.5763712159363	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTTCAGCTTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2603.97532683523	42.8344990834764	0.0164496562782474	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2595.05251729882	2595.05251729882
"AML-0024"	"2020-09-15-AML0024:AGATCGTTCAGGAAAT"	-0.245934854180175	-16.384888671991	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTTCAGGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.23364549243	37.9995304659092	0.0141829849478936	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.14835177086	2670.14835177086
"AML-0024"	"2020-09-15-AML0024:AGATCGTTCGGCATCG"	-0.852233926684219	-15.859344505426	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTTCGGCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.11221786315	35.5888990674062	0.0131756462512174	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.87101861977	2691.87101861977
"AML-0024"	"2020-09-15-AML0024:AGATCGTTCTAAGCGT"	-0.534780840308029	-16.1959543458191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTTCTAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2856.383789905	33.3724432452913	0.0116834591217174	3317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.49413642465	2849.49413642465
"AML-0024"	"2020-09-15-AML0024:AGATCGTTCTACGCGG"	-0.459808985621291	-16.1391630402771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATCGTTCTACGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.63874983695	40.862059654133	0.0137045641952324	3263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2974.65271150632	2974.65271150632
"AML-0024"	"2020-09-15-AML0024:AGATGAAAGAGAGAAC"	-1.4051093858784	-14.9963693848816	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Ery-3"	72	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0434782608695652	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGAAAGAGAGAAC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1669.018615458	47.794099286753	0.0286360492591855	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1665.60164924755	1665.60164924755
"AML-0024"	"2020-09-15-AML0024:AGATGAAAGGATGAGA"	-1.61370263519939	-16.0056524506775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGAAAGGATGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.0660625532	38.2989989740344	0.0146287366548285	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.82399949358	2607.82399949358
"AML-0024"	"2020-09-15-AML0024:AGATGAACAGATACCT"	-1.45611927929576	-16.9551191559997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGAACAGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.24014429548	29.3906681531236	0.0113379419024125	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.22798502266	2586.22798502266
"AML-0024"	"2020-09-15-AML0024:AGATGAACAGGACTAG"	-1.23995635929759	-16.122883819696	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGAACAGGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2967.83953855258	36.1869660349268	0.0121930332030603	3224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2956.03866348524	2956.03866348524
"AML-0024"	"2020-09-15-AML0024:AGATGAACATCTCAAG"	-0.157366136938888	-16.3744001618591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGAACATCTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.81040339396	39.4843453223541	0.01414798557234	2916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2782.24631959023	2782.24631959023
"AML-0024"	"2020-09-15-AML0024:AGATGCTCAGTTAAAG"	-2.42900143089946	-15.7057762376037	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGCTCAGTTAAAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.76450122433	33.4536612225634	0.012838328715755	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.16896779186	2601.16896779186
"AML-0024"	"2020-09-15-AML0024:AGATGCTTCATCGCCT"	-1.32908854904826	-16.8105306855408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGCTTCATCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.21413736628	39.5481494341693	0.0172007247134759	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2296.80968516221	2296.80968516221
"AML-0024"	"2020-09-15-AML0024:AGATGCTTCGCAGTCG"	1.2785140472347	-16.1939459077087	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGCTTCGCAGTCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2878.39098247709	39.3478263977234	0.0136700770108241	3444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2864.67551880841	2864.67551880841
"AML-0024"	"2020-09-15-AML0024:AGATGCTTCTGACCCT"	-1.93322680416759	-16.3857755891052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGATGCTTCTGACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.62672044107	30.9354280596053	0.0113748801727423	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.64163536604	2711.64163536604
"AML-0024"	"2020-09-15-AML0024:AGCATCAAGCCAGTAG"	-1.96671519699748	-16.7153806916443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCAAGCCAGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.06617376719	36.2180951032749	0.0140431042334876	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.59691587067	2566.59691587067
"AML-0024"	"2020-09-15-AML0024:AGCATCAAGGAACATT"	-2.31700025025066	-16.3839979401794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCAAGGAACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.88918765961	38.3601118799993	0.0162481628026033	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2354.5728677194	2354.5728677194
"AML-0024"	"2020-09-15-AML0024:AGCATCAAGGATAATC"	-0.769234756857711	-16.6779985657898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCAAGGATAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.33610909705	40.2944094480774	0.0134389234501839	2868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2989.93387132245	2989.93387132245
"AML-0024"	"2020-09-15-AML0024:AGCATCAAGTGGTTAA"	-0.977762321860153	-16.6890650025574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCAAGTGGTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.68317463734	31.2694059367165	0.0116170455094254	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.07204380469	2683.07204380469
"AML-0024"	"2020-09-15-AML0024:AGCATCACAAACAGGC"	-2.11289797249492	-16.7667799226013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCACAAACAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.73660778083	38.1104829998739	0.0155379435684108	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2446.75319098723	2446.75319098723
"AML-0024"	"2020-09-15-AML0024:AGCATCACACCAGCGT"	0.522777428000611	-16.3069219819275	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCATCACACCAGCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2656.27586121636	44.1402789532462	0.0166173549960408	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2646.88109772704	2646.88109772704
"AML-0024"	"2020-09-15-AML0024:AGCCAATAGCTCGCAC"	-1.86883888664897	-15.9964571229187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATAGCTCGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.73956520699	39.7042368452035	0.0149278663838328	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.8658993753	2654.8658993753
"AML-0024"	"2020-09-15-AML0024:AGCCAATCAATGCTCA"	-1.39149854603465	-16.1683244935242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATCAATGCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.08644591992	33.6423246074073	0.012771913639933	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.03820102252	2630.03820102252
"AML-0024"	"2020-09-15-AML0024:AGCCAATGTATGTCTG"	-0.61080632630046	-16.6433305970398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATGTATGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.77707089565	35.0211103708731	0.013926129189018	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.91834490719	2502.91834490719
"AML-0024"	"2020-09-15-AML0024:AGCCAATGTGCCTGCA"	-1.6148466867512	-16.6349077454773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATGTGCCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.62205920238	36.2348838056476	0.0142453882543423	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.76711675054	2540.76711675054
"AML-0024"	"2020-09-15-AML0024:AGCCAATTCCTGTAAG"	-0.953802327544051	-16.763472580072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATTCCTGTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.16089716085	45.7092299279746	0.0209371787427204	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2172.73018734577	2172.73018734577
"AML-0024"	"2020-09-15-AML0024:AGCCAATTCGACGCTG"	-2.21212134781535	-15.8796034089294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAATTCGACGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.11536789572	33.3991687497179	0.0134126993392848	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2484.60270229572	2484.60270229572
"AML-0024"	"2020-09-15-AML0024:AGCCACGAGTGGAAAG"	-0.028094875544864	-15.9030628434387	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCACGAGTGGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.82567753018	39.7646283497168	0.0137745166461653	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2883.4199446841	2883.4199446841
"AML-0024"	"2020-09-15-AML0024:AGCCACGCACAGCTTA"	-0.738483468920547	-16.1826734772888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCACGCACAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.70830792701	34.3727486997772	0.012134235142951	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.20510032613	2819.20510032613
"AML-0024"	"2020-09-15-AML0024:AGCCACGCAGCCGTCA"	-2.06615004959758	-16.4456987611023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCACGCAGCCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.88350050891	38.5602548736578	0.0165645122985012	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2321.66964850214	2321.66964850214
"AML-0024"	"2020-09-15-AML0024:AGCCACGGTTACCGTA"	-1.52559254589732	-16.2546034089294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCACGGTTACCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.00463291396	38.3620476609482	0.0138992692995759	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.40805608422	2754.40805608422
"AML-0024"	"2020-09-15-AML0024:AGCCAGCCACGGGTAA"	-0.615382413298446	-16.2998781434265	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCCACGGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.66880016255	36.1424538996231	0.01392950572241	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.84979043283	2585.84979043283
"AML-0024"	"2020-09-15-AML0024:AGCCAGCCAGATCATC"	-2.10518370094951	-15.7263384095398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCCAGATCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.63428423905	31.5247444848374	0.0111134327960413	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.68168783922	2828.68168783922
"AML-0024"	"2020-09-15-AML0024:AGCCAGCCAGCAGATG"	-2.78735981407817	-16.0566110841003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCCAGCAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.3441959144	37.8640200003774	0.0148874934274338	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.55611513723	2539.55611513723
"AML-0024"	"2020-09-15-AML0024:AGCCAGCCATGCGTGC"	-1.3018014234608	-15.8732118836609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCCATGCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.28705591685	34.372005633143	0.0116701716948412	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2936.50344188573	2936.50344188573
"AML-0024"	"2020-09-15-AML0024:AGCCAGCGTATCTCGA"	-2.26440821114238	-16.4778375855652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCGTATCTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.33763659514	40.6024020699474	0.0150695300835633	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.36492880453	2686.36492880453
"AML-0024"	"2020-09-15-AML0024:AGCCAGCGTTGGCCGT"	-0.277918944985229	-16.3295450440613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCGTTGGCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.34479229167	34.0045562116368	0.0123502716793178	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.58421727511	2743.58421727511
"AML-0024"	"2020-09-15-AML0024:AGCCAGCTCGTGCACG"	-1.70782421055492	-15.6542072526184	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCCAGCTCGTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.26211801428	34.0600596617932	0.012954227510613	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.77469202014	2625.77469202014
"AML-0024"	"2020-09-15-AML0024:AGCGATTCACACAGAG"	-1.10534964028056	-16.1084280244079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGATTCACACAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.411905128	37.4416785660909	0.0149145558502209	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.04808974032	2505.04808974032
"AML-0024"	"2020-09-15-AML0024:AGCGATTTCACTGGGC"	-1.25143371048625	-16.0309591523376	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGATTTCACTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.25316972191	35.1660494850068	0.0146754315985268	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2391.51010169421	2391.51010169421
"AML-0024"	"2020-09-15-AML0024:AGCGATTTCATTCTTG"	-1.25910196724589	-16.7172899476257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGATTTCATTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.33518393664	27.3179153294334	0.0112868314730695	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2414.30789100897	2414.30789100897
"AML-0024"	"2020-09-15-AML0024:AGCGATTTCCATAGGT"	-1.43713078919109	-16.1232652894226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGATTTCCATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.80937400611	37.254747016226	0.0133586566953874	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2782.34605680744	2782.34605680744
"AML-0024"	"2020-09-15-AML0024:AGCGATTTCGAGTACT"	-2.3085220855778	-15.6541090241638	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGATTTCGAGTACT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.00727481761	43.8059301787876	0.0160343387744866	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.93348745843	2719.93348745843
"AML-0024"	"2020-09-15-AML0024:AGCGCCAAGTTGCGAG"	-0.0492126372760117	-16.1208677521911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCAAGTTGCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.48915946898	35.3380158811561	0.012778215296979	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.36659960092	2759.36659960092
"AML-0024"	"2020-09-15-AML0024:AGCGCCAGTCGGCACT"	0.111877598881167	-15.9547949067322	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCAGTCGGCACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2681.5994094154	38.0997203717189	0.0142078344132783	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2677.04249518289	2677.04249518289
"AML-0024"	"2020-09-15-AML0024:AGCGCCAGTCTACAGT"	-1.49206898632701	-16.7096071473328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCAGTCTACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2097.69948990252	48.5054310946406	0.0231231553080535	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2092.24984988414	2092.24984988414
"AML-0024"	"2020-09-15-AML0024:AGCGCCAGTGCATCTA"	-1.86150227013286	-15.9471655122009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCAGTGCATCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.9785674736	41.783834579604	0.0147230972983705	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.15740958092	2829.15740958092
"AML-0024"	"2020-09-15-AML0024:AGCGCCAGTGGTACAG"	9.20450558242146	7.90900800311891	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCAGTGGTACAG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1898.20631200097	36.8507137489072	0.0194134396856269	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1893.00942315637	1893.00942315637
"AML-0024"	"2020-09-15-AML0024:AGCGCCATCACAAGAA"	-1.37997422638591	-15.4963293305603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCATCACAAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.97652233348	33.1009513631845	0.0123604337405997	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.12700329617	2669.12700329617
"AML-0024"	"2020-09-15-AML0024:AGCGCCATCCGAACGC"	-1.81838367405589	-16.5818815461365	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCATCCGAACGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.28012768321	35.2843720489207	0.0139008975660721	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.03625738885	2530.03625738885
"AML-0024"	"2020-09-15-AML0024:AGCGCCATCTGTGCAA"	-1.92296634140666	-16.5926199189392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCCATCTGTGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.99412550361	28.3413263095448	0.0116200879752807	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.41331207467	2433.41331207467
"AML-0024"	"2020-09-15-AML0024:AGCGCTGAGGGACCAT"	-0.367236952215987	-16.0442877045837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGAGGGACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.57527530502	34.0709610507023	0.013264536717405	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.37695882744	2559.37695882744
"AML-0024"	"2020-09-15-AML0024:AGCGCTGAGGTCATAA"	-2.215244392783	-16.5334463349548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGAGGTCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.54581824193	35.2973454540869	0.0128235269401007	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.67532035068	2739.67532035068
"AML-0024"	"2020-09-15-AML0024:AGCGCTGGTAACCAGG"	-2.9576977294987	-15.6185198060242	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGGTAACCAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.80356598786	32.7528250301994	0.0117401903953054	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.97619244406	2784.97619244406
"AML-0024"	"2020-09-15-AML0024:AGCGCTGGTCTTGAGT"	-0.381656090647537	-15.7819872132507	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGGTCTTGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.24947906487	33.9551520925979	0.0123103991681382	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2753.91494095175	2753.91494095175
"AML-0024"	"2020-09-15-AML0024:AGCGCTGGTTGGTACT"	-2.01608143273051	-15.6933088532654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGGTTGGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.29859282892	36.3217599091562	0.0134809705226545	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.41171360855	2687.41171360855
"AML-0024"	"2020-09-15-AML0024:AGCGCTGTCTAGGCCG"	-0.556134740740615	10.7149772414002	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGTCTAGGCCG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1838.24387338112	34.9384605499443	0.019006433833875	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1836.44905715777	1836.44905715777
"AML-0024"	"2020-09-15-AML0024:AGCGCTGTCTTACCAT"	-2.63302693787273	-15.6088066331116	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGCTGTCTTACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.84212347003	37.1936872802268	0.0132984579172745	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.65760936304	2785.65760936304
"AML-0024"	"2020-09-15-AML0024:AGCGTATAGAGCAAGA"	-1.86317382279094	-16.3744325867859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGTATAGAGCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.33688494343	31.0429412273574	0.012658514178028	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.22176924454	2444.22176924454
"AML-0024"	"2020-09-15-AML0024:AGCGTATAGTCCGCGT"	-0.0157492932980836	-15.97718908703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGTATAGTCCGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2943.29211430693	39.6234868324528	0.0134623018353661	2851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2929.55866807989	2929.55866807989
"AML-0024"	"2020-09-15-AML0024:AGCGTATCAAGCTGCC"	0.880551953881425	-16.314253830072	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGTATCAAGCTGCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2451.83834644596	49.4208290928454	0.0201566425308923	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2438.87062743698	2438.87062743698
"AML-0024"	"2020-09-15-AML0024:AGCGTATGTGTCTAAC"	-1.77975581112559	-15.5800047150818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCGTATGTGTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.75746651369	33.5564648625612	0.0126735417752386	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.23965196464	2645.23965196464
"AML-0024"	"2020-09-15-AML0024:AGCTACAGTGTTATCG"	-0.857725064188796	-16.1765508881775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTACAGTGTTATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.24113930564	39.8730739717482	0.0153935760523195	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.89393834184	2583.89393834184
"AML-0024"	"2020-09-15-AML0024:AGCTACAGTTTGGGAG"	-0.652712444693405	-15.7200651398865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTACAGTTTGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.07182589728	35.6875160522145	0.0130959909801511	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.63333979716	2717.63333979716
"AML-0024"	"2020-09-15-AML0024:AGCTACATCCAACTAG"	-0.178127298981506	-16.0611486664978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTACATCCAACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.37411464431	37.7159499420427	0.0128182034209481	3266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2933.89368551828	2933.89368551828
"AML-0024"	"2020-09-15-AML0024:AGCTACATCGGAAACG"	-1.18848524513896	-16.5254621735779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTACATCGGAAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.85124939517	31.9700301184843	0.0118020618982392	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.17580324158	2701.17580324158
"AML-0024"	"2020-09-15-AML0024:AGCTCAAAGGATACCG"	-0.609248439699966	-16.2256803742615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTCAAAGGATACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.92571702158	34.8101785281531	0.0129892326145668	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.7130876443	2667.7130876443
"AML-0024"	"2020-09-15-AML0024:AGCTCAACACGACTAT"	-0.422021488577682	-15.8792391053406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTCAACACGACTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.95449997582	32.1210562545683	0.0114638036609251	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.31117787787	2794.31117787787
"AML-0024"	"2020-09-15-AML0024:AGCTCAAGTTAAACCC"	-2.66192422333415	-16.2079763642517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTCAAGTTAAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.25285720008	36.6577274570374	0.0141795520523045	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.68810293952	2579.68810293952
"AML-0024"	"2020-09-15-AML0024:AGCTTCCGTACCTATG"	-1.72355900231059	-16.8213358155456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCGTACCTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.91131179801	41.3582744137144	0.0157440695572651	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.08516540591	2619.08516540591
"AML-0024"	"2020-09-15-AML0024:AGCTTCCGTGAACGGT"	-0.977817515761215	-15.948889755365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCGTGAACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.51698453982	36.5576386315	0.0134773860734745	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.19486236566	2706.19486236566
"AML-0024"	"2020-09-15-AML0024:AGCTTCCGTGACCTGC"	-1.20765219155009	-17.1426038972107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCGTGACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.92951635612	44.3680634438794	0.0170127540509115	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.97708580931	2601.97708580931
"AML-0024"	"2020-09-15-AML0024:AGCTTCCGTGTGACCC"	-1.50204024735149	-15.6418686143127	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCGTGTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.34926185286	37.4298446146327	0.014170729011572	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.89720913841	2638.89720913841
"AML-0024"	"2020-09-15-AML0024:AGCTTCCTCCGTAGTA"	-1.05368445339854	-15.8287620774475	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCTCCGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.2885016715	34.7785319552482	0.0129274358246857	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.56202547488	2680.56202547488
"AML-0024"	"2020-09-15-AML0024:AGCTTCCTCTCTAGGA"	-2.20384726944621	-15.5108251801697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGCTTCCTCTCTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2961.71219079149	35.2488724654779	0.0119015185118504	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2954.34900518972	2954.34900518972
"AML-0024"	"2020-09-15-AML0024:AGGAAATAGACAGCGT"	-0.549786309630233	-16.5702867737976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAAATAGACAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.70696488269	36.8306544452254	0.0137084746965822	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.63489645987	2675.63489645987
"AML-0024"	"2020-09-15-AML0024:AGGAAATCACTGTGAT"	1.1188494163448	-16.2219724885193	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAAATCACTGTGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3015.69555684308	40.687607253735	0.0134919478729902	3828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3007.16564174462	3007.16564174462
"AML-0024"	"2020-09-15-AML0024:AGGAAATGTCCAGCCA"	-1.94543538513835	-16.1110296479431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAAATGTCCAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.07368679991	33.9869330735408	0.0124490900146285	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.90321500009	2725.90321500009
"AML-0024"	"2020-09-15-AML0024:AGGAAATTCTCAGTCC"	-1.14429603043254	-16.6606760255066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAAATTCTCAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.17140260762	29.3055908778656	0.0108895296856491	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.30340615578	2685.30340615578
"AML-0024"	"2020-09-15-AML0024:AGGAAATTCTGGGATT"	-1.56889603558238	-16.3172655335632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAAATTCTGGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.5010486887	34.1686100536923	0.0132205827778745	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.02692448814	2577.02692448814
"AML-0024"	"2020-09-15-AML0024:AGGAATAAGACGCATG"	-1.99109683457072	-15.9564428559509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATAAGACGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2906.8925134114	36.0776404917917	0.0124110679446667	2880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.22531062162	2892.22531062162
"AML-0024"	"2020-09-15-AML0024:AGGAATACATATGAAG"	-1.94357786598857	-16.522053741571	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATACATATGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.49537895322	31.7233040628987	0.0109788388290799	2728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.45161772461	2875.45161772461
"AML-0024"	"2020-09-15-AML0024:AGGAATAGTCTAGGCC"	0.211981748312157	-16.1673364869324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATAGTCTAGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.97223409528	39.4599624541585	0.0140328421368123	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.13121531283	2799.13121531283
"AML-0024"	"2020-09-15-AML0024:AGGAATATCCAGGACC"	-1.6963087123936	-16.5216112366882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATATCCAGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.70362935627	28.3801634069383	0.0104006030928443	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.55247634753	2719.55247634753
"AML-0024"	"2020-09-15-AML0024:AGGAATATCCGTTGAA"	-0.598468582064468	-15.8375292054382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATATCCGTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.92659421295	39.8765933595124	0.0148741832191863	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.96553286399	2674.96553286399
"AML-0024"	"2020-09-15-AML0024:AGGAATATCTCTGCTG"	-0.780221561819869	-16.0330534211365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAATATCTCTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.52086727003	30.742312155989	0.0120439023830071	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.46588623108	2547.46588623108
"AML-0024"	"2020-09-15-AML0024:AGGACGAAGGGTAGCT"	-1.33489010754283	-15.1164436570373	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGAAGGGTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2131.26808711199	25.3172326775748	0.0118789526435791	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2124.99446102006	2124.99446102006
"AML-0024"	"2020-09-15-AML0024:AGGACGACAGCACCCA"	-1.85750017586406	-16.1168050996033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGACAGCACCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.01546180997	36.3321365549114	0.0129019662880541	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.75201130953	2809.75201130953
"AML-0024"	"2020-09-15-AML0024:AGGACGACATATACCG"	8.78473820266072	8.01295659625856	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGACATATACCG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1735.33449778274	37.5229657987095	0.0216229008566666	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1732.40996830446	1732.40996830446
"AML-0024"	"2020-09-15-AML0024:AGGACGAGTCCTGTCT"	-1.8452961248463	-15.4937649003235	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGAGTCCTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.88132977523	34.6539864538122	0.0117755296835088	3296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.94135633644	2934.94135633644
"AML-0024"	"2020-09-15-AML0024:AGGACGAGTGATAGTA"	-1.64225790920909	-15.1503505936828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGAGTGATAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.77046086029	36.5743518450923	0.015108558385207	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2411.72073957863	2411.72073957863
"AML-0024"	"2020-09-15-AML0024:AGGACGAGTGCATTTG"	-0.7680620950764	-16.3832559815613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGAGTGCATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.02953009399	31.9622432112221	0.0113946191540276	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.63167691527	2796.63167691527
"AML-0024"	"2020-09-15-AML0024:AGGACGATCGTGGGTC"	-2.07622394982036	-15.8371000519958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACGATCGTGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.73603202618	37.7474349911201	0.0139302996841706	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.89717141335	2705.89717141335
"AML-0024"	"2020-09-15-AML0024:AGGACTTAGGATTCCT"	-1.48133001747783	-15.6321096650329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTAGGATTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.78279054114	39.223940577459	0.0144111207969173	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.44318838799	2716.44318838799
"AML-0024"	"2020-09-15-AML0024:AGGACTTAGTCGGGAT"	-1.16511319103892	-16.4954748383728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTAGTCGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.37209516527	45.699099541944	0.016266659592935	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.11732405438	2803.11732405438
"AML-0024"	"2020-09-15-AML0024:AGGACTTCAGGCGAAT"	-2.81115589562114	-15.5012550584045	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTCAGGCGAAT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.22441632377	37.9953754875969	0.0131598275744618	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.02736300435	2879.02736300435
"AML-0024"	"2020-09-15-AML0024:AGGACTTGTCCAAATC"	-1.02055881443675	-16.0224008790222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTGTCCAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.43560766169	38.1306186830019	0.01445198001887	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.15167712568	2631.15167712568
"AML-0024"	"2020-09-15-AML0024:AGGACTTGTGGCGTAA"	-1.16075585308726	-15.887911819574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTGTGGCGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.65692486802	37.6862373288232	0.0139132560431807	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.32314746195	2702.32314746195
"AML-0024"	"2020-09-15-AML0024:AGGACTTTCATGCAGT"	-0.608844797045547	-15.7506141892639	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGACTTTCATGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2958.35580145178	33.4708861820678	0.0113140164430669	2933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2951.55079504789	2951.55079504789
"AML-0024"	"2020-09-15-AML0024:AGGAGGTAGCTACTAC"	-1.92607877674754	-15.412078880426	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTAGCTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2328.860219423	36.5941967834965	0.0157133504528508	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2320.36063332721	2320.36063332721
"AML-0024"	"2020-09-15-AML0024:AGGAGGTAGGCTTAAA"	-0.453532974154311	-16.0945196381775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTAGGCTTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.38611055363	34.4613136416887	0.0126492032491994	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.21371429114	2716.21371429114
"AML-0024"	"2020-09-15-AML0024:AGGAGGTAGTGCTCAT"	-0.289092282683212	-15.9090643159119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTAGTGCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.5593724032	41.2939996542147	0.0147396482334024	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.02570674	2796.02570674
"AML-0024"	"2020-09-15-AML0024:AGGAGGTAGTGGTGAC"	-1.58296177807506	-15.8012619248596	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTAGTGGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.4502536088	31.759211372636	0.011021953730716	3140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.76619179038	2872.76619179038
"AML-0024"	"2020-09-15-AML0024:AGGAGGTCAGAGATGC"	0.650406082242173	-16.2993917695251	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTCAGAGATGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2645.03345845291	46.6369050900517	0.0176318771851491	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2627.86089959444	2627.86089959444
"AML-0024"	"2020-09-15-AML0024:AGGAGGTCATATCGGT"	-0.761037032038528	-15.6621837846008	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTCATATCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.22718847868	34.0782256445727	0.012328301301214	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.23008021336	2758.23008021336
"AML-0024"	"2020-09-15-AML0024:AGGAGGTGTCAGTCCG"	-1.01189980927165	-15.7885704270569	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTGTCAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.64368472241	35.6979828818175	0.0130492077901731	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.48078241659	2727.48078241659
"AML-0024"	"2020-09-15-AML0024:AGGAGGTGTTTCTATC"	-1.81579456749614	-15.9070549241272	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTGTTTCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.00735601386	32.6721685590128	0.0126244496496856	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.86201874696	2580.86201874696
"AML-0024"	"2020-09-15-AML0024:AGGAGGTTCCGTCACT"	-1.05780528011974	-16.0320310822693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGAGGTTCCGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.52185927219	39.8267298616439	0.0150714854909897	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.76240120787	2637.76240120787
"AML-0024"	"2020-09-15-AML0024:AGGATAAAGTTGCGCC"	-1.74888346615489	-16.9602022401062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAAAGTTGCGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.0971059751	35.8900218200312	0.0141740305833216	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.41630192305	2518.41630192305
"AML-0024"	"2020-09-15-AML0024:AGGATAACAATTGCGT"	-2.52213559570964	-15.5365915528503	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAACAATTGCGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.0755509106	33.6103396176492	0.0124203256654602	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.88856765897	2699.88856765897
"AML-0024"	"2020-09-15-AML0024:AGGATAACACTCAAGT"	-1.36684904518779	-16.8497553101745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAACACTCAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.8957083526	39.5651769347738	0.0149817263929194	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.86519348659	2630.86519348659
"AML-0024"	"2020-09-15-AML0024:AGGATAAGTGCCGGTT"	-0.276639561087447	-16.1212740174499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAAGTGCCGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.58415892263	35.7390542471165	0.013278074225783	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.40310923351	2686.40310923351
"AML-0024"	"2020-09-15-AML0024:AGGATAAGTTAGAGTA"	-1.21816037121471	-16.5339918366638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAAGTTAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.92266398671	33.3788921318472	0.012085382609398	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.05826158533	2753.05826158533
"AML-0024"	"2020-09-15-AML0024:AGGATAATCACTGATG"	-1.18592153015788	-15.1421566239563	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAATCACTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2269.24027386312	31.9661627497349	0.0140867245826358	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2263.64342726197	2263.64342726197
"AML-0024"	"2020-09-15-AML0024:AGGATAATCCAACACA"	-2.01767716828044	-15.3455572358337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAATCCAACACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1940.11313216318	34.2131005250382	0.0176345904565325	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1938.57385727555	1938.57385727555
"AML-0024"	"2020-09-15-AML0024:AGGATAATCTCTAAGG"	-3.02969942513164	13.6689071425232	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATAATCTCTAAGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2116.72037975422	34.9914234419168	0.01653096165965	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2113.26704161398	2113.26704161398
"AML-0024"	"2020-09-15-AML0024:AGGATCTAGGTTCTTG"	-0.380456785590011	-16.5643358460632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATCTAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.70162113467	34.4667285699958	0.0128238671655245	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.88159816363	2679.88159816363
"AML-0024"	"2020-09-15-AML0024:AGGATCTAGTTGTCGT"	-0.888909737498123	-15.7850170365539	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATCTAGTTGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.96117168866	39.197665221887	0.0144111120518502	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.85735025768	2713.85735025768
"AML-0024"	"2020-09-15-AML0024:AGGATCTCAATCAAGA"	-1.03428051891978	-15.9460668793884	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATCTCAATCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.47666596755	38.191917020434	0.0141165205750446	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.11857019288	2700.11857019288
"AML-0024"	"2020-09-15-AML0024:AGGATCTCAGCGTTGC"	-1.8516984981602	-16.1881666413513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATCTCAGCGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.74016733819	32.5631392841458	0.0124727614381273	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.93202958506	2604.93202958506
"AML-0024"	"2020-09-15-AML0024:AGGATCTGTGAGAACC"	-1.23768327656444	-16.0051965943542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGATCTGTGAGAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2131.73344288601	41.5934756922019	0.0195115744095524	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2122.6829948654	2122.6829948654
"AML-0024"	"2020-09-15-AML0024:AGGCATTAGTAGTCAA"	-0.690606216818649	-16.635766052362	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTAGTAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3046.17780129585	42.2263901141603	0.0138620897625205	3358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3032.51793139316	3032.51793139316
"AML-0024"	"2020-09-15-AML0024:AGGCATTCACAACGAG"	-0.237471888691741	-16.2520647278992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTCACAACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2767.20594970388	37.1613917933114	0.0134292107160611	2749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.61080365625	2757.61080365625
"AML-0024"	"2020-09-15-AML0024:AGGCATTCAGATACCT"	-0.734781722456771	-15.6370525590149	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTCAGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.77631587328	39.1093604857905	0.0151014434127307	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.85818108471	2580.85818108471
"AML-0024"	"2020-09-15-AML0024:AGGCATTCAGGATCTT"	-1.85483000698741	-16.1673193207947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTCAGGATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.10045474058	38.9336679839439	0.0160016689438723	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2426.18616935166	2426.18616935166
"AML-0024"	"2020-09-15-AML0024:AGGCATTGTATCGAAA"	-0.159974764019805	-16.0972261658874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTGTATCGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.71887344511	33.9933569011691	0.0129167888121232	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.59945931509	2624.59945931509
"AML-0024"	"2020-09-15-AML0024:AGGCATTGTTAAGTCC"	0.686646063893479	-16.1964025727478	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCATTGTTAAGTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2718.08799799845	36.8565162157885	0.0135597214817655	3137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2707.00598687709	2707.00598687709
"AML-0024"	"2020-09-15-AML0024:AGGCCACAGAGGACTC"	0.278406177728814	-16.3549509278503	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACAGAGGACTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3050.78440538619	37.684912596394	0.0123525321979032	3208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3044.00231962557	3044.00231962557
"AML-0024"	"2020-09-15-AML0024:AGGCCACAGGTAGTCG"	-0.489700297743636	-16.1550779572693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACAGGTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.5127611191	34.648656221143	0.0132829161266123	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.10737415131	2600.10737415131
"AML-0024"	"2020-09-15-AML0024:AGGCCACAGTAGGGTC"	-1.30418858948405	-16.6072321168152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACAGTAGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.23152011031	37.962966577053	0.0144939331577127	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.84485908063	2610.84485908063
"AML-0024"	"2020-09-15-AML0024:AGGCCACCACTGCGAC"	-1.40986512127574	-16.4091825715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACCACTGCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.88059128213	29.3986683952971	0.0106290446839823	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.32855147654	2760.32855147654
"AML-0024"	"2020-09-15-AML0024:AGGCCACCAGACAAAT"	-0.48203549805339	-15.9162464371887	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACCAGACAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.90355065388	34.733554305655	0.0121876244891466	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.79070438897	2842.79070438897
"AML-0024"	"2020-09-15-AML0024:AGGCCACTCAAGGTGG"	-1.19517038288768	-15.481903099176	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACTCAAGGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.30435176952	37.6209714483745	0.015216966075171	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2466.08609793516	2466.08609793516
"AML-0024"	"2020-09-15-AML0024:AGGCCACTCATTTCGT"	-2.40195069733318	-15.7330208054748	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCCACTCATTTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.86694013108	32.0452888598391	0.0112287256316047	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.30293188588	2847.30293188588
"AML-0024"	"2020-09-15-AML0024:AGGCTGCCACCCTCTA"	-2.18363485756572	-16.0208368531433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCTGCCACCCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.80344583448	36.2828533729904	0.0140915041230385	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.89253529703	2570.89253529703
"AML-0024"	"2020-09-15-AML0024:AGGCTGCCAGTTCTAG"	-1.23825798454936	-16.5399027100769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCTGCCAGTTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.38226689953	34.4878551473548	0.0132371573974042	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.7823652924	2598.7823652924
"AML-0024"	"2020-09-15-AML0024:AGGCTGCGTAGCGATG"	-1.90405724468883	-16.6253080598083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCTGCGTAGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.39065952233	41.5811839897308	0.0154153362409486	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.93893243794	2686.93893243794
"AML-0024"	"2020-09-15-AML0024:AGGCTGCGTTGTCAGT"	-0.190549204975921	-16.1592283478943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGCTGCGTTGTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.22837342244	36.0276105500357	0.0137027315368345	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.026393885	2620.026393885
"AML-0024"	"2020-09-15-AML0024:AGGGAGTAGCCTCAAT"	-1.89164302769359	-16.3802900544372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTAGCCTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.77677453737	34.3172069301579	0.0133801924872577	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.58978834354	2556.58978834354
"AML-0024"	"2020-09-15-AML0024:AGGGAGTAGGATATAC"	-2.41275463524516	-16.2877702943054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTAGGATATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.61288044576	36.6927203549488	0.0138640299932224	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.00061188828	2638.00061188828
"AML-0024"	"2020-09-15-AML0024:AGGGAGTAGGCGAAGG"	-1.17607365074809	-16.3508711091247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTAGGCGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.70369764193	46.0169326641516	0.0158585911792259	2962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.3905192162	2890.3905192162
"AML-0024"	"2020-09-15-AML0024:AGGGAGTCACCGTGAC"	-0.384071747690994	-15.945773147699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTCACCGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.53903377661	38.3304502309373	0.0145547302467622	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.0086789896	2629.0086789896
"AML-0024"	"2020-09-15-AML0024:AGGGAGTCACTTGTGA"	-0.514924506575424	-16.3338861695495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTCACTTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.58827420004	32.5642798354157	0.0114719982927404	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.70461791938	2829.70461791938
"AML-0024"	"2020-09-15-AML0024:AGGGAGTGTAGGTTTC"	-1.95243535462077	-16.7492265931335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTGTAGGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2486.96129072032	45.1550589964681	0.0181567196743096	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2478.02620237132	2478.02620237132
"AML-0024"	"2020-09-15-AML0024:AGGGAGTGTGCGGATA"	-1.4213070673054	-16.465168975946	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGAGTGTGCGGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2907.38200918393	36.9651704019897	0.0127142461104949	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2899.26168327689	2899.26168327689
"AML-0024"	"2020-09-15-AML0024:AGGGCCTGTCCTATAG"	-1.42742751064952	-15.973074936029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCCTGTCCTATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.5425398985	37.3179881706282	0.0133826139055374	2884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.66809241622	2780.66809241622
"AML-0024"	"2020-09-15-AML0024:AGGGCCTTCCATTTCA"	0.152363834052724	-16.4498033753601	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCCTTCCATTTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2704.6126116967	38.8536663386523	0.0143657047854547	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2695.8062346294	2695.8062346294
"AML-0024"	"2020-09-15-AML0024:AGGGCCTTCTCAGTCC"	-1.11548374119456	-15.5695238343445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCCTTCTCAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.22205568978	35.3847335618915	0.0125914368546959	2489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.6606337253	2806.6606337253
"AML-0024"	"2020-09-15-AML0024:AGGGCTCCAATCACGT"	-1.0547675890034	-16.3699617615906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCTCCAATCACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.7255239444	38.8415347364972	0.0147253891217666	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.12942676918	2632.12942676918
"AML-0024"	"2020-09-15-AML0024:AGGGCTCCAGACAAGC"	-2.27259025993999	-16.5228891602722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCTCCAGACAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2279.27354147858	39.2492080495652	0.017220051624038	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2277.93099228828	2277.93099228828
"AML-0024"	"2020-09-15-AML0024:AGGGCTCGTCAACGCC"	-0.954872469336349	-16.820679687616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCTCGTCAACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.86193837311	39.4346970725202	0.0147316888133899	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.93197296185	2669.93197296185
"AML-0024"	"2020-09-15-AML0024:AGGGCTCTCCCTTGGT"	-1.08376393738444	-17.3786077729431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCTCTCCCTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3000.03772047332	37.0890381162522	0.0123628572611416	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.05379760895	2988.05379760895
"AML-0024"	"2020-09-15-AML0024:AGGGCTCTCTTAAGGC"	8.53468193587605	8.23818490588991	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGCTCTCTTAAGGC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1903.34865457604	34.9728930620716	0.0183744018616818	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1900.32837981945	1900.32837981945
"AML-0024"	"2020-09-15-AML0024:AGGGTCCAGCATGAAT"	-0.865282515913802	-16.3587408295837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTCCAGCATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.86863570072	32.0077888773772	0.0113508084994262	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.53662983131	2813.53662983131
"AML-0024"	"2020-09-15-AML0024:AGGGTCCGTAATTAGG"	-1.28290710869487	-16.0266943207947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTCCGTAATTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.11715167416	35.8687356581996	0.0142386135691871	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.70239888913	2515.70239888913
"AML-0024"	"2020-09-15-AML0024:AGGGTCCGTCCCTGAG"	-2.70806417885478	-15.6600370637146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTCCGTCCCTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.29637501371	37.5761886580238	0.0142859143231826	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.65649969924	2624.65649969924
"AML-0024"	"2020-09-15-AML0024:AGGGTCCTCTGCTGAA"	-2.3287287754124	-16.4920435181824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTCCTCTGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.62996506252	40.997162595776	0.0143767470176928	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.83519616243	2842.83519616243
"AML-0024"	"2020-09-15-AML0024:AGGGTGAAGCAGATAT"	-1.55203793469127	-16.741930984613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTGAAGCAGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.21417476452	36.6991353562307	0.0122403314830279	3171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.03276832761	2988.03276832761
"AML-0024"	"2020-09-15-AML0024:AGGGTGACAGGGACTA"	-0.0278814015096009	-16.2583322755066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTGACAGGGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.00175934627	38.9830320848898	0.0130771583621738	2908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2969.5822491754	2969.5822491754
"AML-0024"	"2020-09-15-AML0024:AGGGTGACATCTTCGC"	-1.37605069103892	-15.0979128113953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTGACATCTTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.72836120669	29.211700155059	0.010584991104808	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.03077008659	2756.03077008659
"AML-0024"	"2020-09-15-AML0024:AGGGTGAGTGATTAGA"	-0.749205092818099	-16.0003786317078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTGAGTGATTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.76329817681	32.130359785351	0.0119454227839044	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.90190516572	2685.90190516572
"AML-0024"	"2020-09-15-AML0024:AGGGTTTCACGACGAA"	-2.83750305596049	-15.9347887269226	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTTTCACGACGAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.39337210534	37.3894240326933	0.015486053128157	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2411.03515625983	2411.03515625983
"AML-0024"	"2020-09-15-AML0024:AGGGTTTCAGGCAATG"	-1.65315125408824	-15.6637230149475	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTTTCAGGCAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.89314965745	42.6391273259892	0.0162503291460461	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.15205843669	2620.15205843669
"AML-0024"	"2020-09-15-AML0024:AGGGTTTCAGTGCGCT"	-1.61693296852763	-16.6271944276062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTTTCAGTGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.71099361354	48.1860453507686	0.018869028434022	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.55253659426	2535.55253659426
"AML-0024"	"2020-09-15-AML0024:AGGGTTTTCATCTACT"	-2.08131561699565	-15.6349239579407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGGTTTTCATCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.4594787043	32.2349298320801	0.0125064739517398	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.88634572942	2568.88634572942
"AML-0024"	"2020-09-15-AML0024:AGGTAGGAGATGGTAT"	-1.91370258751567	-15.7620926133362	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGAGATGGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.29149034798	32.6317245943765	0.0123872869475298	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.3266025893	2627.3266025893
"AML-0024"	"2020-09-15-AML0024:AGGTAGGAGTGACCTT"	-2.24294052544292	-15.6813650361267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGAGTGACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2920.07444491441	35.051203766277	0.0120035308782357	2723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2915.47701841071	2915.47701841071
"AML-0024"	"2020-09-15-AML0024:AGGTAGGCACGCACCA"	-2.05683288994487	-16.1748781434265	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGCACGCACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2316.11480526211	38.1698274497307	0.0164801102963509	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2310.69884261508	2310.69884261508
"AML-0024"	"2020-09-15-AML0024:AGGTAGGGTACATACC"	-1.48405883732494	-16.8769865266052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGGTACATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.21391496358	39.3100565333823	0.01432470563575	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.83525060949	2732.83525060949
"AML-0024"	"2020-09-15-AML0024:AGGTAGGTCAAGTCGT"	-2.39245424690898	-15.4045868149963	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGTCAAGTCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.63142802019	36.9068950991702	0.0134714818649315	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.59808114249	2733.59808114249
"AML-0024"	"2020-09-15-AML0024:AGGTAGGTCCTATTTG"	0.0449275230871558	-16.3254995576111	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTAGGTCCTATTTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2752.77200098774	40.2652434872962	0.0146271625375615	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2746.46866764323	2746.46866764323
"AML-0024"	"2020-09-15-AML0024:AGGTCATAGCCACAAG"	-2.98497591438945	-15.91118051922	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATAGCCACAAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.22869266832	41.3205229255521	0.0157158344729675	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.75744844285	2625.75744844285
"AML-0024"	"2020-09-15-AML0024:AGGTCATAGTAGCCAG"	-0.145114834338981	-16.2017507783142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATAGTAGCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.62127000157	36.5113541831116	0.0143540843181773	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.96734669583	2538.96734669583
"AML-0024"	"2020-09-15-AML0024:AGGTCATCAGAGGTTG"	-1.1967775625294	-16.4781179658142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATCAGAGGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2835.4543691591	34.0391894635656	0.0120048447380447	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.67177472285	2827.67177472285
"AML-0024"	"2020-09-15-AML0024:AGGTCATCATGGCGCT"	-1.72182736817058	-16.4719057313171	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATCATGGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.91495118409	35.4109201912382	0.0122447999989555	3223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.90787055428	2884.90787055428
"AML-0024"	"2020-09-15-AML0024:AGGTCATGTCAACCTA"	-1.56996105137523	-15.5642891160217	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.AGGTCATGTCAACCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.96580874991	36.3271480070228	0.0135753408687958	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.78746895481	2666.78746895481
"AML-0024"	"2020-09-15-AML0024:TGATCTTAGTTAGTGA"	-0.901432136923629	-16.0036058655945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCTTAGTTAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.38570022534	39.2535315303797	0.0147216254299077	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.91173966491	2659.91173966491
"AML-0024"	"2020-09-15-AML0024:TGATCTTGTCGATGCC"	-2.38187251511272	-15.6309032670227	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCTTGTCGATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.82948732714	40.0338277374672	0.0151595655568003	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.99904582815	2633.99904582815
"AML-0024"	"2020-09-15-AML0024:TGATCTTTCTCTGACC"	-2.30151234093364	-16.5777483216492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCTTTCTCTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.91519668482	43.4250617098769	0.0165686634061281	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.96753874746	2607.96753874746
"AML-0024"	"2020-09-15-AML0024:TGATGCACAAGCTACT"	-2.36598310890849	-16.3435774079529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGCACAAGCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1394.49373905174	53.9973933591384	0.0387218614519251	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1392.47877847001	1392.47877847001
"AML-0024"	"2020-09-15-AML0024:TGATGCACACGCGTCA"	-1.09499810162242	-16.3500681153503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGCACACGCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.8513946542	39.8299295908688	0.0172360410898811	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2304.73867057794	2304.73867057794
"AML-0024"	"2020-09-15-AML0024:TGATGCAGTAAGGAGA"	-1.71173069897349	-16.3431120148865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGCAGTAAGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.83369724803	39.5386160344497	0.015243311888653	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.12308187179	2586.12308187179
"AML-0024"	"2020-09-15-AML0024:TGATGCAGTCGCCTAG"	-1.39593420448955	-16.038655304071	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGCAGTCGCCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.24401090979	33.9109775770805	0.0134500974242647	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.3462031734	2510.3462031734
"AML-0024"	"2020-09-15-AML0024:TGATGCATCGGAGTGA"	-2.90289745751079	-15.7755794755188	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGCATCGGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.84898321026	34.9432080414557	0.0127304665047866	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.03838015272	2739.03838015272
"AML-0024"	"2020-09-15-AML0024:TGATGGTAGAACTGAT"	-2.61898742142375	-15.8498697510925	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGGTAGAACTGAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.75895841732	37.044369780735	0.0137672568792725	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.18484666773	2682.18484666773
"AML-0024"	"2020-09-15-AML0024:TGATGGTCACAAGCAG"	-1.79165945473369	-15.9697485200134	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGGTCACAAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.99608757951	39.9575839581372	0.015380155554955	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.19792270496	2593.19792270496
"AML-0024"	"2020-09-15-AML0024:TGATGGTCACGCGTGT"	-1.33306119862254	-16.1020860902038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGGTCACGCGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.7071301489	35.2927101043558	0.0129576009526496	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.43029706016	2714.43029706016
"AML-0024"	"2020-09-15-AML0024:TGATGGTGTTAAACAG"	-0.333011339337188	-15.7657947770325	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGGTGTTAAACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.93892806988	35.2348669842682	0.0124860487354232	2707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.66267984014	2809.66267984014
"AML-0024"	"2020-09-15-AML0024:TGATGGTGTTCCTACC"	-2.0100568336552	13.6986942061218	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATGGTGTTCCTACC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2213.26597535127	42.6774021729103	0.0192825456353645	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2213.26597535127	2213.26597535127
"AML-0024"	"2020-09-15-AML0024:TGATTCTAGAGAGCGG"	-0.950245718390304	-15.9229803315369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTAGAGAGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.17558552464	41.6432069757059	0.0161459371783077	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.52444928716	2571.52444928716
"AML-0024"	"2020-09-15-AML0024:TGATTCTAGCTTAGTC"	-0.988074044615585	-16.4227037659851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTAGCTTAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.41093427824	33.85188465607	0.0131289718818796	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.95335836613	2573.95335836613
"AML-0024"	"2020-09-15-AML0024:TGATTCTAGGCTCACC"	-1.58656845513042	-16.9818525544372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTAGGCTCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1690.03661394793	45.786688873723	0.0270921283573645	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1680.52618285551	1680.52618285551
"AML-0024"	"2020-09-15-AML0024:TGATTCTCACTACGGC"	-2.19952187958415	-16.2866907349792	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTCACTACGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.16128877755	49.5262178233406	0.0176239769657083	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.43269988003	2791.43269988003
"AML-0024"	"2020-09-15-AML0024:TGATTCTCATGTTCAG"	-1.54676530781444	-16.026921295282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTCATGTTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.05058362517	36.9036457903918	0.0137032872738377	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.80449745325	2685.80449745325
"AML-0024"	"2020-09-15-AML0024:TGATTCTGTTTGGGTT"	-0.725163797766525	-15.9103851548401	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTGTTTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.09051882759	32.6420586732013	0.0124157226384725	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.79031476926	2622.79031476926
"AML-0024"	"2020-09-15-AML0024:TGATTCTTCCGTCCTA"	-2.48232016983684	-15.8135738602844	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTCTTCCGTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.63883940142	39.9510382661555	0.0146952356036199	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.64592783404	2710.64592783404
"AML-0024"	"2020-09-15-AML0024:TGATTTCAGAGGCCAT"	-1.34055004540141	-16.0145025483337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCAGAGGCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.61775156066	33.0948199221906	0.0127208618185118	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.27351756143	2594.27351756143
"AML-0024"	"2020-09-15-AML0024:TGATTTCAGAGGTCGT"	-2.05414972725566	-16.6762666932312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCAGAGGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.29691881756	36.9158694848692	0.0133159869111763	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.54625270502	2763.54625270502
"AML-0024"	"2020-09-15-AML0024:TGATTTCAGCAGGCAT"	-0.652922908694106	-16.3601064912048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCAGCAGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.74569539903	34.3516170368531	0.0134778519092212	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.24117283948	2544.24117283948
"AML-0024"	"2020-09-15-AML0024:TGATTTCAGTTGGGAC"	-1.97813806954082	-15.5829963914123	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCAGTTGGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.47035260094	35.8012859408198	0.0134618105089257	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.81969747527	2650.81969747527
"AML-0024"	"2020-09-15-AML0024:TGATTTCCAAGCGGAT"	-0.538809816271621	-16.1148290864197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCCAAGCGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.34914353932	39.4145979748962	0.0142995665361484	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.05403447339	2750.05403447339
"AML-0024"	"2020-09-15-AML0024:TGATTTCGTTCAGCGC"	-2.43372331085857	-16.3501577607361	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCGTTCAGCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.73842122486	35.9250253688004	0.0136196315296944	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.09205704232	2630.09205704232
"AML-0024"	"2020-09-15-AML0024:TGATTTCTCGATACTG"	-2.21834288063701	-16.3340215913025	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATTTCTCGATACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.86317052949	38.1456768642896	0.0141918224419047	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.8562550484	2678.8562550484
"AML-0024"	"2020-09-15-AML0024:TGCACGGGTATGTCTG"	-0.753367761999923	-15.7985010377136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCACGGGTATGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.81887864284	41.0147897370302	0.0190251556581833	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2148.60957991447	2148.60957991447
"AML-0024"	"2020-09-15-AML0024:TGCACGGGTCCCTGTT"	-2.62775955620463	-16.3197622529236	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCACGGGTCCCTGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2312.94891124012	36.6404646423618	0.0158414500485947	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2306.20672630717	2306.20672630717
"AML-0024"	"2020-09-15-AML0024:TGCACGGGTCTTGAAC"	-1.50068304958995	-15.8776331177917	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCACGGGTCTTGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.22382995125	36.3103404707582	0.0141108363944563	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.98388115824	2567.98388115824
"AML-0024"	"2020-09-15-AML0024:TGCACGGTCATCGACA"	-1.59458265724834	-16.5516844025818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCACGGTCATCGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.01019737302	48.3907853265436	0.0217877366721592	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2208.86961300688	2208.86961300688
"AML-0024"	"2020-09-15-AML0024:CCTCAGTAGGTAAGTT"	-0.409914682537872	-16.3463697663513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTAGGTAAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.54704476588	33.5897354141855	0.011930092049653	2663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.01625876915	2811.01625876915
"AML-0024"	"2020-09-15-AML0024:CCTCAGTAGTCGGCCT"	0.684228797524613	-16.31800939953	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTAGTCGGCCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2514.48380107918	48.9728891365174	0.01947631920138	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2504.11264189892	2504.11264189892
"AML-0024"	"2020-09-15-AML0024:CCTCAGTAGTGGCCTC"	-2.13876138153728	-16.3707018128601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTAGTGGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.50111853601	32.4823147323469	0.0121999252906258	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.53201866916	2657.53201866916
"AML-0024"	"2020-09-15-AML0024:CCTCAGTCACCGTGGT"	-1.24501655522044	-15.9131832352844	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTCACCGTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.44519673086	42.4438589250717	0.0164930106065556	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.17719480207	2566.17719480207
"AML-0024"	"2020-09-15-AML0024:CCTCAGTGTCTTGGTA"	-1.76936028423961	-15.7141008607117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTGTCTTGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.47180841428	34.0409484872605	0.0137014830967179	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2480.5853554749	2480.5853554749
"AML-0024"	"2020-09-15-AML0024:CCTCAGTGTGCGACAA"	-2.1552816433018	-16.6892137757507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTGTGCGACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.54265717756	44.6988623700407	0.020452065862565	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2180.53048257336	2180.53048257336
"AML-0024"	"2020-09-15-AML0024:CCTCAGTTCAGCAATC"	-0.161383817822295	-16.2323427430359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTTCAGCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.43187596017	40.7892294791922	0.0144160493227462	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.98053598236	2816.98053598236
"AML-0024"	"2020-09-15-AML0024:CCTCAGTTCTCGCCTA"	-1.82454452934917	-16.5195379487244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTTCTCGCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.53419286196	33.9549650541005	0.0129424518828397	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.3944552132	2617.3944552132
"AML-0024"	"2020-09-15-AML0024:CCTCAGTTCTCTCCGA"	-1.90586290779765	-16.8076753846374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTTCTCTCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2108.56095055276	34.3388327498853	0.0162854352115757	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2104.07814489862	2104.07814489862
"AML-0024"	"2020-09-15-AML0024:CCTCAGTTCTGGCCTT"	-0.237444500357467	-16.1253137818542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCAGTTCTGGCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2892.60693999506	40.2177297200303	0.0139036276114649	3368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.08680535297	2884.08680535297
"AML-0024"	"2020-09-15-AML0024:CCTCATGAGCGTTAGG"	0.741775889962357	-16.1797361603943	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGAGCGTTAGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3042.90474292938	46.9999101628319	0.0154457382446963	2814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3023.53296657305	3023.53296657305
"AML-0024"	"2020-09-15-AML0024:CCTCATGAGGAGAGTA"	-0.827480356127578	-15.6567144623962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.35154337445	36.9276757126348	0.0132530569591779	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.21074910077	2777.21074910077
"AML-0024"	"2020-09-15-AML0024:CCTCATGAGTTGAAGT"	-2.13446650925334	-15.7601900330749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGAGTTGAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.71504177083	32.067605162029	0.0136358379278309	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2343.96744950664	2343.96744950664
"AML-0024"	"2020-09-15-AML0024:CCTCATGCAAGATTGA"	-0.653563479811508	-16.5170507661072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGCAAGATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.87229624461	32.639848135655	0.0115177554679894	2764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.34896580186	2821.34896580186
"AML-0024"	"2020-09-15-AML0024:CCTCATGCAGCTAACT"	-1.97198758545573	-16.8015756837097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGCAGCTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.02065011035	37.3519840712407	0.01471697405993	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.55290754767	2527.55290754767
"AML-0024"	"2020-09-15-AML0024:CCTCATGCAGCTGTGC"	-1.69343636456187	-16.1859274140564	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGCAGCTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3032.67683536255	45.4965185248371	0.0150020991337833	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3020.76266955032	3020.76266955032
"AML-0024"	"2020-09-15-AML0024:CCTCATGGTAGACGTG"	-0.830515424639541	-16.2003259888855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCATGGTAGACGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.09696090384	47.9061323414721	0.0200856120848512	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.89315023943	2382.89315023943
"AML-0024"	"2020-09-15-AML0024:CCTCCAAAGACGCTCC"	-2.34665499153789	-15.7462520829407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAAAGACGCTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2147.53993813076	31.1796073090332	0.0145187555096983	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2144.60256704511	2144.60256704511
"AML-0024"	"2020-09-15-AML0024:CCTCCAAAGCAATAGT"	0.0887758965486705	-16.4618463746277	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAAAGCAATAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2664.07915216568	33.7208816177456	0.0126576125151286	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2649.59664974293	2649.59664974293
"AML-0024"	"2020-09-15-AML0024:CCTCCAAAGCGTGTCC"	-1.80383620682414	-16.5341787568298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAAAGCGTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.56650354417	41.1396283537762	0.0151384072110556	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.40990855638	2707.40990855638
"AML-0024"	"2020-09-15-AML0024:CCTCCAACAAGGAGTC"	0.0439481782609641	-16.074881576654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAACAAGGAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.80356854336	33.3332377538356	0.0119225964688222	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2789.89419986486	2789.89419986486
"AML-0024"	"2020-09-15-AML0024:CCTCCAAGTAGCGCCT"	-1.37731299820598	-16.7760267487732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAAGTAGCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.67059993286	37.6959292021893	0.0138452037507287	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.72267317664	2711.72267317664
"AML-0024"	"2020-09-15-AML0024:CCTCCAAGTTGCCAAT"	-1.25198219242747	-16.3154478303161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAAGTTGCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.60592249267	31.0449677408737	0.0119009803179503	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.56214564519	2603.56214564519
"AML-0024"	"2020-09-15-AML0024:CCTCCAATCCGGGACT"	-0.515753428370315	-15.9941911927429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCAATCCGGGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2955.13038061771	34.6691779822213	0.0117318607021916	2918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2944.4198434893	2944.4198434893
"AML-0024"	"2020-09-15-AML0024:CCTCCTCAGAGCTGCA"	-2.0970016521519	11.1668977507385	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCAGAGCTGCA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1998.12498728569	31.8403213792228	0.0159350999471137	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1994.7033392806	1994.7033392806
"AML-0024"	"2020-09-15-AML0024:CCTCCTCAGCCTATTG"	-1.26983414116557	-15.6382999650207	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCAGCCTATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.59965954734	30.8724654385281	0.0110117239219214	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.12788319779	2795.12788319779
"AML-0024"	"2020-09-15-AML0024:CCTCCTCAGGTCCGAA"	-1.20561979237254	-16.287865661737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCAGGTCCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.60538422538	27.9349691999964	0.0105790018330176	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.27345316887	2633.27345316887
"AML-0024"	"2020-09-15-AML0024:CCTCCTCAGTGCTCGC"	-1.37415049496349	-15.6711645356384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCAGTGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.46037698038	39.931964070776	0.0160146776100506	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.05288954444	2486.05288954444
"AML-0024"	"2020-09-15-AML0024:CCTCCTCCACCAAATC"	-1.22584925118144	-16.6375913850036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCCACCAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.70838516574	42.4264968870559	0.016060249922095	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.07281902709	2633.07281902709
"AML-0024"	"2020-09-15-AML0024:CCTCCTCCACTGGCGT"	-1.64760396900828	-15.8106899491516	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCCACTGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.09241528638	31.1218357186649	0.0106178282050599	2693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.64070394392	2922.64070394392
"AML-0024"	"2020-09-15-AML0024:CCTCCTCCATGAGGGT"	-0.207068691880065	-15.9297561875549	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCCATGAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.67360153812	28.0545859876414	0.010270109127183	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.57806389448	2726.57806389448
"AML-0024"	"2020-09-15-AML0024:CCTCCTCGTACGGGAT"	-1.8503089946812	-15.624442123529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCGTACGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.68390405725	39.2380988213594	0.0157097936843092	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.7886916122	2495.7886916122
"AML-0024"	"2020-09-15-AML0024:CCTCCTCTCATGCATG"	-2.01061735573466	-16.5837354890076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCTCATGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2271.77147504679	47.8124812486561	0.0210463428094902	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.06855168035	2257.06855168035
"AML-0024"	"2020-09-15-AML0024:CCTCCTCTCTACCAGA"	-0.457150201231796	-16.5216207734314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCCTCTCTACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.64358176784	27.8926307106524	0.0105388692692884	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.28310947446	2640.28310947446
"AML-0024"	"2020-09-15-AML0024:CCTCTAGAGAGACAAG"	-1.01636467400249	-16.1937647095886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGAGAGACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2537.44273999994	36.649168796402	0.0144433481073953	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.44868169492	2529.44868169492
"AML-0024"	"2020-09-15-AML0024:CCTCTAGAGGACAACC"	-0.666528980166274	-16.4533186188904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGAGGACAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.48754600572	36.6865612668328	0.0135400368681951	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.60201886784	2697.60201886784
"AML-0024"	"2020-09-15-AML0024:CCTCTAGAGGCTGAAC"	-2.74544463577922	-16.2000227204529	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGAGGCTGAAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.81629963371	40.1892871499882	0.0170596014452557	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.3677291342	2351.3677291342
"AML-0024"	"2020-09-15-AML0024:CCTCTAGCAACAGTGG"	-1.03214905682262	-15.9109640351501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGCAACAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.40390128585	41.1823191053116	0.0151606022527862	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.37394780653	2709.37394780653
"AML-0024"	"2020-09-15-AML0024:CCTCTAGCAGCGCGTT"	-3.72284565392192	12.0014352568421	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGCAGCGCGTT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1779.45293036696	39.4290827990879	0.0221579802006659	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1777.51398547879	1777.51398547879
"AML-0024"	"2020-09-15-AML0024:CCTCTAGCAGGCAATG"	-1.01094291630443	-17.457543396112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGCAGGCAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3013.0914819094	37.8853280031231	0.0125735737632218	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.79859756436	3000.79859756436
"AML-0024"	"2020-09-15-AML0024:CCTCTAGCATATCTGG"	-2.86505399170573	-15.8956976166931	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGCATATCTGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.87912751829	39.6843440698392	0.0155938031165113	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.34391512311	2539.34391512311
"AML-0024"	"2020-09-15-AML0024:CCTCTAGGTGACTCGC"	-1.08338485184367	-16.1228552094665	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGGTGACTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.64088510029	34.5468118371085	0.0131075565083268	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.67459241161	2630.67459241161
"AML-0024"	"2020-09-15-AML0024:CCTCTAGGTGGTATGG"	-1.02406309071239	14.2222947844299	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGGTGGTATGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1966.20439272154	45.4511909504713	0.0231162086295411	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1962.72455189654	1962.72455189654
"AML-0024"	"2020-09-15-AML0024:CCTCTAGTCCATGCAA"	-1.3938789171284	-16.7135553590027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTAGTCCATGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.71664365106	23.4334163338549	0.00859715788449169	2647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.16148447938	2714.16148447938
"AML-0024"	"2020-09-15-AML0024:CCTCTCCCAACTCCCT"	-1.41894886913951	-16.1291761628357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTCCCAACTCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2952.87815525725	31.3267593430981	0.0106088899358494	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2944.7898948906	2944.7898948906
"AML-0024"	"2020-09-15-AML0024:CCTCTCCCACCAGCCA"	-0.0402116504615128	-16.4721441498962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTCTCCCACCAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2990.02262083065	31.3775403152896	0.0104940812476438	3252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2981.74512993984	2981.74512993984
"AML-0024"	"2020-09-15-AML0024:CCTGCATAGCGCCTAC"	-1.54106877270396	-15.6436271897522	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATAGCGCCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.79162996686	36.2648701114362	0.0132363606468405	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.57539083089	2737.57539083089
"AML-0024"	"2020-09-15-AML0024:CCTGCATAGTAGTCAA"	-2.56312952461894	-16.3071642152038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATAGTAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.58560303632	45.0322071506481	0.0187510314409422	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2390.69851421875	2390.69851421875
"AML-0024"	"2020-09-15-AML0024:CCTGCATCACTCTCGT"	-2.45504699173625	-15.7978496781555	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATCACTCTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.03557372735	31.6849258056407	0.0121350034922769	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.75534086468	2605.75534086468
"AML-0024"	"2020-09-15-AML0024:CCTGCATCAGGTGAGT"	-0.516287605196792	-16.1754007569519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATCAGGTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.58405117659	39.4976940442599	0.0167676861390411	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.9872045043	2351.9872045043
"AML-0024"	"2020-09-15-AML0024:CCTGCATCATCCTGTC"	-2.00707135620769	-15.9856806031433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATCATCCTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.43455053507	36.8731902414967	0.0140072581230944	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.612998267	2623.612998267
"AML-0024"	"2020-09-15-AML0024:CCTGCATTCCCTTCCC"	-1.46262894097026	-15.987837814447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGCATTCCCTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.36354410329	33.0431216200496	0.0112186903671715	3319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.0892493195	2935.0892493195
"AML-0024"	"2020-09-15-AML0024:CCTGTTGAGAAGTCCG"	-1.06544182720836	-16.142170929071	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGTTGAGAAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.71729503729	32.6561233459007	0.0117946759694225	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.61563638961	2761.61563638961
"AML-0024"	"2020-09-15-AML0024:CCTGTTGAGAGGGTGG"	-0.868833403021652	-16.7390642396179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGTTGAGAGGGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.90520445033	38.743893831627	0.0146595851286633	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.41778633837	2631.41778633837
"AML-0024"	"2020-09-15-AML0024:CCTGTTGAGCGACTTT"	-2.53592167320903	-15.527894996759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGTTGAGCGACTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.0580871024	33.5099159262815	0.0128289321327668	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.45266618104	2604.45266618104
"AML-0024"	"2020-09-15-AML0024:CCTGTTGGTATCAGCT"	-1.97559795799907	-16.6732149354187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGTTGGTATCAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.68371719036	38.4999287972867	0.0166833645834971	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2297.18984966189	2297.18984966189
"AML-0024"	"2020-09-15-AML0024:CCTGTTGTCTTACACT"	-1.11903653565105	-15.9578123322693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTGTTGTCTTACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.09250218305	30.2669553404356	0.0114426831256206	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.32933851866	2639.32933851866
"AML-0024"	"2020-09-15-AML0024:CCTTCAGCAACAGAGC"	-1.64988527718242	-15.6542444459167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGCAACAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.05695462179	41.2052259099286	0.0145239332762784	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.10721180001	2826.10721180001
"AML-0024"	"2020-09-15-AML0024:CCTTCAGCATTCCTAT"	-1.98302970352824	-15.4848270646301	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGCATTCCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.66087513427	33.4772112185541	0.0115055371244971	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.83607121234	2903.83607121234
"AML-0024"	"2020-09-15-AML0024:CCTTCAGGTATTAAGG"	-0.541806916624862	-16.5277281037536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGGTATTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.5771736502	41.1185438575612	0.0150695916738738	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.10936298579	2717.10936298579
"AML-0024"	"2020-09-15-AML0024:CCTTCAGGTGCCCGTA"	-0.70968077603038	-16.3962469330994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGGTGCCCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.29383531228	37.1128434091243	0.0148790983979952	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2482.10966016045	2482.10966016045
"AML-0024"	"2020-09-15-AML0024:CCTTCAGTCAGCGGAA"	-1.95229897919353	-16.3778562775818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGTCAGCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.72450255574	40.9467239077709	0.0146409572592339	3013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.16444409943	2788.16444409943
"AML-0024"	"2020-09-15-AML0024:CCTTCAGTCCGGCTTT"	-0.723685244948226	-16.1603784791199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTCAGTCCGGCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3337.23003150691	39.4337192384259	0.0118163024023309	5266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3328.58990696035	3328.58990696035
"AML-0024"	"2020-09-15-AML0024:CCTTGTGGTTGATGTC"	-0.751159767538863	-15.6616220704285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTGTGGTTGATGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.66120597543	33.5046247826978	0.0123969015090093	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.12509987996	2691.12509987996
"AML-0024"	"2020-09-15-AML0024:CCTTTGGAGATAGCAT"	-1.76881013336833	-16.6779356232849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGAGATAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.89252463931	36.1384158267438	0.0130233569429653	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.59918733451	2761.59918733451
"AML-0024"	"2020-09-15-AML0024:CCTTTGGAGCGTCTGC"	-1.38381872597392	-15.1863193742004	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGAGCGTCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.29410636279	39.2116930683043	0.0150449993239735	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.48327340571	2604.48327340571
"AML-0024"	"2020-09-15-AML0024:CCTTTGGAGTAGGATT"	-2.41810117188151	-15.9071007004944	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGAGTAGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.76389623263	43.0214252101562	0.0151283393347634	2606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2833.38008348735	2833.38008348735
"AML-0024"	"2020-09-15-AML0024:CCTTTGGAGTAGTCTC"	-2.50103483620341	-16.2483873597351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGAGTAGTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.40749604095	36.0957747593972	0.0134164712269475	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.06643331787	2680.06643331787
"AML-0024"	"2020-09-15-AML0024:CCTTTGGCATGTACGT"	-1.69336781922038	-16.1508054963318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGCATGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.85234916808	36.3239061193847	0.0125261226247624	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.70910491349	2887.70910491349
"AML-0024"	"2020-09-15-AML0024:CCTTTGGGTCCCGGTA"	-1.19379935684856	-16.4393911591736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGGTCCCGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.72554904787	37.1107509937672	0.014138907211548	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.90392780147	2613.90392780147
"AML-0024"	"2020-09-15-AML0024:CCTTTGGTCTCCTGAC"	-0.305566112429458	-15.9277954331604	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CCTTTGGTCTCCTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.56407860095	38.7417626649724	0.0149089118040263	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.53059129909	2595.53059129909
"AML-0024"	"2020-09-15-AML0024:CGAAGGAAGACCCGCT"	-1.01358125630077	-16.7079477540222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAAGACCCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.87988520874	31.9664420578533	0.0121412458796308	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.97230781484	2623.97230781484
"AML-0024"	"2020-09-15-AML0024:CGAAGGAAGGCATCGA"	-0.528991977602798	-16.0907259217468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAAGGCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.78854845123	40.8398467170863	0.016616501343381	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2451.23179312159	2451.23179312159
"AML-0024"	"2020-09-15-AML0024:CGAAGGACAAATAGCA"	-1.58274946633037	-16.503218673822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGACAAATAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.87033703283	38.7639621889848	0.0139545614034636	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.52801271729	2758.52801271729
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTCAAATCC"	-0.98914466324504	-17.3071184388367	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTCAAATCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2865.92388306607	48.744491060473	0.0170082992603154	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2859.56010218813	2859.56010218813
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTCGGTACC"	-2.90587625923808	-15.8071003190246	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTCGGTACC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1825.75305160357	47.5463621961918	0.0260420554436053	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1822.32105783193	1822.32105783193
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTGCAATGG"	-2.70651565018352	-16.1689806214538	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTGCAATGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.40187164591	36.2104871203636	0.0145810017838009	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.62163832178	2476.62163832178
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTGTCTAAC"	-2.98821769180949	-15.7530718079773	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTGTCTAAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2487.84866673176	40.5016076265566	0.0162797714218537	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2484.64228124967	2484.64228124967
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTTGTATGC"	-1.9909077686375	-15.397843383905	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTTGTATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.9944913695	40.0000166358019	0.0152033828907718	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.3669911976	2621.3669911976
"AML-0024"	"2020-09-15-AML0024:CGAAGGAGTTTGAAAG"	-1.71484635296519	-15.8109350434509	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGAGTTTGAAAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.27269540096	32.7103873776618	0.0116271655538888	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.13470737612	2809.13470737612
"AML-0024"	"2020-09-15-AML0024:CGAAGGATCGTCAGAT"	11.5613247352535	-2.32308247005614	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGGATCGTCAGAT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2413.07702862993	37.0385927876263	0.0153491133304832	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	2407.08494648731	2407.08494648731
"AML-0024"	"2020-09-15-AML0024:CGAAGTTAGACTTCGT"	-0.784149984747726	-15.8490009537903	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTAGACTTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2921.24468985846	38.0489319420568	0.0130249041013748	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.4641400492	2912.4641400492
"AML-0024"	"2020-09-15-AML0024:CGAAGTTAGGGTTGCA"	0.0274631726438224	-16.5500803223816	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTAGGGTTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.46778273617	42.772822852708	0.015500388560542	2511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.16518947637	2753.16518947637
"AML-0024"	"2020-09-15-AML0024:CGAAGTTGTACGCTAT"	-0.839828531176406	-15.975443863031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTGTACGCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.96501033525	40.8752508669988	0.0159484232918389	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.316658363	2558.316658363
"AML-0024"	"2020-09-15-AML0024:CGAAGTTGTATCGAAA"	-1.98060379448588	-16.1074323884216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTGTATCGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.65064234049	34.4634525520478	0.0142372682572342	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2412.96334985986	2412.96334985986
"AML-0024"	"2020-09-15-AML0024:CGAAGTTGTCGATTCA"	-0.451741437346298	-16.1246805421081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTGTCGATTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.63539639211	35.3188309542987	0.0136490755241419	2608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.18983387568	2578.18983387568
"AML-0024"	"2020-09-15-AML0024:CGAAGTTGTTTCGTGA"	-0.915613035590011	-16.0056505433288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTGTTTCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.85223433084	40.9915648627114	0.014439485214127	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.35000299475	2829.35000299475
"AML-0024"	"2020-09-15-AML0024:CGAAGTTTCCAAGCAT"	-0.757925311953384	-16.1814165345398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTTCCAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.97071771183	31.755008796098	0.0123082826398361	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.18019623198	2568.18019623198
"AML-0024"	"2020-09-15-AML0024:CGAAGTTTCGCAGTCG"	-1.87742195549663	-16.4402170411316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAAGTTTCGCAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1897.9147103285	38.6462113471406	0.0203624594597571	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1893.14826740457	1893.14826740457
"AML-0024"	"2020-09-15-AML0024:CGAATTGAGACGCCAA"	-2.45078955116923	-15.6321583024231	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGAGACGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2878.64479569525	37.6126044826631	0.01306608044831	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.54496746339	2868.54496746339
"AML-0024"	"2020-09-15-AML0024:CGAATTGAGCACTAAA"	-2.76069817963298	-15.5299024811951	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGAGCACTAAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.88743011867	36.3675708366245	0.0135000336057184	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.98470162122	2692.98470162122
"AML-0024"	"2020-09-15-AML0024:CGAATTGAGCCTGTGC"	-1.37921200218852	-15.7731724015442	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGAGCCTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.50516047282	39.5801393017708	0.0134374707038087	2791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2938.79004399744	2938.79004399744
"AML-0024"	"2020-09-15-AML0024:CGAATTGAGCTGTTCA"	-1.65250275555308	-16.8021021119324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGAGCTGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.43062569947	33.616597879185	0.0125555439444496	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.36180041341	2670.36180041341
"AML-0024"	"2020-09-15-AML0024:CGAATTGCACCTCTGT"	-1.95602736893352	-16.7782602540222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGCACCTCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.48355346043	36.804250551889	0.0146078550508256	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.08648926583	2509.08648926583
"AML-0024"	"2020-09-15-AML0024:CGAATTGGTGTCTTGA"	-1.48016641560252	-16.6141252747742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGGTGTCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.57460911832	41.8704967173674	0.0158746207870736	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.68422960424	2629.68422960424
"AML-0024"	"2020-09-15-AML0024:CGAATTGGTTCAACGT"	-2.80043516579326	-16.109742187616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGGTTCAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1860.13009984233	45.1700395328582	0.0242832689695667	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1855.19235359193	1855.19235359193
"AML-0024"	"2020-09-15-AML0024:CGAATTGGTTTCCCAC"	-0.489851931959945	-15.8103409043518	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAATTGGTTTCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.18288089459	32.4559540720921	0.012766962721687	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.6035857147	2536.6035857147
"AML-0024"	"2020-09-15-AML0024:CGACAGCAGAACGTGC"	-0.802911381155807	-15.8818073502746	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCAGAACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.83301685038	34.8675750276782	0.0130794295093822	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.9465448308	2658.9465448308
"AML-0024"	"2020-09-15-AML0024:CGACAGCAGACGAAGA"	-1.32205853882487	-15.5667019120422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCAGACGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.75043094275	35.3608389757656	0.0121860372962113	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2896.60135877627	2896.60135877627
"AML-0024"	"2020-09-15-AML0024:CGACAGCAGTGATAAC"	-1.94678948345836	-16.5766630402771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCAGTGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2197.00340975201	33.8222526253515	0.0153947201334427	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2195.86228883799	2195.86228883799
"AML-0024"	"2020-09-15-AML0024:CGACAGCCACTGTGTA"	-0.0320453745430291	-16.0457506409851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCCACTGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3034.54396112032	38.3579013339471	0.0126404170858628	3311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3025.58784699565	3025.58784699565
"AML-0024"	"2020-09-15-AML0024:CGACAGCGTTGGCCTG"	-2.5515926879948	-16.455933593866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCGTTGGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.61606126672	37.6899059753106	0.0141286846044155	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.66914059075	2660.66914059075
"AML-0024"	"2020-09-15-AML0024:CGACAGCTCCTACCAC"	-1.9244569343632	-16.1962099305359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCTCCTACCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2861.1907654341	35.9518874977708	0.0125653584277231	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2853.68649240507	2853.68649240507
"AML-0024"	"2020-09-15-AML0024:CGACAGCTCGAGAGCA"	-0.703903476626235	-16.6967516175476	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCTCGAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.26115909068	34.5558734592325	0.0114641272389474	2754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3004.72922261126	3004.72922261126
"AML-0024"	"2020-09-15-AML0024:CGACAGCTCGATGCAT"	-1.09948049011882	-15.7350864640442	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCTCGATGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.87586914864	34.9244783009264	0.0136911712260552	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.92157496689	2546.92157496689
"AML-0024"	"2020-09-15-AML0024:CGACAGCTCTAGGCCG"	-0.488628844649154	-16.4390478364197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCTCTAGGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.47538991078	47.562095701413	0.0187808718263946	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.36147116059	2526.36147116059
"AML-0024"	"2020-09-15-AML0024:CGACAGCTCTCTGCTG"	-2.04425297203715	-16.8448324433533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGACAGCTCTCTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2181.61915112187	36.1909769028383	0.0165890443729501	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2174.10046043728	2174.10046043728
"AML-0024"	"2020-09-15-AML0024:CGAGAAGAGGAAGTCC"	0.234257702797097	-16.3356104127136	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGAAGAGGAAGTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3160.60966350236	44.2047845692336	0.0139861575061594	3988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3150.9977634707	3150.9977634707
"AML-0024"	"2020-09-15-AML0024:CGAGAAGAGTGTACAA"	-0.354527245194274	-16.3179426423279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGAAGAGTGTACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2954.43540766564	41.5084457814219	0.0140495357162736	3342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2945.48036216166	2945.48036216166
"AML-0024"	"2020-09-15-AML0024:CGAGAAGCACGCTTAA"	-1.0879365009373	-16.5754308930603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGAAGCACGCTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.1858839089	33.4102413269889	0.0128392985042258	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.21562529391	2599.21562529391
"AML-0024"	"2020-09-15-AML0024:CGAGGAAAGGTCATCT"	-1.10754952850993	-15.8630390397278	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAAAGGTCATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2160.7261942604	36.4699227273204	0.0168785488990677	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2158.36516444718	2158.36516444718
"AML-0024"	"2020-09-15-AML0024:CGAGGAACAAACAGGC"	-2.12575684014018	-16.5337076417175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAACAAACAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.08341890931	35.9366016200887	0.0129637518751973	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.23960222003	2762.23960222003
"AML-0024"	"2020-09-15-AML0024:CGAGGAACAACAACAA"	-0.5261546773022	-15.7033233872619	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAACAACAACAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2934.14075554752	30.9461432427778	0.0105469184408651	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2924.76564525037	2924.76564525037
"AML-0024"	"2020-09-15-AML0024:CGAGGAACACGTGTGC"	-1.61863754215892	-16.0774317017761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAACACGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.65208715973	37.0533740558152	0.0144420883257148	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.08923646236	2562.08923646236
"AML-0024"	"2020-09-15-AML0024:CGAGGAACAGTTAAAG"	-2.04861650887187	-16.1329984894958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAACAGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.8710615479	41.3919299660809	0.0150742438513291	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.64904643184	2740.64904643184
"AML-0024"	"2020-09-15-AML0024:CGAGGAAGTACTTCCC"	-1.45680377903636	-16.9620294800964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAAGTACTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.86605740388	39.2970547814783	0.0161459397742681	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.32552996297	2423.32552996297
"AML-0024"	"2020-09-15-AML0024:CGAGGAAGTGAGTGAC"	-2.59759221497234	-15.484230064508	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGAAGTGAGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.79962711247	34.8742463618391	0.0130624957797142	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.69872358872	2664.69872358872
"AML-0024"	"2020-09-15-AML0024:CGAGGCTAGAAACTGT"	-1.40640173378642	-16.1419611207214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTAGAAACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3074.84397290148	40.607049775383	0.0132062147326017	2749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3063.21331368985	3063.21331368985
"AML-0024"	"2020-09-15-AML0024:CGAGGCTAGGCTTTCA"	-2.35363421860393	-15.9299230805603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTAGGCTTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.6660968291	37.0058469391743	0.0148876983060523	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2478.06243688734	2478.06243688734
"AML-0024"	"2020-09-15-AML0024:CGAGGCTAGGTTCTTG"	-2.40145168724712	-15.8406448594299	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.23219227433	32.3270168857998	0.0122999090342264	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.20554345281	2622.20554345281
"AML-0024"	"2020-09-15-AML0024:CGAGGCTCAATGAGCG"	-1.00064669075664	-15.8184452286926	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTCAATGAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2102.27885847485	42.0121604206118	0.0199841045117537	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2093.14344012623	2093.14344012623
"AML-0024"	"2020-09-15-AML0024:CGAGGCTCACGTTCGG"	-2.15345869484599	-16.6763773194519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTCACGTTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1840.66354903952	50.0928300693305	0.02721454993525	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1829.64782934526	1829.64782934526
"AML-0024"	"2020-09-15-AML0024:CGAGGCTCACTTTAGG"	-2.55800805512126	-16.0221662751404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTCACTTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.98025871914	43.9189781253028	0.0167566993224	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.57881298332	2612.57881298332
"AML-0024"	"2020-09-15-AML0024:CGAGGCTCAGCGACCT"	-2.70254311981853	13.6987352141174	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTCAGCGACCT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1989.17518387478	29.5255108580804	0.0148430923014869	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1985.59635531536	1985.59635531536
"AML-0024"	"2020-09-15-AML0024:CGAGGCTCATCGATCA"	-1.29139016094859	-16.0664625397888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTCATCGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2353.01325831825	29.8921632333331	0.0127037801965883	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.76391171891	2345.76391171891
"AML-0024"	"2020-09-15-AML0024:CGAGGCTGTACGCTTA"	-2.0079210800236	-15.7774505845276	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTGTACGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1643.3870664009	29.8181707058409	0.0181443381875605	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1638.80790847279	1638.80790847279
"AML-0024"	"2020-09-15-AML0024:CGAGGCTGTAGGGAGG"	-2.54455409470256	-15.869863533136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTGTAGGGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.91956547696	40.0630032542493	0.0157176412299823	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2545.92771603105	2545.92771603105
"AML-0024"	"2020-09-15-AML0024:CGAGGCTGTGCTCTCT"	-0.654754082590896	-15.968586944696	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTGTGCTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.94120849173	38.1984889225041	0.0126697292852398	3185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3001.90861679987	3001.90861679987
"AML-0024"	"2020-09-15-AML0024:CGAGGCTGTTCCGCAG"	-1.31499908390697	-16.6102380982605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTGTTCCGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.48170225797	35.748829010223	0.013800070071548	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.31834450001	2579.31834450001
"AML-0024"	"2020-09-15-AML0024:CGAGGCTGTTTGCCGG"	-0.748734514147598	-15.8086462250915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGGCTGTTTGCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2329.95292075737	35.4957840497585	0.0152345499059356	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2325.61426284971	2325.61426284971
"AML-0024"	"2020-09-15-AML0024:CGAGTGCAGCACACCC"	-1.30189416828807	-16.4515276185242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCAGCACACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.66305451086	36.6915614159655	0.0144702038982239	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.73267319683	2528.73267319683
"AML-0024"	"2020-09-15-AML0024:CGAGTGCAGGGTGGGA"	-2.33334837380107	-15.9149685136047	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCAGGGTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.02018620886	32.1581895654013	0.0118140893033531	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.2986182081	2716.2986182081
"AML-0024"	"2020-09-15-AML0024:CGAGTGCAGTCTACCA"	1.02958585795705	-16.2326517335144	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCAGTCTACCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2890.26911196585	44.3368281876691	0.0153400346023533	3557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2881.14096134681	2881.14096134681
"AML-0024"	"2020-09-15-AML0024:CGAGTGCCAGAGGAAA"	-0.582852165133315	-16.4346132508484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCCAGAGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.9928444538	38.1006588847837	0.0140801033391033	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.82915730342	2697.82915730342
"AML-0024"	"2020-09-15-AML0024:CGAGTGCCAGTAACCT"	-0.779538671404678	-16.4524965516296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCCAGTAACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.52862149038	41.6264422978501	0.0160501187274075	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.39754597668	2583.39754597668
"AML-0024"	"2020-09-15-AML0024:CGAGTGCGTCCCGCAA"	-1.7615569633549	-16.4910364381042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCGTCCCGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.13768046163	35.2043932604135	0.0133090967326395	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.68686067733	2640.68686067733
"AML-0024"	"2020-09-15-AML0024:CGAGTGCGTGTCTAAC"	-0.866464058787185	-17.3212576142517	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCGTGTCTAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3004.01652877221	47.1820374935636	0.0157063175390875	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2989.44307375565	2989.44307375565
"AML-0024"	"2020-09-15-AML0024:CGAGTGCTCAGTGTGT"	-0.423874716193038	-16.5185175172058	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTGCTCAGTGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2486.0719694916	42.8507521105293	0.0172363280855832	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2479.72056403333	2479.72056403333
"AML-0024"	"2020-09-15-AML0024:CGAGTTAAGAATCGCG"	-0.843392054468948	-16.6632585755554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTTAAGAATCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.71037486456	40.5321839525622	0.016266811890112	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.98007987913	2487.98007987913
"AML-0024"	"2020-09-15-AML0024:CGAGTTAAGTAGTCAA"	-1.78522990170177	-16.4488668671814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTTAAGTAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.35072712319	33.3051388036094	0.0129624727570377	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.64953959453	2560.64953959453
"AML-0024"	"2020-09-15-AML0024:CGAGTTACACACAGAG"	-1.29187510433849	-16.1659918061462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTTACACACAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.72991404162	32.6558808389507	0.0123943940761872	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.07722790952	2629.07722790952
"AML-0024"	"2020-09-15-AML0024:CGAGTTATCATACAGC"	-1.21570489826854	-16.0905370942322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTTATCATACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.7320504426	34.271934083836	0.0123692704526811	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.45382622689	2765.45382622689
"AML-0024"	"2020-09-15-AML0024:CGAGTTATCCAATGCA"	-0.725435237318832	-16.0015974274841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGAGTTATCCAATGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1908.14359664075	50.0405365284883	0.0262247226134258	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1906.34658624406	1906.34658624406
"AML-0024"	"2020-09-15-AML0024:CGATCGGAGACCAACG"	-0.969935278326827	-17.3861379853454	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATCGGAGACCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.38440113486	36.1956355368081	0.0148623911362582	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2427.43413276167	2427.43413276167
"AML-0024"	"2020-09-15-AML0024:CGATCGGCAGAACGCA"	-2.24457297745402	-16.3916044465271	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATCGGCAGAACGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2940.08183069917	35.7076122084898	0.0121451082876827	2776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.22490484283	2934.22490484283
"AML-0024"	"2020-09-15-AML0024:CGATCGGCATGGGATG"	-2.34152088585551	-15.6093664399353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATCGGCATGGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.86842245467	39.2493477150644	0.0138013936949961	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.67595502199	2835.67595502199
"AML-0024"	"2020-09-15-AML0024:CGATCGGGTCCGAAAG"	-1.09085379067119	-16.8715067139831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATCGGGTCCGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.58010192716	39.6643643567927	0.0145954720262578	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.40748401833	2712.40748401833
"AML-0024"	"2020-09-15-AML0024:CGATCGGGTGTAGCAG"	-1.34580586376842	-15.0987568131653	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATCGGGTGTAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.98932171496	39.0477257472838	0.0148640595622187	2627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.1443822636	2622.1443822636
"AML-0024"	"2020-09-15-AML0024:CGATGCGAGCTGAGCA"	-0.514036456972915	-16.5612993470398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGAGCTGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.55741535693	41.8229079136683	0.0161755866124886	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.89027398754	2580.89027398754
"AML-0024"	"2020-09-15-AML0024:CGATGCGAGGTAACTA"	-2.62288484993632	-16.0809145203796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGAGGTAACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.2472385082	46.0836929581517	0.0162595882010659	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.16647309029	2826.16647309029
"AML-0024"	"2020-09-15-AML0024:CGATGCGAGTCACTCA"	-2.06920800629314	-15.4928121796814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGAGTCACTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.46631500449	27.2979853459282	0.0100601895055709	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.15806378727	2709.15806378727
"AML-0024"	"2020-09-15-AML0024:CGATGCGCAGTTCACA"	-1.91673753681834	-16.1317568055359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGCAGTTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.32121476188	47.681034930599	0.017970321371315	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.99411983423	2645.99411983423
"AML-0024"	"2020-09-15-AML0024:CGATGCGGTGCAATAA"	-1.88846526566203	-15.9034309617248	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGGTGCAATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.03834820247	37.7678270575712	0.0136838051841447	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.60695460045	2757.60695460045
"AML-0024"	"2020-09-15-AML0024:CGATGCGTCAATGCAC"	-1.93752167645152	-16.7592134705749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGTCAATGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.84790054824	42.2758723344759	0.015948056591905	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.01635059441	2630.01635059441
"AML-0024"	"2020-09-15-AML0024:CGATGCGTCACTCTTA"	-0.379306535155135	-16.6884470216003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGCGTCACTCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.51311956693	40.3193467765027	0.015808327535029	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2541.32761232428	2541.32761232428
"AML-0024"	"2020-09-15-AML0024:CGATGGCAGAAGCGGG"	-2.09463272514995	-15.640386604425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGGCAGAAGCGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2979.52688739956	40.568336967636	0.0136156975589648	2828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.5205628445	2970.5205628445
"AML-0024"	"2020-09-15-AML0024:CGATGGCCAGGCAATG"	-2.5468729538029	-15.827660583612	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGGCCAGGCAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.38070395606	35.1576171245791	0.0129906398878721	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.28621469033	2698.28621469033
"AML-0024"	"2020-09-15-AML0024:CGATGGCGTGACCGTC"	-1.75102518025096	-15.6580076447693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGGCGTGACCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.51750167693	37.8969245549187	0.0150175001876291	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.03304836205	2518.03304836205
"AML-0024"	"2020-09-15-AML0024:CGATGGCGTGAGTGAC"	-1.92744050446208	-15.5176382294861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGATGGCGTGAGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.32084647115	26.7644623066751	0.0100304513012635	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.54637564573	2661.54637564573
"AML-0024"	"2020-09-15-AML0024:CGCAGGTAGAAACTAC"	-1.92527518692668	-16.4449587098328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTAGAAACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.43445014067	48.4795601003999	0.0199879902330852	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2417.06224262901	2417.06224262901
"AML-0024"	"2020-09-15-AML0024:CGCAGGTAGAGCATAT"	-0.584414283663589	-15.8659038773743	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTAGAGCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.23622418802	34.8002344432778	0.0135978985114276	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.46228242567	2556.46228242567
"AML-0024"	"2020-09-15-AML0024:CGCAGGTAGAGGTCGT"	-0.121864865452606	-16.0696344605652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTAGAGGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.11526960794	44.2479044216752	0.0160777802115747	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.16243931477	2748.16243931477
"AML-0024"	"2020-09-15-AML0024:CGCAGGTAGCTGGAGT"	-1.29933867874797	-16.1200533143249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTAGCTGGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.2788265799	36.2874896698642	0.0142176823676002	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.83963007662	2548.83963007662
"AML-0024"	"2020-09-15-AML0024:CGCAGGTAGGAGAATG"	-0.536675433546859	-16.5906763306824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTAGGAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.04510729861	33.5171379860306	0.0126477613130884	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.02873511163	2643.02873511163
"AML-0024"	"2020-09-15-AML0024:CGCAGGTCAATCGCAT"	-0.555145303637344	-15.6164293519226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTCAATCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.30558928546	36.2823282567444	0.0131921079599634	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.98890707787	2743.98890707787
"AML-0024"	"2020-09-15-AML0024:CGCAGGTGTCCTCCTA"	-2.7241772216862	-15.7932977906433	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTGTCCTCCTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.62464142509	34.1667131352884	0.0123362251419413	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.70594062489	2760.70594062489
"AML-0024"	"2020-09-15-AML0024:CGCAGGTGTCGGCACT"	-2.3453200859135	-16.492196106073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTGTCGGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2905.97100714757	39.0028704999526	0.0134216309811834	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2899.29341093607	2899.29341093607
"AML-0024"	"2020-09-15-AML0024:CGCAGGTTCCGTATAG"	-0.370064924389678	-15.8166885606018	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTTCCGTATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.35701793429	34.4364242770172	0.0126309298637304	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.93701337249	2720.93701337249
"AML-0024"	"2020-09-15-AML0024:CGCAGGTTCGGAACTT"	-0.731794337660629	-16.2305307618347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCAGGTTCGGAACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2869.26126114145	36.7837775936244	0.0128199471033847	2906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.1518227746	2859.1518227746
"AML-0024"	"2020-09-15-AML0024:CGCATAAAGGCATCAG"	-2.10651336136516	-15.4439411393371	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAAAGGCATCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.44533550985	38.149385784778	0.013521220951773	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.14171957227	2813.14171957227
"AML-0024"	"2020-09-15-AML0024:CGCATAAAGGCTAGCA"	0.748046358197373	-16.2029390565124	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAAAGGCTAGCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2860.80369013674	37.2618820824553	0.0130249699449578	3818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2847.89762657465	2847.89762657465
"AML-0024"	"2020-09-15-AML0024:CGCATAAAGGTCACAG"	-2.20091257515605	-15.493905090448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAAAGGTCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.68235280076	34.6769606761597	0.0132421408954285	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.93385495136	2609.93385495136
"AML-0024"	"2020-09-15-AML0024:CGCATAAAGTGTTCAC"	-1.9083186191624	-15.7265463105408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAAAGTGTTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3099.68922747542	38.0849692036004	0.0122867056690774	3658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3089.58497702513	3089.58497702513
"AML-0024"	"2020-09-15-AML0024:CGCATAACAAGAAATC"	-1.24782929840739	-16.2192430726257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAACAAGAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3114.71302449713	38.5572624732219	0.0123790738247698	3940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3100.80236253177	3100.80236253177
"AML-0024"	"2020-09-15-AML0024:CGCATAACACAAGCAG"	-0.589099268347579	13.3026399382385	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAACACAAGCAG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2119.32654545354	46.6451170402455	0.0220094053652612	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2115.02251294704	2115.02251294704
"AML-0024"	"2020-09-15-AML0024:CGCATAACACATATCG"	-0.264298478991348	-16.3138990632263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAACACATATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.84318469647	35.6973601512219	0.0124691985722602	2943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.45835688371	2852.45835688371
"AML-0024"	"2020-09-15-AML0024:CGCATAACACCCGTAG"	1.31330670890157	-16.1691351166931	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAACACCCGTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2662.74619676056	48.1398562874838	0.0180790254610258	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2656.16369388209	2656.16369388209
"AML-0024"	"2020-09-15-AML0024:CGCATAAGTCTCGGGT"	-1.71935818615611	-15.5590009919372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAAGTCTCGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.80220024181	36.3876716249238	0.0131753358809468	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.97520124031	2760.97520124031
"AML-0024"	"2020-09-15-AML0024:CGCATAATCCGAGTGC"	-0.267030547291595	-15.8533172837463	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATAATCCGAGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.54912672589	36.2900127487256	0.0130326351222957	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.24077035475	2776.24077035475
"AML-0024"	"2020-09-15-AML0024:CGCATGGAGCTCCATA"	-1.43510375443156	-16.5697088471619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGAGCTCCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.41218404292	33.9030524078815	0.0124578895496511	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.51423900409	2712.51423900409
"AML-0024"	"2020-09-15-AML0024:CGCATGGAGGTAGGCT"	-2.55607304993327	-16.0519781342712	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGAGGTAGGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.29298335837	36.3056514479494	0.0134301578376629	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.02740964021	2699.02740964021
"AML-0024"	"2020-09-15-AML0024:CGCATGGCATTAAGCC"	-1.24859521809276	-15.7241258851257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGCATTAAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.65751519785	37.1084435646678	0.0129223082377604	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.49394027956	2863.49394027956
"AML-0024"	"2020-09-15-AML0024:CGCATGGGTTATAGCC"	-2.52383099022563	-16.2218103638855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGGTTATAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.30697152856	33.6264841464406	0.011822382212272	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.98050322377	2835.98050322377
"AML-0024"	"2020-09-15-AML0024:CGCATGGGTTCAGCTA"	-2.77649102631267	-15.7805423966614	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGGTTCAGCTA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.17450376723	45.3418695790268	0.0191382565982069	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2369.17450376723	2369.17450376723
"AML-0024"	"2020-09-15-AML0024:CGCATGGGTTCGGGTC"	-1.82574687424358	-16.5938139191833	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCATGGGTTCGGGTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2253.24419910123	40.2163271630895	0.0178481884826913	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2245.04797065778	2245.04797065778
"AML-0024"	"2020-09-15-AML0024:CGCCAGAAGGCATCGA"	-2.17842302742656	-15.768729232904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGAAGGCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.11355526784	29.3177260481034	0.0113585572352167	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.33134361723	2574.33134361723
"AML-0024"	"2020-09-15-AML0024:CGCCAGAAGTGGGAAA"	-2.25838098946269	-15.6520862809387	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGAAGTGGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.44941533805	34.1240991776371	0.0120051737749496	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.89566359302	2835.89566359302
"AML-0024"	"2020-09-15-AML0024:CGCCAGACAATCGCGC"	-0.925024609000045	-16.1415605775085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGACAATCGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.57456574211	44.6926807419565	0.0154775849850549	2812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2880.25906441142	2880.25906441142
"AML-0024"	"2020-09-15-AML0024:CGCCAGACACTTACAG"	-1.7404627603596	-16.8767938843933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGACACTTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1886.64253896844	49.9545995107289	0.0264780415361791	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1874.68754218155	1874.68754218155
"AML-0024"	"2020-09-15-AML0024:CGCCAGACACTTCTCG"	-2.10972676697429	-16.5323095551697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGACACTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.54735570513	37.4959205640495	0.0132048935506266	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.99832696446	2831.99832696446
"AML-0024"	"2020-09-15-AML0024:CGCCAGACAGACTCTA"	-0.247092972428161	-16.110131286737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGACAGACTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.68269534632	35.8740986676313	0.0123760005623331	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.3955089624	2885.3955089624
"AML-0024"	"2020-09-15-AML0024:CGCCAGAGTCACAATC"	-2.39102158966716	-15.7060327759949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGAGTCACAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.51895088504	31.5180054761531	0.0131956271330711	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2387.52624274305	2387.52624274305
"AML-0024"	"2020-09-15-AML0024:CGCCAGAGTCCCGCAA"	-1.75293133679088	-15.7071571580139	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGAGTCCCGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.37713523588	37.47220420438	0.0139749846121827	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.87970917185	2670.87970917185
"AML-0024"	"2020-09-15-AML0024:CGCCAGAGTGTTCCAA"	-2.82921824875529	-15.9368639222351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCAGAGTGTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.08079181111	38.2082385888585	0.0145108493091766	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.77304737939	2626.77304737939
"AML-0024"	"2020-09-15-AML0024:CGCCATTAGAATTGTG"	-1.22976301136668	-15.52921202099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTAGAATTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.35048335002	36.6048950122485	0.0130203954395006	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.97758792146	2803.97758792146
"AML-0024"	"2020-09-15-AML0024:CGCCATTAGCGTTGTT"	-0.915718714625198	-16.2465353242126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTAGCGTTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.38955591761	43.5717053397878	0.0170309111991978	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.63189065196	2553.63189065196
"AML-0024"	"2020-09-15-AML0024:CGCCATTAGTAACGAT"	-1.34381566467937	-15.9807024232117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTAGTAACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.33428162405	45.7549208162089	0.0191576703346132	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2385.54810382001	2385.54810382001
"AML-0024"	"2020-09-15-AML0024:CGCCATTCAGACTGCC"	-0.192895452410537	9.62478349292604	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000796178343949045	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTCAGACTGCC"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1949.86732495642	33.2224612266047	0.0170383188647706	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1948.5089213753	1948.5089213753
"AML-0024"	"2020-09-15-AML0024:CGCCATTCATACTGTG"	-0.143208603293258	-16.0836801758972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTCATACTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.57251226308	37.5222275923805	0.0139926209046326	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.24599441074	2670.24599441074
"AML-0024"	"2020-09-15-AML0024:CGCCATTGTAACCCTA"	-0.877356509596664	-16.0719995728699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTGTAACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.71229693976	33.1035935739508	0.0127728658821579	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.42835976657	2589.42835976657
"AML-0024"	"2020-09-15-AML0024:CGCCATTGTTACGATC"	1.16697575625722	-16.2187090150085	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTGTTACGATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2905.69432259479	48.5140206170003	0.0166961886664242	2786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2892.09952492674	2892.09952492674
"AML-0024"	"2020-09-15-AML0024:CGCCATTTCACCTCAC"	-2.06095490875896	-16.6267481080261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTTCACCTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.13718799786	29.6925016665346	0.0110869980072725	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.12371662684	2671.12371662684
"AML-0024"	"2020-09-15-AML0024:CGCCATTTCGTCCTTG"	-2.8869973224705	-16.1481905213562	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCCATTTCGTCCTTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2530.11534720448	34.1009068312534	0.0134780048146546	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.48005959242	2518.48005959242
"AML-0024"	"2020-09-15-AML0024:CGCGTGAAGAGAATCT"	-2.21165452423747	-16.1874399415222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCGTGAAGAGAATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.09145306357	38.0500267817743	0.0143147921934439	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.78859352494	2650.78859352494
"AML-0024"	"2020-09-15-AML0024:CGCGTGAAGCTAATCC"	-2.4704409641331	-16.0039625397888	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCGTGAAGCTAATCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.43328610709	34.6810181564621	0.0120360302366456	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.21223800389	2873.21223800389
"AML-0024"	"2020-09-15-AML0024:CGCGTGAAGGTCCCTG"	-2.17504535141643	-16.7372541657654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCGTGAAGGTCCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2052.02221897299	43.4769834683409	0.0211873843598539	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2045.01054071511	2045.01054071511
"AML-0024"	"2020-09-15-AML0024:CGCGTGACAAGATGGC"	-2.63308558884318	-15.7606411210266	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCGTGACAAGATGGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.36356578936	36.7168607122779	0.0136121289610186	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.33593723271	2692.33593723271
"AML-0024"	"2020-09-15-AML0024:CGCGTGAGTACATTGC"	-0.959968308836776	-16.7562017670837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGCGTGAGTACATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.35562528806	41.3877695153733	0.0158734654812578	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.36656571862	2600.36656571862
"AML-0024"	"2020-09-15-AML0024:CGGAACCAGTAGCCAG"	-0.892879824072677	-15.8255329362121	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAACCAGTAGCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.96200199244	36.6477316395344	0.0138609146470022	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.36898946858	2640.36898946858
"AML-0024"	"2020-09-15-AML0024:CGGAACCCAATAGAGT"	-1.70287917080577	-15.4732980958191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAACCCAATAGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.78544995597	34.4628930110833	0.0135638737271896	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.85695829595	2533.85695829595
"AML-0024"	"2020-09-15-AML0024:CGGAACCCACTAGGTT"	-2.58432159844096	-15.7238817445007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAACCCACTAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.27401524809	35.8043058696643	0.0128364247018878	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.24027661173	2783.24027661173
"AML-0024"	"2020-09-15-AML0024:CGGAACCGTTAAGAAC"	-1.66036520424541	-15.8417778245178	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAACCGTTAAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2937.78535201577	40.5858556539826	0.0138151194831626	2736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2930.25182393128	2930.25182393128
"AML-0024"	"2020-09-15-AML0024:CGGAACCGTTCCAAAC"	-0.555956701666671	-15.9490671387878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAACCGTTCCAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.29141588454	33.265339222911	0.0118411849460754	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.96711709517	2801.96711709517
"AML-0024"	"2020-09-15-AML0024:CGGAATTAGAGAGTTT"	-1.53124831143077	-16.1674700013367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTAGAGAGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.33488361035	31.5366424606421	0.0115209295908462	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.01275679615	2730.01275679615
"AML-0024"	"2020-09-15-AML0024:CGGAATTAGGTACCTT"	-0.722963611513931	-15.7691745988098	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTAGGTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2996.40849734133	41.0686921004466	0.013705972378895	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2989.29872067934	2989.29872067934
"AML-0024"	"2020-09-15-AML0024:CGGAATTAGGTATTGA"	-1.28388987007793	-15.89346983349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTAGGTATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.4276829805	34.3418334610349	0.0123824513874214	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.36800154691	2759.36800154691
"AML-0024"	"2020-09-15-AML0024:CGGAATTAGTAACGAT"	-0.480271438986617	-16.5752897492615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTAGTAACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2959.96120833944	35.0225257389243	0.0118320894342302	3414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2950.56357767087	2950.56357767087
"AML-0024"	"2020-09-15-AML0024:CGGAATTAGTTAACGA"	-1.68486724320109	-16.8943987122742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTAGTTAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.25956535162	40.0807918292884	0.0175081901746393	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2285.09927533645	2285.09927533645
"AML-0024"	"2020-09-15-AML0024:CGGAATTCATCGATAC"	-2.75406012955363	-15.5316038361755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTCATCGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2876.9242994889	41.6227847855809	0.014467806745202	2746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.31045158983	2872.31045158983
"AML-0024"	"2020-09-15-AML0024:CGGAATTGTAGCTTAC"	0.0790587282622277	-16.4868135682312	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTGTAGCTTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3175.09187404925	38.0841490046235	0.0119946604745185	5087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3162.84353162766	3162.84353162766
"AML-0024"	"2020-09-15-AML0024:CGGAATTGTTAGAGAT"	-1.08936236324962	-15.6834402314392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTGTTAGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.38490724782	36.4729862208995	0.0135065879397437	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.97876532959	2696.97876532959
"AML-0024"	"2020-09-15-AML0024:CGGAATTTCGGTCGGT"	-2.61149559441264	-15.5375051728454	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTTCGGTCGGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2921.14949273647	36.2739177214235	0.0124176861922403	2772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2917.99844510832	2917.99844510832
"AML-0024"	"2020-09-15-AML0024:CGGAATTTCGTCTACC"	-0.313470105559188	-15.9568071595398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAATTTCGTCTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.20205047599	39.7564663488528	0.0152662756492286	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.69088704868	2595.69088704868
"AML-0024"	"2020-09-15-AML0024:CGGACACCAGATACTC"	-2.34152803841289	-16.3787718049255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGACACCAGATACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2216.2286124699	47.5167498041591	0.021440364742518	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2207.76652108711	2207.76652108711
"AML-0024"	"2020-09-15-AML0024:CGGACACGTTCGTGCG"	-0.331377128989059	-15.9360504380432	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGACACGTTCGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.16614751947	39.4105349765729	0.0138908096767718	2861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.33987749566	2830.33987749566
"AML-0024"	"2020-09-15-AML0024:CGGAGAAAGTGGGAAA"	-0.876613656908828	-16.4994516602722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAAAGTGGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.96423004052	30.2075621712175	0.0116903948669382	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.11205217644	2576.11205217644
"AML-0024"	"2020-09-15-AML0024:CGGAGAACAATGAGCG"	0.218518679111642	-16.2023744813171	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAACAATGAGCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3051.98310172386	39.2839233974713	0.0128716058012518	3318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3042.63041764402	3042.63041764402
"AML-0024"	"2020-09-15-AML0024:CGGAGAACAGGACAGT"	-1.86939464035686	-16.9149255982605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAACAGGACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.90729104191	35.2557874450221	0.0133246495689344	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.23806790876	2635.23806790876
"AML-0024"	"2020-09-15-AML0024:CGGAGAACATCAGCGC"	-1.66268895092662	-17.0230951539245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAACATCAGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1774.18126601167	45.2272986167559	0.0254919266047861	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1765.52261769173	1765.52261769173
"AML-0024"	"2020-09-15-AML0024:CGGAGAAGTTGATGTC"	-2.14375744286235	-15.949320816156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAAGTTGATGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.98596149359	35.9961642172371	0.0139629015653686	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.54264187346	2574.54264187346
"AML-0024"	"2020-09-15-AML0024:CGGAGAATCGCCAACG"	-1.26673696461375	-16.2505007020203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAATCGCCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.30500757227	39.2136764443462	0.0159191315422988	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2459.3962671067	2459.3962671067
"AML-0024"	"2020-09-15-AML0024:CGGAGAATCTCAGAAC"	-1.80959508839305	-15.7873745194641	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAATCTCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.72089549757	33.954501592251	0.0127998771562743	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.14857798804	2647.14857798804
"AML-0024"	"2020-09-15-AML0024:CGGAGAATCTTGATTC"	-1.37080870094951	-16.080309890863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGAGAATCTTGATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.45407229127	37.0071638191202	0.0132810959229949	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.57259198115	2779.57259198115
"AML-0024"	"2020-09-15-AML0024:CGGCAGTAGAGTCAAT"	-0.783375362784225	-15.7098245850769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTAGAGTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.85862522957	35.6346220379722	0.0132330088568739	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.47723308289	2688.47723308289
"AML-0024"	"2020-09-15-AML0024:CGGCAGTAGCCTGCCA"	-1.16731880131419	-16.1739111176697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTAGCCTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.31193949734	36.0543009601252	0.0135526591543011	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.99619255268	2650.99619255268
"AML-0024"	"2020-09-15-AML0024:CGGCAGTCAGACACAG"	-0.817758302122909	-16.6272192231384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTCAGACACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.56913618511	33.8329734441883	0.0125980645920918	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.94617656743	2677.94617656743
"AML-0024"	"2020-09-15-AML0024:CGGCAGTCATGACACT"	-1.1912593645161	-16.1913538209167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTCATGACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.13064588792	41.345329054587	0.0156189227452046	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.49976604491	2637.49976604491
"AML-0024"	"2020-09-15-AML0024:CGGCAGTCATGCTGCG"	-1.9201115173405	-16.2663431397644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTCATGCTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.13867274834	38.4722006494312	0.0158639178376681	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2422.25341896392	2422.25341896392
"AML-0024"	"2020-09-15-AML0024:CGGCAGTGTGGCTAGA"	-0.626701573759872	-15.624330543634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTGTGGCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.18887880547	34.7504601748904	0.0119904056043488	3095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2891.36120870358	2891.36120870358
"AML-0024"	"2020-09-15-AML0024:CGGCAGTTCCCTTGGT"	-0.612589101225692	-15.7459621659485	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTTCCCTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.41985072281	33.076646579568	0.0112260466109247	3291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.68725761823	2939.68725761823
"AML-0024"	"2020-09-15-AML0024:CGGCAGTTCCGTAGGC"	-1.43723760071452	-16.2180528870788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTTCCGTAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.65690774154	37.3952565761306	0.0130585673426999	3011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2851.8259400128	2851.8259400128
"AML-0024"	"2020-09-15-AML0024:CGGCAGTTCGAACCAT"	-1.84015796604808	-15.3952884904114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGCAGTTCGAACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2954.36598797911	37.8362184075758	0.0128068826142482	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.80762067327	2947.80762067327
"AML-0024"	"2020-09-15-AML0024:CGGGACTCATTAGGCT"	-0.297341446310836	-16.3240442506042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGACTCATTAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.36920460032	33.9839050875368	0.0123921698911032	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.17887509993	2733.17887509993
"AML-0024"	"2020-09-15-AML0024:CGGGACTTCTCGTCGT"	0.153811735182446	-16.2636537781921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGACTTCTCGTCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2799.17831719036	36.9796258836295	0.0132108860862952	2506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2793.45161130854	2793.45161130854
"AML-0024"	"2020-09-15-AML0024:CGGGACTTCTTTGCAT"	-1.66224632683452	-16.3430814973083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGACTTCTTTGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.66022049047	36.8941509766535	0.0127942088025816	3190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.13606146002	2878.13606146002
"AML-0024"	"2020-09-15-AML0024:CGGGCATAGACATACA"	-2.3750093978947	-15.4224033585754	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATAGACATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.91062848308	33.8400687086818	0.0119664562125267	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.1599291737	2822.1599291737
"AML-0024"	"2020-09-15-AML0024:CGGGCATAGGACGCAT"	-1.46055660668071	-16.1543894044128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATAGGACGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.7300623664	30.6586881902634	0.0107058582766454	2750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.99064121925	2857.99064121925
"AML-0024"	"2020-09-15-AML0024:CGGGCATCATGACTAC"	-1.48731503906901	-16.5730314484802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATCATGACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.78486291287	33.1949290157237	0.0131684895066236	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.90807596167	2517.90807596167
"AML-0024"	"2020-09-15-AML0024:CGGGCATGTGATACCT"	-0.965788225561935	-17.4584646455017	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATGTGATACCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2996.97170312993	43.2863919266922	0.0144433769199374	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2987.87487515826	2987.87487515826
"AML-0024"	"2020-09-15-AML0024:CGGGCATTCAACACCA"	-0.414630184799987	-15.8554601899353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATTCAACACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.40800791059	38.314410173284	0.0135271507728676	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2823.3749440414	2823.3749440414
"AML-0024"	"2020-09-15-AML0024:CGGGCATTCACAAGAA"	-2.34973035278972	-16.5190134278503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATTCACAAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.03026391263	37.4437749268973	0.01631515519236	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2287.84062001378	2287.84062001378
"AML-0024"	"2020-09-15-AML0024:CGGGCATTCTGCGGCA"	-2.54685984078105	-16.4568166962829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATTCTGCGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2182.35131410117	45.6949626217881	0.0209384081868635	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2173.26211003244	2173.26211003244
"AML-0024"	"2020-09-15-AML0024:CGGGCATTCTTAAGGC"	-1.65781281414683	-16.5002565613953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGCATTCTTAAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.19351523969	33.6931559112049	0.0121803321877448	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.66551928672	2757.66551928672
"AML-0024"	"2020-09-15-AML0024:CGGGTCAGTACCGTCG"	-1.73609624329265	-15.58452036297	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTCAGTACCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.07074428492	37.318957576524	0.0136246782433021	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.25310889174	2735.25310889174
"AML-0024"	"2020-09-15-AML0024:CGGGTCATCAAGTGGG"	-1.50027773800548	-15.510129951593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTCATCAAGTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.54317296756	39.3186894533565	0.0141763394334646	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.07392465926	2770.07392465926
"AML-0024"	"2020-09-15-AML0024:CGGGTCATCGCACTCT"	-0.55290643397029	-15.7339754334656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTCATCGCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2997.59058999725	37.4315561836702	0.0124872143342646	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2989.91827511445	2989.91827511445
"AML-0024"	"2020-09-15-AML0024:CGGGTGTAGGTGCGAT"	-1.18344400349315	-17.0482092133728	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTAGGTGCGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2746.68552963558	43.8398597037451	0.0159610043562437	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2738.30829073332	2738.30829073332
"AML-0024"	"2020-09-15-AML0024:CGGGTGTCACATATCG"	-0.429901908070403	-15.7909231415954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTCACATATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.66631171493	36.0468532405889	0.0140223774187718	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.55710889132	2565.55710889132
"AML-0024"	"2020-09-15-AML0024:CGGGTGTCACTGCTTC"	-1.92351291599925	-15.3807029954162	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTCACTGCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2910.58022148946	47.2584395064237	0.0162367761443248	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.0764141674	2901.0764141674
"AML-0024"	"2020-09-15-AML0024:CGGGTGTGTCTACGAT"	-0.682419638068038	-15.8129549256531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTGTCTACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.10280744071	39.6812929901381	0.0140112473621666	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.42652168427	2822.42652168427
"AML-0024"	"2020-09-15-AML0024:CGGGTGTGTTGCTTGA"	-2.07110081139262	-15.8848896256653	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTGTTGCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.37524051994	41.1535491984187	0.0155098866417229	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.65796588217	2644.65796588217
"AML-0024"	"2020-09-15-AML0024:CGGGTGTTCCTCAGAA"	-0.582717399031478	-16.3296079865661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTTCCTCAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.68286334241	44.2089860095057	0.0183998423945164	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2395.50926528518	2395.50926528518
"AML-0024"	"2020-09-15-AML0024:CGGGTGTTCGAGAACG"	-2.14962301674541	-16.4438085786072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTTCGAGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.28084673329	38.9636865499604	0.016335051951355	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2371.00690272635	2371.00690272635
"AML-0024"	"2020-09-15-AML0024:CGGGTGTTCGTCCATC"	-2.15668163719829	-16.3517465821472	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTTCGTCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.55596469794	46.2187739393188	0.0186474602944669	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.75197694349	2470.75197694349
"AML-0024"	"2020-09-15-AML0024:CGGGTGTTCGTGCACG"	-0.428643862635452	-16.1442976227966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGGTGTTCGTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.16404630453	40.8913803190013	0.0154181187909468	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.60304137715	2645.60304137715
"AML-0024"	"2020-09-15-AML0024:CGGTCAGAGGTCCTGC"	-2.70283756676372	-15.9690923920837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGAGGTCCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.08822840019	44.3341513547825	0.016280835447197	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.14061675611	2715.14061675611
"AML-0024"	"2020-09-15-AML0024:CGGTCAGCACAACGCC"	-1.37169692936595	-16.3332185975281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGCACAACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.95681749967	34.4042658320785	0.0131617575323939	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.45961852087	2607.45961852087
"AML-0024"	"2020-09-15-AML0024:CGGTCAGCAGGTACGA"	-1.24743423882182	-16.1295614472595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGCAGGTACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2982.68233993278	39.9939020218115	0.0134087031281758	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.43840320171	2973.43840320171
"AML-0024"	"2020-09-15-AML0024:CGGTCAGCAGTTGCGC"	-1.41922698441203	-15.5232181779114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGCAGTTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.6897623445	39.0791997207077	0.014855115293367	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.1358797837	2625.1358797837
"AML-0024"	"2020-09-15-AML0024:CGGTCAGGTCCGTTTC"	-0.959344367415267	-15.7991781464783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGGTCCGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.10346223844	33.6724606113452	0.0125732486015311	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.07451136878	2674.07451136878
"AML-0024"	"2020-09-15-AML0024:CGGTCAGGTTACCCAA"	-1.82170377197917	-16.1768923035828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGGTTACCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.00127948994	29.8967349206866	0.0116692896135628	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.29441700171	2555.29441700171
"AML-0024"	"2020-09-15-AML0024:CGGTCAGGTTATCTGG"	-1.07799766483958	-16.2994890443054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGGTTATCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.43907298076	35.9388479925739	0.0131961270399339	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.5513082921	2712.5513082921
"AML-0024"	"2020-09-15-AML0024:CGGTCAGGTTGTGCCG"	-2.8914660018986	13.7062835463318	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGGTTGTGCCG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2026.38783238509	36.7544004691318	0.0181378904283448	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2020.81443180727	2020.81443180727
"AML-0024"	"2020-09-15-AML0024:CGGTCAGTCTCGTTTA"	-2.38102350655254	-15.8919277421203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGGTCAGTCTCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.17471471627	30.4336759508179	0.0123554678314094	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.5636662377	2455.5636662377
"AML-0024"	"2020-09-15-AML0024:CGTAAGTAGTAGAATC"	-0.984271745116073	-16.5410089722839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTAGTAGAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.13463928296	35.1568742543641	0.0145268257739497	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2406.62422257047	2406.62422257047
"AML-0024"	"2020-09-15-AML0024:CGTAAGTCAACGCATT"	-2.78643355789836	-15.9378786317078	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTCAACGCATT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2546.68465946612	41.309596333354	0.0162209310759401	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.60867961653	2538.60867961653
"AML-0024"	"2020-09-15-AML0024:CGTAAGTCAAGCAGGT"	-1.77309844914134	-16.5257349244324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTCAAGCAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2242.21198279745	38.2383066847388	0.0170538320988863	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2228.81879524903	2228.81879524903
"AML-0024"	"2020-09-15-AML0024:CGTAAGTGTATGTCTG"	-1.53004179421123	-15.6220245591369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTGTATGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.05050951244	35.7925611186529	0.0131684679859291	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.68882414697	2713.68882414697
"AML-0024"	"2020-09-15-AML0024:CGTAAGTGTGTTCGTA"	-0.979218463332015	-16.4145536652771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTGTGTTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.88081632072	39.9948310343565	0.0156481596399047	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.11927195312	2550.11927195312
"AML-0024"	"2020-09-15-AML0024:CGTAAGTGTTAACAGA"	-0.781625310808975	-16.1010790101257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTGTTAACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.5699417705	36.0746136169269	0.0128627969228513	2532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.35024799037	2798.35024799037
"AML-0024"	"2020-09-15-AML0024:CGTAAGTTCCGGACTG"	-2.74055085602458	-16.100874923822	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTTCCGGACTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.96506110481	36.4860653202767	0.0141475609230031	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.54229152058	2576.54229152058
"AML-0024"	"2020-09-15-AML0024:CGTAAGTTCTCGTGAA"	-1.5628504556721	-16.1615762940613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTTCTCGTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.47829844505	34.265050884488	0.0133979830465507	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.27737900198	2553.27737900198
"AML-0024"	"2020-09-15-AML0024:CGTAAGTTCTTAGGAC"	-0.81328527155574	-16.5268182984558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAAGTTCTTAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.39590068364	33.847984115249	0.0134670324345013	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2503.93834637152	2503.93834637152
"AML-0024"	"2020-09-15-AML0024:CGTAATGAGCTACGTT"	-1.68923590603526	-16.0262556306091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAATGAGCTACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.19855676084	32.3497591319065	0.0120969922185174	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.23285038714	2664.23285038714
"AML-0024"	"2020-09-15-AML0024:CGTAATGCATCGAGCC"	-1.84741828861888	-16.0099725953308	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAATGCATCGAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.31490447276	46.4401800086807	0.0189527394719387	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.92569704759	2442.92569704759
"AML-0024"	"2020-09-15-AML0024:CGTAATGGTCTTACAG"	-2.85827670517619	-15.6318645707336	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAATGGTCTTACAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.83669442363	36.4824769083955	0.0136238617479427	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.61433062758	2672.61433062758
"AML-0024"	"2020-09-15-AML0024:CGTAATGTCGTTATCT"	1.57548572596852	-4.74732592022093	"2020-09-15-AML0024"	"AML0024"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00337078651685393	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAATGTCGTTATCT"	"cDC2"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2108.2184963839	42.2794678086849	0.0200545948539985	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"DC_AML-0024"	2108.2184963839	2108.2184963839
"AML-0024"	"2020-09-15-AML0024:CGTAATGTCTTCTGTA"	-0.791874508292037	-16.8671732178894	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAATGTCTTCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2115.18353410464	32.7134444411483	0.015466007518348	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2111.01298291881	2111.01298291881
"AML-0024"	"2020-09-15-AML0024:CGTAGTAAGCATGAAT"	-2.37051425400432	-15.9344835511413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTAAGCATGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3037.76459577014	36.279704016567	0.011942895136471	3284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3030.87223246944	3030.87223246944
"AML-0024"	"2020-09-15-AML0024:CGTAGTACACTGTCCT"	-2.27330050888713	-15.4783849946228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTACACTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.86800466016	32.6610188868061	0.0119163049191987	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.97002379242	2733.97002379242
"AML-0024"	"2020-09-15-AML0024:CGTAGTACAGGTATGG"	-0.974762658507186	-17.3416948548523	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTACAGGTATGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2641.15059249649	43.3757811385402	0.0164230624568591	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2636.23784634758	2636.23784634758
"AML-0024"	"2020-09-15-AML0024:CGTAGTAGTCGATGCC"	-2.76638708534892	-15.8522501221863	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTAGTCGATGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2546.10526018936	41.4245531233707	0.0162697724132151	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.18245675925	2540.18245675925
"AML-0024"	"2020-09-15-AML0024:CGTAGTAGTTAGGCTT"	-1.72621736946757	-16.5306310883728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTAGTTAGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.90295207929	38.5970517433398	0.0146762266314138	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.09387644215	2623.09387644215
"AML-0024"	"2020-09-15-AML0024:CGTAGTATCCTTCAGC"	-1.405376414687	-16.240300201532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTAGTATCCTTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1785.47074439391	53.1824161188178	0.0297862153641006	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1783.9126660485	1783.9126660485
"AML-0024"	"2020-09-15-AML0024:CGTCAAAAGAAGGCTC"	8.52327122268025	8.23346803272096	"2020-09-15-AML0024"	"AML0024"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCAAAAGAAGGCTC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2035.00123410027	50.5598163280852	0.0248451035217377	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	2028.77082112499	2028.77082112499
"AML-0024"	"2020-09-15-AML0024:CGTCAAACACCATTCC"	-2.13143382492717	-16.6543169251648	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCAAACACCATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.09416780238	41.8918546139863	0.0171330229999437	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.96842909285	2441.96842909285
"AML-0024"	"2020-09-15-AML0024:CGTCAAATCTAGGAAA"	-1.86123869839366	-15.6414289704529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCAAATCTAGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.71432533361	37.5998135621253	0.0133583053966476	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.25630430971	2809.25630430971
"AML-0024"	"2020-09-15-AML0024:CGTCCATAGTATGTAG"	-1.08369360390361	-16.4979944459167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCCATAGTATGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.82681252596	33.0273845009222	0.0123152562822706	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.28615240079	2674.28615240079
"AML-0024"	"2020-09-15-AML0024:CGTCCATGTTGCTTGA"	-0.636754850775558	-16.6219511262146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCCATGTTGCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.56528325971	39.6700532591417	0.0140595907861864	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.5623424326	2804.5623424326
"AML-0024"	"2020-09-15-AML0024:CGTCCATTCAAGTGGG"	-1.78559909287151	-16.2848825684753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCCATTCAAGTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.86802211502	32.1095161203246	0.0126821445035281	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.52475110866	2527.52475110866
"AML-0024"	"2020-09-15-AML0024:CGTCCATTCAGCGCGT"	-1.31743739071544	-16.4477815858093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCCATTCAGCGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.51046430497	37.6443038151687	0.0173355387569902	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2166.65600928578	2166.65600928578
"AML-0024"	"2020-09-15-AML0024:CGTCCATTCCGTATGA"	-2.04131088677104	-15.971163772699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTCCATTCCGTATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.56639031214	42.8932278131864	0.0166927883143646	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.88949847826	2564.88949847826
"AML-0024"	"2020-09-15-AML0024:CGTGAATAGTGAGCCA"	-1.41296289387401	-16.1385336152283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATAGTGAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.10210056714	35.9717093688602	0.0151772825990292	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2364.27682733574	2364.27682733574
"AML-0024"	"2020-09-15-AML0024:CGTGAATCAAGCGATG"	-1.72490177574809	-15.6852388611999	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATCAAGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.48952103843	34.2768256726013	0.0119369495940928	2974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.90182404611	2864.90182404611
"AML-0024"	"2020-09-15-AML0024:CGTGAATCAATGTCAC"	-0.851113776594955	-16.3105154267517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATCAATGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.02233347891	35.223829430036	0.0137645650720642	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.37313847651	2553.37313847651
"AML-0024"	"2020-09-15-AML0024:CGTGAATCAGACAAGC"	-0.659110288054305	-16.0493574372497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATCAGACAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.62770515621	39.6526147654973	0.01528847593919	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.10940954879	2588.10940954879
"AML-0024"	"2020-09-15-AML0024:CGTGAATCATTGGCAT"	0.230132912367028	-15.9276066056457	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATCATTGGCAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2969.70347597928	42.394118325028	0.0142755391802369	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2957.5591469787	2957.5591469787
"AML-0024"	"2020-09-15-AML0024:CGTGAATGTAGATCCT"	-2.57419143143352	-15.9608488312927	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATGTAGATCCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.3664498027	29.1307938589581	0.0107638024632924	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.83764450223	2699.83764450223
"AML-0024"	"2020-09-15-AML0024:CGTGAATGTATCGAAA"	0.0245634886318862	-16.3138838044372	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATGTATCGAAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2652.1064685756	41.141356224738	0.0155127091284666	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2641.35181200428	2641.35181200428
"AML-0024"	"2020-09-15-AML0024:CGTGAATGTTGTGTTG"	-1.9510215324467	-15.7460012665954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGAATGTTGTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.53499143491	36.2702262532352	0.0159252114192037	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2276.27193472873	2276.27193472873
"AML-0024"	"2020-09-15-AML0024:CGTGATAAGCTCAGAG"	-1.14333413067515	-16.5244837037292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATAAGCTCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.82255292866	43.3623711521448	0.0168343782466081	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.62400895838	2566.62400895838
"AML-0024"	"2020-09-15-AML0024:CGTGATACACGTCGGT"	-1.98619900170024	-16.3168592683044	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATACACGTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.26444886632	42.5326321704607	0.0165866793455194	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.16744050646	2555.16744050646
"AML-0024"	"2020-09-15-AML0024:CGTGATAGTCCAGCCA"	-1.32845650139506	-16.4814234009949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATAGTCCAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.29806012005	36.7313350823261	0.0149053946341769	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2454.55138036885	2454.55138036885
"AML-0024"	"2020-09-15-AML0024:CGTGATAGTGACTAAA"	0.828854878514451	-16.3432646027771	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATAGTGACTAAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2325.15144892559	48.3481282018379	0.0207935393731788	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2309.614033937	2309.614033937
"AML-0024"	"2020-09-15-AML0024:CGTGATATCCCGAAAT"	-0.772551814944106	-15.7093897095886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATATCCCGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.78340080888	34.1918214802709	0.0134943742505202	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.27249530457	2526.27249530457
"AML-0024"	"2020-09-15-AML0024:CGTGATATCCTTTAGT"	-2.07991323891338	-15.4339590302673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATATCCTTTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.98642438764	40.0640393663624	0.0141419807103461	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.2947775733	2828.2947775733
"AML-0024"	"2020-09-15-AML0024:CGTGATATCGGCATTA"	-2.31888304176982	-16.4561662903992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGATATCGGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2530.179167238	38.1652151899904	0.0150839970877052	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.38022051099	2512.38022051099
"AML-0024"	"2020-09-15-AML0024:CGTGCTTCACAGCATT"	-1.0838203233784	-15.9062891236511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTCACAGCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.17859640785	43.7673344888087	0.0167294903141947	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.56230321328	2610.56230321328
"AML-0024"	"2020-09-15-AML0024:CGTGCTTGTACAACGG"	-0.826927642256576	-15.922878288385	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTGTACAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.30236476631	30.8051680615878	0.0106397067320028	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.67155965548	2881.67155965548
"AML-0024"	"2020-09-15-AML0024:CGTGCTTGTACACGCC"	0.13207128372733	-16.4791097871033	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTGTACACGCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2386.34426945724	44.737840170085	0.0187474375523614	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2376.44899777818	2376.44899777818
"AML-0024"	"2020-09-15-AML0024:CGTGCTTGTGCAATGG"	-2.68817577782329	-15.9336757889953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTGTGCAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.43692583756	35.8782890486142	0.0142519118077516	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.44846900715	2511.44846900715
"AML-0024"	"2020-09-15-AML0024:CGTGCTTTCCAAAGGG"	1.31088652190511	-16.183171295282	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTTCCAAAGGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2928.38753798472	38.8694569398542	0.0132733309494288	3934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2919.73801672603	2919.73801672603
"AML-0024"	"2020-09-15-AML0024:CGTGCTTTCGACCCAG"	-3.05957184258159	10.8221883543762	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGCTTTCGACCCAG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1965.95653302265	35.0714513437502	0.0178393828930836	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1957.39755369963	1957.39755369963
"AML-0024"	"2020-09-15-AML0024:CGTGTCTGTACAGTCT"	-1.05145297470744	-16.8044843903747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTGTACAGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1949.50322528152	40.5954997590426	0.0208235099242682	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1948.08175229679	1948.08175229679
"AML-0024"	"2020-09-15-AML0024:CGTGTCTGTCACGTGC"	-2.5396503013676	-15.7261800996033	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTGTCACGTGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.48015341714	32.9825988402347	0.012538622957253	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.04974435613	2625.04974435613
"AML-0024"	"2020-09-15-AML0024:CGTGTCTGTCAGCGTC"	-1.53785393658336	-16.3797369233337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTGTCAGCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.7564564288	33.2881483872171	0.0130862167654016	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.24606227176	2537.24606227176
"AML-0024"	"2020-09-15-AML0024:CGTGTCTGTTCTCTCG"	-1.36896560612376	-16.3917494050232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTGTTCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.46975949225	35.8889650850592	0.0136176728857529	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.25264551709	2633.25264551709
"AML-0024"	"2020-09-15-AML0024:CGTGTCTTCATGCCGG"	0.446779121726197	-16.1239595643249	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTTCATGCCGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2512.86381180496	39.0443004166677	0.0155377701860502	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2508.0006953218	2508.0006953218
"AML-0024"	"2020-09-15-AML0024:CGTGTCTTCATTTACC"	-0.144890393049079	-15.9939947358337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTTCATTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.7087787369	37.1078468857465	0.0150678988949634	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2454.38561666175	2454.38561666175
"AML-0024"	"2020-09-15-AML0024:CGTGTCTTCTGCCTCA"	-2.42503557625468	-16.2568941346374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTGTCTTCTGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1970.44616740852	31.0576462716996	0.0157617329442427	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1965.5882239247	1965.5882239247
"AML-0024"	"2020-09-15-AML0024:CGTTAGACAGAACTAA"	-0.179880718619186	-15.9434147111145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTAGACAGAACTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.07636713222	39.737762828407	0.0144549505075629	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.98597555008	2739.98597555008
"AML-0024"	"2020-09-15-AML0024:CGTTAGACAGCAGTTT"	-1.34246168556865	-15.8267565003601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTAGACAGCAGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.52147068343	33.8325161682743	0.0130299389203083	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.89660919007	2589.89660919007
"AML-0024"	"2020-09-15-AML0024:CGTTAGAGTACAAAGT"	-0.943062941462356	-16.7311067811218	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTAGAGTACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.5148950439	32.9605703891289	0.012558728644052	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.87414298785	2616.87414298785
"AML-0024"	"2020-09-15-AML0024:CGTTAGAGTCCTCCAT"	-2.78707371178325	-15.927348159906	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTAGAGTCCTCCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.1056369266	33.650886339137	0.013164904397143	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.43114406579	2546.43114406579
"AML-0024"	"2020-09-15-AML0024:CGTTCTGGTCTAGTGT"	-1.43118737164195	-16.0336675873962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGGTCTAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.31631457209	37.5521563467816	0.0165989857850114	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2259.74797488143	2259.74797488143
"AML-0024"	"2020-09-15-AML0024:CGTTCTGGTGGCCCAT"	-0.134209270507652	-16.2224836579529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGGTGGCCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.4786910016	38.9499168951864	0.0143067848515856	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.93217664244	2717.93217664244
"AML-0024"	"2020-09-15-AML0024:CGTTCTGTCACTGTCC"	-0.866990129381973	-16.547314666864	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGTCACTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2549.61839195356	42.8789597696831	0.0168177951276969	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.50146536139	2536.50146536139
"AML-0024"	"2020-09-15-AML0024:CGTTCTGTCTCAACGA"	-2.1309212249821	-16.2958173981872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGTCTCAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.02450235458	35.6370079951787	0.0141415323390234	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.85171196378	2510.85171196378
"AML-0024"	"2020-09-15-AML0024:CGTTCTGTCTCACCCA"	-1.29705355587657	-15.8056869736877	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGTCTCACCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.55291004533	31.2033772143115	0.0124835833996191	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.7007046411	2497.7007046411
"AML-0024"	"2020-09-15-AML0024:CGTTCTGTCTCATGGA"	-0.00852832841928605	-16.5362749329773	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTCTGTCTCATGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2935.7986000832	46.5501770184272	0.0158560525974459	3064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2928.01726249549	2928.01726249549
"AML-0024"	"2020-09-15-AML0024:CGTTGGGAGCGGTATG"	-1.83856294575389	-15.7898054352966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGAGCGGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.81498756737	37.7364429631835	0.0130674725097164	3033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.17754618974	2881.17754618974
"AML-0024"	"2020-09-15-AML0024:CGTTGGGAGGATCATA"	-0.5582152408665	-16.1576605073181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGAGGATCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.34993761251	35.4303177559932	0.0139745276304372	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.23917588005	2534.23917588005
"AML-0024"	"2020-09-15-AML0024:CGTTGGGAGTCGTTAC"	-0.0893714827602685	-16.1321420899597	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGAGTCGTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.6680104058	36.7923772973151	0.0143068145454395	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.15729682018	2562.15729682018
"AML-0024"	"2020-09-15-AML0024:CGTTGGGCACCCTGAG"	-2.78281126442607	-15.4832620850769	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGCACCCTGAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.98398075116	40.4668005456633	0.016777391918275	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2406.00379908676	2406.00379908676
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTAGCTTAC"	0.024225234135431	-16.0557699433533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTAGCTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2857.44021283203	37.601491051862	0.0131591523360676	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2846.34948478158	2846.34948478158
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTGACAGGT"	-1.06911049309428	-16.297257446405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTGACAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2353.675295571	36.7029983923145	0.0155939090074913	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2348.65329225668	2348.65329225668
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTGGATACG"	-0.744266788393813	-16.3578729859558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTGGATACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.52458042546	34.6843955655012	0.013733541076705	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2521.52569893531	2521.52569893531
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTTATGTCG"	-1.92389736595805	-16.5648298493591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTTATGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.24574150557	37.7928639059904	0.0151338185417049	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.86866229495	2489.86866229495
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTTATGTGC"	-2.50885806503947	-16.1760950318542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTTATGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.52242891907	40.4974504591384	0.01519306310079	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.72505454475	2658.72505454475
"AML-0024"	"2020-09-15-AML0024:CGTTGGGGTTTAAGGA"	-0.743604640395004	-15.9146309128967	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CGTTGGGGTTTAAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.0180480207	38.9728367394289	0.0146348376303329	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.98281733068	2657.98281733068
"AML-0024"	"2020-09-15-AML0024:CTAACCCCAGTTCACA"	-2.15121851387675	-16.6127119294372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACCCCAGTTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.63798620056	40.9746567517409	0.0161150179357499	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.32108094098	2528.32108094098
"AML-0024"	"2020-09-15-AML0024:CTAACCCCATAATGAG"	-1.64259443703349	-16.0219393006531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACCCCATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.29688262919	39.2556865268	0.0160732656238501	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.58543892948	2433.58543892948
"AML-0024"	"2020-09-15-AML0024:CTAACCCTCATGTCAG"	-2.50672302666362	-15.9305820695129	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACCCTCATGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.63712262855	37.5913819691634	0.0136664271924174	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.92602672811	2747.92602672811
"AML-0024"	"2020-09-15-AML0024:CTAACCCTCTCAAAGC"	-0.781182746321517	-15.5169763795105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACCCTCTCAAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.24674273863	33.9106752191617	0.0118434344874961	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.64356696384	2856.64356696384
"AML-0024"	"2020-09-15-AML0024:CTAACTTAGGCCTAAG"	1.79490413245503	-8.4617433778015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.166666666666667	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTAGGCCTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1337.90889556066	48.3947315003545	0.0361719184773598	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1331.4196889647	1331.4196889647
"AML-0024"	"2020-09-15-AML0024:CTAACTTCAATACGAA"	-0.454922596842605	-15.860209488031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTCAATACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.11712354547	34.6463696024216	0.0124891517046482	2929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.03153629591	2760.03153629591
"AML-0024"	"2020-09-15-AML0024:CTAACTTCACAAGCCC"	-1.513126830489	-16.8288030854431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTCACAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.4320467361	42.1558159011521	0.0164450686160482	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.67916773758	2548.67916773758
"AML-0024"	"2020-09-15-AML0024:CTAACTTCACCAGCGT"	-1.15082869949992	-16.3906793824402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTCACCAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.83211764628	30.805593145491	0.0105037015109524	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.68907828273	2922.68907828273
"AML-0024"	"2020-09-15-AML0024:CTAACTTCATGGAATA"	0.189931725233239	-16.1222734681335	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTCATGGAATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2807.64280963554	37.2463753447408	0.0132660661879478	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2803.09952240817	2803.09952240817
"AML-0024"	"2020-09-15-AML0024:CTAACTTGTACCGGCT"	-1.48638854447063	-15.6293030015198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTGTACCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3019.27551744815	31.5632920463233	0.0104539290514965	2775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3015.12218747703	3015.12218747703
"AML-0024"	"2020-09-15-AML0024:CTAACTTGTCAGTTTG"	-3.06872997704204	9.97278974140016	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTGTCAGTTTG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1988.02483851879	26.0537205505573	0.0131053294937548	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1982.86907311784	1982.86907311784
"AML-0024"	"2020-09-15-AML0024:CTAACTTGTTGACTAC"	-1.98286686363872	-16.3435087434021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTGTTGACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.53955230434	36.3287369853018	0.0162360200282889	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2230.92420323967	2230.92420323967
"AML-0024"	"2020-09-15-AML0024:CTAACTTGTTGTGTTG"	-1.30060444298442	-16.2898283234802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTGTTGTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.26040870528	28.8441023341486	0.0115226135618336	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2493.49275771397	2493.49275771397
"AML-0024"	"2020-09-15-AML0024:CTAACTTGTTTACCAG"	-2.15414462509807	-16.7335653535095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTGTTTACCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.87876990064	41.0589971394609	0.0161403120405241	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.65575528641	2534.65575528641
"AML-0024"	"2020-09-15-AML0024:CTAACTTTCCCGAATA"	-1.89273343506511	-16.9209585419861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTTCCCGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1333.32239193901	50.6219133596968	0.0379667465766318	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1322.26451293451	1322.26451293451
"AML-0024"	"2020-09-15-AML0024:CTAACTTTCCGATAGT"	-0.888438205153304	-16.0344534150329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAACTTTCCGATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.02056229643	36.098137955398	0.0130082416130011	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.3056205632	2765.3056205632
"AML-0024"	"2020-09-15-AML0024:CTAAGTGAGCACGTCC"	-2.85722885552104	-15.7511158219543	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGAGCACGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.64138682014	36.4701752115111	0.0124614431326472	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2917.81121911085	2917.81121911085
"AML-0024"	"2020-09-15-AML0024:CTAAGTGAGTATGCAA"	-1.88110981407817	-15.8070278397766	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGAGTATGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.89518068903	31.0317981934367	0.0128982336564428	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2400.52654303262	2400.52654303262
"AML-0024"	"2020-09-15-AML0024:CTAAGTGGTACGGTTT"	-0.41406429830249	-15.8372593156067	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGGTACGGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.59911923802	37.5879925275413	0.0128435740585228	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2918.55859775236	2918.55859775236
"AML-0024"	"2020-09-15-AML0024:CTAAGTGTCATCCTAT"	-1.31471369686778	-16.1970319977966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGTCATCCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.24065923686	33.4855933005479	0.0134359389316766	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.2207897014	2487.2207897014
"AML-0024"	"2020-09-15-AML0024:CTAAGTGTCCACTAGA"	-0.530792395502883	-15.9597444764343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGTCCACTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2861.83414045844	41.8510391305942	0.0146238520740723	2809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.21891738904	2849.21891738904
"AML-0024"	"2020-09-15-AML0024:CTAAGTGTCGAAGCAG"	-1.71093569222148	-15.6402054063049	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGTCGAAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3169.29119737359	39.4374843636596	0.0124436291611013	3416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3162.73106235543	3162.73106235543
"AML-0024"	"2020-09-15-AML0024:CTAAGTGTCTCGAGTA"	-0.281623552471954	-16.5731077424255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAAGTGTCTCGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.64443011352	40.880302124625	0.0145499913392861	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.23553554382	2801.23553554382
"AML-0024"	"2020-09-15-AML0024:CTACAGAAGCTAGAAT"	-1.90007124367412	-16.2130480042663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAAGCTAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.25360630161	36.4581229826152	0.0120872206854378	3070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3007.63669686862	3007.63669686862
"AML-0024"	"2020-09-15-AML0024:CTACAGAAGGACAGCT"	-2.14825997772868	-16.7145128480163	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAAGGACAGCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2323.31097466759	33.1637783849974	0.0142743604909551	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2319.83055240175	2319.83055240175
"AML-0024"	"2020-09-15-AML0024:CTACAGAAGGAGAGTA"	-1.76596126976665	-16.5654039612976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.14505945929	46.1081679287768	0.0172036090979639	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.16748142114	2675.16748142114
"AML-0024"	"2020-09-15-AML0024:CTACAGAAGGGAGGTG"	0.701729138463181	-16.2086477509704	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAAGGGAGGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2999.29188226528	43.7677173668881	0.0145926835683066	3846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2988.68036083154	2988.68036083154
"AML-0024"	"2020-09-15-AML0024:CTACAGAAGGTCGACA"	-1.93094537678416	-16.5585985413757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAAGGTCGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.73279693314	44.6399346575862	0.0166832557827715	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.99535253698	2664.99535253698
"AML-0024"	"2020-09-15-AML0024:CTACAGACACACCAGC"	-1.40509722653087	-15.8497343293396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGACACACCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.32321891195	39.3141909973883	0.0151247796777827	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.78460467299	2590.78460467299
"AML-0024"	"2020-09-15-AML0024:CTACAGACACCGCTGA"	-2.81632790985759	-16.0304880372253	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGACACCGCTGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.39698194883	38.0425618399001	0.0161101933011298	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2354.6446498527	2354.6446498527
"AML-0024"	"2020-09-15-AML0024:CTACAGAGTACAGAAT"	-1.76795051518138	-15.8349418870178	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAGTACAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.94651013192	33.2635859557886	0.0136496988413537	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2431.43981504008	2431.43981504008
"AML-0024"	"2020-09-15-AML0024:CTACAGAGTATAATGG"	-1.1042836708134	-16.1602277985779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACAGAGTATAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.08413744523	33.3640929120081	0.0118983922295591	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.69407494152	2796.69407494152
"AML-0024"	"2020-09-15-AML0024:CTACATTAGCATGATA"	-2.29027567330058	-15.4466085664001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGCATGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.69300849076	34.0841803142468	0.0124499643344002	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.60338224325	2732.60338224325
"AML-0024"	"2020-09-15-AML0024:CTACATTAGCTAGTTC"	-2.03704724732097	-16.022656463739	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGCTAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.0521066441	36.8610699611567	0.0150757809459323	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2436.44528543829	2436.44528543829
"AML-0024"	"2020-09-15-AML0024:CTACATTAGGTTGTTC"	-2.65187011185344	-16.1429472199646	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGGTTGTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.54176409404	36.8541665164822	0.014182633900953	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.58247147419	2594.58247147419
"AML-0024"	"2020-09-15-AML0024:CTACATTAGTCATTGC"	-1.73787675324138	-15.411045097467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGTCATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.44314380271	35.6054850129066	0.0132389803796196	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.34531920403	2686.34531920403
"AML-0024"	"2020-09-15-AML0024:CTACATTAGTCTCGTA"	-1.87472675266917	-16.4114370576111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGTCTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.93167004963	31.8275258597215	0.0119700427875709	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.91716903134	2653.91716903134
"AML-0024"	"2020-09-15-AML0024:CTACATTAGTGCAGCA"	-0.31876171651538	-16.1051492921081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTAGTGCAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.87547792255	42.2273653372177	0.0149009247816964	2782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.56853580492	2826.56853580492
"AML-0024"	"2020-09-15-AML0024:CTACATTCACACACGC"	-1.05393050137218	-16.080367111322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTCACACACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.56235235134	35.4389678208327	0.0143503029138302	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.49681846706	2464.49681846706
"AML-0024"	"2020-09-15-AML0024:CTACATTCACAGAAGC"	-1.59006200256999	-16.8719587556091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTCACAGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.68376604933	36.2302570601717	0.0138458676322482	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.99412021462	2610.99412021462
"AML-0024"	"2020-09-15-AML0024:CTACATTGTTACTCAG"	-2.10355601730998	-15.4263820878235	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTGTTACTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2982.15384600012	35.2079534019132	0.0118062163188316	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2972.57384114185	2972.57384114185
"AML-0024"	"2020-09-15-AML0024:CTACATTTCGATTCCC"	-1.88525436344798	-15.7399273148743	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACATTTCGATTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.86375878061	29.470924520213	0.0120394464007644	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.94676843031	2442.94676843031
"AML-0024"	"2020-09-15-AML0024:CTACCCAAGCCATCCG"	-2.1093455356663	-16.7972345582214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCAAGCCATCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.09792421669	42.3888997728073	0.0157223146058846	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.67343518358	2689.67343518358
"AML-0024"	"2020-09-15-AML0024:CTACCCAGTCGAACGA"	-1.78150294247325	-15.5942535630432	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCAGTCGAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.09588991602	31.6461141456012	0.0115830905724813	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.27890839039	2727.27890839039
"AML-0024"	"2020-09-15-AML0024:CTACCCATCACGGACC"	-1.93740270558055	-16.7134638062683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCATCACGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.91894319963	45.7780634532519	0.0174132654685564	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.34259097256	2609.34259097256
"AML-0024"	"2020-09-15-AML0024:CTACCCATCACTTTGT"	-2.15102730217631	-16.1265325776306	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCATCACTTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.06466189186	40.3189049187628	0.014698488693648	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.71260338052	2733.71260338052
"AML-0024"	"2020-09-15-AML0024:CTACCCATCGACCTAA"	-1.25793228569682	-16.7684259644714	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCATCGACCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.34660872009	43.6147158454849	0.0154205696398794	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.87798122467	2824.87798122467
"AML-0024"	"2020-09-15-AML0024:CTACCCATCTTAGCAG"	-1.80665622177776	-16.2303037873474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCCATCTTAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.52758376823	36.8475542039879	0.0131667647007333	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.15624776634	2787.15624776634
"AML-0024"	"2020-09-15-AML0024:CTACCTGAGGAGAGGC"	-1.0090288919514	-15.7344923249451	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGAGGAGAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.58201952396	33.0304789161935	0.011836412148111	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.97260472286	2781.97260472286
"AML-0024"	"2020-09-15-AML0024:CTACCTGAGTCACAGG"	-0.0402614352410615	-16.0785417786804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGAGTCACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.52948600362	34.0605768242003	0.0124058317340378	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.01730773507	2736.01730773507
"AML-0024"	"2020-09-15-AML0024:CTACCTGCAAAGAGTT"	-1.52396676960643	-16.6331968537536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGCAAAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1592.7000011793	49.2142154899773	0.030899865293864	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1585.53675039138	1585.53675039138
"AML-0024"	"2020-09-15-AML0024:CTACCTGCAATTGAAG"	1.25608124312703	-16.1823358765808	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGCAATTGAAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2908.77311933694	38.7128830063875	0.0133090074124489	3510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2899.9008774134	2899.9008774134
"AML-0024"	"2020-09-15-AML0024:CTACCTGCATAAGCAA"	-1.05592451515849	-16.3414602509704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGCATAAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.41780993133	39.4722684428169	0.0143722736941485	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.2966559007	2736.2966559007
"AML-0024"	"2020-09-15-AML0024:CTACCTGGTTTATGCG"	-1.44531212273296	-16.9262171021667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGGTTTATGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.98270078446	44.2691151988093	0.0172523046181393	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.18575565848	2559.18575565848
"AML-0024"	"2020-09-15-AML0024:CTACCTGTCTGCGGCA"	-0.762591819197494	-15.9118576279846	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACCTGTCTGCGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.02483534668	36.2015494467435	0.0125829812109985	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.45252062665	2868.45252062665
"AML-0024"	"2020-09-15-AML0024:CTACGGGAGCTCGGCT"	-0.521667997271377	-16.4653806916443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGAGCTCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.48528969234	41.019891845506	0.0153088699547277	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.48266219841	2673.48266219841
"AML-0024"	"2020-09-15-AML0024:CTACGGGAGTTGGCTT"	-3.03310571137126	-15.9384117356506	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGAGTTGGCTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.00569820897	34.8684173710583	0.0135358463668389	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.94975520107	2565.94975520107
"AML-0024"	"2020-09-15-AML0024:CTACGGGCAAGCAATA"	-2.33387384834941	-16.1944990388122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGCAAGCAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2362.25529484664	42.1098818590241	0.0178261350290498	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.05002536398	2351.05002536398
"AML-0024"	"2020-09-15-AML0024:CTACGGGCACGTGTGC"	0.7807221013004	-16.2020464173523	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGCACGTGTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2964.44764655391	41.619959582111	0.0140397013354218	4133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2957.60892514489	2957.60892514489
"AML-0024"	"2020-09-15-AML0024:CTACGGGCAGAGGGTT"	-1.09139869633372	-16.5504999390808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGCAGAGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.70342704615	36.083985090223	0.0141633381292184	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.30052713772	2540.30052713772
"AML-0024"	"2020-09-15-AML0024:CTACGGGGTCCACTCT"	-2.27971420708354	-16.3348894349304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGGTCCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.27424860462	33.7298774561945	0.0129170183768398	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.82839570995	2607.82839570995
"AML-0024"	"2020-09-15-AML0024:CTACGGGGTTAAGTCC"	-0.446345518261749	-15.9076996079651	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGGTTAAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2913.84225811893	40.0248926161368	0.0137361219553372	2965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.1569508671	2903.1569508671
"AML-0024"	"2020-09-15-AML0024:CTACGGGTCTATCCAT"	-2.95402250710185	-15.8412189713684	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGTCTATCCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.5666836992	33.743940087793	0.0129011966309606	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.21639013692	2610.21639013692
"AML-0024"	"2020-09-15-AML0024:CTACGGGTCTTAATCC"	-1.08671067181285	-15.5279751054016	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACGGGTCTTAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.66579011099	37.909613741315	0.0139801939750707	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.4393301806	2707.4393301806
"AML-0024"	"2020-09-15-AML0024:CTACTATCAAGTACCT"	-1.71529863300975	-16.3001833192078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACTATCAAGTACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.56685911724	49.0176455432937	0.0212145540605655	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2302.94923820954	2302.94923820954
"AML-0024"	"2020-09-15-AML0024:CTACTATCATTGCCTC"	-0.997414569289047	-16.7395773164001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACTATCATTGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.49186659761	33.0703845063245	0.0123558696064203	2419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.71965133033	2665.71965133033
"AML-0024"	"2020-09-15-AML0024:CTACTATGTACTTCCC"	-0.89813337746318	-16.1997785798279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTACTATGTACTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.11280036418	40.522698260269	0.0157301723179747	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.50094873051	2569.50094873051
"AML-0024"	"2020-09-15-AML0024:CTAGACAAGGAGTCTG"	-0.790472070605117	-16.4283724061218	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACAAGGAGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.66168150779	33.0450019746065	0.0125424080847053	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.92688621592	2625.92688621592
"AML-0024"	"2020-09-15-AML0024:CTAGACAAGGCCCGTT"	-1.26274297657664	-15.3426771393982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACAAGGCCCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.57913096571	37.5290586536123	0.013521163289823	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.1617730212	2770.1617730212
"AML-0024"	"2020-09-15-AML0024:CTAGACACACACAGAG"	-2.77059922638591	-16.1277628174988	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACACACACAGAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.05551317665	38.9644088931745	0.0161741432192216	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2405.45316751487	2405.45316751487
"AML-0024"	"2020-09-15-AML0024:CTAGACACACGGCCAT"	-0.365344594151336	-16.4512300721374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACACACGGCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.24705176773	31.7925163094256	0.0109280909265192	3086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.12855530716	2902.12855530716
"AML-0024"	"2020-09-15-AML0024:CTAGACAGTGGCCACT"	-2.05724273148234	-15.4459629288879	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACAGTGGCCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.95461234097	34.968269746771	0.012129316776991	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.40653413832	2877.40653413832
"AML-0024"	"2020-09-15-AML0024:CTAGACATCGCTACGG"	-1.00959918919261	-16.5897798768249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGACATCGCTACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.33735319275	33.2658906629933	0.0138646158360045	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2393.82453664639	2393.82453664639
"AML-0024"	"2020-09-15-AML0024:CTAGGTAAGCCTGTCG"	-0.0165578899091065	-16.1016702882019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTAAGCCTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.90429563453	41.8309014171701	0.0151183044108784	2605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.17769309762	2759.17769309762
"AML-0024"	"2020-09-15-AML0024:CTAGGTAAGGGTTAGC"	-0.753205041319686	-15.9407339326111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTAAGGGTTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.8789453015	40.1542304777791	0.0148067931082797	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.98612724895	2705.98612724895
"AML-0024"	"2020-09-15-AML0024:CTAGGTAAGGTGAGCT"	-1.75651548329051	-16.3775320283142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTAAGGTGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.4686124569	40.1477519673725	0.0153383890742008	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.03514867041	2611.03514867041
"AML-0024"	"2020-09-15-AML0024:CTAGGTACACTTTAGG"	-2.04046378555949	-16.2827139130798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTACACTTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.80932601287	37.5773790797834	0.0144761707661717	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.20012380211	2590.20012380211
"AML-0024"	"2020-09-15-AML0024:CTAGGTAGTTGCTCAA"	0.231428180902642	-16.1102285615173	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTAGTTGCTCAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2815.54839864255	39.8239435805118	0.0141442937367768	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2809.90538106543	2809.90538106543
"AML-0024"	"2020-09-15-AML0024:CTAGGTATCAAGAATG"	-3.07621393624004	11.4061012038025	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTATCAAGAATG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2267.2078887351	45.9481249687049	0.020266392507279	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2259.23775946714	2259.23775946714
"AML-0024"	"2020-09-15-AML0024:CTAGGTATCTGGAAGG"	-0.505502442747909	-16.5446958771911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTAGGTATCTGGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.22011688657	37.1143882966563	0.014312085601594	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.39117901227	2585.39117901227
"AML-0024"	"2020-09-15-AML0024:CTATAGGAGACAACTA"	-1.36387322369273	-15.7554378739563	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGAGACAACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.99817324973	38.2648520329864	0.0142460454419039	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.74028788633	2680.74028788633
"AML-0024"	"2020-09-15-AML0024:CTATAGGAGATTAGCA"	-1.70137618008311	-16.3528013459411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGAGATTAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.91989407163	43.0042037637317	0.0171884814800152	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.28535550416	2489.28535550416
"AML-0024"	"2020-09-15-AML0024:CTATAGGAGTTGTCGT"	0.136257757514161	-15.9504041901794	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGAGTTGTCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2572.44709282568	41.6400611982625	0.0161869456185874	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2567.27663221272	2567.27663221272
"AML-0024"	"2020-09-15-AML0024:CTATAGGCAAAGTATG"	-0.571716169745284	-15.7862196198669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGCAAAGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.14896193045	37.7166034390205	0.014242629089689	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.39590834298	2645.39590834298
"AML-0024"	"2020-09-15-AML0024:CTATAGGCAACGATTC"	-1.5069684785908	-15.8529482117859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGCAACGATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.71770563852	40.2760600464574	0.0144892626919487	2742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.48310693194	2773.48310693194
"AML-0024"	"2020-09-15-AML0024:CTATAGGGTGGAGAAA"	-0.699545065790969	-16.339478515741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGGTGGAGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.11133510719	39.655068114974	0.0145410521398516	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.90164737022	2714.90164737022
"AML-0024"	"2020-09-15-AML0024:CTATAGGTCGTCCATC"	-1.33276627484019	-16.5197725526062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATAGGTCGTCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.43320550602	41.4349566945598	0.0175614027122558	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2350.06036580402	2350.06036580402
"AML-0024"	"2020-09-15-AML0024:CTATCCGCAGTTCCAA"	-2.00797973099406	-16.1580629578796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGCAGTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3031.17810932713	36.331537524639	0.0119859461286173	3272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3023.63936895779	3023.63936895779
"AML-0024"	"2020-09-15-AML0024:CTATCCGGTAACAGTA"	-2.20558414879497	-16.1573229066101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGGTAACAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.86003835	35.9329005246097	0.0134335628815835	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.81359773462	2668.81359773462
"AML-0024"	"2020-09-15-AML0024:CTATCCGGTTGGAGAC"	-0.663987676531631	-16.3428621522156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGGTTGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.15277888449	39.1990719297807	0.0146530217784893	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.95743259956	2669.95743259956
"AML-0024"	"2020-09-15-AML0024:CTATCCGTCGCTTGAA"	-0.462719718844253	-15.8331575623718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGTCGCTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.9708941428	34.0526193643744	0.0127826544348682	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.12336274722	2661.12336274722
"AML-0024"	"2020-09-15-AML0024:CTATCCGTCGCTTGCT"	-1.21663890305217	-16.3008737794128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGTCGCTTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.42753213493	29.4825121959167	0.0105807568493725	2493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.82388028159	2780.82388028159
"AML-0024"	"2020-09-15-AML0024:CTATCCGTCGTTCGCT"	-2.06405435028728	-16.262984298822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCCGTCGTTCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.6546243894	35.5622612160519	0.0141476322447004	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.58268917057	2507.58268917057
"AML-0024"	"2020-09-15-AML0024:CTATCTACATAGGTTC"	-1.43183801594432	-15.9283380738464	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCTACATAGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.3819841669	35.3853311431966	0.0131525305147901	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.49906271149	2684.49906271149
"AML-0024"	"2020-09-15-AML0024:CTATCTAGTTAGCGGA"	-2.29237876358684	-16.159489654657	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCTAGTTAGCGGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.46852381933	30.7109112497456	0.0122282684248186	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.16881488993	2507.16881488993
"AML-0024"	"2020-09-15-AML0024:CTATCTATCAAGAGTA"	-2.84022341194804	-16.0169592133728	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCTATCAAGAGTA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.73230475574	34.920702461174	0.0155845043993244	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2238.01413088638	2238.01413088638
"AML-0024"	"2020-09-15-AML0024:CTATCTATCTCTTCAA"	-0.821589629084426	-15.9351825944153	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTATCTATCTCTTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.66922951196	33.48535827607	0.0123077652780587	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.73787255353	2713.73787255353
"AML-0024"	"2020-09-15-AML0024:CTCAACCAGATAGTCA"	-1.43499825421031	-16.2252760163513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCAGATAGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2654.13189871683	34.4593493484039	0.0129832844272222	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.84401691657	2648.84401691657
"AML-0024"	"2020-09-15-AML0024:CTCAACCAGGCGAAGG"	-0.765073935419875	-16.4969911805359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCAGGCGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.20740153728	34.104919226871	0.0128300444905644	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.03503625219	2649.03503625219
"AML-0024"	"2020-09-15-AML0024:CTCAACCAGGGCCTCT"	-1.06819055500682	-15.9837332001892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCAGGGCCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.69754563723	34.154751702099	0.0117787290448574	2775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.52304177668	2892.52304177668
"AML-0024"	"2020-09-15-AML0024:CTCAACCAGGTATCTC"	-0.674236814410049	-16.2648782960144	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCAGGTATCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.87539440494	36.9861533441429	0.0136335614309539	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.78928836535	2706.78928836535
"AML-0024"	"2020-09-15-AML0024:CTCAACCAGTTCCGTA"	-0.756120244891006	-16.3367681733337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCAGTTCCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.18566414592	36.1728751187143	0.0140358048789248	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.70279884865	2570.70279884865
"AML-0024"	"2020-09-15-AML0024:CTCAACCCAACACTAC"	-2.92505536499675	-15.7051792374817	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCCAACACTAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.28846551333	30.3987193186767	0.0110649899711193	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.87829048926	2741.87829048926
"AML-0024"	"2020-09-15-AML0024:CTCAACCCATGCCGCA"	11.9138962226803	-2.2067270508972	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCCATGCCGCA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1365.36131723731	15.2575740740465	0.0111747519732864	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1364.00867346123	1364.00867346123
"AML-0024"	"2020-09-15-AML0024:CTCAACCGTCACCCTT"	-0.907992283732253	-16.3408823243347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCGTCACCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.62586086913	37.4958542605629	0.013863601174217	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.8486918226	2697.8486918226
"AML-0024"	"2020-09-15-AML0024:CTCAACCGTTACGCCG"	9.90910019454305	7.71768758380739	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCGTTACGCCG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1991.30010911771	40.014221002086	0.0200945205691849	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1987.40382108219	1987.40382108219
"AML-0024"	"2020-09-15-AML0024:CTCAACCGTTGCTAGT"	-1.37785945358928	-15.8075466386047	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCGTTGCTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.79921279409	34.8904720647027	0.0121366639831489	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.78225722009	2868.78225722009
"AML-0024"	"2020-09-15-AML0024:CTCAACCGTTTGGAGG"	-2.89434347572978	-15.8217687836853	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAACCGTTTGGAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.7468892436	36.9210345713126	0.013939057265625	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.71756408009	2642.71756408009
"AML-0024"	"2020-09-15-AML0024:CTCAAGACACGTCATA"	-2.38955913010295	-16.3451986542908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGACACGTCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1707.9189562969	52.572220519823	0.0307814491583428	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1697.34956420801	1697.34956420801
"AML-0024"	"2020-09-15-AML0024:CTCAAGACAGACCTAT"	-2.23630176010783	-16.1822386018005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGACAGACCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.32455961679	39.2229482182485	0.0167524609337666	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2333.64766436165	2333.64766436165
"AML-0024"	"2020-09-15-AML0024:CTCAAGACATGCGGTC"	-1.54205987873729	-15.6249685517517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGACATGCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2872.46636190072	39.9712839170678	0.013915318364466	2813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.11760360157	2865.11760360157
"AML-0024"	"2020-09-15-AML0024:CTCAAGAGTAACATGA"	-1.11043904247935	-16.7810411683288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGAGTAACATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.19013473346	43.9460952159713	0.0168428105836221	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.40654045006	2595.40654045006
"AML-0024"	"2020-09-15-AML0024:CTCAAGAGTACATTGC"	-1.4592253965443	-15.7559576264587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGAGTACATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.17940862098	37.3913702689143	0.0148781142088982	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.81014155551	2510.81014155551
"AML-0024"	"2020-09-15-AML0024:CTCAAGAGTACTGACT"	-2.67588434639629	-16.1747484437195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGAGTACTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.13587557107	40.7011702304108	0.0161056517078701	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.11387207435	2519.11387207435
"AML-0024"	"2020-09-15-AML0024:CTCAAGATCCGTAGTA"	-1.74399695816692	-16.4079962006775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAAGATCCGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.61957299686	38.096856501809	0.0147227424384053	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.08769155255	2581.08769155255
"AML-0024"	"2020-09-15-AML0024:CTCAATTAGCATCTTG"	-1.49047456207927	-16.9030084840027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTAGCATCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.10183551182	41.4544840797922	0.0171504913325318	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2403.45499126519	2403.45499126519
"AML-0024"	"2020-09-15-AML0024:CTCAATTAGGTATAGT"	-1.98202333870586	-15.7853651276794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTAGGTATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3025.20634515606	36.7383102432721	0.0121440675615722	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3014.57996758637	3014.57996758637
"AML-0024"	"2020-09-15-AML0024:CTCAATTCAAAGACTA"	0.296780963509721	-16.3278646699158	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTCAAAGACTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2941.82046722278	40.1094245012737	0.0136342189974424	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2932.52970454544	2932.52970454544
"AML-0024"	"2020-09-15-AML0024:CTCAATTCAAGTTCGT"	-2.39422522011455	-15.5046234360901	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTCAAGTTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.04380476551	36.7031879485211	0.013523432408893	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.75444147475	2706.75444147475
"AML-0024"	"2020-09-15-AML0024:CTCAATTCATCGATAC"	-0.751607160002548	-16.680932067987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTCATCGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.11473487334	33.1086828487639	0.0119305636025442	2832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.74297592017	2765.74297592017
"AML-0024"	"2020-09-15-AML0024:CTCAATTCATGTACGT"	-1.57294223728831	-16.4178724518982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTCATGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.65208054249	36.3519227289096	0.0136320455878572	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.07616428602	2661.07616428602
"AML-0024"	"2020-09-15-AML0024:CTCAATTGTAGCTCGC"	-1.69210765782054	-15.9787969819275	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTGTAGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.05817650204	33.7625031986145	0.0120793561588287	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.61223738257	2786.61223738257
"AML-0024"	"2020-09-15-AML0024:CTCAATTTCGACGCGT"	1.40574719485585	-10.070676826593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.285714285714286	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAATTTCGACGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.83432816959	48.3697096007064	0.0221084882789886	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2181.05357870827	2181.05357870827
"AML-0024"	"2020-09-15-AML0024:CTCACTGAGCTCCCTT"	-1.33947012844737	-15.8030510178772	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGAGCTCCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.52607883446	37.138883463914	0.0135319841739985	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.6342184419	2736.6342184419
"AML-0024"	"2020-09-15-AML0024:CTCACTGAGGCGCTTC"	-0.19106418910678	-16.4337244263855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGAGGCGCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.40089640912	35.3100458668458	0.0135996124156637	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.05418382013	2585.05418382013
"AML-0024"	"2020-09-15-AML0024:CTCACTGCAGTTTCGA"	-1.52295837822612	-15.6177931061951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGCAGTTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.82094119904	33.1168654919303	0.0120872371598989	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.14973885721	2735.14973885721
"AML-0024"	"2020-09-15-AML0024:CTCACTGGTGCATGTT"	-1.84514329853709	-15.6274309388367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGGTGCATGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.61131911148	45.1563447147245	0.0155947534866595	2951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.90784333943	2886.90784333943
"AML-0024"	"2020-09-15-AML0024:CTCACTGGTGCCGTAC"	-0.908286134630996	-17.2237272492615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGGTGCCGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3122.95531005214	34.9517935390493	0.0111918967993383	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3117.55346791717	3117.55346791717
"AML-0024"	"2020-09-15-AML0024:CTCACTGGTTTCGTTT"	-0.359679947525817	-16.6578150025574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCACTGGTTTCGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3107.65289677499	39.3901653358829	0.0126752139457919	3891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3091.79044152987	3091.79044152987
"AML-0024"	"2020-09-15-AML0024:CTCAGAACACTCTAGA"	-1.06079612198527	-16.4504060975281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGAACACTCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.64077746976	39.4075864364715	0.0151705296506997	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.84991054848	2592.84991054848
"AML-0024"	"2020-09-15-AML0024:CTCAGAAGTCACTCAA"	-1.59505520287212	-16.1375723115173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGAAGTCACTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.96241437649	32.3515483867002	0.0126473900495469	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.48944451595	2550.48944451595
"AML-0024"	"2020-09-15-AML0024:CTCAGAATCAGTCCGG"	-2.41627083244975	-15.5332355729309	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGAATCAGTCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.29764378669	38.8833025913864	0.0157658596841888	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.42879889374	2458.42879889374
"AML-0024"	"2020-09-15-AML0024:CTCAGAATCTACCACC"	-0.911394993693191	-17.2365427247253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGAATCTACCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.875689766	32.7225992204697	0.0115632638348066	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.3006347412	2822.3006347412
"AML-0024"	"2020-09-15-AML0024:CTCAGGGAGTTGTCGT"	-1.90281281891521	-15.9220581284729	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGAGTTGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.33730001829	38.2139722370779	0.0137691271748576	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.83129098338	2769.83129098338
"AML-0024"	"2020-09-15-AML0024:CTCAGGGCAGGACTTT"	-2.30127964440044	-16.5912447205749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGCAGGACTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.47308421639	49.2750206325303	0.0196669526976545	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.123482327	2501.123482327
"AML-0024"	"2020-09-15-AML0024:CTCAGGGCAGTAACGG"	0.733137209981126	-16.3394975892273	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGCAGTAACGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2685.82397795149	52.8020007859427	0.0196595164908072	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2672.11766872586	2672.11766872586
"AML-0024"	"2020-09-15-AML0024:CTCAGGGGTAGTGCGA"	-1.02210126343425	-15.9928941956726	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGGTAGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.92339550714	42.8068552014183	0.0164900302048611	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.72231553923	2582.72231553923
"AML-0024"	"2020-09-15-AML0024:CTCAGGGTCCTAGCTC"	-2.30077491226848	-16.234456085321	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGTCCTAGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.99789496266	39.0226101398315	0.0138673203024373	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.793679406	2804.793679406
"AML-0024"	"2020-09-15-AML0024:CTCAGGGTCGGTAGAG"	-1.68518803539928	-16.4876890412536	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGGGTCGGTAGAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1981.79904392788	29.4928680159444	0.0148818661035835	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1970.27889315675	1970.27889315675
"AML-0024"	"2020-09-15-AML0024:CTCAGTCCAACTTGCA"	-2.23434338989909	-16.7415056458679	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCCAACTTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2393.31347358709	43.3326288123794	0.0181057054542181	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.96521940301	2378.96521940301
"AML-0024"	"2020-09-15-AML0024:CTCAGTCCAGGAAGTC"	-2.72482905808147	-16.0410318604675	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCCAGGAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.14492055088	48.6690228865271	0.0236240773166158	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2051.21386407559	2051.21386407559
"AML-0024"	"2020-09-15-AML0024:CTCAGTCCATCGAACT"	-1.0382276577061	-17.4531851044861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCCATCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3030.0715899214	31.5987323515671	0.0104283781467971	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3024.86809852827	3024.86809852827
"AML-0024"	"2020-09-15-AML0024:CTCAGTCGTGACTGTT"	-1.61123178425487	-15.5522518388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.68779241443	38.6136574491669	0.013569182660198	2606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2837.19978322905	2837.19978322905
"AML-0024"	"2020-09-15-AML0024:CTCAGTCTCACTTTGT"	0.14190892603938	-16.3172273865906	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCTCACTTTGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2528.20752599812	33.3041941225926	0.0131730460336496	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2521.6089559821	2521.6089559821
"AML-0024"	"2020-09-15-AML0024:CTCAGTCTCGTAGGGA"	-2.36858783188518	-15.8316917649475	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCTCGTAGGGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.55797188859	46.1456554131462	0.0163778903126579	2494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.07160446717	2813.07160446717
"AML-0024"	"2020-09-15-AML0024:CTCAGTCTCTTCCAGC"	-2.04477057877238	-15.7543936005798	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCAGTCTCTTCCAGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.5502151162	33.5007319192293	0.0119964653591145	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.90200712482	2788.90200712482
"AML-0024"	"2020-09-15-AML0024:CTCATCGCAGTGTGGA"	1.25778867778127	-16.1931066743103	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATCGCAGTGTGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3018.44742492838	42.0255769838182	0.0139229117051179	3437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3001.1339357538	3001.1339357538
"AML-0024"	"2020-09-15-AML0024:CTCATCGTCGAAACAA"	-1.37968728962596	-15.0797291032043	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATCGTCGAAACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.30090703966	47.4538186946998	0.0183623426225	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.55471358759	2572.55471358759
"AML-0024"	"2020-09-15-AML0024:CTCATCGTCGAGAGCA"	-1.35132739964183	14.3438682326111	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATCGTCGAGAGCA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2120.85391536063	52.3043254366731	0.0246619180405829	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2118.33286471906	2118.33286471906
"AML-0024"	"2020-09-15-AML0024:CTCATCGTCGTGCATA"	-2.73862586441692	-16.1417207947937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATCGTCGTGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2239.63173696066	40.6230938828055	0.0181382917612758	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2234.60424795785	2234.60424795785
"AML-0024"	"2020-09-15-AML0024:CTCATGCAGGGCAAGG"	-1.59385786476787	-16.6360273591247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATGCAGGGCAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1777.99263769907	50.5146006156006	0.0284110291260668	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1772.68604212095	1772.68604212095
"AML-0024"	"2020-09-15-AML0024:CTCATGCAGTCGGGAT"	-1.4201412004536	-15.1307211152283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATGCAGTCGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3058.95518546617	39.6804059401905	0.0129718820755275	3198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3051.96328033307	3051.96328033307
"AML-0024"	"2020-09-15-AML0024:CTCATGCGTTCGTAAC"	-0.473124186426955	-15.9557428590027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATGCGTTCGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.59422081749	38.7125177967192	0.0149262045257477	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.09377084811	2582.09377084811
"AML-0024"	"2020-09-15-AML0024:CTCATGCTCACTCGAA"	-2.40251527252849	-15.8098097077576	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATGCTCACTCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3148.09810890578	36.3141122264695	0.011535254293295	3550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3140.18893175733	3140.18893175733
"AML-0024"	"2020-09-15-AML0024:CTCATTAAGCCGTTGC"	-1.28139601174052	-15.962296508905	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTAAGCCGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2890.2978539664	30.9407296634037	0.0107050315319382	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.59023594351	2885.59023594351
"AML-0024"	"2020-09-15-AML0024:CTCATTAAGCGGGTAT"	-2.09276042404826	-16.1947489014831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTAAGCGGGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.17571472486	32.5956632122023	0.0122716516951435	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.47855681853	2649.47855681853
"AML-0024"	"2020-09-15-AML0024:CTCATTACACTGAGGA"	-1.67179367962535	-15.7020731202331	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTACACTGAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.52674090119	34.7802056276145	0.0131170487897073	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.25536594169	2642.25536594169
"AML-0024"	"2020-09-15-AML0024:CTCATTACAGAACTAA"	-2.00917110863383	-15.5071010819641	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTACAGAACTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.28404596571	31.3962505836256	0.0122819882372519	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.06317834987	2550.06317834987
"AML-0024"	"2020-09-15-AML0024:CTCATTACATTATGCG"	-0.838474254042465	-16.0956697694031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTACATTATGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.98980449962	34.1747125975857	0.0113274206451134	3678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3007.26162802169	3007.26162802169
"AML-0024"	"2020-09-15-AML0024:CTCATTAGTAGCTCGC"	0.0618241886491	-15.9071521989075	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTAGTAGCTCGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2681.32556115278	34.6489649349932	0.0129223267166769	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2674.3390589964	2674.3390589964
"AML-0024"	"2020-09-15-AML0024:CTCATTAGTGTGCCTG"	-1.70487020435985	-16.9260664216247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTAGTGTGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.69827649181	37.2671101221055	0.0140699718245997	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.29440271515	2633.29440271515
"AML-0024"	"2020-09-15-AML0024:CTCATTATCTGGTCAA"	-1.52010426941569	-16.4416475526062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCATTATCTGGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.57390362047	30.7404285692432	0.0122982675266043	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2493.70444807458	2493.70444807458
"AML-0024"	"2020-09-15-AML0024:CTCCAACCAGAGAGGG"	-4.06381497803386	13.2439765700134	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCAACCAGAGAGGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2423.10659461909	32.6626640731731	0.0134796645536379	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2418.65815667247	2418.65815667247
"AML-0024"	"2020-09-15-AML0024:CTCCAACGTGGCTGCT"	-0.915046255022842	-16.5373144379822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCAACGTGGCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.26514315305	26.930210178327	0.0107666355372383	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2494.10208835829	2494.10208835829
"AML-0024"	"2020-09-15-AML0024:CTCCACAAGTAGAGTT"	-0.798201779753524	-16.3981714478699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCACAAGTAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.07922999339	39.918602594946	0.0143794896642921	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.92174920014	2761.92174920014
"AML-0024"	"2020-09-15-AML0024:CTCCACAAGTGCGCTC"	-1.11724374714549	-15.6042347184387	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCACAAGTGCGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.76102574117	34.2981754996669	0.0125323969382304	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.81271164802	2733.81271164802
"AML-0024"	"2020-09-15-AML0024:CTCCACACACTAGGCC"	-0.812353889376479	-15.8592167130676	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCACACACTAGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2892.93363415958	32.460248137404	0.011220529829691	2799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.61353195823	2885.61353195823
"AML-0024"	"2020-09-15-AML0024:CTCCACACACTATCCC"	-0.441801200539428	-16.4551553956238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCACACACTATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.15794801322	30.7466462225115	0.0108677729513488	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.53450810478	2821.53450810478
"AML-0024"	"2020-09-15-AML0024:CTCCACACATGAAAGT"	0.114893638610285	-16.3093729249206	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCACACATGAAAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2831.06193540207	39.2592241910949	0.0138673137807984	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2820.61769140798	2820.61769140798
"AML-0024"	"2020-09-15-AML0024:CTCCATGAGAATTGCA"	-0.841761450201827	-15.9546499482361	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGAGAATTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.86040372048	37.2360715064386	0.0126358450707157	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.46393786955	2934.46393786955
"AML-0024"	"2020-09-15-AML0024:CTCCATGAGGTCTACT"	0.174225923686665	-16.4658956757751	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGAGGTCTACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3199.72488304294	43.2036284511879	0.0135022947379467	4702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3190.62837980205	3190.62837980205
"AML-0024"	"2020-09-15-AML0024:CTCCATGAGTCCCGGT"	-0.436893741518813	-15.8090410462585	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGAGTCCCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.63769514781	41.9738496241343	0.0150787761271157	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.10154205967	2775.10154205967
"AML-0024"	"2020-09-15-AML0024:CTCCATGCAATCCTAG"	-2.11552081528361	-15.6826744309631	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGCAATCCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.98345121495	38.2943742916752	0.013884918082016	2514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.23093811444	2752.23093811444
"AML-0024"	"2020-09-15-AML0024:CTCCATGCATAATGAG"	-1.90159545365031	-16.1542101136413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGCATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.68056744844	30.9597743865785	0.0112512239802917	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.44660315285	2742.44660315285
"AML-0024"	"2020-09-15-AML0024:CTCCATGCATCGTGCG"	-0.94726792994197	-16.2957315674988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGCATCGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.67867096566	37.6776966285337	0.0144210985634172	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.95846460359	2607.95846460359
"AML-0024"	"2020-09-15-AML0024:CTCCATGCATCTGGGC"	-0.78523419323619	-16.7210779420105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGCATCTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.36325317868	38.7898692760935	0.013618301399165	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.93533971306	2839.93533971306
"AML-0024"	"2020-09-15-AML0024:CTCCATGGTTCTCCTG"	-0.849305908114272	-15.8930654755798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGGTTCTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3038.56030390721	34.8491496117202	0.0114689675787933	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3028.27791634366	3028.27791634366
"AML-0024"	"2020-09-15-AML0024:CTCCATGTCAAAGAAC"	-1.69321177426036	-16.6723852387634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCATGTCAAAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.22714256655	42.0485407597791	0.0164301714609084	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.27518535227	2550.27518535227
"AML-0024"	"2020-09-15-AML0024:CTCCCAAGTAACCCGC"	-2.43755302849467	-16.2189932099548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCAAGTAACCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.69591217788	35.9654459650454	0.0132924937363327	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.02660615427	2699.02660615427
"AML-0024"	"2020-09-15-AML0024:CTCCCAAGTGCAAGAC"	-2.42287455025371	-16.2793646088806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCAAGTGCAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.30636159162	36.0577397557106	0.0130157950238379	2914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.6885126664	2765.6885126664
"AML-0024"	"2020-09-15-AML0024:CTCCCAATCAACTCTT"	-1.7313508791035	-16.2691297761169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCAATCAACTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.82992308629	37.8416383144375	0.0139234754879237	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.48870412927	2711.48870412927
"AML-0024"	"2020-09-15-AML0024:CTCCCTCAGGACTAAT"	-2.08221874657329	-16.0255174866882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCAGGACTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.006214527	34.3355060960991	0.0131452620231675	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.006214527	2612.006214527
"AML-0024"	"2020-09-15-AML0024:CTCCCTCCAACCCTAA"	-1.84187052670177	-16.5037241212097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCCAACCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.7907735084	32.1850818621181	0.0119345861674863	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.72638778831	2691.72638778831
"AML-0024"	"2020-09-15-AML0024:CTCCCTCGTAACTGCT"	-1.53391883793529	-16.4902773133484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCGTAACTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.03618040661	40.3937910041095	0.0148177750884012	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.32200505783	2718.32200505783
"AML-0024"	"2020-09-15-AML0024:CTCCCTCGTTCCACGG"	-1.4164448780125	-16.4054956666199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCGTTCCACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.2424654832	37.7889588215938	0.0132861242598647	2786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.77144770597	2835.77144770597
"AML-0024"	"2020-09-15-AML0024:CTCCCTCTCGGAGTGA"	-0.428046981722671	-16.1604166260925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCTCGGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.11628619733	34.8362504664123	0.0133722439382015	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.48783613646	2595.48783613646
"AML-0024"	"2020-09-15-AML0024:CTCCCTCTCTTCGTGC"	-2.93128166618999	-15.8393612138	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCCTCTCTTCGTGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.4977084451	36.3712315059982	0.0132187031791322	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.36896676659	2745.36896676659
"AML-0024"	"2020-09-15-AML0024:CTCCGATAGCGCCTTG"	-1.16693840447124	-16.7390279999939	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATAGCGCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.55209411416	30.3950936907457	0.0111192663041586	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.99797200663	2724.99797200663
"AML-0024"	"2020-09-15-AML0024:CTCCGATAGTAGAGTT"	-1.26292739334758	-15.9706697694031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATAGTAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.19987358592	39.3333953740391	0.0152325138640087	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.04379658526	2580.04379658526
"AML-0024"	"2020-09-15-AML0024:CTCCGATCACGATTCA"	-2.40103946152385	-16.5336561433044	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATCACGATTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.09880928052	43.3910237057751	0.0164229375348726	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.29828281832	2635.29828281832
"AML-0024"	"2020-09-15-AML0024:CTCCGATCATTCACCC"	-0.688644508749801	-16.2201891175476	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATCATTCACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.22568234673	36.4536119311549	0.0137757003018832	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.51992179087	2642.51992179087
"AML-0024"	"2020-09-15-AML0024:CTCCGATGTAAGGCTG"	-1.99111042442973	-15.8320884934631	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATGTAAGGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.84854844191	29.6431268462504	0.0115439545156341	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.04368664023	2562.04368664023
"AML-0024"	"2020-09-15-AML0024:CTCCGATGTAGTCTGT"	-2.86123357239421	-16.0093355408874	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATGTAGTCTGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.54658955037	32.5559363537881	0.011542421059238	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.45240888517	2817.45240888517
"AML-0024"	"2020-09-15-AML0024:CTCCGATTCAGCGGAA"	-1.82849214497264	-15.7501878968445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCGATTCAGCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.10828002375	45.6989298567707	0.0174283153006774	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.07408471697	2612.07408471697
"AML-0024"	"2020-09-15-AML0024:CTCCTCCCAAGCGATG"	-2.8706148666447	-15.7732210389343	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTCCCAAGCGATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.60126558442	34.5522833988267	0.0127848246942025	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.26581328285	2692.26581328285
"AML-0024"	"2020-09-15-AML0024:CTCCTCCCAGGCGTTC"	-0.199622074992019	-16.2798967591492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTCCCAGGCGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3012.53271940094	35.26801598348	0.0117070980694588	3255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3006.16114770129	3006.16114770129
"AML-0024"	"2020-09-15-AML0024:CTCCTCCCATGTGCCG"	-1.81446192684825	-16.074938797113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTCCCATGTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.1521285719	33.8935433452868	0.0130302041825963	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.53585480034	2593.53585480034
"AML-0024"	"2020-09-15-AML0024:CTCCTCCGTCTACACA"	-1.00854919377025	-16.3756571046081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTCCGTCTACACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.62195077106	32.9430143797986	0.0126140057790801	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.55825870371	2607.55825870371
"AML-0024"	"2020-09-15-AML0024:CTCCTCCTCCTACACC"	-1.82326744023021	-16.5493021241394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTCCTCCTACACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.26197598624	34.6467593240413	0.0127038618325298	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.62097226924	2717.62097226924
"AML-0024"	"2020-09-15-AML0024:CTCCTTTAGACCTTTG"	-2.79252801361735	-15.858277343866	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTAGACCTTTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.67991697509	31.5775834197898	0.0117884870154434	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.40585914535	2675.40585914535
"AML-0024"	"2020-09-15-AML0024:CTCCTTTAGAGAGGGC"	-0.20851899209674	-16.6677618256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTAGAGAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.22866127239	43.1201141472785	0.0163257785210107	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.37487451732	2626.37487451732
"AML-0024"	"2020-09-15-AML0024:CTCCTTTAGAGCTTTC"	-0.946398655802566	-15.9833345643249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTAGAGCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.19032904688	40.1028580327774	0.0152761716318441	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.24852941258	2615.24852941258
"AML-0024"	"2020-09-15-AML0024:CTCCTTTAGAGTGAAG"	-1.03616807881053	-16.4189100495544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTAGAGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.4473315152	31.488665972485	0.0121182621600891	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.10651893158	2594.10651893158
"AML-0024"	"2020-09-15-AML0024:CTCCTTTCACGGCACT"	1.79102172431294	-10.042920135614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00099304865938431	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTCACGGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2184.1867844643	50.8581330950141	0.0232846995764091	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2183.12930520114	2183.12930520114
"AML-0024"	"2020-09-15-AML0024:CTCCTTTCATTGAGCT"	-1.7650035423344	-16.299683593866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTCATTGAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.46882923567	33.6919242745214	0.0127020999844247	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.47732222398	2643.47732222398
"AML-0024"	"2020-09-15-AML0024:CTCCTTTGTCTGTCCT"	-1.43018827858623	-15.8426113358703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCCTTTGTCTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.76457644353	36.8175547582781	0.0138424111232838	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.10740297688	2650.10740297688
"AML-0024"	"2020-09-15-AML0024:CTCGAGGAGCATGATA"	-1.98983154717143	-16.8596029511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCGAGGAGCATGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.82578690817	37.7515326881025	0.0144818011536082	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.2185860593	2603.2185860593
"AML-0024"	"2020-09-15-AML0024:CTCGAGGAGGTCGTGA"	-0.285607318312484	-16.022189163324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCGAGGAGGTCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.28681534997	37.5441836463101	0.0136212905845733	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.85269226659	2744.85269226659
"AML-0024"	"2020-09-15-AML0024:CTCGAGGCACTCTGCT"	-2.62149224701579	-15.779266380426	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCGAGGCACTCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.29015227292	38.0516514968902	0.0143846796784069	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.65234733902	2642.65234733902
"AML-0024"	"2020-09-15-AML0024:CTCGAGGGTCAAATCC"	-1.79510436478313	-16.7078409424988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCGAGGGTCAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2268.79579102816	39.6861049930348	0.0174921450180627	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2262.87485003957	2262.87485003957
"AML-0024"	"2020-09-15-AML0024:CTCTCAGAGAGGATGA"	0.00531280142013427	-16.0842752686706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCAGAGAGGATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.87233530414	35.6498901810888	0.0140195359736079	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.39461930903	2533.39461930903
"AML-0024"	"2020-09-15-AML0024:CTCTCAGCAGGGAGAG"	-1.63996289196666	-16.4485712281433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCAGCAGGGAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.68420314113	28.5837761574718	0.0108490331112144	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.48914289558	2629.48914289558
"AML-0024"	"2020-09-15-AML0024:CTCTCAGCAGTAGAAT"	-1.43195841732677	-16.3362570039001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCAGCAGTAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.96224809096	34.1204849385599	0.0121125105463104	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.899170207	2805.899170207
"AML-0024"	"2020-09-15-AML0024:CTCTCAGGTGTATTCG"	-0.0833505940740884	-15.872377418634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCAGGTGTATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.9201339024	36.7431603199205	0.0125278420967542	2656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.36879723963	2924.36879723963
"AML-0024"	"2020-09-15-AML0024:CTCTCAGTCGGCTTCT"	-2.23747096481975	-16.3270044556824	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCAGTCGGCTTCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.3643153316	38.1755594388935	0.0161530573984051	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2357.67722302073	2357.67722302073
"AML-0024"	"2020-09-15-AML0024:CTCTCGACAAGTGGGT"	1.08006836947743	-16.2202215424744	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCGACAAGTGGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2766.37534245958	45.808559880677	0.0165590544340048	3213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2746.95546684405	2746.95546684405
"AML-0024"	"2020-09-15-AML0024:CTCTCGAGTCACTGAT"	-3.13259659233745	10.9790639647278	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCGAGTCACTGAT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2131.48367523228	48.7599538497536	0.0228760625363175	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2131.48367523228	2131.48367523228
"AML-0024"	"2020-09-15-AML0024:CTCTCGAGTCTTGCGG"	-1.63039002838786	-16.013155960199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTCGAGTCTTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.38531721605	38.0980243164933	0.0131627341010483	2980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.50658293995	2887.50658293995
"AML-0024"	"2020-09-15-AML0024:CTCTGGTAGACACACG"	-1.26022479954417	-16.8260030976501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTAGACACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.81660249066	31.6189176659485	0.0119460175805891	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.41157207968	2639.41157207968
"AML-0024"	"2020-09-15-AML0024:CTCTGGTAGTAAATGC"	-0.797659675509292	-15.591956161615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTAGTAAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.05514914567	34.5857361494526	0.0132968100122031	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.62198402534	2598.62198402534
"AML-0024"	"2020-09-15-AML0024:CTCTGGTAGTAAGCAT"	-1.0836275619572	-16.5051546326843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTAGTAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.89907317061	31.7258140263949	0.0124909742916638	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.43808667204	2535.43808667204
"AML-0024"	"2020-09-15-AML0024:CTCTGGTCATAATGAG"	-1.55244908753093	-15.5395832291809	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTCATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.18887951376	39.7308199436823	0.014290690908249	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.51639998043	2774.51639998043
"AML-0024"	"2020-09-15-AML0024:CTCTGGTGTCCAGGTC"	-0.948103765875655	-16.4780550233093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTGTCCAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3001.16549484167	35.0215221144921	0.0116693071990486	2785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2991.41152224104	2991.41152224104
"AML-0024"	"2020-09-15-AML0024:CTCTGGTGTTAGGGTG"	-2.47381077233012	-16.2498274079529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTCTGGTGTTAGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1834.3529882766	45.4952921175347	0.024801819719703	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1825.93832971879	1825.93832971879
"AML-0024"	"2020-09-15-AML0024:CTGAATGAGCTAAGTA"	-2.00384388390239	-16.0887327424255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGAGCTAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.12941563819	45.147939558303	0.015267488571703	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2948.47278267182	2948.47278267182
"AML-0024"	"2020-09-15-AML0024:CTGAATGAGTTAGTGA"	-0.729449371725875	-16.4747953644958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGAGTTAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.30524720241	42.8012723611025	0.0174677307694501	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.58883931302	2445.58883931302
"AML-0024"	"2020-09-15-AML0024:CTGAATGCATTCTGTT"	-1.43260274353679	-16.2974367371765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGCATTCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3000.42277765834	36.4209992103484	0.0121386224239949	3206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2992.21886633082	2992.21886633082
"AML-0024"	"2020-09-15-AML0024:CTGAATGGTATGGTTC"	-0.255124221474487	-15.9854803315369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGGTATGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.72235415853	39.9888551660212	0.0142678617832722	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.19794181572	2797.19794181572
"AML-0024"	"2020-09-15-AML0024:CTGAATGGTTAGAGAT"	-1.3442886871403	-16.0007429352966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGGTTAGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.41705122436	39.6326115705227	0.0141523961772748	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.56354969798	2796.56354969798
"AML-0024"	"2020-09-15-AML0024:CTGAATGGTTCGGTCG"	-0.794510225684005	-16.290593170282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGGTTCGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.67531667446	33.8385717489976	0.0130516040829985	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.89547155153	2584.89547155153
"AML-0024"	"2020-09-15-AML0024:CTGAATGTCCACAAGT"	-1.88116071644481	-16.7406664124695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGTCCACAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.47321535144	45.0887582935272	0.0167836247299525	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.77143779286	2673.77143779286
"AML-0024"	"2020-09-15-AML0024:CTGAATGTCGGTCGAC"	-1.53717432442363	-16.0556287995544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAATGTCGGTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.7685699566	31.1663312685086	0.0112118438942545	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.22392770477	2774.22392770477
"AML-0024"	"2020-09-15-AML0024:CTGAGCGAGAAGGCTC"	-1.51899824562724	-16.2503710023132	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGAGAAGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2767.39625999619	41.1802083316947	0.0148804885397046	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.75211366696	2759.75211366696
"AML-0024"	"2020-09-15-AML0024:CTGAGCGAGGGTTAAT"	-2.496813873679	-16.2637109986511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGAGGGTTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.36285873329	27.8271913512851	0.012039300210325	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.47145790246	2305.47145790246
"AML-0024"	"2020-09-15-AML0024:CTGAGCGAGTGCACCC"	-1.14713762226756	14.0134906538757	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGAGTGCACCC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2009.69495529217	53.2098976115577	0.0264766040594564	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2003.29563112649	2003.29563112649
"AML-0024"	"2020-09-15-AML0024:CTGAGCGCACCAAATC"	0.41163190182988	-16.0892629853454	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGCACCAAATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2796.54621792508	38.7720804088654	0.013864273066666	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2786.17313250898	2786.17313250898
"AML-0024"	"2020-09-15-AML0024:CTGAGCGGTGCCCAGT"	-2.40627632561381	-16.4314813843933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGGTGCCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.6686710467	39.0150039869548	0.0166754397619474	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2335.43516131265	2335.43516131265
"AML-0024"	"2020-09-15-AML0024:CTGAGCGGTTCCGGTG"	-2.78375850144084	-16.1668844453064	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGGTTCCGGTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.32573596203	35.4175507180288	0.0137955033215749	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.27126413991	2559.27126413991
"AML-0024"	"2020-09-15-AML0024:CTGAGCGGTTGCCTAA"	1.37848510321919	-10.2600746384827	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGGTTGCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.88902355755	45.8447241916857	0.0188981127110484	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2419.14357775635	2419.14357775635
"AML-0024"	"2020-09-15-AML0024:CTGAGCGGTTTGTTGG"	-1.31767449799235	-15.8413820496765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGGTTTGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.70442581486	34.9162495606592	0.0130542460032838	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.67070631488	2670.67070631488
"AML-0024"	"2020-09-15-AML0024:CTGAGCGTCCGTTGAA"	-1.06062267246898	-15.5933666459289	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGCGTCCGTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.0172536996	34.4954881806318	0.0150109787579259	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.31831004542	2294.31831004542
"AML-0024"	"2020-09-15-AML0024:CTGAGGCAGTACCGGA"	-1.93527195873912	-16.6324663392273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCAGTACCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.65655148098	39.4071931364275	0.0151469620822914	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.42666271023	2594.42666271023
"AML-0024"	"2020-09-15-AML0024:CTGAGGCCAATTTCCT"	-2.43805275383647	-16.4198599091736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCCAATTTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2331.37625894809	36.3988526880376	0.0156126033060235	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2321.40838178358	2321.40838178358
"AML-0024"	"2020-09-15-AML0024:CTGAGGCCAGAAACCG"	-2.09595857086833	-16.0191793671814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCCAGAAACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.75198942803	35.9087836765281	0.0164964974654571	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2173.2363030156	2173.2363030156
"AML-0024"	"2020-09-15-AML0024:CTGAGGCGTGTAAACA"	-2.17774496498759	-16.4201688996521	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCGTGTAAACA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.24786816603	32.1793616459063	0.0143963280780617	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2228.28281124665	2228.28281124665
"AML-0024"	"2020-09-15-AML0024:CTGAGGCTCCAATGCA"	-2.84551439705547	-15.5353183976379	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCTCCAATGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.95244524364	41.1679391712563	0.0172326323419375	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2383.87168042069	2383.87168042069
"AML-0024"	"2020-09-15-AML0024:CTGAGGCTCTCCTGAC"	-2.01802096787151	-16.1927900544372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCTCTCCTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.49130091886	33.8876262408106	0.0125162456585954	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.48171695396	2700.48171695396
"AML-0024"	"2020-09-15-AML0024:CTGAGGCTCTTTCCGG"	-1.7523344558781	-16.944401764032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGAGGCTCTTTCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1942.26976634253	49.1312705560665	0.0252958015449034	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1934.00159491812	1934.00159491812
"AML-0024"	"2020-09-15-AML0024:CTGATCCAGAGTTCGG"	-0.55970791998561	-16.6321707001892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGATCCAGAGTTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.13515865541	34.1629940243283	0.0131743977595223	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.23669344954	2585.23669344954
"AML-0024"	"2020-09-15-AML0024:CTGATCCCAAACTCGT"	-2.8511839908665	-15.9827814332214	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGATCCCAAACTCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.77870377143	38.416473084014	0.0144761403915927	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.96166001962	2648.96166001962
"AML-0024"	"2020-09-15-AML0024:CTGATCCGTACCACGC"	-1.8134847683018	-16.8259268037048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGATCCGTACCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.99253544996	31.4389031909263	0.0130614876148958	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2399.40277756175	2399.40277756175
"AML-0024"	"2020-09-15-AML0024:CTGATCCGTATACGGG"	0.0624512285808146	-16.0102529755798	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGATCCGTATACGGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2786.96569520083	40.2679912661104	0.0144486856567528	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2778.93451035436	2778.93451035436
"AML-0024"	"2020-09-15-AML0024:CTGATCCTCAGTGATC"	-0.600442032248336	-16.7108221284119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGATCCTCAGTGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.7784454556	33.0834230241203	0.0121819300390574	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.44564055333	2709.44564055333
"AML-0024"	"2020-09-15-AML0024:CTGCAGGCACACAGAG"	-2.09588871422465	-15.7244911423889	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCAGGCACACAGAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.46097248148	30.81504664483	0.0114619653996269	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.47135926934	2680.47135926934
"AML-0024"	"2020-09-15-AML0024:CTGCAGGGTCGTGATT"	-0.137777517468292	-16.1588735810486	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCAGGGTCGTGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.46563129314	39.3360849210611	0.0150398018809417	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.37461775667	2608.37461775667
"AML-0024"	"2020-09-15-AML0024:CTGCAGGGTGACTCTA"	-2.05195675316508	-16.6569166413513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCAGGGTGACTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.72898092464	35.607924358555	0.0135045826158698	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.96481171791	2631.96481171791
"AML-0024"	"2020-09-15-AML0024:CTGCAGGGTGGTCCGT"	-1.06459734860118	-15.7942276231018	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCAGGGTGGTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.02137371518	44.9710049309778	0.0175529390161822	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.83016639576	2553.83016639576
"AML-0024"	"2020-09-15-AML0024:CTGCAGGTCGAATGCT"	-0.96847234192546	-15.9993067017761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCAGGTCGAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.09083114917	40.0066067092996	0.0150395641535355	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.75642598669	2654.75642598669
"AML-0024"	"2020-09-15-AML0024:CTGCATCAGGGTTAGC"	-0.20767773214038	-15.752823852655	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCAGGGTTAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2536.73080874569	39.6219607506855	0.0156193004847357	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2532.876660716	2532.876660716
"AML-0024"	"2020-09-15-AML0024:CTGCATCAGTGGAAGA"	-1.67519996586497	-15.8429947129455	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCAGTGGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.84546365786	37.8178515851686	0.0134542620980503	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.3255997745	2805.3255997745
"AML-0024"	"2020-09-15-AML0024:CTGCATCAGTTGAAGT"	-2.05029616776164	-15.8088894120422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCAGTTGAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.34900660351	34.4666777937582	0.0132904123995632	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.09992658279	2583.09992658279
"AML-0024"	"2020-09-15-AML0024:CTGCATCGTGTTCGTA"	-2.11679778519328	-16.6170397034851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCGTGTTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.71200417321	38.1733162435271	0.0150305688915914	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.63281750641	2537.63281750641
"AML-0024"	"2020-09-15-AML0024:CTGCATCGTTAGGACG"	-2.17464051666911	-15.5752754441467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCGTTAGGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.05234157676	36.9608934515683	0.0138687307843645	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.60628101533	2658.60628101533
"AML-0024"	"2020-09-15-AML0024:CTGCATCTCATGCCCT"	-1.03883610191997	-16.281596206781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCATCTCATGCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.97278950596	39.2779164559796	0.0154517454388697	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.03070424371	2533.03070424371
"AML-0024"	"2020-09-15-AML0024:CTGCCATAGAATCTAG"	-2.10016928139384	-16.5164728394714	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATAGAATCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.08661150441	32.0901176140242	0.0124183599230607	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.0749745792	2576.0749745792
"AML-0024"	"2020-09-15-AML0024:CTGCCATAGCGCGTTC"	-1.16934631291087	-15.5858850709167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATAGCGCGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.98845062066	34.2240970127426	0.0128276780976248	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.18517574483	2663.18517574483
"AML-0024"	"2020-09-15-AML0024:CTGCCATCACATATCG"	-1.02741418305095	-16.2364073029724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATCACATATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.22979580427	36.9269400668429	0.0129104801722616	2554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.26863972232	2849.26863972232
"AML-0024"	"2020-09-15-AML0024:CTGCCATGTAGCTGCC"	-0.824429313570815	-16.1577539674011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATGTAGCTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.12401629019	35.4090095735389	0.0147591409752517	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2393.97874434644	2393.97874434644
"AML-0024"	"2020-09-15-AML0024:CTGCCATGTTGCTGAT"	-0.814519981772262	-16.4638986817566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATGTTGCTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.7198764369	26.1564650764559	0.0103765854036223	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.92807082982	2516.92807082982
"AML-0024"	"2020-09-15-AML0024:CTGCCATTCCGCCTAT"	-1.00991938534434	-16.8474493256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATTCCGCCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3240.57296006459	46.1002322982766	0.0142259510482855	3993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3230.5631183911	3230.5631183911
"AML-0024"	"2020-09-15-AML0024:CTGCCATTCTGTAACG"	-2.45578442040141	-15.6523723832336	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCATTCTGTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.46566546807	37.2147457528526	0.0131665302740162	2544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.29223192617	2821.29223192617
"AML-0024"	"2020-09-15-AML0024:CTGCCTAAGCAATTAG"	-0.895516614348251	-16.2540598145691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAAGCAATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.42895895789	41.2858642358152	0.0160306748482478	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.42154815164	2568.42154815164
"AML-0024"	"2020-09-15-AML0024:CTGCCTAAGGCGACAT"	-1.1440603536671	-16.3426580659119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAAGGCGACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.58031575084	31.4772691191863	0.0120946388968999	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.24530597607	2598.24530597607
"AML-0024"	"2020-09-15-AML0024:CTGCCTAAGGTTCTAC"	-0.810734013945419	-15.9106884232727	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAAGGTTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.12974878696	32.6767244011484	0.0111978312186879	2719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.66022880845	2912.66022880845
"AML-0024"	"2020-09-15-AML0024:CTGCCTAAGTAGGTTA"	-1.94971428337749	-15.7510318986145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAAGTAGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2872.58975308527	34.8234918054769	0.0121226818998693	3189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.59130725636	2865.59130725636
"AML-0024"	"2020-09-15-AML0024:CTGCCTACAGGCTATT"	-1.84632358971294	-16.6755323640076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTACAGGCTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.88780531022	43.9236945861809	0.01862051026221	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2352.40860641952	2352.40860641952
"AML-0024"	"2020-09-15-AML0024:CTGCCTACATAGTCGT"	-2.32969174805339	-15.9135666123596	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTACATAGTCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.4826749138	35.0704636630735	0.0134087921894682	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.12888664389	2609.12888664389
"AML-0024"	"2020-09-15-AML0024:CTGCCTAGTAACGCGA"	-2.16058741036113	-16.4492578736511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAGTAACGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.97715162921	38.0660856520478	0.0155500167257336	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.8769808269	2433.8769808269
"AML-0024"	"2020-09-15-AML0024:CTGCCTAGTGGGCTCT"	-0.208132873207885	-16.5401334992615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTAGTGGGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.22060470166	35.8387028815755	0.0121808347152166	2766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2933.32826189865	2933.32826189865
"AML-0024"	"2020-09-15-AML0024:CTGCCTATCAACTCTT"	-0.837567190558273	-16.6108312836853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTATCAACTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.95214141818	37.9227987837369	0.0153474436627378	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.06505238198	2462.06505238198
"AML-0024"	"2020-09-15-AML0024:CTGCCTATCTTCTGTA"	-1.09806464138682	-16.4206571809021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCCTATCTTCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2970.7406557761	34.6322909112245	0.0116577968002316	2963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2962.16686479361	2962.16686479361
"AML-0024"	"2020-09-15-AML0024:CTGCGAGAGATAGTGT"	-0.29474506798442	-15.824583076593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGAGATAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.55971416501	31.449483425104	0.0120102219762181	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.66052496925	2608.66052496925
"AML-0024"	"2020-09-15-AML0024:CTGCGAGAGTAAGAGG"	-0.413584659725982	-16.2650404206482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGAGTAAGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.80978996522	37.9624061181422	0.0168961370418142	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2244.06304814237	2244.06304814237
"AML-0024"	"2020-09-15-AML0024:CTGCGAGCAACCGGAA"	-1.12756357613261	-16.4476423493591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGCAACCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.50780792872	30.1998366228881	0.0120581922433151	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.81312922065	2495.81312922065
"AML-0024"	"2020-09-15-AML0024:CTGCGAGCAGGCTCTG"	9.29746880111043	6.56864736163942	"2020-09-15-AML0024"	"AML0024"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGCAGGCTCTG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1557.94437599742	37.0639938885809	0.0237903191279548	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1557.94437599742	1557.94437599742
"AML-0024"	"2020-09-15-AML0024:CTGCGAGCAGTCGGAA"	0.169657168059987	-16.3771429291931	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGCAGTCGGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2748.07775191831	41.292826923904	0.0150260766439666	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2741.64627430452	2741.64627430452
"AML-0024"	"2020-09-15-AML0024:CTGCGAGTCACACCCT"	-2.07073841515239	-15.7530937424866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGTCACACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.4034014222	36.0281020802916	0.0128929495512191	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.43224375812	2787.43224375812
"AML-0024"	"2020-09-15-AML0024:CTGCGAGTCATCACTT"	-1.16770301285442	-15.7473154298035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGTCATCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.019657092	35.593178429081	0.0124756162617401	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.38666275772	2850.38666275772
"AML-0024"	"2020-09-15-AML0024:CTGCGAGTCCCATAGA"	-1.20266972008403	-16.7587938538757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCGAGTCCCATAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3042.44334373007	36.9444769390355	0.01214302873221	3407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3033.42767291851	3033.42767291851
"AML-0024"	"2020-09-15-AML0024:CTGCTCAAGTGCAGCA"	0.256155689328355	-16.4038858643738	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCTCAAGTGCAGCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2782.31978258584	39.2552002916633	0.0141088024954414	2858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2771.26670274192	2771.26670274192
"AML-0024"	"2020-09-15-AML0024:CTGCTCAAGTTGAAAC"	-0.0479512018268884	-16.0348119965759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCTCAAGTTGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3012.42142174221	45.6777891465662	0.0151631471004973	3215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2996.54840703151	2996.54840703151
"AML-0024"	"2020-09-15-AML0024:CTGCTCACAAACCATC"	-2.16786823692973	-16.4920568696228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCTCACAAACCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.76491229117	36.0502870713011	0.0130297615497255	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.21446840545	2763.21446840545
"AML-0024"	"2020-09-15-AML0024:CTGCTCATCGCCGAGT"	-2.70670090141948	-15.5357036820618	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGCTCATCGCCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2916.61318797424	35.2876755626146	0.0120988534606209	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2907.33123813135	2907.33123813135
"AML-0024"	"2020-09-15-AML0024:CTGGACGAGAGCTTTC"	-0.710428277880508	-16.1230497590271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGAGAGCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.94543524001	34.4802225027019	0.0136937925739504	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2514.17766720309	2514.17766720309
"AML-0024"	"2020-09-15-AML0024:CTGGACGAGAGTATAC"	-1.47040841999705	-16.027503036615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGAGAGTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2892.9851123497	35.3950448148039	0.0122347829111557	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.75631166661	2879.75631166661
"AML-0024"	"2020-09-15-AML0024:CTGGACGAGGTGCTTT"	-0.38569481197055	-16.0915422669617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGAGGTGCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.64089524633	25.9501127752278	0.00909687329326006	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.18512055454	2845.18512055454
"AML-0024"	"2020-09-15-AML0024:CTGGACGAGTCGAGGT"	-2.35999403420146	-16.125496887323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGAGTCGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.49101786812	39.7420807444993	0.0145018102542133	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.92634925555	2726.92634925555
"AML-0024"	"2020-09-15-AML0024:CTGGACGAGTTGCCTA"	-1.27584824982341	-16.1748342744079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGAGTTGCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.51492658783	35.252450673109	0.0135820643187182	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.64884307395	2588.64884307395
"AML-0024"	"2020-09-15-AML0024:CTGGACGCAGCTGTAT"	-3.17433271828349	9.82144067371217	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGCAGCTGTAT"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1910.77312246549	33.655841360451	0.0176137297331379	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1910.77312246549	1910.77312246549
"AML-0024"	"2020-09-15-AML0024:CTGGACGGTTCGGACC"	-1.60226235809978	-16.6390848389831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGGTTCGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.81077836247	39.9850082605977	0.0149543148618339	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.23048340926	2665.23048340926
"AML-0024"	"2020-09-15-AML0024:CTGGACGTCATCTCTA"	11.830360074609	-2.40729310428771	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGTCATCTCTA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1560.64610096296	32.0711918958252	0.0205499452284771	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1557.69998952454	1557.69998952454
"AML-0024"	"2020-09-15-AML0024:CTGGACGTCCGGTTCT"	-2.85821447792705	-15.9351511231628	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGTCCGGTTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.71959939602	41.5562000420728	0.0159114324721854	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.71437410575	2602.71437410575
"AML-0024"	"2020-09-15-AML0024:CTGGACGTCTGCCTCA"	-1.92136512222942	-16.171883606073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGACGTCTGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.66768453732	40.717914621587	0.0143541363140774	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.88313649145	2829.88313649145
"AML-0024"	"2020-09-15-AML0024:CTGGCAGAGAAGTCCG"	-1.99176178398784	-16.8053465119568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGAGAAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.07493046607	40.0746474273653	0.0173103025305956	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.00350667028	2305.00350667028
"AML-0024"	"2020-09-15-AML0024:CTGGCAGAGATAACGT"	-2.14377961579021	-15.4962616196838	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGAGATAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.20260896202	31.1562101299245	0.0111702929108901	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.70931535097	2781.70931535097
"AML-0024"	"2020-09-15-AML0024:CTGGCAGAGGAACGCT"	-2.81191931191142	-16.1158933869568	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGAGGAACGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.3671071095	35.8288387852373	0.0140650472738075	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.28599194083	2539.28599194083
"AML-0024"	"2020-09-15-AML0024:CTGGCAGAGGTAAACT"	0.612612445920151	-16.3322248688904	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGAGGTAAACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2634.47234594476	43.9484036748712	0.0166820516231726	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2626.41405003595	2626.41405003595
"AML-0024"	"2020-09-15-AML0024:CTGGCAGAGTATGATG"	-2.2131384414738	-16.4598226777283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGAGTATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.0878295042	32.6951530007674	0.0134432451838849	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2425.99395916112	2425.99395916112
"AML-0024"	"2020-09-15-AML0024:CTGGCAGCAACCGCCA"	-0.653096060187179	-16.6489534608093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGCAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.31239375822	33.3516157227769	0.0131083021898553	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.34876159277	2533.34876159277
"AML-0024"	"2020-09-15-AML0024:CTGGCAGCAGGTCCCA"	-1.27467701855357	-15.7756319276062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGCAGGTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.33834867584	31.8523292994489	0.0127290257595677	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.95575099384	2497.95575099384
"AML-0024"	"2020-09-15-AML0024:CTGGCAGCAGTTGTTG"	-2.1067558330601	-16.4248037568298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGCAGTTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.08558502636	35.1823046998926	0.0130931090903632	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.15881686461	2680.15881686461
"AML-0024"	"2020-09-15-AML0024:CTGGCAGCATGGGCAA"	-1.9782751602238	-16.7437315217224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGCATGGGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.43334224062	47.2832353676453	0.0182178577265352	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.39270143082	2585.39270143082
"AML-0024"	"2020-09-15-AML0024:CTGGCAGTCAGCCTTC"	-1.8472492498463	-15.7276535264221	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGTCAGCCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.13640377596	31.1694330574219	0.0124322845021428	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.04102081646	2500.04102081646
"AML-0024"	"2020-09-15-AML0024:CTGGCAGTCCAAGAGG"	-1.68183348599132	-16.7244653931824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGTCCAAGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.24991821562	37.2250667025785	0.0127954172893508	3126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.80683936219	2886.80683936219
"AML-0024"	"2020-09-15-AML0024:CTGGCAGTCCAGTTCC"	-3.38426099243816	13.4958724745545	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGTCCAGTTCC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1869.21182562319	33.6087849725776	0.0179801906407117	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1861.43718710831	1861.43718710831
"AML-0024"	"2020-09-15-AML0024:CTGGCAGTCCTGGTCT"	-0.353139589459258	-16.1840505830017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGTCCTGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.04034784168	35.4066711978319	0.0133860609070569	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.33040918997	2638.33040918997
"AML-0024"	"2020-09-15-AML0024:CTGGCAGTCGATACTG"	0.671024878590745	-16.2178068391052	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGCAGTCGATACTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2911.32047972226	38.9493249237958	0.0133785769018159	2701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2905.95052502124	2905.95052502124
"AML-0024"	"2020-09-15-AML0024:CTGGTCTGTTTCACTT"	-0.208989719778854	-15.7924652329651	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGGTCTGTTTCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.4725602913	37.6116337627166	0.0133826724708596	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.23619450063	2800.23619450063
"AML-0024"	"2020-09-15-AML0024:CTGTACCGTATCAAGA"	-1.83373282375987	-16.313147567865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTACCGTATCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2973.44348535239	37.8590744741978	0.0127324008882957	3348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2965.0868718486	2965.0868718486
"AML-0024"	"2020-09-15-AML0024:CTGTACCGTATTCCGA"	-2.81013522568401	-15.9419450989929	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTACCGTATTCCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.34078388744	31.3183385449237	0.0109760245680346	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.09154507573	2843.09154507573
"AML-0024"	"2020-09-15-AML0024:CTGTAGACACTAAACC"	-0.648711840540725	-15.6369695893494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTAGACACTAAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.14603003942	26.4891014282077	0.00941618428099749	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.76539849812	2809.76539849812
"AML-0024"	"2020-09-15-AML0024:CTGTAGATCCACCTGT"	-2.20038423958476	-15.4070434800354	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTAGATCCACCTGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.95539297359	38.5455147584405	0.0140936539065567	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.96241709071	2730.96241709071
"AML-0024"	"2020-09-15-AML0024:CTGTAGATCGTGGGAA"	-0.137915189296562	-16.2456274262634	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTAGATCGTGGGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2694.21303258114	42.1837690915712	0.0156571765415142	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2685.75118901454	2685.75118901454
"AML-0024"	"2020-09-15-AML0024:CTGTAGATCTGGGTCG"	-1.50582001629527	-15.9927377930847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTAGATCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1538.41596930562	41.2891833151487	0.026838764117734	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1538.41596930562	1538.41596930562
"AML-0024"	"2020-09-15-AML0024:CTGTATTAGGCTTAAA"	-1.14216707173045	-16.1774606934753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTATTAGGCTTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.68409437304	36.1232190528386	0.0133508635128408	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.45434248411	2698.45434248411
"AML-0024"	"2020-09-15-AML0024:CTGTATTCAAGTGGCA"	-1.8535637659138	-15.778178238031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTATTCAAGTGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.27753261469	31.1548834383496	0.0109573838927006	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.28426211014	2838.28426211014
"AML-0024"	"2020-09-15-AML0024:CTGTATTCAGTCAGAG"	-0.948739747435409	-17.4920644990173	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTATTCAGTCAGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2913.38785755339	43.0414396096166	0.014773673027443	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2907.58562703689	2907.58562703689
"AML-0024"	"2020-09-15-AML0024:CTGTATTTCGGTTGTA"	-2.1160708469456	-16.5336370698181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTATTTCGGTTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.97257314981	38.0406858534947	0.0143931443859665	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.8762194542	2639.8762194542
"AML-0024"	"2020-09-15-AML0024:CTGTCGTAGCTGACCC"	-1.59818945351298	-16.0887289277283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTCGTAGCTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.95918403794	43.0250165546783	0.0167415174614085	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.02180612852	2563.02180612852
"AML-0024"	"2020-09-15-AML0024:CTGTCGTGTGACCGTC"	-2.87368569794353	-15.9567823640076	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTCGTGTGACCGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2261.10913614849	34.4809424472057	0.0152495701759622	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.22002009843	2257.22002009843
"AML-0024"	"2020-09-15-AML0024:CTGTCGTGTTACGTAC"	-2.19578609886821	-16.2829523316589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTCGTGTTACGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2134.20783437428	45.2577233355724	0.0212058650552379	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2131.30402760394	2131.30402760394
"AML-0024"	"2020-09-15-AML0024:CTGTCGTTCAAGATAG"	-2.13593779030498	-15.7256222001282	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTCGTTCAAGATAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.07684029739	36.8774617202613	0.0134585502048398	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.75538866814	2729.75538866814
"AML-0024"	"2020-09-15-AML0024:CTGTGAAAGGTTGGTG"	-1.39495716515239	-15.8316316834656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAAAGGTTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.00241474429	37.1431651760971	0.013756715539684	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.71414451387	2690.71414451387
"AML-0024"	"2020-09-15-AML0024:CTGTGAAAGTGCCGAA"	-0.745672146708328	-15.7314014664856	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAAAGTGCCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.99505988779	35.2178116193926	0.0129239909964617	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.80538942843	2718.80538942843
"AML-0024"	"2020-09-15-AML0024:CTGTGAACACGCTGCA"	-1.32834802094157	-15.1425457230774	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAACACGCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.82690012377	29.5452135177246	0.0116281882548888	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.36563692467	2536.36563692467
"AML-0024"	"2020-09-15-AML0024:CTGTGAAGTAAGCGGT"	-0.934543172747451	-16.4120741120544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAAGTAAGCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.55934299407	29.011355786013	0.0115741747216562	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.97497876516	2500.97497876516
"AML-0024"	"2020-09-15-AML0024:CTGTGAATCCCGTTCA"	-2.32843242111858	-15.611409210321	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAATCCCGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2960.45015603107	34.5402022949676	0.0116672129151041	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2951.9629047757	2951.9629047757
"AML-0024"	"2020-09-15-AML0024:CTGTGAATCGTTAGAC"	-0.0619718534057916	-15.865897201654	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAATCGTTAGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2763.02634575381	40.3706047286868	0.0146110096962079	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2755.21426517306	2755.21426517306
"AML-0024"	"2020-09-15-AML0024:CTGTGAATCTTCGTGC"	-2.47933445397075	-16.1026563874451	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGAATCTTCGTGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.85921883643	43.9359114725107	0.0160241310606589	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.00630781533	2732.00630781533
"AML-0024"	"2020-09-15-AML0024:CTGTGGGAGGCTAGCA"	-1.54614673081096	-15.5982961884704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGGGAGGCTAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.60713343518	36.1837175127822	0.0163312876938978	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2210.44899263579	2210.44899263579
"AML-0024"	"2020-09-15-AML0024:CTGTGGGCAACCTATG"	-2.34376202049907	-15.7682152024475	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGGGCAACCTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.01153405264	34.0376355842929	0.0121519083982656	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.7169670214	2796.7169670214
"AML-0024"	"2020-09-15-AML0024:CTGTGGGCAAGTTGGG"	-1.6777095598286	-15.8146476975647	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGGGCAAGTTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.85994904596	37.7997836996118	0.0127021379859392	3144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.68913025104	2970.68913025104
"AML-0024"	"2020-09-15-AML0024:CTGTGGGCATGAGGGT"	0.120983463793439	-16.327681564447	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGGGCATGAGGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2915.38678716876	39.1526487768465	0.0134296584416057	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2905.0685687583	2905.0685687583
"AML-0024"	"2020-09-15-AML0024:CTGTGGGGTACGATCT"	-1.49042079868968	-16.1629400483337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTGTGGGGTACGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.43982757368	37.0938856151174	0.0145156560584473	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.27326242705	2546.27326242705
"AML-0024"	"2020-09-15-AML0024:CTTACCGAGACATAAC"	-1.44830987873729	-16.3382311097351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGAGACATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.68076306152	28.6150697491025	0.0102354568258239	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.17774076683	2787.17774076683
"AML-0024"	"2020-09-15-AML0024:CTTACCGCAACTCCCT"	-1.15737126293834	-16.7115526429382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGCAACTCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.39825255148	29.4342015230093	0.0118763001437348	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2469.11611136907	2469.11611136907
"AML-0024"	"2020-09-15-AML0024:CTTACCGGTAGCTGTT"	0.52052461084668	-16.1543646088806	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGGTAGCTGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2822.20526014686	39.4876632150342	0.013991775783516	3423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2812.24953610009	2812.24953610009
"AML-0024"	"2020-09-15-AML0024:CTTACCGGTCGATTCA"	-0.110297660261947	-16.0986795655456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGGTCGATTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.65031826354	36.884440803256	0.0137903787090951	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.65318067536	2668.65318067536
"AML-0024"	"2020-09-15-AML0024:CTTACCGGTTTCGTGA"	-2.92050919953044	11.9415721663269	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGGTTTCGTGA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2674.73721401148	34.5589943680406	0.0129205195138442	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2671.52759520651	2671.52759520651
"AML-0024"	"2020-09-15-AML0024:CTTACCGTCTCGGTAA"	-1.37391028824504	-16.0552683106628	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTACCGTCTCGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.23144867055	35.4119742821139	0.0143820656263789	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.9700767693	2455.9700767693
"AML-0024"	"2020-09-15-AML0024:CTTAGGAAGCGTGCTC"	-2.22164855423625	-16.1681738129822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAAGCGTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.47742136168	34.8429745503409	0.0121004506900644	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.49773752127	2869.49773752127
"AML-0024"	"2020-09-15-AML0024:CTTAGGAAGCTTCGTA"	-0.44102636995967	-15.9433021775452	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAAGCTTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.06897595466	43.140024538137	0.015813392153342	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.62986733712	2719.62986733712
"AML-0024"	"2020-09-15-AML0024:CTTAGGAAGTTGCATC"	-2.75436864319499	-16.0227251282898	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAAGTTGCATC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.27558820808	31.7956012487483	0.0123225601924287	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.76826079107	2573.76826079107
"AML-0024"	"2020-09-15-AML0024:CTTAGGAGTGAGCAGT"	-0.921968857676345	-16.2736349335876	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAGTGAGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.88825799123	35.198760014277	0.0130322903623032	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.78508136348	2691.78508136348
"AML-0024"	"2020-09-15-AML0024:CTTAGGAGTTCCCAAA"	-1.90598390522655	-16.658154510614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAGTTCCCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.12228422867	34.0646101854819	0.0144272960418101	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2356.84923507579	2356.84923507579
"AML-0024"	"2020-09-15-AML0024:CTTAGGAGTTGCTCAA"	-2.05681977692302	-15.6366873017517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAGTTGCTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.48847646732	36.1493802832022	0.0128577373109579	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.00302170732	2806.00302170732
"AML-0024"	"2020-09-15-AML0024:CTTAGGAGTTTCTATC"	-1.17565689507182	-15.6233673325744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGAGTTTCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.02136751027	31.8890328577611	0.0119567969144283	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.35052973584	2657.35052973584
"AML-0024"	"2020-09-15-AML0024:CTTAGGATCATTCATC"	0.222234402864617	-16.1564588776794	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTAGGATCATTCATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2763.48609464167	40.2068443936711	0.0145493203210363	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2759.18968214012	2759.18968214012
"AML-0024"	"2020-09-15-AML0024:CTTCAATAGATGTTGA"	-2.13455782356914	-16.0775079957214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATAGATGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.70041448845	36.1643481956518	0.013204930340074	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.27082284676	2732.27082284676
"AML-0024"	"2020-09-15-AML0024:CTTCAATAGCGGCTCT"	-0.983600954443771	-17.4577131501404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATAGCGGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3173.46568047661	42.8623736211806	0.0135064872088811	3066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3165.22296543078	3165.22296543078
"AML-0024"	"2020-09-15-AML0024:CTTCAATAGCTTTGTG"	0.738149781792802	-16.2009916535583	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATAGCTTTGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2917.97075429779	44.7687967720261	0.0153424419028489	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2907.24384081557	2907.24384081557
"AML-0024"	"2020-09-15-AML0024:CTTCAATAGTGACCTT"	-2.82719860497172	-16.1007108918396	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATAGTGACCTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3029.55211216885	36.3982044497099	0.0120143846687795	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3020.62446492428	3020.62446492428
"AML-0024"	"2020-09-15-AML0024:CTTCAATCAGAGGGTT"	-0.976250152022201	-17.4633131257263	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATCAGAGGGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2788.5351040426	49.5659899162963	0.0177749205467915	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2781.84406323809	2781.84406323809
"AML-0024"	"2020-09-15-AML0024:CTTCAATCAGCAGAAC"	-1.29516957226451	-15.2428865662781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATCAGCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.3214396355	35.7640554000904	0.0133332474145792	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.64345078592	2676.64345078592
"AML-0024"	"2020-09-15-AML0024:CTTCAATGTATTAAGG"	-1.01069508019145	-15.8046150437561	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATGTATTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.55948200545	40.8695773981257	0.0161695808502589	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.59261763328	2520.59261763328
"AML-0024"	"2020-09-15-AML0024:CTTCAATGTCCATCTC"	-0.9441816014355	-15.6917753449646	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATGTCCATCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2965.71409707006	33.7892489802147	0.0113932927700604	2699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.16654184028	2957.16654184028
"AML-0024"	"2020-09-15-AML0024:CTTCAATTCCACCCTA"	-1.1514073413914	-16.3086920014587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCAATTCCACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.44355743829	35.4467036667479	0.0126983415345419	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.9126964493	2784.9126964493
"AML-0024"	"2020-09-15-AML0024:CTTCCGACACATACGT"	-1.41740224781688	-16.7467260590759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGACACATACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.78093544215	39.3586215373245	0.0157763838011488	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.34323440682	2489.34323440682
"AML-0024"	"2020-09-15-AML0024:CTTCCGACATCTCAAG"	-0.493610541254836	-16.3801985017029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGACATCTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2933.66445978553	39.1555707013004	0.0133469833507009	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.36945961463	2920.36945961463
"AML-0024"	"2020-09-15-AML0024:CTTCCGAGTTATGGTC"	-1.78432009640391	-15.6315365067688	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGAGTTATGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.32796447302	32.6658253558324	0.0123159073061022	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.98001535966	2645.98001535966
"AML-0024"	"2020-09-15-AML0024:CTTCCGAGTTTGATCG"	-0.70267746868785	-16.0079469910828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGAGTTTGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.25855848462	39.2098024056262	0.0143087966222098	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.46202077729	2734.46202077729
"AML-0024"	"2020-09-15-AML0024:CTTCCGATCAACACGT"	-2.90818343582805	-15.7184543839661	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGATCAACACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.55597336886	35.8886780638081	0.0133586191464326	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.61579723302	2678.61579723302
"AML-0024"	"2020-09-15-AML0024:CTTCCGATCAAGCCCG"	-2.17276916924174	-16.3173494569031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGATCAAGCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.25590557706	36.2138942013185	0.0150436412337463	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2399.81296125164	2399.81296125164
"AML-0024"	"2020-09-15-AML0024:CTTCCGATCTGGCCGA"	-2.58771381798442	-15.9888849488464	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCGATCTGGCCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.11147755593	39.4829034280028	0.0144885461579039	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.95157876733	2718.95157876733
"AML-0024"	"2020-09-15-AML0024:CTTCCTTAGACGCAGT"	0.249439229338807	-16.2790270081726	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTAGACGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.30522938685	29.4712825921579	0.0101195720471795	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.62367120588	2902.62367120588
"AML-0024"	"2020-09-15-AML0024:CTTCCTTAGGCAGCTA"	-2.31909785690959	-16.4973135224548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTAGGCAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2978.98446688423	31.0148796321165	0.0104112256968414	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2964.41942122293	2964.41942122293
"AML-0024"	"2020-09-15-AML0024:CTTCCTTCAAGCAGGT"	1.08016922053639	-16.2369928590027	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTCAAGCAGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2942.17060885931	42.05788188124	0.0142948480807325	3963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2931.74910866129	2931.74910866129
"AML-0024"	"2020-09-15-AML0024:CTTCCTTCATGGGAAC"	-0.967805485159713	-16.5797739258972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTCATGGGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.86565286925	31.5476403559545	0.0123191313533405	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.09742822202	2555.09742822202
"AML-0024"	"2020-09-15-AML0024:CTTCCTTGTGCCGTAC"	-1.04473362389262	-15.9104519120422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTGTGCCGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.58881596819	38.5711236930403	0.0138715668679729	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.60721300032	2772.60721300032
"AML-0024"	"2020-09-15-AML0024:CTTCCTTTCATTCACT"	-2.11661611023601	-15.906578086969	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTTCATTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.2334393518	33.2990949808401	0.0125220653772152	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.87477226674	2654.87477226674
"AML-0024"	"2020-09-15-AML0024:CTTCCTTTCTGACAGT"	-2.38769565048869	-16.5158529511658	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCCTTTCTGACAGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.5616367123	44.8617325358215	0.0181218402606209	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2465.8514817833	2465.8514817833
"AML-0024"	"2020-09-15-AML0024:CTTCGGTAGGTATTGA"	-1.57086871090587	-16.9669122925964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCGGTAGGTATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.2378487965	36.249503381952	0.015261420409042	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2371.87541080621	2371.87541080621
"AML-0024"	"2020-09-15-AML0024:CTTCGGTGTCGAGCAA"	-1.84233293953593	-16.2238245240417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCGGTGTCGAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.59032611631	42.1802652891801	0.0163388686665228	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.77938215419	2572.77938215419
"AML-0024"	"2020-09-15-AML0024:CTTCTAAAGACATCAA"	8.62990250167195	7.70345590198366	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTAAAGACATCAA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1955.55290072839	33.7612628498868	0.0172643055768584	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1954.25489818183	1954.25489818183
"AML-0024"	"2020-09-15-AML0024:CTTCTAAAGAGCAACC"	-2.67026005211528	-16.3488779298035	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTAAAGAGCAACC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.3108849633	43.1971648559755	0.017708757470094	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2430.48045628178	2430.48045628178
"AML-0024"	"2020-09-15-AML0024:CTTCTAAGTAGTCCTA"	-0.575471739203292	-15.7754183045593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTAAGTAGTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.22265047363	33.7729069366588	0.0122979493053246	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.66303150148	2742.66303150148
"AML-0024"	"2020-09-15-AML0024:CTTCTAATCCATAGGT"	-1.71045146408733	-16.7137060395447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTAATCCATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.31111702589	39.9107813871342	0.0162350408419497	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.957749259	2453.957749259
"AML-0024"	"2020-09-15-AML0024:CTTCTAATCCGTTGGG"	-2.60622225228007	-15.803719543573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTAATCCGTTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.89374375221	38.3333274282947	0.014363002467982	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.11625831973	2661.11625831973
"AML-0024"	"2020-09-15-AML0024:CTTCTCTGTAGCTGCC"	-1.45691428604777	-16.5748739472595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTGTAGCTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.07513960193	32.4528973376414	0.0119264980467937	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.79453398624	2711.79453398624
"AML-0024"	"2020-09-15-AML0024:CTTCTCTGTATCCCTC"	-1.34269891205485	-16.5785150757995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTGTATCCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.65351086598	34.8443290740005	0.0134396397081082	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.01633665962	2576.01633665962
"AML-0024"	"2020-09-15-AML0024:CTTCTCTGTCAAATCC"	-2.12042150917705	-16.6827459565369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTGTCAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.58437954767	36.8262750046736	0.0158899392529825	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2308.63292310834	2308.63292310834
"AML-0024"	"2020-09-15-AML0024:CTTCTCTGTCTTAGTG"	1.16105260428731	-16.2116537324158	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTGTCTTAGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3248.89460697916	39.8249234228896	0.0122579917912201	4861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3231.11444346026	3231.11444346026
"AML-0024"	"2020-09-15-AML0024:CTTCTCTGTGGTATGG"	-1.1082446378773	-16.0779428712097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTGTGGTATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.95493586668	31.3700099912532	0.0122111951257993	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.03234376144	2560.03234376144
"AML-0024"	"2020-09-15-AML0024:CTTCTCTTCAAGCCTA"	-1.8106977743214	-15.8767128220764	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTTCAAGCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2212.1076728748	34.8247167604825	0.0157427765327649	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2205.28087735415	2205.28087735415
"AML-0024"	"2020-09-15-AML0024:CTTCTCTTCCAAGCTA"	-0.558871249586898	-15.562918686029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTCTCTTCCAAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.03225149064	32.9801898716811	0.0136505586178881	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.35906354558	2413.35906354558
"AML-0024"	"2020-09-15-AML0024:CTTGAGAAGACCGTTT"	-1.23911927166637	-16.5046167603699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGAAGACCGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.24873863052	37.4634161735876	0.0133929513154161	2910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.29595694917	2788.29595694917
"AML-0024"	"2020-09-15-AML0024:CTTGAGACACAGCGCT"	-0.697380999953109	-15.9253072968689	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGACACAGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.65436545242	36.094375702486	0.0127873876958721	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.42022413033	2813.42022413033
"AML-0024"	"2020-09-15-AML0024:CTTGAGACACCTCGTT"	0.777555366128129	-16.2370805970398	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGACACCTCGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3044.53744311581	39.8286784202773	0.0130820130034322	3715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3031.68698232477	3031.68698232477
"AML-0024"	"2020-09-15-AML0024:CTTGAGACATCTGGGC"	-1.00484834137614	-16.3743257752624	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGACATCTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.04472806938	34.2776048483811	0.0120312624476096	3108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.96222095248	2841.96222095248
"AML-0024"	"2020-09-15-AML0024:CTTGAGAGTAACGCGA"	-0.62072447958644	-16.0302400819031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGAGTAACGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3017.80677633061	34.3806047604751	0.0113925798795769	3542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3011.65172310231	3011.65172310231
"AML-0024"	"2020-09-15-AML0024:CTTGAGATCCCGAGTG"	14.1749597984249	1.90176591956941	"2020-09-15-AML0024"	"AML0024"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00760456273764259	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGAGATCCCGAGTG"	"Plasma cell"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1221.65810535794	27.6600814790436	0.0226414259093705	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1206.41867982478	1206.41867982478
"AML-0024"	"2020-09-15-AML0024:CTTGATTAGATTGCGG"	-2.46829972687419	-15.4930906525818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGATTAGATTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.81720247777	35.2912767003274	0.0131105769990037	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.48069584161	2683.48069584161
"AML-0024"	"2020-09-15-AML0024:CTTGATTGTAAGTCAA"	-0.962806085974532	-15.8684749833313	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGATTGTAAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2917.49923110177	39.7189235194489	0.0136140305012006	2948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2904.88025422296	2904.88025422296
"AML-0024"	"2020-09-15-AML0024:CTTGATTGTTAGAGAT"	0.0846748175913512	-16.2551412812439	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGATTGTTAGAGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3259.12539069153	40.5056820293485	0.01242839018868	4275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3250.76402323653	3250.76402323653
"AML-0024"	"2020-09-15-AML0024:CTTGATTTCAGAGCAG"	-2.00492916527446	-16.2359743348328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTGATTTCAGAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.24878056963	35.8987926297574	0.0139183133089741	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.98077108524	2569.98077108524
"AML-0024"	"2020-09-15-AML0024:CTTTCAAAGAGCAGAA"	-0.818644682795364	-15.6796150437561	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAAAGAGCAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2996.63816144206	42.2597665214712	0.0141023921624007	3193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.56619029597	2988.56619029597
"AML-0024"	"2020-09-15-AML0024:CTTTCAAAGTCCGCGT"	0.704111178486985	-16.2426100007263	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAAAGTCCGCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2640.7223854414	38.7222726542737	0.0146635151304635	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2633.24373246235	2633.24373246235
"AML-0024"	"2020-09-15-AML0024:CTTTCAACAAACACCT"	-1.67694638195689	-16.9054212800232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAACAAACACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.42979380051	39.3138704085353	0.0153424185527543	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.86825791117	2551.86825791117
"AML-0024"	"2020-09-15-AML0024:CTTTCAACAAGGCGTA"	1.25707974013631	-16.182740234491	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAACAAGGCGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2959.24125708901	41.1213448948867	0.0138959082151137	3627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2949.98835866032	2949.98835866032
"AML-0024"	"2020-09-15-AML0024:CTTTCAAGTACATTGC"	-2.66675267639812	-16.2363672486511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAAGTACATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.998207794	38.2164260601684	0.0149809693881425	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.38500719444	2544.38500719444
"AML-0024"	"2020-09-15-AML0024:CTTTCAAGTCACGACC"	-1.06225166741069	-16.0161600342956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAAGTCACGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.67007283404	35.6439797555342	0.0127862978129608	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.75052252003	2779.75052252003
"AML-0024"	"2020-09-15-AML0024:CTTTCAAGTGATGTAA"	-2.61628804627116	-15.4754114381042	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAAGTGATGTAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.06608598718	37.9012771607171	0.0137419757101836	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.07024391153	2751.07024391153
"AML-0024"	"2020-09-15-AML0024:CTTTCAATCACAATGC"	-2.60693035546001	-16.4952459565369	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAATCACAATGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.32554886957	41.9421398647928	0.0168827068110608	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.24430666587	2476.24430666587
"AML-0024"	"2020-09-15-AML0024:CTTTCAATCACACGAT"	0.100521058856887	-16.2791109315124	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAATCACACGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2842.0906748771	40.0923069952666	0.0141066248693843	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2830.13025557128	2830.13025557128
"AML-0024"	"2020-09-15-AML0024:CTTTCAATCCCAGCGA"	-0.709921340376693	-16.1473875275818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAATCCCAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.54271052333	35.6838246393345	0.0122559852927318	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.21881104003	2908.21881104003
"AML-0024"	"2020-09-15-AML0024:CTTTCAATCTAAACGC"	-0.873754958540756	-16.4152593842712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAATCTAAACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.332537971	43.0881565768284	0.0178099355506394	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2405.52783881244	2405.52783881244
"AML-0024"	"2020-09-15-AML0024:CTTTCAATCTATACTC"	-1.77633915367778	-15.9458837739197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCAATCTATACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.45891326336	34.8940866821522	0.0130520377586647	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.37172481205	2668.37172481205
"AML-0024"	"2020-09-15-AML0024:CTTTCGGAGGTCGTGA"	-1.9442859691685	-16.8405218354431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCGGAGGTCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.38150441947	39.9420088294618	0.0157787393009422	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.50627455931	2526.50627455931
"AML-0024"	"2020-09-15-AML0024:CTTTCGGAGTCCGCGT"	-1.47284434261974	-16.7329263917175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCGGAGTCCGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.61258989924	37.6916717408583	0.0136930536026641	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.93551977986	2744.93551977986
"AML-0024"	"2020-09-15-AML0024:CTTTCGGCAGCGTGCT"	-4.89612660828288	2.87279841983644	"2020-09-15-AML0024"	"AML0024"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00279329608938547	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCGGCAGCGTGCT"	"MEP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2533.25879088541	43.049204784807	0.0169936071828495	3004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	2532.31594131033	2532.31594131033
"AML-0024"	"2020-09-15-AML0024:CTTTCGGGTCGTACAT"	-0.00721560689862374	-16.3799085847107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCGGGTCGTACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.43099437614	35.0087031411271	0.0133243092648527	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.25430366968	2620.25430366968
"AML-0024"	"2020-09-15-AML0024:CTTTCGGTCGAGAAAT"	-2.23261247101482	-15.605778717157	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.CTTTCGGTCGAGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.58297333852	35.599983021805	0.0134513005563916	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.76267247316	2641.76267247316
"AML-0024"	"2020-09-15-AML0024:GAAACCTCAAGTTCCA"	-3.19670901718791	11.1046600111756	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAACCTCAAGTTCCA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.98309108985	33.3803499063686	0.014789809475378	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2249.70603870258	2249.70603870258
"AML-0024"	"2020-09-15-AML0024:GAAACCTCATGTTTGG"	-1.57451758804973	-16.552083038446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAACCTCATGTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.75266546869	38.3211471243159	0.013835584527845	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.93642444444	2765.93642444444
"AML-0024"	"2020-09-15-AML0024:GAAACCTGTAGCGATG"	-1.82818017426189	-15.4998808137146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAACCTGTAGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.46688437317	41.367515467079	0.0138748867827107	3218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2969.58435313128	2969.58435313128
"AML-0024"	"2020-09-15-AML0024:GAAATGAAGCTGCGAA"	-2.04162011566814	-16.3316889039245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAAGCTGCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.7316096129	32.5256076514088	0.0126621276935625	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.13622806887	2560.13622806887
"AML-0024"	"2020-09-15-AML0024:GAAATGAAGTGTAGTA"	1.72316743907277	-4.62628366863402	"2020-09-15-AML0024"	"AML0024"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00337078651685393	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAAGTGTAGTA"	"cDC2"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1832.15093355381	44.1031020465935	0.0240717624508407	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"DC_AML-0024"	1832.15093355381	1832.15093355381
"AML-0024"	"2020-09-15-AML0024:GAAATGACAAAGGAGA"	-2.0300158065861	-16.0229959717956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGACAAAGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.5733697336	42.1951473686131	0.0171834195176953	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2446.10620902374	2446.10620902374
"AML-0024"	"2020-09-15-AML0024:GAAATGACAAGCTCTA"	0.99206848916356	-16.2225218049255	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGACAAGCTCTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2980.68718898562	47.7603964261945	0.0160232836919893	3097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2971.14647560075	2971.14647560075
"AML-0024"	"2020-09-15-AML0024:GAAATGAGTCCACAGC"	-1.09544775906261	-16.6156835786072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAGTCCACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.75927080113	43.3627689406328	0.0162665734357931	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.90139651001	2651.90139651001
"AML-0024"	"2020-09-15-AML0024:GAAATGAGTGACTGTT"	-2.20766411247905	-15.5915155640808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.01486256324	33.6919982467387	0.0132958960677358	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.0745261048	2527.0745261048
"AML-0024"	"2020-09-15-AML0024:GAAATGAGTTAAGGAT"	-1.84056792679484	-15.9530897370544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAGTTAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.78642707545	35.5398250887643	0.0126395891048273	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.04834818646	2804.04834818646
"AML-0024"	"2020-09-15-AML0024:TCGCTTGAGTCGCGAA"	-1.48778770390208	-15.5744858018127	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTTGAGTCGCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.48922107189	33.7741565540916	0.0125812226359418	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.57091707637	2678.57091707637
"AML-0024"	"2020-09-15-AML0024:TCGCTTGAGTTGAAAC"	-0.661289791495162	-16.7326212159363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTTGAGTTGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.24049647548	34.4526051300519	0.012887955713478	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.41364542895	2667.41364542895
"AML-0024"	"2020-09-15-AML0024:TCGCTTGGTTAGAAAC"	-1.89268491688426	-15.4149580231872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTTGGTTAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3176.8286103489	39.0392423944381	0.0122887467920879	3496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3167.74780911674	3167.74780911674
"AML-0024"	"2020-09-15-AML0024:TCGCTTGGTTGAATCC"	-0.684544841677505	-16.5522032014099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTTGGTTGAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.72598452067	42.1801726700047	0.0164462686948165	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.96861763896	2556.96861763896
"AML-0024"	"2020-09-15-AML0024:TCGCTTGTCTGGGCCA"	-1.68212364140208	-15.9323644868103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCTTGTCTGGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2977.78949336048	34.0205042527968	0.0114247512554704	3082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2971.51572887389	2971.51572887389
"AML-0024"	"2020-09-15-AML0024:TCGGATAAGACATAGT"	-0.0335780111258805	-16.5715646973816	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAAGACATAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2876.1791799543	46.4770643611004	0.0161593076971786	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2864.70310695968	2864.70310695968
"AML-0024"	"2020-09-15-AML0024:TCGGATAAGACCTCCG"	-0.89428953352626	-16.185067199823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAAGACCTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.79944675144	38.4406694976361	0.0140100143044888	3101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.21776270478	2734.21776270478
"AML-0024"	"2020-09-15-AML0024:TCGGATAAGGTAAGAG"	-1.63883243027385	-16.3251161805359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAAGGTAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3030.70900413175	43.1099011824695	0.014224361733079	3370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3017.56527948679	3017.56527948679
"AML-0024"	"2020-09-15-AML0024:TCGGATAAGTTAACGA"	-1.61166868630107	-16.5407781830994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAAGTTAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.24426420695	35.2456514023208	0.0133595102926967	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.28614237336	2627.28614237336
"AML-0024"	"2020-09-15-AML0024:TCGGATACAGAGTTGG"	-1.00122056427653	-16.6438150635925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATACAGAGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.06383587687	35.8743954128532	0.012582810304498	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.87953172721	2838.87953172721
"AML-0024"	"2020-09-15-AML0024:TCGGATACATAAGCAA"	-1.80781910839732	-16.4289522401062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATACATAAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.34010732624	32.8813424865657	0.0121632281478216	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.16922053075	2697.16922053075
"AML-0024"	"2020-09-15-AML0024:TCGGATAGTAAGCGGT"	-1.34825346890147	-15.1282816163269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAGTAAGCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.64256850104	35.5224704442986	0.0142280961209541	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.1306882395	2490.1306882395
"AML-0024"	"2020-09-15-AML0024:TCGGATAGTGACTGTT"	-1.97033057633098	-16.8205404511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.74935970675	36.9244998001396	0.0132452724530529	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.32444387563	2779.32444387563
"AML-0024"	"2020-09-15-AML0024:TCGGATAGTGGGACAT"	-2.53813133660014	-16.3341341248718	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAGTGGGACAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2089.62119203508	36.5928959700264	0.0175117366293498	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2083.00445036284	2083.00445036284
"AML-0024"	"2020-09-15-AML0024:TCGGATAGTGGTCTTA"	-2.08740292015727	-15.8908376923767	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATAGTGGTCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.96660385694	41.5367197945554	0.0148985715026473	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.08413129483	2785.08413129483
"AML-0024"	"2020-09-15-AML0024:TCGGATATCCAATGCA"	-0.220479975373107	-16.4624414674011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGATATCCAATGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.85384284184	32.729789108012	0.0115658938325746	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2823.44552424051	2823.44552424051
"AML-0024"	"2020-09-15-AML0024:TCGGGACCAGTAGAGC"	-2.26972756806071	10.9941625365051	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGACCAGTAGAGC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1819.15524371795	44.294924447771	0.0243491722879253	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1812.62177744256	1812.62177744256
"AML-0024"	"2020-09-15-AML0024:TCGGGACTCGGAGTGA"	-1.35361824455913	-15.0955562821594	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGACTCGGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2330.4218496436	39.5969483770418	0.0169913221432838	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2323.25381950324	2323.25381950324
"AML-0024"	"2020-09-15-AML0024:TCGGGCAAGAGGGTGG"	0.227701474993867	-16.1278066865173	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCAAGAGGGTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3012.64610086167	37.1292934522352	0.0123244789494576	2999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3006.1569076016	3006.1569076016
"AML-0024"	"2020-09-15-AML0024:TCGGGCACAGGATCTT"	-2.04320106926616	-16.3515463105408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCACAGGATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.54273853277	41.2522803866907	0.0178771468444917	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2302.72185355351	2302.72185355351
"AML-0024"	"2020-09-15-AML0024:TCGGGCACAGTATGAA"	-1.60706839981731	-15.9513616791931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCACAGTATGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.26776830919	40.368575591673	0.0146301769097277	2978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.64384867433	2754.64384867433
"AML-0024"	"2020-09-15-AML0024:TCGGGCAGTGTCTCCT"	-1.68067131462749	-16.905541442987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCAGTGTCTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.67789613865	40.4049901842939	0.0167330765933237	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2410.72888798138	2410.72888798138
"AML-0024"	"2020-09-15-AML0024:TCGGGCATCACCATCC"	-0.506930748850662	-15.7093630067078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCATCACCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.02600272816	35.4590855814323	0.0122864747399756	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.11819176419	2879.11819176419
"AML-0024"	"2020-09-15-AML0024:TCGGGCATCAGATTGC"	-1.67870305004771	-15.8632812730041	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCATCAGATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.09201747044	33.2979204628879	0.0136573682306851	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2432.50053271497	2432.50053271497
"AML-0024"	"2020-09-15-AML0024:TCGGGCATCCAAGGGA"	-1.80285964432414	-16.2266912690369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCATCCAAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.26934453206	39.3719511944239	0.0156283214733981	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.11271080413	2509.11271080413
"AML-0024"	"2020-09-15-AML0024:TCGGGCATCTTGTTAC"	-1.71490238133128	-16.4289598695007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGCATCTTGTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.90291279297	34.5605063933527	0.0135271309998906	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.70789371521	2547.70789371521
"AML-0024"	"2020-09-15-AML0024:TCGGGTGAGAAGCGCT"	-2.52024708214458	-15.7989816895691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGAGAAGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.32094427362	33.2824413338607	0.0131326860589869	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.70908308903	2531.70908308903
"AML-0024"	"2020-09-15-AML0024:TCGGGTGAGACTCATC"	-0.832218210131484	-16.7585878602234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGAGACTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.10862687242	38.6355784912465	0.0145843692853245	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.61723007694	2643.61723007694
"AML-0024"	"2020-09-15-AML0024:TCGGGTGAGCACTCAT"	-0.928135733038741	-16.7026205292908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGAGCACTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.72242127495	39.7502384073684	0.0144403366282597	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.67862426402	2744.67862426402
"AML-0024"	"2020-09-15-AML0024:TCGGGTGCAGAGTTCT"	-1.0202833217686	-15.9670191041199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGCAGAGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.03915181034	48.3525030916146	0.0177177755253307	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.62280840315	2721.62280840315
"AML-0024"	"2020-09-15-AML0024:TCGGGTGCAGCGTTTA"	-2.33837447586711	-16.6354818574158	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGCAGCGTTTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.0380039834	44.380954844181	0.0197596633563058	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2244.72343489048	2244.72343489048
"AML-0024"	"2020-09-15-AML0024:TCGGGTGCATCAGTGT"	-1.20393858376201	-16.1459055176941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGCATCAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.35367006078	30.8036586089033	0.0125557350270417	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2446.75836820651	2446.75836820651
"AML-0024"	"2020-09-15-AML0024:TCGGGTGGTATATGGA"	-1.78697345677074	-16.1855535737244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGGTGGTATATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.75211194786	35.9006110293086	0.0135282458627824	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.94622924948	2637.94622924948
"AML-0024"	"2020-09-15-AML0024:TCGGTCTGTAGCGCCT"	-1.73360989514049	-16.1846971741882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGTCTGTAGCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.6139204936	36.0568271207373	0.0139613694616213	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.7422453879	2577.7422453879
"AML-0024"	"2020-09-15-AML0024:TCGGTCTGTCTGTGTA"	-1.2046162885731	-16.0027933350769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGTCTGTCTGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.42446130893	38.978750959461	0.0140442485475098	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.7497705524	2766.7497705524
"AML-0024"	"2020-09-15-AML0024:TCGGTCTGTGTGACCC"	-0.957407931715804	-17.4378347626892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGTCTGTGTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.50743799217	44.4122492632508	0.0144547247352714	2735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3063.92835448628	3063.92835448628
"AML-0024"	"2020-09-15-AML0024:TCGGTCTTCCACGTCT"	-1.1452593607014	-16.3426904908386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGTCTTCCACGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.20784526348	38.8838962381104	0.0142316757875939	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.87926129264	2724.87926129264
"AML-0024"	"2020-09-15-AML0024:TCGGTCTTCCATCTCG"	-1.24048922482188	-16.0181627503601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGGTCTTCCATCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1442.79999864763	30.0481730157835	0.0208262912697174	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1438.48149075493	1438.48149075493
"AML-0024"	"2020-09-15-AML0024:TCGTAGACAGGCATGA"	-0.0267337140744508	-16.0165930024353	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTAGACAGGCATGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2779.6020930618	38.791307907108	0.0139557053881689	2475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2770.70521546178	2770.70521546178
"AML-0024"	"2020-09-15-AML0024:TCGTCCACAAACTAAG"	-1.83499226990398	-16.5232782593933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTCCACAAACTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.2552568517	32.2589544053874	0.0108205945570236	3035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.9054462263	2970.9054462263
"AML-0024"	"2020-09-15-AML0024:TCGTCCACAATCACGT"	-0.966911296278793	-16.3102445832458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTCCACAATCACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.69362780837	35.7297929083383	0.013515103464526	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.89917933714	2630.89917933714
"AML-0024"	"2020-09-15-AML0024:TCGTCCAGTAAGTCAA"	-1.77908060970958	-16.590792678949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTCCAGTAAGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.4514059401	36.6033908593629	0.0133469605988571	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.71349043936	2734.71349043936
"AML-0024"	"2020-09-15-AML0024:TCGTCCAGTGACGCCT"	-0.991778234869796	-15.665255569574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTCCAGTGACGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.43777465438	37.8260490381042	0.014727259274636	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.03420793186	2561.03420793186
"AML-0024"	"2020-09-15-AML0024:TCGTGCTCACATACGT"	-1.00616834583934	-16.149926208612	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGCTCACATACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2210.89984428981	38.5051776140325	0.0174160660029361	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2202.35454722809	2202.35454722809
"AML-0024"	"2020-09-15-AML0024:TCGTGCTTCATCGGGC"	0.138355900614899	-16.4155321351257	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGCTTCATCGGGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2162.58664006345	45.1998588635089	0.0209008314516281	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2150.71281396321	2150.71281396321
"AML-0024"	"2020-09-15-AML0024:TCGTGCTTCGACACTA"	-0.0741192800110162	-16.1758699647156	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGCTTCGACACTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2753.56153125087	37.3782212751117	0.0135745000977449	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2742.84898786019	2742.84898786019
"AML-0024"	"2020-09-15-AML0024:TCGTGGGAGTGATAAC"	-1.3170956176823	-16.2456007233826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGAGTGATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1754.46071809053	45.0060654234999	0.0256523642618128	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1750.73313424241	1750.73313424241
"AML-0024"	"2020-09-15-AML0024:TCGTGGGGTCACAGTT"	-0.63457820835765	-16.369559311029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGGTCACAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.35571304019	36.039144650573	0.0135569308779062	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.81766965238	2654.81766965238
"AML-0024"	"2020-09-15-AML0024:TCGTGGGGTGCAATGG"	-0.198638419539291	-15.7093343964783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGGTGCAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.65103981365	40.7607006410668	0.0166597933165701	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.74121287097	2441.74121287097
"AML-0024"	"2020-09-15-AML0024:TCGTGGGGTGCCTTTC"	-1.97487531128581	-15.8583593598572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGGTGCCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.14213935082	36.0074078217857	0.0138163637654679	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.80343479693	2599.80343479693
"AML-0024"	"2020-09-15-AML0024:TCGTGGGTCGCTACGG"	-2.08554277840312	-16.6799936524597	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGTCGCTACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2344.23244155741	35.5428052503898	0.015161809307091	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2334.39676925736	2334.39676925736
"AML-0024"	"2020-09-15-AML0024:TCGTGGGTCGCTCTAC"	-0.651018242270309	-15.6243648759094	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGTGGGTCGCTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.39418600181	41.4639921542526	0.0163605142338434	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.36956159677	2527.36956159677
"AML-0024"	"2020-09-15-AML0024:TCTAACTCAACGACAG"	-1.84346483174022	-16.3183279267517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTAACTCAACGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2345.25201173263	43.8653908115041	0.0187039135206187	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2337.71728390987	2337.71728390987
"AML-0024"	"2020-09-15-AML0024:TCTAACTCACACCGAC"	0.198939998715562	10.7191524275574	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Naive"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTAACTCACACCGAC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1856.35776188138	35.3357658131042	0.0190349977459582	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1854.76450764298	1854.76450764298
"AML-0024"	"2020-09-15-AML0024:TCTAACTCACTAACCA"	-1.94124482098277	-16.3594618073669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTAACTCACTAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.07589581857	36.5672895909922	0.0119031205058326	3241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3063.72196965287	3063.72196965287
"AML-0024"	"2020-09-15-AML0024:TCTAACTCATCCGATA"	-2.22178254547771	-15.5814361802307	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTAACTCATCCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.72020246309	37.2877862497868	0.0135852777329817	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.76395245323	2736.76395245323
"AML-0024"	"2020-09-15-AML0024:TCTAACTGTAAGCGGT"	-0.679704825312454	-16.1222200623718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTAACTGTAAGCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.65893158848	34.785030613342	0.0130297657883378	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.37370874494	2667.37370874494
"AML-0024"	"2020-09-15-AML0024:TCTACATAGGATACCG"	-1.76585851135905	-15.8921900025574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATAGGATACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.78888899305	42.3736408232656	0.0169102995904389	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.33266417422	2495.33266417422
"AML-0024"	"2020-09-15-AML0024:TCTACATAGGGTAATT"	-0.82725558701213	-15.6745701066223	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATAGGGTAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.89617866733	38.1955997171994	0.014247325212044	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.67484549312	2671.67484549312
"AML-0024"	"2020-09-15-AML0024:TCTACATCACTACCGG"	-2.80858216705974	-15.8246355286804	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATCACTACCGG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.45784962868	52.8816023743236	0.0236558262027207	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2226.15234265201	2226.15234265201
"AML-0024"	"2020-09-15-AML0024:TCTACATCATAGGTAA"	-0.612241665751296	-16.1999807587829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATCATAGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.10482140242	40.4744208796142	0.014912622593073	2514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.57462560647	2706.57462560647
"AML-0024"	"2020-09-15-AML0024:TCTACATGTACAAGCG"	-1.1022209924763	-16.3449564210144	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATGTACAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.48372066887	38.9263565722125	0.0157374622064164	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.66043167011	2468.66043167011
"AML-0024"	"2020-09-15-AML0024:TCTACATGTATCGTGT"	-1.34368095818217	-16.2522325745788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATGTATCGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.72453865905	38.3916394690473	0.0148647828656865	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.63413219905	2572.63413219905
"AML-0024"	"2020-09-15-AML0024:TCTACATGTTGGTACT"	-0.794083456427413	-15.7486067048279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATGTTGGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.15535503044	30.3872259177	0.0126658016764048	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2389.16209319349	2389.16209319349
"AML-0024"	"2020-09-15-AML0024:TCTACATTCAGATGCT"	-0.2931044799393	-15.9424438706604	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACATTCAGATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.57490200125	37.7137922333254	0.0136418051853197	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.10005079154	2763.10005079154
"AML-0024"	"2020-09-15-AML0024:TCTACCGAGACCAAGC"	-0.256241689354736	-16.4332304230896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGAGACCAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.74636529181	34.0129669918886	0.0119228850505991	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.86060064509	2847.86060064509
"AML-0024"	"2020-09-15-AML0024:TCTACCGAGCTCCATA"	-0.103289301425773	-16.4805155030456	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGAGCTCCATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2710.43314929799	45.050376484945	0.0166210985489951	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2706.85065346551	2706.85065346551
"AML-0024"	"2020-09-15-AML0024:TCTACCGAGGTTTGAA"	0.201572005718392	-15.988591217157	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGAGGTTTGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2784.40309219756	45.2776161097395	0.016261157099206	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2775.39768282476	2775.39768282476
"AML-0024"	"2020-09-15-AML0024:TCTACCGCAACCGCCA"	0.299488415091676	-16.2810926667419	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGCAACCGCCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2818.98260750506	37.8618999763564	0.0134310512862178	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2810.55189273401	2810.55189273401
"AML-0024"	"2020-09-15-AML0024:TCTACCGCACCTCTAC"	-1.42408571663554	-15.1215706101623	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGCACCTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.73533943447	32.1819350247553	0.011392902752864	2964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.19036015283	2817.19036015283
"AML-0024"	"2020-09-15-AML0024:TCTACCGGTATCGCTA"	-1.30333373966869	-16.2705202332703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGGTATCGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.96291527548	43.3847546716881	0.0166866821125759	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.62427576225	2592.62427576225
"AML-0024"	"2020-09-15-AML0024:TCTACCGGTGTCTTGA"	-2.94602570954021	-15.577120803949	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGGTGTCTTGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2654.42845062235	34.767730872857	0.0130980101817043	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.52004386801	2645.52004386801
"AML-0024"	"2020-09-15-AML0024:TCTACCGTCCGTGGCA"	-0.98460696163829	-17.3874845734802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGTCCGTGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3144.56946639263	41.9950532530251	0.0133547863075834	2859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3137.03408022206	3137.03408022206
"AML-0024"	"2020-09-15-AML0024:TCTACCGTCGTGAGAG"	-2.20061431351359	-16.8045168153015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTACCGTCGTGAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1562.72947246253	46.6510711665185	0.0298523013666635	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1558.53017358866	1558.53017358866
"AML-0024"	"2020-09-15-AML0024:TCTATACAGATCACTC"	-0.943907181650955	-16.0481558076111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACAGATCACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.33500918482	33.4739253230472	0.0127406384058473	2474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.80967983902	2617.80967983902
"AML-0024"	"2020-09-15-AML0024:TCTATACAGCGTACAG"	-1.95274053040202	-16.4537077180115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACAGCGTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.22661236266	34.6671813011957	0.0125504479415407	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.06287450054	2754.06287450054
"AML-0024"	"2020-09-15-AML0024:TCTATACAGCTGTTCA"	-0.704014281660873	-16.2020311585632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACAGCTGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.20492733043	34.7153993419156	0.0121885188136563	2752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.66358815689	2842.66358815689
"AML-0024"	"2020-09-15-AML0024:TCTATACAGGACTAAT"	-3.29608927193339	13.4271926649841	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACAGGACTAAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2181.94312976731	32.0799142107425	0.014702452036027	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2176.81589508987	2176.81589508987
"AML-0024"	"2020-09-15-AML0024:TCTATACAGGCTAGCA"	-0.783174375922042	-16.0285425416199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACAGGCTAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3063.68225091489	34.1834094828149	0.0111576223260774	3105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3051.29221205688	3051.29221205688
"AML-0024"	"2020-09-15-AML0024:TCTATACCAGCTGTGC"	-1.02607629719432	-16.2748441926208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACCAGCTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.20085719905	35.7999602687424	0.0134273305674171	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.10235618235	2657.10235618235
"AML-0024"	"2020-09-15-AML0024:TCTATACGTCACCGCA"	-1.49059544029887	-15.1463890305725	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACGTCACCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.38784400436	37.6157127608908	0.0131138865476358	2981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.86478872686	2863.86478872686
"AML-0024"	"2020-09-15-AML0024:TCTATACTCCGTGGGT"	-1.04660318318065	-16.5430841675964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACTCCGTGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.8890193499	31.1219365230426	0.0111833193155194	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.38270196117	2774.38270196117
"AML-0024"	"2020-09-15-AML0024:TCTATACTCGAGAAAT"	-2.84202108803447	-16.160616897699	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATACTCGAGAAAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.36868482921	47.0667922191535	0.0192237355880234	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2439.16688167336	2439.16688167336
"AML-0024"	"2020-09-15-AML0024:TCTATCAAGGAAAGTG"	0.304178048937958	-16.1887312165466	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAAGGAAAGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2702.60706676351	36.0381198974318	0.013334576209996	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2692.50305734978	2692.50305734978
"AML-0024"	"2020-09-15-AML0024:TCTATCAAGGATGTTA"	-1.97043476525005	-16.7714624634949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAAGGATGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.58166483826	42.5778955069737	0.0152249784235914	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.63010838357	2791.63010838357
"AML-0024"	"2020-09-15-AML0024:TCTATCAAGGCCCACT"	-0.923168997198898	-16.7791109315124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAAGGCCCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.0238861436	34.3641166544942	0.014037492382735	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.2186295272	2441.2186295272
"AML-0024"	"2020-09-15-AML0024:TCTATCAAGTGTAGAT"	0.61411096629445	-16.1649503937927	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAAGTGTAGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2977.92400992541	38.1681370209452	0.0128170285385829	2798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2971.3667531915	2971.3667531915
"AML-0024"	"2020-09-15-AML0024:TCTATCAGTACGGATG"	-2.51657972756084	-15.7655802003113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAGTACGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.11823134283	40.1670425905224	0.0150657394403292	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.74959419784	2655.74959419784
"AML-0024"	"2020-09-15-AML0024:TCTATCAGTAGCTCGC"	-0.724093596369582	-16.5352564088074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAGTAGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.42137480196	40.5661233090771	0.0161655287216475	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.43213331027	2504.43213331027
"AML-0024"	"2020-09-15-AML0024:TCTATCAGTGGATTTC"	-1.79804490032848	-15.6363649598328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTATCAGTGGATTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.03427345876	35.1908451468327	0.0130238337435248	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.20798996508	2694.20798996508
"AML-0024"	"2020-09-15-AML0024:TCTCACGCACGGCACT"	-2.21731148186381	-16.4584665528503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCACGCACGGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2451.68758517878	42.1975829740161	0.0172116476948832	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.74854514241	2442.74854514241
"AML-0024"	"2020-09-15-AML0024:TCTCACGCATAGACTC"	-1.90832696381267	-15.6367321244446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCACGCATAGACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.04703118837	37.1648601823692	0.0131694687479106	2724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.07871565044	2817.07871565044
"AML-0024"	"2020-09-15-AML0024:TCTCACGCATCATCCC"	-0.609050731093246	-15.7285623780456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCACGCATCATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.77435897003	32.3511942046598	0.0113362831588184	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2851.20098691233	2851.20098691233
"AML-0024"	"2020-09-15-AML0024:TCTCACGTCGATTTCT"	-1.83222077313121	-16.2506590119568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCACGTCGATTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2977.01442090221	38.4813953868767	0.0129261702989046	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.56325997787	2973.56325997787
"AML-0024"	"2020-09-15-AML0024:TCTCAGCAGAAGGGAT"	-1.05836174908336	-16.4847727051941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCAGAAGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.68195514803	46.100023425029	0.0195697145466872	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2339.36396381393	2339.36396381393
"AML-0024"	"2020-09-15-AML0024:TCTCAGCCACGTCATA"	-0.626466910273391	-16.3314275971619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCCACGTCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.79859330597	37.7294179228085	0.01414783179259	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.77260554919	2659.77260554919
"AML-0024"	"2020-09-15-AML0024:TCTCAGCCAGACATCT"	-0.526730994612533	-16.4633226624695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCCAGACATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.14833556957	34.4923659694539	0.0131894491414926	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.30355580001	2603.30355580001
"AML-0024"	"2020-09-15-AML0024:TCTCAGCCAGCCCAGT"	-0.873109797865707	-15.8293104401794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCCAGCCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.23324942134	33.4128188234373	0.0123740491050533	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.89633682011	2694.89633682011
"AML-0024"	"2020-09-15-AML0024:TCTCAGCCATGGAATA"	-0.650805096060592	-16.5933943024841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCCATGGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2549.56743937946	38.0229895818721	0.0149135061087564	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2545.62754425951	2545.62754425951
"AML-0024"	"2020-09-15-AML0024:TCTCAGCGTAGACGTG"	-0.934697191149551	-15.542208694574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCGTAGACGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.40448198426	37.6324460122859	0.0143613118780004	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.32958418807	2613.32958418807
"AML-0024"	"2020-09-15-AML0024:TCTCAGCGTCTGATAC"	-2.55559335175212	-16.0855417481628	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCGTCTGATAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2163.80500319418	44.7717461651112	0.0206912111299399	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2160.69938032365	2160.69938032365
"AML-0024"	"2020-09-15-AML0024:TCTCAGCGTGTGTGGA"	-1.13236997547801	-16.1558141938415	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCGTGTGTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.24513704671	34.7739063864945	0.012755238299724	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.62683030532	2716.62683030532
"AML-0024"	"2020-09-15-AML0024:TCTCAGCTCACCCTCA"	-1.9511869949406	-15.9224119416443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCTCACCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.9766507971	35.2390772099077	0.0118173551763016	2897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2976.35213424101	2976.35213424101
"AML-0024"	"2020-09-15-AML0024:TCTCAGCTCCCTCAAC"	-1.51234457913097	-15.6218538514343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCAGCTCCCTCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.28517100543	35.1746899179398	0.012153152795832	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.9778791602	2887.9778791602
"AML-0024"	"2020-09-15-AML0024:TCTCCGAAGATGGCAC"	-1.39162359657939	-16.0610838166443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAAGATGGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.16621324554	32.7961280164792	0.0135399989633802	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2417.52839262579	2417.52839262579
"AML-0024"	"2020-09-15-AML0024:TCTCCGAAGGCATTTC"	-2.24710832062419	-16.0029440156189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAAGGCATTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.58965325735	38.6320667551882	0.014427926515249	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.94419990309	2672.94419990309
"AML-0024"	"2020-09-15-AML0024:TCTCCGAAGGTAGTCG"	0.0134821581536948	-16.0523329011169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAAGGTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.77917772213	40.719653206621	0.0157475369735523	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.5343034192	2580.5343034192
"AML-0024"	"2020-09-15-AML0024:TCTCCGACAACCACAT"	0.286223461001557	-16.0691309205261	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGACAACCACAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2709.98943955741	38.3130409141102	0.014137708566262	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2704.9098682678	2704.9098682678
"AML-0024"	"2020-09-15-AML0024:TCTCCGACAACTGCCG"	-2.92587552490886	-16.0011129609314	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGACAACTGCCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.77753280675	40.974833859572	0.0153132438542421	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.62278106024	2663.62278106024
"AML-0024"	"2020-09-15-AML0024:TCTCCGACACGGCCAT"	-2.17038808289226	-16.4794111481872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGACACGGCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.31409985667	43.0326577858379	0.0170337717658621	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.72005396048	2517.72005396048
"AML-0024"	"2020-09-15-AML0024:TCTCCGACACGTATAC"	-2.22451291504558	-16.7450781098572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGACACGTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1603.15913120814	48.8565565210305	0.0304751759011048	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1601.14517244682	1601.14517244682
"AML-0024"	"2020-09-15-AML0024:TCTCCGACATTGCTTT"	-0.819886366755325	-17.3098821870056	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGACATTGCTTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3172.46694645504	39.2516070090477	0.0123725818650082	4512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3159.55415299757	3159.55415299757
"AML-0024"	"2020-09-15-AML0024:TCTCCGAGTCCACTCT"	-0.64215979996379	-16.4206705323425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAGTCCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2952.24617155885	34.5428349818285	0.0117005266412418	2948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2946.66393858256	2946.66393858256
"AML-0024"	"2020-09-15-AML0024:TCTCCGAGTGGAGGTT"	-0.579525153071243	-16.6245870820251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAGTGGAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3011.95733755105	35.2361295520473	0.0116987478915279	3235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3001.64810394251	3001.64810394251
"AML-0024"	"2020-09-15-AML0024:TCTCCGAGTGTCATCA"	-2.7842997116154	-15.8014574280945	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAGTGTCATCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.11224283549	37.2977334054177	0.0145858804242631	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.98488097021	2551.98488097021
"AML-0024"	"2020-09-15-AML0024:TCTCCGAGTGTGCCTG"	-1.64832506600078	-16.1191702119079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGAGTGTGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.70514379777	36.9888659563615	0.0139385741640558	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.91845381473	2640.91845381473
"AML-0024"	"2020-09-15-AML0024:TCTCCGATCAGTCACA"	-0.808117310435134	-16.0212526551453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCCGATCAGTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.41311291956	35.0515183618041	0.0126384050751478	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.42376496286	2766.42376496286
"AML-0024"	"2020-09-15-AML0024:TCTCTGGAGTGTTGAA"	9.69516815718953	7.27685926044313	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGAGTGTTGAA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1646.56240409197	32.4948566141895	0.0197349681575594	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1642.90058772148	1642.90058772148
"AML-0024"	"2020-09-15-AML0024:TCTCTGGAGTTAGTAG"	0.720241447060746	-16.1970644227234	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGAGTTAGTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2675.94223839622	36.0215588195736	0.0134612617203436	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2670.426986849	2670.426986849
"AML-0024"	"2020-09-15-AML0024:TCTCTGGCAGTACTAC"	-1.8824876350468	-16.1692304841247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGCAGTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.00114225207	37.7280821215185	0.0148418824423082	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.15751978367	2537.15751978367
"AML-0024"	"2020-09-15-AML0024:TCTCTGGGTAACGATA"	-0.530474404723007	-15.8080692521301	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGGTAACGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.14110025614	36.6621312892483	0.0136182057046565	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2685.7893809491	2685.7893809491
"AML-0024"	"2020-09-15-AML0024:TCTCTGGGTCCCTAAA"	-0.58454261246379	-16.5738954774109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGGTCCCTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2950.60006377512	35.8896351863175	0.0121635038333182	3248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2943.83761213625	2943.83761213625
"AML-0024"	"2020-09-15-AML0024:TCTCTGGGTTCAACGT"	-2.58158669892009	-16.1730547181335	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGGTTCAACGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2546.49236233846	38.8683791599658	0.0152634972461778	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.19228701451	2537.19228701451
"AML-0024"	"2020-09-15-AML0024:TCTCTGGTCCACAGCG"	-2.87206516686137	-15.9341106644836	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGTCCACAGCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.76992668495	35.3491787725435	0.0148477928826011	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2374.55958139117	2374.55958139117
"AML-0024"	"2020-09-15-AML0024:TCTCTGGTCGGCGATC"	-1.00120304051097	-17.4842024079529	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGTCGGCGATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3073.90474743654	40.3313879159606	0.0131205717905198	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3066.61725688061	3066.61725688061
"AML-0024"	"2020-09-15-AML0024:TCTCTGGTCGGTTGTA"	-1.04907272282298	-15.8633823624817	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTCTGGTCGGTTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.2140637572	37.2399474698902	0.0161757101809702	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2298.40338899987	2298.40338899987
"AML-0024"	"2020-09-15-AML0024:TCTGCCAAGCCTCAGC"	-2.74032650414165	-16.167359375116	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGCCAAGCCTCAGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2198.8978532792	45.3149622409833	0.0206080342356082	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2194.42773373937	2194.42773373937
"AML-0024"	"2020-09-15-AML0024:TCTGCCAAGGTACAGC"	0.165505026548547	-16.1587782136169	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGCCAAGGTACAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2712.21543706673	39.7245706241756	0.0146465395341669	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2708.4719609915	2708.4719609915
"AML-0024"	"2020-09-15-AML0024:TCTGCCAAGTATGAGT"	1.22726561602895	-16.1993398896423	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGCCAAGTATGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2959.62402759263	40.8316221364713	0.0137962193021132	4000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2948.38178729403	2948.38178729403
"AML-0024"	"2020-09-15-AML0024:TCTGCCAAGTTCGCAT"	-0.166652182967025	-16.1479521027771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGCCAAGTTCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.10899386792	39.9101180877482	0.0144334701367127	3092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.64101194865	2756.64101194865
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGACCACGA"	-2.77162752571757	-15.6747818223205	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGACCACGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.62976524097	40.0468845478335	0.0140435076937308	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.13890938314	2849.13890938314
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGCTCTTCC"	-0.796298961073715	-16.3182554475036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGCTCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3071.22702623869	39.5703682887397	0.0128842211763164	3118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3065.05480116835	3065.05480116835
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGCTGTACT"	0.0172149288350761	-16.0346861115661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGCTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.7972899728	37.54158733847	0.0136973235765431	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.3082747467	2734.3082747467
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGGACTGGT"	-2.21338735047038	13.9353799589905	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGGACTGGT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2083.65450529364	39.6521603038777	0.0190301032167949	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2080.20627511704	2080.20627511704
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGGTTGGTG"	8.74115624007527	7.39037082279054	"2020-09-15-AML0024"	"AML0024"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGGTTGGTG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1652.68238442664	46.3457547408748	0.028042747461699	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1650.99594096022	1650.99594096022
"AML-0024"	"2020-09-15-AML0024:TCTGGCTAGTGTTGAA"	-0.529418091208297	-15.9119777909485	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTAGTGTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.07531906517	39.8919574217708	0.0150815960264865	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.74975267808	2637.74975267808
"AML-0024"	"2020-09-15-AML0024:TCTGGCTCAAACACGG"	-1.23497066918071	-16.3678751221863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTCAAACACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.53839057989	39.9748268354653	0.0152195859686786	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.28072528297	2620.28072528297
"AML-0024"	"2020-09-15-AML0024:TCTGGCTTCCGCATAA"	-1.65333269062694	-15.7538881531921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGGCTTCCGCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2968.16051954678	32.7360527726085	0.0110290708865055	2793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2958.92909367233	2958.92909367233
"AML-0024"	"2020-09-15-AML0024:TCTGTCGAGATTAGCA"	-0.720005731016952	-16.6477785340515	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGAGATTAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.71192043595	44.3120246279289	0.0174270723599437	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.20154308295	2534.20154308295
"AML-0024"	"2020-09-15-AML0024:TCTGTCGAGGTTCCAT"	-1.29579899731334	-16.8776216736999	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGAGGTTCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.47288131008	38.7008535627261	0.015038376290573	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.23287333337	2561.23287333337
"AML-0024"	"2020-09-15-AML0024:TCTGTCGCAAGTCGTT"	-0.962532381445724	-17.4883203736511	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGCAAGTCGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2739.73115160225	39.5054581235734	0.0144194652458763	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2731.43911179849	2731.43911179849
"AML-0024"	"2020-09-15-AML0024:TCTGTCGCACCCAACG"	-1.62371037426646	-16.9018831483093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGCACCCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.17319805939	30.358300561226	0.0117751206878099	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.44249187391	2571.44249187391
"AML-0024"	"2020-09-15-AML0024:TCTGTCGCATGGGATG"	-1.0343042415684	-16.7951708070007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGCATGGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.2214116087	38.8887384573077	0.0151305013185487	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.17414203447	2562.17414203447
"AML-0024"	"2020-09-15-AML0024:TCTGTCGGTCTACATG"	-2.40329156342204	-16.4205789796081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGGTCTACATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.75656610913	40.347636857734	0.0179421985757866	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2241.15598493522	2241.15598493522
"AML-0024"	"2020-09-15-AML0024:TCTGTCGTCCTCTTTC"	-1.80860791626628	-15.9275570145813	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGTCCTCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3111.42024766794	36.5433176165516	0.0117448993410458	3521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3104.63532826956	3104.63532826956
"AML-0024"	"2020-09-15-AML0024:TCTGTCGTCGGCCCAA"	-1.57332501831706	-15.0843963853088	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTGTCGTCGGCCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.45305220318	34.7183202706355	0.0135753499915576	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.61555767898	2556.61555767898
"AML-0024"	"2020-09-15-AML0024:TCTTAGTAGCAACTTC"	-0.268981258303481	-16.5724191895691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTAGTAGCAACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.40994812279	40.7343038335891	0.0141713619729822	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.66089470214	2865.66089470214
"AML-0024"	"2020-09-15-AML0024:TCTTAGTAGCGAGAAA"	-0.687042216688949	-16.3201456299988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTAGTAGCGAGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.19111424534	35.8588950413291	0.0134747537857678	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.19321786125	2655.19321786125
"AML-0024"	"2020-09-15-AML0024:TCTTAGTCACAATTCG"	-2.21903024140056	-16.2639723054138	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTAGTCACAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.23271244182	46.0597903728025	0.0172687557999524	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.4240865654	2662.4240865654
"AML-0024"	"2020-09-15-AML0024:TCTTAGTGTTCTAAGC"	-0.958691458136398	-16.2561521760193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTAGTGTTCTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.11308252318	38.5584954529956	0.0134344864973397	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2862.97097070207	2862.97097070207
"AML-0024"	"2020-09-15-AML0024:TCTTAGTGTTGCGTAT"	-1.84725735607799	-16.6276064149109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTAGTGTTGCGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.33066231835	38.8193585859833	0.0153537506642379	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2523.54749985915	2523.54749985915
"AML-0024"	"2020-09-15-AML0024:TCTTCCTCAATCGTCA"	-1.90991220894511	-16.0657606354919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTCCTCAATCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.05694783611	33.2826982617471	0.0126163683801624	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.48931697502	2630.48931697502
"AML-0024"	"2020-09-15-AML0024:TCTTCCTGTAGACGTG"	-1.70531628552135	-16.7619924775329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTCCTGTAGACGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.10065423422	40.6260438048996	0.0183903090730751	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2206.54310578999	2206.54310578999
"AML-0024"	"2020-09-15-AML0024:TCTTCCTGTATCAAGA"	-2.42434511604961	-16.4518594971863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTCCTGTATCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.54377824685	43.761935264303	0.0168409459292727	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.29711191945	2592.29711191945
"AML-0024"	"2020-09-15-AML0024:TCTTCCTGTTGCCTAA"	-2.06452188912089	-16.4919767609802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTCCTGTTGCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.56564404429	35.2300174084485	0.0126792100391661	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.46579044668	2765.46579044668
"AML-0024"	"2020-09-15-AML0024:TCTTCCTTCCTTCTTC"	-2.1642030281132	-15.6257925263611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTCCTTCCTTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.73734373232	32.7718348772058	0.0114237836896454	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.39325810949	2863.39325810949
"AML-0024"	"2020-09-15-AML0024:TCTTGCGCAAAGCACG"	-1.67925141277965	-15.7616100541321	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGCAAAGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.72246188423	33.3087469224328	0.0125045861192578	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.24210723956	2658.24210723956
"AML-0024"	"2020-09-15-AML0024:TCTTGCGCAGCACAGA"	-1.72152231159862	-16.6601190797058	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGCAGCACAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.11144348943	42.6315803051415	0.016339501484891	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.79349549483	2600.79349549483
"AML-0024"	"2020-09-15-AML0024:TCTTGCGCATAGCACT"	-0.481707076460677	-16.1852140656677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGCATAGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.7862776549	37.9756329006522	0.0141658561956952	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.48054172745	2671.48054172745
"AML-0024"	"2020-09-15-AML0024:TCTTGCGGTAACCCTA"	-0.892054597765762	-16.7254572144714	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGGTAACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.21083896292	38.5290322643686	0.0135703314933956	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.10569507483	2832.10569507483
"AML-0024"	"2020-09-15-AML0024:TCTTGCGGTACCTGTA"	-1.23230324211772	-15.9782057038513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGGTACCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.28042091617	31.6260666712133	0.0127664459801112	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2472.83742534104	2472.83742534104
"AML-0024"	"2020-09-15-AML0024:TCTTGCGGTACGGTTT"	-1.21002839031871	-16.9451627961365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGGTACGGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.78485526906	40.5001344019827	0.0158588670139622	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.20588859298	2547.20588859298
"AML-0024"	"2020-09-15-AML0024:TCTTGCGTCCAATCCC"	-1.51609311524089	-16.3626127473083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTGCGTCCAATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.89295294979	31.412438030365	0.0123530320039332	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.45150210613	2539.45150210613
"AML-0024"	"2020-09-15-AML0024:TCTTTGAAGTCTAACC"	-2.79277143898662	-15.4466095200744	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTTGAAGTCTAACC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.07254521662	34.8607148331261	0.0123923980888455	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.4178580261	2803.4178580261
"AML-0024"	"2020-09-15-AML0024:TCTTTGACAGTAACGG"	-2.86531076851543	12.969229675177	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTTGACAGTAACGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2069.21964793428	32.4068441301666	0.0156613843109979	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2065.92263296747	2065.92263296747
"AML-0024"	"2020-09-15-AML0024:TCTTTGATCAGGAAGC"	-1.63876758042033	-16.1048727265564	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTTGATCAGGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2654.96307155101	33.8143729019716	0.0127362874701746	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.02796686563	2650.02796686563
"AML-0024"	"2020-09-15-AML0024:TCTTTGATCTTTGGAG"	-1.74505231800731	-16.4900217286316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCTTTGATCTTTGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3013.74447859524	37.5569367861052	0.0124618848919836	3699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.71952754823	3000.71952754823
"AML-0024"	"2020-09-15-AML0024:TGAACGTAGAAGAACG"	-1.74496267262157	-16.2627153626648	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTAGAAGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.98557256284	34.1191021237625	0.0134912205486355	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.01786638738	2522.01786638738
"AML-0024"	"2020-09-15-AML0024:TGAACGTAGAGCTGAC"	0.799812217324418	-16.217631363031	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTAGAGCTGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3163.16593177979	41.1529611389741	0.0130100544917727	3971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3153.31011417116	3153.31011417116
"AML-0024"	"2020-09-15-AML0024:TGAACGTAGTCAGAGC"	-1.54264722290691	-16.1358041993347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTAGTCAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.70558381676	29.2086228879068	0.0112396814282469	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.8838710594	2588.8838710594
"AML-0024"	"2020-09-15-AML0024:TGAACGTCAAATTGCC"	-1.54877291145976	-15.9727068177429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTCAAATTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.86756472768	39.1291478774999	0.0144076052844732	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.01668737059	2708.01668737059
"AML-0024"	"2020-09-15-AML0024:TGAACGTCAAGTGATA"	-1.61209593239482	-16.5162687531677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTCAAGTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.78985200584	35.5340245170436	0.0128756269218169	2756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.50769553073	2749.50769553073
"AML-0024"	"2020-09-15-AML0024:TGAACGTCATCCGTGG"	-2.05277142944987	-16.600350402948	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTCATCCGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.10942539723	42.4336739571366	0.0175048508588606	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2411.30663724686	2411.30663724686
"AML-0024"	"2020-09-15-AML0024:TGAACGTGTACGACTT"	0.914536793797654	-16.3051653138367	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTGTACGACTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2458.51749841885	48.9131884490645	0.0198953997604337	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2449.23551573146	2449.23551573146
"AML-0024"	"2020-09-15-AML0024:TGAACGTGTCCGTACG"	-1.0700286430424	-17.3339433900085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTGTCCGTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.93931193381	37.3991136905703	0.0133858003038315	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.81065027843	2785.81065027843
"AML-0024"	"2020-09-15-AML0024:TGAACGTTCTTCTGGC"	-0.487345675856429	-16.0060281983581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAACGTTCTTCTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.40658600372	37.3940638051671	0.0136205922998089	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.90736757018	2740.90736757018
"AML-0024"	"2020-09-15-AML0024:TGAATCGAGACCTCAT"	-1.69112656536754	-16.3290548554626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGAGACCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2968.85747355909	40.7844288768416	0.013737415568134	3598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2959.89786136408	2959.89786136408
"AML-0024"	"2020-09-15-AML0024:TGAATCGAGGCACGAT"	-1.41428909722026	-16.4453535309997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGAGGCACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2958.33338916701	35.5337505942708	0.0120114084248889	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2950.39299889196	2950.39299889196
"AML-0024"	"2020-09-15-AML0024:TGAATCGAGGTAGACC"	0.575965662568253	-16.2286329499451	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGAGGTAGACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2938.56035131679	35.6409457626373	0.0121287098107978	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2930.96667608472	2930.96667608472
"AML-0024"	"2020-09-15-AML0024:TGAATCGAGTACAGAT"	-2.0525041622227	-15.8047161332336	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGAGTACAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.77920453695	31.4576884490245	0.0117257836186538	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.59827393598	2676.59827393598
"AML-0024"	"2020-09-15-AML0024:TGAATCGCAAGTCATC"	-0.117032478482086	-16.0497465363708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGCAAGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2971.83773714846	36.0123094791054	0.0121178585993931	3010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2964.51647416229	2964.51647416229
"AML-0024"	"2020-09-15-AML0024:TGAATCGCACGCTATA"	-0.878205935389358	-16.2603616944519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGCACGCTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.63145201008	42.8988696212713	0.0176710800091797	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2420.60829959287	2420.60829959287
"AML-0024"	"2020-09-15-AML0024:TGAATCGCAGCCCACA"	-0.920395533472854	-17.357150100824	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGCAGCCCACA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3236.33856598451	47.4636737530106	0.0146658554985182	3713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3225.82157961411	3225.82157961411
"AML-0024"	"2020-09-15-AML0024:TGAATCGGTAGTTACC"	-0.209035645157653	-16.3205404511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGGTAGTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.36202295645	35.856139507236	0.0131035803034921	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.88305299924	2725.88305299924
"AML-0024"	"2020-09-15-AML0024:TGAATCGTCACGATCA"	-1.64793453636821	-16.281128906366	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGTCACGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.63870922849	33.2514285063218	0.013082673153186	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.50835958422	2538.50835958422
"AML-0024"	"2020-09-15-AML0024:TGAATCGTCGGTCTAA"	-1.79171274128612	-15.8307562104431	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATCGTCGGTCTAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.0296505846	44.8877707091047	0.0180923959125309	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2472.56910090927	2472.56910090927
"AML-0024"	"2020-09-15-AML0024:TGAATGCAGAATCGAT"	-2.38967476311381	-15.4762382737366	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCAGAATCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2920.57810106823	35.0666635399663	0.0120067542542829	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2914.50147786873	2914.50147786873
"AML-0024"	"2020-09-15-AML0024:TGAATGCAGCTACTAC"	-1.82135305824931	-15.6012106171814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCAGCTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.12013237045	32.0765211654547	0.0117663637726644	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.45378428081	2723.45378428081
"AML-0024"	"2020-09-15-AML0024:TGAATGCAGTTTCTTC"	-1.15273521366771	-16.0740270844665	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCAGTTTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.39408840783	29.916128881869	0.0112281171212724	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.29044935525	2660.29044935525
"AML-0024"	"2020-09-15-AML0024:TGAATGCCAACCTATG"	-1.39375350895579	-16.7293806306091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCCAACCTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.6640776264	39.394310500241	0.0160618451012522	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2437.1924515857	2437.1924515857
"AML-0024"	"2020-09-15-AML0024:TGAATGCCACGTCGTG"	-0.661605874926406	-16.1955404511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCCACGTCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.59379091832	35.1709662383233	0.0135816537565341	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.24733948786	2584.24733948786
"AML-0024"	"2020-09-15-AML0024:TGAATGCCATACTGTG"	-0.175946633250076	-16.5475740662781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCCATACTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.75183408966	37.1599955646919	0.0141953851701204	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.99820336432	2610.99820336432
"AML-0024"	"2020-09-15-AML0024:TGAATGCGTGGACTGA"	-0.816873351961929	-15.6319723359314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCGTGGACTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.23722095111	32.0177989785839	0.0123896516616226	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.48371741196	2577.48371741196
"AML-0024"	"2020-09-15-AML0024:TGAATGCGTTGTCTAG"	-2.45010195198711	-16.2436628571716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAATGCGTTGTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.1856584943	30.6430698353759	0.0123154274001882	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.66178285887	2485.66178285887
"AML-0024"	"2020-09-15-AML0024:TGACAGTCAAAGGCTG"	10.2571951347286	7.8014459379944	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTCAAAGGCTG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2085.52037703701	43.0778079568695	0.020655663896256	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	2082.84959576904	2082.84959576904
"AML-0024"	"2020-09-15-AML0024:TGACAGTCAAGGCAAC"	-1.74560735645946	-16.4205522767273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTCAAGGCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.13733321219	40.3716185358013	0.0171128734081926	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2355.22927725234	2355.22927725234
"AML-0024"	"2020-09-15-AML0024:TGACAGTCACCCAATA"	0.179191206663293	-16.2063932648865	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTCACCCAATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2740.5796777213	39.30730313726	0.0143426967136904	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2731.37875240727	2731.37875240727
"AML-0024"	"2020-09-15-AML0024:TGACAGTCACCCTTAC"	-2.17181764069255	-15.4561071625915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTCACCCTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2903.40855277241	31.6343208840035	0.0108955802495644	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2896.55309227851	2896.55309227851
"AML-0024"	"2020-09-15-AML0024:TGACAGTGTAAGTTAG"	-0.228360514075118	-16.5931082001892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTGTAAGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.52655012927	40.2893373481464	0.0142742102271106	2791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.98257523225	2810.98257523225
"AML-0024"	"2020-09-15-AML0024:TGACAGTGTCTGCGCA"	-2.39506469193156	-16.0301790467468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACAGTGTCTGCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.02691573149	37.9180496310627	0.013960851938336	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.94880467057	2707.94880467057
"AML-0024"	"2020-09-15-AML0024:TGACCCTAGCTAATGA"	-2.73778734627422	-16.2089052430359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTAGCTAATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.3185747822	35.6011804245663	0.013675306883079	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.45980026795	2596.45980026795
"AML-0024"	"2020-09-15-AML0024:TGACCCTCAAGATTGA"	-0.693078617483932	-15.7732820740906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTCAAGATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.67553665322	37.0504125737664	0.0137545937027739	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.53464988506	2686.53464988506
"AML-0024"	"2020-09-15-AML0024:TGACCCTCACCAGCTG"	-2.55559597435649	-15.8244638673035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTCACCAGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.11055737743	39.9523851875517	0.016005855617841	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.23137371474	2486.23137371474
"AML-0024"	"2020-09-15-AML0024:TGACCCTCAGCGACAA"	-1.08327756348308	-16.7989740601745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTCAGCGACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.70555205169	38.6855915712539	0.0157726195624638	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2439.92624428478	2439.92624428478
"AML-0024"	"2020-09-15-AML0024:TGACCCTGTCGTTATG"	10.0002047019893	6.91940257633058	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTGTCGTTATG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1600.87440178421	32.1158535134597	0.020061444843934	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1600.87440178421	1600.87440178421
"AML-0024"	"2020-09-15-AML0024:TGACCCTGTCTTCCGT"	-0.428996722132522	-16.474862121698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTGTCTTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.69385606717	26.7647737311472	0.00991033236552138	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.89766352413	2691.89766352413
"AML-0024"	"2020-09-15-AML0024:TGACCCTTCATTCGGA"	-1.23694882813151	-16.7053976289001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTTCATTCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.78678404315	41.4840050038533	0.0158047142175687	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.58802696556	2618.58802696556
"AML-0024"	"2020-09-15-AML0024:TGACCCTTCTAGATCG"	-0.0627535906737626	-16.0951585999695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACCCTTCTAGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3071.63052268246	40.5704945478551	0.0132081297696003	3546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3061.65069166262	3061.65069166262
"AML-0024"	"2020-09-15-AML0024:TGACGCGAGAGGGCGA"	-2.51824198189433	-16.2987375489441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGAGAGGGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.891503207	37.8697820971359	0.0145715132972673	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.65911242173	2589.65911242173
"AML-0024"	"2020-09-15-AML0024:TGACGCGAGCAATAAC"	-0.947763304144698	-16.0530119172302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGAGCAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.19980816602	34.5680297165255	0.013892786906854	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.10279170912	2481.10279170912
"AML-0024"	"2020-09-15-AML0024:TGACGCGAGGCGTTAG"	0.0265663443947255	-16.3696756592956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGAGGCGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.0218422714	38.6526417702923	0.013784714936094	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.21462710413	2796.21462710413
"AML-0024"	"2020-09-15-AML0024:TGACGCGAGTCGCCCA"	-2.46540580216106	-16.129080795404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGAGTCGCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.0429435894	37.4142499711214	0.0150014457719302	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.86827127764	2486.86827127764
"AML-0024"	"2020-09-15-AML0024:TGACGCGCAAATCAAG"	-1.31267116490062	-15.3222227326599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGCAAATCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2113.46580646604	35.1284895505991	0.0166212717722356	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2105.96324194916	2105.96324194916
"AML-0024"	"2020-09-15-AML0024:TGACGCGCAGACCTAT"	1.00823434171025	-16.235375427362	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGCAGACCTAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2861.16806786523	46.0732657388442	0.0161029567805922	2927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2850.10805093338	2850.10805093338
"AML-0024"	"2020-09-15-AML0024:TGACGCGCAGTCACGC"	-0.172362740070182	-16.147017501947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGCAGTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.98372997054	39.3208624169172	0.0145579782582941	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.72476344363	2693.72476344363
"AML-0024"	"2020-09-15-AML0024:TGACGCGCAGTTAGGG"	-2.86298928681071	-15.9163475266662	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGCAGTTAGGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.14208245892	36.2337982510934	0.0137763653502773	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.56390253069	2624.56390253069
"AML-0024"	"2020-09-15-AML0024:TGACGCGCATGCCGCA"	-2.7102840942448	-16.0447664490906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGCATGCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2108.72417261908	52.0129002247113	0.0246655778408943	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2102.7862173145	2102.7862173145
"AML-0024"	"2020-09-15-AML0024:TGACGCGGTGCCAAGA"	-2.17535005036052	-15.7991857758728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGGTGCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.4972496816	38.1660620844011	0.0134269477617529	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.69995549197	2838.69995549197
"AML-0024"	"2020-09-15-AML0024:TGACGCGTCAGAACCT"	-1.64962182465251	-16.6045561066833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACGCGTCAGAACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.87761149672	38.7806028035871	0.0153169342102053	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.34217501295	2526.34217501295
"AML-0024"	"2020-09-15-AML0024:TGACTCCAGATGCTTC"	0.100023050873917	-16.3511648408142	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCAGATGCTTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2888.35308515501	38.4014676989282	0.0132952816247766	2764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2879.30605030493	2879.30605030493
"AML-0024"	"2020-09-15-AML0024:TGACTCCAGGGCTTCC"	-1.95778594437297	-15.5723600617615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCAGGGCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.61717683376	34.8843260863406	0.0131956799161524	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.21521970886	2639.21521970886
"AML-0024"	"2020-09-15-AML0024:TGACTCCAGGTGCTGA"	-0.204905520111877	-16.0598058930603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCAGGTGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.04200728886	36.4717808979628	0.0126023674867558	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.49301433051	2884.49301433051
"AML-0024"	"2020-09-15-AML0024:TGACTCCCACACGTGC"	-0.738317827612716	-16.2940607300964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCCACACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.49786261743	40.3693203790171	0.0138322254390182	3068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.87726005748	2912.87726005748
"AML-0024"	"2020-09-15-AML0024:TGACTCCGTCCATACA"	-2.91324458542522	-15.9601679078308	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCGTCCATACA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.08231824261	32.9898585029616	0.0122544018358612	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.21150182468	2682.21150182468
"AML-0024"	"2020-09-15-AML0024:TGACTCCTCGCAACAT"	-2.16964660111125	-15.7544470063415	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGACTCCTCGCAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.31151274894	39.6829465929052	0.0160834764430263	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.20922475277	2462.20922475277
"AML-0024"	"2020-09-15-AML0024:TGAGACTAGGCTAGCA"	-2.85350428047832	-15.8160333863464	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGACTAGGCTAGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.79867511791	38.3385474475843	0.0161303301995834	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2372.35399697308	2372.35399697308
"AML-0024"	"2020-09-15-AML0024:TGAGACTAGGTGCCAA"	-2.20121846619304	-15.7176342240539	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGACTAGGTGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.71236080235	34.8922086955597	0.0116903086387125	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2978.83906178847	2978.83906178847
"AML-0024"	"2020-09-15-AML0024:TGAGACTCAACGGCCT"	-1.42546496811565	-16.7372637025085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGACTCAACGGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.84340458898	43.8057502883381	0.0167016262624352	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.8575923853	2612.8575923853
"AML-0024"	"2020-09-15-AML0024:TGAGACTGTCACTCTC"	-0.253032187849838	-15.8837270966736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGACTGTCACTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.1473915391	36.1073438147108	0.0129040178240397	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.74771838485	2793.74771838485
"AML-0024"	"2020-09-15-AML0024:TGAGACTTCACCATAG"	-0.63891033354457	-16.2541342011658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGACTTCACCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3116.42710638961	41.2853135440909	0.0132476429368245	3945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3108.17024505256	3108.17024505256
"AML-0024"	"2020-09-15-AML0024:TGAGCATCACAATGAA"	-0.895244995982009	-16.4269647828308	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATCACAATGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.15498136804	42.734451578444	0.0157334363729569	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.99155410614	2705.99155410614
"AML-0024"	"2020-09-15-AML0024:TGAGCATGTATCTCTT"	-0.208956370980102	-16.0475664368835	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATGTATCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3009.88299039527	36.1426371736069	0.0120079874496585	3580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2996.71223546872	2996.71223546872
"AML-0024"	"2020-09-15-AML0024:TGAGCATGTTCTAAGC"	-2.30431709709819	-16.2572641602722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATGTTCTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.84953690713	35.601495305537	0.0123323002637952	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.38679155086	2881.38679155086
"AML-0024"	"2020-09-15-AML0024:TGAGCATTCATGACAC"	9.75456490096394	7.04831693256227	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATTCATGACAC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1722.91685518145	38.8680591657868	0.0225594514609897	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1721.62647639014	1721.62647639014
"AML-0024"	"2020-09-15-AML0024:TGAGCATTCGCCAATA"	-2.23998890343364	-16.7320604554382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATTCGCCAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1538.40317277411	50.0631092300855	0.0325422555777817	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1535.9727824992	1535.9727824992
"AML-0024"	"2020-09-15-AML0024:TGAGCATTCTCTAAGG"	-2.05690417710002	-15.7679615250793	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATTCTCTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.44775806528	34.3287306629661	0.0128406214632034	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.86272415132	2669.86272415132
"AML-0024"	"2020-09-15-AML0024:TGAGCATTCTGAACGT"	-1.3322756094044	-16.0458688966003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCATTCTGAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.41781593263	42.354259625786	0.0185000131173227	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2283.37326495985	2283.37326495985
"AML-0024"	"2020-09-15-AML0024:TGAGCGCAGCAATAAC"	-0.841847459704238	-15.4695854417053	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCAGCAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.97715958251	36.7800611710739	0.0130797865998793	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.95218109452	2805.95218109452
"AML-0024"	"2020-09-15-AML0024:TGAGCGCAGCAGATAT"	-2.85648236694987	-15.7262764207092	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCAGCAGATAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.62472137017	36.0759346885757	0.0136103517022686	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.51416730184	2646.51416730184
"AML-0024"	"2020-09-15-AML0024:TGAGCGCCACGCTGCA"	-0.808421592146713	-15.9711675873962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCCACGCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.81365915189	39.4911689880602	0.0146327883194687	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.33944209811	2691.33944209811
"AML-0024"	"2020-09-15-AML0024:TGAGCGCCAGTAGAGC"	-2.16903648796733	-16.5062341920105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCCAGTAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.59897620248	37.565640021433	0.0158665552735145	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2357.90532081193	2357.90532081193
"AML-0024"	"2020-09-15-AML0024:TGAGCGCCAGTGGCTC"	-0.609317223460037	-16.5769586793152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCCAGTGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.52134690882	29.8611747830645	0.0123366707016235	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2407.13900808802	2407.13900808802
"AML-0024"	"2020-09-15-AML0024:TGAGCGCCATACCGTA"	0.972971160977524	-16.2174711457458	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCCATACCGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2788.02731666866	42.4303608981505	0.0152187751692653	3349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2777.34565659383	2777.34565659383
"AML-0024"	"2020-09-15-AML0024:TGAGCGCTCGCTTACC"	1.07393517073933	-16.2099352112976	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGCGCTCGCTTACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3031.00533974718	40.5626992019507	0.0133825891594549	3982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3020.71375438868	3020.71375438868
"AML-0024"	"2020-09-15-AML0024:TGAGGAGAGGCCTTCG"	-1.11667678776439	-16.7073869935242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGAGGCCTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.85383802275	34.2438818814222	0.0138928651075278	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.13976649861	2455.13976649861
"AML-0024"	"2020-09-15-AML0024:TGAGGAGAGTTGCGCC"	-2.71853623810466	-15.9244060746399	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGAGTTGCGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.3706800674	41.5277894668182	0.0155048700972836	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.1896724529	2666.1896724529
"AML-0024"	"2020-09-15-AML0024:TGAGGAGCAAATTAGG"	-2.72059832039531	-15.8319368592468	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGCAAATTAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2885.70294837186	41.8183391320925	0.0144915605938188	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.16720671671	2879.16720671671
"AML-0024"	"2020-09-15-AML0024:TGAGGAGCAAGGTCAG"	1.00903858718221	-16.2237997285095	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGCAAGGTCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1899.01288526987	51.0746713860843	0.0268953790583817	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	1891.2472612251	1891.2472612251
"AML-0024"	"2020-09-15-AML0024:TGAGGAGCATAGAATG"	-1.27224038067515	-16.0315885773865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGCATAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.59178296601	39.9244469005396	0.0157394055948003	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.47563338802	2527.47563338802
"AML-0024"	"2020-09-15-AML0024:TGAGGAGCATTGTCGA"	-1.02685056152995	-15.6833534470764	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGCATTGTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.69784485168	38.0076574610027	0.0146200288376864	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.7365969589	2591.7365969589
"AML-0024"	"2020-09-15-AML0024:TGAGGAGGTACGGCAA"	-2.22294936600383	-16.0147543183533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGGTACGGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.53674340591	40.5055939385173	0.0155161937639194	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.6464544842	2605.6464544842
"AML-0024"	"2020-09-15-AML0024:TGAGGAGGTAGCACGA"	9.6664101081783	7.2959356077942	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGGTAGCACGA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1711.11374164057	36.1555115388012	0.0211298119224595	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1706.90703942224	1706.90703942224
"AML-0024"	"2020-09-15-AML0024:TGAGGAGTCAAGTGGG"	-2.62793670120891	-15.6911993256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGTCAAGTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3035.51812274928	38.7518878382786	0.0127661526867054	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3025.9335313106	3025.9335313106
"AML-0024"	"2020-09-15-AML0024:TGAGGAGTCGAATGCT"	-2.90270624581035	-15.8165607682434	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGTCGAATGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2884.25513312304	40.4747789447443	0.0140330092438524	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.21746026109	2877.21746026109
"AML-0024"	"2020-09-15-AML0024:TGAGGAGTCTCCAATT"	1.32537068900411	-16.170397781488	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGAGTCTCCAATT"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2885.23955489929	41.6836114324349	0.014447192560373	3527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	2874.39580010784	2874.39580010784
"AML-0024"	"2020-09-15-AML0024:TGAGGGACAAGCAGGT"	-0.0817251754110635	-16.3128023377624	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGGACAAGCAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3004.20924582374	39.4644348279467	0.0131363801914955	3043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2991.31876373017	2991.31876373017
"AML-0024"	"2020-09-15-AML0024:TGAGGGACAAGGCGTA"	-0.999517897993881	-15.7506351700989	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGGACAAGGCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.61083664726	37.4661974210803	0.0129255700514859	3336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2891.22153212447	2891.22153212447
"AML-0024"	"2020-09-15-AML0024:TGAGGGAGTATGTCCA"	-1.2801562351292	-16.4678354493347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGGAGTATGTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.72987183069	36.4219014355571	0.0133818942917575	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.82222871333	2712.82222871333
"AML-0024"	"2020-09-15-AML0024:TGAGGGATCGGTTCAA"	-0.872383872896987	-16.5948362580505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGGATCGGTTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.07097805235	44.4866229030384	0.0167490339191386	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.25767979543	2647.25767979543
"AML-0024"	"2020-09-15-AML0024:TGAGGTTCACCTGCGA"	-1.0535263818806	-16.8408518067566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTCACCTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3007.176525128	43.2040302897715	0.0143669751106256	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2999.20747743873	2999.20747743873
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCACCACAA"	0.395167787640733	-16.2403059235779	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCACCACAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2859.6282745309	32.3247728102689	0.011303837319755	2576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2851.06527870383	2851.06527870383
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCAGTGGGA"	-1.43242762509044	-16.3584985963074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCAGTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.69075136233	33.3855799737373	0.0140648397246256	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.57610866705	2370.57610866705
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCCAAATGC"	-2.69213066521342	-15.3974800339905	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCCAAATGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.22491391535	34.8024000988847	0.0119381526731475	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.13887243492	2912.13887243492
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCCCAAGCG"	-0.747838179499465	-16.8183279267517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCCCAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.18678831509	35.6837178588882	0.0132693340655767	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.07647212375	2679.07647212375
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCCTTGGAA"	0.106203381984872	-16.3526697388855	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCCTTGGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2786.21365060051	38.8096663362593	0.0139291781618738	2566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2779.87761470919	2779.87761470919
"AML-0024"	"2020-09-15-AML0024:TGAGGTTTCTAAGCCA"	-0.397179375321227	-16.3431291810242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGGTTTCTAAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2191.27025899116	46.366807810534	0.0211597851156346	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2187.42152384154	2187.42152384154
"AML-0024"	"2020-09-15-AML0024:TGAGTCACACCAGGTC"	-0.797909001738387	-16.6893968812195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGTCACACCAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.20644218558	36.2264883519396	0.0132590597081532	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.71097045387	2726.71097045387
"AML-0024"	"2020-09-15-AML0024:TGAGTCACACCCTCTA"	-2.45940170708354	-16.2106428376404	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGTCACACCCTCTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.02130401904	34.119087809106	0.0125206682820369	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.97860288098	2717.97860288098
"AML-0024"	"2020-09-15-AML0024:TGAGTCAGTCATGCAT"	-1.58973668041881	-16.302254699823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGTCAGTCATGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.88235255467	32.7377190050258	0.0113637819940808	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2874.59359011075	2874.59359011075
"AML-0024"	"2020-09-15-AML0024:TGAGTCAGTCGCATCG"	-1.53488681736644	-15.8743562928406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGTCAGTCGCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.19189341055	39.2683430378808	0.0151545484291383	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.37628085946	2587.37628085946
"AML-0024"	"2020-09-15-AML0024:TGAGTCAGTGACTATC"	-1.36653135243114	-16.0418920747009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGAGTCAGTGACTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2812.49974903222	35.2067739383427	0.0125179651839817	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.72421028715	2807.72421028715
"AML-0024"	"2020-09-15-AML0024:TGATCAGAGGGCCTCT"	-1.11600838127788	-16.877055191156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGAGGGCCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.33266901186	36.6540453426655	0.0134543206707425	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.65343111608	2718.65343111608
"AML-0024"	"2020-09-15-AML0024:TGATCAGAGGTAAGTT"	0.237066661089104	-16.3391123048035	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGAGGTAAGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2753.59365957974	40.6278263736674	0.0147544741150618	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2744.42691958441	2744.42691958441
"AML-0024"	"2020-09-15-AML0024:TGATCAGCAAGGCGTA"	-1.78468618813213	-16.8690748444763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGCAAGGCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1903.4924470446	44.3481170185241	0.0232982889358872	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1896.23732021686	1896.23732021686
"AML-0024"	"2020-09-15-AML0024:TGATCAGGTAGGACTG"	-1.72803030434306	-16.5223226777283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGGTAGGACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.574355274	39.4180204610107	0.0157133155643319	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2503.18791375733	2503.18791375733
"AML-0024"	"2020-09-15-AML0024:TGATCAGTCATGCCCT"	-0.45764265480693	-16.2090444794861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGTCATGCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.87323755629	37.103975147338	0.0137734673740612	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.87023502959	2687.87023502959
"AML-0024"	"2020-09-15-AML0024:TGATCAGTCCACGTGG"	-1.77763877335246	-16.5723142853943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGTCCACGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.52358809469	43.6690518654959	0.0176760311360452	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2463.33741089468	2463.33741089468
"AML-0024"	"2020-09-15-AML0024:TGATCAGTCTGCGATA"	1.11471738395039	-16.2206850281921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCAGTCTGCGATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2893.02518167221	43.1796933098819	0.0149254467549859	3585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2882.20088676875	2882.20088676875
"AML-0024"	"2020-09-15-AML0024:TGATCTTAGCTGAAGC"	-0.703457872301894	-15.9898710480896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCTTAGCTGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.99896048318	32.3781842602694	0.0120994756494312	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.44998931606	2668.44998931606
"AML-0024"	"2020-09-15-AML0024:TGATCTTAGGTCCGAA"	-1.0599037212437	-16.5083112946716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGATCTTAGGTCCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.75243262071	33.217159415858	0.0122448178523124	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.23631430214	2702.23631430214
"AML-0024"	"2020-09-15-AML0024:GAGTTGTCAAGAGGTC"	-1.1899930042332	-16.2569551697937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTGTCAAGAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.31203179275	35.24786225857	0.0140636368542497	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.72036123442	2498.72036123442
"AML-0024"	"2020-09-15-AML0024:GAGTTGTTCCACGAAT"	-1.1780870956486	-15.8188390961853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTGTTCCACGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.63893027899	38.1681571582228	0.0142490862530126	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.59301306856	2668.59301306856
"AML-0024"	"2020-09-15-AML0024:GAGTTGTTCGTGGACC"	-1.50888095322307	-16.0807886353699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTGTTCGTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.94390524451	35.845202691383	0.0148862282934881	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2404.77669303776	2404.77669303776
"AML-0024"	"2020-09-15-AML0024:GAGTTTGCAGTCACGC"	-0.171576912433463	-16.4109945527283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTTGCAGTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3022.09787495433	34.015632975242	0.0112556357810734	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3016.34029420537	3016.34029420537
"AML-0024"	"2020-09-15-AML0024:GAGTTTGGTCTGCCTT"	-1.94290087643321	-15.5254020920959	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTTGGTCTGCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.63039919804	35.1124063418397	0.0135955986395664	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.40896252294	2576.40896252294
"AML-0024"	"2020-09-15-AML0024:GAGTTTGTCCTTCTTC"	0.0749352807993114	-16.4666509858337	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTTGTCCTTCTTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2719.10769695975	38.8567902210912	0.0142902726010217	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2709.53450771218	2709.53450771218
"AML-0024"	"2020-09-15-AML0024:GATAGAACAATGGCCC"	-2.78648267212566	-15.6566496125427	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAACAATGGCCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.00380724245	32.783431551839	0.0121555006573603	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.67017697233	2690.67017697233
"AML-0024"	"2020-09-15-AML0024:GATAGAACATAGCACT"	-2.14072547379192	-15.9171867600647	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAACATAGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.09477111249	36.9848217331825	0.0137946715392817	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.06852971208	2674.06852971208
"AML-0024"	"2020-09-15-AML0024:GATAGAAGTACTTCCC"	0.309162487357301	-16.0994920960632	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAAGTACTTCCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3077.06110923447	39.9657430574565	0.0129882838327509	3288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3068.74174054936	3068.74174054936
"AML-0024"	"2020-09-15-AML0024:GATAGAAGTGAACCGA"	-2.89036260071452	-15.7899742356506	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAAGTGAACCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.28579312593	34.9988973314236	0.0130530275516139	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.76762775914	2675.76762775914
"AML-0024"	"2020-09-15-AML0024:GATAGAAGTGACAGGT"	-1.88584218445476	-16.5199651948181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAAGTGACAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.67953782157	35.1746842980746	0.014512927038898	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2421.7235861457	2421.7235861457
"AML-0024"	"2020-09-15-AML0024:GATAGAATCTCTCGAC"	-2.16678319397624	-16.7196855775085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAATCTCTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.1160574901	40.92027040718	0.0174714956059999	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2331.15861696063	2331.15861696063
"AML-0024"	"2020-09-15-AML0024:GATAGAATCTCTGGTC"	-1.38144503060039	-16.5687380067078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGAATCTCTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.89183860586	32.2103188583858	0.0122757799633616	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.77881415045	2614.77881415045
"AML-0024"	"2020-09-15-AML0024:GATAGCTAGTACCATC"	-2.65939150276836	-16.0273695222107	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGCTAGTACCATC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.13671682381	37.267711317269	0.0133617370179359	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.31265830642	2779.31265830642
"AML-0024"	"2020-09-15-AML0024:GATAGCTCACCCGTAG"	1.2249354320461	-16.2003088227478	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGCTCACCCGTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2817.05505360743	40.9356855487346	0.0145313757699956	3689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2806.14593433072	2806.14593433072
"AML-0024"	"2020-09-15-AML0024:GATAGCTCACTACTTT"	-2.87162504616435	-15.7286758652893	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGCTCACTACTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.84557125081	35.8202840523152	0.0139116242357457	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.93576890936	2559.93576890936
"AML-0024"	"2020-09-15-AML0024:GATAGCTGTCATTGCA"	-1.07021913948711	-16.3485059968201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGCTGTCATTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.7299306965	41.2067813152675	0.0149803079013408	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.36521646402	2745.36521646402
"AML-0024"	"2020-09-15-AML0024:GATAGCTTCTTGAACG"	-0.454911808401901	-16.6150999299255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATAGCTTCTTGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.32233111192	36.3426868930014	0.0142223493492452	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.35634127378	2550.35634127378
"AML-0024"	"2020-09-15-AML0024:GATCACACACACTTAG"	-2.35011563721355	-16.0491934052673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCACACACACTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2922.55637731252	34.8466219948872	0.0119233361126573	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2917.74553844218	2917.74553844218
"AML-0024"	"2020-09-15-AML0024:GATCACACAGTAACCT"	-0.995067457587081	-15.6466121903625	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCACACAGTAACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2963.12639636749	40.3428731129418	0.0136149686906365	2863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2954.05204460572	2954.05204460572
"AML-0024"	"2020-09-15-AML0024:GATCACAGTACTGCGC"	-1.28021989288982	-15.576237701532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCACAGTACTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.84368926729	35.941251123174	0.0132193149849155	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.71439856985	2713.71439856985
"AML-0024"	"2020-09-15-AML0024:GATCACAGTCACATTG"	-2.0529936355656	-16.1615381470886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCACAGTCACATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.14186593058	30.0118669751042	0.01099278662022	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.16834105419	2720.16834105419
"AML-0024"	"2020-09-15-AML0024:GATCACATCAAAGCCT"	-1.41149518910106	-16.0860491028992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCACATCAAAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.75825181268	39.6171757299933	0.0143241643422841	2637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.15872946666	2760.15872946666
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGACGACGT"	-2.8913336795872	-15.8031254044739	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGACGACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.06841588757	46.4562577117272	0.0157688998195689	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.66765565855	2935.66765565855
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGCCAAGGT"	-2.60267982903178	13.5532121428284	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGCCAAGGT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1961.48868635569	49.6369278665914	0.0253057426289893	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1956.33225176107	1956.33225176107
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGCGTTCCG"	0.149781380861443	-16.223267578241	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGCGTTCCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2914.16840010222	36.1621324908099	0.0124090743999357	2981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2905.54010685115	2905.54010685115
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGGGAGTTC"	-1.61326692524608	-15.6846208802429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGGGAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.85365423287	34.3018292294248	0.0119816914772112	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.02732471655	2858.02732471655
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGGTTCTAC"	-3.83742533150371	10.90256116474	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGGTTCTAC"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2155.38807490475	41.5912384524252	0.019296403713407	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2151.06925388502	2151.06925388502
"AML-0024"	"2020-09-15-AML0024:GATCAGTAGTGTTCAC"	-2.9258750480717	-16.0514765015808	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTAGTGTTCAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2386.70186502458	38.9992202335411	0.0163402144210163	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.05238508547	2380.05238508547
"AML-0024"	"2020-09-15-AML0024:GATCAGTCAACCCTAA"	0.0997713479096114	-16.485812210199	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTCAACCCTAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2801.01179840002	36.9215901514261	0.0131815189684371	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2796.96373157332	2796.96373157332
"AML-0024"	"2020-09-15-AML0024:GATCAGTGTCTGCGCA"	-2.37082801285442	-16.4575014344421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTGTCTGCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.47382225647	34.9562682211798	0.0130022721187743	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.38786971252	2675.38786971252
"AML-0024"	"2020-09-15-AML0024:GATCAGTTCAAGAAAC"	-1.78200111809428	-15.945508026239	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTTCAAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.55819795063	33.5340773524506	0.0126088902202971	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.6399071206	2651.6399071206
"AML-0024"	"2020-09-15-AML0024:GATCAGTTCAGTGGGA"	-2.72757564011272	-15.685763382074	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTTCAGTGGGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.22099737815	37.908585252891	0.0145733812279311	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.76769427711	2595.76769427711
"AML-0024"	"2020-09-15-AML0024:GATCAGTTCCACTTCG"	-2.69758663597758	-15.8075447312561	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCAGTTCCACTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.62251046729	32.2193783271387	0.0116626061668081	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.4593346847	2756.4593346847
"AML-0024"	"2020-09-15-AML0024:GATCATGAGAATCGCG"	-2.32091699066814	-16.2351808778015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGAGAATCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3161.13182312604	38.3667900901384	0.0121370421218934	3964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3146.93936286342	3146.93936286342
"AML-0024"	"2020-09-15-AML0024:GATCATGAGTATGGCG"	-0.73870817843135	-16.2170229188171	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGAGTATGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.95035158953	34.9071044384611	0.0151575583965011	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2300.71674877027	2300.71674877027
"AML-0024"	"2020-09-15-AML0024:GATCATGCAAATTGCC"	2.17964758452718	-10.7892341843811	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00099304865938431	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGCAAATTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.30414393216	44.762611276072	0.0175312492177827	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.27566706196	2547.27566706196
"AML-0024"	"2020-09-15-AML0024:GATCATGGTGCGTCGT"	-2.27415523949321	-16.4347219697204	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGGTGCGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2275.61089800064	41.1524227879628	0.0180841209822468	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2270.16264003973	2270.16264003973
"AML-0024"	"2020-09-15-AML0024:GATCATGGTGGAACAC"	-2.66350732269939	-16.2490091553894	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGGTGGAACAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.95050506735	36.5943374661022	0.0151720930380702	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2404.1506929496	2404.1506929496
"AML-0024"	"2020-09-15-AML0024:GATCATGGTTTACTTC"	-1.26085505905803	-16.4662561646667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGGTTTACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.50278397056	34.8229546125658	0.0122207126129011	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.15173795563	2841.15173795563
"AML-0024"	"2020-09-15-AML0024:GATCATGTCCTTCAGC"	-1.9146023792332	-16.8080587617126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGTCCTTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.63419329269	39.8387801592238	0.0147026415070488	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.96023129566	2695.96023129566
"AML-0024"	"2020-09-15-AML0024:GATCATGTCGGCAGTC"	-1.95764337006267	-16.4586515656677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCATGTCGGCAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.49727824924	43.7935642403026	0.0162529628787592	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.94972621252	2689.94972621252
"AML-0024"	"2020-09-15-AML0024:GATCCCTCACAAGGTG"	-1.24377546730693	-16.2584848633972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCCCTCACAAGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2914.49922775808	34.9937432336266	0.0120067773222726	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.50458117547	2902.50458117547
"AML-0024"	"2020-09-15-AML0024:GATCCCTTCACTCACC"	-2.40133605423625	-15.7221317521301	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCCCTTCACTCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.51721948418	35.2610425515308	0.0143774903072636	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.88254031474	2449.88254031474
"AML-0024"	"2020-09-15-AML0024:GATCCCTTCGGTGCAC"	-1.68640790405925	-16.2510519257751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCCCTTCGGTGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.84194913934	36.1371008490946	0.0127790383971399	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.35657682104	2822.35657682104
"AML-0024"	"2020-09-15-AML0024:GATCGTAAGATTACCC"	-0.277848134667236	-15.978503250238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAAGATTACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.20064159322	37.3987508323088	0.0131306588047774	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.73228483844	2838.73228483844
"AML-0024"	"2020-09-15-AML0024:GATCGTAAGCCGAACA"	-0.519354204565841	-15.9112549058166	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAAGCCGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.71433253603	31.5803671692727	0.0114392013679527	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.76871364123	2756.76871364123
"AML-0024"	"2020-09-15-AML0024:GATCGTAAGGGCCAAT"	-0.977823595434982	-17.4892339936462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAAGGGCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.37506892569	42.3311293046007	0.0144555011937492	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2919.54755870355	2919.54755870355
"AML-0024"	"2020-09-15-AML0024:GATCGTAAGTCCTGTA"	10.4436251121456	6.41496846759645	"2020-09-15-AML0024"	"AML0024"	"Pre-B"	"Pre-B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAAGTCCTGTA"	"Pre-B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1656.7089086311	33.9531434125627	0.0204943326106801	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1654.83266965682	1654.83266965682
"AML-0024"	"2020-09-15-AML0024:GATCGTACAAGTCATC"	-1.97038779678996	-15.8929901353088	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTACAAGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.33835680984	34.0270166401431	0.0118753921536958	2849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.16539896909	2859.16539896909
"AML-0024"	"2020-09-15-AML0024:GATCGTACAGCGACCT"	-0.598702530295211	-16.0720129243103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTACAGCGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.27607227141	31.3433276474614	0.0117115449979941	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.09891021919	2669.09891021919
"AML-0024"	"2020-09-15-AML0024:GATCGTACATACTGTG"	-1.10775015774425	-16.363102935907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTACATACTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.93573018616	37.1334012416084	0.0142824304502902	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.82255000691	2595.82255000691
"AML-0024"	"2020-09-15-AML0024:GATCGTAGTATCGCTA"	-1.31110976162608	-16.1815309754578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAGTATCGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.79290989254	37.6229650283447	0.0131328742466609	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.81364069057	2856.81364069057
"AML-0024"	"2020-09-15-AML0024:GATCGTAGTCACGACC"	-2.09823165360149	-16.6525545350281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTAGTCACGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1708.44254692628	50.4250922333989	0.029515240254418	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1706.70763739231	1706.70763739231
"AML-0024"	"2020-09-15-AML0024:GATCGTATCGTGACTA"	-1.68942103806193	-16.1211290589538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATCGTATCGTGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.15409088207	38.947608617235	0.0150600494976504	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.9097068042	2577.9097068042
"AML-0024"	"2020-09-15-AML0024:GATGACTAGAACGTGC"	-1.63081441345866	-15.207995437738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTAGAACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.29570872739	35.0747080351659	0.0130181360277387	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.30840459823	2688.30840459823
"AML-0024"	"2020-09-15-AML0024:GATGACTAGCGATTCT"	-1.39530692520793	-16.2502622834411	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTAGCGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.98635093291	28.7749507995225	0.0112666815110471	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.44014498802	2546.44014498802
"AML-0024"	"2020-09-15-AML0024:GATGACTAGGGACTGT"	-2.77647648277934	-16.3275194398132	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTAGGGACTGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.84152281435	32.8301265063534	0.0116798212349881	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.07999231246	2805.07999231246
"AML-0024"	"2020-09-15-AML0024:GATGACTCAAATTGGA"	-2.50854835930522	-15.7340536347595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTCAAATTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.54691913281	37.581061188122	0.014874475872002	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2523.13453741749	2523.13453741749
"AML-0024"	"2020-09-15-AML0024:GATGACTCACAGGATG"	-1.02592215958293	-15.2570142976013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTCACAGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.65239332648	36.4980692727243	0.0133954956463875	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.36122663739	2720.36122663739
"AML-0024"	"2020-09-15-AML0024:GATGACTCATGACTGT"	1.14389123496358	-16.223979019281	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTCATGACTGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2936.23225655207	41.444394833262	0.0141148217211975	4049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2925.0857178374	2925.0857178374
"AML-0024"	"2020-09-15-AML0024:GATGACTGTATCAAGA"	-1.12117336216624	-17.2982416382995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTGTATCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3046.33784035038	41.4740085073411	0.0136143824752447	2474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3041.82154392269	3041.82154392269
"AML-0024"	"2020-09-15-AML0024:GATGACTGTATGAGAT"	11.3982178169185	-1.99664165889891	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTGTATGAGAT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1480.70326845105	37.1589635305449	0.0250954828845732	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1475.38738659706	1475.38738659706
"AML-0024"	"2020-09-15-AML0024:GATGACTGTGATTCTG"	-0.79213241758998	-16.3563261262146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTGTGATTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.71055507028	33.434484676615	0.0131233450401483	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.61945078699	2538.61945078699
"AML-0024"	"2020-09-15-AML0024:GATGACTTCCATTCGC"	-0.568583886057693	-16.4558725587097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGACTTCCATTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.37665163329	35.4844691814623	0.0126532465461784	2686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.4123196513	2796.4123196513
"AML-0024"	"2020-09-15-AML0024:GATGAGGCAAAGGGTC"	-1.53924546662028	-16.0287084809509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGAGGCAAAGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.53789960167	39.1177613280008	0.0160942815721621	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2422.254165101	2422.254165101
"AML-0024"	"2020-09-15-AML0024:GATGAGGCAGTGACCC"	-2.86576686325725	-16.102360748407	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGAGGCAGTGACCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.01140144582	37.8839317992301	0.0143065591706084	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.95526661897	2638.95526661897
"AML-0024"	"2020-09-15-AML0024:GATGAGGTCGATCCCT"	-1.53845677796062	-15.7797527543274	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGAGGTCGATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.4657506559	33.6549789585716	0.0124304357129609	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.36369007864	2699.36369007864
"AML-0024"	"2020-09-15-AML0024:GATGATCAGCCTCAAT"	-2.09946761551555	-16.317750000116	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGATCAGCCTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.34488607368	36.153402306133	0.012715095690012	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.30955971325	2834.30955971325
"AML-0024"	"2020-09-15-AML0024:GATGATCCAAACTCGT"	1.02945407208745	-16.2122202149597	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGATCCAAACTCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2751.84539848591	40.1702997607452	0.0145975859628042	3422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2739.45877594825	2739.45877594825
"AML-0024"	"2020-09-15-AML0024:GATGATCCAGGTGGAT"	-0.999600152403671	-16.693741821405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGATCCAGGTGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.5885350803	34.4045325745522	0.0156271401428321	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2198.26342268756	2198.26342268756
"AML-0024"	"2020-09-15-AML0024:GATGATCGTAGATTAG"	-2.69301257553752	-16.2092180482117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGATCGTAGATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.30388203352	35.0929750038982	0.0137981840281859	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.54217480799	2538.54217480799
"AML-0024"	"2020-09-15-AML0024:GATGATCTCAAATAGG"	-1.60875509205516	-16.864697479364	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGATCTCAAATAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.33359533275	40.6875188748196	0.0153344905240674	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.58182029265	2636.58182029265
"AML-0024"	"2020-09-15-AML0024:GATGCTAAGGAACTCG"	-1.47714863243755	-16.1213312379089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGCTAAGGAACTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.65472451809	35.603642069097	0.0134982193606109	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.58367157587	2629.58367157587
"AML-0024"	"2020-09-15-AML0024:GATGCTAAGGGCAGGA"	1.33096947249715	-16.1763124695984	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGCTAAGGGCAGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3131.07774142223	39.0510351983762	0.0124720746092488	4630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3119.13618691529	3119.13618691529
"AML-0024"	"2020-09-15-AML0024:GATGCTATCCACACAA"	-1.41963265362437	-16.5487623444763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGCTATCCACACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.89434140017	40.6989684399209	0.0154520125580608	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.5501281997	2626.5501281997
"AML-0024"	"2020-09-15-AML0024:GATGCTATCGTTCTCG"	-0.431519220501739	-16.4045076600281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGCTATCGTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.24581527413	36.2781020227261	0.0124314757286196	3879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2908.28558352643	2908.28558352643
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGACAAGCC"	-1.94793711128886	-16.4006090394226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGACAAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.80189570479	41.7181381797199	0.0186424626146726	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2232.97193974622	2232.97193974622
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGACTAGAT"	1.10714699801747	-16.2143926850525	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGACTAGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3037.90548784882	44.4026054481851	0.0146161905384447	3874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3028.82205914242	3028.82205914242
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGCAAGCCA"	-1.26966093006786	-16.6270609132019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGCAAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.4292634719	37.0886731608292	0.0138938587616257	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.18640910345	2664.18640910345
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGCGACAGT"	-0.362785081297714	-16.4159231415954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGCGACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.4382257615	30.1456490538849	0.0113695460678617	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.63069439624	2644.63069439624
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGCGTGTTT"	-1.1375644010609	-15.2453909150329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGCGTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.26004892905	35.0129427129573	0.0141967765030137	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.71489626886	2458.71489626886
"AML-0024"	"2020-09-15-AML0024:GATGGAGAGCTAAACA"	-2.47425899925883	-16.054904007074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGAGCTAAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.22505516775	38.4102772438732	0.0155808400386631	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.25205061448	2458.25205061448
"AML-0024"	"2020-09-15-AML0024:GATGGAGCAAGTAGTA"	-1.70143554630931	-16.4472913972107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGCAAGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.65739915332	37.6276147688902	0.0150651625725953	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2484.21234394555	2484.21234394555
"AML-0024"	"2020-09-15-AML0024:GATGGAGCACTAAACC"	-2.03950725022014	11.0877122648987	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGCACTAAACC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1928.08053238111	42.2993196505152	0.0219385647747177	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1925.07305310968	1925.07305310968
"AML-0024"	"2020-09-15-AML0024:GATGGAGCAGGTTCAT"	0.293743764131707	-16.080388092157	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGCAGGTTCAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2838.70821010762	32.5791287878257	0.0114767444825161	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2834.60213522	2834.60213522
"AML-0024"	"2020-09-15-AML0024:GATGGAGCATATAGCC"	-0.0803785425728143	-16.5488748780456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGCATATAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.33109571094	34.3826267935684	0.0134132601329179	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.94646774912	2554.94646774912
"AML-0024"	"2020-09-15-AML0024:GATGGAGGTAATGCTC"	-3.03887663307841	13.6285924681458	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGGTAATGCTC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2829.78763084832	37.333567442911	0.0131930633366007	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2827.91156559184	2827.91156559184
"AML-0024"	"2020-09-15-AML0024:GATGGAGGTTCCTTGC"	-0.0596712929313958	-16.1523370972839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGGTTCCTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3010.06747894582	39.8633643799427	0.0132433457584491	3731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2998.73210478862	2998.73210478862
"AML-0024"	"2020-09-15-AML0024:GATGGAGTCGAACCAT"	-0.876043180853683	-16.5784445039001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGTCGAACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.40503257516	35.3179844632087	0.0145616851572663	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2419.68917838222	2419.68917838222
"AML-0024"	"2020-09-15-AML0024:GATGGAGTCGTTGTTT"	-2.93185840073283	-15.7549944153992	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGGAGTCGTTGTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2031.02796436253	41.2965649721723	0.0203328391813324	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2024.25706230003	2024.25706230003
"AML-0024"	"2020-09-15-AML0024:GATGTTGAGACCTTTG"	-1.99542103233989	-15.7183923951355	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGAGACCTTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.8926215177	35.0909519642875	0.0128214573302581	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.38755229252	2728.38755229252
"AML-0024"	"2020-09-15-AML0024:GATGTTGAGCTGCCTG"	-1.38538048687633	-16.9609060517517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGAGCTGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2138.31316174903	43.6576148316999	0.0204168480149045	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2132.92840286244	2132.92840286244
"AML-0024"	"2020-09-15-AML0024:GATGTTGAGGACAAGA"	-2.50842700424846	-15.9608412018982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGAGGACAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.14356008824	37.0445932154587	0.0129384337313205	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.53159874872	2857.53159874872
"AML-0024"	"2020-09-15-AML0024:GATGTTGCAGACGGAT"	-2.9539078277653	-15.5393686524597	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGCAGACGGAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.30772406368	36.3068618758555	0.0131104469035239	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.83621326132	2762.83621326132
"AML-0024"	"2020-09-15-AML0024:GATGTTGCATAGCTGT"	-0.800581316382247	-16.6780672303406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGCATAGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.89436166875	33.9441996720585	0.0126757052697575	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.95122809121	2672.95122809121
"AML-0024"	"2020-09-15-AML0024:GATGTTGGTGTGTACT"	-0.35980055752452	-15.9546308747497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGGTGTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.89644923375	36.2075437117808	0.012881137518122	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.05459502008	2803.05459502008
"AML-0024"	"2020-09-15-AML0024:GATGTTGTCACCGACG"	-1.13190613213237	-16.2329092255798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGTCACCGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.48322916854	35.8122339302649	0.0126612855826592	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.35558348744	2817.35558348744
"AML-0024"	"2020-09-15-AML0024:GATGTTGTCATAGGCT"	-0.28932554546054	-16.3535490266052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGTCATAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.57145249404	35.1460466627114	0.0128996604697371	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.06056342944	2720.06056342944
"AML-0024"	"2020-09-15-AML0024:GATGTTGTCCGACATA"	-2.10694323006328	-16.1837434998718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATGTTGTCCGACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.50636521942	39.644999339361	0.014232600519022	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.90101766977	2778.90101766977
"AML-0024"	"2020-09-15-AML0024:GATTCGAAGCTAGAGC"	-1.51623127880748	-15.585135482904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAAGCTAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.52833820128	39.9866631311692	0.015224150659099	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.6694885874	2615.6694885874
"AML-0024"	"2020-09-15-AML0024:GATTCGAAGGTCGACA"	-1.44305417957957	-16.1076956025329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAAGGTCGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.62430238492	37.8803440776937	0.0141787690896053	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2667.26016098925	2667.26016098925
"AML-0024"	"2020-09-15-AML0024:GATTCGAAGTGCGTCC"	-2.88403187218364	-15.9824266663757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAAGTGCGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.56554211558	36.6991252581405	0.0143044972563352	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.70827329335	2557.70827329335
"AML-0024"	"2020-09-15-AML0024:GATTCGAAGTTCTCTT"	-2.19940195503886	-16.0316725007263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAAGTTCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.81913000817	36.1104183681229	0.0126755742362694	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.03386696169	2840.03386696169
"AML-0024"	"2020-09-15-AML0024:GATTCGACACTGCGTG"	-0.235852907330352	-16.4214067689148	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGACACTGCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.48526771572	35.1464099169457	0.0138399739363561	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.11588876113	2529.11588876113
"AML-0024"	"2020-09-15-AML0024:GATTCGAGTAATTGGA"	-1.10371563854869	-16.4624490967956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAGTAATTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2487.58034525893	45.2953558909885	0.0182086001673541	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2479.8032130043	2479.8032130043
"AML-0024"	"2020-09-15-AML0024:GATTCGAGTACGGATG"	-0.548949400812942	-15.7158146134582	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAGTACGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.03417475637	38.9204415465842	0.0142982927648466	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.13794343309	2715.13794343309
"AML-0024"	"2020-09-15-AML0024:GATTCGAGTTTCTATC"	-2.34112582626994	-16.5020017853943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGAGTTTCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.06166273436	37.2648386256924	0.0142283166356561	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.50964244926	2612.50964244926
"AML-0024"	"2020-09-15-AML0024:GATTCGATCCACGAAT"	-1.37769995155986	-15.8577404252258	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCGATCCACGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.06063537673	31.4355169069783	0.0117689267291922	2326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.86204209495	2663.86204209495
"AML-0024"	"2020-09-15-AML0024:GATTCTTAGGCAATGC"	1.21059920367543	-16.2135668030945	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCTTAGGCAATGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2873.85078448444	42.2394694378517	0.0146978645049692	3951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2862.17214099494	2862.17214099494
"AML-0024"	"2020-09-15-AML0024:GATTCTTCAGAGTTGG"	-1.81582436981853	-16.8723535767761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTCTTCAGAGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1764.4069166005	46.193335315906	0.026180658713868	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1756.92233419704	1756.92233419704
"AML-0024"	"2020-09-15-AML0024:GATTGGTCAAATAAGC"	-1.29991851273234	-15.4256744614807	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTGGTCAAATAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.69399097961	34.1060502336203	0.0134876146956824	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.96351669749	2522.96351669749
"AML-0024"	"2020-09-15-AML0024:GATTGGTCACCCATAA"	-0.00596178966816071	-16.0520963898865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTGGTCACCCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.37952636699	31.6596725660996	0.0115530247768534	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.85727636469	2733.85727636469
"AML-0024"	"2020-09-15-AML0024:GATTGGTCATTGTCGA"	1.0097562271053	-16.1753339997497	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTGGTCATTGTCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2863.48639134525	40.8734271737376	0.0142740078309	3558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2852.1161017652	2852.1161017652
"AML-0024"	"2020-09-15-AML0024:GATTGGTGTAGTGATA"	-1.81790063801463	-16.2753553620544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTGGTGTAGTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2512.5907313589	37.1161762428711	0.0147720740109542	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.86083484034	2505.86083484034
"AML-0024"	"2020-09-15-AML0024:GATTGGTTCGACCATA"	0.624889214604539	-16.1907091370788	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTGGTTCGACCATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2792.25857299649	35.8210665611047	0.0128287068065704	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2784.00461331861	2784.00461331861
"AML-0024"	"2020-09-15-AML0024:GATTTCTAGCGCCCAT"	-0.794040064246017	-16.3720770112244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTAGCGCCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.00311579884	29.828099178659	0.0112686301729785	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.68929053565	2642.68929053565
"AML-0024"	"2020-09-15-AML0024:GATTTCTAGTAGCATA"	-1.48285160484965	-16.5167360535828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTAGTAGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2145.44276429024	31.8109657312562	0.0148272264638018	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2142.94114462013	2142.94114462013
"AML-0024"	"2020-09-15-AML0024:GATTTCTCAAACCACT"	-0.305456141859847	-16.6443453065124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTCAAACCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.2628855384	37.3139550960156	0.0133204046248747	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.17835063097	2791.17835063097
"AML-0024"	"2020-09-15-AML0024:GATTTCTCACACCTTC"	-1.4622440141743	-16.0154924622742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTCACACCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.87381042096	37.2051393774616	0.0133453455598996	2326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.53871060214	2771.53871060214
"AML-0024"	"2020-09-15-AML0024:GATTTCTCACCTTCCA"	-1.72978506508525	-15.6892585984436	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTCACCTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.03952713126	33.6162005429569	0.0122461626547462	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.97075276392	2738.97075276392
"AML-0024"	"2020-09-15-AML0024:GATTTCTGTAAGATAC"	-0.543648759753066	-15.9026594392029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTGTAAGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.57504121083	32.838640117613	0.0115443043835591	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.60411160169	2839.60411160169
"AML-0024"	"2020-09-15-AML0024:GATTTCTTCGCTAGCG"	-2.19218717041667	-16.6326456299988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GATTTCTTCGCTAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.22946780709	36.6410624997595	0.0140752334563212	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.94498142796	2595.94498142796
"AML-0024"	"2020-09-15-AML0024:GCAACATGTAAGGCCA"	-1.96952615204509	-16.5242109528747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACATGTAAGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.47249067233	40.6288328003939	0.0160621761850412	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.88857571476	2517.88857571476
"AML-0024"	"2020-09-15-AML0024:GCAACATGTGATGGCA"	-1.09997449341472	-15.9124517670837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACATGTGATGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.93827271945	31.8364961148481	0.0112102774981663	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.8545733339	2832.8545733339
"AML-0024"	"2020-09-15-AML0024:GCAACATTCATCGCAA"	-2.43542323532756	-16.3126936188904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACATTCATCGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.67871657074	31.4920476651939	0.0134888143030877	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2325.73898346084	2325.73898346084
"AML-0024"	"2020-09-15-AML0024:GCAACATTCCCAACTC"	-2.8098660511082	-16.1723852387634	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACATTCCCAACTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.70175115669	45.9682260178221	0.0177709803603243	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.26759896279	2576.26759896279
"AML-0024"	"2020-09-15-AML0024:GCAACCGAGATTACCC"	-0.911289374262649	-16.2608881226745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGAGATTACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.82464719589	39.0668891728266	0.0144916284571634	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.96579477917	2683.96579477917
"AML-0024"	"2020-09-15-AML0024:GCAACCGAGGTTCACT"	-0.332125256687957	-16.4591264954773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGAGGTTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.66692260068	39.2886601626936	0.0138796478840389	2995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.84949924787	2821.84949924787
"AML-0024"	"2020-09-15-AML0024:GCAACCGAGTATAGAC"	-0.175122256309348	-16.321614288446	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGAGTATAGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2603.79937514683	34.4316842495367	0.0132236318121073	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2594.53793323023	2594.53793323023
"AML-0024"	"2020-09-15-AML0024:GCAACCGAGTATCTGC"	-1.14985380592998	-16.8498068085876	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGAGTATCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.02605872319	35.3579929993984	0.0130663904308747	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.51322367587	2702.51322367587
"AML-0024"	"2020-09-15-AML0024:GCAACCGCAGGACAGT"	-2.30514440956767	-15.7192363969055	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGCAGGACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2991.13575531718	34.7148015663874	0.0116058930139419	3324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2984.1166771218	2984.1166771218
"AML-0024"	"2020-09-15-AML0024:GCAACCGCAGGTTCGC"	-1.38099108162578	-16.2444181672302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGCAGGTTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.31363071301	45.027616294839	0.017965675062793	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.56700951116	2498.56700951116
"AML-0024"	"2020-09-15-AML0024:GCAACCGGTGAATGAT"	-1.12839219990428	-16.080948852655	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGGTGAATGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.81920273778	35.2808799012372	0.0141020901361013	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2494.47839148028	2494.47839148028
"AML-0024"	"2020-09-15-AML0024:GCAACCGTCAGAGCGA"	-1.29751370373424	-15.6185016862121	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGTCAGAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.48175127898	34.9669336977292	0.0147821616796761	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2361.00702168326	2361.00702168326
"AML-0024"	"2020-09-15-AML0024:GCAACCGTCAGCAATC"	0.684127827256364	-16.2599764100281	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGTCAGCAATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2715.53097203018	40.36231328305	0.0148635068790522	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2704.83203485644	2704.83203485644
"AML-0024"	"2020-09-15-AML0024:GCAACCGTCATCCCGT"	-1.09439740601237	-16.7366514435974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGTCATCCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3037.71206794287	39.6805002341301	0.0130626271834254	3315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3025.07115209163	3025.07115209163
"AML-0024"	"2020-09-15-AML0024:GCAACCGTCCGCAACG"	-1.81250331822093	-16.1144151917663	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGTCCGCAACG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.51017882212	37.2541468327109	0.0154805689834834	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.6661450098	2397.6661450098
"AML-0024"	"2020-09-15-AML0024:GCAACCGTCTGTGCAA"	-1.13210866871532	-16.2969236603943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAACCGTCTGTGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.83790522118	44.3640152128124	0.0175919376582301	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.3182283447	2512.3182283447
"AML-0024"	"2020-09-15-AML0024:GCACATAAGCTAAATG"	0.967179794877213	-16.2228861085144	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATAAGCTAAATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3148.67010182778	40.3795666691047	0.0128243243538485	4674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3139.53070479855	3139.53070479855
"AML-0024"	"2020-09-15-AML0024:GCACATACACGCTGAC"	-0.600693742663223	-16.5140791169372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATACACGCTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.35544267448	39.4014830918353	0.0148496814479255	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.42871580901	2643.42871580901
"AML-0024"	"2020-09-15-AML0024:GCACATACAGTCACGC"	-0.380554179579574	-16.2568731538025	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATACAGTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3135.28062939266	31.1160793553597	0.00992449577356884	3938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3126.22696190381	3126.22696190381
"AML-0024"	"2020-09-15-AML0024:GCACATACATCGTGGC"	-2.0602048439091	-15.8205700150696	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATACATCGTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.16832239102	33.5502026879905	0.0138914552567399	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2406.52731763742	2406.52731763742
"AML-0024"	"2020-09-15-AML0024:GCACATAGTGGCTGCT"	-1.6760415834492	-15.2623348466125	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATAGTGGCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.86204795866	36.6930259897432	0.0127279853767978	2962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2868.26332318675	2868.26332318675
"AML-0024"	"2020-09-15-AML0024:GCACATAGTTGCGGAA"	-2.06418762627299	-16.4137010804382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATAGTTGCGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.61672041051	42.6715025890346	0.0156672200861666	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.1097321042	2713.1097321042
"AML-0024"	"2020-09-15-AML0024:GCACATAGTTGTATGC"	-2.08478746834453	-15.5055332413879	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATAGTTGTATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.93136105812	39.0330293506075	0.0134553439886872	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2889.05986488536	2889.05986488536
"AML-0024"	"2020-09-15-AML0024:GCACATATCGGCTGGT"	-2.58325086060222	-15.8005047074524	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACATATCGGCTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.99388613911	39.760670417067	0.0144427020405878	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.98558382085	2740.98558382085
"AML-0024"	"2020-09-15-AML0024:GCACGGTAGCATGCGA"	-0.789911548525649	-16.484549545404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGGTAGCATGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.18377978553	38.9264464740942	0.0161173848548912	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2405.07178980716	2405.07178980716
"AML-0024"	"2020-09-15-AML0024:GCACGGTCAACCGTAT"	-1.62564228001292	13.8499765166077	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGGTCAACCGTAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2314.88690404627	25.7431341858238	0.0111206876417273	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2311.99053092374	2311.99053092374
"AML-0024"	"2020-09-15-AML0024:GCACGGTCAATCAAGA"	-2.19780812683757	-15.7374887696472	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGGTCAATCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.41410846254	33.5374573441551	0.0135045771181987	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2480.88454406233	2480.88454406233
"AML-0024"	"2020-09-15-AML0024:GCACGGTGTCTGTCCT"	-1.81393478336986	-15.7462158433166	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGGTGTCTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.37178805667	36.2328591628829	0.0131070861450059	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.97485326188	2751.97485326188
"AML-0024"	"2020-09-15-AML0024:GCACGTGAGCAGCGAT"	-3.48664174500163	13.4477414854797	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGAGCAGCGAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1773.14377693609	40.6505745635799	0.0229257069236778	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1771.15497436964	1771.15497436964
"AML-0024"	"2020-09-15-AML0024:GCACGTGAGGTGCCAA"	-3.10766301575359	13.5575008162293	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGAGGTGCCAA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1938.94765209078	37.1583510405528	0.0191641847578942	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1937.06137690834	1937.06137690834
"AML-0024"	"2020-09-15-AML0024:GCACGTGCAAACTCTG"	-0.14878054979499	-16.3331728211609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGCAAACTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.51699306568	35.1507897023452	0.0122029447446289	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.17545050875	2872.17545050875
"AML-0024"	"2020-09-15-AML0024:GCACGTGGTGTTAAAG"	-2.19263372841533	-16.3758383027283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGGTGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.46613755415	39.8714004602608	0.0154452541058848	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.75074788233	2576.75074788233
"AML-0024"	"2020-09-15-AML0024:GCACGTGTCAACGCTA"	-1.4705859226292	-15.7768135300842	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGTCAACGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.97944774348	32.8388178849566	0.0130262140432563	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.16951213305	2518.16951213305
"AML-0024"	"2020-09-15-AML0024:GCACGTGTCAAGCCCG"	-2.62332473221477	-15.659338974115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGTCAAGCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.42191031847	36.6376511479499	0.0134035843532407	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.10175070114	2728.10175070114
"AML-0024"	"2020-09-15-AML0024:GCACGTGTCGTTCTCG"	-2.45092497292216	-15.5483808747497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGTCGTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.12879330146	36.150434251661	0.0132315996011218	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.00195487876	2725.00195487876
"AML-0024"	"2020-09-15-AML0024:GCACGTGTCTAACACG"	-2.74074707451518	-15.6427984467712	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACGTGTCTAACACG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2294.90888061082	30.8405642470205	0.0134386879181068	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2291.3121463064	2291.3121463064
"AML-0024"	"2020-09-15-AML0024:GCACTAAAGAGTGTGC"	-1.26593957367595	-15.4985971680847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACTAAAGAGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.58227259304	41.0035726376194	0.0149944556609512	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.00986727785	2725.00986727785
"AML-0024"	"2020-09-15-AML0024:GCACTAAAGATAGCTA"	-1.93893490257915	-16.6376734009949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACTAAAGATAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.09216159312	35.7057881632354	0.0125853465906393	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.26429839381	2826.26429839381
"AML-0024"	"2020-09-15-AML0024:GCACTAAGTCTAATCG"	-0.650797228247482	-16.373486541864	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACTAAGTCTAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3074.689053186	34.3283191519037	0.0111648100208158	3767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3066.79555332267	3066.79555332267
"AML-0024"	"2020-09-15-AML0024:GCACTAAGTTTAGACC"	-1.30377374115642	-16.860131286737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACTAAGTTTAGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.72351784639	40.4922732376899	0.0156236855354607	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.38793003588	2584.38793003588
"AML-0024"	"2020-09-15-AML0024:GCACTAATCTACGCAA"	-1.80457733097728	-16.7685461274353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCACTAATCTACGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.7630040085	39.0272975587061	0.0140145849045426	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.0588099756	2777.0588099756
"AML-0024"	"2020-09-15-AML0024:GCAGCCAAGAAGCCAC"	-0.198456595570403	-16.0336599580017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCAAGAAGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.94953418298	35.5779153957524	0.0130899838088595	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.74152348302	2703.74152348302
"AML-0024"	"2020-09-15-AML0024:GCAGCCAAGGTCCCGT"	0.836081822484177	-16.223376297113	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCAAGGTCCCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3138.15827915798	36.972203502828	0.0117814973669041	4830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3124.66721365008	3124.66721365008
"AML-0024"	"2020-09-15-AML0024:GCAGCCAAGTAAGCAT"	-2.09595261040385	-15.8477649918762	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCAAGTAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.88492827555	32.6264122533966	0.0123216881160484	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.66755799565	2639.66755799565
"AML-0024"	"2020-09-15-AML0024:GCAGCCAGTACCTTCC"	0.188981060951394	-16.0873289338318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCAGTACCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.65268695878	37.3244347152267	0.0130795295747796	3009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.12507369765	2845.12507369765
"AML-0024"	"2020-09-15-AML0024:GCAGCCAGTCTTTATC"	-2.29051123085673	-16.5716028443542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCAGTCTTTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.34231940114	35.3743329608523	0.0138378701054166	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.16849502586	2550.16849502586
"AML-0024"	"2020-09-15-AML0024:GCAGCCATCCAAGCAT"	-1.69130168381389	-16.6163988343445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCCATCCAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.4209155167	36.905494472128	0.0125425612214448	3274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.94345885394	2934.94345885394
"AML-0024"	"2020-09-15-AML0024:GCAGCTGAGCAACTCT"	-2.1176212829655	-15.9695959321228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCTGAGCAACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.58609407448	42.6748916648455	0.0146518902056374	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.05395624026	2906.05395624026
"AML-0024"	"2020-09-15-AML0024:GCAGCTGAGCCACTCG"	-1.82817469063457	-15.8981914750305	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCTGAGCCACTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.39487339187	35.5709200768234	0.0136737872595419	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2597.39081744687	2597.39081744687
"AML-0024"	"2020-09-15-AML0024:GCAGCTGGTAATACCC"	-1.87702439251598	-16.9356870881286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCTGGTAATACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1307.09459586778	45.6416156310377	0.0349183722244191	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1293.60620349601	1293.60620349601
"AML-0024"	"2020-09-15-AML0024:GCAGCTGGTACCAGAG"	-2.15975079956706	-16.2224798432556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGCTGGTACCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.11418089257	35.5603868872667	0.01359282677606	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.05396055569	2610.05396055569
"AML-0024"	"2020-09-15-AML0024:GCAGGCTAGAGTTGAT"	-0.979985217482406	-17.4816026917663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTAGAGTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.74725442673	45.4522215956388	0.0158053603374471	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2866.79121809417	2866.79121809417
"AML-0024"	"2020-09-15-AML0024:GCAGGCTCACGCGTCA"	0.692730982869309	-16.2635565034119	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTCACGCGTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2987.4274362778	42.1580849448808	0.014111835632536	3251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2970.07196646774	2970.07196646774
"AML-0024"	"2020-09-15-AML0024:GCAGGCTCAGGCAATG"	-2.98178873482402	-15.722402595636	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTCAGGCAATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.78079141678	42.2946102177664	0.0171665475942952	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2459.38498844005	2459.38498844005
"AML-0024"	"2020-09-15-AML0024:GCAGGCTGTCGGTGTC"	0.582365234463853	-16.2167253724304	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTGTCGGTGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2843.76381717066	27.6363919355987	0.00971824445079792	2765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2837.00662135422	2837.00662135422
"AML-0024"	"2020-09-15-AML0024:GCAGGCTTCCTTGACC"	-2.69575272026713	13.7218713530335	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTTCCTTGACC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2336.63787936673	25.0660017933847	0.010727379717125	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2336.63787936673	2336.63787936673
"AML-0024"	"2020-09-15-AML0024:GCAGGCTTCGAGCCTG"	-0.807713786990005	-15.756615661737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGGCTTCGAGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.31264407716	44.6636069783019	0.0160758030862784	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.47336262923	2769.47336262923
"AML-0024"	"2020-09-15-AML0024:GCAGTTACAACAGCCC"	-1.01530180397685	-16.0628385773865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTACAACAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.85344142599	33.3913026626762	0.0126970203497616	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.85638969432	2624.85638969432
"AML-0024"	"2020-09-15-AML0024:GCAGTTACAAGTCCCG"	-2.53778491440471	-15.6039142838684	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTACAAGTCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.95245731696	34.1951761049785	0.0120027191107227	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.58703586848	2840.58703586848
"AML-0024"	"2020-09-15-AML0024:GCAGTTACACAGACGA"	-2.43763075295146	-15.5217972031799	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTACACAGACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3079.99998004626	37.9511801433358	0.012321811814676	3448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3074.55085631167	3074.55085631167
"AML-0024"	"2020-09-15-AML0024:GCAGTTAGTCGAATTC"	0.111827810376328	-16.0679579011169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTAGTCGAATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.54593575876	37.6817749310972	0.0128758528853666	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.40682870338	2920.40682870338
"AML-0024"	"2020-09-15-AML0024:GCAGTTATCAAGCCAT"	-0.734715561301071	-16.6710901490417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTATCAAGCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.13732536967	35.878065676662	0.012641412857635	2699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.326730901	2828.326730901
"AML-0024"	"2020-09-15-AML0024:GCAGTTATCATTGCTT"	-1.74273369732555	-16.5824880830017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTATCATTGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.94635754316	29.4608072350484	0.0104882057131259	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.18539384181	2800.18539384181
"AML-0024"	"2020-09-15-AML0024:GCAGTTATCTAAGCGT"	-2.31166229668315	-16.1061620942322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTATCTAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.21136754782	39.3865471286686	0.0139806858592054	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.56475874238	2806.56475874238
"AML-0024"	"2020-09-15-AML0024:GCAGTTATCTGACCCT"	-2.66150007668193	-15.7806148759094	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCAGTTATCTGACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.4313490488	43.8796403250677	0.0151757503561352	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2883.83516260159	2883.83516260159
"AML-0024"	"2020-09-15-AML0024:GCATCGGAGACTCTTG"	-1.89444063130077	-15.5303468934265	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCGGAGACTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.78273278917	38.0684892130363	0.0138593011957594	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.3348456355	2741.3348456355
"AML-0024"	"2020-09-15-AML0024:GCATCGGAGGGACAGG"	-1.67817006531413	-16.471932434198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCGGAGGGACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.90236027584	40.7152862565928	0.0144693315700555	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2808.93165966475	2808.93165966475
"AML-0024"	"2020-09-15-AML0024:GCATCGGGTGACCTGC"	-2.48534903946574	-15.5536890259949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCGGGTGACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.43003926257	35.6297870602982	0.0126148591273306	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.73216776338	2819.73216776338
"AML-0024"	"2020-09-15-AML0024:GCATCGGTCGACCATA"	-0.259628931910354	-16.3803091279236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCGGTCGACCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.30775103004	36.1600211855901	0.0140793178586514	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.9803885653	2558.9803885653
"AML-0024"	"2020-09-15-AML0024:GCATCTCCAGAGGTAC"	-1.41596768322642	-15.5490722886291	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCCAGAGGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.97558650702	36.8951208815669	0.0152271946473696	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.63593762063	2413.63593762063
"AML-0024"	"2020-09-15-AML0024:GCATCTCCATCCTAAG"	-2.063299993903	-16.716036819574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCCATCCTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.33278451195	39.5855470597823	0.0139911244362903	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.048313578	2824.048313578
"AML-0024"	"2020-09-15-AML0024:GCATCTCGTTCAGGTT"	0.0519347250460691	-16.4078569642273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCGTTCAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.98666366346	37.7844818957147	0.0133845768320708	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.92162301341	2816.92162301341
"AML-0024"	"2020-09-15-AML0024:GCATCTCTCCCGTTGT"	-2.28018508377727	-16.4230718842712	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCTCCCGTTGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.04814944242	32.1910021415138	0.0131442912418209	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.77804356868	2445.77804356868
"AML-0024"	"2020-09-15-AML0024:GCATCTCTCGCCTATC"	-1.64062343064006	-16.7228803864685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCTCGCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.00470105294	40.2161229739737	0.0153145662526227	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.58536626007	2620.58536626007
"AML-0024"	"2020-09-15-AML0024:GCATCTCTCTGGGTCG"	-1.06944845143016	-16.5377302399841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATCTCTCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2391.21182037364	36.4893752833381	0.0152597837516697	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2389.32064443413	2389.32064443413
"AML-0024"	"2020-09-15-AML0024:GCATGATAGCATCTTG"	-0.23050300303157	-16.2008371583191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATAGCATCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.52425588527	40.8348480252365	0.0150154380630607	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.18203263989	2712.18203263989
"AML-0024"	"2020-09-15-AML0024:GCATGATAGTCCCGGT"	-0.957668165594894	-17.5366239777771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATAGTCCCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3170.25948141202	43.9258032256161	0.013855586106804	3043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3163.28227375134	3163.28227375134
"AML-0024"	"2020-09-15-AML0024:GCATGATCAAGAGTAT"	-1.48180816593822	-15.7622184983459	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATCAAGAGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.1725735204	33.8767886279179	0.0127491864719331	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.66085190253	2648.66085190253
"AML-0024"	"2020-09-15-AML0024:GCATGATCACTACGGC"	-2.95300946655925	-16.0283022156921	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATCACTACGGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.56714358484	34.8335906560193	0.0122672185212156	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.87731267504	2827.87731267504
"AML-0024"	"2020-09-15-AML0024:GCATGATGTGATACCT"	-2.14133749428447	-15.5110149613586	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATGTGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.33301791316	36.4098162717776	0.0139697483098036	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.54727351344	2594.54727351344
"AML-0024"	"2020-09-15-AML0024:GCATGATGTGGACTAG"	-1.07459578934367	-16.1508913270203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATGTGGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.59405003728	33.9538756659993	0.0136219035207484	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.08673735743	2486.08673735743
"AML-0024"	"2020-09-15-AML0024:GCATGATTCACCATCC"	-0.272050837904769	-16.0096788636413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATTCACCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3015.50240761144	36.0017649348375	0.0119388944422546	3812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3009.64558489542	3009.64558489542
"AML-0024"	"2020-09-15-AML0024:GCATGATTCTCGTTTA"	-1.03569791737254	-16.1927938691345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATGATTCTCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.76453522082	34.034052992298	0.0122171319801084	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.14134847856	2775.14134847856
"AML-0024"	"2020-09-15-AML0024:GCATTAGAGCGGTAAC"	-0.594801108271438	-16.4481897584167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGAGCGGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.54558995985	36.891251428583	0.0153935112201229	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2389.15859963218	2389.15859963218
"AML-0024"	"2020-09-15-AML0024:GCATTAGAGCGTTAGG"	-1.82563660565074	-16.5355005494324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGAGCGTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.43658187164	41.8993960997071	0.0174549065016489	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2388.03890179483	2388.03890179483
"AML-0024"	"2020-09-15-AML0024:GCATTAGAGTTAGTAG"	-0.100366140634376	-16.2050390473572	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGAGTTAGTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2707.95624609648	38.1797116758355	0.0140990873581771	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2699.89931894507	2699.89931894507
"AML-0024"	"2020-09-15-AML0024:GCATTAGCAGAGATTA"	-2.19853315773662	-16.2231912842956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGCAGAGATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.37076909246	30.174173946441	0.0131686125848555	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2285.11751504084	2285.11751504084
"AML-0024"	"2020-09-15-AML0024:GCATTAGCAGGGTTGA"	-1.68094454231914	-16.497136139032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGCAGGGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1922.01153036844	42.5827227882337	0.0221552899737655	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1918.50712991327	1918.50712991327
"AML-0024"	"2020-09-15-AML0024:GCATTAGGTATTGACC"	-2.26112018051799	-16.06996252453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGGTATTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.91025382106	35.8300395257572	0.0136812781092747	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.04070699395	2616.04070699395
"AML-0024"	"2020-09-15-AML0024:GCATTAGGTCGCATCG"	-0.0923908752506555	-16.5660162202087	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGGTCGCATCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2643.5208721174	39.4556878180609	0.0149254307897549	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2635.97738415547	2635.97738415547
"AML-0024"	"2020-09-15-AML0024:GCATTAGTCTCAGGCG"	-0.424470911652404	-16.0420179597107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCATTAGTCTCAGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.00615760415	49.6774395533287	0.0225600820332761	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2194.27834249218	2194.27834249218
"AML-0024"	"2020-09-15-AML0024:GCCAACGAGGCGACAT"	-1.1639395755833	-16.5094404450622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAACGAGGCGACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.65921652186	37.6819957668019	0.0131220290868783	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.1904209889	2863.1904209889
"AML-0024"	"2020-09-15-AML0024:GCCAACGCACTGGCCA"	-0.565106074244338	-16.3951254121033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAACGCACTGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.97844039607	31.9883066427508	0.0112754845744563	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.64730597439	2827.64730597439
"AML-0024"	"2020-09-15-AML0024:GCCAACGCATGCGGTC"	-2.67511210861858	-16.1934480897156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAACGCATGCGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.67625743106	45.5933571255862	0.0164913909912735	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.01742193025	2754.01742193025
"AML-0024"	"2020-09-15-AML0024:GCCAACGGTTGACTAC"	-1.00388441506084	-16.0762434235779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAACGGTTGACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.98209489095	44.7542219251921	0.0171341993548622	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.16860822296	2608.16860822296
"AML-0024"	"2020-09-15-AML0024:GCCAACGTCATTCCTA"	-2.21309266510661	-16.1567297211853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAACGTCATTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.97888987233	39.0898272922852	0.014147711166223	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.72354001975	2750.72354001975
"AML-0024"	"2020-09-15-AML0024:GCCAGCACACGTAGAG"	-0.153656686574775	-16.4796705476013	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCACACGTAGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2819.91818947172	40.6060957211893	0.014399742472244	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2806.62702486891	2806.62702486891
"AML-0024"	"2020-09-15-AML0024:GCCAGCACATCAGTGT"	-2.09138856354411	-16.3036966553894	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCACATCAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2947.84033532755	34.7691861802877	0.0117947996584504	3417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2939.96362090806	2939.96362090806
"AML-0024"	"2020-09-15-AML0024:GCCAGCACATCGAACT"	-1.64192662659343	-16.9203005067078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCACATCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1764.01908518353	47.3147793023114	0.0268221470502904	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1751.10055859804	1751.10055859804
"AML-0024"	"2020-09-15-AML0024:GCCAGCAGTAGTGTGG"	-0.0222120312159837	-16.4931993714538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCAGTAGTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.26871741839	41.4094643855449	0.0142876552945823	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.97019870393	2890.97019870393
"AML-0024"	"2020-09-15-AML0024:GCCAGCAGTATCGTAC"	-0.883927802473861	-16.1761083832947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCAGTATCGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.28839687032	33.5062809759293	0.0117061163412344	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.86497230158	2855.86497230158
"AML-0024"	"2020-09-15-AML0024:GCCAGCAGTCATCCCT"	-1.93823180618938	-15.5469417802063	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCAGTCATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.61912891751	32.5857476398748	0.0128057465534093	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.20832131314	2537.20832131314
"AML-0024"	"2020-09-15-AML0024:GCCAGCAGTGGACCAA"	-1.56091258946117	-16.8776197663513	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCAGTGGACCAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.00870137761	38.6775592568625	0.0141055567173913	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.14977789004	2737.14977789004
"AML-0024"	"2020-09-15-AML0024:GCCAGCATCTCCAAGA"	-0.607640842825729	-16.6115484467712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGCATCTCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.43489102974	40.2471776699356	0.0144595362369141	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.49999003959	2777.49999003959
"AML-0024"	"2020-09-15-AML0024:GCCAGGTAGCGTCAAG"	-0.0201490772074044	-16.5604105225769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTAGCGTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.48332914927	34.9838284488119	0.0125054644952793	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.90399890653	2787.90399890653
"AML-0024"	"2020-09-15-AML0024:GCCAGGTAGGCATGCA"	-1.57929287377055	-16.8724603882995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTAGGCATGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.32043901023	49.882062378774	0.01919042440099	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.75655096861	2587.75655096861
"AML-0024"	"2020-09-15-AML0024:GCCAGGTAGTGTCATC"	-0.817841152579147	-16.1133165589538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTAGTGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2393.27450122925	41.3191329905212	0.0172646860898316	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.55945898146	2382.55945898146
"AML-0024"	"2020-09-15-AML0024:GCCAGGTCAAAGGCTG"	-1.94781217995341	-16.5265226594177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTCAAAGGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.23373554723	47.5326462851251	0.0185295576096831	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.84846218738	2553.84846218738
"AML-0024"	"2020-09-15-AML0024:GCCAGGTCAAAGGTTA"	-2.10462198677714	-16.1441526643005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTCAAAGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3232.69942090755	34.7645513743596	0.0107540314913039	3181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3223.7661897391	3223.7661897391
"AML-0024"	"2020-09-15-AML0024:GCCAGGTCAAATGCTC"	-0.786462466151077	-15.7903509370056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTCAAATGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2873.06101459646	35.7113822761093	0.0124297333383033	2969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2860.67153416971	2860.67153416971
"AML-0024"	"2020-09-15-AML0024:GCCAGGTGTCGAATGG"	-1.40170047703441	-16.4096651307312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTGTCGAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.61815802404	46.1820771170421	0.0176158671222549	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.44762492209	2609.44762492209
"AML-0024"	"2020-09-15-AML0024:GCCAGGTGTTTGATCG"	-2.50598869743999	-15.7922344437805	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTGTTTGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.84302458223	32.0609748685995	0.0128767052991138	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2482.5834051873	2482.5834051873
"AML-0024"	"2020-09-15-AML0024:GCCAGGTTCTGCTGAA"	0.01014126565997	-16.2276296845642	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGGTTCTGCTGAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2841.28072979131	40.0107135960419	0.0140819290316943	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2834.24769381833	2834.24769381833
"AML-0024"	"2020-09-15-AML0024:GCCAGTGAGGTTATAG"	-1.39086852493938	-15.7833214036194	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGAGGTTATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.03952353097	38.0258895742293	0.0138778617051578	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.42642685488	2731.42642685488
"AML-0024"	"2020-09-15-AML0024:GCCAGTGCAGTAGGAC"	-1.8780439895695	-15.2449970475403	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGCAGTAGGAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.34489835781	40.1900919846637	0.0149664544056302	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.60924558058	2677.60924558058
"AML-0024"	"2020-09-15-AML0024:GCCAGTGCATCTGCGG"	-0.792025725275832	-15.7541284791199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGCATCTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.8534100852	33.8971286866969	0.012322404589944	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.37066498081	2747.37066498081
"AML-0024"	"2020-09-15-AML0024:GCCAGTGCATTGCAAC"	0.890641112893265	-16.3143663636413	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGCATTGCAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2788.19838553581	51.0378043088764	0.0183049400550702	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2774.41796543401	2774.41796543401
"AML-0024"	"2020-09-15-AML0024:GCCAGTGGTGCGGCTT"	-0.010303589433986	-16.0781145325867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGGTGCGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.91927563719	41.201246897163	0.0148210227751017	2653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.27508160764	2773.27508160764
"AML-0024"	"2020-09-15-AML0024:GCCAGTGTCACACCCT"	-1.49570761147197	-16.10414221203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGTCACACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.4908340908	34.4705905351498	0.0130645102456943	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.6498535356	2630.6498535356
"AML-0024"	"2020-09-15-AML0024:GCCAGTGTCTGCGGAC"	0.167595592408818	-16.0861025086609	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCAGTGTCTGCGGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2885.95683451309	40.3953314693458	0.0139972057053172	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2880.85439864869	2880.85439864869
"AML-0024"	"2020-09-15-AML0024:GCCATGGAGGCCTAAG"	-2.09209928932841	-15.8608980408874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGAGGCCTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.5497077878	36.2719771618098	0.0149049666196391	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2430.28168431855	2430.28168431855
"AML-0024"	"2020-09-15-AML0024:GCCATGGAGGTACTGG"	-2.74497209015544	-15.9055690995422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGAGGTACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.4945920683	37.7721530017241	0.0131176329018881	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2874.29801832595	2874.29801832595
"AML-0024"	"2020-09-15-AML0024:GCCATGGAGGTGCTGA"	-1.94528887692149	-15.9011554948059	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGAGGTGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.30724005246	35.8183058861466	0.0130328608694648	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.99159383517	2738.99159383517
"AML-0024"	"2020-09-15-AML0024:GCCATGGCAACCGTAT"	9.54030384597127	7.93227670276491	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGCAACCGTAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2266.30497938706	41.1053163695707	0.0181375925762154	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	2260.93832620273	2260.93832620273
"AML-0024"	"2020-09-15-AML0024:GCCATGGGTGTTTCTT"	-1.78008912029918	-16.0670480958191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGGTGTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.47964066115	38.7100458993193	0.0135421800276898	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2853.37687752406	2853.37687752406
"AML-0024"	"2020-09-15-AML0024:GCCATGGTCCACAGCG"	-1.44563625279124	-16.5765257111755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGTCCACAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.18404056143	35.7609910276234	0.013195041551575	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.23156026921	2698.23156026921
"AML-0024"	"2020-09-15-AML0024:GCCATGGTCCTCGCAT"	-1.57172952118571	-15.7443266144958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGTCCTCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.46113797375	41.3271740674434	0.0147731003324598	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.03269160207	2788.03269160207
"AML-0024"	"2020-09-15-AML0024:GCCATGGTCGGATTAC"	0.0551623912410855	-15.8931942216125	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGTCGGATTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2494.06279160409	36.7897357025714	0.0147509260097295	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2489.63404759209	2489.63404759209
"AML-0024"	"2020-09-15-AML0024:GCCATGGTCGTGGCTG"	-1.08135090294536	-16.1238832703796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATGGTCGTGGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.67729284743	37.2565425539915	0.013350358584807	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.41027981486	2784.41027981486
"AML-0024"	"2020-09-15-AML0024:GCCATTCAGATGGTCG"	1.2038023668224	-16.2092771760193	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCAGATGGTCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2883.15393666122	43.8341300066017	0.0152035343826847	3185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2872.44596871174	2872.44596871174
"AML-0024"	"2020-09-15-AML0024:GCCATTCAGGACTAAT"	-1.84676585617717	-16.4622640839783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCAGGACTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2996.6760299521	33.2623789895973	0.0110997580843362	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2990.37421967318	2990.37421967318
"AML-0024"	"2020-09-15-AML0024:GCCATTCAGGCTCTCG"	9.84461178359334	7.71131513202516	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCAGGCTCTCG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1955.27518792242	30.727635290853	0.0157152484114027	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1951.13085466439	1951.13085466439
"AML-0024"	"2020-09-15-AML0024:GCCATTCAGGTCTGGA"	-0.0568021712010682	-16.1242685548035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCAGGTCTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.94196678503	41.1385763008363	0.0156423893836434	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.77798230428	2626.77798230428
"AML-0024"	"2020-09-15-AML0024:GCCATTCAGTGAACAT"	-1.0460309785908	-16.099768661615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCAGTGAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.82645383297	34.1603798933172	0.0120036764179022	2832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.72784843614	2841.72784843614
"AML-0024"	"2020-09-15-AML0024:GCCATTCTCATGTCTT"	-2.41389427605327	-15.7734766236511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCTCATGTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2896.64505212827	36.6212727568436	0.0126426511007749	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.18270155541	2886.18270155541
"AML-0024"	"2020-09-15-AML0024:GCCATTCTCCATAGGT"	-1.85964498940166	-15.6918974152771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCTCCATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.75311653388	27.4423178626373	0.0108908756507012	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.92928255315	2515.92928255315
"AML-0024"	"2020-09-15-AML0024:GCCATTCTCCGGACGT"	-1.15955899182017	-16.1336660615173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCTCCGGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.83901376797	37.6896412079036	0.0138217331560852	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.27366422099	2722.27366422099
"AML-0024"	"2020-09-15-AML0024:GCCATTCTCGTCTAAG"	-1.80185423317607	-16.533455871698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCATTCTCGTCTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.60521273564	37.3148838676077	0.0144653467450686	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.05508624001	2574.05508624001
"AML-0024"	"2020-09-15-AML0024:GCCCAGAAGGAATGTT"	-0.639770428568679	-16.1728105775085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGAAGGAATGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.22432813479	34.2488258685411	0.0134192067252845	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.38626689949	2548.38626689949
"AML-0024"	"2020-09-15-AML0024:GCCCAGAAGGGAGGAC"	-0.728608529002029	-16.4277773133484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGAAGGGAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.94271235318	39.1613755425597	0.0161760851848057	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.04207079754	2415.04207079754
"AML-0024"	"2020-09-15-AML0024:GCCCAGACAGCGATTT"	-2.41453061524089	-16.1102972260681	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGACAGCGATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1982.32394785354	43.4497208312097	0.0219185773739236	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1977.24331817023	1977.24331817023
"AML-0024"	"2020-09-15-AML0024:GCCCAGACATGGCTAT"	-0.0191118669813454	-16.3223257294861	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGACATGGCTAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2872.90018892624	38.0347757700993	0.0132391566949338	3177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2862.36998549388	2862.36998549388
"AML-0024"	"2020-09-15-AML0024:GCCCAGAGTCCTTAAG"	-0.276661942631561	-15.8823671570984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGAGTCCTTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2919.88248323815	45.6988003223718	0.0156509039609333	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.01485913657	2912.01485913657
"AML-0024"	"2020-09-15-AML0024:GCCCAGAGTTCCAAAC"	-1.89043674889262	-16.3210096589294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGAGTTCCAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.49448076385	39.4636471050664	0.0154305893529357	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.63898490923	2553.63898490923
"AML-0024"	"2020-09-15-AML0024:GCCCAGATCGTAGGGA"	-2.29044042053874	-15.385057472345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGATCGTAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3007.67360633778	38.215370213461	0.0127059565682039	3011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.14981279481	3000.14981279481
"AML-0024"	"2020-09-15-AML0024:GCCCAGATCTGAATGC"	-3.38009319725688	11.3567991026672	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCAGATCTGAATGC"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2139.33843223261	30.1712747153433	0.0141030863844467	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2139.33843223261	2139.33843223261
"AML-0024"	"2020-09-15-AML0024:GCCCGAAAGCAATAAC"	1.09987701949422	-16.2051763764587	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAAAGCAATAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3114.53950032553	40.5173470268025	0.0130090971787539	3882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3105.77661115258	3105.77661115258
"AML-0024"	"2020-09-15-AML0024:GCCCGAAAGCTGCCTG"	-2.49611387673076	-16.2859087220398	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAAAGCTGCCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2186.83872992837	37.8977189399798	0.0173299102587327	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2179.04403715387	2179.04403715387
"AML-0024"	"2020-09-15-AML0024:GCCCGAAAGTCGAGGT"	-2.31664286080058	-16.3904562226501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAAAGTCGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.99318187683	34.1487996403167	0.0134444453961423	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.71464788704	2533.71464788704
"AML-0024"	"2020-09-15-AML0024:GCCCGAAAGTGACCTT"	-0.390624980360824	-16.0624952546326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAAAGTGACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.05001347356	33.0773444772938	0.011609955711857	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.79986157871	2845.79986157871
"AML-0024"	"2020-09-15-AML0024:GCCCGAACACTTCTCG"	-1.34691009941753	-16.9381990662781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAACACTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2093.0554788894	46.6451138839626	0.0222856557575401	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2084.17469940892	2084.17469940892
"AML-0024"	"2020-09-15-AML0024:GCCCGAACAGCCTTCT"	-1.0185549062794	-16.0121107331482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAACAGCCTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.37602426487	34.485343985916	0.0119975061351744	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.85600378989	2867.85600378989
"AML-0024"	"2020-09-15-AML0024:GCCCGAAGTCGTGTTA"	-1.96643338623698	-15.9389477006164	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAAGTCGTGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.02402152332	35.288050200593	0.0141038015211015	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.49072180971	2495.49072180971
"AML-0024"	"2020-09-15-AML0024:GCCCGAATCACCTTGC"	-1.29711995545085	-15.9610338441101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAATCACCTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.67042587933	27.9113782415462	0.0102364326750436	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.12987471468	2719.12987471468
"AML-0024"	"2020-09-15-AML0024:GCCCGAATCTCGGTAA"	-1.52985666218455	-16.7547235718933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCCGAATCTCGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.33203104694	44.4076947622795	0.0173580654205024	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.18488956671	2547.18488956671
"AML-0024"	"2020-09-15-AML0024:GCCGATGAGATAGGGA"	-1.19790444794353	-15.6280699006286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGAGATAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.54007468834	35.4250862543061	0.0131129227310807	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.63822864992	2695.63822864992
"AML-0024"	"2020-09-15-AML0024:GCCGATGAGCCGAACA"	-3.01520810547526	13.6182279356751	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGAGCCGAACA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1901.29116963714	31.2610469394212	0.0164420092191283	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1899.46207310156	1899.46207310156
"AML-0024"	"2020-09-15-AML0024:GCCGATGAGCCTCAGC"	-2.18491802635844	-15.7690029374328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGAGCCTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.32572392906	37.0876743611887	0.0146053237722507	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.80995809667	2535.80995809667
"AML-0024"	"2020-09-15-AML0024:GCCGATGAGGGATCTG"	-0.905839065939742	-15.904908203241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGAGGGATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.45139468583	36.6532167030917	0.0143881907931798	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2541.50800388075	2541.50800388075
"AML-0024"	"2020-09-15-AML0024:GCCGATGAGTAAACTG"	-1.37164221230205	-16.7753458253113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGAGTAAACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3019.40870583999	34.2307848016729	0.0113369166404884	2814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3003.42745487002	3003.42745487002
"AML-0024"	"2020-09-15-AML0024:GCCGATGCAATTTCTC"	-1.19273291054423	-15.8969011536804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGCAATTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.61567096396	34.9173199937685	0.0119883032773123	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.46447771896	2903.46447771896
"AML-0024"	"2020-09-15-AML0024:GCCGATGCATCGGCCA"	-2.07806144180949	-16.0804796448913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGCATCGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.03289057063	35.34246388345	0.0128985546140979	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.38847053545	2734.38847053545
"AML-0024"	"2020-09-15-AML0024:GCCGATGGTAACAAGT"	-0.794742743403274	-16.0728445283142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGGTAACAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.48007581835	32.13841887207	0.0112274733870006	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2854.87401007016	2854.87401007016
"AML-0024"	"2020-09-15-AML0024:GCCGATGGTAGGTAGC"	-1.29045436802562	-15.1046543351379	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGGTAGGTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.80443275001	32.6732716609137	0.0129306689656841	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.83207516202	2517.83207516202
"AML-0024"	"2020-09-15-AML0024:GCCGATGGTGGTACAG"	-0.920373300940353	-15.5962667695251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGATGGTGGTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2922.76014812379	40.364250520532	0.0138103191760169	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2917.7376493131	2917.7376493131
"AML-0024"	"2020-09-15-AML0024:GCCGTGACAATGCAAA"	-0.805700997740585	-16.5272836915222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGTGACAATGCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.91831686769	35.3814912876465	0.0138213360381511	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.97172293377	2556.97172293377
"AML-0024"	"2020-09-15-AML0024:GCCGTGACATATCTCT"	-0.173127899796325	-15.9129524460998	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGTGACATATCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.61358585856	44.6195484642725	0.0162689883454014	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.34482261448	2731.34482261448
"AML-0024"	"2020-09-15-AML0024:GCCGTGAGTAGCTGTT"	-0.677904765040237	-16.6219034424988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGTGAGTAGCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.42846886192	34.4565272607345	0.013736300511837	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.18144186637	2502.18144186637
"AML-0024"	"2020-09-15-AML0024:GCCGTGATCAAGGTGG"	-1.03424022617992	-17.1425600281921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCGTGATCAAGGTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2196.66596988906	41.2801509032374	0.0187921839137529	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2194.86563090398	2194.86563090398
"AML-0024"	"2020-09-15-AML0024:GCCTGTTAGATGAAGG"	-0.966632584959823	-17.5121431580749	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTAGATGAAGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2641.84237669089	41.8868309585718	0.0158551590087817	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2633.85978924182	2633.85978924182
"AML-0024"	"2020-09-15-AML0024:GCCTGTTCAAATCGTC"	-0.783216635615188	-15.4695072404114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTCAAATCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.21942881219	38.912693207956	0.0144752667103332	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.47757709069	2684.47757709069
"AML-0024"	"2020-09-15-AML0024:GCCTGTTCATCGGCCA"	-1.70151148262675	-16.332154296991	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTCATCGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.08005616529	37.5780804051863	0.0146555800061041	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.63951537344	2555.63951537344
"AML-0024"	"2020-09-15-AML0024:GCCTGTTTCTCCATAT"	-2.10847435417827	-15.6453056565491	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTTCTCCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2977.64239463427	33.2367620991111	0.0111621066918593	2989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.8876009863	2970.8876009863
"AML-0024"	"2020-09-15-AML0024:GCCTGTTTCTGAGCAT"	-0.676469306380111	-15.608407043573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTTCTGAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.58738875832	36.0472336179839	0.0131579061014447	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.33957500367	2734.33957500367
"AML-0024"	"2020-09-15-AML0024:GCCTGTTTCTGTACAG"	-0.520803670317489	-16.7116632691589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTTCTGTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.98146663061	39.8606183655382	0.0139422444079412	2752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.49963107901	2852.49963107901
"AML-0024"	"2020-09-15-AML0024:GCCTGTTTCTTCACAT"	-1.45969388905223	-15.6143503419128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCCTGTTTCTTCACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.20566949602	34.2484298040017	0.012182826100426	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.7725181587	2805.7725181587
"AML-0024"	"2020-09-15-AML0024:GCGAGAAAGAGGACTC"	-1.2053773206776	-16.8427019349304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGAGAAAGAGGACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.76363389016	35.2858019624982	0.0135414438606697	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.24755734566	2595.24755734566
"AML-0024"	"2020-09-15-AML0024:GCGAGAAGTTAGAGTA"	-2.16300545159038	-15.5609627000061	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGAGAAGTTAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.98855264661	32.6546354790762	0.0126324100915817	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.45973182349	2580.45973182349
"AML-0024"	"2020-09-15-AML0024:GCGATCGAGCTTACGT"	-1.30231736126598	-16.0548601380554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGAGCTTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.00189313257	39.5872225762004	0.0186380354481772	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2119.8460524978	2119.8460524978
"AML-0024"	"2020-09-15-AML0024:GCGATCGAGGCTCTAT"	-2.10670957985576	-15.4630041352478	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGAGGCTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2948.80646705081	39.2652309844819	0.0133156351300844	2798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2943.39230755055	2943.39230755055
"AML-0024"	"2020-09-15-AML0024:GCGATCGAGGTCCAGA"	-0.790761629969436	-16.1640997163025	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGAGGTCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.58671792272	39.8138792862625	0.0180759644840732	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2197.61111656684	2197.61111656684
"AML-0024"	"2020-09-15-AML0024:GCGATCGCATGCAGGA"	-0.510707835585433	-16.6645517579285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGCATGCAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.84531027916	40.0841645593553	0.0154953852091873	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.44974492816	2575.44974492816
"AML-0024"	"2020-09-15-AML0024:GCGATCGGTACTAGCT"	1.06081463870351	-16.2177019349304	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGGTACTAGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2701.31985446457	40.4670719537344	0.014980481443859	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2693.5755313208	2693.5755313208
"AML-0024"	"2020-09-15-AML0024:GCGATCGGTAGATTGA"	-1.39023421230968	-16.2129583588806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGGTAGATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.92286251624	32.4102724628422	0.0126359638086921	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.9686130915	2558.9686130915
"AML-0024"	"2020-09-15-AML0024:GCGATCGGTAGTCACT"	-1.61745975437816	-16.8501119843689	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGGTAGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2394.5771948559	40.94701464456	0.0170998933475703	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2381.54121155057	2381.54121155057
"AML-0024"	"2020-09-15-AML0024:GCGATCGTCATGAGTC"	-0.946372489363509	-17.5020723572937	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGATCGTCATGAGTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.72426952577	45.0668288219948	0.0170467205455124	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.6062174073	2634.6062174073
"AML-0024"	"2020-09-15-AML0024:GCGGAAAAGACCTCAT"	-0.095459814102012	-16.0617513886658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAAAGACCTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.88811847595	33.308693891883	0.011549925837444	2847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.10326308935	2875.10326308935
"AML-0024"	"2020-09-15-AML0024:GCGGAAACAACCCGCA"	-1.84045467796977	-16.5971441498962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAACAACCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2260.96700020799	36.4986800898458	0.0161429512622202	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2253.22659596675	2253.22659596675
"AML-0024"	"2020-09-15-AML0024:GCGGAAACACCAGGTC"	-0.31997842612918	-16.3965025178161	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAACACCAGGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2284.29579667343	37.7276084028887	0.0165160783720876	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2280.60464133426	2280.60464133426
"AML-0024"	"2020-09-15-AML0024:GCGGAAACACGCTTAA"	-1.41556904736217	-15.6147356263367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAACACGCTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.06489218035	35.6105198393915	0.0134274692690928	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.27722908091	2643.27722908091
"AML-0024"	"2020-09-15-AML0024:GCGGAAAGTTTACCAG"	-0.662247995764571	-16.6822347871033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAAGTTTACCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3018.07874100558	39.4757319749833	0.0130797554877016	3345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3003.57345438475	3003.57345438475
"AML-0024"	"2020-09-15-AML0024:GCGGAAATCAGGAAGC"	-2.3364454311436	-15.7951021424499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAATCAGGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2644.55919058025	38.16458239902	0.0144313587440054	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.08881125623	2639.08881125623
"AML-0024"	"2020-09-15-AML0024:GCGGAAATCCTGGTCT"	-2.01072440567668	-16.5116205445495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGAAATCCTGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.22067858758	39.7765682687027	0.015701975198971	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.42204622177	2522.42204622177
"AML-0024"	"2020-09-15-AML0024:GCGGATCAGACCAAGC"	-2.58914194527324	-16.2840757600036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGATCAGACCAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.67662393964	37.7489035718095	0.015278771493623	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2463.71498937042	2463.71498937042
"AML-0024"	"2020-09-15-AML0024:GCGGATCAGATACCAA"	-1.37725589695628	-15.7089939347473	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGATCAGATACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.75856172683	34.7150705280383	0.0152208441132649	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2273.78415547904	2273.78415547904
"AML-0024"	"2020-09-15-AML0024:GCGGATCAGGTGGGTT"	-2.215723614127	-15.4474601975647	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGATCAGGTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.30318630982	34.3984380643709	0.0127245949468683	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.06406422221	2696.06406422221
"AML-0024"	"2020-09-15-AML0024:GCGGATCGTCTGTCCT"	-2.24399791184123	-16.2020025483337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGATCGTCTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.65662336768	42.6679506677075	0.0182057176133577	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2333.6823636012	2333.6823636012
"AML-0024"	"2020-09-15-AML0024:GCGGATCTCTATTCGT"	-1.81369457665141	-15.9718199006286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGGATCTCTATTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.0361777486	30.0615887889302	0.0108956848885761	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.80455158211	2754.80455158211
"AML-0024"	"2020-09-15-AML0024:GCGTGCAAGCATCAGG"	-1.91152594509776	-16.142529510614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAAGCATCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.6168948572	37.7549705715713	0.0136663793817575	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.27821629369	2754.27821629369
"AML-0024"	"2020-09-15-AML0024:GCGTGCAAGGGCGAAG"	-1.44436846199687	-16.7294340363708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAAGGGCGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.93261814898	28.4258799807414	0.0115087673938427	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2463.97658143832	2463.97658143832
"AML-0024"	"2020-09-15-AML0024:GCGTGCAAGGTCTACT"	-0.859364489943343	-16.2764921418396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAAGGTCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.25344719014	35.3517027579679	0.0147038170203244	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2401.01249887794	2401.01249887794
"AML-0024"	"2020-09-15-AML0024:GCGTGCACAGAACTAA"	-1.59969482842143	-16.1001196137634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCACAGAACTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.26410424265	28.9511143038281	0.0119078442581813	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2426.31861630104	2426.31861630104
"AML-0024"	"2020-09-15-AML0024:GCGTGCACAGGAGACT"	-2.27004299584087	-15.3872003785339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCACAGGAGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2537.11744036351	39.3572162570231	0.0155125717205208	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.49172094903	2529.49172094903
"AML-0024"	"2020-09-15-AML0024:GCGTGCAGTAGACGGT"	-0.339729766280013	-16.5130243531433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAGTAGACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.51808978011	38.7822063091932	0.0156284197439116	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.69053647619	2475.69053647619
"AML-0024"	"2020-09-15-AML0024:GCGTGCAGTCCCGGTA"	-0.955409745604354	-16.0375108948913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAGTCCCGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.01632896534	37.2752466135604	0.0158819715711108	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2341.28325090398	2341.28325090398
"AML-0024"	"2020-09-15-AML0024:GCGTGCAGTTGTGCCG"	-0.720351676375228	-16.4356718293396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTGCAGTTGTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.03292037552	35.5421090030176	0.0144890468887702	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.28338622324	2442.28338622324
"AML-0024"	"2020-09-15-AML0024:GCGTTTCAGACATCAA"	0.0688563073867976	-16.3717069855896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCAGACATCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.68557761367	33.5723005175442	0.0122675037250054	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.56135467967	2726.56135467967
"AML-0024"	"2020-09-15-AML0024:GCGTTTCAGCTAGAAT"	-1.45799217644389	-16.0072221986023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCAGCTAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.39222464955	35.7094894798036	0.0138227130743369	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.84708902354	2571.84708902354
"AML-0024"	"2020-09-15-AML0024:GCGTTTCCAAGTCCAT"	-0.681092600256759	-15.8367490998474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCCAAGTCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.52411732186	34.6781229856908	0.0125077804622267	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.57135937524	2765.57135937524
"AML-0024"	"2020-09-15-AML0024:GCGTTTCCACTCCTTG"	-1.81435773792918	-15.6474714509216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCCACTCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.07589644209	41.0139266563782	0.0150395251961588	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.85433406845	2720.85433406845
"AML-0024"	"2020-09-15-AML0024:GCGTTTCCAGTGGCTC"	-2.33483992043193	-15.6320114365784	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCCAGTGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.87535169179	39.6464661773657	0.0141955730868368	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.92644833752	2774.92644833752
"AML-0024"	"2020-09-15-AML0024:GCGTTTCCAGTTAGAA"	-0.345698694617111	-16.5446272126404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCCAGTTAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.25905791678	34.9392359939321	0.0133597610103542	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.5980695319	2607.5980695319
"AML-0024"	"2020-09-15-AML0024:GCGTTTCGTACAGGTG"	-1.64857194843944	-15.4817686310974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCGTACAGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.08357053866	41.0572160459334	0.0158028850617076	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.06682614812	2591.06682614812
"AML-0024"	"2020-09-15-AML0024:GCGTTTCGTCCAGCAC"	0.108544123440427	-16.1330709687439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCGTCCAGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.63038740129	38.0829716335757	0.0129859431987003	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.98610133338	2921.98610133338
"AML-0024"	"2020-09-15-AML0024:GCGTTTCGTGACATCT"	-1.34201322022136	-16.0013685456482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCGTGACATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.66973205822	43.4743476791832	0.0166080339115203	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.39143781506	2607.39143781506
"AML-0024"	"2020-09-15-AML0024:GCGTTTCTCGTTCCTG"	-2.78031740608867	-15.6008424988953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCTCGTTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.40825945922	39.2455171972231	0.0143998672716323	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.0492652007	2720.0492652007
"AML-0024"	"2020-09-15-AML0024:GCGTTTCTCTGCTGAA"	-1.39440319958385	-15.9337072602478	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCTCTGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.40871463907	42.1604652955489	0.0154467394602439	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.62302780938	2716.62302780938
"AML-0024"	"2020-09-15-AML0024:GCGTTTCTCTGGCCGA"	-0.419836859137374	-16.6787233582703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCGTTTCTCTGGCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.1726311317	48.3148241788177	0.0231041777515377	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2087.30726831954	2087.30726831954
"AML-0024"	"2020-09-15-AML0024:GCTACAAAGCCGCACT"	-1.03952000561412	-16.2111520997253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAAGCCGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.76580368785	33.6960037471602	0.0127987091369694	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.26293031606	2626.26293031606
"AML-0024"	"2020-09-15-AML0024:GCTACAAAGCCTTCTC"	-0.513258437544662	-16.5659303895203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAAGCCTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.49294832535	33.7869347846079	0.0121470503115781	2540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.6397826356	2771.6397826356
"AML-0024"	"2020-09-15-AML0024:GCTACAAAGTAGCAAT"	-1.95866284790691	13.9051389464172	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAAGTAGCAAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2305.30030234615	31.5093374651454	0.0136682138257986	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2298.76279932206	2298.76279932206
"AML-0024"	"2020-09-15-AML0024:GCTACAAAGTTGTAGA"	-0.98256347599681	-16.5768728486267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAAGTTGTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.33943740889	37.6661481722315	0.0140790165335849	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.79077694364	2669.79077694364
"AML-0024"	"2020-09-15-AML0024:GCTACAACATCATGAC"	-1.01744637909587	-17.4432363740173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAACATCATGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3012.66162517926	41.1914540693446	0.0136727781590452	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3008.87186874498	3008.87186874498
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTACGACTT"	-1.63689372959788	-16.2582540742126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTACGACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.95795002905	32.1328002048137	0.011215801685497	2881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.49816075923	2856.49816075923
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTAGCACAG"	-0.608354250819045	-15.8311004868713	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTAGCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.34733831638	30.8986722511966	0.0110417573358805	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.09953753122	2790.09953753122
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTGAATGAT"	-1.9688552421635	-15.3342142335144	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTGAATGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.23674941845	31.3256798472813	0.0113653806603844	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.81402865599	2748.81402865599
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTGCATGTT"	-1.3664564889973	-16.1881075135437	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTGCATGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2944.73780043958	39.2895599043798	0.0133422948211263	3211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2936.50510798816	2936.50510798816
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTTGTCTAG"	0.170161050825757	-15.9906244507995	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTTGTCTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2738.66549788277	42.4720984991475	0.0155083191181918	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2728.33992049466	2728.33992049466
"AML-0024"	"2020-09-15-AML0024:GCTACAAGTTTGATCG"	-1.82282684269603	-16.3223924866882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACAAGTTTGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.81351622864	40.0696634923238	0.0174838237092963	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2280.37330357647	2280.37330357647
"AML-0024"	"2020-09-15-AML0024:GCTACCTAGCGGTAGT"	-1.82099817219432	11.1593322523865	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTAGCGGTAGT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1876.10854597785	32.2017232681892	0.0171641045701891	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1872.42851860449	1872.42851860449
"AML-0024"	"2020-09-15-AML0024:GCTACCTAGGCTCAAG"	-2.24492750588115	-16.2354498139587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTAGGCTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.68769522279	32.5348550833583	0.0122188025061032	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.52366284006	2654.52366284006
"AML-0024"	"2020-09-15-AML0024:GCTACCTAGGTCATTC"	-0.635850052267867	-15.7532978287903	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTAGGTCATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2929.19750092878	40.0248977618916	0.0136641171341982	2879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.81674787277	2920.81674787277
"AML-0024"	"2020-09-15-AML0024:GCTACCTAGTACAACA"	-1.73161147061046	-16.8780050507751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTAGTACAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.04106847411	36.6998200399321	0.0148339574906762	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.30406460628	2468.30406460628
"AML-0024"	"2020-09-15-AML0024:GCTACCTAGTCTGGTT"	-1.58859680119212	-15.1855449906555	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTAGTCTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.16163840032	36.0411552546666	0.0140120102549548	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.82850872286	2561.82850872286
"AML-0024"	"2020-09-15-AML0024:GCTACCTTCCAGCACG"	-0.748033563525039	-16.1873293153015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTTCCAGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.17353179755	34.4587838836221	0.0122143439583691	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.72058030979	2815.72058030979
"AML-0024"	"2020-09-15-AML0024:GCTACCTTCGCTTAAG"	-0.985604504973251	-16.4411821595398	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTTCGCTTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.16565176627	35.4660582757565	0.0133272644084434	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.25665028336	2654.25665028336
"AML-0024"	"2020-09-15-AML0024:GCTACCTTCGTCGATA"	-2.53121958199199	-16.0603628388611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTACCTTCGTCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.99277583151	37.7247907887488	0.0139052308302541	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.80597175537	2703.80597175537
"AML-0024"	"2020-09-15-AML0024:GCTCAAAAGAGGCTGT"	-0.791351537138778	-15.9141712418762	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAAAGAGGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.73245682059	37.2566686177896	0.0135196972861343	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.84256122087	2749.84256122087
"AML-0024"	"2020-09-15-AML0024:GCTCAAACAAGAGTTA"	-2.84444675865825	-15.6874895325867	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAACAAGAGTTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3009.78345152329	39.0206887809327	0.0129646166939963	2972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3000.64907471798	3000.64907471798
"AML-0024"	"2020-09-15-AML0024:GCTCAAACACGCTATA"	-0.438213388354141	-16.3021745911804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAACACGCTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.86291764428	33.2795707365226	0.0119673539193059	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.56950385742	2773.56950385742
"AML-0024"	"2020-09-15-AML0024:GCTCAAACAGTCGAGA"	-1.11004767838176	-16.3776903382507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAACAGTCGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.01587447774	42.7573513438303	0.0159541410746914	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.53547251222	2670.53547251222
"AML-0024"	"2020-09-15-AML0024:GCTCAAATCCCTCATG"	-0.0449064997142136	-16.4583158723083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAATCCCTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.56929876545	26.5893595897074	0.00965632482960521	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.75939094015	2742.75939094015
"AML-0024"	"2020-09-15-AML0024:GCTCAAATCCTGTAAG"	-0.684705655009109	-16.1196222535339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAATCCTGTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.77918672076	33.3042126009512	0.0124187005275685	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.13439825594	2674.13439825594
"AML-0024"	"2020-09-15-AML0024:GCTCAAATCTAACGCA"	-1.45461271229442	9.25428102100221	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000796178343949045	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTCAAATCTAACGCA"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1740.74915505734	52.224380815713	0.0300010950250857	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1739.26530097119	1739.26530097119
"AML-0024"	"2020-09-15-AML0024:GCTGAATAGCAAACAT"	9.59904350814168	7.39248273456422	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATAGCAAACAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1750.38075711281	29.9507302572929	0.0171109800742414	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1741.41555202171	1741.41555202171
"AML-0024"	"2020-09-15-AML0024:GCTGAATAGCCAGACA"	-1.6106325191563	-16.5095262757507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATAGCCAGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.49662633802	37.4172060326019	0.0131866962185225	2762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2825.5416498322	2825.5416498322
"AML-0024"	"2020-09-15-AML0024:GCTGAATAGTAGTGCG"	-0.477889875799972	-15.9728784791199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATAGTAGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.38397572816	36.1470468580442	0.0156930182891531	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2296.87896000395	2296.87896000395
"AML-0024"	"2020-09-15-AML0024:GCTGAATAGTATAACG"	-2.62346063080485	-15.9698171845642	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.09088674803	35.0657841595782	0.0128724721815134	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.78574329604	2714.78574329604
"AML-0024"	"2020-09-15-AML0024:GCTGAATGTAATTGGA"	0.206599821417969	-16.0707712403503	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATGTAATTGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3095.95299658814	43.1296374147915	0.0139309729386467	2906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3088.27871808011	3088.27871808011
"AML-0024"	"2020-09-15-AML0024:GCTGAATGTATCAAGA"	-2.45178614082988	-16.3715524903503	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATGTATCAAGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.90035070805	38.4140529848655	0.0158284426361627	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2417.05482759371	2417.05482759371
"AML-0024"	"2020-09-15-AML0024:GCTGAATGTCGTATGT"	-0.172905619174796	-16.4738512269226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATGTCGTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.88003860704	32.3511147688089	0.0111868799317111	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.62572678274	2878.62572678274
"AML-0024"	"2020-09-15-AML0024:GCTGAATGTTTCTTAC"	-1.1015274328297	-16.193310760614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATGTTTCTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.18722705502	45.4035631589872	0.0193026994776403	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.53247120612	2345.53247120612
"AML-0024"	"2020-09-15-AML0024:GCTGAATTCCAGTGCG"	-1.84117565575297	-15.83549692547	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATTCCAGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.16841508851	35.9148186300722	0.0141331910222178	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.00461159215	2529.00461159215
"AML-0024"	"2020-09-15-AML0024:GCTGAATTCCATTCAT"	-1.80617402020152	-16.1631937257019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATTCCATTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.50070141898	35.7038524503143	0.0129151178843934	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.75354112456	2755.75354112456
"AML-0024"	"2020-09-15-AML0024:GCTGAATTCGGACCAC"	-1.1675845188206	-16.5471792451111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGAATTCGGACCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.50433881173	31.4266351593916	0.012689917262358	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2473.16032798288	2473.16032798288
"AML-0024"	"2020-09-15-AML0024:GCTGCAGAGGCATCTT"	-1.13530848446544	-16.10609533703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGAGGCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.15329974338	35.6914311630655	0.0128379363707606	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.03276340336	2776.03276340336
"AML-0024"	"2020-09-15-AML0024:GCTGCAGAGGTCCCTG"	-0.359524796635467	-15.8151283494202	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGAGGTCCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.11978677761	36.2340902324849	0.012875816588453	2551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.07023641969	2809.07023641969
"AML-0024"	"2020-09-15-AML0024:GCTGCAGCATCGGATT"	-2.01760302010234	-15.5856189957825	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGCATCGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.70952962295	31.0684919293363	0.0116943503167791	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.22047623312	2646.22047623312
"AML-0024"	"2020-09-15-AML0024:GCTGCAGGTAGCTAAA"	-1.54190991345103	-16.8485517731872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGGTAGCTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.36723615756	33.9076915666756	0.0128080800818136	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.57165647876	2637.57165647876
"AML-0024"	"2020-09-15-AML0024:GCTGCAGGTCGTACTA"	-2.13660369339641	-15.6831341019836	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGGTCGTACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2522.65810324898	34.0180117025785	0.013484986990019	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.36235841116	2515.36235841116
"AML-0024"	"2020-09-15-AML0024:GCTGCAGTCACAACCA"	-2.91259417954143	-15.7634897462097	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGTCACAACCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2917.01675049403	44.0836928158692	0.0151125950196903	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2907.80639781179	2907.80639781179
"AML-0024"	"2020-09-15-AML0024:GCTGCAGTCATTTACC"	-2.16127095642741	-15.9389066926208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGTCATTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.39095462464	44.1331175640482	0.0157765283008038	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.76420997352	2788.76420997352
"AML-0024"	"2020-09-15-AML0024:GCTGCAGTCCGTGCGA"	-1.45242915573772	-15.7126856080261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGTCCGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.14815049944	29.9702978494943	0.0118687285114604	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.38484935771	2518.38484935771
"AML-0024"	"2020-09-15-AML0024:GCTGCAGTCGTTCTCG"	-1.81443474713023	-16.7305078736511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGCAGTCGTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.97638257992	44.5638126161076	0.0185684379811282	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2390.26526473745	2390.26526473745
"AML-0024"	"2020-09-15-AML0024:GCTGGGTAGGAGAGTA"	-1.33575878563579	-16.1293897858826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGGGTAGGAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.39175930085	46.7471523882355	0.0186363044029713	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.91821096392	2502.91821096392
"AML-0024"	"2020-09-15-AML0024:GCTGGGTGTAATGTGA"	-2.64429245415385	-16.1711912385193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGGGTGTAATGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.86455011706	38.8909359634995	0.0150747976135936	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.11668949296	2572.11668949296
"AML-0024"	"2020-09-15-AML0024:GCTGGGTGTCTCGGGT"	-1.95730886879619	-16.6935281983581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGGGTGTCTCGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.73149458067	38.4034899614821	0.0153815057986169	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2492.9305008637	2492.9305008637
"AML-0024"	"2020-09-15-AML0024:GCTGGGTTCCATGAGT"	-2.49424133721049	-15.4007425538269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTGGGTTCCATGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.78235962149	34.0695260956004	0.0117692875881885	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.05849361292	2890.05849361292
"AML-0024"	"2020-09-15-AML0024:GCTTCACAGAGCAGCT"	-0.722133736044723	-16.3863401643005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTCACAGAGCAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.10649728548	34.1844294558856	0.0127501199562554	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.39941659946	2670.39941659946
"AML-0024"	"2020-09-15-AML0024:GCTTCACAGGAGGTTC"	-2.85407171669658	-16.1897840729919	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTCACAGGAGGTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.07939919295	51.0143898659571	0.0197570957275373	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.49641496087	2573.49641496087
"AML-0024"	"2020-09-15-AML0024:GCTTCACAGTCATGGG"	-1.1988893550938	-15.9301071397034	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTCACAGTCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.26441481925	26.8661853117854	0.011603938254233	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2309.58730607541	2309.58730607541
"AML-0024"	"2020-09-15-AML0024:GCTTCACCACTACCCT"	-1.45259151879008	-16.3437261811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTCACCACTACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.1419034878	34.2973822510216	0.0125532946173983	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.67905793633	2725.67905793633
"AML-0024"	"2020-09-15-AML0024:GCTTCACGTACCACGC"	0.0184904235297858	-15.8590202561584	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTCACGTACCACGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2752.92239554595	39.8177492781111	0.0144638110186228	2752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2748.77190823673	2748.77190823673
"AML-0024"	"2020-09-15-AML0024:GCTTGGGAGTAAATGC"	-0.930856506258804	-16.1091280213562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTGGGAGTAAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.19474258758	32.5645340279862	0.0127995445800137	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.83272245093	2536.83272245093
"AML-0024"	"2020-09-15-AML0024:GCTTGGGCACTGGACC"	-1.00096176090892	-15.5133352509704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTGGGCACTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.88761332983	39.8958832747884	0.0145399115769079	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.54293775265	2737.54293775265
"AML-0024"	"2020-09-15-AML0024:GCTTGGGCAGTGCGCT"	-0.704840640456039	-15.9062805405823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTGGGCAGTGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.47325155063	35.6404201128954	0.0132913576864081	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.49820959046	2671.49820959046
"AML-0024"	"2020-09-15-AML0024:GCTTGGGGTATTCTCT"	-2.36425481262859	9.79262158954469	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTGGGGTATTCTCT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1993.29041717372	40.9799331169546	0.020558937505484	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1991.61338019837	1991.61338019837
"AML-0024"	"2020-09-15-AML0024:GCTTGGGGTTCGAACT"	-0.990937332541305	-16.2328081361023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTGGGGTTCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.77673573345	33.6499896067183	0.0129883787910393	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.00364865541	2583.00364865541
"AML-0024"	"2020-09-15-AML0024:GCTTTCGAGCATTGTC"	-0.00104154172595147	-16.4710111848083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGAGCATTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.75248541314	42.8027561191769	0.0162949331377314	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.05956056988	2619.05956056988
"AML-0024"	"2020-09-15-AML0024:GCTTTCGAGCCGGAAT"	-2.43239984932597	-15.6026792756286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGAGCCGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.99594609098	35.768990106887	0.0128943916292637	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.55613014109	2769.55613014109
"AML-0024"	"2020-09-15-AML0024:GCTTTCGAGGTAGTAT"	-1.4628817838734	-16.074830078241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGAGGTAGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.98338882001	34.85194343306	0.0126781207826869	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.53574438965	2742.53574438965
"AML-0024"	"2020-09-15-AML0024:GCTTTCGAGTCCTGCG"	-1.31844351711925	-15.7004814377991	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGAGTCCTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.42455559757	33.1252594323105	0.0115001308983906	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.35023964411	2873.35023964411
"AML-0024"	"2020-09-15-AML0024:GCTTTCGGTGCACGCT"	-1.87144527855571	-16.3170423737732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGGTGCACGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2857.93833688675	33.7715936867845	0.0118167677905791	2605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2851.66239099825	2851.66239099825
"AML-0024"	"2020-09-15-AML0024:GCTTTCGGTGGTCCCA"	-0.940917472273666	-16.7564554444519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GCTTTCGGTGGTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.68244997266	42.2702130741795	0.0150391279792531	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.3830510277	2800.3830510277
"AML-0024"	"2020-09-15-AML0024:GGAACCCAGCCTGAAG"	-2.23051391068156	-16.2056761018005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCAGCCTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.70486584926	37.0308885179872	0.0145865275700724	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.08865154426	2533.08865154426
"AML-0024"	"2020-09-15-AML0024:GGAACCCAGGAGAGGC"	-3.03720364990886	11.4931287535462	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCAGGAGAGGC"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2200.81584422248	34.9372750418945	0.0158746926207438	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2199.26355636029	2199.26355636029
"AML-0024"	"2020-09-15-AML0024:GGAACCCCATACATCG"	-1.61360679093059	-15.5395422211853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCCATACATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.55521701239	35.8494212286913	0.0137747014911925	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.96171737395	2598.96171737395
"AML-0024"	"2020-09-15-AML0024:GGAACCCGTCCGGCAT"	-2.76271877709087	-15.8163891068664	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCGTCCGGCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.82997092253	38.5056573901919	0.014862286534566	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.48915219265	2583.48915219265
"AML-0024"	"2020-09-15-AML0024:GGAACCCTCCACCTCA"	-1.94040117684062	-15.594659828302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCTCCACCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.30363631286	36.3099229805295	0.0137261834452924	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.19774126409	2639.19774126409
"AML-0024"	"2020-09-15-AML0024:GGAACCCTCGTTCCCA"	-1.54943821850474	-16.240185760614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAACCCTCGTTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.68440123742	37.6321329352493	0.0150067260922785	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.40896623788	2500.40896623788
"AML-0024"	"2020-09-15-AML0024:GGAAGTGAGCAAACAT"	-0.967059711844283	-17.5314207307068	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGAGCAAACAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2794.20389912364	39.6531483827098	0.0141912150345028	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2789.93609680248	2789.93609680248
"AML-0024"	"2020-09-15-AML0024:GGAAGTGAGTACGTCT"	-2.85979948464091	-15.8496389619079	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGAGTACGTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2288.38241198949	41.3948363410624	0.0180891253682877	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2286.73386099797	2286.73386099797
"AML-0024"	"2020-09-15-AML0024:GGAAGTGGTGGCTCTG"	-2.26063499870952	-15.5058336487976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGGTGGCTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.10209426188	38.6675369846636	0.0173778709230376	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2217.69973639971	2217.69973639971
"AML-0024"	"2020-09-15-AML0024:GGAAGTGGTGGCTGCT"	0.253588114946526	-16.2028951874939	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGGTGGCTGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2974.41542913867	36.386034133623	0.0122330034255368	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2970.89787967307	2970.89787967307
"AML-0024"	"2020-09-15-AML0024:GGAAGTGTCACGGGCT"	-1.37889609757121	-16.2970094910828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGTCACGGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.64655274472	40.0937114870571	0.0149790832285808	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.45885525534	2672.45885525534
"AML-0024"	"2020-09-15-AML0024:GGAAGTGTCCACTGAA"	-1.41590688648875	-15.9710531464783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGTCCACTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.17437030824	33.9093822370943	0.0131168646210318	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.00649924977	2577.00649924977
"AML-0024"	"2020-09-15-AML0024:GGAAGTGTCTTTCAGT"	-2.85024748268779	-15.9162664643494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAAGTGTCTTTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.15756242197	35.7498387702981	0.0130657091028973	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.97072294029	2729.97072294029
"AML-0024"	"2020-09-15-AML0024:GGAATCTAGAGAGCCT"	-0.0903265279835046	-16.2083463898865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTAGAGAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.84710301647	33.5808966282845	0.0120368233054692	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.94945304328	2774.94945304328
"AML-0024"	"2020-09-15-AML0024:GGAATCTAGCCTCCAG"	0.169680287211579	-16.1888094178406	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTAGCCTCCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2890.51783941917	43.1854132125786	0.0149403724909224	3286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2883.47517673826	2883.47517673826
"AML-0024"	"2020-09-15-AML0024:GGAATCTAGCTAGTTC"	-2.78273425522502	-16.1246366730896	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTAGCTAGTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.15327608416	36.6769341941933	0.0139183304922191	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.5655639982	2628.5655639982
"AML-0024"	"2020-09-15-AML0024:GGAATCTAGGAGTATT"	-1.84193609181102	-16.0108022919861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTAGGAGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.53619923697	33.6022252718439	0.0118170555665374	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.81364132977	2835.81364132977
"AML-0024"	"2020-09-15-AML0024:GGAATCTCAACTCCAA"	-2.80920086327251	11.4338207014832	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTCAACTCCAA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1867.32020162463	30.4555776307934	0.0163097778325839	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1865.54683543956	1865.54683543956
"AML-0024"	"2020-09-15-AML0024:GGAATCTCAAGGTCAG"	-1.11565003815349	-16.1274824372497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTCAAGGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.44069580038	37.3742842838248	0.0132418315606898	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.7686317556	2815.7686317556
"AML-0024"	"2020-09-15-AML0024:GGAATCTCAATTTCTC"	0.0548115643555343	-16.0650129548279	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTCAATTTCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2692.86074513284	41.2473472549476	0.015317296792825	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2684.88384908224	2684.88384908224
"AML-0024"	"2020-09-15-AML0024:GGAATCTCACTGTGAT"	-1.79175756397899	-16.138623260614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTCACTGTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.16195214112	35.4161575578679	0.0152645195845853	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2313.99154976623	2313.99154976623
"AML-0024"	"2020-09-15-AML0024:GGAATCTGTAGCTGAG"	-1.69621727886851	-15.6602850190369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTGTAGCTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.68615440908	31.5849213743466	0.0106143322028592	3353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2968.03240189962	2968.03240189962
"AML-0024"	"2020-09-15-AML0024:GGAATCTGTCAGCTTA"	-1.64916024628337	-15.5315504304138	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTGTCAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.23081823258	27.0324474575701	0.0101009402004505	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.60540534461	2669.60540534461
"AML-0024"	"2020-09-15-AML0024:GGAATCTGTTTACGAC"	-0.725862543017227	-16.4758997193542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTGTTTACGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.47661733189	37.0067468678333	0.0147703421424232	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2499.1717644584	2499.1717644584
"AML-0024"	"2020-09-15-AML0024:GGAATCTTCGCTTACC"	-1.73731611195262	-16.4700060120788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTTCGCTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.04031929864	34.1854858631269	0.013485184280061	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.19994329196	2531.19994329196
"AML-0024"	"2020-09-15-AML0024:GGAATCTTCGGAACTT"	-2.73936567726787	-15.9701528779236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTTCGGAACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.86944834326	37.4048821205604	0.0152432241844872	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.01509173671	2449.01509173671
"AML-0024"	"2020-09-15-AML0024:GGAATCTTCTCTTGCG"	-1.31415806236919	-16.1068697205749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATCTTCTCTTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.42014944117	36.1631683342821	0.013086380781292	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.09081288611	2758.09081288611
"AML-0024"	"2020-09-15-AML0024:GGAATGGAGCACTTTG"	11.4237762885982	-1.48078229343566	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATGGAGCACTTTG"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1270.12654601827	34.8748446071387	0.0274577716027338	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1264.15983569287	1264.15983569287
"AML-0024"	"2020-09-15-AML0024:GGAATGGAGTCTTCGA"	-2.20302186432536	-15.5086584321228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATGGAGTCTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.74493105615	33.2500224388129	0.0116554487843759	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2848.14802639232	2848.14802639232
"AML-0024"	"2020-09-15-AML0024:GGAATGGCAGGAATCG"	-2.37709770622905	-16.1593294373718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATGGCAGGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.89268658396	37.3810647340612	0.0129083045470709	2974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.84526872891	2884.84526872891
"AML-0024"	"2020-09-15-AML0024:GGAATGGGTGCATTAC"	-1.94080684605296	-15.6827488175598	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAATGGGTGCATTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.17979972721	41.3370115479609	0.0150415964603422	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.95393748428	2741.95393748428
"AML-0024"	"2020-09-15-AML0024:GGACGTCAGGATACCG"	-0.903776327998	-15.7203903428284	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGACGTCAGGATACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.26460786747	36.0839896074283	0.0127628625587491	2957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.65116327933	2815.65116327933
"AML-0024"	"2020-09-15-AML0024:GGACGTCCACTGGATT"	-1.78486464443858	-16.608614944574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGACGTCCACTGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.86802220893	38.6075704159547	0.0139333848117302	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.88352629987	2762.88352629987
"AML-0024"	"2020-09-15-AML0024:GGACGTCTCGTCGACG"	-1.01918325844463	-15.692557357904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGACGTCTCGTCGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.11685307373	34.9239605613909	0.0137760752602181	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.45094426369	2531.45094426369
"AML-0024"	"2020-09-15-AML0024:GGACGTCTCTTCGCTG"	-1.18113217774089	-16.0715151063171	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGACGTCTCTTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.83247269278	40.5441750715513	0.013862050373854	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2918.82234284233	2918.82234284233
"AML-0024"	"2020-09-15-AML0024:GGAGAACAGGGTTTCT"	-1.70173190060313	-16.3708620301453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGAACAGGGTTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2487.14428369106	36.5131917899744	0.0146807694388308	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.55353231569	2481.55353231569
"AML-0024"	"2020-09-15-AML0024:GGAGAACCAACCCTCT"	-0.574604432017165	-16.3669119111267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGAACCAACCCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.61178404211	32.1240385754585	0.0124966510987301	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.18359000403	2558.18359000403
"AML-0024"	"2020-09-15-AML0024:GGAGAACCAACTCCAA"	-0.689016620547134	-16.3962660065857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGAACCAACTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.20008023065	34.4942318696752	0.012889257467888	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.39871880071	2670.39871880071
"AML-0024"	"2020-09-15-AML0024:GGAGAACGTCCGGCAT"	-2.02185259285625	-15.5107851258484	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGAACGTCCGGCAT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2350.39265115248	47.092308284744	0.0200359324054443	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2341.51186484644	2341.51186484644
"AML-0024"	"2020-09-15-AML0024:GGAGAACGTTCGTGCG"	-1.13980541649516	-16.2513418427673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGAACGTTCGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.14491951727	34.3418442542606	0.014189994978115	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.93136399205	2413.93136399205
"AML-0024"	"2020-09-15-AML0024:GGAGATGAGAGCCTGA"	-2.20287952843364	-16.1624326935974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGATGAGAGCCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.09953249525	35.0343444624687	0.0122579161656705	2892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.36058521856	2849.36058521856
"AML-0024"	"2020-09-15-AML0024:GGAGATGAGTGCAACG"	-0.442402194172698	-16.1147737733093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGATGAGTGCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.26209552151	37.0361008375668	0.0129259033215339	2891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.08370830233	2856.08370830233
"AML-0024"	"2020-09-15-AML0024:GGAGATGGTACAAACA"	-1.61072216454204	-16.8191824189392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGATGGTACAAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.91339212043	33.4274811154191	0.0135448355773531	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.96964398542	2462.96964398542
"AML-0024"	"2020-09-15-AML0024:GGAGCAACAGACGCTC"	-0.566077570349532	-16.1811361542908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAACAGACGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.71190835364	30.4479755748504	0.012136896019612	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2499.67740034322	2499.67740034322
"AML-0024"	"2020-09-15-AML0024:GGAGCAAGTCTTCATT"	0.020306252955836	-16.4703054658142	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAAGTCTTCATT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2553.37329318849	41.0434081639587	0.0160741902774061	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2543.13357762378	2543.13357762378
"AML-0024"	"2020-09-15-AML0024:GGAGCAAGTGACCGTC"	-0.836215536028701	-15.7298107377258	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAAGTGACCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.20316357848	35.1459774020529	0.013231660094367	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.83727139968	2651.83727139968
"AML-0024"	"2020-09-15-AML0024:GGAGCAAGTGTCCGGT"	-2.96041164818462	-16.0272512665954	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAAGTGTCCGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.33510517612	37.3473608571277	0.014847866902614	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.76986463266	2511.76986463266
"AML-0024"	"2020-09-15-AML0024:GGAGCAATCTCCATAT"	-1.32994220677074	-15.9579553834167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAATCTCCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.3340824559	38.9679234800712	0.0148317352331706	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.52864421312	2623.52864421312
"AML-0024"	"2020-09-15-AML0024:GGAGCAATCTGTGCTC"	-2.58728871765788	-15.8707876435486	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGCAATCTGTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2907.99670749075	38.036033193568	0.0130798061413173	2635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.47584682126	2901.47584682126
"AML-0024"	"2020-09-15-AML0024:GGAGGATAGCAGGCAT"	-0.677037159830886	-16.4258699647156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATAGCAGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.6724181748	37.6281344171626	0.0131398180107295	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.02072105267	2856.02072105267
"AML-0024"	"2020-09-15-AML0024:GGAGGATAGGTTTACC"	-1.86669383469279	-16.5759763947693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATAGGTTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.32472380619	32.7911446697568	0.0128274566859147	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.24720665537	2549.24720665537
"AML-0024"	"2020-09-15-AML0024:GGAGGATCAAGACTGG"	-0.704392234713394	-15.7813472977844	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATCAAGACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.02007739405	30.1251915483895	0.010994514893132	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.85910638279	2736.85910638279
"AML-0024"	"2020-09-15-AML0024:GGAGGATCAGACAAGC"	0.395818849175614	-16.3013487092224	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATCAGACAAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2944.34880275387	39.4248375127286	0.0133900023923301	2875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2936.19352192253	2936.19352192253
"AML-0024"	"2020-09-15-AML0024:GGAGGATCATAATGAG"	-1.5189040702885	-16.9387197724548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATCATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.40404992691	38.3535615178616	0.0156583237130705	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2438.76724052096	2438.76724052096
"AML-0024"	"2020-09-15-AML0024:GGAGGATGTAGGCTCC"	-0.755486587912399	-16.759997390863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATGTAGGCTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2869.79960878484	46.8728891333412	0.0163331575451669	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.49146841338	2863.49146841338
"AML-0024"	"2020-09-15-AML0024:GGAGGATGTCTGCATA"	-1.59338829937633	-15.5851898423401	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATGTCTGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.04401014776	29.8285165375944	0.0115210542658532	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.96831161662	2582.96831161662
"AML-0024"	"2020-09-15-AML0024:GGAGGATTCATTCATC"	-1.08165131035503	-17.3988313904968	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGATTCATTCATC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3081.40320157774	42.2843033311517	0.0137224181858127	2771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3074.48992821371	3074.48992821371
"AML-0024"	"2020-09-15-AML0024:GGAGGTAAGTATAGAC"	10.3641573387081	6.71462915027467	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTAAGTATAGAC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1600.9078904979	32.9571258861363	0.0205865222363832	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1598.98267894197	1598.98267894197
"AML-0024"	"2020-09-15-AML0024:GGAGGTAAGTATCCTG"	-0.923485974699813	-16.3974428406921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTAAGTATCCTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2346.39263513036	41.0300287115429	0.0174864292093482	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2337.93670493907	2337.93670493907
"AML-0024"	"2020-09-15-AML0024:GGAGGTAAGTCACTAC"	-1.88739571991618	-16.027991317865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTAAGTCACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.38292983941	38.7758117394881	0.0132142984288728	3026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2923.68157747988	2923.68157747988
"AML-0024"	"2020-09-15-AML0024:GGAGGTACACATGACT"	-0.609575430781204	-16.3424368134704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTACACATGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.42690947434	31.6215967930194	0.0127484493383926	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.08229258619	2475.08229258619
"AML-0024"	"2020-09-15-AML0024:GGAGGTAGTCAAGCCC"	-1.95074305954631	-16.8258314362732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTAGTCAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.02745906567	39.8724611173467	0.015784650706883	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.57388541767	2519.57388541767
"AML-0024"	"2020-09-15-AML0024:GGAGGTAGTGGCTTAT"	-2.17519793930705	13.6828183897766	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTAGTGGCTTAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1927.382600612	40.2659127020838	0.020891499533771	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1919.94759111723	1919.94759111723
"AML-0024"	"2020-09-15-AML0024:GGAGGTATCGGTGCAC"	-0.700187425047714	-15.8078088990417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTATCGGTGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.76814185107	35.407019154796	0.0133070667067457	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.33978188588	2648.33978188588
"AML-0024"	"2020-09-15-AML0024:GGAGGTATCTAGGAAA"	-1.69368443909343	-16.5117655030456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTATCTAGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.28353945158	39.5305632902273	0.0148260913384922	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.78708473426	2657.78708473426
"AML-0024"	"2020-09-15-AML0024:GGAGGTATCTCGGCTT"	-1.84582255306895	-15.5174999467102	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGAGGTATCTCGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.33536643983	39.3781664417935	0.0146151688955581	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.45357534188	2687.45357534188
"AML-0024"	"2020-09-15-AML0024:GGATCTAAGAAGCGGG"	-1.26448510113414	-16.4351511231628	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAAGAAGCGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.42257638316	33.5604066918795	0.0123500875364581	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.1877990303	2708.1877990303
"AML-0024"	"2020-09-15-AML0024:GGATCTAAGGAGTATT"	-0.276554684073287	-16.1984548798767	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAAGGAGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2936.42621764134	35.8942979212619	0.0122238037876169	2920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2928.02242061067	2928.02242061067
"AML-0024"	"2020-09-15-AML0024:GGATCTAAGTATAGGT"	0.0285715582663238	-16.1181688538757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAAGTATAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.81348560983	37.5370643008901	0.0141499070720613	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.83567564796	2640.83567564796
"AML-0024"	"2020-09-15-AML0024:GGATCTACAAGCACAG"	-0.989083866507369	-17.4602766267029	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTACAAGCACAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3117.23765961357	45.5190692452695	0.0146023737089434	2975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3105.96107009973	3105.96107009973
"AML-0024"	"2020-09-15-AML0024:GGATCTAGTCGAGCAA"	-0.423091064125854	-16.6021642914978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAGTCGAGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.76081534389	37.3691239261381	0.0137045844710165	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.95911407317	2719.95911407317
"AML-0024"	"2020-09-15-AML0024:GGATCTAGTCGCGTTG"	1.01561923798863	-16.2681207886902	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAGTCGCGTTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2732.69230753764	47.5619575872408	0.0174047979920936	2958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2720.05138695258	2720.05138695258
"AML-0024"	"2020-09-15-AML0024:GGATCTAGTCTGTTAG"	-2.54954610291179	-15.7737684479919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATCTAGTCTGTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1988.42963242926	48.2942959873709	0.0242876565505463	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1983.41751423367	1983.41751423367
"AML-0024"	"2020-09-15-AML0024:GGATGTTAGACATCCT"	-0.46939984980281	-16.3597440949646	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTAGACATCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.46817368945	39.0084152504386	0.013449006475675	2946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2889.52119575748	2889.52119575748
"AML-0024"	"2020-09-15-AML0024:GGATGTTAGACTTGTC"	-1.69345901432689	-16.9151029816833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTAGACTTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.28689188553	36.8150217629667	0.0150431981983944	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.34220932171	2441.34220932171
"AML-0024"	"2020-09-15-AML0024:GGATGTTAGAGAGTGA"	-0.992036561400253	-17.4205579987732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTAGAGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.47840983328	42.9826737779267	0.0154810041474472	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.29257714355	2764.29257714355
"AML-0024"	"2020-09-15-AML0024:GGATGTTCACGCGTCA"	-2.69234500351604	-15.6696624985901	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTCACGCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.04215766112	45.7693188376312	0.0182708776767113	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.26134507781	2498.26134507781
"AML-0024"	"2020-09-15-AML0024:GGATGTTCAGACGATG"	-0.708090106875259	-16.7072134247986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTCAGACGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.4622727434	34.7163465986017	0.0134535377499216	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.96764669198	2573.96764669198
"AML-0024"	"2020-09-15-AML0024:GGATGTTCAGTTAGAA"	-0.270349035889465	-16.3868303528992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTCAGTTAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.22825183692	35.9517974445056	0.0126180826058169	3044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.97578891129	2842.97578891129
"AML-0024"	"2020-09-15-AML0024:GGATGTTTCGAGAAAT"	-2.25471983376201	-16.2587843171326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTTCGAGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.252081629	36.7540499857446	0.0143893589243174	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2545.72998514086	2545.72998514086
"AML-0024"	"2020-09-15-AML0024:GGATGTTTCGCCTATC"	-2.08015380325969	-15.482092880365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGATGTTTCGCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.88597525052	34.8224485368902	0.012441538828238	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.23608795592	2794.23608795592
"AML-0024"	"2020-09-15-AML0024:GGCACGTAGAAACACT"	-1.28930066052135	-15.5639181367126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCACGTAGAAACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.25204948985	35.404997689069	0.0134147845772868	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.54515599639	2634.54515599639
"AML-0024"	"2020-09-15-AML0024:GGCACGTCACGAAAGC"	-1.92749379101451	-15.9085760346619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCACGTCACGAAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.33196696589	37.0887073403107	0.0144183207364396	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.10110831227	2562.10110831227
"AML-0024"	"2020-09-15-AML0024:GGCACGTCACTGCGTG"	-1.32723210278209	-16.2041807404724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCACGTCACTGCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.06897132578	41.4513196616093	0.0160286984304052	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.55282241497	2580.55282241497
"AML-0024"	"2020-09-15-AML0024:GGCACGTCATGTGACT"	-0.653306166560012	-16.336096786615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCACGTCATGTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.61904394831	34.6293278702745	0.0125850734848036	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.17909078601	2743.17909078601
"AML-0024"	"2020-09-15-AML0024:GGCACGTGTTGGGATG"	-0.980163435370284	-16.1074819794861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCACGTGTTGGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.84778776387	35.3565270791182	0.0126596684695899	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.6675632497	2785.6675632497
"AML-0024"	"2020-09-15-AML0024:GGCAGTCAGCAGGCTA"	-0.29200572791751	-15.8557796708313	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCAGTCAGCAGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.92086704336	36.4937715551268	0.0126586102214293	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.36198219443	2876.36198219443
"AML-0024"	"2020-09-15-AML0024:GGCAGTCAGTGGTCAG"	-0.356352816254455	-16.2475290528503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCAGTCAGTGGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3104.81054210263	39.4660601850042	0.012711261975514	4099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3097.55322160589	3097.55322160589
"AML-0024"	"2020-09-15-AML0024:GGCAGTCCACTTGTCC"	-2.16154537621196	-15.9413423768249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCAGTCCACTTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.37205310171	33.473999405639	0.0133289686664691	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.14879836538	2505.14879836538
"AML-0024"	"2020-09-15-AML0024:GGCAGTCCATGCGTGC"	-1.73623381081279	-16.280785583612	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCAGTCCATGCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.11944645281	36.4213417542748	0.0141655580430239	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.44724753613	2562.44724753613
"AML-0024"	"2020-09-15-AML0024:GGCAGTCGTACGTGAG"	-2.31425652924235	-15.9969034424988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCAGTCGTACGTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.10536517576	37.4068143592721	0.014442197936119	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.02760967538	2585.02760967538
"AML-0024"	"2020-09-15-AML0024:GGCGTCAAGACTTAAG"	-2.36102972450908	-15.7797374955383	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAAGACTTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.90963271222	33.6482976540801	0.0138990308433706	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2418.84150979001	2418.84150979001
"AML-0024"	"2020-09-15-AML0024:GGCGTCAAGAGCCTGA"	-0.850968102843124	-15.7895088425842	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAAGAGCCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.51852545912	38.9550040400454	0.0145326374990724	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.59165679849	2671.59165679849
"AML-0024"	"2020-09-15-AML0024:GGCGTCAAGATCGCTT"	-1.87386701527293	-16.8497057191101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAAGATCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.09298653941	37.6634232195771	0.0151374660928415	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.07401234503	2476.07401234503
"AML-0024"	"2020-09-15-AML0024:GGCGTCAAGCAGATAT"	-2.09357724610026	-15.5643987885681	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAAGCAGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.80726487902	43.1036738711357	0.0162851577608564	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.24327483444	2643.24327483444
"AML-0024"	"2020-09-15-AML0024:GGCGTCAAGGTGATCG"	-3.15935073319133	9.92250726306764	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAAGGTGATCG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1975.76296017673	36.8017118692539	0.0186265825460976	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1972.33797962648	1972.33797962648
"AML-0024"	"2020-09-15-AML0024:GGCGTCAGTACCAATC"	-2.22648415985759	-16.0074129334656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAGTACCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.97775477164	42.4429216726378	0.0183103231190496	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2309.81796856391	2309.81796856391
"AML-0024"	"2020-09-15-AML0024:GGCGTCAGTGCGTTTA"	-0.942077736288863	-15.9633474580017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCAGTGCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.45207465749	41.6644931755191	0.0148884068992386	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.68081113628	2791.68081113628
"AML-0024"	"2020-09-15-AML0024:GGCGTCATCCACCTGT"	-1.4576133293217	-15.5335827103821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCATCCACCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.25502610741	31.5997011562208	0.0120184998573546	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.77970091943	2624.77970091943
"AML-0024"	"2020-09-15-AML0024:GGCGTCATCCGTAGGC"	-0.191752429038841	-16.0718279114929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCATCCGTAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.9568193867	41.5725460791661	0.014810539938498	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.67161722781	2801.67161722781
"AML-0024"	"2020-09-15-AML0024:GGCGTCATCGTAGCTA"	-0.624350647360641	-16.2649641267029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCATCGTAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2551.2958576449	39.260324794305	0.0153883857400004	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.76884064565	2537.76884064565
"AML-0024"	"2020-09-15-AML0024:GGCGTCATCTTTGCTA"	-1.98616562309917	-16.7023134461609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCGTCATCTTTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2841.17011805597	38.7745285901603	0.0136473801212197	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.36731488627	2832.36731488627
"AML-0024"	"2020-09-15-AML0024:GGCTGTGAGCCTGAAG"	-1.26514182511027	-16.2269106141296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGAGCCTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2505.36346982802	37.468742163138	0.0149554117054761	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.08719259267	2498.08719259267
"AML-0024"	"2020-09-15-AML0024:GGCTGTGCATAATCCG"	-3.18838582459148	11.2772540816101	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGCATAATCCG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1794.62309844997	36.9591943449087	0.0205944046840981	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1792.76681476479	1792.76681476479
"AML-0024"	"2020-09-15-AML0024:GGCTGTGCATCGTTCC"	-1.02452359619792	-16.1111898652283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGCATCGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.92486044688	37.5473334023078	0.0147886745241051	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.72607515994	2533.72607515994
"AML-0024"	"2020-09-15-AML0024:GGCTGTGCATCTGCGG"	-1.89937828007396	-16.1631136170593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGCATCTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.86434866885	44.8408206314117	0.0176132010548235	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.30140002183	2538.30140002183
"AML-0024"	"2020-09-15-AML0024:GGCTGTGGTCGAAGCA"	-2.16231117668803	-15.992117904779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGGTCGAAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.51734775976	33.71660951011	0.015008390450994	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2243.01033331285	2243.01033331285
"AML-0024"	"2020-09-15-AML0024:GGCTGTGGTGTCTAAC"	-2.25226579132732	-16.5510206452576	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGGTGTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.19963766298	36.1105903886009	0.0135134328586999	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.49913050387	2660.49913050387
"AML-0024"	"2020-09-15-AML0024:GGCTGTGGTGTTTACG"	-1.14993009987529	-16.7549753419128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTGTGGTGTTTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.37414714259	39.0394140166219	0.0159515512011933	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.86980380825	2442.86980380825
"AML-0024"	"2020-09-15-AML0024:GGCTTGGAGGGTTAAT"	-1.12479124489482	-16.3636427155701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGAGGGTTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.33009646087	37.5702195200263	0.0141223901387302	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.83545825924	2653.83545825924
"AML-0024"	"2020-09-15-AML0024:GGCTTGGAGGTGCATG"	-1.76465008679088	-16.5491571656433	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGAGGTGCATG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.69572232815	41.3425754098033	0.0151677148227281	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.45280210592	2712.45280210592
"AML-0024"	"2020-09-15-AML0024:GGCTTGGAGTCACGAG"	-0.750903586775619	-15.6491794816223	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGAGTCACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.49868574264	40.0673216528537	0.0152318348874377	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.15041121846	2626.15041121846
"AML-0024"	"2020-09-15-AML0024:GGCTTGGAGTCATGGG"	-1.72867379608806	-16.5194978944031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGAGTCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.67687193553	40.2927153462952	0.0143765111667935	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.90711349233	2794.90711349233
"AML-0024"	"2020-09-15-AML0024:GGCTTGGCAAATCCCA"	-1.69923589649852	-15.6407432786194	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGCAAATCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.3925319492	33.3547414711553	0.0131712367061365	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.82392951585	2527.82392951585
"AML-0024"	"2020-09-15-AML0024:GGCTTGGTCGAATGCT"	-1.22100780430492	-16.7703314057556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTGGTCGAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.05544594625	34.1589030536526	0.0121171448056378	2459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.77878864276	2810.77878864276
"AML-0024"	"2020-09-15-AML0024:GGCTTTCAGACGAAGA"	-2.02791867676433	-16.5717325440613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCAGACGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.31412489553	44.6438407947129	0.021668463199502	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2054.63352205282	2054.63352205282
"AML-0024"	"2020-09-15-AML0024:GGCTTTCCACTCCGAG"	-2.58406076851543	-15.9630995026794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCCACTCCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.77546918678	39.1522234574191	0.0156310311798648	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2491.47377683168	2491.47377683168
"AML-0024"	"2020-09-15-AML0024:GGCTTTCGTGATTAGA"	-0.51513365927394	-16.5697775117126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCGTGATTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.30033682836	35.7309538333697	0.0137094537143218	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.60275715087	2598.60275715087
"AML-0024"	"2020-09-15-AML0024:GGCTTTCGTGGTAACG"	0.508298863738221	-16.3203649750915	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCGTGGTAACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3060.45036086202	40.857880219374	0.0133502835863235	3012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3042.75450043896	3042.75450043896
"AML-0024"	"2020-09-15-AML0024:GGCTTTCGTTGAAGTA"	-1.48570034924205	-16.3212347260681	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCGTTGAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3095.5309707405	43.0811544800597	0.0139172099672949	3689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3081.29688530928	3081.29688530928
"AML-0024"	"2020-09-15-AML0024:GGCTTTCGTTGCGGCT"	-1.14240858975108	-15.9600248566833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCGTTGCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.92778390597	41.8224011741132	0.0147213883475108	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.37840158175	2834.37840158175
"AML-0024"	"2020-09-15-AML0024:GGCTTTCTCCTTCGAC"	-2.16799555245097	-15.764937423822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCTCCTTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.04810860962	34.7098934491852	0.0124050381201033	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.09656361849	2788.09656361849
"AML-0024"	"2020-09-15-AML0024:GGCTTTCTCGTTCAGA"	0.0720074093783319	-15.8844614258972	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGCTTTCTCGTTCAGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2552.07332941171	33.5670076783047	0.0131528382399742	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2540.50792164952	2540.50792164952
"AML-0024"	"2020-09-15-AML0024:GGGAAGTAGACATACA"	-1.70673773708995	-16.6073408356872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTAGACATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.23765067654	36.2382151012491	0.0139525988666496	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.25663887923	2590.25663887923
"AML-0024"	"2020-09-15-AML0024:GGGAAGTAGATACAGT"	-2.0256761116093	-15.5192518464294	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTAGATACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.50946912415	27.6605459181778	0.0097241883770894	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.6024513596	2840.6024513596
"AML-0024"	"2020-09-15-AML0024:GGGAAGTAGGAAAGGT"	-2.1524478000706	-16.3727312318054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTAGGAAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.70040888718	39.3410781037725	0.0158269588575982	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.00369019151	2474.00369019151
"AML-0024"	"2020-09-15-AML0024:GGGAAGTAGGTGCTAG"	-1.54989765110667	-16.3064928284851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTAGGTGCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.69785324148	40.7275526628344	0.0166731847775559	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2437.46979242167	2437.46979242167
"AML-0024"	"2020-09-15-AML0024:GGGAAGTAGTGGTTCT"	-1.15904162350352	-16.5141992799011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTAGTGGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.25773428851	39.7015001774326	0.0143624451819256	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.32851319431	2758.32851319431
"AML-0024"	"2020-09-15-AML0024:GGGAAGTCAGGTGTGA"	-1.3592246574467	-16.8715181580749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAAGTCAGGTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.14604783509	34.0426905447564	0.0128165733102301	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.59531767208	2640.59531767208
"AML-0024"	"2020-09-15-AML0024:GGGACAAAGGAGCTGT"	-1.44122682038005	-15.5330915681091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAAGGAGCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3068.96911464455	39.9440365695533	0.0130154573335221	3328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3060.30172838446	3060.30172838446
"AML-0024"	"2020-09-15-AML0024:GGGACAAAGTAACCGG"	-2.09784398499187	-15.9687853089538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAAGTAACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2139.95189141719	50.2170696737716	0.0234664479492178	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2133.70308059127	2133.70308059127
"AML-0024"	"2020-09-15-AML0024:GGGACAAAGTGTCATC"	-0.799891154200393	-15.7298212281433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAAGTGTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.91342148182	32.723645216524	0.0122656323676158	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.01195811266	2659.01195811266
"AML-0024"	"2020-09-15-AML0024:GGGACAAAGTTCGGTT"	-0.510820965201217	-16.0923433533874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAAGTTCGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.63784809557	36.858359175471	0.0140915376348096	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.94123535402	2608.94123535402
"AML-0024"	"2020-09-15-AML0024:GGGACAACACGTAGTT"	-0.363444219261962	-16.5092668763367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAACACGTAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.41996896347	31.3137580238722	0.0108750228731464	2608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2875.20919811213	2875.20919811213
"AML-0024"	"2020-09-15-AML0024:GGGACAACAGGTACGA"	-0.26791943135913	-16.2133646241394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAACAGGTACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.83796059095	33.1464547645489	0.0120891370099073	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.50605339206	2734.50605339206
"AML-0024"	"2020-09-15-AML0024:GGGACAAGTACTAGCT"	-1.30752227726634	-15.0763120881286	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAGTACTAGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2626.04725961982	32.6878165086243	0.0124475355075509	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2620.83693651047	2620.83693651047
"AML-0024"	"2020-09-15-AML0024:GGGACAAGTATCAGCT"	-1.07006702843364	-16.3588628998962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAAGTATCAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.60499935226	33.639348240563	0.0119389865677752	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.80999672488	2810.80999672488
"AML-0024"	"2020-09-15-AML0024:GGGACAATCGCGAAGA"	-2.2982579273289	-15.5865469208923	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACAATCGCGAAGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.15948334836	34.7115357855816	0.0124273375697009	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.83844178721	2787.83844178721
"AML-0024"	"2020-09-15-AML0024:GGGACCTAGTATGAAC"	-1.06718609753307	-17.2697115174499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTAGTATGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.39780532865	33.4590291043375	0.0119778962525536	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.10961573599	2781.10961573599
"AML-0024"	"2020-09-15-AML0024:GGGACCTCAAGTTTGC"	-2.56297240677531	-15.9344310990539	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTCAAGTTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.54325530262	34.2037820464785	0.0125955578058604	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.3629924375	2712.3629924375
"AML-0024"	"2020-09-15-AML0024:GGGACCTGTGTGAATA"	-1.17325137081798	-15.8704509965149	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTGTGTGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.30004668606	40.7745161781426	0.0143557073224417	2737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2833.31500478854	2833.31500478854
"AML-0024"	"2020-09-15-AML0024:GGGACCTTCAGAGTGG"	-0.537548105151016	-15.8286619416443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTTCAGAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2096.39306686662	38.3922935384885	0.0183134995747108	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2092.09318470738	2092.09318470738
"AML-0024"	"2020-09-15-AML0024:GGGACCTTCGCATGAT"	-0.83867851916011	-16.3227796784607	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTTCGCATGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.2930420535	38.4151450576574	0.0143324421826002	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.68675174895	2666.68675174895
"AML-0024"	"2020-09-15-AML0024:GGGACCTTCGTAGCCG"	0.840349515050095	-16.2189436188904	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACCTTCGTAGCCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3155.28078867193	41.2524485698277	0.0130740974679439	4472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3147.64214159505	3147.64214159505
"AML-0024"	"2020-09-15-AML0024:GGGACTCCAAAGAACT"	-1.30200026455577	-16.6346674195495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACTCCAAAGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.27059795434	33.3321207941565	0.0133956977273933	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2478.84883808877	2478.84883808877
"AML-0024"	"2020-09-15-AML0024:GGGACTCCAACCCGCA"	-2.66622744026836	9.10406777942506	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACTCCAACCCGCA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2155.04569652966	35.7787826385507	0.0166023313084109	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2152.07090962311	2152.07090962311
"AML-0024"	"2020-09-15-AML0024:GGGACTCCACGGTGTC"	-2.11313853684123	-16.1683931580749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACTCCACGGTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3048.61935999414	31.8349078339256	0.0104424016496395	3422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3037.72777330596	3037.72777330596
"AML-0024"	"2020-09-15-AML0024:GGGACTCTCCTACGGG"	-0.673477689654189	-16.7928743592468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGACTCTCCTACGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2381.08978228522	44.5212433028779	0.0186978431616086	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2373.13653437344	2373.13653437344
"AML-0024"	"2020-09-15-AML0024:GGGAGATAGATTGCGG"	-1.53780613365825	-16.8489961854187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATAGATTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.60774728078	37.4033952761363	0.0139533265596499	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.65600644992	2671.65600644992
"AML-0024"	"2020-09-15-AML0024:GGGAGATAGCAAGTGC"	-2.00181613388713	-16.0637674561706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATAGCAAGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.55658376146	38.5123435083631	0.0167769088249863	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2287.32793290365	2287.32793290365
"AML-0024"	"2020-09-15-AML0024:GGGAGATAGGCATCAG"	-2.3605948490208	-16.30433752453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATAGGCATCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.86973411736	42.1649222230074	0.0158403402249843	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.72985951753	2651.72985951753
"AML-0024"	"2020-09-15-AML0024:GGGAGATAGGCTCTCG"	-2.45091066780742	-15.7786102524963	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATAGGCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2210.1391316523	42.9854295571974	0.0194491961802701	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2204.9556686022	2204.9556686022
"AML-0024"	"2020-09-15-AML0024:GGGAGATAGTGGTTAA"	-1.1266373199528	-15.8340540162292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATAGTGGTTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.77972498523	38.9048608112197	0.0135520188026338	3147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2861.95358556314	2861.95358556314
"AML-0024"	"2020-09-15-AML0024:GGGAGATCAACATACC"	0.444670100777787	-16.2586965790954	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATCAACATACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3058.48474129104	38.4023224335288	0.0125559960836419	3125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3052.30175694572	3052.30175694572
"AML-0024"	"2020-09-15-AML0024:GGGAGATCAAGTGACG"	-2.11232648316081	-16.5041990510193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATCAAGTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.55692563289	34.7243490198288	0.0132406464395235	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.86355295339	2610.86355295339
"AML-0024"	"2020-09-15-AML0024:GGGAGATCACTATCCC"	10.791406293481	-0.400888972636782	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.15625	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATCACTATCCC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1180.93686679082	40.4020296261346	0.0342118454951166	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1177.43987859482	1177.43987859482
"AML-0024"	"2020-09-15-AML0024:GGGAGATCAGGACATG"	-1.7118161720341	-15.9581327668396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATCAGGACATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.60145130888	39.6295474429516	0.015452516968173	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.67057323973	2563.67057323973
"AML-0024"	"2020-09-15-AML0024:GGGAGATCATTGCTGA"	-1.67124698582347	-16.9105558625427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATCATTGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.52514063318	44.1648529417847	0.0187415157089807	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2341.9183343425	2341.9183343425
"AML-0024"	"2020-09-15-AML0024:GGGAGATGTACAACGG"	-0.893783251673538	-16.6151838532654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATGTACAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.03539533977	39.5556393680975	0.0148759356259126	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.48323678502	2653.48323678502
"AML-0024"	"2020-09-15-AML0024:GGGAGATGTGGTGATG"	-0.503340463072616	-15.7547502747742	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATGTGGTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.24272499662	40.2549100657285	0.0144685112136567	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.37771050924	2777.37771050924
"AML-0024"	"2020-09-15-AML0024:GGGAGATGTTCCACAA"	-1.93726621094401	-16.0012979737488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATGTTCCACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.44507986222	30.9648498231114	0.0122272542332077	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2525.73967430795	2525.73967430795
"AML-0024"	"2020-09-15-AML0024:GGGAGATTCTACTCAT"	-1.25452051582988	-15.6794405213562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATTCTACTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.70299113279	37.951683600758	0.0143936134363215	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.06578159961	2633.06578159961
"AML-0024"	"2020-09-15-AML0024:GGGAGATTCTATTCGT"	-1.96150145950969	-16.6646661988464	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGATTCTATTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.15934418194	45.988303266776	0.0187465618064496	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2445.7446382263	2445.7446382263
"AML-0024"	"2020-09-15-AML0024:GGGAGTAAGCACGATG"	-0.85886929455455	-15.801537536737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTAAGCACGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.94521389141	34.087211625528	0.0119858889893613	2604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2836.98814476714	2836.98814476714
"AML-0024"	"2020-09-15-AML0024:GGGAGTAAGCTGGTGA"	-0.877387623221237	-16.2193670502869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTAAGCTGGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.48992748376	39.3674855031844	0.0141279841405111	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.68000520006	2777.68000520006
"AML-0024"	"2020-09-15-AML0024:GGGAGTACAGGTGTTT"	-2.7950418991154	-15.9950609437195	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTACAGGTGTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.12172448308	37.6076847690267	0.0143698645795525	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.62684555685	2613.62684555685
"AML-0024"	"2020-09-15-AML0024:GGGAGTACATCGCTGG"	-1.38438079777415	-16.4450865021911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTACATCGCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.36863802796	39.0938873290431	0.0161187403498504	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2416.22880492404	2416.22880492404
"AML-0024"	"2020-09-15-AML0024:GGGAGTAGTATGTCCA"	-2.71522889557536	-16.1600313416687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTAGTATGTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1890.46844036414	48.4904799249597	0.0256499811843563	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1887.15189764473	1887.15189764473
"AML-0024"	"2020-09-15-AML0024:GGGAGTAGTGGCATCC"	-0.618616740137893	-15.8154134980408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTAGTGGCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.59930159722	32.1590619914502	0.0126680338922399	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.89725101547	2534.89725101547
"AML-0024"	"2020-09-15-AML0024:GGGAGTATCAACACGT"	-2.58424959603007	-15.8047943345276	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGAGTATCAACACGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.93990047279	37.8728272884024	0.0141161668517914	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.51114163919	2678.51114163919
"AML-0024"	"2020-09-15-AML0024:GGGATCCCAGGCTATT"	-2.30893550339397	-15.7614727250305	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATCCCAGGCTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.13352791718	29.4897590858328	0.0110072001931008	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.73652813524	2672.73652813524
"AML-0024"	"2020-09-15-AML0024:GGGATCCGTTCCATTT"	0.043388300656718	-16.4257135621277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATCCGTTCCATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2997.48550136776	36.1115499864018	0.0120472809526265	3024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2991.96522857639	2991.96522857639
"AML-0024"	"2020-09-15-AML0024:GGGATGAAGAAGTATC"	-0.704809467226821	-16.2447061768738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGAAGAAGTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.03368440243	35.5444765930726	0.0126266611977035	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.87041882005	2807.87041882005
"AML-0024"	"2020-09-15-AML0024:GGGATGAAGTATTAGG"	-1.26768992367442	-16.9457197419372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGAAGTATTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2042.09707885205	37.2340536206772	0.0182332436622494	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2035.62211182173	2035.62211182173
"AML-0024"	"2020-09-15-AML0024:GGGATGAGTCATACCA"	-1.89472327652629	-15.6829395524231	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGAGTCATACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.53856715168	38.7426823243909	0.01360567430809	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.29111401256	2844.29111401256
"AML-0024"	"2020-09-15-AML0024:GGGATGAGTGTTAGCT"	-1.92483935776408	-16.2446718445984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGAGTGTTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.93320457558	37.8499328323709	0.0156603139717373	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.20086981379	2413.20086981379
"AML-0024"	"2020-09-15-AML0024:GGGATGAGTTCGGCGT"	-2.33756480637248	-16.147297882196	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGAGTTCGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.30215150057	37.2974927343321	0.0137563025624753	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.04482436714	2703.04482436714
"AML-0024"	"2020-09-15-AML0024:GGGATGATCAATCCGA"	0.973423262208146	-16.2705202332703	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGATCAATCCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2583.16007097932	46.3743857889447	0.0179525792109985	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2566.43026584632	2566.43026584632
"AML-0024"	"2020-09-15-AML0024:GGGATGATCGTTGTGA"	-0.686657707125503	-15.8860969773498	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGATGATCGTTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.95919371251	35.3728634311539	0.0134295411696552	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.29572629597	2630.29572629597
"AML-0024"	"2020-09-15-AML0024:GGGCCATAGCGTGAGT"	-0.89721659842189	-17.4427595368591	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATAGCGTGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2656.1869313878	48.1468397591651	0.0181262994671875	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2649.99697422108	2649.99697422108
"AML-0024"	"2020-09-15-AML0024:GGGCCATAGCGTTCCG"	0.0691136560285508	-16.3154115906921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATAGCGTTCCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2812.05254295363	43.3092685249576	0.0154013013140458	2652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2803.34899840587	2803.34899840587
"AML-0024"	"2020-09-15-AML0024:GGGCCATAGGTCATTC"	-0.248770664364654	-15.9702120057312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATAGGTCATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3047.01061964702	36.1523909832458	0.0118648719995055	3028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3038.22259102064	3038.22259102064
"AML-0024"	"2020-09-15-AML0024:GGGCCATCAGACAATA"	-1.53531251373943	-15.8309040299621	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATCAGACAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.06403043762	37.128229070264	0.014181558830728	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.17516773537	2607.17516773537
"AML-0024"	"2020-09-15-AML0024:GGGCCATGTAGCGATG"	11.7894541221553	-1.81883242046507	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATGTAGCGATG"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1176.52162384485	37.8108756665774	0.0321378501680336	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1171.92849316458	1171.92849316458
"AML-0024"	"2020-09-15-AML0024:GGGCCATTCCCTTGTG"	-2.6067992252415	-15.6898489228454	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATTCCCTTGTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.07247036138	38.6068795321801	0.0135459290715105	3079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.98000377187	2843.98000377187
"AML-0024"	"2020-09-15-AML0024:GGGCCATTCTCGTCGT"	-1.88602004471477	-15.8080606690613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATTCTCGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2823.72701159272	36.3309665775835	0.0128663169026	3010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.06444808598	2815.06444808598
"AML-0024"	"2020-09-15-AML0024:GGGCCATTCTTCACGC"	-1.7025936645573	-16.212956451532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCCATTCTTCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.70169042776	37.1927027276892	0.0136251894696453	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.46985545957	2716.46985545957
"AML-0024"	"2020-09-15-AML0024:GGGCGTTAGACCAGAC"	-1.82226822796519	-16.1554308167663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTAGACCAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2878.15110017374	33.7535578677706	0.0117275141898329	2753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.71850419704	2869.71850419704
"AML-0024"	"2020-09-15-AML0024:GGGCGTTAGAGGATGA"	-1.31416449967082	-16.3376779786316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTAGAGGATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.76013043663	35.5634178947437	0.0136794996886004	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.86891410095	2592.86891410095
"AML-0024"	"2020-09-15-AML0024:GGGCGTTAGTGGCGAT"	-0.571415404707748	-16.6773061982361	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTAGTGGCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.82432951289	35.4898597081181	0.0135621865433834	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.20228874123	2609.20228874123
"AML-0024"	"2020-09-15-AML0024:GGGCGTTCAGCAGATG"	-0.876893679529983	-16.5874777070251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTCAGCAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2395.52621192917	47.3624095312994	0.0197711923565877	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2385.94451912588	2385.94451912588
"AML-0024"	"2020-09-15-AML0024:GGGCGTTGTCGAATGG"	-1.746046046645	-15.6923532716003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTGTCGAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.38023501907	40.9091832233118	0.0155881311242288	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.90117601499	2617.90117601499
"AML-0024"	"2020-09-15-AML0024:GGGCGTTGTGACTGTT"	-2.00363049927409	-15.5585165253845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2623.46060672705	31.8529892289894	0.0121415923484089	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.20023528754	2620.20023528754
"AML-0024"	"2020-09-15-AML0024:GGGCGTTTCGGTCGAC"	-0.69528971138652	-15.813973449823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCGTTTCGGTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.80132940705	41.0362165943974	0.016150895435801	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.80191810586	2533.80191810586
"AML-0024"	"2020-09-15-AML0024:GGGCTACAGTAGGCCA"	-1.51052878323253	-16.7012510529724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACAGTAGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.11348470188	34.0766634304187	0.0128828738832955	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.69801593242	2629.69801593242
"AML-0024"	"2020-09-15-AML0024:GGGCTACCAAACGGCA"	-2.29541645470317	-15.932589553949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACCAAACGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2876.57146484978	36.4766698089398	0.0126806061502959	2907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2870.767921165	2870.767921165
"AML-0024"	"2020-09-15-AML0024:GGGCTACCACGCGTCA"	-0.714807550341445	-15.860715889093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACCACGCGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.48402053651	37.7674374440197	0.0138368413809567	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.48155469584	2723.48155469584
"AML-0024"	"2020-09-15-AML0024:GGGCTACCAGGAGACT"	-1.33895192566569	-16.3844843140808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACCAGGAGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.97851574605	44.1634243804183	0.0177936368506975	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.42758358451	2476.42758358451
"AML-0024"	"2020-09-15-AML0024:GGGCTACGTACCGCGT"	-2.53755674782451	-15.9354181519714	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACGTACCGCGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2230.44223621356	36.9384468046288	0.0165610416646953	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2228.01715461688	2228.01715461688
"AML-0024"	"2020-09-15-AML0024:GGGCTACGTCTGTAGT"	-0.0364435714786828	-16.4266939393249	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACGTCTGTAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2565.78127207237	41.3026680969793	0.0160975015861813	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2558.84668671686	2558.84668671686
"AML-0024"	"2020-09-15-AML0024:GGGCTACGTTCCACAA"	-1.7166100544041	-15.9680071107117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACGTTCCACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.80563759907	34.2156403893729	0.0127204880200615	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.76808534125	2681.76808534125
"AML-0024"	"2020-09-15-AML0024:GGGCTACGTTCTCCAC"	-2.21045694771464	-15.9220123521057	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACGTTCTCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2994.13439662927	37.8190941210297	0.0126310609716136	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.03516779199	2988.03516779199
"AML-0024"	"2020-09-15-AML0024:GGGCTACGTTGGCCGT"	-1.57999191704448	-15.8301792374817	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACGTTGGCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2394.41129006575	48.5533627499155	0.0202777872587555	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2386.56957723607	2386.56957723607
"AML-0024"	"2020-09-15-AML0024:GGGCTACTCAGGAACG"	-1.89524004879649	-16.542151474115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACTCAGGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.25234795371	35.1296402560631	0.0136200865665331	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.12591665076	2568.12591665076
"AML-0024"	"2020-09-15-AML0024:GGGCTACTCCCTATTA"	-0.903510312468368	-15.9092722169128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACTCCCTATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.5044517329	38.8866080768727	0.0147773293908984	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.02364117868	2626.02364117868
"AML-0024"	"2020-09-15-AML0024:GGGCTACTCTATGTGG"	0.769559879868668	-16.2713861695495	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTACTCTATGTGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2973.44163839186	42.1460310946805	0.014174157834648	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2962.61204012516	2962.61204012516
"AML-0024"	"2020-09-15-AML0024:GGGCTCAAGATGGTAT"	-0.566127519041854	-16.4637403718201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCAAGATGGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.60250187686	41.8623494206373	0.0153251980812999	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.06624340064	2724.06624340064
"AML-0024"	"2020-09-15-AML0024:GGGCTCAAGCCTATCA"	1.02646686610524	-16.2220640412536	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCAAGCCTATCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2239.08492479136	42.3006631469683	0.0188919422745477	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2228.58831192923	2228.58831192923
"AML-0024"	"2020-09-15-AML0024:GGGCTCAAGGTAGACC"	-0.394406537443954	-15.9540605775085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCAAGGTAGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.67556430466	34.4434926639066	0.0123822825012005	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.526911989	2775.526911989
"AML-0024"	"2020-09-15-AML0024:GGGCTCACACTGCATA"	-0.231571833521682	-15.9429798356262	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCACACTGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.74802827282	35.3979381107475	0.0128544579051226	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.87634821044	2748.87634821044
"AML-0024"	"2020-09-15-AML0024:GGGCTCATCAGTGTTG"	-2.19837675514873	-15.6877479783264	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCATCAGTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.39634375435	40.3950558782836	0.016046363131695	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.95708654424	2511.95708654424
"AML-0024"	"2020-09-15-AML0024:GGGCTCATCGCGGACT"	-0.881889860064346	-15.9394502869812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGCTCATCGCGGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.7812653379	38.563179753892	0.0139027472121866	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.04701336672	2766.04701336672
"AML-0024"	"2020-09-15-AML0024:GGGTAGAAGGGAGGCA"	-1.87940202179607	-16.2506914368835	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGAAGGGAGGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2085.07868794255	48.5756361665462	0.0232967880049065	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2080.51966269685	2080.51966269685
"AML-0024"	"2020-09-15-AML0024:GGGTAGAAGTGCTCGC"	-1.76093492928203	-15.1563034287659	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGAAGTGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.70440260872	31.0795863704528	0.0125133998787492	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.35508386366	2475.35508386366
"AML-0024"	"2020-09-15-AML0024:GGGTAGACATCGGATT"	-1.64006481590922	-16.5314779511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGACATCGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.87476939096	34.2875277260024	0.0139500710748166	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.79160985819	2455.79160985819
"AML-0024"	"2020-09-15-AML0024:GGGTAGAGTAAGGCTG"	-1.1430975002354	-16.2244215241638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGAGTAAGGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.45469991572	38.7282481417493	0.0147342269748804	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.59811883715	2621.59811883715
"AML-0024"	"2020-09-15-AML0024:GGGTAGAGTGAATATG"	-1.14938948574718	-16.6550150147644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGAGTGAATATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.02555495252	34.0701702185982	0.0137322931440947	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.62891967945	2476.62891967945
"AML-0024"	"2020-09-15-AML0024:GGGTAGATCAACACGT"	1.34338798102681	-16.1474313966003	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGATCAACACGT"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3053.04074693962	36.6671748169777	0.0120100509152172	4193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	3045.15867441581	3045.15867441581
"AML-0024"	"2020-09-15-AML0024:GGGTAGATCTGGCTGG"	-1.85455809059795	-16.527331375238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTAGATCTGGCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.11020921303	39.8771550080832	0.0144949318549802	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.21518843804	2745.21518843804
"AML-0024"	"2020-09-15-AML0024:GGGTATTAGAAGCCTG"	-0.909444491297561	-17.5946588746277	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTAGAAGCCTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2793.4733654781	43.6222797118149	0.0156157850835098	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2787.91140015442	2787.91140015442
"AML-0024"	"2020-09-15-AML0024:GGGTATTAGAGAGGGC"	-1.25530455532725	-16.0206423035828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTAGAGAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.56816645288	37.0130128763911	0.013145841509858	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.11181651453	2807.11181651453
"AML-0024"	"2020-09-15-AML0024:GGGTATTAGCCTGCCA"	-1.74579141560252	-16.3051920167175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTAGCCTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.82906703282	33.9338483934389	0.012467295909376	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.86992873815	2709.86992873815
"AML-0024"	"2020-09-15-AML0024:GGGTATTAGCTAAGTA"	-2.23522458496745	-15.7412662736145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTAGCTAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.9337186019	36.5127321241061	0.0130779365859696	2524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.30099868316	2783.30099868316
"AML-0024"	"2020-09-15-AML0024:GGGTATTCAATTGGTC"	-1.92254565182384	-15.6386289826599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTCAATTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.18686499545	32.984584810007	0.0119718140461088	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.10193263983	2741.10193263983
"AML-0024"	"2020-09-15-AML0024:GGGTATTCACCTGCTT"	-1.40114353123363	-15.6220436326233	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTCACCTGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.99273460463	37.353231010012	0.0136475448172528	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.02350597314	2734.02350597314
"AML-0024"	"2020-09-15-AML0024:GGGTATTCATGTCTAG"	-1.53080115738567	-15.1096439591614	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTCATGTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.65683753298	38.9585614730082	0.0166442858467326	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2334.73643461059	2334.73643461059
"AML-0024"	"2020-09-15-AML0024:GGGTATTGTCGGATTT"	-1.34132788601573	-15.8928318253723	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTGTCGGATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.33356886241	35.4581070003256	0.0128969825276593	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.7147210031	2745.7147210031
"AML-0024"	"2020-09-15-AML0024:GGGTATTTCACTTTGT"	-2.44943437996562	-16.0400190583435	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTTCACTTTGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2948.70361696937	31.9645159803197	0.0108401928889592	3021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2940.80652864286	2940.80652864286
"AML-0024"	"2020-09-15-AML0024:GGGTATTTCATTATCC"	-1.60880325260814	-16.2370519868103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTTCATTATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.83221677151	35.2586575323002	0.0133513433032125	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.45998082864	2638.45998082864
"AML-0024"	"2020-09-15-AML0024:GGGTATTTCGAACGCC"	-0.0293702882831872	-16.0872278443542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTATTTCGAACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.95670567732	38.1741911388214	0.0142656236021423	2800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.14971506355	2669.14971506355
"AML-0024"	"2020-09-15-AML0024:GGGTCACCAGAACTCT"	-0.766399840742904	-16.2199316254822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCACCAGAACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.69820678375	36.6973177924743	0.0129320720944695	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.87840365184	2828.87840365184
"AML-0024"	"2020-09-15-AML0024:GGGTCACCAGCAGAAC"	-0.999433378607589	-16.0622587434021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCACCAGCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.24879423292	32.7646986530919	0.0144768435253698	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.95154505495	2257.95154505495
"AML-0024"	"2020-09-15-AML0024:GGGTCACGTCCAGTTA"	-0.796214143664199	-15.7411689988342	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCACGTCCAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1913.53878300554	42.4198466389451	0.0221682711715503	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1906.83676854858	1906.83676854858
"AML-0024"	"2020-09-15-AML0024:GGGTCACTCCGTGACG"	-2.05955157700236	-15.9012689820495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCACTCCGTGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.99066885317	30.5447295989393	0.0113718673535008	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.42606688772	2680.42606688772
"AML-0024"	"2020-09-15-AML0024:GGGTCACTCGCAAGAG"	-0.501115064055282	-16.6241884461609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCACTCGCAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.30515622723	33.2112819647554	0.0120842774280373	2440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.11746114352	2740.11746114352
"AML-0024"	"2020-09-15-AML0024:GGGTCTGAGTGCGCTC"	-0.846201161772567	-16.4758520356384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCTGAGTGCGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.22112867416	40.2425840074568	0.0146378127200209	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.68909521944	2738.68909521944
"AML-0024"	"2020-09-15-AML0024:GGGTCTGCACCATTCC"	-1.68040333214458	-16.0404539338318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCTGCACCATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.85549324163	32.0624804515249	0.0128360029386309	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2491.60376879996	2491.60376879996
"AML-0024"	"2020-09-15-AML0024:GGGTCTGTCAACACCA"	-2.27688155594524	-16.301537536737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCTGTCAACACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.41916930747	37.4202526270755	0.0135756756605626	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.53029451631	2744.53029451631
"AML-0024"	"2020-09-15-AML0024:GGGTCTGTCCGCGAGT"	0.209464256733102	-16.2052431336609	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTCTGTCCGCGAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2644.91878774097	39.9472712224909	0.0151034018162085	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2640.40221049193	2640.40221049193
"AML-0024"	"2020-09-15-AML0024:GGGTGAACATAGGCGA"	-2.47620044174846	-16.049906753656	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAACATAGGCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.10418235165	35.1092474156057	0.0132482517666345	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.73358459552	2644.73358459552
"AML-0024"	"2020-09-15-AML0024:GGGTGAAGTATGACAA"	11.5034004646236	-1.84341945564421	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAAGTATGACAA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1365.96613203442	39.5643641645631	0.0289643815001749	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1358.68811957366	1358.68811957366
"AML-0024"	"2020-09-15-AML0024:GGGTGAAGTTCAGGTT"	-0.556169549853164	-15.8340721360412	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAAGTTCAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.43746624179	31.4058046748858	0.0112226215714095	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.60832484737	2792.60832484737
"AML-0024"	"2020-09-15-AML0024:GGGTGAAGTTGACTAC"	-2.36556730690654	-16.4816694489685	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAAGTTGACTAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.82752637193	36.0890506648165	0.0134218540649619	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.0731045946	2684.0731045946
"AML-0024"	"2020-09-15-AML0024:GGGTGAAGTTGCCGCA"	-2.04047427597697	-16.4909067383972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAAGTTGCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.38344122617	36.8635194859375	0.014219933247414	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.62097829689	2590.62097829689
"AML-0024"	"2020-09-15-AML0024:GGGTGAATCTCTGGTC"	-1.23120544377025	-16.6067686310974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGAATCTCTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3070.99000455497	35.7912684457304	0.0116546352780842	3824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3055.84645020409	3055.84645020409
"AML-0024"	"2020-09-15-AML0024:GGGTGTCAGGTCGCCT"	-0.554410676390487	-16.5370283356872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCAGGTCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.1574471319	34.4186346026122	0.0126951810338508	2700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.67194213437	2701.67194213437
"AML-0024"	"2020-09-15-AML0024:GGGTGTCAGTAAACTG"	-0.341737340123016	-16.3393888703552	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCAGTAAACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2287.05031002857	37.1039445713459	0.0162234929457596	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2282.09356386779	2282.09356386779
"AML-0024"	"2020-09-15-AML0024:GGGTGTCAGTAGGTTA"	-0.655193845660049	-16.0414629212585	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCAGTAGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.75697903446	31.6852361959599	0.0114314625833458	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.49748326053	2765.49748326053
"AML-0024"	"2020-09-15-AML0024:GGGTGTCCAATGCAGG"	-0.960711101919967	-16.0660143128601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCCAATGCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.2785423728	35.2655875667733	0.012442527098007	2899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.76798566695	2824.76798566695
"AML-0024"	"2020-09-15-AML0024:GGGTGTCCACGTGTGC"	-2.02614603462871	-16.0800619355408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCCACGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.99218410482	36.078021136665	0.014038183213087	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.09452503969	2562.09452503969
"AML-0024"	"2020-09-15-AML0024:GGGTGTCCACTTGTCC"	-2.63662872734721	-15.7932882539001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCCACTTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.23044580343	34.6146938469532	0.0141560047668962	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2439.96603962044	2439.96603962044
"AML-0024"	"2020-09-15-AML0024:GGGTGTCGTACTCGCG"	-1.84672937813457	-17.030734085199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCGTACTCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1335.51924370561	51.9210362805934	0.0388770409152101	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1322.02292538642	1322.02292538642
"AML-0024"	"2020-09-15-AML0024:GGGTGTCGTATGGTTC"	-2.29339371147807	-15.9212856522766	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCGTATGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.70510525999	41.5720652684608	0.0144814823341793	2947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.14705190274	2865.14705190274
"AML-0024"	"2020-09-15-AML0024:GGGTGTCGTCAGTCGC"	-2.05538258972819	-16.6582079163757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCGTCAGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.65775184313	37.915739985306	0.0159533866228328	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.215940318	2370.215940318
"AML-0024"	"2020-09-15-AML0024:GGGTGTCGTGAGAGGG"	-1.41503427448924	-16.0013990632263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCGTGAGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.27115528691	36.1676947760166	0.014448173023378	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.53952974121	2497.53952974121
"AML-0024"	"2020-09-15-AML0024:GGGTGTCGTGATGTAA"	-0.826967934996444	-16.1115064851013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCGTGATGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.78335184725	43.4384499266516	0.0173007559153571	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2498.5372856648	2498.5372856648
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCATTTACC"	-1.9104394716328	-16.4670782319275	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCATTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2524.70001928986	29.8702899920541	0.0118312234181611	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.33693432026	2516.33693432026
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCCCGAACG"	-1.82019219818767	-15.6840620270935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCCCGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.4965929372	46.3117461952707	0.017251557076703	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.06014471372	2679.06014471372
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCCTACCAC"	-0.537975172430831	-16.5559511414734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCCTACCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.53672440633	37.7405648181397	0.0132027566747381	2836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2849.3522244655	2849.3522244655
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCGAACCTA"	-1.95496187630351	-16.6095228425232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCGAACCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2103.26221509371	44.8981228329692	0.021346897458037	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2099.07704288603	2099.07704288603
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCGGAGTAG"	-0.664324204356033	-16.6215028992859	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCGGAGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.52685999734	38.4058217007997	0.0151291768095926	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.18014277661	2531.18014277661
"AML-0024"	"2020-09-15-AML0024:GGGTGTCTCTGTAAGC"	-2.90673647347148	-15.7206268540588	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTGTCTCTGTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.72687909783	32.0656007014609	0.0120695886934187	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.45622077686	2648.45622077686
"AML-0024"	"2020-09-15-AML0024:GGGTTATGTATCGATC"	-1.49880180779155	-16.7908544770447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATGTATCGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.20097333758	33.7222758763906	0.0127774565927599	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.38029033515	2633.38029033515
"AML-0024"	"2020-09-15-AML0024:GGGTTATGTCGTTTCC"	0.17994031783883	-16.1401834717956	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATGTCGTTTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2375.97700931498	51.9566826341764	0.0218675022655863	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2366.38545623368	2366.38545623368
"AML-0024"	"2020-09-15-AML0024:GGGTTATGTGCCTAAT"	-1.95658502999004	-15.4961977235046	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATGTGCCTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.6493287727	38.5000704899367	0.0127709946634525	3735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3005.36702224892	3005.36702224892
"AML-0024"	"2020-09-15-AML0024:GGGTTATGTTAGTTCG"	-0.295759241015273	-16.056462310907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATGTTAGTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.9685706636	40.9282083251409	0.0153751658739299	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.24387614464	2656.24387614464
"AML-0024"	"2020-09-15-AML0024:GGGTTATTCATTTCCA"	-2.0320032638615	-15.7910862199036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATTCATTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.91924461639	39.8320629770455	0.0145429855426878	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.46102790502	2725.46102790502
"AML-0024"	"2020-09-15-AML0024:GGGTTATTCGCCGTGA"	-0.455166975886184	-16.461470626947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATTCGCCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.4348917688	31.1685734025599	0.0118989685525312	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.63767502199	2610.63767502199
"AML-0024"	"2020-09-15-AML0024:GGGTTATTCGCTCATC"	-0.959203342825729	-17.5081625214783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATTCGCTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3004.15668371006	41.0955785982545	0.013679572314285	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2997.75839139694	2997.75839139694
"AML-0024"	"2020-09-15-AML0024:GGGTTATTCTAGGCAT"	-1.17162142220195	-17.2793913117615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATTCTAGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.49222271379	44.7099779358869	0.0154465704157146	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.92220821857	2884.92220821857
"AML-0024"	"2020-09-15-AML0024:GGGTTATTCTCGACCT"	9.39169754561726	7.04495141589967	"2020-09-15-AML0024"	"AML0024"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTATTCTCGACCT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2103.12473227112	35.3775671018295	0.016821430778205	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	2099.37086078361	2099.37086078361
"AML-0024"	"2020-09-15-AML0024:GGGTTTACACTGGACC"	-1.52181539955791	-16.1936502686706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTTACACTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.19107023907	32.1998806079892	0.012915127521655	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.8347051848	2486.8347051848
"AML-0024"	"2020-09-15-AML0024:GGGTTTAGTAAGATCA"	-0.87825701656993	-16.2424993745056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTTAGTAAGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.8940849019	35.791633934529	0.0139653191855952	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.21599679257	2558.21599679257
"AML-0024"	"2020-09-15-AML0024:GGGTTTATCAGGACAG"	-2.11892924729045	-15.4817238084045	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTTATCAGGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.77264202688	29.8787209707385	0.0106947575193741	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.60336717323	2783.60336717323
"AML-0024"	"2020-09-15-AML0024:GGGTTTATCGATTGGT"	0.810445149510544	-16.1962423554626	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGGTTTATCGATTGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2763.31143386072	38.1493634977663	0.0138056691802076	3020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2750.70529230183	2750.70529230183
"AML-0024"	"2020-09-15-AML0024:GGTAACTAGACAACAT"	-1.93892667713817	-16.6037340394226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTAGACAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.97735471012	41.7245759121844	0.0171003947358935	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2426.25201173509	2426.25201173509
"AML-0024"	"2020-09-15-AML0024:GGTAACTAGACTGGGT"	-2.29845009270366	-15.396287941095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTAGACTGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.3913440443	32.2966207256961	0.011942288159153	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.53609051737	2700.53609051737
"AML-0024"	"2020-09-15-AML0024:GGTAACTAGTCATCCA"	-1.52052674713786	-16.42054846203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTAGTCATCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.54096532433	38.8950887148241	0.0160753999507549	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.21437071592	2415.21437071592
"AML-0024"	"2020-09-15-AML0024:GGTAACTCACAGTCCG"	-1.77351687374766	-16.8070898286072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTCACAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.9733071827	45.4233942706578	0.0215688366589146	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2094.05632955177	2094.05632955177
"AML-0024"	"2020-09-15-AML0024:GGTAACTCATGGCGCT"	1.10680248317067	-16.2103166810242	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTCATGGCGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2983.19787562879	38.6153799847787	0.0129442905213384	4071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2966.72517716899	2966.72517716899
"AML-0024"	"2020-09-15-AML0024:GGTAACTGTCCATCTC"	-2.78177533569987	-15.7960691682068	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTGTCCATCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.28093633866	34.9683072575821	0.0138308630006211	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.91355085437	2520.91355085437
"AML-0024"	"2020-09-15-AML0024:GGTAACTTCAGCTTCC"	-2.30083928528484	-16.599410080072	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTTCAGCTTCC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1969.1113414949	44.8701457007612	0.0227870028246838	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1961.15313486908	1961.15313486908
"AML-0024"	"2020-09-15-AML0024:GGTAACTTCCTCCACA"	-1.52278612080272	-16.0527258149353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAACTTCCTCCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2974.70702216127	35.1136160719167	0.0118040586216806	2821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2965.84915978865	2965.84915978865
"AML-0024"	"2020-09-15-AML0024:GGTAATCAGATCGGTG"	-0.820582072169143	-16.0063162080017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCAGATCGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3059.00234891441	37.2462739122044	0.0121759546622848	4351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3050.12731024061	3050.12731024061
"AML-0024"	"2020-09-15-AML0024:GGTAATCAGTCTAACC"	-2.27876053276713	-15.6216106644836	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCAGTCTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.19191554064	34.4446122293806	0.0123537451053479	2634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.38470854458	2780.38470854458
"AML-0024"	"2020-09-15-AML0024:GGTAATCGTAGTTCCA"	-1.97467956963237	-16.1782045594421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCGTAGTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.06082216366	37.3160427743064	0.0141452549011743	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.15542583812	2628.15542583812
"AML-0024"	"2020-09-15-AML0024:GGTAATCGTCGCCACA"	-0.441144685179549	-16.180335067865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCGTCGCCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.47176117405	34.1715053091524	0.0135146873435065	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2521.09788623073	2521.09788623073
"AML-0024"	"2020-09-15-AML0024:GGTAATCGTGTTATCG"	-0.421494970948058	-16.5466699830261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCGTGTTATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.47376379077	48.3512053064911	0.0176756238522598	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.29289029691	2722.29289029691
"AML-0024"	"2020-09-15-AML0024:GGTAATCTCAGAGCAG"	0.162715916603249	-16.1880254975525	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCTCAGAGCAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.17972285571	42.1978259205128	0.0152991574736192	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2752.38695774021	2752.38695774021
"AML-0024"	"2020-09-15-AML0024:GGTAATCTCTTTGCGC"	-1.59946070137675	-16.3698950043884	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAATCTCTTTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.04691100708	36.5186276741794	0.0137647877701179	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.23315151804	2647.23315151804
"AML-0024"	"2020-09-15-AML0024:GGTAGAGCACAATTCG"	-1.48526428166087	-15.6785650483337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGCACAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.83668444764	29.842831147114	0.0119618375555999	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2491.68646272937	2491.68646272937
"AML-0024"	"2020-09-15-AML0024:GGTAGAGGTACGTAGG"	-2.96437082710918	-15.5821790925232	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGGTACGTAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.67363689384	37.5437702411529	0.014508696037194	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.73712034137	2585.73712034137
"AML-0024"	"2020-09-15-AML0024:GGTAGAGGTATCGTTG"	-1.11175427857097	-16.622717880365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGGTATCGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.58635699761	32.1932824964313	0.011885640054732	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.88972603159	2702.88972603159
"AML-0024"	"2020-09-15-AML0024:GGTAGAGTCAGCAGAG"	-1.3316265148228	-16.1060343018738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGTCAGCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.58243350932	36.7715628435942	0.0143494165739822	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.70087836945	2558.70087836945
"AML-0024"	"2020-09-15-AML0024:GGTAGAGTCATCGCCT"	-0.621965329081374	-16.6430483094421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGTCATCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2412.20674490073	40.5016154858975	0.0167902753657064	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2400.23531210388	2400.23531210388
"AML-0024"	"2020-09-15-AML0024:GGTAGAGTCGGTGTTA"	-1.71206913414653	-16.3033399811951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGTCGGTGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.28368051595	33.2137445383604	0.011827061763311	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.85467719332	2805.85467719332
"AML-0024"	"2020-09-15-AML0024:GGTAGAGTCTATGCCC"	-1.97060380402263	-16.9217519990173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGTCTATGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1545.1408843866	49.8523410841338	0.0322639453708615	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1531.47619001105	1531.47619001105
"AML-0024"	"2020-09-15-AML0024:GGTAGAGTCTCGGCTT"	-1.99674044075664	-16.0202913514343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTAGAGTCTCGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.43454517016	51.3718929858949	0.0227466822519864	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2247.5669506242	2247.5669506242
"AML-0024"	"2020-09-15-AML0024:GGTCACGAGATCGGTG"	0.00496770915333625	-16.4419317475525	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGAGATCGGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2514.81495677002	45.9385300241343	0.0182671611286807	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2508.10843886304	2508.10843886304
"AML-0024"	"2020-09-15-AML0024:GGTCACGAGCCTTCTC"	-1.25920758667644	-16.4253339997497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGAGCCTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.63603266485	42.023872771973	0.017630155022028	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.83279121142	2370.83279121142
"AML-0024"	"2020-09-15-AML0024:GGTCACGAGTAACAGT"	-2.43627462807353	-15.7737674943176	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGAGTAACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.59900665711	35.0311554388958	0.0125308226807481	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.71720996771	2791.71720996771
"AML-0024"	"2020-09-15-AML0024:GGTCACGAGTTGGAAT"	-2.40877542915996	-16.1975298157898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGAGTTGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.26974437862	36.0244018275378	0.0138541018313261	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.69910278838	2590.69910278838
"AML-0024"	"2020-09-15-AML0024:GGTCACGCAAAGTATG"	-1.62509284439738	-16.7601900330749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGCAAAGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.14448823875	34.6123685563083	0.0134200967468652	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.7648517896	2574.7648517896
"AML-0024"	"2020-09-15-AML0024:GGTCACGTCCATTCAT"	-0.499558667570907	-16.3952245942322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGTCCATTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.71998226986	36.6670675870658	0.0132961532798139	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.92566882719	2744.92566882719
"AML-0024"	"2020-09-15-AML0024:GGTCACGTCTACTATC"	-1.74075100842174	-16.7160997620788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCACGTCTACTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.88662321508	38.5573820786632	0.0162081629710258	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.66967816779	2368.66967816779
"AML-0024"	"2020-09-15-AML0024:GGTCTGGAGCGATTCT"	-2.15639863434489	-15.9585085145203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCTGGAGCGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.95212163161	34.7756404779016	0.0138275556734418	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.10703805175	2511.10703805175
"AML-0024"	"2020-09-15-AML0024:GGTCTGGAGGATCACG"	-1.73843357983287	-15.9395256272522	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCTGGAGGATCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.19330769562	39.3286689952731	0.0134127135793039	2834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.45813092767	2920.45813092767
"AML-0024"	"2020-09-15-AML0024:GGTCTGGGTCGCTTGG"	-0.179047400981742	-16.1415872803894	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTCTGGGTCGCTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2835.98751205056	43.3216769028192	0.0152756938169645	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.386658828	2829.386658828
"AML-0024"	"2020-09-15-AML0024:GGTGAAGAGAAGCTCG"	-1.88771245899852	-16.1115389100281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGAAGAGAAGCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2950.24651626267	43.9057115311437	0.014882048428537	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2942.85175181415	2942.85175181415
"AML-0024"	"2020-09-15-AML0024:GGTGAAGAGAGCCATG"	-1.09201524677928	-17.27504064953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGAAGAGAGCCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.5858399591	42.4228074454702	0.0165095895166302	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.37769223926	2560.37769223926
"AML-0024"	"2020-09-15-AML0024:GGTGAAGAGGTACTGG"	-0.713000635535079	-16.6290369263855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGAAGAGGTACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.92942336015	37.1197311859082	0.0134009664191656	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.64864479901	2762.64864479901
"AML-0024"	"2020-09-15-AML0024:GGTGAAGGTACACTCA"	-2.80938253822978	-15.9779691926208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGAAGGTACACTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.93832573262	30.8727833360124	0.0117167005521575	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.87827778383	2623.87827778383
"AML-0024"	"2020-09-15-AML0024:GGTGATTAGAGGGTAA"	-1.70633063736613	-15.6598015061584	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTAGAGGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.78044316344	35.9409808536525	0.0129573993292211	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.34021108933	2768.34021108933
"AML-0024"	"2020-09-15-AML0024:GGTGATTAGTTTGTCG"	-2.56157908859904	-15.7179241410461	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTAGTTTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.29163783166	39.7499044861141	0.0144898573443445	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.05783192938	2740.05783192938
"AML-0024"	"2020-09-15-AML0024:GGTGATTGTAGTGCGA"	-0.917148451239425	-16.0493650666443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTGTAGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.07850554018	34.3680967644614	0.0133308961269433	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.97458035221	2570.97458035221
"AML-0024"	"2020-09-15-AML0024:GGTGATTGTGGACCTC"	-2.59225545349773	-15.4962187043396	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTGTGGACCTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.49737041469	32.3859853200225	0.0125163355489061	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.02255600784	2580.02255600784
"AML-0024"	"2020-09-15-AML0024:GGTGATTTCAGCAATC"	-0.667536835104781	-15.72048571026	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTTCAGCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.91228989107	39.2158307144918	0.0148493499252523	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.38223827459	2637.38223827459
"AML-0024"	"2020-09-15-AML0024:GGTGATTTCCGCAACG"	-0.687910477549392	-16.6855840913025	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTTCCGCAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3005.5034986787	33.1622931398229	0.0110338561091018	3503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2997.49793055935	2997.49793055935
"AML-0024"	"2020-09-15-AML0024:GGTGATTTCTCTAAGG"	-1.62708638134654	-15.5978288880554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGATTTCTCTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.77030638292	33.5419631080615	0.01207513919743	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.5954413633	2769.5954413633
"AML-0024"	"2020-09-15-AML0024:GGTGGCTAGCTGAGTG"	-1.29156957092937	-15.5596580735412	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTAGCTGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.08970844809	33.4471407187339	0.0131573408316707	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2534.84262537586	2534.84262537586
"AML-0024"	"2020-09-15-AML0024:GGTGGCTAGCTGCGAA"	-0.527777711779434	-15.9425735703674	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTAGCTGCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.73641835433	36.7125520549127	0.0142865049476256	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.65017504995	2563.65017504995
"AML-0024"	"2020-09-15-AML0024:GGTGGCTAGGATACGC"	8.93847908553426	7.96039769733278	"2020-09-15-AML0024"	"AML0024"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTAGGATACGC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1671.6339899571	43.2126276790696	0.02585053183812	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1670.0746822084	1670.0746822084
"AML-0024"	"2020-09-15-AML0024:GGTGGCTCACTACCCT"	-1.49645696106609	-16.0460920563904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTCACTACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.58610171711	35.7567863475821	0.0135361048138234	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.36604865717	2637.36604865717
"AML-0024"	"2020-09-15-AML0024:GGTGGCTCATCGGCCA"	-1.9713913005894	-16.2011060944763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTCATCGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.50504751684	35.1560933957604	0.0129750979530301	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.27785588481	2700.27785588481
"AML-0024"	"2020-09-15-AML0024:GGTGGCTCATTACGGT"	-0.462922374636489	-16.4308748475281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTCATTACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.72951709855	31.7667774625738	0.0118899676255671	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.64447390534	2665.64447390534
"AML-0024"	"2020-09-15-AML0024:GGTGGCTGTAGGTGCA"	1.29318859156911	-16.1787538758484	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTGTAGGTGCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2911.50903006366	48.7247847146153	0.0167352339324704	2849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2907.37352334336	2907.37352334336
"AML-0024"	"2020-09-15-AML0024:GGTGGCTGTGGCTAGA"	-0.78833250227626	-16.5922250977722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTGTGGCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2428.51245354552	34.1918613153701	0.0140793436185396	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.09861431359	2423.09861431359
"AML-0024"	"2020-09-15-AML0024:GGTGGCTGTTCTCACC"	-2.75740371170695	-16.0237150422302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTGTTCTCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.59996424194	36.4978266184825	0.0152800080234723	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.96606815178	2380.96606815178
"AML-0024"	"2020-09-15-AML0024:GGTGGCTTCATGAAAG"	-1.6403081220692	-16.9131212464538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTTCATGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2005.76444279052	44.2086301565417	0.0220407886456679	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1989.67820500254	1989.67820500254
"AML-0024"	"2020-09-15-AML0024:GGTGGCTTCTTGGTCC"	-1.88320968571361	-16.7353468171326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGGCTTCTTGGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.49760193558	39.1611037932541	0.0135622982914352	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2878.71435612218	2878.71435612218
"AML-0024"	"2020-09-15-AML0024:GGTGTCGAGACCGCCT"	-0.965127925307113	-15.7133960953918	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGAGACCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.32668169402	38.8910783861896	0.0155047899741369	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.80577046739	2504.80577046739
"AML-0024"	"2020-09-15-AML0024:GGTGTCGAGTCGAAAT"	-0.638706664473373	-16.4020624390808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGAGTCGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.23891023492	37.7396837759762	0.0143483862356083	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.68232929046	2624.68232929046
"AML-0024"	"2020-09-15-AML0024:GGTGTCGAGTGATCGG"	-1.1275716823643	-16.4553899995056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGAGTGATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.05407500596	34.3014855855066	0.012661794351754	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.14976175507	2703.14976175507
"AML-0024"	"2020-09-15-AML0024:GGTGTCGAGTGGAAAG"	-1.20472798767741	-16.6941423646179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGAGTGGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.07386116693	38.2927153948693	0.0155973781483985	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2452.05119196305	2452.05119196305
"AML-0024"	"2020-09-15-AML0024:GGTGTCGCAATTGAAG"	-0.860317985445815	-15.9523592225281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGCAATTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.58429011644	42.6573464438534	0.0157722377519308	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.95980919773	2702.95980919773
"AML-0024"	"2020-09-15-AML0024:GGTGTCGCAGAGGTTG"	1.00083728608434	-16.2270117036072	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGCAGAGGTTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2775.56392489966	45.6797885786844	0.0164578405739063	3044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2762.17849873036	2762.17849873036
"AML-0024"	"2020-09-15-AML0024:GGTGTCGGTACGAAAT"	11.6309944587642	-2.02157809650572	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGGTACGAAAT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1244.32510534235	35.2857803694382	0.0283573643398685	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1243.35064540355	1243.35064540355
"AML-0024"	"2020-09-15-AML0024:GGTGTCGGTGTGTACT"	9.28333916243855	7.75395248020021	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGGTGTGTACT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1701.51750649129	37.1584445337083	0.0218384144694069	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1699.88878685188	1699.88878685188
"AML-0024"	"2020-09-15-AML0024:GGTGTCGTCCCTTGGT"	-1.60755620423015	-16.0337877503601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGTCCCTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.51924741596	31.0596636418685	0.0121160251373875	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.41958456299	2555.41958456299
"AML-0024"	"2020-09-15-AML0024:GGTGTCGTCGCGATCG"	-0.933606306940872	-16.3452730408874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTCGTCGCGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.23386869042	37.7621251524674	0.0139075037284653	2816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.10183292659	2707.10183292659
"AML-0024"	"2020-09-15-AML0024:GGTGTTAAGATTCGCT"	0.17334727671687	-16.4116163483826	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTAAGATTCGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2886.53116017511	35.802793964108	0.0124033977038155	3108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2874.79621303594	2874.79621303594
"AML-0024"	"2020-09-15-AML0024:GGTGTTAAGCCAGAGT"	-1.96313558045085	-16.1084738007751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTAAGCCAGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.5614619294	35.9677317593763	0.0131050924740783	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.58677996489	2740.58677996489
"AML-0024"	"2020-09-15-AML0024:GGTGTTACAACGGCTC"	-0.419701198965865	-16.3885641328064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTACAACGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.06354153275	36.3996660866299	0.0130883978532072	2622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.53866214669	2774.53866214669
"AML-0024"	"2020-09-15-AML0024:GGTGTTACACATACGT"	-0.456642846495467	-16.5393457642761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTACACATACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.14451876027	43.0965759688957	0.0166708575308443	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.1206513215	2574.1206513215
"AML-0024"	"2020-09-15-AML0024:GGTGTTACAGACAATA"	-1.76470611515697	-15.887776397821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTACAGACAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.14566779989	28.520954902964	0.0106894294592551	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.80312564474	2657.80312564474
"AML-0024"	"2020-09-15-AML0024:GGTGTTAGTGTCGCTG"	-1.29185519638713	-16.0658293000427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTGTTAGTGTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.56206773568	37.9146261410529	0.01444057507037	2754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.46194728318	2618.46194728318
"AML-0024"	"2020-09-15-AML0024:GGTTAACAGGTACAGC"	-0.939818601042587	-15.6686458817688	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACAGGTACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.3755072267	31.5806152669733	0.0115876198282523	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.1413169383	2721.1413169383
"AML-0024"	"2020-09-15-AML0024:GGTTAACCAAGTGATA"	-0.962313513190109	-16.0077524415222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACCAAGTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.27284975523	34.0467313694994	0.0131899002357414	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.72099272528	2575.72099272528
"AML-0024"	"2020-09-15-AML0024:GGTTAACCAATCGCCG"	-1.97472868385966	-16.5771608582703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACCAATCGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.79300431341	48.3974799892649	0.0210168607854074	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2289.22119587845	2289.22119587845
"AML-0024"	"2020-09-15-AML0024:GGTTAACCACGTGAGA"	-2.83918366852458	-15.6088466874328	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACCACGTGAGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.08680254139	37.7460640389308	0.0135919640698261	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.52806452659	2768.52806452659
"AML-0024"	"2020-09-15-AML0024:GGTTAACCATGTACGT"	-2.13237891617473	-15.5361900559631	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACCATGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3058.34430480701	32.0654293218219	0.0104845714301763	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3048.31997503948	3048.31997503948
"AML-0024"	"2020-09-15-AML0024:GGTTAACGTGTACAGG"	-1.27039919319804	-16.6343393555847	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACGTGTACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.96446207299	30.6427812400181	0.0119466689278232	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.80533524362	2561.80533524362
"AML-0024"	"2020-09-15-AML0024:GGTTAACTCTAACACG"	-1.23325870457347	-16.7909689179626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACTCTAACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.70305615538	40.0123355802677	0.0158734823931603	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.22176794305	2510.22176794305
"AML-0024"	"2020-09-15-AML0024:GGTTAACTCTCTCAAT"	-2.21524606171306	-16.3318929902283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTAACTCTCTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.47413652938	38.5431296880137	0.0170358321740369	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.71307777533	2257.71307777533
"AML-0024"	"2020-09-15-AML0024:GGTTCTCAGGCCCAAA"	-3.84206018868144	13.3672704466614	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCAGGCCCAAA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2352.43539203523	30.6945654537692	0.0130479950938051	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2347.51713101567	2347.51713101567
"AML-0024"	"2020-09-15-AML0024:GGTTCTCAGGGATCTG"	-0.0261015919154466	-16.5278177491394	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCAGGGATCTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.80026223079	38.6525609545007	0.0130990095972404	3575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2938.45208792402	2938.45208792402
"AML-0024"	"2020-09-15-AML0024:GGTTCTCAGGGATGTC"	-0.718025724322158	-16.0510225526062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCAGGGATGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.96922603855	30.1746654289765	0.0115524582480403	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.52951219603	2604.52951219603
"AML-0024"	"2020-09-15-AML0024:GGTTCTCAGGTTACAA"	-0.871278027922469	-16.1610346070495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCAGGTTACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.75502679762	38.7674388866275	0.013951369772709	2644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.50357091912	2769.50357091912
"AML-0024"	"2020-09-15-AML0024:GGTTCTCGTGCAACAG"	0.24568054553811	-16.4218740693298	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCGTGCAACAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2591.49021791768	49.4446828986729	0.0190796332383623	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2581.04354393961	2581.04354393961
"AML-0024"	"2020-09-15-AML0024:GGTTCTCGTGGTAACG"	-1.26601717892345	-16.6358099213806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCGTGGTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.22629089655	39.3390115914414	0.0160815096043398	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2437.91993731695	2437.91993731695
"AML-0024"	"2020-09-15-AML0024:GGTTCTCTCCATACAG"	-1.7774991792744	-16.2282705537048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCTCCATACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.25116192087	34.8750731626969	0.0135898908416246	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.00357208874	2560.00357208874
"AML-0024"	"2020-09-15-AML0024:GGTTCTCTCCGCGAGT"	-1.01084349575694	-15.7783994904724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCTCCGCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.82172570548	39.13829957542	0.0135154382011845	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.57963410464	2887.57963410464
"AML-0024"	"2020-09-15-AML0024:GGTTCTCTCTTACACT"	-0.674073974520522	-16.0531797639099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTCTCTCTTACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.32103149375	37.7344155768895	0.014226941282307	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.86203201722	2645.86203201722
"AML-0024"	"2020-09-15-AML0024:GGTTGTACACAGAGAC"	-1.5671468776768	-15.6133852235046	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTGTACACAGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.97678979737	34.4914655682857	0.0125015424906198	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2750.56950433529	2750.56950433529
"AML-0024"	"2020-09-15-AML0024:GGTTGTACACCCTAAA"	1.19733335551564	-16.2088041535583	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTGTACACCCTAAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3202.00855869743	39.7703960193954	0.0124204527534349	4746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3191.20693075732	3191.20693075732
"AML-0024"	"2020-09-15-AML0024:GGTTGTATCTAAGGAA"	-2.12906108322795	-16.5890894166199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTGTATCTAAGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.04356220839	46.0553969904073	0.0180111898252651	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.79599963448	2549.79599963448
"AML-0024"	"2020-09-15-AML0024:GGTTGTATCTGAATCG"	-1.6325685781544	-16.0383196107117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GGTTGTATCTGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.82434345257	35.9284831694791	0.013862236945278	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.554678052	2587.554678052
"AML-0024"	"2020-09-15-AML0024:GTAACACAGCCTGTCG"	-1.45791719380077	-15.0811672440735	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACAGCCTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.82468014589	32.0284842298321	0.0129994980925086	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2452.33827809847	2452.33827809847
"AML-0024"	"2020-09-15-AML0024:GTAACACAGGCAGTCA"	0.824736734002274	-16.1967210999695	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACAGGCAGTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3060.46478877992	48.4056059801398	0.0158164230993937	3342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3044.96009513003	3044.96009513003
"AML-0024"	"2020-09-15-AML0024:GTAACACAGGGCAGTT"	-2.7688082260197	-16.1958837739197	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACAGGGCAGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.39039444645	41.9968474688057	0.0175837449214575	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2384.70858554196	2384.70858554196
"AML-0024"	"2020-09-15-AML0024:GTAACACCAAGGAGTC"	-2.61598978462871	-15.4736948243347	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACCAAGGAGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.43510869438	34.6608479146498	0.012315383576468	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.5721478314	2806.5721478314
"AML-0024"	"2020-09-15-AML0024:GTAACACCACTGAGGA"	-1.77911565724071	-16.0914755097595	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACCACTGAGGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2039.83175431434	41.2662903520938	0.0202302421583612	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2036.5826958483	2036.5826958483
"AML-0024"	"2020-09-15-AML0024:GTAACACGTGAATAAC"	-2.14656482163127	-16.0438852540222	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACGTGAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.13376812572	43.0351831449129	0.0158326215028732	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.97439423342	2710.97439423342
"AML-0024"	"2020-09-15-AML0024:GTAACACTCCGCTTAC"	-1.53616295281108	-16.4898195496765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACTCCGCTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.79625299739	31.3627030113471	0.0118762297453844	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.50884801556	2632.50884801556
"AML-0024"	"2020-09-15-AML0024:GTAACACTCGAAGCCC"	-1.94181058827098	-16.3563547364441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACACTCGAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2939.26712802217	37.3056960396592	0.0126921761156027	2963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.4747343438	2924.4747343438
"AML-0024"	"2020-09-15-AML0024:GTAACCAAGGTTTACC"	0.880346019833726	-16.2369318238464	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCAAGGTTTACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2810.42952511752	40.7998282895847	0.0145172927927729	3284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2798.89680271841	2798.89680271841
"AML-0024"	"2020-09-15-AML0024:GTAACCACAAAGCTAA"	-0.748262266547042	-16.2987394562927	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCACAAAGCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.01942796726	35.0670289265022	0.0126686354048657	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.25529940788	2752.25529940788
"AML-0024"	"2020-09-15-AML0024:GTAACCACACAGTGAG"	-1.2380260032719	-15.6590261689392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCACACAGTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2083.09899299342	43.9909233112841	0.0211180186151734	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2078.57198900346	2078.57198900346
"AML-0024"	"2020-09-15-AML0024:GTAACCAGTCACTCGG"	-0.875110487372238	-16.3541727296081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCAGTCACTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.79926806767	32.1508504116595	0.0130123279649518	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2466.67231938164	2466.67231938164
"AML-0024"	"2020-09-15-AML0024:GTAACCAGTCCGGTGT"	-0.775233487517196	-16.7897234193054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCAGTCCGGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.76236169111	43.5379330232695	0.0192325545119255	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2254.3758062047	2254.3758062047
"AML-0024"	"2020-09-15-AML0024:GTAACCAGTGAATATG"	-0.770187417895156	-16.1954584351745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCAGTGAATATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.22557449778	32.6256680006069	0.012456226878001	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.36258472631	2612.36258472631
"AML-0024"	"2020-09-15-AML0024:GTAACCAGTGTACGCC"	-1.38297126713451	-16.1905393830505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAACCAGTGTACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.25293024331	39.5960039574242	0.0150999941694222	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.55311774289	2614.55311774289
"AML-0024"	"2020-09-15-AML0024:GTAAGTCAGCACCAGA"	-1.91201732578929	-16.0928125611511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCAGCACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.83316150145	41.7305266847863	0.0172737618432436	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2411.6872462572	2411.6872462572
"AML-0024"	"2020-09-15-AML0024:GTAAGTCAGCCTCTGG"	-1.38450811329539	-16.4565038911072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCAGCCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2561.58276896475	38.4476514850251	0.015009334053478	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.95823734844	2553.95823734844
"AML-0024"	"2020-09-15-AML0024:GTAAGTCAGTTAACGA"	-0.00356586548741463	-16.1420183411804	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCAGTTAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.81084088619	40.7775937988219	0.0157636550590813	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.8529578583	2582.8529578583
"AML-0024"	"2020-09-15-AML0024:GTAAGTCCAGCGTTTA"	-0.831903438002425	-16.5856752625671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCCAGCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2522.03298709786	35.3505261035693	0.0140166787208631	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.32646921511	2515.32646921511
"AML-0024"	"2020-09-15-AML0024:GTAAGTCGTGTCCGTG"	-1.61763260784801	-15.7774000397888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCGTGTCCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.0932456017	37.0027041559701	0.0133146680898642	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.4767644	2775.4767644
"AML-0024"	"2020-09-15-AML0024:GTAAGTCTCACTGGTA"	1.14250757273976	-16.2118425599304	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCTCACTGGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3005.5130085746	49.1716511831316	0.0163604852292594	3452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2990.05564948201	2990.05564948201
"AML-0024"	"2020-09-15-AML0024:GTAAGTCTCCCAGCGA"	-0.248392711312133	-16.2675543061462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAAGTCTCCCAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.14829781186	37.5522626000287	0.0142939257107434	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.72328986509	2619.72328986509
"AML-0024"	"2020-09-15-AML0024:GTAATCGAGCTAAATG"	-1.95292411270793	-16.6593790284363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGAGCTAAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2308.7722977849	40.6888969661599	0.0176236075793173	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2293.93552477196	2293.93552477196
"AML-0024"	"2020-09-15-AML0024:GTAATCGAGGGAGGAC"	-2.44046554985698	-16.0572958222595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGAGGGAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.28003455223	40.2514163113099	0.0158017240999518	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2542.55816844036	2542.55816844036
"AML-0024"	"2020-09-15-AML0024:GTAATCGAGGTGAGCT"	1.07922651347463	-16.231432937738	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGAGGTGAGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.87991686577	40.2436988578327	0.0136378639563812	3847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2941.95533985422	2941.95533985422
"AML-0024"	"2020-09-15-AML0024:GTAATCGCACGGCTAC"	-1.79328141632732	-15.7640733948913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGCACGGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.08094019209	37.8637249838767	0.0140387796375069	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.11109543445	2687.11109543445
"AML-0024"	"2020-09-15-AML0024:GTAATCGCAGCTTTGA"	-1.60966513577159	-16.9267149201599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGCAGCTTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.44528815236	33.937739082439	0.0136107815333645	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.86132140629	2489.86132140629
"AML-0024"	"2020-09-15-AML0024:GTAATCGGTATGAAAC"	-1.73279903355296	-16.6743669739929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGGTATGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.26224025351	48.3230990873605	0.0208265678978083	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2319.25880981276	2319.25880981276
"AML-0024"	"2020-09-15-AML0024:GTAATCGTCACGATAC"	-3.16362653198894	13.4861135252747	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATCGTCACGATAC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1702.19080846015	27.6727247761504	0.0162571226672196	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1696.21084849801	1696.21084849801
"AML-0024"	"2020-09-15-AML0024:GTAATGCAGTCGAAGC"	-0.723397652537185	-16.1147299042908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCAGTCGAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.93422451975	39.9000467645494	0.0147508380805946	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.10856335965	2699.10856335965
"AML-0024"	"2020-09-15-AML0024:GTAATGCCACTGAGGA"	-0.391594956547576	-15.9857874146667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCCACTGAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.09347412912	38.7494242459272	0.014705142199456	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.55101658852	2628.55101658852
"AML-0024"	"2020-09-15-AML0024:GTAATGCCAGAGAATT"	-1.63310728493388	-16.4884367219177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCCAGAGAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.61193001791	35.4451190377834	0.0130764270035325	2326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.49483982984	2704.49483982984
"AML-0024"	"2020-09-15-AML0024:GTAATGCGTAGCTCGC"	-2.49983320656474	-15.6927337876526	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCGTAGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.75585023668	38.1451399289503	0.0136683902053687	2883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2782.93274423988	2782.93274423988
"AML-0024"	"2020-09-15-AML0024:GTAATGCGTGACAGGT"	-1.4365932745045	-15.8269319764343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCGTGACAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.92749790276	37.4326564989544	0.0140043665712313	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.51245101073	2669.51245101073
"AML-0024"	"2020-09-15-AML0024:GTAATGCTCACTTATC"	-1.04531357708629	-16.292410873529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAATGCTCACTTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2869.39329297311	36.2335580493206	0.0126276025451281	2715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.31188143431	2859.31188143431
"AML-0024"	"2020-09-15-AML0024:GTACAACAGCACCTGC"	-1.78791723671611	-16.2433881989685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACAGCACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.35676305641	36.3204207684654	0.0130679232156308	2652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.0066153655	2773.0066153655
"AML-0024"	"2020-09-15-AML0024:GTACAACCAAGTCGTT"	-1.26793358746226	-16.1122503510681	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACCAAGTCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.54688811513	38.6838169174097	0.0145343360622909	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.01590120611	2657.01590120611
"AML-0024"	"2020-09-15-AML0024:GTACAACCAGAACCGA"	-2.67742119255717	-16.2599992982117	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACCAGAACCGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.48302342193	41.4463050534569	0.0155492661890033	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.13088527096	2657.13088527096
"AML-0024"	"2020-09-15-AML0024:GTACAACCATACAGGG"	-0.813664416701156	-16.4995966187683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACCATACAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.52957783136	30.6676488712614	0.0117341885591777	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.86312162946	2603.86312162946
"AML-0024"	"2020-09-15-AML0024:GTACAACGTTTGGGTT"	8.27287258681599	-8.47964289104613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	33	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.333333333333333	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACGTTTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1513.68747692606	48.0732450140652	0.0317590293550493	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1509.80536536928	1509.80536536928
"AML-0024"	"2020-09-15-AML0024:GTACAACTCTGCTAGA"	-0.332084636122543	-15.9877939454285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAACTCTGCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.39897626191	36.2028243468829	0.0127726634994161	2741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.54998456693	2830.54998456693
"AML-0024"	"2020-09-15-AML0024:GTACAGTAGGCTAAAT"	-1.5532765192097	-16.0965662232605	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTAGGCTAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.20275031143	34.5957606616726	0.0118959246077213	3343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2898.14776848929	2898.14776848929
"AML-0024"	"2020-09-15-AML0024:GTACAGTGTGTTCATG"	-2.06581054154094	-15.603355430719	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTGTGTTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2104.02711560419	43.1104686495069	0.0204895024069722	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2100.64711355114	2100.64711355114
"AML-0024"	"2020-09-15-AML0024:GTACAGTGTTGCTTGA"	-0.309250722557861	-16.1125917664734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTGTTGCTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.51650392364	38.5012278895803	0.0140951840614091	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.89147640996	2721.89147640996
"AML-0024"	"2020-09-15-AML0024:GTACAGTGTTTACTTC"	0.0810640576178252	-16.1305036774841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTGTTTACTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.55367048735	36.7536178873623	0.0127636509310632	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.49105973831	2867.49105973831
"AML-0024"	"2020-09-15-AML0024:GTACAGTTCTCCTGAC"	-0.69499240341838	-16.3038912049499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTTCTCCTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.96112784609	35.7814752282784	0.0132036857874481	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.11293864665	2703.11293864665
"AML-0024"	"2020-09-15-AML0024:GTACAGTTCTGGGCCA"	-2.04820118370708	-15.6458711854187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTACAGTTCTGGGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.46111379417	35.1782693608976	0.0138091487129722	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.86510240392	2539.86510240392
"AML-0024"	"2020-09-15-AML0024:GTAGAAAAGAGATTCA"	-2.91312871399577	-15.7255125275818	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAAGAGATTCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.87355017548	34.4137021140887	0.0121651609743935	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.84972568842	2820.84972568842
"AML-0024"	"2020-09-15-AML0024:GTAGAAAAGTTTAGGA"	-2.28900394859965	-15.5984325638977	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAAGTTTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.88184425989	39.3458310544608	0.0144606908004722	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.66953010393	2717.66953010393
"AML-0024"	"2020-09-15-AML0024:GTAGAAACAAAGAACT"	-0.77361379090007	-15.9708605042663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAACAAAGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.76753943164	38.746837137377	0.0143892246805512	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.28404930517	2684.28404930517
"AML-0024"	"2020-09-15-AML0024:GTAGAAACAGGAATAT"	-2.95159802857097	-15.8771372071472	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAACAGGAATAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.41100395	37.2380926204011	0.014298086040922	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.44503585879	2592.44503585879
"AML-0024"	"2020-09-15-AML0024:GTAGAAACATCGCCTT"	-0.906259397894698	-16.7585668793884	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAACATCGCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.02779020859	43.5978892556666	0.0151696129745852	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.80135350835	2864.80135350835
"AML-0024"	"2020-09-15-AML0024:GTAGAAACATCTAGAC"	-1.85686169090922	-16.6127767792908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAACATCTAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.06558465219	36.1240883996007	0.0126084682295278	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.16222546843	2855.16222546843
"AML-0024"	"2020-09-15-AML0024:GTAGAAACATTCGATG"	-1.06683669510539	-17.0811891785828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAACATTCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2893.08676473146	45.3323439922513	0.0156691961488611	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2880.55080303667	2880.55080303667
"AML-0024"	"2020-09-15-AML0024:GTAGAAAGTAGCGAGT"	-1.70840774002727	-15.4747333756653	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAGTAGCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.85503845728	36.0303135184511	0.0139877100925797	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.07683782419	2566.07683782419
"AML-0024"	"2020-09-15-AML0024:GTAGAAAGTAGGCTCC"	0.103130170225543	-16.1460504761902	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAGTAGGCTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2750.48236596739	42.4553462808327	0.0154356002445776	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2743.61007149704	2743.61007149704
"AML-0024"	"2020-09-15-AML0024:GTAGAAAGTGAGGATC"	-2.12176166001018	-15.8056993714538	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAGTGAGGATC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.27665634531	35.7953854090275	0.0142085964710821	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.91246582374	2512.91246582374
"AML-0024"	"2020-09-15-AML0024:GTAGAAAGTTACCTTT"	0.0867547365719497	-16.4069166413513	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAAGTTACCTTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2151.77310862259	45.9200250217462	0.0213405515840566	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2141.02291141015	2141.02291141015
"AML-0024"	"2020-09-15-AML0024:GTAGAAATCGGCGATC"	-1.01240752163585	-16.6398954621521	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAATCGGCGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.13082591124	31.3226963478836	0.0117000992423379	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.67251371047	2669.67251371047
"AML-0024"	"2020-09-15-AML0024:GTAGAAATCTCTCGAC"	-1.95430932465251	-16.7683992615906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAAATCTCTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2959.72367275821	33.637676432632	0.0113651408549517	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2948.12020137587	2948.12020137587
"AML-0024"	"2020-09-15-AML0024:GTAGAGGAGACTCGAG"	-1.77794919434245	-15.9411993256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGAGACTCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.06614624452	39.1702548890996	0.0157622584607233	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2477.48174614951	2477.48174614951
"AML-0024"	"2020-09-15-AML0024:GTAGAGGAGGTTCCGC"	-1.77004383030589	-16.7959108582703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGAGGTTCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.75618704793	32.1181724349478	0.0129783178654301	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2466.03352008663	2466.03352008663
"AML-0024"	"2020-09-15-AML0024:GTAGAGGAGTGCAAAT"	-1.93259368363078	-16.672917389032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGAGTGCAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.34108426141	38.9660979199	0.0159153061517386	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2443.1935611189	2443.1935611189
"AML-0024"	"2020-09-15-AML0024:GTAGAGGCACCTGATA"	-1.16185019436534	-17.1934786072937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGCACCTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.25203184498	43.573890407533	0.01600068223506	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.55842631572	2716.55842631572
"AML-0024"	"2020-09-15-AML0024:GTAGAGGCACTTCAGA"	-1.10802171650584	-15.8425588837829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGCACTTCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.59315220273	36.4135466999827	0.0139057671747717	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.75925427868	2609.75925427868
"AML-0024"	"2020-09-15-AML0024:GTAGAGGGTCCAGCAC"	0.191989888518494	-16.3076734772888	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGAGGGTCCAGCAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2958.61787338084	41.6065566228241	0.0140628355547923	2920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2949.82461768049	2949.82461768049
"AML-0024"	"2020-09-15-AML0024:GTAGATCCAACCGCCA"	-1.39460967007335	-16.476155304071	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCCAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.09000671359	36.4454399840991	0.0134530192403283	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.46653158029	2699.46653158029
"AML-0024"	"2020-09-15-AML0024:GTAGATCCAGCGCTTG"	-1.57241557064708	-15.8953247300354	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCCAGCGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.80594349113	43.0710084383519	0.0174956960162636	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.80896038204	2450.80896038204
"AML-0024"	"2020-09-15-AML0024:GTAGATCGTGGCGTAA"	-2.38899693909343	-15.5171938172546	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCGTGGCGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.85094116958	33.9232770098114	0.0124862488757693	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.14146722494	2712.14146722494
"AML-0024"	"2020-09-15-AML0024:GTAGATCGTTTAGTCG"	-1.08936689320262	-16.5021219483581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCGTTTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.23381689933	46.297467417113	0.0211671322285723	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2181.4301241393	2181.4301241393
"AML-0024"	"2020-09-15-AML0024:GTAGATCTCACAACCA"	-1.31924734535869	-16.3630552521911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCTCACAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2936.4396105263	35.73898025326	0.0121708548424241	3152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2927.95411441527	2927.95411441527
"AML-0024"	"2020-09-15-AML0024:GTAGATCTCACTAGCA"	-2.61762414398845	-15.9189892045227	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGATCTCACTAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2345.81882634714	35.0293975815778	0.0149326952227274	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2341.09093525147	2341.09093525147
"AML-0024"	"2020-09-15-AML0024:GTAGCTAGTGCGGTAA"	-0.374157438904601	-15.9464464417663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGCTAGTGCGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2907.68347143212	43.2351697770848	0.0148692834697685	2803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2897.78524299386	2897.78524299386
"AML-0024"	"2020-09-15-AML0024:GTAGCTATCAAACTGC"	-2.61137829247172	-16.2665434113708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGCTATCAAACTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.38065248723	35.4863204604318	0.0140853349911211	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.36897687063	2512.36897687063
"AML-0024"	"2020-09-15-AML0024:GTAGCTATCACCTTGC"	11.3991171317989	-1.83027675068053	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGCTATCACCTTGC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1284.68149122613	34.2336962633351	0.0266476138226773	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1283.44191129976	1283.44191129976
"AML-0024"	"2020-09-15-AML0024:GTAGCTATCCCAGTGG"	-0.338420639664489	-16.0494299164978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGCTATCCCAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.03030824223	31.7081542353464	0.0122613235174722	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.32905582782	2582.32905582782
"AML-0024"	"2020-09-15-AML0024:GTAGCTATCGGTCATA"	-2.02283630791362	-16.799662613031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGCTATCGGTCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.45109633011	38.3451448397754	0.0163696671831699	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2337.33484002076	2337.33484002076
"AML-0024"	"2020-09-15-AML0024:GTAGGAGCAAGAATGT"	-1.93597207489665	-16.1726694337097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGAGCAAGAATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.65926556048	37.5545971063577	0.0149105508711995	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2514.05169016638	2514.05169016638
"AML-0024"	"2020-09-15-AML0024:GTAGGAGGTACCATAC"	-0.216250966221648	-16.4902563325134	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGAGGTACCATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.64769855208	36.2253556815298	0.0131697547819732	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.04905139717	2743.04905139717
"AML-0024"	"2020-09-15-AML0024:GTAGGAGTCCGTATGA"	-0.839685360819656	-16.3785467377869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGAGTCCGTATGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.25164120699	32.4595713910411	0.0128083458103559	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.15994553183	2526.15994553183
"AML-0024"	"2020-09-15-AML0024:GTAGGAGTCGCAATGT"	-1.04502616348918	-15.9347076646057	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGAGTCGCAATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.88290781986	39.3999932691209	0.015050326793238	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.66092952173	2607.66092952173
"AML-0024"	"2020-09-15-AML0024:GTAGGTTAGCGTTCCG"	-1.14123866978343	-15.7939167252746	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTAGCGTTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.34800427316	40.7945818283475	0.0152826015053273	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.42517132849	2664.42517132849
"AML-0024"	"2020-09-15-AML0024:GTAGGTTAGCTAAATG"	-1.86758230152782	-16.3675146332947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTAGCTAAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.92243587016	31.0084122899793	0.0124236281722307	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2478.61751485492	2478.61751485492
"AML-0024"	"2020-09-15-AML0024:GTAGGTTAGGGCAACT"	-0.356924275786239	-15.8833084336487	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTAGGGCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.18851908102	35.1847536441784	0.0124231679519678	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2825.13467392264	2825.13467392264
"AML-0024"	"2020-09-15-AML0024:GTAGGTTAGTATGAAC"	-1.65803978863414	-15.8785085908142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTAGTATGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.79385847259	41.9838750984031	0.015713740401516	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.36220935279	2661.36220935279
"AML-0024"	"2020-09-15-AML0024:GTAGGTTAGTCTGCAT"	-0.774181167513686	-16.3562841645447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTAGTCTGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.38538793637	35.124099667148	0.0130748550914839	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.71590921081	2681.71590921081
"AML-0024"	"2020-09-15-AML0024:GTAGGTTCAAACTCTG"	-2.00989995423015	-16.0890646210876	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTCAAACTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.23548439393	35.7448580986994	0.0135848191128103	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.11216785455	2628.11216785455
"AML-0024"	"2020-09-15-AML0024:GTAGGTTCACCGTCTT"	-2.10871992531474	-16.0187978974548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTCACCGTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.44883219987	39.0124994200402	0.014680432957855	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.08659908286	2648.08659908286
"AML-0024"	"2020-09-15-AML0024:GTAGGTTCAGTTCACA"	-2.0494798225468	-16.0221166840759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTCAGTTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.06066870199	34.0757539170511	0.0130705642281876	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.6939473175	2600.6939473175
"AML-0024"	"2020-09-15-AML0024:GTAGGTTTCGAGCCAC"	-1.52193365517314	-15.720069908258	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGGTTTCGAGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.71207043046	34.97908186941	0.0134291549021882	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.05606133308	2602.05606133308
"AML-0024"	"2020-09-15-AML0024:GTAGTACAGGTTCTTG"	-0.813614944845992	-16.6216573945251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.0072069358	37.1137884810324	0.0138535605223259	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.18576125744	2670.18576125744
"AML-0024"	"2020-09-15-AML0024:GTAGTACGTACGAGTG"	-1.77134833756145	-15.7896623841492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACGTACGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.83839820264	36.3235916845238	0.0131805956794179	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2747.82242465298	2747.82242465298
"AML-0024"	"2020-09-15-AML0024:GTAGTACGTTGTTTGG"	-1.46455059471782	-15.8247995606628	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACGTTGTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.56894010229	34.0673739073291	0.0123139436048427	2454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.06968820966	2761.06968820966
"AML-0024"	"2020-09-15-AML0024:GTAGTACTCACCCTCA"	-1.73682425442393	-15.8733320466247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACTCACCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.3844308947	35.3234975113774	0.0128946843360136	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.32655697431	2733.32655697431
"AML-0024"	"2020-09-15-AML0024:GTAGTACTCCTATGGA"	-0.582811753184158	-16.2103586426941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACTCCTATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.6791545826	30.245004840678	0.0108885883348982	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.96802201367	2773.96802201367
"AML-0024"	"2020-09-15-AML0024:GTAGTACTCCTATTGT"	-1.40603361550029	-16.5807237855163	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTAGTACTCCTATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.31230496736	35.2730824846523	0.0138962736837483	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.6500689103	2536.6500689103
"AML-0024"	"2020-09-15-AML0024:GTATTGGAGAAGCTCG"	-2.23797569695171	-16.5172357789245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGAGAAGCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.49135283057	46.5658657845781	0.0182005171653444	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.51228679283	2546.51228679283
"AML-0024"	"2020-09-15-AML0024:GTATTGGAGTAACCGG"	-1.01360056820567	-15.4630098572937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGAGTAACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.00669050587	35.1072676582439	0.012489215261144	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.20736658909	2801.20736658909
"AML-0024"	"2020-09-15-AML0024:GTATTGGAGTGGACGT"	-0.534180383116561	-16.6872740021911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGAGTGGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.15227802892	39.5512978949326	0.0136329617009295	2815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.89939057412	2892.89939057412
"AML-0024"	"2020-09-15-AML0024:GTATTGGAGTGGTTAA"	0.297671695321244	-16.5079107514587	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGAGTGGTTAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3177.47693925889	40.0924186925968	0.012617689902715	4314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3161.65362135261	3161.65362135261
"AML-0024"	"2020-09-15-AML0024:GTATTGGGTCATCCCT"	-1.48865507069286	-16.8688764802185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGGTCATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2260.14570873223	47.0145516543104	0.020801557825527	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2252.6040506758	2252.6040506758
"AML-0024"	"2020-09-15-AML0024:GTATTGGGTCTTACAG"	-1.8626551431721	-16.0933618775574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTGGGTCTTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.1532733747	36.1122846517361	0.0136316327993108	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2645.57706011783	2645.57706011783
"AML-0024"	"2020-09-15-AML0024:GTATTTCAGTGCAGGT"	-0.933645824820358	-17.3611021271911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTTCAGTGCAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.78571535065	45.9703667612118	0.0159520419982435	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.6356164834	2877.6356164834
"AML-0024"	"2020-09-15-AML0024:GTATTTCCACTCCTGT"	-1.98486600342448	-16.8969202271667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTTCCACTCCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2391.74452143492	45.1162075078931	0.0188633054674358	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2379.21353837234	2379.21353837234
"AML-0024"	"2020-09-15-AML0024:GTATTTCGTCGAACGA"	-0.740108589560348	-15.6578111878601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTTCGTCGAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2922.53565327397	39.5903593477129	0.0135465787400615	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.37647515627	2916.37647515627
"AML-0024"	"2020-09-15-AML0024:GTATTTCGTTGCATGT"	-0.461741606623489	-16.5401430360046	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTATTTCGTTGCATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.25144648903	42.3610747522045	0.0159657219100963	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.41961764481	2637.41961764481
"AML-0024"	"2020-09-15-AML0024:GTCAAACAGTACGTCT"	-0.396641562611419	-15.7470684281555	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACAGTACGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2893.64492709029	30.8730096013879	0.0106692460129973	2552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.57552626534	2885.57552626534
"AML-0024"	"2020-09-15-AML0024:GTCAAACCAATCACGT"	-2.13647494736369	-15.8586969605652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACCAATCACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.42551273876	32.8643199835421	0.0130133792573837	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.13034599401	2518.13034599401
"AML-0024"	"2020-09-15-AML0024:GTCAAACCACAGTATC"	-2.409735540778	-16.38614561474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACCACAGTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2332.30167443678	38.0742899751997	0.0163247706728994	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2324.86185265141	2324.86185265141
"AML-0024"	"2020-09-15-AML0024:GTCAAACCATCTAGAC"	-1.92628477039989	-15.8205147019592	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACCATCTAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3025.97737051102	37.6998629221382	0.0124587392125049	3662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3018.27041635237	3018.27041635237
"AML-0024"	"2020-09-15-AML0024:GTCAAACTCGCGCCAA"	-0.583113233477432	-15.7454872361389	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACTCGCGCCAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1619.0509062739	33.6318628740891	0.020772579011422	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	1617.05287476018	1617.05287476018
"AML-0024"	"2020-09-15-AML0024:GTCAAACTCGCTTACC"	-1.28550956669505	-15.902050994989	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAACTCGCTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.46793717362	35.5253223638953	0.0140168758274024	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.12155057054	2529.12155057054
"AML-0024"	"2020-09-15-AML0024:GTCAAGTAGTTAGAAC"	-1.48177693310435	-16.8771620026794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAGTAGTTAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.64170426063	35.2348746546737	0.0132330514459729	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.55459379785	2654.55459379785
"AML-0024"	"2020-09-15-AML0024:GTCAAGTCACGCGCTA"	-1.42125902596172	-16.0374326935974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAGTCACGCGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.58205552526	40.8339395954566	0.0152845537762935	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.50948269013	2663.50948269013
"AML-0024"	"2020-09-15-AML0024:GTCAAGTCAGTAGAGC"	-1.38417563858684	-15.8617191544739	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAGTCAGTAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.15856220819	37.088162445022	0.0138898726727115	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.80719039128	2662.80719039128
"AML-0024"	"2020-09-15-AML0024:GTCAAGTGTTCTAAGC"	-2.57123432579692	-15.6500959626404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAAGTGTTCTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.69125782475	37.8907279267889	0.0133762293444876	2902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.90245631809	2829.90245631809
"AML-0024"	"2020-09-15-AML0024:GTCACGGAGAAGCGAA"	-2.07178769531901	-15.6685533753601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGAGAAGCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2947.94192162773	35.8431704900511	0.0121587098535035	2936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2942.53675090684	2942.53675090684
"AML-0024"	"2020-09-15-AML0024:GTCACGGAGGCAATGC"	-1.56805096092876	-16.8777742615906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGAGGCAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.14806772603	38.4597462812912	0.0154758369453948	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.49531273921	2474.49531273921
"AML-0024"	"2020-09-15-AML0024:GTCACGGAGTCATGGG"	-2.50842438164409	-16.2497854462829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGAGTCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.391563532	37.7590085036815	0.0148869003692399	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.75657870716	2526.75657870716
"AML-0024"	"2020-09-15-AML0024:GTCACGGCACGGCGTT"	-0.854943613440353	-16.2651529542175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGCACGGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.45201625493	35.568456859097	0.0138428180927618	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.77595375635	2562.77595375635
"AML-0024"	"2020-09-15-AML0024:GTCACGGCATGCAGGA"	0.79058208045308	-16.2123022309509	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGCATGCAGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2722.53257407254	42.2931728217716	0.0155344965289091	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2717.42989040301	2717.42989040301
"AML-0024"	"2020-09-15-AML0024:GTCACGGGTCGGTACC"	-1.6807031435078	-15.8114452592102	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGGTCGGTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.44446838888	36.3968309830569	0.0133937717610972	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.71007369865	2710.71007369865
"AML-0024"	"2020-09-15-AML0024:GTCACGGTCTCGTCGT"	-2.70470581474956	-15.6351976624695	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACGGTCTCGTCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2974.54411866356	34.7448916920846	0.0116807451179091	2898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2964.11492548374	2964.11492548374
"AML-0024"	"2020-09-15-AML0024:GTCACTCAGTCTTCCC"	-1.54663083973582	-16.8276071778503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCAGTCTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.42296543183	33.9986432579354	0.0131501281270072	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.20733376253	2575.20733376253
"AML-0024"	"2020-09-15-AML0024:GTCACTCCAACTCGTA"	-1.56836328926738	-15.8358059159485	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCCAACTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.66581932197	35.1583996981734	0.012800392188538	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.81233663758	2738.81233663758
"AML-0024"	"2020-09-15-AML0024:GTCACTCGTACCATAC"	-2.98260531845744	-15.7114839783874	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCGTACCATAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.24612792926	35.4384024539333	0.0126329030815177	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.61607746868	2794.61607746868
"AML-0024"	"2020-09-15-AML0024:GTCACTCGTCACAATC"	-1.8994257253712	-15.9589987031189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCGTCACAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2823.097517855	40.587402956528	0.0143769043399417	2686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.03245057422	2817.03245057422
"AML-0024"	"2020-09-15-AML0024:GTCACTCTCACAACCA"	-1.19443390789683	-16.480155014154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCTCACAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.68415248496	28.4643137213647	0.0108283506386481	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.04173845432	2620.04173845432
"AML-0024"	"2020-09-15-AML0024:GTCACTCTCTCGGCTT"	-0.432905147702056	-16.4254560700622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCTCTCGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3039.9297077078	41.2250173940558	0.0135611745526645	2963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3032.0271729644	3032.0271729644
"AML-0024"	"2020-09-15-AML0024:GTCACTCTCTGCCTGT"	-0.708237568766433	-15.8574714890686	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCACTCTCTGCCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.80528577465	33.9848718434473	0.0114203950123707	2930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.46473448059	2970.46473448059
"AML-0024"	"2020-09-15-AML0024:GTCAGCGAGCTCGGCT"	-1.7389272255009	-15.8017521134582	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGAGCTCGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.14542422822	36.7388026819474	0.0142666904697074	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.75609918193	2570.75609918193
"AML-0024"	"2020-09-15-AML0024:GTCAGCGAGGTAAACT"	-1.68731222572978	-15.7038593522278	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGAGGTAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.82820961995	36.7370342660802	0.0144302880010762	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2545.82820961995	2545.82820961995
"AML-0024"	"2020-09-15-AML0024:GTCAGCGCAATTCTTC"	-1.87066231194194	-16.0725298157898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGCAATTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.28178366837	39.5380361607848	0.0139597819640583	3018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.75319318917	2824.75319318917
"AML-0024"	"2020-09-15-AML0024:GTCAGCGCACGTCATA"	-2.66877160492595	-16.1760511628357	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGCACGTCATA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.8474485362	42.5706709658948	0.0186807901482128	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2277.57279296356	2277.57279296356
"AML-0024"	"2020-09-15-AML0024:GTCAGCGGTTCGGTCG"	-0.536749820143539	-16.2895269623962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGGTTCGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.02329710602	37.7128887318832	0.0134832229573859	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.2605492234	2783.2605492234
"AML-0024"	"2020-09-15-AML0024:GTCAGCGTCTAGTACG"	-0.775420705706436	-16.2499284974304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGTCTAGTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.7697886326	44.7658798462881	0.0166802234811267	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.91758437068	2672.91758437068
"AML-0024"	"2020-09-15-AML0024:GTCAGCGTCTTACCGC"	-2.19975648346599	-15.8118477097717	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCAGCGTCTTACCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.47684552027	37.9486573877156	0.0151765682036618	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.09931951526	2497.09931951526
"AML-0024"	"2020-09-15-AML0024:GTCATCCAGATTGGGC"	-0.822753052145797	-15.6132402650085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATCCAGATTGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.01558621774	37.8144612862922	0.0142910954429958	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.50258809472	2642.50258809472
"AML-0024"	"2020-09-15-AML0024:GTCATCCAGTCACGAG"	-2.13984141770061	-16.5336504212585	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATCCAGTCACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3060.2903871477	36.7488566692423	0.0120082907241667	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3049.02582638473	3049.02582638473
"AML-0024"	"2020-09-15-AML0024:GTCATCCCAACCAATC"	-1.16081855717357	-15.5959301224914	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATCCCAACCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.28608111481	38.450659656846	0.0149306362267144	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.85107065997	2567.85107065997
"AML-0024"	"2020-09-15-AML0024:GTCATCCTCGAACACT"	-0.509150008589584	-16.5958566895691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATCCTCGAACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.83752766173	42.3604224466001	0.0167708421395635	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2514.41408162452	2514.41408162452
"AML-0024"	"2020-09-15-AML0024:GTCATCCTCGTCAAAC"	-1.88629672947581	-15.9389505616394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATCCTCGTCAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.93556886139	37.3015354083159	0.013668895606751	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.7667788932	2721.7667788932
"AML-0024"	"2020-09-15-AML0024:GTCATGAAGATTGCGG"	-2.93672142449077	-15.8907709351745	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGAAGATTGCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2561.80064819534	36.6513332369928	0.0143068639094973	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.53009926086	2554.53009926086
"AML-0024"	"2020-09-15-AML0024:GTCATGAAGGATTTGA"	-1.15462718430217	-16.5005979768005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGAAGGATTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.24721730876	38.5473801807573	0.0169271829109149	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2270.75369848422	2270.75369848422
"AML-0024"	"2020-09-15-AML0024:GTCATGACAAGTATCC"	-2.76888189736064	-16.0848512879578	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGACAAGTATCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.28072857181	37.9751585669752	0.0163244092170637	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.62715084404	2316.62715084404
"AML-0024"	"2020-09-15-AML0024:GTCATGACAGCTCATA"	-1.19821796837505	-15.9021635285583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGACAGCTCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.55965999585	34.2540086867246	0.0121702904982213	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.20156166733	2810.20156166733
"AML-0024"	"2020-09-15-AML0024:GTCATGATCCACAGGC"	-1.53882859173473	-17.010506652948	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGATCCACAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2156.66623074975	47.8291870427221	0.0221773709630046	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2148.23877365042	2148.23877365042
"AML-0024"	"2020-09-15-AML0024:GTCATGATCGTTAGTG"	-0.704666714102584	-15.831081413385	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATGATCGTTAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.19562762389	51.8382273457121	0.0187466763030637	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.19707673237	2754.19707673237
"AML-0024"	"2020-09-15-AML0024:GTCATTTAGAATCCCT"	-0.944607297808486	-17.3196668854919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTAGAATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3144.99160188826	40.3161230498665	0.0128191512580385	3271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3131.45609001619	3131.45609001619
"AML-0024"	"2020-09-15-AML0024:GTCATTTGTCAAACGG"	-1.11482129517253	-16.3757753602234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTGTCAAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.62998205426	44.8366693323861	0.0172739063897316	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.57716065246	2590.57716065246
"AML-0024"	"2020-09-15-AML0024:GTCATTTGTGTGATGG"	-1.11021349850352	-16.2653722993103	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTGTGTGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.52666212623	32.2786135701857	0.0118430738611834	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.95815151481	2716.95815151481
"AML-0024"	"2020-09-15-AML0024:GTCATTTGTGTTAAAG"	-1.90506980839427	-16.9394502869812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTGTGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1738.52168655116	46.2730891711908	0.0266163427981082	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1732.88181875354	1732.88181875354
"AML-0024"	"2020-09-15-AML0024:GTCATTTTCACCTCAC"	-0.541509429842788	-16.0092249146667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTTCACCTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.73457295575	40.826126214078	0.0157828818777598	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.95246230502	2578.95246230502
"AML-0024"	"2020-09-15-AML0024:GTCATTTTCGGTCGGT"	-0.963034729391891	-17.569359802362	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTTCGGTCGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2811.74348678684	44.9955254896802	0.0160027135124974	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2805.20835208958	2805.20835208958
"AML-0024"	"2020-09-15-AML0024:GTCATTTTCGTAGTGT"	-0.437302837998229	-16.6072397462097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCATTTTCGTAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2247.26763392548	49.7283804977594	0.0221283748081642	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2246.03443178431	2246.03443178431
"AML-0024"	"2020-09-15-AML0024:GTCCACTCACGTCTCT"	-0.192486057907897	-16.1954756013122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTCACGTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.85558893431	37.1403267340634	0.0135407517930952	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.08252019527	2732.08252019527
"AML-0024"	"2020-09-15-AML0024:GTCCACTCAGAGCGTA"	-0.0460080680554688	-16.6000585786072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTCAGAGCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.03699996831	42.2317443972673	0.0154863114793668	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.58798063557	2719.58798063557
"AML-0024"	"2020-09-15-AML0024:GTCCACTCATAATCGC"	-2.6480372947758	-15.9173031083313	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTCATAATCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1679.6938470622	46.4230800342121	0.0276378222825586	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1675.81276853892	1675.81276853892
"AML-0024"	"2020-09-15-AML0024:GTCCACTGTAAGGCTG"	-2.58690414848979	-15.4550743333069	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTGTAAGGCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.09792971958	36.3370573681984	0.0128304381663088	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.04879093167	2826.04879093167
"AML-0024"	"2020-09-15-AML0024:GTCCACTGTTTCCCAC"	-2.01828298988994	-15.668540977594	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTGTTTCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.00712328656	31.2454484294776	0.0113044022811074	2528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.91081008804	2761.91081008804
"AML-0024"	"2020-09-15-AML0024:GTCCACTTCCCGTTCA"	-1.97445974770244	-16.6228952637878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCACTTCCCGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1973.48672838198	43.7061762921017	0.0221466785986119	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1966.70380051969	1966.70380051969
"AML-0024"	"2020-09-15-AML0024:GTCCCATCATGGGAAC"	-1.1078818840092	-15.6402788392273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCCATCATGGGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.23081402311	40.3046245895219	0.0145860506422337	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.59237504643	2752.59237504643
"AML-0024"	"2020-09-15-AML0024:GTCCCATGTTCGAACT"	-1.16853819313701	-15.8449917069641	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCCATGTTCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.03296009644	37.8949672382418	0.0141134085880572	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.17672043234	2675.17672043234
"AML-0024"	"2020-09-15-AML0024:GTCCTCAAGAGCGACT"	1.19945981082265	-16.2095155945984	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCAAGAGCGACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2832.88094428298	46.1208190087342	0.0162805355805052	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2820.91930780062	2820.91930780062
"AML-0024"	"2020-09-15-AML0024:GTCCTCACACAGTCCG"	-1.68756661835368	-15.7274456254211	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCACACAGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.9069688699	30.4540796507661	0.0115098830038508	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.36255279346	2643.36255279346
"AML-0024"	"2020-09-15-AML0024:GTCCTCACATCTAGAC"	-0.905102531344253	-15.6279402009216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCACATCTAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.06621086035	35.7461298116548	0.0128904710863591	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.8037953157	2760.8037953157
"AML-0024"	"2020-09-15-AML0024:GTCCTCAGTTCCGCAG"	-2.19197402420695	-15.6718168488708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCAGTTCCGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.98469776182	36.6375672878243	0.0125514763115808	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.18954630919	2912.18954630919
"AML-0024"	"2020-09-15-AML0024:GTCCTCATCCAGTGTA"	-1.99329934540446	-16.1974477997986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCATCCAGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3052.09636585795	36.2423386399924	0.0118745721941858	2975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3042.21788290826	3042.21788290826
"AML-0024"	"2020-09-15-AML0024:GTCCTCATCGTAGGAG"	-2.62196002426799	-16.1807737580505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCATCGTAGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.54515945297	35.1241918321038	0.0136322826336803	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.58647929387	2571.58647929387
"AML-0024"	"2020-09-15-AML0024:GTCCTCATCTGTTGGA"	-1.98053584519084	-15.6810913315979	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCCTCATCTGTTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.54129319552	32.2602105808521	0.012008082906658	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.49373888215	2678.49373888215
"AML-0024"	"2020-09-15-AML0024:GTCGAATAGGGAGGGT"	-0.663872758776504	-16.3099985352722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATAGGGAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.09507185885	35.5821268302346	0.015708888899323	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2257.15626592355	2257.15626592355
"AML-0024"	"2020-09-15-AML0024:GTCGAATAGTTGGACG"	-2.30720339241679	-15.6490593186584	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATAGTTGGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.24244030821	39.1670124065357	0.0154064820040481	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2538.50797252667	2538.50797252667
"AML-0024"	"2020-09-15-AML0024:GTCGAATCAAGGCCTC"	-1.41862676563914	-16.0184049836365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATCAAGGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.94894272696	40.353855256572	0.0154674760382213	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.24107228213	2605.24107228213
"AML-0024"	"2020-09-15-AML0024:GTCGAATGTATGCGGA"	-0.666638116270858	-15.668540977594	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATGTATGCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.01724528021	35.0876424383083	0.0129092788131633	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.84373073688	2711.84373073688
"AML-0024"	"2020-09-15-AML0024:GTCGAATGTCGTGATT"	-2.59984479370769	-15.3488970032898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATGTCGTGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.7275650173	35.9640958246033	0.0126157603644545	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2845.90311693777	2845.90311693777
"AML-0024"	"2020-09-15-AML0024:GTCGAATTCAGCTAGT"	-0.932221929461318	-17.483328842279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATTCAGCTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.95336450611	45.7303484648274	0.016426406077007	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.77524759826	2769.77524759826
"AML-0024"	"2020-09-15-AML0024:GTCGAATTCCCATTTA"	-1.05380580845531	-16.005867981073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATTCCCATTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.7565520065	38.7700155678563	0.0149763080417146	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.805601752	2581.805601752
"AML-0024"	"2020-09-15-AML0024:GTCGAATTCCGATCGG"	-2.4087213081425	-15.8936805955139	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGAATTCCGATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.68862245944	36.1716342085749	0.01474774819655	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.28264391656	2449.28264391656
"AML-0024"	"2020-09-15-AML0024:GTCGCGAAGCGTGCCT"	-0.811201373965103	-16.4482412568298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGAAGCGTGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.4589214886	40.9560720091964	0.0172558587967932	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.20387714759	2370.20387714759
"AML-0024"	"2020-09-15-AML0024:GTCGCGACATACCACA"	-1.49139378491099	-16.1575250855652	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGACATACCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.36212541971	37.5685795099708	0.0142609776945473	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.59100329969	2625.59100329969
"AML-0024"	"2020-09-15-AML0024:GTCGCGAGTAAGTTGA"	-0.880921224982101	-16.7039652100769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGAGTAAGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.05541121216	40.2959111117028	0.0162479882221695	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.03795687752	2476.03795687752
"AML-0024"	"2020-09-15-AML0024:GTCGCGAGTATGTCCA"	-2.74966655197795	-15.837130569574	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGAGTATGTCCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.39252217283	34.9122755951585	0.0143471615356098	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2431.43175474314	2431.43175474314
"AML-0024"	"2020-09-15-AML0024:GTCGCGAGTCTCACAA"	0.0972200418705165	-16.327401184198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGAGTCTCACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.48619501138	37.2002677236768	0.0142285194676711	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2605.08713720323	2605.08713720323
"AML-0024"	"2020-09-15-AML0024:GTCGCGAGTCTTGAAC"	-2.10511312905009	-16.7218218079773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGAGTCTTGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1996.6459015712	42.7977365296127	0.0214348155053103	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1992.55813899795	1992.55813899795
"AML-0024"	"2020-09-15-AML0024:GTCGCGATCGTGGGAA"	-1.26855657520946	-15.286105178949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGATCGTGGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.88884718909	41.2800957288739	0.0147276963088537	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.76488604844	2797.76488604844
"AML-0024"	"2020-09-15-AML0024:GTCGCGATCTTGGATG"	-2.92054520073588	-15.5988998643127	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGCGATCTTGGATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.41357904792	35.3483537070037	0.0137895632588997	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.38228168881	2558.38228168881
"AML-0024"	"2020-09-15-AML0024:GTCGTAAAGGTAGTCG"	-1.02191124382671	-17.3843279114929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAAAGGTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.66259975752	47.7758911600587	0.0190823999865979	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.31184342882	2502.31184342882
"AML-0024"	"2020-09-15-AML0024:GTCGTAAAGGTGCCAA"	-3.64260278168376	12.7678146132263	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAAAGGTGCCAA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1447.53308807219	26.950875403748	0.0186184866002897	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1445.12327396475	1445.12327396475
"AML-0024"	"2020-09-15-AML0024:GTCGTAACACAACCGC"	-1.13344643536265	-15.4736623994079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAACACAACCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2287.23668117205	33.7861680180768	0.014771609906485	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2284.03076840439	2284.03076840439
"AML-0024"	"2020-09-15-AML0024:GTCGTAACAGTCGCAC"	-0.425123999745208	-16.2555170289245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAACAGTCGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.56166241747	35.4875761888975	0.0137465537645402	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.65805337395	2578.65805337395
"AML-0024"	"2020-09-15-AML0024:GTCGTAACATTCTGTT"	-0.774474958807784	-15.7681427231994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAACATTCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.18766548497	32.7313324849045	0.0128449458131551	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.42708125471	2544.42708125471
"AML-0024"	"2020-09-15-AML0024:GTCGTAAGTCGAAACG"	-0.490563492209274	-16.2605257264343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAAGTCGAAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.87841190402	35.7726766266418	0.0142414045429555	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.72169193805	2501.72169193805
"AML-0024"	"2020-09-15-AML0024:GTCGTAAGTGACTGAG"	-2.27808843079265	-15.4100656739441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAAGTGACTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.01307736356	34.2997382779398	0.0123468599040907	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.99270995656	2772.99270995656
"AML-0024"	"2020-09-15-AML0024:GTCGTAATCAAACCTG"	-1.04769502106364	-17.4660768738953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAATCAAACCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.40900243064	47.1439237329337	0.01626544897335	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2891.55369837269	2891.55369837269
"AML-0024"	"2020-09-15-AML0024:GTCGTAATCGTGAGAG"	-0.744899730116683	-16.0103311768738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAATCGTGAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.57569131681	31.6190785266083	0.0133663355785532	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2360.39631013512	2360.39631013512
"AML-0024"	"2020-09-15-AML0024:GTCGTAATCTGGCCGA"	-0.514980952174026	-16.633065246698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTAATCTGGCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.06094646025	34.4813837675814	0.0118571736983548	2939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2897.8888998842	2897.8888998842
"AML-0024"	"2020-09-15-AML0024:GTCGTTCCAACGTTAC"	-1.84116921845134	-16.1284609070984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTTCCAACGTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2332.3761767936	34.2830660487458	0.0146987721748539	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2326.47307700766	2326.47307700766
"AML-0024"	"2020-09-15-AML0024:GTCGTTCCACGGATCC"	-0.788092116743881	-16.1386690369812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTTCCACGGATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.61138189694	35.0334477716411	0.0144075027911372	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.63743045302	2423.63743045302
"AML-0024"	"2020-09-15-AML0024:GTCGTTCGTGCACATT"	-1.49858746948894	-16.5266332856384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCGTTCGTGCACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.25434693005	40.7205742263996	0.0150691123034592	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.87665074804	2688.87665074804
"AML-0024"	"2020-09-15-AML0024:GTCTACCAGATCACCT"	-0.416153053671676	-15.8834257355896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCAGATCACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.09980749325	39.9269988858181	0.0152854032496311	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.6353943432	2604.6353943432
"AML-0024"	"2020-09-15-AML0024:GTCTACCAGGTGCTAG"	-1.03993723812755	-15.7501373521057	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCAGGTGCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.87511981992	29.3459823203747	0.0119785625328248	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.51327827415	2444.51327827415
"AML-0024"	"2020-09-15-AML0024:GTCTACCAGTCTCGTA"	0.0231887540662706	-15.9563665620056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCAGTCTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.93895041865	37.2322683432272	0.0137951502524545	2815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.81220265696	2687.81220265696
"AML-0024"	"2020-09-15-AML0024:GTCTACCCAACCGCCA"	-1.22010634365733	-15.6149797669617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCCAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.56361777691	36.8923087210617	0.0139766696557718	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.43043880055	2633.43043880055
"AML-0024"	"2020-09-15-AML0024:GTCTACCCACACTTAG"	-1.26757595959361	-15.885916732904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCCACACTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.74842965586	36.4181863660843	0.0139067143501333	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.69900317786	2615.69900317786
"AML-0024"	"2020-09-15-AML0024:GTCTACCCAGAGATGC"	-0.783855955035049	-16.2736425629822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCCAGAGATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3107.34602916386	34.0336219236648	0.010952633406207	3685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3098.0173824762	3098.0173824762
"AML-0024"	"2020-09-15-AML0024:GTCTACCGTACCGTCG"	-0.730709354311782	-16.3179407349792	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCGTACCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2779.82501374249	41.7156577709977	0.0150065768761595	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.29377493482	2771.29377493482
"AML-0024"	"2020-09-15-AML0024:GTCTACCGTAGCCAGA"	-0.410319755703765	-16.2976427308288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCGTAGCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.66974695925	42.6128165905868	0.0174523260746688	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.90311135218	2433.90311135218
"AML-0024"	"2020-09-15-AML0024:GTCTACCGTCCGGATC"	-2.43676052513774	-15.6622848740784	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCGTCCGGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.83690695372	34.0810460468828	0.0123310626474145	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.1123224265	2755.1123224265
"AML-0024"	"2020-09-15-AML0024:GTCTACCTCTCGTTTA"	-2.31812510910686	-16.3324976197449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTACCTCTCGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.80515743816	35.8490490101148	0.013483142572454	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.8392229978	2649.8392229978
"AML-0024"	"2020-09-15-AML0024:GTCTAGAAGTGAGTTA"	-2.47373710098918	-16.2291975251404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTAGAAGTGAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.60736303446	37.7674723736214	0.0155831645627347	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2419.2480980346	2419.2480980346
"AML-0024"	"2020-09-15-AML0024:GTCTAGACAATCCTTT"	0.566595693200272	-16.1459665528503	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTAGACAATCCTTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2769.98251996421	37.0684097386128	0.0133821818265812	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2760.44733642797	2760.44733642797
"AML-0024"	"2020-09-15-AML0024:GTCTAGACACCACTGG"	-1.0684429210728	-16.4278707734314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTAGACACCACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.53838025287	33.1690501918602	0.01345852450813	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2457.27316728215	2457.27316728215
"AML-0024"	"2020-09-15-AML0024:GTCTAGACAGTTGCGC"	-2.66455469551738	-16.3012323609558	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTAGACAGTTGCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.58543856595	36.9851374730111	0.0143878265698276	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.02726337276	2559.02726337276
"AML-0024"	"2020-09-15-AML0024:GTCTAGATCTGTGCGG"	-2.06625519219096	-15.7107715836731	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTAGATCTGTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.32890474108	31.3200137992524	0.013048217574429	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2394.19395622496	2394.19395622496
"AML-0024"	"2020-09-15-AML0024:GTCTCACCATGGCTAT"	-1.22263668003734	-16.6280508271423	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTCACCATGGCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.03222157713	37.7108913538998	0.0155828054757567	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.76927708819	2413.76927708819
"AML-0024"	"2020-09-15-AML0024:GTCTCACGTCGCACAC"	-1.88569496098216	-15.6182136765686	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTCACGTCGCACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.53032002822	33.9069626249151	0.0124086318004936	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.40835441049	2726.40835441049
"AML-0024"	"2020-09-15-AML0024:GTCTCACGTTCGAACT"	-1.2209464115208	-16.5510473481384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTCACGTTCGAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.26015033144	45.3005856963927	0.0177980178923925	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.94674977831	2535.94674977831
"AML-0024"	"2020-09-15-AML0024:GTCTCACTCCCGTAAA"	-1.99606881561931	-16.043143295404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTCACTCCCGTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.50155152718	44.5827279582476	0.0177091163781816	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.93748119527	2511.93748119527
"AML-0024"	"2020-09-15-AML0024:GTCTGTCAGACTCTAC"	-0.614476065069991	-16.6259260407654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTGTCAGACTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.2206584704	33.0595010820176	0.0123484409017319	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.6162817504	2670.6162817504
"AML-0024"	"2020-09-15-AML0024:GTCTGTCGTTCAACGT"	-2.9120012325352	-15.7915840378967	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTGTCGTTCAACGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.98854304429	32.6532131381168	0.0129269046876846	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.15536479815	2520.15536479815
"AML-0024"	"2020-09-15-AML0024:GTCTGTCTCGTAGTGT"	-2.2262912792271	-15.9611063233581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTGTCTCGTAGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.09619214057	33.1389821243007	0.0134541972944634	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.26768343055	2455.26768343055
"AML-0024"	"2020-09-15-AML0024:GTCTTTAAGCCTTGAT"	-1.92633984509166	-15.9698629609314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTTTAAGCCTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.04287252369	37.7752537573024	0.0144564232583061	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.41947919379	2603.41947919379
"AML-0024"	"2020-09-15-AML0024:GTCTTTAAGTAGAATC"	-2.3557017845219	-15.405149482843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTTTAAGTAGAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2624.55728531523	40.9876007909784	0.0156169579609901	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2615.62286969493	2615.62286969493
"AML-0024"	"2020-09-15-AML0024:GTCTTTACACGTGTGC"	-0.560126225382644	-15.8986139527527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTTTACACGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3165.6197939981	42.6700651420618	0.0134792135249352	3486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3156.36372509052	3156.36372509052
"AML-0024"	"2020-09-15-AML0024:GTCTTTAGTAGGATAT"	-2.23770676079448	-16.3427858582703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTTTAGTAGGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.16366743159	41.1054591216674	0.0147693287328665	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.00576957234	2773.00576957234
"AML-0024"	"2020-09-15-AML0024:GTCTTTAGTCATGACT"	-2.52453933182414	-16.5206518403259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTCTTTAGTCATGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1687.87621947712	50.7179982109786	0.0300484109117256	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1678.5772234443	1678.5772234443
"AML-0024"	"2020-09-15-AML0024:GTGACGCAGAACCCGA"	-2.55704842034038	-16.1894560090271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGACGCAGAACCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1545.41002332222	52.6214231791382	0.0340501371060195	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1534.94463433375	1534.94463433375
"AML-0024"	"2020-09-15-AML0024:GTGACGCGTACACGCC"	-2.12565861168559	-16.521119140741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGACGCGTACACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2978.28167816422	39.1592479037481	0.013148268745314	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.98513456043	2970.98513456043
"AML-0024"	"2020-09-15-AML0024:GTGACGCGTAGAATGT"	-1.93267009678538	-15.5218010178772	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGACGCGTAGAATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.22431887597	36.1527668384701	0.0138930247389611	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.52311627597	2596.52311627597
"AML-0024"	"2020-09-15-AML0024:GTGACGCTCAGGGTAG"	-2.94617877426799	-15.663637184259	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGACGCTCAGGGTAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2381.78344946742	49.7831886772219	0.0209016435513286	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2375.48275074603	2375.48275074603
"AML-0024"	"2020-09-15-AML0024:GTGACGCTCCACTGGG"	-1.57049951973613	-16.0168199769226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGACGCTCCACTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.95468653829	36.4673835387565	0.0153034313848966	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.91393512935	2378.91393512935
"AML-0024"	"2020-09-15-AML0024:GTGAGCCAGCACCGAA"	-2.72323594513591	-15.9371729127136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGCCAGCACCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.60326672133	36.9735220293651	0.0139543615807497	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.81865751591	2633.81865751591
"AML-0024"	"2020-09-15-AML0024:GTGAGCCAGGCAGGGA"	-1.87280605259593	-15.6124296418396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGCCAGGCAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.34904589709	34.2637323421599	0.0132427947425547	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.60588354388	2582.60588354388
"AML-0024"	"2020-09-15-AML0024:GTGAGCCCACAAGTGG"	-0.994934181601363	-17.4679670563904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGCCCACAAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3057.30808745399	47.9697213036966	0.0156901823210248	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3045.93286703075	3045.93286703075
"AML-0024"	"2020-09-15-AML0024:GTGAGCCTCACCTTAT"	-1.94309161129649	-16.9255171052185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGCCTCACCTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1938.14208433502	49.7951398486495	0.0256922029871377	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1930.59608073985	1930.59608073985
"AML-0024"	"2020-09-15-AML0024:GTGAGCCTCAGAGCAG"	-1.90207121792491	-15.618061088678	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGCCTCAGAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.80216193085	33.8985335958256	0.0117916057128111	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.34168606188	2867.34168606188
"AML-0024"	"2020-09-15-AML0024:GTGAGGAAGACGATAT"	-1.99870214882548	-15.4498491517273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGAAGACGATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2319.30199329868	32.0955044237351	0.0138384326476116	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2313.11026327518	2313.11026327518
"AML-0024"	"2020-09-15-AML0024:GTGAGGAAGTCATGGG"	-1.69834099236186	-16.321261428949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGAAGTCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.15165444078	41.6123296960864	0.0176088274393602	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2354.61654281555	2354.61654281555
"AML-0024"	"2020-09-15-AML0024:GTGAGGAAGTGGAAGA"	-0.00209671902711991	-16.1601515046326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGAAGTGGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.5045310939	36.7475890630489	0.0136329168210064	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.47373067682	2690.47373067682
"AML-0024"	"2020-09-15-AML0024:GTGAGGACAGGACTTT"	-1.45842490616496	-15.9833059540954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGACAGGACTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.52083464149	33.4147680170815	0.0129338101590028	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.97001722324	2575.97001722324
"AML-0024"	"2020-09-15-AML0024:GTGAGGAGTCGTCAGC"	-2.18124709549602	-16.3014230958191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGAGTCGTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.33648651011	48.220429070203	0.0182078181212336	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.02715716569	2641.02715716569
"AML-0024"	"2020-09-15-AML0024:GTGAGGATCATTATCC"	-0.504191557795364	-16.574637436029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGATCATTATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.34140265902	30.3075186168431	0.0111533716695245	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.20379919422	2704.20379919422
"AML-0024"	"2020-09-15-AML0024:GTGAGGATCCAGTGTA"	-2.52531085434611	-16.1570673218933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGGATCCAGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.03959653598	37.1202597498345	0.0142330123358319	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.81333843081	2600.81333843081
"AML-0024"	"2020-09-15-AML0024:GTGAGTTAGGTCGAGT"	-1.73730228367503	-15.6142788163391	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTAGGTCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.64870071266	39.1730925955749	0.0153580901143422	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.32808760701	2543.32808760701
"AML-0024"	"2020-09-15-AML0024:GTGAGTTCAAGCACCC"	-1.08953175965007	-15.501922630426	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTCAAGCACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2960.17235630979	36.1000269623991	0.0121952449442512	2756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2954.72256236209	2954.72256236209
"AML-0024"	"2020-09-15-AML0024:GTGAGTTCAGTGTACT"	-0.271371136338073	-16.6051359406677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTCAGTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.22549751581	37.9190066525455	0.0131152020778477	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.28244379543	2877.28244379543
"AML-0024"	"2020-09-15-AML0024:GTGAGTTGTCCGAAAG"	-2.06423507157024	-16.7761068574158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTGTCCGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.58915199598	39.9066447585722	0.0174068017044522	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2284.97082803056	2284.97082803056
"AML-0024"	"2020-09-15-AML0024:GTGAGTTGTTGCCTAA"	-0.330528537661392	-16.2266130677429	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTGTTGCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.71158357086	35.9223544083324	0.0130167060290596	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.18785219925	2751.18785219925
"AML-0024"	"2020-09-15-AML0024:GTGAGTTTCCTACGGG"	-0.957059244543868	-16.7203474274841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTTCCTACGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.86808332288	39.8511995264191	0.0151706131645595	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.64425830366	2622.64425830366
"AML-0024"	"2020-09-15-AML0024:GTGAGTTTCGAATGCT"	-0.996278981596786	-15.5947580567566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTTCGAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.19578299978	38.5276466520334	0.0157435898344047	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2440.82962959302	2440.82962959302
"AML-0024"	"2020-09-15-AML0024:GTGAGTTTCTGCGTCT"	-0.345309059054214	-16.5193853608337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGAGTTTCTGCGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.60362899127	37.4061213199428	0.0151098992107976	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.51928672275	2464.51928672275
"AML-0024"	"2020-09-15-AML0024:GTGATGTAGACCACGA"	-1.00848458233531	-16.055672668573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTAGACCACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.70625442389	34.6641172663193	0.0134633289551998	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.47953266036	2569.47953266036
"AML-0024"	"2020-09-15-AML0024:GTGATGTCAAGCCATT"	-1.51944003525432	-15.7436952820984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTCAAGCCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.09761334499	31.0405042321491	0.0111612422675143	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.06423313111	2776.06423313111
"AML-0024"	"2020-09-15-AML0024:GTGATGTCACTATCCC"	-0.974723915488082	-16.1994829407898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTCACTATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.02699389889	35.6005103986693	0.0123226645074107	3250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2882.13707797418	2882.13707797418
"AML-0024"	"2020-09-15-AML0024:GTGATGTGTCTGTGAT"	-0.887247483164626	-16.1590719453064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTGTCTGTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2530.63956994392	44.353917065973	0.0175267618481742	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.11470554576	2522.11470554576
"AML-0024"	"2020-09-15-AML0024:GTGATGTTCCCGTGAG"	0.291300301521462	-16.2613039246765	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTTCCCGTGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2735.28689791015	39.1218768946837	0.0143026594119155	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2726.30087650018	2726.30087650018
"AML-0024"	"2020-09-15-AML0024:GTGATGTTCGCTAGCG"	-1.66618607464488	-16.7020559540954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGATGTTCGCTAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.02671341337	46.8694831776102	0.0210741547729327	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2219.85582271185	2219.85582271185
"AML-0024"	"2020-09-15-AML0024:GTGCACGAGCGCTGAA"	-1.1743109029835	-15.9206609955994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGAGCGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2200.10512899826	29.9328130835921	0.0136051739933087	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2193.48096985076	2193.48096985076
"AML-0024"	"2020-09-15-AML0024:GTGCACGAGTGCAAAT"	-0.859583060175735	-17.1937723389831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGAGTGCAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.84105086938	40.7459074071461	0.0140753522183573	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.01996461433	2890.01996461433
"AML-0024"	"2020-09-15-AML0024:GTGCACGAGTTTCGAC"	0.0332019246066034	-16.3644953004089	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGAGTTTCGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2663.27023986006	44.8799074917296	0.016851428300452	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2649.77408278632	2649.77408278632
"AML-0024"	"2020-09-15-AML0024:GTGCACGGTACTGCCG"	8.10736813124959	8.36914918506471	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGGTACTGCCG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1543.79288990187	36.5423376331458	0.0236704922481335	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1543.79288990187	1543.79288990187
"AML-0024"	"2020-09-15-AML0024:GTGCACGGTGACACGA"	-0.971492866904098	-16.1127748719421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGGTGACACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2549.92432820683	37.8318354721407	0.0148364541855816	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2542.01859894223	2542.01859894223
"AML-0024"	"2020-09-15-AML0024:GTGCACGGTTTGGAAA"	-1.88341079178508	-16.8613920441833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGGTTTGGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.13838263014	33.2022035844422	0.0135511544245108	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2438.03971910966	2438.03971910966
"AML-0024"	"2020-09-15-AML0024:GTGCACGTCCACGTGG"	-1.00304053250011	-16.1711187592712	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCACGTCCACGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.40749361629	36.2607116914566	0.0130040934743114	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.22659859804	2775.22659859804
"AML-0024"	"2020-09-15-AML0024:GTGCAGCAGAGTAACT"	-1.43237195435222	-16.293013595697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCAGAGTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.98800701348	34.0103267463581	0.013050837783914	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.2457903702	2600.2457903702
"AML-0024"	"2020-09-15-AML0024:GTGCAGCAGGATGCGT"	-1.60969064655955	-15.4782152405945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCAGGATGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.81310242375	41.1504198190698	0.0153901631276202	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.18291592289	2671.18291592289
"AML-0024"	"2020-09-15-AML0024:GTGCAGCAGTCAGGGT"	-1.00845835629161	-16.2205133668152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.0487189049	38.2159908198819	0.0143289436555825	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.04136788161	2659.04136788161
"AML-0024"	"2020-09-15-AML0024:GTGCAGCGTCAGGTAG"	-1.23169706288036	-15.8877573243347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCGTCAGGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2301.81735493923	36.2426064977709	0.0157452138502656	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2299.19175432539	2299.19175432539
"AML-0024"	"2020-09-15-AML0024:GTGCAGCGTTAGGCTT"	-2.99688039246257	-15.6357069245544	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCGTTAGGCTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.99237847549	37.6420493792271	0.017196062329574	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2180.17125925551	2180.17125925551
"AML-0024"	"2020-09-15-AML0024:GTGCAGCGTTTGGGTT"	-0.435967544943649	-15.784996055719	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCGTTTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.20735831161	36.5979055559667	0.0134540866688496	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.47860684926	2714.47860684926
"AML-0024"	"2020-09-15-AML0024:GTGCAGCTCAGCTAGT"	-0.011317859322387	-15.9644155732361	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCAGCTCAGCTAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2751.07014043559	38.2561997209672	0.0139059339704476	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2747.19922112618	2747.19922112618
"AML-0024"	"2020-09-15-AML0024:GTGCGTGAGAGGTCGT"	-1.00337634506877	-16.5389375916687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGAGAGGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.64834324635	46.5787925833515	0.0216781832772955	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2134.381743928	2134.381743928
"AML-0024"	"2020-09-15-AML0024:GTGCGTGAGCCAGAGT"	-2.02954612198527	-16.1163416138855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGAGCCAGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.40383825001	41.2467673392151	0.0173422051696502	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2373.36067670088	2373.36067670088
"AML-0024"	"2020-09-15-AML0024:GTGCGTGAGGCTAAAT"	-2.32158289375957	-15.9917612305847	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGAGGCTAAAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.82910530855	37.913646325159	0.0143894138138872	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.4277853395	2632.4277853395
"AML-0024"	"2020-09-15-AML0024:GTGCGTGCAAACGAGC"	-2.58099041405376	-15.8347387543884	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGCAAACGAGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.93316931229	31.9304366515377	0.0119682295714208	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.72084214357	2661.72084214357
"AML-0024"	"2020-09-15-AML0024:GTGCGTGGTCGTGGTC"	-1.36906502667125	-15.1029348603454	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGGTCGTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2273.72064218064	37.2271179848447	0.016372775658641	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2265.00444578913	2265.00444578913
"AML-0024"	"2020-09-15-AML0024:GTGCGTGGTTCCGCAG"	-1.85714135590251	-16.9132070771423	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGGTTCCGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1878.46001526225	52.0407848676722	0.0277039619927214	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1875.24788722879	1875.24788722879
"AML-0024"	"2020-09-15-AML0024:GTGCGTGTCACGAGGA"	-0.493406872183639	-16.1149454346863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCGTGTCACGAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.8905655787	32.3672099599633	0.0129422736066316	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.47595003995	2497.47595003995
"AML-0024"	"2020-09-15-AML0024:GTGCTGGAGAGAGTGA"	-0.689288060099441	-16.5810537568298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGAGAGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.32199744415	44.0392884821648	0.0180022452188125	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2438.99446937456	2438.99446937456
"AML-0024"	"2020-09-15-AML0024:GTGCTGGAGCAGCACA"	-1.41583548012431	-15.0828857651916	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGAGCAGCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.75240175751	32.7390871561307	0.0136826054931899	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2384.94716633215	2384.94716633215
"AML-0024"	"2020-09-15-AML0024:GTGCTGGAGCGTGTTT"	-2.92539534989055	-15.9797582856384	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGAGCGTGTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.44930912569	37.8067374234521	0.0141204307004407	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.9416765202	2670.9416765202
"AML-0024"	"2020-09-15-AML0024:GTGCTGGAGGGTATAT"	-1.39324818077739	-15.2235918275085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGAGGGTATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.58997269206	40.8078944687661	0.0150494340515104	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.38995488825	2702.38995488825
"AML-0024"	"2020-09-15-AML0024:GTGCTGGAGTCAAGCG"	-2.0423518222874	-15.5566759339538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGAGTCAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.39598897472	35.0431604999172	0.0131375921103439	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.30196046546	2662.30196046546
"AML-0024"	"2020-09-15-AML0024:GTGCTGGGTGATTAGA"	-1.79702220383342	-16.3976717225281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGGTGATTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.32240237924	34.5275129112325	0.0127251788733091	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.74767344841	2705.74767344841
"AML-0024"	"2020-09-15-AML0024:GTGCTGGGTGGATCAG"	-1.18328354778941	-16.1996851197449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGGTGGATCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.92926589664	38.8878203994986	0.0146363777533141	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.8283316177	2646.8283316177
"AML-0024"	"2020-09-15-AML0024:GTGCTGGTCAAGAAAC"	-1.61291811886485	-15.6175174943176	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGTCAAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.69789606971	32.1574193084812	0.0125974246141671	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2545.8407979921	2545.8407979921
"AML-0024"	"2020-09-15-AML0024:GTGCTGGTCGGCTTCT"	-1.60441420498546	-16.3502454987732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGTCGGCTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1979.02252432905	52.7676373823859	0.0266634849950866	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1977.58851250519	1977.58851250519
"AML-0024"	"2020-09-15-AML0024:GTGCTGGTCGGTAAGG"	-2.87177286568339	-16.0350084534851	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTGGTCGGTAAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.45651092733	45.9612055916407	0.017539388804959	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.12407105791	2613.12407105791
"AML-0024"	"2020-09-15-AML0024:GTGCTTCAGAGCGACT"	-0.971450666815597	-16.2070417634216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTTCAGAGCGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.38999135947	28.2926880989985	0.0114388301876518	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2467.82577862209	2467.82577862209
"AML-0024"	"2020-09-15-AML0024:GTGCTTCGTAACTAAG"	-1.02319631996806	-16.1419363251892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTTCGTAACTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.85544725267	32.4022673601128	0.0131031789165483	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.66248593	2468.66248593
"AML-0024"	"2020-09-15-AML0024:GTGCTTCGTAGTCGGA"	-1.64098391953166	-15.8526306382385	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTTCGTAGTCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.4337661533	42.635479148068	0.0164651746282758	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.11759940703	2582.11759940703
"AML-0024"	"2020-09-15-AML0024:GTGCTTCGTGAGTAAT"	-1.30066976967509	-15.5593013993469	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGCTTCGTGAGTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.48936659269	39.0115908306353	0.0139302763638414	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.33497007678	2793.33497007678
"AML-0024"	"2020-09-15-AML0024:GTGGAAGAGGTAATCA"	-2.47985086861308	-15.6416130295959	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGAGGTAATCA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.00295921244	32.5618894286662	0.0124376824380908	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.59808569306	2610.59808569306
"AML-0024"	"2020-09-15-AML0024:GTGGAAGAGTTTCGAC"	-1.52193258228953	-15.7846307984558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGAGTTTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.7993011464	37.4419743917765	0.0133018273723911	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.84951073643	2802.84951073643
"AML-0024"	"2020-09-15-AML0024:GTGGAAGCAACGCCCA"	-1.50059793415721	-15.5413322678772	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGCAACGCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.00546223389	38.8751814306839	0.0175191914090865	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2217.85494515321	2217.85494515321
"AML-0024"	"2020-09-15-AML0024:GTGGAAGCAGACGCTC"	-1.60135660591777	-16.7255220643249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGCAGACGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.76712020897	35.9286941642032	0.0143728165210845	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.35263829206	2489.35263829206
"AML-0024"	"2020-09-15-AML0024:GTGGAAGCAGCCGTTG"	-0.785186211497146	-16.4211359254089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGCAGCCGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.562743329	37.6355849753115	0.0144776597802427	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.68922473097	2591.68922473097
"AML-0024"	"2020-09-15-AML0024:GTGGAAGCAGCGTGAA"	-3.879626373679	11.2348356016907	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGCAGCGTGAA"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2390.86759704566	32.2422052817889	0.0134855670475562	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2384.94674232564	2384.94674232564
"AML-0024"	"2020-09-15-AML0024:GTGGAAGCAGGCGATA"	-1.14149902287181	-16.0388612977234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGCAGGCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.66660551831	40.8435287220106	0.0149464002083283	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.21004911532	2726.21004911532
"AML-0024"	"2020-09-15-AML0024:GTGGAAGGTGTGTCCG"	0.0210753428632438	-16.2962465516296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGGTGTGTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.72617835545	45.586217898586	0.017998873422703	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.64097884468	2522.64097884468
"AML-0024"	"2020-09-15-AML0024:GTGGAAGTCTATCACT"	1.13245954093282	-16.2210951081482	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGTCTATCACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2900.59458317907	40.8329803583718	0.0140774517732218	3544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2885.38140687404	2885.38140687404
"AML-0024"	"2020-09-15-AML0024:GTGGAAGTCTGGGATT"	-2.84439669075664	-15.6080141297546	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAAGTCTGGGATT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.18378564597	35.7865091986053	0.0128627409099419	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.86634995759	2776.86634995759
"AML-0024"	"2020-09-15-AML0024:GTGGAGAAGTTGCGAG"	1.30908026274983	-16.1788358918396	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGAAGTTGCGAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2753.91699732734	37.5274028756316	0.0136269186442626	2911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2744.11221287027	2744.11221287027
"AML-0024"	"2020-09-15-AML0024:GTGGAGACAATAGGGC"	-0.735486249358016	-16.7864256135193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGACAATAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.30757740046	36.3486963627505	0.0143200519457835	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.95301525561	2526.95301525561
"AML-0024"	"2020-09-15-AML0024:GTGGAGACACCCATAA"	-0.770825187594253	-16.4607782593933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGACACCCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.2395147311	36.1859202533813	0.0132975873889429	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.10843421611	2714.10843421611
"AML-0024"	"2020-09-15-AML0024:GTGGAGAGTCTTCGAA"	-0.934988359839279	-15.7803020707336	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGAGTCTTCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1966.18227315054	46.3342138948929	0.0235655740200773	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1961.31688637463	1961.31688637463
"AML-0024"	"2020-09-15-AML0024:GTGGAGATCAGGAACG"	-0.973950724036056	-17.4430246583191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGATCAGGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.73816926719	41.5212431798179	0.0144989662900791	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.82066821424	2855.82066821424
"AML-0024"	"2020-09-15-AML0024:GTGGAGATCTAGCAAC"	0.976996083825272	-16.2276392213074	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGAGATCTAGCAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2836.56424119399	39.1595850614416	0.0138052875703454	3447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2820.95449212297	2820.95449212297
"AML-0024"	"2020-09-15-AML0024:GTGGCGTAGCGCCATC"	-1.6409834426945	-16.280297302362	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTAGCGCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.77171338815	38.7355173056295	0.0132123238411575	3119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.17772908509	2924.17772908509
"AML-0024"	"2020-09-15-AML0024:GTGGCGTAGTACTCGT"	-2.25074658814128	-16.6518011323181	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTAGTACTCGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.49285415206	39.6753500152914	0.0176453084749756	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2245.99431633709	2245.99431633709
"AML-0024"	"2020-09-15-AML0024:GTGGCGTCAAGTTCCA"	-1.2802736562794	-15.4964018098083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTCAAGTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.54115984537	35.9741790415196	0.015928059971235	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2250.41779341204	2250.41779341204
"AML-0024"	"2020-09-15-AML0024:GTGGCGTCATCCGAGC"	1.19866253909413	-16.1906748048035	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTCATCCGAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2697.0008183812	42.1981007689356	0.0156463062529821	2902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2686.99497001343	2686.99497001343
"AML-0024"	"2020-09-15-AML0024:GTGGCGTGTCTTGCTC"	-1.83615551415141	-16.1673727265564	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTGTCTTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.25567197799	36.0239988218631	0.0135568433258994	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.81451760363	2650.81451760363
"AML-0024"	"2020-09-15-AML0024:GTGGCGTTCAGGAAAT"	-2.71763644638713	-15.9408731690613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGCGTTCAGGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.46658356875	41.2739251893464	0.0154441314413856	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.43389542759	2666.43389542759
"AML-0024"	"2020-09-15-AML0024:GTGGGAAAGAGTCTTC"	1.27692617949788	-16.2368936768738	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGGAAAGAGTCTTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2922.9842199921	37.9767048456263	0.0129924426501793	4230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2906.39398072671	2906.39398072671
"AML-0024"	"2020-09-15-AML0024:GTGGGAACAGTGTGCC"	-1.09556112709697	-16.4198427430359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGGAACAGTGTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.30729139696	39.6778873210342	0.0150906238501903	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.62406194477	2624.62406194477
"AML-0024"	"2020-09-15-AML0024:GTGGGAAGTACTTCCC"	-1.53442917290385	-16.2910986176697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGGAAGTACTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.28162377152	43.8668813241063	0.0167030378338141	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.65743997063	2617.65743997063
"AML-0024"	"2020-09-15-AML0024:GTGGGAAGTGTGAATA"	-0.95211241665538	-16.4397230378357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGGAAGTGTGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.46154614281	33.3751608625774	0.0122546840838807	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.51592783903	2718.51592783903
"AML-0024"	"2020-09-15-AML0024:GTGGGAATCTCAACCC"	-0.487913827330428	-16.308415435907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGGAATCTCAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2955.45360805435	38.2915531941554	0.0129562355808264	3410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2945.91176472409	2945.91176472409
"AML-0024"	"2020-09-15-AML0024:GTGGTTAAGATACAGT"	-0.619770984083968	-16.1588030091492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTAAGATACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.54493421278	34.3453715593011	0.0121081711574694	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.84935644665	2828.84935644665
"AML-0024"	"2020-09-15-AML0024:GTGGTTACAACTGTGT"	-1.52020357075389	-16.3021593323913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTACAACTGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3047.15788836348	33.937215271799	0.0111373340388428	2928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3034.21316855063	3034.21316855063
"AML-0024"	"2020-09-15-AML0024:GTGGTTACACGCAGTC"	-1.25424347344096	-15.6219549409119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTACACGCAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.56792297139	39.5721367827843	0.0145723244290956	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.3691409588	2710.3691409588
"AML-0024"	"2020-09-15-AML0024:GTGGTTACACGTAACT"	-2.79626117172893	-16.0756216279236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTACACGTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.20947794658	48.3704514206092	0.0208026209592633	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2317.25878813098	2317.25878813098
"AML-0024"	"2020-09-15-AML0024:GTGGTTACACGTAGAG"	-0.0304995951360047	-16.3725347748962	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTACACGTAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.05748609941	38.5395834820914	0.0136613960091182	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2814.11550613773	2814.11550613773
"AML-0024"	"2020-09-15-AML0024:GTGGTTACAGCGTGCT"	-1.3909663957661	-16.0197553864685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTACAGCGTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.52640925523	36.4219186201001	0.0143420121513057	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.15812613522	2531.15812613522
"AML-0024"	"2020-09-15-AML0024:GTGGTTAGTATCGAGG"	-1.44621656361278	-15.1032028428284	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTAGTATCGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.78599507056	35.7165322575358	0.0128348109846766	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.81378170424	2773.81378170424
"AML-0024"	"2020-09-15-AML0024:GTGGTTAGTTATAGAG"	-1.36262224140819	-15.0480613938537	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGGTTAGTTATAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.27832184421	35.8817776441725	0.014136266041189	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.81383344384	2528.81383344384
"AML-0024"	"2020-09-15-AML0024:GTGTAACCATGTGCCG"	-2.14320097389873	-15.383026146051	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTAACCATGTGCCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.82112346501	37.2493142994211	0.0148001437019642	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.93313870863	2511.93313870863
"AML-0024"	"2020-09-15-AML0024:GTGTAACGTCGAAACG"	1.06460454043691	-16.2102041474548	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTAACGTCGAAACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2919.79099972482	43.9048994495785	0.0150370007489291	3724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2903.91793219609	2903.91793219609
"AML-0024"	"2020-09-15-AML0024:GTGTAACTCACTACTT"	-1.07439539852794	-16.2186022034851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTAACTCACTACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.96348991236	37.1214103396804	0.0140082723709179	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.01362020228	2649.01362020228
"AML-0024"	"2020-09-15-AML0024:GTGTAACTCATTCATC"	-1.98428068581279	-16.543522857782	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTAACTCATTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.37779000204	34.1606256564794	0.0129035703878339	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.89520317349	2643.89520317349
"AML-0024"	"2020-09-15-AML0024:GTGTAACTCTTGGTCC"	-1.8525655073231	-16.6145410767761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTAACTCTTGGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.92228783451	35.0174726091313	0.0135520610561698	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.52129765201	2575.52129765201
"AML-0024"	"2020-09-15-AML0024:GTGTCCTAGACGTCCC"	-0.935223440558273	-15.6408691636291	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTAGACGTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.22768739547	36.8872451253749	0.0138557814945808	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.74174037163	2657.74174037163
"AML-0024"	"2020-09-15-AML0024:GTGTCCTAGACTCTAC"	-2.28680787506755	-16.501021408197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTAGACTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.67323604337	40.1623174341308	0.0165027567544056	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.44397832896	2423.44397832896
"AML-0024"	"2020-09-15-AML0024:GTGTCCTAGAGCTTTC"	-2.34501634064372	-16.4891119233337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTAGAGCTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.32384434788	38.0595595097188	0.0166539020733751	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2274.17788571147	2274.17788571147
"AML-0024"	"2020-09-15-AML0024:GTGTCCTAGTCAAGCG"	-2.29966292801555	-15.9835081330505	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTAGTCAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.18898654826	37.7330609139108	0.0134081474606978	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.18977375969	2801.18977375969
"AML-0024"	"2020-09-15-AML0024:GTGTCCTAGTCAGCCC"	-1.06856201115306	-16.1767111054626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTAGTCAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.13826881124	34.7618901677327	0.0115252972740648	3377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3012.11398958331	3012.11398958331
"AML-0024"	"2020-09-15-AML0024:GTGTCCTCAATCTGCA"	-2.85761175575908	-15.9945345154968	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTCAATCTGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.8452927968	34.2395956708941	0.0137351466494255	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.72248333357	2485.72248333357
"AML-0024"	"2020-09-15-AML0024:GTGTCCTCACAAAGTA"	-1.61877344074901	-15.8965702286926	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTCACAAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.87179744882	29.8876363419471	0.0109483662822109	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.67072432858	2722.67072432858
"AML-0024"	"2020-09-15-AML0024:GTGTCCTCATTAGGAA"	-0.484879056841689	-16.3336076966492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTCATTAGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.31473925148	32.9550473380204	0.012276893933537	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.26399706581	2675.26399706581
"AML-0024"	"2020-09-15-AML0024:GTGTCCTGTCTTGTCC"	-0.939449946314651	-17.4145937195984	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTGTCTTGTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2864.04233373753	46.342394163781	0.0161807643755408	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2854.71044199462	2854.71044199462
"AML-0024"	"2020-09-15-AML0024:GTGTCCTTCTCTGCTG"	-2.66762004318889	-16.2002001038757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTTCTCTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.20388123273	33.9487928810311	0.0132085991811469	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2560.52957657782	2560.52957657782
"AML-0024"	"2020-09-15-AML0024:GTGTCCTTCTTTGCTA"	-0.75211856785472	-15.9712896577087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTCCTTCTTTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.14145108682	31.4352856108436	0.0118796693948211	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.69456500095	2639.69456500095
"AML-0024"	"2020-09-15-AML0024:GTGTGATAGCGGCTCT"	1.29559602317159	-16.1760893098083	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATAGCGGCTCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3072.81407092069	39.1151832862091	0.0127294337969785	3816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3062.82796344527	3062.82796344527
"AML-0024"	"2020-09-15-AML0024:GTGTGATCAGAGTTCT"	0.452855904668015	-16.3383779755798	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATCAGAGTTCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3093.76375356891	39.6276813679941	0.0128088905697083	3909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3081.63830401538	3081.63830401538
"AML-0024"	"2020-09-15-AML0024:GTGTGATCAGGAAGTC"	-0.408059458166915	-16.083727859613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATCAGGAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.40505568224	32.866519115158	0.0136014113353519	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.98143178803	2409.98143178803
"AML-0024"	"2020-09-15-AML0024:GTGTGATGTACAGAAT"	-2.81425629082378	-15.4845438233581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATGTACAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.29082190588	36.8820402540932	0.0130913145236255	2449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2808.42031970544	2808.42031970544
"AML-0024"	"2020-09-15-AML0024:GTGTGATGTCAAAGTA"	-1.19710216942485	-16.2974024049011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATGTCAAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.12997342035	29.0674253396084	0.0116263656884375	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.17616236074	2488.17616236074
"AML-0024"	"2020-09-15-AML0024:GTGTGATGTCCACGCA"	-1.49843547764476	-16.3089952698913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATGTCCACGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.44773482444	42.3886786951511	0.0159149654565852	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.11300824275	2656.11300824275
"AML-0024"	"2020-09-15-AML0024:GTGTGATTCGGTCAGC"	-1.10049508038219	-16.0752878419128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATTCGGTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2443.98148888109	39.3034500065175	0.0160817298270584	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.76557204548	2433.76557204548
"AML-0024"	"2020-09-15-AML0024:GTGTGATTCGTCGGGT"	0.0420367811689198	-16.1521349183288	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGATTCGTCGGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2881.02424537055	35.0778522880301	0.0121754797254469	3321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2872.00983880039	2872.00983880039
"AML-0024"	"2020-09-15-AML0024:GTGTGGCAGCGTGTTT"	-1.51939700070079	-15.7843342057434	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCAGCGTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.76940071539	46.0559299711509	0.0168655507708141	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.40166491966	2726.40166491966
"AML-0024"	"2020-09-15-AML0024:GTGTGGCAGGTCCCTG"	0.512995143502396	13.4153833159241	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCAGGTCCCTG"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1794.1882303016	35.6544468788937	0.0198721885902129	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1792.42235156981	1792.42235156981
"AML-0024"	"2020-09-15-AML0024:GTGTGGCCAACACGTT"	-2.02182493630107	-15.8841343156067	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCCAACACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2855.62050535586	34.2708449748206	0.0120011902528869	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2846.36269913194	2846.36269913194
"AML-0024"	"2020-09-15-AML0024:GTGTGGCGTGTGTGTT"	-0.587039629847366	-16.4615450135437	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCGTGTGTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.02815332814	38.1474317320536	0.0157242329111973	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2420.02433909854	2420.02433909854
"AML-0024"	"2020-09-15-AML0024:GTGTGGCGTTGGGCCT"	-1.22541258755382	-16.0798597565857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCGTTGGGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.56105147436	35.8012246890788	0.0121998568307488	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2924.55265549474	2924.55265549474
"AML-0024"	"2020-09-15-AML0024:GTGTGGCTCCAAGAGG"	-2.90136228027995	-15.4990778199402	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTGGCTCCAAGAGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.09031550737	35.3536018892573	0.0131961217151285	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.91289236404	2673.91289236404
"AML-0024"	"2020-09-15-AML0024:GTGTTAGCAAACTAAG"	-0.889423112303573	-16.6512422791687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTAGCAAACTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.79437548996	36.2376855252528	0.0131305744540549	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.07114698528	2745.07114698528
"AML-0024"	"2020-09-15-AML0024:GTGTTAGCATCAGCAT"	-1.27042148533519	-16.4910173646179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTAGCATCAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.2792968407	35.3970847670075	0.0130989734511866	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.2288219025	2691.2288219025
"AML-0024"	"2020-09-15-AML0024:GTGTTAGCATCCTGTC"	-2.54375563088115	-16.3712759247986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTAGCATCCTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2156.69408834732	41.7654049559969	0.0193654747706949	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2148.08417243636	2148.08417243636
"AML-0024"	"2020-09-15-AML0024:GTGTTAGTCCACTAGA"	-1.75725267353709	-16.2931909791199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTAGTCCACTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.20073761799	36.8742282769373	0.0140355579796198	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.70920372212	2614.70920372212
"AML-0024"	"2020-09-15-AML0024:GTGTTAGTCCTTCTAA"	-2.91331730309184	-15.7510528794494	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTAGTCCTTCTAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.69093341761	26.8381445535869	0.0100491390515348	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.27137963463	2662.27137963463
"AML-0024"	"2020-09-15-AML0024:GTGTTCCCAAATGGAT"	-0.690060655505019	-15.9683580628601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCCAAATGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2133.45594068311	34.2722868014758	0.0160642111927102	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2121.19478621913	2121.19478621913
"AML-0024"	"2020-09-15-AML0024:GTGTTCCCACGTCGGT"	-1.25839124146159	-16.8839693299499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCCACGTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2522.93808020178	36.4018809406765	0.0144283687444938	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.62741673479	2511.62741673479
"AML-0024"	"2020-09-15-AML0024:GTGTTCCCAGAGATGC"	-0.965995768935043	-17.3805170289245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCCAGAGATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.30372056198	47.925612517772	0.0175147269499488	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.04620466008	2726.04620466008
"AML-0024"	"2020-09-15-AML0024:GTGTTCCCATAGCACT"	-2.82215795937236	-16.0140428773132	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCCATAGCACT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.48850726947	35.557020423025	0.0131474104354485	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.43455555574	2698.43455555574
"AML-0024"	"2020-09-15-AML0024:GTGTTCCGTGGTCCGT"	-1.13327155533488	-15.6055202714172	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCGTGGTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.99735232378	41.5863202130274	0.0154768742801561	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.96401656664	2681.96401656664
"AML-0024"	"2020-09-15-AML0024:GTGTTCCTCATGAGGG"	-2.74315009537395	-15.590376876947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCTCATGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.42205446702	34.5218903258512	0.0155614619212507	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2212.92599103288	2212.92599103288
"AML-0024"	"2020-09-15-AML0024:GTGTTCCTCTCGAGTA"	-1.74085221710857	-15.5326137772766	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTGTTCCTCTCGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.00650072708	33.9157563472641	0.0132276405452352	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2558.45161182276	2558.45161182276
"AML-0024"	"2020-09-15-AML0024:GTTACAGTCCTGGCTT"	-1.35380826416667	-16.8828134766785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACAGTCCTGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.8605365619	34.5208068901412	0.0129930820286159	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.07835684748	2649.07835684748
"AML-0024"	"2020-09-15-AML0024:GTTACAGTCGTCTCAC"	-1.76402912560161	-15.9981966248718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACAGTCGTCTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.34251657387	39.3936478879412	0.0139380303897826	2923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.97942753671	2819.97942753671
"AML-0024"	"2020-09-15-AML0024:GTTACCCAGACATACA"	-0.677222589880782	-15.9072723618713	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCAGACATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3054.08683932719	31.4848670932017	0.0103090936013259	3728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3046.85858171392	3046.85858171392
"AML-0024"	"2020-09-15-AML0024:GTTACCCAGAGCATTA"	-0.273472557694274	-16.5204725495544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCAGAGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.42713255825	40.0764999471643	0.0141391886518504	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.17587528853	2827.17587528853
"AML-0024"	"2020-09-15-AML0024:GTTACCCAGCATACTC"	-1.71045456352885	-16.8136492005554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCAGCATACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.6687025787	43.8193776162463	0.0201591795310213	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2163.98157029851	2163.98157029851
"AML-0024"	"2020-09-15-AML0024:GTTACCCAGGTCCGAA"	-1.453845123679	-15.1503563157287	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCAGGTCCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.38123191791	41.5758878715782	0.013866111296656	3001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2988.76604641937	2988.76604641937
"AML-0024"	"2020-09-15-AML0024:GTTACCCAGTAATCCC"	-2.90603051605876	-16.0845060578552	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCAGTAATCCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.94752580898	31.9607751906986	0.0125733418436823	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.08805650086	2537.08805650086
"AML-0024"	"2020-09-15-AML0024:GTTACCCCACAATGCT"	-0.495089153677779	-16.6801710358826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCCACAATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.49346086268	43.6054202271604	0.0187349270622647	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.7444708456	2316.7444708456
"AML-0024"	"2020-09-15-AML0024:GTTACCCGTAAGATCA"	-0.815295080572921	-15.939929031488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCGTAAGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.67018469405	35.9287554644599	0.012792087750372	2645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.65621104551	2804.65621104551
"AML-0024"	"2020-09-15-AML0024:GTTACCCGTAGGGTAC"	1.24341632899587	-16.1995058289734	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCGTAGGGTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3259.18073596557	41.7723702442996	0.0128168314764919	4745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3249.37389254691	3249.37389254691
"AML-0024"	"2020-09-15-AML0024:GTTACCCTCGCTTACC"	-0.718037764460403	9.40956685626832	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACCCTCGCTTACC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1771.64572319945	39.0717242416389	0.022053915029399	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1764.67669474916	1764.67669474916
"AML-0024"	"2020-09-15-AML0024:GTTACGAAGCAGCACA"	-1.9861732524937	-16.374764465448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACGAAGCAGCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.29975132795	35.4744704612414	0.013553843209301	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.57336688415	2609.57336688415
"AML-0024"	"2020-09-15-AML0024:GTTACGAGTCAATCTG"	9.72921433028523	7.00950763309327	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACGAGTCAATCTG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1722.45117128188	35.8832870328072	0.020832687527567	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1719.4774185894	1719.4774185894
"AML-0024"	"2020-09-15-AML0024:GTTACGATCCATTGCC"	-2.4695602459019	-15.5078315964905	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACGATCCATTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.01199172028	40.2107794961944	0.0149481785285572	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.29460075934	2686.29460075934
"AML-0024"	"2020-09-15-AML0024:GTTACGATCGAAATCC"	1.1222548681194	-16.2065706483093	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTACGATCGAAATCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2938.63695703583	39.5116823685103	0.013445581385584	3227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2928.72689134323	2928.72689134323
"AML-0024"	"2020-09-15-AML0024:GTTAGACAGAGGTTTA"	-0.435750375420409	-16.4237108460632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACAGAGGTTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.95397325089	34.7184788739408	0.0134883837219869	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.10463795102	2570.10463795102
"AML-0024"	"2020-09-15-AML0024:GTTAGACAGGTTCTAC"	0.701070864766282	-16.2615308991638	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACAGGTTCTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2881.86722611764	38.5894318736065	0.0133904267080316	3735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2866.18034579773	2866.18034579773
"AML-0024"	"2020-09-15-AML0024:GTTAGACGTATGGAGC"	-1.63875840130504	-16.0875005952087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACGTATGGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.09949279199	36.2777294546734	0.0152421062920011	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2375.05515494119	2375.05515494119
"AML-0024"	"2020-09-15-AML0024:GTTAGACGTTCGGTAT"	-0.227684329182464	-16.0030260316101	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACGTTCGGTAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2394.00827465137	32.606596994083	0.0136200853352653	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2390.66646923668	2390.66646923668
"AML-0024"	"2020-09-15-AML0024:GTTAGACTCACCTTAT"	-0.794338564307052	-15.8264436951843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACTCACCTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2930.04081292552	33.4250453493768	0.0114077064052918	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2925.42766057756	2925.42766057756
"AML-0024"	"2020-09-15-AML0024:GTTAGACTCACGATCA"	0.0270132879609286	-16.5318174592224	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGACTCACGATCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2702.29562212111	29.3565781097906	0.0108635701695538	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2692.33095196484	2692.33095196484
"AML-0024"	"2020-09-15-AML0024:GTTAGTGCACAGACGA"	-0.88638941469844	-16.6308012238708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGTGCACAGACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.64933218849	38.1064636149825	0.014247274645085	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2666.36827028967	2666.36827028967
"AML-0024"	"2020-09-15-AML0024:GTTAGTGCACCCTGAG"	-1.6887016099995	-15.6301775208679	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGTGCACCCTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.2569147998	37.6010830296482	0.0137972617647355	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.96238561313	2718.96238561313
"AML-0024"	"2020-09-15-AML0024:GTTAGTGTCCCTTGGT"	-1.38140545311626	-16.2346601716247	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTAGTGTCCCTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.5487874215	34.209600230176	0.0125422505320304	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.1165551495	2719.1165551495
"AML-0024"	"2020-09-15-AML0024:GTTATGGCAAGTGGTG"	-2.02098141136821	-15.5459470978943	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTATGGCAAGTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.82908351257	41.5009105760286	0.0158531780540627	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.88902006246	2607.88902006246
"AML-0024"	"2020-09-15-AML0024:GTTATGGGTCTGTAAC"	0.196077277033967	-16.1209650269714	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTATGGGTCTGTAAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2707.82178279918	37.2308858782009	0.0137493856186185	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2704.47631087978	2704.47631087978
"AML-0024"	"2020-09-15-AML0024:GTTCATTAGTCCTGTA"	-1.09149501743968	-16.0842657319275	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCATTAGTCCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2549.3851621721	41.9984102990074	0.0164739369014074	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.36210879284	2547.36210879284
"AML-0024"	"2020-09-15-AML0024:GTTCATTCACGCTATA"	-2.41704402390178	-15.521963142511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCATTCACGCTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.13008341834	36.8216363524942	0.0132445731845827	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.33963529716	2774.33963529716
"AML-0024"	"2020-09-15-AML0024:GTTCATTGTACGATGG"	-2.2980629009312	-16.0247450104919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCATTGTACGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.2399229439	37.0772737848138	0.0130405012554916	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.58572047885	2835.58572047885
"AML-0024"	"2020-09-15-AML0024:GTTCATTGTATGCTTG"	-0.799235920340377	-16.0888376466003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCATTGTATGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.70585338817	31.3107488096048	0.0118659488966536	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.64653250953	2631.64653250953
"AML-0024"	"2020-09-15-AML0024:GTTCCGTAGAGAGTGA"	-0.961038450629073	-17.4206724396911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCCGTAGAGAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3024.59190942702	50.8354153950463	0.0168073634121029	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3017.12611627467	3017.12611627467
"AML-0024"	"2020-09-15-AML0024:GTTCCGTAGCTAGCCC"	-1.87867794457133	-16.7294950715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCCGTAGCTAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.58447637034	44.8031116157038	0.01808338405532	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2463.90265405551	2463.90265405551
"AML-0024"	"2020-09-15-AML0024:GTTCCGTGTCACGTGC"	-0.205727199942428	-16.1342210999695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCCGTGTCACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.06943991751	37.8980802966188	0.0142684824903508	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.27942599322	2650.27942599322
"AML-0024"	"2020-09-15-AML0024:GTTCCGTTCCGTGCGA"	-2.07690177384074	-16.7740087739197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCCGTTCCGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.25195149183	43.7573366442557	0.0177857136208031	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.84632435585	2453.84632435585
"AML-0024"	"2020-09-15-AML0024:GTTCGCTAGCATTGTC"	-1.96946988526042	-15.5697536698547	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTAGCATTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.33244626949	35.4562493010952	0.0132431253916557	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.13624254048	2672.13624254048
"AML-0024"	"2020-09-15-AML0024:GTTCGCTAGCTCCCTT"	2.19483866271321	-4.35629322445067	"2020-09-15-AML0024"	"AML0024"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00337078651685393	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTAGCTCCCTT"	"cDC2"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2626.24285814561	48.1343494891864	0.0183282171867281	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"DC_AML-0024"	2625.44644649547	2625.44644649547
"AML-0024"	"2020-09-15-AML0024:GTTCGCTAGTTGAATG"	-1.01513836804088	-16.8446874848572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTAGTTGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.47577219604	33.1230092371407	0.0121709734018366	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.03419608948	2714.03419608948
"AML-0024"	"2020-09-15-AML0024:GTTCGCTCACTTCAGA"	0.00221555036250946	-16.1260023347107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTCACTTCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.96901960926	39.1354819117541	0.0146686418110979	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.00515512062	2662.00515512062
"AML-0024"	"2020-09-15-AML0024:GTTCGCTCAGTTCCAA"	-0.721959392458755	-16.1219606629578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTCAGTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.40334410139	38.6092399931771	0.0145838147705	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.79143495362	2640.79143495362
"AML-0024"	"2020-09-15-AML0024:GTTCGCTCATAAGATG"	-2.55118785324748	-16.2280092469421	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTCATAAGATG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2412.94314619675	41.2163162302408	0.0170813457810664	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2395.88014558074	2395.88014558074
"AML-0024"	"2020-09-15-AML0024:GTTCGCTGTAAGTAGT"	-2.19405661049541	-16.3327474824158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTGTAAGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.71740069641	36.0928551137498	0.0129796918970301	2326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.92289882751	2775.92289882751
"AML-0024"	"2020-09-15-AML0024:GTTCGCTGTATGGAAT"	-2.31426463547404	-16.2676477662292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTGTATGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.39624157858	37.1987367588974	0.0156074496174668	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2379.85758376627	2379.85758376627
"AML-0024"	"2020-09-15-AML0024:GTTCGCTGTCTACAAC"	-0.673245171934921	-15.6008033982483	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTGTCTACAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.68668321782	36.9898821001501	0.0126431453895353	2637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2919.72892831785	2919.72892831785
"AML-0024"	"2020-09-15-AML0024:GTTCGCTGTGGTCTGC"	-0.526942829520065	-16.4178819886413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTGTGGTCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.81059335367	38.7086430509637	0.0138999194930338	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.58856656828	2778.58856656828
"AML-0024"	"2020-09-15-AML0024:GTTCGCTTCAAGTCTG"	-0.965619305998641	-15.7528133622375	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTTCAAGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2966.25219910736	35.9160044659674	0.0121082099751248	3141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.61558017859	2957.61558017859
"AML-0024"	"2020-09-15-AML0024:GTTCGCTTCTGCGGGT"	-2.82755217972453	-15.6857271424499	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCGCTTCTGCGGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.08499666687	33.2865194321717	0.0113023968645537	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2940.32731262527	2940.32731262527
"AML-0024"	"2020-09-15-AML0024:GTTCTATAGTTAACAG"	-0.712004582316238	-16.602620147821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCTATAGTTAACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.87791505976	35.4538010105439	0.0130880025317648	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.66923264963	2697.66923264963
"AML-0024"	"2020-09-15-AML0024:GTTCTATGTAGGAAAG"	0.197258939116639	-16.2183199158874	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCTATGTAGGAAAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2705.87662765823	33.4611698777371	0.0123661106850595	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2697.07554702003	2697.07554702003
"AML-0024"	"2020-09-15-AML0024:GTTCTATGTTTGTTCT"	-2.12020836296733	-15.4038439027038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTCTATGTTTGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.37513681461	39.6703773717407	0.0144183818632849	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.95153042866	2744.95153042866
"AML-0024"	"2020-09-15-AML0024:GTTGAACAGATACCAA"	-0.852291385561782	-16.321764968988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACAGATACCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.04239582015	31.6504351740882	0.0112995202148023	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.49365850297	2791.49365850297
"AML-0024"	"2020-09-15-AML0024:GTTGAACAGTAGTCTC"	-0.516306142241317	-16.628161453363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACAGTAGTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.44693107958	35.9523684767976	0.0119903300952714	3177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2989.79917362617	2989.79917362617
"AML-0024"	"2020-09-15-AML0024:GTTGAACCAACTAGAA"	-0.623995344073135	-16.4670400849548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACCAACTAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.60374863392	37.5731846335442	0.012913505714029	2869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.86423165305	2902.86423165305
"AML-0024"	"2020-09-15-AML0024:GTTGAACCACCCAAGC"	-3.1156669658726	13.2576455839905	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACCACCCAAGC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1806.33477158197	32.867279808228	0.0181955639260839	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1806.33477158197	1806.33477158197
"AML-0024"	"2020-09-15-AML0024:GTTGAACCAGACCAGA"	-0.594322780997115	-16.7188844910828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACCAGACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2164.99384228617	43.4048950228668	0.02004850737914	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2161.5292607697	2161.5292607697
"AML-0024"	"2020-09-15-AML0024:GTTGAACCAGGAACCA"	-0.81246797266658	-15.8159094086853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACCAGGAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.67832918148	35.1743778819179	0.0124746065953305	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.75566655076	2812.75566655076
"AML-0024"	"2020-09-15-AML0024:GTTGAACGTGGCAACA"	-0.355679313570815	-16.255208038446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACGTGGCAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.39970838495	37.0675778368415	0.0127144067862227	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.60321052561	2906.60321052561
"AML-0024"	"2020-09-15-AML0024:GTTGAACGTTGTTTGG"	-0.901115397841293	14.2290534743103	"2020-09-15-AML0024"	"AML0024"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACGTTGTTTGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1757.17699682442	30.5093993022987	0.0173627354315675	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1753.35414402861	1753.35414402861
"AML-0024"	"2020-09-15-AML0024:GTTGAACTCACCATCC"	-2.24055419388469	-16.6108885041443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACTCACCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.38320766621	37.5180140788637	0.0141077878399437	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.24904701047	2653.24904701047
"AML-0024"	"2020-09-15-AML0024:GTTGAACTCACCTCAC"	-0.508046488196212	-15.9521093598572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACTCACCTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.08324124272	38.7879336883472	0.0135145674978933	2646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.1847915746	2865.1847915746
"AML-0024"	"2020-09-15-AML0024:GTTGAACTCACGGGAA"	11.0596910911495	-2.52022602474364	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGAACTCACGGGAA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1359.25350168741	48.8625775545294	0.0359480976093643	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1357.82451166052	1357.82451166052
"AML-0024"	"2020-09-15-AML0024:GTTGCGGCAACGTTAC"	-1.95247111740764	-15.7746563187805	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGCGGCAACGTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.53971306347	29.9617066042639	0.0115435361876627	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.7039869261	2588.7039869261
"AML-0024"	"2020-09-15-AML0024:GTTGCGGCACCTGCGA"	-1.35544238510783	-16.2213182679382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGCGGCACCTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.64270857403	31.5551918128485	0.0117934998240724	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.09602164228	2671.09602164228
"AML-0024"	"2020-09-15-AML0024:GTTGCGGGTGATACAA"	1.03377654132192	-16.1891737214294	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGCGGGTGATACAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2806.31166151724	40.8405841119599	0.0145531177709176	3381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2795.32540656372	2795.32540656372
"AML-0024"	"2020-09-15-AML0024:GTTGCGGTCACGGGAA"	-1.23948119106944	-15.8588752976623	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGCGGTCACGGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.99155545945	37.4828280395885	0.0141231903931584	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.98734583576	2649.98734583576
"AML-0024"	"2020-09-15-AML0024:GTTGCTCCATGGAACG"	-1.62959704819377	-16.2520590058533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGCTCCATGGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.34678660956	35.5487329654475	0.0145611156761617	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.93830969531	2433.93830969531
"AML-0024"	"2020-09-15-AML0024:GTTGTAGAGGCGTTGA"	0.0714211772078693	-15.8731088868347	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTAGAGGCGTTGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2542.1808816679	39.0460849917923	0.0153592866948848	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2535.47824791982	2535.47824791982
"AML-0024"	"2020-09-15-AML0024:GTTGTAGAGGTCTACT"	-1.77780065956767	-16.889973663446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTAGAGGTCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.5468889311	33.917919155958	0.0129331983725875	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.54138990856	2617.54138990856
"AML-0024"	"2020-09-15-AML0024:GTTGTAGCAGCTTTCC"	-0.348975668579894	-16.1418123475281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTAGCAGCTTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.72186365129	50.849331840701	0.0211720318702499	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.80495923037	2397.80495923037
"AML-0024"	"2020-09-15-AML0024:GTTGTAGGTCCTTGTC"	-0.929408351809341	-15.6975069276062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTAGGTCCTTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.91961142675	38.6280670351562	0.0152143718380469	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2532.85573621368	2532.85573621368
"AML-0024"	"2020-09-15-AML0024:GTTGTCCGTGTCTTGA"	0.00439161163513061	9.17695710742799	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTCCGTGTCTTGA"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1822.94250346901	41.7263780874286	0.0228895744150046	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1813.56930852212	1813.56930852212
"AML-0024"	"2020-09-15-AML0024:GTTGTCCTCCCTGGTT"	-1.30925128880199	-15.9128847352234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTCCTCCCTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.07673022372	37.8643673243553	0.0142236198132325	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.69580806681	2651.69580806681
"AML-0024"	"2020-09-15-AML0024:GTTGTCCTCGGTAAGG"	-0.963201860815841	-17.461449646112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTCCTCGGTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.58971764845	46.31504599229	0.0159016718735392	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.83066002252	2902.83066002252
"AML-0024"	"2020-09-15-AML0024:GTTGTCCTCTAGTTCT"	-0.673071901232559	-15.7257251969543	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTCCTCTAGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.83538777146	34.3700639976249	0.0122713616614835	2740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.52385747452	2792.52385747452
"AML-0024"	"2020-09-15-AML0024:GTTGTGAGTCGGTACC"	-1.57347414913829	-15.5168352357117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTGAGTCGGTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.82940449253	36.5740274893324	0.0156511328636225	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2333.7985175031	2333.7985175031
"AML-0024"	"2020-09-15-AML0024:GTTGTGATCCAAGCAT"	-2.63582477989848	-16.1561193696228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTGATCCAAGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2479.76566107074	33.2146021508624	0.0133942503811109	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.13583100278	2474.13583100278
"AML-0024"	"2020-09-15-AML0024:GTTGTGATCCTCTAGC"	-2.07101974907573	-15.7349748841492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTGATCCTCTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1675.5958046941	29.3976903018571	0.0175446191853076	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1671.71905020345	1671.71905020345
"AML-0024"	"2020-09-15-AML0024:GTTGTGATCTTTGCGC"	-1.2698269886082	-16.1860838166443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTGTGATCTTTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.84209994424	37.1081642618147	0.0147030451162672	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.06909050486	2516.06909050486
"AML-0024"	"2020-09-15-AML0024:GTTTACTCACGTTCGG"	-0.488732497126418	-16.3923235169617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTACTCACGTTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.06348391058	37.0002322293292	0.014740755549212	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.66495462146	2501.66495462146
"AML-0024"	"2020-09-15-AML0024:GTTTACTGTAACCCGC"	-1.33274434033092	-15.9623346558777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTACTGTAACCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.86128758427	39.4993388717879	0.0155029392943282	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.78851758008	2539.78851758008
"AML-0024"	"2020-09-15-AML0024:GTTTACTGTATGGAAT"	-0.425183127552825	-15.9329071274963	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTACTGTATGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.84364598458	42.9330365643056	0.0179123225815046	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2392.53094281594	2392.53094281594
"AML-0024"	"2020-09-15-AML0024:GTTTACTTCGGTATGT"	-0.954910139471847	-17.5431909791199	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes (cycling)"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTACTTCGGTATGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2882.08335160169	48.46022121051	0.0168143024675462	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2871.33157477783	2871.33157477783
"AML-0024"	"2020-09-15-AML0024:GTTTACTTCGTTCTAT"	-0.831026892096359	-16.5940561524597	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTACTTCGTTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.57221166689	31.9389142239667	0.0122626334109302	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.20642196002	2598.20642196002
"AML-0024"	"2020-09-15-AML0024:GTTTGGAAGATTAGTG"	-1.36778889122661	-16.4665518037048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGAAGATTAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.09158718932	49.7755217390435	0.0194125365832216	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.50965748224	2553.50965748224
"AML-0024"	"2020-09-15-AML0024:GTTTGGAAGCACTAGG"	-2.82610617104228	-15.797106765863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGAAGCACTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2118.57400514262	38.8922406755968	0.0183577446816538	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2112.97705068741	2112.97705068741
"AML-0024"	"2020-09-15-AML0024:GTTTGGAAGTAAACGT"	-1.21156356754954	-16.488289856073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGAAGTAAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.58952046405	38.3219941919597	0.0147132566920303	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.20797576397	2594.20797576397
"AML-0024"	"2020-09-15-AML0024:GTTTGGACAACCTATG"	0.0666551451081454	-15.9780740967956	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGACAACCTATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2780.12480705718	35.0498048637705	0.0126072774771833	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2773.75368850892	2773.75368850892
"AML-0024"	"2020-09-15-AML0024:GTTTGGACAAGACAAT"	-1.59806285324748	-15.8468857041565	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGACAAGACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.66684045458	37.2749092998015	0.0134388560140454	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.20459282314	2765.20459282314
"AML-0024"	"2020-09-15-AML0024:GTTTGGAGTTGTGGCC"	-1.31013057652171	-16.807719253656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GTTTGGAGTTGTGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.85524421671	41.6582494401615	0.0151989965643248	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.98038662248	2729.98038662248
"AML-0024"	"2020-09-15-AML0024:TAACACGAGAAGTCTA"	-0.527304272085983	-15.9392299882141	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACACGAGAAGTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.17104847874	39.1752835523383	0.014573210873061	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.95728210419	2679.95728210419
"AML-0024"	"2020-09-15-AML0024:TAACACGAGACCATGG"	-1.30477271500285	-15.811378502008	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACACGAGACCATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.31376354644	35.6729600736119	0.0132106722393479	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.7588133478	2694.7588133478
"AML-0024"	"2020-09-15-AML0024:TAACACGCACTCTAGA"	-2.59304676476176	-15.4797001115051	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACACGCACTCTAGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.22883375429	34.4398353868054	0.0124907425039189	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.99296911545	2752.99296911545
"AML-0024"	"2020-09-15-AML0024:TAACACGCAGGTGTTT"	-2.92258677902873	-15.9658022156921	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACACGCAGGTGTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.74530835254	35.0599590723138	0.0135275480037812	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.73542823093	2590.73542823093
"AML-0024"	"2020-09-15-AML0024:TAACCAGAGGCATCTT"	-2.00412116470988	-16.3453722230163	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACCAGAGGCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.69409612382	50.7279608015848	0.0207757232497368	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.46660268698	2434.46660268698
"AML-0024"	"2020-09-15-AML0024:TAACCAGGTACTCCGG"	-2.16793737831767	-16.5491476289001	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACCAGGTACTCCGG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.53076664566	38.0694914423047	0.0161411892440342	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.69845138129	2345.69845138129
"AML-0024"	"2020-09-15-AML0024:TAACCAGGTCGGATTT"	-2.03032837334331	-15.6694679490295	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACCAGGTCGGATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.3360391814	34.8620012448641	0.0126663317082578	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.55597596262	2746.55597596262
"AML-0024"	"2020-09-15-AML0024:TAACCAGGTGTAAATG"	-1.02443859997447	-16.7241602174011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACCAGGTGTAAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2330.82882327445	51.0335440448603	0.0218950201470249	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2322.05244121201	2322.05244121201
"AML-0024"	"2020-09-15-AML0024:TAACGACAGCGCCTAC"	-0.98714921894725	-17.4661646119324	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACAGCGCCTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3034.06573006084	39.5758239053641	0.0130438254890973	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3024.6658952359	3024.6658952359
"AML-0024"	"2020-09-15-AML0024:TAACGACAGTGATCGG"	-1.42189178887065	-16.5747461549011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACAGTGATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.17636154612	50.4860716076588	0.0211223206872489	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2382.12554616366	2382.12554616366
"AML-0024"	"2020-09-15-AML0024:TAACGACCATGAGTAA"	-1.87152395668681	-16.6624326935974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACCATGAGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.8801160791	36.3084818167597	0.0133247997233012	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.38310247193	2711.38310247193
"AML-0024"	"2020-09-15-AML0024:TAACGACGTGTGTTTG"	0.12887774136607	-16.0550852051941	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACGTGTGTTTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2456.2357388328	42.1388721633381	0.0171558745348126	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2453.12508840721	2453.12508840721
"AML-0024"	"2020-09-15-AML0024:TAACGACGTGTTGATC"	-0.873049835593063	-16.0913858643738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACGTGTTGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1803.3976092591	48.3281922681445	0.0267984120750829	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1797.17381168361	1797.17381168361
"AML-0024"	"2020-09-15-AML0024:TAACGACTCGGCTTGG"	-0.626994113356429	-16.3176565400329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACGACTCGGCTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.3335296121	36.3348265591884	0.0131441543395406	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.00248866868	2759.00248866868
"AML-0024"	"2020-09-15-AML0024:TAACTTCAGCCTCAGC"	-0.961373428732711	-15.8143434754578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACTTCAGCCTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.03254747153	31.2920251896031	0.0115680771452649	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.1149459401	2701.1149459401
"AML-0024"	"2020-09-15-AML0024:TAACTTCGTTCAAGGG"	-2.85966477814372	-15.9397201768127	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAACTTCGTTCAAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.95247559362	33.8895916717876	0.0119205621489368	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.46047349068	2835.46047349068
"AML-0024"	"2020-09-15-AML0024:TAAGCACAGCGCAATG"	-1.81845496121104	-15.5200405350891	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACAGCGCAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.76738929097	35.0221934207628	0.0127735830390118	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.29697030014	2734.29697030014
"AML-0024"	"2020-09-15-AML0024:TAAGCACAGGTTCATC"	1.24446143683736	-16.2008600465027	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACAGGTTCATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3094.49550636808	41.6269834287645	0.0134519450240278	4455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3085.83848245487	3085.83848245487
"AML-0024"	"2020-09-15-AML0024:TAAGCACCACGGTGCT"	-0.549176315695602	-16.5379629365173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACCACGGTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.7676051101	39.6998310993602	0.0147212652006547	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.85785309748	2686.85785309748
"AML-0024"	"2020-09-15-AML0024:TAAGCACGTCACCACG"	-1.795846204192	-15.7694921723572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACGTCACCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.01301783639	34.6645028611535	0.0137885136692675	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.78764544189	2504.78764544189
"AML-0024"	"2020-09-15-AML0024:TAAGCACGTGAGACGT"	-1.20889459076579	-15.5690574876037	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACGTGAGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.19409640744	34.5613032570192	0.012012155627656	2779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2870.27429721738	2870.27429721738
"AML-0024"	"2020-09-15-AML0024:TAAGCACGTTTGGGTT"	-2.10457740250285	-15.9968424073425	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACGTTTGGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.68049214316	37.8207201170753	0.0140197181346071	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.13731974498	2694.13731974498
"AML-0024"	"2020-09-15-AML0024:TAAGCACTCAGCAGAG"	-0.636911312968093	-15.8010244599548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACTCAGCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.42009954039	29.2375946865424	0.0110730844275998	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.30738671205	2631.30738671205
"AML-0024"	"2020-09-15-AML0024:TAAGCACTCCAAGGGA"	-1.17177460613902	-15.9441776505676	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACTCCAAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2933.4270024137	39.11270331258	0.0133334503570046	2604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.3064495157	2922.3064495157
"AML-0024"	"2020-09-15-AML0024:TAAGCACTCCAGCTCT"	-1.25506804409679	-15.9443912736145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACTCCAGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.64638576054	34.4712022716649	0.0129267991645745	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.00787096205	2663.00787096205
"AML-0024"	"2020-09-15-AML0024:TAAGCACTCCCGGTAG"	-2.67054210129436	-15.5131016007629	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACTCCCGGTAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.49752586603	31.3006769793735	0.0122723808441042	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.7382333971	2543.7382333971
"AML-0024"	"2020-09-15-AML0024:TAAGCACTCGTTATCT"	-1.82798419418986	-15.6033258668152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCACTCGTTATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.87170534733	34.752920897835	0.0138354681187945	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.46343380761	2504.46343380761
"AML-0024"	"2020-09-15-AML0024:TAAGCCAAGATGATTG"	-1.57343826714213	-16.4426603547302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCAAGATGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.81683681068	35.3689770882252	0.0121550527307387	3389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2901.64619456872	2901.64619456872
"AML-0024"	"2020-09-15-AML0024:TAAGCCAAGGAACATT"	-1.61740014973338	-16.8560991517273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCAAGGAACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.93011269803	36.4033161960949	0.0125966077989716	3016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.48945240651	2881.48945240651
"AML-0024"	"2020-09-15-AML0024:TAAGCCAGTGAATAAC"	-2.38802562180217	-16.5192117921081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCAGTGAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.04621462612	43.1340786331804	0.0168819171983126	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.63726416295	2548.63726416295
"AML-0024"	"2020-09-15-AML0024:TAAGCCAGTGTCCACG"	-1.51703331890758	-16.76625158703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCAGTGTCCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.17311056779	44.1231775479537	0.0178986122146169	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2456.20765043832	2456.20765043832
"AML-0024"	"2020-09-15-AML0024:TAAGCCATCATTATCC"	-0.937072138220626	-16.1978788605896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCATCATTATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2897.26106216746	37.0955473653338	0.012803660619241	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.36157563116	2884.36157563116
"AML-0024"	"2020-09-15-AML0024:TAAGCCATCATTGGTG"	-1.26451359215434	-15.8945141068664	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCATCATTGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.43094923303	32.9704041623623	0.0125485330725767	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.21326258737	2620.21326258737
"AML-0024"	"2020-09-15-AML0024:TAAGCCATCCTTTGAT"	-0.786890963942367	-16.3297777405945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCATCCTTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.64721781466	31.865553699198	0.0122907403214146	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.93688035687	2583.93688035687
"AML-0024"	"2020-09-15-AML0024:TAAGCCATCGTTCCCA"	11.9882055717403	-2.0602324238983	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCCATCGTTCCCA"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1813.16413010601	19.6364318542117	0.0108299251723359	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1811.59337697396	1811.59337697396
"AML-0024"	"2020-09-15-AML0024:TAAGCGTAGTTTAGGA"	-0.845534841448623	-15.9323015443054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTAGTTTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3028.75566494256	36.2392567260843	0.0119650644472741	3424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3019.37579916147	3019.37579916147
"AML-0024"	"2020-09-15-AML0024:TAAGCGTCAAGTGCTT"	-0.131193171173888	-15.8795662156311	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTCAAGTGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.08462542232	38.6567191471349	0.014488565609502	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.68875006718	2663.68875006718
"AML-0024"	"2020-09-15-AML0024:TAAGCGTCACTAAACC"	-0.433900068432647	-16.037793182489	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTCACTAAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.63512609128	37.3578547334129	0.0128129389027821	2786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.77518888586	2906.77518888586
"AML-0024"	"2020-09-15-AML0024:TAAGCGTCATCTAGAC"	-1.66104362431224	-16.876753830072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTCATCTAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.96779371141	29.5249044373017	0.0120659146038535	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.39332836583	2444.39332836583
"AML-0024"	"2020-09-15-AML0024:TAAGCGTCATGTCTAG"	-1.79139051857646	-16.428490661737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTCATGTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.21068196992	38.1638214170337	0.015047575380209	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2523.70710227744	2523.70710227744
"AML-0024"	"2020-09-15-AML0024:TAAGCGTGTGTGTACT"	-1.42754016342815	-16.573250793573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTGTGTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.46713366717	38.8019131157621	0.0145627291196338	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.23767627885	2653.23767627885
"AML-0024"	"2020-09-15-AML0024:TAAGCGTTCTCTGCTG"	0.45186080512349	-5.80126049434813	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGCGTTCTCTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1653.16360826969	44.2822777638694	0.0267863855351971	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1648.85260969291	1648.85260969291
"AML-0024"	"2020-09-15-AML0024:TAAGTCGCATGTCAGT"	-0.807972828776199	-16.7977342835632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGTCGCATGTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2990.71253850275	37.8472598438263	0.0126549306750738	3131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2977.63983599552	2977.63983599552
"AML-0024"	"2020-09-15-AML0024:TAAGTCGGTACCCAGC"	10.0046621757442	6.88346240604249	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGTCGGTACCCAGC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1606.68652732676	46.0502456633104	0.0286616243306215	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1595.76940071619	1595.76940071619
"AML-0024"	"2020-09-15-AML0024:TAAGTCGGTATAATGG"	0.997928102582139	-16.2383566132751	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGTCGGTATAATGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3010.1144612893	36.4304938416652	0.0121026938710036	2937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3000.33933066425	3000.33933066425
"AML-0024"	"2020-09-15-AML0024:TAAGTCGGTCCACTCT"	-0.582089583308059	-15.8241958848205	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGTCGGTCCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.93948333669	32.0649750372668	0.0119380854394505	2624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.2309811946	2679.2309811946
"AML-0024"	"2020-09-15-AML0024:TAAGTCGTCGAAGAAT"	-1.75313029709514	-16.8879881135193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAAGTCGTCGAAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.26433859451	38.7779584026436	0.0158973989776718	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2435.5293371086	2435.5293371086
"AML-0024"	"2020-09-15-AML0024:TAATCTCCACAATCTG"	-1.37986014309581	-15.7662248841492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATCTCCACAATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.51645189947	36.4114917738275	0.0128684502786277	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.94864604804	2820.94864604804
"AML-0024"	"2020-09-15-AML0024:TAATCTCCAGCTCCTT"	-0.732558648020583	-15.9045295945373	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATCTCCAGCTCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.81711478657	30.3695021671911	0.0111783388001724	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.02324799237	2713.02324799237
"AML-0024"	"2020-09-15-AML0024:TAATCTCTCAAGCTGT"	-1.92526159706767	-15.3471203080383	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATCTCTCAAGCTGT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2095.00992946894	34.2627101519854	0.0163544380721243	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2092.3295009413	2092.3295009413
"AML-0024"	"2020-09-15-AML0024:TAATTCCAGCCTTCTC"	-0.806213299662429	-15.7341671220032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCAGCCTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.73000313363	31.5043260335636	0.0111807469127728	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.89387877922	2810.89387877922
"AML-0024"	"2020-09-15-AML0024:TAATTCCCACTCCTTG"	-0.703936795622665	-16.1734495393005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCCACTCCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.38370333564	39.8148044374065	0.0142736922101447	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.24450201823	2781.24450201823
"AML-0024"	"2020-09-15-AML0024:TAATTCCGTTCCTAGA"	-0.336601714522201	-16.2752561799255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCGTTCCTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.06210708524	35.7788796947101	0.0131779231131919	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.45707969815	2702.45707969815
"AML-0024"	"2020-09-15-AML0024:TAATTCCTCGAACGCC"	-0.549351374537307	-16.3185110322204	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCTCGAACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.21399318057	38.9854338048657	0.0145510712858681	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.99698757684	2670.99698757684
"AML-0024"	"2020-09-15-AML0024:TAATTCCTCGCCTCTA"	-0.841327707201797	-15.8095379105774	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCTCGCCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2897.38956268916	36.0801185433934	0.0124526294316827	2702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.5749778662	2892.5749778662
"AML-0024"	"2020-09-15-AML0024:TAATTCCTCTCGTCGT"	-1.73080919209178	-16.0832472077576	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAATTCCTCTCGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.09813245517	35.9077991451285	0.0142996399388105	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2506.09744299047	2506.09744299047
"AML-0024"	"2020-09-15-AML0024:TACAACGAGCAAACAT"	-0.389778296381789	-16.2111101380554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGAGCAAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.2698251349	41.1051631372078	0.0133794117954477	3290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3063.71161142181	3063.71161142181
"AML-0024"	"2020-09-15-AML0024:TACAACGAGCAACAAT"	-0.983356694609481	-16.1491499177185	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGAGCAACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.8680356679	37.5525974215234	0.0135184958174208	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.03073854214	2770.03073854214
"AML-0024"	"2020-09-15-AML0024:TACAACGAGGTACAGC"	-2.16045318070109	-16.5167646638122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGAGGTACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.03731884739	39.0231784647732	0.0168128181946474	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.3721708682	2316.3721708682
"AML-0024"	"2020-09-15-AML0024:TACAACGGTTATAGCC"	-1.44788072529491	-16.0128946534363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGGTTATAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.03599021773	31.7060435025509	0.0126065963373376	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.84844645267	2511.84844645267
"AML-0024"	"2020-09-15-AML0024:TACAACGTCAGTGTGT"	-2.3882044357365	-15.445697807428	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGTCAGTGTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.16143496758	31.6848845105579	0.0114049832064305	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.50754661112	2773.50754661112
"AML-0024"	"2020-09-15-AML0024:TACAACGTCCTTATGT"	-0.490849117667037	-15.9243850938049	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAACGTCCTTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.06494549584	37.3788917592781	0.0137066379079145	2726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.13547639519	2713.13547639519
"AML-0024"	"2020-09-15-AML0024:TACACCCCAGTCGCTG"	-2.36799059334453	-16.2751131287781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACACCCCAGTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.46629127702	36.2136768679542	0.0123787708564388	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.26322146689	2916.26322146689
"AML-0024"	"2020-09-15-AML0024:TACACCCGTATAATGG"	0.82596649703328	-16.1971788636413	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACACCCGTATAATGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3109.72871470854	43.3497716593068	0.0139400493214308	3396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3101.30800975472	3101.30800975472
"AML-0024"	"2020-09-15-AML0024:TACACCCTCCGTCCTA"	-2.22112260285075	-15.7466764680115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACACCCTCCGTCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.08361352193	34.6053063059709	0.0120782884459808	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.48513553826	2859.48513553826
"AML-0024"	"2020-09-15-AML0024:TACACCCTCGACGATT"	-0.942187170416671	-16.5693941346374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACACCCTCGACGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.74501714751	38.3274932156037	0.0136847492295601	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2789.17727673445	2789.17727673445
"AML-0024"	"2020-09-15-AML0024:TACACCCTCTCGGTCT"	-0.350549320608932	-15.9655237427917	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACACCCTCTCGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.30947090001	36.0688651303617	0.0127889742251766	2858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.79015588239	2811.79015588239
"AML-0024"	"2020-09-15-AML0024:TACAGGTAGAGTCAGC"	0.869527240365189	-16.2157240143982	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAGGTAGAGTCAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3046.29403879176	40.0350750808023	0.0131422228356791	3863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3037.41812979229	3037.41812979229
"AML-0024"	"2020-09-15-AML0024:TACAGGTAGGCCATAG"	-2.7147151035374	-16.3225774995056	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAGGTAGGCCATAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2386.03790938248	46.7170145898411	0.019579326215287	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2381.30045647853	2381.30045647853
"AML-0024"	"2020-09-15-AML0024:TACAGGTAGTCCGCGT"	-1.80585895004924	-15.8428802720276	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAGGTAGTCCGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.84147490225	37.5982929470011	0.0147164876241254	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.32000388009	2546.32000388009
"AML-0024"	"2020-09-15-AML0024:TACAGGTGTTCTCCCA"	-1.79544423046764	-16.0720205537048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAGGTGTTCTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.01951061917	39.4005161897112	0.0146906150509752	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.20171385216	2673.20171385216
"AML-0024"	"2020-09-15-AML0024:TACAGGTTCCTAGCCT"	-1.69299648228343	-16.8744783631531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACAGGTTCCTAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.84770246955	29.9863026120758	0.0115294342623766	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.89849215904	2590.89849215904
"AML-0024"	"2020-09-15-AML0024:TACATTCAGAGTGAAG"	-0.0943577540224374	-16.1359567872253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCAGAGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.80807321844	38.0701147613339	0.0139460774311687	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.39916116695	2717.39916116695
"AML-0024"	"2020-09-15-AML0024:TACATTCAGCGCCTCA"	-1.77163265171703	-15.9384155503479	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCAGCGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.49353244839	29.3114409466153	0.0107663950702777	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2716.47454478587	2716.47454478587
"AML-0024"	"2020-09-15-AML0024:TACATTCAGCTAGTTC"	-2.84647784653361	-15.9944887391296	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCAGCTAGTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.04820822192	35.5170347376839	0.0136182431849671	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.40369800166	2596.40369800166
"AML-0024"	"2020-09-15-AML0024:TACATTCAGTGTTCCA"	-2.71092782440837	-15.8943186036316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCAGTGTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2471.14605980416	31.8773265499424	0.0128998148140498	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2465.66162186192	2465.66162186192
"AML-0024"	"2020-09-15-AML0024:TACATTCCAAGCACAG"	-0.262122522026855	-16.1956892243591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCCAAGCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3073.86139828999	41.2301723318983	0.0134131527058555	3433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3057.94016727257	3057.94016727257
"AML-0024"	"2020-09-15-AML0024:TACATTCGTCAGACGA"	-1.07541904869731	-16.9140272370544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACATTCGTCAGACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.05441219538	46.1206487261652	0.0189558640756208	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.4211354761	2415.4211354761
"AML-0024"	"2020-09-15-AML0024:TACCCACAGTTTGCTG"	-2.76041016998943	-15.8704490891662	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCACAGTTTGCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.90255144601	32.1832515144175	0.0116949095808304	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.50406319205	2742.50406319205
"AML-0024"	"2020-09-15-AML0024:TACCCACCATAGTCAC"	-1.42935607853587	-15.6937494507995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCACCATAGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.74390289137	35.4749871064216	0.0142484482300465	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.23113219611	2485.23113219611
"AML-0024"	"2020-09-15-AML0024:TACCCACCATTGTCGA"	-2.2852455181187	-16.2954378358093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCACCATTGTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.54452188221	45.2653912730339	0.0167989027108057	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2684.33527209338	2684.33527209338
"AML-0024"	"2020-09-15-AML0024:TACCCACGTGGTCCGT"	9.57879414138142	7.95570085132448	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCACGTGGTCCGT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1836.46835788788	36.7497243577147	0.0200110849717991	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1827.94800868244	1827.94800868244
"AML-0024"	"2020-09-15-AML0024:TACCCACGTTAGAGAT"	-1.39240179482158	-16.115695022699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCACGTTAGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.32789979356	33.8203994352746	0.0141904097368239	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.64811907582	2378.64811907582
"AML-0024"	"2020-09-15-AML0024:TACCCGTAGCTACAAA"	-1.94613764706309	-15.76527502453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTAGCTACAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2940.45607941124	36.2286194124431	0.0123207483580904	2817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.53802834218	2934.53802834218
"AML-0024"	"2020-09-15-AML0024:TACCCGTCAACCCGCA"	1.29302265223805	-16.1470232239929	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	64	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCAACCCGCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3232.93200408421	45.8273846057361	0.0141751773770192	4029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3215.12730710352	3215.12730710352
"AML-0024"	"2020-09-15-AML0024:TACCCGTCAACTCGTA"	-0.398866276175338	-16.14369299328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCAACTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3086.9163735591	38.0762136891807	0.0123347085186115	3534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3076.80143199041	3076.80143199041
"AML-0024"	"2020-09-15-AML0024:TACCCGTCAATCGCAT"	-0.504348318011123	-15.831530593988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCAATCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2962.17568913368	42.2338041891196	0.0142576972540988	2919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2960.25337850467	2960.25337850467
"AML-0024"	"2020-09-15-AML0024:TACCCGTCACGGTGTC"	-0.590595881373245	-15.7518434754578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCACGGTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.82956646244	38.3189006519989	0.0132005340908445	2631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.93612376664	2892.93612376664
"AML-0024"	"2020-09-15-AML0024:TACCCGTCAGCTGGTC"	-1.72881541672404	-16.8664503327576	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCAGCTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.72112946123	38.4582480352892	0.0140938726277546	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.79548092945	2721.79548092945
"AML-0024"	"2020-09-15-AML0024:TACCCGTCATGATAGA"	-1.62725100937541	-16.0442400208679	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTCATGATAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.92904596848	34.4578753520977	0.01285296058242	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.03707508891	2677.03707508891
"AML-0024"	"2020-09-15-AML0024:TACCCGTGTCAGTCGC"	-0.628898183733779	-16.4047918549744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTGTCAGTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2894.17456396375	39.8248267336895	0.0137603402467704	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.02402743284	2881.02402743284
"AML-0024"	"2020-09-15-AML0024:TACCCGTGTGACCGTC"	-2.10272703591045	-15.5388765565124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTGTGACCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3030.39589645942	32.7513413699695	0.0108076114438495	3042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3020.66518898823	3020.66518898823
"AML-0024"	"2020-09-15-AML0024:TACCCGTGTTTGCCGG"	-0.98456178131755	-17.493042968866	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTGTTTGCCGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2807.36074442883	43.5917314850155	0.0155276558495458	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2804.1457881099	2804.1457881099
"AML-0024"	"2020-09-15-AML0024:TACCCGTTCGGTCGGT"	-2.04840836945232	-16.471386932489	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCCGTTCGGTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.5135236102	36.9639622039131	0.0146652504966403	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.90997191983	2510.90997191983
"AML-0024"	"2020-09-15-AML0024:TACCGAAAGAGATGCC"	-0.898888866335708	-16.5361623994079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAAAGAGATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.11933469114	32.8571526833986	0.0124171091804647	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.90463923583	2634.90463923583
"AML-0024"	"2020-09-15-AML0024:TACCGAAAGCATCAAA"	-0.781068424612838	-16.4272775880066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAAAGCATCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2878.0070488711	41.7147538754129	0.0144943195645665	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.02124698935	2869.02124698935
"AML-0024"	"2020-09-15-AML0024:TACCGAAAGGCTGTAG"	-2.94527373734172	-15.9313698044983	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAAAGGCTGTAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.18774791653	40.8081149055096	0.0154799729032053	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.15504626402	2619.15504626402
"AML-0024"	"2020-09-15-AML0024:TACCGAAAGTTGGACG"	-1.51198265972789	-15.7803888550964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAAAGTTGGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.11866528003	31.6526527594025	0.0119754943942515	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.64313563853	2633.64313563853
"AML-0024"	"2020-09-15-AML0024:TACCGAACATGATGCT"	-2.15050516548808	-16.4334230653015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAACATGATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.01488321593	46.4293119763567	0.0177277770637734	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.1250972768	2611.1250972768
"AML-0024"	"2020-09-15-AML0024:TACCGAATCCAACTGA"	-0.980569700629073	-16.7318601838318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAATCCAACTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3044.64718635932	36.2548579710607	0.0119077370059462	3410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3035.50066475612	3035.50066475612
"AML-0024"	"2020-09-15-AML0024:TACCGAATCCTATGGA"	-1.73502335968669	-16.4057836762634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGAATCCTATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.44906553035	29.8888704888736	0.0111382291070117	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.72392973716	2673.72392973716
"AML-0024"	"2020-09-15-AML0024:TACCGGGAGGTTCTTG"	-0.219888101250488	-16.1675691834656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.72108230829	46.6348737377184	0.0182258527747182	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.83043573656	2554.83043573656
"AML-0024"	"2020-09-15-AML0024:TACCGGGAGTATGATG"	-0.931680182844955	-16.3234434357849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGAGTATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.33331807844	36.7485049037951	0.0127098818645433	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2880.94965497162	2880.94965497162
"AML-0024"	"2020-09-15-AML0024:TACCGGGGTCAGCTTA"	-0.425806860358077	-16.3445463410583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGGTCAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2874.06752688517	37.4395168064892	0.0130266656772205	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2871.79603314733	2871.79603314733
"AML-0024"	"2020-09-15-AML0024:TACCGGGGTGGACCTC"	-1.70861218395885	-16.3608732453552	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGGTGGACCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3043.61863728244	39.6900955590997	0.0130404299253923	3015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3037.48211210798	3037.48211210798
"AML-0024"	"2020-09-15-AML0024:TACCGGGTCACATACG"	0.15606035020892	-15.9835825196472	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGTCACATACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1979.77665034335	36.581775980697	0.0184777287752903	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	1977.09846883505	1977.09846883505
"AML-0024"	"2020-09-15-AML0024:TACCGGGTCGATTTCT"	-2.83625636521037	-15.8786621323791	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCGGGTCGATTTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.90867642101	37.1008744862218	0.0137009326825812	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.23223128682	2698.23223128682
"AML-0024"	"2020-09-15-AML0024:TACCTCGAGCATCTTG"	-1.66827009144481	-15.961491607782	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGAGCATCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2087.01026039857	46.0793806651038	0.0220791347026266	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2084.42356088584	2084.42356088584
"AML-0024"	"2020-09-15-AML0024:TACCTCGAGGACCCAA"	-1.74002478542979	-16.3942899934021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGAGGACCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.34031015063	33.0724424413486	0.0132589936933471	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.80569666103	2490.80569666103
"AML-0024"	"2020-09-15-AML0024:TACCTCGCATGGCACC"	-2.81132207337077	-16.0991010895935	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGCATGGCACC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.91916771438	31.9316910166146	0.0111457563537786	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2860.98937715594	2860.98937715594
"AML-0024"	"2020-09-15-AML0024:TACCTCGGTATCTCGA"	-2.34883914414104	-16.0577669373718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGGTATCTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.70538945663	30.6749882922827	0.0115245618143129	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.50558619546	2653.50558619546
"AML-0024"	"2020-09-15-AML0024:TACCTCGGTCGAGATG"	-1.78784702244456	-16.6103162995544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGGTCGAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.64731819301	43.893345093949	0.0164972429054443	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.22654907825	2652.22654907825
"AML-0024"	"2020-09-15-AML0024:TACCTCGGTCTACGAT"	-1.4754767221516	-15.8437671891418	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGGTCTACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.71779322324	33.0442398370398	0.0132191881526079	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2496.96058775557	2496.96058775557
"AML-0024"	"2020-09-15-AML0024:TACCTCGTCATCACAG"	-2.35636387291606	-15.990035080072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTCGTCATCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.1834621045	35.7885755833747	0.0124214844539035	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.98565634608	2869.98565634608
"AML-0024"	"2020-09-15-AML0024:TACCTGCAGACCATAA"	-0.565142015845138	-16.7511110535828	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTGCAGACCATAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2091.42669792422	50.7659176515983	0.0242733430255933	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2067.59098728563	2067.59098728563
"AML-0024"	"2020-09-15-AML0024:TACCTGCCACGGCTAC"	-0.876530508429366	-16.369429611322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTGCCACGGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2886.26067583814	35.218258778843	0.0122020367299693	2780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2870.6062290864	2870.6062290864
"AML-0024"	"2020-09-15-AML0024:TACCTGCCATGCAGCC"	-2.4982422393864	-15.9656973115173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTGCCATGCAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.21166246879	32.9596890537387	0.0114554273095979	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.63327553277	2869.63327553277
"AML-0024"	"2020-09-15-AML0024:TACCTGCGTTGCGAAG"	-2.16056881371196	-15.6797123185364	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTGCGTTGCGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.99191552267	39.7035400101055	0.0153177715456336	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2589.37999217335	2589.37999217335
"AML-0024"	"2020-09-15-AML0024:TACCTGCTCCGACATA"	-0.952125887305099	-17.1980123749939	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACCTGCTCCGACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3211.04995955764	34.2023062819225	0.0106514400936429	3550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3199.69645559735	3199.69645559735
"AML-0024"	"2020-09-15-AML0024:TACGCTCAGCCGAATG"	-2.1857307952946	13.6555137404236	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGCTCAGCCGAATG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2122.05033772103	29.0036607250255	0.0136677534031421	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2122.05033772103	2122.05033772103
"AML-0024"	"2020-09-15-AML0024:TACGCTCAGTTGGCTT"	0.0725691198254048	13.0444211729797	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGCTCAGTTGGCTT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1887.35947281459	34.3683312468933	0.0182097431580643	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1883.9259259987	1883.9259259987
"AML-0024"	"2020-09-15-AML0024:TACGCTCTCAGACATC"	-1.60413859310802	-16.0942754975525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGCTCTCAGACATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.84402735895	31.441938780599	0.0116804459920539	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.97212654079	2682.97212654079
"AML-0024"	"2020-09-15-AML0024:TACGGGCAGGAGAATG"	-0.793926457793075	-15.8803339234558	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCAGGAGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.76294478271	35.0931482871354	0.0128275545050643	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.29650646586	2728.29650646586
"AML-0024"	"2020-09-15-AML0024:TACGGGCCATGATCTG"	-0.914933721453506	-16.4477358094421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCCATGATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2914.40159896277	38.5659602410568	0.0132328915324444	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.5239866346	2906.5239866346
"AML-0024"	"2020-09-15-AML0024:TACGGGCGTGACACAG"	-1.22937426987346	-16.5226640931335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCGTGACACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.10274234954	41.6866833209378	0.0143149768429201	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.89877022518	2906.89877022518
"AML-0024"	"2020-09-15-AML0024:TACGGGCGTTGGGACA"	-0.394395570189315	-15.7967767945495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCGTTGGGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.29484242331	40.3065367978839	0.0137833354602789	2703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2912.67050631615	2912.67050631615
"AML-0024"	"2020-09-15-AML0024:TACGGGCTCATTTGCT"	1.15519311007802	-16.2186784974304	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCTCATTTGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2971.03666558765	36.3882655532259	0.0122476662690491	3156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2957.1999761475	2957.1999761475
"AML-0024"	"2020-09-15-AML0024:TACGGGCTCTTTGCTA"	-2.03786883774455	-16.0224924317566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGGCTCTTTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.16028220896	32.903083206794	0.012122748764128	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.06783302192	2710.06783302192
"AML-0024"	"2020-09-15-AML0024:TACGGTAAGATACGAT"	-2.77634892883952	-16.0002260438171	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTAAGATACGAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.46279268614	40.1007122254587	0.0149939316168922	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2664.41947174275	2664.41947174275
"AML-0024"	"2020-09-15-AML0024:TACGGTAAGTGGATTA"	-0.762056152254897	-16.0313806763855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTAAGTGGATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.29723714056	35.8348948644774	0.0135568918852435	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.36389200392	2635.36389200392
"AML-0024"	"2020-09-15-AML0024:TACGGTAAGTTCGCAT"	-2.00006781044658	-15.7072162858215	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTAAGTTCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.03311923119	34.0069090213968	0.0129351390717137	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.98323577757	2620.98323577757
"AML-0024"	"2020-09-15-AML0024:TACGGTACAGACACCC"	-0.970805863768417	-16.0986509553161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTACAGACACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2906.82118386195	43.3952847145388	0.0149287768217254	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.73611296901	2903.73611296901
"AML-0024"	"2020-09-15-AML0024:TACGGTAGTCTACATG"	-0.640840212733108	-15.90798571026	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTAGTCTACATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.50012065799	37.5307854390609	0.0145439967774507	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.67186288772	2573.67186288772
"AML-0024"	"2020-09-15-AML0024:TACGGTAGTGAAGCGT"	-1.6144884628361	-16.3894796601501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTAGTGAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3009.05187558366	37.1684892732601	0.0123522261529807	3518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3002.63387388235	3002.63387388235
"AML-0024"	"2020-09-15-AML0024:TACGGTATCAGTCATG"	-0.558733622462112	-16.5243692628113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTATCAGTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2306.36283860365	46.4332618475672	0.0201326786359771	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2291.22198431869	2291.22198431869
"AML-0024"	"2020-09-15-AML0024:TACGGTATCCGCTTAC"	-1.99749479714091	-15.2501144639221	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	72	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0434782608695652	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTATCCGCTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2158.583040996	48.8719624573937	0.0226407608737829	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2148.62349508868	2148.62349508868
"AML-0024"	"2020-09-15-AML0024:TACGGTATCGGATAAA"	-1.42468462410625	-16.0227918854919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTATCGGATAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.94540828198	34.7242628131675	0.0147077787954596	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2349.66035957535	2349.66035957535
"AML-0024"	"2020-09-15-AML0024:TACGGTATCTAGGAAA"	-0.931336740881759	12.0947894820007	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTATCTAGGAAA"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1798.10181091244	40.8852971995876	0.0227380323802914	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1796.42129116166	1796.42129116166
"AML-0024"	"2020-09-15-AML0024:TACGGTATCTGTCCGT"	-2.15326271477397	-15.84672739422	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGGTATCTGTCCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.91410424315	38.0317859182289	0.0141597178622157	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.13122819603	2677.13122819603
"AML-0024"	"2020-09-15-AML0024:TACGTCCCAACCGCCA"	-0.654923955828506	-16.3122492066589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCCAACCGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.48938286804	36.0772884901939	0.014825332193426	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2424.24813067686	2424.24813067686
"AML-0024"	"2020-09-15-AML0024:TACGTCCCACCTTCCA"	-1.72850666466411	-16.3785734406677	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCCACCTTCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.18734117892	32.2326193114015	0.0123962680692028	2378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.2541330899	2591.2541330899
"AML-0024"	"2020-09-15-AML0024:TACGTCCCATTGCCTC"	-1.50865660134013	-16.5755605927673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCCATTGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.98278293866	38.5730680198558	0.0142917058469922	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.87303007294	2682.87303007294
"AML-0024"	"2020-09-15-AML0024:TACGTCCGTAGTTACC"	-1.48392591896709	-16.2593641511169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCGTAGTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.06006692284	32.8138830980739	0.0108797180327886	3542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3007.26808720894	3007.26808720894
"AML-0024"	"2020-09-15-AML0024:TACGTCCGTATCGGTT"	11.8910252052242	-2.58396222507628	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCGTATCGGTT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1589.46166993704	35.1199497942099	0.0220954996641102	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1589.46166993704	1589.46166993704
"AML-0024"	"2020-09-15-AML0024:TACGTCCGTATGTCAC"	-1.82861040058787	-16.6924371949402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCGTATGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.36260400071	37.7954491902703	0.0132552237085666	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2836.52115187545	2836.52115187545
"AML-0024"	"2020-09-15-AML0024:TACGTCCGTGCATGTT"	0.0975679206544578	-16.1531915894714	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCGTGCATGTT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2612.57524273251	46.0086528235916	0.017610460388299	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2603.79443322019	2603.79443322019
"AML-0024"	"2020-09-15-AML0024:TACGTCCTCTCGGGAC"	-1.35260150852855	-16.0430765382019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACGTCCTCTCGGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.4853268166	40.7677093445026	0.0145729841560579	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.71633427358	2790.71633427358
"AML-0024"	"2020-09-15-AML0024:TACTGCCCAATTCTCT"	-2.01307259026225	-15.9072361222473	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTGCCCAATTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.38172276111	47.7392296641226	0.0170962405587292	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2783.66095308027	2783.66095308027
"AML-0024"	"2020-09-15-AML0024:TACTGCCCACAACGTT"	-1.60606704178508	-16.3661432496277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTGCCCACAACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.84352372004	40.4939067036393	0.0149653541857319	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2702.18111401895	2702.18111401895
"AML-0024"	"2020-09-15-AML0024:TACTGCCCACTGCACG"	-0.0893515450065911	-15.9826975098816	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTGCCCACTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2964.49738061628	34.5821972669802	0.0116654504379393	3119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2954.09950265535	2954.09950265535
"AML-0024"	"2020-09-15-AML0024:TACTGCCGTAGCCAGA"	-0.0225111794775308	-16.0636778107849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTGCCGTAGCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.3009583151	35.0093907428892	0.0127617754212398	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.96395827415	2734.96395827415
"AML-0024"	"2020-09-15-AML0024:TACTGCCGTGAGTGAC"	-1.21331081810649	-16.5685701600281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTGCCGTGAGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.07790410144	37.9568687808403	0.0154605557393636	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2451.94990679078	2451.94990679078
"AML-0024"	"2020-09-15-AML0024:TACTTACAGTCGCCAC"	-2.22258625450786	-16.5374498597351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTACAGTCGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.38369390354	37.8559788681082	0.0137939818518098	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.93223193954	2735.93223193954
"AML-0024"	"2020-09-15-AML0024:TACTTACGTGCATTAC"	-2.58722219887431	-15.8692713013855	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTACGTGCATTAC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.63103665218	36.5589558805044	0.0130305643910072	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.41364529394	2796.41364529394
"AML-0024"	"2020-09-15-AML0024:TACTTACGTTTAGTCG"	-0.808851401240188	-16.5923147431579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTACGTTTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.84562258997	33.9741734318167	0.011992949125394	2693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.90749874498	2824.90749874498
"AML-0024"	"2020-09-15-AML0024:TACTTACTCTCTCAAT"	0.00467412275020477	-15.9814405671326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTACTCTCTCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.00316997136	33.9174783411202	0.0123291309553356	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.3867910782	2745.3867910782
"AML-0024"	"2020-09-15-AML0024:TACTTACTCTTCTGTA"	-0.447298775345641	-16.503218673822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTACTCTTCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.32696680907	39.1933294686367	0.0146663675348964	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.43243123059	2668.43243123059
"AML-0024"	"2020-09-15-AML0024:TACTTCAAGCTGACCC"	-0.70233384791072	-15.6028909913269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTCAAGCTGACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3002.76117275089	38.0423282366317	0.0126691155400082	3524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2996.31297233315	2996.31297233315
"AML-0024"	"2020-09-15-AML0024:TACTTCACAAATGCTC"	-1.79569898071941	-15.7221927872864	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTCACAAATGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.56838264088	37.7145472334201	0.0131383552684167	2807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.49566689485	2863.49566689485
"AML-0024"	"2020-09-15-AML0024:TACTTCACACCTATCC"	-1.6434774202412	-16.5217619172302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTCACACCTATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.48753175809	34.6792318739526	0.0137154055293441	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.85670492781	2515.85670492781
"AML-0024"	"2020-09-15-AML0024:TACTTCAGTATCTCTT"	-0.704232255846816	-16.1033716431824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTCAGTATCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.51749592468	37.7540259571194	0.0133053015572037	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.58572152736	2831.58572152736
"AML-0024"	"2020-09-15-AML0024:TACTTCATCCTCTAGC"	-0.582568864256698	12.5659246214661	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTCATCCTCTAGC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1669.38000669155	28.9503712638395	0.0173419899290723	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1667.48762665839	1667.48762665839
"AML-0024"	"2020-09-15-AML0024:TACTTGTAGAAGCGCT"	0.668901284306687	-16.2145471802917	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTAGAAGCGCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2551.33884448721	43.816088267626	0.0171737628509445	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2543.74795734854	2543.74795734854
"AML-0024"	"2020-09-15-AML0024:TACTTGTAGCTCTGTA"	-0.486424605280715	-15.7208957902161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTAGCTCTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.57009141609	37.906015164273	0.0138263892223502	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.46998511023	2737.46998511023
"AML-0024"	"2020-09-15-AML0024:TACTTGTAGTAAACTG"	-1.346711854369	-16.9024019471374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTAGTAAACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.40154370842	45.2896400266707	0.0188596697396684	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2391.27810358316	2391.27810358316
"AML-0024"	"2020-09-15-AML0024:TACTTGTAGTGGCGAT"	-1.00097845020946	-16.3415575257507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTAGTGGCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.8433854993	35.5662570924156	0.0124320881292173	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.27739260744	2857.27739260744
"AML-0024"	"2020-09-15-AML0024:TACTTGTCAACACTAC"	-1.32949731770213	-16.1175470582214	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTCAACACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.08379665848	33.6458347292014	0.0132407419123468	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2531.51870489128	2531.51870489128
"AML-0024"	"2020-09-15-AML0024:TACTTGTCAACCGTGC"	-1.78574822369273	-16.6903753510681	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTCAACCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.90343247025	36.5716352331055	0.0137131456609325	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.73237592339	2658.73237592339
"AML-0024"	"2020-09-15-AML0024:TACTTGTCACTATGTG"	-2.05801616135295	-16.1578607789245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTCACTATGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2945.46803091403	33.7409048600541	0.0114551930307605	2791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2936.44887806754	2936.44887806754
"AML-0024"	"2020-09-15-AML0024:TACTTGTGTCTTCCGT"	-2.78072915497478	-16.1130552521911	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTGTCTTCCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.42656595249	41.8350813146005	0.0169138157932295	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2457.50710564856	2457.50710564856
"AML-0024"	"2020-09-15-AML0024:TACTTGTGTTCCAGGC"	-2.2075437110966	-15.8863249055115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTGTTCCAGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.87014249593	33.2740891626632	0.0129075893366944	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2572.5692760076	2572.5692760076
"AML-0024"	"2020-09-15-AML0024:TACTTGTTCCTTTAGT"	0.0403680113026917	-16.0541811219421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTTCCTTTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.59244981932	41.3194632966663	0.0142059996405591	3011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2899.73878543111	2899.73878543111
"AML-0024"	"2020-09-15-AML0024:TACTTGTTCTGACAGT"	-0.563250283629257	-15.9609956971374	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TACTTGTTCTGACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.97905798533	35.5978310254006	0.0122330196596144	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2904.19159193392	2904.19159193392
"AML-0024"	"2020-09-15-AML0024:TAGACCAAGGGTTAAT"	-1.14912710610088	-15.5752983323303	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCAAGGGTTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.81650162824	40.840011049634	0.0156007921197808	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.55060599068	2611.55060599068
"AML-0024"	"2020-09-15-AML0024:TAGACCACAGAAGTTA"	-1.92439518395122	-15.8124666444031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCACAGAAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.86611490715	36.9804089324815	0.013601408590781	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.66220803666	2711.66220803666
"AML-0024"	"2020-09-15-AML0024:TAGACCAGTACGAGCA"	0.0523464863304093	-16.3505087128845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCAGTACGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2914.26406805285	36.7012434362436	0.0125936574652157	2758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2905.60433609195	2905.60433609195
"AML-0024"	"2020-09-15-AML0024:TAGACCAGTGCCCAGT"	-1.96713195267375	-15.4719705811706	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCAGTGCCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.68240761688	38.7655007083992	0.0138612452392948	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.00724114612	2786.00724114612
"AML-0024"	"2020-09-15-AML0024:TAGACCATCAAAGGAT"	-0.619850496680099	-16.3597631684509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCATCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2604.64843743571	35.3515974293427	0.0135725025002401	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.73940246538	2599.73940246538
"AML-0024"	"2020-09-15-AML0024:TAGACCATCATGCTAG"	-0.798472265631515	-17.1729994050232	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCATCATGCTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2960.96324336748	43.734600908099	0.0147703964262521	2551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2952.99234392352	2952.99234392352
"AML-0024"	"2020-09-15-AML0024:TAGACCATCCACAGCG"	0.125654389231843	-16.4584093323913	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCATCCACAGCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2749.41191739222	43.0037720070198	0.0156410800924324	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2743.65074751768	2743.65074751768
"AML-0024"	"2020-09-15-AML0024:TAGACCATCCGAGTGC"	-1.97566996040996	-16.0483885041443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACCATCCGAGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.17307241325	34.960082709739	0.013570548921618	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.4093916716	2569.4093916716
"AML-0024"	"2020-09-15-AML0024:TAGACTGAGCCGAATG"	-0.468825141817886	-16.0581064454285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACTGAGCCGAATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2873.27283780231	38.1704618817478	0.0132846631825411	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.58466588788	2864.58466588788
"AML-0024"	"2020-09-15-AML0024:TAGACTGCACCCTATC"	-0.706531862646896	-16.5133466950622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACTGCACCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.06876650971	35.1959071923766	0.0131865868852834	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.98028259175	2660.98028259175
"AML-0024"	"2020-09-15-AML0024:TAGACTGTCCGGTTCT"	-1.67777214470561	-16.089587234613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACTGTCCGGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2856.29015489636	32.8014009643695	0.0114839176643662	2867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.64677826692	2847.64677826692
"AML-0024"	"2020-09-15-AML0024:TAGACTGTCGCACGAC"	-0.39213071289714	-16.3905611268249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGACTGTCGCACGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2357.93644227348	29.7105191799281	0.012600220534902	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2350.15661796986	2350.15661796986
"AML-0024"	"2020-09-15-AML0024:TAGAGTCAGCCTTCTC"	-1.24680946293529	-16.5697298279968	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGAGTCAGCCTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.00596822108	35.6402497881486	0.0137872988404259	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.31525290495	2576.31525290495
"AML-0024"	"2020-09-15-AML0024:TAGAGTCCAGTCAACT"	-0.878851572901565	-16.0327425233093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGAGTCCAGTCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.20662225375	38.9086681028712	0.0135324772145844	2975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2862.29901960418	2862.29901960418
"AML-0024"	"2020-09-15-AML0024:TAGAGTCCATTCACCC"	-1.81455657902415	-15.5703687897888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGAGTCCATTCACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.19733770396	32.6091532395687	0.0116954251403245	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.56780167961	2785.56780167961
"AML-0024"	"2020-09-15-AML0024:TAGAGTCTCGCCAGAC"	-1.17098865929301	-16.2506189576355	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGAGTCTCGCCAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.22647215388	35.0118644913437	0.0133265498282833	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.44575910028	2618.44575910028
"AML-0024"	"2020-09-15-AML0024:TAGAGTCTCTAGATCG"	-2.2872408432072	-16.4027204743591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGAGTCTCTAGATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.06492229134	38.2069512010163	0.0148257620017759	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.96785476412	2569.96785476412
"AML-0024"	"2020-09-15-AML0024:TAGATCGAGACGACTG"	-1.21733162823375	-16.395178817865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGATCGAGACGACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.7782138348	35.1752047480668	0.0127456636086672	2449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.25860278883	2753.25860278883
"AML-0024"	"2020-09-15-AML0024:TAGATCGAGCGTTACT"	-2.57446704331096	-15.8920717469421	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGATCGAGCGTTACT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.41230527804	36.5894117314027	0.0142293056840009	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2566.75141991943	2566.75141991943
"AML-0024"	"2020-09-15-AML0024:TAGATCGAGGTAAGTT"	-0.939403037459213	-16.0791006318298	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGATCGAGGTAAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.97709405173	36.1234967978715	0.0131838681703919	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.16080713086	2735.16080713086
"AML-0024"	"2020-09-15-AML0024:TAGATCGGTTAAACCC"	-0.234738866717178	-16.1596269837585	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGATCGGTTAAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.64523261733	36.2264681036757	0.0130000287369377	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.13661577996	2775.13661577996
"AML-0024"	"2020-09-15-AML0024:TAGATCGTCCATCTGC"	-0.140180374414283	-16.4613619080749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGATCGTCCATCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.93772425977	34.2810450678917	0.0123271530925838	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.39593057481	2776.39593057481
"AML-0024"	"2020-09-15-AML0024:TAGCACAAGGCCCACT"	-1.00219712677653	-16.0650205842224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGCACAAGGCCCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.18934858908	35.9681816468989	0.0132567900819761	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.43417701872	2705.43417701872
"AML-0024"	"2020-09-15-AML0024:TAGCACAGTAAGTTGA"	-2.75170789185222	-15.9773912659851	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGCACAGTAAGTTGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.68634440542	44.358296126589	0.0215259814998133	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2057.2945624665	2057.2945624665
"AML-0024"	"2020-09-15-AML0024:TAGCACAGTTACCCAA"	-0.931936840445358	-15.7599201432434	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGCACAGTTACCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.23000033725	35.0083001131659	0.0142354721227233	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2457.29845389977	2457.29845389977
"AML-0024"	"2020-09-15-AML0024:TAGCACATCAGGGATG"	0.875192602246445	-16.204915069696	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGCACATCAGGGATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.40570761815	43.0142973436609	0.0145791127073118	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2935.5478897214	2935.5478897214
"AML-0024"	"2020-09-15-AML0024:TAGCACATCTACTTCA"	-0.368527422577697	-15.9645700684753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGCACATCTACTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.18988717695	34.7619285537184	0.0123655569167642	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2807.94939905438	2807.94939905438
"AML-0024"	"2020-09-15-AML0024:TAGGAGGAGACCGCCT"	-2.32648477974589	-15.6916342011658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGAGGAGACCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.36151589734	47.3150472460634	0.0168719499885604	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.7929147962	2797.7929147962
"AML-0024"	"2020-09-15-AML0024:TAGGAGGAGGAGGTTC"	-2.28736982765849	-16.0298605195251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGAGGAGGAGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.79921380602	32.4703905239091	0.0130413690966965	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2483.29790595677	2483.29790595677
"AML-0024"	"2020-09-15-AML0024:TAGGAGGAGGCAGGGA"	-0.696058611304122	-16.5304002991882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGAGGAGGCAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.03231157278	38.1308175404484	0.0160751678442212	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2368.01659326618	2368.01659326618
"AML-0024"	"2020-09-15-AML0024:TAGGAGGCAGAACATA"	-1.86979375305827	-16.7727995148865	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGAGGCAGAACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2126.52557457659	45.2825604990166	0.0212941527910064	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2117.81520405391	2117.81520405391
"AML-0024"	"2020-09-15-AML0024:TAGGGTTAGCGAATGC"	-0.935565809637863	-16.2997026673523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTAGCGAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.60960610272	37.4920002604603	0.0146647341741052	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.75157235842	2550.75157235842
"AML-0024"	"2020-09-15-AML0024:TAGGGTTAGCGGCTCT"	-0.904829303652603	-15.7070436707703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTAGCGGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.53003752916	36.715115652146	0.0134906156264508	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.60581781061	2712.60581781061
"AML-0024"	"2020-09-15-AML0024:TAGGGTTCACCACATA"	-0.979198793799239	-15.9740820161072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTCACCACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.6578388478	29.2523553096777	0.0116559137492255	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2503.59852461609	2503.59852461609
"AML-0024"	"2020-09-15-AML0024:TAGGGTTGTAGACAAT"	-2.02676139298137	-16.7541055909363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTGTAGACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.06830698854	48.3014858439425	0.0183651069881331	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.16583523237	2619.16583523237
"AML-0024"	"2020-09-15-AML0024:TAGGGTTGTCATCGCG"	-1.59134171429332	-16.9277773133484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTGTCATCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2211.98867793512	47.6885882584405	0.0215591466331363	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2210.58212454369	2210.58212454369
"AML-0024"	"2020-09-15-AML0024:TAGGGTTGTCGGTAAG"	-1.233630279929	-15.6108522645203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTGTCGGTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.20518646284	40.6589538953441	0.0149800590235888	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.50747631591	2708.50747631591
"AML-0024"	"2020-09-15-AML0024:TAGGGTTGTTAAGGGC"	-1.60344109955485	-16.2743158570495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGGTTGTTAAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.54814028075	38.0872852752706	0.013857237832982	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.9718483422	2743.9718483422
"AML-0024"	"2020-09-15-AML0024:TAGGTACAGTCTCGTA"	-0.755393187434036	-15.6542406312195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTACAGTCTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.1575146171	32.989276881404	0.0133335394721259	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2469.81071589285	2469.81071589285
"AML-0024"	"2020-09-15-AML0024:TAGGTACGTCCGAAAG"	-1.4372150701588	-16.5460386506286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTACGTCCGAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.01201558094	33.4616457300708	0.0125984541989174	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.28640718469	2649.28640718469
"AML-0024"	"2020-09-15-AML0024:TAGGTTGAGACGGAAA"	-2.66437540474589	-15.4607839814392	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGAGACGGAAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.85744948737	31.2185945149274	0.012433439628881	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2504.09420898039	2504.09420898039
"AML-0024"	"2020-09-15-AML0024:TAGGTTGAGCATTGAA"	-0.421466897160369	-16.5382871857849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGAGCATTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3047.1446793394	33.7581766848545	0.0110786261360498	3589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3035.91344692408	3035.91344692408
"AML-0024"	"2020-09-15-AML0024:TAGGTTGAGGCATTTC"	-0.224288920790511	-16.2085066071716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGAGGCATTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2903.35043287647	41.0790184535235	0.0141488323243243	2665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2896.29230882829	2896.29230882829
"AML-0024"	"2020-09-15-AML0024:TAGGTTGCAATACCTG"	-1.49923525276836	-16.2042570344177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGCAATACCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3103.08842173243	35.4273552907228	0.0114168049619881	4176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3093.24676031649	3093.24676031649
"AML-0024"	"2020-09-15-AML0024:TAGGTTGGTCGCTCGA"	-1.20242951336558	-16.8724069825378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGGTCGCTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.6421710453	51.3718921548514	0.0175591850101398	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.10383679085	2916.10383679085
"AML-0024"	"2020-09-15-AML0024:TAGGTTGGTTGTCATG"	-0.805198590189773	-16.1330900422302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGGTTGTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2943.43491872167	36.1083568607669	0.0122674215186822	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2935.07749363754	2935.07749363754
"AML-0024"	"2020-09-15-AML0024:TAGGTTGTCTCTGAGA"	-0.775804440409499	-16.0997743836609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGTCTCTGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.79542990498	25.6056360239043	0.00906459836093886	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.13231584535	2816.13231584535
"AML-0024"	"2020-09-15-AML0024:TAGGTTGTCTGGGATT"	-0.251369277865249	-16.0446558228699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGTCTGGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.05453099632	35.668230916614	0.0130031067605713	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.07947551904	2736.07947551904
"AML-0024"	"2020-09-15-AML0024:TAGGTTGTCTTGTGCC"	-1.33895550194438	-15.6924572221008	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGGTTGTCTTGTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.27101142574	39.5658005333935	0.015163545818023	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2606.29610930031	2606.29610930031
"AML-0024"	"2020-09-15-AML0024:TAGTGCAAGAGGCGTT"	-0.750850479037124	-16.3656206361023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGTGCAAGAGGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.82490528299	35.0329458734968	0.0133773532559677	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.18009306091	2611.18009306091
"AML-0024"	"2020-09-15-AML0024:TAGTGCACAATCGAAA"	-1.7319909137791	-16.6024656525818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGTGCACAATCGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.38768621061	34.2063632256426	0.0124823080317307	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.03778383564	2733.03778383564
"AML-0024"	"2020-09-15-AML0024:TAGTGCAGTTCCGTTC"	-1.50294051590617	-15.608033203241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGTGCAGTTCCGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.1900519699	38.3493025113799	0.0151987372023126	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.84138746417	2518.84138746417
"AML-0024"	"2020-09-15-AML0024:TAGTGCATCAAACCCA"	0.0956569435888946	-15.8882818452087	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TAGTGCATCAAACCCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2341.97430378013	43.8131722029831	0.0187077937329479	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2338.51177481158	2338.51177481158
"AML-0024"	"2020-09-15-AML0024:TATACCTAGCCTCTTC"	-1.33435283127483	-16.0411844483581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTAGCCTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.50105115484	34.1528551159936	0.0123273207572895	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.67823611721	2763.67823611721
"AML-0024"	"2020-09-15-AML0024:TATACCTCACAATTCG"	-1.71219191971477	-16.312487625238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTCACAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.85509274886	37.5157235343987	0.0135491827046658	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.21926598806	2759.21926598806
"AML-0024"	"2020-09-15-AML0024:TATACCTCACTCGATA"	-1.99594364586528	-16.6685343018738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTCACTCGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.99137979638	36.2167165878751	0.0149409428142923	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2417.49540180266	2417.49540180266
"AML-0024"	"2020-09-15-AML0024:TATACCTCAGCTCGGT"	-1.40294919434245	-15.6844082108703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTCAGCTCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2807.22877480385	42.8508089468954	0.015264452021688	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.57676949028	2799.57676949028
"AML-0024"	"2020-09-15-AML0024:TATACCTGTCGGATTT"	-1.30865130844768	-16.1687269440857	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTGTCGGATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.28522254941	36.3629301467427	0.0130788488360196	2846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.57676880771	2769.57676880771
"AML-0024"	"2020-09-15-AML0024:TATACCTTCTCTTGCG"	-2.07189879837688	-15.8062668076721	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATACCTTCTCTTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.47192882733	38.5945593915041	0.0143662619279074	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.58270547536	2681.58270547536
"AML-0024"	"2020-09-15-AML0024:TATATCCCAGCACAAG"	-2.46139440956767	-16.3346300355163	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATATCCCAGCACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.22540598467	39.3189773027197	0.0146700263399206	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.78318914915	2669.78318914915
"AML-0024"	"2020-09-15-AML0024:TATATCCGTTTGTGGT"	-0.842219094664413	-16.1502809754578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATATCCGTTTGTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.72236128079	41.9024743533869	0.015916024784703	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.65240352267	2621.65240352267
"AML-0024"	"2020-09-15-AML0024:TATATCCTCGTTTACT"	-1.17946193638499	-16.9492006531921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATATCCTCGTTTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.66238483911	36.6236107546417	0.013728727804081	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.53853495712	2662.53853495712
"AML-0024"	"2020-09-15-AML0024:TATCAGGCAGAATCGG"	-2.09569964829143	-15.5375871888367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCAGGCAGAATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2629.05604963609	36.0014679206661	0.0136936859621724	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.93222656149	2624.93222656149
"AML-0024"	"2020-09-15-AML0024:TATCAGGGTAGTACGG"	-1.69460246983226	-16.3042478791443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCAGGGTAGTACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.88446791865	38.199681995089	0.0135082187509606	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.72015447723	2817.72015447723
"AML-0024"	"2020-09-15-AML0024:TATCAGGGTCCTTTGC"	-1.99621591988261	-16.1464758149353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCAGGGTCCTTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.6264823141	36.6714380844458	0.0125948291469379	2602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.5012360766	2906.5012360766
"AML-0024"	"2020-09-15-AML0024:TATCAGGTCAGGGATG"	-2.03472814980205	-16.5261068574158	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCAGGTCAGGGATG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.07400889341	44.9465854500334	0.0196954986012168	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2280.59594382668	2280.59594382668
"AML-0024"	"2020-09-15-AML0024:TATCAGGTCTAATTCC"	0.766231198876542	-16.2511034241882	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCAGGTCTAATTCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3025.53544136179	40.5691201672126	0.0134089059452407	3302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3013.79854017487	3013.79854017487
"AML-0024"	"2020-09-15-AML0024:TATCCTAAGCTGACAG"	-1.11699305000957	-15.2558546296326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCCTAAGCTGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.00734499211	30.7302586004824	0.0119712390618722	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.64667799945	2559.64667799945
"AML-0024"	"2020-09-15-AML0024:TATCCTAGTACATACC"	0.256385152309579	-16.1014242402283	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCCTAGTACATACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2680.14003324552	41.2103777715269	0.0153762032059284	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2672.22576550788	2672.22576550788
"AML-0024"	"2020-09-15-AML0024:TATCGCCAGACTCGAG"	-1.82266388359721	-16.666979812738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCAGACTCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.57312414399	45.3404905677805	0.0172951462426154	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.36156297278	2613.36156297278
"AML-0024"	"2020-09-15-AML0024:TATCGCCAGATCGACG"	-2.53950915756877	-15.613139175531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCAGATCGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.80320984501	35.3847432081596	0.0127521631381334	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.36010311573	2765.36010311573
"AML-0024"	"2020-09-15-AML0024:TATCGCCCAAGGCCTC"	-2.65533886376079	-15.6857404938904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCCAAGGCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2549.64726975023	32.3027495441858	0.0126694974349728	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.07516513552	2543.07516513552
"AML-0024"	"2020-09-15-AML0024:TATCGCCCACCCTAGG"	-2.00002370300944	-16.1378679505554	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCCACCCTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.40220606359	34.3664060128626	0.0134537959336569	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.07190314306	2547.07190314306
"AML-0024"	"2020-09-15-AML0024:TATCGCCCAGGTGTTT"	-1.59590588036235	-16.589644455072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCCAGGTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.08200192661	37.5902796370953	0.01508388552545	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.17537517885	2485.17537517885
"AML-0024"	"2020-09-15-AML0024:TATCGCCTCCATCAGA"	-2.41399941864665	-15.7357444993225	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCTCCATCAGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.02493824439	31.3404127202559	0.0114841063857839	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2725.95822895783	2725.95822895783
"AML-0024"	"2020-09-15-AML0024:TATCGCCTCGGCCCAA"	-1.38948247852977	-16.8552847138611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCTCGGCCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.74669815228	32.2614402874175	0.0132613232244527	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2428.11035832495	2428.11035832495
"AML-0024"	"2020-09-15-AML0024:TATCGCCTCTCAACGA"	-2.30759272995647	-16.4394788972107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCGCCTCTCAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.92375496965	35.6625287755345	0.0145982979219004	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2439.95573090855	2439.95573090855
"AML-0024"	"2020-09-15-AML0024:TATCTGTCAGGTGACA"	-1.99070630493816	-16.0029115906921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTCAGGTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.36686384412	39.2212746728919	0.0134118858881252	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.423564083	2921.423564083
"AML-0024"	"2020-09-15-AML0024:TATCTGTCATGTCAGT"	-0.603268186480361	-16.2686720124451	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTCATGTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2867.28935409478	38.9865071136813	0.0135969908506111	2535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2860.58281464693	2860.58281464693
"AML-0024"	"2020-09-15-AML0024:TATCTGTGTGTTCCAA"	-1.9858389896458	-16.4336729279724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTGTGTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.31972902005	35.3361983638911	0.0135371150020603	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.38126636513	2602.38126636513
"AML-0024"	"2020-09-15-AML0024:TATCTGTGTTAGAAAC"	-2.575267414481	-16.26136877453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTGTTAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.84349743212	39.660390223719	0.0152725377031527	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.89565949427	2586.89565949427
"AML-0024"	"2020-09-15-AML0024:TATCTGTGTTCTAACG"	-2.65013919296916	-15.662998222467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTGTTCTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.43880694985	33.7357146814659	0.0132274158429276	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.68634896588	2543.68634896588
"AML-0024"	"2020-09-15-AML0024:TATCTGTTCGGTGCAC"	-1.10736928406413	-17.3645944825378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTTCGGTGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.01118594212	37.2283122563726	0.0136267056474495	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.89217502398	2724.89217502398
"AML-0024"	"2020-09-15-AML0024:TATCTGTTCTGAGTCA"	-1.9999340576237	-16.1050672761169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTGTTCTGAGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.98404019483	31.8540370083109	0.0121906741557961	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.96486304404	2608.96486304404
"AML-0024"	"2020-09-15-AML0024:TATCTTGAGACAAGCC"	-2.74127064171489	-16.2268705598083	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGAGACAAGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.07776694183	35.7986216063501	0.0142619571703412	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2496.84400437406	2496.84400437406
"AML-0024"	"2020-09-15-AML0024:TATCTTGAGACGCATG"	-0.233460883528549	-16.1565313569275	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGAGACGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.92831993303	32.9111172747026	0.0128512450030477	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.89832918953	2553.89832918953
"AML-0024"	"2020-09-15-AML0024:TATCTTGAGCAAGTGC"	-0.941231827170211	-17.4355726472107	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGAGCAAGTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2836.57584723907	48.2279693320462	0.0170021786581127	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2828.29623428613	2828.29623428613
"AML-0024"	"2020-09-15-AML0024:TATCTTGAGCCTCTGG"	-2.12210355225261	-15.8280124894348	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGAGCCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.26692825536	29.569402634516	0.0115403287254891	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.56052123522	2557.56052123522
"AML-0024"	"2020-09-15-AML0024:TATCTTGAGGTTTACC"	-1.75605724278148	-16.9603452912536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGAGGTTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1455.80449722221	47.5612290831681	0.0326700660520824	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1444.18317317595	1444.18317317595
"AML-0024"	"2020-09-15-AML0024:TATCTTGCAGACCGCT"	-1.41762266579326	-16.0913439027038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGCAGACCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2923.05090555858	31.7588882648995	0.0108649795337145	2880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2916.52720641264	2916.52720641264
"AML-0024"	"2020-09-15-AML0024:TATCTTGGTAACATCC"	-1.83427200737651	-16.1314268342224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGGTAACATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.71105964916	29.2268926334912	0.0110678116512203	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.33008251206	2637.33008251206
"AML-0024"	"2020-09-15-AML0024:TATCTTGGTAGCTCGC"	-0.188781524926978	-16.5600385895935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGGTAGCTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1811.61219654783	46.2272865888538	0.0255172087475142	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1808.22691231981	1808.22691231981
"AML-0024"	"2020-09-15-AML0024:TATCTTGGTGAGTTTC"	-1.47849379006084	-16.0248480073181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGGTGAGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.85771419239	33.707340088983	0.0127831471177074	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.42437691701	2631.42437691701
"AML-0024"	"2020-09-15-AML0024:TATCTTGGTGTCTTAG"	-1.44898841801341	-16.6908159486023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATCTTGGTGTCTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.91614887886	40.0064658879713	0.0167326929916513	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.95126246415	2380.95126246415
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGATTGCGG"	-2.26387081566508	-15.6410923234192	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGATTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.7276328568	37.5046500518635	0.0131700270837487	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2844.71946098316	2844.71946098316
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGCTGAGCA"	-2.5062612098759	-15.5915069810119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGCTGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.94310214843	33.5569479411725	0.0123783298567124	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.32957858395	2704.32957858395
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGGCGATAC"	-0.404422382742721	-16.0201330414978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGGCGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.72222765831	38.3755539825453	0.0133446664679413	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2864.5063145174	2864.5063145174
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGGTCCAGA"	-0.993516544730026	-17.4611139527527	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGGTCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.06258284974	38.3442055491175	0.0128496653419712	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.85841653887	2973.85841653887
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGGTGCCAA"	-1.79788563671764	-16.2635526887146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGGTGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.20837685149	33.5569133251667	0.0128955519564381	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.65570114918	2591.65570114918
"AML-0024"	"2020-09-15-AML0024:TATGTTCAGTCTCCTC"	-2.59934125366862	-15.8747511140076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCAGTCTCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2959.60033424801	35.6664552470701	0.0120511052909218	2873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2949.62919554977	2949.62919554977
"AML-0024"	"2020-09-15-AML0024:TATGTTCCAAGTGATA"	-0.686662892729598	-15.9324045411316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCCAAGTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.62675590467	38.4144069924045	0.0140782930128779	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.95325092398	2722.95325092398
"AML-0024"	"2020-09-15-AML0024:TATGTTCCAATGTTGC"	-0.191937412053901	-16.2452993622986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCCAATGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.9080806391	36.2113083283776	0.012530263011123	2910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.82568277084	2879.82568277084
"AML-0024"	"2020-09-15-AML0024:TATGTTCTCCACGTAA"	-2.00256667557414	-16.3370447388855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCTCCACGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.14487684684	36.6016836349711	0.0150988020495623	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.30190209042	2415.30190209042
"AML-0024"	"2020-09-15-AML0024:TATGTTCTCCCTTGGT"	0.133157049387139	-16.4339361420837	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCTCCCTTGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2546.02080327198	41.8816495810532	0.0164498457857177	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2539.54912812657	2539.54912812657
"AML-0024"	"2020-09-15-AML0024:TATGTTCTCCGATAGT"	-0.658443669707137	-16.2114267579285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCTCCGATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.2956853683	36.4396396449665	0.013575121341361	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2672.34404296518	2672.34404296518
"AML-0024"	"2020-09-15-AML0024:TATGTTCTCTGTAACG"	-2.84181938591655	-15.8274421921936	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATGTTCTCTGTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.88158444449	31.7236785189815	0.0119807768992951	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.2578111902	2640.2578111902
"AML-0024"	"2020-09-15-AML0024:TATTCCAAGCGTATGG"	0.512500246136826	-16.1944437257019	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTCCAAGCGTATGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2880.73585142356	38.0238744901259	0.0131993617086884	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2872.23451371371	2872.23451371371
"AML-0024"	"2020-09-15-AML0024:TATTCCAGTGTTCGAT"	-0.421791533858138	-15.9391079179016	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTCCAGTGTTCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.13181889563	33.4562162626791	0.0118089162105138	2972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.21243098159	2820.21243098159
"AML-0024"	"2020-09-15-AML0024:TATTGCTAGATGTAGT"	-2.25382457199748	-16.5178137055603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTAGATGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.00901585842	43.3310777852807	0.0175074424002661	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.22776161738	2470.22776161738
"AML-0024"	"2020-09-15-AML0024:TATTGCTAGGCTCCCA"	-1.78244708004649	-16.6853151551453	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTAGGCTCCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.80807839654	38.1197003716163	0.0140776965235251	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.70175730436	2693.70175730436
"AML-0024"	"2020-09-15-AML0024:TATTGCTAGGTACAAT"	-0.477835277945358	-16.0069132081238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTAGGTACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.19555904952	33.4933499388185	0.0125434071018906	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.98371865519	2663.98371865519
"AML-0024"	"2020-09-15-AML0024:TATTGCTAGTTGCATC"	-2.29567037048991	-15.7255382767883	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTAGTTGCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.37334649406	38.5314272700994	0.0141536161157768	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.55438714617	2713.55438714617
"AML-0024"	"2020-09-15-AML0024:TATTGCTTCAAAGCCT"	-1.03958259049113	-17.4250517121521	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTTCAAAGCCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.50550853201	41.9607257886861	0.0154465822568354	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.45842737215	2708.45842737215
"AML-0024"	"2020-09-15-AML0024:TATTGCTTCCCAGTGG"	-1.44639251652415	-15.9349518052307	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGCTTCCCAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.8114667232	28.675850989786	0.0105744264826921	2326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.85960188731	2703.85960188731
"AML-0024"	"2020-09-15-AML0024:TATTGGGCACAACATC"	-1.11196790161784	-16.536400817987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGCACAACATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2903.41035722483	37.8005485615797	0.0130193613408855	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2898.90606785354	2898.90606785354
"AML-0024"	"2020-09-15-AML0024:TATTGGGCACCCTTAC"	0.0803183010662019	-15.8677244416443	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGCACCCTTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2475.4200862145	43.2956738662233	0.0174902329133285	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2470.22937551826	2470.22937551826
"AML-0024"	"2020-09-15-AML0024:TATTGGGCATAGTCGT"	-2.77156482163127	-16.1381788483826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGCATAGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.82901340074	44.4612058358635	0.0179508579701339	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.46537993194	2462.46537993194
"AML-0024"	"2020-09-15-AML0024:TATTGGGGTAGACAAT"	-2.15287862244304	-16.2577448121277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGGTAGACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.95059480323	37.453506305896	0.0142628373816387	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.03004355461	2622.03004355461
"AML-0024"	"2020-09-15-AML0024:TATTGGGGTCCAAATC"	-1.896312336356	-16.8510580292908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGGTCCAAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2073.67914628907	51.4970269763127	0.0248336523364613	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2063.21613276081	2063.21613276081
"AML-0024"	"2020-09-15-AML0024:TATTGGGTCATTACGG"	-3.01107678833659	-15.8177528611389	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTGGGTCATTACGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.34792314303	30.1681619204871	0.012114035006969	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.16670011693	2488.16670011693
"AML-0024"	"2020-09-15-AML0024:TATTTCGAGGCCCACT"	-1.21385548535045	-15.8259840241638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGAGGCCCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2969.71826222946	35.3044245166171	0.0118881393449468	3341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2952.31897881811	2952.31897881811
"AML-0024"	"2020-09-15-AML0024:TATTTCGCACCAGTAT"	-0.675053576857406	-15.9085579148498	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGCACCAGTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.97475416462	32.6465996462518	0.0113239283830328	2746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.27784352253	2876.27784352253
"AML-0024"	"2020-09-15-AML0024:TATTTCGGTAGCGATG"	-1.50242803517039	-16.0362825623718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGGTAGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.79533506111	35.0468414668745	0.0132763479809934	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.18990342422	2633.18990342422
"AML-0024"	"2020-09-15-AML0024:TATTTCGGTGTCTTAG"	-0.894628862768966	-16.7054662934509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGGTGTCTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.16589965561	41.6448785783788	0.0161029416496152	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.56437220776	2578.56437220776
"AML-0024"	"2020-09-15-AML0024:TATTTCGGTTAAAGTG"	-1.884992937476	-15.8681650391785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGGTTAAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.44177233484	36.8800906125906	0.0137795228701791	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.02999985764	2673.02999985764
"AML-0024"	"2020-09-15-AML0024:TATTTCGTCAATCTCT"	-1.11871490898784	-15.7049741975036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TATTTCGTCAATCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.80323375032	33.287123078415	0.0119402699141127	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.2811114322	2784.2811114322
"AML-0024"	"2020-09-15-AML0024:TCAAGCAAGAATCGAT"	-1.15067587319072	-16.4216013184753	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAAGAATCGAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2892.87267408398	40.4254343283068	0.0139741491875744	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2884.70241269866	2884.70241269866
"AML-0024"	"2020-09-15-AML0024:TCAAGCAAGCATAGGC"	-0.959886292845565	-17.4561376801697	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAAGCATAGGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3036.32521552132	35.1867084774261	0.011588583560666	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3029.7312479123	3029.7312479123
"AML-0024"	"2020-09-15-AML0024:TCAAGCACACAAGCCC"	-0.866218189627487	-16.2315740815369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCACACAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2939.75894666944	36.5849847508706	0.0124448927325552	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2927.36373839655	2927.36373839655
"AML-0024"	"2020-09-15-AML0024:TCAAGCACACTCCCTA"	-1.78710470619853	-16.3176203004089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCACACTCCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.24735824955	40.4325661466044	0.0152503937517544	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.73098125057	2647.73098125057
"AML-0024"	"2020-09-15-AML0024:TCAAGCACATTGGCAT"	-1.79450784149821	-15.8531332246033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCACATTGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2841.39342813909	32.924675817487	0.0115875103712935	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2835.00536378628	2835.00536378628
"AML-0024"	"2020-09-15-AML0024:TCAAGCAGTAACATAG"	-2.79265056076701	-15.7881412736145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAGTAACATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1995.22077916578	42.972561113642	0.0215377473823269	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1993.47633151574	1993.47633151574
"AML-0024"	"2020-09-15-AML0024:TCAAGCAGTAATGCGG"	-2.10739670220073	-16.2153005830017	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAGTAATGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2925.72210533717	34.4571820369566	0.0117773256640127	2981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2914.60969603066	2914.60969603066
"AML-0024"	"2020-09-15-AML0024:TCAAGCAGTATGCTAC"	-0.0149911222165406	-15.9836092225281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAGTATGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.61191395563	39.2745341953667	0.0139736596149598	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.37688823738	2799.37688823738
"AML-0024"	"2020-09-15-AML0024:TCAAGCAGTGATACCT"	-0.979932765395004	-16.5116510621277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAGTGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.16907992742	45.8680988839245	0.0187356744515719	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2440.40444955611	2440.40444955611
"AML-0024"	"2020-09-15-AML0024:TCAAGCAGTTTGGGAG"	-2.33876572075542	-15.6707620850769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCAGTTTGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.32881334994	33.0493769639873	0.0129183460669826	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.87627311492	2555.87627311492
"AML-0024"	"2020-09-15-AML0024:TCAAGCATCGGACTTA"	-0.417561720043975	-16.3657942048279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGCATCGGACTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2554.71911910685	32.0446313255297	0.0125433090024913	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.75755123525	2544.75755123525
"AML-0024"	"2020-09-15-AML0024:TCAAGTGAGGGTCAAC"	-2.48911509934123	-16.2464113465515	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGTGAGGGTCAAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2456.57957036696	37.1262626461105	0.0151129900671464	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2451.45800322643	2451.45800322643
"AML-0024"	"2020-09-15-AML0024:TCAAGTGCACACCTGG"	-1.77535341206248	-15.9353513947693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGTGCACACCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.14575322399	37.9984955677147	0.0145135142002401	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.88179189346	2613.88179189346
"AML-0024"	"2020-09-15-AML0024:TCAAGTGCACAGCGCT"	-1.25525436821635	-15.8684368363586	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGTGCACAGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.86335218423	40.5252159323211	0.0152472909862042	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.63485465092	2649.63485465092
"AML-0024"	"2020-09-15-AML0024:TCAAGTGGTCCGCAGT"	-1.54328010502513	-16.5240259400574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGTGGTCCGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.25694469933	31.8353994141538	0.0113121864988611	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.15525505754	2810.15525505754
"AML-0024"	"2020-09-15-AML0024:TCAAGTGTCTACGGTA"	1.0049744444782	-16.2238741151062	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAAGTGTCTACGGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2886.01001859358	39.5948030952531	0.0137195653653859	3460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2873.90101145348	2873.90101145348
"AML-0024"	"2020-09-15-AML0024:TCAATCTAGGATTACA"	-2.74188218537028	-16.1863184205261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATCTAGGATTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.65508736508	38.512613542825	0.0138104614361665	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.04718169666	2780.04718169666
"AML-0024"	"2020-09-15-AML0024:TCAATCTAGTCATAGA"	-1.61066399040874	-16.192162536737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATCTAGTCATAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.26588067	35.8150636177258	0.0142731242207633	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.0308751081	2501.0308751081
"AML-0024"	"2020-09-15-AML0024:TCAATCTCAAGTCCAT"	-1.20021245899852	-15.9685049287048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATCTCAAGTCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.32200696327	37.888793549399	0.0137162841456893	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.83203386303	2752.83203386303
"AML-0024"	"2020-09-15-AML0024:TCAATCTTCAAGTGTC"	-1.58517311039622	-16.6849756470886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATCTTCAAGTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.09571837585	40.1235409849027	0.0148380623926293	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.59530418254	2697.59530418254
"AML-0024"	"2020-09-15-AML0024:TCAATTCAGTACCGGA"	-2.0566454929417	-16.6970281830994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATTCAGTACCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.94129812471	42.5419188880916	0.0187910874382345	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2256.44789093035	2256.44789093035
"AML-0024"	"2020-09-15-AML0024:TCAATTCGTAGATGTA"	-1.43611941757854	-15.0779524079529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATTCGTAGATGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.59119856537	35.0202954442241	0.0128817806306092	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.20337662904	2710.20337662904
"AML-0024"	"2020-09-15-AML0024:TCAATTCTCGCCATAA"	-0.724185089499313	-16.7155161133972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAATTCTCGCCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.89795266201	44.593018244213	0.0166522470357336	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.64825214265	2669.64825214265
"AML-0024"	"2020-09-15-AML0024:TCACAAGAGCAAGTGC"	0.805194755166215	-16.2148256531921	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACAAGAGCAAGTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2865.59629257877	39.7484286332567	0.0138709101265227	3197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2854.11497045061	2854.11497045061
"AML-0024"	"2020-09-15-AML0024:TCACAAGAGTCCCAAT"	-2.16242990914043	-15.5785961381164	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACAAGAGTCCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2968.43888880929	36.5899982129129	0.0123263437731036	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2960.27916139426	2960.27916139426
"AML-0024"	"2020-09-15-AML0024:TCACACCAGAATTTGG"	-1.6103871864384	-15.7954206696716	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCAGAATTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.25495716735	45.6855048672787	0.0208871419939287	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2183.07466965014	2183.07466965014
"AML-0024"	"2020-09-15-AML0024:TCACACCCAAACCATC"	-1.00744305077251	-17.3938284150329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCCAAACCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3114.84023840745	37.2536669250005	0.0119600570410146	3157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3105.48562188365	3105.48562188365
"AML-0024"	"2020-09-15-AML0024:TCACACCCAACCGATT"	-1.61814973774608	-15.5538187257019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCCAACCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.24615032874	34.4693324930982	0.0127558077893477	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.53977197657	2692.53977197657
"AML-0024"	"2020-09-15-AML0024:TCACACCCATGAGATA"	-2.02703843537028	-16.2973699799744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCCATGAGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.46085964059	33.4203377284975	0.0121862587795974	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.33891726634	2734.33891726634
"AML-0024"	"2020-09-15-AML0024:TCACACCGTAGCGTAG"	-1.09652696076091	-16.8927221528259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCGTAGCGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.29607218926	35.4585379341268	0.0139804411334044	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.27298673089	2530.27298673089
"AML-0024"	"2020-09-15-AML0024:TCACACCGTAGGCTGA"	-1.9071526331013	-16.686511062738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCGTAGGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2959.39444718241	33.3680958889098	0.0112753120560455	2781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2952.7229768219	2952.7229768219
"AML-0024"	"2020-09-15-AML0024:TCACACCGTTGACTGT"	-2.14149866524394	-16.6031332246033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCGTTGACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.60798818959	35.3186881456795	0.0137554830441942	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.32650845605	2555.32650845605
"AML-0024"	"2020-09-15-AML0024:TCACACCTCAGCGCAC"	-0.771748344332534	-16.0015001527038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCTCAGCGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.71535477028	38.1974166284274	0.0146366217904212	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.59973113425	2602.59973113425
"AML-0024"	"2020-09-15-AML0024:TCACACCTCCCTGTTG"	-1.54541907730754	-15.8748340836731	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCTCCCTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.93978798377	30.1088672017267	0.011012995726556	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2728.1313773056	2728.1313773056
"AML-0024"	"2020-09-15-AML0024:TCACACCTCGTTAGAC"	-0.506521622568923	-16.3188905945984	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACACCTCGTTAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.54855338708	40.3928573252714	0.0140372461405477	3091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2871.16196414589	2871.16196414589
"AML-0024"	"2020-09-15-AML0024:TCACATTCACAGTGTT"	-0.34665028277095	-15.8568716279236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTCACAGTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.21636992755	34.8163014519985	0.0133435853972376	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2606.99692830429	2606.99692830429
"AML-0024"	"2020-09-15-AML0024:TCACATTGTACGGTTT"	-2.18600163880046	-16.6170683137146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTGTACGGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.51445648152	37.0199850533296	0.0146874718207359	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.9100167051	2510.9100167051
"AML-0024"	"2020-09-15-AML0024:TCACATTGTTTCGTTT"	0.027641031041187	-16.0625257722107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTGTTTCGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.84493955789	36.0892216100111	0.0129777899862869	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.06017637045	2773.06017637045
"AML-0024"	"2020-09-15-AML0024:TCACATTTCCCTGTTG"	-2.6898914379185	-16.1654367676941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTTCCCTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.95367598571	32.9645273677716	0.0121329000413716	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.39549848993	2707.39549848993
"AML-0024"	"2020-09-15-AML0024:TCACATTTCCGGCAGT"	-0.752547840506393	-16.4720068207947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTTCCGGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.34149694033	37.0815896199425	0.0134094069976424	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.48672428423	2757.48672428423
"AML-0024"	"2020-09-15-AML0024:TCACATTTCGTGGGAA"	-2.90413818779643	-15.6454124680725	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTTCGTGGGAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.78574569579	33.1242017747072	0.0121033229681214	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.81481664314	2731.81481664314
"AML-0024"	"2020-09-15-AML0024:TCACATTTCTATGCCC"	1.23305716094319	-16.2021951905456	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTTCTATGCCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3032.87935223558	39.51416029686	0.0130285961648074	4163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3018.63226399431	3018.63226399431
"AML-0024"	"2020-09-15-AML0024:TCACATTTCTGAGCAT"	-1.98618040505107	13.8723621138367	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACATTTCTGAGCAT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2199.27625329827	28.7455690099204	0.0130704675989705	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2194.57661339405	2194.57661339405
"AML-0024"	"2020-09-15-AML0024:TCACGCTAGAGGTTAT"	-0.602006058127242	-16.0547209016052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTAGAGGTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.18138296422	27.8527725105581	0.0106830973451072	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.07232050253	2601.07232050253
"AML-0024"	"2020-09-15-AML0024:TCACGCTCAGAGCCCT"	-2.81053147736247	-16.2472181550232	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTCAGAGCCCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.66894106573	41.1836199226845	0.0172701624168758	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.56947448411	2378.56947448411
"AML-0024"	"2020-09-15-AML0024:TCACGCTGTATACGGG"	-0.797394196421462	-16.2662630311218	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTGTATACGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.95145475299	38.4921606141635	0.0144276090727173	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.02968120401	2659.02968120401
"AML-0024"	"2020-09-15-AML0024:TCACGCTGTGTGCCTG"	-1.70212827149089	-16.4970846406189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTGTGTGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.82823049246	36.7693378261227	0.0143471721548257	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.86398478919	2554.86398478919
"AML-0024"	"2020-09-15-AML0024:TCACGCTGTTTCAGAC"	-2.18919930878337	-15.5376987687317	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTGTTTCAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.69002308961	32.5690823449415	0.0118662151539719	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.42423971782	2740.42423971782
"AML-0024"	"2020-09-15-AML0024:TCACGCTTCATCCTAT"	-1.4003269476002	-15.5633602372375	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTTCATCCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2955.62091310743	35.7220190995018	0.0120861301735563	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2949.23345245232	2949.23345245232
"AML-0024"	"2020-09-15-AML0024:TCACGCTTCTTTCCAA"	-1.1050982278889	-16.0900926820007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGCTTCTTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.16213382818	32.292234993087	0.0111692923116453	3179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2887.56351604954	2887.56351604954
"AML-0024"	"2020-09-15-AML0024:TCACGGGAGTCAGGGT"	-1.39119694653209	-16.0002660981384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGGGAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.22810425505	37.3404701536069	0.0137269628584449	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.25426348284	2713.25426348284
"AML-0024"	"2020-09-15-AML0024:TCACGGGCAGTTTGGT"	0.0243212460422933	-16.4368314973083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGGGCAGTTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.59898373047	44.8500937625917	0.0152988502218403	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.31254004168	2921.31254004168
"AML-0024"	"2020-09-15-AML0024:TCACGGGTCACCCTCA"	-1.973775724799	-15.5529585114685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGGGTCACCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.75385689887	33.3888164463337	0.0127840594005971	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2604.58939508955	2604.58939508955
"AML-0024"	"2020-09-15-AML0024:TCACGGGTCATATGGC"	-1.95686064186748	-15.5720205537048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGGGTCATATGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.24178425658	35.6519713552943	0.0139361226818734	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.47082649941	2551.47082649941
"AML-0024"	"2020-09-15-AML0024:TCACGGGTCCCTGTTG"	-1.97162423554118	-16.4419069520203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACGGGTCCCTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.10163344832	44.0923493672146	0.0198694592003425	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2213.53534054796	2213.53534054796
"AML-0024"	"2020-09-15-AML0024:TCACTATAGCTACTAC"	-2.07123551788982	-16.336377166864	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTATAGCTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.12705006372	30.7856711557071	0.0113218950747394	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.15804455774	2708.15804455774
"AML-0024"	"2020-09-15-AML0024:TCACTATAGGATGTTA"	-1.1444356245106	-16.7575731507507	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTATAGGATGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.12086109475	35.7033840632033	0.0150957968577881	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2356.51781590695	2356.51781590695
"AML-0024"	"2020-09-15-AML0024:TCACTATCAAAGCTCT"	-1.51246104660686	-16.3712473145691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTATCAAAGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.3104332047	38.6789539900513	0.0128232669834837	4068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3006.6034830277	3006.6034830277
"AML-0024"	"2020-09-15-AML0024:TCACTATGTCGAACGA"	-2.46434030953105	-16.4889040223328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTATGTCGAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.84381424506	42.4763591420302	0.0187712288734348	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2256.7812678694	2256.7812678694
"AML-0024"	"2020-09-15-AML0024:TCACTATTCTCCCTAG"	-1.15846298161204	-16.4136724702087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTATTCTCCCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.5008760695	34.2274979524892	0.0123542635370135	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.71723415415	2762.71723415415
"AML-0024"	"2020-09-15-AML0024:TCACTCGAGAAATTCG"	-2.59154973450359	-16.2521181336609	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTCGAGAAATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.48274674683	43.108158275042	0.0167119389844374	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.60902442367	2569.60902442367
"AML-0024"	"2020-09-15-AML0024:TCACTCGCACCGGTCA"	-1.73882172527965	-16.3035631409851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTCGCACCGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.71365359501	38.0430177830183	0.0140862833541712	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.2992493169	2694.2992493169
"AML-0024"	"2020-09-15-AML0024:TCACTCGGTTGAGGAC"	-2.54922662201579	-16.3601904145447	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCACTCGGTTGAGGAC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.68935389753	36.9753275745269	0.0167332695472821	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2199.78496022144	2199.78496022144
"AML-0024"	"2020-09-15-AML0024:TCAGCAAAGGGTCAAC"	-0.63112978163417	-16.057942413446	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCAAAGGGTCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2958.36356249999	42.1767226606946	0.0142567746558685	3097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2948.84193336895	2948.84193336895
"AML-0024"	"2020-09-15-AML0024:TCAGCAAAGTATGATG"	-1.05411265316661	-16.793824218866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCAAAGTATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.81041250591	38.7575554151512	0.0147209822747023	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.65595596875	2621.65595596875
"AML-0024"	"2020-09-15-AML0024:TCAGCAACAAGTTCGT"	-1.27350376072581	13.9492940672669	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCAACAAGTTCGT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1747.57059023673	40.0686279988253	0.0229281885508256	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1745.81106804557	1745.81106804557
"AML-0024"	"2020-09-15-AML0024:TCAGCAACACTAACGT"	-0.430743227631408	-16.1548357239929	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCAACACTAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.03705710937	32.8226344110602	0.0123997638502663	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.88335251612	2639.88335251612
"AML-0024"	"2020-09-15-AML0024:TCAGCAACATGACGTT"	-2.36250553551372	-15.8860244981018	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCAACATGACGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.44567771983	32.4938002131853	0.0117669525333615	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.810285267	2748.810285267
"AML-0024"	"2020-09-15-AML0024:TCAGCCTAGTCATACC"	-1.51020036163982	-15.7745990983215	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCCTAGTCATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.83256233517	33.4383929897122	0.0118122115149505	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.07248857411	2829.07248857411
"AML-0024"	"2020-09-15-AML0024:TCAGCCTGTATGAGAT"	-1.93268511715587	-15.6711263886658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCCTGTATGAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.89995669926	36.3423188623963	0.0134357349418365	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.9483924196	2696.9483924196
"AML-0024"	"2020-09-15-AML0024:TCAGCCTGTCTGTGCG"	-0.978011946112472	-16.8510179749695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCCTGTCTGTGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.27252662384	43.8275975694522	0.0183973903403758	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.58970477695	2378.58970477695
"AML-0024"	"2020-09-15-AML0024:TCAGCCTGTTGCCAAT"	-3.45143304291423	12.0402087935242	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCCTGTTGCCAAT"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2045.21406290283	34.7060081195525	0.0169693768242006	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2043.50960008399	2043.50960008399
"AML-0024"	"2020-09-15-AML0024:TCAGCCTTCAGATGCT"	-2.15438018265422	-15.9776582947937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGCCTTCAGATGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.34170348676	33.4061218347464	0.0128864654647242	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.86546528777	2582.86546528777
"AML-0024"	"2020-09-15-AML0024:TCAGGGCAGAATAGTC"	-0.767598907381851	-15.7903509370056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCAGAATAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.0221841629	40.4929749791434	0.0154611042334816	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.25211548478	2614.25211548478
"AML-0024"	"2020-09-15-AML0024:TCAGGGCCACCTGATA"	-1.26459894600566	-15.0956821671692	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCCACCTGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.79088526324	36.1290773359605	0.0140975518305894	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.57200293851	2553.57200293851
"AML-0024"	"2020-09-15-AML0024:TCAGGGCCAGCTATTG"	-0.574217121035415	-16.2881078950134	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCCAGCTATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.77466459482	41.4384271588631	0.0151912940965079	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.28010653708	2720.28010653708
"AML-0024"	"2020-09-15-AML0024:TCAGGGCCATCCCGTT"	-2.05823550644572	-16.015238784906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCCATCCCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2989.26011065874	31.7087283534007	0.010607550758242	3540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2975.82815697955	2975.82815697955
"AML-0024"	"2020-09-15-AML0024:TCAGGGCGTGGTGATG"	-2.88497910919841	-15.962281250116	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCGTGGTGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.08040836648	39.9227234803369	0.0165648927487013	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2403.15107342485	2403.15107342485
"AML-0024"	"2020-09-15-AML0024:TCAGGGCTCATGGGAG"	-1.54935155335124	-16.1139211884704	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGGCTCATGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.80443296952	35.9879249571243	0.0140808602148447	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.01523941203	2549.01523941203
"AML-0024"	"2020-09-15-AML0024:TCAGGTAAGGAGTACC"	1.03119583901708	-16.2253828278747	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTAAGGAGTACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2877.83658677363	39.7714086064844	0.0138198981795115	3602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2864.52848132256	2864.52848132256
"AML-0024"	"2020-09-15-AML0024:TCAGGTACACACAGCC"	-2.83558164063151	-16.1471262208191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTACACACAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.00937076689	35.3266932866854	0.0132012591856364	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.88946623263	2670.88946623263
"AML-0024"	"2020-09-15-AML0024:TCAGGTAGTAACCCTA"	-2.3272856277531	-16.7548437348572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTAGTAACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1930.92247616331	48.8436215630298	0.025295485533982	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1919.06224034941	1919.06224034941
"AML-0024"	"2020-09-15-AML0024:TCAGGTAGTATGACAA"	-1.81763647022899	-16.7381410828796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTAGTATGACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.39019913674	43.4110945893028	0.0173825838686756	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.93185343498	2488.93185343498
"AML-0024"	"2020-09-15-AML0024:TCAGGTAGTCGGCTAC"	-1.23501441898997	-15.7170458070007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTAGTCGGCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.14879754349	35.6770025455197	0.0127365610055443	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.49432517247	2792.49432517247
"AML-0024"	"2020-09-15-AML0024:TCAGGTAGTTCTCTCG"	-2.1085094017094	-16.0504541627136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTAGTTCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.96791536623	37.0713703900309	0.0136293410597233	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.09747991735	2713.09747991735
"AML-0024"	"2020-09-15-AML0024:TCAGGTATCATCGCCT"	0.0570067773455798	-15.9044208756653	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTATCATCGCCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2851.72814169387	45.6194467175668	0.0159971233058947	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2846.62226589933	2846.62226589933
"AML-0024"	"2020-09-15-AML0024:TCAGGTATCATGTCAG"	-1.18673382225688	-15.5979500046936	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTATCATGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.85850619341	35.0042779003399	0.0120751936755634	2753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2889.92212442344	2889.92212442344
"AML-0024"	"2020-09-15-AML0024:TCAGGTATCCAGCAAT"	-1.74970767918285	-15.9708700410095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTATCCAGCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.62249730274	35.1026546367327	0.012498174699677	2906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.62602244533	2800.62602244533
"AML-0024"	"2020-09-15-AML0024:TCAGGTATCTTCACGC"	-0.0767853063648522	-16.0157385102478	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGGTATCTTCACGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2810.28554485359	48.126809922345	0.0171252383980975	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2802.62449232295	2802.62449232295
"AML-0024"	"2020-09-15-AML0024:TCAGTCCAGAATTGTG"	-1.81575248661693	-15.6109075776306	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTCCAGAATTGTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2898.14103156425	39.7497006190376	0.0137155853307742	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.71347836046	2894.71347836046
"AML-0024"	"2020-09-15-AML0024:TCAGTCCCATATCTGG"	-2.25455699387248	-16.1836996308533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTCCCATATCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.12024551042	33.4699340444555	0.0125632219870177	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.64935003257	2656.64935003257
"AML-0024"	"2020-09-15-AML0024:TCAGTCCGTAAGAACT"	1.27386035498921	-16.1856527558533	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTCCGTAAGAACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2913.04336870529	44.8685616753324	0.0154026411543864	3530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2898.69665438818	2898.69665438818
"AML-0024"	"2020-09-15-AML0024:TCAGTCCTCACGGTCG"	-1.59992824021037	-15.8050928345886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTCCTCACGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.94069473272	33.9632603731727	0.012039693155049	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.29257079283	2815.29257079283
"AML-0024"	"2020-09-15-AML0024:TCAGTGACAATGAGCG"	-1.24324963513072	-16.8686838380066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGACAATGAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.67176751224	46.0139472873069	0.0168631301995177	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.41972468248	2721.41972468248
"AML-0024"	"2020-09-15-AML0024:TCAGTGACATCTAACG"	-1.90085218372996	-16.6254739991394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGACATCTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.52594587792	39.1350692738583	0.0143429346284872	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.95437287418	2720.95437287418
"AML-0024"	"2020-09-15-AML0024:TCAGTGAGTCTACGAT"	-2.09149394455608	-16.3311319581238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGAGTCTACGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.62385030407	28.5584454735659	0.0100429757861653	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.71472221691	2839.71472221691
"AML-0024"	"2020-09-15-AML0024:TCAGTGAGTGATTCAC"	-0.839957456023055	-15.820809387323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGAGTGATTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.75795733367	35.0186366010647	0.0131760066805317	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.81095798556	2649.81095798556
"AML-0024"	"2020-09-15-AML0024:TCAGTGAGTTCGATTG"	-1.04038057747539	-16.4215479127136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGAGTTCGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.30923554145	31.9151802670923	0.0125882791020861	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2527.17257324434	2527.17257324434
"AML-0024"	"2020-09-15-AML0024:TCAGTGAGTTGTTGTG"	0.410877336829346	-16.1388654938904	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTGAGTTGTTGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2947.9377731708	43.0905757026257	0.0146171931086176	2971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2941.30191300023	2941.30191300023
"AML-0024"	"2020-09-15-AML0024:TCAGTTTGTCACAGAG"	-1.83216033402141	-15.8401766053406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTTTGTCACAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.72347715942	32.8783279606256	0.0124646606231949	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2629.74899900923	2629.74899900923
"AML-0024"	"2020-09-15-AML0024:TCAGTTTGTTCCGCGA"	-0.625263194472152	12.5356883772644	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTTTGTTCCGCGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2191.69735754993	28.3990779551568	0.0129575727494164	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2186.95081058927	2186.95081058927
"AML-0024"	"2020-09-15-AML0024:TCAGTTTTCTGTCGCT"	-1.63700352135356	-16.8241415253845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCAGTTTTCTGTCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.16134225679	37.2290115855042	0.0140372348364844	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.064228607	2647.064228607
"AML-0024"	"2020-09-15-AML0024:TCATACTAGATGAATC"	-0.343234251171905	-16.0113249055115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTAGATGAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2921.3715476849	34.9603451222376	0.0119670998883873	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2913.97163951484	2913.97163951484
"AML-0024"	"2020-09-15-AML0024:TCATACTAGCCAAGTG"	-1.03228674355205	-17.4146299592224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTAGCCAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2970.48441370994	45.2905772034276	0.0152468657954891	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.5036723231	2957.5036723231
"AML-0024"	"2020-09-15-AML0024:TCATACTAGTCGCGAA"	-1.49932430210765	-15.8749866715637	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTAGTCGCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.78981311223	42.8350993024392	0.0169322759860994	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2525.73993213178	2525.73993213178
"AML-0024"	"2020-09-15-AML0024:TCATACTCAACTTGGT"	0.0230587023193061	-16.3340559235779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTCAACTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.26803375148	33.697432185917	0.0120941100345419	2721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2773.6764188129	2773.6764188129
"AML-0024"	"2020-09-15-AML0024:TCATACTCACGTATAC"	-0.530788580805618	-16.0049448243347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTCACGTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.6477091519	34.0917343034758	0.0120013946796853	2879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2828.69583447655	2828.69583447655
"AML-0024"	"2020-09-15-AML0024:TCATACTTCATCAGTG"	0.147328008979005	-16.0543394318786	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTTCATCAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.52009252699	44.4724797576699	0.0152851598694561	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.01832007061	2903.01832007061
"AML-0024"	"2020-09-15-AML0024:TCATACTTCTATCCAT"	-2.74981604042705	-15.8740759125915	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATACTTCTATCCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.2159364226	31.0716235626857	0.0111239604348243	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.26638300509	2784.26638300509
"AML-0024"	"2020-09-15-AML0024:TCATATCAGTCATAGA"	-2.33432970467265	-16.1447496644226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCAGTCATAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.93467957862	36.9231829681415	0.0131542722517805	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.51299803498	2800.51299803498
"AML-0024"	"2020-09-15-AML0024:TCATATCCAGAGGTTG"	-2.24971423569377	-16.5413923493591	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCCAGAGGTTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.79888483586	34.2268652585179	0.0130249181000987	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.2873618854	2623.2873618854
"AML-0024"	"2020-09-15-AML0024:TCATATCGTAAGATCA"	-0.95091031017955	-17.4743662110535	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCGTAAGATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.20686313763	44.9246391631108	0.0158285288315619	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.25168373124	2829.25168373124
"AML-0024"	"2020-09-15-AML0024:TCATATCGTAGTTACC"	1.03538711842839	-16.214737915155	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCGTAGTTACC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3105.68021239464	47.0606586658827	0.0151530922205272	3952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3094.73100753739	3094.73100753739
"AML-0024"	"2020-09-15-AML0024:TCATATCGTCAAGCGA"	-0.782915572554427	-16.4210767976013	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCGTCAAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.29030802143	33.8023282072189	0.0121709740280266	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.86389315767	2772.86389315767
"AML-0024"	"2020-09-15-AML0024:TCATATCGTCAGCGTC"	-2.25405750694926	-15.4118614426819	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCGTCAGCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.00755193588	34.0426861578958	0.014859264051369	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2285.85152358222	2285.85152358222
"AML-0024"	"2020-09-15-AML0024:TCATATCGTGTAAACA"	-1.46356234970744	-16.8490572205749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCGTGTAAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.4123659181	42.2390049462073	0.0197709981556185	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2131.03136765892	2131.03136765892
"AML-0024"	"2020-09-15-AML0024:TCATATCTCATGCATG"	-0.699960987002212	-16.7449197999206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCTCATGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2876.12937872532	33.7838239249657	0.0117462810174202	2823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.67328186103	2863.67328186103
"AML-0024"	"2020-09-15-AML0024:TCATATCTCCGTCACT"	-0.17285511913951	-16.2536592713562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCTCCGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.06751924821	43.6793616888513	0.0155052590647554	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.91434093569	2810.91434093569
"AML-0024"	"2020-09-15-AML0024:TCATATCTCTACCAGA"	-0.182193393737632	-15.8305921784607	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATATCTCTACCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2903.27763411411	37.7121896605886	0.0129895223307143	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2893.44897171076	2893.44897171076
"AML-0024"	"2020-09-15-AML0024:TCATCATAGACTCTTG"	-1.55152342739757	-16.5117712250915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCATAGACTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.30097819448	30.8574967094336	0.0117538891600366	2528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.44675301652	2616.44675301652
"AML-0024"	"2020-09-15-AML0024:TCATCATAGGTACATA"	0.0830462752724111	-16.1538038483826	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCATAGGTACATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2780.22384048248	40.8811599718903	0.0147042692666054	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2774.06275678274	2774.06275678274
"AML-0024"	"2020-09-15-AML0024:TCATCATGTGCTGATT"	-0.941547672182876	-17.4548521271911	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCATGTGCTGATT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3197.78487715246	43.4597778350844	0.0135905883305647	3009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3191.27019570288	3191.27019570288
"AML-0024"	"2020-09-15-AML0024:TCATCATTCGAACGCC"	-1.12312386456187	-16.0483522645203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCATTCGAACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2962.42931482241	36.9487916296953	0.0124724635436273	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2956.1117356813	2956.1117356813
"AML-0024"	"2020-09-15-AML0024:TCATCATTCGGCAGTC"	0.211731125682038	-16.0285616151062	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCATTCGGCAGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2869.23945163746	41.7463695196642	0.0145496289951819	3523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2860.55872977966	2860.55872977966
"AML-0024"	"2020-09-15-AML0024:TCATCCGAGCGCATCC"	-2.19312701645549	-15.4599828950134	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGAGCGCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.69449071274	40.1327941444643	0.0154911334734121	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2583.06581586549	2583.06581586549
"AML-0024"	"2020-09-15-AML0024:TCATCCGAGCTCGACC"	-0.810153643519241	-16.2771368256775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGAGCTCGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.45830950596	37.5062204608167	0.0135330271186733	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.22220499211	2764.22220499211
"AML-0024"	"2020-09-15-AML0024:TCATCCGAGGGAGGAC"	-2.36582050743755	-16.4222669831482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGAGGGAGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.39011002809	42.3918062211847	0.0177938138857892	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2378.00472069488	2378.00472069488
"AML-0024"	"2020-09-15-AML0024:TCATCCGCATGGCTGC"	-0.460542480379897	-16.4605074158874	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGCATGGCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.16823957591	31.6968946541838	0.0117868767701877	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.27917880757	2680.27917880757
"AML-0024"	"2020-09-15-AML0024:TCATCCGGTAGGCTCC"	-1.15948579731639	-16.5263014069763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGGTAGGCTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.00345828722	37.3480075904105	0.0156924173619849	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.3751035079	2370.3751035079
"AML-0024"	"2020-09-15-AML0024:TCATCCGGTTGCTGAT"	-2.76051817360576	-15.8676157227722	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGGTTGCTGAT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.3030588068	35.1854478731591	0.0150217315991053	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2337.09992260343	2337.09992260343
"AML-0024"	"2020-09-15-AML0024:TCATCCGTCACACCGG"	-1.2794602912968	13.6219062575134	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGTCACACCGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2023.67555802901	34.8220864220221	0.017207346446353	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2019.9389850796	2019.9389850796
"AML-0024"	"2020-09-15-AML0024:TCATCCGTCTACCACC"	-1.3936826986378	-15.8703937760559	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATCCGTCTACCACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3000.19288535317	37.5137005481479	0.0125037629184738	2946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2992.49766802852	2992.49766802852
"AML-0024"	"2020-09-15-AML0024:TCATGAGAGACTAAGT"	-1.41956339302714	-16.1238718262878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGAGAGACTAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.68630812213	43.0097532943898	0.0173588372157521	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.41962372242	2470.41962372242
"AML-0024"	"2020-09-15-AML0024:TCATGAGAGGCTATCT"	-2.05215678635295	-16.539969467279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGAGAGGCTATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.14624485093	34.4262272839179	0.0137202952416842	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2501.04191667427	2501.04191667427
"AML-0024"	"2020-09-15-AML0024:TCATGAGGTATCAGCT"	-1.18971870365794	-15.7683716050354	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGAGGTATCAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.55826241476	37.6482839547751	0.0135740014785185	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.71124378622	2769.71124378622
"AML-0024"	"2020-09-15-AML0024:TCATGAGGTTCGTAAC"	-1.54257784310039	-16.900643371698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGAGGTTCGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.63835581516	44.7639774886185	0.0183110836750706	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.92053045745	2434.92053045745
"AML-0024"	"2020-09-15-AML0024:TCATGAGTCAGTAGGG"	-1.17793391171153	-16.1310224763122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGAGTCAGTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.56814085882	33.0589397227244	0.0131521955523469	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2506.58853062866	2506.58853062866
"AML-0024"	"2020-09-15-AML0024:TCATGCCAGAACCCGA"	-0.971344928175765	-17.472363494989	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGCCAGAACCCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3074.6543468752	35.9635632484617	0.0116967825293961	3074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3069.27200823568	3069.27200823568
"AML-0024"	"2020-09-15-AML0024:TCATGCCAGTTCACTG"	-1.08764717999156	-16.2797327271667	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGCCAGTTCACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.20584346914	32.2557447977848	0.0125060761937478	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2573.28086735058	2573.28086735058
"AML-0024"	"2020-09-15-AML0024:TCATGCCCACTCCGGA"	-2.03748355332072	-16.058077835199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGCCCACTCCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.76143057015	28.8368715567076	0.0106694106370404	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.62632904007	2700.62632904007
"AML-0024"	"2020-09-15-AML0024:TCATGCCGTACTAACC"	-2.03885660591777	-15.602023147699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGCCGTACTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.18740867745	38.3175288601721	0.0146128109430204	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2616.06012027769	2616.06012027769
"AML-0024"	"2020-09-15-AML0024:TCATGCCGTCTCAGAT"	-1.86013720455821	-16.5831747285095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGCCGTCTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.34276881021	33.0970676615962	0.0125398898743705	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.3207733601	2627.3207733601
"AML-0024"	"2020-09-15-AML0024:TCATGGAAGATGTAGT"	-0.719793955714065	-15.8458566895691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGAAGATGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.92605622742	33.3920665370247	0.0121340711395427	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.60168011638	2746.60168011638
"AML-0024"	"2020-09-15-AML0024:TCATGGAAGCCTTTCC"	-2.00862298432048	-16.098584198114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGAAGCCTTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3154.67127741886	41.0981961464726	0.0130277269903376	2692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3144.15180334299	3144.15180334299
"AML-0024"	"2020-09-15-AML0024:TCATGGAAGGCGCTCT"	-0.143307338387328	-16.616478942987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGAAGGCGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2421.15298625263	44.9520908193887	0.0185663983542667	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2410.60548992908	2410.60548992908
"AML-0024"	"2020-09-15-AML0024:TCATGGAGTCATGCAT"	-1.78051064434703	-15.5574674836365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGAGTCATGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.17111661695	40.1767078219002	0.0146835508853611	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.09683012818	2727.09683012818
"AML-0024"	"2020-09-15-AML0024:TCATGGATCCAAGGGA"	-1.8423059982365	-15.2203436127869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGATCCAAGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.76214212466	35.3629773896144	0.0132407812855555	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2661.45298688914	2661.45298688914
"AML-0024"	"2020-09-15-AML0024:TCATGGATCTCTATGT"	-0.0106017542188943	-16.0520525208679	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGGATCTCTATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.4125436101	40.3093373939543	0.0153243404696633	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.17484305539	2625.17484305539
"AML-0024"	"2020-09-15-AML0024:TCATGTTAGAACTCCT"	-2.07476196709331	-15.6798906556335	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTAGAACTCCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.95560153042	32.1029676620522	0.0124770779732682	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.85899731953	2565.85899731953
"AML-0024"	"2020-09-15-AML0024:TCATGTTAGCGAGAAA"	-0.948474625975448	-17.496325515863	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTAGCGAGAAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2708.28518865022	42.3158900934911	0.0156246064006948	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2702.2721012055	2702.2721012055
"AML-0024"	"2020-09-15-AML0024:TCATGTTAGCGTGCTC"	-1.87271664562877	-16.0889635316101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTAGCGTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.08115235515	34.9019457322993	0.0139770970997002	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2492.3740770697	2492.3740770697
"AML-0024"	"2020-09-15-AML0024:TCATGTTAGTATAACG"	-1.33167062225993	-16.2149801484314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTAGTATAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.19061041188	32.8217769677031	0.0123334934518738	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.22186464899	2655.22186464899
"AML-0024"	"2020-09-15-AML0024:TCATGTTCAAATGGCG"	-2.38816461983379	-16.1622343293396	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTCAAATGGCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2451.19334297281	36.102183151969	0.0147284110637247	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2448.2029070236	2448.2029070236
"AML-0024"	"2020-09-15-AML0024:TCATGTTCAACCCGCA"	-1.81332717362102	-16.0948515168396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTCAACCCGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2939.95430693555	40.418302438221	0.0137479355862339	3028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2926.77687325027	2926.77687325027
"AML-0024"	"2020-09-15-AML0024:TCATGTTTCATTACTC"	-2.11711202088054	-15.4082622758118	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATGTTTCATTACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3113.83562323574	32.6350933644903	0.0104806731353974	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3106.68924514509	3106.68924514509
"AML-0024"	"2020-09-15-AML0024:TCATTACAGACATGCG"	-1.23990188065227	-16.0478296509949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACAGACATGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.56379256118	34.2290223430829	0.012972596091701	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.96488707899	2636.96488707899
"AML-0024"	"2020-09-15-AML0024:TCATTACAGCCAAGGT"	-1.7688070339268	-16.7044630280701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACAGCCAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.17194767029	34.7923192448554	0.013005638488081	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.27537237014	2670.27537237014
"AML-0024"	"2020-09-15-AML0024:TCATTACAGGAGTATT"	-2.47468696060832	-16.5468321076599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACAGGAGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.39028356979	40.5907622671952	0.0161626659674329	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2503.70715748463	2503.70715748463
"AML-0024"	"2020-09-15-AML0024:TCATTACAGGCATCGA"	-0.900560299784499	-15.8003092042175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACAGGCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.49418195892	34.8313191750006	0.014473884639375	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2395.0832446614	2395.0832446614
"AML-0024"	"2020-09-15-AML0024:TCATTACGTGGTATGG"	-1.90159306946452	-16.7211179963318	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACGTGGTATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.90741778312	25.8073096426405	0.0101248517159113	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2536.75678941138	2536.75678941138
"AML-0024"	"2020-09-15-AML0024:TCATTACTCGAAGCCC"	-1.87223837795909	-15.5622902146545	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACTCGAAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.44225625804	37.4669748400927	0.0139311319114255	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.62254960774	2681.62254960774
"AML-0024"	"2020-09-15-AML0024:TCATTACTCGCGCCAA"	-1.53026781502422	-16.7768507233826	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTACTCGCGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.78751896718	35.6632719446899	0.0154133738091081	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2303.72765529237	2303.72765529237
"AML-0024"	"2020-09-15-AML0024:TCATTCACACATTGTG"	-1.12851200524028	-16.0783434144226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTCACACATTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.76536753691	35.1275458724064	0.0124797421048082	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.47276209631	2801.47276209631
"AML-0024"	"2020-09-15-AML0024:TCATTCAGTACGACTT"	-1.09974525395091	-15.6352462998596	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTCAGTACGACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.87611082479	32.9673515230768	0.011384240990091	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2888.71254013175	2888.71254013175
"AML-0024"	"2020-09-15-AML0024:TCATTCAGTAGAATAC"	-0.554740290076095	-16.2827043763367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTCAGTAGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.88497579589	39.4204377288026	0.0144086604800828	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.51809603003	2729.51809603003
"AML-0024"	"2020-09-15-AML0024:TCATTCAGTTTGCCGG"	-0.0456158620422662	-16.079089187738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTCAGTTTGCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.50507977717	38.2265855192946	0.0132569856690693	3075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.11361170752	2872.11361170752
"AML-0024"	"2020-09-15-AML0024:TCATTCATCTCATAGG"	-2.59420977059062	9.35277078235475	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTCATCTCATAGG"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1949.62204710319	41.2735078907076	0.0211700046950296	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1945.47097551912	1945.47097551912
"AML-0024"	"2020-09-15-AML0024:TCATTGTAGCGCCTCA"	-1.54785380783733	-15.1157217255798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTAGCGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.60220275786	33.1880357787972	0.0125922021707486	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.41432232921	2631.41432232921
"AML-0024"	"2020-09-15-AML0024:TCATTGTCAACCTAAC"	-1.8138304752415	-16.1746034852234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTCAACCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.12708486307	36.2439036292261	0.0136917882924767	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.79725066021	2641.79725066021
"AML-0024"	"2020-09-15-AML0024:TCATTGTCACAGTCAT"	-2.49485025826152	-16.3862161866394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTCACAGTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.61134750395	38.8211675475784	0.0146516460174998	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.62311805798	2637.62311805798
"AML-0024"	"2020-09-15-AML0024:TCATTGTCAGTAGTTC"	-1.27340147915538	-15.8068466416565	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTCAGTAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.91748419187	38.5298711827536	0.0152056534686415	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2526.28251826259	2526.28251826259
"AML-0024"	"2020-09-15-AML0024:TCATTGTGTCCACTCT"	-2.80050859871562	-15.9123678437439	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTGTCCACTCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.24869963321	29.2166223303772	0.0107128559028396	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.29478412477	2724.29478412477
"AML-0024"	"2020-09-15-AML0024:TCATTGTGTGTAGCAG"	-2.19064913216289	-15.7058134309021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTGTGTAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.98364556617	36.6742761910864	0.0171617018535348	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2128.59871815862	2128.59871815862
"AML-0024"	"2020-09-15-AML0024:TCATTGTGTTTCGTGA"	-0.417971591383773	12.9148664244446	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTGTTTCGTGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2020.97405332355	37.4517955345048	0.0185315568366226	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2014.85492479862	2014.85492479862
"AML-0024"	"2020-09-15-AML0024:TCATTGTTCTCCGATC"	1.07386126097981	-16.2174673310486	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTTCTCCGATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2746.79379033527	41.0159584442891	0.0149323034690867	3604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2736.00379594426	2736.00379594426
"AML-0024"	"2020-09-15-AML0024:TCATTGTTCTGTGCGG"	-2.24070988121684	-16.5034971467224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTGTTCTGTGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.78775388509	38.1040879639203	0.0145502772828348	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.73950367015	2613.73950367015
"AML-0024"	"2020-09-15-AML0024:TCATTTGAGAACAAGG"	-1.03685889664348	-17.3426447144714	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTTGAGAACAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.73626454003	36.7170208045724	0.0137788573275225	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.99688081546	2656.99688081546
"AML-0024"	"2020-09-15-AML0024:TCATTTGCAGACCTAT"	-1.69053218784984	-16.1335916749206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTTGCAGACCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.53799634595	30.9845075073287	0.011490476881585	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.63679198954	2690.63679198954
"AML-0024"	"2020-09-15-AML0024:TCATTTGCATAATGAG"	-2.19994173470195	-15.6931905976501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTTGCATAATGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.33582098805	36.9483344641723	0.0151717615885853	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2427.3239433979	2427.3239433979
"AML-0024"	"2020-09-15-AML0024:TCATTTGCATGTGTCA"	-2.30556950989421	-15.9272070161072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTTGCATGTGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.53225583071	43.3329745803991	0.0176183802744084	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.92598467589	2453.92598467589
"AML-0024"	"2020-09-15-AML0024:TCATTTGGTAGCGCTC"	-1.89296577397044	-16.0499449006286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCATTTGGTAGCGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.45603142267	35.9216566539342	0.0138402100513505	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.34784301336	2587.34784301336
"AML-0024"	"2020-09-15-AML0024:TCCACCAAGTTAGTGA"	-1.51067195358928	-16.8738126984802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCAAGTTAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.6815541846	42.423361643806	0.0186256773102741	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2269.41092486083	2269.41092486083
"AML-0024"	"2020-09-15-AML0024:TCCACCACATTCAGGT"	-1.26559195938762	-16.1773176423279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCACATTCAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.556149652	36.8228032756695	0.0125822985764507	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.33048806769	2921.33048806769
"AML-0024"	"2020-09-15-AML0024:TCCACCACATTCGATG"	-2.76457128945048	-15.9045429459778	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCACATTCGATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.02019436459	37.1472765417966	0.012858088224602	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.01101141326	2881.01101141326
"AML-0024"	"2020-09-15-AML0024:TCCACCAGTGGTACAG"	-2.94114003601726	-15.9753465882507	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCAGTGGTACAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.65332369303	40.2901280285538	0.0154863554116281	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.50112082435	2593.50112082435
"AML-0024"	"2020-09-15-AML0024:TCCACCAGTGTGCCTG"	0.293406938284081	-16.2326479188171	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCAGTGTGCCTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3049.53692449162	42.683328543386	0.0139966590338963	3259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3038.55270073256	3038.55270073256
"AML-0024"	"2020-09-15-AML0024:TCCACCATCAATGCAC"	-1.31368384781535	-16.8310098878113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACCATCAATGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.00492482216	37.6946450794137	0.0142674393697245	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.7212286476	2633.7212286476
"AML-0024"	"2020-09-15-AML0024:TCCACGTAGTCCCAAT"	-0.737160066992599	-16.4080000153747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACGTAGTCCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.25337201196	37.9589794698435	0.0136776626785339	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2767.76012584828	2767.76012584828
"AML-0024"	"2020-09-15-AML0024:TCCACGTCAAATTAGG"	-1.87150047245677	-15.5370912781921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACGTCAAATTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.84586526936	37.2663464791212	0.0140848516416988	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.51855356269	2639.51855356269
"AML-0024"	"2020-09-15-AML0024:TCCACGTCAGCTGTCG"	-2.01070747795756	-16.6842298737732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACGTCAGCTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2073.20634019666	52.3284055444524	0.0252403267971332	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2068.81124171645	2068.81124171645
"AML-0024"	"2020-09-15-AML0024:TCCACGTGTAATGCGG"	-1.70714424076732	-16.9987173310486	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACGTGTAATGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1633.68683309083	46.142049293872	0.0282441214308951	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1627.71243184808	1627.71243184808
"AML-0024"	"2020-09-15-AML0024:TCCACGTTCCTTCGAC"	-0.6048580807751	-16.3729791871277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCACGTTCCTTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.81403228268	38.9585364821795	0.0149162750489285	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.5026918949	2608.5026918949
"AML-0024"	"2020-09-15-AML0024:TCCAGAACAGGTCCCA"	-2.80624471131023	-16.2365312806335	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCAGAACAGGTCCCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.77340452325	43.2700898979883	0.0171043342540566	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2519.62707168232	2519.62707168232
"AML-0024"	"2020-09-15-AML0024:TCCAGAATCCTATGGA"	-0.0227925655549348	-16.0276956788269	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCAGAATCCTATGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2698.87706841838	32.7236737516597	0.0121249219294144	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2693.58904597403	2693.58904597403
"AML-0024"	"2020-09-15-AML0024:TCCAGAATCGACATCA"	-2.06255493584331	-15.4212999573913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCAGAATCGACATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.08910450322	33.6622017032351	0.0130216794634257	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.92366224987	2582.92366224987
"AML-0024"	"2020-09-15-AML0024:TCCATCGAGACATAGT"	-1.86686346951182	-16.7289972535339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGAGACATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.96152337717	43.1067520949073	0.0163100187852245	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.84513685467	2631.84513685467
"AML-0024"	"2020-09-15-AML0024:TCCATCGAGGTCGCCT"	-0.526066104800063	-15.8120661011902	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGAGGTCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2693.0907857773	41.7079994025313	0.0154870380244138	2607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.9137472502	2686.9137472502
"AML-0024"	"2020-09-15-AML0024:TCCATCGAGGTCGTCC"	-0.30765144053157	-15.8871259919372	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGAGGTCGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2319.58399659105	30.4057788942269	0.0131082896497443	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2316.0529810711	2316.0529810711
"AML-0024"	"2020-09-15-AML0024:TCCATCGAGTTGGAAT"	-0.645847539336044	-16.1935129395691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGAGTTGGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.97319911206	36.9609205002529	0.013543892813707	3007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.27770501799	2718.27770501799
"AML-0024"	"2020-09-15-AML0024:TCCATCGCAGGACTAG"	10.4925276237423	6.15182826602785	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGCAGGACTAG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1751.53497222836	38.1080530371631	0.0217569467018297	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1749.70311206884	1749.70311206884
"AML-0024"	"2020-09-15-AML0024:TCCATCGTCAAAGCCT"	-0.526379446417648	-16.0602197877136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGTCAAAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2678.04815633835	34.9120484011297	0.0130363781243069	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2671.56855390361	2671.56855390361
"AML-0024"	"2020-09-15-AML0024:TCCATCGTCCCTCAAC"	-1.37522862377818	-15.8965158692566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGTCCCTCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.62459628585	34.7050935370114	0.0122953273994275	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.62388623008	2813.62388623008
"AML-0024"	"2020-09-15-AML0024:TCCATCGTCTATGTGG"	-0.722736100584823	-16.8200254670349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATCGTCTATGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.46504212057	37.4848559339659	0.0164518020864953	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2270.70346384447	2270.70346384447
"AML-0024"	"2020-09-15-AML0024:TCCATGCAGGCTCAAG"	0.9628709751064	-16.2139940491882	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCAGGCTCAAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2811.44610697347	42.0755107946264	0.0149657895594238	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2798.96684019077	2798.96684019077
"AML-0024"	"2020-09-15-AML0024:TCCATGCCATCCGGTG"	-0.45908878269847	-16.5663805237976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCCATCCGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.86507206234	39.3835041360893	0.0146960772565243	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.87583052779	2673.87583052779
"AML-0024"	"2020-09-15-AML0024:TCCATGCCATTGCAAC"	-2.95289264145549	-15.8356161347595	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCCATTGCAAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.45516613356	29.0340594277661	0.0115975951239452	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2499.11593064331	2499.11593064331
"AML-0024"	"2020-09-15-AML0024:TCCATGCGTAGACAAT"	-2.43286786499675	-15.8575010529724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCGTAGACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.88170056516	37.7878102651808	0.0147098288943657	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.42851233463	2556.42851233463
"AML-0024"	"2020-09-15-AML0024:TCCATGCGTCCTCATC"	-2.73073063316997	-15.5199671021667	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCGTCCTCATC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3032.38800207011	41.5035067827641	0.0136867402042321	2772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3024.25817818326	3024.25817818326
"AML-0024"	"2020-09-15-AML0024:TCCATGCTCCCGTAAA"	-2.90734587135966	-15.6685238114563	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCTCCCGTAAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.91676600704	37.6892650374782	0.0134512436253374	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2795.59999763144	2795.59999763144
"AML-0024"	"2020-09-15-AML0024:TCCATGCTCGTTCCTG"	-2.87769160690959	-15.94314196026	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCTCGTTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.68618079431	37.1908002803165	0.0135748395349185	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.71436407269	2732.71436407269
"AML-0024"	"2020-09-15-AML0024:TCCATGCTCTTGAACG"	-1.96625433388408	-16.6350240937439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCATGCTCTTGAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1916.92657458805	40.0310056234297	0.0208829102554606	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1913.52468624382	1913.52468624382
"AML-0024"	"2020-09-15-AML0024:TCCCACACACACAGAG"	-0.388403723866302	-16.3179712525574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACACACACAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.22330305451	35.2004167946797	0.0127898113338453	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.8637748258	2745.8637748258
"AML-0024"	"2020-09-15-AML0024:TCCCACACACCCTATC"	-1.16169188442882	-15.8305587998596	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACACACCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2962.70216141813	37.7934559436171	0.0127564142072002	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2953.22459811432	2953.22459811432
"AML-0024"	"2020-09-15-AML0024:TCCCACACACGCCACA"	-0.96354434910472	-15.5185070267883	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACACACGCCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.32685094317	39.4883743448464	0.0140862540989684	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.37216670198	2796.37216670198
"AML-0024"	"2020-09-15-AML0024:TCCCACACAGAGATGC"	-1.26759288731273	-15.5386829606262	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACACAGAGATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.41955789645	36.880238346384	0.0139359000111452	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.69050617169	2638.69050617169
"AML-0024"	"2020-09-15-AML0024:TCCCACAGTATAGGAT"	-1.68700049343761	-16.8416605225769	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACAGTATAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.70603368216	33.601958608951	0.0130356053676733	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.97012198118	2569.97012198118
"AML-0024"	"2020-09-15-AML0024:TCCCACAGTGTATCCA"	-1.8257751268452	-15.8528766862121	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACAGTGTATCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.28578360513	42.0569562407573	0.015928940913105	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.66873525235	2636.66873525235
"AML-0024"	"2020-09-15-AML0024:TCCCACAGTTCGGTTA"	-1.87208412113841	-16.7386713257995	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACAGTTCGGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.66687079847	37.1353837074485	0.0141378353381218	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.21473762464	2618.21473762464
"AML-0024"	"2020-09-15-AML0024:TCCCACATCAAAGAAC"	1.66663410243337	-8.15174391185912	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00537634408602151	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACATCAAAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.91071944684	36.6788850703452	0.0130813313048645	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.08585215334	2801.08585215334
"AML-0024"	"2020-09-15-AML0024:TCCCACATCATCGCTC"	-1.0444532436436	-16.1590833893982	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACATCATCGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.68686438913	36.8739484159498	0.0133133997528932	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.52310980248	2762.52310980248
"AML-0024"	"2020-09-15-AML0024:TCCCACATCCATTCGC"	-0.775927047163802	-15.7255726090637	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACATCCATTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.05110185411	43.5935955569146	0.0155688571283746	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.33030892631	2793.33030892631
"AML-0024"	"2020-09-15-AML0024:TCCCACATCGGTAAGG"	-1.31582735005077	-15.7743149033752	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCACATCGGTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.6647795146	35.2303572833278	0.0122512044986254	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.50950469142	2865.50950469142
"AML-0024"	"2020-09-15-AML0024:TCCCAGTAGTCTGGTT"	-1.43934116783794	-16.1450739136902	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTAGTCTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3035.32979083317	38.1603702734466	0.0125720672556546	3577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3025.23395408835	3025.23395408835
"AML-0024"	"2020-09-15-AML0024:TCCCAGTCAGGATTCT"	-0.0787323665922463	-16.5433168641296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTCAGGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2989.01882965619	36.8102754137606	0.0123151701315962	2944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2976.49433479349	2976.49433479349
"AML-0024"	"2020-09-15-AML0024:TCCCAGTGTAAGCGGT"	-1.33689794960673	-16.0186319581238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTGTAAGCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.46217842377	37.9025416086827	0.0146485393775967	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.78491178394	2581.78491178394
"AML-0024"	"2020-09-15-AML0024:TCCCAGTGTACCGTGC"	-0.150674487382728	-16.4827375642029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTGTACCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.07386168305	38.6660068828958	0.0141785697212589	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2715.14642028685	2715.14642028685
"AML-0024"	"2020-09-15-AML0024:TCCCAGTGTCCTTTGC"	-0.947733263403732	-15.7863884202209	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTGTCCTTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.76318772387	38.8560308073911	0.0149921223479971	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2585.17560426697	2585.17560426697
"AML-0024"	"2020-09-15-AML0024:TCCCAGTGTTCCACAA"	-2.65038643303569	-15.6868429414001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTGTTCCACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.16627622459	29.2230130049018	0.0109936738217924	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2652.41155135125	2652.41155135125
"AML-0024"	"2020-09-15-AML0024:TCCCAGTGTTCGCGTG"	-0.701694349676925	-16.3930711976257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCAGTGTTCGCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.52027591505	35.0284230764611	0.0135479204718532	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.96888504649	2576.96888504649
"AML-0024"	"2020-09-15-AML0024:TCCCATGCAATCCAGT"	-1.07996008816417	-15.9254245988098	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCATGCAATCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.11292009203	41.9558010123058	0.0162423410474874	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.39861034487	2577.39861034487
"AML-0024"	"2020-09-15-AML0024:TCCCATGCAGCCCAGT"	-1.09533725205119	-16.2417841187683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCATGCAGCCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.79433233034	37.3646113737457	0.0136826896597007	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.28376255922	2724.28376255922
"AML-0024"	"2020-09-15-AML0024:TCCCATGTCCCTATTA"	-1.88852069798167	-16.7942877045837	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCATGTCCCTATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.95872195608	34.3175525878397	0.0144802321955697	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2362.54773253602	2362.54773253602
"AML-0024"	"2020-09-15-AML0024:TCCCATGTCTCAGTCC"	-2.79449043694194	-15.8403501740661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCCATGTCTCAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.95616189786	41.3938244831023	0.0151074769219776	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.05724624719	2732.05724624719
"AML-0024"	"2020-09-15-AML0024:TCCGAAAAGCTGAGTG"	-0.507566372782546	-15.920509361383	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAAAGCTGAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.03077649772	40.020561234982	0.0141714323965741	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2816.19283083326	2816.19283083326
"AML-0024"	"2020-09-15-AML0024:TCCGAAACAACACGTT"	1.66522111472432	-10.7521219483581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAACAACACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1984.83765287532	49.5287704340507	0.0249535625053773	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1971.46534985444	1971.46534985444
"AML-0024"	"2020-09-15-AML0024:TCCGAAACAACTCCCT"	-2.03891406479533	-16.7272711030212	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAACAACTCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.8327478672	40.5151953423596	0.0163115634002124	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2476.67807593734	2476.67807593734
"AML-0024"	"2020-09-15-AML0024:TCCGAAAGTGACTGTT"	-0.134894872934181	-15.9966516724792	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAAGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.68161074243	38.484920503116	0.0135764525925141	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.27948341449	2826.27948341449
"AML-0024"	"2020-09-15-AML0024:TCCGAAATCAAAGGAT"	-1.45583663407024	-16.9798898926941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAATCAAAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2429.89391689577	44.0782634651883	0.0181399949844309	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2421.24551465594	2421.24551465594
"AML-0024"	"2020-09-15-AML0024:TCCGAAATCAAGCTTG"	-0.985634664923507	-17.5272855988708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAATCAAGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3061.30158572707	41.9559987845788	0.0137052811066356	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3053.47904216782	3053.47904216782
"AML-0024"	"2020-09-15-AML0024:TCCGAAATCATAGAGA"	-2.67010865631755	-15.8061237565246	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAATCATAGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.34048141143	37.9758814499021	0.014432142749361	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2625.65833115738	2625.65833115738
"AML-0024"	"2020-09-15-AML0024:TCCGAAATCTCCCAAC"	-1.70289049568828	-15.9092951050964	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAATCTCCCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3191.91344017519	32.5591058185187	0.0102004977355312	4098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3180.34282197651	3180.34282197651
"AML-0024"	"2020-09-15-AML0024:TCCGAAATCTCTAAGG"	-0.644632200629073	-16.3137636414734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGAAATCTCTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.20450298394	43.0049541713668	0.0156711914598948	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.06952509843	2733.06952509843
"AML-0024"	"2020-09-15-AML0024:TCCGATCAGGTGCAGT"	-2.66981897774394	-15.7633123627869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGATCAGGTGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.2502034676	36.2043794563402	0.0134726492567095	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.65789020187	2678.65789020187
"AML-0024"	"2020-09-15-AML0024:TCCGATCAGTATGAAC"	-1.50845513764079	-16.2838163605896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGATCAGTATGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.92414448465	32.4799244991409	0.011802623471376	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.50474777595	2739.50474777595
"AML-0024"	"2020-09-15-AML0024:TCCGATCAGTGCCGAA"	9.14266075667683	7.54051635349122	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGATCAGTGCCGAA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1794.89222215526	35.4570723795459	0.0197544297879736	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1793.3467168258	1793.3467168258
"AML-0024"	"2020-09-15-AML0024:TCCGGGAAGAGGCGTT"	-1.2370893758839	-16.3952856293884	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGGGAAGAGGCGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.96460763309	34.4035479127528	0.0133297247901059	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.8589988314	2575.8589988314
"AML-0024"	"2020-09-15-AML0024:TCCGGGAGTCCAGGTC"	-2.37715135040935	-16.4365701905456	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGGGAGTCCAGGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2312.49131373287	45.2491087843611	0.0195672556760091	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.9503047144	2305.9503047144
"AML-0024"	"2020-09-15-AML0024:TCCGGGATCAGAACCT"	-0.946340660483199	-17.5628862611023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGGGATCAGAACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.48386366339	40.7261219517816	0.015267616987887	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.12987902118	2655.12987902118
"AML-0024"	"2020-09-15-AML0024:TCCGGGATCTAATTCC"	-2.00581250611003	-16.8983030549255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGGGATCTAATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.58981362137	41.2769853541686	0.0175902005176047	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2332.58358091936	2332.58358091936
"AML-0024"	"2020-09-15-AML0024:TCCGGGATCTGCGAGC"	-2.79120502892192	-16.1997595063415	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGGGATCTGCGAGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.2565464763	48.010996102163	0.0181498449237816	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.12950179863	2632.12950179863
"AML-0024"	"2020-09-15-AML0024:TCCGTGTCATGATCTG"	-1.63055990162547	-16.4638414612976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGTGTCATGATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.53954538573	33.811569684492	0.0133561293743646	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.53150304643	2522.53150304643
"AML-0024"	"2020-09-15-AML0024:TCCGTGTGTATCGCAT"	-1.51687834683116	-15.6539221039978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGTGTGTATCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.30533162587	35.8684541397217	0.012882370957059	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2776.63874799338	2776.63874799338
"AML-0024"	"2020-09-15-AML0024:TCCGTGTGTTGACGGA"	-0.869772295386154	-16.4797640076843	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGTGTGTTGACGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.36132961597	39.7725547381704	0.0145988545299815	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.1602202877	2719.1602202877
"AML-0024"	"2020-09-15-AML0024:TCCGTGTTCTGCCTCA"	-1.39730105820354	-15.9538126221863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCGTGTTCTGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.28855115637	35.1874003500533	0.0140116914616803	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2509.03598378248	2509.03598378248
"AML-0024"	"2020-09-15-AML0024:TCCTAATAGATGCTTC"	-1.56444142285045	-16.539818786737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATAGATGCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.52845528109	31.8470198950106	0.0117928844010998	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.11602124187	2695.11602124187
"AML-0024"	"2020-09-15-AML0024:TCCTAATAGCGGACAT"	11.6336542564327	-1.76221051132353	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATAGCGGACAT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1231.3909214755	29.4148518000148	0.0238875009446788	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1230.13470413852	1230.13470413852
"AML-0024"	"2020-09-15-AML0024:TCCTAATAGTCTAACC"	-1.43347380581554	-16.5903330079285	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATAGTCTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.29055553284	31.6016040813935	0.0118879420519399	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.30641919889	2649.30641919889
"AML-0024"	"2020-09-15-AML0024:TCCTAATCAAGCTCTA"	-2.03620968285258	-15.5331392518249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATCAAGCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3021.01831799709	30.3390604105083	0.0100426601949977	3061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3012.73567274515	3012.73567274515
"AML-0024"	"2020-09-15-AML0024:TCCTAATCAATGCAGG"	1.1726813512737	-16.2048044434753	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATCAATGCAGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2842.81590816204	41.6720013233493	0.0146587055474483	3445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2832.71046974197	2832.71046974197
"AML-0024"	"2020-09-15-AML0024:TCCTAATCACCCTTGT"	-1.82551930370982	-16.4913454285828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATCACCCTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.50585563417	32.959103699452	0.011714602844508	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2806.76127147276	2806.76127147276
"AML-0024"	"2020-09-15-AML0024:TCCTAATCACTGCGTG"	-1.71287880364116	-16.4198961487976	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATCACTGCGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.18785499178	35.5678068008851	0.0134411495895084	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2640.6559024305	2640.6559024305
"AML-0024"	"2020-09-15-AML0024:TCCTAATGTAACATCC"	1.1279796558315	-16.2249479523865	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATGTAACATCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3031.37729501669	45.6963076764735	0.0150744375342502	3450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3015.38448915829	3015.38448915829
"AML-0024"	"2020-09-15-AML0024:TCCTAATTCGCAGAGA"	-0.771817604929763	-16.3855371705261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATTCGCAGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.52063036815	37.6909929122857	0.0136982410730618	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.02183215819	2742.02183215819
"AML-0024"	"2020-09-15-AML0024:TCCTAATTCTATTGTC"	-2.6528185409611	-16.2530069581238	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTAATTCTATTGTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.4095251599	34.7881137242672	0.0132808991454452	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.48411872077	2613.48411872077
"AML-0024"	"2020-09-15-AML0024:TCCTCCCAGCATATGA"	1.06220461901967	12.4386415251526	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCCCAGCATATGA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2171.93296213223	48.4667163794825	0.0223150148851288	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2168.01446816551	2168.01446816551
"AML-0024"	"2020-09-15-AML0024:TCCTCCCAGCTGCCAC"	-0.953649382025558	-15.7720251313415	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCCCAGCTGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.12840697694	40.0765544437689	0.0148921004066055	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.98887321054	2679.98887321054
"AML-0024"	"2020-09-15-AML0024:TCCTCCCGTTAATCGC"	-0.063772770494777	-15.993582748529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCCCGTTAATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.54778533571	37.1249507547432	0.0130101030533034	2670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2846.16115175713	2846.16115175713
"AML-0024"	"2020-09-15-AML0024:TCCTCCCTCTACTGCC"	-0.736202041537124	-15.695282005426	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCCCTCTACTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.51719342525	31.7524577630691	0.0114319572308072	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.71213374978	2774.71213374978
"AML-0024"	"2020-09-15-AML0024:TCCTCGAAGCCATCCG"	-1.15791390362437	-16.4237966767517	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCGAAGCCATCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3170.03721218518	38.1085497001364	0.0120214833925774	3439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3163.64441674996	3163.64441674996
"AML-0024"	"2020-09-15-AML0024:TCCTCGAGTCCGACGT"	-1.73776791516002	-16.6050939789978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCGAGTCCGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.49303723233	36.4149521348155	0.0145224539386992	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.524063486	2497.524063486
"AML-0024"	"2020-09-15-AML0024:TCCTCGATCATGCAGT"	-1.22146473351176	-16.8259859315124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCGATCATGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.75003856452	48.6841397007747	0.021364405431428	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2270.80929786297	2270.80929786297
"AML-0024"	"2020-09-15-AML0024:TCCTCGATCTATCGCC"	-0.940554778010207	-15.6171636811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCGATCTATCGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.6898661944	38.2009246733891	0.0135000393964604	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.71138197539	2821.71138197539
"AML-0024"	"2020-09-15-AML0024:TCCTCTTAGGCATCTT"	-2.85331235352214	-16.087914489862	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTAGGCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.58764552067	47.7676417733842	0.0182976587111892	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.84998807357	2601.84998807357
"AML-0024"	"2020-09-15-AML0024:TCCTCTTAGGTATAGT"	-2.0617540878361	-15.8338375321594	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTAGGTATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.99181538815	36.1246749643594	0.0137880869520989	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.88145650334	2614.88145650334
"AML-0024"	"2020-09-15-AML0024:TCCTCTTAGTGAGGTC"	-2.02862654152568	-16.31876280224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTAGTGAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.34258797224	29.2275232974734	0.012100777522418	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.03876528462	2409.03876528462
"AML-0024"	"2020-09-15-AML0024:TCCTCTTCATTCACCC"	-2.26109252396281	-15.7578430405823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTCATTCACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.63157718123	38.5704901213303	0.0133849484530772	2916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.74642363107	2873.74642363107
"AML-0024"	"2020-09-15-AML0024:TCCTCTTGTCACTCGG"	-0.947160522372085	-15.3845606080261	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTGTCACTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2524.18787124197	37.1334210244986	0.0147110369428358	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.92794288921	2517.92794288921
"AML-0024"	"2020-09-15-AML0024:TCCTCTTGTGCCTTTC"	-2.38443932953532	-16.2932844392029	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTGTGCCTTTC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.99540233719	36.3103703056091	0.0137487442323738	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.97221329244	2633.97221329244
"AML-0024"	"2020-09-15-AML0024:TCCTCTTTCGAGAATA"	0.723552902310532	-16.2041902772156	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTCTTTCGAGAATA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3085.42952338269	35.4533644607721	0.0114905766578337	4393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3075.6653031248	3075.6653031248
"AML-0024"	"2020-09-15-AML0024:TCCTGCAAGACGCAGT"	-1.76076291027721	-16.4627638093201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAAGACGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2923.72340074196	33.4549990764874	0.0114426005784259	3025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2913.666563317	2913.666563317
"AML-0024"	"2020-09-15-AML0024:TCCTGCAAGCTTTCTT"	-2.23896274986919	-16.3465547791687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAAGCTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.01767767012	33.7269462434324	0.0125518140515832	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.42663836305	2676.42663836305
"AML-0024"	"2020-09-15-AML0024:TCCTGCACAACTTGCA"	-1.97931824150737	-16.7018213502136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCACAACTTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.17027006306	39.7717486873876	0.0149115896850662	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.05630032471	2659.05630032471
"AML-0024"	"2020-09-15-AML0024:TCCTGCACAGACATCT"	-1.60016153279002	-16.6909742585388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCACAGACATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2828.56084893604	37.7998554471509	0.0133636352427664	2635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2814.32761013636	2814.32761013636
"AML-0024"	"2020-09-15-AML0024:TCCTGCACATGGAGAC"	-0.441591243178207	-16.0027723542419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCACATGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.84327832775	38.5562576606457	0.0144684897510523	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.49744170653	2658.49744170653
"AML-0024"	"2020-09-15-AML0024:TCCTGCAGTATGAGCG"	-0.224083403975326	-16.3442430726257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAGTATGAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.70976041847	35.7370433931195	0.0126740148559885	2870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2809.64631879565	2809.64631879565
"AML-0024"	"2020-09-15-AML0024:TCCTGCAGTCTACAAC"	-0.0799358290737451	-15.9883375397888	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAGTCTACAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.79704628881	39.4651295625566	0.0138971655084055	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.44504511966	2831.44504511966
"AML-0024"	"2020-09-15-AML0024:TCCTGCAGTGACCGTC"	-2.03350005570109	-15.5291290513244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAGTGACCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.35701897804	35.0206858109236	0.012609356871163	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2769.62060941995	2769.62060941995
"AML-0024"	"2020-09-15-AML0024:TCCTGCAGTTAGCTAC"	0.145071831613225	-16.0806093445984	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCAGTTAGCTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2805.08905253021	38.7451034072845	0.0138124325758343	3234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2796.7405087524	2796.7405087524
"AML-0024"	"2020-09-15-AML0024:TCCTGCATCCGTCACT"	-0.213430355221587	-16.0300913087097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCATCCGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.74497146334	34.0818976600233	0.0121126463150278	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2801.25639002683	2801.25639002683
"AML-0024"	"2020-09-15-AML0024:TCCTGCATCGTAGCTA"	-2.32206831398662	-16.6437521210876	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCATCGTAGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.29333846148	34.2829772277559	0.0142000048965064	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2408.09118097653	2408.09118097653
"AML-0024"	"2020-09-15-AML0024:TCCTGCATCTTGGTGA"	-2.02754435959514	-15.579821609613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTGCATCTTGGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.63738906226	35.5922734281263	0.0130583303453918	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.02659653618	2717.02659653618
"AML-0024"	"2020-09-15-AML0024:TCCTTCTAGAATACAC"	-1.99034033241923	-16.662097000238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTAGAATACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.0452464648	42.0996740746971	0.0163174169648313	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.21558505088	2574.21558505088
"AML-0024"	"2020-09-15-AML0024:TCCTTCTAGACAGCGT"	-1.29281697693523	12.1330222853455	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTAGACAGCGT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2381.98628241972	35.7500191136369	0.0150084907614668	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2378.53775222576	2378.53775222576
"AML-0024"	"2020-09-15-AML0024:TCCTTCTAGAGTGGCT"	-1.87017474594768	-16.5151663056579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTAGAGTGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.03001284932	36.0577020970844	0.0128500771310249	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2791.89520431157	2791.89520431157
"AML-0024"	"2020-09-15-AML0024:TCCTTCTAGCTACTAC"	-1.45530090752299	-16.2873602143494	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTAGCTACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.2909264211	33.8742458154323	0.0128932222445483	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.4929399916	2621.4929399916
"AML-0024"	"2020-09-15-AML0024:TCCTTCTAGTAGACCG"	-1.6555384201115	-16.7109136811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTAGTAGACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.07496948144	38.3430881122555	0.0149890400280287	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.05156127782	2553.05156127782
"AML-0024"	"2020-09-15-AML0024:TCCTTCTCAACCAATC"	-1.85579452934917	-16.7799787751404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTCAACCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.95284143881	33.5334178440704	0.012229757323789	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.71563900855	2731.71563900855
"AML-0024"	"2020-09-15-AML0024:TCCTTCTCAATCTCTT"	-1.81867227974589	-16.7614679566589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTCAATCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.02127306954	39.4034350539064	0.0163634082034825	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2398.28749257198	2398.28749257198
"AML-0024"	"2020-09-15-AML0024:TCCTTCTCAGTAACAA"	-1.60225711289104	-16.5900469056335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTCAGTAACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.98204812529	33.2633719293562	0.0114662453533113	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.03802540455	2894.03802540455
"AML-0024"	"2020-09-15-AML0024:TCCTTCTGTGATACAA"	1.05640747126881	-16.2450075379578	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTGTGATACAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3173.11441764136	44.8027793214333	0.0141194969435537	3198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3160.51452321601	3160.51452321601
"AML-0024"	"2020-09-15-AML0024:TCCTTCTTCCGACATA"	10.7867504554683	5.59030864322511	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTTCCGACATA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1682.61294865253	35.6379987344323	0.0211801524307606	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1675.35123364081	1675.35123364081
"AML-0024"	"2020-09-15-AML0024:TCCTTCTTCGGTAACT"	-2.94279299202617	-15.5996532670227	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTTCGGTAACT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2982.41293056744	34.7618403095749	0.0116556094406957	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2979.86879915191	2979.86879915191
"AML-0024"	"2020-09-15-AML0024:TCCTTCTTCTCCGATC"	-1.37338040295299	-16.3040304414001	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTCTTCTCCGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.00697758843	40.1442957297615	0.013943799387172	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2872.84933211712	2872.84933211712
"AML-0024"	"2020-09-15-AML0024:TCCTTTCAGACTCTAC"	-0.0424079400604546	-16.518527053949	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCAGACTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2947.84164122797	32.4168635780819	0.0109968131003734	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2937.81952604422	2937.81952604422
"AML-0024"	"2020-09-15-AML0024:TCCTTTCAGAGTTCGG"	-0.753962795168716	-16.6971903077331	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCAGAGTTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2332.56590207976	34.4163812847878	0.0147547305111943	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2326.55375668242	2326.55375668242
"AML-0024"	"2020-09-15-AML0024:TCCTTTCCACTATCGA"	-2.00143514099773	-16.6654119721619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCCACTATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.80985417191	43.4468936473873	0.0187448049585196	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.35050141598	2305.35050141598
"AML-0024"	"2020-09-15-AML0024:TCCTTTCCACTTCATT"	-1.87461982193645	-16.7381220093933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCCACTTCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2718.01570411699	32.7550907391635	0.0120511042999307	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.03152622626	2712.03152622626
"AML-0024"	"2020-09-15-AML0024:TCCTTTCTCACGGAGA"	-1.80025122585948	-15.7559557191101	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCTCACGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.28054514619	25.8283418554721	0.00930992429754832	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2767.24797510647	2767.24797510647
"AML-0024"	"2020-09-15-AML0024:TCCTTTCTCATCTCTA"	-0.0151251730626405	-16.4604711762634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCCTTTCTCATCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.64366497533	36.6531218480984	0.0139172669163813	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.57731488573	2620.57731488573
"AML-0024"	"2020-09-15-AML0024:TCGAACAAGCGTGCCT"	-1.77146671238597	-16.3352384797302	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACAAGCGTGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.59664063493	42.3272949183512	0.0172863485214027	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.13152086387	2444.13152086387
"AML-0024"	"2020-09-15-AML0024:TCGAACAAGGGACACT"	-2.15258608284648	-15.5512256852356	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACAAGGGACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.45256052763	38.0792517970758	0.0130791249403613	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2903.91152642858	2903.91152642858
"AML-0024"	"2020-09-15-AML0024:TCGAACAAGTAGCATA"	-0.988300184637863	-17.4026003113953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACAAGTAGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2932.14698743591	37.4490913001052	0.012771901088374	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2927.1245063062	2927.1245063062
"AML-0024"	"2020-09-15-AML0024:TCGAACAAGTTGGAGC"	-2.24633894386943	-16.3269529572693	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACAAGTTGGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.70967436674	45.4215724495772	0.0177865060016427	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.75336989066	2544.75336989066
"AML-0024"	"2020-09-15-AML0024:TCGAACACATCGCCTT"	-0.840925435454208	-16.8953180543152	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACACATCGCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.4791447291	37.1610803084356	0.0143563375366985	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.93961047415	2579.93961047415
"AML-0024"	"2020-09-15-AML0024:TCGAACACATGGAGAC"	-2.12576327744182	-16.2574072114197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACACATGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.53088492032	34.1537284664954	0.0125957364736043	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.09168693217	2701.09168693217
"AML-0024"	"2020-09-15-AML0024:TCGAACAGTTCGTAAC"	-1.17223999920543	-16.3509207001892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACAGTTCGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.80487837735	32.7704144362748	0.01280191889354	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2551.48386734535	2551.48386734535
"AML-0024"	"2020-09-15-AML0024:TCGAACATCCCTAGGG"	-2.32333550873454	-15.6047010651794	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACATCCCTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.82797600892	40.8219243014744	0.0148885796843082	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.84161299006	2738.84161299006
"AML-0024"	"2020-09-15-AML0024:TCGAACATCGCCCAGA"	-1.36327062073405	-15.6909198991028	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAACATCGCCCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3076.98891862467	38.2755457544577	0.0124392861874738	3854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3070.51212962727	3070.51212962727
"AML-0024"	"2020-09-15-AML0024:TCGAAGTAGACGGTCA"	-0.938848773867446	-17.2920351258484	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAAGTAGACGGTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2681.4975211888	37.0105258597936	0.0138021853711749	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2676.25294083026	2676.25294083026
"AML-0024"	"2020-09-15-AML0024:TCGAAGTAGGCGTTGA"	-1.10025391998943	-16.4116106263367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAAGTAGGCGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2337.63717686869	41.766197735976	0.0178668435586409	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2328.68125649756	2328.68125649756
"AML-0024"	"2020-09-15-AML0024:TCGAAGTAGGTCCTGC"	-1.21419403973277	-15.5550766221252	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAAGTAGGTCCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.16091159968	41.5278507204654	0.0154254712419064	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.93123891004	2687.93123891004
"AML-0024"	"2020-09-15-AML0024:TCGAAGTTCAAGTAAG"	-1.01393077793773	-15.9876318207947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAAGTTCAAGTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.11406235569	39.0336306456119	0.0152171130393185	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.24405522082	2557.24405522082
"AML-0024"	"2020-09-15-AML0024:TCGAAGTTCCCGAATA"	-1.90399287167247	-16.6669416657654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGAAGTTCCCGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.01333135503	36.0946714850286	0.012412140995313	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2900.3873588817	2900.3873588817
"AML-0024"	"2020-09-15-AML0024:TCGACCTAGTGTTGAA"	-1.32278178158458	-15.434560798761	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTAGTGTTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2854.41812315377	42.4186932600369	0.0148607146640345	3093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2842.58915447071	2842.58915447071
"AML-0024"	"2020-09-15-AML0024:TCGACCTAGTTCCATG"	-0.427768866450149	-16.2100324860779	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTAGTTCCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.96188496345	35.3861934404248	0.0128725660526557	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.7000833254	2743.7000833254
"AML-0024"	"2020-09-15-AML0024:TCGACCTAGTTGGGAC"	-2.23538074913676	-16.4124651185242	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTAGTTGGGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.71327312479	32.9283023972842	0.0117111167458016	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.50144938757	2804.50144938757
"AML-0024"	"2020-09-15-AML0024:TCGACCTCAGGATGAC"	-1.56447539749797	-16.2580862275329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTCAGGATGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.69109735635	31.8852999287452	0.0116170814119872	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.86548766171	2738.86548766171
"AML-0024"	"2020-09-15-AML0024:TCGACCTTCAACACGT"	-0.523724893957931	-15.8378620377746	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTTCAACACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.67961283628	32.342633575043	0.0119447786295382	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.91319417436	2701.91319417436
"AML-0024"	"2020-09-15-AML0024:TCGACCTTCCGCACGA"	-1.872182349593	-16.4889974824158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTTCCGCACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3004.38224868974	32.3364248222348	0.0107630861007574	3058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2996.8631288613	2996.8631288613
"AML-0024"	"2020-09-15-AML0024:TCGACCTTCGGTAAGG"	-2.18914256516154	-16.2084455720154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACCTTCGGTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.92071935424	41.9640537543443	0.0153831647146542	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.17551191184	2724.17551191184
"AML-0024"	"2020-09-15-AML0024:TCGACGGCAAATCAGA"	14.1604391532833	1.72652933681337	"2020-09-15-AML0024"	"AML0024"	"Plasmablast"	"Plasmablast"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00760456273764259	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGCAAATCAGA"	"Plasmablast"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1637.62050562837	12.165434289687	0.00742872615961718	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1624.52249184164	1624.52249184164
"AML-0024"	"2020-09-15-AML0024:TCGACGGCAAGAGTTA"	-0.611688594252425	-16.6021623841492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGCAAGAGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.86065057623	37.3917980613031	0.0134412908330106	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.81930642608	2774.81930642608
"AML-0024"	"2020-09-15-AML0024:TCGACGGCAAGGTCAG"	-1.44181929054912	-16.0192575684753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGCAAGGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.62772037176	38.8633048931586	0.0149841492624038	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.99124366499	2584.99124366499
"AML-0024"	"2020-09-15-AML0024:TCGACGGCACAACGTT"	-2.79520354691203	-15.9905119172302	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGCACAACGTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.98372033983	45.6559310315168	0.0208096033750173	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2187.16587620735	2187.16587620735
"AML-0024"	"2020-09-15-AML0024:TCGACGGCACCGTCGA"	-1.75856373730357	-16.1934595338074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGCACCGTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1986.66047754092	38.7934514579121	0.0195269659292414	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1985.26089916812	1985.26089916812
"AML-0024"	"2020-09-15-AML0024:TCGACGGTCACATACG"	-0.847802500159103	-16.7918234101501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGTCACATACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1696.39054118194	48.7761972405547	0.0287529292674377	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1685.76813967679	1685.76813967679
"AML-0024"	"2020-09-15-AML0024:TCGACGGTCCCTGTTG"	-1.71190700951274	-16.5004453889099	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGACGGTCCCTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2023.05459405748	41.924104794755	0.0207231702584314	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2021.59546940095	2021.59546940095
"AML-0024"	"2020-09-15-AML0024:TCGATTTAGGGATCTG"	-1.86537180367168	-16.1653433076111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTAGGGATCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.25815354049	36.5239211901869	0.0143610750404325	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2535.48991155997	2535.48991155997
"AML-0024"	"2020-09-15-AML0024:TCGATTTCAAAGTGTA"	-2.36384258690532	-15.4392643204895	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTCAAAGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.91225340796	32.5756396866051	0.0121013007186116	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.53047168299	2689.53047168299
"AML-0024"	"2020-09-15-AML0024:TCGATTTCACCCTATC"	-1.34553442421611	-15.5648317567078	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTCACCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.40874521985	28.4216192642881	0.0127142829359795	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2230.00544113258	2230.00544113258
"AML-0024"	"2020-09-15-AML0024:TCGATTTTCAAGATAG"	-2.18517075005229	10.0078181990418	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTTCAAGATAG"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	1802.66926096293	34.7134733515123	0.0192567067643731	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1800.83071090164	1800.83071090164
"AML-0024"	"2020-09-15-AML0024:TCGATTTTCAGTCACA"	-2.24476132813151	-15.8304987183777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTTCAGTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.91714982023	33.8239880883404	0.0120416467571872	2884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.00216242952	2798.00216242952
"AML-0024"	"2020-09-15-AML0024:TCGATTTTCATGCATG"	-1.45954857292827	-16.558093093988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTTCATGCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.0657048041	38.4610588063823	0.0144586875192298	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.61399196869	2649.61399196869
"AML-0024"	"2020-09-15-AML0024:TCGATTTTCCAGCCTT"	-1.03635249558147	-15.639750503656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGATTTTCCAGCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.16105668512	34.4698366301773	0.013120564703281	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.98774463874	2624.98774463874
"AML-0024"	"2020-09-15-AML0024:TCGCACTAGACCATTC"	-2.10920963707622	-16.0389681092468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTAGACCATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.80018001155	39.1437078641956	0.0146726535808338	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.07317279907	2657.07317279907
"AML-0024"	"2020-09-15-AML0024:TCGCACTAGGTAATCA"	1.14675690707509	-16.2193136445251	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTAGGTAATCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2808.65325829332	40.3216450014175	0.0143562203281437	3685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2792.28667212803	2792.28667212803
"AML-0024"	"2020-09-15-AML0024:TCGCACTAGGTCTGGA"	-1.03574667397197	-17.3367128602234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTAGGTCTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.2550803181	41.2864346254845	0.0158412869627655	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.10627282084	2596.10627282084
"AML-0024"	"2020-09-15-AML0024:TCGCACTAGTGGAATT"	-1.16078684750255	-16.1703062287536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTAGTGGAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.15770859276	34.4638673624722	0.0133884055539522	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.89359237919	2568.89359237919
"AML-0024"	"2020-09-15-AML0024:TCGCACTCACCTGAAT"	-2.90374002876933	-15.6783886185852	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTCACCTGAAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.18571825513	31.4631336857346	0.0113659764510189	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.11305054302	2765.11305054302
"AML-0024"	"2020-09-15-AML0024:TCGCACTGTAGTCACT"	-2.26775393906291	-16.5638418427673	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTGTAGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.80604194467	47.8439169107566	0.0176428240702816	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.92883794046	2698.92883794046
"AML-0024"	"2020-09-15-AML0024:TCGCACTGTCTAATCG"	-2.027091841132	-15.4284372559753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCACTGTCTAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.07981202367	39.2399295566411	0.0164247043397863	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2379.49553981033	2379.49553981033
"AML-0024"	"2020-09-15-AML0024:TCGCAGGAGAGACAAG"	0.346833040087861	-16.3177385560242	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGAGAGACAAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2859.6618448638	39.9081100346455	0.013955534674956	2707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2849.72027785824	2849.72027785824
"AML-0024"	"2020-09-15-AML0024:TCGCAGGAGGGATCAC"	-0.300310085446197	-16.1799459687439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGAGGGATCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.05585519591	30.9541627888216	0.0112599250140065	2809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.67672494998	2740.67672494998
"AML-0024"	"2020-09-15-AML0024:TCGCAGGCAAGTTTGC"	-1.08068023148234	-15.9490843049255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGCAAGTTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.92395388012	36.7381551410571	0.0131776030296402	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.36369781861	2785.36369781861
"AML-0024"	"2020-09-15-AML0024:TCGCAGGCACCGGTCA"	-0.21169743958171	-16.1716776124206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGCACCGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.97275867194	34.1919184723705	0.0124471268833772	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.70421684906	2740.70421684906
"AML-0024"	"2020-09-15-AML0024:TCGCAGGGTAACCCTA"	-1.4673766893452	-15.8952045670715	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TCGCAGGGTAACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.74350132448	39.6315818661822	0.0152385584529959	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.98972727542	2592.98972727542
"AML-0024"	"2020-09-15-AML0024:TTTGGTTAGTCTAACC"	-1.11815212193187	-16.7516432038513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTAGTCTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2471.36185720138	40.6746601939702	0.0164583992730353	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2465.51525625481	2465.51525625481
"AML-0024"	"2020-09-15-AML0024:TTTGGTTCAAATGATG"	-1.05323515358623	-16.823889755365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTCAAATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.16816843645	34.1097793144911	0.0126324647898662	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.15332339164	2689.15332339164
"AML-0024"	"2020-09-15-AML0024:TTTGGTTGTCATTGCA"	-2.01111231270488	-16.2862177125183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTGTCATTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.35741578569	37.6314981515083	0.0160382633516672	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2336.17636667646	2336.17636667646
"AML-0024"	"2020-09-15-AML0024:TTTGGTTGTGAATTAG"	-1.27369711819347	-16.4713945618835	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTGTGAATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.20661975057	38.1788375416301	0.0148775384054386	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.39099578832	2562.39099578832
"AML-0024"	"2020-09-15-AML0024:TTTGGTTGTGTTACAC"	-1.97732410851176	-16.1645918122497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTGTGTTACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.33969804941	34.676372605372	0.0138964537102817	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.78355672305	2487.78355672305
"AML-0024"	"2020-09-15-AML0024:TTTGGTTTCAAAGCCT"	-1.49730990353282	-15.1338329545227	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTTCAAAGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.14492083811	45.4770582271643	0.0181752295194522	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2494.96541576529	2494.96541576529
"AML-0024"	"2020-09-15-AML0024:TTTGGTTTCCGTTGGG"	-1.09556696835216	-16.839514755365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTTCCGTTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.4517175408	39.607783027809	0.0151785843599115	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.91079401923	2602.91079401923
"AML-0024"	"2020-09-15-AML0024:TTTGGTTTCGATTGGT"	-0.595881323248702	-15.7413063279358	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGTTTCGATTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.52029309525	37.329236722368	0.013792335796484	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.75260163993	2698.75260163993
"AML-0024"	"2020-09-15-AML0024:TTTGTTGAGCCATTTG"	-1.65617237511333	-16.8046369782654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGTTGAGCCATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2312.37090863855	48.9246625803858	0.0211577919431581	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2301.04323533135	2301.04323533135
"AML-0024"	"2020-09-15-AML0024:TTTGTTGAGTGCTACT"	-1.80028269711192	-16.6854734650818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGTTGAGTGCTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.39390699749	30.1539116203854	0.0126463633093058	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2380.92062657797	2380.92062657797
"AML-0024"	"2020-09-15-AML0024:TTTGTTGCAATCTCGA"	0.0782290204310834	-16.3603620759216	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGTTGCAATCTCGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2683.93930905204	38.667973393026	0.0144071713032451	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2670.72123455479	2670.72123455479
"AML-0024"	"2020-09-15-AML0024:TTTGTTGCAGGTCTCG"	-0.820927421480972	-16.5345163575378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGTTGCAGGTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.63950650889	33.861149875811	0.0121034714433475	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.98481809435	2790.98481809435
"AML-0024"	"2020-09-15-AML0024:TTTGTTGGTCGTAATC"	-2.06498752060588	-15.8095188370911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGTTGGTCGTAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3132.91295849118	39.8189632132882	0.0127098849348388	3049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3120.49728808367	3120.49728808367
"AML-0024"	"2020-09-15-AML0024:GAAATGAGTTATTCTC"	-2.19370541992839	-16.0909528962341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGAGTTATTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2953.7195819016	30.809823135459	0.0104308558348737	3308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2944.66764338459	2944.66764338459
"AML-0024"	"2020-09-15-AML0024:GAAATGATCGATACTG"	-0.923745076090652	-16.5211611024109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGATCGATACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.21177820127	34.0381754112082	0.0131410781534032	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.9255046855	2586.9255046855
"AML-0024"	"2020-09-15-AML0024:GAAATGATCTTCCTAA"	0.111379531293553	-15.8935518494812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAATGATCTTCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1827.45619151252	42.0685233012537	0.0230202636301969	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1826.20156340229	1826.20156340229
"AML-0024"	"2020-09-15-AML0024:GAACACTAGGACTTCT"	-2.01360998573955	-16.2473993531433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTAGGACTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.40735462505	36.8677558910478	0.0136476106900083	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.65213013165	2691.65213013165
"AML-0024"	"2020-09-15-AML0024:GAACACTCACTCATAG"	-1.60691533508952	-15.6860103837219	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTCACTCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2991.23163139744	34.6673744397951	0.0115896656333496	2771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2981.49428604791	2981.49428604791
"AML-0024"	"2020-09-15-AML0024:GAACACTGTAGCGTCC"	-2.23820982399638	-16.448531173822	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTGTAGCGTCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2940.69836160609	31.1525349652835	0.0105935839499938	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2936.42928893664	2936.42928893664
"AML-0024"	"2020-09-15-AML0024:GAACACTGTGTTCAGT"	-2.55123362961467	-16.3051004639831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTGTGTTCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1426.43912559946	48.8585722190751	0.0342521256899361	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1423.11293824834	1423.11293824834
"AML-0024"	"2020-09-15-AML0024:GAACACTTCGTTAGTG"	-1.4976855320042	-15.5784006348816	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTTCGTTAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.42838235582	34.5277407195106	0.0137154808301634	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2508.26403644796	2508.26403644796
"AML-0024"	"2020-09-15-AML0024:GAACACTTCTCGGGAC"	1.0592391687328	-16.2240076295105	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACACTTCTCGGGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2837.1138072586	39.4799721987542	0.0139155405390319	3482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2828.30868170005	2828.30868170005
"AML-0024"	"2020-09-15-AML0024:GAACGTTCACTAGGCC"	-0.420499573380309	-15.8578996888367	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTCACTAGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2943.64677913479	37.689076347602	0.0128035322086707	2781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2937.67713206104	2937.67713206104
"AML-0024"	"2020-09-15-AML0024:GAACGTTCATTGCCGG"	-1.94898209992107	-16.9135275117126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTCATTGCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1598.68029931763	49.3435996382421	0.0308652077962701	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1589.01841684962	1589.01841684962
"AML-0024"	"2020-09-15-AML0024:GAACGTTGTCGTGCCA"	-1.70489571514781	-16.185570739862	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTGTCGTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.70544182799	38.6802842693084	0.0155924535082269	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.77624208358	2474.77624208358
"AML-0024"	"2020-09-15-AML0024:GAACGTTGTTCTCAGA"	-2.32592521134074	-16.5650892487732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTGTTCTCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.86550308517	36.5641383162311	0.0149984231164346	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2423.6724607198	2423.6724607198
"AML-0024"	"2020-09-15-AML0024:GAACGTTTCGCAGTGC"	-2.49444971504863	-15.7384109727112	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTTCGCAGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.93434208688	35.6256545965043	0.0142849208157956	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.41344490748	2489.41344490748
"AML-0024"	"2020-09-15-AML0024:GAACGTTTCTTCGCTG"	-0.718745867640334	-15.6792268983093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACGTTTCTTCGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1738.30521486785	31.3893231303567	0.0180574290762529	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1736.58168056264	1736.58168056264
"AML-0024"	"2020-09-15-AML0024:GAACTGTAGAGTGTTA"	-3.12214718285258	11.3600301512512	"2020-09-15-AML0024"	"AML0024"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTAGAGTGTTA"	"gd T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2041.4910068107	32.9811369423174	0.0161554162287699	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2038.43987641281	2038.43987641281
"AML-0024"	"2020-09-15-AML0024:GAACTGTAGCCTCTGG"	-0.933284203440505	-15.5604000321594	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTAGCCTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.04486862207	33.2458626527602	0.0124560898333357	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.91354592417	2662.91354592417
"AML-0024"	"2020-09-15-AML0024:GAACTGTAGTATGTAG"	-1.07863841477092	-15.9300060502258	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTAGTATGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.10586190749	28.0795741040879	0.0114232566380596	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2455.41249160117	2455.41249160117
"AML-0024"	"2020-09-15-AML0024:GAACTGTCACAACGAG"	-2.50442061844524	-16.2142114869324	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTCACAACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.85541052363	30.3946178820454	0.0105249791147037	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.35773649061	2876.35773649061
"AML-0024"	"2020-09-15-AML0024:GAACTGTCAGCTTTCC"	11.8570724922115	-1.86249043857726	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTCAGCTTTCC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1105.99945521446	7.81595062004504	0.00706686660937775	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1100.13298819858	1100.13298819858
"AML-0024"	"2020-09-15-AML0024:GAACTGTGTACTAGCT"	-1.54033861580547	-15.8394890061584	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTGTACTAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.7431362408	30.3683228013961	0.0115568079629124	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.98281734693	2624.98281734693
"AML-0024"	"2020-09-15-AML0024:GAACTGTGTCTCAAGT"	-1.46855543080028	-16.2658491364685	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTGTCTCAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.7255889794	38.1453367419594	0.0146222112832047	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.28480713905	2603.28480713905
"AML-0024"	"2020-09-15-AML0024:GAACTGTTCAAGCTTG"	-0.0549153861707032	-16.2574072114197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTTCAAGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2936.39195610345	36.5887767276236	0.0124604539430003	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2928.18719291514	2928.18719291514
"AML-0024"	"2020-09-15-AML0024:GAACTGTTCGCTTAAG"	-1.81215892258342	-15.9809789887634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTTCGCTTAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.91475292156	33.579332615113	0.0130358866018481	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.89109994402	2568.89109994402
"AML-0024"	"2020-09-15-AML0024:GAACTGTTCTGGGCGT"	-0.167160699993926	-16.162850402948	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAACTGTTCTGGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.45061373245	38.2084466868582	0.0141699041296253	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2691.0311264444	2691.0311264444
"AML-0024"	"2020-09-15-AML0024:GAAGAATAGTGCTAGG"	-0.816139559180099	-15.9972315064636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATAGTGCTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2969.05961176541	34.8708794457858	0.0117447555810614	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2962.82005947345	2962.82005947345
"AML-0024"	"2020-09-15-AML0024:GAAGAATCACAAAGTA"	-0.409282932907897	-15.8064604035583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATCACAAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.07852222464	35.05701899913	0.0132938851474001	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.30268856918	2632.30268856918
"AML-0024"	"2020-09-15-AML0024:GAAGAATGTGTACAGG"	-0.628147999674636	-16.0106439820495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATGTGTACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.35217586828	34.6988009308682	0.0140460948320748	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.95399354276	2464.95399354276
"AML-0024"	"2020-09-15-AML0024:GAAGAATTCACTGCTC"	-0.522202352911788	-15.7727213135925	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATTCACTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.55148985516	34.776881416051	0.0132860352703034	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.76358484428	2613.76358484428
"AML-0024"	"2020-09-15-AML0024:GAAGAATTCCGTGGTG"	1.16256179389302	-16.2024107209411	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATTCCGTGGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2886.84636211776	44.8832023840944	0.0155474856483767	3159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2871.59610950814	2871.59610950814
"AML-0024"	"2020-09-15-AML0024:GAAGAATTCTGGGCAC"	-0.398709635168868	-15.9364080659119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGAATTCTGGGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.89153779804	31.5506086449191	0.011188589426938	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2813.05921799789	2813.05921799789
"AML-0024"	"2020-09-15-AML0024:GAAGCCCCAAGACCGA"	-2.53036365929301	-16.1055288544861	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCCAAGACCGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.15465372483	40.647199613189	0.0142514009750856	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.26413432396	2831.26413432396
"AML-0024"	"2020-09-15-AML0024:GAAGCCCCACAACCGC"	-2.92132888260539	-15.8351707688537	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCCACAACCGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.88661146584	30.8432343817295	0.0116658688190221	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.43775137036	2638.43775137036
"AML-0024"	"2020-09-15-AML0024:GAAGCCCCATTGCCTC"	1.14261688765828	-16.2061662903992	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCCATTGCCTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.71308692846	41.9045583957745	0.0151898936479947	2843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2744.73342583569	2744.73342583569
"AML-0024"	"2020-09-15-AML0024:GAAGCCCGTGCACATT"	-0.0352726680343926	-16.0089807740417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCGTGCACATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.50326776113	30.2450329311486	0.0130676129744268	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2311.91081813903	2311.91081813903
"AML-0024"	"2020-09-15-AML0024:GAAGCCCGTTCAAACC"	-2.22358498993571	-16.0810575715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCGTTCAAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.40673061092	36.6323679150854	0.0135705255157287	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.99472143307	2692.99472143307
"AML-0024"	"2020-09-15-AML0024:GAAGCCCTCTCGACCT"	-1.76749787750896	-16.7395067445007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCCCTCTCGACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.50143919673	34.851911977696	0.0130214433914729	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.522631893	2670.522631893
"AML-0024"	"2020-09-15-AML0024:GAAGCGAAGACTGTTC"	-2.25798426094707	-15.864998840448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAAGACTGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.13906908686	31.8640172028565	0.0125739023526985	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.98781985977	2530.98781985977
"AML-0024"	"2020-09-15-AML0024:GAAGCGAAGGAACTCG"	-2.8498629135197	-16.068139099237	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAAGGAACTCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.63997309486	40.381949124447	0.0166137106159041	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2412.65966242799	2412.65966242799
"AML-0024"	"2020-09-15-AML0024:GAAGCGAAGGAAGTAG"	-2.25750575485881	-16.2534647217956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAAGGAAGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2864.01837510927	33.9808214097939	0.0118647358219192	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.60145550766	2855.60145550766
"AML-0024"	"2020-09-15-AML0024:GAAGCGAAGGATGGCT"	-0.529931227595168	-15.9213848344055	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAAGGATGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.36823120362	37.5062493045472	0.0135579381231647	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.575774403	2758.575774403
"AML-0024"	"2020-09-15-AML0024:GAAGCGAAGGGAGAAT"	-0.537115315825301	-16.2763681641785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAAGGGAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.4501851179	37.6129816727071	0.0133169215980126	2708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2815.36538618641	2815.36538618641
"AML-0024"	"2020-09-15-AML0024:GAAGCGACAAAGTGTA"	-0.00996585089023713	-16.4539709321228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGACAAAGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.73027075557	51.1871595382178	0.0187792460932052	2548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2721.61777050556	2721.61777050556
"AML-0024"	"2020-09-15-AML0024:GAAGCGACAGCACACC"	11.8714825111324	-1.95210053836974	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGACAGCACACC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1340.64186371468	33.020012694331	0.0246300026785963	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1332.40400208919	1332.40400208919
"AML-0024"	"2020-09-15-AML0024:GAAGCGAGTGCTAGCC"	-1.22284267368968	-16.3710947266785	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAGTGCTAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.37300933554	32.8864372841605	0.0125790914941088	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.6086741521	2607.6086741521
"AML-0024"	"2020-09-15-AML0024:GAAGCGAGTTCATCGA"	-2.86918149414714	-16.1329088441101	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGAGTTCATCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.57393814072	40.5737727664385	0.0156078548761948	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2593.04452081961	2593.04452081961
"AML-0024"	"2020-09-15-AML0024:GAAGCGATCCAAACCA"	-1.65168056908305	-15.9132442704407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGATCCAAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.85033427299	42.957200981754	0.0193863278206685	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2211.27243346417	2211.27243346417
"AML-0024"	"2020-09-15-AML0024:GAAGCGATCCGAAGGA"	-0.845517317683059	-15.7005186310974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGCGATCCGAAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.06515294204	39.4296331601469	0.0151706982472194	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.65042423131	2595.65042423131
"AML-0024"	"2020-09-15-AML0024:GAAGGACAGGGAGTGG"	-0.120614896447021	-16.2374353638855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGACAGGGAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.70991165186	39.2846688969213	0.0150302329733652	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.33537130671	2608.33537130671
"AML-0024"	"2020-09-15-AML0024:GAAGGACAGGTGCTAG"	-0.812440971762496	-15.8354826203552	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGACAGGTGCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.06782799129	33.7238111460608	0.0126067125450737	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.01715492377	2669.01715492377
"AML-0024"	"2020-09-15-AML0024:GAAGGACGTATCAGCT"	-1.11733696880992	-16.2220793000427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGACGTATCAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.85943987939	36.8927519705299	0.0137308083269834	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.2984630461	2681.2984630461
"AML-0024"	"2020-09-15-AML0024:GAAGGACTCAATCGGT"	1.09845830973927	-16.2114649049011	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGACTCAATCGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3087.47477942585	40.7016757543791	0.0131828366746847	4161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3074.35911555833	3074.35911555833
"AML-0024"	"2020-09-15-AML0024:GAAGGGTCAATAGTAG"	0.627908011048478	-16.3221845856872	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTCAATAGTAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2754.45097586632	41.0863520099492	0.0149163489820424	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2744.02745394099	2744.02745394099
"AML-0024"	"2020-09-15-AML0024:GAAGGGTCAGCTCCTT"	-1.37854681435283	-16.0863504639831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTCAGCTCCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.44288210533	35.8555622024747	0.0133270111181163	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.13320841095	2681.13320841095
"AML-0024"	"2020-09-15-AML0024:GAAGGGTCATCATCCC"	-0.538643459708053	-15.7432022324768	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTCATCATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.43755432057	38.5474509218841	0.0136092853532055	2607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.08035356816	2821.08035356816
"AML-0024"	"2020-09-15-AML0024:GAAGGGTGTAACGATA"	-1.01065502587016	-17.4249258271423	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTGTAACGATA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.89670437168	44.5510261702476	0.0155127536803224	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2865.12630373331	2865.12630373331
"AML-0024"	"2020-09-15-AML0024:GAAGGGTGTAGGTCAG"	7.80873169478719	7.06458423221437	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTGTAGGTCAG"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1574.2592216104	50.221832580302	0.0319018824161165	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1574.2592216104	1574.2592216104
"AML-0024"	"2020-09-15-AML0024:GAAGGGTGTATCAGGG"	-1.29967794838603	-16.3559408417908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGGGTGTATCAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.02583666057	32.1685756031449	0.0131513637840649	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.91485854416	2442.91485854416
"AML-0024"	"2020-09-15-AML0024:GAAGTAAAGGCTCTCG"	0.219951500266236	-16.0740595093933	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAAAGGCTCTCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2923.33390053002	41.1145749993124	0.0140642760622924	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2918.78551380448	2918.78551380448
"AML-0024"	"2020-09-15-AML0024:GAAGTAAAGGGCCTCT"	-1.62257502499278	-16.8881082764831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAAAGGGCCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.2235149691	38.8753084294911	0.0171769638183623	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2254.59151507852	2254.59151507852
"AML-0024"	"2020-09-15-AML0024:GAAGTAACAAGAGAGA"	9.60633530196492	6.85063121402589	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAACAAGAGAGA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1725.02283361867	37.7546450923203	0.0218864610696894	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1721.69300391968	1721.69300391968
"AML-0024"	"2020-09-15-AML0024:GAAGTAACACGTCTCT"	-1.53002450886424	-16.5157728425232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAACACGTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.06703504845	38.6255003165016	0.0141016995284375	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2730.83917225231	2730.83917225231
"AML-0024"	"2020-09-15-AML0024:GAAGTAACAGTAACAA"	-1.5552912754124	-16.3741693726745	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAACAGTAACAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2840.01831660693	39.3034863126474	0.0138391664880544	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2832.64923175728	2832.64923175728
"AML-0024"	"2020-09-15-AML0024:GAAGTAACAGTATTCG"	-0.949592093855697	-16.3039846650329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAACAGTATTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.37813121662	41.4436690066683	0.0169131729012336	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2443.4796864416	2443.4796864416
"AML-0024"	"2020-09-15-AML0024:GAAGTAACATCGGATT"	-0.897698084742385	-15.8875437012878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAACATCGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.04435826933	37.131534342319	0.0134629938894888	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2746.47353585067	2746.47353585067
"AML-0024"	"2020-09-15-AML0024:GAAGTAAGTAGGACCA"	-0.919685224921066	-16.4675874940124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAAGTAGGACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.68488769192	36.1718887697579	0.0133688475455153	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.27335177118	2698.27335177118
"AML-0024"	"2020-09-15-AML0024:GAAGTAAGTGCAATGG"	-0.451732615858871	-16.4466009370056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAAGTGCAATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.84769442667	33.5003212174296	0.0115524416271293	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.46303844384	2892.46303844384
"AML-0024"	"2020-09-15-AML0024:GAAGTAATCAACACGT"	-1.18648050251659	-16.4628324738708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAAGTAATCAACACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.97294574265	38.4584316806688	0.0142071725323867	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.77681972466	2700.77681972466
"AML-0024"	"2020-09-15-AML0024:GAATAGAAGACATCAA"	0.367457022040528	-16.0886736146179	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGAAGACATCAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2870.26149073814	39.9754768076265	0.0139274686075191	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2862.54578021113	2862.54578021113
"AML-0024"	"2020-09-15-AML0024:GAATAGAAGGCAGGTT"	-1.69652805748637	-15.2317238084045	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGAAGGCAGGTT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.23917480208	39.2370617492503	0.0155811497739622	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2506.3855035855	2506.3855035855
"AML-0024"	"2020-09-15-AML0024:GAATAGAAGTGCCTCG"	-1.26281557503398	-15.6444978944031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGAAGTGCCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.80354955023	34.9631670778344	0.0127101650292516	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.20999012751	2743.20999012751
"AML-0024"	"2020-09-15-AML0024:GAATAGACACCTCTAC"	-1.65779469433482	-15.8610229722229	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGACACCTCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.51455644886	36.784528202056	0.0132627853409048	2686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.84757206404	2763.84757206404
"AML-0024"	"2020-09-15-AML0024:GAATAGACATAGCACT"	-2.31413016739543	-15.5927076569763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGACATAGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.06991625162	36.3045433611175	0.0134308562064356	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.27370185159	2697.27370185159
"AML-0024"	"2020-09-15-AML0024:GAATAGAGTACCGTCG"	-2.13506184044536	-16.1533613434997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGAGTACCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.09169547136	34.3668168687199	0.0128230003946472	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.37124508588	2675.37124508588
"AML-0024"	"2020-09-15-AML0024:GAATAGATCAACTACG"	-1.71372542801555	-16.7237005463806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATAGATCAACTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.59162860605	40.6573226698681	0.0138686856222196	3104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2920.24290741599	2920.24290741599
"AML-0024"	"2020-09-15-AML0024:GAATCACAGCGAATGC"	-2.62521872940715	-16.3925695649353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACAGCGAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.66977966861	38.511404307607	0.0159820256835786	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2399.73536149291	2399.73536149291
"AML-0024"	"2020-09-15-AML0024:GAATCACCACCAAAGG"	-1.30283461037334	-16.1795702210632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACCACCAAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.52117466252	35.714763902901	0.0121830141332725	3319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2921.32864003269	2921.32864003269
"AML-0024"	"2020-09-15-AML0024:GAATCACCAGGTGTTT"	-2.56414971771892	-15.5698538056579	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACCAGGTGTTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.90385465139	35.4056500593586	0.0124891890076859	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.25558160673	2829.25558160673
"AML-0024"	"2020-09-15-AML0024:GAATCACCATTGTGCA"	-1.72338388386424	-16.8425283662048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACCATTGTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.32859771952	36.5921122253955	0.0149579710017317	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.44839241317	2434.44839241317
"AML-0024"	"2020-09-15-AML0024:GAATCACGTCTTCTAT"	-1.28929458084758	-16.4999761811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACGTCTTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.12864550044	32.8341752364707	0.0131698680273596	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.42810703581	2485.42810703581
"AML-0024"	"2020-09-15-AML0024:GAATCACTCTAGCAAC"	-0.538242499262649	-16.1335230103699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCACTCTAGCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.65692322258	42.3719255795212	0.0156489270173458	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.45018220725	2697.45018220725
"AML-0024"	"2020-09-15-AML0024:GAATCGTAGCTGTGCC"	-2.58539591255839	-15.6360283127991	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCGTAGCTGTGCC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.31931167647	37.2738187623897	0.0131601753406564	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2829.58554661279	2829.58554661279
"AML-0024"	"2020-09-15-AML0024:GAATCGTCAACAAAGT"	-1.34209201756175	-16.4800443879333	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCGTCAACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2855.67592196278	37.9902618117163	0.0133034219742991	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2848.0101304642	2848.0101304642
"AML-0024"	"2020-09-15-AML0024:GAATCGTCATAGAAAC"	-1.68507740917857	-16.3588514558044	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCGTCATAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.33654433139	37.506730639259	0.013742068825172	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.50993440242	2723.50993440242
"AML-0024"	"2020-09-15-AML0024:GAATCGTGTTCTAACG"	-2.46410451355632	-16.0615492097107	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCGTGTTCTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.25676067791	41.1659265503297	0.0151721455731467	2526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.19721634589	2703.19721634589
"AML-0024"	"2020-09-15-AML0024:GAATCGTTCGGATACT"	-0.742750744253951	-16.4634733430115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAATCGTTCGGATACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3201.48832327896	39.2826257906629	0.0122701137171194	4201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3189.73287702455	3189.73287702455
"AML-0024"	"2020-09-15-AML0024:GACACGCAGACTCATC"	-0.56105206432994	-16.1843271485535	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCAGACTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.55791311752	42.8338986592711	0.0156696510630794	3154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2724.14612825004	2724.14612825004
"AML-0024"	"2020-09-15-AML0024:GACACGCAGCATCAAA"	-2.85114608231242	-15.5762081376282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCAGCATCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.51723216163	29.2131850939195	0.0105901767635606	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.5511006039	2749.5511006039
"AML-0024"	"2020-09-15-AML0024:GACACGCAGTGGTGAC"	-1.42077467861827	-16.3935690156189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCAGTGGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.66056752167	30.2683501857932	0.0117334623658928	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.81259186122	2569.81259186122
"AML-0024"	"2020-09-15-AML0024:GACACGCCAGGAAGTC"	-0.401202867657501	-15.9427318803039	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCCAGGAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2800.88168948934	37.8818441493971	0.0135249711873063	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2796.22039322793	2796.22039322793
"AML-0024"	"2020-09-15-AML0024:GACACGCCATCGTCCT"	-0.886692981154281	-15.9572973481384	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCCATCGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.4318797491	36.2503336456084	0.0138021221586266	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.26576059213	2621.26576059213
"AML-0024"	"2020-09-15-AML0024:GACACGCGTAGCGAGT"	-0.13435554030593	-16.0636301270691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCGTAGCGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.02836261377	37.36118439903	0.0129231469611913	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.22148788666	2885.22148788666
"AML-0024"	"2020-09-15-AML0024:GACACGCGTCCAGGTC"	1.1183713870937	-16.2379236451355	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCGTCCAGGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2872.43991911643	43.4488384760408	0.0151261087087962	3564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2859.37861547774	2859.37861547774
"AML-0024"	"2020-09-15-AML0024:GACACGCTCACTGGTA"	-1.01446185532268	-16.6496553651062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACACGCTCACTGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2965.27656032126	35.8834031231664	0.0121011994642681	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2954.7211301881	2954.7211301881
"AML-0024"	"2020-09-15-AML0024:GACAGCCAGACGACGT"	-0.0218125906890214	-15.8390112153259	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACAGCCAGACGACGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2873.51176600923	42.6768487101199	0.0148518092791352	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2865.53071971923	2865.53071971923
"AML-0024"	"2020-09-15-AML0024:GACAGCCAGCGTTCAT"	-1.59712050381358	-15.4595775834289	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACAGCCAGCGTTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2855.79659417703	36.7170889823075	0.0128570392783483	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.65685315104	2850.65685315104
"AML-0024"	"2020-09-15-AML0024:GACAGCCGTCGCATGC"	-2.15543518486674	-16.4906225434509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACAGCCGTCGCATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.67944046917	43.2060364722937	0.0171474338276335	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2508.35288751269	2508.35288751269
"AML-0024"	"2020-09-15-AML0024:GACAGCCGTCTCTCAC"	-1.81867609444316	-15.5362997285095	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACAGCCGTCTCTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.95278891688	38.710629666234	0.014476930866799	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.13242171089	2670.13242171089
"AML-0024"	"2020-09-15-AML0024:GACAGCCGTGGACCTC"	-0.428464571863967	-16.5825357667175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACAGCCGTGGACCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2920.25317607992	42.4330401668073	0.0145306032074138	2780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2904.90105593004	2904.90105593004
"AML-0024"	"2020-09-15-AML0024:GACATCAAGAGTCGAC"	-1.60055802288707	-15.6052093735901	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACATCAAGAGTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.95271843384	36.2846903557022	0.0132379847750292	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.19601224568	2736.19601224568
"AML-0024"	"2020-09-15-AML0024:GACATCAAGGATGTTA"	-2.45943103256877	-15.9395332566467	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACATCAAGGATGTTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.1795088155	42.7416070192719	0.0150701346252665	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2826.51513648387	2826.51513648387
"AML-0024"	"2020-09-15-AML0024:GACATCAGTGTCGCTG"	-2.92946563187297	-16.0483141175476	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACATCAGTGTCGCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.47074435944	37.8539808502805	0.0146978881174189	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.12140766646	2570.12140766646
"AML-0024"	"2020-09-15-AML0024:GACCAATAGAGGTATT"	-2.24499545517619	-16.6529379121033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATAGAGGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.07355603497	44.075471165442	0.0184256337160886	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2383.68727535849	2383.68727535849
"AML-0024"	"2020-09-15-AML0024:GACCAATAGAGTCTGG"	-2.19798264923747	-15.7384443513122	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATAGAGTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2862.29975284448	32.7059431598662	0.0114264563406973	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2856.09737917474	2856.09737917474
"AML-0024"	"2020-09-15-AML0024:GACCAATAGGGTGAGG"	-1.05695841732677	-16.2587156525818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATAGGGTGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.82138177697	37.4580116175147	0.0129084484154489	3278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.52961770076	2892.52961770076
"AML-0024"	"2020-09-15-AML0024:GACCAATCAATGCAAA"	-1.29154835167583	-16.7096872559753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATCAATGCAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.33458467601	31.0830208808699	0.0120835839420108	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.94794250995	2563.94794250995
"AML-0024"	"2020-09-15-AML0024:GACCAATCACCATAAC"	-1.77397976341899	-16.2730570069519	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATCACCATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2512.7136060825	28.775152477105	0.0114518234021773	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.50080202476	2507.50080202476
"AML-0024"	"2020-09-15-AML0024:GACCAATCATCTTTCA"	-1.85983334007915	-16.6617307893005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATCATCTTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.81151157145	42.1629932354733	0.0159357509221929	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.99061518594	2639.99061518594
"AML-0024"	"2020-09-15-AML0024:GACCAATGTATAGCTC"	-0.396743903786498	-15.7899637452331	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATGTATAGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2856.65401795099	35.8483276883398	0.0125490617565417	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.13560712255	2847.13560712255
"AML-0024"	"2020-09-15-AML0024:GACCAATGTCAAGCGA"	-1.18727920475658	-15.9981756440369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATGTCAAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3082.66570105328	32.9825476350858	0.0106993592019454	2957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3071.68364626872	3071.68364626872
"AML-0024"	"2020-09-15-AML0024:GACCAATGTTGCAACT"	-2.18810663643535	-16.7179880372253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATGTTGCAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.37560825587	36.6384153993096	0.0149035059070177	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.07357369072	2450.07357369072
"AML-0024"	"2020-09-15-AML0024:GACCAATGTTGGGCCT"	-1.01320991936381	-16.1866007081238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATGTTGGGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.81939178552	31.577453235369	0.0114418549740457	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.08897875065	2751.08897875065
"AML-0024"	"2020-09-15-AML0024:GACCAATGTTTGAACC"	-1.45892808857616	-15.8632221451965	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATGTTTGAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.08453002383	33.1920760080349	0.0122975311216881	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.36888461552	2696.36888461552
"AML-0024"	"2020-09-15-AML0024:GACCAATTCGAGTCTA"	-1.12494931641276	-16.0724458924499	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCAATTCGAGTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2951.86278822226	38.9138035583791	0.013182795526148	3074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2943.2546321292	2943.2546321292
"AML-0024"	"2020-09-15-AML0024:GACCCAGCATGGACAG"	-2.46293721619304	-15.6463794938293	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCAGCATGGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.29435582844	31.7021214483806	0.0133353790920574	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.16897555595	2370.16897555595
"AML-0024"	"2020-09-15-AML0024:GACCCAGGTGCACAAG"	-1.36016807976421	-16.5543279877869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCAGGTGCACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.92309269201	40.0078319421071	0.0155314543573179	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.37782922035	2567.37782922035
"AML-0024"	"2020-09-15-AML0024:GACCCAGTCGCCTCTA"	-0.973351816565353	-17.4984598389831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCAGTCGCCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.86735870928	29.0214168654081	0.0104136340664771	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.30854684977	2777.30854684977
"AML-0024"	"2020-09-15-AML0024:GACCCTTAGTGAGGCT"	-0.645590583712417	-15.9063453904358	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTAGTGAGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.21658966193	39.2701461380712	0.0157129823403514	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.87854191127	2495.87854191127
"AML-0024"	"2020-09-15-AML0024:GACCCTTCAGATAAAC"	-1.66006515446361	-15.9390583268371	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTCAGATAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.96391978051	27.0060744435553	0.0106324638051902	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2533.59802547165	2533.59802547165
"AML-0024"	"2020-09-15-AML0024:GACCCTTCAGCGCTTG"	-1.87659273567851	-16.9473009339538	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTCAGCGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1749.61603589002	51.4452591342624	0.0294037423520142	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1740.05447787883	1740.05447787883
"AML-0024"	"2020-09-15-AML0024:GACCCTTGTAACTTCG"	-1.57604120197948	-15.9277487031189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTGTAACTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.34748000563	39.4096679727357	0.0141743678645002	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.49224230664	2771.49224230664
"AML-0024"	"2020-09-15-AML0024:GACCCTTGTGCCGAAA"	-1.82363210144694	-16.4257192841736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTGTGCCGAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.63977854486	36.3796616346786	0.0145075309244732	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.13867995081	2500.13867995081
"AML-0024"	"2020-09-15-AML0024:GACCCTTGTGGGACAT"	-2.54151735726054	-16.1260748139587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTGTGGGACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.82844752831	39.4697743677641	0.0157260845483818	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.64400082317	2502.64400082317
"AML-0024"	"2020-09-15-AML0024:GACCCTTGTTCTTCAT"	-0.885477523238021	-16.3582163087097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTGTTCTTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.22913167962	34.9696789299093	0.0127059475271843	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.59915592052	2741.59915592052
"AML-0024"	"2020-09-15-AML0024:GACCCTTTCACCTGGG"	-0.909955303103286	-16.6696386567322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTTCACCTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.96755035517	42.0826307007128	0.016887310869965	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.57827511474	2485.57827511474
"AML-0024"	"2020-09-15-AML0024:GACCCTTTCGCTAGCG"	-0.672023097903091	-16.3825121155945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCCTTTCGCTAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2953.28209023	33.4708071870554	0.0113334270701004	3445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2943.63953814801	2943.63953814801
"AML-0024"	"2020-09-15-AML0024:GACCGTGCACACACTA"	0.541383286088151	-16.1713266602722	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGCACACACTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2753.76840387851	42.3078282922213	0.0153636116358345	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2748.44877824902	2748.44877824902
"AML-0024"	"2020-09-15-AML0024:GACCGTGCATCCTATT"	-2.18520102921184	-16.2838773957458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGCATCCTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.21973259331	37.1841285960412	0.0143611328648413	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.32166207873	2581.32166207873
"AML-0024"	"2020-09-15-AML0024:GACCGTGGTAGCTAAA"	-1.25035629692729	-15.9230690232483	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGGTAGCTAAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.9170572511	40.1772024705762	0.0150876657465444	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.64594073318	2655.64594073318
"AML-0024"	"2020-09-15-AML0024:GACCGTGGTCAAATCC"	-1.19009218636211	-16.1335439912048	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGGTCAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.1704271846	28.1580923493244	0.0105335941408647	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.68458215907	2665.68458215907
"AML-0024"	"2020-09-15-AML0024:GACCGTGGTGAGTGAC"	1.01243241605107	-16.2143507233826	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGGTGAGTGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2761.03632176429	42.0755974100742	0.0152390597249326	3241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2753.25819950348	2753.25819950348
"AML-0024"	"2020-09-15-AML0024:GACCGTGGTTAGGACG"	-1.51804790917094	-15.599241279718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGGTTAGGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2331.73064348857	34.2320787791782	0.0146809747835893	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2326.23160429735	2326.23160429735
"AML-0024"	"2020-09-15-AML0024:GACCGTGTCAGCAATC"	-1.58507035198863	-16.4800520173279	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCGTGTCAGCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2699.69091764315	32.2085188301973	0.0119304467854845	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.51305377889	2693.51305377889
"AML-0024"	"2020-09-15-AML0024:GACCTTCAGAACGTGC"	-0.889672736555892	-16.5585985413757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCAGAACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.96187337785	37.6113618337387	0.0135197258429969	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2768.79339252693	2768.79339252693
"AML-0024"	"2020-09-15-AML0024:GACCTTCAGCGCATCC"	-1.83888183060344	-16.4532537690369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCAGCGCATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.03862458859	40.3916085686117	0.016486110938514	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.48805906355	2441.48805906355
"AML-0024"	"2020-09-15-AML0024:GACCTTCAGCTCACTA"	-2.90295420113261	-15.8161983720032	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCAGCTCACTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.30102192272	34.5866206728454	0.0119996559727038	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2871.26441848667	2871.26441848667
"AML-0024"	"2020-09-15-AML0024:GACCTTCAGGTCGTCC"	-2.03246007385905	-15.4175777665344	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCAGGTCGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.16033053932	38.0355720490636	0.0132520722429177	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2861.98202738995	2861.98202738995
"AML-0024"	"2020-09-15-AML0024:GACCTTCCAAACCACT"	-0.837814728648025	-16.4754171601501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCCAAACCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2914.53079035663	44.051604134778	0.0151144754690987	2983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2907.87212122725	2907.87212122725
"AML-0024"	"2020-09-15-AML0024:GACCTTCCACCCTTGT"	-0.554698626429397	-16.6971483460632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCCACCCTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.2374027219	33.6304768242351	0.0121839073664721	2825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.62127409633	2749.62127409633
"AML-0024"	"2020-09-15-AML0024:GACCTTCCAGGCACTC"	-3.01231894913371	-15.6868047944275	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACCTTCCAGGCACTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.61589957172	35.5638859199081	0.0123373654898635	2541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.5477583048	2879.5477583048
"AML-0024"	"2020-09-15-AML0024:GACGCTGAGAATCTAG"	-0.98043785515483	-15.7984123460022	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACGCTGAGAATCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2735.3321301601	36.3143572746745	0.0132760321404001	2627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.60867728737	2729.60867728737
"AML-0024"	"2020-09-15-AML0024:GACGCTGCAAGCTGTT"	-1.96600327912028	-15.7975216141907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACGCTGCAAGCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.92308573217	36.5482829109553	0.0150347343877181	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2418.05954340909	2418.05954340909
"AML-0024"	"2020-09-15-AML0024:GACGTTAAGTAGGGTC"	-0.587474028498489	-15.9195041886536	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACGTTAAGTAGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2863.57053004572	39.4695966774958	0.0137833506328428	2742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.03226225841	2858.03226225841
"AML-0024"	"2020-09-15-AML0024:GACGTTAGTCGGAACA"	-0.864395658404189	-15.8959207764831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACGTTAGTCGGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2498.23297423027	34.5393981570802	0.0138255312908605	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2491.14646870924	2491.14646870924
"AML-0024"	"2020-09-15-AML0024:GACGTTATCGATAACC"	-0.369640032679397	-16.3899698487488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACGTTATCGATAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.82396440173	32.4112116846212	0.0119386052685606	2414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.92550752328	2709.92550752328
"AML-0024"	"2020-09-15-AML0024:GACTATGAGAAAGCGA"	-2.35413465920146	-16.3473692170349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTATGAGAAAGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.22379284454	45.1571715518508	0.0176104642963932	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.63575719027	2557.63575719027
"AML-0024"	"2020-09-15-AML0024:GACTATGAGCACTCGC"	-1.27906940403636	-16.6615820161072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTATGAGCACTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.73395630583	36.0664311245518	0.013804096294422	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.4596635535	2609.4596635535
"AML-0024"	"2020-09-15-AML0024:GACTATGCAATAGTCC"	-2.27465448799785	-16.5193643799988	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTATGCAATAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2244.71001043506	44.5072093433098	0.0198275987260749	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2240.74396660648	2240.74396660648
"AML-0024"	"2020-09-15-AML0024:GACTCAAAGACTCATC"	-0.920021693140823	-16.4029760590759	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAAAGACTCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.86492583423	40.4224134306328	0.0149002676269267	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.0465721339	2708.0465721339
"AML-0024"	"2020-09-15-AML0024:GACTCAAAGAGAGGTA"	-0.16861523214038	-16.2327566376892	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAAAGAGAGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3051.6544662885	40.6573433659828	0.0133230494523947	3817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3043.88508162792	3043.88508162792
"AML-0024"	"2020-09-15-AML0024:GACTCAAAGATCCGAG"	-1.74235830727275	-16.3509149781433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAAAGATCCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.50890543897	35.6618703100945	0.0134954588938918	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.86069809643	2637.86069809643
"AML-0024"	"2020-09-15-AML0024:GACTCAACAATGTCTG"	-0.78616569462474	-16.5807695618835	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAACAATGTCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2977.49605981421	36.6369279106782	0.0123046100396735	3424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2968.57012405284	2968.57012405284
"AML-0024"	"2020-09-15-AML0024:GACTCAACACTATCCC"	-0.478182653815109	-16.5306940308777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAACACTATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2812.95873333461	34.8879238841747	0.0124025722349709	2629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.63874478732	2799.63874478732
"AML-0024"	"2020-09-15-AML0024:GACTCAACATACAGAA"	-2.79853616181071	-16.1597643128601	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAACATACAGAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.14394358375	41.6492516001265	0.0175133434258664	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2375.98628128351	2375.98628128351
"AML-0024"	"2020-09-15-AML0024:GACTCAAGTATACCCA"	-1.06418381157573	-15.5883636704651	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAAGTATACCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.25016130956	38.4544857367192	0.0135058331927647	2853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.79603855062	2841.79603855062
"AML-0024"	"2020-09-15-AML0024:GACTCAAGTTCAAGTC"	-2.41943798485454	-15.8180294266907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCAAGTTCAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.6249535189	32.7424749097199	0.0118734329220289	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.89063177796	2753.89063177796
"AML-0024"	"2020-09-15-AML0024:GACTCTCAGCGTTACT"	-1.47045050087627	-15.6571769944397	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCTCAGCGTTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2924.14315412656	40.0091027352231	0.0136823338073453	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2918.16643623299	2918.16643623299
"AML-0024"	"2020-09-15-AML0024:GACTCTCCATGTGGCC"	-1.52172623100932	-16.4998197785583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCTCCATGTGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3036.31583008621	38.5289143673227	0.0126893632031121	2832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3029.46632652497	3029.46632652497
"AML-0024"	"2020-09-15-AML0024:GACTCTCGTACAGAAT"	-1.01553605023082	-17.4003000489441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCTCGTACAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3078.43750570704	42.2681809479234	0.0137304008509393	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3067.42792269713	3067.42792269713
"AML-0024"	"2020-09-15-AML0024:GACTCTCTCTGGGATT"	-0.753800968558151	-16.3370218507019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTCTCTCTGGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.58512823611	34.0099597838568	0.0121222341256275	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2799.10981678368	2799.10981678368
"AML-0024"	"2020-09-15-AML0024:GACTGATCAGTTTCGA"	-1.70343420925792	-15.7056055299011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTGATCAGTTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2522.0475510119	36.8545992126454	0.0146129676253957	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.13471664945	2520.13471664945
"AML-0024"	"2020-09-15-AML0024:GACTGATCATTAGGAA"	-2.53371892395671	-15.5150394669739	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTGATCATTAGGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3140.55793729802	38.6116905636053	0.0122945321610035	3351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3127.90783793806	3127.90783793806
"AML-0024"	"2020-09-15-AML0024:GACTGATGTTGAATCC"	-1.82887909832652	-16.789143585321	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTGATGTTGAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.46688669888	38.9075127741312	0.0155787902459675	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.66081244792	2488.66081244792
"AML-0024"	"2020-09-15-AML0024:GACTGATTCATTCATC"	-1.01115796986278	-17.4001665345398	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTGATTCATTCATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2800.77612190666	49.5168829008299	0.0176797004635703	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2789.20442973816	2789.20442973816
"AML-0024"	"2020-09-15-AML0024:GACTGATTCTACTTCA"	0.0164385485345542	-16.0640936127869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTGATTCTACTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.95632650439	39.0776614959352	0.0142154537411756	2795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.33411754361	2735.33411754361
"AML-0024"	"2020-09-15-AML0024:GACTTCCAGCCGAACA"	-2.04881320419963	-15.8013677827087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTTCCAGCCGAACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.71333765988	31.8726137918869	0.0109463433022918	2635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2904.31715092934	2904.31715092934
"AML-0024"	"2020-09-15-AML0024:GACTTCCAGTCGTCTA"	-0.939589003950912	-16.4011926881042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTTCCAGTCGTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.18672723931	29.3931688142298	0.012134972289164	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2415.07898677061	2415.07898677061
"AML-0024"	"2020-09-15-AML0024:GACTTCCCAATTAGGA"	-0.786319355398971	-16.5156088105408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTTCCCAATTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.34631085581	32.9072004751579	0.0118101616970399	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.44989103759	2778.44989103759
"AML-0024"	"2020-09-15-AML0024:GACTTCCCAGTTTGGT"	-2.15936122360881	-16.6698770753113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTTCCCAGTTTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.70477100179	38.7151561918533	0.0151663273527161	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.86550013248	2546.86550013248
"AML-0024"	"2020-09-15-AML0024:GACTTCCTCGTCGCTT"	-2.41050539436992	-16.3281431428161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GACTTCCTCGTCGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.80997285302	38.5465542039936	0.0143626242520505	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.28753578045	2675.28753578045
"AML-0024"	"2020-09-15-AML0024:GAGAAATCAATGTGGG"	-0.554562072188217	-15.7470617524353	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATCAATGTGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2900.41972617142	35.0880028828355	0.0120975604207299	2730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.30828184006	2894.30828184006
"AML-0024"	"2020-09-15-AML0024:GAGAAATCAGATTCGT"	0.126498763530892	-16.256917022821	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATCAGATTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.16861856405	38.1226930320808	0.0133055670040065	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2854.44199849521	2854.44199849521
"AML-0024"	"2020-09-15-AML0024:GAGAAATCATGTCGTA"	-0.905899207026321	-16.8677664033142	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATCATGTCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2456.61256825615	41.2827427370043	0.0168047429498862	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2441.43109868219	2441.43109868219
"AML-0024"	"2020-09-15-AML0024:GAGAAATGTAGGCAAC"	-2.58625064316447	-16.0518198243347	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATGTAGGCAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.87773615143	40.9945180597686	0.0166314610491699	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2462.20992023176	2462.20992023176
"AML-0024"	"2020-09-15-AML0024:GAGAAATGTGACCTGC"	0.836204250424546	-16.2380838624206	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATGTGACCTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2864.94975509308	33.8021761957334	0.0117985232151603	3328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2850.75593051191	2850.75593051191
"AML-0024"	"2020-09-15-AML0024:GAGAAATTCGCAAGAG"	-1.29041800919231	-16.3455858460632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATTCGCAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.6105733482	38.3734344002075	0.014615051748239	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.75069901859	2619.75069901859
"AML-0024"	"2020-09-15-AML0024:GAGAAATTCTCCTGTG"	-1.13490293446239	-16.1418352357117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAAATTCTCCTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.03404789052	34.3274539294039	0.012505292586729	2616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.2589033216	2736.2589033216
"AML-0024"	"2020-09-15-AML0024:GAGACCCAGTTGCATC"	-1.15355930748637	-16.1052217713562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCAGTTGCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.56721521094	40.6563218052599	0.0147382023468842	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.24829742064	2744.24829742064
"AML-0024"	"2020-09-15-AML0024:GAGACCCCAGAGGTTG"	-0.901231090456802	-15.9201240769592	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCCAGAGGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.57568151215	39.0976279958384	0.013587002505975	2903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2866.9491751064	2866.9491751064
"AML-0024"	"2020-09-15-AML0024:GAGACCCGTAACAGTA"	-2.79703603211101	-15.4912643662659	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCGTAACAGTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.25219835892	43.512593274942	0.0167275565600265	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.55538395362	2595.55538395362
"AML-0024"	"2020-09-15-AML0024:GAGACCCGTACTTCCC"	-1.44499609890636	-16.6330480805603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCGTACTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.5678984919	35.2176312074178	0.0131577574502261	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.34244682102	2665.34244682102
"AML-0024"	"2020-09-15-AML0024:GAGACCCGTTCTCTCG"	-1.91547236862834	-16.8413877717224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCGTTCTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.72385609001	38.9198841738481	0.0151573480464185	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.78285605586	2557.78285605586
"AML-0024"	"2020-09-15-AML0024:GAGACCCGTTGGACTT"	-2.01116095009502	-16.0557966462341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCGTTGGACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.148331359	41.0124446110081	0.0149019746296728	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.04843174999	2740.04843174999
"AML-0024"	"2020-09-15-AML0024:GAGACCCTCCATAGAC"	-1.36177132549937	-16.2250395051208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACCCTCCATAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2832.54533774677	37.8308122356915	0.0133557658306663	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.33997195687	2824.33997195687
"AML-0024"	"2020-09-15-AML0024:GAGACTTAGCCTTGAT"	-1.78167663040813	-15.4479189149109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTAGCCTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2730.26618396636	38.1669883334945	0.013979218787396	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2723.41429365606	2723.41429365606
"AML-0024"	"2020-09-15-AML0024:GAGACTTAGCGTGCTC"	-0.147590766579467	-16.0486250153747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTAGCGTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.14344807081	38.4891060463412	0.0137798529727949	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.83840986337	2785.83840986337
"AML-0024"	"2020-09-15-AML0024:GAGACTTAGGACTGGT"	-0.946545879275161	-16.449809097406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTAGGACTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.35357782114	38.9487503882795	0.014863929325395	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.47112158333	2612.47112158333
"AML-0024"	"2020-09-15-AML0024:GAGACTTCAATGTTGC"	-2.30955586853679	-16.6274767152038	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTCAATGTTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.17002357167	36.5511294432481	0.0146077720933903	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.29015199295	2495.29015199295
"AML-0024"	"2020-09-15-AML0024:GAGACTTCACCGGTCA"	-1.28338215771373	-16.032048248407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTCACCGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.9702997737	43.2323202062561	0.0160002943814286	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.85277842395	2696.85277842395
"AML-0024"	"2020-09-15-AML0024:GAGACTTCACTAACCA"	0.254419152706307	-16.1853857270447	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTCACTAACCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3045.12686210791	31.8356349164854	0.0104546169529528	3342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3035.22584990041	3035.22584990041
"AML-0024"	"2020-09-15-AML0024:GAGACTTGTATCGCTA"	-1.27097640457805	-15.1035280457703	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTGTATCGCTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2787.71438400829	33.593939618687	0.0120507107225182	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2779.41359890196	2779.41359890196
"AML-0024"	"2020-09-15-AML0024:GAGACTTGTATCGTAC"	-1.52629957619365	-16.3947859040466	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTGTATCGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2053.79341874058	52.5412958342033	0.0255825612034644	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2043.96572907896	2043.96572907896
"AML-0024"	"2020-09-15-AML0024:GAGACTTGTGTCGATT"	-0.238449762493926	-16.0389604798523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTGTGTCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.15322338445	37.9305912090379	0.0144930724231678	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2609.47424437134	2609.47424437134
"AML-0024"	"2020-09-15-AML0024:GAGACTTGTGTTCCTC"	-1.63710937920268	-16.3676595917908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTGTGTTCCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.3572632696	36.3066289883333	0.0135101608872653	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.83593543644	2677.83593543644
"AML-0024"	"2020-09-15-AML0024:GAGACTTTCTTCCTAA"	-1.01862440529521	-15.9693994752136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGACTTTCTTCCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.87172863863	34.188371095256	0.0120259984827483	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2838.47646526516	2838.47646526516
"AML-0024"	"2020-09-15-AML0024:GAGAGGTAGTATGTAG"	-2.23630009117778	-15.9971895447937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTAGTATGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.5736219009	39.7380103083842	0.0151580752783018	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.32129759431	2611.32129759431
"AML-0024"	"2020-09-15-AML0024:GAGAGGTCAATACGAA"	-2.04925642433818	-16.7078161469665	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTCAATACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.2103592393	39.5747954764079	0.0154697190297422	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.06714173825	2553.06714173825
"AML-0024"	"2020-09-15-AML0024:GAGAGGTCACTTACAG"	-1.6306623024052	-16.1561117402283	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTCACTTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.19459883298	35.2731964628983	0.0127147520501037	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2765.05014092884	2765.05014092884
"AML-0024"	"2020-09-15-AML0024:GAGAGGTGTCTCGCGA"	-2.17785773697551	-15.8118105164734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTGTCTCGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1890.52375926254	48.9325050753103	0.0258830415833536	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1884.97980216166	1884.97980216166
"AML-0024"	"2020-09-15-AML0024:GAGAGGTGTGTCTAAC"	1.31450726565663	-16.1859903565613	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTGTGTCTAAC"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3074.6323906168	37.1941290750952	0.0120970979127796	4667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	3062.73995401028	3062.73995401028
"AML-0024"	"2020-09-15-AML0024:GAGAGGTTCAAACTGC"	-0.166941459209281	-16.377709411737	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTTCAAACTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2838.20682547558	38.3511485181659	0.0135124572930796	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.23794701349	2830.23794701349
"AML-0024"	"2020-09-15-AML0024:GAGAGGTTCGACATCA"	-0.487387935549575	-16.3610010377136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGAGGTTCGACATCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2801.13215736686	38.3693471099834	0.0136977996589963	2938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.94293747747	2794.94293747747
"AML-0024"	"2020-09-15-AML0024:GAGATGGCATGGCCAC"	-1.21755443039592	-15.9188566437927	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGCATGGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.97803607996	36.7376849845716	0.0132246131925552	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.89195873877	2772.89195873877
"AML-0024"	"2020-09-15-AML0024:GAGATGGGTATTTCTC"	-1.21283934536632	-16.4791403046814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGGTATTTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.4608767891	36.661283919541	0.0125920578949949	2632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.99374574724	2902.99374574724
"AML-0024"	"2020-09-15-AML0024:GAGATGGGTGAGTTTC"	-0.226133595139343	-16.1648302308288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGGTGAGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.6185400983	37.0201389570548	0.0136776344389152	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.63606095578	2694.63606095578
"AML-0024"	"2020-09-15-AML0024:GAGATGGGTTCAAGTC"	-0.590853671461898	-16.1094827882019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGGTTCAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.25162008934	36.0253919556536	0.0139349654307183	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.00460940127	2579.00460940127
"AML-0024"	"2020-09-15-AML0024:GAGATGGTCAACGCTA"	-0.694052259356338	-15.7996521226135	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGTCAACGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.16710925512	40.6459125485207	0.0149369409950155	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.57556381167	2714.57556381167
"AML-0024"	"2020-09-15-AML0024:GAGATGGTCAAGAAAC"	-1.40931425514873	-16.4771661988464	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGTCAAGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.92387615093	34.9754134094885	0.0135096337639282	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.37059368355	2584.37059368355
"AML-0024"	"2020-09-15-AML0024:GAGATGGTCAGCTAGT"	-0.603469650179702	-15.9978590241638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGTCAGCTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.44450748385	32.1463339726681	0.0122441490882914	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.35423320128	2617.35423320128
"AML-0024"	"2020-09-15-AML0024:GAGATGGTCGAGAGCA"	-1.11558983746226	-15.9913645020691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGTCGAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.2080233612	34.7518556514046	0.0128510289708444	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.8324774152	2699.8324774152
"AML-0024"	"2020-09-15-AML0024:GAGATGGTCTAAGCCA"	-0.275824318558532	-15.9046030274597	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGATGGTCTAAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2999.25016219945	37.4230218171457	0.0124774592959269	3542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2986.42504287851	2986.42504287851
"AML-0024"	"2020-09-15-AML0024:GAGCCTGAGAGTGAAG"	-1.83743582192119	-15.9459886780945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGAGAGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3077.23053858326	35.4937348097408	0.0115343112466582	3416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3069.3658937174	3069.3658937174
"AML-0024"	"2020-09-15-AML0024:GAGCCTGAGCTAGCCC"	-1.33830521526988	-17.0353994599548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGAGCTAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.97714078101	42.5905430289798	0.0173486515705113	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2446.58719433337	2446.58719433337
"AML-0024"	"2020-09-15-AML0024:GAGCCTGCACGATAGG"	-0.457398991019088	-16.3673181763855	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGCACGATAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2421.01855859263	41.544425826807	0.0171598956477878	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2414.69068727419	2414.69068727419
"AML-0024"	"2020-09-15-AML0024:GAGCCTGGTACAATAG"	-2.54024086418803	-15.6342735520569	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGGTACAATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.96520243521	39.8745876179162	0.0153720595713782	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.98464634501	2586.98464634501
"AML-0024"	"2020-09-15-AML0024:GAGCCTGGTCTAGGTT"	-0.968246678740341	-15.6803798905578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGGTCTAGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.36825715138	35.6804277959753	0.0136897108449948	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.91837222795	2601.91837222795
"AML-0024"	"2020-09-15-AML0024:GAGCCTGGTTGGTGTT"	-1.7816917699879	-16.5267248383728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGGTTGGTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2304.72769919881	45.3995824474029	0.0196984582877991	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.72824752886	2294.72824752886
"AML-0024"	"2020-09-15-AML0024:GAGCCTGTCGAACACT"	-1.09553633156474	-15.6482725373474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGTCGAACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2690.39690675455	39.0891789480602	0.0145291495280575	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.6709892082	2680.6709892082
"AML-0024"	"2020-09-15-AML0024:GAGCCTGTCGGCATAT"	-1.52896068516429	-16.1316766968933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCCTGTCGGCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.04764173216	30.5892228242493	0.011159683019927	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.24716566278	2734.24716566278
"AML-0024"	"2020-09-15-AML0024:GAGCTGCAGATTAGTG"	-0.927620152861434	-17.4885549775329	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCTGCAGATTAGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2922.83558963674	45.0078607549765	0.0153986973863864	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2912.75415244302	2912.75415244302
"AML-0024"	"2020-09-15-AML0024:GAGCTGCAGTCAGGGT"	-1.41530774059947	-15.6194620362488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCTGCAGTCAGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.33304514843	39.5997299011759	0.0147247400141139	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.78019297469	2682.78019297469
"AML-0024"	"2020-09-15-AML0024:GAGCTGCGTTACCGTA"	-1.09484074536021	-15.9187774888244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCTGCGTTACCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.6124630698	37.5832598412937	0.0144129008330666	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.92759394425	2596.92759394425
"AML-0024"	"2020-09-15-AML0024:GAGCTGCTCCATTCGC"	-1.60014400902446	-15.8050852051941	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGCTGCTCCATTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.59886662737	34.3331431297348	0.0126569186296321	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2705.07083583915	2705.07083583915
"AML-0024"	"2020-09-15-AML0024:GAGGCAAAGATGTTCC"	-1.9110657972401	-15.6040067902771	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCAAAGATGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.69560248529	31.3317291186535	0.0124396648359323	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.50043319117	2515.50043319117
"AML-0024"	"2020-09-15-AML0024:GAGGCAAAGTCGGCAA"	-0.701560120016891	-15.9158087006775	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCAAAGTCGGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.14404880843	39.563891315479	0.0158119958498473	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2499.42513118913	2499.42513118913
"AML-0024"	"2020-09-15-AML0024:GAGGCAACACTCATAG"	-1.05946646156963	-15.887703918573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCAACACTCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.70767002477	34.8223966550819	0.0130974898247303	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.9092989663	2650.9092989663
"AML-0024"	"2020-09-15-AML0024:GAGGCCTCAGTCAGCC"	-1.46779618683513	-16.0046167603699	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCCTCAGTCAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.33561137252	34.9996776352212	0.0128517680630563	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.94681569715	2720.94681569715
"AML-0024"	"2020-09-15-AML0024:GAGGCCTTCGTTAGTG"	-2.05741653862651	-15.5678911439148	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCCTTCGTTAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2729.5684651726	32.9281983230938	0.0120635180041222	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.37789390699	2722.37789390699
"AML-0024"	"2020-09-15-AML0024:GAGGCCTTCTAGTTCT"	-1.93302140656169	-16.7252092591492	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCCTTCTAGTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.72237585637	50.1897874573462	0.0206396042392262	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2427.80797445435	2427.80797445435
"AML-0024"	"2020-09-15-AML0024:GAGGCCTTCTGCTTAT"	-0.710466722876388	-16.7146101227966	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGCCTTCTGCTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.71986573457	36.5550180217882	0.0136566468870124	2593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.76687195749	2668.76687195749
"AML-0024"	"2020-09-15-AML0024:GAGGGATCATAGGTAA"	-0.220012704760391	-16.2626772156921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATCATAGGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.83332046075	33.9603120229585	0.0117597895219036	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.61441418526	2879.61441418526
"AML-0024"	"2020-09-15-AML0024:GAGGGATGTAGTATAG"	-0.837676028639633	-16.2212782136169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATGTAGTATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.90954531234	33.9979163494489	0.0130314661198339	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.27530289582	2603.27530289582
"AML-0024"	"2020-09-15-AML0024:GAGGGATGTTCCTACC"	-2.24952397766765	-16.7316637269226	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATGTTCCTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.13466163737	39.0639521526469	0.0176350236530414	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2203.59950600184	2203.59950600184
"AML-0024"	"2020-09-15-AML0024:GAGGGATTCGAGCCAC"	-0.964899520308334	-17.4977407685486	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATTCGAGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3218.03909276265	41.5133103300574	0.0129001883238213	3149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3206.61491244501	3206.61491244501
"AML-0024"	"2020-09-15-AML0024:GAGGGATTCTACTGCC"	1.09277762946431	-16.2245626679626	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATTCTACTGCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2672.26389014051	43.4849133912931	0.0162726868224854	3333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2659.19189444888	2659.19189444888
"AML-0024"	"2020-09-15-AML0024:GAGGGATTCTCCGCAT"	-0.810256819159347	-16.054280304071	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATTCTCCGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.24389094977	34.0967793032166	0.0126931063177443	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.73682067422	2681.73682067422
"AML-0024"	"2020-09-15-AML0024:GAGGGATTCTTCGATT"	-0.662311772734481	-16.4462061158386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGATTCTTCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.24459937542	35.8460705465193	0.0129163644006682	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.45535279266	2763.45535279266
"AML-0024"	"2020-09-15-AML0024:GAGGGTAAGGTAAGTT"	-2.51416144791301	-15.7740736237732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTAAGGTAAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.69899830498	36.3068629462791	0.0137907383144274	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.14720995441	2623.14720995441
"AML-0024"	"2020-09-15-AML0024:GAGGGTAAGTTCAACC"	-1.53596697273906	-15.7071867219177	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTAAGTTCAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.44642020165	32.3500694688563	0.0119441423051846	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.51793641187	2700.51793641187
"AML-0024"	"2020-09-15-AML0024:GAGGGTACACCCTATC"	-0.148514280945617	-16.1638708344665	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTACACCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.51527874364	37.9721128914199	0.0131141124241955	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2890.36432918092	2890.36432918092
"AML-0024"	"2020-09-15-AML0024:GAGGGTAGTACTCCGG"	-1.59670494023021	-16.598267578241	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTAGTACTCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.35285185627	37.9530846738735	0.0138547630503881	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.37465967984	2734.37465967984
"AML-0024"	"2020-09-15-AML0024:GAGGGTAGTATATGGA"	-1.95343957367595	-16.6993475190369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTAGTATATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1811.12950408317	45.149179788539	0.0249287418082201	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1803.75691390637	1803.75691390637
"AML-0024"	"2020-09-15-AML0024:GAGGGTAGTTACCCAA"	-2.22723660889323	-16.0026560059753	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTAGTTACCCAA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.60176276527	39.7137228945108	0.0168664287619791	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2347.93546019458	2347.93546019458
"AML-0024"	"2020-09-15-AML0024:GAGGGTATCAGTCTTT"	-1.23497937145885	-15.8960943452087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTATCAGTCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2077.78005360401	29.3987202374644	0.0141491011940706	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2075.36965648688	2075.36965648688
"AML-0024"	"2020-09-15-AML0024:GAGGGTATCATTTGGG"	-2.82706866684611	-15.7052984467712	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTATCATTTGGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.75663078135	47.4271916370415	0.0179869431571269	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2632.45104416659	2632.45104416659
"AML-0024"	"2020-09-15-AML0024:GAGGGTATCGGCATTA"	-1.83776400509532	-16.4891004792419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTATCGGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.88725402778	33.1337791190576	0.0144632954156965	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2283.93311213007	2283.93311213007
"AML-0024"	"2020-09-15-AML0024:GAGGGTATCGGCTCTT"	-1.67793951454814	-16.6895456544128	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGGGTATCGGCTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2757.60388781655	38.6728625221309	0.0140240818099339	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.07232447009	2751.07232447009
"AML-0024"	"2020-09-15-AML0024:GAGTCATAGCCGCACT"	-0.226861606270629	-16.5021238557068	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATAGCCGCACT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2229.96377608694	45.995888233506	0.0206262939007098	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2226.64270249098	2226.64270249098
"AML-0024"	"2020-09-15-AML0024:GAGTCATAGCGTCGAA"	-1.1889205974644	-16.6502676240173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATAGCGTCGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.38354776312	38.9474950707763	0.0171394899901978	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2269.63930070468	2269.63930070468
"AML-0024"	"2020-09-15-AML0024:GAGTCATAGTGCTAGG"	-2.26420531693156	13.6661929854187	"2020-09-15-AML0024"	"AML0024"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATAGTGCTAGG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1931.16311494568	34.9300860173494	0.0180875896743357	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1926.25294048404	1926.25294048404
"AML-0024"	"2020-09-15-AML0024:GAGTCATCAGCTATAC"	-2.43801079216655	-15.8122053376404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATCAGCTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.58065360581	45.5301524731569	0.0191336874436949	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2373.06413939612	2373.06413939612
"AML-0024"	"2020-09-15-AML0024:GAGTCATCATCGAGCC"	-2.58076582375224	-16.2096395722595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATCATCGAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.22774306279	42.4267603553508	0.0179225511696892	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2361.51053144066	2361.51053144066
"AML-0024"	"2020-09-15-AML0024:GAGTCATTCCGCACTT"	-2.84944901886638	-15.7688150635925	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCATTCCGCACTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.79864858429	37.4830292818019	0.0134792316951407	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.24618204085	2771.24618204085
"AML-0024"	"2020-09-15-AML0024:GAGTCTACAAAGTATG"	-1.9063061279362	-15.9820947877136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCTACAAAGTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.05800052092	49.7650228754609	0.0197554097067911	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2514.04363189662	2514.04363189662
"AML-0024"	"2020-09-15-AML0024:GAGTCTACAATCTGCA"	-2.08836732330974	-16.3145513764587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCTACAATCTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.841845444	32.7827329663399	0.0124751544782563	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.78129108386	2623.78129108386
"AML-0024"	"2020-09-15-AML0024:GAGTCTACACCAAAGG"	0.605984528630418	-16.1687078705994	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCTACACCAAAGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2798.121252795	44.5674692289693	0.015927640442476	2730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2795.57686050009	2795.57686050009
"AML-0024"	"2020-09-15-AML0024:GAGTCTACATTGAAGA"	-1.52382300320323	-16.8627710572449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCTACATTGAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2244.66786368927	38.2285447508762	0.0170308246352513	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2242.56609837666	2242.56609837666
"AML-0024"	"2020-09-15-AML0024:GAGTCTATCTAGTCAG"	0.0258736210757911	-16.3079252473083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTCTATCTAGTCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.25709541101	33.0167083879612	0.0116697448392066	2791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2822.38454268635	2822.38454268635
"AML-0024"	"2020-09-15-AML0024:GAGTGAGAGAATGTTG"	-0.338176558644134	-16.4061594239441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGAGAATGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.20677513971	35.9430485049968	0.013770192019777	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2603.09748034324	2603.09748034324
"AML-0024"	"2020-09-15-AML0024:GAGTGAGAGTAAAGCT"	-0.903588275343734	-15.964364074823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGAGTAAAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.94074588747	35.287243353429	0.0136089663481112	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.86085224043	2586.86085224043
"AML-0024"	"2020-09-15-AML0024:GAGTGAGCAACCAATC"	-0.701467852026779	-15.8459644547668	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGCAACCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.19675512474	38.4781816626753	0.0144318612603199	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.77064995265	2659.77064995265
"AML-0024"	"2020-09-15-AML0024:GAGTGAGCAAGACAAT"	-1.70987627926524	-16.3441820374695	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGCAAGACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.30517964521	32.5256143704545	0.0124413991999467	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.79730625688	2610.79730625688
"AML-0024"	"2020-09-15-AML0024:GAGTGAGCACCCTGTT"	-1.72054801407512	-15.1727609864441	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGCACCCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.9012014296	31.4071597461808	0.0111337326278085	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2811.26350635555	2811.26350635555
"AML-0024"	"2020-09-15-AML0024:GAGTGAGGTAGGCAAC"	-2.15640411797221	-15.9335384598938	"2020-09-15-AML0024"	"AML0024"	"CD11c+"	"CD11c+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGGTAGGCAAC"	"CD11c+"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.2118382717	33.0215592224478	0.0135711813920414	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2427.18602657938	2427.18602657938
"AML-0024"	"2020-09-15-AML0024:GAGTGAGGTGGTTTAC"	-0.384300033480483	-16.2715692750183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGGTGGTTTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.48277256076	41.2690260330716	0.0146267155817564	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.95108307657	2812.95108307657
"AML-0024"	"2020-09-15-AML0024:GAGTGAGGTTACGCCG"	-0.489995817572433	-16.5712423554626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGAGGTTACGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.1754626485	35.2086946239447	0.0134119395540987	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2618.64045793127	2618.64045793127
"AML-0024"	"2020-09-15-AML0024:GAGTGTTAGCCAAGCA"	-2.90755949440654	-15.5674152604309	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGTTAGCCAAGCA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.85986420377	35.8419732930944	0.0129259951993234	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.59823463544	2766.59823463544
"AML-0024"	"2020-09-15-AML0024:GAGTGTTAGCGTGAAC"	8.42676987227742	7.90742824161378	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGTTAGCGTGAAC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1552.97178013949	41.9450908636699	0.0270095641144891	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1550.81584372796	1550.81584372796
"AML-0024"	"2020-09-15-AML0024:GAGTGTTGTCCAGAAG"	-1.24814198437389	-16.9671373597351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGTTGTCCAGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.84109293577	39.4249474344048	0.0176964809381678	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2223.57083354091	2223.57083354091
"AML-0024"	"2020-09-15-AML0024:GAGTGTTTCCTACAAG"	-1.26050446453746	-15.9042282334534	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTGTTTCCTACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.30171619333	42.8635998242396	0.0163770189577461	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.54570901386	2608.54570901386
"AML-0024"	"2020-09-15-AML0024:GAGTTACAGACTACCT"	-1.15456018868144	-16.5926275483337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACAGACTACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2897.96594439998	34.6029534645876	0.0119404279168478	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2885.71897559133	2885.71897559133
"AML-0024"	"2020-09-15-AML0024:GAGTTACAGTAACCGG"	-2.30430374565776	-15.7442655793396	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACAGTAACCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2903.07335612077	35.9030733839888	0.0123672635788867	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.06767281112	2894.06767281112
"AML-0024"	"2020-09-15-AML0024:GAGTTACAGTCATGAA"	-1.966371635825	-16.4688387147156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACAGTCATGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.81722541182	40.9979181593383	0.0166602857522168	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.01270950706	2450.01270950706
"AML-0024"	"2020-09-15-AML0024:GAGTTACCAAAGAGTT"	-1.0295983356541	-16.1396284333435	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACCAAAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.57280759015	33.6269740793949	0.013117229976786	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2557.52592826546	2557.52592826546
"AML-0024"	"2020-09-15-AML0024:GAGTTACCAAATCAAG"	-0.345678727061111	-15.8153286210266	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACCAAATCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.54461051088	35.7800394603948	0.0125564061458859	2723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2843.13319281914	2843.13319281914
"AML-0024"	"2020-09-15-AML0024:GAGTTACGTAAGGAGA"	-1.41804931584056	-16.2024755707947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACGTAAGGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.76082500403	31.2486741047007	0.012989102565775	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2394.14101057249	2394.14101057249
"AML-0024"	"2020-09-15-AML0024:GAGTTACGTCGAGCTC"	-1.20605550232585	-15.5216388932434	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACGTCGAGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.6627404448	35.9955368852962	0.012838754236034	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2798.56183583665	2798.56183583665
"AML-0024"	"2020-09-15-AML0024:GAGTTACGTCGCATGC"	-0.345767359167892	-16.2813749543396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACGTCGCATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.49417290006	28.0767213093687	0.011117317794928	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2523.30644540696	2523.30644540696
"AML-0024"	"2020-09-15-AML0024:GAGTTACTCGTTACCC"	-2.27674446526225	-16.6701441041199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTACTCGTTACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2247.9484690781	39.6636677445359	0.0176443847757784	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2235.25778398924	2235.25778398924
"AML-0024"	"2020-09-15-AML0024:GAGTTGTAGGACAAGA"	0.022636485367459	-16.0727758637634	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.GAGTTGTAGGACAAGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2895.50851449217	40.2627558427379	0.0139052451896518	2888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2886.1312950371	2886.1312950371
"AML-0024"	"2020-09-15-AML0024:TGTTCTACAGATACCT"	-1.07613263550456	-15.7710733643738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTACAGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.38966859168	32.8847513691264	0.013519524356542	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2427.12175692192	2427.12175692192
"AML-0024"	"2020-09-15-AML0024:TGTTCTATCATGCAGT"	-1.17552302303966	-16.5099554291931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTATCATGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.77887014012	45.2897006997439	0.0164882951416593	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.75680700586	2743.75680700586
"AML-0024"	"2020-09-15-AML0024:TGTTGAGCACCATAAC"	-1.89757821980174	-16.567650817987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGAGCACCATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.45346554085	37.8434761702209	0.0133043048967669	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.6644150183	2834.6644150183
"AML-0024"	"2020-09-15-AML0024:TGTTGAGGTGGCTACC"	-2.75362215462382	-15.7920856705871	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGAGGTGGCTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.46980871745	37.8050072119634	0.0143283834770655	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.18126684277	2634.18126684277
"AML-0024"	"2020-09-15-AML0024:TGTTGAGGTGTTTCTT"	-1.97480950775798	-16.7783346406189	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGAGGTGTTTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.21825146821	34.2749209373331	0.0121231959787801	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2819.98325432513	2819.98325432513
"AML-0024"	"2020-09-15-AML0024:TGTTGAGTCCCTTTGG"	-1.29429231110271	-15.5834303132263	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGAGTCCCTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.10879839993	38.1373575950774	0.0152603830691545	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.38151018511	2495.38151018511
"AML-0024"	"2020-09-15-AML0024:TGTTGAGTCTGCATAG"	0.618975301354569	-16.294011139032	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGAGTCTGCATAG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2001.06402240742	49.817315741076	0.0248954132317777	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	1995.12793220469	1995.12793220469
"AML-0024"	"2020-09-15-AML0024:TGTTGGACAGTAGTTC"	-2.09357200089152	-16.1547022095886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGGACAGTAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2792.73583145722	36.87050076052	0.0132022872858982	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2789.4648670759	2789.4648670759
"AML-0024"	"2020-09-15-AML0024:TGTTGGAGTAGGAGTC"	-2.18697295609172	-16.5897035828796	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGGAGTAGGAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.81859614237	42.3544002968858	0.0166761517382447	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.38539522239	2528.38539522239
"AML-0024"	"2020-09-15-AML0024:TGTTGGAGTGGACCTC"	-1.06098876419719	-16.2649069062439	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	21	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.269230769230769	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGGAGTGGACCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1790.04449782569	48.857713591206	0.0272941335539714	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1788.03703530637	1788.03703530637
"AML-0024"	"2020-09-15-AML0024:TGTTGGATCACAGAGG"	-2.70119772377666	-15.7747593156067	"2020-09-15-AML0024"	"AML0024"	"CD11c+"	"CD11c+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTGGATCACAGAGG"	"CD11c+"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.53066690868	33.8063980072043	0.0153908153965282	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2182.42929877768	2182.42929877768
"AML-0024"	"2020-09-15-AML0024:TGTTTGTAGCGCCTCA"	-1.540186504752	-15.4787407151428	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTTGTAGCGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2780.101161345	31.2181022257267	0.0112291245584112	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.20216079208	2772.20216079208
"AML-0024"	"2020-09-15-AML0024:TGTTTGTCAGCTGAAG"	-1.48493001881297	-15.5823173752991	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTTGTCAGCTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.46652238272	33.1115584819173	0.012225205003748	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2701.16612483406	2701.16612483406
"AML-0024"	"2020-09-15-AML0024:TGTTTGTGTTGGAGAC"	-0.302767942578155	-16.4215498200622	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTTGTGTTGGAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2570.88446090925	38.9054630907701	0.0151331044558145	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2559.97384340266	2559.97384340266
"AML-0024"	"2020-09-15-AML0024:TGTTTGTTCGAAGAAT"	-1.00815294209178	-17.3956022492615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTTGTTCGAAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.57726216385	44.8195376227181	0.0172676569008597	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2586.41472557184	2586.41472557184
"AML-0024"	"2020-09-15-AML0024:TGTTTGTTCGAGTTGT"	-0.808786491782028	-15.8518495789734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTTGTTCGAGTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3005.26689118945	39.1678729079324	0.013033076370941	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2997.90491975338	2997.90491975338
"AML-0024"	"2020-09-15-AML0024:TTAATCCCAAGAAACT"	-2.65211329880412	-15.619616531488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAATCCCAAGAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.05330153195	36.9683999763932	0.0135711000792837	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.01952794547	2720.01952794547
"AML-0024"	"2020-09-15-AML0024:TTAATCCGTAGGCAGT"	-1.06975684586223	-15.561589264032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAATCCGTAGGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.89322883582	43.0291896610444	0.015269985825127	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.04905376098	2810.04905376098
"AML-0024"	"2020-09-15-AML0024:TTAATCCGTCATGACT"	-2.82969699326213	-15.8479881516662	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAATCCGTCATGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.84789354524	38.1056089088422	0.0147704866648077	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.10858746505	2576.10858746505
"AML-0024"	"2020-09-15-AML0024:TTAATCCTCAGCGCAC"	-0.747112314135391	-15.9875326386658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAATCCTCAGCGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.65424349617	31.2682044687716	0.0114007095655313	2447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.69956974759	2735.69956974759
"AML-0024"	"2020-09-15-AML0024:TTAATCCTCTGAATCG"	1.93910576876943	-10.7510233155456	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	33	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.333333333333333	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAATCCTCTGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.43790592847	50.9436598967889	0.0232785493976241	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2179.1503779496	2179.1503779496
"AML-0024"	"2020-09-15-AML0024:TTACAGGAGAAACTAC"	-1.96291718903239	-16.388529800531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGAGAAACTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2413.53261410534	38.3599971521783	0.0158937140223389	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.19730585016	2409.19730585016
"AML-0024"	"2020-09-15-AML0024:TTACAGGAGCACCTGC"	9.13295616683308	7.83919475162355	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGAGCACCTGC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1987.23583627429	45.5528361297182	0.0229227126937895	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1983.16517708329	1983.16517708329
"AML-0024"	"2020-09-15-AML0024:TTACAGGAGCTAGATA"	-2.97489724579509	-16.0253248444763	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGAGCTAGATA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.59136314522	41.3209992978123	0.0166309035404134	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2482.62578233044	2482.62578233044
"AML-0024"	"2020-09-15-AML0024:TTACAGGAGGCTAAAT"	-1.88816736164745	-15.5175009003845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGAGGCTAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.10310355408	41.6774305866455	0.0161408855166471	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2576.84844676412	2576.84844676412
"AML-0024"	"2020-09-15-AML0024:TTACAGGCACTCAAGT"	1.07219340380971	-16.2177953950134	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGCACTCAAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2715.42313809759	41.2168653148683	0.0151788002159194	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2703.96172293985	2703.96172293985
"AML-0024"	"2020-09-15-AML0024:TTACAGGCAGAACATA"	-2.85420046272929	-15.6792745820251	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGCAGAACATA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2973.97202678658	35.0117817399738	0.011772734048815	2993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2963.66600692958	2963.66600692958
"AML-0024"	"2020-09-15-AML0024:TTACAGGGTGAATAAC"	-1.42440197888072	-16.5545053712097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGGTGAATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2752.34510719321	31.1016375300596	0.0113000500732179	2632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.56068260698	2744.56068260698
"AML-0024"	"2020-09-15-AML0024:TTACAGGGTGCTCTCT"	-0.0665083331173242	-16.3973093262878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACAGGGTGCTCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.3744355446	35.3284061742062	0.0127384192056522	3226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.99248585943	2766.99248585943
"AML-0024"	"2020-09-15-AML0024:TTACCATAGGAAAGAC"	-0.883851806551772	-16.8487406007019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATAGGAAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2961.4035035532	35.9650578866579	0.012144598952323	2866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.33838011986	2947.33838011986
"AML-0024"	"2020-09-15-AML0024:TTACCATAGGCGAAGG"	-0.848853151232559	-16.0041437379089	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATAGGCGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.70241004248	34.5357701873771	0.0126333320190622	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.97127961355	2727.97127961355
"AML-0024"	"2020-09-15-AML0024:TGCAGATAGCGCTGAA"	-1.70051358166392	-16.6740694276062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGATAGCGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.22973891005	45.4663087333889	0.0173454116052775	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2608.0440416781	2608.0440416781
"AML-0024"	"2020-09-15-AML0024:TGCAGATCATGGATCT"	-2.34863028946574	-16.3463926545349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGATCATGGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.40356818539	32.4538243929196	0.0136394787445284	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2371.55824656511	2371.55824656511
"AML-0024"	"2020-09-15-AML0024:TGCAGATGTATTGCCA"	-1.95369086685832	-15.8097191086975	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGATGTATTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.97081564317	33.3158609936236	0.011620579048744	2656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.64318053607	2858.64318053607
"AML-0024"	"2020-09-15-AML0024:TGCAGATGTCGATTCA"	-0.416674534708816	-15.9324674836365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGATGTCGATTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.21221533568	36.737263659219	0.0134018312970053	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.30344802931	2735.30344802931
"AML-0024"	"2020-09-15-AML0024:TGCAGGCAGCAAGCCA"	0.00161421400253173	-16.0712690583435	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCAGCAAGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2930.39698868139	38.7006157382054	0.0132066118985536	3004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.1534887868	2922.1534887868
"AML-0024"	"2020-09-15-AML0024:TGCAGGCAGCGACTAG"	-1.58513698998149	-16.4747152558533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCAGCGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.00754682363	35.9259036392091	0.013345394845419	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2689.28705996364	2689.28705996364
"AML-0024"	"2020-09-15-AML0024:TGCAGGCAGGAAACGA"	-2.46164856377299	-16.1077852479187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCAGGAAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2766.72742054485	35.2980432610841	0.0127580487325827	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.85687282878	2751.85687282878
"AML-0024"	"2020-09-15-AML0024:TGCAGGCAGTGCACCC"	-1.97163782540019	-16.4045305482117	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCAGTGCACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.90682277738	34.3314760263387	0.0135008784902475	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2537.3825780711	2537.3825780711
"AML-0024"	"2020-09-15-AML0024:TGCAGGCCATGACGTT"	-2.65968571129497	-16.4305067292419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCCATGACGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2102.40067180706	47.9946218662345	0.0228284848410851	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2084.35348240489	2084.35348240489
"AML-0024"	"2020-09-15-AML0024:TGCAGGCGTAGCTGTT"	-2.82704792442973	9.53309056842653	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCGTAGCTGTT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1623.10427919768	40.7076175548714	0.025080099952046	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1623.10427919768	1623.10427919768
"AML-0024"	"2020-09-15-AML0024:TGCAGGCGTAGGTACG"	1.20770802077596	-16.2141008607117	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCGTAGGTACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3061.3727312095	40.9697552500123	0.0133828053122515	4309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3048.66515959531	3048.66515959531
"AML-0024"	"2020-09-15-AML0024:TGCAGGCTCCAGTGTA"	-0.825759570032913	-16.0985460511413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCTCCAGTGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.95791706474	31.1341792701977	0.0125847651067312	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.40670709152	2468.40670709152
"AML-0024"	"2020-09-15-AML0024:TGCAGGCTCTTCTGGC"	-0.73129508915599	-16.3791094056335	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGGCTCTTCTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.73303604364	35.9089319204533	0.0130023182732735	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.19745736094	2755.19745736094
"AML-0024"	"2020-09-15-AML0024:TGCAGTACAAGAGATT"	-2.44677267494853	-16.4880304566589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGTACAAGAGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.73044498909	35.9771563723592	0.0134056519869698	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2675.33716861348	2675.33716861348
"AML-0024"	"2020-09-15-AML0024:TGCAGTACAATGGCAG"	-1.06215522709544	-16.2960424653259	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGTACAATGGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2706.74075747649	38.3992675838521	0.0141865331867437	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2696.8094435653	2696.8094435653
"AML-0024"	"2020-09-15-AML0024:TGCAGTAGTCCATCTC"	-2.14442406120952	-16.3959627381531	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCAGTAGTCCATCTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.90457348698	36.3461005395013	0.0129858305580672	2767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2793.41928438642	2793.41928438642
"AML-0024"	"2020-09-15-AML0024:TGCATCCAGCGATCGA"	-2.69290290299113	-15.8780727616516	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCAGCGATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.38814297259	32.4740274555492	0.012956503782784	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.15757432448	2500.15757432448
"AML-0024"	"2020-09-15-AML0024:TGCATCCAGCGGTAAC"	-1.17780600014384	-16.8974447480408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCAGCGGTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.00824403475	33.2949189715311	0.0126982510628178	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.74398803454	2610.74398803454
"AML-0024"	"2020-09-15-AML0024:TGCATCCCACCTCTGT"	-2.48850355568584	-16.0137243500915	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCCACCTCTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2943.24168223383	34.8344195554308	0.0118353921683361	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2931.33935155816	2931.33935155816
"AML-0024"	"2020-09-15-AML0024:TGCATCCCACGGTGTC"	-1.52233300629314	-15.8243885270325	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCCACGGTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2976.76723901383	37.7376247485937	0.0126773851357944	3159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2970.7097002518	2970.7097002518
"AML-0024"	"2020-09-15-AML0024:TGCATCCCACTCAGAT"	-0.808157066733199	-16.1673135987488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCCACTCAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.13777434771	33.3675215987188	0.0124128762733582	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.20602523471	2681.20602523471
"AML-0024"	"2020-09-15-AML0024:TGCATCCCATAGGCGA"	-1.92247603359874	-16.7733736268249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCCATAGGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.13146178428	37.9239622133861	0.0144355022826414	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.06735112372	2620.06735112372
"AML-0024"	"2020-09-15-AML0024:TGCATCCGTCCGCAGT"	-1.33067880097087	-15.7050495377746	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCGTCCGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.06462662878	42.761579950339	0.0159972114120822	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.36584623405	2668.36584623405
"AML-0024"	"2020-09-15-AML0024:TGCATCCGTTTGGGAG"	-2.34772072258647	-16.486918472406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCGTTTGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.72425393504	39.0485711282364	0.0151425927253174	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2568.47779453954	2568.47779453954
"AML-0024"	"2020-09-15-AML0024:TGCATCCTCTCTGCCA"	0.141793315380257	-16.4326238862244	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATCCTCTCTGCCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2828.76224175975	35.1112675264803	0.0124122370583672	2753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2819.21719375489	2819.21719375489
"AML-0024"	"2020-09-15-AML0024:TGCATGAGTAGTCACT"	-1.27142618122752	-15.5896749726501	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATGAGTAGTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.17381680249	33.4363987832295	0.0121138743435962	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.18843692094	2752.18843692094
"AML-0024"	"2020-09-15-AML0024:TGCATGAGTTAAGGGC"	-1.36951289597209	-16.6932420960632	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCATGAGTTAAGGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.77806178548	40.5321921460436	0.0159778235063715	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2528.25674741652	2528.25674741652
"AML-0024"	"2020-09-15-AML0024:TGCCGAGAGTAAACGT"	-1.95368943634685	-15.5249243012634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGAGTAAACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.96582305579	35.7118357016306	0.0133954589337897	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2658.18308561745	2658.18308561745
"AML-0024"	"2020-09-15-AML0024:TGCCGAGAGTATGATG"	-1.92259190502818	-16.508252166864	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGAGTATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.8296428919	31.6230531216756	0.0120660467983649	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.89043347967	2610.89043347967
"AML-0024"	"2020-09-15-AML0024:TGCCGAGCAAATACGA"	-1.35477016392406	-15.1111936799255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGCAAATACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.90192322217	40.0283868944335	0.0152031439308026	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.82642757014	2624.82642757014
"AML-0024"	"2020-09-15-AML0024:TGCCGAGCAAGGACAC"	-2.23191223564799	-15.7438898316589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGCAAGGACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.83667947248	33.8172897784238	0.0121783502891672	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.68817993347	2770.68817993347
"AML-0024"	"2020-09-15-AML0024:TGCCGAGGTCCCGTGA"	-1.86927328530009	-15.3639812699524	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGGTCCCGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.29652380933	37.4851289019832	0.012844866378778	2647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2911.36978195411	2911.36978195411
"AML-0024"	"2020-09-15-AML0024:TGCCGAGTCAGAGCAG"	-0.0452759665554345	-15.8430996171203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGTCAGAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.35678041507	36.1270451934192	0.0131881489303285	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.98682457478	2732.98682457478
"AML-0024"	"2020-09-15-AML0024:TGCCGAGTCGGCTGGT"	-0.675492922694045	-16.0584898225036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCCGAGTCGGCTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.24034956845	35.9397326028699	0.0146439335532844	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.30902565762	2449.30902565762
"AML-0024"	"2020-09-15-AML0024:TGCGACGAGTATGCAA"	-1.32891617241557	-16.8175020447937	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGACGAGTATGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.05100732879	39.3312777559832	0.0164562503625985	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2384.6261974306	2384.6261974306
"AML-0024"	"2020-09-15-AML0024:TGCGACGCAAGGACAC"	-0.226943532854873	-16.0853471986023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGACGCAAGGACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.95274875606	36.4156694541044	0.0127686790989044	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2847.06183872572	2847.06183872572
"AML-0024"	"2020-09-15-AML0024:TGCGACGCAGTTCACA"	-1.65738497200664	-15.7574024430481	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGACGCAGTTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.16465179286	39.2042714979409	0.0155377380822468	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2515.17163442464	2515.17163442464
"AML-0024"	"2020-09-15-AML0024:TGCGACGCATGGCTAT"	-2.0773631137913	-16.1142111054626	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGACGCATGGCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.27104272053	37.6453589776182	0.0148135945929315	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.76132336259	2530.76132336259
"AML-0024"	"2020-09-15-AML0024:TGCGACGTCGTGCACG"	-1.71514676037486	-15.7989349595276	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGACGTCGTGCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.91531081178	34.4577081108808	0.0125853812843701	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.13689756907	2732.13689756907
"AML-0024"	"2020-09-15-AML0024:TGCGATAAGATCACTC"	-1.76665232601817	-15.3863678208557	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATAAGATCACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.63455564347	32.0274572008473	0.0118504579666421	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2697.31630732944	2697.31630732944
"AML-0024"	"2020-09-15-AML0024:TGCGATAAGCAGTCTT"	-2.16870890083964	-16.1010580292908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATAAGCAGTCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.60665536623	32.7383889492262	0.0110022569314347	3161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2966.0833392458	2966.0833392458
"AML-0024"	"2020-09-15-AML0024:TGCGATAAGCCTAGGA"	-2.0347572368687	-15.4420614472595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATAAGCCTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.37328054222	40.5239969105776	0.0172122225670369	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2345.4194820005	2345.4194820005
"AML-0024"	"2020-09-15-AML0024:TGCGATAAGGCCTGCT"	-2.98587475243266	-15.6583204499451	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATAAGGCCTGCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.72162969655	39.4095202166682	0.0141014116747461	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.13453050521	2787.13453050521
"AML-0024"	"2020-09-15-AML0024:TGCGATACATGGGAAC"	-0.929801444441634	-15.6830911866394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATACATGGGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.75982656549	37.9644357941927	0.0141776851745834	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2674.34211900119	2674.34211900119
"AML-0024"	"2020-09-15-AML0024:TGCGATAGTACTGTTG"	-0.925681094557601	-15.8592100373474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGATAGTACTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.93722770603	38.9462595350253	0.0149452024864425	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.38634179974	2600.38634179974
"AML-0024"	"2020-09-15-AML0024:TGCGGCAAGGCTCTAT"	-1.82766960087474	-16.8819418183533	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGCAAGGCTCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1883.18717146051	51.8809623415545	0.0275495517003326	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1871.34694830977	1871.34694830977
"AML-0024"	"2020-09-15-AML0024:TGCGGCACACCATAAC"	-2.11277518692668	-16.0697374573913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGCACACCATAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.63720679222	32.2630648793251	0.0115570407217768	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.150952805	2785.150952805
"AML-0024"	"2020-09-15-AML0024:TGCGGCAGTATTTCGG"	-2.92731318894084	-15.5464744797912	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGCAGTATTTCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2748.10806945714	40.1302591752364	0.0146028679225718	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.02939440717	2742.02939440717
"AML-0024"	"2020-09-15-AML0024:TGCGGCAGTCGTGCCA"	-0.733526389033157	-15.8291616669861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGCAGTCGTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.07862467797	29.6637695397718	0.0112572616475142	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.30701057245	2631.30701057245
"AML-0024"	"2020-09-15-AML0024:TGCGGCATCCATTCAT"	-0.5196889442509	-15.6888761750427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGCATCCATTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.41638687138	30.8329707166277	0.0109088564798329	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2814.4908146995	2814.4908146995
"AML-0024"	"2020-09-15-AML0024:TGCGGGTAGCTGTACT"	-2.32787189903911	-15.5342617264953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGGTAGCTGTACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2905.88304841779	38.7961190201325	0.0133508879654521	3014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2902.09533896576	2902.09533896576
"AML-0024"	"2020-09-15-AML0024:TGCGGGTAGGGTACAC"	-0.371587107807952	-16.5304956666199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGGTAGGGTACAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.82431588585	32.5476454173352	0.0140000451625238	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2321.23885203773	2321.23885203773
"AML-0024"	"2020-09-15-AML0024:TGCGGGTCACGCAAAG"	-2.55097780647929	-15.4950742951599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGGTCACGCAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.07922361747	34.9157123232517	0.0135485599368731	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.30781212295	2569.30781212295
"AML-0024"	"2020-09-15-AML0024:TGCGGGTGTCTAATCG"	-2.93257008019145	13.5769233473572	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGGTGTCTAATCG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1799.9623164936	44.4195039604815	0.0246780188415347	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1797.89622783689	1797.89622783689
"AML-0024"	"2020-09-15-AML0024:TGCGGGTTCATTTACC"	-0.996007780463058	-16.0522527924744	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCGGGTTCATTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.25767621546	33.0114865426587	0.0117259200895017	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2808.26250610558	2808.26250610558
"AML-0024"	"2020-09-15-AML0024:TGCTCCAAGCAATAGT"	8.31235088881795	7.22624824130861	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCAAGCAATAGT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1520.19907899473	36.9260826070804	0.0242902940261605	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1520.19907899473	1520.19907899473
"AML-0024"	"2020-09-15-AML0024:TGCTCCAAGGTTAAAC"	-0.536808053881484	-16.2580480805603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCAAGGTTAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.84454443248	33.9367624919073	0.0127159008053516	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.41169146044	2659.41169146044
"AML-0024"	"2020-09-15-AML0024:TGCTCCACAGGAATAT"	-1.42837248268779	-16.152352356073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCACAGGAATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.02392461372	34.2180998807765	0.0133194944402558	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.73884654677	2565.73884654677
"AML-0024"	"2020-09-15-AML0024:TGCTCCAGTCAGGTGA"	-1.43742440167125	-16.909468673822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCAGTCAGGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2980.96757556224	37.1803978955899	0.0124725938652913	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2971.20627904834	2971.20627904834
"AML-0024"	"2020-09-15-AML0024:TGCTCCAGTCATCTAG"	-0.845659415156204	-16.5695791474548	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCAGTCATCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.00790146	26.3313051952677	0.0102535919692059	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.73455543099	2563.73455543099
"AML-0024"	"2020-09-15-AML0024:TGCTCCATCACACCGG"	-2.79179988327678	-16.2065553895203	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCATCACACCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.35828810587	38.2365434583199	0.0159162534779387	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.04329582287	2397.04329582287
"AML-0024"	"2020-09-15-AML0024:TGCTCCATCTCCACTG"	-1.21835217896159	-16.368453048822	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCATCTCCACTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3025.83016303097	37.2950439482687	0.0123255575953775	3404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3014.07694522498	3014.07694522498
"AML-0024"	"2020-09-15-AML0024:TGCTCCATCTGAATGC"	0.809654493897599	-16.214644455072	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCCATCTGAATGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2688.3060670881	41.2275212193184	0.0153358732936145	3018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2676.6102312102	2676.6102312102
"AML-0024"	"2020-09-15-AML0024:TGCTCGTAGAGCATTA"	-0.962423543364364	-17.487183593866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTAGAGCATTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3055.55179941921	42.9040344907664	0.0140413376395457	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3041.16533572191	3041.16533572191
"AML-0024"	"2020-09-15-AML0024:TGCTCGTAGTTGAAAC"	-0.383454780012923	-16.5448866120544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTAGTTGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2960.20604012183	35.4649436433268	0.0119805659344804	3379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2948.50751657006	2948.50751657006
"AML-0024"	"2020-09-15-AML0024:TGCTCGTCAACCGTGC"	0.0267219255561053	-16.3961439362732	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTCAACCGTGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2717.83250253028	41.8971994414599	0.0154156664924913	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2710.90198183668	2710.90198183668
"AML-0024"	"2020-09-15-AML0024:TGCTCGTCACTGTCGG"	-2.67472062531169	-16.2609319916931	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTCACTGTCGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.5096244466	36.4263841567421	0.0141819146052803	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.34896917289	2563.34896917289
"AML-0024"	"2020-09-15-AML0024:TGCTCGTTCAACTACG"	-1.92798433724101	-16.5936994782654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTTCAACTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2953.67718520734	39.9769508342095	0.0135346377845293	2919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2943.68591054877	2943.68591054877
"AML-0024"	"2020-09-15-AML0024:TGCTCGTTCTCTATAC"	11.9304062324459	-2.89053084766539	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTCGTTCTCTATAC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1773.59758821704	40.6666363074526	0.0229288969367251	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1766.8599414602	1766.8599414602
"AML-0024"	"2020-09-15-AML0024:TGCTGAAAGGCATCGA"	-1.66256449642833	-16.2603903046814	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTGAAAGGCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.53352256527	42.8733606559132	0.017016388260737	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2513.7382890162	2513.7382890162
"AML-0024"	"2020-09-15-AML0024:TGCTGAAGTCGTGATT"	-1.05495391312297	-16.2312898865906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTGAAGTCGTGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.01603096311	34.6736272980765	0.0126131048009672	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.59943235872	2742.59943235872
"AML-0024"	"2020-09-15-AML0024:TGCTGAAGTGGTATGG"	0.0227420284295499	-15.9402532807556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTGAAGTGGTATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.22392874958	35.8537612825162	0.0129332125412712	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.26306827642	2763.26306827642
"AML-0024"	"2020-09-15-AML0024:TGCTGAATCAGATGCT"	1.08203305777852	-16.2406187287536	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTGAATCAGATGCT"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2784.05073141473	47.6165095755249	0.0171033196479607	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	2772.68569142995	2772.68569142995
"AML-0024"	"2020-09-15-AML0024:TGCTTCGAGATCCGAG"	-2.837225775153	-15.5686006776062	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGAGATCCGAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2605.94777513085	39.9445251058278	0.0153282139753634	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2602.52866908796	2602.52866908796
"AML-0024"	"2020-09-15-AML0024:TGCTTCGAGCCGCACT"	-0.893737356097061	-15.5566683045593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGAGCCGCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2775.39935226239	32.9935867653692	0.0118878700243532	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2770.50114886002	2770.50114886002
"AML-0024"	"2020-09-15-AML0024:TGCTTCGAGCTTTCCC"	-2.79802999916728	-15.9552355042663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGAGCTTTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.51377401695	36.2384594020646	0.013404207424555	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.37297896635	2699.37297896635
"AML-0024"	"2020-09-15-AML0024:TGCTTCGGTCAAATCC"	-0.426303843886215	-16.6719999543396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGGTCAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.42671810863	37.445058332336	0.0134047040108821	2723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.9491861227	2779.9491861227
"AML-0024"	"2020-09-15-AML0024:TGCTTCGGTCTGTCAA"	-2.363681892783	-15.7371587983337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGGTCTGTCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2660.24562707097	32.6846473415077	0.0122863268748212	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.11587946194	2651.11587946194
"AML-0024"	"2020-09-15-AML0024:TGCTTCGGTGTTTGCA"	-0.712625781924087	-15.7358627549377	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGGTGTTTGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.69073839832	44.3890715352278	0.0158833572979413	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.08389232684	2792.08389232684
"AML-0024"	"2020-09-15-AML0024:TGCTTCGGTTCACCGG"	-2.41982922974284	-15.6373138657776	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGGTTCACCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.1560194313	33.8903354962279	0.0127065440676598	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.75911154129	2655.75911154129
"AML-0024"	"2020-09-15-AML0024:TGCTTCGTCAGGACGA"	-2.48239956322368	-15.5440531007019	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGTCAGGACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3017.0714578479	35.4436291264647	0.0117476929604269	3055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3011.20233635431	3011.20233635431
"AML-0024"	"2020-09-15-AML0024:TGCTTCGTCTCGCTCA"	0.0630403143236458	-16.4243307343689	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTCGTCTCGCTCA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2709.71151304885	38.0999340683865	0.0140605130416699	2999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2695.63469816665	2695.63469816665
"AML-0024"	"2020-09-15-AML0024:TGCTTGCCAAGTGCAG"	-0.439657400280792	-16.5144911042419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTGCCAAGTGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2524.44030505449	40.4777564763793	0.0160343488397543	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.56643981083	2516.56643981083
"AML-0024"	"2020-09-15-AML0024:TGCTTGCCACTAAACC"	9.83118691024129	6.9072055586609	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTGCCACTAAACC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1831.30917722196	39.7253898510205	0.0216923446598365	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1826.55836577075	1826.55836577075
"AML-0024"	"2020-09-15-AML0024:TGCTTGCGTGAGGATC"	-1.57115791264232	-16.8993616334167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTGCGTGAGGATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.95189475947	42.0233237802815	0.0183431716206741	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2280.81153508326	2280.81153508326
"AML-0024"	"2020-09-15-AML0024:TGCTTGCGTGCCTACG"	0.00451915067378875	-16.1845178834167	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTGCGTGCCTACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.76719360185	42.0740334185788	0.0201237294842456	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2086.26600191617	2086.26600191617
"AML-0024"	"2020-09-15-AML0024:TGCTTGCTCTATTGTC"	-2.21699128571208	-16.1412916413513	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGCTTGCTCTATTGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.69437012111	41.694976185749	0.0160137751435893	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.41660798955	2598.41660798955
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGAATCGAT"	-0.767634431750137	-16.3908529511658	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGAATCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.24572086969	41.1103143303255	0.0147124907531504	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.31235075775	2788.31235075775
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGACTGAGC"	-2.53593240204509	-16.0940809479919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGACTGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2304.13481683549	41.9944948293385	0.0182257108058521	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2298.49585610582	2298.49585610582
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGCGATTCT"	0.0141722495550334	-16.4716806641785	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGCGATTCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2664.39565662598	41.3169385315793	0.0155070582061751	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2656.86209962448	2656.86209962448
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGCGCCTAC"	-1.98304949227031	-15.7355613938537	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGCGCCTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.17265583694	37.5888045884063	0.0145909492918651	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.40903950638	2571.40903950638
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGGAACGCT"	-2.14353142204936	-15.6562090150085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGGAACGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.66500930105	37.1829070839206	0.0135424048301457	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.29260422555	2742.29260422555
"AML-0024"	"2020-09-15-AML0024:TGGAACTAGTTGCTCA"	-0.274708847433883	-16.4489565125671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTAGTTGCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.38592368314	35.3677829806638	0.0123993680823509	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.06660022315	2839.06660022315
"AML-0024"	"2020-09-15-AML0024:TGGAACTGTCGTTATG"	-0.262978563935119	-16.3206873170105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTGTCGTTATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2797.35886933542	30.7599656260688	0.0109960741767025	2807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.59031414092	2790.59031414092
"AML-0024"	"2020-09-15-AML0024:TGGAACTGTGTCTTAG"	-0.115087012678939	-16.0650415650574	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAACTGTGTCTTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.39209773959	39.5475193934171	0.0141473961471795	2529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.29836615804	2785.29836615804
"AML-0024"	"2020-09-15-AML0024:TGGAGAGCACGAAGAC"	-0.802010576159316	-15.7806244126526	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGAGCACGAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2778.87303271148	37.7120022231921	0.0135709698785319	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2772.56667490375	2772.56667490375
"AML-0024"	"2020-09-15-AML0024:TGGAGAGCATGGCGCT"	-0.229705373675185	-16.0738268128601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGAGCATGGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.91106020992	39.5981021939731	0.0154143531114453	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2563.03327348767	2563.03327348767
"AML-0024"	"2020-09-15-AML0024:TGGAGAGTCATCGCCT"	-1.44610057297404	-15.945565246698	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGAGTCATCGCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.78376229324	34.7897903900793	0.0126887433168621	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.2872370114	2739.2872370114
"AML-0024"	"2020-09-15-AML0024:TGGAGAGTCCTTCTTC"	-2.85792122307475	-15.5128021470276	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGAGTCCTTCTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2967.31061606725	37.4490511096064	0.0126205362211927	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2957.75754410447	2957.75754410447
"AML-0024"	"2020-09-15-AML0024:TGGAGAGTCGACGAGA"	-1.88715742054637	-15.6183853379455	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGAGTCGACGAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.08650215458	36.7814301776823	0.0138845712088929	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.68391509214	2641.68391509214
"AML-0024"	"2020-09-15-AML0024:TGGAGGAAGCACTCTA"	-1.4681445163792	-16.2174139252869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGAAGCACTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.59113628786	36.8125174012721	0.0136768608370596	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.32663028926	2682.32663028926
"AML-0024"	"2020-09-15-AML0024:TGGAGGAAGGCAGCTA"	-0.906457523733932	-17.5856733552185	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGAAGGCAGCTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.04847051082	51.076879710347	0.0173139120326056	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2940.5812501521	2940.5812501521
"AML-0024"	"2020-09-15-AML0024:TGGAGGACAACGGGTA"	-0.965800504118759	-17.4328165284363	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACAACGGGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2686.35341726302	51.5345195915425	0.0191838196941519	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2672.59153671388	2672.59153671388
"AML-0024"	"2020-09-15-AML0024:TGGAGGACACAGCCAC"	-0.892377535731155	14.0992536314758	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACACAGCCAC"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2523.86191698419	47.9230483486469	0.0189879834653994	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2521.1649116268	2521.1649116268
"AML-0024"	"2020-09-15-AML0024:TGGAGGACACCTGTCT"	-1.62583718720134	-16.9269514313904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACACCTGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1667.1770180844	52.1674062812963	0.0312908621672564	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1657.37928572999	1657.37928572999
"AML-0024"	"2020-09-15-AML0024:TGGAGGACACTCATAG"	-0.971688966185409	-16.3732919923035	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACACTCATAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.93041670994	28.7012719976606	0.0112292853553524	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.67803878821	2546.67803878821
"AML-0024"	"2020-09-15-AML0024:TGGAGGACAGAACCGA"	-1.75709412518199	-15.9321127167908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACAGAACCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.53251680697	36.3498325993841	0.0142630444617306	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2542.45031726031	2542.45031726031
"AML-0024"	"2020-09-15-AML0024:TGGAGGACAGGGTCTC"	-0.477202574641067	-16.1688795319763	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGACAGGGTCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.47603759573	37.961266794749	0.0140990175083032	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2683.76821916728	2683.76821916728
"AML-0024"	"2020-09-15-AML0024:TGGAGGAGTAATCAGA"	-1.12871430340465	-16.4074678651062	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGAGTAATCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.7953890366	33.1013436815568	0.011631666777267	3087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.36922672047	2839.36922672047
"AML-0024"	"2020-09-15-AML0024:TGGAGGAGTCTTAGTG"	-2.77301154556926	-15.9962225190369	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGAGGAGTCTTAGTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.58097385965	37.3086314868546	0.0143297373354003	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.32933234565	2596.32933234565
"AML-0024"	"2020-09-15-AML0024:TGGATCAAGCAACCAG"	-2.06128964844401	-15.5010557404724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCAAGCAACCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2128.98413446492	42.7591422920674	0.0200842935369333	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2123.3435193288	2123.3435193288
"AML-0024"	"2020-09-15-AML0024:TGGATCACAACAGCTT"	-0.50712345066722	-15.817994140741	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCACAACAGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.09000472701	37.2660995008896	0.0135903998178935	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2735.3373441565	2735.3373441565
"AML-0024"	"2020-09-15-AML0024:TGGATCACAATTTCCT"	-2.44179592552837	-15.587618850824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCACAATTTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.32879958201	32.8140591374154	0.0119920015249732	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.76176958192	2731.76176958192
"AML-0024"	"2020-09-15-AML0024:TGGATCACATCGTTCC"	-2.05728445473369	-16.1957254639831	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCACATCGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2788.09881012411	39.0329302180686	0.0139998374793363	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.34057829566	2781.34057829566
"AML-0024"	"2020-09-15-AML0024:TGGATCAGTACAGTCT"	-1.12622223320659	-16.4805288544861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCAGTACAGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.20673338289	39.2040246280039	0.0170808250332297	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2294.21556952425	2294.21556952425
"AML-0024"	"2020-09-15-AML0024:TGGATCAGTCATAAAG"	-1.5364912551945	-16.8482008210388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCAGTCATAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.16024285455	31.1579015947801	0.0108709558973396	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2858.70999218401	2858.70999218401
"AML-0024"	"2020-09-15-AML0024:TGGATCAGTGGGCTTC"	-1.77380881729777	-16.4627104035583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCAGTGGGCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2093.58602516637	36.9722698929433	0.017659780610164	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2090.80468104344	2090.80468104344
"AML-0024"	"2020-09-15-AML0024:TGGATCATCCGTAGTA"	-2.86451874199565	9.38474271381227	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCATCCGTAGTA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2471.70684104198	48.0215205313322	0.0194284855040043	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2468.32420618543	2468.32420618543
"AML-0024"	"2020-09-15-AML0024:TGGATCATCTTCCAGC"	-0.0442437780206979	-16.1461172333923	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCATCTTCCAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2808.77621554843	36.3019463293666	0.0129244708526124	3009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2802.62626604086	2802.62626604086
"AML-0024"	"2020-09-15-AML0024:TGGATCATCTTGGTCC"	-1.75788412514384	-16.8599882355896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATCATCTTGGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.29831457111	35.7524455961531	0.0148455219936157	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2398.94383118852	2398.94383118852
"AML-0024"	"2020-09-15-AML0024:TGGATGTAGCCGATTT"	-1.31704495373424	-16.0831194153992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTAGCCGATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.29717947904	40.9665648724542	0.0154224328470991	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.66363568535	2646.66363568535
"AML-0024"	"2020-09-15-AML0024:TGGATGTAGTATGGCG"	-0.857654194266158	-15.6520624390808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTAGTATGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.2404997908	34.4564131851816	0.0119505858729723	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.17705415968	2879.17705415968
"AML-0024"	"2020-09-15-AML0024:TGGATGTAGTTGTAGA"	-1.24529228630717	-16.4936743012634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTAGTTGTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.85631996538	33.2214675938203	0.0125560361472142	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.70320519979	2639.70320519979
"AML-0024"	"2020-09-15-AML0024:TGGATGTGTCAAATCC"	-0.576375941664535	-16.528027557489	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTGTCAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2956.69460289158	38.8782776804306	0.0131492368682273	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.582708301	2947.582708301
"AML-0024"	"2020-09-15-AML0024:TGGATGTGTGGCCTCA"	-1.82195196572002	-16.7440576783386	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTGTGGCCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.78610380311	35.4590481866846	0.0143281264316917	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2469.14985498726	2469.14985498726
"AML-0024"	"2020-09-15-AML0024:TGGATGTTCTCGGCTT"	-0.408311108977157	-16.4995489350525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGATGTTCTCGGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.42040082884	34.7183254108564	0.0124822286485389	2607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2771.71005545865	2771.71005545865
"AML-0024"	"2020-09-15-AML0024:TGGCGTGAGCAGCACA"	-1.51767323437389	-15.9745416871277	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGAGCAGCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.81954992395	29.7865576223885	0.0112113589435312	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2651.04621357826	2651.04621357826
"AML-0024"	"2020-09-15-AML0024:TGGCGTGCATGTTCGA"	-1.31399879875835	-16.2718420258728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGCATGTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.78401436491	33.3142311390818	0.0123854669970398	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2679.17306467848	2679.17306467848
"AML-0024"	"2020-09-15-AML0024:TGGCGTGGTACGAAAT"	1.24630381640736	-16.1918134919372	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGGTACGAAAT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3025.74995086495	41.659790865468	0.0137684182572849	3651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3015.03968106763	3015.03968106763
"AML-0024"	"2020-09-15-AML0024:TGGCGTGTCCAAGAGG"	11.6037603813106	-2.31848933612975	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGTCCAAGAGG"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2440.14979864615	38.2272968608503	0.0156659631642531	2646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	2435.47073984875	2435.47073984875
"AML-0024"	"2020-09-15-AML0024:TGGCGTGTCGCACGGT"	-2.07675419274028	-16.8290834656921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGTCGCACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1481.99376708378	47.3042845270028	0.0319193545733238	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1474.44363340289	1474.44363340289
"AML-0024"	"2020-09-15-AML0024:TGGCGTGTCGTCGGGT"	-0.320779542357284	-16.0237608185974	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGTCGTCGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.50153373112	43.8561374406145	0.0164470700225882	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.28761600149	2660.28761600149
"AML-0024"	"2020-09-15-AML0024:TGGCGTGTCGTGCACG"	0.21609434959237	-16.4414358369079	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGTCGTGCACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2900.31356905314	36.1752538903896	0.0124728768214533	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2889.91383930347	2889.91383930347
"AML-0024"	"2020-09-15-AML0024:TGGCGTGTCTGTGTGA"	-0.801499287516433	-16.3532743684021	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGCGTGTCTGTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.08173572648	33.5971550730703	0.0133902194554625	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2502.02837213346	2502.02837213346
"AML-0024"	"2020-09-15-AML0024:TGGGAAGAGCATCCCG"	-1.46715233746226	-15.5073976746765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGAGCATCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2207.89298805889	32.4444810564851	0.0146947706396809	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2203.56210627812	2203.56210627812
"AML-0024"	"2020-09-15-AML0024:TGGGAAGAGCGGCTCT"	-1.85549090328868	-16.1742754212585	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGAGCGGCTCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2212.68924085315	49.7790705350762	0.0224970906966958	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2205.96882447708	2205.96882447708
"AML-0024"	"2020-09-15-AML0024:TGGGAAGCAACCACGC"	-2.85393653336223	-15.8381138077942	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGCAACCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.559004299	33.5037727414328	0.0122162450065487	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.67938571602	2734.67938571602
"AML-0024"	"2020-09-15-AML0024:TGGGAAGCAATGGCCC"	0.615366538136643	-16.3121824494568	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGCAATGGCCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2720.70367058282	42.799557857119	0.0157310619013318	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2710.80557880754	2710.80557880754
"AML-0024"	"2020-09-15-AML0024:TGGGAAGCACACCGAC"	-0.352981786162215	-16.4860506287781	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGCACACCGAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2868.06207296693	47.8282660517558	0.0166761614061856	3029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2854.32793781063	2854.32793781063
"AML-0024"	"2020-09-15-AML0024:TGGGAAGTCAGTCACA"	-1.41576574268993	-15.8690147629944	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGTCAGTCACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.20701625277	35.7413528549327	0.0135373296998734	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2637.15928867873	2637.15928867873
"AML-0024"	"2020-09-15-AML0024:TGGGAAGTCATCACTT"	-1.92805574360545	-15.7564764252869	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGTCATCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.03116627049	32.1288492508094	0.0117043659269126	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.12508352122	2737.12508352122
"AML-0024"	"2020-09-15-AML0024:TGGGAAGTCGAACGGA"	0.912413318722886	-16.2086935273376	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGTCGAACGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2732.03397108909	52.4133963449132	0.0191847527884213	2447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2722.93201279334	2722.93201279334
"AML-0024"	"2020-09-15-AML0024:TGGGAAGTCTCTGGTC"	-0.860051373869735	-15.612048172113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAAGTCTCTGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.64853227557	35.2640432188326	0.0131305503289193	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.15109060499	2680.15109060499
"AML-0024"	"2020-09-15-AML0024:TGGGAGAAGGTTCCGC"	-3.26427970352824	11.8472575911316	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGAAGGTTCCGC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2164.77003794856	36.0015016360671	0.016630635589443	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2163.18944530837	2163.18944530837
"AML-0024"	"2020-09-15-AML0024:TGGGAGAGTCCTGTTC"	-1.57585440102275	-16.4262056580749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGAGTCCTGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.93520758119	37.567203538016	0.0146922782503956	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.90839958117	2550.90839958117
"AML-0024"	"2020-09-15-AML0024:TGGGAGAGTTAATCGC"	-0.629055599600631	-15.9346504441467	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGAGTTAATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.59441995232	33.4494364828512	0.0129268467364633	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.73703806657	2578.73703806657
"AML-0024"	"2020-09-15-AML0024:TGGGAGATCCCATGGG"	-2.14111791077312	-16.7905493012634	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGATCCCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.66695344391	45.2178229391262	0.0193100999579056	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2334.59826015777	2334.59826015777
"AML-0024"	"2020-09-15-AML0024:TGGGAGATCCGGCTTT"	-1.25891516628917	-16.5351686707703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGATCCGGCTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.25413552278	41.9488104441531	0.0151754536260175	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.56516017013	2755.56516017013
"AML-0024"	"2020-09-15-AML0024:TGGGAGATCGGCTTCT"	-1.02757738056834	-17.3026552430359	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGAGATCGGCTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.48477503027	45.0270182049591	0.0159586252612247	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2814.50592536886	2814.50592536886
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTATCCCAA"	-0.0874438685482324	-16.0064325562683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTATCCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.67822359305	39.4022300390798	0.0145735648921698	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.89545951177	2695.89545951177
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTATGCGGA"	-0.0478554320638955	-15.845392250177	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTATGCGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2754.44575888503	40.3207573838084	0.0146384285309469	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2747.11719229153	2747.11719229153
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTCCTGGTG"	1.1051867204601	11.3068990477356	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTCCTGGTG"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1451.25002097273	43.0936291837241	0.0296941454339065	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1442.38104816309	1442.38104816309
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTGATACTC"	-2.19478903237041	-16.5238676301208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTGATACTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.16535561169	38.2413870657027	0.0155127066744834	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2454.31765949985	2454.31765949985
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTTATAGCC"	-1.84318409386333	-16.0634813538757	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTTATAGCC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.20284916168	35.7979705998978	0.0135229420031919	2410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.00322622916	2641.00322622916
"AML-0024"	"2020-09-15-AML0024:TGGGATTGTTGCTCCT"	-2.03899369660075	-15.3998966447082	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTGTTGCTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.52593538155	36.3656219429758	0.0138192147202619	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2623.8676291074	2623.8676291074
"AML-0024"	"2020-09-15-AML0024:TGGGATTTCCTATGGA"	-2.20192299309428	-15.9004688492981	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTTCCTATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2882.37542728086	34.6988736301894	0.0120382908145047	2661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2874.84920582279	2874.84920582279
"AML-0024"	"2020-09-15-AML0024:TGGGATTTCGCTATTT"	-1.43303535404857	-15.7301864854065	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTTCGCTATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.54259749344	36.2774285233226	0.0126158550233076	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.72874868321	2869.72874868321
"AML-0024"	"2020-09-15-AML0024:TGGGATTTCGTTCTCG"	-1.52581725540813	-15.6802730790344	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTTCGTTCTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.50931254682	39.6933518632614	0.0155629119517409	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2544.68182486618	2544.68182486618
"AML-0024"	"2020-09-15-AML0024:TGGGATTTCTACGCAA"	-0.568435708910781	-15.8036461106506	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGATTTCTACGCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.82340642198	44.6880378809341	0.0164668186497266	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2707.83285709016	2707.83285709016
"AML-0024"	"2020-09-15-AML0024:TGGGCGTAGCTACTAC"	-2.9611590904301	-15.6865129700867	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTAGCTACTAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.97299680984	30.241906699355	0.0116540352198397	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2591.56314193813	2591.56314193813
"AML-0024"	"2020-09-15-AML0024:TGGGCGTCAACCGTGC"	-0.499626497656661	-15.7013120881286	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTCAACCGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.26377958872	34.5737770911518	0.0128945825302034	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2678.12311729729	2678.12311729729
"AML-0024"	"2020-09-15-AML0024:TGGGCGTCAGGTGAGT"	-0.375594655901748	-15.7882395020691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTCAGGTGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.29611454183	38.4638848065954	0.0141865304200073	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.62152083664	2706.62152083664
"AML-0024"	"2020-09-15-AML0024:TGGGCGTCATGCACTA"	-2.31537161293681	-15.8448848954407	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTCATGCACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2835.79749021885	39.4961062959202	0.0139276892768785	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.06798572093	2827.06798572093
"AML-0024"	"2020-09-15-AML0024:TGGGCGTGTGCAATGG"	-2.71251974526103	-15.4952364197937	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTGTGCAATGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.37927193281	34.0649230746508	0.0131100657408307	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.70162599899	2590.70162599899
"AML-0024"	"2020-09-15-AML0024:TGGGCGTGTTAGAGTA"	-1.765408496291	-16.6271066895691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTGTTAGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.34461756771	42.504986978555	0.0168047432854085	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.44249624458	2517.44249624458
"AML-0024"	"2020-09-15-AML0024:TGGGCGTTCATCTCTA"	-0.772207359701949	-16.3581228486267	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCGTTCATCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.15043759692	35.7347083440307	0.0138929309194747	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2565.59944681286	2565.59944681286
"AML-0024"	"2020-09-15-AML0024:TGGGCTGCAATAAGGT"	-2.06986794892009	-16.3278513184753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCTGCAATAAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.10157561193	35.7261363789159	0.0143415012573865	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2480.80764376905	2480.80764376905
"AML-0024"	"2020-09-15-AML0024:TGGGCTGCAATAGGAT"	-2.43405018273051	-16.074637436029	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCTGCAATAGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.18926185294	35.6169381543249	0.0125580258811979	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.74557459307	2827.74557459307
"AML-0024"	"2020-09-15-AML0024:TGGGCTGCAATGCTCA"	-1.7663690847462	-16.3421240082947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCTGCAATGCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3014.37193646354	35.4651961614471	0.0117653683450407	2707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3005.72180720119	3005.72180720119
"AML-0024"	"2020-09-15-AML0024:TGGGCTGGTAGTTAGA"	-0.989245156676132	-16.0347089997497	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCTGGTAGTTAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.08904446058	35.169527529414	0.0132112513676418	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.46953883873	2653.46953883873
"AML-0024"	"2020-09-15-AML0024:TGGGCTGGTTAAACCC"	-2.87068925324138	-15.7959966889587	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGCTGGTTAAACCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2755.25687708095	35.8824832822801	0.0130232805444608	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.42525182388	2752.42525182388
"AML-0024"	"2020-09-15-AML0024:TGGGTTACAGCCGTTG"	-1.83229122582133	-16.6278352967468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGTTACAGCCGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.21649686875	33.8222257803637	0.0129725421041881	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.37497726752	2600.37497726752
"AML-0024"	"2020-09-15-AML0024:TGGGTTAGTCGAGATG"	-0.353682826191741	-15.9742059937683	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGTTAGTCGAGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.00185261476	39.1324633348821	0.0142610921700336	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2739.57067084478	2739.57067084478
"AML-0024"	"2020-09-15-AML0024:TGGGTTAGTGTTGACT"	-1.63656411591228	-16.9386911622253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGTTAGTGTTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.56956157285	44.0671333894477	0.0184183290204856	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2386.18101057102	2386.18101057102
"AML-0024"	"2020-09-15-AML0024:TGGGTTATCCGACATA"	-2.35588036003764	-15.7216501466003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGTTATCCGACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.51155065946	39.5478492707996	0.0146771867654902	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.59661277591	2690.59661277591
"AML-0024"	"2020-09-15-AML0024:TGGGTTATCCGATCGG"	-1.78120277348216	-15.3041601411072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGGTTATCCGATCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.16957704256	38.4213356035645	0.0150661885191658	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2547.03739039836	2547.03739039836
"AML-0024"	"2020-09-15-AML0024:TGGTACAAGAAGATCT"	-1.08695624294932	-15.9295339814392	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTACAAGAAGATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.41263100662	36.9616692870109	0.0146591116553004	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.77514989052	2512.77514989052
"AML-0024"	"2020-09-15-AML0024:TGGTACACAAGAAACT"	-1.35788486424144	-16.1043272248474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTACACAAGAAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.48518792396	40.9175477049288	0.0142645142032414	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2863.08476883966	2863.08476883966
"AML-0024"	"2020-09-15-AML0024:TGGTACAGTAGACTGG"	-0.516602079302627	-15.8512583008972	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTACAGTAGACTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2725.7060194362	35.0949523186845	0.0128755456635576	2484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2720.33769255399	2720.33769255399
"AML-0024"	"2020-09-15-AML0024:TGGTACAGTGCAAGAC"	-1.42239056053813	-15.9364090195862	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTACAGTGCAAGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.52619369925	46.0380863968646	0.0178060800579226	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.13337350566	2580.13337350566
"AML-0024"	"2020-09-15-AML0024:TGGTACATCGAGATGG"	-1.06320212307628	-16.3677053681579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTACATCGAGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.92468405357	37.7505380571508	0.0147065234487273	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.11941048163	2561.11941048163
"AML-0024"	"2020-09-15-AML0024:TGGTAGTAGGTTACAA"	-0.285285930067855	-16.2351694337097	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTAGGTTACAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2602.01369452026	30.7586318675513	0.0118210876185348	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2592.0220588128	2592.0220588128
"AML-0024"	"2020-09-15-AML0024:TGGTAGTCAATGTCAC"	-0.874778966337997	-16.7252550355163	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTCAATGTCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.9042127142	37.3292330081172	0.0148668486910401	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2505.40608685544	2505.40608685544
"AML-0024"	"2020-09-15-AML0024:TGGTAGTCATTGCCGG"	-0.904161433607894	-17.350480102655	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTCATTGCCGG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3043.86499571787	47.001294625148	0.0154413203907761	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3035.23318794472	3035.23318794472
"AML-0024"	"2020-09-15-AML0024:TGGTAGTGTAGGCAGT"	0.550649722188157	-16.1885462037292	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTGTAGGCAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2945.43950374973	32.7251418930008	0.0111104444180027	3740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2934.92493394741	2934.92493394741
"AML-0024"	"2020-09-15-AML0024:TGGTAGTGTCTGTGAT"	0.0588892750324726	-16.1012888184753	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTGTCTGTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.3785676791	37.8640141044466	0.0127257803480052	2795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2966.789461941	2966.789461941
"AML-0024"	"2020-09-15-AML0024:TGGTAGTGTGCATCTA"	-2.80713115158733	-15.7571840516296	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTGTGCATCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.45234238843	34.0523014957831	0.0131809288435727	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2581.17768586461	2581.17768586461
"AML-0024"	"2020-09-15-AML0024:TGGTAGTTCATTTCGT"	-2.82280359688457	-16.0671015015808	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTAGTTCATTTCGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.33608303317	48.3397211981621	0.0206903970491285	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2328.84275068689	2328.84275068689
"AML-0024"	"2020-09-15-AML0024:TGGTGATAGTATTGCC"	-1.93136833134349	-16.3635034791199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATAGTATTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.48838644131	39.0750649081849	0.015113223912782	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.94765565363	2570.94765565363
"AML-0024"	"2020-09-15-AML0024:TGGTGATCAGCACCCA"	-1.96496687355693	-16.400456451532	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATCAGCACCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2607.00269453523	34.9912452957506	0.0134220211467748	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2600.19196165589	2600.19196165589
"AML-0024"	"2020-09-15-AML0024:TGGTGATCAGCTACAT"	-0.880473772913772	-16.5519476166931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATCAGCTACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.00703099942	33.3089692764063	0.0119045338011566	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2786.80928531318	2786.80928531318
"AML-0024"	"2020-09-15-AML0024:TGGTGATGTAGCGATG"	-0.951568822295028	-15.9272928467956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATGTAGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2845.93639149584	34.2416069908041	0.0120317541506283	2644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2836.85796391106	2836.85796391106
"AML-0024"	"2020-09-15-AML0024:TGGTGATTCACTGAAC"	-2.03990564766582	-15.6099148026672	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATTCACTGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2847.63511475156	26.4664839275353	0.00929419776797645	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.76823628848	2841.76823628848
"AML-0024"	"2020-09-15-AML0024:TGGTGATTCACTGGTA"	-1.16804478588756	-15.9098778001037	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATTCACTGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2561.1523114937	33.9285576479921	0.0132473798983882	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.02053613314	2553.02053613314
"AML-0024"	"2020-09-15-AML0024:TGGTGATTCCTTCAGC"	-1.25327501717265	-16.7852258912292	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTGATTCCTTCAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2777.5378852157	37.5657564496501	0.0135248403449708	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.99215580902	2764.99215580902
"AML-0024"	"2020-09-15-AML0024:TGGTTAGAGCGATTCT"	-0.163112680346328	-16.0138216248718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGAGCGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3147.47318660996	42.1101137586859	0.0133790222384837	3323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3135.23716004048	3135.23716004048
"AML-0024"	"2020-09-15-AML0024:TGGTTAGAGGATATAC"	-0.737110118300277	-16.4051542512146	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGAGGATATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.33077178853	38.5326868670785	0.0155165342067286	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2474.12259941246	2474.12259941246
"AML-0024"	"2020-09-15-AML0024:TGGTTAGAGTAGGATT"	-2.20544515076335	-15.5610838166443	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGAGTAGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2809.95064919295	37.5095376311686	0.0133488243439228	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2808.20050916613	2808.20050916613
"AML-0024"	"2020-09-15-AML0024:TGGTTAGAGTTCCATG"	-0.883501867682296	-16.2148618928161	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGAGTTCCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.48581371405	40.6110672515453	0.0153221220960387	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.87780004949	2639.87780004949
"AML-0024"	"2020-09-15-AML0024:TGGTTAGCACCCTCTA"	-0.771123568445998	-16.4886102906433	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGCACCCTCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.0505119753	37.3498540296544	0.0129684718633764	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2870.4840275911	2870.4840275911
"AML-0024"	"2020-09-15-AML0024:TGGTTAGCATAACGGG"	-2.90949831429179	-15.8312416306702	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGCATAACGGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.92831665804	37.8566661576699	0.0135399273050461	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2788.30048978491	2788.30048978491
"AML-0024"	"2020-09-15-AML0024:TGGTTAGCATAGATGA"	0.786038358777207	-16.2303972474304	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGCATAGATGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2933.80753481167	38.9004397722376	0.0132593700543259	3165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2921.84711319663	2921.84711319663
"AML-0024"	"2020-09-15-AML0024:TGGTTAGGTCATCCGG"	-2.4202483696049	-16.5425081483093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGGTCATCCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.78699919546	34.4308274734452	0.0134506611230805	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.64714793554	2550.64714793554
"AML-0024"	"2020-09-15-AML0024:TGGTTAGTCCTACAAG"	-1.86820147457774	-16.3575334778992	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGGTTAGTCCTACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2528.457623312	35.2578715246555	0.013944418605075	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2522.45942840628	2522.45942840628
"AML-0024"	"2020-09-15-AML0024:TGTAACGAGAGATCGC"	-0.742670993239242	-16.8149385682312	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAACGAGAGATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.4264151241	40.4263615910736	0.0181983797959003	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2218.9875232428	2218.9875232428
"AML-0024"	"2020-09-15-AML0024:TGTAACGCAAGTAGTA"	-0.471917073160964	-16.1063814393249	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAACGCAAGTAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.02279630658	41.5635220584636	0.0146246265555922	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.30053767565	2831.30053767565
"AML-0024"	"2020-09-15-AML0024:TGTAACGCACAGTGAG"	-0.133331264287788	-16.559371017572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAACGCACAGTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.02586176049	46.2722981103177	0.0178655737741806	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2582.13349765867	2582.13349765867
"AML-0024"	"2020-09-15-AML0024:TGTAACGGTATTTCCT"	-2.06044636192973	-15.9329538575378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAACGGTATTTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.81867770068	38.4152146938081	0.0161760622208859	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2366.50012071308	2366.50012071308
"AML-0024"	"2020-09-15-AML0024:TGTAACGTCGAGCCAC"	-1.9892786544865	-15.7085323563782	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAACGTCGAGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.6642134777	39.5487984634108	0.0138686729932974	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2841.48327018776	2841.48327018776
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGAGGATCC"	1.33470108088796	-16.1745290986267	"2020-09-15-AML0024"	"AML0024"	"GMP"	"GMP"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGAGGATCC"	"GMP"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3365.75969444446	39.2486424477242	0.0116611540962084	5235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	10	TRUE	"HSPC_AML-0024"	3351.86500649001	3351.86500649001
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGCAACAAT"	-1.0195361179417	-16.6430464020935	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGCAACAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2841.44270790203	34.7402294032307	0.0122262642518247	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2830.13896841924	2830.13896841924
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGGATATAC"	-1.63544247570689	-16.694193863031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGGATATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.37458605481	39.1859932868103	0.015836726382358	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2468.91468716853	2468.91468716853
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGGTAGTCG"	-2.57107339325603	-15.7167864075867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGGTAGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.15187665642	38.154180410812	0.0140110365264162	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2712.61888076022	2712.61888076022
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGGTCACAG"	-2.28491149368938	-16.3894758454529	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGGTCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.09910542547	33.3132531286173	0.0135469339381723	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.85178956442	2450.85178956442
"AML-0024"	"2020-09-15-AML0024:TGTAAGCAGGTTCTTG"	-2.51514826241191	-15.7785082093445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCAGGTTCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2160.24256022147	34.9206853666757	0.0161651686758248	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2155.02737705051	2155.02737705051
"AML-0024"	"2020-09-15-AML0024:TGTAAGCCAATGCAGG"	-1.46517036381419	-16.0792284241882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCCAATGCAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.38632575083	35.429296538951	0.0137568861745905	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.53696753367	2571.53696753367
"AML-0024"	"2020-09-15-AML0024:TGTAAGCCAGCAATTC"	-1.1397080225056	-16.3705892792908	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCCAGCAATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2890.01239994749	42.1346622919335	0.014579405366115	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2877.65170191764	2877.65170191764
"AML-0024"	"2020-09-15-AML0024:TGTAAGCCATGGCCAC"	-0.574360231787521	-15.9842977753845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCCATGGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.95156767414	37.8895816343553	0.0140855999378146	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2682.17578613937	2682.17578613937
"AML-0024"	"2020-09-15-AML0024:TGTAAGCCATTACGGT"	-1.28642163696941	-16.4336481324402	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCCATTACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2616.24538743147	37.6927410788943	0.0144071887369478	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2611.57646072368	2611.57646072368
"AML-0024"	"2020-09-15-AML0024:TGTAAGCGTGATAGTA"	-1.52350459519084	-16.322030090448	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCGTGATAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.34080865469	42.2476134956465	0.0165201342553444	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.62370223151	2549.62370223151
"AML-0024"	"2020-09-15-AML0024:TGTAAGCGTGGAAATT"	-0.87577466192897	-15.9296255341736	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCGTGGAAATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.97325915182	32.2399833023613	0.0118705083688599	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.79659811633	2708.79659811633
"AML-0024"	"2020-09-15-AML0024:TGTAAGCTCAGCAATC"	-2.34070382538493	-15.5524692765442	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCTCAGCAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.06986064637	40.2727289732179	0.0146282989577906	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2744.90577887886	2744.90577887886
"AML-0024"	"2020-09-15-AML0024:TGTAAGCTCGCAGATT"	-1.02336321297343	-16.1648454896179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCTCGCAGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2772.36335114408	41.5462902904123	0.0149858748757688	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.35929067579	2763.35929067579
"AML-0024"	"2020-09-15-AML0024:TGTAAGCTCGTTCCTG"	-1.82677267018016	-15.5444927445618	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAAGCTCGTTCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.53982367434	30.6370713192343	0.0132597027782511	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.68587768036	2305.68587768036
"AML-0024"	"2020-09-15-AML0024:TGTACAGAGAGCAGAA"	-2.66531620445903	-15.9296636811462	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGAGAGCAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.31676823284	35.7485583316167	0.0134074685939548	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2657.28524748255	2657.28524748255
"AML-0024"	"2020-09-15-AML0024:TGTACAGAGGGACACT"	-1.93473182144817	-16.8234720460144	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGAGGGACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.04918921874	36.4239690796429	0.0146278110638734	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2485.0349949399	2485.0349949399
"AML-0024"	"2020-09-15-AML0024:TGTACAGAGTTTGCTG"	-1.88345442238505	-16.1587076417175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGAGTTTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.66932132759	32.8291128501043	0.0140315182794619	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2335.84903183338	2335.84903183338
"AML-0024"	"2020-09-15-AML0024:TGTACAGCACCCTATC"	-1.12263272228892	-16.2420358887878	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGCACCCTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.04551746927	40.7474097979669	0.0147686616766447	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.7480965224	2751.7480965224
"AML-0024"	"2020-09-15-AML0024:TGTACAGGTTGGAGGT"	-2.33626566353496	-16.1140756837097	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGGTTGGAGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.12525535962	38.2952728441564	0.0151118310995728	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.38153273546	2530.38153273546
"AML-0024"	"2020-09-15-AML0024:TGTACAGGTTGTTTGG"	-0.753321270376998	-16.433861755487	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGGTTGTTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.03390104708	31.6266328525685	0.0122345137677916	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.53003359566	2577.53003359566
"AML-0024"	"2020-09-15-AML0024:TGTACAGTCCGACAGC"	-0.588134030730087	-16.2021589509216	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTACAGTCCGACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.58585520725	42.0535914790788	0.0161957253963868	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.68013713357	2588.68013713357
"AML-0024"	"2020-09-15-AML0024:TGTAGACCAATGTGGG"	-2.85348139229472	-15.8906355134216	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAGACCAATGTGGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.75490397425	41.9623649028033	0.0162597249503171	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2571.87621390347	2571.87621390347
"AML-0024"	"2020-09-15-AML0024:TGTAGACGTAGACAGC"	-0.734797636896926	-16.4246244660583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAGACGTAGACAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.21455737163	41.1124376039733	0.0166096460129216	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2467.29202275578	2467.29202275578
"AML-0024"	"2020-09-15-AML0024:TGTAGACGTCATGGCC"	-2.70783672753032	-15.9375982514587	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAGACGTCATGGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.6214961396	35.3682938613646	0.0144382688987266	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2442.0331135632	2442.0331135632
"AML-0024"	"2020-09-15-AML0024:TGTAGACTCCATGATG"	-1.84177682820018	-16.8803167573181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAGACTCCATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.21695258878	41.5312086602922	0.0147576428398983	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2800.65633002576	2800.65633002576
"AML-0024"	"2020-09-15-AML0024:TGTAGACTCGCCGATG"	-0.493505577475387	-15.9567327729431	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTAGACTCGCCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2456.38500932019	34.2638041986569	0.0139488736776404	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.07359910128	2449.07359910128
"AML-0024"	"2020-09-15-AML0024:TGTCAGAGTGATCATC"	1.0530159669811	-16.2165918580261	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCAGAGTGATCATC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2973.8418356785	43.2747084379228	0.0145517854778748	3455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2964.55681850587	2964.55681850587
"AML-0024"	"2020-09-15-AML0024:TGTCAGATCGATCCCT"	-2.9452899498051	-15.8723507157532	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCAGATCGATCCCT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.42977210961	42.6186361503764	0.0177842207797555	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2386.85593824507	2386.85593824507
"AML-0024"	"2020-09-15-AML0024:TGTCAGATCGATTCCC"	-1.83651647988017	-16.8149194947449	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCAGATCGATTCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2486.34762735088	35.1516191078777	0.0141378537422503	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.99325067007	2475.99325067007
"AML-0024"	"2020-09-15-AML0024:TGTCAGATCGGCTTCT"	-0.322269122034866	-16.2826547852722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCAGATCGGCTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.80046458564	34.4340765269599	0.0137857595172928	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2490.76596912412	2490.76596912412
"AML-0024"	"2020-09-15-AML0024:TGTCCACAGAGGTATT"	-0.231884608895141	-16.0628137818542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACAGAGGTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2938.22490489977	36.4330737775598	0.0123996885727856	2836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2930.50618864228	2930.50618864228
"AML-0024"	"2020-09-15-AML0024:TGTCCACAGCACGTCC"	-2.3453680080479	-16.3688574067322	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACAGCACGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.55727563732	40.6577047312599	0.0156703824244053	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.69706452546	2584.69706452546
"AML-0024"	"2020-09-15-AML0024:TGTCCACAGCCTTGAT"	-0.610524515539962	-15.8907871476379	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACAGCCTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.36299757338	35.6861469479506	0.0142098720823842	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.54955513573	2507.54955513573
"AML-0024"	"2020-09-15-AML0024:TGTCCACAGCGAGGAG"	-2.35041366043742	-16.3142729035583	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACAGCGAGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.793057388	40.355744092818	0.0153631227170009	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.42314085613	2620.42314085613
"AML-0024"	"2020-09-15-AML0024:TGTCCACAGCGCCCAT"	-1.43034182015117	-16.0145387879578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACAGCGCCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.40024776047	34.0703145088016	0.0128402469765192	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.90927401989	2646.90927401989
"AML-0024"	"2020-09-15-AML0024:TGTCCACCATGCCGGT"	1.10290183600728	-16.2225389710632	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACCATGCCGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3076.87249552376	41.2839142533835	0.0134174927019054	3832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3065.55898127556	3065.55898127556
"AML-0024"	"2020-09-15-AML0024:TGTCCACGTCAATGGG"	-1.38387964192088	-15.1401138535705	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACGTCAATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.10669757847	30.8701666619687	0.0123475396837538	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2496.43994909315	2496.43994909315
"AML-0024"	"2020-09-15-AML0024:TGTCCACTCTCAGGCG"	-1.68438516083415	-16.1243944398132	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCACTCTCAGGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.70672627798	36.9934643227419	0.0138619444236708	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.01761296056	2663.01761296056
"AML-0024"	"2020-09-15-AML0024:TGTCCCATCAAGCCAT"	-2.21804366532024	-16.4128999940124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCCATCAAGCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.47793904642	38.0801377644426	0.0161597684126219	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2349.06126238482	2349.06126238482
"AML-0024"	"2020-09-15-AML0024:TGTCCCATCCCGTTCA"	-2.66443620148357	-15.8223591080871	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCCATCCCGTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.6142142108	34.4639237617967	0.012244635015268	2765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.67658549435	2803.67658549435
"AML-0024"	"2020-09-15-AML0024:TGTCCCATCGTGGACC"	-0.552532116801101	-15.9454965821472	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCCATCGTGGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.09187854627	41.3960712943729	0.015914882375285	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2598.63468277831	2598.63468277831
"AML-0024"	"2020-09-15-AML0024:TGTCCCATCTGGGTCG"	-0.24287043038066	-16.1766767731872	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCCATCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.75364671703	38.1596835848823	0.0154508056443633	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2464.38584810009	2464.38584810009
"AML-0024"	"2020-09-15-AML0024:TGTCCTGAGGATAATC"	-2.02900896492656	-16.7904501191345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGAGGATAATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.65250164659	45.4272118076739	0.0195163203165157	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2322.06246597519	2322.06246597519
"AML-0024"	"2020-09-15-AML0024:TGTCCTGAGTGAACAT"	-1.22476659241374	-15.9315691224304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGAGTGAACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.74171649976	33.8020782457262	0.0127856961346735	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2638.79842425768	2638.79842425768
"AML-0024"	"2020-09-15-AML0024:TGTCCTGCAATGGGTG"	-2.43983111801799	-15.5408478013244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGCAATGGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.41218164004	38.1864065742887	0.0138235730453583	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.69943909019	2756.69943909019
"AML-0024"	"2020-09-15-AML0024:TGTCCTGCAATTAGGA"	-2.48191938820537	-16.2490644684997	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGCAATTAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.11245217812	31.6788840295397	0.0118332287475506	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.09738019193	2663.09738019193
"AML-0024"	"2020-09-15-AML0024:TGTCCTGGTCAAAGAT"	-2.39136991921123	-15.7029543153015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGGTCAAAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.37846604546	37.2981896161588	0.014136785186874	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2634.91757826962	2634.91757826962
"AML-0024"	"2020-09-15-AML0024:TGTCCTGGTGCATTTG"	-0.994633774191696	-17.3737459412781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGGTGCATTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3148.31959994282	46.1916258297363	0.0146718350419618	3050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3138.86983869914	3138.86983869914
"AML-0024"	"2020-09-15-AML0024:TGTCCTGGTTCCGGTG"	-2.05772958222087	-16.7051210633484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGGTTCCGGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.61681116312	39.9002673759259	0.0154915386493022	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2570.94751967362	2570.94751967362
"AML-0024"	"2020-09-15-AML0024:TGTCCTGTCATTTACC"	-0.496501664549667	-16.0369005433288	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGTCATTTACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.54971891767	39.7286839610299	0.0152711607516609	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.30810547652	2594.30810547652
"AML-0024"	"2020-09-15-AML0024:TGTCCTGTCTTAGCTT"	-1.7745672267979	-16.4696016541687	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTCCTGTCTTAGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.164118112	34.4066597344331	0.0126627094422034	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2709.41547384064	2709.41547384064
"AML-0024"	"2020-09-15-AML0024:TGTGAGTAGAACGTGC"	-2.70086322251018	-16.1849813691345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTAGAACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.23168823408	42.9404282932883	0.0167851991243724	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2549.89911532167	2549.89911532167
"AML-0024"	"2020-09-15-AML0024:TGTGAGTCAGTAACGG"	-1.53610728207286	-16.1487417451111	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTCAGTAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.17309334973	38.7326207316629	0.0147039011329391	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2627.4692676778	2627.4692676778
"AML-0024"	"2020-09-15-AML0024:TGTGAGTGTGTTGACT"	-2.7858661216801	-16.0196314088074	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTGTGTTGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2261.97948330771	40.6536040962425	0.0179725786180847	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2255.92898692639	2255.92898692639
"AML-0024"	"2020-09-15-AML0024:TGTGAGTTCCAAGAGG"	-0.576180617243606	-15.8951254121033	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTTCCAAGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.48645416596	38.325901651024	0.0141190248314574	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.87436366502	2708.87436366502
"AML-0024"	"2020-09-15-AML0024:TGTGAGTTCCCATACC"	-1.28404007378276	-15.9233389130798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTTCCCATACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.09459085612	36.2085347739117	0.0135404839072351	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2669.58080282961	2669.58080282961
"AML-0024"	"2020-09-15-AML0024:TGTGAGTTCCTTGGAA"	-2.73587713661845	10.6916484602722	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00369499496137051	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTTCCTTGGAA"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2037.90660262542	24.8467605581188	0.0121922960189191	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2036.48479271967	2036.48479271967
"AML-0024"	"2020-09-15-AML0024:TGTGAGTTCGAGGCAA"	-2.93164573136027	-15.8685322037903	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTTCGAGGCAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2767.67299702951	34.1062081997418	0.0123230628171563	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2759.82830239872	2759.82830239872
"AML-0024"	"2020-09-15-AML0024:TGTGAGTTCTCTCTTC"	-0.506200711161453	-16.1818094483581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGAGTTCTCTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.4792644956	44.5587058501528	0.01607758947396	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.91763667166	2758.91763667166
"AML-0024"	"2020-09-15-AML0024:TGTGATGAGAAGGGAT"	-0.892809848219711	-16.2876100770203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGATGAGAAGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2732.33933304965	45.0708668262172	0.0164953401947745	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.08549368747	2726.08549368747
"AML-0024"	"2020-09-15-AML0024:TGTGATGGTATTGACC"	-1.65883050385173	-16.2229356995788	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGATGGTATTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.98387696045	39.3404477506041	0.014969820817967	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.77763473541	2614.77763473541
"AML-0024"	"2020-09-15-AML0024:TGTGATGGTCGGAAAC"	-0.361472020775634	-16.1017694703308	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGATGGTCGGAAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.32750931729	42.1105116436467	0.0150055585115549	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2797.91455705006	2797.91455705006
"AML-0024"	"2020-09-15-AML0024:TGTGATGGTCTGTCCT"	-0.73132018271144	-16.7131014100281	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGATGGTCTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.42816999942	38.2204233683225	0.0151582439758065	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.6264922602	2511.6264922602
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGAGTCGAC"	-1.77064142647441	-15.7134886018005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGAGTCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1651.07226308615	34.7605874966674	0.0210533410764794	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1649.01683975642	1649.01683975642
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGCCTTGAT"	-0.122322539717513	-16.1569032899109	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGCCTTGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.43247369348	39.4998756100289	0.0138672325831233	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2839.78043035141	2839.78043035141
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGCTGCCAC"	1.11005165156667	-16.2261381379333	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGCTGCCAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2864.42222532814	45.1525297262053	0.0157632241947267	3181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2850.97961711295	2850.97961711295
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGGCTAACG"	-0.739121477038223	-16.3321256867615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGGCTAACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2395.50192441343	34.408292786232	0.0143637090981078	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2393.43472086533	2393.43472086533
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGGGCAGAG"	-1.91956935349162	-16.9165792695251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGGGCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.27779163412	46.6636135487105	0.0193041998359506	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.72236170057	2413.72236170057
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGGTGAGAA"	-1.86915622177776	-16.3842230073181	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGGTGAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.11106435337	37.1739985128673	0.0141933646949199	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.57278897353	2612.57278897353
"AML-0024"	"2020-09-15-AML0024:TGTGCGGAGTTCTCTT"	-3.50577769699748	13.4906911619934	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGAGTTCTCTT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2245.97952087055	22.8732470950341	0.0101840853322511	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2244.3833347861	2244.3833347861
"AML-0024"	"2020-09-15-AML0024:TGTGCGGGTGACCGTC"	-2.26490745964702	-16.3004942170349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGGTGACCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.4478588795	31.8130125890873	0.0122714184897194	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.71045174656	2579.71045174656
"AML-0024"	"2020-09-15-AML0024:TGTGCGGGTGCAATAA"	-2.38745890083964	-16.1363764039245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGGTGCAATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.36277702008	37.7892718081772	0.0146279384933181	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.57905240055	2574.57905240055
"AML-0024"	"2020-09-15-AML0024:TGTGCGGGTTGCCGAC"	-2.72906885567363	-16.0500059357849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGGTTGCCGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2885.16645193688	37.4339296106581	0.012974616970722	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.50553067234	2879.50553067234
"AML-0024"	"2020-09-15-AML0024:TGTGCGGTCGGACAAG"	-0.364738116890746	-16.6363077393738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGTCGGACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.48501732408	42.9774963202756	0.0167326248860313	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2556.27959271629	2556.27959271629
"AML-0024"	"2020-09-15-AML0024:TGTGCGGTCTAGTGTG"	-1.57069514218028	-16.9025335541931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGCGGTCTAGTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.57012479147	35.2869469441133	0.0142713634652078	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2466.8964114618	2466.8964114618
"AML-0024"	"2020-09-15-AML0024:TGTGGCGAGCACTTTG"	-1.39228377762492	-16.4784593812195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGAGCACTTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.86360505602	35.0293056233259	0.013593775609464	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2569.58853946562	2569.58853946562
"AML-0024"	"2020-09-15-AML0024:TGTGGCGAGCATGTTC"	-1.94060979309734	-15.5569648972717	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGAGCATGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.69131135564	31.4795008646224	0.0117914384823156	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.2843700831	2660.2843700831
"AML-0024"	"2020-09-15-AML0024:TGTGGCGAGCCTCATA"	-2.54371915283855	-16.1581526032654	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGAGCCTCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.79992814329	36.8144580385826	0.0127306379948006	2889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2882.3750530388	2882.3750530388
"AML-0024"	"2020-09-15-AML0024:TGTGGCGAGTCGGGAT"	-1.10198197785075	-17.4451360932556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGAGTCGGGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.5457266136	45.2055113419231	0.0164710359545368	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.62483124548	2732.62483124548
"AML-0024"	"2020-09-15-AML0024:TGTGGCGCAAGGCGTA"	-0.977043609053451	-17.2202196351257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGCAAGGCGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.81202976483	46.8511685450149	0.0166800654684384	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.53104150014	2802.53104150014
"AML-0024"	"2020-09-15-AML0024:TGTGGCGCATATCGGT"	0.97884096679036	-16.1667146912781	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGCATATCGGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3096.01327162573	49.7203509511612	0.0160594760386969	3105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3078.91478708627	3078.91478708627
"AML-0024"	"2020-09-15-AML0024:TGTGGCGCATTGCTGA"	-2.04617128792461	-16.3770876160828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGCATTGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2471.13581572528	48.958180756353	0.0198120153675098	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2460.14137577581	2460.14137577581
"AML-0024"	"2020-09-15-AML0024:TGTGGCGGTACATTGC"	-1.00440762463267	-17.261950515863	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGGCGGTACATTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.70813567343	32.4496559220452	0.0125447689573208	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2579.41854019476	2579.41854019476
"AML-0024"	"2020-09-15-AML0024:TGTGTGAAGCTTAGTC"	-2.0009482902592	-16.1634359589783	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGAAGCTTAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.88688564331	33.2414871143254	0.0123809637166001	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.09786984684	2681.09786984684
"AML-0024"	"2020-09-15-AML0024:TGTGTGAAGGAGGTTC"	-1.73064742508586	-16.5914850465027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGAAGGAGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.93163918379	37.6502686021573	0.0136269273072857	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2756.75971468979	2756.75971468979
"AML-0024"	"2020-09-15-AML0024:TGTGTGAAGTAGAGTT"	-1.55400798741038	-16.5932321778503	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGAAGTAGAGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.30911869373	37.9228532339551	0.015871890722406	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2381.23746193916	2381.23746193916
"AML-0024"	"2020-09-15-AML0024:TGTGTGAAGTGGCAGT"	-0.880620340735275	-16.1785555115906	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGAAGTGGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.20135809489	36.8429719117829	0.0139282296219286	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.83096916957	2635.83096916957
"AML-0024"	"2020-09-15-AML0024:TGTGTGACAACGCATT"	-0.49203978005107	-15.7811041108337	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGACAACGCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.78968415552	36.1247154075024	0.0131996680697258	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.75568638035	2729.75568638035
"AML-0024"	"2020-09-15-AML0024:TGTGTGACATGTAACC"	-1.10472236099895	-16.0992918244568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGACATGTAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3115.39024087588	35.6511363201614	0.0114435539575094	4023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3105.66762328781	3105.66762328781
"AML-0024"	"2020-09-15-AML0024:TGTGTGAGTAGGAGGG"	-2.03004799309428	-16.73087217724	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGAGTAGGAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2555.69609715872	33.7823987289121	0.013218472558795	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2550.40170865114	2550.40170865114
"AML-0024"	"2020-09-15-AML0024:TGTGTGATCCCAGTGG"	-0.993371109396774	-17.567240738031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGATCCCAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.10951494153	38.7415067013328	0.0136697281799049	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2824.595662693	2824.595662693
"AML-0024"	"2020-09-15-AML0024:TGTGTGATCTACTGCC"	-1.98244772377666	-16.3003397217956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTGTGATCTACTGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.26266620547	43.8927135764166	0.0167576601395247	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2607.43339196829	2607.43339196829
"AML-0024"	"2020-09-15-AML0024:TGTTACTAGTAGCATA"	-0.453893820673782	-16.4187574616638	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTAGTAGCATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.30279175786	32.9009788806759	0.0126430248566314	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.71122703469	2592.71122703469
"AML-0024"	"2020-09-15-AML0024:TGTTACTCAAAGCGTG"	-2.15339432182963	-16.1051912537781	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTCAAAGCGTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2998.5291861749	33.5047163408371	0.0111737169327265	2977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2994.8766308597	2994.8766308597
"AML-0024"	"2020-09-15-AML0024:TGTTACTCACCACATA"	-1.97893081131633	-15.5495548478332	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTCACCACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.61483469046	37.8946639490421	0.0140422647433452	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2694.2649189894	2694.2649189894
"AML-0024"	"2020-09-15-AML0024:TGTTACTCAGATGCGA"	-0.313582788140136	-16.030339264032	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTCAGATGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2524.69039155362	41.728467565522	0.0165281524043998	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.88486154866	2516.88486154866
"AML-0024"	"2020-09-15-AML0024:TGTTACTCATTCATCT"	-3.31252727928813	13.6283836134705	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTCATTCATCT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2161.09604913685	40.8165682078785	0.0188869755345584	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2155.99505102427	2155.99505102427
"AML-0024"	"2020-09-15-AML0024:TGTTACTTCCAGCCTT"	-2.56092653694804	-15.6404037705627	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTTCCAGCCTT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.80284198864	39.878154363303	0.0148091623127718	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2686.19698951044	2686.19698951044
"AML-0024"	"2020-09-15-AML0024:TGTTACTTCCATTGTT"	-1.2115435403889	-15.6163625947204	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTACTTCCATTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2885.47166110406	46.9235103863829	0.0162619896840119	2740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2881.55192266683	2881.55192266683
"AML-0024"	"2020-09-15-AML0024:TGTTCATAGGAAGTGA"	-1.34014580670055	-16.7626505128113	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCATAGGAAGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.46890397675	37.4412638558238	0.0141262792404948	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2639.22008904324	2639.22008904324
"AML-0024"	"2020-09-15-AML0024:TGTTCATCATAATCGC"	-1.28140268746074	-15.7559604874817	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCATCATAATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.52756548959	34.59210100807	0.0120929095127071	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.17477665827	2850.17477665827
"AML-0024"	"2020-09-15-AML0024:TGTTCATGTCCACTCT"	-2.20009217682536	-16.0586214295593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCATGTCCACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.18178332693	35.2541388063888	0.0143883768323997	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2444.26021793112	2444.26021793112
"AML-0024"	"2020-09-15-AML0024:TGTTCATGTCCTGTTC"	-1.44123611870463	-16.1413717499939	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCATGTCCTGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.95076814309	43.495444178045	0.0180109030593156	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2410.33057164709	2410.33057164709
"AML-0024"	"2020-09-15-AML0024:TGTTCATTCTGCTGAA"	-2.31379685822185	-15.6439819565979	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCATTCTGCTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2879.40725932261	37.1384808111236	0.0128979604017045	2928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.59830760525	2873.59830760525
"AML-0024"	"2020-09-15-AML0024:TGTTCCGAGAAACACT"	-2.13867173615153	-16.6571188203064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGAGAAACACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2238.80909728736	38.9713514880371	0.0174071793505111	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2234.71627210506	2234.71627210506
"AML-0024"	"2020-09-15-AML0024:TGTTCCGAGAGAACCC"	-1.42741260948833	-16.6303529969421	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGAGAGAACCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.23272209772	43.5142966320257	0.0170028681863517	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.81395235972	2548.81395235972
"AML-0024"	"2020-09-15-AML0024:TGTTCCGAGGATGTTA"	-0.465359608561355	-16.1729364625183	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGAGGATGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.61704352335	41.8203138906065	0.0172767162829419	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.16652101943	2413.16652101943
"AML-0024"	"2020-09-15-AML0024:TGTTCCGAGGCGCTCT"	-0.647222201258498	-16.6380472413269	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGAGGCGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.55507526172	37.1361083973151	0.0142636154503404	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.68373716715	2592.68373716715
"AML-0024"	"2020-09-15-AML0024:TGTTCCGAGTCCGTCG"	-1.85629306259807	-15.4576368561951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGAGTCCGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.45309528111	36.8439939816522	0.0143504058747442	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2562.25136222675	2562.25136222675
"AML-0024"	"2020-09-15-AML0024:TGTTCCGCACATTGTG"	-1.91424677792247	-15.4953193894592	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGCACATTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2796.46940803108	32.6560903785695	0.0116776140245932	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2787.87033199433	2787.87033199433
"AML-0024"	"2020-09-15-AML0024:TGTTCCGCATGAATCC"	-1.47250256958659	-15.9598875275818	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGCATGAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2745.64087478681	34.2361415924911	0.0124692715303306	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.39102573644	2737.39102573644
"AML-0024"	"2020-09-15-AML0024:TGTTCCGCATGACGAG"	-0.47584835711177	-16.0322542420593	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGCATGACGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.34019987193	35.6879209788585	0.0139496385119716	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.3078931846	2553.3078931846
"AML-0024"	"2020-09-15-AML0024:TGTTCCGCATGTGCCG"	-1.73880455914195	-16.5692587128845	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGCATGTGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.68326490521	38.6654201977776	0.0137078206117116	3006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.16859597516	2812.16859597516
"AML-0024"	"2020-09-15-AML0024:TGTTCCGGTGAGTAGC"	-1.33699284020122	-16.5865869752136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGGTGAGTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.83338523479	42.4864832101251	0.0195985925392156	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2160.84651692084	2160.84651692084
"AML-0024"	"2020-09-15-AML0024:TGTTCCGGTTTGGAGG"	-0.391639570624191	-16.2899465790954	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGGTTTGGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.14760093846	38.7509690023028	0.0140700407592892	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.76015023548	2738.76015023548
"AML-0024"	"2020-09-15-AML0024:TGTTCCGTCCACCCTA"	-2.38684425774272	-15.8644113770691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGTCCACCCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.88223041157	37.2031119296463	0.0152666843991731	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2431.94676372525	2431.94676372525
"AML-0024"	"2020-09-15-AML0024:TGTTCCGTCCTGCCAT"	9.66068234023396	6.95527026737062	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCCGTCCTGCCAT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1778.62456864831	32.6272037674502	0.0183440644768816	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1769.51898908926	1769.51898908926
"AML-0024"	"2020-09-15-AML0024:TGTTCTAAGAGATGCC"	-1.47389278832133	-16.0294447175232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTAAGAGATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2761.27353407881	40.6601227624076	0.0147251339863988	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2748.41292167218	2748.41292167218
"AML-0024"	"2020-09-15-AML0024:TGTTCTAAGCATCGAG"	-1.18636427345927	-16.0077715150085	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTAAGCATCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.30555552334	36.0228672269638	0.0138746640010569	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.83435271454	2588.83435271454
"AML-0024"	"2020-09-15-AML0024:TGTTCTAAGCTAGCCC"	-1.98776565018352	-15.7920532456604	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTAAGCTAGCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.16085594026	37.1264909257286	0.0139827652410088	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.89327541431	2649.89327541431
"AML-0024"	"2020-09-15-AML0024:TGTTCTAAGGGCCAAT"	-0.894419710070449	-16.5264654389587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTAAGGGCCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.08161729953	37.6987576595257	0.0142308781327605	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.62920953599	2642.62920953599
"AML-0024"	"2020-09-15-AML0024:TGTTCTACAAACGTGG"	-0.0340485450928986	-16.5281591645447	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTACAAACGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.66540951417	39.1915612811719	0.0159596503372687	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2450.42951353926	2450.42951353926
"AML-0024"	"2020-09-15-AML0024:TGTTCTACAGACCTGC"	-1.0935038131779	-17.3995466462341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TGTTCTACAGACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2977.20085967875	45.2718980665967	0.0152061954165503	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2969.940144403	2969.940144403
"AML-0024"	"2020-09-15-AML0024:TTTATGCCACTGTCGG"	-2.48174605789836	-16.029118560907	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCACTGTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.09508880733	40.6652596417233	0.0154380378348968	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.3375322317	2624.3375322317
"AML-0024"	"2020-09-15-AML0024:TTTATGCCAGAGCGTA"	0.144902763038319	-16.1788149110046	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCAGAGCGTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2869.40139739533	32.5243083251095	0.0113348757530519	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2863.79349920674	2863.79349920674
"AML-0024"	"2020-09-15-AML0024:TTTATGCCAGGTATGG"	-1.59533880177196	-16.4960890046326	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCAGGTATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.71083865176	33.4199874772167	0.0121894646970324	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2736.6749670979	2736.6749670979
"AML-0024"	"2020-09-15-AML0024:TTTATGCCATCGAACT"	-0.969624618918258	12.5562982329163	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0167597765363128	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCATCGAACT"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2068.84492124076	45.8669111832755	0.0221702993358089	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2065.98918248858	2065.98918248858
"AML-0024"	"2020-09-15-AML0024:TTTATGCCATTCTTCA"	-0.974691013724166	-15.7061529389587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCATTCTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.89134224788	32.551808954067	0.0125204497684594	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.12777788214	2592.12777788214
"AML-0024"	"2020-09-15-AML0024:TTTATGCGTATCTCGA"	-2.39726052704509	-16.5173158875671	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCGTATCTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.36594118595	38.0586380434437	0.0133148235133438	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.3189644109	2852.3189644109
"AML-0024"	"2020-09-15-AML0024:TTTATGCGTATTGACC"	-0.211605618626434	-16.0484819642273	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCGTATTGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.38637193158	43.6299273074411	0.0162109490344667	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.92239513072	2680.92239513072
"AML-0024"	"2020-09-15-AML0024:TTTATGCGTTCCATTT"	-0.816599289805251	-16.0858812562195	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCGTTCCATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.41753507761	36.58521356702	0.0131110176549269	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.22468623473	2785.22468623473
"AML-0024"	"2020-09-15-AML0024:TTTATGCTCCGATTAG"	-0.598327497870284	-16.748543762323	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCTCCGATTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2667.0169372785	39.08781971509	0.0146560073049166	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2660.41975330476	2660.41975330476
"AML-0024"	"2020-09-15-AML0024:TTTATGCTCCGTGTAA"	0.56220038708989	-16.0938654175964	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCTCCGTGTAA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2684.72589929508	40.3571010849829	0.0150321122523455	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2674.20362071119	2674.20362071119
"AML-0024"	"2020-09-15-AML0024:TTTCACAAGAGCAGTC"	-2.74291406098064	-15.9599828950134	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACAAGAGCAGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.10789768936	34.7218169853787	0.0137833782416494	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2514.34800817829	2514.34800817829
"AML-0024"	"2020-09-15-AML0024:TTTCACAAGTGGGAAA"	-2.80963693085368	-15.842330001947	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACAAGTGGGAAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.71218073311	44.1359915364761	0.0170165340103392	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2577.80800835781	2577.80800835781
"AML-0024"	"2020-09-15-AML0024:TTTCACACAGCTATAC"	-1.78103206577953	-15.606999420282	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACACAGCTATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.54452292644	39.8859712287359	0.0139046024595236	2725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2862.47822417946	2862.47822417946
"AML-0024"	"2020-09-15-AML0024:TTTCACACAGCTCTGG"	-2.61389337006267	-16.4429674378601	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACACAGCTCTGG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.28857860598	33.0763296148123	0.0115397765115818	2444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2854.98237562548	2854.98237562548
"AML-0024"	"2020-09-15-AML0024:TTTCACAGTCACATTG"	-1.13694546642955	-16.5325899354187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACAGTCACATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.86697579538	34.3256476624898	0.0131020574630774	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2610.46899241409	2610.46899241409
"AML-0024"	"2020-09-15-AML0024:TTTCACATCGTTGTTT"	-0.50152967396434	-16.4859228364197	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCACATCGTTGTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.50692312247	36.6414294511393	0.0137620034460485	2622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2653.68968160044	2653.68968160044
"AML-0024"	"2020-09-15-AML0024:TTTCAGTAGAAGAGCA"	-2.13615045967754	-16.3703088990417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTAGAAGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.63311059475	41.3454268391048	0.0167212137789257	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2470.23591632046	2470.23591632046
"AML-0024"	"2020-09-15-AML0024:TTTCAGTAGGTCACTT"	-0.729892174631912	-16.5613966218201	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTAGGTCACTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2860.71744333827	33.4861824254877	0.0117055190135841	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.66650488982	2850.66650488982
"AML-0024"	"2020-09-15-AML0024:TTTCAGTCAATACCCA"	-1.85787902298625	-16.1697778931824	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTCAATACCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.64707451143	35.0606610372854	0.0143594303219687	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2434.82003154013	2434.82003154013
"AML-0024"	"2020-09-15-AML0024:TTTCAGTCACCGGCTA"	-1.00281820717509	-15.6828632584778	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTCACCGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.73612262001	28.7170352978729	0.0110038080283162	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2599.69373787542	2599.69373787542
"AML-0024"	"2020-09-15-AML0024:TTTCAGTGTTGCAACT"	-2.61294398728068	-15.7721872559753	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTGTTGCAACT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2771.6043149095	34.4574220395678	0.0124323020620975	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2762.75482921665	2762.75482921665
"AML-0024"	"2020-09-15-AML0024:TTTCAGTGTTTACCTT"	-2.12060866776164	-15.9511614075867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTGTTTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.4194873638	34.3635782203154	0.0126643072994589	2552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.48268917896	2708.48268917896
"AML-0024"	"2020-09-15-AML0024:TTTCAGTTCACCTGTC"	-2.86969719353374	-15.6273689500061	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTTCACCTGTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.91866458894	43.2568099442818	0.0209382928213627	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2064.72073027348	2064.72073027348
"AML-0024"	"2020-09-15-AML0024:TTTCAGTTCGCGGTAC"	1.15543939647023	-16.2205057374206	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTTCGCGGTAC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2884.72762278486	46.3925564672761	0.0160821271654374	3345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2870.28673240482	2870.28673240482
"AML-0024"	"2020-09-15-AML0024:TTTCAGTTCGGTCTGG"	-1.93420646610911	-15.5992346039978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCAGTTCGGTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2854.89987320721	36.4362760136337	0.0127627159031329	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2848.33856391462	2848.33856391462
"AML-0024"	"2020-09-15-AML0024:TTTCATGAGCATGATA"	-0.752019802958328	-15.8401556245056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCATGAGCATGATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.60840950519	43.4318265014553	0.0158822836756046	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2726.39492880572	2726.39492880572
"AML-0024"	"2020-09-15-AML0024:TTTCATGGTCACATTG"	-2.26694021645244	-16.2984132996765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCATGGTCACATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.44721156851	37.9850265127963	0.0138255710074628	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.66945017211	2722.66945017211
"AML-0024"	"2020-09-15-AML0024:TTTCATGGTTTCGTAG"	-1.60403023186381	-15.7667551270691	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCATGGTTTCGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.0548044861	39.3667172184347	0.0134907395015042	3256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2910.73643480395	2910.73643480395
"AML-0024"	"2020-09-15-AML0024:TTTCATGTCTTAGCAG"	-2.62352714958842	-16.1061964265076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCATGTCTTAGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.98456558976	35.6044721065258	0.0122774695179404	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.98012073011	2886.98012073011
"AML-0024"	"2020-09-15-AML0024:TTTCCTCAGCGCCATC"	-2.68143926087077	-15.8514585725036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCAGCGCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.23271243176	38.0549967059817	0.0153186118657662	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2475.84831834866	2475.84831834866
"AML-0024"	"2020-09-15-AML0024:TTTCCTCAGGTCATCT"	-0.0629243654316247	-15.9997320405212	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCAGGTCATCT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2795.94059119921	35.7072781953676	0.0127711147753867	2875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2779.86263442007	2779.86263442007
"AML-0024"	"2020-09-15-AML0024:TTACCATAGTAAAGCT"	-1.7309127849644	-15.7820921174255	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATAGTAAAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2937.87073482648	41.5499902684388	0.014142892597653	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2934.57201928632	2934.57201928632
"AML-0024"	"2020-09-15-AML0024:TTACCATAGTGGTGAC"	-1.42023966732677	-15.8425083390442	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATAGTGGTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.8143899611	40.3807289701465	0.015314209875327	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.63643699818	2633.63643699818
"AML-0024"	"2020-09-15-AML0024:TTACCATCAATAGTCC"	-1.96558509293254	-15.5767851105896	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATCAATAGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.31809603382	39.5814905724122	0.0144073198620699	2634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.25126594112	2742.25126594112
"AML-0024"	"2020-09-15-AML0024:TTACCATCAGCAGTAG"	-0.86683170023616	-16.4585485688415	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATCAGCAGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3092.24027464002	37.7421914081308	0.012205452376279	3625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3081.63064895808	3081.63064895808
"AML-0024"	"2020-09-15-AML0024:TTACCATTCGGAATTC"	-0.455085436732131	-16.2113008729187	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATTCGGAATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.19974436683	38.8939546815156	0.0136796420155057	2810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2834.13848430225	2834.13848430225
"AML-0024"	"2020-09-15-AML0024:TTACCATTCTGAGAGG"	-0.662101487547714	-15.7397499314514	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCATTCTGAGAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.74934777421	40.3733476678237	0.0151395359678333	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2663.62819964193	2663.62819964193
"AML-0024"	"2020-09-15-AML0024:TTACCGCAGGATATGT"	-2.47927532616313	-16.369730972406	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCGCAGGATATGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.55263780874	43.2055212197062	0.0156227441231926	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.08844059806	2757.08844059806
"AML-0024"	"2020-09-15-AML0024:TTACCGCAGGGATCTG"	-2.88561091843303	-15.8675585023132	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCGCAGGGATCTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.34728578721	41.9120792533829	0.016356908170044	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.39034677556	2554.39034677556
"AML-0024"	"2020-09-15-AML0024:TTACCGCGTTATTCCT"	-1.93024502220805	-16.4920015565124	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACCGCGTTATTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2869.60857835592	38.7025508273032	0.0134870487631024	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2860.03775727763	2860.03775727763
"AML-0024"	"2020-09-15-AML0024:TTACGCCAGGTGGCTA"	-1.2464579147404	-16.6154356232849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGCCAGGTGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.26733508551	30.0298342510331	0.0104587385103724	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.67543261701	2859.67543261701
"AML-0024"	"2020-09-15-AML0024:TTACGCCCACTGTCCT"	-0.963806847960311	-16.4164152375427	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGCCCACTGTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.76779453776	32.4881408882787	0.0115543470379707	2762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.04885518478	2803.04885518478
"AML-0024"	"2020-09-15-AML0024:TTACGCCGTTGAAGTA"	-0.626139144331771	-15.6911955109802	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGCCGTTGAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.45917334265	37.4300503496968	0.0150778110478639	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.26189700078	2481.26189700078
"AML-0024"	"2020-09-15-AML0024:TTACGCCTCCCTCGAT"	-0.288748989731628	-15.8909387818542	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGCCTCCCTCGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.86388122944	37.087418823362	0.0128737143969241	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2874.42824147675	2874.42824147675
"AML-0024"	"2020-09-15-AML0024:TTACGCCTCCGTGGGT"	-1.9240439933842	-15.6096105805603	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGCCTCCGTGGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.87349676671	31.2111167278433	0.0114457516143858	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2722.27109316587	2722.27109316587
"AML-0024"	"2020-09-15-AML0024:TTACGTTAGAGCATCG"	0.0976649458402812	-16.1446581116882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTAGAGCATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.26056011133	33.9563494491282	0.0122002050170143	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.78739561474	2775.78739561474
"AML-0024"	"2020-09-15-AML0024:TTACGTTAGATGAAGG"	-1.51720200005229	-16.1947622529236	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTAGATGAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.74002232997	33.1279217814623	0.0132791078368649	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.31303672713	2489.31303672713
"AML-0024"	"2020-09-15-AML0024:TTACGTTAGCGTCGAA"	-2.9741350215977	-15.8328581086365	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTAGCGTCGAA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.78130570256	39.6435657525362	0.0182371454058132	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2171.10632453532	2171.10632453532
"AML-0024"	"2020-09-15-AML0024:TTACGTTCATTACGGT"	-1.44670198383983	-16.6951418153015	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTCATTACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.28490909288	39.5813965241644	0.015280711548455	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2578.21932507632	2578.21932507632
"AML-0024"	"2020-09-15-AML0024:TTACGTTCATTGGCAT"	-2.09809527817424	-16.4738970032898	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTCATTGGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.48882577326	33.859576265748	0.0130104598069456	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2590.98705176726	2590.98705176726
"AML-0024"	"2020-09-15-AML0024:TTACGTTGTAACCCGC"	-0.67105726423915	-16.2530660859314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTGTAACCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2724.65877675461	41.1812916597384	0.0151142932139158	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2714.94273496121	2714.94273496121
"AML-0024"	"2020-09-15-AML0024:TTACGTTGTGGGAGAG"	-1.14542923393901	-16.1222563019958	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTGTGGGAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2806.07274747495	35.0970972110896	0.0125075507193004	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2803.00216986437	2803.00216986437
"AML-0024"	"2020-09-15-AML0024:TTACGTTTCCCATGGG"	-2.01932774010356	-15.9691553345886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACGTTTCCCATGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3002.71878864537	39.3471973800914	0.0131038569208948	3102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2991.38363934019	2991.38363934019
"AML-0024"	"2020-09-15-AML0024:TTACTGTAGACGACGT"	-1.25322792950328	-16.7467832795349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTAGACGACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.08569304849	47.782996499284	0.021837808569879	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2174.2924011313	2174.2924011313
"AML-0024"	"2020-09-15-AML0024:TTACTGTCAAGATTGA"	-0.882598320872146	-16.3482408753601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTCAAGATTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2786.08533740624	40.4318931489344	0.0145120799446061	2624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.11189920139	2777.11189920139
"AML-0024"	"2020-09-15-AML0024:TTACTGTGTCATCACA"	-2.66160092774089	-15.7746868363586	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTGTCATCACA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.94718667555	34.7315717263069	0.0126621365132449	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2734.68933484234	2734.68933484234
"AML-0024"	"2020-09-15-AML0024:TTACTGTGTCTTGTCC"	-1.67104218426402	-16.6383695832458	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTGTCTTGTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.58338812211	37.0820986008671	0.0131423011479901	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2805.27214699554	2805.27214699554
"AML-0024"	"2020-09-15-AML0024:TTACTGTGTTCTAAGC"	-0.11202166500743	-16.1197595826355	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTGTTCTAAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.92193403997	35.1452084786813	0.0124016148986077	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2827.45155854636	2827.45155854636
"AML-0024"	"2020-09-15-AML0024:TTACTGTTCGCGTTTC"	-2.1147509616917	-16.6260938874451	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTACTGTTCGCGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.48615300017	37.2440402503431	0.0147882648494914	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2507.11028552368	2507.11028552368
"AML-0024"	"2020-09-15-AML0024:TTAGGCAAGATCCTAC"	8.05916370925252	7.59624049747316	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAAGATCCTAC"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1680.2143215182	32.603020008716	0.019404084104733	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1678.51783547835	1678.51783547835
"AML-0024"	"2020-09-15-AML0024:TTAGGCAAGGTTCACT"	-1.78283892098125	-16.6535425416199	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAAGGTTCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.75528686353	34.0321064668299	0.0132536408905225	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2561.67772611449	2561.67772611449
"AML-0024"	"2020-09-15-AML0024:TTAGGCAAGTTACGTC"	-1.03572819653209	-15.5192985764709	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAAGTTACGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.76817137066	41.9993937036015	0.014523776186282	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2888.01223281537	2888.01223281537
"AML-0024"	"2020-09-15-AML0024:TTAGGCAAGTTGCTGT"	0.990276654332322	-16.2185812226501	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAAGTTGCTGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2600.21572210089	36.2001191269469	0.0139219676349385	3507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2592.65747729473	2592.65747729473
"AML-0024"	"2020-09-15-AML0024:TTAGGCACAACAAAGT"	-1.40892968598064	-16.5299120179382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCACAACAAAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.12172712638	28.518400050048	0.0110317435928826	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.35994851366	2575.35994851366
"AML-0024"	"2020-09-15-AML0024:TTAGGCACAGATTCGT"	11.8178736167843	-1.86459948932799	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCACAGATTCGT"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1254.11434630371	35.9584179984103	0.028672359984073	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1254.11434630371	1254.11434630371
"AML-0024"	"2020-09-15-AML0024:TTAGGCACAGTAACGG"	-1.91812596741374	-16.0360346070495	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCACAGTAACGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.25291264761	30.3361830699615	0.0118953625813007	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.49974591801	2543.49974591801
"AML-0024"	"2020-09-15-AML0024:TTAGGCACAGTCTCTC"	-2.7406636280125	-15.9106884232727	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCACAGTCTCTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.6179003984	38.0392094436206	0.0137642795837069	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2752.810636259	2752.810636259
"AML-0024"	"2020-09-15-AML0024:TTAGGCAGTACGCGTC"	-0.434857885271865	-16.0342626801697	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAGTACGCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.34976134347	30.939847021236	0.0119166714292093	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2594.44863559128	2594.44863559128
"AML-0024"	"2020-09-15-AML0024:TTAGGCAGTCGCAGTC"	0.146693159907502	-16.0248460999695	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAGTCGCAGTC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2906.6267684897	46.2557799433568	0.0159139042015331	2956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2898.47204346626	2898.47204346626
"AML-0024"	"2020-09-15-AML0024:TTAGGCAGTTAAAGTG"	-1.34771762314494	-16.2262068024841	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCAGTTAAAGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.60130346417	35.9770429751916	0.012892218938811	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2785.13130680721	2785.13130680721
"AML-0024"	"2020-09-15-AML0024:TTAGGCATCAGACCCG"	-2.66543422165568	-16.0931997529236	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCATCAGACCCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.64699722176	47.0727895497701	0.0189074152288656	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.63220348695	2486.63220348695
"AML-0024"	"2020-09-15-AML0024:TTAGGCATCCTACAAG"	-1.36355112019237	-15.7346782914368	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGCATCCTACAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.02714962637	37.3386749330584	0.0134892733758404	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2755.07752710205	2755.07752710205
"AML-0024"	"2020-09-15-AML0024:TTAGGGTAGCCTGTCG"	-0.713449100882369	-16.5752840272156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGGTAGCCTGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.12448156949	38.9688866524844	0.0159373835345474	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2438.67807503309	2438.67807503309
"AML-0024"	"2020-09-15-AML0024:TTAGGGTCACATATCG"	-1.05575809899028	-15.6146784058777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGGTCACATATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.76262702059	38.8184520713618	0.0143625088208925	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2695.97793620973	2695.97793620973
"AML-0024"	"2020-09-15-AML0024:TTAGGGTGTTTCTTAC"	-2.68466792526897	-15.8959446183411	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGGTGTTTCTTAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.02272285281	38.0740303920495	0.0137848360467954	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.80982159363	2754.80982159363
"AML-0024"	"2020-09-15-AML0024:TTAGGGTTCGCCTTGT"	-1.63621066036876	-16.3205595246521	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGGTTCGCCTTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2883.38613590884	31.5424291407959	0.010939370467235	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2876.03752216029	2876.03752216029
"AML-0024"	"2020-09-15-AML0024:TTAGGGTTCTGAATCG"	-0.936949650675613	-16.1905203095642	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGGGTTCTGAATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.1987034747	33.2938650237054	0.0120403155772744	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2760.52713458869	2760.52713458869
"AML-0024"	"2020-09-15-AML0024:TTAGTCTAGGACTATA"	-1.91829739037212	-16.2818994752136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTAGGACTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.19262858824	33.6151643772868	0.0134235537608134	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2495.86977431181	2495.86977431181
"AML-0024"	"2020-09-15-AML0024:TTAGTCTAGGTAGACC"	-0.494088570505935	-15.8718872300354	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTAGGTAGACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.84133889741	31.5771283946867	0.0115928662744611	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.46805436578	2713.46805436578
"AML-0024"	"2020-09-15-AML0024:TTAGTCTAGTAGCAAT"	-2.01604566994365	-16.0789442292419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTAGTAGCAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2684.65307842255	33.859039584256	0.0126120726198824	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2676.77086907626	2676.77086907626
"AML-0024"	"2020-09-15-AML0024:TTAGTCTAGTGTAGAT"	-2.76971850815471	-16.0932531586853	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTAGTGTAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.22533050547	35.8754026221553	0.0140675422649984	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.03083042929	2543.03083042929
"AML-0024"	"2020-09-15-AML0024:TTAGTCTCACGCGCTA"	-2.48445496979411	-16.4231539002624	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTCACGCGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1426.78646950342	48.4489020776638	0.0339566593272544	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1424.67124655434	1424.67124655434
"AML-0024"	"2020-09-15-AML0024:TTAGTCTGTGAGCAGT"	-1.00945434990581	-15.8799143067566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTGTGAGCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.98241602759	32.9312062614068	0.012934577259488	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2540.91736989534	2540.91736989534
"AML-0024"	"2020-09-15-AML0024:TTAGTCTTCTTTCTAG"	-0.570812920958358	-15.964701675531	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTAGTCTTCTTTCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.64045566631	36.9854615234532	0.0138800945714099	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2655.18240125094	2655.18240125094
"AML-0024"	"2020-09-15-AML0024:TTATTGCAGCGCCATC"	-1.03970382633861	-15.9887552491394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCAGCGCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2590.88409212257	33.3351689956854	0.0128663297200516	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.20416909815	2587.20416909815
"AML-0024"	"2020-09-15-AML0024:TTATTGCAGGACATCG"	-1.4005186361378	-15.1512632600036	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCAGGACATCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2913.17326520632	34.048016057863	0.0116876041890531	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2905.93369463151	2905.93369463151
"AML-0024"	"2020-09-15-AML0024:TTATTGCAGTATTAGG"	-0.792481343180496	-16.5102815858093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCAGTATTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.0289786152	38.2123505836204	0.0153894098348106	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2473.95805788739	2473.95805788739
"AML-0024"	"2020-09-15-AML0024:TTATTGCAGTGAATAC"	-1.3870441717213	-16.9047384492126	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCAGTGAATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.91664151497	41.9244801767596	0.0182366247734549	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2285.84909326077	2285.84909326077
"AML-0024"	"2020-09-15-AML0024:TTATTGCCACAAAGTA"	9.58619560775105	7.1783089407715	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00453352421856359	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCCACAAAGTA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1713.02549988422	25.7768479846857	0.0150475564937171	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1707.78446845882	1707.78446845882
"AML-0024"	"2020-09-15-AML0024:TTATTGCCAGAGATTA"	0.209148337214631	-16.3042249909607	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCCAGAGATTA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2778.68846197827	26.601977861592	0.00957357336944957	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2768.3766461513	2768.3766461513
"AML-0024"	"2020-09-15-AML0024:TTATTGCCAGAGGCTA"	-0.366004268557388	-16.2159624329773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTATTGCCAGAGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.52213734568	39.3955646185415	0.0133204631407758	3558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2947.63277381991	2947.63277381991
"AML-0024"	"2020-09-15-AML0024:TTCAATCCAGACCTAT"	-1.66135821762736	-16.4584093323913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCCAGACCTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.06338689349	38.147505395262	0.0151796829296924	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.81110724284	2500.81110724284
"AML-0024"	"2020-09-15-AML0024:TTCAATCCAGATGCGA"	-1.80479834500011	-16.3435354462829	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCCAGATGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2891.4671339521	34.7918625104728	0.0120325982965328	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2879.20998926093	2879.20998926093
"AML-0024"	"2020-09-15-AML0024:TTCAATCGTAACTTCG"	-0.423011342913467	-15.983105682489	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCGTAACTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.48979390138	36.0845571922212	0.0132688702392423	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.21357310031	2711.21357310031
"AML-0024"	"2020-09-15-AML0024:TTCAATCGTACTGCGC"	-1.09898946705516	-15.5191326371399	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCGTACTGCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.88110504113	39.9108360038397	0.016623412096517	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2392.27614222647	2392.27614222647
"AML-0024"	"2020-09-15-AML0024:TTCAATCGTGACTCGC"	-2.25858936730083	-15.6663027039734	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCGTGACTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.17919966171	34.432611513704	0.0142508517242947	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2409.46029952885	2409.46029952885
"AML-0024"	"2020-09-15-AML0024:TTCAATCGTTCGTACA"	-0.369601200253326	-15.9654207459656	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCGTTCGTACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2756.38037802551	31.2547948024374	0.0113390717230494	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.44935135527	2751.44935135527
"AML-0024"	"2020-09-15-AML0024:TTCAATCTCCAACCAA"	-2.99561534348186	13.3683366545471	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCTCCAACCAA"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2433.52868713553	31.6021833751893	0.0129861560877623	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2424.69421212287	2424.69421212287
"AML-0024"	"2020-09-15-AML0024:TTCAATCTCGGTAGGA"	-2.84397015991862	-16.0168237916199	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAATCTCGGTAGGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.0585283238	42.5366879613438	0.0173827832350543	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2435.74432415063	2435.74432415063
"AML-0024"	"2020-09-15-AML0024:TTCACCGCATCATCTT"	-0.549672345549423	-16.1510401002136	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACCGCATCATCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2895.43129824409	37.9081002060395	0.0130923846229847	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2886.64683563102	2886.64683563102
"AML-0024"	"2020-09-15-AML0024:TTCACGCCAGCGGTTC"	-0.441368917853194	-16.5719251862732	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCCAGCGGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.84392757731	40.5717041841504	0.0151282868353945	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.11440684573	2670.11440684573
"AML-0024"	"2020-09-15-AML0024:TTCACGCCAGTATGAA"	-1.67360804501231	-16.3014230958191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCCAGTATGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.36188918033	34.5036019822608	0.0127208696302276	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.58589778932	2698.58589778932
"AML-0024"	"2020-09-15-AML0024:TTCACGCGTCTTGCTC"	-1.65486119213756	-16.5007829896179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCGTCTTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.18591411066	47.3279967533354	0.0178718557866923	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2642.92710661412	2642.92710661412
"AML-0024"	"2020-09-15-AML0024:TTCACGCGTGAATTGA"	-2.71319327774699	-15.494860672113	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCGTGAATTGA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.44992341001	34.4911522253401	0.012338318757385	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2790.38961846174	2790.38961846174
"AML-0024"	"2020-09-15-AML0024:TTCACGCGTGCACGCT"	-0.789919177920181	-16.6982450715271	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCGTGCACGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2741.34475386162	41.1172569970615	0.0149989369046492	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.33871284374	2733.33871284374
"AML-0024"	"2020-09-15-AML0024:TTCACGCGTTCGCGTG"	0.59226687726323	-16.1610365143982	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCGTTCGCGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2958.12669443513	33.4019503530254	0.0112915888341976	3197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2950.58515551837	2950.58515551837
"AML-0024"	"2020-09-15-AML0024:TTCACGCTCGGAATTC"	-1.75327799740489	-15.537437461969	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCTCGGAATTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.7205850523	34.2887567810072	0.013058798783163	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2622.09132689488	2622.09132689488
"AML-0024"	"2020-09-15-AML0024:TTCACGCTCTCTGCCA"	-0.135361592203933	-15.9555025330749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCACGCTCTCTGCCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3087.90828710822	40.0441962492118	0.0129680652810815	3591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3077.22905410577	3077.22905410577
"AML-0024"	"2020-09-15-AML0024:TTCAGGAAGATCCCAT"	-2.56557164612468	-16.1555357209411	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGAAGATCCCAT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2479.90035766976	35.7231760915799	0.0144050852612269	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2471.02600221847	2471.02600221847
"AML-0024"	"2020-09-15-AML0024:TTCAGGAAGCGTACAG"	-0.853645722300369	-16.2960252991882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGAAGCGTACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.63740571901	35.2571902063568	0.0124687805215222	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2817.49033251146	2817.49033251146
"AML-0024"	"2020-09-15-AML0024:TTCAGGAAGCTCCACG"	-2.1952146095341	-16.5669813386169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGAAGCTCCACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.28525540704	34.7768979412677	0.0133948678670193	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2588.296891307	2588.296891307
"AML-0024"	"2020-09-15-AML0024:TTCAGGACAACAGAGC"	-0.948852519423324	-15.6432686082092	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGACAACAGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2935.58833800156	33.436462769061	0.0113900380159649	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2930.58856067466	2930.58856067466
"AML-0024"	"2020-09-15-AML0024:TTCAGGACAACCACAT"	-0.0538522181218446	-16.0120554200378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGACAACCACAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2829.56010347951	37.5763857887908	0.0132799390769551	3232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.06717486579	2820.06717486579
"AML-0024"	"2020-09-15-AML0024:TTCAGGACACATCATG"	-1.50627384606059	-15.8373737565246	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGACACATCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.07830940253	33.2256103516402	0.0120379230685062	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.87630884646	2751.87630884646
"AML-0024"	"2020-09-15-AML0024:TTCAGGAGTTGTGTTG"	-1.29815338078197	-16.0006952515808	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGAGTTGTGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.17186113353	37.1365985574506	0.0142113112075766	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2606.70051289902	2606.70051289902
"AML-0024"	"2020-09-15-AML0024:TTCAGGATCCCTTCCC"	-0.939398686320144	-17.5327100983826	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGATCCCTTCCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3123.04031167208	38.376329703717	0.0122881313956432	3343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3113.43609567813	3113.43609567813
"AML-0024"	"2020-09-15-AML0024:TTCAGGATCGACGCTG"	-0.62851713123973	-15.9396524659363	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGATCGACGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.55960037176	37.4173780565872	0.0130895917131555	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.38077028835	2850.38077028835
"AML-0024"	"2020-09-15-AML0024:TTCAGGATCGGACTTA"	-0.97560010376628	-16.7369261018005	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCAGGATCGGACTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.44596527757	34.2073734079315	0.0147799403922697	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2308.27479664789	2308.27479664789
"AML-0024"	"2020-09-15-AML0024:TTCATGTCAAGCCCAC"	-2.0191527408665	-16.1119146577087	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATGTCAAGCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.33239388267	38.8694467821042	0.015760019565292	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2459.45894317624	2459.45894317624
"AML-0024"	"2020-09-15-AML0024:TTCATGTCAGAAGCGT"	-1.25668511810954	-15.9288053742615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATGTCAGAAGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.27987013117	33.8496422497326	0.0123032348025426	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.59730785467	2745.59730785467
"AML-0024"	"2020-09-15-AML0024:TTCATGTGTCTTGAAC"	-0.439414749771911	-15.9120073548523	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATGTGTCTTGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.71956638378	41.7020834039702	0.0163683962529525	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2543.03007240302	2543.03007240302
"AML-0024"	"2020-09-15-AML0024:TTCATGTTCGCAGATT"	-1.49177346649821	-16.0769567719665	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATGTTCGCAGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2798.96610965528	37.9894441814257	0.0135726702979281	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.14501083756	2792.14501083756
"AML-0024"	"2020-09-15-AML0024:TTCATGTTCGCCATAA"	-0.141711319715339	-16.3561582795349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATGTTCGCCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2993.92984662422	39.7560686422059	0.0132788911827819	3181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2987.84890851861	2987.84890851861
"AML-0024"	"2020-09-15-AML0024:TTCATTGAGGTGGCTA"	-2.77447996559795	-15.9986524811951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATTGAGGTGGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.8186526493	34.8981049994654	0.0131254175476361	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2656.26119127684	2656.26119127684
"AML-0024"	"2020-09-15-AML0024:TTCATTGCACTTTAGG"	-1.61269197884257	-15.9077129594055	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATTGCACTTTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.58236848913	36.5023942381672	0.0139184929620328	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2614.02470308778	2614.02470308778
"AML-0024"	"2020-09-15-AML0024:TTCATTGCATACCAGT"	0.192689542740029	-16.2042017213074	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATTGCATACCAGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2926.99287338011	37.3736242488311	0.0127686078735381	2707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2917.15141121613	2917.15141121613
"AML-0024"	"2020-09-15-AML0024:TTCATTGTCTCCAAGA"	-2.11287150803264	-16.3925905457703	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCATTGTCTCCAAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2987.81009174119	35.7021648471637	0.0119492751382862	3084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2979.2441327073	2979.2441327073
"AML-0024"	"2020-09-15-AML0024:TTCCAATCATACTGAC"	-0.442181478173095	-16.1000013581482	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCAATCATACTGAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2941.53382308821	40.8303262770124	0.0138806244403969	2887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2929.88936230273	2929.88936230273
"AML-0024"	"2020-09-15-AML0024:TTCCAATTCCGTGTGG"	-1.80750487271007	-16.2204771271911	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCAATTCCGTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.1075461155	35.9124511838468	0.0136336313362781	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.98848885601	2621.98848885601
"AML-0024"	"2020-09-15-AML0024:TTCCACGAGTATGAGT"	-0.584146003157455	-16.4923753968445	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGAGTATGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2538.594219431	35.5021368854588	0.0139849593187115	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2530.39004574577	2530.39004574577
"AML-0024"	"2020-09-15-AML0024:TTCCACGCACACAGAG"	-0.8187332552975	-15.9964475861755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGCACACAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.5416005101	36.1625936573707	0.0137315444914051	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.95508647397	2628.95508647397
"AML-0024"	"2020-09-15-AML0024:TTCCACGCAGGAATCG"	-2.84266958656963	-16.0334120026794	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGCAGGAATCG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.48302123258	37.9164919534818	0.014727808123329	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.19201865642	2564.19201865642
"AML-0024"	"2020-09-15-AML0024:TTCCACGCATTACGGT"	-1.72842035713847	-15.4442930451599	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGCATTACGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.17616066028	35.2961448529103	0.012216681465641	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2882.37253638395	2882.37253638395
"AML-0024"	"2020-09-15-AML0024:TTCCACGGTCAGCTTA"	-0.938711623579818	-16.5425997010437	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGGTCAGCTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.07491997314	33.298374531125	0.0148648485969051	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2225.05046404157	2225.05046404157
"AML-0024"	"2020-09-15-AML0024:TTCCACGGTGAAGCGT"	-0.947382311255294	-17.4013433686462	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGGTGAAGCGT"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3122.69745720529	47.2974117276806	0.01514633177753	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3111.98042067119	3111.98042067119
"AML-0024"	"2020-09-15-AML0024:TTCCACGGTGACCTGC"	-0.414280573756057	-16.2411165467468	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGGTGACCTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3036.97687563502	34.8838584639117	0.0114863760550095	3012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3030.8498667463	3030.8498667463
"AML-0024"	"2020-09-15-AML0024:TTCCACGGTTCTTCAT"	-0.754561702639419	-16.6659269562927	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGGTTCTTCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.92408807528	32.7430169880098	0.0127111731046684	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2567.68766340138	2567.68766340138
"AML-0024"	"2020-09-15-AML0024:TTCCACGTCCCTGGTT"	-1.51477859440501	-16.3590002289978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGTCCCTGGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2397.04572181589	37.1425075943776	0.0154951185354279	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2389.45745516525	2389.45745516525
"AML-0024"	"2020-09-15-AML0024:TTCCACGTCTTCGATT"	-2.22891459885295	-15.9577608338562	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCACGTCTTCGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.78607722686	32.6993368979923	0.0118356383679239	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2753.90662900539	2753.90662900539
"AML-0024"	"2020-09-15-AML0024:TTCCGGTAGCGCAATG"	-2.95014033737834	-15.7500972977844	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGGTAGCGCAATG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.06656571803	38.3570092092519	0.0143440741905961	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.56165226918	2668.56165226918
"AML-0024"	"2020-09-15-AML0024:TTCCGGTCACGTCGGT"	-2.81753001633342	-15.9085026017395	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGGTCACGTCGGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.56167499725	36.0032429860786	0.01412688707489	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2546.15288189033	2546.15288189033
"AML-0024"	"2020-09-15-AML0024:TTCCGGTTCGACGATT"	-1.15440605107005	-16.4591417542663	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGGTTCGACGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.57201249822	35.7081115504769	0.0134464858728815	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2643.55622433937	2643.55622433937
"AML-0024"	"2020-09-15-AML0024:TTCCGGTTCTGCGAGC"	-1.0375134748524	-15.9179296723572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGGTTCTGCGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.83908658531	33.7452479470069	0.0129697674698609	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.18172014043	2596.18172014043
"AML-0024"	"2020-09-15-AML0024:TTCCGGTTCTTCTAAC"	-1.59283206883128	-16.0399084321228	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGGTTCTTCTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.93961255327	35.6646255530266	0.0129082175343197	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2757.16944738161	2757.16944738161
"AML-0024"	"2020-09-15-AML0024:TTCCGTGAGCCTTTCC"	11.7574478584224	-1.895743273851	"2020-09-15-AML0024"	"AML0024"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.337349397590361	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGTGAGCCTTTCC"	"Ery"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1310.11116336036	40.4772867923982	0.030896070443806	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"Ery_AML-0024"	1304.37824788832	1304.37824788832
"AML-0024"	"2020-09-15-AML0024:TTCCGTGCAACGACAG"	-2.11779962006267	-16.3315801850525	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGTGCAACGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.47415835116	37.4041644585499	0.0137795249748372	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2706.80534881867	2706.80534881867
"AML-0024"	"2020-09-15-AML0024:TTCCGTGTCTCCATAT"	-0.624450067908126	-16.482523941156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCGTGTCTCCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.92639087462	48.6463588236004	0.0178983356528453	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2708.06347825073	2708.06347825073
"AML-0024"	"2020-09-15-AML0024:TTCCTAAAGATAGGGA"	0.430143375962418	-16.3356065980163	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAAAGATAGGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2711.68549999459	47.3078104288886	0.0174459060348197	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2700.0686467185	2700.0686467185
"AML-0024"	"2020-09-15-AML0024:TTCCTAACAATCGCCG"	0.780441363423508	-16.2037649384704	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAACAATCGCCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2957.98720214491	48.0521123808481	0.0162448682489243	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2948.03319853194	2948.03319853194
"AML-0024"	"2020-09-15-AML0024:TTCCTAACATTGACCA"	-2.14520178261455	-16.6193952790466	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAACATTGACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.15611678968	43.3739299076173	0.015122583339768	2554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2855.83676695433	2855.83676695433
"AML-0024"	"2020-09-15-AML0024:TTCCTAAGTAGCGTAG"	-2.88713632050212	-16.1201391450134	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAAGTAGCGTAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.59858698445	42.7586317922051	0.0164292073337933	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2592.65378400052	2592.65378400052
"AML-0024"	"2020-09-15-AML0024:TTCCTAAGTCATGGCC"	-1.34062872353252	-16.7926492921081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAAGTCATGGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.62519773158	33.5532530280546	0.0133751558656092	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2497.91428390714	2497.91428390714
"AML-0024"	"2020-09-15-AML0024:TTCCTAATCCTGGTCT"	-1.97020326080974	-16.1282911530701	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAATCCTGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.44501437629	32.3730495346376	0.0110320859229044	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2926.94511438606	2926.94511438606
"AML-0024"	"2020-09-15-AML0024:TTCCTAATCTCTCTTC"	-0.608840326697189	-16.3248529664245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTAATCTCTCTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3106.15951923153	41.9365206329881	0.0135010840149521	3163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3090.88210436306	3090.88210436306
"AML-0024"	"2020-09-15-AML0024:TTCCTCTAGCCTAACT"	-1.75199983540233	-15.5423641434875	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTAGCCTAACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.99999775133	45.337708026197	0.018695962089995	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2419.81144154389	2419.81144154389
"AML-0024"	"2020-09-15-AML0024:TTCCTCTAGTTCATGC"	-1.15621385994609	-16.210228942987	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTAGTTCATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.62873246567	34.5984488389789	0.0121286196290513	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.65665101942	2840.65665101942
"AML-0024"	"2020-09-15-AML0024:TTCCTCTCAACAGTGG"	-0.610633055598098	-16.4552202454773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTCAACAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.34145763392	36.3539176296734	0.0123891231319027	2857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2923.78377012112	2923.78377012112
"AML-0024"	"2020-09-15-AML0024:TTCCTCTCACCTGCAG"	-2.75965605202373	-15.5387392274109	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTCACCTGCAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.72610433084	36.1091616039603	0.0129529086619605	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2781.24186051305	2781.24186051305
"AML-0024"	"2020-09-15-AML0024:TTCCTCTCACTCCGAG"	-1.5768006843632	-15.8987903825012	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTCACTCCGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.01200858173	44.4733092854762	0.0164289294412022	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.42640745141	2698.42640745141
"AML-0024"	"2020-09-15-AML0024:TTCCTCTTCGCTTTAT"	-0.00547767701800469	-16.1717176667419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTTCGCTTTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3082.27792474404	40.333126715594	0.0130854931645865	3009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3068.59618440463	3068.59618440463
"AML-0024"	"2020-09-15-AML0024:TTCCTCTTCTGGGTCG"	-2.38397036019023	-15.5834951630798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTCTTCTGGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2722.36117891024	30.4139424516309	0.0111718983826406	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.8746795124	2713.8746795124
"AML-0024"	"2020-09-15-AML0024:TTCCTTCAGAGATGCC"	-0.954021434218246	-17.5507650605408	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTTCAGAGATGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3099.68995656174	40.9673976317431	0.013216611404963	3418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3091.1087208915	3091.1087208915
"AML-0024"	"2020-09-15-AML0024:TTCCTTCGTTCTCGCT"	1.70788969573323	-4.63929464733275	"2020-09-15-AML0024"	"AML0024"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00337078651685393	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTTCGTTCTCGCT"	"cDC2"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2166.16059266387	39.6794682273487	0.0183178792753091	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"DC_AML-0024"	2166.16059266387	2166.16059266387
"AML-0024"	"2020-09-15-AML0024:TTCCTTCTCAGCATTG"	-1.23871932449992	-15.7102689973083	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCCTTCTCAGCATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.33245753556	40.5234971824926	0.0145960535354846	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.48294891868	2764.48294891868
"AML-0024"	"2020-09-15-AML0024:TTCGATTAGAACGTGC"	-2.48237476769145	-16.0174284211365	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTAGAACGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.09526471111	36.6079725505232	0.0133260659070638	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2741.97161287587	2741.97161287587
"AML-0024"	"2020-09-15-AML0024:TTCGATTAGCTGAAAT"	-1.13721607151683	-16.2163343659607	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTAGCTGAAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2789.38604673023	34.830926504564	0.0124869508633964	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.64613046381	2779.64613046381
"AML-0024"	"2020-09-15-AML0024:TTCGATTAGGAGCTGT"	-2.81102047386821	-16.1980371705261	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTAGGAGCTGT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.94753203266	39.6165500190614	0.0158787106784508	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2488.93764190668	2488.93764190668
"AML-0024"	"2020-09-15-AML0024:TTCGATTAGTCTGTAC"	-2.27334676209148	-15.5610914460388	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTAGTCTGTAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.49506857931	35.0290970959442	0.0127913676010805	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.0781919142	2729.0781919142
"AML-0024"	"2020-09-15-AML0024:TTCGATTCACGCCAGT"	-0.523089985281783	-16.314835571405	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTCACGCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.07611083109	37.5490482635739	0.0130329942074117	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2873.47577678182	2873.47577678182
"AML-0024"	"2020-09-15-AML0024:TTCGATTCAGAAATTG"	-1.01250789585765	-16.2319326630798	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTCAGAAATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.85651741632	30.1711966328725	0.0108418082082379	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.71498570918	2775.71498570918
"AML-0024"	"2020-09-15-AML0024:TTCGATTCAGCAGAAC"	-2.69120107117351	-15.9751711121765	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTCAGCAGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2890.06857153409	37.1630694594592	0.0128588884794981	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2884.93997689442	2884.93997689442
"AML-0024"	"2020-09-15-AML0024:TTCGATTCAGTAGAAT"	-2.13921914520915	-15.8911180726257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTCAGTAGAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.22305390175	28.2251193082676	0.0105545119981994	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2670.29291700684	2670.29291700684
"AML-0024"	"2020-09-15-AML0024:TTCGATTCATTACTCT"	-0.55533734980281	-16.2794656983581	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTCATTACTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3056.20757905699	37.4702103048631	0.0122603616853881	3682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3045.6941539313	3045.6941539313
"AML-0024"	"2020-09-15-AML0024:TTCGATTGTTGCAAGG"	-1.95766220513042	-16.2873106232849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTGTTGCAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.74888316141	36.7913551404887	0.01395330263547	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2631.41074222626	2631.41074222626
"AML-0024"	"2020-09-15-AML0024:TTCGATTGTTTCCCAC"	-0.915123025805312	-16.2579488984314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTGTTTCCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.73158255506	36.8353591179189	0.0124539222339095	3263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2944.84016032229	2944.84016032229
"AML-0024"	"2020-09-15-AML0024:TTCGATTTCAGACTGT"	-1.99899707260783	-16.8321600190369	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGATTTCAGACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1455.35284497327	48.4623922971922	0.0332994108367461	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1446.86174166447	1446.86174166447
"AML-0024"	"2020-09-15-AML0024:TTCGCTGAGGCATCGA"	-0.432351599366027	-15.9344988099304	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGCTGAGGCATCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.22785360966	31.4858776787075	0.0125181015443676	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.29688870843	2511.29688870843
"AML-0024"	"2020-09-15-AML0024:TTCGCTGAGTGAGGTC"	-1.5827685398167	-16.6480627289978	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGCTGAGTGAGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1570.48843288954	51.0251377013812	0.032489979953243	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1560.03469139232	1560.03469139232
"AML-0024"	"2020-09-15-AML0024:TTCGCTGCAGTAGTTC"	-1.52965054932292	-16.1968565217224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGCTGCAGTAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.87084549187	35.9146455336073	0.0136616241894103	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2619.91775915873	2619.91775915873
"AML-0024"	"2020-09-15-AML0024:TTCGCTGGTGTGAGCA"	-1.74884293499644	-16.512553238031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGCTGGTGTGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.48707005841	37.0913663652411	0.0143682169844848	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2575.13665581879	2575.13665581879
"AML-0024"	"2020-09-15-AML0024:TTCGGTCAGAGCGACT"	-1.33819399300273	-16.6236620179382	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCAGAGCGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.66619810031	37.3050829691774	0.0156371763153132	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2374.35963493545	2374.35963493545
"AML-0024"	"2020-09-15-AML0024:TTCGGTCAGAGTGTGC"	-0.383891324431258	-15.7691641083923	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCAGAGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2393.67842387168	35.2065764857127	0.0147081479845432	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2391.57861507867	2391.57861507867
"AML-0024"	"2020-09-15-AML0024:TTCGGTCAGCGACTAG"	-1.62047813358958	-16.4526548615661	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCAGCGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3123.05308687117	37.8462738062643	0.0121183575025875	3940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3114.61443930615	3114.61443930615
"AML-0024"	"2020-09-15-AML0024:TTCGGTCAGTGATTCC"	-2.56899772110637	-15.6979046097961	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCAGTGATTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.73036946203	43.9171327795789	0.0176180838961162	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2489.32815110024	2489.32815110024
"AML-0024"	"2020-09-15-AML0024:TTCGGTCCAGCAGACA"	-0.859731118113357	-17.2777414551941	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCCAGCAGACA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2729.0846256948	42.8464266622394	0.0156999259967364	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2721.64568847845	2721.64568847845
"AML-0024"	"2020-09-15-AML0024:TTCGGTCCAGGATTCT"	-2.06286297264751	-16.5789785615173	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCCAGGATTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.72428647911	44.7757740434405	0.0170073920286281	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2628.76648260292	2628.76648260292
"AML-0024"	"2020-09-15-AML0024:TTCGGTCCATATTCGG"	-1.76007793369945	-16.3211794129578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCCATATTCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.73514949104	44.0677898788952	0.0174613369741996	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2510.66202568613	2510.66202568613
"AML-0024"	"2020-09-15-AML0024:TTCGGTCGTAACGCGA"	-1.59589991989787	-15.5339784852234	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCGTAACGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.97595100782	37.0740486047165	0.0130405776354084	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2840.42228743436	2840.42228743436
"AML-0024"	"2020-09-15-AML0024:TTCGGTCGTAAGCGGT"	-1.89974687519725	-16.1725969544617	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCGTAAGCGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.71395175796	32.7941180252382	0.0125038866717649	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2617.55737049601	2617.55737049601
"AML-0024"	"2020-09-15-AML0024:TTCGGTCGTCAACCAT"	-1.37337670746501	-16.0313768616882	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCGTCAACCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.14828347428	37.3249999592157	0.0140788050943352	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2641.14990230996	2641.14990230996
"AML-0024"	"2020-09-15-AML0024:TTCGGTCGTCGTTGGC"	-1.70451174202617	-15.6557779542175	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCGTCGTTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2926.22102658651	37.2647747063176	0.0127347778475188	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2919.34747426466	2919.34747426466
"AML-0024"	"2020-09-15-AML0024:TTCGGTCTCATTGGTG"	-0.0710526061361611	-16.5604028931824	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCGGTCTCATTGGTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2800.740556295	38.6828522859598	0.0138116514216268	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2784.6029109691	2784.6029109691
"AML-0024"	"2020-09-15-AML0024:TTCTAACCATTCAGCA"	-2.06679282608684	-16.2875375977722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACCATTCAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.69950691306	50.4505156715223	0.0226672628154978	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2221.28216182404	2221.28216182404
"AML-0024"	"2020-09-15-AML0024:TTCTAACGTCAAGTTC"	-0.6784824532574	-16.3224668732849	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACGTCAAGTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.35098656369	40.7406697166234	0.0147059596109725	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.19661517	2763.19661517
"AML-0024"	"2020-09-15-AML0024:TTCTAACGTCACAGAG"	-2.84254131737407	-15.9941606751648	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACGTCACAGAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.77865356397	37.2142536018113	0.0148336137781405	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2500.37569547431	2500.37569547431
"AML-0024"	"2020-09-15-AML0024:TTCTAACGTGGCTGCT"	-1.7917163175648	-15.9742670289245	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACGTGGCTGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.53591645431	38.4746405412363	0.0160542724509465	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2392.06096352985	2392.06096352985
"AML-0024"	"2020-09-15-AML0024:TTCTAACTCAAGGACG"	-0.794101993471938	-16.1546716920105	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACTCAAGGACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.46234596025	40.9520518985778	0.0141240157699014	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2894.27189488106	2894.27189488106
"AML-0024"	"2020-09-15-AML0024:TTCTAACTCACGTAGT"	-1.78210995617564	-16.1814928284851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAACTCACGTAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.91359314038	32.2734834238155	0.0124468025117365	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2587.44301729763	2587.44301729763
"AML-0024"	"2020-09-15-AML0024:TTCTAGTAGACATACA"	-1.85001156750377	-16.7866888276306	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAGTAGACATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.06897240888	40.7867680570384	0.017151213244973	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.62586232542	2370.62586232542
"AML-0024"	"2020-09-15-AML0024:TTCTAGTAGAGAGCGG"	-0.763833741576034	-16.6613245240417	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAGTAGAGAGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2767.14446034441	34.7187288091145	0.0125467713401537	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2761.62093369569	2761.62093369569
"AML-0024"	"2020-09-15-AML0024:TTCTAGTCACAGCCTG"	0.147794974117917	-15.9777155152527	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAGTCACAGCCTG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2998.59091462293	35.4670033078605	0.0118278899382047	3469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2984.65154610491	2984.65154610491
"AML-0024"	"2020-09-15-AML0024:TTCTAGTTCCGTGTAA"	-2.13324842873271	-16.5601053467956	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTAGTTCCGTGTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2494.94437995546	42.8131345423373	0.0171599555029365	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2486.17125766918	2486.17125766918
"AML-0024"	"2020-09-15-AML0024:TTCTCTCAGAAACTGT"	-1.42086396637614	-16.4733419648376	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCAGAAACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.4806718053	34.5411619124741	0.0125218067559881	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2749.70361035653	2749.70361035653
"AML-0024"	"2020-09-15-AML0024:TTCTCTCAGCTATCTG"	-2.81600342217143	-15.5281677476135	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCAGCTATCTG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.55507623778	39.7900667492953	0.015218676061149	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.42596854656	2613.42596854656
"AML-0024"	"2020-09-15-AML0024:TTCTCTCAGTGGTTGG"	-1.53084383431132	-16.8549852601257	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCAGTGGTTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1748.71883515241	47.9204122865241	0.0274031544255355	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1743.64592904397	1743.64592904397
"AML-0024"	"2020-09-15-AML0024:TTCTCTCAGTTTGAGA"	9.37824596938435	7.91117904270021	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCAGTTTGAGA"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1907.69114313392	45.0182737290551	0.0235983030539734	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1897.41858991376	1897.41858991376
"AML-0024"	"2020-09-15-AML0024:TTCTCTCCAAACCACT"	-1.57762287083324	-16.0578317872253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCCAAACCACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.76210101011	35.4742041692251	0.0131300250884274	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2699.3004461694	2699.3004461694
"AML-0024"	"2020-09-15-AML0024:TTCTCTCCAAATTAGG"	-0.997490386397201	-16.7781172028747	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCCAAATTAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.70646379745	34.8984364762885	0.013719521876038	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2529.20683096819	2529.20683096819
"AML-0024"	"2020-09-15-AML0024:TTCTCTCCACCGGTCA"	-0.397410343319732	-16.5697412720886	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCCACCGGTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3017.85373903765	38.2744888695742	0.0126826851727345	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3007.95053064653	3007.95053064653
"AML-0024"	"2020-09-15-AML0024:TTCTCTCCACGGTGAA"	-2.36278806152995	-15.6698637238708	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCCACGGTGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2082.85167440584	42.1147268437864	0.0202197436146288	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2080.16297699077	2080.16297699077
"AML-0024"	"2020-09-15-AML0024:TTCTCTCTCATGAGAA"	-1.43641553345378	-15.594394706842	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTCTCTCATGAGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1531.75374091337	45.1884033140248	0.0295010889198673	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1529.49489244895	1529.49489244895
"AML-0024"	"2020-09-15-AML0024:TTCTGTAGTATTAAGG"	-1.19923220101054	-15.9126358262268	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTGTAGTATTAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.75705349377	26.7300594452108	0.0103414204476511	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2580.64745289852	2580.64745289852
"AML-0024"	"2020-09-15-AML0024:TTCTGTATCTCGCTCA"	-0.210725794464904	-16.2652330628601	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTGTATCTCGCTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3127.34905991696	39.8131906806591	0.0127306513976781	3233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3116.76305257023	3116.76305257023
"AML-0024"	"2020-09-15-AML0024:TTCTTCCCAACTGCTA"	-1.0027246278828	-16.4980802766052	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTCCCAACTGCTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.49358023412	32.9109695380143	0.0124639460532588	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2636.16011384343	2636.16011384343
"AML-0024"	"2020-09-15-AML0024:TTCTTGAAGAATCGCG"	-0.52710853043254	-15.8966322175232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGAAGAATCGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.16831131251	37.8283807648486	0.0145933350854423	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2584.25237475796	2584.25237475796
"AML-0024"	"2020-09-15-AML0024:TTCTTGAAGAGCCTGA"	-1.33650563183482	-16.3773260346619	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGAAGAGCCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.59419921032	37.2575086285841	0.0157630733063366	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2361.34516650727	2361.34516650727
"AML-0024"	"2020-09-15-AML0024:TTCTTGAAGTCTGCAT"	-2.21662579003032	-16.5963449708191	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGAAGTCTGCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2381.72504920447	35.7219093969721	0.0149983346771718	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2370.07082947753	2370.07082947753
"AML-0024"	"2020-09-15-AML0024:TTCTTGACACTATCCC"	-1.97443495217021	-16.2675676575867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGACACTATCCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.81136851604	39.8558459208468	0.0162093954953938	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2453.66098961963	2453.66098961963
"AML-0024"	"2020-09-15-AML0024:TTCTTGACATTCGATG"	-1.33532677117046	14.1062955626282	"2020-09-15-AML0024"	"AML0024"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0331882480957563	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGACATTCGATG"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1849.22153102415	33.2674734144984	0.0179899881416987	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	1847.22181674321	1847.22181674321
"AML-0024"	"2020-09-15-AML0024:TTCTTGATCGGTGTTA"	-1.75940690460857	-15.7250595322815	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTCTTGATCGGTGTTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.72509392774	40.0789930664297	0.014884175572475	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2687.40119260015	2687.40119260015
"AML-0024"	"2020-09-15-AML0024:TTGAACGCAGAACCGA"	-2.9265173477238	-15.9889173737732	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGCAGAACCGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.06026846004	35.621449196078	0.0132665361796546	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2677.45337742446	2677.45337742446
"AML-0024"	"2020-09-15-AML0024:TTGAACGCAGCGGTCT"	-1.83011637154277	-16.9236688843933	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGCAGCGGTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1447.8959078398	48.8235443058936	0.0337203413874803	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1436.73020952251	1436.73020952251
"AML-0024"	"2020-09-15-AML0024:TTGAACGCAGGCTATT"	-1.73622558537181	-16.0810861817566	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGCAGGCTATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3133.5576500402	38.3163276589273	0.012227739821042	3649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3118.96446901782	3118.96446901782
"AML-0024"	"2020-09-15-AML0024:TTGAACGCAGTGTATC"	-1.20380018177684	-15.8826475373474	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGCAGTGTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2721.00591766654	41.0405821806186	0.0150828713433354	2730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2713.56695880878	2713.56695880878
"AML-0024"	"2020-09-15-AML0024:TTGAACGCATCTCGTC"	-2.5021108192509	-16.2997751466003	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGCATCTCGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2222.28745075561	35.3918793921075	0.0159258782566917	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2216.6337178785	2216.6337178785
"AML-0024"	"2020-09-15-AML0024:TTGAACGTCTCTTAAC"	-1.25326857987102	-15.9531221619812	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGTCTCTTAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2791.15722203685	36.9937727548484	0.0132539193646183	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2780.02691174972	2780.02691174972
"AML-0024"	"2020-09-15-AML0024:TTGAACGTCTTGAACG"	0.397378315299195	-16.1605539551941	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAACGTCTTGAACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2849.91102624793	43.0592524083204	0.0151089813021322	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2840.36498576377	2840.36498576377
"AML-0024"	"2020-09-15-AML0024:TTGACCCAGGCTTTCA"	-1.74938962879832	-16.2863474122253	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCAGGCTTTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2760.36781114571	35.9321050522721	0.0130171439136432	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2754.20881650502	2754.20881650502
"AML-0024"	"2020-09-15-AML0024:TTGACCCCAATGGCAG"	-0.874194483191329	-16.1037893525329	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCCAATGGCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3012.31582060917	35.6847748554561	0.0118462926799753	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2997.5511004084	2997.5511004084
"AML-0024"	"2020-09-15-AML0024:TTGACCCCAGTGAGCA"	-1.21709523621257	-15.7486782304016	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCCAGTGAGCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.77546405206	37.8251313545841	0.0142640777348416	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2646.38523894852	2646.38523894852
"AML-0024"	"2020-09-15-AML0024:TTGACCCGTAAGATAC"	-0.846434394747573	-16.3382921448913	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCGTAAGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.80340835598	33.601342589588	0.012418249783344	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.82395568494	2698.82395568494
"AML-0024"	"2020-09-15-AML0024:TTGACCCGTGATAGAT"	-1.35919437828715	-16.614827179071	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCGTGATAGAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2984.25879396959	37.61432375409	0.0126042432479712	3135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2973.76772459566	2973.76772459566
"AML-0024"	"2020-09-15-AML0024:TTGACCCGTGCCTAAT"	-0.806376377970535	-16.6191702119079	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGACCCGTGCCTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3177.22084507346	38.1332003310199	0.0120020616099597	4178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3168.76426818323	3168.76426818323
"AML-0024"	"2020-09-15-AML0024:TTGAGTGAGAATCTAG"	-1.98752532425578	-16.8126325837341	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGAGAATCTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.81388824514	35.1610663142459	0.0126124152198621	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2777.64805509109	2777.64805509109
"AML-0024"	"2020-09-15-AML0024:TTGAGTGAGCTCATAC"	-0.882085482508498	-16.0367155305115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGAGCTCATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.00350211908	36.5367929559058	0.0137563045104252	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2647.30975342999	2647.30975342999
"AML-0024"	"2020-09-15-AML0024:TTGAGTGAGTATGGCG"	-1.04774306240733	-17.4248457184997	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGAGTATGGCG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2749.30270622334	42.458278983945	0.0154432899978006	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2743.53769841315	2743.53769841315
"AML-0024"	"2020-09-15-AML0024:TTGAGTGAGTTCCAGT"	-1.7448984188145	-15.9563112488953	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGAGTTCCAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2337.4503787756	33.8354065248522	0.0144753475120083	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2333.73824093328	2333.73824093328
"AML-0024"	"2020-09-15-AML0024:TTGAGTGCAAGCACCC"	1.24550559100453	-16.2048750153747	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGCAAGCACCC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2897.69489831082	37.9139515432456	0.0130841765174612	3904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2884.1271341692	2884.1271341692
"AML-0024"	"2020-09-15-AML0024:TTGAGTGCACGTGTGC"	-1.62359378758128	-16.6082010499206	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGCACGTGTGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.44218964926	36.3202433119191	0.013555150938589	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2673.7538514	2673.7538514
"AML-0024"	"2020-09-15-AML0024:TTGAGTGCACTTGTGA"	-0.64129344645198	-16.5451708070007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGCACTTGTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.17876825633	42.2012949805268	0.0164837297706632	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2548.50945214901	2548.50945214901
"AML-0024"	"2020-09-15-AML0024:TTGAGTGGTTCTGACA"	-1.64001129093822	-15.8996887437073	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGGTTCTGACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.29998325638	40.3614193795288	0.0144493679953687	2702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2784.58916842241	2784.58916842241
"AML-0024"	"2020-09-15-AML0024:TTGAGTGTCCTTCTAA"	-1.78197179260905	-16.3838834992615	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGAGTGTCCTTCTAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.05338372974	41.7738907910234	0.0162921298971779	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2554.52784110775	2554.52784110775
"AML-0024"	"2020-09-15-AML0024:TTGATGGCAATTTCCT"	-1.44590816918071	-16.1424036256042	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGCAATTTCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2802.88535237346	30.3106807747778	0.0108140993883717	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2794.75895474127	2794.75895474127
"AML-0024"	"2020-09-15-AML0024:TTGATGGCACGACGAA"	-1.74155281010326	-15.7972059479919	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGCACGACGAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.74546843875	36.6715481953925	0.015249658925109	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2399.0995355894	2399.0995355894
"AML-0024"	"2020-09-15-AML0024:TTGATGGCACTTGAAC"	-2.25477276268657	-15.6066837540832	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGCACTTGAAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.15075229232	35.5925961321098	0.0130464183851289	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2717.86749395208	2717.86749395208
"AML-0024"	"2020-09-15-AML0024:TTGATGGCATAATCGC"	-0.276299039751846	-16.3571615449158	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGCATAATCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2819.37719090897	39.7172730788215	0.0140872506193528	2924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2812.05758539115	2812.05758539115
"AML-0024"	"2020-09-15-AML0024:TTGATGGGTCGATGCC"	0.0714959344709336	10.2977628477844	"2020-09-15-AML0024"	"AML0024"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0024330900243309	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGGTCGATGCC"	"CD4+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2417.84799474138	48.6125206318419	0.0201056976028147	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	2414.78732030986	2414.78732030986
"AML-0024"	"2020-09-15-AML0024:TTGATGGGTGACTGTT"	-2.53217945519145	-15.6480541459289	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGGTGACTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.65268243688	28.2269589153041	0.00999307245482376	2474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2814.11978565175	2814.11978565175
"AML-0024"	"2020-09-15-AML0024:TTGATGGGTGCAACGA"	-1.83498273316081	-16.6969709626404	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGGTGCAACGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1873.59219780914	45.6954778441932	0.0243892336323917	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1864.75297059227	1864.75297059227
"AML-0024"	"2020-09-15-AML0024:TTGATGGGTTCCATTT"	-1.69187066975291	-15.5844278565613	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGGTTCCATTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2972.65248941913	34.2797417863801	0.0115317017069421	3303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2963.5534005471	2963.5534005471
"AML-0024"	"2020-09-15-AML0024:TTGATGGTCCGCGATG"	-2.43490419808086	-16.4246206513611	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGATGGTCCGCGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.69370678728	39.2230693954863	0.0134708775528331	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2906.17881539023	2906.17881539023
"AML-0024"	"2020-09-15-AML0024:TTGCATTAGAGAGGTA"	-1.2607424062794	-15.5993271104065	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCATTAGAGAGGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2867.49604114907	36.5940836775647	0.0127616858584749	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2857.13773687303	2857.13773687303
"AML-0024"	"2020-09-15-AML0024:TTGCATTTCGTGTTCC"	-0.849155048758346	-16.1393995515076	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCATTTCGTGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.1698440101	35.0930642723793	0.0128068938314504	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.28826624711	2733.28826624711
"AML-0024"	"2020-09-15-AML0024:TTGCATTTCTCCGTGT"	9.89414276656453	6.30377624118654	"2020-09-15-AML0024"	"AML0024"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151515151515152	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCATTTCTCCGTGT"	"B"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1488.26673209381	40.922080659521	0.0274964694009848	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	58	TRUE	"B_AML-0024"	1486.04663135929	1486.04663135929
"AML-0024"	"2020-09-15-AML0024:TTGCCTGAGTCACGCC"	-1.92959008637126	-16.1688356629578	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGAGTCACGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.20179982628	36.6508567643669	0.0130096668142931	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2802.9282583922	2802.9282583922
"AML-0024"	"2020-09-15-AML0024:TTGCCTGAGTTGCCCG"	-1.73201749745067	-16.9177561036316	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGAGTTGCCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.34750106608	43.3477592211488	0.0188850530043995	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2284.14086451945	2284.14086451945
"AML-0024"	"2020-09-15-AML0024:TTGCCTGCAGTTAAAG"	-1.10904941979106	-16.2891378632751	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGCAGTTAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.84672904081	38.4414965472904	0.0142595260083529	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2688.38732271289	2688.38732271289
"AML-0024"	"2020-09-15-AML0024:TTGCCTGCATGACTCA"	-1.16073177281078	-16.181160949823	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGCATGACTCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.37424649332	38.0457257920726	0.0148420488518674	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2555.45420123245	2555.45420123245
"AML-0024"	"2020-09-15-AML0024:TTGCCTGGTTGGATCT"	-2.33248076859172	-15.6049165955749	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGGTTGGATCT"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.88142132806	36.8315519169963	0.0142930720878938	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2574.17810259876	2574.17810259876
"AML-0024"	"2020-09-15-AML0024:TTGCCTGTCAATGTCG"	-1.27351496639903	-15.9696874848572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGTCAATGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2619.14333898705	41.369248263589	0.0157949538873227	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2613.10583977749	2613.10583977749
"AML-0024"	"2020-09-15-AML0024:TTGCCTGTCGTAATGC"	-0.102063040167648	-16.1337557069031	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGTCGTAATGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2934.70069757049	35.3502159389014	0.0120455949624322	2934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.8869282368	2922.8869282368
"AML-0024"	"2020-09-15-AML0024:TTGCCTGTCTACTGAG"	-0.154227848083335	-16.2093382111755	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCCTGTCTACTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.5423575588	38.7753452167558	0.0126199546513538	4248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3062.84288602252	3062.84288602252
"AML-0024"	"2020-09-15-AML0024:TTGCGTCAGGTTCCGC"	-0.291332106024581	-16.1186800233093	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCGTCAGGTTCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2677.6713041472	40.8924157115877	0.0152716338440245	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2668.72645040941	2668.72645040941
"AML-0024"	"2020-09-15-AML0024:TTGCGTCTCATGGCCG"	-0.432699183852035	-15.9503565064636	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCGTCTCATGGCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.64145837417	38.5631148186923	0.0163151287950491	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2355.90549445956	2355.90549445956
"AML-0024"	"2020-09-15-AML0024:TTGCGTCTCCTTGAAG"	-1.74052951756175	-16.7929907075134	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCGTCTCCTTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.38616438317	35.6034695926666	0.0135251697013114	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2624.45590676696	2624.45590676696
"AML-0024"	"2020-09-15-AML0024:TTGCTGCAGGCACTAG"	-1.42196700993236	-15.8415460816589	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCAGGCACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.72403891213	41.0916627847197	0.0150313865627315	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.4883256461	2727.4883256461
"AML-0024"	"2020-09-15-AML0024:TTGCTGCAGGCTATCT"	-0.920314471155959	-16.6780710450378	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCAGGCTATCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.68786333275	38.3460524667529	0.0144283506711984	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2649.98805293482	2649.98805293482
"AML-0024"	"2020-09-15-AML0024:TTGCTGCAGTTGCGCC"	-2.92051468315776	-15.9565839997497	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCAGTTGCGCC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2927.97469729735	32.4880198422907	0.0110957310772797	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2922.35165553647	2922.35165553647
"AML-0024"	"2020-09-15-AML0024:TTGCTGCCAACTCATG"	-1.4858982366627	-15.8550491563049	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCCAACTCATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2989.77088607929	32.5128854500007	0.0108747080257502	2940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2978.60654337502	2978.60654337502
"AML-0024"	"2020-09-15-AML0024:TTGCTGCCACAGCGCT"	-0.641437689692336	-15.8175201646057	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCCACAGCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2969.75217186173	40.5592284320481	0.0136574454987676	3698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2960.04097379878	2960.04097379878
"AML-0024"	"2020-09-15-AML0024:TTGCTGCCACGTTGGC"	-1.14022670212443	-16.6797476044861	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCCACGTTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.32275019274	36.2616393345208	0.0133840234914578	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2703.94144835995	2703.94144835995
"AML-0024"	"2020-09-15-AML0024:TTGCTGCCACTTCAAG"	-0.427877615124542	-15.872133278009	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCCACTTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2784.73741477773	37.1419456085832	0.0133376832628751	2823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.39076879539	2778.39076879539
"AML-0024"	"2020-09-15-AML0024:TTGCTGCGTACGATGG"	-1.02298007431682	-17.2748251191345	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCGTACGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.2593872981	35.4123152771029	0.0132518255695634	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.39314943219	2665.39314943219
"AML-0024"	"2020-09-15-AML0024:TTGCTGCGTCGCAGTC"	-1.64506612244304	-16.2263860932556	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCGTCGCAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.44503095495	35.461619691061	0.0134200027912201	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2635.04005005941	2635.04005005941
"AML-0024"	"2020-09-15-AML0024:TTGCTGCTCACGACTA"	-1.82234023037608	-16.2639646760193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGCTGCTCACGACTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.99783301743	47.4892496403203	0.0181742399631005	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2601.74054357347	2601.74054357347
"AML-0024"	"2020-09-15-AML0024:TTGGATGAGCACTGGA"	-0.836525897414047	-16.1895513764587	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGATGAGCACTGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.42803514664	39.4243591517943	0.0149992157383129	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2620.4060404314	2620.4060404314
"AML-0024"	"2020-09-15-AML0024:TTGGATGAGTCAAGCG"	-1.54376409474071	-16.8240251771179	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGATGAGTCAAGCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.54744847637	35.9887515924718	0.0149918934596831	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2389.28093858683	2389.28093858683
"AML-0024"	"2020-09-15-AML0024:TTGGATGCATGGTACT"	-2.73313365402873	-16.1714868775574	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGATGCATGGTACT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.9974875297	46.4070563315951	0.0206529186566266	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2240.25470655568	2240.25470655568
"AML-0024"	"2020-09-15-AML0024:TTGGATGGTCAACCTA"	-2.55875549736674	-15.8933725587097	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGATGGTCAACCTA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2867.02107075583	35.0156428260911	0.0122132492095218	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2859.29450183992	2859.29450183992
"AML-0024"	"2020-09-15-AML0024:TTGGATGTCCGTGTGG"	-1.49180827561076	-15.8584852448669	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGATGTCCGTGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2944.25471254692	39.0584848309197	0.0132660006162076	3321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2938.26621958337	2938.26621958337
"AML-0024"	"2020-09-15-AML0024:TTGGGATAGGGCTTCC"	-2.32801924172099	-16.3850355378357	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGATAGGGCTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.5027455825	40.7291527185321	0.014404637725698	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2810.50732588589	2810.50732588589
"AML-0024"	"2020-09-15-AML0024:TTGGGATCACTGGATT"	-1.52335498753245	-16.7206678620544	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGATCACTGGATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.75850910259	40.2972282823862	0.0144758347933625	2658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2775.64693683003	2775.64693683003
"AML-0024"	"2020-09-15-AML0024:TTGGGATCATGGAATA"	-1.73477445069011	-15.9347563019958	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGATCATGGAATA"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2770.43434261152	40.2786228057446	0.0145387393544134	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2764.7150116241	2764.7150116241
"AML-0024"	"2020-09-15-AML0024:TTGGGATGTAATTGGA"	1.34049751338307	-16.1494360200134	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGATGTAATTGGA"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2977.45131595076	38.1538208979129	0.0128142551629697	3975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2966.8023968889	2966.8023968889
"AML-0024"	"2020-09-15-AML0024:TTGGGATTCAAGCCGC"	-2.21786699715312	-15.7957496873108	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGATTCAAGCCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2599.88823042563	29.0567564314124	0.0111761559944658	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2596.57268139483	2596.57268139483
"AML-0024"	"2020-09-15-AML0024:TTGGGCGAGGAACTAT"	-0.750013629824478	-15.9899168244568	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGAGGAACTAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.83054584195	34.6007000671081	0.0128206271121456	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2693.6736210101	2693.6736210101
"AML-0024"	"2020-09-15-AML0024:TTGGGCGAGTCTTCGA"	-2.74395690384563	-15.6812315217224	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGAGTCTTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2710.2741648027	35.356955356991	0.0130455272076008	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2704.80674212364	2704.80674212364
"AML-0024"	"2020-09-15-AML0024:TTGGGCGCACATACGT"	-0.586314658552963	-16.411141418573	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGCACATACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2691.3593255499	32.9717821319828	0.0122509773477557	2484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2680.90316320767	2680.90316320767
"AML-0024"	"2020-09-15-AML0024:TTGGGCGCAGAGTAAT"	-1.45119224014934	-15.971070312616	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGCAGAGTAAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.47356020357	31.0420356105243	0.0118234043873279	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2621.08143917107	2621.08143917107
"AML-0024"	"2020-09-15-AML0024:TTGGGCGCATGGGATG"	-0.535543541342574	-16.2973127595154	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGCATGGGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2655.41235863678	36.847429806685	0.0138763494441223	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.78513466065	2648.78513466065
"AML-0024"	"2020-09-15-AML0024:TTGGGCGGTAGTGCGA"	-1.59873447838481	-15.7600765458313	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGGTAGTGCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.43277877126	42.5366037335364	0.0152820661084239	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2778.1361944024	2778.1361944024
"AML-0024"	"2020-09-15-AML0024:TTGGGCGGTCGCCTAG"	-2.93525586548503	-15.5753011933533	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGGTCGCCTAG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2785.12884731361	34.4121247558738	0.0123556670597362	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2779.81444866283	2779.81444866283
"AML-0024"	"2020-09-15-AML0024:TTGGGCGGTTCGGGTC"	-1.30246625366862	-16.8057985535828	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGGTTCGGGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2297.05230158782	42.8848089381842	0.0186694960791883	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2284.90015487682	2284.90015487682
"AML-0024"	"2020-09-15-AML0024:TTGGGCGTCGTAACCA"	-0.82211003723796	-15.7221031419006	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGCGTCGTAACCA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.23258722344	48.5179835103924	0.0198988331813097	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.88225365735	2433.88225365735
"AML-0024"	"2020-09-15-AML0024:TTGGGTAAGCCTTTGA"	-2.7209840816563	-15.8272962800232	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTAAGCCTTTGA"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3016.74402097905	35.2626970308173	0.0116889921006202	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3002.4133470045	3002.4133470045
"AML-0024"	"2020-09-15-AML0024:TTGGGTAAGGCTTCCG"	-0.932508985430557	-16.2303209534851	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTAAGGCTTCCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2871.43945168424	37.168778661373	0.0129443017297724	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2867.98264277616	2867.98264277616
"AML-0024"	"2020-09-15-AML0024:TTGGGTAAGGTGGTTG"	-1.68003986302074	-16.4620504609314	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTAAGGTGGTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2839.13670599577	38.7214644382402	0.0136384642403682	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2831.73717583084	2831.73717583084
"AML-0024"	"2020-09-15-AML0024:TTGGGTAAGTAAAGCT"	-1.47129521790202	-16.8718328705994	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTAAGTAAAGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.28745312834	34.421385396142	0.0125429227018123	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2737.78781062435	2737.78781062435
"AML-0024"	"2020-09-15-AML0024:TTGGGTACAACACAGG"	-1.22476504269298	-16.0635442963806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTACAACACAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2751.63961722124	35.8590574471955	0.0130318873237506	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2742.10981072706	2742.10981072706
"AML-0024"	"2020-09-15-AML0024:TTGGGTACATAGAATG"	0.422408987849396	-16.3021116486755	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTACATAGAATG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2523.83557232814	45.1562778539767	0.0178919254285341	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2518.70584495054	2518.70584495054
"AML-0024"	"2020-09-15-AML0024:TTGGGTATCAGTAGGG"	-0.681102494627792	-15.6311645737854	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGGTATCAGTAGGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.50547127805	36.5671163254187	0.0126639123939854	2998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2883.07100496899	2883.07100496899
"AML-0024"	"2020-09-15-AML0024:TTGGTTTAGTACCGGA"	-0.974893311888534	-16.4200639954773	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTAGTACCGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.03643633498	37.2118970532237	0.0147605550308196	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2517.84965153589	2517.84965153589
"AML-0024"	"2020-09-15-AML0024:TTGGTTTAGTTTGCTG"	-2.17534838143047	-15.7966585389343	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTAGTTTGCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3076.80869392479	34.3071159641383	0.0111502271921807	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3069.86638928751	3069.86638928751
"AML-0024"	"2020-09-15-AML0024:TTGGTTTCAGAAACCG"	-0.384829769760925	-16.0274114838806	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTCAGAAACCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2742.24194456541	30.683358237077	0.0111891506502136	2532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2732.09695549729	2732.09695549729
"AML-0024"	"2020-09-15-AML0024:TTGGTTTCAGTGCCTG"	-1.4366047185963	-17.0356836549011	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTCAGTGCCTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.84413303097	35.2106117096246	0.0141246744002454	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2481.39202047755	2481.39202047755
"AML-0024"	"2020-09-15-AML0024:TTGGTTTGTAAGCTCT"	0.0268151136929214	-16.2555895081726	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTGTAAGCTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2795.48545068131	36.9353071344817	0.0132124841234569	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2792.89875749848	2792.89875749848
"AML-0024"	"2020-09-15-AML0024:TTGGTTTGTAGCTGTT"	-1.57494602623637	-16.9531679383484	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTGTAGCTGTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.54879999923	33.3021117722365	0.0123270443133383	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2698.03685799561	2698.03685799561
"AML-0024"	"2020-09-15-AML0024:TTGGTTTTCACACCCT"	-0.675523201853591	-15.7358684769836	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTTCACACCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2094.36695055502	39.2683808637132	0.0187495227869724	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2090.24404507658	2090.24404507658
"AML-0024"	"2020-09-15-AML0024:TTGGTTTTCGCGTTTC"	-2.3846324485844	-16.2648420563904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGGTTTTCGCGTTTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3186.71346892116	43.8791058775181	0.0137693916649409	3373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3175.30936150732	3175.30936150732
"AML-0024"	"2020-09-15-AML0024:TTGTGGAAGCGACTAG"	-2.46933446350749	-15.6225710145203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGAAGCGACTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.51236161533	37.377308363577	0.0145975894996254	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2552.60368555949	2552.60368555949
"AML-0024"	"2020-09-15-AML0024:TTGTGGAGTTTGAACC"	-1.10114417496379	-16.0250787965027	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGAGTTTGAACC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.49630271243	37.6372623473668	0.0146477199860672	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.71882193512	2564.71882193512
"AML-0024"	"2020-09-15-AML0024:TTGTGGATCCGGGACT"	-1.30356262150462	-16.024365448114	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGATCCGGGACT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.20448159415	37.1117843519359	0.0140670613710393	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.80951648733	2633.80951648733
"AML-0024"	"2020-09-15-AML0024:TTGTGGATCCTCATAT"	-0.707071701914626	-16.0923395386902	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGATCCTCATAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.60204868721	35.5063427364634	0.0133804323651427	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.77347311018	2648.77347311018
"AML-0024"	"2020-09-15-AML0024:TTGTGGATCCTTCTGG"	-0.249254177243072	-16.1800756684509	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGATCCTTCTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3026.85332009814	34.4244305023844	0.0113730091490751	3607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3017.72405717076	3017.72405717076
"AML-0024"	"2020-09-15-AML0024:TTGTGGATCGGTGAAG"	-2.87713299217876	-15.7327842942444	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGGATCGGTGAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.0608601425	31.7769447749673	0.0119639369909854	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2644.63982293443	2644.63982293443
"AML-0024"	"2020-09-15-AML0024:TTGTGTTAGTACGAGC"	-1.13508294048961	-16.6744337311951	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTAGTACGAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2641.09699662288	33.1920324881238	0.0125675174105934	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.3127857253	2633.3127857253
"AML-0024"	"2020-09-15-AML0024:TTGTGTTCAAATCAAG"	-1.55262468281444	-16.0385599366394	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTCAAATCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.68948360853	37.3229892035348	0.0153548980465108	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2420.14659409097	2420.14659409097
"AML-0024"	"2020-09-15-AML0024:TTGTGTTCAACCACGC"	-1.26629076424297	-15.9429464570251	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTCAACCACGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.17735433196	40.3919898619845	0.0151953705407048	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2650.16761221139	2650.16761221139
"AML-0024"	"2020-09-15-AML0024:TTGTGTTCACGCAAAG"	-0.70155636492427	-16.4137087098328	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTCACGCAAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.98369375863	32.7151288914428	0.0130704522658379	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2491.37679200942	2491.37679200942
"AML-0024"	"2020-09-15-AML0024:TTGTGTTGTCCCTGAG"	-0.168816993862945	-16.2089662781921	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTGTCCCTGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.22866102751	31.0432207189288	0.0123127351353674	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2518.56556137032	2518.56556137032
"AML-0024"	"2020-09-15-AML0024:TTGTGTTTCTCATTGT"	-1.37003741684611	-16.493042968866	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTTCTCATTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.57488882402	32.0579666623458	0.0116719798148565	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2740.6485597515	2740.6485597515
"AML-0024"	"2020-09-15-AML0024:TTGTGTTTCTTGGCTC"	-1.50550804558452	-15.8623600236145	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTGTTTCTTGGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2739.51939861517	37.9582954429799	0.0138558228359938	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2733.50973733683	2733.50973733683
"AML-0024"	"2020-09-15-AML0024:TTGTTCAAGAAGCCAC"	-0.976493100554305	-15.9786405793396	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCAAGAAGCCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.19506785049	37.3172551609037	0.0152802106810201	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2433.76614687959	2433.76614687959
"AML-0024"	"2020-09-15-AML0024:TTGTTCAAGCGACTTT"	-0.804787794977981	-16.5531645051208	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCAAGCGACTTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.53031809724	43.7694692283235	0.0163591752006201	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2665.75316595215	2665.75316595215
"AML-0024"	"2020-09-15-AML0024:TTGTTCAAGGGCAGAG"	-0.497859935194808	-15.7830877534119	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCAAGGGCAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.22307675398	38.6199226142837	0.0144848804854326	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2662.17305803217	2662.17305803217
"AML-0024"	"2020-09-15-AML0024:TTGTTCACAAGAGATT"	-2.91960583153422	-15.8270378342834	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCACAAGAGATT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2738.65188991469	34.1527303674588	0.0124706358238625	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2727.41269575638	2727.41269575638
"AML-0024"	"2020-09-15-AML0024:TTGTTCACAGACCGCT"	-0.258651296526748	-16.4941339722839	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCACAGACCGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2826.02134133451	38.1222417255349	0.0134897218106403	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2820.31288059763	2820.31288059763
"AML-0024"	"2020-09-15-AML0024:TTGTTCAGTCTTCATT"	-0.666670481592971	-16.1432333222595	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCAGTCTTCATT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.49077686904	37.4867332491765	0.0136093152186143	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.09970982483	2751.09970982483
"AML-0024"	"2020-09-15-AML0024:TTGTTCATCATGGGAG"	-0.336202273995239	-16.0497179261413	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCATCATGGGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2989.42392464247	40.1073640494716	0.0134164190360751	3069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2983.35142782463	2983.35142782463
"AML-0024"	"2020-09-15-AML0024:TTGTTCATCCTCTAGC"	-1.75032077255901	-16.4228563538757	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCATCCTCTAGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.82633726536	39.7780880297973	0.0162636600251318	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2436.61590831213	2436.61590831213
"AML-0024"	"2020-09-15-AML0024:TTGTTCATCGAGATGG"	-1.91199133816417	-15.9957971802917	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTCATCGAGATGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.7220978634	33.1014569624146	0.0128713195682828	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.18365726704	2564.18365726704
"AML-0024"	"2020-09-15-AML0024:TTGTTGTAGACCATAA"	-1.34565673294719	-15.9662695161072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTGTAGACCATAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.88251089437	29.33436000235	0.0134199161465214	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2179.32918366885	2179.32918366885
"AML-0024"	"2020-09-15-AML0024:TTGTTGTAGATCCCAT"	-1.6670905155247	-16.4413862458435	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTGTAGATCCCAT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.88769617656	43.4442932962046	0.0185430540981981	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2332.3071309407	2332.3071309407
"AML-0024"	"2020-09-15-AML0024:TTGTTGTAGTTGTCGT"	-1.29115937176402	-16.093737625238	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTGTAGTTGTCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.57023616614	43.0797171119592	0.0181268436574611	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2372.45924185242	2372.45924185242
"AML-0024"	"2020-09-15-AML0024:TTGTTGTGTTTCACAG"	-1.29010866108592	-16.8226423493591	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTGTGTTTCACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.34393421737	35.4498279979188	0.0143792626683435	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2456.37145938206	2456.37145938206
"AML-0024"	"2020-09-15-AML0024:TTGTTGTTCATCAGTG"	-2.92233071747478	-15.981490158197	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTGTTCATCAGTG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.7149693725	47.0125998051457	0.0211035076082413	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2216.41307233624	2216.41307233624
"AML-0024"	"2020-09-15-AML0024:TTGTTTGAGCATGTTC"	-2.83677778664287	-15.5950041047302	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTTGAGCATGTTC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.89994253467	37.5711064495814	0.0136925934751379	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2738.54503996087	2738.54503996087
"AML-0024"	"2020-09-15-AML0024:TTGTTTGAGCGCTTCG"	-0.935389797121841	-16.373917602655	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTGTTTGAGCGCTTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.26893999453	38.6253362823712	0.0143627644330915	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2681.34795219589	2681.34795219589
"AML-0024"	"2020-09-15-AML0024:TTTACCAAGATACAGT"	-1.84059784832652	-16.1331396332947	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACCAAGATACAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.23315183853	36.4169892326008	0.0133530898185404	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2718.37981829474	2718.37981829474
"AML-0024"	"2020-09-15-AML0024:TTTACCAGTCTTTATC"	-0.949385384947616	-16.3400335541931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACCAGTCTTTATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2719.7259181088	31.4807325034085	0.0115749650704873	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2710.99493675897	2710.99493675897
"AML-0024"	"2020-09-15-AML0024:TTTACCATCAACTGGT"	-2.55593405190166	-15.8414478532043	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACCATCAACTGGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.96257769748	46.1331095343719	0.0195399579689074	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2351.07529672358	2351.07529672358
"AML-0024"	"2020-09-15-AML0024:TTTACCATCAGGAAGC"	1.30291773852651	-16.1874571076599	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACCATCAGGAAGC"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3052.04789898408	39.201601680072	0.0128443599109702	4273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3041.09640166119	3041.09640166119
"AML-0024"	"2020-09-15-AML0024:TTTACCATCGCGATCG"	0.480968226760072	-16.3399229279724	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACCATCGCGATCG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2701.27237597968	47.8375738117772	0.0177092744282878	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2696.82569014791	2696.82569014791
"AML-0024"	"2020-09-15-AML0024:TTTACGTAGACATACA"	-1.59398267689403	-16.5166654816833	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTAGACATACA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2912.96879852372	37.1167367322882	0.0127418929962788	2701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2907.51975343412	2907.51975343412
"AML-0024"	"2020-09-15-AML0024:TTTACGTAGCATCGAG"	-2.7372866672581	-15.7147178879944	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTAGCATCGAG"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.06889685944	36.9853490799461	0.0127444765766832	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2892.50840974023	2892.50840974023
"AML-0024"	"2020-09-15-AML0024:TTTACGTAGGCGTTGA"	-0.173945526511031	-15.999800705072	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTAGGCGTTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2865.24963168088	42.723610288652	0.0149109556864644	2948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2850.24380058472	2850.24380058472
"AML-0024"	"2020-09-15-AML0024:TTTACGTAGGGAGTGG"	-0.136168758303481	-16.0899934998718	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTAGGGAGTGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2638.22326290284	39.4034488079725	0.0149356005467925	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2626.68881365776	2626.68881365776
"AML-0024"	"2020-09-15-AML0024:TTTACGTAGGGCCCTT"	-2.52583322945293	-16.4099607697693	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTAGGGCCCTT"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2548.74278608277	38.6595241377566	0.0151680759427174	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2542.60938822382	2542.60938822382
"AML-0024"	"2020-09-15-AML0024:TTTACGTCAGGAAGTC"	-2.3017467063969	-16.2181139222351	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTCAGGAAGTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2859.9739792665	36.1988227588435	0.0126570461903739	2644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2852.7290593553	2852.7290593553
"AML-0024"	"2020-09-15-AML0024:TTTACGTCATCTAACG"	0.645154793828171	-16.2637815705505	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	79	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTCATCTAACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3066.81866065755	41.5437474550169	0.0135462027761725	3440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	3050.7025157476	3050.7025157476
"AML-0024"	"2020-09-15-AML0024:TTTACGTGTGCGAGTA"	-1.84019396725352	-16.6515569916931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTGTGCGAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.75462623029	33.1285076062063	0.013490153801343	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2449.00181759545	2449.00181759545
"AML-0024"	"2020-09-15-AML0024:TTTACGTTCAGGAACG"	-2.73479352417644	-15.6981420747009	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTTCAGGAACG"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.100925824	32.9927880880814	0.0132230274721996	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.75324757247	2487.75324757247
"AML-0024"	"2020-09-15-AML0024:TTTACGTTCTTCTGGC"	-1.88140128079112	-15.4208593598572	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACGTTCTTCTGGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2933.21991486923	36.3974711625886	0.0124087085929291	2897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2928.29522022498	2928.29522022498
"AML-0024"	"2020-09-15-AML0024:TTTACTGAGCGCCATC"	-0.238702605397064	-16.2975931397644	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACTGAGCGCCATC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.53220076931	38.3118603990693	0.0151999091252934	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2516.54583363889	2516.54583363889
"AML-0024"	"2020-09-15-AML0024:TTTACTGGTGTTCCAA"	-2.51053033295329	-15.9800119630066	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACTGGTGTTCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.99875083477	35.913809571204	0.0136140358519273	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2633.07769245723	2633.07769245723
"AML-0024"	"2020-09-15-AML0024:TTTACTGTCTACGCGG"	-2.13633380356486	-16.6396875611511	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTACTGTCTACGCGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.9405653782	38.6602556647843	0.0170614605941051	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2253.94918913705	2253.94918913705
"AML-0024"	"2020-09-15-AML0024:TTTAGTCAGGCTAACG"	-1.0815683406895	-17.2032442322937	"2020-09-15-AML0024"	"AML0024"	"Granulocyte"	"Granulocytes"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCAGGCTAACG"	"Granulocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2596.1045201076	37.3730468943372	0.0143958175046004	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	452	TRUE	"Gran_AML-0024"	2592.09290829972	2592.09290829972
"AML-0024"	"2020-09-15-AML0024:TTTAGTCAGGGTTAGC"	-2.96460137787517	10.2427491911682	"2020-09-15-AML0024"	"AML0024"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00253914515446466	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCAGGGTTAGC"	"CD8+ T"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1901.30309143722	34.2021844120051	0.0179888122867097	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	65	TRUE	"T_AML-0024"	1896.04579065561	1896.04579065561
"AML-0024"	"2020-09-15-AML0024:TTTAGTCGTTGAAGTA"	-0.416446517140228	-15.8266239396301	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCGTTGAAGTA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.5033566842	32.0651530137848	0.0116452202376822	2836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2745.35850078313	2745.35850078313
"AML-0024"	"2020-09-15-AML0024:TTTAGTCTCATCGTAG"	-1.52946851673778	-16.1483259431091	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCTCATCGTAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.16481557965	35.2799212903587	0.0127910852502642	2494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2751.0338106837	2751.0338106837
"AML-0024"	"2020-09-15-AML0024:TTTAGTCTCGCAAGAG"	-1.50599823418315	-16.5875902405945	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCTCGCAAGAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.24868701716	47.0138040101308	0.0194091565668367	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2413.76487031012	2413.76487031012
"AML-0024"	"2020-09-15-AML0024:TTTAGTCTCGTGGCGT"	-1.96262059631999	-15.9017257920471	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTAGTCTCGTGGCGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.0624672108	33.4700818781482	0.0133025639523377	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2512.00796828703	2512.00796828703
"AML-0024"	"2020-09-15-AML0024:TTTATGCAGGTACATA"	-1.54542885246928	-15.1468105546203	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	84	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCAGGTACATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2018.57954722843	43.7139932127002	0.0216558189508661	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2014.75713106283	2014.75713106283
"AML-0024"	"2020-09-15-AML0024:TTTATGCCACGCTATA"	-0.422744880348998	-15.9133892289368	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTATGCCACGCTATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.99726982758	38.9760518922751	0.0142665047006928	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2729.07161515303	2729.07161515303
"AML-0024"	"2020-09-15-AML0024:TTTCGATGTTGTTGTG"	-2.22373352471049	-15.7775840989319	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATGTTGTTGTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.41980358609	35.3253487171052	0.0132731216133233	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2654.7865601353	2654.7865601353
"AML-0024"	"2020-09-15-AML0024:TTTCGATTCCTATGGA"	-1.74592850628551	-15.933939956781	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATTCCTATGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.92060833027	33.6629465630895	0.0122681926222253	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2731.47135037656	2731.47135037656
"AML-0024"	"2020-09-15-AML0024:TTTCGATTCGGCTTCT"	-2.11538730087932	-16.2169904938904	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATTCGGCTTCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.32000210474	44.234605797119	0.0163328579203132	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2700.85398507522	2700.85398507522
"AML-0024"	"2020-09-15-AML0024:TTTCGATTCTTAGCTT"	-1.02986047688182	-16.8473692170349	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATTCTTAGCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.98355301149	32.3153578740061	0.0130779332119075	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2461.14018922117	2461.14018922117
"AML-0024"	"2020-09-15-AML0024:TTTGACTCAAATGATG"	-0.893228213221389	-16.0340719453064	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGACTCAAATGATG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2781.62669397177	32.1496197168795	0.0115578484296807	2540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2774.58524001734	2774.58524001734
"AML-0024"	"2020-09-15-AML0024:TTTGACTCATGACGGA"	-1.30507419529613	-16.5639944306579	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGACTCATGACGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.74762370609	36.7482523841681	0.013754387599377	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2659.39827969413	2659.39827969413
"AML-0024"	"2020-09-15-AML0024:TTTGACTGTGACTCGC"	-0.633004824549514	-16.655526184198	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGACTGTGACTCGC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.6753228522	36.2909302832672	0.0141724059896999	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2553.00583255521	2553.00583255521
"AML-0024"	"2020-09-15-AML0024:TTTGACTTCTCGGGAC"	-2.78741608086284	-16.0709276429382	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGACTTCTCGGGAC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2850.01728455893	33.1247664210277	0.011622654571428	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2837.58718797507	2837.58718797507
"AML-0024"	"2020-09-15-AML0024:TTTGACTTCTGGCCAG"	-1.19446633282359	-16.0061521760193	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGACTTCTGGCCAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3095.09075167119	38.8730877981435	0.0125595954745928	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3084.30361396401	3084.30361396401
"AML-0024"	"2020-09-15-AML0024:TTTGATCAGAATCCCT"	-0.430276493460494	-15.8313102952209	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCAGAATCCCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3000.05708983504	35.0846111188391	0.0116946478244413	2823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2990.85710197234	2990.85710197234
"AML-0024"	"2020-09-15-AML0024:TTTGATCAGGTACCTT"	-0.187152768403846	-16.0566034547058	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCAGGTACCTT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.41088320768	39.6392263455202	0.0149502389827882	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2648.0115248466	2648.0115248466
"AML-0024"	"2020-09-15-AML0024:TTTGATCCATCGATAC"	-1.685330371291	-16.7622709504333	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCCATCGATAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.36611154442	37.5189334565255	0.0156174919702	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2397.13217867692	2397.13217867692
"AML-0024"	"2020-09-15-AML0024:TTTGATCCATTCGGGC"	-2.03618345680888	-15.5920801392761	"2020-09-15-AML0024"	"AML0024"	"HLA-II+ monocyte"	"HLA-II+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCCATTCGGGC"	"HLA-II+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.56557119192	44.8814138741402	0.0170226807042203	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2630.79705339009	2630.79705339009
"AML-0024"	"2020-09-15-AML0024:TTTGATCGTCTTGCTC"	-0.689912537962753	-15.9741144410339	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCGTCTTGCTC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.61599304285	36.1913619607795	0.0142227204653783	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2539.03468489941	2539.03468489941
"AML-0024"	"2020-09-15-AML0024:TTTGATCGTTCGGTCG"	-1.00549624386485	-17.4058389893738	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCGTTCGGTCG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.58689221251	38.591557021961	0.014143422418433	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2719.94075269887	2719.94075269887
"AML-0024"	"2020-09-15-AML0024:TTTGATCTCCAGTTCC"	-1.60026011887248	-15.7956047288147	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCTCCAGTTCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1613.22659667799	39.7859846803434	0.0246623659455355	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1609.1887938442	1609.1887938442
"AML-0024"	"2020-09-15-AML0024:TTTGATCTCCTCTCTT"	-1.8580792945927	13.7115220793518	"2020-09-15-AML0024"	"AML0024"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00748916042569965	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCTCCTCTCTT"	"NK"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2153.93478756392	37.6146104793947	0.017463207659103	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	59	TRUE	"NK_AML-0024"	2149.20300076323	2149.20300076323
"AML-0024"	"2020-09-15-AML0024:TTTGATCTCGAGAATA"	-1.67997966232951	-16.765934967157	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCTCGAGAATA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2618.06771042613	31.8538372692402	0.0121669264482299	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2612.78139646786	2612.78139646786
"AML-0024"	"2020-09-15-AML0024:TTTGATCTCTTACTGT"	-1.29443989220317	-15.8714800111023	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGATCTCTTACTGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2812.3325288348	33.6587761881422	0.0119682775216086	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2804.92004927833	2804.92004927833
"AML-0024"	"2020-09-15-AML0024:TTTGGAGAGACAAGCC"	-2.13883099976237	-16.5355806580749	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGAGACAAGCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.89769948551	37.8436799324436	0.0136280425236605	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2763.12681683086	2763.12681683086
"AML-0024"	"2020-09-15-AML0024:TTTGGAGAGATGGGCT"	-2.02460966530498	-15.9112215272156	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGAGATGGGCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2569.5559773587	31.3035782869451	0.0121824854421435	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2564.42299194667	2564.42299194667
"AML-0024"	"2020-09-15-AML0024:TTTGGAGAGCAATAGT"	-2.06761608544047	-16.5127020112244	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGAGCAATAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2773.83845456865	34.6666873241263	0.012497731173576	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2766.84705014962	2766.84705014962
"AML-0024"	"2020-09-15-AML0024:TTTGGAGCAGATACCT"	-0.989522199065048	-16.5797624818054	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGCAGATACCT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.37295016221	39.0156652029412	0.0143578617725669	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2711.63713468466	2711.63713468466
"AML-0024"	"2020-09-15-AML0024:TTTGGAGCAGCGCTTG"	-1.40102253380473	-16.0150766602722	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGCAGCGCTTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.54451495534	38.6785418446001	0.0153697030252161	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2511.11417419559	2511.11417419559
"AML-0024"	"2020-09-15-AML0024:TTTGGAGGTACTGGGA"	-0.151145706803161	-16.0938978425232	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGGTACTGGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2602.69667272384	36.7649484751996	0.0141257138645831	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2595.08065741895	2595.08065741895
"AML-0024"	"2020-09-15-AML0024:TTTGGAGGTCCACACG"	-1.44457207146342	-15.8605747452942	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGGTCCACACG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.54968915304	38.0328367147979	0.0152402642512423	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2487.58017991508	2487.58017991508
"AML-0024"	"2020-09-15-AML0024:TTTGGAGGTTCGATTG"	-2.5749560398167	-15.8745985261169	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGGTTCGATTG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2523.07170487759	36.0391339640269	0.0142838326371606	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2520.19268093658	2520.19268093658
"AML-0024"	"2020-09-15-AML0024:TTTGGAGGTTGTACGT"	-2.16057334366496	-16.5853815308777	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGGTTGTACGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3122.56049727061	38.0293746078542	0.0121789072272884	3423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3110.42217526763	3110.42217526763
"AML-0024"	"2020-09-15-AML0024:TTTGGAGTCATAGCAC"	-2.61219988289531	-16.2008524171081	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGTCATAGCAC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1899.11869355868	46.0153249921939	0.0242298309991188	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	1892.7367020976	1892.7367020976
"AML-0024"	"2020-09-15-AML0024:TTTGGAGTCCTCTCGA"	-0.777742008597213	-16.0537004700867	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGTCCTCTCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.41129243854	36.1010630729821	0.0127908583591979	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2818.54291913798	2818.54291913798
"AML-0024"	"2020-09-15-AML0024:TTTGGAGTCGAAATCC"	-0.273007879883605	-16.4217176667419	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGTCGAAATCC"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.26537119546	37.2684384332605	0.0131678247603753	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2821.2464797107	2821.2464797107
"AML-0024"	"2020-09-15-AML0024:TTTCCTCCAAGACCGA"	-1.82380102101024	-16.1027212372986	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCCAAGACCGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3080.56448275828	33.9794924850821	0.0110302811953014	3741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	3068.41696651098	3068.41696651098
"AML-0024"	"2020-09-15-AML0024:TTTCCTCCAATGTTGC"	-2.84869704666789	-16.0525179139343	"2020-09-15-AML0024"	"AML0024"	"CD16+ monocyte"	"CD16+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCCAATGTTGC"	"CD16+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.9696849589	35.4673023842357	0.0145658086025964	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2428.15430117759	2428.15430117759
"AML-0024"	"2020-09-15-AML0024:TTTCCTCGTGAGCCAA"	-1.7369752925938	-16.750475906488	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCGTGAGCCAA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.28921288072	39.4925657629969	0.0145982786516726	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2692.03719019378	2692.03719019378
"AML-0024"	"2020-09-15-AML0024:TTTCCTCGTTTAAGGA"	-1.76658521118816	-16.7161321870056	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCGTTTAAGGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.34728963548	43.082266012794	0.0186233455762635	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2305.00339261886	2305.00339261886
"AML-0024"	"2020-09-15-AML0024:TTTCCTCTCAGGACAG"	-1.64397356930431	-16.801917099115	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCTCAGGACAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2316.70014543789	42.0851281404919	0.0181659798413563	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2312.86265625689	2312.86265625689
"AML-0024"	"2020-09-15-AML0024:TTTCCTCTCCATGAGT"	-1.57165358486827	-16.8825044861999	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCTCCATGAGT"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.50453497799	35.9521467327002	0.0149519978896731	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2392.32246353523	2392.32246353523
"AML-0024"	"2020-09-15-AML0024:TTTCCTCTCGCGCTGA"	-1.76185272160228	-16.8098192445007	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCCTCTCGCGCTGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.13152767564	38.3222523939831	0.0155457232053322	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2458.75205190479	2458.75205190479
"AML-0024"	"2020-09-15-AML0024:TTTCGATCATTAAAGG"	-0.964301089674789	-17.3421545258728	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	80	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATCATTAAAGG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.56463410096	45.9473280576997	0.0166200954359824	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2758.29491181172	2758.29491181172
"AML-0024"	"2020-09-15-AML0024:TTTCGATGTCTTCAAG"	-0.792953650385696	-15.9533148041931	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+ IFN+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTCGATGTCTTCAAG"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2694.68921292296	40.5034024143014	0.0150308251578916	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2690.08312226579	2690.08312226579
"AML-0024"	"2020-09-15-AML0024:TTTGGAGTCTTGCAGA"	-0.194703648716766	-16.4509496918884	"2020-09-15-AML0024"	"AML0024"	"CD14+ monocyte"	"CD14+"	7	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613779"	"2020-09-15"	"2020.09.15.AML0024.TTTGGAGTCTTGCAGA"	"CD14+ monocyte"	"U-06-0024"	"M"	64	"CITE-seq"	"OSU"	"AML0024"	"AML"	"Adverse"	"48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)"	137	""	""	""	""	""	""	""	NA	NA	"0+T2:BL24"	"0,46"	"0"	"0,99"	"0"	0	"0"	"0"	"0"	"0,06"	"0"	"0"	"0"	"0"	"0,17"	"0"	"0"	"0,17"	0	0	"0"	0	0	0	"0"	0	"0"	"0,45"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2877.47737626152	34.2328216462322	0.0118968169580218	2605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5451	TRUE	"Mono_AML-0024"	2869.87224126763	2869.87224126763
"AML-0160"	"2019-07-01-count-3:GCCCAGAGTGTCACAT"	2.09474243697469	-9.07580759441527	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCCAGAGTGTCACAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2050.74177105261	42.610956587539	0.0207783140661672	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2050.74177105261	2050.74177105261
"AML-0160"	"2019-07-01-count-1:CCCTCTCAGTCAACAA"	1.6333290534908	-9.0499363175598	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTCTCAGTCAACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.33574594831	37.2186574688422	0.0143627306986505	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2586.95025307494	2586.95025307494
"AML-0160"	"2019-07-01-count-3:ATTCATCGTCGAGATG"	1.99052633818929	-7.58196642315062	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCATCGTCGAGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2037.76846354918	45.1691491321105	0.0221659869313314	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2033.3883905512	2033.3883905512
"AML-0160"	"2019-07-01-count-3:ATCGTCCAGGCACTCC"	4.6433969932491	-4.92014076625975	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGTCCAGGCACTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.30895209792	45.1803853544617	0.020846305881184	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2158.63008026211	2158.63008026211
"AML-0160"	"2019-07-01-count-1:ACGGAAGCAATGTTGC"	2.04937603053395	-9.7563162080017	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGAAGCAATGTTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.62454872759	51.597664148738	0.0226442149837939	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2266.19529595073	2266.19529595073
"AML-0160"	"2019-07-01-count-3:TCAGGTACAAACCACT"	2.29544248160664	-3.96749451076659	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGGTACAAACCACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2849.78453924511	44.2364242791998	0.0155227259008563	2506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2840.20464280334	2840.20464280334
"AML-0160"	"2019-07-01-count-3:GGCGTCATCAAGGACG"	3.41397776183431	-7.80458023464354	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCGTCATCAAGGACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.28929401665	33.3487092306144	0.0150606830465774	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2210.93036091927	2210.93036091927
"AML-0160"	"2019-07-01-count-1:AATCGACTCGACGCTG"	1.64554228362386	-9.07308580791625	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCGACTCGACGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2386.20136491084	43.8037593227491	0.018357109323163	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2383.29119179068	2383.29119179068
"AML-0160"	"2019-07-01-count-1:ACACGCGGTTTCGGCG"	1.96532215651814	-9.36875917827757	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACACGCGGTTTCGGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.51353091198	36.8881456526344	0.0151459415784159	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2431.38402384125	2431.38402384125
"AML-0160"	"2019-07-01-count-1:GAGACTTGTGAATATG"	2.3821402984554	-9.19397261058959	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGACTTGTGAATATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.8519912713	42.4881910657408	0.0183071523843565	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.54335064281	2313.54335064281
"AML-0160"	"2019-07-01-count-1:GCTGAATCATGTTTGG"	1.51695992526357	-7.36804821407469	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00611995104039168	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGAATCATGTTTGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2699.49031899741	42.1396160705243	0.0156102119625956	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2695.25617688776	2695.25617688776
"AML-0160"	"2019-07-01-count-2:CGTTGGGGTCTCTCTG"	1.34493770179097	-8.56056883251341	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTGGGGTCTCTCTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2217.33683711669	44.4726656709459	0.0200567928726498	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2215.92438680664	2215.92438680664
"AML-0160"	"2019-07-01-count-1:AGATCCATCCGATGTA"	2.80774225768391	-9.09233477031859	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATCCATCCGATGTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2226.61200583923	46.0680360583506	0.0206897456483385	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2226.61200583923	2226.61200583923
"AML-0160"	"2019-07-01-count-1:GTCGCGAAGGAAGTCC"	2.19850816306416	-8.3989877930847	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGCGAAGGAAGTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1869.96581217301	47.1754388567043	0.0252279686342948	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1865.39454616656	1865.39454616656
"AML-0160"	"2019-07-01-count-1:GGGTTATCAAATCGGG"	2.44404377517049	-9.29306127941283	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTTATCAAATCGGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.75762833182	39.4020315270783	0.0164054986491062	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2398.37556422632	2398.37556422632
"AML-0160"	"2019-07-01-count-3:CTTCTAATCTTACCGC"	3.6341687637264	-5.57549908077391	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCTAATCTTACCGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2417.0901793939	46.5295278365987	0.0192502241882701	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2416.04938816926	2416.04938816926
"AML-0160"	"2019-07-01-count-3:GTCCCATCAACACAGG"	1.93811025199239	-4.11319687282714	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCCCATCAACACAGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2072.81443970209	40.9531915829757	0.0197572878684026	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2070.49818791015	2070.49818791015
"AML-0160"	"2019-07-01-count-3:TCCTCTTCAAATGGTA"	2.27899422225301	-4.46896173870238	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCTTCAAATGGTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2348.78677896895	39.1073302779895	0.0166500129463248	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2344.75973219305	2344.75973219305
"AML-0160"	"2019-07-01-count-1:CACTGGGCACCTGCTT"	1.59289242801015	-9.01458456432494	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGGGCACCTGCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.76625895621	37.8525701100748	0.0144378126695188	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2613.79876057771	2613.79876057771
"AML-0160"	"2019-07-01-count-1:GTACAACTCGGCTGAC"	1.71053423461263	-8.44927408611449	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTACAACTCGGCTGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.01439395262	41.4432525454246	0.0174717542402284	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2364.32489218514	2364.32489218514
"AML-0160"	"2019-07-01-count-2:GATCATGTCCTACGGG"	2.162454743951	-9.40200903331908	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCATGTCCTACGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.67317180792	41.6596384317086	0.0173100522828422	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2399.36191517624	2399.36191517624
"AML-0160"	"2019-07-01-count-2:ACATGCAAGAGAGCCT"	1.54757704314534	-8.80290701305541	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATGCAAGAGAGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2250.53098076821	39.2346983148523	0.0174335295315329	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.27002777204	2247.27002777204
"AML-0160"	"2019-07-01-count-2:GGTGAAGCATCCTCAC"	2.22979344901387	-9.60489942943724	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGAAGCATCCTCAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.98618757034	41.2550074807362	0.0172616091654806	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2388.86906318783	2388.86906318783
"AML-0160"	"2019-07-01-count-3:AGTAGCTGTATCCCAA"	1.8519330221111	-8.79218008434447	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTAGCTGTATCCCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2211.61864882732	46.663242205119	0.0210991357980553	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2210.43137073154	2210.43137073154
"AML-0160"	"2019-07-01-count-1:TACTGCCCAATAAGGT"	-1.59441659870799	-11.9865102997986	"2019-07-01-count-1"	"AML0160"	"CD16+ monocyte"	"CD16+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTGCCCAATAAGGT"	"CD16+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1990.9715348553	45.14806644763	0.0226763997662635	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1978.59460955338	1978.59460955338
"AML-0160"	"2019-07-01-count-1:CAACCTCAGGCGCTCT"	-6.91836152496989	-2.60801126873168	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0217391304347826	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACCTCAGGCGCTCT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3363.62708781862	44.199169305637	0.0131403298141177	4198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	3348.79900834844	3348.79900834844
"AML-0160"	"2019-07-01-count-3:TGTCAGAGTCGAAGCA"	2.37627162513081	-8.7504978409973	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTCAGAGTCGAAGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.80049042791	40.468785649911	0.0195898809383709	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2060.94520865245	2060.94520865245
"AML-0160"	"2019-07-01-count-2:CTGTACCCACCTGCGA"	2.63130106505696	-8.113720916864	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTACCCACCTGCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2101.06839815042	45.7669560672283	0.0217827064114224	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2101.06839815042	2101.06839815042
"AML-0160"	"2019-07-01-count-2:GTGAGGACACATACGT"	2.03867950019185	-9.1444883576599	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGGACACATACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2110.66472584367	39.326526132471	0.0186322942014163	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2108.23939103939	2108.23939103939
"AML-0160"	"2019-07-01-count-3:ACTGCAACAGCCTACG"	2.44114293631856	-8.56370451366576	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTGCAACAGCCTACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.88938053545	42.7445384154463	0.0173554438754993	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2457.10168089815	2457.10168089815
"AML-0160"	"2019-07-01-count-1:TCCGATCTCCTGCCAT"	5.32347406920735	-4.97405340587767	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGATCTCCTGCCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.69942584249	41.7521840709023	0.0175672967380391	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2373.33391469955	2373.33391469955
"AML-0160"	"2019-07-01-count-1:CTCTCGAAGTGAGGTC"	1.53281070765797	-8.75050260936888	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCTCGAAGTGAGGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.88596381342	41.473171510884	0.0175965965887382	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2353.09398236497	2353.09398236497
"AML-0160"	"2019-07-01-count-1:CCGGTAGGTTGAATCC"	2.34482850608174	-3.93521120464476	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTAGGTTGAATCC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2698.55615298444	40.7230738751797	0.0150906898232014	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2693.50205402992	2693.50205402992
"AML-0160"	"2019-07-01-count-3:TGTGTGATCCGATGTA"	1.54897059974019	-8.52971270000609	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGTGATCCGATGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.96257716407	38.2654892165705	0.0157085702281679	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2430.02544987551	2430.02544987551
"AML-0160"	"2019-07-01-count-1:GTCAAGTGTAGGCAAC"	1.61280812796895	-8.74812319194945	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCAAGTGTAGGCAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2141.14655304557	45.5603926677779	0.0212785026802452	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2135.70266805676	2135.70266805676
"AML-0160"	"2019-07-01-count-1:GGGTATTAGTCTAGCT"	-7.63506970825847	3.64909575069276	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTAGTCTAGCT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2341.5960182009	33.1575289831322	0.0141602260703398	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2331.48507811695	2331.48507811695
"AML-0160"	"2019-07-01-count-1:ATTCCCGAGGGAACAA"	1.96161677417104	-7.9002461663452	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCCGAGGGAACAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.06886932714	39.3054529131865	0.0162213519437032	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2419.25313155879	2419.25313155879
"AML-0160"	"2019-07-01-count-3:ATTTCACAGCGTTAGG"	-8.17156920853313	2.88135311687318	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTTCACAGCGTTAGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2118.11602242131	39.0889925391059	0.0184546040563073	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2113.14277975098	2113.14277975098
"AML-0160"	"2019-07-01-count-2:CGAATTGGTCCCACGA"	1.66487743434255	-8.79110243236693	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAATTGGTCCCACGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.92467867081	44.5652328960504	0.0188841759649512	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2354.67816145065	2354.67816145065
"AML-0160"	"2019-07-01-count-2:TCTCCGAGTCGTATGT"	1.74910928782765	-8.82067205822142	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCCGAGTCGTATGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.94351751794	41.9390529185556	0.0175775547956743	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2381.69935236391	2381.69935236391
"AML-0160"	"2019-07-01-count-1:GTTCTATTCCCGTGTT"	1.56499447402303	-8.89986421978148	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCTATTCCCGTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.54897535063	41.2557027052098	0.0165582547697679	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2486.93031488811	2486.93031488811
"AML-0160"	"2019-07-01-count-1:TCATACTTCTTGGAAC"	1.71793760833089	-8.909131073114	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATACTTCTTGGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.21276018118	39.9854064503141	0.0168415430667902	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2369.00244036146	2369.00244036146
"AML-0160"	"2019-07-01-count-3:GCTTCACAGTGTGTTC"	1.81165279921834	-7.42917635357054	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTTCACAGTGTGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.24893963124	45.9873597663318	0.0204003022726738	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.79888465813	2247.79888465813
"AML-0160"	"2019-07-01-count-2:ACAGCCGGTAGGAAAG"	7.98729910430257	7.15176103198854	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAGCCGGTAGGAAAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1822.41730527556	46.7120135674484	0.0256318974980241	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1814.45216244136	1814.45216244136
"AML-0160"	"2019-07-01-count-2:CAATTTCAGAAACTCA"	-8.17029796066936	2.23290703380433	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATTTCAGAAACTCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2283.47250975355	43.5146688906596	0.0190563576766492	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2272.72699461962	2272.72699461962
"AML-0160"	"2019-07-01-count-1:ATACTTCTCTAACGCA"	-7.58444819870647	3.21718404376832	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATACTTCTCTAACGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2376.10867049782	41.9185808526901	0.0176416934853017	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2365.26391860376	2365.26391860376
"AML-0160"	"2019-07-01-count-3:CATACTTGTAGCTTTG"	1.67983152446095	-9.03463842785033	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATACTTGTAGCTTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2084.32706294133	42.205007664268	0.0202487452255741	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2078.89336841909	2078.89336841909
"AML-0160"	"2019-07-01-count-2:TACTTGTTCGGTCGAC"	12.4049602943355	-2.75511362468871	"2019-07-01-count-2"	"AML0160"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0833333333333333	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACTTGTTCGGTCGAC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1691.13709488131	44.5881085541246	0.026365756324004	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1691.13709488131	1691.13709488131
"AML-0160"	"2019-07-01-count-2:CTACCTGAGGCCTTGC"	-8.03707251969035	2.17331049526063	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACCTGAGGCCTTGC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2350.14021373968	39.9566886164816	0.017001831798325	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2340.52445897389	2340.52445897389
"AML-0160"	"2019-07-01-count-1:TTCGGTCCATAACTCG"	2.03487779673879	-10.3436279526916	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGGTCCATAACTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.4258653199	42.2723519185458	0.0175082418249959	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2410.19565071537	2410.19565071537
"AML-0160"	"2019-07-01-count-2:ATGATCGGTCTCAGAT"	1.7022713619167	-8.74080946361693	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGATCGGTCTCAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1910.18906631197	42.4518593727087	0.0222239044926957	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1908.65927778949	1908.65927778949
"AML-0160"	"2019-07-01-count-1:ATCGGCGTCGTCCTTG"	2.61339344558064	-8.92699243938597	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGGCGTCGTCCTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.85729068194	38.0988415194078	0.0173424289693307	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.51836457245	2195.51836457245
"AML-0160"	"2019-07-01-count-2:GTTATGGCAGATCACT"	-8.18819556656535	2.09634850108949	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTATGGCAGATCACT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2511.57544239985	39.1285417394245	0.0155792818638315	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2502.48853117919	2502.48853117919
"AML-0160"	"2019-07-01-count-3:AGCGCTGTCGGCAGTC"	3.25527228888814	-9.41287233745726	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGCTGTCGGCAGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2130.66745690424	37.8064190758779	0.0177439322843974	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2127.97960899604	2127.97960899604
"AML-0160"	"2019-07-01-count-3:AGAGCAGGTCAAGGCA"	1.75530495223348	-8.83978559887084	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCAGGTCAAGGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.86858663417	41.1445569696284	0.0190849095463026	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2153.33575669607	2153.33575669607
"AML-0160"	"2019-07-01-count-3:CTGTGGGAGCTGTTAC"	3.23392405089681	-8.81530096447142	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTGGGAGCTGTTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2200.957558825	37.3648246772695	0.0169766220740836	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2197.00895655917	2197.00895655917
"AML-0160"	"2019-07-01-count-1:TTGAGTGGTGTGAGCA"	1.88610066947286	-9.01024725353392	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAGTGGTGTGAGCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2353.54007085012	40.7010523451223	0.0172935455186114	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2347.09542418085	2347.09542418085
"AML-0160"	"2019-07-01-count-2:GGTTCTCGTGCATGAG"	2.49830140647237	-8.17200758373412	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTTCTCGTGCATGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2178.30484875388	48.5619840707606	0.0222934747166087	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2170.23907895143	2170.23907895143
"AML-0160"	"2019-07-01-count-3:AAGCATCGTTCGAACT"	-7.9694713157719	1.27842638576356	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCATCGTTCGAACT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2321.78919725953	39.8078109092131	0.0171453166188383	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2316.00601797514	2316.00601797514
"AML-0160"	"2019-07-01-count-1:GTATTTCTCGATTTCT"	1.69849302348439	-8.7271185151306	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTATTTCTCGATTTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2720.21820984473	39.4168223085386	0.0144903163157593	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2715.01445165742	2715.01445165742
"AML-0160"	"2019-07-01-count-2:GCCATGGAGGGTGGGA"	2.82682313498799	-10.0125103226868	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCATGGAGGGTGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.39788213618	45.1259218178718	0.0205735230189622	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2190.02306921243	2190.02306921243
"AML-0160"	"2019-07-01-count-3:ATGGGAGCAACCGTGC"	2.46526660498921	-8.54886724865111	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGGAGCAACCGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1804.54070118657	47.6704911297044	0.0264169664327099	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1798.89662308043	1798.89662308043
"AML-0160"	"2019-07-01-count-1:TTCGGTCAGTGATTCC"	2.05700244483296	-8.27524759685668	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGGTCAGTGATTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2153.10319948743	43.8070539489596	0.0203460075482626	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2151.73817512959	2151.73817512959
"AML-0160"	"2019-07-01-count-1:TACGCTCCAGTCAGTT"	2.99801554259602	-8.93687250530394	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGCTCCAGTCAGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1865.49758734189	50.1321687469228	0.0268733495487149	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1863.83807669751	1863.83807669751
"AML-0160"	"2019-07-01-count-3:GTGAGTTAGTGCCCGT"	-8.78226886215861	1.36361465537874	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGTTAGTGCCCGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2659.6119031078	48.0393429632713	0.0180625387136885	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2651.70317881281	2651.70317881281
"AML-0160"	"2019-07-01-count-2:AGAACCTGTGGATCGA"	2.53467359122578	-9.11329748546752	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAACCTGTGGATCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2135.92730154824	44.820640271517	0.0209841600128564	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2132.08425221892	2132.08425221892
"AML-0160"	"2019-07-01-count-2:CTGTGGGCACGGGTAA"	-7.99361358109172	2.1306147345337	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTGGGCACGGGTAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2400.10785513948	42.83989927838	0.0178491558979921	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2391.13084005002	2391.13084005002
"AML-0160"	"2019-07-01-count-3:CCTACGTGTGCACAAG"	1.51545550402943	-8.49613382732543	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTACGTGTGCACAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.70829871983	44.2969158291429	0.0205868592204146	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2149.24652371894	2149.24652371894
"AML-0160"	"2019-07-01-count-3:CTCATCGGTTCCACAA"	5.13667263564412	-4.5632009736267	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATCGGTTCCACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.73306116117	47.9864396296061	0.0232861016955622	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2052.87880209633	2052.87880209633
"AML-0160"	"2019-07-01-count-3:TCCATCGCATACAGGG"	8.39914288100545	5.84143445575563	"2019-07-01-count-3"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCATCGCATACAGGG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1668.52164475318	43.8928247170523	0.0263064161349524	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1666.82326682576	1666.82326682576
"AML-0160"	"2019-07-01-count-1:ATTGGGTGTACAAAGT"	1.37821199473683	-8.39731981670531	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTGGGTGTACAAAGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2625.71617434774	46.2202231682712	0.0176029014940097	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2620.77486612519	2620.77486612519
"AML-0160"	"2019-07-01-count-3:ACTCTCGAGTGGTGGT"	2.43903770026509	-5.21392776882323	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCTCGAGTGGTGGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2274.69198271552	45.7678482401884	0.0201204596437496	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2270.02580696017	2270.02580696017
"AML-0160"	"2019-07-01-count-3:TGTTTGTAGGGAACAA"	1.95197977599446	-9.3983364335266	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTTGTAGGGAACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1950.43872118363	42.352586653869	0.0217143897902966	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1948.86470049494	1948.86470049494
"AML-0160"	"2019-07-01-count-1:AGGAAATAGGTTCTAC"	1.84663738784139	-9.02852919017943	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGAAATAGGTTCTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2381.08708119435	41.4258183970143	0.0173978594584769	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2376.23852804531	2376.23852804531
"AML-0160"	"2019-07-01-count-1:GTGGAAGAGATGCTTC"	1.75141372260396	-8.65303041851195	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAAGAGATGCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.83764434157	43.5622004235217	0.020057761010367	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2164.98957954332	2164.98957954332
"AML-0160"	"2019-07-01-count-1:TTGGTTTTCGCAGTTA"	2.25011624869649	-9.00771524822386	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGTTTTCGCAGTTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.81661636789	40.087805439518	0.0174993516081081	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.64267100488	2286.64267100488
"AML-0160"	"2019-07-01-count-1:TATTTCGCACCTCTGT"	1.91897406157796	-9.1107387772766	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTTCGCACCTCTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.41201334075	43.3239599501803	0.0183233546884946	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.69321131698	2358.69321131698
"AML-0160"	"2019-07-01-count-1:AGAAGTATCAACTACG"	-7.99389491501506	2.25759694660035	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAGTATCAACTACG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2454.63801248901	43.0918699372053	0.0175552850228657	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2446.52709434215	2446.52709434215
"AML-0160"	"2019-07-01-count-3:TGAGTCACACATACGT"	2.00722410258595	-8.7677793732849	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGTCACACATACGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2056.06399925289	45.6113903264295	0.0221838378294661	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2056.06399925289	2056.06399925289
"AML-0160"	"2019-07-01-count-1:AGATGCTAGAGTTGTA"	2.03208543834035	-9.8580589524475	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATGCTAGAGTTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.63816433234	45.4056161652183	0.0197103941357813	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2300.04722393816	2300.04722393816
"AML-0160"	"2019-07-01-count-1:GGGCTCAGTTGATCGT"	5.49227728423421	-4.29807093059691	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCTCAGTTGATCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.47620800698	44.1536776047835	0.0188411034231639	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2335.33077174328	2335.33077174328
"AML-0160"	"2019-07-01-count-2:TGAATGCCATGTTTGG"	2.19539918479268	-9.418652557489	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAATGCCATGTTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1895.3549261132	40.1532021758998	0.0211850570163352	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1881.79121689063	1881.79121689063
"AML-0160"	"2019-07-01-count-1:CAATGACTCCTACCGT"	2.02085294303243	-8.93362715160521	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATGACTCCTACCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.61024996182	39.9598461357963	0.0156483731753481	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2551.40965437527	2551.40965437527
"AML-0160"	"2019-07-01-count-3:GATCAGTGTGTGTGGA"	2.11157717284505	-8.90076925670775	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCAGTGTGTGTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.35181002001	37.8058489983121	0.0170423144009656	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2216.95567824961	2216.95567824961
"AML-0160"	"2019-07-01-count-1:GAACGTTAGAACTTCC"	1.47311772879903	-8.89048960125121	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACGTTAGAACTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.78043464042	39.8973355856085	0.0161542034368805	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2462.87241245402	2462.87241245402
"AML-0160"	"2019-07-01-count-3:ATTCATCAGCACCAGA"	-7.94261537018474	2.59772226894227	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCATCAGCACCAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2203.86420164239	35.7285801501706	0.0162117884230546	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2195.52080887686	2195.52080887686
"AML-0160"	"2019-07-01-count-1:TTACCGCCACGACGAA"	2.61860050734822	-10.4261675111023	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACCGCCACGACGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.27481270788	40.4853755957445	0.0170373289230842	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.03775401633	2370.03775401633
"AML-0160"	"2019-07-01-count-3:GATCATGGTCACTTCC"	2.34364904937093	-9.40805151378783	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCATGGTCACTTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.11716276167	37.4555074492299	0.0163481414473286	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2287.51535390537	2287.51535390537
"AML-0160"	"2019-07-01-count-1:ATGAAAGTCCGGCTTT"	1.61949708041493	-8.62730600750121	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGAAAGTCCGGCTTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2607.16949848893	40.8341193905104	0.0156622419118424	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2600.43019490121	2600.43019490121
"AML-0160"	"2019-07-01-count-1:CGGGTCATCGCATAGT"	-7.82428155365642	4.28042171085206	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGTCATCGCATAGT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1907.40453656846	36.0052595236441	0.0188765722390594	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1901.99926430596	1901.99926430596
"AML-0160"	"2019-07-01-count-2:CTACCTGAGGATTTAG"	2.21239127692525	-9.34518625652465	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACCTGAGGATTTAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.85935577784	38.2532310972738	0.0172633840670116	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2215.85935577784	2215.85935577784
"AML-0160"	"2019-07-01-count-3:CGACAGCTCCTTCAGC"	1.85999824580495	-8.96199800884398	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGACAGCTCCTTCAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.99909904187	42.7086275439997	0.0191948965563136	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2220.54738813577	2220.54738813577
"AML-0160"	"2019-07-01-count-3:TCTCCGAGTGTTTCTT"	1.83900048312489	-9.14620687877806	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCCGAGTGTTTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2119.1779425731	41.1916622860331	0.0194375665481013	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2116.74074642885	2116.74074642885
"AML-0160"	"2019-07-01-count-1:CGAGGAAGTTGGTGTT"	-8.00591121140178	2.18393538081972	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGGAAGTTGGTGTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2217.54975196781	46.2666345117758	0.0208638541122786	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2210.26654296285	2210.26654296285
"AML-0160"	"2019-07-01-count-1:CGTGAATCAACCGCTG"	7.95714058455769	6.73100802982179	"2019-07-01-count-1"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGAATCAACCGCTG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1539.22808252469	44.4188174257891	0.0288578527965341	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1531.52340040387	1531.52340040387
"AML-0160"	"2019-07-01-count-2:AGGACGAAGAAATCCA"	1.65675093707387	-8.62818148052367	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACGAAGAAATCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2305.3788889415	32.3149209215876	0.0140171843667853	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2300.71768490001	2300.71768490001
"AML-0160"	"2019-07-01-count-2:GATCATGTCCAATCTT"	-6.82522044602092	1.60446522319642	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCATGTCCAATCTT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2128.87564255017	43.864973686469	0.0206047609403447	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2120.5403711673	2120.5403711673
"AML-0160"	"2019-07-01-count-1:AGCGTCGAGGTAGATT"	-9.77963862839397	2.80105373943178	"2019-07-01-count-1"	"AML0160"	"MEP"	"MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCGTCGAGGTAGATT"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1954.57694632701	36.7078079200423	0.0187804363440501	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1952.60791511947	1952.60791511947
"AML-0160"	"2019-07-01-count-1:GACCCTTAGATCCGAG"	2.45814504203145	-9.45936300670775	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCCTTAGATCCGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.40487402196	47.842612994359	0.0221760011625301	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2150.94960099872	2150.94960099872
"AML-0160"	"2019-07-01-count-1:GAAACCTCAATTGCTG"	2.1248856979305	-9.21832754528197	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAACCTCAATTGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.71319831447	35.7676477397126	0.0146246288258013	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2440.68785220459	2440.68785220459
"AML-0160"	"2019-07-01-count-1:TTACTGTGTATGCGTT"	2.98730482634847	-9.60634329235228	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACTGTGTATGCGTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1960.07389633876	52.0228936497557	0.0265412920129847	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1956.331871466	1956.331871466
"AML-0160"	"2019-07-01-count-3:GCGTGCATCATGGCCG"	2.83978595313374	-7.48034193432006	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCGTGCATCATGGCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.92274459425	43.6478587528301	0.021127536771179	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2061.73408483046	2061.73408483046
"AML-0160"	"2019-07-01-count-1:AACCATGGTCGAGCTC"	8.86830486831014	7.59986827457277	"2019-07-01-count-1"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCATGGTCGAGCTC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2108.13872859298	41.601635579558	0.0197338225493935	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2101.1598603551	2101.1598603551
"AML-0160"	"2019-07-01-count-3:AGACAAACATACAGAA"	-8.46026549759563	0.902047491911329	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACAAACATACAGAA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2996.74517736309	40.6307904927327	0.0135583067921994	3611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2987.19798732532	2987.19798732532
"AML-0160"	"2019-07-01-count-1:AGGAAATGTTTCGATG"	2.07491459426228	-8.82686903392943	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGAAATGTTTCGATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.71756138564	44.9158751279195	0.0193709988124118	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2315.00692634848	2315.00692634848
"AML-0160"	"2019-07-01-count-2:CTACATTAGGCATTTC"	1.96859945830647	-9.25804331218871	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACATTAGGCATTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.03433682975	37.0028455762078	0.0159012890315227	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2322.23251420675	2322.23251420675
"AML-0160"	"2019-07-01-count-2:TTTGTTGGTCTAGGTT"	1.06687774237935	9.89224145496217	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGTTGGTCTAGGTT"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1712.98548263571	31.9797438326075	0.0186690104246543	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1711.6602512354	1711.6602512354
"AML-0160"	"2019-07-01-count-3:ATCCCTGAGGTCGCCT"	2.34527887877766	-4.96499540722045	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCCTGAGGTCGCCT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2104.14189870734	43.7788112960412	0.0208060166108267	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2101.56524223356	2101.56524223356
"AML-0160"	"2019-07-01-count-1:AGGGTTTAGCAAGGAA"	6.75044550475423	-10.4582138291565	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTTTAGCAAGGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2051.98527776416	44.4832134989105	0.021678134819456	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2044.73277727798	2044.73277727798
"AML-0160"	"2019-07-01-count-3:CCTGTTGGTGATCGTT"	1.69768549975697	-8.18358328258666	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTGTTGGTGATCGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1924.89486333914	48.6769095919776	0.0252880874270386	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1921.8998947892	1921.8998947892
"AML-0160"	"2019-07-01-count-1:TGAGGAGGTCACTCTC"	1.49370207366292	-8.64176371013793	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGGAGGTCACTCTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2403.51809263316	37.2912162442585	0.0155152633793592	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2402.66712002023	2402.66712002023
"AML-0160"	"2019-07-01-count-1:CCATAAGAGGGTACAC"	-7.56865868988689	3.80711219394533	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCATAAGAGGGTACAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2025.6503304645	34.129370536787	0.0168485991997251	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2016.41962048004	2016.41962048004
"AML-0160"	"2019-07-01-count-3:ACCCTCACAATCGCAT"	1.92608847197835	-4.65138389980467	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCTCACAATCGCAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2441.88100364881	41.5703995707567	0.0170239252071004	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2438.05437503502	2438.05437503502
"AML-0160"	"2019-07-01-count-1:ACCCTTGCATAATCGC"	3.27609052237813	-7.81289770519408	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCCTTGCATAATCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.54092437046	41.6396214281919	0.0156449299903367	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2657.03273592335	2657.03273592335
"AML-0160"	"2019-07-01-count-2:TGCATCCAGCATTTCG"	-7.99336562576945	2.36041543567506	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCATCCAGCATTTCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2039.0017783846	42.9700171455	0.0210740459380781	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2032.36010113427	2032.36010113427
"AML-0160"	"2019-07-01-count-3:CGTTAGAAGTAATACG"	2.19808592376057	-9.10579397594603	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTTAGAAGTAATACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.8606547499	42.2896988147935	0.0194537302666526	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2172.58326512263	2172.58326512263
"AML-0160"	"2019-07-01-count-2:ATCACGAAGGACAAGA"	-1.16631732407268	11.1953515776428	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCACGAAGGACAAGA"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1919.51526577477	44.7604581664848	0.0233186257825452	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1917.99968506898	1917.99968506898
"AML-0160"	"2019-07-01-count-1:TTTGTTGCAACCAATC"	1.74424972113912	-9.11880400097045	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGTTGCAACCAATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2397.38096037185	39.6796767331159	0.0165512604750816	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2390.29594758608	2390.29594758608
"AML-0160"	"2019-07-01-count-3:CCATCACCAGCTATAC"	2.12692441520039	-7.91815044796141	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCATCACCAGCTATAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2446.09299946499	38.4496725434128	0.0157188105897128	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2441.09472358142	2441.09472358142
"AML-0160"	"2019-07-01-count-2:CCCTCTCAGTCCCGAC"	1.86528386649434	-8.11529924785765	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTCTCAGTCCCGAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2566.24687644534	38.1050771837098	0.014848562518853	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2562.5273993632	2562.5273993632
"AML-0160"	"2019-07-01-count-3:TACCCGTGTCGAGCAA"	1.96122719821278	-9.07192137157591	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCCGTGTCGAGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2074.63448774816	42.8803647890756	0.0206688768755688	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.63448774816	2074.63448774816
"AML-0160"	"2019-07-01-count-2:GTCTACCTCCAGTACA"	1.70876242694203	-8.41973879253539	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTACCTCCAGTACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.46494382526	41.9323611359782	0.0168846197085392	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2481.52265041513	2481.52265041513
"AML-0160"	"2019-07-01-count-1:AGACAAATCGACCAAT"	1.92838766154591	-8.67044355785521	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACAAATCGACCAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.6734771952	42.9301902490928	0.0174962930675545	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2450.75117491955	2450.75117491955
"AML-0160"	"2019-07-01-count-1:TAACCAGCAGAACTAA"	1.83248009261433	-8.62696459209593	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACCAGCAGAACTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.92331335926	38.7332745100736	0.0146167529885882	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2644.39877123522	2644.39877123522
"AML-0160"	"2019-07-01-count-3:TCCTCTTAGGTAAACT"	-7.99266562882121	3.94396779620973	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCTTAGGTAAACT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2109.1774844168	39.5883575900421	0.0187695714953019	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2100.99316880583	2100.99316880583
"AML-0160"	"2019-07-01-count-1:CTGCTCATCGAGCCTG"	1.97580780562703	-9.23932650005492	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCTCATCGAGCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.44000238631	49.7184461099523	0.0241300140030142	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2054.97199521463	2054.97199521463
"AML-0160"	"2019-07-01-count-2:GAGGCAATCCGTGTGG"	-4.73801312866862	3.68106219852296	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGGCAATCCGTGTGG"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2441.49000673919	39.4097731402258	0.0161416893091694	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2431.38839496392	2431.38839496392
"AML-0160"	"2019-07-01-count-1:GTAGTACGTTCCGCTT"	0.293948416679543	11.9984531172547	"2019-07-01-count-1"	"AML0160"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGTACGTTCCGCTT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1768.0388737244	44.7039216432243	0.0252844676141395	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1764.37883946479	1764.37883946479
"AML-0160"	"2019-07-01-count-2:TTTGACTAGTGATCGG"	2.23642339286153	-8.92234041607054	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGACTAGTGATCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2169.66140040786	43.6337707320469	0.0201108664807534	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2166.52510467407	2166.52510467407
"AML-0160"	"2019-07-01-count-1:CATGCTCTCATTGCGA"	1.34853651103322	-8.78316309368285	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCTCTCATTGCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2143.46824590616	37.8888566433402	0.0176764254453989	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2141.05234780242	2141.05234780242
"AML-0160"	"2019-07-01-count-2:TCCCACACACCTCTGT"	-9.45538363876994	4.18755862796632	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCCACACACCTCTGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2009.54436047462	48.8538742954235	0.0243109210507226	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2002.32085305514	2002.32085305514
"AML-0160"	"2019-07-01-count-2:CGTTCTGCATACACCA"	-8.92305884781535	3.93657348239747	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTCTGCATACACCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2278.90636059177	36.2906058245887	0.0159245708608954	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2269.73103153275	2269.73103153275
"AML-0160"	"2019-07-01-count-3:ATGATCGGTGACTATC"	1.78702940520589	-8.68304064190062	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGATCGGTGACTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.65252307908	37.7726404820457	0.0152514897144656	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2472.28202901422	2472.28202901422
"AML-0160"	"2019-07-01-count-1:CTTTCAAAGTTCCATG"	1.35653307017629	-6.20382692730101	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00611995104039168	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTTCAAAGTTCCATG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2517.33823922524	51.8448716676556	0.0205951154516335	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2513.79112931286	2513.79112931286
"AML-0160"	"2019-07-01-count-3:GCCCGAAGTAATCAGA"	-7.69164500656779	3.53098890865175	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCCGAAGTAATCAGA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1964.15892328741	39.1483766917964	0.0199313692123618	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1954.05473650282	1954.05473650282
"AML-0160"	"2019-07-01-count-2:AATGACCCATGACAGG"	2.46875061568562	-9.23940279400023	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGACCCATGACAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1978.2950725407	49.2852748583006	0.0249130049113473	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1973.28395013183	1973.28395013183
"AML-0160"	"2019-07-01-count-1:ACACAGTAGGGAGGTG"	-3.17457161369975	-5.66175653850707	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00611995104039168	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACACAGTAGGGAGGTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1641.04942610114	42.2955942885119	0.0257735042076089	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1641.04942610114	1641.04942610114
"AML-0160"	"2019-07-01-count-1:GAGGCCTAGTGTTCCA"	1.5400479036266	-8.78641798412474	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCCTAGTGTTCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.50706232837	43.2792396548287	0.0181883215813949	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.10035945809	2370.10035945809
"AML-0160"	"2019-07-01-count-3:ACTATTCGTCCGAAAG"	1.84154297885243	-8.89288904583129	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATTCGTCCGAAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2162.96497541	39.0810886302835	0.0180682947133139	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2160.64139415865	2160.64139415865
"AML-0160"	"2019-07-01-count-2:CCTATCGGTTCAATCG"	8.082780500024	7.72543952548829	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTATCGGTTCAATCG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1808.89868151622	39.6000150497049	0.0218917816980839	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1804.35545780354	1804.35545780354
"AML-0160"	"2019-07-01-count-3:GATTCTTAGATGAAGG"	1.86704303798024	-9.24613668834838	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTCTTAGATGAAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.53420030219	41.138107566698	0.0192545981996822	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2132.97441711674	2132.97441711674
"AML-0160"	"2019-07-01-count-1:AATCGACGTTGATCGT"	1.79710914668385	-8.55193807994994	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCGACGTTGATCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2199.35870394808	48.9344278357105	0.0222494074058353	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2193.29368226733	2193.29368226733
"AML-0160"	"2019-07-01-count-1:AGGAAATTCTTCGGAA"	2.13488735732381	-8.75142099773558	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGAAATTCTTCGGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1887.41788768677	52.7230223043646	0.0279339422648909	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1885.74637736449	1885.74637736449
"AML-0160"	"2019-07-01-count-3:TTTAGTCAGCGTGAAC"	-8.89916358414348	4.92221257770387	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTAGTCAGCGTGAAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1897.97715918978	44.9993498875816	0.0237091103387099	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1889.60721397979	1889.60721397979
"AML-0160"	"2019-07-01-count-3:GCAGTTATCGCACGGT"	1.3580627637798	9.94331452930299	"2019-07-01-count-3"	"AML0160"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGTTATCGCACGGT"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1463.92603437438	35.9947235524873	0.0245878020523556	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1461.14639883688	1461.14639883688
"AML-0160"	"2019-07-01-count-3:TGAGGTTTCAAGCCTA"	-7.61977754059489	1.11128161037294	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGTTTCAAGCCTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2641.56196130739	43.8845727011084	0.0166131150220639	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2631.34820356136	2631.34820356136
"AML-0160"	"2019-07-01-count-3:AGAGCAGTCTTGAACG"	2.24015917357747	-9.50796606456908	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCAGTCTTGAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1968.44270795135	42.5295183444036	0.0216056673494278	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1963.77914358173	1963.77914358173
"AML-0160"	"2019-07-01-count-2:AGCTCAATCCTAGCGG"	-4.10675940933879	-9.65905764019164	"2019-07-01-count-2"	"AML0160"	"DC precursor"	"DC precursor"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCTCAATCCTAGCGG"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2430.67892937063	36.6453802641422	0.0150761911914177	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2425.05698685978	2425.05698685978
"AML-0160"	"2019-07-01-count-2:GGAGATGGTGAGAGGG"	1.89682139930074	-8.96443846141966	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGATGGTGAGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2249.55576682743	39.3518424728674	0.0174931615624563	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2243.36152718287	2243.36152718287
"AML-0160"	"2019-07-01-count-1:ACCCAAAGTATGAGCG"	1.82975580272023	-9.06240084087523	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCCAAAGTATGAGCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.41785213743	39.1909345331064	0.0165054918610164	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2368.36390633781	2368.36390633781
"AML-0160"	"2019-07-01-count-3:AGCGTCGAGGGTTTCT"	-9.14092002335246	4.45770070636598	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGTCGAGGGTTTCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1732.96847657718	41.3146816505474	0.0238404115302484	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1725.76566002913	1725.76566002913
"AML-0160"	"2019-07-01-count-2:GCACTAACAGTGTATC"	2.25265898284261	-9.04609205639037	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACTAACAGTGTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2212.70625044283	41.0284081830879	0.0185421847906277	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2207.16245862735	2207.16245862735
"AML-0160"	"2019-07-01-count-1:CACGTGGTCGCCGATG"	-7.83491025391276	2.60104081714479	"2019-07-01-count-1"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGTGGTCGCCGATG"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2329.87645390819	11.6901934330654	0.00501751644961946	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2322.63382296684	2322.63382296684
"AML-0160"	"2019-07-01-count-1:AGGGTGATCGGCTTGG"	1.66952504691426	-9.38982393657836	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTGATCGGCTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1933.16449701583	40.1787176720067	0.0207839103883966	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1929.56870715174	1929.56870715174
"AML-0160"	"2019-07-01-count-2:AATGGAACAGTCAGTT"	1.78810181197469	-8.87866403972777	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGGAACAGTCAGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.63071429597	42.6092702473917	0.0198124531395155	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.18584130666	2147.18584130666
"AML-0160"	"2019-07-01-count-3:TCACAAGCAATAACGA"	5.22884525832478	-5.14558508312377	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACAAGCAATAACGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.14825079465	39.5485443042792	0.0163684261887788	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.94942736815	2409.94942736815
"AML-0160"	"2019-07-01-count-2:CATACTTAGGAATCGC"	1.65109803256337	-9.33191111004027	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATACTTAGGAATCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2112.7586187612	40.7261907240102	0.019276310299891	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2110.26730781301	2110.26730781301
"AML-0160"	"2019-07-01-count-3:GTTGCGGGTACGTGTT"	1.26475181159322	-3.61657049572142	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGCGGGTACGTGTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2056.85695954363	38.7729125660516	0.0188505634220935	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2051.73289478953	2051.73289478953
"AML-0160"	"2019-07-01-count-1:TTAGGGTCAAGTCGTT"	-8.50885425034221	3.89083240115968	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGGGTCAAGTCGTT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1958.44693951871	35.9144447832806	0.0183382271220004	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1948.61500350034	1948.61500350034
"AML-0160"	"2019-07-01-count-1:AACCAACCATCGCCTT"	2.29556097564046	-9.31938078319701	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCAACCATCGCCTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2127.98452762164	34.3146855479566	0.0161254394017182	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2124.70416011077	2124.70416011077
"AML-0160"	"2019-07-01-count-2:CTTCTCTCAGATACCT"	2.06066622313802	-9.18541624462279	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCTCTCAGATACCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.16388964965	43.6888177237776	0.0192278461614466	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2271.09865682229	2271.09865682229
"AML-0160"	"2019-07-01-count-1:CATTGCCAGTGCTCAT"	1.94885088977162	-8.38722612774047	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTGCCAGTGCTCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.3271397787	37.8887035351302	0.0134915562359006	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2804.93233201589	2804.93233201589
"AML-0160"	"2019-07-01-count-1:TATTTCGGTGTCACAT"	1.45208062705342	-8.43173506176146	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTTCGGTGTCACAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2570.29173164515	47.2284579153739	0.0183747460780044	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2565.56349514768	2565.56349514768
"AML-0160"	"2019-07-01-count-1:GTCGAATTCGTCGACG"	2.04415359076802	-9.53795912182006	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGAATTCGTCGACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.88784103665	42.5731121358456	0.0184788128039643	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2303.88784103665	2303.88784103665
"AML-0160"	"2019-07-01-count-1:TCAGTGACAGCTACTA"	2.10821618613545	-9.33653738414916	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGTGACAGCTACTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.74856079013	48.565720937549	0.0219283226084241	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2211.27812456655	2211.27812456655
"AML-0160"	"2019-07-01-count-1:ACCATTTTCCATCCGT"	-8.09439788284953	2.52346942508546	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCATTTTCCATCCGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2378.8887922226	39.8841167641947	0.016765860133769	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2371.65836072182	2371.65836072182
"AML-0160"	"2019-07-01-count-1:TTCCAATCAGTTGGTT"	-7.89564309540446	1.77090678298799	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCAATCAGTTGGTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2519.07431883042	35.5667659430004	0.0141189823885441	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2506.02179021197	2506.02179021197
"AML-0160"	"2019-07-01-count-2:CGTAGTATCAGTCTTT"	2.31564893302266	-8.78097250377806	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTAGTATCAGTCTTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.38926297642	40.7402286487685	0.016755946597747	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2430.1808378031	2430.1808378031
"AML-0160"	"2019-07-01-count-2:CATGCTCAGATAACAC"	2.03285171565358	-8.91361429607543	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCTCAGATAACAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.09430788812	39.6001432929767	0.0173677655156533	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2274.42136936713	2274.42136936713
"AML-0160"	"2019-07-01-count-3:TTACGTTTCATAAGGA"	1.83121468600575	-8.76582720195922	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACGTTTCATAAGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2206.91784047522	41.9407674974058	0.0190042269486456	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2204.50500304703	2204.50500304703
"AML-0160"	"2019-07-01-count-1:AGATCCAAGACTCAAA"	2.5150257545406	-9.3622036210266	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATCCAAGACTCAAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2407.43808097031	49.3436742671284	0.0204963420065369	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2401.27215392701	2401.27215392701
"AML-0160"	"2019-07-01-count-1:GTAGTACGTGCGTCGT"	1.95494498786275	-9.08308412944945	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGTACGTGCGTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1882.84258841882	39.3303808406831	0.0208888311123831	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1878.31575392776	1878.31575392776
"AML-0160"	"2019-07-01-count-1:TTCCAATGTACTCCCT"	1.83808126029317	-8.25871088421019	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCAATGTACTCCCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1710.58736308203	43.4661440369709	0.0254100696492088	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1710.58736308203	1710.58736308203
"AML-0160"	"2019-07-01-count-1:GGGAAGTAGACCAACG"	2.48904051360432	-9.65757372295531	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAAGTAGACCAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.80283809638	46.1647243034789	0.0205285779266258	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.59588107652	2247.59588107652
"AML-0160"	"2019-07-01-count-3:GGGTGAAAGAGAGGGC"	2.6015485721523	-5.01128294384154	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTGAAAGAGAGGGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2044.56220401305	38.0257877113993	0.0185984988066211	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2039.63039550852	2039.63039550852
"AML-0160"	"2019-07-01-count-3:CTATCCGCAAAGACTA"	9.2060190635616	5.85445926273195	"2019-07-01-count-3"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATCCGCAAAGACTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2094.92137692511	41.3906548302518	0.0197576172958836	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2087.18508886324	2087.18508886324
"AML-0160"	"2019-07-01-count-3:GAGCTGCAGGTTGCCC"	1.87427022036855	-9.05018522655638	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGCTGCAGGTTGCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.12630831318	40.2478716511447	0.0181859803934196	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2210.64186246244	2210.64186246244
"AML-0160"	"2019-07-01-count-1:CCACTTGAGGAGATAG"	2.14424457129781	-9.31274130260619	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACTTGAGGAGATAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.86437712954	43.675023029024	0.020324699638497	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2145.63602038803	2145.63602038803
"AML-0160"	"2019-07-01-count-2:CAGGTATCATTGGCAT"	1.61495270308797	-8.05710890209349	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGTATCATTGGCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.02486604591	42.6735031323676	0.0189489484666719	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.93537366033	2247.93537366033
"AML-0160"	"2019-07-01-count-2:GCATGATTCGCCGAGT"	2.84436859664266	-9.58812048351439	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCATGATTCGCCGAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2122.52848230333	44.1177934308017	0.0207854894757058	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2114.96989650894	2114.96989650894
"AML-0160"	"2019-07-01-count-2:AGTCACAGTAGGAGTC"	-7.15086970749553	0.921884573343672	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCACAGTAGGAGTC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2327.92207885399	36.7674079076755	0.0157940887462074	2544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2315.37753633355	2315.37753633355
"AML-0160"	"2019-07-01-count-1:TCATGCCAGGAAGTAG"	1.75462092933003	-8.91443350231322	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGCCAGGAAGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.90937806389	44.9283115763462	0.0218638895008972	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2050.21772296695	2050.21772296695
"AML-0160"	"2019-07-01-count-1:GTCGCGAGTACAAAGT"	1.54149188575093	-8.55313017284545	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGCGAGTACAAAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2319.19292239219	43.7091915620535	0.0188467251430591	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.58156554882	2313.58156554882
"AML-0160"	"2019-07-01-count-1:GAGTCATGTTATCCAG"	1.85229887542073	-4.08066275036009	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTCATGTTATCCAG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2201.35179440546	38.4918958948992	0.0174855722709668	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2197.96295257618	2197.96295257618
"AML-0160"	"2019-07-01-count-2:AAGGAATAGGGCGAAG"	1.75377490100209	-8.88607790386351	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGAATAGGGCGAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.66213921362	44.4030422471011	0.0205411573999507	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2157.62579712483	2157.62579712483
"AML-0160"	"2019-07-01-count-3:GCATCGGAGTCTTCGA"	1.50706650790517	-8.62524034893187	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGAGTCTTCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2232.59855330567	40.9555463137325	0.0183443397170943	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2231.33968228024	2231.33968228024
"AML-0160"	"2019-07-01-count-2:GACGTTAGTTCGATTG"	1.69431330737416	-8.64582636272582	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACGTTAGTTCGATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2044.8956119177	44.2563742282101	0.021642363536937	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2041.95807764509	2041.95807764509
"AML-0160"	"2019-07-01-count-3:CACGAATAGACAAGCC"	6.53195871886556	-10.2754984132019	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACGAATAGACAAGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1944.8943056251	51.9384713027836	0.0267050354112124	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1936.38926241942	1936.38926241942
"AML-0160"	"2019-07-01-count-3:CCATAAGCATCATCTT"	1.72881128367726	-8.80248453533324	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCATAAGCATCATCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.9797918934	44.3202756360583	0.0204054732928351	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2166.17400730288	2166.17400730288
"AML-0160"	"2019-07-01-count-3:GATGACTGTGACTCTA"	1.81961347636525	-8.8027496567932	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGACTGTGACTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2328.70711873495	43.315989894011	0.018600874942806	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.39964889534	2321.39964889534
"AML-0160"	"2019-07-01-count-1:ACAGAAACAATGACCT"	2.0109963613445	-6.03082563793334	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGAAACAATGACCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2564.35742679901	41.9547922348243	0.0163607427718042	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2559.58595495643	2559.58595495643
"AML-0160"	"2019-07-01-count-1:GTGGAGATCTTCGGAA"	1.81646396693532	-9.56558325206908	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAGATCTTCGGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.78417014638	39.4924894033152	0.016878689029187	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.57972614468	2337.57972614468
"AML-0160"	"2019-07-01-count-1:CGTAGTAGTACTGGGA"	1.83097304877583	-9.38590242778929	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTAGTAGTACTGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2127.6760676139	39.7486333183335	0.0186817128431162	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2124.13462766536	2124.13462766536
"AML-0160"	"2019-07-01-count-1:GTCTGTCCACCAGTAT"	-9.96370158615764	5.41167209232179	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTGTCCACCAGTAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2448.1696229597	36.2862820227879	0.0148218006148282	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2438.01283639904	2438.01283639904
"AML-0160"	"2019-07-01-count-1:CATGCCTGTGAGTAAT"	1.04939653453175	-9.52217485820922	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCCTGTGAGTAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2312.02476598657	48.410960847716	0.0209387726117451	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2306.33484096791	2306.33484096791
"AML-0160"	"2019-07-01-count-1:GCCGTGACAGCGTGCT"	2.11061038550679	-9.06566431438597	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCGTGACAGCGTGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.28278809112	41.0548610864948	0.0179963927755085	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2277.93627768156	2277.93627768156
"AML-0160"	"2019-07-01-count-1:GCTCAAAAGCCTCTCT"	1.51053454455678	-9.47590067302855	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTCAAAAGCCTCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.20617996203	43.3363887263132	0.0178617914191412	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2422.86452793594	2422.86452793594
"AML-0160"	"2019-07-01-count-3:AATCACGGTAACGCGA"	-8.36071620407756	-0.475069188233934	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCACGGTAACGCGA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2854.37296890801	47.0194404705011	0.0164727738745681	3288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2837.98810838076	2837.98810838076
"AML-0160"	"2019-07-01-count-3:TATTCCAAGAACGCGT"	1.56036998805348	-8.97818376934203	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTCCAAGAACGCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.56185993334	40.2061686126202	0.0182542744174445	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.88246263211	2195.88246263211
"AML-0160"	"2019-07-01-count-2:TCACTCGAGGAAGTAG"	2.26103963431661	-4.671178363916	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCACTCGAGGAAGTAG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2233.94430378394	40.9674817094567	0.0183386316480963	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2225.57786285215	2225.57786285215
"AML-0160"	"2019-07-01-count-3:CGACAGCAGTGAACAT"	-7.99003920975383	3.55936238849489	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGACAGCAGTGAACAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2013.84081617294	40.5915030970372	0.0201562619900497	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2008.9220241041	2008.9220241041
"AML-0160"	"2019-07-01-count-2:CTCCATGGTGTTCATG"	-1.24633369866069	10.9938163527283	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCATGGTGTTCATG"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1953.49015910414	44.6863199336278	0.0228751190403338	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1948.87183104242	1948.87183104242
"AML-0160"	"2019-07-01-count-1:CGTAGTAGTCGTTCAA"	1.98131706294362	-3.88104441082152	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTAGTAGTCGTTCAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1574.53295643741	44.6544723955906	0.0283604558501127	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1574.53295643741	1574.53295643741
"AML-0160"	"2019-07-01-count-1:TGTTCCGCAACCGACC"	1.93437530574147	-9.24827768718871	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTCCGCAACCGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.75863538409	52.9595250187988	0.0243295348220608	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2172.11195037818	2172.11195037818
"AML-0160"	"2019-07-01-count-2:CTGTCGTCAAGTGTCT"	2.50839891013448	-10.2435865632263	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTCGTCAAGTGTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2020.64872329932	47.4904592371022	0.0235025804779961	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2017.75470616261	2017.75470616261
"AML-0160"	"2019-07-01-count-1:TGATTTCGTCGAAACG"	1.68587877330129	-8.82127287304076	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATTTCGTCGAAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.35530317399	39.5598252996012	0.0171823285680818	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2299.36204899716	2299.36204899716
"AML-0160"	"2019-07-01-count-1:CTGATCCCATATGAAG"	1.6899365383083	-8.81448271190795	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGATCCCATATGAAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.8674267431	41.7241873207244	0.0173282743299372	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2405.76347570963	2405.76347570963
"AML-0160"	"2019-07-01-count-3:TCTGTCGAGTGCACTT"	2.38907827910725	-8.47863199627074	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGTCGAGTGCACTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.05011379484	46.3748534036727	0.0206472923817891	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2243.42080619074	2243.42080619074
"AML-0160"	"2019-07-01-count-3:AGGTGTTTCGATGGAG"	2.26084317740743	-9.60312273418578	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTGTTTCGATGGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1870.2070397596	45.2801087946854	0.0242112813351969	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1866.99472736809	1866.99472736809
"AML-0160"	"2019-07-01-count-1:GTGGTTAAGGTAGATT"	1.51680185374562	-8.67177774822386	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGTTAAGGTAGATT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2411.67176295528	46.1428081196649	0.0191331211935414	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2407.67387856353	2407.67387856353
"AML-0160"	"2019-07-01-count-1:TTGTGTTAGGGAGTTC"	1.88860680636708	-9.24432756817015	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGTTAGGGAGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2021.65091639943	50.2108496424596	0.0248365577039806	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2014.38867978343	2014.38867978343
"AML-0160"	"2019-07-01-count-1:GTTGTGAAGCTCTTCC"	-8.16615424576457	1.69834790313569	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGAAGCTCTTCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2301.70543150663	41.6220920748725	0.0180831532589416	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2293.07236118417	2293.07236118417
"AML-0160"	"2019-07-01-count-2:TCGTAGATCCACTGAA"	0.763064225285691	-9.60612680828246	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGATCCACTGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2144.69988875488	39.6619690710324	0.0184930158662238	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2139.31468295447	2139.31468295447
"AML-0160"	"2019-07-01-count-2:TGGGCTGGTTGTGGCC"	1.86252286013905	-8.97216513073119	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCTGGTTGTGGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1970.79310485384	51.7107965985461	0.0262385719085318	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1969.49929313465	1969.49929313465
"AML-0160"	"2019-07-01-count-2:GAAGAATTCCCTATTA"	1.83787002143208	-9.01609327709349	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGAATTCCCTATTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.60966151142	44.1640010857182	0.0191135706828256	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2303.45315072489	2303.45315072489
"AML-0160"	"2019-07-01-count-2:CATTGTTCAAGAATGT"	2.12587537345235	-9.52016355907591	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGTTCAAGAATGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.13988995364	37.5166165404833	0.0164536468599066	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2272.48171337711	2272.48171337711
"AML-0160"	"2019-07-01-count-3:AGGGTGAGTGACTCGC"	1.69712342795674	-8.82218077098998	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTGAGTGACTCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.94756815479	39.815505716086	0.0173567636282606	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2291.70976822823	2291.70976822823
"AML-0160"	"2019-07-01-count-2:TGCTGAAGTGGTTTGT"	1.76628090915028	-9.11374571239623	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTGAAGTGGTTTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.72553481188	46.8661210786055	0.0217201494455557	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2151.78008380694	2151.78008380694
"AML-0160"	"2019-07-01-count-2:TTTCCTCGTGGGACAT"	-2.46294126930888	-11.6567697755066	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	31	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	1	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCCTCGTGGGACAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2075.50263449344	45.5089044226943	0.0219266907525759	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.0039066005	2074.0039066005
"AML-0160"	"2019-07-01-count-2:CATGCAAAGGTTGCCC"	1.85348047789876	-9.96425249492797	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCAAAGGTTGCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.16999186623	42.0004226080382	0.0177503825813089	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.26135225422	2358.26135225422
"AML-0160"	"2019-07-01-count-2:AGTGATCCATCACCAA"	2.13796486434285	-8.6492023698059	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGATCCATCACCAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2364.88352171037	39.098527646776	0.016532961259123	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2359.51518257214	2359.51518257214
"AML-0160"	"2019-07-01-count-2:GTAGAAACAATCCTTT"	2.8838128047878	-8.33290293132933	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGAAACAATCCTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1595.37519518196	50.6587949181812	0.0317535304993903	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1591.03989595541	1591.03989595541
"AML-0160"	"2019-07-01-count-2:AAACGCTAGAGATGCC"	-0.429752270609695	11.1985149153504	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAACGCTAGAGATGCC"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1778.0566772729	39.5326561855103	0.0222336310708293	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1778.0566772729	1778.0566772729
"AML-0160"	"2019-07-01-count-2:GCACTAAGTCTACAAC"	1.94492818888966	-8.9184780350891	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACTAAGTCTACAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.90765820151	42.1164170110393	0.0170656373106487	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2460.07830272474	2460.07830272474
"AML-0160"	"2019-07-01-count-2:CATCAAGTCCACTTTA"	1.63452364978139	-8.34535696422728	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCAAGTCCACTTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2526.49000816774	44.764744937741	0.0177181563327081	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2522.61492686181	2522.61492686181
"AML-0160"	"2019-07-01-count-2:GTTGTCCCAGACCAAG"	2.17013921317403	-8.951536201593	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGTCCCAGACCAAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2160.82256673459	37.5241039684084	0.0173656572020693	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2156.40433800166	2156.40433800166
"AML-0160"	"2019-07-01-count-3:ATACCGAAGAGTATAC"	1.4457172351772	-8.57689764415892	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATACCGAAGAGTATAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2362.44048481608	38.4155511363224	0.016260960385342	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2361.50160078239	2361.50160078239
"AML-0160"	"2019-07-01-count-3:AGAACAAGTTGATGTC"	2.41339554366414	-8.60133650219115	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAACAAGTTGATGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1491.71599191224	50.0890882771602	0.0335781667212341	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1489.5823621607	1489.5823621607
"AML-0160"	"2019-07-01-count-3:TGTGATGTCCAATGCA"	1.75419559058492	-8.82939531719359	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGATGTCCAATGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2323.13382552585	42.8893369335048	0.0184618451430781	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2317.10871743055	2317.10871743055
"AML-0160"	"2019-07-01-count-1:TACTTGTTCCTCTCTT"	6.02524485167806	-10.1252537003723	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTTGTTCCTCTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.37678731555	39.481541180379	0.0159626068227275	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2468.21789706866	2468.21789706866
"AML-0160"	"2019-07-01-count-3:GATCCCTAGATCACTC"	2.08897103843037	-8.31650164043578	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCCCTAGATCACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.59527879018	37.5193575416967	0.0173092080005995	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2164.92148784908	2164.92148784908
"AML-0160"	"2019-07-01-count-3:CGGACACCAAATCCCA"	2.22577824172322	-8.94602301036986	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGACACCAAATCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2084.01337724431	48.1265134062141	0.0230931883315699	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2075.99205103983	2075.99205103983
"AML-0160"	"2019-07-01-count-3:ACTCCCAAGTTGTCGT"	-8.46254573288615	3.83942196452943	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCCCAAGTTGTCGT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2031.66445095647	34.9755642711338	0.017215226783472	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2022.97598504155	2022.97598504155
"AML-0160"	"2019-07-01-count-3:GAGCTGCAGCGTGCCT"	-8.23262343826945	2.83632752979127	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGCTGCAGCGTGCCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2225.34581246865	37.4710697098063	0.0168383131735549	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2216.45955637339	2216.45955637339
"AML-0160"	"2019-07-01-count-3:TCAGCCTAGACTTGTC"	-6.73468194428142	4.575168586615	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTAGACTTGTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1994.53294562137	39.283830513829	0.0196957541363603	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1988.47230391646	1988.47230391646
"AML-0160"	"2019-07-01-count-1:ATGAGGGGTACGAGTG"	1.79406227645223	-9.00481321727904	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGAGGGGTACGAGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1970.55573991803	46.3052297017095	0.0234985637623404	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1968.84613118525	1968.84613118525
"AML-0160"	"2019-07-01-count-3:TCTTCCTTCTTGATTC"	7.76105942305867	6.60607287967531	"2019-07-01-count-3"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTCCTTCTTGATTC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1831.82418587377	45.1911327847196	0.0246700164421968	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1828.09912700901	1828.09912700901
"AML-0160"	"2019-07-01-count-3:ACTCCCATCTTTGCGC"	1.54655887660329	-8.01256563579711	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCCCATCTTTGCGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2515.61000082914	44.79270167775	0.0178059006217126	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2512.52769960723	2512.52769960723
"AML-0160"	"2019-07-01-count-2:CAATCGAAGCTTAGTC"	1.69362344321553	-8.6510277024475	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATCGAAGCTTAGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.42650157534	47.354185675182	0.0213844016233974	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2210.54913634651	2210.54913634651
"AML-0160"	"2019-07-01-count-2:GATTTCTGTTGTCAGT"	2.41028179702107	-8.57747270977172	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTTCTGTTGTCAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.03718891144	40.7709738522001	0.0171375941671829	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.13073909926	2374.13073909926
"AML-0160"	"2019-07-01-count-2:GCAGCTGTCATTGTTC"	7.85301651534383	6.74008319461671	"2019-07-01-count-2"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGCTGTCATTGTTC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1767.6015162929	40.4831901705541	0.0229028940048984	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1761.52601394249	1761.52601394249
"AML-0160"	"2019-07-01-count-2:AAGGTAACATGGGATG"	-8.18797812882121	2.95628855312196	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGTAACATGGGATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2504.16397420056	44.5954913610918	0.0178085348325997	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2494.83780959894	2494.83780959894
"AML-0160"	"2019-07-01-count-2:CGACAGCTCGAACGGA"	-8.48833594742473	5.23559901798097	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGACAGCTCGAACGGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1652.56049249447	39.7633707910063	0.0240616733678445	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1629.44304476145	1629.44304476145
"AML-0160"	"2019-07-01-count-2:CTGTCGTCATAGAGGC"	1.78499581393544	-8.9235821000305	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTCGTCATAGAGGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2114.62460155675	44.6629131825063	0.0211209654657504	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2109.53239171851	2109.53239171851
"AML-0160"	"2019-07-01-count-2:AAGCGAGCACCGAATT"	1.88105084475819	-8.98099615490111	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCGAGCACCGAATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2003.08061856193	47.6771343682564	0.0238019048891228	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1999.80677605248	1999.80677605248
"AML-0160"	"2019-07-01-count-3:CAGGTATAGAGCAAGA"	2.08592786368672	-9.28024866497191	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGTATAGAGCAAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2229.31453974662	43.2504019109802	0.0194007624944194	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2225.28490863392	2225.28490863392
"AML-0160"	"2019-07-01-count-3:GTTCGCTTCTCGAGTA"	2.47609343108479	-8.67546656047972	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTCGCTTCTCGAGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.17725038257	49.1687780828748	0.0231472105607098	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2117.85198094172	2117.85198094172
"AML-0160"	"2019-07-01-count-3:ACGGTTACATTGAGGG"	-9.60112986984904	3.51447031581727	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGGTTACATTGAGGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1912.81828517456	42.7552920806702	0.0223519883786392	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1909.7818585634	1909.7818585634
"AML-0160"	"2019-07-01-count-2:TCCTTTCCAAATTGCC"	-7.82728848877605	2.21361134136049	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTTCCAAATTGCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2562.85411126612	41.4841898383712	0.016186715293707	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2556.1185591195	2556.1185591195
"AML-0160"	"2019-07-01-count-1:AATCACGTCCGGTTCT"	1.87377323684041	-9.01848890697631	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCACGTCCGGTTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2274.49448370661	47.3264450436633	0.0208074565063522	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2268.67251924191	2268.67251924191
"AML-0160"	"2019-07-01-count-2:TGAGCGCAGCCGATCC"	1.46407308158223	-8.5507383576599	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGCGCAGCCGATCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2250.46817312355	42.1127382335577	0.0187128788296114	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2245.29741846549	2245.29741846549
"AML-0160"	"2019-07-01-count-2:AACAAGACAAGGACAC"	2.09227170523946	-9.25643160259398	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAGACAAGGACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1980.80089196782	41.6914205172269	0.0210477593615221	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1979.28573672269	1979.28573672269
"AML-0160"	"2019-07-01-count-1:GGGTGTCTCGGTTGTA"	2.84949650344197	-9.65669634258422	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTGTCTCGGTTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2094.10607764011	48.4138740723849	0.0231191125365261	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2087.11158390174	2087.11158390174
"AML-0160"	"2019-07-01-count-2:CTGTATTTCCTAAGTG"	2.23875512656514	-8.71386434948119	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTATTTCCTAAGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2271.07236001178	36.6172437045948	0.0161233276179738	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2268.83806699685	2268.83806699685
"AML-0160"	"2019-07-01-count-1:CTACAGAGTGGATACG"	2.71686019477193	-8.08243658458861	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACAGAGTGGATACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1503.15831550283	49.4458222081419	0.032894620412356	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1500.90019528948	1500.90019528948
"AML-0160"	"2019-07-01-count-1:TAGGAGGAGCTGAGTG"	1.61986162242238	-9.10737612163695	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGGAGGAGCTGAGTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2454.750249322	44.0912923749713	0.0179616204895587	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2446.76490562135	2446.76490562135
"AML-0160"	"2019-07-01-count-1:CAGGGCTTCCATGAGT"	1.41667618331258	-8.67894747173461	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGGGCTTCCATGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.44557812875	40.789438611557	0.0154831206042714	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2629.31820697886	2629.31820697886
"AML-0160"	"2019-07-01-count-3:ATCGTCCAGTATAGGT"	1.63971783694569	-9.01676561748656	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGTCCAGTATAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2053.59741323009	47.6545332184861	0.0232053921140905	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2045.17943053947	2045.17943053947
"AML-0160"	"2019-07-01-count-1:GACAGCCCACAGCTGC"	-7.90493855896648	3.55006311023561	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACAGCCCACAGCTGC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2371.56877884344	38.5121594379065	0.0162391071182376	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2356.30134295545	2356.30134295545
"AML-0160"	"2019-07-01-count-3:GACTCTCTCTGGTCAA"	1.12540330466573	-9.16055300151976	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCTCTCTGGTCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2152.58007650647	46.1670173792243	0.0214472938233968	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2148.79233637076	2148.79233637076
"AML-0160"	"2019-07-01-count-1:AGCTTCCGTATGACAA"	2.25437535819356	-9.40133669292601	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTTCCGTATGACAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.2563754614	42.936130192871	0.017353145219183	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2469.86657342617	2469.86657342617
"AML-0160"	"2019-07-01-count-2:TGGTTAGAGTGCGTCC"	2.29902376708333	-9.79041864788207	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTTAGAGTGCGTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2102.18532861799	44.5117502999054	0.0211740371764311	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2095.69926021077	2095.69926021077
"AML-0160"	"2019-07-01-count-1:CTCCTCCAGGCGTTGA"	2.5779353576595	-4.92985727703246	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCAGGCGTTGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2373.37266220229	36.4707590854396	0.0153666382301707	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2367.08231185889	2367.08231185889
"AML-0160"	"2019-07-01-count-2:AACAGGGAGTCCGCCA"	0.949399610131425	9.58710858905641	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAGGGAGTCCGCCA"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1524.27840012214	35.4434852466423	0.0232526323562693	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1522.87024993223	1522.87024993223
"AML-0160"	"2019-07-01-count-2:GTGAGCCCAAAGGCTG"	3.68702067908589	-8.46242525493773	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGCCCAAAGGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2020.210063797	45.9393366315883	0.0227398810919915	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2018.55443122906	2018.55443122906
"AML-0160"	"2019-07-01-count-3:TGAGGTTCAACTCCAA"	-8.22147784653361	2.73120400989381	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGTTCAACTCCAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2379.64653243985	39.1031231648812	0.0164323241421863	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2374.29268488659	2374.29268488659
"AML-0160"	"2019-07-01-count-2:CGGACACCACCCTTAC"	1.7526636320049	-8.71212770855101	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGACACCACCCTTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.49182109518	33.8969183544721	0.0158582680971871	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.3752163286	2136.3752163286
"AML-0160"	"2019-07-01-count-2:TCGCTTGCAGAGAGGG"	2.06687798079793	-8.98913481151732	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCTTGCAGAGAGGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2141.31158973388	46.3402520335805	0.0216410597391571	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.81324323618	2136.81324323618
"AML-0160"	"2019-07-01-count-1:TTCCGGTCACTGTGTA"	1.96756650981252	-9.35294344341429	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCGGTCACTGTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.30511511491	41.3059288288807	0.0166200634995155	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2478.6977506586	2478.6977506586
"AML-0160"	"2019-07-01-count-2:TCTCCGAAGCAATTCC"	11.862282415002	-2.6971895924774	"2019-07-01-count-2"	"AML0160"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0833333333333333	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCCGAAGCAATTCC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1955.47391827111	37.7771811717047	0.0193186832198225	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1951.64216414911	1951.64216414911
"AML-0160"	"2019-07-01-count-1:GTCGCGATCCGCTGTT"	1.79993488368337	-8.77363493358763	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGCGATCCGCTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.16727147083	43.6135497384886	0.0195299072737007	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2226.91093662125	2226.91093662125
"AML-0160"	"2019-07-01-count-1:TGAGACTGTCAAATCC"	1.53191067752187	-8.40956880962523	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGACTGTCAAATCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2639.70969313606	44.9515060470372	0.0170289582085193	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2629.67078174242	2629.67078174242
"AML-0160"	"2019-07-01-count-3:CATGCCTTCGTACCTC"	1.75854100760762	-8.66691782390746	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGCCTTCGTACCTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.83587976608	39.8986345834288	0.0161937062898917	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2456.1688784952	2456.1688784952
"AML-0160"	"2019-07-01-count-2:AGTTCGACAGGTCAAG"	1.93927683409993	-7.81437160885008	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTCGACAGGTCAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1894.31039755836	48.6588534600678	0.025686842833564	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1892.61409799717	1892.61409799717
"AML-0160"	"2019-07-01-count-2:GATTGGTTCTGGAAGG"	2.04824544963185	-8.86631014263304	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTGGTTCTGGAAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2169.45398583899	41.7428134113854	0.0192411609943607	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2165.97064300533	2165.97064300533
"AML-0160"	"2019-07-01-count-1:ACGTAGTGTAGAAACT"	2.09184135970418	-10.2145424119202	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTAGTGTAGAAACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2156.80754933511	40.643930455608	0.0188444863651083	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2154.36901320514	2154.36901320514
"AML-0160"	"2019-07-01-count-1:TCGTGCTCACCCTTGT"	2.56704916533772	-7.97686674511107	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGTGCTCACCCTTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1873.68311776063	49.9807436423073	0.0266751315462792	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1867.39509181847	1867.39509181847
"AML-0160"	"2019-07-01-count-2:CTCACTGAGTGAGGTC"	1.92161979255025	-9.42529966747435	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCACTGAGTGAGGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.72761157159	41.716362114045	0.0194054176396551	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2141.37532442354	2141.37532442354
"AML-0160"	"2019-07-01-count-2:ATCCATTGTATTCTCT"	2.20190395888631	-9.19867231762084	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCATTGTATTCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.88285211118	40.0073163741847	0.0163302977281989	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2443.89376409755	2443.89376409755
"AML-0160"	"2019-07-01-count-2:CTCACTGAGTAACAGT"	1.46909024295155	-8.09428503429564	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCACTGAGTAACAGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2347.9110339234	43.3652450433209	0.0184697138932291	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2345.61825739032	2345.61825739032
"AML-0160"	"2019-07-01-count-2:ATCGGCGCACAAGCAG"	2.13428415831868	-9.32120706951293	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGCGCACAAGCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2131.87596076239	44.61535018929	0.0209277420499338	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2128.06426462541	2128.06426462541
"AML-0160"	"2019-07-01-count-2:GTCATGAGTTCGTGCG"	2.10129394110982	-8.76016619121703	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCATGAGTTCGTGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2008.63445571007	48.021375759806	0.0239074738677776	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2005.36712720676	2005.36712720676
"AML-0160"	"2019-07-01-count-2:CTCAACCCACGGAAGT"	1.22596969184224	-8.83905031597289	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCCACGGAAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.54145030688	45.6347935895828	0.0196571091089286	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2315.87323519515	2315.87323519515
"AML-0160"	"2019-07-01-count-1:ATTATCCCAGAGGCAT"	1.43993641909901	-8.13827803051146	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTATCCCAGAGGCAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2455.51916921676	44.5736235848625	0.0181524233830682	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2450.07865851847	2450.07865851847
"AML-0160"	"2019-07-01-count-3:TCGGGCAGTAGGAAAG"	1.86637069758717	-8.5882196656433	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGCAGTAGGAAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1893.06461149935	51.0655804761841	0.02697508588243	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1891.43087354795	1891.43087354795
"AML-0160"	"2019-07-01-count-2:GTCGTTCGTGGGACAT"	2.01847102221791	-9.16161634838256	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGTTCGTGGGACAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1857.71262592779	49.2145154804967	0.0264919960136018	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1857.71262592779	1857.71262592779
"AML-0160"	"2019-07-01-count-2:TAGCACACACATTCTT"	1.66209127482716	-9.20121862804564	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGCACACACATTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.5778504827	43.4126043944701	0.0179793765547014	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2406.84927067582	2406.84927067582
"AML-0160"	"2019-07-01-count-1:ACTTCCGAGAACAAGG"	2.17900170859639	-9.29785158550414	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGAGAACAAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.9765880781	48.7732084750941	0.0213732291250943	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2275.74458120891	2275.74458120891
"AML-0160"	"2019-07-01-count-2:CGAAGTTAGATGAAGG"	1.69385184821431	-8.9335565797058	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAAGTTAGATGAAGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2258.1978297585	41.1498196625083	0.0182224157335715	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2254.66132176921	2254.66132176921
"AML-0160"	"2019-07-01-count-3:TCCTTCTGTATTAAGG"	2.25499596175496	-9.44897177135619	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTTCTGTATTAAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2231.26964675242	40.9005766282663	0.0183306292396333	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2225.90655279274	2225.90655279274
"AML-0160"	"2019-07-01-count-3:AACGAAACACTTGACA"	5.07907976683919	-5.22459652340087	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGAAACACTTGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.93204701497	41.6564834748095	0.0171571867202891	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2423.77061897932	2423.77061897932
"AML-0160"	"2019-07-01-count-2:CGTCAAAAGACCTTTG"	2.16751207885091	-9.34667017376097	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCAAAAGACCTTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2350.23211643828	40.0166526333188	0.0170266810471313	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2345.98590224628	2345.98590224628
"AML-0160"	"2019-07-01-count-1:AAACGCTTCAAGAGTA"	1.72142972525899	-8.03613569652709	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGCTTCAAGAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.10292176645	47.0428460685299	0.0208329060713183	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2254.63735351299	2254.63735351299
"AML-0160"	"2019-07-01-count-1:AATGCCATCCTGGGTG"	1.57406749305074	-8.90981008922728	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGCCATCCTGGGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.57471977118	39.9423907106396	0.0160181246601285	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2489.70750482371	2489.70750482371
"AML-0160"	"2019-07-01-count-3:TTGGGTAAGGGTCTTT"	3.02624525603597	-8.94030859386595	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGTAAGGGTCTTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1886.03239379499	48.4201139425887	0.0256730022781633	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1884.1991927863	1884.1991927863
"AML-0160"	"2019-07-01-count-3:CATAGACGTAGGTTTC"	2.71107687529866	-9.29063131725463	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATAGACGTAGGTTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1942.17225078498	42.2801562425688	0.0217695192717743	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1939.03408498055	1939.03408498055
"AML-0160"	"2019-07-01-count-1:TGCATCCGTAACCCTA"	-8.1933778328007	2.82053325260011	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCATCCGTAACCCTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2660.11763613076	34.3183010855682	0.012901046412175	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2648.52379965457	2648.52379965457
"AML-0160"	"2019-07-01-count-2:CCCTTAGCAAGTGATA"	-7.96764312210734	1.8070953854355	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTTAGCAAGTGATA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2168.4170791175	40.1940681313143	0.0185361333474059	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2165.98769326959	2165.98769326959
"AML-0160"	"2019-07-01-count-2:TGATTCTTCAGGACGA"	3.48311485823933	-9.42648794567259	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATTCTTCAGGACGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1974.95399233982	41.1419826138592	0.0208318688807107	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1972.04867848903	1972.04867848903
"AML-0160"	"2019-07-01-count-3:TGACAGTAGGCCTGCT"	1.81250705298726	-4.23621799862059	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGACAGTAGGCCTGCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1510.8201375054	48.6490305607474	0.032200411785002	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1508.74373253195	1508.74373253195
"AML-0160"	"2019-07-01-count-1:CCTCCAAGTCGAAGCA"	2.26615585860555	-5.16886951839598	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCAAGTCGAAGCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2263.37632197878	49.246332560272	0.0217579074597802	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2255.94157550008	2255.94157550008
"AML-0160"	"2019-07-01-count-1:TCTTGCGAGTTGGGAC"	1.88977970656697	-9.62938311016234	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTGCGAGTTGGGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1982.9974816774	51.7706091946747	0.0261072490878216	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1978.45498048021	1978.45498048021
"AML-0160"	"2019-07-01-count-1:TTGTTGTGTGACTCGC"	2.29019441184346	-4.33256294643553	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTGTGTGACTCGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2401.66091692776	45.0477584746604	0.0187569186628919	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2394.85697976076	2394.85697976076
"AML-0160"	"2019-07-01-count-3:TGCATGAGTCCAGCCA"	-8.15515647354778	0.293685115221418	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCATGAGTCCAGCCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2649.23457893424	41.5101912425431	0.0156687488426345	2389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2641.57810752963	2641.57810752963
"AML-0160"	"2019-07-01-count-1:TCATGGAAGCATCCCG"	1.86272110518758	-8.83457853710326	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGGAAGCATCCCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.8448918266	38.2441130571187	0.0168413585598778	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2264.33370753484	2264.33370753484
"AML-0160"	"2019-07-01-count-1:CATCGCTTCAGCCTTC"	1.8984919982845	-7.76632311260375	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGCTTCAGCCTTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2678.66901020658	45.9865652221541	0.0171676922557176	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2675.28189952789	2675.28189952789
"AML-0160"	"2019-07-01-count-1:ACTGTCCTCGACGCTG"	1.93302263793294	-9.71418287670287	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGTCCTCGACGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.58045488039	41.8682576127224	0.0166900198601438	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2505.1317386324	2505.1317386324
"AML-0160"	"2019-07-01-count-2:TCGCTTGAGTCAACAA"	-7.37479815903361	4.16452548587648	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.119047619047619	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCTTGAGTCAACAA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1993.3972661271	35.7987515759675	0.0179586639272962	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1983.54110990575	1983.54110990575
"AML-0160"	"2019-07-01-count-1:ATTTACCAGCCTCAAT"	1.75066663798634	-8.9591274491516	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTACCAGCCTCAAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2665.58585397081	37.2344761082511	0.013968590076656	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2659.61670350691	2659.61670350691
"AML-0160"	"2019-07-01-count-1:GTGGCGTAGTCACTCA"	1.55436219748799	-8.45110800182494	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGCGTAGTCACTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2306.64121155774	43.5202903543741	0.018867386109426	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2305.57523272134	2305.57523272134
"AML-0160"	"2019-07-01-count-2:GCCAACGAGATAACAC"	2.04040779647176	-9.15021040355834	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAACGAGATAACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2264.28522059713	40.0493640332508	0.0176874201487254	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2258.87631122686	2258.87631122686
"AML-0160"	"2019-07-01-count-2:TGCTCCACATCAGCGC"	2.13482298430745	-9.05487444317015	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTCCACATCAGCGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2114.97637722478	32.7935343482701	0.0155053903681425	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2108.2006881088	2108.2006881088
"AML-0160"	"2019-07-01-count-1:TCCGTGTTCCTATTTG"	1.46858229216878	-8.39700891887816	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGTGTTCCTATTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2613.39435067961	39.5914077671406	0.0151494196644471	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2611.52445121054	2611.52445121054
"AML-0160"	"2019-07-01-count-2:ATAGACCGTCGGTGAA"	2.43290843543355	-4.9742527238098	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATAGACCGTCGGTGAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2047.99028669241	36.7851883763333	0.0179616029506385	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2046.77171746855	2046.77171746855
"AML-0160"	"2019-07-01-count-3:TTAGGCAGTTCGTTCC"	2.68258704718892	-9.38414289867552	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGGCAGTTCGTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1682.6603634414	44.5638266974865	0.0264841483556099	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1682.6603634414	1682.6603634414
"AML-0160"	"2019-07-01-count-1:TCAGTGATCAACGTGT"	2.04483737525288	-8.95165064251097	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGTGATCAACGTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.06465755453	39.6405303772139	0.0161464303008213	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2451.85950472628	2451.85950472628
"AML-0160"	"2019-07-01-count-1:GCCGATGTCCACAGGC"	1.52873673018758	-8.98323538219603	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCGATGTCCACAGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.04051963318	46.3123028668589	0.0190269235426854	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2427.20469614499	2427.20469614499
"AML-0160"	"2019-07-01-count-3:CATTCATGTGTAAACA"	1.64359225806538	-8.98861505901488	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTCATGTGTAAACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2413.53186983987	40.1171398775461	0.0166217568447554	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2405.67398600948	2405.67398600948
"AML-0160"	"2019-07-01-count-1:TCGGGCAAGGGCAGAG"	1.66502716121022	-9.3763637772766	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGCAAGGGCAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2101.26752743306	49.7707583446979	0.0236860645752702	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2101.26752743306	2101.26752743306
"AML-0160"	"2019-07-01-count-1:CACTGTCGTGTGCTTA"	1.60380723056142	-9.17884161388548	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGTCGTGTGCTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.61495894612	36.2317057061776	0.0153224547485421	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.81712158334	2356.81712158334
"AML-0160"	"2019-07-01-count-1:TCGGGCAAGGCTGAAC"	1.63049771365468	-8.75888636028441	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGCAAGGCTGAAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2476.77721809465	38.0529075457885	0.0153638798305251	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2471.49069244634	2471.49069244634
"AML-0160"	"2019-07-01-count-1:CTTACCGCACGCTTAA"	1.82307614859883	-9.073118232843	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTACCGCACGCTTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.28568813782	46.1347883515285	0.0179912825489548	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2556.35380487598	2556.35380487598
"AML-0160"	"2019-07-01-count-1:GTTCTATTCCAATCTT"	1.9473486143047	-9.26276495372923	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCTATTCCAATCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.7650839776	43.3449377253589	0.01870117814139	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2315.56826869604	2315.56826869604
"AML-0160"	"2019-07-01-count-3:CGGAGAATCGGTGTAT"	-7.52299104157146	1.43323359573213	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAGAATCGGTGTAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2408.68634961171	42.264353379586	0.01754664046915	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2397.63288329076	2397.63288329076
"AML-0160"	"2019-07-01-count-3:CAATACGTCAACTGAC"	-7.81542716446574	1.54873929107515	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATACGTCAACTGAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2636.65320899286	39.6877292964422	0.0150523129705032	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2624.49050523635	2624.49050523635
"AML-0160"	"2019-07-01-count-1:AGAAGCGAGAGTCTGG"	2.98041286048238	-8.69972326671752	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAGCGAGAGTCTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.54187018189	46.7590348310711	0.0201326983299591	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.29470844673	2321.29470844673
"AML-0160"	"2019-07-01-count-1:CATGCTCCACTGTGAT"	2.15224470671956	-7.39931156551512	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCTCCACTGTGAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2483.0003685009	42.2628152027218	0.0170208654573168	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2475.79068296237	2475.79068296237
"AML-0160"	"2019-07-01-count-2:TAGGTACGTTTACTGG"	2.264261384576	-9.32451441204222	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGTACGTTTACTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2269.07980818347	39.0971879840035	0.0172304155380516	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2263.21649556703	2263.21649556703
"AML-0160"	"2019-07-01-count-1:TTCCTAAAGGGCAGAG"	1.95416988906209	-10.1537380448547	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCTAAAGGGCAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2184.21022519891	48.2033813600172	0.0220690210145077	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2179.21336751923	2179.21336751923
"AML-0160"	"2019-07-01-count-3:TGATCAGAGGTAAACT"	1.80289413508717	-8.47641184246215	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGATCAGAGGTAAACT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2141.91579356644	40.8198364712908	0.0190576289665071	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2138.75998972109	2138.75998972109
"AML-0160"	"2019-07-01-count-1:TTGTGGATCGGCTATA"	-8.42401347580608	-0.829082512017809	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGGATCGGCTATA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2779.71210660274	38.4214110718772	0.0138220828626869	3366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2767.06033055316	2767.06033055316
"AML-0160"	"2019-07-01-count-2:GCCAGGTAGCAAGCCA"	0.988233347504777	-4.01192476665648	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAGGTAGCAAGCCA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1998.10544957081	47.1935717502986	0.0236191597197414	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1995.51905717317	1995.51905717317
"AML-0160"	"2019-07-01-count-2:AAACGAAAGCGGTAAC"	1.1280036168987	9.67571256244508	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAACGAAAGCGGTAAC"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1863.13098929045	34.9860306478715	0.0187780842297059	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1859.18574089918	1859.18574089918
"AML-0160"	"2019-07-01-count-3:GGAACCCGTTTAGAGA"	2.10365237769429	-4.70714571392211	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAACCCGTTTAGAGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2051.7241280706	45.7059735543961	0.0222768611671868	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2051.7241280706	2051.7241280706
"AML-0160"	"2019-07-01-count-1:CATGCTCTCTGTGCAA"	-8.00847468796428	2.3172614344391	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCTCTCTGTGCAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2349.15205582432	37.8683001850131	0.0161199868229582	2714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2340.82799821878	2340.82799821878
"AML-0160"	"2019-07-01-count-3:TGTTCTATCGCACTCT"	-8.47534690323528	2.9874753721985	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCTATCGCACTCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2247.99489600611	39.9918506133109	0.0177900095255386	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2240.31460917745	2240.31460917745
"AML-0160"	"2019-07-01-count-2:CAAGCTACAGAGAGGG"	1.85396434840505	-9.35888769542845	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGCTACAGAGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1836.6600029536	46.5061073152264	0.0253210214413327	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1826.16837223994	1826.16837223994
"AML-0160"	"2019-07-01-count-3:AGAGCAGTCTCGCCTA"	1.5326278406078	-8.65731432354125	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCAGTCTCGCCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2197.91798985476	42.6263084514212	0.0193939485677707	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2195.77446684309	2195.77446684309
"AML-0160"	"2019-07-01-count-3:GTGGGAAGTTTGTTGG"	1.50309922274892	-8.96855070507201	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGGAAGTTTGTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2229.8137930749	43.8758437858021	0.0196769093105741	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2225.94460142556	2225.94460142556
"AML-0160"	"2019-07-01-count-3:AGGCATTCACTTGTGA"	2.10954942282979	-4.64922430431517	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCATTCACTTGTGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2351.57654045151	40.0189444631462	0.0170179212858886	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2345.92289991931	2345.92289991931
"AML-0160"	"2019-07-01-count-2:CTGGTCTCAGAGGACT"	-8.08247313919719	-0.995707177278124	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGGTCTCAGAGGACT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2259.56314376532	37.8051398577669	0.0167311721126628	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2251.91507733554	2251.91507733554
"AML-0160"	"2019-07-01-count-3:GTTTGGACATTGCTGA"	2.31237330016438	-8.80830480968627	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTTGGACATTGCTGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2349.56980469756	37.868241060437	0.0161170955571211	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2349.56980469756	2349.56980469756
"AML-0160"	"2019-07-01-count-3:GCGTTTCCACTTCATT"	2.40745987471883	-4.95032980358275	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCGTTTCCACTTCATT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2360.4789354911	42.9869548847189	0.0182111156504667	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2358.23388570801	2358.23388570801
"AML-0160"	"2019-07-01-count-1:CCGATGGAGATGATTG"	1.75396122512166	-8.62823202526244	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGATGGAGATGATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.41730140078	37.7260437290124	0.0150517807660872	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2498.12309710942	2498.12309710942
"AML-0160"	"2019-07-01-count-3:GACAGCCCAGTTAGAA"	1.90175880965535	-9.00120451366576	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACAGCCCAGTTAGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2192.78705911288	45.144161455978	0.0205875719980953	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2188.13537874928	2188.13537874928
"AML-0160"	"2019-07-01-count-1:CCCTCTCGTTATCCAG"	-8.29298816147502	2.60604617679445	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTCTCGTTATCCAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2271.50159535927	37.4479788820307	0.0164860015764628	2646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2265.24164947938	2265.24164947938
"AML-0160"	"2019-07-01-count-2:TTCACGCGTCGTAATC"	1.93390013751332	-9.13519194042357	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCACGCGTCGTAATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1592.47787085042	44.5376943164312	0.0279675436197094	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1588.58452290595	1588.58452290595
"AML-0160"	"2019-07-01-count-1:GAACGTTGTCGGCACT"	1.6204260784084	-9.14395239269408	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACGTTGTCGGCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.37248490017	42.2330673866907	0.0178925435103421	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.13906013574	2356.13906013574
"AML-0160"	"2019-07-01-count-2:GATAGCTGTATTTCTC"	1.8577592569286	-9.43085195934447	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATAGCTGTATTTCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.34962586807	45.2597243849734	0.020559989132633	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.94094063861	2195.94094063861
"AML-0160"	"2019-07-01-count-3:TGTTGGACAGTGTGGA"	2.24374260482137	-8.96656324779662	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTGGACAGTGTGGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.0163779088	42.260189992694	0.0187654896328668	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2249.85305794488	2249.85305794488
"AML-0160"	"2019-07-01-count-2:ACACGCGCAGCTGAGA"	1.3835309940273	-8.73016073619994	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACGCGCAGCTGAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.54811650613	44.723356282667	0.020633155011459	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2165.13580873308	2165.13580873308
"AML-0160"	"2019-07-01-count-1:CCTTCAGTCGGTGTAT"	1.8128078180248	-8.67499067699584	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTTCAGTCGGTGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.44828589029	37.1050151949609	0.0150500075005881	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2463.36616406091	2463.36616406091
"AML-0160"	"2019-07-01-count-1:CACGTGGGTTGCTCCT"	2.15327133712117	-9.45127108013304	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGTGGGTTGCTCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2487.67166074124	40.4600419182511	0.016264221101508	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2477.30366211911	2477.30366211911
"AML-0160"	"2019-07-01-count-2:ACCCAAACACAATTCG"	1.64750101146047	-8.70347597515257	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCCAAACACAATTCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2126.80354072398	43.6834057128593	0.0205394644481309	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2120.44280426959	2120.44280426959
"AML-0160"	"2019-07-01-count-2:CTAACCCTCTCGGTCT"	8.2097393470699	8.12345407092897	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAACCCTCTCGGTCT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1977.27405147898	43.3007108924328	0.0218991954403308	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1974.08624370758	1974.08624370758
"AML-0160"	"2019-07-01-count-3:GGCTGTGTCCCTCATG"	2.16878261145894	-9.6178655854431	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCTGTGTCCCTCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1899.19707322776	48.5423976463708	0.0255594315780358	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1897.48486891422	1897.48486891422
"AML-0160"	"2019-07-01-count-2:GTAGAGGGTATCAGCT"	2.15283240851704	-8.36608030712279	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGAGGGTATCAGCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.84867506134	39.8148488250437	0.0162851996653923	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2443.97119443645	2443.97119443645
"AML-0160"	"2019-07-01-count-2:TCATCCGGTCAACCTA"	1.56599428233449	-8.52879335796507	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATCCGGTCAACCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2391.36020795128	42.2546260532522	0.0176697035907662	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2385.60818837977	2385.60818837977
"AML-0160"	"2019-07-01-count-1:CATCGGGTCCATAGGT"	1.91557647761647	-9.62809660350951	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGGGTCCATAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2279.30859114063	43.3684597524008	0.0190270242129426	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2271.93445517379	2271.93445517379
"AML-0160"	"2019-07-01-count-2:CTCCCAAAGGCTCACC"	-6.43529448929484	-2.26148631488951	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0217391304347826	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCCAAAGGCTCACC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3172.8453440153	35.5258306426007	0.0111968365270657	2896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	3164.79446090678	3164.79446090678
"AML-0160"	"2019-07-01-count-2:CATCCACTCCTTGACC"	2.01939608630483	-10.0106849900452	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCCACTCCTTGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.03696805267	37.2906196265582	0.0141895338915989	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2619.99972022074	2619.99972022074
"AML-0160"	"2019-07-01-count-2:ACATCCCAGTAGATCA"	1.75202741202657	-9.32702352916869	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATCCCAGTAGATCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2118.03046276481	43.6230860354387	0.0205960616725477	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2116.84292810428	2116.84292810428
"AML-0160"	"2019-07-01-count-3:CGGAGAACATACAGAA"	2.85304560241048	-5.82133486187132	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAGAACATACAGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.18501718858	38.9538453249106	0.0172500680982322	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2254.00544814795	2254.00544814795
"AML-0160"	"2019-07-01-count-1:TCTCCGACAGACTCTA"	1.99574722823445	-8.78577902233275	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCCGACAGACTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.93995983011	42.1578222969905	0.0168365947160534	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2495.84832153599	2495.84832153599
"AML-0160"	"2019-07-01-count-1:TGCTCCAAGCATAGGC"	1.89349891719167	-8.74692442333373	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTCCAAGCATAGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2232.16967842141	45.1849144892015	0.0202425984574597	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2226.81716762242	2226.81716762242
"AML-0160"	"2019-07-01-count-2:ACCAACACATGCCATA"	-7.95979152146037	2.37744400585023	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCAACACATGCCATA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2643.42078166998	38.0736666352636	0.0144031804922146	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2634.86553461989	2634.86553461989
"AML-0160"	"2019-07-01-count-1:AATCACGGTTCCACAA"	1.82054557380025	-8.94645693218382	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCACGGTTCCACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.14104631079	40.3328923110718	0.0164413262628039	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2450.65041644045	2450.65041644045
"AML-0160"	"2019-07-01-count-3:CCGTAGGCAATTGCTG"	2.14729370650594	-8.89044001018675	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGTAGGCAATTGCTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2261.02775179172	44.5724010084611	0.0197133365449143	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2255.56806713723	2255.56806713723
"AML-0160"	"2019-07-01-count-1:ACATTTCAGTATGCAA"	1.74890675124471	-8.49009802257689	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACATTTCAGTATGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.81552499532	44.9913531543087	0.0186622960935163	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2406.64391788845	2406.64391788845
"AML-0160"	"2019-07-01-count-2:GTGCAGCTCAGCTCTC"	1.5104019838268	-8.70728304302367	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCAGCTCAGCTCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.94465548811	43.8263956027432	0.017962044960391	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2437.42719774982	2437.42719774982
"AML-0160"	"2019-07-01-count-2:TGTCCCACACAGAGAC"	2.02972664412801	-9.1342230073181	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCCCACACAGAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1968.60558159066	42.1753739146611	0.0214239837116498	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1967.16401768025	1967.16401768025
"AML-0160"	"2019-07-01-count-1:CTGCCTACAGGTCCGT"	1.56404270705525	-8.5899982682434	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCCTACAGGTCCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.57493210029	40.4308678238747	0.0165593393396677	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2437.95731390296	2437.95731390296
"AML-0160"	"2019-07-01-count-1:GTCGAATAGTCTGTAC"	2.04806699332539	-9.38268473064574	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGAATAGTCTGTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.98319241242	40.0935110671833	0.0177957435289398	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2250.75751206246	2250.75751206246
"AML-0160"	"2019-07-01-count-3:ACCCAAAGTCCGAAGA"	2.0979331928188	-9.48789217388304	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCAAAGTCCGAAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2100.06667147199	48.0723367052044	0.0228908621608233	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2088.81602236425	2088.81602236425
"AML-0160"	"2019-07-01-count-2:CGGAATTTCAGGAGAC"	1.80924500998799	-9.95680620586547	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAATTTCAGGAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.29733069357	46.5334988301506	0.0225311378359858	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2061.7051865071	2061.7051865071
"AML-0160"	"2019-07-01-count-3:TCAAGTGGTAGTTACC"	8.32457031783406	6.83460614765016	"2019-07-01-count-3"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAAGTGGTAGTTACC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1693.51151374494	45.1032086025326	0.026632950668752	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1688.01377458923	1688.01377458923
"AML-0160"	"2019-07-01-count-1:GTATTGGGTCTGCCTT"	1.72207548198048	-9.01238062297972	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTATTGGGTCTGCCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.61770625231	46.5135125459702	0.0205301681822177	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2261.86315193956	2261.86315193956
"AML-0160"	"2019-07-01-count-2:GAAGTAACACAAATGA"	2.07675709304158	-9.47200586712035	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGTAACACAAATGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2210.5964756317	38.5607864778493	0.0174436116690316	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2205.48318442082	2205.48318442082
"AML-0160"	"2019-07-01-count-1:TCACTCGCATGGAACG"	1.82785906371419	-8.92471029674681	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACTCGCATGGAACG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2512.35922239464	43.783014604645	0.0174270519177243	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2506.13253100965	2506.13253100965
"AML-0160"	"2019-07-01-count-1:CCACGTTTCTGTGTGA"	1.50226141986195	-8.39519693767699	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACGTTTCTGTGTGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2696.07982588679	41.4712730782027	0.0153820642400905	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2688.56454126237	2688.56454126237
"AML-0160"	"2019-07-01-count-1:TTCCAATGTTTACACG"	2.49133433875386	-4.43790485775145	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCAATGTTTACACG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2738.54742786867	43.5492074551235	0.0159023017136557	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2733.38496499301	2733.38496499301
"AML-0160"	"2019-07-01-count-2:CTCAACCTCTCCCTAG"	1.69041647490804	-8.89696600353392	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCTCTCCCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.04284434679	40.8321605594441	0.0171632724717303	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.44124383545	2374.44124383545
"AML-0160"	"2019-07-01-count-2:GATTCGAGTACCGTCG"	2.90446104583089	-8.85874273693236	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCGAGTACCGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1956.66414786179	49.7006157624513	0.0254006881133706	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1953.24751419905	1953.24751419905
"AML-0160"	"2019-07-01-count-2:GGGTTTAGTCTAACTG"	6.54098381575887	-10.3809995881286	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTTTAGTCTAACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2027.90354258499	42.5713182773994	0.0209927727741593	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2027.90354258499	2027.90354258499
"AML-0160"	"2019-07-01-count-3:TCGCTTGCACCATTCC"	2.53947557982747	-9.18351461803588	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCTTGCACCATTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2024.80540587926	39.4119980519192	0.0194645855534966	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2024.80540587926	2024.80540587926
"AML-0160"	"2019-07-01-count-2:CTACAGACATCGCTCT"	1.95527829703633	-8.86793424999388	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACAGACATCGCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2075.48297100148	39.6343952268277	0.0190964685235182	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2071.16524537314	2071.16524537314
"AML-0160"	"2019-07-01-count-3:AAGGTAAAGGTCTGGA"	1.77967562255208	-9.16409304058226	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGTAAAGGTCTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.70360697252	42.5902200643567	0.0195933888722185	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2167.80454646446	2167.80454646446
"AML-0160"	"2019-07-01-count-2:TTGTTGTAGTCCCAGC"	2.2554518180782	-9.70234682476195	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTGTAGTCCCAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.53613491291	40.2011975628773	0.018411052109509	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2175.40227885311	2175.40227885311
"AML-0160"	"2019-07-01-count-3:AGGCCACAGACGCATG"	2.43768920478169	-10.2640066376892	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCCACAGACGCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2126.89155899265	37.8101726784892	0.0177771981456342	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2125.40108324939	2125.40108324939
"AML-0160"	"2019-07-01-count-1:CCACTTGGTTAGAAGT"	2.03783597525899	-4.25587656414183	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACTTGGTTAGAAGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2154.66597309132	45.5322341088947	0.0211319223849668	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2152.42344674712	2152.42344674712
"AML-0160"	"2019-07-01-count-1:CTCCTCCGTCGAGTGA"	2.39363398131673	-9.44095137035521	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCGTCGAGTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2100.43659952318	40.6199693225931	0.0193388219057953	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2096.42447786033	2096.42447786033
"AML-0160"	"2019-07-01-count-3:AGCTTCCAGTACCCTA"	3.2567569213802	-9.32749845897826	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTTCCAGTACCCTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.65126167946	41.8600270381858	0.0176874504985076	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2362.06485873467	2362.06485873467
"AML-0160"	"2019-07-01-count-2:GAATAGATCAACGAGG"	2.16931333121602	-8.88353159343871	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATAGATCAACGAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2211.77877132222	40.4326837142349	0.0182806184047349	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2199.62108846234	2199.62108846234
"AML-0160"	"2019-07-01-count-1:TTCCGGTCAACGTATC"	2.14940990981404	-9.66641237651976	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCGGTCAACGTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.13958356016	35.0646357652757	0.0137070846292431	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2550.45725559682	2550.45725559682
"AML-0160"	"2019-07-01-count-2:TACATTCAGGATCATA"	-7.9186295074528	2.0968446501526	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACATTCAGGATCATA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2455.72591836634	34.7030834572558	0.0141314970036811	2598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2446.15886151133	2446.15886151133
"AML-0160"	"2019-07-01-count-1:CAACAACTCGCTCATC"	1.83966161784474	-8.76324942028197	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACTCGCTCATC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2447.7676597688	42.482867243227	0.0173557596750174	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2442.35007556489	2442.35007556489
"AML-0160"	"2019-07-01-count-1:CTGGACGTCAGCTAGT"	1.59285964545552	-8.67062380230101	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGACGTCAGCTAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.31691517335	44.1336684601688	0.0190123408706876	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2316.4251685449	2316.4251685449
"AML-0160"	"2019-07-01-count-2:AAAGTCCTCAGTGATC"	1.75134076651875	-8.79597475444945	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGTCCTCAGTGATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2095.20508698637	37.0202883683144	0.0176690523511292	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2089.21511308016	2089.21511308016
"AML-0160"	"2019-07-01-count-1:GTCGTAATCGCCAATA"	2.25214137610738	-9.11746599590453	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGTAATCGCCAATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2194.78549972777	39.3244294229816	0.0179172085052773	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2190.43056722028	2190.43056722028
"AML-0160"	"2019-07-01-count-2:GGGACAAGTGAGTCAG"	2.06891789016072	-8.91822340404662	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACAAGTGAGTCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.17755710212	43.314472452324	0.0183056729290305	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2362.90681642125	2362.90681642125
"AML-0160"	"2019-07-01-count-3:AGATAGATCCATATGG"	1.63883163508717	-8.79145624553832	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATAGATCCATATGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2207.40840994069	42.8447803107358	0.0194095393121598	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2196.42784289501	2196.42784289501
"AML-0160"	"2019-07-01-count-2:ACGTAACAGGATTTCC"	1.88458671149556	-9.06681539928588	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAACAGGATTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.1261791212	42.0799058438205	0.01764263300289	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2375.89644180317	2375.89644180317
"AML-0160"	"2019-07-01-count-1:CAGTTAGAGGAGCTGT"	5.05595936354939	-5.36672308361205	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGTTAGAGGAGCTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2418.07682137891	37.3819303539335	0.015459364244936	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2414.71206553506	2414.71206553506
"AML-0160"	"2019-07-01-count-1:CTGGACGTCCCTCTCC"	1.92635705050771	-8.7135219804016	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGACGTCCCTCTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.73977397693	47.089981391028	0.0210623713632219	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2231.98202344578	2231.98202344578
"AML-0160"	"2019-07-01-count-1:TAGATCGAGGGCAGTT"	-8.10569129410442	5.11513803088991	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGATCGAGGGCAGTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1911.32129048005	37.7533165195472	0.0197524700360896	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1906.08713231192	1906.08713231192
"AML-0160"	"2019-07-01-count-3:GGCTTTCTCCTCTAAT"	-8.59063468399699	4.92600629413453	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCTTTCTCCTCTAAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1819.93123909235	50.8928005882436	0.0279641337513527	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1807.91544805912	1807.91544805912
"AML-0160"	"2019-07-01-count-3:ATCCATTTCTAGTGAC"	2.2307092147762	-4.517698310968	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCATTTCTAGTGAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2110.84937148108	40.621935717757	0.0192443555028537	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2108.48753985364	2108.48753985364
"AML-0160"	"2019-07-01-count-1:CTGAGGCCAGCTATAC"	1.27220298823659	-9.38907911693724	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAGGCCAGCTATAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2429.37251342792	42.6788378137255	0.0175678441975555	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2423.81263977898	2423.81263977898
"AML-0160"	"2019-07-01-count-1:GTGTGGCCAAACTAGA"	-8.27952323380168	2.6210157641205	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGGCCAAACTAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1949.82861195006	41.9529957412571	0.0215162478815506	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1943.61573902474	1943.61573902474
"AML-0160"	"2019-07-01-count-3:GCCATTCAGTAAGGGA"	8.31540360030476	6.90557429874269	"2019-07-01-count-3"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATTCAGTAAGGGA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1646.73686925198	37.5695461740084	0.0228145412151208	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1643.97974335823	1643.97974335823
"AML-0160"	"2019-07-01-count-1:TGACCCTTCTATCCAT"	2.62387885627095	-10.1199579468933	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACCCTTCTATCCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.95015216287	35.4274504758698	0.0134350095495023	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2630.79830729376	2630.79830729376
"AML-0160"	"2019-07-01-count-2:TTCCGGTCAATAGTCC"	-7.87558494034465	-0.737263821717821	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCGGTCAATAGTCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2569.31865870487	42.6808856065205	0.0166117524822845	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2563.29923298879	2563.29923298879
"AML-0160"	"2019-07-01-count-3:GAGTCATTCCGGACTG"	2.06065406379048	-7.71067526256713	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTCATTCCGGACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.28501429355	43.3069641268472	0.0191769257878172	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2254.70009644601	2254.70009644601
"AML-0160"	"2019-07-01-count-2:TTTCACAAGCCTAGGA"	1.84482051905934	-9.24221041118773	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCACAAGCCTAGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.44598598077	40.6000826405087	0.017633457152835	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2293.87321431239	2293.87321431239
"AML-0160"	"2019-07-01-count-1:GGGTATTCAAGATGGC"	-8.02778468552287	1.9489308365616	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTCAAGATGGC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2359.49741556353	38.3640197116734	0.0162594031502724	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2348.01202627217	2348.01202627217
"AML-0160"	"2019-07-01-count-1:TCGATTTTCTCAGAAC"	1.99579848822896	-8.96489241039427	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGATTTTCTCAGAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.54983789134	37.4149882294781	0.0152121285176134	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2456.58479381436	2456.58479381436
"AML-0160"	"2019-07-01-count-2:ATACTTCCAACCGTAT"	-4.46313748779948	-8.70604517376097	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACTTCCAACCGTAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2697.40993498435	42.0961369420153	0.0156061325333035	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2687.02686631993	2687.02686631993
"AML-0160"	"2019-07-01-count-3:AAGTCGTTCTCATAGG"	0.860217888920945	9.86654660785524	"2019-07-01-count-3"	"AML0160"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGTCGTTCTCATAGG"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1618.41407034788	35.9569352868461	0.0222173891994878	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1617.08926069559	1617.08926069559
"AML-0160"	"2019-07-01-count-1:CGAGGCTAGCAAATGT"	-8.16779551926311	4.80855081165162	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGGCTAGCAAATGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1866.03440422095	41.845202522186	0.0224246682845356	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1856.82493048872	1856.82493048872
"AML-0160"	"2019-07-01-count-2:ATTCGTTGTGTCCGTG"	1.98116828975026	-8.15293981945189	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCGTTGTGTCCGTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2339.85520943842	39.8476452876103	0.0170299619937483	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2337.31501509477	2337.31501509477
"AML-0160"	"2019-07-01-count-2:CCTAAGAAGAGGGTGG"	2.4504665332729	-5.08210327541503	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTAAGAAGAGGGTGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2325.25806665152	44.5261925762597	0.0191489251085062	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2322.32393220354	2322.32393220354
"AML-0160"	"2019-07-01-count-2:AGGTAGGGTCGCCACA"	-7.7656606239384	0.952371216658033	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTAGGGTCGCCACA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2440.3315769775	38.2229100522031	0.0156629985911769	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2429.2774808469	2429.2774808469
"AML-0160"	"2019-07-01-count-2:ATGGGTTGTGTTTGCA"	2.25806011733357	-8.51370623027953	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGGTTGTGTTTGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.72742215001	40.0339236957212	0.0179064421266624	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.35879216058	2233.35879216058
"AML-0160"	"2019-07-01-count-2:TAACACGAGCGAGAAA"	6.70966114577596	-10.4104185334411	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACACGAGCGAGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1760.44155448722	24.9350553014924	0.014164091524615	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1754.80282210453	1754.80282210453
"AML-0160"	"2019-07-01-count-1:AGGAATAAGGAGCAAA"	-0.395373473793823	11.0283269652161	"2019-07-01-count-1"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGAATAAGGAGCAAA"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1771.39406543441	40.5074411424874	0.0228675493121027	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1768.36883121223	1768.36883121223
"AML-0160"	"2019-07-01-count-2:AGCGATTGTGACAGGT"	-7.62175689163859	4.16536138141481	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.012987012987013	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGATTGTGACAGGT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1779.3144882551	35.2901418286804	0.0198335606558725	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1774.42022213268	1774.42022213268
"AML-0160"	"2019-07-01-count-3:CCTCTAGGTTTGATCG"	1.28637220439259	9.89123342120973	"2019-07-01-count-3"	"AML0160"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCTAGGTTTGATCG"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1477.91648422636	49.1311955585089	0.0332435533962039	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1477.91648422636	1477.91648422636
"AML-0160"	"2019-07-01-count-2:CACGTTCTCTCCGAGG"	5.3224479156429	-4.75021984493407	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTTCTCTCCGAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1921.94055084224	47.2701969658084	0.0245950359625294	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1916.84886544166	1916.84886544166
"AML-0160"	"2019-07-01-count-2:ACCGTTCGTCACTCGG"	1.49183775958363	-7.89551403438719	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCGTTCGTCACTCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.40572564206	43.840685019409	0.0191159743473368	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.16019958458	2288.16019958458
"AML-0160"	"2019-07-01-count-2:AGCATCAAGAGGTGCT"	1.56931187686269	-8.51261618053588	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCATCAAGAGGTGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.49921397048	43.4505183025501	0.0190697973631661	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2274.89004994947	2274.89004994947
"AML-0160"	"2019-07-01-count-1:ATCTCTAAGTTCCATG"	1.99045588549916	-4.18941547786864	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTCTAAGTTCCATG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2448.22271711457	42.1929266079613	0.0172341046886817	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2442.03388179234	2442.03388179234
"AML-0160"	"2019-07-01-count-1:CGTGATAGTGCAATAA"	2.20257868346516	-9.29484369671019	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGATAGTGCAATAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.77300559948	44.025244598656	0.0186803075621012	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2351.24700595393	2351.24700595393
"AML-0160"	"2019-07-01-count-2:GTAATGCGTTCTCAGA"	-9.35987506333049	3.36228272998659	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAATGCGTTCTCAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2111.58560220384	36.7668249433783	0.0174119509552467	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2105.15475730507	2105.15475730507
"AML-0160"	"2019-07-01-count-3:ATCCTATAGATTGAGT"	2.13074817237203	-9.74202730571898	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCTATAGATTGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2212.7474664281	41.1932079483224	0.0186163168519262	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2209.16611205896	2209.16611205896
"AML-0160"	"2019-07-01-count-1:GCTGGGTTCGCAGTGC"	6.88855280455892	-10.5531997910705	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGGGTTCGCAGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2174.48882613275	49.9123648902856	0.0229536083563386	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2161.82115502473	2161.82115502473
"AML-0160"	"2019-07-01-count-2:AAGTGAACAGGCATGA"	2.30748834189717	-10.1796579591003	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGTGAACAGGCATGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1756.63107272692	48.552445538487	0.0276395233423237	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1753.04380970109	1753.04380970109
"AML-0160"	"2019-07-01-count-3:GTCTCACCAGTGTACT"	2.18777980384175	-9.79506590282591	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCTCACCAGTGTACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2049.12482825475	48.6455679593153	0.0237396801251718	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2047.07041669203	2047.07041669203
"AML-0160"	"2019-07-01-count-1:AGACCCGTCGTCGACG"	1.45088257369344	-8.28212740337523	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCCGTCGTCGACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.3285574885	46.3483478571991	0.019711557412761	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2344.14396471384	2344.14396471384
"AML-0160"	"2019-07-01-count-3:GTTGTCCTCAAGAGTA"	2.22822870787923	-9.3337612382141	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTCCTCAAGAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2007.93439808994	40.8912121019825	0.020364814777256	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2005.01364297489	2005.01364297489
"AML-0160"	"2019-07-01-count-3:GGGATGAGTCCTCCAT"	6.95176281508748	-0.755582832452379	"2019-07-01-count-3"	"AML0160"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00179533213644524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATGAGTCCTCCAT"	"pDC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2431.31093405797	43.0545447780674	0.0177083663693345	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2424.23066447808	2424.23066447808
"AML-0160"	"2019-07-01-count-2:AAGGTAACAGCTGTCG"	2.34859051284139	-9.13968756115111	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGTAACAGCTGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2181.6313562425	37.4310494682144	0.0171573668306103	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2177.20062077609	2177.20062077609
"AML-0160"	"2019-07-01-count-2:ATTCCCGTCGCCAGAC"	1.84634413298909	-8.90249063884886	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCCGTCGCCAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.99069264744	40.0970478264057	0.0168192971348716	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2378.79816910211	2378.79816910211
"AML-0160"	"2019-07-01-count-1:TCTACCGGTCCGTTTC"	-7.97417769852336	2.23863623226014	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTACCGGTCCGTTTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2356.43161905888	44.6142494100309	0.0189329701100552	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2347.56025578876	2347.56025578876
"AML-0160"	"2019-07-01-count-3:TCTATCACAATAGGGC"	8.89278187331502	7.52231309497682	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTATCACAATAGGGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1776.55899381133	46.1945782372588	0.0260022765346821	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1768.17759981575	1768.17759981575
"AML-0160"	"2019-07-01-count-1:CGTCCATAGCAACCAG"	2.5784555869991	-9.46505453502806	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTCCATAGCAACCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1886.74960633882	53.6152249955211	0.028416714552579	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1881.84836093538	1881.84836093538
"AML-0160"	"2019-07-01-count-3:CTCAGGGGTCTCCCTA"	9.94418873366658	7.00000903690187	"2019-07-01-count-3"	"AML0160"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCAGGGGTCTCCCTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1577.29059435296	41.7116760469015	0.0264451434607157	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1568.73866651824	1568.73866651824
"AML-0160"	"2019-07-01-count-1:CTCCACATCGGTGTAT"	5.00651945647542	-5.39299204265746	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCACATCGGTGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.97647381017	42.3510487027515	0.0166214441687607	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2543.9436439475	2543.9436439475
"AML-0160"	"2019-07-01-count-3:GTCGAATAGCCATTGT"	2.8937906223232	-9.24065210735472	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGAATAGCCATTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1891.70080357453	39.7591891602933	0.0210176942808107	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1890.08078454707	1890.08078454707
"AML-0160"	"2019-07-01-count-2:ATCCATTGTGTAGTGG"	-8.77297721329387	5.16511104190675	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCATTGTGTAGTGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1820.36730297214	39.4780617411925	0.0216868659839891	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1815.31220740511	1815.31220740511
"AML-0160"	"2019-07-01-count-2:TAACGACTCCTCTCGA"	1.99413361129109	-9.40431406414183	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACGACTCCTCTCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.17795022547	42.9991439789639	0.0208210357728589	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2062.19318434357	2062.19318434357
"AML-0160"	"2019-07-01-count-2:TGTACAGTCTGAGGTT"	3.62313832816426	-9.5512790909973	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTACAGTCTGAGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2111.89317552795	48.0414531308015	0.0227480507477807	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2106.07921547625	2106.07921547625
"AML-0160"	"2019-07-01-count-1:GCTTGGGTCTTTCTAG"	2.13031711158101	-9.64071657573851	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTGGGTCTTTCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.55755334229	47.9380489458778	0.0208829653937802	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.61529266328	2288.61529266328
"AML-0160"	"2019-07-01-count-2:ATAGGCTTCCATCTCG"	-8.2790130180424	-1.04096403038176	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATAGGCTTCCATCTCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1831.56737350124	19.9564080025537	0.0108958088527231	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1829.63044051913	1829.63044051913
"AML-0160"	"2019-07-01-count-2:GGCAGTCCACAGTACT"	-8.85134635391887	3.66869804942933	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCAGTCCACAGTACT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1961.91330588194	40.5083004471032	0.0206473447759678	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1958.96899405928	1958.96899405928
"AML-0160"	"2019-07-01-count-3:TTGACCCCAACAGCCC"	1.74782540377919	-9.06934740459593	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGACCCCAACAGCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.33465410705	39.6354576363151	0.0159093269830188	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2486.34882386155	2486.34882386155
"AML-0160"	"2019-07-01-count-2:TCCTCTTTCATACGGT"	2.13665928420369	-8.80901720440062	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTCTTTCATACGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2398.81313677004	44.9715134668182	0.0187474016952281	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2396.33552518299	2396.33552518299
"AML-0160"	"2019-07-01-count-3:TATTGCTGTCTCGCGA"	2.35921515998189	-9.29423906719359	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTGCTGTCTCGCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.2419409383	43.2360937147197	0.0201826380524425	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.92389111518	2137.92389111518
"AML-0160"	"2019-07-01-count-1:AGTTCGAGTGTTCATG"	2.01049913939778	-4.41066458141478	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTCGAGTGTTCATG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2230.94395479819	43.1806319889164	0.0193553190325763	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2227.54645807438	2227.54645807438
"AML-0160"	"2019-07-01-count-1:CACGAATTCCTACTGC"	1.2286944585735	-7.91602995311888	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGAATTCCTACTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.6221344236	50.274755327038	0.0222196868677966	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2258.85719722353	2258.85719722353
"AML-0160"	"2019-07-01-count-3:GGGCCATGTCAGCTTA"	2.51906313475911	-9.25980856334838	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGCCATGTCAGCTTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.26763628383	36.5996672341546	0.0156792934388713	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2331.88681056675	2331.88681056675
"AML-0160"	"2019-07-01-count-3:GTGGTTAAGGAGTATT"	2.57657756385152	-8.43002893840941	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGTTAAGGAGTATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1408.17553262296	43.050436859935	0.0305717830359873	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1408.17553262296	1408.17553262296
"AML-0160"	"2019-07-01-count-1:CGATGGCGTCTTCCGT"	1.53736533698384	-8.23582365429076	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGATGGCGTCTTCCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2223.64184780922	49.2665364055005	0.0221557875671565	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2221.2897488797	2221.2897488797
"AML-0160"	"2019-07-01-count-3:AGGTTGTCAGCAGAAC"	3.85095920142476	-7.91397907650145	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTTGTCAGCAGAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2031.67004008344	47.0386905679333	0.0231527214753836	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2030.34518455422	2030.34518455422
"AML-0160"	"2019-07-01-count-3:GGTCTGGTCGCCGAAC"	12.2107559638912	-2.82837250148924	"2019-07-01-count-3"	"AML0160"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0833333333333333	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTCTGGTCGCCGAAC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1828.44632535022	35.7941286265763	0.0195762534181693	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1823.9744502566	1823.9744502566
"AML-0160"	"2019-07-01-count-1:TGGTACAGTTTCGTGA"	1.98685433444325	-8.96480276500853	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTACAGTTTCGTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.05081308858	47.550987509357	0.0221162156819212	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2138.83240712392	2138.83240712392
"AML-0160"	"2019-07-01-count-1:CACGTGGCACATATGC"	2.51438607749287	-5.09842874920043	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGTGGCACATATGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2482.93870441375	44.7185354460424	0.0180103259764525	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2479.29747222817	2479.29747222817
"AML-0160"	"2019-07-01-count-1:TTCGGTCGTCGTCATA"	1.78264596041982	-9.05778791820677	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGGTCGTCGTCATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.29518297387	39.9481815885867	0.0159074018297125	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2510.31724076628	2510.31724076628
"AML-0160"	"2019-07-01-count-3:GTGACGCTCTGTACAG"	1.81619991835896	-8.89338591015013	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGACGCTCTGTACAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2291.14982325581	41.4178361167396	0.0180773145851646	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2285.92066057092	2285.92066057092
"AML-0160"	"2019-07-01-count-3:TGCACGGTCTACAGGT"	1.57706775245015	-8.72813227092894	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCACGGTCTACAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2306.95622840044	42.3658073526041	0.0183643741615241	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2304.64316128155	2304.64316128155
"AML-0160"	"2019-07-01-count-1:AAGTTCGGTCTGTGAT"	2.22987260398213	-9.24521162426146	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGTTCGGTCTGTGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.03504434252	44.3536508327985	0.0181477147537097	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2441.02087519461	2441.02087519461
"AML-0160"	"2019-07-01-count-1:TTCATGTAGAAGCCTG"	2.32829680022542	-9.89145853435668	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATGTAGAAGCCTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2033.17295830025	38.3183100749473	0.0188465570125336	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2030.21292242621	2030.21292242621
"AML-0160"	"2019-07-01-count-2:GTTAGACCATCTGGGC"	1.4084321456844	-8.6285667649475	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTAGACCATCTGGGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2444.82313264315	37.4677294503874	0.0153253333339824	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2442.69645863897	2442.69645863897
"AML-0160"	"2019-07-01-count-1:TTTAGTCCATTAAGCC"	2.02447833594624	-8.75378420269164	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTAGTCCATTAAGCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.96738744975	40.6644274212041	0.01633130924773	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2485.89944440985	2485.89944440985
"AML-0160"	"2019-07-01-count-3:TCTTCCTGTAAGGTCG"	1.90931942042653	-7.98446943676146	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTCCTGTAAGGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1765.91566799636	47.4143097454762	0.0268497021713802	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1760.45345218961	1760.45345218961
"AML-0160"	"2019-07-01-count-2:TTTGACTCAGAGCGTA"	1.51350237902943	-8.63550474559935	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGACTCAGAGCGTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2218.01084576599	48.3607415626594	0.0218036542314373	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2213.64056597998	2213.64056597998
"AML-0160"	"2019-07-01-count-1:TTCTAACTCAGAACCT"	-4.78534541550334	-4.82452013408812	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00451807228915663	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTAACTCAGAACCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3025.58498165703	43.2271430820458	0.014287201762342	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	3011.04155346903	3011.04155346903
"AML-0160"	"2019-07-01-count-2:TGCTTGCAGTGCACCC"	9.03080715712849	7.79511830890504	"2019-07-01-count-2"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTGCAGTGCACCC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2046.32765272926	41.4427995647856	0.0202522794966445	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2039.32937374607	2039.32937374607
"AML-0160"	"2019-07-01-count-3:TGAGGAGAGAGCCATG"	2.10159840163533	-9.74835779583129	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGAGAGAGCCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1719.62671665727	52.1646330110311	0.0303348584351099	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1715.80551569138	1715.80551569138
"AML-0160"	"2019-07-01-count-1:GTGAGGATCCATCACC"	1.92888261851613	-8.83464338695677	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGAGGATCCATCACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.83967918637	37.9309748417678	0.0150768648557267	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2509.55762719117	2509.55762719117
"AML-0160"	"2019-07-01-count-1:GGCAGTCGTGAATGAT"	1.58715917643849	-8.84331896221312	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCAGTCGTGAATGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2401.63379319236	40.6922763836288	0.0169435808652321	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2400.52316118437	2400.52316118437
"AML-0160"	"2019-07-01-count-3:TGTTCCGAGTAGCATA"	2.42826404151265	-9.44657900249632	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCCGAGTAGCATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2073.22819660457	47.1403309981075	0.0227376470546327	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2067.645446142	2067.645446142
"AML-0160"	"2019-07-01-count-1:GTCCCATTCACTGCTC"	1.63532378253285	-9.19140055095824	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCCATTCACTGCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2279.68965378542	46.5144084294522	0.0204038336324486	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2274.76422861759	2274.76422861759
"AML-0160"	"2019-07-01-count-3:AGTACCAGTATGAAGT"	1.86021198806111	-8.93541815197142	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTACCAGTATGAAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.59459067244	36.3134627436122	0.0170919491666967	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2119.79568813548	2119.79568813548
"AML-0160"	"2019-07-01-count-3:TCTATACGTTTCGTAG"	1.73616506633107	-9.04363253032836	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTATACGTTTCGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2170.69354617105	43.3540007732778	0.0199724188841632	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2165.28341704636	2165.28341704636
"AML-0160"	"2019-07-01-count-3:GGTCACGGTTAGGAGC"	-7.97893176499065	1.79992315852968	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTCACGGTTAGGAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2376.0117558003	34.4658624881711	0.0145057626099843	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2367.87378127936	2367.87378127936
"AML-0160"	"2019-07-01-count-1:GAACACTAGGACTATA"	2.36906256255452	-8.77901461040648	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACACTAGGACTATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.69655951569	35.0255620932055	0.0138293558940607	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2531.86860111524	2531.86860111524
"AML-0160"	"2019-07-01-count-2:TCAATCTCACGGATCC"	3.06543483313863	-8.96848966991576	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAATCTCACGGATCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1973.38699724983	49.9248568210242	0.0252990705272716	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1970.10081659993	1970.10081659993
"AML-0160"	"2019-07-01-count-2:TGTTGGACAACATACC"	1.94853355464284	-9.37474253093871	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTGGACAACATACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1955.07153149657	49.732154775565	0.0254375116073098	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1953.40455370484	1953.40455370484
"AML-0160"	"2019-07-01-count-1:CGATGCGAGACCGTTT"	-7.26761517944987	3.92838618839113	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGATGCGAGACCGTTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2172.22862896913	42.5575212385405	0.0195916399733379	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2165.32225701274	2165.32225701274
"AML-0160"	"2019-07-01-count-3:TCCAGAAGTTAGGGTG"	2.24140872535054	-9.0560398331848	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCAGAAGTTAGGGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2098.73591494163	29.3124833221423	0.0139667326000649	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2092.91573285119	2092.91573285119
"AML-0160"	"2019-07-01-count-3:CCTCAACTCGACCTAA"	2.0912512737209	-9.85273363506468	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCAACTCGACCTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.96470625378	47.4583781797982	0.0213876219148708	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2212.22460922137	2212.22460922137
"AML-0160"	"2019-07-01-count-3:GTGTGATGTCGGTAAG"	2.22240867194478	-8.38254930889281	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTGATGTCGGTAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.48274525753	39.7261644936988	0.0179311549948817	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2213.0869264838	2213.0869264838
"AML-0160"	"2019-07-01-count-2:GGGCTACAGTCACTGT"	1.53812028941457	-9.96076967632445	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGCTACAGTCACTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2159.64615688914	41.8328718765325	0.0193702434739544	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2153.71176169584	2153.71176169584
"AML-0160"	"2019-07-01-count-3:GATCACATCTTCGATT"	1.34433521804158	-8.58762266552123	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCACATCTTCGATT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2271.89230964234	41.0660129261468	0.0180756864010917	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2268.36380391213	2268.36380391213
"AML-0160"	"2019-07-01-count-3:ACCCAAATCGAACGCC"	2.35811390456502	-9.40707781231078	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCAAATCGAACGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2081.6298327287	39.1779301208185	0.0188207958518073	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2076.66850467006	2076.66850467006
"AML-0160"	"2019-07-01-count-1:GGAATCTTCTGCTGAA"	-2.8837915462559	-11.6023340455261	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAATCTTCTGCTGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2498.342922397	40.180370506596	0.0160828083872672	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2492.36083755713	2492.36083755713
"AML-0160"	"2019-07-01-count-2:AAGCGTTAGGCACTAG"	3.75233783301656	-9.47676660930785	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCGTTAGGCACTAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.30274042004	36.9311274588028	0.0171668667384266	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2145.99381664092	2145.99381664092
"AML-0160"	"2019-07-01-count-3:GTCAAACCAATACGCT"	-8.74373088303264	4.8884067305359	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCAAACCAATACGCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1770.78228499374	35.6766533480175	0.0201473968032968	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1768.19489841182	1768.19489841182
"AML-0160"	"2019-07-01-count-1:CTTAGGACATCAGCGC"	2.25430168685262	-8.87335779583129	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTAGGACATCAGCGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.844366201	39.5630987834257	0.0161492294487166	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2445.75890915745	2445.75890915745
"AML-0160"	"2019-07-01-count-1:TGTGATGGTTGCTCAA"	3.84977974471394	-6.86157991802367	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGATGGTTGCTCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.14500355612	42.4110369173985	0.0177813243447111	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2381.83362884895	2381.83362884895
"AML-0160"	"2019-07-01-count-3:TACCGAATCTGGACCG"	-8.20625148239787	-0.558881365415178	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGAATCTGGACCG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2793.56199243265	44.868499887767	0.0160613940228673	2742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2782.86815305018	2782.86815305018
"AML-0160"	"2019-07-01-count-3:AATCGTGCAATTGAGA"	1.51163079318349	-8.6508360139099	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCGTGCAATTGAGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2246.39178742991	40.3338425903139	0.0179549457116115	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2246.39178742991	2246.39178742991
"AML-0160"	"2019-07-01-count-3:AGTGCCGTCGTTAGAC"	1.85475077208821	-8.97787191784056	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTGCCGTCGTTAGAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2087.57567681947	44.8598703824072	0.021488979240625	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2083.36916625185	2083.36916625185
"AML-0160"	"2019-07-01-count-2:CTTGATTGTTAGAGAT"	1.80111720141713	-8.68045141613158	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTGATTGTTAGAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.03192882403	43.7443779448909	0.0197221588095369	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2213.67015780017	2213.67015780017
"AML-0160"	"2019-07-01-count-1:CAATTTCCAAATGATG"	-9.19433246079143	4.85932824695436	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCCAAATGATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1858.96382149171	46.1594681750298	0.024830751218165	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1850.2688521323	1850.2688521323
"AML-0160"	"2019-07-01-count-1:GTCGCGACACAATGTC"	2.10021628913228	-9.01365950023802	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGCGACACAATGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2071.50616122033	45.2688437628687	0.0218531060203078	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2068.6369307843	2068.6369307843
"AML-0160"	"2019-07-01-count-1:ACGTAACTCTCGTGGG"	2.10693611678426	-9.85652353679808	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTAACTCTCGTGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2190.91223490162	44.2527081071934	0.0201983025162943	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2185.1753561719	2185.1753561719
"AML-0160"	"2019-07-01-count-2:CGTCCATCAAATCCCA"	2.02249302443807	-9.12646105205687	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATCAAATCCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.6996150288	45.8074739964005	0.0195199563263397	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2336.64016146852	2336.64016146852
"AML-0160"	"2019-07-01-count-2:TTTGGTTTCATCCTGC"	2.00805010375325	-9.20089723980101	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGGTTTCATCCTGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.95826045632	40.6992607125593	0.0177496736048129	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.93375967651	2288.93375967651
"AML-0160"	"2019-07-01-count-3:TGAGGTTGTCGCAGTC"	5.3983231979305	-4.74261763012084	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGTTGTCGCAGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.60618592487	43.9882091288701	0.0191869887636741	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2290.36444130721	2290.36444130721
"AML-0160"	"2019-07-01-count-3:ATCCACCGTAACACCT"	-8.47091613236125	5.346972442511	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCACCGTAACACCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1790.59933382125	43.1471244221868	0.0240964707219611	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1780.99686410644	1780.99686410644
"AML-0160"	"2019-07-01-count-1:GGTGAAGGTAAGATTG"	1.59012832221333	-8.70390417492064	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGAAGGTAAGATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.08861849515	50.0813446326112	0.0206343288213608	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2423.78388643558	2423.78388643558
"AML-0160"	"2019-07-01-count-2:AAGGAATTCCACAAGT"	1.54018439826314	-8.68125345623168	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGAATTCCACAAGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2451.14326729291	39.8208142396101	0.0162458126258727	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2448.37502443662	2448.37502443662
"AML-0160"	"2019-07-01-count-3:GCCCGAACAACACTAC"	1.46549751338307	-8.4303188554016	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCCGAACAACACTAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2369.88276020526	36.1209002968686	0.0152416401787488	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2364.05288039491	2364.05288039491
"AML-0160"	"2019-07-01-count-1:CTCAGTCAGCGTTCAT"	2.58857550200765	-9.18357851421507	"2019-07-01-count-1"	"AML0160"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAGTCAGCGTTCAT"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2165.50831554546	45.094987784397	0.0208242043961111	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2164.22217935774	2164.22217935774
"AML-0160"	"2019-07-01-count-1:GTCAAACGTTCGGCCA"	1.61387040194814	-8.73328974163207	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCAAACGTTCGGCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.9707463184	39.6209407511054	0.0148061935301856	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2671.37108986964	2671.37108986964
"AML-0160"	"2019-07-01-count-3:TAAGCCACACTTGTCC"	1.55627097663228	-9.05191519176634	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAAGCCACACTTGTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.57454724594	42.4876383067985	0.0177063214625121	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2397.35050925616	2397.35050925616
"AML-0160"	"2019-07-01-count-3:GGTAGAGGTCACGACC"	2.49134244498555	-9.18871118938597	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTAGAGGTCACGACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.86089781662	42.2405842295222	0.0201928265276199	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2089.01274571964	2089.01274571964
"AML-0160"	"2019-07-01-count-2:CCACACTTCCTTCGAC"	2.87917437133138	-9.51486208355101	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACACTTCCTTCGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.62009961932	37.4880334514733	0.0163658886332585	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2285.70717910148	2285.70717910148
"AML-0160"	"2019-07-01-count-1:AATGACCCAATAACCC"	2.06275357779805	-9.02824976360472	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGACCCAATAACCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2465.02414481535	36.1233968630619	0.0146543785135086	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2458.57256225995	2458.57256225995
"AML-0160"	"2019-07-01-count-3:GATCCCTTCTTGTGCC"	2.81787504729573	-7.4392824403015	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCCCTTCTTGTGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.6971457247	35.9597429526355	0.0142657927048579	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2517.59006077842	2517.59006077842
"AML-0160"	"2019-07-01-count-3:AATGACCGTAACATCC"	2.1913444000179	-8.62093737041625	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGACCGTAACATCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.52840519937	38.1354260860464	0.0152692662100082	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2488.56591152612	2488.56591152612
"AML-0160"	"2019-07-01-count-2:AATCGTGGTATGCGGA"	-5.80265555802043	1.81151971900789	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCGTGGTATGCGGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2069.43683407193	45.8503324269228	0.0221559468122085	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2063.17311460132	2063.17311460132
"AML-0160"	"2019-07-01-count-1:TGTTTGTTCCAACACA"	2.13995613631551	-8.89707090770873	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTTGTTCCAACACA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.82955781094	38.3349506179739	0.0144179797104165	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2651.08146431053	2651.08146431053
"AML-0160"	"2019-07-01-count-3:ATCGGCGGTGGAGGTT"	1.88570787486379	-8.9552326432434	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGGCGGTGGAGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2050.78678101612	45.5928230750492	0.0222318690061279	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2044.15642394362	2044.15642394362
"AML-0160"	"2019-07-01-count-1:TAGATCGAGCCTGTCG"	1.47854687747304	-9.00272371685179	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGATCGAGCCTGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.3032093915	41.6558141540621	0.0175002134138663	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2368.60528167505	2368.60528167505
"AML-0160"	"2019-07-01-count-1:CATCCACCAACGTTAC"	-8.07616839829143	1.64322135532228	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCACCAACGTTAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2362.31614581757	38.6149294331647	0.0163462157685929	3040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2356.22316000336	2356.22316000336
"AML-0160"	"2019-07-01-count-3:CTGGTCTTCAACGTGT"	1.77797617492024	-8.7908392182556	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGGTCTTCAACGTGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2538.12373631174	44.7784826700024	0.0176423560559234	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2531.88628121435	2531.88628121435
"AML-0160"	"2019-07-01-count-2:CTCAGAAGTTCCTAGA"	5.16872849044148	-5.17907431041869	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAGAAGTTCCTAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.23756540429	35.9866382062785	0.0157681385810962	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2276.36776254567	2276.36776254567
"AML-0160"	"2019-07-01-count-1:TCGATTTGTCTCTCTG"	1.90643896636311	-7.78913643276366	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGATTTGTCTCTCTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2682.41201768907	41.5668211312508	0.0154960613273203	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2679.01734877569	2679.01734877569
"AML-0160"	"2019-07-01-count-2:ATCCCTGCAAACTGCT"	2.01388694819753	-9.63108065044554	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCCTGCAAACTGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.59619756002	45.0382724717784	0.0213897956901561	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2099.21536837897	2099.21536837897
"AML-0160"	"2019-07-01-count-2:TCAGTCCAGGACCCAA"	4.88887943801228	1.91351232612459	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	30	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0909090909090909	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGTCCAGGACCCAA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2186.73388470257	39.7995962022626	0.0182004753667938	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2167.56931147135	2167.56931147135
"AML-0160"	"2019-07-01-count-1:TTGAGTGCAAATAAGC"	1.45872034606282	-8.42752840435179	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAGTGCAAATAAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.96954232039	40.2894992922533	0.0168366118246477	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2390.26347279013	2390.26347279013
"AML-0160"	"2019-07-01-count-1:CTGGTCTAGATACAGT"	2.35506906089131	-9.15981485759886	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGTCTAGATACAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1470.05058038164	29.0172122397612	0.0197389209779625	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1470.05058038164	1470.05058038164
"AML-0160"	"2019-07-01-count-2:CTCGAGGAGTGCAGCA"	-6.18771062317546	3.54251334750978	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCGAGGAGTGCAGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1927.38487225766	36.5701292155792	0.0189739629805969	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1914.62287522861	1914.62287522861
"AML-0160"	"2019-07-01-count-2:GTCGAATCAACGACTT"	1.42519881305043	-8.42166235363158	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGAATCAACGACTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2287.40950114182	43.0621264971793	0.018825718121606	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2282.48668672176	2282.48668672176
"AML-0160"	"2019-07-01-count-1:GTTGTGACACGCTATA"	2.12952842292134	-4.34950592434081	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGACACGCTATA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2009.42718487304	40.8474378182387	0.0203279014665164	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2005.92327963409	2005.92327963409
"AML-0160"	"2019-07-01-count-2:AATTCCTCATCAACCA"	2.28698911246602	-9.14175798809203	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATTCCTCATCAACCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1875.57273796969	49.7585784947489	0.0265298047297342	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1872.21166149706	1872.21166149706
"AML-0160"	"2019-07-01-count-1:TTGAGTGTCTTCCGTG"	-8.23766837540324	2.63020536983339	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAGTGTCTTCCGTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2354.93583728078	46.002240186504	0.0195343921724943	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2349.2996451561	2349.2996451561
"AML-0160"	"2019-07-01-count-2:GTCGCGAAGATGCTAA"	2.13112773474995	-9.01044084942015	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGCGAAGATGCTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1776.54920480515	41.0729652678614	0.0231195202231205	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1776.54920480515	1776.54920480515
"AML-0160"	"2019-07-01-count-2:CAGCGTGAGTCATGAA"	0.72233291444127	-8.64993383800658	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	20	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.333333333333333	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCGTGAGTCATGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1706.6986342135	53.6108161915998	0.0314119992345956	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1702.89969501105	1702.89969501105
"AML-0160"	"2019-07-01-count-3:AACAACCAGCACTCCG"	1.5102821784908	-8.54729082500609	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAACCAGCACTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.21993332938	43.0641633818102	0.0180621606169001	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2378.139960571	2378.139960571
"AML-0160"	"2019-07-01-count-2:GTAATCGTCGCGAAGA"	2.65889443930928	-9.29155161296996	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAATCGTCGCGAAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2074.02858551329	38.5603562271207	0.0185920080834265	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.02858551329	2074.02858551329
"AML-0160"	"2019-07-01-count-2:AGTCATGCACGCGCTA"	1.95907964286153	-9.2116384736267	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCATGCACGCGCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2072.10097632001	42.0375948292549	0.0202874258106438	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2066.27012400497	2066.27012400497
"AML-0160"	"2019-07-01-count-1:CACAGATTCTAGCCAA"	1.52067675170247	-8.9861746064392	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACAGATTCTAGCCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.79642393435	45.1396546543451	0.0187628737848589	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2399.925528674	2399.925528674
"AML-0160"	"2019-07-01-count-1:GAGAGGTTCATTGCCC"	2.36105050620381	-10.4492740861145	"2019-07-01-count-1"	"AML0160"	"CD11c+"	"CD11c+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGAGGTTCATTGCCC"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.54877434091	39.2409505464414	0.0154337061072166	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2532.20368676757	2532.20368676757
"AML-0160"	"2019-07-01-count-1:GGTGTCGAGCGAAACC"	2.006231089204	-8.94276525890502	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGTCGAGCGAAACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2357.36412531356	39.1609769637607	0.0166121883943372	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2351.10714231508	2351.10714231508
"AML-0160"	"2019-07-01-count-2:TCAGTTTTCAATCTTC"	2.58519520339314	-8.84765341198119	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGTTTTCAATCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1606.15305084831	46.1886985655459	0.0287573457219103	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1603.96883412662	1603.96883412662
"AML-0160"	"2019-07-01-count-3:TATGTTCCAATGTTGC"	1.7716769176418	-9.04537393963011	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATGTTCCAATGTTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.02419566599	36.6887277019301	0.0154477279721532	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2371.0926227472	2371.0926227472
"AML-0160"	"2019-07-01-count-2:AGTCATGTCTGCGATA"	2.14255299147908	-9.09948255932006	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCATGTCTGCGATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.25907935558	44.5705422239809	0.0193175281539815	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2302.15013545306	2302.15013545306
"AML-0160"	"2019-07-01-count-1:CATGCCTGTGTATCCA"	2.59163631972615	-9.18581106578978	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCCTGTGTATCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2125.78868636181	49.6776593767127	0.023369048718447	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2125.78868636181	2125.78868636181
"AML-0160"	"2019-07-01-count-3:GTCATGAGTCCGTTTC"	2.15570678290669	-9.20831015026244	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCATGAGTCCGTTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1975.1976151276	47.3504510437915	0.0239725132721632	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1969.07751415095	1969.07751415095
"AML-0160"	"2019-07-01-count-1:TGAGTCAAGCCGGAAT"	1.76192059096639	-9.02583982860716	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGTCAAGCCGGAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.3968274478	43.8686525040649	0.0184291341671379	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2379.39675897461	2379.39675897461
"AML-0160"	"2019-07-01-count-3:ATGAGGGTCCCAACTC"	2.14712657508199	-9.19641687786254	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGAGGGTCCCAACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.26058249319	44.577935159834	0.0207507113071444	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2145.60442096036	2145.60442096036
"AML-0160"	"2019-07-01-count-2:GCTTTCGTCAGTGTTG"	5.4129020172054	-4.48756840145262	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTTTCGTCAGTGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2128.75724936887	45.2298255236576	0.0212470564866273	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2115.20463893257	2115.20463893257
"AML-0160"	"2019-07-01-count-2:GCTTTCGTCAAGCTGT"	1.81099917468373	-9.2608738175598	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTTTCGTCAAGCTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.06317002777	41.1452941871601	0.0170793753767303	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2404.11330139142	2404.11330139142
"AML-0160"	"2019-07-01-count-3:CAACAGTTCACTTGGA"	1.7334119277889	-9.8599891892639	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACAGTTCACTTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.12721016417	38.582743140938	0.0172774497419256	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2229.72360859301	2229.72360859301
"AML-0160"	"2019-07-01-count-1:GTTAGTGGTTAGCTAC"	2.35924710807149	-5.08803751384886	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTAGTGGTTAGCTAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2471.48651276947	42.2929737900796	0.0171123627709736	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2466.80731360988	2466.80731360988
"AML-0160"	"2019-07-01-count-2:AGCCAATGTCCTGTCT"	3.66235079345052	-8.22544863140257	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCCAATGTCCTGTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2165.46603742497	46.7390962986904	0.0215838510006232	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2160.87550257488	2160.87550257488
"AML-0160"	"2019-07-01-count-1:ACTATCTGTTGTGGAG"	1.55103864249532	-7.81599237835082	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATCTGTTGTGGAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2030.55670349049	36.6852450759531	0.0180665947485691	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2024.88019314371	2024.88019314371
"AML-0160"	"2019-07-01-count-1:CCATCACCATTATGCG"	1.87317230281178	-8.87238027965697	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCATCACCATTATGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.72567682717	37.3804351710712	0.0139806545955864	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2666.69281664959	2666.69281664959
"AML-0160"	"2019-07-01-count-3:TCATTGTTCTTAGCTT"	1.853154917329	-4.80287840282591	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTGTTCTTAGCTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2080.39285453978	42.1481968801015	0.0202597296890954	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2071.72109031831	2071.72109031831
"AML-0160"	"2019-07-01-count-1:TTGGGATCAAGTTCGT"	2.35773243483846	-9.1981353989807	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGATCAAGTTCGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.25048322572	44.1623906678315	0.0188788635439047	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.23672620271	2332.23672620271
"AML-0160"	"2019-07-01-count-3:GGGTCTGAGGTAGCCA"	2.08869208869283	-4.35264542019042	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTCTGAGGTAGCCA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2084.43309642287	43.6191515038909	0.0209261460963878	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2084.43309642287	2084.43309642287
"AML-0160"	"2019-07-01-count-3:AACACACTCCATCAGA"	2.63154711303059	-8.69366743480834	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACACACTCCATCAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.28460372111	39.3911188004144	0.0163497159030425	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2408.04068915157	2408.04068915157
"AML-0160"	"2019-07-01-count-2:AGGGTGATCTATTCGT"	1.68015625056569	-9.04433061992797	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGTGATCTATTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2207.21448848578	44.1407727230432	0.0199984065677845	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2204.95950916529	2204.95950916529
"AML-0160"	"2019-07-01-count-2:TCGCAGGGTCAAAGCG"	2.85211171683614	-8.32124903118285	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCAGGGTCAAAGCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1907.13398745498	37.7691474581023	0.0198041394608588	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1902.73608897669	1902.73608897669
"AML-0160"	"2019-07-01-count-2:ACTATGGGTCGTGATT"	2.02667786654775	-8.71853926098021	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTATGGGTCGTGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.11834708147	41.2330477716777	0.0188440665591396	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2184.35397883511	2184.35397883511
"AML-0160"	"2019-07-01-count-3:TGCGGGTTCTCGTGGG"	2.03595544871632	-9.26497557079466	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGGTTCTCGTGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2079.2761481924	45.1207086949691	0.0217002002039	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2077.9260147528	2077.9260147528
"AML-0160"	"2019-07-01-count-3:TCTGGCTGTCTGCGCA"	1.91913892802541	-8.85170175945433	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGGCTGTCTGCGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2395.87972730695	45.8778310759896	0.019148636950803	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2393.41325583308	2393.41325583308
"AML-0160"	"2019-07-01-count-2:CATTGCCCACGGATCC"	2.1850823360378	-9.87034227764281	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGCCCACGGATCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.75624145523	44.1082041955783	0.0210866846343875	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2090.36822423515	2090.36822423515
"AML-0160"	"2019-07-01-count-3:TGTTCTAAGGAAAGGT"	1.6657301383907	-8.69836904918822	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCTAAGGAAAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2162.08348514082	44.9906137718268	0.0208089160668542	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2156.38267827928	2156.38267827928
"AML-0160"	"2019-07-01-count-3:TGTTCTATCTACCCAC"	2.13799752768819	-8.75601675426634	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCTATCTACCCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.95406907091	44.6048180185794	0.0197983698961843	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2248.91054630323	2248.91054630323
"AML-0160"	"2019-07-01-count-2:CCATCACCAAGGCGTA"	1.55547942694966	-8.36865808880004	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCATCACCAAGGCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2175.13182747783	46.0790967823954	0.0211845076239936	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.16596907832	2171.16596907832
"AML-0160"	"2019-07-01-count-2:GTTACAGTCGAGAACG"	1.53694989260976	-8.64089109813841	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTACAGTCGAGAACG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2230.57142155793	36.4369467138799	0.0163352521966908	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2228.44821262467	2228.44821262467
"AML-0160"	"2019-07-01-count-2:ATTACTCCACGTCTCT"	1.68458594855611	-8.89302160656127	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTACTCCACGTCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.80018938742	47.2866259729872	0.0215546640034666	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2192.41497500296	2192.41497500296
"AML-0160"	"2019-07-01-count-2:TTGTTCAGTCATTGCA"	5.23784794387166	-5.06298353588256	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTCAGTCATTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.49018865473	38.2536087361375	0.0157585018942288	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2420.91232617034	2420.91232617034
"AML-0160"	"2019-07-01-count-2:CTGAATGGTATCTCTT"	2.11672105368916	-10.4877310029236	"2019-07-01-count-2"	"AML0160"	"CD11c+"	"CD11c+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGAATGGTATCTCTT"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2165.93519402679	41.1556244453184	0.0190013184876525	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2163.33628072008	2163.33628072008
"AML-0160"	"2019-07-01-count-1:TCCAGAAGTTAGGCCC"	-8.12772212448772	0.999242044332899	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCAGAAGTTAGGCCC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2715.01362293333	35.8289191143424	0.0131965890748027	3064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2706.74457283701	2706.74457283701
"AML-0160"	"2019-07-01-count-2:CGTTGGGCACTCATAG"	11.9932962852413	-2.54873659526976	"2019-07-01-count-2"	"AML0160"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0833333333333333	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTGGGCACTCATAG"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1747.02036367154	29.6932226332676	0.0169964948610354	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1744.21737282615	1744.21737282615
"AML-0160"	"2019-07-01-count-1:CATGGATTCTATGTGG"	1.773489733308	-8.82294084942015	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGGATTCTATGTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.51844437295	40.886554975818	0.0168637838456999	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2421.78523180576	2421.78523180576
"AML-0160"	"2019-07-01-count-2:TGCTTCGCACTTCAAG"	2.48631252822224	-8.65119841015013	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTCGCACTTCAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1776.06660857348	47.6601631155453	0.0268346710002197	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1774.39510666881	1774.39510666881
"AML-0160"	"2019-07-01-count-2:GAGAGGTCACATGGTT"	1.99022807654683	-9.44604208385619	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGAGGTCACATGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2132.92862303842	40.4410464179217	0.018960337435161	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2130.17685788423	2130.17685788423
"AML-0160"	"2019-07-01-count-1:GGTTGTAGTCTGCATA"	2.05587019500081	-8.82845117962035	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTTGTAGTCTGCATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.78956304076	49.6436201832925	0.0211899613035918	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2336.75857906471	2336.75857906471
"AML-0160"	"2019-07-01-count-3:TACCCACCAGTGACCC"	1.9369281726772	-9.2077617875305	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCCACCAGTGACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2200.10344148521	43.9646704550458	0.0199830015380399	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2190.11457585542	2190.11457585542
"AML-0160"	"2019-07-01-count-3:AACCTGAAGCCAGTAG"	-8.10553107681926	1.98534844005433	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCTGAAGCCAGTAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2505.90072737967	40.9955189384373	0.0163595941732715	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2495.81269782317	2495.81269782317
"AML-0160"	"2019-07-01-count-2:GAGTTGTAGTCGAAGC"	1.87613465365712	-9.43846418773802	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTGTAGTCGAAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2174.17830775458	42.3190026189623	0.0194643661322644	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2167.79961136759	2167.79961136759
"AML-0160"	"2019-07-01-count-2:CATACCCCAAGGTCGA"	1.67856146869008	-8.59145834362181	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATACCCCAAGGTCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.1452074131	37.0072150776453	0.0171715645657429	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2155.1452074131	2155.1452074131
"AML-0160"	"2019-07-01-count-2:ATGAGTCCATCTTAGG"	1.69347836551015	-8.81328394329222	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGAGTCCATCTTAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1974.50832341772	38.7423701224701	0.0196212746550544	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1972.68019294463	1972.68019294463
"AML-0160"	"2019-07-01-count-1:TTGCTGCTCATTCACT"	1.96197034892384	-4.0865426293579	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCTGCTCATTCACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2338.32269070828	37.0537965990905	0.0158463144314213	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2329.97700384462	2329.97700384462
"AML-0160"	"2019-07-01-count-1:GTAACACAGAATTCAG"	-6.96321759644206	0.0194693461987152	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAACACAGAATTCAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2099.96650234318	45.0556895275069	0.0214554324924864	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2095.07216664095	2095.07216664095
"AML-0160"	"2019-07-01-count-1:ATTACCTCATGTCGTA"	2.07480039176289	-8.75646593486937	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTACCTCATGTCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.35407595786	44.3803165721939	0.0190771976763342	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2320.01896614272	2320.01896614272
"AML-0160"	"2019-07-01-count-3:GGAATCTTCAACCCGG"	-9.8672984642094	4.06751296604005	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAATCTTCAACCCGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2085.75442222185	44.6307240334037	0.0213978805740039	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2079.6684729335	2079.6684729335
"AML-0160"	"2019-07-01-count-1:GCCAACGGTCATCCCT"	1.96043064174001	-9.75058271801146	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAACGGTCATCCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2039.37700291167	47.5059022673255	0.0232943208634304	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2036.91425962556	2036.91425962556
"AML-0160"	"2019-07-01-count-2:AGCGCTGAGCGACTAG"	2.05132486399953	-9.15496351635131	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGCTGAGCGACTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.88384500853	41.5583627295177	0.0192232172072842	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2160.73170596322	2160.73170596322
"AML-0160"	"2019-07-01-count-2:CTAACTTCAGCAGATG"	2.0352347093517	-8.88376428997191	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAACTTCAGCAGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.67935478186	48.8394604658074	0.0229867440260518	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2120.27811964265	2120.27811964265
"AML-0160"	"2019-07-01-count-3:CTACGGGAGAAATTCG"	5.34430517730061	-4.93793442165526	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACGGGAGAAATTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.10339808937	44.6760525186258	0.020788228504196	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2149.10339808937	2149.10339808937
"AML-0160"	"2019-07-01-count-2:AATCGTGAGCTGGAGT"	2.82477511939351	-5.17610218441161	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCGTGAGCTGGAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.01056993314	40.4386583221308	0.0179566911727823	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2248.08238805649	2248.08238805649
"AML-0160"	"2019-07-01-count-2:ACACGCGTCCTCTAGC"	5.27662195739095	-4.98447754299315	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACGCGTCCTCTAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2055.76026259667	43.4518563878296	0.021136636006839	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2051.14478287117	2051.14478287117
"AML-0160"	"2019-07-01-count-2:ATCGGCGAGCGCACAA"	1.92272593554799	-4.11101152813109	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGCGAGCGCACAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1772.50016888979	51.3337192051923	0.0289611928428448	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1770.75757518534	1770.75757518534
"AML-0160"	"2019-07-01-count-1:CCCTTAGAGGTTAGTA"	1.62825812873189	-9.06345751201781	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTTAGAGGTTAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2132.34386390455	43.0427456755453	0.0201856494180677	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2123.88342572725	2123.88342572725
"AML-0160"	"2019-07-01-count-3:GCTACCTAGAATTCAG"	2.22005357322041	-9.02701761638793	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTACCTAGAATTCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.9053849687	39.8632574784309	0.0174999619130268	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2273.12761757254	2273.12761757254
"AML-0160"	"2019-07-01-count-2:CCACCATTCGTTCCCA"	1.62592830237691	-8.69214918529662	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACCATTCGTTCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.84544396395	42.2501122158018	0.0161577856593134	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2610.52639483336	2610.52639483336
"AML-0160"	"2019-07-01-count-1:TGGCGTGCAATACAGA"	2.1547392803127	-9.31224348461302	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGCAATACAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1980.5158787679	48.1542750733773	0.02431400605752	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1980.5158787679	1980.5158787679
"AML-0160"	"2019-07-01-count-1:ACTATGGCAATAACGA"	1.81577219542806	-8.92881300365599	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATGGCAATAACGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.05738908173	42.9240105950985	0.0168325665057112	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2545.21617551467	2545.21617551467
"AML-0160"	"2019-07-01-count-3:CCTGCATAGTGATCGG"	-7.97571216049846	3.56178472125856	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTGCATAGTGATCGG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1866.11139451486	39.0498648210466	0.0209257951780518	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1863.42355171436	1863.42355171436
"AML-0160"	"2019-07-01-count-3:TTAATCCCAAGTTCCA"	1.50411834296529	-8.78672315990599	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAATCCCAAGTTCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.19866244707	42.3159799144219	0.0179062304777221	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2359.57134274991	2359.57134274991
"AML-0160"	"2019-07-01-count-3:CTCCTTTCACATGACT"	-2.83847794953044	-5.13821175014647	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCTTTCACATGACT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1940.59831330356	43.6200747779714	0.0224776423224419	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1932.12642163618	1932.12642163618
"AML-0160"	"2019-07-01-count-1:GAACACTAGGCATTTC"	1.54415061053578	-8.52152922069701	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACACTAGGCATTTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2221.24761955793	41.5473216153481	0.0187044979810115	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2216.41302333095	2216.41302333095
"AML-0160"	"2019-07-01-count-3:TTTGTTGCAACCGTAT"	1.7876783805782	-9.41903307354125	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGTTGCAACCGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.50286441376	41.5288192224369	0.017935118915498	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2311.92695403351	2311.92695403351
"AML-0160"	"2019-07-01-count-2:TGGAACTAGCTGTCCG"	2.46339311179463	-10.0297994843689	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGAACTAGCTGTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.04452827604	43.6676618872617	0.0185500577252213	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2354.04452827604	2354.04452827604
"AML-0160"	"2019-07-01-count-2:CTGTATTGTTTCTATC"	1.67566635188405	-7.99972250377806	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTATTGTTTCTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1891.65526949516	49.9818776595859	0.0264222971624872	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1889.96255703482	1889.96255703482
"AML-0160"	"2019-07-01-count-3:ACAGCCGCAGCTATAC"	2.30460538443868	-3.86497142231139	"2019-07-01-count-3"	"AML0160"	"DC precursor"	"DC precursor"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACAGCCGCAGCTATAC"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2568.81846450535	41.6194592679489	0.0162017907621834	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2565.75031527036	2565.75031527036
"AML-0160"	"2019-07-01-count-2:CCGGTGAGTGAGAGGG"	2.85218538817708	-6.79426338588866	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTGAGTGAGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2169.37427096143	43.1122912674246	0.0198731458395687	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2166.82032477911	2166.82032477911
"AML-0160"	"2019-07-01-count-3:AGTAGCTTCCGTGGGT"	2.58906044539754	-9.17991545116576	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTAGCTTCCGTGGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1911.18094185472	46.6429636618822	0.0244053101621122	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1904.91428016054	1904.91428016054
"AML-0160"	"2019-07-01-count-2:TCGGGACTCGTGCGAC"	-7.92007527771648	2.37223479831544	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGGGACTCGTGCGAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2257.47584626144	38.734742173471	0.0171584303936713	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2250.16487496856	2250.16487496856
"AML-0160"	"2019-07-01-count-2:CGAGTGCTCTCTGCTG"	1.9787481027538	-8.83071806347045	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAGTGCTCTCTGCTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.87802777013	39.5277771675206	0.0161874494622553	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2437.67684089974	2437.67684089974
"AML-0160"	"2019-07-01-count-2:GCCCAGACACCCTTGT"	1.93149735507314	-7.94160559093627	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCAGACACCCTTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1914.17097824796	47.2103102538405	0.0246635806259334	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1910.69263142588	1910.69263142588
"AML-0160"	"2019-07-01-count-2:TTTACGTAGGTAGGCT"	1.71846975859944	-9.16757776653441	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACGTAGGTAGGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.97722562823	37.8852332965497	0.0161078231896698	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2350.77573729169	2350.77573729169
"AML-0160"	"2019-07-01-count-3:TTACAGGCAGTTCTAG"	1.92421187934224	-8.77201845562132	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACAGGCAGTTCTAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2093.30481886283	41.0168322014277	0.0195942950266124	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2089.20310843959	2089.20310843959
"AML-0160"	"2019-07-01-count-1:CCTCAACAGGTACAAT"	2.01207270201985	-9.59049608623656	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCAACAGGTACAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.44307806405	46.1580073496197	0.0208440703700421	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2207.56025422759	2207.56025422759
"AML-0160"	"2019-07-01-count-2:GAAGTAAGTCACTTCC"	1.98112251338307	-9.25932886516722	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGTAAGTCACTTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1972.01154771082	40.1473734701236	0.0203585894396653	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1969.40220314491	1969.40220314491
"AML-0160"	"2019-07-01-count-3:AACGGGAGTGTTCAGT"	1.93282081660573	-8.37580492412718	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGGGAGTGTTCAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2039.15418234971	45.4664121768246	0.0222967015296675	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2034.89024866392	2034.89024866392
"AML-0160"	"2019-07-01-count-1:CTCCTCCCAATTTCTC"	-6.0902193588322	1.49840769851533	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCCAATTTCTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2621.46730039154	32.9218449687454	0.0125585564099267	2991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2611.23201039193	2611.23201039193
"AML-0160"	"2019-07-01-count-2:TAGTGCAAGCCTGTGC"	7.81921829757039	6.54021165454713	"2019-07-01-count-2"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGTGCAAGCCTGTGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1693.3990493594	46.4822463239989	0.0274490802044461	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1689.43896399647	1689.43896399647
"AML-0160"	"2019-07-01-count-1:TCTGCCACATGTCTAG"	1.65703274783437	-8.75022890484007	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTGCCACATGTCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.28238648603	42.6586919668504	0.0165904344816629	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2567.39663010788	2567.39663010788
"AML-0160"	"2019-07-01-count-3:CTCGAGGTCGTAATGC"	2.59165086325948	-8.66718485271605	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCGAGGTCGTAATGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2018.10378004758	37.5538952010385	0.0186085054556278	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2016.55065280619	2016.55065280619
"AML-0160"	"2019-07-01-count-1:ATTCAGGCAGGTCCCA"	1.5957017141277	-8.18519117748412	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCAGGCAGGTCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2004.27446382272	46.6764823041252	0.023288468294457	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2002.85134989497	2002.85134989497
"AML-0160"	"2019-07-01-count-3:AATGGAAGTCAGGTGA"	-9.23641143265422	5.17227122867433	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGGAAGTCAGGTGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1926.56538256822	44.2196601543013	0.0229525873112876	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1921.64132048399	1921.64132048399
"AML-0160"	"2019-07-01-count-3:GTTGAACGTATAGGAT"	-8.39484630051311	0.586754060629286	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGAACGTATAGGAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2359.05517364252	41.8900940319215	0.0177571489212949	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2348.11458807933	2348.11458807933
"AML-0160"	"2019-07-01-count-1:TATTTCGGTCAGTCTA"	3.60325445708577	-9.9274530640808	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTTCGGTCAGTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2082.92394731849	45.4441593299342	0.021817483729273	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2077.50407724562	2077.50407724562
"AML-0160"	"2019-07-01-count-3:CAATGACTCAAGTGTC"	2.34505929526631	-4.38268997585448	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATGACTCAAGTGTC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2172.97352534446	40.1191777040622	0.0184628009665707	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2171.63620348956	2171.63620348956
"AML-0160"	"2019-07-01-count-2:CAATTTCTCTGTGTGA"	1.78598393973653	-9.12071897899779	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATTTCTCTGTGTGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.09523754876	41.1740267828225	0.0182017211739676	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2256.86577984618	2256.86577984618
"AML-0160"	"2019-07-01-count-2:TCAAGTGAGCTTGTTG"	2.74724092063252	-7.7979135743347	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAAGTGAGCTTGTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2222.21633395442	41.4935045743535	0.0186721265343757	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2218.96666510734	2218.96666510734
"AML-0160"	"2019-07-01-count-1:TGTGGCGTCGTCAACA"	1.85842349108998	-9.15912916576537	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGGCGTCGTCAACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2335.1097637581	38.2005611198204	0.0163592143344648	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2331.70736291981	2331.70736291981
"AML-0160"	"2019-07-01-count-1:ATGCCTCAGTACGAGC"	-6.12811789932902	2.11936304653016	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.119047619047619	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCCTCAGTACGAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1797.28804259565	47.0682306302095	0.0261884736974233	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1788.12599951478	1788.12599951478
"AML-0160"	"2019-07-01-count-3:TCCGATCAGCCTCATA"	2.89192452010457	-5.73878910457762	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCGATCAGCCTCATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2545.61937220466	40.1241626537042	0.0157620432543119	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2541.55551489235	2541.55551489235
"AML-0160"	"2019-07-01-count-3:ACTTAGGAGTCAACAA"	2.37906469878499	-9.1712970963684	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTTAGGAGTCAACAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2114.53433865575	45.3857724380758	0.021463719745941	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2114.53433865575	2114.53433865575
"AML-0160"	"2019-07-01-count-2:GATCAGTCAGCAATTC"	1.51328696784322	-8.73069002544554	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCAGTCAGCAATTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2556.40707673639	39.5068952011047	0.0154540705041158	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2553.42672155574	2553.42672155574
"AML-0160"	"2019-07-01-count-1:ACTTAGGTCAAGCCAT"	2.51345171508138	-5.12518789684447	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTAGGTCAAGCCAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2547.53558505743	36.8711020434533	0.0144732431844017	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2542.30163179507	2542.30163179507
"AML-0160"	"2019-07-01-count-2:TAACCAGTCAAACGAA"	1.52696885642354	-8.94415285503539	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACCAGTCAAACGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.47908961955	42.1334652089796	0.0190263549592686	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2210.8634214417	2210.8634214417
"AML-0160"	"2019-07-01-count-3:GAACTGTCAGTCAGAG"	9.32478489455525	7.35475347125856	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAACTGTCAGTCAGAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1551.07648022147	46.8539072358435	0.0302073481438861	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1547.22559412927	1547.22559412927
"AML-0160"	"2019-07-01-count-3:TTGTTTGGTCGATTTG"	2.12145318564717	-4.52020218288573	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTTTGGTCGATTTG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2138.84112581297	44.9611706768909	0.0210212764913997	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2132.61975174323	2132.61975174323
"AML-0160"	"2019-07-01-count-2:GATGTTGCACTCCACT"	1.98448409613912	-8.87239077007445	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGTTGCACTCCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.83876608013	37.8610202349679	0.0159291495810665	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.55707710586	2370.55707710586
"AML-0160"	"2019-07-01-count-2:ACACTGAGTTGATGTC"	-8.17677722397502	2.13811490619508	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACTGAGTTGATGTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2183.5100834395	43.1549134249003	0.0197640092217582	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2178.98465623862	2178.98465623862
"AML-0160"	"2019-07-01-count-3:AACGAAACACCCGTAG"	-7.46950040283855	3.74022624576417	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGAAACACCCGTAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2259.30297275653	39.7310562141844	0.0175855370852318	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2250.99927587098	2250.99927587098
"AML-0160"	"2019-07-01-count-3:AAGTCGTGTATTTCCT"	2.24560584601704	-8.51945974743041	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGTCGTGTATTTCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1587.63330607412	38.5585027560394	0.0242867812161149	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1585.5994470925	1585.5994470925
"AML-0160"	"2019-07-01-count-2:AGATGAACATGCGGTC"	-7.81022630158122	-0.34133236920508	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATGAACATGCGGTC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2798.09907184072	45.2747347941237	0.0161805331518658	2851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2792.48577246937	2792.48577246937
"AML-0160"	"2019-07-01-count-3:ACATCGACATGTGACT"	2.05994095382039	-9.27373411571654	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACATCGACATGTGACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.50167538187	45.2321456372627	0.0210430846159853	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2144.62845806521	2144.62845806521
"AML-0160"	"2019-07-01-count-2:ATGGATCGTTACCGTA"	1.94303204593007	-8.61848452007445	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGATCGTTACCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.49592649846	36.9401664456341	0.0164654484143809	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2240.11157226353	2240.11157226353
"AML-0160"	"2019-07-01-count-1:CATGAGTTCAGGACGA"	1.51643433150594	-9.15450479900511	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGAGTTCAGGACGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.60615131481	38.3478296203258	0.0163837173540642	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2335.5375326311	2335.5375326311
"AML-0160"	"2019-07-01-count-2:GTGAGTTAGGTTCATC"	-8.30354247513469	3.94455740535585	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGTTAGGTTCATC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1807.86537987914	36.4282113921056	0.0201498473268739	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1802.02158878375	1802.02158878375
"AML-0160"	"2019-07-01-count-1:ATTCCATCAAGATGTA"	1.73765220221822	-8.81495001232298	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCATCAAGATGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2486.31686979196	41.4018776103449	0.0166518910414702	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2482.70400609894	2482.70400609894
"AML-0160"	"2019-07-01-count-1:CCTCATGAGTAAGACT"	0.682299395173234	-10.2557811967102	"2019-07-01-count-1"	"AML0160"	"CD11c+"	"CD11c+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.166666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCATGAGTAAGACT"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.70059386763	49.5595924917852	0.0224281934979442	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2204.0115078723	2204.0115078723
"AML-0160"	"2019-07-01-count-3:GAAGCCCCAATGCAAA"	1.92207254943196	-8.89819528972777	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGCCCCAATGCAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1990.22715228977	39.7131797899502	0.0199540940561784	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1988.89530463637	1988.89530463637
"AML-0160"	"2019-07-01-count-1:AACCATGTCAGACCCG"	2.02741398391072	-9.13777925884398	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCATGTCAGACCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.53625847462	39.3403741744641	0.0171079599329998	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2294.45104024958	2294.45104024958
"AML-0160"	"2019-07-01-count-3:CTAACCCGTTCGGACC"	-7.71634946289714	1.38590071285097	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTAACCCGTTCGGACC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2517.04587039815	38.1307999087314	0.0151490286121404	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2509.03804775296	2509.03804775296
"AML-0160"	"2019-07-01-count-1:GTCACGGGTTATGTGC"	2.10000528868977	-10.0112610093323	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCACGGGTTATGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.86998329281	36.2693107584919	0.0153691987335184	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.06346210955	2356.06346210955
"AML-0160"	"2019-07-01-count-1:GGGAAGTCACTTTATC"	1.84766020354573	-9.31419279491576	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAAGTCACTTTATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.77556411695	39.9246059749697	0.0156091122829822	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2549.56287102304	2549.56287102304
"AML-0160"	"2019-07-01-count-1:TTGTTCAAGCACCGAA"	2.15408577498738	-8.84087850963744	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTCAAGCACCGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2453.28711007442	39.0189816031267	0.0159047758588447	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2449.21859766291	2449.21859766291
"AML-0160"	"2019-07-01-count-2:GCCTGTTAGATCGACG"	-5.80454383316691	-5.17529442226561	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCTGTTAGATCGACG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2849.57107808715	41.8452414654345	0.0146847509041691	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2839.4429959974	2839.4429959974
"AML-0160"	"2019-07-01-count-2:TGGGAGAAGAGGTCGT"	1.51017405566518	-8.70484545147093	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGAGAAGAGGTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.93337445518	45.0872573980848	0.0194431016840567	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2314.33022278258	2314.33022278258
"AML-0160"	"2019-07-01-count-3:TGCGATATCGGATACT"	1.87457682666127	-7.87425901806029	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGATATCGGATACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1839.95923156593	47.3405613289737	0.0257291360138908	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1833.7253825138	1833.7253825138
"AML-0160"	"2019-07-01-count-1:ATTCCTAAGGTACAGC"	3.6623350578243	-10.7074003449646	"2019-07-01-count-1"	"AML0160"	"CD16+ monocyte"	"CD16+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCTAAGGTACAGC"	"CD16+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.80659922553	48.9273128594864	0.0230267135264545	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2119.08731651567	2119.08731651567
"AML-0160"	"2019-07-01-count-3:TCGCACTAGGAGAATG"	2.31128491935078	-7.63338663494261	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCACTAGGAGAATG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2195.54976816985	42.1217665535204	0.0191850657016224	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2189.21372136156	2189.21372136156
"AML-0160"	"2019-07-01-count-2:TTAGTCTTCCAACCGG"	1.43659319457356	-8.79203703319701	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTAGTCTTCCAACCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.88643734199	41.7263427529191	0.0173578677032083	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2397.95872419017	2397.95872419017
"AML-0160"	"2019-07-01-count-2:ATGGTTGCAGCTGCCA"	3.74540938910787	-9.73644449627074	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGTTGCAGCTGCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.30728311103	39.1236608535713	0.0166038025405228	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2349.56305964735	2349.56305964735
"AML-0160"	"2019-07-01-count-1:CTGTACCGTCTACGAT"	1.66870393332784	-8.57670786296996	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTACCGTCTACGAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2353.95876850525	43.4572946339636	0.0184613661103158	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2349.79094386341	2349.79094386341
"AML-0160"	"2019-07-01-count-3:GTTACGAGTACCTGTA"	-8.21562610092815	3.50332377040712	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTACGAGTACCTGTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1982.01901787357	45.1055533621071	0.0227573766726512	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1977.13155156271	1977.13155156271
"AML-0160"	"2019-07-01-count-1:GTCTCACTCGCCTATC"	1.69771649417226	-8.81980230724486	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTCACTCGCCTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.06572466105	45.1842631182076	0.0191129470923174	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.04002194263	2358.04002194263
"AML-0160"	"2019-07-01-count-1:CAGATCAGTTGTACGT"	2.13178171691243	-9.13297083294066	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGATCAGTTGTACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.07425172945	34.0175147963602	0.0141381816342156	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2397.00401762619	2397.00401762619
"AML-0160"	"2019-07-01-count-3:CGAGGAAGTTGTGGAG"	-8.40057216110881	5.01728484714357	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGGAAGTTGTGGAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1954.58245476272	38.9631300666593	0.019934247323114	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1949.53065734626	1949.53065734626
"AML-0160"	"2019-07-01-count-3:CTGAGGCGTGTGAGCA"	2.44695367392842	-9.47260858928832	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAGGCGTGTGAGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1938.81915503202	45.1540300383042	0.0232894491067469	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1931.89085489983	1931.89085489983
"AML-0160"	"2019-07-01-count-2:CCGAACGTCGAGTCCG"	2.10172071036641	-9.05756952678832	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGAACGTCGAGTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2092.61458618548	47.8403990232945	0.0228615433243731	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2089.63316814307	2089.63316814307
"AML-0160"	"2019-07-01-count-1:GGGACCTCATGACAAA"	2.15964498099629	-8.78276731884154	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGACCTCATGACAAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2400.10336472591	45.9522798736899	0.0191459586903823	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2391.77869074774	2391.77869074774
"AML-0160"	"2019-07-01-count-3:CTAAGTGTCCACAAGT"	1.77994622763936	-9.26264955913695	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTAAGTGTCCACAAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2177.20351823654	42.1896873926316	0.0193779254163634	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2172.36359663868	2172.36359663868
"AML-0160"	"2019-07-01-count-1:GGGACTCCAACGGTAG"	2.44498791274373	-7.62082340633544	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGACTCCAACGGTAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2554.19113617414	36.7952023920508	0.0144058139858575	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2551.61987753139	2551.61987753139
"AML-0160"	"2019-07-01-count-2:CAGATACAGACTCTTG"	1.74711968478505	-8.94155409252318	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGATACAGACTCTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.42841553381	41.0657641212488	0.0165759639567226	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2475.35341962876	2475.35341962876
"AML-0160"	"2019-07-01-count-2:TTTCATGAGGCGCTCT"	2.31549849089925	-9.32663919841918	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCATGAGGCGCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2192.01569222302	45.3324335193836	0.0206807066574464	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2189.4012667504	2189.4012667504
"AML-0160"	"2019-07-01-count-3:ATGTCCCCACAAAGCG"	-8.48770842972453	-0.620609604474627	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCCCCACAAAGCG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2785.57382696585	39.9797454851022	0.014352427172483	3053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2777.57510397651	2777.57510397651
"AML-0160"	"2019-07-01-count-3:TTGTGGACAAGCAATA"	1.92785920676534	-8.81899168407591	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTGGACAAGCAATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.49182028011	39.8478845762447	0.0181004009232134	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2197.03187275724	2197.03187275724
"AML-0160"	"2019-07-01-count-2:TGGGCGTCAATTGCAC"	-7.19043431702312	1.0313111313614	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCGTCAATTGCAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2262.24013206267	42.4700192967106	0.0187734355406325	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2254.51439464402	2254.51439464402
"AML-0160"	"2019-07-01-count-1:GTCGTTCCACATTCTT"	1.70392276820485	-8.63420011913451	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGTTCCACATTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.04241433814	37.6724532932671	0.0167952478528513	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2238.47231878644	2238.47231878644
"AML-0160"	"2019-07-01-count-2:CTCACTGTCACTTGTT"	2.11061014708821	-9.84288980877074	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCACTGTCACTTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.22466998474	33.3724010788287	0.0132523525309721	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2511.71004354691	2511.71004354691
"AML-0160"	"2019-07-01-count-2:CATTCATGTGAAGCTG"	2.00507583197896	-9.07226278698119	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCATGTGAAGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.40964817151	41.7178363574347	0.0172074205317977	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2418.755625652	2418.755625652
"AML-0160"	"2019-07-01-count-1:TCTTAGTCAACTGCTA"	2.65836443480794	-9.03264810955199	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTAGTCAACTGCTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1700.56950374692	36.9662835094486	0.0217375905118841	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1698.69920184857	1698.69920184857
"AML-0160"	"2019-07-01-count-3:GTTGTGATCATGCTAG"	2.86455168303792	-5.72798254406127	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTGATCATGCTAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2131.22819364551	42.7991052914224	0.0200818971046989	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2128.74162650011	2128.74162650011
"AML-0160"	"2019-07-01-count-2:CCGATGGCATGTTCAG"	1.96842243251149	-8.74582292949828	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGATGGCATGTTCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.01457351401	47.4025267911591	0.0206815992092423	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.69994319265	2288.69994319265
"AML-0160"	"2019-07-01-count-3:GGTTCTCCAATTCTTC"	1.88041617450063	-9.04882242595824	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTTCTCCAATTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2344.13359090883	36.4626455599491	0.0155548496473754	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2338.44065631467	2338.44065631467
"AML-0160"	"2019-07-01-count-2:TTCCTTCCAACTTCTT"	1.8636552291805	-8.84332086956175	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTTCCAACTTCTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2474.47737938857	39.5858683232618	0.0159976682967469	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2466.76970206323	2466.76970206323
"AML-0160"	"2019-07-01-count-1:ATTCTTGAGCTGACTT"	1.58461370047871	-8.20715620433959	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCTTGAGCTGACTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2457.48234694682	42.9394198402571	0.0174729311458148	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2452.22632107368	2452.22632107368
"AML-0160"	"2019-07-01-count-2:CGTTCTGCAGGTCTCG"	1.95507194575612	-8.82311727916869	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTCTGCAGGTCTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.87210929444	38.2247644361649	0.0167221798108221	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2283.57366654546	2283.57366654546
"AML-0160"	"2019-07-01-count-3:TAGGTTGGTGGTAACG"	1.90620913085286	-9.00688936626586	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGGTTGGTGGTAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1903.93153304976	45.0502506127142	0.0236616967735976	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1898.79905169851	1898.79905169851
"AML-0160"	"2019-07-01-count-2:ATATCCTAGGAGAGTA"	-5.34064851227458	3.16326019847719	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATATCCTAGGAGAGTA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2436.09302791601	44.7352397245528	0.0183635186390326	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2428.54395634173	2428.54395634173
"AML-0160"	"2019-07-01-count-1:TGGCGTGGTACGATGG"	1.49779882010762	-8.46536066448363	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGGTACGATGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2417.01101974771	43.7846606566424	0.0181152093635108	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2414.99817827208	2414.99817827208
"AML-0160"	"2019-07-01-count-1:CCGTTCACAACGCATT"	-7.90134177628215	2.16800568187562	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGTTCACAACGCATT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2485.95914694446	40.2536320865393	0.0161923948492942	2908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2480.65644855815	2480.65644855815
"AML-0160"	"2019-07-01-count-3:AGGTTACTCGCGTCGA"	2.13063492354695	-4.42822935497435	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTTACTCGCGTCGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1923.16679503015	49.0659666604185	0.0255131103486265	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1921.69766057317	1921.69766057317
"AML-0160"	"2019-07-01-count-1:TCACATTGTGCCGTAC"	-7.831526140601	3.62751338565675	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACATTGTGCCGTAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2162.6345804398	34.51633665273	0.0159603184767862	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2150.43552424514	2150.43552424514
"AML-0160"	"2019-07-01-count-1:CAGCACGTCTTGGTGA"	1.60673775252644	-8.66120150005492	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCACGTCTTGGTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.85625876651	41.3016744805164	0.0177499896372674	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2320.51282522341	2320.51282522341
"AML-0160"	"2019-07-01-count-1:AGGCCACGTTCCGCAG"	-7.63744101944621	3.69499228084413	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGCCACGTTCCGCAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2256.97856995249	26.2038411447593	0.0116101417592596	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2244.24265275988	2244.24265275988
"AML-0160"	"2019-07-01-count-2:AAGAACATCGAGAAAT"	2.33401073989217	-9.50285913860472	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGAACATCGAGAAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2212.52711212403	41.9045188266537	0.0189396634269604	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2207.82969376292	2207.82969376292
"AML-0160"	"2019-07-01-count-1:CCTGTTGAGTAGACCG"	1.69444503363912	-8.67074682628783	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTGTTGAGTAGACCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2506.28029137009	37.0872062804712	0.0147977089426805	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2501.14823066693	2501.14823066693
"AML-0160"	"2019-07-01-count-3:TTTGGAGAGAGTTGTA"	1.81352259692494	-8.85758879100951	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGGAGAGAGTTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2029.23067285027	43.4324804954965	0.0214034220340712	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2018.5493471713	2018.5493471713
"AML-0160"	"2019-07-01-count-3:TTGAGTGTCATGCCAA"	4.42069925841634	-8.58181002056273	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGAGTGTCATGCCAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2053.93799259345	38.5724423010627	0.0187797501385903	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2049.04213323422	2049.04213323422
"AML-0160"	"2019-07-01-count-3:GTGACGCTCCATCCGT"	1.99179210242574	-4.29389145290526	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGACGCTCCATCCGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2189.69481903108	44.8768505236913	0.0204945685278412	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2184.82071264581	2184.82071264581
"AML-0160"	"2019-07-01-count-1:TGCGGCAGTTCGTACA"	1.31742348250691	-9.43482305919798	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCGGCAGTTCGTACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2241.12083718155	46.0616384498906	0.0205529472957014	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2238.891884199	2238.891884199
"AML-0160"	"2019-07-01-count-1:TACCGAATCATTCGTT"	1.93687715110127	-4.14287044918212	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCGAATCATTCGTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2490.03639362956	41.9783003451349	0.0168585087561495	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2477.63435161059	2477.63435161059
"AML-0160"	"2019-07-01-count-3:TTGTTCACAGTTTGGT"	1.50143696841542	-8.60412027752074	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTTCACAGTTTGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.90286730772	44.7792144155055	0.0205701481163862	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.49380722194	2171.49380722194
"AML-0160"	"2019-07-01-count-1:GCGATCGGTTGGCCTG"	1.5993433195049	-9.30669786846312	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGATCGGTTGGCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2082.7864939277	41.8529956894622	0.0200947124496357	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2075.39277955714	2075.39277955714
"AML-0160"	"2019-07-01-count-1:GAATAGACATCATCCC"	2.10918201979939	-9.34552385723265	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAATAGACATCATCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.16353331184	43.1226643646469	0.0185460780486374	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2316.65720594876	2316.65720594876
"AML-0160"	"2019-07-01-count-1:CCACCATGTATGAGAT"	1.83539511737172	-8.68793775951537	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACCATGTATGAGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.93401541494	42.3911684999007	0.0188494496545197	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2244.15240987463	2244.15240987463
"AML-0160"	"2019-07-01-count-2:TTCGATTGTTTAAGGA"	3.02439107474629	-9.25299837505492	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGATTGTTTAAGGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2134.88307329303	41.2471286248803	0.0193205563062791	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2132.20982181678	2132.20982181678
"AML-0160"	"2019-07-01-count-3:TCGCTTGTCACTTCTA"	-7.37139211121257	3.33907077396242	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.012987012987013	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCTTGTCACTTCTA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2056.3931602094	47.9880890951375	0.0233360478062721	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2046.77581693252	2046.77581693252
"AML-0160"	"2019-07-01-count-2:GTAGAGGGTAAGTTGA"	-9.72401557388957	2.56419704044191	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGAGGGTAAGTTGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2197.19078399194	47.0523642906664	0.021414783201111	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2190.5185810703	2190.5185810703
"AML-0160"	"2019-07-01-count-1:ACCAACATCGACCTAA"	2.89177860793416	-9.62793638622435	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCAACATCGACCTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2143.22030692993	46.0185911547651	0.0214717035882722	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.39757467488	2137.39757467488
"AML-0160"	"2019-07-01-count-1:TTCATGTTCGATCCCT"	1.50941612300221	-8.90103723919066	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATGTTCGATCCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.69108781033	38.3663797485507	0.0154411065169319	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2475.84893755909	2475.84893755909
"AML-0160"	"2019-07-01-count-3:GCAGCCAGTTACGCCG"	1.77439047869985	-9.11750032817992	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCCAGTTACGCCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2276.19917554617	40.0967908149461	0.0176156775934711	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2273.03687472128	2273.03687472128
"AML-0160"	"2019-07-01-count-3:TGCTGAACACGTACTA"	-2.11190114441569	-11.736351989862	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTGAACACGTACTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2468.4361038241	43.7739940064202	0.0177334928534733	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2463.88877350254	2463.88877350254
"AML-0160"	"2019-07-01-count-1:GAGGCCTAGACAGCTG"	-9.35878405991252	4.92582128131715	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCCTAGACAGCTG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2132.61577689219	34.6964552976663	0.0162694357200286	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2122.36835296897	2122.36835296897
"AML-0160"	"2019-07-01-count-3:ACCATTTGTTCTCTAT"	1.53134228762929	-8.40827276622923	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCATTTGTTCTCTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.2034419388	42.4189688371324	0.0179345962740359	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2361.62691695171	2361.62691695171
"AML-0160"	"2019-07-01-count-1:CAGCGTGCACTCCACT"	-7.88939700546916	2.03842077339021	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCGTGCACTCCACT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2518.60002272482	40.7896042646821	0.0161953481682862	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2512.86299127723	2512.86299127723
"AML-0160"	"2019-07-01-count-2:GGTAACTCAGCCCAGT"	1.76114370402638	-9.15296556865843	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTAACTCAGCCCAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.34956863355	43.1295353542452	0.0194421726693021	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2213.43189425348	2213.43189425348
"AML-0160"	"2019-07-01-count-2:TTTGATCCACGCGTGT"	3.32203974303548	-10.3054628602234	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGATCCACGCGTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1950.90416272869	35.7508446931303	0.0183252695730202	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1949.3638729415	1949.3638729415
"AML-0160"	"2019-07-01-count-3:GCTACAATCAGCTGAT"	1.94340457495992	-4.19831707393798	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTACAATCAGCTGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1655.98221376744	46.1181130943953	0.0278494012260399	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1652.42231737311	1652.42231737311
"AML-0160"	"2019-07-01-count-1:TTCGCTGCAAACTCTG"	5.43787302550618	-4.40246870433959	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGCTGCAAACTCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2036.39857319612	50.2546173207974	0.0246781833292699	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2028.99108797689	2028.99108797689
"AML-0160"	"2019-07-01-count-3:CGAGTGCCAAGAGATT"	2.08176817473714	-5.20990230953368	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGTGCCAAGAGATT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2259.72247309214	40.5301886825059	0.0179359143280305	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2257.33241879742	2257.33241879742
"AML-0160"	"2019-07-01-count-2:GACCTTCAGGGTCTTT"	2.85463561591451	-9.75540735637816	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACCTTCAGGGTCTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1833.46668310158	50.7869440932284	0.02769995471492	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1831.67956190725	1831.67956190725
"AML-0160"	"2019-07-01-count-2:CCGGTAGGTGGTGATG"	2.50737728652303	-9.29713632976683	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTAGGTGGTGATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.37420301246	38.4694801281243	0.0169292012192031	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2272.37420301246	2272.37420301246
"AML-0160"	"2019-07-01-count-1:TACCTGCTCTAAACGC"	-8.81982741776164	5.28832290256349	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCTGCTCTAAACGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1803.04459790429	51.2831044342027	0.0284425046911263	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1796.6017740675	1796.6017740675
"AML-0160"	"2019-07-01-count-2:AAGCCATCATCATTTC"	3.2124568420345	-9.01938154613646	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCCATCATCATTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2003.76944584692	47.4203859341784	0.0236655898873313	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1997.19008771529	1997.19008771529
"AML-0160"	"2019-07-01-count-2:CTGTATTGTTCGTGCG"	1.58541228350942	-8.77194597637328	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTATTGTTCGTGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.56465780343	44.3688492197102	0.0194126423281113	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2284.45240117547	2284.45240117547
"AML-0160"	"2019-07-01-count-2:CTGTATTTCTTCTTCC"	1.84706427630727	-8.81828787243041	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTATTTCTTCTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.66669923467	41.9111785528045	0.0168815163814476	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2476.65717606156	2476.65717606156
"AML-0160"	"2019-07-01-count-2:TGAATCGAGGCCACTC"	1.81237890300099	-8.91520121013793	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAATCGAGGCCACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.35955937315	41.2244544822867	0.0168513472700023	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2442.40148174298	2442.40148174298
"AML-0160"	"2019-07-01-count-2:CTCAACCCATTGGATC"	1.66010477122609	-9.03420927440795	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCCATTGGATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.75424924225	43.4484723165924	0.0171073529376141	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2534.37403686624	2534.37403686624
"AML-0160"	"2019-07-01-count-1:AGTCAACCACCATAAC"	1.49395730075185	-8.57122137462767	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTCAACCACCATAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2566.57702358135	39.3459172744813	0.015330113576556	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2563.09379486353	2563.09379486353
"AML-0160"	"2019-07-01-count-2:CAATGACTCCTGTAAG"	3.68498363074605	-8.16053869640502	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATGACTCCTGTAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.61724311502	36.6088635320154	0.0149752946540486	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2440.55594667705	2440.55594667705
"AML-0160"	"2019-07-01-count-2:TCTCACGAGTCGCCAC"	1.53415801104848	-8.17266561901244	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCACGAGTCGCCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2397.9689774664	39.2012323650347	0.0163476811974662	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2395.98331611519	2395.98331611519
"AML-0160"	"2019-07-01-count-3:AGGGCCTGTTGTTGCA"	1.61372687396352	-9.24029066478881	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGCCTGTTGTTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.93416891034	41.1077256320102	0.018197841352694	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2252.44886302542	2252.44886302542
"AML-0160"	"2019-07-01-count-2:TGTGGCGCATAATGAG"	1.80425693568532	-9.31388761913451	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTGGCGCATAATGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.39352873279	39.2011097193841	0.0171528925878776	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2281.08947955555	2281.08947955555
"AML-0160"	"2019-07-01-count-3:CACCAAAGTACAAGCG"	4.14167179641072	-7.76829435741576	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAAGTACAAGCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2022.65597144846	42.4570638680956	0.0209907490287097	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2019.6079452053	2019.6079452053
"AML-0160"	"2019-07-01-count-1:CGAAGTTAGTCGCTAT"	1.52631070193593	-8.75175573742064	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAAGTTAGTCGCTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2362.11921662448	41.0464204724958	0.0173769470158886	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.36311484004	2356.36311484004
"AML-0160"	"2019-07-01-count-1:CAGGGCTTCCTCTGCA"	1.70647050914113	-9.01010229503783	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGGGCTTCCTCTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.68662196948	44.9628679132042	0.0210039467952752	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.71680388824	2137.71680388824
"AML-0160"	"2019-07-01-count-3:CATGCAAGTGGTCTCG"	2.64439811286275	-10.2296171418396	"2019-07-01-count-3"	"AML0160"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGCAAGTGGTCTCG"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2214.16167575905	40.8178321425379	0.0184348923519981	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2209.27292169071	2209.27292169071
"AML-0160"	"2019-07-01-count-2:AGGGCCTGTTATCCAG"	-8.25708232346233	3.09775445545045	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGCCTGTTATCCAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2149.84694850265	37.2263787844473	0.0173158274408209	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2145.55930783987	2145.55930783987
"AML-0160"	"2019-07-01-count-2:ACCGTTCGTCCTCCAT"	3.72398628768269	-8.38721468364867	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCGTTCGTCCTCCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1993.06697666894	39.3043224113528	0.0197205226274148	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1988.79724713154	1988.79724713154
"AML-0160"	"2019-07-01-count-3:ACCCTCAGTCACTCGG"	2.36948575553243	-4.97396423732909	"2019-07-01-count-3"	"AML0160"	"cDC1"	"cDC1"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCTCAGTCACTCGG"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2269.29814928259	44.1352017813595	0.0194488334621488	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2267.27888066724	2267.27888066724
"AML-0160"	"2019-07-01-count-2:AGAACCTAGGTCGAGT"	2.04494752463643	-9.16375639354857	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAACCTAGGTCGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1872.86059441212	49.0630923916002	0.0261968736690734	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1866.33120768677	1866.33120768677
"AML-0160"	"2019-07-01-count-1:CAACAACGTTGTAAAG"	-8.02373538437541	1.97185335243074	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACGTTGTAAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2528.31026651602	42.7507986046254	0.0169088419134315	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2516.93484205367	2516.93484205367
"AML-0160"	"2019-07-01-count-2:CCCTCAAAGAAAGTCT"	1.97819783267323	-9.47266867077025	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTCAAAGAAAGTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.8937508247	41.9480703760289	0.0178282892550188	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2350.45709469486	2350.45709469486
"AML-0160"	"2019-07-01-count-2:TGCGACGCAATGGCAG"	7.93008150634114	6.3148793944153	"2019-07-01-count-2"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGACGCAATGGCAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1570.41271979674	40.9423909285377	0.0260711024639668	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1568.67361861011	1568.67361861011
"AML-0160"	"2019-07-01-count-3:AAGGTAATCTTACCGC"	2.11421813544576	-10.2843046418396	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGTAATCTTACCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2055.48886833033	43.9062708006846	0.0213605004031716	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2054.0284567444	2054.0284567444
"AML-0160"	"2019-07-01-count-1:GACAGCCTCTTCGATT"	1.69085111197774	-8.84035208141478	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACAGCCTCTTCGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.37941628864	42.2084027462299	0.0162503800875349	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2588.3879638817	2588.3879638817
"AML-0160"	"2019-07-01-count-3:CCGGTGAAGGATCACG"	1.64025988158528	-8.6199989548889	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGGTGAAGGATCACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.69286036231	44.9899395943523	0.0218961872415418	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2054.69286036231	2054.69286036231
"AML-0160"	"2019-07-01-count-2:TCGGTCTAGAAGTCTA"	1.67591418799703	-8.89463331615599	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGGTCTAGAAGTCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2142.41227758515	41.9812730360136	0.0195953288147384	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2134.79067007123	2134.79067007123
"AML-0160"	"2019-07-01-count-2:ACCTACCGTAGAAACT"	1.93816306170766	-8.94609262859496	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTACCGTAGAAACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.64987452837	39.9203089932503	0.0170552244603837	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.56329712391	2332.56329712391
"AML-0160"	"2019-07-01-count-3:GCATCGGGTGATGTAA"	1.87726642665212	-8.98802950298461	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGGTGATGTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2146.98078938237	42.6802706340614	0.0198792047162841	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2145.60860512326	2145.60860512326
"AML-0160"	"2019-07-01-count-3:GACCAATAGACAACTA"	1.68328620967214	-9.49026205455931	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCAATAGACAACTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.17399839037	47.692931812389	0.0207706087804417	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.10560030169	2286.10560030169
"AML-0160"	"2019-07-01-count-2:TCTCCGAGTACTCGAT"	2.76621951636617	-9.37710955059203	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCCGAGTACTCGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.91085592149	39.5717727872308	0.0158864668694021	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2487.80991610712	2487.80991610712
"AML-0160"	"2019-07-01-count-1:GACATCAGTAAGGAGA"	2.58280958709065	-9.58410742199095	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACATCAGTAAGGAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2228.41461101681	49.9497837155724	0.0224149417566333	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2225.51623558693	2225.51623558693
"AML-0160"	"2019-07-01-count-2:GGGTATTCAAACGTGG"	2.19467749175374	-9.1022052994934	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTATTCAAACGTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2330.36509125319	43.0392362620419	0.0184688813025846	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2326.57263797528	2326.57263797528
"AML-0160"	"2019-07-01-count-3:AGACACTTCGATACAC"	4.94601835784261	-4.82520630275878	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACACTTCGATACAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2299.44725330969	39.5283483563784	0.0171903696853597	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2295.77670888679	2295.77670888679
"AML-0160"	"2019-07-01-count-3:TTCATTGGTCAGATTC"	2.35359992560689	-9.34416582500609	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCATTGGTCAGATTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.42592871197	45.372974048301	0.018839264893883	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2404.87042503775	2404.87042503775
"AML-0160"	"2019-07-01-count-2:GTGAGGAGTACGGATG"	-7.79180465164836	2.01578710162965	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGGAGTACGGATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2323.99059144142	45.5346081852823	0.0195932842211036	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2311.94759072303	2311.94759072303
"AML-0160"	"2019-07-01-count-3:TCTATACAGCCTTCTC"	5.13014139708821	-5.09793379223021	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTATACAGCCTTCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2204.43467279337	45.9819699267407	0.020858848980303	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2200.08383574726	2200.08383574726
"AML-0160"	"2019-07-01-count-3:GCCATGGCAGGCATTT"	-9.25504432144817	3.31225226009218	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATGGCAGGCATTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2160.27216414335	41.5943510266634	0.0192542179254333	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2149.12189392003	2149.12189392003
"AML-0160"	"2019-07-01-count-2:CCGTTCATCCTTGACC"	1.58240415629689	-9.42637445842894	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGTTCATCCTTGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2518.2437062269	40.1498915638917	0.0159436084222557	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2515.15139394054	2515.15139394054
"AML-0160"	"2019-07-01-count-2:TGCGGCAAGCAATTAG"	1.5123049217159	-8.57968332683715	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGGCAAGCAATTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.42001486994	40.1441154906677	0.0166061814842827	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2411.06832082584	2411.06832082584
"AML-0160"	"2019-07-01-count-1:ATCGTAGTCGGTCTGG"	2.17606677588765	-9.23615839397582	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGTAGTCGGTCTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.10758574273	45.7369236024359	0.0193218609402939	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2362.67534713858	2362.67534713858
"AML-0160"	"2019-07-01-count-1:GTTACCCAGTGTTCAC"	1.51072885569875	-8.60753538524779	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACCCAGTGTTCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.73849863595	39.5825568229687	0.016759923609591	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2360.18900829827	2360.18900829827
"AML-0160"	"2019-07-01-count-1:AGGTCATGTACGATTC"	4.95185436782185	-5.20765354549559	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTCATGTACGATTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2256.72102882891	47.8446756518286	0.0212009703639164	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.45591852472	2247.45591852472
"AML-0160"	"2019-07-01-count-3:CACAACAGTCCAACGC"	8.53585590895955	6.95557115161744	"2019-07-01-count-3"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAACAGTCCAACGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2064.23370143146	45.4528729831953	0.0220192476034451	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2058.83766629305	2058.83766629305
"AML-0160"	"2019-07-01-count-2:GGGTCACAGCCACAAG"	5.10182680663411	-5.25382950222167	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTCACAGCCACAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2371.8189305064	38.4792865056809	0.0162235346091387	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2365.56863039458	2365.56863039458
"AML-0160"	"2019-07-01-count-3:AGACCATCACAAATGA"	2.25270952758138	-10.1667919388977	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACCATCACAAATGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1971.21109185033	41.2711159768109	0.0209369337192958	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1968.69989517995	1968.69989517995
"AML-0160"	"2019-07-01-count-2:TGCGGCAAGTCGAAGC"	2.00734700736348	-8.59221174633177	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGGCAAGTCGAAGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2245.63358523537	45.5118498351601	0.0202668191883093	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2240.6472807096	2240.6472807096
"AML-0160"	"2019-07-01-count-1:AGACAGGTCATTCATC"	2.13994874533955	-7.80796577846678	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACAGGTCATTCATC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2353.71507255721	46.9424408638237	0.019943977676458	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2349.46279899342	2349.46279899342
"AML-0160"	"2019-07-01-count-2:CGGCAGTGTTCGAGCC"	2.22591151770894	-8.83146955883177	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGCAGTGTTCGAGCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.77805607623	42.229405225564	0.0178350353054393	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2360.85954584384	2360.85954584384
"AML-0160"	"2019-07-01-count-2:CAACCTCTCGCTAATG"	2.3023370700771	-9.85516264354857	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACCTCTCGCTAATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2124.92680235465	49.4076338658593	0.0232514521493683	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2117.61426977904	2117.61426977904
"AML-0160"	"2019-07-01-count-1:TCAGGGCGTACGCTAT"	1.70918502387349	-8.47732450878295	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGGGCGTACGCTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.93378863962	44.4462845951593	0.01924136735596	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2306.58060704181	2306.58060704181
"AML-0160"	"2019-07-01-count-1:TACTGCCGTCGATTTG"	-8.06954799118694	5.45891902530519	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTGCCGTCGATTTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1576.09758184635	43.1388086423636	0.0273706457894745	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1568.53595855298	1568.53595855298
"AML-0160"	"2019-07-01-count-1:ACTTCCGTCGTCGCTT"	1.02275278148	-9.24586775219115	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGTCGTCGCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.3303213989	52.6856592260858	0.0224449276464369	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2341.22884786972	2341.22884786972
"AML-0160"	"2019-07-01-count-3:ACGTTCCTCGACGATT"	1.64981832084004	-7.84678127681883	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTTCCTCGACGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1957.38035717918	49.1920199098019	0.0251315589887157	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1950.88710326765	1950.88710326765
"AML-0160"	"2019-07-01-count-3:CTCCACACAGGACTTT"	1.50170161303822	-8.62206461345824	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCACACAGGACTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.64938512635	43.9501988240709	0.0196412356270861	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.55058898522	2233.55058898522
"AML-0160"	"2019-07-01-count-3:TCTCTGGCAGCAAGAC"	2.15319146689717	-9.51546385204466	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCTGGCAGCAAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2515.84721543612	40.1964270073202	0.0159772925639891	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2510.71673633656	2510.71673633656
"AML-0160"	"2019-07-01-count-3:GTCATCCGTATGGGAC"	2.0836042362148	-8.87773992931517	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCATCCGTATGGGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2013.42890668865	37.9017163914392	0.0188244622223953	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2010.90410928838	2010.90410928838
"AML-0160"	"2019-07-01-count-1:CTCATTAGTACAGAGC"	1.75009193000142	-9.0408621064392	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCATTAGTACAGAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.61814784661	38.9132970592676	0.0167685050189652	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.05633749596	2313.05633749596
"AML-0160"	"2019-07-01-count-1:CATAAGCGTGATTAGA"	1.97120513495747	-9.50152399456175	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATAAGCGTGATTAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.36564233841	41.3309729811169	0.0174660129616631	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2359.47968154475	2359.47968154475
"AML-0160"	"2019-07-01-count-1:GAGAGGTCAGCACACC"	2.07455601271932	-9.02470018779906	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGAGGTCAGCACACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.090735823	39.5773155133936	0.0159967114141544	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2465.90202166496	2465.90202166496
"AML-0160"	"2019-07-01-count-3:CACGTTCGTTAGCGGA"	-7.97882495346721	3.59856865489808	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACGTTCGTTAGCGGA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2059.46061786576	39.6511737536843	0.0192531837752621	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2048.87507047512	2048.87507047512
"AML-0160"	"2019-07-01-count-2:TATCTGTCAACCAGAG"	1.71564616736714	-9.01329233562621	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCTGTCAACCAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1981.0088203825	42.0409054861887	0.021221967844682	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1977.21845215708	1977.21845215708
"AML-0160"	"2019-07-01-count-2:ATCCGTCCACCGAATT"	1.90955915030782	-8.61125376140746	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCGTCCACCGAATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2378.05278086344	40.9410910220913	0.0172162246992794	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2373.7102396192	2373.7102396192
"AML-0160"	"2019-07-01-count-2:CATTCTATCGTGGAAG"	2.00202085551564	-9.16996481334838	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCTATCGTGGAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.91325611963	43.4229378123035	0.0201787584554429	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2149.62052023378	2149.62052023378
"AML-0160"	"2019-07-01-count-1:AGACCCGAGAGTGACC"	1.98175777968709	-9.19415857708129	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCCGAGAGTGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2371.83848897152	43.2626569367625	0.0182401361382419	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2369.39439632865	2369.39439632865
"AML-0160"	"2019-07-01-count-1:ATCTCTAGTAGGAGGG"	2.2223605113918	-4.41272594844969	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTCTAGTAGGAGGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2196.74947028865	42.4671243714607	0.019331801348235	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2195.71030633807	2195.71030633807
"AML-0160"	"2019-07-01-count-1:CGAGTTAGTCGCAACC"	2.32643069800679	-9.03349497234496	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGTTAGTCGCAACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.93147509105	39.9315191766154	0.016473864705732	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2418.81994385218	2418.81994385218
"AML-0160"	"2019-07-01-count-1:CGAGTTACAGCCGTTG"	1.46935619887654	-8.25882723247679	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGTTACAGCCGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2306.46633241422	51.5515027404297	0.0223508585475296	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2297.69149456818	2297.69149456818
"AML-0160"	"2019-07-01-count-3:GATGATCCACGAGAAC"	2.11102451857869	-9.28572084819945	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGATCCACGAGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.53105657741	44.8514224748935	0.0184990092633452	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2422.48151080674	2422.48151080674
"AML-0160"	"2019-07-01-count-1:GTCATCCTCAGTCATG"	2.09445871886556	-8.8797645798889	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATCCTCAGTCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.44184281903	33.9805729738943	0.0148228724232795	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2285.99839907143	2285.99839907143
"AML-0160"	"2019-07-01-count-3:GTGGAAGTCTCTCGCA"	2.13196219977681	-9.66409590160521	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGAAGTCTCTCGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2239.80429919879	41.8202412961742	0.0186713818306063	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2235.12580798346	2235.12580798346
"AML-0160"	"2019-07-01-count-1:GATGTTGGTCTTTATC"	1.79157008704488	-9.25447847759398	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGTTGGTCTTTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.53778030498	42.7198369827624	0.0180668870417678	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.37984438194	2356.37984438194
"AML-0160"	"2019-07-01-count-1:TCGCTCACATGTGGTT"	1.93685497817342	-9.39495375072631	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGCTCACATGTGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.63943768476	47.2990108070339	0.0206578424657385	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.37580660284	2288.37580660284
"AML-0160"	"2019-07-01-count-2:GGTGTCGCACCTGTCT"	2.32774462279622	-4.5592398873535	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGTCGCACCTGTCT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1973.70056544264	37.6571388999462	0.0190794589408758	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1972.38565980875	1972.38565980875
"AML-0160"	"2019-07-01-count-2:ACAACCACATCAGCGC"	2.63974990424458	-9.59939100658568	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAACCACATCAGCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.47899459282	45.9021209570952	0.022342463017585	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2050.38010891641	2050.38010891641
"AML-0160"	"2019-07-01-count-3:AGGGTTTCAGAACTTC"	1.53525139865224	-8.50810911571654	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTTTCAGAACTTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2428.49100991531	38.6007810719141	0.0158949656038712	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2426.63550099473	2426.63550099473
"AML-0160"	"2019-07-01-count-3:ACGTCCTAGAATCCCT"	2.13681187209432	-9.09594252025756	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTAGAATCCCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.96903699177	38.6880524214654	0.0162352308489516	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2380.7496190614	2380.7496190614
"AML-0160"	"2019-07-01-count-3:TTCCTAAGTCCATAGT"	1.55000116404836	-8.79918863689574	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTAAGTCCATAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.69866217399	42.4958142799942	0.018847669088968	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2240.08996706291	2240.08996706291
"AML-0160"	"2019-07-01-count-2:CCTCAACAGCTTGTGT"	-8.35889945450481	-0.466031335946642	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCAACAGCTTGTGT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2850.66364191903	40.2926750679801	0.0141344894134391	3115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2840.18711420255	2840.18711420255
"AML-0160"	"2019-07-01-count-1:TACTTGTAGAGCATAT"	1.61912228640859	-8.86443045055541	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTTGTAGAGCATAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.48129330224	38.3463539885043	0.015171765698176	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2519.33442014129	2519.33442014129
"AML-0160"	"2019-07-01-count-1:TGATCAGAGAGTTGCG"	-8.51548800888713	3.73691008174745	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATCAGAGAGTTGCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2165.86156389469	38.4829638882285	0.017767970275546	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2157.87854010584	2157.87854010584
"AML-0160"	"2019-07-01-count-2:ACGGAAGAGTTAGTAG"	1.55171110209767	-8.62653162395629	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGAAGAGTTAGTAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2168.53543747888	47.7176781994815	0.0220045646360097	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2165.97237396321	2165.97237396321
"AML-0160"	"2019-07-01-count-3:CTGTGAACAAGTCCAT"	2.01173665103261	-9.01284506237181	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTGAACAAGTCCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.64698995698	39.4647453544126	0.0178602037039323	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2207.31344330875	2207.31344330875
"AML-0160"	"2019-07-01-count-1:CCACAAAGTTCAAACC"	2.07379235801045	-8.99312784588011	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACAAAGTTCAAACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.83404863148	40.8541856798366	0.0164812104716697	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2475.97294320567	2475.97294320567
"AML-0160"	"2019-07-01-count-3:AATCGACGTCCATACA"	-8.32214961472209	2.94737289035646	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCGACGTCCATACA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2095.11554648102	41.5405799149421	0.0198273455536685	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2087.91816748332	2087.91816748332
"AML-0160"	"2019-07-01-count-1:TACTTGTTCGATAACC"	1.7349405485088	-7.88924553310546	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTTGTTCGATAACC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2275.89120934847	40.2883666143707	0.0177022374570813	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2270.97762410393	2270.97762410393
"AML-0160"	"2019-07-01-count-3:CGGAACCTCCCAGTGG"	1.89070977744405	-9.03771593486937	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAACCTCCCAGTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.62569092039	37.7751912278524	0.0174269899946668	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2163.31901502658	2163.31901502658
"AML-0160"	"2019-07-01-count-1:CGATGCGCACAGAAGC"	2.4871834712917	-9.9853668442932	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGATGCGCACAGAAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2464.35332909269	45.4742940356916	0.0184528304033553	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2458.80615269063	2458.80615269063
"AML-0160"	"2019-07-01-count-1:TATCCTAGTGCCGGTT"	1.71038701114003	-8.7406215897766	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCCTAGTGCCGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2222.29447843695	40.5864648900761	0.0182633153634178	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2221.3151043356	2221.3151043356
"AML-0160"	"2019-07-01-count-1:GATTCGATCTCCTGCA"	1.92494597014729	-9.22889521038207	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTCGATCTCCTGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.87122014981	44.871563035182	0.0186431092197733	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2398.15473865078	2398.15473865078
"AML-0160"	"2019-07-01-count-2:TTGAGTGAGCTACAAA"	1.84002329882924	-9.4349632493225	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAGTGAGCTACAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2353.81260475043	42.9473127245178	0.0182458504291472	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2344.69857275684	2344.69857275684
"AML-0160"	"2019-07-01-count-1:TCGGATACAATCGCCG"	1.59562434729878	-8.1751804581848	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGATACAATCGCCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2360.2809000226	44.7949961917337	0.0189786716451016	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2357.00982397279	2357.00982397279
"AML-0160"	"2019-07-01-count-3:CCTATCGAGCTGACAG"	2.88316525992696	-9.9186058274475	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTATCGAGCTGACAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2058.42122912549	48.7568135005916	0.0236865092580228	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2058.42122912549	2058.42122912549
"AML-0160"	"2019-07-01-count-1:ACGCACGGTACAGCGA"	2.27471627768819	-9.51656343853148	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGCACGGTACAGCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.32965530402	42.0161710533309	0.0176736831425921	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2369.75768001746	2369.75768001746
"AML-0160"	"2019-07-01-count-3:TCTACATTCTGAGCAT"	-8.26742873612102	1.31185648525087	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTACATTCTGAGCAT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2608.10000413774	42.1499392955997	0.0161611668374407	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2597.35918400197	2597.35918400197
"AML-0160"	"2019-07-01-count-2:TGTTTGTCACACGGAA"	-8.10922561112102	2.21977470004884	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTTGTCACACGGAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2458.39017707264	39.5866571418266	0.0161026746327814	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2453.79941883523	2453.79941883523
"AML-0160"	"2019-07-01-count-2:GAGAGGTCAAGACTGG"	1.56966902789418	-8.78223230755004	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGAGGTCAAGACTGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2430.52368689854	36.6837317756565	0.0150929332527784	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2426.0282474173	2426.0282474173
"AML-0160"	"2019-07-01-count-3:TACATTCGTAGGTAGC"	1.74925448474233	-9.23709585582884	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACATTCGTAGGTAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1561.18460453689	48.3408571070356	0.0309642158695098	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1556.98282588622	1556.98282588622
"AML-0160"	"2019-07-01-count-2:GTCAGCGTCACGGGCT"	2.52204551276509	-8.58570101177367	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCAGCGTCACGGGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2107.13586672696	43.8723115584147	0.0208208271005144	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2104.63235427962	2104.63235427962
"AML-0160"	"2019-07-01-count-1:TAGACTGCACTACGGC"	2.44677152213399	-5.12004854595336	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGACTGCACTACGGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2016.53330557543	33.3070374715728	0.0165169786085276	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2016.53330557543	2016.53330557543
"AML-0160"	"2019-07-01-count-3:AAAGTCCCAAGCCTGC"	2.2447461086208	-9.95670511638793	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGTCCCAAGCCTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.70514521914	41.7882904480692	0.0193311703682109	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2156.31981789023	2156.31981789023
"AML-0160"	"2019-07-01-count-1:GGGTTTACAACCCTAA"	-8.83353076401408	4.83844420993654	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTTTACAACCCTAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2018.40785887949	36.9942860202134	0.0183284492564107	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2011.663940544	2011.663940544
"AML-0160"	"2019-07-01-count-1:GGGTTTAAGCATGATA"	3.14126910743062	-8.29255297100218	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTTTAAGCATGATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2644.81288724319	40.4704343596536	0.0153018138087787	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2639.15565604447	2639.15565604447
"AML-0160"	"2019-07-01-count-3:AATCGTGTCAACGCTA"	-8.1292441886967	4.12838265979616	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCGTGTCAACGCTA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2248.96733138752	37.484714948955	0.0166675231008485	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2238.60484113756	2238.60484113756
"AML-0160"	"2019-07-01-count-2:GTTAGACCAGTTGTCA"	5.36901678618733	-4.83213570034178	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTAGACCAGTTGTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.67244482009	41.3180257189136	0.0167913554710995	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2453.24559114834	2453.24559114834
"AML-0160"	"2019-07-01-count-2:CTCCACAGTCGCGTCA"	1.91159512576405	-8.40756323253783	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCACAGTCGCGTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.68269980827	40.160915606589	0.0171358160427921	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2339.58191035118	2339.58191035118
"AML-0160"	"2019-07-01-count-2:CCTCATGGTGCATCTA"	1.98958339270894	-9.25494100963744	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCATGGTGCATCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2126.30510615358	43.7143556942985	0.0205588349328551	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2125.11111273531	2125.11111273531
"AML-0160"	"2019-07-01-count-2:ATCGGATGTGTGCTTA"	1.67902221259419	-8.78973772442015	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATGTGTGCTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2251.39911511296	43.1502579837503	0.019165974479645	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2247.03868275036	2247.03868275036
"AML-0160"	"2019-07-01-count-3:TCATGGAAGTACAGCG"	1.62489106234853	-9.29407026683959	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGGAAGTACAGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2048.52492272811	40.9873106854781	0.020008206993593	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2044.52842318271	2044.52842318271
"AML-0160"	"2019-07-01-count-1:CTAACCCCAGAGGCTA"	2.09758581694905	-4.24608137523802	"2019-07-01-count-1"	"AML0160"	"cDC1"	"cDC1"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAACCCCAGAGGCTA"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2543.98464101632	47.2980008607051	0.0185920937171262	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2538.25134264264	2538.25134264264
"AML-0160"	"2019-07-01-count-2:TTCGCTGCATCGTTCC"	1.79400469836537	-9.14798452770384	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGCTGCATCGTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2220.68172043895	41.747113455781	0.0187992331686006	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2218.57982326873	2218.57982326873
"AML-0160"	"2019-07-01-count-3:ATCGGCGCAGGGATAC"	2.61375035819356	-9.17376615917357	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGGCGCAGGGATAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2178.41031475737	40.9206903053546	0.018784656879442	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2173.2853631597	2173.2853631597
"AML-0160"	"2019-07-01-count-2:ATCGGATTCTATGCCC"	2.09732331809346	-8.59683992778929	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATTCTATGCCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2429.85971890895	44.2700271505802	0.0182191699405833	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2424.55822003765	2424.55822003765
"AML-0160"	"2019-07-01-count-2:TCCTTCTTCTATTGTC"	2.0785936313564	-9.24770357525023	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTCTTCTATTGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2044.916249048	48.385507611306	0.0236613639477077	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2040.22836108322	2040.22836108322
"AML-0160"	"2019-07-01-count-2:ATGCATGAGGAGTACC"	-7.66727147522624	4.16349408710328	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGCATGAGGAGTACC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1680.83880776931	46.5606160186341	0.0277008216394206	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1674.70908291286	1674.70908291286
"AML-0160"	"2019-07-01-count-2:CTCTGGTGTGGATGAC"	3.18486036834065	-8.66603281414183	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCTGGTGTGGATGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2113.71232290203	38.1532073439169	0.0180503311309338	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2109.11230307305	2109.11230307305
"AML-0160"	"2019-07-01-count-3:AGCTACACAGGGAGAG"	2.32175602492635	-9.23944094097289	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTACACAGGGAGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.55542215325	38.7183767023616	0.0165353236297764	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2336.80755299385	2336.80755299385
"AML-0160"	"2019-07-01-count-3:GAAACCTTCGCATGAT"	1.61457552489583	-8.72907068645629	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAACCTTCGCATGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2284.1623547812	44.2878237542804	0.0193890874970325	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2278.91744886562	2278.91744886562
"AML-0160"	"2019-07-01-count-1:GTCCTCATCGTCTACC"	1.82345583018605	-9.34059431469115	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCTCATCGTCTACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.52623483993	41.3682783199752	0.0166503688871856	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2472.25246427568	2472.25246427568
"AML-0160"	"2019-07-01-count-1:CTCAATTTCTCGGCTT"	2.37642254409139	-8.17510511791381	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAATTTCTCGGCTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2578.9483586724	37.8670698243803	0.0146831438857789	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2576.03676925276	2576.03676925276
"AML-0160"	"2019-07-01-count-2:CAGCAGCAGCCTATCA"	-8.08496985855754	-0.896289133187853	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAGCAGCCTATCA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2282.60400827953	44.9263967818062	0.0196820809123474	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2267.76356297696	2267.76356297696
"AML-0160"	"2019-07-01-count-3:GACTCTCAGTCTGGTT"	2.05344285544698	-9.42149736797484	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCTCAGTCTGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2030.58117292767	43.4944583044324	0.0214197092361113	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2027.70269583732	2027.70269583732
"AML-0160"	"2019-07-01-count-3:TCAAGCATCAGACCCG"	2.78307785567586	-9.04294588482054	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAAGCATCAGACCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1884.40491331072	46.9653171805129	0.0249231557659226	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1882.56449741063	1882.56449741063
"AML-0160"	"2019-07-01-count-3:TCGGGACCATTGAGGG"	1.64757420596425	-8.08533289348754	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGACCATTGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.91545672676	41.8030534898149	0.019229383258886	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.76541729463	2171.76541729463
"AML-0160"	"2019-07-01-count-3:TGCATCCGTCCTCCAT"	-8.08048377457317	2.41245052898256	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCATCCGTCCTCCAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1842.844091477	41.4596485375225	0.0224976430340851	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1839.96530014047	1839.96530014047
"AML-0160"	"2019-07-01-count-1:AACAAGATCAGCCCAG"	1.72343267974202	-8.76589682018431	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAAGATCAGCCCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2085.55656778913	45.2967761813639	0.0217192747878244	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2083.26053123789	2083.26053123789
"AML-0160"	"2019-07-01-count-1:GTAGTACGTTGGCCTG"	5.24154867705647	-5.03380062496337	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGTACGTTGGCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.78257785352	38.5929315079252	0.0161762148261838	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2383.17587580401	2383.17587580401
"AML-0160"	"2019-07-01-count-3:TTCTAACGTAAGTTGA"	5.2347580390865	-4.93628218090209	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTAACGTAAGTTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.36975605506	41.3909283855788	0.0174618024381414	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2366.64046141792	2366.64046141792
"AML-0160"	"2019-07-01-count-3:CATTTCACATTGCAAC"	1.83763947066609	-8.94466307079466	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTTCACATTGCAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2087.78369966268	43.0857978779001	0.0206370985101864	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2085.01429063629	2085.01429063629
"AML-0160"	"2019-07-01-count-1:GCAACATTCGAAACAA"	1.65938880023305	-9.01569940960082	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACATTCGAAACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.65485538627	44.1542251979082	0.0185470922414514	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.95119425721	2374.95119425721
"AML-0160"	"2019-07-01-count-2:CGTCAAAAGGCTAGCA"	2.26201715049092	-10.6075115433899	"2019-07-01-count-2"	"AML0160"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCAAAAGGCTAGCA"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.77760455149	41.7308687200813	0.0183773473176929	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2262.37865534805	2262.37865534805
"AML-0160"	"2019-07-01-count-3:GTCAAACGTCAAAGAT"	1.38254596766774	-9.32840826427611	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCAAACGTCAAAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2120.18308715648	45.5757359169842	0.0214961321939931	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2117.22874805452	2117.22874805452
"AML-0160"	"2019-07-01-count-2:TTGCTGCGTCACCTTC"	-7.8472150367802	2.49945685947267	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGCTGCGTCACCTTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2169.34594189181	32.7832325722115	0.0151120353555147	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2159.23365485734	2159.23365485734
"AML-0160"	"2019-07-01-count-1:CTCACTGTCTGGTCAA"	1.6376574235851	-8.71475317394408	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCACTGTCTGGTCAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2654.29929138656	41.1485425129469	0.0155026008734123	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2649.93271710867	2649.93271710867
"AML-0160"	"2019-07-01-count-1:GCAACCGAGAGGTTAT"	1.67559458789174	-8.90937902843627	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACCGAGAGGTTAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2653.70063215022	38.3993988501187	0.0144701321561674	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2646.45705518499	2646.45705518499
"AML-0160"	"2019-07-01-count-3:CTTCCGAGTACGTACT"	-5.61625752869304	3.98692677104799	"2019-07-01-count-3"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCCGAGTACGTACT"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2675.09850112222	43.6659507022784	0.0163231188249555	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2658.60742478327	2658.60742478327
"AML-0160"	"2019-07-01-count-2:AAAGGGCTCAGAGTTC"	11.1678492027218	-0.753238820191942	"2019-07-01-count-2"	"AML0160"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0689655172413793	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGGCTCAGAGTTC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1486.02822126547	13.1966246257397	0.00888046703076854	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1486.02822126547	1486.02822126547
"AML-0160"	"2019-07-01-count-3:CGGGACTAGCCTCTTC"	1.79935481128041	-8.97449495708617	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGGACTAGCCTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2287.81309042946	41.4578752013995	0.0181211810417682	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.56602336104	2286.56602336104
"AML-0160"	"2019-07-01-count-2:AAAGGGCTCTGAGTCA"	1.77529158171956	-8.93661310588988	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGGCTCTGAGTCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.56428520537	37.8229767703518	0.0162639996713794	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.19232996874	2321.19232996874
"AML-0160"	"2019-07-01-count-2:CCAATTTTCTTCCTAA"	1.76904012736623	-9.18465139782103	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCAATTTTCTTCCTAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2506.97448553987	41.2880088394088	0.0164692576959025	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2502.44089997698	2502.44089997698
"AML-0160"	"2019-07-01-count-2:GTAGGAGCAAGGTTGG"	1.40981044349019	-8.42287161266478	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGAGCAAGGTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.46338348306	43.7417098003984	0.0190557209995771	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2290.09245004586	2290.09245004586
"AML-0160"	"2019-07-01-count-3:GTGTTAGGTTGCGAAG"	-8.71941028061565	3.89749572360841	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTTAGGTTGCGAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1839.1704799108	37.3820505159918	0.0203254950665611	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1833.33253526808	1833.33253526808
"AML-0160"	"2019-07-01-count-1:CAATTTCTCCGGGACT"	1.81993569907491	-8.4911737672058	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCTCCGGGACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.28121059537	42.1781294666142	0.0167354854249182	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2513.77752467458	2513.77752467458
"AML-0160"	"2019-07-01-count-2:TGGATCACAGGTGACA"	1.52724279937093	-8.52557661449584	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGATCACAGGTGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.94583597505	41.8473874718432	0.0178762732690109	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2334.38609644446	2334.38609644446
"AML-0160"	"2019-07-01-count-2:CTTTCAACACTCGATA"	2.3722993331844	-8.82273485576781	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTTCAACACTCGATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2085.38163411235	37.048058427936	0.0177656011839318	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.89381544105	2074.89381544105
"AML-0160"	"2019-07-01-count-3:ACCCTTGCAGAGAAAG"	3.10126628455464	-9.39200975811156	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCTTGCAGAGAAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1659.07386855593	50.7787300180028	0.0306066721804261	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1659.07386855593	1659.07386855593
"AML-0160"	"2019-07-01-count-2:CTTTCAATCAGTCTTT"	-7.99046550217326	2.86112282359926	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTTCAATCAGTCTTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2472.48626057168	38.1445883357729	0.0154276239848359	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2464.29467478483	2464.29467478483
"AML-0160"	"2019-07-01-count-3:AGGGTCCGTTTCGACA"	-3.6877420944279	-9.48964884197386	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTCCGTTTCGACA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2127.45439582093	48.4541494059163	0.0227756465666655	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2116.23630559588	2116.23630559588
"AML-0160"	"2019-07-01-count-3:CGGGCATCAGAGAGGG"	1.76600744304005	-8.69672968303832	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGGCATCAGAGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2011.52756126626	46.2591672974789	0.0229970337907568	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2006.47343326031	2006.47343326031
"AML-0160"	"2019-07-01-count-3:TACCTCGAGATAGGGA"	3.38133539733235	-9.26583959972533	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+ IFN+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCTCGAGATAGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.58161258187	42.3274884281486	0.019636226334966	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2152.93461850519	2152.93461850519
"AML-0160"	"2019-07-01-count-2:TTGGATGGTTTGTTCT"	3.38145412978474	-8.01351454174193	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGATGGTTTGTTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.52670627103	38.6997182934395	0.0163598737612415	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.67061984853	2358.67061984853
"AML-0160"	"2019-07-01-count-3:AATGGCTCATGGGCAA"	2.22921003875081	-9.01232530986937	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGGCTCATGGGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2072.77129757048	42.9678644217736	0.0207296697287042	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2071.2411078378	2071.2411078378
"AML-0160"	"2019-07-01-count-1:CCGCAAGTCTAGCCAA"	1.716396232217	-8.22068788921507	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGCAAGTCTAGCCAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2330.34096223408	40.4711001399902	0.0173670294587238	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2325.72013555436	2325.72013555436
"AML-0160"	"2019-07-01-count-3:CTCATTAGTTCTTAGG"	1.81277741965596	-4.68217089092406	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATTAGTTCTTAGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2196.61556826468	45.6917307113636	0.0208009682583922	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2192.79077465271	2192.79077465271
"AML-0160"	"2019-07-01-count-3:TAAGCCAGTCGATGCC"	1.96058573302571	-9.08721449291381	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAAGCCAGTCGATGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.02339855512	34.6395414641494	0.0160292301727551	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2159.65947956804	2159.65947956804
"AML-0160"	"2019-07-01-count-2:CTGATCCGTACGGTTT"	-9.23050342026408	2.23968837344972	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGATCCGTACGGTTT"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2334.41610216853	43.5631218549713	0.0186612497294307	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2329.13061890207	2329.13061890207
"AML-0160"	"2019-07-01-count-2:ATTCCTAAGGTTCTAC"	1.71187784251515	-8.97721769725951	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCTAAGGTTCTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2050.95782704459	45.1436729749582	0.0220110196219928	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2050.95782704459	2050.95782704459
"AML-0160"	"2019-07-01-count-3:AGTCACATCATCGACA"	1.83308412608449	-9.18005564129027	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTCACATCATCGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2177.33326501606	43.2710671533863	0.0198734239946806	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2165.520733856	2165.520733856
"AML-0160"	"2019-07-01-count-1:TGCAGTACACCGTGAC"	1.99773659285848	-10.2155781022278	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGTACACCGTGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.75565587921	40.9122127285693	0.0178130453815767	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2291.70644125778	2291.70644125778
"AML-0160"	"2019-07-01-count-3:AGTCATGCAACAGCCC"	2.17076434668843	-9.2453241578308	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTCATGCAACAGCCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2144.08538817538	42.9752550440913	0.020043630389489	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2141.45251066749	2141.45251066749
"AML-0160"	"2019-07-01-count-3:AACAGGGAGTAACCGG"	1.59473576125447	-8.68162252819213	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAGGGAGTAACCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.08678329304	45.0030848085454	0.0192231595725994	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2338.99982242468	2338.99982242468
"AML-0160"	"2019-07-01-count-3:CAGCACGTCTCGACCT"	2.08851637420003	-8.10002138530882	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCACGTCTCGACCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2280.77363323021	40.832810965483	0.0179030528810754	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2278.41746979669	2278.41746979669
"AML-0160"	"2019-07-01-count-1:TCGATTTAGGTGAGAA"	1.49565615233724	-8.30509760296019	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGATTTAGGTGAGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.21079417674	39.7397591831643	0.0158945634806963	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2492.3292772177	2492.3292772177
"AML-0160"	"2019-07-01-count-3:AGTCATGAGCGGTAGT"	2.11623205718343	-9.50839426433715	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTCATGAGCGGTAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2121.83480449215	41.0661937903495	0.019354095664473	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2118.92909378405	2118.92909378405
"AML-0160"	"2019-07-01-count-1:AGATGCTTCGTGCAGC"	11.0489050346309	-0.767888926621996	"2019-07-01-count-1"	"AML0160"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0689655172413793	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATGCTTCGTGCAGC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1526.04710735011	50.0836785746333	0.0328192218532497	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1522.20486189759	1522.20486189759
"AML-0160"	"2019-07-01-count-2:GGAGGTAGTGGGAGAG"	2.29823936995808	-8.22975065624388	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGTAGTGGGAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.46928641663	40.3121205166701	0.0188157285484796	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2141.26420384763	2141.26420384763
"AML-0160"	"2019-07-01-count-3:CAGCAGCCATTCTCCG"	1.77640547332112	-8.72553064739379	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCAGCCATTCTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1914.5196759025	37.5613030958338	0.0196191784125319	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1910.60587166853	1910.60587166853
"AML-0160"	"2019-07-01-count-1:AAAGAACGTGACTCTA"	3.35321106490437	-9.86041452800902	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGAACGTGACTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1941.0862038544	52.481540313551	0.0270372022681624	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1930.96814436689	1930.96814436689
"AML-0160"	"2019-07-01-count-1:TACACCCAGCCATTTG"	1.85127546366994	-8.9491873017517	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACACCCAGCCATTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.55471860221	43.202945835467	0.0169785878525731	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2540.46207678463	2540.46207678463
"AML-0160"	"2019-07-01-count-3:CAACGATAGTCTTCGA"	2.65814485129659	-5.39888336574706	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGATAGTCTTCGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2243.17031187395	42.8861215482757	0.0191185311794041	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2240.80025600146	2240.80025600146
"AML-0160"	"2019-07-01-count-3:AGTCATGGTATGGAGC"	2.11698379096333	-8.78735830700072	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTCATGGTATGGAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.92061880685	41.5072671869907	0.018630496453334	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2223.16703539117	2223.16703539117
"AML-0160"	"2019-07-01-count-1:CCGGTAGTCGAGGCAA"	1.66762616214101	-8.77938272869261	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTAGTCGAGGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.91798330558	38.8870031002134	0.0175015474884274	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2218.90432568257	2218.90432568257
"AML-0160"	"2019-07-01-count-2:TAAGCACAGCTAGAGC"	2.07852115210835	-9.15213968670043	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCACAGCTAGAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.21699646758	41.1473915729865	0.0178884825371589	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2296.55360448415	2296.55360448415
"AML-0160"	"2019-07-01-count-3:ACATGCATCGTAACCA"	3.9373640018398	-7.98715784465941	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACATGCATCGTAACCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.65741626474	40.4945542182058	0.0186812518963375	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2164.20229507169	2164.20229507169
"AML-0160"	"2019-07-01-count-3:GTAGAGGTCTTCGACC"	-8.57662330094035	3.66969535434572	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGAGGTCTTCGACC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2153.98888815167	40.1529708739872	0.0186412154189163	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2139.03895551551	2139.03895551551
"AML-0160"	"2019-07-01-count-1:CTCTCGAGTGAATAAC"	2.39463533934895	-8.26862432872923	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCTCGAGTGAATAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.84379406658	43.2584810238417	0.0177372905673928	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2432.65371001222	2432.65371001222
"AML-0160"	"2019-07-01-count-1:TCCGTGTGTAGGCTCC"	-8.58096156540569	-0.750161849614702	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGTGTGTAGGCTCC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2784.3567866076	36.7847375574971	0.0132112155074475	2724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2769.70622502497	2769.70622502497
"AML-0160"	"2019-07-01-count-1:CACAGATGTTTACCTT"	1.52479817447011	-8.55113699352416	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACAGATGTTTACCTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2706.49013556348	37.4491375023333	0.0138367906870411	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2701.37316647735	2701.37316647735
"AML-0160"	"2019-07-01-count-3:TCTCTGGCACTATCCC"	3.36006083068196	-10.0373516312805	"2019-07-01-count-3"	"AML0160"	"CD11c+"	"CD11c+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCTGGCACTATCCC"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.93951598129	41.8743418739996	0.0194679309031597	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2139.56995138881	2139.56995138881
"AML-0160"	"2019-07-01-count-3:AACCAACGTTCCATTT"	1.41118218478505	-8.42608072673949	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCAACGTTCCATTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.74002347523	43.0039604305976	0.0183562665936809	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2339.21951613837	2339.21951613837
"AML-0160"	"2019-07-01-count-1:AGACCATTCTCTCCGA"	1.42064811763112	-8.40887644207152	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATTCTCTCCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.35239499221	45.1850260489807	0.0180425990125568	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2502.37138726059	2502.37138726059
"AML-0160"	"2019-07-01-count-1:TATACCTAGTAACGTA"	1.73740698870961	-9.07869150554808	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATACCTAGTAACGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2512.55357860795	39.1764875698969	0.0155922993656526	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2508.35349707535	2508.35349707535
"AML-0160"	"2019-07-01-count-2:CTCTCAGTCGTTAGTG"	3.03775276717488	-10.7213983765808	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCTCAGTCGTTAGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1915.71698019248	42.9964421181311	0.0224440470918679	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1906.84764056682	1906.84764056682
"AML-0160"	"2019-07-01-count-1:GCAGTTATCCGCGATG"	2.72501697120015	-5.57746174251708	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAGTTATCCGCGATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2565.88430076058	35.8674430820348	0.0139785893975823	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2559.35043257217	2559.35043257217
"AML-0160"	"2019-07-01-count-3:GTCATGAGTCGTCAGC"	1.69268204745595	-8.97073748027953	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCATGAGTCGTCAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1852.94300289302	46.9968904394424	0.0253633761891572	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1845.27335417579	1845.27335417579
"AML-0160"	"2019-07-01-count-2:AACGTCATCCTAGCCT"	1.46368732032124	-8.36930277263793	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACGTCATCCTAGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.70036702836	40.1345138728637	0.0170952453884329	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2345.45119389706	2345.45119389706
"AML-0160"	"2019-07-01-count-3:GGGTGTCCACACAGCC"	-8.14729056778606	1.11777434432832	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTGTCCACACAGCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2703.05256601166	43.0849948983505	0.0159393847682075	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2692.11196256462	2692.11196256462
"AML-0160"	"2019-07-01-count-2:ACAAAGAAGTCCGTCG"	2.13490881499593	-9.10912325298461	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAAAGAAGTCCGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1957.63889358839	47.0789094559816	0.0240488220836709	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1950.46150039502	1950.46150039502
"AML-0160"	"2019-07-01-count-1:GTCATCCTCGACATCA"	1.44984724101369	-8.66150667583617	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATCCTCGACATCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.90453598544	47.9081993510499	0.0195312123436565	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2449.5673742945	2449.5673742945
"AML-0160"	"2019-07-01-count-1:GTTTGGATCCCAAGTA"	2.07174934920613	-9.27801802074584	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTTGGATCCCAAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2234.29179863995	41.4048326770879	0.0185315242629865	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2228.17847955437	2228.17847955437
"AML-0160"	"2019-07-01-count-1:TCTACCGCAGCGTTTA"	2.08979811248128	-9.48887827312621	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTACCGCAGCGTTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.89656904805	47.5166625095948	0.0212327339729589	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.92441211786	2233.92441211786
"AML-0160"	"2019-07-01-count-3:ACTATCTGTACACGCC"	2.36664928969685	-4.12898638164672	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATCTGTACACGCC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2571.24997357018	45.1968940644706	0.0175777907745448	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2567.29889138124	2567.29889138124
"AML-0160"	"2019-07-01-count-2:AACAAAGTCGTTCTAT"	1.52115931090657	-8.50091555034789	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAAGTCGTTCTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.08740361088	45.7226174228981	0.0208200353718707	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2191.41057720598	2191.41057720598
"AML-0160"	"2019-07-01-count-3:CCACGAGTCTCCCTAG"	2.364603181451	-8.44005396282347	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACGAGTCTCCCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1576.38895713478	45.8386538913913	0.0290782637647418	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1576.38895713478	1576.38895713478
"AML-0160"	"2019-07-01-count-3:AATGGCTGTTATGTCG"	2.27183308181111	-9.9635629883972	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGGCTGTTATGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1767.8379691934	44.4735217589639	0.0251570124264588	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1760.08815636746	1760.08815636746
"AML-0160"	"2019-07-01-count-3:CCGAACGTCCTTCTAA"	-0.675241510302383	10.7585859068665	"2019-07-01-count-3"	"AML0160"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGAACGTCCTTCTAA"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1688.22481596705	47.7412151064705	0.028278944045212	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1686.39263393619	1686.39263393619
"AML-0160"	"2019-07-01-count-3:ACTATGGAGATGGTAT"	1.52857377108876	-8.50333597576293	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATGGAGATGGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.69170290099	42.2403263261894	0.0202039957721063	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2090.69170290099	2090.69170290099
"AML-0160"	"2019-07-01-count-2:AACAACCCATGATCTG"	2.04680754718129	-8.7495794526306	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAACCCATGATCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2134.04962300283	46.0964052247451	0.0216004373693441	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2131.72547989541	2131.72547989541
"AML-0160"	"2019-07-01-count-3:GCACGTGAGTAAGGGA"	2.11782517012898	-8.93734934246215	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCACGTGAGTAAGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2125.04491517976	52.3288958992048	0.0246248422917585	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2119.17868546813	2119.17868546813
"AML-0160"	"2019-07-01-count-2:AGCCACGGTAGGACCA"	1.69781937178914	-8.88598921215209	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCCACGGTAGGACCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.02294831741	41.3868387292063	0.0180254464614719	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2290.21510899576	2290.21510899576
"AML-0160"	"2019-07-01-count-3:CAGGGCTCACAGAAGC"	11.8278604942257	-2.08372952854308	"2019-07-01-count-3"	"AML0160"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0833333333333333	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGGCTCACAGAAGC"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1744.38471467795	36.9945164307652	0.0212077737895078	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	1743.39611285688	1743.39611285688
"AML-0160"	"2019-07-01-count-1:ATTCTACTCCCAAGTA"	2.13155760344807	-8.90393068706664	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCTACTCCCAAGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2546.64866109678	36.8198442973508	0.014458156266241	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2542.16799920946	2542.16799920946
"AML-0160"	"2019-07-01-count-3:CAAGAGGGTACTTCCC"	1.93842699107472	-7.74835779583129	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAAGAGGGTACTTCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2094.63928890338	43.8318950918244	0.0209257485639792	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2090.40344873316	2090.40344873316
"AML-0160"	"2019-07-01-count-3:CCTGCATTCAAGCCCG"	1.6213706928188	-8.99283411419066	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTGCATTCAAGCCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.97182210889	40.3015475499516	0.0171279346277214	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2348.51304790084	2348.51304790084
"AML-0160"	"2019-07-01-count-3:TGTTCTAGTTCCCACT"	1.56899954852406	-8.7975006333557	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCTAGTTCCCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.80662657724	41.9260982124614	0.0188702732771348	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2217.38343971315	2217.38343971315
"AML-0160"	"2019-07-01-count-1:GTGGTTAGTCGCATTA"	7.51614584502522	-9.7615366212097	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGTTAGTCGCATTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1429.42513233619	48.155270613133	0.0336885573953986	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1418.44285521465	1418.44285521465
"AML-0160"	"2019-07-01-count-2:CAGATTGAGAGGCGGA"	5.2052432495052	-4.98761274730834	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGATTGAGAGGCGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.53510294775	32.1297657907542	0.0150101559869343	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.57060423775	2137.57060423775
"AML-0160"	"2019-07-01-count-1:TAACCAGAGAGTCACG"	1.87241138991658	-9.38325312053832	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACCAGAGAGTCACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.74240559219	43.5920984020138	0.0190047924717856	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2287.60367777057	2287.60367777057
"AML-0160"	"2019-07-01-count-2:TTTCCTCGTGCCGTTG"	1.73053147372548	-9.36191942608031	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCCTCGTGCCGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2425.68395659947	37.7551853145097	0.0155647586371632	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2422.91130862287	2422.91130862287
"AML-0160"	"2019-07-01-count-2:AACAAGATCATCACCC"	1.80072881755177	-9.11937429821166	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAGATCATCACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.75671735701	43.6978231490535	0.0183854842314893	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2371.46590498472	2371.46590498472
"AML-0160"	"2019-07-01-count-2:CAAGCTAGTGCATTTG"	2.8203612762386	-9.23911001598509	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGCTAGTGCATTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2222.34759590518	39.3010322291189	0.0176844667780745	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2222.34759590518	2222.34759590518
"AML-0160"	"2019-07-01-count-1:AAAGTGAGTCGTCGGT"	1.92615892466847	-8.90690138256224	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGTGAGTCGTCGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2329.12390528192	38.7894843404888	0.0166541094067701	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2329.12390528192	2329.12390528192
"AML-0160"	"2019-07-01-count-3:GTTCATTAGGAGAGTA"	2.46342601355855	-8.40485479747923	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTCATTAGGAGAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1741.69890698694	41.7802147601936	0.0239881960036776	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1740.07746878456	1740.07746878456
"AML-0160"	"2019-07-01-count-1:TTGCGTCTCCGGTAAT"	1.45722617682759	-8.18803503429564	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCGTCTCCGGTAAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2493.10616151737	39.6700223152047	0.0159118865163209	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2490.36403582746	2490.36403582746
"AML-0160"	"2019-07-01-count-3:AACCCAAGTTGGTACT"	-7.94419322434123	2.03058967674104	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCCAAGTTGGTACT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2239.87932599427	31.0616078804124	0.0138675363087359	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2229.36256117306	2229.36256117306
"AML-0160"	"2019-07-01-count-2:TTGTTGTAGCCTGAGA"	1.95352580127065	-9.25272753154906	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTGTAGCCTGAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1999.62353500846	43.5706155475349	0.0217894092486517	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1999.62353500846	1999.62353500846
"AML-0160"	"2019-07-01-count-3:TCCTCTTGTAAGTTGA"	1.43608488616292	9.87259957874147	"2019-07-01-count-3"	"AML0160"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCTTGTAAGTTGA"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1576.51443510431	38.9079588998213	0.0246797352649974	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1576.51443510431	1576.51443510431
"AML-0160"	"2019-07-01-count-2:TCGCTTGCAAATCCCA"	1.49963273581807	-8.40437223827513	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCTTGCAAATCCCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2395.00306416287	45.2223275202105	0.0188819497548397	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2387.61172013998	2387.61172013998
"AML-0160"	"2019-07-01-count-1:TCTCACGAGTCTAACC"	2.82408442076985	-2.84282996570738	"2019-07-01-count-1"	"AML0160"	"DC precursor"	"DC precursor"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCACGAGTCTAACC"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2774.48079095641	42.3021645539757	0.0152468759891444	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2768.20153922354	2768.20153922354
"AML-0160"	"2019-07-01-count-1:ACTCCCAAGCGACATG"	1.77823998507802	-9.06576158916625	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTCCCAAGCGACATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2141.88547871873	44.9081204194994	0.0209666300396057	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2140.7988632785	2140.7988632785
"AML-0160"	"2019-07-01-count-2:GAGTTGTCAATGTCAC"	-7.84052596512492	4.01340005481569	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTGTCAATGTCAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2079.75217376214	33.2859605195327	0.0160047725587037	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2072.89138161271	2072.89138161271
"AML-0160"	"2019-07-01-count-1:CGGGTCACACGCAGTC"	3.34241451796834	-9.40255262767943	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGTCACACGCAGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.33263071474	47.5270472269731	0.0203425858981533	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.73476708142	2332.73476708142
"AML-0160"	"2019-07-01-count-3:CGTGAATTCATACAGC"	-7.84332070770915	0.306414610985197	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTGAATTCATACAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2387.85666018878	46.2413993602405	0.0193652324828345	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2379.44642350043	2379.44642350043
"AML-0160"	"2019-07-01-count-1:CACGTGGGTTAAGCAA"	2.22056498107259	-8.80027487194213	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGTGGGTTAAGCAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2413.54299025335	41.8476137996763	0.017338665177571	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.08419339358	2409.08419339358
"AML-0160"	"2019-07-01-count-3:GAGCCTGTCCCAGGCA"	-7.76888308945354	1.92409763419954	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGCCTGTCCCAGGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2344.71788531611	40.2776421915135	0.0171780334187554	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2337.10966966706	2337.10966966706
"AML-0160"	"2019-07-01-count-1:ATTACCTGTATCGGTT"	2.09662713584248	-9.63646604931029	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTACCTGTATCGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.86049900788	38.7910053190629	0.0173107631359637	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2236.54664517198	2236.54664517198
"AML-0160"	"2019-07-01-count-2:TAGGGTTAGATGTTGA"	2.0047878223354	-8.50862028515013	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGGTTAGATGTTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2079.26755966299	40.5011868508484	0.0194785835342003	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2076.70959862673	2076.70959862673
"AML-0160"	"2019-07-01-count-3:GCAGCCAGTCTTTCTA"	3.00592460212056	-9.3992490998474	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCCAGTCTTTCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2138.71894119019	40.9285163003808	0.0191369307636113	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2135.67645744702	2135.67645744702
"AML-0160"	"2019-07-01-count-3:GTGAGCCAGCTTGTTG"	1.65689112719838	-8.44723799144896	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGCCAGCTTGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1869.27108044853	46.4346290291039	0.0248410353719065	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1867.75725628814	1867.75725628814
"AML-0160"	"2019-07-01-count-3:GTCCTCAAGGTGCATG"	1.95380296286885	-9.01893904125365	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCCTCAAGGTGCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2223.34569562926	41.28760058955	0.0185700319436221	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2220.85497915658	2220.85497915658
"AML-0160"	"2019-07-01-count-3:TGCTGAAGTATACGGG"	5.33556952056233	-4.99507906353148	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTGAAGTATACGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2205.91621629581	42.6345027650536	0.0193273445519367	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2199.39944632815	2199.39944632815
"AML-0160"	"2019-07-01-count-1:GCCAACGTCATAGCAC"	1.686087389558	-8.90316965496215	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAACGTCATAGCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2304.06526300684	41.2210884317742	0.0178905906415082	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2296.29102668714	2296.29102668714
"AML-0160"	"2019-07-01-count-3:TTCGCTGTCCTTCACG"	-7.7602199119633	3.60043952548829	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCGCTGTCCTTCACG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2051.36274084255	42.1985620257359	0.0205709898037846	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2040.9073316538	2040.9073316538
"AML-0160"	"2019-07-01-count-1:GGAAGTGCAGCCTTCT"	2.27553381499593	-8.91387941753539	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAAGTGCAGCCTTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.20883740459	34.6949367073311	0.0138546498954495	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2497.86137979172	2497.86137979172
"AML-0160"	"2019-07-01-count-3:GCCATTCAGCCTTCTC"	-9.23220858994182	4.00145194614259	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATTCAGCCTTCTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2286.7532205042	41.9701593354106	0.0183536023734807	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2279.84012881801	2279.84012881801
"AML-0160"	"2019-07-01-count-1:CTAACTTTCGCTACGG"	1.79512216624562	-9.82668878948363	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAACTTTCGCTACGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.15339251641	40.6997470587948	0.0168031253448037	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2412.68452423302	2412.68452423302
"AML-0160"	"2019-07-01-count-3:ACCCAAAAGAAACTAC"	2.40903558310811	-5.55291988765868	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCAAAAGAAACTAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2094.81137498696	40.5558790725733	0.0193601579391967	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2088.90610643958	2088.90610643958
"AML-0160"	"2019-07-01-count-1:ATAGACCGTGCCTATA"	1.76781429824178	-8.8278961411682	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATAGACCGTGCCTATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.09066017805	41.675662251533	0.0190902114198656	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2178.21729954894	2178.21729954894
"AML-0160"	"2019-07-01-count-1:AGCTCAACATATGGCT"	1.92432572421376	-9.01532938396605	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTCAACATATGGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.64453032173	42.7353987322447	0.0177498788521468	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2403.49754057077	2403.49754057077
"AML-0160"	"2019-07-01-count-2:CTAAGTGAGCAGCAGT"	2.09101142463033	-4.50495865261229	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAAGTGAGCAGCAGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1425.09785526304	41.0292613500993	0.0287904870522216	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1420.27632289156	1420.27632289156
"AML-0160"	"2019-07-01-count-1:AGCTCAAAGGAGACCT"	1.58311714705769	-9.10590937053832	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTCAAAGGAGACCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2338.61150586729	45.6039848618779	0.0195004534731242	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2335.82311897745	2335.82311897745
"AML-0160"	"2019-07-01-count-3:CCTTTGGTCCGATAAC"	2.31827749785725	-9.00025656139525	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTTTGGTCCGATAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.63163026845	45.0268700920983	0.0190418116359995	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2360.96372594997	2360.96372594997
"AML-0160"	"2019-07-01-count-2:CAAAGAAAGCGAGAAA"	1.56697167929952	-7.41186764156493	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAAGAAAGCGAGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.92298181219	45.9546900035034	0.0213849869876442	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2145.96625902154	2145.96625902154
"AML-0160"	"2019-07-01-count-3:CAGATCACACTGTGAT"	1.52147509631459	-9.35879995739134	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGATCACACTGTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2024.42509590778	50.2584536725973	0.0248260376608603	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2019.70346204977	2019.70346204977
"AML-0160"	"2019-07-01-count-2:CACGTGGTCGCATTAG"	3.35569085654561	-8.46396925365599	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTGGTCGCATTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.00965888544	42.8423755395912	0.0192376244838707	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2224.3384192052	2224.3384192052
"AML-0160"	"2019-07-01-count-3:TACCGAAGTCACCCTT"	-8.10166011276897	1.59773991191713	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGAAGTCACCCTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2541.98910592388	41.0281852865592	0.0161401892679031	2554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2534.30288523241	2534.30288523241
"AML-0160"	"2019-07-01-count-3:TCTTTGAAGTGCCAGA"	7.88912596282308	6.7234167822632	"2019-07-01-count-3"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTTGAAGTGCCAGA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1663.02123409149	48.0618946109811	0.0289003493315209	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1655.39576730544	1655.39576730544
"AML-0160"	"2019-07-01-count-3:TTGCCTGTCAATCGGT"	1.86059405383412	-9.34474279796752	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCCTGTCAATCGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1996.89956543614	41.6238663088173	0.0208442462651977	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1995.45172150629	1995.45172150629
"AML-0160"	"2019-07-01-count-1:GAACACTTCGGAGTGA"	1.48097672042195	-8.8193044892517	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACACTTCGGAGTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.80642316851	41.9391592964071	0.0176229288601417	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2376.50367036919	2376.50367036919
"AML-0160"	"2019-07-01-count-1:ACACGCGAGTGTTCCA"	3.09719290313069	-5.39000751888426	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACACGCGAGTGTTCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.48313107626	34.1361481148399	0.0136518209983472	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2489.84579886026	2489.84579886026
"AML-0160"	"2019-07-01-count-3:GGAGAACAGCCAAGCA"	2.05461873587911	-9.15918161785277	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAGAACAGCCAAGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2250.01631604736	36.2350408106012	0.0161043458005922	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2245.19434807578	2245.19434807578
"AML-0160"	"2019-07-01-count-3:CAATCGATCATTCTTG"	1.93410017070119	-8.05255415355834	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATCGATCATTCTTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2469.28318182533	40.497168859339	0.0164003744719967	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2464.33754982398	2464.33754982398
"AML-0160"	"2019-07-01-count-2:AGTTAGCTCTACGCAA"	2.19547857817952	-9.37982180034789	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTAGCTCTACGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.31739988966	42.0483917709055	0.0194910548503694	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2156.17182377721	2156.17182377721
"AML-0160"	"2019-07-01-count-3:TCGAACAGTAACAGTA"	2.3718213039333	-4.46846535122069	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGAACAGTAACAGTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2385.2514279738	40.6330876291419	0.0170351381630483	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2380.82611323766	2380.82611323766
"AML-0160"	"2019-07-01-count-3:TAGACTGGTTAAACCC"	2.01822771605794	-9.14076998150023	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGACTGGTTAAACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1915.07185147653	41.9330754654571	0.0218963457862568	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1915.07185147653	1915.07185147653
"AML-0160"	"2019-07-01-count-3:TCTTTGATCGGTCATA"	2.00095595893208	-8.30960371410521	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTTGATCGGTCATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.03421821272	38.9197404734452	0.0174290837802727	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2227.70408285429	2227.70408285429
"AML-0160"	"2019-07-01-count-1:ATTCACTGTCATGACT"	2.30074157294576	-8.89959242260131	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCACTGTCATGACT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.97375965303	36.1140243133225	0.0143311112566089	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2514.27613188703	2514.27613188703
"AML-0160"	"2019-07-01-count-2:TTTACGTGTCGAACGA"	2.14795078810994	-4.45525267040404	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACGTGTCGAACGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2163.9606940051	37.3296075651668	0.0172505940928513	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2161.6766228729	2161.6766228729
"AML-0160"	"2019-07-01-count-3:AACGGGATCACAATGC"	1.65608646449391	-8.09489347850951	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGGGATCACAATGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2110.47325053636	41.0467738676075	0.0194490851078903	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2109.1296437467	2109.1296437467
"AML-0160"	"2019-07-01-count-1:ATATCCTCAGCAAGAC"	1.94747449931447	-8.86635687267455	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATATCCTCAGCAAGAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2402.39646369211	41.6109062365679	0.0173205825372463	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2397.00943940268	2397.00943940268
"AML-0160"	"2019-07-01-count-1:TCCCAGTTCAGCAGAG"	2.11050619658772	-8.93660452282103	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCCAGTTCAGCAGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.26827468381	41.4897148281513	0.0166206954792977	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2494.04552750357	2494.04552750357
"AML-0160"	"2019-07-01-count-1:CTGCTCAAGTGCAGCA"	2.09830202636067	-4.72420122539672	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCTCAAGTGCAGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.07677286216	45.2424597711215	0.0199299249752152	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2264.03904295325	2264.03904295325
"AML-0160"	"2019-07-01-count-3:GAGGGATAGACGAAGA"	-9.31934771958049	-3.55709865009459	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	41	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.25	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGGGATAGACGAAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2030.74107200546	42.0205623550808	0.0206922305036079	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2022.0115244269	2022.0115244269
"AML-0160"	"2019-07-01-count-1:CACTGTCAGTTCCGTA"	1.75193478640859	-3.98355867778929	"2019-07-01-count-1"	"AML0160"	"DC precursor"	"DC precursor"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGTCAGTTCCGTA"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2444.61592207635	42.5158455707751	0.0173916258937985	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2440.21766034922	2440.21766034922
"AML-0160"	"2019-07-01-count-2:CACAACAAGAGCACTG"	2.30726112899129	-9.18058493053588	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACAACAAGAGCACTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2081.35504364379	43.4131672087137	0.0208581267003399	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2078.76581458898	2078.76581458898
"AML-0160"	"2019-07-01-count-2:AAGGAATTCATACAGC"	2.46015133437459	-9.0802211991516	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGAATTCATACAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2114.30457499889	36.3965855301426	0.0172144477009239	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2107.00549574246	2107.00549574246
"AML-0160"	"2019-07-01-count-2:GCAGTTAGTGTTGCCG"	1.67756774005238	-8.75363447582396	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGTTAGTGTTGCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.71259271305	41.6851957825646	0.017539014145156	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2372.01705676418	2372.01705676418
"AML-0160"	"2019-07-01-count-2:ATACCGAAGGAACTAT"	1.2775716978008	9.59236428821412	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACCGAAGGAACTAT"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1683.81845277516	33.6873733459379	0.0200065353188264	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1682.45426573805	1682.45426573805
"AML-0160"	"2019-07-01-count-2:ATACCGACAATCGAAA"	2.34984030303304	-9.59916021740111	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACCGACAATCGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1700.19551839929	43.4034650987724	0.0255285140026932	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1698.42095701165	1698.42095701165
"AML-0160"	"2019-07-01-count-2:AACCTGATCTGCACCT"	1.37506832656209	-8.39504721080931	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCTGATCTGCACCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2394.14885897835	38.8474938603968	0.0162260143995283	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2393.12598504993	2393.12598504993
"AML-0160"	"2019-07-01-count-1:GTAATGCAGTAAAGCT"	1.77115072783772	-9.29039480602416	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAATGCAGTAAAGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.11849202826	45.9047326219694	0.019599662774626	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.98733977779	2337.98733977779
"AML-0160"	"2019-07-01-count-3:CATACTTCACTTGAAC"	1.88471080836598	-8.9045562974182	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATACTTCACTTGAAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2419.94213612838	36.8544326895049	0.015229468564264	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2416.27083140767	2416.27083140767
"AML-0160"	"2019-07-01-count-1:TCCGAAAAGGAAGTGA"	2.03294076499287	-9.4040851823059	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGAAAAGGAAGTGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2244.0454600814	41.0947990543174	0.0183128193191001	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2237.58779223119	2237.58779223119
"AML-0160"	"2019-07-01-count-3:GCATCGGTCAAAGACA"	-8.49579940262492	5.02650115573732	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGTCAAAGACA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1753.28618428635	38.5866395310382	0.0220081809101487	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1749.71481011656	1749.71481011656
"AML-0160"	"2019-07-01-count-3:TAGCACAAGGGAGGCA"	-8.62133918228801	0.16323590213386	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGCACAAGGGAGGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2369.6863202075	43.5859249360684	0.0183931200363481	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2362.03325448332	2362.03325448332
"AML-0160"	"2019-07-01-count-3:AGCATCAGTGCCTTCT"	5.26944078978841	-5.11171009456786	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCATCAGTGCCTTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2335.89853611555	36.5634810019843	0.0156528549663749	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.83007948414	2332.83007948414
"AML-0160"	"2019-07-01-count-1:CGTCAAATCGCAATTG"	2.63579978522603	-9.24620630657347	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTCAAATCGCAATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2186.36186291333	50.3741894091494	0.0230401884809798	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2181.8427085562	2181.8427085562
"AML-0160"	"2019-07-01-count-2:TTCCACGGTGCAAGAC"	2.78015174445454	-8.82641603862914	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCACGGTGCAAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1448.51713405675	51.5290853518443	0.0355736802418972	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1446.37612217162	1446.37612217162
"AML-0160"	"2019-07-01-count-2:CACACAACAATATCCG"	-8.16134581986125	2.42676184261171	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACACAACAATATCCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2324.09958401735	41.2859122345208	0.0177642612728133	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2317.19756584337	2317.19756584337
"AML-0160"	"2019-07-01-count-2:TTCCGGTAGCTCGACC"	2.02173687991444	-9.28167440807494	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCGGTAGCTCGACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.58311269277	42.3764172381836	0.0180127184495851	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2345.84680420169	2345.84680420169
"AML-0160"	"2019-07-01-count-3:TTACGTTCAAGTATCC"	-7.86527810517009	2.97934672916261	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACGTTCAAGTATCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2138.32136937837	42.415505211287	0.0198358889448023	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2128.0716851708	2128.0716851708
"AML-0160"	"2019-07-01-count-1:TGGAACTAGCACTCCG"	1.9150650697643	-8.73505785381468	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGAACTAGCACTCCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.78175049034	43.5257957512387	0.0191677583025493	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2266.10718858342	2266.10718858342
"AML-0160"	"2019-07-01-count-3:ATGGGAGTCTTAGGAC"	2.11538090285603	-9.86374094402465	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGGAGTCTTAGGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.35755015287	40.4709789730601	0.0197000658283893	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2051.63756029329	2051.63756029329
"AML-0160"	"2019-07-01-count-3:GTCGTTCTCGCAATGT"	7.4772707420284	6.91875312412111	"2019-07-01-count-3"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGTTCTCGCAATGT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1512.15019042495	44.3858429992569	0.0293528005884015	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1510.13236858836	1510.13236858836
"AML-0160"	"2019-07-01-count-1:GTGCTTCGTCTGATAC"	-7.69111953201945	3.19456646526185	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.119047619047619	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCTTCGTCTGATAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2064.49666583937	36.5809173589715	0.0177190488918027	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2054.71178974649	2054.71178974649
"AML-0160"	"2019-07-01-count-2:GAATCACTCTTACCGC"	2.46881761130635	-9.15196230327757	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATCACTCTTACCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1808.3148855801	46.4581664464314	0.0256914140434827	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1803.2853059306	1803.2853059306
"AML-0160"	"2019-07-01-count-2:CGATGCGTCTAGTGAC"	1.6418420272762	-9.8425503007141	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATGCGTCTAGTGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2043.54985658752	48.1205974890119	0.0235475524778082	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2040.28504327666	2040.28504327666
"AML-0160"	"2019-07-01-count-1:TTAGTCTGTTCCGCTT"	2.34321345862691	-8.81593134319457	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGTCTGTTCCGCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.19607644649	39.3520588998938	0.0153827375712953	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2555.07203156437	2555.07203156437
"AML-0160"	"2019-07-01-count-1:AGGTCATGTTCCACGG"	2.01234247264211	-8.62403013622435	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTCATGTTCCACGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2284.8388576137	46.5141356761697	0.0203577313652436	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2283.71275586656	2283.71275586656
"AML-0160"	"2019-07-01-count-1:TCGCACTAGACTTAAG"	-7.96482978287395	4.01633665645448	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGCACTAGACTTAAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2149.7616449671	35.3350874656126	0.016436746626463	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2134.522743772	2134.522743772
"AML-0160"	"2019-07-01-count-3:CATAGACGTTAGGAGC"	-8.95491729202922	3.36768243396608	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATAGACGTTAGGAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2080.2000182585	40.5652926316704	0.019500669298922	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2075.14315194601	2075.14315194601
"AML-0160"	"2019-07-01-count-2:ACTGTGAGTAACGGTG"	-8.05024657669719	4.55911109531251	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTGTGAGTAACGGTG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1680.02738282315	34.0564136315503	0.0202713443719716	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1667.99171317759	1667.99171317759
"AML-0160"	"2019-07-01-count-2:AGGACGACAGCGAGTA"	4.22508062896077	-7.93095877086791	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACGACAGCGAGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.00041544141	37.0187285464945	0.0153796103685781	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2402.71497994178	2402.71497994178
"AML-0160"	"2019-07-01-count-1:CTCATTAAGCTACGTT"	2.38367523726766	-9.55946829235228	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCATTAAGCTACGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.48235789111	42.8277613065382	0.0170663727409222	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2507.45885999905	2507.45885999905
"AML-0160"	"2019-07-01-count-3:CAACGATTCTGAACGT"	2.52854289588277	-5.54231836712035	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGATTCTGAACGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2265.89770060504	31.909241523709	0.0140823839995904	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2262.70176959715	2262.70176959715
"AML-0160"	"2019-07-01-count-1:GTTGTGAGTTTATGCG"	2.07898511466328	-4.56194975292357	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGAGTTTATGCG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2124.34127517154	42.9258696090519	0.02020667305708	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2120.54124824033	2120.54124824033
"AML-0160"	"2019-07-01-count-1:AGCCAATGTAGTTCCA"	1.74662138995473	-8.91801073467406	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCCAATGTAGTTCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.10536598044	35.8978890626159	0.0139295387516912	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2571.50741941321	2571.50741941321
"AML-0160"	"2019-07-01-count-3:AGGACTTAGGGACACT"	-9.2449782890385	4.2727217444214	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGACTTAGGGACACT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2013.77835152888	42.9578125228448	0.0213319467309949	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2010.22439866888	2010.22439866888
"AML-0160"	"2019-07-01-count-1:TACAGGTGTTAGGACG"	1.39623703536336	-8.63468649303588	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACAGGTGTTAGGACG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2371.66456818271	41.9455354870311	0.0176861163461964	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2369.92696655802	2369.92696655802
"AML-0160"	"2019-07-01-count-2:TGTCAGACAGTCGGTC"	2.06354989585225	-9.25667192852172	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCAGACAGTCGGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2119.39947837398	38.566175374921	0.0181967466579303	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2116.89458240257	2116.89458240257
"AML-0160"	"2019-07-01-count-2:AGCATCAAGAAACCCG"	2.14715590056722	-9.61299898540648	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCATCAAGAAACCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.39684488065	36.375478947566	0.0153263366073933	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2371.32503071496	2371.32503071496
"AML-0160"	"2019-07-01-count-2:GTGCACGCAAACCACT"	2.18113007125203	-8.95929148113402	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCACGCAAACCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1997.26052946464	51.307553008169	0.0256889635834949	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1997.26052946464	1997.26052946464
"AML-0160"	"2019-07-01-count-3:TGACCCTCACTGATTG"	2.35185899314229	-4.84094955837401	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGACCCTCACTGATTG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2229.03011243813	44.4091884408989	0.0199230993754157	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2225.39546497405	2225.39546497405
"AML-0160"	"2019-07-01-count-3:GTTGTCCAGCTTCGTA"	2.03909148749654	-9.02880194103392	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTCCAGCTTCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1799.04659412037	46.2915767303283	0.0257311716559305	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1799.04659412037	1799.04659412037
"AML-0160"	"2019-07-01-count-3:ATCCTATCACTGCGAC"	1.83744968947713	-3.84334828769835	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCTATCACTGCGAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1543.12706966382	44.2226019055424	0.0286577837787374	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1539.06595886157	1539.06595886157
"AML-0160"	"2019-07-01-count-1:TGGATCACACTTCTCG"	2.40226807174031	-9.13205339824828	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGATCACACTTCTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1610.56732152285	30.7974189136776	0.0191220935021564	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1610.56732152285	1610.56732152285
"AML-0160"	"2019-07-01-count-3:CTGAGGCTCCAAGAGG"	2.049568315118	-8.73629763042601	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAGGCTCCAAGAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2245.08823167614	44.2011709841447	0.0196879438235463	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2240.64756305423	2240.64756305423
"AML-0160"	"2019-07-01-count-1:ACATCGAAGTGCGACA"	2.22371758994405	-9.51421835338744	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACATCGAAGTGCGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2255.02454118721	48.7636218839982	0.0216244306850539	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2249.7943667284	2249.7943667284
"AML-0160"	"2019-07-01-count-1:TCTTTGACAAGTGGGT"	7.84857143935506	-10.1543922654358	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.304347826086957	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTTGACAAGTGGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1847.52024499173	49.6751733660384	0.0268874852661009	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1842.74370953658	1842.74370953658
"AML-0160"	"2019-07-01-count-3:ACCAAACAGCCTGACC"	5.24396051940267	-5.11424019252928	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAAACAGCCTGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2287.41606592856	43.6820987688861	0.0190967001672928	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2282.07258976229	2282.07258976229
"AML-0160"	"2019-07-01-count-3:GAAGGACAGCGTTCAT"	1.8619188266689	-3.95335295116576	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGGACAGCGTTCAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2225.98927162653	46.2155652803132	0.0207618095331355	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2221.10778479435	2221.10778479435
"AML-0160"	"2019-07-01-count-2:CCGATCTAGTTATGGA"	1.70844616469685	-8.04614450847777	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGATCTAGTTATGGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2329.05108350874	36.8724857168898	0.0158315487272787	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2326.06327395028	2326.06327395028
"AML-0160"	"2019-07-01-count-3:TTCTTGAGTTATCTTC"	2.75617565688435	-9.14715101635131	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTTGAGTTATCTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.24054342573	42.5541302175987	0.019553964448531	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2170.20656781416	2170.20656781416
"AML-0160"	"2019-07-01-count-1:AGTTCCCCATGTTCAG"	2.25434960898702	-8.47366812145384	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTCCCCATGTTCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.88927531317	41.4845929532987	0.0180063310324059	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2298.85093601184	2298.85093601184
"AML-0160"	"2019-07-01-count-2:GTCGTTCGTCGGCACT"	1.4997921186382	-8.6389484635559	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGTTCGTCGGCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.2886783027	38.9161830301328	0.017347826611231	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2240.82126800124	2240.82126800124
"AML-0160"	"2019-07-01-count-1:TCCTCGAAGGTCTGGA"	-8.91948447647746	3.61766884410707	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTCGAAGGTCTGGA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2028.48625920683	38.1528540157391	0.0188085346117441	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2020.50698801532	2020.50698801532
"AML-0160"	"2019-07-01-count-1:AGGCATTCAGAGTGTG"	3.52994241294209	-8.73279573833617	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGCATTCAGAGTGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1397.04146288209	32.9631972706533	0.0235950028302313	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1389.70414637054	1389.70414637054
"AML-0160"	"2019-07-01-count-2:CACCAAACATAGGCGA"	2.16921915587727	-9.22979357158812	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCAAACATAGGCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2106.8647657623	47.6625277691832	0.0226224903200837	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2104.35862926454	2104.35862926454
"AML-0160"	"2019-07-01-count-3:CATCCCATCCCGGTAG"	-9.53999076309856	4.50736091220704	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCCCATCCCGGTAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1796.49211300318	40.3912948100983	0.02248342451255	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1791.21127015382	1791.21127015382
"AML-0160"	"2019-07-01-count-1:TCCTCCCTCCAGCCTT"	2.40447582778279	-9.13086702739867	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTCCCTCCAGCCTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.21791675822	39.6954277196023	0.0146519877467446	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2703.31614589841	2703.31614589841
"AML-0160"	"2019-07-01-count-3:GTTGTGATCCTTTGAT"	1.77158119258229	-8.97068121349486	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTGATCCTTTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.49507038964	43.2916290845477	0.0200285578614545	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2157.65232103641	2157.65232103641
"AML-0160"	"2019-07-01-count-2:GGAACCCTCTCGCTTG"	2.2434524494106	-9.14544680034789	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCTCTCGCTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.18573805485	45.4989379457895	0.0221493787552402	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2046.04989034697	2046.04989034697
"AML-0160"	"2019-07-01-count-1:GCCTGTTTCTGGCCAG"	-8.31911883774455	0.95198325002519	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCTGTTTCTGGCCAG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2574.53988251265	40.0862664810262	0.0155702643230773	2729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2560.81792787498	2560.81792787498
"AML-0160"	"2019-07-01-count-2:ACTTCCGAGTCTGTAC"	2.18295397338216	-9.1683616868225	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTCCGAGTCTGTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2301.40524784937	40.6489272928683	0.0176626551672523	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2298.73516470958	2298.73516470958
"AML-0160"	"2019-07-01-count-2:CACCAAAGTTCCCAAA"	1.7407098012859	-8.50443651592406	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCAAAGTTCCCAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.94645957409	41.6720326106591	0.0172988621000846	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2405.19237820252	2405.19237820252
"AML-0160"	"2019-07-01-count-1:ACTATTCAGGCTAACG"	2.26970758017842	-8.64337541973265	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATTCAGGCTAACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.93354113836	39.3224077330074	0.0150722151840824	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2605.73404685449	2605.73404685449
"AML-0160"	"2019-07-01-count-3:GCCAGGTCAGCGTAGA"	2.58961858329121	-10.6414213410583	"2019-07-01-count-3"	"AML0160"	"CD11c+"	"CD11c+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCAGGTCAGCGTAGA"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.74715059554	47.8232120686385	0.0211256862569909	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2259.96912763439	2259.96912763439
"AML-0160"	"2019-07-01-count-3:TGGGATTAGCCTATTG"	3.34564747390096	-3.98867037212523	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGATTAGCCTATTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1950.25290616255	40.2567947694268	0.0206418329859787	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1946.23087402657	1946.23087402657
"AML-0160"	"2019-07-01-count-2:TGCAGGCGTCAATCTG"	1.71435513076131	-8.72048857128295	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCAGGCGTCAATCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.90294601414	39.1577534794281	0.0158668125675975	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2463.01984261437	2463.01984261437
"AML-0160"	"2019-07-01-count-1:TGGCGTGGTGAGTAAT"	1.72970773753468	-9.20294001018675	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGGTGAGTAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.89561329953	44.0783563294828	0.0183897688680756	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2392.32515998711	2392.32515998711
"AML-0160"	"2019-07-01-count-3:CTACCCAAGAAACCAT"	-7.84439311447795	4.03413198078004	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCCAAGAAACCAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1996.74987169661	42.6689600350633	0.0213692063487192	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1986.96769822486	1986.96769822486
"AML-0160"	"2019-07-01-count-3:GGCTGTGAGAATTTGG"	5.34323324736897	-4.84525587474974	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCTGTGAGAATTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2229.00422342976	40.6300048980697	0.0182278725499912	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2219.58257855673	2219.58257855673
"AML-0160"	"2019-07-01-count-3:GAAGTAACAGTGTATC"	2.41105641898457	-8.82536222850951	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGTAACAGTGTATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2169.99352662456	39.9733366819361	0.0184209474320943	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2164.49201252294	2164.49201252294
"AML-0160"	"2019-07-01-count-3:TTAGTCTTCCGAGATT"	-9.54613528671916	3.62812159145204	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGTCTTCCGAGATT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2248.18555692238	42.5999009031016	0.0189485697797197	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2241.91530537704	2241.91530537704
"AML-0160"	"2019-07-01-count-2:TTTCGATAGCTCTTCC"	-8.09639201584514	-0.754264079686724	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATAGCTCTTCC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2471.38408734278	46.142556415488	0.0186707346105397	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2458.9490666394	2458.9490666394
"AML-0160"	"2019-07-01-count-1:AACGTCAAGTTCTCTT"	2.26003326949422	-4.57672884380492	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACGTCAAGTTCTCTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2405.79154302979	37.724677291179	0.0156807755852652	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2397.15518718909	2397.15518718909
"AML-0160"	"2019-07-01-count-1:TTCAGGAGTTAGTTCG"	-8.08182654801067	2.48158691013185	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCAGGAGTTAGTTCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2360.93547544855	37.9373639101072	0.0160687847273334	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2351.8716627605	2351.8716627605
"AML-0160"	"2019-07-01-count-1:TTCATGTCAAGCGCAA"	2.36763681945149	-4.42671778118285	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATGTCAAGCGCAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2381.60053533791	41.89138820764	0.0175895947225659	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2376.75208837419	2376.75208837419
"AML-0160"	"2019-07-01-count-2:TTTCGATCACTGAGTT"	1.52080347117726	-8.50258734142455	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATCACTGAGTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2013.78972516917	43.8308444539839	0.021765353108206	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2010.96463803109	2010.96463803109
"AML-0160"	"2019-07-01-count-3:CTGCCATGTGTCCAAT"	2.27725209769551	-4.87545349514159	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCCATGTGTCCAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.59015000876	36.8481533520554	0.0175001546962509	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2102.40653303653	2102.40653303653
"AML-0160"	"2019-07-01-count-2:CTTCGGTGTATGGGAC"	1.69329955157582	-8.06468679821166	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCGGTGTATGGGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1791.35571221422	44.0554691548661	0.0245933673889989	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1787.97706692216	1787.97706692216
"AML-0160"	"2019-07-01-count-1:TCACGCTGTCGCTTGG"	1.56361391124074	-8.69506552135619	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACGCTGTCGCTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.55554720917	42.3349372667926	0.01828284245559	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.59608355513	2313.59608355513
"AML-0160"	"2019-07-01-count-1:CGTTGGGTCCTCAGAA"	1.54517271098439	-8.42820360576781	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTGGGTCCTCAGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.16382137826	45.2306089254952	0.0184828692424936	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2442.12978460646	2442.12978460646
"AML-0160"	"2019-07-01-count-2:TCTACCGTCACCACAA"	1.7475127178127	-9.12719824230345	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTACCGTCACCACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.60897884328	40.1941063152188	0.0176088443915555	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2278.03689545601	2278.03689545601
"AML-0160"	"2019-07-01-count-2:GTGGAAGGTGACGCCT"	1.70996512946431	-9.01092340862425	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGAAGGTGACGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.42532032776	42.8797070787743	0.0180894570738239	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2368.15433779226	2368.15433779226
"AML-0160"	"2019-07-01-count-2:GATGGAGTCACTTCTA"	1.38733472403828	-7.86937286770018	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGGAGTCACTTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.83960070335	47.3894976676143	0.0198212785390007	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2384.34025444075	2384.34025444075
"AML-0160"	"2019-07-01-count-2:ATCGGATTCGTTCTGC"	1.84658946570699	-8.8698187104431	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATTCGTTCTGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.38471764562	38.4483256159457	0.0167211364504995	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2294.27976528284	2294.27976528284
"AML-0160"	"2019-07-01-count-1:TGGGAGAGTATCGCTA"	2.29954375800435	-9.24130632793578	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAGAGTATCGCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2305.14277310524	41.6557826502196	0.018070803742063	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2300.99826224154	2300.99826224154
"AML-0160"	"2019-07-01-count-1:TGGGAGACATGCCGGT"	-7.8680923980778	2.3895156153473	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAGACATGCCGGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2163.70777060475	44.1029434611773	0.0203830406584206	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2161.1436021929	2161.1436021929
"AML-0160"	"2019-07-01-count-1:GATCATGTCTGGCCAG"	1.73501088198964	-9.00681402599486	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATCATGTCTGGCCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.44245304716	41.7568871176494	0.0172232948095622	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2421.41180456823	2421.41180456823
"AML-0160"	"2019-07-01-count-1:CTTACCGAGTCCGTCG"	2.44644584235494	-8.92545702373656	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTACCGAGTCCGTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.59691987631	44.7708463008601	0.0185187389728933	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2413.24103039048	2413.24103039048
"AML-0160"	"2019-07-01-count-1:TCTCAGCTCCGAGAAG"	1.29020859774892	-10.1038475266662	"2019-07-01-count-1"	"AML0160"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCAGCTCCGAGAAG"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2162.30585349322	44.6485521720354	0.0206485831317089	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2159.94420074351	2159.94420074351
"AML-0160"	"2019-07-01-count-1:CGCATAATCCATCCGT"	-8.26592383804973	2.96625945651857	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCATAATCCATCCGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2266.26488762476	38.2078095695789	0.0168593749910779	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2260.16074153579	2260.16074153579
"AML-0160"	"2019-07-01-count-2:ACTCTCGTCACCTGGG"	-8.35376773300822	1.55269954288331	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTCTCGTCACCTGGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2543.89779315545	44.0101553826419	0.0173002844300799	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2537.10929533304	2537.10929533304
"AML-0160"	"2019-07-01-count-3:ACTCTCGTCCATAGAC"	-7.90792642059978	4.1972183951172	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCTCGTCCATAGAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1814.87330952965	40.4417050154323	0.0222834865679486	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1807.40526411742	1807.40526411742
"AML-0160"	"2019-07-01-count-2:AGGCTGCGTCTTTCTA"	1.84739114817922	-8.33880140697631	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGCTGCGTCTTTCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2147.85986380997	43.9748013958448	0.0204737758439418	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2146.4618776788	2146.4618776788
"AML-0160"	"2019-07-01-count-1:AAGAACAGTAGGGAGG"	-8.45072684708293	4.96004865253297	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGAACAGTAGGGAGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1595.46293088475	48.0018305194209	0.0300864592904091	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1585.80143657184	1585.80143657184
"AML-0160"	"2019-07-01-count-2:TATTTCGAGATTTGCC"	-8.33775649491008	3.15793535793153	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATTTCGAGATTTGCC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2201.80001817659	36.1254972176715	0.0164072562991387	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2190.85143010182	2190.85143010182
"AML-0160"	"2019-07-01-count-3:TGAGGAGGTCGCACAC"	1.84746982631032	-9.16350557720336	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGAGGTCGCACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2192.72304269109	45.2296257383969	0.0206271493744543	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2190.29586347398	2190.29586347398
"AML-0160"	"2019-07-01-count-2:CGGAACCGTTGGACCC"	1.49521758136098	-8.49146749889525	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAACCGTTGGACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.35525544272	42.3848880764733	0.0181181921719077	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2331.06152440935	2331.06152440935
"AML-0160"	"2019-07-01-count-1:TGGGCGTCATATAGCC"	-7.95454917374309	3.98912904346315	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGCGTCATATAGCC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2131.95913139058	31.4784958233249	0.0147650559336908	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2121.57874947168	2121.57874947168
"AML-0160"	"2019-07-01-count-3:AACAAAGCACAGTCGC"	3.19632401046101	-7.76424696361693	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAAAGCACAGTCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2236.0172691954	42.7112807276109	0.019101498595751	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.31135020016	2233.31135020016
"AML-0160"	"2019-07-01-count-1:ATGCATGAGCTGGCCT"	1.38352038440053	-9.33324530040892	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCATGAGCTGGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2216.62786012125	44.6604355306924	0.0201479176248599	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2213.35405874795	2213.35405874795
"AML-0160"	"2019-07-01-count-1:AGCTCAAGTCGAGTGA"	3.16018666800801	-5.93956186687621	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTCAAGTCGAGTGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2743.34865984331	35.0184610848506	0.0127648598216644	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2740.20675029879	2740.20675029879
"AML-0160"	"2019-07-01-count-1:TTTCAGTAGCGGCTCT"	1.71524347838704	-8.95302107250365	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTCAGTAGCGGCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2177.9923071659	47.3124295166136	0.0217229552927938	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2176.62230594044	2176.62230594044
"AML-0160"	"2019-07-01-count-2:TGCATGATCCACTGAA"	-2.19109330597575	10.9960508116516	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCATGATCCACTGAA"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1788.33770999091	37.2948561534561	0.0208544817598493	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1784.8535190902	1784.8535190902
"AML-0160"	"2019-07-01-count-3:GTAAGTCTCCATCACC"	1.91171171244923	-8.74609854137572	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAAGTCTCCATCACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.29997692172	44.0862656774728	0.0192323282822152	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2285.05868862853	2285.05868862853
"AML-0160"	"2019-07-01-count-1:CAGGGCTCATCCGAAT"	2.10260095176045	-8.99493601238402	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGGGCTCATCCGAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.7625635297	40.7035807703651	0.0182219817965106	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2225.32918896349	2225.32918896349
"AML-0160"	"2019-07-01-count-3:ATTCAGGTCGACGCGT"	-10.0093425315922	3.28728077495424	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCAGGTCGACGCGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2087.0433411323	46.3085587903371	0.0221885946868804	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2079.51892105355	2079.51892105355
"AML-0160"	"2019-07-01-count-3:GTGAGTTCATTGTGCA"	-9.19780002060588	4.87896583164064	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGTTCATTGTGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1801.8916747399	41.5682746158516	0.0230692417300012	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1789.92731303645	1789.92731303645
"AML-0160"	"2019-07-01-count-3:TGGTACACACCCTCTA"	-8.7440017265385	3.16842339122621	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGTACACACCCTCTA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2348.62125974213	38.5357306774496	0.0164078096958386	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2341.84968337545	2341.84968337545
"AML-0160"	"2019-07-01-count-3:GTGAGTTTCCCGTGAG"	1.53966631469075	-8.46256830608519	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGTTTCCCGTGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2178.2345293472	40.1156186473876	0.0184165745730833	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.59429964104	2171.59429964104
"AML-0160"	"2019-07-01-count-2:TGCCGAGCAGTTGTCA"	-6.41887078705485	1.1860962876114	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCCGAGCAGTTGTCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2122.33987172261	38.6281920574264	0.018200756896714	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2112.81881540224	2112.81881540224
"AML-0160"	"2019-07-01-count-3:TATCCTAAGGGTGAAA"	1.62267388877217	-8.755979560968	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCCTAAGGGTGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.78327419845	45.6886609327977	0.0221705317123017	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2054.97657099738	2054.97657099738
"AML-0160"	"2019-07-01-count-3:AGATGAAGTACCGTGC"	1.76925327357594	-8.81920530712279	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATGAAGTACCGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2112.989094869	43.5763659428636	0.0206230907905207	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2111.46254016136	2111.46254016136
"AML-0160"	"2019-07-01-count-2:AGGGAGTTCTTCGTAT"	1.54168369349782	-8.11822225963744	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGAGTTCTTCGTAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2264.53453529381	48.2107087734998	0.0212894561871828	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2259.51096003495	2259.51096003495
"AML-0160"	"2019-07-01-count-3:TTCACGCTCTTCGACC"	2.07391514357869	-9.23137476360472	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCACGCTCTTCGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2190.69278550735	41.9566860543971	0.0191522455051498	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2186.41590370975	2186.41590370975
"AML-0160"	"2019-07-01-count-1:TGAGACTAGACGTCGA"	1.80684246596639	-9.53991320049437	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGACTAGACGTCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2258.97811923968	43.0942778849198	0.0190768903505026	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2257.96017443647	2257.96017443647
"AML-0160"	"2019-07-01-count-2:AAAGGTAGTCGCACGT"	2.45369638976399	-9.15938379680785	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGTAGTCGCACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2143.34831756692	39.948292205746	0.0186382641954782	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2138.18026790576	2138.18026790576
"AML-0160"	"2019-07-01-count-1:TCAGCAACAAGAGGCT"	2.38579692420308	-9.15524485027465	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGCAACAAGAGGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2189.37417469539	45.0911192038471	0.0205954376026751	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2183.41508649776	2183.41508649776
"AML-0160"	"2019-07-01-count-3:CATGCCTGTCTTGAAC"	2.70575918731038	-9.41866209423216	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGCCTGTCTTGAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2217.24537532109	41.1881451496191	0.0185762683769966	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2211.90576494915	2211.90576494915
"AML-0160"	"2019-07-01-count-2:ATCATTCTCTAGTGTG"	2.23143305358235	-9.42488577282103	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCATTCTCTAGTGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.92108524033	41.5665088801941	0.0187581178576519	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2206.5646454376	2206.5646454376
"AML-0160"	"2019-07-01-count-3:TTGCTGCTCAGCCCAG"	2.60299315032307	-8.22003366863402	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCTGCTCAGCCCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2079.65005753477	42.7981025868412	0.0205794731819325	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2078.34214832076	2078.34214832076
"AML-0160"	"2019-07-01-count-2:TCAAGCAGTGCTCTTC"	2.53124537047688	-9.01199915325316	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAAGCAGTGCTCTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2359.07514716691	37.4820263224404	0.0158884410136124	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2355.64527751017	2355.64527751017
"AML-0160"	"2019-07-01-count-1:CAGTGCGTCTGGACCG"	1.73202015933339	-8.86936762249144	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGTGCGTCTGGACCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.75627521073	43.876995529957	0.0186809487187087	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2344.57374095878	2344.57374095878
"AML-0160"	"2019-07-01-count-1:CAGTGCGTCAAACGAA"	2.08782639083211	-9.40712358867797	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGTGCGTCAAACGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2154.75667794778	43.131422024307	0.0200168410965947	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.98459348408	2147.98459348408
"AML-0160"	"2019-07-01-count-3:CATGCGGAGAGCCGTA"	2.15888061103169	-9.0974970093933	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGCGGAGAGCCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1885.95461794826	49.0568359981659	0.0260116736274042	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1885.95461794826	1885.95461794826
"AML-0160"	"2019-07-01-count-3:TTTATGCAGCCAACCC"	1.74802507933919	-8.05664350902709	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTATGCAGCCAACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2256.52628785424	43.8220560194455	0.0194201398208023	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2253.90200360932	2253.90200360932
"AML-0160"	"2019-07-01-count-1:CTGGACGGTACCTATG"	1.72258557853047	-8.96500017559203	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGACGGTACCTATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2310.20594214305	47.950193355322	0.0207558090300994	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2305.84314584083	2305.84314584083
"AML-0160"	"2019-07-01-count-1:GGGCTCAAGGAACTCG"	2.69776930388753	-5.02148773586424	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCTCAAGGAACTCG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2394.31366479894	33.860845553184	0.0141421928342156	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2392.66420213614	2392.66420213614
"AML-0160"	"2019-07-01-count-1:AGGTAGGCACTCGATA"	1.40845646437947	-8.32720568096312	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTAGGCACTCGATA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2477.95831723884	41.2055940878914	0.0166288487587662	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2472.33998080785	2472.33998080785
"AML-0160"	"2019-07-01-count-2:TTCTCTCGTGAACGGT"	1.5698090988094	-8.61122324382933	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCTCTCGTGAACGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2234.34857454036	49.2664673640157	0.0220495888266451	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2227.94258321962	2227.94258321962
"AML-0160"	"2019-07-01-count-3:GTACAGTAGCTCATAC"	3.40360965308492	-8.75689985668334	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTACAGTAGCTCATAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1488.37524476435	49.8116497209591	0.0334671312870739	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1486.17410526147	1486.17410526147
"AML-0160"	"2019-07-01-count-1:GATGAGGCACATATCG"	1.80192746695821	-9.57979967510375	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGAGGCACATATCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.15361349744	43.6269097261668	0.0183525833073866	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2368.87145283475	2368.87145283475
"AML-0160"	"2019-07-01-count-2:AGAAGTAGTCTTACAG"	2.65041865882222	-9.32122518932494	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAGTAGTCTTACAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2130.28033784816	36.8492820969331	0.0172978557996528	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2127.10053691913	2127.10053691913
"AML-0160"	"2019-07-01-count-2:TCTCTGGAGCTACGTT"	1.18589593943898	-8.49916555797728	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCTGGAGCTACGTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1972.14016477621	46.6271504824225	0.0236429191571754	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1969.1255567338	1969.1255567338
"AML-0160"	"2019-07-01-count-3:TCGTAGAAGTTGCCCG"	2.09822811660115	-9.21643831646117	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTAGAAGTTGCCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.63784992389	43.3753983398008	0.0201873937673291	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2144.71444366008	2144.71444366008
"AML-0160"	"2019-07-01-count-2:GTAGTACAGGTATTGA"	2.11278237876241	-8.93623545086058	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGTACAGGTATTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1991.46368642258	50.9668358463512	0.0255926513718695	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1983.58831725721	1983.58831725721
"AML-0160"	"2019-07-01-count-3:ACCGTTCGTCTTTATC"	1.90917076644246	-8.94976522838744	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCGTTCGTCTTTATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.71547315595	39.7875117783087	0.0170416961877269	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2329.45005369938	2329.45005369938
"AML-0160"	"2019-07-01-count-1:TTCCGTGTCTACCACC"	7.18935122069661	-10.2976351014343	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCGTGTCTACCACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2000.13731435364	47.6127874730485	0.0238047593689511	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2000.13731435364	2000.13731435364
"AML-0160"	"2019-07-01-count-2:TGTTCATCACCGCTGA"	2.87186851081197	-8.78352453624877	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTCATCACCGCTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2182.05062364903	42.0206159870329	0.0192573973910661	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2179.4547997066	2179.4547997066
"AML-0160"	"2019-07-01-count-3:CGCATGGGTCTAACGT"	1.83835401114766	-7.82167150890502	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCATGGGTCTAACGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.89019339926	36.4999633439391	0.0166370967215024	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2189.97526479757	2189.97526479757
"AML-0160"	"2019-07-01-count-2:AGGGTTTCATTGAGCT"	1.75296749648396	-8.77859880840453	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGTTTCATTGAGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.8391963114	37.8361037000789	0.0158652641061081	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2378.46886758908	2378.46886758908
"AML-0160"	"2019-07-01-count-1:CCCAACTCACCTGAAT"	1.96903218802754	-4.22680857097777	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCAACTCACCTGAAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1892.61447186353	42.2652226523193	0.0223316598708577	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1892.61447186353	1892.61447186353
"AML-0160"	"2019-07-01-count-1:ACGTTCCCACTTGGCG"	1.91126312789266	-9.22494032299193	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTTCCCACTTGGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.89968409074	49.8792182232126	0.0218586375952315	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2276.95434802547	2276.95434802547
"AML-0160"	"2019-07-01-count-2:TTGGGCGGTCCTTTGC"	1.58014072951619	-8.26074697887572	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGGCGGTCCTTTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2135.60454028116	46.7094987567712	0.0218717922142185	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2134.52168500269	2134.52168500269
"AML-0160"	"2019-07-01-count-3:GTGCTGGGTGGGTCAA"	-8.6620057624882	3.81086919391481	"2019-07-01-count-3"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCTGGGTGGGTCAA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1882.83505042334	30.9244636106097	0.0164244146632264	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1876.78511821441	1876.78511821441
"AML-0160"	"2019-07-01-count-1:TCAGGTACATCTTAGG"	2.09746970710103	-8.835475944635	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGGTACATCTTAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.1976259802	43.2647816320085	0.0188173392070043	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2295.27471899387	2295.27471899387
"AML-0160"	"2019-07-01-count-2:CCTAAGATCAGACCTA"	2.00648023661916	-10.2253608933655	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTAAGATCAGACCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2152.73927530504	37.4694741919241	0.0174054864059721	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.49857652517	2147.49857652517
"AML-0160"	"2019-07-01-count-1:TCAAGTGCACGCCACA"	-7.889716009528	2.10530898654786	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAAGTGCACGCCACA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2438.21245697389	44.9797902328631	0.0184478551506903	3021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2429.49651941447	2429.49651941447
"AML-0160"	"2019-07-01-count-2:ATGGGTTCATAAGCGG"	2.31662978705708	-9.67475225841673	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGGTTCATAAGCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1965.46442068723	45.9195975206152	0.0233632301034273	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1962.6803249296	1962.6803249296
"AML-0160"	"2019-07-01-count-2:TAAGCACCAAGCAGGT"	2.58313622054402	-9.27852919017943	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCACCAAGCAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1948.45922495263	49.8825137259109	0.0256010046744107	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1946.95519149869	1946.95519149869
"AML-0160"	"2019-07-01-count-1:ACTTCCGTCAGCTTCC"	2.00335850295369	-9.51311590587767	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGTCAGCTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.81917212571	45.3464126565531	0.0197689570335791	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2292.65492464718	2292.65492464718
"AML-0160"	"2019-07-01-count-3:CTGTAGACAACCCGCA"	2.03460075434987	-8.74096205150756	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTAGACAACCCGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.56646966104	46.8285350351349	0.0217244681127827	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2153.1288591247	2153.1288591247
"AML-0160"	"2019-07-01-count-3:TGTAACGCATGAGGGT"	-8.29476771774944	1.35063955867616	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGCATGAGGGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2411.89803835798	38.6672450538315	0.0160318738349968	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2401.81639442831	2401.81639442831
"AML-0160"	"2019-07-01-count-2:TCTGTCGAGATCGACG"	2.60990562018697	-9.09090139782103	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGTCGAGATCGACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2076.89047045135	30.0981554105864	0.0144919319717643	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2073.62329668213	2073.62329668213
"AML-0160"	"2019-07-01-count-1:GATGGAGTCTGGAGAG"	2.05069531974141	-4.27780916607054	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGGAGTCTGGAGAG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2233.17551907494	41.8661889440673	0.0187473794990416	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2226.15497825775	2226.15497825775
"AML-0160"	"2019-07-01-count-1:CTAGGTAGTGTCCTAA"	3.30954804000203	-8.55406286632689	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGGTAGTGTCCTAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.7599460043	38.2847970153135	0.015737186514516	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2430.73299282426	2430.73299282426
"AML-0160"	"2019-07-01-count-3:GATGAGGCAGTAGATA"	-8.29710708084758	3.86623356426088	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGAGGCAGTAGATA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1852.16996667255	46.2094549480408	0.0249488199136803	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1844.55284352274	1844.55284352274
"AML-0160"	"2019-07-01-count-2:TCTGTCGCATCGGCCA"	2.63202538070027	-9.36504938518675	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGTCGCATCGGCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2175.41901698073	43.2028016376337	0.0198595311066072	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2170.9879387285	2170.9879387285
"AML-0160"	"2019-07-01-count-3:TCGTGCTCAAGACGAC"	-8.98700080338176	5.46630189502565	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTGCTCAAGACGAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1584.23749213456	44.7202510660393	0.0282282494184534	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1582.04945601697	1582.04945601697
"AML-0160"	"2019-07-01-count-3:GCACATAGTGGGAGAG"	1.74722959575002	-8.67470076000365	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCACATAGTGGGAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2229.41332796348	43.006151145726	0.0192903445073647	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2227.07143342899	2227.07143342899
"AML-0160"	"2019-07-01-count-2:GCTTTCGTCTCTTGCG"	2.41745199736897	-9.23163607036742	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTTTCGTCTCTTGCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2241.96374116449	42.6412560987594	0.0190196011272739	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2237.01159618819	2237.01159618819
"AML-0160"	"2019-07-01-count-2:TCCTCCCGTCTTTCTA"	1.65289284762685	-8.74293329631957	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTCCCGTCTTTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2420.8631508497	43.1537591058322	0.01782577387354	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2412.90592686874	2412.90592686874
"AML-0160"	"2019-07-01-count-3:AGACTCAGTTACCGTA"	1.67068554934804	-8.90973856365355	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACTCAGTTACCGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2284.12093653421	41.0459049121516	0.0179701101879624	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2280.33304953343	2280.33304953343
"AML-0160"	"2019-07-01-count-3:TCGTGGGCACTAGTAC"	-0.761269668967086	-7.01307203685912	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTGGGCACTAGTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1609.34572346568	43.8135527125436	0.0272244503301581	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1609.34572346568	1609.34572346568
"AML-0160"	"2019-07-01-count-3:AGACTCAGTGCAACAG"	-8.74378619614299	4.02666590297548	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACTCAGTGCAACAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2037.27605413315	38.6415782921977	0.0189672765327031	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2025.53923417848	2025.53923417848
"AML-0160"	"2019-07-01-count-1:CTGTAGACAGCGACCT"	1.96397354182546	-4.05573799526366	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTAGACAGCGACCT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2507.62990397927	40.3488300344002	0.0160904246557165	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2500.86993349062	2500.86993349062
"AML-0160"	"2019-07-01-count-2:ACCAAACCAAGATCCT"	-7.95336947861369	1.84969351375429	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCAAACCAAGATCCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2492.13240863581	38.5885730193335	0.0154841584201607	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2484.44213134452	2484.44213134452
"AML-0160"	"2019-07-01-count-2:CTCTGGTCATGACAAA"	2.27972950515096	-4.7870493165222	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCTGGTCATGACAAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2057.03140657641	40.959502736981	0.0199119481627902	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2055.68670737996	2055.68670737996
"AML-0160"	"2019-07-01-count-3:TTCCTAACATGATCTG"	1.73511149463002	-8.54928400432738	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTAACATGATCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.84642528688	41.82328108724	0.0195358623548326	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2132.18305951135	2132.18305951135
"AML-0160"	"2019-07-01-count-2:ACGCACGCAAGGACAC"	2.02305140075032	-8.94245531475218	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGCACGCAAGGACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2141.8322510529	44.1275054411572	0.0206026897855632	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.27305295297	2136.27305295297
"AML-0160"	"2019-07-01-count-2:GGAACCCTCCATGATG"	1.0538635450298	-10.5218544236389	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+ IFN+"	24	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.142857142857143	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCTCCATGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1924.49975482166	37.5496268511272	0.0195113700363172	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1922.33398568781	1922.33398568781
"AML-0160"	"2019-07-01-count-3:CTCAAGACAAGTGGCA"	2.34930958327596	-9.00868990337523	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCAAGACAAGTGGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.38306645577	41.7278346886234	0.017776320910258	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2346.1291125811	2346.1291125811
"AML-0160"	"2019-07-01-count-3:TTTCGATTCCACGAAT"	2.22291054305379	-4.33945562755736	"2019-07-01-count-3"	"AML0160"	"DC precursor"	"DC precursor"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTCGATTCCACGAAT"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2348.63483164303	37.9814179783356	0.0161717000304236	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2344.76315094864	2344.76315094864
"AML-0160"	"2019-07-01-count-3:GATGATCTCTGTCAGA"	1.66759063777272	-8.30271055614623	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGATCTCTGTCAGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2146.47971178093	42.4070493102535	0.0197565572492965	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2141.57310639957	2141.57310639957
"AML-0160"	"2019-07-01-count-3:ACTATGGCAAGACTGG"	-8.73267589035686	4.87429711902467	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATGGCAAGACTGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1860.34443015028	51.6904169768117	0.0277854015305306	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1851.26052803995	1851.26052803995
"AML-0160"	"2019-07-01-count-2:TTGTGTTAGCAGCCTC"	-7.95426879349406	1.97089705550996	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTGTTAGCAGCCTC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2818.38787552919	39.0328267983045	0.0138493452718872	3391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2805.43084560605	2805.43084560605
"AML-0160"	"2019-07-01-count-1:CTGTATTTCGTCAGAT"	2.06331100043599	-8.90425779735716	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTATTTCGTCAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2147.39686167892	45.3147385492195	0.0211021722895648	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2138.08001718385	2138.08001718385
"AML-0160"	"2019-07-01-count-2:AAACGAAAGAATTCAG"	2.93397631224934	-9.15892317211302	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAACGAAAGAATTCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.25249707357	36.1160704291161	0.014794074137112	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2432.8797051083	2432.8797051083
"AML-0160"	"2019-07-01-count-3:AGGTTACGTACTCCCT"	1.8771708208019	-9.2242756119934	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTTACGTACTCCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.20159581511	43.3611771608434	0.0195920594142142	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2209.01472204064	2209.01472204064
"AML-0160"	"2019-07-01-count-2:CGCATGGGTCGCGTTG"	-7.71904216232951	0.530876285675444	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCATGGGTCGCGTTG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2659.72617296153	40.1460847974471	0.0150940669026637	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2649.67321035915	2649.67321035915
"AML-0160"	"2019-07-01-count-3:TGATTTCCACTGAGTT"	5.05989660796468	-4.78500845348509	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGATTTCCACTGAGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.38508207885	39.6074605624451	0.0172477433647973	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2289.94954589197	2289.94954589197
"AML-0160"	"2019-07-01-count-1:CATACTTCACTTACAG"	3.55625524100606	-2.26614096080931	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	17	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATACTTCACTTACAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1858.63776471131	51.01766386622	0.0274489547317168	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1852.24626395346	1852.24626395346
"AML-0160"	"2019-07-01-count-3:CATCCGTCATACACCA"	1.60792984542195	-9.00243475353392	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCCGTCATACACCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2340.48669216417	43.5381797839787	0.0186021907023622	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2337.11458446989	2337.11458446989
"AML-0160"	"2019-07-01-count-2:CCTCACAGTCACTCGG"	1.09043623980824	9.71601197803346	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCACAGTCACTCGG"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1523.32631485222	40.796524160511	0.0267812114599155	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1521.04307752277	1521.04307752277
"AML-0160"	"2019-07-01-count-3:TGTAGACAGGTCCCTG"	1.75816633281056	-9.04014780437621	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAGACAGGTCCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2078.70481232353	45.5640843446916	0.0219194587295736	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.71626186285	2074.71626186285
"AML-0160"	"2019-07-01-count-1:ACGCACGGTGATAGTA"	2.23640241202657	-10.4509239426819	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGCACGGTGATAGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2349.2798838967	45.9690730925831	0.019567303754517	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2347.31102877111	2347.31102877111
"AML-0160"	"2019-07-01-count-2:TGTTTGTGTTACTCAG"	1.87220873412434	-9.38982202922972	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTTGTGTTACTCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.89157781004	48.6323093769465	0.0209361081858138	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.67407508392	2321.67407508392
"AML-0160"	"2019-07-01-count-3:TTCCTCTTCTGAACGT"	1.96038188514058	-8.72439958965453	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTCTTCTGAACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2301.91760980336	42.2700950324902	0.0183629921646505	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2299.33985850542	2299.33985850542
"AML-0160"	"2019-07-01-count-3:CATTGAGAGTTTCGAC"	1.5575621324474	-8.72746946727904	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGAGAGTTTCGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1943.48935605332	42.7386386166998	0.021990672850141	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1941.93843890198	1941.93843890198
"AML-0160"	"2019-07-01-count-3:CTCAATTGTTATCTGG"	2.39209522780721	-9.42738439953002	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCAATTGTTATCTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.49031076262	38.7099531807429	0.0171854027499177	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2248.68132767613	2248.68132767613
"AML-0160"	"2019-07-01-count-2:AATCACGCATGGCCCA"	-7.84788976135905	1.84925541961519	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCACGCATGGCCCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2465.0949242394	39.8362616669165	0.0161601329324906	2889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2455.22739746333	2455.22739746333
"AML-0160"	"2019-07-01-count-1:AGAGAGCCATTACGGT"	1.92230238494222	-9.1466970673767	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAGAGCCATTACGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.45684697141	37.5104894280756	0.0145872521532898	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2566.53301866532	2566.53301866532
"AML-0160"	"2019-07-01-count-1:TCATCATAGATTCGAA"	2.27220263060872	-9.01272489940795	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCATAGATTCGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.94313412804	41.2100867775666	0.0164121943732817	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2507.98961332285	2507.98961332285
"AML-0160"	"2019-07-01-count-2:CCTCATGCAGCTACCG"	1.72987379607503	-8.98567869579466	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCATGCAGCTACCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2075.82177175933	46.7641625146732	0.0225280239136518	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2069.01400360013	2069.01400360013
"AML-0160"	"2019-07-01-count-2:TCCTGCACAATGGCAG"	1.60139324244801	-9.42577459728392	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTGCACAATGGCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.10321254871	42.7303355470216	0.0192123887533325	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2217.89153039194	2217.89153039194
"AML-0160"	"2019-07-01-count-1:CTCAACCGTGTAGCAG"	-7.92041287842448	2.06398651683656	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAACCGTGTAGCAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2003.76771165747	42.9049112275177	0.0214121182699504	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1999.88624674947	1999.88624674947
"AML-0160"	"2019-07-01-count-1:ATACCTTTCTCTTAAC"	2.24511184272115	-8.61754896557006	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATACCTTTCTCTTAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.33406513112	41.163711021575	0.0151653075980485	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2710.94088614523	2710.94088614523
"AML-0160"	"2019-07-01-count-3:AAAGTGATCGTTGCCT"	1.92168690738026	-8.09317495739134	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGTGATCGTTGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2130.3253402472	45.6850189382921	0.0214450901349138	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2126.79972136779	2126.79972136779
"AML-0160"	"2019-07-01-count-3:ACGGAAGCATTCAGCA"	2.33342232283894	-4.66176273739012	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGGAAGCATTCAGCA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2239.18036917574	39.3483821094864	0.0175726719701329	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2236.87316471865	2236.87316471865
"AML-0160"	"2019-07-01-count-1:CATCAAGAGAACAAGG"	1.8859803872997	-8.84935762798461	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCAAGAGAACAAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.87417695828	42.1653670095177	0.0170304967037217	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2468.91271449835	2468.91271449835
"AML-0160"	"2019-07-01-count-1:CGCAGGTGTTGCCGAC"	1.74621822413747	-9.05057623302611	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCAGGTGTTGCCGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.68461832562	42.1327638328024	0.017412502238394	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2415.50555637036	2415.50555637036
"AML-0160"	"2019-07-01-count-2:TGCTTGCAGGGCAACT"	-2.63661585274394	-11.4545879594055	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	31	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	1	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTGCAGGGCAACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2168.37074828813	50.0857008755724	0.0230983105242098	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2162.98020526317	2162.98020526317
"AML-0160"	"2019-07-01-count-1:TAACGACTCCCTGTTG"	-7.45703349533732	0.169197037163652	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACGACTCCCTGTTG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2066.43492862078	36.7087860154022	0.0177643077490483	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2063.13521867085	2063.13521867085
"AML-0160"	"2019-07-01-count-3:GATGTTGGTGGTCTTA"	3.47445263442342	-3.93032243168028	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGTTGGTGGTCTTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2102.66657014341	46.2609036477503	0.0220010648880936	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2100.26627951229	2100.26627951229
"AML-0160"	"2019-07-01-count-1:AATCACGAGGAGACCT"	1.86926998671834	-10.270178817865	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCACGAGGAGACCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.38542227799	44.9624778976046	0.0213559367429057	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2101.60504899906	2101.60504899906
"AML-0160"	"2019-07-01-count-2:AATCGTGAGACGCCCT"	-0.29882643643077	11.0039176710877	"2019-07-01-count-2"	"AML0160"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCGTGAGACGCCCT"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1527.72675041562	48.6932902477838	0.0318730363492926	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1524.29818257019	1524.29818257019
"AML-0160"	"2019-07-01-count-3:ACGGGTCGTAGTCGGA"	-8.14050040665324	2.38277623737184	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGGGTCGTAGTCGGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1996.27863202818	47.7198739187519	0.0239044155225312	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1994.17957710675	1994.17957710675
"AML-0160"	"2019-07-01-count-3:GACTCAAGTATACCCA"	1.98774435099904	-9.29461386119994	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCAAGTATACCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1544.24747431276	47.8376660285969	0.0309779791285631	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1537.77793768395	1537.77793768395
"AML-0160"	"2019-07-01-count-2:TTGTTTGCAACGAGGT"	2.75814857062642	-9.47898580944213	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTTGCAACGAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.54387026689	43.7192014474828	0.0202634125080732	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2153.50030691894	2153.50030691894
"AML-0160"	"2019-07-01-count-2:TTTGATCAGAGCATTA"	-7.82947049561198	1.86886618221132	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGATCAGAGCATTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2456.93442011738	46.3882293779525	0.018880532177874	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2447.869666039	2447.869666039
"AML-0160"	"2019-07-01-count-3:TCATGGACAGTTCACA"	2.2809747653896	-9.21594335949095	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGGACAGTTCACA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.44435546634	43.8151206919901	0.0196177355324537	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2231.96659339499	2231.96659339499
"AML-0160"	"2019-07-01-count-3:TCCTTCTCAGAGTGTG"	2.06093730506245	-9.77015211498412	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTTCTCAGAGTGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2023.3562740264	42.6510056241787	0.0210793354446199	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2017.6073956229	2017.6073956229
"AML-0160"	"2019-07-01-count-2:AGTAACCCACTAGAGG"	1.74623002585713	-9.46725847637328	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTAACCCACTAGAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.54023878307	42.0291165896051	0.0183570115421707	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2283.12757488842	2283.12757488842
"AML-0160"	"2019-07-01-count-3:GATGTTGTCAGCTGAT"	2.96277727660481	-9.44948103344115	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGTTGTCAGCTGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2086.87355911672	37.88390745113	0.0181534273054686	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2084.12335018394	2084.12335018394
"AML-0160"	"2019-07-01-count-1:GCAACATAGTTCGCAT"	2.61940660056416	-5.22254564678343	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACATAGTTCGCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.50619739814	39.9042559504734	0.0161587996792705	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2464.90508550092	2464.90508550092
"AML-0160"	"2019-07-01-count-2:AGTAACCGTGCGTGCT"	2.24313654479329	-4.44310905849608	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTAACCGTGCGTGCT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2274.62013591611	37.7708794491601	0.0166053570232499	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2268.86870654648	2268.86870654648
"AML-0160"	"2019-07-01-count-3:CTTCAATAGTTAGTAG"	-8.71434913101848	4.15742251956788	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCAATAGTTAGTAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1802.26589769042	37.3412346760847	0.0207190485732083	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1794.62873721227	1794.62873721227
"AML-0160"	"2019-07-01-count-2:GCGTGCATCGCGAAGA"	1.40058972415273	-7.48513128673705	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGTGCATCGCGAAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1680.90987772295	34.9336784918838	0.0207826005158628	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1680.90987772295	1680.90987772295
"AML-0160"	"2019-07-01-count-1:AATCGACAGAATTTGG"	1.69857408580129	-8.69660284435423	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCGACAGAATTTGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2444.53181710355	43.013989713326	0.0175960032151645	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2435.49426430509	2435.49426430509
"AML-0160"	"2019-07-01-count-3:GATTCGACAGAGCTAG"	1.73116626319234	-8.98183443462523	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTCGACAGAGCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2128.40674083561	43.7121899610447	0.020537517158907	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2125.83248794628	2125.83248794628
"AML-0160"	"2019-07-01-count-2:GAGCTGCAGGGCATGT"	2.77747907218282	-9.71207430278929	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGCTGCAGGGCATGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1920.75802650469	48.3277173706717	0.0251607525278008	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1908.58863661109	1908.58863661109
"AML-0160"	"2019-07-01-count-2:TGAATCGCAAGGTCAG"	2.20895685729329	-7.88143494045409	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAATCGCAAGGTCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2069.96075689	40.4702428671676	0.0195512126171763	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2065.80331945164	2065.80331945164
"AML-0160"	"2019-07-01-count-3:CTTCAATTCTGTGTGA"	1.77832128581349	-7.93732502376708	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCAATTCTGTGTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.61451689724	41.3632806347342	0.018618567856904	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2219.26096558965	2219.26096558965
"AML-0160"	"2019-07-01-count-3:CCTCACATCATGGTAC"	2.12760963019673	-9.38172724163207	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCACATCATGGTAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2169.71658682582	41.1125133150141	0.0189483334204305	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2167.26856781474	2167.26856781474
"AML-0160"	"2019-07-01-count-1:CATCCGTAGCTCGACC"	-7.13861594620402	4.07549998843995	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCGTAGCTCGACC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2240.62238688755	32.2652548295011	0.0144001305254835	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2227.71282454883	2227.71282454883
"AML-0160"	"2019-07-01-count-1:CATTCTAGTAAGGTCG"	2.00719561156575	-9.17998983776244	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTCTAGTAAGGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2088.35544515377	49.0715908788504	0.0234977196974422	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2084.45213059562	2084.45213059562
"AML-0160"	"2019-07-01-count-3:CAACAACAGGCTAAAT"	1.58874346789662	-8.73766233837279	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACAACAGGCTAAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.8340104905	45.5618774030309	0.0197422679429823	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2305.62340075271	2305.62340075271
"AML-0160"	"2019-07-01-count-3:CCTCAGTAGATCCGAG"	1.9575740295345	-9.22655584728392	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCAGTAGATCCGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.57503544047	43.8501399600669	0.0203994460472888	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2144.0511251583	2144.0511251583
"AML-0160"	"2019-07-01-count-2:CTACAGACAGTCAGAG"	1.96486928042714	-8.67017080700072	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACAGACAGTCAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.21957832577	44.5317508332882	0.0193597825411524	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2296.72783716106	2296.72783716106
"AML-0160"	"2019-07-01-count-1:TTCTGTATCTATACGG"	3.62285818633382	-9.9257793656555	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTGTATCTATACGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.96593801817	52.3065438295377	0.0250035351336028	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2083.13960298502	2083.13960298502
"AML-0160"	"2019-07-01-count-2:GCCCAGACAAGCACCC"	-7.68931565704997	0.836398697737135	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCAGACAAGCACCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2535.98036614296	45.4187838504145	0.0179097537413088	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2526.920685168	2526.920685168
"AML-0160"	"2019-07-01-count-1:GTTGCGGTCTCCCATG"	2.19944014128987	-9.17074110424193	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCGGTCTCCCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2217.94193407209	49.2897795740171	0.0222232055838911	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2215.47005284498	2215.47005284498
"AML-0160"	"2019-07-01-count-1:CCGATGGTCATTGCTT"	-3.69002280655559	-9.71100809490355	"2019-07-01-count-1"	"AML0160"	"cDC1"	"cDC1"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGATGGTCATTGCTT"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2455.21026866168	38.9041408702727	0.0158455434008424	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2448.18264058363	2448.18264058363
"AML-0160"	"2019-07-01-count-3:ATCGTCCGTACCCACG"	1.55263294753377	-8.22826483165892	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGTCCGTACCCACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2232.12041266921	44.5781699799737	0.0199712209641353	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2227.10749412297	2227.10749412297
"AML-0160"	"2019-07-01-count-2:TGGTTAGGTGTCTTCC"	-7.5358661216801	3.50645730579225	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTTAGGTGTCTTCC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1920.37455873205	47.3452855820227	0.024654193301375	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1909.48908268988	1909.48908268988
"AML-0160"	"2019-07-01-count-3:TGCATGAGTTGAGAGC"	1.592457194894	-8.25910475170287	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCATGAGTTGAGAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.021253484	41.9223059721356	0.0182825631940564	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.98945618769	2286.98945618769
"AML-0160"	"2019-07-01-count-1:GTCGCGAGTTGCGTAT"	1.74443687972371	-9.05796625530394	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGCGAGTTGCGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.22247992217	41.1934239913883	0.0188336688972098	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2182.06214390112	2182.06214390112
"AML-0160"	"2019-07-01-count-1:CATCGGGAGTAAGCAT"	2.39537419852559	-4.94448139583739	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGGGAGTAAGCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.63389930348	47.4620925710204	0.0221512842611373	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.9892759715	2137.9892759715
"AML-0160"	"2019-07-01-count-3:ATTCCCGAGGGTTAGC"	2.25961651381795	-9.70715525066527	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCCCGAGGGTTAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.22984740948	44.3400617777355	0.0186676930765646	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.55376374553	2370.55376374553
"AML-0160"	"2019-07-01-count-3:TCCGAAATCCTAAACG"	1.68328966674153	-8.91586687481078	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCGAAATCCTAAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.2915564629	42.9533076424516	0.0183381558644713	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2336.99795103407	2336.99795103407
"AML-0160"	"2019-07-01-count-1:AGTCATGTCCTACCGT"	1.87582757052724	-8.97010519420775	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTCATGTCCTACCGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.69948698918	42.7593785000478	0.0174123009458592	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2452.24895413568	2452.24895413568
"AML-0160"	"2019-07-01-count-3:CTCATGCTCATGGTAC"	-9.11224399033244	3.45804116809694	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATGCTCATGGTAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1881.34265396258	44.2515981847154	0.0235212857644568	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1879.99704013414	1879.99704013414
"AML-0160"	"2019-07-01-count-2:GAGGCCTTCCTTATCA"	-7.83251271668132	-0.671771072503649	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGGCCTTCCTTATCA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3430.28757937544	37.4297754213984	0.010911556117465	4454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	3417.01077481117	3417.01077481117
"AML-0160"	"2019-07-01-count-3:TGTGCGGGTCTAGATC"	2.00168861922566	-9.02351000225218	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGCGGGTCTAGATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.92372959633	44.1095635105831	0.0205263513558339	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.6297970881	2147.6297970881
"AML-0160"	"2019-07-01-count-1:ATGCCTCCAAACCATC"	-8.64389739456828	4.77878806674806	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCCTCCAAACCATC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1797.13190809349	47.6250228530512	0.0265005716266953	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1787.26552864753	1787.26552864753
"AML-0160"	"2019-07-01-count-3:TGTGCGGGTGACTATC"	2.15638818320577	-9.44343759929808	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGCGGGTGACTATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2109.80194145597	46.9372207957409	0.0222472166099864	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2105.49893254351	2105.49893254351
"AML-0160"	"2019-07-01-count-1:CCGCAAGTCCCATTCG"	9.13105454024617	7.82216117465822	"2019-07-01-count-1"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGCAAGTCCCATTCG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2136.00955353796	39.2546653539043	0.0183775701231698	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2131.55661941583	2131.55661941583
"AML-0160"	"2019-07-01-count-1:AATGACCGTGCATTTG"	-3.02732191506084	-5.57969334041747	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00611995104039168	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGACCGTGCATTTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2321.3823958581	44.2370551024349	0.019056341247941	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2313.30741965321	2313.30741965321
"AML-0160"	"2019-07-01-count-1:CTCAGTCCAGAGGACT"	2.09056152877156	-9.3603086701599	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAGTCCAGAGGACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2368.93199520892	45.5173194891699	0.0192142786628012	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2359.65027013841	2359.65027013841
"AML-0160"	"2019-07-01-count-3:CAACCAAGTCTTCAAG"	1.54107083854024	-8.74406244671019	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACCAAGTCTTCAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2664.88231741324	41.5702576140811	0.0155992845696964	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2661.52464982583	2661.52464982583
"AML-0160"	"2019-07-01-count-1:TGTGTGATCTTTCTAG"	1.6273875432903	-8.57603361522826	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGTGATCTTTCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.39766989404	41.0216028381421	0.0167750232786963	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2441.34114335837	2441.34114335837
"AML-0160"	"2019-07-01-count-3:GATTTCTGTCAGACTT"	-7.94677911225017	3.63432214343873	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTTCTGTCAGACTT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2066.66353357299	32.7774082522313	0.0158600602951384	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2061.99995231021	2061.99995231021
"AML-0160"	"2019-07-01-count-1:AAACGCTAGATGAACT"	1.75039138373677	-8.67995645916136	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGCTAGATGAACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.78992443267	42.4496377948343	0.0179128273595799	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2366.48885687673	2366.48885687673
"AML-0160"	"2019-07-01-count-1:TGCAGTAGTCGTTGGC"	1.92469205436055	-9.10677149212035	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGTAGTCGTTGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2238.48370088854	46.5898791620046	0.0208131420137262	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2234.80233199778	2234.80233199778
"AML-0160"	"2019-07-01-count-3:TCTCCGAGTAGCGCCT"	1.81057085570638	-9.24721243297728	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCCGAGTAGCGCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.73410920871	44.523878480857	0.0215535379322908	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2060.2890097098	2060.2890097098
"AML-0160"	"2019-07-01-count-2:AGTCAACGTGCCTGCA"	1.97191490706746	-9.15452959453734	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCAACGTGCCTGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.12711542862	40.9099055306108	0.0185185837631952	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2206.48528602043	2206.48528602043
"AML-0160"	"2019-07-01-count-3:ACGTCCTTCCGTGTCT"	5.22569193419759	-5.1782117119995	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTTCCGTGTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.07869557398	37.9584452032488	0.0149203109437167	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2536.65296470119	2536.65296470119
"AML-0160"	"2019-07-01-count-3:CTCCAACCATCAGTCA"	1.52138354358022	-8.7352619401184	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACCATCAGTCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2431.31682144114	43.1600093315705	0.0177517010333469	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2430.31303610825	2430.31303610825
"AML-0160"	"2019-07-01-count-3:ACGTCCTGTCGGTAAG"	-7.78732476654704	0.868778026941694	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTGTCGGTAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2461.95460802585	43.1941399399486	0.017544653260112	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2458.26863628626	2458.26863628626
"AML-0160"	"2019-07-01-count-1:TAGTGCACAAATGAAC"	1.8837351995403	-8.98460485851439	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGTGCACAAATGAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.06706846486	40.2239191514824	0.0164577804228373	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2442.28121419201	2442.28121419201
"AML-0160"	"2019-07-01-count-3:TCGACGGAGGGCGAGA"	3.18329252776448	-9.09668161785277	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGACGGAGGGCGAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1591.01408643456	51.1734033546773	0.0321640165168846	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1588.94299143855	1588.94299143855
"AML-0160"	"2019-07-01-count-2:TAACGACTCTCCAATT"	1.70774938639943	-8.84334471141966	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACGACTCTCCAATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.99471338884	41.8498639410289	0.0169090720536234	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2471.34129656573	2471.34129656573
"AML-0160"	"2019-07-01-count-2:AAATGGACAGGTCAGA"	2.17804207381551	-8.33384706890257	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAATGGACAGGTCAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2205.05800229478	45.3791826282169	0.0205795868321792	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.51181837169	2195.51181837169
"AML-0160"	"2019-07-01-count-1:GCAGCTGAGTCACACT"	1.73573984679524	-8.65687944805297	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAGCTGAGTCACACT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2360.87413536636	39.2693311019052	0.0166333861317056	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2358.7616801809	2358.7616801809
"AML-0160"	"2019-07-01-count-2:GGTGAAGGTCGCTTGG"	2.08380403098409	-9.10823633587035	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGAAGGTCGCTTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.8686422242	37.9694150895667	0.016530947565551	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2293.70858781921	2293.70858781921
"AML-0160"	"2019-07-01-count-1:ATGGAGGGTCAGGAGT"	1.7104307609493	-9.24754621898802	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGAGGGTCAGGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.75165351888	40.0441348131558	0.0181215544060746	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2206.46910353247	2206.46910353247
"AML-0160"	"2019-07-01-count-1:CTTCTAAAGCCATTCA"	-7.96752391281779	2.25567100131837	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCTAAAGCCATTCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2359.75214105496	49.7758741948707	0.0210936874805071	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2353.11071821759	2353.11071821759
"AML-0160"	"2019-07-01-count-1:TCAGTCCAGCCTTGAT"	2.73328389701192	-4.91505815899047	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGTCCAGCCTTGAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2601.00626512438	39.6471072900885	0.0152429880011045	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2593.46531744135	2593.46531744135
"AML-0160"	"2019-07-01-count-2:ACGTTCCTCGCTAAAC"	5.44666685637776	-4.94565107738646	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTTCCTCGCTAAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.62863974764	40.2832445464529	0.01694261411266	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.30654701968	2370.30654701968
"AML-0160"	"2019-07-01-count-2:ACGTTCCTCGTAGCTA"	2.92630137976949	-9.27164270794066	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTTCCTCGTAGCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2087.67951357595	47.9522424711178	0.0229691588959366	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2081.98641755635	2081.98641755635
"AML-0160"	"2019-07-01-count-2:CCTTGTGAGGTGAGCT"	1.42149402674977	-9.3603668442932	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTTGTGAGGTGAGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1716.37506899481	49.0881050584861	0.0285998707073009	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1714.45526580944	1714.45526580944
"AML-0160"	"2019-07-01-count-2:GTTGAACCAGAAATTG"	-8.69915519180949	0.0732465882780924	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGAACCAGAAATTG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2656.62355187875	40.6688039157649	0.0153084556850383	3066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2643.41041874212	2643.41041874212
"AML-0160"	"2019-07-01-count-3:GAGACTTGTATGGTAA"	2.58159269866292	-8.32167818462523	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGACTTGTATGGTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1950.45459469275	50.2258276097179	0.025750831496608	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1947.07215050774	1947.07215050774
"AML-0160"	"2019-07-01-count-1:GGTGTCGAGCTCATAC"	1.96446682986562	-8.66690065776976	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGTCGAGCTCATAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2675.16487774665	43.6457335145567	0.0163151564517102	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2668.41601915536	2668.41601915536
"AML-0160"	"2019-07-01-count-2:TTAGTCTGTCAACCTA"	1.9113151031429	-9.24811746990355	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTAGTCTGTCAACCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1991.09563455134	48.0780911820897	0.0241465504457918	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1987.90391112269	1987.90391112269
"AML-0160"	"2019-07-01-count-3:ATAGGCTAGACTTGTC"	2.06715073165242	-8.63776590740355	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATAGGCTAGACTTGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1527.02308020205	29.8001209207165	0.0195151738746303	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1527.02308020205	1527.02308020205
"AML-0160"	"2019-07-01-count-3:TCCTAATGTGACTCGC"	2.21991052207295	-7.20531608974608	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTAATGTGACTCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2121.39940614415	41.5062686860045	0.0195655134840667	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2116.33743368263	2116.33743368263
"AML-0160"	"2019-07-01-count-3:TGGATGTCAAGCTACT"	-8.54509768906291	0.0224936150941028	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGATGTCAAGCTACT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2941.71036218873	41.7166992777536	0.014181103555931	3124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2925.75056377114	2925.75056377114
"AML-0160"	"2019-07-01-count-2:TGCACGGCACTGAGGA"	2.19388522681538	-8.91298296367797	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCACGGCACTGAGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.40367430834	41.9549258029666	0.0187265028548567	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2235.33106050556	2235.33106050556
"AML-0160"	"2019-07-01-count-2:ATGAAAGCATGGAAGC"	2.50949849662129	-8.42765428936156	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGAAAGCATGGAAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2226.73156678166	41.2809624900923	0.0185388140653866	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2222.98376835794	2222.98376835794
"AML-0160"	"2019-07-01-count-3:ACAAAGATCGCTTACC"	1.71855606612508	-9.06589701091918	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACAAAGATCGCTTACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.91444687042	43.8655134934632	0.0200857288875592	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2183.91444687042	2183.91444687042
"AML-0160"	"2019-07-01-count-3:TCACGCTCAGTTTCAG"	1.5558258491451	-8.48337461864623	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACGCTCAGTTTCAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2428.84304851854	39.177845131852	0.0161302498141032	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2426.10991585915	2426.10991585915
"AML-0160"	"2019-07-01-count-3:GAGAGGTTCGTGGAAG"	1.95880021628682	-8.96274855053099	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGAGGTTCGTGGAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1938.73123398918	43.3298492597197	0.0223495905466809	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1937.11523988341	1937.11523988341
"AML-0160"	"2019-07-01-count-1:ATGGGTTCACACAGAG"	1.5310033756191	-9.22235586559447	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGGTTCACACAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.66183809069	45.8020567552152	0.01887451149405	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2422.72649873012	2422.72649873012
"AML-0160"	"2019-07-01-count-2:ACTATCTAGGATCACG"	2.75270738181416	-9.43627073681029	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTATCTAGGATCACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.32814948541	41.7395902169145	0.0190302532827599	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2187.26081677157	2187.26081677157
"AML-0160"	"2019-07-01-count-2:CGTTAGAGTACAGAAT"	1.67006160792653	-8.34532549297484	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTAGAGTACAGAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2102.85864233962	47.5435121218289	0.0226089910013792	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2097.92209790462	2097.92209790462
"AML-0160"	"2019-07-01-count-1:CGGCAGTGTACAGAAT"	-8.21109805527385	2.54086515987245	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGCAGTGTACAGAAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2298.24940340931	39.9965427696598	0.0174030471672602	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2288.1870639027	2288.1870639027
"AML-0160"	"2019-07-01-count-1:CCGTGAGCAGCGGATA"	2.07685889777486	-4.27417137539061	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGTGAGCAGCGGATA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2220.77214236918	40.0099549333967	0.0180162359613864	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2212.71217091755	2212.71217091755
"AML-0160"	"2019-07-01-count-1:TGTTGGATCGCAGTCG"	5.28991474685018	-5.00103189861449	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTGGATCGCAGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.01992468486	40.5202844720109	0.0172278661616525	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2352.01992468486	2352.01992468486
"AML-0160"	"2019-07-01-count-1:GCATCGGGTCTGTGGC"	2.12726106223409	-9.82936956798705	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATCGGGTCTGTGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2362.26371290045	44.9750928407322	0.0190389805317335	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2357.7346481695	2357.7346481695
"AML-0160"	"2019-07-01-count-1:TCTATACCACTATGTG"	2.48578514632527	-9.0880165330139	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTATACCACTATGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2438.34190041401	39.2345262531825	0.01609065826516	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2431.0836897596	2431.0836897596
"AML-0160"	"2019-07-01-count-3:TGCGGGTAGGCACTCC"	1.81100608882253	-9.06317903911742	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGGTAGGCACTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2264.19573684116	43.5857673989648	0.0192499997636125	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2263.05026077221	2263.05026077221
"AML-0160"	"2019-07-01-count-1:AAAGTCCAGGGAGATA"	-7.13080726090129	-0.22305696522864	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGTCCAGGGAGATA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1975.08162705995	46.5354731645606	0.0235612911015895	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1973.88493816311	1973.88493816311
"AML-0160"	"2019-07-01-count-2:GTGCGTGGTCGACTTA"	-3.19389424744304	9.62440488422243	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000337040781934614	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCGTGGTCGACTTA"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2040.69169044528	42.4456056647844	0.0207996170433382	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	2039.14605211073	2039.14605211073
"AML-0160"	"2019-07-01-count-1:ACATGCATCGTGCTCT"	2.23308410224263	-9.13211538707884	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACATGCATCGTGCTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2016.23070568549	40.2236442503955	0.0199499214732572	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2011.93508063585	2011.93508063585
"AML-0160"	"2019-07-01-count-3:GGCAGTCAGTCGGGAT"	1.81823601302449	-9.00084021007689	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCAGTCAGTCGGGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1921.81673556287	47.7379261783147	0.0248399992022824	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1918.72295859175	1918.72295859175
"AML-0160"	"2019-07-01-count-1:TACCCACGTCCGACGT"	2.08986439284627	-9.29396250164183	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCCACGTCCGACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.87309728254	14.2323289573181	0.00680362923343998	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2091.87309728254	2091.87309728254
"AML-0160"	"2019-07-01-count-2:CTAGACAAGGGATCAC"	2.63496913489644	-9.41827394878539	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAGACAAGGGATCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.54925439581	42.8609019187548	0.0190277312849486	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2250.14048831499	2250.14048831499
"AML-0160"	"2019-07-01-count-1:TCATACTAGCTCCCTT"	1.88752879676167	-8.55914881145629	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATACTAGCTCCCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1355.53786407702	30.9861609855951	0.0228589416841509	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1355.53786407702	1355.53786407702
"AML-0160"	"2019-07-01-count-1:TTTACGTGTGTCATGT"	1.95524372634236	-9.59340860759886	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTACGTGTGTCATGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2164.91610995268	49.5127314354002	0.0228705081031904	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2163.6636712028	2163.6636712028
"AML-0160"	"2019-07-01-count-1:ACTATTCAGCCATCCG"	1.86922683295552	-8.20351412212523	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATTCAGCCATCCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.76294781408	38.1581717140727	0.0138316239691082	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2754.72432130803	2754.72432130803
"AML-0160"	"2019-07-01-count-1:CGTTAGAAGTGGTTCT"	2.15168776091878	-9.04627230083617	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTAGAAGTGGTTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2223.25661102134	47.8551758206683	0.021524809859301	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2221.9705518769	2221.9705518769
"AML-0160"	"2019-07-01-count-1:ACCAAACAGATCGACG"	1.73364677008931	-9.05013468181761	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCAAACAGATCGACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.08816542562	39.6106669198297	0.0157868772670691	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2502.26253074175	2502.26253074175
"AML-0160"	"2019-07-01-count-1:GTGAGCCAGCTCTGTA"	2.19898666915242	-8.71557810222777	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGAGCCAGCTCTGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.04369782348	40.9293628935437	0.0171968955574106	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.07643675028	2374.07643675028
"AML-0160"	"2019-07-01-count-1:GCATGATCATGGGCAA"	1.54525460776631	-8.38495829021605	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATGATCATGGGCAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2384.75833201227	43.5063849959934	0.0182435194426106	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2382.55682028983	2382.55682028983
"AML-0160"	"2019-07-01-count-2:ACACCAAAGACAACAT"	-7.88871417465861	1.51302645290224	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACCAAAGACAACAT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.56043075761	39.7661815100659	0.0149185068367644	2925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2654.18741008176	2654.18741008176
"AML-0160"	"2019-07-01-count-1:AAAGTGACAGGGATAC"	-7.94060025635417	3.45558617198793	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGTGACAGGGATAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2264.85818822329	41.0817413261391	0.0181387698089682	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2259.99705382907	2259.99705382907
"AML-0160"	"2019-07-01-count-1:ACAAAGACAGCGTGAA"	1.65852214869801	-8.82479097759398	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAAAGACAGCGTGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2416.07903903598	40.7202462444203	0.016853855187067	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.74032210666	2409.74032210666
"AML-0160"	"2019-07-01-count-2:TCATCATGTGCAGGAT"	1.79443933543507	-9.07860853588256	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATCATGTGCAGGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.73561169101	36.451216091054	0.0157474641626241	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2312.63853881063	2312.63853881063
"AML-0160"	"2019-07-01-count-3:TCCTCTTCAAGAATGT"	1.53312112864797	-8.46394255077513	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCTTCAAGAATGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2259.89267041928	45.2733966179508	0.0200334277864405	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2257.65187438461	2257.65187438461
"AML-0160"	"2019-07-01-count-2:CAAGGGATCACATACG"	2.70678295668904	-9.27546694194945	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGGGATCACATACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.91356011245	41.7170567098022	0.0189458194297471	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2198.10307623081	2198.10307623081
"AML-0160"	"2019-07-01-count-1:CGGGTCAAGCAGGGAG"	2.24036111411397	-8.08833506023558	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGTCAAGCAGGGAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2238.4755235366	43.3757523395266	0.0193773628004637	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2231.58267775501	2231.58267775501
"AML-0160"	"2019-07-01-count-1:TATCGCCTCAGGAAAT"	1.518163104623	-8.70532419597777	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCGCCTCAGGAAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.42952251359	41.7463817525032	0.0177762974584908	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2344.65309019661	2344.65309019661
"AML-0160"	"2019-07-01-count-1:GCATTAGTCACATCAG"	1.52865984019582	-8.87088587200316	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATTAGTCACATCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2256.6765906225	42.0190805312704	0.018619894718578	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2255.58533781257	2255.58533781257
"AML-0160"	"2019-07-01-count-1:ACTCCCAAGTACTCGT"	3.18505587157552	-9.16950228130492	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTCCCAAGTACTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1525.37274386292	46.2465431953716	0.0303181916560635	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1525.37274386292	1525.37274386292
"AML-0160"	"2019-07-01-count-1:GTAGGAGAGTCACGAG"	2.01192321357076	-9.22543051159056	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGGAGAGTCACGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2350.68100075809	41.7308158042212	0.0177526494623316	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2348.43400013376	2348.43400013376
"AML-0160"	"2019-07-01-count-2:ACACGCGCAATTCTTC"	-8.38167319718059	5.16631696307985	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACGCGCAATTCTTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1879.51095461071	38.9941580050272	0.020746970327238	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1872.09031036872	1872.09031036872
"AML-0160"	"2019-07-01-count-1:CATTCATAGTAGTCTC"	2.01589300212209	-4.20086576854857	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTCATAGTAGTCTC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2505.37066918921	48.1542647138142	0.0192204152886479	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2498.52590953793	2498.52590953793
"AML-0160"	"2019-07-01-count-2:GTCTCACGTAGAATGT"	1.88789381560628	-9.12198355114134	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTCACGTAGAATGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.03013038952	40.7948406403764	0.0187905455890919	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2169.18940907871	2169.18940907871
"AML-0160"	"2019-07-01-count-1:TCCATCGGTGATACTC"	1.60314466533009	-9.194362663385	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATCGGTGATACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2357.74937168324	45.3564309955679	0.0192371723391393	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2349.40405113692	2349.40405113692
"AML-0160"	"2019-07-01-count-1:ACTCTCGAGCTGCGAA"	2.87295283850972	-9.09352209484252	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTCTCGAGCTGCGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1523.85000904131	40.0089098001756	0.0262551494981754	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1519.38815279483	1519.38815279483
"AML-0160"	"2019-07-01-count-1:CAGCCAGCACGGTGCT"	9.45314468917195	6.41096589649049	"2019-07-01-count-1"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGCACGGTGCT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2026.82538103511	38.4975288505471	0.0189940037315332	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2012.84154246977	2012.84154246977
"AML-0160"	"2019-07-01-count-1:GTGTCCTGTGCCTGCA"	2.1933614211971	-8.99455645000609	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTCCTGTGCCTGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.9915004617	39.6966313122835	0.0163226850524549	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2429.17960554429	2429.17960554429
"AML-0160"	"2019-07-01-count-3:CTACCTGGTCCGATCG"	2.02794088897054	-9.54512407695922	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCTGGTCCGATCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2107.50941685861	46.1515303541301	0.0218986116906287	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2104.23166513935	2104.23166513935
"AML-0160"	"2019-07-01-count-3:GGAATCTTCAAGAAAC"	1.76604368266408	-8.8218507996765	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAATCTTCAAGAAAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2137.02912428129	42.5618238392346	0.0199163517968192	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2137.02912428129	2137.02912428129
"AML-0160"	"2019-07-01-count-2:TCATCCGTCGAACACT"	2.38201918181722	-5.06096985256346	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATCCGTCGAACACT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2471.13209975812	36.1534042070784	0.0146303001003536	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2464.15836066284	2464.15836066284
"AML-0160"	"2019-07-01-count-1:CACGTTCCACAGAGCA"	1.7259279685909	-8.79424383556517	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGTTCCACAGAGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2413.21750631685	43.8543529258784	0.0181725653867026	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.01031623351	2409.01031623351
"AML-0160"	"2019-07-01-count-1:CCACGAGGTCATCCCT"	2.72269525107686	-8.37949564373168	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACGAGGTCATCCCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.46733287985	38.5698330925159	0.0150400953047831	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2561.8709281153	2561.8709281153
"AML-0160"	"2019-07-01-count-3:CGGACACTCATACAGC"	2.76187600669209	-7.7813382378784	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGACACTCATACAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.77615538311	39.4600667860304	0.0157225442999744	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2508.68771778435	2508.68771778435
"AML-0160"	"2019-07-01-count-3:TCAGCCTAGTGGTCAG"	1.65733828124349	-8.9372129670349	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTAGTGGTCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.89609748856	42.7282333291044	0.0190930371508559	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2234.55027653348	2234.55027653348
"AML-0160"	"2019-07-01-count-2:GTGGAGATCAGCTCTC"	1.46976198729817	-8.60340216076048	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGAGATCAGCTCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.61334775824	44.7357065243891	0.0202093588610195	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2211.12806270629	2211.12806270629
"AML-0160"	"2019-07-01-count-1:ACTGATGAGAGATTCA"	1.96656467494313	-9.29004957592162	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGATGAGAGATTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.05328046748	50.9625484910782	0.0246785634894328	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2058.96323607313	2058.96323607313
"AML-0160"	"2019-07-01-count-3:ACTCTCGTCAACACGT"	-8.10079322281535	1.24494514549104	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCTCGTCAACACGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2473.23072055908	42.2609463795488	0.0170873449162057	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2468.33057120447	2468.33057120447
"AML-0160"	"2019-07-01-count-3:CGTGCTTCAGGCCTGT"	3.53137197074239	-9.42517664348754	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTGCTTCAGGCCTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1841.32208962555	46.6213335303584	0.0253194885311126	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1839.5383006424	1839.5383006424
"AML-0160"	"2019-07-01-count-2:CATAGACTCACCCATC"	-5.09208140793498	3.11541054332582	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATAGACTCACCCATC"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2618.96847009751	39.0885670186729	0.0149251766353711	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2611.30486999239	2611.30486999239
"AML-0160"	"2019-07-01-count-3:GCAGCTGTCTTGGTCC"	2.29532637175862	-9.04631044780882	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCTGTCTTGGTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.07802969325	41.8767303698816	0.0177437906048066	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.83665045918	2358.83665045918
"AML-0160"	"2019-07-01-count-2:TACGTCCAGCTTCTAG"	-8.12191901627238	2.15602061832277	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACGTCCAGCTTCTAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2349.0026859526	43.5348537744168	0.0185333350339537	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2341.7414610681	2341.7414610681
"AML-0160"	"2019-07-01-count-1:GTAACCATCATGAGAA"	2.05207731303517	-9.48203279888304	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAACCATCATGAGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2242.46869948023	47.7293917861526	0.0212843067986704	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2232.06893374717	2232.06893374717
"AML-0160"	"2019-07-01-count-1:AACAAGAAGGCTCCCA"	1.67007484015767	-8.74855234539183	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAAGAAGGCTCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.11661976638	36.54710231013	0.0144505405660202	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2523.68140184424	2523.68140184424
"AML-0160"	"2019-07-01-count-3:CTCCTTTGTGCCTATA"	1.80450965937917	-9.51401522075804	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCTTTGTGCCTATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.1239351702	38.7820052302522	0.0170236590869912	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2273.55937881687	2273.55937881687
"AML-0160"	"2019-07-01-count-2:GAAGGGTTCTGCGATA"	1.83128549632375	-9.0485878220764	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGGGTTCTGCGATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.13939986143	48.3478897855496	0.0226227122988254	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2130.12557987624	2130.12557987624
"AML-0160"	"2019-07-01-count-1:GGCGTCAGTACGACTT"	2.01880576190297	-8.91966535961302	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCGTCAGTACGACTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.97864134578	45.627423189475	0.0193748777115875	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2352.19574123019	2352.19574123019
"AML-0160"	"2019-07-01-count-3:GAGGCAATCCGACATA"	-2.48829994621928	-11.423927330133	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	31	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	1	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGGCAATCCGACATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2085.93032962941	43.7094318250637	0.0209544063884575	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2084.72917134377	2084.72917134377
"AML-0160"	"2019-07-01-count-1:CCTATCGGTGCTTCAA"	-7.56351504746135	3.62545893276063	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTATCGGTGCTTCAA"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2037.42368140521	30.6142182829528	0.0150259460329028	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2031.47803259405	2031.47803259405
"AML-0160"	"2019-07-01-count-1:ATAGAGATCTTCCCAG"	1.44934107837026	-8.72846796428832	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATAGAGATCTTCCCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.47677516464	41.6896452774407	0.016820672154441	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2474.9693566316	2474.9693566316
"AML-0160"	"2019-07-01-count-2:AGTTAGCCATAACTCG"	2.05997027930562	-8.80684950267943	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTAGCCATAACTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2412.26478395689	32.6806680037216	0.0135477117690682	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.68540574748	2409.68540574748
"AML-0160"	"2019-07-01-count-3:AGCTCAACACATAGCT"	1.66589941558186	-8.98079683696898	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTCAACACATAGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.05721466446	44.3691297974915	0.0191159138676836	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2317.6491610332	2317.6491610332
"AML-0160"	"2019-07-01-count-1:CACTGGGCAAGAGTAT"	1.88687409934346	-10.06618883526	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGGGCAAGAGTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.9619747254	40.8675018150431	0.0175701504406012	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2322.73784448794	2322.73784448794
"AML-0160"	"2019-07-01-count-3:TATCAGGGTATGTCAC"	2.51251997527425	-9.37860586559447	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCAGGGTATGTCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2001.82075776602	46.9502512435819	0.0234537738013953	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1998.79991265147	1998.79991265147
"AML-0160"	"2019-07-01-count-2:TAGTGCAAGGTAATCA"	1.51983847197835	-8.37361624157103	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGTGCAAGGTAATCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.05534650767	38.1410840502439	0.0160051188513683	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2379.29628980661	2379.29628980661
"AML-0160"	"2019-07-01-count-1:TCGAACACAGAACTTC"	2.1705879169399	-9.50403311168822	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGAACACAGAACTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.24737180368	43.7780865519835	0.0181557840410361	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2406.37362339383	2406.37362339383
"AML-0160"	"2019-07-01-count-3:TCTCACGTCACTTTGT"	1.67736067351643	-8.57145788585814	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCACGTCACTTTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.7941189058	45.526956925582	0.0189003105613122	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2407.69081941458	2407.69081941458
"AML-0160"	"2019-07-01-count-1:GTGCACGTCGCAATGT"	-9.50358233872111	4.18995711887208	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCACGTCGCAATGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1581.84266516816	40.8355738822176	0.025815193117121	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1576.06743518216	1576.06743518216
"AML-0160"	"2019-07-01-count-3:GTTGAACGTAACATGA"	-9.47265372696574	4.02487943256227	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGAACGTAACATGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2010.921215202	46.7452192735935	0.0232456741319415	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2006.87810396165	2006.87810396165
"AML-0160"	"2019-07-01-count-3:GACAGCCGTGGTATGG"	2.16615666922871	-9.42902376567992	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACAGCCGTGGTATGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2471.87522571157	43.6859238393321	0.0176731913427209	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2465.18037045716	2465.18037045716
"AML-0160"	"2019-07-01-count-2:GTGGGAATCGCTGTCT"	1.82115902480428	-9.05302622234496	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGGAATCGCTGTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2050.59740713206	43.2937834988594	0.0211127661374592	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2047.5851232355	2047.5851232355
"AML-0160"	"2019-07-01-count-1:AAGATAGTCTAGCAAC"	2.02031304416005	-8.9034052125183	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGATAGTCTAGCAAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.54925089838	35.6478046500997	0.0143017453465568	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2484.53474696238	2484.53474696238
"AML-0160"	"2019-07-01-count-1:TCTGGCTTCAAGGACG"	1.70824315127675	-9.29537584697875	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTGGCTTCAAGGACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.48426814398	50.3388471335343	0.0233321966128816	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2155.06125023502	2155.06125023502
"AML-0160"	"2019-07-01-count-3:AACGTCATCAAAGAAC"	5.32162584838216	-4.93623115932616	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGTCATCAAAGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.31409712925	38.5365791603063	0.0164593803144812	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2340.16548507111	2340.16548507111
"AML-0160"	"2019-07-01-count-1:CACTGTCAGAGGGCGA"	1.50959469851796	-8.88935186779173	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGTCAGAGGGCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2264.93861670097	44.2846136605314	0.0195522356915062	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2262.17638524713	2262.17638524713
"AML-0160"	"2019-07-01-count-3:CTCTCGACAGCTACTA"	1.81903268870656	-8.29656126415404	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCTCGACAGCTACTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.23049329329	44.277695859954	0.0186492827823707	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2369.19313434257	2369.19313434257
"AML-0160"	"2019-07-01-count-3:CCCTAACGTGGAGAAA"	1.79944862899129	-9.01838781749877	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTAACGTGGAGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1995.98674343555	40.9468811493633	0.0205146057628039	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1991.8979969738	1991.8979969738
"AML-0160"	"2019-07-01-count-1:TTAGGCAGTACGATCT"	2.01718928393666	-8.90766909038695	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGGCAGTACGATCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2482.89915052131	39.7591688805482	0.0160132033039684	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2477.06012849016	2477.06012849016
"AML-0160"	"2019-07-01-count-2:AACCTGATCTAGCCTC"	-7.84096322479899	2.15788314426271	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCTGATCTAGCCTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2270.50385897463	34.4856061213733	0.0151885256592108	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2262.87701427415	2262.87701427415
"AML-0160"	"2019-07-01-count-1:GTGCGTGCAGGCTATT"	1.79476847228352	-8.71005346691283	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCGTGCAGGCTATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2335.63490230321	44.7435894356146	0.0191569279049102	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2335.63490230321	2335.63490230321
"AML-0160"	"2019-07-01-count-1:CTCCTTTCACCCTGTT"	1.68940450724904	-8.96136763012084	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTTTCACCCTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.64831655147	40.5671069650559	0.0156349154165808	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2586.26523730606	2586.26523730606
"AML-0160"	"2019-07-01-count-2:CGATCGGGTCAGTTTG"	2.30797233161275	-9.8011684647766	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATCGGGTCAGTTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1990.12836559297	46.7135624790768	0.0234726378894451	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1986.94355331797	1986.94355331797
"AML-0160"	"2019-07-01-count-2:TGATGGTGTGACAGGT"	1.92025973376576	-8.89544966137084	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATGGTGTGACAGGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.9730831176	40.8245575294263	0.0189972400539333	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2144.26730910801	2144.26730910801
"AML-0160"	"2019-07-01-count-3:TCAGTGAAGAACTTCC"	3.59839620169942	-9.15501120006713	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTGAAGAACTTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2035.63983950327	37.8714265031695	0.0186041881123779	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2032.02672025564	2032.02672025564
"AML-0160"	"2019-07-01-count-3:TGAATGCGTATCGCGC"	-7.9094127220219	2.50471398914186	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAATGCGTATCGCGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2206.96821942307	35.0045669807868	0.0158609293385917	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2200.93384374514	2200.93384374514
"AML-0160"	"2019-07-01-count-2:AACCTTTCATCTTTCA"	1.846523185342	-9.52545359050902	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCTTTCATCTTTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.30677052358	47.4319025404234	0.0207551577548412	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2279.23766792852	2279.23766792852
"AML-0160"	"2019-07-01-count-3:TTACGTTCAACACGTT"	1.61078633841817	-8.58459761058959	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACGTTCAACACGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2316.76267462355	33.8694663187821	0.0146193076614054	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.51930828029	2313.51930828029
"AML-0160"	"2019-07-01-count-1:ACTTATCCACCAGGTC"	2.19926061209981	-9.54019548809203	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTATCCACCAGGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.40229532555	41.4469027905241	0.0176040020317739	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2350.98657940658	2350.98657940658
"AML-0160"	"2019-07-01-count-3:GGAGGTACATATGCGT"	2.06686725196187	-9.02696611797484	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAGGTACATATGCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2134.42604276269	38.6024632859534	0.0180856410634816	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2131.0498435749	2131.0498435749
"AML-0160"	"2019-07-01-count-3:ATACTTCTCCATCACC"	1.46558107909505	-8.79607775127562	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATACTTCTCCATCACC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2443.40830416469	42.5870899917436	0.0174293792483048	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2439.2603910261	2439.2603910261
"AML-0160"	"2019-07-01-count-3:GTCGTTCTCCAGTGCG"	2.18920816954915	-8.71460058605345	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGTTCTCCAGTGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1624.22941475674	42.5355043606772	0.0261881135597139	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1615.81820738214	1615.81820738214
"AML-0160"	"2019-07-01-count-3:TGGAGGACAAGATGGC"	1.97243406352345	-8.69376184856566	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAGGACAAGATGGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2406.31082548091	41.5409506077505	0.0172633352964484	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2405.07121365569	2405.07121365569
"AML-0160"	"2019-07-01-count-2:GTGAGTTAGTGCAGGT"	-9.56852183762248	2.5501396425995	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGTTAGTGCAGGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2239.21523930797	40.1637299288477	0.017936520448682	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2229.84522883947	2229.84522883947
"AML-0160"	"2019-07-01-count-3:TCAGTGATCGCCGAAC"	5.29048742827718	-5.14225866710814	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTGATCGCCGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2288.66442152922	40.58861045171	0.0177346272655341	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2284.23709850288	2284.23709850288
"AML-0160"	"2019-07-01-count-3:CTGAATGAGTTATGGA"	1.74773420867268	-8.2006292573181	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAATGAGTTATGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.34777167216	39.262552293479	0.0177229746026934	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2214.1234801924	2214.1234801924
"AML-0160"	"2019-07-01-count-1:CATTTCAAGACCAGAC"	5.26034607467	-5.08102180874022	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTTCAAGACCAGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.85440278439	39.2706561630931	0.0157217554871563	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2490.07554114671	2490.07554114671
"AML-0160"	"2019-07-01-count-3:TAATCTCCAGTTGCGC"	1.84788682040517	-9.71483614360961	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAATCTCCAGTTGCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2234.09144286749	42.1574216203426	0.0188700519644947	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2229.12181761788	2229.12181761788
"AML-0160"	"2019-07-01-count-2:GTGTCCTGTACATTGC"	10.3297802406246	7.68422792041627	"2019-07-01-count-2"	"AML0160"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000957854406130268	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTCCTGTACATTGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2297.35937673239	38.8639338158205	0.0169167846395447	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2290.1700299017	2290.1700299017
"AML-0160"	"2019-07-01-count-1:CTAGACACACATGGTT"	1.62979306754414	-8.82416155254515	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGACACACATGGTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.49469731784	39.2402156484644	0.0146337099557625	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2673.04082209448	2673.04082209448
"AML-0160"	"2019-07-01-count-2:TTCTGTAGTTGCTCCT"	2.10241808471028	-10.2120895615784	"2019-07-01-count-2"	"AML0160"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCTGTAGTTGCTCCT"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.31012067581	43.597770612957	0.0186609518261839	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.74027137778	2332.74027137778
"AML-0160"	"2019-07-01-count-3:GTTGCTCTCTGAGTCA"	1.92078806933705	-7.97007467662963	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGCTCTCTGAGTCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2212.9809741912	37.6516810838331	0.0170140102978491	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2211.71361221853	2211.71361221853
"AML-0160"	"2019-07-01-count-1:GAAGCCCGTTCGGACC"	1.83758725699727	-9.27947904979857	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGCCCGTTCGGACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.11806606745	42.3473926580447	0.0179581307939623	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2352.03828782717	2352.03828782717
"AML-0160"	"2019-07-01-count-3:TGACAGTCACGACGCT"	1.5501352744991	-9.03860571300658	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGACAGTCACGACGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2247.83881472271	40.8954156551342	0.0181932153619204	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2242.72240051144	2242.72240051144
"AML-0160"	"2019-07-01-count-3:AATTTCCCACCGTCGA"	1.4196648794109	-8.62644960796507	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATTTCCCACCGTCGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2165.83903698307	41.8385282335816	0.0193174688973475	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2163.39059272279	2163.39059272279
"AML-0160"	"2019-07-01-count-2:TAAGCACAGAGTTGTA"	9.72792114791219	6.30005261981813	"2019-07-01-count-2"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCACAGAGTTGTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1839.11418834424	38.1436550227949	0.0207402320446104	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1834.19849009155	1834.19849009155
"AML-0160"	"2019-07-01-count-2:ACATTTCAGGTAGATT"	1.76474871215169	-8.90999987041625	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATTTCAGGTAGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.99581252176	36.7219198111987	0.0159107393574842	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2304.68310017235	2304.68310017235
"AML-0160"	"2019-07-01-count-1:GCCCGAATCGCTTAAG"	1.87468268451039	-9.02163698589476	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCCGAATCGCTTAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.96385405882	37.3143736490129	0.0151563450403612	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2457.03062995049	2457.03062995049
"AML-0160"	"2019-07-01-count-1:CAGATCAAGTGGGAAA"	2.37602295455281	-10.3433370820251	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGATCAAGTGGGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.43144948183	47.2483950150372	0.0220742388299683	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2133.1678346841	2133.1678346841
"AML-0160"	"2019-07-01-count-1:GTACAGTGTGTCTCCT"	1.76739790019338	-9.27268888866576	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTACAGTGTGTCTCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2080.94082902429	48.9574027731194	0.0235265712942326	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2076.52704732219	2076.52704732219
"AML-0160"	"2019-07-01-count-1:TTGTTGTTCGAGGCAA"	2.80627765235249	-2.6570353738037	"2019-07-01-count-1"	"AML0160"	"DC precursor"	"DC precursor"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTGTTCGAGGCAA"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2813.72038286221	38.9035845502266	0.0138263861566275	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2804.90155363072	2804.90155363072
"AML-0160"	"2019-07-01-count-1:TACAGGTGTAACCCGC"	8.6170126396114	7.19731805408327	"2019-07-01-count-1"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACAGGTGTAACCCGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2069.59570445863	41.7866545710435	0.0201907331374048	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2065.70486751445	2065.70486751445
"AML-0160"	"2019-07-01-count-2:AGACACTCATTGCAAC"	1.69598855552022	-8.98184778606566	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACACTCATTGCAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.38998222816	38.5520920322645	0.0160273769813213	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2400.67927486612	2400.67927486612
"AML-0160"	"2019-07-01-count-1:CCAATGACACTTGAGT"	1.58347274836842	-9.09361078655394	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCAATGACACTTGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.57726871068	45.3979035060641	0.0190301542949393	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2379.88580281393	2379.88580281393
"AML-0160"	"2019-07-01-count-2:GTGCACGCATGGGAAC"	1.61525895175282	-9.46434595501097	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCACGCATGGGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2226.78371480656	35.5957880432274	0.0159852920634098	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2223.7663347316	2223.7663347316
"AML-0160"	"2019-07-01-count-1:ACTTCGCCAATGGGTG"	2.2732216316158	-8.81721689617308	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCGCCAATGGGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.22936985667	38.9910175556471	0.0158035641242031	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2464.57556723772	2464.57556723772
"AML-0160"	"2019-07-01-count-3:TCGCACTCAGTCGCTG"	1.70772113379781	-8.06034376537474	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCACTCAGTCGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2199.19598497266	41.4904004190646	0.0188661677733921	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2192.48177790503	2192.48177790503
"AML-0160"	"2019-07-01-count-2:ATTCTACTCGATCCAA"	1.36799444732015	-8.48026373302611	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTACTCGATCCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.60999667231	36.0432354738982	0.0154122472430997	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2332.37916860379	2332.37916860379
"AML-0160"	"2019-07-01-count-1:GAAGCGATCCCTATTA"	2.3713706928188	-8.85328390514525	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGCGATCCCTATTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.71991542848	41.0745404621947	0.0165308533195829	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2480.39096698537	2480.39096698537
"AML-0160"	"2019-07-01-count-1:CAGATTGCATTGACCA"	1.98987581309621	-9.67899324810179	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGATTGCATTGACCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1942.28690975428	49.999743493668	0.0257427176399976	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1938.01123162518	1938.01123162518
"AML-0160"	"2019-07-01-count-1:GCCGTGAGTGAATGAT"	2.14476432380025	-8.73880007183226	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCGTGAGTGAATGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.96669005654	44.0052362727594	0.0182596865153049	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.96669005654	2409.96669005654
"AML-0160"	"2019-07-01-count-1:TCTTTGACACCGAATT"	-2.42114983025249	-11.494842552301	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTTGACACCGAATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.24970894397	47.1760509035632	0.0202103702627882	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2326.828953496	2326.828953496
"AML-0160"	"2019-07-01-count-3:CTCCATGTCCTACAAG"	1.71242310580556	-8.88997461712035	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCATGTCCTACAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.72660446672	41.3148262855989	0.0171379144400068	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2405.27174579193	2405.27174579193
"AML-0160"	"2019-07-01-count-3:TGGGAAGGTCGGCTAC"	2.48614325103108	-10.1028604737488	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGAAGGTCGGCTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2068.11808417731	41.1757648224596	0.0199097745614652	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2063.95402623911	2063.95402623911
"AML-0160"	"2019-07-01-count-1:ACTTTCACACCGGAAA"	2.06423368033711	-8.36439134990843	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+ IFN+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTTCACACCGGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.19282166312	37.6436448560458	0.0152638692828001	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2463.37600019617	2463.37600019617
"AML-0160"	"2019-07-01-count-2:TTTCATGGTCTATGAC"	1.41906168040578	-8.65760424053343	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCATGGTCTATGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1584.08444843388	27.2679214214006	0.0172136791370935	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1577.53120783273	1577.53120783273
"AML-0160"	"2019-07-01-count-3:TGGCGTGTCCCAGGCA"	1.93868221816365	-10.0655431977478	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGCGTGTCCCAGGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1980.25715415697	49.0204858747957	0.0247546061237005	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1976.73869190458	1976.73869190458
"AML-0160"	"2019-07-01-count-2:TGCAGATGTAACGCGA"	1.80722000178639	-8.97351934826048	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCAGATGTAACGCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2267.82924325602	40.5053347388258	0.0178608397696956	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2264.13362991272	2264.13362991272
"AML-0160"	"2019-07-01-count-3:GATGCTAAGGGACACT"	2.18898405608479	-4.68897201931151	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGCTAAGGGACACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2039.72613831994	47.2020174648304	0.0231413504872322	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2038.22941107758	2038.22941107758
"AML-0160"	"2019-07-01-count-2:TTCAATCAGTGCAAAT"	2.12188663062398	-8.57509615337523	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCAATCAGTGCAAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2429.87528638785	45.2933985077228	0.0186402153071214	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2427.71270942307	2427.71270942307
"AML-0160"	"2019-07-01-count-1:ACGATGTAGCAACAGC"	1.50518574294392	-8.88720419323119	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGATGTAGCAACAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2512.76364440275	35.8775347279302	0.0142781175650358	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2506.45766993259	2506.45766993259
"AML-0160"	"2019-07-01-count-1:GTTCATTGTGGTTCTA"	1.87395431575124	-8.19023325359496	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCATTGTGGTTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.00641568888	42.0026712609816	0.0167541139895488	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2502.82400245047	2502.82400245047
"AML-0160"	"2019-07-01-count-2:GTCACTCGTGAAGCTG"	2.01923241195027	-8.99840643322142	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACTCGTGAAGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2068.06936753543	50.6909032697935	0.0245112200129936	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2068.06936753543	2068.06936753543
"AML-0160"	"2019-07-01-count-3:TTAGGGTTCAAATGAG"	1.56336631354634	-8.59911253368529	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGGGTTCAAATGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2170.85631833731	46.8511668290405	0.0215818828880045	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2167.02019896172	2167.02019896172
"AML-0160"	"2019-07-01-count-3:AATCGACCAGCACACC"	-7.70813165131267	3.68066690051881	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCGACCAGCACACC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2061.589149021	32.4754653669403	0.0157526369317388	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2058.58445507652	2058.58445507652
"AML-0160"	"2019-07-01-count-1:AACGGGACATGGACAG"	2.10447325286214	-8.89916517650756	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACGGGACATGGACAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2081.98992476362	53.5966766001409	0.0257430047872234	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2077.26332073267	2077.26332073267
"AML-0160"	"2019-07-01-count-3:CGGAACCCAAATACGA"	2.3841663795406	-5.39573099529418	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAACCCAAATACGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2189.04521783331	39.9852427497536	0.0182660652342899	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2184.54868761227	2184.54868761227
"AML-0160"	"2019-07-01-count-2:TTTCCTCCACATACTG"	1.46086229857747	-8.14659597789916	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCCTCCACATACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2610.72252246999	38.7279596309956	0.0148341921815403	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2607.82184915918	2607.82184915918
"AML-0160"	"2019-07-01-count-2:TGTCCTGGTGAGCTCC"	1.89878608760182	-8.80641939556273	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCCTGGTGAGCTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2162.92347923932	43.6262062152671	0.0201700183265892	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2156.50699330237	2156.50699330237
"AML-0160"	"2019-07-01-count-1:TGAATCGCAAAGGAGA"	1.77077045020406	-8.79472353374632	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAATCGCAAAGGAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2442.81746348545	43.9404118480253	0.0179875952685103	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2436.77544379718	2436.77544379718
"AML-0160"	"2019-07-01-count-3:AGAGCAGGTTCCGCGA"	8.57223381575887	6.69640348041383	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCAGGTTCCGCGA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1768.09048411245	44.6485033614101	0.0252523859851114	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1764.48149225565	1764.48149225565
"AML-0160"	"2019-07-01-count-1:TAGACCAGTACAGGTG"	-4.40257916870769	-8.3229084244934	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGACCAGTACAGGTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2527.84090296131	42.4577202065701	0.0167960413002384	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2513.94289889359	2513.94289889359
"AML-0160"	"2019-07-01-count-3:TAACACGAGGATATGT"	-8.46150050583537	1.17181012714235	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAACACGAGGATATGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2859.1210225309	39.1978114126394	0.0137097419464746	3180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2851.41087854207	2851.41087854207
"AML-0160"	"2019-07-01-count-3:AGAACAACAGATCATC"	2.17658605155293	-9.71896078502806	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAACAACAGATCATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1873.04838531419	49.4922415771974	0.0264233652292412	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1873.04838531419	1873.04838531419
"AML-0160"	"2019-07-01-count-3:CGAGTTAAGTCATGCT"	2.2901722389156	-9.35456755077513	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGTTAAGTCATGCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2451.47215918785	41.2880380037591	0.0168421402825302	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2446.02353086559	2446.02353086559
"AML-0160"	"2019-07-01-count-2:CATGCAATCCACGGAC"	2.0351069169933	-10.4976616135803	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCAATCCACGGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2371.89630514412	39.1253298240305	0.0164953795573509	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2364.79184064591	2364.79184064591
"AML-0160"	"2019-07-01-count-2:CACGAATCAGTCGCTG"	2.12632717665974	-8.96802618419798	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGAATCAGTCGCTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.3360027053	39.2948500137009	0.0166127983376393	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2360.11517399037	2360.11517399037
"AML-0160"	"2019-07-01-count-2:GGGATGACAGGTTCGC"	2.32793297347371	-10.3222551575867	"2019-07-01-count-2"	"AML0160"	"CD11c+"	"CD11c+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGATGACAGGTTCGC"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2129.64310584735	39.466593153415	0.0185320221238252	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2118.90055105043	2118.90055105043
"AML-0160"	"2019-07-01-count-2:TTCGATTTCGCTGATA"	1.4874572950298	-8.53106310283812	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGATTTCGCTGATA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2728.04857026106	38.2290641327829	0.0140133370606098	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2726.12872488988	2726.12872488988
"AML-0160"	"2019-07-01-count-2:ACGGTCGGTCGTGATT"	9.67234291610066	6.42390821063844	"2019-07-01-count-2"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGTCGGTCGTGATT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1795.36864699313	43.552586636858	0.0242582974308923	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1791.92871840785	1791.92871840785
"AML-0160"	"2019-07-01-count-3:ATCGGATGTAACATGA"	1.72199453887288	-8.77061083233031	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGGATGTAACATGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1961.15708356789	50.5585551711048	0.0257799620411459	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1959.68064411793	1959.68064411793
"AML-0160"	"2019-07-01-count-1:GGGATCCGTGCTGATT"	-8.7242959541386	4.93491456592409	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGATCCGTGCTGATT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1872.75751975072	34.5955096903714	0.0184730320532774	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1868.68261734323	1868.68261734323
"AML-0160"	"2019-07-01-count-3:GAATAGAAGTACCCTA"	1.87445654448811	-9.28865053569945	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAATAGAAGTACCCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.79740591093	37.6392687632777	0.0172356962515839	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2181.13266565414	2181.13266565414
"AML-0160"	"2019-07-01-count-3:TGGGCGTCAGCAGACA"	1.84315039691274	-8.57732202922972	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGCGTCAGCAGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1903.69975455667	45.3047938450929	0.0237982873804821	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1900.70100820381	1900.70100820381
"AML-0160"	"2019-07-01-count-1:GCGATCGTCTCTCTTC"	1.47528304633443	-8.08751680767211	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGATCGTCTCTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.53773679169	46.6520041056961	0.0204386562174739	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2279.17734055739	2279.17734055739
"AML-0160"	"2019-07-01-count-2:CATTTCAGTCGACTTA"	-8.14759955826457	2.5618264445099	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTTCAGTCGACTTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2537.03525925426	43.1595574829499	0.0170118083008575	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2524.4513578577	2524.4513578577
"AML-0160"	"2019-07-01-count-1:CTGTGGGCAGTCCGTG"	1.54996170577351	-8.71733190929564	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTGGGCAGTCCGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.6019338294	44.19049981046	0.0189854197868607	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.66545569499	2321.66545569499
"AML-0160"	"2019-07-01-count-2:TCACTATGTTAAAGTG"	1.53440227088277	-8.76492311870726	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCACTATGTTAAAGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.53730417489	43.7313078429819	0.0186603847803391	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2339.79381500984	2339.79381500984
"AML-0160"	"2019-07-01-count-1:CCTTGTGGTTCGTTCC"	1.79893257197682	-9.05556776439818	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTTGTGGTTCGTTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.5368948982	45.0561145513822	0.0191929313866379	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2346.34262216598	2346.34262216598
"AML-0160"	"2019-07-01-count-3:ATTCACTGTCACGCTG"	2.1490453678066	-8.91056444561156	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCACTGTCACGCTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2506.03617646689	41.0727581261003	0.0163895312094043	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2501.74400269029	2501.74400269029
"AML-0160"	"2019-07-01-count-1:AGGGCCTAGCGACTAG"	-8.48340926590617	3.66383121097413	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCCTAGCGACTAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2058.67450176998	33.0601054199923	0.0160589279128722	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2050.81563478041	2050.81563478041
"AML-0160"	"2019-07-01-count-1:CTCAAGATCGATACGT"	-1.62830696526225	10.5657825239929	"2019-07-01-count-1"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAAGATCGATACGT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1903.8214259618	42.6562208219461	0.0224055787167099	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1902.25945381037	1902.25945381037
"AML-0160"	"2019-07-01-count-1:CATTCCGCAACGATCT"	-1.27481172505077	10.39852235401	"2019-07-01-count-1"	"AML0160"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTCCGCAACGATCT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1908.25537072103	39.5327523025302	0.0207166990902234	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1908.25537072103	1908.25537072103
"AML-0160"	"2019-07-01-count-3:TTCAATCCATGCCATA"	1.83881284770314	-8.30358602916869	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCAATCCATGCCATA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2520.04993248596	40.7698738306277	0.0161782007987474	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2512.46602651501	2512.46602651501
"AML-0160"	"2019-07-01-count-1:ACTCTCGTCTGCACCT"	1.68734552439992	-8.94807245647582	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTCTCGTCTGCACCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2333.61667690162	37.8546211293867	0.0162214392381044	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2330.31471428106	2330.31471428106
"AML-0160"	"2019-07-01-count-3:AAGCGTTTCAGTGTTG"	1.67482997950856	-9.00547411358031	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCGTTTCAGTGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2163.35624700319	45.2625592231915	0.0209223789590327	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2160.65002708511	2160.65002708511
"AML-0160"	"2019-07-01-count-1:CCACGTTAGTCACTAC"	-8.52217421951945	2.79232499683229	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACGTTAGTCACTAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2288.69557570996	44.5470567873994	0.019463950234439	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2282.61115881471	2282.61115881471
"AML-0160"	"2019-07-01-count-3:GGCTTTCAGAGTGGCT"	-9.37157950821574	4.17192647540895	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCTTTCAGAGTGGCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2100.14540228326	37.2192635893389	0.0177222317792256	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2094.25358173394	2094.25358173394
"AML-0160"	"2019-07-01-count-3:TCATGGATCGCCACTT"	2.55643763121907	-9.77665712749632	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGGATCGCCACTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.59168704591	38.9873789663294	0.0181455505024004	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.15162198022	2147.15162198022
"AML-0160"	"2019-07-01-count-2:TGTGGCGAGAGGCCAT"	2.83960713919942	-6.88917686855467	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTGGCGAGAGGCCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2057.47591970084	45.3997181218758	0.0220657348585042	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2056.3057109222	2056.3057109222
"AML-0160"	"2019-07-01-count-2:CGAGGAATCATGCTAG"	1.94793083247487	-9.0297422639099	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAGGAATCATGCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2108.16544206611	45.9654358342495	0.021803524010526	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2102.64240613627	2102.64240613627
"AML-0160"	"2019-07-01-count-2:TCTATACTCTTCGACC"	-0.91539035263713	10.8283853300842	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTATACTCTTCGACC"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1930.66617571227	47.217433568567	0.0244565498492495	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1930.66617571227	1930.66617571227
"AML-0160"	"2019-07-01-count-2:ATCGGCGCATGACAAA"	2.24968065795247	-9.0952186814514	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGCGCATGACAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2180.66530190317	39.1064460534554	0.0179332637701555	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2177.19972091329	2177.19972091329
"AML-0160"	"2019-07-01-count-1:TTCTGTAAGTGCAGCA"	2.09884371337239	-8.99444582378539	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTGTAAGTGCAGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.17651491332	45.2300146091762	0.0185965181111816	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2425.27272090199	2425.27272090199
"AML-0160"	"2019-07-01-count-3:TATCAGGAGACCAACG"	2.2680684524471	-8.80217363750609	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCAGGAGACCAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2242.14880721315	39.6863844541712	0.0177001563529135	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2242.14880721315	2242.14880721315
"AML-0160"	"2019-07-01-count-2:TACACCCGTCGCTTGG"	1.71569194373433	-8.7827358475891	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACACCCGTCGCTTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.88696092861	42.743336503629	0.0188223091853724	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2264.3914815926	2264.3914815926
"AML-0160"	"2019-07-01-count-3:GTAAGTCGTACTCGTA"	-8.37634597244914	3.4635324248108	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAAGTCGTACTCGTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2089.27901213313	45.6937386835417	0.0218705775620121	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2083.62365533676	2083.62365533676
"AML-0160"	"2019-07-01-count-2:GATTCGAAGTTCATCG"	-8.07202659073528	2.35774300182191	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCGAAGTTCATCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2140.29110608916	41.4620993094393	0.0193721775470071	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2131.9485514966	2131.9485514966
"AML-0160"	"2019-07-01-count-2:ACGTAACTCTTCCCAG"	1.4706732231075	-8.58598139202269	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAACTCTTCCCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.5432340488	35.1052780782203	0.0157173040320263	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2229.98456896821	2229.98456896821
"AML-0160"	"2019-07-01-count-3:GACCCAGGTCCAGAAG"	1.6005103784496	-8.83058073436888	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCCAGGTCCAGAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2065.07995921824	47.1570279778282	0.022835448945851	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2065.07995921824	2065.07995921824
"AML-0160"	"2019-07-01-count-3:CCGGGTAGTCTTGAAC"	2.25102486190144	-8.08634188091429	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGGGTAGTCTTGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2130.57799023847	38.4585239600196	0.0180507468565912	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2123.5088983003	2123.5088983003
"AML-0160"	"2019-07-01-count-1:GGCTGTGAGCCATCCG"	-1.99320064011272	3.45951960170595	"2019-07-01-count-1"	"AML0160"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0013986013986014	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTGTGAGCCATCCG"	"Ery"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3307.78477156019	48.5289516158249	0.0146711333920723	4348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	8	TRUE	"Ery_AML-0160"	3297.93413363787	3297.93413363787
"AML-0160"	"2019-07-01-count-1:TTGGGCGTCCATCGTC"	1.7180139022762	-9.12103083049925	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGCGTCCATCGTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2067.12727083256	44.9768968134864	0.0217581652799595	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2062.91785794244	2062.91785794244
"AML-0160"	"2019-07-01-count-2:CTCAAGACAAACGAGC"	-8.1657956642216	1.28740010345308	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAAGACAAACGAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2639.7392910935	45.055679553287	0.0170682308307132	2858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2632.10284945174	2632.10284945174
"AML-0160"	"2019-07-01-count-1:GTGCACGTCATTCATC"	1.61063637313191	-8.49919512188109	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCACGTCATTCATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.03987220138	44.7195859717911	0.0196393512989114	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2272.27088104913	2272.27088104913
"AML-0160"	"2019-07-01-count-2:TTCTAGTGTTATAGAG"	1.97329213198964	-9.09792234813841	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCTAGTGTTATAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2260.50103202227	39.9390163876891	0.0176682141799153	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2255.70556573511	2255.70556573511
"AML-0160"	"2019-07-01-count-1:CTTAGGATCAGCTGTA"	5.22152294692342	-5.151722454187	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTAGGATCAGCTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2333.75690846409	38.510346081351	0.0165014384924503	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2326.74906779148	2326.74906779148
"AML-0160"	"2019-07-01-count-3:CGATGGCTCCGGACTG"	2.22161187705342	-9.33377554332884	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGATGGCTCCGGACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2210.71793410375	39.3993791237276	0.0178219837618952	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2207.76802238715	2207.76802238715
"AML-0160"	"2019-07-01-count-1:GTTGCTCCAGGTCCGT"	2.11673821982686	-8.98983004009398	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCTCCAGGTCCGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.8387049558	38.4138013188361	0.0152931003264846	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2505.12101462589	2505.12101462589
"AML-0160"	"2019-07-01-count-1:TCATGGAGTGTGTGGA"	1.60216428813283	-9.21696474468382	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGGAGTGTGTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.33597045316	48.6984621413243	0.0192382452229786	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2528.53392541049	2528.53392541049
"AML-0160"	"2019-07-01-count-3:TCTCAGCAGCGTCAAG"	-8.01920733872111	2.19871423328248	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCAGCAGCGTCAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2239.68662852394	41.8817518432195	0.018699826712285	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2234.08320015378	2234.08320015378
"AML-0160"	"2019-07-01-count-2:CTCAAGATCATTCTTG"	1.60453035411183	-8.35329630291136	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAAGATCATTCTTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2516.7713494609	40.9132152938417	0.0162562305481606	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2511.96585214945	2511.96585214945
"AML-0160"	"2019-07-01-count-2:GCTCAAAAGTTCCAGT"	1.80162241038625	-8.20785334026488	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTCAAAAGTTCCAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1963.70038623733	45.2328077711109	0.0230344751613468	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1959.79101986736	1959.79101986736
"AML-0160"	"2019-07-01-count-1:TGGTACATCGGACGTC"	2.28714575347249	-9.13745787059935	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTACATCGGACGTC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2245.48678400571	46.7087414989446	0.0208011651779224	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2243.02576229935	2243.02576229935
"AML-0160"	"2019-07-01-count-2:GGGTAGAAGAGTTGAT"	1.55069794234578	-8.93413355266722	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTAGAAGAGTTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2177.9456478779	41.5834615298884	0.01909297487309	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2174.01202810327	2174.01202810327
"AML-0160"	"2019-07-01-count-1:TTCCGGTAGCGCACAA"	1.70917191085164	-8.67799475109252	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCGGTAGCGCACAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.81604750106	38.6406457413664	0.0156832511017037	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2458.37647384095	2458.37647384095
"AML-0160"	"2019-07-01-count-3:GATTGGTTCACCTCGT"	2.01612498339955	-8.70213034069213	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTGGTTCACCTCGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2210.84662059156	41.3500314047985	0.0187032564899208	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2208.2388501264	2208.2388501264
"AML-0160"	"2019-07-01-count-1:AAACGAAAGAAGTATC"	-8.06976733627971	2.28297088229982	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGAAAGAAGTATC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2302.13997907606	42.9182333330504	0.0186427557503585	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2293.85919487306	2293.85919487306
"AML-0160"	"2019-07-01-count-1:GCTACCTTCATACAGC"	2.16002621230428	-9.63453581249388	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTACCTTCATACAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.09038223821	44.7657231790385	0.0191054188598036	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.01565975388	2337.01565975388
"AML-0160"	"2019-07-01-count-1:TGGTGATAGACTTCCA"	2.04455103453938	-9.38813879406127	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTGATAGACTTCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.91009862708	38.8125280410942	0.0162878692164913	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2375.69284148902	2375.69284148902
"AML-0160"	"2019-07-01-count-1:CTGGACGCAAGATTGA"	-7.83692679825481	-0.498753451463305	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGACGCAAGATTGA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2427.46218514395	49.2300060420301	0.0202804419954788	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2421.40115248032	2421.40115248032
"AML-0160"	"2019-07-01-count-1:TCGACCTAGAGAGGGC"	1.90120687064473	-8.43349459087523	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGACCTAGAGAGGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1934.02488469429	42.3734753654588	0.0219094778463291	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1929.43270890569	1929.43270890569
"AML-0160"	"2019-07-01-count-1:CAACAGTGTAGGAAAG"	0.853655775159043	-9.04148104107054	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAGTGTAGGAAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.21838032544	42.1168575980252	0.0188423905103595	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2229.52169298566	2229.52169298566
"AML-0160"	"2019-07-01-count-1:AGGGTTTGTTCTTAGG"	2.23775019225423	-4.67320253765257	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTTTGTTCTTAGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2413.2528302436	38.9468246326897	0.0161387253521871	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2408.54131663882	2408.54131663882
"AML-0160"	"2019-07-01-count-2:GTAGGTTGTTCCACAA"	10.1531616645748	6.9879054793152	"2019-07-01-count-2"	"AML0160"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000957854406130268	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGTTGTTCCACAA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1911.69352992953	46.4291229607158	0.0242869069931033	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1901.8740472542	1901.8740472542
"AML-0160"	"2019-07-01-count-3:GACCAATCATCATCTT"	2.35874213752095	-9.77497293865355	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCAATCATCATCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.43636747372	44.3166511943956	0.020685165668025	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2142.43636747372	2142.43636747372
"AML-0160"	"2019-07-01-count-1:AGGTAGGGTAGTCGTT"	1.86789586123769	-8.93381693279418	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTAGGGTAGTCGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.5632832001	42.3720747292409	0.0182044780629916	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2323.22577125043	2323.22577125043
"AML-0160"	"2019-07-01-count-2:ATCCATTGTGCATTTG"	2.69038810309712	-9.51218893444213	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCATTGTGCATTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2051.22193515431	48.456728694299	0.0236233475587583	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2048.08667413511	2048.08667413511
"AML-0160"	"2019-07-01-count-1:AGACACTTCCTGCTAC"	1.87399973449056	-9.85277273571166	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACACTTCCTGCTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.45749340611	45.6533282171791	0.0194978248999803	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2340.22122259651	2340.22122259651
"AML-0160"	"2019-07-01-count-1:GGGTAGAAGGAACATT"	1.83100940760915	-9.78227045452269	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTAGAAGGAACATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.40242625236	39.6352407174089	0.0159729193048584	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2477.37454342797	2477.37454342797
"AML-0160"	"2019-07-01-count-2:AAGTACCAGAACGTGC"	2.72296871718709	-9.13695719158324	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGTACCAGAACGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2066.15192773716	48.0401386444756	0.023251019443226	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2062.70876208883	2062.70876208883
"AML-0160"	"2019-07-01-count-2:TCTCTGGCACCTAAAC"	1.64696933802907	-8.71185591137084	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCTGGCACCTAAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.95551192567	46.8711982893033	0.0196199544341961	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2383.89747367291	2383.89747367291
"AML-0160"	"2019-07-01-count-2:CACTGGGTCTCCGAGG"	1.68536831912343	-8.92556860363158	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACTGGGTCTCCGAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.79196449664	43.2278604036924	0.0200333772277146	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2148.64851058833	2148.64851058833
"AML-0160"	"2019-07-01-count-3:CCGTGAGCAAATTGGA"	2.29454888877217	-9.36338999187621	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGTGAGCAAATTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1969.30556662781	45.1260506550568	0.0229147022279176	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1965.06538028952	1965.06538028952
"AML-0160"	"2019-07-01-count-1:TTTGATCGTAATGATG"	2.16796888884847	-4.35954096233519	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGATCGTAATGATG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2299.19120859192	46.2333418609868	0.0201085241141389	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2294.09404836169	2294.09404836169
"AML-0160"	"2019-07-01-count-1:GACCCAGAGCAATTCC"	1.39236654815022	-9.77594759380492	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCCAGAGCAATTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.70942825073	41.4283032646727	0.0178438794969647	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2317.78304775572	2317.78304775572
"AML-0160"	"2019-07-01-count-2:GTTCTATAGGGTACGT"	8.09703602370564	6.17898175800172	"2019-07-01-count-2"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCTATAGGGTACGT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1836.14396929401	46.5078362399397	0.0253290793193204	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1829.98605422718	1829.98605422718
"AML-0160"	"2019-07-01-count-1:GTTGTGAAGGATACAT"	2.35198511657063	-8.58094122326048	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGAAGGATACAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.86997174919	39.5575256635372	0.0163808097853335	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2411.84814975827	2411.84814975827
"AML-0160"	"2019-07-01-count-3:GCTGGGTGTGTATACC"	1.7400686937267	-8.25592806255492	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTGGGTGTGTATACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2250.6630935096	40.5497996544525	0.0180168234736638	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2244.62000568355	2244.62000568355
"AML-0160"	"2019-07-01-count-1:GGGTGTCTCACGAGGA"	1.88160504874532	-9.15373518383177	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTGTCTCACGAGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.25040991924	45.6536414925852	0.0191079349837292	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2376.78567292868	2376.78567292868
"AML-0160"	"2019-07-01-count-1:TCAGGTAAGGACTATA"	1.47166420993153	-8.59313967144164	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGGTAAGGACTATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2288.36568210213	46.0708986041694	0.0201326645319414	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.09621096539	2286.09621096539
"AML-0160"	"2019-07-01-count-3:AAGTGAATCCAAGGGA"	2.08388437804524	-9.4528436890808	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGTGAATCCAAGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2044.67634406409	44.2906216971389	0.0216614340092109	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2040.84274693867	2040.84274693867
"AML-0160"	"2019-07-01-count-2:AGGACGACAATTGCCA"	-6.74845061722453	1.56245575034944	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACGACAATTGCCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2310.6292402559	39.7314620466995	0.0171950832069879	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2298.60991187861	2298.60991187861
"AML-0160"	"2019-07-01-count-1:GCTGCAGGTTACACTG"	1.70142128047292	-8.97911074077757	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGCAGGTTACACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2231.34531320785	42.8011717707545	0.0191817785967077	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2226.56263698549	2226.56263698549
"AML-0160"	"2019-07-01-count-3:ACCTACCTCATTACCT"	1.88048185881917	-9.10120298778685	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCTACCTCATTACCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.58208089869	38.1496047999156	0.0170266490681805	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2236.83322593038	2236.83322593038
"AML-0160"	"2019-07-01-count-1:TTCCTCTCATAGAATG"	-7.87613044205363	1.11409280383912	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCTCTCATAGAATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2576.60848291566	42.0436545654912	0.0163174400939312	2879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2571.00698260327	2571.00698260327
"AML-0160"	"2019-07-01-count-1:GGGTATTTCTCCAAGA"	1.66744997081105	-9.0111408463684	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTTCTCCAAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.54627446193	38.6726950036447	0.0161368446817608	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2392.46919847095	2392.46919847095
"AML-0160"	"2019-07-01-count-2:CATTCTAAGGCACTAG"	-1.70187507095988	-12.033419632074	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	68	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCTAAGGCACTAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.8747402248	40.7606266421371	0.0190214695600271	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2137.76707494561	2137.76707494561
"AML-0160"	"2019-07-01-count-3:GTGCTTCTCCCAATAG"	1.90712549266164	-8.62320043956908	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCTTCTCCCAATAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2235.02353702575	40.9989047178142	0.0183438357756059	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2233.93459758662	2233.93459758662
"AML-0160"	"2019-07-01-count-1:GAGTTGTGTACGAAAT"	-7.84864411774333	1.87849018657533	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTTGTGTACGAAAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2260.88156978022	38.8795491587122	0.0171966323572144	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2257.21532426266	2257.21532426266
"AML-0160"	"2019-07-01-count-2:CTCAGTCTCTGTTCAT"	1.65079607543294	-8.88395216381224	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAGTCTCTGTTCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2131.04203184025	44.6744905243441	0.0209636834266313	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2121.11335551247	2121.11335551247
"AML-0160"	"2019-07-01-count-3:CAGCGTGCAATCTAGC"	-9.38321624222453	3.56861732089845	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCGTGCAATCTAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2018.52152866117	44.8969639041683	0.0222424994069532	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2013.11606646674	2013.11606646674
"AML-0160"	"2019-07-01-count-3:GGTGTCGTCTAGCCAA"	2.59014501151387	-9.00773050701293	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTGTCGTCTAGCCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1670.97640390154	45.7537480563864	0.0273814447346813	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1668.92338234486	1668.92338234486
"AML-0160"	"2019-07-01-count-2:CAGAGCCGTCTGTAAC"	1.75286306914632	-8.78331377422484	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGAGCCGTCTGTAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2120.63060086656	48.9149869768044	0.0230662459349667	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2112.038012805	2112.038012805
"AML-0160"	"2019-07-01-count-2:CGGGCATAGTGAATAC"	1.57138409194295	-8.55790522014769	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGGCATAGTGAATAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2398.71730287285	40.0289062394119	0.0166876297558995	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2393.12406185933	2393.12406185933
"AML-0160"	"2019-07-01-count-2:GTCAAACGTGCCTAAT"	1.77551331099812	-8.62414457714232	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCAAACGTGCCTAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2129.22963136183	44.4705086856521	0.0208857269458576	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2129.22963136183	2129.22963136183
"AML-0160"	"2019-07-01-count-3:GTTAGACCACACGGAA"	-4.55469546738322	1.75425753677217	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.119047619047619	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTAGACCACACGGAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1636.15721894538	46.5971777906618	0.0284796456300801	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1631.30228576011	1631.30228576011
"AML-0160"	"2019-07-01-count-1:ACCTGTCAGTCATGGG"	3.30175461348836	-8.07513906871947	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCTGTCAGTCATGGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2490.18132217808	40.0143011213282	0.0160688303156691	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2485.50087306728	2485.50087306728
"AML-0160"	"2019-07-01-count-3:GACCGTGCATAACTCG"	-7.45537219467815	3.83697173679201	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCGTGCATAACTCG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2202.3700078965	36.8185793834613	0.0167177083103429	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2188.04906527586	2188.04906527586
"AML-0160"	"2019-07-01-count-1:CTGTAGAAGTAACCTC"	1.60524549063985	-8.66830828106078	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTAGAAGTAACCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.61358476719	41.6904354195212	0.016786200427966	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2479.13564918678	2479.13564918678
"AML-0160"	"2019-07-01-count-1:CCCGAAGTCGGACGTC"	1.95217063006703	-8.83732893383177	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCGAAGTCGGACGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2509.8175607343	37.1979901689903	0.014820993665415	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2506.04146079045	2506.04146079045
"AML-0160"	"2019-07-01-count-2:AGGTCATTCCTAGCTC"	1.74409439143483	-8.84210493480834	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTCATTCCTAGCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2440.26053354836	39.0748850677754	0.0160125873981812	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2437.4500011476	2437.4500011476
"AML-0160"	"2019-07-01-count-2:GTCACGGCACTTTAGG"	2.36440577086751	-5.34932949459227	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACGGCACTTTAGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2383.21089212744	38.396336579674	0.0161111787070587	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2383.21089212744	2383.21089212744
"AML-0160"	"2019-07-01-count-2:ATCCTATAGGATAATC"	2.75551809844319	-9.41165258800658	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCTATAGGATAATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2172.71889764157	36.4307367080651	0.0167673493094802	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2168.48825539391	2168.48825539391
"AML-0160"	"2019-07-01-count-3:GTGGAGAGTGTGAATA"	2.41403998908345	-8.1471157304016	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGAGAGTGTGAATA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2187.45790614066	40.2324252243065	0.0183923197385264	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2183.95277477102	2183.95277477102
"AML-0160"	"2019-07-01-count-1:GGGTGAATCCCTATTA"	1.73924972590749	-8.83587171947631	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTGAATCCCTATTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.31709111015	45.0452379819095	0.0192969661891509	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2333.24815802841	2333.24815802841
"AML-0160"	"2019-07-01-count-3:GACCTTCAGTCAGCGA"	2.03653814372365	-8.83843805706175	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCTTCAGTCAGCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2164.67251702051	44.544316229225	0.0205778545618237	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2159.40051037869	2159.40051037869
"AML-0160"	"2019-07-01-count-3:TGTTCCGTCACACGAT"	1.29720475253407	9.55295560443727	"2019-07-01-count-3"	"AML0160"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00646203554119548	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCCGTCACACGAT"	"CD4+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1493.72750042933	40.5807533231708	0.0271674407222916	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1492.27545784463	1492.27545784463
"AML-0160"	"2019-07-01-count-1:GATAGAATCCTTCGAC"	2.36609043654744	-9.06406023418578	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGAATCCTTCGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2315.33844485413	26.9788027812897	0.011652206977019	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2310.42397787258	2310.42397787258
"AML-0160"	"2019-07-01-count-3:ATCGATGAGTTCATCG"	2.36301245269124	-5.19622280513915	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGATGAGTTCATCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2023.47305753743	42.2012940652763	0.0208558714968191	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2016.31610521073	2016.31610521073
"AML-0160"	"2019-07-01-count-1:TCACACCTCGCTGTCT"	1.60369302806203	-9.04653646862181	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACACCTCGCTGTCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2385.53053235432	43.7390292783363	0.0183351370628526	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2381.22016573959	2381.22016573959
"AML-0160"	"2019-07-01-count-1:AGACTCAGTTTCAGAC"	-8.32609878006633	3.36415050113527	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACTCAGTTTCAGAC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2277.56092152033	43.6797472071104	0.0191783002572563	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2269.57866103157	2269.57866103157
"AML-0160"	"2019-07-01-count-1:GGGAGTAAGATGTAGT"	2.13360108908955	-4.69802858745726	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAGTAAGATGTAGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2401.35908542645	40.5700958711863	0.0168946394220678	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2392.99273226726	2392.99273226726
"AML-0160"	"2019-07-01-count-2:CCTCAACGTAGTTAGA"	1.36798836764638	-8.67097475444945	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCAACGTAGTTAGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1969.51897936501	41.2045192155975	0.0209211079696638	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1965.09055564068	1965.09055564068
"AML-0160"	"2019-07-01-count-3:ACCAACACAGTTCACA"	2.10524429854695	-7.4077096215454	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAACACAGTTCACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2106.45974551923	42.8586372470225	0.0203462882868707	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2103.53927743896	2103.53927743896
"AML-0160"	"2019-07-01-count-2:AGGAGGTTCTTAGCAG"	2.57612647589986	-9.28617861187132	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAGGTTCTTAGCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1944.61493583814	43.584955358824	0.0224131546845487	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1941.92985947304	1941.92985947304
"AML-0160"	"2019-07-01-count-3:GAACACTAGCAATTAG"	8.9690977531368	7.51540086353151	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAACACTAGCAATTAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1796.88392747533	42.1060939260409	0.0234328401975308	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1785.35374860451	1785.35374860451
"AML-0160"	"2019-07-01-count-3:AGGCATTAGCCTATCA"	3.14495172080342	-9.51066782390746	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCATTAGCCTATCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1796.67584573508	50.3365843607046	0.0280165086429992	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1788.86446608104	1788.86446608104
"AML-0160"	"2019-07-01-count-2:TCATCATAGGCAGGGA"	1.99136378344838	-8.02159979259642	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATCATAGGCAGGGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2412.04096112469	42.2486410970425	0.0175157228993917	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2405.8983306822	2405.8983306822
"AML-0160"	"2019-07-01-count-3:CGGAATTCAACTCGTA"	3.82877792891805	-9.93649580394896	"2019-07-01-count-3"	"AML0160"	"CD11c+"	"CD11c+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAATTCAACTCGTA"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1941.65868244884	44.6339015184555	0.0229875116166981	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1936.60873247695	1936.60873247695
"AML-0160"	"2019-07-01-count-3:CATTCTACAGAACTAA"	2.35469188269917	-5.00067951595458	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTCTACAGAACTAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2052.03699888857	43.9967318373621	0.0214405158684721	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2050.51391421966	2050.51391421966
"AML-0160"	"2019-07-01-count-2:GTTACCCAGGTCACAG"	-3.93254361572917	3.67791888797609	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTACCCAGGTCACAG"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2627.58844698835	48.9826342600027	0.0186416690620424	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2619.10399693153	2619.10399693153
"AML-0160"	"2019-07-01-count-1:ATGACCAAGCGCTTCG"	1.97360314902608	-8.86728670513304	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGACCAAGCGCTTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.86830487707	40.1060439080737	0.0155578327380794	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2568.22012414349	2568.22012414349
"AML-0160"	"2019-07-01-count-1:GGATGTTGTTGCTTGA"	1.90556706961934	-8.86691667949828	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGATGTTGTTGCTTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.49371678465	40.8641194425905	0.0160914434135046	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2531.1989846648	2531.1989846648
"AML-0160"	"2019-07-01-count-2:AGGTTACCAGCGTGAA"	1.924453039735	-9.51578333294066	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTTACCAGCGTGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.55850975266	41.0580795150799	0.0185484500789941	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2208.91802492404	2208.91802492404
"AML-0160"	"2019-07-01-count-1:AAGTTCGGTGTGAATA"	1.53227200087849	-8.44617845928343	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGTTCGGTGTGAATA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2412.56523948115	48.8643709386461	0.020254113811718	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2407.4741763634	2407.4741763634
"AML-0160"	"2019-07-01-count-3:ACTCCCAAGACCATTC"	2.40515460547749	-9.26428701793822	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCCCAAGACCATTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2319.72556973665	41.3277479571358	0.017815791874824	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2313.41655805317	2313.41655805317
"AML-0160"	"2019-07-01-count-3:CCATAAGAGTGCTAGG"	1.88567604598348	-9.01239302074584	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCATAAGAGTGCTAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2220.13454543177	37.9201600844977	0.0170801180327218	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2215.98826061011	2215.98826061011
"AML-0160"	"2019-07-01-count-1:GACTCAATCTAATTCC"	1.57371403750722	-9.00648786937865	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTCAATCTAATTCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2456.48543679692	39.9229754343624	0.0162520708799394	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2449.08742495626	2449.08742495626
"AML-0160"	"2019-07-01-count-2:CTCCACACAGACAAGC"	2.70870484885518	-9.64672853862914	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCACACAGACAAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1701.89479345101	51.6001993635705	0.0303192650698098	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1698.73823717653	1698.73823717653
"AML-0160"	"2019-07-01-count-3:CCTCAACAGCCACAAG"	2.07852282103841	-9.33841326152953	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCAACAGCCACAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2245.08447982639	43.0214215060381	0.0191624956176994	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2242.31863442065	2242.31863442065
"AML-0160"	"2019-07-01-count-1:TGTCCCACATGATCTG"	-8.5594838661259	4.89818427646486	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCCCACATGATCTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1863.65388609872	42.5494211968941	0.022831182074245	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1858.49683614205	1858.49683614205
"AML-0160"	"2019-07-01-count-3:ACTCCCAGTTTCACTT"	2.98507275161092	-10.2103414765564	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTCCCAGTTTCACTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.85172801427	41.0508825295209	0.016943208721718	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2419.58192020882	2419.58192020882
"AML-0160"	"2019-07-01-count-1:ACCAACAGTTCTCAGA"	-8.22194705429729	2.9404771097931	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCAACAGTTCTCAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2346.05740365309	40.3849647861637	0.0172139712878634	2508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2341.09187106903	2341.09187106903
"AML-0160"	"2019-07-01-count-1:TGGGAGAAGACTTCGT"	1.98841299590413	-9.03421118175658	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAGAAGACTTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2223.03490950869	46.6413275262244	0.0209809244680429	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2220.63957610289	2220.63957610289
"AML-0160"	"2019-07-01-count-1:AGTAGCTGTCTACAGT"	2.23512186583821	-8.94952013408812	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAGCTGTCTACAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.01790570654	41.4083183702711	0.0169288696839323	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2437.71536019807	2437.71536019807
"AML-0160"	"2019-07-01-count-3:TACCCGTAGAAATTCG"	1.87700738486592	-9.29960157787474	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCCGTAGAAATTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.01646810479	41.1753105077371	0.0181228046036496	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2267.08277624762	2267.08277624762
"AML-0160"	"2019-07-01-count-2:GGACGTCCAGTATGAA"	1.46837391433064	-8.36419966137084	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGACGTCCAGTATGAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2262.21652342512	43.0520929170408	0.0190309338081651	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2258.53082996225	2258.53082996225
"AML-0160"	"2019-07-01-count-1:CATTCATGTTGTGTTG"	1.80488719519917	-8.7774172059265	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTCATGTTGTGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1947.97079611314	35.6453312378623	0.0182986989892183	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1941.45809864203	1941.45809864203
"AML-0160"	"2019-07-01-count-3:CATCGTCCACTGCTTC"	2.24989308890645	-8.99410154735716	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGTCCACTGCTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.85239750067	34.305720891421	0.0144942375484196	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2364.65930794755	2364.65930794755
"AML-0160"	"2019-07-01-count-1:CGGGTGTCAACACACT"	2.14803399619405	-9.1180458298889	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGTGTCAACACACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2078.21880990776	48.2475209353774	0.0232158041806574	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2072.48677256401	2072.48677256401
"AML-0160"	"2019-07-01-count-3:CACATGAGTAACGTTC"	2.18783440169637	-8.83554651653441	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACATGAGTAACGTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2418.28562906832	39.7179233000654	0.0164240000530323	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2415.99280087743	2415.99280087743
"AML-0160"	"2019-07-01-count-2:TGAGGTTTCTCATGGA"	1.82250978526418	-4.11507370388182	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGGTTTCTCATGGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2168.86448864423	44.2036633098471	0.0203810166754489	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2158.09221703677	2158.09221703677
"AML-0160"	"2019-07-01-count-1:GTGAGTTTCAGACCCG"	1.61652125891988	-9.42078306591185	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGAGTTTCAGACCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.7329418058	41.97656313035	0.0176614555182026	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.30082725067	2374.30082725067
"AML-0160"	"2019-07-01-count-2:TTCAGGATCCAACTAG"	2.73597349700276	-9.48631861126097	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCAGGATCCAACTAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2249.41921776157	39.5359783636393	0.0175760827734823	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2245.23621757652	2245.23621757652
"AML-0160"	"2019-07-01-count-1:TCCATGCCATTGCAAC"	-7.92879043045695	2.2586619623932	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATGCCATTGCAAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2610.61312669837	44.0989387822339	0.0168921769109488	2814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2601.45105945309	2601.45105945309
"AML-0160"	"2019-07-01-count-2:ACGTAACCATGCGGTC"	-7.53523669663127	2.12075588786928	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAACCATGCGGTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2233.66504053078	39.2878025149546	0.0175889409567062	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2221.58607925391	2221.58607925391
"AML-0160"	"2019-07-01-count-1:AAGACAAAGACTCCGC"	1.69360937651936	-9.04053976452025	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGACAAAGACTCCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.98354843458	38.4148469953779	0.0154153694230885	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2489.0785197516	2489.0785197516
"AML-0160"	"2019-07-01-count-1:TACCTGCTCATTGGTG"	1.4680686193401	-8.59286215221556	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCTGCTCATTGGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.9706908248	39.8118711839814	0.0154072456492429	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2575.58102279937	2575.58102279937
"AML-0160"	"2019-07-01-count-1:GTTGTGAAGCATTTGC"	0.663497109978837	-5.19831230556639	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+ IFN+"	21	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0952380952380952	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGAAGCATTTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.95993959338	35.0682948858174	0.0144138398315257	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2424.6644449858	2424.6644449858
"AML-0160"	"2019-07-01-count-2:ACAGAAACAAGTTCGT"	2.10741200026814	-8.79984190380248	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAGAAACAAGTTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2194.08647629507	38.6498284962706	0.0176154535902955	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2184.1412355404	2184.1412355404
"AML-0160"	"2019-07-01-count-1:GGAATCTCACCGGAAA"	2.24124993857686	-9.00325395977172	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAATCTCACCGGAAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.09755697026	43.4211762315854	0.0173608486844409	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2495.84521503409	2495.84521503409
"AML-0160"	"2019-07-01-count-1:ATGCATGAGGGTACGT"	1.65937354144399	-8.51027777111205	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCATGAGGGTACGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2388.8916301146	39.8989100656108	0.0167018501645873	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2383.86381727151	2383.86381727151
"AML-0160"	"2019-07-01-count-2:GGAGATGAGTTTCTTC"	2.40396251258199	-9.23757364666136	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGATGAGTTTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2051.85696972167	44.4153637315666	0.0216464229168915	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2049.16701259612	2049.16701259612
"AML-0160"	"2019-07-01-count-2:TGGTGATTCAAGCTGT"	2.03704120692555	-4.19170429622801	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTGATTCAAGCTGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1598.74137380537	41.0974259951672	0.0257061127387639	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1596.63997817379	1596.63997817379
"AML-0160"	"2019-07-01-count-1:CCGGTAGAGTCCCTAA"	1.71959139880483	-8.76381113445433	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTAGAGTCCCTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2352.96197348861	42.0196954989903	0.0178582127431026	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2347.93928288925	2347.93928288925
"AML-0160"	"2019-07-01-count-3:AATTTCCAGCGCATCC"	1.64586700972859	-9.11674597179564	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATTTCCAGCGCATCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.09444851602	43.5049429442769	0.0194644763102346	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2232.65091856168	2232.65091856168
"AML-0160"	"2019-07-01-count-3:TCCTTCTTCCGCAACG"	0.540797104209107	-5.65010073101195	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTTCTTCCGCAACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.70730466005	39.1313769827518	0.0170380339294231	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2293.01339915075	2293.01339915075
"AML-0160"	"2019-07-01-count-2:CATCAAGAGTCTTGGT"	2.00500526007954	-8.81650354778441	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCAAGAGTCTTGGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.84434780865	40.8308383330467	0.0176082704178194	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2317.7174735732	2317.7174735732
"AML-0160"	"2019-07-01-count-1:AATGGAAAGATACTGA"	2.49862589415852	-9.05714895641478	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGAAAGATACTGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.96939578858	37.9704219882084	0.0152554796585509	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2484.64938590821	2484.64938590821
"AML-0160"	"2019-07-01-count-1:TTGGGTAAGCCGCACT"	-1.82570801201518	-11.90896227276	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	31	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	1	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGTAAGCCGCACT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.87128346926	37.0881272085747	0.0163177420025142	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2266.74356959359	2266.74356959359
"AML-0160"	"2019-07-01-count-1:TAGTGCAGTTGGAGGT"	5.07886137542073	-5.35873367702635	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGTGCAGTTGGAGGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.45484139348	41.7242485474431	0.01812163600229	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2299.01748312619	2299.01748312619
"AML-0160"	"2019-07-01-count-2:GAAATGATCCTCAGGG"	1.98492505130116	-8.87905599987181	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAATGATCCTCAGGG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2323.8664205815	38.14063511008	0.016412576373704	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2316.93132178614	2316.93132178614
"AML-0160"	"2019-07-01-count-1:GTATTGGGTGTTCGAT"	2.01642682132069	-4.62553598796996	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTATTGGGTGTTCGAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2251.62668292858	48.1053613984088	0.021364714569753	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2243.03401801632	2243.03401801632
"AML-0160"	"2019-07-01-count-1:GGAATGGGTCATGGCC"	2.01922168311421	-8.69229795848998	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAATGGGTCATGGCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.3169263311	45.5842647970348	0.0189593411325331	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2401.17659336768	2401.17659336768
"AML-0160"	"2019-07-01-count-2:TTTACGTGTCTCTCAC"	-8.07895789566692	2.30625436389772	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACGTGTCTCTCAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2532.91848134736	37.4753625424494	0.0147953291108345	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2524.36936575548	2524.36936575548
"AML-0160"	"2019-07-01-count-1:CTTAGGATCGGATACT"	2.24069013175313	-4.55263521587523	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTAGGATCGGATACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2472.95913854405	44.3232032341058	0.0179231441972798	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2467.31846925514	2467.31846925514
"AML-0160"	"2019-07-01-count-3:TGTGATGTCAGCTGAT"	2.1167708831722	-8.90666963970336	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGATGTCAGCTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2116.98870396333	37.5707882062043	0.0177472785451647	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2109.20141296714	2109.20141296714
"AML-0160"	"2019-07-01-count-3:AACAACCTCAAACGTC"	1.83932830867116	-9.04986383831175	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAACCTCAAACGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2112.22705217154	42.5723854903966	0.0201552126920393	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2107.77360694418	2107.77360694418
"AML-0160"	"2019-07-01-count-2:ACGTCCTAGATGCGAC"	1.92339803752248	-8.97788908397826	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTCCTAGATGCGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.70729796664	40.1937609124328	0.0176156516430709	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2278.37373975673	2278.37373975673
"AML-0160"	"2019-07-01-count-3:TGTGCGGCACGTGTGC"	1.70845653590505	-8.8570184937683	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGCGGCACGTGTGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2250.7720792485	43.1755465416912	0.019182549374838	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2247.90835016477	2247.90835016477
"AML-0160"	"2019-07-01-count-3:TCCGAAAGTCACTCGG"	-1.63566837731059	9.70876119220582	"2019-07-01-count-3"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCGAAAGTCACTCGG"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1728.68264882463	40.7978878178911	0.0236005653470465	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1726.93789802838	1726.93789802838
"AML-0160"	"2019-07-01-count-2:CATCCACGTACCCGCA"	-7.22696671906169	1.63629314983217	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCCACGTACCCGCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2333.77569838209	41.359041939291	0.0177219438731681	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2325.98299291124	2325.98299291124
"AML-0160"	"2019-07-01-count-2:TTTACTGGTGCCGTTG"	2.49525394019429	-8.96375658428343	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACTGGTGCCGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1979.57155632446	48.7359912179959	0.0246194642786673	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1971.15499167612	1971.15499167612
"AML-0160"	"2019-07-01-count-1:TAGGTACCACGTCGTG"	-8.01895461502727	2.13593170726625	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGGTACCACGTCGTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2104.47920692427	40.9413814203948	0.0194544005403747	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2098.32558081497	2098.32558081497
"AML-0160"	"2019-07-01-count-3:CCTCATGGTGACACAG"	-7.39582953873332	4.37027881229249	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.012987012987013	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCATGGTGACACAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1894.37658286355	35.8377544684515	0.0189179674161084	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1886.24967252551	1886.24967252551
"AML-0160"	"2019-07-01-count-3:CAATTTCCAGACAAAT"	-7.39792333069499	4.40665528858034	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.012987012987013	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATTTCCAGACAAAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1746.25623015445	36.3595728763642	0.0208214420361142	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1740.31100574841	1740.31100574841
"AML-0160"	"2019-07-01-count-1:GAGAAATGTCCTCCTA"	1.93874718722646	-4.19248964702757	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGAAATGTCCTCCTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1762.12040725363	31.9124168826394	0.0181102362535922	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1760.22868429029	1760.22868429029
"AML-0160"	"2019-07-01-count-2:AATGGCTCAACTCATG"	2.07282485541646	-8.77492525493773	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGGCTCAACTCATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.85529760029	39.5632065252655	0.0174760315145597	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2260.27683517478	2260.27683517478
"AML-0160"	"2019-07-01-count-1:TCGTGGGAGCTCCCTT"	3.17418183860127	-9.73913099682006	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGTGGGAGCTCCCTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1822.91767139892	44.9566744452232	0.0246619335313827	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1822.91767139892	1822.91767139892
"AML-0160"	"2019-07-01-count-1:AGATGCTAGCCACAAG"	-7.9411018890446	1.97465596282808	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATGCTAGCCACAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2510.12109782372	39.1128883745542	0.0155820722786901	3118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2496.83593382021	2496.83593382021
"AML-0160"	"2019-07-01-count-2:CTCCTCCGTGCTAGCC"	1.76811875876729	-9.11198046123656	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCTCCGTGCTAGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.96422432403	37.0902440980187	0.0155451803174152	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2378.99591679182	2378.99591679182
"AML-0160"	"2019-07-01-count-1:GGAGAACTCGTTCTAT"	-8.36663947525676	4.33114526355592	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGAACTCGTTCTAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2194.43352982419	36.8889607051061	0.0168102429186185	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2185.21508123954	2185.21508123954
"AML-0160"	"2019-07-01-count-2:CAACCAACATCGTTCC"	1.78828837451283	-8.96783640300902	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACCAACATCGTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.90107490025	45.845037084463	0.0177425666678175	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2575.15626318781	2575.15626318781
"AML-0160"	"2019-07-01-count-2:TGGCGTGTCAGCCTTC"	2.77441277083699	-9.47626593029173	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGCGTGTCAGCCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1876.10361456621	50.2824048002225	0.0268015073420392	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1872.50711756625	1872.50711756625
"AML-0160"	"2019-07-01-count-3:GGGTCTGAGGTCGTAG"	2.02474250373189	-8.95679571544798	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTCTGAGGTCGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2120.34504621985	43.9546878711846	0.0207299693743464	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2117.55735325169	2117.55735325169
"AML-0160"	"2019-07-01-count-3:CTTCTAACAAGATGGC"	1.91679169711415	-9.09872438823851	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCTAACAAGATGGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2394.84177618229	41.7050221586282	0.0174145208979575	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2391.74128238245	2391.74128238245
"AML-0160"	"2019-07-01-count-3:TCTGGCTCATCCGCGA"	2.53822197493855	-9.2183876267639	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGGCTCATCCGCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2035.99554757589	45.0888824462944	0.0221458649553425	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2030.71862131602	2030.71862131602
"AML-0160"	"2019-07-01-count-2:TGGGAAGAGTTTAGGA"	-7.93668542328532	1.77518568122713	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGAAGAGTTTAGGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2289.86987190075	39.1523592159524	0.0170980716836338	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2278.46695944085	2278.46695944085
"AML-0160"	"2019-07-01-count-3:GGGTGAAAGGTCGTAG"	-8.58616958084758	-0.569039010163866	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTGAAAGGTCGTAG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2582.78191459246	39.515600142947	0.01529962708802	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2566.31698250641	2566.31698250641
"AML-0160"	"2019-07-01-count-1:CTCATCGAGCCAGAGT"	1.79120292243306	-8.5995722047058	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCATCGAGCCAGAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2385.70056022684	40.1197707999696	0.0168167671453935	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2380.68651846495	2380.68651846495
"AML-0160"	"2019-07-01-count-2:TTCCGGTCAAAGAGTT"	1.99983050402943	-9.00998690044554	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCGGTCAAAGAGTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1842.40017205449	29.383728616545	0.0159486136954594	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1839.31461103544	1839.31461103544
"AML-0160"	"2019-07-01-count-2:GTAAGTCTCCGAACGC"	1.72015442427937	-9.87370016491088	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAAGTCTCCGAACGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2178.22652788567	48.3360108901617	0.0221905344882012	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2174.04647259319	2174.04647259319
"AML-0160"	"2019-07-01-count-1:TGGCGTGGTCAAATCC"	-8.49891505661662	4.06748483264772	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGGTCAAATCC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1916.11868870905	41.4615165259209	0.0216382819969544	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1911.47599267832	1911.47599267832
"AML-0160"	"2019-07-01-count-3:CTCCCTCAGTATCCTG"	2.06294192847554	-9.44749071514281	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCCTCAGTATCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.70460689815	42.5330395057033	0.0166619511677013	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2547.32321864064	2547.32321864064
"AML-0160"	"2019-07-01-count-3:AGTCATGCAGCAGTTT"	1.68730558928792	-8.54576208507689	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTCATGCAGCAGTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1973.97293765942	45.6467135791305	0.0231242853983879	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1973.97293765942	1973.97293765942
"AML-0160"	"2019-07-01-count-3:CGGTCAGAGTGTAGTA"	1.62587120112721	-8.82359697734984	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGTCAGAGTGTAGTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2196.94497380238	40.6158811369399	0.0184874367001753	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2193.69111085109	2193.69111085109
"AML-0160"	"2019-07-01-count-1:GTGAGCCAGGAGGCAG"	1.70929982241933	-9.17485334789427	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGAGCCAGGAGGCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.20851126923	39.5531047223937	0.0166454688360942	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2372.14184719869	2372.14184719869
"AML-0160"	"2019-07-01-count-2:AATTTCCAGGTCACAG"	2.08127131041829	-9.04017832195433	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATTTCCAGGTCACAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2470.38819988023	40.5396165770066	0.0164102211057243	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2466.68635772448	2466.68635772448
"AML-0160"	"2019-07-01-count-1:ATGTCCCTCGGACAAG"	1.62788476523702	-8.189573310968	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGTCCCTCGGACAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.69397076853	42.6903835979685	0.0182852160208028	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2329.10264959467	2329.10264959467
"AML-0160"	"2019-07-01-count-1:CGGGTCAAGAGTGTGC"	1.56819381293599	-8.31216528331908	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGTCAAGAGTGTGC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2289.454193167	44.6146178262606	0.0194870104671302	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2288.39478611865	2288.39478611865
"AML-0160"	"2019-07-01-count-1:TAGTGCAGTGGCATCC"	2.35099281844441	-4.57446625148924	"2019-07-01-count-1"	"AML0160"	"cDC1"	"cDC1"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGTGCAGTGGCATCC"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2403.90649442027	43.0648272293483	0.0179145184429205	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2396.43875768726	2396.43875768726
"AML-0160"	"2019-07-01-count-3:TACGCTCTCGATCCCT"	1.87665631350819	-9.34714033519896	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACGCTCTCGATCCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2277.63169880915	43.6631145132596	0.0191704016659448	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2277.63169880915	2277.63169880915
"AML-0160"	"2019-07-01-count-3:CATAGACTCTCTCAAT"	3.70010985907857	-8.13484861766966	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATAGACTCTCTCAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.90754000327	41.4046052651079	0.0185014816407685	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2236.61386371014	2236.61386371014
"AML-0160"	"2019-07-01-count-3:CGGTCAGGTGGAATGC"	1.61755361136739	-9.11799433147582	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGTCAGGTGGAATGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1828.72160796396	36.4842438120869	0.0199506822980603	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1828.72160796396	1828.72160796396
"AML-0160"	"2019-07-01-count-3:TATCTTGTCTCATGGA"	2.61563887175862	-9.29330446636351	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCTTGTCTCATGGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2158.26169890606	43.1956893117251	0.0200141110476173	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2155.65234683183	2155.65234683183
"AML-0160"	"2019-07-01-count-2:CTACGGGAGTTAGTAG"	1.49922194060628	-8.62882234966429	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACGGGAGTTAGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2294.06297117883	46.0080191766789	0.0200552555682624	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2292.85592170719	2292.85592170719
"AML-0160"	"2019-07-01-count-2:GACAGCCAGAGAAGGT"	2.22390856322591	-9.1796970597473	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACAGCCAGAGAAGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1955.9569500846	52.0044630920416	0.0265877339937325	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1954.53702448643	1954.53702448643
"AML-0160"	"2019-07-01-count-2:CATCGGGCAAACAGGC"	1.56594671782796	-8.95422365581664	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCGGGCAAACAGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.66947472701	41.7789427335696	0.0181910994130035	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2292.71701775726	2292.71701775726
"AML-0160"	"2019-07-01-count-3:GAAGCGACACGACTAT"	1.74846496161763	-9.31770327007445	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGCGACACGACTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2379.57932806027	42.7098661578664	0.0179484943637839	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2376.27451860244	2376.27451860244
"AML-0160"	"2019-07-01-count-2:GTTGCGGAGAAGCGAA"	2.13202728804891	-9.4595051041809	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGCGGAGAAGCGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.88207914939	40.137640122261	0.0182702751791766	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.71645012506	2195.71645012506
"AML-0160"	"2019-07-01-count-3:GTTACGATCGGTGTTA"	8.93054260787312	6.28007075870363	"2019-07-01-count-3"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTACGATCGGTGTTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1866.35763934258	48.0883967312843	0.0257659066609674	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1861.61355117226	1861.61355117226
"AML-0160"	"2019-07-01-count-3:GTAGCTACATGTACGT"	3.54797544059102	-9.7340183488098	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGCTACATGTACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1797.30895342548	43.9881443518781	0.0244744479061551	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1792.04158216908	1792.04158216908
"AML-0160"	"2019-07-01-count-2:GAGTCTAGTCGTATGT"	-9.18809161606486	4.17098901355592	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTCTAGTCGTATGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1839.86287280516	48.2084754258157	0.0262022111203941	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1832.89876940825	1832.89876940825
"AML-0160"	"2019-07-01-count-1:AAAGGTAAGTGACCTT"	1.44901301440541	-8.61227133190306	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGGTAAGTGACCTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2484.60216471403	40.4245126088782	0.0162700142433189	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2477.35535987699	2477.35535987699
"AML-0160"	"2019-07-01-count-2:GTTGCGGGTCCTTTGC"	2.48596419867818	-5.02864077007445	"2019-07-01-count-2"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGCGGGTCCTTTGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2156.42625456788	39.5994512924287	0.0183634618659213	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2154.06055051567	2154.06055051567
"AML-0160"	"2019-07-01-count-2:GGCACGTCAGGGTCTC"	-8.09143100205119	2.43696019733278	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCACGTCAGGGTCTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2328.18118799165	39.8853041768216	0.0171315292738138	2198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2326.74079186763	2326.74079186763
"AML-0160"	"2019-07-01-count-1:TGCATGATCCGCTAGG"	2.25239243087117	-4.96630194103392	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCATGATCCGCTAGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2336.51453913285	36.9153525755745	0.0157993250019642	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2329.75287679024	2329.75287679024
"AML-0160"	"2019-07-01-count-1:TATATCCCAGAGGACT"	2.14028038558308	-9.48419191753539	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATATCCCAGAGGACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.44812732142	40.5426919310432	0.01721961569702	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2350.44670601868	2350.44670601868
"AML-0160"	"2019-07-01-count-3:CCTGCATAGATAGCTA"	2.34910168227498	-8.48904707348021	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTGCATAGATAGCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.17761484276	41.6108667016392	0.0177734770902608	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.86675994482	2337.86675994482
"AML-0160"	"2019-07-01-count-3:CTTGAGATCCACGTCT"	1.92030360278432	-9.71244623577269	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTGAGATCCACGTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1929.47709257928	43.2867963897103	0.0224344702283278	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1929.47709257928	1929.47709257928
"AML-0160"	"2019-07-01-count-3:CTTGATTCACGTAGTT"	2.44166316565816	-9.11610510265502	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTGATTCACGTAGTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2255.85300433766	41.7759218893703	0.018518902521149	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2253.20575324603	2253.20575324603
"AML-0160"	"2019-07-01-count-1:TAACACGAGCCACTCG"	1.87409760531728	-8.72067358410033	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACACGAGCCACTCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2317.16164165947	37.8912850572542	0.0163524565468457	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2311.88674666951	2311.88674666951
"AML-0160"	"2019-07-01-count-1:TGAACGTCAGAATTCC"	2.17399015006368	-9.68242552196654	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAACGTCAGAATTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.51970865711	35.3459563005055	0.0144003554649979	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2450.739140927	2450.739140927
"AML-0160"	"2019-07-01-count-2:AAGTTCGGTGCGACAA"	-9.61649165573772	2.99204323375551	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGTTCGGTGCGACAA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2077.19354323518	37.7200912737766	0.0181591606601224	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2069.11263563171	2069.11263563171
"AML-0160"	"2019-07-01-count-3:GAAGGACTCTTAGCTT"	-8.57205901566203	4.8909291991028	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGGACTCTTAGCTT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1821.31957611913	43.2558771510954	0.0237497459085489	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1817.2596260957	1817.2596260957
"AML-0160"	"2019-07-01-count-3:TGCGGCATCTATTGTC"	1.9004211622173	-8.92219927227172	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCATCTATTGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.50253600821	39.7242387695588	0.0178978118407574	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2215.24258620667	2215.24258620667
"AML-0160"	"2019-07-01-count-1:GATCCCTAGTTGTCAC"	2.36908521231953	-9.07667829906615	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATCCCTAGTTGTCAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.81517164119	40.6252842132533	0.0150697587284966	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2690.58739633072	2690.58739633072
"AML-0160"	"2019-07-01-count-3:TTAGGGTAGGATTTCC"	1.37673439559285	-7.84494450008544	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGGGTAGGATTTCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2229.50022212658	42.5637046506641	0.0190911416954537	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2228.30880639918	2228.30880639918
"AML-0160"	"2019-07-01-count-1:GTCATGACACATGACT"	2.17076577719991	-4.68789722835692	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATGACACATGACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2344.01936378813	37.1732135331393	0.0158587484845109	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2342.22419104116	2342.22419104116
"AML-0160"	"2019-07-01-count-2:TAAGCGTTCGCTTTAT"	2.60577334937398	-8.81524183666381	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCGTTCGCTTTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1550.10983533782	45.0447921135502	0.0290590970308459	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1550.10983533782	1550.10983533782
"AML-0160"	"2019-07-01-count-2:TTTACGTAGACGGTCA"	-8.25411735001262	0.599559880140699	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACGTAGACGGTCA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2877.62562997368	38.0021510789014	0.01320607888777	3278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2872.31311483433	2872.31311483433
"AML-0160"	"2019-07-01-count-2:AGGTGTTCACGCAGTC"	1.82518674907033	-9.46763613140257	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTGTTCACGCAGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2353.50695031575	47.6442044140406	0.0202439191469771	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2349.95797416072	2349.95797416072
"AML-0160"	"2019-07-01-count-3:CATGAGTCAGAACTCT"	1.86489882048909	-8.59567835247191	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGAGTCAGAACTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2119.15458356915	48.7138210013	0.022987384393287	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2117.77007038414	2117.77007038414
"AML-0160"	"2019-07-01-count-3:TCTATCATCCTTCTGG"	1.72006263312642	-8.73214819347533	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTATCATCCTTCTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2468.03680445327	36.3966921302945	0.0147472242166815	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2464.73830342446	2464.73830342446
"AML-0160"	"2019-07-01-count-2:ATTACCTGTTCGCGTG"	2.49291362342183	-5.28888466274413	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTACCTGTTCGCGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.3058329254	39.6475750458507	0.0168619387961636	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2345.24132301473	2345.24132301473
"AML-0160"	"2019-07-01-count-1:CAGCAATTCTTTGGAG"	1.82007588919942	-8.38379385387572	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCAATTCTTTGGAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1968.36395850159	49.0978141525023	0.024943463296228	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1965.4470859098	1965.4470859098
"AML-0160"	"2019-07-01-count-1:CCTCCAAAGTAACGAT"	2.03711511668507	-10.5782222977844	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCAAAGTAACGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2207.53491836614	51.6029828358972	0.0233758399047613	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2199.21990090803	2199.21990090803
"AML-0160"	"2019-07-01-count-2:TGGGTTAAGTGACACG"	1.73892988738362	-8.82370092785033	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGTTAAGTGACACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2030.73508680395	48.2365269058875	0.023753234589453	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2030.73508680395	2030.73508680395
"AML-0160"	"2019-07-01-count-1:TGGGTTAGTCGTGGAA"	2.14396371421162	-9.41343500530394	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGTTAGTCGTGGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.98510903635	40.0945794447526	0.0170834400654613	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2339.49080063906	2339.49080063906
"AML-0160"	"2019-07-01-count-3:TTGGGTACAGCTATTG"	3.12532224234883	-9.36740686809691	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGTACAGCTATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1391.35339895311	46.0003429052854	0.0330615808606908	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1391.35339895311	1391.35339895311
"AML-0160"	"2019-07-01-count-1:ATACCTTCAATCCTTT"	1.5138724046642	-8.89087488567504	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATACCTTCAATCCTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.72053996303	45.7963391549723	0.0193419528960489	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2364.49307354224	2364.49307354224
"AML-0160"	"2019-07-01-count-3:TGAGCATTCCCACAGG"	1.83289863642995	-9.3181944123474	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGCATTCCCACAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1916.65132773434	46.0472730673496	0.0240248564780855	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1915.0083506651	1915.0083506651
"AML-0160"	"2019-07-01-count-3:TGCTCGTTCTGGGCAC"	2.21334375914876	-9.21594431316527	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTCGTTCTGGGCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.52065949607	38.2033797560694	0.017723504336535	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2151.6395620126	2151.6395620126
"AML-0160"	"2019-07-01-count-2:TGAGGAGTCTTACTGT"	1.97026087817494	-8.94228556072386	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGGAGTCTTACTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.79467556953	47.7253461727075	0.0220767248213034	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2161.79467556953	2161.79467556953
"AML-0160"	"2019-07-01-count-3:TCGCTTGAGGTTGTTC"	1.8490238386089	-9.87105467235716	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCTTGAGGTTGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2118.69669825682	38.3318189153192	0.0180921690900152	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2114.8597066017	2114.8597066017
"AML-0160"	"2019-07-01-count-2:GCCAGTGGTCCTATAG"	-8.0661223930424	2.16174600208131	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAGTGGTCCTATAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2325.6141161173	40.1076886485521	0.017246063467964	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2317.38856516799	2317.38856516799
"AML-0160"	"2019-07-01-count-2:TGGTACACAACGCCCA"	3.24909009513203	-9.84525301372679	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTACACAACGCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1918.16868277916	50.8665363471674	0.0265182811104334	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1911.61060263693	1911.61060263693
"AML-0160"	"2019-07-01-count-2:AGCGATTTCGAGAATA"	-8.31401286545451	5.24449775302736	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGATTTCGAGAATA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1908.33379339272	45.6928228622141	0.0239438315353518	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1904.89193744252	1904.89193744252
"AML-0160"	"2019-07-01-count-3:TTGATGGGTGACCGTC"	2.05902161177937	-4.26698782360228	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGATGGGTGACCGTC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1989.27759777102	45.9033481677959	0.0230753858683325	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1985.58940022057	1985.58940022057
"AML-0160"	"2019-07-01-count-1:ATTTACCGTCTACACA"	-8.47671161118205	-0.114885859843813	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0763052208835341	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTACCGTCTACACA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2910.4786883972	40.1198902785045	0.0137846363343751	3430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2899.62238216161	2899.62238216161
"AML-0160"	"2019-07-01-count-2:ATCGCCTTCAATCTTC"	1.83374514159505	-9.09265806591185	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGCCTTCAATCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.56686746576	52.159353344526	0.0228611986298967	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2277.4282617419	2277.4282617419
"AML-0160"	"2019-07-01-count-1:TAGACTGTCGAAGAAT"	1.88745214518849	-9.22479059612425	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGACTGTCGAAGAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2367.66759615422	38.0875414812053	0.0160865239457898	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2359.75109041433	2359.75109041433
"AML-0160"	"2019-07-01-count-1:GTGTCCTGTATGGTTC"	-7.97983394089397	2.20065782153932	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTCCTGTATGGTTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2282.39368306067	41.2899258216096	0.0180906239480299	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2274.25694714341	2274.25694714341
"AML-0160"	"2019-07-01-count-1:TGGGAGACACCCTGAG"	5.3110782104427	-4.88794853603514	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAGACACCCTGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.73269628041	40.6987781801317	0.0166407302981345	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2441.62956250128	2441.62956250128
"AML-0160"	"2019-07-01-count-2:AGTGTTGAGATGAACT"	2.52678432044331	-9.22222425853881	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGTTGAGATGAACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2038.4182732718	41.5311333570722	0.0203741959644091	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2038.4182732718	2038.4182732718
"AML-0160"	"2019-07-01-count-1:GGGATGATCTAACGCA"	2.35455860671346	-10.2004261246887	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00214132762312634	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGATGATCTAACGCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2079.64397244384	46.4591128548382	0.0223399358113413	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2072.10579184439	2072.10579184439
"AML-0160"	"2019-07-01-count-3:CGGAGAAAGACCTGGA"	2.07193197783772	-9.18976213848265	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAGAAAGACCTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2036.09008082483	51.0957996527036	0.0250950584818941	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2027.56976269914	2027.56976269914
"AML-0160"	"2019-07-01-count-1:ATTTCACCAGTAGAAT"	-8.38138137283977	3.24024889552919	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTCACCAGTAGAAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2154.77900552705	40.1656715246939	0.0186402742098694	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2152.01803551014	2152.01803551014
"AML-0160"	"2019-07-01-count-1:TCTCAGCTCCCTTGGT"	2.2900148826534	-8.84096243297728	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCAGCTCCCTTGGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2659.08728398296	37.2848344524191	0.0140216662600753	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2653.77120372698	2653.77120372698
"AML-0160"	"2019-07-01-count-1:AGGGCTCAGCGTGTTT"	5.17567839202229	-5.06203510677489	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCTCAGCGTGTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.80853443587	47.0516932560014	0.018613630191933	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2521.81734329174	2521.81734329174
"AML-0160"	"2019-07-01-count-3:CATCGTCGTTTGGGTT"	-0.700738052756149	12.4649343260559	"2019-07-01-count-3"	"AML0160"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGTCGTTTGGGTT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1540.34788201097	44.7579526678906	0.0290570417180421	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1540.34788201097	1540.34788201097
"AML-0160"	"2019-07-01-count-1:GGGCCATCACATGAAA"	2.28537311133687	-5.06896116649779	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCCATCACATGAAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2385.16094663463	48.7599253028269	0.0204430335703866	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2379.18088020683	2379.18088020683
"AML-0160"	"2019-07-01-count-3:GTAACCAGTTCTGACA"	2.08008803901021	-9.50011637127074	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAACCAGTTCTGACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.3565068708	47.8689142048824	0.0223649256800058	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.59817259509	2136.59817259509
"AML-0160"	"2019-07-01-count-3:AGTTAGCTCACTACTT"	5.26090588149373	-5.0111966363159	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTTAGCTCACTACTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2014.42999654321	35.1113099487411	0.0174298982883459	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2009.22163725139	2009.22163725139
"AML-0160"	"2019-07-01-count-2:AACCAACCATCCGTTC"	1.64820768412892	-8.71721651470336	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCAACCATCCGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2522.29971806898	39.0953224516801	0.0154998718715358	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2516.58288262765	2516.58288262765
"AML-0160"	"2019-07-01-count-1:GTGCTGGTCGGTCAGC"	1.56397988375966	-8.26923563396605	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCTGGTCGGTCAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.08272599116	43.0537542504078	0.0179160516551298	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2401.06520041905	2401.06520041905
"AML-0160"	"2019-07-01-count-1:GCCCAGACAAACGGCA"	1.93670131739919	-10.1125507584778	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCCAGACAAACGGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2267.2436491678	40.7184206311111	0.0179594375073261	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2263.47933417449	2263.47933417449
"AML-0160"	"2019-07-01-count-1:AGGTCATAGACAACAT"	1.96028163012807	-8.95889761364134	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTCATAGACAACAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.7454588476	35.225953912292	0.0148962983650082	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2360.6167894583	2360.6167894583
"AML-0160"	"2019-07-01-count-2:TGGTGATCAGAGTCTT"	1.94813408431355	-8.98073198711547	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTGATCAGAGTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2126.81119476561	40.9338418099945	0.0192465800023709	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2116.14030872877	2116.14030872877
"AML-0160"	"2019-07-01-count-1:TCATTACGTGGTCCCA"	2.1710602241451	-8.88750650798949	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTACGTGGTCCCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.53726916892	43.4951769208948	0.0174571648833506	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2482.54514592716	2482.54514592716
"AML-0160"	"2019-07-01-count-3:TCTTTGACAAGCGAGT"	2.27114882048909	-8.92449476635131	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTTGACAAGCGAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2072.80747271309	43.2823755009172	0.020881039879823	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2069.84886958356	2069.84886958356
"AML-0160"	"2019-07-01-count-3:CTCCAACAGCTTTGTG"	9.86475910720174	6.38253161990968	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACAGCTTTGTG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1741.22644139587	42.5895552892848	0.0244595155901391	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1735.9881740536	1735.9881740536
"AML-0160"	"2019-07-01-count-1:AGTAACCCACGAGGAT"	1.67299344119374	-8.21660807048949	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAACCCACGAGGAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2277.94255771564	46.3483452239529	0.0203465820799414	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2271.36887885182	2271.36887885182
"AML-0160"	"2019-07-01-count-1:GATAGCTGTGCTGATT"	2.33070482787434	-8.28141977703246	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGCTGTGCTGATT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.51300874011	37.363445034659	0.015278366911615	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2439.88036433519	2439.88036433519
"AML-0160"	"2019-07-01-count-3:GGTTGTAAGCCTCTCT"	2.30627336081807	-9.48434450542601	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTTGTAAGCCTCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1987.18842113641	45.7369483117696	0.0230159092239548	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1980.92934929527	1980.92934929527
"AML-0160"	"2019-07-01-count-3:ACCAACACAACCTATG"	1.78498639640157	-8.93642427837523	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAACACAACCTATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2304.98799798494	44.9764727076184	0.0195126711058529	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2303.79389651577	2303.79389651577
"AML-0160"	"2019-07-01-count-2:GAATCGTCAAGTCCAT"	2.21810116347615	-8.84270574962767	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATCGTCAAGTCCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.85819625027	37.0732057642435	0.0164560760308613	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2242.90609831949	2242.90609831949
"AML-0160"	"2019-07-01-count-3:CATAGACTCCTCTGCA"	1.75939049300496	-9.11428739940795	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATAGACTCCTCTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.84469110645	38.3157803468379	0.0165307798636618	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2311.78405239896	2311.78405239896
"AML-0160"	"2019-07-01-count-2:TCTACATTCCAGTGTA"	1.97164930877034	-8.88968946849974	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTACATTCCAGTGTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2141.61002194179	40.9285978467179	0.0191111348132412	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2140.35544768015	2140.35544768015
"AML-0160"	"2019-07-01-count-3:ACTTCCGTCAACGTGT"	9.22772182998006	7.47670648181764	"2019-07-01-count-3"	"AML0160"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000957854406130268	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTTCCGTCAACGTGT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1823.86044387231	41.1689064053846	0.0225723994090125	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1822.14865254945	1822.14865254945
"AML-0160"	"2019-07-01-count-1:TTGTTCATCCATTTCA"	-8.01148257675822	2.33242700183717	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTCATCCATTTCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2284.5482919424	34.2990090584014	0.0150134751711636	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2277.73243357253	2277.73243357253
"AML-0160"	"2019-07-01-count-2:CATCAAGTCACGACTA"	1.61822571334187	-8.6346645585266	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCAAGTCACGACTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2246.50216707001	41.5027975067975	0.0184744079552469	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2242.12317814796	2242.12317814796
"AML-0160"	"2019-07-01-count-2:TCTGGCTTCTTCGTGC"	1.47281422194783	-8.41687872326048	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGGCTTCTTCGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2553.77205383082	40.4769168070716	0.0158498550198925	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2549.18088914354	2549.18088914354
"AML-0160"	"2019-07-01-count-1:GAACGTTCAAATCCCA"	1.51241519030873	-8.91555216228636	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACGTTCAAATCCCA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2419.64837375678	40.8930936346471	0.016900428210218	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2413.40626419835	2413.40626419835
"AML-0160"	"2019-07-01-count-2:GCAGTTAAGCTCACTA"	2.02947356280629	-9.13413336193236	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGTTAAGCTCACTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.81734897955	41.4520771488132	0.018673643202162	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2213.77051765899	2213.77051765899
"AML-0160"	"2019-07-01-count-2:TTTGGTTTCTGATGGT"	1.71895207938496	-9.39047434246215	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGGTTTCTGATGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.66181018911	41.2632830046974	0.0177731669718667	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2320.58080456324	2320.58080456324
"AML-0160"	"2019-07-01-count-2:GAATAGAGTACGCTTA"	1.84647001799886	-9.38889124309691	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATAGAGTACGCTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.07576134533	45.2701088490403	0.0219749728133672	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2050.16600196703	2050.16600196703
"AML-0160"	"2019-07-01-count-1:CACTGTCAGACCCTTA"	-6.79452214661296	1.74143502796022	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGTCAGACCCTTA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2150.82227736009	43.1893127578692	0.0200803726149236	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2139.47546948712	2139.47546948712
"AML-0160"	"2019-07-01-count-3:GAACGTTCATAATGAG"	-8.19188628616985	2.86139533603517	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAACGTTCATAATGAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2089.89656435619	44.8368408909065	0.0214540956981376	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2086.34261519755	2086.34261519755
"AML-0160"	"2019-07-01-count-3:GGAGCAAAGGTTGGAC"	-8.11746440354045	2.50202558124391	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAGCAAAGGTTGGAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2097.40684369345	42.0641326952243	0.0200553043972866	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2091.45663552457	2091.45663552457
"AML-0160"	"2019-07-01-count-3:TACCGGGTCCGTTGAA"	2.04127170619313	-9.117138885614	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGGGTCCGTTGAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2242.50384710505	43.0925044839768	0.0192162455103954	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2240.26498494874	2240.26498494874
"AML-0160"	"2019-07-01-count-2:GTCCCATAGCGTTCCG"	1.58525206622426	-7.60225632106932	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCCCATAGCGTTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1882.54894480184	45.4542770639743	0.0241450705382637	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1880.85779501897	1880.85779501897
"AML-0160"	"2019-07-01-count-2:TGATGGTAGTGATAAC"	8.92642654952351	6.5082912215027	"2019-07-01-count-2"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATGGTAGTGATAAC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1714.05287343018	46.215716684346	0.0269628302608068	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1708.55687166609	1708.55687166609
"AML-0160"	"2019-07-01-count-1:CCTCACACATTGAGGG"	1.98772074755971	-9.36673357402953	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCACACATTGAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.3638156228	41.1882044036809	0.0174425491451929	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.3918981155	2358.3918981155
"AML-0160"	"2019-07-01-count-3:ACAGGGAGTTGATGTC"	2.29431047019307	-9.06126882946166	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACAGGGAGTTGATGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.16920649744	44.4170362064409	0.0192184267952213	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2311.16920649744	2311.16920649744
"AML-0160"	"2019-07-01-count-1:CGTCAAACAAAGCTCT"	1.95696439322774	-8.93303301250609	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTCAAACAAAGCTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2205.0667113619	46.9518025343039	0.0212926902811504	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2203.77657355574	2203.77657355574
"AML-0160"	"2019-07-01-count-3:TTGGATGCATACAGGG"	1.88842489299123	-9.02759268200072	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGATGCATACAGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1975.58958599842	46.0507077590495	0.0233098554909503	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1975.58958599842	1975.58958599842
"AML-0160"	"2019-07-01-count-1:GCCATGGTCCCGAATA"	2.75358523902242	-10.8540506592956	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCATGGTCCCGAATA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.2152896361	39.6332747498074	0.0159092130313622	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2483.58157360012	2483.58157360012
"AML-0160"	"2019-07-01-count-1:GTGCTGGCATCCGAGC"	2.85338773307149	-8.63918974315795	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCTGGCATCCGAGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2431.07092370864	39.1304056511875	0.0160959539557544	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2426.5012680874	2426.5012680874
"AML-0160"	"2019-07-01-count-3:AGGAATAAGGTCGCCT"	1.78482522544209	-8.0549936524597	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGAATAAGGTCGCCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2298.87290138551	40.6933249891647	0.0177014244522345	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2295.28245215653	2295.28245215653
"AML-0160"	"2019-07-01-count-2:TCGTAGACAAGCTGTT"	1.8385315137798	-9.39018728649291	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGACAAGCTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2007.3772607549	46.0566843367005	0.0229437112978854	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2004.27256319446	2004.27256319446
"AML-0160"	"2019-07-01-count-1:GGCTTTCGTCTATGAC"	2.52062191542928	-9.25345423137816	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTTTCGTCTATGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2019.70220604568	44.6799722866155	0.0221220594565242	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2014.1769780813	2014.1769780813
"AML-0160"	"2019-07-01-count-2:GCCGATGAGTAGAATC"	3.07878865775411	-9.3059931031433	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGATGAGTAGAATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2216.66162932362	41.9731739607137	0.0189353094786601	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2212.87846954029	2212.87846954029
"AML-0160"	"2019-07-01-count-2:TGATTCTAGATGCGAC"	8.00014128264729	6.98250911319581	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATTCTAGATGCGAC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1616.33260957833	42.030012942277	0.0260033193002533	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1616.33260957833	1616.33260957833
"AML-0160"	"2019-07-01-count-1:ACTTATCCAGGTAGTG"	2.49218740042989	-9.08157064830931	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTATCCAGGTAGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2104.19670656659	48.0312584505442	0.0228264108106682	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2099.99309217572	2099.99309217572
"AML-0160"	"2019-07-01-count-1:CTGAGCGAGGATACAT"	2.49655832824056	-4.9776559106079	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAGCGAGGATACAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2355.49478241928	42.1490479873891	0.0178939254300104	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2352.26879356747	2352.26879356747
"AML-0160"	"2019-07-01-count-3:ATGTCCCCATCGGAAG"	2.60582818564717	-9.39218904888304	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCCCCATCGGAAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2018.37800722717	37.7608222632868	0.0187084986697622	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2011.78804649902	2011.78804649902
"AML-0160"	"2019-07-01-count-1:TTTGACTGTAACACCT"	9.39176525649373	7.83198592746583	"2019-07-01-count-1"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGACTGTAACACCT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2257.97317408736	39.4946652522244	0.0174912021566366	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2252.25824975963	2252.25824975963
"AML-0160"	"2019-07-01-count-1:TGAGCGCGTGACACAG"	2.37442626532857	-9.32798006450804	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGCGCGTGACACAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.67633647045	45.1503458333054	0.0202679110488923	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2226.45801925681	2226.45801925681
"AML-0160"	"2019-07-01-count-1:TCATACTTCATGTCTT"	1.85505952414815	-8.74457933818968	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATACTTCATGTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2463.46052220901	37.8928156184355	0.0153819455505042	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2458.79314975955	2458.79314975955
"AML-0160"	"2019-07-01-count-1:GATGCTAGTAGAATGT"	8.46130337294881	7.48187110507814	"2019-07-01-count-1"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGCTAGTAGAATGT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2040.60058181732	42.7272605866671	0.0209385712066273	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2039.36985174327	2039.36985174327
"AML-0160"	"2019-07-01-count-2:GGGATCCCATGGCCAC"	1.72414948520009	-8.67040922557982	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGATCCCATGGCCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2139.2535440135	45.1627468518532	0.021111451224768	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.94044076771	2136.94044076771
"AML-0160"	"2019-07-01-count-1:TCGGGCAGTTGAATCC"	3.15838303145711	-9.86933138286742	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGCAGTTGAATCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2205.94889320044	41.0757084716426	0.0186204261568586	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2201.36794645951	2201.36794645951
"AML-0160"	"2019-07-01-count-2:CCCGGAAAGGGATCGT"	-0.738509039313155	11.9480571516785	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGGAAAGGGATCGT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1827.47240519143	41.599589244904	0.0227634568526064	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1825.90191995202	1825.90191995202
"AML-0160"	"2019-07-01-count-2:TCTAACTTCGGTCGAC"	-8.95095477524455	4.44130799854127	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTAACTTCGGTCGAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2021.48193908697	35.375568389085	0.0174998191698229	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2016.20437093262	2016.20437093262
"AML-0160"	"2019-07-01-count-1:GCCAGGTAGACCAACG"	1.56762995299641	-8.72265245830687	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAGGTAGACCAACG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2505.66202758475	36.139788769889	0.0144232495731775	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2496.61735057645	2496.61735057645
"AML-0160"	"2019-07-01-count-1:TGTCCACGTCGAATTC"	-8.29209552231486	4.97316882694093	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCCACGTCGAATTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1744.81740710555	41.7502287608655	0.023928136314346	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1742.24928555733	1742.24928555733
"AML-0160"	"2019-07-01-count-3:CCGATGGCATCCGTGG"	2.25970615920369	-4.75093557750853	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGATGGCATCCGTGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2272.94910935558	44.8388879078373	0.0197271851460633	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2268.26509303847	2268.26509303847
"AML-0160"	"2019-07-01-count-2:CACTTCGTCCGGCAGT"	-7.55217538300212	1.81325743282167	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACTTCGTCCGGCAGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2298.49143540505	37.8164274419696	0.0164527162727084	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2295.35934251522	2295.35934251522
"AML-0160"	"2019-07-01-count-3:GAGTTTGGTGGCCCAT"	2.0195447402889	-8.77141096508177	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTTTGGTGGCCCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2089.27951725798	42.3146478194248	0.0202532248413364	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2085.61066576683	2085.61066576683
"AML-0160"	"2019-07-01-count-2:TATTCCACACACGTGC"	1.74296309527699	-8.82176020061644	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATTCCACACACGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2260.38603771863	45.1334008699016	0.0199671207115817	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2258.03204006037	2258.03204006037
"AML-0160"	"2019-07-01-count-2:ATAGACCAGAAGTCCG"	2.05666651305501	-9.23422720348509	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATAGACCAGAAGTCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2285.42853987885	36.2701132598174	0.0158701585400435	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2280.19425009949	2280.19425009949
"AML-0160"	"2019-07-01-count-3:TAGTGCACATCACAGT"	1.72698046740834	-9.2486839524475	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGTGCACATCACAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.19947153832	41.2762422248577	0.0184499606539223	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.62245447834	2233.62245447834
"AML-0160"	"2019-07-01-count-1:AACCCAATCCACACAA"	2.30228747901265	-9.01422312175902	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCCAATCCACACAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.34551985561	51.5145663037029	0.0210062431605216	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2448.06066664423	2448.06066664423
"AML-0160"	"2019-07-01-count-1:TGTACAGAGAAATCCA"	1.88750924643819	-9.16723730480345	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTACAGAGAAATCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.12673440626	41.1949642668161	0.0179098671610588	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2292.61235242115	2292.61235242115
"AML-0160"	"2019-07-01-count-1:GACCGTGCATCCGTTC"	1.44605638560597	-8.43676950847777	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCGTGCATCCGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2393.22582373522	25.2255126197419	0.0105403812584519	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2386.56345324311	2386.56345324311
"AML-0160"	"2019-07-01-count-3:TATGTTCAGTCCCAAT"	3.11387219008748	-8.20279600536498	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATGTTCAGTCCCAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1468.39494211792	38.4759963474213	0.0262027573398788	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1468.39494211792	1468.39494211792
"AML-0160"	"2019-07-01-count-3:TAATTCCTCCTGATAG"	2.01778080043141	-9.91063692485961	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAATTCCTCCTGATAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2123.76751169371	40.4339864970503	0.0190388007512198	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2119.82095553614	2119.82095553614
"AML-0160"	"2019-07-01-count-1:CAGATCATCCCGAATA"	-8.0425218147343	2.22306296909181	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGATCATCCCGAATA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2349.84551324216	38.2143277536353	0.016262485145634	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2344.91567623097	2344.91567623097
"AML-0160"	"2019-07-01-count-1:GCTTCACAGACATCAA"	1.75660814818684	-8.99107553875121	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTCACAGACATCAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2253.21755307629	44.004930465132	0.0195298187718503	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2246.72080609237	2246.72080609237
"AML-0160"	"2019-07-01-count-2:TCGCACTAGCACCTGC"	-8.03034053269084	1.81373260104982	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCACTAGCACCTGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2597.68460555169	40.6399847789395	0.0156446955462126	2816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2592.93114759879	2592.93114759879
"AML-0160"	"2019-07-01-count-1:AGACCCGCATATTCGG"	-7.60402760925944	3.80139539325563	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCCGCATATTCGG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2362.73672810294	33.4885278520882	0.0141736180141307	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2348.21259667559	2348.21259667559
"AML-0160"	"2019-07-01-count-3:CTGAGGCTCCTGCTAC"	1.90306021746938	-8.76661493694457	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAGGCTCCTGCTAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.71784773969	43.6747657302434	0.0194653555812471	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2241.17107801378	2241.17107801378
"AML-0160"	"2019-07-01-count-2:GTGCACGTCGACATTG"	1.54549040374104	-8.61196806347045	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCACGTCGACATTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.54586389884	40.7109931722563	0.018483607465132	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2197.94437206217	2197.94437206217
"AML-0160"	"2019-07-01-count-3:TCGCAGGAGGGCTGAT"	2.49533118781392	-9.44533541118773	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCAGGAGGGCTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2098.79824275723	38.5313599001892	0.0183587727086953	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2096.03326023749	2096.03326023749
"AML-0160"	"2019-07-01-count-3:ACCAAACCAGAGTAAT"	-7.8683365387028	3.67832443797914	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAAACCAGAGTAAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2156.0829994675	38.4883794172607	0.0178510657645213	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2147.83975493872	2147.83975493872
"AML-0160"	"2019-07-01-count-3:GAAGGACGTTTGAACC"	1.95013823088948	-9.42002584850463	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGGACGTTTGAACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.18805228598	42.2580951403007	0.0194184023278276	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.42152886616	2171.42152886616
"AML-0160"	"2019-07-01-count-3:GTTGTGAGTTCCTACC"	2.01277901706044	-9.21053507244261	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTGAGTTCCTACC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2125.96568026555	39.9668732881809	0.018799397214723	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2123.31886895001	2123.31886895001
"AML-0160"	"2019-07-01-count-3:TAGGTACTCACCGGGT"	2.22750176963155	-4.82960894024047	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGGTACTCACCGGGT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2413.19790586267	40.999182552513	0.0169895649473708	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2409.66473345307	2409.66473345307
"AML-0160"	"2019-07-01-count-2:CGCATGGAGCACGTCC"	-9.49489913407024	3.03294870937196	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCATGGAGCACGTCC"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2165.02034845457	43.6683458703503	0.0201699470868814	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2160.7552042284	2160.7552042284
"AML-0160"	"2019-07-01-count-2:CATCGTCCAGCTGGTC"	5.25250067290608	-5.06674721157225	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCGTCCAGCTGGTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2476.66078308744	35.3750549766447	0.0142833670312112	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2467.48145134314	2467.48145134314
"AML-0160"	"2019-07-01-count-3:AGCGATTGTCATCTAG"	2.12381281432454	-9.05340578472289	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGATTGTCATCTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2036.21666313864	41.8459380712354	0.0205508278312258	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2034.96706869287	2034.96706869287
"AML-0160"	"2019-07-01-count-1:CTTGAGATCACATTGG"	1.75072469291036	-8.95123579418334	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTGAGATCACATTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.78175547236	44.5890725945131	0.020141584636467	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2208.67672639013	2208.67672639013
"AML-0160"	"2019-07-01-count-2:AGTCTCCCAGACCAGA"	3.10757388648335	-9.32148744976195	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCTCCCAGACCAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.05439364174	41.7816991711233	0.0194418993277881	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2142.40321319354	2142.40321319354
"AML-0160"	"2019-07-01-count-1:GCGGATCAGGTTTACC"	1.78489043292348	-9.10077192699584	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGGATCAGGTTTACC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2094.50121356259	48.9463946508719	0.0233689979905133	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2091.42263539868	2091.42263539868
"AML-0160"	"2019-07-01-count-2:GCTGCAGAGGTCGTAG"	1.92770196971242	-8.9080324403015	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTGCAGAGGTCGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.14440431848	40.1188307759916	0.0184357392351248	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2172.20032229572	2172.20032229572
"AML-0160"	"2019-07-01-count-1:GATAGAAGTTGCTAGT"	1.64086784896199	-9.36259844219359	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGAAGTTGCTAGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2341.50716256816	43.2084661386684	0.0184532709655594	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.98371147801	2337.98371147801
"AML-0160"	"2019-07-01-count-3:TATTGCTCAACAAGAT"	2.17668904837911	-4.36403181469115	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTGCTCAACAAGAT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2245.08391485404	42.5498768066088	0.0189524661083214	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2243.065579127	2243.065579127
"AML-0160"	"2019-07-01-count-3:CGTGCTTTCTGGGATT"	2.23470463332478	-8.95033552562865	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTGCTTTCTGGGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1529.57198180259	51.478343417273	0.0336553912007502	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1527.63242168749	1527.63242168749
"AML-0160"	"2019-07-01-count-3:TTCTAACAGCATAGGC"	1.87718250331227	-3.96506788646849	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTAACAGCATAGGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1905.86074284617	44.276385438979	0.0232317002200579	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1904.46293963622	1904.46293963622
"AML-0160"	"2019-07-01-count-2:CACGTGGTCCACGGGT"	-7.08238301697429	0.771096444967665	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTGGTCCACGGGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2250.46415483947	38.7057211376836	0.0171989947293537	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2246.3731918814	2246.3731918814
"AML-0160"	"2019-07-01-count-2:TTACGCCCAATCGCCG"	1.93367304381673	-8.75369551098021	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTACGCCCAATCGCCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2491.00547766364	35.8722790320247	0.0144007226614652	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2484.26262162907	2484.26262162907
"AML-0160"	"2019-07-01-count-3:TGCTTGCAGTATGGCG"	2.49935998496358	-8.64901926433715	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTTGCAGTATGGCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1874.05011049342	37.6263112141436	0.0200775374166686	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1874.05011049342	1874.05011049342
"AML-0160"	"2019-07-01-count-3:GTCGAATCAATTGTGC"	2.14479007300679	-8.84309484874877	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGAATCAATTGTGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2195.96519014238	43.0605200581962	0.0196089265219201	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2183.9560407071	2183.9560407071
"AML-0160"	"2019-07-01-count-2:CTAAGTGCATGGACAG"	2.72019495543782	-9.15997316753539	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAAGTGCATGGACAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2398.39196915855	40.285937475086	0.0167970615283622	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2397.34822979097	2397.34822979097
"AML-0160"	"2019-07-01-count-1:TGTAACGTCATCGCAA"	2.84174146231953	-8.05621054088744	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTAACGTCATCGCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2355.58964428769	41.1915998095128	0.0174867468573749	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2353.5499254361	2353.5499254361
"AML-0160"	"2019-07-01-count-2:GGGTCACGTAAGATAC"	2.66009153899495	-8.80344965374144	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTCACGTAAGATAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2089.32592015945	41.422575039751	0.0198258082379937	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2086.6657405139	2086.6657405139
"AML-0160"	"2019-07-01-count-2:CCTCACAGTGTGACCC"	2.18728174743001	-10.3701582184997	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCACAGTGTGACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.17876299208	33.9121494500012	0.0141113719762482	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2399.29769598541	2399.29769598541
"AML-0160"	"2019-07-01-count-1:AGACCATCACAGCCAC"	1.79113544997517	-8.77840235149535	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATCACAGCCAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.64587846817	41.3553642661458	0.0157385607417749	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2622.04773272841	2622.04773272841
"AML-0160"	"2019-07-01-count-2:CGGGACTGTCATTCCC"	2.26168503341023	-8.67052843486937	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGGACTGTCATTCCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.12497497871	37.335190685757	0.0146981707803845	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2537.5473991361	2537.5473991361
"AML-0160"	"2019-07-01-count-3:GTAGGTTCAGAATCGG"	-8.28128467026408	2.73750684345094	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGGTTCAGAATCGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2401.75694053344	49.5458986635303	0.0206290227905102	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2395.01117419106	2395.01117419106
"AML-0160"	"2019-07-01-count-3:TGATCTTCAGATACTC"	1.96218492564504	-9.15541746532591	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGATCTTCAGATACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.75953782969	41.6918161900424	0.0202312862926019	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2054.42092962345	2054.42092962345
"AML-0160"	"2019-07-01-count-1:GTCCACTCAAGGACAC"	2.3137387233669	-4.69791033184203	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCACTCAAGGACAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2541.29921840684	38.7927745881058	0.0152649378346031	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2538.28329242754	2538.28329242754
"AML-0160"	"2019-07-01-count-2:AATCACGTCAACACCA"	-8.21537242355998	1.03093836391298	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCACGTCAACACCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2457.71324125111	39.1675402030808	0.015936578582757	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2449.25848457153	2449.25848457153
"AML-0160"	"2019-07-01-count-2:TTACAGGAGGCGAAGG"	1.87417318400685	-9.29649736797484	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTACAGGAGGCGAAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1654.92125815974	45.6568681561655	0.0275885441262236	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1653.06294622658	1653.06294622658
"AML-0160"	"2019-07-01-count-3:TTTGGAGTCGGTAACT"	-7.24452147904094	-2.49312593853148	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00451807228915663	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGGAGTCGGTAACT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1428.5780915264	48.7192041504074	0.034103283845234	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1428.5780915264	1428.5780915264
"AML-0160"	"2019-07-01-count-3:ACCACAATCGGCTATA"	2.09003986892049	-3.92717912113341	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCACAATCGGCTATA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2078.7218608342	48.0730124425374	0.0231262360531704	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2072.87048205293	2072.87048205293
"AML-0160"	"2019-07-01-count-3:AAGCGAGAGGGCTTCC"	2.31451501426045	-9.21177580272826	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCGAGAGGGCTTCC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2011.70030861878	47.4264627325927	0.0235753121523132	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2010.16272038659	2010.16272038659
"AML-0160"	"2019-07-01-count-2:ATCGGATCAACACAGG"	0.288570125668687	11.5787534483704	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0136108887109688	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATCAACACAGG"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1611.41318236741	42.0074085016368	0.0260686762161903	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	1609.71956485933	1609.71956485933
"AML-0160"	"2019-07-01-count-3:TGCTGAACAACGCCCA"	5.34967007216756	-4.77544786846312	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTGAACAACGCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1965.93745399257	49.8511986501712	0.0253574693075457	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1959.72159077839	1959.72159077839
"AML-0160"	"2019-07-01-count-3:GAATAGAGTAAGACCG"	2.01814128932301	-9.28765776073607	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAATAGAGTAAGACCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.68826304114	40.8716440080066	0.0189423304135697	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2154.12014497459	2154.12014497459
"AML-0160"	"2019-07-01-count-2:ATCGGATGTTCTTAGG"	2.0967182117397	-8.35246374523314	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATGTTCTTAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1812.76003630606	47.785285611096	0.0263605136113162	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1807.69012928781	1807.69012928781
"AML-0160"	"2019-07-01-count-3:GCTACAAAGGTGCCTC"	-7.85595784607585	1.93585465038148	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTACAAAGGTGCCTC"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2509.36811890808	39.5298752811491	0.0157529200212961	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2499.47605656031	2499.47605656031
"AML-0160"	"2019-07-01-count-3:CGATCGGAGTAACCGG"	-9.5890134376591	5.07603738391725	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGATCGGAGTAACCGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1768.80641849811	48.7641263373884	0.0275689447004574	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1766.11526705873	1766.11526705873
"AML-0160"	"2019-07-01-count-2:CCTCCAAAGCATTTCG"	2.51724900779073	-9.48111536419066	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCCAAAGCATTTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.79384821618	43.3544387297518	0.0186326944103747	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.87006647741	2321.87006647741
"AML-0160"	"2019-07-01-count-3:CTACCTGGTTGGATCT"	2.13591541823689	-8.67395212566527	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCTGGTTGGATCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.08152726115	39.3890189347185	0.0171848245650255	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.40392067981	2288.40392067981
"AML-0160"	"2019-07-01-count-2:TCCTTCTCATGACTAC"	1.78901066359822	-9.01032926952513	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTCTCATGACTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.11184454518	46.0878747965035	0.0192988761819408	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2381.73222605064	2381.73222605064
"AML-0160"	"2019-07-01-count-3:CTGCGAGAGTTGAAAC"	5.23664059218709	-5.03793337261351	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCGAGAGTTGAAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2153.1656192821	37.7607851740729	0.0175373342560908	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2147.36902952855	2147.36902952855
"AML-0160"	"2019-07-01-count-1:ACTCTCGTCGATTCCC"	-8.59299407425578	5.29205319965211	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTCTCGTCGATTCCC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1426.57442968934	46.8736300832946	0.0328574724933924	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1424.58808628224	1424.58808628224
"AML-0160"	"2019-07-01-count-3:TCCTTCTCAATCGAAA"	1.52715708789174	-8.34999468242797	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTTCTCAATCGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.07328871013	44.4451781784533	0.0212648898096211	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2086.97838446888	2086.97838446888
"AML-0160"	"2019-07-01-count-1:TCCATGCGTGTTACTG"	2.11765970763509	-8.79189398204955	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATGCGTGTTACTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.10247214159	36.3006135016283	0.0141077216685488	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2566.58107488291	2566.58107488291
"AML-0160"	"2019-07-01-count-2:AGTGTTGGTCATACCA"	1.50742079791371	-9.0547781220642	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGTTGGTCATACCA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.53781409314	38.1558576187893	0.0165856250590822	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2297.38446777407	2297.38446777407
"AML-0160"	"2019-07-01-count-2:ATTCACTGTTCTCCTG"	1.79767455634419	-9.18267443096312	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCACTGTTCTCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2551.67700690511	38.5462152244901	0.0151062282256649	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2549.63861923045	2549.63861923045
"AML-0160"	"2019-07-01-count-3:ACCGTTCGTCCGGCAT"	2.26040782508199	-9.38037779247435	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCGTTCGTCCGGCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1978.56808476721	46.153718595522	0.0233268286044107	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1977.05798490585	1977.05798490585
"AML-0160"	"2019-07-01-count-3:ACTTTGTTCTGTACAG"	9.62376560744588	5.21885392749635	"2019-07-01-count-3"	"AML0160"	"B"	"Naive B"	48	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000700770847932726	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTTTGTTCTGTACAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1476.92906794055	50.5518627560037	0.0342276848992444	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1474.88684283458	1474.88684283458
"AML-0160"	"2019-07-01-count-2:GGTCTGGCAACCACAT"	1.91150428828542	-9.39738943493041	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTCTGGCAACCACAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2368.36423106829	41.0542957898746	0.0173344518766677	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2364.23309616419	2364.23309616419
"AML-0160"	"2019-07-01-count-3:TGCGACGTCATGCCGG"	1.73336889323537	-3.89617230808409	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGACGTCATGCCGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1912.45669173517	43.0127416308985	0.0224908317227686	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1909.92378643409	1909.92378643409
"AML-0160"	"2019-07-01-count-1:CACACAAGTGTCATGT"	1.5221994119579	-8.21520426189574	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACACAAGTGTCATGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2359.68738596139	41.7116480863297	0.0176767686832107	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2354.54616662409	2354.54616662409
"AML-0160"	"2019-07-01-count-3:CAACCTCGTATACGGG"	2.67687072333638	-9.4447174302307	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACCTCGTATACGGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1917.27536209355	54.1623952188073	0.0282496694474106	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1915.55276083095	1915.55276083095
"AML-0160"	"2019-07-01-count-2:CTCCTTTCAGCACGAA"	-7.98012957993205	2.4694499739441	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCTTTCAGCACGAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2456.01637556496	49.1547059206244	0.0200139976303364	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2451.92032284337	2451.92032284337
"AML-0160"	"2019-07-01-count-2:TGGCGTGGTGACTATC"	-4.80533109131511	3.0673789747986	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGCGTGGTGACTATC"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2577.00272482263	50.3078009844582	0.019521826849415	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2560.83024589013	2560.83024589013
"AML-0160"	"2019-07-01-count-2:TAGGTACTCCGAGATT"	-7.95402369919475	4.40431211078493	"2019-07-01-count-2"	"AML0160"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000562429696287964	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGTACTCCGAGATT"	"CD8+ T"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2082.14635751117	36.6822967104566	0.0176175399861437	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	27	TRUE	"T_AML-0160"	2075.27734069529	2075.27734069529
"AML-0160"	"2019-07-01-count-1:TCCATGCTCATCGACA"	0.851076562970322	-10.1542263261047	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATGCTCATCGACA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1993.78661221477	49.1109053157967	0.0246319766693801	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1987.97775692022	1987.97775692022
"AML-0160"	"2019-07-01-count-2:AGATCCAAGTTCGCAT"	2.09008493003194	-9.46179678356322	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATCCAAGTTCGCAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.64380498902	43.2781576255462	0.0191019248172401	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2265.64380498902	2265.64380498902
"AML-0160"	"2019-07-01-count-2:GATTCTTTCCGACATA"	2.06148089942281	-9.69092848217162	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCTTTCCGACATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.02445264431	37.4101785708275	0.0160007644610031	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2331.37762140748	2331.37762140748
"AML-0160"	"2019-07-01-count-2:TAGCACAGTGAGGATC"	1.99834050711934	-9.072461151239	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGCACAGTGAGGATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2081.05025294207	43.8660122089479	0.021078785650146	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2074.30540994101	2074.30540994101
"AML-0160"	"2019-07-01-count-3:CTCCAACTCGCGGACT"	5.26867165145223	-4.96997549450072	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACTCGCGGACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.03177651918	39.0188120972497	0.0161432764253689	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.69022530193	2409.69022530193
"AML-0160"	"2019-07-01-count-2:TGGGTTAGTGTTCCTC"	2.1430160003597	-9.07287790691527	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGTTAGTGTTCCTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.1813066164	41.9443284663714	0.0180936358802725	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2314.17047819109	2314.17047819109
"AML-0160"	"2019-07-01-count-1:AGTACCACAAATTAGG"	2.06728424605672	-9.12658979808959	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTACCACAAATTAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.91888168736	40.7963575438748	0.0173755396159837	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2344.52121211927	2344.52121211927
"AML-0160"	"2019-07-01-count-2:ACCTGTCTCCTACACC"	-7.85980830612834	2.35098812663881	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTGTCTCCTACACC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2509.22874582063	40.9297065143953	0.0163116681101983	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2497.60676700407	2497.60676700407
"AML-0160"	"2019-07-01-count-2:CTAACCCAGTCTCGTA"	8.43453278121297	8.00853965366212	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAACCCAGTCTCGTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1977.06458799765	41.3332732979239	0.0209063849248273	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1974.5247799591	1974.5247799591
"AML-0160"	"2019-07-01-count-1:TGGAGAGGTTTGGGAG"	1.89244033870046	-8.755078338739	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGAGAGGTTTGGGAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.78598591135	39.6384433440939	0.0170650432646474	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2318.29507985423	2318.29507985423
"AML-0160"	"2019-07-01-count-1:AGGTGTTCAAGGTCTT"	1.80076112326924	-10.0071869126526	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTGTTCAAGGTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2157.17933660122	44.1644303822004	0.0204732307754182	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2154.81586957459	2154.81586957459
"AML-0160"	"2019-07-01-count-1:TCAATCTAGATCGCTT"	2.10968436774556	-9.18404867565306	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAATCTAGATCGCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.87771152144	36.1907680592457	0.0152647130990241	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2365.89877114632	2365.89877114632
"AML-0160"	"2019-07-01-count-2:GTCCACTTCGCCACTT"	1.6790574985439	-8.94694330608519	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCCACTTCGCCACTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2412.72548629653	40.9986005032982	0.0169926503185532	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2404.85705591921	2404.85705591921
"AML-0160"	"2019-07-01-count-3:AAGGTAATCCTTCTAA"	1.82521404799764	-9.07617189800414	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGTAATCCTTCTAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2223.29425743812	42.2461906247056	0.0190016190989426	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2220.95568430434	2220.95568430434
"AML-0160"	"2019-07-01-count-1:TCGTGCTTCTTTGATC"	1.87360455569569	-9.23156454479369	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGTGCTTCTTTGATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.35370092357	37.712278879125	0.0157900728290545	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2385.08979899235	2385.08979899235
"AML-0160"	"2019-07-01-count-2:GCTGCAGAGAAACTCA"	-0.464438239962417	-7.3524322739807	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTGCAGAGAAACTCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.51180842229	42.109596317002	0.0183124070782196	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2296.88721258494	2296.88721258494
"AML-0160"	"2019-07-01-count-3:GTGCAGCCAGCGAACA"	1.80916335162465	-8.83311941539916	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCAGCCAGCGAACA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2107.21535303057	41.2958255677019	0.0195973446702117	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2107.21535303057	2107.21535303057
"AML-0160"	"2019-07-01-count-3:CCTCATGCAGCGTGAA"	3.23394050177876	-7.77689411556395	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.031413612565445	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCATGCAGCGTGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.24955162061	41.0078565739942	0.0167225462624281	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2444.32687698646	2444.32687698646
"AML-0160"	"2019-07-01-count-2:TCATGGATCACTTTGT"	2.73851503905599	-9.09663584148558	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATGGATCACTTTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1663.25463640386	49.9705023509777	0.0300438076391113	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1661.38307495116	1661.38307495116
"AML-0160"	"2019-07-01-count-3:TCGGTCTAGACTCATC"	2.21001329001729	-8.9677362672058	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGTCTAGACTCATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2588.7712704385	41.1527576376847	0.0158966371836759	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2580.82872441249	2580.82872441249
"AML-0160"	"2019-07-01-count-3:CTCATGCCACTTACAG"	-8.75996909561809	5.02542302692262	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATGCCACTTACAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1945.38497018997	38.391945107788	0.0197348831702134	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1940.78270615979	1940.78270615979
"AML-0160"	"2019-07-01-count-2:GTAACCACAATCGAAA"	2.22479857978169	-9.41446783458861	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAACCACAATCGAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1967.36988419656	40.1924562211589	0.020429537192785	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1963.62678575983	1963.62678575983
"AML-0160"	"2019-07-01-count-3:GTGTTCCCAAATGAAC"	1.81258167800252	-8.89792921459349	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTTCCCAAATGAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2041.12577354658	41.9664300229642	0.0205604331525563	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2041.12577354658	2041.12577354658
"AML-0160"	"2019-07-01-count-2:CATGGTAGTTATAGAG"	2.59871663626973	-8.85462191021117	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGGTAGTTATAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1433.70179093296	49.6651763910965	0.0346412180728168	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1433.70179093296	1433.70179093296
"AML-0160"	"2019-07-01-count-1:CGAGAAGAGAGACAAG"	8.85162128981892	6.84731671893922	"2019-07-01-count-1"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGAAGAGAGACAAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1728.29026411915	40.7075422894534	0.0235536490221454	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1720.3584747573	1720.3584747573
"AML-0160"	"2019-07-01-count-2:GCTGAATGTACCACGC"	2.08780731734578	-8.92335417186888	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTGAATGTACCACGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2227.37230911385	46.1992290994377	0.0207415836635851	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2222.06183549739	2222.06183549739
"AML-0160"	"2019-07-01-count-2:TGGAACTAGCGATGGT"	1.72083940085713	-8.34498693859252	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGAACTAGCGATGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.11940970927	39.4431869707771	0.0168552026905658	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2337.77489169169	2337.77489169169
"AML-0160"	"2019-07-01-count-3:GGTGTCGCACAATTCG"	-5.02567658844646	-6.52124359523924	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTGTCGCACAATTCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2957.88431292378	39.0116964893822	0.0131890541894859	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2944.68618418217	2944.68618418217
"AML-0160"	"2019-07-01-count-1:TACGTCCGTTCGGTTA"	1.27438594874684	-7.26610090648802	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00611995104039168	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGTCCGTTCGGTTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2649.01632871268	40.3371334814947	0.0152272120954034	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2642.80055453555	2642.80055453555
"AML-0160"	"2019-07-01-count-2:TTCTGTAAGCATGTTC"	1.89118065413777	-9.31692507183226	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCTGTAAGCATGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.90805495742	40.5164180202276	0.0171613705731367	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2354.64214401693	2354.64214401693
"AML-0160"	"2019-07-01-count-2:GATGAGGAGTACGAGC"	-7.93637595596965	0.987171686533369	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGAGGAGTACGAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2707.29137189837	38.3634574826186	0.0141704206207099	2663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2696.28523909143	2696.28523909143
"AML-0160"	"2019-07-01-count-3:AGGGAGTCACTCCTGT"	1.87728764590566	-9.53009321605834	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGAGTCACTCCTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2159.37690544884	38.8533860147044	0.0179928691080581	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2157.95068465129	2157.95068465129
"AML-0160"	"2019-07-01-count-2:ACTTATCGTAGGTACG"	-7.6032694381779	0.27734293723432	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCGTAGGTACG"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2437.40640540207	40.1532800840057	0.0164737731036618	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2428.24019717881	2428.24019717881
"AML-0160"	"2019-07-01-count-3:ACGTCCTAGTATTAGG"	2.87047209319417	-5.55348637020262	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTAGTATTAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.70212460264	38.918020447544	0.0170491016011643	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2279.2404615595	2279.2404615595
"AML-0160"	"2019-07-01-count-2:ATACCTTGTCACCACG"	2.69063009795491	-9.24502851879271	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACCTTGTCACCACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.63099458148	43.5759463727659	0.0203946991704581	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2129.98707971573	2129.98707971573
"AML-0160"	"2019-07-01-count-3:CTATAGGTCAGCAGAG"	2.39583172377889	-8.17009069835814	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATAGGTCAGCAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2096.29164329127	40.7802436145481	0.0194535162819813	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2096.29164329127	2096.29164329127
"AML-0160"	"2019-07-01-count-1:AACAAGAAGCTTACGT"	2.48762597617452	-9.47949793255004	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAAGAAGCTTACGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.94457017871	36.1956511578525	0.016260805252193	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2218.64481504799	2218.64481504799
"AML-0160"	"2019-07-01-count-3:ACTGATGGTGACACGA"	2.04780437526051	-7.95103552257689	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTGATGGTGACACGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1990.54309794276	41.3437766132668	0.0207700987012016	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1987.70013230254	1987.70013230254
"AML-0160"	"2019-07-01-count-3:TGGAGAGGTGCCCACA"	2.5361029106075	-8.74565985119017	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAGAGGTGCCCACA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.06264669993	38.1529941836388	0.0148278528051277	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2568.74738397727	2568.74738397727
"AML-0160"	"2019-07-01-count-3:CATCAAGCAATATCCG"	1.9508271413738	-4.09472753917845	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCAAGCAATATCCG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2062.74187575306	44.4206684432725	0.0215347683418002	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2061.48911805643	2061.48911805643
"AML-0160"	"2019-07-01-count-2:GTCACGGAGAAGCGGG"	-9.8195689720219	4.5072245367798	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACGGAGAAGCGGG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1763.75050881921	51.363627412238	0.0291218214568367	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1756.30927409438	1756.30927409438
"AML-0160"	"2019-07-01-count-2:TATCGCCTCAAATAGG"	1.66338707980458	-8.84876730358275	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCGCCTCAAATAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.24347344435	40.5107411342269	0.0160996904956793	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2511.01070927485	2511.01070927485
"AML-0160"	"2019-07-01-count-3:GCGAGAAGTATGTCAC"	3.27721561965291	-9.11747743999632	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCGAGAAGTATGTCAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1610.84322921057	46.7173313689699	0.02900178646923	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1610.84322921057	1610.84322921057
"AML-0160"	"2019-07-01-count-1:TTGTTTGCACTATCCC"	1.97506930407826	-9.46397306835326	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTTGCACTATCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.13025659621	36.5392472134205	0.0136690859426907	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2668.37213866937	2668.37213866937
"AML-0160"	"2019-07-01-count-3:GTCAGCGAGTATGATG"	1.96134986457173	-9.11015989696654	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCAGCGAGTATGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2160.43969584315	42.6333043555818	0.0197336238718496	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2153.70819453661	2153.70819453661
"AML-0160"	"2019-07-01-count-2:GCATTAGAGTAATACG"	2.11053218421285	-8.93363001262816	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCATTAGAGTAATACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.79242621456	42.2909576210949	0.016944901818313	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2489.03725273623	2489.03725273623
"AML-0160"	"2019-07-01-count-2:CGGGTGTCATTCCTAT"	1.46524776992146	-8.60836889660033	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGGTGTCATTCCTAT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2272.92765574421	28.5988198580496	0.0125823713683864	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2268.53779200088	2268.53779200088
"AML-0160"	"2019-07-01-count-2:CCTTCAGTCGTTTACT"	1.80356957492177	-9.05946543132933	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTTCAGTCGTTTACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2236.89379244836	38.5293165934374	0.017224472938103	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2235.55840106284	2235.55840106284
"AML-0160"	"2019-07-01-count-3:CGTCCATTCTTTACAC"	2.07883109626119	-9.31640627300414	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTCCATTCTTTACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.42259844154	44.2365203864577	0.0197711958470743	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2233.77064968834	2233.77064968834
"AML-0160"	"2019-07-01-count-3:ACTATTCTCCTGTACC"	1.63828112658803	-8.59414102947386	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATTCTCCTGTACC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2183.15408286775	48.054532520746	0.0220115166848977	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2177.69551598514	2177.69551598514
"AML-0160"	"2019-07-01-count-3:CCATAAGAGCCAAGCA"	2.41190614280049	-9.5265684357849	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCATAAGAGCCAAGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1905.35695772755	41.3411887427821	0.0216973457782358	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1901.12321223755	1901.12321223755
"AML-0160"	"2019-07-01-count-2:ACATTTCAGTCGAAGC"	2.25548519667928	-4.8434424630371	"2019-07-01-count-2"	"AML0160"	"DC precursor"	"DC precursor"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATTTCAGTCGAAGC"	"DC precursor"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2325.21578437824	42.5549666549506	0.0183015128922023	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2319.05299856989	2319.05299856989
"AML-0160"	"2019-07-01-count-1:TCAGTGATCCGACAGC"	-7.68375382843669	2.20079825008241	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGTGATCCGACAGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2437.00089844924	34.7044857938661	0.0142406536722863	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2426.50767129312	2426.50767129312
"AML-0160"	"2019-07-01-count-2:AGTGATCTCAACTTTC"	1.55347301539723	-8.80076219951781	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGATCTCAACTTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.76421529809	38.3296800378489	0.0161472145341258	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2366.78128580776	2366.78128580776
"AML-0160"	"2019-07-01-count-2:AAGTTCGGTTACCGTA"	-7.14807401123698	0.719640291574873	"2019-07-01-count-2"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGTTCGGTTACCGTA"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2334.19264475531	42.9064829148283	0.0183817231243679	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2332.52516952584	2332.52516952584
"AML-0160"	"2019-07-01-count-3:ACCAAACCATGCTGCG"	5.27907576140706	-4.77639152919921	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.444444444444444	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAAACCATGCTGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.6183563578	35.6882397774139	0.0153920284809074	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2307.05502367072	2307.05502367072
"AML-0160"	"2019-07-01-count-2:TAAGCGTCACCAGCTG"	1.47809054431264	-8.6291132203308	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCGTCACCAGCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.65744195587	38.8165570277647	0.0171552954981162	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2260.55800151818	2260.55800151818
"AML-0160"	"2019-07-01-count-1:GACCGTGGTCACTCGG"	1.89613403853719	-8.68538954174193	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCGTGGTCACTCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.63906668125	40.4140819534308	0.0168067143686592	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2401.70806958151	2401.70806958151
"AML-0160"	"2019-07-01-count-2:CTCTCGAAGTCGCGAA"	-5.10601268234904	-4.4125695458618	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00451807228915663	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCTCGAAGTCGCGAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3350.96929459193	38.5229262119685	0.0114960546711484	3123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	3339.04275810864	3339.04275810864
"AML-0160"	"2019-07-01-count-1:GTTAGTGAGGTGGTTG"	2.14249720153157	-9.15707781231078	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTAGTGAGGTGGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2104.22477085572	50.4474787911621	0.0239743774001134	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2099.11483471803	2099.11483471803
"AML-0160"	"2019-07-01-count-3:AGACTCACATTATGCG"	1.34971000727956	-7.91198494350585	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACTCACATTATGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2268.81529559051	42.2081132892871	0.0186035916503734	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2265.38370148725	2265.38370148725
"AML-0160"	"2019-07-01-count-3:GTGGAGAAGCATAGGC"	-7.76509509506877	0.805577076319136	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGAGAAGCATAGGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2103.7968487018	33.8812502157247	0.0161048108027312	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2097.24198123657	2097.24198123657
"AML-0160"	"2019-07-01-count-1:CAACGGCTCAAGCGTT"	2.11250271376912	-9.41429712688597	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACGGCTCAAGCGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.12057943853	49.5108364466025	0.0231130016311126	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2135.09275148298	2135.09275148298
"AML-0160"	"2019-07-01-count-1:ATCTTCACACACCTAA"	1.90090241011922	-4.27424528515013	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTTCACACACCTAA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2347.78167710191	40.4351559745943	0.0172227070212539	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2340.57629011204	2340.57629011204
"AML-0160"	"2019-07-01-count-3:CTCCGATAGCACACCC"	1.88760199126546	-8.92273428356322	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCGATAGCACACCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1977.44887638615	50.6263209420497	0.0256018355501412	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1968.77558116449	1968.77558116449
"AML-0160"	"2019-07-01-count-3:GAAACCTCATACCGTA"	-6.25675473633464	4.15182063663331	"2019-07-01-count-3"	"AML0160"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAACCTCATACCGTA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2087.41261155678	42.0082311749116	0.020124546025226	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2080.46856246098	2080.46856246098
"AML-0160"	"2019-07-01-count-1:CATGGTACACTCCTGT"	1.91472782668416	-8.55489542400511	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGGTACACTCCTGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2601.27362575416	42.3638906712607	0.0162858263935915	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2595.78041735209	2595.78041735209
"AML-0160"	"2019-07-01-count-1:TGATGCATCAGACCCG"	1.6658464866573	-8.50122072612914	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATGCATCAGACCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.57194343207	47.1164754081247	0.0191485867884868	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2454.18877926818	2454.18877926818
"AML-0160"	"2019-07-01-count-1:AGTACTGGTTATCTGG"	2.03411318835561	-3.72378256237181	"2019-07-01-count-1"	"AML0160"	"cDC1"	"cDC1"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTACTGGTTATCTGG"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1757.26612270782	45.2657500503415	0.0257591889272811	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1751.52786707982	1751.52786707982
"AML-0160"	"2019-07-01-count-3:TCTTGCGCAGCGAGTA"	1.81957127627675	-4.06882574474486	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTGCGCAGCGAGTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2104.29333732201	41.0119134257778	0.019489637066461	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2099.43964978498	2099.43964978498
"AML-0160"	"2019-07-01-count-1:CATGAGTAGCCGATTT"	2.27810706672017	-9.09856417095336	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGAGTAGCCGATTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.07445020447	45.6588405406	0.0191676798920709	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2376.57220524818	2376.57220524818
"AML-0160"	"2019-07-01-count-2:ATGATCGGTGGGACAT"	1.6941827732021	-9.07352354442748	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGATCGGTGGGACAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.28999577609	40.2443588336486	0.01856897734594	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2162.58107039888	2162.58107039888
"AML-0160"	"2019-07-01-count-1:ATCACGAAGTCACGCC"	1.62642325934712	-4.07585194027098	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCACGAAGTCACGCC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2385.81937938388	42.5571708657535	0.0178375493272854	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2380.38189218533	2380.38189218533
"AML-0160"	"2019-07-01-count-1:CATTGTTAGCTAATGA"	2.55848373946492	-8.92764093792113	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTGTTAGCTAATGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2305.18141544363	43.869844266444	0.0190309725614378	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2304.29408708071	2304.29408708071
"AML-0160"	"2019-07-01-count-2:GGGTATTGTCGCTGCA"	1.81829239901845	-8.79996302044066	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTATTGTCGCTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2201.33135949013	45.255621824957	0.0205582960647229	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2199.97622502138	2199.97622502138
"AML-0160"	"2019-07-01-count-1:ACAGCCGCAGGAGGTT"	2.19664563712422	-8.68309690868529	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGCCGCAGGAGGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2186.88574007331	40.1283913218786	0.0183495601011754	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2181.52928991733	2181.52928991733
"AML-0160"	"2019-07-01-count-1:CACACAAGTCATCAGT"	2.02635623988454	-9.6922006837097	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACACAAGTCATCAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.59021744601	40.5361795129021	0.0161396469978779	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2502.77200468979	2502.77200468979
"AML-0160"	"2019-07-01-count-3:CTGCCTATCGATTTCT"	1.26980700072591	-7.75364925777587	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCCTATCGATTTCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2297.22455040999	41.5454742093902	0.0180850732254169	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2295.92613400575	2295.92613400575
"AML-0160"	"2019-07-01-count-3:CGCCAGATCGCTACGG"	2.0458696084911	-4.464635395166	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCCAGATCGCTACGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2143.07038160659	37.8929903391214	0.0176816359669505	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2137.01443147433	2137.01443147433
"AML-0160"	"2019-07-01-count-3:CTACGGGGTAGCTAAA"	-0.644588510424453	-6.59537889873656	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACGGGGTAGCTAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1885.38663794135	42.2751956611161	0.0224225603440557	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1883.79072816319	1883.79072816319
"AML-0160"	"2019-07-01-count-2:ATCACGACATATGAAG"	1.91917385634724	-9.58762171184691	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCACGACATATGAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.95619802615	36.7482663430365	0.0171644176452168	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2136.59887598192	2136.59887598192
"AML-0160"	"2019-07-01-count-1:GGGCCATAGCTGTGCC"	2.10051693496053	-9.65661051189574	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCCATAGCTGTGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.83462918834	41.799306885524	0.0185376374588368	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2251.30630118006	2251.30630118006
"AML-0160"	"2019-07-01-count-2:ACTCCCAGTAGAGACC"	-9.07831130448039	3.14072201335756	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTCCCAGTAGAGACC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1914.1703587506	44.1915091184672	0.0230865079048197	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1904.20891463045	1904.20891463045
"AML-0160"	"2019-07-01-count-1:GAGCTGCAGCGTTACT"	2.16153945502583	-9.93377306377562	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGCTGCAGCGTTACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2308.18214229033	46.902297665127	0.0203200158279482	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2304.92154712785	2304.92154712785
"AML-0160"	"2019-07-01-count-2:TTCGATTAGGAGGCAG"	1.98436512526814	-9.22282221233519	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGATTAGGAGGCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.10432763667	36.4781898693654	0.0159844532204809	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2277.64951953529	2277.64951953529
"AML-0160"	"2019-07-01-count-3:GCAACCGCACGTCTCT"	1.38539673861806	-10.5163059464661	"2019-07-01-count-3"	"AML0160"	"CD11c+"	"CD11c+"	68	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAACCGCACGTCTCT"	"CD11c+"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.78713642247	41.2324128487324	0.0176600308462859	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2326.52977660992	2326.52977660992
"AML-0160"	"2019-07-01-count-2:GAGTTACGTGACATCT"	1.68280055102651	-7.92638828670653	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTACGTGACATCT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2074.36989796214	48.3262780470249	0.0232968469579609	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2073.00183344615	2073.00183344615
"AML-0160"	"2019-07-01-count-2:CGCAGGTGTGCGTGCT"	1.77151729640309	-9.11351396953734	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCAGGTGTGCGTGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2301.74169980177	42.2974869008721	0.0183762960476907	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2292.82106873441	2292.82106873441
"AML-0160"	"2019-07-01-count-1:TTTGGAGGTGGAACCA"	-8.90606913986858	4.66102502429811	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGGAGGTGGAACCA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1866.73265260276	40.9887075636344	0.0219574600071865	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1862.48382348863	1862.48382348863
"AML-0160"	"2019-07-01-count-1:GTGGAAGGTCAAGTTC"	2.68207468566243	-9.31406118786009	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAAGGTCAAGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.56132454549	45.6925619909083	0.019673350067452	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2319.28724888196	2319.28724888196
"AML-0160"	"2019-07-01-count-3:GTCGTTCCAGCTACTA"	2.39884628829305	-9.02946951305541	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGTTCCAGCTACTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1954.98999130025	50.4596807255974	0.0258107105152171	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1954.98999130025	1954.98999130025
"AML-0160"	"2019-07-01-count-1:TGTGTGATCCACGAAT"	1.52922966059987	-8.50445272838744	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGTGATCCACGAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.58902851914	48.95683133417	0.0223793549409556	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2182.62042857863	2182.62042857863
"AML-0160"	"2019-07-01-count-3:AGGGCTCAGTCGTTAC"	1.63356306132619	-8.7995701066223	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGCTCAGTCGTTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.20434664055	41.6557582379581	0.0182524226190684	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2274.32729384956	2274.32729384956
"AML-0160"	"2019-07-01-count-1:TGCACGGTCGAACCAT"	2.68738712844197	-9.60395147716673	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCACGGTCGAACCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.81472855226	37.6070881038677	0.0150801451580566	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2488.413997449	2488.413997449
"AML-0160"	"2019-07-01-count-3:GACTTCCAGAACTGAT"	1.60644461688344	-8.54338457500609	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTTCCAGAACTGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1949.73599295308	41.3428267002776	0.0212043204052768	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1944.13703416756	1944.13703416756
"AML-0160"	"2019-07-01-count-1:AGGGCCTTCATTACGG"	2.36226381835286	-8.79838373577269	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCCTTCATTACGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2173.72010781168	49.3198677343369	0.0226891528293346	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2173.72010781168	2173.72010781168
"AML-0160"	"2019-07-01-count-1:CAGCCAGGTAGCACGA"	2.25380076941792	-9.30720999157103	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGGTAGCACGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.74999696415	41.2587441949358	0.0165714406045764	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2485.99322881363	2485.99322881363
"AML-0160"	"2019-07-01-count-1:TTGCTGCGTGCATTAC"	1.91485442694966	-8.89959432994994	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCTGCGTGCATTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2323.38868727512	41.6046069551636	0.0179068647372807	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.33876109019	2321.33876109019
"AML-0160"	"2019-07-01-count-1:TCCTGCAAGCGTATGG"	1.95821168002431	-4.03320314800414	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTGCAAGCGTATGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1861.12808573629	39.6992421304459	0.0213307415189215	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1857.63151974273	1857.63151974273
"AML-0160"	"2019-07-01-count-1:CTGCATCGTGGTCCCA"	1.63389339026753	-9.2417316666809	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCATCGTGGTCCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.14439762609	43.4736086204895	0.0182881648518718	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2370.61867696856	2370.61867696856
"AML-0160"	"2019-07-01-count-1:TCATCCGAGCTCCCTT"	2.50988258895223	-7.40089657222899	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCCGAGCTCCCTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2396.72307520148	39.0428238956719	0.0162900855337197	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2394.93022666299	2394.93022666299
"AML-0160"	"2019-07-01-count-1:AGGGAGTGTCGTGTTA"	2.19309486922566	-8.57004740154418	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGAGTGTCGTGTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2180.95408442708	43.9899836942095	0.0201700641055749	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2179.71335082654	2179.71335082654
"AML-0160"	"2019-07-01-count-1:CCTTGTGGTAGTGGCA"	2.54500164565389	-3.26842381870421	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTTGTGGTAGTGGCA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2475.62516232083	41.7691343661633	0.0168721561736777	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2464.14657548173	2464.14657548173
"AML-0160"	"2019-07-01-count-2:ACACCAACACATAACC"	2.42264523085896	-8.00667383587035	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACCAACACATAACC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2516.8568824364	37.5926412065765	0.014936344401985	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2513.85409896852	2513.85409896852
"AML-0160"	"2019-07-01-count-2:GACTCAAAGTAAATGC"	-2.36257610741313	-11.5829687348572	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACTCAAAGTAAATGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.36013532328	45.1835307571515	0.0206755536658801	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2179.61708894549	2179.61708894549
"AML-0160"	"2019-07-01-count-3:TTCTCTCGTGGAACAC"	1.54296841201131	-8.68539240276488	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTCTCGTGGAACAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2119.99793597072	43.041311664425	0.0203025252685999	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2115.91669413607	2115.91669413607
"AML-0160"	"2019-07-01-count-3:TCACAAGGTCAACGCC"	-3.68527827683147	-9.46638395702513	"2019-07-01-count-3"	"AML0160"	"cDC1"	"cDC1"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.625	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACAAGGTCAACGCC"	"cDC1"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2450.3083837739	43.857489707054	0.0178987632730154	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2441.18924219586	2441.18924219586
"AML-0160"	"2019-07-01-count-2:TCGTAGAGTAGCGTCC"	1.83557118949239	-8.98184683239134	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGAGTAGCGTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2052.56881793956	43.2718648584907	0.021081809525845	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2048.76502049063	2048.76502049063
"AML-0160"	"2019-07-01-count-1:TGCAGATAGCCAAGTG"	1.4569648700649	-8.66170694744261	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGATAGCCAAGTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2484.15097948815	42.0098564246977	0.0169111526519832	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2483.45910382065	2483.45910382065
"AML-0160"	"2019-07-01-count-2:CAGGGCTAGCTGAAGC"	8.4157358604366	7.30192992770997	"2019-07-01-count-2"	"AML0160"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGGCTAGCTGAAGC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2067.23333961617	38.4028299105455	0.0185769207445522	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2060.51512295111	2060.51512295111
"AML-0160"	"2019-07-01-count-1:CTGAGCGTCAAACGAA"	1.6649372774059	-8.5406646958557	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAGCGTCAAACGAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2006.05473863307	36.6924172247645	0.0182908354982212	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1996.88605008955	1996.88605008955
"AML-0160"	"2019-07-01-count-3:CCCTCAACATGCCGCA"	2.05092908915822	-9.70096781170043	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	68	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTCAACATGCCGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1774.43883112676	44.7756732149094	0.0252337090630941	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1769.13561772272	1769.13561772272
"AML-0160"	"2019-07-01-count-3:CAATACGAGACGCATG"	-8.13053641739543	1.60544393146364	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATACGAGACGCATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2501.85289954948	35.9595035225576	0.0143731486087903	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2490.98274428326	2490.98274428326
"AML-0160"	"2019-07-01-count-1:AGACACTGTTGGATCT"	1.7683285671169	-8.83641054546507	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACACTGTTGGATCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.93420407859	39.41109136412	0.0172936503798952	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2274.36425986983	2274.36425986983
"AML-0160"	"2019-07-01-count-1:CCTCAGTAGCCATATC"	1.66291095790212	-8.96144297039183	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCAGTAGCCATATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.48753021963	45.7187154268946	0.0182547187299772	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2498.83892799119	2498.83892799119
"AML-0160"	"2019-07-01-count-2:CCACGAGAGTTCATCG"	-8.45601211014445	3.10990903461305	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACGAGAGTTCATCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2197.08682278884	35.6333551931174	0.0162184556493251	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2188.80724013479	2188.80724013479
"AML-0160"	"2019-07-01-count-1:CTCCTCCTCTCTGAGA"	1.81214894828145	-9.36082746898802	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCTCTCTGAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.3583003662	43.3883253945904	0.0180381963834597	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2404.20577805361	2404.20577805361
"AML-0160"	"2019-07-01-count-1:TCCGGGATCCCATTCG"	2.10460915145223	-8.85220053112181	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGGGATCCCATTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2582.82914388058	33.8790868763336	0.013117045297635	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2579.34166176043	2579.34166176043
"AML-0160"	"2019-07-01-count-2:CATACCCAGTCCGTCG"	1.64146973666493	-9.1867132416931	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATACCCAGTCCGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2129.75733939653	37.1474776978488	0.0174421174707042	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2129.75733939653	2129.75733939653
"AML-0160"	"2019-07-01-count-3:GTGCTTCCAGCAAGAC"	2.44566645201985	-9.27440454876097	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCTTCCAGCAAGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.79972443661	39.9912135490623	0.0183715631255019	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2171.26766993085	2171.26766993085
"AML-0160"	"2019-07-01-count-1:TCGCACTTCATAGAGA"	1.88025345382039	-4.24295046245726	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGCACTTCATAGAGA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2345.86785458992	41.6583453035968	0.0177581807185295	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2335.35450176296	2335.35450176296
"AML-0160"	"2019-07-01-count-2:CCTGTTGAGCCTGTCG"	1.48513986644093	-8.65101911937865	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTGTTGAGCCTGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2205.26079522868	40.5262675443368	0.0183770861169889	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2203.06058387262	2203.06058387262
"AML-0160"	"2019-07-01-count-2:GGAGGATAGAGGCGGA"	2.16336383399312	-8.86768057262572	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATAGAGGCGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.31002790143	41.3289689135822	0.0178966740776419	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2304.51480470572	2304.51480470572
"AML-0160"	"2019-07-01-count-3:GGGAGTAAGAAGCCTG"	1.78410055217091	-9.4754734269348	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGAGTAAGAAGCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.13495370335	40.555827226936	0.0177710030518238	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2278.88710531089	2278.88710531089
"AML-0160"	"2019-07-01-count-3:CTCATGCTCCAAGCCG"	1.92963435229604	-9.31345369732054	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATGCTCCAAGCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.29800825279	44.9844459769239	0.0218977216529474	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2045.89289293301	2045.89289293301
"AML-0160"	"2019-07-01-count-1:AAAGTGATCAAGCTTG"	2.38640369948689	-9.21768953716429	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGTGATCAAGCTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.43187655868	39.6414025170215	0.0167021446490805	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2371.34855661558	2371.34855661558
"AML-0160"	"2019-07-01-count-1:AGGTCTACATTACGGT"	1.9431172805721	-9.20182993328246	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTCTACATTACGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2446.0851173317	44.5998645570079	0.0182331613241895	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2440.83688014992	2440.83688014992
"AML-0160"	"2019-07-01-count-1:TTTACTGTCTGGCCGA"	3.57822074469869	-2.0852740040985	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	17	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTACTGTCTGGCCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2239.17551865696	46.0064511251577	0.0205461567178763	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2231.29326645112	2231.29326645112
"AML-0160"	"2019-07-01-count-1:CTGCAGGAGTATCCTG"	1.74592949923818	-8.84912588512572	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCAGGAGTATCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.48271001764	46.2009561489055	0.0205111257651091	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2244.57919494296	2244.57919494296
"AML-0160"	"2019-07-01-count-3:TGGAGAGGTTTCGTTT"	1.93996002253835	-9.10789110576781	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAGAGGTTTCGTTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1879.608378325	49.4245861300824	0.0262951510006179	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1876.27279640413	1876.27279640413
"AML-0160"	"2019-07-01-count-2:CAGTTAGGTCTCGGGT"	2.69529714164082	-9.65891649639281	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGTTAGGTCTCGGGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2129.84685779268	44.851070025568	0.0210583544358915	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2124.04867122502	2124.04867122502
"AML-0160"	"2019-07-01-count-1:CTGAATGGTGTTCATG"	2.36581506308858	-5.16347601329955	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAATGGTGTTCATG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1924.92123488693	35.8278435951478	0.0186126283745071	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1923.17474940836	1923.17474940836
"AML-0160"	"2019-07-01-count-1:TCCACCAAGATCACTC"	2.30011000212972	-8.93847658550414	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCACCAAGATCACTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.67966984696	33.0804249239372	0.0130151825646577	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2536.54797152626	2536.54797152626
"AML-0160"	"2019-07-01-count-2:AGCCAATGTGCCTTTC"	1.64649679240529	-9.10488798534545	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCCAATGTGCCTTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.21183541794	42.0180459571372	0.0181017713747663	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2308.1113020165	2308.1113020165
"AML-0160"	"2019-07-01-count-1:GTCCACTCAGGGACTA"	2.20070828971211	-4.44623567974242	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCACTCAGGGACTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2299.39389521983	42.7007436063294	0.0185704344501824	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2297.41233577837	2297.41233577837
"AML-0160"	"2019-07-01-count-1:AAACGCTAGGGAGTGG"	1.6379345851833	-8.21329786693724	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGCTAGGGAGTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2082.47862766685	46.9301977350912	0.0225357403968513	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2077.58408013928	2077.58408013928
"AML-0160"	"2019-07-01-count-3:TACCGGGGTAGCTAAA"	2.41977085646932	-8.98262693798216	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGGGGTAGCTAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1493.05487608842	45.0072850422031	0.030144427886077	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1488.90942627983	1488.90942627983
"AML-0160"	"2019-07-01-count-2:CATGCGGCAGGAGGAG"	1.66161908683125	-9.05062010204466	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCGGCAGGAGGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.90597946672	36.5154168557155	0.016065520169155	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2266.84129646599	2266.84129646599
"AML-0160"	"2019-07-01-count-3:TCAGTCCGTATATGGA"	-7.58057294312175	1.45666477763978	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTCCGTATATGGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2408.17120322932	46.6762422838876	0.0193824434995715	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2398.26080873757	2398.26080873757
"AML-0160"	"2019-07-01-count-1:TCATGTTAGGGAACAA"	1.46811749514882	-7.83742573177489	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGTTAGGGAACAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1977.68951128355	46.0529027764525	0.0232862148045491	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1972.83820201521	1972.83820201521
"AML-0160"	"2019-07-01-count-1:TTAGGCAAGGGATCTG"	1.58949257907216	-8.92706205761107	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGGCAAGGGATCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2087.27350911282	45.0841155993246	0.021599524644227	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2083.73309870842	2083.73309870842
"AML-0160"	"2019-07-01-count-1:CATGCCTTCGCCTTTG"	2.55564012107198	-9.58668424999388	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCCTTCGCCTTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3029.27727976693	43.5287498834022	0.0143693514536085	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	3020.41585860474	3020.41585860474
"AML-0160"	"2019-07-01-count-3:ACCTACCCAAGCGCTC"	2.08381022986714	-9.63811876690062	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCTACCCAAGCGCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2192.47776081284	39.8728117241591	0.0181861875348631	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2186.37810843921	2186.37810843921
"AML-0160"	"2019-07-01-count-1:CGGAACCGTTTGCCGG"	2.95345582541768	-8.85318281566771	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGAACCGTTTGCCGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2182.50746121036	41.7215806390426	0.0191163518936631	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2179.18244977211	2179.18244977211
"AML-0160"	"2019-07-01-count-2:TTGAGTGTCCCAAGCG"	3.19895638999287	-8.78895666515502	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAGTGTCCCAAGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1483.81013457105	36.6222246753272	0.0246812067272436	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1483.81013457105	1483.81013457105
"AML-0160"	"2019-07-01-count-2:GTATTTCAGGTGGGTT"	2.42035498198811	-8.66735746776732	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTATTTCAGGTGGGTT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1983.27712477119	39.0089783585885	0.0196689498766286	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	1977.01438238715	1977.01438238715
"AML-0160"	"2019-07-01-count-1:TGGGAAGTCATTCGGA"	2.15769853171651	-8.82531168377074	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAAGTCATTCGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.97979636946	43.3852168356642	0.0186524478430047	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2319.9110804679	2319.9110804679
"AML-0160"	"2019-07-01-count-3:TGCGGCAGTTGGCCTG"	1.96235467967336	-8.95596601879271	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCAGTTGGCCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.12245301767	44.0350149750179	0.0190700215648897	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2306.61176120591	2306.61176120591
"AML-0160"	"2019-07-01-count-3:CTGAGGCAGGGCCAAT"	2.15746106681172	-8.53034403240355	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAGGCAGGGCCAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2164.52764344882	52.4586477734764	0.024235609987356	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2163.35679150617	2163.35679150617
"AML-0160"	"2019-07-01-count-1:CTCCAACGTACGATGG"	-7.71681724014934	3.89181850040285	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCAACGTACGATGG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2022.63889233174	40.6450487087672	0.0200950594111788	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2006.87567351491	2006.87567351491
"AML-0160"	"2019-07-01-count-2:ACGATCACATCTCATT"	1.91662265834157	-8.99686148082884	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGATCACATCTCATT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2417.461309209	33.8828446353412	0.0140158787676431	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2410.57555637184	2410.57555637184
"AML-0160"	"2019-07-01-count-1:TATATCCGTCCTTAAG"	8.93449558791463	7.04510972583619	"2019-07-01-count-1"	"AML0160"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATATCCGTCCTTAAG"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1796.81316404851	39.5140563932548	0.021991188167958	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1793.78875816524	1793.78875816524
"AML-0160"	"2019-07-01-count-1:GTTGTCCAGTAGACCG"	5.23528494414632	-5.13391592418822	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTCCAGTAGACCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.91326158249	38.0483326979837	0.0162120745239338	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2340.58026834388	2340.58026834388
"AML-0160"	"2019-07-01-count-3:TGGAGAGGTGCCGTTG"	2.22182859954182	-9.5944280854431	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAGAGGTGCCGTTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1958.63807047901	42.3471063777525	0.0216206899151082	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1957.20458035497	1957.20458035497
"AML-0160"	"2019-07-01-count-1:TTGAACGTCCATGATG"	1.8242504793102	-9.25459291851195	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAACGTCCATGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2318.52538380876	40.6024026812726	0.0175121665541452	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2316.72310816619	2316.72310816619
"AML-0160"	"2019-07-01-count-3:AGTAACCCACTCAAGT"	-7.39777408066447	0.945507086161055	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTAACCCACTCAAGT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2356.62029301951	44.0327223762714	0.0186846911684074	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2350.54307471728	2350.54307471728
"AML-0160"	"2019-07-01-count-2:TTGAGTGCACACAGAG"	2.01768996295277	-9.24906923687132	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAGTGCACACAGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.83223979199	44.8538524050814	0.0198219963532093	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2261.37035591239	2261.37035591239
"AML-0160"	"2019-07-01-count-2:GGTAACTAGCATCCCG"	1.92405929145162	-9.17137815868529	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTAACTAGCATCCCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1885.4523556476	43.4699558015358	0.0230554517441546	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1882.13918955592	1882.13918955592
"AML-0160"	"2019-07-01-count-1:GTCCCATAGTGTGTTC"	1.71744908866231	-8.73796465313109	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCCATAGTGTGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.79660101877	41.8069881909726	0.0180063094986996	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2318.71715711513	2318.71715711513
"AML-0160"	"2019-07-01-count-1:GGAACCCCAGGTTTAC"	-7.89420209351237	2.13478276813356	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAACCCCAGGTTTAC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2344.79648000998	41.552046629065	0.0177209608523841	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2340.13787823247	2340.13787823247
"AML-0160"	"2019-07-01-count-2:CGCCATTCAGACCCGT"	1.95235194739644	-9.23029043590697	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCCATTCAGACCCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2516.05250964949	43.274254295535	0.0171992651701707	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2512.1946028505	2512.1946028505
"AML-0160"	"2019-07-01-count-1:GTCTTTAAGTAGTCCT"	-7.64665971222575	1.411594367865	"2019-07-01-count-1"	"AML0160"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTTTAAGTAGTCCT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2556.3478528121	37.6537871661693	0.0147295240453088	2735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2543.32580984514	2543.32580984514
"AML-0160"	"2019-07-01-count-3:CCCTTAGAGCACAAAT"	2.20428313788716	-9.07951071178588	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTTAGAGCACAAAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2078.75867535036	44.9440283354772	0.0216206089087769	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2077.48086521549	2077.48086521549
"AML-0160"	"2019-07-01-count-1:GAGGCCTTCAACCCGG"	2.16151156005208	-9.13457777416381	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCCTTCAACCCGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.55255569894	45.2213283785565	0.0185595538552151	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2428.55363580748	2428.55363580748
"AML-0160"	"2019-07-01-count-3:TGGATCATCCGTGGGT"	1.45975830134694	-8.82471277630004	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGATCATCCGTGGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.04509136276	45.1813444207529	0.0188017047966132	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2399.00379020725	2399.00379020725
"AML-0160"	"2019-07-01-count-2:ATCCCTGTCAACTTTC"	2.68453206595723	-9.31460478222045	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCCTGTCAACTTTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2261.38884985955	46.854613021849	0.0207193968541762	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2255.69499483783	2255.69499483783
"AML-0160"	"2019-07-01-count-2:TATTCCAAGATGCTTC"	1.61507679995839	-8.21257021343382	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATTCCAAGATGCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.13523727275	37.3000167150927	0.0153237240659169	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2430.2169568232	2430.2169568232
"AML-0160"	"2019-07-01-count-2:CACAGATAGATGGTCG"	1.54292406615559	-8.63391878521117	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACAGATAGATGGTCG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2250.60078448961	42.501671297339	0.0188845892129099	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2243.937100941	2243.937100941
"AML-0160"	"2019-07-01-count-2:GTGTTAGTCTGCTTTA"	1.60393132743184	-8.48448183452757	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTTAGTCTGCTTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2350.95491347807	36.8422767868181	0.0156711966595363	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2348.94695938227	2348.94695938227
"AML-0160"	"2019-07-01-count-2:CGTCCATCAGACCAGA"	2.19068111953084	-5.2790737382141	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATCAGACCAGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.05272003018	45.6363176448887	0.0213547926156189	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2133.37367842648	2133.37367842648
"AML-0160"	"2019-07-01-count-1:AACCAACTCCTACGGG"	-7.73842654648479	4.67632577503053	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCAACTCCTACGGG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1959.19208402336	31.4398369321936	0.0160473478780239	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1952.57669954892	1952.57669954892
"AML-0160"	"2019-07-01-count-1:ACCTACCCAACCCTAA"	1.72082140025441	-8.21247103130492	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCTACCCAACCCTAA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2500.04616027857	39.8638155962208	0.0159452318239512	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2499.27578026043	2499.27578026043
"AML-0160"	"2019-07-01-count-3:TAGTGCAAGTTGCTGT"	2.09423102912251	-9.03927709972533	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGTGCAAGTTGCTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2100.27385980776	46.2468574006835	0.022019441505079	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2100.27385980776	2100.27385980776
"AML-0160"	"2019-07-01-count-1:TACCTCGTCTGGACCG"	1.68897797641103	-8.45429994976195	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCTCGTCTGGACCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.80887269183	44.8216855075639	0.0188579258612416	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2374.96839799036	2374.96839799036
"AML-0160"	"2019-07-01-count-2:TTTGGTTTCAGGACGA"	1.91768874701802	-9.01841642772826	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGGTTTCAGGACGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.88437198597	44.9953409325577	0.0205656850557029	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2185.23165685245	2185.23165685245
"AML-0160"	"2019-07-01-count-1:TTTGTTGCATGAGGGT"	9.9163576560909	7.38485810840455	"2019-07-01-count-1"	"AML0160"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.000957854406130268	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGTTGCATGAGGGT"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2053.6360515141	38.6882490947532	0.0188389023781645	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2044.51310662399	2044.51310662399
"AML-0160"	"2019-07-01-count-3:CTTTCGGGTTTACTGG"	1.66097797927205	-7.76393272792967	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTTCGGGTTTACTGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2078.87400459168	46.921922392952	0.0225708351200284	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2076.25352136015	2076.25352136015
"AML-0160"	"2019-07-01-count-3:TCGAAGTTCGTTGTTT"	1.78998758372609	-3.88616492664488	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGAAGTTCGTTGTTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1995.44198554822	46.3829578562399	0.0232444532049359	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1987.90794217238	1987.90794217238
"AML-0160"	"2019-07-01-count-2:CATTCTATCTACTTCA"	-8.35485682907756	3.83849642360536	"2019-07-01-count-2"	"AML0160"	"MEP"	"MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCTATCTACTTCA"	"MEP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1826.50736006301	24.8375803118272	0.0135984014381253	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1823.89089853241	1823.89089853241
"AML-0160"	"2019-07-01-count-1:CGGAGAATCTTGCAAG"	2.27009310302083	-8.70587637340697	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGAGAATCTTGCAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2498.35754226824	40.7065403233556	0.0162933205654778	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2490.34183577646	2490.34183577646
"AML-0160"	"2019-07-01-count-2:GGCACGTCACTCAGAT"	2.2386118369991	-9.349316619989	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCACGTCACTCAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2018.26945792671	45.7699608784258	0.0226778246574882	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2013.35662237899	2013.35662237899
"AML-0160"	"2019-07-01-count-1:TGGCGTGTCCTCTAGC"	1.51331963118855	-8.48124887859496	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGTCCTCTAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.45958493403	44.3342311966044	0.0189182828164081	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2342.33769328246	2342.33769328246
"AML-0160"	"2019-07-01-count-1:ATCCTATAGAGTCTTC"	1.56780328330342	-9.11850168621215	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCCTATAGAGTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2520.44925803175	45.1567190099435	0.0179161389050169	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2514.35607712329	2514.35607712329
"AML-0160"	"2019-07-01-count-2:AGGTAGGGTTATCCAG"	2.133552690118	-9.19325544750365	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTAGGGTTATCCAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2106.53950127494	44.003290667467	0.0208888988983283	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2104.04132496874	2104.04132496874
"AML-0160"	"2019-07-01-count-2:AGGACTTAGCGTCAGA"	2.07364930686299	-9.20485594188841	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACTTAGCGTCAGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.98078050951	41.171953554404	0.0179713221100211	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2282.28819598754	2282.28819598754
"AML-0160"	"2019-07-01-count-1:CGTGCTTCAGGACGAT"	1.81649746474568	-8.77179338848265	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGCTTCAGGACGAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.97171884317	40.3329928907972	0.0169682258190378	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2368.81317646346	2368.81317646346
"AML-0160"	"2019-07-01-count-1:TTTGGTTAGACTCGAG"	2.05381264266316	-9.0518255463806	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGGTTAGACTCGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2472.27370095606	37.2158045517422	0.0150532704115043	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2462.52533931411	2462.52533931411
"AML-0160"	"2019-07-01-count-3:TTGCATTTCGATGGAG"	2.50351156768147	-5.29746439373168	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCATTTCGATGGAG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2084.83501810543	39.6312363210184	0.0190092913716659	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2080.25048025465	2080.25048025465
"AML-0160"	"2019-07-01-count-1:GAGGCAAGTAGGGTAC"	1.95097007331197	-9.2751035920349	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCAAGTAGGGTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.00848415928	42.8429396883887	0.0178362982358008	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2398.80854456168	2398.80854456168
"AML-0160"	"2019-07-01-count-3:CCCAACTCAATACCTG"	2.08749975737874	-4.32142593776854	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCAACTCAATACCTG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2381.25290163169	45.024068285026	0.0189077221718762	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2377.32434461029	2377.32434461029
"AML-0160"	"2019-07-01-count-3:CTACCTGCATGGGCAA"	2.37227334555928	-9.41989805614623	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCTGCATGGGCAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.78325423948	41.3966710237199	0.0183757895686663	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2244.89424691851	2244.89424691851
"AML-0160"	"2019-07-01-count-3:ATAGGCTGTCATAAAG"	-8.31386409226115	0.859769261721052	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATAGGCTGTCATAAAG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2706.75213674794	43.5341490212556	0.016083537325128	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2699.64537861293	2699.64537861293
"AML-0160"	"2019-07-01-count-1:CCAATTTGTTGTATGC"	1.53467704829518	-9.08832838451537	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCAATTTGTTGTATGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.4887165391	37.7402963491051	0.0155278632203837	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2424.26919946503	2424.26919946503
"AML-0160"	"2019-07-01-count-1:ACGGTCGCAGCATTGT"	1.55635370787923	-8.26020815288695	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTCGCAGCATTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.08763680948	42.4027709679267	0.0178757185484763	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2367.78452530557	2367.78452530557
"AML-0160"	"2019-07-01-count-2:GGATCTAAGAATTGCA"	2.1785155731136	-9.7204742661682	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGATCTAAGAATTGCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2088.94518455969	43.5495276589605	0.0208476162901995	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2086.18630620953	2086.18630620953
"AML-0160"	"2019-07-01-count-2:GTGCACGTCGTTATCT"	2.17599238929097	-9.11217501079711	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCACGTCGTTATCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.3769263655	39.8257615983215	0.0177525948182249	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2236.47445522485	2236.47445522485
"AML-0160"	"2019-07-01-count-3:TTTGATCAGCTGAGTG"	2.38603033599202	-9.2952566376892	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGATCAGCTGAGTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2012.8766865341	44.8089137312902	0.0222611320559558	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2011.37970348378	2011.37970348378
"AML-0160"	"2019-07-01-count-2:ACTATTCTCGCTTACC"	2.71323694762532	-5.73782398616942	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes (cycling)"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTATTCTCGCTTACC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2731.22963539201	40.6573966058993	0.0148861143270598	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2725.17321635952	2725.17321635952
"AML-0160"	"2019-07-01-count-2:TTCCAATTCAAGTAAG"	1.99056448516194	-8.65419676220091	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCAATTCAAGTAAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.81431439234	41.4595287196506	0.0180351794662501	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2295.33625193094	2295.33625193094
"AML-0160"	"2019-07-01-count-3:GGTGTCGCACAAGCTT"	1.9136378961498	-4.02907516872557	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTGTCGCACAAGCTT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1803.84693533784	44.2030060058274	0.024504854120313	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1800.96099334538	1800.96099334538
"AML-0160"	"2019-07-01-count-1:TCCATGCAGTCACTAC"	-1.39381251755412	-7.08026745235594	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATGCAGTCACTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1865.33130887689	52.135309466013	0.0279496244007203	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1856.01105102598	1856.01105102598
"AML-0160"	"2019-07-01-count-3:ATGGTTGAGTCCCGAC"	2.52196969565694	-9.2327394715515	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGTTGAGTCCCGAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.86181860419	41.0327929363384	0.0191485949210977	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2133.43609379164	2133.43609379164
"AML-0160"	"2019-07-01-count-3:ACATCCCGTTCTCTCG"	-8.74032435837444	4.99495122516481	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACATCCCGTTCTCTCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1916.67168594737	32.5290807801109	0.0169716498754624	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1903.76101288281	1903.76101288281
"AML-0160"	"2019-07-01-count-2:TTGATGGCATCAGTGT"	1.78608061847035	-8.97196867382201	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGATGGCATCAGTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2293.07155217075	43.3350089982358	0.0188982367153839	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2288.18532507422	2288.18532507422
"AML-0160"	"2019-07-01-count-2:GTCTACCTCCCGTGAG"	2.3277129131252	-8.23746397411498	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00590030518819939	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTACCTCCCGTGAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1584.6675562107	41.2458095383387	0.0260280519890031	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1582.4290753794	1582.4290753794
"AML-0160"	"2019-07-01-count-1:CGGACACCATGGAGAC"	2.23097528991048	-8.32797720348509	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGACACCATGGAGAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.91541375202	29.9494443019697	0.0117085358417068	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2549.97817965088	2549.97817965088
"AML-0160"	"2019-07-01-count-3:AACCTTTGTTGGGACA"	2.24339141425435	-9.02787401592406	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCTTTGTTGGGACA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2266.94312171585	42.476618558085	0.0187373993423948	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2264.35206560698	2264.35206560698
"AML-0160"	"2019-07-01-count-3:AACTTCTCACGGCACT"	1.79708435115163	-8.89019110119017	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACTTCTCACGGCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2032.58860551556	44.510726765132	0.0218985419107188	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2031.12084858735	2031.12084858735
"AML-0160"	"2019-07-01-count-2:TTACTGTTCTATGCCC"	-8.84474978867229	4.99447915637819	"2019-07-01-count-2"	"AML0160"	"HSC"	"HSC"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTACTGTTCTATGCCC"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1922.7510122891	40.2558630121809	0.0209365969669962	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1918.38000295595	1918.38000295595
"AML-0160"	"2019-07-01-count-2:GTGGAAGAGATAGGGA"	2.18934883651082	-9.65839579021605	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGAAGAGATAGGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2006.95008129152	48.7523377537978	0.0242917540442384	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2002.43570679037	2002.43570679037
"AML-0160"	"2019-07-01-count-2:CCTCATGTCAGGTAAA"	1.49820282038991	-8.59321119701537	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCATGTCAGGTAAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2230.9980565184	42.6248718543004	0.0191057413652879	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2227.18344936182	2227.18344936182
"AML-0160"	"2019-07-01-count-3:CTGTAGAAGAGTCTTC"	1.87106802043263	-9.3164968720642	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTAGAAGAGTCTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.70082926912	39.0571336530438	0.0182791774674435	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2130.41509952126	2130.41509952126
"AML-0160"	"2019-07-01-count-3:GCATCGGGTGGGCTCT"	2.82322611388509	-9.09615042125853	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGGTGGGCTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.06574231256	44.1139919128045	0.0209561112634621	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2103.60708567912	2103.60708567912
"AML-0160"	"2019-07-01-count-2:TCGTCCATCATTGAGC"	2.06009497222249	-8.57065775310668	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTCCATCATTGAGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1971.99876673863	49.2916040231006	0.0249957580372228	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1970.47746250082	1970.47746250082
"AML-0160"	"2019-07-01-count-3:CCTCATGTCGTAATGC"	-8.30324397507365	2.89547989452211	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCATGTCGTAATGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2088.00215182782	41.094038006713	0.0196810324025479	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2085.27756649387	2085.27756649387
"AML-0160"	"2019-07-01-count-3:GAACGTTCACTTTATC"	2.16017689284627	-8.66703989421996	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAACGTTCACTTTATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.1398613946	46.9042835657701	0.0202773227631343	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2307.21903928659	2307.21903928659
"AML-0160"	"2019-07-01-count-1:CCTCTAGGTATCGAAA"	1.84905602511708	-4.14715292369994	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCTAGGTATCGAAA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1834.33809247322	32.0223267464635	0.0174571562777111	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1829.08144802009	1829.08144802009
"AML-0160"	"2019-07-01-count-1:CAGCCAGAGTGCAACG"	1.55661382254903	-8.80847170269164	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGAGTGCAACG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.54643379483	45.7876990242151	0.0187535647040914	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2436.4876155506	2436.4876155506
"AML-0160"	"2019-07-01-count-1:TCATCATGTGTCTAAC"	2.08139147338216	-4.72580435192259	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCATGTGTCTAAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2708.58479324704	42.1881082320634	0.015575701501849	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2702.74989589165	2702.74989589165
"AML-0160"	"2019-07-01-count-3:TCTCAGCCAAGCCCAC"	2.23234262046162	-4.93796160137328	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCAGCCAAGCCCAC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2536.75758127287	42.9897205645256	0.0169467200499918	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2530.39110081543	2530.39110081543
"AML-0160"	"2019-07-01-count-2:ATACCGAGTTAGCGGA"	5.24743952330892	-4.98271086132201	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACCGAGTTAGCGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1853.15081724512	51.4461287992703	0.027761436533131	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1845.24267008572	1845.24267008572
"AML-0160"	"2019-07-01-count-2:ACGATGTAGGCCCACT"	2.44091095504109	-8.70109655773314	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGATGTAGGCCCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2577.53381880732	38.5587044301102	0.0149595338570387	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2573.47893525315	2573.47893525315
"AML-0160"	"2019-07-01-count-1:CAGCAGCTCACAACCA"	2.10408391532246	-9.26757147228392	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCAGCTCACAACCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2391.83182015327	43.4615741236191	0.0181708319779917	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2386.39002250199	2386.39002250199
"AML-0160"	"2019-07-01-count-1:GTCGTAAAGCAACCAG"	-7.97872958603557	4.12473533237306	"2019-07-01-count-1"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGTAAAGCAACCAG"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2000.32673641732	37.4320926314962	0.0187129892082225	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1994.06887610952	1994.06887610952
"AML-0160"	"2019-07-01-count-1:GTCCCATCATAAGATG"	2.043393989175	-9.01448824321898	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCCATCATAAGATG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.91358429064	40.4776824034656	0.0157874597067064	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2558.16255691483	2558.16255691483
"AML-0160"	"2019-07-01-count-3:CATCGCTGTATGCTTG"	1.76718558844869	-8.8787355653015	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGCTGTATGCTTG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2272.79721191029	46.0536290899843	0.0202629732422437	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2268.75447413998	2268.75447413998
"AML-0160"	"2019-07-01-count-3:GGGACTCAGAATCGAT"	-8.04157672348674	4.67945811832277	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGACTCAGAATCGAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1864.70213645629	50.7693362067379	0.0272265125963876	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1859.91141153603	1859.91141153603
"AML-0160"	"2019-07-01-count-1:TAGACTGCACGTCATA"	1.70834686335866	-8.72128488933715	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGACTGCACGTCATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.76850680086	38.7586707002708	0.0149950258981768	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2578.98774958332	2578.98774958332
"AML-0160"	"2019-07-01-count-2:CTGCCTAAGAATCGCG"	5.29361214217488	-4.98603203212889	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCCTAAGAATCGCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2305.70734481668	35.8531507520832	0.0155497404441558	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2295.68185534527	2295.68185534527
"AML-0160"	"2019-07-01-count-1:TAAGTCGGTGTTCCAA"	1.61236061629598	-8.623561882135	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAAGTCGGTGTTCCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.96044162388	42.4353476769017	0.0182363855086801	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2325.15752719777	2325.15752719777
"AML-0160"	"2019-07-01-count-2:CGTGAATTCGATGCTA"	1.83331002768819	-9.01985266124877	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTGAATTCGATGCTA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.48905227999	42.2893768255224	0.0180224053397699	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2343.16639352443	2343.16639352443
"AML-0160"	"2019-07-01-count-3:CAGTTCCAGAAGTCAT"	-7.74960599365886	0.881082452181257	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGTTCCAGAAGTCAT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2423.16102839216	37.1055576496386	0.0153128732324732	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2418.94647576821	2418.94647576821
"AML-0160"	"2019-07-01-count-1:CTCCTTTCAGCAGTAG"	5.27520145949666	-5.01843550121459	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTTTCAGCAGTAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.33910005337	41.5901192884455	0.0173339897172186	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2397.22369993871	2397.22369993871
"AML-0160"	"2019-07-01-count-3:GGGTGTCCATTGAAAG"	2.21402468261067	-9.14399244701537	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTGTCCATTGAAAG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2230.2778299575	38.3104497470772	0.0171774337853715	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2226.505299919	2226.505299919
"AML-0160"	"2019-07-01-count-1:GTGGGAAAGACCTGGA"	1.61503650721852	-8.80447199260863	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGGAAAGACCTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.29096664039	39.8031852855113	0.0168636773381236	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2359.30154370024	2359.30154370024
"AML-0160"	"2019-07-01-count-2:TGGTAGTCACAAGTGG"	2.0806254344875	-9.11768057262572	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTAGTCACAAGTGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2328.53509530968	38.9754313822351	0.01673817648733	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2321.34363303372	2321.34363303372
"AML-0160"	"2019-07-01-count-2:ACGTAGTTCTACCTTA"	1.81874312934224	-9.01140215313109	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAGTTCTACCTTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.25256654872	42.299150242726	0.018254009447803	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2314.73412269538	2314.73412269538
"AML-0160"	"2019-07-01-count-3:AATTTCCCAAGCCATT"	2.31431045111958	-9.50733663952025	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATTTCCCAAGCCATT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.63304294542	40.5274449140157	0.0171317546628261	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2358.62158680615	2358.62158680615
"AML-0160"	"2019-07-01-count-1:GTTAGTGCAACACAGG"	1.64677812632863	-7.50443174755248	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTAGTGCAACACAGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2087.32962935052	51.0445974813997	0.0244544976335541	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2085.75801519436	2085.75801519436
"AML-0160"	"2019-07-01-count-2:ACCTGTCGTTACCTGA"	1.88612343844716	-8.83618452465209	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTGTCGTTACCTGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2333.48268839275	41.8982648658454	0.0179552499250397	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2331.39553972732	2331.39553972732
"AML-0160"	"2019-07-01-count-3:TCGCAGGGTACAGCGA"	-9.02945075455363	1.90863940799562	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCAGGGTACAGCGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2426.21658405605	42.5140849190055	0.0175227905036953	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2416.14487160134	2416.14487160134
"AML-0160"	"2019-07-01-count-1:CAACGATGTAAGTTGA"	1.72463013705556	-8.72664072429808	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACGATGTAAGTTGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2219.91507122635	39.6715467810245	0.0178707497846342	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2215.94169835077	2215.94169835077
"AML-0160"	"2019-07-01-count-2:GAACTGTCAGCTTTCC"	2.26037444648091	-8.34595491802367	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAACTGTCAGCTTTCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2228.21549702857	43.8569936369357	0.0196825637804876	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2221.89115195419	2221.89115195419
"AML-0160"	"2019-07-01-count-3:AAAGTCCTCCGATAGT"	-8.05126128616985	2.28273818576661	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGTCCTCCGATAGT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2306.63414347724	46.1430360500624	0.0200044884363421	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2298.20065541757	2298.20065541757
"AML-0160"	"2019-07-01-count-3:CGGGCATAGCCGTCGT"	1.80029477652852	-8.50848104869994	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGGCATAGCCGTCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.07968050344	46.4602216010831	0.0211559817312423	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2193.95843114073	2193.95843114073
"AML-0160"	"2019-07-01-count-3:TCTTCCTCATCAGCAT"	-7.83006606522258	3.55691335285035	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTCCTCATCAGCAT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2210.9888067348	38.3112770687954	0.0173276666766005	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2195.79163285066	2195.79163285066
"AML-0160"	"2019-07-01-count-1:GCTTCACCAGAGGTAC"	2.12462629851643	-9.10545351421507	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTCACCAGAGGTAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.90886516275	40.8399577482241	0.0164351933870819	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2480.53388181637	2480.53388181637
"AML-0160"	"2019-07-01-count-1:CTGTGAATCTAGTGTG"	1.74268176135365	-8.58708574688109	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTGAATCTAGTGTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.815147612	41.079119786509	0.0167340990324546	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2449.15655251396	2449.15655251396
"AML-0160"	"2019-07-01-count-2:TTGGATGAGGTACCTT"	2.29952182349507	-9.000852607843	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGATGAGGTACCTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2195.42433476366	41.6170925450358	0.0189562864390478	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2187.07508298422	2187.07508298422
"AML-0160"	"2019-07-01-count-3:CCCTAACTCGGAATTC"	-6.5757249397343	1.22849068725435	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTAACTCGGAATTC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2075.00405142397	46.553563417361	0.0224354084443419	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2064.0968739693	2064.0968739693
"AML-0160"	"2019-07-01-count-2:GGTAGAGTCTTCCCGA"	-7.99445949021037	3.12573144519655	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_MEP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTAGAGTCTTCCCGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1973.34737180377	44.2116477518095	0.0224043918387249	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1970.84518476653	1970.84518476653
"AML-0160"	"2019-07-01-count-3:TGAGCATCATGCCATA"	1.72671558436696	-8.82412531292113	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGCATCATGCCATA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2121.77130076987	41.6227581868099	0.0196169861340415	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2119.39476195027	2119.39476195027
"AML-0160"	"2019-07-01-count-3:ATGTCCCCAAGCTGTT"	-7.433257440955	3.53970954501954	"2019-07-01-count-3"	"AML0160"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCCCCAAGCTGTT"	"HSC"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2112.16105125637	35.4026769959488	0.0167613530108845	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2102.69483952167	2102.69483952167
"AML-0160"	"2019-07-01-count-3:CTGTAGAAGGTCTGGA"	2.26130690154378	-8.85861017620238	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTAGAAGGTCTGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2326.48580592051	41.853057340635	0.017989818478207	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2323.08095473829	2323.08095473829
"AML-0160"	"2019-07-01-count-2:CCGATCTTCCACCTGT"	1.63229515132253	-9.30371000682982	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGATCTTCCACCTGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.5451697377	48.4451169270197	0.0221661476494827	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2178.64955043615	2178.64955043615
"AML-0160"	"2019-07-01-count-1:GCTGGGTCATGACAGG"	2.02912022647206	-8.92759802257689	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGGGTCATGACAGG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2488.39660219784	39.6282692260195	0.0159252223664903	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2487.41399844317	2487.41399844317
"AML-0160"	"2019-07-01-count-1:GTAGGTTTCCAGCCTT"	1.7694808441097	-8.92314054882201	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGGTTTCCAGCCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2231.01286824392	48.4654529436801	0.02172352012556	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2223.43459993426	2223.43459993426
"AML-0160"	"2019-07-01-count-3:GAGTTACAGCGTCAGA"	2.37641992148702	-9.30514814769896	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTTACAGCGTCAGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2084.48554585768	45.3523911697446	0.0217571147278375	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2082.96198403975	2082.96198403975
"AML-0160"	"2019-07-01-count-1:AGCTACACATCTCAAG"	1.49670650538747	-8.79930212413939	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTACACATCTCAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2614.99756217569	41.5040498041864	0.0158715443580203	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2610.33696738905	2610.33696738905
"AML-0160"	"2019-07-01-count-1:TCTCACGCACTCAGAT"	1.63082506236379	-8.85844805156859	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCACGCACTCAGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2671.23353319982	34.565624526684	0.0129399485657394	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2668.79933268995	2668.79933268995
"AML-0160"	"2019-07-01-count-3:GTAACCACAGACAAAT"	2.89981522139851	-9.5560398331848	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.00519159456118665	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAACCACAGACAAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2085.93760601715	48.4212450125045	0.0232131799497872	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2082.85552648702	2082.85552648702
"AML-0160"	"2019-07-01-count-1:TGCAGGCTCACTGGGC"	-9.63087115708049	3.63905832851259	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_MEP"	1	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.827586206896552	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGGCTCACTGGGC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1554.51239482334	39.8088523338793	0.0256085782695887	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1554.51239482334	1554.51239482334
"AML-0160"	"2019-07-01-count-3:TGAGCGCAGTACCGGA"	1.8372788625652	-8.8731374970642	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGCGCAGTACCGGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.96865554873	39.9601774054332	0.0165126838786977	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2415.55587496793	2415.55587496793
"AML-0160"	"2019-07-01-count-3:TCGTGCTTCTGACGCG"	-8.25356803360637	2.45976326549379	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTGCTTCTGACGCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1915.99760218713	43.78934379519	0.0228545921692199	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	1907.41063009082	1907.41063009082
"AML-0160"	"2019-07-01-count-1:GGAGGATTCTTAAGGC"	1.85507287558858	-8.85927202617797	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGGATTCTTAAGGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2451.93251936431	40.3583815573984	0.0164598255615378	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2445.47258347663	2445.47258347663
"AML-0160"	"2019-07-01-count-1:TTATTGCCAGTGTACT"	1.91286828097646	-9.11503889476927	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTATTGCCAGTGTACT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.10999036406	42.9218986296865	0.018117309371141	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2361.25926818811	2361.25926818811
"AML-0160"	"2019-07-01-count-3:TCAGTCCCAGTAACCT"	-7.94918570938762	2.16065046871034	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTCCCAGTAACCT"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2319.76252200436	37.1657444897501	0.0160213574179298	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2314.63719593989	2314.63719593989
"AML-0160"	"2019-07-01-count-3:TGTAACGCAGTAACGG"	2.25438370284383	-4.30656769191893	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGCAGTAACGG"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1919.16660465805	48.441784644899	0.0252410523022467	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	1916.47885362808	1916.47885362808
"AML-0160"	"2019-07-01-count-1:GAAGGACAGTTTGAGA"	-8.13148055496867	1.89332423293916	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGGACAGTTTGAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2420.81569603516	40.540032347806	0.0167464348542531	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2413.04889703134	2413.04889703134
"AML-0160"	"2019-07-01-count-3:ATGGTTGCATTGTAGC"	2.11936440047566	-4.57555916225585	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGTTGCATTGTAGC"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2233.95378228831	42.1814644183545	0.0188819772158163	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2226.83999942543	2226.83999942543
"AML-0160"	"2019-07-01-count-2:CGTCCATCAACTTCTT"	2.96833576735799	-8.80920698558959	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.348101265822785	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATCAACTTCTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1591.00433138755	39.0074061410832	0.0245174732535542	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1588.84086703242	1588.84086703242
"AML-0160"	"2019-07-01-count-3:TGTCCACCAGCTTCGG"	1.84832443770711	-8.29451467907103	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTCCACCAGCTTCGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2005.31475090093	46.2311776055654	0.0230543248060161	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2003.96123801497	2003.96123801497
"AML-0160"	"2019-07-01-count-3:ATACTTCCAGATACCT"	2.29416336592976	-4.76588871395262	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATACTTCCAGATACCT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2329.46574072387	41.9760582551443	0.018019607466775	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2323.04886968323	2323.04886968323
"AML-0160"	"2019-07-01-count-1:GCATTAGTCGCTAATG"	-8.09550414505656	1.9890018471512	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATTAGTCGCTAATG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2597.61532795299	40.9834288346275	0.0157773279182657	2651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2589.78181233564	2589.78181233564
"AML-0160"	"2019-07-01-count-3:AAGCGTTAGAATGTTG"	2.29041447219197	-9.37050630962523	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCGTTAGAATGTTG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1999.14664822077	44.545604168874	0.0222823094086266	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1991.50754169742	1991.50754169742
"AML-0160"	"2019-07-01-count-1:CCTCTAGGTGAGACCA"	1.7135189968044	-8.72042944347533	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCTAGGTGAGACCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.08531320407	40.560491235127	0.0165750213187375	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2441.45544483255	2441.45544483255
"AML-0160"	"2019-07-01-count-3:GATGTTGAGAGTAACT"	2.1552525955135	-3.82628157055052	"2019-07-01-count-3"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGTTGAGAGTAACT"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2338.04919552115	43.4412855082049	0.0185801417658031	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2327.77609146454	2327.77609146454
"AML-0160"	"2019-07-01-count-1:TCACGCTAGCATACTC"	1.93955006179158	-8.82069876110228	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACGCTAGCATACTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.23562169392	40.694753337045	0.0171690750761572	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2365.00370411657	2365.00370411657
"AML-0160"	"2019-07-01-count-1:CTCAAGACAAACCATC"	2.35371055182759	-9.59622099315795	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAAGACAAACCATC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2397.70484216032	39.2040818867381	0.0163506705234892	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2391.10179330869	2391.10179330869
"AML-0160"	"2019-07-01-count-1:GATTCTTAGATACCAA"	1.62471022185628	-7.73016693508299	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTCTTAGATACCAA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.72541592289	52.4134095833871	0.0228010745521531	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2290.30058195997	2290.30058195997
"AML-0160"	"2019-07-01-count-2:TGTGATGGTCCATCTC"	2.28581227835957	-9.59530737316283	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTGATGGTCCATCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2096.3383957481	46.2707944034847	0.0220721971688033	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2091.34521059837	2091.34521059837
"AML-0160"	"2019-07-01-count-2:CACTTCGCAACGATTC"	1.47445013102834	-8.63155271923216	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACTTCGCAACGATTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.56338239251	41.392558591526	0.0180709073190069	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2280.10122841348	2280.10122841348
"AML-0160"	"2019-07-01-count-2:ATTATCCTCTGCCCTA"	9.20453037795369	7.70384833896486	"2019-07-01-count-2"	"AML0160"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTATCCTCTGCCCTA"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2089.07681707533	44.790353188523	0.0214402614697667	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	2080.35946997547	2080.35946997547
"AML-0160"	"2019-07-01-count-3:GTGTTCCGTGGTACAG"	1.3616758781368	-7.92353966152342	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTTCCGTGGTACAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2279.58304473961	41.8798393438425	0.0183717103180271	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2278.47178142119	2278.47178142119
"AML-0160"	"2019-07-01-count-2:TGTCCACGTTCTTGCC"	1.84393825110738	-8.93344404613646	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCCACGTTCTTGCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1978.79056648173	45.5756514527927	0.0230320743512669	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1977.42277696501	1977.42277696501
"AML-0160"	"2019-07-01-count-3:TGTTTGTTCGAGTGGA"	1.49274303492848	-6.28803827678832	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTTGTTCGAGTGGA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2421.1180006837	41.2024591117375	0.017017947535024	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2419.09809235249	2419.09809235249
"AML-0160"	"2019-07-01-count-1:GATTCGAAGAAGTGTT"	2.15154757079427	-9.28050234234007	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTCGAAGAAGTGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2097.21550625461	44.9085893128904	0.0214134356621709	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2095.12136085759	2095.12136085759
"AML-0160"	"2019-07-01-count-2:TCCACCACAACTCCCT"	1.67927791652028	-10.0487308732239	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCACCACAACTCCCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.3862819217	37.5415822734775	0.0154467553379183	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2425.43491776496	2425.43491776496
"AML-0160"	"2019-07-01-count-2:TCGACCTAGCGTGCTC"	1.70317425307576	-8.68578531658324	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGACCTAGCGTGCTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.14090076564	46.7680578515339	0.0204303972009288	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2280.38151866214	2280.38151866214
"AML-0160"	"2019-07-01-count-3:AGAGCCCTCAGAGCAG"	1.96977676925008	-8.9829254380432	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCCCTCAGAGCAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2216.05679338785	40.5818297191051	0.0183126307232698	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2211.25748299489	2211.25748299489
"AML-0160"	"2019-07-01-count-1:CAACGGCAGCGATCGA"	2.01894905146901	-9.00818731701048	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACGGCAGCGATCGA"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2289.65939102021	40.0676357022245	0.0174993869653125	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2286.93505569601	2286.93505569601
"AML-0160"	"2019-07-01-count-3:GAGACCCCAGATTAAG"	1.98151292380635	-9.17025949871215	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGACCCCAGATTAAG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1852.20452640286	45.0599334124518	0.0243277309660623	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1850.59820440419	1850.59820440419
"AML-0160"	"2019-07-01-count-1:GGTGTCGGTCGTGCCA"	2.12074627456014	-9.38366415416869	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGTCGGTCGTGCCA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2414.85370980825	36.9219587907675	0.0152895219452855	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2409.04285909847	2409.04285909847
"AML-0160"	"2019-07-01-count-2:TAAGTCGTCGTGGGTC"	2.85338916358296	-9.15744783794554	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGTCGTCGTGGGTC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1773.29903355752	49.5258863804849	0.027928671613342	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1771.40321540396	1771.40321540396
"AML-0160"	"2019-07-01-count-1:TTTATGCGTATCGATC"	-7.43826566162761	3.79551074588624	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.675675675675676	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTATGCGTATCGATC"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2076.26690555652	29.839581312906	0.0143717463458331	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2064.33558766611	2064.33558766611
"AML-0160"	"2019-07-01-count-1:GTTCGCTCAATTGAAG"	2.17856254157369	-8.94822313701781	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCGCTCAATTGAAG"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2462.84976328397	39.7694237952828	0.0161477262592965	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2458.65588496705	2458.65588496705
"AML-0160"	"2019-07-01-count-2:AGGATCTTCGCTCATC"	8.73880829390828	7.91777608478395	"2019-07-01-count-2"	"AML0160"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0151515151515152	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGATCTTCGCTCATC"	"B"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1983.15726930029	39.5396362382894	0.0199377209515209	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	45	TRUE	"B_AML-0160"	1981.76005274281	1981.76005274281
"AML-0160"	"2019-07-01-count-1:AATCGTGGTCGGCACT"	1.77550794658009	-8.76470949566039	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCGTGGTCGGCACT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.52944537476	39.9396394650997	0.0159788633572634	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2496.08412394731	2496.08412394731
"AML-0160"	"2019-07-01-count-2:GATCCCTCAGATCCTA"	1.64904250678365	-9.28397848522338	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCCCTCAGATCCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2196.49091881458	41.6203943521483	0.0189485847611017	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2195.20084044038	2195.20084044038
"AML-0160"	"2019-07-01-count-1:ACAGCCGAGCAGGCTA"	1.53857006606404	-8.35062982952269	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGCCGAGCAGGCTA"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2419.86272234166	40.8828140664522	0.0168946831938014	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2418.73847794099	2418.73847794099
"AML-0160"	"2019-07-01-count-1:CCCATTGCAGTCCCGA"	1.49309339103047	-8.1645193330017	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCATTGCAGTCCCGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2456.63679446722	40.6347984050978	0.0165408246333421	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2453.93535760157	2453.93535760157
"AML-0160"	"2019-07-01-count-2:CTACTATTCCATCAGA"	-8.1032603782719	1.87089536273805	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACTATTCCATCAGA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2324.81684809076	39.9492797898931	0.0171838395883535	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2317.75108044178	2317.75108044178
"AML-0160"	"2019-07-01-count-2:ACTTATCGTAAGATAC"	1.28775014457051	-8.85833551799925	"2019-07-01-count-2"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCGTAAGATAC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2337.85816001475	37.9830429861561	0.0162469407408003	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2332.04819001039	2332.04819001039
"AML-0160"	"2019-07-01-count-1:CGTTGGGCAGATCATC"	2.0020475583965	-9.54197504436644	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTGGGCAGATCATC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2269.2357726056	46.5100287367792	0.0204958996761166	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2259.61247398428	2259.61247398428
"AML-0160"	"2019-07-01-count-3:TGCCGAGAGACGCCCT"	-7.65448890152629	0.193295336607374	"2019-07-01-count-3"	"AML0160"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0882352941176471	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCCGAGAGACGCCCT"	"GMP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2834.97096493422	41.7364947637596	0.0147220184192355	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2823.93416141196	2823.93416141196
"AML-0160"	"2019-07-01-count-2:GCAACCGAGCATATGA"	2.02097906646077	-9.05676748668822	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAACCGAGCATATGA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2147.77973667155	49.0406057934471	0.0228331634553207	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2142.57460528041	2142.57460528041
"AML-0160"	"2019-07-01-count-3:TCTGCCATCCAGTGTA"	1.80778779563252	-9.16019346630248	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGCCATCCAGTGTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2123.66054936543	47.0897819983331	0.0221738742627225	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2122.27523376229	2122.27523376229
"AML-0160"	"2019-07-01-count-2:TGATTTCCATTACGGT"	1.92649199542348	-9.20447828685912	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATTTCCATTACGGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2166.6793796459	47.4723678393665	0.021910195059467	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2162.2472210609	2162.2472210609
"AML-0160"	"2019-07-01-count-1:GTGTGATTCATGCATG"	1.90076531943623	-9.62162306224974	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGATTCATGCATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.74748021006	46.4747767353281	0.0216086626454115	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2142.29113045408	2142.29113045408
"AML-0160"	"2019-07-01-count-1:AGTCTCCGTGATCGTT"	2.36408390578572	-9.84495355999144	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTCTCCGTGATCGTT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2467.82722451837	44.2482983933528	0.0179300633179409	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2464.90694570485	2464.90694570485
"AML-0160"	"2019-07-01-count-1:TACTTCATCCCTTCCC"	1.70794763144795	-8.57468511974486	"2019-07-01-count-1"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTTCATCCCTTCCC"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2783.69709409656	40.9808082288466	0.0147217196568389	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2777.84182219797	2777.84182219797
"AML-0160"	"2019-07-01-count-3:GTGAGGAAGGTTCCAT"	2.1139825778896	-8.59607603466185	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGGAAGGTTCCAT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2191.6511231166	42.5679790471971	0.0194227897853852	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2185.69173905704	2185.69173905704
"AML-0160"	"2019-07-01-count-2:CTAACCCAGTACGTCT"	2.25404467162434	-9.42342951213988	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAACCCAGTACGTCT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.10460730601	42.8783969683687	0.0200356547161236	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2138.75016747672	2138.75016747672
"AML-0160"	"2019-07-01-count-3:CATCGGGTCGCAGATT"	1.76955880698506	-9.26837732708129	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGGGTCGCAGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2153.45073786831	39.8851323260958	0.0185214974388399	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2151.1998121932	2151.1998121932
"AML-0160"	"2019-07-01-count-2:CGCATAAGTGACTCTA"	1.60964026030843	-8.83389189159545	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCATAAGTGACTCTA"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2213.40708442503	39.2373856608594	0.0177271437942705	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2208.97575570759	2208.97575570759
"AML-0160"	"2019-07-01-count-3:TCCAGAAAGATGGCAC"	1.92124797877614	-8.40452291881713	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCAGAAAGATGGCAC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2279.00436423604	40.3772841259206	0.0177170718755757	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2276.77081637516	2276.77081637516
"AML-0160"	"2019-07-01-count-3:GACGTTAGTTCAGTAC"	1.58707394179646	-8.86043264782103	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACGTTAGTTCAGTAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2301.78755263718	37.9483439860357	0.0164864667647359	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2294.95579230315	2294.95579230315
"AML-0160"	"2019-07-01-count-3:AGAGCCCTCGTGCACG"	2.81179823455159	-9.42329027568968	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCCCTCGTGCACG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2048.38819017423	44.8812596383003	0.0219105245058472	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2045.77156976065	2045.77156976065
"AML-0160"	"2019-07-01-count-1:GGCTTGGAGGGTAGCT"	1.92941476878468	-10.0885448685852	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTTGGAGGGTAGCT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2362.02047937856	40.6104228326206	0.0171930866760754	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2356.17121127408	2356.17121127408
"AML-0160"	"2019-07-01-count-3:TTTCAGTCAACCGATT"	1.60258318957631	-8.74234297191771	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTCAGTCAACCGATT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.85012166697	36.7721923670478	0.015071496417134	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2436.42258032077	2436.42258032077
"AML-0160"	"2019-07-01-count-1:ACCTGTCTCTTTGCGC"	1.41103734549825	-8.6816730729309	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCTGTCTCTTTGCGC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.8816167977	41.1619917482288	0.0170734188943309	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2406.2949501171	2406.2949501171
"AML-0160"	"2019-07-01-count-1:AAACGAAGTATGAAAC"	1.75134803828542	-8.39846613323363	"2019-07-01-count-1"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGAAGTATGAAAC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2489.70459952341	41.6933671946197	0.016746310868607	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2484.69087560475	2484.69087560475
"AML-0160"	"2019-07-01-count-2:GCTTCACGTATACGGG"	1.61585952815358	-8.53428079998168	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTTCACGTATACGGG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2447.44513654992	40.4222159841244	0.0165160866654221	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2442.37352626701	2442.37352626701
"AML-0160"	"2019-07-01-count-1:GATGCTATCCCAAGTA"	2.3285047012264	-4.4287901154724	"2019-07-01-count-1"	"AML0160"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.0741127348643006	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGCTATCCCAAGTA"	"cDC2"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2404.89819922923	41.7867407954431	0.0173756796894088	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	123	TRUE	"DC_AML-0160"	2397.80073370984	2397.80073370984
"AML-0160"	"2019-07-01-count-3:TCCACCACATGACGTT"	2.06011333045308	-9.10581018840941	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCACCACATGACGTT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2186.60169056772	40.9394611831935	0.0187228709095913	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2180.32673268497	2180.32673268497
"AML-0160"	"2019-07-01-count-2:GAGTGAGGTAACGTTC"	1.69242717799489	-8.79065229808959	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTGAGGTAACGTTC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.46731389905	45.2961682204283	0.0196728821933732	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2299.9284784313	2299.9284784313
"AML-0160"	"2019-07-01-count-2:ACTTATCCAAACTCTG"	2.38984384116475	-8.87484838878783	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCCAAACTCTG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2060.36282040023	48.648109684027	0.0236114286291465	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2057.22146330345	2057.22146330345
"AML-0160"	"2019-07-01-count-3:CTGTCGTAGGTAGTCG"	1.90026273307149	-8.81352617656859	"2019-07-01-count-3"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTCGTAGGTAGTCG"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1990.69984589944	43.3085008048869	0.0217554147573259	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1987.86704713824	1987.86704713824
"AML-0160"	"2019-07-01-count-2:GGACGTCAGCAAGTCG"	1.76631917533223	-8.04383375560912	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGACGTCAGCAAGTCG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2101.80911147275	45.4691485379199	0.0216333387697893	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2096.97800327696	2096.97800327696
"AML-0160"	"2019-07-01-count-3:ACCTGTCGTAGGACTG"	-8.13482890549358	0.892779208067335	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCTGTCGTAGGACTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2546.73852489984	43.1826438398242	0.0169560570971935	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2537.11487303867	2537.11487303867
"AML-0160"	"2019-07-01-count-1:CTCAGGGAGCGTCTGC"	2.47644438323323	-8.86165239727172	"2019-07-01-count-1"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAGGGAGCGTCTGC"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2040.7682227149	38.9972859311494	0.0191091205248532	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2039.26570671016	2039.26570671016
"AML-0160"	"2019-07-01-count-3:CCTTCAGGTTGGGATG"	2.81637301024739	-9.45236399089965	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	68	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTTCAGGTTGGGATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1875.22273641526	43.8219114442464	0.0233689100463968	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1872.00662724883	1872.00662724883
"AML-0160"	"2019-07-01-count-3:GCAGCTGAGCTGAAAT"	2.1267839866573	-9.30338385021361	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCTGAGCTGAAAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2039.77650383121	42.848074935584	0.0210062596834038	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2032.91034169344	2032.91034169344
"AML-0160"	"2019-07-01-count-3:GTAGTACGTCTTCCGT"	2.12068285521809	-9.6534052125183	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGTACGTCTTCCGT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1994.14419242097	45.1956549056778	0.0226641860089408	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1989.90517492291	1989.90517492291
"AML-0160"	"2019-07-01-count-3:TGGATGTTCGGTCGGT"	1.56737055358235	-8.64414789592894	"2019-07-01-count-3"	"AML0160"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGATGTTCGGTCGGT"	"Granulocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2159.42213381666	38.7797058895155	0.017958371956193	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"Gran_AML-0160"	2154.8816520925	2154.8816520925
"AML-0160"	"2019-07-01-count-2:CTGGACGAGCGGTATG"	2.13020934638326	-9.24309160625609	"2019-07-01-count-2"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGGACGAGCGGTATG"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2244.98658323763	37.9852331597051	0.0169200268025319	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2242.53286216144	2242.53286216144
"AML-0160"	"2019-07-01-count-3:TGTACAGAGAGGTTAT"	2.08865775641744	-9.27579405223998	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTACAGAGAGGTTAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1958.64401836854	45.3566413374947	0.0231571642994498	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	1953.86951810907	1953.86951810907
"AML-0160"	"2019-07-01-count-3:CATACTTCAAGAGCTG"	-8.22111831131633	1.11401424491731	"2019-07-01-count-3"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATACTTCAAGAGCTG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2579.65829864526	39.1306161974195	0.0151689145100998	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2570.74207644633	2570.74207644633
"AML-0160"	"2019-07-01-count-3:TTCTTGAGTCATTCCC"	2.31296362456624	-10.9319553605286	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTTGAGTCATTCCC"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2208.54948559525	41.2557874882665	0.0186800376253047	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2206.01472304542	2206.01472304542
"AML-0160"	"2019-07-01-count-2:CACATGAAGGCTTAAA"	-8.0136436027592	2.46448204601137	"2019-07-01-count-2"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACATGAAGGCTTAAA"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2484.28448568427	36.8363826117624	0.0148277634159987	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2475.02660293461	2475.02660293461
"AML-0160"	"2019-07-01-count-3:TCATATCTCCGCGGAT"	2.4202262359554	-9.33750536358031	"2019-07-01-count-3"	"AML0160"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATATCTCCGCGGAT"	"CD14+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2257.62418405226	45.0193649437624	0.0199410359181022	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2254.99664566215	2254.99664566215
"AML-0160"	"2019-07-01-count-1:AGGTGTTTCTTGGGCG"	-8.16953025284465	2.38327691638795	"2019-07-01-count-1"	"AML0160"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.487113402061856	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTGTTTCTTGGGCG"	"MPP"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2617.41493700634	41.3888822058778	0.0158128853093565	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	319	TRUE	"HSPC_AML-0160"	2603.81244351523	2603.81244351523
"AML-0160"	"2019-07-01-count-2:AATGCCAGTTTGCAGT"	2.63295950469319	-8.23862268840941	"2019-07-01-count-2"	"AML0160"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_low"	0.966314398943197	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGCCAGTTTGCAGT"	"HLA-II+ monocyte"	"U-16-0160"	"M"	74	"CITE-seq"	"OSU"	"AML0160"	"AML"	"Adverse"	"46,XY[30]"	3	"Blasts/promonocytes (30%) and monocytes (33%) represent the majority of the differential count of the bone marrow aspirates. Flow cytometric analysis demonstrates 11% CD34 positive myeloid blasts. The findings are those of an acute myeloid leukemia which in the absence of recurrent cytogenetic/molecular abnormalities, is best classified as acute myelomonocytic leukemia. The blasts represent 10.7% of
the total events analyzed and express CD34+, CD33+, CD13+, HLA-DR+, CD117+
with subsets expressing CD4 (29.1%), CD8 (12.4%), and CD11b (7.1%)."	""	""	""	"x"	""	"x"	NA	NA	"0"	"0"	"0,45"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0,76"	0	0	0	"0"	0	"0,43"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2371.2083001967	43.4235094869621	0.0183128194530021	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1456	TRUE	"Mono_AML-0160"	2369.10486754933	2369.10486754933
"AML-0693"	"2021-03-09-AML0693:ACGCACGCACGCGGTT"	-2.25882325592693	3.85947010600892	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGCACGCGGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3270.99799600406	21.8394200886219	0.00667668403199928	4524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3266.68088210087	3266.68088210087
"AML-0693"	"2021-03-09-AML0693:ACGCACGGTGCATACT"	8.14909901198689	6.63466832721559	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGGTGCATACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1786.55369342252	49.8487903672249	0.0279022066623304	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1781.18105967324	1781.18105967324
"AML-0693"	"2021-03-09-AML0693:ACGCACGTCAACTACG"	-5.22669110718425	2.04777166927186	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGTCAACTACG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1341.11845971424	52.3966466220729	0.0390693650083957	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1298.61760560853	1298.61760560853
"AML-0693"	"2021-03-09-AML0693:ACGGAAGAGCCACTCG"	-7.27858767929729	-2.63905026828917	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGAAGAGCCACTCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2029.27117646703	0	0	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2022.72537400463	2022.72537400463
"AML-0693"	"2021-03-09-AML0693:ACGCACGGTAGACAAT"	-2.31690249863322	10.1650571593079	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGGTAGACAAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2003.07088343943	43.3568565634181	0.02164519334881	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1992.69959472572	1992.69959472572
"AML-0693"	"2021-03-09-AML0693:ACGGGTCCAAGAGGTC"	-6.93245158615764	3.94889280879823	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGGTCCAAGAGGTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2102.310082889	44.3557517652083	0.0210985772870644	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2093.41910680448	2093.41910680448
"AML-0693"	"2021-03-09-AML0693:ACGGGTCGTTTGTGGT"	10.500393529504	6.26310203159181	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGGTCGTTTGTGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1740.8244103641	46.5360945608043	0.0267322162325786	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1730.71105934482	1730.71105934482
"AML-0693"	"2021-03-09-AML0693:ACGGGTCTCACACCGG"	-8.62300906601604	-3.95020248806151	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGGTCTCACACCGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3143.3136294076	48.8612644914545	0.0155445082012586	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3136.79227822228	3136.79227822228
"AML-0693"	"2021-03-09-AML0693:ACGGGTCTCTCTATAC"	-8.14716563645061	-4.65680935299071	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGGTCTCTCTATAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3039.47746439998	48.1663263592703	0.0158469101756538	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3024.72781408889	3024.72781408889
"AML-0693"	"2021-03-09-AML0693:ACGGTCGAGAGTGTTA"	-6.91884122315105	3.89893291080324	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTCGAGAGTGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2006.13376518875	38.523325044574	0.0192027698815734	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1991.78599720598	1991.78599720598
"AML-0693"	"2021-03-09-AML0693:ACGGTCGGTCGTCATA"	-8.37834678116496	-3.28949811374816	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTCGGTCGTCATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2555.11759905328	51.188524369183	0.0200337254098008	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2542.63113719535	2542.63113719535
"AML-0693"	"2021-03-09-AML0693:ACGGTCGGTGCGAGTA"	-7.7979978126591	-3.69334866916808	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTCGGTGCGAGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2338.03058716946	16.5135649158813	0.00706302347219224	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2321.60162224088	2321.60162224088
"AML-0693"	"2021-03-09-AML0693:ACGGTCGTCATTTGTC"	-2.58268580856975	3.40643332088319	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTCGTCATTTGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2511.50381333389	39.6669606512201	0.0157941072757378	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2504.36918901206	2504.36918901206
"AML-0693"	"2021-03-09-AML0693:ACGGTTAAGTCACGCC"	-5.93039832535441	-4.48396255886229	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTTAAGTCACGCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3699.45677889491	41.6977594486134	0.0112713195316933	5195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3680.09243533194	3680.09243533194
"AML-0693"	"2021-03-09-AML0693:ACGGTTACAACCAGAG"	-8.70226607742961	-4.16122963344725	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTTACAACCAGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2918.52916310369	41.6704029896984	0.0142778778833185	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2907.26334461921	2907.26334461921
"AML-0693"	"2021-03-09-AML0693:ACGGTTACAGCAGTGA"	7.67224707183186	6.46318862521974	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTTACAGCAGTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1695.86427786059	43.9551220878376	0.0259190093580418	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1682.60582016567	1682.60582016567
"AML-0693"	"2021-03-09-AML0693:ACGGTTACAGCCGTCA"	13.9280067878658	1.66330752456514	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTTACAGCCGTCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1174.14413061623	49.3619467946735	0.0420407899741972	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1146.30637143132	1146.30637143132
"AML-0693"	"2021-03-09-AML0693:ACGGAAGCAACTCGTA"	1.33315624770467	-10.3357343903747	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGAAGCAACTCGTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2432.28370229932	45.2069178798909	0.0185862026856305	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2419.52332483324	2419.52332483324
"AML-0693"	"2021-03-09-AML0693:ACGTAACAGCCTGAAG"	-2.39003358307536	3.96764729106752	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAACAGCCTGAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3571.60904594115	26.7414042736768	0.00748721484622353	5597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3564.38735742367	3564.38735742367
"AML-0693"	"2021-03-09-AML0693:ACGTAACAGCTTCGTA"	-7.02971110764201	3.53916618907777	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAACAGCTTCGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2232.1843310762	52.6604881117894	0.0235914603371489	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2215.16065512807	2215.16065512807
"AML-0693"	"2021-03-09-AML0693:ACGTAACAGGACATCG"	9.41075577315633	6.56711051547853	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAACAGGACATCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1612.50812116085	44.4378387209215	0.0275582108007807	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1610.36322644461	1610.36322644461
"AML-0693"	"2021-03-09-AML0693:ACGTAACCACTAGTAC"	8.81453289565389	7.04172132099	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAACCACTAGTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1443.92056334862	51.5439861857611	0.0356972450521965	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1437.02744673633	1437.02744673633
"AML-0693"	"2021-03-09-AML0693:ACGTACACAGGCGATA"	-7.6288836998051	-2.59070541774901	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTACACAGGCGATA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2184.04642005985	15.6043524432972	0.00714469816207918	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2171.11342031738	2171.11342031738
"AML-0693"	"2021-03-09-AML0693:ACGTACAGTGTTCATG"	13.9594608741695	1.79367587650148	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTACAGTGTTCATG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1245.26140614343	50.4622380823312	0.0405234096498762	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1233.6009910847	1233.6009910847
"AML-0693"	"2021-03-09-AML0693:ACGTAGTAGGCTCCCA"	-1.96942148628886	3.9904210337433	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAGTAGGCTCCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3338.56602340691	10.6589733531145	0.00319268011427174	5498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3335.04055989185	3335.04055989185
"AML-0693"	"2021-03-09-AML0693:ACGTAGTTCGGACGTC"	-7.7408336204594	-2.89773466503295	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTAGTTCGGACGTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1502.60631680705	41.8291415769431	0.0278377250974343	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1488.86688717093	1488.86688717093
"AML-0693"	"2021-03-09-AML0693:ACGTCCTAGAAGTATC"	0.889817615121049	9.61380765521852	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTAGAAGTATC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1675.163258017	46.2190782606112	0.0275907903539645	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1675.163258017	1675.163258017
"AML-0693"	"2021-03-09-AML0693:ACGTCCTAGGGTTAGC"	-7.56778703156169	-2.55954625522765	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTAGGGTTAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2794.29908408758	8.15964691954925	0.00292010506892952	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2749.49649220731	2749.49649220731
"AML-0693"	"2021-03-09-AML0693:ACGTCCTCAAATGAAC"	11.2876488166744	-2.74791791355284	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTCAAATGAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1538.52165416202	40.3004649068654	0.0261942786426466	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1531.81697691464	1531.81697691464
"AML-0693"	"2021-03-09-AML0693:ACGTCCTCACAGCCAC"	-7.77295957031901	-4.20160629665526	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTCACAGCCAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2165.68168328121	41.4243852592516	0.0191276426166609	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2141.32688073599	2141.32688073599
"AML-0693"	"2021-03-09-AML0693:ACGGTTATCACAGTGT"	-7.11369071427043	3.71576044643251	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGGTTATCACAGTGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1939.25752004405	48.6751720149098	0.025099901128038	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1929.32701050324	1929.32701050324
"AML-0693"	"2021-03-09-AML0693:AAACCCAAGTTCCGGC"	-2.22297726097758	3.48367331111757	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACCCAAGTTCCGGC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1768.95957334299	50.2508710447333	0.0284070206023809	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1763.62570439441	1763.62570439441
"AML-0693"	"2021-03-09-AML0693:AAACCCACAGCCTATA"	14.2329470115596	1.85378680312959	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACCCACAGCCTATA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1365.86775307642	4.07482987922848	0.00298332680455374	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1339.08336573519	1339.08336573519
"AML-0693"	"2021-03-09-AML0693:AAACCCAGTGTAAACA"	9.09172405776326	7.02649495685426	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACCCAGTGTAAACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.78043151952	37.6156790041831	0.0212544326596981	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1769.78043151952	1769.78043151952
"AML-0693"	"2021-03-09-AML0693:AAACCCAGTGTACGCC"	-6.9028881591862	3.87836978519288	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACCCAGTGTACGCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2283.19340862579	52.2867479344124	0.0229007090406252	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2271.59897689962	2271.59897689962
"AML-0693"	"2021-03-09-AML0693:AAACGAACAAATGGCG"	-2.56240401688274	3.5348067053589	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAACAAATGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3634.08466284511	26.9760850130256	0.00742307555154924	5394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3628.29839022033	3628.29839022033
"AML-0693"	"2021-03-09-AML0693:AAACGAACAACAACAA"	-4.62917123261149	9.18989751422731	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAACAACAACAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1989.84529954465	50.7630900247563	0.0255110736680749	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1984.20268917302	1984.20268917302
"AML-0693"	"2021-03-09-AML0693:AAACGAACACAGAGAC"	-6.97789082947429	-2.77509262478026	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAACACAGAGAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2642.04567675202	48.365283622156	0.018305998282972	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2623.01008891719	2623.01008891719
"AML-0693"	"2021-03-09-AML0693:AAACGAAGTACAGAAT"	-7.07988868179973	-2.68801000034484	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAAGTACAGAAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2421.27657971532	13.9199239207204	0.00574900200883166	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2410.02259555957	2410.02259555957
"AML-0693"	"2021-03-09-AML0693:AAACGAAGTTCGGGTC"	-8.56543574753459	-4.31544353878173	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAAGTTCGGGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2611.76575227806	47.9264149871392	0.0183501965845659	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2597.15848878525	2597.15848878525
"AML-0693"	"2021-03-09-AML0693:AAACGAATCCTGTACC"	11.3087154823238	-1.63292767917784	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGAATCCTGTACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1587.35666029784	44.7391454679362	0.0281846837493608	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1575.16926956266	1575.16926956266
"AML-0693"	"2021-03-09-AML0693:AAACGCTAGAAGGGAT"	1.17820396003072	9.82799527728883	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGCTAGAAGGGAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1791.00354942033	34.2630605028324	0.0191306491346273	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1789.27815968251	1789.27815968251
"AML-0693"	"2021-03-09-AML0693:AAACGCTAGGATTCCT"	8.79318394240681	8.02583024585573	"2021-03-09-AML0693"	"AML0693"	"B"	"Atypical memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGCTAGGATTCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1804.81449825731	38.0506934683875	0.02108288331301	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1797.68615395125	1797.68615395125
"AML-0693"	"2021-03-09-AML0693:AAACGCTCATGTCTAG"	9.74323143538777	6.93677423084108	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGCTCATGTCTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1874.42081052297	51.3291921601015	0.0273840281072107	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1859.88825914205	1859.88825914205
"AML-0693"	"2021-03-09-AML0693:AAACGCTGTTGGACTT"	11.6928812461788	-2.94398977672728	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGCTGTTGGACTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2126.63304876525	49.8233606013779	0.0234282828578753	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2121.61261620868	2121.61261620868
"AML-0693"	"2021-03-09-AML0693:AAACGCTTCGACGATT"	-7.78101859512981	-3.21992900287779	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAACGCTTCGACGATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2640.92824976081	1.16179471005825	0.000439919073970857	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2623.68911457295	2623.68911457295
"AML-0693"	"2021-03-09-AML0693:AAAGAACAGAAATTCG"	14.0365120368892	1.71044931495515	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGAACAGAAATTCG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1308.19552710891	3.71597842441881	0.00284053747885155	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1288.81980470832	1288.81980470832
"AML-0693"	"2021-03-09-AML0693:AAAGAACAGCGGGTAT"	8.75153889235799	6.25942800128785	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGAACAGCGGGTAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1667.78045698061	48.8573911249044	0.0292948576777048	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1660.02178834617	1660.02178834617
"AML-0693"	"2021-03-09-AML0693:AAAGAACAGGGACCAT"	-7.11755452576335	4.13728234851686	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGAACAGGGACCAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2260.26922108817	42.3726488279555	0.0187467264663082	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2241.99487998424	2241.99487998424
"AML-0693"	"2021-03-09-AML0693:AAAGAACGTACAAGCG"	9.06997265395467	6.52030322635499	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGAACGTACAAGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1426.39756234254	46.4657579030421	0.0325756010314069	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1417.29586260496	1417.29586260496
"AML-0693"	"2021-03-09-AML0693:AAAGAACGTCATCCGG"	11.4895883994991	-2.40641381656798	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGAACGTCATCCGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1600.51794566536	40.5118082741227	0.025311686372427	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1595.99993250327	1595.99993250327
"AML-0693"	"2021-03-09-AML0693:AAAGGATAGAGGCGGA"	-7.61723170700725	-3.29137780582579	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGATAGAGGCGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3071.82005499195	37.7921981844334	0.0123028684974623	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3062.06056785152	3062.06056785152
"AML-0693"	"2021-03-09-AML0693:AAAGGATAGTCCCAAT"	-8.81545863571819	-3.83300568973693	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGATAGTCCCAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2764.32719063969	51.0381453171779	0.0184631347150216	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2759.11079517284	2759.11079517284
"AML-0693"	"2021-03-09-AML0693:AAAGGATGTCCCACGA"	-6.97235331955607	-2.55388238346251	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGATGTCCCACGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1641.74796566899	40.5235954779709	0.0246832012741116	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1634.75422364471	1634.75422364471
"AML-0693"	"2021-03-09-AML0693:AAAGGATGTGCTGTCG"	8.42554630812947	6.1783442267212	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGATGTGCTGTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1673.03770027989	44.9599100025673	0.0268732198892146	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1666.44081102592	1666.44081102592
"AML-0693"	"2021-03-09-AML0693:AAAGGATGTTACAGCT"	-2.12918506088908	13.7614650496277	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGATGTTACAGCT"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1992.7400164697	35.4332241086731	0.0177811575096715	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1983.51134957046	1983.51134957046
"AML-0693"	"2021-03-09-AML0693:AAAGGGCAGTGGTGGT"	-6.89263711395915	3.98259756648866	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGGCAGTGGTGGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2097.18720371439	38.6210964669641	0.0184156647525605	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2088.09592393158	2088.09592393158
"AML-0693"	"2021-03-09-AML0693:AAAGGGCCAAACCGGA"	9.96464218673055	6.65914914691774	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGGCCAAACCGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1782.65911988025	40.7743828916423	0.0228727873079747	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1776.95729079196	1776.95729079196
"AML-0693"	"2021-03-09-AML0693:AAAGGTAAGGAGGGTG"	-7.4614409011906	-3.21176268970641	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGGTAAGGAGGGTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2049.54621093812	36.603260644885	0.0178592024173639	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2036.45777065733	2036.45777065733
"AML-0693"	"2021-03-09-AML0693:AAAGTCCAGTGCCCGT"	-6.86358056488689	3.86222717845765	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTCCAGTGCCCGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1962.92303008739	38.7414457732824	0.0197366097291943	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1947.28670741234	1947.28670741234
"AML-0693"	"2021-03-09-AML0693:AAAGTCCCAAGAGAGA"	14.345665593713	1.95287654483644	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTCCCAAGAGAGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1305.69386686801	1.00456486153133	0.000769372428730936	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1288.94012573305	1288.94012573305
"AML-0693"	"2021-03-09-AML0693:AAAGTCCCAATACCTG"	9.74368156966512	6.97027251804201	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTCCCAATACCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2131.17938440203	43.1468734006063	0.0202455380886263	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2125.2724321921	2125.2724321921
"AML-0693"	"2021-03-09-AML0693:AAAGTCCGTGTCACAT"	-7.022040228278	3.34172389591066	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTCCGTGTCACAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2405.12420954112	26.9432471801955	0.0112024348153462	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2391.71981835531	2391.71981835531
"AML-0693"	"2021-03-09-AML0693:AAAGTCCTCTCTGGTC"	-9.77534327927287	-2.49850752269896	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTCCTCTCTGGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3212.24197846961	49.3052570457531	0.0153491727510651	3137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3199.59981167173	3199.59981167173
"AML-0693"	"2021-03-09-AML0693:AAAGTGAAGGTCCTGC"	8.3603741126949	6.45820424640504	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTGAAGGTCCTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1700.59498182683	45.8237677548163	0.0269457267865103	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1691.07909110007	1691.07909110007
"AML-0693"	"2021-03-09-AML0693:AAAGTGACACTTTATC"	-1.75912723961528	11.5626868971619	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTGACACTTTATC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2321.63457010915	33.0383554683861	0.0142306441736146	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2312.35739983887	2312.35739983887
"AML-0693"	"2021-03-09-AML0693:AAAGTGACAGTGTGGA"	-1.13798199120219	9.8262090452942	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTGACAGTGTGGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1861.19129897909	45.1943434452879	0.024282481585895	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1855.34897049361	1855.34897049361
"AML-0693"	"2021-03-09-AML0693:AAAGTGACATGGGTTT"	8.14623417434041	6.21154782855836	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTGACATGGGTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1576.71288734641	43.6079126940436	0.0276574847862348	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1572.30032750469	1572.30032750469
"AML-0693"	"2021-03-09-AML0693:AAAGTGAGTATCGGTT"	9.21128811415974	6.88876245105592	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAAGTGAGTATCGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1620.92959235111	50.8440591226753	0.0313672224645659	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1618.05509867909	1618.05509867909
"AML-0693"	"2021-03-09-AML0693:AAATGGAAGCTCCACG"	-7.10583434525188	-2.80099990284117	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAATGGAAGCTCCACG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2850.62726488017	6.72606039995654	0.00235950188325982	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2832.38039540816	2832.38039540816
"AML-0693"	"2021-03-09-AML0693:AAATGGACAGAGAAAG"	-3.81677399101909	-7.15378811275633	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	40	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAATGGACAGAGAAAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3296.12965168693	38.8291398574007	0.0117802222486996	2890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3287.9245630841	3287.9245630841
"AML-0693"	"2021-03-09-AML0693:AAATGGAGTCCCTCAT"	-4.93718514862712	2.97649166667787	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAATGGAGTCCCTCAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2719.83688956756	42.5440890564941	0.0156421472256957	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2708.74722521838	2708.74722521838
"AML-0693"	"2021-03-09-AML0693:AAATGGAGTGCATTAC"	-8.31839213791545	-4.70387127315673	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAATGGAGTGCATTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2464.53091505405	42.0158273270818	0.0170482046179406	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2459.59923993827	2459.59923993827
"AML-0693"	"2021-03-09-AML0693:AACAAAGAGGACGCTA"	9.13379921492879	6.94902513110963	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAAGAGGACGCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1492.84521994098	46.8057545500234	0.0313533874274479	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1484.44585981404	1484.44585981404
"AML-0693"	"2021-03-09-AML0693:AACAAAGCATGAATCC"	9.75430836257283	7.26749703967897	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAAGCATGAATCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1779.08460511606	34.4498044980411	0.0193637809011302	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1774.0665714138	1774.0665714138
"AML-0693"	"2021-03-09-AML0693:AACAAAGGTTTAGTCG"	8.36815704879109	6.65541169727174	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAAGGTTTAGTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1938.72765309841	43.7569651140716	0.0225699391269014	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1935.3596065135	1935.3596065135
"AML-0693"	"2021-03-09-AML0693:AACAAAGTCCGGGACT"	-7.08513198319133	-2.68148281490477	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAAGTCCGGGACT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1700.81752279738	50.0909444168336	0.0294510985131714	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1688.35577688327	1688.35577688327
"AML-0693"	"2021-03-09-AML0693:AACAACCCACAGCCTG"	-6.96710906449016	3.88698670947877	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAACCCACAGCCTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2473.28020017185	41.3186424122693	0.0167060094563481	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2465.82169258857	2465.82169258857
"AML-0693"	"2021-03-09-AML0693:AACAACCCACATAACC"	11.9572655158931	-3.06679823314818	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAACCCACATAACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2475.90064729343	35.5884377306885	0.0143739361147599	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2466.27535889868	2466.27535889868
"AML-0693"	"2021-03-09-AML0693:AACAACCTCCCGAGGT"	14.1200319724971	1.95899245822755	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAACCTCCCGAGGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1216.08467102278	26.3648610595227	0.0216801195572581	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1207.63279881058	1207.63279881058
"AML-0693"	"2021-03-09-AML0693:AACAAGAAGTTACGGG"	-2.52715311470683	3.32793591106264	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAGAAGTTACGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3469.26738087076	9.6604639127828	0.00278458327139896	5059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3462.40960823735	3462.40960823735
"AML-0693"	"2021-03-09-AML0693:AACAAGACAAGAGAGA"	-1.47505197945293	10.5947170027527	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAGACAAGAGAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2089.12101627174	41.6412336665927	0.0199324181520637	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2087.47583563652	2087.47583563652
"AML-0693"	"2021-03-09-AML0693:AACAAGAGTACGCGTC"	14.293886800378	1.93982384288637	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAAGAGTACGCGTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1477.54627376095	32.8541582748849	0.022235620540843	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1469.74736641011	1469.74736641011
"AML-0693"	"2021-03-09-AML0693:AACACACAGCAGGCAT"	8.36986698684041	5.89754436099855	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACAGCAGGCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1685.59871206093	42.6542638976416	0.0253051118231393	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1679.49266058953	1679.49266058953
"AML-0693"	"2021-03-09-AML0693:AACACACCAGCTCCTT"	1.20052387294118	-9.88337042247923	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACCAGCTCCTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2667.26603416147	44.6143238871942	0.0167266119373878	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2653.97067471569	2653.97067471569
"AML-0693"	"2021-03-09-AML0693:AACACACCAGTTAGAA"	14.2690178352291	2.00232789600221	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACCAGTTAGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1158.66322680045	16.053887246837	0.0138555249493578	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1143.56103086932	1143.56103086932
"AML-0693"	"2021-03-09-AML0693:AACACACGTTACGATC"	-7.06547341767009	-2.7607140771118	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACGTTACGATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1986.95962807254	41.3385047090746	0.0208049041988716	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1982.17915104722	1982.17915104722
"AML-0693"	"2021-03-09-AML0693:AACACACTCCACGTCT"	-8.07104335251506	-3.3058173886505	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACTCCACGTCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2849.21684051347	52.1309285290376	0.0182965816387786	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2835.94889468275	2835.94889468275
"AML-0693"	"2021-03-09-AML0693:AACACACTCTGGAAGG"	1.27135612544362	10.1453761824402	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACACACTCTGGAAGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1848.37205472997	41.1827353496359	0.0222805442466248	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1839.72205528674	1839.72205528674
"AML-0693"	"2021-03-09-AML0693:AACAGGGAGTGGACTG"	11.4589230018551	-2.17817189609679	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAGGGAGTGGACTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1404.00291379641	50.8249026552875	0.0361999979885067	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1401.7615852476	1401.7615852476
"AML-0693"	"2021-03-09-AML0693:AACAGGGGTTCGGACC"	9.42498459395711	7.82888314807741	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAGGGGTTCGGACC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1873.42251908841	52.3159909349793	0.0279253560806112	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1868.23681570825	1868.23681570825
"AML-0693"	"2021-03-09-AML0693:AACAGGGTCACCTGGG"	11.392742772668	-2.504674457666	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACAGGGTCACCTGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1485.92412475249	34.0206041395541	0.022895249880421	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1474.94291796951	1474.94291796951
"AML-0693"	"2021-03-09-AML0693:AACCAACAGCACCTGC"	8.12253918227498	6.60104653919069	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCAACAGCACCTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1764.9920217732	45.7360931274026	0.0259129177714094	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1759.44264410851	1759.44264410851
"AML-0693"	"2021-03-09-AML0693:AACCAACAGGCTTTCA"	-6.97081695023234	3.80847737872926	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCAACAGGCTTTCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2240.70560621567	37.5975576573045	0.0167793384159926	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2232.88668201166	2232.88668201166
"AML-0693"	"2021-03-09-AML0693:AACCAACGTAACCAGG"	-7.82231936875041	-3.73976757442626	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCAACGTAACCAGG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1852.99329938047	31.0245160654509	0.0167429186472631	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1837.17511828893	1837.17511828893
"AML-0693"	"2021-03-09-AML0693:AACCAACGTCAAAGCG"	6.76036800917928	-1.27525200760039	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCAACGTCAAAGCG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2201.85485120464	32.971465818541	0.014974404784449	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2197.34615714894	2197.34615714894
"AML-0693"	"2021-03-09-AML0693:AACCACAAGTCCCTAA"	14.2514215904171	2.01141581619111	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCACAAGTCCCTAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1239.70861734515	35.0456589203467	0.0282692710448343	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1225.04364955631	1225.04364955631
"AML-0693"	"2021-03-09-AML0693:AACCACAAGTCGTTAC"	0.159797114401501	11.397491432074	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCACAAGTCGTTAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1702.62723662498	47.7119392398917	0.0280225396455353	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1698.76528376428	1698.76528376428
"AML-0693"	"2021-03-09-AML0693:AACCACACAAGTTCCA"	10.4111334281856	5.79660413349	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCACACAAGTTCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1885.64332525277	47.3743344805827	0.025123698552181	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1875.47419900332	1875.47419900332
"AML-0693"	"2021-03-09-AML0693:AACCACAGTAGACAAT"	-6.89640174332316	3.89441416347352	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCACAGTAGACAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2312.83838936678	42.0857610263518	0.0181965852952978	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2301.13130357409	2301.13130357409
"AML-0693"	"2021-03-09-AML0693:AACCACAGTCTTCATT"	-9.00156627121623	-2.48445513164672	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCACAGTCTTCATT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2744.38699666868	53.9246367533763	0.0196490643698697	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2731.80955709126	2731.80955709126
"AML-0693"	"2021-03-09-AML0693:AACCATGAGGCCTGAA"	-9.38836322251018	-2.32169272815856	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCATGAGGCCTGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3218.65000761707	49.6185388452806	0.0154159472846865	3103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3209.45217359142	3209.45217359142
"AML-0693"	"2021-03-09-AML0693:AACCATGAGTATAGGT"	-2.05327854576762	3.12425372684327	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCATGAGTATAGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2082.73183569708	42.7929121981816	0.0205465300259642	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2056.78573450213	2056.78573450213
"AML-0693"	"2021-03-09-AML0693:AACCATGGTAATCAGA"	-6.81751761856731	-2.47165110027465	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCATGGTAATCAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1431.85138987166	30.0965260759417	0.0210193084902752	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1401.9616120096	1401.9616120096
"AML-0693"	"2021-03-09-AML0693:AACCATGTCCGCTTAC"	-7.14762053909953	-2.78522708332213	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCATGTCCGCTTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2330.00829311366	38.2132473232904	0.0164004769580562	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2311.99816510379	2311.99816510379
"AML-0693"	"2021-03-09-AML0693:AACCCAAAGACCAAAT"	0.971596081822556	10.2477531203064	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCCAAAGACCAAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1681.08378055524	36.9086461826168	0.0219552687436116	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1671.50248077205	1671.50248077205
"AML-0693"	"2021-03-09-AML0693:AACCCAACAGCATCTA"	-8.70463309708293	-2.24842693721923	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCCAACAGCATCTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3296.03875491052	41.1090865798569	0.0124722703938513	4521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3283.40468086215	3283.40468086215
"AML-0693"	"2021-03-09-AML0693:AACCCAACAGTTGAAA"	2.25084867057149	-7.30847122585448	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCCAACAGTTGAAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1444.7183198229	46.3269479868802	0.0320664224653558	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1442.72981525944	1442.72981525944
"AML-0693"	"2021-03-09-AML0693:AACCCAAGTAACATGA"	-1.1722368997639	10.9892720946106	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCCAAGTAACATGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1756.68488033229	46.4549328124839	0.0264446591033997	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1754.55736860422	1754.55736860422
"AML-0693"	"2021-03-09-AML0693:AACCCAAGTGGACCAA"	9.63745846328084	6.53549192035524	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCCAAGTGGACCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1648.25321160034	52.1697688647698	0.0316515499545829	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1639.90848064718	1639.90848064718
"AML-0693"	"2021-03-09-AML0693:AACCTGAAGGCTAAAT"	-8.44827113571819	-3.9306588402954	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTGAAGGCTAAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3272.1655084763	41.9448565865135	0.0128186842865553	3063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3262.58073648903	3262.58073648903
"AML-0693"	"2021-03-09-AML0693:AACCTGACAACATACC"	-6.89784322205241	3.85270617091981	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTGACAACATACC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2710.20619022286	30.3212332399466	0.0111877957290966	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2691.03118401047	2691.03118401047
"AML-0693"	"2021-03-09-AML0693:AACCTGACACGCGCTA"	-7.51787457886394	-3.39534571087035	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTGACACGCGCTA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1745.42209756333	14.1797978553673	0.00812399354583788	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1734.40130059859	1734.40130059859
"AML-0693"	"2021-03-09-AML0693:AACCTGACATTCCTAT"	-2.10791740837749	10.0867919691834	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTGACATTCCTAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2032.85980759798	40.4744719447885	0.0199101147031939	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2032.85980759798	2032.85980759798
"AML-0693"	"2021-03-09-AML0693:AACCTGATCGTAGTGT"	-1.8780109685963	3.24050281131593	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTGATCGTAGTGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2589.39120107255	41.763371113964	0.0161286448709122	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2581.17513428096	2581.17513428096
"AML-0693"	"2021-03-09-AML0693:AACCTTTGTATCCTTT"	-8.60973582688029	-4.23700907146605	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTTTGTATCCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2737.93225953983	44.410841053318	0.0162205770060879	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2734.00215679866	2734.00215679866
"AML-0693"	"2021-03-09-AML0693:AACCTTTGTGCCTTTC"	1.03350092944447	-9.17313291942748	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTTTGTGCCTTTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2803.20191849492	42.924287899845	0.0153125922241419	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2800.83725116442	2800.83725116442
"AML-0693"	"2021-03-09-AML0693:AACCTTTGTTTAGACC"	0.956095417111558	9.56243608081666	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACCTTTGTTTAGACC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1786.26673202465	46.358511715478	0.0259527375639655	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1777.03321762897	1777.03321762897
"AML-0693"	"2021-03-09-AML0693:AACGAAAAGATAGTCA"	14.2742353874141	2.04921970451204	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACGAAAAGATAGTCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1164.16796972034	44.9082274725523	0.0385753848590598	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1145.41490306376	1145.41490306376
"AML-0693"	"2021-03-09-AML0693:AACGGGACATAGAATG"	-6.82767615738566	3.89736650073854	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACGGGACATAGAATG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2115.64355963658	52.0304293620277	0.0245931925181978	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2101.95989403902	2101.95989403902
"AML-0693"	"2021-03-09-AML0693:AACGTCAAGCTGAGTG"	8.36411346968953	6.70553729617921	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACGTCAAGCTGAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1714.6192250846	33.1008868681189	0.0193050949061216	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1708.60137486468	1708.60137486468
"AML-0693"	"2021-03-09-AML0693:AACGTCAGTCCTCAGG"	-6.90329156342204	3.87391469562379	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACGTCAGTCCTCAGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2575.96573366047	43.7414490790365	0.0169806020738015	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2557.75014604972	2557.75014604972
"AML-0693"	"2021-03-09-AML0693:AACTTCTAGACCATAA"	-6.90395532074626	-2.56833174144896	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTAGACCATAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2041.18323591863	36.9111802021395	0.0180832271951949	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2034.45403753468	2034.45403753468
"AML-0693"	"2021-03-09-AML0693:AACTTCTAGCTAGATA"	1.39676286753957	10.1341037520203	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTAGCTAGATA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1801.69523335976	49.3573372101898	0.0273949424388215	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1787.55084592319	1787.55084592319
"AML-0693"	"2021-03-09-AML0693:AACTTCTAGGCCACTC"	13.9250971275264	1.85629389369813	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTAGGCCACTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1230.55597638203	40.7921665995729	0.0331493791282103	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1213.7256241251	1213.7256241251
"AML-0693"	"2021-03-09-AML0693:AACTTCTCAGTATTCG"	11.5088039833004	-2.96917607700499	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTCAGTATTCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1945.44991616469	41.1251476683371	0.021139144897347	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1937.92606877366	1937.92606877366
"AML-0693"	"2021-03-09-AML0693:AACTTCTGTATCAGGG"	1.29307355460469	-10.4153127900329	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTGTATCAGGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2012.68147651551	49.6120275910776	0.0246497163957454	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2000.40938067881	2000.40938067881
"AML-0693"	"2021-03-09-AML0693:AACTTCTGTGCATGTT"	-2.89732370796855	3.40462849223939	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AACTTCTGTGCATGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3261.83396572616	29.2158266240803	0.00895687117464183	4651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3254.15747398621	3254.15747398621
"AML-0693"	"2021-03-09-AML0693:AAGAACAAGGCCCAAA"	-2.37483106079753	3.84402988040773	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGAACAAGGCCCAAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3591.09501704299	21.7609756125793	0.00605970477230588	4602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3586.16768120826	3586.16768120826
"AML-0693"	"2021-03-09-AML0693:AAGAACACAGTTGGTT"	9.57187618789021	7.44697091663209	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGAACACAGTTGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1850.01299581999	41.1730972663892	0.0222555719118827	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1846.40237777951	1846.40237777951
"AML-0693"	"2021-03-09-AML0693:AAGAACAGTGATACAA"	1.33111872252766	-10.4695224992004	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGAACAGTGATACAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2380.13381006498	45.8100794918547	0.0192468504493888	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2373.09982672764	2373.09982672764
"AML-0693"	"2021-03-09-AML0693:AAGACAAAGATCGCCC"	-7.18086705628093	-2.76854851162108	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGACAAAGATCGCCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2585.56985835508	8.27488129963386	0.00320040909855682	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2568.79139781933	2568.79139781933
"AML-0693"	"2021-03-09-AML0693:AAGACAATCAATGTCG"	-6.96365342560466	3.80416891658632	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGACAATCAATGTCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2380.17739429064	35.7830242577363	0.0150337635940789	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2365.27345140092	2365.27345140092
"AML-0693"	"2021-03-09-AML0693:AAGACTCAGGGCCAAT"	1.0384199815685	9.62917230213014	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGACTCAGGGCCAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1682.49031293727	35.9814416701586	0.0213858239738347	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1665.68993369715	1665.68993369715
"AML-0693"	"2021-03-09-AML0693:AAGACTCTCCTTATCA"	9.24918427047078	7.33535764301149	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGACTCTCCTTATCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1803.74467621028	51.5795681630713	0.0285958255862694	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1797.59941064787	1797.59941064787
"AML-0693"	"2021-03-09-AML0693:AAGATAGAGAATTCAG"	14.1758419471676	1.90977141940919	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGATAGAGAATTCAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1148.41915481067	39.5629735085082	0.0344499422034029	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1131.97914515624	1131.97914515624
"AML-0693"	"2021-03-09-AML0693:AAGATAGGTAATACCC"	8.25979198989217	7.16048381412355	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGATAGGTAATACCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1823.53021438488	43.9545391556646	0.0241040915082899	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1816.89159662125	1816.89159662125
"AML-0693"	"2021-03-09-AML0693:AAGATAGGTCGATGCC"	12.3442322212154	-2.84733869945677	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGATAGGTCGATGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1735.7167883403	31.45492495668	0.0181221528581039	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1727.99916188732	1727.99916188732
"AML-0693"	"2021-03-09-AML0693:AAGATAGGTCTCACGG"	0.863605518906754	9.31241891467897	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGATAGGTCTCACGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1814.49105600902	24.0683990425381	0.0132645454287753	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1811.11648418833	1811.11648418833
"AML-0693"	"2021-03-09-AML0693:AAGATAGTCGCAAGAG"	-1.39754424515422	8.83737275684205	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGATAGTCGCAAGAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1806.92954237573	50.3534239583131	0.0278668441560311	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1800.90672727412	1800.90672727412
"AML-0693"	"2021-03-09-AML0693:AAGCATCAGTGCCAGA"	-6.98445210877116	-2.67632987415465	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCATCAGTGCCAGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2240.78785384645	40.7651876749282	0.018192345877345	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2224.69705326869	2224.69705326869
"AML-0693"	"2021-03-09-AML0693:AAGCCATAGTAATTGG"	-5.11107764664348	1.98384103858797	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	70	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.8	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCCATAGTAATTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1534.13897504077	50.269519042071	0.0327672524197066	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1442.3342703971	1442.3342703971
"AML-0693"	"2021-03-09-AML0693:AAGCCATGTATAGCTC"	0.879311044781846	9.96861455524293	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCCATGTATAGCTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1378.82183234767	45.0498534324134	0.0326727154847182	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1378.82183234767	1378.82183234767
"AML-0693"	"2021-03-09-AML0693:AAGCGAGAGGCGTTGA"	9.41191067275349	7.10658500278322	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCGAGAGGCGTTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1706.92961898133	32.0174076490336	0.0187573097877	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1699.33679861963	1699.33679861963
"AML-0693"	"2021-03-09-AML0693:AAGCGAGGTCGGCCTA"	-8.21905742111858	-2.6061218014923	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCGAGGTCGGCCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1426.22283526223	33.5724292721838	0.0235393996240504	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1418.47984751676	1418.47984751676
"AML-0693"	"2021-03-09-AML0693:AAGCGAGTCCGGCTTT"	-9.62947307053264	-3.12934400951537	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCGAGTCCGGCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3010.70575530088	48.3116646417151	0.0160466244689153	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2999.6388773672	2999.6388773672
"AML-0693"	"2021-03-09-AML0693:AAGCGAGTCGCTGTTC"	11.8440090614254	-2.77801062976988	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCGAGTCGCTGTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1683.24158081505	43.6480798171496	0.0259309657714221	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1674.8503466738	1674.8503466738
"AML-0693"	"2021-03-09-AML0693:AAGCGTTAGCAATAAC"	-0.275199632078964	-9.59848406231078	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGCGTTAGCAATAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2993.19578454258	46.0189978449771	0.0153745365012966	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2983.67615102172	2983.67615102172
"AML-0693"	"2021-03-09-AML0693:AAGGAATGTCTTTCAT"	9.48355831679646	6.94995734775392	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGGAATGTCTTTCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1943.25283148381	49.7146695355041	0.0255832224865683	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1933.38619171043	1933.38619171043
"AML-0693"	"2021-03-09-AML0693:AAGGAATGTGAGATAT"	11.8275171714718	-2.83920004284056	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGGAATGTGAGATAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1750.02945388534	47.0719689326803	0.026897815250008	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1746.95118010129	1746.95118010129
"AML-0693"	"2021-03-09-AML0693:AAGGAATTCCGTGCGA"	8.34876312789265	6.63818786228029	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGGAATTCCGTGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1731.0949958996	42.3651665959527	0.0244730454979662	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1728.63199439056	1728.63199439056
"AML-0693"	"2021-03-09-AML0693:AAGGAATTCGGCCTTT"	-8.41481719437297	-4.40849068081053	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGGAATTCGGCCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2628.76406480686	51.8457237282654	0.0197224712641051	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2616.09402576425	2616.09402576425
"AML-0693"	"2021-03-09-AML0693:AAGGTAAAGTTTCGGT"	-4.77515969696696	3.68676230991212	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGGTAAAGTTTCGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2724.04446446696	38.4694771658308	0.0141221913473275	2674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2718.87407217774	2718.87407217774
"AML-0693"	"2021-03-09-AML0693:AAGTACCAGGTGCATG"	7.88836206969563	6.30147550189821	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTACCAGGTGCATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.80604284453	43.0348380435458	0.0243161323906307	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1766.3496233925	1766.3496233925
"AML-0693"	"2021-03-09-AML0693:AAGTACCCACACAGCC"	-0.308334301144439	9.93675897205202	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTACCCACACAGCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1727.10687672143	47.5873449039435	0.0275532137271543	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1721.40557917984	1721.40557917984
"AML-0693"	"2021-03-09-AML0693:AAGTACCCACGCTGAC"	-0.198287109762985	10.7221307524475	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTACCCACGCTGAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2005.6540822505	43.5261078204118	0.0217017023053009	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2003.61630484484	2003.61630484484
"AML-0693"	"2021-03-09-AML0693:AAGTACCTCTGTTCAT"	-6.22606835785564	-0.676387869474016	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	85	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.725	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTACCTCTGTTCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2017.13225178574	50.8635564396666	0.0252157767021165	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1874.14122041694	1874.14122041694
"AML-0693"	"2021-03-09-AML0693:AAGTCGTCAAAGGGTC"	-0.845101396471816	10.8231544264588	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTCGTCAAAGGGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1554.13615483577	49.3686981527389	0.0317660058284635	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1551.88183182476	1551.88183182476
"AML-0693"	"2021-03-09-AML0693:AAGTCGTGTGAGCAGT"	-7.18422780457194	-2.86191131984862	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTCGTGTGAGCAGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1953.71569864206	40.4596297136318	0.0207090672106251	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1937.41266767735	1937.41266767735
"AML-0693"	"2021-03-09-AML0693:AAGTGAAAGCACTTTG"	-8.64842830124553	-3.50556042110594	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTGAAAGCACTTTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3018.01206016498	52.2016517510968	0.0172967008449407	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3009.30060691307	3009.30060691307
"AML-0693"	"2021-03-09-AML0693:AAGTGAAAGCGACTAG"	-8.6896222633427	-3.57547881519469	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTGAAAGCGACTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3105.09242602987	33.0349667244445	0.0106389640603009	3261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3093.54855811586	3093.54855811586
"AML-0693"	"2021-03-09-AML0693:AAGTGAAGTAGCTGAG"	8.23718418654744	6.9450907477173	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTGAAGTAGCTGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1757.30839854745	40.4861403207183	0.0230387223746174	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1755.23208654146	1755.23208654146
"AML-0693"	"2021-03-09-AML0693:AAGTTCGGTTGGGACA"	11.167910237878	-2.82594706928404	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AAGTTCGGTTGGGACA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1525.84267402847	48.6149307622845	0.0318610375694456	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1517.03068470252	1517.03068470252
"AML-0693"	"2021-03-09-AML0693:AATAGAGGTCCGAAAG"	14.1671520667965	2.04210159862367	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATAGAGGTCCGAAAG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1117.22628247041	2.41280306006763	0.00215963685953793	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1100.99862298941	1100.99862298941
"AML-0693"	"2021-03-09-AML0693:AATAGAGTCAGTGGGA"	-7.88757834854777	-4.05198719417723	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATAGAGTCAGTGGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1543.65854498673	38.4145462396467	0.0248853908556422	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1537.13242096725	1537.13242096725
"AML-0693"	"2021-03-09-AML0693:AATAGAGTCATGAAAG"	8.24877800521199	6.0977482565674	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATAGAGTCATGAAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1519.01048976874	52.318343896998	0.0344423848613205	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1510.42900825822	1510.42900825822
"AML-0693"	"2021-03-09-AML0693:AATCACGCAGTAGTTC"	8.11877693709676	7.38686273181764	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCACGCAGTAGTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1815.94345090219	38.2171943505963	0.0210453658849396	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1812.73180805268	1812.73180805268
"AML-0693"	"2021-03-09-AML0693:AATCACGGTAGGACCA"	7.81456245955769	6.82371184909669	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCACGGTAGGACCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1579.42926857929	51.4204642912151	0.032556357738937	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1570.65243989088	1570.65243989088
"AML-0693"	"2021-03-09-AML0693:AATCGACCATTGACCA"	-6.96529040756877	-2.67892219936522	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGACCATTGACCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1982.87502939726	12.2645747861124	0.00618524849235733	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1959.26394150356	1959.26394150356
"AML-0693"	"2021-03-09-AML0693:AATCGACGTTGGACCC"	-7.68843398514445	-3.27722361004027	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGACGTTGGACCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3351.89533789581	13.6408719570837	0.00406959960917124	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3333.0788430148	3333.0788430148
"AML-0693"	"2021-03-09-AML0693:AATCGTGCAACCGTAT"	11.4231220680172	-2.38897826587828	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGTGCAACCGTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1550.89117921417	44.5979830663451	0.0287563587078642	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1544.97307498665	1544.97307498665
"AML-0693"	"2021-03-09-AML0693:AATCGTGCAACTCGTA"	-0.843143383890945	9.7469386824402	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGTGCAACTCGTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1587.81388867429	49.2051179445509	0.0309892225376827	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1581.6794390833	1581.6794390833
"AML-0693"	"2021-03-09-AML0693:AATCGTGCATAATGCC"	-2.14084897461589	3.85526249492494	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGTGCATAATGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3460.17890281027	20.8396299715481	0.00602270303267344	5494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3455.10421888994	3455.10421888994
"AML-0693"	"2021-03-09-AML0693:AATCGTGTCATAGACC"	8.04181303557698	6.74215266788331	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGTGTCATAGACC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1639.17244930489	50.6572920140407	0.0309041870704467	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1636.94251229838	1636.94251229838
"AML-0693"	"2021-03-09-AML0693:AATCGTGTCCATTGTT"	-7.20320306244548	4.421266532782	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATCGTGTCCATTGTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2143.58298445779	32.7484815801059	0.0152774498666724	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2131.98266029713	2131.98266029713
"AML-0693"	"2021-03-09-AML0693:AATGAAGAGACCTCAT"	-7.42421803894694	-3.03758981144103	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGAAGAGACCTCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3179.05382177459	1.58785279552988	0.000499473391942612	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3158.98022610847	3158.98022610847
"AML-0693"	"2021-03-09-AML0693:AATGAAGCAGGTACGA"	-6.96258340302165	3.89110109889833	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGAAGCAGGTACGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2482.01014961397	33.9472808103998	0.0136773335982045	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2468.96329461172	2468.96329461172
"AML-0693"	"2021-03-09-AML0693:AATGAAGGTGCGTTTA"	11.8753973442012	-2.88122012531432	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGAAGGTGCGTTTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1493.98243287737	31.0589219643235	0.0207893488442865	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1491.89969028877	1491.89969028877
"AML-0693"	"2021-03-09-AML0693:AATGACCCAACATCGT"	-2.50803337517436	3.32256791675416	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGACCCAACATCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3538.09212480028	26.0362740893861	0.00735884571995302	5215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3531.43127821474	3531.43127821474
"AML-0693"	"2021-03-09-AML0693:AATGACCCAATCCTAG"	9.37466873702351	7.52739760959474	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGACCCAATCCTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1918.65808045936	47.0859436067482	0.024541081126594	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1915.0942516225	1915.0942516225
"AML-0693"	"2021-03-09-AML0693:AATGACCGTCTGTAAC"	10.9060503440792	-2.95651414310607	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGACCGTCTGTAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1831.70761092833	41.6798028313675	0.0227546157381766	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1821.24344573436	1821.24344573436
"AML-0693"	"2021-03-09-AML0693:AATGACCTCACCTCAC"	-9.04423842850383	-3.150510810968	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGACCTCACCTCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2038.41812927938	43.0038294840515	0.0210966674924807	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2036.46177165876	2036.46177165876
"AML-0693"	"2021-03-09-AML0693:AATGCCAAGGGCAAGG"	-4.89031062546428	2.61380312526552	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCAAGGGCAAGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2958.79259514242	20.4187876634467	0.00690105406406962	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2956.0973853568	2956.0973853568
"AML-0693"	"2021-03-09-AML0693:AATGCCATCAAATAGG"	-7.4486816925114	-2.51687624370726	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCATCAAATAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1996.89733827582	42.0526581218314	0.0210589985352682	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1986.68872859626	1986.68872859626
"AML-0693"	"2021-03-09-AML0693:AATGCCATCCAATGCA"	11.9079290824825	-2.40066053783568	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCATCCAATGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1463.95410331352	31.4659257785009	0.0214937925357638	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1459.68538572315	1459.68538572315
"AML-0693"	"2021-03-09-AML0693:AATGCCATCCATTCGC"	0.816214938729447	9.74207398975221	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCATCCATTCGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1304.33242280102	45.5304155731839	0.0349070641634504	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1294.84125030599	1294.84125030599
"AML-0693"	"2021-03-09-AML0693:AATGCCATCCCGGTAG"	0.838595350354356	9.67279336536256	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCATCCCGGTAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1666.98765258781	42.4180218165743	0.0254459124221617	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1658.68553266762	1658.68553266762
"AML-0693"	"2021-03-09-AML0693:AATGCCATCCGGACGT"	-7.55247531357463	-2.53064706241759	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGCCATCCGGACGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2190.62925779053	32.2641725243767	0.0147282669623971	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2139.50873187784	2139.50873187784
"AML-0693"	"2021-03-09-AML0693:AATGGAACACAGAAGC"	-9.11231265488322	-2.60121300136717	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGAACACAGAAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3047.2311966959	40.5639123404736	0.0133117278349135	4396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3040.76070717741	3040.76070717741
"AML-0693"	"2021-03-09-AML0693:AATGGAAGTAAGATTG"	8.13231625136678	7.50004193866578	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGAAGTAAGATTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1902.51555523088	49.9370252591796	0.0262478932810194	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1892.25525387599	1892.25525387599
"AML-0693"	"2021-03-09-AML0693:AATGGAAGTCTACAGT"	8.42009224471394	6.3884067305359	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGAAGTCTACAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1500.66109150446	49.0014102753213	0.0326532156745637	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1492.50722250764	1492.50722250764
"AML-0693"	"2021-03-09-AML0693:AATGGAATCGAGAAAT"	14.1342684226925	1.9558477171692	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGAATCGAGAAAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1184.52097289958	17.7518043939473	0.0149864838192716	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1168.25742173909	1168.25742173909
"AML-0693"	"2021-03-09-AML0693:AATGGCTAGGGCATGT"	-8.25020823898967	-3.95545198833617	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGCTAGGGCATGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2780.98099166384	47.9690436379808	0.0172489649450216	2606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2769.35701361327	2769.35701361327
"AML-0693"	"2021-03-09-AML0693:AATGGCTAGGGCCCTT"	-8.61320338669475	-3.61076881801756	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGCTAGGGCCCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2973.10273598867	39.829356858887	0.0133965625798135	3616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2968.69416386984	2968.69416386984
"AML-0693"	"2021-03-09-AML0693:AATGGCTAGGTACTGG"	9.50523628768269	7.32309148395387	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATGGCTAGGTACTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1907.46991113586	51.5172373048082	0.0270081520049408	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1900.79787082013	1900.79787082013
"AML-0693"	"2021-03-09-AML0693:AATTCCTAGCTGAGTG"	-2.60393200340922	3.45761535251466	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTCCTAGCTGAGTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3363.02063863338	23.3818394371178	0.00695263037297905	4874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3355.39612973676	3355.39612973676
"AML-0693"	"2021-03-09-AML0693:AATTCCTAGGGTGGGA"	8.75766338881795	7.38706014240114	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTCCTAGGGTGGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2109.68282054727	41.7885235748912	0.0198079650494811	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2097.79954916118	2097.79954916118
"AML-0693"	"2021-03-09-AML0693:AATTCCTTCAAGGAGC"	9.3171144920284	7.09429023349611	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTCCTTCAAGGAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1904.36929149932	46.0787750169774	0.0241963442818905	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1899.37961281464	1899.37961281464
"AML-0693"	"2021-03-09-AML0693:AATTTCCCACAAATCC"	-5.02181230011638	2.70114753330079	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTTCCCACAAATCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2781.30791344569	30.1260797079097	0.0108316233388871	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2770.06934130441	2770.06934130441
"AML-0693"	"2021-03-09-AML0693:AATTTCCGTGCCTGCA"	1.14218213137929	-9.37693598186644	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTTCCGTGCCTGCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2793.04073457235	45.6286004119482	0.0163365323846358	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2787.154912608	2787.154912608
"AML-0693"	"2021-03-09-AML0693:AATTTCCTCCACTGAA"	9.86935581740681	6.75845906818239	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTTCCTCCACTGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1831.15177907263	35.7107657536299	0.0195018054547697	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1819.414697597	1819.414697597
"AML-0693"	"2021-03-09-AML0693:AATTTCCTCCGTGGTG"	-2.52392254296001	3.70475218379823	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTTCCTCCGTGGTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3358.20091328341	18.7524790765565	0.00558408491951177	4006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3348.58255744507	3348.58255744507
"AML-0693"	"2021-03-09-AML0693:AATTTCCTCGCCGAGT"	9.61830009993855	6.70499227130739	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AATTTCCTCGCCGAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1655.75753268821	45.2423202316752	0.027324242431935	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1653.68579651279	1653.68579651279
"AML-0693"	"2021-03-09-AML0693:ACAAAGAAGCTCGTGC"	-7.69726119461711	-2.63064315235289	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAAGAAGCTCGTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3479.70645731404	0	0	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3463.1530106959	3463.1530106959
"AML-0693"	"2021-03-09-AML0693:ACAAAGAAGGTCTGGA"	11.8513933616573	-2.716335319635	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAAGAAGGTCTGGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1581.88207890334	53.5027206832276	0.0338221928149783	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1565.51333714496	1565.51333714496
"AML-0693"	"2021-03-09-AML0693:ACAAAGAAGGTTCTTG"	-6.97977290573772	3.88487145984498	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAAGAAGGTTCTTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1907.86164281385	41.71360399439	0.0218640613440228	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1897.08426648288	1897.08426648288
"AML-0693"	"2021-03-09-AML0693:ACAAAGATCCCAGCGA"	-7.04046521607097	3.86246869647828	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAAGATCCCAGCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1999.40942263611	46.3920629424978	0.0232028830199932	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1984.98127014768	1984.98127014768
"AML-0693"	"2021-03-09-AML0693:ACAACCAAGCTATCCA"	0.925432761281174	9.24585912311403	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAACCAAGCTATCCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1897.94204156906	41.7585178598344	0.0220019984516029	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1897.94204156906	1897.94204156906
"AML-0693"	"2021-03-09-AML0693:ACAACCACAGCGATTT"	-7.79119143906291	2.64127752864686	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAACCACAGCGATTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2537.34512067148	42.1402621883074	0.0166080135670135	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2524.95434433954	2524.95434433954
"AML-0693"	"2021-03-09-AML0693:ACAACCATCCTTCAGC"	0.480345090001267	-8.33396913921507	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAACCATCCTTCAGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2226.24411814107	29.9984931893541	0.01347493428277	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2213.39012917571	2213.39012917571
"AML-0693"	"2021-03-09-AML0693:ACAACCATCTCATGCC"	8.11240067061726	6.46490810001222	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAACCATCTCATGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1722.06669229431	33.4168366593144	0.0194050769397282	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1718.00963593225	1718.00963593225
"AML-0693"	"2021-03-09-AML0693:ACAAGCTAGATACAGT"	-7.43797526779826	3.91384337032167	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAGCTAGATACAGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2180.53459396886	41.0133655368225	0.0188088579976036	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2175.66351519195	2175.66351519195
"AML-0693"	"2021-03-09-AML0693:ACAAGCTAGGTAGCAC"	-6.82189641419108	3.89910862529603	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAGCTAGGTAGCAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2575.30286030761	37.2129375103324	0.0144499266800361	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2559.64743789974	2559.64743789974
"AML-0693"	"2021-03-09-AML0693:ACAAGCTCACCTGCGA"	13.9218212562496	1.94617364490358	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAGCTCACCTGCGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1131.38664680471	45.0744183914864	0.0398399773576846	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1106.82248530147	1106.82248530147
"AML-0693"	"2021-03-09-AML0693:ACAAGCTTCCATACAG"	-8.67441211167033	-3.91351582920226	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAAGCTTCCATACAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3039.80680935965	45.1282454521089	0.0148457610244039	4072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3032.51297702018	3032.51297702018
"AML-0693"	"2021-03-09-AML0693:ACACAGTAGCCGATTT"	13.9148260551387	1.74836037242738	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTAGCCGATTT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1359.19096925259	44.9650805061432	0.0330822390108059	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1340.47353738006	1340.47353738006
"AML-0693"	"2021-03-09-AML0693:ACACAGTAGTGTAGTA"	11.8919578987056	-2.8568747273651	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTAGTGTAGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1437.14745174818	24.6833871535856	0.0171752641829202	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1433.77170933961	1433.77170933961
"AML-0693"	"2021-03-09-AML0693:ACACAGTCATCCTGTC"	14.1438642936641	1.96129450881807	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTCATCCTGTC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1256.03338339852	2.29846445419213	0.0018299389845619	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1242.64533003519	1242.64533003519
"AML-0693"	"2021-03-09-AML0693:ACACAGTCATGGAATA"	-7.12263856354411	4.13351008975831	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTCATGGAATA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2129.87787347158	39.296816238341	0.0184502673734478	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2114.26856359903	2114.26856359903
"AML-0693"	"2021-03-09-AML0693:ACACAGTCATGGAGAC"	1.00492664155309	10.5855283507141	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTCATGGAGAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1758.90506170451	19.0103770547323	0.0108080745621994	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1756.83251425036	1756.83251425036
"AML-0693"	"2021-03-09-AML0693:ACACAGTGTAGATCCT"	-6.03656516495402	-2.3629417649475	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTGTAGATCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1794.20403899276	37.0493289900371	0.0206494513360009	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1778.0941906359	1778.0941906359
"AML-0693"	"2021-03-09-AML0693:ACACAGTGTGGTCCCA"	-2.66791902008708	4.08188865268556	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACAGTGTGGTCCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3210.76203011459	40.6036315371706	0.0126461043068089	4317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3205.07872095213	3205.07872095213
"AML-0693"	"2021-03-09-AML0693:ACACCAACAATCCTTT"	9.45518745955769	7.73812244022218	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACCAACAATCCTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1896.13398681949	37.6837698148669	0.0198740015615016	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1891.1235952234	1891.1235952234
"AML-0693"	"2021-03-09-AML0693:ACACCAATCCGGCAAC"	-8.5040172142094	-3.2427926293579	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACCAATCCGGCAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3309.0090303019	49.8150911560612	0.0150543835631407	3822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3301.28544550557	3301.28544550557
"AML-0693"	"2021-03-09-AML0693:ACACCAATCTACCACC"	-6.01381526413615	4.36973760211793	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	67	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.75	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACCAATCTACCACC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2724.3897557142	33.7874145816826	0.0124018285235496	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2707.74096011979	2707.74096011979
"AML-0693"	"2021-03-09-AML0693:ACACGCGAGTAGGATT"	-8.39694819870647	-3.58044555103453	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACGCGAGTAGGATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2801.92014159677	44.3594643968099	0.0158318089578135	3058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2792.25012904774	2792.25012904774
"AML-0693"	"2021-03-09-AML0693:ACACGCGGTCTTCCGT"	13.9109960990841	1.83644638145296	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACGCGGTCTTCCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1613.04075697603	47.2526713382735	0.0292941583366177	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1608.51496702946	1608.51496702946
"AML-0693"	"2021-03-09-AML0693:ACACGCGGTGTCATTG"	-9.43163810196574	-2.25606157695922	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACGCGGTGTCATTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3128.70945614095	50.961936018915	0.0162884846718152	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3116.06983411125	3116.06983411125
"AML-0693"	"2021-03-09-AML0693:ACACTGAAGGCACTAG"	-7.09063039246257	4.06180808627931	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACTGAAGGCACTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1911.20811215459	43.669628861117	0.0228492274511572	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1894.52830316688	1894.52830316688
"AML-0693"	"2021-03-09-AML0693:ACACTGACAACAGTGG"	10.9458242851192	-2.48907067691954	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACTGACAACAGTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1780.03863157194	49.153994971763	0.0276140046063806	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1765.53502501235	1765.53502501235
"AML-0693"	"2021-03-09-AML0693:ACACTGACAGGCGATA"	8.48094906386678	8.21136567676393	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACTGACAGGCGATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2107.08948444468	40.6279747719961	0.0192815611638362	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2097.79282232916	2097.79282232916
"AML-0693"	"2021-03-09-AML0693:ACACTGAGTCGTTGGC"	-8.9475625557011	-4.03977587139281	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACTGAGTCGTTGGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2764.0734956074	50.2847974063147	0.0181922794333168	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2750.2648484703	2750.2648484703
"AML-0693"	"2021-03-09-AML0693:ACACTGAGTGCAAGAC"	-1.46040366116222	9.19099710071412	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACACTGAGTGCAAGAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1784.61725616885	51.0935737718809	0.0286299897612593	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1780.82449976777	1780.82449976777
"AML-0693"	"2021-03-09-AML0693:ACAGAAAAGGATTCCT"	-2.14615450325664	3.34547588908998	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGAAAAGGATTCCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2932.48158746348	36.5743690865812	0.0124721564298779	3897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2925.32619761853	2925.32619761853
"AML-0693"	"2021-03-09-AML0693:ACAGAAAAGTCACGCC"	-6.9285491508549	3.98262283885805	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGAAAAGTCACGCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2095.99312785867	47.9494408711507	0.0228767166427388	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2075.56219544352	2075.56219544352
"AML-0693"	"2021-03-09-AML0693:ACAGAAACATGTTCGA"	-8.29368243637736	-4.46380808269652	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGAAACATGTTCGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2005.36256111499	34.6292224477906	0.0172683100399244	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2003.45607396092	2003.45607396092
"AML-0693"	"2021-03-09-AML0693:ACAGAAAGTTTCTATC"	-7.18719182434733	-2.78441526806029	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGAAAGTTTCTATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2350.31746515102	5.18808915490174	0.00220739931172165	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2340.48066389408	2340.48066389408
"AML-0693"	"2021-03-09-AML0693:ACAGCCGAGAATCTAG"	-0.13445551219638	12.4733466872009	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGAGAATCTAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1780.83606698631	45.0504473675231	0.0252973579110858	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1778.82766554733	1778.82766554733
"AML-0693"	"2021-03-09-AML0693:ACAGCCGAGTCACGAG"	-1.7207809490269	3.80281016910402	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGAGTCACGAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3255.03325005115	14.4746534913154	0.00444685272910436	4126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3248.41202895838	3248.41202895838
"AML-0693"	"2021-03-09-AML0693:ACAGCCGCAAAGGTTA"	11.7838779884273	-2.76130821621092	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGCAAAGGTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1838.70824190667	47.7253891396686	0.0259559336559992	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1836.90136462647	1836.90136462647
"AML-0693"	"2021-03-09-AML0693:ACAGCCGCAAGCCTGC"	-7.64338479462321	-2.4980290166107	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGCAAGCCTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1471.57293731901	45.9019794929203	0.0311924596660134	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1469.04163115019	1469.04163115019
"AML-0693"	"2021-03-09-AML0693:ACAGCCGCATTCACCC"	-0.620249370962936	10.7762002714905	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGCATTCACCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1860.66413221271	52.6611570270211	0.0283023443701235	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1857.55291839925	1857.55291839925
"AML-0693"	"2021-03-09-AML0693:ACAGCCGGTCTTACAG"	-0.751507977873641	11.6585387953552	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGCCGGTCTTACAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1701.36106626126	48.0786990291662	0.0282589627696248	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1697.16200920407	1697.16200920407
"AML-0693"	"2021-03-09-AML0693:ACAGGGAAGAGAGCGG"	14.0352674919063	2.18090913379518	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGAAGAGAGCGG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1138.22362410553	41.0896463860354	0.0360998010547581	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1128.98278661313	1128.98278661313
"AML-0693"	"2021-03-09-AML0693:ACAGGGAAGCGGATCA"	-2.3599787754124	11.7958755263123	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGAAGCGGATCA"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1884.68614957018	45.0021720993211	0.0238778069810638	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1882.63684166159	1882.63684166159
"AML-0693"	"2021-03-09-AML0693:ACAGGGAAGTCCGTCG"	-7.20943580094035	-3.00802256977233	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGAAGTCCGTCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2341.7929460655	38.7165404206423	0.0165328623462168	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2328.59197817255	2328.59197817255
"AML-0693"	"2021-03-09-AML0693:ACAGGGAAGTCCTACA"	0.31027396497075	11.3046226271423	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGAAGTCCTACA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1881.06943252281	52.4427538911818	0.027879222842321	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1877.22619407052	1877.22619407052
"AML-0693"	"2021-03-09-AML0693:ACAGGGACACATTACG"	-7.2093394798344	-2.6906891099182	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGACACATTACG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2228.06488920622	23.7687003618275	0.010667867204844	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2198.63692617677	2198.63692617677
"AML-0693"	"2021-03-09-AML0693:ACAGGGACAGAACCGA"	7.99287666854207	7.03741405093995	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACAGGGACAGAACCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1772.93628337199	42.1420903956564	0.0237696587242861	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1769.43291394085	1769.43291394085
"AML-0693"	"2021-03-09-AML0693:ACATCCCAGCAGAAAG"	-7.68889937821086	-2.68950560009154	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCCCAGCAGAAAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2052.36776320603	20.2068548925566	0.0098456306198219	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2027.08912133225	2027.08912133225
"AML-0693"	"2021-03-09-AML0693:ACATCCCGTGAGACCA"	10.1258665519649	6.18374106967775	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCCCGTGAGACCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1761.03452393964	50.1321915349445	0.0284674666245571	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1752.76877601312	1752.76877601312
"AML-0693"	"2021-03-09-AML0693:ACATCGAAGCCAAGTG"	9.08949818190877	6.96897504413453	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCGAAGCCAAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1571.15416086115	41.5457433073809	0.0264428178611128	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1564.63115765205	1564.63115765205
"AML-0693"	"2021-03-09-AML0693:ACATCGACAAGAGGCT"	8.79500736769978	7.01650140369264	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCGACAAGAGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1951.73041769583	41.7479653150964	0.0213902314257023	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1946.41814034953	1946.41814034953
"AML-0693"	"2021-03-09-AML0693:ACATCGACACTCCACT"	-6.96168551865275	-2.64975740825804	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCGACACTCCACT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1261.53464216467	45.9366221267724	0.0364132863192324	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1250.12198553431	1250.12198553431
"AML-0693"	"2021-03-09-AML0693:ACATCGAGTTCAAGTC"	8.38784184035603	6.56385657871095	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCGAGTTCAAGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1912.97764714783	45.2370313058185	0.0236474437499387	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1911.25221628513	1911.25221628513
"AML-0693"	"2021-03-09-AML0693:ACATCGATCTGCTCTG"	-7.40425763550456	-2.36259343540343	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATCGATCTGCTCTG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1998.51770122449	20.018290710014	0.0100165691290844	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1977.02593989952	1977.02593989952
"AML-0693"	"2021-03-09-AML0693:ACATGCAAGCAGATAT"	-8.41366610947307	-3.47303583538207	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATGCAAGCAGATAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2276.15329143614	47.9795282764199	0.0210792166138104	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2270.08556005513	2270.08556005513
"AML-0693"	"2021-03-09-AML0693:ACATGCAAGCCTCAGC"	-6.9887412590092	-2.64026858722838	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATGCAAGCCTCAGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1880.52370127293	49.8431315706205	0.026504920696762	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1860.19294347726	1860.19294347726
"AML-0693"	"2021-03-09-AML0693:ACATGCAAGCTGGTGA"	-7.40279565277751	3.05604097926942	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATGCAAGCTGGTGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2382.33105221208	37.7766143998641	0.0158569961822843	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2370.9232915887	2370.9232915887
"AML-0693"	"2021-03-09-AML0693:ACATGCATCCGTTGGG"	-3.36404691162761	3.43085763538209	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATGCATCCGTTGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3352.47964698654	18.1874369275811	0.00542507005044141	4426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3348.48264838817	3348.48264838817
"AML-0693"	"2021-03-09-AML0693:ACATTTCAGTTCATGC"	-7.99817023697551	-2.72064115917357	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATTTCAGTTCATGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1460.16396383367	52.0072329504997	0.035617392456361	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1460.16396383367	1460.16396383367
"AML-0693"	"2021-03-09-AML0693:ACATTTCCACTATCCC"	9.14298691329305	7.5130953558716	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATTTCCACTATCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1686.60480315353	53.6626352316142	0.0318169586208213	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1671.67199147958	1671.67199147958
"AML-0693"	"2021-03-09-AML0693:ACATTTCCATAGATGA"	-7.27250371399577	-0.401816093083941	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACATTTCCATAGATGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3533.71148007786	30.3686877463856	0.00859399187443465	3724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3519.23917716299	3519.23917716299
"AML-0693"	"2021-03-09-AML0693:ACCAAACGTGTGGACA"	0.3184498148853	11.3973417052063	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCAAACGTGTGGACA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1870.18309024838	41.6153891863282	0.0222520401362421	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1866.38317216203	1866.38317216203
"AML-0693"	"2021-03-09-AML0693:ACCAACATCGGACTGC"	-7.83686194840129	-3.64390256321105	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCAACATCGGACTGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1543.17728545856	41.9178096081422	0.0271633142887314	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1536.91358885145	1536.91358885145
"AML-0693"	"2021-03-09-AML0693:ACCACAACACGTACAT"	-8.74817023697551	-4.02345707332762	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCACAACACGTACAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2842.44352117823	38.7135401071031	0.013619809793461	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2838.08657550742	2838.08657550742
"AML-0693"	"2021-03-09-AML0693:ACCACAAGTAGTACGG"	-6.89179358902629	-2.47312953388365	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCACAAGTAGTACGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2252.99043106967	44.9038351255359	0.0199307704579183	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2230.12967964077	2230.12967964077
"AML-0693"	"2021-03-09-AML0693:ACCACAAGTATGAGGC"	14.1042839485103	1.7247446545395	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCACAAGTATGAGGC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1326.33711212251	7.70812842282322	0.00581159069769832	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1294.0824907651	1294.0824907651
"AML-0693"	"2021-03-09-AML0693:ACCACAAGTGAGTTTC"	-9.07329688492473	-4.04792358791503	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCACAAGTGAGTTTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3111.00535114045	45.3657167781705	0.0145823332517059	3613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3094.06519579948	3094.06519579948
"AML-0693"	"2021-03-09-AML0693:ACCATTTAGGCATGCA"	-8.69804702225383	-3.80155422603758	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCATTTAGGCATGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2643.43715326392	46.6566687730563	0.0176500011416758	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2642.49038131234	2642.49038131234
"AML-0693"	"2021-03-09-AML0693:ACCATTTCACATGACT"	-8.30589423599895	-3.4053411713806	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCATTTCACATGACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2963.60258429145	48.6457810967729	0.0164144077058845	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2950.61717646504	2950.61717646504
"AML-0693"	"2021-03-09-AML0693:ACCATTTCATCCGGTG"	-8.13757071915324	-4.41022064602049	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCATTTCATCCGGTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3083.43889180079	50.8508010309509	0.0164915870932837	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3068.85778751982	3068.85778751982
"AML-0693"	"2021-03-09-AML0693:ACCATTTTCGTGCTCT"	7.75208916243855	6.84123895252077	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCATTTTCGTGCTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1898.0546595304	38.8190784206032	0.0204520339947467	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1876.91865195477	1876.91865195477
"AML-0693"	"2021-03-09-AML0693:ACCCAAAAGTCAAGCG"	-2.02441726151164	2.94307086551515	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCAAAAGTCAAGCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2033.46846377706	48.0453868000238	0.0236273085400016	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2018.90791175241	2018.90791175241
"AML-0693"	"2021-03-09-AML0693:ACCCAAACAAGGTACG"	14.1090465980465	1.88166604125825	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCAAACAAGGTACG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1367.41952802395	45.4032782731838	0.0332036199152397	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1346.44296087855	1346.44296087855
"AML-0693"	"2021-03-09-AML0693:ACCCAAACACAATGAA"	-6.87256131592448	3.83525440776674	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCAAACACAATGAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2415.75911900645	36.4183267565732	0.0150753137885499	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2399.02171813008	2399.02171813008
"AML-0693"	"2021-03-09-AML0693:ACCCAAAGTGCCAAGA"	10.3173204856807	6.22306773746339	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCAAAGTGCCAAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1621.42766334924	48.6957995934992	0.0300326685514373	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1610.41430674536	1610.41430674536
"AML-0693"	"2021-03-09-AML0693:ACCCTCAAGGGTCTTT"	8.08631672438924	6.25418851459352	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCTCAAGGGTCTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1523.12636555315	46.1248927897555	0.0302830374635426	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1515.98412229639	1515.98412229639
"AML-0693"	"2021-03-09-AML0693:ACCCTCACATTGCTTT"	9.52026238021199	6.99394605243532	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCTCACATTGCTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1739.16146147756	29.8667765566608	0.0171730901461481	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1737.28703486621	1737.28703486621
"AML-0693"	"2021-03-09-AML0693:ACCCTTGCATCTTCGC"	-8.49831614914592	-3.56079866802367	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCTTGCATCTTCGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2737.46951064827	43.7060440294016	0.0159658560065758	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2732.12982591676	2732.12982591676
"AML-0693"	"2021-03-09-AML0693:ACCCTTGGTCCAAAGG"	14.1552969413692	2.0465289124283	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCTTGGTCCAAAGG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1210.6703022508	1.39408086212218	0.00115149505156804	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1197.76426868807	1197.76426868807
"AML-0693"	"2021-03-09-AML0693:ACCCTTGTCAGCTGTA"	-4.67269263687785	10.6173000105652	"2021-03-09-AML0693"	"AML0693"	"gd T"	"gd T"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCCTTGTCAGCTGTA"	"gd T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"gd_T"	2392.55355893264	43.8407265698001	0.0183238224306912	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2385.66440542972	2385.66440542972
"AML-0693"	"2021-03-09-AML0693:ACCGTTCCACCTCTAC"	-7.06916938248332	3.2401437529358	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCGTTCCACCTCTAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2564.9737712141	42.5449595015044	0.0165868984622662	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2536.86403957544	2536.86403957544
"AML-0693"	"2021-03-09-AML0693:ACCGTTCTCGCTAATG"	8.95402683791463	7.67373035037843	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCGTTCTCGCTAATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1890.85360703256	52.3372469135874	0.0276791639072068	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1884.55056609804	1884.55056609804
"AML-0693"	"2021-03-09-AML0693:ACCTACCAGCCATTTG"	-5.78712497177775	-5.52995493328246	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTACCAGCCATTTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3780.13288751762	40.7915271073901	0.0107910299243944	5259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3763.55728355901	3763.55728355901
"AML-0693"	"2021-03-09-AML0693:ACCTACCAGGTTGCCC"	-5.79437766495402	-5.58508636867674	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTACCAGGTTGCCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3632.69043952391	47.7292727066057	0.0131388219010649	4576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3608.50677257904	3608.50677257904
"AML-0693"	"2021-03-09-AML0693:ACCTACCCAGCAGGAT"	-4.85669265213664	2.64653012836305	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTACCCAGCAGGAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3324.08899501444	42.110261394673	0.0126682111874354	3641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3308.5789753358	3308.5789753358
"AML-0693"	"2021-03-09-AML0693:ACCTACCGTCGGCACT"	-6.92946134033855	3.88399908626405	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTACCGTCGGCACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2400.48949088016	34.5218789690883	0.0143811831296252	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2383.2054991644	2383.2054991644
"AML-0693"	"2021-03-09-AML0693:ACCTACCTCACTTTGT"	8.60887779769246	6.44327590549318	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTACCTCACTTTGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1962.95805833484	39.1391790345203	0.0199388768742832	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1957.09818489782	1957.09818489782
"AML-0693"	"2021-03-09-AML0693:ACCTGAACAAGGTCGA"	-6.85394607010539	3.89193699443666	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTGAACAAGGTCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2301.6756075877	33.400236818973	0.0145112702714778	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2283.65124387896	2283.65124387896
"AML-0693"	"2021-03-09-AML0693:ACCTGAAGTACCGGCT"	8.64869370040242	6.25993726337282	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTGAAGTACCGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1664.38366499081	42.6547814830767	0.0256279741145574	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1658.18527736567	1658.18527736567
"AML-0693"	"2021-03-09-AML0693:ACCTGAATCTTGCAAG"	-6.96209655228313	3.81021497333375	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTGAATCTTGCAAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2621.29517040143	36.0045153221964	0.0137353914693562	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2606.13122632165	2606.13122632165
"AML-0693"	"2021-03-09-AML0693:ACCTGTCCAACCACAT"	9.55624260482137	7.2729544409546	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTGTCCAACCACAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1976.82633456979	42.0848371400771	0.0212890917143897	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1971.36790416929	1971.36790416929
"AML-0693"	"2021-03-09-AML0693:ACCTGTCCAGGGATAC"	-0.443529943854171	11.3624133833679	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACCTGTCCAGGGATAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1815.93034875826	50.504059043845	0.027811671895004	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1808.52494093427	1808.52494093427
"AML-0693"	"2021-03-09-AML0693:ACGATCAAGACCATTC"	9.2064548927242	7.57997176730958	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATCAAGACCATTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1684.1015889733	46.3912290736793	0.027546574017522	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1676.44204571752	1676.44204571752
"AML-0693"	"2021-03-09-AML0693:ACGATCACAACCGACC"	1.34251823005025	-10.0145206681457	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATCACAACCGACC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2470.73715050479	51.1987499036246	0.0207220545063502	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2466.76036091999	2466.76036091999
"AML-0693"	"2021-03-09-AML0693:ACGATCAGTACCTATG"	-6.27386699143107	-0.748753868695818	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	85	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.725	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATCAGTACCTATG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1757.74296702091	40.405821656136	0.0229873322859129	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1647.44437243479	1647.44437243479
"AML-0693"	"2021-03-09-AML0693:ACGATCATCGCAGTTA"	1.09921028193776	-9.36083986675414	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATCATCGCAGTTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2730.78573228765	33.2679649863932	0.0121825614485409	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2721.82793935513	2721.82793935513
"AML-0693"	"2021-03-09-AML0693:ACGATCATCGGACGTC"	-6.92887864533122	3.90891859615175	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATCATCGGACGTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2330.40528740027	39.9957040017797	0.0171625528907024	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2318.53056670132	2318.53056670132
"AML-0693"	"2021-03-09-AML0693:ACGATGTAGGAGAGTA"	8.56864990767781	6.65797374332277	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATGTAGGAGAGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1643.80742545133	43.9075561612686	0.0267108880769371	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1633.69834117634	1633.69834117634
"AML-0693"	"2021-03-09-AML0693:ACGATGTAGTGGATAT"	-7.15342507782634	-2.79732444202574	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATGTAGTGGATAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2515.69846320975	37.1534794501992	0.0147686537132894	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2508.77429595749	2508.77429595749
"AML-0693"	"2021-03-09-AML0693:ACGATGTGTAGGCTCC"	-3.67518458786662	2.90061614597169	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGATGTGTAGGCTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3311.07451276494	32.8266592020805	0.00991420128889468	3659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3306.20350615933	3306.20350615933
"AML-0693"	"2021-03-09-AML0693:ACGCACGAGGAAAGAC"	14.2707926231319	1.97996006095735	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGAGGAAAGAC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1475.24554496447	25.0347744023275	0.0169699034088121	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1460.84104061652	1460.84104061652
"AML-0693"	"2021-03-09-AML0693:ACGCACGAGGCCATAG"	-8.45734725418742	-0.0295496589508877	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGCACGAGGCCATAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2834.47165894357	34.327568604444	0.0121107468110082	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2815.21812337859	2815.21812337859
"AML-0693"	"2021-03-09-AML0693:CGAGTTAGTCTGCGCA"	14.1451336341793	2.11633107745973	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTAGTCTGCGCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1117.60578089499	5.03375431741823	0.00450405178952021	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1103.07151418045	1103.07151418045
"AML-0693"	"2021-03-09-AML0693:CGAGTTAGTTGCTTGA"	8.36877979811971	7.1492390402588	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTAGTTGCTTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1709.15740175153	46.7162377814902	0.0273329055203551	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1700.76477505566	1700.76477505566
"AML-0693"	"2021-03-09-AML0693:CGAGTTATCCATCTAT"	-2.05684290352519	3.88610241496889	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTATCCATCTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3191.52270530061	19.0700094199396	0.00597520719130945	4359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3185.0468218296	3185.0468218296
"AML-0693"	"2021-03-09-AML0693:CGATCGGCACTCTCGT"	11.4253479438717	-2.36354710971984	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATCGGCACTCTCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1385.98700439348	47.3652345496601	0.0341743713321377	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1378.67801095787	1378.67801095787
"AML-0693"	"2021-03-09-AML0693:CGATCGGGTCGCAGTC"	0.768226881592911	9.82156560504762	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATCGGGTCGCAGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1556.9480567138	43.6884980317184	0.0280603439808586	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1552.47876828767	1552.47876828767
"AML-0693"	"2021-03-09-AML0693:CGATCGGTCGTAGGAG"	10.9427801567012	-2.95093324100646	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATCGGTCGTAGGAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1974.0709278677	52.3771372827945	0.0265325508538691	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1968.48900825649	1968.48900825649
"AML-0693"	"2021-03-09-AML0693:CGATCGGTCTAATTCC"	8.37350239333455	6.33907697284547	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATCGGTCTAATTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1800.69488677463	44.5377525119998	0.0247336474597176	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1794.55776911302	1794.55776911302
"AML-0693"	"2021-03-09-AML0693:CGATGCGAGGTACAAT"	-6.9549449485844	3.81017634952394	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGCGAGGTACAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2322.18351193264	40.5754392758229	0.01747296846581	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2294.9614147693	2294.9614147693
"AML-0693"	"2021-03-09-AML0693:CGATGCGCATACTTTC"	-1.06330559673961	11.9472818144592	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGCGCATACTTTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2169.22123997589	40.6038651181227	0.0187181760762097	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2164.78855679094	2164.78855679094
"AML-0693"	"2021-03-09-AML0693:CGATGCGGTGGATCAG"	-6.92035899582561	3.84482262218324	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGCGGTGGATCAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2046.07027578465	42.1974104042392	0.0206236368826856	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2033.23419967804	2033.23419967804
"AML-0693"	"2021-03-09-AML0693:CGATGCGTCTGGACTA"	-8.08964477005656	4.81331584537355	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGCGTCTGGACTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1581.21734903883	49.598797225063	0.0313674759862788	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1575.56978528296	1575.56978528296
"AML-0693"	"2021-03-09-AML0693:CGATGGCGTTCCTAGA"	-7.32718835297282	-1.15870311176451	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGGCGTTCCTAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3628.03443709012	31.9345974622386	0.00880217594843225	4466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3615.86375334933	3615.86375334933
"AML-0693"	"2021-03-09-AML0693:CGATGGCTCCACTGAA"	-8.17726359787639	-4.83039810573729	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGGCTCCACTGAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2140.30932033862	42.0879908594508	0.0196644431061918	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2136.82836111085	2136.82836111085
"AML-0693"	"2021-03-09-AML0693:CGATGGCTCGACCAAT"	-7.80105243149455	0.580188012960829	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0412371134020619	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGATGGCTCGACCAAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2920.45001983466	52.1923618447375	0.0178713422555653	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2914.10156690025	2914.10156690025
"AML-0693"	"2021-03-09-AML0693:CGCAGGTCACGCTGAC"	-2.41250024262126	3.47844836795656	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCAGGTCACGCTGAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3619.28863999897	14.9815745786247	0.00413936993392959	5418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3608.9719236906	3608.9719236906
"AML-0693"	"2021-03-09-AML0693:CGCAGGTCATACCAGT"	-7.86779532852824	-4.84234239971312	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCAGGTCATACCAGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2347.84305845793	47.5649711275496	0.0202590079248271	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2341.19613553302	2341.19613553302
"AML-0693"	"2021-03-09-AML0693:CGCATAAAGCCTTGAT"	-6.88684258881267	3.83478639209596	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCATAAAGCCTTGAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2577.84594774849	35.3925830488295	0.0137295182746438	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2553.02713227974	2553.02713227974
"AML-0693"	"2021-03-09-AML0693:CGCATAAAGGTAAGTT"	8.3666635948116	6.33599422061769	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCATAAAGGTAAGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1862.8639888831	44.0867858056786	0.0236661324008476	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1854.24855933053	1854.24855933053
"AML-0693"	"2021-03-09-AML0693:CGCATAATCGTCAACA"	7.90820946273152	6.66111657703248	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCATAATCGTCAACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1425.66706574454	53.6281292996879	0.0376161662061549	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1418.26424091216	1418.26424091216
"AML-0693"	"2021-03-09-AML0693:CGCATGGGTATTAAGG"	-8.09696803513225	-2.52091410076293	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCATGGGTATTAAGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1419.50959568447	44.762863675218	0.031534033874307	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1416.39548048108	1416.39548048108
"AML-0693"	"2021-03-09-AML0693:CGCATGGTCGCTTAAG"	11.2646385627681	-2.45972921764525	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCATGGTCGCTTAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1729.53239694349	48.4697657716177	0.0280247804882266	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1721.77250562723	1721.77250562723
"AML-0693"	"2021-03-09-AML0693:CGCCATTAGGATATAC"	-7.47222361984904	-2.54206945812377	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCCATTAGGATATAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2396.22761837303	34.8232732516194	0.0145325398074092	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2385.25570002414	2385.25570002414
"AML-0693"	"2021-03-09-AML0693:CGCGTGACACCTCTGT"	12.087214131921	-3.05787565624388	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCGTGACACCTCTGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2337.67150409365	39.036034684278	0.0166986826916953	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2329.89610079505	2329.89610079505
"AML-0693"	"2021-03-09-AML0693:CGCGTGAGTACGAGTG"	-7.20780787888225	-2.78179242527159	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCGTGAGTACGAGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2666.20163720966	45.4786683589945	0.0170574752202878	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2646.76252545189	2646.76252545189
"AML-0693"	"2021-03-09-AML0693:CGCGTGATCCAGCTCT"	14.1591888862545	1.95685813510744	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCGTGATCCAGCTCT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1327.85952524462	3.52564422034364	0.00265513343340602	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1320.6801535547	1320.6801535547
"AML-0693"	"2021-03-09-AML0693:CGCGTGATCTCCTGAC"	-7.11854014816936	-2.75700619136962	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGCGTGATCTCCTGAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1978.89506127126	43.4501033675805	0.0219567496114058	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1967.68462234941	1967.68462234941
"AML-0693"	"2021-03-09-AML0693:CGGAACCCAAGGTTGG"	10.9292847114498	-3.05557849323424	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAACCCAAGGTTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1831.25469883748	43.9744148828379	0.0240132707431434	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1823.2599399804	1823.2599399804
"AML-0693"	"2021-03-09-AML0693:CGGAACCGTCAAGCGA"	10.7480551200802	6.07335898959962	"2021-03-09-AML0693"	"AML0693"	"Pre-B"	"Pre-B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAACCGTCAAGCGA"	"Pre-B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1724.45768743188	49.9110446742743	0.028943038172542	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1718.29885897048	1718.29885897048
"AML-0693"	"2021-03-09-AML0693:CGGAACCTCTTCCGTG"	-7.79524693909343	-2.69024493610533	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAACCTCTTCCGTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2018.67550032904	44.7686623577625	0.02217724560013	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2005.37063804649	2005.37063804649
"AML-0693"	"2021-03-09-AML0693:CGGAATTAGGCATCGA"	1.44118620929067	-10.5134353867737	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTAGGCATCGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2438.65123752318	48.1341891680812	0.0197380373328696	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2433.16577094906	2433.16577094906
"AML-0693"	"2021-03-09-AML0693:CGGAATTAGTCGCGAA"	-2.35725484314616	9.63046548450319	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTAGTCGCGAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2381.25976619403	42.8844769806096	0.0180091553174612	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2378.00390185068	2378.00390185068
"AML-0693"	"2021-03-09-AML0693:CGGAATTAGTGTCATC"	11.1780735450679	-2.38225366985472	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTAGTGTCATC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1988.59777204314	44.8490307126207	0.0225530931107006	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1983.16850720669	1983.16850720669
"AML-0693"	"2021-03-09-AML0693:CGGAATTGTCCTCCAT"	8.01727833327596	6.9156169661316	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTGTCCTCCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1813.20319735366	48.4680480982355	0.0267306213495397	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1801.62040140242	1801.62040140242
"AML-0693"	"2021-03-09-AML0693:CGGAATTTCACCTGGG"	-8.46031508866008	-3.34048774158629	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTTCACCTGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2643.35595331641	43.6115001237885	0.0164985347770029	2447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2636.09704972878	2636.09704972878
"AML-0693"	"2021-03-09-AML0693:CGGAATTTCCATCTCG"	9.83919872817342	7.10045478427736	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAATTTCCATCTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1785.01419495526	49.8907014936271	0.0279497505591981	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1772.28821903519	1772.28821903519
"AML-0693"	"2021-03-09-AML0693:CGGACACAGGAAGAAC"	0.0321397102320611	-10.1140680543152	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGACACAGGAAGAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2643.64908558602	41.3583061075072	0.0156444008900445	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2632.53697658105	2632.53697658105
"AML-0693"	"2021-03-09-AML0693:CGGACACCAATCCTAG"	11.5827480750972	-2.49255683338317	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGACACCAATCCTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1455.08467051867	48.5542535712831	0.0333686791944387	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1452.74896309798	1452.74896309798
"AML-0693"	"2021-03-09-AML0693:CGGACACTCATCACAG"	-2.6220727962559	4.00240466678468	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGACACTCATCACAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3708.52738037405	26.0493295908998	0.00702417076081353	5540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3701.87772378151	3701.87772378151
"AML-0693"	"2021-03-09-AML0693:CGGACACTCCACAAGT"	-8.36206469956096	-4.79169180309447	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGACACTCCACAAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2624.4310985024	49.6848204563941	0.0189316536009447	2692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2617.24298692611	2617.24298692611
"AML-0693"	"2021-03-09-AML0693:CGGACACTCGTCCTCA"	-6.99071870270427	3.90873596752015	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGACACTCGTCCTCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2192.95455792248	32.8669516639723	0.0149875206238241	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2184.66608609978	2184.66608609978
"AML-0693"	"2021-03-09-AML0693:CGGAGAAAGATCCCAT"	-6.91059146347697	-2.640012764093	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAGAAAGATCCCAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2018.34805487485	42.5332902516953	0.0210733179289697	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2007.71995004247	2007.71995004247
"AML-0693"	"2021-03-09-AML0693:CGGAGAACAACGGTAG"	-7.5959828895634	-2.56601669704589	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAGAACAACGGTAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2556.74253646383	49.7297601970939	0.0194504372215256	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2539.96323678649	2539.96323678649
"AML-0693"	"2021-03-09-AML0693:CGGAGAACATAGTCAC"	-3.13524494591411	-6.27445175563964	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	63	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00611995104039168	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGAGAACATAGTCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1424.76868895524	52.5512012299909	0.036884023096076	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1424.76868895524	1424.76868895524
"AML-0693"	"2021-03-09-AML0693:CGGGACTAGCAATAGT"	-8.46985469284709	-4.36037876522215	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGACTAGCAATAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2765.39340700137	50.2386381926115	0.0181669045949912	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2749.24001904472	2749.24001904472
"AML-0693"	"2021-03-09-AML0693:CGGGCATCACATACTG"	-7.56512151184733	-3.45824315464171	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGCATCACATACTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2253.93770230017	5.66702386848697	0.00251427706395954	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2240.93475495281	2240.93475495281
"AML-0693"	"2021-03-09-AML0693:CGGGCATCAGCTGTTA"	-6.98440680924113	3.91472694957582	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGCATCAGCTGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2262.66563661028	53.0091960831472	0.0234277637956975	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2238.41053730529	2238.41053730529
"AML-0693"	"2021-03-09-AML0693:CGGGCATGTTCCGCTT"	10.9985424476558	-2.59203817760619	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGCATGTTCCGCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1392.56601658895	47.614800251977	0.0341921314212507	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1386.63330236003	1386.63330236003
"AML-0693"	"2021-03-09-AML0693:CGGGCATTCCTCACCA"	-5.19749913635905	3.34133455837098	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGCATTCCTCACCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3012.43304837395	52.1659615396524	0.0173168866168861	3073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3003.50695892531	3003.50695892531
"AML-0693"	"2021-03-09-AML0693:CGGGTGTAGCATCAGG"	12.2179418998653	-2.68528106128844	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGTGTAGCATCAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1558.20434930772	33.3199319157348	0.0213835444179951	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1553.77147563733	1553.77147563733
"AML-0693"	"2021-03-09-AML0693:CGGGTGTAGGTGGTTG"	-6.78433118286784	3.8860656985077	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGTGTAGGTGGTTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2490.12278457064	44.3327171461601	0.0178034261687237	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2462.98900970046	2462.98900970046
"AML-0693"	"2021-03-09-AML0693:CGGGTGTGTTTGTGGT"	-2.79631863060649	3.47806332195131	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGGTGTGTTTGTGGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3417.34002397999	28.5640257640547	0.00835855535697842	4512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3408.04490197251	3408.04490197251
"AML-0693"	"2021-03-09-AML0693:CGGTCAGAGAAGGGAT"	1.43664469298665	-10.55957605755	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGTCAGAGAAGGGAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2245.66276657646	47.4973265178816	0.0211506942292551	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2232.09342113904	2232.09342113904
"AML-0693"	"2021-03-09-AML0693:CGGTCAGGTGTCCCTT"	-8.54668555679973	-3.2725925675598	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGGTCAGGTGTCCCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2753.12811255103	50.0983381927749	0.0181968786575479	2716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2748.84277680904	2748.84277680904
"AML-0693"	"2021-03-09-AML0693:CGTAAGTGTTGCCAAT"	-1.24517546120341	10.6768417128357	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAAGTGTTGCCAAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1456.72820520586	50.9667757539828	0.0349871551685788	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1456.72820520586	1456.72820520586
"AML-0693"	"2021-03-09-AML0693:CGTAAGTTCAGACCCG"	7.94569935378377	6.17147395694581	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAAGTTCAGACCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1616.13605063734	36.0125467152378	0.022283115769267	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1609.45267827209	1609.45267827209
"AML-0693"	"2021-03-09-AML0693:CGTAATGAGCCATGCC"	-8.84330974045451	-2.91405060207518	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGAGCCATGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2941.05064175321	50.4672280287192	0.0171595916480496	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2936.0764543364	2936.0764543364
"AML-0693"	"2021-03-09-AML0693:CGTAATGAGGCTTTCA"	7.90304579314534	6.4070138701233	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGAGGCTTTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1729.11128548254	45.7961212703822	0.0264853521313997	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1725.66998103538	1725.66998103538
"AML-0693"	"2021-03-09-AML0693:CGTAATGGTAAGGCCA"	1.06885530528371	-9.50486090099486	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGGTAAGGCCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2534.56822465277	52.1960895060759	0.0205936810058552	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2525.46681453356	2525.46681453356
"AML-0693"	"2021-03-09-AML0693:CGTAATGGTCCAAATC"	9.4981447654659	6.18022201145021	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGGTCCAAATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1485.46209249984	49.0871188244954	0.0330450161416696	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1483.20919934622	1483.20919934622
"AML-0693"	"2021-03-09-AML0693:CGTAATGGTCTGTGTA"	-1.64934287491496	3.75996611202089	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGGTCTGTGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3083.97867628526	0	0	3594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3078.37273230783	3078.37273230783
"AML-0693"	"2021-03-09-AML0693:CGTAATGGTTCTCTCG"	9.65152420577351	6.6928558119568	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAATGGTTCTCTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2086.76390189255	37.3931163113485	0.0179191887867313	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2077.50682630551	2077.50682630551
"AML-0693"	"2021-03-09-AML0693:CGTAGTAAGACCGTTT"	-8.87546477738078	1.56469891155092	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTAGTAAGACCGTTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2308.30945023105	51.4279221526551	0.0222794747677818	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2295.79594426411	2295.79594426411
"AML-0693"	"2021-03-09-AML0693:CGTCCATGTATCCCTC"	11.0052753883297	-2.70452668583068	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTCCATGTATCCCTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1630.21147157031	37.0148722315898	0.0227055648160389	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1628.16816636462	1628.16816636462
"AML-0693"	"2021-03-09-AML0693:CGTCCATGTTATTCCT"	1.21491636809651	-9.88243486797484	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTCCATGTTATTCCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2215.29555535143	37.9864863167894	0.0171473671876543	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2204.70048406833	2204.70048406833
"AML-0693"	"2021-03-09-AML0693:CGTCCATTCCTGCTAC"	11.5576597648555	-2.61022641575011	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTCCATTCCTGCTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1607.31714959068	40.0633170410853	0.0249255830134631	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1602.91317575481	1602.91317575481
"AML-0693"	"2021-03-09-AML0693:CGTCCATTCTATCCAT"	14.2264887290889	1.82672724807588	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTCCATTCTATCCAT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1316.39041064591	7.3781544631686	0.00560483759491104	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1288.10413895611	1288.10413895611
"AML-0693"	"2021-03-09-AML0693:CGTGAATCAATCACGT"	-2.22286353531535	3.84931132877199	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGAATCAATCACGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3387.10908559568	19.1725153190249	0.00566043632918692	5345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3382.10908407911	3382.10908407911
"AML-0693"	"2021-03-09-AML0693:CGTGAATTCGGTAGAG"	-7.09081397476848	4.13136861408082	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGAATTCGGTAGAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1608.28616142933	46.8214586218253	0.0291126416086387	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1602.24579921657	1602.24579921657
"AML-0693"	"2021-03-09-AML0693:CGTGATATCTAACGGT"	-7.4507716697758	-2.23842503940734	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGATATCTAACGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2507.71299336135	43.6424205116271	0.0174032756647835	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2498.52015901415	2498.52015901415
"AML-0693"	"2021-03-09-AML0693:CGTGCTTAGCATTGTC"	0.351133306592149	9.45877549732057	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGCTTAGCATTGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1551.99630982956	46.7823422417661	0.0301433334251314	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1532.13058221297	1532.13058221297
"AML-0693"	"2021-03-09-AML0693:CGTGCTTGTAGAGATT"	-0.977290491492111	10.1753253706726	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGCTTGTAGAGATT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1620.33620150549	41.2669169372576	0.0254681200721897	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1616.01903358947	1616.01903358947
"AML-0693"	"2021-03-09-AML0693:CGTGCTTTCCTTCTTC"	0.449435313313645	10.8372039564881	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGCTTTCCTTCTTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1609.79324088205	49.5224265883091	0.0307632218415668	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1600.04754282104	1600.04754282104
"AML-0693"	"2021-03-09-AML0693:CGTGTCTAGAAGCGGG"	-8.62440715256389	-5.11035158550414	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGTCTAGAAGCGGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2105.88136964717	40.9406909169584	0.0194411192895533	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2102.75310004278	2102.75310004278
"AML-0693"	"2021-03-09-AML0693:CGTGTCTCAATACCTG"	-7.01811252060588	-2.80281259929808	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGTCTCAATACCTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1878.26508636414	37.6820591735977	0.02006216238973	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1869.43137042614	1869.43137042614
"AML-0693"	"2021-03-09-AML0693:CGTGTCTGTGAATGTA"	-6.98727879944499	3.79766676509706	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGTCTGTGAATGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2100.09780922759	30.4989728076684	0.0145226439805134	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2096.01173717236	2096.01173717236
"AML-0693"	"2021-03-09-AML0693:CGTGTCTGTGTTCGTA"	-6.90872750702556	-2.62570860302123	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTGTCTGTGTTCGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1442.78014901412	49.8926620198384	0.0345809179963636	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1433.88699345812	1433.88699345812
"AML-0693"	"2021-03-09-AML0693:CGTTAGAAGCATGAAT"	-8.34856925430949	-3.62023212825926	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGAAGCATGAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2981.5384812431	48.1384314309185	0.0161455006312204	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2975.5308487157	2975.5308487157
"AML-0693"	"2021-03-09-AML0693:CGTTAGACAAGCAATA"	8.33561291274373	6.97556302631227	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGACAAGCAATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1898.02569804453	46.6098884216179	0.0245570375941898	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1886.9453060061	1886.9453060061
"AML-0693"	"2021-03-09-AML0693:CGTTAGACACTCTCGT"	-8.51228843155559	-4.10774710094603	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGACACTCTCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2767.32222602636	43.5354975417945	0.0157319943201222	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2760.89933808055	2760.89933808055
"AML-0693"	"2021-03-09-AML0693:CGTTAGACAGGAGACT"	0.719853778451127	10.9969405897888	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGACAGGAGACT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1710.78520761061	42.6452082977824	0.0249272720550018	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1708.72411048412	1708.72411048412
"AML-0693"	"2021-03-09-AML0693:CGTTAGATCCACTTCG"	-8.84169040146526	-4.84768345272215	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGATCCACTTCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2781.39988032789	47.4301893651428	0.0170526322736274	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2762.08287948084	2762.08287948084
"AML-0693"	"2021-03-09-AML0693:CGTTAGATCTGTACAG"	-2.41200981560405	4.13009831989137	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTAGATCTGTACAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3377.35469279301	34.4714902717929	0.0102066538481588	5411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3371.08133483029	3371.08133483029
"AML-0693"	"2021-03-09-AML0693:CGTTCTGGTATACAGA"	-6.91202626648601	-2.8770163289276	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTCTGGTATACAGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1883.09811746895	42.684203272681	0.0226670096882962	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1877.41884261507	1877.41884261507
"AML-0693"	"2021-03-09-AML0693:CGTTGGGAGGACAGCT"	-2.50111971321757	3.65059087360231	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTGGGAGGACAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3599.53597304857	31.6204315210136	0.00878458550151209	5592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3593.68907525383	3593.68907525383
"AML-0693"	"2021-03-09-AML0693:CGTTGGGAGGAGAGTA"	-8.99090991440471	-4.03793861782225	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGTTGGGAGGAGAGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2434.80729741443	46.4821022939634	0.0190906698625898	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2432.35167766012	2432.35167766012
"AML-0693"	"2021-03-09-AML0693:CTAACCCAGCAATTCC"	-1.24414382401164	9.98502633655397	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACCCAGCAATTCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1675.48634992674	46.8449056834855	0.0279589897497725	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1669.35154671479	1669.35154671479
"AML-0693"	"2021-03-09-AML0693:CTAACCCGTTCGCGTG"	-2.77527699890788	10.2237319716248	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACCCGTTCGCGTG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1917.06679398181	43.0436259900982	0.0224528566898262	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1913.14252422149	1913.14252422149
"AML-0693"	"2021-03-09-AML0693:CTAACCCGTTGACTAC"	-8.29410682144817	-3.76349213039549	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACCCGTTGACTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3003.07201446671	50.1447443358171	0.0166978161343633	2659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2997.22870059047	2997.22870059047
"AML-0693"	"2021-03-09-AML0693:CTAACCCTCAAACTGC"	-7.891340593726	-2.70552971279296	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACCCTCAAACTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2826.41181448864	14.1958233446188	0.00502256014917882	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2798.40989392049	2798.40989392049
"AML-0693"	"2021-03-09-AML0693:CTAACCCTCCACCTGT"	14.2705570655758	2.11591646755067	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACCCTCCACCTGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1249.08895851309	3.93603062546727	0.00315112114204637	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1238.41903281825	1238.41903281825
"AML-0693"	"2021-03-09-AML0693:CTAACTTAGTGATGGC"	-6.953445772559	3.92439649188844	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACTTAGTGATGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2264.22208588534	49.7216551008975	0.0219597076677466	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2244.1789202352	2244.1789202352
"AML-0693"	"2021-03-09-AML0693:CTAACTTTCACTTATC"	-6.96633658829387	-2.62714650547179	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACTTTCACTTATC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1778.22011391402	43.2383522000865	0.0243155230681286	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1764.51717349068	1764.51717349068
"AML-0693"	"2021-03-09-AML0693:CTAACTTTCCGTCACT"	-2.30735145035442	10.3341827162537	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACTTTCCGTCACT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2036.1850606806	40.0177464746333	0.0196532953941118	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2030.91214487903	2030.91214487903
"AML-0693"	"2021-03-09-AML0693:CTAACTTTCTGTGTGA"	-7.09388575974162	-2.76885964786681	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAACTTTCTGTGTGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.33112737432	35.2042795087661	0.0160505995056523	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2187.19930101367	2187.19930101367
"AML-0693"	"2021-03-09-AML0693:CTAAGTGAGACTACGG"	-7.96922526779826	-3.63920333301695	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAAGTGAGACTACGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1784.23728706924	45.3616311539205	0.0254235417467544	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1775.51730190424	1775.51730190424
"AML-0693"	"2021-03-09-AML0693:CTAAGTGAGGTTGTTC"	1.15476300296132	9.9170989760193	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAAGTGAGGTTGTTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1818.86719518448	46.9323639862689	0.0258030735341888	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1813.05955896649	1813.05955896649
"AML-0693"	"2021-03-09-AML0693:CTAAGTGCAACTGCCG"	-2.36169062081035	3.88206837261049	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAAGTGCAACTGCCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3369.96557678614	20.9989552618864	0.00623120764394057	4485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3360.91716708107	3360.91716708107
"AML-0693"	"2021-03-09-AML0693:CTAAGTGTCGGTTGTA"	-7.62141976776774	4.26381108844606	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	67	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.75	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAAGTGTCGGTTGTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1685.61247182106	45.6393919205783	0.0270758508753032	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1678.9734181123	1678.9734181123
"AML-0693"	"2021-03-09-AML0693:CTACAGAAGCTCGAAG"	-0.85230795565303	10.0414647825989	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACAGAAGCTCGAAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1698.12152604169	45.4863057703047	0.0267862488477682	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1695.89044589765	1695.89044589765
"AML-0693"	"2021-03-09-AML0693:CTACAGACACGTTCGG"	1.24685527858083	10.4334850081238	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACAGACACGTTCGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1863.08289498172	41.1181873882664	0.0220699720334612	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1855.07896519723	1855.07896519723
"AML-0693"	"2021-03-09-AML0693:CTACAGACATGTTCGA"	-0.829202453524429	9.61609265888063	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACAGACATGTTCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1853.22195999197	47.8907433064768	0.0258418820521014	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1849.51976851826	1849.51976851826
"AML-0693"	"2021-03-09-AML0693:CTACAGATCTCTGAGA"	8.35541214522664	7.00039241397706	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACAGATCTCTGAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1596.33507050859	43.6061913479005	0.0273164401092859	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1588.53867893278	1588.53867893278
"AML-0693"	"2021-03-09-AML0693:CTACATTAGTTGGCTT"	-7.08900914612468	-2.67627956783446	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACATTAGTTGGCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2104.87229752333	43.4050338021709	0.0206212195643616	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2086.95249160836	2086.95249160836
"AML-0693"	"2021-03-09-AML0693:CTACATTCAACTGTGT"	-6.93138728562053	3.63959977710573	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACATTCAACTGTGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2895.26384738275	38.2692464776841	0.0132178787478311	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2881.76001659613	2881.76001659613
"AML-0693"	"2021-03-09-AML0693:CTACATTGTGCTGATT"	-2.04618153992351	3.10572526538698	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACATTGTGCTGATT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2426.30117531197	23.9805081115376	0.00988356612754563	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2416.29104102071	2416.29104102071
"AML-0693"	"2021-03-09-AML0693:CTACATTTCTTCACAT"	11.9896418052608	-2.82131554996642	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACATTTCTTCACAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1823.75186749228	42.8470508066286	0.0234939037323892	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1815.44383683311	1815.44383683311
"AML-0693"	"2021-03-09-AML0693:CTACATTTCTTTGCAT"	-2.31484995308574	3.52861068332521	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACATTTCTTTGCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3167.95099923162	22.2812907217752	0.00703334449528403	4311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3160.21850950452	3160.21850950452
"AML-0693"	"2021-03-09-AML0693:CTACCCAAGGGATGTC"	-8.13213477554973	-3.79549600994261	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCAAGGGATGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2433.14637400659	48.5556525853554	0.0199559110393348	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2424.56286396282	2424.56286396282
"AML-0693"	"2021-03-09-AML0693:CTACCCACACCCTTGT"	1.37841810759847	-9.93274691021117	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCACACCCTTGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2727.25976588787	40.2039104086601	0.0147415038756206	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2715.83922132279	2715.83922132279
"AML-0693"	"2021-03-09-AML0693:CTACCCACATCGTTCC"	8.39495625075642	6.89192960346071	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCACATCGTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2047.28820799383	36.6992896181264	0.0179258052065315	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2035.009368835	2035.009368835
"AML-0693"	"2021-03-09-AML0693:CTACCCAGTAGTCTTG"	-2.34884963455852	3.6744084128174	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCAGTAGTCTTG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2203.32547970304	3.7020270133094	0.00168019979227415	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2199.73798038441	2199.73798038441
"AML-0693"	"2021-03-09-AML0693:CTACCCAGTTCGGCTG"	-7.14137015762981	4.16657493198244	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCAGTTCGGCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1560.53812236085	42.2995300144948	0.027105733213683	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1546.45593276218	1546.45593276218
"AML-0693"	"2021-03-09-AML0693:CTACCCATCAGTCCGG"	14.1365314918453	1.95778331840364	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCATCAGTCCGG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1181.66525392862	5.30478041103973	0.00448924125796474	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1166.44259087561	1166.44259087561
"AML-0693"	"2021-03-09-AML0693:CTACCCATCATTATCC"	-6.94469581070598	3.80050227725831	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCCATCATTATCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2299.70879970722	42.6068972480632	0.0185270836261911	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2286.51539818947	2286.51539818947
"AML-0693"	"2021-03-09-AML0693:CTACCTGCAGCAGGAT"	9.63166012343709	7.14451358402101	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCTGCAGCAGGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1965.0445803087	46.2212968267324	0.0235217548191559	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1952.54179568865	1952.54179568865
"AML-0693"	"2021-03-09-AML0693:CTACCTGCATCATTGG"	-7.61142669144328	-2.39560487186583	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCTGCATCATTGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2863.62645257164	3.70748535268534	0.00129468190565005	2535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2836.13153358927	2836.13153358927
"AML-0693"	"2021-03-09-AML0693:CTACCTGCATCGCTAA"	-7.13090835037883	3.32626793468324	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACCTGCATCGCTAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2787.60475901991	33.6409799511979	0.0120680594486521	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2768.789086493	2768.789086493
"AML-0693"	"2021-03-09-AML0693:CTACGGGAGGTTGACG"	-7.2031138938969	-2.89735367214354	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACGGGAGGTTGACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2470.93550645366	10.0259567455936	0.00405755501080766	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2458.42323350482	2458.42323350482
"AML-0693"	"2021-03-09-AML0693:CTACGGGCAGGCAATG"	-2.37059364739116	4.02520725810853	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACGGGCAGGCAATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3376.57863302985	22.9113146019173	0.00678536385256892	5181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3373.6843491985	3373.6843491985
"AML-0693"	"2021-03-09-AML0693:CTACGGGGTAGATCGG"	1.00252928313557	9.38322351062623	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACGGGGTAGATCGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1619.11689047312	50.5554616612526	0.031224096270455	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1619.11689047312	1619.11689047312
"AML-0693"	"2021-03-09-AML0693:CTACGGGGTGTAGTGG"	11.2271410423214	-3.00113060390624	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACGGGGTGTAGTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1957.29387663903	31.9059169497951	0.0163010354911969	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1950.06948044383	1950.06948044383
"AML-0693"	"2021-03-09-AML0693:CTACGGGTCTCTGACC"	-9.00877891007121	-3.85544373905333	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACGGGTCTCTGACC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2687.08182697168	48.5703617415634	0.0180755052764068	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2673.04832221446	2673.04832221446
"AML-0693"	"2021-03-09-AML0693:CTACTATCAACGTATC"	8.70453896102254	6.84110019290773	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACTATCAACGTATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1996.41116065035	47.2718584249829	0.0236784182320358	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1990.99584657595	1990.99584657595
"AML-0693"	"2021-03-09-AML0693:CTACTATCACGCTTAA"	-1.00605140152629	8.75499055469362	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTACTATCACGCTTAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1989.9189831031	41.7101667242834	0.0209607361296892	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1972.58426998938	1972.58426998938
"AML-0693"	"2021-03-09-AML0693:CTAGACAAGACTCTTG"	1.38331939753835	-9.91669657146605	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGACAAGACTCTTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1953.18782918653	48.555111143407	0.0248594172141802	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1943.35805067795	1943.35805067795
"AML-0693"	"2021-03-09-AML0693:CTAGACACAAGTCGTT"	11.9904371696407	-2.82699515735777	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGACACAAGTCGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1414.56955151053	24.4281223069477	0.0172689439560341	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1393.96677062498	1393.96677062498
"AML-0693"	"2021-03-09-AML0693:CTAGACAGTTTACTGG"	-0.723912517458755	11.853075958136	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGACAGTTTACTGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1824.1685974668	40.9353134516723	0.0224405318173543	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1814.22698359117	1814.22698359117
"AML-0693"	"2021-03-09-AML0693:CTAGACATCACGGGCT"	-7.80003295365031	-2.41719438945922	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGACATCACGGGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3337.8103732967	28.4604235596231	0.00852667478875179	2884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3316.71720933718	3316.71720933718
"AML-0693"	"2021-03-09-AML0693:CTAGGTACATGGGTCC"	-7.5104526084965	-2.89162328159484	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGGTACATGGGTCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1614.61000429086	14.6948024048594	0.00910114663343324	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1604.01312638645	1604.01312638645
"AML-0693"	"2021-03-09-AML0693:CTAGGTAGTCAGACTT"	-6.96981797638591	3.83450219714967	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGGTAGTCAGACTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2340.81803068124	32.7561205355546	0.0139934501982718	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2326.49744118307	2326.49744118307
"AML-0693"	"2021-03-09-AML0693:CTAGGTATCCATAGAC"	10.9898611503536	-2.8655040494171	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTAGGTATCCATAGAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1915.51702739129	46.0607583845754	0.0240461231750598	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1910.55399505613	1910.55399505613
"AML-0693"	"2021-03-09-AML0693:CTATAGGAGGCATGCA"	-8.97432647171672	-4.23193266307982	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATAGGAGGCATGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2739.74982535066	48.6655763962058	0.0177627810926047	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2725.76868293179	2725.76868293179
"AML-0693"	"2021-03-09-AML0693:CTATAGGCAAGAAATC"	7.97730173644368	6.70017812335817	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATAGGCAAGAAATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1550.05628257106	46.0443172176392	0.0297049324823651	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1545.64586292424	1545.64586292424
"AML-0693"	"2021-03-09-AML0693:CTATAGGCATTGTGCA"	-8.62312636795695	4.48541877353517	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATAGGCATTGTGCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1909.80113799243	49.4389456306518	0.0258869599808815	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1898.29398260961	1898.29398260961
"AML-0693"	"2021-03-09-AML0693:CTATAGGGTGCTGCAC"	-7.76094518128093	-2.67680337345275	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATAGGGTGCTGCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2654.13594595039	1.51427363278274	0.000570533561060872	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2628.21372646791	2628.21372646791
"AML-0693"	"2021-03-09-AML0693:CTATAGGTCCTATTGT"	-8.59503970566447	-4.33359672939452	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATAGGTCCTATTGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3048.85519865649	43.3984777407722	0.0142343518839124	3491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3034.26785196557	3034.26785196557
"AML-0693"	"2021-03-09-AML0693:CTATCCGAGGAACGTC"	1.14536847647969	10.5460996397766	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCCGAGGAACGTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1776.1626051625	21.0591399624886	0.0118565383041391	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1765.98440077784	1765.98440077784
"AML-0693"	"2021-03-09-AML0693:CTATCCGCACACAGAG"	9.27450241622273	7.7434420355591	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCCGCACACAGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2000.49923542705	47.0662202786688	0.023527237324148	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1990.89107437551	1990.89107437551
"AML-0693"	"2021-03-09-AML0693:CTATCCGTCTCCGATC"	-6.85077891770061	-2.79413463985594	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCCGTCTCCGATC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2706.16436292449	0.687869576481542	0.000254186178011072	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2694.0086009034	2694.0086009034
"AML-0693"	"2021-03-09-AML0693:CTATCTAAGCAATAGT"	-8.20840297165569	-4.21695949947508	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCTAAGCAATAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1866.23194269268	50.1689704902309	0.0268824947974286	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1854.56405757237	1854.56405757237
"AML-0693"	"2021-03-09-AML0693:CTATCTAAGGGAGGGT"	-8.37521682205852	-3.62693431293639	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCTAAGGGAGGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2014.38133169224	49.0411158642188	0.0243454975940531	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2009.59692032155	2009.59692032155
"AML-0693"	"2021-03-09-AML0693:CTATCTACAAACTCTG"	9.57047905501668	7.26203630054323	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCTACAAACTCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1752.50884746346	39.2912288728629	0.0224199888803598	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1741.99165155196	1741.99165155196
"AML-0693"	"2021-03-09-AML0693:CTATCTACATCGATGT"	11.3831688362056	-2.87009146129759	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTATCTACATCGATGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1592.72288515596	39.7260782048888	0.0249422410986445	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1591.26265281292	1591.26265281292
"AML-0693"	"2021-03-09-AML0693:CTCAACCAGCACCTGC"	9.96805061873738	6.74105260455934	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCAGCACCTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1835.49278214901	50.9485951695319	0.0277574478445406	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1826.64513982125	1826.64513982125
"AML-0693"	"2021-03-09-AML0693:CTCAACCAGTCTAGCT"	-8.38529334488567	-2.78261520778807	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCAGTCTAGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1557.00624706701	50.9203999092024	0.0327040434199432	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1552.12352228516	1552.12352228516
"AML-0693"	"2021-03-09-AML0693:CTCAACCCAAAGGATT"	10.3402887779171	6.60427186572877	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCCAAAGGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1867.99809627104	44.0772343094307	0.0235959738917395	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1854.45743269037	1854.45743269037
"AML-0693"	"2021-03-09-AML0693:CTCAACCCACTAACCA"	-8.38577018204387	-3.47577598011168	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCCACTAACCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2917.62787591317	44.8246065596634	0.0153633734204825	3121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2905.46858917332	2905.46858917332
"AML-0693"	"2021-03-09-AML0693:CTCAACCCAGTCACGC"	8.50218834456746	7.15775153720704	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCCAGTCACGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1940.75267328298	43.8942313132967	0.0226171175325731	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1930.2747786299	1930.2747786299
"AML-0693"	"2021-03-09-AML0693:CTCAACCTCCGGTAGC"	-6.97509656372722	3.91350052440492	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCTCCGGTAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2138.89339989778	43.9525794531349	0.0205492145869613	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2114.25517768057	2114.25517768057
"AML-0693"	"2021-03-09-AML0693:CTCAACCTCTAGTCAG"	9.23597683486287	7.62774131381837	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAACCTCTAGTCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1872.71616421406	51.1957768035648	0.0273377128802915	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1863.79686154627	1863.79686154627
"AML-0693"	"2021-03-09-AML0693:CTCAAGAAGGTGCTAG"	-7.04477057877238	3.86689827525941	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAAGAAGGTGCTAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1984.68116297455	51.6092576760919	0.0260038028469734	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1977.84590965047	1977.84590965047
"AML-0693"	"2021-03-09-AML0693:CTCAAGACAACGGCCT"	-8.41406760636028	-4.32428743755492	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAAGACAACGGCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2736.61702155941	50.937221385126	0.0186132078342845	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2724.51740641156	2724.51740641156
"AML-0693"	"2021-03-09-AML0693:CTCAAGACAGGCTTGC"	-8.49871573868449	-3.23586275493773	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAAGACAGGCTTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3071.13112561213	26.6790074316612	0.00868702974261432	4140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3062.63175555052	3062.63175555052
"AML-0693"	"2021-03-09-AML0693:CTCAAGACATATCGGT"	-8.43812785568889	-3.73435213482054	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAAGACATATCGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2932.50976435478	44.7257776687161	0.0152517063071252	3401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2919.94788259085	2919.94788259085
"AML-0693"	"2021-03-09-AML0693:CTCAATTAGCACACAG"	-7.10144696655925	-2.75050260936888	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAATTAGCACACAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1581.89563194064	46.9310866748684	0.0296676251753058	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1566.50156400344	1566.50156400344
"AML-0693"	"2021-03-09-AML0693:CTCAATTCAATCCTTT"	-8.49750934067424	-3.63401129161986	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAATTCAATCCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3006.77214173736	48.988648505213	0.0162927705179903	2736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2995.34936109992	2995.34936109992
"AML-0693"	"2021-03-09-AML0693:CTCAATTCATATACCG"	1.27711274203603	-9.61406423961791	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAATTCATATACCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2657.04039266945	38.7044982950442	0.0145667707581061	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2645.78483075933	2645.78483075933
"AML-0693"	"2021-03-09-AML0693:CTCAATTGTGCAGGAT"	8.63646378096883	6.65010020816652	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAATTGTGCAGGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1630.23799473157	38.048780853706	0.0233394025759846	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1627.93941619521	1627.93941619521
"AML-0693"	"2021-03-09-AML0693:CTCACTGAGACTTGTC"	-8.66888843002971	-3.11492946064147	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGAGACTTGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3033.41209263224	41.8262420468403	0.0137885129911728	3631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3023.7434801273	3023.7434801273
"AML-0693"	"2021-03-09-AML0693:CTCACTGAGCGATTCT"	-6.80404458466228	3.9177675017151	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGAGCGATTCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1909.86739133353	44.6832004250206	0.0233959701222091	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1892.08511305933	1892.08511305933
"AML-0693"	"2021-03-09-AML0693:CTCACTGAGGTAAACT"	-2.24870286408122	3.53213927829591	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGAGGTAAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2743.0721184352	37.4961580837281	0.0136694029412242	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2736.32540191132	2736.32540191132
"AML-0693"	"2021-03-09-AML0693:CTCACTGTCACCTTGC"	-2.17603645744975	3.46508095348207	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGTCACCTTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3296.14531531516	23.7454873104281	0.00720401712876473	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3290.88077682289	3290.88077682289
"AML-0693"	"2021-03-09-AML0693:CTCACTGTCCGCACTT"	1.21523882922475	-9.98183157360228	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGTCCGCACTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2625.80418852928	43.5418501196596	0.0165822913642496	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2616.98639544702	2616.98639544702
"AML-0693"	"2021-03-09-AML0693:CTCACTGTCGTAGCCG"	-6.81863532486613	3.92685411060182	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGTCGTAGCCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2058.8058275633	51.5327857783534	0.0250304254478165	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2044.66434232717	2044.66434232717
"AML-0693"	"2021-03-09-AML0693:CTCACTGTCTCCGCAT"	-8.10740886154826	-3.95571710979613	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCACTGTCTCCGCAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	2347.64624735855	40.8535188965442	0.0174019058205684	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2323.16095019296	2323.16095019296
"AML-0693"	"2021-03-09-AML0693:CTCAGAAAGGCCACTC"	10.9945599037105	-2.78530170833739	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGAAAGGCCACTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1870.7254914843	39.7873389427363	0.0212684004809106	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1858.39094777503	1858.39094777503
"AML-0693"	"2021-03-09-AML0693:CTCAGAAAGTATGGCG"	11.2677446800167	-2.44865682041319	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGAAAGTATGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1721.63528533402	51.4941343945983	0.0299100133653497	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1705.01114436002	1705.01114436002
"AML-0693"	"2021-03-09-AML0693:CTCAGAACAATTGTGC"	-7.7083629173344	-3.43501498615416	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGAACAATTGTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2417.07267007409	0	0	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2389.12553304083	2389.12553304083
"AML-0693"	"2021-03-09-AML0693:CTCAGAACAGTTTCAG"	8.51971497115437	7.35720107639161	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGAACAGTTTCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1948.22970051126	42.4066073716074	0.0217667389838472	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1938.16859765645	1938.16859765645
"AML-0693"	"2021-03-09-AML0693:CTCAGGGAGATTGGGC"	14.186223645776	1.85250041568605	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGGGAGATTGGGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1299.4345618567	10.0700196442229	0.0077495396380979	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1289.03288023035	1289.03288023035
"AML-0693"	"2021-03-09-AML0693:CTCAGGGAGATTTGCC"	-7.34771190109904	-2.99914624607237	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGGGAGATTTGCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3088.56759113579	30.1465134905662	0.00976067791978615	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3067.63235660887	3067.63235660887
"AML-0693"	"2021-03-09-AML0693:CTCAGGGAGGGTCACA"	1.14812459525411	9.67883870685426	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGGGAGGGTCACA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1644.84679608687	42.499683886597	0.0258380804751571	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1641.02938290492	1641.02938290492
"AML-0693"	"2021-03-09-AML0693:CTCAGGGCAGATTTCG"	-2.20845327797588	3.68114802921144	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGGGCAGATTTCG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1590.11109325512	49.6993551591284	0.0312552722699323	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1585.92317279418	1585.92317279418
"AML-0693"	"2021-03-09-AML0693:CTCAGTCAGATGGCGT"	0.334426780312699	-8.71952249920043	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGTCAGATGGCGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1770.60666108903	36.575370146532	0.0206569708283126	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1764.06436966778	1764.06436966778
"AML-0693"	"2021-03-09-AML0693:CTCAGTCAGCCTTTCC"	9.34043469008748	7.56566236102907	"2021-03-09-AML0693"	"AML0693"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGTCAGCCTTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1966.0656338648	43.8336431942302	0.0222951067549377	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1959.15009793664	1959.15009793664
"AML-0693"	"2021-03-09-AML0693:CTCAGTCCATCGTCCT"	0.915714819996995	9.7623252638611	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGTCCATCGTCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1772.46475699746	32.7732102457749	0.0184901900680341	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1766.98474000241	1766.98474000241
"AML-0693"	"2021-03-09-AML0693:CTCAGTCGTTGGATCT"	-7.59354577484782	-2.55260541355284	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCAGTCGTTGGATCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3168.37123215784	33.9510031788815	0.0107156013898532	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3138.40483379921	3138.40483379921
"AML-0693"	"2021-03-09-AML0693:CTCATCGTCCGTTGGG"	9.64234413680379	7.05025241458742	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATCGTCCGTTGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1645.08517717113	48.2970837300406	0.0293584091573251	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1638.79240657609	1638.79240657609
"AML-0693"	"2021-03-09-AML0693:CTCATGCCAGACCTGC"	14.023321767419	1.77678511226503	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATGCCAGACCTGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1238.78967229375	43.4492544917357	0.0350739560261952	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1222.77160207733	1222.77160207733
"AML-0693"	"2021-03-09-AML0693:CTCATGCGTGTCCATA"	-7.25861678543742	-2.84810259258422	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATGCGTGTCCATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2602.50504656094	37.1510258167806	0.0142751023156991	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2581.6295475794	2581.6295475794
"AML-0693"	"2021-03-09-AML0693:CTCATGCGTTGGGACA"	-6.50664315643962	-2.50817181980284	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATGCGTTGGGACA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1599.36492904051	42.080933353394	0.026311026701479	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1584.44957861153	1584.44957861153
"AML-0693"	"2021-03-09-AML0693:CTCATGCTCTGCGGCA"	-6.59708104553874	3.28936956012575	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATGCTCTGCGGCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2354.38776095617	50.6862487485962	0.0215284200797966	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2342.89767052434	2342.89767052434
"AML-0693"	"2021-03-09-AML0693:CTCATTAAGTATGCAA"	0.0446554269524336	9.5951823958191	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTAAGTATGCAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1609.88665862144	44.2090214742615	0.0274609527555922	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1598.17572237571	1598.17572237571
"AML-0693"	"2021-03-09-AML0693:CTCATTAGTCCATACA"	14.0828520255977	1.95847604358522	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTAGTCCATACA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1156.92365686937	2.84300966479014	0.00245738744117595	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1139.54484512027	1139.54484512027
"AML-0693"	"2021-03-09-AML0693:CTCATTATCCGTGTCT"	-7.20321164551433	-2.75869753276976	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTATCCGTGTCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1847.59963980157	44.6212063395293	0.0241509066024291	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1837.47532106312	1837.47532106312
"AML-0693"	"2021-03-09-AML0693:CTCATTATCCTTATGT"	-8.25226817551311	-3.78513219272765	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTATCCTTATGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3069.79357867254	46.5034009681676	0.0151487061837809	2848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3059.73288415072	3059.73288415072
"AML-0693"	"2021-03-09-AML0693:CTCATTATCTACACAG"	11.771633763879	-2.80011179363402	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTATCTACACAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1699.74851486501	24.8993399135267	0.0146488375755423	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1693.45206573203	1693.45206573203
"AML-0693"	"2021-03-09-AML0693:CTCATTATCTCAGAAC"	1.42110039767568	-9.9855642548767	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCATTATCTCAGAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2460.29303165313	46.8947728714798	0.0190606453248254	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2450.80083101806	2450.80083101806
"AML-0693"	"2021-03-09-AML0693:CTCCAACTCGTTCCTG"	9.06971802291219	6.87606380069581	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCAACTCGTTCCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1702.09107847861	49.3727351327148	0.0290071052935934	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1697.73727616207	1697.73727616207
"AML-0693"	"2021-03-09-AML0693:CTCCAACTCTGGGAGA"	6.80725397643392	-1.15627362644347	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCAACTCTGGGAGA"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2368.80167900191	22.6096764525893	0.00954477390530889	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2356.59415611695	2356.59415611695
"AML-0693"	"2021-03-09-AML0693:CTCCACACAGCTTCGG"	-7.12734065476115	-2.90381290828856	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCACACAGCTTCGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2303.63677252348	40.2194806264831	0.0174591242448459	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2284.8730002947	2284.8730002947
"AML-0693"	"2021-03-09-AML0693:CTCCACAGTAGGAGTC"	-0.337870637804824	13.070324874762	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCACAGTAGGAGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1979.86914237307	44.935491374628	0.0226961925982484	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1975.99775099759	1975.99775099759
"AML-0693"	"2021-03-09-AML0693:CTCCACATCCGCTGTT"	0.158970710902852	12.7671870955261	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ IFN+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCACATCCGCTGTT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2115.74200373328	52.1912304402521	0.0246680504277739	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2110.61026549408	2110.61026549408
"AML-0693"	"2021-03-09-AML0693:CTCCACATCGCTAATG"	-8.27291713181194	-4.47715189373168	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCACATCGCTAATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2253.19832486043	45.0241056915374	0.0199823092333989	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2243.12009961713	2243.12009961713
"AML-0693"	"2021-03-09-AML0693:CTCCATGAGTATGAGT"	8.0112530189449	6.99455020511476	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGAGTATGAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1642.44942395417	41.4960849970766	0.025264756644485	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1640.42068970528	1640.42068970528
"AML-0693"	"2021-03-09-AML0693:CTCCATGCAAACTAGA"	-8.32817016068156	-4.52007009899291	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGCAAACTAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1988.83456877865	50.7987353506943	0.0255419611807582	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1987.24454617327	1987.24454617327
"AML-0693"	"2021-03-09-AML0693:CTCCATGCAGCGGTTC"	14.2263103919918	2.18346521938173	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGCAGCGGTTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1113.20193533718	1.90660180646597	0.00171271873138495	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1107.99944293057	1107.99944293057
"AML-0693"	"2021-03-09-AML0693:CTCCATGCAGCTACTA"	-8.60492549362834	-3.35515930568846	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGCAGCTACTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3029.75970033059	53.0019880880147	0.0174937926866713	2926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3016.62225763925	3016.62225763925
"AML-0693"	"2021-03-09-AML0693:CTCCATGGTATCGATC"	7.62407984313313	7.07185313785402	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGGTATCGATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1810.67963724884	40.8817250793812	0.022578110582553	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1802.57991149456	1802.57991149456
"AML-0693"	"2021-03-09-AML0693:CTCCATGTCAGATGCT"	-7.52548680725749	-3.09169676220091	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGTCAGATGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2083.13495365624	46.7764991427234	0.0224548577904773	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2062.19069033783	2062.19069033783
"AML-0693"	"2021-03-09-AML0693:CTCCATGTCTCCCATG"	-0.320940534502822	12.4922284849915	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCATGTCTCCCATG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1918.0747063633	38.3616240986604	0.0200000677613828	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1918.0747063633	1918.0747063633
"AML-0693"	"2021-03-09-AML0693:CTCCCAAAGACCGTTT"	-6.90402779999431	3.67605135524598	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAAGACCGTTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2466.01170943882	29.4957857000329	0.0119609268630541	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2446.08324192126	2446.08324192126
"AML-0693"	"2021-03-09-AML0693:CTCCCAAAGACTAGAT"	-8.14662585678752	0.118539809528269	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAAGACTAGAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2791.16873604431	42.2739499499296	0.0151456088641351	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2777.90769760079	2777.90769760079
"AML-0693"	"2021-03-09-AML0693:CTCCCAAAGGTCCGAA"	7.80545057830159	6.99151227557985	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAAGGTCCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1729.20019440761	47.0785290463456	0.0272256093878556	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1723.15791730469	1723.15791730469
"AML-0693"	"2021-03-09-AML0693:CTCCCAACACAATTCG"	11.965520520776	-2.81900479709777	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAACACAATTCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2293.10600007222	34.6151393870912	0.015095307144982	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2286.98426895255	2286.98426895255
"AML-0693"	"2021-03-09-AML0693:CTCCCAACACAGCTGC"	-6.90205178681071	3.80797574603883	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAACACAGCTGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2245.99159183351	39.1546106142243	0.0174331064980793	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2229.02246150591	2229.02246150591
"AML-0693"	"2021-03-09-AML0693:CTCCCAAGTCCCACGA"	0.285857801407021	11.6658057936463	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAGTCCCACGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2056.65700540549	45.099590428517	0.0219285910630612	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2055.08113762852	2055.08113762852
"AML-0693"	"2021-03-09-AML0693:CTCCCAAGTCCCTAAA"	-6.93264041367229	3.87441847408143	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAGTCCCTAAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2255.63034986862	34.1177968950015	0.0151256152839887	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2240.58109576221	2240.58109576221
"AML-0693"	"2021-03-09-AML0693:CTCCCAAGTCTCGGAC"	-7.5190728706425	-2.40311791813048	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAAGTCTCGGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2551.46046249631	26.4301065883006	0.0103588148735967	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2525.6421817557	2525.6421817557
"AML-0693"	"2021-03-09-AML0693:CTCCCAATCGGCCTTT"	-2.31144247475322	3.33726236903993	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCAATCGGCCTTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3553.06615511529	27.8566046292974	0.00784015929148765	4835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3545.75271931549	3545.75271931549
"AML-0693"	"2021-03-09-AML0693:CTCCCTCAGAAGCCTG"	1.24395658549611	-10.3462887040344	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCTCAGAAGCCTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2554.16632399656	44.8992859220095	0.0175788418710942	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2547.46045827313	2547.46045827313
"AML-0693"	"2021-03-09-AML0693:CTCCCTCCAGTCAGCC"	12.5028044181759	-2.76476933872374	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCTCCAGTCAGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1812.41269502572	40.3109715587106	0.022241607371956	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1810.71777070534	1810.71777070534
"AML-0693"	"2021-03-09-AML0693:CTCCCTCTCCCGTGTT"	8.05328716811482	6.54594609821168	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCCTCTCCCGTGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1787.99857223207	40.4075800068502	0.02259933572341	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1787.99857223207	1787.99857223207
"AML-0693"	"2021-03-09-AML0693:CTCCGATAGACGGATC"	8.48147167739217	6.82923219287721	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCGATAGACGGATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1623.97385180835	48.038142902539	0.0295806135357703	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1615.71310301213	1615.71310301213
"AML-0693"	"2021-03-09-AML0693:CTCCGATAGGTTATAG"	12.2030445533687	-2.91853525554808	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCGATAGGTTATAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1864.22872168509	14.3502384570969	0.00769768123952385	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1863.50613158019	1863.50613158019
"AML-0693"	"2021-03-09-AML0693:CTCCGATGTCAACCTA"	-1.42183456841167	3.58296225154725	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCGATGTCAACCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2941.5252278749	17.1228516750068	0.00582107932060037	3279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2937.61216823689	2937.61216823689
"AML-0693"	"2021-03-09-AML0693:CTCCGATGTGTCCGTG"	-7.68813548508342	4.72242734515993	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCGATGTGTCCGTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1419.91331004548	35.9205545854382	0.0252977096075589	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1417.51618691403	1417.51618691403
"AML-0693"	"2021-03-09-AML0693:CTCCTCCCAGGTCCGT"	-8.12298808518108	-3.75847866451415	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTCCCAGGTCCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2344.89135476352	50.8882867415961	0.0217017673924293	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2336.7732804417	2336.7732804417
"AML-0693"	"2021-03-09-AML0693:CTCCTCCCAGGTGTTT"	-1.99022350731547	-9.00249483501586	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTCCCAGGTGTTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3092.30058524611	25.2039494246789	0.00815054964091501	3073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3086.32792500829	3086.32792500829
"AML-0693"	"2021-03-09-AML0693:CTCCTCCGTACACGCC"	9.32936920699422	7.47030017459718	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTCCGTACACGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1808.69083516736	46.589905320487	0.0257589104863109	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1793.41114815736	1793.41114815736
"AML-0693"	"2021-03-09-AML0693:CTCCTCCGTCCCTAAA"	7.62831606444661	6.75011680209962	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTCCGTCCCTAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1544.18064597676	52.8434826762955	0.0342210497288482	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1535.45506356576	1535.45506356576
"AML-0693"	"2021-03-09-AML0693:CTCCTCCGTTCAGGTT"	8.93963493880574	6.84164378726808	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTCCGTTCAGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2058.59299290409	38.3881961890179	0.0186477833750241	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2045.47227850795	2045.47227850795
"AML-0693"	"2021-03-09-AML0693:CTCCTTTAGACCGCCT"	-2.41193972054179	10.6976222761902	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTTTAGACCGCCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1975.6826245271	48.5937049835321	0.0245959064377374	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1963.57525583164	1963.57525583164
"AML-0693"	"2021-03-09-AML0693:CTCCTTTCATCCAATG"	10.2714477973873	7.48744247043458	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCCTTTCATCCAATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2232.00775717679	49.0103474014339	0.0219579646369267	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2218.80474234443	2218.80474234443
"AML-0693"	"2021-03-09-AML0693:CTCGAGGCATACAGGG"	-7.61166415634807	-3.01198699390563	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCGAGGCATACAGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1995.134588128	43.9158351708817	0.0220114650070235	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1981.45238348794	1981.45238348794
"AML-0693"	"2021-03-09-AML0693:CTCGAGGTCCATTCGC"	1.26160862025563	-10.1646671525207	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCGAGGTCCATTCGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2780.87409489008	25.4069735292987	0.00913632644353969	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2768.30687183739	2768.30687183739
"AML-0693"	"2021-03-09-AML0693:CTCGAGGTCGCAGTGC"	0.332738627761048	11.6950120695862	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCGAGGTCGCAGTGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1826.6237322377	44.9330172408829	0.0245989452824189	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1821.89548854612	1821.89548854612
"AML-0693"	"2021-03-09-AML0693:CTCTCAGCACTACCCT"	-8.97869525376018	-3.67534758960875	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTCAGCACTACCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2908.6696978061	48.134689286389	0.0165486955506482	3353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2896.58746988137	2896.58746988137
"AML-0693"	"2021-03-09-AML0693:CTCTCAGGTATGAGCG"	9.83931507644002	7.02917144382326	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTCAGGTATGAGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1633.41194526712	49.4160082472438	0.0302532428457064	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1627.21763256377	1627.21763256377
"AML-0693"	"2021-03-09-AML0693:CTCTCAGTCTGGGTCG"	-8.39529166641887	1.92196414554445	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTCAGTCTGGGTCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2540.43769947029	46.9385352963826	0.0184765543772909	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2522.07210790027	2522.07210790027
"AML-0693"	"2021-03-09-AML0693:CTCTCGACACTTGGCG"	-2.97941694679912	11.0610027083191	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTCGACACTTGGCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1820.18657965751	29.9597247114977	0.0164596998166721	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1818.02204625776	1818.02204625776
"AML-0693"	"2021-03-09-AML0693:CTCTCGATCCATTTGT"	-2.25984678688701	3.66489908778993	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTCGATCCATTTGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1747.46437332054	32.8098480025933	0.0187756892234935	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1742.62596631649	1742.62596631649
"AML-0693"	"2021-03-09-AML0693:CTCTGGTAGAGCATAT"	9.60550083693806	6.7309736975464	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTGGTAGAGCATAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1608.836674759	41.7349866820507	0.0259410960334445	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1606.86499801338	1606.86499801338
"AML-0693"	"2021-03-09-AML0693:CTCTGGTGTGATGAAT"	13.9579149681026	1.77771995151369	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTGGTGTGATGAAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1480.16221022273	49.1794782363827	0.0332257355962237	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1443.93747609655	1443.93747609655
"AML-0693"	"2021-03-09-AML0693:CTCTGGTTCGACGATT"	-3.21721086922343	10.6400394209656	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTCTGGTTCGACGATT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1910.66871965528	39.6245558084755	0.0207385798494804	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1906.66604620632	1906.66604620632
"AML-0693"	"2021-03-09-AML0693:CTGAATGAGCAGTACG"	0.239650164812249	-10.1610355607239	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAATGAGCAGTACG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2550.01681715437	45.040571919943	0.0176628528945174	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2544.98967633513	2544.98967633513
"AML-0693"	"2021-03-09-AML0693:CTGAATGAGGTACATA"	13.9556147056514	1.65914330566255	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAATGAGGTACATA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1225.92655103489	11.4831877384922	0.00936694594696428	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1206.54590875796	1206.54590875796
"AML-0693"	"2021-03-09-AML0693:CTGAATGCACAATTCG"	-0.432919363409835	10.9777908095154	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAATGCACAATTCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1903.67195233671	43.1946324872334	0.0226901659365276	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1895.73408472337	1895.73408472337
"AML-0693"	"2021-03-09-AML0693:CTGAATGGTGGACAGT"	-8.25271258774455	-0.364563726541124	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAATGGTGGACAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3181.4795740943	31.36803229034	0.00985957368570245	3228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3154.85596498442	3154.85596498442
"AML-0693"	"2021-03-09-AML0693:CTGAATGTCGCCTTTG"	8.08067287978474	6.03864381397096	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAATGTCGCCTTTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1575.93706855788	39.3728203961528	0.0249837516876118	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1569.172138057	1569.172138057
"AML-0693"	"2021-03-09-AML0693:CTGAGCGGTAGATGTA"	9.98067917403523	1.79368064487306	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245901639344262	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGCGGTAGATGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1508.05013219431	43.3231348846225	0.0287279142514875	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1503.75589907667	1503.75589907667
"AML-0693"	"2021-03-09-AML0693:CTGAGGCAGTCTCGTA"	14.279596944421	2.06803319537965	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCAGTCTCGTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1133.56456765339	38.986018635905	0.0343924111147991	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1120.19420588366	1120.19420588366
"AML-0693"	"2021-03-09-AML0693:CTGAGGCCACACAGCC"	-3.2222093147343	11.0698957213196	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCCACACAGCC"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	2151.4236736213	43.4851571377989	0.0202122704472264	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	2151.4236736213	2151.4236736213
"AML-0693"	"2021-03-09-AML0693:CTGAGGCCAGGTACGA"	1.32384028014485	9.89468286121217	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCCAGGTACGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1840.18836396877	29.9781014299612	0.0162907787142545	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1831.80969822478	1831.80969822478
"AML-0693"	"2021-03-09-AML0693:CTGAGGCCATCAGTGT"	-6.84421382370647	3.90493152225343	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCCATCAGTGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2342.51440737409	45.4481133365309	0.0194014231858994	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2332.43960677628	2332.43960677628
"AML-0693"	"2021-03-09-AML0693:CTGAGGCGTCATCCCT"	8.70317425307576	7.48853108966676	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCGTCATCCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1858.76547776855	39.1936870755098	0.0210858699197285	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1847.693244577	1847.693244577
"AML-0693"	"2021-03-09-AML0693:CTGAGGCTCAGATTGC"	-8.70423255387004	-3.79707696354064	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGAGGCTCAGATTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3254.08812713801	50.4212955190312	0.0154947541520263	2972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3245.32795114006	3245.32795114006
"AML-0693"	"2021-03-09-AML0693:CTGATCCTCCACACCT"	-6.88091407242473	-2.71742536937865	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGATCCTCCACACCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1963.86802874068	51.5699465537806	0.026259374764021	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1955.434471961	1955.434471961
"AML-0693"	"2021-03-09-AML0693:CTGATCCTCCGATGTA"	-0.799298624426681	11.6298122175964	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGATCCTCCGATGTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1709.49731801734	49.5280467554461	0.0289722869017943	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1705.33946815967	1705.33946815967
"AML-0693"	"2021-03-09-AML0693:CTGCAGGGTCGTCAGC"	9.17450680312459	6.91117856586305	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCAGGGTCGTCAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1799.12495730608	38.9286724253106	0.0216375590073524	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1793.60400081945	1793.60400081945
"AML-0693"	"2021-03-09-AML0693:CTGCAGGTCCATGAGT"	-2.04292593422588	4.02592585170595	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCAGGTCCATGAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3452.41118892097	25.6021140588475	0.00741571981373667	5700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3447.76614024882	3447.76614024882
"AML-0693"	"2021-03-09-AML0693:CTGCAGGTCCTGCCAT"	-7.49094376984294	-3.09523084079894	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCAGGTCCTGCCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1351.36661198105	45.1876316728234	0.0334384698217312	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1339.19088013931	1339.19088013931
"AML-0693"	"2021-03-09-AML0693:CTGCATCCAAAGCAAT"	-2.92439399185832	3.64218447292177	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCATCCAAAGCAAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1880.50822193834	48.3511233762696	0.0257117319734085	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1874.70294914135	1874.70294914135
"AML-0693"	"2021-03-09-AML0693:CTGCATCCATAATGAG"	-7.56125960770305	-4.69557144558104	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCATCCATAATGAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2926.8507771527	37.5586305361851	0.0128324377960679	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2922.96723941627	2922.96723941627
"AML-0693"	"2021-03-09-AML0693:CTGCCATCAGTTCTAG"	-6.87060437622722	-2.43981101429137	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCATCAGTTCTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1453.24100446305	38.4448648210728	0.0264545692717207	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1448.26740268433	1448.26740268433
"AML-0693"	"2021-03-09-AML0693:CTGCCATCATTACTCT"	-3.09812126579936	13.0669173964295	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	26	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000974658869395711	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCATCATTACTCT"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	2451.62612613112	34.2175806597441	0.0139570957802373	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	2446.80825704017	2446.80825704017
"AML-0693"	"2021-03-09-AML0693:CTGCCATTCAGGAAAT"	-7.27491555634196	-2.62300255214842	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCATTCAGGAAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3063.63888256894	0.255825810713466	8.35039051661824e-05	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3042.33121720787	3042.33121720787
"AML-0693"	"2021-03-09-AML0693:CTGCCATTCTGAGAAA"	-7.63417993012126	-3.4723692170349	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCATTCTGAGAAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1795.62512953116	43.4945208205417	0.0242224950549106	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1786.27859238439	1786.27859238439
"AML-0693"	"2021-03-09-AML0693:CTGCCTAAGCGTATGG"	-8.04918990555461	2.49728796565858	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCTAAGCGTATGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2574.93699568808	43.1468133612682	0.016756454015582	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2560.44718944633	2560.44718944633
"AML-0693"	"2021-03-09-AML0693:CTGCCTACATGAAAGT"	9.14977039870564	7.20675084674684	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCCTACATGAAAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1673.45038008408	34.6094676853763	0.0206815021809235	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1663.21644490669	1663.21644490669
"AML-0693"	"2021-03-09-AML0693:CTGCGAGTCCGGGACT"	-4.68941960755046	3.26491592014161	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCGAGTCCGGGACT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1434.74792256569	47.7078573781378	0.0332517347666371	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1432.57536682994	1432.57536682994
"AML-0693"	"2021-03-09-AML0693:CTGCGAGTCTCAGGCG"	10.9711233573848	-2.00686337864073	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCGAGTCTCAGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1297.46547914193	13.9893263501804	0.0107820412759129	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1297.46547914193	1297.46547914193
"AML-0693"	"2021-03-09-AML0693:CTGCTCACACGACGAA"	-7.12801347199138	4.07230041110841	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCTCACACGACGAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2232.02067363989	47.8325698738426	0.0214301643523038	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2217.16232954338	2217.16232954338
"AML-0693"	"2021-03-09-AML0693:CTGCTCAGTGCATTTG"	8.18989529189412	7.18264482105104	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCTCAGTGCATTTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1771.7009214256	51.4024595517918	0.029013056848461	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1765.83803782123	1765.83803782123
"AML-0693"	"2021-03-09-AML0693:CTGCTCAGTTCCTACC"	-2.59192500534709	3.41870257938234	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGCTCAGTTCCTACC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1714.76534391149	47.6296093145721	0.0277761674410365	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1714.76534391149	1714.76534391149
"AML-0693"	"2021-03-09-AML0693:CTGGACGCAGGAATCG"	-2.51973710480388	3.47651145541994	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGACGCAGGAATCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3227.51052466379	28.3433961942342	0.00878181371606425	4101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3225.0861054231	3225.0861054231
"AML-0693"	"2021-03-09-AML0693:CTGGACGGTCATAGTC"	-7.03282056275066	-2.8500764600006	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGACGGTCATAGTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2522.29328575734	45.8714890988293	0.0181864216020604	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2513.13541802028	2513.13541802028
"AML-0693"	"2021-03-09-AML0693:CTGGACGGTCTTCCGT"	14.3083025413448	1.94888875568239	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGACGGTCTTCCGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1302.82815503	6.01295803945055	0.00461531170955703	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1293.02638334097	1293.02638334097
"AML-0693"	"2021-03-09-AML0693:CTGGACGTCCGATCGG"	1.30020167407338	-9.78093721782836	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGACGTCCGATCGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2332.96777407152	36.1148875577707	0.0154802342146127	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2325.98011756418	2325.98011756418
"AML-0693"	"2021-03-09-AML0693:CTGGCAGGTACAAAGT"	-8.47974620285686	-3.39618089115294	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGCAGGTACAAAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2865.2774093582	49.060259128107	0.0171223417906667	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2859.15590886207	2859.15590886207
"AML-0693"	"2021-03-09-AML0693:CTGGCAGGTCAAGCCC"	-6.98685965958293	4.04061529720155	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGCAGGTCAAGCCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1861.91669886329	26.2660420157964	0.0141069909474639	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1850.02661164449	1850.02661164449
"AML-0693"	"2021-03-09-AML0693:CTGGCAGGTGGCTCTG"	-7.08266530457194	-2.67085125362548	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGCAGGTGGCTCTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2519.41187335128	34.9183954555374	0.0138597407692175	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2512.8736087221	2512.8736087221
"AML-0693"	"2021-03-09-AML0693:CTGGCAGTCACTCACC"	11.5106979804928	-1.70173277771147	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGCAGTCACTCACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1434.52511970618	43.0687488360532	0.0300230008135895	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1423.47215003077	1423.47215003077
"AML-0693"	"2021-03-09-AML0693:CTGGTCTAGGGTTGCA"	-8.53198085251506	-3.57027270710143	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGTCTAGGGTTGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2907.30441658086	41.3574033267657	0.0142253432736171	3019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2897.78907697022	2897.78907697022
"AML-0693"	"2021-03-09-AML0693:CTGGTCTCAGAGATGC"	14.2644697624141	2.07013628566591	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGTCTCAGAGATGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1201.72402548291	6.77716344744024	0.00563953395599031	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1177.14602699469	1177.14602699469
"AML-0693"	"2021-03-09-AML0693:CTGGTCTGTACGCGTC"	-7.02198491516765	-2.64317777073058	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGTCTGTACGCGTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2440.12703104873	47.9995486958885	0.0196709220811586	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2430.75155816662	2430.75155816662
"AML-0693"	"2021-03-09-AML0693:CTGGTCTTCCCGGTAG"	0.552552183240098	8.66317365253297	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGTCTTCCCGGTAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1556.57886464304	49.3067986820716	0.0316763896787066	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1545.27112318056	1545.27112318056
"AML-0693"	"2021-03-09-AML0693:CTGGTCTTCTGTCAGA"	-8.34978805008586	-4.45857241069945	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGGTCTTCTGTCAGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2197.68697869606	51.7487706079292	0.0235469250669324	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2186.35714640205	2186.35714640205
"AML-0693"	"2021-03-09-AML0693:CTGTACCAGAAGCGCT"	-8.85133777085002	-4.11812403118285	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTACCAGAAGCGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2743.92743416768	52.1600470786004	0.0190092662178664	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2730.62439684621	2730.62439684621
"AML-0693"	"2021-03-09-AML0693:CTGTACCCACCTGTCT"	1.08293380317037	10.3106908568176	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTACCCACCTGTCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2094.56433150268	40.8473476977077	0.019501596147397	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2086.91529401143	2086.91529401143
"AML-0693"	"2021-03-09-AML0693:CTGTACCTCTCGGTAA"	-2.55735240402873	3.43178532207338	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTACCTCTCGGTAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2927.94504722189	33.997506231477	0.011611388083849	2923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2914.44086654946	2914.44086654946
"AML-0693"	"2021-03-09-AML0693:CTGTAGAGTACAAACA"	1.24950565871541	9.49668119037477	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTAGAGTACAAACA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1574.94066497341	43.56044894082	0.027658469877375	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1570.74084716618	1570.74084716618
"AML-0693"	"2021-03-09-AML0693:CTGTATTCAACTTCTT"	-7.61126456680949	-3.42825653469237	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTATTCAACTTCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1851.75392784806	24.0980974648849	0.0130136607799124	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1835.57842240444	1835.57842240444
"AML-0693"	"2021-03-09-AML0693:CTGTATTCAATTGAAG"	-9.73127780380901	-2.91182162677916	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTATTCAATTGAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3161.68399286874	45.626271104204	0.0144310029740845	3608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3152.67600853614	3152.67600853614
"AML-0693"	"2021-03-09-AML0693:CTGTATTCAGATGCGA"	10.7501379447872	5.91179368579713	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTATTCAGATGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1630.99075982538	46.318361838131	0.0283989112501717	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1618.14188333957	1618.14188333957
"AML-0693"	"2021-03-09-AML0693:CTGTCGTCACGGTAGA"	13.9948994117672	1.68048784816591	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTCGTCACGGTAGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1245.53586917885	1.83074536819899	0.00146984556085562	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1238.46833153315	1238.46833153315
"AML-0693"	"2021-03-09-AML0693:CTGTCGTGTGAACCGA"	-3.74159369888957	2.78364751422731	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTCGTGTGAACCGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2730.24056756704	27.8831698137123	0.0102127153720229	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2725.25680112623	2725.25680112623
"AML-0693"	"2021-03-09-AML0693:CTGTGAAGTAGATCGG"	11.488973279565	-2.98719241535338	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGAAGTAGATCGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1895.03656265397	50.5950635430366	0.0266987268425992	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1889.36329711719	1889.36329711719
"AML-0693"	"2021-03-09-AML0693:CTGTGAAGTCAGGTAG"	8.37037338790242	6.28246495807496	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGAAGTCAGGTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1635.86889227347	40.5963767455847	0.024816399980053	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1631.4924170055	1631.4924170055
"AML-0693"	"2021-03-09-AML0693:CTGTGAAGTTCAGTAC"	7.97684301909749	6.19312236392824	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGAAGTTCAGTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1484.54118075457	44.9599892597038	0.0302854443127345	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1482.24458743621	1482.24458743621
"AML-0693"	"2021-03-09-AML0693:CTGTGAATCAGCGCGT"	-7.12850556793864	-2.77211310779723	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGAATCAGCGCGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2670.76804678018	29.816101438352	0.0111638678148399	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2656.98647136304	2656.98647136304
"AML-0693"	"2021-03-09-AML0693:CTGTGGGCACGTCTCT"	0.0226616254890382	12.2818021544251	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGGGCACGTCTCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1726.4832357366	38.5152068125162	0.0223084742529133	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1719.81839739546	1719.81839739546
"AML-0693"	"2021-03-09-AML0693:CTGTGGGGTGCCGTTG"	10.6140190559322	6.64506862247316	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGGGGTGCCGTTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1867.76376204674	36.1592868299972	0.0193596682646701	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1856.30613677974	1856.30613677974
"AML-0693"	"2021-03-09-AML0693:CTGTGGGTCGACACTA"	8.55570663985555	6.56474444949952	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTGTGGGTCGACACTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1564.02767222675	41.7997259194636	0.0267256946035693	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1560.09972165042	1560.09972165042
"AML-0693"	"2021-03-09-AML0693:CTTACCGCACGATTCA"	-9.7421535057133	-2.25601127063902	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTACCGCACGATTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2562.3628892397	48.627431457599	0.0189775740437872	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2552.20274571647	2552.20274571647
"AML-0693"	"2021-03-09-AML0693:CTTACCGCAGAAGCGT"	8.41361774977986	6.78714988315431	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTACCGCAGAAGCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1671.44922946215	33.206651782002	0.0198669820157729	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1664.54815361114	1664.54815361114
"AML-0693"	"2021-03-09-AML0693:CTTACCGGTGTCTTAG"	10.018062253564	7.45905492389528	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTACCGGTGTCTTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1886.80271380474	45.9749427765459	0.024366587158356	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1880.51861238577	1880.51861238577
"AML-0693"	"2021-03-09-AML0693:CTTACCGGTTCCTAAG"	9.26961388167683	6.75848147952882	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTACCGGTTCCTAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1689.47937303513	46.0476146037816	0.0272555056538261	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1683.20100128325	1683.20100128325
"AML-0693"	"2021-03-09-AML0693:CTTAGGACAAGCACAG"	-6.92841134491618	3.86995432460634	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGACAAGCACAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2057.82583107158	49.7891962237885	0.0241950487120971	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2036.89632163552	2036.89632163552
"AML-0693"	"2021-03-09-AML0693:CTTAGGACACCGTGGT"	-7.06614718857463	4.00141260707704	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGACACCGTGGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2083.3927718293	41.6681755788557	0.0200001536639054	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2074.38453774942	2074.38453774942
"AML-0693"	"2021-03-09-AML0693:CTTAGGACACTTCATT"	-2.25622663918193	3.92200276935426	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGACACTTCATT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3292.55418119003	27.2661161651066	0.00828114426206704	4017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3286.08986226661	3286.08986226661
"AML-0693"	"2021-03-09-AML0693:CTTAGGACAGTGTGCC"	-0.647813896567184	12.0081090697083	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGACAGTGTGCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1797.54530098404	36.9670515826298	0.020565296219457	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1795.59460067717	1795.59460067717
"AML-0693"	"2021-03-09-AML0693:CTTAGGAGTGCTGATT"	9.3432089286739	7.76685474002687	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGAGTGCTGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1799.87068255637	44.4957244452527	0.024721622990189	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1786.91896919607	1786.91896919607
"AML-0693"	"2021-03-09-AML0693:CTTAGGATCACCTGGG"	0.114241984754246	9.60425565326539	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGATCACCTGGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1745.4736310173	46.0874447491778	0.0264039765082656	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1741.20794684843	1741.20794684843
"AML-0693"	"2021-03-09-AML0693:CTTAGGATCCTAGCCT"	-7.97535643997844	-1.0671334496704	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGATCCTAGCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3223.6682225617	35.647330017824	0.0110580021133492	3331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3213.62297558855	3213.62297558855
"AML-0693"	"2021-03-09-AML0693:CTTAGGATCGCCTTGT"	-0.418979297310668	9.09061620319215	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTAGGATCGCCTTGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1776.58646561145	45.1194442603046	0.0253967060616866	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1765.04971821439	1765.04971821439
"AML-0693"	"2021-03-09-AML0693:CTTCAATAGACCAGAC"	-7.41501889649089	-3.08290388500365	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATAGACCAGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1510.14269179521	49.6977862301923	0.0329093313500814	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1491.7344820507	1491.7344820507
"AML-0693"	"2021-03-09-AML0693:CTTCAATAGCAACTTC"	-2.53571615639384	3.22583148563234	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATAGCAACTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3431.21614069118	29.8319572344077	0.0086942809812029	4503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3421.61798618538	3421.61798618538
"AML-0693"	"2021-03-09-AML0693:CTTCAATAGGTTACCT"	-7.97724376145061	-4.80594684993895	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATAGGTTACCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2277.94972227342	46.27296873103	0.0203134284653346	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2268.06153133646	2268.06153133646
"AML-0693"	"2021-03-09-AML0693:CTTCAATAGTGTTCAC"	13.9127155738765	1.7993045815262	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATAGTGTTCAC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1402.44809724606	50.9244026135075	0.0363110782591571	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1383.07304328637	1383.07304328637
"AML-0693"	"2021-03-09-AML0693:CTTCAATCATCAGCAT"	-6.85051522675212	3.87891624057619	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATCATCAGCAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2363.88604317135	15.7252714614997	0.00665229675809708	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2347.79011542383	2347.79011542383
"AML-0693"	"2021-03-09-AML0693:CTTCAATGTCAACACT"	7.7196213203365	6.18996093356935	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATGTCAACACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1716.44378273151	51.5974443930345	0.0300606666598329	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1714.43534392105	1714.43534392105
"AML-0693"	"2021-03-09-AML0693:CTTCAATGTTCCTACC"	11.177112241357	-3.00542571460875	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATGTTCCTACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2755.99607084431	30.4748859009101	0.0110576666720624	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2736.43229865866	2736.43229865866
"AML-0693"	"2021-03-09-AML0693:CTTCAATTCATGACAC"	-8.57589469376262	-3.3368666402069	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATTCATGACAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2625.00759127905	43.7661997664387	0.0166727897899577	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2616.61895190954	2616.61895190954
"AML-0693"	"2021-03-09-AML0693:CTTCAATTCTGGAGAG"	-8.3623517555302	-4.64951040661009	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCAATTCTGGAGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2414.36388036934	34.3328717687622	0.0142202557153523	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2411.53448275059	2411.53448275059
"AML-0693"	"2021-03-09-AML0693:CTTCCGACAACCGTGC"	9.45370354232137	7.33861873233644	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCCGACAACCGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1975.91249385968	41.7585486610254	0.0211338046552131	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1967.44073228048	1967.44073228048
"AML-0693"	"2021-03-09-AML0693:CTTCCGACACAAATAG"	-7.29846702042277	-2.83688785946044	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCCGACACAAATAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2323.35203117917	10.2256323429957	0.00440124105420472	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2307.59057024637	2307.59057024637
"AML-0693"	"2021-03-09-AML0693:CTTCCGAGTTTAGTCG"	1.33629347857777	-10.5140123597351	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCCGAGTTTAGTCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2527.33409310735	31.5113108316153	0.0124682015399366	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2512.02712198406	2512.02712198406
"AML-0693"	"2021-03-09-AML0693:CTTCCTTAGAACCCGA"	-0.203188876540023	-9.5832147828308	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCCTTAGAACCCGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3152.2378114491	42.4027436895193	0.0134516322136325	3267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3142.0057472101	3142.0057472101
"AML-0693"	"2021-03-09-AML0693:CTTCCTTTCCATATGG"	7.94090666350667	6.64680764758912	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCCTTTCCATATGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1602.57881511552	42.4461003815191	0.0264861234787128	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1598.30053045384	1598.30053045384
"AML-0693"	"2021-03-09-AML0693:CTTCGGTAGGTCGCCT"	-0.573483328253585	11.2917747267517	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCGGTAGGTCGCCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2019.57062609304	41.1255439715609	0.0203635086786345	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2017.6326321203	2017.6326321203
"AML-0693"	"2021-03-09-AML0693:CTTCGGTGTAGAATAC"	8.15372719344441	6.56262586200563	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCGGTGTAGAATAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1503.50187413746	39.2535137480555	0.0261080577439085	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1501.27395353441	1501.27395353441
"AML-0693"	"2021-03-09-AML0693:CTTCGGTGTTAAGACA"	-8.13128600540813	-4.04095079815062	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCGGTGTTAAGACA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3096.46388358168	1.94127677485419	0.00062693344661547	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3064.17826691423	3064.17826691423
"AML-0693"	"2021-03-09-AML0693:CTTCTAACATTCGATG"	-7.46180377426799	-3.1809177628723	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCTAACATTCGATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2558.35498016929	19.892083116566	0.00777534129186782	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2545.6606450684	2545.6606450684
"AML-0693"	"2021-03-09-AML0693:CTTCTAAGTGACTGTT"	-7.06890521469768	-2.72484424030455	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCTAAGTGACTGTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2355.46953671344	4.45438916447737	0.00189108332544709	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2343.17577344365	2343.17577344365
"AML-0693"	"2021-03-09-AML0693:CTTCTAAGTTCTTGCC"	-2.81176791611369	3.38602206790773	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTCTAAGTTCTTGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3436.82531122269	1.0437224456724	0.00030368795360771	3090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3429.23810217956	3429.23810217956
"AML-0693"	"2021-03-09-AML0693:CTTGAGATCGAAGCAG"	0.173766193061513	8.40571115100709	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTGAGATCGAAGCAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1841.25781174355	49.7433368366418	0.0270159542674463	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1830.59049206952	1830.59049206952
"AML-0693"	"2021-03-09-AML0693:CTTGAGATCGTCGATA"	12.5469070869381	-2.51339747821959	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTGAGATCGTCGATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1415.31409382744	41.2617750719051	0.0291537936715664	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1410.58605389182	1410.58605389182
"AML-0693"	"2021-03-09-AML0693:CTTGATTGTAACACGG"	1.89404263076131	-6.97379686748656	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	3	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000657462195923734	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTGATTGTAACACGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1584.2278981696	47.4553818169412	0.0299548959286543	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1579.14474819783	1579.14474819783
"AML-0693"	"2021-03-09-AML0693:CTTTCGGGTCATCGCG"	-7.36472306671794	3.66953132236329	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTTCGGGTCATCGCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2216.12623670923	36.304214180364	0.0163818349239314	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2204.04454235027	2204.04454235027
"AML-0693"	"2021-03-09-AML0693:CTTTCGGGTGGTACAG"	14.273716588586	2.18264935100404	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTTCGGGTGGTACAG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1111.09397215185	5.86968494466764	0.00528279793769365	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1101.27483735964	1101.27483735964
"AML-0693"	"2021-03-09-AML0693:CTTTCGGGTTTGACAC"	-3.45058880272563	-4.70413305675658	"2021-03-09-AML0693"	"AML0693"	"DC precursor"	"DC precursor"	36	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00224971878515186	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTTCGGGTTTGACAC"	"DC precursor"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2978.43585693053	42.1320106417135	0.0141456833940796	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2974.02582991691	2974.02582991691
"AML-0693"	"2021-03-09-AML0693:CTTTCGGTCATTGTTC"	-6.93741164627727	-2.72217132961424	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CTTTCGGTCATTGTTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2046.03621220946	22.124378251616	0.0108132877216892	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2038.14393116786	2038.14393116786
"AML-0693"	"2021-03-09-AML0693:GAAACCTAGCCTAACT"	-1.1653040451115	10.4809245833191	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTAGCCTAACT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2275.54286280093	49.1117381607105	0.0215824271928939	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2266.06182857816	2266.06182857816
"AML-0693"	"2021-03-09-AML0693:GAAACCTAGGTTGCCC"	9.46378292617146	7.41769692981569	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTAGGTTGCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1958.48962381226	34.6462695041043	0.0176903002614148	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1949.11379707882	1949.11379707882
"AML-0693"	"2021-03-09-AML0693:GAAACCTCAACAGATA"	14.0924593406612	1.77523694122163	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTCAACAGATA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1264.19025384918	1.08296917997038	0.000856650473829378	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1249.44020486236	1249.44020486236
"AML-0693"	"2021-03-09-AML0693:GAAACCTCAGTAGATA"	10.9095980125362	-2.86846449291381	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTCAGTAGATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1533.00707233674	47.8931294172842	0.0312412971091395	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1514.29552953972	1514.29552953972
"AML-0693"	"2021-03-09-AML0693:GAAACCTCATACCGTA"	8.53082909163777	6.89234588229982	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTCATACCGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1944.03314287556	38.6130500866974	0.0198623414565773	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1938.59677972836	1938.59677972836
"AML-0693"	"2021-03-09-AML0693:GAAACCTGTGAAAGTT"	-4.2299350303715	3.61963460529176	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTGTGAAAGTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2971.94562768577	39.7119095756079	0.0133622597956246	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2963.68413955176	2963.68413955176
"AML-0693"	"2021-03-09-AML0693:GAAACCTGTGCGGCTT"	-8.65539489212688	-4.20788290416869	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAACCTGTGCGGCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2795.91066997826	48.7228738988718	0.0174264773270637	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2787.75803055433	2787.75803055433
"AML-0693"	"2021-03-09-AML0693:GAAATGAAGGTGCCAA"	-6.79650626602824	3.83032367313234	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAATGAAGGTGCCAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2228.60831079636	40.5316040996659	0.0181869572608668	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2213.68635931269	2213.68635931269
"AML-0693"	"2021-03-09-AML0693:GAAATGACAGTAGAAT"	-1.88429043713267	3.84315941417543	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAATGACAGTAGAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3060.88986949749	28.7720201695504	0.00939988741714313	3782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3055.73595167806	3055.73595167806
"AML-0693"	"2021-03-09-AML0693:GAAATGAGTCGTCAGC"	-7.09229550781901	4.13169477069703	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAATGAGTCGTCAGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1839.99598478967	51.1233275484758	0.0277844777766293	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1830.74491343885	1830.74491343885
"AML-0693"	"2021-03-09-AML0693:GAAATGATCATAGCAC"	-8.52020965042766	-3.35339000141295	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAATGATCATAGCAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2789.10438370114	48.1623565748786	0.0172680365985325	2939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2781.32424629928	2781.32424629928
"AML-0693"	"2021-03-09-AML0693:GAACACTGTCGATGCC"	0.864282031624955	9.60461995685426	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACACTGTCGATGCC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1837.44678785942	47.9077387090124	0.0260729938007205	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1834.19816394894	1834.19816394894
"AML-0693"	"2021-03-09-AML0693:GAACACTTCAAATAGG"	8.42186703261678	7.82345912540285	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACACTTCAAATAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1941.57110187137	45.7181482161769	0.0235469863411707	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1927.17258909393	1927.17258909393
"AML-0693"	"2021-03-09-AML0693:GAACGTTAGACATAAC"	-6.81358085098918	-2.60770418560179	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACGTTAGACATAAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1452.25217367465	38.6445796129107	0.0266101027861628	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1452.25217367465	1452.25217367465
"AML-0693"	"2021-03-09-AML0693:GAACGTTCACAGTACT"	-0.991672496229965	9.69363305652467	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACGTTCACAGTACT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1968.05582955276	50.7344183480359	0.0257789528051983	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1966.20460425375	1966.20460425375
"AML-0693"	"2021-03-09-AML0693:GAACGTTCACATATGC"	11.9122063117916	-2.69407298481139	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACGTTCACATATGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1950.07206698689	42.3798780545342	0.0217324676210641	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1940.26317942198	1940.26317942198
"AML-0693"	"2021-03-09-AML0693:GAACGTTTCTGTCGCT"	-8.79641280594524	-3.89302017604979	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACGTTTCTGTCGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3003.28159854628	36.3008793307011	0.0120870714715105	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2999.17594017199	2999.17594017199
"AML-0693"	"2021-03-09-AML0693:GAACTGTAGCGGGTTA"	0.415856768458527	9.34958455646364	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACTGTAGCGGGTTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1893.14777446185	39.3912960759356	0.0208073012615896	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1887.84096064458	1887.84096064458
"AML-0693"	"2021-03-09-AML0693:GAACTGTAGCTACGTT"	8.03844227370564	6.46046302402345	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACTGTAGCTACGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1839.65554044225	24.7144104785267	0.0134342598031072	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1833.47967695349	1833.47967695349
"AML-0693"	"2021-03-09-AML0693:GAACTGTAGGTATAGT"	11.9007393318111	-2.67174365436705	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAACTGTAGGTATAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1922.99190380892	47.9108075774177	0.0249147214205735	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1912.34125124216	1912.34125124216
"AML-0693"	"2021-03-09-AML0693:GAAGAATTCTTCTCAA"	-8.72989879074748	-4.51190617000731	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGAATTCTTCTCAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3035.93731652615	47.4024733108532	0.0156137852559792	2658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3030.92822675636	3030.92822675636
"AML-0693"	"2021-03-09-AML0693:GAAGCCCAGAATCGTA"	-6.83530936661418	2.95714876735536	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCAGAATCGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2441.63204481747	47.0143132511528	0.0192552818721985	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2428.54147626284	2428.54147626284
"AML-0693"	"2021-03-09-AML0693:GAAGCCCAGTTGAATG"	14.3344828086788	2.03031394565431	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCAGTTGAATG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1286.1353299253	23.5679768495092	0.0183246477265173	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1276.0990527752	1276.0990527752
"AML-0693"	"2021-03-09-AML0693:GAAGCCCCAACAGAGC"	13.9153191047603	1.73901341045228	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCCAACAGAGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1424.53129873608	40.6755721676887	0.0285536528427127	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1413.48533570916	1413.48533570916
"AML-0693"	"2021-03-09-AML0693:GAAGCCCTCATGCGGC"	-6.99044928970988	3.86993072116701	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCTCATGCGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2416.57428742255	35.2395208018718	0.0145824281029893	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2398.20099387137	2398.20099387137
"AML-0693"	"2021-03-09-AML0693:GAAGCCCTCGTTAGAC"	11.2338091331417	-2.82131364261778	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCTCGTTAGAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1483.55100642342	44.5401013897211	0.0300226289469477	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1471.68977439855	1471.68977439855
"AML-0693"	"2021-03-09-AML0693:GAAGCCCTCTCCTGAC"	-7.03070960465129	3.49463603580324	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCCCTCTCCTGAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.79278178774	33.0094829543547	0.0121233915320876	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2701.53450199544	2701.53450199544
"AML-0693"	"2021-03-09-AML0693:GAAGCGACATCGCCTT"	-8.0251182121342	-3.82709004795226	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCGACATCGCCTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2327.54455579772	2.68406053300466	0.00115317256819805	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2298.57761360973	2298.57761360973
"AML-0693"	"2021-03-09-AML0693:GAAGCGAGTATGTGTC"	-6.95216165009196	3.91470120036928	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGCGAGTATGTGTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2163.03566612697	48.0195204242252	0.0222000594702198	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2150.25497350471	2150.25497350471
"AML-0693"	"2021-03-09-AML0693:GAAGGACGTACAAAGT"	-8.88435302200969	-2.72006561672362	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGACGTACAAAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3388.43496964649	47.0705259278526	0.0138915240662752	4068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3379.06677527148	3379.06677527148
"AML-0693"	"2021-03-09-AML0693:GAAGGACGTAGGTAGC"	-8.58518634262736	-0.0762416056362019	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGACGTAGGTAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2823.2491531518	41.8104783750583	0.0148093477078997	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2812.80596462133	2812.80596462133
"AML-0693"	"2021-03-09-AML0693:GAAGGACGTGGTAATA"	7.67842115935628	6.72251412952272	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGACGTGGTAATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1504.07687762568	34.303084715863	0.0228067362952973	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1499.60064901575	1499.60064901575
"AML-0693"	"2021-03-09-AML0693:GAAGGGTCACCAAAGG"	-7.91789184036906	-3.82222130214842	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTCACCAAAGG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1828.46797168521	23.6700337103584	0.0129452821033244	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1809.70658161136	1809.70658161136
"AML-0693"	"2021-03-09-AML0693:GAAGGGTCACGACGAA"	-7.00574336472209	3.46194288814393	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTCACGACGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2495.65852139807	35.794024305844	0.0143425168142764	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2478.79408054413	2478.79408054413
"AML-0693"	"2021-03-09-AML0693:GAAGGGTGTTTCGATG"	14.2658392387325	2.02851710403291	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTGTTTCGATG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1180.51052120202	0	0	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1169.41394694468	1169.41394694468
"AML-0693"	"2021-03-09-AML0693:GAAGGGTGTTTGAACC"	11.6390119987423	-2.52135541355284	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTGTTTGAACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1561.84086314043	45.0838195659532	0.0288658214994467	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1557.46439809575	1557.46439809575
"AML-0693"	"2021-03-09-AML0693:GAAGGGTTCCATTGTT"	-7.06699071350749	-2.75297167217406	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTTCCATTGTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1326.12222300214	40.2256691150987	0.0303333044400943	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1316.25635417004	1316.25635417004
"AML-0693"	"2021-03-09-AML0693:GAAGGGTTCGACCTAA"	1.1931309896404	10.2250785597595	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGGGTTCGACCTAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2105.51652745937	38.9732237600024	0.0185100535909968	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2099.60282336893	2099.60282336893
"AML-0693"	"2021-03-09-AML0693:GAAGTAAAGTGAGCCA"	-8.78335318985637	-3.99071457302245	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGTAAAGTGAGCCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2921.86756642727	49.062566533194	0.0167915093404406	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2908.91273678476	2908.91273678476
"AML-0693"	"2021-03-09-AML0693:GAAGTAACAACTTGGT"	14.319895406335	2.16156838023988	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGTAACAACTTGGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1121.00395988141	14.3036598528588	0.0127596871775297	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1106.25272134485	1106.25272134485
"AML-0693"	"2021-03-09-AML0693:GAAGTAAGTTTGTTCT"	-1.13604317131694	10.4009952315125	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAAGTAAGTTTGTTCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1691.68444847504	50.9368503461461	0.0301101369064797	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1682.59340476204	1682.59340476204
"AML-0693"	"2021-03-09-AML0693:GAATAGAAGGTTTACC"	-1.20927462998088	10.6186837919983	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGAAGGTTTACC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1750.75116065774	49.2983612269387	0.028158405565996	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1736.61785553031	1736.61785553031
"AML-0693"	"2021-03-09-AML0693:GAATAGACACCCAAGC"	-7.79404673996623	-2.85641171848448	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGACACCCAAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2326.47724298762	4.2450975997847	0.00182468907124715	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2306.92058355837	2306.92058355837
"AML-0693"	"2021-03-09-AML0693:GAATAGACAGTCGCAC"	1.00694652375523	-9.23730947887572	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGACAGTCGCAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2620.67116951677	44.5974077387905	0.0170175519376641	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2616.25723987282	2616.25723987282
"AML-0693"	"2021-03-09-AML0693:GAATAGAGTGAGGATC"	13.9994951682979	1.68949196422426	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGAGTGAGGATC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1303.38881455887	5.48477368071484	0.00420808711832559	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1292.86800030015	1292.86800030015
"AML-0693"	"2021-03-09-AML0693:GAATAGAGTGGTCTTA"	-6.74310002747233	4.00630877101747	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGAGTGGTCTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1981.42611374645	41.5901385566731	0.0209900022353269	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1955.91672928495	1955.91672928495
"AML-0693"	"2021-03-09-AML0693:GAATAGAGTTGTCATG"	-1.40613911572154	13.7777461775574	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56bright NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATAGAGTTGTCATG"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	2323.67498627489	37.4510746358542	0.0161171742421226	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	2318.63099348844	2318.63099348844
"AML-0693"	"2021-03-09-AML0693:GAATCACAGGATTTCC"	-7.42030606690105	-2.36503603374632	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCACAGGATTTCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2242.07938116903	28.4428816187755	0.0126859387128145	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2225.04143796263	2225.04143796263
"AML-0693"	"2021-03-09-AML0693:GAATCGTAGCATCAAA"	-6.86652455750163	-2.6045553914276	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTAGCATCAAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1979.21938285887	35.9692964169671	0.0181734762343584	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1968.61247614803	1968.61247614803
"AML-0693"	"2021-03-09-AML0693:GAATCGTGTACCCACG"	-7.40108094635661	-1.21599199688109	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTGTACCCACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3211.94990888213	38.413587882052	0.0119595849785283	3236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3195.0042198729	3195.0042198729
"AML-0693"	"2021-03-09-AML0693:GAATCGTGTACGCGTC"	7.92763866957967	5.98210189426271	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTGTACGCGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1414.26981915418	49.2487927393286	0.0348227700770581	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1404.68062441201	1404.68062441201
"AML-0693"	"2021-03-09-AML0693:GAATCGTGTGTCTCCT"	-7.55251679840739	-2.51717045223387	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTGTGTCTCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1801.32813296215	48.7836946411551	0.0270820700284817	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1794.58878465363	1794.58878465363
"AML-0693"	"2021-03-09-AML0693:GAATCGTTCCATCTAT"	-8.84337077561076	-4.49950935756835	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTTCCATCTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3140.66839097832	42.0184143981557	0.0133788127771958	3472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3131.1505288319	3131.1505288319
"AML-0693"	"2021-03-09-AML0693:GAATCGTTCCTCAGAA"	0.926572998135728	-9.50241568004759	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTTCCTCAGAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2126.20412277826	48.164009079034	0.0226525800430202	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2118.54133481414	2118.54133481414
"AML-0693"	"2021-03-09-AML0693:GAATCGTTCGTGTCAA"	-8.36543975296672	-3.64713766491088	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAATCGTTCGTGTCAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3185.74937327786	49.2822972773352	0.0154696090316194	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3178.19326594686	3178.19326594686
"AML-0693"	"2021-03-09-AML0693:GACACGCAGCTAGAAT"	-8.21103797379192	-4.43760492717894	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACACGCAGCTAGAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2854.43580005071	51.5605461091298	0.0180633055780108	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2846.80568402795	2846.80568402795
"AML-0693"	"2021-03-09-AML0693:GACACGCAGGGTAGCT"	10.9999672370845	-2.7744817963806	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACACGCAGGGTAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2321.68332419195	43.0190111106689	0.0185292329330235	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2315.48641098461	2315.48641098461
"AML-0693"	"2021-03-09-AML0693:GACACGCCATAGATCC"	1.37111391600911	9.99604508960573	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACACGCCATAGATCC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2001.55417660192	36.4738109498695	0.0182227447931446	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1993.7620444545	1993.7620444545
"AML-0693"	"2021-03-09-AML0693:GACACGCGTATGAGAT"	8.05341114577596	7.04820726001588	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACACGCGTATGAGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1893.95571971824	48.3132647156083	0.0255091838803897	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1886.86674503477	1886.86674503477
"AML-0693"	"2021-03-09-AML0693:GACAGCCGTGCCTATA"	-7.24565015259441	-2.8882878056732	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACAGCCGTGCCTATA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2694.02751555616	8.88988361313905	0.00329984885521995	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2684.00815898125	2684.00815898125
"AML-0693"	"2021-03-09-AML0693:GACATCAAGATTGGGC"	-0.195249537855941	11.0725078352722	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCAAGATTGGGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1645.14468505906	49.9050115319673	0.0303347249547086	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1640.64484642445	1640.64484642445
"AML-0693"	"2021-03-09-AML0693:GACATCAAGGTGCTTT"	9.75287403640096	7.72817800128785	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCAAGGTGCTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1923.74327258197	46.8006089734836	0.0243278870109678	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1913.53534736691	1913.53534736691
"AML-0693"	"2021-03-09-AML0693:GACATCAAGTATGGAT"	-0.78091392937358	10.7800111540589	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCAAGTATGGAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1814.51171803081	38.9974586126179	0.0214919849924914	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1808.4947255475	1808.4947255475
"AML-0693"	"2021-03-09-AML0693:GACATCACATGACGGA"	-7.50411353531535	-3.46963193332823	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCACATGACGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	3436.052555542	31.072651900558	0.00904312474803127	2939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	3408.5175090098	3408.5175090098
"AML-0693"	"2021-03-09-AML0693:GACATCATCAAACTGC"	-7.28416142883952	-3.12131168758544	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCATCAAACTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2925.36990788931	9.42271315884027	0.00322103305070191	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2914.32154249613	2914.32154249613
"AML-0693"	"2021-03-09-AML0693:GACATCATCTCGTCGT"	-8.87608371201213	1.73335442626802	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACATCATCTCGTCGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2798.70498776302	51.3377738737461	0.0183434031447451	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2782.00277701439	2782.00277701439
"AML-0693"	"2021-03-09-AML0693:GACCAATAGTTCCGTA"	-7.66985927048381	-2.49711086666258	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCAATAGTTCCGTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2512.84004187862	7.73096862481278	0.00307658605242259	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2483.1004791728	2483.1004791728
"AML-0693"	"2021-03-09-AML0693:GACCAATAGTTGTAAG"	-6.98193345490153	3.75926468456117	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCAATAGTTGTAAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2551.01842426509	38.4064096671272	0.0150553242978602	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2533.39319750657	2533.39319750657
"AML-0693"	"2021-03-09-AML0693:GACCAATTCAAGCTGT"	8.77870525893514	7.08231113040773	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCAATTCAAGCTGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1717.68703426161	46.4083848346896	0.0270179514131568	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1712.36360903097	1712.36360903097
"AML-0693"	"2021-03-09-AML0693:GACCCAGCAGATGCGA"	-8.83910212937053	-4.17442037975463	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCAGCAGATGCGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.23305687991	45.016912503937	0.0165367591838493	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2713.9552706055	2713.9552706055
"AML-0693"	"2021-03-09-AML0693:GACCCAGCAGCCCACA"	1.13358988341634	-9.09667017376097	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCAGCAGCCCACA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2667.79163425839	42.7671497309188	0.016030918300262	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2663.1142633865	2663.1142633865
"AML-0693"	"2021-03-09-AML0693:GACCCAGGTGTCCGGT"	-6.96152911606486	-2.65401770984801	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCAGGTGTCCGGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2325.21034528305	30.0653275513963	0.0129301538729118	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2319.37551721237	2319.37551721237
"AML-0693"	"2021-03-09-AML0693:GACCCAGTCTCCTGTG"	-8.81529174271281	-4.34331228649291	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCAGTCTCCTGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2812.93919807647	49.941140566287	0.017754077514522	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2800.61726239331	2800.61726239331
"AML-0693"	"2021-03-09-AML0693:GACCCTTAGTGCGCTC"	0.402902891009492	10.4105930098328	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCTTAGTGCGCTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1399.3028551176	52.5146682668393	0.0375291653803034	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1399.3028551176	1399.3028551176
"AML-0693"	"2021-03-09-AML0693:GACCCTTGTTGTCATG"	1.30437328395192	9.64314076984254	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCCTTGTTGTCATG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1928.81350299417	38.3928398163066	0.0199048999588129	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1918.8080023542	1918.8080023542
"AML-0693"	"2021-03-09-AML0693:GACCGTGAGGCGTCCT"	3.7001904445583	-10.1908893815246	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCGTGAGGCGTCCT"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2793.39234566237	51.6403587514984	0.0184866113890827	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2783.44376207301	2783.44376207301
"AML-0693"	"2021-03-09-AML0693:GACCGTGCAGCGATTT"	-7.15550933304484	4.29815099323121	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCGTGCAGCGATTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2008.8514686202	40.2487589104531	0.0200357067404781	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1992.39337768223	1992.39337768223
"AML-0693"	"2021-03-09-AML0693:GACCGTGGTGCCCACA"	8.45473160323445	6.81215188587037	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCGTGGTGCCCACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.69146043548	51.8905266344345	0.028673687072573	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1800.16426242768	1800.16426242768
"AML-0693"	"2021-03-09-AML0693:GACCTTCTCGCCTTGT"	-7.68087468567546	-2.62740280544432	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACCTTCTCGCCTTGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2627.51824066677	35.1679779893258	0.0133844848134723	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2606.57134345955	2606.57134345955
"AML-0693"	"2021-03-09-AML0693:GACGCTGCAGGAGGTT"	-1.97070751610454	13.4588174589905	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGCTGCAGGAGGTT"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1977.73945433776	52.7958106514764	0.0266950282736585	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1975.83295486576	1975.83295486576
"AML-0693"	"2021-03-09-AML0693:GACGCTGTCAGGAAGC"	0.889117320149583	9.52568147266237	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGCTGTCAGGAAGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1672.06526758601	45.2057605069309	0.0270358827393115	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1658.84910946596	1658.84910946596
"AML-0693"	"2021-03-09-AML0693:GACGCTGTCGTGGACC"	11.3683268028194	-2.44137861644896	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGCTGTCGTGGACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1446.55570111225	32.9154549259879	0.0227543639700009	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1444.33103949672	1444.33103949672
"AML-0693"	"2021-03-09-AML0693:GACGTTAAGACCTGGA"	-7.81551490250285	-3.63603546535643	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGTTAAGACCTGGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2464.17385150187	37.8640480640125	0.0153658184632286	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2439.48963905899	2439.48963905899
"AML-0693"	"2021-03-09-AML0693:GACGTTAAGATGGGCT"	11.1201235252315	-2.91144277965697	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGTTAAGATGGGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2110.27813773242	39.7591946557871	0.018840736652141	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2100.10274620908	2100.10274620908
"AML-0693"	"2021-03-09-AML0693:GACGTTATCAGAGCGA"	-7.143781999976	-2.78552558338317	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACGTTATCAGAGCGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1630.82572877874	42.9871117711351	0.0263591081576364	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1626.47452858108	1626.47452858108
"AML-0693"	"2021-03-09-AML0693:GACTATGAGTGATAAC"	-6.97907338562663	3.87167022312013	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTATGAGTGATAAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2317.43546027849	37.6037209502646	0.0162264371952545	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2309.28278360496	2309.28278360496
"AML-0693"	"2021-03-09-AML0693:GACTATGCACTTGGCG"	-6.1279276413029	-3.51972319996031	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTATGCACTTGGCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1490.5292626831	45.043062686675	0.030219509146431	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1488.0887423132	1488.0887423132
"AML-0693"	"2021-03-09-AML0693:GACTATGGTATGTCAC"	9.62990154799764	7.05106637561647	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTATGGTATGTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.84238245997	46.0226679317732	0.0254291027648598	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1803.30730176657	1803.30730176657
"AML-0693"	"2021-03-09-AML0693:GACTATGTCAGTGCGC"	-7.5213340324467	-2.56052162563475	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTATGTCAGTGCGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1637.05161401095	38.2674955894533	0.0233758638163483	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1627.98757569846	1627.98757569846
"AML-0693"	"2021-03-09-AML0693:GACTATGTCTCATGGA"	-2.73186622086223	3.58615467632142	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTATGTCTCATGGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3489.68745803294	36.686020086298	0.0105126950557851	5025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3480.1418459616	3480.1418459616
"AML-0693"	"2021-03-09-AML0693:GACTCAACAAGAGTTA"	-8.92108664932903	-4.18979265606078	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCAACAAGAGTTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2809.7153439176	46.6328253617391	0.0165969928102107	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2802.62408814854	2802.62408814854
"AML-0693"	"2021-03-09-AML0693:GACTCAAGTCTCGCGA"	1.34694578227345	-10.5551023713318	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCAAGTCTCGCGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2055.7741717257	46.5595906446769	0.0226482029422487	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2036.83189871285	2036.83189871285
"AML-0693"	"2021-03-09-AML0693:GACTCAAGTGCCTTTC"	-7.20036206665691	-0.339125507232271	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCAAGTGCCTTTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3059.89713432581	49.4494524678719	0.0161604950418594	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3056.76461288627	3056.76461288627
"AML-0693"	"2021-03-09-AML0693:GACTCAATCGGCATTA"	9.00310291823689	7.06877706134645	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCAATCGGCATTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1624.26427731072	51.005779167419	0.0314023893032165	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1620.14732786945	1620.14732786945
"AML-0693"	"2021-03-09-AML0693:GACTCAATCTTGGTCC"	-2.20665011826213	3.13966176593629	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCAATCTTGGTCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2937.0130567441	6.75717576925582	0.00230069653716374	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2888.41713703559	2888.41713703559
"AML-0693"	"2021-03-09-AML0693:GACTCTCAGAGCAGAA"	8.86650433120076	6.65567443454591	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCAGAGCAGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1515.63291877211	45.5041274361459	0.0300231849496981	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1506.69496440744	1506.69496440744
"AML-0693"	"2021-03-09-AML0693:GACTCTCAGCTTCATG"	-8.48985801163371	-4.26782801067504	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCAGCTTCATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2759.82426722786	52.4892894436974	0.0190190694628614	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2754.02720998332	2754.02720998332
"AML-0693"	"2021-03-09-AML0693:GACTCTCCACAAATAG"	-0.409871588379699	11.1399106749329	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCCACAAATAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1939.95893066827	35.6081209615731	0.018355090099411	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1930.17671271202	1930.17671271202
"AML-0693"	"2021-03-09-AML0693:GACTCTCCAGGGTCTC"	-6.91761575165446	3.86250851238099	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCCAGGGTCTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2168.52650531332	24.7409272719591	0.0114090960895977	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2157.66187724086	2157.66187724086
"AML-0693"	"2021-03-09-AML0693:GACTCTCTCACCGACG"	-8.45257506790813	-3.35484101688536	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCTCACCGACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3266.20604625897	51.1719752622851	0.015667099545326	3730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3254.02913071856	3254.02913071856
"AML-0693"	"2021-03-09-AML0693:GACTCTCTCACCGGTG"	8.24757351455037	7.69899461353151	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCTCACCGGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2036.01574665844	43.1168153987914	0.0211770539935931	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2027.17201341198	2027.17201341198
"AML-0693"	"2021-03-09-AML0693:GACTCTCTCCCATTCG"	1.09638561782185	8.95496652210084	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTCTCTCCCATTCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1857.74538290423	35.511923924758	0.0191156033822256	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1848.25790244407	1848.25790244407
"AML-0693"	"2021-03-09-AML0693:GACTGATAGCAACCAG"	12.1870304542476	-2.96812250530394	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTGATAGCAACCAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2205.18867916195	42.6134143898089	0.0193241579700125	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2198.52861731511	2198.52861731511
"AML-0693"	"2021-03-09-AML0693:GACTGATCAACTCGTA"	-2.53304610672649	3.85917065227357	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTGATCAACTCGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3695.05348366168	23.2034160778417	0.00627958869348974	5912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3689.07414982333	3689.07414982333
"AML-0693"	"2021-03-09-AML0693:GACTGATGTGCGGCTT"	1.39957966384236	-10.5616560212341	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTGATGTGCGGCTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2165.03638039551	48.6652982060953	0.0224778200711829	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2159.50751406983	2159.50751406983
"AML-0693"	"2021-03-09-AML0693:GACTGATTCATCCTAT"	-1.7106046480244	10.1436862715515	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTGATTCATCCTAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2047.27503784841	33.2020945723728	0.0162177010702317	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2039.75936734364	2039.75936734364
"AML-0693"	"2021-03-09-AML0693:GACTTCCTCGGAATTC"	-6.90105901184733	3.87692115390626	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GACTTCCTCGGAATTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2311.17790765685	51.7972016824348	0.0224116029799491	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2289.44587719207	2289.44587719207
"AML-0693"	"2021-03-09-AML0693:GAGAAATCAAGAATGT"	10.0507790046627	6.31653544986574	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGAAATCAAGAATGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1628.33369817853	47.9431495031586	0.029443073957622	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1626.27140166559	1626.27140166559
"AML-0693"	"2021-03-09-AML0693:GAGAAATGTCTGTGGC"	-1.94766126099284	3.11901233280031	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGAAATGTCTGTGGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2341.26977164759	50.9778908240963	0.0217736082537051	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2328.72426732809	2328.72426732809
"AML-0693"	"2021-03-09-AML0693:GAGACCCAGGGCTAAC"	8.91433682021443	6.90062711322633	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGACCCAGGGCTAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1741.76582069042	45.2734857585733	0.0259928661021878	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1734.92948525362	1734.92948525362
"AML-0693"	"2021-03-09-AML0693:GAGACCCCAAGACAAT"	-6.85332093659099	3.82491228664247	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGACCCCAAGACAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2548.70222098352	42.8612166405457	0.0168168789149507	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2528.93428141352	2528.93428141352
"AML-0693"	"2021-03-09-AML0693:GAGACTTAGGTCCTGC"	-8.73308883133586	-3.26857855236205	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGACTTAGGTCCTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1417.80648105355	49.3407428479348	0.0348007598408426	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1407.23045933451	1407.23045933451
"AML-0693"	"2021-03-09-AML0693:GAGACTTCAAGGACAC"	-2.13780007782634	3.91000506961671	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGACTTCAAGGACAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3319.56125976615	38.3297149734311	0.0115466207652186	5084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3312.63281080021	3312.63281080021
"AML-0693"	"2021-03-09-AML0693:GAGACTTCAGCTGTAT"	3.42430724677388	-9.58599665081175	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGACTTCAGCTGTAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2989.19232324102	33.3353478594237	0.0111519582063157	2813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2977.35210817574	2977.35210817574
"AML-0693"	"2021-03-09-AML0693:GAGAGGTAGTAGGTTA"	-7.17211995545085	4.18057057941285	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGAGGTAGTAGGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1932.34482606297	45.6814432593476	0.0236404199929578	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1923.85602562278	1923.85602562278
"AML-0693"	"2021-03-09-AML0693:GAGAGGTGTTGGCCTG"	9.67033638533894	5.92223594272462	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGAGGTGTTGGCCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1720.5765550148	48.5102073303193	0.0281941580506437	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1716.8622679215	1716.8622679215
"AML-0693"	"2021-03-09-AML0693:GAGATGGGTTCAACGT"	8.14025845107381	6.20267150485841	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGATGGGTTCAACGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1763.84080894419	47.9017006038884	0.0271576098936966	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1759.59491156542	1759.59491156542
"AML-0693"	"2021-03-09-AML0693:GAGCCTGTCCAAGCAT"	2.08135380324666	-9.64529039776	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGCCTGTCCAAGCAT"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2446.02882316913	42.6259506448711	0.0174265937674618	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2439.78723727658	2439.78723727658
"AML-0693"	"2021-03-09-AML0693:GAGCTGCAGAGGTCGT"	-8.52589545670207	1.42995808208314	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGCTGCAGAGGTCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2623.28701300498	24.5840287924976	0.00937145980238607	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2609.54648299123	2609.54648299123
"AML-0693"	"2021-03-09-AML0693:GAGCTGCAGGGACAGG"	8.72380890425984	6.97919795596925	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGCTGCAGGGACAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1473.1078753521	53.1988262922827	0.0361133269208593	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1462.8692982167	1462.8692982167
"AML-0693"	"2021-03-09-AML0693:GAGCTGCTCATAGCAC"	-2.74325428429301	3.57036635959474	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGCTGCTCATAGCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3542.44934743722	31.1305156046644	0.00878785059472644	5174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3534.54075326938	3534.54075326938
"AML-0693"	"2021-03-09-AML0693:GAGGCAACATACGCAT"	11.4449240165645	-2.20527961170348	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGCAACATACGCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1337.73794148721	46.2848407508499	0.0345993331843406	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1335.25067522099	1335.25067522099
"AML-0693"	"2021-03-09-AML0693:GAGGCAAGTCAGGTGA"	9.42040791091267	7.09815976703493	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGCAAGTCAGGTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1892.23072686543	49.5529695410063	0.0261875937418547	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1883.74438583904	1883.74438583904
"AML-0693"	"2021-03-09-AML0693:GAGGCCTAGCATCTTG"	-7.34299550476726	4.23271129215089	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGCCTAGCATCTTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1980.5622207417	35.6004692247378	0.0179749309826812	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1974.81126314873	1974.81126314873
"AML-0693"	"2021-03-09-AML0693:GAGGCCTGTCTGGTTA"	-7.14922795715983	4.20216987216798	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGCCTGTCTGGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1785.83488059586	44.7575053395409	0.025062510440275	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1776.33878022013	1776.33878022013
"AML-0693"	"2021-03-09-AML0693:GAGGCCTTCCTCGATC"	-8.74190173569377	-4.64993431484374	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGCCTTCCTCGATC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2232.22641143763	33.8323465811259	0.0151563239319154	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2200.36706828468	2200.36706828468
"AML-0693"	"2021-03-09-AML0693:GAGGGATCACCGTGCA"	-8.28974948349651	-0.0040675296452866	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGATCACCGTGCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3228.14780152163	35.6158280315922	0.0110328988080423	3884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3210.76346058167	3210.76346058167
"AML-0693"	"2021-03-09-AML0693:GAGGGATCAGCTGCCA"	-2.0403724712437	2.99523470485536	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGATCAGCTGCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2457.89936552616	47.0880749732786	0.0191578530975366	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2444.6628398497	2444.6628398497
"AML-0693"	"2021-03-09-AML0693:GAGGGATCAGTCTGGC"	-9.51742301407512	-2.37067725574645	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGATCAGTCTGGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3345.82510519159	47.9787601921626	0.0143398888715718	3744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3334.51303066364	3334.51303066364
"AML-0693"	"2021-03-09-AML0693:GAGGGATGTACTCAAC"	7.78691305693929	6.0188736685547	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGATGTACTCAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1384.59462751017	46.9958589764878	0.0339419625374377	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1364.70603592393	1364.70603592393
"AML-0693"	"2021-03-09-AML0693:GAGGGATTCACCACAA"	-0.659538666636306	11.6819753416809	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGATTCACCACAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1424.71682504317	47.6394949063614	0.0334378692445904	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1422.2179040337	1422.2179040337
"AML-0693"	"2021-03-09-AML0693:GAGGGTAGTAGCGTCC"	3.0095497566158	-6.6901746026245	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGTAGTAGCGTCC"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	1513.41409325561	49.2845980250298	0.0325651771347063	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1513.41409325561	1513.41409325561
"AML-0693"	"2021-03-09-AML0693:GAGGGTATCCAATCCC"	-7.34428344193156	-2.23779561435851	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGGGTATCCAATCCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1352.87857555679	43.9010871084764	0.032450131077291	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1347.83858545973	1347.83858545973
"AML-0693"	"2021-03-09-AML0693:GAGTCATAGACAGCGT"	-2.16937766495402	3.08836577022401	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCATAGACAGCGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3185.03274907295	24.9948258980873	0.00784758835065744	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3166.53977737615	3166.53977737615
"AML-0693"	"2021-03-09-AML0693:GAGTCATAGCGTGAAC"	9.75496544417683	6.68469283664552	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCATAGCGTGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1714.49919313002	49.5412807818225	0.0288954821211546	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1703.40611112759	1703.40611112759
"AML-0693"	"2021-03-09-AML0693:GAGTCATGTGGTCTCG"	-8.27809367600139	-4.44207575237425	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCATGTGGTCTCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2683.36323998859	31.7278071129341	0.0118238957141967	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2673.76894438636	2673.76894438636
"AML-0693"	"2021-03-09-AML0693:GAGTCATGTGTTACAC"	-6.99959693375285	-2.67165830051573	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCATGTGTTACAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2241.68388025814	8.72574541855713	0.00389249594708792	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2234.18530058729	2234.18530058729
"AML-0693"	"2021-03-09-AML0693:GAGTCATTCATTTGTC"	-7.36590753021892	1.80856690490571	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCATTCATTTGTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2550.3806692824	51.0367986954658	0.0200114435112253	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2539.54703177138	2539.54703177138
"AML-0693"	"2021-03-09-AML0693:GAGTCTAAGCAGGTCA"	0.830523093312424	-9.40595629131468	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTAAGCAGGTCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2025.9230444724	50.3886398382031	0.0248719416937801	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2020.73207675671	2020.73207675671
"AML-0693"	"2021-03-09-AML0693:GAGTCTACAAAGGCAC"	-7.48432145538982	-2.73912885105284	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTACAAAGGCAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1572.50042923665	30.3842791975755	0.0193222708449912	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1572.50042923665	1572.50042923665
"AML-0693"	"2021-03-09-AML0693:GAGTCTACAATCTCGA"	-9.09240661087688	-4.32944633876952	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTACAATCTCGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2473.12514647515	42.9679796964761	0.0173739609407622	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2465.97723755536	2465.97723755536
"AML-0693"	"2021-03-09-AML0693:GAGTCTACAGAGGGTT"	1.40080132064168	-10.3016395798889	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTACAGAGGGTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2648.00287969729	45.2750666271283	0.0170978162351183	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2640.24816690963	2640.24816690963
"AML-0693"	"2021-03-09-AML0693:GAGTCTAGTCCGGATC"	-1.45045504990276	9.89618394458619	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTAGTCCGGATC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1620.39290546953	48.2153566664849	0.0297553491525031	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1618.25320577754	1618.25320577754
"AML-0693"	"2021-03-09-AML0693:GAGTCTATCCCGTGTT"	-6.86208997193034	3.8364310034546	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTCTATCCCGTGTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2372.71481378197	37.9456124869113	0.0159924877050134	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2362.98340903232	2362.98340903232
"AML-0693"	"2021-03-09-AML0693:GAGTGAGAGGTAACTA"	-6.52320466461833	-2.60530426418456	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGAGAGGTAACTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1669.29464056112	42.7502516448571	0.0256097699028656	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1662.41013630973	1662.41013630973
"AML-0693"	"2021-03-09-AML0693:GAGTGAGCAAGACGAC"	-5.76984105530437	-5.47188331997069	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGAGCAAGACGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3184.4036311439	36.3239226014712	0.0114068211222404	4179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3176.7478604174	3176.7478604174
"AML-0693"	"2021-03-09-AML0693:GAGTGAGCACCTGTCT"	0.482647647231263	9.26974485004274	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGAGCACCTGTCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1830.9561668701	42.1233555717009	0.0230062064476988	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1825.76419586784	1825.76419586784
"AML-0693"	"2021-03-09-AML0693:GAGTGAGCAGCACGAA"	-2.80794606629069	3.9943101176056	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGAGCAGCACGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3118.10311508199	40.6656218306136	0.0130417822405929	2991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3108.54962846715	3108.54962846715
"AML-0693"	"2021-03-09-AML0693:GAGTGAGTCACATACG"	11.7867475944454	-2.94444897091063	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGAGTCACATACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1556.69167677025	36.3174796202717	0.0233299118651559	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1543.73018391605	1543.73018391605
"AML-0693"	"2021-03-09-AML0693:GAGTGTTAGTCACTGT"	-1.79528854313548	3.89966676318971	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGTTAGTCACTGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3234.92397056352	23.6366485363589	0.00730670913797131	4173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3226.63452759284	3226.63452759284
"AML-0693"	"2021-03-09-AML0693:GAGTGTTGTCCACTCT"	8.73113693770711	6.73640058124391	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGTTGTCCACTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1751.15520552935	48.5800713376397	0.0277417279657714	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1739.45967300978	1739.45967300978
"AML-0693"	"2021-03-09-AML0693:GAGTGTTGTCTTGCGG"	-5.72106872025188	-5.59338810360106	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGTTGTCTTGCGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3595.78516313069	40.4856568129868	0.011259197915411	4189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3589.59655945182	3589.59655945182
"AML-0693"	"2021-03-09-AML0693:GAGTGTTTCGCAATGT"	-0.163044015795547	11.3878431090149	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGTTTCGCAATGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1514.14975860949	27.4988939846755	0.0181612775277453	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1511.63348709996	1511.63348709996
"AML-0693"	"2021-03-09-AML0693:GAGTGTTTCTCGGTAA"	-6.77315650406535	-2.79978969013365	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTGTTTCTCGGTAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1887.77843611442	30.4662958752072	0.0161387031933235	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1875.75689339194	1875.75689339194
"AML-0693"	"2021-03-09-AML0693:GAGTTACAGCCTTTCC"	-7.1836727661198	3.06011459911195	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTTACAGCCTTTCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2815.63992451669	34.096457995382	0.0121096656211233	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2798.48706835612	2798.48706835612
"AML-0693"	"2021-03-09-AML0693:GAGTTACCAACTGTGT"	14.1738277870113	2.04129407489625	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTTACCAACTGTGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1318.09023280877	17.7058198901811	0.0134329345969366	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1309.6451011064	1309.6451011064
"AML-0693"	"2021-03-09-AML0693:GAGTTGTCACACACTA"	7.96837820586507	7.06921193683473	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTTGTCACACACTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1742.23538985143	34.6685540594027	0.0198988921137453	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1736.48134423111	1736.48134423111
"AML-0693"	"2021-03-09-AML0693:GAGTTTGGTACTCGTA"	-7.04654584351237	4.03867504680482	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTTTGGTACTCGTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1840.57930986804	35.6226368619315	0.019354035259956	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1832.53333422173	1832.53333422173
"AML-0693"	"2021-03-09-AML0693:GAGTTTGGTGATTCAC"	-1.43095586720164	9.69167611682741	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GAGTTTGGTGATTCAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1498.62791436388	39.5932636698707	0.0264196758183813	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1491.06092379974	1491.06092379974
"AML-0693"	"2021-03-09-AML0693:GATAGAAGTACGATGG"	-2.20245228233989	3.48160479152528	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGAAGTACGATGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3168.35339310584	31.7040204286858	0.0100064659761982	4675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3164.62906793062	3164.62906793062
"AML-0693"	"2021-03-09-AML0693:GATAGCTAGGCACCAA"	-2.01176319542583	3.42387507045595	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTAGGCACCAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3576.56958082386	43.6279032857738	0.0121982537456252	3574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3571.65953984965	3571.65953984965
"AML-0693"	"2021-03-09-AML0693:GATAGCTCACAATGAA"	10.9820953803951	-2.80439236080321	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTCACAATGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1809.47899864232	36.2524039638918	0.0200347193811547	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1802.4110316153	1802.4110316153
"AML-0693"	"2021-03-09-AML0693:GATAGCTGTGACTAAA"	-7.05718932572063	3.84094069087831	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTGTGACTAAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2510.09104734375	27.3686138439035	0.0109034347072254	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2498.44322422682	2498.44322422682
"AML-0693"	"2021-03-09-AML0693:GATAGCTGTGGAGAAA"	-7.03752646866496	-2.66839315807494	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTGTGGAGAAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1820.53127223699	38.9111974261788	0.0213735397021587	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1802.04450032297	1802.04450032297
"AML-0693"	"2021-03-09-AML0693:GATAGCTGTGGCTGAA"	11.3851849037105	-3.17826225673827	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTGTGGCTGAA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1702.40913952771	38.8236240238374	0.0228051078453491	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1700.38785385462	1700.38785385462
"AML-0693"	"2021-03-09-AML0693:GATAGCTTCTGTTGGA"	-1.60473821583446	3.72963688457338	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATAGCTTCTGTTGGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1655.26192118527	33.8239314648503	0.0204341868993339	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1655.26192118527	1655.26192118527
"AML-0693"	"2021-03-09-AML0693:GATCACAAGATCGCCC"	9.77400841292683	7.25297734821168	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCACAAGATCGCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1712.83946452383	50.6784366078193	0.0295873826225204	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1709.73651652248	1709.73651652248
"AML-0693"	"2021-03-09-AML0693:GATCACACACTTGGCG"	-2.47556720200236	3.85798547351686	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCACACACTTGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3421.66489215833	8.49900837270222	0.00248388098793076	4700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3414.73278760285	3414.73278760285
"AML-0693"	"2021-03-09-AML0693:GATCACACATACATCG"	9.62346329268758	7.89287183368532	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCACACATACATCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1785.18413416437	34.7504187884636	0.0194660136864425	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1778.70376020183	1778.70376020183
"AML-0693"	"2021-03-09-AML0693:GATCACATCCGTGACG"	9.89668049392049	6.76700065219728	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCACATCCGTGACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1736.81878078245	48.4404686648237	0.0278903413532879	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1728.43422548101	1728.43422548101
"AML-0693"	"2021-03-09-AML0693:GATCAGTGTCCAATCA"	8.11606564101521	6.17145679080812	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCAGTGTCCAATCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1639.2656939364	50.3889262773911	0.0307387182344987	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1625.94157340486	1625.94157340486
"AML-0693"	"2021-03-09-AML0693:GATCATGAGGTACTGG"	-6.72875438156779	3.91980526531068	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCATGAGGTACTGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2059.86851895477	40.7048507051781	0.0197608975187566	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2048.408777993	2048.408777993
"AML-0693"	"2021-03-09-AML0693:GATCATGCACGAGGTA"	11.8758942085201	-2.89536073124083	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCATGCACGAGGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1801.22897732558	46.7246085302702	0.0259404046450806	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1793.40386051	1793.40386051
"AML-0693"	"2021-03-09-AML0693:GATCATGTCTATCGGA"	-7.97120128098186	-4.55364277279051	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCATGTCTATCGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2135.25431120272	47.536356217162	0.0222626204137653	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2122.7229971836	2122.7229971836
"AML-0693"	"2021-03-09-AML0693:GATCCCTAGCTCACTA"	1.21142150935475	9.03320787036744	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCCCTAGCTCACTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1690.00097093808	48.1704098558957	0.0285031847225256	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1682.20426474675	1682.20426474675
"AML-0693"	"2021-03-09-AML0693:GATCCCTCAGTCGAGA"	-0.653861145407516	12.3497428664002	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCCCTCAGTCGAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1589.58315915974	37.1719276715394	0.0233847014906654	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1585.04788483459	1585.04788483459
"AML-0693"	"2021-03-09-AML0693:GATCGTATCGACATTG"	-1.91796706143077	3.50923750484315	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATCGTATCGACATTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3004.05933579877	51.6556905887072	0.0171952963688622	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2996.52369938911	2996.52369938911
"AML-0693"	"2021-03-09-AML0693:GATGACTAGCGGACAT"	14.127774854272	1.95388147914735	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGACTAGCGGACAT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1162.93029105575	3.50950540269936	0.00301781235701867	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1147.92334447362	1147.92334447362
"AML-0693"	"2021-03-09-AML0693:GATGACTAGGTGATCG"	12.3369299369747	-2.81147696888121	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGACTAGGTGATCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1986.35856720709	52.2536065987482	0.0263062306380157	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1980.09236185625	1980.09236185625
"AML-0693"	"2021-03-09-AML0693:GATGACTAGTGCACCC"	-8.24607787552531	-3.74405839359435	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGACTAGTGCACCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2724.41506629938	42.8150807178809	0.0157153295940465	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2718.98047473443	2718.98047473443
"AML-0693"	"2021-03-09-AML0693:GATGACTCACTGAATC"	14.2733494239742	2.04769978607026	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGACTCACTGAATC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1209.15115303369	13.1875285132245	0.0109064350475437	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1189.14179860853	1189.14179860853
"AML-0693"	"2021-03-09-AML0693:GATGACTTCTCATGGA"	8.43486084517781	6.56888196552125	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGACTTCTCATGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1707.4736461328	46.8728437453553	0.0274515766913979	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1699.73622582809	1699.73622582809
"AML-0693"	"2021-03-09-AML0693:GATGAGGCAAACCACT"	-8.58759437027629	-4.03794195568236	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGAGGCAAACCACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3069.17159879135	48.8435041957205	0.0159142304767043	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3061.33785045511	3061.33785045511
"AML-0693"	"2021-03-09-AML0693:GATGAGGTCTTACCGC"	-5.47757373276408	-5.55743267452391	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGAGGTCTTACCGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3153.97187668026	46.3780352019951	0.0147046444975948	3695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3133.9600423059	3133.9600423059
"AML-0693"	"2021-03-09-AML0693:GATGATCCAGAAGTGC"	-1.76526771012004	3.74678800189821	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGATCCAGAAGTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3005.24084805608	11.5438383291747	0.00384123566556796	3474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2999.18988442884	2999.18988442884
"AML-0693"	"2021-03-09-AML0693:GATGATCGTAACGTTC"	11.8129974800045	-2.80035474216612	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGATCGTAACGTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1506.68231213893	42.3124302951856	0.0280831798145407	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1504.75082531185	1504.75082531185
"AML-0693"	"2021-03-09-AML0693:GATGATCTCGTAGCCG"	-7.37201199951823	4.39438340747682	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGATCTCGTAGCCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1982.52435187191	46.2527527161972	0.0233302318191074	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1967.16559174739	1967.16559174739
"AML-0693"	"2021-03-09-AML0693:GATGCTAGTAGCTAAA"	8.30182041701619	6.75557134235231	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGCTAGTAGCTAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1653.84430857392	49.7661918742174	0.0300912193585683	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1645.77247518403	1645.77247518403
"AML-0693"	"2021-03-09-AML0693:GATGCTAGTTATTCTC"	-2.59190760079082	3.44037649715272	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGCTAGTTATTCTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3389.49321026672	10.5818732765553	0.00312196326120465	4665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3384.82856829023	3384.82856829023
"AML-0693"	"2021-03-09-AML0693:GATGCTAGTTGAATCC"	-7.08923612061198	3.59812042796937	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGCTAGTTGAATCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2709.41020811409	36.3358914855008	0.0134109967463335	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2684.70591717297	2684.70591717297
"AML-0693"	"2021-03-09-AML0693:GATGCTATCTGAGGTT"	-2.49099407616313	3.31194899165956	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGCTATCTGAGGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3422.96767688616	27.35567277507	0.00799179991087592	4811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3414.07472604262	3414.07472604262
"AML-0693"	"2021-03-09-AML0693:GATGGAGAGAGGACTC"	-6.94595704498942	-2.79462602054747	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGAGAGGACTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2825.52998145869	0.640970739291374	0.000226849739163083	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2799.68952391867	2799.68952391867
"AML-0693"	"2021-03-09-AML0693:GATGGAGAGGTTCCAT"	10.1084791618282	6.72701404178468	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGAGGTTCCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1716.48177674667	43.5464241074394	0.0253695813712482	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1710.01175080452	1710.01175080452
"AML-0693"	"2021-03-09-AML0693:GATGGAGCAAACAGGC"	1.88065542754475	-7.10460712825926	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	3	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000657462195923734	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGCAAACAGGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1637.91056330164	48.0502174343647	0.0293362888737386	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1637.91056330164	1637.91056330164
"AML-0693"	"2021-03-09-AML0693:GATGGAGCATCACCAA"	-2.54583106461223	4.07461497867433	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGCATCACCAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3480.49638575763	28.6015645873027	0.00821766823385933	4202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3475.49569331101	3475.49569331101
"AML-0693"	"2021-03-09-AML0693:GATGGAGGTCCATCTC"	-7.44573817673381	-2.88720204746398	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGGTCCATCTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3089.55547245776	12.2053023172627	0.00395050434474099	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3070.20871742732	3070.20871742732
"AML-0693"	"2021-03-09-AML0693:GATGGAGGTTTGAACC"	-8.41837344589885	-3.95877745067748	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGGAGGTTTGAACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2556.972954828	52.2042928061397	0.0204164430865681	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2542.1898938125	2542.1898938125
"AML-0693"	"2021-03-09-AML0693:GATGTTGAGCAGGGAG"	14.1919228034908	1.77676782691804	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGTTGAGCAGGGAG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1306.54082735091	2.95537318079598	0.00226198303101493	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1291.34440039994	1291.34440039994
"AML-0693"	"2021-03-09-AML0693:GATGTTGCACTGGAAG"	8.23939003524129	6.07548902118532	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGTTGCACTGGAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1672.40306920699	47.5212478608318	0.0284149489652426	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1672.40306920699	1672.40306920699
"AML-0693"	"2021-03-09-AML0693:GATGTTGGTATACCCA"	-1.31143091145213	9.5134067305359	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGTTGGTATACCCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1743.72146366586	48.8484444502963	0.0280139032914129	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1737.8799245399	1737.8799245399
"AML-0693"	"2021-03-09-AML0693:GATGTTGTCCACAAGT"	-7.82260642471965	-3.82893016254576	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATGTTGTCCACAAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2885.80867549687	0.320247912026738	0.000110973369352561	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2854.06605943485	2854.06605943485
"AML-0693"	"2021-03-09-AML0693:GATTCGAAGTTGCTCA"	-7.5065692466801	-3.24137046253356	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGAAGTTGCTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1921.087533023	16.0521491976544	0.00835576147454089	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1899.03079354655	1899.03079354655
"AML-0693"	"2021-03-09-AML0693:GATTCGAAGTTTGGCT"	0.517341722815674	-9.03049662029418	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGAAGTTTGGCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1935.00143575026	46.903425630114	0.0242394784642256	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1891.73184565143	1891.73184565143
"AML-0693"	"2021-03-09-AML0693:GATTCGACAGCTCGGT"	-8.81379065933879	-3.9545469514099	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGACAGCTCGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2542.48926464983	50.6349737294524	0.0199155113193472	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2537.16273410459	2537.16273410459
"AML-0693"	"2021-03-09-AML0693:GATTCGAGTCGTCGGT"	-5.84070001068767	-5.48661520397338	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGAGTCGTCGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3237.95887081549	46.391029582553	0.0143272448580761	3178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3230.13685873407	3230.13685873407
"AML-0693"	"2021-03-09-AML0693:GATTCGAGTGAGTAGC"	-6.79192290726359	3.88607761943666	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGAGTGAGTAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2238.08006147401	42.8186612384085	0.0191318719895158	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2216.74389273172	2216.74389273172
"AML-0693"	"2021-03-09-AML0693:GATTCGATCCAACCGG"	10.3591610389644	5.99009988391725	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCGATCCAACCGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1908.0749922224	38.4415212796631	0.0201467559903864	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1897.19029570189	1897.19029570189
"AML-0693"	"2021-03-09-AML0693:GATTCTTTCTGTGCTC"	-7.12269864502605	-2.80786611950072	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTCTTTCTGTGCTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2215.34217179341	24.0152157379062	0.0108404092350505	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2201.9556051162	2201.9556051162
"AML-0693"	"2021-03-09-AML0693:GATTGGTAGAAATGGG"	-8.98596892777141	-2.74466874515685	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTGGTAGAAATGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2928.56135708414	50.9360165311483	0.0173928459473573	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2922.25592887923	2922.25592887923
"AML-0693"	"2021-03-09-AML0693:GATTGGTGTACGTAGG"	-8.90231452408488	-2.9496219388214	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTGGTGTACGTAGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3306.8488994647	49.0695272162785	0.0148387569883286	3215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3295.29739301539	3295.29739301539
"AML-0693"	"2021-03-09-AML0693:GATTGGTGTCTGTTAG"	-2.8062404197758	3.489222026709	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTGGTGTCTGTTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3577.77710713355	25.5567526971218	0.00714319308661387	4895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3573.02968840289	3573.02968840289
"AML-0693"	"2021-03-09-AML0693:GATTGGTGTGACAGGT"	-8.34857020798381	-3.44388511097106	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTGGTGTGACAGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2431.8331267994	47.8479449738803	0.019675669537759	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2425.9217922945	2425.9217922945
"AML-0693"	"2021-03-09-AML0693:GATTGGTTCTTCCCGA"	8.07613720473592	7.65593574130861	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTGGTTCTTCCCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1771.23576970661	47.8466161260582	0.0270131266228796	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1763.59584300641	1763.59584300641
"AML-0693"	"2021-03-09-AML0693:GATTTCTAGGCGTTGA"	8.36259808120076	7.33227679813234	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTTCTAGGCGTTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1388.23599924139	45.3346185512228	0.0326562764371447	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1385.80110668018	1385.80110668018
"AML-0693"	"2021-03-09-AML0693:GATTTCTCAAACTCTG"	-0.0409202081268609	12.7807731398377	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTTCTCAAACTCTG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1914.39576519556	53.4324101227339	0.0279108484745712	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1904.1772724809	1904.1772724809
"AML-0693"	"2021-03-09-AML0693:GATTTCTCAATAACCC"	14.0302950340206	2.15980002963869	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GATTTCTCAATAACCC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1233.91109653669	31.1005380402734	0.0252048450877585	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1227.84655623184	1227.84655623184
"AML-0693"	"2021-03-09-AML0693:GCAACATAGAAGCGCT"	-8.59363875809367	1.21021733367769	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACATAGAAGCGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2731.43204881337	41.9239446810997	0.0153487049766854	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2704.27584278021	2704.27584278021
"AML-0693"	"2021-03-09-AML0693:GCAACATCACTTGTGA"	-2.32756028595622	3.35427925670473	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACATCACTTGTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3240.18700626354	15.4364558283133	0.00476406324649577	4429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3231.34464081726	3231.34464081726
"AML-0693"	"2021-03-09-AML0693:GCAACATCAGAGTCTT"	-6.95835624161418	3.43062279308168	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACATCAGAGTCTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2431.22161276549	39.7386245116446	0.0163451263772052	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2409.06874971669	2409.06874971669
"AML-0693"	"2021-03-09-AML0693:GCAACATCATTGTCGA"	8.18895496901814	6.41811606967775	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACATCATTGTCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1667.03258892185	39.9090790634381	0.0239401912887913	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1661.06402799726	1661.06402799726
"AML-0693"	"2021-03-09-AML0693:GCAACATGTATGTCAC"	8.40990032729451	6.4679121741089	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACATGTATGTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1509.67856207599	51.310611767665	0.0339877726667237	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1505.42988994996	1505.42988994996
"AML-0693"	"2021-03-09-AML0693:GCAACCGAGTCATGGG"	-7.72999272766765	-1.27487459098967	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACCGAGTCATGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3210.59262323978	32.2225396278518	0.0100363214549893	3050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3196.19243597448	3196.19243597448
"AML-0693"	"2021-03-09-AML0693:GCAACCGCATTGAGGG"	8.56610264357869	6.35596559131471	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACCGCATTGAGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1457.24008905109	48.0795486952578	0.0329935671249381	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1448.48013371744	1448.48013371744
"AML-0693"	"2021-03-09-AML0693:GCAACCGGTAACGCGA"	0.941631217568558	10.5719995268616	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACCGGTAACGCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1835.25928111135	31.4466566987932	0.0171347215199753	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1824.66479747155	1824.66479747155
"AML-0693"	"2021-03-09-AML0693:GCAACCGGTATACGGG"	-6.99815020981486	-2.62844159519347	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAACCGGTATACGGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2359.40823411129	7.06342223230243	0.00299372619378985	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2348.20287607842	2348.20287607842
"AML-0693"	"2021-03-09-AML0693:GCACATAGTCACTTAG"	8.92576565322224	5.38860938632814	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACATAGTCACTTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1757.46921354985	46.9911649833915	0.0267379733432006	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1753.36990934314	1753.36990934314
"AML-0693"	"2021-03-09-AML0693:GCACGGTGTGAGTGAC"	8.85417713698689	7.01339910114137	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGGTGTGAGTGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1709.36549223384	38.1314189471257	0.0223073527109142	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1707.45370711809	1707.45370711809
"AML-0693"	"2021-03-09-AML0693:GCACGGTTCAACCTTT"	0.729471762746018	10.168954826239	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGGTTCAACCTTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1817.26163239929	43.1861295772975	0.0237643984814007	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1811.7087775532	1811.7087775532
"AML-0693"	"2021-03-09-AML0693:GCACGTGAGGAGAATG"	0.891315420239609	-9.07232286846312	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGTGAGGAGAATG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2914.95859398302	39.3275755599226	0.0134916412332928	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2906.3455150378	2906.3455150378
"AML-0693"	"2021-03-09-AML0693:GCACGTGGTCGAATTC"	-6.1509669822758	-0.574324928876482	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	85	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.725	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGTGGTCGAATTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1672.49246951136	53.8543367366263	0.0322000473654512	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1574.27430404602	1574.27430404602
"AML-0693"	"2021-03-09-AML0693:GCACGTGGTCGCACAC"	-2.23377452316936	3.48116800868837	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGTGGTCGCACAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1900.53205108404	49.1781172315967	0.0258759736272514	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1896.18821601839	1896.18821601839
"AML-0693"	"2021-03-09-AML0693:GCACGTGTCCATTTAC"	9.77919258651082	7.23338744724122	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACGTGTCCATTTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2086.625172674	37.7710665329204	0.0181015100496065	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2066.32011647415	2066.32011647415
"AML-0693"	"2021-03-09-AML0693:GCACTAAAGGTCCTGC"	-8.69358478012736	-3.85299160396727	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACTAAAGGTCCTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2988.71277124644	40.3763575001635	0.0135096145366035	3800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2980.23636621798	2980.23636621798
"AML-0693"	"2021-03-09-AML0693:GCACTAACAGCTTTGA"	-0.998486380011398	11.5665054091248	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCACTAACAGCTTTGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1373.82458120913	42.802857938602	0.0311559849227115	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1352.74405558629	1352.74405558629
"AML-0693"	"2021-03-09-AML0693:GCAGCCAAGCAAGGAA"	8.67965282973592	7.47089336002199	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGCCAAGCAAGGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1855.32718763916	38.2271182255365	0.0206039767434116	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1847.19447835746	1847.19447835746
"AML-0693"	"2021-03-09-AML0693:GCAGCCAAGGGACTGT"	10.9271255927974	-2.21954276477965	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGCCAAGGGACTGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1901.61901064417	44.567717523042	0.023436722747079	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1889.92435645064	1889.92435645064
"AML-0693"	"2021-03-09-AML0693:GCAGCTGAGCCGCTTG"	-2.75159702721294	4.01905748927919	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGCTGAGCCGCTTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3143.71085380757	40.4307739046254	0.0128608436923061	3045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3133.95955985098	3133.95955985098
"AML-0693"	"2021-03-09-AML0693:GCAGCTGCAATCCAGT"	1.1658659177715	-9.77228357708129	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGCTGCAATCCAGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2280.44709604545	43.5191405364465	0.0190836001466176	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2272.80973668968	2272.80973668968
"AML-0693"	"2021-03-09-AML0693:GCAGCTGGTCGTACAT"	10.6274458366329	5.95082662189332	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGCTGGTCGTACAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1732.78498753826	25.4924928554155	0.0147118615631777	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1724.28875592618	1724.28875592618
"AML-0693"	"2021-03-09-AML0693:GCAGGCTCACAGCGCT"	-6.96871886673625	3.80937073314515	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGGCTCACAGCGCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2579.92379390407	38.7887299417745	0.0150348355379433	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2559.34746562773	2559.34746562773
"AML-0693"	"2021-03-09-AML0693:GCAGGCTTCCGGCTTT"	11.8774477439815	-3.06797172939452	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGGCTTCCGGCTTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2115.19469041134	36.9888279463132	0.0174871978045293	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2107.26803744689	2107.26803744689
"AML-0693"	"2021-03-09-AML0693:GCAGGCTTCTCATTGT"	-2.11850676956828	2.91350982272951	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGGCTTCTCATTGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2613.31150805539	40.4302027458804	0.0154708700517548	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2590.2591305745	2590.2591305745
"AML-0693"	"2021-03-09-AML0693:GCAGTTAAGATCGACG"	-8.28432307663615	-4.43373205578002	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGTTAAGATCGACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2299.92913656995	52.6679099554378	0.0228997968319951	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2293.91004597638	2293.91004597638
"AML-0693"	"2021-03-09-AML0693:GCAGTTAAGCCTGTGC"	9.67597450789754	6.84385058963624	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGTTAAGCCTGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1626.53507780567	43.271780166569	0.0266036562979915	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1616.89059901984	1616.89059901984
"AML-0693"	"2021-03-09-AML0693:GCAGTTAAGTTCACTG"	-7.24762425842937	4.54956767642824	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	67	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.75	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGTTAAGTTCACTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1934.35707208023	45.3626545683984	0.0234510242308133	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1925.30428207569	1925.30428207569
"AML-0693"	"2021-03-09-AML0693:GCAGTTATCCATGCAA"	8.18176807936971	6.54145763004152	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCAGTTATCCATGCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1680.36773076495	38.4333278373472	0.0228719744694522	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1678.19038160143	1678.19038160143
"AML-0693"	"2021-03-09-AML0693:GCATCGGCATGTTCAG"	-8.18900809708293	-3.97570087825926	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCGGCATGTTCAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2792.11858852138	52.4292273515068	0.0187775789921845	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2783.45288022379	2783.45288022379
"AML-0693"	"2021-03-09-AML0693:GCATCTCAGTTAGTAG"	-6.98757634583171	3.84208319270936	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCAGTTAGTAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2299.48390436416	34.3407316949298	0.0149341039655703	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2291.8638656819	2291.8638656819
"AML-0693"	"2021-03-09-AML0693:GCATCTCCAACACGAG"	-6.98154864731486	3.9084467657837	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCCAACACGAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2293.1116222766	39.9242126853808	0.0174104968539403	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2280.32987752839	2280.32987752839
"AML-0693"	"2021-03-09-AML0693:GCATCTCCATTGTGCA"	11.1732918220455	5.47740218723146	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	48	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000700770847932726	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCCATTGTGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1839.20267743267	49.5832194914963	0.0269590840095498	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1830.15029872667	1830.15029872667
"AML-0693"	"2021-03-09-AML0693:GCATCTCGTCGCTCGA"	-6.9123571914738	3.79091165149537	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCGTCGCTCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2182.22870011597	51.3843794634609	0.0235467435016	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2168.44150072818	2168.44150072818
"AML-0693"	"2021-03-09-AML0693:GCATCTCTCTAAGCCA"	1.13653268393819	-9.54655649578246	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCTCTAAGCCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2623.9605608678	38.1785197583431	0.0145499594497398	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2614.507559071	2614.507559071
"AML-0693"	"2021-03-09-AML0693:GCATCTCTCTGAGTCA"	-4.85468039932902	2.57933352077333	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATCTCTCTGAGTCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3458.22564836474	23.7861343905427	0.0068781325480569	3884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3448.69084823821	3448.69084823821
"AML-0693"	"2021-03-09-AML0693:GCATGATAGATGCTTC"	-7.76925073090251	-2.75985457813414	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATGATAGATGCTTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3387.71863731893	0	0	3922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3350.90277973082	3350.90277973082
"AML-0693"	"2021-03-09-AML0693:GCATGATAGGATTTGA"	11.4121681648189	-2.7818322411743	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATGATAGGATTTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1959.04324161049	32.098732172805	0.0163849023293724	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1948.51432373573	1948.51432373573
"AML-0693"	"2021-03-09-AML0693:GCATGATCATTACTCT"	-7.04740653458293	3.75917742336122	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATGATCATTACTCT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2556.56490829895	19.5428174265988	0.0076441702548448	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2544.93601951648	2544.93601951648
"AML-0693"	"2021-03-09-AML0693:GCATGATGTTGAGTCT"	11.295616765588	-2.68515732204589	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATGATGTTGAGTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1742.70268546655	47.87714449505	0.0274729274788675	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1734.03855403614	1734.03855403614
"AML-0693"	"2021-03-09-AML0693:GCATTAGAGCCAGAGT"	8.25655998763387	6.421510673407	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATTAGAGCCAGAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1475.47264604951	35.5849368884871	0.0241176527289501	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1473.20128629417	1473.20128629417
"AML-0693"	"2021-03-09-AML0693:GCATTAGGTATCAGGG"	-2.36976895752605	3.49046394908754	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATTAGGTATCAGGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1497.84768397945	49.5393001755646	0.0330736567579085	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1497.84768397945	1497.84768397945
"AML-0693"	"2021-03-09-AML0693:GCATTAGGTTAGAGTA"	-7.21134887161906	4.2290262945923	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATTAGGTTAGAGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1932.54141566684	43.4535425193874	0.022485180481575	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1916.67376293783	1916.67376293783
"AML-0693"	"2021-03-09-AML0693:GCATTAGTCATTGCGA"	7.82336582717244	6.13574931705324	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATTAGTCATTGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1499.77467212518	50.8911334547572	0.0339325195981905	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1485.86645004719	1485.86645004719
"AML-0693"	"2021-03-09-AML0693:GCATTAGTCCGCACTT"	8.17600025710408	6.84921405399171	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCATTAGTCCGCACTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1517.46540733435	51.6141202326791	0.034013375186817	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1512.87963781125	1512.87963781125
"AML-0693"	"2021-03-09-AML0693:GCCAACGGTTCGGTCG"	7.63547100600545	6.49819657886354	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAACGGTTCGGTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1812.37138743496	47.5605472124674	0.0262421640190312	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1804.04338239785	1804.04338239785
"AML-0693"	"2021-03-09-AML0693:GCCAACGGTTGGAGGT"	-2.02715859833415	3.25024530971376	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAACGGTTGGAGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1597.96080208008	32.8824706891441	0.0205777705224939	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1587.9127879563	1587.9127879563
"AML-0693"	"2021-03-09-AML0693:GCCAACGGTTGGTACT"	-8.07578692856486	-3.13504054462584	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAACGGTTGGTACT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1872.09387709734	43.5371321926652	0.023255848825364	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1868.2202831799	1868.2202831799
"AML-0693"	"2021-03-09-AML0693:GCCAGCACACGCTGCA"	14.2072893577511	1.97327122772066	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAGCACACGCTGCA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1315.56279581715	4.47757266395635	0.00340354157033998	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1298.9052235229	1298.9052235229
"AML-0693"	"2021-03-09-AML0693:GCCAGGTAGAGCATCG"	-6.9410174888676	3.92962167346803	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAGGTAGAGCATCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2079.8569340717	39.5725943798329	0.0190265944409755	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2068.45620389856	2068.45620389856
"AML-0693"	"2021-03-09-AML0693:GCCAGGTAGCTTCATG"	11.5367933708126	-2.60299184238585	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAGGTAGCTTCATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1827.20875037189	44.1225430795761	0.0241475108252387	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1823.30224635871	1823.30224635871
"AML-0693"	"2021-03-09-AML0693:GCCAGGTGTACTTGTG"	-6.99695907059367	3.99154923045961	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAGGTGTACTTGTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2361.59987947068	45.5982533944784	0.0193082044891951	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2345.74842117156	2345.74842117156
"AML-0693"	"2021-03-09-AML0693:GCCAGTGTCGAAGAAT"	11.1130520301754	-2.48356296932372	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCAGTGTCGAAGAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2029.18557638294	46.8562501647256	0.0230911606656734	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2018.13189615872	2018.13189615872
"AML-0693"	"2021-03-09-AML0693:GCCATGGAGAATAACC"	-4.91082559052165	2.93221447551576	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATGGAGAATAACC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3103.1227217132	31.4877514367182	0.010147117681293	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3093.66013581546	3093.66013581546
"AML-0693"	"2021-03-09-AML0693:GCCATGGCACCAGTTA"	1.46154787120168	-10.3906851044861	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATGGCACCAGTTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2232.35788415501	44.4576386202116	0.0199151036380708	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2221.14767116383	2221.14767116383
"AML-0693"	"2021-03-09-AML0693:GCCATGGTCATGGAGG"	-7.15342603150066	3.76150295818178	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATGGTCATGGAGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2108.47639703121	49.3042837029222	0.0233838442642014	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2093.37310943932	2093.37310943932
"AML-0693"	"2021-03-09-AML0693:GCCATTCAGAAACTAC"	-5.77821956101115	-5.57199051296385	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATTCAGAAACTAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3407.63251992267	50.7006699358445	0.0148785614761638	3518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3400.01806943897	3400.01806943897
"AML-0693"	"2021-03-09-AML0693:GCCATTCAGCTGAAAT"	0.371895958750886	11.3243169554505	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATTCAGCTGAAAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1869.7616484786	31.3973271289476	0.0167921548473813	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1865.7757363281	1865.7757363281
"AML-0693"	"2021-03-09-AML0693:GCCATTCAGGAGAGTA"	-7.32352481308635	-3.30851104175719	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATTCAGGAGAGTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2189.92362810769	27.9057357017519	0.0127427894487194	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2176.66207512663	2176.66207512663
"AML-0693"	"2021-03-09-AML0693:GCCATTCGTTATGTCG"	-7.34677491608317	-2.97553684627684	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCATTCGTTATGTCG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	3113.93866478676	29.5302382189256	0.00948324337690442	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	3087.26817896201	3087.26817896201
"AML-0693"	"2021-03-09-AML0693:GCCCAGAAGCACCCAC"	11.6770788627559	-2.73072650348815	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGAAGCACCCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1763.0495875495	41.3679081277148	0.0234638369900946	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1752.28702838068	1752.28702838068
"AML-0693"	"2021-03-09-AML0693:GCCCAGAAGCTTAAGA"	-7.71656976166423	-2.47302272236022	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGAAGCTTAAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3113.07997687378	49.534646731072	0.0159117809690247	2843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3091.1296405306	3091.1296405306
"AML-0693"	"2021-03-09-AML0693:GCCCAGAAGGATGTTA"	-7.98695216599162	-3.48779656803282	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGAAGGATGTTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2281.98958064677	24.1801805060496	0.0105960959292357	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2272.05063669634	2272.05063669634
"AML-0693"	"2021-03-09-AML0693:GCCCAGAAGTGCGACA"	-6.94782290878947	3.71605274761049	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGAAGTGCGACA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2376.91086138735	47.2227767711074	0.0198672897407454	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2359.94612138741	2359.94612138741
"AML-0693"	"2021-03-09-AML0693:GCCCAGACAGCTGGTC"	14.2343384223873	2.06599519336549	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGACAGCTGGTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1117.39506550692	0	0	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1097.62854370376	1097.62854370376
"AML-0693"	"2021-03-09-AML0693:GCCCAGACAGTAGTGG"	-8.06715331497844	-4.55739595806273	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGACAGTAGTGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2640.56276999393	48.7954413534349	0.0184791825090933	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2633.03973191773	2633.03973191773
"AML-0693"	"2021-03-09-AML0693:GCCCAGAGTTCACCGG"	11.0135284858638	-2.28533723270568	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGAGTTCACCGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1380.24896547413	48.5723401108453	0.0351909991065708	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1372.8805932318	1372.8805932318
"AML-0693"	"2021-03-09-AML0693:GCCCAGATCATGCTAG"	-1.79390368881877	3.33531234348146	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCAGATCATGCTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3251.96044956687	46.0744231357184	0.014168199106436	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3243.32236854662	3243.32236854662
"AML-0693"	"2021-03-09-AML0693:GCCCGAAGTAAGATCA"	1.40726151046101	-9.9688406220642	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCGAAGTAAGATCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2508.42221273057	31.6562945040386	0.0126200024634524	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2501.82113981194	2501.82113981194
"AML-0693"	"2021-03-09-AML0693:GCCCGAAGTACTCCGG"	-7.02580867233928	-0.605521761533342	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCCGAAGTACTCCGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3411.79901283767	31.6346065600411	0.00927211903192676	4682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3400.82077475495	3400.82077475495
"AML-0693"	"2021-03-09-AML0693:GCCGATGCATTGAAGA"	8.65367474135701	7.28770063007203	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCGATGCATTGAAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1691.02118318569	45.2009538454692	0.0267299749375793	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1683.32683031908	1683.32683031908
"AML-0693"	"2021-03-09-AML0693:GCCGATGGTCCAACGC"	9.65946831282918	7.10738656604616	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCGATGGTCCAACGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1844.74871696067	51.3353115658005	0.0278278071662673	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1833.22940303944	1833.22940303944
"AML-0693"	"2021-03-09-AML0693:GCCGATGTCTGCACCT"	-9.22038588944133	-2.02443673526915	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCGATGTCTGCACCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3198.46456579241	47.0216091053852	0.0147013068733922	3422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3191.13881423325	3191.13881423325
"AML-0693"	"2021-03-09-AML0693:GCCTGTTAGTGACACG"	-8.72759566727336	0.734249211195387	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCTGTTAGTGACACG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2239.5476362702	48.2726336867886	0.0215546358134998	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2221.93735872949	2221.93735872949
"AML-0693"	"2021-03-09-AML0693:GCCTGTTCACACACTA"	-2.55709348145183	3.31077287280885	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCTGTTCACACACTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3468.86011204976	20.9165512607061	0.00602980534961568	4317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3463.86730792913	3463.86730792913
"AML-0693"	"2021-03-09-AML0693:GCCTGTTTCAAGCCAT"	8.52053703841512	6.84868428790895	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCTGTTTCAAGCCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1775.33106693581	47.7986179652564	0.0269237771227403	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1768.33704658579	1768.33704658579
"AML-0693"	"2021-03-09-AML0693:GCCTGTTTCCCAGCGA"	8.94049229201619	6.71062705600587	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCCTGTTTCCCAGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1628.68886318418	46.9140937192446	0.0288048225660025	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1622.61943678006	1622.61943678006
"AML-0693"	"2021-03-09-AML0693:GCGAGAACATTCTCTA"	10.2785192924434	7.07779738986818	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGAGAACATTCTCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1759.57340261555	47.9449916833575	0.0272480770691855	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1753.88846427047	1753.88846427047
"AML-0693"	"2021-03-09-AML0693:GCGAGAATCAGGCGAA"	-7.42243562164958	-4.88212253963622	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGAGAATCAGGCGAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1791.92547866123	47.5400938598142	0.0265301735066192	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1778.33154223458	1778.33154223458
"AML-0693"	"2021-03-09-AML0693:GCGGAAACACGCCAGT"	9.00013699111287	7.19672296130983	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGAAACACGCCAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.17224323577	40.2388392086239	0.0227444441107826	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1765.60707468191	1765.60707468191
"AML-0693"	"2021-03-09-AML0693:GCGGAAACAGTTAGAA"	8.98368134078328	6.8927340277466	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGAAACAGTTAGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1829.82848625047	50.8661506399837	0.0277983160838283	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1818.6214024775	1818.6214024775
"AML-0693"	"2021-03-09-AML0693:GCGGATCAGAGTTGAT"	12.3186851936275	-2.66306617176207	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGATCAGAGTTGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1349.93827522603	42.0977291113294	0.0311849288844562	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1342.46534532754	1342.46534532754
"AML-0693"	"2021-03-09-AML0693:GCGGATCAGCCTAGGA"	-2.11238918724712	3.84347889507142	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGATCAGCCTAGGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1495.84777025351	37.5965079053628	0.0251339131247232	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1493.37799859893	1493.37799859893
"AML-0693"	"2021-03-09-AML0693:GCGGATCCAAGATGGC"	-6.94877944412883	3.58711860263673	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGATCCAAGATGGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2366.0810999541	40.9948420999899	0.0173260511234316	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2352.17454669521	2352.17454669521
"AML-0693"	"2021-03-09-AML0693:GCGGATCCAGCGATTT"	-7.54969106140788	-2.23867680942687	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGGATCCAGCGATTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2458.33041317338	21.5961411960312	0.00878488143021973	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2450.82346664015	2450.82346664015
"AML-0693"	"2021-03-09-AML0693:GCGTGCAAGAGGTATT"	-8.14427409592326	-4.01274683391722	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAAGAGGTATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2851.33918880734	52.3195061408921	0.0183490993797817	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2848.80388493466	2848.80388493466
"AML-0693"	"2021-03-09-AML0693:GCGTGCAAGCAGCCTC"	8.49230541762654	6.92186305606691	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAAGCAGCCTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1979.76401635299	37.7708143099646	0.0190784426820445	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1958.43188978713	1958.43188978713
"AML-0693"	"2021-03-09-AML0693:GCGTGCAAGCTTTCTT"	-7.76690135422404	-2.49230673229369	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAAGCTTTCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.05143907001	32.2943098254038	0.0147257420642621	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2176.10507792214	2176.10507792214
"AML-0693"	"2021-03-09-AML0693:GCGTGCAGTCTTCCGT"	-7.52268300476726	-2.52773430263671	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAGTCTTCCGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3028.01218179895	0.733590887277863	0.000242268142673731	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3004.00027104922	3004.00027104922
"AML-0693"	"2021-03-09-AML0693:GCGTGCAGTGCAACGA"	-1.86794803562816	11.4286155470642	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAGTGCAACGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1771.10696939258	44.1781738581253	0.0249438202331035	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1762.37166586473	1762.37166586473
"AML-0693"	"2021-03-09-AML0693:GCGTGCAGTTACCTGA"	0.908534784882706	9.66700360858766	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTGCAGTTACCTGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1492.65532189818	41.2655545656832	0.0276457357303403	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1488.72612706131	1488.72612706131
"AML-0693"	"2021-03-09-AML0693:GCGTTTCAGACGGTCA"	11.8377977806026	-2.66742851650389	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCAGACGGTCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1276.14875382695	41.3290258987521	0.0323857432566646	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1271.4284430701	1271.4284430701
"AML-0693"	"2021-03-09-AML0693:GCGTTTCAGCCTTGAT"	0.987485011189622	-8.97812368786009	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCAGCCTTGAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2814.90927581097	35.4496022358708	0.0125935150168056	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2801.70374511867	2801.70374511867
"AML-0693"	"2021-03-09-AML0693:GCGTTTCAGGAGTCTG"	9.57935204085652	7.03529403293458	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCAGGAGTCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1826.43301614856	42.5670367935308	0.0233061034361352	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1820.902418954	1820.902418954
"AML-0693"	"2021-03-09-AML0693:GCGTTTCAGTTTCGAC"	-8.5476373237675	-4.48274376308592	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCAGTTTCGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2704.12108607764	45.0773185285755	0.0166698594824985	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2693.97468875723	2693.97468875723
"AML-0693"	"2021-03-09-AML0693:GCGTTTCCATTGTCGA"	0.972161431878251	9.70727918231813	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCCATTGTCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1843.95552938085	34.6808497266365	0.0188078558154173	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1835.25935440114	1835.25935440114
"AML-0693"	"2021-03-09-AML0693:GCGTTTCGTACCTTCC"	-8.59017215195354	-3.20703723346861	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCGTACCTTCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2884.03597623483	48.5232430791935	0.016824770383947	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2875.64729316505	2875.64729316505
"AML-0693"	"2021-03-09-AML0693:GCGTTTCGTCTTTCAT"	1.38249566134755	10.6097984083923	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCGTCTTTCAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1809.51482437518	33.7761634285325	0.0186658672112263	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1805.9050628855	1805.9050628855
"AML-0693"	"2021-03-09-AML0693:GCGTTTCTCCTTACCG"	9.44954456862752	7.44981143558351	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCGTTTCTCCTTACCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1853.91244412708	45.4809938889728	0.0245324389687603	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1842.29948204086	1842.29948204086
"AML-0693"	"2021-03-09-AML0693:GCTACAACAAAGCTCT"	-8.42547545853313	-4.38424637233885	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACAACAAAGCTCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2462.95766306716	46.5957267272315	0.0189186064486407	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2454.44407389088	2454.44407389088
"AML-0693"	"2021-03-09-AML0693:GCTACAACATGTGCTA"	-6.99504313889201	3.92048595035402	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACAACATGTGCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2258.1169663591	43.2172943823911	0.0191386429605872	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2248.02052545299	2248.02052545299
"AML-0693"	"2021-03-09-AML0693:GCTACAAGTTGCTAGT"	-8.17814002457317	-4.64648201381835	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACAAGTTGCTAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2680.64013244311	40.7057146059711	0.0151850724434512	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2672.99695417704	2672.99695417704
"AML-0693"	"2021-03-09-AML0693:GCTACCTAGTACAGAT"	8.83414520797078	6.31231353366701	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTAGTACAGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1838.81182875547	40.8742416914647	0.0222286158117272	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1836.95563994594	1836.95563994594
"AML-0693"	"2021-03-09-AML0693:GCTACCTAGTGCTCGC"	9.80296673354451	7.189914680365	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTAGTGCTCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1672.19398835752	41.459958653714	0.0247937493749976	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1666.66651133572	1666.66651133572
"AML-0693"	"2021-03-09-AML0693:GCTACCTGTCACGTGC"	-8.23758635941203	-3.69890930568846	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTGTCACGTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3331.38087725493	25.7170091118492	0.00771962440183068	3185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3306.89633100744	3306.89633100744
"AML-0693"	"2021-03-09-AML0693:GCTACCTGTGATGGCA"	-2.42427740517314	3.45382831180421	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTGTGATGGCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1879.0808645629	42.4559138063199	0.022593979113398	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1877.11029729679	1877.11029729679
"AML-0693"	"2021-03-09-AML0693:GCTACCTGTGATTCAC"	8.15975822982137	6.29550788486329	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTGTGATTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1577.24503397101	49.9813019655709	0.0316889899090275	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1565.26679159521	1565.26679159521
"AML-0693"	"2021-03-09-AML0693:GCTACCTTCCGACATA"	11.888372083276	-2.91986157810362	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTACCTTCCGACATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2044.81322360928	53.1049292684647	0.0259705525450045	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2036.13999291397	2036.13999291397
"AML-0693"	"2021-03-09-AML0693:GCTCAAAAGACGATAT"	-7.58122287216838	4.93181178653566	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTCAAAAGACGATAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1491.63823931179	51.0847622384162	0.0342474206493832	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1487.05769708537	1487.05769708537
"AML-0693"	"2021-03-09-AML0693:GCTCAAACACGAGGAT"	-4.32692609253581	2.50822684848634	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTCAAACACGAGGAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3430.33139074103	29.8854253203226	0.00871211026461985	3288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3422.55142852854	3422.55142852854
"AML-0693"	"2021-03-09-AML0693:GCTCAAATCAGTCACA"	-7.00564179840739	-2.75503208553465	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTCAAATCAGTCACA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1922.21064773091	41.4234721475911	0.0215499129590661	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1913.54496034076	1913.54496034076
"AML-0693"	"2021-03-09-AML0693:GCTCAAATCGGTCTAA"	-7.48117766800578	-3.42539098179015	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTCAAATCGGTCTAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2256.21837717286	27.3501013434425	0.0121220984724507	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2246.51042704677	2246.51042704677
"AML-0693"	"2021-03-09-AML0693:GCTGAATCACCGTGAC"	8.72257008132283	5.95937583530275	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGAATCACCGTGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1487.97161342765	44.7299681253887	0.0300610359241665	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1481.63708294485	1481.63708294485
"AML-0693"	"2021-03-09-AML0693:GCTGAATCATATAGCC"	-6.94045529785808	3.79294393146364	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGAATCATATAGCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2144.56694576501	54.1053311608458	0.0252290241009685	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2130.20313723971	2130.20313723971
"AML-0693"	"2021-03-09-AML0693:GCTGAATGTCGCTTGG"	-7.75391612473186	-4.10007336055907	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGAATGTCGCTTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1505.9489662692	49.6764600307105	0.0329868150537516	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1501.31376388221	1501.31376388221
"AML-0693"	"2021-03-09-AML0693:GCTGAATGTGAGTTTC"	-2.8606358570164	3.57516214931337	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGAATGTGAGTTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3386.59729457945	26.4869282244407	0.00782110357993713	4411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3380.64434012737	3380.64434012737
"AML-0693"	"2021-03-09-AML0693:GCTGCAGAGCGTCTGC"	-7.4497312110966	-4.55962469494017	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGCAGAGCGTCTGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1747.81652233685	44.1201454836333	0.0252430074437357	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1743.48073042952	1743.48073042952
"AML-0693"	"2021-03-09-AML0693:GCTGCAGCACCCTATC"	-9.05538974228557	-1.98625590717467	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGCAGCACCCTATC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3654.93027531534	0	0	4938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3639.96818468078	3639.96818468078
"AML-0693"	"2021-03-09-AML0693:GCTGCAGCATGTCTAG"	-2.3021801513737	3.9026148089203	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGCAGCATGTCTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3569.09849657714	16.9714128106441	0.00475509791251771	5092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3553.9321290892	3553.9321290892
"AML-0693"	"2021-03-09-AML0693:GCTGCAGTCCGCAAAT"	0.797932167618912	8.84994504535524	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGCAGTCCGCAAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1624.64401081885	40.666660770421	0.0250311209714947	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1618.80762876222	1618.80762876222
"AML-0693"	"2021-03-09-AML0693:GCTGCAGTCTCACGAA"	14.3315359550411	1.97069273078767	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGCAGTCTCACGAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1456.5944576423	1.89981015035863	0.00130428214963397	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1443.26887865589	1443.26887865589
"AML-0693"	"2021-03-09-AML0693:GCTGGGTAGAAACTAC"	-2.35563693466838	3.93883631313173	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGGGTAGAAACTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3526.46499319407	17.4309348410238	0.00494289178388692	4202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3521.45393653289	3521.45393653289
"AML-0693"	"2021-03-09-AML0693:GCTGGGTGTGCAATGG"	10.7392651039058	-2.36028053676756	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGGGTGTGCAATGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1548.33458785728	54.2731378481312	0.0350525902306679	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1544.10702776851	1544.10702776851
"AML-0693"	"2021-03-09-AML0693:GCTGGGTTCTTCTTCC"	9.65850796279256	7.2336125143799	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTGGGTTCTTCTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2215.01658100182	34.9889355631759	0.0157962409235559	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2210.18083874464	2210.18083874464
"AML-0693"	"2021-03-09-AML0693:GCTTCACCACTGCACG"	8.20326008376424	6.59882018649904	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTCACCACTGCACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1745.30989284366	47.8747863991267	0.027430536316461	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1741.02454340148	1741.02454340148
"AML-0693"	"2021-03-09-AML0693:GCTTCACCATAGCTGT"	-2.57459531250651	10.4100513228211	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTCACCATAGCTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1731.63755433252	41.8691286458691	0.0241789215884776	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1727.13068146401	1727.13068146401
"AML-0693"	"2021-03-09-AML0693:GCTTCACGTTCAGGTT"	11.1182676750118	6.04862878406373	"2021-03-09-AML0693"	"AML0693"	"Pre-B"	"Pre-B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTCACGTTCAGGTT"	"Pre-B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1814.34621729555	41.4109086907631	0.0228241491596295	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1807.619945413	1807.619945413
"AML-0693"	"2021-03-09-AML0693:GCTTCACTCTTTCTAG"	9.40258945998494	6.97155091846315	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTCACTCTTTCTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1744.91439136869	46.1002691051506	0.0264197884625103	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1737.3119676124	1737.3119676124
"AML-0693"	"2021-03-09-AML0693:GCTTGGGAGCTAAATG"	10.8776470619137	-2.78874995624694	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGAGCTAAATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1767.40041554239	51.0684729068553	0.0288946819621421	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1762.16703592503	1762.16703592503
"AML-0693"	"2021-03-09-AML0693:GCTTGGGAGTGACACG"	8.13484158095662	6.47787330234376	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGAGTGACACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1647.5821572374	47.4091715450695	0.0287749969473834	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1633.60066411886	1633.60066411886
"AML-0693"	"2021-03-09-AML0693:GCTTGGGCAGAAATTG"	-9.18605647507365	-4.28288032924803	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGCAGAAATTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2178.1227164844	47.0214162204615	0.0215880472962315	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2170.0507315819	2170.0507315819
"AML-0693"	"2021-03-09-AML0693:GCTTGGGCAGACAAAT"	1.07106616076772	-10.425223373529	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGCAGACAAAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2315.26002421947	12.6426496269725	0.00546057440404976	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2304.36898897859	2304.36898897859
"AML-0693"	"2021-03-09-AML0693:GCTTGGGCAGAGTGTG"	-7.41243062439616	-2.61266114627989	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGCAGAGTGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2671.40911471193	15.8856516672837	0.00594654393435981	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2651.8230646979	2651.8230646979
"AML-0693"	"2021-03-09-AML0693:GCTTGGGCATGGTGGA"	-7.16588149491008	-2.78873374378356	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGCATGGTGGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2757.82254090384	22.4141034963853	0.00812746402784838	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2744.65423691257	2744.65423691257
"AML-0693"	"2021-03-09-AML0693:GCTTGGGGTGCCTACG"	8.1487156349117	6.59184691989747	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGGTGCCTACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1710.33176103912	47.3534597058104	0.0276867101368922	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1710.33176103912	1710.33176103912
"AML-0693"	"2021-03-09-AML0693:GCTTGGGTCGGCATTA"	-7.04885516586955	-2.71182753955992	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTGGGTCGGCATTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1805.46771253472	43.1970947917178	0.0239257088298039	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1790.79297899827	1790.79297899827
"AML-0693"	"2021-03-09-AML0693:GCTTTCGTCCAAATGC"	-7.1085709137028	-2.73986985599669	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTTCGTCCAAATGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2489.47047036893	8.76960639228164	0.00352267941984546	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2474.82762100071	2474.82762100071
"AML-0693"	"2021-03-09-AML0693:GCTTTCGTCCGTTGGG"	8.88624348220174	6.16197822177736	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTTCGTCCGTTGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1551.14815115389	53.1733791855645	0.0342800132572825	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1547.22205589587	1547.22205589587
"AML-0693"	"2021-03-09-AML0693:GCTTTCGTCGCTACAA"	0.833766301243943	-8.53449823772582	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GCTTTCGTCGCTACAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1425.02640783125	49.7095577900397	0.034883253753657	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1414.28239419578	1414.28239419578
"AML-0693"	"2021-03-09-AML0693:GGAACCCTCATCACAG"	-8.72079787674602	-4.55566885387572	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAACCCTCATCACAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2773.74902959935	49.0094248377323	0.017669019191982	2535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2770.07119868013	2770.07119868013
"AML-0693"	"2021-03-09-AML0693:GGAAGTGTCTGAGCAT"	8.82182087477986	6.11386582935182	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAAGTGTCTGAGCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1677.76645846149	44.6873855483736	0.0266350452549586	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1675.79291690184	1675.79291690184
"AML-0693"	"2021-03-09-AML0693:GGAATCTCAATAGAGT"	1.35502984103505	-9.88055899059447	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATCTCAATAGAGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2255.22782045514	49.1678278855735	0.0218017121993692	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2246.04539526553	2246.04539526553
"AML-0693"	"2021-03-09-AML0693:GGAATCTCAGAGCCCT"	14.1219803291256	2.18442175472108	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATCTCAGAGCCCT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1176.4477080112	28.2870252248695	0.02404443906197	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1162.94476668484	1162.94476668484
"AML-0693"	"2021-03-09-AML0693:GGAATCTCATCCTTCG"	-8.83739219132121	-3.80546071445616	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATCTCATCCTTCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3279.16914230967	49.0988556017643	0.014972956096794	5029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3270.7498575471	3270.7498575471
"AML-0693"	"2021-03-09-AML0693:GGAATCTTCCGGTAGC"	0.383164812892121	12.0651254423889	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATCTTCCGGTAGC"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	2043.4533462044	45.214691399461	0.0221266081182841	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2038.07381799913	2038.07381799913
"AML-0693"	"2021-03-09-AML0693:GGAATGGAGTATGAAC"	-7.32172618332561	-3.14996411716612	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATGGAGTATGAAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1630.02149052773	49.646506076331	0.030457577623874	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1619.01931053107	1619.01931053107
"AML-0693"	"2021-03-09-AML0693:GGAATGGGTCGAAGCA"	-1.03002438965495	10.644263244513	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATGGGTCGAAGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1767.31632982257	42.9599411601991	0.0243080089485237	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1765.17164743591	1765.17164743591
"AML-0693"	"2021-03-09-AML0693:GGAATGGTCTAATTCC"	11.1388651328975	-2.87608578121337	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAATGGTCTAATTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1496.836254328	48.9092311997594	0.0326750712099213	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1489.60280090941	1489.60280090941
"AML-0693"	"2021-03-09-AML0693:GGACGTCAGCGTCTGC"	8.18902267989461	6.86367604816285	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGACGTCAGCGTCTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1739.89066877766	50.8580730551143	0.0292306142953477	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1733.95121037611	1733.95121037611
"AML-0693"	"2021-03-09-AML0693:GGACGTCCACCCTATC"	11.7571340995723	-2.87324931537779	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGACGTCCACCCTATC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1432.48236323914	48.6648982673629	0.0339724240355193	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1430.14705871702	1430.14705871702
"AML-0693"	"2021-03-09-AML0693:GGACGTCCACGGTGCT"	3.20723142203633	-10.2269439927307	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGACGTCCACGGTGCT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2491.15521442066	43.9457877427409	0.0176407264743481	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2482.34401808718	2482.34401808718
"AML-0693"	"2021-03-09-AML0693:GGACGTCGTATTCCGA"	-1.95540175858195	3.9380471476349	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGACGTCGTATTCCGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3131.33244237993	24.3224857011591	0.00776745559557169	3541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3122.50338893044	3122.50338893044
"AML-0693"	"2021-03-09-AML0693:GGAGAACAGCAGCCCT"	8.50104488906209	6.32837483966676	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGAACAGCAGCCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1681.21421510491	47.1757944051962	0.0280605493228311	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1672.86411575156	1672.86411575156
"AML-0693"	"2021-03-09-AML0693:GGAGAACTCGCTTGAA"	-7.94235310974773	-4.52520611202391	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGAACTCGCTTGAA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	3032.03935100632	41.7079308759959	0.0137557353476145	3642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	3010.50997366351	3010.50997366351
"AML-0693"	"2021-03-09-AML0693:GGAGAACTCTGGACTA"	8.52308907088582	6.78693339908449	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGAACTCTGGACTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1669.6196235972	54.1871661186618	0.0324547971003811	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1663.78763998116	1663.78763998116
"AML-0693"	"2021-03-09-AML0693:GGAGATGCATTGTGCA"	14.2390524345333	2.03781721675722	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGATGCATTGTGCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1692.08612579139	39.1790851781901	0.0231543090986967	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1678.28025558008	1678.28025558008
"AML-0693"	"2021-03-09-AML0693:GGAGATGGTAGTGCGA"	1.02570374783818	9.36568448627321	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGATGGTAGTGCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1784.06373302812	28.4359104092829	0.0159388422525793	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1777.63503144048	1777.63503144048
"AML-0693"	"2021-03-09-AML0693:GGAGATGGTTCGTACA"	-3.23226986351665	11.5552892454895	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGATGGTTCGTACA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1912.05766893018	8.37777825008973	0.00438155103071615	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1905.83023490613	1905.83023490613
"AML-0693"	"2021-03-09-AML0693:GGAGATGTCTGAGCAT"	-7.56301150742229	-2.39856817638548	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGATGTCTGAGCAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2286.8025393397	44.7306923344083	0.0195603649921274	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2271.45786629619	2271.45786629619
"AML-0693"	"2021-03-09-AML0693:GGAGCAAGTACAGTAA"	-7.13720641556438	4.24417874896852	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGCAAGTACAGTAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2186.3627604431	40.1516161412629	0.0183645719126342	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2168.29004713036	2168.29004713036
"AML-0693"	"2021-03-09-AML0693:GGAGCAAGTTCCCAAA"	-0.926536778837997	10.4428891905579	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGCAAGTTCCCAAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1547.62857574013	47.2420494501564	0.0305254440184806	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1545.53529829344	1545.53529829344
"AML-0693"	"2021-03-09-AML0693:GGAGCAATCGCACGGT"	7.61181749877278	6.78764197910158	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGCAATCGCACGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1619.00262742803	34.3799952090951	0.0212352930295807	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1613.95715962628	1613.95715962628
"AML-0693"	"2021-03-09-AML0693:GGAGGATCAGCTCGGT"	14.2566400962764	1.99401626670686	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGGATCAGCTCGGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1125.20211895996	2.2349198369951	0.00198623856046492	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1099.35486685288	1099.35486685288
"AML-0693"	"2021-03-09-AML0693:GGAGGATGTGAGTAAT"	0.717103798955125	11.2519883879456	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGGATGTGAGTAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1447.22255386029	48.4289652666825	0.0334633848384302	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1443.05542852844	1443.05542852844
"AML-0693"	"2021-03-09-AML0693:GGAGGTATCGCAACAT"	10.6030317741329	-0.566307925340258	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245901639344262	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGAGGTATCGCAACAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1607.64437152472	34.5694391971368	0.021503163143196	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1594.3158399684	1594.3158399684
"AML-0693"	"2021-03-09-AML0693:GGATCTATCAGTCTTT"	-8.24027667465861	-4.24550774013671	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATCTATCAGTCTTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2522.39655403864	49.2501799798682	0.0195251535294929	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2512.23068546931	2512.23068546931
"AML-0693"	"2021-03-09-AML0693:GGATCTATCGGTCAGC"	-2.65044770661052	3.28085110271303	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATCTATCGGTCAGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3373.01768078376	26.9622873299009	0.00799352090073712	4355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3367.75257596944	3367.75257596944
"AML-0693"	"2021-03-09-AML0693:GGATGTTCAAGTAGTA"	8.34002651748006	7.05563256824342	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATGTTCAAGTAGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1481.78829758535	40.5267402914843	0.027349885511665	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1474.80239290497	1474.80239290497
"AML-0693"	"2021-03-09-AML0693:GGATGTTCAGGGTCTC"	-2.27474246445354	3.57882473552553	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATGTTCAGGGTCTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3221.18076745237	24.7059590712974	0.00766984557989812	4151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3216.58176481035	3216.58176481035
"AML-0693"	"2021-03-09-AML0693:GGATGTTTCCATGCAA"	-7.76123319092448	-3.34004928981932	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATGTTTCCATGCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2728.37149686381	29.6298595859042	0.0108599065852883	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2717.89028718102	2717.89028718102
"AML-0693"	"2021-03-09-AML0693:GGATGTTTCCCATTTA"	8.73782982405965	6.79547975147096	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGATGTTTCCCATTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1647.95868988723	45.9940683027863	0.0279097216362466	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1644.29272135714	1644.29272135714
"AML-0693"	"2021-03-09-AML0693:GGCACGTGTGTCTTCC"	8.31768955764119	6.21659610355226	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCACGTGTGTCTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1554.99183613887	38.2317617274327	0.024586471027632	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1544.01537167677	1544.01537167677
"AML-0693"	"2021-03-09-AML0693:GGCACGTGTTAAACAG"	-6.94310269776042	3.96620390498964	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCACGTGTTAAACAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1905.09209332479	49.6598178519348	0.0260668857038128	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1894.91846895091	1894.91846895091
"AML-0693"	"2021-03-09-AML0693:GGCACGTGTTGGAGAC"	-2.61777697029765	3.22381684863893	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCACGTGTTGGAGAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3000.18263338723	43.5799096476787	0.0145257522534475	2714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2992.19302917023	2992.19302917023
"AML-0693"	"2021-03-09-AML0693:GGCACGTTCAGCTGTA"	8.06244339522664	6.10720059955446	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCACGTTCAGCTGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1845.19985695632	43.8532245747005	0.0237661109767464	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1838.74494970282	1838.74494970282
"AML-0693"	"2021-03-09-AML0693:GGCAGTCCACGATAGG"	10.0943705039913	7.29886910999147	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCAGTCCACGATAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1954.51175458799	51.08085506096	0.0261348415741444	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1945.40059743684	1945.40059743684
"AML-0693"	"2021-03-09-AML0693:GGCAGTCCATCGAAGG"	-7.45369468155559	-2.19275786792906	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCAGTCCATCGAAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2245.87085600559	31.2212059773646	0.0139016034220655	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2229.88890123877	2229.88890123877
"AML-0693"	"2021-03-09-AML0693:GGCAGTCTCAGTGTTG"	0.959493954747361	-9.47241499340209	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCAGTCTCAGTGTTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2328.89731698005	32.7001111224214	0.014041027435604	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2314.85007187485	2314.85007187485
"AML-0693"	"2021-03-09-AML0693:GGCAGTCTCCTTCTAA"	-6.93166099014934	-2.60287310993346	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCAGTCTCCTTCTAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1431.02872464853	44.7823907308287	0.0312938447422343	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1418.9265203595	1418.9265203595
"AML-0693"	"2021-03-09-AML0693:GGCGTCAAGCTAGAAT"	-7.51476464691814	-2.42815997516783	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCGTCAAGCTAGAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2002.541351628	22.9609926922064	0.0114659268701442	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1984.85699314446	1984.85699314446
"AML-0693"	"2021-03-09-AML0693:GGCTGTGGTCAGCTTA"	9.15005459365193	7.41179082477418	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTGTGGTCAGCTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1691.43093404926	46.2124430963731	0.0273215075863259	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1682.9386677233	1682.9386677233
"AML-0693"	"2021-03-09-AML0693:GGCTGTGTCCGGCAGT"	-5.81038222733195	-5.58213760769042	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTGTGTCCGGCAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3689.38008235762	46.2703217716589	0.0125414895561779	4903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3682.02540040026	3682.02540040026
"AML-0693"	"2021-03-09-AML0693:GGCTGTGTCGCTGTCT"	-2.2187548679417	3.96796271884767	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTGTGTCGCTGTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3468.10832846936	18.0898899113572	0.00521606829949892	4948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3465.28639647903	3465.28639647903
"AML-0693"	"2021-03-09-AML0693:GGCTTGGCAATGTGGG"	1.23516776141469	-10.2765684357849	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTGGCAATGTGGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2327.05305435096	45.480919535582	0.0195444274252988	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2324.76291737351	2324.76291737351
"AML-0693"	"2021-03-09-AML0693:GGCTTGGCAATTGCGT"	0.678830643265885	-9.15303995525511	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTGGCAATTGCGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2784.78836652488	50.1384345854221	0.018004396739128	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2777.70877347649	2777.70877347649
"AML-0693"	"2021-03-09-AML0693:GGCTTGGCACTGTCCT"	-8.55085788193401	-2.8137097588745	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTGGCACTGTCCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3296.58115014729	45.8356281036344	0.0139039890164956	3648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3286.73043228568	3286.73043228568
"AML-0693"	"2021-03-09-AML0693:GGCTTGGCATGTTTGG"	-7.70558104935344	-2.47827484523924	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTGGCATGTTTGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2047.87088612087	33.2298112137603	0.0162265167393952	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2031.3411809133	2031.3411809133
"AML-0693"	"2021-03-09-AML0693:GGCTTGGTCCGGCTTT"	-2.45936212959941	3.37696263873903	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTGGTCCGGCTTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3278.79959285472	21.4876038748147	0.00655349717672324	3631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3272.84289314628	3272.84289314628
"AML-0693"	"2021-03-09-AML0693:GGCTTTCGTCTGCATA"	8.49759926375691	6.42712066257326	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTTCGTCTGCATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1543.16706320057	48.0315577548052	0.0311253129361033	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1540.91055634975	1540.91055634975
"AML-0693"	"2021-03-09-AML0693:GGCTTTCGTTAGCGGA"	1.52951004084889	-10.564555191156	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGCTTTCGTTAGCGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2045.05653938271	51.5801311080789	0.0252218606746433	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2029.72101090738	2029.72101090738
"AML-0693"	"2021-03-09-AML0693:GGGAAGTGTACGGGAT"	-2.58628664436992	3.41866824710695	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAAGTGTACGGGAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1929.4475946132	24.580161344557	0.0127394811930534	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1927.56315765362	1927.56315765362
"AML-0693"	"2021-03-09-AML0693:GGGAAGTTCCAGGACC"	1.37812151488606	-10.2928829423157	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAAGTTCCAGGACC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2463.73820171383	45.2364733290202	0.0183609091654108	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2448.35576302963	2448.35576302963
"AML-0693"	"2021-03-09-AML0693:GGGAAGTTCTCCTGCA"	0.353156437247437	11.3461332091126	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAAGTTCTCCTGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1881.3106649144	46.1199879891502	0.0245148177009079	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1879.23662410813	1879.23662410813
"AML-0693"	"2021-03-09-AML0693:GGGAAGTTCTTTCGAT"	9.85767998275105	7.01807019794313	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAAGTTCTTTCGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1666.12954037589	41.7749794936288	0.0250730681386298	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1666.12954037589	1666.12954037589
"AML-0693"	"2021-03-09-AML0693:GGGACAAAGATGATTG"	-7.33702168884929	-0.537603520509325	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACAAAGATGATTG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3527.87464971525	21.437545401392	0.00607661766075571	3466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3517.08911490579	3517.08911490579
"AML-0693"	"2021-03-09-AML0693:GGGACAACAGTCTTCC"	11.3031870323116	-2.63140442287596	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACAACAGTCTTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1853.16759920168	42.1808122489707	0.0227614665112544	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1851.77847445011	1851.77847445011
"AML-0693"	"2021-03-09-AML0693:GGGACAAGTACAATAG"	10.0106731849605	6.69731042468873	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACAAGTACAATAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1658.42008045147	45.4764027930956	0.0274215220432664	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.8300830818	1651.8300830818
"AML-0693"	"2021-03-09-AML0693:GGGACCTCATGTGCCG"	0.865732272236985	9.70633504474489	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACCTCATGTGCCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2010.67249833588	27.7833867647335	0.01381795731912	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2002.67447675134	2002.67447675134
"AML-0693"	"2021-03-09-AML0693:GGGACCTTCAAGCCTA"	-3.58516631546672	-5.79629661953124	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	63	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00611995104039168	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACCTTCAAGCCTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2526.36612665765	43.0903477162938	0.0170562561228216	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2518.3465416083	2518.3465416083
"AML-0693"	"2021-03-09-AML0693:GGGACCTTCCTGGGAC"	-7.77841601792033	-3.57355310833129	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACCTTCCTGGGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2562.04511662473	51.8833844014732	0.0202507692252606	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2547.84141026647	2547.84141026647
"AML-0693"	"2021-03-09-AML0693:GGGACTCCAGAATGTA"	-1.96393380585368	3.88436386669008	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACTCCAGAATGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3064.43972110346	11.6416604553197	0.00379895234197253	3744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3061.04680678879	3061.04680678879
"AML-0693"	"2021-03-09-AML0693:GGGACTCGTGGGTTGA"	-8.41717849198039	-3.31965138828429	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACTCGTGGGTTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2563.96149898972	51.5424558619526	0.0201026637421279	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2557.22083245666	2557.22083245666
"AML-0693"	"2021-03-09-AML0693:GGGACTCTCTCCAAGA"	14.2046743827755	2.02520713889924	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACTCTCTCCAAGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1285.36983605361	7.36783770751724	0.00573207609269736	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1274.49503070647	1274.49503070647
"AML-0693"	"2021-03-09-AML0693:GGGACTCTCTTTGCGC"	8.20388283309285	6.34017131412355	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGACTCTCTTTGCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1673.96227018628	42.9138442005742	0.0256360880796905	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1670.04801309764	1670.04801309764
"AML-0693"	"2021-03-09-AML0693:GGGAGATAGGTCGTGA"	-7.48667464676555	-3.39524199878844	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAGATAGGTCGTGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2818.29698392172	36.0382520880181	0.0127872443158457	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2803.7312662679	2803.7312662679
"AML-0693"	"2021-03-09-AML0693:GGGAGTAAGGCTGGAT"	-2.68136892738994	3.33167264545289	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGAGTAAGGCTGGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3538.96541892693	33.3776238713937	0.00943146369639134	5287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3534.58049075146	3534.58049075146
"AML-0693"	"2021-03-09-AML0693:GGGATCCCAGAGATGC"	-2.71900973740276	4.01100561702577	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATCCCAGAGATGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3896.58349516123	20.8872626666103	0.00536040423426011	5708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3881.76042413662	3881.76042413662
"AML-0693"	"2021-03-09-AML0693:GGGATGAAGAGCCTGA"	-7.11385379257854	-2.73359825527342	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATGAAGAGCCTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2847.49062776946	0.105398621385915	3.70145630535324e-05	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2812.39313960382	2812.39313960382
"AML-0693"	"2021-03-09-AML0693:GGGATGAAGTGTTCCA"	-6.97962222519572	3.69918153369752	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATGAAGTGTTCCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2272.38074795006	38.7111849345695	0.0170355187921264	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2257.06044872718	2257.06044872718
"AML-0693"	"2021-03-09-AML0693:GGGATGACAATTGGTC"	-7.01509795609172	-2.67899110233458	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATGACAATTGGTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1848.20569050899	25.9296467966608	0.0140296325943677	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1843.74066185406	1843.74066185406
"AML-0693"	"2021-03-09-AML0693:GGGATGAGTCAACACT"	11.0449301200802	-2.8346534005371	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATGAGTCAACACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1549.73528117628	45.2713046507328	0.0292122823817825	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1541.96358618627	1541.96358618627
"AML-0693"	"2021-03-09-AML0693:GGGATGATCAGCTAGT"	8.98963417586629	6.78617189014284	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGATGATCAGCTAGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1675.40632397781	43.4735383258019	0.0259480567213005	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1669.2388744669	1669.2388744669
"AML-0693"	"2021-03-09-AML0693:GGGCCATAGGTGCTGA"	-6.91879687729533	3.85954330051271	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATAGGTGCTGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2506.8673259906	33.9430613421734	0.0135400310141106	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2488.50405957604	2488.50405957604
"AML-0693"	"2021-03-09-AML0693:GGGCCATCAAGAGATT"	8.8810564475948	6.81789157474367	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATCAAGAGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1789.90409494568	28.5147754184199	0.0159308956825897	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1782.23755004214	1782.23755004214
"AML-0693"	"2021-03-09-AML0693:GGGCCATGTCAGCTTA"	8.17970242080037	6.6824364432129	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATGTCAGCTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1807.52114815653	48.9385378977909	0.0270749462310317	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1803.95333836914	1803.95333836914
"AML-0693"	"2021-03-09-AML0693:GGGCCATGTGCATACT"	8.47559418258015	6.45111081683961	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATGTGCATACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1656.32391003113	45.8517585650068	0.0276828452981429	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.84645360335	1651.84645360335
"AML-0693"	"2021-03-09-AML0693:GGGCCATTCGATGCTA"	-6.84573159638103	3.86245391452638	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATTCGATGCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2390.20606337427	36.038337890293	0.0150775024975953	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2367.85736662258	2367.85736662258
"AML-0693"	"2021-03-09-AML0693:GGGCCATTCTAGGAAA"	7.88724293288533	6.30486724460451	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCCATTCTAGGAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1695.47875571212	45.5119633518411	0.0268431339516994	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1686.74834108647	1686.74834108647
"AML-0693"	"2021-03-09-AML0693:GGGCGTTCAAGACTGG"	7.77438177642171	6.41540763461915	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCGTTCAAGACTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1638.06531159537	44.8247894624128	0.0273644702351681	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1616.85505496689	1616.85505496689
"AML-0693"	"2021-03-09-AML0693:GGGCGTTTCACCTCGT"	-6.94985661926921	3.978977180365	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCGTTTCACCTCGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2257.71823509452	41.3893147299653	0.0183323649898378	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2247.2908060986	2247.2908060986
"AML-0693"	"2021-03-09-AML0693:GGGCGTTTCCGTAGGC"	7.9394175010616	7.00805900180665	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCGTTTCCGTAGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1687.52287155701	41.0916835628975	0.0243502972644061	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1685.38828041933	1685.38828041933
"AML-0693"	"2021-03-09-AML0693:GGGCGTTTCGAGCACC"	14.213585515588	1.94027254665224	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCGTTTCGAGCACC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1108.87903672444	0.653272750955141	0.000589128957550563	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1087.69158477272	1087.69158477272
"AML-0693"	"2021-03-09-AML0693:GGGCTCATCTTCCCGA"	-6.97657332840617	3.89280769908754	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGCTCATCTTCCCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2336.00339771329	33.9801384790802	0.0145462709995813	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2327.21098575748	2327.21098575748
"AML-0693"	"2021-03-09-AML0693:GGGTAGAGTATACCCA"	8.15002598342244	6.61597011173097	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTAGAGTATACCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1493.40823446436	51.2298969893788	0.0343040140044181	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1491.01524650673	1491.01524650673
"AML-0693"	"2021-03-09-AML0693:GGGTAGAGTTCAGCGC"	-2.41579757157024	9.97889325702516	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTAGAGTTCAGCGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1986.15531254478	43.4455044649498	0.0218741727751818	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1982.09110352066	1982.09110352066
"AML-0693"	"2021-03-09-AML0693:GGGTATTAGCTGTTAC"	-7.72980151596721	-2.45826103603514	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTATTAGCTGTTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3376.62673741745	32.0025481578903	0.00947766829044506	3040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3348.64792601063	3348.64792601063
"AML-0693"	"2021-03-09-AML0693:GGGTATTCAAATGAAC"	11.367807050317	-2.85507943546446	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTATTCAAATGAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1613.89387604564	44.9883459690231	0.0278756531868462	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1602.7176258261	1602.7176258261
"AML-0693"	"2021-03-09-AML0693:GGGTATTGTACGACTT"	-7.21388183060344	-3.04771187221678	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTATTGTACGACTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2262.17011265561	47.4581346494836	0.0209790299960119	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2246.30276622575	2246.30276622575
"AML-0693"	"2021-03-09-AML0693:GGGTATTTCCACAAGT"	8.56634678420369	6.33623693073121	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTATTTCCACAAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1713.35673205847	31.0555376681692	0.0181255526575942	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1704.6863670767	1704.6863670767
"AML-0693"	"2021-03-09-AML0693:GGGTCACGTACTTCCC"	1.13671972331349	-9.60830023204955	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCACGTACTTCCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1521.51426932414	48.4929556311373	0.0318715089360799	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1515.51138469339	1515.51138469339
"AML-0693"	"2021-03-09-AML0693:GGGTCACTCCCAGCGA"	13.7988926368648	2.17536017978517	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCACTCCCAGCGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1227.37544889524	45.4614001327095	0.0370395221556935	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1214.13330406048	1214.13330406048
"AML-0693"	"2021-03-09-AML0693:GGGTCACTCGGCTGAC"	0.907583673566025	-9.12702944194945	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCACTCGGCTGAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2243.41469544923	41.5764106077779	0.0185326461006589	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2235.34429266756	2235.34429266756
"AML-0693"	"2021-03-09-AML0693:GGGTCTGGTAAGATCA"	9.153825421899	6.4818544157776	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCTGGTAAGATCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1454.41747044097	33.9131755758499	0.0233173598812504	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1451.93217136447	1451.93217136447
"AML-0693"	"2021-03-09-AML0693:GGGTCTGGTATGATCC"	11.9684673744137	-2.89190819179686	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCTGGTATGATCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1697.77102976182	18.59862024463	0.0109547282399083	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1692.02632314532	1692.02632314532
"AML-0693"	"2021-03-09-AML0693:GGGTCTGTCTGGCCGA"	-7.14349589768107	4.10636851871339	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTCTGTCTGGCCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1877.47825251858	49.092665549026	0.0261481939847611	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1867.20075734151	1867.20075734151
"AML-0693"	"2021-03-09-AML0693:GGGTGAACATCGCTGG"	9.53000702437703	7.65162704074708	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAACATCGCTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1853.41905009548	40.0056591439978	0.0215847890103088	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1850.00100660047	1850.00100660047
"AML-0693"	"2021-03-09-AML0693:GGGTGAAGTATAGGAT"	-9.48996005478557	-2.61251761829527	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAAGTATAGGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3273.32138387495	49.9380171654825	0.0152560690836798	4213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3260.75275244949	3260.75275244949
"AML-0693"	"2021-03-09-AML0693:GGGTGAAGTGAGAGGG"	12.0273128944332	-2.6874935857025	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAAGTGAGAGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1567.48357376599	26.3001013535241	0.016778549895956	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1558.67661486093	1558.67661486093
"AML-0693"	"2021-03-09-AML0693:GGGTGAAGTTTCGCTC"	-7.70099387589152	-4.14987518703612	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAAGTTTCGCTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2645.5517206946	52.5471204938006	0.0198624430899443	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2637.25332989803	2637.25332989803
"AML-0693"	"2021-03-09-AML0693:GGGTGAATCACGAACT"	-2.17145786705669	3.79756972873536	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAATCACGAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2807.71746305009	7.89256922892362	0.00281102686890359	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2806.50953644489	2806.50953644489
"AML-0693"	"2021-03-09-AML0693:GGGTGAATCGCAAGAG"	-9.71110282364543	-2.64357974445494	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGAATCGCAAGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3121.99622721824	44.5806949692753	0.0142795479958019	3267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3108.87061877303	3108.87061877303
"AML-0693"	"2021-03-09-AML0693:GGGTGTCAGGAAGAAC"	9.69904293593709	6.62194058978883	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCAGGAAGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1511.61902809095	46.2105707079669	0.0305702494141841	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1502.8706575803	1502.8706575803
"AML-0693"	"2021-03-09-AML0693:GGGTGTCAGTCAGCGA"	-6.91680036011394	3.79179904544679	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCAGTCAGCGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2603.47511287572	51.3209779609824	0.0197124903200226	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2597.88723263175	2597.88723263175
"AML-0693"	"2021-03-09-AML0693:GGGTGTCAGTCGAGGT"	-7.11203942719157	-2.80989458477172	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCAGTCGAGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2401.22137257026	35.4977871021537	0.0147832213671149	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2381.83145716563	2381.83145716563
"AML-0693"	"2021-03-09-AML0693:GGGTGTCCAGAGCCCT"	-2.04295382919963	3.47044012630311	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCCAGAGCCCT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1600.58144356274	10.6277139645292	0.00663990827038013	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1600.58144356274	1600.58144356274
"AML-0693"	"2021-03-09-AML0693:GGGTGTCTCGGCATCG"	8.78782143172566	6.8566479452881	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCTCGGCATCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1906.03016279385	49.1929797521168	0.0258091297359166	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1903.66340498049	1903.66340498049
"AML-0693"	"2021-03-09-AML0693:GGGTGTCTCTCGTGAA"	8.99965443190877	6.74858758533327	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTGTCTCTCGTGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1650.01097260873	47.2191920670094	0.0286175018535507	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.77409032646	1643.77409032646
"AML-0693"	"2021-03-09-AML0693:GGGTTATAGTCAAGCG"	-6.26344380798991	-0.546255909558855	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	85	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.725	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTTATAGTCAAGCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1612.86721806453	39.2534570395193	0.0243376866984898	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1552.90862650123	1552.90862650123
"AML-0693"	"2021-03-09-AML0693:GGGTTTAGTCTGCGCA"	8.22501816329305	6.69790456378785	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTTTAGTCTGCGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1676.04139701046	46.1716790063338	0.0275480540568328	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1668.04060023527	1668.04060023527
"AML-0693"	"2021-03-09-AML0693:GGGTTTAGTTCCTTGC"	-7.07150540772136	4.01114389980165	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTTTAGTTCCTTGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2213.81749843264	36.6821480379276	0.0165696350597546	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2194.72757482917	2194.72757482917
"AML-0693"	"2021-03-09-AML0693:GGGTTTAGTTCTTGCC"	-6.9090555709904	3.7473938235077	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTTTAGTTCTTGCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2448.97434920141	35.0142017003576	0.0142974963015743	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2431.72343769938	2431.72343769938
"AML-0693"	"2021-03-09-AML0693:GGGTTTATCTCTAGGA"	1.13992108878438	-9.08145811473998	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGGTTTATCTCTAGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2571.91697413862	45.2043200088408	0.0175761194717339	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2569.87451747842	2569.87451747842
"AML-0693"	"2021-03-09-AML0693:GGTAACTAGTCATGGG"	-7.19814191284831	-2.91109063541564	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAACTAGTCATGGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2103.21347489668	14.3105355296184	0.00680412887252037	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2095.42007579168	2095.42007579168
"AML-0693"	"2021-03-09-AML0693:GGTAACTCAGTTCCAA"	-7.3233622116154	-2.63499572193297	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAACTCAGTTCCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3004.05619145838	10.354789604776	0.00344693605739415	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2981.6534916632	2981.6534916632
"AML-0693"	"2021-03-09-AML0693:GGTAACTCATCGGATT"	-8.25560698929485	-4.41441872036131	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAACTCATCGGATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2500.56178546434	49.7449721921037	0.0198935185210256	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2494.50515914878	2494.50515914878
"AML-0693"	"2021-03-09-AML0693:GGTAACTTCAATGCAC"	-5.44749770584758	-5.72066690838011	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAACTTCAATGCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1633.26870468927	48.9441830616653	0.0299670121157296	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1627.48175447224	1627.48175447224
"AML-0693"	"2021-03-09-AML0693:GGTAACTTCGGCATAT"	0.942045231431168	9.4761342772278	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAACTTCGGCATAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1912.68858601909	33.2222892962341	0.017369418910676	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1905.6028738186	1905.6028738186
"AML-0693"	"2021-03-09-AML0693:GGTAATCCAGTCGGAA"	14.0659223991329	1.70263896072236	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAATCCAGTCGGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1409.00716662893	8.16971710770983	0.00579820834215909	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1385.39790055047	1385.39790055047
"AML-0693"	"2021-03-09-AML0693:GGTAATCCATCAGCTA"	-7.41655478897746	-2.53777339374694	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAATCCATCAGCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2222.29471350264	44.424490394728	0.0199903685702914	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2217.2812843485	2217.2812843485
"AML-0693"	"2021-03-09-AML0693:GGTAGAGAGTGTTGAA"	14.2114750343258	2.1185035475525	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAGAGAGTGTTGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1226.98522101763	21.9466196527025	0.0178866210258837	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1210.78930411701	1210.78930411701
"AML-0693"	"2021-03-09-AML0693:GGTAGAGTCCCTTCCC"	9.93043865737264	5.92807624423829	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAGAGTCCCTTCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1607.27471003239	47.8939503161242	0.0297982354958842	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1602.95414409373	1602.95414409373
"AML-0693"	"2021-03-09-AML0693:GGTAGAGTCGGTCGGT"	-7.17992291870769	-2.91174008762511	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTAGAGTCGGTCGGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1492.20767846238	31.3190297061891	0.020988385302012	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1476.40621373095	1476.40621373095
"AML-0693"	"2021-03-09-AML0693:GGTCACGAGGTCATCT"	1.18383159217183	-9.79521753704222	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCACGAGGTCATCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2376.42463370336	41.1111789600622	0.0172995930007658	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2367.31289824542	2367.31289824542
"AML-0693"	"2021-03-09-AML0693:GGTCACGAGTAGACCG"	-7.70744643631633	-2.36342193996581	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCACGAGTAGACCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2964.1431163082	0	0	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2944.42408915714	2944.42408915714
"AML-0693"	"2021-03-09-AML0693:GGTCACGGTTCAGCGC"	9.03522934493367	7.35309503162233	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCACGGTTCAGCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1903.67962919108	40.3517425158673	0.0211967086778219	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1894.1048167515	1894.1048167515
"AML-0693"	"2021-03-09-AML0693:GGTCACGTCATACGGT"	9.86790623244588	7.28507659519044	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCACGTCATACGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1641.34676251765	46.9961556274893	0.028632679395183	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1632.91937563866	1632.91937563866
"AML-0693"	"2021-03-09-AML0693:GGTCTGGCACTACGGC"	-2.22699747505839	3.36406610095827	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCTGGCACTACGGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3358.54658216485	23.4955103321251	0.00699573751839417	4656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3351.47252275126	3351.47252275126
"AML-0693"	"2021-03-09-AML0693:GGTCTGGGTAACACCT"	0.688611467450303	10.1948976286682	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCTGGGTAACACCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1575.93309863868	49.2728532180294	0.0312658280104607	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1573.57436159914	1573.57436159914
"AML-0693"	"2021-03-09-AML0693:GGTCTGGGTCACTAGT"	11.5530640083248	-2.88481261646422	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCTGGGTCACTAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1984.7316108315	40.3032743662015	0.0203066621936437	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1977.65945933604	1977.65945933604
"AML-0693"	"2021-03-09-AML0693:GGTCTGGGTCGTACTA"	-8.09795222702678	-1.04371454631957	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCTGGGTCGTACTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2803.87105093895	33.9313406334676	0.0121016052511062	3018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2793.01236372459	2793.01236372459
"AML-0693"	"2021-03-09-AML0693:GGTCTGGTCTTCTGTA"	9.80055489119832	6.83993146503297	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTCTGGTCTTCTGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1734.54785101416	45.5958160465621	0.0262868597253764	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1725.44685985182	1725.44685985182
"AML-0693"	"2021-03-09-AML0693:GGTGAAGCAGTCTGGC"	9.41119350966756	7.50483319843141	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGAAGCAGTCTGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.79437958219	42.8518514247913	0.023677745885521	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1796.67526426698	1796.67526426698
"AML-0693"	"2021-03-09-AML0693:GGTGAAGTCGTGGGAA"	-7.04264674606975	3.74870393359987	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGAAGTCGTGGGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2503.45876591319	46.6051341967868	0.0186162979120555	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2492.97496926808	2492.97496926808
"AML-0693"	"2021-03-09-AML0693:GGTGATTTCCTCGCAT"	-8.47003302994426	-3.38077571308287	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGATTTCCTCGCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3200.57524524788	50.1455134021177	0.0156676564553739	3297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3194.42417810048	3194.42417810048
"AML-0693"	"2021-03-09-AML0693:GGTGGCTCACGAAAGC"	8.36264385756795	6.62505529010621	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGGCTCACGAAAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1857.01665174343	28.2523305067848	0.0152138272321148	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1853.39293925769	1853.39293925769
"AML-0693"	"2021-03-09-AML0693:GGTGGCTGTAGCTCGC"	13.9158140617305	1.71796879852144	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGGCTGTAGCTCGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1272.01651913502	52.0644123039904	0.0409306101931714	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1258.02286912453	1258.02286912453
"AML-0693"	"2021-03-09-AML0693:GGTGGCTTCACGTCCT"	-2.66176710549052	3.66518972003785	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGGCTTCACGTCCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3239.93463545927	35.446461916133	0.0109404867395136	4162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3232.56679970291	3232.56679970291
"AML-0693"	"2021-03-09-AML0693:GGTGTCGCATCGTTCC"	-8.45982013168986	-3.3735172978607	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGTCGCATCGTTCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2491.5491296145	50.9276527286983	0.0204401559348653	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2481.11894885758	2481.11894885758
"AML-0693"	"2021-03-09-AML0693:GGTGTTACAGAACTCT"	-7.13691554489787	3.93775889957277	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGTTACAGAACTCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2302.43211428787	34.2252552283619	0.0148648270739342	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2280.1569100703	2280.1569100703
"AML-0693"	"2021-03-09-AML0693:GGTGTTAGTGGACTGA"	14.0241419273311	1.72562120044557	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGTTAGTGGACTGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1159.57803039397	1.2049661991079	0.00103914197020317	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1142.98198135795	1142.98198135795
"AML-0693"	"2021-03-09-AML0693:GGTGTTAGTGGTAATA"	8.99973454055135	7.60370633685914	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTGTTAGTGGTAATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1800.97069978037	45.2426602072559	0.025121263889953	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1797.34056934247	1797.34056934247
"AML-0693"	"2021-03-09-AML0693:GGTTAACAGCTTCTAG"	-2.01334391060527	3.04367349231569	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTAACAGCTTCTAG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2558.40902071899	48.1551697257482	0.0188223107938445	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2548.55127961476	2548.55127961476
"AML-0693"	"2021-03-09-AML0693:GGTTAACCAGTTTGGT"	0.247575094073456	11.0442609556946	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTAACCAGTTTGGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1522.56225913967	52.8497680990354	0.0347110719327159	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1522.56225913967	1522.56225913967
"AML-0693"	"2021-03-09-AML0693:GGTTAACGTGTCATCA"	14.2581411796505	1.90591142261354	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTAACGTGTCATCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1323.60101202869	16.3221510807527	0.0123316248117215	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1305.6407640621	1305.6407640621
"AML-0693"	"2021-03-09-AML0693:GGTTAACTCCGACAGC"	7.8709794479305	5.99442145908204	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTAACTCCGACAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1381.00597342538	43.1299156876361	0.0312307958963122	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1375.73577065222	1375.73577065222
"AML-0693"	"2021-03-09-AML0693:GGTTCTCAGGCAGGGA"	-8.09906421127971	-4.01976921474608	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTCTCAGGCAGGGA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2906.3405938266	40.4616997651776	0.0139218713220064	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2898.59340650712	2898.59340650712
"AML-0693"	"2021-03-09-AML0693:GGTTCTCAGTGGATAT"	-7.22712026062663	-1.2935909262863	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTCTCAGTGGATAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2660.87623764282	44.980651192063	0.0169044507052721	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2658.6244271644	2658.6244271644
"AML-0693"	"2021-03-09-AML0693:GGTTCTCCAGGACATG"	11.1285578208858	-2.96543266689452	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTCTCCAGGACATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2195.13688829885	48.829172153298	0.0222442492828494	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2181.62763287065	2181.62763287065
"AML-0693"	"2021-03-09-AML0693:GGTTCTCTCATGTCTT"	-8.82990775528606	-3.74266221439513	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTCTCTCATGTCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3241.66720770666	37.9023030567408	0.0116922252125798	2834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3223.79795029231	3223.79795029231
"AML-0693"	"2021-03-09-AML0693:GGTTGTACAGATACCT"	11.5752378898555	-2.0647011033264	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTACAGATACCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1301.06626492279	44.762167885169	0.0344042183645622	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1296.26820550749	1296.26820550749
"AML-0693"	"2021-03-09-AML0693:GGTTGTACAGCAGACA"	0.794452090829056	-9.08427145397338	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTACAGCAGACA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2782.94975151392	44.4742383750972	0.0159809706772115	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2773.66265628921	2773.66265628921
"AML-0693"	"2021-03-09-AML0693:GGTTGTAGTATGAGGC"	3.56123437461202	-1.58000173484953	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	17	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.6	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTAGTATGAGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2053.17660725962	45.7685669079635	0.0222915879453015	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1966.92165581058	1966.92165581058
"AML-0693"	"2021-03-09-AML0693:GGTTGTAGTGACTGTT"	8.31075348433797	6.94204328143922	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTAGTGACTGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1868.94104271764	43.4609985265235	0.0232543443228827	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1863.31712422171	1863.31712422171
"AML-0693"	"2021-03-09-AML0693:GGTTGTAGTGCGAACA"	-4.16134105148967	13.0400476225647	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000974658869395711	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTAGTGCGAACA"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1945.71441528272	47.2695528828496	0.0242941885569476	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1941.63085291318	1941.63085291318
"AML-0693"	"2021-03-09-AML0693:GGTTGTAGTGTTCGTA"	10.03063072738	6.46294257724611	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GGTTGTAGTGTTCGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1660.10942671078	31.5111018093146	0.0189813402070419	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1660.10942671078	1660.10942671078
"AML-0693"	"2021-03-09-AML0693:GTAACACGTGTTGACT"	1.6527781682903	-10.5039005509582	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	61	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00427350427350427	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAACACGTGTTGACT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2201.9737705919	49.4084258225239	0.0224382444888264	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2194.64279323079	2194.64279323079
"AML-0693"	"2021-03-09-AML0693:GTAACACTCATGGATC"	0.909675975411576	-9.14784433757933	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAACACTCATGGATC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2153.17329134196	31.2475044642309	0.0145123035799668	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2132.01557331856	2132.01557331856
"AML-0693"	"2021-03-09-AML0693:GTAACACTCTAGGCCG"	1.00580545243565	10.0647353895935	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAACACTCTAGGCCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1573.21345168815	35.9062975340982	0.0228235383415827	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1566.97244728948	1566.97244728948
"AML-0693"	"2021-03-09-AML0693:GTAACCAAGATGCAGC"	-8.34709964218791	-3.73513820087584	"2021-03-09-AML0693"	"AML0693"	"DC precursor"	"DC precursor"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAACCAAGATGCAGC"	"DC precursor"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	3172.9788490765	44.0508144160051	0.0138831100083841	3868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	3166.30144931631	3166.30144931631
"AML-0693"	"2021-03-09-AML0693:GTAACCATCCTCTGCA"	-6.98101935806926	3.60418531978456	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAACCATCCTCTGCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2704.97718904762	29.1878882093915	0.0107904378371738	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2683.22875887264	2683.22875887264
"AML-0693"	"2021-03-09-AML0693:GTAAGTCAGCCGGATA"	-7.03978047791179	3.98621199214784	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCAGCCGGATA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1967.04175294162	47.1040433105508	0.0239466413156248	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1958.92443612237	1958.92443612237
"AML-0693"	"2021-03-09-AML0693:GTAAGTCAGCCTCTTC"	-0.545445362955886	11.4591645964417	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	6	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCAGCCTCTTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1435.29938007172	48.1564170223826	0.0335514790091919	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1427.45556565431	1427.45556565431
"AML-0693"	"2021-03-09-AML0693:GTAAGTCAGCGACTAG"	-8.33520255509074	-4.55163862621459	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCAGCGACTAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2566.04133128768	47.8623020318572	0.0186521945099922	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2550.59297663604	2550.59297663604
"AML-0693"	"2021-03-09-AML0693:GTAAGTCAGGAGTATT"	-8.59298263016399	-3.64861514484557	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCAGGAGTATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3213.00563757735	39.8457029326287	0.0124013797133182	3459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3205.64585892146	3205.64585892146
"AML-0693"	"2021-03-09-AML0693:GTAAGTCCAAGCCTGC"	4.14205612716023	-10.0767278901306	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.019047619047619	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCCAAGCCTGC"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1415.98355812117	16.6284376942967	0.0117433833175016	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1411.21515686666	1411.21515686666
"AML-0693"	"2021-03-09-AML0693:GTAAGTCGTTCAAGGG"	-8.95657954636272	-3.89963176166686	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCGTTCAAGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3222.23464215242	41.6575756936265	0.0129281633151954	3946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3212.47801424405	3212.47801424405
"AML-0693"	"2021-03-09-AML0693:GTAAGTCTCTGTACAG"	13.9257732826168	1.98884401405183	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAAGTCTCTGTACAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1410.96231853047	42.3305150921663	0.0300011662510264	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1400.0491983798	1400.0491983798
"AML-0693"	"2021-03-09-AML0693:GTAATCGCACCATAAC"	-7.67155347290691	-4.02411463176879	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATCGCACCATAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1667.04684226916	53.7389291127149	0.0322360042622236	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1663.39838485431	1663.39838485431
"AML-0693"	"2021-03-09-AML0693:GTAATCGGTAGTAAGT"	8.53931107100789	6.67421243274537	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATCGGTAGTAAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1541.14734819797	44.0915463554923	0.0286095592397752	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1534.04180699587	1534.04180699587
"AML-0693"	"2021-03-09-AML0693:GTAATCGTCCCGTAAA"	-5.85356507721599	-2.30645992672118	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATCGTCCCGTAAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1620.81529920446	34.506758100597	0.0212897534454011	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1596.58411533958	1596.58411533958
"AML-0693"	"2021-03-09-AML0693:GTAATCGTCCTGGGTG"	-6.80781016770061	3.9216680296692	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATCGTCCTGGGTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2060.8235317927	32.7900386405621	0.0159111336486139	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2049.20738890305	2049.20738890305
"AML-0693"	"2021-03-09-AML0693:GTAATGCCAACTCCCT"	0.525586892932099	11.4759597548279	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATGCCAACTCCCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1709.66762593636	44.6981713318655	0.0261443631813434	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1705.37915247176	1705.37915247176
"AML-0693"	"2021-03-09-AML0693:GTAATGCCACAGTGTT"	-2.66673956337627	3.56656572902528	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATGCCACAGTGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3343.86894631147	25.9147342914896	0.00774992522361724	4226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3335.73087534995	3335.73087534995
"AML-0693"	"2021-03-09-AML0693:GTAATGCGTAAGGCCA"	-7.5076736015385	-3.55759169971617	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATGCGTAAGGCCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1763.28018036979	12.7954326198982	0.00725660774864196	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1753.75286285445	1753.75286285445
"AML-0693"	"2021-03-09-AML0693:GTAATGCGTACCGTCG"	-7.18640838089641	1.27746567809907	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATGCGTACCGTCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2807.48071583358	36.1704800037553	0.0128836076414565	2552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2798.41981890191	2798.41981890191
"AML-0693"	"2021-03-09-AML0693:GTAATGCGTGGCAACA"	-7.024734835059	3.80496618831483	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAATGCGTGGCAACA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2267.23156503529	48.84417549057	0.0215435318755408	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2259.31572931664	2259.31572931664
"AML-0693"	"2021-03-09-AML0693:GTACAACAGGTCCAGA"	-3.26705537262614	3.35819671237794	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTACAACAGGTCCAGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3319.95798211905	31.0403122852303	0.00934960998073174	4109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3313.66824407336	3313.66824407336
"AML-0693"	"2021-03-09-AML0693:GTACAACTCCCATTCG"	10.9987427192623	-2.93218233501586	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTACAACTCCCATTCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2397.01972969574	42.2092305770331	0.0176090459557422	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2386.55245801701	2386.55245801701
"AML-0693"	"2021-03-09-AML0693:GTACAACTCTGCCCTA"	-8.54107318344768	-3.57962920581969	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTACAACTCTGCCCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2740.10724543776	52.6190412782417	0.0192032780344097	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2735.37567257856	2735.37567257856
"AML-0693"	"2021-03-09-AML0693:GTACAGTAGGGTAATT"	-7.60165343704875	4.12391660297243	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTACAGTAGGGTAATT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2520.78419400793	37.0984148727707	0.0147170134440529	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2497.21526762759	2497.21526762759
"AML-0693"	"2021-03-09-AML0693:GTACAGTCATTCAGCA"	8.71815266188924	6.63212487781373	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTACAGTCATTCAGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1506.43284938605	37.2385083121819	0.024719660307035	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1499.46003022326	1499.46003022326
"AML-0693"	"2021-03-09-AML0693:GTAGAAAAGACGCATG"	-1.82202432575877	3.82356617534486	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAAAAGACGCATG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2386.16288714667	9.21946306865518	0.00386371907731733	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2380.05986011869	2380.05986011869
"AML-0693"	"2021-03-09-AML0693:GTAGAAAAGGGAACAA"	-8.22285685959514	-4.28276398098143	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	11	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAAAAGGGAACAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	2445.38146764735	19.5306974419195	0.00798676922202637	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2422.9018072088	2422.9018072088
"AML-0693"	"2021-03-09-AML0693:GTAGAAATCAGTCTTT"	14.0160585838253	2.16253802860109	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAAATCAGTCTTT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1122.06397060263	14.8445881610276	0.0132297164421516	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1115.96801498048	1115.96801498048
"AML-0693"	"2021-03-09-AML0693:GTAGAAATCATGAGGG"	8.7454010444576	6.61349818790285	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAAATCATGAGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1757.19356600267	38.6849229280064	0.0220151744670954	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1755.19928784144	1755.19928784144
"AML-0693"	"2021-03-09-AML0693:GTAGAAATCTCATTAC"	1.42244531688039	9.86866090381471	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAAATCTCATTAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1837.11690862385	45.9710437679886	0.0250234721329872	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1832.21011948247	1832.21011948247
"AML-0693"	"2021-03-09-AML0693:GTAGAGGCAAAGGCAC"	-4.7149261039799	3.01746580684511	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAGGCAAAGGCAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2776.09911532962	38.1511660671504	0.0137427247667346	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2770.50129743732	2770.50129743732
"AML-0693"	"2021-03-09-AML0693:GTAGAGGCAATTCTCT"	10.9659077125484	-2.81574013149413	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAGGCAATTCTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1508.60051703023	50.3457507754048	0.0333724867564764	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1506.18774768911	1506.18774768911
"AML-0693"	"2021-03-09-AML0693:GTAGAGGCAGTTGCGC"	-8.61029754105266	-3.25003364002379	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAGGCAGTTGCGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2874.44520511328	42.599138374209	0.0148199514460845	3283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2870.26170823102	2870.26170823102
"AML-0693"	"2021-03-09-AML0693:GTAGAGGGTATGTCTG"	-8.25686488571819	-3.74307682430419	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAGGGTATGTCTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3248.95143286788	42.5711198342071	0.0131030336137186	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3235.64208800603	3235.64208800603
"AML-0693"	"2021-03-09-AML0693:GTAGAGGGTTCCGTTC"	-7.00219617310222	3.9754383333954	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGAGGGTTCCGTTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2272.82878346818	33.1559883607959	0.0145879833104728	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2256.15687544382	2256.15687544382
"AML-0693"	"2021-03-09-AML0693:GTAGCTAAGATACGAT"	0.936972637742203	9.27590653980104	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTAAGATACGAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1996.45233932225	42.2059768593341	0.0211404880687821	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1987.83587079076	1987.83587079076
"AML-0693"	"2021-03-09-AML0693:GTAGCTAAGGTCCGAA"	8.96954025801961	6.79194686496583	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTAAGGTCCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1795.71138445082	45.2167164206301	0.0251803919116204	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1785.87319394945	1785.87319394945
"AML-0693"	"2021-03-09-AML0693:GTAGCTAAGTTGCGCC"	8.96446289595906	7.46411178195802	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTAAGTTGCGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2052.57467740684	43.788418200475	0.021333410512399	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2042.9184691272	2042.9184691272
"AML-0693"	"2021-03-09-AML0693:GTAGCTAGTGAGGAAA"	-0.474542061716872	10.4525203474793	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTAGTGAGGAAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1511.9794731353	48.9400714234031	0.0323682115352525	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1497.62019590869	1497.62019590869
"AML-0693"	"2021-03-09-AML0693:GTAGCTATCCGCACGA"	11.1184517341549	-2.6911020508972	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTATCCGCACGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1429.33541299712	41.4913835098327	0.0290284443613071	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1429.33541299712	1429.33541299712
"AML-0693"	"2021-03-09-AML0693:GTAGCTATCCTCCACA"	-6.9452522796696	3.90215060794679	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGCTATCCTCCACA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2330.43627818555	43.2256628157239	0.018548313558429	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2310.11683824567	2310.11683824567
"AML-0693"	"2021-03-09-AML0693:GTAGGAGCAATACCTG"	-2.61564050141032	3.3001351126465	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGAGCAATACCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3527.61948759089	30.1448913510571	0.00854539200078065	4531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3522.34402249834	3522.34402249834
"AML-0693"	"2021-03-09-AML0693:GTAGGAGGTCTACGAT"	8.1058746772701	6.4637617834839	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGAGGTCTACGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1631.05423596926	44.1399301209533	0.0270622086914988	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1623.807365222	1623.807365222
"AML-0693"	"2021-03-09-AML0693:GTAGGAGTCGCTACGG"	-0.720778982073623	11.8061742552551	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGAGTCGCTACGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1599.89397725775	48.8660134388562	0.0305432823258786	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1593.39143984428	1593.39143984428
"AML-0693"	"2021-03-09-AML0693:GTAGGAGTCTATTGTC"	8.89409603652303	6.85303924167482	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGAGTCTATTGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1652.08754107098	43.0105762323777	0.026034078196907	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1650.03408064795	1650.03408064795
"AML-0693"	"2021-03-09-AML0693:GTAGGTTCAAGACCTT"	0.948347588151139	9.20697782123414	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGTTCAAGACCTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1591.27958457103	49.6984755770605	0.0312317684830086	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1586.98091807577	1586.98091807577
"AML-0693"	"2021-03-09-AML0693:GTAGGTTCACATAACC"	7.99519981917684	6.39166400516359	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGTTCACATAACC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1586.56852823706	47.3786247998066	0.0298623248580709	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1586.56852823706	1586.56852823706
"AML-0693"	"2021-03-09-AML0693:GTAGGTTGTGATCATC"	-2.12682424011882	3.77412746036378	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGTTGTGATCATC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1796.74817766638	46.037748227269	0.0256228161517119	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1796.74817766638	1796.74817766638
"AML-0693"	"2021-03-09-AML0693:GTAGGTTTCTACGGGC"	-7.19953523102458	-2.81875922596129	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGGTTTCTACGGGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2582.94948231363	17.2851624090071	0.00669202496114024	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2557.95613631204	2557.95613631204
"AML-0693"	"2021-03-09-AML0693:GTAGTACTCCGCATAA"	-7.99921927872356	-4.44199230587157	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTAGTACTCCGCATAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2731.08092729606	50.3133470567211	0.0184225031758888	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2722.64876571706	2722.64876571706
"AML-0693"	"2021-03-09-AML0693:GTATTGGAGTCACTGT"	-8.37038360062297	-4.24148609554442	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTGGAGTCACTGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2723.68607550693	39.2231616759316	0.0144007644745297	3606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2717.26227528631	2717.26227528631
"AML-0693"	"2021-03-09-AML0693:GTATTGGCAAAGGGCT"	-7.03419909897502	3.95356175983278	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTGGCAAAGGGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2371.68044864513	40.3331634314714	0.0170061542036629	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2361.42516742898	2361.42516742898
"AML-0693"	"2021-03-09-AML0693:GTATTGGCACACGTGC"	8.19098438796346	6.33626506412355	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTGGCACACGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2138.71258079112	44.9034916443319	0.0209955709091691	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2132.52840400637	2132.52840400637
"AML-0693"	"2021-03-09-AML0693:GTATTGGCAGAAACCG"	8.87366165694539	6.76467321002809	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTGGCAGAAACCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1574.49763869535	42.7832299643557	0.0271726225006005	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1572.3344285103	1572.3344285103
"AML-0693"	"2021-03-09-AML0693:GTATTTCCACCTCGTT"	-7.84980855408366	-2.84736063396605	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTTCCACCTCGTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2662.91661496021	1.20654749371485	0.000453092480228819	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2640.63386229901	2640.63386229901
"AML-0693"	"2021-03-09-AML0693:GTATTTCGTAGACTGG"	-1.81050239029582	3.85185048663942	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTTCGTAGACTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2157.84737445495	6.2380294190822	0.0028908575708038	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2157.84737445495	2157.84737445495
"AML-0693"	"2021-03-09-AML0693:GTATTTCTCTTCGCTG"	13.9971329170162	1.76218888843385	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTATTTCTCTTCGCTG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1392.97900531408	51.963822728431	0.0373040961351135	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1390.60198559719	1390.60198559719
"AML-0693"	"2021-03-09-AML0693:GTCAAACAGCACGATG"	11.8118330436641	-2.71795561229857	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAAACAGCACGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2154.43843170628	44.3853947076699	0.0206018394651999	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2149.77848808664	2149.77848808664
"AML-0693"	"2021-03-09-AML0693:GTCAAACTCACGGACC"	-4.09046302262004	3.46643707836	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAAACTCACGGACC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2969.81832788544	38.5108701734525	0.0129674161587092	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2954.96135626169	2954.96135626169
"AML-0693"	"2021-03-09-AML0693:GTCAAGTCATTGTGCA"	3.64255156096761	-10.1471758118835	"2021-03-09-AML0693"	"AML0693"	"CD16+ monocyte"	"CD16+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAAGTCATTGTGCA"	"CD16+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2889.97992933339	41.8477575112935	0.0144802934741994	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2872.11613491608	2872.11613491608
"AML-0693"	"2021-03-09-AML0693:GTCAAGTGTCTTCATT"	-8.59672198715861	-4.86232902919921	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAAGTGTCTTCATT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2261.53971335057	48.7598880246494	0.0215604827705676	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2256.14718023605	2256.14718023605
"AML-0693"	"2021-03-09-AML0693:GTCAAGTTCAGTCAGT"	1.01541932401006	9.96797940814821	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAAGTTCAGTCAGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1539.11044244023	32.9960854463946	0.0214384130836511	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1532.72552532124	1532.72552532124
"AML-0693"	"2021-03-09-AML0693:GTCACGGAGCCTCAGC"	-7.08617577973064	2.13589880550233	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACGGAGCCTCAGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2408.04104298454	45.3601281122503	0.0188369414401802	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2388.40286284168	2388.40286284168
"AML-0693"	"2021-03-09-AML0693:GTCACGGCAATTCTCT"	-3.43350015106853	3.03948447788087	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACGGCAATTCTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3438.18366667985	28.9190453428778	0.00841114034225054	4253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3432.26883059759	3432.26883059759
"AML-0693"	"2021-03-09-AML0693:GTCACGGCATCGTTCC"	7.85891451415364	6.67820642078248	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACGGCATCGTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1713.42176368561	39.5353926060829	0.023073940954877	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1707.32817938871	1707.32817938871
"AML-0693"	"2021-03-09-AML0693:GTCACGGGTAACGATA"	-2.25587234917338	3.88711116397706	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACGGGTAACGATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3426.56263062199	24.4562048111594	0.00713724144208043	5140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3422.41576802576	3422.41576802576
"AML-0693"	"2021-03-09-AML0693:GTCACGGGTTGCATCA"	-6.97543464127238	4.00179574573366	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACGGGTTGCATCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2189.45377645971	38.8209859773754	0.0177309000056388	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2168.45667359356	2168.45667359356
"AML-0693"	"2021-03-09-AML0693:GTCACTCCAAAGTGTA"	-8.45819411698039	-4.21208193218382	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACTCCAAAGTGTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2721.98475813394	45.4713608648263	0.0167052224407014	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2712.01291077196	2712.01291077196
"AML-0693"	"2021-03-09-AML0693:GTCACTCTCGCGTTTC"	8.41668953475301	6.78234193408815	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCACTCTCGCGTTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1642.21765331904	51.1469509394542	0.0311450500097125	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1634.72310458293	1634.72310458293
"AML-0693"	"2021-03-09-AML0693:GTCAGCGAGAACAAGG"	-7.00754771652873	-2.7080915204254	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAGCGAGAACAAGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1582.56593143167	46.010273972038	0.0290732114588204	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1575.49765968466	1575.49765968466
"AML-0693"	"2021-03-09-AML0693:GTCAGCGAGGGTGAAA"	9.42226471480672	7.67218444431154	"2021-03-09-AML0693"	"AML0693"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAGCGAGGGTGAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1895.46453685951	39.3677716013792	0.0207694582704278	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1890.85771770116	1890.85771770116
"AML-0693"	"2021-03-09-AML0693:GTCAGCGAGTGGGAAA"	-7.77167163315471	4.80131194675294	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCAGCGAGTGGGAAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1575.50101227413	36.597522289617	0.0232291328310802	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1571.31818972393	1571.31818972393
"AML-0693"	"2021-03-09-AML0693:GTCATCCCAATCAAGA"	-6.93340478363689	-2.92551186000975	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATCCCAATCAAGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1486.03403994197	42.0816420189996	0.0283180875322632	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1481.56602771757	1481.56602771757
"AML-0693"	"2021-03-09-AML0693:GTCATCCCATCCTAAG"	-6.97239766541179	-2.64833381092223	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATCCCATCCTAAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1909.19639586764	46.4311824876502	0.0243197518014114	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1887.74191847719	1887.74191847719
"AML-0693"	"2021-03-09-AML0693:GTCATCCCATGTTCAG"	11.2306276756221	-2.79812600528868	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATCCCATGTTCAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1846.00038644536	37.2280286011767	0.0201668585090942	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1839.64709906252	1839.64709906252
"AML-0693"	"2021-03-09-AML0693:GTCATCCTCTCGAGTA"	-0.158375660807449	13.1580009230408	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATCCTCTCGAGTA"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1917.71518460295	54.4817832805596	0.0284097366063458	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1914.04114250566	1914.04114250566
"AML-0693"	"2021-03-09-AML0693:GTCATGAAGGTAGACC"	-8.15232978287395	-3.35211660778197	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATGAAGGTAGACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2779.62739538488	50.2881188553062	0.0180916762220726	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2772.9390185997	2772.9390185997
"AML-0693"	"2021-03-09-AML0693:GTCATGAAGTTGCCTA"	-7.20257554474528	-2.82063724910887	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATGAAGTTGCCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1833.20717176266	40.0383039823633	0.0218405778676208	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1819.08736431323	1819.08736431323
"AML-0693"	"2021-03-09-AML0693:GTCATGACAGACGCTC"	-7.19870648804362	-0.711039208528124	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATGACAGACGCTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1756.74293624518	22.6393985890621	0.0128871436577118	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1754.41041100737	1754.41041100737
"AML-0693"	"2021-03-09-AML0693:GTCATGAGTCGCGTCA"	-6.97250781479533	2.93716738307802	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATGAGTCGCGTCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2259.3082529128	38.2585033742143	0.0169337244375086	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2247.04675261252	2247.04675261252
"AML-0693"	"2021-03-09-AML0693:GTCATGATCTGGTCAA"	8.30804314193074	6.20497510516969	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATGATCTGGTCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1474.37679853411	46.8544778112436	0.031779174670836	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1472.09793949882	1472.09793949882
"AML-0693"	"2021-03-09-AML0693:GTCATTTAGTAGGATT"	9.32378544387166	5.7364725836548	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTAGTAGGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1692.5506130777	28.8178311568343	0.0170262743897699	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1688.11086886762	1688.11086886762
"AML-0693"	"2021-03-09-AML0693:GTCATTTAGTGAGGCT"	-4.9231256050175	2.5501453646454	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTAGTGAGGCT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3163.12349304684	35.0014571526487	0.0110654728560515	3091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3153.23377688577	3153.23377688577
"AML-0693"	"2021-03-09-AML0693:GTCATTTCACAAGCAG"	-9.49180922928508	-5.00914575969847	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTCACAAGCAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2089.78251795037	51.0384651189788	0.0244228596423692	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2080.74165771413	2080.74165771413
"AML-0693"	"2021-03-09-AML0693:GTCATTTTCAAATAGG"	-7.7943995994633	-2.60088016903075	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTTCAAATAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1567.52816207174	47.0431458415934	0.0300110371091633	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1555.88702906718	1555.88702906718
"AML-0693"	"2021-03-09-AML0693:GTCATTTTCGTTGTGA"	-6.97334657135661	3.76946280086366	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTTCGTTGTGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2154.46623784384	47.2304299800038	0.0219221026305204	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2138.18283759723	2138.18283759723
"AML-0693"	"2021-03-09-AML0693:GTCATTTTCTCGAGTA"	-3.18428025665935	3.32031009281007	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTTCTCGAGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3599.70881395581	26.8735528581194	0.00746547963933432	4571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3585.41586272581	3585.41586272581
"AML-0693"	"2021-03-09-AML0693:GTCATTTTCTGCTGAA"	-8.36603866043742	-4.70030596172484	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCATTTTCTGCTGAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2771.0669907782	50.3090938734837	0.0181551344810164	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2750.01940008435	2750.01940008435
"AML-0693"	"2021-03-09-AML0693:GTCCACTGTCTTTCAT"	8.26319088515584	6.00031230533449	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTGTCTTTCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1518.20147251731	45.1776256771651	0.0297573322743895	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1513.48595117762	1513.48595117762
"AML-0693"	"2021-03-09-AML0693:GTCCACTGTGTGACCC"	11.0243069129879	-2.95138409053954	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTGTGTGACCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2160.46516109471	44.35693239077	0.0205311954062218	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2157.19286536817	2157.19286536817
"AML-0693"	"2021-03-09-AML0693:GTCCACTGTTCAGTAC"	-7.64446864548381	-2.4352803460327	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTGTTCAGTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1982.81197526796	51.1892665368912	0.0258165005937961	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1980.20464023809	1980.20464023809
"AML-0693"	"2021-03-09-AML0693:GTCCACTGTTTCGTAG"	0.864248295396012	9.60371587360231	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTGTTTCGTAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1784.77458487701	43.2327495392271	0.0242230867166939	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1779.23408825386	1779.23408825386
"AML-0693"	"2021-03-09-AML0693:GTCCACTTCCAGCCTT"	-7.12675557556804	-2.84935953533324	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTTCCAGCCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1789.971658255	48.8287054865856	0.0272790383363877	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1779.98309433873	1779.98309433873
"AML-0693"	"2021-03-09-AML0693:GTCCACTTCGAACCTA"	-7.19581399384196	3.22538993442384	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCACTTCGAACCTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2815.48599858714	42.02659545408	0.0149269417340984	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2799.92582945432	2799.92582945432
"AML-0693"	"2021-03-09-AML0693:GTCCTCAAGCAGCCCT"	1.24728192862813	9.45916459644166	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCTCAAGCAGCCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1578.63355638837	50.8793708657144	0.0322300071855291	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1576.39018723687	1576.39018723687
"AML-0693"	"2021-03-09-AML0693:GTCCTCACAATAGGGC"	-2.12906370583232	2.89945552432863	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCCTCACAATAGGGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2601.64443894462	32.8682110827139	0.0126336291734189	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2592.82887293558	2592.82887293558
"AML-0693"	"2021-03-09-AML0693:GTCGAATGTAACAGTA"	-8.37258658829387	-3.26852133190306	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGAATGTAACAGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1542.81605887433	46.2710107752521	0.0299912685696391	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1536.30021095691	1536.30021095691
"AML-0693"	"2021-03-09-AML0693:GTCGAATGTAGTTAGA"	-6.96149144592937	3.7518694170746	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGAATGTAGTTAGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2637.572426557	38.3259777035006	0.0145307773608818	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2620.11678168119	2620.11678168119
"AML-0693"	"2021-03-09-AML0693:GTCGCGACACGTCATA"	9.58905663070027	6.93473908984987	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGCGACACGTCATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1742.63126288866	32.9133056288377	0.0188871313913416	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1734.39483361724	1734.39483361724
"AML-0693"	"2021-03-09-AML0693:GTCGCGAGTAATGCGG"	-6.84600005570109	3.8397531279358	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGCGAGTAATGCGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2090.75834263654	39.6135393748283	0.0189469718077862	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2075.17606400704	2075.17606400704
"AML-0693"	"2021-03-09-AML0693:GTCGCGAGTGTGTCGC"	-6.61771665039714	-2.71587874805602	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGCGAGTGTGTCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1519.21733482268	38.2617811788951	0.0251851926000837	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1510.70682835211	1510.70682835211
"AML-0693"	"2021-03-09-AML0693:GTCGCGATCACCATCC"	-8.33791289749797	-3.34541513836058	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGCGATCACCATCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2450.97638990187	47.9823273737342	0.0195768215358677	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2445.19822724433	2445.19822724433
"AML-0693"	"2021-03-09-AML0693:GTCGCGATCATGGGAG"	7.88819613036458	6.47739741885988	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGCGATCATGGGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1637.9872004354	25.5617676759441	0.0156055967159875	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1629.28951479706	1629.28951479706
"AML-0693"	"2021-03-09-AML0693:GTCGTAACAGAGATTA"	8.83334507521931	6.97756288135377	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGTAACAGAGATTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1501.31566643614	42.5793002092486	0.0283613241113538	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1491.87562173674	1491.87562173674
"AML-0693"	"2021-03-09-AML0693:GTCGTTCCAAGCGAAC"	-7.09684405747111	-2.72575619136962	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGTTCCAAGCGAAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1664.72274806061	9.0594797007354	0.00544203514446453	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1656.60126051717	1656.60126051717
"AML-0693"	"2021-03-09-AML0693:GTCGTTCGTACAAAGT"	-8.34536872330363	-4.35441830074462	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGTTCGTACAAAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2609.36838588645	51.5161197850591	0.0197427546312354	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2599.37231695645	2599.37231695645
"AML-0693"	"2021-03-09-AML0693:GTCGTTCGTGGTTTAC"	3.7314895587856	-10.1290760270325	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCGTTCGTGGTTTAC"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2597.07825045683	38.4299852360832	0.0147973921191336	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2591.43251882192	2591.43251882192
"AML-0693"	"2021-03-09-AML0693:GTCTACCAGCGACTTT"	-7.14965091171916	-2.81929232990416	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCAGCGACTTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1599.56874654883	32.1287524582928	0.0200858841032076	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1592.89947842389	1592.89947842389
"AML-0693"	"2021-03-09-AML0693:GTCTACCAGTCATGGG"	-7.49588475647624	-2.10885813152465	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCAGTCATGGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2573.92399492641	27.4629033438079	0.0106696636722535	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2559.6387907487	2559.6387907487
"AML-0693"	"2021-03-09-AML0693:GTCTACCCAAAGGAGA"	-6.95528588715251	3.9274384745392	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCCAAAGGAGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.84134321782	40.0126469110441	0.0182386237886991	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2172.67598660509	2172.67598660509
"AML-0693"	"2021-03-09-AML0693:GTCTACCCAGAACTAA"	-0.511047939688522	11.0825223692688	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCCAGAACTAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1629.23361719311	39.4265829361659	0.0241994656383848	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1626.91417879027	1626.91417879027
"AML-0693"	"2021-03-09-AML0693:GTCTACCCAGCTATAC"	-2.66258368912395	3.60608956897584	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCCAGCTATAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3397.49477025691	35.5782625196237	0.0104719109006703	3219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3390.59944704592	3390.59944704592
"AML-0693"	"2021-03-09-AML0693:GTCTACCGTAGAAACT"	-8.32013831558879	-3.58503701603087	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCGTAGAAACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2600.28771163114	41.4800426291459	0.0159520973173872	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2595.56110454671	2595.56110454671
"AML-0693"	"2021-03-09-AML0693:GTCTACCGTGTATTCG"	-0.571052054793197	12.5798911818298	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCGTGTATTCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1775.86133628056	40.1715743448366	0.0226208958572034	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1773.70811611041	1773.70811611041
"AML-0693"	"2021-03-09-AML0693:GTCTACCTCGGTCGGT"	8.29752316054646	5.99053952777711	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCTCGGTCGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1484.63242526424	33.4703351631913	0.0225445265734609	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1478.12203253734	1478.12203253734
"AML-0693"	"2021-03-09-AML0693:GTCTACCTCTGTGTGA"	-5.8360107940739	-5.50779249584349	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTACCTCTGTGTGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3457.84372993476	42.7166482930653	0.0123535508337941	4502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3451.97985045808	3451.97985045808
"AML-0693"	"2021-03-09-AML0693:GTCTAGACAAGCAGGT"	-8.42010245743449	-4.14296963131102	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTAGACAAGCAGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2409.90888646748	52.6431174664837	0.0218444430667458	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2406.58738315403	2406.58738315403
"AML-0693"	"2021-03-09-AML0693:GTCTAGACACAATGTC"	9.26138748702351	6.35083911502687	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTAGACACAATGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1716.75832020537	48.8064961130096	0.0284294507494631	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1712.29856298448	1712.29856298448
"AML-0693"	"2021-03-09-AML0693:GTCTAGAGTACGGCAA"	-9.25477347794231	-3.75473596965941	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTAGAGTACGGCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3144.74925411402	47.5674367605391	0.0151259871350031	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3133.18989604255	3133.18989604255
"AML-0693"	"2021-03-09-AML0693:GTCTAGAGTACTCCGG"	-7.39599452439006	-2.97880818760069	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTAGAGTACTCCGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3114.08578065968	32.2812386704723	0.0103662008512925	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3098.14417176164	3098.14417176164
"AML-0693"	"2021-03-09-AML0693:GTCTAGAGTGCAATGG"	0.967341800301713	9.63540837848512	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTAGAGTGCAATGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1639.43138191899	46.0699540378682	0.0281011785829927	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1633.00928635064	1633.00928635064
"AML-0693"	"2021-03-09-AML0693:GTCTCACAGCGAATGC"	-8.29367480698283	-3.74138381397399	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTCACAGCGAATGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2649.62324168083	43.8910416885313	0.0165650123376365	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2639.51585801873	2639.51585801873
"AML-0693"	"2021-03-09-AML0693:GTCTCACGTCGGAAAC"	10.1130081611568	6.81842658603517	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTCACGTCGGAAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1834.34859891884	46.963962241771	0.0256025284776576	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1827.52943565639	1827.52943565639
"AML-0693"	"2021-03-09-AML0693:GTCTCACTCCCATTTA"	9.17462696608846	6.15550992572633	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTCACTCCCATTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1603.48665715113	40.0254399828373	0.0249615048583874	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1596.67255770599	1596.67255770599
"AML-0693"	"2021-03-09-AML0693:GTCTGTCGTAGCGTTT"	-1.94372640076335	3.21762607181398	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTGTCGTAGCGTTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2979.21781494692	0	0	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2969.45995451037	2969.45995451037
"AML-0693"	"2021-03-09-AML0693:GTCTGTCTCTGCAGCG"	0.831339438527268	9.44970510089723	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTGTCTCTGCAGCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1448.57198491624	48.1328152943673	0.0332277689997923	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1445.12469284857	1445.12469284857
"AML-0693"	"2021-03-09-AML0693:GTCTTTATCAGTGTTG"	1.09452166137044	10.5124158629212	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTTTATCAGTGTTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1929.27049926111	41.7299603963163	0.0216299168065331	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1910.51361073952	1910.51361073952
"AML-0693"	"2021-03-09-AML0693:GTCTTTATCGGACGTC"	-6.96858392182048	-2.58547546779784	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTCTTTATCGGACGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2519.58302675333	27.8265547151123	0.011044111037281	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2492.21103006708	2492.21103006708
"AML-0693"	"2021-03-09-AML0693:GTGACGCCATGAAAGT"	-6.17595515671428	-0.778579198476397	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	1	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGACGCCATGAAAGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1651.98732404655	43.144015473091	0.0261164325204443	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1532.50850176874	1532.50850176874
"AML-0693"	"2021-03-09-AML0693:GTGACGCGTGAGGAAA"	-6.92089257660564	3.97078273380128	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGACGCGTGAGGAAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2059.04135944388	48.7607413261581	0.0236812830895868	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2052.34012900089	2052.34012900089
"AML-0693"	"2021-03-09-AML0693:GTGACGCGTTGTCTAG"	-7.14515958252605	4.25070521915285	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGACGCGTTGTCTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2253.69939594346	39.5168813823474	0.0175342290340387	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2244.36797628464	2244.36797628464
"AML-0693"	"2021-03-09-AML0693:GTGAGCCCATGAATCC"	-7.18195090714152	4.27298352802125	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGCCCATGAATCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2190.25709439108	48.6236040887492	0.0221999527878562	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2171.57547311026	2171.57547311026
"AML-0693"	"2021-03-09-AML0693:GTGAGCCTCTACGCAA"	-6.92371926727946	3.89897391879884	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGCCTCTACGCAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.24628022322	36.5864402329294	0.0166814099095181	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2183.75971631261	2183.75971631261
"AML-0693"	"2021-03-09-AML0693:GTGAGGAAGAGATGCC"	-7.53044877472575	-3.78027703678282	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGGAAGAGATGCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2369.2098396328	20.9408105811183	0.00883873189736704	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2349.70689752153	2349.70689752153
"AML-0693"	"2021-03-09-AML0693:GTGAGGAAGCGATCGA"	-2.26473317566569	3.49016783321229	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGGAAGCGATCGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3244.18111554095	33.538528138699	0.0103380566448759	4686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3239.82238419605	3239.82238419605
"AML-0693"	"2021-03-09-AML0693:GTGAGGACACGATAGG"	-8.72986159744914	-3.67006137287291	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGGACACGATAGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2750.59493427863	39.0799527763659	0.0142078182030154	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2737.38084490023	2737.38084490023
"AML-0693"	"2021-03-09-AML0693:GTGAGTTCACGCTTAA"	-3.46566472473796	2.97105810726014	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGTTCACGCTTAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3183.93413649596	21.8828233724795	0.00687288820508151	3393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3175.68030708109	3175.68030708109
"AML-0693"	"2021-03-09-AML0693:GTGAGTTCAGGACATG"	-6.95364365997966	3.84871552074281	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGTTCAGGACATG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2054.38822721056	43.910312705688	0.0213739117680349	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2043.50918554219	2043.50918554219
"AML-0693"	"2021-03-09-AML0693:GTGAGTTGTGCCTAAT"	-8.44357142868694	-3.73122861301573	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGAGTTGTGCCTAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2806.4152425451	52.1591460868524	0.0185856837206849	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2798.37202602074	2798.37202602074
"AML-0693"	"2021-03-09-AML0693:GTGATGTAGAAGCGAA"	1.59601416167561	-8.96816828167113	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGATGTAGAAGCGAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2874.83706329033	38.5380933762627	0.0134053139457423	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2863.99460330699	2863.99460330699
"AML-0693"	"2021-03-09-AML0693:GTGATGTCAATCGTCA"	8.94252647933308	6.41605517947999	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGATGTCAATCGTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1462.87714414142	51.5407162028502	0.0352324297424854	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1458.04221950594	1458.04221950594
"AML-0693"	"2021-03-09-AML0693:GTGCACGAGCAATAGT"	-8.47036776962932	-3.39179112827452	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGAGCAATAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2753.8743512706	44.4731926519662	0.0161493180077177	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2746.8684986259	2746.8684986259
"AML-0693"	"2021-03-09-AML0693:GTGCACGGTGAGATCG"	-7.1694315475529	4.05446741664735	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGGTGAGATCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1815.84926455713	35.3808327700596	0.0194844547180454	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1802.60597851379	1802.60597851379
"AML-0693"	"2021-03-09-AML0693:GTGCACGGTGCTCGTG"	-8.65864882889445	-4.2190938225952	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGGTGCTCGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2726.33528388204	49.2677129364952	0.0180710396214888	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2716.4948896254	2716.4948896254
"AML-0693"	"2021-03-09-AML0693:GTGCACGGTTAGAAAC"	-2.58186636391338	3.28984139049379	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGGTTAGAAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3781.51738003585	18.399303500827	0.00486558744856347	5431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3776.43278768123	3776.43278768123
"AML-0693"	"2021-03-09-AML0693:GTGCACGTCCGGCAAC"	-7.60901961746867	-2.45963981067809	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGTCCGGCAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2753.74665676612	37.6437387712346	0.0136700079793984	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2738.78126154208	2738.78126154208
"AML-0693"	"2021-03-09-AML0693:GTGCACGTCTCTCTAA"	-7.98149047318156	-4.10686209118041	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCACGTCTCTCTAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2662.86298911903	44.9742673891802	0.0168894410162873	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2657.16431924983	2657.16431924983
"AML-0693"	"2021-03-09-AML0693:GTGCAGCAGAGATGCC"	-5.09657798233684	3.47354290569154	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCAGAGATGCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2498.09751394956	47.1481857490693	0.0188736370320976	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2485.86693277177	2485.86693277177
"AML-0693"	"2021-03-09-AML0693:GTGCAGCAGTCCTGTA"	7.84931006011311	6.24571464145509	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCAGTCCTGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1651.76361871512	41.7396455961393	0.0252697450913757	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1647.42533502266	1647.42533502266
"AML-0693"	"2021-03-09-AML0693:GTGCAGCCAGTCGTTA"	1.01968057927434	-9.16620066082152	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCCAGTCGTTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1656.74176858267	31.1134533811117	0.0187799052158436	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1654.49041053791	1654.49041053791
"AML-0693"	"2021-03-09-AML0693:GTGCAGCGTCATCAGT"	-8.82490287247356	-4.66847612774047	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCGTCATCAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1627.82312317367	48.227959358604	0.0296272725654473	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1616.47126079919	1616.47126079919
"AML-0693"	"2021-03-09-AML0693:GTGCAGCGTCCAACGC"	-2.0603977245396	3.01612589443056	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCGTCCAACGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2590.41533078768	49.944306578589	0.0192804242566778	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2575.11845128316	2575.11845128316
"AML-0693"	"2021-03-09-AML0693:GTGCAGCGTGCCTGCA"	1.2720568376476	-10.1620350114075	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCGTGCCTGCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2328.95093696457	46.1399492274817	0.0198114732668512	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2320.69525776165	2320.69525776165
"AML-0693"	"2021-03-09-AML0693:GTGCAGCGTGTGTGTT"	-5.82072053375896	-5.54950430309447	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCAGCGTGTGTGTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3680.57853125707	40.9607027733788	0.0111288761876761	5122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3668.81343580911	3668.81343580911
"AML-0693"	"2021-03-09-AML0693:GTGCGTGCAAACCACT"	-6.85707793656047	3.8390435942444	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCGTGCAAACCACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2112.65252958882	34.5080590823566	0.016333996527613	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2101.1807819766	2101.1807819766
"AML-0693"	"2021-03-09-AML0693:GTGCGTGCACAGTCAT"	-1.68784425678905	3.80657837474672	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCGTGCACAGTCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2805.27140393018	29.6114397260829	0.0105556416696785	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2797.04497976805	2797.04497976805
"AML-0693"	"2021-03-09-AML0693:GTGCTGGAGGATTACA"	9.41066517409627	6.62148997867433	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCTGGAGGATTACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1727.6332680372	46.4966269049651	0.0269134820249155	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1721.28323763658	1721.28323763658
"AML-0693"	"2021-03-09-AML0693:GTGCTGGGTCCAATCA"	11.6275412040645	-3.24452378666075	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCTGGGTCCAATCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3012.82898778225	15.7396283658595	0.00522420237912193	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3005.58487510882	3005.58487510882
"AML-0693"	"2021-03-09-AML0693:GTGCTTCAGAGGTCGT"	7.79856409606282	6.16347882831422	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCTTCAGAGGTCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1427.47423856885	45.4766624740424	0.0318581318284498	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1425.16878961846	1425.16878961846
"AML-0693"	"2021-03-09-AML0693:GTGCTTCCATACGCAT"	8.68658985671346	7.16791198337404	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCTTCCATACGCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1799.79905767331	46.6227306478019	0.0259044088555494	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1787.7841197426	1787.7841197426
"AML-0693"	"2021-03-09-AML0693:GTGCTTCTCAGGTGTT"	-4.99369082871135	3.52915976131288	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGCTTCTCAGGTGTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3202.35898987974	35.0758005859165	0.0109531132195875	3321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3191.51377018655	3191.51377018655
"AML-0693"	"2021-03-09-AML0693:GTGGAAGAGGTGGGTT"	-6.98096881333049	3.88401887500612	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAAGAGGTGGGTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2060.33294224753	43.9255218603522	0.0213196231345191	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2051.05459759329	2051.05459759329
"AML-0693"	"2021-03-09-AML0693:GTGGAAGCAGCTACTA"	-8.08599219742473	-4.60761692440184	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAAGCAGCTACTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2597.97450149486	50.7860555873396	0.0195483271903237	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2588.06674506281	2588.06674506281
"AML-0693"	"2021-03-09-AML0693:GTGGAAGTCATTTCCA"	-1.61994955959972	11.8730258711609	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAAGTCATTTCCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1531.39785449102	51.4490739783861	0.0335961512728421	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1531.39785449102	1531.39785449102
"AML-0693"	"2021-03-09-AML0693:GTGGAAGTCTAGCCAA"	0.635146160691422	9.82367894733278	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAAGTCTAGCCAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1747.26820506777	39.0899046993069	0.022372011684257	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1745.32422272974	1745.32422272974
"AML-0693"	"2021-03-09-AML0693:GTGGAGAAGACCAAGC"	0.647677441209	9.23152635181276	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAGAAGACCAAGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1377.30849724563	42.5617230508915	0.0309020986482023	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1357.76134548622	1357.76134548622
"AML-0693"	"2021-03-09-AML0693:GTGGAGAAGCTATCTG"	1.21303309974019	-9.34609129345091	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAGAAGCTATCTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1813.31060017791	34.6095903794097	0.0190864104450799	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1803.34575299832	1803.34575299832
"AML-0693"	"2021-03-09-AML0693:GTGGAGACAGAGAAAG"	0.297552739351434	9.55248258197633	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAGACAGAGAAAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2004.05926093106	46.0888689621014	0.0229977575317254	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1994.96074053234	1994.96074053234
"AML-0693"	"2021-03-09-AML0693:GTGGAGATCATAGGCT"	-7.20107016983684	3.81030104244081	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGAGATCATAGGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2167.29208303065	40.6583399183026	0.0187599725190006	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2159.65850043558	2159.65850043558
"AML-0693"	"2021-03-09-AML0693:GTGGCGTAGTAGTCTC"	1.13471486148183	-10.3247738114563	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGCGTAGTAGTCTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2589.58321092034	34.8972492426599	0.013476009998635	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2585.82430205309	2585.82430205309
"AML-0693"	"2021-03-09-AML0693:GTGGCGTGTCGTAATC"	-4.90672049942668	2.56007216060487	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGCGTGTCGTAATC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3254.05894464165	34.8297180937348	0.0107034687097748	3308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3237.24020524608	3237.24020524608
"AML-0693"	"2021-03-09-AML0693:GTGGCGTTCCGTAGTA"	-8.44951377335246	-4.48343470012816	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGCGTTCCGTAGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2484.57107575813	51.1539775546122	0.0205886553432581	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2471.01571147013	2471.01571147013
"AML-0693"	"2021-03-09-AML0693:GTGGCGTTCGCATAGT"	-6.84885154190715	3.98939035022584	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGCGTTCGCATAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2220.72475828781	44.8313210237368	0.0201876981181144	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2212.3773790749	2212.3773790749
"AML-0693"	"2021-03-09-AML0693:GTGGCGTTCTCCAAGA"	10.0372749763424	6.93381068790285	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGCGTTCTCCAAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2119.83230792093	46.3336055628391	0.0218572032276844	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2110.23839450392	2110.23839450392
"AML-0693"	"2021-03-09-AML0693:GTGGGAAAGCGTTCAT"	11.02583851394	-2.73336031353148	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAAGCGTTCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1443.05092621973	52.6780286770359	0.0365046220614218	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1439.93468362294	1439.93468362294
"AML-0693"	"2021-03-09-AML0693:GTGGGAACAACCACAT"	-7.05967984619792	-2.82505133068236	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAACAACCACAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1997.84045049026	41.7020531251122	0.0208735653114235	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1989.60854798606	1989.60854798606
"AML-0693"	"2021-03-09-AML0693:GTGGGAACAATGTGGG"	-2.75390944901164	3.59474465930787	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAACAATGTGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3171.78877835671	38.3929735466897	0.0121045177436377	4097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3166.15399198011	3166.15399198011
"AML-0693"	"2021-03-09-AML0693:GTGGGAAGTACAGCGA"	-0.212609956890899	11.7235555418762	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAGTACAGCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1738.77258275786	46.1364663838024	0.0265339279220894	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1730.55008109104	1730.55008109104
"AML-0693"	"2021-03-09-AML0693:GTGGGAAGTACCGTCG"	-7.16989074173625	-2.95984437381896	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAGTACCGTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2837.04633223154	41.6855678903235	0.0146932982435768	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2806.84830171971	2806.84830171971
"AML-0693"	"2021-03-09-AML0693:GTGGGAAGTAGGTAGC"	-7.34283194962199	-3.01690056240233	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAGTAGGTAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2947.01811047668	45.4520235061655	0.0154230553740349	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2922.72235656329	2922.72235656329
"AML-0693"	"2021-03-09-AML0693:GTGGGAAGTCTTGCGG"	1.30002357539479	-10.1852827302185	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAGTCTTGCGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1841.96616093998	51.1747635524701	0.0277826838720831	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1837.08219272854	1837.08219272854
"AML-0693"	"2021-03-09-AML0693:GTGGGAAGTTGGCCTG"	-7.8787411254948	-3.64970257198485	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAAGTTGGCCTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3144.21030333589	9.1253727589613	0.00290227811710929	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3123.95143710537	3123.95143710537
"AML-0693"	"2021-03-09-AML0693:GTGGGAATCCGAAATC"	-2.81464109841045	3.23998091304628	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAATCCGAAATC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3292.98500791373	38.5715583541853	0.0117132505193585	4664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3288.43410091641	3288.43410091641
"AML-0693"	"2021-03-09-AML0693:GTGGGAATCCTAAACG"	11.4833418327266	-2.52884199535521	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGGAATCCTAAACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1572.66280866787	49.0590551298715	0.0311948975072586	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1560.86638144542	1560.86638144542
"AML-0693"	"2021-03-09-AML0693:GTGGTTAAGCCACCGT"	-6.73926244202312	3.25394556606141	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGTTAAGCCACCGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2745.309105828	29.5625216923995	0.0107683763659405	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2726.46889602698	2726.46889602698
"AML-0693"	"2021-03-09-AML0693:GTGGTTACAACTTCTT"	-7.44434104386027	-3.22371461307677	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGTTACAACTTCTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2133.1132220298	4.03687929279864	0.00189248242948739	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2110.32064615842	2110.32064615842
"AML-0693"	"2021-03-09-AML0693:GTGGTTACAGCTCGGT"	-8.97160182419475	-3.88068010723265	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGTTACAGCTCGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3068.98249903663	49.783430912033	0.0162214776160048	3429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3059.92165603298	3059.92165603298
"AML-0693"	"2021-03-09-AML0693:GTGGTTATCATGCGGC"	-6.96387801590617	-2.7368054619995	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGTTATCATGCGGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2095.41826034919	40.1182140456496	0.0191456831339076	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2079.91756545541	2079.91756545541
"AML-0693"	"2021-03-09-AML0693:GTGGTTATCGCCGATG"	-6.84257302704509	3.77193067157594	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGGTTATCGCCGATG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2235.61971462404	37.0100143722056	0.016554700305293	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2224.65499322019	2224.65499322019
"AML-0693"	"2021-03-09-AML0693:GTGTAACCAAGACTGG"	14.2729011970455	1.8538779982361	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTAACCAAGACTGG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1708.39460434747	38.3355617554121	0.0224395240173768	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1697.4532265744	1697.4532265744
"AML-0693"	"2021-03-09-AML0693:GTGTAACGTGACTGAG"	0.830967445939225	10.6257400282654	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTAACGTGACTGAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1744.72022029312	51.9411533588339	0.0297704770969569	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1741.6320256953	1741.6320256953
"AML-0693"	"2021-03-09-AML0693:GTGTAACTCCCTTGTG"	11.1843706565792	-2.66912271892699	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTAACTCCCTTGTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1770.83729985559	43.0074429593324	0.0242865016243105	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1767.59843920514	1767.59843920514
"AML-0693"	"2021-03-09-AML0693:GTGTCCTAGAGTGTTA"	-2.39526424828227	11.3853711851868	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTCCTAGAGTGTTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1577.77346915548	45.0899221239873	0.0285781976978749	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1577.77346915548	1577.77346915548
"AML-0693"	"2021-03-09-AML0693:GTGTCCTCAAGAGGCT"	-9.03930697861369	-4.38687708294066	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTCCTCAAGAGGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2573.84841726674	44.8245312052841	0.0174153733780814	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2558.37577388143	2558.37577388143
"AML-0693"	"2021-03-09-AML0693:GTGTCCTCAAGCGATG"	9.04283203658406	7.00049207294313	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTCCTCAAGCGATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1673.10040866233	41.6416916002056	0.024888937558445	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1667.17476674534	1667.17476674534
"AML-0693"	"2021-03-09-AML0693:GTGTGATAGGAGGCAG"	-8.28351149979289	-0.166771732923113	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGATAGGAGGCAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2513.17083221672	38.4363462294628	0.0152939647940925	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2505.95394666353	2505.95394666353
"AML-0693"	"2021-03-09-AML0693:GTGTGATGTAGCGCCT"	-8.30809817734416	-3.53149034893187	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGATGTAGCGCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2789.24634293386	49.5299266381906	0.0177574586639389	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2785.7956148832	2785.7956148832
"AML-0693"	"2021-03-09-AML0693:GTGTGATTCGAAGCCC"	-8.64499793472942	-3.77437951481017	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGATTCGAAGCCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3037.83339556628	47.9448716389824	0.0157825875865865	3118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3026.38766849279	3026.38766849279
"AML-0693"	"2021-03-09-AML0693:GTGTGGCCACGCTATA"	9.41560997542683	5.90265224063722	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGGCCACGCTATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1440.37087726372	49.7075915876642	0.0345102725779168	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1438.43148355731	1438.43148355731
"AML-0693"	"2021-03-09-AML0693:GTGTGGCCAGGACATG"	-8.69580398026164	-4.43267395412596	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGGCCAGGACATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2486.87681693075	47.3473667425024	0.019038887016904	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2480.18765277326	2480.18765277326
"AML-0693"	"2021-03-09-AML0693:GTGTGGCGTTTAGACC"	-0.314340154558975	9.24710843646852	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGGCGTTTAGACC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1547.43627035042	42.4061681349992	0.0274041451318678	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1532.57752106265	1532.57752106265
"AML-0693"	"2021-03-09-AML0693:GTGTGGCTCCTAAACG"	-8.42956290665324	-3.61783602153929	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTGGCTCCTAAACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2610.32777160596	40.7526321852545	0.0156120747089865	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2606.72258662843	2606.72258662843
"AML-0693"	"2021-03-09-AML0693:GTGTTAGAGCAAGGAA"	1.0661025243694	9.05175778949586	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTAGAGCAAGGAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1361.53367691716	50.2342012299069	0.0368953056994147	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1358.69618166911	1358.69618166911
"AML-0693"	"2021-03-09-AML0693:GTGTTAGCATAGATGA"	0.967065950005692	-8.58253385936888	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTAGCATAGATGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2784.04550531507	47.4629521087923	0.0170481955191393	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2779.60211432827	2779.60211432827
"AML-0693"	"2021-03-09-AML0693:GTGTTAGCATCATCTT"	7.75807299193684	6.96564052188722	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTAGCATCATCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1609.33744101548	49.0028893253916	0.0304491078604815	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1609.33744101548	1609.33744101548
"AML-0693"	"2021-03-09-AML0693:GTGTTAGTCTTACGTT"	-8.72045741501506	-4.84643795406493	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTAGTCTTACGTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2350.70732222736	50.9817328145062	0.0216878266096519	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2341.67990435736	2341.67990435736
"AML-0693"	"2021-03-09-AML0693:GTGTTCCAGCCTCCAG"	8.65914501723592	6.59095094287721	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTCCAGCCTCCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1592.07976607321	40.8547059854837	0.0256612180219148	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1590.14088060822	1590.14088060822
"AML-0693"	"2021-03-09-AML0693:GTGTTCCCATCCTTCG"	8.47962822493855	6.30299804294435	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTCCCATCCTTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1643.00276456361	50.6369342465054	0.0308197498742217	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.00276456361	1643.00276456361
"AML-0693"	"2021-03-09-AML0693:GTGTTCCCATGCAGCC"	-8.85422358933147	-3.76678659832152	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTCCCATGCAGCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3389.08979454541	43.4482996771398	0.0128200497216297	3655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3384.31565857399	3384.31565857399
"AML-0693"	"2021-03-09-AML0693:GTGTTCCGTGGCTCTG"	10.8452927070553	-2.86278941547545	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTGTTCCGTGGCTCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1833.3063766417	49.7692359136603	0.0271472551166428	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1824.84117950944	1824.84117950944
"AML-0693"	"2021-03-09-AML0693:GTTACAGCAGGACATG"	11.1686941581661	-2.87030222332152	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACAGCAGGACATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2026.07161037661	49.4256199899216	0.0243948040813494	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2019.49870985562	2019.49870985562
"AML-0693"	"2021-03-09-AML0693:GTTACCCAGCTGTTAC"	-7.21332631531413	-2.93515517627867	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACCCAGCTGTTAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3039.11403949459	5.09960800356689	0.00167799165720512	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3019.94147224692	3019.94147224692
"AML-0693"	"2021-03-09-AML0693:GTTACCCCATGATGCT"	0.941553671925706	-9.06509210979613	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACCCCATGATGCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1873.37067413421	28.3822088531812	0.0151503433063497	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1857.68978357927	1857.68978357927
"AML-0693"	"2021-03-09-AML0693:GTTACCCGTCACTGAT"	-2.32578907433208	3.40285084331361	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACCCGTCACTGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3349.76304276879	31.9713096150159	0.00954434961721639	5061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3343.14717261162	3343.14717261162
"AML-0693"	"2021-03-09-AML0693:GTTACGAGTGTCCGTG"	11.9025255638057	-2.66031601345214	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACGAGTGTCCGTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1488.71360032026	43.8352607362605	0.0294450596319067	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1479.54387183593	1479.54387183593
"AML-0693"	"2021-03-09-AML0693:GTTACGAGTTAGAGAT"	1.09069277819936	9.37668035114137	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTACGAGTTAGAGAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1746.84385167562	27.7669870767965	0.0158955175359043	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1737.84225518232	1737.84225518232
"AML-0693"	"2021-03-09-AML0693:GTTAGACCAACTGCTA"	0.470560689538163	-4.3448205224243	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	36	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00224971878515186	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTAGACCAACTGCTA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	3036.82012048529	38.822645111004	0.0127839791527725	2785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	3029.63057112112	3029.63057112112
"AML-0693"	"2021-03-09-AML0693:GTTAGACCATAGACTC"	12.0025631385738	-2.59530117427977	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTAGACCATAGACTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1640.0327139959	46.7428894824895	0.0285011933503458	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1634.45109798097	1634.45109798097
"AML-0693"	"2021-03-09-AML0693:GTTAGTGAGCAGAAAG"	7.9741698699886	6.11578986728517	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTAGTGAGCAGAAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1468.28166434833	49.4841260936565	0.0337020663645073	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1450.3150818549	1450.3150818549
"AML-0693"	"2021-03-09-AML0693:GTTAGTGCAAGCTGCC"	-3.3350719017094	2.99153468692628	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTAGTGCAAGCTGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1637.40578885652	50.3810786130066	0.0307688411485281	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1637.40578885652	1637.40578885652
"AML-0693"	"2021-03-09-AML0693:GTTAGTGGTCCGACGT"	-7.88437734070476	-0.914464675542437	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTAGTGGTCCGACGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2992.43805900743	45.3795056900282	0.0151647268198027	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2982.57318982186	2982.57318982186
"AML-0693"	"2021-03-09-AML0693:GTTATGGAGGGTCAAC"	-7.74427829209025	-3.54080870067748	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTATGGAGGGTCAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2800.56313864205	3.66344797485008	0.00130811118817569	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2792.31583058917	2792.31583058917
"AML-0693"	"2021-03-09-AML0693:GTTATGGGTCTGTCCT"	-6.87028584900554	-2.43322350895079	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTATGGGTCTGTCCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2189.18167952002	31.2498036217769	0.0142746506213356	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2182.17924208748	2182.17924208748
"AML-0693"	"2021-03-09-AML0693:GTTATGGGTGATTAGA"	-5.79758630219157	-5.56001331722411	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTATGGGTGATTAGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3857.97497906045	4.18756836060645	0.00108543170532077	5211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3849.10094969488	3849.10094969488
"AML-0693"	"2021-03-09-AML0693:GTTATGGGTTCCAGGC"	8.59519257125203	6.51416728580324	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTATGGGTTCCAGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1815.44821489888	48.8312981474248	0.0268976541146588	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1798.70731421641	1798.70731421641
"AML-0693"	"2021-03-09-AML0693:GTTCATTAGAGAGTGA"	-1.74275384369548	11.4048576124939	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ NK-like"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCATTAGAGAGTGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1631.95283361541	47.7276206511822	0.0292457108245261	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1622.78364397714	1622.78364397714
"AML-0693"	"2021-03-09-AML0693:GTTCATTCAAAGGCGT"	14.1265407997066	1.83531007850496	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCATTCAAAGGCGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1349.83764097716	15.2692873076665	0.0113119436324304	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1333.31340493724	1333.31340493724
"AML-0693"	"2021-03-09-AML0693:GTTCATTCACAAAGTA"	-6.98054299774821	-2.66702678119811	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCATTCACAAAGTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1594.21554371086	32.0330492882062	0.0200932988105502	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1589.83467248982	1589.83467248982
"AML-0693"	"2021-03-09-AML0693:GTTCATTTCCATCTCG"	14.2531076866085	1.94131324375001	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCATTTCCATCTCG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1143.71537295771	33.7977594878551	0.0295508483028012	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1121.18118071259	1121.18118071259
"AML-0693"	"2021-03-09-AML0693:GTTCCGTAGTGAATAC"	-2.74392018738444	3.50607273662416	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCCGTAGTGAATAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2085.18556051727	31.1453338125246	0.0149364806673601	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2079.84143756862	2079.84143756862
"AML-0693"	"2021-03-09-AML0693:GTTCCGTGTTATCTGG"	-0.501112024218398	11.2749595412048	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCCGTGTTATCTGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1752.78042598569	50.3464438826975	0.0287237597683604	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1750.63478030317	1750.63478030317
"AML-0693"	"2021-03-09-AML0693:GTTCGCTAGGTCACAG"	-6.86243329468425	-2.61555793201598	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTAGGTCACAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1600.47271680105	54.270177526707	0.0339088426544251	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1582.55989152888	1582.55989152888
"AML-0693"	"2021-03-09-AML0693:GTTCGCTCAACCGTAT"	-7.55237565460857	-2.26749040996703	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTCAACCGTAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3277.21876318847	0	0	2993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3252.70384097343	3252.70384097343
"AML-0693"	"2021-03-09-AML0693:GTTCGCTCAAGCAATA"	-2.25916324082072	11.0217609175476	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTCAAGCAATA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2076.88839503515	44.3764246289895	0.0213667834704418	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2071.56975343941	2071.56975343941
"AML-0693"	"2021-03-09-AML0693:GTTCGCTCAGGAGGTT"	7.76149906691853	6.68844792926637	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTCAGGAGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1489.53977349578	51.5901260297415	0.0346349435897675	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1485.34756991247	1485.34756991247
"AML-0693"	"2021-03-09-AML0693:GTTCGCTCATTCTCCG"	9.82749428328816	6.76542279804078	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTCATTCTCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1551.57706025977	47.7489028273922	0.0307744320603695	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1537.77757795789	1537.77757795789
"AML-0693"	"2021-03-09-AML0693:GTTCGCTGTACCGGCT"	-7.03028951111491	3.80011103237001	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTGTACCGGCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.16342435001	44.7317764681021	0.0164324360793229	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2703.48871770809	2703.48871770809
"AML-0693"	"2021-03-09-AML0693:GTTCGCTGTGCGTTTA"	-8.38868937912639	-4.56777288829955	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTGTGCGTTTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2313.03757745576	40.5933602028445	0.0175498057612602	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2305.58390282011	2305.58390282011
"AML-0693"	"2021-03-09-AML0693:GTTCGCTTCCGTTGGG"	-6.74604068222697	-2.76038410579833	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCGCTTCCGTTGGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1630.73227870585	35.8817105614839	0.0220034343037348	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1607.75139348123	1607.75139348123
"AML-0693"	"2021-03-09-AML0693:GTTCTATAGCAGGTCA"	-8.38622413101848	-4.14367439663085	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATAGCAGGTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2720.38337270136	49.083455681206	0.0180428450540285	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2712.05020616657	2712.05020616657
"AML-0693"	"2021-03-09-AML0693:GTTCTATAGGTGATCG"	8.90524830397908	6.23426911914674	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATAGGTGATCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1460.85560744495	43.6507414769733	0.0298802573331111	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1456.6861643985	1456.6861643985
"AML-0693"	"2021-03-09-AML0693:GTTCTATCAACAGCTT"	3.54182614859883	-10.2884741059509	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATCAACAGCTT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2438.70524156672	35.2667359895521	0.0144612540246542	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2433.70254118784	2433.70254118784
"AML-0693"	"2021-03-09-AML0693:GTTCTATCAAGGCTTT"	-8.56135211411174	-4.46316292202147	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATCAAGGCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2438.80382088189	43.2251658169659	0.0177239208200582	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2421.83836919415	2421.83836919415
"AML-0693"	"2021-03-09-AML0693:GTTCTATCAATGTGGG"	-9.03758559647258	-4.2113304368225	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATCAATGTGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2570.741480502	44.9780320542275	0.0174961319118889	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2559.32373470452	2559.32373470452
"AML-0693"	"2021-03-09-AML0693:GTTCTATTCCTGTAGA"	-6.86802087250407	3.80904743755189	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTCTATTCCTGTAGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2426.47129227489	43.1373014438144	0.0177777918004428	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2413.54717349062	2413.54717349062
"AML-0693"	"2021-03-09-AML0693:GTTGAACCACTGAGGA"	-8.27114901962932	-2.76657273685607	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGAACCACTGAGGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1394.10763379908	44.4435872938976	0.0318795953887609	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1391.50976748562	1391.50976748562
"AML-0693"	"2021-03-09-AML0693:GTTGAACGTCTGCCTT"	-7.14806638184245	-0.722991370317064	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGAACGTCTGCCTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3204.56807838794	21.0626627933251	0.00657269943346644	3641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3199.06618438374	3199.06618438374
"AML-0693"	"2021-03-09-AML0693:GTTGAACTCAATCCGA"	9.87021030959431	7.05663964832155	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGAACTCAATCCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1800.47949539574	42.7233093252358	0.023728850805849	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1796.74649097509	1796.74649097509
"AML-0693"	"2021-03-09-AML0693:GTTGAACTCTTCCGTG"	-8.63017020645793	-1.73593642627867	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGAACTCTTCCGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3488.72122972731	43.1041639349855	0.0123552904048899	4883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3482.59622616131	3482.59622616131
"AML-0693"	"2021-03-09-AML0693:GTTGCGGAGAGATTCA"	-2.70914230766948	3.23618266666261	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGCGGAGAGATTCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3266.42382792842	36.3757169160406	0.0111362513967179	3992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3258.5320132701	3258.5320132701
"AML-0693"	"2021-03-09-AML0693:GTTGCGGAGATCCTAC"	0.807385762303513	-4.31377746975096	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	36	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00224971878515186	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGCGGAGATCCTAC"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2667.63243287125	46.3036650917791	0.0173575881449084	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2663.71615347266	2663.71615347266
"AML-0693"	"2021-03-09-AML0693:GTTGCGGTCAGAGTTC"	-9.28249965134319	-4.05036690151366	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGCGGTCAGAGTTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3059.17868215061	46.9965222044658	0.0153624639445471	3143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3044.93070684189	3044.93070684189
"AML-0693"	"2021-03-09-AML0693:GTTGCGGTCTTTGCAT"	-2.52382574501689	3.28278706157533	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGCGGTCTTTGCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3409.46356269503	17.791109500171	0.00521815504785978	4026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3400.90664545222	3400.90664545222
"AML-0693"	"2021-03-09-AML0693:GTTGCTCCATGGAGAC"	-7.04187331619914	3.9607898958954	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGCTCCATGGAGAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2467.68729502759	36.8328136802602	0.0149260458383356	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2457.3272564296	2457.3272564296
"AML-0693"	"2021-03-09-AML0693:GTTGTAGGTTCAAGTC"	-6.88760362091716	3.93685910785524	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTAGGTTCAAGTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2083.55825788241	48.6253671782183	0.0233376566238363	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2071.81509432864	2071.81509432864
"AML-0693"	"2021-03-09-AML0693:GTTGTAGGTTCCCACT"	12.0060821968013	-2.98197772419127	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTAGGTTCCCACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1996.44090899338	44.2537891276337	0.0221663405755129	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1990.68117570853	1990.68117570853
"AML-0693"	"2021-03-09-AML0693:GTTGTCCCAGACCTAT"	14.152625699609	2.01509413802949	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTCCCAGACCTAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1134.49227700736	16.3686811080905	0.0144281996800092	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1122.6620627418	1122.6620627418
"AML-0693"	"2021-03-09-AML0693:GTTGTCCGTAGGCAAC"	-0.81284604492839	10.7144689329895	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTCCGTAGGCAAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1810.68645358612	41.7674783687788	0.0230672065205198	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1804.69373967909	1804.69373967909
"AML-0693"	"2021-03-09-AML0693:GTTGTCCTCCAGTTCC"	9.92809547957722	6.87868592822877	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTCCTCCAGTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1876.29295367712	44.8979515103678	0.0239290732411364	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1866.51354905865	1866.51354905865
"AML-0693"	"2021-03-09-AML0693:GTTGTCCTCGGCTTGG"	-2.49193344536479	10.3707246550354	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTCCTCGGCTTGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1735.88756293387	43.9956598215325	0.0253447635440017	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1733.89988090259	1733.89988090259
"AML-0693"	"2021-03-09-AML0693:GTTGTGAAGAGGTCGT"	1.50958122786824	-6.68395855343016	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	3	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000657462195923734	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTGAAGAGGTCGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1322.03716389062	46.9411094638945	0.0355066489399977	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1319.89689745998	1319.89689745998
"AML-0693"	"2021-03-09-AML0693:GTTGTGACACCTAAAC"	-3.29182658615764	3.4142856367859	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTGACACCTAAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3415.97298421255	41.6991502730931	0.0122071077452346	4284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3411.70362595302	3411.70362595302
"AML-0693"	"2021-03-09-AML0693:GTTGTGACACTTGGCG"	-2.20680127564128	3.82902286136476	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTGACACTTGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3396.30832703768	27.6156043538381	0.00813106517273269	4504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3388.46599798975	3388.46599798975
"AML-0693"	"2021-03-09-AML0693:GTTGTGAGTACCTAAC"	-6.88026700440105	-3.08467080509337	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTGAGTACCTAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1880.13515984465	42.9562376549097	0.0228474200006233	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1864.33979933039	1864.33979933039
"AML-0693"	"2021-03-09-AML0693:GTTGTGATCGGAGTGA"	1.41237642344777	-6.90277149593505	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTGTGATCGGAGTGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1717.57512974099	42.3537565572957	0.0246590415894544	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1710.70596913398	1710.70596913398
"AML-0693"	"2021-03-09-AML0693:GTTTACTCAAGAGTGC"	0.679414053528947	-9.59579851543578	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTTACTCAAGAGTGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	3295.76505382358	45.3174206918587	0.0137501975874414	3556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	3285.20691487849	3285.20691487849
"AML-0693"	"2021-03-09-AML0693:GTTTACTGTGTACAGG"	8.49845947799031	6.95326039874879	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTTACTGTGTACAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1718.23597012021	48.2229322732371	0.0280653723422303	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1710.49456822252	1710.49456822252
"AML-0693"	"2021-03-09-AML0693:GTTTACTTCTCGCTCA"	-7.42603955689128	-2.89401318943175	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTTACTTCTCGCTCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2305.55183171479	5.83662043883317	0.00253155030329208	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2296.89452781051	2296.89452781051
"AML-0693"	"2021-03-09-AML0693:GTTTGGACAATTGCCA"	-7.46066174927409	-2.27335741436156	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTTGGACAATTGCCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2301.42852038982	37.9563672310056	0.0164925249229884	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2287.56479475204	2287.56479475204
"AML-0693"	"2021-03-09-AML0693:GTTTGGACATCGATAC"	8.12690796431844	6.31523130023805	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.GTTTGGACATCGATAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1651.28960181199	47.7418382781469	0.028911850608009	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.70580553707	1643.70580553707
"AML-0693"	"2021-03-09-AML0693:TAACACGAGCTGCGAA"	-6.57970653000529	-2.62997438823851	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACACGAGCTGCGAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2613.00200805516	19.9809903898109	0.0076467566148878	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2593.99672785098	2593.99672785098
"AML-0693"	"2021-03-09-AML0693:TAACACGGTACCAGAG"	1.19862844523732	-9.7652912369934	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACACGGTACCAGAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2549.10764808375	39.0427995302848	0.015316261578688	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2541.87788013114	2541.87788013114
"AML-0693"	"2021-03-09-AML0693:TAACACGTCTTGTGCC"	-2.5272732776707	3.39505074107973	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACACGTCTTGTGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2699.1230689515	32.413876433439	0.0120090398271578	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2693.16165231783	2693.16165231783
"AML-0693"	"2021-03-09-AML0693:TAACCAGCATCAGTCA"	-7.75405345383342	-2.47420527851256	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACCAGCATCAGTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3143.38591715501	37.2016525118981	0.0118348982569625	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3114.33654708712	3114.33654708712
"AML-0693"	"2021-03-09-AML0693:TAACCAGTCAACGCTA"	-2.28091440621074	3.361696220282	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACCAGTCAACGCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3240.05157956056	33.7825702156355	0.0104265532156181	4098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3233.46647565129	3233.46647565129
"AML-0693"	"2021-03-09-AML0693:TAACCAGTCTCCTGTG"	0.241945211857003	9.42948720538942	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACCAGTCTCCTGTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1807.42906280516	30.0441812795621	0.0166226060528943	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1802.07344689864	1802.07344689864
"AML-0693"	"2021-03-09-AML0693:TAACGACTCTCCGAGG"	-6.92923818054851	3.85224101627199	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACGACTCTCCGAGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2478.87075857353	43.6997518544741	0.0176288948116122	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2461.54546336715	2461.54546336715
"AML-0693"	"2021-03-09-AML0693:TAACTTCAGGCAGGTT"	-2.31568274918254	3.62425134265748	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACTTCAGGCAGGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3366.51712814744	22.4899272462482	0.00668047313890372	5422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3362.24584150294	3362.24584150294
"AML-0693"	"2021-03-09-AML0693:TAACTTCAGGCCCGTT"	-7.08133635941203	-2.80360653316649	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACTTCAGGCCCGTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2447.99329033435	4.93938932242302	0.00201772992676315	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2424.40156814405	2424.40156814405
"AML-0693"	"2021-03-09-AML0693:TAACTTCAGGCTCAAG"	-8.99710975113567	-4.67151977932128	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACTTCAGGCTCAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2630.6216307095	47.7892028151817	0.01816650568721	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2621.75606699256	2621.75606699256
"AML-0693"	"2021-03-09-AML0693:TAACTTCGTTATGGTC"	9.77461590346639	6.84652898395387	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACTTCGTTATGGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1627.18530337834	38.726644260818	0.0237997750965513	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1627.18530337834	1627.18530337834
"AML-0693"	"2021-03-09-AML0693:TAACTTCTCAGGACGA"	-7.91080460968669	-4.1063270798889	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAACTTCTCAGGACGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2006.9323104163	0	0	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1989.49163862935	1989.49163862935
"AML-0693"	"2021-03-09-AML0693:TAAGCACGTCTAACGT"	8.15486874160115	5.97915313327638	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCACGTCTAACGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1382.58980710043	36.680138320829	0.0265300222325194	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1382.58980710043	1382.58980710043
"AML-0693"	"2021-03-09-AML0693:TAAGCCAAGCGATGGT"	-7.51064525070842	-3.2770362130371	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCCAAGCGATGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2350.17041648204	38.742734232667	0.0164850744273519	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2332.08090037534	2332.08090037534
"AML-0693"	"2021-03-09-AML0693:TAAGCCAGTAAGCAAT"	-7.18451104584392	-2.92758014118346	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCCAGTAAGCAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2946.10727576144	7.59170219647743	0.00257685871079332	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2928.54599795329	2928.54599795329
"AML-0693"	"2021-03-09-AML0693:TAAGCGTAGACCAAGC"	-6.9623912376469	3.89308545673219	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCGTAGACCAAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1588.88697606734	37.6364472066548	0.0236873029822479	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1573.55381014378	1573.55381014378
"AML-0693"	"2021-03-09-AML0693:TAAGCGTCACCACATA"	-7.22616467896159	-2.79362609302672	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCGTCACCACATA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3236.96232022325	0.329305007354432	0.000101732728026232	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3211.1548918304	3211.1548918304
"AML-0693"	"2021-03-09-AML0693:TAAGCGTGTCAGCGTC"	-2.13043818894084	3.69475243175355	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCGTGTCAGCGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2866.84648978482	36.377303085817	0.0126889609246386	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2860.80891693995	2860.80891693995
"AML-0693"	"2021-03-09-AML0693:TAAGCGTGTCGAAACG"	-9.06189761582072	-3.87218310749205	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGCGTGTCGAAACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2613.75503840354	52.886630977055	0.0202339661521448	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2598.02757638411	2598.02757638411
"AML-0693"	"2021-03-09-AML0693:TAAGTCGAGAACGTGC"	-8.49269137802776	-3.34292867099913	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGTCGAGAACGTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3048.88405871041	50.7423540465162	0.0166429267461153	2815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3036.7564722625	3036.7564722625
"AML-0693"	"2021-03-09-AML0693:TAAGTCGAGGTAGCCA"	12.1960884529049	-2.4785936108795	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGTCGAGGTAGCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1344.22068111984	44.177783537454	0.0328649783163954	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1335.34128353539	1335.34128353539
"AML-0693"	"2021-03-09-AML0693:TAAGTCGGTAGGCAAC"	9.07777847823445	6.82796332919923	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGTCGGTAGGCAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1579.38617375309	42.1910782655498	0.0267135922592581	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1570.66098275178	1570.66098275178
"AML-0693"	"2021-03-09-AML0693:TAAGTCGGTAGTCTGT"	8.76845230635945	7.2268700369629	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGTCGGTAGTCTGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1738.79655772767	40.5529550002246	0.0233224265484059	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1730.06431582506	1730.06431582506
"AML-0693"	"2021-03-09-AML0693:TAAGTCGGTTTCGATG"	8.50623192366902	6.5989951857361	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAAGTCGGTTTCGATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1817.73480787755	40.0440476799583	0.0220296423363951	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1810.60737955214	1810.60737955214
"AML-0693"	"2021-03-09-AML0693:TAATCTCAGAGCAGCT"	-1.76726637306865	3.35710475528566	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAATCTCAGAGCAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3125.85160866063	27.3981228912504	0.00876501073030462	3477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3119.98915852299	3119.98915852299
"AML-0693"	"2021-03-09-AML0693:TAATCTCCAAAGAACT"	11.2557331520015	-2.46840383922728	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAATCTCCAAAGAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1742.82211839671	51.1418285152784	0.0293442618012709	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1737.11937218817	1737.11937218817
"AML-0693"	"2021-03-09-AML0693:TAATCTCCAAGTCATC"	-8.53541503372844	-3.58724906360777	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAATCTCCAAGTCATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2878.88425027428	36.4694485467823	0.0126679106821706	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2864.88654623585	2864.88654623585
"AML-0693"	"2021-03-09-AML0693:TAATTCCCACAGTACT"	-7.02308545532878	-2.71929719364318	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAATTCCCACAGTACT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1975.74831119004	18.3252595992489	0.00927509819720468	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1965.90532086314	1965.90532086314
"AML-0693"	"2021-03-09-AML0693:TAATTCCTCTCGGTAA"	-7.16599450531657	-2.77900125896605	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAATTCCTCTCGGTAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1951.91849266254	15.5233232754345	0.00795285424764832	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1947.90233872017	1947.90233872017
"AML-0693"	"2021-03-09-AML0693:TACAACGAGATCACTC"	-6.98269925537761	3.98293445194093	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAACGAGATCACTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2396.12274048548	46.2574424357987	0.0193051222519705	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2378.84239615743	2378.84239615743
"AML-0693"	"2021-03-09-AML0693:TACAACGCAATTGAAG"	-8.71542964401897	-4.46121933376464	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAACGCAATTGAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.32519638947	38.3099081343473	0.0140724951542	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2711.22683190475	2711.22683190475
"AML-0693"	"2021-03-09-AML0693:TACAACGGTCAACATC"	9.87365879592244	6.85654828632203	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAACGGTCAACATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1808.63363360867	43.0473139835538	0.0238010137507306	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1802.3592518454	1802.3592518454
"AML-0693"	"2021-03-09-AML0693:TACAACGTCATGGCCG"	-6.94774423065837	3.93473622882692	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAACGTCATGGCCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2094.21750316922	39.7398632290726	0.0189759961269226	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2090.51021447978	2090.51021447978
"AML-0693"	"2021-03-09-AML0693:TACAACGTCGCGGTAC"	-7.11392054978068	3.35633657062379	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAACGTCGCGGTAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2536.62942309642	39.8451759853005	0.0157079215523181	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2525.79355543329	2525.79355543329
"AML-0693"	"2021-03-09-AML0693:TACACCCAGAAGCTGC"	-6.99192843857463	-2.65774252330931	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACACCCAGAAGCTGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1386.71579150497	45.2248283185769	0.0326129035204073	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1369.82103555164	1369.82103555164
"AML-0693"	"2021-03-09-AML0693:TACACCCGTGCCTGAC"	-7.06350598755534	-2.76518037235411	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACACCCGTGCCTGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2487.61372054832	14.7770236617421	0.0059402404560162	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2469.83139144898	2469.83139144898
"AML-0693"	"2021-03-09-AML0693:TACAGGTAGGTCACTT"	2.66231693801228	-9.44111540233763	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAGGTAGGTCACTT"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1574.84894423141	44.1126261251444	0.0280107030497919	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1568.37139282082	1568.37139282082
"AML-0693"	"2021-03-09-AML0693:TACAGGTCACCTATCC"	-6.86715636673625	3.80660626972047	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAGGTCACCTATCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2489.72743017634	42.1644827821544	0.0169353810666608	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2467.08485487284	2467.08485487284
"AML-0693"	"2021-03-09-AML0693:TACAGGTCACGCTTAA"	9.91697945174519	6.59593293750612	"2021-03-09-AML0693"	"AML0693"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAGGTCACGCTTAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1916.7177434798	40.9435110994017	0.0213612626265299	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1905.7847023879	1905.7847023879
"AML-0693"	"2021-03-09-AML0693:TACAGGTGTGTTCATG"	1.26581682738606	9.94216153705446	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACAGGTGTGTTCATG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1775.3811089056	39.5953347891595	0.0223024423266322	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1771.82846948238	1771.82846948238
"AML-0693"	"2021-03-09-AML0693:TACATTCTCTGACAGT"	11.0287462669307	5.38747499072877	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACATTCTCTGACAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1902.63840602004	49.1279612090631	0.0258209657986615	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1897.20483176471	1897.20483176471
"AML-0693"	"2021-03-09-AML0693:TACCCACCATGAATAG"	-7.11437735977824	-2.75537803089293	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCACCATGAATAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2395.38435607638	36.9003690219455	0.0154047800004789	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2379.58479927974	2379.58479927974
"AML-0693"	"2021-03-09-AML0693:TACCCACTCACCATAG"	-7.01014457169231	3.92337224567262	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCACTCACCATAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2058.49714038689	52.4576283421218	0.0254834594194591	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2051.75651234884	2051.75651234884
"AML-0693"	"2021-03-09-AML0693:TACCCACTCCTGTTAT"	-7.34321675720866	-2.31596925174864	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCACTCCTGTTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3472.53064620346	53.9932575036964	0.015548677032621	4192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3458.72977585735	3458.72977585735
"AML-0693"	"2021-03-09-AML0693:TACCCGTCAAATCCCA"	-8.27088580551799	-4.68609049236449	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCGTCAAATCCCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2251.79867577158	39.5280763542872	0.0175540010657227	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2248.35486916769	2248.35486916769
"AML-0693"	"2021-03-09-AML0693:TACCCGTCAATGCAAA"	-7.71551118317302	-2.56730654155882	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCGTCAATGCAAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2345.43604524454	31.883128868047	0.0135936892982826	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2331.00052392725	2331.00052392725
"AML-0693"	"2021-03-09-AML0693:TACCCGTCATGGAAGC"	-7.04335866394694	4.01484725559083	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCGTCATGGAAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2016.59014266348	41.4403023589624	0.0205496900347974	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2005.22562788349	2005.22562788349
"AML-0693"	"2021-03-09-AML0693:TACCCGTGTATGAGGC"	8.22239174422566	6.79529044711915	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCGTGTATGAGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1659.993530786	53.8113469248151	0.0324166003823736	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1657.99705446377	1657.99705446377
"AML-0693"	"2021-03-09-AML0693:TACCCGTTCTGTGCGG"	-7.40705380860026	-2.45931246196898	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCCGTTCTGTGCGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2657.23395567271	0.991902749150297	0.00037328393573805	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2633.10507332928	2633.10507332928
"AML-0693"	"2021-03-09-AML0693:TACCGAAGTTGTGTTG"	14.1000057655269	1.71232793414918	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGAAGTTGTGTTG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1344.72741573981	41.720343300699	0.0310251303069821	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1328.05985636322	1328.05985636322
"AML-0693"	"2021-03-09-AML0693:TACCGAATCAGGTGTT"	-8.7746881050175	-1.97362782871398	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGAATCAGGTGTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3441.68167956463	36.1613713485022	0.0105068901529198	5245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3426.9763151285	3426.9763151285
"AML-0693"	"2021-03-09-AML0693:TACCGAATCCGTCAAA"	-8.70317492905315	-4.23343136226805	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGAATCCGTCAAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2829.75344725906	47.8407334251783	0.0169063256982751	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2819.42901014508	2819.42901014508
"AML-0693"	"2021-03-09-AML0693:TACCGAATCCTTTGAT"	-7.12426410141643	3.01965091312257	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGAATCCTTTGAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2848.55138881777	46.9315543468443	0.0164755863387538	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2820.33092120406	2820.33092120406
"AML-0693"	"2021-03-09-AML0693:TACCGGGCACAGAGCA"	0.353113700717133	13.4167842634949	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ IFN+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGGGCACAGAGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1843.13622238566	50.322982157821	0.027302909869942	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1841.21686486266	1841.21686486266
"AML-0693"	"2021-03-09-AML0693:TACCGGGCAGCAAGAC"	-9.15286097946819	-3.91911580478819	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGGGCAGCAAGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3593.9128766991	46.4928466118646	0.0129365536135553	4394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3577.53304267697	3577.53304267697
"AML-0693"	"2021-03-09-AML0693:TACCGGGTCTATCGGA"	-7.60158048096355	2.50320885265199	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCGGGTCTATCGGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2190.10036844418	40.3293339007508	0.0184143770220907	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2177.35504691973	2177.35504691973
"AML-0693"	"2021-03-09-AML0693:TACCTCGGTGTCTTAG"	-8.54062877121623	-3.32600047504576	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTCGGTGTCTTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2958.4808549427	43.449629264416	0.0146864662625162	3347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2951.83167160244	2951.83167160244
"AML-0693"	"2021-03-09-AML0693:TACCTCGTCGACCCAG"	11.829679151147	-2.7869751683441	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTCGTCGACCCAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2080.45830223476	41.7534934132024	0.020069372872483	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2076.25154175793	2076.25154175793
"AML-0693"	"2021-03-09-AML0693:TACCTCGTCGCGTGAC"	8.38883461531941	6.87110564792482	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTCGTCGCGTGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1715.10511728752	48.4641174806556	0.028257228663222	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1708.81330194933	1708.81330194933
"AML-0693"	"2021-03-09-AML0693:TACCTCGTCTCCACTG"	8.62360062178914	6.75196311557619	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTCGTCTCCACTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1534.7919093761	48.8583583596666	0.0318338649436377	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1527.9575272624	1527.9575272624
"AML-0693"	"2021-03-09-AML0693:TACCTGCAGACAACTA"	11.3822123008663	-2.4360242119995	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTGCAGACAACTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1933.9962480643	44.5016214333572	0.0230101901582788	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1930.05963889972	1930.05963889972
"AML-0693"	"2021-03-09-AML0693:TACCTGCAGTCATAGA"	-8.9963792366093	-4.06774856960448	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTGCAGTCATAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1944.00253885322	33.8970030319356	0.0174367071824565	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1935.86264841053	1935.86264841053
"AML-0693"	"2021-03-09-AML0693:TACCTGCGTTCCGCTT"	-6.79005513611491	3.76278660381166	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTGCGTTCCGCTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2378.8793269688	26.8379720690387	0.0112817711116251	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2357.16078424889	2357.16078424889
"AML-0693"	"2021-03-09-AML0693:TACCTGCTCTTTGCTA"	-4.59171758118327	-5.88138296520384	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	62	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACCTGCTCTTTGCTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3214.35619831312	47.7900336275989	0.0148676844379223	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3206.80119051671	3206.80119051671
"AML-0693"	"2021-03-09-AML0693:TACGCTCTCACCTCGT"	8.51827206191365	6.80473086917726	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGCTCTCACCTCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1770.13596490855	44.5252325442931	0.0251535664078738	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1757.81411976065	1757.81411976065
"AML-0693"	"2021-03-09-AML0693:TACGGGCAGTCGGGAT"	-8.05322299423869	-2.88401415264281	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGGCAGTCGGGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1339.34572056119	41.7843995490262	0.0311976205303576	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1335.60548575303	1335.60548575303
"AML-0693"	"2021-03-09-AML0693:TACGGGCGTTCGTACA"	-7.29402623596843	-2.63422706043395	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGGCGTTCGTACA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3013.47641088305	32.1958053531282	0.0106839413897034	2551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2996.53989429803	2996.53989429803
"AML-0693"	"2021-03-09-AML0693:TACGGGCTCAATCAGC"	-7.56453977051433	-2.45152809536131	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGGCTCAATCAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1966.50415115151	12.7911950506015	0.00650453498565536	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1956.61396250038	1956.61396250038
"AML-0693"	"2021-03-09-AML0693:TACGGTACACCGCTAG"	8.58077683028523	6.33839652622072	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTACACCGCTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1542.76599826901	49.6264542838936	0.032167194726598	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1528.82159895224	1528.82159895224
"AML-0693"	"2021-03-09-AML0693:TACGGTAGTACGTTCA"	8.31211247023885	6.61978719318239	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTAGTACGTTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1884.10353291085	47.6572475650061	0.0252943889401756	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1884.10353291085	1884.10353291085
"AML-0693"	"2021-03-09-AML0693:TACGGTAGTCCTCCAT"	-7.16924701157268	-2.86075999653014	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTAGTCCTCCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2630.08134991022	38.6497028303691	0.0146952499517509	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2626.70843970519	2626.70843970519
"AML-0693"	"2021-03-09-AML0693:TACGGTAGTGACCGTC"	-1.53605637970622	12.200638748053	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTAGTGACCGTC"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1736.06920418934	45.8511006112896	0.0264108714679377	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1731.79143661573	1731.79143661573
"AML-0693"	"2021-03-09-AML0693:TACGGTAGTTGCTAGT"	-6.85949645462688	3.88890502536622	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTAGTTGCTAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2079.09756382232	45.0642065657289	0.0216748878695623	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2058.48859323674	2058.48859323674
"AML-0693"	"2021-03-09-AML0693:TACGGTATCGGACTGC"	14.1323753791744	1.96663186633912	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTATCGGACTGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1196.33521920416	2.68350938627213	0.00224310823855648	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1178.96060162691	1178.96060162691
"AML-0693"	"2021-03-09-AML0693:TACGGTATCTGCTGAA"	-8.47893271866496	-4.1878814927307	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGGTATCTGCTGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2538.17954089441	52.02745516393	0.0204979412707726	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2528.79925503769	2528.79925503769
"AML-0693"	"2021-03-09-AML0693:TACGTCCAGGTCATAA"	0.977044005959672	-9.10930159008177	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCAGGTCATAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1596.53043845771	49.0785562917791	0.0307407582778004	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1585.01636673197	1585.01636673197
"AML-0693"	"2021-03-09-AML0693:TACGTCCGTAGCCAGA"	0.17414760318343	9.32429215991823	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCGTAGCCAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2049.59153912726	31.8276927800036	0.0155287978957779	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2038.03026612106	2038.03026612106
"AML-0693"	"2021-03-09-AML0693:TACGTCCGTCCACAGC"	-7.2259090942448	-2.77409007465514	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCGTCCACAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2322.11035576425	8.56503670939322	0.00368847100144572	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2311.55097245734	2311.55097245734
"AML-0693"	"2021-03-09-AML0693:TACGTCCGTCCTGGGT"	-7.68567071381267	-3.43347289478453	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCGTCCTGGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1803.4233082231	33.8351812388474	0.018761641309929	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1781.01021288979	1781.01021288979
"AML-0693"	"2021-03-09-AML0693:TACGTCCGTCTGGTTA"	-7.45063624802287	-3.49591400539549	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCGTCTGGTTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2799.77113461515	5.66868349802369	0.0020246953145343	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2771.71748915662	2771.71748915662
"AML-0693"	"2021-03-09-AML0693:TACGTCCTCTACCAGA"	1.32022525843922	9.43109414661256	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACGTCCTCTACCAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1844.3556693584	49.0272603341607	0.0265823241952112	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1836.37427803985	1836.37427803985
"AML-0693"	"2021-03-09-AML0693:TACTGCCCACAATGAA"	14.3575207191402	1.92965290630189	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTGCCCACAATGAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1457.93535422942	24.8039834771344	0.017013088684062	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1433.61525832682	1433.61525832682
"AML-0693"	"2021-03-09-AML0693:TACTGCCCAGCACAGA"	9.07352413710896	6.84252688968507	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTGCCCAGCACAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1820.50698466436	42.9616610555631	0.0235987345379419	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1816.531748095	1816.531748095
"AML-0693"	"2021-03-09-AML0693:TACTGCCGTCAAATCC"	-7.89998708191569	-3.07640936290892	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTGCCGTCAAATCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2461.43111146765	43.9713676228043	0.0178641471694838	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2449.03879013743	2449.03879013743
"AML-0693"	"2021-03-09-AML0693:TACTGCCGTCCTGAAT"	1.09170319613759	-9.37410738384398	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTGCCGTCCTGAAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2861.71413420884	26.2789131239922	0.00918292739650508	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2858.4731205266	2858.4731205266
"AML-0693"	"2021-03-09-AML0693:TACTGCCGTTACCGTA"	-8.43555007401164	-4.14416744625243	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTGCCGTTACCGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2473.23449881942	46.0457081952529	0.0186176071121572	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2456.75294766452	2456.75294766452
"AML-0693"	"2021-03-09-AML0693:TACTTACAGCTCCACG"	11.1847855049068	-2.79804041301879	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACAGCTCCACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1385.39467607721	48.1544064801957	0.0347586195556537	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1382.98387253211	1382.98387253211
"AML-0693"	"2021-03-09-AML0693:TACTTACAGTATGCAA"	-7.52634416046794	-3.29557039653929	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACAGTATGCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2263.87521313554	3.662934081285	0.00161799292647925	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2252.89174897192	2252.89174897192
"AML-0693"	"2021-03-09-AML0693:TACTTACAGTCTAGCT"	9.46068157729451	6.8005070456299	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACAGTCTAGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1733.03557881269	42.0905429467578	0.0242871776328991	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1730.00755757553	1730.00755757553
"AML-0693"	"2021-03-09-AML0693:TACTTACGTATGCAAA"	8.79651608046834	6.73988101566163	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACGTATGCAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1800.8284429125	43.5528258946796	0.0241848833885815	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1798.8784198494	1798.8784198494
"AML-0693"	"2021-03-09-AML0693:TACTTACTCCTCACTG"	-8.64554820480998	-2.55623652851256	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	63	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00611995104039168	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACTCCTCACTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3284.16808397289	42.779375248899	0.0130259396459235	4451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3276.96503804296	3276.96503804296
"AML-0693"	"2021-03-09-AML0693:TACTTACTCTCTCAAT"	-7.69635854187663	-4.65364982998046	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTACTCTCTCAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3060.17198722083	46.6107765227447	0.0152314238276115	3309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3050.08149022603	3050.08149022603
"AML-0693"	"2021-03-09-AML0693:TACTTCACATAGATGA"	0.901327450841111	9.45478913867799	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTCACATAGATGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1884.90973893925	47.1263017877591	0.0250018877902768	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1874.80043754253	1874.80043754253
"AML-0693"	"2021-03-09-AML0693:TACTTCAGTACGTTCA"	-7.66750274124797	-2.53971197521361	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTCAGTACGTTCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1968.94002545957	42.880116253487	0.0217782744517464	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1962.9586078102	1962.9586078102
"AML-0693"	"2021-03-09-AML0693:TACTTCAGTGCGACAA"	-2.67027864876445	3.634814239386	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTCAGTGCGACAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3344.58363098707	41.6645874855879	0.0124573316390033	4586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3339.5036849371	3339.5036849371
"AML-0693"	"2021-03-09-AML0693:TACTTGTCAGTCTGGC"	8.85871853408162	6.75638387286989	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTGTCAGTCTGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1754.92469871975	45.6152941536313	0.0259927358632017	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1746.99051162075	1746.99051162075
"AML-0693"	"2021-03-09-AML0693:TACTTGTGTCAACCAT"	-6.96252141419108	-2.6348071328369	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TACTTGTGTCAACCAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2027.59059583715	47.0239598690214	0.0231920388492462	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2016.28519960518	2016.28519960518
"AML-0693"	"2021-03-09-AML0693:TAGACCACACCATAAC"	-8.01372752609904	-2.69892480289611	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACCACACCATAAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2775.55398216649	16.6465829023086	0.00599757129901503	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2758.59730839308	2758.59730839308
"AML-0693"	"2021-03-09-AML0693:TAGACCACATGGGATG"	11.4987522560054	-3.0643828145233	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACCACATGGGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2278.56592163813	34.6217086489667	0.0151945170074676	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2268.23471412744	2268.23471412744
"AML-0693"	"2021-03-09-AML0693:TAGACCATCTCATGGA"	-7.12214312973674	-2.82247974788817	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACCATCTCATGGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1954.56332635016	16.2741909752112	0.00832625413350032	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1950.29387032571	1950.29387032571
"AML-0693"	"2021-03-09-AML0693:TAGACCATCTGTGCTC"	7.54467310485188	6.21653125369874	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACCATCTGTGCTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1676.47248341791	43.1744285056846	0.0257531387676955	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1667.90357517773	1667.90357517773
"AML-0693"	"2021-03-09-AML0693:TAGACTGAGAAGCGAA"	9.13405384597127	7.34470889652101	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACTGAGAAGCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1793.25843588638	46.2439638066778	0.0257876739243221	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1785.22140334463	1785.22140334463
"AML-0693"	"2021-03-09-AML0693:TAGACTGAGGGACTGT"	-8.72927508774455	-3.42798116123351	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACTGAGGGACTGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3269.47414143198	47.4162191118441	0.0145027050408407	3025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3264.21431575787	3264.21431575787
"AML-0693"	"2021-03-09-AML0693:TAGACTGGTGTAAATG"	-6.94316325607951	3.91849253261415	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACTGGTGTAAATG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2074.96027970527	38.8588710475387	0.0187275252580056	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2069.54409426301	2069.54409426301
"AML-0693"	"2021-03-09-AML0693:TAGACTGTCAATCTCT"	-7.40130553665813	-2.4698627225128	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGACTGTCAATCTCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3173.2878442461	43.3742283201101	0.0136685451963513	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3146.89401614965	3146.89401614965
"AML-0693"	"2021-03-09-AML0693:TAGAGTCTCTTCGTGC"	-8.79647193375285	-2.60930516636046	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGAGTCTCTTCGTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3196.07554440855	48.6825506925164	0.015231977472399	3216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3190.29779284593	3190.29779284593
"AML-0693"	"2021-03-09-AML0693:TAGATCGAGCCATATC"	8.65919556197469	6.84923074329225	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGATCGAGCCATATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1728.91343594217	44.2139212457776	0.0255732417405174	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1724.8865160504	1724.8865160504
"AML-0693"	"2021-03-09-AML0693:TAGATCGGTGTGACCC"	1.46299197253529	-10.5681581727234	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGATCGGTGTGACCC"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2318.65887692842	41.0507383455886	0.017704518225626	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2311.71129777314	2311.71129777314
"AML-0693"	"2021-03-09-AML0693:TAGCACAAGAGCTGCA"	-1.0824376148289	9.99870202625123	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGCACAAGAGCTGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1695.92306625768	49.005346405131	0.0288959725710135	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1691.62819149116	1691.62819149116
"AML-0693"	"2021-03-09-AML0693:TAGCACAAGTTGCCTA"	14.0822216468746	1.85341641986696	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGCACAAGTTGCCTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1349.20045814015	9.79455304158903	0.00725952395175632	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1338.22803074319	1338.22803074319
"AML-0693"	"2021-03-09-AML0693:TAGCACATCGATACTG"	8.63120045241658	7.15028998935548	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGCACATCGATACTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1767.46397824497	39.5646107771183	0.0223849601825576	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1767.46397824497	1767.46397824497
"AML-0693"	"2021-03-09-AML0693:TAGGAGGAGCTGAAAT"	1.15462162074391	10.6501531370911	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGAGGAGCTGAAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1887.39839687419	52.5734394268515	0.0278549772607208	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1880.78835744496	1880.78835744496
"AML-0693"	"2021-03-09-AML0693:TAGGAGGCAGTCAGAG"	-8.20937190476115	-3.93511297619017	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGAGGCAGTCAGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2008.11852731669	45.9415614589967	0.0228779132476733	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2002.592390517	2002.592390517
"AML-0693"	"2021-03-09-AML0693:TAGGGTTAGTTACGAA"	-2.08981810036357	3.86772129619447	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGGTTAGTTACGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3360.11188899364	19.6432415658831	0.00584600817318804	4849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3354.13263198531	3354.13263198531
"AML-0693"	"2021-03-09-AML0693:TAGGGTTGTCAGACGA"	8.77009930190389	6.99428794467775	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGGTTGTCAGACGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1507.56794313684	46.162920639912	0.0306207894974601	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1501.15033374458	1501.15033374458
"AML-0693"	"2021-03-09-AML0693:TAGGTACAGCTGCCTG"	7.8996020751888	6.77487371051637	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACAGCTGCCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1815.69903118025	39.815285167353	0.0219283507253249	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1812.18876557373	1812.18876557373
"AML-0693"	"2021-03-09-AML0693:TAGGTACCAGTCGAGA"	-7.01111970368083	3.97089741313783	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACCAGTCGAGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2206.15447727529	39.941424805681	0.0181045458135872	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2195.10936024701	2195.10936024701
"AML-0693"	"2021-03-09-AML0693:TAGGTACGTACATTGC"	-8.71475253525432	-3.95475199138793	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACGTACATTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3199.08885514639	44.7807301739412	0.0139979638583349	3157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3182.96011194652	3182.96011194652
"AML-0693"	"2021-03-09-AML0693:TAGGTACTCACATTGG"	-2.97201047363933	3.40624187076417	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACTCACATTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3446.47153059226	33.9272400271682	0.00984405056766505	4710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3439.24943520434	3439.24943520434
"AML-0693"	"2021-03-09-AML0693:TAGGTACTCCGTACGG"	-7.01626429978068	-2.73253347789916	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACTCCGTACGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2419.40392546131	8.72017210033967	0.00360426467386052	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2402.72419199132	2402.72419199132
"AML-0693"	"2021-03-09-AML0693:TAGGTACTCTCGGTCT"	0.094157406210345	9.49396798694459	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACTCTCGGTCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1440.56408360185	45.8794249104987	0.0318482360019598	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1435.1128588422	1435.1128588422
"AML-0693"	"2021-03-09-AML0693:TAGGTACTCTTCCGTG"	-8.80715594711955	-3.90001180088194	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTACTCTTCCGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2556.36487506365	50.6862316267605	0.0198274636462052	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2550.73849446179	2550.73849446179
"AML-0693"	"2021-03-09-AML0693:TAGGTTGAGGTCGTGA"	1.40625288066213	-10.1200266114441	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTTGAGGTCGTGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2194.13372676855	46.4776598637595	0.0211826924205802	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2189.04752749377	2189.04752749377
"AML-0693"	"2021-03-09-AML0693:TAGGTTGCACTAACGT"	-7.22307048264201	-3.0839095345703	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTTGCACTAACGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2449.85597145814	22.4268574935196	0.00915435754379116	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2426.363407804	2426.363407804
"AML-0693"	"2021-03-09-AML0693:TAGGTTGCAGGGCTTC"	-0.823352853686172	12.0073318251404	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGGTTGCAGGGCTTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1604.49893567502	47.1142723339392	0.0293638539025381	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1604.49893567502	1604.49893567502
"AML-0693"	"2021-03-09-AML0693:TAGTGCAAGTCCTGCG"	-7.67745910111125	-3.72292759334715	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGTGCAAGTCCTGCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1672.1607518162	11.0381975546283	0.00660115813784008	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1658.54124786314	1658.54124786314
"AML-0693"	"2021-03-09-AML0693:TAGTGCAGTTTAGACC"	-7.02403006973918	4.05064580524293	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGTGCAGTTTAGACC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2280.43822045926	39.2362267328128	0.0172055644309062	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2266.57423903823	2266.57423903823
"AML-0693"	"2021-03-09-AML0693:TAGTGCATCTCATGGA"	-7.77738795700725	-3.40931036388548	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TAGTGCATCTCATGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2802.38439262666	17.2587064050962	0.00615857926218311	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2782.13779970345	2782.13779970345
"AML-0693"	"2021-03-09-AML0693:TATACCTAGATTACCC"	8.61284699019734	7.48754069888917	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATACCTAGATTACCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1833.36056672099	34.6703453919009	0.0189108165743466	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1829.3307101933	1829.3307101933
"AML-0693"	"2021-03-09-AML0693:TATACCTAGGTAATCA"	1.27106072482411	-9.65362455761107	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATACCTAGGTAATCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2112.11985777399	49.7405368067564	0.0235500540481538	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2094.55436380099	2094.55436380099
"AML-0693"	"2021-03-09-AML0693:TATACCTCAACGGGTA"	-8.44006190720256	-4.89967157756957	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATACCTCAACGGGTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2450.40081617765	49.6313268406497	0.0202543708412851	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2439.92698280899	2439.92698280899
"AML-0693"	"2021-03-09-AML0693:TATACCTTCCGTATGA"	-8.88679919663127	-2.00912930881652	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATACCTTCCGTATGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3382.1739018693	42.9201230017822	0.0126900993996969	4133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3373.60148463243	3373.60148463243
"AML-0693"	"2021-03-09-AML0693:TATATCCAGAAGTCTA"	-7.52951989594157	-2.3247120610443	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATATCCAGAAGTCTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3017.2748153756	39.3009835504834	0.0130253244915615	2781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2998.47361097133	2998.47361097133
"AML-0693"	"2021-03-09-AML0693:TATATCCAGGTACAGC"	-7.0010875267094	3.66106484020082	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATATCCAGGTACAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2667.55853745937	34.8207334684773	0.0130534093177356	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2657.23605169376	2657.23605169376
"AML-0693"	"2021-03-09-AML0693:TATATCCGTGCATTAC"	-8.28772864762004	-3.91391494190367	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATATCCGTGCATTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2687.56296058311	46.551849005003	0.0173212124470203	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2674.8370641993	2674.8370641993
"AML-0693"	"2021-03-09-AML0693:TATCAGGCAACAACAA"	-7.37474189224895	-3.08893396770629	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGCAACAACAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2140.94528773783	46.885489616078	0.0218994338083335	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2115.41838468312	2115.41838468312
"AML-0693"	"2021-03-09-AML0693:TATCAGGCACCTCAGG"	-7.069807390601	-2.69545247471007	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGCACCTCAGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1665.05115226582	36.1917917020332	0.0217361440534623	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1654.3441974336	1654.3441974336
"AML-0693"	"2021-03-09-AML0693:TATCAGGGTAGCGATG"	-5.87527547302898	-5.43175461208495	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGGTAGCGATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3495.21065555896	38.3654506892104	0.0109765775142028	4116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3484.79820549535	3484.79820549535
"AML-0693"	"2021-03-09-AML0693:TATCAGGGTCGTACAT"	1.13937272605245	-9.56628324901732	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGGTCGTACAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2383.5074852751	40.4057323224593	0.0169522154103056	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2369.72901417259	2369.72901417259
"AML-0693"	"2021-03-09-AML0693:TATCAGGGTTTATGCG"	-5.8136170906132	-5.49546196376952	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGGTTTATGCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3682.20723745936	41.8149677942906	0.0113559517696082	4244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3669.98896700464	3669.98896700464
"AML-0693"	"2021-03-09-AML0693:TATCAGGTCCTACACC"	1.18769862231557	10.620952583197	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGTCCTACACC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2082.5135270898	33.5511275970197	0.0161108809909655	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2077.74447643078	2077.74447643078
"AML-0693"	"2021-03-09-AML0693:TATCAGGTCTCCTGTG"	1.18576671656911	10.1252603300842	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCAGGTCTCCTGTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1960.74548851298	38.3590495092066	0.0195635026238403	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1956.1846282356	1956.1846282356
"AML-0693"	"2021-03-09-AML0693:TATCCTAGTGAGACGT"	0.559806843369645	9.43722150409547	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCCTAGTGAGACGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1706.66090798531	42.7844500193615	0.0250690982720569	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1699.01441463237	1699.01441463237
"AML-0693"	"2021-03-09-AML0693:TATCCTATCGCTGCGA"	-5.15735040131267	1.93918416583864	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.8	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCCTATCGCTGCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1429.24432762246	52.0505804820864	0.0364182522722844	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1377.63013853416	1377.63013853416
"AML-0693"	"2021-03-09-AML0693:TATCCTATCTTCCCAG"	-7.58371959152873	-2.40064527904662	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCCTATCTTCCCAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1767.56122324555	52.5253539454857	0.0297162854981848	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1761.27343042319	1761.27343042319
"AML-0693"	"2021-03-09-AML0693:TATCGCCAGACTTCCA"	11.0959764915401	-2.82242443477782	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCGCCAGACTTCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1679.32541237121	47.113972837866	0.0280552967821413	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1675.10204693207	1675.10204693207
"AML-0693"	"2021-03-09-AML0693:TATCGCCAGCAGTCTT"	11.9007049995357	-2.88761498844298	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCGCCAGCAGTCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2240.46696363725	33.1109416800356	0.0147785895607593	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2232.35294772513	2232.35294772513
"AML-0693"	"2021-03-09-AML0693:TATCGCCAGTAGGTTA"	-6.92386660996135	-2.78242018139037	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCGCCAGTAGGTTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1930.19968248653	49.8389821603907	0.0258206353532225	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1924.60284807238	1924.60284807238
"AML-0693"	"2021-03-09-AML0693:TATCGCCCATCTTTCA"	-8.45173201981242	-4.37592031871947	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCGCCCATCTTTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.47297062882	49.4734730248517	0.0181722549897069	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2708.67054666626	2708.67054666626
"AML-0693"	"2021-03-09-AML0693:TATCGCCTCTACAGGT"	8.16414703902547	5.74515578830568	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCGCCTCTACAGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1405.11770148946	24.6214160652531	0.0175226716161598	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1402.6701839156	1402.6701839156
"AML-0693"	"2021-03-09-AML0693:TATCTGTAGCGGGTAT"	-8.46698604050334	-4.55204393779906	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTAGCGGGTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2606.07044301521	44.1499961435299	0.0169412136428855	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2599.13458244466	2599.13458244466
"AML-0693"	"2021-03-09-AML0693:TATCTGTAGGTTCTTG"	11.6238399940426	-2.60884025013121	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTAGGTTCTTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1904.88473328663	47.8785433394547	0.0251346144482173	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1893.95804861044	1893.95804861044
"AML-0693"	"2021-03-09-AML0693:TATCTGTCATGCCGGT"	9.48943008956258	7.19330785358278	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTCATGCCGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1711.71604782381	42.7791396850358	0.0249919604010391	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1704.00505152983	1704.00505152983
"AML-0693"	"2021-03-09-AML0693:TATCTGTGTTGATCGT"	0.191976894705933	11.6326112517151	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTGTTGATCGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1902.19048383345	41.9316391148252	0.0220438696708865	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1897.99865266935	1897.99865266935
"AML-0693"	"2021-03-09-AML0693:TATCTGTTCCATCCGT"	8.5886513191158	8.08893106067506	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTTCCATCCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2284.94608732508	22.8529483899318	0.0100015263015177	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2280.41094081106	2280.41094081106
"AML-0693"	"2021-03-09-AML0693:TATCTGTTCGATCCCT"	-6.84023557129558	3.98262736881105	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTGTTCGATCCCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2116.39668756558	41.7035713623181	0.0197049880144578	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2109.52435530036	2109.52435530036
"AML-0693"	"2021-03-09-AML0693:TATCTTGCATGTGGTT"	-8.780425409705	-4.06024124538573	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATCTTGCATGTGGTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2865.52965664056	40.6633695528621	0.0141905247634164	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2858.65111474113	2858.65111474113
"AML-0693"	"2021-03-09-AML0693:TATGTTCAGTGTTGTC"	8.95032467421834	7.06403920734254	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATGTTCAGTGTTGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1826.43653116152	44.055999140119	0.0241212866631077	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1822.53147892919	1822.53147892919
"AML-0693"	"2021-03-09-AML0693:TATGTTCCAGGTGACA"	0.954246779053849	9.29840371692506	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATGTTCCAGGTGACA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1834.29670916072	32.5200753768084	0.0177289067872165	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1829.02979413305	1829.02979413305
"AML-0693"	"2021-03-09-AML0693:TATGTTCGTCGCAACC"	0.289782484143418	9.85620877826539	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATGTTCGTCGCAACC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1393.89563796367	45.4295130925503	0.0325917607138205	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1378.82499667076	1378.82499667076
"AML-0693"	"2021-03-09-AML0693:TATGTTCGTTGCTCCT"	8.12825932082478	6.42452285373536	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATGTTCGTTGCTCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1490.8988123759	48.9987169468137	0.0328652196514458	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1480.07699748771	1480.07699748771
"AML-0693"	"2021-03-09-AML0693:TATTCCACAAGCTACT"	11.1408335166866	-2.62982227718505	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCACAAGCTACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1417.88440324526	54.4258600745974	0.0383852590169039	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1417.88440324526	1417.88440324526
"AML-0693"	"2021-03-09-AML0693:TATTCCAGTACCGGCT"	9.13963284072224	7.75325200641481	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCAGTACCGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1746.67583459513	47.5641662253551	0.0272312499453456	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1746.67583459513	1746.67583459513
"AML-0693"	"2021-03-09-AML0693:TATTCCAGTAGACTGG"	0.254790430038613	10.4423961409363	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCAGTAGACTGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1482.62317126694	47.8215445740958	0.0322546858169166	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1471.39492321519	1471.39492321519
"AML-0693"	"2021-03-09-AML0693:TATTCCATCACCCTCA"	1.03614189204518	12.2280378111633	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCATCACCCTCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1977.68672704792	34.5430670491913	0.0174663997976836	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1970.92992840356	1970.92992840356
"AML-0693"	"2021-03-09-AML0693:TATTCCATCCTACGGG"	-2.41529450836833	4.08649299228517	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCATCCTACGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2071.87975437035	4.1574031908261	0.00200658517081246	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2066.05025599273	2066.05025599273
"AML-0693"	"2021-03-09-AML0693:TATTCCATCCTCACGT"	-7.18494687500651	1.667369342688	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCATCCTCACGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2833.89155699346	41.3840998091028	0.0146032757347314	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2827.41237046314	2827.41237046314
"AML-0693"	"2021-03-09-AML0693:TATTCCATCTTACCGC"	11.90718617019	-2.62127211010131	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTCCATCTTACCGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1732.11448250647	42.9860205159446	0.0248170781724203	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1723.63042661794	1723.63042661794
"AML-0693"	"2021-03-09-AML0693:TATTGCTGTTGCGAAG"	-0.85076473179515	11.7953309782776	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGCTGTTGCGAAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1890.82527150214	50.8808471547193	0.0269093331475825	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1888.79378420225	1888.79378420225
"AML-0693"	"2021-03-09-AML0693:TATTGGGAGCCTCAAT"	-6.92414365235026	3.80618856036989	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGGGAGCCTCAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2335.51557783087	40.2027819112732	0.0172136646370014	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2318.84753290902	2318.84753290902
"AML-0693"	"2021-03-09-AML0693:TATTGGGCATCGGTTA"	14.0976578193599	1.79603240573732	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGGGCATCGGTTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1434.65683236953	45.0990241178823	0.0314354088729324	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1423.25098431971	1423.25098431971
"AML-0693"	"2021-03-09-AML0693:TATTGGGGTTAAGCAA"	-7.06370006027873	-2.80625083362731	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGGGGTTAAGCAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1499.7277804565	49.5976672836741	0.0330711132580188	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1487.48028939442	1487.48028939442
"AML-0693"	"2021-03-09-AML0693:TATTGGGGTTATAGAG"	8.47351517257039	6.69190452182619	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGGGGTTATAGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1552.30907478779	47.3732229469746	0.0305179063347619	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1545.77939112287	1545.77939112287
"AML-0693"	"2021-03-09-AML0693:TATTGGGTCAGAGCGA"	-0.164852376014549	12.0113897093567	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTGGGTCAGAGCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1616.28862423398	39.7165853598848	0.0245727061147312	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1613.83857376935	1613.83857376935
"AML-0693"	"2021-03-09-AML0693:TATTTCGCAATCCTAG"	8.98380531844441	7.40554139697877	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TATTTCGCAATCCTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1750.66732145712	42.000997018939	0.0239914211593215	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1746.87212457899	1746.87212457899
"AML-0693"	"2021-03-09-AML0693:TCAAGACAGGGTCAAC"	-6.86204133454021	3.94566199863283	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGACAGGGTCAAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2401.48303066204	19.2189250954578	0.00800294020406196	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2394.34667710005	2394.34667710005
"AML-0693"	"2021-03-09-AML0693:TCAAGACCACGGATCC"	-2.10704312744792	3.43854520404664	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGACCACGGATCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1824.33599227419	19.0232453774129	0.0104274900336197	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1824.33599227419	1824.33599227419
"AML-0693"	"2021-03-09-AML0693:TCAAGACCATCCTATT"	9.36041225966756	7.24283740604249	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGACCATCCTATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1731.57022177439	52.0545416592183	0.0300620448449826	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1727.89120651137	1727.89120651137
"AML-0693"	"2021-03-09-AML0693:TCAAGACGTCATAAAG"	6.89706911620442	-1.03382053291472	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGACGTCATAAAG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2361.60890584407	46.9510475453538	0.0198809580321145	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2352.73952479716	2352.73952479716
"AML-0693"	"2021-03-09-AML0693:TCAAGCAAGCAAGGAA"	-8.640364031226	-4.08613207256468	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCAAGCAAGGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3058.78927155097	52.4677365859326	0.0171531059932509	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3049.24543788831	3049.24543788831
"AML-0693"	"2021-03-09-AML0693:TCAAGCACAAACGGCA"	-8.57517753067668	-3.62192108547362	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCACAAACGGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2662.80599963108	49.5095234429047	0.0185929892939118	3086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2647.99428787923	2647.99428787923
"AML-0693"	"2021-03-09-AML0693:TCAAGCACAACCTAAC"	0.440643538802308	9.99577519977418	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCACAACCTAAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1692.38647305242	49.2087775490653	0.0290765604267159	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1682.07816843188	1682.07816843188
"AML-0693"	"2021-03-09-AML0693:TCAAGCACATCGTTCC"	-0.926545957953292	11.1462726362976	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCACATCGTTCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1471.90900708822	47.2960641551792	0.032132464661482	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1467.22122846798	1467.22122846798
"AML-0693"	"2021-03-09-AML0693:TCAAGCATCCAAGCCG"	9.18417801436726	6.99071405017702	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCATCCAAGCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1715.53129609264	32.4667489534523	0.0189251860501757	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1707.0408300882	1707.0408300882
"AML-0693"	"2021-03-09-AML0693:TCAAGCATCTCGGCTT"	-7.57183633270915	-2.35752203380736	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGCATCTCGGCTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3175.0315301481	25.2325097780082	0.00794716825279251	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3153.32041427065	3153.32041427065
"AML-0693"	"2021-03-09-AML0693:TCAAGTGAGGAGGCAG"	-7.4883168739384	-2.6851217976776	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGTGAGGAGGCAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2677.21656596588	41.7412946105803	0.0155913029753426	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2656.47614501698	2656.47614501698
"AML-0693"	"2021-03-09-AML0693:TCAAGTGGTCGCATTA"	14.0342308479244	1.80059573734132	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGTGGTCGCATTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1172.16863333876	49.9392104600123	0.0426041177349775	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1159.38224703539	1159.38224703539
"AML-0693"	"2021-03-09-AML0693:TCAAGTGTCGCTTAAG"	13.9766499000484	1.99073300445405	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAAGTGTCGCTTAAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1327.72694050039	49.0291003484416	0.0369270961165884	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1295.68827633496	1295.68827633496
"AML-0693"	"2021-03-09-AML0693:TCAATCTCACGAGGAT"	-9.04857764664348	-3.69752910053404	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATCTCACGAGGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3128.89941268761	48.997412228946	0.0156596316360516	4203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3116.80579765843	3116.80579765843
"AML-0693"	"2021-03-09-AML0693:TCAATCTCAGTCGCAC"	-7.01077018204387	3.4205157526764	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATCTCAGTCGCAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2547.82354825708	41.9498959060333	0.0164649926148655	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2532.10504736312	2532.10504736312
"AML-0693"	"2021-03-09-AML0693:TCAATCTGTATCAAGA"	1.47228052195851	9.9185523756775	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATCTGTATCAAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1718.00376815737	21.4710492819893	0.0124976729853264	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1712.34620931067	1712.34620931067
"AML-0693"	"2021-03-09-AML0693:TCAATCTGTCTCACAA"	14.3189951377803	2.11323115909425	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATCTGTCTCACAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1278.74363772272	6.24848536297741	0.0048864253777287	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1260.05244459131	1260.05244459131
"AML-0693"	"2021-03-09-AML0693:TCAATTCAGAGATTCA"	0.696034093468827	-9.22927000438841	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATTCAGAGATTCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2253.54475013609	47.8106354250575	0.0212157470678895	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2195.04974437725	2195.04974437725
"AML-0693"	"2021-03-09-AML0693:TCAATTCAGTCGCCCA"	-8.23773036423381	-3.50995972072753	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATTCAGTCGCCCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2459.38154796959	51.3718795471964	0.0208881292085841	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2453.20989387722	2453.20989387722
"AML-0693"	"2021-03-09-AML0693:TCAATTCCAGAAATTG"	1.09050824221913	-10.1694641343323	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATTCCAGAAATTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2733.55741880106	34.7562183904811	0.0127146472766338	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2728.38604343484	2728.38604343484
"AML-0693"	"2021-03-09-AML0693:TCAATTCCATCGAGCC"	-2.31579909744914	3.50999281490175	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATTCCATCGAGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3114.23825456408	34.7512955878323	0.0111588429488022	3880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3109.08916097381	3109.08916097381
"AML-0693"	"2021-03-09-AML0693:TCAATTCTCACTAGCA"	-0.361307720572311	10.7702245482239	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAATTCTCACTAGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1698.15725460144	42.9340269993854	0.0252827156513618	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1693.70691204733	1693.70691204733
"AML-0693"	"2021-03-09-AML0693:TCACAAGAGCATTGTC"	14.0487925010616	2.16782806003419	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGAGCATTGTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1297.34686633592	48.6956422251301	0.0375347900308732	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1281.37734701799	1281.37734701799
"AML-0693"	"2021-03-09-AML0693:TCACAAGAGCCGCTTG"	11.0452410179073	-2.58487632190856	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGAGCCGCTTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1962.93987623084	46.685063675409	0.0237832366852988	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1949.82881920959	1949.82881920959
"AML-0693"	"2021-03-09-AML0693:TCACAAGAGTCGGGAT"	1.25642075118367	10.4518842467102	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGAGTCGGGAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1910.49253909671	41.3959508311088	0.0216676851565623	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1900.72397576149	1900.72397576149
"AML-0693"	"2021-03-09-AML0693:TCACAAGGTGAATGTA"	-8.56011424484904	-3.5397680035797	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGGTGAATGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2705.58573350669	43.510421029424	0.0160817010862304	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2698.63727142065	2698.63727142065
"AML-0693"	"2021-03-09-AML0693:TCACAAGTCCGAGCTG"	11.1824451881344	-2.84058883106383	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGTCCGAGCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1476.21759942265	51.3262748835399	0.0347687731833123	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1473.88224299156	1473.88224299156
"AML-0693"	"2021-03-09-AML0693:TCACAAGTCTCGGGAC"	-5.59463677826579	3.67005870426027	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACAAGTCTCGGGAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2513.96270372387	25.383624360975	0.0100970568590277	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2504.51578986503	2504.51578986503
"AML-0693"	"2021-03-09-AML0693:TCACACCCAAGAATAC"	0.976835330098313	10.1322421797547	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACACCCAAGAATAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1794.45666716086	49.416766036317	0.0275385674899037	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1782.69505578578	1782.69505578578
"AML-0693"	"2021-03-09-AML0693:TCACACCGTAGACAAT"	-6.96634231033977	3.93086407268373	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACACCGTAGACAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2412.10825468763	40.1305348212206	0.0166371201388793	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2399.84310800077	2399.84310800077
"AML-0693"	"2021-03-09-AML0693:TCACACCTCCGTACGG"	-7.30994973602946	-2.97799136554869	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACACCTCCGTACGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1522.34805452735	49.8379137772799	0.0327375291274985	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1503.40737454975	1503.40737454975
"AML-0693"	"2021-03-09-AML0693:TCACACCTCTGCGGGT"	1.07146408137624	9.6377496489319	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACACCTCTGCGGGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1707.61085687107	47.1307415716528	0.0276003993427475	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1707.61085687107	1707.61085687107
"AML-0693"	"2021-03-09-AML0693:TCACATTGTAGTCGGA"	-6.99330506745036	3.85128877246705	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACATTGTAGTCGGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2066.42578376287	46.2020614001265	0.0223584421773884	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2059.76769561505	2059.76769561505
"AML-0693"	"2021-03-09-AML0693:TCACATTGTTGGCCGT"	-7.34540257874187	-2.52740838443907	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACATTGTTGGCCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3004.72025528145	10.9822214729099	0.00365498966288336	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2983.07442811057	2983.07442811057
"AML-0693"	"2021-03-09-AML0693:TCACATTTCCGTGGTG"	-7.33778939667399	-3.31567599689635	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACATTTCCGTGGTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2567.80164915391	48.7401060872069	0.0189812581915222	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2558.8038475565	2558.8038475565
"AML-0693"	"2021-03-09-AML0693:TCACGCTAGTAACAGT"	-8.47482238236125	-0.924807511922441	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACGCTAGTAACAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3003.84949212759	38.7495417654385	0.0128999611555081	2898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2997.46081017709	2997.46081017709
"AML-0693"	"2021-03-09-AML0693:TCACGCTGTACCTGTA"	8.63531460341756	6.73293969714967	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACGCTGTACCTGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1828.46431778179	39.1997784778071	0.0214386346490822	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1811.37644631917	1811.37644631917
"AML-0693"	"2021-03-09-AML0693:TCACGCTTCAGATGCT"	-8.31356940689738	-3.38229920780333	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACGCTTCAGATGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2524.17717234769	44.2300856173053	0.0175225757137197	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2519.34243437046	2519.34243437046
"AML-0693"	"2021-03-09-AML0693:TCACGCTTCGTGCGAC"	14.2252232032711	2.13194749439088	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACGCTTCGTGCGAC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1229.40648303022	21.5290613728639	0.017511751947004	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1222.40446261254	1222.40446261254
"AML-0693"	"2021-03-09-AML0693:TCACGGGGTCTACGTA"	-8.30824218216594	-4.38301279461058	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACGGGGTCTACGTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2948.6341183675	49.8223303005817	0.0168967489015442	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2937.52148583451	2937.52148583451
"AML-0693"	"2021-03-09-AML0693:TCACTATTCATGGTAC"	11.5669552284176	-3.03293373500975	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACTATTCATGGTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1855.15944682326	50.1503812159586	0.0270329223193377	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1850.2032212835	1850.2032212835
"AML-0693"	"2021-03-09-AML0693:TCACTCGCAGCTACAT"	-8.69872508469279	-2.48423960125121	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACTCGCAGCTACAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3276.58579839944	41.9787558791733	0.012811737113577	4439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3266.54732932511	3266.54732932511
"AML-0693"	"2021-03-09-AML0693:TCACTCGGTCTCTCAC"	8.01638617095296	6.46773574436036	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCACTCGGTCTCTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1623.72983542955	42.2557541648902	0.0260238823250493	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1619.58104351461	1619.58104351461
"AML-0693"	"2021-03-09-AML0693:TCAGCAAAGCACTCCG"	1.19157733496968	-10.3055448762146	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCAAAGCACTCCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2568.10436730402	45.3947203001497	0.0176763533749233	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2557.51450566424	2557.51450566424
"AML-0693"	"2021-03-09-AML0693:TCAGCAACAAAGCAAT"	8.2768141227657	7.06634805286256	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCAACAAAGCAAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1931.73401460801	33.2651848481925	0.0172203753708518	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1929.78385062884	1929.78385062884
"AML-0693"	"2021-03-09-AML0693:TCAGCAACATCTTTCA"	13.9706741767818	1.76563427532045	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCAACATCTTTCA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1241.36541374442	4.57913452412459	0.00368878854962797	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1231.07500857419	1231.07500857419
"AML-0693"	"2021-03-09-AML0693:TCAGCCTAGTGTGTTC"	-6.9706371826237	3.84857318485109	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCCTAGTGTGTTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2307.87329059929	43.4269023048375	0.0188168486033134	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2288.41032129106	2288.41032129106
"AML-0693"	"2021-03-09-AML0693:TCAGCCTCATGTAACC"	11.9011265235836	-2.84212448513182	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCCTCATGTAACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1920.70023215591	39.8469835361902	0.0207460710781835	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1912.41327995783	1912.41327995783
"AML-0693"	"2021-03-09-AML0693:TCAGCCTGTGGGAGAG"	-7.14834104004558	-2.68550326740416	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCCTGTGGGAGAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3228.74988356111	4.17010032508348	0.00129155260564318	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3213.35934167171	3213.35934167171
"AML-0693"	"2021-03-09-AML0693:TCAGCCTGTGTGTCCG"	8.86101212081258	6.94791028583375	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGCCTGTGTGTCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1642.88065188741	50.3522542951127	0.0306487596876048	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1639.12382640378	1639.12382640378
"AML-0693"	"2021-03-09-AML0693:TCAGGGCAGCTCGGCT"	8.12560715255086	6.25064847553102	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGGCAGCTCGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1705.15271274599	48.4602366042371	0.0284198806605401	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1696.9040233045	1696.9040233045
"AML-0693"	"2021-03-09-AML0693:TCAGGGCGTGGACTGA"	-7.04311690750774	3.55544874751893	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGGCGTGGACTGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2426.57403455355	40.0426529724221	0.0165017231711166	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2413.48879571376	2413.48879571376
"AML-0693"	"2021-03-09-AML0693:TCAGGTAAGACCAAAT"	-6.85592256012614	3.86706278407899	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGTAAGACCAAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2372.46557506151	21.7078295189195	0.00914990284668587	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2364.15242119183	2364.15242119183
"AML-0693"	"2021-03-09-AML0693:TCAGGTAGTGGTGATG"	-9.00846038284953	-4.17255165493163	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGTAGTGGTGATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2687.06575193221	51.1525317228278	0.0190365761187813	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2670.84207385701	2670.84207385701
"AML-0693"	"2021-03-09-AML0693:TCAGGTATCCATACTT"	10.490986486047	6.73528430545656	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGTATCCATACTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1878.3627341706	44.1855758856345	0.023523452143627	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1874.33677912014	1874.33677912014
"AML-0693"	"2021-03-09-AML0693:TCAGGTATCCGTCAAA"	9.03335442122762	7.35666606510011	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGGTATCCGTCAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1725.90891454306	48.7709148712408	0.0282581047355869	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1718.54298337239	1718.54298337239
"AML-0693"	"2021-03-09-AML0693:TCAGTCCAGAGAAGGT"	-7.50868020477946	-2.14259936725768	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCAGAGAAGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3337.97895361985	1.40961677831321	0.000422296484759006	2622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3315.41246328359	3315.41246328359
"AML-0693"	"2021-03-09-AML0693:TCAGTCCAGCCATTGT"	-0.780091504484969	12.0925245054993	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCAGCCATTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1804.84080482293	54.0689992462187	0.0299577664144862	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1802.75761793811	1802.75761793811
"AML-0693"	"2021-03-09-AML0693:TCAGTCCCAGGGAGAG"	8.87619843062703	7.65668342197267	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCCAGGGAGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1708.01627029209	45.6437984648812	0.0267232808368246	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1705.97097612447	1705.97097612447
"AML-0693"	"2021-03-09-AML0693:TCAGTCCGTCATCGGC"	-6.89246163788493	3.90381190860597	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCGTCATCGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2236.75237158158	46.2577564812693	0.0206807678261501	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2227.95533890434	2227.95533890434
"AML-0693"	"2021-03-09-AML0693:TCAGTCCTCCTAAGTG"	8.4511476951534	6.54986331546632	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCTCCTAAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1763.94542300651	39.7710147728945	0.0225466243196503	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1757.61655094847	1757.61655094847
"AML-0693"	"2021-03-09-AML0693:TCAGTCCTCTGGACTA"	-7.15841041031535	-2.85729529773863	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTCCTCTGGACTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1462.22995269119	46.7815247109948	0.0319932748094067	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1458.09558532207	1458.09558532207
"AML-0693"	"2021-03-09-AML0693:TCAGTGACAAACGGCA"	-0.734930018812972	9.79699990833131	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTGACAAACGGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1844.3143739648	32.226055488123	0.0174731900065634	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1836.58746154139	1836.58746154139
"AML-0693"	"2021-03-09-AML0693:TCAGTGACAGTGCCTG"	8.92440666732137	6.75602004611818	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTGACAGTGCCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1720.66623705667	48.6083831583024	0.0282497454250341	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1720.66623705667	1720.66623705667
"AML-0693"	"2021-03-09-AML0693:TCAGTGATCACGGAGA"	8.01097454604451	6.50172088229982	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTGATCACGGAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1371.89876713946	50.0949223208209	0.0365150283101964	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1357.43681577014	1357.43681577014
"AML-0693"	"2021-03-09-AML0693:TCAGTGATCTCTGCTG"	-2.41070161286052	3.49848244273988	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCAGTGATCTCTGCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3307.8013303641	24.6426745232517	0.00744986535226382	4159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3302.11503821667	3302.11503821667
"AML-0693"	"2021-03-09-AML0693:TCATACTCAGCGTGCT"	10.9095026451046	-2.86485936557921	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATACTCAGCGTGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1687.3004504755	36.4811089904417	0.0216209916735107	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1681.96702742768	1681.96702742768
"AML-0693"	"2021-03-09-AML0693:TCATACTCATGCCGGT"	-9.0449403328007	-3.56473019039305	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATACTCATGCCGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2846.65741533381	47.1314650311352	0.0165567745445085	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2840.39724266379	2840.39724266379
"AML-0693"	"2021-03-09-AML0693:TCATACTTCTTAATCC"	10.377608914941	6.70965240085451	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATACTTCTTAATCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1866.91540059587	49.7558531220406	0.0266513700118173	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1856.23924360286	1856.23924360286
"AML-0693"	"2021-03-09-AML0693:TCATATCCATAGGAGC"	-6.93184123459514	3.64871618831483	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATATCCATAGGAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2026.4980954937	49.8755990835056	0.0246117177185675	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2018.41283049371	2018.41283049371
"AML-0693"	"2021-03-09-AML0693:TCATATCGTTGTGCCG"	-0.00761417943294648	10.4910096892151	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATATCGTTGTGCCG"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	1524.7141385866	44.3094812026211	0.0290608449684186	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1522.79446967881	1522.79446967881
"AML-0693"	"2021-03-09-AML0693:TCATCATCACAAGCAG"	-6.96233497086223	3.68741581523744	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCATCACAAGCAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2457.97255244231	41.014400296892	0.0166862726990743	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2442.56738569705	2442.56738569705
"AML-0693"	"2021-03-09-AML0693:TCATCATCATGTTTGG"	-7.83244500580485	-3.98723366176756	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCATCATGTTTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2183.7427372266	48.7200303383478	0.0223103342293073	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2164.88507713622	2164.88507713622
"AML-0693"	"2021-03-09-AML0693:TCATCATGTTCCCACT"	2.15321387824361	-8.48542406475218	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCATGTTCCCACT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2290.69564827098	40.3094648872677	0.0175970408455149	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2279.67665615019	2279.67665615019
"AML-0693"	"2021-03-09-AML0693:TCATCCGAGCATGTTC"	-0.0509972301429093	11.0582799681458	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCCGAGCATGTTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1677.8230147	42.8205537580054	0.0255214962381844	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1675.83686387162	1675.83686387162
"AML-0693"	"2021-03-09-AML0693:TCATCCGAGTTAGAAC"	8.34917225417439	5.93294522846071	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCCGAGTTAGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1714.74344973664	49.8281143444274	0.0290586410183285	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1704.3210834983	1704.3210834983
"AML-0693"	"2021-03-09-AML0693:TCATCCGCAATACAGA"	9.52044548568074	6.50212762439577	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCCGCAATACAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1747.95413436519	49.6164288798566	0.0283854295169341	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1742.48392025869	1742.48392025869
"AML-0693"	"2021-03-09-AML0693:TCATCCGCATTGACAC"	-7.09298549118693	-2.68878533756407	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATCCGCATTGACAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1973.62819153252	44.1035811941656	0.0223464487300008	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1962.42614658313	1962.42614658313
"AML-0693"	"2021-03-09-AML0693:TCATGAGAGTTGCGCC"	14.0737406211788	1.80178461158601	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGAGAGTTGCGCC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1249.09524045218	9.56047203044291	0.00765391758836738	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1226.52337787079	1226.52337787079
"AML-0693"	"2021-03-09-AML0693:TCATGCCCACACTTAG"	14.1202589469845	1.88161430442659	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGCCCACACTTAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1216.08561706521	5.93398088160874	0.00487957492329304	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1207.71265253142	1207.71265253142
"AML-0693"	"2021-03-09-AML0693:TCATGGAAGAGGTCGT"	-8.33794913712199	5.4508280524048	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGGAAGAGGTCGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1493.42253823801	47.4023869108736	0.0317407737577072	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1483.92351924162	1483.92351924162
"AML-0693"	"2021-03-09-AML0693:TCATGGACACCCTTAC"	-7.30838952484782	-2.83456065570983	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGGACACCCTTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2648.17649306696	0	0	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2634.7221357342	2634.7221357342
"AML-0693"	"2021-03-09-AML0693:TCATGGACATACTGTG"	0.791762014001054	-10.2405348054138	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGGACATACTGTG"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2916.28936333516	45.8957646651566	0.0157377265926276	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2907.62613528439	2907.62613528439
"AML-0693"	"2021-03-09-AML0693:TCATGGAGTAGGCTCC"	9.2032228904659	6.91367290103761	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATGGAGTAGGCTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1700.98940506161	49.2173267971547	0.0289345287223421	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1687.07829929616	1687.07829929616
"AML-0693"	"2021-03-09-AML0693:TCATTACTCAAGAATG"	-7.53491912308391	-2.97930004512938	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTACTCAAGAATG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1684.46945699013	43.7233272486079	0.0259567349631464	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1661.21711196392	1661.21711196392
"AML-0693"	"2021-03-09-AML0693:TCATTACTCAGTGATC"	-6.91997657242473	3.32109997356264	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTACTCAGTGATC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2783.3935475003	34.6351584174275	0.012443500290691	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2772.08178186349	2772.08178186349
"AML-0693"	"2021-03-09-AML0693:TCATTCACAAATAGCA"	8.62213768538777	6.58219287479249	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTCACAAATAGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1808.19224182885	40.4141924694145	0.0223506060553266	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1806.4078153925	1806.4078153925
"AML-0693"	"2021-03-09-AML0693:TCATTCACACAATGTC"	-8.34522757950481	-3.77525331890257	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTCACACAATGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2964.26328743491	48.9974081653668	0.0165293711840847	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2957.27428722823	2957.27428722823
"AML-0693"	"2021-03-09-AML0693:TCATTCAGTCGCTGCA"	-9.09067664566692	-2.11452724849852	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTCAGTCGCTGCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3393.08537466844	35.9196864846428	0.0105861428518145	4236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3379.21303527952	3379.21303527952
"AML-0693"	"2021-03-09-AML0693:TCATTCAGTCGTGGTC"	-7.71975837174113	-2.61712481891783	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTCAGTCGTGGTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1929.10457922682	42.452237513581	0.0220061877260152	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1908.53402212385	1908.53402212385
"AML-0693"	"2021-03-09-AML0693:TCATTCAGTGGACTGA"	14.3006569343502	2.05813953960267	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTCAGTGGACTGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1342.58945794056	7.77788382586109	0.00579319596162467	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1326.5226729963	1326.5226729963
"AML-0693"	"2021-03-09-AML0693:TCATTGTCACCATAAC"	8.38664879378621	6.3734035261902	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTGTCACCATAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1659.41242124612	42.9311553890937	0.0258712992860781	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.25392631724	1651.25392631724
"AML-0693"	"2021-03-09-AML0693:TCATTGTCATACACCA"	-8.60171828690227	-4.40052368557128	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTGTCATACACCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2763.22970982512	50.1440619180567	0.0181469031473428	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2750.68921240115	2750.68921240115
"AML-0693"	"2021-03-09-AML0693:TCATTGTTCGGCTTCT"	-8.16965232315715	-3.56672217762145	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTGTTCGGCTTCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3242.80939954769	44.9081067068529	0.0138485187298139	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3226.8167908664	3226.8167908664
"AML-0693"	"2021-03-09-AML0693:TCATTTGAGATGGTCG"	-7.88161883774455	1.08010540092317	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTTGAGATGGTCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2591.6963505366	20.404130438871	0.00787288620236953	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2587.2586307939	2587.2586307939
"AML-0693"	"2021-03-09-AML0693:TCATTTGCAACTTCTT"	9.82244648513142	6.90588042819826	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTTGCAACTTCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1959.73212019538	52.1226955346075	0.0265968470881679	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1951.05517085769	1951.05517085769
"AML-0693"	"2021-03-09-AML0693:TCATTTGTCGGACCAC"	-2.59539637985881	3.62341544711915	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCATTTGTCGGACCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3446.47992201662	22.7943317023788	0.00661380081072436	4975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3439.00383403874	3439.00383403874
"AML-0693"	"2021-03-09-AML0693:TCCACCATCCGATCTC"	-8.66034923020061	-3.50659015094908	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACCATCCGATCTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3050.47968257258	45.3945762089426	0.0148811272103474	2964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3041.35479877385	3041.35479877385
"AML-0693"	"2021-03-09-AML0693:TCCACCATCCGTGTGG"	1.2046797471935	11.6476011046204	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACCATCCGTGTGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1704.36601267487	40.2846577632098	0.0236361541262995	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1698.50691262196	1698.50691262196
"AML-0693"	"2021-03-09-AML0693:TCCACGTAGAGAAGGT"	7.64599957045857	6.02314374530641	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	8	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTAGAGAAGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1475.6078304487	50.5701772540512	0.034270743357789	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1467.11832649601	1467.11832649601
"AML-0693"	"2021-03-09-AML0693:TCCACGTAGGCTGGAT"	12.1339107948238	-2.52563645755919	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTAGGCTGGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1562.26333031349	45.7504821217972	0.0292847442771488	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1558.14133626827	1558.14133626827
"AML-0693"	"2021-03-09-AML0693:TCCACGTAGTGTACCT"	0.896063168614548	10.1371469267639	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTAGTGTACCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1659.13547884969	40.5613748999164	0.024447295243206	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1656.84087166621	1656.84087166621
"AML-0693"	"2021-03-09-AML0693:TCCACGTCATACCATG"	-8.27955089035686	-3.37934663211974	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTCATACCATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1656.6085672798	41.2491156115725	0.024899735777236	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1655.11276251899	1655.11276251899
"AML-0693"	"2021-03-09-AML0693:TCCACGTGTCAGGCAA"	-6.87182746353801	3.96203587138978	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTGTCAGGCAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2045.99620807201	48.6174398332322	0.0237622335962419	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2028.81619030483	2028.81619030483
"AML-0693"	"2021-03-09-AML0693:TCCACGTTCCCATAGA"	1.11836924132649	9.49566838825075	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCACGTTCCCATAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1794.9120503404	16.3455417841735	0.00910659760798512	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1789.33096937962	1789.33096937962
"AML-0693"	"2021-03-09-AML0693:TCCAGAACACTTTAGG"	-7.23951230469401	-2.97174646770629	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCAGAACACTTTAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2340.54081170637	29.8983212466335	0.0127741080595968	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2306.45360155658	2306.45360155658
"AML-0693"	"2021-03-09-AML0693:TCCAGAACAGCGGATA"	14.1398941474849	1.7656085261139	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCAGAACAGCGGATA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1455.49386315069	0	0	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1432.28333392909	1432.28333392909
"AML-0693"	"2021-03-09-AML0693:TCCAGAAGTAGGTACG"	8.52349438247029	6.92124030673829	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCAGAAGTAGGTACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1703.24239009574	44.5119402575067	0.0261336498647176	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1692.99947092512	1692.99947092512
"AML-0693"	"2021-03-09-AML0693:TCCAGAATCTGGAGAG"	-7.01957211914714	4.01913330638734	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCAGAATCTGGAGAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2042.74934463237	42.7444455739761	0.0209249586525599	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2032.26090246678	2032.26090246678
"AML-0693"	"2021-03-09-AML0693:TCCATCGAGATCCCGC"	9.28077473220174	7.13213536823121	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCATCGAGATCCCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1778.12624384912	46.401078540943	0.0260954916454628	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1767.02545980692	1767.02545980692
"AML-0693"	"2021-03-09-AML0693:TCCATCGGTGTTATCG"	7.92183746871297	6.25318000400392	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCATCGGTGTTATCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1622.40657869627	42.6133103557085	0.0262654940600349	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1618.32683243542	1618.32683243542
"AML-0693"	"2021-03-09-AML0693:TCCATCGTCGCTGATA"	10.8790232139522	-2.78428604519042	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCATCGTCGCTGATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1466.04464745298	45.8455791603488	0.0312716118434717	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1461.89098907407	1461.89098907407
"AML-0693"	"2021-03-09-AML0693:TCCATGCGTTCACCGG"	-1.13342462006267	10.1228008040222	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCATGCGTTCACCGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1699.68903674836	49.9597790378776	0.0293934819591791	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1694.11028563817	1694.11028563817
"AML-0693"	"2021-03-09-AML0693:TCCATGCGTTTAAGGA"	-0.263045052916366	11.8255204924378	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCATGCGTTTAAGGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1944.98427436531	38.6299337971334	0.0198613090636628	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1935.53409646143	1935.53409646143
"AML-0693"	"2021-03-09-AML0693:TCCCACAAGACTGGGT"	12.4249264198238	-2.74630620395812	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCACAAGACTGGGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1881.44734280052	44.620367098436	0.0237159797584443	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1865.20445140405	1865.20445140405
"AML-0693"	"2021-03-09-AML0693:TCCCACACAGTTGTTG"	-8.4263804954594	-3.74317386066588	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCACACAGTTGTTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2837.93416068089	41.1705364399401	0.0145072204318025	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2831.87525146218	2831.87525146218
"AML-0693"	"2021-03-09-AML0693:TCCCACAGTCCTGGTG"	-9.69926104965861	-2.49888160144957	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCACAGTCCTGGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2857.17150242266	38.2070657023027	0.0133723389267694	2378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2848.80039727197	2848.80039727197
"AML-0693"	"2021-03-09-AML0693:TCCCACAGTGTCCGGT"	-7.10195908966716	-2.87185003673705	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCACAGTGTCCGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1601.74373460689	45.6516934128261	0.0285012467515786	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1592.77839570718	1592.77839570718
"AML-0693"	"2021-03-09-AML0693:TCCCAGTAGCATTGAA"	-7.10565600815471	-2.72601249134215	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCAGTAGCATTGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2328.31940620921	29.1363811208155	0.0125139106958925	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2318.45674963936	2318.45674963936
"AML-0693"	"2021-03-09-AML0693:TCCCAGTCACAGTATC"	-8.20011649552043	-4.38970091259154	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCAGTCACAGTATC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2776.09932668207	47.8595257433113	0.0172398463136086	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2766.45475124713	2766.45475124713
"AML-0693"	"2021-03-09-AML0693:TCCCAGTCAGGTCCCA"	1.07921292361562	-9.19324781810912	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCAGTCAGGTCCCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1886.23706048704	44.2279529949136	0.0234477171090539	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1880.29910351425	1880.29910351425
"AML-0693"	"2021-03-09-AML0693:TCCCAGTGTTTACACG"	-7.15442595902141	-2.92255642330321	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCAGTGTTTACACG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	3085.59843419791	0	0	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	3062.13295160123	3062.13295160123
"AML-0693"	"2021-03-09-AML0693:TCCCAGTTCTCCGTGT"	-7.60885034027751	-2.58394052898558	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCAGTTCTCCGTGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2212.26821938309	38.6241146397515	0.0174590559595537	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2192.60098272441	2192.60098272441
"AML-0693"	"2021-03-09-AML0693:TCCCATGGTCCGTACG"	-0.761372844607192	11.9230661162171	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCATGGTCCGTACG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1509.66280137541	44.0545832732075	0.0291817372946268	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1498.10108179374	1498.10108179374
"AML-0693"	"2021-03-09-AML0693:TCCCATGTCGAGAACG"	-8.7387994331425	-3.73265697872313	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCCATGTCGAGAACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3363.1557383784	50.6267804428725	0.0150533559493391	2807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3353.9588112961	3353.9588112961
"AML-0693"	"2021-03-09-AML0693:TCCGAAACATCAGCGC"	0.621996899216813	8.91712567890016	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGAAACATCAGCGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1557.93565083682	45.6408640894159	0.029295731222853	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1546.65595512484	1546.65595512484
"AML-0693"	"2021-03-09-AML0693:TCCGAAACATTGAGGG"	-2.08092914047893	2.96019456470338	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGAAACATTGAGGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2730.504585852	28.6304509646697	0.0104854066581749	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2707.00647667901	2707.00647667901
"AML-0693"	"2021-03-09-AML0693:TCCGAAATCACCATCC"	-8.63643775406535	-3.17944528972777	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGAAATCACCATCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2205.37330773596	50.2180035496695	0.0227707496837456	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2201.00248973735	2201.00248973735
"AML-0693"	"2021-03-09-AML0693:TCCGATCCACGGCCAT"	-0.120594854385215	11.4009132155213	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGATCCACGGCCAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1706.83020396761	43.3259336740606	0.0253838569140313	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1701.94178952671	1701.94178952671
"AML-0693"	"2021-03-09-AML0693:TCCGATCGTACAAGTA"	-2.2048855823582	3.84662053668825	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGATCGTACAAGTA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1879.67802434961	35.2231094714504	0.0187389058206594	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1875.79567720689	1875.79567720689
"AML-0693"	"2021-03-09-AML0693:TCCGATCGTTTGGAGG"	-7.08771501007732	-2.81843593036803	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGATCGTTTGGAGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2049.24904503481	10.1645200395063	0.00496011944674769	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2037.43709175127	2037.43709175127
"AML-0693"	"2021-03-09-AML0693:TCCGATCTCACTTCTA"	-7.41482005539592	-2.97649552738341	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGATCTCACTTCTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1764.46812650403	43.6968173219391	0.024764866344464	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1752.85712122182	1752.85712122182
"AML-0693"	"2021-03-09-AML0693:TCCGGGAAGAGAGCAA"	-8.12683234635051	-4.51978399669798	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGGGAAGAGAGCAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2636.34504426475	48.4227757287813	0.0183673892892445	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2631.99363198281	2631.99363198281
"AML-0693"	"2021-03-09-AML0693:TCCGGGAGTACTGTTG"	0.895186801522416	-9.48149683391722	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGGGAGTACTGTTG"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2634.79307908768	46.4471598560996	0.0176283899577352	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2614.68032620142	2614.68032620142
"AML-0693"	"2021-03-09-AML0693:TCCGGGAGTCCAACGC"	-7.28913197937663	-3.02199413692626	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGGGAGTCCAACGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2027.90679101199	24.328158905929	0.0119966849629161	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2014.04836492469	2014.04836492469
"AML-0693"	"2021-03-09-AML0693:TCCGGGAGTTCTTAGG"	-3.40534863892253	3.04238579356996	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGGGAGTTCTTAGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2328.85543636953	4.73502517250479	0.00203319841092681	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2327.3947443507	2327.3947443507
"AML-0693"	"2021-03-09-AML0693:TCCGTGTCAACCCTCT"	1.25201584872548	-10.2480287781921	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGTGTCAACCCTCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2395.43122175477	40.4700034515336	0.0168946630919703	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2375.86485273857	2375.86485273857
"AML-0693"	"2021-03-09-AML0693:TCCGTGTTCCTCTCTT"	14.1769691902095	1.87360212886659	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCGTGTTCCTCTCTT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1183.59703505353	8.02666849917932	0.00678158888664021	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1164.64356863538	1164.64356863538
"AML-0693"	"2021-03-09-AML0693:TCCTAATCAAGGCAAC"	-2.14132199707683	3.45028421962587	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTAATCAAGGCAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3381.26926109791	25.726737029171	0.00760860346886939	4209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3376.02756225248	3376.02756225248
"AML-0693"	"2021-03-09-AML0693:TCCTAATCACATATGC"	-6.04038939896281	-2.54465200817259	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTAATCACATATGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1902.57379196164	27.0489072391015	0.0142170082198036	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1873.11361744384	1873.11361744384
"AML-0693"	"2021-03-09-AML0693:TCCTAATTCGAACGGA"	-0.918710271746475	10.72593591297	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTAATTCGAACGGA"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	1664.92070843663	51.8832726915769	0.0311626087829106	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1662.7051235621	1662.7051235621
"AML-0693"	"2021-03-09-AML0693:TCCTAATTCGTGACTA"	-8.44015441361125	-3.31388857280882	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTAATTCGTGACTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3157.72769079018	49.9195708181653	0.0158087003397287	3039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3139.20187549606	3139.20187549606
"AML-0693"	"2021-03-09-AML0693:TCCTAATTCTCCCATG"	8.66816677626912	7.50801274860231	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTAATTCTCCCATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1923.49105930622	42.453635694133	0.0220711375229607	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1914.89902005656	1914.89902005656
"AML-0693"	"2021-03-09-AML0693:TCCTCCCAGTCGCGAA"	-1.75140045109447	13.5764875181946	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCCCAGTCGCGAA"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1918.0031714445	42.6382987752917	0.0222305673995208	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1915.90441236589	1915.90441236589
"AML-0693"	"2021-03-09-AML0693:TCCTCCCGTTCGGCCA"	11.5779205757076	-2.16703679477843	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCCCGTTCGGCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1340.9420457033	46.6237401531096	0.0347693923853781	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1340.9420457033	1340.9420457033
"AML-0693"	"2021-03-09-AML0693:TCCTCCCTCTGGGCCA"	8.84774078902547	6.67290875995485	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCCCTCTGGGCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.65328727143	47.9551126732978	0.0301480612129868	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1584.88331531997	1584.88331531997
"AML-0693"	"2021-03-09-AML0693:TCCTCGAGTTATGACC"	-8.61266932907756	-3.73485519802245	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCGAGTTATGACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2465.00337459321	45.0272828581951	0.0182666211828719	2653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2459.59377810346	2459.59377810346
"AML-0693"	"2021-03-09-AML0693:TCCTCTTAGAAACTGT"	0.640034456818741	9.95014283740846	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTAGAAACTGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1957.93049209224	42.4057354912957	0.021658447867565	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1951.50962769682	1951.50962769682
"AML-0693"	"2021-03-09-AML0693:TCCTCTTAGAGGACTC"	-8.37273631516154	-3.67021920597228	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTAGAGGACTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2763.713075405	52.2494603308432	0.0189055299538236	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2758.79488536842	2758.79488536842
"AML-0693"	"2021-03-09-AML0693:TCCTCTTAGGTACATA"	9.83123459395711	7.0226201781067	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTAGGTACATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1706.56366158007	48.1330933931466	0.0282046866910205	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1698.12337009868	1698.12337009868
"AML-0693"	"2021-03-09-AML0693:TCCTCTTCAATGCAGG"	1.16813304004018	-9.42921640789183	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTCAATGCAGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2827.10762811771	40.2611848049821	0.0142411220586561	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2819.56288005306	2819.56288005306
"AML-0693"	"2021-03-09-AML0693:TCCTCTTCAGTAGAGC"	-7.49877295914348	-2.9593818417755	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTCAGTAGAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3002.38555299517	10.2495980911548	0.00341381808240112	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2978.56557598582	2978.56557598582
"AML-0693"	"2021-03-09-AML0693:TCCTCTTGTTATGGTC"	1.32118143615071	-10.092667602655	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00124100273020601	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTGTTATGGTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2496.77937930309	46.2288990950419	0.0185154120857668	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2481.22313263736	2481.22313263736
"AML-0693"	"2021-03-09-AML0693:TCCTCTTTCAGCAGAG"	-8.53002009812053	-3.65507986461791	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTCTTTCAGCAGAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2469.0617658821	41.5813509245124	0.0168409520973068	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2466.32194060415	2466.32194060415
"AML-0693"	"2021-03-09-AML0693:TCCTGCAAGGTGCGAT"	-7.12590012970622	-2.81748225605162	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTGCAAGGTGCGAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2142.7376722506	51.17724041081	0.0238840437976043	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2131.13818308836	2131.13818308836
"AML-0693"	"2021-03-09-AML0693:TCCTGCAGTTGCATGT"	-8.45502314987834	-3.49992277538451	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTGCAGTTGCATGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3319.6390438738	45.0294606320618	0.0135645653147625	2651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3312.99590063402	3312.99590063402
"AML-0693"	"2021-03-09-AML0693:TCCTGCAGTTTGGCTA"	-2.47854457321818	3.93449900234071	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTGCAGTTTGGCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2388.3933190348	6.08422410911617	0.00254741296612525	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2385.5421230032	2385.5421230032
"AML-0693"	"2021-03-09-AML0693:TCCTGCATCAGGCGAA"	-0.188779006630737	11.3457450636658	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTGCATCAGGCGAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1808.44098735744	48.8917091052071	0.0270352803586085	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1800.88998553837	1800.88998553837
"AML-0693"	"2021-03-09-AML0693:TCCTTCTAGTAACGAT"	-1.87397478047069	3.93268535220949	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTCTAGTAACGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3407.37718706215	13.7163414990012	0.00402548375069314	4611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3402.75401551818	3402.75401551818
"AML-0693"	"2021-03-09-AML0693:TCCTTCTGTGTTCGTA"	8.77080025252644	7.94515607440797	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTCTGTGTTCGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1608.45293167587	48.3235405409358	0.0300434906047185	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1599.47346795504	1599.47346795504
"AML-0693"	"2021-03-09-AML0693:TCCTTCTTCACAATGC"	-0.59761349383052	11.9673194655213	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTCTTCACAATGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1972.99670733157	48.5446590808097	0.0246045312191449	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1969.16105677199	1969.16105677199
"AML-0693"	"2021-03-09-AML0693:TCCTTTCAGGCTTAGG"	-7.06648002091106	3.56117103183595	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTTCAGGCTTAGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2581.87988737137	47.4863751164731	0.0183921705067463	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2560.08648196907	2560.08648196907
"AML-0693"	"2021-03-09-AML0693:TCCTTTCCAAGGTACG"	8.49082912978474	6.73001048648683	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTTCCAAGGTACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1648.120533982	40.4038071108563	0.0245150802248893	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.58615694895	1643.58615694895
"AML-0693"	"2021-03-09-AML0693:TCCTTTCGTAACGCGA"	0.806868572800797	10.3752736815247	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTTCGTAACGCGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1786.76342268381	34.1549452818465	0.019115538659586	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1779.47481122243	1779.47481122243
"AML-0693"	"2021-03-09-AML0693:TCCTTTCTCGCTCTCA"	-6.72655282440837	-2.51541592991027	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCCTTTCTCGCTCTCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1368.15119788925	38.0351880178999	0.0278004273771639	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1364.35726397796	1364.35726397796
"AML-0693"	"2021-03-09-AML0693:TCGAACACAACGACAG"	1.24485888060872	-9.63641550457152	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACACAACGACAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2407.4346903846	37.2835300860842	0.0154868292938522	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2404.54091943918	2404.54091943918
"AML-0693"	"2021-03-09-AML0693:TCGAACACACTAGGCC"	-8.4576076072758	-3.5695941678253	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACACACTAGGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2739.91607491867	45.6888118694613	0.0166752596138615	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2732.97850679072	2732.97850679072
"AML-0693"	"2021-03-09-AML0693:TCGAACACACTCCGAG"	8.53728355941121	6.55985782230226	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACACACTCCGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1883.38876162759	46.6040327140693	0.0247447758336388	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1877.96690686084	1877.96690686084
"AML-0693"	"2021-03-09-AML0693:TCGAACACATGGCCCA"	0.933304567902726	-9.44818308269652	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACACATGGCCCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2382.8924927659	49.5274579807173	0.0207845960869301	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2374.25422304422	2374.25422304422
"AML-0693"	"2021-03-09-AML0693:TCGAACAGTATAGGGC"	9.11294998702351	7.69934651935426	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACAGTATAGGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1783.96788179725	44.8187710483671	0.0251230818142391	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1772.32738970144	1772.32738970144
"AML-0693"	"2021-03-09-AML0693:TCGAACAGTATGGTTC"	-8.57952437821086	-3.93093922054442	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACAGTATGGTTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3000.38697948768	50.1011575672384	0.0166982318980044	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2991.56415560771	2991.56415560771
"AML-0693"	"2021-03-09-AML0693:TCGAACAGTCCTGTTC"	9.52260078963582	6.30069015109865	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACAGTCCTGTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1566.02465751076	43.5495401657926	0.0278089747545966	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1564.07561561681	1564.07561561681
"AML-0693"	"2021-03-09-AML0693:TCGAACAGTTAAACAG"	-6.89507756653483	-2.63093354618224	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACAGTTAAACAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1945.52229991085	49.6451230833773	0.0255176325070405	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1938.30453553585	1938.30453553585
"AML-0693"	"2021-03-09-AML0693:TCGAACATCATCTCTA"	11.9130045371944	-2.79307463085326	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACATCATCTCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1338.05555029539	51.5060609134778	0.0384932156980383	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1330.78204603307	1330.78204603307
"AML-0693"	"2021-03-09-AML0693:TCGAACATCGACGACC"	-8.28965125504192	-4.78195001995238	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACATCGACGACC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2615.86994226789	43.1405014634043	0.0164918372914223	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2606.90110457643	2606.90110457643
"AML-0693"	"2021-03-09-AML0693:TCGAACATCGGCATTA"	11.8969208198482	-2.48415543949278	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAACATCGGCATTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1382.47917350467	40.1909319477073	0.0290716364614889	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1382.47917350467	1382.47917350467
"AML-0693"	"2021-03-09-AML0693:TCGAAGTAGAGGATGA"	8.97743286666219	7.44455049121705	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAAGTAGAGGATGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1721.51652592989	49.963517463577	0.0290229670822293	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1715.61800766098	1715.61800766098
"AML-0693"	"2021-03-09-AML0693:TCGAAGTGTGAATGTA"	-2.22368536415752	3.54954693401185	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAAGTGTGAATGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3195.83775904145	28.6017110593407	0.00894967555171493	4758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3187.45526695884	3187.45526695884
"AML-0693"	"2021-03-09-AML0693:TCGAAGTGTGGAGAAA"	8.17749371108357	6.54707667911378	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAAGTGTGGAGAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1598.58802165756	39.2770533954847	0.0245698409242169	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1592.57731929201	1592.57731929201
"AML-0693"	"2021-03-09-AML0693:TCGAAGTGTGTTTGCA"	-7.01253114166911	4.1382002600464	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAAGTGTGTTTGCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1815.21418584801	52.6240037281444	0.0289905203134804	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1807.68842384474	1807.68842384474
"AML-0693"	"2021-03-09-AML0693:TCGAAGTTCCATCTGC"	1.37731387194936	-10.4946642152038	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGAAGTTCCATCTGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2218.98257600359	35.0528098542821	0.0157967936446858	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2205.79367198989	2205.79367198989
"AML-0693"	"2021-03-09-AML0693:TCGACCTAGTGAGGTC"	-2.35658154907878	3.93127868259279	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACCTAGTGAGGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3533.04213740533	23.6001378338934	0.00667983480412871	5150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3528.42807048396	3528.42807048396
"AML-0693"	"2021-03-09-AML0693:TCGACCTCAAGATCCT"	-8.15783439102824	-2.5114739171234	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACCTCAAGATCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3276.16526087904	2.07104001841639	0.000632153708223101	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3241.11114961025	3241.11114961025
"AML-0693"	"2021-03-09-AML0693:TCGACCTCAAGCTGTT"	-6.9666727584904	3.96430752361146	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACCTCAAGCTGTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2332.52856037921	35.4177199069255	0.0151842599094124	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2312.01489815816	2312.01489815816
"AML-0693"	"2021-03-09-AML0693:TCGACCTTCCCTCTCC"	-7.08011517944987	-2.75343611156615	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACCTTCCCTCTCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2514.9837064846	50.6378698593575	0.0201344723342714	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2498.88384123509	2498.88384123509
"AML-0693"	"2021-03-09-AML0693:TCGACGGAGCTGTGCC"	8.39724602279012	6.79052207553712	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACGGAGCTGTGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1629.67420599224	38.0607168587491	0.0233548010509104	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1623.72712407813	1623.72712407813
"AML-0693"	"2021-03-09-AML0693:TCGACGGCAACCACAT"	8.27955975112264	6.77056548679201	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACGGCAACCACAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1610.25898090534	44.1400827438191	0.0274117910641939	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1603.74171644225	1603.74171644225
"AML-0693"	"2021-03-09-AML0693:TCGACGGTCCTAGCTC"	-6.95473943176921	3.62835977161256	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGACGGTCCTAGCTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2477.1968692517	39.5463280358171	0.0159641442013299	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2457.74335642013	2457.74335642013
"AML-0693"	"2021-03-09-AML0693:TCGATTTAGGTACAGC"	8.16004719313924	6.62727353656618	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGATTTAGGTACAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1658.42760340241	46.6763880416062	0.0281449657168305	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1656.28951125998	1656.28951125998
"AML-0693"	"2021-03-09-AML0693:TCGATTTCAACTTCTT"	-1.05755637112315	11.7194280394348	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGATTTCAACTTCTT"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	2010.80698846287	39.0005289212189	0.0193954611979105	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2006.80576295255	2006.80576295255
"AML-0693"	"2021-03-09-AML0693:TCGATTTTCTGCACCT"	8.946305890649	6.66922710025636	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGATTTTCTGCACCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2004.78988957614	45.6122673039045	0.0227516447190125	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2000.21570132705	2000.21570132705
"AML-0693"	"2021-03-09-AML0693:TCGCACTCAAACTCGT"	8.16344418105428	6.29808662021486	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCACTCAAACTCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1694.46347614058	34.4141495752025	0.0203097617976319	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1682.44542418224	1682.44542418224
"AML-0693"	"2021-03-09-AML0693:TCGCACTTCATGCGGC"	14.2623144584591	1.89322743499605	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCACTTCATGCGGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1369.18354193736	0.241199931488471	0.000176163329532269	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1348.04236990153	1348.04236990153
"AML-0693"	"2021-03-09-AML0693:TCGCACTTCGGTAGAG"	-5.35825143280681	1.80315563762514	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.8	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCACTTCGGTAGAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1432.16100975063	43.6116797897394	0.0304516597594939	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1419.32721126043	1419.32721126043
"AML-0693"	"2021-03-09-AML0693:TCGCAGGAGGCTCACC"	-7.17846570435222	4.03464195812074	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCAGGAGGCTCACC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2178.83503550733	47.3266845520592	0.0217210958061538	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2155.71585777856	2155.71585777856
"AML-0693"	"2021-03-09-AML0693:TCGCTCAAGAGCATCG"	-7.79078135910686	-4.40230419552001	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTCAAGAGCATCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2222.02938455781	34.3574028557738	0.0154621730452998	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2219.57170663739	2219.57170663739
"AML-0693"	"2021-03-09-AML0693:TCGCTCAAGTGGAAAG"	-7.2265170616215	-1.28043308174285	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTCAAGTGGAAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2765.15303156912	27.8948151006378	0.0100879823945254	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2755.3473379997	2755.3473379997
"AML-0693"	"2021-03-09-AML0693:TCGCTCACAGGCACAA"	11.5768124061519	-2.70285823261412	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTCACAGGCACAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1914.23068928058	21.7066374046484	0.0113396141469273	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1913.04855568315	1913.04855568315
"AML-0693"	"2021-03-09-AML0693:TCGCTCAGTTGATGTC"	-8.29856238785442	0.338666594866194	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTCAGTTGATGTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2830.80763190016	29.6608688947847	0.0104778821988957	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2823.12909696869	2823.12909696869
"AML-0693"	"2021-03-09-AML0693:TCGCTCAGTTGTGGAG"	9.08147110518758	7.19582793796388	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTCAGTTGTGGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1810.94768461592	41.3368475944672	0.0228260860021664	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1809.06822310673	1809.06822310673
"AML-0693"	"2021-03-09-AML0693:TCGCTTGAGCCTGGAA"	14.1709486442501	1.78801808441011	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTTGAGCCTGGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1422.47234501459	30.7965872967041	0.0216500429021614	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1397.95586274213	1397.95586274213
"AML-0693"	"2021-03-09-AML0693:TCGCTTGAGTGCCCGT"	9.1102520423824	6.72894332492677	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTTGAGTGCCCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1641.25279224419	43.0988144292467	0.026259705167243	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1639.12925708256	1639.12925708256
"AML-0693"	"2021-03-09-AML0693:TCGCTTGGTACTGCCG"	1.37214400348012	-10.1905880204407	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTTGGTACTGCCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2322.98014468765	48.6604296759248	0.0209474152360728	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2315.81209695102	2315.81209695102
"AML-0693"	"2021-03-09-AML0693:TCGCTTGGTCGACGCT"	13.9770657020504	1.70241663539735	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTTGGTCGACGCT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1194.91952065584	9.55209591009137	0.00799392406347888	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1167.61078346932	1167.61078346932
"AML-0693"	"2021-03-09-AML0693:TCGCTTGTCGCCGAAC"	-7.44624219361003	-3.40815188800963	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGCTTGTCGCCGAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1786.05940119145	37.7850394291066	0.0211555334631653	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1778.2873848499	1778.2873848499
"AML-0693"	"2021-03-09-AML0693:TCGGATAAGAGTTGTA"	-0.0203525898164094	8.09463498676149	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Naive"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGATAAGAGTTGTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1843.9267592609	50.3245553969714	0.027292057639612	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1843.9267592609	1843.9267592609
"AML-0693"	"2021-03-09-AML0693:TCGGATAAGCCAAGCA"	-0.869481484324294	10.308621383551	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGATAAGCCAAGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1526.55304605142	50.9832946096649	0.0333976567283647	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1519.80714648656	1519.80714648656
"AML-0693"	"2021-03-09-AML0693:TCGGATACACTTGGCG"	8.72801174697224	7.99290511691896	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGATACACTTGGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2213.50920157354	52.343588459762	0.0236473326709245	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2203.29734118451	2203.29734118451
"AML-0693"	"2021-03-09-AML0693:TCGGATATCTTCCCAG"	7.87576927718465	6.2321886786255	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGATATCTTCCCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1349.46650512065	47.3779971982304	0.0351086870392493	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1349.46650512065	1349.46650512065
"AML-0693"	"2021-03-09-AML0693:TCGGGACCAATCTCTT"	0.427738298743409	10.1495103606018	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGACCAATCTCTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1362.23514899295	39.5017932214747	0.0289977785778592	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1357.27085651134	1357.27085651134
"AML-0693"	"2021-03-09-AML0693:TCGGGACCACACCTTC"	-7.51620231095012	-2.5777421227661	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGACCACACCTTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2081.61813249045	47.7002768305277	0.0229149987147061	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2069.1644983809	2069.1644983809
"AML-0693"	"2021-03-09-AML0693:TCGGGACTCAAGCCGC"	-6.74608359757121	-2.66136863147887	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGACTCAAGCCGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1405.43647307978	39.6680843774252	0.028224743798273	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1405.43647307978	1405.43647307978
"AML-0693"	"2021-03-09-AML0693:TCGGGCAAGTCACACT"	-7.23683820191081	-1.34386529838713	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGCAAGTCACACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3622.44407953787	30.5168084340523	0.00842436978018041	4410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3614.87129440995	3614.87129440995
"AML-0693"	"2021-03-09-AML0693:TCGGGCACAACTCCCT"	11.8935238319332	-2.73662378704222	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGCACAACTCCCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1333.27767925929	44.0943269681849	0.033072125675037	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1322.84979830042	1322.84979830042
"AML-0693"	"2021-03-09-AML0693:TCGGGCAGTGGCCCAT"	1.41202308711354	-10.5771503678528	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGCAGTGGCCCAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2226.77256395046	45.2005734737882	0.0202986933670491	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2216.92048577078	2216.92048577078
"AML-0693"	"2021-03-09-AML0693:TCGGGCATCAATGCAC"	-0.395568589598495	12.0476960905823	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGCATCAATGCAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2100.1076618851	35.6464618922754	0.0169736354660401	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2089.03109405111	2089.03109405111
"AML-0693"	"2021-03-09-AML0693:TCGGGTGAGATGCCGA"	9.41333832320515	7.48835895145265	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGAGATGCCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2059.2990637802	47.9221358288885	0.0232710909608821	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2041.93359114209	2041.93359114209
"AML-0693"	"2021-03-09-AML0693:TCGGGTGGTATGACAA"	-2.0208731693333	3.98184368694154	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGGTATGACAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3465.57829247185	30.1377513193607	0.00869631235422611	5221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3459.14990313219	3459.14990313219
"AML-0693"	"2021-03-09-AML0693:TCGGGTGGTGTCTAAC"	-9.83235869827922	-2.10164096271666	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGGTGTCTAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2918.29405682473	45.6047422917177	0.0156271922581161	2961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2909.37105120093	2909.37105120093
"AML-0693"	"2021-03-09-AML0693:TCGGGTGGTTTGGAGG"	-2.14766416969951	3.71695230090944	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGGTTTGGAGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1597.54011596587	16.7599057583714	0.0104910703592807	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1597.54011596587	1597.54011596587
"AML-0693"	"2021-03-09-AML0693:TCGGGTGTCGTAGCCG"	-2.86540518227275	10.5313663252625	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGTCGTAGCCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1705.71562161351	39.7008298261621	0.0232751751365256	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1705.71562161351	1705.71562161351
"AML-0693"	"2021-03-09-AML0693:TCGGGTGTCTACGCAA"	-6.99590859833415	3.65497992122499	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGGTGTCTACGCAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2333.19942317334	42.4991362400252	0.0182149608892938	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2319.22980767819	2319.22980767819
"AML-0693"	"2021-03-09-AML0693:TCGGTCTAGGTAGTCG"	-9.01143298569377	-1.94501569187316	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGTCTAGGTAGTCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3386.86592294571	40.7689779158532	0.0120373758050613	4528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3381.73057683359	3381.73057683359
"AML-0693"	"2021-03-09-AML0693:TCGGTCTCATCCAATG"	-1.738761763007	3.8791408308777	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGGTCTCATCCAATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3162.23906790393	14.3728128128873	0.00454513795581377	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3153.37842676521	3153.37842676521
"AML-0693"	"2021-03-09-AML0693:TCGTAGAAGGGTATAT"	-3.50742659989055	-2.78261902248534	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGAAGGGTATAT"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	1379.41766111183	35.2715755533285	0.0255699028276172	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1375.45973161512	1375.45973161512
"AML-0693"	"2021-03-09-AML0693:TCGTAGAAGTGCACCC"	-4.25100455704387	3.18093726718751	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGAAGTGCACCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2853.64484506436	39.5971169561488	0.0138759793548365	3014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2838.8705760674	2838.8705760674
"AML-0693"	"2021-03-09-AML0693:TCGTAGACACAGCCAC"	9.85501923140828	7.37734458530275	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGACACAGCCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1958.49561198381	50.6077374430768	0.0258401076486533	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1943.45498059884	1943.45498059884
"AML-0693"	"2021-03-09-AML0693:TCGTAGACACCCAATA"	-7.1440409225529	-2.79048612033995	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGACACCCAATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2085.95112876889	35.4201015216	0.0169803122580847	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2073.59111206944	2073.59111206944
"AML-0693"	"2021-03-09-AML0693:TCGTAGAGTCCATACA"	-7.05838094177898	-2.74533393299254	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGAGTCCATACA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1574.57577254619	42.6086799668718	0.0270604188822051	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1570.54153085966	1570.54153085966
"AML-0693"	"2021-03-09-AML0693:TCGTAGAGTTCGGCTG"	-5.18078551712688	2.13585422122804	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGAGTTCGGCTG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3132.66595201144	29.0948345163393	0.00928756367963775	3076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3120.25285583736	3120.25285583736
"AML-0693"	"2021-03-09-AML0693:TCGTAGATCCGAAATC"	-2.35225019875224	3.70194289768068	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTAGATCCGAAATC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1418.59195723246	38.5552912446274	0.0271785632563751	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1418.59195723246	1418.59195723246
"AML-0693"	"2021-03-09-AML0693:TCGTCCAAGGATTACA"	8.18884434279744	6.38496873462526	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTCCAAGGATTACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1388.72367760289	41.903267098862	0.0301739415656772	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1383.73570859876	1383.73570859876
"AML-0693"	"2021-03-09-AML0693:TCGTCCAGTAGTAAGT"	-7.0729583305424	-2.72172620212706	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTCCAGTAGTAAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1556.26240108385	45.7430140195121	0.029392867158941	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1538.59809415161	1538.59809415161
"AML-0693"	"2021-03-09-AML0693:TCGTCCATCGACCACG"	0.822731872170609	10.4638232954773	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTCCATCGACCACG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1621.3144645053	54.6776923755535	0.0337242981374604	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1619.20150172848	1619.20150172848
"AML-0693"	"2021-03-09-AML0693:TCGTGCTAGAAGCTGC"	-7.49327073517497	-4.6966557732788	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTGCTAGAAGCTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2486.94229729709	45.7468279945606	0.0183948087755314	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2477.53330840369	2477.53330840369
"AML-0693"	"2021-03-09-AML0693:TCGTGCTAGGAGTCTG"	-7.12924848023112	4.28564260089723	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTGCTAGGAGTCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1651.45323027209	28.6496667222026	0.017348155065513	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1639.469086847	1639.469086847
"AML-0693"	"2021-03-09-AML0693:TCGTGCTGTACCTATG"	-7.04784808579143	-2.67653777515563	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTGCTGTACCTATG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2064.95102328208	4.38400801347908	0.00212305665560582	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2051.98232190452	2051.98232190452
"AML-0693"	"2021-03-09-AML0693:TCGTGGGAGCACCAGA"	-6.81573186340983	-2.58640673076781	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTGGGAGCACCAGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1559.9031746604	18.7269459981571	0.012005197695834	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1549.83900158662	1549.83900158662
"AML-0693"	"2021-03-09-AML0693:TCGTGGGTCATACGAC"	-7.6746691268986	-0.906316601392351	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCGTGGGTCATACGAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2882.49613198978	44.6724729585947	0.0154978431585119	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2876.6804482839	2876.6804482839
"AML-0693"	"2021-03-09-AML0693:TCTAACTCACGCCAGT"	11.8591143089229	-2.85070063984069	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTAACTCACGCCAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1643.23737901867	42.5091066446434	0.0258691210335232	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1634.61305907103	1634.61305907103
"AML-0693"	"2021-03-09-AML0693:TCTAACTCAGGGACTA"	-8.27134738388713	-3.64728476917418	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTAACTCAGGGACTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2351.93575734791	43.5110511556991	0.0185001018925632	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2347.69859295423	2347.69859295423
"AML-0693"	"2021-03-09-AML0693:TCTACATCAGTCGGTC"	14.2249647575313	2.07271502101747	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACATCAGTCGGTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1185.88568642832	50.1485826206034	0.0422878724269304	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1168.31649088526	1168.31649088526
"AML-0693"	"2021-03-09-AML0693:TCTACATGTCACAGTT"	-7.17871652069743	-2.97594454204711	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACATGTCACAGTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2823.37634451143	44.548263012638	0.0157783651829621	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2805.27085086415	2805.27085086415
"AML-0693"	"2021-03-09-AML0693:TCTACATGTCCAGTTA"	-6.98865781250651	3.88757655704347	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACATGTCCAGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2416.31879644246	40.2854139257021	0.0166722263573061	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2408.6371273369	2408.6371273369
"AML-0693"	"2021-03-09-AML0693:TCTACATGTCCGGCAT"	1.199763794511	10.3793229826721	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACATGTCCGGCAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1897.54817741154	33.7275047480745	0.0177742547723254	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1892.14599904906	1892.14599904906
"AML-0693"	"2021-03-09-AML0693:TCTACCGAGCTCTATG"	-7.62619576874431	-4.57553865825804	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGAGCTCTATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2716.29076200316	50.8995484278867	0.0187386229559424	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2712.2077124923	2712.2077124923
"AML-0693"	"2021-03-09-AML0693:TCTACCGCAAATTGGA"	-7.43954644623454	-2.84133269703063	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGCAAATTGGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2842.11482730884	5.43908644884868	0.00191374619933948	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2827.10321667919	2827.10321667919
"AML-0693"	"2021-03-09-AML0693:TCTACCGCAATGAACA"	8.9681564765865	7.18137595737306	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGCAATGAACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.01974232121	47.3180285866375	0.0267481630954268	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1762.79781179912	1762.79781179912
"AML-0693"	"2021-03-09-AML0693:TCTACCGCAGATCCAT"	8.86482586440389	6.71627900684205	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGCAGATCCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1755.20478152437	38.7828738169776	0.0220959253445602	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1753.32081789807	1753.32081789807
"AML-0693"	"2021-03-09-AML0693:TCTACCGGTTCTCTAT"	-6.94711051407512	2.21177289569703	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGGTTCTCTAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2756.18567796914	29.5980376466948	0.0107387676684046	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2746.53576599742	2746.53576599742
"AML-0693"	"2021-03-09-AML0693:TCTACCGTCGATACAC"	-6.93224130097087	3.74721524799196	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTACCGTCGATACAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2333.99142247784	28.4526621560792	0.0121905598632719	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2323.2577185098	2323.2577185098
"AML-0693"	"2021-03-09-AML0693:TCTATACAGATGTTCC"	-8.40713916245158	-3.39293839847716	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATACAGATGTTCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3309.38224110776	47.9231568305409	0.0144809977630446	3408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3302.7443420714	3302.7443420714
"AML-0693"	"2021-03-09-AML0693:TCTATACAGTCGAGGT"	-8.57644114914592	-4.21800901806029	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATACAGTCGAGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2595.04413038799	46.946555362131	0.0180908504839614	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2580.30058135573	2580.30058135573
"AML-0693"	"2021-03-09-AML0693:TCTATACCAGGACTAG"	-0.566552380949813	12.9746856459412	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATACCAGGACTAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1813.49121291521	49.8557655077321	0.027491594749769	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1811.5263658463	1811.5263658463
"AML-0693"	"2021-03-09-AML0693:TCTATACTCCGAAGGA"	14.3673349815303	1.91962752425996	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATACTCCGAAGGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1264.67968629406	9.89555838368493	0.00782455707237796	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1239.50453532336	1239.50453532336
"AML-0693"	"2021-03-09-AML0693:TCTATCACAAATGGAT"	11.5290094810421	-2.57771422779235	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATCACAAATGGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1371.05683081512	47.4871564322088	0.0346354398774097	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1361.45212437436	1361.45212437436
"AML-0693"	"2021-03-09-AML0693:TCTATCAGTCGAGATG"	1.13446201857869	-9.27810003673705	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTATCAGTCGAGATG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2531.3023964798	37.5490821586448	0.0148338982378649	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2522.08519267858	2522.08519267858
"AML-0693"	"2021-03-09-AML0693:TCTCACGCATCCGATA"	-8.48437056961711	-3.43052174961241	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCACGCATCCGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2373.75945472077	44.9264109621487	0.0189262694131885	2823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2370.71585210256	2370.71585210256
"AML-0693"	"2021-03-09-AML0693:TCTCACGGTGCAGGAT"	1.31546105918233	-9.67193224346312	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCACGGTGCAGGAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1748.14493956768	52.3511898481432	0.0299467101744377	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1739.65038768244	1739.65038768244
"AML-0693"	"2021-03-09-AML0693:TCTCACGGTGTCCATA"	-8.64410911026653	-4.34255125438841	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCACGGTGTCCATA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1767.94488600285	48.6830354009105	0.0275365119050618	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1766.37812148422	1766.37812148422
"AML-0693"	"2021-03-09-AML0693:TCTCAGCAGGCGCTTC"	1.20530023154561	-10.1387872925964	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCAGCAGGCGCTTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2850.17241879823	34.3869039162657	0.0120648504242999	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2839.79149051441	2839.79149051441
"AML-0693"	"2021-03-09-AML0693:TCTCAGCCACGACGAA"	-6.98418937149699	3.8480231531891	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCAGCCACGACGAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2409.76975257939	48.2053926430501	0.0200041487745672	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2395.46408095439	2395.46408095439
"AML-0693"	"2021-03-09-AML0693:TCTCAGCCACTTGGCG"	3.73385753211324	-9.95846178447875	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCAGCCACTTGGCG"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2680.969239165	37.5568945194026	0.0140087002755391	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2677.84894121134	2677.84894121134
"AML-0693"	"2021-03-09-AML0693:TCTCAGCGTGGCACTC"	-4.22204480591472	3.57081792438356	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCAGCGTGGCACTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2620.4506012947	39.1275618753499	0.0149316159045387	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2615.51333929823	2615.51333929823
"AML-0693"	"2021-03-09-AML0693:TCTCAGCTCGTTCTAT"	-6.96357045593913	-2.70287325298461	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCAGCTCGTTCTAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1938.95506916307	30.9727586842371	0.0159739434795703	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1930.67259728597	1930.67259728597
"AML-0693"	"2021-03-09-AML0693:TCTCCGAAGGTAAACT"	-3.08678231659587	3.47639582240907	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCCGAAGGTAAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3210.05211997948	35.4366312432166	0.0110392697435215	3898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3202.22883322026	3202.22883322026
"AML-0693"	"2021-03-09-AML0693:TCTCCGACAAGCACCC"	-7.17969356003459	-2.884228729364	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCCGACAAGCACCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2983.81002356679	50.1839203802589	0.0168187384531506	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2961.66814507898	2961.66814507898
"AML-0693"	"2021-03-09-AML0693:TCTCCGACACCCTATC"	11.7697159248287	-2.64246632969054	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCCGACACCCTATC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1939.43840021844	40.0414872619498	0.0206459185594345	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1935.92130213199	1935.92130213199
"AML-0693"	"2021-03-09-AML0693:TCTCTGGAGGAACGTC"	-6.9423488182133	-2.74132420932921	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCTGGAGGAACGTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1856.83561123852	38.0475587149144	0.0204905369568695	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1847.31231826385	1847.31231826385
"AML-0693"	"2021-03-09-AML0693:TCTCTGGCAAGGGTCA"	8.22027649459187	6.18951747501222	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCTGGCAAGGGTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1669.682257581	45.7975353928667	0.0274288926440515	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1660.81046354447	1660.81046354447
"AML-0693"	"2021-03-09-AML0693:TCTCTGGCAGCGTAGA"	9.13165630873982	7.49890468204347	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTCTGGCAGCGTAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2112.18162446845	39.1173478220169	0.0185198788630979	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2104.15205629778	2104.15205629778
"AML-0693"	"2021-03-09-AML0693:TCTGCCACAAATGGCG"	-1.70723805847819	3.57918307864992	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGCCACAAATGGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2804.69892126008	36.184435102406	0.0129013616499518	3206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2799.10394556793	2799.10394556793
"AML-0693"	"2021-03-09-AML0693:TCTGGCTAGACTCAAA"	-0.860938112170059	12.3648118742737	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGGCTAGACTCAAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1987.7842888166	41.6479913625503	0.0209519672717329	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1984.09216185636	1984.09216185636
"AML-0693"	"2021-03-09-AML0693:TCTGGCTCACCGTGGT"	11.1145082908565	-2.80569770252379	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGGCTCACCGTGGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1539.1993478942	44.2878212402941	0.0287732848255717	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1529.4288727659	1529.4288727659
"AML-0693"	"2021-03-09-AML0693:TCTGGCTGTTCAGTAC"	9.06863083419148	7.7771048315796	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGGCTGTTCAGTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1897.5004873243	48.8758487115109	0.0257580164210822	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1890.50113204794	1890.50113204794
"AML-0693"	"2021-03-09-AML0693:TCTGTCGAGTCGTCTA"	-7.84149203720744	-1.38567938720854	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGTCGAGTCGTCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2994.05908468597	39.8679746663615	0.0133156940256384	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2982.46028589882	2982.46028589882
"AML-0693"	"2021-03-09-AML0693:TCTGTCGTCAACTGAC"	8.49288525161092	6.35635850513307	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGTCGTCAACTGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1408.14025672275	48.8436767884668	0.0346866560736951	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1396.6116231711	1396.6116231711
"AML-0693"	"2021-03-09-AML0693:TCTGTCGTCACAACCA"	8.51738895949666	6.12489602649537	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTGTCGTCACAACCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1672.85579269646	41.2863054943628	0.024680134219946	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1657.70839708369	1657.70839708369
"AML-0693"	"2021-03-09-AML0693:TCTTAGTCACAACCGC"	-7.61937079849895	-3.57632305538329	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTAGTCACAACCGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1748.79869789969	12.6888500851092	0.00725575224887146	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1738.0784661798	1738.0784661798
"AML-0693"	"2021-03-09-AML0693:TCTTCCTAGAGCTGCA"	14.1435133415157	1.91025362098543	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTCCTAGAGCTGCA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1172.28296648229	28.5953470359814	0.0243928708797914	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1156.47417080492	1156.47417080492
"AML-0693"	"2021-03-09-AML0693:TCTTCCTAGTTGCGCC"	-9.00993571701701	-3.49471928989562	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTCCTAGTTGCGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2936.82589016535	51.3131380419696	0.0174723119316687	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2928.66330736433	2928.66330736433
"AML-0693"	"2021-03-09-AML0693:TCTTCCTCATCATTTC"	-7.00820575180705	-2.70783784305724	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTCCTCATCATTTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1610.74724489869	45.2929819172258	0.0281192360009745	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1597.43612386591	1597.43612386591
"AML-0693"	"2021-03-09-AML0693:TCTTCCTTCCGAGTGC"	9.24094166335408	7.03175828540651	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTCCTTCCGAGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.25082915263	48.3716391899356	0.0267357286289545	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1807.2105022984	1807.2105022984
"AML-0693"	"2021-03-09-AML0693:TCTTGCGAGACTTGTC"	-8.1426776451176	-2.66836907779845	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTGCGAGACTTGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1294.55673890583	48.2021260642593	0.0372344638250466	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1294.55673890583	1294.55673890583
"AML-0693"	"2021-03-09-AML0693:TCTTGCGAGGCCCGTT"	-6.85725627365764	-2.604368232843	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTGCGAGGCCCGTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1456.88668597787	39.9217774322356	0.0274021156322393	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1444.22217910146	1444.22217910146
"AML-0693"	"2021-03-09-AML0693:TCTTGCGCAATTCTCT"	-6.9884971183842	3.770716167334	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTGCGCAATTCTCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2436.67880274139	40.2169955326277	0.0165048407231111	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2425.80123958646	2425.80123958646
"AML-0693"	"2021-03-09-AML0693:TCTTGCGCAGTTGTTG"	-2.6626926464146	3.45573017680971	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTGCGCAGTTGTTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3319.76734015338	36.7725194292255	0.0110768363145372	4047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3314.35558716544	3314.35558716544
"AML-0693"	"2021-03-09-AML0693:TCTTGCGGTGCACAAG"	-8.53563533249553	-3.40703823482665	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTGCGGTGCACAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.09144807786	40.4382038021602	0.0148555640298986	2489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2716.49950606789	2716.49950606789
"AML-0693"	"2021-03-09-AML0693:TCTTTGAGTGCAACGA"	8.22369350966756	6.81688449466554	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTTGAGTGCAACGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1796.62704269303	47.1825386984713	0.0262617324448973	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1791.74698289766	1791.74698289766
"AML-0693"	"2021-03-09-AML0693:TCTTTGAGTTCAATCG"	14.0194689231807	1.66673908317415	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTTGAGTTCAATCG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1163.12184962455	28.2229646940895	0.0242648392369207	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1153.16209769039	1153.16209769039
"AML-0693"	"2021-03-09-AML0693:TCTTTGATCTGTCCCA"	8.35574307021443	6.12747619235841	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TCTTTGATCTGTCCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1686.70160248065	50.1549674701437	0.0297355308113659	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1682.30961713303	1682.30961713303
"AML-0693"	"2021-03-09-AML0693:TGAACGTAGCCTTCTC"	-8.64811931076701	-4.06833794033202	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAACGTAGCCTTCTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3045.60458314728	40.3275771097859	0.0132412386469789	3666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3033.92853457421	3033.92853457421
"AML-0693"	"2021-03-09-AML0693:TGAACGTCAGGGACTA"	11.7786804634029	-2.83993484890135	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAACGTCAGGGACTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2029.2363737912	30.3663407433686	0.0149644177167175	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2024.18954347911	2024.18954347911
"AML-0693"	"2021-03-09-AML0693:TGAATCGAGCAAACAT"	-7.02342830124553	3.79186127269594	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATCGAGCAAACAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2437.1678601849	41.4267462252089	0.0169979043717021	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2422.34506588312	2422.34506588312
"AML-0693"	"2021-03-09-AML0693:TGAATCGGTTTGTTCT"	-0.0728737813537896	11.2814025648865	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATCGGTTTGTTCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1621.53012932069	52.5404611113064	0.0324017791351907	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1619.28924989636	1619.28924989636
"AML-0693"	"2021-03-09-AML0693:TGAATCGTCCTATTTG"	-9.39435420456584	-2.3209495774475	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATCGTCCTATTTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3086.10492836024	48.5990113882624	0.0157476860043398	3143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3077.02033325366	3077.02033325366
"AML-0693"	"2021-03-09-AML0693:TGAATGCAGCCTTGAT"	10.2461172538692	7.21958730304567	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATGCAGCCTTGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2139.20066243548	36.0879390019634	0.0168698241523903	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2135.73407776832	2135.73407776832
"AML-0693"	"2021-03-09-AML0693:TGAATGCCAACTCCAA"	-1.77423832836803	3.48041722858278	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATGCCAACTCCAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2826.2210154816	34.7662234469096	0.0123013109224175	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2818.06168618123	2818.06168618123
"AML-0693"	"2021-03-09-AML0693:TGAATGCGTATACCTG"	8.55592407759969	6.30969998920289	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATGCGTATACCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1713.70243197172	44.9204763623694	0.0262125299727126	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1705.61647203141	1705.61647203141
"AML-0693"	"2021-03-09-AML0693:TGAATGCGTTACGCCG"	-5.66114030304607	-4.75799992000731	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATGCGTTACGCCG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3106.74257833124	42.1619292541101	0.0135711048440831	3091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3096.17877674855	3096.17877674855
"AML-0693"	"2021-03-09-AML0693:TGAATGCTCGATGCTA"	0.78746779736821	9.53539846027223	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAATGCTCGATGCTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1656.95041447469	50.6690942257082	0.0305797287493193	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1654.83391161319	1654.83391161319
"AML-0693"	"2021-03-09-AML0693:TGACAGTAGGCTCCCA"	-6.98638234558757	-2.7426705590454	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTAGGCTCCCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1948.92012313846	21.4731935663359	0.011017995715369	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1933.77368690445	1933.77368690445
"AML-0693"	"2021-03-09-AML0693:TGACAGTCAAACGTGG"	-7.37489114227946	-3.04240729725035	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTCAAACGTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2041.97031567185	30.9313404666596	0.0151477914391143	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2023.89111133398	2023.89111133398
"AML-0693"	"2021-03-09-AML0693:TGACAGTGTCTCGGGT"	3.70131434974019	-10.1664591065613	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTGTCTCGGGT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2794.73074532604	42.223925773041	0.0151084056464677	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2786.55209299718	2786.55209299718
"AML-0693"	"2021-03-09-AML0693:TGACAGTGTGTCCTAA"	10.2168222862178	5.80233047092286	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTGTGTCCTAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1505.07618216288	47.1302473402672	0.031314193858638	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1493.35015213055	1493.35015213055
"AML-0693"	"2021-03-09-AML0693:TGACAGTTCACCATGA"	-0.00499874252136353	11.1739015349182	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTTCACCATGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1683.86976543151	47.722371049155	0.0283408919317022	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1681.72257569106	1681.72257569106
"AML-0693"	"2021-03-09-AML0693:TGACAGTTCCGTACGG"	9.20900024947469	7.00070808017579	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACAGTTCCGTACGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1641.59430092377	51.9104997856298	0.0316220029250944	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1631.82323349063	1631.82323349063
"AML-0693"	"2021-03-09-AML0693:TGACCCTCAGCTATTG"	1.03507657822911	-9.26146414196166	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACCCTCAGCTATTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2924.64530945174	45.0668440134915	0.0154093366015518	2885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2918.83328203403	2918.83328203403
"AML-0693"	"2021-03-09-AML0693:TGACCCTGTACCTTCC"	-2.65939460220988	3.65308234775392	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACCCTGTACCTTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3055.51351404913	44.3639535582328	0.0145193118453736	3505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3051.35720714648	3051.35720714648
"AML-0693"	"2021-03-09-AML0693:TGACCCTGTCATCCGG"	6.67039360579793	-0.776785217877947	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACCCTGTCATCCGG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2239.73276814447	44.5366772431914	0.0198848174552932	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2235.59003822976	2235.59003822976
"AML-0693"	"2021-03-09-AML0693:TGACCCTTCATGGATC"	-8.37645755234416	-4.39173414623412	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACCCTTCATGGATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2571.37069484547	52.2426291618044	0.0203170352942612	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2562.74766102314	2562.74766102314
"AML-0693"	"2021-03-09-AML0693:TGACCCTTCCACCTGT"	-7.36968932572063	-0.618037544843279	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACCCTTCCACCTGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2650.88689751428	38.5305701955184	0.0145349732693795	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2646.07647580915	2646.07647580915
"AML-0693"	"2021-03-09-AML0693:TGACGCGAGTTGGAGC"	-7.72407708588298	-2.96309974109801	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACGCGAGTTGGAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1715.52857157477	47.3100953537292	0.0275775618882878	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1715.52857157477	1715.52857157477
"AML-0693"	"2021-03-09-AML0693:TGACTCCCAGCACAAG"	-7.25412879410441	-2.94145944034728	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACTCCCAGCACAAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2852.61832184822	10.6458858423784	0.00373196994523994	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2832.3509274728	2832.3509274728
"AML-0693"	"2021-03-09-AML0693:TGACTCCTCACAAGGG"	10.9016968208248	-2.93613769924315	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACTCCTCACAAGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2177.31089655456	30.8727532579241	0.0141793040703457	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2161.96739304129	2161.96739304129
"AML-0693"	"2021-03-09-AML0693:TGACTCCTCCGCAAAT"	-5.74899564209636	3.3095333346161	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACTCCTCCGCAAAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2594.5538708409	7.05263071978616	0.00271824408775925	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2584.72994126722	2584.72994126722
"AML-0693"	"2021-03-09-AML0693:TGACTCCTCTTAATCC"	-7.65865836563762	-1.51004722034606	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGACTCCTCTTAATCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2674.82383303309	49.4186331569455	0.0184754721214323	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2650.67661322093	2650.67661322093
"AML-0693"	"2021-03-09-AML0693:TGAGACTGTATGTCTG"	9.13786758956258	7.49150464618532	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGACTGTATGTCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1787.41162673251	46.7009042000042	0.0261276717134129	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1785.48846010593	1785.48846010593
"AML-0693"	"2021-03-09-AML0693:TGAGCATGTTCTTAGG"	11.6287390190059	-2.60404374515685	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGCATGTTCTTAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1644.10160626689	33.4966230351069	0.0203738156494869	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1640.82110796313	1640.82110796313
"AML-0693"	"2021-03-09-AML0693:TGAGCATTCGCCGAGT"	1.0227179127628	9.68001554096071	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGCATTCGCCGAGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1607.36297829069	31.201341707321	0.0194115094902219	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1607.36297829069	1607.36297829069
"AML-0693"	"2021-03-09-AML0693:TGAGCGCCAGCTCATA"	-7.06068692627605	-2.78430797969969	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGCGCCAGCTCATA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1950.82647234565	41.0054007319508	0.0210195018948284	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1941.03997606784	1941.03997606784
"AML-0693"	"2021-03-09-AML0693:TGAGCGCCAGTAACAA"	0.784182329743546	-8.89191152965697	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGCGCCAGTAACAA"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2385.5952905159	46.1406140678867	0.0193413418660415	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2371.82475556129	2371.82475556129
"AML-0693"	"2021-03-09-AML0693:TGAGCGCTCCACAAGT"	11.0665584999019	-2.72997357761534	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGCGCTCCACAAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1463.9686230897	41.2718183588993	0.0281917369730202	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1454.59666260161	1454.59666260161
"AML-0693"	"2021-03-09-AML0693:TGAGGAGAGAGGCGGA"	-7.99209819260295	-4.61738731777342	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGAGAGGCGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2902.44977605311	50.6460169045231	0.0174494033703467	3202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2891.54699627265	2891.54699627265
"AML-0693"	"2021-03-09-AML0693:TGAGGAGAGCCTCTTC"	11.5590225654537	-3.15062668239745	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGAGCCTCTTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1455.40648386939	27.6133213210198	0.0189729272385857	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1455.40648386939	1455.40648386939
"AML-0693"	"2021-03-09-AML0693:TGAGGAGGTATAGCTC"	-4.83177838745769	2.88508746707765	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGGTATAGCTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3148.24668948447	44.5965073389717	0.0141655059903436	3078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3138.76283918249	3138.76283918249
"AML-0693"	"2021-03-09-AML0693:TGAGGAGGTCCAGCGT"	14.1201149421627	1.7916973599228	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGGTCCAGCGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1324.55633988669	3.39225501338003	0.00256104999933051	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1287.24270572983	1287.24270572983
"AML-0693"	"2021-03-09-AML0693:TGAGGAGGTTCTGAGT"	0.642876585095566	8.58461949909059	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGGTTCTGAGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1795.17074154345	43.1151210515259	0.0240172815063019	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1786.17756718705	1786.17756718705
"AML-0693"	"2021-03-09-AML0693:TGAGGAGTCCACGTGG"	-8.48367343369182	-3.35588171398314	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGAGTCCACGTGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3433.66520261834	46.1078544623316	0.0134281741933291	3064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3420.79310202532	3420.79310202532
"AML-0693"	"2021-03-09-AML0693:TGAGGGAAGGTGATCG"	-8.72870955887492	-3.99476005947264	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGGAAGGTGATCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2781.19459516011	52.6375231616595	0.0189262280508024	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2776.20210352021	2776.20210352021
"AML-0693"	"2021-03-09-AML0693:TGAGGGAGTGTCTTAG"	-6.90261683884318	-2.67725207721861	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGGAGTGTCTTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1433.48612430951	11.8134120861945	0.00824103692798899	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1425.60347022981	1425.60347022981
"AML-0693"	"2021-03-09-AML0693:TGAGGGATCAGGAACG"	-8.68907676163371	-4.65827801143798	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGGATCAGGAACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2639.13917770377	33.1732773756855	0.0125697339708126	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2632.94446259428	2632.94446259428
"AML-0693"	"2021-03-09-AML0693:TGAGGGATCTCATGCC"	9.5820423561031	7.31607673251954	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGGATCTCATGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1849.38145055631	48.5387858632943	0.026245956910995	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1846.17209034021	1846.17209034021
"AML-0693"	"2021-03-09-AML0693:TGAGGTTAGGCTGTAG"	8.36506046828572	6.90482995593873	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTAGGCTGTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1616.46978473972	42.8622056771287	0.0265159337228381	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1610.64575475372	1610.64575475372
"AML-0693"	"2021-03-09-AML0693:TGAGGTTAGGCTTTCA"	-7.29272733154948	-2.90458300029906	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTAGGCTTTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1929.19309220631	43.5622245771397	0.0225805414466419	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1900.59043618126	1900.59043618126
"AML-0693"	"2021-03-09-AML0693:TGAGGTTAGTGCACAG"	3.33078708228413	-9.69466211712035	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTAGTGCACAG"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2884.1889719902	41.6558586260491	0.0144428326405066	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2875.39976640303	2875.39976640303
"AML-0693"	"2021-03-09-AML0693:TGAGGTTCACAAACGG"	12.0180794197017	-3.12070681965026	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTCACAAACGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2180.51321878828	47.0499351517499	0.0215774592634186	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2170.42942933081	2170.42942933081
"AML-0693"	"2021-03-09-AML0693:TGAGGTTCAGGTCCCA"	11.0366054969722	-2.88010051166686	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTCAGGTCCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1833.75692460466	44.3663414780573	0.0241942325521809	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1826.15206181634	1826.15206181634
"AML-0693"	"2021-03-09-AML0693:TGAGGTTTCCCAATAG"	0.66996850547139	-8.51596643840941	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGGTTTCCCAATAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1503.09828812161	45.1136339831878	0.0300137618010098	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1487.95906960205	1487.95906960205
"AML-0693"	"2021-03-09-AML0693:TGAGTCACAATACGAA"	14.0388990837032	1.6998662718567	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGTCACAATACGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1330.46757308254	2.83842801496234	0.00213340638463365	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1314.24140062918	1314.24140062918
"AML-0693"	"2021-03-09-AML0693:TGAGTCATCAGGGTAG"	-7.83947024765666	-3.95637180721434	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGTCATCAGGGTAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1858.24202672203	34.4077654898373	0.018516299273746	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1848.75760901359	1848.75760901359
"AML-0693"	"2021-03-09-AML0693:TGAGTCATCCCTCTAG"	-8.66712317887004	-3.1705680123535	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGTCATCCCTCTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2933.58535676266	51.4925164007023	0.0175527588730285	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2925.74806492099	2925.74806492099
"AML-0693"	"2021-03-09-AML0693:TGAGTCATCCTACTGC"	-7.27141557160075	-3.09566380893859	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGTCATCCTACTGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2159.23671703543	0.490760900980722	0.000227284436721937	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2147.55688333465	2147.55688333465
"AML-0693"	"2021-03-09-AML0693:TGAGTCATCGGTCGAC"	8.31696857985799	6.26798579776613	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGAGTCATCGGTCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1564.86889547908	38.3577330588505	0.0245117870063533	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1557.74585808652	1557.74585808652
"AML-0693"	"2021-03-09-AML0693:TGATCAGAGAAACTAC"	8.58687080916707	7.01992080295411	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGAGAAACTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1864.65935843662	40.2107132241568	0.0215646429157283	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1847.1520447883	1847.1520447883
"AML-0693"	"2021-03-09-AML0693:TGATCAGCAAGTGGGT"	9.57675137099568	7.69679257953493	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGCAAGTGGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1735.18153562263	47.4831829916785	0.0273649655767229	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1723.52001622403	1723.52001622403
"AML-0693"	"2021-03-09-AML0693:TGATCAGCAATTAGGA"	8.72712482985799	6.85703036868898	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGCAATTAGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1598.57647058719	45.6562304278456	0.0285605545107736	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1588.0425008657	1588.0425008657
"AML-0693"	"2021-03-09-AML0693:TGATCAGCAGATGCGA"	-7.0253361267155	3.91091010654298	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGCAGATGCGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2416.98175649289	39.8718269983464	0.0164965361824665	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2397.69609619392	2397.69609619392
"AML-0693"	"2021-03-09-AML0693:TGATCAGCAGGCACTC"	14.2325769859249	2.05144426906434	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGCAGGCACTC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1125.12794890945	1.96707049974367	0.0017483082716506	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1105.57742835954	1105.57742835954
"AML-0693"	"2021-03-09-AML0693:TGATCAGTCATCCCGT"	-1.48277781429942	12.1047878035339	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCAGTCATCCCGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1894.21276192067	44.1517271121602	0.0233087475703583	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1892.30099630432	1892.30099630432
"AML-0693"	"2021-03-09-AML0693:TGATCTTGTCAACGCC"	-7.70560965958293	-3.76041629230651	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCTTGTCAACGCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2441.42476101246	6.50368667202919	0.00266388986295531	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2425.6696419865	2425.6696419865
"AML-0693"	"2021-03-09-AML0693:TGATCTTTCCAACTGA"	0.475356062024277	11.333993888739	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATCTTTCCAACTGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1791.67383112795	47.8511684651053	0.0267075221135426	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1779.18697491953	1779.18697491953
"AML-0693"	"2021-03-09-AML0693:TGATGCAAGTTTCGGT"	1.59380032595937	-10.1219845048157	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATGCAAGTTTCGGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2389.00785507152	33.0256527493438	0.0138240034159934	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2383.06517367393	2383.06517367393
"AML-0693"	"2021-03-09-AML0693:TGATGCAGTTGCATTG"	11.2682453590328	-2.85835959827574	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATGCAGTTGCATTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1474.91054045712	48.898677427483	0.0331536565006362	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1471.3864187896	1471.3864187896
"AML-0693"	"2021-03-09-AML0693:TGATGCATCTGGAGAG"	-7.47594485703166	-2.52264287387999	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATGCATCTGGAGAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3163.52057335609	7.47805659529434	0.00236384003893519	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3144.55220103014	3144.55220103014
"AML-0693"	"2021-03-09-AML0693:TGATGGTAGTCTGCGC"	1.29350568827931	-10.3614969483581	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATGGTAGTCTGCGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2025.33960492147	49.9364298246248	0.0246558304114934	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2016.13078577901	2016.13078577901
"AML-0693"	"2021-03-09-AML0693:TGATGGTGTAACGGTG"	-7.78888879242595	-3.51885583316954	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATGGTGTAACGGTG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	1418.58105464216	50.0140716608821	0.0352564074482852	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1411.09085529185	1411.09085529185
"AML-0693"	"2021-03-09-AML0693:TGATTCTAGGGCTTCC"	7.9562164741451	7.66820476138917	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTCTAGGGCTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1557.14741776985	45.0289438443863	0.0289175856637111	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1552.79981688698	1552.79981688698
"AML-0693"	"2021-03-09-AML0693:TGATTCTCATGAGATA"	8.26327862319295	6.77683112705079	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTCTCATGAGATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1904.43713529229	42.9146545398165	0.0225340357759985	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1896.40692057882	1896.40692057882
"AML-0693"	"2021-03-09-AML0693:TGATTCTGTCCCTGTT"	11.3818947273189	-2.54005076801451	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTCTGTCCCTGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1766.50595601019	53.3633650094782	0.0302084263163223	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1760.58188014091	1760.58188014091
"AML-0693"	"2021-03-09-AML0693:TGATTTCAGTTCCGTA"	-6.97008881989177	-2.67108871853026	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTTCAGTTCCGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1883.50832110745	5.99498865388812	0.00318288408217025	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1878.68772007123	1878.68772007123
"AML-0693"	"2021-03-09-AML0693:TGATTTCGTCTGTGGC"	1.3022366958553	10.4891395338806	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTTCGTCTGTGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1987.78103189288	45.3174359141431	0.0227980019866621	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1978.58780787684	1978.58780787684
"AML-0693"	"2021-03-09-AML0693:TGATTTCGTTATTCTC"	-1.83262393894847	4.06241462314454	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGATTTCGTTATTCTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3383.63059201645	21.1519692870075	0.00625126434809838	4968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3378.915386739	3378.915386739
"AML-0693"	"2021-03-09-AML0693:TGCACGGGTACAAGTA"	-7.06641040268596	3.34301183307496	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCACGGGTACAAGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2730.39564690226	36.8747040729312	0.0135052603511022	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2714.50428852243	2714.50428852243
"AML-0693"	"2021-03-09-AML0693:TGCACGGGTGCCCGTA"	-0.748964230448562	11.1725024946961	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCACGGGTGCCCGTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1662.7380527888	50.4307218075647	0.0303299258250454	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1654.01837901044	1654.01837901044
"AML-0693"	"2021-03-09-AML0693:TGCACGGTCATTTACC"	1.31230868872945	-10.4514360657898	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCACGGTCATTTACC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2773.05028899937	35.9263092272259	0.0129555202694104	2706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2762.22961239037	2762.22961239037
"AML-0693"	"2021-03-09-AML0693:TGCAGATAGAGTCACG"	11.1995569663936	-2.51133062755736	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGATAGAGTCACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1606.89427952538	40.9040392916232	0.0254553394164207	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1604.86250264105	1604.86250264105
"AML-0693"	"2021-03-09-AML0693:TGCAGATCACCCAACG"	1.43247689780537	-10.4069795838562	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	61	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00427350427350427	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGATCACCCAACG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2024.91851211632	47.7368127396832	0.0235746833534509	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2013.8922912107	2013.8922912107
"AML-0693"	"2021-03-09-AML0693:TGCAGATGTCCTTGTC"	-8.36498580399211	-4.62477638637694	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGATGTCCTTGTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2310.00934846346	50.6448502953816	0.0219240888912717	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2302.47246602224	2302.47246602224
"AML-0693"	"2021-03-09-AML0693:TGCAGGCCATGCCGCA"	-9.19922290268596	-1.86723103439482	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGGCCATGCCGCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3479.87569166564	47.6848245646919	0.0137030252772816	4603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3467.92955932983	3467.92955932983
"AML-0693"	"2021-03-09-AML0693:TGCAGGCGTCTACACA"	-7.34161410751994	-3.10413219844969	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGGCGTCTACACA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1374.29645606463	48.5505295538568	0.0353275520282456	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1363.93608816722	1363.93608816722
"AML-0693"	"2021-03-09-AML0693:TGCAGGCTCAACTCTT"	-6.90867219391521	3.93307015979616	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGGCTCAACTCTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1878.8204194508	47.674652876068	0.0253747789743545	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1859.18227813071	1859.18227813071
"AML-0693"	"2021-03-09-AML0693:TGCAGGCTCTAACGCA"	-9.49779925766643	-4.42628576671752	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGGCTCTAACGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2693.39756540352	46.8536273459221	0.0173957339041786	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2676.1401648667	2676.1401648667
"AML-0693"	"2021-03-09-AML0693:TGCAGTAAGCAAATCA"	-7.16884408417399	-2.78946592723998	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGTAAGCAAATCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2673.86810612681	40.6272330185942	0.0151941798944766	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2649.49464527509	2649.49464527509
"AML-0693"	"2021-03-09-AML0693:TGCAGTACATAATCCG"	-6.96306453171428	3.55636355960695	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGTACATAATCCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2354.88498305085	43.1191483456702	0.018310511407571	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2344.53819253031	2344.53819253031
"AML-0693"	"2021-03-09-AML0693:TGCAGTAGTACTAAGA"	-7.02785764160808	-2.74116423046263	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGTAGTACTAAGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2048.91094129139	48.2079397796778	0.0235285676932807	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2022.3429312156	2022.3429312156
"AML-0693"	"2021-03-09-AML0693:TGCAGTAGTCAAATCC"	8.33836807784383	5.96347377384035	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGTAGTCAAATCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1530.54733638165	48.4661947388976	0.0316659234163092	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1525.93045871379	1525.93045871379
"AML-0693"	"2021-03-09-AML0693:TGCAGTATCCGAAGGA"	-7.20842490616496	4.31646297061769	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCAGTATCCGAAGGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2304.6962664371	35.6896220183612	0.0154856075996231	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2289.484419594	2289.484419594
"AML-0693"	"2021-03-09-AML0693:TGCATCCAGACTAAGT"	9.85572113570515	6.40563247287599	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCATCCAGACTAAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1577.26061514981	36.7022842048511	0.023269638417596	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1572.66803737326	1572.66803737326
"AML-0693"	"2021-03-09-AML0693:TGCATCCCATCCGAAT"	-2.35954938355144	4.13776919925538	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCATCCCATCCGAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3569.67436015952	30.7653133696051	0.00861852098134528	4107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3552.72361944465	3552.72361944465
"AML-0693"	"2021-03-09-AML0693:TGCATCCTCCAACCGG"	-0.415322969586211	11.3028678664002	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCATCCTCCAACCGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1813.7891889659	49.9834495894262	0.027557474646722	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1804.00004402576	1804.00004402576
"AML-0693"	"2021-03-09-AML0693:TGCATCCTCTTCGGTC"	8.12820591506306	6.14326379382936	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCATCCTCTTCGGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1474.11133197249	40.2361202090708	0.027295170545383	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1469.3519363825	1469.3519363825
"AML-0693"	"2021-03-09-AML0693:TGCATGAGTAGACGGT"	-2.69446692887004	3.93053481662599	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCATGAGTAGACGGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1886.35033276429	13.1659118122828	0.00697956873842689	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1882.41125174155	1882.41125174155
"AML-0693"	"2021-03-09-AML0693:TGCCGAGAGCTCCACG"	-1.0701176923817	11.7933435210022	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCCGAGAGCTCCACG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1892.90189464134	49.7386147879297	0.0262763828007864	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1890.89799665899	1890.89799665899
"AML-0693"	"2021-03-09-AML0693:TGCCGAGAGTACCGGA"	-7.36254868927653	-3.08611514484557	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCCGAGAGTACCGGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2712.23588744576	0	0	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2694.9582373166	2694.9582373166
"AML-0693"	"2021-03-09-AML0693:TGCCGAGCACCGTCTT"	12.0933700996334	-3.0200884572235	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCCGAGCACCGTCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2205.61574246544	47.3282854024616	0.0214580828796397	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2194.40630400046	2194.40630400046
"AML-0693"	"2021-03-09-AML0693:TGCCGAGCAGCGACCT"	9.23101105269734	6.28359363162843	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCCGAGCAGCGACCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1839.80896679227	38.9873401485657	0.0211909719173402	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1838.06342492508	1838.06342492508
"AML-0693"	"2021-03-09-AML0693:TGCCGAGGTAGGTCAG"	-0.747437934309799	10.4118127592835	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCCGAGGTAGGTCAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1962.94679757943	45.9890656862143	0.0234285848923286	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1962.94679757943	1962.94679757943
"AML-0693"	"2021-03-09-AML0693:TGCGACGCACCGTCTT"	-2.21313414993938	4.07197330081788	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGACGCACCGTCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2170.9329471333	39.6532271164059	0.0182655236628877	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2162.7431722306	2162.7431722306
"AML-0693"	"2021-03-09-AML0693:TGCGACGCAGAGCTAG"	14.1025444465572	1.79812250221101	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGACGCAGAGCTAG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1153.54103451413	39.037474855281	0.0338414271250643	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1144.36319782474	1144.36319782474
"AML-0693"	"2021-03-09-AML0693:TGCGACGGTCGCACGT"	8.23227943953816	6.60517022693483	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGACGGTCGCACGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1600.20976478268	50.9515473844321	0.0318405427249418	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1593.00692484069	1593.00692484069
"AML-0693"	"2021-03-09-AML0693:TGCGACGTCGCGATCG"	11.7492062049801	-2.65326049244078	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGACGTCGCGATCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1343.14924619044	53.429792103657	0.0397794900717097	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1343.14924619044	1343.14924619044
"AML-0693"	"2021-03-09-AML0693:TGCGATACAGACATCT"	-1.52322266522105	10.2155160673889	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGATACAGACATCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1627.62725927236	50.5715300430597	0.0310707072242499	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1627.62725927236	1627.62725927236
"AML-0693"	"2021-03-09-AML0693:TGCGATAGTCACTCTC"	-8.21060786667522	-4.27562000667723	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGATAGTCACTCTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2923.00149780676	37.7695731764831	0.0129215031893836	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2911.28540679396	2911.28540679396
"AML-0693"	"2021-03-09-AML0693:TGCGATATCTCCACTG"	-7.06334243241008	-2.67194201862486	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGATATCTCCACTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2757.63986689969	48.6801426003203	0.0176528281247434	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2730.81933381763	2730.81933381763
"AML-0693"	"2021-03-09-AML0693:TGCGGCAAGTCACGCC"	-8.05127749863322	-3.76977302944335	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGGCAAGTCACGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2663.98351739772	49.4473002610367	0.0185614137392782	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2654.58185627997	2654.58185627997
"AML-0693"	"2021-03-09-AML0693:TGCGGCAGTCATCCCT"	-9.52928672257121	-2.16501166736754	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCGGCAGTCATCCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3335.24319339817	51.4755812881905	0.0154338314489576	3582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3325.88259886386	3325.88259886386
"AML-0693"	"2021-03-09-AML0693:TGCTCCAGTCAATCTG"	11.8427025276119	-2.8750791779724	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCAGTCAATCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1791.98526378445	36.7088534517337	0.0204850197117186	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1783.34429093999	1783.34429093999
"AML-0693"	"2021-03-09-AML0693:TGCTCCAGTCTTACAG"	8.23778214034383	6.64101455295411	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCAGTCTTACAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1700.38316511056	39.3504440358226	0.023142103993522	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1698.40649854089	1698.40649854089
"AML-0693"	"2021-03-09-AML0693:TGCTCCAGTGGCTGCT"	1.04778369244878	-9.49961378490599	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCAGTGGCTGCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2007.49270128416	51.8786876329932	0.0258425286427229	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1998.39257445722	1998.39257445722
"AML-0693"	"2021-03-09-AML0693:TGCTCCATCAAGTGTC"	-8.36471591416057	-3.70585110103758	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCATCAAGTGTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2564.18465093723	52.1108355246043	0.0203225752504046	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2557.02859015218	2557.02859015218
"AML-0693"	"2021-03-09-AML0693:TGCTCCATCCGTGGGT"	11.9749037223751	-2.96044828807982	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCATCCGTGGGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2141.25543556046	46.77760009243	0.0218458757024411	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2126.56696722409	2126.56696722409
"AML-0693"	"2021-03-09-AML0693:TGCTCCATCGGACTTA"	14.0726896720821	1.72590432250825	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCATCGGACTTA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1338.53763028634	16.3524104231814	0.0122166236145959	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1321.79875604322	1321.79875604322
"AML-0693"	"2021-03-09-AML0693:TGCTCCATCGTTCAGA"	8.75601639327351	7.13172814929811	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCCATCGTTCAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1874.41277773467	46.8165486485667	0.0249766482626879	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1862.85548873916	1862.85548873916
"AML-0693"	"2021-03-09-AML0693:TGCTCGTCAGCTCTGG"	1.32910098609273	-10.3323822251526	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCGTCAGCTCTGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1549.5233348251	47.7453399360039	0.0308129208918258	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1540.19180458144	1540.19180458144
"AML-0693"	"2021-03-09-AML0693:TGCTCGTCATCTCATT"	-2.62626729431804	3.26895973766176	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCGTCATCTCATT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3298.98710774066	16.3938053782736	0.0049693450877112	4697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3293.76052991623	3293.76052991623
"AML-0693"	"2021-03-09-AML0693:TGCTCGTGTTAAGGGC"	1.21201815184895	-10.122546218988	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCGTGTTAAGGGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2092.54918609098	48.4842992128149	0.0231699687324371	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2087.88613947024	2087.88613947024
"AML-0693"	"2021-03-09-AML0693:TGCTCGTTCTCACTCG"	14.1239925819332	1.93156216228334	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTCGTTCTCACTCG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1153.40554695471	4.60698337846796	0.00399424416731095	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1139.67385301991	1139.67385301991
"AML-0693"	"2021-03-09-AML0693:TGCTGAACAAGGGCAT"	-1.81289015236552	3.75367162311403	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTGAACAAGGGCAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1632.24636469066	41.4965099334591	0.0254229452312632	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1630.12537214622	1630.12537214622
"AML-0693"	"2021-03-09-AML0693:TGCTGAACACGCTTAA"	-8.34645209732707	-3.40160634433898	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTGAACACGCTTAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2572.69582143892	52.5637644687662	0.0204313949712745	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2568.18231484347	2568.18231484347
"AML-0693"	"2021-03-09-AML0693:TGCTGAAGTTGTGCCG"	-7.00140128555949	3.94568560207216	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTGAAGTTGTGCCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1822.63989210262	53.7861579994977	0.0295100300572535	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1813.0313289298	1813.0313289298
"AML-0693"	"2021-03-09-AML0693:TGCTGAATCGTCAACA"	-6.83272824707683	3.8890228041443	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTGAATCGTCAACA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2568.31027446676	44.1635315198118	0.017195559258891	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2549.11052235686	2549.11052235686
"AML-0693"	"2021-03-09-AML0693:TGCTTCGAGCCTATTG"	8.35594524916951	6.40505406940309	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTCGAGCCTATTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1451.94896393977	34.5271301292997	0.0237798510738371	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1439.96956434554	1439.96956434554
"AML-0693"	"2021-03-09-AML0693:TGCTTCGAGGACCCAA"	-6.93613944473918	-2.71851780330809	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTCGAGGACCCAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2331.39005228773	28.7837860640931	0.0123461906495863	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2323.29971733578	2323.29971733578
"AML-0693"	"2021-03-09-AML0693:TGCTTCGCAGACGCTC"	8.31829227980916	6.58256051624147	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTCGCAGACGCTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1797.48460824281	45.7064142763005	0.0254279864576878	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1793.44326701465	1793.44326701465
"AML-0693"	"2021-03-09-AML0693:TGCTTCGGTGAGATTA"	8.30061878737752	6.98640487277833	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTCGGTGAGATTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1480.23415849692	49.4884815512903	0.0334328736215239	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1475.19502946796	1475.19502946796
"AML-0693"	"2021-03-09-AML0693:TGCTTGCCACATATGC"	-6.18794761124309	2.227503276709	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	47	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTGCCACATATGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2380.11131096487	48.3792737626677	0.020326475295416	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2361.39052935403	2361.39052935403
"AML-0693"	"2021-03-09-AML0693:TGCTTGCCACTTCTCG"	-7.05475411835368	4.04472253406373	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTGCCACTTCTCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2375.10206830302	51.04476721527	0.0214916099381534	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2355.25562571887	2355.25562571887
"AML-0693"	"2021-03-09-AML0693:TGCTTGCTCGTCACCT"	7.07959904250447	-0.50465383445891	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGCTTGCTCGTCACCT"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2352.55702118898	27.1281704657838	0.0115313551261228	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2344.91621823122	2344.91621823122
"AML-0693"	"2021-03-09-AML0693:TGGAACTCACGATTCA"	12.2251945930416	-2.93591310894164	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGAACTCACGATTCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2030.50485965741	38.0464246862289	0.0187374211419756	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2025.91605147134	2025.91605147134
"AML-0693"	"2021-03-09-AML0693:TGGAACTGTGAGCGAT"	-7.06716332855876	-2.74805214321288	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGAACTGTGAGCGAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2081.83231699772	8.46989124138381	0.00406847908557713	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2072.274818794	2072.274818794
"AML-0693"	"2021-03-09-AML0693:TGGAGAGTCCGCAAAT"	-6.99000726166423	-2.7469041577545	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGAGAGTCCGCAAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2385.3208667616	47.959490503983	0.0201060960696221	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2372.3607128176	2372.3607128176
"AML-0693"	"2021-03-09-AML0693:TGGAGGAAGTTCTCTT"	11.8675800758297	-2.9741351834503	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGAGGAAGTTCTCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2086.44072267081	50.2876695083362	0.0241021319043102	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2079.42975294966	2079.42975294966
"AML-0693"	"2021-03-09-AML0693:TGGATCAAGGACCCAA"	14.1547914939815	1.84342477405397	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCAAGGACCCAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1234.60284473262	47.4501586621822	0.0384335406844608	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1221.21103875104	1221.21103875104
"AML-0693"	"2021-03-09-AML0693:TGGATCACAACATCGT"	-6.83708081665691	3.93415734851686	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCACAACATCGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2332.46086462474	39.7272770429455	0.0170323445273913	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2317.70293459143	2317.70293459143
"AML-0693"	"2021-03-09-AML0693:TGGATCACAAGTGGCA"	8.36328758773152	6.04748199069826	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCACAAGTGGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1640.34593931321	43.5792479860515	0.0265671081578667	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1632.44016426024	1632.44016426024
"AML-0693"	"2021-03-09-AML0693:TGGATCACAATGAAAC"	11.0683056312496	-2.55776908313902	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCACAATGAAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1630.21402479282	45.4407143870557	0.0278740789221407	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1620.43475420196	1620.43475420196
"AML-0693"	"2021-03-09-AML0693:TGGATCAGTAGCTGTT"	-7.3279918235844	3.88628981197206	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCAGTAGCTGTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2695.2882129211	30.326881417789	0.0112518139145206	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2671.00458536836	2671.00458536836
"AML-0693"	"2021-03-09-AML0693:TGGATCAGTGTATTCG"	14.2199579673702	2.05767772281495	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATCAGTGTATTCG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1260.10924312092	2.03660656628835	0.00161621429047237	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1254.27212185595	1254.27212185595
"AML-0693"	"2021-03-09-AML0693:TGGATGTAGTCACAGG"	1.18106569823567	9.35244939411012	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATGTAGTCACAGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1749.52618590489	41.5594469659304	0.0237546870122639	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1745.89623394364	1745.89623394364
"AML-0693"	"2021-03-09-AML0693:TGGATGTGTGGTAATA"	9.42894901809041	7.62742898547975	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATGTGTGGTAATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1916.52049864323	43.7570136078805	0.0228314873954428	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1901.44602410956	1901.44602410956
"AML-0693"	"2021-03-09-AML0693:TGGATGTTCTGCTCTG"	-7.519035200507	-3.03194620525511	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGATGTTCTGCTCTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2463.43803938694	28.736826547936	0.0116653336063153	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2443.51159893327	2443.51159893327
"AML-0693"	"2021-03-09-AML0693:TGGCGTGTCTGGCCAG"	-7.04507480087932	-2.68556692516478	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGCGTGTCTGGCCAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2100.76769328709	51.0288147344715	0.0242905557323315	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2082.43625350158	2082.43625350158
"AML-0693"	"2021-03-09-AML0693:TGGGAAGAGGTAGACC"	-3.05644116821941	3.64356086337892	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAAGAGGTAGACC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2065.41564234271	40.8564583339124	0.0197812282895131	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2061.49290049618	2061.49290049618
"AML-0693"	"2021-03-09-AML0693:TGGGAAGCACGTGAGA"	-8.11981425705608	-2.34687998211058	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	52	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.428571428571429	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAAGCACGTGAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1329.16909459024	44.5758777968308	0.0335366493083957	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1327.6046905164	1327.6046905164
"AML-0693"	"2021-03-09-AML0693:TGGGAAGGTATCGTGT"	-7.36224255982097	-2.45129015361937	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAAGGTATCGTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2124.98192828169	33.3006759513425	0.0156710396018615	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2115.02701729332	2115.02701729332
"AML-0693"	"2021-03-09-AML0693:TGGGAAGGTTGCTCCT"	1.5980872112209	-9.97900297557982	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAAGGTTGCTCCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2042.24516925785	41.0553086449984	0.0201030264451148	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2027.3865989874	2027.3865989874
"AML-0693"	"2021-03-09-AML0693:TGGGAGAAGCTCAGAG"	-6.74578795853313	-2.54551913654479	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAGAAGCTCAGAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1842.44504465392	34.4096747168717	0.0186760928455997	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1839.11190817092	1839.11190817092
"AML-0693"	"2021-03-09-AML0693:TGGGAGAGTCACGCTG"	-2.37665424767192	3.56125662410585	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAGAGTCACGCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3236.2216668875	18.7970622987863	0.00580833584148912	4586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3230.92852132531	3230.92852132531
"AML-0693"	"2021-03-09-AML0693:TGGGAGATCTGTGCTC"	-2.65090642395671	3.2900614508423	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGAGATCTGTGCTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3415.20124461261	30.025469627919	0.00879171313119054	4274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3407.77650557493	3407.77650557493
"AML-0693"	"2021-03-09-AML0693:TGGGATTAGGGAGGTG"	-7.63686738434489	-3.50719191944274	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTAGGGAGGTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1837.34309610423	33.08242254163	0.0180055769724096	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1818.262930181	1818.262930181
"AML-0693"	"2021-03-09-AML0693:TGGGATTAGTAGCCAG"	7.79038824614827	6.29411790454713	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTAGTAGCCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1529.26708401071	42.1335703262505	0.0275514792456983	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1525.01944218772	1525.01944218772
"AML-0693"	"2021-03-09-AML0693:TGGGATTGTGGTCTAT"	-7.31003938141521	-3.24141600048216	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTGTGGTCTAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1672.43686588367	26.9633901998413	0.0161222170772914	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1670.20396686912	1670.20396686912
"AML-0693"	"2021-03-09-AML0693:TGGGATTGTTAAGGGC"	-6.84730611267741	3.78894469821779	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTGTTAAGGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2478.53666988003	44.1271776536777	0.017803721925895	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2452.57595456152	2452.57595456152
"AML-0693"	"2021-03-09-AML0693:TGGGATTTCCACTGAA"	-7.8882831138676	-4.44114687359007	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTTCCACTGAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3170.04888824393	43.1040636935292	0.0135972867337724	3349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3157.7791894888	3157.7791894888
"AML-0693"	"2021-03-09-AML0693:TGGGATTTCTTTGATC"	1.02577867087666	-8.29395391857298	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	56	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.285714285714286	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGATTTCTTTGATC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2381.09717816591	49.1048710403711	0.0206227916653931	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2377.03203901951	2377.03203901951
"AML-0693"	"2021-03-09-AML0693:TGGGCGTAGCGACAGT"	-2.70660100403484	3.23076508128969	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGCGTAGCGACAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3499.43913829547	18.557828484509	0.00530308650932796	4974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3489.68125797719	3489.68125797719
"AML-0693"	"2021-03-09-AML0693:TGGGCGTTCCAGTGTA"	-6.83989129486735	-2.63054993068846	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGCGTTCCAGTGTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1719.36840904708	44.8890326616752	0.0261078617156598	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1717.03297322607	1717.03297322607
"AML-0693"	"2021-03-09-AML0693:TGGGCTGAGTCAACAA"	-9.14051661911662	-3.8455381623474	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGCTGAGTCAACAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3233.5919168754	44.0561262455947	0.0136245164442908	2795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3226.5140819428	3226.5140819428
"AML-0693"	"2021-03-09-AML0693:TGGGCTGGTCGAACAG"	6.73153986510579	-1.11308398162993	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGCTGGTCGAACAG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2292.04761646144	45.0694769306601	0.019663412141603	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2290.58629688257	2290.58629688257
"AML-0693"	"2021-03-09-AML0693:TGGGCTGTCCAATCCC"	-7.51464162293132	-2.26497652446898	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGCTGTCCAATCCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2734.66940046407	0.619267762130793	0.000226450686150839	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2714.91510002462	2714.91510002462
"AML-0693"	"2021-03-09-AML0693:TGGGTTAAGAATTGTG"	-7.07162032547649	3.81027958476869	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGTTAAGAATTGTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2281.95251299099	39.2537911774821	0.0172018440147256	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2271.23684688313	2271.23684688313
"AML-0693"	"2021-03-09-AML0693:TGGGTTAAGTCGAATA"	-6.81275592270549	3.84262344920961	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGTTAAGTCGAATA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2404.76471042692	37.6738870650941	0.0156663506004319	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2380.59421242853	2380.59421242853
"AML-0693"	"2021-03-09-AML0693:TGGGTTACACATTACG"	-7.42185006561931	-2.51918914234313	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGTTACACATTACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2923.26776818421	10.9088169008765	0.00373172003591466	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2906.85911842288	2906.85911842288
"AML-0693"	"2021-03-09-AML0693:TGGGTTACACCTCTAC"	-7.19500766220744	-2.90009357845458	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGGTTACACCTCTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2114.72854910423	45.2464071072678	0.0213958463493735	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2101.28746376211	2101.28746376211
"AML-0693"	"2021-03-09-AML0693:TGGTACAAGATGACAT"	10.2076164680416	6.84265229785768	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACAAGATGACAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1736.23039995301	44.3448139418359	0.0255408579086255	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1732.65877344185	1732.65877344185
"AML-0693"	"2021-03-09-AML0693:TGGTACAGTAATACCC"	1.89497377452199	-6.67114021694335	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	3	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000657462195923734	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACAGTAATACCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1656.29709488159	41.8565877683528	0.0252711834716736	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1651.07895987612	1651.07895987612
"AML-0693"	"2021-03-09-AML0693:TGGTACAGTTGCAACT"	-1.67921386185344	3.85068199718324	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACAGTTGCAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3438.89009875172	20.8778184594495	0.00607109208492239	4529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3435.46974560394	3435.46974560394
"AML-0693"	"2021-03-09-AML0693:TGGTACATCAAATGCC"	-2.54674134674724	3.55458448016969	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACATCAAATGCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1479.00261167833	21.6359820804733	0.0146287652973928	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1479.00261167833	1479.00261167833
"AML-0693"	"2021-03-09-AML0693:TGGTACATCGGTTCAA"	-6.9114650291508	3.93806336009828	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACATCGGTTCAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1870.23555617327	46.3622160885026	0.024789506292654	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1859.09232826492	1859.09232826492
"AML-0693"	"2021-03-09-AML0693:TGGTACATCTGCTTAT"	-7.90648446503337	0.469527996424116	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTACATCTGCTTAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2931.15089344376	36.0610122016088	0.0123026802483175	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2924.7684723634	2924.7684723634
"AML-0693"	"2021-03-09-AML0693:TGGTAGTGTATGGGAC"	-7.09667907181438	-2.74214389240416	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTAGTGTATGGGAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2883.87772282837	4.30244271006681	0.00149189498431548	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2870.71030294136	2870.71030294136
"AML-0693"	"2021-03-09-AML0693:TGGTGATAGTTCGCAT"	-7.49640450897868	-2.14623000538024	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTGATAGTTCGCAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2896.06217369803	18.3478465397578	0.00633544635415377	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2879.29092174969	2879.29092174969
"AML-0693"	"2021-03-09-AML0693:TGGTGATGTGAGTAGC"	9.00301136550252	6.30816981876222	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTGATGTGAGTAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1662.08432214518	39.105797074336	0.0235281667441901	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1655.91001179771	1655.91001179771
"AML-0693"	"2021-03-09-AML0693:TGGTGATTCGTCGCTT"	-5.43722234192546	1.758384800795	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTGATTCGTCGCTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1912.95156339035	26.0570447299469	0.0136213823855349	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1900.48038982287	1900.48038982287
"AML-0693"	"2021-03-09-AML0693:TGGTTAGCAAACGGCA"	-2.72229609909709	3.57434079730836	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTTAGCAAACGGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3355.74690003523	15.031014881314	0.00447918610344426	3709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3352.31739338503	3352.31739338503
"AML-0693"	"2021-03-09-AML0693:TGGTTAGGTTGGCCGT"	9.36030258712117	6.75104997241823	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTTAGGTTGGCCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1810.37696310957	46.3988444241395	0.0256293829238984	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1804.64759451224	1804.64759451224
"AML-0693"	"2021-03-09-AML0693:TGGTTAGTCGTGCGAC"	8.73018230971639	6.92252299869386	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGGTTAGTCGTGCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1413.85991371828	46.7100807063163	0.0330372763617539	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1411.65611101248	1411.65611101248
"AML-0693"	"2021-03-09-AML0693:TGTAACGGTTGGCCTG"	9.57831062850301	7.0569219359192	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAACGGTTGGCCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1651.81911144493	46.1560592670172	0.0279425628067967	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.81911144493	1651.81911144493
"AML-0693"	"2021-03-09-AML0693:TGTAAGCAGACATCAA"	-7.74799571457561	-2.58353283321532	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCAGACATCAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1676.54731773274	36.7961700199724	0.0219475881359156	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1667.67473397216	1667.67473397216
"AML-0693"	"2021-03-09-AML0693:TGTAAGCCAAGCTCTA"	9.39286961135213	7.25360391223756	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCCAAGCTCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1681.05578650413	45.150594266468	0.0268584746734443	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1675.1903262932	1675.1903262932
"AML-0693"	"2021-03-09-AML0693:TGTAAGCCAATCACGT"	-7.95413909378703	-4.83051397716673	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCCAATCACGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2163.29683564291	50.3993250622773	0.023297461648299	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2156.95295511993	2156.95295511993
"AML-0693"	"2021-03-09-AML0693:TGTAAGCCATCATCTT"	-0.00852300125415924	11.1641225584778	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCCATCATCTT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2031.89002489912	47.3169431461468	0.0232871575559293	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2024.1738842783	2024.1738842783
"AML-0693"	"2021-03-09-AML0693:TGTAAGCCATCGCCTT"	2.04229785975758	-7.40436937725218	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCCATCGCCTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1495.5926764614	40.1568494729378	0.0268501244389279	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1495.5926764614	1495.5926764614
"AML-0693"	"2021-03-09-AML0693:TGTAAGCGTCAACCAT"	0.831822236149949	11.1172065504822	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCGTCAACCAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1550.99318507084	44.8591102896684	0.0289228287535122	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1548.91082463234	1548.91082463234
"AML-0693"	"2021-03-09-AML0693:TGTAAGCTCCGATGCG"	14.2299133735592	2.03817412937013	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAAGCTCCGATGCG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1192.31861445739	15.0929792484191	0.0126585117982811	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1183.37029473359	1183.37029473359
"AML-0693"	"2021-03-09-AML0693:TGTACAGAGCCTGTGC"	-7.9479754966801	-2.65557672893675	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTACAGAGCCTGTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1550.18505271446	46.8619139532507	0.0302298837620663	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1543.09206894013	1543.09206894013
"AML-0693"	"2021-03-09-AML0693:TGTACAGAGTGCACCC"	-7.04031453552898	-3.05882837688597	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTACAGAGTGCACCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1358.79601429651	20.6390350635853	0.0151892078328407	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1346.55733686194	1346.55733686194
"AML-0693"	"2021-03-09-AML0693:TGTACAGTCGCAGAGA"	-8.34876094284709	-3.81268241321715	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTACAGTCGCAGAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2624.92378225245	52.4760041760064	0.0199914391917988	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2616.5867696571	2616.5867696571
"AML-0693"	"2021-03-09-AML0693:TGTACAGTCGGTCTGG"	9.23998131331746	6.14221618259279	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTACAGTCGGTCTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1554.36015529508	47.7897037251541	0.0307455794992903	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1548.20551592392	1548.20551592392
"AML-0693"	"2021-03-09-AML0693:TGTAGACAGAGAGAAC"	-5.83291612091716	-5.50521995937499	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACAGAGAGAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3608.64127788557	46.8318304168888	0.012977690718078	4711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3601.02181098227	3601.02181098227
"AML-0693"	"2021-03-09-AML0693:TGTAGACAGCTGTGCC"	-6.96428809586223	3.89278814876405	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACAGCTGTGCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2053.72623868732	46.6914710022344	0.0227350024178871	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2043.55312270725	2043.55312270725
"AML-0693"	"2021-03-09-AML0693:TGTAGACGTCGAGCTC"	-6.85556970062907	3.90879128063051	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACGTCGAGCTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2137.70319247366	40.9954983130537	0.0191773574822683	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2111.21180810337	2111.21180810337
"AML-0693"	"2021-03-09-AML0693:TGTAGACTCCGCACTT"	9.52228321608846	6.93689248645631	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACTCCGCACTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1778.3482246596	46.7145572262399	0.0262685094957607	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1769.11494716689	1769.11494716689
"AML-0693"	"2021-03-09-AML0693:TGTAGACTCTTCTTCC"	0.971062620251816	9.52343080127565	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACTCTTCTTCC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1627.67201649537	28.2342108813692	0.0173463760482667	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1623.85870244923	1623.85870244923
"AML-0693"	"2021-03-09-AML0693:TGTAGACTCTTTACAC"	10.881325383752	-2.39322283184203	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTAGACTCTTTACAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1454.11802768004	42.2394157580537	0.029048134301343	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1444.58335900345	1444.58335900345
"AML-0693"	"2021-03-09-AML0693:TGTCAGATCGCATTAG"	0.186028246849221	9.41879746997682	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCAGATCGCATTAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1511.16476747071	38.593575076423	0.0255389590249767	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1508.85141543869	1508.85141543869
"AML-0693"	"2021-03-09-AML0693:TGTCCACAGGTCACCC"	-7.24740157547649	4.04498097980348	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCACAGGTCACCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2102.27559563226	43.6044449294319	0.0207415455043219	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2087.22513795116	2087.22513795116
"AML-0693"	"2021-03-09-AML0693:TGTCCACTCGGAGTGA"	-6.89630637589152	3.93033406818239	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCACTCGGAGTGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1488.961221818	47.1850227870074	0.0316898936625059	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1475.92379329395	1475.92379329395
"AML-0693"	"2021-03-09-AML0693:TGTCCCAAGAACTCCT"	-3.21716461601909	11.818597770575	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCCAAGAACTCCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1743.64540315562	49.4300869356619	0.0283487037250832	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1739.55936270743	1739.55936270743
"AML-0693"	"2021-03-09-AML0693:TGTCCCAGTCCCGTGA"	-7.54405103150066	-3.4926157227722	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCCAGTCCCGTGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1862.48440275806	47.9448967354876	0.0257424420115886	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1843.82595061699	1843.82595061699
"AML-0693"	"2021-03-09-AML0693:TGTCCCATCACCTGGG"	-6.89516768875774	3.88577625835267	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCCATCACCTGGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2530.15197682498	49.8530051639685	0.0197035615332987	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2521.81330407894	2521.81330407894
"AML-0693"	"2021-03-09-AML0693:TGTCCCATCATAGGCT"	-7.22251496735271	-2.5619790784088	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCCATCATAGGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1821.36637709963	34.1427471508205	0.0187456777395824	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1811.76840171135	1811.76840171135
"AML-0693"	"2021-03-09-AML0693:TGTCCTGCATCGCTAA"	-0.600698153406936	12.058606124762	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCTGCATCGCTAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1501.20654918594	39.3730463306826	0.0262276009600634	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1498.72290118693	1498.72290118693
"AML-0693"	"2021-03-09-AML0693:TGTCCTGGTGAGGATC"	-7.74162946167644	-3.10180642521056	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCTGGTGAGGATC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2947.64010962009	31.9423865907372	0.0108365965324221	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2914.9574447113	2914.9574447113
"AML-0693"	"2021-03-09-AML0693:TGTCCTGGTTGCTTGA"	-2.85704479637797	3.30212304675905	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTCCTGGTTGCTTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2570.22863596246	0.821462409480191	0.000319606745480283	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2564.81513259779	2564.81513259779
"AML-0693"	"2021-03-09-AML0693:TGTGAGTCATTGCCGG"	-7.25237594071086	2.36986515605775	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGAGTCATTGCCGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2535.41857500556	40.7263986956742	0.0160629882170777	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2525.72277131762	2525.72277131762
"AML-0693"	"2021-03-09-AML0693:TGTGAGTGTCGTACTA"	-2.31373415413554	3.46545503223268	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGAGTGTCGTACTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3331.7430667389	26.0706540073465	0.00782492931931405	5073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3325.96485758155	3325.96485758155
"AML-0693"	"2021-03-09-AML0693:TGTGCGGAGGGTGGGA"	-7.1304181617802	3.47500107372133	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGCGGAGGGTGGGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2702.44390746395	40.5513396032591	0.0150054324869646	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2686.92308803544	2686.92308803544
"AML-0693"	"2021-03-09-AML0693:TGTGCGGGTAACCAGG"	-7.71875701370891	-2.62283875858458	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGCGGGTAACCAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2011.62259568723	37.7665469374781	0.018774171168313	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1991.14904689045	1991.14904689045
"AML-0693"	"2021-03-09-AML0693:TGTGCGGGTTGGTAGG"	9.26218380507771	6.33976934039918	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGCGGGTTGGTAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1662.21123107065	44.9085955980148	0.0270173818817771	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1658.18411044259	1658.18411044259
"AML-0693"	"2021-03-09-AML0693:TGTGTGACAGCTTTGA"	-9.47477469864543	-2.83779838001402	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGTGACAGCTTTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3076.01998799044	50.8650556183066	0.0165359964554511	2825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3058.81178244762	3058.81178244762
"AML-0693"	"2021-03-09-AML0693:TGTGTGAGTGGGAGAG"	0.130983484059018	11.2489633330139	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGTGAGTGGGAGAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1888.37320679271	47.2711929137781	0.0250327598081448	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1884.21232196647	1884.21232196647
"AML-0693"	"2021-03-09-AML0693:TGTGTGAGTGGTTTGT"	-6.97083888474162	3.84183857524721	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGTGAGTGGTTTGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2176.13068031054	32.0156512199288	0.0147121914642369	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2159.39815133637	2159.39815133637
"AML-0693"	"2021-03-09-AML0693:TGTGTGATCCATAGGT"	9.22045483168904	7.20848414981691	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGTGATCCATAGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1783.45202717958	49.5478274054872	0.0277819793582248	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1777.61576306251	1777.61576306251
"AML-0693"	"2021-03-09-AML0693:TGTGTGATCCGAGATT"	8.15900387343709	6.39629314029542	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTGTGATCCGAGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1758.15227487437	42.4808614734797	0.0241622196669598	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1756.17518213832	1756.17518213832
"AML-0693"	"2021-03-09-AML0693:TGTTACTAGACAACTA"	1.26377727565114	-10.3046941987244	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTACTAGACAACTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2356.05427184862	40.9888733038554	0.0173972534476867	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2349.70713039412	2349.70713039412
"AML-0693"	"2021-03-09-AML0693:TGTTACTAGATGTTGA"	-4.96592173996623	8.86673448169557	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTACTAGATGTTGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1771.19445554978	45.2192578101604	0.0255303745269033	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1766.58939512025	1766.58939512025
"AML-0693"	"2021-03-09-AML0693:TGTTACTGTGGCTTAT"	-8.6318887275761	-3.11191489612731	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTACTGTGGCTTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2982.88656643297	44.3785152720799	0.0148777079797403	3579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2972.80671004489	2972.80671004489
"AML-0693"	"2021-03-09-AML0693:TGTTACTGTTAGCGGA"	-8.68841681900676	-2.99375488674315	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTACTGTTAGCGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3102.96039778639	48.3010205061307	0.015566109235744	3280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3097.98255257551	3097.98255257551
"AML-0693"	"2021-03-09-AML0693:TGTTCATAGGAAAGTG"	8.35129513320271	6.43926951968995	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCATAGGAAAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1583.23106086871	45.8172886650631	0.0289391042138368	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1581.26994539692	1581.26994539692
"AML-0693"	"2021-03-09-AML0693:TGTTCATTCGCAACAT"	-7.70397601547893	-2.66055085575255	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCATTCGCAACAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2042.19412152489	48.5607317205571	0.0237787050744701	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2030.90052851186	2030.90052851186
"AML-0693"	"2021-03-09-AML0693:TGTTCATTCTGGGTCG"	-6.86299453201945	3.8280081518921	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCATTCTGGGTCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1921.73381713936	49.3118986692899	0.0256601087151051	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1911.30277303265	1911.30277303265
"AML-0693"	"2021-03-09-AML0693:TGTTCATTCTTAAGGC"	-2.72441182556804	3.48539612377015	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCATTCTTAAGGC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2349.25954968903	2.9593120495797	0.00125967862936704	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2346.85394256327	2346.85394256327
"AML-0693"	"2021-03-09-AML0693:TGTTCCGAGGGCATGT"	-6.98715291443523	3.97548863971559	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCCGAGGGCATGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2259.02864903672	43.3719373386062	0.0191993746325885	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2248.03850101017	2248.03850101017
"AML-0693"	"2021-03-09-AML0693:TGTTCCGAGTGTAGAT"	8.37158169326131	6.26247260654298	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCCGAGTGTAGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1576.8988518793	44.9157787272917	0.028483614325524	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1570.66786702316	1570.66786702316
"AML-0693"	"2021-03-09-AML0693:TGTTCCGTCATGGAGG"	6.84902061995809	-0.617576145288073	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCCGTCATGGAGG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	1996.86519926873	48.3589309818283	0.024217423889974	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1989.27102845843	1989.27102845843
"AML-0693"	"2021-03-09-AML0693:TGTTCCGTCTCCGAAA"	-8.53604255142863	-3.65589072620543	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCCGTCTCCGAAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2753.3655784053	50.948578845516	0.0185041097503022	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2749.70421584898	2749.70421584898
"AML-0693"	"2021-03-09-AML0693:TGTTCTAAGGCTAGCA"	-4.19225726547893	3.37537691676942	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCTAAGGCTAGCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2937.60725174484	14.5539455565438	0.00495435376798557	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2927.83967327997	2927.83967327997
"AML-0693"	"2021-03-09-AML0693:TGTTCTAGTGTTGCCG"	0.133462597697419	11.2239494093689	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCTAGTGTTGCCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1951.1762374018	38.6006904045024	0.0197832925927303	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1947.29328154056	1947.29328154056
"AML-0693"	"2021-03-09-AML0693:TGTTCTATCTTCCGTG"	-1.73834274235423	3.83483359897462	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTCTATCTTCCGTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3069.79316841333	21.1759883450682	0.00689818081653145	3268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3064.77960208142	3064.77960208142
"AML-0693"	"2021-03-09-AML0693:TGTTGAGAGATGCTGG"	14.1083456474239	1.74562702262727	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGAGATGCTGG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1422.64108702878	2.20544871636393	0.00155024955800346	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1410.9931892478	1410.9931892478
"AML-0693"	"2021-03-09-AML0693:TGTTGAGAGGAAAGTG"	9.81424488601033	6.48253772342531	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGAGGAAAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1806.87841843263	47.0064235826621	0.0260152664967007	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1799.6196276743	1799.6196276743
"AML-0693"	"2021-03-09-AML0693:TGTTGAGAGGACTGGT"	1.09525873240773	-9.52361109172972	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGAGGACTGGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1889.15246939288	50.1409827415774	0.0265415224837259	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1871.79552073671	1871.79552073671
"AML-0693"	"2021-03-09-AML0693:TGTTGAGCACATATCG"	-7.08454118195232	-2.86181666767272	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGCACATATCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2950.66105651791	29.0224785376552	0.00983592421553994	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2934.90189559105	2934.90189559105
"AML-0693"	"2021-03-09-AML0693:TGTTGAGCATGCAGGA"	11.8777691322262	-2.56686665928038	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGCATGCAGGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1758.33337211447	38.9165461758157	0.0221326324080495	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1753.87839691021	1753.87839691021
"AML-0693"	"2021-03-09-AML0693:TGTTGAGTCTCAGAAC"	-6.99546227875407	3.96359083736268	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGAGTCTCAGAAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2380.230277251	48.0012879516838	0.0201666571551732	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2363.78659316999	2363.78659316999
"AML-0693"	"2021-03-09-AML0693:TGTTGGACAGCACGAA"	-1.71972463551219	10.7834653624329	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGGACAGCACGAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1762.8416642243	50.4101236617939	0.028595945220058	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1760.81863324318	1760.81863324318
"AML-0693"	"2021-03-09-AML0693:TGTTGGATCGCCGTGA"	0.955686290829819	-8.83977129375609	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTGGATCGCCGTGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2859.89062461917	47.2095563965957	0.0165074691983657	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2852.62849755564	2852.62849755564
"AML-0693"	"2021-03-09-AML0693:TGTTTGTCAGTGGTGA"	-7.11244950714763	-2.78856661235961	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTTGTCAGTGGTGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2201.57698159839	44.9555539567871	0.0204197056621424	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2194.22753566114	2194.22753566114
"AML-0693"	"2021-03-09-AML0693:TGTTTGTGTCATCGGC"	-8.16116557541545	-4.12298920070799	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTTGTGTCATCGGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2664.46730095555	49.046644168052	0.018407673515251	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2654.35424262337	2654.35424262337
"AML-0693"	"2021-03-09-AML0693:TGTTTGTTCGTGACTA"	0.856336017220658	9.51378629291383	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTTGTTCGTGACTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1493.26342937618	48.14979591724	0.0322446763042706	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1486.19855979985	1486.19855979985
"AML-0693"	"2021-03-09-AML0693:TGTTTGTTCGTTGTTT"	-8.47625575485881	-4.25841047680052	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TGTTTGTTCGTTGTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2543.47515973894	50.9878262936901	0.0200465202494541	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2534.97772513684	2534.97772513684
"AML-0693"	"2021-03-09-AML0693:TTAATCCCAAAGGAGA"	9.57815804061238	7.48552987659303	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCCAAAGGAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1629.06715072145	51.4030663712927	0.0315536817181098	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1621.44994068435	1621.44994068435
"AML-0693"	"2021-03-09-AML0693:TTAATCCGTAGTGCGA"	8.03036655959431	7.07479379260866	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCGTAGTGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1718.61219143975	36.6098155656705	0.0213019643105179	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1716.44908454266	1716.44908454266
"AML-0693"	"2021-03-09-AML0693:TTAATCCGTTCGTGCG"	9.5355392890865	7.35824916446535	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCGTTCGTGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1630.49315540789	45.6908457481717	0.0280227154567488	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1625.64240118723	1625.64240118723
"AML-0693"	"2021-03-09-AML0693:TTAATCCTCATTTACC"	-1.97220454636272	10.2751254805359	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCTCATTTACC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2017.39740940909	38.8060452488513	0.0192356969766397	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2009.9559207504	2009.9559207504
"AML-0693"	"2021-03-09-AML0693:TTAATCCTCTGAATCG"	-7.24712739411052	-2.16541173374327	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	57	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCTCTGAATCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3224.73338792666	52.0329896675062	0.0161355942982191	4486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3213.09241057021	3213.09241057021
"AML-0693"	"2021-03-09-AML0693:TTAATCCTCTGAGAGG"	-6.89163384857829	-2.6787901154724	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAATCCTCTGAGAGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1402.05616490231	35.7408816423888	0.0254917616976344	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1384.21196257575	1384.21196257575
"AML-0693"	"2021-03-09-AML0693:TTACAGGAGGCCCGTT"	8.36040272292439	6.35963628375856	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACAGGAGGCCCGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1518.18559104073	53.607593513679	0.0353103031869316	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1516.13074980247	1516.13074980247
"AML-0693"	"2021-03-09-AML0693:TTACAGGTCAAAGGTA"	-6.99312673035319	3.52542946422426	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACAGGTCAAAGGTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2373.09503359777	38.4384988368652	0.0161976230587739	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2365.63161511829	2365.63161511829
"AML-0693"	"2021-03-09-AML0693:TTACAGGTCGACCACG"	14.2493196922237	2.15164921367494	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACAGGTCGACCACG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1145.59000903521	0.219829885695675	0.000191892286037665	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1132.78147548546	1132.78147548546
"AML-0693"	"2021-03-09-AML0693:TTACCATGTTCTTCAT"	-6.96236358109172	-2.66939856922301	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACCATGTTCTTCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1713.00796141839	48.8507682779424	0.0285175372083464	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1713.00796141839	1713.00796141839
"AML-0693"	"2021-03-09-AML0693:TTACCATTCCTTATCA"	-7.69272551956828	-4.88601162349852	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACCATTCCTTATCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2478.81792429005	41.3704591965924	0.0166895917571038	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2472.64583077766	2472.64583077766
"AML-0693"	"2021-03-09-AML0693:TTACCATTCGCACGGT"	-2.26339993897136	3.70853731716005	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACCATTCGCACGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1658.47304096268	46.7684275843305	0.0281996911792931	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1656.19559876443	1656.19559876443
"AML-0693"	"2021-03-09-AML0693:TTACCGCAGAAGCGAA"	-6.93568787995036	3.58925411784974	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACCGCAGAAGCGAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2406.89840866118	37.8909542161192	0.0157426479155785	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2394.19747060174	2394.19747060174
"AML-0693"	"2021-03-09-AML0693:TTACCGCTCCACAGGC"	-6.99383244934733	-2.63604452526244	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACCGCTCCACAGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1974.11477152267	33.2112480660352	0.0168233623217452	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1943.58174019737	1943.58174019737
"AML-0693"	"2021-03-09-AML0693:TTACGCCCAGGTGTTT"	8.84543575820271	6.73458621585695	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGCCCAGGTGTTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1840.99800783015	41.0247265400339	0.0222839603114979	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1836.05704534412	1836.05704534412
"AML-0693"	"2021-03-09-AML0693:TTACGTTCAAGCCTGC"	11.6069780784542	-2.68207075512084	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTCAAGCCTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1625.28246673132	47.5153510298435	0.029235134201259	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1625.28246673132	1625.28246673132
"AML-0693"	"2021-03-09-AML0693:TTACGTTCAAGTGACG"	6.68378414687459	-0.806018733140551	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTCAAGTGACG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2239.99809847118	38.7613598137219	0.0173041931777428	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2229.97808148469	2229.97808148469
"AML-0693"	"2021-03-09-AML0693:TTACGTTCAAGTGATA"	-0.471993665129501	10.6982307204041	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTCAAGTGATA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1827.16436857293	51.0250708337228	0.0279258241411389	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1823.16302820796	1823.16302820796
"AML-0693"	"2021-03-09-AML0693:TTACGTTCATCCTCAC"	10.8803831535274	-2.70843579685362	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTCATCCTCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1676.05047437474	47.8610219805383	0.0285558357056002	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1674.04569466209	1674.04569466209
"AML-0693"	"2021-03-09-AML0693:TTACGTTGTGGTCTCG"	14.3312784629757	2.08095738971559	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTGTGGTCTCG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1224.2621528128	8.57560968172343	0.00700471681005622	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1208.72702344011	1208.72702344011
"AML-0693"	"2021-03-09-AML0693:TTACGTTGTGTACAGG"	-2.56862531128581	3.40513298595277	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACGTTGTGTACAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3406.19814142617	36.5826916875876	0.0107400363010798	4620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3398.09476335515	3398.09476335515
"AML-0693"	"2021-03-09-AML0693:TTACTGTAGACCGTTT"	-1.57090340080913	-6.9857444993225	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACTGTAGACCGTTT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2432.97426077655	42.0705557469601	0.0172918211364605	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2427.32645038725	2427.32645038725
"AML-0693"	"2021-03-09-AML0693:TTACTGTAGGATCATA"	0.772933025925797	9.33337781513063	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACTGTAGGATCATA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1382.310856379	45.4310125729265	0.0328659884014326	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1366.50220198916	1366.50220198916
"AML-0693"	"2021-03-09-AML0693:TTACTGTGTGCAATAA"	-1.79143462601359	3.73507354343263	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTACTGTGTGCAATAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3226.8703229023	23.9806743168398	0.00743155810961475	3881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3217.27716742027	3217.27716742027
"AML-0693"	"2021-03-09-AML0693:TTAGGCATCTTCTCAA"	10.5774027305538	6.28047368610231	"2021-03-09-AML0693"	"AML0693"	"Pre-B"	"Pre-B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGGCATCTTCTCAA"	"Pre-B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1863.71579024377	34.9160268222981	0.0187346305724711	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1850.95742734965	1850.95742734965
"AML-0693"	"2021-03-09-AML0693:TTAGGGTCAACCTATG"	-7.76144729080852	-2.64356019413146	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGGGTCAACCTATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2059.12263453886	37.1642705594939	0.0180485950356312	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2047.34479132139	2047.34479132139
"AML-0693"	"2021-03-09-AML0693:TTAGGGTCACAAGCTT"	-1.91417978230174	3.49173567378847	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGGGTCACAAGCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3275.7503335095	27.134790745797	0.00828353445261682	4394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3268.51658382597	3268.51658382597
"AML-0693"	"2021-03-09-AML0693:TTAGGGTGTGGTCCGT"	-7.38035235825236	-2.8848116627899	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGGGTGTGGTCCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2584.52983901787	1.36760766049247	0.000529151430115493	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2571.2778715431	2571.2778715431
"AML-0693"	"2021-03-09-AML0693:TTAGTCTAGCCTCATA"	-8.45187697830852	-3.43282344257506	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTAGCCTCATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2936.44421119812	49.2944687268164	0.016787129324246	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2926.85751049183	2926.85751049183
"AML-0693"	"2021-03-09-AML0693:TTAGTCTAGGTTCCAT"	-2.48461447182353	3.358371711615	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTAGGTTCCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3233.16417045191	37.5407206698854	0.0116111396423888	4515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3227.52415347746	3227.52415347746
"AML-0693"	"2021-03-09-AML0693:TTAGTCTCAACCCGCA"	8.51058544692342	6.19332168186036	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTCAACCCGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1618.75391622432	51.244006276125	0.031656452387556	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1614.46552057999	1614.46552057999
"AML-0693"	"2021-03-09-AML0693:TTAGTCTCAAGGTCAG"	-2.15660033646281	3.73372552478639	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTCAAGGTCAG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1405.33149016505	43.7486646998785	0.0311304948377271	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1400.23966165254	1400.23966165254
"AML-0693"	"2021-03-09-AML0693:TTAGTCTCATCGGTTA"	14.2021032768184	1.95573220336763	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTCATCGGTTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1353.69372104556	3.70640273818915	0.00273799211783772	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1346.63300857615	1346.63300857615
"AML-0693"	"2021-03-09-AML0693:TTAGTCTGTGAGACGT"	-8.66876922074016	-4.39494135296019	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTAGTCTGTGAGACGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2519.28176092028	47.4327935784772	0.0188279033787591	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2515.20795240857	2515.20795240857
"AML-0693"	"2021-03-09-AML0693:TTATTGCGTGCGCTCA"	11.9487186866695	-2.92630984699401	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTATTGCGTGCGCTCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1626.03566109075	46.2982224840441	0.0284730670992708	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1608.55988086884	1608.55988086884
"AML-0693"	"2021-03-09-AML0693:TTCAATCAGAACTTCC"	8.38614716109578	7.04329822147218	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAATCAGAACTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1899.74775201587	43.1790049950781	0.0227288096270991	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1889.80710167237	1889.80710167237
"AML-0693"	"2021-03-09-AML0693:TTCAATCCACTCCACT"	11.5168682533199	-2.97636797344359	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAATCCACTCCACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1618.734819686	48.3443287851417	0.0298655024882455	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1618.734819686	1618.734819686
"AML-0693"	"2021-03-09-AML0693:TTCAATCCATGGAACG"	-8.73753867569621	-2.99641778385314	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAATCCATGGAACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1664.49228242556	42.9898407271596	0.0258275999120364	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1660.74812814588	1660.74812814588
"AML-0693"	"2021-03-09-AML0693:TTCAATCGTGGTCAAG"	8.93269505080525	6.37790582263795	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAATCGTGGTCAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1622.42161984179	36.5825647629657	0.0225481245537969	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1611.74144783804	1611.74144783804
"AML-0693"	"2021-03-09-AML0693:TTCAATCTCTTTCAGT"	-8.75885425034221	-3.98328354274901	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAATCTCTTTCAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3011.69513994442	50.4234875979875	0.0167425603372717	2746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2997.86640349728	2997.86640349728
"AML-0693"	"2021-03-09-AML0693:TTCACCGGTCGGCACT"	14.09894814071	1.81817588889924	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCACCGGTCGGCACT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1138.13604485106	3.36437331681429	0.00295603792888799	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1117.72448351614	1117.72448351614
"AML-0693"	"2021-03-09-AML0693:TTCACCGGTGACGTCC"	6.8009201484615	-1.15816965019377	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCACCGGTGACGTCC"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2431.66265276437	44.0571764056551	0.0181181284976228	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2428.41452833163	2428.41452833163
"AML-0693"	"2021-03-09-AML0693:TTCACCGGTGGATCGA"	8.43235840377156	6.97155997836915	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCACCGGTGGATCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1709.27415078715	41.7791122654156	0.0244426046261657	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1695.29062485474	1695.29062485474
"AML-0693"	"2021-03-09-AML0693:TTCACGCGTGGTTTAC"	-4.79500518265422	-5.57925178920897	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCACGCGTGGTTTAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3221.59837578381	43.8324529715634	0.0136058092470633	3920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3213.27977539374	3213.27977539374
"AML-0693"	"2021-03-09-AML0693:TTCAGGAAGTTCCATG"	-8.47820125046428	-4.13681652462157	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAGGAAGTTCCATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2621.21219559956	51.8670267074988	0.0197874200320646	2198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2613.49530904681	2613.49530904681
"AML-0693"	"2021-03-09-AML0693:TTCAGGATCGGTTGTA"	-6.83096633377727	3.90835640514223	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAGGATCGGTTGTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2053.93144133187	42.9834521616406	0.0209274035621014	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2041.6116583718	2041.6116583718
"AML-0693"	"2021-03-09-AML0693:TTCAGGATCGTGCACG"	-1.8074554008549	11.4520902403626	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAGGATCGTGCACG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1879.24704236812	42.6798456291992	0.0227111415726463	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1871.47227449774	1871.47227449774
"AML-0693"	"2021-03-09-AML0693:TTCAGGATCTACTGCC"	11.4348894554073	-1.83227481758269	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCAGGATCTACTGCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1391.71666315477	53.0372849413452	0.0381092548113345	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1391.71666315477	1391.71666315477
"AML-0693"	"2021-03-09-AML0693:TTCATGTCAAACACCT"	-1.97602448883708	4.06774327838746	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATGTCAAACACCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3349.74471701634	12.2001099457146	0.00364210140663536	5342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3343.98655851059	3343.98655851059
"AML-0693"	"2021-03-09-AML0693:TTCATGTGTTGGGTTT"	-8.22460875931438	-4.8385277024475	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATGTGTTGGGTTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2448.35561100135	45.5578367810208	0.0186075244038541	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2437.31659874178	2437.31659874178
"AML-0693"	"2021-03-09-AML0693:TTCATTGAGCTCGGCT"	14.2404457527095	1.85513255679933	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGAGCTCGGCT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1369.8340892331	4.21399840260926	0.00307628378920578	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1347.29241441803	1347.29241441803
"AML-0693"	"2021-03-09-AML0693:TTCATTGCAACATCGT"	-6.98632464829143	2.77192876422731	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGCAACATCGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2677.12651627057	43.0431261379726	0.0160781068344632	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2672.68584963839	2672.68584963839
"AML-0693"	"2021-03-09-AML0693:TTCATTGGTAGATTGA"	-7.1743348640507	-2.90923359310301	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGGTAGATTGA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2913.29647930103	2.48303477137052	0.000852311046614197	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2899.59902889303	2899.59902889303
"AML-0693"	"2021-03-09-AML0693:TTCATTGGTCGCGTCA"	-8.7008994621342	0.344029314163603	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGGTCGCGTCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2759.3856343062	39.6445744498304	0.0143671743292954	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2731.18547367872	2731.18547367872
"AML-0693"	"2021-03-09-AML0693:TTCATTGGTCTAGGTT"	-7.91534123840983	-2.83506228840026	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGGTCTAGGTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1685.51418348897	45.0484431770503	0.026726825332197	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1685.51418348897	1685.51418348897
"AML-0693"	"2021-03-09-AML0693:TTCATTGGTGAATATG"	14.2170874076778	1.9863847264084	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGGTGAATATG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1132.80224411185	10.5732825025978	0.00933374078093172	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1127.21353982439	1127.21353982439
"AML-0693"	"2021-03-09-AML0693:TTCATTGTCAACTTTC"	7.91730370101277	7.9783577688965	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGTCAACTTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1813.63192718662	48.1097032094514	0.0265267182873656	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1806.23467869151	1806.23467869151
"AML-0693"	"2021-03-09-AML0693:TTCATTGTCTGCCTCA"	-6.72557197037395	-2.81538298046263	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCATTGTCTGCCTCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1550.24507685571	46.291616828951	0.0298608378249728	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1537.06169906247	1537.06169906247
"AML-0693"	"2021-03-09-AML0693:TTCCAATCAATTGCTG"	11.8992325263912	-2.7796156636444	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCAATCAATTGCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1522.50235880702	38.4871822408029	0.0252788982678228	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1517.68012729334	1517.68012729334
"AML-0693"	"2021-03-09-AML0693:TTCCAATTCCCTGTTG"	14.1219107109005	1.87856290424196	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCAATTCCCTGTTG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1141.3913929975	23.832724265341	0.0208804135124517	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1125.26170483029	1125.26170483029
"AML-0693"	"2021-03-09-AML0693:TTCCACGAGAGTCACG"	-8.30678973618205	-0.412001811620318	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCACGAGAGTCACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2966.35097015019	39.9306928047542	0.0134612165608753	2975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2945.80472730237	2945.80472730237
"AML-0693"	"2021-03-09-AML0693:TTCCACGAGCAGTAAT"	11.0631281333858	-2.47831394588622	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCACGAGCAGTAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1638.88650564386	43.5999385489487	0.0266033910211616	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1631.26585432389	1631.26585432389
"AML-0693"	"2021-03-09-AML0693:TTCCACGGTCGTTATG"	8.51368107375447	7.1932048567566	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCACGGTCGTTATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.10549034204	44.9833008708993	0.0248649407737934	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1805.62342485249	1805.62342485249
"AML-0693"	"2021-03-09-AML0693:TTCCACGGTCGTTGCG"	-2.40690932694133	3.3536715277466	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCACGGTCGTTGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3198.09129085661	22.6625887880012	0.00708628576451019	4499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3191.595590102	3191.595590102
"AML-0693"	"2021-03-09-AML0693:TTCCACGTCTAGTCAG"	9.02956451949422	6.27897451007692	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCACGTCTAGTCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1407.82033114777	46.4731200925331	0.0330106896912366	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1395.19475572832	1395.19475572832
"AML-0693"	"2021-03-09-AML0693:TTCCGGTAGCCTAGGA"	-7.84177051010783	-4.00014974987181	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTAGCCTAGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2441.86799585909	1.86111460051271	0.000762168390620941	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2416.6287486223	2416.6287486223
"AML-0693"	"2021-03-09-AML0693:TTCCGGTCACGACTAT"	12.2212988334591	-2.68007781421813	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTCACGACTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1406.65346940966	40.4798191027461	0.0287773925725536	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1401.83284673762	1401.83284673762
"AML-0693"	"2021-03-09-AML0693:TTCCGGTCAGGCTTGC"	0.573400993912858	-9.22088911449584	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTCAGGCTTGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3122.65523093525	42.9972884372701	0.0137694638880746	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3108.44772701251	3108.44772701251
"AML-0693"	"2021-03-09-AML0693:TTCCGGTGTCGTGGAA"	14.084601064294	1.74281606757966	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTGTCGTGGAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1369.78914891132	17.5706981809407	0.0128273013367828	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1359.10265663052	1359.10265663052
"AML-0693"	"2021-03-09-AML0693:TTCCGGTGTGGACAGT"	-6.82851729813274	-2.59294536029967	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTGTGGACAGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1713.66567407409	30.1793892398685	0.0176110134528864	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1709.36273823546	1709.36273823546
"AML-0693"	"2021-03-09-AML0693:TTCCGGTTCCGGTAGC"	12.0945221382076	-2.50309922611388	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGGTTCCGGTAGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1633.50186341019	44.8940738828695	0.0274833319070393	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1621.0855476294	1621.0855476294
"AML-0693"	"2021-03-09-AML0693:TTCCGTGAGAAACCAT"	-1.57011888447459	9.33071611011354	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGAGAAACCAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1980.8092586548	40.6821798730017	0.020538161206208	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1971.71185913178	1971.71185913178
"AML-0693"	"2021-03-09-AML0693:TTCCGTGAGGAGGCAG"	0.664797325699967	-9.02535536205443	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGAGGAGGCAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2877.37780785408	47.5160638291393	0.0165136686949623	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2866.33811449307	2866.33811449307
"AML-0693"	"2021-03-09-AML0693:TTCCGTGAGTGCTAGG"	0.0930029238456904	11.3910074003967	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGAGTGCTAGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1695.10800755165	54.451323304633	0.0321226276213989	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1682.3882603555	1682.3882603555
"AML-0693"	"2021-03-09-AML0693:TTCCGTGCAGCTGTAT"	-2.44019089165385	3.27299091899721	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGCAGCTGTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3463.92438289766	21.7280973044353	0.00627268234021297	4465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3456.23590583344	3456.23590583344
"AML-0693"	"2021-03-09-AML0693:TTCCGTGCATTCTGTT"	-6.83356175842937	3.86588523471681	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGCATTCTGTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1905.59365637627	50.5587652102631	0.0265317661197546	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1881.05526136766	1881.05526136766
"AML-0693"	"2021-03-09-AML0693:TTCCGTGGTGGAGAAA"	-2.29070029678996	3.36359379375306	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGGTGGAGAAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3118.00761151051	31.3117977483439	0.0100422454495469	4398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3113.90694389699	3113.90694389699
"AML-0693"	"2021-03-09-AML0693:TTCCGTGTCCTGCTAC"	14.2847753959591	2.00827322089998	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCGTGTCCTGCTAC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1461.71568158354	4.30770373536922	0.00294701889679565	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1446.89131680971	1446.89131680971
"AML-0693"	"2021-03-09-AML0693:TTCCTAAAGATCACCT"	14.279578824609	2.13710758769838	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTAAAGATCACCT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1214.70060084295	4.74356783859772	0.00390513335986322	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1191.20966247676	1191.20966247676
"AML-0693"	"2021-03-09-AML0693:TTCCTAACAAGAGGCT"	-7.57177720490153	-3.3948762646881	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTAACAAGAGGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1735.61337436985	27.9592388595892	0.0161091400149762	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1709.87345466059	1709.87345466059
"AML-0693"	"2021-03-09-AML0693:TTCCTAAGTGAGATAT"	8.26232399520222	6.32330081546632	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTAAGTGAGATAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1676.19128225872	44.2892649056239	0.0264225601065904	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1672.24699233472	1672.24699233472
"AML-0693"	"2021-03-09-AML0693:TTCCTCTAGGTATTGA"	-7.44133410874065	-1.53185477173003	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTCTAGGTATTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2899.69046840657	40.434201154433	0.0139443163313401	2675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2887.94637280868	2887.94637280868
"AML-0693"	"2021-03-09-AML0693:TTCCTCTCATTATGCG"	11.0300318199093	-3.07960226452025	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTCTCATTATGCG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1990.65759529047	43.1842684126563	0.0216934687888175	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1980.17876763076	1980.17876763076
"AML-0693"	"2021-03-09-AML0693:TTCCTCTGTACAGAAT"	-8.46463809433635	-4.3408527604309	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTCTGTACAGAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2736.13147773045	50.8536829019699	0.0185859792615492	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2722.73112570306	2722.73112570306
"AML-0693"	"2021-03-09-AML0693:TTCCTCTGTTATCCAG"	-7.15243134918864	-2.79052379047545	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTCTGTTATCCAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2777.92267304	0.271536017287144	9.77478674703319e-05	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2761.45025499218	2761.45025499218
"AML-0693"	"2021-03-09-AML0693:TTCCTCTTCAGACCTA"	11.9780632453853	-3.1235013238159	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTCTTCAGACCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2565.98187103428	37.1228967420364	0.0144673261962966	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2559.67854509881	2559.67854509881
"AML-0693"	"2021-03-09-AML0693:TTCCTTCAGTTGGCGA"	0.274593939154786	11.650496459845	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTTCAGTTGGCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1666.45565019936	40.2654259748022	0.0241623147726645	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1657.52606478596	1657.52606478596
"AML-0693"	"2021-03-09-AML0693:TTCCTTCCACTGTGAT"	-5.74455056610759	-5.55273010646971	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTTCCACTGTGAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3261.8121332578	40.7621083335506	0.0124967676457929	3145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3257.63081878491	3257.63081878491
"AML-0693"	"2021-03-09-AML0693:TTCCTTCCAGGATCTT"	-7.94042239609416	-4.58249285137328	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTTCCAGGATCTT"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2709.78753268762	50.799917706965	0.0187468268615808	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2693.19445198758	2693.19445198758
"AML-0693"	"2021-03-09-AML0693:TTCCTTCCAGTTTCGA"	-7.7011436027592	-4.63566400921019	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCCTTCCAGTTTCGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2659.3391715587	49.179524446448	0.0184931373073495	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2653.47735869236	2653.47735869236
"AML-0693"	"2021-03-09-AML0693:TTCGATTAGCATCCCG"	8.10693230208699	6.87775323474733	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTAGCATCCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1789.166197837	44.8416657995739	0.0250628845178189	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1781.51601756346	1781.51601756346
"AML-0693"	"2021-03-09-AML0693:TTCGATTAGGTAGCAC"	-3.67856202545818	-6.09248735820922	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTAGGTAGCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3190.81653207508	51.3991073008041	0.0161084496034555	3122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3184.08483713282	3184.08483713282
"AML-0693"	"2021-03-09-AML0693:TTCGATTAGTCCTGTA"	9.97552837905232	6.32518241489259	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTAGTCCTGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1663.16370733365	46.3231168111521	0.0278524096015878	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1655.67592572167	1655.67592572167
"AML-0693"	"2021-03-09-AML0693:TTCGATTCAGAATTCC"	-6.96380172196086	-2.58490731632384	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTCAGAATTCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1413.31481067531	17.8639414867945	0.0126397468928092	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1403.10756619504	1403.10756619504
"AML-0693"	"2021-03-09-AML0693:TTCGATTTCCCTTGGT"	-7.06282458725627	-2.73794486438902	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTTCCCTTGGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1765.8429077652	18.3452161405078	0.0103889287432283	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1753.89370356703	1753.89370356703
"AML-0693"	"2021-03-09-AML0693:TTCGATTTCGTTGTAG"	-9.1292031807011	-3.91774132167967	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTTCGTTGTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2748.77677409974	38.3581909905496	0.0139546402428813	2920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2741.73187338097	2741.73187338097
"AML-0693"	"2021-03-09-AML0693:TTCGATTTCTCCGCAT"	8.02513517913167	6.95219752872316	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGATTTCTCCGCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1706.07625876332	44.942014091805	0.0263423243017179	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1700.33540838793	1700.33540838793
"AML-0693"	"2021-03-09-AML0693:TTCGCTGGTATGCAAA"	-6.85247168961223	3.88019750202028	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGCTGGTATGCAAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2438.78544388062	49.1920671365595	0.0201707236116206	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2424.48913066165	2424.48913066165
"AML-0693"	"2021-03-09-AML0693:TTCGCTGGTGCGAACA"	-6.80717120590861	4.00152657115785	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGCTGGTGCGAACA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2052.78109950852	33.6866614004349	0.0164102550478959	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2043.03055566288	2043.03055566288
"AML-0693"	"2021-03-09-AML0693:TTCGCTGTCGTCCTTG"	8.41776718673055	6.89438102329103	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGCTGTCGTCCTTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1863.81147402628	30.4237989849382	0.0163234315320613	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1859.85481016564	1859.85481016564
"AML-0693"	"2021-03-09-AML0693:TTCGGTCAGACATACA"	11.7073694663936	-2.3540945283142	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCAGACATACA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1516.07823992782	50.0816822462612	0.0330337056012661	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1509.66867043203	1509.66867043203
"AML-0693"	"2021-03-09-AML0693:TTCGGTCCAGTCGGAA"	-6.94070563736613	4.0381710299286	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCCAGTCGGAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2129.56201345793	48.0993564501425	0.0225865018938988	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2119.78394028767	2119.78394028767
"AML-0693"	"2021-03-09-AML0693:TTCGGTCGTACGAAAT"	12.120019574731	-2.88447573101195	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCGTACGAAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2231.99546873676	53.8034899047351	0.0241055551672721	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2223.54076380215	2223.54076380215
"AML-0693"	"2021-03-09-AML0693:TTCGGTCGTAGAGTTA"	0.955363293259782	9.47890279376832	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCGTAGAGTTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1835.13566948827	37.5120929555729	0.0204410461740048	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1830.04384642295	1830.04384642295
"AML-0693"	"2021-03-09-AML0693:TTCGGTCTCCATTGTT"	9.48435463485066	7.11770579898683	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCTCCATTGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1851.92149563517	51.6129292933381	0.027869933695886	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1843.51129522916	1843.51129522916
"AML-0693"	"2021-03-09-AML0693:TTCGGTCTCGTGCAGC"	9.49370541152303	7.35776040637819	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCGGTCTCGTGCAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2050.61080404191	41.1005499935272	0.0200430768786134	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2044.15912297535	2044.15912297535
"AML-0693"	"2021-03-09-AML0693:TTCTAACCATGGTACT"	-7.10580573502238	-2.73027660762938	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAACCATGGTACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1615.89208432867	34.1958615110022	0.0211622185928395	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1601.19534883023	1601.19534883023
"AML-0693"	"2021-03-09-AML0693:TTCTAACGTACCGGAA"	-6.99909005585368	3.48832581127015	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAACGTACCGGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2556.29994063604	36.3490735839906	0.0142194086875997	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2547.99331932747	2547.99331932747
"AML-0693"	"2021-03-09-AML0693:TTCTAACTCACTACTT"	11.0138584571773	-3.0357761613098	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAACTCACTACTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2492.03178150748	52.2171435586972	0.0209536427047932	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2480.76829554071	2480.76829554071
"AML-0693"	"2021-03-09-AML0693:TTCTAGTCAACTTGGT"	-8.50413737717326	-4.31621935283812	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAGTCAACTTGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2507.13711115354	48.0254018472841	0.0191554748376676	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2498.44660206853	2498.44660206853
"AML-0693"	"2021-03-09-AML0693:TTCTAGTGTCGTGATT"	8.12048973616902	6.23250911319581	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAGTGTCGTGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1646.65764324212	39.53791467375	0.0240110109323656	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1631.98531483338	1631.98531483338
"AML-0693"	"2021-03-09-AML0693:TTCTAGTGTTAAACAG"	-8.09503589096721	-0.64322760021361	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAGTGTTAAACAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2955.9872518998	44.1233905224467	0.0149267864717917	2579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2940.58355605212	2940.58355605212
"AML-0693"	"2021-03-09-AML0693:TTCTAGTGTTGGGCCT"	-8.0939715904301	0.239389828685202	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTAGTGTTGGGCCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2823.85417120624	33.4696186584886	0.0118524600171516	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2811.59483943603	2811.59483943603
"AML-0693"	"2021-03-09-AML0693:TTCTCTCCAACACTAC"	0.891326625912827	10.3740682371887	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTCTCCAACACTAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2023.98323751954	47.8559792055473	0.023644454320776	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2017.29241098554	2017.29241098554
"AML-0693"	"2021-03-09-AML0693:TTCTCTCCATCACAGT"	-7.10509381714519	-2.75401856815489	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTCTCCATCACAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2241.07428750744	8.67994655115307	0.00387311861973441	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2218.50091897189	2218.50091897189
"AML-0693"	"2021-03-09-AML0693:TTCTCTCGTCGCCACA"	8.37411560592	7.03159568393556	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTCTCGTCGCCACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1707.18914383094	43.3957496929887	0.0254194152123112	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1700.07309575259	1700.07309575259
"AML-0693"	"2021-03-09-AML0693:TTCTCTCGTTCTCGCT"	11.9571567970211	-2.71188642894896	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTCTCGTTCTCGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1671.1022618553	46.1675479864868	0.0276270034696921	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1667.01921339078	1667.01921339078
"AML-0693"	"2021-03-09-AML0693:TTCTCTCGTTGCCAAT"	-1.40320442143138	9.43607328021852	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTCTCGTTGCCAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2044.12889854746	36.7683952944429	0.0179873173949892	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2032.66976871241	2032.66976871241
"AML-0693"	"2021-03-09-AML0693:TTCTGTAAGACATGCG"	-0.381895254284698	10.6331567534241	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTGTAAGACATGCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1426.03380915116	52.5201990406934	0.0368295609147975	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1423.56886196923	1423.56886196923
"AML-0693"	"2021-03-09-AML0693:TTCTGTAAGTTGGCTT"	9.05983318862264	6.75658509815065	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTGTAAGTTGGCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1506.37952563666	46.7680828047311	0.0310466798099668	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1504.18555245038	1504.18555245038
"AML-0693"	"2021-03-09-AML0693:TTCTGTACAGAGTTCT"	-0.247072349221069	-4.64339830791625	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	64	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTGTACAGAGTTCT"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	1840.0448279071	43.0057873559982	0.0233721411042544	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1836.69370678813	1836.69370678813
"AML-0693"	"2021-03-09-AML0693:TTCTGTATCATACGAC"	-7.99070201340373	-0.803557120915972	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTGTATCATACGAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2945.65848911329	48.3260482972709	0.0164058557622605	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2933.56073366751	2933.56073366751
"AML-0693"	"2021-03-09-AML0693:TTCTGTATCCGCAAAT"	11.9062735038692	-2.76993086254271	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTGTATCCGCAAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1533.86664345149	43.208651803728	0.0281697577740528	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1532.03661709728	1532.03661709728
"AML-0693"	"2021-03-09-AML0693:TTCTTCCCACATATGC"	3.55171551284139	-10.2330885163513	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTCCCACATATGC"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2694.78139505968	35.0504909083945	0.0130068030648617	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2682.38406707019	2682.38406707019
"AML-0693"	"2021-03-09-AML0693:TTCTTCCCAGGACGAT"	-3.34274945679362	-5.80318739330443	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	63	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00611995104039168	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTCCCAGGACGAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2379.94087415626	42.3483560080262	0.0177938689435045	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2377.30347155135	2377.30347155135
"AML-0693"	"2021-03-09-AML0693:TTCTTCCGTTAACAGA"	-8.86559043350871	-3.64816834842833	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTCCGTTAACAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3127.30060272146	47.8952080800479	0.0153151916507061	3175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3117.73479029528	3117.73479029528
"AML-0693"	"2021-03-09-AML0693:TTCTTCCTCTGTTGGA"	-8.62533317032512	-4.44793131267699	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTCCTCTGTTGGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2268.86349742313	52.9766523112315	0.0233494224625677	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2252.54715157262	2252.54715157262
"AML-0693"	"2021-03-09-AML0693:TTCTTGAAGCACCGAA"	9.15626968917195	6.53076932514039	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTGAAGCACCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1560.08728272704	48.1570363780174	0.0308681680257264	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1556.09917395497	1556.09917395497
"AML-0693"	"2021-03-09-AML0693:TTCTTGAGTACCAGAG"	8.89376606520955	6.44390914523927	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTCTTGAGTACCAGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1433.99991343808	47.9956646713276	0.0334697821258968	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1431.49926921635	1431.49926921635
"AML-0693"	"2021-03-09-AML0693:TTGAACGAGTAACGTA"	0.998840709298295	-8.91653158580931	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGAACGAGTAACGTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2965.10065144441	48.3119555707271	0.0162935297144778	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2960.80699270221	2960.80699270221
"AML-0693"	"2021-03-09-AML0693:TTGACCCTCGACCCAG"	8.69593109664265	6.78259322727052	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGACCCTCGACCCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1823.51811380861	43.9337900331207	0.0240928728376382	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1818.3215864104	1818.3215864104
"AML-0693"	"2021-03-09-AML0693:TTGACCCTCGTCCATC"	0.686828752129716	11.6565723189148	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGACCCTCGTCCATC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1939.28954671001	42.7667002569377	0.022052766864799	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1932.82676449534	1932.82676449534
"AML-0693"	"2021-03-09-AML0693:TTGACCCTCGTGGTAT"	-7.10462794724162	3.93773720348207	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGACCCTCGTGGTAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2411.76505455173	37.3313170900389	0.0154788365556518	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2395.14354658145	2395.14354658145
"AML-0693"	"2021-03-09-AML0693:TTGAGTGAGCACACCC"	1.76681544360463	-6.89316751873168	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	3	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.000657462195923734	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGAGTGAGCACACCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1627.29075246466	48.5239170209065	0.0298188365830834	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1623.85815603545	1623.85815603545
"AML-0693"	"2021-03-09-AML0693:TTGAGTGAGCCATTTG"	-7.59528718414958	-2.29914739048155	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGAGTGAGCCATTTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2911.2153935811	1.81196971127872	0.00062241004745781	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2887.58758384158	2887.58758384158
"AML-0693"	"2021-03-09-AML0693:TTGAGTGGTGCAGATG"	-8.49649749222453	-3.64766194736632	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGAGTGGTGCAGATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2343.52918838234	51.3159109872927	0.0218968516550521	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2329.12493253496	2329.12493253496
"AML-0693"	"2021-03-09-AML0693:TTGATGGAGTAGAATC"	-8.90082583847697	-4.12502577221068	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGATGGAGTAGAATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2756.01814619667	50.6085992966496	0.0183629412478615	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2738.10517795103	2738.10517795103
"AML-0693"	"2021-03-09-AML0693:TTGATGGGTATGCAAA"	-7.10022626343425	4.16707227313844	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGATGGGTATGCAAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1831.94347877132	46.2183412437581	0.0252291305814504	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1820.14698466135	1820.14698466135
"AML-0693"	"2021-03-09-AML0693:TTGCATTCAGTAACAA"	-7.53830657425578	-3.15057971393736	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTCAGTAACAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2015.0483613959	32.9259106921281	0.0163400101570362	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2004.29517692744	2004.29517692744
"AML-0693"	"2021-03-09-AML0693:TTGCATTCAGTCTTCC"	8.8398138481075	6.62776086414186	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTCAGTCTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1679.21885229085	40.857680313157	0.0243313611310505	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1673.17694545405	1673.17694545405
"AML-0693"	"2021-03-09-AML0693:TTGCATTCATACCATG"	0.440910120576066	9.97666452014772	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTCATACCATG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1429.25463619467	51.9683092861221	0.0363604272955066	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1429.25463619467	1429.25463619467
"AML-0693"	"2021-03-09-AML0693:TTGCATTGTCTACAGT"	-6.897772650153	3.85437009418336	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTGTCTACAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2258.13436489355	30.346562398006	0.0134387762171258	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2232.86116568036	2232.86116568036
"AML-0693"	"2021-03-09-AML0693:TTGCATTGTGACTCGC"	-7.14731202545817	-2.74453070079955	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTGTGACTCGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1454.05415789869	19.1268583810379	0.013154158170201	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1441.27799958811	1441.27799958811
"AML-0693"	"2021-03-09-AML0693:TTGCATTTCGCGAAGA"	-7.2119930786198	-2.99838020717772	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTTCGCGAAGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2190.12959847044	0	0	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2183.01164174055	2183.01164174055
"AML-0693"	"2021-03-09-AML0693:TTGCATTTCTGGCCGA"	-2.40737066689189	11.5580625304016	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCATTTCTGGCCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1585.90581722763	45.09315831939	0.0284336924863663	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1576.02187250921	1576.02187250921
"AML-0693"	"2021-03-09-AML0693:TTGCCTGAGATAGCAT"	-8.31168017807658	-4.17120411312255	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCCTGAGATAGCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2615.16721817163	49.7980601682212	0.0190420175896198	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2607.55556187288	2607.55556187288
"AML-0693"	"2021-03-09-AML0693:TTGCCTGTCGCATTAG"	6.76480593261067	-1.13660635864409	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCCTGTCGCATTAG"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2341.8817561519	33.6203785596269	0.0143561383794503	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2333.06270375336	2333.06270375336
"AML-0693"	"2021-03-09-AML0693:TTGCCTGTCGTGGTAT"	14.1893841224605	1.93003902519075	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCCTGTCGTGGTAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1243.150506357	44.7498688167465	0.0359971448251137	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1226.98720090036	1226.98720090036
"AML-0693"	"2021-03-09-AML0693:TTGCCTGTCTCCTACG"	-6.89857945862468	3.88581941211549	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCCTGTCTCCTACG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2558.86343985315	18.2349990996403	0.00712621033840194	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2547.14976879051	2547.14976879051
"AML-0693"	"2021-03-09-AML0693:TTGCGTCCAAGTACCT"	8.88503517684285	7.00374648654786	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCGTCCAAGTACCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1820.75623241087	39.2837531802615	0.0215755148772692	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1803.85452646885	1803.85452646885
"AML-0693"	"2021-03-09-AML0693:TTGCGTCCACATACTG"	0.965004642575425	-9.24665071880492	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCGTCCACATACTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2629.80643868605	45.0376985778358	0.0171258606395147	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2625.53270280755	2625.53270280755
"AML-0693"	"2021-03-09-AML0693:TTGCTGCGTATAGCTC"	9.39917625960652	6.09323690021364	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCTGCGTATAGCTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1814.83913424717	50.4770131997669	0.0278134917014041	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1796.85552367989	1796.85552367989
"AML-0693"	"2021-03-09-AML0693:TTGCTGCGTTGCATGT"	-6.10503850403483	-4.76125910198363	"2021-03-09-AML0693"	"AML0693"	"DC precursor"	"DC precursor"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGCTGCGTTGCATGT"	"DC precursor"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	3253.10517453357	0.145477800713707	4.47196733301331e-05	2524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	3237.77312897787	3237.77312897787
"AML-0693"	"2021-03-09-AML0693:TTGGATGCACATTCTT"	9.23535503920857	7.1910304793152	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGATGCACATTCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.40058774541	50.3240381483965	0.0284412916424539	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1756.86490171899	1756.86490171899
"AML-0693"	"2021-03-09-AML0693:TTGGATGTCGCTTTAT"	-7.73099980774577	-4.79608299648436	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGATGTCGCTTTAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2388.79442567371	46.6896928357064	0.0195452954569494	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2375.93384672692	2375.93384672692
"AML-0693"	"2021-03-09-AML0693:TTGGGATCAACACAAA"	-8.60868487778361	-4.18238069927367	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGATCAACACAAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2651.82080852908	48.4425951898011	0.0182676729264642	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2647.11275147849	2647.11275147849
"AML-0693"	"2021-03-09-AML0693:TTGGGATCAAGGGCAT"	0.297949646680993	10.1827306517395	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGATCAAGGGCAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1580.51097161626	34.236872277132	0.0216619010509751	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1575.91104770168	1575.91104770168
"AML-0693"	"2021-03-09-AML0693:TTGGGATGTTGGAGGT"	-3.56860027733501	3.69439909541932	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGATGTTGGAGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3076.14649658128	29.4727956640841	0.00958107674547982	3071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3071.80594596057	3071.80594596057
"AML-0693"	"2021-03-09-AML0693:TTGGGATGTTTACGTG"	8.20810379561726	6.10230252826539	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGATGTTTACGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1498.84029325123	45.2530087342429	0.0301920150785923	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1487.35754108658	1487.35754108658
"AML-0693"	"2021-03-09-AML0693:TTGGGCGCAGGAAGTC"	-2.59021530571635	3.45222971523134	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGCGCAGGAAGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3653.97992898527	18.5978612290096	0.00508975462111374	5276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3649.2025694552	3649.2025694552
"AML-0693"	"2021-03-09-AML0693:TTGGGCGTCGTTGTAG"	-8.69307456436809	-4.01432564174803	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGCGTCGTTGTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2062.23970644043	45.658831353118	0.0221404093862243	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2057.67111856986	2057.67111856986
"AML-0693"	"2021-03-09-AML0693:TTGGGTAAGAAGCCAC"	8.42767204818074	6.2667550810608	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTAAGAAGCCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1926.43290231024	46.9274478039236	0.0243597624125122	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1916.64172632286	1916.64172632286
"AML-0693"	"2021-03-09-AML0693:TTGGGTACATCAGCTA"	-6.9622634452885	3.82538507068483	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTACATCAGCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2449.25256279871	40.2904829416677	0.0164501136198174	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2431.70489966447	2431.70489966447
"AML-0693"	"2021-03-09-AML0693:TTGGGTACATCGATGT"	-6.96707377854045	3.98383615100709	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTACATCGATGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2367.77517305596	31.4091874579186	0.0132652744294892	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2350.32709309921	2350.32709309921
"AML-0693"	"2021-03-09-AML0693:TTGGGTAGTGTTCATG"	8.73407425460164	6.30329225147096	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTAGTGTTCATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1691.74087783812	43.4631958742294	0.0256914025330943	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1686.4933464662	1686.4933464662
"AML-0693"	"2021-03-09-AML0693:TTGGGTATCCCGGTAG"	-2.11665521088298	3.96032641017763	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTATCCCGGTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3542.07303683948	13.9077472194631	0.00392644281323818	5610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3534.34706930017	3534.34706930017
"AML-0693"	"2021-03-09-AML0693:TTGGGTATCGCTCCTA"	-8.99485812607463	-1.81303741848143	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGGGTATCGCTCCTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3528.92546195802	46.0624697607375	0.0130528315934392	3953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3519.15428771563	3519.15428771563
"AML-0693"	"2021-03-09-AML0693:TTGTGGAAGGACTAAT"	-7.55117545548137	-3.07394101535948	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGGAAGGACTAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2195.14183452726	11.585691362602	0.00527787825842109	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2171.35418246288	2171.35418246288
"AML-0693"	"2021-03-09-AML0693:TTGTGGACATAATGAG"	-8.99389491501506	-4.10696556484374	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGGACATAATGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2817.45598791269	44.6497224882053	0.0158475314893149	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2807.56026336915	2807.56026336915
"AML-0693"	"2021-03-09-AML0693:TTGTGTTAGGAATCGC"	11.8588921028072	-2.9080209962097	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGTTAGGAATCGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1782.09846635804	0	0	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1778.73432760411	1778.73432760411
"AML-0693"	"2021-03-09-AML0693:TTGTGTTGTTAGGGAC"	-1.1880273622578	12.4775018461975	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGTTGTTAGGGAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1923.11541287419	41.9414224358704	0.0218091031641137	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1912.94437331502	1912.94437331502
"AML-0693"	"2021-03-09-AML0693:TTGTGTTTCCGGCTTT"	14.2211929756099	1.89168772781221	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGTTTCCGGCTTT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1298.01323499793	0.133038186458998	0.000102493705666422	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1281.96476665301	1281.96476665301
"AML-0693"	"2021-03-09-AML0693:TTGTGTTTCTATGTGG"	0.922435899346512	9.78737733447877	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTGTTTCTATGTGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1567.18990315471	37.6830034201021	0.0240449503562059	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1562.74973250571	1562.74973250571
"AML-0693"	"2021-03-09-AML0693:TTGTTCACACAACGCC"	-4.44265923920329	3.20475790584413	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTCACACAACGCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2971.70914115013	51.8368029206028	0.0174434308535797	2926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2964.91533973979	2964.91533973979
"AML-0693"	"2021-03-09-AML0693:TTGTTCACATGTACGT"	-2.1262665790623	4.19984481418458	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTCACATGTACGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3294.96150411574	37.9514294233316	0.0115180190651474	5130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3290.90232951635	3290.90232951635
"AML-0693"	"2021-03-09-AML0693:TTGTTGTCAATTCGTG"	0.93163307484929	9.88690850818483	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTGTCAATTCGTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1424.01773732369	38.1416979390538	0.0267845666099199	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1424.01773732369	1424.01773732369
"AML-0693"	"2021-03-09-AML0693:TTGTTGTCACAGCATT"	-8.75503001633342	-3.09332301532897	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTGTCACAGCATT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3127.84550184656	41.889160066838	0.0133923366873806	2758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3114.02866330592	3114.02866330592
"AML-0693"	"2021-03-09-AML0693:TTGTTGTCACTCTCGT"	-2.27542887154277	4.00705072963563	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTGTCACTCTCGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1757.26948033818	34.0591748284612	0.0193818735313758	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1755.06108053371	1755.06108053371
"AML-0693"	"2021-03-09-AML0693:TTGTTGTTCGACATTG"	0.878388662903947	9.7330693968567	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTGTTCGACATTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1824.63629479377	47.8464703094827	0.0262224698949609	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1812.75736053904	1812.75736053904
"AML-0693"	"2021-03-09-AML0693:TTGTTGTTCTGGTGCG"	9.40489449080769	7.25305221164552	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTGTTCTGGTGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1681.7112041555	46.489285235094	0.0276440360985995	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1673.14788813297	1673.14788813297
"AML-0693"	"2021-03-09-AML0693:TTGTTTGAGTAAAGCT"	11.0677429634029	-2.93110849773558	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGAGTAAAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2001.95936393201	45.7724082094931	0.0228638048474633	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1996.94768749674	1996.94768749674
"AML-0693"	"2021-03-09-AML0693:TTGTTTGAGTAATTGG"	8.74274029311482	6.26273391330568	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGAGTAATTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1371.65053367152	50.2374021071592	0.0366255112901738	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1364.41773410318	1364.41773410318
"AML-0693"	"2021-03-09-AML0693:TTGTTTGGTCTGGTTA"	-7.57687840881999	-2.31609227573546	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGGTCTGGTTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3398.13483871548	32.905187151051	0.00968330825962439	3155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3373.41172019223	3373.41172019223
"AML-0693"	"2021-03-09-AML0693:TTGTTTGGTGACACGA"	-7.02898822251018	-2.71317460453185	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGGTGACACGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1565.10505652184	49.6273080795314	0.0317086114269025	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1554.43017999931	1554.43017999931
"AML-0693"	"2021-03-09-AML0693:TTGTTTGGTTGCTCGG"	-7.64136586609538	-2.10582210933837	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGGTTGCTCGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3620.3460461278	44.9818671673269	0.0124247424401427	5595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3603.98833853711	3603.98833853711
"AML-0693"	"2021-03-09-AML0693:TTGTTTGGTTGCTGAT"	-8.21084819260295	-3.38563110744628	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGGTTGCTGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2593.05311879988	52.3242302328847	0.0201786187307653	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2583.72390824894	2583.72390824894
"AML-0693"	"2021-03-09-AML0693:TTGTTTGTCACTAGCA"	-8.25055156174358	-3.46583082592162	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTGTTTGTCACTAGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2730.41599221766	49.9817286775172	0.0183055361600493	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2725.32686473158	2725.32686473158
"AML-0693"	"2021-03-09-AML0693:TTTACCAAGAATAACC"	-7.4556602043217	-2.2448723546234	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACCAAGAATAACC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2428.40805509719	31.5246881244465	0.0129816272262302	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2416.67780446354	2416.67780446354
"AML-0693"	"2021-03-09-AML0693:TTTACCAGTCTACATG"	9.33895458754842	7.11219880664674	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACCAGTCTACATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2056.67831297872	53.7338100400904	0.026126501991586	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2053.69888281614	2053.69888281614
"AML-0693"	"2021-03-09-AML0693:TTTACGTAGACGCATG"	7.94832911071126	6.19804952228395	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACGTAGACGCATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1487.96110347135	47.6251763225302	0.0320070035509817	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1483.48906293612	1483.48906293612
"AML-0693"	"2021-03-09-AML0693:TTTACGTAGTTTCGAC"	6.77705301818196	-1.21698036110076	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACGTAGTTTCGAC"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2380.21396434009	31.4273137175099	0.0132035666491954	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2372.05489167623	2372.05489167623
"AML-0693"	"2021-03-09-AML0693:TTTACGTTCGACATCA"	1.03538682040517	-9.05853559887084	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACGTTCGACATCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1751.16373708228	45.8814342537569	0.0262005392655073	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1741.44067893576	1741.44067893576
"AML-0693"	"2021-03-09-AML0693:TTTACTGAGATACAGT"	-7.24614129486735	4.31034371936647	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACTGAGATACAGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1542.85705729589	51.7147355335828	0.0335188119268944	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1532.7355448357	1532.7355448357
"AML-0693"	"2021-03-09-AML0693:TTTACTGCAACAGAGC"	1.22701503810231	-10.3625335923401	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACTGCAACAGAGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2361.76642928531	39.8708124235332	0.016881776254055	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2359.67180682061	2359.67180682061
"AML-0693"	"2021-03-09-AML0693:TTTACTGCAATGGGTG"	-8.36726127091106	-3.60859348690184	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACTGCAATGGGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2934.72209974622	38.2774926527677	0.0130429701183896	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2921.85233628162	2921.85233628162
"AML-0693"	"2021-03-09-AML0693:TTTACTGCAGATTTCG"	8.00609125670735	6.6462774046692	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACTGCAGATTTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1878.02033636219	37.9568123318632	0.0202110763110197	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1870.01036197338	1870.01036197338
"AML-0693"	"2021-03-09-AML0693:TTTACTGTCTATCCAT"	-7.49952969971355	-3.38271477138671	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTACTGTCTATCCAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2218.09287469683	44.6978677708265	0.0201514861170707	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2194.2828056955	2194.2828056955
"AML-0693"	"2021-03-09-AML0693:TTTAGTCAGCTATCTG"	-6.22457442703899	-0.658897184487902	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	85	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.725	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTAGTCAGCTATCTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1621.00385166154	44.2065727459524	0.0272711090110245	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1536.51887585259	1536.51887585259
"AML-0693"	"2021-03-09-AML0693:TTTAGTCCACATGTTG"	-7.0479453605717	-2.68389799511107	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTAGTCCACATGTTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1951.04200451315	39.1013926206532	0.0200412869278077	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1935.23196258554	1935.23196258554
"AML-0693"	"2021-03-09-AML0693:TTTAGTCCACTGGAAG"	10.787861486047	-2.68724801456603	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTAGTCCACTGGAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1764.8705283512	23.0665322951678	0.0130698155613247	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1761.11058753913	1761.11058753913
"AML-0693"	"2021-03-09-AML0693:TTTATGCAGGTTTGAA"	8.27173580703084	6.99202106082765	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTATGCAGGTTTGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1672.38787895966	37.3499508707035	0.0223333063702529	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1670.47368889385	1670.47368889385
"AML-0693"	"2021-03-09-AML0693:TTTATGCAGTAATTGG"	1.30717148360555	-10.2995805970398	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTATGCAGTAATTGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2354.84267962432	44.8104545349227	0.0190290650507793	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2346.50847695375	2346.50847695375
"AML-0693"	"2021-03-09-AML0693:TTTATGCCAAACTAAG"	8.19780697402303	6.02672336185304	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTATGCCAAACTAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1723.55414832699	45.0031048551967	0.026110641721863	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1710.00225525799	1710.00225525799
"AML-0693"	"2021-03-09-AML0693:TTTCACAAGGACAGTC"	-2.10444436493571	13.9072112807068	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACAAGGACAGTC"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	2069.58511113794	45.4813027069813	0.0219760484660493	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	2060.11413347669	2060.11413347669
"AML-0693"	"2021-03-09-AML0693:TTTCACACACAAGCAG"	-1.52471421185191	12.7325801619324	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACACACAAGCAG"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1755.71136805107	51.1611952703556	0.0291398667237355	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1751.55448586656	1751.55448586656
"AML-0693"	"2021-03-09-AML0693:TTTCACATCAGCCTTC"	-7.18740592423137	-2.77791740810546	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACATCAGCCTTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1951.36315850056	2.70642186433267	0.00138693910077317	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1934.48413938663	1934.48413938663
"AML-0693"	"2021-03-09-AML0693:TTTCACATCCAAGCTA"	-6.99759850922282	3.41963670337526	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACATCCAAGCTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2672.66104140469	27.455490336209	0.0102727169330006	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2652.07307221047	2652.07307221047
"AML-0693"	"2021-03-09-AML0693:TTTCACATCCGAGCTG"	-7.27313027802165	-2.97908070003661	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACATCCGAGCTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1789.5414086252	39.8965529621351	0.0222942887880897	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1777.66583058739	1777.66583058739
"AML-0693"	"2021-03-09-AML0693:TTTCACATCGCACGAC"	9.60744728621785	7.29304120624391	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCACATCGCACGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1804.67751967086	46.8454677283192	0.0259578053240575	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1795.42054668747	1795.42054668747
"AML-0693"	"2021-03-09-AML0693:TTTCAGTAGGCGCTTC"	11.0905043083126	-2.68294002926024	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCAGTAGGCGCTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1634.61351809784	50.2354481065124	0.0307323092280371	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1625.02498599305	1625.02498599305
"AML-0693"	"2021-03-09-AML0693:TTTCAGTCAATACGAA"	-7.00808368149455	-2.68032028591307	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCAGTCAATACGAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1920.18912610015	46.763297003047	0.0243534849601101	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1916.79668716148	1916.79668716148
"AML-0693"	"2021-03-09-AML0693:TTTCAGTCAGAGTTGG"	-7.46097646179851	-3.02409865772399	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCAGTCAGAGTTGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1590.321767287	32.3079272541205	0.0203153399008277	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1573.85478541001	1573.85478541001
"AML-0693"	"2021-03-09-AML0693:TTTCAGTCATGGGAAC"	-1.83803067627605	4.11111304843751	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCAGTCATGGGAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2444.21346433654	28.7053543098495	0.011744209222594	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2444.21346433654	2444.21346433654
"AML-0693"	"2021-03-09-AML0693:TTTCAGTGTGTACAGG"	-7.34945235672649	4.42179868305055	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCAGTGTGTACAGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1746.00135533217	51.0948149159432	0.0292639033525966	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1744.20602573187	1744.20602573187
"AML-0693"	"2021-03-09-AML0693:TTTCATGCACCGGAAA"	10.4265400367672	6.22758386218873	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCATGCACCGGAAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1637.57956830723	45.6447272086125	0.0278732881699273	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1633.63532495022	1633.63532495022
"AML-0693"	"2021-03-09-AML0693:TTTCCTCAGGGCAGAG"	-2.37242803993877	3.73202631557313	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCCTCAGGGCAGAG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1813.41298526473	41.264188653391	0.0227549868610691	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1806.57741442944	1806.57741442944
"AML-0693"	"2021-03-09-AML0693:TTTCCTCCATCCTAAG"	11.0287481742794	-2.54417493259581	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCCTCCATCCTAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1733.59513323789	45.0815282064099	0.0260046462649036	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1727.0196844859	1727.0196844859
"AML-0693"	"2021-03-09-AML0693:TTTCCTCTCAACTTTC"	-6.94995246353801	3.87980053508607	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCCTCTCAACTTTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2572.17617209013	41.2890682508081	0.0160521929636168	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2553.05509933519	2553.05509933519
"AML-0693"	"2021-03-09-AML0693:TTTCGATCAAGAGGTC"	14.2458254295284	2.15211842143861	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATCAAGAGGTC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1445.06021768118	36.9426744933365	0.0255647993359175	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1435.39572746703	1435.39572746703
"AML-0693"	"2021-03-09-AML0693:TTTCGATCACGAGGAT"	7.63128914412801	6.24679133975831	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATCACGAGGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1560.83349372248	52.5858528262252	0.0336908792883548	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1555.08764373548	1555.08764373548
"AML-0693"	"2021-03-09-AML0693:TTTCGATCATCTGGGC"	1.25645114955251	9.65482328021852	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATCATCTGGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1865.0517412011	30.4455424712337	0.016324234764461	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1853.50933779678	1853.50933779678
"AML-0693"	"2021-03-09-AML0693:TTTCGATGTAGCGATG"	11.3489757972652	-2.74896647846373	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATGTAGCGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1771.0228991529	13.1789583863354	0.00744143872596961	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1766.65998961266	1766.65998961266
"AML-0693"	"2021-03-09-AML0693:TTTCGATGTGGTCTGC"	-2.42954025688823	4.14175603473512	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATGTGGTCTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3280.60541132305	30.4591282734203	0.00928460587435789	5136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3275.71652491354	3275.71652491354
"AML-0693"	"2021-03-09-AML0693:TTTCGATTCCGGTTCT"	-7.0141171020573	-2.85439970409545	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTCGATTCCGGTTCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1966.14660220877	28.5974299280963	0.0145449123152719	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1962.60027301035	1962.60027301035
"AML-0693"	"2021-03-09-AML0693:TTTGACTAGCACTGGA"	7.966804643243	6.07130382144777	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGACTAGCACTGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.90947690688	50.4071299067377	0.0316844739681491	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1588.48619297674	1588.48619297674
"AML-0693"	"2021-03-09-AML0693:TTTGACTTCGTGGTAT"	0.115564298897427	12.6684341200623	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGACTTCGTGGTAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1903.65263045898	43.7187850581531	0.0229657366888476	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1896.1814281315	1896.1814281315
"AML-0693"	"2021-03-09-AML0693:TTTGATCAGGATTTAG"	-6.94109139862712	3.90812561595765	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGATCAGGATTTAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2242.38487383199	33.8419598804758	0.0150919497698196	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2229.72419817874	2229.72419817874
"AML-0693"	"2021-03-09-AML0693:TTTGATCTCTAGCAAC"	-1.11052999916728	9.70842073047487	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGATCTCTAGCAAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1752.62000895143	43.7524818514951	0.0249640433339978	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1747.0834097876	1747.0834097876
"AML-0693"	"2021-03-09-AML0693:TTTGGAGCATCCGATA"	7.81071152266805	6.97368524158327	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGAGCATCCGATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1522.14520452974	45.8113594392824	0.0300965763995134	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1522.14520452974	1522.14520452974
"AML-0693"	"2021-03-09-AML0693:TTTGGAGCATGATGCT"	6.71684898909871	-1.05027153408202	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGAGCATGATGCT"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2206.39549854526	45.3935293353717	0.0205736140076886	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2193.35988110706	2193.35988110706
"AML-0693"	"2021-03-09-AML0693:TTTGGAGGTAGTAAGT"	-2.50125251236613	11.5946435698303	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ NK-like"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGAGGTAGTAAGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1899.70644501626	47.2876067298107	0.0248920599568771	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1887.37946233026	1887.37946233026
"AML-0693"	"2021-03-09-AML0693:TTTGGAGGTGTTCGTA"	8.37850632247273	6.1656718024048	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGAGGTGTTCGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1577.41293539604	33.4119592005909	0.021181491828075	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1568.46727669938	1568.46727669938
"AML-0693"	"2021-03-09-AML0693:TTTGGTTAGTAGGGTC"	-7.74237285080607	-3.13539602672728	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGTTAGTAGGGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3099.72099529947	33.1178679410176	0.0106841447960119	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3079.80010187824	3079.80010187824
"AML-0693"	"2021-03-09-AML0693:TTTGGTTTCTGGGCCA"	-7.15016398850139	3.86737368190614	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGGTTTCTGGGCCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1467.36542361537	49.5293793075859	0.0337539501139075	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1465.61427956143	1465.61427956143
"AML-0693"	"2021-03-09-AML0693:TTTGTTGAGCCACCGT"	-2.24048958244975	3.73504088008729	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGTTGAGCCACCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3123.94319611332	25.8459815867556	0.00827351202125318	4555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3117.13197771302	3117.13197771302
"AML-0693"	"2021-03-09-AML0693:TTTGTTGCATCATGAC"	-8.6179669899052	-4.50053837215575	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGTTGCATCATGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2603.31095972634	41.7876226448167	0.0160517215543123	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2596.24737504646	2596.24737504646
"AML-0693"	"2021-03-09-AML0693:TTTGTTGGTACACGCC"	8.61048092421834	6.59795186603395	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGTTGGTACACGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1579.62313966949	45.2821999754114	0.028666457738069	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1579.62313966949	1579.62313966949
"AML-0693"	"2021-03-09-AML0693:TTTGTTGGTCCGGTGT"	-9.60716853562053	-2.04218819057616	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.TTTGTTGGTCCGGTGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3182.5740986378	41.8691690702538	0.0131557562440336	3577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3175.3777126804	3175.3777126804
"AML-0693"	"2021-03-09-AML0693:ACGTCCTCACAGCGCT"	14.117017407983	2.15257546985475	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTCACAGCGCT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1192.19444029764	8.71945476619916	0.00731378579824804	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1174.63236214702	1174.63236214702
"AML-0693"	"2021-03-09-AML0693:ACGTCCTGTGGTCTCG"	8.21828712996785	7.12483117664186	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTGTGGTCTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1677.38667563345	49.9840167755894	0.0297987443811746	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1671.74413690762	1671.74413690762
"AML-0693"	"2021-03-09-AML0693:ACGTCCTTCCCTCAAC"	-7.87215409699138	-4.69478371059569	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTTCCCTCAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2253.51913295507	45.5630588167629	0.0202186252383913	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2248.38077855305	2248.38077855305
"AML-0693"	"2021-03-09-AML0693:ACGTCCTTCGTAACCA"	-7.00370583954509	-2.67734601413878	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTCCTTCGTAACCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1668.98343765235	16.8873073752169	0.0101183193279444	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1651.57874461019	1651.57874461019
"AML-0693"	"2021-03-09-AML0693:ACGTTCCGTAACGATA"	-7.50593553009685	-2.39274337207945	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTTCCGTAACGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2363.82113315637	32.6355391723283	0.0138062642365629	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2360.50801554957	2360.50801554957
"AML-0693"	"2021-03-09-AML0693:ACGTTCCGTCAATGGG"	0.37125982817952	10.9776038893494	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTTCCGTCAATGGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1661.39039038737	42.4875176986541	0.0255734702358232	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1655.64065628272	1655.64065628272
"AML-0693"	"2021-03-09-AML0693:ACGTTCCGTGAGCGAT"	-6.78909287872966	3.93982527339784	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACGTTCCGTGAGCGAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2360.35059835059	42.1222449075862	0.0178457577179514	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2341.23608261311	2341.23608261311
"AML-0693"	"2021-03-09-AML0693:ACTACGACATCCTATT"	-0.7069527906483	11.4618606337341	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTACGACATCCTATT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2141.05400084615	41.1069306586985	0.0191993899464717	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2135.60821487267	2135.60821487267
"AML-0693"	"2021-03-09-AML0693:ACTACGAGTCACTGAT"	-8.58145270767863	-4.25900318538817	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTACGAGTCACTGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2708.85819961581	49.9063321666373	0.0184233830230447	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2697.89991865758	2697.89991865758
"AML-0693"	"2021-03-09-AML0693:ACTACGATCAGTCACA"	8.34651341018025	6.88022277438966	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTACGATCAGTCACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1383.73794964842	46.4524622787299	0.0335702741191224	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1370.73141383016	1370.73141383016
"AML-0693"	"2021-03-09-AML0693:ACTACGATCCCATAAG"	7.95119871672933	6.36881015384523	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTACGATCCCATAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1561.87535228338	44.6021767174151	0.0285568093844423	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1557.99101279689	1557.99101279689
"AML-0693"	"2021-03-09-AML0693:ACTATCTAGCGTTACT"	-8.73365149918254	-4.28192474758299	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTAGCGTTACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2705.47974824588	45.4532825057204	0.0168004519476408	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2697.47398372007	2697.47398372007
"AML-0693"	"2021-03-09-AML0693:ACTATCTAGGGCGAAG"	-7.56474624100383	-3.50049045002135	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTAGGGCGAAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1625.45655871269	24.7395105432839	0.0152200379706713	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1611.45770668597	1611.45770668597
"AML-0693"	"2021-03-09-AML0693:ACTATCTCACGCTGTG"	-7.62184319916423	-3.03438808834227	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTCACGCTGTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2528.64964349493	28.4335677551387	0.0112445659794291	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2504.67660116989	2504.67660116989
"AML-0693"	"2021-03-09-AML0693:ACTATCTTCACAAGGG"	11.8763891654903	-3.17546036159667	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTTCACAAGGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2106.79727981976	9.98533325167375	0.00473957952543399	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2092.69654016494	2092.69654016494
"AML-0693"	"2021-03-09-AML0693:ACTATCTTCGCAGTGC"	8.20055737075154	6.46678445422975	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTTCGCAGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1647.41438879122	51.364187604427	0.0311786687999704	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.23524109672	1643.23524109672
"AML-0693"	"2021-03-09-AML0693:ACTATCTTCTAGTTCT"	-8.27584300461467	-0.00752659207256893	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATCTTCTAGTTCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3312.26054893426	36.025690453946	0.0108764663654064	3630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3280.15990156868	3280.15990156868
"AML-0693"	"2021-03-09-AML0693:ACTATGGAGCATGATA"	-9.29021010819133	-4.09585049068602	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATGGAGCATGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2594.6899698212	48.7544503955631	0.0187900870480194	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2583.58098701643	2583.58098701643
"AML-0693"	"2021-03-09-AML0693:ACTATGGCATAGAATG"	11.6073385673458	-2.60986235057982	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATGGCATAGAATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1599.48320881483	41.4532387355191	0.0259166451432989	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1588.98011856445	1588.98011856445
"AML-0693"	"2021-03-09-AML0693:ACTATGGTCCAATCCC"	-2.14578328552898	3.86478779399721	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATGGTCCAATCCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2302.60123240489	19.18652860324	0.00833254509431542	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2300.68543505961	2300.68543505961
"AML-0693"	"2021-03-09-AML0693:ACTATTCCACGACCTG"	1.31198098239247	-10.4944095841614	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATTCCACGACCTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1580.12730750252	48.0801266899078	0.0304280082127693	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1567.78377808721	1567.78377808721
"AML-0693"	"2021-03-09-AML0693:ACTATTCGTTCACGAT"	9.01115288314168	6.62393663013307	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATTCGTTCACGAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1771.41480991363	50.4882478430686	0.02850165165184	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1767.6829140376	1767.6829140376
"AML-0693"	"2021-03-09-AML0693:ACTATTCGTTCAGCTA"	-6.94779715958293	4.01354453647462	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTATTCGTTCAGCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2187.26555764011	36.5367338614289	0.016704297168584	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2177.22412878789	2177.22412878789
"AML-0693"	"2021-03-09-AML0693:ACTCCCAAGCAGTACG"	-1.33776829662974	8.88254067981569	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCCCAAGCAGTACG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1905.96231227249	38.4836261633203	0.0201911789732275	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1886.90179874955	1886.90179874955
"AML-0693"	"2021-03-09-AML0693:ACTCCCACATACCGTA"	-3.39292536202129	-7.5888447991577	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	56	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.285714285714286	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCCCACATACCGTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1559.18177162922	50.2866780706837	0.032251966374734	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1559.18177162922	1559.18177162922
"AML-0693"	"2021-03-09-AML0693:ACTCCCATCATGGCCG"	8.59261288222615	6.85063121402589	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCCCATCATGGCCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1576.00785627836	36.5728570260191	0.0232060118738136	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1571.33526154237	1571.33526154237
"AML-0693"	"2021-03-09-AML0693:ACTCCCATCGCTGTTC"	-1.87345848503764	3.04245827281801	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCCCATCGCTGTTC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1723.18155302203	44.4663086186709	0.0258047728869243	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1702.88266200716	1702.88266200716
"AML-0693"	"2021-03-09-AML0693:ACTCTCGAGACTTCCA"	11.024919171899	-2.55725386058959	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCTCGAGACTTCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1684.58513137701	49.0453884577435	0.0291142237600381	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1682.50029995124	1682.50029995124
"AML-0693"	"2021-03-09-AML0693:ACTCTCGAGGTGCTAG"	-6.86151824417766	-2.60257460987242	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCTCGAGGTGCTAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1740.89663609508	43.64625735424	0.0250711365909355	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1732.61913133225	1732.61913133225
"AML-0693"	"2021-03-09-AML0693:ACTCTCGGTAACGATA"	-8.77449737015422	-4.19787886058959	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTCTCGGTAACGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2564.0842650672	44.6470503663779	0.017412473909163	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2559.48062929417	2559.48062929417
"AML-0693"	"2021-03-09-AML0693:ACTGATGAGACGCTCC"	10.0223328071529	6.63992736423341	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGAGACGCTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1663.29798294924	48.6870626597113	0.029271401251496	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1649.96747182838	1649.96747182838
"AML-0693"	"2021-03-09-AML0693:ACTGATGAGAGTCTTC"	10.39582314071	6.21805570209352	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGAGAGTCTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1762.4144265264	44.8503224585834	0.025448227036464	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1760.39961468541	1760.39961468541
"AML-0693"	"2021-03-09-AML0693:ACTGATGAGTCAGAGC"	-6.85170922699626	3.84636828983156	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGAGTCAGAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2280.80727565907	42.4667339517405	0.0186191680485012	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2268.02127715355	2268.02127715355
"AML-0693"	"2021-03-09-AML0693:ACTGATGGTAGAGTTA"	0.8692190843517	9.69226453388063	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGGTAGAGTTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1616.83950246187	40.6454313978868	0.0251388163982871	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1613.39822700136	1613.39822700136
"AML-0693"	"2021-03-09-AML0693:ACTGATGGTTAAAGTG"	9.59278168258015	6.77252814853517	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGGTTAAAGTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1748.02410579475	41.0475888653731	0.0234822784933568	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1741.7316689022	1741.7316689022
"AML-0693"	"2021-03-09-AML0693:ACTGATGGTTACACAC"	11.0417152839595	-1.61089208042296	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGATGGTTACACAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1574.75706995569	46.39080135523	0.0294590208485523	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1572.50483206798	1572.50483206798
"AML-0693"	"2021-03-09-AML0693:ACTGCAACATCGTGGC"	2.87541427192037	-9.99786093151244	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGCAACATCGTGGC"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2543.09152106545	48.7341443630426	0.0191633466429966	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2528.26458429779	2528.26458429779
"AML-0693"	"2021-03-09-AML0693:ACTGCAATCATCCTGC"	-6.90273366394694	3.84673569286195	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGCAATCATCCTGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2271.87437851195	49.1399545706563	0.0216296970622303	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2261.71079956402	2261.71079956402
"AML-0693"	"2021-03-09-AML0693:ACTGTCCCATCGAACT"	-7.74450145188029	-3.48513820087584	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGTCCCATCGAACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2248.41401397836	36.9362055090749	0.0164276709180084	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2234.18457277372	2234.18457277372
"AML-0693"	"2021-03-09-AML0693:ACTGTCCTCAGAGTGG"	-2.19739780846294	3.35117051685182	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGTCCTCAGAGTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3355.32075032191	22.9403371117726	0.00683700272457461	4733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3348.54436382669	3348.54436382669
"AML-0693"	"2021-03-09-AML0693:ACTGTGAAGCATGATA"	0.95471896704976	9.82507035816041	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTGTGAAGCATGATA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1958.43300119404	45.4351958175597	0.023199770321404	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1955.53921778449	1955.53921778449
"AML-0693"	"2021-03-09-AML0693:ACTTAGGAGCCATGCC"	10.3663126426632	6.5464558371338	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTAGGAGCCATGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1759.46293004315	49.1511991987492	0.0279353422908113	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1755.22256821293	1755.22256821293
"AML-0693"	"2021-03-09-AML0693:ACTTAGGGTGTCTCCT"	-6.98119721832927	-2.66978814518126	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTAGGGTGTCTCCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2124.46811062653	47.8858397921743	0.0225401546639607	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2119.85540653878	2119.85540653878
"AML-0693"	"2021-03-09-AML0693:ACTTATCAGTCAACAA"	-7.06513200226482	3.94369790637819	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTATCAGTCAACAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2053.06069724632	36.1891355306541	0.0176269194472394	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2046.22307831421	2046.22307831421
"AML-0693"	"2021-03-09-AML0693:ACTTATCCAGGTCCCA"	-4.04854855957683	2.78989884937135	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTATCCAGGTCCCA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3306.01754243867	34.050309591399	0.0102994945290829	4146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3297.69894218362	3297.69894218362
"AML-0693"	"2021-03-09-AML0693:ACTTATCTCACCTCTG"	-6.95240912857707	3.91962406719056	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTATCTCACCTCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2284.64157385889	38.8376589808922	0.0169994538422468	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2266.49432389793	2266.49432389793
"AML-0693"	"2021-03-09-AML0693:ACTTCCGAGGATACCG"	7.77186455306355	6.91693875873414	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCCGAGGATACCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1568.33898333907	47.5999206544227	0.0303505308227945	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1562.10275740823	1562.10275740823
"AML-0693"	"2021-03-09-AML0693:ACTTCCGCATTCATCT"	-7.50095305863078	-2.90896775638732	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCCGCATTCATCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3146.92082066084	0	0	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3129.38661671102	3129.38661671102
"AML-0693"	"2021-03-09-AML0693:ACTTCCGTCTTCGTGC"	8.12195457991902	6.95278737628785	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCCGTCTTCGTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1859.2555353846	43.8825469711404	0.0236022139700463	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1845.74681627369	1845.74681627369
"AML-0693"	"2021-03-09-AML0693:ACTTCGCAGCGCTGAA"	11.4542671638424	-2.40133883869322	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCGCAGCGCTGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1413.07448413376	34.9301472698332	0.0247192541242764	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1407.34569044461	1407.34569044461
"AML-0693"	"2021-03-09-AML0693:ACTTCGCCAATCTAGC"	-7.73360524597819	-4.55902340328368	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCGCCAATCTAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2660.10039990021	50.3581978064619	0.0189309387752248	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2654.8750262688	2654.8750262688
"AML-0693"	"2021-03-09-AML0693:ACTTCGCGTTGGGCCT"	11.0421673255855	-2.87347652828368	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTCGCGTTGGGCCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1662.93369827259	43.1630875680345	0.0259559882711326	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1657.63656820586	1657.63656820586
"AML-0693"	"2021-03-09-AML0693:ACTTTCACACACCTGG"	9.36562981185262	7.76341769779054	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCACACACCTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2089.81920539837	40.2595728151665	0.019264619978211	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2083.97415800559	2083.97415800559
"AML-0693"	"2021-03-09-AML0693:ACTTTCACACCGTGCA"	-8.32923350754436	-4.20106222545775	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCACACCGTGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2779.07006581755	34.1226828398292	0.0122784535947967	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2768.04507008055	2768.04507008055
"AML-0693"	"2021-03-09-AML0693:ACTTTCAGTAGCTTTG"	0.672349472611588	-9.15037348186644	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCAGTAGCTTTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3068.27446168144	47.9806384060789	0.0156376618210957	3436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3055.93078988973	3055.93078988973
"AML-0693"	"2021-03-09-AML0693:ACTTTCATCAGCGGAA"	8.15114464339558	6.27834746921388	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCATCAGCGGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1528.12145059046	47.9954603181985	0.0314081451442574	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1528.12145059046	1528.12145059046
"AML-0693"	"2021-03-09-AML0693:ACTTTCATCCAGTACA"	14.1388918357784	1.74858245933381	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCATCCAGTACA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1884.00462669671	5.00121015580672	0.00265456362735983	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1859.75655755664	1859.75655755664
"AML-0693"	"2021-03-09-AML0693:ACTTTCATCGCAGAGA"	-0.27616579356845	11.4024848707947	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCATCGCAGAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1803.06538124102	51.1152589605957	0.028349087887991	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1803.06538124102	1803.06538124102
"AML-0693"	"2021-03-09-AML0693:ACTTTCATCTCACGAA"	8.66401829299275	6.65891645038453	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTCATCTCACGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1584.28715898051	50.9067784841136	0.0321322925553926	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1581.42524331341	1581.42524331341
"AML-0693"	"2021-03-09-AML0693:ACTTTGTAGCGCCTCA"	0.668390889733475	10.2296104201111	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTAGCGCCTCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1770.57486866405	43.7860696958787	0.0247298606067511	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1768.45380580347	1768.45380580347
"AML-0693"	"2021-03-09-AML0693:ACTTTGTCACAGTACT"	-0.920030931860763	10.6901702650818	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTCACAGTACT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1647.74356016967	37.9347650117546	0.0230222505059273	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1647.74356016967	1647.74356016967
"AML-0693"	"2021-03-09-AML0693:ACTTTGTCACCGTGAC"	6.70365776595418	-9.92315485393675	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	10	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.111111111111111	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTCACCGTGAC"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2518.55557084644	48.7963767423164	0.0193747469014221	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2510.79892778287	2510.79892778287
"AML-0693"	"2021-03-09-AML0693:ACTTTGTTCCAAGCTA"	8.40201057967488	6.26070449436036	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTTCCAAGCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1514.31192465689	45.213381015659	0.0298573763301133	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1505.56646961566	1505.56646961566
"AML-0693"	"2021-03-09-AML0693:ACTTTGTTCCATGCAA"	-8.54412208023723	-4.17270042812499	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTTCCATGCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2872.58022813702	48.2645630064556	0.0168018155015142	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2855.88494007839	2855.88494007839
"AML-0693"	"2021-03-09-AML0693:ACTTTGTTCGCACGAC"	-7.58566461029704	-2.80395986950072	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ACTTTGTTCGCACGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2872.04147908563	5.33320925362774	0.00185694019131147	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2850.89124942985	2850.89124942985
"AML-0693"	"2021-03-09-AML0693:AGAAATGAGCACTCGC"	-0.308107565075713	11.907555557135	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAATGAGCACTCGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1720.42399034758	42.0145944646239	0.0244210698643743	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1712.49849615482	1712.49849615482
"AML-0693"	"2021-03-09-AML0693:AGAAATGAGTAGGTTA"	0.703756530850571	9.519504524115	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAATGAGTAGGTTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1489.80509052035	47.2950212013165	0.0317457776874675	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1478.56420665789	1478.56420665789
"AML-0693"	"2021-03-09-AML0693:AGAAATGGTTCCAGGC"	14.2667442756588	1.95336327636567	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAATGGTTCCAGGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1355.97916303719	15.1212194269754	0.0111515131199407	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1336.20238079657	1336.20238079657
"AML-0693"	"2021-03-09-AML0693:AGAAATGTCTGACAGT"	14.1482035118038	1.81886801803438	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAATGTCTGACAGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1133.89436555989	6.15636428625191	0.00542939842832011	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1117.72087653024	1117.72087653024
"AML-0693"	"2021-03-09-AML0693:AGAACAAGTGAACCGA"	-2.56448636475261	3.74002239787904	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACAAGTGAACCGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3246.44496756948	29.3670292831949	0.00904590392769884	3778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3241.28318482255	3241.28318482255
"AML-0693"	"2021-03-09-AML0693:AGAACAATCACGTCCT"	0.551786233752412	10.0527686842713	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACAATCACGTCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1775.85870037232	48.7907349667885	0.0274744465629835	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1768.20335030611	1768.20335030611
"AML-0693"	"2021-03-09-AML0693:AGAACAATCTACGCGG"	9.91302742537801	7.09801337802736	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACAATCTACGCGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1756.61777291447	52.3524104680618	0.0298029607096609	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1746.14634715367	1746.14634715367
"AML-0693"	"2021-03-09-AML0693:AGAACCTCAGCTTTCC"	8.13650955733601	6.54371450031129	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACCTCAGCTTTCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1668.57213693356	41.5653386086344	0.024910723179773	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1659.15315700269	1659.15315700269
"AML-0693"	"2021-03-09-AML0693:AGAACCTCATACACCA"	-4.1757586998051	3.52740094745485	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.157894736842105	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACCTCATACACCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1532.41176314979	50.9571633635298	0.0332529184315253	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1532.41176314979	1532.41176314979
"AML-0693"	"2021-03-09-AML0693:AGAACCTGTATGGGAC"	0.0826496790045917	11.2530946501526	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAACCTGTATGGGAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1447.26395988343	48.0012529539624	0.0331668958009766	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1444.87413218689	1444.87413218689
"AML-0693"	"2021-03-09-AML0693:AGAAGCGAGGTGCGAT"	11.3317181068355	-1.24251677906188	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.289473684210526	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAGCGAGGTGCGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1646.88704916521	43.5146523493532	0.0264223659852146	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1633.02173039761	1633.02173039761
"AML-0693"	"2021-03-09-AML0693:AGAAGTAAGCACTTTG"	-7.54496179047282	-4.65094854747923	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAGTAAGCACTTTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2741.91825511331	33.6554755938373	0.0122744270479524	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2735.72344963999	2735.72344963999
"AML-0693"	"2021-03-09-AML0693:AGAAGTAGTGACACGA"	-8.62152324143108	-4.50800087368163	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAGTAGTGACACGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2899.12710784019	48.4718694209991	0.0167194702467219	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2887.12940754432	2887.12940754432
"AML-0693"	"2021-03-09-AML0693:AGAAGTATCTTGAGCA"	-5.39120755615886	1.8439469107422	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.8	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAAGTATCTTGAGCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1783.38743046108	21.9858212722908	0.0123281239380534	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1768.0664725763	1768.0664725763
"AML-0693"	"2021-03-09-AML0693:AGACAAACACCTCTAC"	-6.90040812912639	3.69313237750856	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACAAACACCTCTAC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2697.20385203537	41.7098959314738	0.0154641244116564	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2683.20818925267	2683.20818925267
"AML-0693"	"2021-03-09-AML0693:AGACACTAGTCCCGAC"	9.27817596968953	7.81154439533082	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACACTAGTCCCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1909.95605514517	50.4543380613113	0.0264164915864917	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1899.60159294646	1899.60159294646
"AML-0693"	"2021-03-09-AML0693:AGACACTCAAGAGATT"	-4.85845838013347	2.89621183955995	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACACTCAAGAGATT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3332.5624264547	30.1698180636695	0.00905303913414316	3308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3319.0210397395	3319.0210397395
"AML-0693"	"2021-03-09-AML0693:AGACACTCAAGCTGTT"	10.8360735374386	-2.95196845447692	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACACTCAAGCTGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1953.1964972969	43.2928732128534	0.0221651396942233	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1945.38381590839	1945.38381590839
"AML-0693"	"2021-03-09-AML0693:AGACACTGTAGGTAGC"	-7.01312814179118	3.78191659534303	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACACTGTAGGTAGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2495.01292285265	38.2053480418108	0.0153126854341616	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2484.43466271371	2484.43466271371
"AML-0693"	"2021-03-09-AML0693:AGACACTTCAGCTTCC"	-8.49694190445598	-3.43204691326293	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACACTTCAGCTTCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3030.76379408459	50.9471905863247	0.0168100168959926	2735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3021.83751759771	3021.83751759771
"AML-0693"	"2021-03-09-AML0693:AGACAGGGTCCGAAGA"	-8.85519538345988	-4.14212849056395	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACAGGGTCCGAAGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2651.85218104193	48.9238735405624	0.018448944436013	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2646.14402495726	2646.14402495726
"AML-0693"	"2021-03-09-AML0693:AGACAGGGTGCATGAG"	1.4292742210323	-10.1933746567932	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACAGGGTGCATGAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2920.06929676002	35.2195376670994	0.012061199268859	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2908.5143009714	2908.5143009714
"AML-0693"	"2021-03-09-AML0693:AGACAGGGTTAAGACA"	-7.57299075546916	-2.43519976055297	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACAGGGTTAAGACA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2546.59020678435	0	0	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2534.1094806581	2534.1094806581
"AML-0693"	"2021-03-09-AML0693:AGACAGGTCGAACGCC"	-1.86996052685435	11.5458421477112	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACAGGTCGAACGCC"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	2121.34090871899	49.0135765609904	0.0231049975793793	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2116.0284103505	2116.0284103505
"AML-0693"	"2021-03-09-AML0693:AGACCATAGGGATCTG"	-7.20619044724162	-2.8361912003723	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACCATAGGGATCTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3208.06595531181	40.6553287361735	0.012672846912283	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3189.97181331932	3189.97181331932
"AML-0693"	"2021-03-09-AML0693:AGACCATCAAGGACAC"	8.30275597152058	5.9646367796692	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACCATCAAGGACAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1486.070618686	53.8851878029071	0.036260179782407	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1479.55779663517	1479.55779663517
"AML-0693"	"2021-03-09-AML0693:AGACCATGTGTTAACC"	1.34337772902791	-10.4339618912903	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACCATGTGTTAACC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2349.23813702386	23.6531420615851	0.0100684309899507	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2345.18246259788	2345.18246259788
"AML-0693"	"2021-03-09-AML0693:AGACTCAAGCTAAATG"	8.71322407302205	8.14399812305299	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACTCAAGCTAAATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1968.02967863608	42.2038715821404	0.0214447332986305	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1950.45178820583	1950.45178820583
"AML-0693"	"2021-03-09-AML0693:AGACTCAGTTGTTGCA"	3.63277926024739	-1.68488612091216	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	17	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.6	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGACTCAGTTGTTGCA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2563.7064249361	49.2353850044399	0.0192047671783118	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2550.71778625856	2550.71778625856
"AML-0693"	"2021-03-09-AML0693:AGAGAATAGGTTGACG"	0.748488445847672	9.35644528949586	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAATAGGTTGACG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1689.51633670153	31.6786963712529	0.0187501568840108	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1685.67480206707	1685.67480206707
"AML-0693"	"2021-03-09-AML0693:AGAGAATGTAGTTACC"	11.9758783775264	-2.92614295398863	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAATGTAGTTACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1616.20457169851	41.2435461001474	0.0255187658928619	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1612.21046291747	1612.21046291747
"AML-0693"	"2021-03-09-AML0693:AGAGAATGTGACTAAA"	-2.39510522309001	3.85594794833986	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAATGTGACTAAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3237.90084098983	23.4874234805356	0.00725390449985351	3579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3235.37615404867	3235.37615404867
"AML-0693"	"2021-03-09-AML0693:AGAGAATGTTCAGTAC"	-7.60505757752116	-3.25320079242858	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAATGTTCAGTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1895.35456335829	25.9933039631892	0.0137142170999039	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1871.29046875477	1871.29046875477
"AML-0693"	"2021-03-09-AML0693:AGAGAGCGTACCGTCG"	-7.15343747559245	-2.93898632442626	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAGCGTACCGTCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1451.32172314804	28.1203431994337	0.0193756785631502	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1441.84526384903	1441.84526384903
"AML-0693"	"2021-03-09-AML0693:AGAGAGCTCTGCGTCT"	-7.47236953201945	-0.595192276593767	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAGCTCTGCGTCT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3402.01733139755	32.1236279034767	0.00944252329551782	4386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3393.62967395912	3393.62967395912
"AML-0693"	"2021-03-09-AML0693:AGAGAGCTCTGTGCTC"	-6.9072998565739	-2.70212175762328	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGAGCTCTGTGCTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1638.04057127154	13.359793287211	0.00815595994477739	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1625.58242276949	1625.58242276949
"AML-0693"	"2021-03-09-AML0693:AGAGCAGAGCTGAAGC"	-8.03991446915324	-2.69090273296507	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGCAGAGCTGAAGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1368.78335883647	45.0998201078993	0.0329488372405669	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1366.7540473204	1366.7540473204
"AML-0693"	"2021-03-09-AML0693:AGAGCAGCAAGCACAG"	-6.96288762512858	-2.89091827785643	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGCAGCAAGCACAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1965.20347124538	47.7583030549688	0.0243019635135814	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1956.33473768882	1956.33473768882
"AML-0693"	"2021-03-09-AML0693:AGAGCAGTCATGCCAA"	-8.3310903114384	-4.65208389675292	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGCAGTCATGCCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2231.19529675541	50.660896792316	0.022705720501467	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2224.82029871572	2224.82029871572
"AML-0693"	"2021-03-09-AML0693:AGAGCCCCAATACCTG"	8.41245998915974	6.50907943332521	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGCCCCAATACCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1698.19613409406	43.3701793594251	0.0255389695505118	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1695.07158570749	1695.07158570749
"AML-0693"	"2021-03-09-AML0693:AGAGCCCGTCACGACC"	-8.65513072434123	0.809549249056257	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGAGCCCGTCACGACC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2754.60483945631	42.3596076851667	0.0153777438703431	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2735.88750034593	2735.88750034593
"AML-0693"	"2021-03-09-AML0693:AGATAGACAGATCCTA"	-6.94939790192302	3.87590715968934	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATAGACAGATCCTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2236.59001450989	42.6693250630296	0.0190778483254473	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2228.63610685388	2228.63610685388
"AML-0693"	"2021-03-09-AML0693:AGATAGAGTCACGTGC"	-2.80870757523234	3.64237759197084	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATAGAGTCACGTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3291.38606560739	29.6316728154657	0.00900279463569933	4232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3285.36044686692	3285.36044686692
"AML-0693"	"2021-03-09-AML0693:AGATAGATCATCACCC"	-0.86114345017131	10.0566797026428	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATAGATCATCACCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2031.18451335605	51.5614659287477	0.0253849247026577	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2029.42659673685	2029.42659673685
"AML-0693"	"2021-03-09-AML0693:AGATAGATCTCAGAAC"	8.61527313765828	6.92014310443727	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATAGATCTCAGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1415.58167200621	48.5179923860703	0.0342742445353286	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1399.05130722966	1399.05130722966
"AML-0693"	"2021-03-09-AML0693:AGATCCACAGATGCGA"	9.48011745986287	6.83182809436647	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCCACAGATGCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1712.18178526282	47.1396596453106	0.027531924501857	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1704.74595082553	1704.74595082553
"AML-0693"	"2021-03-09-AML0693:AGATCCATCCGTTGGG"	8.28759445723836	6.47854087436525	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCCATCCGTTGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1669.40873902897	46.1242321176699	0.0276290827041545	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1656.6008905831	1656.6008905831
"AML-0693"	"2021-03-09-AML0693:AGATCGTAGAAACTCA"	-7.0280912918156	3.98636291110841	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTAGAAACTCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2284.49151178427	35.2751531136684	0.0154411399349509	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2270.95863217239	2270.95863217239
"AML-0693"	"2021-03-09-AML0693:AGATCGTAGAGAATCT"	-7.85625920715983	-3.13964512264403	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTAGAGAATCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1479.36724976887	42.8253094625099	0.0289483963290393	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1467.80047223886	1467.80047223886
"AML-0693"	"2021-03-09-AML0693:AGATCGTAGATGAATC"	0.882227917283219	-9.38418390667113	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTAGATGAATC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1908.19934430282	43.0569895340005	0.0225641988938697	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1891.32017807913	1891.32017807913
"AML-0693"	"2021-03-09-AML0693:AGATCGTCAGACAAGC"	-7.38489947739299	-2.2272258034912	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTCAGACAAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2014.53633641651	22.6991455922026	0.011267677421287	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2002.5592994567	2002.5592994567
"AML-0693"	"2021-03-09-AML0693:AGATCGTGTCCAACGC"	-6.98720727387126	3.97944519603578	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTGTCCAACGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1892.31441271795	45.1276379285304	0.0238478540485845	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1885.39872506672	1885.39872506672
"AML-0693"	"2021-03-09-AML0693:AGATCGTTCGAACCAT"	11.8080736595089	-2.91694166576537	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATCGTTCGAACCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1936.51895668278	40.6245014879273	0.0209781067971141	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1930.58778731562	1930.58778731562
"AML-0693"	"2021-03-09-AML0693:AGATGAAGTCAGGTGA"	11.5551048713619	-2.51596691524657	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATGAAGTCAGGTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1610.45888208017	46.6908846042437	0.0289922860644135	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1606.16145327102	1606.16145327102
"AML-0693"	"2021-03-09-AML0693:AGATGAAGTGGTCCCA"	10.9086567359859	-2.83298637783202	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATGAAGTGGTCCCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1659.68501094755	49.1559989538513	0.0296176675872894	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1658.40432905774	1658.40432905774
"AML-0693"	"2021-03-09-AML0693:AGATGCTGTCTTTATC"	9.76008286055867	6.94846389377443	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATGCTGTCTTTATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1791.76643347799	50.1751088333654	0.0280031525849999	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1783.61778597655	1783.61778597655
"AML-0693"	"2021-03-09-AML0693:AGATGCTTCACCCTCA"	-5.27732787552531	-5.88991405880126	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATGCTTCACCCTCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3221.75237307395	50.1768676071715	0.0155744023117756	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3214.29812076696	3214.29812076696
"AML-0693"	"2021-03-09-AML0693:AGATGCTTCCGATAGT"	-6.92685351792033	3.86898181522218	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGATGCTTCCGATAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2059.42124401798	41.9266953216731	0.0203584844253977	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2047.73498190147	2047.73498190147
"AML-0693"	"2021-03-09-AML0693:AGCATCACAATTTCTC"	0.855805893510026	9.85799596393434	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCATCACAATTTCTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1668.97281442555	49.2790676335348	0.0295265849794542	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1666.99148572798	1666.99148572798
"AML-0693"	"2021-03-09-AML0693:AGCATCAGTACTAAGA"	-2.31092963638957	3.93270418727723	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCATCAGTACTAAGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3477.55522750486	31.4255336295582	0.00903667420750236	5626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3473.06666898295	3473.06666898295
"AML-0693"	"2021-03-09-AML0693:AGCATCAGTTGCTCGG"	12.0968271690303	-2.74478700077208	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCATCAGTTGCTCGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1513.07327153219	43.6746579043669	0.0288648664450602	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1513.07327153219	1513.07327153219
"AML-0693"	"2021-03-09-AML0693:AGCATCATCAGCTGAT"	1.66600479659383	-9.78821470653685	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCATCATCAGCTGAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2361.40805695522	45.7816775287308	0.0193874486850703	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2347.22614477156	2347.22614477156
"AML-0693"	"2021-03-09-AML0693:AGCCAATGTGGTTCTA"	-7.00463853302653	3.7932889231476	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCAATGTGGTTCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2521.50106176904	38.8147545701256	0.0153935110948927	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2502.54186476708	2502.54186476708
"AML-0693"	"2021-03-09-AML0693:AGCCACGAGGTCGACA"	14.1845232444698	2.01495978916017	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCACGAGGTCGACA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1146.3926233331	12.2816227653662	0.0107132779079281	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1135.55428063547	1135.55428063547
"AML-0693"	"2021-03-09-AML0693:AGCCACGAGTGTTCCA"	-7.06172070923503	4.0383193262848	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCACGAGTGTTCCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2270.25378564599	36.8703946347454	0.0162406488947904	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2257.03197122766	2257.03197122766
"AML-0693"	"2021-03-09-AML0693:AGCCACGGTCCAGTTA"	-7.27106128159221	-2.74273159420165	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCACGGTCCAGTTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3112.04824770547	0.495420904258487	0.000159194480555937	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3090.66047242228	3090.66047242228
"AML-0693"	"2021-03-09-AML0693:AGCCACGGTCTACATG"	14.1851259666378	2.00538477981416	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCACGGTCTACATG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1454.26958375637	14.8493765129563	0.0102108829606409	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1443.84709828232	1443.84709828232
"AML-0693"	"2021-03-09-AML0693:AGCCACGGTGTTAGCT"	8.66512264785115	6.0935168036255	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCACGGTGTTAGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1473.75690937502	46.8226006675792	0.0317709117220935	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1466.60231461269	1466.60231461269
"AML-0693"	"2021-03-09-AML0693:AGCCAGCCAATTCACG"	-9.04679332199748	-3.72018458759459	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCAGCCAATTCACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3133.83336327213	48.3064751637138	0.0154145002506692	3149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3124.814043186	3124.814043186
"AML-0693"	"2021-03-09-AML0693:AGCCAGCTCAGCGCGT"	14.302244802087	2.04400405967561	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCAGCTCAGCGCGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1471.34654270976	3.31065203566721	0.00225008313104134	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1453.26959130537	1453.26959130537
"AML-0693"	"2021-03-09-AML0693:AGCCAGCTCCTGCCAT"	-9.10012946549113	-3.81878664409789	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCCAGCTCCTGCCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3021.43267353858	27.0712273187184	0.008959732101862	3016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3009.33808663303	3009.33808663303
"AML-0693"	"2021-03-09-AML0693:AGCGATTGTACAGTTC"	-7.29744754257854	-3.02655746853026	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGATTGTACAGTTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1838.40097301674	38.2685968171465	0.0208162405149022	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1828.10757570896	1828.10757570896
"AML-0693"	"2021-03-09-AML0693:AGCGATTGTATTAAGG"	8.03569283065144	6.0627231367859	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGATTGTATTAAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1472.99963494221	47.5565937678544	0.0322855434853656	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1463.98845288465	1463.98845288465
"AML-0693"	"2021-03-09-AML0693:AGCGCCAGTGTACGCC"	9.41095509108846	7.58949515903322	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGCCAGTGTACGCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.81390485374	45.8589205954952	0.0288273320063239	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1580.28282699458	1580.28282699458
"AML-0693"	"2021-03-09-AML0693:AGCGCTGAGGTACCTT"	8.94476856765096	6.86789128864137	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGCTGAGGTACCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1910.23600183163	45.5695928026674	0.0238554779404079	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1903.5741334173	1903.5741334173
"AML-0693"	"2021-03-09-AML0693:AGCGCTGCACCAGCCA"	8.50869717177693	7.02918241107789	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGCTGCACCAGCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.88669242922	39.8007032782387	0.0250179371464002	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1586.9888873187	1586.9888873187
"AML-0693"	"2021-03-09-AML0693:AGCGCTGCATTGCTGA"	-8.90424666824992	-3.80944945728453	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGCTGCATTGCTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3273.63051461545	50.4088881438247	0.0153984659902115	2995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3258.04187392144	3258.04187392144
"AML-0693"	"2021-03-09-AML0693:AGCGCTGTCGTTTACT"	-7.02921328964885	4.01448700511781	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGCTGTCGTTTACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1760.05892840313	52.5333176849015	0.029847476602709	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1758.15164886829	1758.15164886829
"AML-0693"	"2021-03-09-AML0693:AGCGTCGGTTACCCAA"	-7.05631719055827	-2.66799619114073	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCGTCGGTTACCCAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1894.48130673707	25.3410133156115	0.0133762276911865	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1888.27721320565	1888.27721320565
"AML-0693"	"2021-03-09-AML0693:AGCTACAGTCTCAAGT"	-7.79815373840983	-3.55852010166319	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTACAGTCTCAAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3383.70077683108	21.4290750997248	0.0063330289860304	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3364.8515323468	3364.8515323468
"AML-0693"	"2021-03-09-AML0693:AGCTCAAAGTTACGTC"	0.10016350176875	12.8678378828797	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ IFN+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAAAGTTACGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1550.63203273218	50.3430802628153	0.0324661681173399	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1545.86310759289	1545.86310759289
"AML-0693"	"2021-03-09-AML0693:AGCTCAACACGATAGG"	-7.37745938721355	-2.52068593418273	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAACACGATAGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2155.4394169228	32.3571111858596	0.0150118397816321	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2144.71407795737	2144.71407795737
"AML-0693"	"2021-03-09-AML0693:AGCTCAACATGGGTCC"	11.9849935966427	-2.72920753872069	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAACATGGGTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1502.5912603161	51.6765068855592	0.0343915928771527	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1484.4409107038	1484.4409107038
"AML-0693"	"2021-03-09-AML0693:AGCTCAAGTATACCCA"	8.75581612166707	6.92058799350587	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAAGTATACCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1579.39099583138	37.157880106218	0.0235267139070008	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1575.87076574303	1575.87076574303
"AML-0693"	"2021-03-09-AML0693:AGCTCAAGTCTCGGAC"	-8.69254908981975	-4.25592949306639	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAAGTCTCGGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2462.48880352266	51.7279848382681	0.0210063837708702	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2448.54614489315	2448.54614489315
"AML-0693"	"2021-03-09-AML0693:AGCTCAAGTGCTGCAC"	1.18402876433675	-9.98778726970824	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAAGTGCTGCAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2766.76065328732	35.6107873829233	0.0128709316942947	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2759.43243992237	2759.43243992237
"AML-0693"	"2021-03-09-AML0693:AGCTCAAGTTGTGCAT"	-7.01597199860271	3.61326263034669	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAAGTTGTGCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2696.74783108242	32.273544432204	0.011967579638045	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2680.79700444321	2680.79700444321
"AML-0693"	"2021-03-09-AML0693:AGCTCAATCGTGGCGT"	-7.23623214188274	-2.44056036388548	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTCAATCGTGGCGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1772.8212395876	49.4659642049736	0.0279023982228917	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1764.02003047534	1764.02003047534
"AML-0693"	"2021-03-09-AML0693:AGCTTCCGTAGAGGAA"	-7.03181300583537	-2.69610884105834	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCGTAGAGGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1943.32205109943	2.06341065389767	0.00106179552315083	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1930.03070659983	1930.03070659983
"AML-0693"	"2021-03-09-AML0693:AGCTTCCGTCGTTGGC"	-8.2942307991093	-4.48783781444701	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCGTCGTTGGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2205.25389559925	46.9553808973672	0.0212925055890708	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2190.15161386042	2190.15161386042
"AML-0693"	"2021-03-09-AML0693:AGCTTCCGTCTAGGCC"	1.3831795650417	-10.1624927750793	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCGTCTAGGCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2685.69176233764	30.0490010089185	0.0111885516537325	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2678.26240318516	2678.26240318516
"AML-0693"	"2021-03-09-AML0693:AGCTTCCTCCGTGCGA"	-0.908356170088607	10.6970710524353	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCTCCGTGCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1504.13694065583	48.1522502549236	0.032013209006042	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1499.48630587325	1499.48630587325
"AML-0693"	"2021-03-09-AML0693:AGCTTCCTCGCTTGAA"	-8.71884856644328	-4.07391168987425	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCTCGCTTGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2898.57070254124	44.3281290245753	0.0152930991076781	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2886.23810419637	2886.23810419637
"AML-0693"	"2021-03-09-AML0693:AGCTTCCTCGTTCTAT"	1.27585997161214	10.0791301497254	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGCTTCCTCGTTCTAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1771.82842689827	52.7509772153149	0.0297720571667652	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1767.07772746315	1767.07772746315
"AML-0693"	"2021-03-09-AML0693:AGGAAATAGTTAACGA"	10.2362925010616	6.8280925520691	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATAGTTAACGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1814.1221487262	41.3491235129176	0.0227929103571947	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1810.57149969958	1810.57149969958
"AML-0693"	"2021-03-09-AML0693:AGGAAATCAAATCGTC"	-9.02226005020793	-1.75181820308837	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATCAAATCGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3090.25412789783	47.4123750983761	0.0153425489089561	3358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3081.6296526643	3081.6296526643
"AML-0693"	"2021-03-09-AML0693:AGGAAATCAGGGTTGA"	-8.10115466538127	-4.78614761745604	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATCAGGGTTGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2492.28966165021	47.5872334223817	0.0190937811742448	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2482.20483074879	2482.20483074879
"AML-0693"	"2021-03-09-AML0693:AGGAAATCAGTCGGTC"	1.09315695342366	10.387310005072	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATCAGTCGGTC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1705.42705288997	39.7439104340511	0.0233043743305832	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1701.72670121027	1701.72670121027
"AML-0693"	"2021-03-09-AML0693:AGGAAATCATCGGATT"	0.697095950215501	9.74465653980104	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATCATCGGATT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1597.07396822805	38.3144518724174	0.0239904053504343	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1590.85341216308	1590.85341216308
"AML-0693"	"2021-03-09-AML0693:AGGAAATGTACAGTAA"	-4.88066897812541	2.95929286563722	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATGTACAGTAA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3392.83541300386	47.1370591146231	0.0138931169292678	3280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3379.79870128597	3379.79870128597
"AML-0693"	"2021-03-09-AML0693:AGGAAATGTGTGTTTG"	-7.23327956619914	-2.9155311814514	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATGTGTGTTTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2967.89860566752	2.89262245625646	0.000974636549487467	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2942.11255485415	2942.11255485415
"AML-0693"	"2021-03-09-AML0693:AGGAAATTCACACCCT"	0.480113764374894	9.28383443439332	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATTCACACCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1602.68671310215	46.972764722517	0.0293087628034282	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1589.8922854814	1589.8922854814
"AML-0693"	"2021-03-09-AML0693:AGGAAATTCGGCTTGG"	8.70614399489705	7.91830728137819	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAAATTCGGCTTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1917.11485744373	34.7136667613652	0.0181072441364583	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1907.60706825212	1907.60706825212
"AML-0693"	"2021-03-09-AML0693:AGGAATACAGCGTGAA"	0.101649605750483	11.4100913771423	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAATACAGCGTGAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1833.12759591005	46.9300465444247	0.025601080169832	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1821.35955091488	1821.35955091488
"AML-0693"	"2021-03-09-AML0693:AGGAATAGTCAGGCAA"	9.01977409896199	7.04349801624147	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAATAGTCAGGCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1771.49690202295	37.3718737412631	0.0210962117396798	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1766.29660664385	1766.29660664385
"AML-0693"	"2021-03-09-AML0693:AGGAATATCCGTGTGG"	8.42399563369099	6.53223798358766	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAATATCCGTGTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1739.16740477753	50.1760488778201	0.028850614805674	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1728.94280045546	1728.94280045546
"AML-0693"	"2021-03-09-AML0693:AGGACGAAGCATCCTA"	-7.13975129547771	3.8619858988556	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACGAAGCATCCTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2422.6209956381	29.9608740634423	0.0123671321751881	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2402.98790287546	2402.98790287546
"AML-0693"	"2021-03-09-AML0693:AGGACGAAGTTGGAGC"	-7.60048470917399	-4.17468788540038	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACGAAGTTGGAGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1691.6003628501	30.996929628622	0.0183240263535985	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1679.03978000779	1679.03978000779
"AML-0693"	"2021-03-09-AML0693:AGGACGACATTACGGT"	-7.74433455887492	-2.73509480869444	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACGACATTACGGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1440.24351929383	37.6119900170646	0.0261150211844079	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1427.29310204274	1427.29310204274
"AML-0693"	"2021-03-09-AML0693:AGGACGATCCACGTCT"	-7.04203448715861	3.99278209293214	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACGATCCACGTCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1963.29000831604	42.3793248450371	0.021585870994875	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1935.78972555421	1935.78972555421
"AML-0693"	"2021-03-09-AML0693:AGGACTTCAGGGATAC"	8.68159260329549	7.50146291339723	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACTTCAGGGATAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1664.60099838353	47.1265774142984	0.0283110351730308	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1661.15786129854	1661.15786129854
"AML-0693"	"2021-03-09-AML0693:AGGACTTCATCCGTGG"	11.3378874259884	-2.86499621784361	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACTTCATCCGTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1823.45915319658	38.7412585463245	0.0212460248853997	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1815.46420547587	1815.46420547587
"AML-0693"	"2021-03-09-AML0693:AGGACTTTCACGATAC"	14.0407511192257	1.70795903289644	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGACTTTCACGATAC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1339.56291977019	14.7235965685231	0.010991343781783	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1326.62777700906	1326.62777700906
"AML-0693"	"2021-03-09-AML0693:AGGAGGTCACCGCTGA"	14.0585018592769	2.14366791332094	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAGGTCACCGCTGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1158.10430753059	5.34447306390476	0.00461484602824828	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1138.84884733465	1138.84884733465
"AML-0693"	"2021-03-09-AML0693:AGGAGGTCACTGCACG"	1.22162594374959	10.0945052870545	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAGGTCACTGCACG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1952.43101539822	38.8550342414268	0.0199008487034826	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1942.83437278538	1942.83437278538
"AML-0693"	"2021-03-09-AML0693:AGGAGGTGTGCCGTAC"	8.05422272261922	6.32036206806032	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAGGTGTGCCGTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1504.95678314488	42.5408849505704	0.0282671804446594	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1502.70009847561	1502.70009847561
"AML-0693"	"2021-03-09-AML0693:AGGAGGTTCCGCACTT"	0.935965498059434	9.85373017871705	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGAGGTTCCGCACTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1829.09330919401	30.1543282613328	0.0164859431226176	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1819.72108148966	1819.72108148966
"AML-0693"	"2021-03-09-AML0693:AGGATAAAGCCAAGCA"	0.457884271710557	9.92483899677125	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAAAGCCAAGCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1366.60813508727	40.6017010168071	0.0297098341319433	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1359.5469579552	1359.5469579552
"AML-0693"	"2021-03-09-AML0693:AGGATAAAGCGCACAA"	-2.72731695595439	3.23297760570375	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAAAGCGCACAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3344.08724443037	27.104165288038	0.0081051011253311	4738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3338.60596006784	3338.60596006784
"AML-0693"	"2021-03-09-AML0693:AGGATAACAATTGAAG"	-2.4237245124882	3.7541498907837	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAACAATTGAAG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1472.29624805897	47.4782140659048	0.0322477314796521	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1470.08931704932	1470.08931704932
"AML-0693"	"2021-03-09-AML0693:AGGATAAGTAACACGG"	11.7427717643673	-2.84613301670226	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAAGTAACACGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1517.36040308686	52.1588098204672	0.0343747007727086	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1504.59093477619	1504.59093477619
"AML-0693"	"2021-03-09-AML0693:AGGATAAGTCTAACGT"	-0.084272469312507	10.9682998427185	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAAGTCTAACGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1692.2211002123	47.8343087555816	0.0282671742773924	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1688.01788411265	1688.01788411265
"AML-0693"	"2021-03-09-AML0693:AGGATAATCACATTGG"	-7.7712439102238	-2.60994508182677	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATAATCACATTGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2455.49602662821	8.63027841287423	0.00351467822357871	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2444.9073526164	2444.9073526164
"AML-0693"	"2021-03-09-AML0693:AGGATCTAGCGGTATG"	-8.91836486283	-3.79191806232604	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATCTAGCGGTATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3296.5290572123	44.9617829432353	0.0136391283567987	4630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3284.55357667737	3284.55357667737
"AML-0693"	"2021-03-09-AML0693:AGGATCTAGTCCCAGC"	1.41064753112141	-8.28956320202025	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00124100273020601	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGATCTAGTCCCAGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2761.08045904397	31.8162832024581	0.0115231278749025	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2757.34151751465	2757.34151751465
"AML-0693"	"2021-03-09-AML0693:AGGCATTAGACAGTCG"	0.311915745108765	11.1145133742127	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCATTAGACAGTCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1780.97444505546	48.5255965041417	0.0272466551324551	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1778.74559676681	1778.74559676681
"AML-0693"	"2021-03-09-AML0693:AGGCATTAGACGCCAA"	1.00109334763829	10.1149720915589	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCATTAGACGCCAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1664.40198806743	49.7727772736925	0.0299043005418929	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1664.40198806743	1664.40198806743
"AML-0693"	"2021-03-09-AML0693:AGGCATTGTATCACCA"	-7.05300937119182	1.41669080341188	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCATTGTATCACCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2614.68926129094	48.8033991292608	0.0186650856955619	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2604.47228534231	2604.47228534231
"AML-0693"	"2021-03-09-AML0693:AGGCATTTCTTGGATG"	8.48071541365926	7.86801288211671	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCATTTCTTGGATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1686.45750338083	39.5031834791217	0.0234237645478347	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1686.45750338083	1686.45750338083
"AML-0693"	"2021-03-09-AML0693:AGGCCACCAGTAGTGG"	8.97973599013631	6.47709653461305	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCCACCAGTAGTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1857.39152516463	49.3377018251198	0.026562898105582	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1851.80956462349	1851.80956462349
"AML-0693"	"2021-03-09-AML0693:AGGCCACGTCCACACG"	-2.02759800377544	3.73009965503541	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCCACGTCCACACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3002.41109036709	9.55119914234342	0.003181176346233	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2998.60138552932	2998.60138552932
"AML-0693"	"2021-03-09-AML0693:AGGCTGCAGGTTCTAC"	-6.93884454193767	3.87898824298707	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCAGGTTCTAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2502.72039621711	42.382003001715	0.0169343739179878	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2491.79421472743	2491.79421472743
"AML-0693"	"2021-03-09-AML0693:AGGCTGCCAGAGGACT"	-6.91867623749431	3.89639828288881	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCCAGAGGACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2097.62756362763	40.1162349040049	0.0191245746383252	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2088.41062939021	2088.41062939021
"AML-0693"	"2021-03-09-AML0693:AGGCTGCGTCGTCATA"	-8.38383231583293	-3.56529285823973	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCGTCGTCATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2711.94949391266	45.6283319475163	0.0168249195089862	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2701.36791163922	2701.36791163922
"AML-0693"	"2021-03-09-AML0693:AGGCTGCGTGAGTCAG"	-6.88587794724162	3.80034992778627	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCGTGAGTCAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2532.50134522378	38.7541690342416	0.0153027239678789	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2512.79551060559	2512.79551060559
"AML-0693"	"2021-03-09-AML0693:AGGCTGCTCCCAGGCA"	8.59317841109578	7.782350517157	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCTCCCAGGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1907.94174803647	38.0738819022091	0.019955473976809	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1903.54636257868	1903.54636257868
"AML-0693"	"2021-03-09-AML0693:AGGCTGCTCGGTAACT"	-7.01647267761882	3.89819905841676	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCTCGGTAACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2246.47204060316	45.8644521238796	0.0204162131978128	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2236.80387239935	2236.80387239935
"AML-0693"	"2021-03-09-AML0693:AGGCTGCTCTTACCAT"	-8.39708266678508	-3.42142584240111	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGCTGCTCTTACCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2917.99986840836	51.9468737956404	0.0178022193756901	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2906.41461590697	2906.41461590697
"AML-0693"	"2021-03-09-AML0693:AGGGAGTGTCGTCATA"	-2.4402063888615	3.35936949336854	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGAGTGTCGTCATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3302.06948395522	21.2774899434795	0.00644368328615341	4010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3298.24277360209	3298.24277360209
"AML-0693"	"2021-03-09-AML0693:AGGGCCTCATCATTGG"	8.75731529769246	6.2717132338318	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGCCTCATCATTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1717.29749328702	35.2584734700644	0.0205313718839578	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1715.32271680479	1715.32271680479
"AML-0693"	"2021-03-09-AML0693:AGGGCCTCATCTAACG"	-6.88281760636027	3.81784699046937	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGCCTCATCTAACG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2196.85840813645	36.320131513045	0.0165327594070364	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2174.21982214808	2174.21982214808
"AML-0693"	"2021-03-09-AML0693:AGGGCCTTCCTTGGAA"	-9.47459540787395	-3.23646809971007	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGCCTTCCTTGGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2901.60979294877	50.9877961711541	0.0175722443090246	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2888.53400186172	2888.53400186172
"AML-0693"	"2021-03-09-AML0693:AGGGCTCGTTCAGCTA"	11.1859079795772	-2.7382760277954	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGCTCGTTCAGCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1701.48805617828	51.4991411516449	0.0302671188108821	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1699.62517625166	1699.62517625166
"AML-0693"	"2021-03-09-AML0693:AGGGTCCAGATCCCAT"	-7.20518956604655	-2.97996284877928	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTCCAGATCCCAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2952.77970869258	20.760549625655	0.00703084946179317	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2935.48746015997	2935.48746015997
"AML-0693"	"2021-03-09-AML0693:AGGGTCCAGTCCGCCA"	0.838514943688554	9.71259305560914	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTCCAGTCCGCCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1603.2911760258	52.9148531362443	0.0330038946932948	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1603.2911760258	1603.2911760258
"AML-0693"	"2021-03-09-AML0693:AGGGTCCCACGAGGAT"	-8.91840300980266	-3.61130955135497	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTCCCACGAGGAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2681.47384805575	40.9167070261921	0.0152590363899538	2987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2677.80172703278	2677.80172703278
"AML-0693"	"2021-03-09-AML0693:AGGGTCCGTCCTTTGC"	8.65370144423787	7.09580943668214	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTCCGTCCTTTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1787.2182948758	43.7493907500439	0.0244790414665513	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1780.34915285529	1780.34915285529
"AML-0693"	"2021-03-09-AML0693:AGGGTCCGTCTCTCCA"	8.01189913329427	5.98365686023561	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTCCGTCTCTCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1568.19133142975	42.0887445350002	0.0268390365967825	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1561.98828769474	1561.98828769474
"AML-0693"	"2021-03-09-AML0693:AGGGTGAAGTTCTACG"	-6.1639326614445	-0.663615786191545	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	10	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.111111111111111	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTGAAGTTCTACG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1455.95117829757	46.5452414892461	0.0319689576017728	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1374.04256351605	1374.04256351605
"AML-0693"	"2021-03-09-AML0693:AGGGTGACAATGGCAG"	-7.63377891007121	-3.60606624996337	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTGACAATGGCAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2185.45296950198	10.3608709077591	0.00474083453286123	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2160.77210752483	2160.77210752483
"AML-0693"	"2021-03-09-AML0693:AGGGTGACACTGCGAC"	9.39116444167439	7.56504628742067	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTGACACTGCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1845.44496981161	46.5805094082963	0.0252408010914849	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1823.45329846052	1823.45329846052
"AML-0693"	"2021-03-09-AML0693:AGGGTGATCGACGCTG"	11.3680635887081	-2.97169830715331	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTGATCGACGCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1739.79173466985	32.0015282648438	0.0183938845248719	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1735.60187414452	1735.60187414452
"AML-0693"	"2021-03-09-AML0693:AGGGTTTAGCATGATA"	-0.312860201031524	12.1737766035828	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	52	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.428571428571429	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTAGCATGATA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2072.87266110063	51.7401400270327	0.024960597434654	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2064.33521390536	2064.33521390536
"AML-0693"	"2021-03-09-AML0693:AGGGTTTAGCCGGATA"	8.09482063826863	6.23944280231325	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTAGCCGGATA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1647.31121110502	51.2264216798257	0.0310969908627423	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1643.41518983008	1643.41518983008
"AML-0693"	"2021-03-09-AML0693:AGGGTTTAGCGCACAA"	1.3888998228008	10.0986184843811	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTAGCGCACAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1964.64861125613	41.1698970747174	0.020955348879612	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1963.03474866985	1963.03474866985
"AML-0693"	"2021-03-09-AML0693:AGGGTTTAGTAAGACT"	-9.35553107681926	-3.27624084865721	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTAGTAAGACT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2614.78109377564	52.2612399134801	0.0199868509214349	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2604.98522092971	2604.98522092971
"AML-0693"	"2021-03-09-AML0693:AGGGTTTCATCAGCTA"	-7.0508283180302	-0.751261972543322	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTCATCAGCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3426.36619283546	27.7870685923485	0.00810977783123455	4875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3419.10414467697	3419.10414467697
"AML-0693"	"2021-03-09-AML0693:AGGGTTTGTAATACCC"	-7.8060167831486	-3.40089943325194	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTGTAATACCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2693.19105197507	4.26216094624124	0.00158256910259506	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2667.30896449852	2667.30896449852
"AML-0693"	"2021-03-09-AML0693:AGGGTTTGTACCTATG"	9.23153461989705	6.65372655475465	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGGTTTGTACCTATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1712.57226501979	32.5756872576864	0.0190214964489746	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1706.3873270818	1706.3873270818
"AML-0693"	"2021-03-09-AML0693:AGGTAGGGTGATAGAT"	11.9942337470943	-2.58177997982176	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTAGGGTGATAGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1931.09493491935	44.7919586973408	0.0231951096175453	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1921.95330009722	1921.95330009722
"AML-0693"	"2021-03-09-AML0693:AGGTAGGTCTCATTTG"	-0.563431004912216	10.8530177840027	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTAGGTCTCATTTG"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	2232.71158816618	43.8203676357725	0.0196265240293593	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2227.1112392884	2227.1112392884
"AML-0693"	"2021-03-09-AML0693:AGGTCATAGGCCTTGC"	8.91803516921346	6.71510837161867	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCATAGGCCTTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1685.66997591533	50.5006079790733	0.029958775264803	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1672.80978513328	1672.80978513328
"AML-0693"	"2021-03-09-AML0693:AGGTCATGTAACCCTA"	0.889613588421982	-10.2007847062317	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	35	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.666666666666667	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCATGTAACCCTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2624.47442085687	30.9295068761167	0.0117850288920013	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2619.89452379194	2619.89452379194
"AML-0693"	"2021-03-09-AML0693:AGGTCATGTTGGATCT"	9.44375290450398	7.63052270496217	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCATGTTGGATCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1685.67167708047	44.3053804176064	0.0262835171403853	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1681.70987894126	1681.70987894126
"AML-0693"	"2021-03-09-AML0693:AGGTCATTCACAGAGG"	8.88708843764607	6.82923934543458	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCATTCACAGAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1475.87228677251	45.3576465240101	0.0307327720227066	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1471.42158598577	1471.42158598577
"AML-0693"	"2021-03-09-AML0693:AGGTCATTCCAGCAAT"	-1.60554073277171	11.7035588988098	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCATTCCAGCAAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1989.56632579355	42.6932350097219	0.0214585633342449	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1983.90026790177	1983.90026790177
"AML-0693"	"2021-03-09-AML0693:AGGTCTACACTGTTCC"	-6.86582265320476	-2.56076028263243	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCTACACTGTTCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1805.81431666477	23.9364396898549	0.0132552054045424	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1793.4276195644	1793.4276195644
"AML-0693"	"2021-03-09-AML0693:AGGTCTAGTAGGCAAC"	14.2040354209835	2.03424034202424	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCTAGTAGGCAAC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1203.35891062314	1.08673649798755	0.000903085927559887	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1181.81835953297	1181.81835953297
"AML-0693"	"2021-03-09-AML0693:AGGTCTAGTTCCACAA"	11.0598217445308	-2.53975465213927	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCTAGTTCCACAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1586.38558177221	42.8849497637045	0.0270331187174534	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1579.79368833457	1579.79368833457
"AML-0693"	"2021-03-09-AML0693:AGGTCTATCGAAGCAG"	-4.81876740875896	2.40193936908571	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTCTATCGAAGCAG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2982.59717637445	32.9216467761602	0.0110379125404319	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2973.5311112943	2973.5311112943
"AML-0693"	"2021-03-09-AML0693:AGGTGTTAGACGCCAA"	-1.60788248005565	11.1310443648132	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTAGACGCCAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2033.65463003834	35.9627721052604	0.0176838149280945	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2025.72408812141	2025.72408812141
"AML-0693"	"2021-03-09-AML0693:AGGTGTTAGATACTGA"	-8.69168506088908	-4.86943056499632	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	11	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTAGATACTGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	2080.00928971265	50.033220726819	0.0240543256101183	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2032.94405743925	2032.94405743925
"AML-0693"	"2021-03-09-AML0693:AGGTGTTCACTTGAGT"	-5.63724694672282	-5.68646576320799	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTCACTTGAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3648.67648539177	39.2748330808191	0.0107641313879331	4258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3631.03479591667	3631.03479591667
"AML-0693"	"2021-03-09-AML0693:AGGTGTTGTGCAAGAC"	-1.67216144028361	-6.89968969738158	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	24	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTGTGCAAGAC"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2760.16998911857	38.2959427951063	0.0138744870591596	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2755.0616117818	2755.0616117818
"AML-0693"	"2021-03-09-AML0693:AGGTGTTGTTGTGTTG"	-6.5809248489445	-2.59835793888243	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTGTTGTGTTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1673.61625056806	24.0054619318065	0.0143434684765152	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1655.5975919986	1655.5975919986
"AML-0693"	"2021-03-09-AML0693:AGGTGTTTCTTCGCTG"	-8.31625304642375	-4.25368072902831	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTGTTTCTTCGCTG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2102.22786590717	36.8066180184071	0.0175083865147625	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2067.0369601394	2067.0369601394
"AML-0693"	"2021-03-09-AML0693:AGGTTACAGCACTCGC"	-7.98420367661174	-4.32202246105345	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTTACAGCACTCGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3074.77652020967	50.1394251365872	0.016306689220187	3585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3065.61346495422	3065.61346495422
"AML-0693"	"2021-03-09-AML0693:AGGTTACAGCATAGGC"	-7.13948855820354	-2.68773033535155	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTTACAGCATAGGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2444.15241021977	32.9721986547781	0.01349023838158	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2428.12028182786	2428.12028182786
"AML-0693"	"2021-03-09-AML0693:AGGTTACGTCGGTGAA"	-1.33367417278941	10.9938115843567	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTTACGTCGGTGAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2062.03447344606	44.320101797064	0.0214933854733265	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2058.43628352494	2058.43628352494
"AML-0693"	"2021-03-09-AML0693:AGGTTGTCAGACAAGC"	-9.84889064255412	-2.38447883045348	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGGTTGTCAGACAAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3491.98766171889	49.5730009312474	0.0141962130836527	4188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3477.77554963481	3477.77554963481
"AML-0693"	"2021-03-09-AML0693:AGTAACCAGTCCCGGT"	-7.85752950134929	-2.4846356145111	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAACCAGTCCCGGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3387.10592445056	0	0	2795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3360.03347132723	3360.03347132723
"AML-0693"	"2021-03-09-AML0693:AGTAACCTCCATAGAC"	-9.2093919319218	-3.00186254894408	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAACCTCCATAGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2796.76728922626	46.3276292120386	0.0165647064703962	4348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2791.70784231652	2791.70784231652
"AML-0693"	"2021-03-09-AML0693:AGTACCAAGACTGTTC"	9.71023716506306	7.21556136691896	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCAAGACTGTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1849.47283468638	41.8578796225193	0.0226323300550761	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1842.01655269356	1842.01655269356
"AML-0693"	"2021-03-09-AML0693:AGTACCAAGTTCATCG"	-6.89113984528239	3.91553661907045	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCAAGTTCATCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1638.62144784355	55.6222664897808	0.0339445492813369	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1627.30149490361	1627.30149490361
"AML-0693"	"2021-03-09-AML0693:AGTACCACAAGGCGTA"	1.05622829970662	9.38130757892457	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCACAAGGCGTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1593.42945303862	34.3728086284561	0.0215715911130602	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1587.97037169653	1587.97037169653
"AML-0693"	"2021-03-09-AML0693:AGTACCACACCCTATC"	8.05357327040974	6.4166106947693	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCACACCCTATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1932.33531336367	52.6916147912301	0.0272683599098069	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1928.10753451246	1928.10753451246
"AML-0693"	"2021-03-09-AML0693:AGTACCACATCTCATT"	-7.987531999976	-0.898225688096605	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCACATCTCATT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3199.23705087436	41.00336699807	0.0128166079430918	3463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3177.29033495119	3177.29033495119
"AML-0693"	"2021-03-09-AML0693:AGTACCAGTCGCTCGA"	1.14450254020039	-9.44048120891722	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCAGTCGCTCGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2541.7486685959	44.7710534263105	0.017614272402095	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2535.70136701857	2535.70136701857
"AML-0693"	"2021-03-09-AML0693:AGTACCAGTCTGTGAT"	-7.80619321289714	-4.82292702114256	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCAGTCTGTGAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2593.00782012306	45.2981796224895	0.0174693571191543	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2578.2567385852	2578.2567385852
"AML-0693"	"2021-03-09-AML0693:AGTACCAGTTGGTAGG"	-4.86746678772624	2.47223374927369	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACCAGTTGGTAGG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3356.85456514492	32.8177372820725	0.00977633574681118	3391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3347.19467162619	3347.19467162619
"AML-0693"	"2021-03-09-AML0693:AGTACTGCAAAGCAAT"	7.97366346892659	6.20453021610109	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACTGCAAAGCAAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1364.03302248826	40.3002580653309	0.0295449284591478	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1364.03302248826	1364.03302248826
"AML-0693"	"2021-03-09-AML0693:AGTACTGCAGCGACAA"	-5.57448182526286	3.69694516742555	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACTGCAGCGACAA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2553.7039948915	49.270212185091	0.01929362693705	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2545.24401242493	2545.24401242493
"AML-0693"	"2021-03-09-AML0693:AGTACTGCATTGCCTC"	-1.65335414829906	10.8790254362854	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACTGCATTGCCTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1897.65813751943	46.714857945963	0.0246171093846374	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1892.05314192045	1892.05314192045
"AML-0693"	"2021-03-09-AML0693:AGTACTGGTCCTCCTA"	9.78204979476277	7.03163049304811	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACTGGTCCTCCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1765.28382480832	38.9756048082305	0.0220789451874475	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1759.41935735175	1759.41935735175
"AML-0693"	"2021-03-09-AML0693:AGTACTGTCACCTCAC"	8.04914679107014	6.74656150424806	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTACTGTCACCTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1540.80580305327	49.5964954601176	0.0321886738496421	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1538.86817850177	1538.86817850177
"AML-0693"	"2021-03-09-AML0693:AGTAGCTCAACTCGAT"	-7.03529773178752	3.92369792545167	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGCTCAACTCGAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2338.92359562602	38.3938454375408	0.016415177267586	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2327.2793160829	2327.2793160829
"AML-0693"	"2021-03-09-AML0693:AGTAGCTCATGGAACG"	-0.919676880270797	11.9130468138489	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGCTCATGGAACG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1744.93561860464	41.1903334133513	0.0236056465202365	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1740.66488200072	1740.66488200072
"AML-0693"	"2021-03-09-AML0693:AGTAGCTGTTCTTGTT"	-1.84837542000468	3.29639170253602	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGCTGTTCTTGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2830.08284939258	10.3110352474739	0.00364336869137486	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2819.04435591913	2819.04435591913
"AML-0693"	"2021-03-09-AML0693:AGTAGCTTCCCATGGG"	10.8897358375484	-2.1391651860443	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGCTTCCCATGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1691.83233520468	36.6125656696987	0.0216407766348013	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1684.22960968031	1684.22960968031
"AML-0693"	"2021-03-09-AML0693:AGTAGCTTCCTGATAG"	0.947480042546433	9.36342046344606	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGCTTCCTGATAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1633.92751241093	40.3032255238624	0.0246664709527984	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1629.02159164606	1629.02159164606
"AML-0693"	"2021-03-09-AML0693:AGTAGTCAGACTTAAG"	-0.00512213531191948	12.0317106016907	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ IFN+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGTCAGACTTAAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1725.43001375646	49.3171235322491	0.028582511686394	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1723.25508126106	1723.25508126106
"AML-0693"	"2021-03-09-AML0693:AGTAGTCCATGCGTGC"	-9.28988013687785	-2.52620198642882	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGTCCATGCGTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3191.79582327331	41.3015356586168	0.0129399052901387	3520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3183.84783438746	3183.84783438746
"AML-0693"	"2021-03-09-AML0693:AGTAGTCTCTAGGCCG"	-7.17941890183147	4.14954612338869	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTAGTCTCTAGGCCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2086.30492054267	46.6910658371667	0.0223797899230482	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2070.87679882916	2070.87679882916
"AML-0693"	"2021-03-09-AML0693:AGTCAACAGTTTGGCT"	8.78170647200887	6.62523315036622	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACAGTTTGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1630.44364110826	46.0000310792688	0.0282131991069628	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1625.12362201844	1625.12362201844
"AML-0693"	"2021-03-09-AML0693:AGTCAACCAAGAATAC"	-8.59498343887981	-4.44197990810546	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACCAAGAATAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2378.81852271816	44.78934502405	0.0188283993067581	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2373.6439671518	2373.6439671518
"AML-0693"	"2021-03-09-AML0693:AGTCAACCATCCGATA"	-9.45667396012004	-1.93627765094908	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACCATCCGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3457.17261136573	49.155104955254	0.0142182964176138	4350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3446.09216217963	3446.09216217963
"AML-0693"	"2021-03-09-AML0693:AGTCAACGTACGCTTA"	8.76729931411092	5.93261859500734	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACGTACGCTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1809.45980480205	48.862869918894	0.0270041201187332	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1795.68727757466	1795.68727757466
"AML-0693"	"2021-03-09-AML0693:AGTCAACGTTTCGGCG"	10.6283651786739	6.49626729572145	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACGTTTCGGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1876.71120655575	51.1384043599138	0.0272489470842805	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1869.98253692044	1869.98253692044
"AML-0693"	"2021-03-09-AML0693:AGTCAACTCATGCTAG"	-7.24649653855022	-2.8508830300537	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACTCATGCTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2362.33508056737	41.4768272559347	0.0175575546403743	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2336.2175550455	2336.2175550455
"AML-0693"	"2021-03-09-AML0693:AGTCAACTCCATTCGC"	9.02605118331258	6.63707444751588	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACTCCATTCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1591.47056734862	50.2329365917142	0.0315638489472049	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1583.14497971965	1583.14497971965
"AML-0693"	"2021-03-09-AML0693:AGTCAACTCGATTTCT"	-8.22401938858684	-3.57872822200926	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACTCGATTTCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2478.86947586911	47.5540256456007	0.0191837553806369	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2472.01743758957	2472.01743758957
"AML-0693"	"2021-03-09-AML0693:AGTCAACTCTTCTTCC"	8.25114788588826	-8.88896944439086	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	33	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.2	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCAACTCTTCTTCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1445.79412075418	45.8192049349733	0.0316913758862654	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1443.47185239709	1443.47185239709
"AML-0693"	"2021-03-09-AML0693:AGTCACAAGCTAAATG"	-1.13188252869304	10.2802333601746	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCACAAGCTAAATG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1685.05978956833	47.5656645270951	0.0282278794031874	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1664.10738535845	1664.10738535845
"AML-0693"	"2021-03-09-AML0693:AGTCACAGTTGCAAGG"	7.76926483687703	6.00863740527955	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCACAGTTGCAAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1595.62497829153	51.0335918521436	0.0319834500878687	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1585.99321843212	1585.99321843212
"AML-0693"	"2021-03-09-AML0693:AGTCACATCCAAAGGG"	-6.84504256668742	3.9030780562195	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCACATCCAAAGGG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1753.1507653591	48.1950359805321	0.0274905255913117	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1736.81273337983	1736.81273337983
"AML-0693"	"2021-03-09-AML0693:AGTCATGCAACGGTAG"	12.0662743049556	-2.87657382404479	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCATGCAACGGTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1611.94177663588	8.59774076962071	0.00533377873459186	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1609.18525144576	1609.18525144576
"AML-0693"	"2021-03-09-AML0693:AGTCATGGTCTCAGGC"	8.43773331221883	7.29928157413331	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCATGGTCTCAGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1877.11543278572	48.7366649472709	0.025963595043776	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1869.42514653666	1869.42514653666
"AML-0693"	"2021-03-09-AML0693:AGTCTCCGTGGTAACG"	14.1554466682369	1.76594541156618	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCTCCGTGGTAACG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1443.00214390409	16.8541708215718	0.0116799347061067	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1424.70844289972	1424.70844289972
"AML-0693"	"2021-03-09-AML0693:AGTCTCCGTGTCTTAG"	-6.8799241584843	3.85215494716493	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCTCCGTGTCTTAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2441.75235325784	18.2596096442941	0.00747807598912795	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2425.08611808969	2425.08611808969
"AML-0693"	"2021-03-09-AML0693:AGTCTCCTCCTACAAG"	1.88855924186055	-9.89407732402953	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00124100273020601	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTCTCCTCCTACAAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1509.86743612929	38.1371892306903	0.0252586341807988	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1507.65152013918	1507.65152013918
"AML-0693"	"2021-03-09-AML0693:AGTGACTTCTTACGGA"	8.17858471450154	6.51085183704225	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGACTTCTTACGGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1648.42151279538	42.0643815823918	0.0255179765951121	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1646.39461544889	1646.39461544889
"AML-0693"	"2021-03-09-AML0693:AGTGATCAGATGGCGT"	12.1631037193233	-2.77161958133849	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCAGATGGCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1714.01654621497	43.2347942704817	0.0252242572371639	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1703.65513169233	1703.65513169233
"AML-0693"	"2021-03-09-AML0693:AGTGATCAGCGCCCAT"	-1.6676164669102	-6.88975002681883	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	24	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCAGCGCCCAT"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2341.49866133049	42.8102940590243	0.0182832878643196	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2328.82267124257	2328.82267124257
"AML-0693"	"2021-03-09-AML0693:AGTGATCAGCGTACAG"	8.32835259017293	7.00102660739747	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCAGCGTACAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1895.5113959741	40.1125565183817	0.0211618651323212	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1893.71023396121	1893.71023396121
"AML-0693"	"2021-03-09-AML0693:AGTGATCCATATTCGG"	10.0359360176021	6.13644549930421	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCCATATTCGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1693.36533441487	49.6994928758136	0.0293495395622864	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1685.44991859583	1685.44991859583
"AML-0693"	"2021-03-09-AML0693:AGTGATCGTCGGCCTA"	-6.9248870414799	3.85652492130128	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCGTCGGCCTA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2247.56488729809	19.0680140284351	0.00848385474261332	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2236.9856221149	2236.9856221149
"AML-0693"	"2021-03-09-AML0693:AGTGATCGTTTGAAAG"	-6.8891466659611	3.79328749263612	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCGTTTGAAAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2412.22918378499	45.0074692790745	0.0186580402814189	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2396.01272802247	2396.01272802247
"AML-0693"	"2021-03-09-AML0693:AGTGATCTCAAGAGGC"	-1.04553852501567	10.5625781782898	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCTCAAGAGGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1928.25615484033	37.3712936218666	0.0193808760978446	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1924.33713567831	1924.33713567831
"AML-0693"	"2021-03-09-AML0693:AGTGATCTCCGAGAAG"	-8.34916434708293	-3.37398936664733	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGATCTCCGAGAAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2518.6550966207	49.6047838421361	0.0196949490657499	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2512.80974093739	2512.80974093739
"AML-0693"	"2021-03-09-AML0693:AGTGCCGAGAAGTATC"	1.32505085048024	10.2459039458069	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGCCGAGAAGTATC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1811.26250065966	28.6170863850585	0.0157995245717483	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1806.28534426483	1806.28534426483
"AML-0693"	"2021-03-09-AML0693:AGTGCCGCAATAACCC"	-6.88352857056316	3.81562540614931	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGCCGCAATAACCC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2551.64063039996	30.8044142068881	0.0120723952424522	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2537.08271229969	2537.08271229969
"AML-0693"	"2021-03-09-AML0693:AGTGCCGGTGACAGCA"	8.95002235946004	7.01701686466066	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGCCGGTGACAGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1935.18029830475	52.0495150117342	0.0268964680228144	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1926.76243462739	1926.76243462739
"AML-0693"	"2021-03-09-AML0693:AGTGCCGGTGTTGAGG"	-6.92062459412273	-2.66464617168578	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGCCGGTGTTGAGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1828.2536931885	37.797910044496	0.0206743244579892	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1822.45704771789	1822.45704771789
"AML-0693"	"2021-03-09-AML0693:AGTGTTGCATCAGTGT"	8.48922314223592	6.18024680698244	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGTTGCATCAGTGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1643.2035973354	47.917138484808	0.0291608042743516	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1635.26539253819	1635.26539253819
"AML-0693"	"2021-03-09-AML0693:AGTGTTGCATGAGATA"	-9.87555156174358	-2.29521038448485	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTGTTGCATGAGATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3470.85560126657	47.9505026711356	0.0138151822431442	3612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3456.826655782	3456.826655782
"AML-0693"	"2021-03-09-AML0693:AGTTAGCCACTTGGCG"	-6.98068271103557	3.8844582804474	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTAGCCACTTGGCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2168.43938927263	32.9716600981677	0.0152052486508408	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2155.18486396535	2155.18486396535
"AML-0693"	"2021-03-09-AML0693:AGTTAGCGTGGAACCA"	-8.13761935654338	-3.87309815799864	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTAGCGTGGAACCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2367.15414331488	38.3916054197671	0.0162184644917144	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2364.03060563967	2364.03060563967
"AML-0693"	"2021-03-09-AML0693:AGTTAGCTCCACAGCG"	-7.09852490845378	-0.865740381833635	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTAGCTCCACAGCG"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3368.7300329668	37.1660580456482	0.0110326614724055	3898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3360.08198212931	3360.08198212931
"AML-0693"	"2021-03-09-AML0693:AGTTAGCTCTTCCACG"	-8.81257472458537	-4.74740364467772	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTAGCTCTTCCACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2380.76260353392	52.9892232953865	0.0222572478317373	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2372.19257691622	2372.19257691622
"AML-0693"	"2021-03-09-AML0693:AGTTCCCTCAAACCCA"	-0.949408988386947	11.4862918623718	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTCCCTCAAACCCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1824.12900302341	51.3953254084416	0.0281752690315521	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1820.51366426738	1820.51366426738
"AML-0693"	"2021-03-09-AML0693:AGTTCCCTCCATAAGC"	8.07688202437703	6.18719623172609	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTCCCTCCATAAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1766.48379061993	42.7974874065601	0.0242275007751645	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1760.7126471318	1760.7126471318
"AML-0693"	"2021-03-09-AML0693:AGTTCGAAGGTAGCCA"	-6.83550916138347	3.86569306934205	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTCGAAGGTAGCCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2297.51110939599	44.9211373815906	0.0195520871250108	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2277.89694020312	2277.89694020312
"AML-0693"	"2021-03-09-AML0693:AGTTCGATCAGCGCAC"	-2.19647989693339	3.69745419109193	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.AGTTCGATCAGCGCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3494.15544649751	39.338114648507	0.0112582611881045	5348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3487.13575331405	3487.13575331405
"AML-0693"	"2021-03-09-AML0693:ATACCGACATCCGAGC"	-6.91811404648479	3.93244311893312	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACCGACATCCGAGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1987.78415430701	44.7668506876591	0.0225209817628644	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1981.18202065062	1981.18202065062
"AML-0693"	"2021-03-09-AML0693:ATACCGATCCATGAGT"	-6.94692883911784	3.7450220354828	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACCGATCCATGAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2494.10725247401	35.8853848768432	0.0143880680517035	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2481.85836156877	2481.85836156877
"AML-0693"	"2021-03-09-AML0693:ATACCGATCTTACCAT"	-2.07334576073344	2.90428445422975	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACCGATCTTACCAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3142.41149311007	11.3738334709546	0.0036194602444309	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3125.29128302456	3125.29128302456
"AML-0693"	"2021-03-09-AML0693:ATACCTTCATGACAAA"	-8.25483928147014	-3.82659771358641	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACCTTCATGACAAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3076.3922827438	39.5467825678282	0.0128549219128052	3390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3069.57356030885	3069.57356030885
"AML-0693"	"2021-03-09-AML0693:ATACCTTGTCCGCAGT"	9.60268749770467	7.22402856433717	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACCTTGTCCGCAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1941.39230714072	46.7843468530278	0.0240983477069257	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1930.47787442441	1930.47787442441
"AML-0693"	"2021-03-09-AML0693:ATACTTCAGGATACGC"	-7.198722700507	-3.15978052532347	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCAGGATACGC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2100.63961233906	16.1621852957465	0.00769393531418268	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2085.51815210162	2085.51815210162
"AML-0693"	"2021-03-09-AML0693:ATACTTCAGGTGCGAT"	-6.84858594361003	3.90678618038026	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCAGGTGCGAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.37101521	41.3587854873811	0.0188562651738248	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2166.43491064142	2166.43491064142
"AML-0693"	"2021-03-09-AML0693:ATACTTCCATCTTCGC"	-1.81212220612224	3.8220381506714	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCCATCTTCGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3085.66488245617	35.9117321219408	0.0116382476678268	3551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3075.43934137453	3075.43934137453
"AML-0693"	"2021-03-09-AML0693:ATACTTCCATGTTCGA"	-1.62575707855876	12.2512597807678	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCCATGTTCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1977.0886028171	52.2782696350355	0.0264420469373732	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1973.30428338065	1973.30428338065
"AML-0693"	"2021-03-09-AML0693:ATACTTCGTACCGTCG"	-7.10404763642009	3.35183188999025	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCGTACCGTCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2765.04474395282	30.0796260508813	0.010878531393268	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2749.26184445476	2749.26184445476
"AML-0693"	"2021-03-09-AML0693:ATACTTCTCCATTCGC"	-6.91866002503093	3.59669253909913	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCTCCATTCGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2610.79196038099	46.5541891347089	0.0178314434245137	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2595.39747719098	2595.39747719098
"AML-0693"	"2021-03-09-AML0693:ATACTTCTCGAGAAAT"	-7.08695970001872	-2.80772998249205	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATACTTCTCGAGAAAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	3072.79415095565	0.612148039845323	0.000199215440336263	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	3042.76079915185	3042.76079915185
"AML-0693"	"2021-03-09-AML0693:ATAGACCAGCATTGAA"	-7.17083154144939	4.21278235996095	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGACCAGCATTGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2004.98258416866	46.1023853834237	0.022993908150349	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1998.38619913766	1998.38619913766
"AML-0693"	"2021-03-09-AML0693:ATAGACCCAGTAGATA"	14.3137327629024	2.18791673267213	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGACCCAGTAGATA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1276.59985364745	5.39110937404818	0.00422302208373668	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1266.02450295073	1266.02450295073
"AML-0693"	"2021-03-09-AML0693:ATAGACCTCTCTCGCA"	10.8874298530513	-2.76075985347899	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGACCTCTCTCGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1881.06230005245	48.4106938877854	0.0257358269773603	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1873.11493922319	1873.11493922319
"AML-0693"	"2021-03-09-AML0693:ATAGAGAAGACATGCG"	-6.85535655441936	3.85705444896547	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGAGAAGACATGCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2309.58868391654	35.1687190878504	0.0152272650679134	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2297.82234993819	2297.82234993819
"AML-0693"	"2021-03-09-AML0693:ATAGAGACAATAAGGT"	9.30697502669637	6.33460710132448	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGAGACAATAAGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1536.98030949553	48.9024523068743	0.0318172275888981	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1532.26755651352	1532.26755651352
"AML-0693"	"2021-03-09-AML0693:ATAGAGACATATACCG"	8.22161449965779	6.93481204593507	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGAGACATATACCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1712.77233134986	55.3196937523812	0.0322983345420946	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1708.83921276131	1708.83921276131
"AML-0693"	"2021-03-09-AML0693:ATAGAGAGTCCATAGT"	14.2451244789058	2.01380548560945	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGAGAGTCCATAGT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1270.92661034701	14.7429054218615	0.0116001233287862	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1264.77999179658	1264.77999179658
"AML-0693"	"2021-03-09-AML0693:ATAGGCTAGAGTATAC"	0.886184652417344	-4.4566164246765	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	36	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00224971878515186	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTAGAGTATAC"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2836.41416864795	41.4558227675045	0.0146155745609131	2566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2831.23882102271	2831.23882102271
"AML-0693"	"2021-03-09-AML0693:ATAGGCTAGGCTTCCG"	14.2718187766964	1.9928476580414	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTAGGCTTCCG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1313.13274444853	5.42741518952496	0.00413318090838127	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1299.99031129411	1299.99031129411
"AML-0693"	"2021-03-09-AML0693:ATAGGCTAGTCGAATA"	-2.26868377152141	3.37102410877077	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTAGTCGAATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2844.73412645715	38.2228205715287	0.0134363419822055	3108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2835.74295568451	2835.74295568451
"AML-0693"	"2021-03-09-AML0693:ATAGGCTCAAGATGTA"	8.76483215865437	5.82399270618287	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTCAAGATGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1496.6984906765	41.4478146466539	0.0276928285188019	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1494.4163081841	1494.4163081841
"AML-0693"	"2021-03-09-AML0693:ATAGGCTGTCTAACTG"	-8.90675483170207	-4.67108013546141	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTGTCTAACTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1918.46008319357	47.018333835246	0.0245083722341394	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1917.19545292995	1917.19545292995
"AML-0693"	"2021-03-09-AML0693:ATAGGCTTCGGTCGAC"	-1.16578302803691	10.7223272093567	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATAGGCTTCGGTCGAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1603.16762500682	51.2793831813005	0.0319862891324807	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1592.18460404926	1592.18460404926
"AML-0693"	"2021-03-09-AML0693:ATATCCTAGGCGCTTC"	8.13013042983357	6.54681346500245	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATATCCTAGGCGCTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1738.69563940799	41.4917592087721	0.0238637276521264	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1727.44352870831	1727.44352870831
"AML-0693"	"2021-03-09-AML0693:ATATCCTGTCTAGGTT"	8.1365782218868	7.07057950580446	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATATCCTGTCTAGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1655.16083299387	54.474815047564	0.0329120977017257	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1646.18513790949	1646.18513790949
"AML-0693"	"2021-03-09-AML0693:ATATCCTGTGTTCATG"	14.2007986503536	1.86496052825776	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATATCCTGTGTTCATG"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1379.66085941251	3.65757271349124	0.00265106652010749	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1365.61727148912	1365.61727148912
"AML-0693"	"2021-03-09-AML0693:ATCACAGCACTGGCCA"	-8.10632358017619	-3.86873938953551	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACAGCACTGGCCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2489.73289803323	50.9513571310518	0.0204645876556883	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2479.16163440803	2479.16163440803
"AML-0693"	"2021-03-09-AML0693:ATCACAGCAGTCGGTC"	11.8427072959835	-2.77254226123961	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACAGCAGTCGGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1431.90228865868	44.3542400710698	0.0309757449390058	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1422.84035820856	1422.84035820856
"AML-0693"	"2021-03-09-AML0693:ATCACAGCATCCTGTC"	-7.08400187912639	3.7466625937256	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACAGCATCCTGTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2278.72103321245	48.013338583367	0.0210703012275617	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2263.5564694393	2263.5564694393
"AML-0693"	"2021-03-09-AML0693:ATCACAGGTCACCTTC"	1.26089050349538	-9.70791437542113	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	31	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACAGGTCACCTTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2967.18681684177	33.6294464452935	0.0113337812956072	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2959.14628219166	2959.14628219166
"AML-0693"	"2021-03-09-AML0693:ATCACGAAGCTACTAC"	8.18859924849812	6.50920198047487	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACGAAGCTACTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1674.04245783683	41.5448745382242	0.0248170972867128	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1668.0842888142	1668.0842888142
"AML-0693"	"2021-03-09-AML0693:ATCACGACACAATGCT"	-7.39826188507732	1.67880163276521	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	42	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0412371134020619	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACGACACAATGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2741.71845013821	44.828135781839	0.0163503790039343	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2738.41960408883	2738.41960408883
"AML-0693"	"2021-03-09-AML0693:ATCACGACAGACGCTC"	-7.70006881180461	-3.63713600551756	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACGACAGACGCTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2827.05272368277	3.88773375340712	0.00137518968812955	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2808.27072142142	2808.27072142142
"AML-0693"	"2021-03-09-AML0693:ATCACGACATGAAGCG"	-6.93910251084025	3.94636128032533	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACGACATGAAGCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2178.37555080959	37.2197667058434	0.0170860193009469	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2164.01013686902	2164.01013686902
"AML-0693"	"2021-03-09-AML0693:ATCACGATCCTGATAG"	-2.48074422302898	3.76719901645509	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACGATCCTGATAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3330.94898438165	31.3650284569453	0.00941624402055134	4013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3324.72955990676	3324.72955990676
"AML-0693"	"2021-03-09-AML0693:ATCACTTCAGAAATCA"	7.71223606643025	6.14675710285035	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACTTCAGAAATCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1583.3837298222	38.6459974324978	0.0244072215121455	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1578.96490277362	1578.96490277362
"AML-0693"	"2021-03-09-AML0693:ATCACTTGTTCGAACT"	11.7638107734615	-2.82479503070983	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACTTGTTCGAACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1865.72365631971	32.9677376763731	0.017670214752706	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1863.93476351163	1863.93476351163
"AML-0693"	"2021-03-09-AML0693:ATCACTTTCTTCCACG"	-8.52235064926799	-3.80669071590575	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCACTTTCTTCCACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3196.75666025495	47.426458349996	0.0148358049705959	3196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3183.58551794348	3183.58551794348
"AML-0693"	"2021-03-09-AML0693:ATCAGGTAGCTAGAAT"	-7.07471785965617	3.49314353549806	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCAGGTAGCTAGAAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2617.78228985775	33.8955902780755	0.0129482082636892	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2599.84375853372	2599.84375853372
"AML-0693"	"2021-03-09-AML0693:ATCAGGTCAACACGTT"	-2.96158681336101	3.16087052905885	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCAGGTCAACACGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3624.301823859	9.53019849968302	0.00262952672344923	5028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3615.59891952166	3615.59891952166
"AML-0693"	"2021-03-09-AML0693:ATCAGGTTCACCTACC"	-9.20049701157268	-1.93436911022338	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCAGGTTCACCTACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3312.14524519344	43.3240588077573	0.0130803620012223	3106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3304.67210618403	3304.67210618403
"AML-0693"	"2021-03-09-AML0693:ATCAGGTTCCTGCCAT"	8.98673691329305	7.22260520541994	"2021-03-09-AML0693"	"AML0693"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCAGGTTCCTGCCAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1943.56787113007	35.2866864508751	0.0181556234670405	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1934.47610070002	1934.47610070002
"AML-0693"	"2021-03-09-AML0693:ATCATTCGTAATCAGA"	11.8074757057125	-3.05987265026244	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCATTCGTAATCAGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2294.97735184257	43.7385374006237	0.0190583743083596	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2287.66898858315	2287.66898858315
"AML-0693"	"2021-03-09-AML0693:ATCATTCGTCTGCATA"	-7.03691373291667	-2.6448853245941	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCATTCGTCTGCATA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2170.2350251295	22.1199186003224	0.0101924069716838	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2155.9080086921	2155.9080086921
"AML-0693"	"2021-03-09-AML0693:ATCATTCGTTACAGCT"	-7.47872195664104	-2.25511386310729	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCATTCGTTACAGCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2714.31448885207	2.63950807285111	0.000972440033640833	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2704.21401079718	2704.21401079718
"AML-0693"	"2021-03-09-AML0693:ATCATTCGTTATGGTC"	14.2641445594722	2.0814752348694	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCATTCGTTATGGTC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1283.101580651	19.6563763608447	0.0153194233856932	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1267.55981699556	1267.55981699556
"AML-0693"	"2021-03-09-AML0693:ATCATTCTCACCTCTG"	-6.83485541763957	3.90889308536378	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCATTCTCACCTCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2403.90401057882	40.7438489008008	0.0169490332066089	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2395.42674895873	2395.42674895873
"AML-0693"	"2021-03-09-AML0693:ATCCACCTCGTGTTCC"	-6.45441375199016	-2.49973394786986	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCACCTCGTGTTCC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2018.22925286039	36.5838611767712	0.0181267123766647	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2016.255782863	2016.255782863
"AML-0693"	"2021-03-09-AML0693:ATCCATTAGCATAGGC"	1.18342139300649	10.1453580626282	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTAGCATAGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1766.76632916061	43.9887380344451	0.0248978811223689	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1763.49970671602	1763.49970671602
"AML-0693"	"2021-03-09-AML0693:ATCCATTAGCGTGCCT"	9.34724487838094	7.06016156757203	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTAGCGTGCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1769.93851754972	42.8454993788501	0.0242073376866021	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1762.72650014182	1762.72650014182
"AML-0693"	"2021-03-09-AML0693:ATCCATTAGCTCGTGC"	-8.07859836044963	-2.72756340419921	"2021-03-09-AML0693"	"AML0693"	"cDC1"	"cDC1"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTAGCTCGTGC"	"cDC1"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	1494.23834546497	42.3404367990496	0.0283357985876572	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1490.48002895621	1490.48002895621
"AML-0693"	"2021-03-09-AML0693:ATCCATTCACTCCACT"	8.55009140548055	7.52217910373536	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTCACTCCACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1941.98572134926	46.7475700253437	0.0240720462109599	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1934.59844102856	1934.59844102856
"AML-0693"	"2021-03-09-AML0693:ATCCATTGTTTGATCG"	-4.80867228928264	9.24453637683717	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTGTTTGATCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2423.29872051991	42.9841952308001	0.0177378854974916	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2423.29872051991	2423.29872051991
"AML-0693"	"2021-03-09-AML0693:ATCCATTTCCAAAGGG"	-8.43406997147258	-3.32574059879454	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCATTTCCAAAGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2730.82880889803	47.5636574686504	0.017417297383736	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2718.39093395845	2718.39093395845
"AML-0693"	"2021-03-09-AML0693:ATCCCTGCAGTTAGAA"	-6.99223218384441	3.74722478473512	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCCTGCAGTTAGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2335.9147064732	45.0949008608182	0.0193050288762055	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2322.93377360702	2322.93377360702
"AML-0693"	"2021-03-09-AML0693:ATCCCTGCATGTAACC"	-2.38960752907451	3.54608175838319	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCCTGCATGTAACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3453.89379372262	30.4095350807826	0.00880442100913794	4594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3447.62962194972	3447.62962194972
"AML-0693"	"2021-03-09-AML0693:ATCCGTCCAAGAAACT"	9.64323486861531	6.66450307453004	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCGTCCAAGAAACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1778.03012611436	40.529575893666	0.0227946508320632	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1769.90113007782	1769.90113007782
"AML-0693"	"2021-03-09-AML0693:ATCCTATAGAATCTAG"	-7.0124925178593	3.6001131304535	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCTATAGAATCTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2464.00465943831	36.3463881783437	0.0147509413341082	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2455.81418568723	2455.81418568723
"AML-0693"	"2021-03-09-AML0693:ATCCTATTCCGGGACT"	8.19528927382771	6.5014667280945	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCCTATTCCGGGACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1700.69767140664	46.3530425573824	0.0272553101804649	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1696.37439157659	1696.37439157659
"AML-0693"	"2021-03-09-AML0693:ATCGATGAGGCTCTCG"	0.704357286065262	9.66243836963502	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGAGGCTCTCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1557.73134513559	44.2302292895997	0.0283940035152529	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1549.83610069781	1549.83610069781
"AML-0693"	"2021-03-09-AML0693:ATCGATGCAACACACT"	-6.93185029450114	3.70617649638978	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGCAACACACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2524.93479803215	31.8043566108528	0.0125961100602044	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2512.3556805524	2512.3556805524
"AML-0693"	"2021-03-09-AML0693:ATCGATGCAGTTCACA"	-8.75086245957072	-3.03295113956603	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGCAGTTCACA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3242.30825207417	49.1746208747608	0.0151665471175675	4200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3234.81312194029	3234.81312194029
"AML-0693"	"2021-03-09-AML0693:ATCGATGGTCAAAGTA"	-2.76894030991252	3.38960955226747	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGGTCAAAGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2600.56511206091	35.5041733572504	0.0136524839130499	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2595.41168311088	2595.41168311088
"AML-0693"	"2021-03-09-AML0693:ATCGATGGTGTCATTG"	-7.18644080582316	3.06189820850221	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGGTGTCATTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2206.11093702298	36.4709918076495	0.0165318031816048	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2202.0020863975	2202.0020863975
"AML-0693"	"2021-03-09-AML0693:ATCGATGTCAATCCAG"	9.09505047377889	6.23902366245119	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGTCAATCCAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1877.04839049934	51.6604391989513	0.0275221669619334	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1857.42332729094	1857.42332729094
"AML-0693"	"2021-03-09-AML0693:ATCGATGTCCGTCACT"	-8.53759799423869	-4.27498819744261	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGATGTCCGTCACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2510.66745940987	47.8618185904302	0.0190633842849424	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2503.74269679755	2503.74269679755
"AML-0693"	"2021-03-09-AML0693:ATCGCCTTCGCTCCTA"	-7.24298510971721	-0.434586249944292	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGCCTTCGCTCCTA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3631.45597478428	0	0	4670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3608.69469266001	3608.69469266001
"AML-0693"	"2021-03-09-AML0693:ATCGGATCAGAGTGAC"	-6.95696864548381	3.84116337383119	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGATCAGAGTGAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2442.44915645659	43.1959208645351	0.0176854943941605	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2425.51917310761	2425.51917310761
"AML-0693"	"2021-03-09-AML0693:ATCGGATTCTCAAAGC"	14.293344159692	1.988294459227	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGATTCTCAAAGC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1147.97876503588	0.974772827609004	0.000849120957022698	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1122.61520353877	1122.61520353877
"AML-0693"	"2021-03-09-AML0693:ATCGGCGAGAGCAAGA"	-7.14224896851237	4.18572805011598	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGCGAGAGCAAGA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2047.33116762878	44.5623371670236	0.0217660620185037	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2028.76508423864	2028.76508423864
"AML-0693"	"2021-03-09-AML0693:ATCGGCGAGTCGAGGT"	-5.6333364051884	-4.73997261440428	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGCGAGTCGAGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2983.69797456231	44.528368102969	0.0149238858901263	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2978.8712156125	2978.8712156125
"AML-0693"	"2021-03-09-AML0693:ATCGGCGGTCACTCAA"	-1.75988374176677	10.0243749388489	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGCGGTCACTCAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1630.19053558564	50.2213990350367	0.0308070731235075	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1623.55882860515	1623.55882860515
"AML-0693"	"2021-03-09-AML0693:ATCGGCGTCGGTGAAG"	14.1416803794796	2.13817594135133	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGGCGTCGGTGAAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1114.70779750931	11.022476538584	0.00988822053924128	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1095.70738685663	1095.70738685663
"AML-0693"	"2021-03-09-AML0693:ATCGTAGCAGGGTTGA"	14.1486526924068	2.01044139945833	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTAGCAGGGTTGA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1245.79561361814	4.19597429931429	0.00336810810171983	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1234.10762879748	1234.10762879748
"AML-0693"	"2021-03-09-AML0693:ATCGTAGGTCACAGAG"	0.833960195153397	9.89637467944948	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTAGGTCACAGAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1635.30220406934	47.2002917792653	0.028863345051337	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1630.85358429351	1630.85358429351
"AML-0693"	"2021-03-09-AML0693:ATCGTAGGTCTCTCTG"	9.06348003920857	6.93407676303712	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTAGGTCTCTCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1969.17219036546	54.8746153851975	0.0278668445825518	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1956.40709806584	1956.40709806584
"AML-0693"	"2021-03-09-AML0693:ATCGTCCAGAAGCCAC"	9.75265755233113	6.93176267230836	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTCCAGAAGCCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1882.87463887381	45.5901945557708	0.0242130801565416	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1872.22784856043	1872.22784856043
"AML-0693"	"2021-03-09-AML0693:ATCGTCCAGAGTCAGC"	9.67955746230428	6.83356998050538	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTCCAGAGTCAGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1812.38571957893	34.2296643878234	0.0188865228952344	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1802.57586360756	1802.57586360756
"AML-0693"	"2021-03-09-AML0693:ATCGTCCAGGCCTTGC"	11.7754999595577	-2.99289777195128	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTCCAGGCCTTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1641.97247525255	50.5326350654663	0.0307755676950029	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1637.73412869372	1637.73412869372
"AML-0693"	"2021-03-09-AML0693:ATCGTCCCACACACTA"	14.2400652366573	2.01250217044679	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTCCCACACACTA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1215.76723775608	46.7866027252523	0.0384831909203325	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1204.84710245123	1204.84710245123
"AML-0693"	"2021-03-09-AML0693:ATCGTCCCATGAGAAT"	-6.97730193558391	-2.65049936687621	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTCCCATGAGAAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2293.88595003424	44.7667831510037	0.0195156969989443	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2281.36198748388	2281.36198748388
"AML-0693"	"2021-03-09-AML0693:ATCGTGACAGACCCGT"	-8.54201350632365	-3.51054694568785	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTGACAGACCCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3002.89061392269	48.3171553396778	0.0160902149134766	2852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2994.53744437149	2994.53744437149
"AML-0693"	"2021-03-09-AML0693:ATCGTGAGTTAAGGGC"	-6.92027602616008	-2.54634978687438	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTGAGTTAAGGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1621.9568191336	43.2850117748992	0.0266869076070846	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1607.55110213661	1607.55110213661
"AML-0693"	"2021-03-09-AML0693:ATCGTGATCACCTTGC"	-8.59240661087688	-3.25586869632872	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTGATCACCTTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2821.34170304615	44.5201294094102	0.0157797722131079	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2809.1382030937	2809.1382030937
"AML-0693"	"2021-03-09-AML0693:ATCGTGATCATTGTGG"	0.834200282662553	9.72344968402711	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTGATCATTGTGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1601.34622555359	36.2396026230177	0.0226307103640186	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1592.3894071574	1592.3894071574
"AML-0693"	"2021-03-09-AML0693:ATCGTGATCGTCTCAC"	9.38647522506062	7.023486114386	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCGTGATCGTCTCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1528.36269539294	51.8174877822246	0.033903920802583	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1523.53002288102	1523.53002288102
"AML-0693"	"2021-03-09-AML0693:ATCTCTAAGGCTCCCA"	0.692921360104722	9.53999230945436	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTCTAAGGCTCCCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1480.26603239542	51.4449461517404	0.0347538516900847	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1480.26603239542	1480.26603239542
"AML-0693"	"2021-03-09-AML0693:ATCTCTACATGGAAGC"	-5.65834556046184	-5.6476712456909	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTCTACATGGAAGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3311.77680883484	42.6503961860828	0.0128784029383575	3386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3301.06406304127	3301.06406304127
"AML-0693"	"2021-03-09-AML0693:ATCTCTAGTCTCCCTA"	9.49600472029988	6.8829774626526	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTCTAGTCTCCCTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1780.87999325766	37.1947389643452	0.0208855953827114	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1772.72081754607	1772.72081754607
"AML-0693"	"2021-03-09-AML0693:ATCTCTATCCTAAACG"	-8.9154523414677	-4.22467901622923	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTCTATCCTAAACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2352.12786433796	39.8481991686238	0.0169413405507356	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2342.54830276542	2342.54830276542
"AML-0693"	"2021-03-09-AML0693:ATCTCTATCTTCCACG"	12.2419659095699	-3.11823155796202	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTCTATCTTCCACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2574.20229332624	37.9797142343483	0.0147539742050626	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2565.36005756785	2565.36005756785
"AML-0693"	"2021-03-09-AML0693:ATCTTCAAGAGTAACT"	-8.33467040482219	-3.33331754123839	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTTCAAGAGTAACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2580.1566085714	50.1863808381036	0.0194509049068503	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2561.40036228466	2561.40036228466
"AML-0693"	"2021-03-09-AML0693:ATCTTCAAGGGAGGCA"	-1.88423417034801	10.4995498427185	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTTCAAGGGAGGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1963.92830942761	37.0838312250697	0.0188824770471779	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1958.54333433168	1958.54333433168
"AML-0693"	"2021-03-09-AML0693:ATCTTCACACGCTATA"	-2.46741018715556	3.29845903003541	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTTCACACGCTATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2511.87682372762	31.4932087413245	0.0125377201795224	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2507.63670059301	2507.63670059301
"AML-0693"	"2021-03-09-AML0693:ATCTTCATCTTTCCAA"	9.52493729171101	6.861452079657	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATCTTCATCTTTCCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1898.50965085777	46.6488549161254	0.0245713024924835	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1891.2002475722	1891.2002475722
"AML-0693"	"2021-03-09-AML0693:ATGAAAGAGGGCTAAC"	-1.196392039687	9.82011888110963	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAAAGAGGGCTAAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1575.30323530143	37.0230881443964	0.0235021977450024	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1572.98114074813	1572.98114074813
"AML-0693"	"2021-03-09-AML0693:ATGAAAGAGTTCCGTA"	-7.30637202683147	4.631724811438	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAAAGAGTTCCGTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1966.43425846545	43.9816982587899	0.0223662184837605	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1948.79946557302	1948.79946557302
"AML-0693"	"2021-03-09-AML0693:ATGAAAGGTACTTCCC"	8.05809464034383	6.49920938098756	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAAAGGTACTTCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1546.36833559345	42.0127453556539	0.0271686534111104	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1544.08611402096	1544.08611402096
"AML-0693"	"2021-03-09-AML0693:ATGAAAGGTGAACTAA"	8.10641159591023	6.61088321292726	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAAAGGTGAACTAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2033.11026240545	32.4400379091389	0.0159558674750664	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2021.67448715384	2021.67448715384
"AML-0693"	"2021-03-09-AML0693:ATGACCACATATTCGG"	-6.9110520881718	-2.67377235805663	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGACCACATATTCGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1711.02731584792	48.535886770783	0.028366517776328	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1691.66631514304	1691.66631514304
"AML-0693"	"2021-03-09-AML0693:ATGACCATCCATTTGT"	0.697358091443223	-9.23985769664916	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	17	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.6	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGACCATCCATTTGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2621.11375987226	47.3473463615721	0.0180638273265482	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2610.59526536092	2610.59526536092
"AML-0693"	"2021-03-09-AML0693:ATGAGGGAGAGAGAAC"	-7.55489621582683	-2.54710104381713	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGAGAGAGAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2668.40761818443	50.8580525881381	0.0190593267091411	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2653.68864711909	2653.68864711909
"AML-0693"	"2021-03-09-AML0693:ATGAGGGAGAGAGCAA"	8.28695358809773	6.55223844135133	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGAGAGAGCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1599.06142750375	49.1953320250079	0.0307651295809226	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1584.45712922973	1584.45712922973
"AML-0693"	"2021-03-09-AML0693:ATGAGGGCACCTCTGT"	10.6511370140011	6.35273549640504	"2021-03-09-AML0693"	"AML0693"	"Pre-B"	"Pre-B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGCACCTCTGT"	"Pre-B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1984.28650650774	46.2051042593111	0.0232855004092278	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1975.44440810897	1975.44440810897
"AML-0693"	"2021-03-09-AML0693:ATGAGGGCAGTTTCGA"	1.12711419638936	-9.4069509736267	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGCAGTTTCGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2742.63261889953	43.6181282084915	0.0159037444198389	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2734.52571879089	2734.52571879089
"AML-0693"	"2021-03-09-AML0693:ATGAGGGGTCTGTGCG"	9.43061031874959	7.10673616016237	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGGTCTGTGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1803.60620013974	25.6211859760658	0.0142055322132296	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1796.80464998999	1796.80464998999
"AML-0693"	"2021-03-09-AML0693:ATGAGGGGTTACGCCG"	-2.22059855881389	13.2678079375061	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGGTTACGCCG"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1855.60723069156	48.8277444612035	0.0263136204976987	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1853.57790043476	1853.57790043476
"AML-0693"	"2021-03-09-AML0693:ATGAGGGTCGCCTATC"	-8.41766963425334	-4.40572311794432	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGGGTCGCCTATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2551.46568463527	47.2212947107218	0.0185075170695357	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2542.88360143588	2542.88360143588
"AML-0693"	"2021-03-09-AML0693:ATGAGTCAGGTAGACC"	0.816351135342759	9.78350350940553	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGTCAGGTAGACC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1654.25006874599	25.5947725682055	0.015472130273271	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1648.52854345105	1648.52854345105
"AML-0693"	"2021-03-09-AML0693:ATGAGTCCAGCGTAGA"	-0.00160572576578263	10.5591354140076	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGTCCAGCGTAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1512.2886598638	47.0915108776215	0.0311392342794282	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1505.10442862278	1505.10442862278
"AML-0693"	"2021-03-09-AML0693:ATGAGTCGTGATGTAA"	-8.24820743027385	-3.50429179584654	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGTCGTGATGTAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2525.34956483405	49.5906558214989	0.019637145095498	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2513.91694383383	2513.91694383383
"AML-0693"	"2021-03-09-AML0693:ATGAGTCTCCGTAATG"	-6.974197725684	3.91330239856569	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGTCTCCGTAATG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2528.84957303083	27.5169630011507	0.0108812178053642	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2516.07264573265	2516.07264573265
"AML-0693"	"2021-03-09-AML0693:ATGAGTCTCTGAGAGG"	-2.29842648926433	3.66410849178163	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGAGTCTCTGAGAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3292.69687296668	26.6637802286712	0.00809785451177821	4912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3288.41731790994	3288.41731790994
"AML-0693"	"2021-03-09-AML0693:ATGATCGAGAAACACT"	-7.38058648529704	-2.2807598344055	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGATCGAGAAACACT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2376.29158101008	25.4231616850595	0.0106986709409848	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2353.59749949501	2353.59749949501
"AML-0693"	"2021-03-09-AML0693:ATGATCGCAAATGATG"	12.2256981330806	-3.02408053791197	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGATCGCAAATGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1941.82949991417	15.8222571609884	0.00814811864877313	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1906.03756965119	1906.03756965119
"AML-0693"	"2021-03-09-AML0693:ATGATCGCATTGGATC"	-7.28788600388225	-3.0464773408142	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGATCGCATTGGATC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1454.8464931453	49.8325927347026	0.0342528184035191	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1437.58765139448	1437.58765139448
"AML-0693"	"2021-03-09-AML0693:ATGATCGTCATCTATC"	-7.85274253311809	-3.39288260852965	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGATCGTCATCTATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2765.63589038288	27.0768664766331	0.00979046684011776	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2739.74739697232	2739.74739697232
"AML-0693"	"2021-03-09-AML0693:ATGCATGAGGTCTTTG"	-8.59697375717815	1.77903506839601	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.25	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCATGAGGTCTTTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2599.44919053143	39.7802520619456	0.0153033389561321	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2590.23952208332	2590.23952208332
"AML-0693"	"2021-03-09-AML0693:ATGCATGCAGAAATCA"	-7.20714793625529	-2.81574990665587	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCATGCAGAAATCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2561.99743008201	40.453566286635	0.0157898543580273	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2541.14072179112	2541.14072179112
"AML-0693"	"2021-03-09-AML0693:ATGCATGGTTGGATCT"	0.437825043767136	9.47630975330202	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCATGGTTGGATCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1929.68328066834	40.1336555849959	0.0207980532282457	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1921.76148090628	1921.76148090628
"AML-0693"	"2021-03-09-AML0693:ATGCATGGTTGTCATG"	1.5236687856609	-7.7258396378723	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCATGGTTGTCATG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2512.49890547099	48.9398600898776	0.0194785597650652	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2506.53801633161	2506.53801633161
"AML-0693"	"2021-03-09-AML0693:ATGCCTCAGGGCAATC"	14.3478743034298	2.0517790087494	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCAGGGCAATC"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1268.95358463521	40.1627029997177	0.0316502537886469	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1249.49786587947	1249.49786587947
"AML-0693"	"2021-03-09-AML0693:ATGCCTCAGTACCATC"	-7.6312292617863	2.61992809856264	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCAGTACCATC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2639.64390610609	39.0606190380064	0.0147976850012422	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2630.6139107427	2630.6139107427
"AML-0693"	"2021-03-09-AML0693:ATGCCTCAGTTCCATG"	-8.35876117172893	-4.16927530681761	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCAGTTCCATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2482.16320776128	51.3844016274733	0.02070145970531	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2472.39163855583	2472.39163855583
"AML-0693"	"2021-03-09-AML0693:ATGCCTCCAAGTTGGG"	8.69712700423543	7.31378743732301	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCCAAGTTGGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1928.82494440489	39.4822169237105	0.0204695698478185	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1921.18268996098	1921.18268996098
"AML-0693"	"2021-03-09-AML0693:ATGCCTCGTCTCACGG"	0.29560393568818	12.9876870878967	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCGTCTCACGG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1529.05193544473	42.090028767821	0.0275268797561013	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1522.26667661298	1522.26667661298
"AML-0693"	"2021-03-09-AML0693:ATGCCTCGTGCTTATG"	-8.57567344132121	-4.33413841640624	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCGTGCTTATG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2606.55172752501	52.1665851212304	0.020013638927766	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2599.61019926612	2599.61019926612
"AML-0693"	"2021-03-09-AML0693:ATGCCTCTCGTGGCTG"	1.37892355498616	-10.2209491959778	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCCTCTCGTGGCTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2726.9213791413	43.9486881939773	0.0161165952675235	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2719.89279865701	2719.89279865701
"AML-0693"	"2021-03-09-AML0693:ATGCGATCAGACGGAT"	-0.566381017596084	13.1436443098816	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCGATCAGACGGAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1692.09346576879	45.1363366104165	0.0266748483600516	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1687.49709251084	1687.49709251084
"AML-0693"	"2021-03-09-AML0693:ATGCGATCAGGCACAA"	8.04424681243245	6.77644584262697	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCGATCAGGCACAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1736.46934228132	40.1630466242334	0.0231291423616316	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1730.95625352329	1730.95625352329
"AML-0693"	"2021-03-09-AML0693:ATGCGATCATACTTTC"	11.0863911109859	-2.84739448940428	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCGATCATACTTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1636.56696193889	34.9330205963814	0.0213453047805604	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1629.08483353598	1629.08483353598
"AML-0693"	"2021-03-09-AML0693:ATGCGATTCTTCGACC"	11.89937367019	-2.93395569240721	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGCGATTCTTCGACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2092.57450571836	42.2121515271338	0.0201723529612834	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2084.89287880175	2084.89287880175
"AML-0693"	"2021-03-09-AML0693:ATGGAGGGTCTTGGTA"	7.82779707488362	6.77351329410402	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGAGGGTCTTGGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1642.06325546424	42.8225832886175	0.0260785223383559	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1638.01588936098	1638.01588936098
"AML-0693"	"2021-03-09-AML0693:ATGGAGGGTTATGGTC"	10.0944067436153	6.31128070438234	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGAGGGTTATGGTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1531.57485735784	38.9291572317008	0.0254177306742019	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1529.1947600469	1529.1947600469
"AML-0693"	"2021-03-09-AML0693:ATGGAGGTCTCACGAA"	8.49706425246541	6.7730617293152	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGAGGTCTCACGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1867.26523370549	40.5985820106253	0.0217422684671634	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1865.63987616131	1865.63987616131
"AML-0693"	"2021-03-09-AML0693:ATGGATCCACCGCTAG"	-9.25548682633098	-1.98484733020934	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGATCCACCGCTAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3117.58623252607	52.091249908413	0.0167088401164144	3289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3112.02811208103	3112.02811208103
"AML-0693"	"2021-03-09-AML0693:ATGGATCGTAATTAGG"	-7.24068198624309	-3.23982574855956	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGATCGTAATTAGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1887.59236336497	25.5465078601196	0.0135339114291491	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1867.68985094351	1867.68985094351
"AML-0693"	"2021-03-09-AML0693:ATGGATCGTATCACGT"	8.60092320021931	6.32419869983522	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGATCGTATCACGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1660.42122240488	48.669278514088	0.029311404755233	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1653.38822977276	1653.38822977276
"AML-0693"	"2021-03-09-AML0693:ATGGGAGAGCTGAAAT"	8.81000771102254	6.24717662418214	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGGAGAGCTGAAAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1780.90016440049	45.205232050232	0.0253833611528974	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1772.65328950984	1772.65328950984
"AML-0693"	"2021-03-09-AML0693:ATGGGAGAGGCGTTGA"	-7.18728433075603	-0.944721542951189	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGGAGAGGCGTTGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3215.36894331683	52.6736823399943	0.0163818470814918	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3188.44283656054	3188.44283656054
"AML-0693"	"2021-03-09-AML0693:ATGGGAGTCTCCTGAC"	-6.83541665497478	3.93594620311586	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGGAGTCTCCTGAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2363.99478099254	45.3579915175025	0.0191870100061975	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2340.56136656406	2340.56136656406
"AML-0693"	"2021-03-09-AML0693:ATGGGTTCAACTTGCA"	1.04856355962102	9.04148099506227	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGGTTCAACTTGCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1985.45140266839	43.3677943340978	0.0218427881316121	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1980.98066187626	1980.98066187626
"AML-0693"	"2021-03-09-AML0693:ATGGGTTTCGTAATGC"	8.47935642775838	6.42102048480836	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGGTTTCGTAATGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1580.96165618839	46.6362625199428	0.0294986676858313	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1574.83129766919	1574.83129766919
"AML-0693"	"2021-03-09-AML0693:ATGGTTGAGTTGCATC"	9.0141884284908	7.1722144850525	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGTTGAGTTGCATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1998.26941422884	43.307787437855	0.0216726469061071	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1990.49523485742	1990.49523485742
"AML-0693"	"2021-03-09-AML0693:ATGGTTGAGTTGGGAC"	-7.641669134528	-2.57454874431761	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGTTGAGTTGGGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2633.79813372062	7.07783305233297	0.00268731037573275	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2603.3665644552	2603.3665644552
"AML-0693"	"2021-03-09-AML0693:ATGGTTGGTCGAACAG"	9.1223484474117	7.0568694838318	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGTTGGTCGAACAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1668.15917120848	40.7909447181286	0.0244526693987948	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1668.15917120848	1668.15917120848
"AML-0693"	"2021-03-09-AML0693:ATGGTTGTCCTCACGT"	-8.96430812302287	-4.21273996746215	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGTTGTCCTCACGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2766.31009909809	49.1886241747253	0.0177813124388197	3238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2752.23550960681	2752.23550960681
"AML-0693"	"2021-03-09-AML0693:ATGGTTGTCGCATTAG"	-6.94918094101604	3.91194984996644	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGGTTGTCGCATTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1969.13547534601	47.8617841686343	0.0243059884745737	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1963.22570599489	1963.22570599489
"AML-0693"	"2021-03-09-AML0693:ATGTCCCAGCTGAGCA"	-8.45321116867717	-3.69660546695861	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCCCAGCTGAGCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2962.86236727899	50.4076059746637	0.0170131446304597	2658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2953.96477682824	2953.96477682824
"AML-0693"	"2021-03-09-AML0693:ATGTCCCCATCCTCAC"	-8.78611884537395	-2.97542717373046	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCCCCATCCTCAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3080.33961363811	48.9317082839404	0.0158851667093124	4267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3065.97585437818	3065.97585437818
"AML-0693"	"2021-03-09-AML0693:ATGTCCCGTACCTTCC"	0.712492366402787	-9.23416235363158	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCCCGTACCTTCC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1679.20133169255	34.2876822482696	0.0204190418391994	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1648.36730669636	1648.36730669636
"AML-0693"	"2021-03-09-AML0693:ATGTCCCGTACTCAAC"	-2.42806015434917	4.02923414790956	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCCCGTACTCAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3410.44885362361	20.5806413447544	0.00603458436941149	5611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3404.27851504003	3404.27851504003
"AML-0693"	"2021-03-09-AML0693:ATGTCCCGTCTCAGAT"	13.9286381202633	2.08015534961549	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCCCGTCTCAGAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1483.41302890622	42.4293314631839	0.0286025069460721	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1466.35313430569	1466.35313430569
"AML-0693"	"2021-03-09-AML0693:ATGTCTTCAATAACCC"	-1.30460892143901	10.3769511946472	"2021-03-09-AML0693"	"AML0693"	"MAIT"	"MAIT"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTCAATAACCC"	"MAIT"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"MAIT"	1765.26697385917	53.8758057007778	0.0305199193655089	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1752.96590646626	1752.96590646626
"AML-0693"	"2021-03-09-AML0693:ATGTCTTCACGACGAA"	-7.85848126831706	-4.57339527523192	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTCACGACGAA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1717.86747383107	49.661429246142	0.0289087662480683	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1708.92692915562	1708.92692915562
"AML-0693"	"2021-03-09-AML0693:ATGTCTTGTACCCACG"	8.42649235305135	6.24998614871827	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTGTACCCACG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1847.32947265159	51.853260399445	0.0280693082458196	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1837.07543660093	1837.07543660093
"AML-0693"	"2021-03-09-AML0693:ATGTCTTGTTGGTACT"	-8.47565207901653	-4.16580107128295	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTGTTGGTACT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2560.91428871436	45.1672005169417	0.0176371387031531	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2550.55371263621	2550.55371263621
"AML-0693"	"2021-03-09-AML0693:ATGTCTTTCATTTCGT"	-7.67912707749065	-3.55181505596312	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTTCATTTCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1899.33785292287	10.7803992909782	0.00567587239647145	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1876.52369311825	1876.52369311825
"AML-0693"	"2021-03-09-AML0693:ATGTCTTTCTCGACCT"	9.79640163955037	2.54203388774721	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	55	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245901639344262	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATGTCTTTCTCGACCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1884.02999549765	48.8344102324235	0.0259201872311615	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1878.45782507489	1878.45782507489
"AML-0693"	"2021-03-09-AML0693:ATTACCTAGCATGAAT"	-7.81806502762492	-4.7029338113037	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTAGCATGAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2265.4729527213	50.8486605483731	0.0224450530240466	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2254.81407500459	2254.81407500459
"AML-0693"	"2021-03-09-AML0693:ATTACCTAGTATGAAC"	-8.67352519455608	-2.76966311847838	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTAGTATGAAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3404.87136994534	46.2870792587557	0.0135943694282638	4338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3394.26170828673	3394.26170828673
"AML-0693"	"2021-03-09-AML0693:ATTACCTCACGCAGTC"	0.244451333850068	11.6222276457581	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTCACGCAGTC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1868.92287304994	51.4018470136693	0.027503460819539	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1863.33594930752	1863.33594930752
"AML-0693"	"2021-03-09-AML0693:ATTACCTGTGTCACAT"	-1.61730096760448	10.7393846281799	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTGTGTCACAT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1948.2274940598	42.8989872263505	0.0220194958531028	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1942.53732886854	1942.53732886854
"AML-0693"	"2021-03-09-AML0693:ATTACCTTCAGCTGTA"	-8.67263446274455	-3.57166697895201	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTTCAGCTGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2997.26705635558	49.756996925994	0.0166007886486079	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2988.5372948135	2988.5372948135
"AML-0693"	"2021-03-09-AML0693:ATTACCTTCGCCTATC"	-8.49468455734904	-3.94157912647399	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACCTTCGCCTATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2882.20206981376	51.1889540496308	0.0177603626705252	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2871.00147642297	2871.00147642297
"AML-0693"	"2021-03-09-AML0693:ATTACTCGTCCTGTCT"	8.68167175826375	6.85274360263673	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTACTCGTCCTGTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1397.16764066145	51.7951179272735	0.0370715126946058	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1392.26393593438	1392.26393593438
"AML-0693"	"2021-03-09-AML0693:ATTATCCAGGCTCTAT"	11.0109554725582	-2.74144556438597	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTATCCAGGCTCTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1501.40365808026	47.9910408691931	0.031964116119549	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1494.46603175375	1494.46603175375
"AML-0693"	"2021-03-09-AML0693:ATTATCCCAAGGCGTA"	10.9747044044429	-2.75142910396727	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTATCCCAAGGCGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1719.58174641918	37.1889322211448	0.0216267312086711	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1712.92217507905	1712.92217507905
"AML-0693"	"2021-03-09-AML0693:ATTATCCTCATCCCGT"	-7.17667804184611	-2.73072984134825	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTATCCTCATCCCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2931.4077689541	0	0	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2910.16712043022	2910.16712043022
"AML-0693"	"2021-03-09-AML0693:ATTATCCTCCATCCGT"	-7.10194478455241	-2.73116090213927	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTATCCTCCATCCGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1973.77529804082	48.0007207659317	0.0243192428305174	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1963.14656952456	1963.14656952456
"AML-0693"	"2021-03-09-AML0693:ATTCACTAGACTAAGT"	8.86606564101521	7.02506444537965	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCACTAGACTAAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1586.22597748201	46.5984105960649	0.0293769054709568	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1584.12053564759	1584.12053564759
"AML-0693"	"2021-03-09-AML0693:ATTCACTGTTCTCCTG"	-7.42501388016399	-2.46108033573302	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCACTGTTCTCCTG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2972.8571560512	4.41011851072601	0.00148346128967189	2632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2959.99047367775	2959.99047367775
"AML-0693"	"2021-03-09-AML0693:ATTCACTTCCGTAGGC"	-6.70461831513103	-2.337517999765	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCACTTCCGTAGGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1509.15624602509	50.3658728125765	0.0333735310344659	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1499.96123534039	1499.96123534039
"AML-0693"	"2021-03-09-AML0693:ATTCAGGCAATTGAAG"	-1.65497038784679	3.80539629543153	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCAGGCAATTGAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2832.04722029069	31.2240581989885	0.0110252604459694	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2821.15080075113	2821.15080075113
"AML-0693"	"2021-03-09-AML0693:ATTCAGGCACATTCGA"	10.1136871772701	6.67289970004884	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCAGGCACATTCGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1883.28533951215	30.5113228717648	0.0162011152700146	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1880.08825624921	1880.08825624921
"AML-0693"	"2021-03-09-AML0693:ATTCAGGCAGCCTATA"	0.574037392705125	9.17344949329225	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCAGGCAGCCTATA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1713.68985514666	47.058485739019	0.0274603281321238	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1702.94233575665	1702.94233575665
"AML-0693"	"2021-03-09-AML0693:ATTCAGGGTAGCGCCT"	9.07980217513387	5.62966487491456	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCAGGGTAGCGCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1469.39692947682	50.3579965849063	0.034271200364381	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1462.40784672459	1462.40784672459
"AML-0693"	"2021-03-09-AML0693:ATTCAGGGTTTACTTC"	8.17011417922322	6.27474687183229	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCAGGGTTTACTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1725.68973926077	52.8719494613849	0.0306381548539737	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1716.97525996764	1716.97525996764
"AML-0693"	"2021-03-09-AML0693:ATTCATCAGTAACGAT"	13.8903318839962	1.75498375976411	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCATCAGTAACGAT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1274.394505335	49.6257852385314	0.0389406773418928	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1266.01585405154	1266.01585405154
"AML-0693"	"2021-03-09-AML0693:ATTCATCCATGGCGCT"	-8.40045104447063	-3.29551269924315	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCATCCATGGCGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2532.32223161444	47.1723194047682	0.0186280872220177	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2525.98200853616	2525.98200853616
"AML-0693"	"2021-03-09-AML0693:ATTCATCTCCCTGTTG"	1.44075610217397	-9.34175875103148	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	13	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00124100273020601	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCATCTCCCTGTTG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1765.62216064897	53.4781049649286	0.0302885329357627	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1762.86849880012	1762.86849880012
"AML-0693"	"2021-03-09-AML0693:ATTCCATGTAGCTGCC"	-7.10573802414592	-2.82946469700011	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCATGTAGCTGCC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1513.04358766614	47.4825232311374	0.0313821251536969	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1500.41426502408	1500.41426502408
"AML-0693"	"2021-03-09-AML0693:ATTCCATTCCCTTTGG"	-8.15939460220988	-0.571954213735186	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCATTCCCTTTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3204.45916160294	36.887396255179	0.0115112705124091	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3192.29951295596	3192.29951295596
"AML-0693"	"2021-03-09-AML0693:ATTCCCGAGCGATTCT"	-7.15029988709148	-3.13941075718077	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCCGAGCGATTCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2505.04100931408	10.0170588518136	0.00399876042530594	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2494.30722482688	2494.30722482688
"AML-0693"	"2021-03-09-AML0693:ATTCCCGCAACTACGT"	1.23521818694417	-10.0959205857483	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCCGCAACTACGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1342.31884934697	52.6564231021618	0.0392279547648301	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1335.67473452326	1335.67473452326
"AML-0693"	"2021-03-09-AML0693:ATTCCCGGTGTGATGG"	7.87440218505208	6.03052232349244	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCCGGTGTGATGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1512.96527691011	45.2787534700009	0.0299271597048628	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1505.93089483535	1505.93089483535
"AML-0693"	"2021-03-09-AML0693:ATTCCTATCGAATCCA"	-9.80659137192424	-2.17734982883605	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCTATCGAATCCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3288.52551235026	51.9415292696213	0.0157947776517323	3281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3279.15602996119	3279.15602996119
"AML-0693"	"2021-03-09-AML0693:ATTCCTATCTTACCAT"	-5.86492381516154	2.91000650012819	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.157894736842105	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCCTATCTTACCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2333.23501708691	25.5623029499843	0.0109557343185683	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2320.84008067576	2320.84008067576
"AML-0693"	"2021-03-09-AML0693:ATTCGTTAGCTAGCCC"	-7.16466317597087	-2.89363410389098	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCGTTAGCTAGCCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2582.97220176443	28.4949747014125	0.0110318549622592	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2568.70778272259	2568.70778272259
"AML-0693"	"2021-03-09-AML0693:ATTCGTTCATATCGGT"	7.67471041259114	6.87400434100953	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCGTTCATATCGGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1730.83594686787	38.9425193648298	0.022499255019114	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1724.55235044131	1724.55235044131
"AML-0693"	"2021-03-09-AML0693:ATTCGTTTCTGGGCCA"	8.25019230422322	6.44373939121095	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCGTTTCTGGGCCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1761.98313599426	48.3591099150817	0.0274458415220833	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1751.42983361666	1751.42983361666
"AML-0693"	"2021-03-09-AML0693:ATTCTACCATGAATAG"	7.90756907042806	6.45803544605104	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTACCATGAATAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1489.71290215917	40.0573576161216	0.0268893137449927	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1480.67984038542	1480.67984038542
"AML-0693"	"2021-03-09-AML0693:ATTCTACGTCAGTCTA"	11.8642689186031	-2.45785071766051	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTACGTCAGTCTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1324.17142272445	23.9484775535044	0.0180856323754751	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1321.94733277758	1321.94733277758
"AML-0693"	"2021-03-09-AML0693:ATTCTTGAGGAACGAA"	0.759642799466294	11.0122337111267	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTTGAGGAACGAA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1659.02439024123	35.4349269770528	0.0213588945319246	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1651.62832693496	1651.62832693496
"AML-0693"	"2021-03-09-AML0693:ATTCTTGAGTGTTCCA"	-9.55980143967326	-2.49065973674925	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTTGAGTGTTCCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3365.59964623839	52.8327963393594	0.0156978850406075	3392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3348.31110094635	3348.31110094635
"AML-0693"	"2021-03-09-AML0693:ATTCTTGCAAATTGGA"	-7.34163318100627	-4.79834749614867	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTTGCAAATTGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2631.08286626474	52.894774281289	0.020103804011457	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2623.44544342313	2623.44544342313
"AML-0693"	"2021-03-09-AML0693:ATTCTTGTCGTTCAGA"	-4.70960507813151	9.26506612384645	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTTGTCGTTCAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2390.64234204349	38.4668259978761	0.016090581732521	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2378.91555297709	2378.91555297709
"AML-0693"	"2021-03-09-AML0693:ATTCTTGTCTCGCCTA"	1.19342960891072	-9.73678877269896	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTCTTGTCTCGCCTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2419.16711129575	40.5642440040506	0.0167678552732654	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2413.76669198324	2413.76669198324
"AML-0693"	"2021-03-09-AML0693:ATTGGGTCAGAACTTC"	11.5049292045528	-2.47274353420409	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTGGGTCAGAACTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1864.81502691746	40.9329913146286	0.021950161664179	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1855.31084170771	1855.31084170771
"AML-0693"	"2021-03-09-AML0693:ATTGGGTGTATAGCTC"	-7.44753776016887	-3.26500894939574	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTGGGTGTATAGCTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2585.74346393875	1.68130028700702	0.000650219293002085	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2565.53356981098	2565.53356981098
"AML-0693"	"2021-03-09-AML0693:ATTGTTCAGAAACTGT"	9.51398052748982	7.11207864368287	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTGTTCAGAAACTGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1748.00267665328	32.7647706544662	0.0187441192694267	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1740.50283776321	1740.50283776321
"AML-0693"	"2021-03-09-AML0693:ATTGTTCAGATTGACA"	8.98213829573933	6.64324710452882	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTGTTCAGATTGACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1763.98451686982	47.810562692616	0.0271037314870856	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1753.32557257583	1753.32557257583
"AML-0693"	"2021-03-09-AML0693:ATTGTTCTCACTTGGA"	-6.77592454376872	3.86038587177125	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTGTTCTCACTTGGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2218.22178019909	48.7411686994253	0.021973081832715	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2184.59731431366	2184.59731431366
"AML-0693"	"2021-03-09-AML0693:ATTTACCAGAACTCCT"	-7.61076341095622	-2.56050088321837	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTACCAGAACTCCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2906.43872495825	0	0	3233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2882.5949183353	2882.5949183353
"AML-0693"	"2021-03-09-AML0693:ATTTACCAGCAGAAAG"	-0.608319024473983	10.8628701933655	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTACCAGCAGAAAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1680.1172915903	36.6175986239988	0.0217946680313842	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1675.92881705153	1675.92881705153
"AML-0693"	"2021-03-09-AML0693:ATTTACCAGGAAGTAG"	-7.3943432373112	2.15557525241701	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTACCAGGAAGTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2698.06308597374	41.3047078630025	0.0153090222677634	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2690.61602125234	2690.61602125234
"AML-0693"	"2021-03-09-AML0693:ATTTCACAGAGAATCT"	-0.484814028174239	10.8886546858582	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTCACAGAGAATCT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1709.33678898284	45.0547669668319	0.0263580397129592	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1704.59269665849	1704.59269665849
"AML-0693"	"2021-03-09-AML0693:ATTTCACGTAGAATGT"	-6.98191962662395	-2.63976075565489	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTCACGTAGAATGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1440.53159324626	30.3408921285903	0.0210622885821037	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1427.55158455455	1427.55158455455
"AML-0693"	"2021-03-09-AML0693:ATTTCTGAGATGAAGG"	8.08779015120808	6.39954946124879	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTCTGAGATGAAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1573.64727421476	50.997611981141	0.0324072699243154	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1571.59140929498	1571.59140929498
"AML-0693"	"2021-03-09-AML0693:ATTTCTGAGGTCGCCT"	14.2260405021602	1.97056100452272	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTCTGAGGTCGCCT"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1177.91016429783	4.30469181419973	0.00365451623109632	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1160.09290519092	1160.09290519092
"AML-0693"	"2021-03-09-AML0693:ATTTCTGGTGGTCTTA"	-7.70227799835857	-3.05435349857482	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.ATTTCTGGTGGTCTTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2247.79891836841	48.2234207389327	0.0214536186243636	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2239.07064950093	2239.07064950093
"AML-0693"	"2021-03-09-AML0693:CAAAGAACAGAGTAAT"	-7.78364692154582	-3.6577620736328	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAAGAACAGAGTAAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2139.7404526633	49.3325544353495	0.0230553917761128	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2120.62097761788	2120.62097761788
"AML-0693"	"2021-03-09-AML0693:CAAAGAAGTGTTGATC"	0.0467132167773366	-9.18478491222533	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	56	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.285714285714286	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAAGAAGTGTTGATC"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	2897.62386458635	43.6327685096492	0.0150581202215071	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2889.21251849886	2889.21251849886
"AML-0693"	"2021-03-09-AML0693:CAACAACAGGAAGTAG"	-7.92859635773357	-5.00757124340209	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACAACAGGAAGTAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2425.86603949935	40.9366505058557	0.0168750664048639	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2419.67275220457	2419.67275220457
"AML-0693"	"2021-03-09-AML0693:CAACAACGTGGCTGAA"	-9.60744986954387	-1.87782456791075	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACAACGTGGCTGAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3481.74155906883	47.9001295481562	0.0137575201190311	4161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3469.77764288951	3469.77764288951
"AML-0693"	"2021-03-09-AML0693:CAACAACTCCTCTAAT"	-6.87889991226848	3.85257551753847	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACAACTCCTCTAAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2334.77637822008	44.8039264751115	0.0191898148760901	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2318.73631497748	2318.73631497748
"AML-0693"	"2021-03-09-AML0693:CAACCAACAACCGCCA"	14.133411069482	2.08119175517885	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCAACAACCGCCA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1305.41367154999	54.4139610216103	0.0416833086763994	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1288.4141617772	1288.4141617772
"AML-0693"	"2021-03-09-AML0693:CAACCAAGTGATGGCA"	0.412778128951234	11.1010989912781	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCAAGTGATGGCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1683.81762276246	39.4618804021619	0.0234359587812253	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1674.22862814337	1674.22862814337
"AML-0693"	"2021-03-09-AML0693:CAACCAAGTGCGTCGT"	-1.0779256624287	11.4905338057312	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCAAGTGCGTCGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1466.1348223338	49.5974097414664	0.0338286827281798	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1466.1348223338	1466.1348223338
"AML-0693"	"2021-03-09-AML0693:CAACCAATCAGCGCGT"	-5.61761937561687	-5.59299995815428	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCAATCAGCGCGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3292.70029164117	46.9753825397202	0.014266522422029	3945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3287.04671204174	3287.04671204174
"AML-0693"	"2021-03-09-AML0693:CAACCTCCAACTGTGT"	-7.19105754318889	-2.65539815342101	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCCAACTGTGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2332.89458706762	31.6868678294356	0.0135826402123317	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2313.00883905394	2313.00883905394
"AML-0693"	"2021-03-09-AML0693:CAACCTCCACGTTGGC"	-6.99168525162395	3.85908029163209	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCCACGTTGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2058.22903256299	36.2879727983457	0.0176306777449148	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2037.40340112477	2037.40340112477
"AML-0693"	"2021-03-09-AML0693:CAACCTCCATACAGAA"	-3.41873536530193	3.64303586566774	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCCATACAGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3455.71099752738	21.7670791351322	0.00629887139020216	4500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3447.12900913918	3447.12900913918
"AML-0693"	"2021-03-09-AML0693:CAACCTCGTCAAACGG"	-8.08170161667522	-4.65018846904906	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCGTCAAACGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2834.72288911488	49.5626192414785	0.0174841143844413	3680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2822.45247430839	2822.45247430839
"AML-0693"	"2021-03-09-AML0693:CAACCTCGTCGTAATC"	-6.79213653031047	-2.5513384572235	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCGTCGTAATC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2550.62098971376	4.53826428279559	0.00177927818405701	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2538.88214399468	2538.88214399468
"AML-0693"	"2021-03-09-AML0693:CAACCTCTCAACTGAC"	-7.68815837326701	-4.51658680355223	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCTCAACTGAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2550.02055821788	45.9239732563141	0.0180092560855309	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2543.18383750414	2543.18383750414
"AML-0693"	"2021-03-09-AML0693:CAACCTCTCGACGCTG"	-7.00826058808024	4.04018066013185	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACCTCTCGACGCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2267.4439628479	36.145020537284	0.0159408660718944	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2246.51991278339	2246.51991278339
"AML-0693"	"2021-03-09-AML0693:CAACGATGTGCGGATA"	-6.78145776215251	3.89193747127382	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGATGTGCGGATA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2294.78706506242	50.6569099497543	0.0220747757911806	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2284.10406115178	2284.10406115178
"AML-0693"	"2021-03-09-AML0693:CAACGATGTTTCACAG"	14.0920454460079	2.14087841594545	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGATGTTTCACAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1154.89900673336	4.5118448924826	0.00390670081641542	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1144.02314126862	1144.02314126862
"AML-0693"	"2021-03-09-AML0693:CAACGATGTTTCGTGA"	9.46976818618123	6.85335872257081	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGATGTTTCGTGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1665.27544064774	46.6566858518244	0.02801739863147	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1654.13360488962	1654.13360488962
"AML-0693"	"2021-03-09-AML0693:CAACGATTCGCTTGAA"	9.57058205184285	5.99865720355836	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGATTCGCTTGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1716.27275335942	44.5487237224442	0.0259566689707361	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1699.54903295765	1699.54903295765
"AML-0693"	"2021-03-09-AML0693:CAACGGCCACAGTGAG"	-0.996296266943771	10.3014306792053	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGGCCACAGTGAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2142.56632235145	32.3424070680765	0.0150951719583555	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2127.09939147761	2127.09939147761
"AML-0693"	"2021-03-09-AML0693:CAACGGCGTCCAAAGG"	-8.70291743698772	-4.1668272248474	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGGCGTCCAAAGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2896.43467500266	46.4678112554769	0.0160431069467963	3204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2888.49349103201	2888.49349103201
"AML-0693"	"2021-03-09-AML0693:CAACGGCTCCACTAGA"	-8.61098800125774	-2.54424335872801	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAACGGCTCCACTAGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2887.4069255867	17.9696406820947	0.00622345278833305	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2857.27179939416	2857.27179939416
"AML-0693"	"2021-03-09-AML0693:CAAGACTCAGACATCT"	8.42048134383504	6.58381078327028	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGACTCAGACATCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1700.12109901413	46.6694747940388	0.0274506767906719	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1696.36442574256	1696.36442574256
"AML-0693"	"2021-03-09-AML0693:CAAGAGGCACTGCTTC"	-7.30495486679729	-2.71959450161131	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGAGGCACTGCTTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2518.3235466032	2.49624345943607	0.000991232227806108	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2503.04059152831	2503.04059152831
"AML-0693"	"2021-03-09-AML0693:CAAGAGGGTTCTCAGA"	9.21711315688435	8.03316495502321	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGAGGGTTCTCAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1932.98459545829	40.7049986650451	0.021058108150828	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1928.05265004534	1928.05265004534
"AML-0693"	"2021-03-09-AML0693:CAAGCTAAGCACCGAA"	8.94542183455769	6.08885667407838	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGCTAAGCACCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1321.23528217231	45.707748109756	0.0345947074881361	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1300.92564207593	1300.92564207593
"AML-0693"	"2021-03-09-AML0693:CAAGCTACAGTTACCA"	-6.91284881058391	3.90864131534425	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGCTACAGTTACCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2499.75894257631	41.6317368425257	0.0166543005941281	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2463.71048338998	2463.71048338998
"AML-0693"	"2021-03-09-AML0693:CAAGCTAGTCGAGTGA"	11.1225630241329	-2.64901878749999	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGCTAGTCGAGTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2112.81480866804	49.9744355827686	0.023653012738146	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2097.99041454114	2097.99041454114
"AML-0693"	"2021-03-09-AML0693:CAAGCTATCGGAAACG"	-7.12970815125163	4.19887158954469	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGCTATCGGAAACG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2187.49230757789	36.9039185183206	0.0168704220766758	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2167.61678486939	2167.61678486939
"AML-0693"	"2021-03-09-AML0693:CAAGGGAAGCGAATGC"	-4.84399590912517	3.70030567729799	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGGGAAGCGAATGC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2606.93122621408	37.7385558324836	0.0144762375980625	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2595.75588180191	2595.75588180191
"AML-0693"	"2021-03-09-AML0693:CAAGGGACAGATCCTA"	0.537615348666352	-8.26152803814086	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGGGACAGATCCTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1665.75917342716	51.7760664844331	0.0310825642207981	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1645.41093124655	1645.41093124655
"AML-0693"	"2021-03-09-AML0693:CAAGGGAGTGTATTCG"	-6.22273669663127	-2.46366193210753	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGGGAGTGTATTCG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1446.21551184834	45.8214301717393	0.0316836804724748	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1440.76950824275	1440.76950824275
"AML-0693"	"2021-03-09-AML0693:CAAGGGATCGAAGCCC"	12.1495930152828	-2.95405366336974	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAAGGGATCGAAGCCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2341.39814238443	50.2194068223309	0.0214484695760408	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2334.16961869393	2334.16961869393
"AML-0693"	"2021-03-09-AML0693:CAATACGAGACTTGTC"	-8.85226951065715	-4.29947807705077	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATACGAGACTTGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3114.97818290123	44.4698628187847	0.0142761394166062	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3102.0846151945	3102.0846151945
"AML-0693"	"2021-03-09-AML0693:CAATACGAGCGCCTAC"	-6.94796262207683	3.82962796771852	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATACGAGCGCCTAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2169.31217326665	43.8299324207376	0.0202045297863869	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2156.69162891477	2156.69162891477
"AML-0693"	"2021-03-09-AML0693:CAATCGACACGTAGTT"	11.0954176383907	-3.12779834186705	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATCGACACGTAGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2573.81939980897	34.8380885330551	0.013535560628551	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2569.44883015357	2569.44883015357
"AML-0693"	"2021-03-09-AML0693:CAATCGACAGAGGTAC"	-2.18724093857463	3.54074976528016	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATCGACAGAGGTAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1910.52937739356	33.3866383232339	0.0174750719451284	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1910.52937739356	1910.52937739356
"AML-0693"	"2021-03-09-AML0693:CAATCGAGTACTGCCG"	-8.71255908432658	-4.57361462032469	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATCGAGTACTGCCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2101.01622377189	24.6185129167705	0.0117174311355738	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2074.5532431386	2074.5532431386
"AML-0693"	"2021-03-09-AML0693:CAATCGATCTTCGACC"	8.42968048629109	7.31936595523683	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATCGATCTTCGACC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1663.30075764103	48.5429728488117	0.0291847235840003	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.47106642011	1651.47106642011
"AML-0693"	"2021-03-09-AML0693:CAATGACGTTCCGCTT"	-6.94597421112712	3.87013027751771	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATGACGTTCCGCTT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2332.86626701333	35.2480017653415	0.0151093109209676	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2323.64170143761	2323.64170143761
"AML-0693"	"2021-03-09-AML0693:CAATTTCGTTGATGTC"	1.18332149562184	-9.0936374894348	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATTTCGTTGATGTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2143.58042903909	45.7430949565763	0.0213395748239228	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2133.48559630174	2133.48559630174
"AML-0693"	"2021-03-09-AML0693:CAATTTCTCCTGTAGA"	8.97351421889607	6.96890399539796	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAATTTCTCCTGTAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1794.62284945351	46.8056724843868	0.0260810634940036	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1784.49983479527	1784.49983479527
"AML-0693"	"2021-03-09-AML0693:CACACAAAGCCAGAGT"	-7.66422114792522	4.91951510989992	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACACAAAGCCAGAGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1582.13787864373	44.523976537118	0.0281416538584398	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1553.92985214943	1553.92985214943
"AML-0693"	"2021-03-09-AML0693:CACACAACAGTGACCC"	-1.01518903198894	11.53439710224	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACACAACAGTGACCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1959.63334677444	54.8238738678793	0.0279765977437154	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1957.08625346016	1957.08625346016
"AML-0693"	"2021-03-09-AML0693:CACACAACATCCGCGA"	-5.68863807144816	-5.58969070827635	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACACAACATCCGCGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3874.81438456283	34.8978714424057	0.00900633371792932	5002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3865.21849894345	3865.21849894345
"AML-0693"	"2021-03-09-AML0693:CACACAATCTGTGCAA"	8.83538975295369	7.4571494826111	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACACAATCTGTGCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1763.87217768232	43.7957048384541	0.0248292962452645	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1758.30447910498	1758.30447910498
"AML-0693"	"2021-03-09-AML0693:CACAGATGTGGATTTC"	1.37079813060109	-10.4966650239197	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGATGTGGATTTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2011.34895418961	48.9602272317709	0.0243419855762908	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2006.18957466237	2006.18957466237
"AML-0693"	"2021-03-09-AML0693:CACAGATTCGGTCGAC"	-1.99228988114055	3.8663964041504	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGATTCGGTCGAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3322.41032852014	15.4642122812923	0.00465451607483422	3820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3315.17429602568	3315.17429602568
"AML-0693"	"2021-03-09-AML0693:CACAGGCAGACATCCT"	-7.4954813522404	-3.39934160625609	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGGCAGACATCCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1911.81648333301	28.9900578401633	0.0151636195696058	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1893.71164903639	1893.71164903639
"AML-0693"	"2021-03-09-AML0693:CACAGGCGTGTTTACG"	-7.39608941498454	-2.47850801860961	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGGCGTGTTTACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2168.31039656438	43.6229212714312	0.0201183932616614	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2160.13027051455	2160.13027051455
"AML-0693"	"2021-03-09-AML0693:CACAGGCTCACTTGGA"	0.512587209313554	9.21418187702028	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGGCTCACTTGGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1629.32521576961	49.0250002813033	0.0300891435342737	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1622.55166061998	1622.55166061998
"AML-0693"	"2021-03-09-AML0693:CACAGGCTCTGGAGAG"	-8.51131759110149	-3.43549730693968	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACAGGCTCTGGAGAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2547.07426981518	49.0781704003781	0.019268448895265	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2540.58051273863	2540.58051273863
"AML-0693"	"2021-03-09-AML0693:CACATGATCAAGAAAC"	-6.86854110184367	3.84411046588746	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACATGATCAAGAAAC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2542.31207833095	42.7315141140585	0.0168081308657087	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2524.36584076507	2524.36584076507
"AML-0693"	"2021-03-09-AML0693:CACATGATCTATTCGT"	0.658064385026139	13.2855672606262	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACATGATCTATTCGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1454.6606421643	51.0229425594684	0.0350754953289686	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1450.21831036637	1450.21831036637
"AML-0693"	"2021-03-09-AML0693:CACCAAAAGTTCCAGT"	-6.98789534989055	-3.07490112697753	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCAAAAGTTCCAGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2397.06948190268	0	0	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2382.9026166724	2382.9026166724
"AML-0693"	"2021-03-09-AML0693:CACCAAACAGTGCGCT"	-7.01136002960857	4.0451769598755	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCAAACAGTGCGCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1985.59459700419	50.600704937815	0.0254839054327403	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1968.72258104285	1968.72258104285
"AML-0693"	"2021-03-09-AML0693:CACCAAAGTCGGCCTA"	0.930111249058884	9.50805471027223	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCAAAGTCGGCCTA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1715.70936417659	41.1120520704858	0.0239621307249881	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1710.66968036037	1710.66968036037
"AML-0693"	"2021-03-09-AML0693:CACCAAAGTGACATCT"	-7.18698583069499	-2.74398662960204	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCAAAGTGACATCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2040.86008660134	36.9533219429742	0.0181067394994788	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2028.20212502701	2028.20212502701
"AML-0693"	"2021-03-09-AML0693:CACCAAAGTTATGGTC"	-4.6285060447758	2.74143383586732	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCAAAGTTATGGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3682.37461381902	37.1343262959024	0.0100843423579303	4913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3658.09672208211	3658.09672208211
"AML-0693"	"2021-03-09-AML0693:CACCGTTAGAAGCGCT"	-7.59295831146892	-3.05763771450194	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTAGAAGCGCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2224.24402526014	52.5738451866225	0.0236367253725561	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2221.53207662708	2221.53207662708
"AML-0693"	"2021-03-09-AML0693:CACCGTTAGCGTTAGG"	9.08800758895222	6.94175527179567	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTAGCGTTAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1579.44338849035	47.1932777900173	0.0298796893474765	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1573.31043770791	1573.31043770791
"AML-0693"	"2021-03-09-AML0693:CACCGTTCAGGTTTAC"	-6.88405499878581	3.37453434551088	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTCAGGTTTAC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2921.97228200262	26.6091978421542	0.00910658804193623	2951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2909.88897560737	2909.88897560737
"AML-0693"	"2021-03-09-AML0693:CACCGTTGTTCGGTCG"	8.85841812667195	6.08622691715089	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTGTTCGGTCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1481.51609743818	48.6159346355717	0.0328149891314971	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1472.31157987138	1472.31157987138
"AML-0693"	"2021-03-09-AML0693:CACCGTTGTTGGGATG"	11.6079927879268	-2.58744313633116	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTGTTGGGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1652.8943148994	42.8637095632106	0.0259325167839418	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1651.08317835521	1651.08317835521
"AML-0693"	"2021-03-09-AML0693:CACCGTTTCACTTGTT"	8.29267277297322	6.05255315387575	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACCGTTTCACTTGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1687.43150494912	39.0010699591957	0.0231126832969565	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1675.4166624944	1675.4166624944
"AML-0693"	"2021-03-09-AML0693:CACGAATAGGATGCGT"	8.56203617629353	6.5744910010132	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGAATAGGATGCGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1658.73094902839	44.7120681782741	0.0269555880683751	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1651.1878987053	1651.1878987053
"AML-0693"	"2021-03-09-AML0693:CACGAATAGTCGCTAT"	-8.56598792496379	-4.39730694210204	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGAATAGTCGCTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2253.04576777347	50.6691778498306	0.0224891915533094	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2243.94454942703	2243.94454942703
"AML-0693"	"2021-03-09-AML0693:CACGAATAGTCTGCAT"	-7.68047318878825	-4.6354174843994	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGAATAGTCTGCAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2702.81336261735	36.5378398460411	0.0135184472414546	2598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2698.01520351955	2698.01520351955
"AML-0693"	"2021-03-09-AML0693:CACGAATGTACGTACT"	-8.40999541702922	-4.22576143657836	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGAATGTACGTACT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2980.45155053636	49.7740764485062	0.0167001796890638	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2973.63736617636	2973.63736617636
"AML-0693"	"2021-03-09-AML0693:CACGAATGTTGATGTC"	-7.27244792404826	-2.9931679002014	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGAATGTTGATGTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2388.30542819069	11.3225945930159	0.00474084866171978	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2371.20292576449	2371.20292576449
"AML-0693"	"2021-03-09-AML0693:CACGGGTGTACAAAGT"	-2.33328686180766	3.91313383663026	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGGGTGTACAAAGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1638.76408702656	44.6465217497669	0.027244020114436	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1636.49356400241	1636.49356400241
"AML-0693"	"2021-03-09-AML0693:CACGTGGAGCGCGTTC"	-7.09682689133342	-2.76555302059325	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTGGAGCGCGTTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2269.45741400696	9.51914514198136	0.00419445858874891	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2250.85084395387	2250.85084395387
"AML-0693"	"2021-03-09-AML0693:CACGTGGGTGAATAAC"	8.13687004622762	7.04885909641115	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTGGGTGAATAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1904.33959673535	44.3611516503913	0.0232947693396916	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1891.49304556517	1891.49304556517
"AML-0693"	"2021-03-09-AML0693:CACGTTCAGGAACGAA"	-6.97434983673747	-2.73094084179076	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTTCAGGAACGAA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2820.02007777299	47.8709184348771	0.0169753821301448	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2802.97185847097	2802.97185847097
"AML-0693"	"2021-03-09-AML0693:CACGTTCCATCAGTGT"	-1.05207703533824	11.9110774763855	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTTCCATCAGTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1939.95392232123	45.3663720055972	0.023385283270705	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1936.12651871178	1936.12651871178
"AML-0693"	"2021-03-09-AML0693:CACGTTCGTATGTCTG"	-8.34998259964641	-4.43200066005858	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTTCGTATGTCTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2706.57433414947	47.1972453638924	0.017438000785123	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2689.89271875506	2689.89271875506
"AML-0693"	"2021-03-09-AML0693:CACGTTCGTCCAGAAG"	11.7594505744869	-2.73957922374877	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACGTTCGTCCAGAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2263.77509101526	27.7792364701532	0.0122711998115037	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2247.36997580267	2247.36997580267
"AML-0693"	"2021-03-09-AML0693:CACTAAGCAGCAGAAC"	-7.48773417893107	-2.57089617168578	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGCAGCAGAAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2386.67266474177	3.18554221373489	0.00133472103686224	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2375.73072919917	2375.73072919917
"AML-0693"	"2021-03-09-AML0693:CACTAAGCATGACTCA"	9.67448391494099	6.76297519290773	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGCATGACTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1738.44751329364	50.1130197186378	0.0288263058478506	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1732.66714870885	1732.66714870885
"AML-0693"	"2021-03-09-AML0693:CACTAAGCATGGTACT"	-6.98084197464641	3.86288235271303	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGCATGGTACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2567.94980848463	40.1389767076532	0.015630748145868	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2554.72245017513	2554.72245017513
"AML-0693"	"2021-03-09-AML0693:CACTAAGGTAGCTTAC"	-2.49394379082378	3.30588123882142	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGGTAGCTTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3374.69242780586	39.1067138337602	0.0115882305337042	4337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3371.29679264419	3371.29679264419
"AML-0693"	"2021-03-09-AML0693:CACTAAGGTCCCGGTA"	-9.21933017197307	4.88004729831544	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGGTCCCGGTA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1534.57475150694	22.4267779943806	0.0146143275017119	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1534.57475150694	1534.57475150694
"AML-0693"	"2021-03-09-AML0693:CACTAAGGTGGAGGTT"	8.54113831099812	6.89332530582277	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGGTGGAGGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1711.06698386421	44.458654257758	0.0259830004769037	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1703.03592023166	1703.03592023166
"AML-0693"	"2021-03-09-AML0693:CACTAAGTCTAAGAAG"	-7.59396729889567	-3.52575590526732	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTAAGTCTAAGAAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1848.76721776495	50.5354527974068	0.0273346759461157	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1840.83407981155	1840.83407981155
"AML-0693"	"2021-03-09-AML0693:CACTGAAAGCGTGAGT"	-8.58409724655803	0.0355049923988952	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGAAAGCGTGAGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3141.59355107891	38.0016062132629	0.0120962834928828	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3115.44536370798	3115.44536370798
"AML-0693"	"2021-03-09-AML0693:CACTGAAAGTGACACG"	-7.3660868209904	-2.33749511158141	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGAAAGTGACACG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1469.62056895522	43.6358501372324	0.0296919157631645	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1461.02508014206	1461.02508014206
"AML-0693"	"2021-03-09-AML0693:CACTGAAGTCAACACT"	12.0140224891597	-3.00765921985777	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGAAGTCAACACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2008.73804662986	38.7916414990171	0.0193114485804157	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1996.02366443843	1996.02366443843
"AML-0693"	"2021-03-09-AML0693:CACTGAAGTGTTACTG"	-5.73372922363933	-1.24150874530943	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	43	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0645161290322581	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGAAGTGTTACTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2821.55441877995	43.3232651407098	0.0153543964462833	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2810.4488691527	2810.4488691527
"AML-0693"	"2021-03-09-AML0693:CACTGGGAGAGGCGGA"	-0.664671878249008	9.17550084674684	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	18	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00436334787782626	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGAGAGGCGGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1372.81848622682	46.8102921677473	0.0340979471338597	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1363.29808239155	1363.29808239155
"AML-0693"	"2021-03-09-AML0693:CACTGGGGTTAGAAAC"	-7.24547324600871	-3.25190069591673	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGGTTAGAAAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1468.61580855204	45.2618141894287	0.0308193701346944	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1462.05584315028	1462.05584315028
"AML-0693"	"2021-03-09-AML0693:CACTGGGTCATTTCGT"	-2.44030485573466	11.0609283217224	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGTCATTTCGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1999.0393655992	41.8040185647637	0.0209120537014704	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1992.67456303753	1992.67456303753
"AML-0693"	"2021-03-09-AML0693:CACTGGGTCCAGCTCT"	11.3391806083614	-2.48123409664305	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGTCCAGCTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1407.36293402259	43.6678340301448	0.0310281257055217	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1399.91862675326	1399.91862675326
"AML-0693"	"2021-03-09-AML0693:CACTGGGTCGGCATAT"	8.89043011245076	6.20239875400392	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGTCGGCATAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2044.35236555569	43.3991656330775	0.0212288088708626	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2040.78609725582	2040.78609725582
"AML-0693"	"2021-03-09-AML0693:CACTGGGTCTTCGTAT"	-7.13675008240398	-2.64010884678038	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGGGTCTTCGTAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2215.81208247822	39.2691428063805	0.0177222351646629	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2200.30398755142	2200.30398755142
"AML-0693"	"2021-03-09-AML0693:CACTGTCAGTTCCTGA"	-7.13229546967204	-2.82209350979003	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGTCAGTTCCTGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2865.77704243419	33.417318028444	0.01166082271357	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2835.33946899291	2835.33946899291
"AML-0693"	"2021-03-09-AML0693:CACTGTCGTCAGGTGA"	-7.14246926727946	-2.77362921154173	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGTCGTCAGGTGA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2461.63522460016	6.72638851382627	0.0027324879196587	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2444.82890590343	2444.82890590343
"AML-0693"	"2021-03-09-AML0693:CACTGTCTCACCTTAT"	11.7961365180904	-2.71675493633422	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTGTCTCACCTTAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1940.56556374145	43.5281389759294	0.0224306458844948	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1924.49237626486	1924.49237626486
"AML-0693"	"2021-03-09-AML0693:CACTTCGCAGCGTTTA"	-7.81734357300456	-2.90771558200987	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTTCGCAGCGTTTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2850.21201718063	6.00255901909296	0.00210600438946663	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2820.26955526865	2820.26955526865
"AML-0693"	"2021-03-09-AML0693:CACTTCGCATGACGTT"	6.9029675918514	-0.283452533837877	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTTCGCATGACGTT"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	2367.48307016791	43.9548177387241	0.01856605366796	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	2363.09919619244	2363.09919619244
"AML-0693"	"2021-03-09-AML0693:CACTTCGTCCTCCACA"	-7.70310960236247	-3.43675949489745	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTTCGTCCTCCACA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3217.36813670663	0	0	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3189.01119831356	3189.01119831356
"AML-0693"	"2021-03-09-AML0693:CACTTCGTCTTCACGC"	-7.28236518326457	-2.60817625438841	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CACTTCGTCTTCACGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1718.27122009658	43.4630988588597	0.0252946673089344	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1707.83565169495	1707.83565169495
"AML-0693"	"2021-03-09-AML0693:CAGAGCCAGAGGTGCT"	9.90916409072224	5.4643835791382	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGAGCCAGAGGTGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1578.33049634418	50.7491453713273	0.0321536873860546	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1571.27170892868	1571.27170892868
"AML-0693"	"2021-03-09-AML0693:CAGAGCCAGGCTAGCA"	9.04401936110799	6.32231662357179	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGAGCCAGGCTAGCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1566.94776347034	48.3286544607743	0.0308425434385509	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1555.4851630589	1555.4851630589
"AML-0693"	"2021-03-09-AML0693:CAGAGCCTCGTAGCCG"	-6.89237676087077	3.89717600429384	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGAGCCTCGTAGCCG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1732.83024014474	38.8618236218868	0.0224267921470719	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1724.3042146435	1724.3042146435
"AML-0693"	"2021-03-09-AML0693:CAGATACCATGAAAGT"	11.3451458412105	-3.0418739548889	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATACCATGAAAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2419.89153050563	35.1282296506984	0.0145164480340813	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2410.28525584405	2410.28525584405
"AML-0693"	"2021-03-09-AML0693:CAGATACGTGATCGTT"	8.36828579482381	6.47040793979494	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATACGTGATCGTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1650.02048590695	44.3512233816391	0.0268791955981449	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1646.14346550016	1646.14346550016
"AML-0693"	"2021-03-09-AML0693:CAGATACTCCCAATAG"	-8.68852553787883	-4.45885469829711	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATACTCCCAATAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2395.30331952202	47.4110037736277	0.0197933194461103	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2392.02184019726	2392.02184019726
"AML-0693"	"2021-03-09-AML0693:CAGATCACAACGGTAG"	-2.69622741165813	12.8369941481384	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATCACAACGGTAG"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1455.44030313638	45.2784896335541	0.0311098225986884	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1450.58945098425	1450.58945098425
"AML-0693"	"2021-03-09-AML0693:CAGATCACACAAAGCG"	9.02904476699178	7.48219392383424	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATCACACAAAGCG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1614.21986068439	44.5749618801485	0.0276139347345471	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1610.10894037186	1610.10894037186
"AML-0693"	"2021-03-09-AML0693:CAGATCATCACAAGAA"	-2.47051797333415	3.35984394634096	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATCATCACAAGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3386.25580662575	26.437782396463	0.00780737897731569	3989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3373.0640990059	3373.0640990059
"AML-0693"	"2021-03-09-AML0693:CAGATCATCGGAGATG"	10.9366308647091	-3.06375672733458	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATCATCGGAGATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2410.37694529238	34.2350146084988	0.0142031787498474	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2402.76900940267	2402.76900940267
"AML-0693"	"2021-03-09-AML0693:CAGATCATCTGCTTAT"	8.77279247817342	6.92162177646486	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATCATCTGCTTAT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1710.89080765468	51.943884708141	0.0303607246445765	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1698.17222599164	1698.17222599164
"AML-0693"	"2021-03-09-AML0693:CAGATTGAGACTCTTG"	11.2861868339473	-2.93875625049742	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGAGACTCTTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1994.75374641026	45.0566695802598	0.0225875848892844	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1992.98625628724	1992.98625628724
"AML-0693"	"2021-03-09-AML0693:CAGATTGCATTGCTTT"	-9.24948535385783	-2.5836653939453	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGCATTGCTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3185.60656030701	34.2973458912533	0.010766347080836	4652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3173.85540012578	3173.85540012578
"AML-0693"	"2021-03-09-AML0693:CAGATTGGTAGCGTTT"	-8.82715354386028	-4.14251139080199	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGGTAGCGTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2722.43968771523	47.6430336964436	0.0175001245799599	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2713.00054636397	2713.00054636397
"AML-0693"	"2021-03-09-AML0693:CAGATTGGTGTGCCTG"	-2.38767371597942	3.92175028407899	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGGTGTGCCTG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3574.22279697377	32.191514404669	0.00900657743885607	5480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3568.83133245125	3568.83133245125
"AML-0693"	"2021-03-09-AML0693:CAGATTGGTTCGGCGT"	-2.33188186112102	3.5448312529358	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGGTTCGGCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3246.56112149034	28.3437591988548	0.00873039445068064	4088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3242.63111511086	3242.63111511086
"AML-0693"	"2021-03-09-AML0693:CAGATTGTCACTTTGT"	1.29498567160909	-9.81322290813597	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGATTGTCACTTTGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1903.32963290451	39.171826013919	0.0205806841530346	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1901.5987549875	1901.5987549875
"AML-0693"	"2021-03-09-AML0693:CAGCAATCAGTAGTTC"	-8.31849894943889	-3.51646330272826	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCAATCAGTAGTTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2423.22325313694	44.7769304819719	0.018478252230374	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2419.02954981364	2419.02954981364
"AML-0693"	"2021-03-09-AML0693:CAGCAATTCATGGATC"	-8.48613200607951	-3.34675624286803	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCAATTCATGGATC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2837.11986030306	51.3440358269402	0.0180972388743053	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2832.40662732078	2832.40662732078
"AML-0693"	"2021-03-09-AML0693:CAGCACGAGGTTGGAC"	8.25898327407185	6.85678718173829	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCACGAGGTTGGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1632.07402034978	49.4486137908909	0.0302980215200616	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1629.86741398336	1629.86741398336
"AML-0693"	"2021-03-09-AML0693:CAGCAGCGTAATGATG"	-7.75740371170695	-2.67502024089965	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCAGCGTAATGATG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2461.86443953415	3.79511490801107	0.00154156128463727	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2439.36135676971	2439.36135676971
"AML-0693"	"2021-03-09-AML0693:CAGCCAGAGGACTAAT"	-2.25900206986125	3.45061490619508	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCCAGAGGACTAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2873.08722678037	40.7289282656952	0.0141760152236438	3752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2868.33944285096	2868.33944285096
"AML-0693"	"2021-03-09-AML0693:CAGCCAGAGTCGTTAC"	0.346810718148392	11.7246923216614	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCCAGAGTCGTTAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1764.2501855611	41.6754416417504	0.0236221835104957	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1759.93481367951	1759.93481367951
"AML-0693"	"2021-03-09-AML0693:CAGCCAGCAGTGGGTA"	-8.75320849838908	-3.52162697231444	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCCAGCAGTGGGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2904.83635241859	49.3618888279774	0.0169930016150061	3210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2896.60761308519	2896.60761308519
"AML-0693"	"2021-03-09-AML0693:CAGCCAGGTGTTGAGG"	11.1761805015499	-2.777867817041	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCCAGGTGTTGAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1465.87596667581	46.6678114558993	0.031836125645561	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1455.96256554221	1455.96256554221
"AML-0693"	"2021-03-09-AML0693:CAGCCAGGTTTGACAC"	11.8584610420162	-2.92108704960021	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCCAGGTTTGACAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2087.71468077109	47.3048759163601	0.022658688158905	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2084.39387882583	2084.39387882583
"AML-0693"	"2021-03-09-AML0693:CAGCGTGGTGTAACGG"	-8.28373179855998	-3.95473959362181	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCGTGGTGTAACGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2371.43832586695	52.2049189689104	0.0220140319060692	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2363.8659137989	2363.8659137989
"AML-0693"	"2021-03-09-AML0693:CAGCGTGTCCTTCTGG"	8.93966545638387	5.77459666812745	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCGTGTCCTTCTGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1644.97464953652	41.336416549732	0.0251289079508787	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1640.46135858159	1640.46135858159
"AML-0693"	"2021-03-09-AML0693:CAGCGTGTCTACCCAC"	11.6408993202144	-2.5701430073944	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGCGTGTCTACCCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1843.21382639745	41.9283625812373	0.0227474219109923	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1835.45839974172	1835.45839974172
"AML-0693"	"2021-03-09-AML0693:CAGGCCAAGCTGTTAC"	1.35015656527821	-10.5446596375671	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGCCAAGCTGTTAC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2255.42674872409	37.1470058697046	0.0164700564497246	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2244.59801570705	2244.59801570705
"AML-0693"	"2021-03-09-AML0693:CAGGCCACAACCGACC"	-8.74323497238811	-4.63633158123168	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGCCACAACCGACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1835.51747655175	47.2747508943395	0.0257555438715578	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1826.91977896151	1826.91977896151
"AML-0693"	"2021-03-09-AML0693:CAGGCCACACTTCCTG"	-6.98342595520671	3.93800160968629	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGCCACACTTCCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2037.32307004409	46.4676749832964	0.0228082014416549	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2023.19702849353	2023.19702849353
"AML-0693"	"2021-03-09-AML0693:CAGGCCACAGAAATCA"	-8.54529605332072	1.42091569984285	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGCCACAGAAATCA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2978.14661540828	48.9177424864264	0.0164255655626008	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2956.26391679704	2956.26391679704
"AML-0693"	"2021-03-09-AML0693:CAGGCCATCACACCCT"	-7.13568625870402	-2.82204391872557	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGCCATCACACCCT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2752.45938684542	38.2434305802849	0.0138942760656373	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2722.92963201246	2722.92963201246
"AML-0693"	"2021-03-09-AML0693:CAGGGCTCAGGCAATG"	-7.01426110687907	-2.7392993203369	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGGCTCAGGCAATG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1572.59087541592	50.9298449584721	0.0323859471364427	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1568.41386427409	1568.41386427409
"AML-0693"	"2021-03-09-AML0693:CAGGGCTCATCGCTGG"	-8.99264083328899	-2.62157418644103	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGGCTCATCGCTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2846.71944772617	47.8793759583314	0.0168191410630841	3279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2838.48652702367	2838.48652702367
"AML-0693"	"2021-03-09-AML0693:CAGGGCTGTAGGCAGT"	-6.99956069412883	-2.69888236438902	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGGCTGTAGGCAGT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1616.74662851433	46.9047658623654	0.0290118222825473	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1601.85946084447	1601.85946084447
"AML-0693"	"2021-03-09-AML0693:CAGGGCTGTGTGTCCG"	-1.50823626938518	10.784433341864	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGGCTGTGTGTCCG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1918.91399582999	41.0059928379426	0.0213693750355947	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1915.72125067114	1915.72125067114
"AML-0693"	"2021-03-09-AML0693:CAGGTATCAGTTAGGG"	-7.03127942505534	-2.68986871158751	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGTATCAGTTAGGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2052.74236522204	49.6974917186235	0.0242102918323351	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2036.51629557125	2036.51629557125
"AML-0693"	"2021-03-09-AML0693:CAGGTATGTGAATATG"	8.81166042861287	7.24917838657228	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGTATGTGAATATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1837.75121302314	47.561228920383	0.0258801238074786	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1836.17626641619	1836.17626641619
"AML-0693"	"2021-03-09-AML0693:CAGGTATTCGTAACCA"	1.31157328662221	-9.91416933452757	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGGTATTCGTAACCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2366.05116506842	45.8804325925118	0.0193911413539466	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2358.33738446241	2358.33738446241
"AML-0693"	"2021-03-09-AML0693:CAGTGCGAGGCATTTC"	-2.92746005478557	3.42101643169252	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTGCGAGGCATTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3445.58522222356	22.1676633316242	0.0064336424444375	4870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3435.22384392239	3435.22384392239
"AML-0693"	"2021-03-09-AML0693:CAGTGCGCACATATGC"	-2.03969750824626	3.0104782351288	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTGCGCACATATGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3237.61204487257	48.1665701701033	0.0148771901952815	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3211.05499192834	3211.05499192834
"AML-0693"	"2021-03-09-AML0693:CAGTTAGTCTGCTTTA"	-1.99369416657146	3.16277263248292	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTTAGTCTGCTTTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2259.86882790074	9.26257485589548	0.00409872234243779	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2253.68129787736	2253.68129787736
"AML-0693"	"2021-03-09-AML0693:CAGTTCCCACTATCGA"	-0.197698811919051	11.2774162062439	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTTCCCACTATCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1965.24879882554	39.5537587013552	0.0201265909563171	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1953.52777840081	1953.52777840081
"AML-0693"	"2021-03-09-AML0693:CAGTTCCGTAGTCACT"	-6.9234131378239	3.80292246425477	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTTCCGTAGTCACT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2277.02433836148	43.0053026977846	0.0188866240791834	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2264.09284804362	2264.09284804362
"AML-0693"	"2021-03-09-AML0693:CAGTTCCGTTGCCGCA"	-3.4472054046696	3.06231949413148	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CAGTTCCGTTGCCGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3464.57987356009	45.8760811221842	0.0132414557598418	3007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3458.83786651609	3458.83786651609
"AML-0693"	"2021-03-09-AML0693:CATAAGCCACCCTTGT"	0.465859879820985	10.3775481947693	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAAGCCACCCTTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1683.54512853364	47.2205396301462	0.0280482767166895	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1679.67569736464	1679.67569736464
"AML-0693"	"2021-03-09-AML0693:CATAAGCCAGAGAATT"	-8.45596347275432	-2.77849295055541	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAAGCCAGAGAATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1745.92250898922	48.0665850367607	0.0275307665656869	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1740.74607547175	1740.74607547175
"AML-0693"	"2021-03-09-AML0693:CATAAGCCAGGATTCT"	8.0733810859615	6.54816434467164	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAAGCCAGGATTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1504.82548867678	46.3667059531997	0.0308120152815665	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1498.06095831481	1498.06095831481
"AML-0693"	"2021-03-09-AML0693:CATACAGCAATTGCAC"	10.17671742019	6.79165074909059	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACAGCAATTGCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1762.78194299629	44.267222857264	0.0251121376827928	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1759.097313895	1759.097313895
"AML-0693"	"2021-03-09-AML0693:CATACAGCACTGCATA"	-7.55246673050578	-3.14131238376769	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACAGCACTGCATA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2055.26927839492	29.8750100530765	0.0145358130767213	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2033.91253200191	2033.91253200191
"AML-0693"	"2021-03-09-AML0693:CATACAGTCAATCCAG"	-7.36461720886882	-3.23440363323363	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACAGTCAATCCAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1850.35122897517	51.9032713873157	0.0280504968865088	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1836.20227990749	1836.20227990749
"AML-0693"	"2021-03-09-AML0693:CATACCCCATGCCGCA"	1.13383199748341	-9.95459463512572	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACCCCATGCCGCA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2768.02989855475	46.4718083893353	0.0167887667736534	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2760.39445432982	2760.39445432982
"AML-0693"	"2021-03-09-AML0693:CATACTTTCAGCTTGA"	14.15780701217	1.95797536456911	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACTTTCAGCTTGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1246.84218218156	2.75006255981243	0.00220562200983667	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1229.34854449346	1229.34854449346
"AML-0693"	"2021-03-09-AML0693:CATACTTTCCATGCAA"	-7.81099114838298	-2.78487207805785	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACTTTCCATGCAA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2741.25305346976	8.4233710448943	0.00307281775180601	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2713.6522998083	2713.6522998083
"AML-0693"	"2021-03-09-AML0693:CATACTTTCCGAGTGC"	11.7576853233272	-3.1270003548828	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACTTTCCGAGTGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2218.98845843299	45.3727171668338	0.0204474777660066	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2213.06525766141	2213.06525766141
"AML-0693"	"2021-03-09-AML0693:CATACTTTCGCCCAGA"	-1.06166992607768	11.2445688017639	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACTTTCGCCCAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1586.23561215991	40.0233695330568	0.0252316674939347	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1579.25978784352	1579.25978784352
"AML-0693"	"2021-03-09-AML0693:CATACTTTCTTAGCAG"	3.43407859381978	-10.1819954148498	"2021-03-09-AML0693"	"AML0693"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATACTTTCTTAGCAG"	"HLA-II+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2425.10435338862	50.4562081646844	0.0208057884577963	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2411.16980654885	2411.16980654885
"AML-0693"	"2021-03-09-AML0693:CATAGACGTCCATCTC"	-8.24619422379192	-4.85036899959715	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAGACGTCCATCTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1565.2360723339	49.2571125348016	0.0314694463061762	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1560.67116037552	1560.67116037552
"AML-0693"	"2021-03-09-AML0693:CATAGACGTTCCAAAC"	9.41087212142293	6.97573802554933	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAGACGTTCCAAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1549.56068883877	46.057821975836	0.0297231481848907	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1545.38715548745	1545.38715548745
"AML-0693"	"2021-03-09-AML0693:CATAGACTCGGACCAC"	-8.68839679184611	-3.84593703663024	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATAGACTCGGACCAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2998.26618966568	50.9170527598329	0.0169821655379806	2761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2993.80106956084	2993.80106956084
"AML-0693"	"2021-03-09-AML0693:CATCAAGAGACGAAGA"	8.39564194258992	7.18652055347291	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCAAGAGACGAAGA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2078.29805531669	43.0618084095657	0.0207197462844202	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2062.06521667394	2062.06521667394
"AML-0693"	"2021-03-09-AML0693:CATCAAGAGCGCGTTC"	-8.656890253455	-2.98888494884642	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCAAGAGCGCGTTC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3177.1655379298	47.6217931556857	0.0149887667441828	3267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3171.17123831736	3171.17123831736
"AML-0693"	"2021-03-09-AML0693:CATCAAGGTAATGTGA"	11.0905682044918	-2.85204365169676	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCAAGGTAATGTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1519.07526166593	49.4334156044262	0.0325417817351682	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1513.35609857471	1513.35609857471
"AML-0693"	"2021-03-09-AML0693:CATCAAGGTATCTTCT"	-5.67968068543132	3.04011938655702	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.157894736842105	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCAAGGTATCTTCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2138.397051637	36.4251964059816	0.0170338788945192	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2124.41143089534	2124.41143089534
"AML-0693"	"2021-03-09-AML0693:CATCAAGTCTTAGCCC"	9.88984932479207	6.92519948566285	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCAAGTCTTAGCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1844.97969915875	43.3511962257318	0.0234968418598311	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1839.15085666813	1839.15085666813
"AML-0693"	"2021-03-09-AML0693:CATCCACCACAACGTT"	11.7077642875606	-2.93429424678954	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCACCACAACGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1758.0418916583	54.4137667095995	0.0309513481833319	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1747.98238355839	1747.98238355839
"AML-0693"	"2021-03-09-AML0693:CATCCCAAGGCAGGGA"	0.982739050954026	-9.08378508007201	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	51	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCCAAGGCAGGGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2964.37027505409	38.3045762280547	0.0129216571055233	3208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2955.72546132671	2955.72546132671
"AML-0693"	"2021-03-09-AML0693:CATCCCACAGCGTACC"	-8.48809943619426	-2.42145802890929	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCCACAGCGTACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3310.56682014639	51.6756990949714	0.0156093206699529	5321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3297.92649581816	3297.92649581816
"AML-0693"	"2021-03-09-AML0693:CATCCCATCCAACCAA"	11.4960829215938	-2.27839639103087	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCCATCCAACCAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1714.37713414864	47.1903575923147	0.0275262406691801	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1712.28011856388	1712.28011856388
"AML-0693"	"2021-03-09-AML0693:CATCCGTAGCTGTTCA"	-2.19408116760905	4.00845406139223	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCGTAGCTGTTCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3548.26774739089	17.5748095507059	0.00495306746894423	5358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3542.17553020422	3542.17553020422
"AML-0693"	"2021-03-09-AML0693:CATCCGTAGGGTACAC"	8.37684120711629	6.20255467975465	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCGTAGGGTACAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1584.93982211281	46.4372978048182	0.0292990920897645	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1582.95163104088	1582.95163104088
"AML-0693"	"2021-03-09-AML0693:CATCCGTTCGAGTGAG"	-0.890684763819534	10.273525215033	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCCGTTCGAGTGAG"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1906.61803576607	45.6034739249362	0.0239185159635883	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1898.88545284229	1898.88545284229
"AML-0693"	"2021-03-09-AML0693:CATCGCTAGGCGAAGG"	-6.95170865479167	3.86794374072877	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGCTAGGCGAAGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1949.8736106534	46.4002194507407	0.0237965267067706	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1941.46772011973	1941.46772011973
"AML-0693"	"2021-03-09-AML0693:CATCGCTCAGGACATG"	-2.17951403084453	3.7951028116974	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGCTCAGGACATG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3316.05936530951	20.7205755805878	0.00624855387010051	4667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3312.69705038184	3312.69705038184
"AML-0693"	"2021-03-09-AML0693:CATCGCTGTAGCGAGT"	-7.23794780197795	-1.18304147636565	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGCTGTAGCGAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3355.09130331642	45.4285778637001	0.0135401912367616	4174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3344.58696856695	3344.58696856695
"AML-0693"	"2021-03-09-AML0693:CATCGCTTCTCTGACC"	11.467525144189	-2.62475278293761	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGCTTCTCTGACC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1611.54756900268	35.9027313501579	0.0222784186087516	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1602.63263953133	1602.63263953133
"AML-0693"	"2021-03-09-AML0693:CATCGGGAGTAAGCAT"	-6.98830781403239	-2.67692806636962	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGGGAGTAAGCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1713.82006011076	7.66652784200121	0.00447335634611825	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1699.1745786601	1699.1745786601
"AML-0693"	"2021-03-09-AML0693:CATCGGGAGTGATCGG"	-5.73658881607707	-5.62483837520751	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0530085959885387	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGGGAGTGATCGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3634.3611734073	49.1088648169892	0.0135123787851136	4977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3628.21106700027	3628.21106700027
"AML-0693"	"2021-03-09-AML0693:CATCGGGGTTCTCGTC"	6.91833796080892	-0.4682091108528	"2021-03-09-AML0693"	"AML0693"	"pDC"	"pDC"	32	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245614035087719	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGGGGTTCTCGTC"	"pDC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"pDC"	1869.25731190562	47.3328637932493	0.0253217486387659	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	1863.693719394	1863.693719394
"AML-0693"	"2021-03-09-AML0693:CATCGGGTCTACACTT"	-8.5409816307133	-2.35980203067931	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGGGTCTACACTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1714.83350620338	50.8967368087657	0.0296802789452432	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1710.55366219134	1710.55366219134
"AML-0693"	"2021-03-09-AML0693:CATCGTCAGACGAGCT"	8.37084068831746	6.63194558704225	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCAGACGAGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1560.56249176533	51.6498070661643	0.0330969168736955	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1556.03849769398	1556.03849769398
"AML-0693"	"2021-03-09-AML0693:CATCGTCAGCATAGGC"	0.942399700253647	9.46183774555055	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCAGCATAGGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1706.84563528164	38.4479496676748	0.0225257333603754	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1698.72815422147	1698.72815422147
"AML-0693"	"2021-03-09-AML0693:CATCGTCAGCGACTAG"	7.92872585830037	6.12622640216676	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCAGCGACTAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1551.49618682678	50.8992380798124	0.0328065505490638	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1549.14072781509	1549.14072781509
"AML-0693"	"2021-03-09-AML0693:CATCGTCCAAAGGTTA"	-1.6542069715565	3.33222076976625	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCCAAAGGTTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2800.54580514787	28.2414468150036	0.0100842652753942	2813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2795.35422468195	2795.35422468195
"AML-0693"	"2021-03-09-AML0693:CATCGTCCAGGCACAA"	-6.87535462799724	3.82301709735719	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCCAGGCACAA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2555.95996251154	51.6665914869591	0.0202141630717057	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2541.50113289705	2541.50113289705
"AML-0693"	"2021-03-09-AML0693:CATCGTCTCCACACCT"	-7.68765817108806	-2.39458730137023	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCTCCACACCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2177.14446265446	30.4489515639053	0.0139857285936739	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2165.73284285479	2165.73284285479
"AML-0693"	"2021-03-09-AML0693:CATCGTCTCCACTTTA"	9.03130306777303	7.55761287296144	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATCGTCTCCACTTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2039.52282881657	47.7163723939045	0.0233958510881645	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2031.3361463444	2031.3361463444
"AML-0693"	"2021-03-09-AML0693:CATGAGTAGACTCTTG"	-8.46683059158977	-3.62004878437194	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGAGTAGACTCTTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3000.85164496129	52.3211720433056	0.0174354410792542	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2989.95112554475	2989.95112554475
"AML-0693"	"2021-03-09-AML0693:CATGAGTGTACCGGCT"	-6.93466029587443	3.84637305820314	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGAGTGTACCGGCT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2616.6111543201	37.5806470273114	0.0143623354067205	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2550.50428390442	2550.50428390442
"AML-0693"	"2021-03-09-AML0693:CATGAGTTCAAGTAAG"	8.9648024040157	6.39975259387819	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGAGTTCAAGTAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1882.00865996496	43.6326283137821	0.0231840741447994	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1865.82240947424	1865.82240947424
"AML-0693"	"2021-03-09-AML0693:CATGAGTTCTACGCGG"	-8.37093577805217	-3.46663596546324	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGAGTTCTACGCGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2822.93391363106	51.4022939255138	0.0182088194404085	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2814.89409276058	2814.89409276058
"AML-0693"	"2021-03-09-AML0693:CATGCAAAGATGATTG"	-7.13726363602336	3.16029212558595	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCAAAGATGATTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2463.41661738227	36.1576343243736	0.0146778397406429	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2454.87573217911	2454.87573217911
"AML-0693"	"2021-03-09-AML0693:CATGCAACACCTTCGT"	-6.7769754928654	-2.6024687520233	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCAACACCTTCGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1576.6116041384	36.0590282194065	0.0228712183297118	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1572.40749874421	1572.40749874421
"AML-0693"	"2021-03-09-AML0693:CATGCAAGTAGAATGT"	-1.24750254574474	10.125105834845	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCAAGTAGAATGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1924.2911783322	40.735650664112	0.0211691718606838	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1920.31007052253	1920.31007052253
"AML-0693"	"2021-03-09-AML0693:CATGCAAGTTCCTAGA"	11.9635034995968	-3.06778051769408	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCAAGTTCCTAGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1958.36007543281	38.6488299969428	0.01973530326817	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1942.57484004552	1942.57484004552
"AML-0693"	"2021-03-09-AML0693:CATGCAATCTACTATC"	9.30891003188435	7.13208673084108	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCAATCTACTATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1682.11311850376	50.6444831446095	0.0301076560116585	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1673.26251152737	1673.26251152737
"AML-0693"	"2021-03-09-AML0693:CATGCCTCATCCTGTC"	-7.17738805237468	-2.84381606495055	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCCTCATCCTGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1707.60598578929	11.9880783130569	0.00702040073226596	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1697.37568651735	1697.37568651735
"AML-0693"	"2021-03-09-AML0693:CATGCCTCATGTGCTA"	-6.99873147431071	-2.70652844822081	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCCTCATGTGCTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2024.27948219184	46.462940075858	0.0229528286408105	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2008.4358330342	2008.4358330342
"AML-0693"	"2021-03-09-AML0693:CATGCCTGTCGAAGCA"	-7.06007419052775	-2.71260430729064	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCCTGTCGAAGCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1907.82861819725	24.308149867078	0.0127412649308339	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1881.56733911728	1881.56733911728
"AML-0693"	"2021-03-09-AML0693:CATGCGGGTGGAGAAA"	-7.91587386551555	-4.53301241314086	"2021-03-09-AML0693"	"AML0693"	"cDC2"	"cDC2"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCGGGTGGAGAAA"	"cDC2"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"DC"	"cDC"	3137.46894009066	45.4274034263728	0.014478997017596	3151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"DC_AML-0693"	3122.40606912696	3122.40606912696
"AML-0693"	"2021-03-09-AML0693:CATGCTCAGAATCGTA"	1.00646050748174	-9.34449102794798	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	51	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCTCAGAATCGTA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2518.23618921555	46.2901033584083	0.0183819546223057	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2511.6073648431	2511.6073648431
"AML-0693"	"2021-03-09-AML0693:CATGCTCCAGGTGTTT"	-8.77226005020793	-3.63376810466918	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCTCCAGGTGTTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3036.37437080174	46.0756859999714	0.0151745734791607	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3028.03499507594	3028.03499507594
"AML-0693"	"2021-03-09-AML0693:CATGCTCTCGAAGAAT"	-6.91861234131511	-2.7354557744232	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGCTCTCGAAGAAT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2003.58173227464	17.3265327494311	0.00864777935949762	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1990.53970849881	1990.53970849881
"AML-0693"	"2021-03-09-AML0693:CATGGATAGCTAGTTC"	11.525199552148	-2.43914940273436	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGGATAGCTAGTTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1711.07238850403	50.1548222678625	0.0293119230985383	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1702.30432602059	1702.30432602059
"AML-0693"	"2021-03-09-AML0693:CATGGATAGTGATGGC"	-2.25747332993205	3.45941612804262	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGGATAGTGATGGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3137.94985553931	16.0361912898025	0.00511040393507067	4330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3131.52721274876	3131.52721274876
"AML-0693"	"2021-03-09-AML0693:CATGGATCACGGTGTC"	-2.22037325325664	11.4308786162171	"2021-03-09-AML0693"	"AML0693"	"gd T"	"gd T"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGGATCACGGTGTC"	"gd T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"gd_T"	2250.39841935471	48.9665991393714	0.0217590799559006	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2242.85741707881	2242.85741707881
"AML-0693"	"2021-03-09-AML0693:CATGGTAAGGGTCACA"	8.53301777419392	6.65432403171388	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATGGTAAGGGTCACA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1504.38559057988	42.8331028311929	0.0284721570715674	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1493.53959377252	1493.53959377252
"AML-0693"	"2021-03-09-AML0693:CATTCCGAGTCGGCCT"	-4.66715083542522	2.94635531986085	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCCGAGTCGGCCT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2773.66968285727	45.6717379459274	0.0164661777241186	2691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2767.12830682516	2767.12830682516
"AML-0693"	"2021-03-09-AML0693:CATTCCGTCTACAGGT"	-7.34957681122478	-0.653495453950487	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCCGTCTACAGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3489.62688416877	26.804932459002	0.00768131761610581	3964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3481.5583326543	3481.5583326543
"AML-0693"	"2021-03-09-AML0693:CATTCTAAGGGAGGTG"	-6.94430575791057	3.9432425268921	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTAAGGGAGGTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2193.95475697732	38.8794873615663	0.0177211892077172	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2184.84814880496	2184.84814880496
"AML-0693"	"2021-03-09-AML0693:CATTCTAAGGTTAAAC"	14.1970392661983	1.96206483924714	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTAAGGTTAAAC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1173.20100042773	2.63415412660398	0.00224527095156209	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1152.95963276026	1152.95963276026
"AML-0693"	"2021-03-09-AML0693:CATTCTAGTATCACGT"	-6.76740107956584	-2.84867789661559	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTAGTATCACGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2544.03225258231	1.55526948099552	0.000611340315916533	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2521.98680091637	2521.98680091637
"AML-0693"	"2021-03-09-AML0693:CATTCTAGTGACACAG"	-8.541975359351	-3.49360849773558	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTAGTGACACAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2916.83553633943	39.2414842692198	0.0134534442481687	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2907.44970934328	2907.44970934328
"AML-0693"	"2021-03-09-AML0693:CATTCTATCAAACGTC"	-6.30221066895183	-1.53124346649321	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.565217391304348	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTATCAAACGTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1289.83405286225	51.1894263163641	0.0396868311879118	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1243.1609466671	1243.1609466671
"AML-0693"	"2021-03-09-AML0693:CATTCTATCTACTGAG"	1.26021422919576	-9.5757160416809	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTCTATCTACTGAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2918.5442842094	42.4630100453687	0.0145493800711239	2493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2906.88511948958	2906.88511948958
"AML-0693"	"2021-03-09-AML0693:CATTGAGAGAAACTAC"	-8.51902327957805	-3.54909565364989	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGAGAGAAACTAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2567.3657310431	48.7696424466966	0.0189959855960537	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2561.94477513379	2561.94477513379
"AML-0693"	"2021-03-09-AML0693:CATTGAGCAGTAACCT"	-2.17879400673564	3.43327972972719	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGAGCAGTAACCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3123.42546391391	19.2371107815144	0.00615897866101427	5209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3119.13802129823	3119.13802129823
"AML-0693"	"2021-03-09-AML0693:CATTGAGCAGTACTAC"	-7.74218831482585	-2.6940865746704	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGAGCAGTACTAC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2107.98393686738	29.1021121508065	0.0138056612490389	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2088.50161634088	2088.50161634088
"AML-0693"	"2021-03-09-AML0693:CATTGAGGTTTGAACC"	-8.98267207565959	-2.53144791042479	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGAGGTTTGAACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2854.1676085102	50.6138472623208	0.0177333128970446	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2841.83107619296	2841.83107619296
"AML-0693"	"2021-03-09-AML0693:CATTGCCCAGGGTTGA"	-1.19815609875377	9.88937089526979	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ TRM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGCCCAGGGTTGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1846.97015395967	49.875779003405	0.0270041066426968	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1826.27008928705	1826.27008928705
"AML-0693"	"2021-03-09-AML0693:CATTGCCGTAGGGAGG"	-1.8772431415623	4.00347516620485	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGCCGTAGGGAGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3152.81208627425	16.766608258882	0.00531798527792864	4623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3150.25515706146	3150.25515706146
"AML-0693"	"2021-03-09-AML0693:CATTGCCTCATTCACT"	9.13333096083943	7.06722114169923	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGCCTCATTCACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1996.48157448238	45.2886876651205	0.0226842502550329	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1983.70576400103	1983.70576400103
"AML-0693"	"2021-03-09-AML0693:CATTGCCTCGTTCAGA"	14.1594301658565	2.10758636081544	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGCCTCGTTCAGA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1122.35936536535	2.52167766192601	0.00224676493086075	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1112.48470207171	1112.48470207171
"AML-0693"	"2021-03-09-AML0693:CATTGTTAGCAATTCC"	-6.29640994492229	3.43491909587709	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGTTAGCAATTCC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3019.60109351699	34.9420733122744	0.0115717514433592	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3004.73321547173	3004.73321547173
"AML-0693"	"2021-03-09-AML0693:CATTGTTAGTTCCAGT"	8.14763416823689	6.36014411533204	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTGTTAGTTCCAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1793.53483055727	37.1420549271613	0.0207088562175404	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1789.80110386267	1789.80110386267
"AML-0693"	"2021-03-09-AML0693:CATTTCAAGACTGGGT"	0.634031136601609	11.4578246840271	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTTCAAGACTGGGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1990.09769436746	20.282506474144	0.0101917139703992	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1986.85408588039	1986.85408588039
"AML-0693"	"2021-03-09-AML0693:CATTTCAAGTTAGTAG"	11.4187952476436	-2.84008219158324	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTTCAAGTTAGTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1265.09978250301	50.5380878830291	0.039947906546185	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1265.09978250301	1265.09978250301
"AML-0693"	"2021-03-09-AML0693:CATTTCAAGTTGAAGT"	10.8824564414913	-2.91426970874938	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTTCAAGTTGAAGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1891.3541984656	49.6901585337346	0.0262722649063019	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1885.00845659685	1885.00845659685
"AML-0693"	"2021-03-09-AML0693:CATTTCATCAAGGACG"	-8.44676909866985	-4.47351744091185	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CATTTCATCAAGGACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2507.92677067576	46.4965609764873	0.0185398399666825	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2499.31249660001	2499.31249660001
"AML-0693"	"2021-03-09-AML0693:CCAAGCGGTATGAGAT"	0.86039843138997	9.58003232562868	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAAGCGGTATGAGAT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1674.57457273627	45.5310487634799	0.027189621474475	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1670.85328764669	1670.85328764669
"AML-0693"	"2021-03-09-AML0693:CCAAGCGGTCTGTTAG"	-6.87764964523967	3.8420724638733	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAAGCGGTCTGTTAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2346.16382318646	47.7778180035337	0.0203642292713575	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2330.44417123356	2330.44417123356
"AML-0693"	"2021-03-09-AML0693:CCAAGCGTCCTACCAC"	9.47669281539265	7.32393167102662	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAAGCGTCCTACCAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1505.59196110309	41.7698504743381	0.0277431412716464	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1491.41406875091	1491.41406875091
"AML-0693"	"2021-03-09-AML0693:CCAATGAAGCCTGTCG"	-7.27601180496867	3.86768267238466	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATGAAGCCTGTCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2120.6425908405	42.8903328114729	0.0202251586366912	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2110.07291028573	2110.07291028573
"AML-0693"	"2021-03-09-AML0693:CCAATGAAGCGTGAGT"	-6.90706429901774	-2.80573584949645	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATGAAGCGTGAGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2324.70965679929	40.8673102406346	0.0175795330488288	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2306.68209727733	2306.68209727733
"AML-0693"	"2021-03-09-AML0693:CCAATGAGTCACTTCC"	-8.46716723862346	-3.43492963230284	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATGAGTCACTTCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2957.73413353888	51.8963115645503	0.0175459690497798	2459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2951.6039969187	2951.6039969187
"AML-0693"	"2021-03-09-AML0693:CCAATTTCACTGCGAC"	7.86578669127767	6.86181638324586	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATTTCACTGCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1975.64944779322	46.6099635016411	0.0235922235868838	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1963.0040738708	1963.0040738708
"AML-0693"	"2021-03-09-AML0693:CCAATTTTCTCATAGG"	8.7154127555782	6.59942386234132	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATTTTCTCATAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1453.1301352142	48.8519158466713	0.0336184039287509	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1450.3576249681	1450.3576249681
"AML-0693"	"2021-03-09-AML0693:CCAATTTTCTCTCGCA"	10.9659811454708	-2.80407311832579	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCAATTTTCTCTCGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1377.0332140808	49.354444420396	0.0358411430572073	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1374.60033802718	1374.60033802718
"AML-0693"	"2021-03-09-AML0693:CCACAAAAGTTCGGTT"	-2.58453498306926	3.80516312206117	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAAAGTTCGGTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3346.59210473108	30.9199227816137	0.00923922659648366	4242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3342.2717342603	3342.2717342603
"AML-0693"	"2021-03-09-AML0693:CCACAAACAATGGCCC"	10.0175863700802	6.87863681400148	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAACAATGGCCC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1884.54660062199	48.3243474637956	0.0256424263787621	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1875.12800306864	1875.12800306864
"AML-0693"	"2021-03-09-AML0693:CCACAAACACAGTCGC"	0.775794704526108	9.60205743396608	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAACACAGTCGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1660.74317643172	48.6376824875781	0.029286697171372	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1656.60898461317	1656.60898461317
"AML-0693"	"2021-03-09-AML0693:CCACAAACAGACCAGA"	-0.313948969275314	11.3786849745545	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAACAGACCAGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1617.0947123272	51.9652959614591	0.0321349736446016	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1617.0947123272	1617.0947123272
"AML-0693"	"2021-03-09-AML0693:CCACAAAGTTAAACAG"	-1.99683247032817	2.95757649028627	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAAGTTAAACAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2314.3736324881	39.3059477205839	0.0169834062956929	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2294.59090637702	2294.59090637702
"AML-0693"	"2021-03-09-AML0693:CCACAAAGTTCTCTAT"	-0.753301839262801	13.1125125654968	"2021-03-09-AML0693"	"AML0693"	"NK"	"Activated NK"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAAGTTCTCTAT"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	2406.78552190998	50.3087959220091	0.0209028995163994	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	2397.14444094198	2397.14444094198
"AML-0693"	"2021-03-09-AML0693:CCACAAATCGCGTGCA"	11.1998154121334	-1.09628798877867	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.289473684210526	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACAAATCGCGTGCA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1727.38662261722	37.2664489365823	0.0215738899726563	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1717.42752798237	1717.42752798237
"AML-0693"	"2021-03-09-AML0693:CCACCATAGTTGGAGC"	-8.16634593430217	-0.293859027978502	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATAGTTGGAGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3050.87048854927	25.7713318255352	0.00844720610798193	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3041.56039267531	3041.56039267531
"AML-0693"	"2021-03-09-AML0693:CCACCATCAAGCACCC"	-7.47975526276286	-2.13040997898253	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATCAAGCACCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3373.71730632465	38.6979854278806	0.0114704291777305	3073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3344.86247807433	3344.86247807433
"AML-0693"	"2021-03-09-AML0693:CCACCATCAGGCGAAT"	-2.36072812500651	3.28439543330995	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATCAGGCGAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3683.94672025283	14.8496903369673	0.00403091886626094	5798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3676.80736389778	3676.80736389778
"AML-0693"	"2021-03-09-AML0693:CCACCATGTCGATTCA"	-6.83388457718547	3.85748002612916	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATGTCGATTCA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2283.19638385338	54.1533714408259	0.0237182275794562	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2257.05294726643	2257.05294726643
"AML-0693"	"2021-03-09-AML0693:CCACCATGTCTTTCTA"	14.001499791711	1.81847570026246	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATGTCTTTCTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1209.55750344534	32.5562933236087	0.026915870664168	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1193.56629946227	1193.56629946227
"AML-0693"	"2021-03-09-AML0693:CCACCATGTTGTAAAG"	1.43199302729909	10.3210506209168	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATGTTGTAAAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1721.50049673125	38.0909817841585	0.0221266167837215	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1717.70276631107	1717.70276631107
"AML-0693"	"2021-03-09-AML0693:CCACCATTCCGTAGTA"	9.19220890578572	7.73241136157838	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACCATTCCGTAGTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2008.76562369296	44.4097336497646	0.0221079717444192	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2002.17644730449	2002.17644730449
"AML-0693"	"2021-03-09-AML0693:CCACGAGGTTGAAGTA"	-2.20617614212688	3.50387666309205	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGAGGTTGAAGTA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3107.50116682997	13.3164671085796	0.00428526536070909	3875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3104.32067456669	3104.32067456669
"AML-0693"	"2021-03-09-AML0693:CCACGAGTCATCACAG"	-7.55714974823649	-2.9145615330902	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGAGTCATCACAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1887.63818958105	47.5421999059388	0.0251860765311653	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1879.33482873093	1879.33482873093
"AML-0693"	"2021-03-09-AML0693:CCACGAGTCCTCTCTT"	8.04535164412801	6.80753610217897	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGAGTCCTCTCTT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1791.64332661143	21.8711777527454	0.0122073280032309	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1789.49030833732	1789.49030833732
"AML-0693"	"2021-03-09-AML0693:CCACGAGTCGCACTCT"	9.58520950850789	7.32025525653688	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGAGTCGCACTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1858.93033280359	36.9924918816257	0.0198998807157203	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1853.56791781725	1853.56791781725
"AML-0693"	"2021-03-09-AML0693:CCACGTTAGGCACTCC"	14.2015510993892	1.8471332558426	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGTTAGGCACTCC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1302.95755880845	8.12497735350957	0.00623579586194646	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1285.30401557328	1285.30401557328
"AML-0693"	"2021-03-09-AML0693:CCACGTTGTGTCCCTT"	12.3533255058223	-2.75161101734313	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGTTGTGTCCCTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1574.27057212248	33.2071692739296	0.0210936860930829	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1570.56517880693	1570.56517880693
"AML-0693"	"2021-03-09-AML0693:CCACGTTGTTCTAAGC"	0.641225238412064	9.83907315814821	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGTTGTTCTAAGC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1481.76371118108	38.9565954388303	0.0262906934114205	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1464.14880112296	1464.14880112296
"AML-0693"	"2021-03-09-AML0693:CCACGTTTCAACCTCC"	11.3388935523922	-2.37223651325377	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGTTTCAACCTCC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1723.23372354847	47.393128720604	0.0275024380459619	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1718.89958240467	1718.89958240467
"AML-0693"	"2021-03-09-AML0693:CCACGTTTCACTTATC"	-7.30281625214274	1.80180976474611	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACGTTTCACTTATC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2888.14556756777	33.5146543190811	0.0116042122999033	2444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2877.00287679259	2877.00287679259
"AML-0693"	"2021-03-09-AML0693:CCACTTGAGTCACGCC"	-8.93975482407268	-2.94360616123351	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACTTGAGTCACGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3156.9631198215	49.6288397807118	0.0157204369823357	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3150.22124561023	3150.22124561023
"AML-0693"	"2021-03-09-AML0693:CCACTTGGTAGAATGT"	-7.76843009415324	-3.948597454187	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACTTGGTAGAATGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2100.23110115945	50.303773367878	0.0239515419708371	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2093.96064484288	2093.96064484288
"AML-0693"	"2021-03-09-AML0693:CCACTTGTCGACGATT"	1.49813189086263	9.78903386676637	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACTTGTCGACGATT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2025.95359012362	44.5948588428327	0.0220117869729245	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2016.83144381143	2016.83144381143
"AML-0693"	"2021-03-09-AML0693:CCACTTGTCTCTCGAC"	9.27420486983601	6.08341834628908	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCACTTGTCTCTCGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1933.89735078703	28.1864387393735	0.0145749404578803	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1928.72530506221	1928.72530506221
"AML-0693"	"2021-03-09-AML0693:CCATAAGCAAGAGGCT"	8.55195011672322	6.57975671375123	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCATAAGCAAGAGGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1619.9543782412	41.3442569333937	0.0255218649912115	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1613.90830591728	1613.90830591728
"AML-0693"	"2021-03-09-AML0693:CCATAAGCAGGACTTT"	-7.17125068131145	1.96604011142579	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCATAAGCAGGACTTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2667.14958377725	49.3072766843923	0.0184868808949826	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2656.42876034106	2656.42876034106
"AML-0693"	"2021-03-09-AML0693:CCATCACTCGAGAGCA"	-8.20105872574504	-4.06303455745848	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCATCACTCGAGAGCA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3121.1521350444	44.9686203987895	0.014407698969198	2972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3110.953637478	3110.953637478
"AML-0693"	"2021-03-09-AML0693:CCCAACTAGGTAAGAG"	12.122048040002	-2.86687710201415	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTAGGTAAGAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1879.88557346974	43.4397609993449	0.0231076623026408	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1871.23214618539	1871.23214618539
"AML-0693"	"2021-03-09-AML0693:CCCAACTCAAGGCTTT"	-6.91415296021159	3.77150008762208	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTCAAGGCTTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2261.95050121373	36.1843837334315	0.0159969830082557	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2242.27796625036	2242.27796625036
"AML-0693"	"2021-03-09-AML0693:CCCAACTCAGGCTCTG"	-8.53234324875529	-3.32843615924986	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTCAGGCTCTG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3078.38911678372	49.8803071211799	0.0162033795043086	2776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3068.98711296711	3068.98711296711
"AML-0693"	"2021-03-09-AML0693:CCCAACTGTCGGCTAC"	8.44093384322469	7.42101380908815	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTGTCGGCTAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1726.85252108314	52.6580919997784	0.030493682209034	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1709.38190917755	1709.38190917755
"AML-0693"	"2021-03-09-AML0693:CCCAACTTCAGACATC"	-7.9588979286259	-2.77760627185973	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ NK-like"	66	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTTCAGACATC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1573.44863114331	38.2265707693327	0.0242947688362449	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1562.82467262922	1562.82467262922
"AML-0693"	"2021-03-09-AML0693:CCCAACTTCTTTCCAA"	-8.00024543228801	-0.749218606111132	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.160583941605839	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCAACTTCTTTCCAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3305.00099459808	33.1765149776524	0.0100382768513166	3526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3294.72526727113	3294.72526727113
"AML-0693"	"2021-03-09-AML0693:CCCATTGCAGCTGGTC"	10.9991375404293	-2.90564181720885	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGCAGCTGGTC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1872.76844640783	48.8174248914019	0.0260669838735477	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1860.37584740373	1860.37584740373
"AML-0693"	"2021-03-09-AML0693:CCCATTGGTCTGGTTA"	8.05986942824666	6.4952034720215	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGGTCTGGTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1715.00501445757	37.4923992416077	0.0218613933636024	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1701.47835655235	1701.47835655235
"AML-0693"	"2021-03-09-AML0693:CCCATTGTCCAAGCAT"	-2.01328502121623	3.18887803638307	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGTCCAAGCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3064.48632339873	40.948107172948	0.0133621438804575	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3052.70564056768	3052.70564056768
"AML-0693"	"2021-03-09-AML0693:CCCATTGTCGCTATTT"	-8.01619658890422	-4.66218044674071	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGTCGCTATTT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2573.66367795706	41.4692376371401	0.016112920267056	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2559.40534457159	2559.40534457159
"AML-0693"	"2021-03-09-AML0693:CCCATTGTCTGGTGGC"	-7.13659558716472	2.94264266574708	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGTCTGGTGGC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2383.73401460797	41.1041330549629	0.0172435904354551	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2370.63220460415	2370.63220460415
"AML-0693"	"2021-03-09-AML0693:CCCATTGTCTTCACAT"	-8.81928954544719	-4.6141658059326	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCATTGTCTTCACAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2341.66934243091	50.7636015330188	0.0216783815772728	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2329.65242006425	2329.65242006425
"AML-0693"	"2021-03-09-AML0693:CCCGAAGAGGTGAGAA"	14.3328062492305	2.08956501567689	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGAAGAGGTGAGAA"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1175.07626773386	38.0682842144296	0.0323964369460413	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1165.95950035036	1165.95950035036
"AML-0693"	"2021-03-09-AML0693:CCCGAAGGTCTCGGGT"	-2.23937831345256	3.70328281009523	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGAAGGTCTCGGGT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1840.46792780476	43.5794440346525	0.0236784588181509	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1840.46792780476	1840.46792780476
"AML-0693"	"2021-03-09-AML0693:CCCGAAGTCCAATCTT"	-7.83795915070232	-4.58502724086913	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGAAGTCCAATCTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1979.39294851605	49.3861101763061	0.0249501293885738	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1968.94748616341	1968.94748616341
"AML-0693"	"2021-03-09-AML0693:CCCGGAAAGGTCTGGA"	-7.57879291001018	-3.16412284290465	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGGAAAGGTCTGGA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2877.828563929	37.0709690392368	0.0128815765830836	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2856.76605252777	2856.76605252777
"AML-0693"	"2021-03-09-AML0693:CCCGGAACATGGACAG"	1.34577753123586	-7.02084638988646	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	8	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00183861082737487	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGGAACATGGACAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1464.71998587905	34.6455035286592	0.0236533288701368	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1462.53589230437	1462.53589230437
"AML-0693"	"2021-03-09-AML0693:CCCGGAAGTTAAGACA"	10.9291359382564	-2.62199761783751	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGGAAGTTAAGACA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1473.46605012276	43.1288034923534	0.029270306899002	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1471.14923798122	1471.14923798122
"AML-0693"	"2021-03-09-AML0693:CCCGGAATCCCGAGGT"	-7.03147015991862	3.96465680682985	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCGGAATCCCGAGGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2290.90146273597	31.1944655885005	0.0136166771447454	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2278.25364457108	2278.25364457108
"AML-0693"	"2021-03-09-AML0693:CCCTAACGTGGTCCGT"	1.18454303321187	-9.00986101543578	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTAACGTGGTCCGT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2646.96151205542	46.9431260535447	0.0177347218082867	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2632.58739663656	2632.58739663656
"AML-0693"	"2021-03-09-AML0693:CCCTAACGTTCCTAAG"	9.47922768172566	7.20437524402467	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTAACGTTCCTAAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2013.53721213191	52.229294843362	0.02593907603429	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1991.62349030775	1991.62349030775
"AML-0693"	"2021-03-09-AML0693:CCCTAACTCGTTCCCA"	0.871438820927781	9.25579259479371	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTAACTCGTTCCCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1638.62568201124	40.5230062012252	0.0247298737265533	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1630.62563910481	1630.62563910481
"AML-0693"	"2021-03-09-AML0693:CCCTCAAAGAATAACC"	-8.50433192673381	-4.39208319103392	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAAAGAATAACC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2608.51387132403	49.5737245225517	0.0190045853570213	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2596.6117875932	2596.6117875932
"AML-0693"	"2021-03-09-AML0693:CCCTCAAAGCAGCCCT"	-8.79707751694377	-3.85741403019103	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAAAGCAGCCCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2911.10580006817	43.4697950566715	0.0149323995904421	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2904.67623952872	2904.67623952872
"AML-0693"	"2021-03-09-AML0693:CCCTCAAGTGATACCT"	-9.2168324989384	-2.50625827228697	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAAGTGATACCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2999.40847425276	49.0857096731907	0.0163651300229854	2524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2988.06355054234	2988.06355054234
"AML-0693"	"2021-03-09-AML0693:CCCTCAAGTTTGTTCT"	-8.38273082199748	-3.37894060527953	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAAGTTTGTTCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2685.85273371313	48.0264249382433	0.0178812577232587	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2681.28380187372	2681.28380187372
"AML-0693"	"2021-03-09-AML0693:CCCTCAATCGAGCACC"	8.03139414367024	6.25670526111452	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAATCGAGCACC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1760.47099632597	38.0679229723485	0.0216237149329893	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1754.57742350562	1754.57742350562
"AML-0693"	"2021-03-09-AML0693:CCCTCAATCGCAGTTA"	-6.84886250916179	3.78603122318117	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCAATCGCAGTTA"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2070.49686631509	37.4478738335623	0.0180864189860905	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2046.59909538585	2046.59909538585
"AML-0693"	"2021-03-09-AML0693:CCCTCTCCAGCAGAAC"	9.96062435683553	7.00108144367067	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCTCCAGCAGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1715.59402623839	34.295693678699	0.0199905648738447	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1706.82170546098	1706.82170546098
"AML-0693"	"2021-03-09-AML0693:CCCTCTCGTATCGCGC"	8.10026230391805	6.23604629123536	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCTCGTATCGCGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1765.50948409298	49.82426613606	0.0282208997374245	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1759.09210864725	1759.09210864725
"AML-0693"	"2021-03-09-AML0693:CCCTCTCTCGACGACC"	-1.89967344227489	10.3056859740051	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCTCTCGACGACC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2057.54714912919	50.2499011476251	0.0244222355579517	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2044.66808451206	2044.66808451206
"AML-0693"	"2021-03-09-AML0693:CCCTCTCTCGTAACTG"	9.46499790725056	7.65118978107301	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCTCTCGTAACTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	2223.4246894794	34.1187369228041	0.0153451282088591	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	2207.84467965339	2207.84467965339
"AML-0693"	"2021-03-09-AML0693:CCCTCTCTCGTTCGCT"	-3.35857758942302	3.15744183147279	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTCTCTCGTTCGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2088.76616725431	55.8352777637635	0.0267312247005413	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2055.68412564473	2055.68412564473
"AML-0693"	"2021-03-09-AML0693:CCCTGATAGGCGCTCT"	8.66047730025594	5.73921916568605	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTGATAGGCGCTCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1448.12405242195	50.5221548500915	0.0348880020089401	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1436.54475728719	1436.54475728719
"AML-0693"	"2021-03-09-AML0693:CCCTGATGTCCGGCAT"	12.0106646018917	-2.92967417156371	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTGATGTCCGGCAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1592.07352623161	45.8933140094973	0.0288261272192155	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1576.84078998911	1576.84078998911
"AML-0693"	"2021-03-09-AML0693:CCCTTAGAGAATAGTC"	0.78372093018834	-9.14448740398558	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGAGAATAGTC"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2772.7707822719	39.6493960940791	0.0142995578096765	2931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2758.55442212548	2758.55442212548
"AML-0693"	"2021-03-09-AML0693:CCCTTAGAGACTCGAG"	-0.715049247176009	11.6938581236633	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	6	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGAGACTCGAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1900.13401738322	48.7005157466968	0.0256300425660318	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1898.04336690969	1898.04336690969
"AML-0693"	"2021-03-09-AML0693:CCCTTAGAGAGGACTC"	-6.98511014404948	3.94241736018983	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGAGAGGACTC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2247.02029261216	52.2544984743667	0.023255018499909	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2238.89157088482	2238.89157088482
"AML-0693"	"2021-03-09-AML0693:CCCTTAGGTGGGTCAA"	-1.72838221016582	10.4768218764099	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGGTGGGTCAA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1973.58342796123	48.5353490131167	0.0245924992708594	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1966.32245090001	1966.32245090001
"AML-0693"	"2021-03-09-AML0693:CCCTTAGGTTTGAAAG"	10.8601309257442	-2.96523477947386	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGGTTTGAAAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2333.14264199896	48.3390069377118	0.0207184104681644	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2324.7770167381	2324.7770167381
"AML-0693"	"2021-03-09-AML0693:CCCTTAGTCGCCAATA"	-1.91559062424358	3.88541076267091	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCCTTAGTCGCCAATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3271.30702129643	13.1383657421766	0.00401624355544893	4633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3267.15062188906	3267.15062188906
"AML-0693"	"2021-03-09-AML0693:CCGAACGAGGTACTGG"	0.419418473809403	10.1874675520691	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGAGGTACTGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1509.33578796218	36.2715269833006	0.0240314496433378	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1502.53648241281	1502.53648241281
"AML-0693"	"2021-03-09-AML0693:CCGAACGAGTCTAGCT"	11.0764376121456	-2.59180905735167	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGAGTCTAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1820.9053950815	12.3149560911644	0.00676309495508593	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1814.88886236051	1814.88886236051
"AML-0693"	"2021-03-09-AML0693:CCGAACGCAAAGGTTA"	8.72876705703084	6.98886249149171	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGCAAAGGTTA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1810.22700111158	41.7730254407053	0.0230761254887118	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1801.29553999138	1801.29553999138
"AML-0693"	"2021-03-09-AML0693:CCGAACGCAACCGGAA"	-8.5516599220341	-4.31695797359618	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGCAACCGGAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2514.48841609739	50.3645086292224	0.0200297238622362	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2507.05075316311	2507.05075316311
"AML-0693"	"2021-03-09-AML0693:CCGAACGGTACTCGCG"	-7.13576445999797	-3.11754419719847	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGGTACTCGCG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2766.81254647724	3.95185063794887	0.00142830443753063	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2746.82217412753	2746.82217412753
"AML-0693"	"2021-03-09-AML0693:CCGAACGGTCCGGCAT"	-6.91901669922526	3.62653706157533	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGGTCCGGCAT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2556.94289517455	40.0014421336158	0.0156442454030187	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2543.80564785493	2543.80564785493
"AML-0693"	"2021-03-09-AML0693:CCGAACGTCCAACCGG"	1.02794172343556	-9.05199530040892	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGTCCAACCGG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2204.78790236258	0.820261968766292	0.000372036678851207	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2189.82002123874	2189.82002123874
"AML-0693"	"2021-03-09-AML0693:CCGAACGTCCATACTT"	-7.09794078293498	-2.9191191426483	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGTCCATACTT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2816.18704203692	9.94826653756673	0.00353253047083521	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2793.97292121183	2793.97292121183
"AML-0693"	"2021-03-09-AML0693:CCGAACGTCCTGATAG"	-6.86361585083659	3.80039093578187	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGAACGTCCTGATAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2458.31474543119	39.3034760359276	0.0159879755466519	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2439.07151163822	2439.07151163822
"AML-0693"	"2021-03-09-AML0693:CCGATCTCAGCGTATT"	-7.18182406845744	-2.97481586849364	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATCTCAGCGTATT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2731.62562276583	37.2452374256484	0.0136348250343094	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2721.9163309529	2721.9163309529
"AML-0693"	"2021-03-09-AML0693:CCGATCTTCCGCGGAT"	-6.80007682266887	3.87857053363649	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATCTTCCGCGGAT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2167.14852424903	37.0429198001654	0.0170929308193133	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2153.84833463843	2153.84833463843
"AML-0693"	"2021-03-09-AML0693:CCGATCTTCTTCTGTA"	-9.28982577744182	-1.94798352634581	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATCTTCTTCTGTA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2361.58069835749	47.1582522730164	0.0199689353431011	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2353.42798629808	2353.42798629808
"AML-0693"	"2021-03-09-AML0693:CCGATGGAGAAGCCTG"	-7.05036769333537	3.48297951305238	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGAGAAGCCTG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2432.89653291059	34.6750893183111	0.0142525951470808	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2422.78704389809	2422.78704389809
"AML-0693"	"2021-03-09-AML0693:CCGATGGAGACGAGCT"	11.9533993202144	-2.91027595913085	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGAGACGAGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1638.84969260954	48.9973432812268	0.0298973990733758	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1636.84374889053	1636.84374889053
"AML-0693"	"2021-03-09-AML0693:CCGATGGAGGAGAGTA"	14.3349291282589	2.0032212504181	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGAGGAGAGTA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1327.23089201449	26.0260721036464	0.019609302541281	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1315.00269114607	1315.00269114607
"AML-0693"	"2021-03-09-AML0693:CCGATGGCACACTTAG"	-8.59368548813518	-2.77270748531493	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGCACACTTAG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1662.41338041714	43.0895484334425	0.0259198758509934	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1658.46612888894	1658.46612888894
"AML-0693"	"2021-03-09-AML0693:CCGATGGGTATGACAA"	3.63626756247823	-10.1323995820251	"2021-03-09-AML0693"	"AML0693"	"CD11c+"	"CD11c+"	29	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0841584158415842	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGGTATGACAA"	"CD11c+"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2854.26179547897	40.429313309893	0.0141645427808799	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2843.93606187649	2843.93606187649
"AML-0693"	"2021-03-09-AML0693:CCGATGGTCCTGGGAC"	9.40374340590779	6.66924760425416	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGATGGTCCTGGGAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1667.99726553791	45.0972048130474	0.0270367378561043	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1662.37099219561	1662.37099219561
"AML-0693"	"2021-03-09-AML0693:CCGCAAGCAACGTAAA"	-8.37606940689738	-3.48612167751464	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGCAAGCAACGTAAA"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2708.19840576338	44.4640580120632	0.0164183162937539	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2695.70912558775	2695.70912558775
"AML-0693"	"2021-03-09-AML0693:CCGCAAGGTCACCGAC"	1.02921213683431	10.6975927122864	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ Naive"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGCAAGGTCACCGAC"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2061.49408093466	28.3238589578503	0.0137394810976166	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2053.23685845753	2053.23685845753
"AML-0693"	"2021-03-09-AML0693:CCGCAAGGTTCTCGCT"	-9.04970298233684	-3.11015059864195	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGCAAGGTTCTCGCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3192.6719210299	39.3812890353461	0.0123349000490606	3258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3184.81110945555	3184.81110945555
"AML-0693"	"2021-03-09-AML0693:CCGCAAGTCCGATCGG"	-6.94757256928142	3.6909506090912	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGCAAGTCCGATCGG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2223.52611795368	33.9001395124633	0.0152461170744699	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2213.70332137786	2213.70332137786
"AML-0693"	"2021-03-09-AML0693:CCGGACACAGTCAGAG"	-8.16340766373332	-3.90771105205687	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGACACAGTCAGAG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3107.83248790356	43.693414556681	0.0140591279377979	2898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3097.33924856257	3097.33924856257
"AML-0693"	"2021-03-09-AML0693:CCGGACATCAGTAGGG"	11.5169083076412	-2.97379376804503	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGACATCAGTAGGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1487.62770042776	24.2337505257576	0.0162901984944145	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1482.78654747942	1482.78654747942
"AML-0693"	"2021-03-09-AML0693:CCGGGTAAGATGCCGA"	-6.90118012848552	3.5199939974579	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGGTAAGATGCCGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2811.48373707563	39.4256279342027	0.0140230681096563	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2799.79518022628	2799.79518022628
"AML-0693"	"2021-03-09-AML0693:CCGGGTAAGCGGCTCT"	-2.23715267601665	3.74356982791749	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGGTAAGCGGCTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3496.30769513128	25.7811645530258	0.00737382599046614	4714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3489.89769405827	3489.89769405827
"AML-0693"	"2021-03-09-AML0693:CCGGGTAGTGCAACAG"	8.56525768813435	6.74581668460695	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGGTAGTGCAACAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.08163390724	38.3063678077021	0.0240908183522461	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1587.79186143075	1587.79186143075
"AML-0693"	"2021-03-09-AML0693:CCGGGTAGTTTGGGTT"	-1.93730709973033	3.1231376894745	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGGTAGTTTGGGTT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2348.63853251526	43.8091300104921	0.0186529895528772	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2292.95606135828	2292.95606135828
"AML-0693"	"2021-03-09-AML0693:CCGGGTATCAGCTGTA"	-0.954592089087325	11.0553416975769	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGGTATCAGCTGTA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2033.00230937738	40.7941870510071	0.0200659816581815	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2031.11755603462	2031.11755603462
"AML-0693"	"2021-03-09-AML0693:CCGGTAGCAGGATTCT"	-8.3807090324467	-3.43631269848021	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTAGCAGGATTCT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2866.94518824854	49.8879871574908	0.0174010955500576	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2853.05989836578	2853.05989836578
"AML-0693"	"2021-03-09-AML0693:CCGGTGAAGCATTGAA"	11.1272465187008	-0.769396566506945	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.289473684210526	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGAAGCATTGAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1489.04769530341	39.2994477669314	0.0263923364516028	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1474.9310064807	1474.9310064807
"AML-0693"	"2021-03-09-AML0693:CCGGTGAAGCCTCTCT"	10.9386373954708	-2.46476819431456	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGAAGCCTCTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1509.73454864251	47.9718638844406	0.0317750321919671	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1503.06429273243	1503.06429273243
"AML-0693"	"2021-03-09-AML0693:CCGGTGAAGTGCCCGT"	-2.14104948464091	3.8392762907776	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGAAGTGCCCGT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3033.17296671528	21.918770991111	0.00722635050214349	4162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3028.98063590101	3028.98063590101
"AML-0693"	"2021-03-09-AML0693:CCGGTGAGTGTATTGC"	-5.65715346756633	3.40548322284547	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGAGTGTATTGC"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2453.61865400848	43.5838515762755	0.0177630910594328	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2440.35705065766	2440.35705065766
"AML-0693"	"2021-03-09-AML0693:CCGGTGAGTTGCGTAT"	-7.18307815018352	-2.92252948200377	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGAGTTGCGTAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2349.82014148169	22.8247545804204	0.00971340494427293	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2325.35628011076	2325.35628011076
"AML-0693"	"2021-03-09-AML0693:CCGGTGATCCGTATAG"	14.1220728355343	1.88428459251253	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGATCCGTATAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1132.75003293661	1.52751086738967	0.00134849774705339	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1112.04474886615	1112.04474886615
"AML-0693"	"2021-03-09-AML0693:CCGGTGATCTGAGAGG"	-7.87673507157024	-4.67216350948485	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGGTGATCTGAGAGG"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2315.54571250876	46.2385755201631	0.0199687595327437	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2307.19766328893	2307.19766328893
"AML-0693"	"2021-03-09-AML0693:CCGTAGGTCCAAATGC"	-8.688459734351	-2.57217075740965	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTAGGTCCAAATGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3156.50450474422	42.3273931273972	0.0134095779251318	4477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3148.83034202397	3148.83034202397
"AML-0693"	"2021-03-09-AML0693:CCGTAGGTCTACAGGT"	13.9868008094722	1.661625243071	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTAGGTCTACAGGT"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1194.26167991982	2.51245991117175	0.00210377671277238	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1181.37405234406	1181.37405234406
"AML-0693"	"2021-03-09-AML0693:CCGTGAGCAATTCACG"	11.46471275863	-2.84651806270751	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTGAGCAATTCACG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1777.12104254025	45.1375702926661	0.0253992661232268	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1775.16198884336	1775.16198884336
"AML-0693"	"2021-03-09-AML0693:CCGTGAGGTCTGTCCT"	-7.52835259857829	-3.27690865909728	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTGAGGTCTGTCCT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2703.37721590285	3.06740882040251	0.0011346580870617	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2672.80459751109	2672.80459751109
"AML-0693"	"2021-03-09-AML0693:CCGTTCAAGTGTAGAT"	-2.4436129135197	3.34210870349733	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTTCAAGTGTAGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3486.74928276015	22.4738994404291	0.0064455163299377	5330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3484.68714487417	3484.68714487417
"AML-0693"	"2021-03-09-AML0693:CCGTTCATCATTGTTC"	-7.07416663590129	-2.77855398571166	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCGTTCATCATTGTTC"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1967.38006900307	50.63851204947	0.0257390591921214	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1960.20686867076	1960.20686867076
"AML-0693"	"2021-03-09-AML0693:CCTAACCCACAGTCCG"	-7.06263909760173	-2.6839912167755	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAACCCACAGTCCG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2543.62337059973	40.2942645045691	0.0158412856912337	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2517.44938596663	2517.44938596663
"AML-0693"	"2021-03-09-AML0693:CCTAACCCAGGTTTAC"	11.053390164941	-0.808372460958086	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.289473684210526	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAACCCAGGTTTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1258.19500038447	45.1727947475879	0.0359028566587726	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1247.7225368015	1247.7225368015
"AML-0693"	"2021-03-09-AML0693:CCTAACCTCCGGCAAC"	-8.92844806137736	-3.88839199459227	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAACCTCCGGCAAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3244.21224950956	34.2638937742385	0.0105615450343665	4734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3228.46375311904	3228.46375311904
"AML-0693"	"2021-03-09-AML0693:CCTAAGAAGAATACAC"	-9.64022384110149	-2.37630512630614	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	60	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAAGAAGAATACAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2939.84876853788	43.0071973660503	0.0146290509315688	3310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2931.10801399347	2931.10801399347
"AML-0693"	"2021-03-09-AML0693:CCTAAGAAGGAACTAT"	-7.61412177506145	-3.88296081936034	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAAGAAGGAACTAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1478.00834916836	47.4256241411122	0.0320875211346387	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1476.23170609725	1476.23170609725
"AML-0693"	"2021-03-09-AML0693:CCTAAGAAGGATTTAG"	-7.61002145233806	2.14636561954347	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAAGAAGGATTTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2828.62276492786	28.5206205354854	0.0100828646679625	2526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2819.9646865277	2819.9646865277
"AML-0693"	"2021-03-09-AML0693:CCTAAGAGTACCACGC"	-7.26041112366374	-3.01130916988524	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAAGAGTACCACGC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2557.11310026171	38.6805114353905	0.0151266330110435	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2539.93365546351	2539.93365546351
"AML-0693"	"2021-03-09-AML0693:CCTAAGATCGCAAGAG"	8.4941164451534	6.28381106937257	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTAAGATCGCAAGAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1590.50923208867	50.3479005538014	0.0316552079912695	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1583.5745063596	1583.5745063596
"AML-0693"	"2021-03-09-AML0693:CCTACGTCAGAGACTG"	9.94255985793416	5.66545913303224	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTACGTCAGAGACTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1696.26110674464	30.2571737092873	0.0178375685140568	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1690.53684788911	1690.53684788911
"AML-0693"	"2021-03-09-AML0693:CCTACGTTCCACATAG"	8.59496082839314	6.90812299335328	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTACGTTCCACATAG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1591.73450504765	46.965883885838	0.0295061040248241	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1581.39140492944	1581.39140492944
"AML-0693"	"2021-03-09-AML0693:CCTACGTTCCGGCAAC"	-3.23781786385234	11.3798455961975	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00590468156895825	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTACGTTCCGGCAAC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1631.83296537425	40.7845363662827	0.0249930827674688	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1625.41066127732	1625.41066127732
"AML-0693"	"2021-03-09-AML0693:CCTATCGGTTGTGTTG"	7.66153015670125	6.24815700137941	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTATCGGTTGTGTTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1954.48541462453	48.2425462300368	0.0246829911694708	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1941.51499972241	1941.51499972241
"AML-0693"	"2021-03-09-AML0693:CCTATCGTCAGAGTGG"	-1.88859711113628	3.95246312702028	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTATCGTCAGAGTGG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3067.28016829478	25.9265830159044	0.00845262955888308	4452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3063.04789634842	3063.04789634842
"AML-0693"	"2021-03-09-AML0693:CCTATCGTCTTGGAAC"	8.54702915725056	6.65873763645021	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTATCGTCTTGGAAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1827.90365675197	31.9597286856481	0.0174843616990393	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1826.07251718534	1826.07251718534
"AML-0693"	"2021-03-09-AML0693:CCTCAACAGACATAAC"	11.6303278404171	-2.65498497402342	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAACAGACATAAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1509.2470291351	46.1484838748565	0.030577157340043	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1502.62517235303	1502.62517235303
"AML-0693"	"2021-03-09-AML0693:CCTCAACAGAGAAGGT"	1.07794525203053	-6.6646299592224	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	56	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.285714285714286	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAACAGAGAAGGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	1632.74025850015	26.7698187810483	0.0163956383397071	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	1631.03362874058	1631.03362874058
"AML-0693"	"2021-03-09-AML0693:CCTCAACTCACTGGGC"	0.446965922682923	11.7752542265686	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAACTCACTGGGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	2091.65868505617	41.4560945395024	0.0198197224220591	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2086.60050701995	2086.60050701995
"AML-0693"	"2021-03-09-AML0693:CCTCAACTCTTCGATT"	8.17633785781209	6.41723344409791	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAACTCTTCGATT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1618.56706277753	33.2256511998751	0.0205278186885	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1616.68601340607	1616.68601340607
"AML-0693"	"2021-03-09-AML0693:CCTCACACAACTCCCT"	8.07787098464314	6.04421279514161	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCACACAACTCCCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1453.54284564716	56.1592766896847	0.0386361343649838	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1443.71757374623	1443.71757374623
"AML-0693"	"2021-03-09-AML0693:CCTCACATCATAAGGA"	-2.02277551117595	13.1233596571716	"2021-03-09-AML0693"	"AML0693"	"NK"	"CD56dim NK"	6	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00827097282394644	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCACATCATAAGGA"	"NK"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"NK"	"NK"	1925.51500883489	49.2954021597124	0.0256011518651006	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	16	TRUE	"NK_AML-0693"	1923.62474175481	1923.62474175481
"AML-0693"	"2021-03-09-AML0693:CCTCACATCTTCGGTC"	-8.9084943336552	-4.08553221141966	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCACATCTTCGGTC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2599.13323181738	49.7858599242926	0.0191547933421948	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2588.58067068208	2588.58067068208
"AML-0693"	"2021-03-09-AML0693:CCTCAGTCAAAGGCGT"	-8.60380874100383	-3.67998530780944	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAGTCAAAGGCGT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3093.33940050307	43.8925120286154	0.0141893618338412	2904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3085.22288263949	3085.22288263949
"AML-0693"	"2021-03-09-AML0693:CCTCAGTTCAATCCGA"	-1.63582776013072	3.55599186504213	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCAGTTCAATCCGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3529.82334369119	32.2940653860675	0.00914891830034111	3309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3523.27231873052	3523.27231873052
"AML-0693"	"2021-03-09-AML0693:CCTCATGAGTAGCAAT"	10.9550749259884	-2.95315673267516	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCATGAGTAGCAAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1867.90364137627	45.3840797030526	0.024296799201919	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1860.61297007743	1860.61297007743
"AML-0693"	"2021-03-09-AML0693:CCTCATGCACAGCTGC"	-8.39232001724895	-3.61930563366088	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCATGCACAGCTGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3138.82430215981	44.4722918370703	0.0141684553055325	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3132.11595340647	3132.11595340647
"AML-0693"	"2021-03-09-AML0693:CCTCATGGTGCTTCAA"	14.0655886131221	1.69684240901796	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCATGGTGCTTCAA"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1173.19698855869	5.33695320919217	0.00454906828200164	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1152.1336080265	1152.1336080265
"AML-0693"	"2021-03-09-AML0693:CCTCATGTCCACCCTA"	-7.1255034011906	-2.84475042736205	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCATGTCCACCCTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2114.4398708105	6.65059788560746	0.00314532372256969	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2110.20705893265	2110.20705893265
"AML-0693"	"2021-03-09-AML0693:CCTCCAACAACACACT"	0.900128801434678	11.2505750426087	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCAACAACACACT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1876.67802842039	38.9677432193561	0.0207642134821366	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1870.81943121283	1870.81943121283
"AML-0693"	"2021-03-09-AML0693:CCTCCAACATTCGGGC"	7.63320984420125	6.32742307269899	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCAACATTCGGGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1845.28236411836	49.5641922663053	0.0268599501247529	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1835.22409198187	1835.22409198187
"AML-0693"	"2021-03-09-AML0693:CCTCCAATCAGAGTTC"	8.81106152114217	6.52634332263795	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCAATCAGAGTTC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1908.16987191802	47.8367166600826	0.0250694224681364	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1902.61879837589	1902.61879837589
"AML-0693"	"2021-03-09-AML0693:CCTCCTCAGCAACAGC"	-0.771644453436691	11.9832277067932	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCAGCAACAGC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1982.36528299569	42.436144445318	0.021406823863052	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1976.29290628281	1976.29290628281
"AML-0693"	"2021-03-09-AML0693:CCTCCTCAGTAACAGT"	-8.3541034263676	-3.87617971813353	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCAGTAACAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3301.03730068788	52.3285163529539	0.0158521433072112	3299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3288.98810150753	3288.98810150753
"AML-0693"	"2021-03-09-AML0693:CCTCCTCAGTTGGCTT"	-7.02710614624675	-2.67985179340514	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCAGTTGGCTT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1590.77925720167	46.241428114095	0.0290684127950211	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1577.62557630823	1577.62557630823
"AML-0693"	"2021-03-09-AML0693:CCTCCTCTCATCCTAT"	-7.07562814179118	-2.8180129758087	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCTCATCCTAT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2159.94865033756	1.45265814117221	0.000672542905566385	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2147.52576854594	2147.52576854594
"AML-0693"	"2021-03-09-AML0693:CCTCCTCTCTAGAGCT"	-7.7468412918156	-3.50304915821227	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCTCTAGAGCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2578.90943735302	2.01886446016649	0.00078283650869053	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2547.73620926685	2547.73620926685
"AML-0693"	"2021-03-09-AML0693:CCTCCTCTCTTTCGAT"	11.9061790901119	-2.9524443379608	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCCTCTCTTTCGAT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1874.89545525453	46.7447438887094	0.0249319202079795	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1865.04729739905	1865.04729739905
"AML-0693"	"2021-03-09-AML0693:CCTCTAGAGGGTTTCT"	11.8512541252071	-3.03230383312377	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTAGAGGGTTTCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2433.5708411362	41.5177766699002	0.0170604348014443	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2425.46544541734	2425.46544541734
"AML-0693"	"2021-03-09-AML0693:CCTCTAGCAGCTACCG"	-8.68828998032268	-3.26682116901549	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTAGCAGCTACCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3297.91257089595	51.4391013182319	0.0155974727080947	2930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3291.21120137088	3291.21120137088
"AML-0693"	"2021-03-09-AML0693:CCTCTAGCAGCTCTGG"	-8.32267985764201	-3.83619954502257	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTAGCAGCTCTGG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3201.89712232809	45.0728428072812	0.014076917866277	2867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3192.98796302593	3192.98796302593
"AML-0693"	"2021-03-09-AML0693:CCTCTAGTCACCGACG"	-8.3821910423344	-4.38050510799559	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	11	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTAGTCACCGACG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2540.19335551312	47.8748445503172	0.0188469292884385	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2533.96805012843	2533.96805012843
"AML-0693"	"2021-03-09-AML0693:CCTCTAGTCGTTCCTG"	-6.88108334961589	3.86799261653749	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTAGTCGTTCCTG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2658.29602195877	35.1840875026344	0.0132355791875688	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2644.95033303294	2644.95033303294
"AML-0693"	"2021-03-09-AML0693:CCTCTCCAGGCATCTT"	-7.58853946152385	-3.17227938091429	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCAGGCATCTT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3066.79217241254	1.00840265305525	0.000328813495132268	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3043.43625386469	3043.43625386469
"AML-0693"	"2021-03-09-AML0693:CCTCTCCGTCTACATG"	8.56160034713094	6.96760842883912	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCGTCTACATG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1755.26306639699	40.9953943173112	0.0233556981298889	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1749.03842449532	1749.03842449532
"AML-0693"	"2021-03-09-AML0693:CCTCTCCGTTACCTGA"	-2.04945550385173	3.69189713085023	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCGTTACCTGA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3331.52875103763	13.4404762942263	0.00403432697077585	5163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3324.1647021042	3324.1647021042
"AML-0693"	"2021-03-09-AML0693:CCTCTCCGTTCCGCGA"	1.3702104288036	-10.5267229310242	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCGTTCCGCGA"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2799.59508651596	37.4416388552924	0.0133739479096914	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2783.91717793427	2783.91717793427
"AML-0693"	"2021-03-09-AML0693:CCTCTCCTCCATGAGT"	8.69606461104695	6.32444999301759	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCTCCATGAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1652.25842629011	47.1716589170634	0.028549806838014	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1650.17426590939	1650.17426590939
"AML-0693"	"2021-03-09-AML0693:CCTCTCCTCTACGGGC"	-6.96001897278483	3.89102337444154	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTCTCCTCTACGGGC"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2167.63099000097	49.3470692194018	0.0227654381428546	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2139.87791664554	2139.87791664554
"AML-0693"	"2021-03-09-AML0693:CCTGCATAGCGGATCA"	-2.12322888794597	9.87182519519655	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00736278447121821	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGCATAGCGGATCA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1721.94717905466	44.0390384272335	0.025575138983886	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1713.0715973488	1713.0715973488
"AML-0693"	"2021-03-09-AML0693:CCTGCATGTCGAACAG"	-7.52386508408244	-2.57488253032836	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGCATGTCGAACAG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1701.37854702112	48.3240895079551	0.0284029028064118	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1691.95349253808	1691.95349253808
"AML-0693"	"2021-03-09-AML0693:CCTGCATTCTGGTCAA"	-2.10101733627971	3.43913958156434	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGCATTCTGGTCAA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1548.88304676207	43.9863794346306	0.0283987738948941	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1548.88304676207	1548.88304676207
"AML-0693"	"2021-03-09-AML0693:CCTGTTGAGTAAAGCT"	9.40904011306111	6.54283187473146	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGTTGAGTAAAGCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1643.74245152898	42.0001595261253	0.0255515451870562	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1637.59879374352	1637.59879374352
"AML-0693"	"2021-03-09-AML0693:CCTGTTGCACTAGTAC"	11.0607630210811	-2.59869315540465	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGTTGCACTAGTAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2030.38892963221	44.3354942705028	0.0218359613882124	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2024.81164441243	2024.81164441243
"AML-0693"	"2021-03-09-AML0693:CCTGTTGGTCAAACGG"	0.97644199904744	8.65522859180299	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	55	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245901639344262	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTGTTGGTCAAACGG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1828.14402909299	53.2458861078539	0.0291256516229036	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1826.33546195835	1826.33546195835
"AML-0693"	"2021-03-09-AML0693:CCTTCAGAGACGTCGA"	-0.836021165282089	10.9438342818054	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGAGACGTCGA"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1548.3648480335	45.537665952779	0.0294101651885303	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1539.5217578726	1539.5217578726
"AML-0693"	"2021-03-09-AML0693:CCTTCAGCAATAACCC"	-7.3781193298405	-3.23830249225768	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGCAATAACCC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2666.85981574555	16.6724684796215	0.00625172286191597	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2651.2996956479	2651.2996956479
"AML-0693"	"2021-03-09-AML0693:CCTTCAGCACCATTCC"	-0.820174316794235	10.2648668059143	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0934510669610007	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGCACCATTCC"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1931.48398158408	50.6649798277722	0.0262311157176774	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1921.31503521552	1921.31503521552
"AML-0693"	"2021-03-09-AML0693:CCTTCAGCAGTCGAGA"	-7.08571706238444	-2.91684963619383	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGCAGTCGAGA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1918.94207068536	28.5639007701182	0.0148852334869684	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1910.33393936859	1910.33393936859
"AML-0693"	"2021-03-09-AML0693:CCTTCAGCAGTTTCGA"	-7.07548413696941	-2.6404440633026	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGCAGTTTCGA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2274.7787406763	35.0657269352305	0.0154150055599716	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2257.45688008143	2257.45688008143
"AML-0693"	"2021-03-09-AML0693:CCTTCAGGTCATCAGT"	9.07250179824178	7.65712401950685	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGGTCATCAGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1902.75150304528	41.9768607273011	0.0220611365488971	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1894.16054041324	1894.16054041324
"AML-0693"	"2021-03-09-AML0693:CCTTCAGGTTCTCGCT"	-2.59164295616801	3.31812427127687	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTCAGGTTCTCGCT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	2485.3713244882	12.0190660563255	0.00483592368589051	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	2484.24145101275	2484.24145101275
"AML-0693"	"2021-03-09-AML0693:CCTTGTGAGAGTGTTA"	-7.52468619766887	-2.143266462442	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGAGAGTGTTA"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2271.7959699709	39.8339526114771	0.0175341241634421	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2252.86048334209	2252.86048334209
"AML-0693"	"2021-03-09-AML0693:CCTTGTGCACGACGAA"	9.06545605239217	6.34949634158937	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGCACGACGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1913.52058468298	38.7796455864003	0.0202661240735098	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1902.90756266413	1902.90756266413
"AML-0693"	"2021-03-09-AML0693:CCTTGTGGTAAGCGGT"	1.08306135711018	9.37558744037477	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGGTAAGCGGT"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1651.79509485439	24.1814004128482	0.0146394673819878	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1651.79509485439	1651.79509485439
"AML-0693"	"2021-03-09-AML0693:CCTTGTGGTAGTGATA"	-2.70236192169841	3.24369332874147	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGGTAGTGATA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3548.53078129961	32.3731298217599	0.00912296717062818	4688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3541.83389244105	3541.83389244105
"AML-0693"	"2021-03-09-AML0693:CCTTGTGTCATAGGCT"	-6.93287692490275	3.73657891834108	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGTCATAGGCT"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2346.79421252726	50.0265599894073	0.0213169777402569	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2333.92791173146	2333.92791173146
"AML-0693"	"2021-03-09-AML0693:CCTTGTGTCTGAGGCC"	-7.20470271530803	-2.79265906726988	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTGTGTCTGAGGCC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2565.76080661051	2.00205735337015	0.000780297737892007	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2541.61742176235	2541.61742176235
"AML-0693"	"2021-03-09-AML0693:CCTTTGGAGAATCGCG"	-8.5330117744511	-3.25708749210509	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTTGGAGAATCGCG"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2757.60720224091	45.8293108464968	0.0166192309075979	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2725.28681550799	2725.28681550799
"AML-0693"	"2021-03-09-AML0693:CCTTTGGCAACGACTT"	-6.82829604569133	-2.78476836597594	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTTGGCAACGACTT"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2767.99505887641	0	0	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2756.79115315909	2756.79115315909
"AML-0693"	"2021-03-09-AML0693:CCTTTGGGTGACCGAA"	8.47537102279012	6.6415805586609	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTTGGGTGACCGAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1719.5861166773	41.9914091088451	0.0244194860039832	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1713.38376777719	1713.38376777719
"AML-0693"	"2021-03-09-AML0693:CCTTTGGGTGCAACAG"	14.03791298446	2.06002328479616	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTTGGGTGCAACAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1454.27899078138	42.459302927603	0.0291961193118727	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1431.20244081383	1431.20244081383
"AML-0693"	"2021-03-09-AML0693:CCTTTGGTCTTTGCGC"	11.7692810493404	-3.0741496316162	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CCTTTGGTCTTTGCGC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1890.97236795175	39.4323454650297	0.0208529464170552	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1887.84957413567	1887.84957413567
"AML-0693"	"2021-03-09-AML0693:CGAAGGAAGCAAGTGC"	14.1562820869381	1.8425653942856	"2021-03-09-AML0693"	"AML0693"	"Plasma cell"	"Plasma cell"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGGAAGCAAGTGC"	"Plasma cell"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1249.64929740571	11.7988531031846	0.00944173147432582	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1232.02164972942	1232.02164972942
"AML-0693"	"2021-03-09-AML0693:CGAAGGATCCTCTAAT"	-8.44205413284953	-3.3555319539276	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGGATCCTCTAAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2611.27772438362	49.6755943219808	0.0190234818219906	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2604.94298381499	2604.94298381499
"AML-0693"	"2021-03-09-AML0693:CGAAGGATCGCGTGCA"	-6.82875714722331	1.39411494815675	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0386473429951691	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGGATCGCGTGCA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2567.16007948568	43.1375462018994	0.0168036058781896	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2560.50151183689	2560.50151183689
"AML-0693"	"2021-03-09-AML0693:CGAAGTTCAATCCTAG"	14.0964790779049	2.08892414653627	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTCAATCCTAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1200.5369279089	12.1336040775127	0.0101068145389306	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1189.95556461561	1189.95556461561
"AML-0693"	"2021-03-09-AML0693:CGAAGTTCAATGCAGG"	8.80498947676961	7.16499230945436	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated NFkB"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTCAATGCAGG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1656.62824145977	37.5699131722198	0.0226785420120052	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1654.56425194917	1654.56425194917
"AML-0693"	"2021-03-09-AML0693:CGAAGTTGTAGATTAG"	-7.19225774231608	-2.70383837139281	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTGTAGATTAG"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3352.1570341576	0	0	2749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3328.26392219601	3328.26392219601
"AML-0693"	"2021-03-09-AML0693:CGAAGTTTCAGACTGT"	0.857752104371232	11.976819015387	"2021-03-09-AML0693"	"AML0693"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.018232044198895	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTTCAGACTGT"	"CD8+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD8_T"	1683.91296606518	45.170017828687	0.0268244373307703	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1681.55684992637	1681.55684992637
"AML-0693"	"2021-03-09-AML0693:CGAAGTTTCCTGCCAT"	-8.59974704209026	-3.28752448475035	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTTCCTGCCAT"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2667.39225326269	40.717544312972	0.0152649256078356	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2662.28567914227	2662.28567914227
"AML-0693"	"2021-03-09-AML0693:CGAAGTTTCGTCACCT"	9.24542583998982	7.2951359518799	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAAGTTTCGTCACCT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1603.8840285154	43.7288689732317	0.0272643583923635	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1599.63973912828	1599.63973912828
"AML-0693"	"2021-03-09-AML0693:CGAATTGAGGATTTAG"	14.1543470817501	2.00640020454255	"2021-03-09-AML0693"	"AML0693"	"Plasmablast"	"Plasmablast"	69	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.45850622406639	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAATTGAGGATTTAG"	"Plasmablast"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"Plasma"	1279.20850802279	1.72625462951373	0.00134947087881859	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1260.5716121837	1260.5716121837
"AML-0693"	"2021-03-09-AML0693:CGAATTGAGTCAGCGA"	-6.87891278687175	3.73545477474061	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAATTGAGTCAGCGA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2832.05849901447	37.7073776978182	0.0133144769823576	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2819.69912056118	2819.69912056118
"AML-0693"	"2021-03-09-AML0693:CGAATTGGTGAATTAG"	-2.19976983490642	3.38705918872682	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAATTGGTGAATTAG"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3264.29076633881	32.8602496377089	0.0100665816833972	4776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3258.17386521299	3258.17386521299
"AML-0693"	"2021-03-09-AML0693:CGACAGCAGGGTACAC"	8.64674152907674	6.72543571079103	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGACAGCAGGGTACAC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1677.74846673106	47.6625617192639	0.0284086456726914	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1675.69933585642	1675.69933585642
"AML-0693"	"2021-03-09-AML0693:CGACAGCCAGGTGTTT"	-2.12043891373332	3.83247420871583	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGACAGCCAGGTGTTT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3496.95621275447	11.3588857958586	0.00324822076822959	5658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3488.76605507981	3488.76605507981
"AML-0693"	"2021-03-09-AML0693:CGAGAAGAGAATTGTG"	0.481938620179337	9.62120530689088	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGAGAATTGTG"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1437.85957073004	47.0427335363266	0.0327171960975589	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1427.60307363001	1427.60307363001
"AML-0693"	"2021-03-09-AML0693:CGAGAAGAGCTACAAA"	-2.10026202622111	3.59558341586915	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGAGCTACAAA"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3286.81788479205	27.7713157867138	0.00844930165288753	4159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3281.80358142295	3281.80358142295
"AML-0693"	"2021-03-09-AML0693:CGAGAAGCATTGGATC"	8.37917961654012	6.24933955753175	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGCATTGGATC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1539.34967231131	34.9641783021578	0.0227136036282514	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1530.53349493088	1530.53349493088
"AML-0693"	"2021-03-09-AML0693:CGAGAAGTCAGTGCGC"	-8.42339740219768	-3.37787988102111	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGTCAGTGCGC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2817.3785801149	51.6986995893234	0.0183499299505624	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2805.15066380413	2805.15066380413
"AML-0693"	"2021-03-09-AML0693:CGAGAAGTCCTAGAGT"	-7.59785018387492	-2.49867942249449	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes (cycling)"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGTCCTAGAGT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2205.56794193697	32.21374467255	0.0146056460379359	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2196.733764956	2196.733764956
"AML-0693"	"2021-03-09-AML0693:CGAGAAGTCTCTCGCA"	0.746955414384049	9.23537156665651	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0664136622390892	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGAAGTCTCTCGCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	1891.6113134302	23.6842015545894	0.0125206491346476	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	1886.28806970232	1886.28806970232
"AML-0693"	"2021-03-09-AML0693:CGAGGAACAATCACGT"	8.70337929305379	6.74954745853273	"2021-03-09-AML0693"	"AML0693"	"B"	"Memory"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGAACAATCACGT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1935.22801801329	41.111021886227	0.0212435028345816	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1924.91931858624	1924.91931858624
"AML-0693"	"2021-03-09-AML0693:CGAGGAACAATGTCTG"	8.63174881514851	7.07781598651735	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGAACAATGTCTG"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1670.67067014224	40.8753602485744	0.0244664379276463	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1661.42506686635	1661.42506686635
"AML-0693"	"2021-03-09-AML0693:CGAGGAAGTCCCGCAA"	9.88567318496053	2.46472499454347	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	55	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0245901639344262	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGAAGTCCCGCAA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1817.82924065979	49.5150555440346	0.0272385625869143	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1812.47724231699	1812.47724231699
"AML-0693"	"2021-03-09-AML0693:CGAGGCTCATCCTCAC"	-2.61921868744548	3.42963264072267	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.215384615384615	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGCTCATCCTCAC"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	3483.10364531232	36.4123677098028	0.0104540006321109	4933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	3475.61662446925	3475.61662446925
"AML-0693"	"2021-03-09-AML0693:CGAGGCTGTACGTTCA"	8.9069410758907	6.4449891814026	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGCTGTACGTTCA"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1706.61047217926	47.0205321537295	0.0275520002485902	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1698.01670513273	1698.01670513273
"AML-0693"	"2021-03-09-AML0693:CGAGGCTGTCCAGTTA"	-6.92383943024333	-2.60747125065001	"2021-03-09-AML0693"	"AML0693"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGCTGTCCAGTTA"	"MPP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1345.23087778305	28.323141619393	0.0210544837225784	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1335.56461429985	1335.56461429985
"AML-0693"	"2021-03-09-AML0693:CGAGGCTTCACAACCA"	-6.49315772476848	-2.52831199085387	"2021-03-09-AML0693"	"AML0693"	"CD4+ T"	"CD4+ TCM"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGCTTCACAACCA"	"CD4+ T"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"T"	"CD4_T"	2228.25161121089	21.5917967199414	0.00969001732627842	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	450	TRUE	"T_AML-0693"	2219.65092442743	2219.65092442743
"AML-0693"	"2021-03-09-AML0693:CGAGGCTTCTACACAG"	1.36663760718648	-10.3983631364075	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	68	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.921875	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGGCTTCTACACAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	2335.24221314472	27.4175699092362	0.0117407820717298	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	2315.70308205237	2315.70308205237
"AML-0693"	"2021-03-09-AML0693:CGAGTGCCAGCATACT"	11.5672317939693	-2.53188660061034	"2021-03-09-AML0693"	"AML0693"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.830769230769231	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCCAGCATACT"	"Ery"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Ery"	"Ery"	1452.79404766486	40.4810952747432	0.0278643041935712	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	458	TRUE	"Ery_AML-0693"	1447.86644748275	1447.86644748275
"AML-0693"	"2021-03-09-AML0693:CGAGTGCGTAAGAACT"	8.2545916038448	6.51954028690187	"2021-03-09-AML0693"	"AML0693"	"B"	"Naive B"	0	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.115445679292357	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCGTAAGAACT"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1684.85171974646	51.4665305647881	0.0305466231607211	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1679.44803708942	1679.44803708942
"AML-0693"	"2021-03-09-AML0693:CGAGTGCGTCGTATGT"	-7.04167876663859	3.85503957355348	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	47	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.26	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCGTCGTATGT"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	1496.65654916565	44.4506666518121	0.0296999780454589	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	1492.18031266595	1492.18031266595
"AML-0693"	"2021-03-09-AML0693:CGAGTGCGTGTACATC"	-7.76499305191691	-2.88407256519469	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCGTGTACATC"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	3051.96079769469	1.31427321278445	0.000430632403200328	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	3017.91567379406	3017.91567379406
"AML-0693"	"2021-03-09-AML0693:CGAGTGCTCCGAGAAG"	-6.88532481613811	4.00849220836488	"2021-03-09-AML0693"	"AML0693"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCTCCGAGAAG"	"HSC"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2160.00916262703	39.9281493263963	0.0184851759044555	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2146.82869148434	2146.82869148434
"AML-0693"	"2021-03-09-AML0693:CGAGTGCTCCTCGCAT"	-5.64659724655803	3.52732584560243	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.240425531914894	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCTCCTCGCAT"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2936.84812396122	30.8739925449886	0.0105126282469608	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2926.54199602498	2926.54199602498
"AML-0693"	"2021-03-09-AML0693:CGAGTGCTCCTGGTCT"	-8.24403891983684	-3.63746025478514	"2021-03-09-AML0693"	"AML0693"	"Granulocyte"	"Granulocytes"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTGCTCCTGGTCT"	"Granulocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Gran"	"Gran"	2279.47933146516	7.7964914150695	0.00342029484867415	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	302	TRUE	"Gran_AML-0693"	2273.44286616358	2273.44286616358
"AML-0693"	"2021-03-09-AML0693:CGAGTTACACACCGAC"	-8.74491153183635	-2.64000632679137	"2021-03-09-AML0693"	"AML0693"	"GMP"	"GMP"	41	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.988235294117647	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTACACACCGAC"	"GMP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	3277.84055090147	39.3478981210237	0.0120042136003846	5016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	3269.36607118395	3269.36607118395
"AML-0693"	"2021-03-09-AML0693:CGAGTTACAGTAGATA"	-6.68317828598674	3.39453694904176	"2021-03-09-AML0693"	"AML0693"	"MEP"	"MEP"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.516693163751987	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTACAGTAGATA"	"MEP"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"HSPC"	"HSPC"	2775.14216387877	37.7958985658604	0.0136194459000377	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1036	TRUE	"HSPC_AML-0693"	2761.42435186724	2761.42435186724
"AML-0693"	"2021-03-09-AML0693:CGAGTTACATGGCTGC"	10.0075680213863	6.80897376621095	"2021-03-09-AML0693"	"AML0693"	"B"	"Activated AP-1"	2	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0393737048123417	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTACATGGCTGC"	"B"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"B"	"B"	1500.56921922065	49.1556693045647	0.0327580152084517	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	820	TRUE	"B_AML-0693"	1498.50056317164	1498.50056317164
"AML-0693"	"2021-03-09-AML0693:CGAGTTAGTACCAGAG"	1.16228093680684	-9.08022215282591	"2021-03-09-AML0693"	"AML0693"	"CD14+ monocyte"	"CD14+"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.972627737226277	"GSM5613784"	"2021-03-09"	"2021.03.09.AML0693.CGAGTTAGTACCAGAG"	"CD14+ monocyte"	"U-11-0693"	"F"	77	"CITE-seq + scTCR-seq"	"OSU"	"AML0693"	"AML"	"Adverse"	"74-89<4n>,XXXX,-8,-9,-9,-12,-17,i(17)(q10),+mar1,+mar2,+dmin[cp18]/46,XX[2] .ish dmin(amp CMYC)"	47	"Immunohistochemical stains are performed on the bone marrow biopsy for CD34, CD117, CD79a, CD3, MPO, TdT, and CD68 (monocytic marker).  The
immature cells are positive for MPO, CD68 and CD117.  They are negative for
the rest stains."	""	""	""	""	"x"	""	NA	NA	""	""	""	""	""	0	""	""	""	"0"	"0"	""	""	""	"0"	""	""	""	NA	NA	""	NA	NA	NA	""	NA	""	""	""	"mut"	""	"AML"	"case"	"Mono"	"Mono"	1271.07251447317	47.2679402238302	0.0371874457874038	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	237	TRUE	"Mono_AML-0693"	1266.31050740437	1266.31050740437
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTGCAGCATGACTAC"	-7.29629645767863	2.00624117935029	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGCAGCATGACTAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2210.40666045962	45.77429137861	0.0207085384773008	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2196.47252498208	2196.47252498208
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAACTGTCAATCGCCG"	1.5946247774059	-7.59412529384764	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACTGTCAATCGCCG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2957.69183380522	42.0001572258658	0.0142003155115151	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2952.696920968	2952.696920968
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTGCAGCACTAACGT"	-2.79859362068828	8.99695584857789	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGCAGCACTAACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2507.73492756417	40.8784499133454	0.0163009453128492	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2507.73492756417	2507.73492756417
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCAGATGCTGG"	-4.26614127579387	9.91084668720094	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCAGATGCTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2695.1435496322	39.8456105540354	0.0147842257083015	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2687.55648210797	2687.55648210797
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATGGCACTGTGAT"	-2.53611550751384	8.65307710254518	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATGGCACTGTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2650.46860139188	41.7408777230937	0.0157484897957945	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2642.92258750633	2642.92258750633
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATGGCAGCCGTCA"	-2.75222764435466	8.88275239551393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATGGCAGCCGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.39582274776	44.6897511567105	0.0183275212087392	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2431.97574000063	2431.97574000063
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATGGGTAGCTCGC"	-3.87675271454509	10.1180515059265	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATGGGTAGCTCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2383.92028524577	44.5494687471486	0.0186874825567231	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2378.69841335878	2378.69841335878
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATGGTCCCTCGAT"	-4.36226401749309	10.6843137511047	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATGGTCCCTCGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2636.26135325482	40.2712305943351	0.0152758870225878	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2632.25971223903	2632.25971223903
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAATAGAGTGCTCCGA"	-2.30008230629619	8.6269960173401	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATAGAGTGCTCCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2532.8547333672	44.8805603024527	0.0177193582052722	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.1832513448	2528.1832513448
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGACGTCAGCTCACTA"	-2.46843324127849	8.63655088031618	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGACGTCAGCTCACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2619.67902806821	45.5128942885012	0.0173734620924393	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2610.6919866844	2610.6919866844
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGACGTCCAGGAATAT"	-4.04097114029582	9.94112870776979	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGACGTCCAGGAATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.46663689121	42.8527785224681	0.0163656003550786	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2605.24988624234	2605.24988624234
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGAATTCCAACCAA"	-2.91404376450236	8.82374951923219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGAATTCCAACCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2696.50958397504	38.8258219240934	0.0143985477206644	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.40079130714	2689.40079130714
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAACGTTCCGCTAGG"	-4.16033921662028	9.96059129321901	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAACGTTCCGCTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2770.50661358096	43.0711539738614	0.01554630974809	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2762.55932513848	2762.55932513848
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGATGGCAGGCCTGAA"	-0.975040058523971	8.69134614551393	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGGCAGGCCTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2558.68813151063	41.0792698503181	0.0160548170542634	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2551.06256348727	2551.06256348727
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGCCCTCTTCGACC"	-6.56031690064128	2.01020870292512	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGCCCTCTTCGACC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2650.74695519975	40.9959604886453	0.0154658144219413	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2637.09813344193	2637.09813344193
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGCGAAGAGCAGCT"	-4.28834281387981	10.297695136908	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGCGAAGAGCAGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2511.05701865675	44.0959359909902	0.0175607067714371	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2504.60016177863	2504.60016177863
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCAGGTCACCATTCC"	-4.00396523895915	9.55709359729616	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCAGGTCACCATTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2548.95910712806	36.721791923099	0.0144065833855114	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2540.02200511082	2540.02200511082
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGGACGTCTTGAGT"	-3.02149115029033	9.04077909076539	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGGACGTCTTGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2518.90007819905	41.2566122830481	0.0163788205177815	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2514.78784988199	2514.78784988199
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCAGGTGTTCAAGGG"	2.18628563460652	-5.4053058854309	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCAGGTGTTCAAGGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2793.29233296287	41.9356098106451	0.0150129685016403	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2790.40831949751	2790.40831949751
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCATAAAGGTATTGA"	-1.3399033350056	8.77995202625123	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATAAAGGTATTGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2539.67333164233	35.2639347115468	0.0138852246358561	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2533.86059062285	2533.86059062285
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGGGTGTGAGCTCC"	-2.78120313111003	8.78193757617799	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGGGTGTGAGCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2603.8805654482	37.5176304375796	0.0144083530310161	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2597.69870985961	2597.69870985961
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCAATGTCCACAGC"	-6.96647439423259	1.83959767902223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAATGTCCACAGC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2564.51888970566	39.387615190384	0.0153586761823013	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2557.82814119491	2557.82814119491
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGTCGCCTTGT"	-4.3706468147343	10.0976257094177	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGTCGCCTTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2656.05096515693	40.4789183260323	0.0152402641579735	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2648.73408357761	2648.73408357761
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCATGGAGTGGAATT"	-0.406059305102187	8.48657987201539	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGAGTGGAATT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2211.8743549348	35.4729206575484	0.0160374935305012	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2199.4769695443	2199.4769695443
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGTAACACATTGTG"	-2.94312367859538	8.88954064929811	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGTAACACATTGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2346.4734042035	42.4770831349887	0.0181025205991658	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2343.81300249277	2343.81300249277
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTGGGTGTGGTCTGC"	-3.89884624901469	10.0850381621155	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGGGTGTGGTCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2388.0902437536	37.1899418754959	0.0155730889872238	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2383.92919061446	2383.92919061446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTCACAGCACGGAT"	-4.35007415238078	10.0144548186096	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTCACAGCACGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2591.9481320567	38.3479499111029	0.0147950298220953	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2587.14048717768	2587.14048717768
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTCACAGTATGTAG"	-4.31368146362956	9.90913579547731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTCACAGTATGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2719.42962657075	41.7021472813625	0.0153348874609231	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2715.92837206781	2715.92837206781
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTCACGTTCTTCAT"	0.15369907495324	-6.0797214738098	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTCACGTTCTTCAT"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2866.98692487999	44.3240463604076	0.0154601494606617	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2862.38492699433	2862.38492699433
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGAATTCAGTAGGG"	-4.28365550461467	10.2928352125916	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGAATTCAGTAGGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2544.05969104774	46.0090520072614	0.0180848948509982	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2540.01758127998	2540.01758127998
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCGCCAAGGTTCTTG"	-4.39699731293376	10.3359851607117	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCCAAGGTTCTTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2686.5586465303	44.7794602922265	0.016667963064964	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2679.18494782839	2679.18494782839
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTGGGAGCCATTTG"	-4.12156758728679	9.74891851032106	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTGGGAGCCATTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.51682979236	40.9464518111198	0.0157515624987858	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2599.51682979236	2599.51682979236
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTTCGGTCAACGCC"	5.42675842818562	-9.90752031719359	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTTCGGTCAACGCC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.28926565948	36.3116052895425	0.013537542633611	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2675.60592673044	2675.60592673044
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTTTCGTCTGCGAGC"	-4.07023272934611	10.0497560271057	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTTCGTCTGCGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2776.52096724957	39.2538280811622	0.0141377747707222	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2767.98268390813	2767.98268390813
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAACCCAGACTCTTG"	-4.1758922142094	9.64752576434938	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAACCCAGACTCTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2603.45988038194	41.6485337266049	0.0159973787345227	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2601.10241977667	2601.10241977667
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCGCTGTCGGAGTGA"	-4.12188563767131	9.8930511244568	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCTGTCGGAGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.8267665644	38.3047542084089	0.0149521250649506	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.32054076185	2555.32054076185
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCACTTCTTGTTAC"	5.53427042540852	-9.92238809978636	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTTCTTGTTAC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.35562681664	40.2594397251741	0.0147289431825824	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2728.95170606178	2728.95170606178
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAACCCCATCTTAGG"	4.64241280135457	-8.58380892192992	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAACCCCATCTTAGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2626.40490855471	40.4256528319877	0.015392010843535	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2624.60537041025	2624.60537041025
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAACCCGTTACGATC"	-1.87138436260875	8.87144277179567	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAACCCGTTACGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2395.56464544406	40.6647300239988	0.0169750084187191	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2386.40851186882	2386.40851186882
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAAGTGGTCCTTAAG"	-4.2033408683842	9.7201823958191	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAAGTGGTCCTTAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2419.83738109319	38.2457753712548	0.015805101479165	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2415.77830039815	2415.77830039815
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAAGTGTCGGTAAGG"	-3.87344537201579	10.3575601347717	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAAGTGTCGGTAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2269.68511622843	38.8328935055508	0.0171093748766701	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2259.30687208841	2259.30687208841
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATCTCATACCATG"	-2.67200432243999	8.74083802783815	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATCTCATACCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2592.78101837389	40.7321548879518	0.0157098322609202	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.2878198253	2579.2878198253
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGGGTCAGCTCCTT"	-4.18444381180461	9.78437707507936	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGGTCAGCTCCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.04521488542	39.756236904816	0.0153733726989679	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2580.14533492292	2580.14533492292
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAATCTTCGATCCCT"	-3.25256429138835	9.61571977222291	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATCTTCGATCCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2370.32334777539	42.8945912362831	0.0180965146702625	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2366.41718834874	2366.41718834874
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAACGAAAGGATTCCT"	-0.495331327349502	8.90779969776002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGAAAGGATTCCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2397.54649913644	40.7943129772953	0.0170150247313196	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2390.36661299774	2390.36661299774
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAACGAAGTGATTAGA"	-0.776630441576797	8.63734529102174	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGAAGTGATTAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2425.25649496841	36.2903302072244	0.0149635019151642	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2420.79599482592	2420.79599482592
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTACGACAGTCTGGC"	-2.83750806275066	8.83186814868776	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTACGACAGTCTGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2737.41989678106	43.9836805022452	0.0160675680607004	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2731.68749728659	2731.68749728659
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAACGAATCAAGAGGC"	-0.144456068903762	8.71887586200563	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGAATCAAGAGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2488.84143411517	37.5390704376108	0.0150829498107246	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.41073414516	2480.41073414516
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAACGAATCGAGAGAC"	0.224958275526208	-6.44657137310179	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGAATCGAGAGAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2917.08402981848	46.8402694464517	0.0160572232296532	2489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2907.34000793603	2907.34000793603
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTACGATCTTGTGCC"	-4.5987585586613	-4.81881239330443	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTACGATCTTGTGCC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2950.32517469916	27.4882735922774	0.00931703184042426	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2945.41029709819	2945.41029709819
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTATCTCAACCTATG"	-2.89452586594279	9.27627847278444	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATCTCAACCTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2525.7052302081	34.6024598398537	0.0137001180604922	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2521.87712429705	2521.87712429705
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCACAGTACCGTCG"	-1.65410492840465	8.70225808704225	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCACAGTACCGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2374.22293856255	45.7799387764849	0.019282072476396	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2369.70499639434	2369.70499639434
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCATCATGGAATA"	-1.35472379151042	8.55000112140504	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCATCATGGAATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.20621253314	46.4587657182659	0.0205369278277434	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2254.5769442924	2254.5769442924
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGAACTCCCACAGG"	-2.40946183624919	8.71933457935182	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGAACTCCCACAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.42276074695	46.1592703672175	0.0190314328348275	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2418.80725920547	2418.80725920547
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGGCCAATCTCGA"	3.63724269446675	-8.23525431072386	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGGCCAATCTCGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2853.96258430734	41.6399418736355	0.0145902199638478	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2845.96728876349	2845.96728876349
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGGCCAATTCTCT"	-0.648307482630569	8.52189729297487	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGGCCAATTCTCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2539.77945226612	38.7172676176812	0.0152443424105726	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.58744489941	2528.58744489941
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGGCGTAGCTGTT"	-4.30355439606364	10.2610463866028	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGGCGTAGCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2810.54978556281	32.5454897906832	0.0115797592193038	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2803.09760521555	2803.09760521555
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGGCTCCAAGCTA"	1.19589390334432	-5.89939691936644	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGGCTCCAAGCTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2702.67515424049	48.2707878574673	0.0178603735568185	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2700.55897827678	2700.55897827678
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGGCTCGAGGCAA"	-1.98519239845927	8.72495935046998	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGGCTCGAGGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2346.12638052551	44.3726526280294	0.0189131553169316	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2339.67364067142	2339.67364067142
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGTAGTATCCTTT"	-4.00464902344401	9.89814279163209	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGTAGTATCCTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.34637029223	37.5280893600431	0.0147553985561672	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2540.70008219903	2540.70008219903
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAAGGTATCGGCTTGG"	-2.1749292415684	8.59968946063844	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGGTATCGGCTTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.00368889693	38.5812742878821	0.0160287557787512	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2401.36156381503	2401.36156381503
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTCTCGCAGTTGTCA"	-2.75839076462443	8.85379884326784	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCTCGCAGTTGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.14692131941	45.1769580296733	0.0174553297795948	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.03342157306	2582.03342157306
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTCTCGCATACTGTG"	14.3646599250728	2.01750824535219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCTCGCATACTGTG"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1185.09537777953	26.7542885980984	0.02257564167386	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1176.28824015791	1176.28824015791
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAATGGAAGCAGCGAT"	1.31442787226979	-5.77668526088866	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAATGGAAGCAGCGAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2872.66257342637	47.4769506364022	0.0165271588370973	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2866.62538240443	2866.62538240443
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTGATGGTAACCAGG"	-3.92248759689983	9.70656201923219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGATGGTAACCAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.47910627892	40.4783211215294	0.0156378782518817	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.40914915181	2582.40914915181
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTGATGGTTCCGCTT"	-2.26612363281901	8.53361699664918	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGATGGTTCCGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2780.11426325102	33.4401565293902	0.0120283388965049	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2777.78845196733	2777.78845196733
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACAAAGGTCTTACAG"	4.46814550933186	-8.68061163341673	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAAAGGTCTTACAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.66458133819	36.1012598359371	0.0138019454380758	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2614.28964397801	2614.28964397801
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACAACCCAGGGACTA"	-2.36160073700603	8.75879380786744	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAACCCAGGGACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2767.67083493977	38.9179331129569	0.0140616191136775	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2759.43738772024	2759.43738772024
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCGTTGCTAGT"	-3.10833225670512	9.31612775409547	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCGTTGCTAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.24672101231	38.8678737394237	0.0155269847806713	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2499.56440483784	2499.56440483784
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCTCATTTGTC"	-4.24491773071941	10.0280933150086	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCTCATTTGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3200.60210545254	42.0000837669162	0.013122557063674	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3192.78257782161	3192.78257782161
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTGTGACAAATGAGT"	-0.103367860347587	8.36134049976198	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTGACAAATGAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2296.85832548051	39.1821515683401	0.0170590197635037	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2288.9134938528	2288.9134938528
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACACACCATACCATG"	-4.13258252564128	10.1434459456238	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACACACCATACCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2949.64032865725	38.2291284490874	0.0129606067823497	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2945.62050234554	2945.62050234554
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACAGGGAGATCACTC"	-0.894963960081893	8.98857686603395	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAGGGAGATCACTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2317.61789310996	46.2993853329062	0.0199771435449085	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2315.36776308817	2315.36776308817
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGCATAGATGCTTC"	-0.835695723921615	8.49608323657838	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATAGATGCTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2905.78827162021	43.3535440961391	0.0149197188658092	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2891.13443567505	2891.13443567505
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTAGGGTTTACCTT"	-0.299535314471084	8.57140920245973	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTAGGGTTTACCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2345.26208361731	40.813879336255	0.0174026944030511	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2329.58339344602	2329.58339344602
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACAGGGTCCGGTTCT"	-2.39297399941142	8.82196996295778	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAGGGTCCGGTTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2364.78034942256	44.0429255750845	0.018624531274475	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.2417190714	2362.2417190714
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTCGCAGCTGGCCT"	-4.05794749680217	10.0345458754334	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTCGCAGCTGGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2832.07360178698	43.0979807155142	0.0152178180285711	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2823.61228929723	2823.61228929723
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACCAACGTGTCCTAA"	-1.94822369042094	8.53698632800905	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCAACGTGTCCTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2735.50828778576	41.0974972974604	0.0150237151468207	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2725.73008994129	2725.73008994129
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACCAACTCACAAGGG"	-2.86501179161723	9.26312635028688	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCAACTCACAAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.53997153406	43.5635660725516	0.0166365862450555	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2607.38141197557	2607.38141197557
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACCACAAGAAGCGAA"	-3.82741556587871	9.41611383045045	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCACAAGAAGCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2886.51980810649	48.2301355682822	0.0167087492117092	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2877.38326644155	2877.38326644155
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACCACAGTGCAGATG"	-2.2566102546757	8.64257237994996	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCACAGTGCAGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2540.39248338309	41.564175403492	0.0163613204161824	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2535.42844479613	2535.42844479613
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTACCGAGTCAGCGA"	-4.16169391098674	10.0105390318665	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTACCGAGTCAGCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2616.19751826488	44.1286009836945	0.0168674577036376	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2612.33530017875	2612.33530017875
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTTCAGTGTACGCC"	-4.93806443634685	8.90621659839479	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTCAGTGTACGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3819.03573214799	36.5994555279709	0.00958342840835005	5499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3806.44996035947	3806.44996035947
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTTCATCTTACGGA"	-1.72389684143718	8.62281987750856	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTCATCTTACGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.27361258321	40.2543096173582	0.0148689476491253	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2695.97748292296	2695.97748292296
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTTGTAGTTGGCGA"	-5.14840636673625	-4.51742031490477	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTGTAGTTGGCGA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3658.87132387341	37.8520916835711	0.0103452918490447	3991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3654.01045641781	3654.01045641781
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGTGGGCACTCCTTG"	2.24272193488423	-5.36274626171263	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTGGGCACTCCTTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2402.64373728311	44.4586651573543	0.0185040605344294	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2400.42805091494	2400.42805091494
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAAATGGTCCGAAAG"	-0.457459072501022	8.71993920886842	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAAATGGTCCGAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2257.3291664917	42.4656286463784	0.0188123332993468	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2248.84335170242	2248.84335170242
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACCTGAGTGACACGA"	-2.19635854187663	8.93926808917848	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCTGAGTGACACGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2646.5842005956	40.4002534341676	0.0152650550188714	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2634.95415302566	2634.95415302566
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCAATAGTCTGCGC"	0.541409690945786	9.35473058307496	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCAATAGTCTGCGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2180.48767527442	40.9862869801698	0.0187968441394706	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2175.16539922769	2175.16539922769
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAACCTGTGGTTCTA"	-0.0400212732261002	-6.43596794521483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAACCTGTGGTTCTA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2808.38287039823	35.5076549021583	0.0126434523142933	2903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2801.00400187146	2801.00400187146
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGAAAAGTGCGCTC"	-4.13471017304118	10.7969550856384	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGAAAAGTGCGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2598.2494831359	39.9827389113598	0.0153883370980617	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2590.68114287891	2590.68114287891
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGAAAGTGTTCGTA"	-4.31272015991862	10.5697049864563	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGAAAGTGTTCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2624.98344960527	42.5187740361168	0.0161977303295038	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2617.0380377714	2617.0380377714
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGAAATCCTATTGT"	0.805318971245927	-7.267116569635	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGAAATCCTATTGT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3292.04538637483	32.1999689873432	0.00978114369887274	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3283.48695641767	3283.48695641767
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGAAATCTCCGAAA"	10.3426777320797	7.7126164206299	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGAAATCTCCGAAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2337.45824724515	44.7572966119346	0.0191478485935243	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2326.02527277319	2326.02527277319
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGGGAAGATAGGGA"	-1.63821254196818	8.48752114856569	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGAAGATAGGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2432.08463325534	39.9028442168503	0.0164068485410561	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2423.28268479098	2423.28268479098
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGGGACAAATCCCA"	-2.75236115875896	8.48665807330934	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGACAAATCCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3390.06273120315	35.3430781309597	0.0104254938428282	2952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3375.39756184916	3375.39756184916
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACAAACACCCAATA"	-3.35117326203044	9.88092515552369	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAAACACCCAATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2395.60867436328	43.5480309536967	0.0181782740310335	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2386.0607456368	2386.0607456368
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACAAAGTAGCACGA"	0.105580979108256	-6.39004852687987	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAAAGTAGCACGA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3240.17793846403	41.5688283096614	0.0128291807114046	3388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3235.40572278303	3235.40572278303
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGGGATCAATCGGT"	3.95589985427205	-8.27625944530638	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGATCAATCGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2841.70256003113	34.4246280993942	0.0121140856131745	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2835.86831469256	2835.86831469256
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACAAATCTCCATAT"	10.4359747367794	7.76041123950807	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAAATCTCCATAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2353.06649675909	42.8016502350673	0.0181897325443282	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2346.52298851018	2346.52298851018
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACACTCACATCATG"	-2.80349741402324	9.02130601489869	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACACTCACATCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2673.86683280536	47.9872791116467	0.0179467722636357	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2658.82918041791	2658.82918041791
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACACTTCACTGCTC"	-4.12629018250163	10.4658174284729	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACACTTCACTGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2792.1597689072	42.2845670905046	0.0151440356534662	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2787.02346444393	2787.02346444393
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACGTCAGTCGTGCCA"	-2.50155220452006	8.57930657947389	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGTCAGTCGTGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2558.89860494159	39.6978022721654	0.0155136284788711	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.56483175802	2556.56483175802
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCTAAAGGTCTACT"	-1.61765335026439	8.87096688831178	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCTAAAGGTCTACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2360.34836870373	43.4330666225654	0.0184011255281008	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.57700066141	2357.57700066141
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCTAATCGTCGACG"	-3.9042366546696	10.4314975508484	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCTAATCGTCGACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2275.39757495416	38.5573023535843	0.0169453034397126	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2270.96824403685	2270.96824403685
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGACAGCAGATTCGCT"	2.42280544814412	-4.40423109447631	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGACAGCAGATTCGCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2907.2183662819	39.3031965010566	0.0135191759094871	3127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2902.76923471094	2902.76923471094
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AACTTCTCACCATATG"	-4.06607518616374	9.85524747455446	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACTTCTCACCATATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2804.43569488248	37.4426138515538	0.0133512114112222	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2799.62098107194	2799.62098107194
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGAACAGTGTACATC"	-2.89265284958537	9.0215444334778	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGAACAGTGTACATC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2507.50630060232	39.9963542520365	0.0159506495526767	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2496.52096806653	2496.52096806653
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTGATTCAACTCGTA"	3.0660466152126	-7.73554327404173	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTGATTCAACTCGTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2931.45915084151	40.5230992508935	0.01382352513398	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2927.11652535567	2927.11652535567
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGAACATCCTTGACC"	-0.606145481497604	8.92606637561647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGAACATCCTTGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3082.56024978275	37.7545289690893	0.0122477829822629	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3071.36388489181	3071.36388489181
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGAACATCTAACGGT"	11.8771912055904	-2.83038713848265	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGAACATCTAACGGT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2338.67838831039	46.6542127876036	0.0199489647746348	2895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2332.88097333228	2332.88097333228
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACCCGGTCAAAGAT"	-6.59445844116862	-2.56141354953917	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCCGGTCAAAGAT"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2186.70931787036	44.0844602445243	0.0201601831044733	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2177.66876884055	2177.66876884055
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACAACAAGGTCGA"	-4.30692182007487	-5.46341516887816	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACAACAAGGTCGA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3232.33161792215	37.2133252135592	0.0115128426202387	3196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3223.67136521294	3223.67136521294
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACAACATCGATCA"	-0.26013426008876	8.98239419544069	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACAACATCGATCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2393.08021823245	37.6548059802688	0.0157348699359861	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2382.17319313734	2382.17319313734
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACAACATTACGGT"	-0.262165794998962	9.08634851062623	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACAACATTACGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2324.97171398703	38.6607751051151	0.0166284926704836	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2310.97119905146	2310.97119905146
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACAAGTTCGGACC"	-4.23712001267131	9.71242616260377	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACAAGTTCGGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2885.06844315444	38.6658468820544	0.0134020553217027	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2879.4721867074	2879.4721867074
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACTCAGAATTCAG"	-0.81103221598323	8.48307416522828	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACTCAGAATTCAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2310.92378868282	38.2623326218252	0.0165571590068031	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2301.74764211191	2301.74764211191
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACTCAGCACGTCC"	-4.35277448120769	10.2499704130921	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACTCAGCACGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2825.2376432115	46.480600834536	0.0164519260693768	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2818.31506319851	2818.31506319851
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGACTCCATACCGTA"	-4.20833716812785	10.0710592039856	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACTCCATACCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2738.65140958484	44.3608176165039	0.0161980518810273	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2724.67153574447	2724.67153574447
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGGAACAAGAGGCT"	-1.65180132809337	8.61611650073854	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGAACAAGAGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.19440706431	45.5406146848924	0.017521049814942	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2589.45015724881	2589.45015724881
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGATAGCATGTGCCG"	-1.12059925022777	8.86725041950075	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGATAGCATGTGCCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2395.82221863765	38.6947144227643	0.0161509122512302	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2393.60461478741	2393.60461478741
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGGAAGTTAGGCTT"	-4.1996525329655	10.6489715346131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGAAGTTAGGCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3216.66115980851	43.7672874396846	0.0136064338969076	3031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3206.36697697022	3206.36697697022
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGGCTCATGGCACC"	4.73806347426717	-7.63712456142577	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGCTCATGGCACC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2650.28499509563	48.4296415432918	0.0182733712158923	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2640.48607577886	2640.48607577886
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAGCAGAGACTCATC"	5.37781633910481	-9.61127569591673	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGCAGAGACTCATC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2637.01148531472	43.0196556690778	0.0163137915434386	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2631.26842974441	2631.26842974441
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAGCAGGTCCAGCGT"	1.52048291739766	-5.69074346935423	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGCAGGTCCAGCGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2407.05386389842	38.7569358349357	0.0161013994810094	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2402.30642571799	2402.30642571799
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTGCGCAGGCATGA"	-2.72157798233684	8.64436051929323	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTGCGCAGGCATGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2357.70323198868	39.3781070658602	0.016701892982793	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2354.7621150704	2354.7621150704
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTGCGCAGTGAGCA"	-4.40465102616008	10.0113868483338	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTGCGCAGTGAGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2684.01131739499	35.9714176619546	0.0134021110227163	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2680.02065233863	2680.02065233863
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGCGTTTCACTCCGT"	4.45479788359944	-8.61977293407591	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCGTTTCACTCCGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2979.42520237869	40.7541237684076	0.0136785188417788	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2975.64843447929	2975.64843447929
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGCGTTTCTGTCAGA"	-4.16012034836467	10.4287242659363	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCGTTTCTGTCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.55172601502	42.5291428069924	0.0177756419410117	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2383.51612095605	2383.51612095605
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGTTACAAATAAGC"	-2.71877704086955	9.16066167438356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGTTACAAATAAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2403.58849864587	38.9827963803565	0.0162185816758229	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.1552432002	2397.1552432002
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAACACTCAGTCAACT"	-3.8763464492863	10.5317268141541	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACACTCAGTCAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2324.53773077335	44.4166115018028	0.019107718026597	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2319.86147652571	2319.86147652571
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGGAATTCCTTACCG"	-4.16295991364177	10.1863364943298	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGGAATTCCTTACCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2847.00594999888	37.4541346431443	0.0131556221872873	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2838.05403473326	2838.05403473326
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGGTAAGTGGCACTC"	4.90841354903523	-8.96723463451537	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGGTAAGTGGCACTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.54399062278	39.8277367192455	0.0153802124480098	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2583.75321872721	2583.75321872721
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTACCAGGTTATAG"	-3.66093287888225	9.74711988056032	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTACCAGGTTATAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.67417413432	41.0543561527574	0.0157921160125493	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2595.79649351252	2595.79649351252
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTCGTAGATGTTGA"	-0.39412889900859	9.20119474017946	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTCGTAGATGTTGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2437.94931641742	41.4631590203814	0.0170073917210518	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2428.57769674778	2428.57769674778
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACAGTTCTAGAACC"	4.31038631972615	-7.64109852230223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACAGTTCTAGAACC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2308.05820321593	42.5118817935727	0.0184188950410084	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2303.10355748493	2303.10355748493
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGATGAATCGCGGTAC"	-3.71171174469646	9.44516656482545	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGAATCGCGGTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2486.41072976629	40.7021870725314	0.0163698565909733	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2478.21496811801	2478.21496811801
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTGAAAGCCTGGAA"	-4.22141395035441	10.0424937971863	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTGAAAGCCTGGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2709.58137615737	38.5670251032804	0.0142335732901939	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2703.26643433587	2703.26643433587
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTGAACAGAGGGTT"	-3.76492438736613	9.69928262317506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTGAACAGAGGGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2483.85688251181	46.9117502202909	0.0188866558901136	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2473.7568095045	2473.7568095045
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTGAATCAATCGGT"	-4.3720420402592	10.0605926283631	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTGAATCAATCGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3007.61561317962	34.9904270864156	0.0116339424935436	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2996.12432089163	2996.12432089163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTGAATCCAACTAG"	10.314096112817	6.71516606891481	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTGAATCCAACTAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2055.37085892372	48.4114116701871	0.0235536139183842	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2048.94444761276	2048.94444761276
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATCGGTGTTTCTT"	4.57043566283528	-8.76527311718138	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATCGGTGTTTCTT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.24731247312	42.000325665644	0.0171763099181837	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2440.22880188994	2440.22880188994
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCAATCACAAGCTT"	-3.29432282868083	9.53567121112672	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAATCACAAGCTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2613.68607107308	44.8028859024365	0.0171416477281995	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2604.19666013706	2604.19666013706
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGCAGATTAAG"	3.5361610847408	-7.80341341411742	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGCAGATTAAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2668.83622559833	35.5537351374854	0.0133218122552704	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2668.83622559833	2668.83622559833
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCATAACACTCCGGA"	-1.97883472862895	8.5934905775818	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATAACACTCCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2732.11702250308	41.6521864665758	0.0152453888773825	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2723.00836273005	2723.00836273005
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATGCCAGTTCCAA"	0.20026365396325	-6.46572639858397	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATGCCAGTTCCAA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2767.04922248156	43.2523898848759	0.0156312325539645	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2762.53848307775	2762.53848307775
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGTCTGGGCCA"	-3.96012196961101	9.64528081500856	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGTCTGGGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2582.31163496333	40.3813978489604	0.015637693492224	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2577.49834665078	2577.49834665078
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATAGAGCACCATATG"	-4.49443374100383	10.6291703947815	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATAGAGCACCATATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2791.85538616892	40.28645623565	0.0144299939155991	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2785.57749560232	2785.57749560232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGTAAGTAAGCGGT"	-4.48301968994792	10.5478229292664	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGTAAGTAAGCGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2455.96289181977	36.6167947815912	0.0149093436645777	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2452.41400159051	2452.41400159051
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAGTAATCTCCACTG"	-4.37417207184489	10.6680869826111	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGTAATCTCCACTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2674.28867117098	42.3856058552636	0.0158493009046418	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2659.83251708646	2659.83251708646
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAATAGAGTCACTCGG"	-4.36026034775432	10.5289249190125	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATAGAGTCACTCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2593.16040426643	40.3442872392418	0.0155579605383704	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2584.30215533742	2584.30215533742
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAATAGATCAGCCTCT"	-2.28132734718974	8.62905309284059	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATAGATCAGCCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2519.70836073991	33.7116571871721	0.0133791901128084	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2512.20868936776	2512.20868936776
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAATCACCACCGCTGA"	-4.02246556702312	10.3073005446228	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATCACCACCGCTGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2455.48014801434	43.6892398225507	0.0177925445082016	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2448.13411438973	2448.13411438973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCAGACAGTTGTCA"	-0.334814111620742	8.82533452594606	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCAGACAGTTGTCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2537.06925380367	44.8435849116793	0.0176753491629951	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2527.44208223809	2527.44208223809
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAATCGTCAAGACCGA"	-4.20814261856731	10.0444001921448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATCGTCAAGACCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2401.28713806602	45.7907069553921	0.0190692342575372	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2392.50658264018	2392.50658264018
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATCGTGGTATAGGGC"	-2.28563723984416	9.24542615497438	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCGTGGTATAGGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.5450026837	41.6883511204531	0.0169015165241642	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.20039255745	2461.20039255745
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACACGCCAAGGCTTT"	-4.03572640839274	9.73624513233034	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACACGCCAAGGCTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2670.24718169796	40.8237861542413	0.0152883921885772	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2666.71323738181	2666.71323738181
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCATTTCAGCCTCT"	-6.91560302200969	1.93375430190889	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCATTTCAGCCTCT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2495.43922628585	47.0928728966555	0.018871576755146	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2487.2330329172	2487.2330329172
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCATTTCGACCAAT"	-3.67010269585307	12.5716514357361	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCATTTCGACCAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.61531303092	40.8823351254554	0.0157931288282413	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2584.02182328556	2584.02182328556
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACAGCCAGATAACGT"	-4.41337428513225	10.3834953078064	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACAGCCAGATAACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2476.82952396404	38.4932059332596	0.0155413223077433	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2474.03549829324	2474.03549829324
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACAGCCGTATCTCTT"	1.91880228099172	-5.40958263790282	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACAGCCGTATCTCTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2552.07361266928	35.9838645807029	0.014099853704089	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2548.76557005943	2548.76557005943
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACATCAAGGCGAACT"	1.59064616736714	-7.66070749675902	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACATCAAGGCGAACT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.0328824382	40.70483943426	0.0157524463836747	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2577.09457453024	2577.09457453024
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACATCAAGGCTGTAG"	10.5797497230465	7.31740138614503	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACATCAAGGCTGTAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2187.61804456148	36.553589189106	0.0167093105123995	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2170.25988779901	2170.25988779901
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGACACAGCGTGCCT"	-2.71575770798381	8.86559770191041	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGACACAGCGTGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2708.66784229798	43.0153303664957	0.0158806220883851	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2702.65378134672	2702.65378134672
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACATCATCATTACGG"	-3.68990526619609	9.767382598761	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACATCATCATTACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2232.26048301344	39.2886244746263	0.0176003762883392	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2228.19391122121	2228.19391122121
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGACACGTCGAAACG"	-4.43776164475139	10.8331355818543	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGACACGTCGAAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2773.45691019115	45.0088891399541	0.016228443634573	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2764.03526830079	2764.03526830079
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGACACTCGATACGT"	-0.31422988596614	9.06983850086061	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGACACTCGATACGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2307.36895458184	38.4287772147953	0.0166548037922091	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2300.63800153944	2300.63800153944
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCAATAGACAGCGT"	-0.299360702664214	8.59745023334352	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCAATAGACAGCGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2374.80476228606	30.9447541766225	0.0130304413516647	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2368.23350915978	2368.23350915978
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGAGAAGTGTTACTG"	-2.63446531716045	9.03484151447145	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAGAAGTGTTACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2679.35515565126	40.8635814958357	0.0152512746993047	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2671.55309176236	2671.55309176236
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGAGAATCTGGACTA"	-4.47219977799113	10.3412122496399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAGAATCTGGACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2879.96876698398	37.7676105724003	0.0131138958885141	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2874.16062371473	2874.16062371473
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCCAGCAAGCCTGC"	1.80945469912831	-5.44487287914427	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCAGCAAGCCTGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3088.61446311128	40.3427764985003	0.0130617715420077	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3082.29627897292	3082.29627897292
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCCAGGTTGCCATA"	-4.11554704132732	10.2987861403259	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCAGGTTGCCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2634.79407392099	39.965245771806	0.0151682615986499	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2624.30775864683	2624.30775864683
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGGCATCAGCATCTA"	-0.544671933085281	8.67544934833375	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGCATCAGCATCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2418.19741273242	40.8446233448702	0.0168905247891727	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2413.61814345943	2413.61814345943
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCCTTGTAGCCCTG"	-3.91514740410503	10.524634338263	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCTTGTAGCCCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2403.79641112005	40.5686757175197	0.0168769183321215	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2398.35187389622	2398.35187389622
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGGCATTCTAAGAAG"	-4.30136666718181	10.0194921263489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGCATTCTAAGAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.92795344117	41.196475037572	0.0160489409071045	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2561.04144091063	2561.04144091063
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATTTCCCACTTCATT"	-3.26187596741374	9.06707379901735	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCCACTTCATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3010.39122026307	38.8492028323721	0.0129050345918087	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3000.85233592586	3000.85233592586
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTAGGAAGAAC"	-1.74869189682658	8.58487794483034	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTAGGAAGAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2821.03422382198	47.4470560372763	0.0168190288641711	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2814.59323525438	2814.59323525438
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTCAAAGGAGA"	-4.27992854538615	9.907688117865	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTCAAAGGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2502.02416592226	44.9882985956405	0.0179807610207704	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2499.4492806766	2499.4492806766
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTCAATAGGAT"	-2.4450880092686	8.78697297656862	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTCAATAGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.81012247205	37.7819683735458	0.0139529607559977	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2694.6846536077	2694.6846536077
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCGTGGTACAAAGT"	-2.85455594483073	8.80749414050905	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCGTGGTACAAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2848.18999261205	39.4516782988073	0.0138514910877228	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2840.30272181042	2840.30272181042
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCGTGTCCTCACCA"	-3.00152621689494	8.97245023334352	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCGTGTCCTCACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2667.57317794868	40.0171171523345	0.0150013193576594	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2661.29862578085	2661.29862578085
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAACCACAATTGCTG"	-4.04037938538249	9.63601014697877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAACCACAATTGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3065.3675095037	34.9509497704475	0.0114018791097927	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3051.74390011895	3051.74390011895
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAACCATCCTCATAT"	-3.79820142212566	9.74304864490358	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAACCATCCTCATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2753.35382131445	40.7072196107749	0.0147845944446549	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2747.72637367138	2747.72637367138
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACCTTCCATCCGAGC"	-2.51726112785991	9.26673600757448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCTTCCATCCGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2556.25334909529	38.9764849763151	0.0152475047084475	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.78350710918	2553.78350710918
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGTCAGGTAGAAACT"	4.58061232146565	-8.44410898601683	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	77	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGTCAGGTAGAAACT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2501.65216040813	39.2510822606944	0.0156900639033249	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2498.61602601937	2498.61602601937
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACGCTGTCCAGTACA"	-2.80902061882671	8.85108563983766	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACGCTGTCCAGTACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2462.43985785274	43.1528590244748	0.0175244316675837	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2459.81861995161	2459.81861995161
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACGTTAGTTTCGATG"	-4.75695786896403	-5.12671997463378	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACGTTAGTTTCGATG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3468.25434966249	37.8160845155479	0.0109034922768072	4230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3462.2144626793	3462.2144626793
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTATGGTCGAGCAA"	-5.27347598496135	-4.32629301464232	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTATGGTCGAGCAA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3764.37250858474	42.6684549106341	0.01133481206053	4175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3757.4109904717	3757.4109904717
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAAGTGTGGTCAAG"	-4.45407567444499	10.2482976683411	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAAGTGTGGTCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2577.17137795765	36.0978952885829	0.0140067888372987	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.89521148235	2571.89521148235
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTATGGTTGATCGT"	-2.18326125565227	8.52601907337037	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTATGGTTGATCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2307.59102046129	41.0987405556537	0.0178102359522261	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2301.82438979457	2301.82438979457
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAATGAGCGAATGC"	-4.30497727814372	9.90070340717164	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAATGAGCGAATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2702.80322601945	39.8195391558536	0.0147326815258015	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2697.03096020147	2697.03096020147
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACCAAAGTCACTAC"	-3.94908700409587	9.78699395740358	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAAAGTCACTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2941.55314979431	49.068294725099	0.0166810838446112	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2927.75804516682	2927.75804516682
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGATAATCCGTCAAA"	-4.04129157486613	9.84303948963014	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGATAATCCGTCAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2278.28176089544	40.0880691254774	0.0175957468534188	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2272.36556272697	2272.36556272697
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAATGTCCGCTGTT"	-3.4745696586674	9.91857144916383	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAATGTCCGCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.67084681205	43.4044254800388	0.017192112601469	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2510.00077992166	2510.00077992166
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTCTCCAGTAGAAT"	9.64254059371297	7.55736682498781	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCTCCAGTAGAAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2235.33416004205	45.4648814405933	0.020339187873252	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2222.25855043977	2222.25855043977
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTCTCGTATCGCTA"	-3.72620377960857	9.57434842670289	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCTCGTATCGCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2607.84770542543	43.6341242682682	0.0167318529289462	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.94345275589	2602.94345275589
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACGCGAGCGCCCAT"	10.5319897132808	7.34440133655397	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACGCGAGCGCCCAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2209.10772135104	42.6006237827657	0.019284086226774	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2202.64855251457	2202.64855251457
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTCTCTCTTTGCGC"	-3.97971902313884	10.6547908552918	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCTCTCTTTGCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2515.80558797899	36.9036249742267	0.0146687109491128	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2509.19733914798	2509.19733914798
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTGATCATGGGCAA"	-0.616564254195052	8.60532472217409	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTGATCATGGGCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2438.95874121658	35.4651678136301	0.0145411101935819	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2428.85058876173	2428.85058876173
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACTGATCGATTTCT"	10.8163210349971	6.75372455203859	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACTGATCGATTTCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2372.36949102236	45.1021194279723	0.0190114227984511	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2366.45015384023	2366.45015384023
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTCAAATCTTCGGTC"	-4.42924008789714	10.2406120070252	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTCAAATCTTCGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2898.26805512718	38.4864412882376	0.0132791172369834	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2884.08455669017	2884.08455669017
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGAAAGTAACACCT"	-0.671345750719863	8.60274598682252	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGAAAGTAACACCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2440.99276458084	40.7630784647082	0.0166993852076034	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.67472200739	2429.67472200739
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTTCCCAATGTTGC"	-2.17625174942668	8.67442128742067	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTTCCCAATGTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2403.562843784	46.5443381644408	0.019364726944757	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2396.24721040941	2396.24721040941
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTTCCCAGAGTTCT"	-2.31297812882121	8.59887597644655	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTTCCCAGAGTTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2498.92268752907	42.2728064980647	0.0169164123040013	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2492.863244043	2492.863244043
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGAATAGGGTAATT"	-3.84617624703105	10.0503539809021	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGAATAGGGTAATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.0263972527	43.026301631804	0.0169193295351894	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2526.36970291994	2526.36970291994
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GACTTCCTCTCCATAT"	-4.10382066193278	9.96849439227907	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTTCCTCTCCATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2830.93222542909	34.4057024746902	0.0121534885807714	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2822.24600358232	2822.24600358232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGAAATGTGTAAATG"	2.4537476497585	-4.77201750194701	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGAAATGTGTAAATG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2565.32193540235	39.1932400850249	0.0152780980601866	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2563.47917435626	2563.47917435626
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGAAATGTTGTTGCA"	-0.518847207457382	8.443820930365	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGAAATGTTGTTGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2310.02464970797	39.7688146451031	0.017215753368749	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.48124443062	2306.48124443062
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGACCCAGCAGTCTT"	4.40124859389607	-8.67118170177611	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACCCAGCAGTCTT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.53115286674	40.7560400615476	0.0147531512972276	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2757.79903105354	2757.79903105354
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGGGAAGAATCGTA"	-3.76872644844707	9.74750993335573	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGAAGAATCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2748.1223410592	36.0883799221544	0.0131320135872281	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2742.83329227836	2742.83329227836
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGACCCGTAAGTTAG"	-6.92985806885417	1.89650700176088	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACCCGTAAGTTAG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2867.2023048652	40.3545360343738	0.0140745338987411	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2855.81296850614	2855.81296850614
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGACCCTCACCTCTG"	-0.370283524424392	8.44285199725953	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACCCTCACCTCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2484.14487555132	36.7278867212429	0.014784921395976	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.69401727091	2480.69401727091
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGATATCTTGTGCC"	-0.349461088806945	8.72622678363649	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGATATCTTGTGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2496.17600741466	36.5952629917383	0.0146605298997489	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2488.09431889522	2488.09431889522
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGACTTAGCCACCGT"	-4.115705828101	9.9002008208069	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACTTAGCCACCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2661.79270462984	39.1717599736668	0.0147163075116753	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2657.63619808106	2657.63619808106
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCCCAGCACCTGC"	5.4882194000179	-9.97280599987181	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCAGCACCTGC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2313.31990672401	41.4972850051275	0.0179384117538216	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2306.76716356061	2306.76716356061
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGCTTTCCAGTTCC"	-0.759595732123214	9.13349244678346	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGCTTTCCAGTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2300.19307824384	43.8712335737512	0.0190728482703053	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2295.04305420506	2295.04305420506
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGTCTAGCAATTAG"	-2.11877618256267	9.59057328784791	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGTCTAGCAATTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.41727600924	41.9612234500558	0.0196042257369047	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2131.46865711906	2131.46865711906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGATGGTCGGCTGGT"	2.20071353492085	-5.48434593593749	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGATGGTCGGCTGGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2837.19150440649	43.7455141301036	0.0154185976033559	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2835.37912015732	2835.37912015732
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGTCTTCAGTAGGG"	-1.87723014774974	8.42901704395143	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGTCTTCAGTAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2676.61233596178	39.0634280883601	0.0145943540510223	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2670.1485191993	2670.1485191993
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCCTGAGCTAAACA"	-0.718326906592208	8.75446603381959	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCCTGAGCTAAACA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.9973631073	37.0062689680548	0.0176472653800668	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2092.59090875493	2092.59090875493
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTTGGGCACTGCTTC"	-3.0014844936436	9.15357492053834	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTGGGCACTGCTTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2429.90586835863	46.1134587689219	0.0189774671395279	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2423.70333471322	2423.70333471322
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTTGGGCATGACAGG"	-7.17319570007976	1.64939282024232	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTGGGCATGACAGG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2444.02087840867	52.4198397194509	0.0214481963646653	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2435.15032437012	2435.15032437012
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCCTGGTGATGTAA"	-2.63153634491618	8.61684224689332	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCCTGGTGATGTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2630.85632575577	39.9705048449558	0.0151929637713961	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2625.8010627267	2625.8010627267
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCGATCTGTGCTC"	-4.30507455292399	9.62728593433229	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCGATCTGTGCTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3307.6851977635	35.7346698051102	0.0108035280471286	3895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3302.25633564363	3302.25633564363
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCTGCAGTGACACG"	9.91544975814168	7.48034713352052	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCTGCAGTGACACG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2059.01373308966	42.9504441975211	0.0208597172069715	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2053.60538313866	2053.60538313866
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCTGCGTAGTCGTT"	-2.7782543701237	8.79113862598268	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCTGCGTAGTCGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2295.92289028351	43.967507849814	0.0191502545821061	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2291.92259479696	2291.92259479696
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCTGCGTATGAGGC"	-3.83775387230571	9.51066968524782	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCTGCGTATGAGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.78969570838	38.9992162239821	0.0153191036516983	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.75240450184	2537.75240450184
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGCTGCTCGCCGAAC"	5.57712950286214	-9.86344721233519	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCTGCTCGCCGAAC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2981.60144696702	48.4927816913976	0.0162640052850545	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2970.44605183249	2970.44605183249
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCAAAGAAGAACG"	-4.43665585938151	10.745054221991	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCAAAGAAGAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2395.02782804246	41.745542572421	0.0174300866502003	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2387.72972323307	2387.72972323307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAACCCTCCCGAACG"	-0.61040167036708	8.38730142200319	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACCCTCCCGAACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2479.18588661637	34.5920160403407	0.0139529739286925	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.20413762157	2472.20413762157
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCAACAACACAAA"	1.64044048365895	-7.61647322094115	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCAACAACACAAA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2510.70617892504	37.2311013222927	0.0148289360319467	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2508.5067254183	2508.5067254183
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCAATCGGTATGT"	-3.62186608734782	9.83561132037965	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCAATCGGTATGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2408.66847975259	40.0566340896264	0.0166301981473768	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2401.62209751485	2401.62209751485
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTAGCTTGTTG"	-1.68037853661235	9.16561124408571	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTAGCTTGTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2369.79465220822	43.1932730648473	0.0182265889682041	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.01168645525	2362.01168645525
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTAGTCGCCAC"	-2.27828464928325	8.50674913013307	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTAGTCGCCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2967.97600889949	39.9075107962422	0.0134460355058732	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2955.05283422633	2955.05283422633
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTCACATCATG"	-4.40801606598552	10.6656894453797	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTCACATCATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2801.0561223644	34.4483919227758	0.012298358339817	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2794.61229267694	2794.61229267694
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCAACAGTCCCGTGA"	-0.474599997431594	8.28078935230104	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAACAGTCCCGTGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2141.302301833	35.9053337030328	0.0167679891215252	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2132.72633395354	2132.72633395354
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCATTCTGCACCT"	-3.95957026901897	10.3599424132141	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCATTCTGCACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2313.47144182552	41.5821368739914	0.017973914059289	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.63736515045	2306.63736515045
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTGTTAGGAGC"	-2.09722505036052	8.97928903186647	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTGTTAGGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.31991271413	46.643174247482	0.0191921952346561	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2427.72452462691	2427.72452462691
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTTCATTGCCC"	2.21434487876241	-8.77432253276976	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.347826086956522	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTTCATTGCCC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2052.80753982894	45.4561275190184	0.0221433946617355	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2035.53821995371	2035.53821995371
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGGATCACAGACGA"	-3.48176942291911	9.4132976301941	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGATCACAGACGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2529.80379819285	38.2403775579989	0.0151159459817855	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2525.22008412931	2525.22008412931
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCACAACATGGGCAA"	14.3519426780636	1.97212908351747	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAACATGGGCAA"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1306.97948175228	31.6281657839963	0.0241994355883782	3533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1293.63280551598	1293.63280551598
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCTATCTGAGGCC"	0.688549120991868	-7.17549230968627	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCTATCTGAGGCC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.30502491521	41.5887281099185	0.0147409541834876	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2817.49989439992	2817.49989439992
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTACCTGGTTTGCCGG"	-0.472246388823348	8.46100995624391	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACCTGGTTTGCCGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2482.05571867689	35.1398381790694	0.0141575541252561	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.79001998993	2461.79001998993
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTGTTGTGATTGGG"	-1.48215506497081	8.56247613513795	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTGTTGTGATTGGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2383.20483198622	39.3138022271415	0.0164961910531108	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2375.9970944353	2375.9970944353
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATACTCACTTCTCG"	-0.900805453688461	8.70936009967653	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATACTCACTTCTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2581.7862926282	40.918388543268	0.015848867375314	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2572.0370520968	2572.0370520968
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGGTAGTATCGTTG"	-4.29183803024943	10.0273504027161	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTAGTATCGTTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2206.19057915844	36.7609475857403	0.0166626346486181	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2204.71608091764	2204.71608091764
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGGTAGTCTAGATC"	2.08652152594869	-7.82571461116942	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTAGTCTAGATC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2363.87052959621	45.1727510934015	0.019109655341876	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2356.38162163209	2356.38162163209
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGGGTATCGAGAGCA"	-4.12755427780803	10.0289973982605	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTATCGAGAGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2279.84408480704	45.7090557291742	0.0200492025019521	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2274.98039797211	2274.98039797211
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTCATCAGTAGTTC"	-3.19966683808025	9.46358106220094	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTCATCAGTAGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.11855877897	38.1574688935826	0.0147661448287468	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2575.73610119882	2575.73610119882
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAGACAAGAAGCGCT"	5.46615185317342	-10.0141182175842	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGACAAGAAGCGCT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2869.14077539594	28.3845808674939	0.0098930596612419	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2865.19772483901	2865.19772483901
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTCATTCTGGTGGC"	-3.84249124947246	10.2934169539246	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTCATTCTGGTGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2337.05620120935	32.044960514029	0.0137116773218576	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2332.38975534072	2332.38975534072
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAGGACACTTTATC"	-4.38076482239421	10.842710471991	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGGACACTTTATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2454.10350323366	39.9108480979118	0.0162629033556747	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2449.81465578736	2449.81465578736
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTCTAGTGTTCCAA"	-2.30433426323588	8.94382283771364	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTCTAGTGTTCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.44461371062	45.4028270278637	0.017732399593704	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.17787341267	2553.17787341267
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTGAGAGTTCATGC"	0.418785472481889	-6.39389612590941	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGAGAGTTCATGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2404.32063575771	48.4292415734533	0.0201425886602645	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2398.82088113588	2398.82088113588
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAGGTAAGAGTCTTC"	3.11836304244344	-7.82264330303343	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTAAGAGTCTTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2397.46783909543	47.0577459076661	0.0196281030928954	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2393.85406167879	2393.85406167879
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAGGTACACATTCTT"	-2.98874459686931	8.71808240497438	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTACACATTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2878.05773913723	41.3516090691399	0.0143678872410447	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2868.7965994776	2868.7965994776
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTGAGTCTTACCGC"	-3.98354564133342	10.3605003126892	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGAGTCTTACCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2454.36574204844	40.2897688013462	0.0164155521367895	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2451.78371056712	2451.78371056712
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTGTTAGCAGCGAT"	-3.75331364098247	9.84813401782838	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGTTAGCAGCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2153.33351215031	44.177671251828	0.0205159446980938	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2153.33351215031	2153.33351215031
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTGTTCATTGACCA"	-3.8370979827946	10.3302535780701	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGTTCATTGACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2308.39464221032	46.4864861969043	0.020138015115298	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2299.95880152553	2299.95880152553
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTACCATCACCCTTG"	-2.61497435990031	9.24614331806032	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACCATCACCCTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2404.51503438637	44.9152592011701	0.0186795501624437	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2401.66841192816	2401.66841192816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTTACCAAAGCTCT"	-4.22207293930705	12.0487403639588	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTACCAAAGCTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2838.8004744825	40.3883325560767	0.0142272529961583	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2820.20021913036	2820.20021913036
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTTGTTCGCAGATT"	-2.49626241150554	8.74304483020631	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTGTTCGCAGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.96684816507	44.4827880551354	0.01787198896921	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2479.7086635312	2479.7086635312
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTTTGAGCATGGGT"	0.399432529776734	-6.36374952709349	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTTGAGCATGGGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2884.86738089447	46.477604446978	0.0161108287870645	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2877.43823559522	2877.43823559522
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAGTTTGAGGAACTCG"	4.71380056914632	-9.17632009899291	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTTGAGGAACTCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.48410222753	52.9192935603042	0.0223054365298457	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2369.91859655958	2369.91859655958
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGAAGTGGCATCC"	0.696737309067887	-7.16098072445067	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAAGTGGCATCC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2825.37207534179	46.1887037210551	0.016347830476617	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2816.59373248185	2816.59373248185
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATAGAAAGAGGGTCT"	-3.93463979187663	9.8209829100403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGAAAGAGGGTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.43737094026	40.0872721066846	0.0154750979724069	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2583.89654473518	2583.89654473518
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATAGAAAGTACTCGT"	0.86693032559697	-7.11570837413939	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGAAAGTACTCGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.01216373607	39.6146859344253	0.0153842713802752	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2573.55883489292	2573.55883489292
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGAATCGAGGCAA"	8.95280041274373	7.9397983320984	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAATCGAGGCAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2362.96406048118	44.9620487050868	0.0190278174167114	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2349.89721553481	2349.89721553481
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAGTCGTACATTGC"	-0.657479504973251	8.72330091083375	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGTCGTACATTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2351.04915209028	43.5389749708006	0.0185189556467124	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2343.26038337082	2343.26038337082
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGTCCAGGGCTTC"	-3.0768178505009	9.61048314655153	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGTCCAGGGCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2393.76190629894	50.3861860957669	0.0210489547699714	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2390.26974520488	2390.26974520488
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGTCGTAACATAG"	0.203620125621003	-6.52541353618773	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGTCGTAACATAG"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3360.67414786232	35.1428268808163	0.0104570765669651	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3354.11215528582	3354.11215528582
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAATTAGAAGTGTT"	-4.38370356980022	9.32672116840211	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAATTAGAAGTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2954.04314737451	42.3964055131463	0.0143519926412813	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2950.36832146116	2950.36832146116
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCACAAGCAGTAAT"	-3.74765763703044	10.8619642027649	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACAAGCAGTAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2314.87652920104	46.6938919437926	0.0201712235424965	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2311.98073955996	2311.98073955996
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCAGTAGATACGAT"	-2.70000706139262	8.79529378497926	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCAGTAGATACGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2506.06950002399	36.7025947687925	0.0146454816071307	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2500.68340824846	2500.68340824846
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGATCAGTCTCGACG"	-2.53926763954814	8.63513753497926	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATCAGTCTCGACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2350.25462879564	40.8365773142601	0.0173753842728038	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2339.32477992103	2339.32477992103
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCAGTGTCGCTCGA"	-1.21528265896495	8.63714406574098	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCAGTGTCGCTCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2367.59639277618	40.0945242606729	0.0169346956191546	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.14405323067	2353.14405323067
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGATGTAGACCGTTT"	-1.16209803047832	8.81945321643678	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATGTAGACCGTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2563.34407027928	34.5745545750343	0.0134880662240818	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.12331678127	2553.12331678127
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCAGTTCTCGTCGT"	-2.1800094646519	9.27801034534303	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCAGTTCTCGTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2161.37861560324	45.2311444672558	0.0209269880532392	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2158.19151955433	2158.19151955433
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCACTGTCCCTAGGG"	-2.08170614662822	9.48935506427614	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCACTGTCCCTAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.44198188917	43.3154606535195	0.018327279021631	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.64317129035	2357.64317129035
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAGAAAGGCTGGAT"	-2.61987052384074	8.64846036517946	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAAAGGCTGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2538.75578276029	37.4075790076833	0.0147346110491224	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2534.60662868007	2534.60662868007
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCATGGTGTTACTG"	-2.5968955558842	9.12249181354371	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCATGGTGTTACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2277.92202225251	43.6950879283132	0.0191819945992294	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2275.29722794134	2275.29722794134
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATACAGCAACAAGTA"	-0.495801190764266	8.85020349109498	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACAGCAACAAGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2415.94891411796	36.4034945320913	0.0150679901877734	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.79791891264	2397.79791891264
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAGAAGTACGTGAG"	-3.92207465592082	9.66945931995241	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAAGTACGTGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.55620562552	44.4963412991433	0.0167812174619343	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2647.20643319981	2647.20643319981
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCCCTTCGAGCCAC"	-0.561287323862869	8.96274278247682	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCCCTTCGAGCCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2645.74126532335	36.803832779843	0.0139105940789509	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2634.1697952882	2634.1697952882
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCGTACAGACCAGA"	-2.07779012146648	8.58707711780397	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCGTACAGACCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2490.6940537061	43.8358859496208	0.0175998677494708	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2481.89563613619	2481.89563613619
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGGTCGAGCAACAGC"	-2.04860554161723	8.92493627155153	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGTCGAGCAACAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2289.29370368022	42.2486985336117	0.018454905312365	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2288.05807689921	2288.05807689921
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATCGTATCGTTCCTG"	-0.57018361511882	8.59300134265748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCGTATCGTTCCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2522.91184260517	39.0290135212983	0.015469828498247	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.78978734701	2515.78978734701
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGATCAGGTGAGCT"	-2.58578215065654	9.027392364386	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGATCAGGTGAGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2166.02497829931	45.126601594371	0.0208338325026164	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2164.5688201083	2164.5688201083
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGATCGTACGATCT"	1.01046880063359	-5.99995949184569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGATCGTACGATCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2577.64923562511	47.875354964722	0.0185732621425163	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2572.53398928109	2572.53398928109
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGCTACAAATGGTA"	3.03391542014424	-7.87665274059447	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGCTACAAATGGTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2963.9502817588	40.0634690872927	0.0135169167087105	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2954.79768825972	2954.79768825972
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGAGTGGTTCT"	-2.88335571709331	8.84139344776002	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGAGTGGTTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.7541883773	41.8446358717261	0.0184927890473752	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2258.57542733146	2258.57542733146
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGTAGTGTTGGGTTT"	-2.32848797264751	8.66097257221071	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTAGTGTTGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2751.71346766994	42.3953207732468	0.0154068805750861	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2748.32224657397	2748.32224657397
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGGAGGTTATTCCT"	-3.92092428627666	9.93874738300172	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGGAGGTTATTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2610.06160265267	43.6832728574096	0.0167364911284137	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2607.49065950257	2607.49065950257
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGTTGAGAACCCGA"	-4.15450034561809	12.1122226485047	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGTTGAGAACCCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2584.86154305823	46.2282668818497	0.0178842332990709	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2580.92144202715	2580.92144202715
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGTTGGTTCCAAAC"	-2.499339680106	8.70213124835817	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGTTGGTTCCAAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2463.30234288802	36.2491489321604	0.0147156718446755	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2453.53862752291	2453.53862752291
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATGTTGTCTCCTGCA"	-0.709204534918624	8.57212636554567	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGTTGTCTCCTGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2555.79521175813	42.231793317079	0.0165239347514185	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2544.03223375457	2544.03223375457
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTCGAAGTATGAGT"	-2.58481655541118	8.8477105864319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCGAAGTATGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2396.29505631262	47.8982164598725	0.0199884468874954	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2388.05111044658	2388.05111044658
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCAACAGGGACTGT"	1.50308312949483	-5.62108805095824	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCAACAGGGACTGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2910.54490184818	37.296341321356	0.0128142126574557	2831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2907.99655524231	2907.99655524231
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTCGAGTTCTATCT"	0.829056878655595	-9.42948439037474	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	17	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.5	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCGAGTTCTATCT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1626.82103704441	34.344891614532	0.0211116593850603	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1612.99913044902	1612.99913044902
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTCGAGTTTCACAG"	3.82749118384663	-8.17693712627562	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCGAGTTTCACAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2854.38608841481	39.4970172316557	0.0138373072206187	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2848.44967373865	2848.44967373865
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTCTTAGTATGCAA"	-2.7001932663029	8.98828599536744	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCTTAGTATGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2450.51864592483	42.1814168976677	0.017213260942868	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2447.78363895757	2447.78363895757
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACCTTCATCTCAAG"	-2.77908144417461	8.69819924915162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCTTCATCTCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2550.02349910607	45.40482771545	0.0178056507053237	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.04521074855	2536.04521074855
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTCTTGTCACCGAC"	-3.93270883980449	9.75841138446657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCTTGTCACCGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2794.88959341649	43.8156526997456	0.0156770603042623	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2788.55390902633	2788.55390902633
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACCTTTCACTCGAA"	-3.9349733394688	9.6493520506653	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCTTTCACTCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2683.29184239221	42.99985891293	0.016025039928044	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2675.63545628389	2675.63545628389
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTGGTAGAACTTCC"	-0.116687874228317	9.0415582426819	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTGGTAGAACTTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2972.530121044	42.2945589359431	0.0142284711049753	2651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2965.26105148089	2965.26105148089
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACTTCCACGGCTAC"	-3.86806378784831	10.0023269423279	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACTTCCACGGCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2693.97636196016	38.2452877844359	0.0141965936763485	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2689.35069878704	2689.35069878704
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTTCTAGCAGAAAG"	-7.45943723145183	1.20119521701661	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTTCTAGCAGAAAG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2989.46857477731	40.5731303775983	0.0135720210340798	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2974.27502531579	2974.27502531579
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTTCTAGCATTTGC"	-6.63684688034709	2.44998428905336	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.238095238095238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTTCTAGCATTTGC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2184.37436397649	46.3632782299693	0.0212249690321253	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2177.19656577186	2177.19656577186
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTTCTTCATTACCT"	-3.19936881485637	-7.38710930263671	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.444444444444444	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTTCTTCATTACCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3342.74884694056	35.6990776438336	0.0106795572382015	3226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3335.17637880506	3335.17637880506
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GATTTCTTCGATTCCC"	-2.51716695252116	9.01432035053102	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTTCTTCGATTCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.40860685919	42.130621740973	0.0172143799866096	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2441.33164516129	2441.33164516129
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAACATAGAGTGTTA"	-4.45664678040202	10.7458486326965	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACATAGAGTGTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2637.73079917389	41.7780698812501	0.0158386405065803	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2630.00925408774	2630.00925408774
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAACATAGCAAATCA"	-2.62215505066569	8.8539132841858	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACATAGCAAATCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2610.86459205677	35.7561027831848	0.0136951195753193	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2604.30321001157	2604.30321001157
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCCTCGTCCCAAAT"	-4.06300149384196	9.63331697070924	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCTCGTCCCAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2939.02800547278	39.2045619410604	0.0133392951234413	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2922.97278612972	2922.97278612972
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCCTCGTCTGTTAG"	4.29107536849324	-7.84453489696654	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCTCGTCTGTTAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2843.87984453419	36.7230240392148	0.012913001268248	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2840.76782315532	2840.76782315532
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCGATAGTATAGAC"	-2.82426438751872	8.93989942157594	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCGATAGTATAGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2625.36215813422	44.0100147995261	0.0167634071601013	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2612.51134948404	2612.51134948404
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCGATCAATAACGA"	-7.44780192795451	1.74689350211946	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCGATCAATAACGA"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2907.05580035252	36.7527628176629	0.0126426065895282	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2899.81866803866	2899.81866803866
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGGCTGTAGCACGA"	-2.0052379173344	8.80161092365114	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGGCTGTAGCACGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.74657926059	41.7126827581195	0.0181774681069838	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2289.30556849756	2289.30556849756
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACATACAAAGAACT"	0.274665211408776	-6.39525034343871	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACATACAAAGAACT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2966.63141624421	37.0242108851538	0.0124802193769076	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2960.00950350633	2960.00950350633
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACATAGTCTTGCGG"	-3.7909337085789	9.53202436054078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACATAGTCTTGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2722.2256453051	42.2998476817797	0.0155387000172937	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2718.7566710096	2718.7566710096
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACATATCATCGGGC"	-0.729015092284042	8.57738587940065	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACATATCATCGGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2254.49508822214	47.9242773826259	0.0212572108198374	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2250.56816648805	2250.56816648805
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACATATCCTGGCTT"	10.6751152473385	7.58936116779176	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACATATCCTGGCTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2778.29855382604	45.1110445855855	0.0162369319609163	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2763.76058360363	2763.76058360363
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTCTCGCAATTCTTC"	5.31084789809529	-9.52278139507445	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCTCGCAATTCTTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.66277022976	47.2932463810394	0.018276433438365	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2577.54024721364	2577.54024721364
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCTTTAGTATAGGT"	-4.13431010666545	10.5452203520569	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCTTTAGTATAGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2872.16388171156	38.8492505038603	0.0135261259816099	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2861.12224880299	2861.12224880299
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACGGTAGTTCTCTT"	-4.15748677673991	10.3481940993103	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTAGTTCTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.62779876536	36.5930264214105	0.0146981916090259	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.65549426765	2485.65549426765
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACGGTGTCACAGTT"	0.0898252921992957	8.1996392973694	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTGTCACAGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2038.54756210114	36.1171691478212	0.0177171088961962	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2030.40391697935	2030.40391697935
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGATGCAAGACGGT"	-4.34214387360271	9.90656087482301	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGATGCAAGACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2864.0798182953	35.6644062480784	0.0124523087730516	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2858.25639068499	2858.25639068499
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACGGTTCTGCTTAT"	-6.55676970902141	1.88315615737764	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTTCTGCTTAT"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1802.22142577206	29.350171652075	0.016285552503351	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1792.77473316273	1792.77473316273
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACGTGAGGAAAGGT"	-4.23154435578044	10.758614517096	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGTGAGGAAAGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2387.34280556425	40.7199313720029	0.0170565916537398	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2381.04577569037	2381.04577569037
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGCAATCGGAATGG"	4.60922827300374	-8.72692968761595	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGCAATCGGAATGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.92820644161	44.7851791937851	0.0158367454632586	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2825.11017433345	2825.11017433345
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACTAACACGAGGAT"	0.350432624190491	-6.31467344677123	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACTAACACGAGGAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3060.67408028289	43.8360936672131	0.014322365765636	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3049.6307724906	3049.6307724906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACTAACACGCGGTT"	0.565566022961777	-7.23987629329833	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACTAACACGCGGTT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2207.63154454591	42.5613424041252	0.0192791874664392	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2206.15573432619	2206.15573432619
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCTGGTCATAAGATG"	-3.25761304321941	9.18060777271119	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTGGTCATAAGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2843.07121578627	37.3277018735303	0.013129358725264	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2838.68317878686	2838.68317878686
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGATGCACAAAGTA"	-4.06605039063151	10.5909423598084	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGCACAAAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2136.51354790267	37.8465318007681	0.0177141548378762	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2136.51354790267	2136.51354790267
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCACTAATCTTCCGTG"	-0.675682465464431	9.03525445545045	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACTAATCTTCCGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2506.7622374325	37.6900805654022	0.0150353631479647	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2496.66012311012	2496.66012311012
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCATTCCAGAGCCCT"	-4.296707491309	10.1108503111633	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCATTCCAGAGCCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2562.49286424789	39.7169037089254	0.015499322656878	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2549.30548508056	2549.30548508056
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGCCATCCACTGAA"	-3.45301280441936	9.41485688770143	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGCCATCCACTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2376.51249934515	41.7989390847298	0.0175883523003761	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2373.95376353123	2373.95376353123
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGAATGCAACACGAG"	-4.31950364533122	11.3557271727356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAATGCAACACGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3033.16192548511	43.6028948117142	0.0143753930330444	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3026.33107520824	3026.33107520824
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGCTGGTTGGGTTT"	-2.08093438568767	8.58719346607057	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGCTGGTTGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2357.06869729713	39.0827744591248	0.0165810926528961	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2351.18802425953	2351.18802425953
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGAGGCAGACAGTCG"	-3.17396722260173	9.0790338286194	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAGGCAGACAGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2147.08847375915	40.2326421412583	0.0187382320910226	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2142.73831734287	2142.73831734287
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGAGGCCAACCGACC"	-2.58170090141948	9.46945474231569	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAGGCCAACCGACC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2753.55323395029	40.973976260182	0.0148804009869822	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2749.45145654203	2749.45145654203
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGAGGCCACTGCACG"	-2.38163958016093	8.5781793364319	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAGGCCACTGCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.53465744052	39.9223286784749	0.015908259549279	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2504.36968916077	2504.36968916077
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGTTAAGTGCCCGT"	1.13480665263478	-5.88712170040282	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTAAGTGCCCGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2681.96856903682	41.3237071666958	0.0154079759337137	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2679.78858026751	2679.78858026751
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGTGAGTAGTAAGT"	-0.756497721106368	8.78962037647096	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTGAGTAGTAAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2496.280095221	37.1699881348711	0.0148901512318394	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2489.34343207906	2489.34343207906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGTTACAATAGTGA"	-2.88965592804607	8.8366489180359	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTACAATAGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.46625207524	41.6254695570726	0.0158063425055364	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2621.99182758892	2621.99182758892
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGTTACAGGATGAC"	-2.93180380287822	8.8343238600525	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTACAGGATGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2787.93193670004	39.2900542433151	0.0140929029601136	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2775.34929316722	2775.34929316722
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGTTAGTCCGGACT"	-4.26977763596232	11.8378467329773	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTAGTCCGGACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2745.76835934333	40.3672602647979	0.0147016262779181	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2739.69220259607	2739.69220259607
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCAGTTATCTACAGGT"	-4.24837432327922	12.2404117354187	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTATCTACAGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2749.21887146895	34.8237329720434	0.0126667735819217	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2741.90424387159	2741.90424387159
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCATCGTGCCTAAT"	0.421744664281052	-7.07431986248168	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCATCGTGCCTAAT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2981.97898793404	41.8275132632694	0.0140267632443139	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2979.39231122529	2979.39231122529
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATCGGCACCAATTG"	-2.83356461945232	8.76973626697389	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATCGGCACCAATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2641.74887181481	34.036435791098	0.0128840542544515	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2635.78755051661	2635.78755051661
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATCGGTCAAGATAG"	-4.08454404297526	10.1934947737488	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATCGGTCAAGATAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.1656061703	37.8478145565605	0.0163902556210901	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.47479544725	2306.47479544725
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCATAGGTACAGC"	10.4621292549068	7.43885610187379	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCATAGGTACAGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2260.90644825102	42.6939754264102	0.0188835656864251	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2250.1748581166	2250.1748581166
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATCTCTCAGAGCGA"	-6.45247636261638	2.04565796935884	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.238095238095238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATCTCTCAGAGCGA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1954.90513001661	51.5071853736107	0.0263476649494356	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1952.90299292472	1952.90299292472
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATGATCACGGTGTC"	-2.43425593796428	9.3570461043152	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATCACGGTGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2496.91877863895	41.7267415885133	0.0167112931127292	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2490.69545933851	2490.69545933851
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATGATGTTCCGCGA"	1.55843665179555	-5.63324024593505	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATGTTCCGCGA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2305.66807167122	41.5245008313957	0.0180097479518365	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2300.00440601678	2300.00440601678
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATGATGTTCCTAGA"	-0.651691297919113	8.36241052234498	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATGTTCCTAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2669.93218942597	39.4761947568036	0.0147854671789589	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2663.03645380403	2663.03645380403
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCTAGTTCCACAA"	-1.21735070172008	8.50883100116578	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCTAGTTCCACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2538.32261834409	37.7432717307311	0.0148693753339178	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2524.59886800567	2524.59886800567
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATGATTCATTATCC"	0.206790645688218	-6.37673284923705	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATTCATTATCC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2884.33709925401	38.7030574538612	0.0134183544162959	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2880.63532116916	2880.63532116916
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCGAGCATGACGGA"	-2.42284880104716	8.65631864154664	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCGAGCATGACGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2243.23723509385	46.8814616217038	0.0208990207938228	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2239.06716587104	2239.06716587104
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATGATTCTGTCGCT"	-1.70281157913859	8.63446614826051	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATTCTGTCGCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2219.37370307571	51.1271584919041	0.0230367506026812	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2213.69974439492	2213.69974439492
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATTAGAGGGCAGTT"	0.946382303803605	-6.15649034893187	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATTAGAGGGCAGTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3039.136522997	40.2736981542874	0.0132516910147137	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3033.57891918999	3033.57891918999
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATTAGGTACTAAGA"	-2.76059685173686	9.2641505965027	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATTAGGTACTAAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.52206920676	44.8506379795305	0.0173535519444398	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.10291397103	2579.10291397103
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCATTAGGTGCCCTTT"	-0.24472356858905	9.05241963947145	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATTAGGTGCCCTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2396.25266549214	36.0263076468965	0.0150344361284195	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2387.77339623288	2387.77339623288
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCTCACAATTGCAC"	-4.1499813598698	9.88289353931276	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCTCACAATTGCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.52476034439	43.5459181307709	0.0169801121845761	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2557.8654047496	2557.8654047496
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAACGCAAATGGTA"	2.25827326354329	-4.98964121257933	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAACGCAAATGGTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2852.33072245075	43.1062991971191	0.0151126581703267	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2848.16203169745	2848.16203169745
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAACGGTATGGAAT"	-2.72186026993449	8.91064260089723	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAACGGTATGGAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.19635724779	44.9354972881247	0.0193671096619715	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2312.87282024756	2312.87282024756
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGCAAGCACTCCG"	0.956385453313035	-6.07576563274535	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGCAAGCACTCCG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2201.60182568204	38.6598956969007	0.0175598944577202	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2201.60182568204	2201.60182568204
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGGACGAGCAGGCAT"	-4.22538981857951	10.6344537504944	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGAGCAGGCAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2424.44169855309	42.1840155919981	0.0173994761833925	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2416.43657769816	2416.43657769816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGCATCGACATAC"	0.776565332978409	-7.78053333675536	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGCATCGACATAC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.77097878961	28.5823679815459	0.0131608573190695	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2171.77097878961	2171.77097878961
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGCATCTATACTC"	-3.36627564850505	9.56098554218141	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGCATCTATACTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2761.38397088623	40.6438391731101	0.0147186481857016	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2758.86963224333	2758.86963224333
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGGTAGCACACAG"	9.90515865859334	7.59162614429323	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated NFkB"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGGTAGCACACAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2231.71644151184	47.608354622576	0.02133261813061	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2226.40266780088	2226.40266780088
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGGTAGTATGGAT"	-4.35180030289348	10.5640325316223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGGTAGTATGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.93075359051	36.2885480775766	0.0149033183075396	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2426.25909776011	2426.25909776011
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGGTCAACCCTCT"	3.92033853110616	-7.89938309108885	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGGTCAACCCTCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.23440706655	37.2854843499381	0.0143724423083644	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2591.38211305679	2591.38211305679
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGGTCAGTGTGGA"	1.32250549372975	-7.32536127483519	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGGTCAGTGTGGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2158.8206923522	40.8154841559252	0.0189063799047867	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2154.38462898566	2154.38462898566
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAACCTTCGTTGCCT"	-1.42357132855113	8.43827054584352	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACCTTCGTTGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2562.9119279886	41.5389235311327	0.0162077061944664	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.34673960756	2556.34673960756
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGAGTGTTCAC"	-0.538139979273635	8.10953233325807	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGAGTGTTCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2185.70073957236	40.6428231437746	0.0185948709299181	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2176.63833206681	2176.63833206681
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAAGCGCATAGTCAC"	-2.64109335365947	9.03840825641481	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAGCGCATAGTCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1913.87434459032	48.4488292508108	0.0253145298633394	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1905.41243118976	1905.41243118976
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAAGTACATTGTAGC"	-4.21688447418864	9.71344564044801	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAGTACATTGTAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2876.4059481707	38.803093982337	0.0134901313241319	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2869.85303509709	2869.85303509709
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTACCGTATCCTCC"	-4.38006291809733	10.0085582503113	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTACCGTATCCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2916.61553653142	36.9849470374548	0.0126807755681913	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2910.90230356407	2910.90230356407
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGGTATCGGTT"	-2.86933622780498	8.89652917468873	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGGTATCGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2504.57984427176	42.4939059232878	0.0169664808332926	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2494.44378192829	2494.44378192829
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAAAGTCTGTCCT"	2.07578672942464	-5.15244533931883	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAAAGTCTGTCCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2730.56379766485	43.4896493608064	0.0159269852614315	2410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2724.17827753726	2724.17827753726
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGTCGTCAGAT"	-3.65167007866557	12.7809142836365	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGTCGTCAGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2463.6362754176	42.3749884129749	0.0172001804145347	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2458.12489334189	2458.12489334189
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCATGGAGTCTGGTT"	-0.921261827380019	8.60414693439332	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCATGGAGTCTGGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2272.19666710916	39.7367199483073	0.0174882396948778	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2264.17229312163	2264.17229312163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAAATCGCCGATG"	-2.28623829308208	8.61064241016237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAAATCGCCGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.42674875211	44.3743277107424	0.0173308327341798	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2551.58744562988	2551.58744562988
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACACTCAAATGATG"	-4.14915690842326	11.9536704787048	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACACTCAAATGATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2718.00448844747	41.4455399944358	0.0152485178632319	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2712.79591048363	2712.79591048363
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTCGTCACATCCCT"	-4.32437453690227	10.7038173445496	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTCGTCACATCCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2710.08037113858	42.8285255973322	0.0158034152984691	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2702.05112286121	2702.05112286121
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCCAGACAAGGTCAG"	3.6635557609493	-7.50266029750975	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCAGACAAGGTCAG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.32537447628	33.8187236226846	0.0120038402128016	2484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2808.10632206897	2808.10632206897
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTGAAAGGCCTTGC"	-3.76461945000346	10.3607082136902	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGAAAGGCCTTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2413.32715516794	44.156078398129	0.0182967644082454	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2403.92447511119	2403.92447511119
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCCGAAAGGATTCCT"	1.24969365176503	-7.16760923778685	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCGAAAGGATTCCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.25155753886	44.5461391501197	0.0169232074428973	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2627.66046944298	2627.66046944298
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAGGTCGCGATCG"	0.840752263634843	-7.2888393632141	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAGGTCGCGATCG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.55260882458	32.2931348179678	0.0115186477030324	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2802.53063547652	2802.53063547652
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCCGAACAGGGACTA"	-1.79727313938792	9.45941541278688	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCGAACAGGGACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1900.08423027806	44.8983920935155	0.0236296851360874	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1896.61796142859	1896.61796142859
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTGAACATAACGGG"	-2.89354954186137	8.88112065875856	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGAACATAACGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2540.99066726464	36.4294162990299	0.0143366981895474	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2534.65252435409	2534.65252435409
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCCGAATCCACGGGT"	-0.0937867564266503	8.41773221576539	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCGAATCCACGGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2262.74899741433	38.5835353791053	0.0170516196993989	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2257.86772884934	2257.86772884934
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCGATGAGAAACACT"	-2.22467980805095	8.66323182666627	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCGATGAGAAACACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2333.93838730137	45.5270523591531	0.0195065356510092	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2324.6313759298	2324.6313759298
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCGATGAGGTTAAAC"	10.6805359321529	7.40983340823976	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCGATGAGGTTAAAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2396.64009299757	45.8781583580344	0.01914269835178	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2391.78165697257	2391.78165697257
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTAGGAGTCGAACGA"	1.05268599566762	-6.03926088726195	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTAGGAGTCGAACGA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2553.6489197607	39.5771813196404	0.0154982860068913	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2550.43323465041	2550.43323465041
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTAGGATCGACGAGA"	-4.37233672562297	9.96844289386598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTAGGATCGACGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2612.59486549265	35.621841182022	0.0136346594156323	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2609.23890537053	2609.23890537053
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCCTGTTTCGGCATTA"	-4.04186950150188	9.96694467151491	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCTGTTTCGGCATTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.29653113954	42.1029106298535	0.0162792278932156	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.08991220588	2579.08991220588
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGAGAAAGACGCCAA"	-4.05858931961711	9.79212949359743	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAAAGACGCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2780.42772876951	41.4101206908039	0.0148934353741071	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2775.77057555662	2775.77057555662
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCAATCACGCTTAA"	-1.59983740273173	8.48913571918336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATCACGCTTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2572.92744731317	38.5068076851193	0.0149661459460626	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.29928692979	2562.29928692979
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGAATAGGACTAAT"	-1.81241426888164	11.226496673468	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGAATAGGACTAAT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2491.69517405955	43.670426195548	0.0175263919319629	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.96876498915	2476.96876498915
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGAGAAGTACCAGAG"	-4.33777652207072	10.6455936201843	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAAGTACCAGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2440.56049893624	45.7664392974828	0.0187524297461304	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2435.10593964317	2435.10593964317
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGAGAATCACTTTGT"	-3.35338793221172	9.41408059680787	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAATCACTTTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.75109584592	36.7112791175927	0.0141047982560396	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2594.86443683959	2594.86443683959
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGAGAATCGTGAGAG"	0.419062783091706	-7.23349573528441	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAATCGTGAGAG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2783.11072470036	44.9989551691202	0.0161685824317913	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2776.09294746031	2776.09294746031
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGATCGAGTGGAAGA"	-0.0515946996515572	9.32915113056032	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGATCGAGTGGAAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2097.31112109754	38.9874089460658	0.0185892348321042	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2088.28404305479	2088.28404305479
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCTAAAGGGCGAAG"	-4.00327525559123	10.6732778319153	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCTAAAGGGCGAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2590.45283974691	38.6287231046339	0.0149119576747083	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2583.30916922417	2583.30916922417
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGGAAAAGACCGTTT"	-2.31126008454021	8.73132703388063	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGGAAAAGACCGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2467.54727857671	49.4152377492505	0.0200260550945769	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2460.65182926126	2460.65182926126
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGGAAAGTTATCTGG"	-2.25640712204631	8.75512502277223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGGAAAGTTATCTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2299.79283544271	43.3201933925143	0.0188365633307902	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2295.54621661373	2295.54621661373
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGGAAATCGCCTATC"	-3.99515757980998	9.77544400775758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGGAAATCGCCTATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2578.69618211175	40.1506889093005	0.0155701509886365	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2577.35196070636	2577.35196070636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGGATCGTTGCGGCT"	-4.27236018601115	10.2470311888489	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGGATCGTTGCGGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2365.90637988805	41.7235060143002	0.0176353157373346	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2363.00800630102	2363.00800630102
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGGATCTCATCGGGC"	-2.61675701561626	8.70022771442262	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGGATCTCATCGGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.16456593894	43.768398585979	0.0189788704728273	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2296.38532282131	2296.38532282131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGTGCACATAACTCG"	-4.01671538773234	9.84379575336305	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTGCACATAACTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2575.5870706913	40.881278429625	0.0158726058593905	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2569.3877755239	2569.3877755239
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTGAGAGTGGACAGT"	0.951775689690751	-6.07603266155394	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTGAGAGTGGACAGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3272.8047316558	39.9706231121529	0.0122129568945993	2753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3259.90505974474	3259.90505974474
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGTGCATCACCTCAC"	-0.165779943496543	9.4225396879944	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTGCATCACCTCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2157.24596562283	41.3440651157814	0.019165206830666	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2147.77937206136	2147.77937206136
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGTGCATCGCAGTGC"	-3.1585935157841	9.50366304004518	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTGCATCGCAGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2192.23828674423	41.9542027998886	0.0191376106573689	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2187.89560764111	2187.89560764111
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGTTTCAGAGGTCGT"	-2.41777525368388	8.7076091536316	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTTTCAGAGGTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2187.65826891527	43.6119512012218	0.0199354496179362	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2184.53073787568	2184.53073787568
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCGTTTCGTCTTTCAT"	5.26580633696858	-9.30266096508177	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTTTCGTCTTTCAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2125.78846967734	34.2226910523092	0.0160988224089406	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2124.17389349226	2124.17389349226
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATGCTGTGCACGCT"	-3.0591221851414	9.71191213214723	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATGCTGTGCACGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2757.91887483795	33.4111236060122	0.0121146143604298	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2747.60920215113	2747.60920215113
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGTTGCAATCAGCT"	-4.12332711640056	9.92116448963014	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGTTGCAATCAGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2758.97967988721	43.6592365830135	0.0158244139677021	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2753.48191030965	2753.48191030965
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGTTGGTGATACTC"	-0.359406779438812	8.99363896930543	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGTTGGTGATACTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2226.2723063834	38.866184784108	0.0174579653498213	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2219.90919733061	2219.90919733061
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTACCTCAAGTAGTA"	-4.39139924469646	9.17314145648805	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACCTCAAGTAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2829.00749953155	46.0192068617546	0.0162669087548813	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2821.06163469861	2821.06163469861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTACCTCACAAGTTC"	-4.33788428726848	10.5621127852234	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACCTCACAAGTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2648.52668958911	44.5234948095402	0.0168106649574475	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2640.04865339436	2640.04865339436
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTTCGGTCGTCAACA"	-3.21824441376384	9.18156621539918	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCGGTCGTCAACA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2408.65862438745	46.6550944104452	0.0193697412900552	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2402.4921368412	2402.4921368412
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTACCTGTTGCCGCA"	-4.36764893952067	10.0502309569153	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACCTGTTGCCGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2788.9897054658	34.7255424787673	0.0124509396397961	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2783.07286448844	2783.07286448844
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTCAAACAACAAGAT"	-4.46695838394816	10.5424756773743	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTCAAACAACAAGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2684.54168024891	44.4540186643782	0.0165592581375963	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2676.73172518785	2676.73172518785
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAATGAAGCGGGTTA"	-3.42033205452617	9.16679761493532	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAATGAAGCGGGTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2972.56897394844	41.3342380035516	0.0139052241901885	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2964.57768935463	2964.57768935463
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAATGACAGATCCTA"	-3.48422799530681	9.2025518187317	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAATGACAGATCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2949.7981644732	40.4757304162285	0.0137215253923846	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2943.91755446425	2943.91755446425
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GCTGAATAGGGCAGAG"	0.868002553551835	-7.11444570934447	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGAATAGGGCAGAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2583.68242815168	43.7989952584661	0.0169521589732679	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2577.4830112707	2577.4830112707
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAATGATCACCGACG"	9.62699379500691	7.85828874194948	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAATGATCACCGACG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2216.37131395689	42.2767433007979	0.0190747565782745	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2210.1516483614	2210.1516483614
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTAAAGATAGCAT"	-2.85442529144939	8.889528251532	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTAAAGATAGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2461.6342996585	42.9265975581426	0.0174382513129987	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2456.52598038122	2456.52598038122
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTAACATCATTTC"	-3.3031841320103	-4.97289278423461	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTAACATCATTTC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3375.5886130418	41.533480128372	0.0123040704568989	3277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3366.28083269497	3366.28083269497
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTACTCCAACTTGCA"	-0.377311746508437	8.28863713825075	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTACTCCAACTTGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2584.52142653451	34.2577647176118	0.0132549741572647	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2572.83316991684	2572.83316991684
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCCATGCGTGC"	1.43999745425526	-5.74373104488524	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCCATGCGTGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3024.83366018159	38.551948232464	0.012745146531512	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3019.40992682995	3019.40992682995
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCGTGTCCGTG"	-0.517136792570907	8.73965165698854	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCGTGTCCGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2340.71941662431	36.085950830262	0.015416606780792	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2323.48642904671	2323.48642904671
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCGTTGTGTTG"	-4.23238406601604	9.94417951190797	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCGTTGTGTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2499.76418162728	36.1460797798134	0.0144597958661377	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2499.76418162728	2499.76418162728
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCTCGCAATTG"	-4.35042224350627	10.192356086615	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCTCGCAATTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2676.27313561393	41.2189001127006	0.0154016044043446	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2666.30395164758	2666.30395164758
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCTCTCCGAGG"	-3.45847497406657	10.233257270697	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCTCTCCGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2450.19491963498	47.7661086081554	0.0194948198714213	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2436.98694279325	2436.98694279325
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTATCCTCGGAAGGT"	3.77231587943379	-7.35336687481078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTATCCTCGGAAGGT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.64274314874	39.5300394393791	0.0151825896787871	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2598.22975201577	2598.22975201577
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCAGGTAGGCT"	-4.17381177368816	12.3790912398132	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCAGGTAGGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2901.61441066051	42.3056506839919	0.0145800387979055	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2896.15308226225	2896.15308226225
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCGCCACACACCAGC"	-3.99267516556438	10.543243385199	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCCACACACCAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2566.46901732108	44.3325258980082	0.0172737428734999	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2555.95506027574	2555.95506027574
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCGCCACATATGGCT"	9.79577793654744	7.52942273700563	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCCACATATGGCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2177.79544184386	43.8081268517526	0.0201158134552169	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2165.86016633935	2165.86016633935
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCACTGTGATGTAA"	-4.09281192246135	9.91272924030153	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTGTGATGTAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2599.48037613984	40.0409803201875	0.0154034555089226	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2590.03561704003	2590.03561704003
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCACTTCCAACACA"	-5.48894153061565	2.14428565585939	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTTCCAACACA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1690.36687613398	40.6012146399056	0.0240191731233897	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1685.6905957479	1685.6905957479
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCGTCGACTTA"	-4.43509231033977	10.0792236098084	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCGTCGACTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2758.33020044062	34.6708726357949	0.0125695149298139	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2751.36843145625	2751.36843145625
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCGATTGTATGAAGT"	-1.91423306885417	8.62053010547487	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGATTGTATGAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.97737429258	43.392823659447	0.0175894696528743	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2454.44896472857	2454.44896472857
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCGTATTCAAACGTC"	-0.482164124876815	8.58877847278444	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGTATTCAAACGTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2684.3867517748	38.469906025084	0.0143309849073161	2848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.56075139164	2674.56075139164
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCGCTGAGCTTCTAG"	-4.23281417313274	11.9109124907288	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGCTGAGCTTCTAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2681.16739796422	39.8332162012733	0.0148566688642859	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2670.37917238416	2670.37917238416
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCAGGTCGGTCAGC"	-4.96506867829021	-5.07718231594237	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.347826086956522	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCAGGTCGGTCAGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2695.24574625812	40.8772828182245	0.0151664399711883	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2690.29742520142	2690.29742520142
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCATCGTCGCCTAG"	-3.47034368935283	9.41937062824098	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCATCGTCGCCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.02614950126	44.6420618817241	0.0177925853385777	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2502.55861697985	2502.55861697985
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGACTAGGCAGTCA"	-4.42645202103313	10.80770204151	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTAGGCAGTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2781.5580413787	42.3604956992947	0.0152290533108194	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2776.46150996797	2776.46150996797
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTAACAGTTGCCTA"	-3.10930309715922	10.2950935133728	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTAACAGTTGCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1993.91502208759	40.4308124654119	0.020277099082729	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1990.5752899281	1990.5752899281
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCTCAAGTCGCATTA"	-4.36804852905925	10.6023425825867	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTCAAGTCGCATTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2600.10965239331	41.7950758071515	0.016074351236949	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2587.40579016822	2587.40579016822
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCTTCCGTACTCGTA"	-4.29406104508098	10.0181112059387	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTTCCGTACTCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2449.08075362083	37.1229948996776	0.01515793011104	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2443.77296510872	2443.77296510872
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCATGTATCGCTA"	1.6319269138271	-5.03112795269164	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATGTATCGCTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2483.33165365614	43.8654133691574	0.0176639367941755	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2476.80566501585	2476.80566501585
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGAAATAGGTTTACC"	-2.53564844551738	8.88728807056276	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAAATAGGTTTACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2481.11315292904	45.1984247647693	0.0182169945419099	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.56537928374	2476.56537928374
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGAAATTCGAGTCCG"	-3.92099008980449	9.71002481067506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAAATTCGAGTCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2607.00359494915	44.2323669946812	0.0169667456847308	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2595.4480158924	2595.4480158924
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGGTTAGGAGC"	-0.469396750361282	8.26149365985719	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGGTTAGGAGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2341.26479355871	37.4892355133491	0.0160123859618483	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2328.20151214648	2328.20151214648
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGGTTCGGACC"	-3.8475230735844	9.93434903705446	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGGTTCGGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2275.68060652244	45.5533494845124	0.0200174617448291	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2268.79505196964	2268.79505196964
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGAATATCGCAGTCG"	-3.95563922348674	9.74709603870241	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAATATCGCAGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2445.22521746933	43.9254351850943	0.0179637584592533	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.62516793456	2437.62516793456
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGAATATCTATTTCG"	-7.14354453507121	1.55282232845155	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAATATCTATTTCG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2659.0370120107	31.2887446076172	0.0117669458778829	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2649.91075391059	2649.91075391059
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGTCGCCTTGT"	-3.67034445229228	9.54076573932496	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGTCGCCTTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2532.9314373237	37.8632312926953	0.0149483838112498	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2526.92385733218	2526.92385733218
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGACGAGTTCGTTCC"	-5.17155347290691	-5.24999143993529	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACGAGTTCGTTCC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3017.64837815328	32.8373391520282	0.0108817645520794	3841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3012.58897486366	3012.58897486366
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGATGAGGCAGGGA"	-4.20939002457316	10.1827964552673	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGATGAGGCAGGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.37811075636	43.4665597909624	0.0179067940006341	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2416.561185462	2416.561185462
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGACGATCGTGAGAG"	-3.5593880218571	9.5110463866028	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACGATCGTGAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.50909995032	41.0815920668224	0.0160443062153614	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2554.34116547817	2554.34116547817
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGACTTCACCAGTTA"	-0.486384789378005	8.98666093433229	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACTTCACCAGTTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.3043656905	40.6672288359378	0.0163171197690659	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.11429052548	2480.11429052548
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGACTTCAGGGACTA"	-4.3218129676884	9.97438905322877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACTTCAGGGACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2828.08847259896	42.0106570442166	0.014854788826889	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2823.43817782338	2823.43817782338
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGACTTGTTCCTAGA"	-4.19643006745036	9.8069801100525	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACTTGTTCCTAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2673.35876919109	37.4006030959622	0.0139901174234384	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2671.22046687774	2671.22046687774
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCTACAGCACTCGC"	-1.59698925438579	8.515016532782	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCTACAGCACTCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2232.47169475584	43.6193602051876	0.0195385949607563	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2226.37270019768	2226.37270019768
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCTACAGGAGGGTG"	0.347531517117661	-7.17801906978758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCTACAGGAGGGTG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2873.00541054756	37.2605165699663	0.0129691773058182	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2866.73920047396	2866.73920047396
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCTACTCGTGGACC"	1.00378682193105	11.2519302138123	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCTACTCGTGGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2341.52792992973	39.3685224010734	0.0168131765151547	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2324.44215303964	2324.44215303964
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCTTGTCATGGGAG"	-3.86054907265361	9.97058484638063	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCTTGTCATGGGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2341.76225757665	45.793285523813	0.0195550531979287	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2334.62596286101	2334.62596286101
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGATAAGTTATAGAG"	-3.51612077179607	10.0767717131409	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAAGTTATAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2009.57573926486	40.7196739521742	0.0202628212296543	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2005.57055821549	2005.57055821549
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTGGGTGTGAGCTCC"	-3.92173753204997	10.0841893919739	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGGGTGTGAGCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2522.07775931971	47.8139439802126	0.0189581561486469	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2511.32808502712	2511.32808502712
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGATGTTAGCATCAAA"	-5.09922109070476	-5.53383686458739	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGATGTTAGCATCAAA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2795.35911520818	46.4891291755525	0.016630825328534	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2787.98379031439	2787.98379031439
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTGGGTTCTTCACAT"	-3.30100880089458	9.362597442511	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGGGTTCTTCACAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.53785337405	41.009567041907	0.016123041765432	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.0026520749	2539.0026520749
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGATCTAGACGGAAA"	5.2523213821346	-9.67918684398802	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATCTAGACGGAAA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.80245793354	41.4876005988567	0.0166362818622109	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2486.11169473932	2486.11169473932
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGATCTAGCGCTGCT"	-4.05356011810954	9.58749101245729	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATCTAGCGCTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2754.89431613676	36.7607691107075	0.0133438037515203	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2749.74531984598	2749.74531984598
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGTCAGTAGACAAT"	-4.32775245133098	10.2884378203186	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGTCAGTAGACAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2778.42529510431	40.6756328569496	0.014639815196263	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2774.99445278559	2774.99445278559
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGCATTAGCTAAGTA"	-3.09578047218974	9.08908746326295	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTAGCTAAGTA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2542.38178983665	45.7345434388085	0.0179888573862649	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2535.76786479671	2535.76786479671
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTACCAGTGTTCCA"	0.209309776395005	-6.45052673732909	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTACCAGTGTTCCA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2986.48603493376	39.2791879808895	0.0131523092763301	3413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2979.47947058153	2979.47947058153
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCAGTCTCCCTTGGT"	1.75087239322011	-5.84170963680419	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCAGTCTCCCTTGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.25797256776	36.2935070821661	0.0125095759926666	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2896.99256320477	2896.99256320477
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTACCTCTGTGCGG"	-3.84813127937968	10.180543876532	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTACCTCTGTGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2401.12615444967	39.3383206860586	0.0163832794096047	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2390.80846251051	2390.80846251051
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGCATTCATTGCCTC"	-2.1228440803593	8.62292764270631	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTCATTGCCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2664.13772354757	38.2775899031913	0.014367721895481	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2660.11089049464	2660.11089049464
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTCACGTCTTTCAT"	-0.299641619355041	9.05064199054567	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCACGTCTTTCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2356.9002010955	35.8389488463514	0.0152059679190885	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2347.18673860271	2347.18673860271
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCTTGGTCAGGAGAC"	3.51015796241109	-8.00802996074828	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTTGGTCAGGAGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.34565794067	43.7529350063847	0.0163602393267577	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2670.39216694044	2670.39216694044
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGCCACTCTGGGTCG"	-3.10279736939128	9.21910379016725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCCACTCTGGGTCG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2597.27267602547	42.9763812248238	0.0165467344347492	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2593.62964924403	2593.62964924403
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGCTGCAGCGTGCTC"	-4.39963708344157	10.9395675429138	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCTGCAGCGTGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2992.25000285416	40.9637214475767	0.013689939479824	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2984.50412423884	2984.50412423884
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTCTGCATATCGGT"	3.68256487426106	-7.89026214992674	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCTGCATATCGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.74387969035	35.600220797116	0.0123579958107705	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2874.40858111438	2874.40858111438
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGAGTTCGACATTG"	-2.89193640175517	8.76706407153932	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGAGTTCGACATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2798.93514330129	44.1977542222206	0.0157909176023601	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2795.40733369495	2795.40733369495
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGCTCGTCATCACA"	-4.34757218781169	10.1424312361511	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGCTCGTCATCACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2417.08592730478	38.826590611233	0.0160633886336542	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2414.18478751973	2414.18478751973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTCCGTCGTACAT"	-0.579753021628219	8.47961709583131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTCCGTCGTACAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2613.64952143554	39.3225001569904	0.0150450547537042	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.56319539922	2602.56319539922
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTCCTCATTTGCT"	14.3940864997799	1.99172542178956	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasmablast"	"Plasmablast"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTCCTCATTTGCT"	"Plasmablast"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	2585.44335924217	30.0336865043624	0.0116164550257894	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2552.77219828841	2552.77219828841
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAAGAAGTGACAACG"	-1.88639543476756	10.724263168219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAAGTGACAACG"	"MAIT"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2074.72335818651	48.0167585372421	0.0231436920723796	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2069.95461642586	2069.95461642586
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTGACACACCTGG"	-4.92177615585979	-4.75764562999877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTGACACACCTGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3176.02396307525	37.6375753672271	0.0118505325541636	3701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3166.58155305827	3166.58155305827
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTGAGTAGAGCTG"	-4.26309094849284	9.92190358722535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTGAGTAGAGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2632.99647570451	46.4361830084646	0.0176362495874742	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2627.45244127916	2627.45244127916
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTGATCCTATTTG"	-4.26855597916301	9.79754636371461	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTGATCCTATTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2969.8244269832	39.4670920294322	0.0132893687824918	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2963.59155157547	2963.59155157547
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGGTGATCGAGATGG"	1.82808007773702	-5.65793564235839	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTGATCGAGATGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2132.075221357	48.057475368692	0.0225402344566928	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2123.61052548719	2123.61052548719
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACAACTCATTACCT"	10.6145531135494	7.55335996234743	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACAACTCATTACCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2385.29831858127	44.1317884495442	0.0185015803288676	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2374.1820306106	2374.1820306106
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACAGTAGCTACAAA"	-4.39198432388957	9.9517669447693	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACAGTAGCTACAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2972.80428334909	39.2944362405627	0.0132179694642711	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2962.27829019954	2962.27829019954
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGTAGGGTGGTAACG"	0.0754387910360515	-6.37181904232176	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTAGGGTGGTAACG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3049.41231776756	44.2647850657199	0.0145158412353124	2889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3043.79846616953	3043.79846616953
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTTTGGCATGAATAG"	0.950030406087083	-6.0266962281433	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTTGGCATGAATAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3431.08681973039	46.259143215272	0.0134823586944113	3534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3422.30731950035	3422.30731950035
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCAAGTACCGTGC"	-4.06446204605754	12.5220813521179	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCAAGTACCGTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2864.93804481309	36.9177471620109	0.012886054282692	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2857.57745308489	2857.57745308489
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCAAGTATACCTG"	1.76785006102864	-7.7875604859558	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCAAGTATACCTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.60309214584	47.9747364883539	0.0206112187469753	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2318.48431810424	2318.48431810424
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCAAGTCGTGATT"	-2.4308811229771	-4.09057762539061	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCAAGTCGTGATT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1880.58381864314	46.8428584841094	0.0249086789005273	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	1872.52980603401	1872.52980603401
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCAAGTGATATAG"	-3.67899284783061	9.76681802356569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCAAGTGATATAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2646.47237576051	45.6985266552343	0.0172677134565223	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2639.50795719616	2639.50795719616
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGTCTATCGGCTCTT"	-2.0059429210728	8.720507598761	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCTATCGGCTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2445.79240469782	43.7744810988113	0.0178978726954627	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2436.6927417582	2436.6927417582
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGTCTATCTCCGAGG"	-2.65488849106486	9.13003537738649	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCTATCTCCGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2629.79729561887	39.6348838500517	0.0150714596581576	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2623.3121198303	2623.3121198303
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCTCCACAACGAG"	-0.444111297756988	8.47551915729371	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCTCCACAACGAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2247.30416411113	32.7020792022593	0.0145516925232032	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2234.45613405845	2234.45613405845
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCTCCAGTTTCGA"	-1.93761930885966	8.95063874805299	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCTCCAGTTTCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.62013413072	42.5922982956913	0.0184652417038503	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2298.25187484847	2298.25187484847
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTCAAGTCACACT"	3.37433566626851	-7.09683897411498	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTCAAGTCACACT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2046.84249226489	43.5927373835687	0.0212975534504036	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2038.76798782855	2038.76798782855
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGTGTTTCTCCCATG"	-2.83437214317973	8.8101539381775	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTGTTTCTCCCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.51481064608	42.5709086226923	0.0165999854810616	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2557.57945577036	2557.57945577036
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGGTTACAGATGGTAT"	-0.698051671416122	8.96300695026246	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTACAGATGGTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2347.95737976587	39.9117602870038	0.0169985028821024	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2342.17524999794	2342.17524999794
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACGATGTAACAGGC"	-4.36091933670695	10.1932792433533	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACGATGTAACAGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2635.16075423544	46.7503459390873	0.0177409844404925	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2626.04239903487	2626.04239903487
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACGATGTGTATTCG"	1.65829922732655	-5.58906986629637	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACGATGTGTATTCG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2381.73165851106	43.3854911081861	0.0182159442492815	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2378.6814650982	2378.6814650982
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACGATGTTTCCCAC"	-4.36941705170329	10.6870078810486	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACGATGTTTCCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2657.04077414266	41.1788346099341	0.0154980062822789	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2653.15294471002	2653.15294471002
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGACTGTCCGCAGT"	-3.85977302017863	12.447935081366	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGACTGTCCGCAGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2812.71805743459	43.1568587172609	0.0153434712744096	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2801.0727765996	2801.0727765996
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAACCAGTACAACA"	1.79972269114797	-5.64923670208129	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAACCAGTACAACA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3258.2512592884	41.9981986407871	0.0128897974092887	3320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3249.15888409036	3249.15888409036
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCTACTCAAGCCGC"	-4.27501569214519	10.9389180907044	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACTCAAGCCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2596.53532933344	40.720590523914	0.0156826637650132	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2594.08803778247	2594.08803778247
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACCACAGTAGGAC"	4.63841690596883	-8.46537020122679	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACCACAGTAGGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3012.3585550445	38.3262496661475	0.0127230039073424	3005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3008.99821841764	3008.99821841764
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACCATCAACCTCC"	-2.67919788780864	8.77662942493287	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACCATCAACCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2820.94528138836	40.4986356077026	0.0143564059448083	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2807.16814699475	2807.16814699475
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACTGAGTTACGAA"	-2.2113712829655	8.75425431812135	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACTGAGTTACGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2508.5942699331	41.7462259461693	0.016641282508902	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2505.08281634624	2505.08281634624
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCTCACAAGCTACT"	-4.29738078537639	10.6302470930847	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTCACAAGCTACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2607.89742477768	38.7905784255823	0.0148742730665065	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2601.29223010497	2601.29223010497
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACTGCAGTGGGTA"	-0.261845330626327	8.55855844104616	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACTGCAGTGGGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2379.67638613848	36.9275432091916	0.0155178844586991	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2372.47074497067	2372.47074497067
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACTGGTACGAAAT"	-1.9436209005421	8.61408898914186	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACTGGTACGAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2421.86614706751	45.8154324423897	0.01891740899796	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2419.53169398529	2419.53169398529
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTACTGGTCAACATC"	3.51536216315572	-8.34423353588256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACTGGTCAACATC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2896.34503855643	38.2130820826327	0.0131935531070837	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2894.2658825913	2894.2658825913
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAGCTAGTGGAAGA"	10.1021105247432	7.80706069553224	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGCTAGTGGAAGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2343.30077716204	43.6237256493107	0.0186163577780839	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2332.06665394669	2332.06665394669
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGGGATCACTACTT"	-0.483673493296462	8.73120687091676	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGGGATCACTACTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2418.97307576424	39.1667212863372	0.0161914664031401	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2410.14137368184	2410.14137368184
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAGCTGTAGGGTAC"	-3.7518392604893	9.67996785724489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGCTGTAGGGTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2035.39129472048	36.7252891203034	0.0180433557004806	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2026.55188008923	2026.55188008923
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAGCTTCAACCGAT"	-1.98113403740581	8.76038739765016	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGCTTCAACCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2581.37984750345	42.7862969433077	0.0165749713219029	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.9833388189	2571.9833388189
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAATACGTCCGGCAAC"	-0.468571524054366	8.91149232471315	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATACGTCCGGCAAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2540.61178836336	40.0089760018622	0.0157477723220499	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.59473506857	2532.59473506857
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGATAAGGGTAATT"	-3.59619746628459	10.0712842711243	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGATAAGGGTAATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2587.46605488811	41.0639906624926	0.0158703495201093	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2580.35359569356	2580.35359569356
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAGTCGTAAGCTCT"	2.30440296706502	-4.35700657283934	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.019047619047619	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGTCGTAAGCTCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2450.50056521192	47.8100577693345	0.0195103230940083	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2441.89224481233	2441.89224481233
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTAGTCTCATACGGT"	-4.37192044678386	9.94442460620729	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGTCTCATACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2836.7826262997	44.0735358580825	0.0155364515594105	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2833.64013086952	2833.64013086952
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCAACTCGTGCATA"	0.828183372586411	-7.07016756450804	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCAACTCGTGCATA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3130.08891113013	51.4003512284805	0.0164213709858875	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3128.04525461753	3128.04525461753
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTATGCTCTCAAAGC"	-3.71239982071574	-8.25227930462035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTATGCTCTCAAAGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2636.20216009378	28.722194611419	0.0108952928748064	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2630.43618226458	2630.43618226458
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCACAAGAGATTCA"	1.35993101176564	-7.39182999050292	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCACAAGAGATTCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.29098293017	40.8123332840094	0.0148177275157002	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2746.60969785848	2746.60969785848
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTAGGTCCCTG"	-3.73849759522136	10.1498203047547	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTAGGTCCCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2728.8600060968	47.214497728529	0.0173019127485627	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2722.38028272242	2722.38028272242
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCACAAGGTGCCAA"	1.6238167482311	-5.50057127391966	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCACAAGGTGCCAA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2680.29555859866	30.226868252569	0.0112774384733796	2419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2674.29891391238	2674.29891391238
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCACAAGTGGATAT"	-4.36048827591594	9.96115300739137	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCACAAGTGGATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2684.7675511744	40.0949965633419	0.0149342525187341	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2678.87590629632	2678.87590629632
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGCAAAGTAATACG"	-2.10938749733623	8.44413373554078	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCAAAGTAATACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2556.94953653272	47.2601980105961	0.01848303900228	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2544.39160767573	2544.39160767573
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACACAAAGTGTGTTC"	-1.41744349423106	8.73342321002809	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACACAAAGTGTGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2285.36594255134	35.7707716484342	0.0156520979780159	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2283.93703687319	2283.93703687319
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACACAACACACAGAG"	9.27348770675008	7.75127694690553	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACACAACACACAGAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2216.60980513309	44.1832748043606	0.0199328157360144	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2209.44031977747	2209.44031977747
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACAGGCAGACCATTC"	-0.274294773966628	8.93910024249879	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAGGCAGACCATTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2366.78989816371	41.6867178004525	0.0176131890003399	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2355.73726051888	2355.73726051888
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCATGTCCGACGGT"	-4.1022199195927	10.074927307013	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGTCCGACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.00473293164	45.3939477221501	0.0174928188554275	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.78826457809	2585.78826457809
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACAGGCGTAGAGACC"	-2.44577727738078	8.79929826343385	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAGGCGTAGAGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2352.44897935924	37.714392200185	0.0160319703131065	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2340.59694220482	2340.59694220482
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCATGTCTCGCGTT"	1.65827109393422	-7.50431730663451	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGTCTCGCGTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.26393992989	44.7046177980557	0.0171725260402369	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2603.26393992989	2603.26393992989
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACAGGCTCCGCATAA"	4.1372820335323	-8.15186407482298	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAGGCTCCGCATAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.04207330324	40.0784916530954	0.0144999571606371	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2759.3565714286	2759.3565714286
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCTCCAGGTGGTTG"	-2.02548847618755	8.59564683521119	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MAIT"	"MAIT"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCTCCAGGTGGTTG"	"MAIT"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2635.75670788902	39.5117540222274	0.0149906681083143	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.51030974676	2629.51030974676
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCTCCCAGAGATGC"	-3.90628800812419	10.9667463072571	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCTCCCAGAGATGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2829.12754681739	43.0778291758544	0.0152265419154801	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2814.56520548813	2814.56520548813
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACATGAGTAAGATTG"	3.11903514441792	-4.46113731777342	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACATGAGTAAGATTG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2000.5608046505	27.0006648389134	0.013496547956027	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	1996.87576327486	1996.87576327486
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTCTCCTCTGCCCTA"	-0.868420521647292	9.20676324451295	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCTCCTCTGCCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.07704518861	44.252429510699	0.0181505459796803	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2425.18942171438	2425.18942171438
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGACTAGGAACTAT"	-0.130890573293525	13.1233100661072	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00224592925322852	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGACTAGGAACTAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2004.13531769376	49.0246324014788	0.024461737672431	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	1995.01387457841	1995.01387457841
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAACTCAAGCGCAA"	-2.71236286583598	8.55669019306032	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTCAAGCGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2742.10000338312	40.5751182790199	0.0147970964694794	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2739.73782514769	2739.73782514769
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAACTCACCTCGTT"	-3.40440164032634	9.98475453937379	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTCACCTCGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2328.45604545635	40.8446097555228	0.0175414991557282	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2324.40138327511	2324.40138327511
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTCTACACTACCGG"	-4.04309592667277	10.0588626631531	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCTACACTACCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2669.28344587165	37.3484402243851	0.0139919349075306	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2662.91626448321	2662.91626448321
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGATCAGCGGTAGT"	-2.66738877716716	8.89705369556276	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGATCAGCGGTAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2751.37604477665	46.721629768513	0.0169811865074611	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2739.86942289686	2739.86942289686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGATCCAGTAACAA"	-0.350296000868636	8.50845334613649	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGATCCAGTAACAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2477.66585868525	34.6298177044555	0.0139767909312967	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.14394249395	2472.14394249395
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACCGTTAGTACCGGA"	-3.98066935959514	9.75025365436403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTAGTACCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.51628202758	36.4420635463293	0.0143726403197015	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2529.10535362833	2529.10535362833
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACCGTTAGTCGGCAA"	-2.26982984963115	9.41800687396852	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTAGTCGGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2389.42717906318	38.55562267741	0.016135927060362	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2379.62621296435	2379.62621296435
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTGTTGTGTGCTTA"	-4.20263419571574	10.4031162031922	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTGTTGTGTGCTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2580.43927988266	38.8544098041167	0.0150572850549243	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2573.01280740012	2573.01280740012
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGCCGGTCACAGAG"	10.6817518669063	6.70549151981202	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGCCGGTCACAGAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2384.54032536915	42.8259761158806	0.0179598456189877	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2376.26886703359	2376.26886703359
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGCCGTCACCATCC"	-4.32782254639323	10.0027122267517	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGCCGTCACCATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2761.98244276952	33.8706236120861	0.0122631567411859	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2757.10425403114	2757.10425403114
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGCCGTCACCTCGT"	10.5515066581661	7.77982995593873	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGCCGTCACCTCGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2490.65084587278	46.6603240651526	0.0187341891548037	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2481.75816879512	2481.75816879512
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTGTTGAGAGGGTAA"	-0.818449358374435	9.01794240558473	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGTTGAGAGGGTAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2440.55938435853	41.2268423235465	0.0168923741777266	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2431.21195824561	2431.21195824561
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGAATAGCCTGAGA"	-3.79729066315349	10.4736766585144	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGAATAGCCTGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2384.36718273997	45.9152465407891	0.0192567851433126	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2369.32724861853	2369.32724861853
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATACCCGTAGCGATG"	-4.23654923859294	10.7358722456726	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACCCGTAGCGATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2743.16693106133	46.9958855034377	0.0171319816418372	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2738.46809050208	2738.46809050208
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTTGTTCTTGGATG"	0.96845187720601	-16.2879057160583	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"GMP"	"GMP"	79	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTGTTCTTGGATG"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2757.13146769244	37.9960199444169	0.013780996803978	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2740.62531271197	2740.62531271197
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTTCCCTCGGATAAA"	-4.08920751038249	9.69363210285035	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTTCCCTCGGATAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2807.44070353135	36.0485118848859	0.0128403466686018	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2802.87388270599	2802.87388270599
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGTTCGATCTGAGGCC"	-4.12028298798259	11.2369470366272	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTTCGATCTGAGGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2295.61741189079	41.3376297430862	0.0180071947219805	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2292.60395516932	2292.60395516932
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATACCGAAGAGCCGAT"	-3.90365181389506	9.56451032245485	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCGAAGAGCCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2806.49903594639	43.7370662018834	0.0155842085251722	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2798.60222515579	2798.60222515579
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTCTGGGTGTCATTG"	-2.16124306145366	8.86666486347047	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCTGGGTGTCATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2296.08717438054	41.8113278075625	0.0182098172378158	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2290.74056437312	2290.74056437312
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTCTGGGTTTCGGCG"	-2.4700439971989	8.67557141864625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCTGGGTTTCGGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2406.83215337281	39.529316259537	0.0164237943240632	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2395.59700836183	2395.59700836183
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGTTCTCTTGGTCC"	-3.74115095558818	9.74266431415407	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGTTCTCTTGGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2498.56234334817	42.7384739634252	0.0171052261622393	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2488.56792842534	2488.56792842534
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATACCTTCACAGTCCG"	4.12774290618245	-8.5742397538391	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCTTCACAGTCCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3396.90304651613	42.4463476440352	0.0124956017474706	3045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3388.74972425119	3388.74972425119
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATACCTTGTATTTCTC"	10.4641367393428	7.52184817874757	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCTTGTATTTCTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2416.15715745354	43.9241935736312	0.0181793611554325	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2405.47992819904	2405.47992819904
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATACCTTGTTTGAACC"	0.918316026299637	-7.07354261791381	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCTTGTTTGAACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3068.43347262006	37.8071977458824	0.0123213353273714	2475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3059.54456616579	3059.54456616579
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTGAAGTGGAACCA"	-4.07738957825358	10.1500291594299	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGAAGTGGAACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.34891553897	41.9092078838465	0.016601987001824	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.03019730223	2515.03019730223
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGTACTCGTCCTTG"	-2.103907207877	8.56374929035035	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGTACTCGTCCTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2577.13874069218	43.9229019549912	0.0170432818619591	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2569.07146931231	2569.07146931231
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATACTTCCATGAATCC"	-4.00234780731853	12.5564956434998	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACTTCCATGAATCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2722.77180256785	46.0447485274747	0.0169109833163579	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2704.25476817256	2704.25476817256
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTGGGAGGTTTACC"	-4.26698241654094	10.6525811919006	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGGGAGGTTTACC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2597.16615164019	45.5349917443618	0.0175325678396066	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2590.48521818035	2590.48521818035
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGACCGTCATCTAG"	-3.81437478485759	9.46896264636842	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCGTCATCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2839.53403189659	38.799162655964	0.0136639188754675	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2835.47162779425	2835.47162779425
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGAGAGTTGACGGA"	-4.02018580856975	9.98689076984254	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAGAGTTGACGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2226.49669411577	46.9777613483198	0.021099407635535	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2220.83434361057	2220.83434361057
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGATTCAATGAACA"	3.52017583426778	-8.18115904247435	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGATTCAATGAACA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.71344334528	29.5288718669416	0.0106999775422869	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2757.35198061677	2757.35198061677
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGACCTCAGGAACG"	-0.566336135298568	9.50856874072877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCTCAGGAACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2538.15140285119	37.871886967043	0.0149210511731098	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2527.24548511963	2527.24548511963
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGACCTCCGATAAC"	-4.36225734177287	10.4063653715881	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCTCCGATAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2757.57537616211	40.7087233373057	0.0147625061092483	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2754.17595125735	2754.17595125735
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGACCTCCGTGGCA"	-3.81326613846477	9.7709750899109	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCTCCGTGGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2623.83756300084	48.7499714082446	0.0185796453620742	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2616.33569893627	2616.33569893627
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTAGATGCTTC"	-2.61797914925273	8.85028169238893	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTAGATGCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2285.20853549166	39.3290599004168	0.0172102717496437	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2276.08166352727	2276.08166352727
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGAGAGTGCCCACA"	-2.50424895706828	8.67552564227907	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGAGAGTGCCCACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2478.88866096222	45.4105693830203	0.0183189225470875	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.82231663186	2472.82231663186
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGAGATCCAATCTT"	-4.33271012726482	9.99022767627565	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGAGATCCAATCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2568.07902132713	41.3528536606014	0.0161026406575414	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.35184594357	2556.35184594357
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTCATCGCTAA"	-3.95394025269206	10.1500978239807	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTCATCGCTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.82455618747	38.4608967974854	0.0157122767235365	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2442.65347639198	2442.65347639198
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGAGCCGTGTTCCAA"	-2.99993191185649	9.21005151355592	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGAGCCGTGTTCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2408.19200745357	44.5343565868917	0.0184928595598083	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2401.96215430013	2401.96215430013
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATAGGCTAGGTAAGTT"	-3.72667131844218	10.1955499419006	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGGCTAGGTAAGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2679.61636154685	41.8160918950558	0.0156052532351746	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.69992241033	2674.69992241033
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTTCATTTCCA"	-1.28422174874004	8.95351693713991	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTTCATTTCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2311.04662292675	42.1243480802577	0.0182273899896103	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.16350186329	2306.16350186329
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATACCAACGAGGT"	-7.09844527664836	1.60931608760682	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATACCAACGAGGT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2522.67527920905	36.5291761964476	0.0144803322478749	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2522.67527920905	2522.67527920905
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATACCACCTCAGG"	-2.89020810547526	8.82606885516969	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATACCACCTCAGG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2633.97708383247	37.5816500228071	0.0142680246739753	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.25432990445	2628.25432990445
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATACCACGGTAGA"	-2.86732302132304	8.7717132338318	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATACCACGGTAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.51012668562	40.1386854660577	0.016460331670065	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2430.75728192388	2430.75728192388
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATATCCTGTGAGTAAT"	-4.42927537384685	10.6755456694397	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATATCCTGTGAGTAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3012.48433584569	39.8704078557168	0.0132350589781653	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3005.81897112945	3005.81897112945
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACAGCACATACGT"	4.09346546706502	-8.45715334331664	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACAGCACATACGT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2935.19890988246	45.010009510347	0.0153345687608441	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2932.49908665301	2932.49908665301
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACAGCATATGCGT"	-2.59322867813762	9.08792302692262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACAGCATATGCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.81222181248	39.0943587330299	0.0182614609234299	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2137.9139573154	2137.9139573154
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATCACATGGGCAA"	-4.31189380112346	10.779327369574	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATCACATGGGCAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.73902311457	42.6428909208438	0.0162403386419805	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2617.2166567179	2617.2166567179
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACGAGTGATGTAA"	-3.8642078441685	9.70326516712037	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACGAGTGATGTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2656.9634627345	36.1354196093526	0.0136002696748275	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2645.72558758775	2645.72558758775
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACGAGTGGGCTCT"	-4.08748946610149	9.76751229846803	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACGAGTGGGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2676.00022375908	44.5933377121731	0.0166641756290779	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.75866181053	2672.75866181053
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAACACTCCACGTCT"	-4.1412595314091	10.1142873533997	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACACTCCACGTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2684.94251575167	44.2148190373638	0.0164676967115572	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2680.1981460737	2680.1981460737
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACTTTCAGAGTTC"	-0.204460005194503	8.88746163928834	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACTTTCAGAGTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2613.66681482286	40.2311808439935	0.0153926202895606	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.54169385706	2602.54169385706
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCACTTTCTATGTGG"	1.72823049601857	-5.51060488140257	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACTTTCTATGTGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2888.27110838691	43.5837136796437	0.0150898970505525	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2884.71392188188	2884.71392188188
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATTGTCACCTGTC"	-7.24642739716228	1.55216274345247	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATTGTCACCTGTC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2954.53158314011	43.2200539577976	0.0146283946343409	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2947.29787855486	2947.29787855486
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAACCATCCAATCTT"	-3.9527157348698	10.110794998053	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACCATCCAATCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2379.10698879058	46.4795918476007	0.0195365706824428	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2375.38369169169	2375.38369169169
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCACCGTGTTATCG"	-0.517108778387863	9.23825547778932	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCACCGTGTTATCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2474.66473834714	42.5809916606703	0.017206771891497	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2471.24216641668	2471.24216641668
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAATCAATTAGGA"	-0.52770827236827	8.90264413440553	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAATCAATTAGGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2445.1782905732	33.7636403414511	0.0138082529489235	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2432.25601975414	2432.25601975414
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAAGTCGTGCAACGA"	-2.80952129784282	8.79166028583375	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAAGTCGTGCAACGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2243.35934187343	39.8295000987585	0.017754400445493	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2241.91155520196	2241.91155520196
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAAGTCTCCAACTAG"	-4.25070128861125	10.1575631865296	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAAGTCTCCAACTAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2514.25327956384	40.512314754042	0.0161130603202673	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2511.84452869905	2511.84452869905
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCATTGTAGTTAGA"	-3.45244727554973	9.22853944385377	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCATTGTAGTTAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2787.71665846034	35.601362903858	0.0127707967722662	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2778.49803934289	2778.49803934289
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCAGATAACAC"	-4.42002902451213	10.7150373228821	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCAGATAACAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2649.48977444139	39.3925753286214	0.0148679854169004	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2641.07221980954	2641.07221980954
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCCTGAGGTAAGAG"	-0.667322496802169	9.05745980823366	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCCTGAGGTAAGAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2139.75151794822	45.5625740289245	0.0212933948856892	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2134.76023891407	2134.76023891407
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCCTGGTATCGCGC"	4.48022045668904	-8.60922815715941	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCCTGGTATCGCGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.97694689719	19.5435560893126	0.00696745693790153	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2802.2485186977	2802.2485186977
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCGTCAGGCATCGA"	10.2372862296993	7.37915513599244	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCGTCAGGCATCGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2200.24511890547	42.0108137655225	0.0190936970633622	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2190.94526802765	2190.94526802765
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCGTTGTCAGT"	0.422549893229645	-6.34200622951659	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCGTTGTCAGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2672.84106344457	42.174589554126	0.0157789365521698	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2666.20128973876	2666.20128973876
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCTCAGGACAG"	-3.25354156914409	9.26251027667848	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCTCAGGACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2531.06230501893	47.1275238573368	0.0186196616985232	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2524.04260326888	2524.04260326888
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCCAGAGCCTGAAG"	-3.61451206627544	9.77050206744996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCCAGAGCCTGAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.71213541563	35.6593299554661	0.0146102153703569	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2434.95036620168	2434.95036620168
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCCTATTCCATGATG"	-4.21449027481731	9.95080468738405	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCTATTCCATGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2690.90650164592	38.8875150034206	0.0144514552919749	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2683.62558484886	2683.62558484886
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGAGGGTCACTCGG"	-3.6793352169102	10.9592103728089	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAGGGTCACTCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2268.07899376305	45.4984882888888	0.0200603631593098	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2268.07899376305	2268.07899376305
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGATGGTCTTGCGG"	-2.54980884018596	9.16709134662477	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGGTCTTGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2405.02531104292	41.9508028518974	0.0174429776931145	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2395.24910432615	2395.24910432615
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCGTGGTCTGTGCG"	-4.17869315567668	9.99525640094606	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCGTGGTCTGTGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2471.84554713678	39.8443151929115	0.0161192576288047	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2466.52237709733	2466.52237709733
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGATGTCATGAGTC"	4.97284855422322	-9.21024610912474	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGTCATGAGTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2911.03196071836	38.6005948090952	0.0132601068383906	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2905.49341036949	2905.49341036949
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGCTAAGAAACACT"	-1.22186313095744	8.64261720264284	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTAAGAAACACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2329.73162254424	42.2565488278238	0.0181379470574712	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2318.58439493968	2318.58439493968
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGCTAAGGCCACTC"	-2.78560386124309	8.86019990527955	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTAAGGCCACTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2396.54543551886	44.3615216908368	0.0185106115800522	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2384.90972200338	2384.90972200338
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGGGCTAGTTGCTCA"	-2.51109657707866	8.71430299365846	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGGCTAGTTGCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2474.09597356798	41.1273782313022	0.0166231943589444	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2471.64107941031	2471.64107941031
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGCCTCAACGACTT"	-2.59982810440715	8.58937642658082	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGCCTCAACGACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2815.09471148845	39.6845525122601	0.014097057676357	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2805.97995602256	2805.97995602256
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGCCTCAGCCTTCT"	10.2239223915035	7.7855014570984	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGCCTCAGCCTTCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2518.33827603367	41.9083840263333	0.016641284622151	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2510.22395805715	2510.22395805715
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGCCTCATTGACTG"	-2.01874170723613	10.1755943068298	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGCCTCATTGACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2310.23428663971	44.1205936851889	0.0190978871451879	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2305.19730136206	2305.19730136206
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTGCGAGACATAAC"	-0.389983783394653	8.82466504657594	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTGCGAGACATAAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2327.0566513758	40.0205806973183	0.017197940013045	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2318.58668174344	2318.58668174344
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGGATCACCGGCTA"	-3.89078126373943	9.62527749622194	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGATCACCGGCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2834.68328015628	38.9584515026463	0.013743493594282	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2829.19979242393	2829.19979242393
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGGATCATCTATCT"	-2.97061477127727	8.81160352313844	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGATCATCTATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2710.4335622787	43.0444259042293	0.0158810112534325	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2702.58770282779	2702.58770282779
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGGATGTCAACGCC"	-3.49807486954387	9.35045335376588	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGATGTCAACGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2665.83201412104	34.2879944320887	0.0128620236573286	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2662.78019672845	2662.78019672845
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTTAGGTCATAACC"	-4.16511664810832	10.2576865919861	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTAGGTCATAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2714.88955152061	38.9111923348981	0.0143325139371154	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2709.16562458323	2709.16562458323
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTTAGTCATGAGTC"	0.857907553284806	-6.05881216442259	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTAGTCATGAGTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2915.92701894695	41.605409569504	0.0142683302082537	2722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2905.48413403815	2905.48413403815
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGGCGCACGATAGG"	-4.47658906403239	10.0367583998474	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGCGCACGATAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2786.81810414982	39.0762383201472	0.0140218115642206	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2783.45133512659	2783.45133512659
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGGCGCACTGCACG"	2.75311364707295	-6.53724577343138	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGCGCACTGCACG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.8450398715	42.2440464588882	0.0156526387527976	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2693.15573734679	2693.15573734679
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGTAGGTCCTCAGG"	-3.93296037140544	9.74647138202516	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTAGGTCCTCAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2945.65200936113	44.4721111779337	0.0150975441215064	2444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2936.80996831789	2936.80996831789
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAAGCAGATGTTAG"	-3.30460462990459	9.53948686206666	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAAGCAGATGTTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2391.46931117443	49.691838880666	0.0207787901138747	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2379.89898632758	2379.89898632758
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGTAGTCGTGGGTC"	-4.42700610581096	10.611753440741	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTAGTCGTGGGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2819.30143781994	40.3271317860958	0.0143039446740676	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2809.92370059386	2809.92370059386
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAAGCTCATCACCC"	-2.92944417420085	9.24257562244264	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAAGCTCATCACCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2643.67536107146	41.2088437169534	0.0155877095666738	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2632.40867607749	2632.40867607749
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAAGCTCCTTATCA"	-4.25003180924113	9.87606999957887	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAAGCTCCTTATCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2667.9539161583	37.5967550914487	0.0140919806986718	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2663.29522019562	2663.29522019562
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGTCCTCCATTTCA"	14.4270950752193	1.96369049632875	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTCCTCCATTTCA"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1194.35095548983	18.7888931846275	0.0157314674537366	3424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1180.07870050786	1180.07870050786
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACCTGTCCAGCAAT"	-4.30455146256145	10.2786931761536	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCTGTCCAGCAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2632.73582915179	44.8391325537553	0.0170313831176147	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.02997492672	2629.02997492672
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGTGACAATGTTGC"	-2.02410111847575	8.56779286945192	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTGACAATGTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2744.10588744076	39.9726980591107	0.014566747676195	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2737.30592406267	2737.30592406267
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCGTGAGTGCCTACG"	-0.646812180907089	8.24613854968873	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTGAGTGCCTACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2281.37716489311	41.2020001820683	0.0180601440288366	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2274.35899675222	2274.35899675222
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATACCCAGTAAATGC"	-3.9954494041508	10.171320892218	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACCCAGTAAATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2251.97291486962	38.7773090036203	0.0172192608301709	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2247.94287231293	2247.94287231293
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCATGAAGCACTCCG"	-4.06987224045451	10.6672954329285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATGAAGCACTCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2316.08448984915	42.1694571809605	0.0182072188496488	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2309.22016660232	2309.22016660232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCATGAGTGCTAGCC"	-4.35587583008464	10.5269546278748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATGAGTGCTAGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2498.85414606433	42.8084520918524	0.0171312327929484	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2489.93981833166	2489.93981833166
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATCTTCACAGCGTTGC"	-2.75092754784282	8.70312497699586	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCTTCACAGCGTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.61060453004	40.3115546099147	0.0152371458372936	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2630.44327404183	2630.44327404183
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATACTTCATTGTACG"	-4.07866130295451	10.1321124800476	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACTTCATTGTACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2333.11341678071	35.7195687198884	0.0153098295449242	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2331.57965425049	2331.57965425049
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCATTTCACTAAACC"	-1.813215593726	8.54757020557252	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATTTCACTAAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2145.56241208966	42.0656487417886	0.0196058844547053	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2132.75787836124	2132.75787836124
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGCAAGCTCTA"	-1.54252300682719	8.47745702350465	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGCAAGCTCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2750.77560727824	42.0196327444348	0.01527555814922	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2741.12901843853	2741.12901843853
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAGACCAAGTGCTT"	-3.28314552727397	-7.22948934948119	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAGACCAAGTGCTT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2437.3413469765	37.290840213416	0.0152998020813437	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2433.43246901919	2433.43246901919
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAGACGTACAAGCG"	-1.04777489128764	8.78183744037477	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAGACGTACAAGCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2200.0361412628	41.7242388781497	0.0189652515681857	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2194.36307141995	2194.36307141995
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGAGAGCATCG"	-2.57911072197612	8.82850072467653	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGAGAGCATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2305.44920067652	44.231842168489	0.0191857804351141	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2299.47216089067	2299.47216089067
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGAGTACGAGC"	-2.89356480065044	8.86221692645875	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGAGTACGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2444.96686186592	34.3177113248004	0.0140360639892723	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2441.13346235034	2441.13346235034
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGCAAGAGTAT"	-2.30655370178874	8.72358892047731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGCAAGAGTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2318.54434865333	43.2211810298313	0.0186415157661036	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2314.61667087997	2314.61667087997
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGCATCACGGC"	0.511802424758118	-7.19219210064086	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGCATCACGGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2596.59695811832	43.966565482173	0.0169323796458709	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2593.50628028901	2593.50628028901
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGACCAGTGTTCATG"	-2.57591615143474	8.53897569263307	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGACCAGTGTTCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2472.79350916177	43.591310194201	0.0176283664740683	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2467.02705911353	2467.02705911353
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGACCAGTTGGCCGT"	-4.29104409638103	9.81269834125368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGACCAGTTGGCCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2709.52450953033	37.2034782907304	0.0137306299167522	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2706.15644229515	2706.15644229515
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGGGCAATATCCG"	3.81859697875325	-8.41703226482543	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGGGCAATATCCG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2530.97830179435	45.2715398391008	0.0178869727199974	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2522.4911481692	2522.4911481692
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCGAATCACCGTCGA"	-7.78666959229167	0.789071775320448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGAATCACCGTCGA"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2610.82595768387	49.7236494548208	0.019045179671391	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2606.80391234375	2606.80391234375
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGGGGTACGACAG"	-4.25269113007243	10.5559997328552	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGGGGTACGACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2712.73322249076	46.0665148394865	0.0169815868576968	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2707.82307246495	2707.82307246495
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGGGGTCACAGAG"	-4.2466004890507	12.1039495238098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGGGGTCACAGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2626.35499097952	39.364358714888	0.0149882094576281	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2621.71272815462	2621.71272815462
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGGGTCGCTATTT"	-4.0893910926884	12.1883830794129	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGGGTCGCTATTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2958.11534050491	39.2122823289576	0.0132558327905715	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2949.60844016657	2949.60844016657
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGTCGTCTACACA"	-2.69618926468547	8.60969636524049	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGTCGTCTACACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2840.09496565089	40.087846420394	0.0141149668955547	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2832.34162617003	2832.34162617003
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCCATCCGTATGA"	-7.04300866547282	1.95375189864961	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCCATCCGTATGA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2885.31798617515	39.1725997597262	0.0135765277683152	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2872.62426990062	2872.62426990062
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGTCTCAACGTGT"	-4.20744214478191	10.1021909483704	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGTCTCAACGTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2554.12889332321	42.9123080010714	0.0168011520926955	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2538.62221349978	2538.62221349978
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGAGTCTCTGTCGTC"	-4.39092383804973	9.98092362964479	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGTCTCTGTCGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2623.8561373978	37.1462633324954	0.014157126529557	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2620.325666829	2620.325666829
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGATCGAGTTCCAGT"	-4.14051852646525	9.71269033038942	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGATCGAGTTCCAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2974.65490395128	35.4127944942677	0.0119048412799845	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2961.44804662552	2961.44804662552
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGATCGCAGAGTTCT"	-4.0634630722111	-8.00734236156615	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGATCGCAGAGTTCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2709.91816524191	34.5437652685083	0.0127471617820697	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2703.82069346526	2703.82069346526
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCAGTGGTATGAGAT"	10.4538494544918	7.60973641956178	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGTGGTATGAGAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2446.95499239837	40.0829536860428	0.0163807482403898	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2435.82351402253	2435.82351402253
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGATCGCATGAAGCG"	4.90174736556355	-9.17952444469603	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGATCGCATGAAGCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2628.15108742708	42.7299487898407	0.0162585587237576	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2622.79058750014	2622.79058750014
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGATCGGTAGCCCTG"	-4.00498090210612	9.64692399585573	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGATCGGTAGCCCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2613.23063086055	41.2332323022962	0.0157786426560896	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2609.11629896649	2609.11629896649
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGCATGAGCAATTCC"	-0.737576584250289	8.96906182849733	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCATGAGCAATTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2385.35987292028	37.4031935356753	0.0156803147232809	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2376.43188956935	2376.43188956935
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCCTAGTTGCTCA"	-2.802961687476	8.85020730579225	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCCTAGTTGCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.54953737903	38.5194414601378	0.0148692163204528	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.29722776051	2585.29722776051
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGCATGTCCGGGACT"	-0.438758323819	8.65858075702516	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCATGTCCGGGACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2589.10300204674	35.2564939049192	0.0136172619926856	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.83442024579	2579.83442024579
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCGGCAGGACATG"	-2.7961188358372	8.75600812518922	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCGGCAGGACATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2355.38783623194	41.8608289525263	0.0177723720521092	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2351.93468097476	2351.93468097476
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCGGGTGTATCCA"	-4.33415065231975	11.1226310499939	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCGGGTGTATCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2294.75548246898	44.8932533828143	0.0195634148064057	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2288.67600129262	2288.67600129262
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGCCTCTCGCACGGT"	5.12118830260579	-9.18160250103148	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCCTCTCGCACGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.10153792445	28.1616853252802	0.0126110187320255	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2229.85469357454	2229.85469357454
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCGGTCGTAACTG"	-4.09896359863933	10.5705108412537	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCGGTCGTAACTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2422.2435614363	45.9128732355794	0.0189546889365472	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2418.50764985863	2418.50764985863
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGATGTCAATGTTGC"	-4.24992595139201	9.79900643909303	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGATGTCAATGTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2770.82028121428	40.758651109798	0.014709958414169	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2768.45616611414	2768.45616611414
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCCAGAGTATGAGAT"	-4.27981458130534	12.2388334044251	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCCAGAGTATGAGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2634.87388219408	40.8954932914572	0.0155208541736363	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2623.15071558368	2623.15071558368
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTCACACGGCTAC"	10.5333029228145	7.31463668430177	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTCACACGGCTAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2244.18570577031	45.6216821326198	0.0203288355394637	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2229.56853271198	2229.56853271198
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCGATGGTACTAGCT"	-0.454186598688918	8.85639855945436	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGATGGTACTAGCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2280.38200189308	42.5439683428973	0.0186565094390234	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2266.46403385157	2266.46403385157
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCGTGCAAGAGCTG"	-3.66340766373332	10.1987313994202	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCGTGCAAGAGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2284.09181049571	43.8095411757002	0.0191802890647343	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2280.25230320265	2280.25230320265
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGGAGCACACCGAC"	-2.81201968613322	8.97018525684205	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGGAGCACACCGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2668.86884730962	42.8299675729471	0.0160479851290266	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2664.29662958155	2664.29662958155
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGGAGGTATGATCC"	-4.3181246322697	9.88204953754274	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGGAGGTATGATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2790.99312590815	37.7128281838599	0.0135123328802856	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2789.87574247293	2789.87574247293
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGGTTAGTTGCTCA"	4.32023443755452	-8.43504145061644	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGGTTAGTTGCTCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.94997050607	38.7451351864487	0.0130194175206043	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2967.66718571909	2967.66718571909
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGGTTCAGCCTATA"	-7.10805497589763	1.74050901019899	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGGTTCAGCCTATA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2581.91470665578	42.1063177657836	0.0163081753464744	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2570.27204585562	2570.27204585562
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGTTGAGGTCATAA"	4.84307970580403	-9.03068258678588	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGTTGAGGTCATAA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.02791818079	45.8676972107462	0.0186527761119034	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2457.75017920855	2457.75017920855
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCTGGGTCGTCGGT"	-2.23616943779643	8.75576970661012	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTGGGTCGTCGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2358.33649988092	49.2273983531276	0.0208737804616149	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2354.602881202	2354.602881202
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGTTGGTGTAAACA"	-4.21824298325236	11.3362073668274	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGTTGGTGTAAACA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2483.5007694978	47.3138972945305	0.0190512915782579	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2473.55748481791	2473.55748481791
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGGTTGTCGACCATA"	-4.47608600083049	10.42719838703	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGTTGTCGACCATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2915.64383362662	42.700097205444	0.0146451691777221	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2906.96607875692	2906.96607875692
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGTCCCAGCTGACTT"	-4.01023564758952	9.64982411945192	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCCCAGCTGACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2920.33316557847	42.7437406536739	0.0146365973435798	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2910.50506386551	2910.50506386551
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGAGTCAAACGTC"	5.35796036300008	-9.73974516307982	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGAGTCAAACGTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.49451797295	44.941778655248	0.0181987764411552	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2464.6285235002	2464.6285235002
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGTCCCTCGCTTTAT"	-4.06056008759196	9.67665383899537	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCCCTCGCTTTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2957.77029711571	40.1641882262422	0.0135792114301129	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2949.5544319442	2949.5544319442
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGTCTTCAAGCGGAT"	-3.71022806587871	9.49669072711793	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCTTCAAGCGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2945.53252408357	41.1727490271335	0.0139780323898965	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2929.74963259016	2929.74963259016
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATGTCTTTCAGAGCGA"	10.5839697318966	6.80719993198244	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCTTTCAGAGCGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2427.9910943119	47.3682570131006	0.0195092383675011	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2417.27479251223	2417.27479251223
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGAGACAGTCAACT"	-4.12315307083781	10.0894546278748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGAGACAGTCAACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2325.48076749741	45.9909362184068	0.0197769583224291	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2319.18632212791	2319.18632212791
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGCCTCTCTATGT"	9.92853321608846	7.97737405383912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGCCTCTCTATGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2707.5938997294	38.6714207396477	0.0142825778797598	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2696.93703136865	2696.93703136865
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTACCTAGGTCGACA"	-4.01283965531047	10.2090263136658	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTACCTAGGTCGACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2672.2996513468	40.1587877521486	0.0150278011419525	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2666.77883013858	2666.77883013858
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGTTTCCAATGCA"	-3.80014739456828	9.69487474048463	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGTTTCCAATGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2686.21185816047	42.1611926509168	0.01569540858173	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2684.94119618672	2684.94119618672
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTTCAAGCGAGTCA"	-0.4029477936333	10.9393739470276	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTTCAAGCGAGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2193.13502083618	37.6634522368858	0.0171733394793568	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2189.0509792594	2189.0509792594
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTACTCGTTAAACCC"	0.0924255895311057	-6.36750605022582	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTACTCGTTAAACCC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3511.7120144466	40.0722270132092	0.0114110231272834	4799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3499.34972315759	3499.34972315759
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTACTCTCTGGCTGG"	-4.290510515601	10.4230127104553	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTACTCTCTGGCTGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2871.36067847397	37.8130272871435	0.0131690273432454	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2862.92666759938	2862.92666759938
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTATCCAGAGCCCAA"	-1.67359946194347	8.57145307147828	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTATCCAGAGCCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.5204808476	41.4487255995733	0.0164184548764908	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.32248124238	2523.32248124238
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTATCCAGCCGAACA"	-2.75246725502666	8.51852128589479	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTATCCAGCCGAACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3562.0871578164	36.5081688603777	0.0102490947702576	3367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3544.15132561188	3544.15132561188
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACGCAGAACGTGC"	-1.7337728542393	8.57133290851442	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCAGAACGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2635.95622885099	42.286932630402	0.0160423500844074	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.63704867239	2626.63704867239
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCAAGCGCAATCCAGT"	1.15399374541585	-7.38137581264647	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAAGCGCAATCCAGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3087.1107903151	41.7844752973551	0.013535139531902	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3082.86188000188	3082.86188000188
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCAAGCGCATCTTAGG"	10.4640203910762	7.74842546069948	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAAGCGCATCTTAGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2606.03121717727	43.8113125569181	0.0168115071945963	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2599.31835710699	2599.31835710699
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCAATTTCATCTCATT"	4.79569925841634	-8.81380846416625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAATTTCATCTCATT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2456.06739512827	42.6443836216812	0.0173628719253668	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2453.38655693637	2453.38655693637
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCACTCAGGATCTT"	-0.547756115824539	8.47980878436891	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCACTCAGGATCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2570.58962606278	40.3238388799082	0.015686610756953	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.75010745812	2562.75010745812
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCACTCAGGCATGA"	1.10114779052083	-6.99104311382445	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCACTCAGGCATGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2994.19692369357	42.4223898059689	0.014168202989681	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2988.54614970887	2988.54614970887
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCACTCAGTCGCAC"	-4.43679032746013	10.4972181090149	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCACTCAGTCGCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3021.08696251844	42.3083705226531	0.0140043537467005	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3016.36995282837	3016.36995282837
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCAGGCAAGACTGG"	1.51499762114827	-5.6103611222473	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCAGGCAAGACTGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3288.15128388386	38.981334323176	0.0118550914960131	3262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3277.19052701331	3277.19052701331
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCAGGCATAGGCGA"	4.39474834975545	-8.07900717174681	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCAGGCATAGGCGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3111.44659744065	36.1197128377716	0.0116086558797063	3638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3104.95225822965	3104.95225822965
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCAGGGTACCTATG"	-1.8581911129063	9.14260575855104	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCAGGGTACCTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2123.93863660033	50.4994073818199	0.0237763024371794	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2116.02104881063	2116.02104881063
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACACTAGTTCCGGC"	-2.08443484726604	8.60391042316285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACACTAGTTCCGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2837.22390848489	44.9896214627692	0.0158569160961266	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2830.7958248733	2830.7958248733
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTCAAACATGAGGGT"	-3.42742286148723	9.8794898756775	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTCAAACATGAGGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2510.75742907552	40.3652261120457	0.0160769119488012	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2507.19927569943	2507.19927569943
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCATCCAGGACTAG"	-3.5257137817448	9.22967622363893	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCCAGGACTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2597.32731082601	34.0435677387916	0.0131071534946302	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2594.86231487773	2594.86231487773
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACACTCATCTATCT"	-4.01990495148357	12.6681012877258	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACACTCATCTATCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2682.77794562043	40.2764736914743	0.0150129733089631	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2678.76710554047	2678.76710554047
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCATCGTAGTAAGT"	-1.52687023106273	8.56380651080934	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCGTAGTAAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2654.64751479682	41.1196545304036	0.0154896852788197	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2647.69796345699	2647.69796345699
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCAATGTCATTGCA"	-4.26764617386516	12.5489463576111	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCAATGTCATTGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3097.54596327197	39.954147401548	0.0128986455327184	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3085.40796125288	3085.40796125288
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTGATTCACTCTTA"	5.35983719405476	-9.72432043468627	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTGATTCACTCTTA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.9928069183	42.1095343140485	0.0154022110839105	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2730.28596224462	2730.28596224462
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACGTTAGGTACTGG"	-0.12765451791938	8.78780839526979	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACGTTAGGTACTGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2316.98486120313	37.2831466397098	0.016091234459059	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2303.10111184535	2303.10111184535
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCATAGAAGGGAT"	-4.27664647522624	10.5052623518738	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCATAGAAGGGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2673.81862593943	40.6156647386069	0.0151901345680606	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2667.83566404564	2667.83566404564
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCATCAACAGCCC"	-4.06716189804729	9.88958261096803	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCATCAACAGCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.35631821178	37.6386132540992	0.0139023493143155	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2697.3597119635	2697.3597119635
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACTTGCACACTGGC"	5.40476193007771	-9.82363607799681	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGCACACTGGC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3027.4505389175	40.5380775559064	0.013390170057213	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3016.62910650137	3016.62910650137
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGCAGGTACCGGCT"	-3.1854866546696	9.08831212604371	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGCAGGTACCGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2819.13056208037	37.5173124034807	0.0133081145329413	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2810.78870332163	2810.78870332163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCCGAGTCGTTAC"	-3.02047048035319	9.53520677173463	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCCGAGTCGTTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2555.62481017883	45.4632574821199	0.0177894882304491	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2548.89365338439	2548.89365338439
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACTTGTCCACTGAA"	-3.07295976105388	8.96240327442018	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGTCCACTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2592.06760352954	42.039345304757	0.0162184602158961	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2587.39629596301	2587.39629596301
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCCGTCCTACTGC"	3.72132100638692	-8.21330740368041	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCCGTCCTACTGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3003.57983469309	36.3973789868323	0.0121179995172499	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2998.14376290319	2998.14376290319
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCCGTCCTTCTTC"	-4.30968604508098	10.2249936827454	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCCGTCCTTCTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3071.66297066176	38.2492380477151	0.0124522899852762	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3060.11558453194	3060.11558453194
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCTACAACCTATG"	1.5382796722347	-7.72047331249388	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCTACAACCTATG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.10351020274	48.9808914168793	0.0192602822576319	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2538.95274176483	2538.95274176483
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTTCGCTTAAG"	-4.43087850037273	10.168315864447	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTTCGCTTAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2861.66093463377	39.2314821185738	0.0137093397906676	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2856.47225535937	2856.47225535937
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCATCACAGGCATCAG"	1.82251264628713	-5.63751795208129	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACAGGCATCAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2856.27956003736	39.8329170346291	0.0139457347214669	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2852.53149817131	2852.53149817131
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCCTATCAAGGAGC"	-4.1539982360905	12.2482967146668	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCTATCAAGGAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3092.23307348526	43.6666771996609	0.0141214055221407	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3077.90803945211	3077.90803945211
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACGATCCGTAATG"	4.49825014647786	-8.21129991924437	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACGATCCGTAATG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2914.70228812809	39.374212127993	0.013508828084559	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2909.38071444354	2909.38071444354
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTTCACGTCAAGCGA"	-3.65826259079631	9.71841237628785	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTCACGTCAAGCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2704.01374410936	44.760810522152	0.0165534700478733	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2693.41196711288	2693.41196711288
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCATCACTCTTCGTGC"	-4.26842437210734	9.8561687239441	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACTCTTCGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2577.61299813927	37.4348790056295	0.0145230796991841	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2573.85394317086	2573.85394317086
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCAACTAGCACTGGA"	3.76045956191365	-8.18914511119994	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCAACTAGCACTGGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3072.73008757953	41.7889176772376	0.0135999311641967	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3063.52896008181	3063.52896008181
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTCTACGTATTTCCT"	-4.24693379822429	10.0243530043396	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCTACGTATTTCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2900.37835392874	43.2954600922602	0.0149275214503011	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2887.75915304033	2887.75915304033
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCAACTCATTGGCAT"	-3.92942605438884	9.81441972339479	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCAACTCATTGGCAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2673.96092879038	42.316483041583	0.0158253931783236	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2668.85903513014	2668.85903513014
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTGGGTAGTGATCGG"	-4.4809754890507	10.2853832014832	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGGGTAGTGATCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2574.3031596724	39.442207730468	0.0153215084953271	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2570.51966964384	2570.51966964384
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCAACTTCAAATGCC"	-3.85750208321269	10.4524745711121	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCAACTTCAAATGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2496.24520316451	43.6167114666619	0.017472927503824	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2494.92081886568	2494.92081886568
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCATTGCATCACGGC"	-0.509177367121536	8.3533258208069	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCATTGCATCACGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2499.78784419469	39.8039971760281	0.0159229501289342	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2487.8369077346	2487.8369077346
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTGGGTTCAGGGATG"	-4.3572863143986	9.96051309192506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGGGTTCAGGGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2734.80182478008	38.4958208649664	0.0140762743816225	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2720.41889267412	2720.41889267412
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTGGGTTCTACGCAA"	-3.85077772560771	9.53179929340211	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGGGTTCTACGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2794.79169979589	43.0702201400424	0.0154108873814059	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2788.7861282433	2788.7861282433
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTGTTCGTAGGTCAG"	-2.78130755844768	9.12783429706422	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGTTCGTAGGTCAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2739.68575320242	43.5591077239872	0.0158993080403732	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2726.10182161902	2726.10182161902
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGAAGGTCTAGATC"	-4.05530915680583	9.82329557025758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGAAGGTCTAGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.83100152897	42.2874863803162	0.0162654750848985	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2591.60985253292	2591.60985253292
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTGTTCTCAGATGCT"	4.85935558852498	-9.25249674236449	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGTTCTCAGATGCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3099.26199149442	39.0262150764366	0.0125920994041613	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3090.15182998003	3090.15182998003
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAAAGAGCCGTA"	-2.3743511241978	8.78738877857057	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAAAGAGCCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2301.33576008392	46.5550317206204	0.0202295695083288	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2301.33576008392	2301.33576008392
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAAAGGATGGCT"	-2.55320892754253	9.10607717120973	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAAAGGATGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.31440383077	36.8269018827151	0.016321706682451	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2252.15668982363	2252.15668982363
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAAAGTGGAAAG"	-4.30822215500529	10.3585481413635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAAAGTGGAAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2534.85635747032	40.7324907554475	0.016068954217231	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2532.07234262917	2532.07234262917
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ATTTCACTCAACCGAT"	-4.27913365784343	10.2396964796814	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTCACTCAACCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2807.27194352631	41.2473742730121	0.0146930454557957	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2798.83309299813	2798.83309299813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGACGTCTCCCTCGTA"	-3.86132917824443	9.8145131834778	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGACGTCTCCCTCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2672.77752787606	41.3467177380793	0.0154695695047001	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2663.88732800355	2663.88732800355
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAAGTTATCCAG"	4.63442434844319	-8.56890203869017	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	77	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	1	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAAGTTATCCAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.02293342862	37.4236396036472	0.0145559337947019	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2567.28334558649	2567.28334558649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAATCATGGATC"	-3.79253564301189	10.3330611952576	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAATCATGGATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2715.55006932624	49.776907639473	0.0183303221699842	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2703.83410077907	2703.83410077907
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACAACAGTAAACTG"	-4.01794705811198	9.65814492786256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAACAGTAAACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2810.86220382133	37.3294600374759	0.0132804304624848	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2799.84725427315	2799.84725427315
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTAACCACTGCTTC"	5.38243212279622	-9.62223055278929	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTAACCACTGCTTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.84313742369	37.9854120673962	0.0138237192473113	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2743.41862115819	2743.41862115819
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACAACCAATACGAA"	-2.9219835800236	8.76307962024537	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAACCAATACGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2858.55619769309	48.6052421367501	0.0170034236780006	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2851.55029016585	2851.55029016585
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCAAAGACCAGAC"	-4.3463924926823	10.6930074461731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCAAAGACCAGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2770.63793404494	41.4162619828238	0.014948276522858	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2761.81498190289	2761.81498190289
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGCTCCACCAGTTA"	1.3402769761974	-7.11568691646727	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGCTCCACCAGTTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2612.74411162615	41.5467367907954	0.0159015713042549	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2607.94412769224	2607.94412769224
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCAGAGAATCT"	-4.17699275437053	10.2463168867859	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCAGAGAATCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2671.93418778301	45.7425655511926	0.0171196452967828	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2668.28279464937	2668.28279464937
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACAGTGTAAGATTG"	-4.18543038788493	10.5786514052185	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAGTGTAAGATTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2607.98250194599	39.3370521696848	0.0150833267249043	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2601.32834981728	2601.32834981728
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCAGGCGTCCT"	-0.523016611964065	9.10346887195436	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCAGGCGTCCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2210.87157376742	42.1055287899089	0.019044764648251	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2206.14589625826	2206.14589625826
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCAACACACCTAA"	-2.79340658608134	8.84492204273073	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAACACACCTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.88700964721	45.287262145752	0.0174189347374358	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.58912837588	2586.58912837588
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCAAGTAAGATAC"	-4.53513846817668	10.7507381209168	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAAGTAAGATAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2984.9562788209	40.9687159880799	0.0137250640080608	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2979.19046574537	2979.19046574537
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCAAGTGGCCACT"	-4.19326911392863	10.243553138617	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAAGTGGCCACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2727.79405551931	39.4199697837435	0.0144512265154265	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2721.66000981589	2721.66000981589
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCGTTAAGGGC"	3.90058197554891	-8.18742086803588	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCGTTAAGGGC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.15243812893	40.3704947311369	0.0144533804099071	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2791.9388767944	2791.9388767944
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCTCTCCTGCA"	10.1274286704952	7.66293332660524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCTCTCCTGCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2504.97634008619	41.7281884266115	0.0166581167889097	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2498.3674758782	2498.3674758782
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCTCGTTGCATAC"	1.55101694640462	-7.42889120494994	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCGTTGCATAC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2803.70014425211	35.8421724440944	0.0127838822270544	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2798.58980720436	2798.58980720436
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTGATCAGAGGTTG"	-4.13050542298015	10.2360839613709	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTGATCAGAGGTTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2368.55996985858	44.6721049019671	0.0188604491633937	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2365.87581132419	2365.87581132419
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCTCTCCTGGGTG"	-4.47295175018962	10.7139692076477	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCTCCTGGGTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2549.2940442623	49.9087568558262	0.0195774814475231	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2543.26903667367	2543.26903667367
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCACGTCATGAAGCG"	-0.46210608902629	8.77774236286012	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCACGTCATGAAGCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2260.26906219099	32.0728808474969	0.0141898508385577	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2246.81121942649	2246.81121942649
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACCTCTCTTAGCTT"	-4.36139855805095	10.1535062559876	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCTCTTAGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3213.12180157499	41.3975418436484	0.0128839005802259	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3205.29051480573	3205.29051480573
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGACCCGTCACAGTT"	-0.92081985893901	8.53166101062623	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGACCCGTCACAGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3104.62258796758	39.0467737777581	0.0125769792209493	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3091.04467744247	3091.04467744247
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGCAAACGTGG"	-1.45082853260692	8.84963605487672	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGCAAACGTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.88726111724	33.9828873028528	0.0148080857298012	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2288.42730989028	2288.42730989028
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACGATTCTGGCCAG"	-6.0100339454716	2.76494906032411	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.238095238095238	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGATTCTGGCCAG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1666.90706195703	40.7101101111485	0.0244225434280379	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1656.21272685325	1656.21272685325
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACGGCAGCACAAAT"	-2.69550023499187	8.92160604083864	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCAGCACAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.44971738906	41.9348833915935	0.0163396473764759	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.97987589227	2555.97987589227
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACACGTCCAACCAA"	1.67265345629994	-5.82626297390135	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACACGTCCAACCAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.44677424853	41.3852240340883	0.0149813652229902	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2760.77566135218	2760.77566135218
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACGGCAGTAAGGGA"	0.574393768876237	-6.18156053936156	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCAGTAAGGGA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3337.54517990028	41.1235796072323	0.0123215049956151	3587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3326.59967383583	3326.59967383583
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACCAGTCGTCCATC"	-0.341649840504485	8.22775266254274	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACCAGTCGTCCATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2177.15744187509	35.1040549066699	0.0161238017203002	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2167.2397681707	2167.2397681707
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACCAGTCTATCGGA"	-3.02590570870097	9.59925553882448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACCAGTCTATCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2439.83036720169	48.1019245723966	0.0197152741514427	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.48266703315	2435.48266703315
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACGGCGTGCCTTCT"	2.10745729979817	-5.30354454433592	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCGTGCCTTCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3138.63085081952	39.3279281858305	0.0125302815320131	3237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3132.83683280786	3132.83683280786
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAACGGCTCAGAGCGA"	-4.1215914291447	12.3380412825379	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCTCAGAGCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2680.60465145532	44.415003649143	0.0165690243151036	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2667.97464097445	2667.97464097445
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGATCTTCACAAGGG"	-4.12575326386149	10.0727863081726	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGATCTTCACAAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2358.06740737536	37.2196388960054	0.0157839588383237	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2350.85519271307	2350.85519271307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAAGACTGTTGCTGAT"	-4.27467618408855	10.3047532805237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTGTTGCTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2604.40220467669	44.1395104365454	0.0169480391151892	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2598.40143847106	2598.40143847106
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCTTTCGTGTTCGTA"	10.251144071191	7.51697251880494	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTTCGTGTTCGTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2209.78363850157	48.1103381771196	0.0217715152465074	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2204.62875590667	2204.62875590667
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGCAAGGTAACACCT"	-4.16387305679973	10.0296315916809	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGCAAGGTAACACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2565.43759026965	41.1550293698441	0.0160421089664935	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.3222020481	2558.3222020481
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAAGACTTCGTAGTCA"	10.9709650474483	6.5334172018799	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTTCGTAGTCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2297.75156462909	41.2147295081965	0.0179369824582622	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2292.36607469307	2292.36607469307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAAGACTTCGTGGACC"	3.43823685225789	-8.04272463237914	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTTCGTGGACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.65332566516	42.2099833608767	0.0163690027429293	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2576.6588532524	2576.6588532524
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGACAAGAGGATGA"	-2.86047897759135	8.87567422473756	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGACAAGAGGATGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2701.36926744216	40.7433583253427	0.0150824838412119	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2698.83326512846	2698.83326512846
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAAGCTAGTACGGTTT"	1.67324497279469	-8.08369448101195	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGCTAGTACGGTTT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.88351528225	48.1113367080833	0.0181628736901844	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2645.30993503108	2645.30993503108
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGACATCCATCCGT"	-2.79776130142863	8.71147916400758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGACATCCATCCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2401.23878752289	46.4801453130532	0.0193567360124988	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2396.00811490114	2396.00811490114
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAAGGGAAGACTTCCA"	-4.25303302231486	11.9897870787415	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGGGAAGACTTCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2906.27897838353	43.4103181936796	0.0149367347445166	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2892.80971586525	2892.80971586525
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGGTACACACAGAG"	-0.516693632037002	8.66076467120973	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGGTACACACAGAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2262.15140565833	36.7461968844928	0.0162439157664599	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2248.99845300105	2248.99845300105
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCACTCTCATTGT"	0.612458367913407	-7.06507065212401	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCACTCTCATTGT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2771.83654768141	37.7606418163687	0.0136229684423329	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2767.30772114549	2767.30772114549
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGGTATCTGATTCT"	-1.68190417710002	10.3006276854309	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGGTATCTGATTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2024.30698530308	42.6606392975264	0.0210741945798005	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2016.04294537496	2016.04294537496
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATACGAGGAGGCAG"	-3.96709046784099	10.0571737059387	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGAGGAGGCAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2807.13975490241	40.8955890900047	0.0145684193380769	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2800.20373822482	2800.20373822482
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCGTAGATGACCG"	-0.285378138453323	8.855273223761	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCGTAGATGACCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2257.27120416229	41.8461423993085	0.0185383760365818	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2249.41270693222	2249.41270693222
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCGTGTACGTGAG"	-2.79847774925883	9.06802175128785	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCGTGTACGTGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2367.09152520604	41.4588142748786	0.0175146646563528	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2356.99434618723	2356.99434618723
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATACGTCAACACGT"	1.6581127839977	-5.69946529781493	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGTCAACACGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3321.35993848401	40.9581188025866	0.0123317314477158	3758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3313.02684555508	3313.02684555508
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGTCGGTGACACAG"	-2.89284549179729	9.11778066242067	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGTCGGTGACACAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2568.41524818572	42.4796856099037	0.0165392592338449	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2567.25021894598	2567.25021894598
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAGATTCACGGAGA"	-0.764119963080245	8.42636392200319	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGATTCACGGAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2062.79982151608	43.8383703435488	0.0212518780961156	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2059.46138241888	2059.46138241888
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGTAGGGTCTTACTT"	-2.26453862610515	8.61353967273561	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTAGGGTCTTACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.98498446382	45.7727774514966	0.0197212725450142	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2316.04404987813	2316.04404987813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATCGAAGCATTTCG"	-0.847369532019454	8.75108621204225	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATCGAAGCATTTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2510.85100194325	40.260378163714	0.0160345548710596	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2504.60158794668	2504.60158794668
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGTGAGAGAGGATGA"	-3.76028929176982	9.8420314558777	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTGAGAGAGGATGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2398.00942324676	47.4475297810178	0.0197862149001803	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2396.69684180686	2396.69684180686
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAATTCCAGTTCCGGC"	10.266018529504	7.14516065204469	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATTCCAGTTCCGGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2375.7503878145	39.017381930341	0.0164231823892214	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2370.19348320887	2370.19348320887
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGGCGTCTATCACT"	-4.34943757477458	10.6948756941589	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGCGTCTATCACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2712.42164502783	41.5477417337827	0.0153175822829553	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2707.60907140725	2707.60907140725
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATGACTCATTTCGT"	-3.87040934982951	9.68395135486452	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATGACTCATTTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2731.17433689431	42.9323284229651	0.0157193657845308	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2721.20140345431	2721.20140345431
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATTTCCAAAGCTAA"	-1.9761405986851	9.88486192310182	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATTTCCAAAGCTAA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2806.58733188209	45.0094218725703	0.0160370644309817	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2796.37893359779	2796.37893359779
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATTTCCAAGATTGA"	-4.41731200638469	10.2915067442688	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATTTCCAAGATTGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2776.20598398022	45.1012615113517	0.0162456466744915	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2770.64913632747	2770.64913632747
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGATGAAGGCACTAG"	-3.83061156693156	9.99492452228395	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGATGAAGGCACTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2620.17106771119	46.7300456397978	0.0178347307989391	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2615.81293170606	2615.81293170606
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATTTCTCGGATACT"	-3.96276936951335	10.2540111311707	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATTTCTCGGATACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.86392772458	39.2651693452388	0.0169768609707482	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2303.77386815631	2303.77386815631
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAATTTCTCGGTTCAA"	-3.62688956680949	9.33505151355592	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATTTCTCGGTTCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2886.42100623528	32.2965020405431	0.0111891168927803	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2882.41376885029	2882.41376885029
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACAACAAGTCCCGAC"	-4.1917875808781	9.68952081287233	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAACAAGTCCCGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.38674735727	39.2622519920564	0.0150870165750449	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2594.28775476567	2594.28775476567
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTAAGACAAATGGCG"	-4.17431483689006	10.341055847052	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTAAGACAAATGGCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2466.64651161285	40.9258891046345	0.0165917122343869	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2462.5641105859	2462.5641105859
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACAACAGTAGCTGCC"	-4.5096906227177	10.61225698078	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAACAGTAGCTGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2782.80931599811	42.1462388027953	0.0151452126311711	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2770.65361327196	2770.65361327196
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTACGTCATTGAAAG"	-0.417089234024841	9.00888917529909	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTACGTCATTGAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2625.63833804396	37.2704974676878	0.0141948329012645	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2610.60692217059	2610.60692217059
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACACAACAGCTATAC"	-4.34463153305705	10.1234750517639	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACACAACAGCTATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3008.92428849132	38.2395734718925	0.0127087190655322	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3000.01575983349	3000.01575983349
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCCGAGTGGAGAAA"	-2.57929716530498	8.64707086170045	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCGAGTGGAGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2470.84850546277	46.6266556210437	0.0188707059611131	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.37070006483	2461.37070006483
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTATCGAGGAAACGA"	-0.365027527243453	8.66654012286989	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTATCGAGGAAACGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2346.595891644	35.4155984728806	0.015092329531042	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2340.76745060208	2340.76745060208
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTATCGCACACGCCA"	-4.08039174500163	12.574155784491	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTATCGCACACGCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2492.98863282238	46.1345988864283	0.0185057397691373	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2489.26016835325	2489.26016835325
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACAGGCAGCTGCGAA"	-0.446791808039504	8.30834481799928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGGCAGCTGCGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2378.15544411316	45.6549220615471	0.0191976189674903	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2367.23344548095	2367.23344548095
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCACAAGTAGGCCA"	-0.57275621119197	8.65380570972291	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCACAAGTAGGCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2537.08820218757	37.5006195884077	0.0147809680231351	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2533.73472884662	2533.73472884662
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACAGGCGTCAGGCAA"	-4.36440787735637	10.3561525114807	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGGCGTCAGGCAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2485.95480509693	39.3119360923213	0.0158136165676545	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2477.59605713751	2477.59605713751
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACATGACAGACACCC"	-3.66330657425578	9.93254754627077	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACATGACAGACACCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2769.55143171257	45.5541910190783	0.0164482199165768	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2758.98609369237	2758.98609369237
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCACACAGCTTCGG"	-4.49282012406047	10.5140514143738	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCACACAGCTTCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2684.86259259577	40.5020908461885	0.0150853496033219	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2677.43276473106	2677.43276473106
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTCACAGATCACTC"	-4.22796664658244	10.0316104658875	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCACAGATCACTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2727.39519209031	40.930448561931	0.01500715726149	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2716.93762632432	2716.93762632432
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACATGATCGCTGTTC"	-4.29118190231975	10.592032409552	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACATGATCGCTGTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2799.90241093222	41.8148030790525	0.0149343787539832	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2790.49257915592	2790.49257915592
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCTCTGTCTCAGAT"	-2.90499864044841	8.85406110370485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCTCTGTCTCAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2572.05100141358	35.1124306953993	0.013651529723206	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2559.68478991537	2559.68478991537
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACCGTTCAAGAGGTC"	-4.35290370407756	10.2072000273499	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACCGTTCAAGAGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2616.17850180871	36.3146214896096	0.0138807888928463	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2610.18639613703	2610.18639613703
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACCGTTTCATTTGTC"	11.7539202171261	-3.09289886867674	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACCGTTTCATTTGTC"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2080.82477144718	35.3134577716886	0.0169708945492458	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2070.74294573979	2070.74294573979
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACCGGGCAGCTACAT"	-2.839502911002	9.40923020923463	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGGGCAGCTACAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2158.87639159823	46.6767044743219	0.0216208323255445	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2152.69850747853	2152.69850747853
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGAATCAACCGATT"	10.4958864646846	6.81670138919679	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGAATCAACCGATT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2481.32210565551	44.3466871861089	0.0178722009065379	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2471.26718929176	2471.26718929176
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGAATCACGACTAT"	-3.46054897728618	9.79777333820192	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGAATCACGACTAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2881.31720060526	46.8278233073163	0.0162522277302476	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2872.89353705493	2872.89353705493
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGCAGCTGCCA"	2.14254726943318	-5.43506195461424	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGCAGCTGCCA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2846.19905010184	46.2502472598116	0.0162498287876798	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2838.91956049447	2838.91956049447
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGAATGTGCATGTT"	-4.19641719284709	10.0835799940857	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGAATGTGCATGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2594.5318604487	39.7350389237053	0.0153149165479253	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.57831731416	2585.57831731416
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGCTCAGGAACGCT"	-4.08931861344035	10.500612235907	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGCTCAGGAACGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2400.38041005648	42.941355685195	0.0178893959912732	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.52758280809	2397.52758280809
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCCTCTCGCTAAAC"	4.1279407936031	-8.48172762310179	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCCTCTCGCTAAAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2697.46551548656	44.8910421198113	0.0166419336455221	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2694.76704083065	2694.76704083065
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTGTCAGTCACGCC"	-4.15871940079387	9.82734677875368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGTCAGTCACGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2672.42649613556	38.0983722411987	0.0142560973318782	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2667.56842134794	2667.56842134794
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGCTCGTAGTCTGT"	-0.688735644251663	8.71222970569459	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGCTCGTAGTCTGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2364.54833851189	41.1341586720534	0.0173962012119156	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2356.10739979985	2356.10739979985
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCTAGGTAGAGTTA"	3.01334895667378	-4.39099981701048	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTAGGTAGAGTTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2515.61078022874	42.1910556382693	0.0167716945601707	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2509.53733985868	2509.53733985868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGTGGCAACAGAGC"	4.06983580169026	-8.49655535137328	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGCAACAGAGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2896.92459101015	39.4268983295426	0.0136099153053185	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2890.49124151602	2890.49124151602
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGGCGTCAGGCAA"	-4.35031781616862	10.5455360182556	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGGCGTCAGGCAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2528.19378445768	42.8764176065294	0.0169593082105163	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2517.55162116192	2517.55162116192
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCTCCCAGAAATTG"	-4.37352452698405	12.8828706511292	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTCCCAGAAATTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3232.68738702348	35.4429311732928	0.0109639216323751	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3209.85164831607	3209.85164831607
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGTGGTCACAACCA"	-1.3921950859135	8.43725679004518	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGTCACAACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2374.57267048306	46.9027815535573	0.0197520935604872	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2366.26910645078	2366.26910645078
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGTGGTCATCGACA"	-4.37260852280315	9.86680791461793	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGTCATCGACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2975.30633219592	39.0662771322515	0.0131301697272357	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2970.75094215731	2970.75094215731
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGTGGTCGGCTATA"	-2.83295689049419	9.01280400836793	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGTCGGCTATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.91907556374	43.8177997347392	0.0161813549489536	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2701.06176814987	2701.06176814987
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTGCATCACATATGC"	-2.51291308823283	8.55881211841432	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGCATCACATATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2650.62387308754	39.5359795908151	0.0149157260644311	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2648.05167272515	2648.05167272515
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACGTTCTCCGCTAGG"	-3.87545857849773	9.60413739765016	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTTCTCCGCTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2768.89671771972	41.2879150670485	0.0149113236340034	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2767.75534947557	2767.75534947557
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACTAAGAGTGCGTCC"	-4.05375180664714	9.89155957782594	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTAAGAGTGCGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2409.24005148802	43.2071324011476	0.0179339258346056	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2403.68602787701	2403.68602787701
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCCTCAGACTGGGT"	-3.65941701355632	9.57589910114137	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCCTCAGACTGGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2836.35513751482	37.8006694148961	0.0133271990220578	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2830.90692815535	2830.90692815535
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGTCCGTAACGTTC"	-3.88647017899211	9.52545926654664	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGTCCGTAACGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2499.8540484477	44.2291471344128	0.0176926917640961	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2498.39957083334	2498.39957083334
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGTCCTCGGCAGTC"	-4.24933562699016	10.3639402159485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGTCCTCGGCAGTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2343.70226440938	42.440153944413	0.018108167828693	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.94368511961	2336.94368511961
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTTGTGTCACGAGGA"	-4.47677407684978	10.7263660200867	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTGTGTCACGAGGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2821.18377038247	40.909605077537	0.0145008650294308	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2815.53153399715	2815.53153399715
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTTGATCAGATTGC"	-3.5308772129124	10.0067271956238	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTTGATCAGATTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2368.09428139277	34.6593522907496	0.0146359680706484	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2365.2822881109	2365.2822881109
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACTGGGAGGCAGCTA"	14.3016163307125	1.94491574848024	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasmablast"	"Plasmablast"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGGGAGGCAGCTA"	"Plasmablast"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1451.28476124657	28.2532326859164	0.0194677388203598	3276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1435.98605241261	1435.98605241261
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGATGCGAGTCACAGG"	-4.20073543015178	9.85394284808961	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGCGAGTCACAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2809.47400785735	37.6019933187896	0.0133839975787734	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2808.34738238665	2808.34738238665
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACTGGGTCAATGTCG"	10.5205418067867	7.29546735370485	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGGGTCAATGTCG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2393.38911153487	48.1834278413983	0.0201318822790576	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2390.17018850797	2390.17018850797
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACTGTCGTTCTAAGC"	-4.30596909943278	10.7245063551697	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGTCGTTCTAAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2761.65068928765	40.344917765637	0.0146089865463918	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2752.31071168014	2752.31071168014
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAAGGATCTTGGGCG"	-2.8332544368809	9.19648931110231	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAAGGATCTTGGGCG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2508.01004195866	45.3134215703594	0.0180674801186089	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2501.89944081371	2501.89944081371
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAAGTTCATCCGAAT"	-2.7331625026768	8.56205365741578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAAGTTCATCCGAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3098.85300426189	35.8380307213371	0.0115649340811096	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3085.98535117935	3085.98535117935
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAATTGAGCTGAAGC"	-3.45602140846904	9.48776433551637	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAATTGAGCTGAAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2330.77055273112	39.7265291139234	0.0170443757612147	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2325.96653102508	2325.96653102508
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CACTTCGCACAACCGC"	-1.52598104897197	8.68403527820436	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTTCGCACAACCGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2673.90141447909	41.1998152473975	0.0154081279976524	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2660.64655248394	2660.64655248394
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGACAGCTCTGAATCG"	-4.02752623978313	9.65912816608278	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGACAGCTCTGAATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2610.14652325476	35.546451184328	0.013618565420612	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2605.72395093529	2605.72395093529
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGAAGCACGCGTCA"	-3.75591454926189	9.90072915637819	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGAAGCACGCGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2343.35656037532	43.8443689662151	0.0187100715732278	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2337.48481060279	2337.48481060279
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGAAGTCGAGAGAC"	-3.99996934357341	10.2690543898377	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGAAGTCGAGAGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2292.55179393702	38.2923411647018	0.0167029339384922	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2287.7478513733	2287.7478513733
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGAAGGTTTCGATG"	-3.98763738098796	10.2953824766907	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGAAGGTTTCGATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2679.79891783085	42.2626453431586	0.0157708270803273	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2669.6706304196	2669.6706304196
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGAAGTCAATCGGT"	-2.77671633186992	9.01833436572877	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGAAGTCAATCGGT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2649.64041286891	45.6148584705624	0.0172154901657666	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.17174634064	2639.17174634064
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATACAGCAAGCCA"	-3.87193093720134	10.1014079817566	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATACAGCAAGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2771.60176843224	42.187404196939	0.0152213080094845	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2763.81285558784	2763.81285558784
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATACAGCAGCGAT"	4.4886609512264	-8.67023565685423	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATACAGCAGCGAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.63697249008	42.3354207221217	0.014809652687464	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2857.53683519656	2857.53683519656
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATCAAGACAGTCG"	-4.36965451660808	10.1609086760315	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATCAAGACAGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2598.75509628156	39.9362895814188	0.0153674694620365	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2589.1542572311	2589.1542572311
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGGAATCATCACTT"	-1.50219510021861	9.09979055011598	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGAATCATCACTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2537.57214439797	42.873197184696	0.01689536089815	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.7462177427	2523.7462177427
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATCAGTACAAAGT"	-3.61684236946757	9.45067498767702	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATCAGTACAAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2559.96297267788	37.0513288125585	0.0144733846575134	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.67056606688	2556.67056606688
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGGCTGTCTCACAA"	-3.28464708748515	11.9762439497742	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGCTGTCTCACAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2735.3300012938	45.5672747226371	0.0166587851195592	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2727.50741565787	2727.50741565787
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCAGAAGATGACAT"	-4.24585137787517	10.7092876204285	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCAGAAGATGACAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2871.06735482406	38.134128056723	0.0132822129695595	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2862.08661111397	2862.08661111397
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGTGCAGCATGGGT"	-5.03417859497722	-5.12401487743529	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTGCAGCATGGGT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3184.50887734329	43.4420273018761	0.0136416725388808	3004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3176.76064459307	3176.76064459307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATTGGTCAGATTC"	-4.29091630402263	9.91084287250368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATTGGTCAGATTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2845.03398745885	34.6056115497035	0.0121635142856809	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2836.81823253563	2836.81823253563
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGTGCGTTCCCACT"	-3.91976628723796	10.2984514006409	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTGCGTTCCCACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2544.43457449376	43.7357062960232	0.017188772206778	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2539.69989134377	2539.69989134377
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATTGGTCTGGTTA"	-1.82260761681255	8.52888772571412	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATTGGTCTGGTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2536.31294447331	39.8476101601904	0.0157108413009598	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.56479789684	2523.56479789684
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGATTGGTGAGTTTC"	-4.24750647965129	9.85285375202028	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATTGGTGAGTTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2600.78405668429	38.2451666179531	0.0147052449509058	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.63979663475	2592.63979663475
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAACCCAGTTGGGTTT"	-2.68531833115276	8.8469142683777	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAACCCAGTTGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2409.49687264521	44.969266337699	0.0186633428946229	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2404.68781560518	2404.68781560518
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGTTACATCCTTGC"	-2.44001040878947	8.70508191669313	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTTACATCCTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2412.29836126983	45.9365853387077	0.0190426632444118	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2404.49090417882	2404.49090417882
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGTTAGTTAAGGGC"	-4.35374484482463	10.5274410017761	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTTAGTTAAGGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2534.26598262327	45.2801112094789	0.0178671502991208	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2528.54940923199	2528.54940923199
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGCAGCAGGTTGTTC"	-0.628108362585861	9.09556672656862	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAGCAGGTTGTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2514.4511592691	33.8156124068264	0.0134485063597958	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2505.3760766791	2505.3760766791
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGAACGTGAGTAAT"	-3.39443073692973	9.551806426886	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGAACGTGAGTAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2319.16861666799	33.565202184365	0.014472946013123	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2308.75079524074	2308.75079524074
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGCAGCGTCTCACAA"	-3.69304976883586	9.54382321918336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAGCGTCTCACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2601.63648175526	37.4687350036071	0.0144019870825027	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2594.03152034896	2594.03152034896
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGCAGCTCCGTGGTG"	-4.25467477265056	10.3119621046814	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAGCTCCGTGGTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2443.46431269513	35.4074205148147	0.0144906640669372	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2430.73237581142	2430.73237581142
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGCCAGAGAGTGTGC"	-3.85825906220134	9.746950126532	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCCAGAGAGTGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.66789306708	41.9949435926291	0.0170249686675137	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.86068308045	2461.86068308045
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGATGCGCATGGCTGC"	-3.81095800820048	9.94186971271364	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGCGCATGGCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2652.0799864836	35.1071221016427	0.0132375804201107	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2649.69256746129	2649.69256746129
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGATGCGGTGAAGCGT"	-2.51484165611919	9.28034589374391	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGCGGTGAAGCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2095.41972124075	38.0791613839725	0.0181725699142628	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2090.68842515693	2090.68842515693
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGCGTGAGCGACTAG"	-1.65287898007091	8.55475423419801	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCGTGAGCGACTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.65337554616	43.9443872572893	0.0174061071840339	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2518.92501733367	2518.92501733367
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGATGGCCACAAATAG"	3.49690069732015	-7.70494940197142	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGGCCACAAATAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.62667279575	37.3355861141433	0.0138145554803991	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2701.57417678992	2701.57417678992
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGCCAGTATCTCGA"	4.36777128753011	-8.58094408428343	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGCCAGTATCTCGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2963.01120225072	42.5085576280038	0.0143464046290861	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2955.30519254668	2955.30519254668
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGGTAGTAACCCGC"	-4.13316808167155	10.3848876723084	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGTAGTAACCCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.85322512691	44.2875036290678	0.0172536174626339	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.98700766625	2562.98700766625
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGGCTCAAGCGGAT"	1.52914084967915	-5.58752109920653	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGGCTCAAGCGGAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2926.08434499619	44.7210209830531	0.0152835720745812	2540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2919.81530023505	2919.81530023505
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGGCTCATCCGTTC"	-4.13791404190715	10.431556678656	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGGCTCATCCGTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2801.73683870465	41.8930418461608	0.0149525256146218	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2795.69745064731	2795.69745064731
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGGCTGTCCGGTCA"	1.78930630263631	-7.65642406856688	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGGCTGTCCGGTCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2913.5456025496	32.9549639022366	0.0113109483762321	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2912.67093764178	2912.67093764178
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGGCTGTGAACGGT"	-4.27648625794108	10.312605834845	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGGCTGTGAACGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2328.79284431052	44.139036433898	0.0189536121865602	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2323.73785391973	2323.73785391973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGGGCTTCTGGGCCA"	-2.62551341477092	9.02372262561647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGGCTTCTGGGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2459.14754402165	43.1538568892417	0.017548299203987	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2451.98303032878	2451.98303032878
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCATGGCACCAGGTC"	3.84036244925801	-8.448757194635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATGGCACCAGGTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2715.19851901063	42.4031738255792	0.0156169700037366	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2711.50691529902	2711.50691529902
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCATGGCACTTCAAG"	-4.33586917343791	10.1665258177551	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATGGCACTTCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2866.19332622495	39.9667410074696	0.0139441888451082	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2857.84368616063	2857.84368616063
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATATCCCAATCCTAG"	0.309777726500672	-6.39613487636717	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATATCCCAATCCTAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2782.95200882508	39.7400065923063	0.0142798030531198	2627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2780.14661414048	2780.14661414048
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTGCGCAAGTTGGG"	5.45068325576131	-9.64282419597777	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTGCGCAAGTTGGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2261.45542718144	30.0238259963484	0.0132763288789506	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2258.77191652417	2258.77191652417
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAATCGCACTGTGAT"	-3.7499705356663	9.51975534046022	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATCGCACTGTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2777.73760327152	45.2837347343136	0.0163023802827812	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2771.50992264781	2771.50992264781
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTTAGGTAACACCT"	-2.84020171585734	8.72951886737672	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTAGGTAACACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2486.59286077755	40.8893639509725	0.0164439320147434	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.07629745865	2480.07629745865
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTTAGGTATTAAGG"	-4.38730893555339	10.1582956084046	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTAGGTATTAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2819.18148740424	39.7324782659267	0.0140936220117245	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2813.04707654755	2813.04707654755
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTTAGGTCTAACGT"	-2.68509445610698	8.81060502612916	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTAGGTCTAACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2541.94306780098	40.9454525774456	0.0161079345545167	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.12422775583	2539.12422775583
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCAGAATCGAT"	-0.401890258223373	9.09189412677614	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCAGAATCGAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2464.60893755679	39.0874423033166	0.0158594906103297	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2460.75060585264	2460.75060585264
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCGTGACACATATCG"	-3.78242431107219	10.4449405440125	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCGTGACACATATCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2225.62395147372	47.4605684830507	0.0213246125661184	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2224.23658867739	2224.23658867739
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCGCCCACAAGGTG"	-4.31813559952434	10.6778058775696	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCGCCCACAAGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.38848012905	46.8231802991655	0.0182590043053107	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2560.86728830968	2560.86728830968
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCGTCTAGGTT"	-0.601308981806594	8.83010861957399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCGTCTAGGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2651.0415455929	33.2667597759625	0.012548562217467	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.76754774328	2639.76754774328
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAACCAGGAAAGTG"	-3.76566229286845	10.2512264021668	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAACCAGGAAAGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2355.78433886998	39.0792853952274	0.0165886514951419	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2348.60652079861	2348.60652079861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAACCCAATGGCAG"	0.719683964818162	-7.15550329601439	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAACCCAATGGCAG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2751.80811626515	43.3059849043105	0.0157372836602746	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2746.51961637991	2746.51961637991
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATAAGCCAACTTGCA"	-4.38314185562785	10.728280998114	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATAAGCCAACTTGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2879.37619359388	39.0457119686206	0.0135604760696052	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2868.42240594915	2868.42240594915
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATAAGCCAGTCGGAA"	-4.30928121033366	9.97370145404664	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATAAGCCAGTCGGAA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2611.34092876174	45.0849396861523	0.0172650530574462	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2603.23218572715	2603.23218572715
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATAAGCGTGTGTACT"	-4.22487149658855	10.0674829252991	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATAAGCGTGTGTACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.45951526618	38.9755413344095	0.015216145756791	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.81320938199	2558.81320938199
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGACACAGGAAGTAG"	-4.11922631684001	10.2271108397278	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACAGGAAGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2587.09377585712	41.7642666032643	0.0161433137805094	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.12760245887	2579.12760245887
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGACACCACTGGATT"	0.860471149056595	-8.04333689129027	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACCACTGGATT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1580.40979804772	48.9425295857425	0.0309682524407285	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1578.05219933433	1578.05219933433
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGACACCATTGAGGG"	-4.40996680679973	10.5182094343933	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACCATTGAGGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2660.28515647048	43.0053507312691	0.0161656920975818	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2650.7729302769	2650.7729302769
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGACACGTAGCTTTG"	1.7327285009319	-5.66960480129393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACGTAGCTTTG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2829.10030087769	43.7102124227984	0.0154502165968587	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2825.18803364863	2825.18803364863
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGACACGTTCTCAGA"	-2.4375778240269	12.4490842589172	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACGTTCTCAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.2993476197	49.0801688671882	0.0205933715024957	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2372.47042042001	2372.47042042001
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGCTAAGAGTCACG"	-2.91512809220012	9.30849645221559	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGCTAAGAGTCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2226.24003371385	39.4076533391978	0.0177014395314136	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2219.71096263622	2219.71096263622
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGAAACAATTGAAG"	5.20312466201131	-4.10627128994139	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGAAACAATTGAAG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.76239266003	46.7157170167048	0.0199660090115367	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2331.64761340973	2331.64761340973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATACCCGTATAGGGC"	-0.3864543241566	8.92760655963746	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACCCGTATAGGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2543.60141164989	42.2746718562989	0.0166200064454587	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.19453844792	2532.19453844792
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGGACTGTATGGTTC"	-0.935819367796737	8.29729459369508	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGACTGTATGGTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2419.52644632107	37.8063910518433	0.0156255332977776	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2412.2616431302	2412.2616431302
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCAACCAAGGCGTA"	0.692799289792222	-7.10349848186644	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCAACCAAGGCGTA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2497.09252681338	42.6326508604171	0.017072915962318	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2493.19742109993	2493.19742109993
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGGCATGTACGTGTT"	-4.30165181580241	9.95553491199342	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGCATGTACGTGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2523.77068852223	40.0892918704159	0.0158846808280708	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.56927779687	2519.56927779687
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCAAGGTCCAAGAG"	9.88143887099568	7.72205302799074	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGGTCCAAGAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2347.00805639376	32.0795736002751	0.0136682843984635	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2339.30600624821	2339.30600624821
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTGCTGTCTACAGT"	-4.34168515625651	10.6129131087097	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGCTGTCTACAGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2513.8971134587	42.8566911963251	0.0170479097839297	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2508.21376384742	2508.21376384742
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCAAGGTTGTAAAG"	-0.547482113272506	8.61390492999879	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGGTTGTAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2583.27872638257	35.8484605459784	0.0138771167740687	2693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.4853172249	2571.4853172249
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCAAGTCCGAGAAG"	-0.628821234137374	8.53258035266725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGTCCGAGAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2359.73877217192	34.7688870302961	0.0147342101762792	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2351.46248227771	2351.46248227771
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTGGGGTAACGATA"	-4.10563121262248	13.1062068709168	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGGGGTAACGATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2633.11862412592	40.568116738929	0.0154068701528386	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2626.2491750086	2626.2491750086
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGTCAGAGCTGACAG"	-4.26002917710002	10.7314491041931	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGTCAGAGCTGACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2292.44363722072	48.0226294711146	0.0209482269013757	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2282.89184484549	2282.89184484549
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCCAAAGTGACCTT"	-3.67776689949687	9.39167974078981	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCCAAAGTGACCTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2460.73005302107	42.5074476291434	0.0172743237629647	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.66128913935	2452.66128913935
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGATATCATTTCCA"	-4.15822110596355	9.88272569263307	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGATATCATTTCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2774.11034035418	44.9954121072436	0.0162197629462348	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2764.60864028997	2764.60864028997
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAAGTCAGGATTCT"	-3.71791181984599	10.4047965773377	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAAGTCAGGATTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2496.45633740873	47.0614696087295	0.0188513089147709	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.06036400002	2485.06036400002
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCCCACAACTGCCG"	-4.33680472794231	10.6220712431702	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCACAACTGCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2999.9629502394	39.1814845666299	0.0130606561536046	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2993.60673691305	2993.60673691305
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCCCACAAGACGAC"	-4.15629468384441	10.5552224882874	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCACAAGACGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2703.2564408306	44.7277627061846	0.0165458822295237	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2692.1337513171	2692.1337513171
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAATGCAATCCTTT"	-0.741647343069869	8.81449792468873	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAATGCAATCCTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2458.1308586512	36.3838069338269	0.0148014117335442	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2451.39848457542	2451.39848457542
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAATGGTGGATTTC"	-3.98861489716228	9.8262033232483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAATGGTGGATTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2744.10609041233	40.1060860681398	0.0146153555098569	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2738.96593169322	2738.96593169322
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAATGTCTATCGTT"	-4.20540700379069	9.84370992267457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAATGTCTATCGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2526.09987589974	37.8949411698795	0.0150013629830777	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2514.77759500116	2514.77759500116
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACGGGAGTGTTAACC"	10.8405653434688	7.0228609808716	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGGGAGTGTTAACC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2246.74970614422	39.6362670694412	0.0176416033174711	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2244.13370148774	2244.13370148774
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAGTACATGTTCGA"	-4.36693177643474	10.6112003096375	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAGTACATGTTCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2213.34168462549	38.1468161685144	0.0172349422746127	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2211.76370178334	2211.76370178334
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAGTAGTCCTTAAG"	0.677322168915909	-7.012402557489	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAGTAGTCCTTAAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.44064417966	38.2147988605017	0.0140112302506204	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2721.82540065085	2721.82540065085
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTCAAAAGGGTCAAC"	-4.01985869827922	9.97779462421266	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCAAAAGGGTCAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2293.09308781654	41.851730776953	0.0182512131754773	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2288.98456117802	2288.98456117802
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACTTCTTCAAACGTC"	-4.10635075989421	10.7298755415711	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACTTCTTCAAACGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2470.83005759952	42.4018441282349	0.0171609714710325	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2466.22207121539	2466.22207121539
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTCAAAGTGATTCTG"	-0.454654077917892	8.59960839832155	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCAAAGTGATTCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2470.87094686116	38.9580401619017	0.0157669263185888	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2458.33943053529	2458.33943053529
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTCAAAGTTAGAGAT"	-4.5182674926823	10.4012489088806	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCAAAGTTAGAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2609.61267280975	38.6619962999225	0.0148152239996196	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2601.93907599277	2601.93907599277
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTCCATAGGTGAGCT"	2.60906710204427	-6.00152733242186	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCCATAGGTGAGCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.5065615729	43.8731968505169	0.0159277881064346	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2751.52132942178	2751.52132942178
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCGCTTCCCTCGTA"	-0.242996822029907	8.59463689411012	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGCTTCCCTCGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2479.17408515989	38.3409471568366	0.0154652097189713	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2467.88851048857	2467.88851048857
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAATCTCACTTGGGC"	-4.28188214722331	11.6148051985535	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATCTCACTTGGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2758.0406273585	39.992286590084	0.0145002528945291	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2744.19721510699	2744.19721510699
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCGTCCAGAACGCA"	10.7350460487301	6.85517881000368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGTCCAGAACGCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2270.5906745383	44.3086091937448	0.0195141333445115	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2258.84433071821	2258.84433071821
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATCGTCTCCCTCGTA"	-2.53487954559978	8.82497212970582	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGTCTCCCTCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2791.11107937234	37.908778953341	0.0135819671361363	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2780.12791347446	2780.12791347446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAATCTTCTCGCGTT"	-2.00931249085124	10.1265077360901	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATCTTCTCGCGTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2037.76819112994	42.8511689183437	0.0210284806215288	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2032.49347613086	2032.49347613086
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGATACAAAGGTTA"	-3.50217304650005	9.59579751575319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGATACAAAGGTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.55402336432	40.5522900232224	0.0167187741986365	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2423.08892390801	2423.08892390801
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATCCGTTGTAGCT"	-4.41782603684123	10.6131734617981	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATCCGTTGTAGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2841.90807070363	35.1291554825268	0.0123611160560268	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2830.30128068035	2830.30128068035
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGAGTCACAAACGG"	-4.351385931403	10.0025253065857	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTCACAAACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3134.40085090734	34.8090838879951	0.0111054984808081	2535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3121.49836640202	3121.49836640202
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGAGTCAGAGTCTT"	-0.557469825178939	8.52906701648561	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTCAGAGTCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2423.87255533856	30.1816420646374	0.0124518271384205	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2413.34644839689	2413.34644839689
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGATATCAACACCA"	-4.32403932038005	10.5210418471131	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGATATCAACACCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2713.90258704507	39.6688203794053	0.0146168917664053	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2706.12040283363	2706.12040283363
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACAAGAGAAGCCAC"	-2.24038110199626	8.77730558002321	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACAAGAGAAGCCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2329.02189491944	42.2880381607048	0.0181569946821679	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2321.89230913291	2321.89230913291
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCAAAGACCTCAT"	-3.00268016281779	8.87495420062868	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAAAGACCTCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2616.94045401986	46.1535682211286	0.0176364609864289	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2612.05088546893	2612.05088546893
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACAAGTCCAGTTCC"	-0.228304813534576	9.15934178912965	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACAAGTCCAGTTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2959.76777392548	34.9282899867081	0.0118010238149135	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2951.95027060192	2951.95027060192
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCAAGTTGTGTTG"	-4.31263099137004	10.394730544928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAAGTTGTGTTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2501.13933118585	43.8276148135643	0.0175230600978893	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2497.05381021663	2497.05381021663
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCAATCAGACAAA"	-2.93779931488689	9.03903672778932	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAATCAGACAAA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2699.16455922147	44.4146380028822	0.0164549574612423	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.67152540497	2689.67152540497
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCAATCCGAAGGA"	-4.54916701737102	10.6747531660828	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAATCCGAAGGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2631.6179527623	41.3318947903839	0.0157058872269053	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2629.33406191546	2629.33406191546
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGTCTGTGACACAG"	-4.36596904221232	10.7611093291077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGTCTGTGACACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2413.05780366034	40.6553562320734	0.0168480656246211	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2401.06981502528	2401.06981502528
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGTCTTCGAAGAAT"	-3.99468980255778	10.961851096991	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGTCTTCGAAGAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2232.61094478033	44.0650125329351	0.0197369867042691	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2229.52039053477	2229.52039053477
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTAGAAGCTTGTGT"	-3.76848969879802	9.72666738117067	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTAGAAGCTTGTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.61491757696	41.3146088719986	0.016927950646559	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2436.88611571788	2436.88611571788
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCCTGTAAGATCA"	-3.49644122543986	9.40657994830934	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTGTAAGATCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2716.35412387767	40.9773924563617	0.0150854382704216	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2706.61259421846	2706.61259421846
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCCTGTATCGAGG"	1.73262824591939	-6.04167416011962	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTGTATCGAGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.24667689474	39.2703771049613	0.0136343797980872	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2873.60806655731	2873.60806655731
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTCTGAGTACAGAT"	-3.91558609429057	9.57466409290162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTCTGAGTACAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2605.93705147269	38.9357195099614	0.0149411588771716	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.48112125066	2602.48112125066
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCATTTTCAGACCGC"	4.37604631957356	-8.64163687145384	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTTCAGACCGC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2762.13286467401	47.8230434002187	0.0173138099227036	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2755.63102133619	2755.63102133619
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCGGAGAATCCCT"	0.528311004012269	-7.44534685527953	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCGGAGAATCCCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	1705.58787883351	39.5345913842104	0.0231794514224908	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	1698.204861462	1698.204861462
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCGGAGCAACTTC"	-4.0605071586674	10.4344196089539	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCGGAGCAACTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2754.10211207505	39.157261826952	0.0142177959398351	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2744.90310012649	2744.90310012649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTCTGTCTATACTC"	-4.35275111618693	10.2035245665344	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTCTGTCTATACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2418.68110445955	41.7568585860603	0.0172643092589053	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2405.06923030299	2405.06923030299
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTGGGAGACTCTAC"	-0.486819903284866	8.80181882465211	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTGGGAGACTCTAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2539.55123655568	40.0966755204036	0.0157888822809441	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2530.52648029853	2530.52648029853
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGCGGTCATTGCTT"	-4.07757506790813	9.81023404682008	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCGGTCATTGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2705.5724483417	39.0607232438652	0.0144371381619466	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2701.2981044993	2701.2981044993
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTGGGGTTTACTGG"	-1.47473726692851	8.74561307514039	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTGGGGTTTACTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2252.5109878009	47.2326162645185	0.0209688727470454	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2249.77863887187	2249.77863887187
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTATCACCGTCGA"	-6.53860793533977	1.51714346492616	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATCACCGTCGA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2038.28240444779	41.0177000432972	0.0201236589953343	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2033.82893621168	2033.82893621168
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAACCCAGGTTGTTC"	-0.577020387083846	9.04901788318483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAACCCAGGTTGTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2384.3460575383	37.0641689750982	0.0155447942876903	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2376.57984566288	2376.57984566288
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGGATAGGACTGGT"	-0.429354200989562	8.85813233936159	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGGATAGGACTGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2478.93656556941	36.9342499462249	0.0148992315734151	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2465.18754525645	2465.18754525645
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAACCCGTGATCATC"	-0.382598380476791	9.24299905383912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAACCCGTGATCATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2249.50117433704	40.3470040059945	0.017935978192092	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2246.82168989355	2246.82168989355
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATGGATGTACAATAG"	-2.87019811096843	8.916872001532	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGGATGTACAATAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2647.33802230101	43.3547211284522	0.0163767228677391	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2632.82598647004	2632.82598647004
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAACTTGTCCTTAAG"	-4.34289822998698	10.7395229109558	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAACTTGTCCTTAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2503.0553633336	42.782931112609	0.017092283190904	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2500.31088172497	2500.31088172497
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAAGTGCATGAATAG"	5.40040363845174	-4.13300850307616	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAAGTGCATGAATAG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2080.79488202348	40.6327895893864	0.0195275324542671	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2076.93026338843	2076.93026338843
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTCATCATGGCCCA"	9.62637390670125	7.8439936407837	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCATCATGGCCCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2376.32112343515	44.6528822817721	0.0187907609966548	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2367.95516520578	2367.95516520578
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACAGACAGATACCT"	1.77886476096455	-5.70915748989256	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGACAGATACCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2345.8097519965	40.0529969850208	0.0170742733723107	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2344.33539939495	2344.33539939495
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACAGAGTGGTAATA"	-4.14483819428142	9.82845685565797	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGAGTGGTAATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2911.19544493508	37.3250984255484	0.0128212272695352	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2901.713189027	2901.713189027
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTCCGAGAGGTGCT"	-3.92703352394755	10.1613349684509	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCCGAGAGGTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.87735860253	41.0893225726835	0.0163710479445743	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2500.89544236781	2500.89544236781
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACAGAGTTCGTACA"	-2.63831410828288	8.8559942015442	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGAGTTCGTACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2211.0762434089	44.4368904454651	0.0200974030533453	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2209.51163308528	2209.51163308528
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGCAAGTGTCATTG"	-2.88927874985393	8.87980744922487	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCAAGTGTCATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.08380505658	45.2794360355224	0.0176591092483903	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.77114211012	2558.77114211012
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTCTAAGACTGGGT"	-2.49483523789104	8.73182962024537	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCTAAGACTGGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2846.15856269919	41.5475334422473	0.0145977578293618	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2833.4219393236	2833.4219393236
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACATTGTATGTCTG"	-4.28529725495036	9.83109662616578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACATTGTATGTCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2800.96801191062	31.8506740244999	0.0113713094505402	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2792.937651813	2792.937651813
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACATTTCGAAGGAC"	10.2682873207027	7.7629766234192	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACATTTCGAAGGAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2328.09175021358	41.5016734133395	0.0178264767312251	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2322.31883412446	2322.31883412446
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGATCACATTCAGGT"	0.421471525996369	-6.34881784832152	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATCACATTCAGGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3303.54481984654	42.1172809726948	0.0127491174691104	3856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3293.19977128973	3293.19977128973
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCAGGACTAAT"	-3.8713620704716	9.91382215106813	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCAGGACTAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.21345995144	38.8991234304167	0.0151877709682012	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2554.17463843874	2554.17463843874
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACCCACACATATGC"	5.34566654738728	-9.58177664196166	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCCACACATATGC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.51673080278	41.4593665803652	0.0148359700707375	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2787.12232565757	2787.12232565757
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGACGCCATCGCTCT"	-2.79821381989177	8.70925614917604	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGACGCCATCGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.46637925291	40.7039177085324	0.0158908654972877	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.00209123847	2558.00209123847
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTGCCAGTAAACTG"	-2.40421758118327	8.64929101550905	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGCCAGTAAACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2858.66351714948	38.9327766938191	0.0136192232699849	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2845.11686551465	2845.11686551465
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTGCCCATCCTAAG"	-3.12631020966228	9.23585412586061	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGCCCATCCTAAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2723.32624971677	38.6858945106456	0.0142053837709195	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2712.95815278985	2712.95815278985
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTGTTAGTCATTGC"	-4.23110375824626	10.0426168211731	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGTTAGTCATTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3172.45667896764	33.8629832578166	0.010674056948458	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3164.58007838011	3164.58007838011
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGCATCACGGC"	5.17962612685506	-9.17851641094359	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC1"	"cDC1"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGCATCACGGC"	"cDC1"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2891.96602191996	37.6914417909764	0.0130331551288259	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2885.3808071163	2885.3808071163
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACCTGTCGTTCTGC"	-3.92237172547038	9.74244973743287	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCTGTCGTTCTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2425.57714656614	36.6796818980376	0.0151220429949897	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2421.09364651218	2421.09364651218
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTGTTTCTCATGCC"	-0.499978641897994	8.62245175922243	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGTTTCTCATGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2830.3413380911	37.9887901285115	0.0134219818709685	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2817.34126366651	2817.34126366651
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTTCAAGTGATAAC"	10.261681218713	7.81243178928224	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCAAGTGATAAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2263.60845295923	46.0272755500063	0.0203335852937969	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2258.36168009516	2258.36168009516
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTTCAAGTGTAGTA"	-4.48302207413371	10.7923536070618	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCAAGTGTAGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2780.07739285262	34.3182338215997	0.0123443447689008	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2773.97905800901	2773.97905800901
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGTCCGTATTGAGA"	-2.38412104073222	8.65890786731569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTCCGTATTGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.42953886661	43.1431389016727	0.0184733207248077	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2319.94358331181	2319.94358331181
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTTCACACACGGAA"	-3.17751942101176	9.05701158130494	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCACACACGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.2711004074	40.1641886506877	0.0155297674108336	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2577.78937786932	2577.78937786932
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGTGAGTTCGCGTG"	-4.02474437180217	9.6854848631653	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTGAGTTCGCGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2622.53557517769	32.7214325473622	0.0124770214204416	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2615.88757933369	2615.88757933369
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CATTTCATCTAGGCCG"	-2.10083852234538	8.57511136615602	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCATCTAGGCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2711.00269818057	43.8282084925994	0.0161667889604145	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2700.87422261559	2700.87422261559
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACTATCACCTGCAG"	-3.97639642182048	9.79731938922731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACTATCACCTGCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.29733175537	39.5768336222744	0.0157720781516906	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2504.23317540376	2504.23317540376
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACTATTCATACGGT"	-0.281688402325469	8.99165628040162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACTATTCATACGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2508.13687549078	33.8467738732197	0.0134947873873896	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2498.51459464515	2498.51459464515
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCAAGCGGTTGCAACT"	-2.41281543198283	8.67634675586549	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAAGCGGTTGCAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2263.77472543976	43.3436314727137	0.0191466186920581	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2259.71737197134	2259.71737197134
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAGACACACCTATCC"	-4.34142909470256	9.99803540790407	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGACACACCTATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2694.24420712561	41.2420151993021	0.0153074524908422	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2681.9674116488	2681.9674116488
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATACTTCATCTGTT"	-2.47263465347942	8.78567502582399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATACTTCATCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2808.96621058519	43.0524593494508	0.0153267985877558	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2799.9066718114	2799.9066718114
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCAATGAGTACTGAGG"	-3.61880979958232	9.45805738056032	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAATGAGTACTGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.88727367316	41.5543988695674	0.0160634749308437	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2584.4068878658	2584.4068878658
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAGGTAAGTCGGCAA"	-0.53507242623027	8.4821567305359	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGGTAAGTCGGCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2198.69906518975	31.9681184514105	0.0145395606690958	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2187.85797867001	2187.85797867001
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTTCGAGTAACGGTG"	-2.03952036324199	9.15501878345338	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTTCGAGTAACGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1873.85132346342	42.7758798040221	0.0228277874922114	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1871.98839140441	1871.98839140441
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATCATCAAACTAGA"	-3.60738597336467	9.68898961627809	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCATCAAACTAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.25258636359	41.9755829812073	0.0172863330680386	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2421.44508558714	2421.44508558714
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACAAAAGAGGATCC"	-2.99067435684856	8.79282949054567	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACAAAAGAGGATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2932.46381049533	38.6177826992432	0.0131690568732782	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2928.40050662633	2928.40050662633
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATAGGGTTTACCTT"	-0.272753129631835	8.71527192676393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATAGGGTTTACCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2222.42693602675	42.1103329325762	0.0189479043157481	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2215.76448556423	2215.76448556423
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACAAACACCGTCGA"	1.5727274614269	-7.81761362468871	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACAAACACCGTCGA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.22769777591	49.4588400737568	0.0212980148850716	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2316.08892173955	2316.08892173955
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATAGGGTTTCCCAC"	0.654176433652085	-6.2349105111328	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATAGGGTTTCCCAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3320.24339853602	41.0516521014255	0.0123640490090354	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3305.67673943493	3305.67673943493
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACACTAGAATGTTG"	-0.301467756659347	-6.59976961528929	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACACTAGAATGTTG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2546.66846140088	42.089179042816	0.0165271528982863	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2539.99426847289	2539.99426847289
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACACTAGAGACAAG"	-4.16088757935222	9.79605863178102	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACACTAGAGACAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2873.78016424792	45.0977337939234	0.015692826596472	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2863.28717030041	2863.28717030041
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACACTCAATTGCAC"	9.63122620162312	7.53640935504762	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACACTCAATTGCAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2471.81024961697	38.0198554673955	0.0153813811045112	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2463.64805977003	2463.64805977003
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCTACAAGCAATA"	-1.94434676590617	8.69272992694703	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTACAAGCAATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2212.58562081495	39.8159547051436	0.0179952153401768	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2211.18931354636	2211.18931354636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCTACACTCCTGT"	10.2378870445186	7.77319905841676	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTACACTCCTGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2448.66847646129	38.4050715934469	0.0156840633849088	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2442.84581721463	2442.84581721463
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACCATCAGTTCCAA"	-0.37216422978099	8.90385816181032	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACCATCAGTTCCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2582.60703304816	37.7910421099322	0.0146329045132851	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2572.59385267171	2572.59385267171
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACCATGTAGAGGAA"	-4.32997069779094	10.002942062262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACCATGTAGAGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.36963989118	42.3836011103842	0.0165537039847831	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.27084788792	2555.27084788792
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACCATTCCGTGTGG"	-0.742247859865981	8.59264085376588	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACCATTCCGTGTGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2785.00259856192	37.403389054143	0.0134302887449573	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2775.84861159901	2775.84861159901
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACGAGGTGTTCCAA"	-0.625899474055129	8.59461686694948	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGAGGTGTTCCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2314.30870158919	36.6392065063157	0.015831598645918	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2310.15418297763	2310.15418297763
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACGAGTCGGCTGGT"	-0.738636831671554	8.61058995807496	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGAGTCGGCTGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2789.05768008579	37.7793883151467	0.0135455744013098	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2778.05935757183	2778.05935757183
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACGAGTCGTCTACC"	-2.97477088394817	8.84405324542848	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGAGTCGTCTACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.83946431449	39.9304049468611	0.0150576252764166	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2643.83369314319	2643.83369314319
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACGTTAGAGAGAAC"	-7.28754268112834	1.70389280402986	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MEP"	"MEP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGTTAGAGAGAAC"	"MEP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2179.83068659991	33.2980581356446	0.015275524993908	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2178.03731517143	2178.03731517143
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAAGAAGTTTGGCT"	-1.51628456535991	8.448534942511	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAAGAAGTTTGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2515.17505849684	44.3336488034482	0.0176264664575449	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2506.56301017355	2506.56301017355
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAAGACACAATGTC"	4.52731337127034	-8.67110254680785	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAAGACACAATGTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.07834026559	36.8679283066025	0.0136140553094143	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2706.97241550324	2706.97241550324
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAAGACACACCTTC"	-4.069168428809	9.79127118671266	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAAGACACACCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2789.07023326119	38.4077269261574	0.013770799482969	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2779.59024743965	2779.59024743965
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAAGATCGGAGTAG"	-1.90818617764171	8.71886632526246	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAAGATCGGAGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2278.24343045331	46.3609188808483	0.0203494140534507	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2274.15322955172	2274.15322955172
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCACTTGGTATTCCTT"	-2.59814105454143	9.91465566242067	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACTTGGTATTCCTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2802.44459301913	45.9148607184084	0.0163838603028163	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2796.8244577568	2796.8244577568
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAATTGTCAATGGG"	10.6850620704586	7.2324909933838	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAATTGTCAATGGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2368.07874905636	40.2724484175322	0.0170063805663473	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2360.59341121334	2360.59341121334
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCATAAGCACTCTCGT"	-0.563926915556747	8.62304780567018	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATAAGCACTCTCGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2432.55773129594	37.2317298199387	0.0153055893970926	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2425.49062942254	2425.49062942254
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCTCCCATCGAGCC"	4.89054026183431	-9.0614805451599	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCTCCCATCGAGCC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2965.69375767803	38.0993483826183	0.0128466900144295	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2961.60686500436	2961.60686500436
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGAAGTCCTGGTG"	-1.992423872382	9.35631558978883	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGAAGTCCTGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2182.53724826507	48.2512592546209	0.0221078743526492	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2174.79812057973	2174.79812057973
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTCAGTGATTCAC"	-3.83820662918742	9.80977151477662	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTCAGTGATTCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2731.30623089557	31.7179343932485	0.0116127346082495	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2724.17711290074	2724.17711290074
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCATCACCATCATCCC"	-4.0153058570927	9.72302243793336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATCACCATCATCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2980.48099949401	45.257941839781	0.0151847778420544	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2971.85846344279	2971.85846344279
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCATCACGTGGCAACA"	-4.1429275077885	10.437566734198	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATCACGTGGCAACA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2577.30917260924	38.2313776523578	0.0148338344730496	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2566.55767172717	2566.55767172717
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCAGCTCCACG"	-4.39333186569865	10.0519952544006	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCAGCTCCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2736.29761798365	44.7014707494756	0.0163364797950654	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2724.18332074933	2724.18332074933
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCAACTAGGACTAAT"	-1.2533532184666	9.39284989917604	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCAACTAGGACTAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2735.30341380473	41.8664092333171	0.0153059470558267	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2727.5894727613	2727.5894727613
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCAACTAGGGTCTTT"	-0.38139788332637	9.12596795642702	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCAACTAGGGTCTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2446.94578813309	36.3402311927527	0.0148512612616884	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.88497943243	2435.88497943243
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCAACTCAAATACAG"	0.628576536744279	-6.32616617595824	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCAACTCAAATACAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3327.22144867245	42.0104123312067	0.0126262747999441	3233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3317.7740259945	3317.7740259945
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCATTGAGAGGCGGA"	-3.86642203751262	10.3544416197571	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGAGAGGCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2160.23856247265	38.4590430323788	0.0178031462360147	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2157.07114236551	2157.07114236551
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCATTGCAGTCCCGA"	-0.0249616977876008	8.31967351520387	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGCAGTCCCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1932.46442741497	45.3592844218266	0.0234722480674602	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1928.84505774868	1928.84505774868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCATTGGTGCTTATG"	-1.12590346756633	8.83749673450319	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGGTGCTTATG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2726.46311530146	41.2621615305492	0.0151339518583536	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2716.00007185723	2716.00007185723
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCATCGCAGCGGTTC"	-4.34646783295329	9.98589322650758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATCGCAGCGGTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2711.9322816788	34.1276237996411	0.0125842463066646	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2704.04486573896	2704.04486573896
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCACCAGTCACGCTG"	-3.52225099030193	10.0811958082947	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACCAGTCACGCTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2378.44650859054	44.8496591702865	0.0188567028975834	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2372.99854648968	2372.99854648968
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCATTGTCCTCAGGG"	4.56849875029866	-8.2373256913391	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGTCCTCAGGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3064.57237450191	40.6757774038459	0.0132729048079529	2971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3058.75259166494	3058.75259166494
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCATTGTCGTTTACT"	-1.4023679298466	8.68419263446657	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGTCGTTTACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2198.95769215705	43.2944757452525	0.0196886351655012	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2190.61903765561	2190.61903765561
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCACGTCAGTCTGGC"	-4.29835114899333	10.1761483916077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACGTCAGTCTGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2612.59347030141	42.5512397717692	0.0162869731764507	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2605.12830489095	2605.12830489095
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCATTACACAATGAA"	-4.22525344315227	9.94477651203004	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATTACACAATGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2630.28140218991	41.2680793718357	0.0156896061909866	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2622.81851278793	2622.81851278793
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCGAAGGTTTACTGG"	-4.15174327316936	9.73878285968629	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGAAGGTTTACTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2570.84094977362	39.5807032702831	0.0153960140061439	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2565.85640900294	2565.85640900294
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCATTAGTACTGGGA"	1.89792968806569	-7.65589573299559	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATTAGTACTGGGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.88652433859	34.4024790274404	0.0127895651791108	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2687.50153413977	2687.50153413977
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTACGACATAGACTC"	-4.04175076904948	10.4299793013367	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACGACATAGACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.38826192241	40.9270024928972	0.0154360653551444	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2646.68402944957	2646.68402944957
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCGGAAAGCCTAACT"	-4.14340339127238	10.1150626906189	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGGAAAGCCTAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2398.99529144342	44.9900203326576	0.0187536926367155	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2396.51086320333	2396.51086320333
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCATCGGTAGTCTGT"	-3.85342250290568	9.73172376239625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATCGGTAGTCTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2558.94080084969	41.2089842931151	0.01610392248208	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2557.64799460486	2557.64799460486
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATTTCTCATTTCGT"	-4.23560843887981	9.82315061176149	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCTCATTTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2534.8035086097	42.0051438972888	0.0165713609574132	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2527.50065742127	2527.50065742127
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCAACGTAGTACGG"	-0.385971913964111	8.30773923480836	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACGTAGTACGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2395.97778031808	34.154047499115	0.0142547430029092	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2391.47629294659	2391.47629294659
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTAACCATTGCAAC"	-4.06558022919353	11.9102468260559	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTAACCATTGCAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2860.78862051249	41.3109466824799	0.0144404051338401	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2845.25284025673	2845.25284025673
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCATGCGTTCGGTAT"	-0.505853037268478	8.70954129779664	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATGCGTTCGGTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2475.70590071015	32.2906885047063	0.0130430227982427	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2466.34199781455	2466.34199781455
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTCAACAAACACCT"	-4.19332728806193	9.95197675311891	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"IFN+ NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCAACAAACACCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3198.73399754238	44.5151599548762	0.0139164932092127	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3190.96358355342	3190.96358355342
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCACACACACAGAG"	4.66415037688558	-8.38102342998656	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCACACACACAGAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.35123214983	42.1956429966544	0.0153642558543482	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2743.9432201711	2743.9432201711
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCACAGTAAGTCAA"	-3.57133446160014	9.96768186176149	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCACAGTAAGTCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2423.02947688829	41.9776867790986	0.0173244639322371	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2418.83313423308	2418.83313423308
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCGTGGAGGTT"	-3.97896371308025	9.86229035938112	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCGTGGAGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2631.75032124299	45.06595925317	0.0171239493691351	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.0199599631	2626.0199599631
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCTCAATCAGC"	-3.56619987908061	9.76007649982301	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCTCAATCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2859.35156458875	42.459535265446	0.0148493580821891	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2849.91420339664	2849.91420339664
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCTCGTAATGC"	-0.670637707144576	8.65084741199342	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCTCGTAATGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2806.95342099865	32.2632623958427	0.01149404979594	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2791.16160219861	2791.16160219861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCATGGTTCAGTAC"	-4.19308553162273	11.8704776533875	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGGTTCAGTAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3302.42403647055	38.8649916418511	0.011768625474089	2877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	3286.52296602735	3286.52296602735
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCTCTGTCAGA"	-3.74035368385966	9.75785062396852	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCTCTGTCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2992.859946042	38.7157013826968	0.0129360217586852	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2988.69950302102	2988.69950302102
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCATGTCCAGTGTA"	-3.48272309723552	9.94745061481325	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGTCCAGTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.65909882879	48.3322428125629	0.0200743713410566	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2399.93684757241	2399.93684757241
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCATTTGTATGACAA"	-4.41019664230998	10.6480073698792	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCATTTGTATGACAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2698.34478593174	39.4723512691658	0.0146283571599009	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2692.02336553932	2692.02336553932
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCAACACACCTGG"	-2.6137994331425	8.68358323657838	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCAACACACCTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.11449761603	41.2835077170724	0.0154151391786354	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2673.32223229883	2673.32223229883
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCGAAAGTGTTGAGG"	0.481103708117646	9.67959306323854	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGAAAGTGTTGAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1868.12383688785	45.8580914847898	0.0245476721506781	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1861.12446381062	1861.12446381062
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGAACGAGAGTGACC"	-1.83079550686534	8.46509454334108	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGAACGAGAGTGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.50984337702	45.3397000490919	0.0195134529678577	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2315.06037215036	2315.06037215036
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCAATCAAGGACG"	-3.40676794472392	9.46703813159791	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCAATCAAGGACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.63765514104	46.8258269955243	0.0187931928620953	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2486.91868611735	2486.91868611735
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGATCTCAACGGCTC"	-2.78312311592754	8.71831414783327	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGATCTCAACGGCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2609.62236378519	45.5619738242478	0.0174592210951784	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2601.9666267701	2601.9666267701
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCAGAAACACT"	-4.35337529602702	9.97756383502809	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCAGAAACACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2798.70842678274	38.136271713672	0.0136263825658722	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2790.65490647861	2790.65490647861
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGATCTGTGCTGATT"	-4.21538196030315	10.6267108687195	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGATCTGTGCTGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2500.44646924683	39.8836147079095	0.0159505973026981	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2492.81337740614	2492.81337740614
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGATGGGTACTGAGG"	-0.726062099367935	9.06048772418825	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGATGGGTACTGAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2444.81365554197	41.4021132002971	0.0169346702994912	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.89286169632	2435.89286169632
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCTATGTACGCTAT"	-4.09875665131267	9.84919164264528	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCTATGTACGCTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2728.46701449658	38.177972936482	0.0139924627029167	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2723.84115431133	2723.84115431133
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCTCGTGTGAT"	-3.17957768860515	10.3046321638855	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCTCGTGTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2308.5941953362	46.2877356368365	0.02005018280404	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2305.61471577248	2305.61471577248
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGAGCCACAAG"	1.29992165145223	-7.40261461651	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGAGCCACAAG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.90777730131	40.3783888181807	0.0152376581419382	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2645.97859302133	2645.97859302133
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCGATAGGTAGACC"	-0.873324255377609	8.5447845228943	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATAGGTAGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.50297246066	42.3050500490784	0.0183894785425242	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2294.99813682031	2294.99813682031
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGAACTCCGCTGTT"	-2.9136577648228	8.73623654926149	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGAACTCCGCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2765.73187477345	39.4903957613941	0.0142784613800023	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2757.91522447952	2757.91522447952
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCGATCAGGTTTAC"	-0.462244967848617	8.68258664691774	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATCAGGTTTAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2350.1892929831	39.2021063723625	0.0166804037825409	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2345.19921294991	2345.19921294991
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTAATTCTGGGATT"	-3.78049169006999	9.69730088794557	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTAATTCTGGGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2721.92629431723	37.5525481931149	0.0137963133944942	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2710.64732992234	2710.64732992234
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCCCGTCGAAACG"	-4.22381959381755	9.77190301502077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCCCGTCGAAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2786.74741857932	38.1347643139126	0.0136843274922108	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2779.91106421969	2779.91106421969
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCTCCAGCCATATC"	-4.37786183777507	10.4087056883606	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTCCAGCCATATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2690.36243013275	42.3293400900912	0.0157336943216244	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2683.08343300157	2683.08343300157
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGGTAAGTTCCGTA"	10.1799780326778	7.8079533346924	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGGTAAGTTCCGTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2484.8422441855	46.3171887117515	0.0186398910514875	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2475.70913680786	2475.70913680786
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGGTACATATCTGG"	-2.76058922234233	13.6695604094299	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00224592925322852	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGGTACATATCTGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2811.20023872214	43.1842633382862	0.015361503867087	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2804.67731416451	2804.67731416451
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCTTTCAATGAACA"	-3.84552226486858	9.646777130011	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTTTCAATGAACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2615.95499135077	38.6289556793144	0.0147666744294282	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2608.35115986016	2608.35115986016
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCTTTGTCCGAAAG"	-1.7010739845341	8.59022615039674	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTTTGTCCGAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2388.33301060783	38.1748615110742	0.0159838939300004	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2384.19838372606	2384.19838372606
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCGATCTTTACAC"	-4.34262643280681	10.8697805174622	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCGATCTTTACAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.46619200087	43.418080987573	0.0159597943599657	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2714.35140398607	2714.35140398607
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGTGAAGCAGGCAT"	-0.299058417708236	8.5300721892151	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGAAGCAGGCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2219.30909804282	37.2442696563343	0.0167819208641012	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2211.19205995978	2211.19205995978
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGTGACAATGTCAC"	-3.89319382134135	12.4601344832214	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGACAATGTCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2944.10126747932	37.1050857340917	0.0126031961413679	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2934.95253810033	2934.95253810033
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTGACAAAGGTTA"	-4.43003068390544	10.7148675688538	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTGACAAAGGTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2563.96116440608	43.453202479144	0.0169476835618177	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2558.48799347202	2558.48799347202
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGTGACACGTCGTG"	-0.736852745444137	8.92910955036012	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGACACGTCGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2411.95583654616	39.547117403936	0.0163962858708749	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2407.29397511206	2407.29397511206
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGGTGACATCCTCAC"	-1.91279123249705	8.64179895007936	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGACATCCTCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2677.79864352019	42.0153224331475	0.0156902471120512	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2670.6720945993	2670.6720945993
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCAGTCTCTGACC"	-0.575443486601669	8.29267499530641	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCAGTCTCTGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2668.27349530335	36.8278477773217	0.0138021262970777	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2653.95203505262	2653.95203505262
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTGCACATCATTGG"	-1.94733307781871	9.03845212543336	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCACATCATTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2558.54430707809	43.8379495608869	0.0171339419214322	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2548.38408383127	2548.38408383127
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGTCGCAACCACAT"	5.15491261061971	-10.096257232782	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTCGCAACCACAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2165.32232946513	46.603038750178	0.0215224486978296	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2160.51482593311	2160.51482593311
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGTAGGTCTGACAGT"	-4.30215058746989	9.88716218555299	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTAGGTCTGACAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2855.04370882544	39.1185328208611	0.0137015530445082	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2849.92669740239	2849.92669740239
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTTGGAGTGTTCCAA"	-3.78047237816508	10.2840537794861	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTGGAGTGTTCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.98938595093	40.993985849634	0.0177233782820756	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2307.00409350985	2307.00409350985
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTTGGATCGGCTCTT"	10.5831552940303	7.4423732527527	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTGGATCGGCTCTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2387.0811348949	40.8449470383069	0.0171108331598897	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2381.55664419008	2381.55664419008
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGTGAGGTCTACGAT"	3.04277362403218	-7.71190073406371	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTGAGGTCTACGAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2656.38350533793	41.4064847916668	0.0155875402435159	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2653.58310381122	2653.58310381122
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCGACACACAGAG"	-3.15636859360393	9.24337861621705	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGACACACAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.91374049366	37.9740216033086	0.0152572670500733	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2484.67224225985	2484.67224225985
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGTGAGTCGCCAGTG"	-2.91872225228007	9.02381227100221	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTGAGTCGCCAGTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2611.42987532819	41.0107791978736	0.015704338678717	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2606.28601041584	2606.28601041584
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCGATCATCACTT"	-3.60445771637614	9.69345662677614	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGATCATCACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2505.52019785746	44.8980015033994	0.0179196326342901	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2497.58987627477	2497.58987627477
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCGTTCAAGGTATCTC"	-4.00225863876994	9.78056428516237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCAAGGTATCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2402.95300028681	42.2770708766995	0.0175937984936257	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2396.31160098502	2396.31160098502
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTGGTTCCAACTGA"	-4.00476727905925	9.72700975025026	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTGGTTCCAACTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3208.85683855025	39.302457774358	0.0122481181778476	2999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3199.17413788608	3199.17413788608
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAATGAGCTTAAGA"	-4.27816567841228	9.80110356891481	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAATGAGCTTAAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2742.61765423177	37.3326290403186	0.0136120428535547	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2738.7528969685	2738.7528969685
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAATGAGTGATGGC"	-3.70568166199382	9.59457681262819	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAATGAGTGATGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2367.53247986909	38.3517022432206	0.0161990184165672	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2363.91462552589	2363.91462552589
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAATGGTCATCAGT"	-6.98323140564616	1.87607429111329	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAATGGTCATCAGT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2615.32588123286	41.5149947228721	0.015873736814512	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2606.39328323333	2606.39328323333
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTAACCCACTCCCTA"	-0.393817673355895	8.53345010364381	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTAACCCACTCCCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2641.56229667651	36.7861920123229	0.0139259225718831	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.47472860737	2626.47472860737
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAGGCAGTACCCTA"	-4.36280475083049	10.2617826231751	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAGGCAGTACCCTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2357.31045072472	45.249626116525	0.0191954462776057	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2353.59937617402	2353.59937617402
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTAAGATCGTGCACG"	10.6205355125362	7.48843953693239	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTAAGATCGTGCACG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2385.36443576656	44.0539537774405	0.0184684374080908	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2375.78036196737	2375.78036196737
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTACGTCAACAAGAT"	5.36692728576009	-9.6267938843933	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTACGTCAACAAGAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2606.45385102238	48.0821320651702	0.0184473368083268	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2603.40062793718	2603.40062793718
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTATCGAGAGTAACT"	-3.10069618645366	8.97669313037721	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTATCGAGAGTAACT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2703.04158221035	41.5520707080923	0.0153723386948839	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2698.50619548783	2698.50619548783
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTTCCCATGTAACC"	-4.48106418076213	10.5278129347595	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTTCCCATGTAACC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2554.24219842647	43.747557744272	0.017127411711866	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2546.40076749984	2546.40076749984
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTATCGCATGACAAA"	-0.632286350161392	8.69695756519166	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTATCGCATGACAAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2518.62871183725	35.4366833290493	0.0140698321918198	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2509.20455455778	2509.20455455778
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTATCGTCTTCACGC"	-2.73097262802776	8.77925775134889	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTATCGTCTTCACGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.76156910134	41.3999443505619	0.0163975659552271	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.85685502251	2519.85685502251
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCAGGGTCTGGTTA"	-4.20888696137126	10.8534116514954	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCAGGGTCTGGTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2120.61769269616	43.6894219144716	0.0206022151305003	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2114.38710435794	2114.38710435794
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCAACGTTTCGATG"	-2.4050158065861	8.92987439716188	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCAACGTTTCGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2355.64456653599	38.8263440063357	0.0164822590631448	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2352.18363175935	2352.18363175935
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCAACTCCGAGAAG"	-3.86516366425212	9.78579042041627	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCAACTCCGAGAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3039.09179729512	46.695627234624	0.0153649940012291	3123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3028.77451410823	3028.77451410823
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCAACTCGGTCAGC"	-4.31291184845622	9.79033944690553	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCAACTCGGTCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2802.91559182623	36.6723024725574	0.0130836271272314	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2796.8864085771	2796.8864085771
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCACAAGGCCTTCG"	-0.861814538866836	9.06581590259401	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCACAAGGCCTTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2596.84033373844	40.0859852887886	0.0154364458869446	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.62325074492	2585.62325074492
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACAACGAGAGTGAAG"	-4.05738053742107	-8.49928667461547	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACAACGAGAGTGAAG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.71522078423	52.0030927670745	0.0219078903449478	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2372.20229566591	2372.20229566591
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCACTCACTCCCTA"	-3.38915000382121	9.71763227069703	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTCACTCCCTA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2235.8066008046	45.1382872407592	0.0201888156267699	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2228.77099694538	2228.77099694538
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCACTGTCCTGTTC"	-4.14559398117717	9.74919889057008	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTGTCCTGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2608.5639136459	39.2614229027597	0.0150509721833441	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2601.57752715763	2601.57752715763
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCATGTGTCCGTG"	0.929461618035477	-6.96403124248656	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCATGTGTCCGTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2915.87699227716	32.9314339298088	0.0112938351024509	2447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2908.93287195472	2908.93287195472
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCCAAAGACGCCAA"	2.36021413382832	-7.74993708049925	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCCAAAGACGCCAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2954.92603671371	46.2097490048557	0.0156382083445471	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2947.32192644578	2947.32192644578
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCCAAAGAGAGGTA"	-0.617484311491805	8.67371461475221	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCCAAAGAGAGGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2562.56407159825	37.6459045554388	0.0146907173844669	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2550.71174140941	2550.71174140941
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACATTCTCCACCTGT"	-4.27324281159099	10.292004562262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACATTCTCCACCTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3013.7737267882	38.8466555646407	0.0128897054278988	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3001.67795318399	3001.67795318399
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCCAAGTTACAGCT"	1.3381675678188	-5.72039749538573	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCCAAGTTACAGCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3158.8856478376	34.2162457878793	0.0108317456224798	2855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3149.0933517884	3149.0933517884
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCAGGTCTGACGCG"	-3.94257340851482	9.66703984821168	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCAGGTCTGACGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2629.33397024867	35.3077275105576	0.0134283920985581	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2621.45846058417	2621.45846058417
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCTATCGGTCAGC"	-3.84797034683879	9.93876264179078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCTATCGGTCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.10826681158	41.1019990756944	0.0160485207159414	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.24025777779	2556.24025777779
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCTAGTCACGGAGA"	-1.33061037483867	8.48258302295534	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTAGTCACGGAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2313.75834125645	41.6260168288368	0.0179906501412038	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2309.93321249338	2309.93321249338
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGGACGCAGTATTCG"	-4.4648531478947	10.5277929075989	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGACGCAGTATTCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2583.49079184873	41.882374579565	0.01621154397442	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2578.92201671315	2578.92201671315
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTCAGTATACGGG"	-3.97135625305827	9.78938672626344	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCAGTATACGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.40897101636	38.1010236780486	0.0149685273022493	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2544.29851684548	2544.29851684548
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCCGTGTTGCTCGG"	-2.37896500054057	8.99008271777955	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTGTTGCTCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.20268770388	38.3966316855563	0.0154067050304532	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2489.72849718737	2489.72849718737
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTCATCCCATTTA"	5.12471928176228	-9.3155145875183	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCATCCCATTTA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.52498152606	39.0509555545039	0.0150281239673017	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2595.5215580037	2595.5215580037
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGGTCTCAAGGATGC"	-3.50684175911601	12.0726661452088	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGTCTCAAGGATGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2688.0754952033	45.4481057437818	0.0169073025757204	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2681.68412880521	2681.68412880521
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTTGGTTCACCGG"	-0.639996747404891	8.54490277850953	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTTGGTTCACCGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2507.65627008369	39.9670471132924	0.0159380085660459	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2492.91725245957	2492.91725245957
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGGTCTGTATTGCCA"	-0.461763541132766	9.0073203810486	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGTCTGTATTGCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2736.37549513475	37.5174868866759	0.0137106500746632	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2726.3414897238	2726.3414897238
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGACAGATGCAGC"	-4.1093786758488	12.1143007048401	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGACAGATGCAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2885.75381844823	42.0638712874271	0.0145763893713035	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2874.10537097401	2874.10537097401
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGACAGGTGAGAA"	-4.40253529968913	10.7820911177429	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGACAGGTGAGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2370.12539199647	41.6045430879673	0.0175537307977287	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2363.05634088694	2363.05634088694
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCTCCTCTCGA"	-0.490417878062087	9.15471456134645	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCTCCTCTCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2743.87174994509	41.9547432722811	0.0152903441179861	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2733.91959987135	2733.91959987135
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCTCGGTACTAACC"	-4.21261201325114	9.98797986591188	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCTCGGTACTAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2344.2721059499	42.6501048912443	0.0181933252470973	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.19948106542	2336.19948106542
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGCATAGAATTCAG"	-4.12187419357951	12.085986114386	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATAGAATTCAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2871.36941967925	42.6346766011842	0.01484820319844	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2853.58254953346	2853.58254953346
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGCAGGTTCGC"	-2.06102023544963	9.80628774249879	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGCAGGTTCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2074.16455183985	44.3964296942445	0.0214044877272941	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2067.96689245044	2067.96689245044
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGCATAGGGCAGTT"	-3.1308482688969	9.50683877551881	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATAGGGCAGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2643.86646726349	44.7199052709895	0.0169145854470012	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.51946688306	2639.51946688306
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGCATCATGACTCA"	2.41695298728291	-5.11630871212157	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATCATGACTCA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2999.79852770981	38.5069790423218	0.0128365217485855	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2990.32035024468	2990.32035024468
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGCATTCCCAACTC"	-4.01508365097697	9.65639684284059	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATTCCCAACTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2894.60467894568	39.418385715997	0.0136178822630642	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2887.17265876088	2887.17265876088
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGTCTATCCAT"	-7.79972348633464	0.570536888483442	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGTCTATCCAT"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2422.23711774619	43.7575064548506	0.0180649145099244	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2411.70427766096	2411.70427766096
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGAGGCACTCC"	10.5651575523311	7.64310786807863	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGAGGCACTCC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2598.90952098698	45.3317229979027	0.0174425937616663	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2586.7920834726	2586.7920834726
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGGCGTTCTTGTT"	-2.4267934364384	8.8921794661316	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCGTTCTTGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2603.0891455538	43.7629990666958	0.0168119478894701	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.49209328075	2592.49209328075
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGAGTTGTCGT"	-4.25658736649211	10.062135673407	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGAGTTGTCGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3060.95057758243	44.9332258844429	0.0146795006144567	2686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3055.31982612644	3055.31982612644
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTTCAAGTCGAAAT"	-1.95696936073955	8.59366700733034	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTCAAGTCGAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2554.94054385603	40.6159484043099	0.0158970229275905	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2547.9524572795	2547.9524572795
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGTAGATCATAGAGA"	-3.64006648483928	9.85883805835573	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTAGATCATAGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2410.09398502461	45.8542666636676	0.0190259246936378	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2403.44858506307	2403.44858506307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGGTATGCTTG"	-2.38410387459453	9.42832276904909	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGGTATGCTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2160.60364444929	41.136417009337	0.0190393166812519	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2157.16968722297	2157.16968722297
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTAGGAAGACCAAAT"	-3.862207989127	12.8842363127503	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTAGGAAGACCAAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2644.3842723074	41.5021490077809	0.015694447075034	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2641.68611526803	2641.68611526803
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGTATCGGCTTGG"	-4.38397632065471	10.5354470976624	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGTATCGGCTTGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2851.03023042433	40.1185276438225	0.0140715897066625	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2841.9273556562	2841.9273556562
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTAGGATCCCGTGTT"	-4.32657990875896	10.265034652594	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTAGGATCCCGTGTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2329.17980281702	42.9822196897516	0.0184538006201869	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2325.3509580764	2325.3509580764
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTGCCGTGTTAACC"	10.504727979272	7.62991187656251	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTGCCGTGTTAACC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2246.61190547174	47.3563506864922	0.0210790081594215	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2240.52781760122	2240.52781760122
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTACATAGCTACTAC"	-3.82312760773357	9.83008668506471	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTACATAGCTACTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2522.22182051814	44.2727759448774	0.0175530857693486	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.78411537109	2515.78411537109
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTAGTCATTCCTAT"	-2.45031438294109	9.40390107715455	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTAGTCATTCCTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2568.39894124536	42.9079129835888	0.0167060935489966	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.41778319453	2558.41778319453
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTACATGTGATGAAT"	-0.272090713412124	9.13018987262575	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTACATGTGATGAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2435.16843261429	38.8583336706396	0.0159571441343476	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2421.78883268932	2421.78883268932
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTTGTGCAAATACGA"	-3.85773787918742	9.93384454334108	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTGTGCAAATACGA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2704.87428911043	38.5143899809373	0.0142388835355464	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2690.0276929587	2690.0276929587
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCCGAAGCGTGTTT"	-2.21947942200359	8.73729894244996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCGAAGCGTGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2179.32848856445	41.3286025666808	0.0189639160794454	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2173.38802118973	2173.38802118973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CCTTGTGTCGCTCTAC"	-4.04002366486247	10.4113063582214	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTGTGTCGCTCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2539.88131480419	42.0393787801844	0.0165517099303616	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2534.84081798118	2534.84081798118
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCCGAGTCTACAAC"	2.20394911345784	-5.11873485958251	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCGAGTCTACAAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2500.52075371584	45.3451458643017	0.0181342809480455	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2493.98528501025	2493.98528501025
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTGTAGCTCTATG"	-4.27982745590861	11.3613548048767	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTAGCTCTATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2620.80631074795	40.6497243690408	0.0155103886167917	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2616.8849030147	2616.8849030147
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGAACTCAAGCGTT"	1.5325092273647	-6.14631798183592	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGAACTCAAGCGTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.67066915611	37.2126734254319	0.0139025969291785	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2672.08770942213	2672.08770942213
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTGTGTGGATCAG"	-0.709836880595046	8.54174325549928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTGTGGATCAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2613.62428013458	42.5302425079949	0.0162725158437099	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.84670816473	2592.84670816473
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAAGGAGTAATGCTC"	-4.35311828079875	10.5551366575989	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAAGGAGTAATGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2582.45402776441	39.8416631841873	0.0154278305657497	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2571.07292831862	2571.07292831862
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCCTTTCACTGGGC"	0.0571305058779239	8.69026181781618	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCTTTCACTGGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2363.54394223235	38.9915018644081	0.0164970496920743	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2346.98377905021	2346.98377905021
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAATTGAGGACACTG"	0.00117127698604461	-6.50637581264647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAATTGAGGACACTG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2951.02186809821	42.2476847549837	0.0143162899644015	2723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2943.18483323201	2943.18483323201
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAATTGAGTTTGTCG"	-3.89475975456889	9.58154962146608	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAATTGAGTTTGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2433.20234011554	43.7854999582114	0.0179950098010066	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2425.51319540091	2425.51319540091
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAATTGGTGGGAGAG"	-2.89386783066447	9.67923352802125	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAATTGGTGGGAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2273.81442004828	46.8234765170328	0.0205924793616352	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2268.82317327565	2268.82317327565
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGACCAGTTCGTTCC"	-4.42196546021159	10.385356880072	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGACCAGTTCGTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2656.4994414451	34.8545729254746	0.0131204894613169	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2652.09858083745	2652.09858083745
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCCGAGTACCTTCC"	-4.33201537552531	10.8597049483093	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCCGAGTACCTTCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2868.85481429576	43.19050612963	0.0150549640624572	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2861.32324250263	2861.32324250263
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGGTATCCCTCATG"	0.660693426697892	-6.39379599010619	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGTATCCCTCATG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3207.96149385808	44.396519177679	0.013839480075643	2919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3201.15211232711	3201.15211232711
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGATCTAAGCAAGGAA"	-2.89154324951823	8.86431024158327	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGATCTAAGCAAGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2501.45547741559	42.347352109707	0.0169290848835969	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.45306815775	2495.45306815775
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGACAGCGTAGCGAGT"	0.0323526981169402	8.21497056567994	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGACAGCGTAGCGAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2183.98756655644	41.0000672670809	0.018773031447119	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2176.46899322095	2176.46899322095
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCTGGTCTCATAGG"	-0.377498219639617	8.76274297321168	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCTGGTCTCATAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2372.89198584225	35.2741496942646	0.0148654679204642	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2355.28779927467	2355.28779927467
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGACAGCTCCTATGGA"	2.26679958876912	-5.31835272228392	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGACAGCTCCTATGGA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2897.15839342857	45.9265779310265	0.0158522840985148	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2893.01835462119	2893.01835462119
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACCCGAGATGACAT"	-2.39906225624736	9.35736272418825	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCCGAGATGACAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.84422872834	41.7127516082696	0.0171951484412237	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2417.12781453382	2417.12781453382
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGAGCGAACTG"	0.37799229201619	-6.44135143673094	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGAGCGAACTG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3231.0497722311	44.3480302373332	0.0137255794133775	3357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3226.80336703726	3226.80336703726
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTGAAAGCTGACTT"	-4.43539033356364	10.9044122465881	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAAAGCTGACTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2377.89949937081	43.6774587750821	0.0183680844319279	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2368.98651312133	2368.98651312133
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGCATCGAGCC"	10.6831747489864	6.57018849933473	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGCATCGAGCC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2251.023962716	46.0692773663328	0.0204659204563719	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2239.9941025133	2239.9941025133
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGAGAGCAAGA"	1.12420692023579	-7.55801727687987	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGAGAGCAAGA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.16089975654	45.6037300619197	0.0174783126890238	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2601.06795681881	2601.06795681881
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGAGGCCGCTT"	3.39161481437032	-8.06120302593382	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGAGGCCGCTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.14525010744	37.9350529033494	0.0136351805865939	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2780.2933040203	2780.2933040203
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGTCGCTAGCG"	9.01613487777058	7.24178168857423	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGTCGCTAGCG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2087.46885305894	40.7704776336035	0.0195310591455576	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2070.71757265933	2070.71757265933
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGCACACATCTCAAG"	-4.08163915100749	12.2477311857971	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGCACACATCTCAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3010.98942211796	40.3424168546175	0.013398392089415	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2993.26076798173	2993.26076798173
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGGAAAGTAGCAAT"	-2.47613702240642	8.94350431049196	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGAAAGTAGCAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2339.56760537689	42.1622516320367	0.0180213863173425	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.72227916116	2336.72227916116
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTGTCGTCAATCAGC"	-2.53335271301921	8.7042836912903	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGTCGTCAATCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2478.34663217862	35.0123752459339	0.0141273116485549	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2468.27017605348	2468.27017605348
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGGAACAGTGAGCA"	4.09897102889363	-8.38930036937865	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGAACAGTGAGCA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2866.24336801308	37.8520094020276	0.0132061393754806	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2862.89238382534	2862.89238382534
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTAGTGTTACCTTT"	3.04395927962605	-7.7352447739807	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTAGTGTTACCTTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2636.99227797987	44.7785842197599	0.0169809311137094	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2634.9494031	2634.9494031
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTCCTAGAACGCGT"	-3.46106014671977	9.89827249133912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTCCTAGAACGCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2213.08197355548	44.2646290846156	0.0200013508824082	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2206.04784324236	2206.04784324236
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAACCTGTTACACAC"	-4.48618588867839	10.241600013617	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAACCTGTTACACAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2527.56273718483	34.6907075559895	0.0137249639922401	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.91982293415	2523.91982293415
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAACCTTCACCTCGT"	-4.3010347885197	10.4164838560852	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAACCTTCACCTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.4162614354	37.7743000133717	0.0143442191675318	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.36179816648	2628.36179816648
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCTGCTCCATTTCA"	-1.1043520969456	8.86216924274293	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCTGCTCCATTTCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2476.68819482078	37.9150106634578	0.0153087541430307	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2469.97387511582	2469.97387511582
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGGTACCAGATCATC"	-4.30740342560466	10.2502946623596	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTACCAGATCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2928.82803453304	39.0675976010824	0.0133389864957746	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2922.35793785424	2922.35793785424
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGTGCGTTCTTAGG"	-4.04611669006999	9.95675275409547	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGTGCGTTCTTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2635.73324601894	43.8238475506247	0.0166268144232035	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.10107372567	2628.10107372567
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGAGTGCTCCTCAGGG"	-4.43520770493205	10.5047111281189	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGTGCTCCTCAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2672.38523539505	35.9658383688202	0.0134583284971276	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2665.3676765745	2665.3676765745
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTTGACAATTCACG"	-4.07320533219035	9.90084550464479	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTTGACAATTCACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2783.06228330586	40.9432836110216	0.0147115944391971	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2773.86199931931	2773.86199931931
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACCTTCTGCAGCG"	4.19071020659749	-7.90866138851317	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACCTTCTGCAGCG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.89108803154	40.5746751255706	0.0162826839906645	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2490.58519297598	2490.58519297598
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGATCGGGTTAGGGTG"	4.61212362822835	-8.603054069635	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATCGGGTTAGGGTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2713.40554343839	40.1329144346953	0.0147906067825893	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2708.80022471714	2708.80022471714
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACTCGTTTACCTT"	-3.76150141182597	10.0051803358826	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACTCGTTTACCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2552.27893231	41.7230025252208	0.016347352163213	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2540.93281315642	2540.93281315642
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAACTGTGTTCAAGTC"	-1.96928201142009	8.49188516223756	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACTGTGTTCAAGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2477.04118947659	47.5913032642614	0.0192129640259707	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2468.64479790546	2468.64479790546
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGAGTAAGTGCACAG"	-3.99986205521281	10.4241370924744	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGAGTAAGTGCACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2171.28280485265	43.6791136148222	0.0201167316929894	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2164.45975490555	2164.45975490555
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGATCCAGCGGGTTA"	-4.3232925933903	10.6586198576721	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATCCAGCGGGTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2577.64739757744	38.2871263243595	0.0148535157913154	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2576.29299540528	2576.29299540528
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAACGTTCGAGAACG"	-3.96371207657512	10.8404960402283	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAACGTTCGAGAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2674.7527860625	43.4413183062646	0.0162412461191281	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2660.44911815053	2660.44911815053
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGATCCTCACCGACG"	0.352623929351014	-6.3865914574829	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATCCTCACCGACG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2887.27326682639	37.863973538626	0.0131140941779456	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2876.25444540385	2876.25444540385
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGATGGCCAGCCGTCA"	-4.19821534577067	11.3493699797424	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGGCCAGCCGTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2502.70903576513	44.1408375724235	0.017637223081719	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2497.1646469329	2497.1646469329
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATCGCACAAGTGG"	-3.87272820892985	10.3803977736267	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATCGCACAAGTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2175.40046568117	45.1079997528893	0.0207354923677306	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2167.550420565	2167.550420565
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATCGGTCACGACC"	-3.07673106613811	9.47747895801393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATCGGTCACGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2423.55824994692	38.5378781485773	0.0159013624489617	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2422.35002047589	2422.35002047589
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCTCCAAATCAAG"	-3.97850737991984	9.66275785053102	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCTCCAAATCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2724.64306515415	36.5787912161067	0.0134251681197872	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2716.51962675482	2716.51962675482
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACCTCAGAACGTGC"	1.65323760089223	-5.58475735103758	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCTCAGAACGTGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2823.71197667488	43.5697360357252	0.01542995050332	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2819.72206101579	2819.72206101579
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATGCAGCACCGAA"	-0.353441427380401	8.40307138049928	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATGCAGCACCGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2342.15534089933	42.6941717018288	0.0182285824327243	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2333.47577910861	2333.47577910861
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCCTATCGTCACCT"	2.50040568885152	-5.50897123729857	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCCTATCGTCACCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2078.0258731855	50.9114197750072	0.0244998969608414	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2069.99082581398	2069.99082581398
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTTCCGTCGTACTA"	-0.577936391264755	8.19153592670289	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTTCCGTCGTACTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2580.61052708689	34.2525669379151	0.0132730478227495	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2568.97506422263	2568.97506422263
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATGCGTGAGTTGG"	-3.03208289566692	9.07244870746461	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATGCGTGAGTTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2331.30201818177	39.7650769909564	0.0170570250790457	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2324.02186395321	2324.02186395321
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAATGCGTTCGAAGG"	-0.30103830519374	8.87579724872438	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATGCGTTCGAAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2374.47401261254	36.5851778913109	0.0154076977456821	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2367.73104824899	2367.73104824899
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATAGAGTCTACAGGT"	-4.47099337998088	10.6066093214783	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATAGAGTCTACAGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2799.83891199625	44.9724757308928	0.0160625225752106	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2796.44170434979	2796.44170434979
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCATGGTCCGAACGC"	0.735986908047837	-7.29634764110716	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGTCCGAACGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2882.21218177468	40.4662134386039	0.01403998418107	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2875.60179459731	2875.60179459731
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATCACGGTACCGTGC"	-4.27627740326579	10.6168403395447	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCACGGTACCGTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2774.0172289349	33.7862056278236	0.0121795226343263	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2769.38011927757	2769.38011927757
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATCACGGTTGGTAGG"	-4.00684199753459	10.1339769133362	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCACGGTTGGTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2349.04644015977	39.1783178114564	0.0166783921942351	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2344.92544457075	2344.92544457075
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATCCAGCAAGCCA"	-4.37085709992107	13.060236907843	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATCCAGCAAGCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2992.31557700207	38.9005023696974	0.0130001336318514	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2988.50654534668	2988.50654534668
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCGATTGTTGCGTAT"	-4.14002881470378	10.0009393461975	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGATTGTTGCGTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2431.631209978	44.0594347724058	0.0181192915239825	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2427.61171159721	2427.61171159721
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATCGACGTGTGATGG"	-0.662704686552841	8.58943078601686	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCGACGTGTGATGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2530.07659173064	35.3908218201493	0.0139880436567895	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2520.11385560037	2520.11385560037
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCAGAGTCCCTGAG"	-2.90283022347148	8.94814679706422	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCAGAGTCCCTGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3000.70593304289	39.8131533367357	0.0132679290224094	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2994.21112705221	2994.21112705221
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCGCCATCCGTATGA"	-0.433248291642028	9.04880902850953	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGCCATCCGTATGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2386.6320525386	38.5801496231323	0.0161651016050403	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2378.779210399	2378.779210399
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCGTATCAAAGACGC"	-4.70717273178752	-4.82086326992186	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGTATCAAAGACGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3767.9752897004	44.476026063265	0.0118036936666857	3648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3757.86412116479	3757.86412116479
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCGTATGTAGGAAAG"	-3.6060815853184	10.5499210127625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGTATGTAGGAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.39219406219	46.2853643400116	0.0216247118020777	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2138.79498420168	2138.79498420168
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATGACCAGTGGATAT"	-2.65331755104716	9.16606137836305	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGACCAGTGGATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.35928495402	40.8218274000993	0.0157591372120505	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.81149489949	2582.81149489949
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATGACCCAAGCTGCC"	3.97652616080586	-8.2032566300598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGACCCAAGCTGCC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2504.88521031473	33.7604454140572	0.013477841329829	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2501.65790868599	2501.65790868599
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATGACCCAGGTTCCG"	-3.39397631111797	9.94495866382448	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGACCCAGGTTCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2752.20137274824	43.511605054171	0.0158097461490334	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2741.39563037535	2741.39563037535
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGAACCCAGCCATTA"	-3.76975021782573	9.76725385272828	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAACCCAGCCATTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.24797513411	41.8733280057936	0.0180469193183428	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2312.97651905736	2312.97651905736
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCTACACAGTCTGGC"	-4.24339232865031	11.526394821051	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTACACAGTCTGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2381.1791881213	41.0914556061736	0.0172567674919895	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2373.94669215227	2373.94669215227
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGCGCTCGGTCAGC"	-4.34550462189372	10.1064500578674	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGCGCTCGGTCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.84009257429	40.0829755848902	0.0160856933413737	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2486.68867350153	2486.68867350153
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCTACATCCTAGCTC"	-3.97331414642985	10.7959718474182	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTACATCCTAGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2645.40920632735	38.046393342808	0.0143820446575175	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2637.2896185102	2637.2896185102
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGGGAAGTATAGGT"	10.9075514274532	6.65039870822755	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGGAAGTATAGGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2152.62831741185	45.4857751145265	0.0211303431932991	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2147.05405686291	2147.05405686291
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATGGAAAGGTAAACT"	-1.55287335339244	8.72232339465944	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGGAAAGGTAAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.46965442226	42.5304542315571	0.0164561631276203	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2575.02065552644	2575.02065552644
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATGGAACAGAGATGC"	-2.9145589870518	8.90527246082155	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGGAACAGAGATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.61946924876	41.1388294151455	0.0158067016331896	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2596.19526504821	2596.19526504821
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCTCAAGTCACATTG"	-4.47858128967937	10.6655530699524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTCAAGTCACATTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2595.73585608737	40.281936005133	0.015518503514395	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2585.12174445519	2585.12174445519
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AATTCCTAGAGAATCT"	-4.34121308746989	9.96242044055787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTCCTAGAGAATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2783.01004712035	40.4896956737534	0.0145488859142457	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2780.95444596978	2780.95444596978
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGAAATAGGTACAGC"	-7.00859246674235	1.61722633922426	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGAAATAGGTACAGC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2079.11441612075	43.1964595398578	0.0207763744048558	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2079.11441612075	2079.11441612075
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGTCATCTTACGTT"	-3.86152873459514	9.75885484302369	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGTCATCTTACGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2619.56881161902	42.5366962311321	0.0162380526300595	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2615.93105626728	2615.93105626728
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGAATATCGTTTACT"	1.05682494220082	-7.34546902095946	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGAATATCGTTTACT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2890.51201760258	39.8765746591765	0.0137956785567183	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2884.30799465297	2884.30799465297
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATCAGCACGGTGAA"	-4.87776885452922	8.75316903674928	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCAGCACGGTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3510.50126374656	39.1150999678633	0.011142311889134	3234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3499.27975508872	3499.27975508872
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATCAGTCTGGAGAG"	-4.21536240997966	12.6928367384705	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCAGTCTGGAGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2668.0643256906	38.383568141359	0.0143862978758669	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2658.23789129041	2658.23789129041
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTAGGTACG"	4.4753757911617	-8.55453588878783	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTAGGTACG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2804.84098594821	32.7796268486408	0.0116868039981095	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2801.27700331117	2801.27700331117
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTCAAAGAT"	-2.36259255829509	8.7843446501526	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTCAAAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2239.83748730983	42.7764657287361	0.0190980220534272	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2236.56366342828	2236.56366342828
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAAAGAAGTTGGACG"	1.76183011111562	-5.58619930660399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAAGAAGTTGGACG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2817.86471427659	39.851280399976	0.0141423682258667	2305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2811.9336008736	2811.9336008736
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAAAGAGTCTACAGT"	-3.85739002648051	9.67702195728151	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAAGAGTCTACAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.4432724561	37.622239224884	0.0142215256008701	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2641.89924136311	2641.89924136311
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAAAGATCTGCGATA"	1.4864191013271	-5.70861198818358	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAAGATCTGCGATA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2812.80992174599	38.6626528216584	0.0137452063585084	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2805.97020484567	2805.97020484567
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATGCATCATTGGTG"	0.618652363389176	-6.23622467434081	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGCATCATTGGTG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3107.19375033782	40.9495395480312	0.0131789462899052	2780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3095.065715377	3095.065715377
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAAGCAGTTCGGTTA"	1.62326600131337	-5.85103800213011	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCAGTTCGGTTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2573.98680076799	44.6444328176936	0.0173444684348705	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2571.75001275372	2571.75001275372
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAACCATCGTGTGGC"	3.76068963584248	-8.31313993847045	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAACCATCGTGTGGC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.39622861726	47.8252438772421	0.0214906645667132	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2223.7062969918	2223.7062969918
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGACTTGTAGTCTTG"	-2.71022377434428	8.86962888324586	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACTTGTAGTCTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2343.54203679488	44.4477913037879	0.0189660738343642	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2337.44055464666	2337.44055464666
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGGATGTTCGAAGG"	-2.70343909683879	8.71205422962037	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGGATGTTCGAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2373.4483702661	41.557327276717	0.0175092611229027	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2365.49981150659	2365.49981150659
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAAGCTTCACTTGTT"	-2.77402267876323	8.795383430365	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAGCTTCACTTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2816.19204798806	44.0730336109244	0.0156498679280098	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2807.60796558207	2807.60796558207
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACAGTAGTGTTGAA"	-4.26263175430949	9.85600946033327	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACAGTAGTGTTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2603.44430553525	40.3501593704845	0.0154987603478573	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2598.91164342892	2598.91164342892
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGAGGTCATGACTCA"	-3.94391165199931	9.73557183826295	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGAGGTCATGACTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2733.10893988058	42.3799020280963	0.0155061151824954	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2721.95492824852	2721.95492824852
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGATAAAGCCTTCTC"	-0.569186250597793	8.66479775989381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGATAAAGCCTTCTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2487.2686103829	36.1175125776231	0.0145209537992211	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2475.46369643796	2475.46369643796
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAAGTTCAACCCGG"	-3.64652834358867	9.68871495807496	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAAGTTCAACCCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2352.22748115478	38.6828024798366	0.016445179214064	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2348.04738199398	2348.04738199398
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCACGGCAAATACAG"	-3.06609306755717	9.54381654346315	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCACGGCAAATACAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2327.16662254561	40.4841501960778	0.0173963264185155	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2322.99901053514	2322.99901053514
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAACTTCTTGGTCC"	-3.07288203659709	9.44073484027711	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTTCTTGGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2209.9291469014	36.8835470664804	0.0166899228955805	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2206.9203256176	2206.9203256176
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACCAATCCACGGGT"	-1.7092299264973	8.72191808307496	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAATCCACGGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.84150111871	41.9198210731637	0.0170903097709512	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2443.24542695978	2443.24542695978
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGCATTAGGCTATCT"	-0.538639525801498	8.38696572864381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCATTAGGCTATCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2453.99401103327	34.0422023664294	0.0138721619585761	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2442.07348356941	2442.07348356941
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAGTACAATAGTAG"	-2.11955247345622	8.59669873798219	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAGTACAATAGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2401.53766962829	42.9662314422484	0.0178911336622501	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2392.5959883835	2392.5959883835
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGATTCAGCAGAG"	-3.87187681618388	10.0821475752625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGATTCAGCAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2451.10022211851	41.7905720276013	0.0170497198158145	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2444.33959133529	2444.33959133529
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACACGCGCAAGTCATC"	-2.36876879158672	8.57501504505006	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACGCGCAAGTCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2784.75275475154	44.7726614822243	0.0160777869438607	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2778.3803296674	2778.3803296674
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGCATTTCGCTTGCT"	-2.84236846390422	8.83037850940553	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCATTTCGCTTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2780.47673289028	37.7291728087414	0.0135693179383387	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2774.96242788033	2774.96242788033
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACAAGTCTCCTACG"	-3.87596831741984	13.2260331877503	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACAAGTCTCCTACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3087.77200449378	41.7978959244095	0.0135365875017907	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3072.63289558259	3072.63289558259
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAGGGAGTGTTGTC"	-2.61853704872783	9.03304383838502	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAGGGAGTGTTGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2364.11459993196	44.0316095008737	0.0186249894578465	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.86507140089	2353.86507140089
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGGCGTGAGATCG"	-4.50691161575969	10.634440399054	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGGCGTGAGATCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2585.27687603611	41.1661877575413	0.0159233187513206	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2582.50319447832	2582.50319447832
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGAGTGTACAA"	1.67065968093221	-7.38423063671263	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGAGTGTACAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2899.72770117456	33.5926332118539	0.0115847543885748	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2897.20154343297	2897.20154343297
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGAGTTGCATC"	-3.95953927460368	9.65150449359743	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGAGTTGCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.1865865311	39.6714017435031	0.0163446032388474	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2425.82945896816	2425.82945896816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGCTGCTCGTAGGGA"	-2.9289279979771	9.10575387561647	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCTGCTCGTAGGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2210.41026597135	46.6677978501173	0.0211127312284761	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2202.02641069516	2202.02641069516
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGGTAGACGGT"	-0.555328528315383	8.82058713519899	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGGTAGACGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2565.15636697177	37.8300395878438	0.014747654402255	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.00636944506	2555.00636944506
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTAGGCCTAAG"	-2.01614294472392	8.87521264636842	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTAGGCCTAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2041.62866926395	43.3511621219805	0.021233617442103	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2031.53806130608	2031.53806130608
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGTCGGCGATC"	-0.812540690333206	8.51237390125123	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGTCGGCGATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2413.8063684591	34.3399938856822	0.0142264907137534	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2404.32229121382	2404.32229121382
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGGGAAGAACAAGG"	-4.31153188172038	10.5150422819885	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGAAGAACAAGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2618.48501544636	40.8850041449979	0.0156139920235627	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2613.9484331544	2613.9484331544
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCATGATCCGACATA"	-4.32456384125407	9.90580365741578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCATGATCCGACATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2711.23403628268	40.7595099469911	0.0150335638316475	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2702.59216283053	2702.59216283053
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTCACAAATAG"	0.397700478404206	-6.39433958446654	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTCACAAATAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2649.76656583508	39.63184265876	0.0149567298379244	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2645.19620922045	2645.19620922045
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGGGAAGTTCCTGA"	-4.57227311554607	9.3478965529236	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGAAGTTCCTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3022.317099381	41.6955947287736	0.0137959033938938	3011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3014.75000719581	3014.75000719581
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTAAGTCCCTCAAC"	-2.68319211426433	8.81080815875856	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTAAGTCCCTCAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2727.8790878501	39.919567621655	0.01463392120254	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2715.90047676263	2715.90047676263
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACAGGGATCGACTCCT"	-2.90767655792888	9.07997891986696	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGATCGACTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2750.74905132336	37.3908301011544	0.0135929630088089	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2746.10722264873	2746.10722264873
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGCTTAGAGTCTTC"	5.45013250884358	-9.74973585521849	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGCTTAGAGTCTTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.8721403592	45.8950826229838	0.015958665887438	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2871.62194909168	2871.62194909168
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCCCAGCGTTCAT"	-4.3155029815739	10.1939811476502	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCAGCGTTCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2853.47192380596	41.4587907264597	0.0145292443148212	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2847.7596120004	2847.7596120004
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCCCGTCTGCATA"	-2.86176810684856	8.82310769641725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCGTCTGCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.23241342674	40.5903132967422	0.0162151596787519	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.75351809831	2495.75351809831
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGCAAAGACAGTCG"	0.19877984103505	-6.40610220348509	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCAAAGACAGTCG"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3112.09294652137	42.3521046457168	0.0136088816669364	3053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3105.2293867136	3105.2293867136
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCGGGTAGGTCGTGA"	1.69304635104482	-7.61944010173949	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGGTAGGTCGTGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.40337311922	39.1282002847274	0.0161459708766372	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2422.21080260676	2422.21080260676
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCCCTCCCTATTA"	-2.89387188378032	8.83399961078493	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCTCCCTATTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3157.66641761181	38.898826460661	0.0123188523789922	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3150.56727924953	3150.56727924953
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTCCCAACTGAAA"	-0.872625033289748	8.58302686298219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTCCCAACTGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2374.22919317535	47.3950926796114	0.0199623072683324	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2363.00128806776	2363.00128806776
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCCCTCTGCATGA"	-4.31394515457805	10.2640809782776	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCTCTGCATGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2576.98690181661	40.3070283078232	0.0156411459753285	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.98803444135	2571.98803444135
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATCGACAGTGACCC"	-4.37776170197185	10.6891288527283	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCGACAGTGACCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2753.65107747751	38.1403746405212	0.0138508378757485	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2750.09680267644	2750.09680267644
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGGGCAGTAGGTTA"	-4.33585296097453	10.0410241850647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGGCAGTAGGTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2516.69819974954	35.0880825249518	0.013942109756523	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2513.91105181612	2513.91105181612
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTGATCACATCAG"	-4.41036210480388	10.4071597822937	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGATCACATCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2451.96177886161	41.6116044113073	0.0169707394177354	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2442.45520621612	2442.45520621612
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATGCAGTTTACACG"	-3.76836286011394	-7.8180027238098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATGCAGTTTACACG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2262.61796978677	41.9004958973727	0.0185185906135632	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2257.7767103111	2257.7767103111
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACATTTCAGGGCAGGA"	-1.22733269158061	8.66381166065065	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATTTCAGGGCAGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2378.42127824359	42.9618748266872	0.0180631897383686	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2368.48995661564	2368.48995661564
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTTTCAGTGACCC"	-4.41423259201701	10.1295928725037	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTTTCAGTGACCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2826.64155951969	38.9985918455503	0.0137967941899846	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2819.27439157607	2819.27439157607
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAACCCGTGACTATC"	-3.97069249573405	9.65190312946168	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACCCGTGACTATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2504.86533872675	38.2861474345654	0.0152847128516803	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2497.24546256223	2497.24546256223
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTAGGAGGTCACTT"	-0.139710734516937	8.6414642103943	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTAGGAGGTCACTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2119.52010879979	37.5413087904834	0.0177121739183412	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2110.15699707696	2110.15699707696
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCAAACCAGGTTACT"	-2.57423315468486	8.67989537799684	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAAACCAGGTTACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2809.00748778582	43.9056589410843	0.0156303103968201	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2795.85701258529	2795.85701258529
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCAAACGTGGAAATT"	-4.59833226624187	10.5623168715271	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAAACGTGGAAATT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2802.22435881925	40.7778916254678	0.0145519724347304	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2795.97146552868	2795.97146552868
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTAGGCATGGCCAC"	-3.79599366608318	10.2241496809754	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTAGGCATGGCCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2328.30144711414	37.9378005915201	0.0162941961997845	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2323.95088263941	2323.95088263941
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCAACACAGCTGGTC"	-4.37817702713664	10.5987453230652	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAACACAGCTGGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2805.73878878239	40.3488057565993	0.0143808133237198	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2799.37897469031	2799.37897469031
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCATAGGGAGGGT"	-0.331907818943816	8.21915242755739	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCATAGGGAGGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2015.31319125041	39.850505034221	0.0197738521274183	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2010.17945766074	2010.17945766074
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTTAACGTAGACAAT"	-3.25818000260051	9.26508805835573	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTTAACGTAGACAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.40585882897	45.491486637187	0.0201075710883871	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2252.43419035985	2252.43419035985
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCATCACAGTGAG"	-4.30435405197795	9.93811509692994	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCATCACAGTGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2862.82193461555	33.4074745049023	0.011669421035573	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2854.45974435176	2854.45974435176
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCACAAAGAATCGAT"	-2.63158879700359	8.69426152789918	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAAAGAATCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2549.2853618741	34.3465236167065	0.0134730007594978	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2545.57484524851	2545.57484524851
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCACAAAGCTCTGTA"	5.39083685454671	-9.95502188121947	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAAAGCTCTGTA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.49649285729	45.0812596185344	0.0180578101141004	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2490.50603636594	2490.50603636594
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCACAACAATAGTCC"	-0.31294027987178	8.66067311847535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAACAATAGTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2473.37751262788	38.2233106115559	0.015453892669601	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2464.89308466787	2464.89308466787
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCTAGTCGACGCT"	-0.441534261137801	8.84541604602662	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCTAGTCGACGCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2176.82093795692	34.6913674102103	0.0159367115619396	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2170.03766545904	2170.03766545904
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAACCAGTCGAATTC"	-0.510808746249038	8.8317250975403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACCAGTCGAATTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2274.28914436738	38.4335542612719	0.0168991503813218	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2266.36695476544	2266.36695476544
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCACAATCAAACTGC"	3.19955124434773	-8.05230333721312	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAATCAAACTGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3045.33624434765	38.5806471878917	0.0126687643308682	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3038.96101697186	3038.96101697186
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAACTTCCTAGAGT"	-3.4381733936375	9.53955743396608	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAACTTCCTAGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2435.76048786164	48.0705962211598	0.0197353543013423	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2425.03693120109	2425.03693120109
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAAGTCAGCCGATCC"	4.41535963591878	-8.55423834240111	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAAGTCAGCCGATCC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2938.74665597836	32.3147510479006	0.0109960996406961	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2934.09388413753	2934.09388413753
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCATTTAGATTGCGG"	-1.83235738697703	8.7382488020691	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTAGATTGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2461.18393502588	40.0516958830354	0.0162733452437451	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2457.78416571683	2457.78416571683
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTACTATCAGCGCTTG"	5.43640055236165	-9.57180216228636	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACTATCAGCGCTTG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2753.73150624535	43.297105896245	0.0157230673353771	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2747.33351749912	2747.33351749912
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCATTTGTCGGCTAC"	-1.70714316788371	8.55123326862184	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTGTCGGCTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.20010822395	42.6897735512343	0.0162121266127502	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2623.62807531188	2623.62807531188
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTACTATGTGCCTTTC"	-4.12230620804484	10.7546958693298	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACTATGTGCCTTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2715.77750222661	43.6207297894008	0.0160619674305561	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2708.09369096635	2708.09369096635
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTGGTTCGAGAAAT"	-2.21876488152202	8.92163369739381	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTGGTTCGAGAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2570.18827067668	41.8251858073995	0.0162731992378083	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2560.66269682066	2560.66269682066
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTTGTGTGTCTTGA"	-3.94328389588054	10.6914691695007	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTGTGTGTCTTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2095.88083767449	43.3890656835797	0.0207020670753985	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2091.33959653325	2091.33959653325
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCAGCGTCGAA"	-3.62705884400066	9.91331288898317	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCAGCGTCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2212.09962463571	44.723280340075	0.0202175706021558	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2207.75224897011	2207.75224897011
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAACCAGTAGTCAA"	4.64404644545857	-8.2867117158142	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAACCAGTAGTCAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3162.85855165775	34.1596283914657	0.0108002390348951	3323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3156.36639547756	3156.36639547756
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGATCAAGTGACCTT"	-4.4196756881779	10.3687076338562	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGATCAAGTGACCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2755.04786912622	41.0388711498415	0.0148958831567806	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2741.97937173355	2741.97937173355
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCCAAAGTCGCACAC"	-4.33425031128581	9.88840005481569	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCAAAGTCGCACAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.640622955	39.0287078794617	0.0144142865742897	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2706.44733214781	2706.44733214781
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCCAAATCACACCGG"	11.0179497199947	-1.11608304893645	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCAAATCACACCGG"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2085.76962249317	35.900857783509	0.0172122833683788	3013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2078.12743801273	2078.12743801273
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGATGTTCCACAGCG"	1.61094953593556	-5.85626509105834	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGATGTTCCACAGCG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2750.46054408637	41.5848590632013	0.015119234905082	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2748.62584409488	2748.62584409488
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTACCACACTTGGCG"	-2.86899624291118	8.86715123737184	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACCACACTTGGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2601.68030587477	36.4059020319209	0.0139932265888756	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2595.09228673562	2595.09228673562
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCCTTGCAACCCTCT"	-4.48022780838664	10.6909570463928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCTTGCAACCCTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2640.06119506353	39.0699276534145	0.0147988719831452	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2633.76296707271	2633.76296707271
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAGGTAGTTCGTACA"	-4.12920556488689	9.72649571979371	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTAGTTCGTACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2733.86447643722	43.7476654730856	0.016002133920734	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2731.76976917178	2731.76976917178
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCGTTCCAGAGCCCT"	-2.91723523560222	8.73866746509401	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCGTTCCAGAGCCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2908.86651523842	38.007037547689	0.0130659270023512	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2896.43590014926	2896.43590014926
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTACCATCAGACATC"	-4.44254813614543	10.2888011702332	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACCATCAGACATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2579.51666513911	42.9264533823945	0.0166412777876275	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2573.2101737284	2573.2101737284
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTATCCGGTATGAGAT"	-3.55064163628276	9.84161183917848	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCCGGTATGAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2380.09108638129	40.0644805621065	0.0168331711300263	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2373.1844180957	2373.1844180957
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGAAGTACGTACT"	-4.40240035477336	10.8179626234802	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAAGTACGTACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2913.08176133421	38.4850146966258	0.0132111000822028	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2905.07756177975	2905.07756177975
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTACTGTCAAATGAG"	-7.07439027252849	1.67444441402284	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACTGTCAAATGAG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2554.8021877583	38.1551328961284	0.0149346720771394	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2543.44811992098	2543.44811992098
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGAATCCTGTTGC"	-0.935550074011642	8.84044835651246	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAATCCTGTTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2379.96814172611	46.3707219200673	0.0194837574113224	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2376.49365463015	2376.49365463015
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACCTGAATCGAGATGG"	-4.30189452591594	10.0498275526795	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAATCGAGATGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2863.94825095059	41.1030274196224	0.0143518750403327	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2855.73658387804	2855.73658387804
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAGCTCAATAGGAT"	-4.2791579765385	12.2785701521668	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGCTCAATAGGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2567.19818934399	47.160176918913	0.0183702906595474	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2561.37732277593	2561.37732277593
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTTGCAAGTGGAC"	-4.43178735199626	10.6849479445252	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTTGCAAGTGGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2545.89576336818	41.1967117181969	0.0161816176101783	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2542.19149758575	2542.19149758575
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTGCGAGGTTTACC"	3.53875841674153	-7.59889652645262	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTGCGAGGTTTACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.54069601171	40.2200649594015	0.0166024310863454	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2418.26883639865	2418.26883639865
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAGTCTCAAATAGG"	-4.32123742523845	9.89213368976442	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGTCTCAAATAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.40025269377	39.431415928169	0.0152338943280246	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2587.13008944489	2587.13008944489
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAGTCTCGAAACAA"	-1.69593868675883	8.74045083606569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGTCTCGAAACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2146.50882065398	44.5958347823729	0.020775984870533	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2141.01668065636	2141.01668065636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTGTGGCAGAT"	4.79646219786946	-8.66563990032347	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTGTGGCAGAT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2615.02599985659	43.0474715302706	0.0164615845244489	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2611.98268968164	2611.98268968164
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACTAACAACAGAGC"	-4.340559343726	10.1516618498596	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACTAACAACAGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.65735611466	35.0761670333845	0.0135604226630431	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2581.83818601655	2581.83818601655
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAATTCATGTGCTA"	-3.45351157608684	9.29363629901735	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAATTCATGTGCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2746.68126110463	37.3889004461016	0.0136123914250848	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2744.52352877473	2744.52352877473
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCACAGTGCCGTTG"	5.34207644042317	-9.51724531566771	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACAGTGCCGTTG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.88093587571	39.6636878265117	0.0160784767718964	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2463.9918436295	2463.9918436295
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGAGCTACGTT"	-2.52260003510173	8.76519582355348	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGAGCTACGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2171.80336868025	39.237976975231	0.0180670025385747	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2170.15054372374	2170.15054372374
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCACATCGACCACG"	-4.04658017578776	9.73546598041383	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACATCGACCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2567.25153955955	43.4547306191121	0.0169265574290268	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2554.34416180157	2554.34416180157
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCATGAGAATCGTA"	-1.85146675530131	8.78816316211549	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCATGAGAATCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2297.9872671216	43.1015859135055	0.0187562335658602	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2291.9564888391	2291.9564888391
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGCACGAGAGTGTGC"	0.69235004958455	-7.16820719158324	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGCACGAGAGTGTGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2321.80764207275	47.2195380084352	0.0203374031305543	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2320.23483009088	2320.23483009088
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCAAGTTCAGGAACG"	10.5782791572506	7.64216373050538	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCAAGTTCAGGAACG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2375.1050170406	41.456587313971	0.0174546333810646	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2365.49848073398	2365.49848073398
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCACGGAGCTATCTG"	-4.37633452835734	10.2677240141663	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCACGGAGCTATCTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2764.8118088724	40.2920347161769	0.0145731563308859	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2757.73959395575	2757.73959395575
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGGAAGCAGAGTGAC"	2.70746626433675	-5.9101715317932	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGAAGCAGAGTGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2868.10286459088	45.0268040473813	0.0156991594001996	2489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2862.68827370715	2862.68827370715
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCTCCAGGAGAATG"	-2.36611328545268	8.73445794666139	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCTCCAGGAGAATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2378.16224069458	40.9249129066709	0.0172086295065883	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2368.34164394292	2368.34164394292
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGTTAGTGAGTTTC"	-3.71573362770732	9.64419934833375	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGTTAGTGAGTTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2443.17171491251	38.4200754425797	0.0157254912571528	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.38107838005	2435.38107838005
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTACACAACCCGCA"	-4.33837018433269	10.0997409590515	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTACACAACCCGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2721.99565432531	39.8116111747892	0.014625890791386	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2716.61490949887	2716.61490949887
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGATCCAAGCAGGT"	-4.04975686493571	9.92860696399537	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGATCCAAGCAGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2420.68781681377	46.0644509498092	0.0190294884907718	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2408.51948018174	2408.51948018174
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGAGAAATGGG"	-4.16697249832805	10.8074569472107	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGAGAAATGGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2429.84335379357	46.3215820701845	0.019063608358895	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2424.18432939459	2424.18432939459
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGGTTATCTCGCAGG"	-4.33911786499675	10.2440223463806	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGTTATCTCGCAGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3179.16254600349	41.7650573228378	0.0131371254909065	2797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3167.20320841359	3167.20320841359
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAGTCAGCCATATC"	3.01642551001851	-7.90094950115355	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGTCAGCCATATC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2218.86119729319	48.3138994650168	0.0217741873732144	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2213.55877259472	2213.55877259472
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCAGTTCACGGGAA"	-4.27200303497966	10.4123029478821	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCAGTTCACGGGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2570.06536143843	40.0018565966361	0.0155645289014158	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2562.44968957336	2562.44968957336
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCACTCATCGGCCA"	-1.96540627899821	8.54731175983278	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCACTCATCGGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2591.60048944761	42.3372214436483	0.0163363225219456	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.46774384512	2579.46774384512
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGTAGTTCTATGCCC"	-6.91841969910319	1.78677103603212	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTAGTTCTATGCCC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2534.91843697953	41.9973558495766	0.0165675373364748	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2525.01887772519	2525.01887772519
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGTCGACCATA"	-3.82498989525493	10.3496322401795	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGTCGACCATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2581.86505404901	42.2467977964947	0.0163628992654907	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2575.41360143429	2575.41360143429
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGTTGCAAGTGGCA"	-2.8159843486851	8.87196443164674	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGTTGCAAGTGGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2582.61720709954	39.6648078941686	0.0153583766828205	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2574.6705748788	2574.6705748788
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGTCCTTCCAACCAA"	-4.28418288651164	10.4424199827942	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTCCTTCCAACCAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2645.76749991327	41.1109209832315	0.0155383725080073	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2642.09686433457	2642.09686433457
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCATCGGTCTCTATAC"	-4.17818532410319	10.265149093512	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCGGTCTCTATAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2713.55851239877	39.3576455030028	0.0145040710650498	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2696.89154317778	2696.89154317778
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACGTTCCTCTATACTC"	-4.04865775528606	9.72568605029909	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTTCCTCTATACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2895.70324312202	45.7433593308189	0.0157969776217471	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2890.31457101971	2890.31457101971
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTACGAAGTTCATGC"	-4.2903622192448	9.9429664381775	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTACGAAGTTCATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2939.96779795853	39.2603448581339	0.0133540050627071	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2932.15670607106	2932.15670607106
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACCGAGTCGATGCC"	-3.91706881943401	10.5162248381409	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCGAGTCGATGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2300.56858419073	44.830003392369	0.0194864885578444	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2295.77136649944	2295.77136649944
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCACAAGCACACCC"	-0.591790954500991	8.59702107990114	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCACAAGCACACCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2588.28223659612	38.8031333444433	0.0149918477961174	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2578.85595385894	2578.85595385894
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCACACAAGACGAC"	-2.53213510933574	8.80550859058229	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCACACAAGACGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2854.21901362236	43.823752496179	0.0153540258428036	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2845.15178811606	2845.15178811606
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTACGATCCTTTGAT"	5.03777613219563	-9.16879751598509	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTACGATCCTTTGAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2340.1997896427	31.9669170273781	0.0136599093670796	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2333.98336825636	2333.98336825636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTACAGTCACTGGGC"	-3.07707605782207	12.7579107054505	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTACAGTCACTGGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2731.38419127864	41.7909838382019	0.0153002949829033	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2726.72035346626	2726.72035346626
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTATCTCAGCCTATA"	-0.409943888813812	8.90738103473512	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTCAGCCTATA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2559.50940052789	36.2850918261817	0.0141765808004838	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2549.17575827094	2549.17575827094
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCATGGTATCCTCC"	-1.99028454247172	8.98493383014528	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGGTATCCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2287.30357111881	42.4488470623424	0.0185584666584414	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2283.45585495835	2283.45585495835
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACTTCGTACTCGTA"	-4.38049493256267	10.5013007887634	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACTTCGTACTCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2676.10251668863	47.1796375818142	0.0176299813955534	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2668.02321953336	2668.02321953336
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACTTCGTTGCCAAT"	-2.79282889786418	9.02046868884889	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACTTCGTTGCCAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.7661013902	42.4887619222556	0.0170448249832023	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2486.20145414577	2486.20145414577
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACAGGCAAACACGG"	-4.38701663437541	10.0050687559876	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACAGGCAAACACGG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2671.46806259348	34.403851452914	0.0128782566913843	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2668.5090286746	2668.5090286746
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGACCCATTCTCTA"	-7.77877126160319	0.387009776476301	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGACCCATTCTCTA"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2048.61829589574	40.9088085054168	0.0199689754735544	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2040.50064354931	2040.50064354931
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTATGGAGTGAACAT"	2.40853108939473	-7.70378067409667	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATGGAGTGAACAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2808.71456439565	40.449123828512	0.0144012938663333	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2798.71222940365	2798.71222940365
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGAGAGTAACACGG"	-0.451009373099166	8.77306268298952	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGAGAGTAACACGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2269.19235441338	40.2357659041302	0.0177313156488806	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2261.72400711996	2261.72400711996
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGAGAGTGTGTGTT"	-4.42761216583903	10.6680669554505	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGAGAGTGTGTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.98720549113	37.9042233864541	0.0146349075802737	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.19188309732	2586.19188309732
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTATGGTCCAACTGA"	10.3647400337154	7.3596529730591	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATGGTCCAACTGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2376.69602469445	45.9115179958627	0.0193173706350458	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2367.92005026735	2367.92005026735
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTATTCGTTGACGGA"	9.83443798598592	7.85761830890504	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATTCGTTGACGGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2147.65811858415	48.4512094755332	0.0225600197053127	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2142.95864764653	2142.95864764653
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTATTCTCACTGATG"	-4.34458384934123	10.1264667280945	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATTCTCACTGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2687.45273039362	42.1239450188896	0.0156743017439863	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2680.3363098282	2680.3363098282
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGGCTAGAATCTAG"	-3.72732911530193	9.73481652820436	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGGCTAGAATCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2157.00851997578	42.5949597833024	0.0197472376158165	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2149.56745267972	2149.56745267972
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTCCCACAGTTGGTT"	10.8596073585445	-0.648222231027208	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCCCACAGTTGGTT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1559.47015362495	34.3330456809917	0.0220158401885316	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1556.02781834803	1556.02781834803
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTCCCATCGCATAGT"	-3.66587076607402	10.2008008726868	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCCCATCGCATAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2702.04950270873	47.4083254453284	0.0175453208380538	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2695.66435362385	2695.66435362385
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCACAGGTATAGGGC"	10.4113241630489	7.54557845676271	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACAGGTATAGGGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2365.75817872431	45.4842137847667	0.0192260621536954	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2358.7724542717	2358.7724542717
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCTCCCAGACTGCC"	-4.18895469132121	11.0708923109802	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCTCCCAGACTGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3240.14470990285	38.7089576178615	0.0119466755603709	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3235.65914801358	3235.65914801358
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCCAGACAGGAATAT"	-4.03146348419841	10.8280191191467	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCCAGACAGGAATAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2021.02525639617	49.5508363751796	0.0245176730069851	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2014.33089488753	2014.33089488753
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTCTCGCAGTGTATC"	1.76002957400624	-7.51280167019042	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCTCGCAGTGTATC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3088.07947271568	45.1045888637604	0.0146060324102006	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3080.33799185931	3080.33799185931
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTCTCGGTAGCGTTT"	-0.604444305331069	8.70028874957887	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCTCGGTAGCGTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2476.17197205183	36.9726958644206	0.0149313926018571	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2468.61208082194	2468.61208082194
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCACGAGTACGGTTT"	-3.95152650299724	9.91242883289186	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGAGTACGGTTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2485.02875554884	42.1297890318969	0.0169534412581041	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.66222036263	2472.66222036263
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCGAGGGTAAGCAAT"	-4.04023490372356	9.81341836536256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCGAGGGTAAGCAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2420.58242079869	39.8487727959875	0.016462473020373	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2417.93893714662	2417.93893714662
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCACGAGTTCCTACC"	-4.36828217926677	10.283534980658	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGAGTTCCTACC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2728.8533371025	43.2591868762055	0.0158525144198985	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2722.62345294693	2722.62345294693
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCGAGGGTGGGATTG"	-3.2859025997227	9.53522107684938	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCGAGGGTGGGATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.48918301314	43.731721606589	0.0170794400916493	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2549.6216075355	2549.6216075355
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGAAGTCATAATGAG"	10.1864038902218	7.93353316867677	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGAAGTCATAATGAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2640.31256556831	42.4328051062949	0.016071129479006	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2632.47140346651	2632.47140346651
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGCAATCTTCGTAT"	-3.41583929482158	10.2306537398132	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGCAATCTTCGTAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2586.33023585532	39.6039201926417	0.0153127855227445	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2579.4112193803	2579.4112193803
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCAGGTCATACATCG"	-2.21913252297099	8.59037301624147	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCAGGTCATACATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2637.28096094357	43.9112101531809	0.0166501828221861	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2619.79775709135	2619.79775709135
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCTCGATCAAGTGGG"	-2.60736689987834	8.85394380176393	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTCGATCAAGTGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2258.69181590999	45.8852960639145	0.0203149875253912	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2257.32960354066	2257.32960354066
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCTTCCAACCAATC"	0.458036233752412	-6.87632801448973	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTTCCAACCAATC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3119.87522009345	48.4403235605442	0.0155263656855781	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3110.71086110684	3110.71086110684
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCAGGTTCTAGCCTC"	-4.13542256775554	12.1146640547547	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCAGGTTCTAGCCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2637.96170541363	38.6721484002959	0.0146598596639719	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2630.63471719808	2630.63471719808
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCTGGTGTGAACCGA"	-2.6956926387852	8.732057548407	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTGGTGTGAACCGA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2632.6427523267	44.6264464833376	0.016951197211964	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2625.76393196288	2625.76393196288
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCACCAGAGGGTGG"	-3.80765924874004	10.1213044890198	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCAGAGGGTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2550.81774156495	34.3181626037811	0.0134537885810401	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2544.34094477903	2544.34094477903
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGCGGGTACCATAC"	-2.5070665878361	8.98091409290162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGCGGGTACCATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.2510918503	43.3134463274939	0.0187321552058751	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2304.98782830692	2304.98782830692
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCTCCGTACGG"	5.38252033767049	-9.64916899120482	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCTCCGTACGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2642.87853341396	44.5326266842536	0.0168500466900869	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2637.06666970338	2637.06666970338
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGCCAGTAAACTG"	-3.96212611618693	11.0755824812683	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGCCAGTAAACTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2707.91381081001	45.9964466434412	0.0169859345078943	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2699.41691918095	2699.41691918095
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGTGAAGTCTCCTC"	-3.78293810311015	10.1278495558533	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTGAAGTCTCCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2362.00792863953	48.3998997731048	0.0204909980132802	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2354.71730193758	2354.71730193758
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGTGAAGTCTCGTA"	-4.4671519798344	10.5572004088196	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTGAAGTCTCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2870.7446172741	39.9841648717586	0.0139281511253778	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2857.6873541804	2857.6873541804
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTGTGACAGTGACCC"	-0.446225891739684	8.75274465167848	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTGACAGTGACCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2544.87671894697	41.9482642871069	0.0164834170452329	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.92005916382	2532.92005916382
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCACCGTGGAGGTT"	-4.29306588593181	10.1842660673889	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCGTGGAGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.0566855447	40.9823529647544	0.0168370577432067	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2432.78314982308	2432.78314982308
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCACCTCGACGATT"	-2.54413209381755	8.68537519061891	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCTCGACGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2641.73090232354	41.367327327497	0.0156591753123349	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.95202499798	2629.95202499798
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCAGGCACAGCTTA"	-1.60261855545695	9.46515176380006	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCAGGCACAGCTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2025.18808506725	45.489449143584	0.0224618392133556	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2016.56492519472	2016.56492519472
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTAGGGTTGGGTTT"	-3.82669053497966	9.63398835742799	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTAGGGTTGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2665.95473509249	40.7010737747789	0.015266978557071	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2662.48989011943	2662.48989011943
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCAGGCAGTGTGCC"	-0.808550099760848	9.02993486011354	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCAGGCAGTGTGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2362.89787153685	43.332716244876	0.0183388020137714	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.15775110131	2353.15775110131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCAAGCGCAAGATCCT"	-3.9483245414799	10.6361684569153	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAAGCGCAAGATCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.06539837854	45.2849339823558	0.0177932299936995	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.22656744911	2539.22656744911
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGGTAGGACTG"	-4.14176640930827	9.71442029559938	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGGTAGGACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2776.27834882292	38.2223252114052	0.0137674686789279	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2769.36628258285	2769.36628258285
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTCCGGTAGGATAT"	-4.40367350998576	10.153179145697	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCCGGTAGGATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2835.71184533182	37.3010969851876	0.0131540505593307	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2831.84580748094	2831.84580748094
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTCGCAGATGCTAA"	-2.58643207970317	9.06874749744264	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCGCAGATGCTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2456.14227494207	42.6702383218993	0.0173728691359729	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2454.36374723161	2454.36374723161
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTCGCCACCCAAGC"	-2.63693104210551	8.67903134906618	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCGCCACCCAAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.79738166381	39.5530863457651	0.0155488352299092	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.61017416414	2537.61017416414
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCATGTGACGCCT"	-4.12831483307536	12.1835212477478	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCATGTGACGCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2858.15885915214	38.2748130215503	0.0133914225582634	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2848.08288094414	2848.08288094414
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCGTCTCAGCCTTC"	-4.26549039307292	10.1849679716858	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCGTCTCAGCCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.25475741085	41.4829883816432	0.0165716207105303	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2494.29937437496	2494.29937437496
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTCAAGCATTGTC"	-3.08119998398479	9.38373181903688	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCAAGCATTGTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2683.30593154259	40.3181923765582	0.0150255667468301	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.63022294473	2674.63022294473
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCTATCAACGTATC"	-4.29990325394328	10.5920676955017	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATCAACGTATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2631.33393927458	40.7979446755179	0.0155046625084634	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2625.68441105434	2625.68441105434
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTCACATCGTGGC"	-2.11331282082255	8.63478658283082	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCACATCGTGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2563.03107270881	40.9292033471884	0.0159690624834802	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2548.18162483199	2548.18162483199
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTCAGTGACTCTA"	-2.2324312728947	8.83027837360231	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCAGTGACTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2638.44038726091	43.8971811746604	0.016637548980302	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.78636548566	2626.78636548566
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTCAGTTGCGGCT"	9.97333778914754	7.53941676700441	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCAGTTGCGGCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2399.87482868469	44.1108683448696	0.0183804871060903	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2388.61651463756	2388.61651463756
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTCATCAACGTGT"	-2.89448986473735	8.6951579817566	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCATCAACGTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2800.79599423011	40.2495755744647	0.0143707630464277	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2797.29209012649	2797.29209012649
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:ACTTTGTGTGTGATGG"	2.25170697745625	-5.0218224755493	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTGTGTGTGATGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2874.76325585573	41.563569282074	0.0144580842256876	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2869.13416953668	2869.13416953668
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAAATGAGTATGTAG"	10.6443630653316	7.49220368945924	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAATGAGTATGTAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2266.18167572829	42.594511303606	0.0187957178190126	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2260.82170604023	2260.82170604023
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCTCAAGGGAGAAT"	-7.21908698502238	1.53903946960298	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCTCAAGGGAGAAT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2743.0263399586	47.1821774012661	0.0172007744562811	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2732.33294957951	2732.33294957951
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAACAAAGCGTATGG"	-4.21168456497844	10.4476814039978	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAAAGCGTATGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2770.73167463475	41.0782368181468	0.0148257722659348	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2762.69878875643	2762.69878875643
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGCCTGTAGCTCGC"	-2.89496121826823	8.88033101642457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGCCTGTAGCTCGC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2464.01358176089	37.0593971891733	0.0150402568652601	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.44629371775	2461.44629371775
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGCCTTCGCCTTGT"	0.666161437600297	-7.1595669022766	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGCCTTCGCCTTGT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2634.65471777654	40.9963705609404	0.0155604338907598	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2631.91426791275	2631.91426791275
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGGATTCTTTCCGG"	-4.14396462860759	9.86408517444459	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGGATTCTTTCCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.21989091717	42.6829309551102	0.0167698402434413	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.10436312648	2539.10436312648
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTGGGCACTGGATT"	-2.91187725487407	9.00907418811647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTGGGCACTGGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2354.64250147259	39.5071665503357	0.0167784139314686	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2350.11860869957	2350.11860869957
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAACAATCCATATGG"	-4.43415341797526	10.123996711615	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAATCCATATGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3046.86005127242	33.8296469563921	0.0111031180911195	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3038.79472428805	3038.79472428805
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGGCGTCACCTGGG"	2.57876863059346	-7.90654995357665	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGGCGTCACCTGGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3051.00727819352	31.0492350079976	0.0101767161389342	2566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3043.91803669457	3043.91803669457
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAACCTTCACAATGC"	-4.19979749146159	9.75507352435914	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACCTTCACAATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2775.33034663156	48.7144130107187	0.0175526538921191	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2769.24741851834	2769.24741851834
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAACCTTCGAGAAAT"	-3.38171682778056	9.39449784839479	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACCTTCGAGAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2593.15032963745	40.4928245712254	0.0156153016307723	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2587.00189583508	2587.00189583508
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGGACGTCGAGCCAC"	-3.85580931130107	9.86885449970094	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGTCGAGCCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2702.88421233551	40.1745234322754	0.0148635754535564	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2702.88421233551	2702.88421233551
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGGCAGAGCCTCTCT"	-4.00753770294841	9.76756761157838	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGCAGAGCCTCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.7934164084	43.8939555401473	0.0168641718791177	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2600.46536185621	2600.46536185621
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAAGCGAGTGACACG"	9.94053806838338	7.18336818302003	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated NFkB"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAGCGAGTGACACG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2219.75334776382	43.8908789862616	0.019772863066285	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2210.72546890143	2210.72546890143
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGTGACACTAGTAC"	-4.08097777786906	10.3540210493836	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTGACACTAGTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2394.5153133632	41.9805865811033	0.0175319766579984	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2387.85991154711	2387.85991154711
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGTGACATGAGGGT"	1.81353821334187	-5.67462685024413	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTGACATGAGGGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2324.12430593556	45.305773658333	0.0194936964183142	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2322.68728252098	2322.68728252098
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCTCTAGTTGCATCA"	-0.0864665758913339	9.04986188495485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTCTAGTTGCATCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2259.3017854728	44.3545238260433	0.0196319606841551	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2252.83375742981	2252.83375742981
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCTCTAGTTTGCCGG"	-3.44254789772685	9.63584420764772	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTCTAGTTTGCCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2207.23482204547	47.9633008334575	0.0217300399370328	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2199.81640085454	2199.81640085454
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTAGACAGCAGTTT"	4.57087435302083	-8.66801168834838	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTAGACAGCAGTTT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.3489731166	48.0565962750766	0.0198306545232206	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2420.27425571988	2420.27425571988
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAAAGTTATCTTC"	-4.18195758286174	10.3011274107727	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAAAGTTATCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2538.54004917478	45.4197464775829	0.0178920740259141	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.57415751822	2528.57415751822
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTAGAGTTAGGGTG"	-4.34998403015788	10.7366561659607	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTAGAGTTAGGGTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2601.39231284957	43.1112657857427	0.0165723814792543	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2596.07226882778	2596.07226882778
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACTGTGTTTCGGCG"	-1.80103836479838	9.23252675617067	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACTGTGTTTCGGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2210.78062710789	48.8920022787941	0.0221152662906921	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2209.28691998458	2209.28691998458
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGACCAAGACGCTCC"	-4.41839824143107	10.4009151228699	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGACCAAGACGCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2497.35499825171	44.1590604198238	0.0176823320876438	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.05906611727	2495.05906611727
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACACTCACTACGGC"	-4.21417365494426	9.85068795764772	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACACTCACTACGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2753.00452027228	34.9133583569124	0.012681911017516	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2746.95012726358	2746.95012726358
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTAGGCACATACATCG"	-4.30785212937053	10.4745568999085	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCACATACATCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2560.62985000494	43.0932226273497	0.0168291495263427	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2552.18657333976	2552.18657333976
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAGGAGGGTGAAA"	-4.4241021675175	11.0730008848938	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAGGAGGGTGAAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2716.42378565156	39.9137542791285	0.014693493147114	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2697.83811164411	2697.83811164411
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACAGGCATCATTTC"	-4.15637956085857	10.0148324736389	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAGGCATCATTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2834.84134547275	40.1052471326659	0.014147263372151	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2828.84057521607	2828.84057521607
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTGAAAGGCGCTTC"	0.922507842152756	-8.31932547008666	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.444444444444444	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGAAAGGCGCTTC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2573.05925905323	36.2913187057564	0.0141043462477852	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2570.07498606439	2570.07498606439
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACCATGTCCCTCAT"	0.503433724015397	-5.87441589748534	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACCATGTCCCTCAT"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3158.84502363481	44.119263709602	0.0139668971980255	3037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3149.56140387237	3149.56140387237
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGAGTCCATGACTAC"	-3.13615761223491	10.7211704024109	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGTCCATGACTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1905.0232112697	38.8098261330345	0.0203723639184258	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1895.74907419256	1895.74907419256
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGAGTCGTCGAAACG"	-3.8215642971104	9.69283292377321	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGTCGTCGAAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.01836251916	40.9803147244693	0.0176637889537958	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2320.01836251916	2320.01836251916
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACCCGGTCAGTCCG"	-4.01687274399455	11.9733161696228	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACCCGGTCAGTCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2796.68869119802	36.9573065208431	0.0132146658429157	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2783.19998120623	2783.19998120623
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACTCACACGTGTGC"	-3.11582146111186	9.19579885089723	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACTCACACGTGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2768.96404742724	35.5064384216922	0.0128230044932085	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2757.61237309637	2757.61237309637
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTATTGCCATCGAAGG"	-1.75418792191203	8.68164918506471	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Activated"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTATTGCCATCGAAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2415.74335278379	40.9175730662221	0.016937880846933	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2409.47669244187	2409.47669244187
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACTCACATAAGCGG"	4.63061203536336	-8.7476263276306	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACTCACATAAGCGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2943.62627897127	43.0691668036931	0.014631329768786	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2934.84370810894	2934.84370810894
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGACTCAGTGATACAA"	-0.240244637162048	-6.52192165767821	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACTCAGTGATACAA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2916.32186220474	41.8435946009709	0.0143480715017296	3147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2905.65022311329	2905.65022311329
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGCATGAGAAGGTAG"	-2.14964447441753	8.61443612659303	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCATGAGAAGGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2185.23215676835	42.223781522183	0.0193223321336374	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2179.14378534644	2179.14378534644
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAATCCAATGAAAC"	-2.69412646713908	8.90892217243043	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCCAATGAAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.97243739366	43.4963132932903	0.0169842957535135	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2558.76616496564	2558.76616496564
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGCATGAGGGCAGGA"	-3.70160637322124	9.96681974017946	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCATGAGGGCAGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2652.65075550306	39.6729611172441	0.014955968491118	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2646.10306997283	2646.10306997283
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGCAGAGCATAGGC"	9.13519348677937	7.56544778430787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGCAGAGCATAGGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2037.0099316519	44.7662147468446	0.0219764342094011	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2030.71401635465	2030.71401635465
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGCCCAGTTGCTGT"	-4.43432889404948	10.1425742872986	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGCCCAGTTGCTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2848.53274792703	41.8694021890203	0.0146985855154693	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2842.02145294613	2842.02145294613
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGCCCGTACGTGTT"	-2.25020418587382	8.86347291553346	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGCCCGTACGTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.68103441584	49.7102516531345	0.0213744924250202	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2322.87827573357	2322.87827573357
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGCCCTCAGCTAGT"	-2.75086412850078	9.31081197345582	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGCCCTCAGCTAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2635.86758364221	47.4631580330707	0.0180066549350278	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.01779679643	2629.01779679643
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGAGCCCTCATTCATC"	-1.75535664978679	8.93665216052858	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGCCCTCATTCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2469.96824110966	45.7453061652222	0.0185206050036783	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2465.32293627862	2465.32293627862
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGAGGAGGTCCGAA"	-4.28063283386882	10.0970525511536	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGAGGAGGTCCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.54652954148	38.4021304629759	0.0167071364314024	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2291.77610410266	2291.77610410266
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATAGAAGCCTGACC"	0.687575598328751	-7.50864317333373	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATAGAAGCCTGACC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2836.19246176894	44.7260597124637	0.0157697548087297	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2834.97323000551	2834.97323000551
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATCCAAGATGGTAT"	5.0125171142513	-9.07315542614134	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCCAAGATGGTAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.19501846583	35.575179099681	0.01249042950677	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2839.94523135984	2839.94523135984
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATCCAGTCAACCAT"	1.54916944083516	-5.66150762951048	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCCAGTCAACCAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2992.51923568604	35.8371076622764	0.011975564679724	2440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2983.92424018158	2983.92424018158
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATCCAGTTTCTTAC"	-4.19781337204631	10.1438312300476	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCCAGTTTCTTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3305.31710583707	38.5309033875895	0.0116572486553697	2798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3291.5658298065	3291.5658298065
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGTCAATCCGA"	-4.4095815223759	10.4434385069641	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGTCAATCCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2596.08415428408	43.8977070716997	0.0169092003428546	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2593.19232883776	2593.19232883776
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGTCTTCGTGC"	-2.32030950012859	9.54198548877565	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGTCTTCGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2161.07830479408	44.7457056602483	0.020705268088151	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2154.00676597244	2154.00676597244
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATCGTTCGACGAGA"	-2.43750987473186	8.82195851886598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCGTTCGACGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2549.76967247936	41.7920897873424	0.0163905352857634	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2547.07344043999	2547.07344043999
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGTTCAACGCCCA"	4.34785427626912	-8.63932516491088	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGTTCAACGCCCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2709.18258650604	30.5122566107393	0.0112625323825406	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2709.18258650604	2709.18258650604
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGATGCTCATGACTAC"	-4.38741288605388	10.463988281134	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATGCTCATGACTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2671.81509808412	43.9510639221588	0.0164498897972674	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2655.10253107813	2655.10253107813
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAGGATCGTACACA"	-1.30116246166881	8.63850686633912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGATCGTACACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2169.75367003892	49.532473789655	0.0228286162035926	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2157.78718008538	2157.78718008538
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTTAGTGTGAATGTA"	-2.34497056427653	8.62685487354127	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTAGTGTGAATGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.19703038936	40.302501222265	0.0158347274262298	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2542.96579277732	2542.96579277732
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTTGGATCACCTCAC"	-4.26586614075358	10.1544017561707	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTGGATCACCTCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2653.881966376	46.1185270729244	0.0173777612031108	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2646.77710817763	2646.77710817763
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAATAGATTGATG"	-4.12441955033	9.81900498950807	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATAGATTGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2668.08382334879	41.3157484999664	0.0154851763420648	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2661.43589780816	2661.43589780816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCCCCAGAATCGG"	10.4291941123897	7.6946983107361	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCCCCAGAATCGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2235.92689034088	47.4395726073381	0.02121696054208	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2226.93357523314	2226.93357523314
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAATCAGCTGTGC"	10.2920376258785	7.15343091571657	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATCAGCTGTGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2387.60706758849	43.71288101898	0.0183082390785224	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2373.88555832203	2373.88555832203
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCAATCATCGAAGG"	-4.29390941086467	10.1428851851257	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATCATCGAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2738.49309074695	38.4590111383859	0.0140438591093526	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2731.00791528331	2731.00791528331
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAACCTGTATCAGGG"	-1.98614392700847	9.20128629291383	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAACCTGTATCAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2431.21461376275	43.234448260372	0.0177830653104947	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2424.96559131468	2424.96559131468
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTGTCAGATTC"	-0.824245194823104	8.26823041522828	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTGTCAGATTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2403.01786812297	40.6580309420412	0.0169195707952849	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2394.34498652688	2394.34498652688
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCACGAGTGAACAT"	-4.34509692612346	10.1460723646912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCACGAGTGAACAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2476.99114135862	40.9330463185892	0.0165253099355606	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.69529552697	2461.69529552697
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCACGCACTCATAG"	-2.60019097748454	8.76857183063356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCACGCACTCATAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2500.60951680404	39.8140199475804	0.0159217261551758	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2491.19737807355	2491.19737807355
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:AGCCACGGTGCGCTCA"	-3.02749286118205	9.09121987903444	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCACGGTGCGCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2513.87758735481	42.8315255984621	0.0170380315310145	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2511.49992814526	2511.49992814526
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTTCGAATGCT"	-2.59102902832683	8.80164239490358	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTTCGAATGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2754.63128018864	43.6108376345617	0.015831824007885	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2746.39462263114	2746.39462263114
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATCGAGTTCCTGA"	-0.610663811594802	8.97551438892213	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGAGTTCCTGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2434.09360008059	40.8246984295306	0.0167720331001975	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2424.52815663744	2424.52815663744
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTACCTTCGCACTCT"	-3.16344891014751	9.17622945392457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTACCTTCGCACTCT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2888.18535103726	42.7742214279592	0.0148100679939386	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2871.10727956156	2871.10727956156
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTAAGTCAAAGTA"	-4.33449731293376	10.4296989210877	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTAAGTCAAAGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2752.60916130359	42.6781712138033	0.0155046244173625	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2743.90076434885	2743.90076434885
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATCGGTTGCATCA"	-4.39822707596477	10.0668401488098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGGTTGCATCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2639.19641976709	43.4006444172584	0.0164446435635467	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.07388743458	2629.07388743458
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAACTGTGTGTTACTG"	-4.17184148255046	9.86472318256227	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACTGTGTGTTACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2709.65882610833	42.1475813640039	0.0155545712832553	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2704.88661403594	2704.88661403594
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAACTGTTCATATGGC"	-4.22849498215373	12.4477386244568	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACTGTTCATATGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3180.64618348952	42.8434598087344	0.0134700489577028	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3161.79236553679	3161.79236553679
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTCTGTCGATTTG"	-0.310720036656219	8.45303151691285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTCTGTCGATTTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2188.05057517424	38.6720615049608	0.0176742082398535	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2180.34548793802	2180.34548793802
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGAATGTCATGCAT"	-2.81162271919902	8.65962693775026	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGAATGTCATGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2682.7111869958	40.9296063012643	0.0152568068078543	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2675.13847266358	2675.13847266358
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGATGAGTCTGCGC"	-2.41108522835429	8.47217652881471	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGAGTCTGCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2568.77192482615	47.1511247586744	0.0183555123376185	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2564.98121146398	2564.98121146398
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCCAACAAAGT"	-3.71823583069499	9.93679330432741	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCCAACAAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2639.67746724581	41.0587982834943	0.0155544754209439	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2631.92579692953	2631.92579692953
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATGCGTAAGACCG"	11.0126100974971	-3.12871601497801	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCGTAAGACCG"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2772.43310140764	45.346474940278	0.0163562016761574	4207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2765.80077137831	2765.80077137831
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCCAGTTAGAA"	-3.15485082092937	9.96771237933961	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCCAGTTAGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2594.14434394535	38.1932559191143	0.0147228723059517	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2587.4966200453	2587.4966200453
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGCCCTCCCGAGAC"	-2.02172837677653	8.50580117786256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCCCTCCCGAGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2815.87959491976	44.5178341408989	0.0158095659421004	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2804.21228565487	2804.21228565487
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAGATCAAATGCTC"	-4.46800313416179	10.4395313032898	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGATCAAATGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2886.32879361948	42.5645985598785	0.0147469680702946	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2877.56131065533	2877.56131065533
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCACTTCGACATCA"	-4.41065917435344	12.573366142157	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTTCGACATCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.08564143249	43.8335929419603	0.0161147841355745	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2707.59537451836	2707.59537451836
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGACGCGTCCACTTCG"	-1.33922551098521	8.76481530750123	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACGCGTCCACTTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2465.80314994361	33.5407528728874	0.0136023643548571	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2456.4295626892	2456.4295626892
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCAGGAGCCTCAAT"	-3.33706174317058	9.14167878711549	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCAGGAGCCTCAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2730.79731868819	36.8628655184936	0.0134989386675543	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2723.9570559816	2723.9570559816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCGCTGTCCTACACC"	0.602913160889786	-7.09901764309081	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGCTGTCCTACACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2011.51216454386	44.3535606467909	0.0220498595179257	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2011.51216454386	2011.51216454386
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCGGTCCATCGCTGG"	2.33988942679707	-5.47805883800658	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGGTCCATCGCTGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2559.7105449855	40.3729946597803	0.0157724844080013	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2556.22509123607	2556.22509123607
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGACTCCTCTTGAACG"	0.670384367077988	-6.53631594097289	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACTCCTCTTGAACG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3054.60292232544	44.8300724718798	0.014676235704558	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3041.83583334465	3041.83583334465
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGTCCAGTCGTCGGT"	-4.30788693848308	12.4938039549622	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTCCAGTCGTCGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2114.76565167081	39.0590482303386	0.0184696815930783	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2111.5622563688	2111.5622563688
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGACTAGTCCCGGT"	10.703009267419	7.68186757648317	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTAGTCCCGGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2986.94559669624	43.8870447816782	0.0146929508291749	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2971.53299184552	2971.53299184552
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGGGTGTTACCTGA"	2.05427970465962	-8.58429434215697	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGGTGTTACCTGA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.0319905578	47.297380543943	0.019674189332634	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2401.00954836996	2401.00954836996
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAGGGTTCGTGTGAT"	-3.85997519913371	9.74277207935182	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGGTTCGTGTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.4460287542	40.2680345408685	0.0165818116046525	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2427.22631534213	2427.22631534213
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTGTAGTTAGA"	9.83734573897664	7.85640523517457	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTGTAGTTAGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2374.42468267176	44.6049505600477	0.0187855824131078	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2357.16999280875	2357.16999280875
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGCATCACGTACTA"	-2.78947387161906	8.97308824146119	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCATCACGTACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.03351128062	41.2990214433646	0.017477120508961	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2359.25668995938	2359.25668995938
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAATAGACACCTCTAC"	-2.80671868744548	8.79766271198121	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATAGACACCTCTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2675.75312888472	38.2334051200334	0.0142888387973107	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.48759989374	2672.48759989374
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACACCCCAACGATTC"	-2.81236539307292	8.67517469013063	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACACCCCAACGATTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2779.07052394707	36.2989202050409	0.0130615325851775	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2773.25442623002	2773.25442623002
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAATAGATCAACACCA"	-7.09336934509929	1.67631421172944	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATAGATCAACACCA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2720.92858693224	42.5145801697557	0.0156250260936431	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2714.07457116092	2714.07457116092
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGGTTCTCCAC"	-6.83058724823649	1.86185333812562	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGGTTCTCCAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2506.94071069042	44.0570923499954	0.0175740463913332	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2494.94239930955	2494.94239930955
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTGTAAGGATCATA"	10.2610222297603	7.37249133670656	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTGTAAGGATCATA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2251.09363732788	46.7647690206857	0.0207742442363246	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2245.4870919891	2245.4870919891
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACAGGTCACTTTAGG"	-4.08867059174235	9.78813073718873	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAGGTCACTTTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2556.18059773777	45.9744152198463	0.0179855896177812	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2548.02505448661	2548.02505448661
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGAGGTGACCGTC"	5.27710403975789	-9.58826258098754	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGAGGTGACCGTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.83979681536	35.2667270772665	0.0143779170262383	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2445.97991092628	2445.97991092628
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTTGACACCTGCAG"	-0.520795206457931	9.12565229022828	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTGACACCTGCAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2645.31473283584	40.413968351409	0.015277565217385	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.10122014002	2639.10122014002
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACACGCAGCTTGTGT"	-3.52494750443156	9.30965135181276	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCAGCTTGTGT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2901.29449556261	45.1774887592505	0.01557149363098	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2894.81246680229	2894.81246680229
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACACGCAGGGAGAAT"	-3.76407037201579	9.91608331287233	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCAGGGAGAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2241.67936933566	43.1554071393535	0.019251373648562	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2233.48338030546	2233.48338030546
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACACGCCAGTGGTGA"	-4.21616874161418	12.3611783751282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCCAGTGGTGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2845.77842119739	43.9303861720392	0.0154370367857224	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2837.92884062522	2837.92884062522
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGGATTCATTTGCT"	-2.67353115502055	9.05508229816285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGATTCATTTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2437.9458610263	37.9287838051828	0.0155576809196312	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2430.84736047644	2430.84736047644
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGGATTCTGCACCT"	-2.54210434380229	8.80442903125612	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGATTCTGCACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2414.59896160152	48.6135316210518	0.0201331701015924	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2410.70576612912	2410.70576612912
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGAGGTAAGAGCCTGA"	-4.24966226044353	10.0947465666565	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGTAAGAGCCTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2582.63339675801	40.138391921277	0.0155416529390749	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.80065810672	2579.80065810672
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGGATCAGCCTCT"	-2.21424827995952	9.83116433704225	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGGATCAGCCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2205.43560789418	34.4936032839168	0.0156402676915389	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2198.48262034866	2198.48262034866
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACACGCTCTAGTGAC"	1.9942944246227	-7.61327173626097	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCTCTAGTGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.06452480028	47.4014996244764	0.0185012903327138	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2559.1283975785	2559.1283975785
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGAGTGAGAGCTGCA"	-2.14522037926372	9.41951463306276	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGAGTGAGAGCTGCA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2165.58884111877	44.3826278384492	0.0204944849159458	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2161.27958589927	2161.27958589927
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGAGTGAGGTTGACG"	0.89033474501912	-7.17013361370238	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGAGTGAGGTTGACG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2955.85989649749	39.9039826924834	0.0134999574031798	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2953.32719319205	2953.32719319205
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGTTTCCACTAGA"	-0.452442984015304	8.35224530780641	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGTTTCCACTAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2622.23624961971	38.0264812740535	0.0145015466396547	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2613.79961086336	2613.79961086336
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCACGTAGGCTCTCG"	-1.86809573593791	8.97408006275026	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCACGTAGGCTCTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2190.53578430027	41.7473591824556	0.0190580585268964	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2188.90463191183	2188.90463191183
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCACGTAGTATGTAG"	-3.93846140328105	12.5524520643982	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCACGTAGTATGTAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2421.58882101548	38.2879297776088	0.0158110780184197	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2413.32248316045	2413.32248316045
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACCCGAGCTGACTT"	-0.730010013014633	8.741991973761	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCCGAGCTGACTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2433.73745530113	40.6170965023396	0.0166891857681148	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2426.74283837235	2426.74283837235
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCAGTCAGGACGCAT"	-0.466768543154556	8.94688031757203	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCAGTCAGGACGCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1883.45614456823	40.5104803392995	0.0215085869963732	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1879.99219665849	1879.99219665849
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACCCAGGTCATGACT"	-0.714021424681503	8.6854791411194	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCAGGTCATGACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.11049304602	36.9170888576243	0.0148135842935687	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2479.95833268041	2479.95833268041
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTATGCAGTGTTCCA"	-1.71036432209666	8.46951100910035	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTATGCAGTGTTCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2412.55160576919	43.4186811915478	0.0179969958311854	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2410.86796389064	2410.86796389064
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCATTAGTTGGGAC"	1.37548138675038	-5.95388414776	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCATTAGTTGGGAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3202.36599269314	42.8976819034076	0.0133956212379496	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3200.46741404673	3200.46741404673
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCATTCATGGGTTT"	-2.38866243782695	8.88653180682985	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCATTCATGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.2773645858	44.6564587564365	0.0179251252354477	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2481.44135280575	2481.44135280575
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCATTTCATGCATG"	-4.00090585175212	10.0865363844666	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCATTTCATGCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2683.51650415997	37.7123002291548	0.0140533140640996	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2677.74970909068	2677.74970909068
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCCTGGTTTCTATC"	-4.13216052475627	9.68819329822389	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCCTGGTTTCTATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2943.26155976333	36.317633091707	0.0123392475844476	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2937.87663136194	2937.87663136194
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCTTTCCATCCGTTC"	-2.74788413468059	9.22469804370729	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTTTCCATCCGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2313.4235036486	41.5376650443983	0.017955063125661	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2304.88013754565	2304.88013754565
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCTTTCCATTCTTCA"	-4.31949887695964	12.1628865965637	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTTTCCATTCTTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2774.83598950811	37.6524088297433	0.0135692375953427	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2764.33725904789	2764.33725904789
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGCTTTCTCAAGAAAC"	-3.38217602196391	9.76004026019899	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTTTCTCAAGAAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2486.79366314211	41.8377742871886	0.016823982989536	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2478.71295491492	2478.71295491492
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGCTGCAGTATAGGT"	-2.59056983414348	8.72675702655641	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCTGCAGTATAGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2188.06003400725	36.4920492571408	0.0166778098818014	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2173.88023865108	2173.88023865108
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATGGTAGAGTTGTA"	-2.78778419914897	8.94029519641725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTAGAGTTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.80156958388	41.8759104983029	0.0171989007323745	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2424.45081523403	2424.45081523403
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTTTAAGTACGAGC"	-4.5417893928593	10.3233594664368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTTAAGTACGAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3052.5455583474	42.6026101112549	0.0139564207304802	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3046.41350957871	3046.41350957871
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACAACATTGAAGA"	-4.3362754386967	10.4234943159851	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACAACATTGAAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2362.07557825472	44.304754395311	0.0187567048248502	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2353.93003204976	2353.93003204976
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACAATCGCTATTT"	-0.67211357775386	8.64448735797731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACAATCGCTATTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2557.1289256843	45.1098298200476	0.0176408116802229	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2551.69604110656	2551.69604110656
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGGGATTCATTTCCA"	-0.242537955672103	8.34544274890748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGGATTCATTTCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2469.4451757603	38.8016798118497	0.0157127115810147	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2460.82064340013	2460.82064340013
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACCTCAAGTGCTT"	10.4884020286495	7.08744142139284	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACCTCAAGTGCTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2098.76606139546	44.5247504224198	0.0212147276637471	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2084.50679177677	2084.50679177677
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCCTCAGGTTTACC"	-2.84198770943339	8.7800836333069	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCCTCAGGTTTACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2952.44806035819	43.8118207198107	0.0148391503674735	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2946.52422480053	2946.52422480053
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGACTCCACCCATAA"	0.254678745835465	-6.37061026012572	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACTCCACCCATAA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3314.64946512076	37.9084542284536	0.0114366404735568	3528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3299.86416358992	3299.86416358992
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACTGCCAGACTAGAT"	-4.07084260407146	10.2340249785217	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTGCCAGACTAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2608.16912821088	43.4805325281757	0.016670902227112	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.12580739427	2602.12580739427
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTATGAGGCTGAAC"	-4.33064017716106	9.90610787952272	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTATGAGGCTGAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2927.71464353311	39.9667713646736	0.0136511840226486	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2922.52240869269	2922.52240869269
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCGATGTTTACGAC"	-4.22467599335368	10.1798343428406	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCGATGTTTACGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2874.6930876462	44.721830528284	0.0155570800655114	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2865.95292068425	2865.95292068425
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACTTACTCGATAACC"	-4.16942487183269	10.7489146956238	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTACTCGATAACC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2561.58882819919	43.5546618302563	0.0170029871112748	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2555.0408228374	2555.0408228374
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCAAAGTTTGAGA"	1.2877240377361	-5.79996445095214	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCAAAGTTTGAGA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3264.99861927331	39.8028425822345	0.0121907685802003	3019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3252.80744800191	3252.80744800191
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTAGAGTCGTGCTCT"	-4.37550244751628	10.0595626601013	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAGAGTCGTGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.24509894002	38.3367540754136	0.0155445839879786	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2460.59231247973	2460.59231247973
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGATGAAGTGTTCCA"	-2.31165204468425	8.76830957019655	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATGAAGTGTTCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2225.12439494103	44.4836308457862	0.0199915253937815	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2220.45182545245	2220.45182545245
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGATGAGTAGGTACG"	0.0499639490967661	8.19672963703004	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATGAGTAGGTACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2219.06936560423	41.9947027399765	0.0189244659905175	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2211.2842412316	2211.2842412316
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCAATCACACCCT"	14.3820120292598	2.08324310863344	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCAATCACACCCT"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1330.63709285318	24.5360487090972	0.0184393241710153	3040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1318.81495207257	1318.81495207257
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTCTGGGTTACCTGA"	-0.336818854243118	8.44178674304811	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTCTGGGTTACCTGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2305.92220978947	42.1551123513567	0.0182812378372493	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2292.11413943506	2292.11413943506
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGATCCACTGAGTT"	-2.9633871120518	8.90525434100953	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGATCCACTGAGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2765.18561761452	37.4438489728049	0.0135411701602539	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2760.98480256686	2760.98480256686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTTCCAGCGAATGC"	-0.737442354590255	9.1038493880066	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTTCCAGCGAATGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2411.00970955038	39.2757041566293	0.0162901476510245	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2401.25615943334	2401.25615943334
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGGCCAACGGGTA"	-3.87376485291179	9.70399949634401	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGGCCAACGGGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2555.6099409413	43.384305578359	0.0169761061276743	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2547.22818848933	2547.22818848933
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGATTCATGTAACC"	-7.25540194931682	1.67966685378877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGATTCATGTAACC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2019.00584396279	48.6457084258241	0.0240938918385423	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2008.62161644994	2008.62161644994
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGAAATAGAGAGAAC"	-3.2712644142216	-7.28346874630126	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAAATAGAGAGAAC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3045.86953513119	40.7346868990896	0.0133737464554059	3274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3030.89842573018	3030.89842573018
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGTATCAAATGCC"	-4.33386741104777	10.1509160765442	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGTATCAAATGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2732.07619003407	37.2213130884004	0.0136238195787418	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2727.66924968308	2727.66924968308
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGAAATGTTACGCCG"	-2.68290648880656	8.80947206104127	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAAATGTTACGCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2746.44126119792	43.6203708443522	0.0158825063767525	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2737.49781883302	2737.49781883302
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCGTTTCTCTTCAA"	-4.01030192795451	9.91086099231569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCGTTTCTCTTCAA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2562.13699558869	45.884602245416	0.0179087231964633	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2556.07565149474	2556.07565149474
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGTATCGCGGTAC"	-0.362436185509521	8.8884649046692	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGTATCGCGGTAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2293.69785869055	46.7931863521199	0.0204007629753091	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2288.71789796126	2288.71789796126
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCTACCAGCTGAGA"	-3.90054355087932	10.0352239378723	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACCAGCTGAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2444.21419653239	41.6762964483883	0.0170510000749993	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2439.05558086088	2439.05558086088
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGGTTTCGTCACCT"	-1.80282614651378	8.70442483508912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGTTTCGTCACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2520.3086062541	40.107745502322	0.0159138231733984	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.19834742703	2519.19834742703
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTTGTCGAGAGAC"	-0.164142678410369	8.31956575000612	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTTGTCGAGAGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2297.93672795516	35.345515549871	0.0153814137351482	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2283.96017006349	2283.96017006349
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCTACTCAATGTCG"	2.03842498835866	-7.66010525142821	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACTCAATGTCG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.00838938451	39.5472044961646	0.0162410957878304	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2431.28721132659	2431.28721132659
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATCCTCGCTCTAC"	-4.27536139908488	10.0966081389221	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATCCTCGCTCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2678.37413983189	41.4930481405076	0.0154918790184824	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2670.35033690075	2670.35033690075
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGCTACTCGATACGT"	-4.25476966324504	12.1737489470276	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACTCGATACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2654.42011203294	39.9622985979035	0.0150550014358118	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2640.94117855524	2640.94117855524
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACCATCTGTCGCT"	-4.0905331176823	11.8095540770325	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACCATCTGTCGCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2824.12584329278	39.0692358954797	0.0138340987843258	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2810.23077415525	2810.23077415525
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGAGGTTCGCCTTGT"	-4.44777474823649	-5.26777794277342	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAGGTTCGCCTTGT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2640.10915193887	33.2111593321705	0.012579464492133	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2632.25170236358	2632.25170236358
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTAGACAGTCTACA"	1.79475309428517	-5.61856892025145	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTAGACAGTCTACA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2381.03428363054	41.2820043112824	0.0173378454040304	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2378.40024195465	2378.40024195465
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGATGGCAGCTTCGG"	-4.10864720764812	9.90088555896608	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGCAGCTTCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2661.61999792012	43.3079969478939	0.0162712922888076	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2657.94201772131	2657.94201772131
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGATGGCAGTCGAGA"	-4.12788138809856	9.74573896015016	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGCAGTCGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2849.15378533003	40.1220062393154	0.0140820781404988	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2846.91590469902	2846.91590469902
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTATTCACAGACGA"	-4.39378819885905	10.3716735609802	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTATTCACAGACGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2633.49771852662	38.4094550797152	0.0145849585551205	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2627.0534313076	2627.0534313076
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACTGCAGCTGTTA"	-3.85814986649211	9.84057900989381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACTGCAGCTGTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2727.01026304519	37.4655001331223	0.013738672215808	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2722.35765905403	2722.35765905403
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTCACAGCGACTAG"	-4.15754208985026	11.0784921416077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACAGCGACTAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2689.21728920624	41.7969300042583	0.0155424145798926	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2684.18745472782	2684.18745472782
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTCACCAGCAATTC"	-3.62611542168315	9.62676618182985	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACCAGCAATTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2431.5825234349	42.8030606755105	0.0176029644328279	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.41043608671	2429.41043608671
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGATGGTCTATACTC"	-0.118748749524909	8.39923570239869	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGTCTATACTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2000.45859689637	43.7858249477551	0.0218878936138379	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1993.78696966126	1993.78696966126
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGCCTGTCCTACAAG"	-2.58677134934123	9.01193807208864	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCCTGTCCTACAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2636.86287176163	48.959418343745	0.0185672978553626	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.12128486079	2626.12128486079
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTCACGTCGCACGT"	-6.97848592224773	1.69591221893159	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACGTCGCACGT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2656.50344256491	40.3558265874765	0.0151913323133179	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2647.03059985284	2647.03059985284
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTCACGTTCCGCTT"	-0.507109681994277	8.5703553923401	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACGTTCCGCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2380.7874690946	39.6745435418379	0.0166644625179105	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2373.125581112	2373.125581112
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCCAATAGTGA"	10.7512604194576	-1.14792671119841	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCCAATAGTGA"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1938.04179253025	48.5189900797916	0.0250350587210231	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1933.26248003562	1933.26248003562
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTCTGAGGTTACCT"	-3.14811644974406	9.57136724078981	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCTGAGGTTACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2243.73708176108	38.5294488874811	0.0171719980922363	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2232.14496091411	2232.14496091411
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAATGACTCGGTGCAC"	-3.69880018654521	10.408794380072	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATGACTCGGTGCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2213.83947601613	45.7875826481211	0.0206824311989039	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2206.52656642909	2206.52656642909
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTGAAAGTGAATAC"	-1.75808582726176	8.48422715747682	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTGAAAGTGAATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2328.91805398761	45.2883626828474	0.0194460954112593	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2322.82312107258	2322.82312107258
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCTCCTCACTG"	-4.1668304008549	10.0095634230408	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCTCCTCACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2663.02107548551	40.4403968259028	0.0151859094162557	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2659.74953449776	2659.74953449776
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTAGTATGGCG"	-4.53245149079021	10.4447803267273	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTAGTATGGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2795.95323535403	35.2531797213225	0.0126086442632717	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2791.3469996829	2791.3469996829
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTGTCTCAGAGCGA"	-4.23227868500407	10.2682752379212	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTGTCTCAGAGCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2418.08049181246	41.5735836072958	0.0171928038574657	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2411.70972784701	2411.70972784701
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGCAATCTGGACTA"	3.77755894240682	-8.37152292644652	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCAATCTGGACTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3094.5832178305	42.1318509535235	0.0136147093123127	2908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3084.99181915679	3084.99181915679
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCCTCGTGCACGCT"	-2.86039791527446	8.95437905872194	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCCTCGTGCACGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2693.71479430818	44.5952000312747	0.0165552790241581	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.01423960472	2689.01423960472
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTTATGTCAACCTA"	9.6911903816158	7.46560475910035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATGTCAACCTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2098.6715056057	50.149563311408	0.0238958613472642	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2092.98165509828	2092.98165509828
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCTCGTAGACTCCGC"	-1.60310552540477	8.78832814777223	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTCGTAGACTCCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2448.10537364706	40.5962947714061	0.0165827399459231	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2434.14955956131	2434.14955956131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTTATTCGCTGATA"	-2.38798628273662	9.05829713428346	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATTCGCTGATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.65924784061	41.6270171143785	0.0179685541381106	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2312.1809038679	2312.1809038679
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGGTTATTCGGCATTA"	-2.10592709007915	9.00758645618287	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATTCGGCATTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2405.16851807796	45.2349939248823	0.0188074114495024	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2392.91241448034	2392.91241448034
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGGATCACTAGGCC"	-2.7835353416508	8.74596688831178	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGGATCACTAGGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2485.36062973137	41.7255344929659	0.0167885231599069	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.94760465838	2476.94760465838
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACATGAAGGGAACAA"	-2.35084877434428	8.65034768665162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACATGAAGGGAACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.1983274384	40.8156183511178	0.0176370442702276	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2303.35563603976	2303.35563603976
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCCTAGTTCAGCTA"	-2.64396295967754	9.39056680286256	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTAGTTCAGCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.32916095695	40.9105603369295	0.0167164110940159	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2442.95426176284	2442.95426176284
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAACTAGAGCCTGA"	-3.31835613671001	9.77046582782594	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTAGAGCCTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2342.52478178944	45.8206053125515	0.0195603502975748	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2337.60597258581	2337.60597258581
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGACTGTCCTACAA"	-3.45119891586955	9.7931451567444	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTGTCCTACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.82278967592	46.2618204948098	0.0185803667179186	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2484.10141946082	2484.10141946082
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAACTGTATCGCTA"	-6.96266828003581	1.79314777934877	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTGTATCGCTA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2841.66814781067	46.9208431957891	0.0165117250696351	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2825.83746100461	2825.83746100461
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAACTGTCATCGGC"	-4.3105357688969	9.94258401477662	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTGTCATCGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2577.17922827643	37.9328423800722	0.0147187444178809	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2572.95388955336	2572.95388955336
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAACTGTGTGTCCG"	10.4972053962642	7.8305077322754	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTGTGTGTCCG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2474.78604515073	46.8771723273498	0.0189419091073365	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2457.17186500919	2457.17186500919
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAACTTCCAGTTCC"	-4.08377395096477	9.73583409869996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTTCCAGTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2557.86039043037	43.4435530440966	0.0169843331585376	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2552.52679448934	2552.52679448934
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTACAGTCATCCGCGA"	-4.39072928848918	10.5422935255798	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTACAGTCATCCGCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2835.97616955452	41.196510305989	0.0145263950904285	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2824.56548572607	2824.56548572607
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAATCCACGGCCAT"	-0.654614846140701	8.60067174518434	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAATCCACGGCCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2632.88248217033	38.7185141413673	0.0147057509796073	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2620.54201677763	2620.54201677763
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAATCTCGTGGGAA"	-4.5233715576237	10.2810821303162	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAATCTCGTGGGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2593.13827283291	42.0800340716034	0.0162274547842111	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2590.68795519398	2590.68795519398
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGGTTCAAGTTCCA"	1.93741347369496	-7.79176571285399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGTTCAAGTTCCA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.82513729739	35.5172626657034	0.0145692412972156	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2434.67798487906	2434.67798487906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAATCTCTCGCAGG"	-4.42835793915446	10.4479274519714	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAATCTCTCGCAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2322.13460332846	33.7308783745432	0.0145258066979385	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2320.72883327689	2320.72883327689
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAGAGAGGTAAACT"	-3.88429031792338	10.6616439589295	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAGAGAGGTAAACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2526.08627868238	35.300772980256	0.013974492192986	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2522.03885995428	2522.03885995428
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAGAGCATGCCATA"	1.71060349520985	-5.4613886109558	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAGAGCATGCCATA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2224.67196608414	47.0398805673054	0.0211446367304681	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2221.82481776515	2221.82481776515
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTAGAGGTACAAGCG"	-4.29139409485515	10.0348262556824	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAGAGGTACAAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2387.282972413	44.0939433994506	0.0184703463766098	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2385.85059073996	2385.85059073996
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACAAGGTGTCCCTT"	-4.47041211548503	10.8068742522034	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACAAGGTGTCCCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.30379648713	43.9268205031689	0.0167320904201436	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2618.7957407876	2618.7957407876
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGCCACCAGCACAGA"	10.6223761039669	6.57767436588136	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCCACCAGCACAGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2033.71800759331	46.5243158657356	0.0228764832154838	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2024.99631386184	2024.99631386184
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGTTGTCCGGTTCT"	1.57235946235005	-5.58824160015257	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGTTGTCCGGTTCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2690.62408524098	47.7625680861446	0.0177514831403387	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2683.00875458101	2683.00875458101
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTTTGAGTCCCAAT"	-3.94861827316936	9.93087956989137	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTTGAGTCCCAAT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2593.79904213075	38.5971178765841	0.0148805351724077	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2584.49826686561	2584.49826686561
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTCACGCATCGGCCA"	-2.99591622772868	8.92867562854616	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCACGCATCGGCCA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2665.72600739311	38.8773587224021	0.0145841540408053	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2659.1672187603	2659.1672187603
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTCTGGGTGATGAAT"	1.09649910506551	-7.41982510006102	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCTGGGTGATGAAT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.08206530046	40.7098245688276	0.015402406570452	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2639.31303666475	2639.31303666475
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGCGTGAGATTAGAC"	-3.39132676544841	12.9836511381897	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGCGTGAGATTAGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2650.03975106331	42.9797891341845	0.0162185450678388	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2645.1903778995	2645.1903778995
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATAGCTAGACGCTCC"	-4.01208625260051	9.68182847583619	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATAGCTAGACGCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2741.13158881431	43.707825627309	0.0159451760016436	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2733.72960402805	2733.72960402805
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGCGTGTCATTACGG"	-2.44204864922221	8.91395661914674	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGCGTGTCATTACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2463.35942790526	43.2882516594019	0.0175728524100165	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2459.96315902805	2459.96315902805
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTCTGGTCTCTATAC"	10.8526550727779	-0.660834335443102	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCTGGTCTCTATAC"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1715.1458863682	31.6747734490862	0.0184676847029947	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1708.13877394229	1708.13877394229
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGAGCACCCAC"	-4.25794587555583	10.6771602400574	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGAGCACCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2462.10226411779	41.1368788727346	0.0167080301546592	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2457.86634318171	2457.86634318171
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCACATCATCACCC"	-4.08336720886882	9.89202592456666	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCACATCATCACCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2523.602678371	43.6476113246842	0.0172957540815652	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2520.09219644626	2520.09219644626
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACTATTCCGCGAGT"	-3.94746361199077	9.6861533888611	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTATTCCGCGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.21743890586	41.6160072339241	0.0163570953478807	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.73209043791	2536.73209043791
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTGTTCTCGCT"	-3.0529194873875	9.04913327777711	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTGTTCTCGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2384.71331796362	43.2497504299171	0.018136247281434	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2377.5345367857	2377.5345367857
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGGTTGAGTCT"	-7.04058251801189	1.86603126609651	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGGTTGAGTCT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2233.77663366592	46.5193042131483	0.0208254055092357	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2223.06652603891	2223.06652603891
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGTCACGATAC"	-2.59809885445293	8.77739331806032	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGTCACGATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2371.48623555581	42.6690150883713	0.017992520660096	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2365.59280495357	2365.59280495357
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGAGAGTCCTCATC"	-2.69668899002727	8.86746594989625	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAGAGTCCTCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.59711390892	41.7735693220843	0.0164101259754881	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.16406068161	2537.16406068161
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTTCGTCTCTGCCA"	-2.97990045967754	8.96460244739381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTTCGTCTCTGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2753.30824758979	41.0267731357803	0.0149009008241974	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2741.54828138686	2741.54828138686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGATTAGCTCCGAC"	-0.606803099543411	8.30299565875856	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGATTAGCTCCGAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2624.89561277552	35.7666751449892	0.0136259419120938	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2613.1210848151	2613.1210848151
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGATTGTAGGTAGC"	-1.3277739090031	8.7417945631775	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGATTGTAGGTAGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2475.2632652322	42.5379721460705	0.0171852314634823	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2466.36127743743	2466.36127743743
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCCCTTCTTGGATG"	-4.26057420197185	10.092053390387	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCCCTTCTTGGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2710.36767847735	35.38772047693	0.0130564280108337	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2705.66726520707	2705.66726520707
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTATTTCTCTGAGTCA"	9.97705616530721	7.78258369052736	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCTCTGAGTCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2472.784330974	42.2018144703272	0.0170665164534201	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2471.61631894091	2471.61631894091
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTGTCTACATG"	-3.35547290268596	9.23604295337526	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTGTCTACATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2671.97541342199	38.4167393477964	0.0143776545079044	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2669.28619301143	2669.28619301143
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCGTATCGGAGTAG"	-2.47423348847087	8.83568856799928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCGTATCGGAGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2533.34072379692	40.4123630468785	0.0159522020339646	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.82301414771	2523.82301414771
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTCATACGCAT"	-3.27774987641032	10.2450713881287	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTCATACGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2039.03022032588	49.4213371308025	0.0242376678080347	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2032.61861303643	2032.61861303643
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTTCTTCCGTG"	2.2164167362148	-8.51852705394896	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000248447204968944	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTTCTTCCGTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.09758789945	46.869297901093	0.0214495215960349	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2180.57120135166	2180.57120135166
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCAAGTTCGGTTCAA"	12.0724674659664	-2.85358717357787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAAGTTCGGTTCAA"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2564.44014423373	42.4571154338048	0.0165560953057422	4894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2554.24302136563	2554.24302136563
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTTCAGTCATG"	3.2281822162563	-4.2476639977661	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTTCAGTCATG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2876.96640821648	40.0525649915295	0.0139218048834847	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2871.44275934308	2871.44275934308
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGTTATCCGTTTCG"	-3.61719069901164	9.99916455829469	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGTTATCCGTTTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2526.44991902101	44.5332866089379	0.0176268234227237	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.29331262001	2519.29331262001
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGCTATCATCCCGT"	-3.01193867150005	8.8790244826111	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGCTATCATCCCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2786.88916210948	35.5638081000148	0.0127611132095026	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2783.99121642543	2783.99121642543
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGTACATCAGCGCGT"	10.9538990455562	-3.11534693157347	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTACATCAGCGCGT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2863.81666694274	48.678390355953	0.0169977327521875	3807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2857.82128847163	2857.82128847163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATCCAGATAGGGA"	-4.47990928116496	10.7188644179138	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATCCAGATAGGGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2604.10027236938	42.3157985632792	0.0162496809405798	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2602.76641670267	2602.76641670267
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGTTGAGTGTAGTA"	-4.50532470169719	10.8240861662659	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGAGTGTAGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2779.82147621419	35.4982019963971	0.0127699574595495	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2773.21575449537	2773.21575449537
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGTTGCAACCAACT"	0.92471214112584	10.2459764250549	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGCAACCAACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2487.91617515492	46.9229826812033	0.0188603551638075	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2475.06570043915	2475.06570043915
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGTTGCATGCAGGA"	-4.39708314362224	10.0143852003845	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGCATGCAGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2622.84758212417	35.6228752853669	0.013581755771152	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2611.77184121401	2611.77184121401
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAATTCAGTCTTCCC"	-5.59208331528361	1.91417703712312	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATTCAGTCTTCCC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2103.09101384527	51.0476167797454	0.0242726617363128	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2091.57832980952	2091.57832980952
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGATAGTAGACAGC"	-4.07157359543498	11.7436475523743	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGATAGTAGACAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2187.72758547736	44.7595379957669	0.0204593745093726	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2186.19473768147	2186.19473768147
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GGTTGTATCCGAACGC"	5.38175596770589	-9.68845751201781	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTTGTATCCGAACGC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2875.06452794995	38.5250657165299	0.0133997221078025	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2867.89832149426	2867.89832149426
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCATCTCCGCTGTT"	-4.44875274124797	10.1807994612488	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCATCTCCGCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2790.86510884842	40.1997046528376	0.0144040299638219	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2785.25267232229	2785.25267232229
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTAACGTCCCGTTGT"	-4.29022822800334	10.4710702666077	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAACGTCCCGTTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2703.11086148396	43.77207888085	0.0161932237055272	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2695.96686657891	2695.96686657891
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAACCACATCGGCCA"	9.34160103377644	7.40803811633912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACCACATCGGCCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1926.27820747227	35.2471033738154	0.0182980336054717	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1918.89043130553	1918.89043130553
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACACCAGCTTCTAG"	-0.169996346265632	9.12636563861696	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACACCAGCTTCTAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2399.48226550897	36.819499356884	0.0153447682802831	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2392.03307498977	2392.03307498977
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAACCAGTGACCGAA"	-2.56281505051311	8.80872724140016	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACCAGTGACCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.46257966417	45.4181915526016	0.0182515067430634	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2477.13518984707	2477.13518984707
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTACAGGTACCCACG"	0.388169665902299	-6.39944937145384	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTACAGGTACCCACG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2783.73567211591	40.7789737116059	0.014649010723281	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2776.89865565875	2776.89865565875
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCCACTTCCCGTGTT"	-3.24176941338237	9.29386422717897	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCACTTCCCGTGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2673.18102981513	41.8995663625217	0.0156740474719812	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2666.53228555803	2666.53228555803
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAAGTCAGTAGCATA"	-2.64057074013408	8.9598064192566	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAAGTCAGTAGCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2385.72415448841	41.4518880511087	0.0173749710221623	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2380.12842979003	2380.12842979003
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTCTTCATCGAGCC"	-2.67761073532756	8.78497026050416	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCTTCATCGAGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2826.66109247672	41.4944349057144	0.0146796639385435	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2817.79376607367	2817.79376607367
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTCTTTCACGATAC"	-4.40668139877971	10.8193988570007	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCTTTCACGATAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2796.14243071476	38.0926414659385	0.0136232836523285	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2791.53195954353	2791.53195954353
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTGGTGTTTATGCG"	-2.81064138832744	8.64966485584108	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTGGTGTTTATGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2635.28043578746	36.8800430944253	0.0139947318674663	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.34095541577	2629.34095541577
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGGAATGTAGACGGT"	-4.21457419815715	9.78329179370729	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGGAATGTAGACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2718.98460831316	42.1850001884004	0.0155149830783969	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2713.91746840205	2713.91746840205
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTACAACAGCAGAAAG"	0.451865871518296	-6.37536766445311	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTACAACAGCAGAAAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2818.40321324025	43.8301286874353	0.015551404597302	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2814.53740369969	2814.53740369969
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACGCTGTTTGCAGT"	10.3018986183101	7.734752155188	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTGTTTGCAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2241.30582462455	38.0590216039391	0.0169807355987729	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2236.9119946716	2236.9119946716
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTACAACTCGGCACTG"	4.83280529555623	-8.66098215496215	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTACAACTCGGCACTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.76936069887	39.1833899698869	0.0138126809012889	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2830.14876564729	2830.14876564729
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCGTGGAACCA"	-0.235981504351455	8.24482820117799	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCGTGGAACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2196.1488919526	43.9061249117727	0.0199923261453989	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2194.24717352794	2194.24717352794
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAACATTCCGAGATT"	-2.66036830368693	9.80238149249879	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACATTCCGAGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2226.9647448442	46.891654149385	0.0210563073609257	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2219.56449347932	2219.56449347932
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGAGGAGCCTCAGC"	-4.06363234940227	9.8638591536316	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAGGAGCCTCAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2628.91157200904	41.7909996477936	0.0158966927958922	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.91157200904	2628.91157200904
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTCCTGCAACACGAG"	1.73234583911244	-5.56430342113646	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCTGCAACACGAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2710.82808214808	38.6038654440245	0.0142406173590449	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2708.86967912173	2708.86967912173
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTCCTGCACGTTGGC"	-3.9003201526707	11.1334552534851	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCTGCACGTTGGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2772.95318467404	42.5120538724609	0.0153309670381104	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2757.75782086103	2757.75782086103
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGAGGGTGATACAA"	1.09275939044301	-7.54002907192381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAGGGTGATACAA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2670.50907023181	34.4292410132628	0.0128923887198309	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2662.95184334557	2662.95184334557
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGATCAGTTGGAAT"	-0.5227047604626	8.71311185443727	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGATCAGTTGGAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2386.13060836851	40.7412358268444	0.0170741851615159	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2380.78493094949	2380.78493094949
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAACCGGTTGTGTAC"	-4.28974709931071	10.6959380873474	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGGTTGTGTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2466.25164525036	42.9358788203912	0.0174093665190571	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2462.31862068596	2462.31862068596
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGAGTCATGGCCAC"	-4.34544358673747	10.5389699705872	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGAGTCATGGCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2468.61882880888	42.9252745964481	0.0173883768913647	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2464.92554258187	2464.92554258187
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGAGTGTGCAGTGA"	-2.82868490639384	9.58108327472535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGAGTGTGCAGTGA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2256.56502529656	42.5649456401109	0.0188627161916227	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2250.73807894849	2250.73807894849
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGATGCAGTATACC"	-3.43442259255107	9.17735955798952	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGATGCAGTATACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3124.50153107949	39.3977075475359	0.0126092777217889	3104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3114.72182793099	3114.72182793099
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACATACAATCACGT"	-4.36926303330119	10.5487184294495	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACATACAATCACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2928.18135523677	42.6641913475683	0.0145702011493474	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2916.88029317801	2916.88029317801
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGCTATCGAGAAAT"	-2.73334489288982	9.47227761829225	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTATCGAGAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2086.29778657689	42.9943908285516	0.0206079837236922	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2079.46999648265	2079.46999648265
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGCTATCTAACGGT"	-4.21928153458293	10.0738191374573	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTATCTAACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2600.6800217302	41.882412372417	0.0161044080865255	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2595.37688918111	2595.37688918111
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGCGGCACTCCGAG"	-3.70565233650859	9.74156091296998	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGCGGCACTCCGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2169.42093270763	43.7953194267207	0.0201875619279013	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2163.24383366619	2163.24383366619
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTAGGAGCACCCTGAG"	-0.508536199957687	9.23203656757203	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGGAGCACCCTGAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2293.31522436004	45.0624479484777	0.0196494783925976	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2275.2696101395	2275.2696101395
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCTCACTCCGATAGT"	10.339110036462	7.8353643187317	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTCACTCCGATAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2515.56072828269	41.012964211414	0.016303706664801	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2504.73242304657	2504.73242304657
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACGTGAGATGCTGG"	-2.88774095001872	9.01380345905153	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGTGAGATGCTGG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2704.62218261738	43.0682154736913	0.0159239304293557	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2695.04170519505	2695.04170519505
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACGTGAGTGTGTTC"	0.791800339787644	-6.20113565838011	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGTGAGTGTGTTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3030.44574673261	36.4366113745982	0.0120235154890609	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3024.19529404804	3024.19529404804
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACGTGCAAACGGCA"	-1.23330114308055	8.88176629627077	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGTGCAAACGGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2331.29372787682	43.7054574607389	0.0187472976648647	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2323.79352226662	2323.79352226662
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCAGCCGATTT"	-4.45148597183879	10.4946794279846	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCAGCCGATTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2632.00866180094	44.4754951758984	0.0168979288789522	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2624.7876660308	2624.7876660308
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACTAAGTCGTAATC"	-0.951603392988998	8.25202939594118	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACTAAGTCGTAATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2499.72731778228	38.5148409963411	0.0154076169518005	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2486.39372159631	2486.39372159631
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTATTGGCAAGAAACT"	-2.95253596726115	9.30295465076295	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTATTGGCAAGAAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2364.78432849319	45.576405220621	0.019272964841433	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.48311489931	2362.48311489931
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACTAATCTGGCCTT"	10.7949425178463	7.61735913837282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACTAATCTGGCCTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2788.61297017788	44.978479476162	0.0161293374007699	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2776.02284631583	2776.02284631583
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTATTTCAGGTTCCAT"	1.97777344760243	-5.22461273586424	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTATTTCAGGTTCCAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2977.63227439912	32.4013322278098	0.0108815761121303	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2976.01379284927	2976.01379284927
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCAAACAGCAACTCT"	-4.16880307617839	9.94924638355104	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCAAACAGCAACTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.76241291061	36.8720587044913	0.0139362697589797	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2638.09536492405	2638.09536492405
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCAAGTGTGGAATGC"	-3.86260257187541	9.76225183093873	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCAAGTGTGGAATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.16197205226	39.5064313383039	0.0162299928237708	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.18416148786	2429.18416148786
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGTAAGCGGTAGT"	-4.30819735947307	10.2856111296448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGTAAGCGGTAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2556.37747314293	40.1212229443529	0.0156945612945908	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.96933762502	2553.96933762502
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGTAAGTTACGAA"	-0.586818675429183	8.61751554096071	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGTAAGTTACGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2311.12863812193	36.9386925591979	0.0159829669149075	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2301.18628569571	2301.18628569571
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCACGGAGCTGCCAC"	-6.80976710739787	-2.41412594234618	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCACGGAGCTGCCAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2209.24863314448	46.3668864389838	0.0209876270797953	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2207.25139784161	2207.25139784161
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCACTCAGTCGCGAA"	-3.75746808472331	10.8138818510803	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCACTCAGTCGCGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2416.1192429088	39.1550380619878	0.0162057556459211	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2409.88021829045	2409.88021829045
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCAGCGAGGAAACGA"	0.0698603047872006	-6.3947963944641	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCAGCGAGGAAACGA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2932.85719461561	44.4676091558264	0.0151618732877495	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2928.02760218649	2928.02760218649
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCATCAGCTGAGA"	10.3342987495357	7.76494596088258	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCATCAGCTGAGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2676.19651655118	44.0947826545845	0.0164766609559037	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2663.30900849891	2663.30900849891
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCACAGTATTTCGG"	10.2857195335323	7.87076375568239	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCACAGTATTTCGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2882.8048419027	41.4480625005969	0.0143776858905372	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2863.49036259879	2863.49036259879
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCATGATCAGCAATC"	-2.53758607330974	8.61999318683473	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATGATCAGCAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.69104276189	44.5525661135873	0.0172370954115972	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2575.45811702388	2575.45811702388
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAGGCTTCGTGTGGC"	-3.60693703118022	-7.30341102993163	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGGCTTCGTGTGGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2734.29719661076	38.8016777171706	0.0141907316312457	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2726.33643055854	2726.33643055854
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGATGTTCATTACTC"	-2.74017248573955	8.57102296436159	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGATGTTCATTACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3337.48647832315	38.6840522484349	0.0115907742247606	2915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3317.83755350955	3317.83755350955
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCATTTTCTAGGCAT"	-4.0071419281071	10.2788114317688	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATTTTCTAGGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.68057659675	39.1631148779727	0.0151169214884142	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.84548939827	2586.84548939827
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAACCAAGTGGTTAA"	-1.38775823536571	8.80196569049684	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAACCAAGTGGTTAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2310.95992781682	41.1701965185032	0.0178151927356858	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2308.37605754026	2308.37605754026
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCTATCTCGACGG"	-4.23202691498454	9.92267510974733	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTATCTCGACGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2683.88352818798	44.0160360083049	0.0164001289720729	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2678.1381592904	2678.1381592904
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCCATAGGCCCGTT"	10.3779913383419	7.88793227756349	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCCATAGGCCCGTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2226.54160093752	46.2972554669763	0.0207933485040127	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2221.48848685967	2221.48848685967
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCCATGTATTTCCT"	4.49317946013753	-8.70938208019408	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCCATGTATTTCCT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2695.21271071588	33.0075057193156	0.01224671640501	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2689.69621925857	2689.69621925857
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCATCGGGTCGCACGT"	-1.7467887205189	8.576539970282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCGGGTCGCACGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2324.81529037703	41.90866461171	0.0180266642193813	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2318.07735669488	2318.07735669488
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATATCAGTTGCCTA"	4.489753861993	-8.54898836528929	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATATCAGTTGCCTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.69527175346	36.7812987976237	0.0148270120947283	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2480.69527175346	2480.69527175346
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCTCAGTCGTGCCA"	-2.96044955673869	9.09012887561647	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCTCAGTCGTGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2424.80970310505	44.8998520068363	0.0185168559616619	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2417.03734642906	2417.03734642906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCTCAGTTCAAGGG"	-3.58809981766399	9.76663205707399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCTCAGTTCAAGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.16931675152	38.8095893947417	0.0159699116959553	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2423.69724327492	2423.69724327492
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCCTCATCCGCTGTT"	-2.16603813591655	8.91889855945436	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCTCATCCGCTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2484.33898134028	41.8372147988226	0.016840380927506	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.80320137048	2476.80320137048
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTTGTCAGCCGTTG"	-7.47643456879314	1.1093642481598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTTGTCAGCCGTTG"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2683.16099582694	43.0825323141833	0.0160566333444726	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2668.17449869338	2668.17449869338
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCGAATGTTAAAGTG"	-2.78102217140849	9.22051045978395	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGAATGTTAAAGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2646.3728116434	46.1607740345473	0.0174430351730682	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.06775775838	2639.06775775838
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCACCAGCACACC"	-2.29338918152507	8.61956975543825	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCACCAGCACACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.55887505495	43.2100767363011	0.0173425870722594	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.50438636342	2485.50438636342
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCGCGAAGGACAGCT"	-3.62407908859904	10.2185554274353	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGCGAAGGACAGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2152.95894565533	41.5607783561651	0.0193040273434079	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2149.66350584068	2149.66350584068
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCGTTCAGAAGTATC"	0.731565673916978	-6.44202091610106	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGTTCAGAAGTATC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2723.74228438531	39.1895949802521	0.0143881435497472	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2721.11611904045	2721.11611904045
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCGTTCCAGCCATTA"	-4.16407332840617	11.8305539854797	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGTTCCAGCCATTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2244.00973303627	38.553431631049	0.0171805991139281	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2237.43442960889	2237.43442960889
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCTACCGTTCGCGTG"	-0.653147379786331	8.78779218280641	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCTACCGTTCGCGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2363.43729051347	41.0421928536159	0.0173654672448277	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2360.5502393627	2360.5502393627
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCTAGAAGGTCGACA"	-3.64228759232219	9.70926663959352	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCTAGAAGGTCGACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.78187761995	39.6578326898535	0.0159282357407804	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2484.87376123642	2484.87376123642
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGCCAGTTAACAG"	-4.26815972748454	9.96541783893434	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCAGTTAACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2971.81572035029	35.9229924078456	0.0120878936610549	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2964.27913222376	2964.27913222376
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTCTAGAGTAGCTTTG"	-3.72758517685588	9.52900693500368	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCTAGAGTAGCTTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.39023203088	39.8089700308038	0.0185989309029091	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2135.18797730992	2135.18797730992
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACAGGTCCAAGCCG"	4.72780193862264	-8.8495664826599	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACAGGTCCAAGCCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.66389021898	27.0360501014935	0.0112291629289811	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2407.66389021898	2407.66389021898
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACGCGGTCCTTAAG"	-4.26621184769328	12.3922090300354	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACGCGGTCCTTAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2946.63891478792	42.0009632934708	0.0142538548183444	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2931.36279726537	2931.36279726537
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGACGCGTAGGTAGC"	-4.04564176026042	12.6748552092346	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGACGCGTAGGTAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2437.151334291	38.459484178286	0.0157805072000071	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2429.33295178061	2429.33295178061
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGACGCGTCTTACAG"	-4.05334935608562	9.94971940601198	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGACGCGTCTTACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2695.28738529419	41.154555566183	0.0152690788339408	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2681.70209925388	2681.70209925388
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCAACATGGCCCA"	-0.677685539156753	8.93612001026002	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCAACATGGCCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2405.35630207204	38.9007925488155	0.0161725697416658	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2395.93925775774	2395.93925775774
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACTGAGTCCGGATC"	-1.89842389050182	8.59890554035035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACTGAGTCCGGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2459.29527278409	40.1485775725618	0.0163252367525234	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2451.73225188448	2451.73225188448
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGAGTTAGGTATAGT"	-4.16220651093181	10.204074836615	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGAGTTAGGTATAGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2171.09794940184	45.7573709045595	0.0210756824293285	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2166.50225065392	2166.50225065392
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGAGTTAGTAGTCAA"	-3.48376117172893	-6.26318933880004	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.001230012300123	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGAGTTAGTAGTCAA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2758.92040375642	41.1624717032099	0.014919775013141	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2757.83868093118	2757.83868093118
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATTCCAGGGTCTC"	-0.889065007597762	8.5430755385193	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATTCCAGGGTCTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2402.11190853171	38.037551499906	0.0158350455550409	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2392.53427327707	2392.53427327707
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGATGTAGATCACCT"	-3.21036873284038	9.26392362201539	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGATGTAGATCACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2536.91858447495	44.5608692928551	0.0175649583575729	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2534.45224500379	2534.45224500379
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACGTTGTCGAGTTT"	-3.73959241333659	9.63167092883912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACGTTGTCGAGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2399.24192360707	40.7315869267837	0.0169768569505267	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2398.0729253371	2398.0729253371
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTGATAGCCACTCG"	-4.39352832260783	10.5951623686585	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTGATAGCCACTCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2835.32603922653	41.732253425533	0.0147186788567418	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2830.96519935037	2830.96519935037
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGAAATCTAGCATG"	-3.84871826592143	10.1599530943665	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAATCTAGCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2394.05546831452	39.0020428113057	0.0162912026590445	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2385.41213485181	2385.41213485181
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTCAGTAGCTTAC"	-6.20978389206584	1.94854984367219	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTCAGTAGCTTAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1825.10904459907	32.7003337720593	0.0179169205636383	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1817.97173534682	1817.97173534682
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACTGTAGGAAGTAG"	-3.76393971863444	9.84791181171266	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACTGTAGGAAGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2210.39566439616	46.9480466699555	0.0212396574179768	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2203.74118533636	2203.74118533636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCGTGCAATAGTCC"	-3.52491293373759	9.5742730864319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCGTGCAATAGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2511.08699851809	43.7504270779595	0.01742290374797	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2505.81108364072	2505.81108364072
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCGTGGTCTAACGT"	-4.16667352142985	10.3753490217957	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCGTGGTCTAACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2263.06822610501	45.8139749460455	0.0202441863738666	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2258.92069686489	2258.92069686489
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCGTGACACACGGAA"	4.22580351409261	-8.36385061657103	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGTGACACACGGAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2639.27325798874	44.7014215238829	0.0169370190784821	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2637.2514384572	2637.2514384572
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCTGGAGTTGCGCC"	-2.32865391197856	8.53491017902223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTGGAGTTGCGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.17750888552	43.0983220135871	0.017000120055709	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2531.00275030077	2531.00275030077
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCTGGCAATAGTGA"	-3.96544585648234	9.88139722431032	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTGGCAATAGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2393.76474980138	41.0230869237925	0.0171374764070681	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2388.49727655891	2388.49727655891
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCTGTTGTATGAGGC"	-3.88268599930461	9.60799024188844	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCTGTTGTATGAGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2403.54543026686	37.3987111804942	0.0155598103990661	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2400.88955877744	2400.88955877744
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGCTGGGTTGGACCC"	-2.61572013321574	8.68871018970338	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTGGGTTGGACCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2554.51601240496	38.3280651012983	0.0150040418283439	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2546.81018983409	2546.81018983409
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTTGTCAAGCCAT"	-4.15778432312663	9.95693776691285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTTGTCAAGCCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2816.88452145482	39.7497438170697	0.014111243650322	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2807.64934869245	2807.64934869245
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAGTCTAGAATCCCT"	-2.29361758652385	9.52025125110475	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGTCTAGAATCCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2435.42354730801	47.50786299392	0.019507022935059	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.41392469539	2429.41392469539
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAGTCTGTACCCGAC"	-3.82838068428691	9.69469926441041	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGTCTGTACCCGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2632.49350546915	44.1293522785537	0.0167633280716069	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2618.39985860693	2618.39985860693
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGAAGCACGAGGTA"	1.11827685412709	-7.54939939891966	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGAAGCACGAGGTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.90625398922	39.4350133343182	0.0165006528053113	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2388.32626686649	2388.32626686649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGAAGCAGTTGGTT"	-0.320987890393096	8.76803109729616	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGAAGCAGTTGGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2294.17684829292	42.7191838064414	0.0186207021652356	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2289.61587020121	2289.61587020121
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGATCGGTGGTCTTA"	-2.15637240830119	8.55179784381715	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGATCGGTGGTCTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2297.0867852128	45.5512804359377	0.0198300215425766	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2280.72984347211	2280.72984347211
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGACGGGTTGGCCTG"	5.4245101409847	-9.84414389049681	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACGGGTTGGCCTG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.43129965073	41.8232820593262	0.0181097753657584	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2304.96630689068	2304.96630689068
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGAGAGTAGCGCCT"	-4.42657075348552	10.0609912642273	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGAGAGTAGCGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2502.87426184262	38.7912537553389	0.01549868259334	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2497.47540606796	2497.47540606796
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGCGTCACAGTCGC"	1.03438480672185	-7.1723294488159	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGCGTCACAGTCGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.49560113201	37.9174204264026	0.0141193381253052	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2684.3171722121	2684.3171722121
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGCGTCAGAAGTGC"	-0.827005247504073	8.57327172839967	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGCGTCAGAAGTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2358.29631799217	36.9091281718555	0.0156507593597397	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.60114821193	2353.60114821193
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGGATCAGGTAGTCG"	-2.23779879036601	8.55569646442262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGGATCAGGTAGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2648.9530195325	43.523169274587	0.0164303288709394	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2645.46536163688	2645.46536163688
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGGATCGTTATCTGG"	5.43143667754476	-9.66022207653197	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGGATCGTTATCTGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3010.5049898507	41.3883082936795	0.0137479620306931	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2990.64458520754	2990.64458520754
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGTGCACAATTCACG"	-2.70251665535625	8.78840158069459	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTGCACAATTCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2361.90399229278	42.2735915493347	0.0178980990282752	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.9311077184	2357.9311077184
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGTGCACAATTGGTC"	-3.91928182068523	9.6596355208191	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTGCACAATTGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2445.39551189701	43.893809450575	0.0179495747158399	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.74315273598	2435.74315273598
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGGAAGTAACAGGC"	1.38121308860127	-7.83163978969725	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGGAAGTAACAGGC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2759.97399008083	39.3781259106394	0.0142675713800789	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2753.55417813403	2753.55417813403
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTAGACGTGTTTGCA"	-2.64263282242473	8.75449655139772	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGACGTGTTTGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.17628531085	41.4300332347459	0.0159950631428833	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.40601321719	2586.40601321719
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGTTTCAGGCGATAC"	1.22702672061269	-6.76679756557616	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTTTCAGGCGATAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2917.49926100582	36.3089815694922	0.012445241051055	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2910.93411469692	2910.93411469692
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACGCCAATTAGGA"	-3.41845927658733	9.30922696674196	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCCAATTAGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2701.23229799933	39.1027657086171	0.0144758989212363	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2694.49247894334	2694.49247894334
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGTTAAGAGTGGCT"	-2.79877195778545	8.79873464191285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGTTAAGAGTGGCT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2315.58258846111	45.8872491424853	0.0198167188556125	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2310.20866992534	2310.20866992534
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGTTACAAAGAGTT"	0.555935760110062	-6.54849483883055	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGTTACAAAGAGTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2902.10137972972	45.0452491017902	0.0155215973557703	2540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2895.1440151065	2895.1440151065
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGGTTAGTCCTCATC"	5.01138319548909	-9.02049925243529	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGTTAGTCCTCATC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.31945193346	44.457237823524	0.0181064984389367	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2451.66561956496	2451.66561956496
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTACAAGTTCGGCCA"	-2.7090257209843	8.76835153186647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTACAAGTTCGGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.37225116361	38.9106085636747	0.0154139741259392	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.62027024011	2519.62027024011
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTAACAGACGACTG"	1.87875892695729	-5.52129509365233	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTAACAGACGACTG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2534.31548545383	43.5876770276946	0.0171989940786276	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2532.9986163112	2532.9986163112
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTACCTCAACCGCCA"	-4.33970246735271	10.0230140455994	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTACCTCAACCGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2933.56101856047	42.7459914573587	0.01457136605883	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2926.61189194722	2926.61189194722
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTACCTCACAAGCCC"	-0.306300233036834	9.29177568042604	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTACCTCACAAGCCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2507.79513352912	49.0873321403404	0.0195739003892482	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.90334997643	2495.90334997643
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTAACGTCTCAAGT"	-4.17053876343425	10.1452121504578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTAACGTCTCAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2315.41965903482	42.5572446923971	0.0183799271662646	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2308.58182481523	2308.58182481523
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCATTGGTCGTTATG"	-1.94171486321147	8.94009206378785	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCATTGGTCGTTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2083.92886041575	46.7554568804147	0.0224362058458593	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2069.57636364246	2069.57636364246
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTCCTCAGCTCATA"	-3.8202899498051	9.95198152149049	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTCCTCAGCTCATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2338.72163231703	42.7031634129281	0.0182591903298132	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2329.14304542737	2329.14304542737
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTCAAAGTAGCGTTT"	-3.86630115929301	9.65803620899049	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTCAAAGTAGCGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2690.44665220492	36.2700666604147	0.0134810577383833	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2683.92440458912	2683.92440458912
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTGATGTAGTTCCA"	-4.33621964874919	10.5436839827332	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTGATGTAGTTCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2576.57290781066	40.3811935716383	0.015672443597162	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2569.71041728015	2569.71041728015
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACCATCATGACTAC"	-4.14703069153483	10.2940139540466	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACCATCATGACTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2516.09017327778	42.5339044979673	0.0169047615819576	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2511.23080590512	2511.23080590512
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCACGAGTTGGCTT"	-1.55997679653819	8.52766130054323	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Activated"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCACGAGTTGGCTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.51842091377	37.2493775961409	0.0149444743451425	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2487.91310136482	2487.91310136482
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTGGCAGGTATCTC"	-2.26750717583354	8.63286397540895	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTGGCAGGTATCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2571.95080490828	44.3780984713861	0.0172546451458929	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.43757469192	2562.43757469192
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTGGCAGTAGCAAT"	9.11700691756551	7.4810695418152	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTGGCAGTAGCAAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1885.03750976876	42.6160682559003	0.0226075439003482	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1876.81811292525	1876.81811292525
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTGTTAGAGCATCTTG"	-4.07239375534709	10.2634391554627	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTTAGAGCATCTTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2326.87192565277	39.2462334160676	0.0168665206638125	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2319.57169748609	2319.57169748609
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGCAGCAAATGCGG"	-4.23014674606975	10.6044759520325	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGCAGCAAATGCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2758.93328114182	36.9406346659663	0.0133894628472776	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2754.22015203966	2754.22015203966
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCACGTCTTCTGTA"	-4.23021922531779	10.1642379530701	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCACGTCTTCTGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2832.76120019991	37.8879934074574	0.0133749337589005	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2830.44614261066	2830.44614261066
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACAGAGCATCCCG"	-3.79545817795451	10.2329892882141	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACAGAGCATCCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2334.16655135278	44.9425663719485	0.019254224316556	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2328.79076951382	2328.79076951382
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACAGAGGTGCTTT"	-4.094878534705	10.1230211027893	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACAGAGGTGCTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2554.96881796469	38.0135897089976	0.0148782988824417	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2543.96293264176	2543.96293264176
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACAGCAGTGCCTG"	-3.86359105530437	9.63349816882936	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACAGCAGTGCCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2626.89864927573	45.9742543234806	0.0175013430138069	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2618.87730385588	2618.87730385588
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTCAGCCCAGT"	4.8269702392513	-8.70273115551146	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTCAGCCCAGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2812.7081287209	41.505599804296	0.01475645459992	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2806.82347728837	2806.82347728837
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACAGTCTACCCAC"	-0.400887141854125	8.71732137286989	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACAGTCTACCCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2461.96803877066	39.3075251099186	0.0159658957756195	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2456.60548552686	2456.60548552686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCGTGGTGCATACT"	-2.6369985145634	8.68229196155397	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGTGGTGCATACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2780.66192533008	42.1412808759416	0.0151551256526588	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2774.99735848301	2774.99735848301
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTTCGTGGCGT"	-4.06463036957439	9.70580003345338	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTTCGTGGCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2623.60740630433	36.682169331294	0.0139815771380846	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2618.87455215643	2618.87455215643
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTACGAGTTGTACGT"	-4.19196448746379	11.2632436522278	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACGAGTTGTACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2421.40851643016	42.5157275212888	0.0175582629832198	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2417.05051245345	2417.05051245345
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCATCACGTTCTCGTC"	-3.99444804611858	9.81584546649782	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACGTTCTCGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.3234570952	35.2792658149468	0.0135933984330543	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2584.35229979281	2584.35229979281
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTAGCAGCTGAAG"	-3.06121859970744	9.95942018115846	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTAGCAGCTGAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2073.46415262589	44.1958502602428	0.0213149815994031	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2059.71445328529	2059.71445328529
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTAAGTGCATTAC"	-4.07572017136272	10.3068208464417	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTAAGTGCATTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2591.01772486453	47.1343043210797	0.018191424886352	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2579.25660768707	2579.25660768707
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTTGGGAGCTCAGAG"	-3.82096109810527	9.69665048206178	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTGGGAGCTCAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2576.48371951058	37.2678741686632	0.0144646262991883	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2576.48371951058	2576.48371951058
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTAGTGAGATGTTGA"	-4.24777636948283	9.98704717243043	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTAGTGAGATGTTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2721.26917419638	40.5586223038324	0.0149043037301923	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2714.95368627921	2714.95368627921
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTATGGAGCTAAACA"	-3.86266074600871	12.2533216246399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTATGGAGCTAAACA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3008.54452192189	42.1670116236345	0.0140157512432948	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2995.67275462205	2995.67275462205
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTCAATCCAGT"	-4.27091966095622	9.81504628742067	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTCAATCCAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3061.52320955928	40.647437724205	0.013276867409428	2716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3053.6707792148	3053.6707792148
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAACCCAGCATGGGT"	0.984997292130631	-6.93324520504149	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAACCCAGCATGGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3333.69482565922	39.960178604436	0.0119867536454943	3022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3327.76445405164	3327.76445405164
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCATTAGCGTTGTT"	-2.70834026756938	-6.71376993572386	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTAGCGTTGTT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1759.14900766123	36.4445311422452	0.0207171370836277	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1754.63389842488	1754.63389842488
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCATTCACTGTCCT"	-2.34413395348247	8.74299905383912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTCACTGTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2590.97263865367	40.8662785729692	0.0157725627678586	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.90568524325	2585.90568524325
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCATTGTCTACAAC"	-1.39124224606212	8.73406980121461	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTGTCTACAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2332.55422340699	36.3631683717202	0.0155894203902395	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2331.2107656698	2331.2107656698
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCATTGTGCGGATA"	-0.508481602103072	9.16287133777467	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTGTGCGGATA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2739.60423521974	43.3032965694229	0.0158064059080963	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2724.14984659381	2724.14984659381
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCATTTCAGTCTTT"	-0.249361555010635	8.61969373309938	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTTCAGTCTTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2298.42367715001	33.4644530037479	0.0145597408069008	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2290.58062512056	2290.58062512056
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCGATTCAGGTGTTT"	-2.53797636452373	8.83517930591432	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGATTCAGGTGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3238.847253445	46.5369735506363	0.014368375508026	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3225.24020506686	3225.24020506686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGACGTCGTAGGTGCA"	10.7924887138302	-2.21250178730162	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGACGTCGTAGGTGCA"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2767.50733593901	42.6833604456798	0.0154230342559137	3548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2761.7435757044	2761.7435757044
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCCGTTCGAGATAA"	-7.9794171852177	-0.88512566005858	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00862068965517241	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCCGTTCGAGATAA"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2614.42179748086	34.1555425086824	0.0130642815713949	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2608.26559379119	2608.26559379119
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCGCTAGATAGCTA"	-2.75569281998332	9.32525250995485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCGCTAGATAGCTA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2594.83854373257	41.0203276319992	0.0158084316001385	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2588.17121314734	2588.17121314734
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGACGTCTCCACCTCA"	-4.31935868683513	9.87182519519655	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGACGTCTCCACCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2462.22223230206	46.8605815190199	0.0190318245462383	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2454.14634797686	2454.14634797686
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCGGTCCAAGTCCCG"	-2.04240618172343	8.72830102527467	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGGTCCAAGTCCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2436.41916091697	44.4436891123031	0.0182413969752135	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2431.28427122766	2431.28427122766
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGAACACACAACGTT"	-2.82815061035808	9.09506127918092	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAACACACAACGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2645.58295790642	43.784120198804	0.0165498950119684	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.66508634271	2639.66508634271
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTCTATGTGATAGAT"	-2.1308630508488	9.24569413745729	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCTATGTGATAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2250.92007577337	36.2661069104025	0.0161116813078946	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2244.34109501736	2244.34109501736
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAGATGAGCCATGCC"	-1.70885370197948	8.54793641651002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGATGAGCCATGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2865.98060912804	40.6710271100411	0.014190963812004	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2853.79965500549	2853.79965500549
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGAACAGGTACATA"	1.78263380107228	-5.34104635631713	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGAACAGGTACATA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2814.311482724	36.0725956581891	0.0128175562227654	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2805.74622784298	2805.74622784298
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGAACGTGTCGCTG"	-3.57749257507976	9.36137960040895	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGAACGTGTCGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2531.02627284653	45.043989156218	0.0177967291922098	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2524.65919296966	2524.65919296966
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGCGGGTGGGCTCT"	-4.32787499848064	10.0261268385681	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGCGGGTGGGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.24544316089	44.0224675153086	0.0180846461637595	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.05808051699	2429.05808051699
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAGCAAGTTATGTGC"	-0.582943598658401	8.7596339949402	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGCAAGTTATGTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2404.77286448545	42.7248470219268	0.0177666870966912	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2394.24428216149	2394.24428216149
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGCTCGTCCGGTCA"	-2.44403038445171	8.84241292560426	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGCTCGTCCGGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2179.01952018143	43.7459599402491	0.0200759835031705	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2177.36772370548	2177.36772370548
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTAGAGAGGACTC"	-2.87718663635905	9.07280442798463	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTAGAGAGGACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.19799169108	39.7465934108372	0.0166150935453047	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2381.32501457664	2381.32501457664
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTAGCATGACGTT"	-2.16299996796306	9.98480508411256	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTAGCATGACGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2299.75995433548	38.9210990975097	0.0169239833157961	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2293.76682667368	2293.76682667368
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGATCTACAGAGGAAA"	-4.35567651215251	10.1849794157776	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATCTACAGAGGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2686.83545496148	46.298873780223	0.0172317488570906	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2680.71458254386	2680.71458254386
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTTCCCATATCTGG"	0.815201600163621	-6.22444059765013	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTTCCCATATCTGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2839.54261358531	41.2402267630951	0.0145235456463264	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2835.68024784007	2835.68024784007
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTCCTCACAAGAA"	-2.53015909615214	8.89033887470094	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTCCTCACAAGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2640.26138544149	39.5051238360174	0.0149625806194228	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2632.10719921353	2632.10719921353
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTCCTCGACACCG"	-4.52421460571941	10.261881805304	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTCCTCGACACCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2735.02521692774	45.2492188851755	0.0165443516224702	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2729.18864346294	2729.18864346294
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTGAAGACCAAAT"	-4.32536206665691	10.1822490462097	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTGAAGACCAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2347.00422758048	35.3458223992224	0.0150599738951729	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2342.65996547946	2342.65996547946
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTGATCGCCAGAC"	1.56685604628865	-5.67732241069945	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTGATCGCCAGAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2625.38442331087	44.7583551962292	0.0170483053067651	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2621.18525821299	2621.18525821299
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTGTGATCTATGCCC"	-4.40493665161784	10.7135495909485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTGATCTATGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2616.58833994127	41.5323010181979	0.0158726920793089	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2612.48115664409	2612.48115664409
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTTACTAGCGGCTCT"	-4.12020717087443	9.76080701434938	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTACTAGCGGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2810.88218560988	39.6213683637316	0.0140957058131324	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2799.56143274321	2799.56143274321
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTGATCAGGAATCG"	4.34954704818074	-8.27108576213988	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTGATCAGGAATCG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2810.02471681551	40.4484142911879	0.014394326871625	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2805.16008256198	2805.16008256198
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTTACTTCTAACGGT"	-3.71829400482829	9.57183358753053	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTACTTCTAACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2954.74463268909	40.9626171558345	0.013863335837099	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2945.39624538338	2945.39624538338
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGAGCACCCAC"	-1.68954263153728	8.62925431812135	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGAGCACCCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2513.2874250879	43.4228065224836	0.0172772943074606	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2507.0853457759	2507.0853457759
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GTTTGGAAGGTCCAGA"	-3.88295135918315	9.68980214679567	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTGGAAGGTCCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2585.32770076335	47.6403972422452	0.0184272180382312	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2579.48171586107	2579.48171586107
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCACTTCATGAAAG"	-3.84194002571757	9.58760640704957	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTTCATGAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2525.37670550155	36.8083539545487	0.01457539141561	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2512.77577502994	2512.77577502994
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACACGAGCGGGTTA"	10.3011766868526	7.64896009052125	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACACGAGCGGGTTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2223.66484193072	46.8492421109684	0.021068481736794	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2214.36484378523	2214.36484378523
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGAGTGCACAGCTGC"	-3.7770713371342	9.65201757037965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAGTGCACAGCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2774.74034362194	40.2428863021286	0.0145032980814336	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2765.56091050311	2765.56091050311
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACACGTCCTGCCAT"	-2.14833984795268	8.58364484393922	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACACGTCCTGCCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2657.17778426763	38.1294666799254	0.0143496106680098	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2651.745844335	2651.745844335
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCTGTGCAGCATACT"	-3.90744672241862	9.65166089618532	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTGTGCAGCATACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2972.77230664069	49.4472210602796	0.0166333697840977	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2956.83172662628	2956.83172662628
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCTAGTACTGAGG"	-2.82687673988994	8.87063596332399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCTAGTACTGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2415.37488058931	42.4351471932141	0.0175687623210111	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2409.65033057975	2409.65033057975
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCCTGAGCCAACCC"	1.7838337617809	-7.56483318721923	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCCTGAGCCAACCC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.93951012897	35.14034847267	0.013382009881463	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2624.55438356581	2624.55438356581
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCTTTCCAGAGCTAG"	-2.80578217926677	9.05548856342164	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTTCCAGAGCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.96307170683	37.4066054266801	0.0146982900626502	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.09423664225	2539.09423664225
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACGACCATTGGGAG"	-3.09173164787944	9.18706891620485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACCATTGGGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2449.20989742457	42.5915462476451	0.0173899126785465	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2443.37668722877	2443.37668722877
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACGACGTGTTCCTC"	-4.27627263489421	11.9453181990418	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACGTGTTCCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2449.78459062153	42.91471843749	0.0175177518063342	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2445.48029801131	2445.48029801131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGATGGCACCGGAAA"	0.710616071789902	-6.62648632442626	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGATGGCACCGGAAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.2060068508	37.6838885928045	0.0133810838060615	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2810.46275857631	2810.46275857631
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACGACTCATCTGTT"	-0.950929979712325	8.65658280933229	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACTCATCTGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2386.05451496611	41.1609647888152	0.0172506388813165	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2378.97442253373	2378.97442253373
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACGACTCCATGATG"	-3.92337499085124	10.4331769713196	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACTCCATGATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2415.21733483173	40.1196308636936	0.0166111886848016	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2405.44727021382	2405.44727021382
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAACTTCAGGTCCCTG"	-4.39351211014445	10.909981704596	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACTTCAGGTCCCTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2913.84339856197	40.7204093846624	0.0139748105216494	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2909.38358180566	2909.38358180566
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAAGTTCACGGGCT"	10.6040255027706	-0.762850844022356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAAGTTCACGGGCT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1734.82276610818	44.4882311259073	0.0256442513869645	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1730.99673717115	1730.99673717115
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCACAGCTTCGTA"	-3.46285758438762	11.563169456366	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCACAGCTTCGTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2488.71150712467	41.428138270835	0.016646420508056	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2481.1843505044	2481.1843505044
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCTCAACACGT"	-3.83385024491008	-8.52180387890013	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCTCAACACGT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2674.8470394861	49.0624532241195	0.0183421528408389	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2663.71341127102	2663.71341127102
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCTCCCGGTAG"	-0.812780122191268	8.46489331806032	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCTCCCGGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2421.70645983263	38.3176382680758	0.0158225775516674	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2413.63046682286	2413.63046682286
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCACGTGAGATCG"	-4.25054107132609	10.2472409971985	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCACGTGAGATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2487.66473907538	43.9245398395088	0.017656937106338	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.17044144421	2480.17044144421
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGCAAGCTGGAGT"	-7.05425343933757	1.74087355220643	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGCAAGCTGGAGT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2693.5559085934	46.4192152613723	0.0172334329921568	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2686.0087970051	2686.0087970051
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGATGCAGGTCCCA"	-4.15346560898479	13.2472600706848	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGCAGGTCCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3055.712684484	38.3018547160629	0.0125345078778343	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3046.25810950919	3046.25810950919
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAAGCCATCGGTAACT"	0.781568904488724	-6.78779842769774	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCCATCGGTAACT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3161.83854403699	44.0649469281809	0.0139364949583793	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3158.3432724822	3158.3432724822
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGTAGAGCTGTTCA"	-4.27002416077312	10.641761756781	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGTAGAGCTGTTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2193.93287253629	42.9942979111725	0.019596906746499	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2186.30403416352	2186.30403416352
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGATGTCCCAGTGG"	0.3956641453201	-6.39554169094237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGTCCCAGTGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2963.98484470157	40.1498615655788	0.013545906497245	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2958.42096723566	2958.42096723566
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGCATGAGATA"	-4.21507821503337	12.4074792631897	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGCATGAGATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2769.59238368418	42.0761175761631	0.0151921697301147	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2761.31214548936	2761.31214548936
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGTGATCGGTAGAG"	-2.6993924182957	8.8929872282776	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGTGATCGGTAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2186.65021113208	39.5766553027075	0.0180992163727082	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2182.26281884503	2182.26281884503
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTCGCTCCATGAGT"	-1.00262341919597	8.71903989398805	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTCGCTCCATGAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2575.88588804605	39.1666222041366	0.015205107643121	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.51503110212	2562.51503110212
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAATCTCAGGTAGCAC"	-4.34945187988933	10.6256570585999	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATCTCAGGTAGCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.91229448971	42.8438759858535	0.0157461437006328	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2716.42376048356	2716.42376048356
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGGATTCATGTCTT"	-4.10430751267131	9.86512181842653	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGATTCATGTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2682.34296920194	33.3176772586963	0.0124211100672965	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.49241639627	2672.49241639627
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAATCTCCATCGTGGC"	-0.539861540228683	8.55524251544801	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATCTCCATCGTGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2399.5786864294	35.7693333766863	0.0149065057040957	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2398.56339751301	2398.56339751301
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAGTAGTGCCTGAC"	3.24072541770284	-8.48538496410521	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGTAGTGCCTGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2909.22168706214	35.9154718624076	0.0123453884666577	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2903.83774008558	2903.83774008558
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGTAGTCCGATCG"	-2.37662444534953	8.67191312396852	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGTAGTCCGATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2477.57410716551	37.7251738733646	0.0152266581105517	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2473.40712225921	2473.40712225921
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAATTCCGTTGAGAGC"	4.63018002089803	-8.78787233745726	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATTCCGTTGAGAGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2603.53599471792	34.3888679577899	0.0132085241101173	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2602.27788996726	2602.27788996726
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGTTCAAGGTTAAAC"	-7.05352483215983	1.67231855476228	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTTCAAGGTTAAAC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2530.98851602499	39.2268452256299	0.0154986263182408	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2520.01769830658	2520.01769830658
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACAACGCAAATGCTC"	10.0500637489254	7.79276225650636	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAACGCAAATGCTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2356.44570752151	46.050189532315	0.019542223860846	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2347.09700329136	2347.09700329136
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAACAAAGAAGTGTT"	-4.28335795822795	9.88245389545289	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAACAAAGAAGTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2480.20698998071	40.5405395713718	0.0163456274960692	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2473.01540815243	2473.01540815243
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACAACGGTGCTATTG"	-4.3298057121342	10.8410701521668	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAACGGTGCTATTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2439.82550003316	37.7747097315351	0.0154825456701808	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2434.09429565975	2434.09429565975
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACAACGTCATTCCTA"	-6.90297971192058	1.77834913814393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAACGTCATTCCTA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1934.31078014534	43.8596162836916	0.0226745447184015	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1922.56338939843	1922.56338939843
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAACCTTCAGTAGGG"	-4.81108174744304	-5.40074064647826	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAACCTTCAGTAGGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3243.27196337945	30.6179899411561	0.00944046329967731	3538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3216.87973219849	3216.87973219849
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGCCATGTGAGAACC"	-2.01025472107585	8.59300897205202	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCCATGTGAGAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2680.33531335249	45.205778595111	0.0168657176473077	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2671.08931757924	2671.08931757924
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACACCCGTACCAGAG"	4.27985348281209	-8.53487398540648	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACACCCGTACCAGAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2430.26542060953	42.4158676898583	0.0174531832326446	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2423.87505440117	2423.87505440117
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACACCCGTTCGGTCG"	-2.20362363281901	8.56467244708864	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACACCCGTTCGGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2253.72026234108	43.6932654099913	0.0193871733506999	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2249.61265876466	2249.61265876466
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAAGTATCCGTGGCA"	-0.617046574980575	8.81977078998414	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAAGTATCCGTGGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2231.55356031132	44.2867534794394	0.0198457049237308	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2222.90577624804	2222.90577624804
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTATCATCAAAGGAT"	1.79754664477651	-5.92755892192992	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTATCATCAAAGGAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2917.79670707279	31.5665721326192	0.0108186331337277	2548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2915.57041850876	2915.57041850876
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACAGGTGTGGTACAG"	-3.63453159752544	9.7177524336609	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAGGTGTGGTACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2260.64995413941	44.7450482235662	0.0197930016284187	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2260.64995413941	2260.64995413941
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACATTCAGACATAAC"	-0.537423233420211	8.53761289203493	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACATTCAGACATAAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2552.6211188052	25.220717750406	0.00988032166803154	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2540.37113000446	2540.37113000446
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGCTCATCCATCTGC"	-3.36006818237956	9.71530816638795	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCTCATCCATCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.45194159731	45.6141560032511	0.0177732359854211	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2564.126280781	2564.126280781
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTCAAGAAACT"	-4.04163489762004	9.75347421253053	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTCAAGAAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2740.8064627242	42.2304172347552	0.015408025998589	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2738.60087491836	2738.60087491836
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACCCACTCTCCGCAT"	5.37698282775227	-9.46967031871947	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCACTCTCCGCAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.99446367629	36.9039284306616	0.0124005366545856	2498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2964.41187234995	2964.41187234995
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACCCGTAGCGCCCAT"	-3.48686919632609	9.30218885028688	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCGTAGCGCCCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.90703944429	42.9631734522601	0.0165058424297138	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2594.64592416297	2594.64592416297
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTATTGTAATCAGA"	1.75222732600514	-7.81838228618773	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTATTGTAATCAGA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.07148578405	33.5093377996569	0.0121187961945784	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2761.82795500901	2761.82795500901
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTTCCCATACC"	-0.523673276335555	8.46613214099733	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTTCCCATACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.89482695312	36.9156324708305	0.0169969705773544	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2166.52945194615	2166.52945194615
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCACACACAGAGAC"	-0.434601138264495	8.602831817511	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCACACACAGAGAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2368.21000647898	37.1099063264298	0.0156700234459377	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2361.44746420241	2361.44746420241
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCTGGGTGGCTGAA"	9.54705204543416	7.7646479376587	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCTGGGTGGCTGAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2267.06342186738	48.991124243828	0.0216099486989534	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2256.56301428916	2256.56301428916
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTCACGTGACAACG"	-0.384133825928527	8.98480985248414	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCACGTGACAACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2522.07401122997	31.2268500454405	0.0123814170029894	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.43573507834	2515.43573507834
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTCTGCAGGACGAT"	-2.81032095375713	8.60756013477174	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCTGCAGGACGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3298.58094598201	35.1069591979017	0.0106430491695726	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3276.63596987029	3276.63596987029
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTACTGCAAGTGGCA"	4.92834248122518	-9.08609011089476	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACTGCAAGTGGCA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.91341860353	40.188010163167	0.0149402616029294	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2687.13710918107	2687.13710918107
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTGAAAGCTAAACA"	-4.3355577987736	10.1757869490418	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAAAGCTAAACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2747.62717467424	37.7089686895944	0.0137241941108932	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2745.24111410613	2745.24111410613
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGTCAAGGCTCACC"	-4.49292502823527	10.4330758818421	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGTCAAGGCTCACC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2894.01241756455	43.0683500531393	0.014881881567524	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2887.68453485489	2887.68453485489
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTGCCACAGCTGTAT"	-4.44162879410441	10.7105016478333	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCACAGCTGTAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2718.89270182164	42.4801031815768	0.0156240454627413	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2713.89286269327	2713.89286269327
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACCTGCTCCATAGGT"	-0.00509258630927208	8.85169122302858	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCTGCTCCATAGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.9402178246	38.6970942050483	0.0185336217362422	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2087.9402178246	2087.9402178246
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGATCGTCCAGCTCT"	1.99746110019032	-5.24728348171385	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGTCCAGCTCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2769.35769997271	38.4125383811665	0.0138705586430908	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2763.845246401	2763.845246401
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTGAACAGCGTACC"	-6.95536837998088	1.91857967460481	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAACAGCGTACC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2308.36815860065	44.0516551253315	0.0190834616052042	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2298.95494562032	2298.95494562032
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACTCACAGGTTCGC"	-4.3565276664799	10.3462915190491	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACTCACAGGTTCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2598.93578215596	42.3796402398199	0.0163065361332875	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2596.38277359658	2596.38277359658
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCACACAACAAGTA"	10.3721519905025	7.45739028537599	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCACACAACAAGTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2366.18988163222	43.2133110076308	0.0182628246968167	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2361.78842200626	2361.78842200626
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGGCCACGCACCA"	-4.90022502365764	-4.77532198345336	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGGCCACGCACCA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3010.29493394952	42.4845507476353	0.01411308582043	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3002.13677401459	3002.13677401459
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGGCGTAGAAACT"	-3.31159649315532	10.3230132826599	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGGCGTAGAAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2357.54553465369	38.024725732988	0.0161289464716845	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2349.21300012513	2349.21300012513
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCTCCCAAGGGTCA"	-2.82435427132304	8.81953904712526	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTCCCAAGGGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.26338690661	42.9970692958935	0.0164219801227458	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2610.38990525938	2610.38990525938
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGTAAGCGGTATG"	-4.15293488922771	10.2042598494324	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGTAAGCGGTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2099.03213708035	40.1081147990221	0.0191079088740445	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2099.03213708035	2099.03213708035
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGTACACAGCTTA"	-3.96826587143596	12.4111003645691	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGTACACAGCTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2698.90483203838	38.2018672125127	0.0141545810578509	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2694.53006175935	2694.53006175935
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGTACAGGGCTTC"	-4.47955832901652	10.3998765715393	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGTACAGGGCTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2693.60507523103	36.77400542222	0.013652337441882	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2688.77584833649	2688.77584833649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTGCGAGCGGTAGT"	-3.55015883866008	9.37885758960573	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTGCGAGCGGTAGT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2453.07289891772	42.1122619085765	0.0171671465316649	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2450.92730558311	2450.92730558311
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACGGTATCGCGTGCA"	-4.15840468826945	11.2008600004944	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGTATCGCGTGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2638.45497848604	43.5824643763685	0.0165181762553236	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2632.90388307148	2632.90388307148
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCATGAGTCATTGC"	-4.11942420426066	9.88239381397096	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCATGAGTCATTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2970.09477596627	39.6119683753125	0.013336937492988	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2961.2421397773	2961.2421397773
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTAACTTCCATTTCA"	-2.78064618530925	8.74198529804078	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAACTTCCATTTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2966.71151413869	43.8999730847322	0.0147975200404605	2332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2957.34175673232	2957.34175673232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTGTTGAGTCAACAA"	10.5823685127193	7.40558431232301	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGTTGAGTCAACAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2508.01124527679	45.2430459874381	0.0180394111360713	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2496.2619935871	2496.2619935871
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAATGAGTTGCCAAT"	0.954728980630082	-7.38013698970946	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAATGAGTTGCCAAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.60639951414	41.5443180015126	0.0155794713494583	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2665.38115814484	2665.38115814484
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATGGTGTACGAAAT"	-2.77251325073894	8.83493135059205	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTGTACGAAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2859.27395828709	37.238316313107	0.0130236965244895	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2851.53873049815	2851.53873049815
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTTGAGTGCTATTG"	-5.5893271965092	2.22673556888429	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTTGAGTGCTATTG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1656.08245000401	47.0197447433788	0.0283921520593766	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1653.66877366965	1653.66877366965
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGTGCACATCGTGCG"	-3.91795311394389	10.60164735401	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGTGCACATCGTGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.53949212169	40.4785974297506	0.0156497117299171	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2577.64001464495	2577.64001464495
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAACGTGTGGTCAAG"	-0.369555155665237	8.78203389728395	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAACGTGTGGTCAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2515.06931766213	43.407404726487	0.0172589297724947	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2500.32651264671	2500.32651264671
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGATCCACACTGAATC"	-4.2439149421757	10.0429401167664	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATCCACACTGAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2694.46326667727	37.0253002053968	0.0137412525393435	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.31465551672	2689.31465551672
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TACTTACTCGTCTCAC"	5.48467506942098	-9.97759535228881	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTACTCGTCTCAC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2726.50479269742	45.1145729442811	0.0165466692246845	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2718.92108191417	2718.92108191417
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATACCTGTTTCACTT"	-4.23462377014812	9.77282044971315	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATACCTGTTTCACTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3075.73845343193	41.3490399331888	0.0134436138050201	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3055.62170687793	3055.62170687793
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTCACGAGATGGCGT"	10.7424360710079	-2.40622212803038	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTCACGAGATGGCGT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2238.27669630419	38.6236008040725	0.0172559544884899	3251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2224.46133157511	2224.46133157511
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCAGGAGTACGAGC"	-3.41655955734904	10.1882257231506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCAGGAGTACGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2182.00470755496	46.9670361560205	0.0215247180693067	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2176.48048748427	2176.48048748427
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGATGCTAGGTGCATG"	-3.28416452828105	11.4453115233215	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGCTAGGTGCATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.3274297881	38.6994360729714	0.0162375658456682	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2379.29259775904	2379.29259775904
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTGTTCAGGCGTTC"	-4.06354175034221	9.73494241321412	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGTTCAGGCGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2629.91263167509	38.1338850769884	0.0145000577653029	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2625.12119710588	2625.12119710588
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCACGGTCATTTGCT"	-2.62855873528178	9.05297849262086	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCACGGTCATTTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.29206485871	42.226237152469	0.0169699681756879	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2479.04460124132	2479.04460124132
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGAAGCACTGAATC"	-4.34507499161418	10.2305307158264	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGAAGCACTGAATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2712.34426487308	40.9348726914768	0.0150920637994279	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2706.37712536606	2706.37712536606
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGATCCAGGAATAT"	-3.95905242386516	9.86548421466676	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGATCCAGGAATAT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2509.44849971884	42.2662599859905	0.0168428481360451	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2503.22681730482	2503.22681730482
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCAATCATGGGAAC"	-4.51395879212077	10.2793149718079	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAATCATGGGAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2684.92711813895	37.9691468345941	0.0141415931099509	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2679.88553832649	2679.88553832649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGACTGGTCCACTTC"	-4.37302098694499	10.0714387663635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACTGGTCCACTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2837.51309432907	35.8401293525612	0.0126308243032216	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2826.58710388435	2826.58710388435
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGACTGTCGCATTAG"	-4.42084584656413	-5.34375526821288	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACTGTCGCATTAG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2402.7830100479	45.8954513444961	0.0191009554972595	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2395.83497364644	2395.83497364644
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGACTGTCTAGATCG"	-2.13190470162089	8.62649915302125	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACTGTCTAGATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.54031375272	40.022137483538	0.0165207312573223	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2407.77134014339	2407.77134014339
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTAGCACTCTA"	-4.10003695908244	10.0587329634461	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTAGCACTCTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2688.39651323729	43.7698990669984	0.0162810429382279	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2679.48564318129	2679.48564318129
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCACGTCGAAGAAT"	10.3877769905025	6.93168304050294	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCACGTCGAAGAAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2289.92805148202	40.8397311249773	0.0178345040572546	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2271.0278182279	2271.0278182279
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGACAGTTCAACTACG"	-0.411432037979919	8.87426469409791	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACAGTTCAACTACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2582.67797096984	41.3609304524913	0.0160147455150824	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2570.59809253131	2570.59809253131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCAGCTCCCGATCT"	0.13147466358487	9.25618264758912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAGCTCCCGATCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2384.63660749248	34.8236336518248	0.0146033293049388	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2373.24802963892	2373.24802963892
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCAGCTCTGAGCAT"	4.97865309295003	-9.06528284465941	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAGCTCTGAGCAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2985.30318967552	36.2631850762131	0.0121472369043208	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2975.59275043255	2975.59275043255
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTTCTAAGCCA"	-4.25898061218913	9.98855588519899	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTTCTAAGCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2529.95029021781	39.749327768179	0.0157115054480999	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2521.49174600723	2521.49174600723
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGCACATCTGTGTGA"	-4.3383358520573	10.6424093016419	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGCACATCTGTGTGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2358.12986555847	46.3575208926268	0.0196585953851392	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2349.73022062689	2349.73022062689
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGGTCCACTTC"	0.261575047939461	-6.38847162639769	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGGTCCACTTC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3099.32195451289	40.9814948275749	0.013222729174006	2616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3092.66073671477	3092.66073671477
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGGAGGGTCTGTGTA"	-2.26295552673991	8.6978435286316	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGAGGGTCTGTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2640.90180011412	35.0260555029144	0.0132629147745671	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2633.46654550515	2633.46654550515
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGGAGGGTGAGGAAA"	-3.47233758392985	9.67783258045045	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGAGGGTGAGGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2296.1471050818	42.2741368865599	0.018410900936181	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2292.02164326942	2292.02164326942
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGTTACACTTGTGA"	-3.61123547974284	9.51539990985719	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTTACACTTGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2624.64452349496	41.3893142622222	0.0157694933129872	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2620.27781404396	2620.27781404396
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAACGCTCAAGGCCTC"	-4.34772048416789	10.3661212691101	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAACGCTCAAGGCCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2895.28557081176	38.6718782296803	0.0133568441812936	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2888.75327829252	2888.75327829252
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGGGTTGTAGGGTAC"	-0.520889262587386	8.23481843555299	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGGTTGTAGGGTAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2524.32141234278	36.9742902988624	0.0146472196916268	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2514.69339141052	2514.69339141052
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGGGTTGTCTACGTA"	-3.84526119652446	9.63419053638307	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGGTTGTCTACGTA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	3068.66936804206	41.6952369529258	0.0135873996029521	2725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3059.03949653785	3059.03949653785
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGTTAAGGTTCTAC"	-4.53566012802775	10.6275090941223	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTTAAGGTTCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2895.58568247499	41.1592503836634	0.014214481938066	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2885.02132319825	2885.02132319825
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGAACTCTTCGACC"	-4.14776549759563	9.85993669116823	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGAACTCTTCGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2515.77461267995	39.006559541689	0.0155047909876699	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2508.13658623215	2508.13658623215
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGGTACGTAACAGGC"	-2.78090582314189	8.68057725513307	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGTACGTAACAGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2630.37469648651	38.5316443695085	0.0146487283431431	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2623.82848938761	2623.82848938761
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTAACAGCAGCCTC"	-2.95160947266276	8.82027623737184	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTAACAGCAGCCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2815.43433342275	40.6636102863072	0.0144431037881363	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2804.60088131806	2804.60088131806
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTAACCACGTACTA"	3.24585237082784	-8.02047731792601	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTAACCACGTACTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2973.7972361677	42.5472788838423	0.0143073906876961	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2964.45334695777	2964.45334695777
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTAACCATGTTCAG"	-4.38584790650066	10.8313617476257	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTAACCATGTTCAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2824.05087121465	39.9446284422455	0.0141444436604872	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2815.80875888922	2815.80875888922
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTAACTCCAGCACG"	-3.95020614090617	9.62958238208619	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTAACTCCAGCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3004.29509798889	36.9221419375758	0.0122897853683854	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2999.32333761827	2999.32333761827
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGTGCAAGCTAAGTA"	-4.31786141815837	9.8843316801819	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGTGCAAGCTAAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2734.38465300974	38.436065751905	0.0140565687090141	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2726.68651707643	2726.68651707643
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTGTATCAAACTGC"	-0.639393011957961	8.67725274646608	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTGTATCAAACTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2368.68873602456	38.3190730397707	0.0161773357794924	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.66108097636	2362.66108097636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGATGGCTCACGGAGA"	-0.660867552191573	8.43397138202516	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGGCTCACGGAGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2428.55184025118	38.8240103727028	0.0159864861557526	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2421.67354247602	2421.67354247602
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TAGTGCATCGTCTACC"	0.00306324762050506	-6.418577217218	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGTGCATCGTCTACC"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2203.88046092796	47.9203218175604	0.0217436120820198	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2200.76120658261	2200.76120658261
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATACCTAGGTCGTGA"	1.5314026075298	-7.90086510097655	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATACCTAGGTCGTGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2041.96632338956	40.4087657462401	0.0197891440634356	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2041.96632338956	2041.96632338956
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCACAGTTCATCGA"	-2.31646714630778	8.9104957350525	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCACAGTTCATCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2655.11856975228	47.0424178942719	0.0177176335664214	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2649.4692688809	2649.4692688809
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATACCTCACGGATCC"	-2.71195779267009	8.77313420856325	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATACCTCACGGATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2640.53469333679	38.4930262122164	0.014577739239462	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2631.65018432532	2631.65018432532
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATACCTCAGGACTAG"	-4.21976409378703	10.0531081923279	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATACCTCAGGACTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2635.58028335418	41.6594882564329	0.0158065715241331	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2623.48759967672	2623.48759967672
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATACCTTCATTCTTG"	-6.90421805802043	1.69798932159273	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATACCTTCATTCTTG"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2360.69998595383	31.2223467299695	0.013225885083129	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2355.31977906059	2355.31977906059
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATATCCAGTGGGAAA"	-2.30477772179301	8.63457105243532	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATATCCAGTGGGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2653.19400271034	40.6775170042726	0.0153315275711912	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2645.88781432343	2645.88781432343
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAATGGACATGAGGGT"	0.139725935726804	8.19311521137086	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAATGGACATGAGGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1919.92088790988	42.202738881914	0.0219814988980395	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1914.01335695451	1914.01335695451
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCAGGCACGGCGTT"	-3.96424708786662	9.76404569232789	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCAGGCACGGCGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.83194617287	46.2048136181612	0.0189765924875378	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2426.81801087551	2426.81801087551
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAAAGAGACTCTTG"	9.6482626396114	7.65687224948732	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAAGAGACTCTTG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2249.64684837202	43.2141647368313	0.0192093104604857	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2242.17334127942	2242.17334127942
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCCTACATTAGGAA"	-2.28706131401713	8.80798146808473	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTACATTAGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.60639116203	42.4046622909647	0.0160283337811031	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.25279577777	2639.25279577777
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCCTAGTCATCGCG"	-3.79199562493022	9.59950158679811	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTAGTCATCGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2336.81802511083	35.5790178008934	0.0152254122565688	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2331.09508029144	2331.09508029144
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGACTTAGCCTTCTC"	-3.66001091423686	9.75285909259645	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACTTAGCCTTCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2377.51315777624	44.1579371161293	0.0185731620334886	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2371.2366428081	2371.2366428081
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCCTAGTTGCCGCA"	-0.166279534727889	9.76833913410035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTAGTTGCCGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2294.64786063702	39.7998194883214	0.0173446305949849	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2285.14936149601	2285.14936149601
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCCTATCCTTCGAC"	3.97757043418233	-8.34744741832884	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTATCCTTCGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2543.42771760246	44.3840087558731	0.0174504698713087	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2536.71743757816	2536.71743757816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAACCCACGCTTAA"	10.2946440177852	7.7088093527588	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCCACGCTTAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2248.14045070547	47.5552526535381	0.0211531502129305	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2244.73615421886	2244.73615421886
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCGCCGTCCCAAAT"	-0.163250829011756	8.57326600635377	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCGCCGTCCCAAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2226.67823887743	36.1084794380111	0.0162162987034063	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2218.89394017947	2218.89394017947
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCGCCTCATCGCTC"	-0.55709938231166	8.90083882892457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCGCCTCATCGCTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2334.02616601952	36.6790333413284	0.0157149195134694	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2328.02548145271	2328.02548145271
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTACAACCACGGTGTC"	-3.63913569870647	9.91609189594118	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTACAACCACGGTGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2691.34065057891	39.9825391816939	0.0148559934890047	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2683.71637837219	2683.71637837219
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAATCTGTTCACCGG"	-3.77228222313579	13.032540298346	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATCTGTTCACCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3198.73437024106	40.4653244312545	0.0126504172424311	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3186.06407250113	3186.06407250113
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAAGAAGGTTCAGG"	-4.03244862976726	10.1544790037903	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAGAAGGTTCAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2398.80234180484	45.1892536701052	0.0188382564426318	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2389.01563671513	2389.01563671513
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAACCTCTACTGCC"	1.80716778811757	-5.5608906975952	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAACCTCTACTGCC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2776.5497204986	45.3245455691217	0.0163240532789676	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2774.56799221996	2774.56799221996
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAATTAGAAACACT"	-3.77570972862895	9.8066081770691	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAATTAGAAACACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2490.07406124079	46.3473537577985	0.0186128414729576	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2479.01552262286	2479.01552262286
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCTTGAGCAGGTCA"	2.93757428702657	-8.06277849590453	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTTGAGCAGGTCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2921.5453558391	42.0804538321453	0.0144034915453364	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2919.15618693647	2919.15618693647
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATCTTGAGGGATCTG"	-0.381968120962936	8.63324830615846	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTTGAGGGATCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2341.4499956536	40.0749239182117	0.0171154301789926	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2330.13049633486	2330.13049633486
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGATCCAACGGCCT"	-3.85242376747783	10.5587777861389	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGATCCAACGGCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2365.42263960568	43.5417695229714	0.0184076066551176	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2362.81753213558	2362.81753213558
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAGGGAGTCGAAGC"	-2.30547056618388	8.60207936847535	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAGGGAGTCGAAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.33773192802	41.7836297564607	0.0161368017934643	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2580.82770202522	2580.82770202522
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGAATAGAGTATAC"	0.248732973902863	-6.38000442897948	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGAATAGAGTATAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3270.61883967459	42.8705036205264	0.0131077651423276	4147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3257.25168721163	3257.25168721163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTTGTAGGGATGTC"	-4.21081719818767	9.97436235034791	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTGTAGGGATGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2547.38271600158	38.5339740450161	0.015126888395278	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2541.00601292632	2541.00601292632
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCAACAGCCTCGTG"	10.7335926490719	6.82959268176881	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCAACAGCCTCGTG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2074.16838191963	41.9494268162533	0.0202246968866768	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2068.82964979723	2068.82964979723
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCAACAGGCGATAC"	-0.625168661505538	8.67595861041871	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCAACAGGCGATAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2469.97993567301	36.7934071719072	0.0148962372691833	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2462.13318291296	2462.13318291296
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTCCATTCATGCCAA"	-4.11556992951091	9.83176038349	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTCCATTCATGCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2682.93297415302	36.8206596336261	0.0137240326122012	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2671.64576311302	2671.64576311302
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGGAGGTCGCCACA"	-3.98388801041301	9.71649644458619	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGAGGTCGCCACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2559.53297634832	43.9758031294795	0.0171811824797115	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.73058034879	2553.73058034879
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGGGTCAAGTCGT"	-2.17144332352336	8.74452779376832	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGGGTCAAGTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2356.57344317906	40.8612998979001	0.0173392855699746	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2352.4597772295	2352.4597772295
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCACAAGTATCTGC"	-2.21048341217693	8.61775109851686	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCACAAGTATCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2622.42254327821	40.4404292166279	0.0154210195150605	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2616.02408492332	2616.02408492332
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTGGGAGCGGGTAT"	0.272943650453728	9.03978059375612	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGGGAGCGGGTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1960.25864435267	48.1530994432019	0.0245646662913217	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1944.41200244042	1944.41200244042
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTGGGCAGACAAAT"	-4.28746638718303	9.82283399188844	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGGGCAGACAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2624.3459299783	41.2087482071211	0.0157024833259927	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2619.29643043618	2619.29643043618
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCATGCAGCACACC"	-0.531865577132064	8.31278607929078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCATGCAGCACACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2145.16131396738	38.2795727865137	0.0178446126812335	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2135.18608784215	2135.18608784215
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGTACAGATCGACG"	-4.39326796951945	10.2705917128357	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGTACAGATCGACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.84175271228	45.0154673248822	0.0173146951263168	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.79768435048	2592.79768435048
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGAAGAGGCATCTT"	-4.13018784943278	9.90419099414674	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAAGAGGCATCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2396.35809493476	37.9248641706351	0.0158260421306806	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2392.20681490924	2392.20681490924
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTAAGCAGCGATTT"	-1.8272878927296	8.91675660693971	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTAAGCAGCGATTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1994.35797252165	45.8880104514284	0.0230089136873497	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1990.95382373132	1990.95382373132
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTTCGAGGCTGAAC"	-3.73901448670085	10.4272165068421	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTTCGAGGCTGAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2249.92122149508	45.9769517577078	0.0204349162621596	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2246.79487436394	2246.79487436394
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TATTTCGCAAGCTGTT"	1.05361845073048	-7.1908488503662	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTTCGCAAGCTGTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2861.84861926563	40.9283607449049	0.0143013716621418	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2855.01873305313	2855.01873305313
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTATTTCAGATAGTGT"	-3.86891446533855	10.4742851027283	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCAGATAGTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2293.98653072484	41.1961874502424	0.0179583388561682	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2286.46026722367	2286.46026722367
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGCCTTCTACTATC"	-1.29016087475474	8.43996236408082	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCCTTCTACTATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3096.50612427759	37.0016362049211	0.0119494794196648	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3086.00509241967	3086.00509241967
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAAGACCAACGCATT"	-3.51876411858256	9.49447629535524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACCAACGCATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2813.90154537956	40.8495699754987	0.0145170573016579	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2805.04939904841	2805.04939904841
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTATTTCGTGGGCTTC"	-0.0158981409972489	8.56080148303834	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCGTGGGCTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2469.051122512	37.3344685370743	0.0151209783372531	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2461.64535791078	2461.64535791078
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCGGGTCAGCTTCCT"	-4.37567267838176	10.0962171324524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGGTCAGCTTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2537.53240611876	38.4401975500878	0.0151486528634656	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2533.42605619751	2533.42605619751
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTTCTGGTCAAACGG"	-1.74477217617686	8.53244874561159	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Activated"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTCTGGTCAAACGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2500.10950991993	38.650172027715	0.0154593916283902	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2490.23088855296	2490.23088855296
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAAGACTCAACTCTT"	-4.16398320618327	10.8814410933289	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACTCAACTCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2500.57104942099	39.6771128780277	0.015867220764319	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2497.81934507303	2497.81934507303
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAAGACTCACAATGC"	-3.7665720981663	10.2404260405335	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACTCACAATGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2761.77732009464	47.5755380651479	0.0172264207251574	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2752.48173726373	2752.48173726373
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTGTGGATACG"	-4.0323523086613	9.86645028674928	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTGTGGATACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2510.92469064438	41.1507781777827	0.0163886947032339	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2505.95746457817	2505.95746457817
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGAACAAGCCACAAG"	0.749481220811051	-7.32941296016844	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGAACAAGCCACAAG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2713.10456120167	42.2866646788011	0.0155860799777182	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2709.65646023059	2709.65646023059
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCCACACCTCTAC"	-4.36066661301311	10.5048942335877	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCACACCTCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2816.39006296233	37.5748506306408	0.0133414938238771	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2805.36002813175	2805.36002813175
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAAGTGAGGCCGCTT"	-4.16622195664104	10.4683904417786	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGTGAGGCCGCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2682.70846482301	42.0286000697905	0.0156664805814311	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2676.43087970645	2676.43087970645
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAAGTGTCTACTATC"	4.42266811904256	-8.68081762706908	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGTGTCTACTATC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2967.04938893539	34.6124229237065	0.0116656039002188	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2963.29223132574	2963.29223132574
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTCCATTCCATCTCG"	-0.251383582979995	8.09453580463258	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCCATTCCATCTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2044.23454539961	47.2378643020123	0.0231078495411974	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2037.9939348758	2037.9939348758
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAATCTGTGTGTACT"	-4.26848349991496	11.620675063971	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATCTGTGTGTACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2465.23235798108	46.5075347348568	0.0188653757461404	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2457.29682854456	2457.29682854456
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCGTAGTTGTACC"	-3.4446042579716	9.53312871539918	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCGTAGTTGTACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.4329840607	43.7883311901211	0.0180389454529329	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2417.77755221258	2417.77755221258
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGAATAGTGACCTT"	-3.95556960526164	10.3998822935852	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGAATAGTGACCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2327.42431480863	42.2495989238368	0.0181529421408106	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2316.74687234734	2316.74687234734
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATCCCAGCGACAA"	-2.23657927933391	8.66351697528688	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATCCCAGCGACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2386.00787561519	46.0056314443048	0.0192814248077211	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2372.3556758667	2372.3556758667
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGATAGTCCAACACA"	1.34218527850453	-7.3723616830078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGATAGTCCAACACA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.76922854082	38.7046776176825	0.0131346144254561	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2944.61028742792	2944.61028742792
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCTCCGTCCTA"	-2.84932861748393	8.84904859149782	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCTCCGTCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3014.13142571616	43.9644224275407	0.0145861000129066	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3008.421628706	3008.421628706
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATCACAATTGCAC"	-2.79313049736674	9.37451646411744	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATCACAATTGCAC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2789.72330674004	43.6330263619222	0.0156406286804515	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2781.02955746592	2781.02955746592
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAATTCTCACGGTCG"	5.33994926986043	-10.0184288254944	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATTCTCACGGTCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2594.91676535858	35.6709499625101	0.0137464717322372	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2591.17219339425	2591.17219339425
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTGAATCCGTAGTA"	9.5580116706783	7.11103866184083	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTGAATCCGTAGTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2118.67764838102	43.4913128891245	0.020527574320878	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2117.37757796432	2117.37757796432
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACAAGCATTGCTGA"	-3.65717230263408	9.59817979419557	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACAAGCATTGCTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2517.10808274723	39.5497975302774	0.0157123954276575	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2506.41305748483	2506.41305748483
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCCATTCCCGAACG"	-2.61363230171855	12.4312534102234	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCCATTCCCGAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2744.57150301645	43.0291715532062	0.015677919670125	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2738.15667044507	2738.15667044507
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAACTAGATGAATC"	1.4935642677242	-7.56624843990477	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAACTAGATGAATC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2805.15954253018	31.8745587886726	0.0113628327748954	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2799.30531733176	2799.30531733176
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACACCTCACCCTGT"	-0.0532992881840051	-6.52208616649779	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACACCTCACCCTGT"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2569.83740464568	41.0248450709389	0.0159639847240044	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2564.0442350504	2564.0442350504
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACATTAGCGATGAC"	-2.7464910549229	9.41026208484498	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTAGCGATGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2516.70140650167	43.1652161791144	0.0171515047703319	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2508.59586718359	2508.59586718359
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCGAGCATTCCTAT"	-2.10154090347942	9.22725007617799	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGAGCATTCCTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.02796074285	39.6831706454009	0.0170825195890931	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2317.1634679229	2317.1634679229
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACATTGTAGCGTCC"	-1.56041083756145	8.85807607257692	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTGTAGCGTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2285.35404241177	35.6151187029513	0.015584070582502	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2277.15512212232	2277.15512212232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACATTGTCTCGACG"	-3.79837713661845	9.80147836292116	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTGTCTCGACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2395.2676963417	43.7588875896608	0.0182688923064816	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2391.05680290777	2391.05680290777
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACATTTCAGTGTTG"	-3.86795912209209	9.96616647327272	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTTCAGTGTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2462.94038332863	39.7570779063672	0.0161421194664225	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2459.11239310465	2459.11239310465
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCGTTTCGGTAAGG"	4.32638468322102	-8.40337469494017	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGTTTCGGTAAGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.17558271809	37.0826546751466	0.0143056106701934	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2588.2081372811	2588.2081372811
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTTGTCAAGCCATT"	-2.46925602379497	8.60688779437868	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTGTCAAGCCATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.56419328397	42.8530038340787	0.0176019198640536	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2428.63056871125	2428.63056871125
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTACTATTCCGTGTAA"	0.527681459754151	-6.53399565136107	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACTATTCCGTGTAA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3249.70227006936	33.2097091209657	0.0102193082199672	2892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3244.31058863021	3244.31058863021
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTTGTCATATGGCT"	-3.05119047585185	8.93559930408327	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTGTCATATGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2716.4820337087	43.8878334340765	0.0161561287317473	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2709.15569751048	2709.15569751048
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTCTGCACCTCTAC"	-1.29260478439983	8.55653665149537	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTCTGCACCTCTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2494.92358663818	41.7720318973984	0.0167428101289806	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2488.42409428386	2488.42409428386
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTCTGTCAGGGATG"	9.08091511306111	7.52895972812501	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTCTGTCAGGGATG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2240.67748073595	44.0336175354651	0.019651921311318	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2230.73121560401	2230.73121560401
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACGCTTCTCTCGAC"	-4.39982400360759	9.96915433490602	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTTCTCTCGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2896.63119536899	37.9796552014018	0.0131116640814068	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2892.92947008703	2892.92947008703
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACGGGGTACAACGG"	-2.07083473625835	9.70212457263795	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MAIT"	"MAIT"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGGGGTACAACGG"	"MAIT"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2357.21815293157	41.2078393095606	0.0174815552214852	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.49760951476	2353.49760951476
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGTGAAGTTTGCCGG"	-3.99923072281535	10.6226320036682	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTGAAGTTTGCCGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2432.68501763229	45.1946805423028	0.0185781061726973	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2430.09662098884	2430.09662098884
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGTTCGCATCTAACG"	-0.720141987234908	8.35353372180787	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTTCGCATCTAACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2284.83639507081	38.6030992944311	0.0168953450574017	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2277.65458456663	2277.65458456663
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTATCAGTATGAA"	2.79965247687642	-7.62917902385863	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATCAGTATGAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.04385006961	37.9208172893097	0.013125732684326	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2885.02191614416	2885.02191614416
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATAGAGCACATGTTG"	-2.23821840706523	8.70567128742067	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATAGAGCACATGTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2360.14030859447	41.5213912363146	0.0175927639069229	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2349.51658995936	2349.51658995936
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTATGTCGTACTA"	10.1884142356807	7.69853398883668	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATGTCGTACTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2284.54207009336	39.4096398215787	0.0172505642760907	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2277.38100547816	2277.38100547816
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTATTCTGGGATT"	5.25387014922444	-9.5218019715515	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATTCTGGGATT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.02938474324	40.1922820520422	0.0166701751153989	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2409.64990745226	2409.64990745226
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTATTCTTTGATC"	-2.79358778420146	8.88666341388551	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATTCTTTGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2649.73291138497	41.3499102881773	0.0156053125620742	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.19455444496	2639.19455444496
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTCGCACTGTTCC"	-4.44285569611247	10.0820970305237	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTCGCACTGTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2899.91697359865	40.5586352162566	0.0139861367016744	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2895.34605361542	2895.34605361542
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTCGCATTCTCTA"	-2.13495836678203	9.28398797595827	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTCGCATTCTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2458.19093979798	44.219590014211	0.0179886717904204	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2450.73141538763	2450.73141538763
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCACTCGTCAAGGAGC"	-0.652593116194564	8.89240644061891	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTCGTCAAGGAGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2780.04270384555	33.4381887336127	0.0120279406813998	3022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2769.27934588867	2769.27934588867
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCGACCAAATACAG"	-2.40945420685466	9.66188523853151	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCGACCAAATACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2532.65151626032	41.7958122341208	0.0165027884672566	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.37814849779	2523.37814849779
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGCAAAGTGGGAAA"	-0.480167786509353	8.60407826984254	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCAAAGTGGGAAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.11833552658	36.5306438233383	0.0155839589109874	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.03931306326	2336.03931306326
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGCAACAAAGGCGT"	0.786792476742905	-6.97315838253173	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCAACAAAGGCGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.17479712613	40.1807358248565	0.0141273791840983	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2841.32532753143	2841.32532753143
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGCGGGTAACGCGA"	-4.21948991242107	12.6898307570252	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGCGGGTAACGCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2785.18608700813	47.1667937357413	0.0169348805653443	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2773.60079368711	2773.60079368711
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCGTGGTGTTCATG"	10.0454040962154	7.18878028476564	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCGTGGTGTTCATG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2123.00209548033	44.7220831304427	0.0210654917513514	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2115.71865185639	2115.71865185639
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGCCTAGTTGCTGT"	-2.12441335144694	8.87570664966432	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCCTAGTTGCTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2499.30946137948	43.8524566885688	0.0175458291044778	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.1268249768	2485.1268249768
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGCCTGTTGGTAGG"	-4.16518722000774	10.5976457365784	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCCTGTTGGTAGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2742.59574751723	41.7349257652843	0.0152173085672817	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2736.82999593436	2736.82999593436
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTTGGTGGCGCTT"	-4.11650453034099	9.84186074817506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTTGGTGGCGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2796.05742972704	39.6219303425365	0.0141706425344792	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2790.88316058773	2790.88316058773
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTGTGTTCAGT"	-4.16690383377727	11.2403688200745	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTGTGTTCAGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2525.45987719892	40.5280669703729	0.0160477968136734	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2521.26971877552	2521.26971877552
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCACAAGCTATCCA"	-3.21655712547954	9.46913812244264	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACAAGCTATCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2304.71410120104	42.2248394321679	0.0183210747962898	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2299.37323805002	2299.37323805002
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGACGCCAACTTCTT"	0.364363838999909	-6.38466122066649	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGACGCCAACTTCTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2578.23035587189	38.4044602174555	0.0148956667622774	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2573.75609534097	2573.75609534097
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGACCCACAGACGA"	-0.516985456377822	8.17318723285524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGACCCACAGACGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2481.51249193874	43.4123334978475	0.01749430383239	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2465.76134098084	2465.76134098084
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCTCACGTAGT"	0.722238321870011	-6.8492379418579	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCTCACGTAGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2846.77124460801	44.4262954155557	0.0156058536490076	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2843.1801038478	2843.1801038478
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGTAAGAAGGCTC"	0.74091656979863	-7.13210203563841	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGTAAGAAGGCTC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2815.44466941	42.9003531433781	0.0152375053253553	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2807.83472274564	2807.83472274564
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCATCGAGAGCATCG"	-3.30196605148967	10.2827071913513	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCATCGAGAGCATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2077.43426015606	43.9923180259371	0.0211762744408731	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2071.01709797975	2071.01709797975
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGTGAGTGCCGTTG"	0.637197275727433	-7.18880751049193	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGTGAGTGCCGTTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2822.94859804984	41.3896309818653	0.0146618436518675	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2820.59205115265	2820.59205115265
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGTACAGCGTACC"	5.52422394332234	-9.78785040294798	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGTACAGCGTACC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2790.09288072556	44.3817012841549	0.0159068902654644	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2779.92756230831	2779.92756230831
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGGTACATGAAGGC"	-2.58305750313457	9.47011659229127	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGTACATGAAGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2329.10216760175	36.6969239347425	0.0157558240446485	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2325.0525782798	2325.0525782798
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGTCCCAGAGATGC"	2.52426447448079	-7.64442016994628	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTCCCAGAGATGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2662.09093860801	34.1883932049031	0.0128426841882344	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2659.98005712343	2659.98005712343
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATTCCTGTCTCACGG"	-4.12205586853679	10.0012321242127	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATTCCTGTCTCACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2746.13004157026	49.1938130544153	0.0179138687206108	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2735.83754907049	2735.83754907049
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACGGGCAGCAGTAG"	-3.79826436463054	12.4493379362854	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGCAGCAGTAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2303.21033099125	35.0842070807467	0.015232741277974	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2301.74081715316	2301.74081715316
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATTTCCCACTTCAAG"	-2.77318320694621	8.56935308063356	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATTTCCCACTTCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3041.9752207636	38.0203045169286	0.0124985582582703	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3022.7968723209	3022.7968723209
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAAAGACATGAGATA"	-3.86968980255778	10.2491512068543	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAAGACATGAGATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2199.27016018422	43.9493658927977	0.0199836139681522	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2194.76236923689	2194.76236923689
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCAGGGTCTCGTTTA"	-3.89409671250041	9.89564130390016	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGGGTCTCGTTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2537.34183419263	41.3082401450351	0.0162801241789241	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2534.49102549615	2534.49102549615
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCAGTGATCGCATTAG"	3.74054636534993	-8.21438600933226	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTGATCGCATTAG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2550.17290759631	41.8158857074882	0.0163972747035816	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2546.03555899013	2546.03555899013
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCAGTGTGGCACTC"	-2.98545465889629	10.1840657957825	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCAGTGTGGCACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2286.11644808138	41.5531519862364	0.0181763059450055	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2272.12781812071	2272.12781812071
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAACCAGTGACGTCC"	-3.42709527435954	9.17932698810426	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAACCAGTGACGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2483.72906678203	43.329579602891	0.0174453728397316	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2474.5182558026	2474.5182558026
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATACTGTAATCAAG"	11.6331945854122	-2.32199432766112	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATACTGTAATCAAG"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2231.17375918643	43.7773874067535	0.0196207880388107	2629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2220.56754393283	2220.56754393283
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCATGCCAACGCATT"	1.26102270659749	-7.09232332622679	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCATGCCAACGCATT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3308.07696408833	38.7551316921969	0.0117153053308351	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3301.62345204228	3301.62345204228
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATACTTCCTTCACG"	-3.28559551659282	9.37344167316285	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATACTTCCTTCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2711.60468438489	43.6288630466652	0.0160896841998789	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2701.8214902908	2701.8214902908
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCATTAGTGCATGTT"	2.31763042983357	-5.30081179058226	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCATTAGTGCATGTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3130.58835325061	33.8625014801282	0.0108166573369404	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3123.63076816011	3123.63076816011
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCATTATCTATGCCC"	1.69520999965016	-5.653027557489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCATTATCTATGCCC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2838.81072987925	45.2122166395897	0.0159264639110029	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2835.91118055044	2835.91118055044
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCAACAGAGATTCA"	-4.45746312561687	10.7460708388123	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCAACAGAGATTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2964.08819927674	42.5099707222939	0.0143416686226363	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2954.30133034715	2954.30133034715
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATCATCACATAACC"	-3.46941695633586	9.58617971027223	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCATCACATAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2546.00602446761	41.7516491783647	0.0163988807477764	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2542.52273183661	2542.52273183661
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGCTGGTCTGCGATA"	5.22340502318684	-9.47900965130004	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTGGTCTGCGATA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.12292222431	31.4601197235749	0.0133242193481133	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2356.46462228377	2356.46462228377
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATCCGCAGACATCT"	-4.09904084625896	10.7526263960632	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCCGCAGACATCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.09714369399	42.08962172056	0.0162627673474751	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2576.79736896413	2576.79736896413
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGCTTCTCGGTCTAA"	-0.937654356390792	8.90689847553102	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTTCTCGGTCTAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2357.45698848131	33.3571444073198	0.0141496301185154	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.64633192222	2353.64633192222
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATCCGGTATTGGCT"	0.782188912003678	-6.96484901821288	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCCGGTATTGGCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3057.56126258586	41.3959856220817	0.0135388900064334	2423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3051.93396896907	3051.93396896907
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGAAGTCCTACGGG"	-4.21472058716472	9.88130567157594	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGAAGTCCTACGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.27928823006	36.8671683630538	0.014366000042217	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.0540327719	2555.0540327719
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATCCGTCGTTGTGA"	-2.74686370316203	9.16823861682741	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCCGTCGTTGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2319.54565480949	44.7156172043507	0.0192777482571358	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2312.12634867577	2312.12634867577
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCTAAGTGAGTGC"	-3.25214825096782	9.34727761829225	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTAAGTGAGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.79494681019	39.1664147701341	0.0154454187312748	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.20023768167	2532.20023768167
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGCGTCAAGTGCTT"	-2.27474437180217	8.73243424976198	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGCGTCAAGTGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.64764357062	43.1926733068607	0.0173558813833884	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2483.89890933997	2483.89890933997
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTAGACGTACGCTAT"	-0.448753754526931	8.75173471057741	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAGACGTACGCTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2783.60724858123	40.288423601295	0.014473458359411	3065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2769.36684845888	2769.36684845888
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCGTAGCTAATGA"	-1.7926096719807	8.58493707263795	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCGTAGCTAATGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2749.61972948964	42.0521068152001	0.0152937900336514	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2740.2748186304	2740.2748186304
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGGAAGTCAAAGAT"	4.35089220580403	-8.72940542614134	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGGAAGTCAAAGAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.54168042448	43.7325191948939	0.0188702190619863	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2314.41425343616	2314.41425343616
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCGTGTGTAGACAAT"	-2.97341595116313	8.91072366321412	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGTGTGTAGACAAT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2287.94760213915	38.7735665901677	0.0169468769974959	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2278.49207679076	2278.49207679076
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGCCTCCGACAGC"	-4.82369695130046	-5.05678083812865	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCTCCGACAGC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3481.7495564457	43.2415111347904	0.0124194777463928	4009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3472.79340359732	3472.79340359732
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGTTACAGAATGTA"	-2.79416785660442	8.76358888233034	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGTTACAGAATGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.49614957698	40.2420915734563	0.0157165210266396	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2550.60434551137	2550.60434551137
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGGACAATCAGCT"	-2.46730623665507	-6.98087122356566	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGGACAATCAGCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1796.63804323411	21.1302139542492	0.0117609743564223	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	1794.80369568534	1794.80369568534
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCCACAGCAAATGT"	-3.08330974999126	9.49360463703004	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCACAGCAAATGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.15670662322	46.637153723159	0.018721083904182	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2478.60655490329	2478.60655490329
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGGAGTATCGATC"	10.4507643180782	7.29617307269899	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGGAGTATCGATC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2432.27498348545	46.1999109068716	0.018994526203064	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2417.18655378755	2417.18655378755
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGTTGTGCCTTTC"	4.55692686614339	-8.6086578599182	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGTTGTGCCTTTC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2870.40297362524	40.4015265259938	0.0140752106576059	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2863.62779184366	2863.62779184366
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATGTTTCCTGGGTG"	0.622168679803055	-6.33653976833495	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGTTTCCTGGGTG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2842.39480283868	41.1803671217283	0.0144879124745802	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2835.91823716509	2835.91823716509
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTACGTCCTTGTC"	1.58247425135915	-5.61795046245726	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTACGTCCTTGTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2957.09742422976	36.2238629832033	0.0122498037049417	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2951.38315519408	2951.38315519408
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTCCTAGCTTAGTC"	-4.29323516312297	10.2727498778137	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTCCTAGCTTAGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2613.36203918212	42.2675771619013	0.0161736401341198	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2604.53517736277	2604.53517736277
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCCTGGTCGGTAAG"	4.88471617278401	-9.05008890545043	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCTGGTCGGTAAG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2821.90647111648	36.5919268468361	0.0129670941334773	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2817.20488399328	2817.20488399328
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTTCTAGTGTTGAA"	4.14926352080647	-8.50178530132445	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTTCTAGTGTTGAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.33544702688	31.7119465690458	0.0121579249345374	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2599.49413386302	2599.49413386302
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCCTGTCGAGTCCG"	-3.81999836388286	9.74807355487672	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCTGTCGAGTCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.47370436282	42.7041678686848	0.0184349892633171	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2311.99676683256	2311.99676683256
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGCCGAGTGGAAAG"	-0.372081081301528	8.59235189044801	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGCCGAGTGGAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2226.37951023432	38.6045061570183	0.0173395892207773	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2221.54640653151	2221.54640653151
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTCAGTTTAGAGA"	-3.89642773094829	10.5614080199036	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTCAGTTTAGAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2375.92683428489	45.2400957347612	0.0190410306756679	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2370.67520543681	2370.67520543681
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGCCGGTACTGACT"	-3.81590614739116	10.0955781706604	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGCCGGTACTGACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.67213994713	44.8850397795813	0.0183904421429392	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2432.78854016841	2432.78854016841
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGTAAGGGAGGGT"	-0.351979474455673	8.46657559955446	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGTAAGGGAGGGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2315.45497815205	41.9383631185183	0.0181123638827947	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2302.74208816653	2302.74208816653
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGGGACAAAGGCAC"	-2.43449173393901	8.96298501575319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGGGACAAAGGCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.9810116808	46.4471778977392	0.0199688551473494	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2319.52968982533	2319.52968982533
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTTGCAATGCTCA"	-4.09892783585246	10.5734767683777	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTTGCAATGCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2479.97258621167	38.9574144985378	0.0157088085227781	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2474.83395167428	2474.83395167428
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCATTTGGTACAAAGT"	-1.80711148205455	8.50922772968141	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTTGGTACAAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2557.64147110176	34.4621448381378	0.0134741891025455	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2548.1871341688	2548.1871341688
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATCGAAGACCTTTG"	-2.74123773995097	8.7050571211609	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGAAGACCTTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2506.98287659025	39.2345791503232	0.0156501185216256	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2498.392810705	2498.392810705
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGACCTGTCACATTG"	-2.49401388588603	8.86260507190553	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACCTGTCACATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2929.84720008133	39.9040573280426	0.0136198424706022	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2917.96949304062	2917.96949304062
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCACCACAGCTTTCC"	-3.87854896012004	-8.45633222973021	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACCACAGCTTTCC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2733.26102818246	38.3146210798691	0.0140179151148792	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2724.62638799233	2724.62638799233
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTACAGCAACAAGTA"	-2.78803620758708	8.84161851489869	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACAGCAACAAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2901.48950402364	38.0928127765402	0.0131287094865293	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2894.04979319675	2894.04979319675
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATCGAGTGCGTGCT"	-2.84037409249004	8.79285047138063	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGAGTGCGTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.59569526376	35.5242890173532	0.0150936242315705	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2347.54523200286	2347.54523200286
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCACGTAGGATTACA"	-3.46628365936931	9.46478936755983	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACGTAGGATTACA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2498.80441279088	46.165357572794	0.0184749784082671	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2488.21046805638	2488.21046805638
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGAGTCTCGGTCT"	-4.40499434891399	10.9106006392273	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGAGTCTCGGTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2567.81246095266	32.3163041667468	0.012585149678243	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2557.62376434637	2557.62376434637
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCAATCAGACCCGCT"	-3.80426822128947	9.38372323596803	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAATCAGACCCGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2460.35327420109	40.3660505936248	0.016406607545712	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2455.32884623873	2455.32884623873
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATTTCCACTATCCC"	-2.83064399185832	8.94793508136598	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCCACTATCCC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2809.64919434043	44.5118672081286	0.0158424999454702	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2802.532195932	2802.532195932
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCAGAAAGGAGCTGT"	-4.10147796097453	10.6008367308411	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCAGAAAGGAGCTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2226.27115517865	40.2595959777694	0.0180838690220279	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2223.14939165844	2223.14939165844
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCATCGAGAGTAACT"	1.9275504547054	-5.56237175380858	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATCGAGAGTAACT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2927.27532107935	40.5037418411882	0.013836669734999	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2922.66135955114	2922.66135955114
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATTTCGTACAGTCT"	-2.83010421219524	8.68995854938356	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0263157894736842	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCGTACAGTCT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3178.53209977483	42.8597854855328	0.0134841442968498	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	3163.8056607375	3163.8056607375
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTACGATCCTGCTAC"	-3.91728887978252	9.83913800800172	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACGATCCTGCTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2639.14671181821	36.6898289742297	0.0139021558786145	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2636.95202720921	2636.95202720921
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCAACAGGTGCGAT"	-2.55480370941814	9.08881471240846	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACAGGTGCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.17975433124	45.9668976988391	0.0187300451883016	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.91648143497	2452.91648143497
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCACTAGGCTTCCG"	-0.649384478957015	8.68548390949098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCACTAGGCTTCCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2874.61650510262	36.2181908666791	0.0125993122221311	2989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2863.33882888807	2863.33882888807
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCAAACCAACCCTCT"	-0.706811468035537	8.64591596210328	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAAACCAACCCTCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2457.71071940208	34.988105777045	0.0142360553261358	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2447.59292527615	2447.59292527615
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACCGTCACAACCA"	-3.15075717392619	9.75069615924684	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACCGTCACAACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2762.25308306396	37.4843077825581	0.0135701931196614	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2755.28969404026	2755.28969404026
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCAACACAACTGCTA"	-3.88070021095927	-8.16751959240111	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACACAACTGCTA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2958.2089019098	44.197508294544	0.0149406312265542	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2949.08184300117	2949.08184300117
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCACAAGGGCAGAG"	-3.84153829041179	9.79586789691774	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCACAAGGGCAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2507.13701782172	41.6078630994598	0.0165957675243494	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2500.14222455091	2500.14222455091
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCACATCAAAGGAT"	-2.06944165650066	8.5457496413025	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCACATCAAAGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2553.96409453036	42.0692870785734	0.0164721529048393	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.92792781115	2539.92792781115
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCAACACAAGTTGGG"	-4.03822884979899	9.99470040881959	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACACAAGTTGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2587.13688607465	43.2552847581343	0.0167193645573828	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.0311252961	2586.0311252961
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCACATCAATCCGA"	-2.80724106255229	8.94089601123659	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCACATCAATCCGA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	3208.44275166966	44.1793550576555	0.0137697189811677	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3203.40702255187	3203.40702255187
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCATTAGATCACTC"	-4.46445641937907	10.6819324263367	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTAGATCACTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2944.44174103398	39.7185856733932	0.0134893433685142	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2932.37612065388	2932.37612065388
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCACAAAGCGTCGAA"	-4.03298364105876	10.3801431425842	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCACAAAGCGTCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2274.79818345729	38.307238399582	0.0168398404210794	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2270.77579880344	2270.77579880344
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCATTGTATTGACC"	4.22779860076253	-8.36708357250365	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTGTATTGACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2967.50304447516	36.5780271339478	0.012326197003251	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2958.9207589535	2958.9207589535
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCATGGTATCTTCT"	-3.84841928902324	10.3363322981629	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCATGGTATCTTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2376.42918409981	42.2738003113059	0.0177887902547869	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2371.93762635316	2371.93762635316
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCCATGTCGCCTTGT"	0.39585848626439	-6.3932996026245	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCATGTCGCCTTGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3087.97368721267	46.2457079347627	0.0149760692995107	2653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3074.2628404874	3074.2628404874
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTAGTGAGCCA"	-0.438993911177474	8.50767610156862	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTAGTGAGCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2349.0747875331	39.1141715461786	0.0166508838942734	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2342.79953829332	2342.79953829332
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCATTTTCTATGCCC"	-0.450482170016128	9.10231206500856	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCATTTTCTATGCCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2543.09476426806	38.5429909297617	0.0151559397122407	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.40159410899	2532.40159410899
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCCAAAGTATCTCTT"	-4.1669524711674	10.1616382368836	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCCAAAGTATCTCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2541.94575392403	39.4160693777991	0.0155062590603879	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2540.77914253016	2540.77914253016
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTGTTACGGAG"	-3.9559477371281	9.79878900134889	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTGTTACGGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2723.41133191662	38.0381802624014	0.0139671080224344	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2717.82081206651	2717.82081206651
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCGATCTCACGGACC"	-2.1202441257542	9.52068708026735	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGATCTCACGGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2285.21993870548	42.4735227063269	0.0185861859451424	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2274.35067522745	2274.35067522745
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCGCTCATAACTCG"	-4.42689738693889	10.9986676939758	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCGCTCATAACTCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2884.2474141698	44.7406777266505	0.0155120803807771	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2878.16622022703	2878.16622022703
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGGTACAGTAA"	-0.630995015532333	8.40959642017213	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGGTACAGTAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2519.65966324835	44.7713665251403	0.0177688150420367	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2509.0832740031	2509.0832740031
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCGGGATCTAGAACC"	0.190541570156258	8.9109954603943	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGGGATCTAGAACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2022.24885413056	39.916677801842	0.0197387565433947	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2013.53192277664	2013.53192277664
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCGTGTGTCATTCCC"	-2.51214824143108	8.98070046985475	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGTGTGTCATTCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1997.88527649281	45.6663019107735	0.0228573194107213	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	1989.41236534329	1989.41236534329
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCTACCCAGACCATT"	-4.39980874481853	10.6363277205261	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTACCCAGACCATT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2716.89518003388	35.5079663083081	0.0130693177157705	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2708.7485980947	2708.7485980947
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCGTATCGTAC"	-2.49894390526469	8.76214120471803	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCGTATCGTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.74616988014	43.8980971660756	0.0176103358201876	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.20080764317	2485.20080764317
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGAACAGCTGTCCG"	-4.10690293732341	9.78121087634889	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGAACAGCTGTCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2507.52245473053	35.6096840148891	0.0142011426249485	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2503.83537407647	2503.83537407647
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTAATCAGAGTGAC"	-3.86410437050517	10.8112048872742	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTAATCAGAGTGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2273.0017079851	42.9996851813094	0.0189175771537041	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2267.05051093403	2267.05051093403
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGAACTCATACGGT"	-3.69209633293803	10.8599910506043	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGAACTCATACGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2246.16458488985	44.8055299781133	0.0199475720877821	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2238.31204709264	2238.31204709264
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTAATCATAGCTGT"	4.78780712661092	-8.24166109478148	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTAATCATAGCTGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2975.48687143785	32.2719042615723	0.0108459239297458	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2975.48687143785	2975.48687143785
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCTGTCCAGCTACAT"	-0.478847364813644	8.47359273517457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGTCCAGCTACAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2598.23424675516	39.7624451004978	0.0153036413672692	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.15071317162	2592.15071317162
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACCGCTCGAAGCCC"	0.798209567635697	-6.78336384212645	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCTCGAAGCCC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3122.78225481661	44.4844702733809	0.0142451399564499	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3116.16875289078	3116.16875289078
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCCCGTGATTGGG"	-7.37806830826457	1.70093927467195	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCCCGTGATTGGG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2340.95134317527	48.9101666012034	0.0208932862888392	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2333.70122961396	2333.70122961396
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCGAAGTAAGCAT"	-7.13027129593547	1.76706109130708	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCGAAGTAAGCAT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2854.75426987036	38.469652349193	0.0134756440353586	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2842.24868061871	2842.24868061871
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCGAAGTAGCCAG"	-2.97843633118327	9.05944345081178	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCGAAGTAGCCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2460.91197208948	41.8079207365659	0.0169887916393321	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2456.06235886143	2456.06235886143
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCTCTACAACCAATC"	-4.37406764450725	10.5696925886902	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTCTACAACCAATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2683.55086358404	39.18697198687	0.0146026566958875	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2672.92556701735	2672.92556701735
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCGAGTAGCGAGT"	-2.76908121529277	8.75330159747926	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCGAGTAGCGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2304.89398426924	43.4423730638989	0.0188478833995795	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2298.88994688188	2298.88994688188
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTCCAGGGACCAT"	-1.29784868183787	-9.49418833171996	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.444444444444444	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTCCAGGGACCAT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.80769536674	47.3465667696237	0.017299924598202	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2734.02764176954	2734.02764176954
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCTTAGTGGATTA"	-0.0165362385218919	8.76582429492799	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCTTAGTGGATTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1996.52381219514	34.7859278124238	0.0174232471458367	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1980.17870791482	1980.17870791482
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTCTTGTAACATCC"	-4.46515403214152	10.2038936384949	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCTTGTAACATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2981.30975002877	38.9170552901726	0.0130536772604045	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2967.51035753098	2967.51035753098
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGAAGCATCCTTGC"	-2.76038203659709	9.26416013324586	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGAAGCATCCTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2461.38349409144	42.4977593353094	0.0172658017075866	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2450.38469287565	2450.38469287565
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTGCAAGCCTCTCT"	-3.03830228272136	9.09038922870485	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCAAGCCTCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2804.75902807618	40.2594000017627	0.0143539603933024	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2796.88661502699	2796.88661502699
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTGCACAATAGGAT"	-4.25260148468669	9.98660752857057	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCACAATAGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.33668675673	34.9596645040352	0.0134701846902656	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2588.30273262503	2588.30273262503
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTGCACATCAGCAT"	-0.658428768545944	8.81190297687379	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCACATCAGCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2503.31457569859	40.2683667346448	0.0160860193623118	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.84000561787	2495.84000561787
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGGTCAGAGCTGCA"	4.65725817260091	-7.46509268200072	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGGTCAGAGCTGCA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.99440492649	39.2424152465369	0.0182523336603188	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2148.269559836	2148.269559836
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCACGTCGGAATTC"	-3.46997080269511	9.8505649336609	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCACGTCGGAATTC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2548.51019092568	41.4699370191795	0.0162722272670672	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.32436078903	2537.32436078903
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCCTGCAGTGATCATC"	-4.02636275711711	10.4775066145691	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCAGTGATCATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2628.88606095016	43.96441570879	0.0167235911673174	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2624.10237403716	2624.10237403716
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCGAAGGCTATCT"	-2.15879712525066	9.01745030963746	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGAAGGCTATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2286.56853902872	42.6798010977055	0.0186654370377346	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2278.27685851616	2278.27685851616
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGAGTCAGGTAAGAG"	-4.02909121933635	10.4266671904358	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGTCAGGTAAGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2553.48870920333	40.3051622204874	0.0157843510626143	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2547.58322641423	2547.58322641423
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTTGGATCTGTGCGG"	-3.93669496002849	10.1465186842713	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTGGATCTGTGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2443.57482387819	47.9820244496866	0.0196359955835257	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.13886370886	2437.13886370886
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGTGGGAGGCGCTCT"	-4.04236684265788	9.64879796588746	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGGGAGGCGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2697.98451738448	35.6413155611554	0.0132103484402895	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2690.58638804945	2690.58638804945
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTAGTCTTCCCTCGAT"	-4.04251275482829	10.1158313521179	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"IFN+ NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGTCTTCCCTCGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2249.62455398937	40.8867231260498	0.0181749096992844	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2241.43478660402	2241.43478660402
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTAACAGACTGAGC"	-4.34113059464152	10.1387309798035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAACAGACTGAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2337.6931304638	31.5888972888381	0.0135128502869711	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.28981271332	2336.28981271332
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGGAACAAGAGAGA"	-4.30908713761027	10.8264798888001	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAACAAGAGAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2549.21825978622	39.659070435354	0.0155573459758129	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2537.9165574035	2537.9165574035
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAACGACTCCGCATAA"	-4.44138703766521	10.6155166395935	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACGACTCCGCATAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3025.37322715238	38.9999987608528	0.0128909710745214	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3009.95388748082	3009.95388748082
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGAAGTAGTACAGAT"	-0.539109925658065	8.05274913394777	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAAGTAGTACAGAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2230.18362004243	38.1541966116683	0.0171080965122246	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2218.77554415574	2218.77554415574
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAACTTCAGATAGCTA"	4.53813566741292	-8.75746252453002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACTTCAGATAGCTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3274.2750756064	40.5527229731446	0.0123852523189837	3061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3266.60055733864	3266.60055733864
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGAAGTCACTGCGTG"	0.00367787954155799	8.38705155933229	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAAGTCACTGCGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2055.90666853771	38.9154368294471	0.0189286009063467	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2048.76602442711	2048.76602442711
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAACTTCGTACAGTCT"	-5.0333174270695	-5.273952507135	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACTTCGTACAGTCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2998.54993229079	45.5537643433875	0.0151919312240987	2576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2981.47758998556	2981.47758998556
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGAAGTTCAAGTGTC"	1.74233915385548	-5.48290159618529	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAAGTTCAAGTGTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2878.47950103654	41.7704236019024	0.0145112805517152	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2868.99261963963	2868.99261963963
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACCTAGTTCCATG"	-0.334400127560455	8.91105744922487	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACCTAGTTCCATG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2502.12122138283	34.7439435619289	0.0138857954862504	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2490.51844366174	2490.51844366174
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACCTTCCCGATCT"	-4.30915484848674	10.0019664534363	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACCTTCCCGATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2777.45741149884	39.4193423271481	0.0141926000967466	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2767.75146867935	2767.75146867935
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACCTTCCGGACTG"	-3.71869764748271	9.56319043720094	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACCTTCCGGACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.77641808582	37.3952826352521	0.0148113244275323	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.24953753126	2515.24953753126
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTCCTTCTGTCAGA"	-4.32592139664348	9.89332769000856	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTCCTTCTGTCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2788.83829419827	38.438313371951	0.0137829122082538	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2784.17921369896	2784.17921369896
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGATCCTCACCCATC"	-3.81089077416118	10.0183181532654	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGATCCTCACCCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.70336647067	47.2180535222519	0.0193460844815938	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2432.64959247488	2432.64959247488
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACGGGTAACCCTA"	-2.05469308319743	8.53475854480592	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGGTAACCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2437.6365772773	41.906173287055	0.0171913129617795	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2428.90509704544	2428.90509704544
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACGGGTGTCATGT"	-2.91834841194804	8.89987943256227	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGGTGTCATGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2315.05159746633	43.0541387025531	0.0185974855807417	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2311.05813273819	2311.05813273819
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACGGTCGAAGAAT"	1.24988808211629	-5.77638056194457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGTCGAAGAAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2890.67125425278	49.9880007401013	0.0172928694906273	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2886.03305358433	2886.03305358433
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGACGGTCGTGGTAT"	-2.17074737969096	8.63481137836305	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGTCGTGGTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2358.62568480711	39.5218085436074	0.0167562868488136	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2354.56027415859	2354.56027415859
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGTCGTCTTTACAC"	-2.38973842087443	8.73198411548463	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGTCGTCTTTACAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2611.93660029128	43.9174324837526	0.0168141265292791	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2603.59286642868	2603.59286642868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAATTCCAGACCAGAC"	-4.0997818512028	9.80437085712282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAATTCCAGACCAGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2760.2526887612	36.23217292999	0.0131263971148421	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2755.69111205684	2755.69111205684
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCACTCACATAGCT"	-2.81619844856914	8.89312837207643	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTCACATAGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2519.82475892369	40.6615342663973	0.0161366516153153	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2515.82321200239	2515.82321200239
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCATCTCAACGAGG"	-3.57578907433208	9.48267839038698	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCATCTCAACGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2574.34597718468	43.069765496528	0.016730371860751	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2566.03295974471	2566.03295974471
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTTCAATCCTACTGC"	-7.32437787476237	1.44976542079774	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCAATCCTACTGC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3086.05716645499	43.1840111391543	0.0139932635106564	2506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	3075.52301501995	3075.52301501995
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCATAGCGGACAT"	-3.2558458847111	9.31181237781373	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCATAGCGGACAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2522.54984683052	48.5197949733701	0.0192344246573891	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2517.20775820191	2517.20775820191
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGACCCTCCTCCACA"	10.6112791496212	7.56089351260988	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGACCCTCCTCCACA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2845.71459484067	36.1603111966801	0.0127069352851616	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2830.08188076298	2830.08188076298
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCACTTCCTACGAA"	4.62569393691365	-8.87372782146605	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTTCCTACGAA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.24901843314	45.3396399173347	0.020302097770156	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2231.5554214625	2231.5554214625
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCAGGGTGTTAAAG"	-0.647900323302108	8.33419988239137	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCAGGGTGTTAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2322.03782159395	41.8018369544595	0.0180022205347908	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2315.99210210615	2315.99210210615
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACAGGTTCCTAGCGG"	-2.37964377823527	8.63504598224489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACAGGTTCCTAGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2574.35814881308	40.7089495937603	0.0158132424629919	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2566.67178900494	2566.67178900494
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTTCGGTCGCGCCAA"	-3.71423993530925	9.90808580005494	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCGGTCGCGCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2203.07039946238	41.1234412739888	0.0186664217739135	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2201.39109212989	2201.39109212989
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCCCTCAGTCATG"	-0.666783372790176	8.44739530170289	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCCCTCAGTCATG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2426.76381453216	32.0146900207331	0.0131923386318108	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2416.60980939915	2416.60980939915
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTCACACTATCGA"	-1.46949932995494	8.50077817523805	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCACACTATCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2513.49265123674	39.650183830411	0.0157749352523078	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2506.00353944726	2506.00353944726
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCCGTCAATCGAAA"	-3.45653877678569	12.6661720045838	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTCAATCGAAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2991.39711519978	41.0471972756173	0.0137217479642036	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2981.34223985206	2981.34223985206
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCTCAAGATTAGCA"	-2.44618473473247	8.75414369190065	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCTCAAGATTAGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2541.02943478944	41.3473235555035	0.0162718790224992	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.1323474134	2536.1323474134
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTGTTGGGTTT"	-3.72389588776286	9.59946820819703	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTGTTGGGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2495.8027873561	39.838232190895	0.0159620913930853	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2491.34771055394	2491.34771055394
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCCGTCAATTCACG"	-0.732216100127059	8.39787671649782	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTCAATTCACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2659.25405713951	37.5284413276996	0.0141123941230602	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2647.23315145889	2647.23315145889
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTCTCGGTCTCGGAC"	-2.5172532600468	9.07392022693483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCTCGGTCTCGGAC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2429.37359738561	49.1253569186507	0.0202214089144286	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2422.66649201311	2422.66649201311
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTTGGTAGTTAGA"	-3.71932087364848	10.1066608198914	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTTGGTAGTTAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2429.79933982617	39.395411231899	0.0162134422321135	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2424.8646095998	2424.8646095998
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGTCAGTCAGCGTCG"	-4.150373796851	10.0992135771546	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGTCAGTCAGCGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2474.18889365682	42.3208040883817	0.0171049204031597	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2466.11432165764	2466.11432165764
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGCTTGTCGTTCGCT"	1.78363217887227	-5.52227117931517	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTTGTCGTTCGCT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2765.83494534807	44.9998860582475	0.0162699101527855	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2759.70124290872	2759.70124290872
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCCACAATGAA"	-2.55506978455241	9.14776036823121	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCCACAATGAA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2730.91727846471	43.4715868207662	0.0159183096330202	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2718.89084024773	2718.89084024773
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCGGGAGCCTCTGG"	0.230657880275887	-6.41222002422484	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGGGAGCCTCTGG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2859.53304597259	50.2434941786111	0.0175705240578964	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2851.52473537466	2851.52473537466
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGACTCATGAGAA"	-4.39226947251018	10.766182876471	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGACTCATGAGAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2600.94158695014	43.9865533239518	0.0169117805431111	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2595.54412727563	2595.54412727563
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTATTAGCTCGGCT"	-3.9630368751591	10.2100543745789	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTATTAGCTCGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2502.6315883434	44.8444030234351	0.0179188991429296	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2493.45159684837	2493.45159684837
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCAGAGGTTAT"	-0.360969851643401	8.95860002124635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCAGAGGTTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2572.41247202862	37.070183462857	0.0144106685323381	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.10583404046	2562.10583404046
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCTGCAGGACAGTC"	-3.30712304535564	13.5140266188416	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00224592925322852	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCTGCAGGACAGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2523.65604840476	49.0853094191927	0.0194500789638985	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2517.49960974958	2517.49960974958
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGGTACCGTCG"	-4.11208234253581	10.3488626250061	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGGTACCGTCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2403.88473926105	37.4304348706275	0.0155708109708012	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2401.00389361872	2401.00389361872
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGGTCGAGTTT"	-4.319168428809	10.3652066954407	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGGTCGAGTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2196.90349839154	41.3855436509541	0.0188381254257433	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2192.60121485248	2192.60121485248
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGTCCAACACA"	1.98024251040761	-5.81205704128417	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGTCCAACACA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3264.07006801399	42.4908074524679	0.013017737538435	2964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3258.05003446234	3258.05003446234
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATGCGTACGCGTC"	-4.28072867813762	10.753071761969	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCGTACGCGTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2680.13962587473	43.1499905876721	0.0160999039643649	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2674.67253168726	2674.67253168726
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGATGTCGCAGTGC"	-2.87466583672221	9.09549520099489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGTCGCAGTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2520.15150090762	43.4373830158918	0.017236020532991	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2509.55133519881	2509.55133519881
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAGATAGTCGGCAA"	-4.24393544617351	9.84112641895143	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGATAGTCGGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2775.64327872157	38.4540373173575	0.0138540991964461	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2765.45390717109	2765.45390717109
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGGTCTTCGAACCTA"	-3.61741886559184	9.97727773273317	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGTCTTCGAACCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2467.5621774794	42.6260000129425	0.0172745393822192	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2457.18135857071	2457.18135857071
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGTCCTCAGAA"	-0.40095360103305	8.4616718062195	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGTCCTCAGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2195.25089262326	38.9727966107783	0.0177532311872594	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2192.43658477424	2192.43658477424
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGACTCCAGCGCGTTC"	-4.27405009689982	10.6052884825501	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACTCCAGCGCGTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2673.41519737872	40.8845038813189	0.0152929870083054	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2670.84936116572	2670.84936116572
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTCCATTCTTCCCGA"	-2.74065528336223	8.67499253833619	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTCCATTCTTCCCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2734.33793405942	36.7408660539067	0.0134368417291278	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2729.14292002691	2729.14292002691
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGATGTTCGTGGGTC"	10.0643812614376	7.44668767536012	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTTCGTGGGTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2241.31031470442	47.1029801016399	0.0210158226607955	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2237.91593762018	2237.91593762018
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACATTTCATCGCCT"	-3.41152558746989	9.21588418567506	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACATTTCATCGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2947.86380106437	39.4889154136266	0.0133957733730332	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2938.21448910492	2938.21448910492
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCGTGGGGTACAGGTG"	-3.81664119187053	10.4010429152283	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTGGGGTACAGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2075.8670958097	40.9969150638739	0.0197492966416922	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2074.15191831976	2074.15191831976
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCATCACACCAGC"	4.08690514144246	-8.33059980785521	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATCACACCAGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2927.56370844447	36.5245533228735	0.0124760917132288	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2924.07741467749	2924.07741467749
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTAGTCAGTAGAAT"	-3.36479435387309	10.1729993590149	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTAGTCAGTAGAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.12435621556	40.0429870845043	0.0171481176057794	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2331.78119562043	2331.78119562043
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGACTGTGGTCCCA"	-2.92708907547649	8.9979095228943	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTGTGGTCCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2735.28446946807	45.0539747927549	0.0164714037225959	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2723.5983584297	2723.5983584297
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCATGTCAAGCCC"	-3.32450352135356	11.1547622450623	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATGTCAAGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2402.45901866909	42.6430886717423	0.0177497673593473	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2392.86739883858	2392.86739883858
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTCTCCACAGCCAC"	-3.57358036461528	11.0716037520203	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTCTCCACAGCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2977.18969958755	42.4475320230485	0.0142575839318969	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2966.66027544813	2966.66027544813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTCAAGGTACAAT"	-4.14102826538737	9.73096273029176	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTCAAGGTACAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2773.09761749806	40.0029373861306	0.0144253621414965	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2763.92031999618	2763.92031999618
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTATACCATCGGAAG"	-0.521549801260787	8.14179132068483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTATACCATCGGAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2396.97739806425	35.5299925535259	0.0148228316972113	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2382.07813028273	2382.07813028273
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTCAGTGATACCT"	-2.63127670708354	8.46567819202272	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTCAGTGATACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3130.72727533778	36.0720248399726	0.0115219313812892	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3115.74319532037	3115.74319532037
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTGGATCTACGGTA"	-0.969230751425582	8.571825958136	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTGGATCTACGGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2542.52393994509	42.2838950110674	0.016630677236408	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2534.89589529649	2534.89589529649
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTTCCGTCTTAGTG"	-2.7771295112675	8.95155236804811	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTCCGTCTTAGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2494.21250856537	46.2271467861739	0.0185337643153602	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2487.7697395929	2487.7697395929
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTGTGTAGTTAGA"	5.05864204940144	-8.85859491741332	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTGTAGTTAGA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.83712660945	38.1633786113095	0.0142303118383472	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2676.30369256606	2676.30369256606
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGAGCATGAGAAT"	2.79990329322163	-7.77059128200682	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGAGCATGAGAAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2859.95722917758	47.8651994880287	0.0167363340261536	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2850.64198882347	2850.64198882347
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTTGAGTCGGCCTA"	4.94178785857503	-8.91394712841185	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTGAGTCGGCCTA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2519.95214864283	42.8336279380425	0.016997794168874	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2515.56630287203	2515.56630287203
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTAGCGTGCCT"	-0.621163288981277	8.94767949664918	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTAGCGTGCCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2506.36151267638	36.7991541332952	0.0146823009957569	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2494.85667915956	2494.85667915956
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCAGCTCACTTGTT"	-2.3718777698582	8.9739084013733	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCAGCTCACTTGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2627.0232784018	44.6292476645954	0.0169885238671149	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2619.38416180578	2619.38416180578
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCAGCTCAGAGCGA"	-1.02534625950511	8.86634538257448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCAGCTCAGAGCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1980.2247283196	41.754598019015	0.0210857875986872	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1965.00267672553	1965.00267672553
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGACCAGTGAATAAC"	-0.555158416659194	8.65340802753297	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGACCAGTGAATAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2322.93918847192	35.9320945615915	0.0154683750396533	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2312.97318513568	2312.97318513568
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACACGCGTTCGAACT"	-0.618459026247817	8.80494401538698	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCGTTCGAACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2737.40578615305	38.4958737675562	0.0140629036302489	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2726.1283776307	2726.1283776307
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGGACAGAGCTAG"	-2.89843807640727	8.8068170317444	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGGACAGAGCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2648.76855296313	36.4814413323462	0.0137729818981485	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2644.17537659472	2644.17537659472
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGACCCGTAACCAGG"	10.3388391929561	7.53373191440431	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGACCCGTAACCAGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2537.60351680694	45.814748768377	0.0180543368831809	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2519.80972956631	2519.80972956631
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTCTGGGTTTCCAAG"	-4.32266555252727	9.9645204314026	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCTGGGTTTCCAAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2737.88832089838	40.2994814176056	0.0147191837994262	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2730.2303108171	2730.2303108171
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTGAGACAACGATCT"	-4.29439721527751	10.0525541075501	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTGAGACAACGATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2569.6735073982	39.2349507008391	0.0152684574860892	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2565.79520676007	2565.79520676007
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTGCCAAGATGATTG"	-3.43241749230083	10.0384740599426	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCAAGATGATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2385.04533343682	41.4341813757349	0.0173724921681169	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2378.44179235067	2378.44179235067
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTGATTCACGAAAGC"	-3.89861283722575	9.56336114490358	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTGATTCACGAAAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2823.26334599921	39.4068608613887	0.0139579118317926	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2819.81083755691	2819.81083755691
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTACTGGTGAGTAAT"	-4.11318192902263	10.9960078963074	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACTGGTGAGTAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2724.61288035246	40.412080244641	0.0148322282905061	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2719.9723957675	2719.9723957675
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCATGTCCTACACC"	-0.684037963778335	8.38743684375612	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCATGTCCTACACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2700.62604972431	28.3161973189953	0.0104850493173188	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2693.83778918267	2693.83778918267
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTGCCAGTACAGAGC"	-1.14499364319499	8.63395879352418	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCAGTACAGAGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2493.92596831365	37.2961979096597	0.0149548135684552	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2481.37767286789	2481.37767286789
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTGTTCGTTAAACAG"	-2.72816381874736	8.57331845844118	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGTTCGTTAAACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3102.34444869493	42.391241950676	0.0136642602559844	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3090.29436328919	3090.29436328919
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTGCCAGTATCAAGA"	1.80078472670857	-5.5273328057495	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCAGTATCAAGA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2653.23171564128	39.4200931168622	0.0148573880239987	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2648.65713621728	2648.65713621728
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACTCAAGCTCGTGC"	1.80660774287526	-7.61299564754637	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACTCAAGCTCGTGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2495.89907185151	39.0544811685523	0.01564746011127	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2490.7388416351	2490.7388416351
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACTCAGTCTAGTGT"	-3.77754912796672	11.8463735350403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACTCAGTCTAGTGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2764.24934581395	37.9715031493209	0.013736641814467	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2753.17559402252	2753.17559402252
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACTCAGTGTATTGC"	-4.19746718826945	10.6310415037903	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACTCAGTGTATTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2628.40012635892	39.0828223249523	0.0148694340458327	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2623.3310575196	2623.3310575196
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGCACAAAGTA"	-3.16547689858134	9.87371060932008	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGCACAAAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2512.38714218159	42.3572021193999	0.0168593452053014	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2504.45814964145	2504.45814964145
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTAAGCGTATGAAGT"	-4.04584632340129	9.85459992969362	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAAGCGTATGAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2608.71166095391	39.0743604881907	0.0149784129357948	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2604.19578754788	2604.19578754788
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGGTCCGGACT"	-4.08788047257121	11.7939719923767	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGGTCCGGACT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2709.81280092221	41.4248063697037	0.0152869623892861	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2706.64716732261	2706.64716732261
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGGGTTAGCTGTTAC"	10.7782570320064	-2.33464052593382	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGGTTAGCTGTTAC"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2453.35214898701	42.6384771119517	0.0173796807480561	3571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2448.51978896192	2448.51978896192
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TCTTCCTAGACAGCGT"	9.97183765944783	0.238915688637175	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Ery"	"Ery-3"	55	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00833333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTCCTAGACAGCGT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1312.01736134458	37.3258224489628	0.0284491833329938	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1303.26436097573	1303.26436097573
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTCTGGTGTTCATG"	-4.36013493958171	10.5654916533264	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCTGGTGTTCATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2941.5891566347	40.5050259215355	0.0137697767311173	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2939.11953707149	2939.11953707149
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAAGAAAGAATTCAG"	-4.43595061722453	10.7538051375183	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAAAGAATTCAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2468.51403473539	38.7457697385557	0.0156959892442779	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2457.71627817697	2457.71627817697
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATGGTCATCAGCTA"	-3.9392560524052	10.0168151625427	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTCATCAGCTA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2522.85747137457	43.422087454007	0.0172114707020483	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2513.8211778122	2513.8211778122
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGGTTGCAGATCCTA"	-4.19103084030803	10.677219367865	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTTGCAGATCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2292.87856212113	41.2383744007994	0.017985415835826	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2290.23674125166	2290.23674125166
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGGTTGGTGGACCTC"	2.36145820197408	-4.85809042369994	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTTGGTGGACCTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2889.17525606842	44.5851742805229	0.0154317998490664	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2885.90617085945	2885.90617085945
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAAGAATCACGGGCT"	-7.53907857361491	1.21808490836946	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAATCACGGGCT"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2698.71052239827	42.3739933591537	0.0157015704379798	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2687.70368870386	2687.70368870386
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTTCTTCCACCCTA"	0.939028878777665	-6.12445690548094	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTTCTTCCACCCTA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3016.44802801258	40.6349942547302	0.013471140187853	2880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3011.80410875401	3011.80410875401
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAGGATCCATCCGT"	-3.51017508927043	12.3123721846375	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGGATCCATCCGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2725.22050731841	39.5921342723439	0.0145280479748416	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2717.84986333067	2717.84986333067
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGGGTAAGCTAAACA"	-4.51805816116984	10.6867494353089	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGGTAAGCTAAACA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2456.62904179511	41.8912637457182	0.0170523359583453	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2451.62424191349	2451.62424191349
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATTCTTCATGGCCG"	-4.17060838165935	9.92055795276491	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTCTTCATGGCCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2848.58711003198	39.403353526184	0.0138325956006105	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2842.74898930581	2842.74898930581
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACGTTACACTACTTT"	-4.19326863709148	9.8237209090027	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGTTACACTACTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2632.60931853846	36.4047797032895	0.0138284019003246	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2630.27626753835	2630.27626753835
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGGTTTGTGCAGGAT"	-3.1084934276646	9.71798608386842	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGTTTGTGCAGGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2425.57459227349	50.5496225364259	0.0208402671669832	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2419.89254692066	2419.89254692066
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGGTTTTCGACATAC"	-3.70567117157634	9.79251573169557	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGTTTTCGACATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.78299708986	38.4400126830604	0.0151054187044708	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.5241425775	2537.5241425775
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCACGGCAGAGAAAG"	-0.514635245234329	8.76238153064577	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCACGGCAGAGAAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2235.9472250752	39.0154711294483	0.0174491914173583	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2228.80028865307	2228.80028865307
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTGGACACCAGCTG"	2.45570673522298	-5.70909311687621	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGGACACCAGCTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1912.12682992735	41.1398243151326	0.0215152173335153	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1910.11038850907	1910.11038850907
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCAAGTAGTGCGA"	-4.28590522232707	10.3383369215759	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCAAGTAGTGCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2608.9000183922	40.2646703778165	0.0154335812388206	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2600.87497928535	2600.87497928535
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTACTCGACACCG"	-4.21495042267497	9.81830880725709	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTACTCGACACCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2726.97568315902	38.4846005804196	0.0141125572985813	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2715.67307891663	2715.67307891663
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGACTTCTGGCCGA"	-0.288879553706008	-7.20977260982665	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTTCTGGCCGA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2659.37997303456	41.2354548527249	0.0155056649560582	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2656.60007418007	2656.60007418007
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTATCCGTCAGAGTTC"	-2.61155710640605	8.75734040820924	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCCGTCAGAGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2637.77889196463	43.0903080383669	0.0163358301825947	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.84294240489	2628.84294240489
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGTCATTGCCC"	-7.4481614631718	1.15239486778108	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGTCATTGCCC"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2711.14717872101	51.0465170287647	0.0188283828445072	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2703.01687805646	2703.01687805646
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTACTGTCTTTACAC"	10.2232138114864	7.83084867084352	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACTGTCTTTACAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2321.34831441684	42.671094338577	0.0183820299924687	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2313.64601067043	2313.64601067043
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTCACAGAGTCTT"	-3.69337377968486	9.7785024412903	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTCACAGAGTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2385.7703201777	45.9208226413001	0.0192477969287	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2382.1174675357	2382.1174675357
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCGCCAGACCAGAC"	-3.98214517059978	10.6094655760559	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCAGACCAGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2743.29787557485	45.9781332766377	0.0167601680029017	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2736.51083505578	2736.51083505578
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACGATCAGTTGCGC"	-1.59224353256877	8.52183435046998	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACGATCAGTTGCGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2544.91030382	39.5894303804636	0.0155563165904269	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.36969302738	2536.36969302738
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCATGGCATTCATCT"	9.14990105208699	8.06443593585817	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00230237912509593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGCATTCATCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2457.66165071735	39.0935497127499	0.0159068070665216	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2450.30089961089	2450.30089961089
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTGTGTGCGAACA"	-2.252588848502	9.00429818713991	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTGTGTGCGAACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.06640261189	43.3056169198215	0.0187546000716292	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.34811367571	2306.34811367571
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGAAATTCGCCTAGG"	3.82182135161702	-8.18719675457152	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAAATTCGCCTAGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3250.35741835874	38.9449725091557	0.0119817507727568	3293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3244.276650116	3244.276650116
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTTGCACCCTGAG"	10.642573972314	7.42469451511232	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTTGCACCCTGAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2274.1331239487	40.1633090987769	0.0176609314009899	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2269.36653765941	2269.36653765941
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCTGTCGTAACGGTG"	-0.722525934607345	8.56473825061647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTGTCGTAACGGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2458.14746507876	46.3676433607658	0.0188628404192505	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.979420898	2452.979420898
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGCCAGAAGGATTTCC"	-4.53062806549724	10.3534898527893	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCAGAAGGATTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3041.90516972918	40.7499203750885	0.0133961836748239	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3035.67076149523	3035.67076149523
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGTTTGTCGCGTTTC"	-3.69039164009746	9.80321500385133	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTTGTCGCGTTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.72243821889	40.5351532686003	0.015390822009328	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2633.72243821889	2633.72243821889
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCTGTCACACCAGC"	-1.37677965584453	8.533740020636	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTCACACCAGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2599.20034837071	39.7206661748971	0.015281879367166	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2589.83098472863	2589.83098472863
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGACGCGGTACGTAGG"	4.50672354277913	-8.60934259807738	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACGCGGTACGTAGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2933.99174409729	39.8672871512645	0.0135880706656626	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2933.04336147402	2933.04336147402
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGACGCGGTGGCTCTG"	-2.7744976085728	8.7993125685486	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACGCGGTGGCTCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2673.92162538891	40.0475504545167	0.0149770846214283	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2665.5180538826	2665.5180538826
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACGTAGGAAAGTG"	-3.90782628479655	9.64027116382448	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACGTAGGAAAGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2389.62518537441	38.6690893284596	0.0161820730569513	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2383.65974306625	2383.65974306625
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGACTGTTACCCTC"	-2.11748228493388	8.61249539935914	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGACTGTTACCCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2347.00256214436	41.0775551852044	0.0175021347857727	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2336.77170944127	2336.77170944127
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCTTGGTGTCCACG"	-2.62406287613567	8.7671851881775	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTTGGTGTCCACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.88297948206	42.370323724474	0.0166492227996657	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.05997001577	2536.05997001577
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGAACCAGTATCTGC"	0.615253110497636	-7.05959656154784	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAACCAGTATCTGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3041.49202751045	41.6272101704411	0.0136864439537967	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3036.34212817108	3036.34212817108
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCTACAAGAGCCGTA"	-3.15792689743693	9.12145898425905	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTACAAGAGCCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2553.68833928714	38.4842906000508	0.0150700811872735	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2550.03746758646	2550.03746758646
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGAATTAGTAGACCG"	-4.04108224335368	9.86945054614869	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAATTAGTAGACCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2735.94851264349	42.4176337098341	0.0155038128509406	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2728.83553797995	2728.83553797995
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCTTGTCCTATGGA"	-2.81375394287761	8.82820222461549	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTTGTCCTATGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2671.50861030913	37.853662935405	0.0141693958197742	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2667.89759799015	2667.89759799015
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGACACCAGGTAGTG"	-0.469385902315933	8.3179311522278	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGACACCAGGTAGTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2260.54019777202	43.1118798435388	0.0190714944534186	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2250.08414004353	2250.08414004353
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATGTTCGTATTGACC"	-0.455432931811172	9.05719754779664	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATGTTCGTATTGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2547.10161683487	38.2152016878353	0.015003406788035	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.57678683864	2537.57678683864
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGGGATCACTGGGC"	10.5193554359371	7.46653888309327	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGGATCACTGGGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2335.41149954643	44.9657326020515	0.0192538799311318	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2321.88772162795	2321.88772162795
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTCCAGTCCTCCTA"	-1.12308774414714	8.57617185199586	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTCCAGTCCTCCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2841.69592520502	39.1496359973043	0.0137768561548258	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2834.4642636297	2834.4642636297
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGGTTCACAAGTTC"	-0.585985581309158	8.55685613239137	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGTTCACAAGTTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2418.60417939389	40.8490511486828	0.0168895148270684	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2412.62260741234	2412.62260741234
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTGCTGTAGCTAAA"	-4.10978112641032	12.3935346373352	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTGCTGTAGCTAAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2884.91064472494	42.0454134409177	0.01457425155188	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2876.80450184532	2876.80450184532
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGGCAGTGTCGCTGCA"	10.4378391700679	7.60103604877321	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGCAGTGTCGCTGCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2638.29589719796	38.8743922621827	0.0147346597110164	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2622.84657801188	2622.84657801188
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCGTGTACGCC"	-2.21482143822368	8.786106086615	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCGTGTACGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2342.56444067801	42.4069495550059	0.0181027889003267	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2341.0365421978	2341.0365421978
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTGGGAGCTTTGTG"	13.9811579185421	1.65318307960359	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTGGGAGCTTTGTG"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1846.55467605331	43.8364706546382	0.0237396006861443	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1817.94676774028	1817.94676774028
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGTCCTCCGCGGAT"	-0.583619634539443	8.90347478473512	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTCCTCCGCGGAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2427.2889167279	36.4856028907212	0.0150314215334141	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2420.56528624155	2420.56528624155
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTTCGCACATTCGA"	-1.59714494171794	8.63453290546266	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTTCGCACATTCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2888.69803306243	41.7929977595734	0.0144677627364418	2924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2879.42263238764	2879.42263238764
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTTCGGTCTGTCCT"	-2.86630878868755	8.70316884601442	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTTCGGTCTGTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2866.88872048384	37.0672238238909	0.0129294253938238	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2857.32305673383	2857.32305673383
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATCTTGTCTTGGTA"	10.3568150001461	7.07382867420045	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCTTGTCTTGGTA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2295.54550481405	48.396017225026	0.0210825780292891	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2287.91830956973	2287.91830956973
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATCTTGTGTAGCAG"	-4.1942871612614	10.0966672667297	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCTTGTGTAGCAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2328.67582204415	44.9529119873272	0.0193040660970434	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2322.01782733178	2322.01782733178
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATCTTTCAGATTGC"	-0.64300505343135	9.16553018176881	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCTTTCAGATTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2351.43121055073	31.4722735897051	0.0133843054597944	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2345.94971180582	2345.94971180582
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTGCAAGAC"	4.45804085311238	-8.5793142548767	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTGCAAGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3032.90127270539	42.0953077393398	0.0138795509495073	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3024.39913173449	3024.39913173449
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCGATCATCATTGG"	-4.07304225388225	10.0399656065735	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCGATCATCATTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2326.08491677194	43.6698602990396	0.0187739750961642	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2313.59630438852	2313.59630438852
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCTTCGAGCGGGTAT"	-3.62042842331584	9.40998170459596	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTTCGAGCGGGTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2480.87941255527	40.5696967617086	0.0163529499081628	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2474.66357415351	2474.66357415351
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATGGTGTGCTCCGA"	-2.53241906586345	8.75531575763551	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGGTGTGCTCCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.07617778817	44.6944096909851	0.01668899864077	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2668.17756457582	2668.17756457582
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCCATTGTTCTAACG"	1.34911360320393	-7.22982981121215	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCCATTGTTCTAACG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.22915266338	35.831229654909	0.0124016572454555	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2883.65144738955	2883.65144738955
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACATGACACCAGGTC"	-4.01771388474162	10.2054939039978	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACATGACACCAGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2417.1756923442	46.8390991765928	0.0193776146785457	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2410.19996390819	2410.19996390819
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGACTGTCAAACGG"	-4.23933015289958	10.8010129698547	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTGTCAAACGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2722.30636094403	44.1203962848658	0.0162069915854606	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2716.07417224558	2716.07417224558
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAACGTTCGTGCGAC"	-3.3815942806309	9.17384240711061	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAACGTTCGTGCGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2608.80224214144	45.2622149089232	0.0173498068108718	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2600.59355636092	2600.59355636092
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATTTCCAATAACCC"	-3.95004210892375	10.6832914122376	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATTTCCAATAACCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.36908279101	35.7868775602012	0.0152066574775255	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2347.91907817316	2347.91907817316
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAATCTGTGTATTCG"	1.63623418387715	-5.63333799755248	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATCTGTGTATTCG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3017.46155078154	39.9970847622892	0.0132552094166468	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3014.28078074992	3014.28078074992
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCACGGAGTCTGCAT"	1.90014423903767	-5.48458959972533	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCACGGAGTCTGCAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2630.37755833675	39.1426559884657	0.0148810028675946	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2626.14474171382	2626.14474171382
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGATCAGGTCTTTG"	-2.84387407723125	8.87684152210084	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGATCAGGTCTTTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2563.70288364902	44.1710952135365	0.0172294127744889	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.96898621623	2553.96898621623
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGATCGTATCTCTT"	-3.89872250977214	9.67138097369996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGATCGTATCTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2688.68590984001	40.5668130193758	0.015087970250043	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2677.36413741884	2677.36413741884
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCACGGTCGTGTTCC"	-3.07874141159709	9.07878682697145	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCACGGTCGTGTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2351.7831440564	38.7705905171925	0.0164856145921346	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2349.85332627005	2349.85332627005
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCACGGTCTCCAATT"	-3.74239573898967	9.7199029692444	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCACGGTCTCCAATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2550.595647065	34.1096751150698	0.0133732193710595	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2550.595647065	2550.595647065
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTGTTAGGCACTAG"	-4.2037390274113	10.6244144209656	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTGTTAGGCACTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.85232015936	40.5169019042856	0.0156444835054504	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.72504821319	2582.72504821319
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGGTTCACCTGATA"	-4.20156894150432	9.78539273822633	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGTTCACCTGATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.92230209595	36.3370688258232	0.0138748174379752	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2617.57576901032	2617.57576901032
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGGCAGCCGATCC"	-4.09584460678752	9.9385080107483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGGCAGCCGATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2457.93193959116	39.8826753475208	0.0162261105383392	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.58016664485	2452.58016664485
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTAGTACATCGGAAG"	3.89777316626851	-8.15236952221068	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAGTACATCGGAAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2597.20107269147	37.1113053747258	0.0142889612070996	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2593.47038248669	2593.47038248669
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGGCAGGGCTGAT"	-2.77330527725871	8.78418443286744	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGGCAGGGCTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2553.65039454896	44.7866895003637	0.0175383010908485	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2547.86770564271	2547.86770564271
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACAAGGTCTGTCCT"	-4.2559999031132	10.062813735846	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACAAGGTCTGTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2474.89097969468	39.2913505833035	0.0158759924803438	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.64236637933	2472.64236637933
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGGCGTATTGAGA"	-3.30735884133037	9.24340245807496	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGGCGTATTGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.14825212271	47.2277256203788	0.0194500997124421	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2421.33400280681	2421.33400280681
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGCTGCAGCTGACTT"	-4.26029382172282	12.0984935530457	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCTGCAGCTGACTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2769.0515508515	41.1538454178248	0.0148620726852014	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2761.51238439852	2761.51238439852
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGATGTCAACTAGAA"	11.766935010522	-2.98480966007384	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTCAACTAGAA"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2289.2042745839	36.7009863501089	0.0160322024371459	4496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2282.37310037087	2282.37310037087
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGAGTGTCTACAAC"	0.957997937768143	-6.90162756359252	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGAGTGTCTACAAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3052.31659997217	40.8994159004973	0.0133994671132314	3015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3050.39839551775	3050.39839551775
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGAGTGTTACGTAC"	-3.9693788093632	11.71186635578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGAGTGTTACGTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2753.02031594525	45.2634385826943	0.0164413747041867	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2730.96179104662	2730.96179104662
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGAGTTCTCAACCC"	-7.52891002121623	1.64843509281007	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGAGTTCTCAACCC"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2473.30859342785	37.6478282647288	0.0152216461644809	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2462.01552713162	2462.01552713162
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CGTGAATCACACCGCA"	-4.30337748947795	9.78830812061159	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGAATCACACCGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2628.17310952428	32.8968320877016	0.0125169959195177	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2615.97309808228	2615.97309808228
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTAGGGCGAGA"	10.5303856330806	7.24809930408327	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTAGGGCGAGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2381.66268555795	43.6625613649936	0.0183328065849781	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2371.93036310974	2371.93036310974
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGGTTAGCAGGTCA"	-4.18960366669353	10.1392030485901	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGTTAGCAGGTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2511.61124652064	45.4877295693773	0.0181109754275834	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2501.31094617016	2501.31094617016
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTAAGCACCCTATC"	0.774834116070908	-7.26827099239501	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTAAGCACCCTATC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2949.10096125597	41.4438558384688	0.0140530474822464	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2943.67989381369	2943.67989381369
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCACAAGATAACGT"	-4.43311152878459	10.2059802778992	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCACAAGATAACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2851.63829748827	35.8731619890081	0.0125798429697782	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2847.09826679931	2847.09826679931
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGACCTTCAAAGAAC"	-4.45876822891887	10.5944118269714	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACCTTCAAAGAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2815.03431461112	40.4208662051456	0.0143589248611804	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2806.2788762234	2806.2788762234
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCGACGGTATGCGTT"	-5.02889476242717	-4.73269274151	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGACGGTATGCGTT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3327.08461995777	40.3427539555885	0.0121255569256007	3780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3320.20324594597	3320.20324594597
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGCCTGTTGATGTC"	-3.31649384918864	9.38222692096559	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCCTGTTGATGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2717.55878196918	40.0240792275864	0.0147279534459911	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2713.16411306185	2713.16411306185
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCATGCAGGCCCTA"	-3.63666735115703	9.93940541828004	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCATGCAGGCCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.19619118344	44.9201832506267	0.0169433644330091	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2642.2877485468	2642.2877485468
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTAATGAGCTTAGTC"	-4.19078193131145	9.83747766101686	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAATGAGCTTAGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.27346368281	44.1701960089708	0.0179096911430952	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2463.64849853872	2463.64849853872
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACTCGGTCATCGCG"	-3.8797918361729	10.260040260199	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTCGGTCATCGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2190.43650407124	40.0413146877208	0.018280061811104	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2180.50241734225	2180.50241734225
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACGGGACAGACTGCC"	-2.33181295815166	8.53748128497926	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGGGACAGACTGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2305.89038096171	39.3770776976974	0.0170767344461859	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2298.84992902788	2298.84992902788
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTGTCGTGGTCCCA"	-3.77033076706584	9.94757840717164	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGTCGTGGTCCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2441.15792768768	42.0951752629397	0.0172439377172182	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.19060151201	2437.19060151201
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTCCAGTCAAGCG"	-3.48638973656352	10.2863158949646	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTCCAGTCAAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.03682113156	41.2554663763132	0.0179837856115855	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2287.56378929563	2287.56378929563
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTGAAGGCTTTCA"	-0.17341915789302	8.34306237781373	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGAAGGCTTTCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2088.62671090236	36.2124137222486	0.0173379060668067	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2077.61853836746	2077.61853836746
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGCCTAGGAAACGA"	-0.487256388098556	8.81289384448854	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCCTAGGAAACGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2776.392311179	43.117983095262	0.0155302198906292	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2761.62025018944	2761.62025018944
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTGACAAATTGCC"	-4.2362884086674	10.2671556242737	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGACAAATTGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2459.79586424772	47.4878187669825	0.0193055933856957	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2456.13895314048	2456.13895314048
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACTTCGGTCTCTCAC"	2.06319894370381	-5.3171801797119	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTTCGGTCTCTCAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2780.67702498974	43.4220141161424	0.0156156265995338	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2773.43152446738	2773.43152446738
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTGATCACGACTA"	-7.04354463043864	1.894291258696	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.238095238095238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGATCACGACTA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1958.21923379137	45.787911662824	0.0233824236187143	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1953.80750212979	1953.80750212979
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGGTGATCCCTCTCC"	0.579365153878373	9.28730294788209	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGATCCCTCTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2136.68982634914	42.4771988091849	0.0198799087660578	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2130.14257988644	2130.14257988644
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCCATCGGACAAG"	-0.303040067583877	8.14269540393678	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCATCGGACAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2147.25032788547	41.8525182132225	0.019491215192612	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2144.12567101021	2144.12567101021
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAACCCGTTATCTTC"	-2.35590420189555	8.87313554370729	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACCCGTTATCTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2506.50904890428	41.0717077825866	0.0163860201504324	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2501.76298226634	2501.76298226634
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGACTCCAATAGTCC"	10.2207189994747	7.88796136463014	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGACTCCAATAGTCC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2549.89022868506	39.6917599829824	0.01556606615315	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2536.01663789447	2536.01663789447
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTAGGAGTGATTCC"	-3.70104942742046	9.88447759235231	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTAGGAGTGATTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2383.41898764073	39.5948996818145	0.0166126475819546	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2379.25068570762	2379.25068570762
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTAGGCACGCGCAT"	-3.33532247963603	10.3349227675232	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTAGGCACGCGCAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2737.44074454833	40.4986431870742	0.0147943451443572	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2727.78345303575	2727.78345303575
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCGTTCTCATGCC"	9.94141830977742	7.46397683704225	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCGTTCTCATGCC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2272.28888860453	43.8411861574319	0.0192938434797152	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2260.24940196017	2260.24940196017
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCCACAAGCAG"	-4.17501388016399	9.90529821002809	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCCACAAGCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2811.99040120384	42.1985307301907	0.0150066411009529	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2805.27424903352	2805.27424903352
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCGTGGTTCTA"	-2.76437054100688	9.19671437824098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCGTGGTTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2159.39214276815	52.6224843849323	0.0243691191343666	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2153.55278364548	2153.55278364548
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCTATCTTGTGCC"	-2.08944616738017	9.24915406787721	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCTATCTTGTGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2810.89512917969	43.3649226623163	0.0154274423873549	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2792.81981146892	2792.81981146892
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTAACGCACCACTGG"	-4.3496655029362	-5.47598364269408	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAACGCACCACTGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3127.16656627787	41.8274234322953	0.0133755022464571	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3118.03852025724	3118.03852025724
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTAAGTGTCGTGAGAG"	-3.39295087280925	9.21564672077028	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAAGTGTCGTGAGAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2676.6744082148	44.4011297880556	0.0165881698766899	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2669.52142226279	2669.52142226279
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCTACACGCCACA"	-3.62506280365642	9.43040368640748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCTACACGCCACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2896.92546612049	36.1650307108885	0.0124839355150273	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2888.17023197973	2888.17023197973
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTAAGCAGGGTCAAC"	-3.68538794937785	9.49333283984987	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAAGCAGGGTCAAC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2662.99441941695	47.1017502688485	0.0176875136971414	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2659.21426892009	2659.21426892009
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTAGAGTGAGCTCC"	-0.942935327917892	8.55048272693483	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTAGAGTGAGCTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2488.53521182256	39.6899216230781	0.0159491099159533	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2480.96099611156	2480.96099611156
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAACTTCCGACAGC"	0.786593158810776	-6.26280596172484	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAACTTCCGACAGC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3052.6241096199	35.7406658395704	0.0117081778024811	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3047.78006180039	3047.78006180039
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTCGAGTAGATTGA"	-4.35547004166301	10.1369971998963	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCGAGTAGATTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.07594132895	36.1465262839833	0.0141138049445058	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2555.26539709949	2555.26539709949
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTCTTAGCAGGTCA"	-3.87722740593608	9.76672647083131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCTTAGCAGGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2534.48261897817	40.308550585244	0.0159040548486757	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.50199746553	2528.50199746553
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAGAGCAACGTATC"	-3.8607910675114	10.835425353888	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGAGCAACGTATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2122.13459442104	35.7685654244149	0.0168549937965519	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2117.59364377446	2117.59364377446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAGAGTCCCAGCGA"	-2.98346195641215	9.17834851825563	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGAGTCCCAGCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2774.6658036439	48.7479585536374	0.0175689477592645	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2767.04228405455	2767.04228405455
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTACTATGTCAGATTC"	-0.757202248007613	8.70179936969606	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACTATGTCAGATTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2974.05517424183	36.6024882535627	0.0123072660421957	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2953.64651810808	2953.64651810808
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTAGAGTGACACAG"	-2.71103606644328	8.89233396137086	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTAGAGTGACACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2902.20331131433	41.8519760743372	0.0144207595350663	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2891.95339677317	2891.95339677317
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTCCACGTACCATAC"	-4.19609675827678	12.1709222563538	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCACGTACCATAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2694.40069119424	37.4834068311187	0.0139115933846146	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2688.42739266168	2688.42739266168
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTCCACGTAGGTAGC"	-1.94925723496135	8.5431394346985	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCACGTAGGTAGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2521.27175013551	44.8255800973257	0.0177789562330663	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2516.56971977457	2516.56971977457
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTAACTGTGCTATTG"	4.47363676604573	-8.50175764476927	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTAACTGTGCTATTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2881.49116717691	40.1497729096656	0.0139336789808735	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2875.01469329387	2875.01469329387
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCGTGCACGCTATA"	-4.3058627647465	10.7396125563416	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGTGCACGCTATA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2910.75255032514	39.4556794726509	0.0135551472653502	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2897.17936549819	2897.17936549819
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATCCGTCGCCGTGA"	-2.79653034630473	8.89713475787965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCCGTCGCCGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2629.270544581	42.5489908597121	0.0161828119770355	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2623.606387914	2623.606387914
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGATCACACTACCCT"	-4.14186940613444	10.6684837111267	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGATCACACTACCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2534.32752248396	37.3289929304324	0.0147293483574078	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2525.23867815091	2525.23867815091
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATGCCCAAGGCAAC"	-2.6461492580479	8.72191522205202	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGCCCAAGGCAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2747.48461029744	39.2399212512904	0.0142821259504862	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2736.40201960767	2736.40201960767
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAACATTCCGTGTAA"	-4.21417699280437	10.5469541319641	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACATTCCGTGTAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2749.39783618781	45.4487734839187	0.0165304463710992	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2741.94393409764	2741.94393409764
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGATGTTCGCTAGCG"	-4.37107024613078	10.4728059538635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGATGTTCGCTAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2472.73188421921	37.7078401504594	0.0152494657391317	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2470.10212903965	2470.10212903965
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGCGTGGTGTTTCTT"	-4.133452753455	10.0225219496521	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGCGTGGTGTTTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2172.26709855684	34.7590976201001	0.0160013000441762	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2167.73874779682	2167.73874779682
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGCAAGACAAT"	-4.23223100128825	12.3520335921082	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGCAAGACAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2840.45534119612	37.7469718334474	0.013289056612153	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2833.85073174829	2833.85073174829
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGCATATAGCC"	1.39257063445393	-5.70086290752562	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGCATATAGCC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3131.9128689805	39.6384596068836	0.0126563098224973	2947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3126.9338637999	3126.9338637999
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTTGGGGTCGGAACA"	5.18514885482137	-9.44578840648802	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTGGGGTCGGAACA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2836.14901363987	39.5817061459555	0.0139561447426054	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2830.85784345307	2830.85784345307
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGGTAACGGTG"	-3.78618703308757	9.99004647815553	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGGTAACGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.31011062546	39.9399501740848	0.0178517720830928	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2234.55286619823	2234.55286619823
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGACCAGTTCTTCAT"	-0.422101984650451	8.72706220233766	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGACCAGTTCTTCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2487.08387657464	36.2296676941926	0.0145671274038776	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.23575263938	2476.23575263938
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGAAGGTATGAAAC"	-3.77338467064555	9.51986024463502	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGAAGGTATGAAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2994.48004643972	40.8960580286527	0.013657148284316	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2988.04574796854	2988.04574796854
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCACGCAGGACTTT"	-2.90515528145488	8.94594762409059	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCACGCAGGACTTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2681.1325503501	47.1634470825825	0.0175908673655183	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.28684792007	2672.28684792007
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTATCTAGTACGTAGG"	10.4461685615474	7.65419910037843	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCTAGTACGTAGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2438.23577311298	44.5666010583432	0.0182782163848919	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2433.09563908174	2433.09563908174
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTGTTCTGAGATC"	-2.91447625580485	9.06705567920534	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTGTTCTGAGATC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2668.79410794876	42.4515174843787	0.0159066288995246	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2664.04105504611	2664.04105504611
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCGTGGTGAGGAAA"	-4.30383382263835	10.4950399168762	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCGTGGTGAGGAAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2645.20962308034	47.1192385785385	0.0178130451996724	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2636.11014214867	2636.11014214867
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCTCACCAGAACTTC"	1.21253945407216	-7.55592777645262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTCACCAGAACTTC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.92883615559	50.0412089199515	0.0191807489060109	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2597.04244661351	2597.04244661351
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTAGATACATG"	5.11615337905232	-9.21947576915892	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTAGATACATG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2702.23603831097	34.9313546718137	0.0129268332508982	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2700.29918340048	2700.29918340048
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTAGATACTGA"	-2.46750984612163	9.26808354938356	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTAGATACTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2326.90181165507	40.3510644304728	0.0173411117857921	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2321.76915918041	2321.76915918041
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGGCGAGCCAGAGT"	-3.3213623565739	9.10485837543336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGGCGAGCCAGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2632.80067747101	39.4701352500953	0.0149916913907851	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2624.77001114322	2624.77001114322
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGATCGAGCACCGAA"	-4.40100417557414	10.2174329527649	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGAGCACCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2662.05188893828	38.2421083337299	0.0143656509824766	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2653.90591048419	2653.90591048419
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGGCGCACGCACCA"	-7.19851479950603	1.45931241596071	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGGCGCACGCACCA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2517.39980900078	49.9970650363733	0.0198605977714038	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2511.3365826385	2511.3365826385
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTCACACACGAGAAC"	-4.43370709839519	10.8549194105896	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACACACGAGAAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2786.48507114202	43.0985223304877	0.0154669848321936	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2775.35535792218	2775.35535792218
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCACGTCAATACGAA"	2.3658205467159	-4.80831434642943	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACGTCAATACGAA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2696.06639071976	41.5578313114524	0.0154142462717166	2198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2690.11130915645	2690.11130915645
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGAGGATTTGA"	-3.56395397606547	9.45384118640748	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGAGGATTTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2413.12360410983	39.5792564210824	0.0164016697502251	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2411.84336718469	2411.84336718469
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCAGAAAGCCATTCA"	-3.75581703606303	9.70453164661256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCAGAAAGCCATTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2711.52227721948	47.4905474968929	0.0175143490045717	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2701.79393586297	2701.79393586297
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGTGAGTCAAAGAT"	-4.32562623444255	10.0495948561463	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGTGAGTCAAAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2652.84473187651	40.1678549938333	0.0151414270542024	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2646.1764744037	2646.1764744037
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGGAACAAGCACAG"	-4.16139493408855	10.5934667357239	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGGAACAAGCACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2613.34527081635	44.3169966025301	0.0169579569517374	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2601.77029970903	2601.77029970903
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAAGCTCTGTAACG"	-4.38169417801555	10.5094451674256	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAAGCTCTGTAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.46401391338	43.3362666569466	0.0170920456449543	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2523.57385265969	2523.57385265969
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCATGCTCGGCATCG"	-4.07752070847209	11.9734887846741	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCATGCTCGGCATCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2839.98846498155	41.0544486718256	0.0144558505001154	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2830.87013298148	2830.87013298148
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGTTACAGCGTATT"	-5.62229428711589	-5.47617819225463	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGTTACAGCGTATT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3097.8706488128	17.7554386034777	0.00573149773386507	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3093.12362931334	3093.12362931334
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCATAGTGAGGTC"	3.71021427687947	-8.40326979076537	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCATAGTGAGGTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3107.348436396	46.5928185499657	0.014994397797244	2816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3102.94119557086	3102.94119557086
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAGCTGGTGTTGACT"	-6.78083262863811	-12.6518326035705	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.444444444444444	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCTGGTGTTGACT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2826.73154376829	28.2396970474376	0.00999022956732265	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2813.62432107657	2813.62432107657
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGACTGTTGCTGAT"	-2.62394485893901	9.02220246875612	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGACTGTTGCTGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.31503027764	40.447759750382	0.0164802640457311	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2446.04877522009	2446.04877522009
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCACATCAGCATTG"	-2.23647962036784	9.01210210407106	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCACATCAGCATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2814.13372092922	45.2747648259502	0.0160883487835825	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2803.25438791042	2803.25438791042
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACGGGGTCATTGCA"	1.07970013198201	-6.95481636440428	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGGTCATTGCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2947.43091906054	43.2384805197666	0.0146698876774857	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2941.51017254087	2941.51017254087
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGAGATCGCCC"	-4.28608117523845	10.6888904341492	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGAGATCGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2414.63820946377	38.7888482825874	0.016064041449589	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2407.4746028148	2407.4746028148
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCTACATACAGGG"	10.1760717826778	7.80528352344362	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTACATACAGGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2331.04743546161	43.8344434145529	0.0188046123591099	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2328.8626905203	2328.8626905203
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCTAGTTGCATTG"	-4.33397565308269	10.2005882033142	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTAGTTGCATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2739.11672329376	43.1224281152197	0.0157431874839439	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2734.4334073466	2734.4334073466
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGGTTCCTTGC"	-2.25927887383159	8.72147080982057	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGGTTCCTTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2393.51764513999	36.4401088551022	0.0152244997771767	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2385.72164872975	2385.72164872975
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAGACAAGTTCACTG"	-4.26701674881633	10.1618261107239	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGACAAGTTCACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2439.80934996157	40.2334212084497	0.0164903955340131	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2433.20004650067	2433.20004650067
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCATTAAGCGATGGT"	-2.55329285088237	9.82310769641725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCATTAAGCGATGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.58572090673	45.5625110020402	0.019821976003604	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2289.55589354779	2289.55589354779
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTGAGAGTTAACAG"	-0.499239186674911	9.01473329151002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGAGAGTTAACAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2656.41347549896	37.3494129852437	0.0140600901665838	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2641.96104510801	2641.96104510801
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAAGCTGTCATGCAT"	-4.13908324661906	9.98405454242555	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAGCTGTCATGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.28997305317	38.3808226628921	0.0148286409415007	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.91749395777	2582.91749395777
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTGGACAACGTATC"	0.427981724112672	-6.36963035976561	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGGACAACGTATC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3199.18500083395	38.5750599897154	0.0120577772087766	2913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3192.78452037931	3192.78452037931
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTAACGCATGCCGGT"	4.09104122695271	-7.63267614757689	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAACGCATGCCGGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.99545648193	44.4045318029953	0.0180433213259455	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2458.04781726129	2458.04781726129
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCAACAGGTATAGT"	2.04267623004262	-5.79767372524413	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCAACAGGTATAGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2898.33131139127	36.6188710162375	0.0126344668990446	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2893.17781227947	2893.17781227947
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTAACGTCATAGAGA"	-1.64625368538554	8.8951730498108	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAACGTCATAGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2378.89060229205	41.9792039462191	0.0176465466321874	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2368.82528112217	2368.82528112217
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCGAAACAGAACCGA"	-0.479767064482528	8.94577596271364	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGAAACAGAACCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2578.24729823327	34.4595454543466	0.0133654927042724	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2563.39023036554	2563.39023036554
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCGATCAGCTCTATG"	-2.72999010506328	8.62617395007936	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGATCAGCTCTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3017.74437730622	40.5809246815461	0.0134474361005257	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3005.50967768633	3005.50967768633
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAATCCGTCACTCTC"	-4.3690107864445	10.0825958021912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAATCCGTCACTCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2904.63694081045	42.289324338382	0.0145592461984534	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2896.29261981	2896.29261981
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTACAGTCAGTGGGA"	-0.717696706682998	8.62714860523073	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTACAGTCAGTGGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2516.88737452099	35.81394924981	0.0142294604090602	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2507.27165679521	2507.27165679521
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACTTCAGTCGCCCA"	-4.34832177582439	11.015149093512	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACTTCAGTCGCCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2574.00348209823	34.6118751461156	0.0134467087503321	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2568.53920298226	2568.53920298226
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAATCCTCGCCTAGG"	11.3605534034664	-2.53516437923583	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAATCCTCGCCTAGG"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1771.62991611692	34.4493092303672	0.0194449805328833	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1767.14132693454	1767.14132693454
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCCATCGGCCTTT"	-3.92961512032207	10.536012626532	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCCATCGGCCTTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2206.94171959534	43.6022831725706	0.0197568802045961	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2200.54878200813	2200.54878200813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAATGCGTCCAGAAG"	-0.934983770281631	8.22640702808229	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATGCGTCCAGAAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2562.88328210812	23.225657494791	0.00906231573514596	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2557.80145861302	2557.80145861302
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTAGACTCGACCATA"	-3.84488687935527	9.77454087817994	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAGACTCGACCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.24577639041	45.8218604125238	0.017703828913971	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2583.31119923974	2583.31119923974
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACGCGAGATAGCTA"	-0.423912594944793	8.64846704089967	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACGCGAGATAGCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.1562975021	41.8452301459124	0.0181923420557791	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2294.68709015501	2294.68709015501
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCAGAAGTTCCAGT"	10.3064075904781	7.70958325946657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCAGAAGTTCCAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2249.46978418282	43.6839304432597	0.0194196564676814	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2239.04452793831	2239.04452793831
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCAGAGTACGATGG"	2.90601863440816	-7.7137284508911	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCAGAGTACGATGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2688.96992176231	38.4189909377403	0.0142876239063921	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2686.67358328283	2686.67358328283
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCAGAGTAGCGCCT"	-4.43238482895549	10.6693973311218	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCAGAGTAGCGCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2601.55148239314	43.6904335418797	0.0167939915229697	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2598.97033591678	2598.97033591678
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATGGCAGCACGAA"	-4.18912778320964	9.85599801624147	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGCAGCACGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2606.69101333484	42.6898394823943	0.016377023308098	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.79320991488	2602.79320991488
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTCGAGTGTGGTCC"	-2.5037776035374	8.66601560199586	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCGAGTGTGGTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.14732327872	40.7393468266761	0.0166954455733174	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.48685461881	2437.48685461881
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTCTTAGACTAAGT"	-0.619818548590499	8.77842328632203	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCTTAGACTAAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2590.55550624719	48.5586974622099	0.0187445114938126	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2581.39642822562	2581.39642822562
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATGGGTCTACACA"	-2.14281998100932	8.67970941150514	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGGTCTACACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2389.18251488281	42.4705919113654	0.0177762023816956	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2386.44508576852	2386.44508576852
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTCCGATTCCAATGCA"	-4.11275754395183	-8.52567865764769	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCGATTCCAATGCA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2698.77424920124	40.7342971669121	0.0150936289609879	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2696.10868132525	2696.10868132525
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTCTTGTTGTAAAG"	-3.58485303345378	9.66472528064577	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCTTGTTGTAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2603.3684351843	44.6271090276015	0.0171420642673815	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2598.75983415262	2598.75983415262
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATTCTCAAGCTGT"	-0.229323903948623	8.63023469531862	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATTCTCAAGCTGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2367.80580575901	42.416155018806	0.0179136966873047	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2359.28803206573	2359.28803206573
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGAAATCGTGCATA"	-4.26298604431804	10.3377856978211	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAATCGTGCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2612.41226641709	37.4109455416141	0.0143204600677071	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2606.06973128204	2606.06973128204
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGGCAGATGAATC"	-4.29091964188274	10.0358295210632	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCAGATGAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2534.60898256784	38.4776108312114	0.0151808863204727	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.83019213864	2528.83019213864
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCACGACACGCTTAA"	3.63930096206014	-8.07300283825072	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGACACGCTTAA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.93259811677	38.2385411881774	0.015222757655538	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2509.26936364517	2509.26936364517
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGAGTAGGCGACAT"	10.2431131797725	7.32897279346315	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGAGTAGGCGACAT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2151.94764629302	38.8300678689687	0.0180441508118741	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2143.34953796745	2143.34953796745
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGCAGTTCTATCGTT"	-0.732652048498946	8.72648522937623	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGCAGTTCTATCGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2336.76783119842	33.7969782198006	0.0144631305551941	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2327.36316608738	2327.36316608738
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGACTCCAGGTGATAT"	-4.1503451866215	9.80370042407838	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACTCCAGGTGATAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2890.62712249456	37.4197196195238	0.0129451907955639	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2882.25475579252	2882.25475579252
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCAACCACAACGAG"	-3.75796781006511	9.64650247180787	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCAACCACAACGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.14381172558	42.0730125186948	0.0168080684464115	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2499.21691327932	2499.21691327932
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGAAGTCACGCAAAG"	-4.24314246597941	10.3440274962219	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGAAGTCACGCAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2547.10117264605	38.4930989682835	0.0151125127582957	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2541.8245198479	2541.8245198479
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTGATGAGCCACTCG"	-0.629076580435592	8.74354837024537	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGAGCCACTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2358.70493754313	40.191979008652	0.0170398502877247	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2348.33418462244	2348.33418462244
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGACCTCATCCGCGA"	-0.746969978243667	8.79548356616823	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACCTCATCCGCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3392.95791825979	38.6388313111273	0.0113879488758719	3351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3377.8571772624	3377.8571772624
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCTGTTGTGACTGAG"	-2.40583882752116	8.67250535571901	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCTGTTGTGACTGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2487.57528039355	45.9980391765124	0.0184911144354334	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2478.98129516032	2478.98129516032
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCTGTTGTTGTATGC"	-4.2676890892094	12.4201698073181	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCTGTTGTTGTATGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3029.84462206488	39.5563245535582	0.0130555620791537	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3024.55038280335	3024.55038280335
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTTCAGACCTA"	-3.60477171364482	9.3796701201233	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTTCAGACCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.74520222822	40.0155048409028	0.0150902525654721	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2642.96462754042	2642.96462754042
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTTCCGTACAGTCT"	-3.98041091385539	9.78436086261598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTCCGTACAGTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2397.81155793848	42.3869973830259	0.0176773680328191	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2393.9449480633	2393.9449480633
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGACGGAGATACGAT"	3.88644518431966	-7.11624815380248	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACGGAGATACGAT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2680.82142988589	36.9212439907912	0.0137723622988059	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2675.3445810861	2675.3445810861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCTCTCTCACGATAC"	-4.25416169586833	9.99044034564821	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTCTCTCACGATAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2922.20138793938	38.782941551901	0.0132718236710062	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2916.49824609591	2916.49824609591
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGAGAATCAAATAGG"	4.51438726958577	-8.36591532146605	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGAGAATCAAATAGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.00167944579	50.6111788974365	0.0199570762541833	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2527.40767885831	2527.40767885831
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGATCGAGATGCTGG"	3.76778902587239	-7.90492346203002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGATCGAGATGCTGG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2889.35907983711	40.538355285632	0.0140302240619803	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2882.04597539782	2882.04597539782
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGCGTTAGTAGGGTC"	-4.21444449845012	10.7427873381409	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCGTTAGTAGGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2232.08983517629	34.2229490420201	0.0153322453705441	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2228.30315696553	2228.30315696553
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGTCTGGAGAG"	-3.31719456139262	9.42264649951784	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGTCTGGAGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.62351575976	43.0393972923747	0.0185225347395841	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2319.36128769179	2319.36128769179
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCAATCTCTACTTCA"	-0.488995353609878	8.52924153888551	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAATCTCTACTTCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2485.80917020405	32.6034502423636	0.0131158299008477	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2473.03728979077	2473.03728979077
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGATTTTCAGTGTTG"	-3.63740787926372	9.98755548084108	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGATTTTCAGTGTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2497.41242361428	45.6853021451751	0.0182930547286455	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2491.76537335142	2491.76537335142
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTACTAGGAAAGGT"	0.967185576527756	-7.31054356014403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTACTAGGAAAGGT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2983.63935850695	40.8192711525109	0.0136810338810309	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2977.56141394639	2977.56141394639
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGGAAGTCGCCCA"	-4.19708667221721	9.90170762622682	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGGAAGTCGCCCA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2512.51008319346	39.6984109505429	0.0158002991574407	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2507.38574525282	2507.38574525282
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCACTAGTGGTGGT"	-4.21926436844524	9.89405343616334	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCACTAGTGGTGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2860.86021721075	40.8123725387841	0.0142657695378682	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2855.38624132271	2855.38624132271
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGACCCAGGCCTTGC"	3.28656448897664	-7.59614994442137	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0463917525773196	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGACCCAGGCCTTGC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2075.96871157971	48.7959507446612	0.0235051474872807	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2075.96871157971	2075.96871157971
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGTGCAGTTAAAGTG"	-4.12639222565349	10.2311858900818	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTGCAGTTAAAGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2473.99499669483	46.8340707011328	0.0189305438223203	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2463.30387117626	2463.30387117626
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTCATCAGCGCTTG"	3.17504181441609	-7.73364593898924	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCATCAGCGCTTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2676.22530223029	38.1230736045679	0.0142450912383189	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2674.97587421894	2674.97587421894
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCATCTCCGGACGT"	-3.95444474640544	9.70088765704957	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCATCTCCGGACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.18435382991	39.091752354714	0.0151156093326536	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2578.66293461985	2578.66293461985
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCATCTCGGTCGAC"	-0.894979099661666	9.06463430011598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCATCTCGGTCGAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2406.40706109317	38.4322587677728	0.0159708053509093	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2400.18264728121	2400.18264728121
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCTCATCCTGCCAT"	-4.2869590324467	12.1966295012268	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTCATCCTGCCAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2031.70523504539	41.6828720690787	0.0205162005541357	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2031.70523504539	2031.70523504539
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCATTCCACGTCT"	0.396958847611588	-6.72197964107665	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCATTCCACGTCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2969.52106816926	35.7796304387859	0.0120489565884254	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2962.88144032317	2962.88144032317
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCTAAGGTTGCCC"	-3.90404687348064	12.461284614447	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCTAAGGTTGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2854.24877446565	44.6327397254045	0.0156372983759134	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2843.77905499184	2843.77905499184
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGCCTAGTAGGTCAG"	-2.57153616371806	8.91779038989869	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCCTAGTAGGTCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2699.83948739424	41.5664417692563	0.0153958937052863	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2691.85989178071	2691.85989178071
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTGGAAGAATCTAG"	-3.90154872360881	9.77717492664186	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTGGAAGAATCTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.82149993088	38.5252713827475	0.0157385950666073	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2443.51086273992	2443.51086273992
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTAGTCTCGAGAAGC"	-3.90723834458049	12.4386520155701	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTAGTCTCGAGAAGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2686.81769523562	42.6116574317062	0.0158595268697489	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2676.04176664647	2676.04176664647
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTTGTGTGAGCTCC"	-0.803897182375747	8.65806672656862	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTTGTGTGAGCTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1891.9811015082	40.6694512941283	0.0214956963691173	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1879.62428103438	1879.62428103438
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCTATGTCATCCCT"	2.69915880736653	-7.7933387986389	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATGTCATCCCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2946.8976129874	32.8637906116703	0.0111519960743919	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2941.64768629147	2941.64768629147
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCTATTCGGCCCAA"	-4.36816726151164	9.9218129881653	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATTCGGCCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2680.40721650225	41.2822999869812	0.015401503074914	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.04803443485	2672.04803443485
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGGGTGTCCAACCAA"	-4.24486384812053	10.1150235899719	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGGTGTCCAACCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2377.1239273513	42.6772142271144	0.0179532979900914	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2375.74540577274	2375.74540577274
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATCAGCACCATTCC"	-2.57816491547282	8.71491334522096	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCAGCACCATTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2845.88875877886	38.156252168073	0.0134074995202712	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2839.69787966789	2839.69787966789
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATCTTAGGTTGTTC"	-3.78972969475444	9.49954221332399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCTTAGGTTGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2701.77999201814	41.5632119637941	0.0153836404468847	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2694.24401653787	2694.24401653787
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACAGGGTACGAGCA"	-0.630848090082961	8.47113511646119	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACAGGGTACGAGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.69300967092	37.7203666945962	0.0151323755264897	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2484.33656477264	2484.33656477264
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTCCACACGACGCT"	-0.533620516688186	8.89059445941774	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTCCACACGACGCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2574.26173382995	41.1782889451299	0.0159961547048541	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2567.90823976576	2567.90823976576
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTGGGAGTAAATGC"	-0.865365008742172	8.70349214160768	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTGGGAGTAAATGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2325.87617679955	41.4295253932254	0.0178124380852609	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2322.05963990504	2322.05963990504
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGAATTCGAAATCC"	-4.40190015259441	10.7562894591126	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATTCGAAATCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2822.02497904728	42.3852440770756	0.0150194432692034	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2809.13594526262	2809.13594526262
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGGACGCAAATTAGG"	-2.81553636017497	8.89163110339967	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGCAAATTAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2777.00298798092	39.9707209876913	0.0143934742456841	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2765.30941755197	2765.30941755197
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGGCGAGTTCCATG"	-4.15012202683147	9.75627133930055	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGGCGAGTTCCATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.10572852553	38.2445134778704	0.0150621980992021	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2529.76088108436	2529.76088108436
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTGGACGGTCATCCCT"	5.07506718215291	-9.33026888286742	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGGTCATCCCT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2754.54312397803	33.8953473073975	0.0123052520079798	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2751.31267855746	2751.31267855746
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTAACTGTGCCCTTT"	-3.57729969444926	9.71434972369996	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTAACTGTGCCCTTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2865.3567040816	41.1349916084412	0.0143559758370907	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2855.53724567592	2855.53724567592
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAGCCCTCTGCCTGT"	-3.46713815155681	9.32986829364625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGCCCTCTGCCTGT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2539.09546878703	49.2757992789816	0.0194068320331892	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.64638044977	2528.64638044977
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGGTAAAGTCGGCAA"	-0.49726233902629	8.16981885516969	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGGTAAAGTCGGCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2132.02356501694	36.5367877124726	0.0171371406545323	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2123.43354642441	2123.43354642441
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCGTGAAGTCCTGCG"	0.797769268124741	10.5387038954529	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTGAAGTCCTGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1744.51029168209	41.0661234539016	0.0235402013101939	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1742.54110367798	1742.54110367798
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACGCCCAATTAGGA"	-0.909461478621322	8.90815827930299	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACGCCCAATTAGGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2470.70359076801	38.6273669635642	0.0156341566458634	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2457.31121040599	2457.31121040599
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACGCCGTACCCGAC"	0.652040322392625	-6.82102491771849	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACGCCGTACCCGAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2977.70501058245	33.8578699890686	0.0113704580771907	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2969.82780129609	2969.82780129609
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTTCACCACTTCATT"	0.754404028027695	-6.21019270336302	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTCACCACTTCATT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3042.2471957595	36.8530121201836	0.0121137467631006	3047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3034.90684225589	3034.90684225589
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACGTTGTGGTCTGC"	-4.13062129440959	9.93778607929078	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACGTTGTGGTCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2372.24780714457	45.7021369813739	0.0192653300568901	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.82468320645	2362.82468320645
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTACATGTGGGTCAA"	-3.91590629044231	13.0673074492249	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACATGTGGGTCAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3242.93445389717	39.7078620660536	0.0122444232624976	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3234.62524131262	3234.62524131262
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACTGTCACGACAGA"	-2.54334698143657	8.54988286578981	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACTGTCACGACAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2474.13373510762	37.7351765458695	0.0152518742258806	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2469.14288851177	2469.14288851177
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTACCGCAATTTCGG"	10.1481644111568	7.91987178409425	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACCGCAATTTCGG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2642.27168688745	44.707308039541	0.0169200269076816	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2631.93998272995	2631.93998272995
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCAACATATCGGT"	-3.20139322701152	9.35869309985963	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCAACATATCGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2471.83793762054	40.5514086399171	0.0164053670439872	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2470.59474887828	2470.59474887828
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTTTCGAGGGCTTCC"	-0.785509924322921	8.70844838703004	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTTCGAGGGCTTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.07349621919	34.6263219852509	0.0144754423473943	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2386.08935794566	2386.08935794566
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTCAAGTTGGGACA"	-4.29257712784465	9.87034890735475	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTCAAGTTGGGACA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	3004.73651507913	47.6856001339702	0.0158701436530832	2634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2997.39509913061	2997.39509913061
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCACGGTAGCGTCC"	-4.21133313599284	12.0470771559509	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCACGGTAGCGTCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2585.49108296147	40.6321422396389	0.0157154447398434	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2574.81459498302	2574.81459498302
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCACGGTGTTTCTT"	-2.4616461795872	9.03124425494996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCACGGTGTTTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2179.27351433587	50.4129400006541	0.0231329108847622	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2174.96673257514	2174.96673257514
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCATTGTCTCCGATC"	-2.09906564179118	8.8619756468567	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCATTGTCTCCGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2473.24443253939	42.7816048834963	0.0172977665776328	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2470.03080095532	2470.03080095532
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCAGCAGGTCGTGA"	-4.02472291413005	9.65958783710328	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCAGCAGGTCGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2664.25432802483	43.474177209959	0.0163175777750125	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2659.2369842595	2659.2369842595
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCAGCAGTTGCATC"	-2.49588809433635	8.66651437366334	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCAGCAGTTGCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2736.75207019491	44.1422952369097	0.0161294461846396	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2727.50790307096	2727.50790307096
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAATCTAGAAACTGT"	-0.485207776457626	8.72946641528932	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAATCTAGAAACTGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2696.87553865668	33.8598927171711	0.0125552300177845	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2690.19168542648	2690.19168542648
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCCGAAGCAGATAT"	-0.693972746760207	8.69330022418825	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGAAGCAGATAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.60163714112	42.8654396795534	0.0171970679312872	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2482.24485052077	2482.24485052077
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGTTAAGCTCTATG"	4.00751318511311	-7.25219681179198	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTTAAGCTCTATG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.474928906	37.9745819372611	0.0138873395897083	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2729.03311202517	2729.03311202517
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCGGTCAGGCTTAGG"	4.93960823592488	-9.09674551403197	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGGTCAGGCTTAGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2973.41828499562	35.0643701918662	0.0117926126871577	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2965.72450189186	2965.72450189186
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGTATCCTGCCAT"	0.597952206700486	8.20973298633424	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGTATCCTGCCAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1934.63343798026	38.8619071307994	0.0200874782622235	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1920.8057424341	1920.8057424341
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTATTGCCACAGTCGC"	-3.4873448413914	9.4076823958191	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTATTGCCACAGTCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2647.59021959509	38.1438058481028	0.0144069900114438	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2642.82645682846	2642.82645682846
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTAACCAAAGCTCT"	-2.66644320908244	9.04287717426149	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAACCAAAGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2125.67423084187	47.534098070597	0.0223618922320807	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2124.18966055856	2124.18966055856
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCAATAGGCAGCTA"	-3.83315287056621	9.45412442767946	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATAGGCAGCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2790.21888953351	44.4696413335806	0.0159376891542066	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2782.61641839648	2782.61641839648
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCAATCAACCAACT"	-1.33845982971843	8.62624166095582	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATCAACCAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2862.91393304792	41.8336931162875	0.0146122775936021	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2851.88583108423	2851.88583108423
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTAACCACCCAATA"	10.5263010459835	6.88385913455812	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTAACCACCCAATA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2362.63097469549	37.3507157963658	0.0158089503593255	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2354.64859912492	2354.64859912492
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGAGCGATCGA"	-2.97145352783855	8.87229821765748	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGAGCGATCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2675.26166655232	43.1962450988659	0.0161465495651998	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2664.21206375794	2664.21206375794
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAATCGTAGCGTAG"	-4.35877738419231	10.633765197638	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCGTAGCGTAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2442.9512308265	36.5965093551557	0.0149804502412331	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.36213297619	2437.36213297619
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGCCTCGTAGCTAAA"	-2.2409430545872	9.20056912982789	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCCTCGTAGCTAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2358.45459388026	37.7568075483131	0.0160091305748624	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.06630669837	2357.06630669837
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAATCTCCGCAACG"	-3.56158171120341	9.6742315062317	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCTCCGCAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.13090908153	41.2686099612135	0.015939174730973	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.45079264333	2586.45079264333
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGCCTCTCACGGTCG"	9.72516979750935	7.06801364505617	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCCTCTCACGGTCG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2203.83840184511	45.6448657569135	0.0207115302640604	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2196.9109461415	2196.9109461415
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGCGATGTCCGGATC"	-0.220929841429549	8.06786630237428	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCGATGTCCGGATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2314.59931932055	40.2076796322331	0.0173713347690935	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2301.85124895162	2301.85124895162
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCACCGGTATGCGGA"	-4.0704062980717	10.2815665968689	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCACCGGTATGCGGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2602.80328814055	44.7875329973267	0.0172074213988423	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2592.65842742352	2592.65842742352
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCACCGGTTACAGCT"	-4.11920533600505	9.9725885161194	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCACCGGTTACAGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2662.19596387402	43.6142074171229	0.0163827937570965	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2649.78033822504	2649.78033822504
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCTAATCAACTCTT"	-4.40133700791057	10.0103130110535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCTAATCAACTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2991.37755693674	38.8186111105712	0.0129768343753714	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2980.81626721813	2980.81626721813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTCTAATCTAGATCG"	-7.2081187767094	1.679771519545	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCTAATCTAGATCG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.46768500784	44.934651138636	0.0168580738725046	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2653.87343766085	2653.87343766085
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGCAGCTTTGA"	5.20115389403645	-9.41819574749144	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGCAGCTTTGA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2913.54425092626	37.4979460170614	0.0128702167489443	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2910.19887505627	2910.19887505627
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTGGCTCAGGTTCAT"	-3.14470658722575	8.92183587634889	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGGCTCAGGTTCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3084.73241840432	40.0117483139704	0.0129708975972275	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3071.3009652893	3071.3009652893
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAGGACAGGAGACT"	10.5732370811397	7.09438607776491	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated NFkB"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGACAGGAGACT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2397.80912593549	45.0309956005337	0.0187800584764916	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2390.95858298385	2390.95858298385
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAGGAGTCAAATCC"	-4.42679152908977	10.0426931151184	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGAGTCAAATCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2656.57544466879	40.0774203949003	0.0150861216741755	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2649.50866466761	2649.50866466761
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:CTTTCAACATAATGAG"	-3.6580790084904	9.44991014087526	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCAACATAATGAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2602.96822799575	41.8262795809596	0.0160686861756915	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2587.1603002913	2587.1603002913
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGACCCAGTTGCGAG"	-3.82413492623027	11.9993533858093	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGACCCAGTTGCGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2822.80934319051	37.4868928613517	0.013279994609548	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2819.44860207353	2819.44860207353
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCAGTCAGTGAACAT"	-4.10088000717815	10.4965886839661	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCAGTCAGTGAACAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2238.08964874401	43.011775218477	0.0192180752199157	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2231.12102954477	2231.12102954477
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGCGTGGTATCTTCT"	-4.5235689682072	10.4127483137879	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCGTGGTATCTTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2726.99581728693	40.8879347294944	0.0149937651060182	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2722.08079386281	2722.08079386281
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGAGTGAGACCATGG"	-3.62179146233256	9.49497697437135	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAGTGAGACCATGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2743.96026705884	39.985924198438	0.0145723408164717	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2732.84143574409	2732.84143574409
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTTGCGTCGCTAAAC"	-3.64488873902019	9.59232328021852	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTGCGTCGCTAAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.60135466472	42.1363518780745	0.0173500487418989	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2424.21356991432	2424.21356991432
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCCCAGAAGCGGG"	-5.64365945282634	1.97827885234682	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCCCAGAAGCGGG"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1585.81813316717	46.1361295455417	0.0290929511906889	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1576.3214730637	1576.3214730637
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGAGTGCACCCTCTA"	-4.12509618225749	10.1092252501282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAGTGCACCCTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2741.0418497444	39.5357930110169	0.0144236371344362	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2731.63180792092	2731.63180792092
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCAATTCGTTCATT"	-3.2755905193394	9.30893991077272	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCAATTCGTTCATT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2741.65203812204	43.8607116276697	0.0159979133083982	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2733.73733958131	2733.73733958131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTCAACGATCT"	10.2347618537838	7.77925298297731	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTCAACGATCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2658.93541224808	44.5889499500897	0.0167694746343577	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2642.83722486863	2642.83722486863
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCACGTCTGTTGGA"	10.2621284919674	7.46207091892091	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCACGTCTGTTGGA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2456.4294087077	45.7085718715992	0.0186077286444987	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2453.46462823711	2453.46462823711
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCCTGCATAATCGC"	-3.81922636452373	9.76254937732545	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCCTGCATAATCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2778.09491248162	38.690490350451	0.013926986503096	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2766.47140981411	2766.47140981411
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGATCTGTTACGATC"	-3.82608375969585	10.342523551825	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGATCTGTTACGATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2557.86371255757	45.711201796006	0.017870851199613	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2552.85417702435	2552.85417702435
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAAATGAGTTGGACTT"	-2.55154238167461	8.74828240955202	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAATGAGTTGGACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.29772392522	37.145011269889	0.0145024184119306	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.69936434664	2553.69936434664
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCGTGTCACGGGCT"	-3.91829882088359	9.84388635242311	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCGTGTCACGGGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2556.17338699032	34.8432874961603	0.0136310344491871	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2553.51801338082	2553.51801338082
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACCAATCCGACATA"	-0.548687557608444	8.44606492603151	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAATCCGACATA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2168.91080829705	38.1243878805025	0.0175776651278881	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2160.97060852306	2160.97060852306
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACATGAGTGCTAGCC"	-4.15725408020671	10.3195581206116	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACATGAGTGCTAGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2615.42420554056	46.7056238305181	0.0178577623207647	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2610.30231088503	2610.30231088503
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAAGTGTAGATTGA"	-3.67717466774638	9.80815789783327	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAAGTGTAGATTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.59751656432	46.5584974230149	0.0183330221105277	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2535.41454514375	2535.41454514375
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCGAAGTACGATGG"	-4.48582492294963	10.2590856322083	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGAAGTACGATGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2724.71592483289	33.1119661567783	0.0121524471065031	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2718.89290114354	2718.89290114354
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATCGTCCGGGACT"	-3.80387125435527	9.85399911487428	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGTCCGGGACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2810.6770305061	36.9575007867335	0.013148967450052	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2809.6145495788	2809.6145495788
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCTCTAGTCAAGCG"	-4.03773866120036	10.0509433516297	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTCTAGTCAAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2562.73761982363	43.4716922940813	0.0169629898737246	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2557.20043865861	2557.20043865861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTATCCCAGGAATAT"	-7.00211892548259	1.53513596141664	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTATCCCAGGAATAT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2326.15268402607	44.8207021888258	0.0192681686359689	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2323.01515888191	2323.01515888191
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGATGAGATTAGCA"	-0.581283370882827	8.5072393187317	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGAGATTAGCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2630.90703169636	34.3649112090659	0.0130620013535439	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2626.66129729208	2626.66129729208
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTATCCTCATCGGGC"	-4.22495541992839	9.88837049091188	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTATCCTCATCGGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2581.99293366709	39.0156457846192	0.0151106710153567	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2568.96089655196	2568.96089655196
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATGCCAGAGTCAG"	-4.21195731583293	9.83645532214967	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCCAGAGTCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2579.31835454294	35.6805359818005	0.0138333199230551	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.83933502477	2571.83933502477
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCACTGTACGCTAT"	-0.477887014777023	8.84823892200319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTGTACGCTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2612.08114726625	43.337391948029	0.0165911353839007	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2598.17918767617	2598.17918767617
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGCAGCGTAGA"	-4.45285592499431	10.4106664427551	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGCAGCGTAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2647.08292678648	43.3921198786912	0.0163924293567065	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2637.54790847383	2637.54790847383
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTCCGTCGGACCAC"	1.48460950431172	-7.41861011898192	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTCCGTCGGACCAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2979.88300596636	41.9307036514225	0.0140712583572806	2673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2974.63408599348	2974.63408599348
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGGCCACTGAATC"	-4.28612313690837	10.4330177077088	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCCACTGAATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2769.32575320337	45.6080404366239	0.0164690052746115	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2761.93100710679	2761.93100710679
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGCATCGTGCG"	-2.63260732117351	8.83692929828493	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGCATCGTGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2285.39633007993	41.3715396663865	0.018102566772276	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2281.24014541426	2281.24014541426
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGACGCGCATGTTTGG"	-0.653625468642074	8.87488744342653	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACGCGCATGTTTGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2309.52575074631	32.9738184440121	0.0142773114494856	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2296.69333044215	2296.69333044215
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTTTCAAGGCTGAAC"	0.781492491334122	-8.14495470440062	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTCAAGGCTGAAC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1626.900059299	45.0418221618317	0.0276856724568806	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1626.900059299	1626.900059299
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTGATTCCAAATGC"	-4.16862235489543	10.6465673216614	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTGATTCCAAATGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2510.05748773816	42.7647861659576	0.017037373197573	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2502.38997143605	2502.38997143605
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGATGTCAGTCCCGA"	-4.45201716843303	10.4805488356384	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTCAGTCCCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2897.29947700575	41.4892591778024	0.0143199760698124	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2887.59554510897	2887.59554510897
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAGGCAGTATGAGCG"	-4.31593165817912	10.8957214125427	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGCAGTATGAGCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2699.68097259035	41.4380342784351	0.0153492337424875	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2692.53415778321	2692.53415778321
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGTTCCACATGGTT"	-4.30345807495769	9.90790174091188	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGTTCCACATGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.60315611869	35.4587378696461	0.0134639639185062	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2630.18663646683	2630.18663646683
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGGTAAGCTGAGCA"	-4.31382451477702	13.0958356627258	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGTAAGCTGAGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2761.11212425205	45.9863292122797	0.0166550024565688	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2753.76923262499	2753.76923262499
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGAGTATCCTGTAAG"	10.1754099327022	7.06348035419313	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGTATCCTGTAAG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2273.95901417484	43.1127512204761	0.018959335217447	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2263.68705301019	2263.68705301019
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGTTCAAGTCCTGTA"	-3.44088159027751	9.48500154102174	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTTCAAGTCCTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2393.29852029205	41.6477072869075	0.0174018021294833	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2391.49665372882	2391.49665372882
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGATCCCAAATCAGA"	-4.14945350113566	10.5378532179627	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGATCCCAAATCAGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2759.00263749886	42.7192025963155	0.0154835671469463	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2741.5879109672	2741.5879109672
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCGTCCTGGTG"	10.0717960792476	6.63684127414552	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCGTCCTGGTG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2300.17833257094	41.5371376991362	0.0180582249258515	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2294.44711853272	2294.44711853272
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTAACCGTCTCAAGT"	-3.73213015022929	9.49933431232301	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTAACCGTCTCAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2847.98178044085	39.9137774529446	0.0140147587063448	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2834.66394803586	2834.66394803586
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGATGATCTGTAACG"	-4.04996381226237	10.0971212157044	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGATGATCTGTAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2539.46105552442	43.8357574074427	0.0172618348732229	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2533.0826954013	2533.0826954013
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGAGAAGTTGGCTT"	4.80605091628377	-9.04096319591673	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAGAAGTTGGCTT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.90394691783	39.9050133656463	0.0163887423223241	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2433.44516700646	2433.44516700646
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGCATTCAGAATAG"	-1.04250226441081	8.96839997852174	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCATTCAGAATAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2513.87823502091	45.7039443179143	0.018180651584954	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2503.14754409515	2503.14754409515
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACTTCACAGTACTAC"	-4.33357415619548	10.2886504896912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTCACAGTACTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3073.79847867194	46.2233736554414	0.0150378673085337	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3065.63160548709	3065.63160548709
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCGGCATCCTAGAGT"	9.60546268996541	8.01718137348024	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGCATCCTAGAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2538.88441610101	38.9386515353385	0.0153369138383766	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2531.11429783501	2531.11429783501
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTAAGATCAACACGT"	-2.98932753029521	9.04863450610963	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTAAGATCAACACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.41348502333	44.0158331415305	0.0181328123177611	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2419.83536188899	2419.83536188899
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGCGCCAGCCGTCA"	-6.13659844818767	2.84349558437196	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.238095238095238	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCGCCAGCCGTCA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2049.83290050384	48.7519367522688	0.0237833711910301	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2040.15014070898	2040.15014070898
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTAGACCCGCT"	5.18886627730672	-9.37583162700804	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTAGACCCGCT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.07420226553	42.8110787549812	0.0166510475338509	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2564.84149430896	2564.84149430896
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGAGGTGTTATCG"	-4.45093760910686	10.3589095839295	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGAGGTGTTATCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2867.73665188375	37.8267569160841	0.0131904569728314	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2861.70625925807	2861.70625925807
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGCAATCCATGCAA"	-2.38517389717754	8.60659310901491	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCAATCCATGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2716.15125012758	40.9597392386291	0.0150800656762782	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2705.32424339735	2705.32424339735
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGAACGCAACTTGGT"	9.98285831984822	7.55558250034181	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGAACGCAACTTGGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2417.92873077358	48.5327040853138	0.0200720159645841	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2404.72186367578	2404.72186367578
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTTCTTACTGT"	-3.61937151375468	9.37676427448121	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTTCTTACTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.35217849159	41.7520814392052	0.0170114467699846	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2450.60107436091	2450.60107436091
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTAGATCTTCGATT"	-3.85419450226482	9.65353772724	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTAGATCTTCGATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.92861334955	38.0979411766293	0.0148708051341129	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2554.41743280347	2554.41743280347
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGAACACATACCGTA"	-0.299039105803329	8.58391568744508	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGAACACATACCGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2274.69260233252	34.12866200527	0.0150036369618795	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2270.93629347476	2270.93629347476
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGTTAGTAGGTACG"	-4.77247367325481	-4.97991087352904	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGTTAGTAGGTACG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3283.55727556383	39.1712176881036	0.0119295064470521	3397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3275.11085546076	3275.11085546076
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGGTTAGAAGCGCT"	-2.39559612694438	8.62200734699098	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGTTAGAAGCGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2621.59714160273	45.7995837721598	0.0174701074567696	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2612.14627036674	2612.14627036674
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTACCAGTTGGTACT"	-4.22164235535319	9.77802369678346	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACCAGTTGGTACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2620.07010060482	41.1620549987172	0.0157102876710113	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2615.19154978231	2615.19154978231
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACAGCCTCAGTCCGG"	-3.99213538590129	9.80287358844606	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACAGCCTCAGTCCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2048.606384686	31.6122408849961	0.0154310955590629	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2043.45786051869	2043.45786051869
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTGATGGAGCGATTCT"	-7.0984972518986	1.70227406108705	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGATGGAGCGATTCT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2838.7094603857	40.0439704657412	0.0141063997653005	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2829.08740532764	2829.08740532764
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGTAGTGTCTGCAAT"	3.72292270240132	-8.04888536846312	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTAGTGTCTGCAAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.4541008804	37.3131822840122	0.0136805903615272	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2721.77788932001	2721.77788932001
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTGTTCAGTCCGCCA"	-2.54986796799358	9.07650182330934	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGTTCAGTCCGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2699.74498397358	40.2248267914661	0.0148994912594529	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2695.91099417623	2695.91099417623
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGTCATCAAAGGAT"	2.52681006964986	-5.18234255230101	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGTCATCAAAGGAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2469.2103557565	33.3906007625152	0.0135227850007479	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2465.80360145391	2465.80360145391
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCATTGCAACAAAGT"	-1.66285822811778	8.86050222003785	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCATTGCAACAAAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2473.41075961131	38.2649604485253	0.0154705239717395	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2467.8780743963	2467.8780743963
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCCTCGTTGGAGAC"	4.71820797499959	-8.83182718670043	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCCTCGTTGGAGAC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.51173359697	41.5759052737954	0.0153048870577651	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2711.64244606899	2711.64244606899
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGATCGGTCTGTCAA"	-2.62947521629985	8.5711517103943	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGGTCTGTCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2911.55841295704	43.866050375371	0.015066175619269	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2899.76440972557	2899.76440972557
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATGAGTACTTCCC"	-3.86746178093608	9.71910379016725	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATGAGTACTTCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2765.33734918122	39.7587731091965	0.014377548952922	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2753.60406242333	2753.60406242333
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTTCACAGTAGTCAA"	-6.9490889114445	1.69288227641908	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCACAGTAGTCAA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2644.17792426548	54.7737030651657	0.0207148325997696	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2632.26741765311	2632.26741765311
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGCTTCAAAGGCTG"	-3.79923901978191	11.9352082976135	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGCTTCAAAGGCTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2568.96492482005	39.7467147193558	0.0154718790962629	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2556.06709800662	2556.06709800662
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATTTCAGCAGGAT"	0.944165607064408	-7.16222002422484	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATTTCAGCAGGAT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2944.58965700895	44.8861220447968	0.015243591560527	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2936.1698413336	2936.1698413336
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATCTTCATTGACAC"	-4.29218230667766	10.3141011961731	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCTTCATTGACAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3102.138463865	42.903612049296	0.0138303343158454	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3089.64273980861	3089.64273980861
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATCTTTCCCGTGTT"	-3.54539714279826	11.979426360968	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCTTTCCCGTGTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2930.92714466318	39.9440605377419	0.0136284726866973	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2919.84002290024	2919.84002290024
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACCTTCAGCTAAATG"	-4.11535201492961	9.73946855151979	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCTTCAGCTAAATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2909.93367946449	35.0132792333131	0.0120323289428907	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2905.50362637423	2905.50362637423
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCTCCGTAGAGACC"	-3.0445741218632	9.27851960742799	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTCCGTAGAGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2056.10393001243	45.2817612776932	0.0220230896973284	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2051.63921813532	2051.63921813532
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGGTACAGAGATGCC"	-4.22848449173625	10.381809211615	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTACAGAGATGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2475.51735504275	42.9933102232673	0.0173674040845191	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2466.49551582762	2466.49551582762
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCATGAGCCTGGAA"	-4.11994872513469	9.84836480701295	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCATGAGCCTGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2746.3118463571	35.7421126378803	0.0130145863388716	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2739.87363490641	2739.87363490641
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATGGTGTAAGGTCG"	0.0282556089455306	-6.39063265239867	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTGTAAGGTCG"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2426.54006956806	44.4912351688722	0.0183352567414194	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2425.55621183283	2425.55621183283
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACGCTGGTCCGGTCA"	-0.511330704123336	8.5408725508484	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGGTCCGGTCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2441.8199154569	39.8621405670979	0.0163247667507204	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2433.75764580443	2433.75764580443
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTGGGTCCGTTGGG"	-4.10411725464519	10.3590535887512	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTGGGTCCGTTGGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.11146581151	39.7682716258202	0.0146200889653454	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2706.54408453826	2706.54408453826
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCGGTTCTGGTCAA"	-2.59380326691325	9.16311833942262	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGGTTCTGGTCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2619.18693507124	40.4453373531051	0.0154419437618358	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2612.2025874178	2612.2025874178
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAGCAGGCCTGAA"	0.275768433778924	8.97726152026979	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAGCAGGCCTGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1508.27866293809	33.2221634038297	0.0220265420576286	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1505.86166751206	1505.86166751206
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCCTCGTGCGAACA"	-2.44200835648234	8.62820718372194	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCCTCGTGCGAACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2682.11129456829	41.8402736821716	0.0155997529882168	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2671.0223423227	2671.0223423227
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAAGAATCTTTGCGC"	-1.96501646462138	8.7042083510193	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAATCTTTGCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2387.34002420259	46.90669311659	0.0196480989892747	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2383.50680165113	2383.50680165113
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCGTAAAGGTTGTTC"	3.84070696410481	-8.30411055004271	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTAAAGGTTGTTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3175.52811070763	35.7745476161861	0.0112657001824538	2746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3171.58377482034	3171.58377482034
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGACTAGACTCAAA"	-4.31916795197185	10.93736169422	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTAGACTCAAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2863.3720786893	41.3580108320817	0.0144438129923419	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2857.08795006752	2857.08795006752
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGACTAGGGTAATT"	-4.38699803772624	10.658122039679	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTAGGGTAATT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2776.62542427708	38.5292972471845	0.0138763035554988	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2767.61231217093	2767.61231217093
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGACTAGGTAAGAG"	1.96859290179555	-5.32945396816405	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTAGGTAAGAG"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2726.75343082182	42.4997898543145	0.0155862240325505	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2720.30149557382	2720.30149557382
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGACTCATCCTAAG"	-4.14360557022746	10.3736133345398	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTCATCCTAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.13921933807	34.3175063514269	0.0141390761922532	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2415.19895298254	2415.19895298254
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGAGTCAACGGTAG"	-4.28506265106853	10.6808175810608	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGAGTCAACGGTAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2653.59879616934	44.402262650685	0.0167328469981155	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2648.57328901337	2648.57328901337
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAACCCGTACGGTTT"	1.25268556651418	-6.31623175060423	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAACCCGTACGGTTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.15146033585	39.2993978470456	0.0144315872324629	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2716.55826714915	2716.55826714915
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCACGAGAAGGGAT"	-3.46221743050273	9.49165818775026	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCACGAGAAGGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.71775326679	40.8279686544869	0.0168521358294562	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2415.95669524712	2415.95669524712
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTGTAACGATA"	-2.45193920555766	8.71967694843141	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTGTAACGATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2507.98818659363	42.1146133387372	0.0167921896777104	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2503.99790252854	2503.99790252854
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAACTTCAAGACCGA"	-3.74861011925395	10.0342559584412	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAACTTCAAGACCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.9993455778	47.5763871358718	0.0190839950360457	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2484.36507131637	2484.36507131637
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATCACGTCTTCGTAT"	-2.49684629860576	9.31505200946657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCACGTCTTCGTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2498.42708805284	39.8900694211428	0.0159660730592828	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2493.84324291819	2493.84324291819
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCCTAGTTCCTAAG"	-4.44064269486125	9.75880715930787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCCTAGTTCCTAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2921.03901496961	36.6478402064882	0.0125461659425557	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2907.99905550992	2907.99905550992
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGTACAGGAGGTT"	-2.95038638535197	9.08458612048952	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGTACAGGAGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2467.68247755953	38.076107340867	0.0154299054627657	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2457.2424589065	2457.2424589065
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGGAGGTCATACCA"	-4.12928901138957	9.71902463519899	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGAGGTCATACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2861.83734290041	36.6001417135893	0.0127890363176601	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2859.72752404286	2859.72752404286
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCAGTATCATTCATC"	11.5884233909542	-2.99810054218444	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.17910447761194	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGTATCATTCATC"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2897.27546326696	49.0747974912245	0.0169382573778083	4327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	2890.08161719158	2890.08161719158
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAGGAAAGTGCACCC"	-0.144384140998679	8.76563069904176	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGAAAGTGCACCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.97499402108	39.9642376372408	0.018190574651965	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2183.33363855821	2183.33363855821
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGATTTCTGCCTCA"	-4.32299695435222	10.069366432074	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGATTTCTGCCTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2949.61488778828	36.6100303698233	0.0124118001035975	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2946.31608868151	2946.31608868151
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGAAGCACCTTCGT"	-3.8221198123997	9.87714860523073	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGAAGCACCTTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2369.27731443924	45.8452078411549	0.0193498699209913	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2363.04309628808	2363.04309628808
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGACGTCTCACGGACC"	-0.846866051585037	8.80195615375368	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGACGTCTCACGGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2274.79482000832	37.4795986067028	0.016476034795334	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2265.94992064799	2265.94992064799
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGACTGTTACGTAC"	-2.63668356362041	8.63979814136354	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGACTGTTACGTAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2713.82718803705	38.1609393147669	0.0140616688796494	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2706.386217861	2706.386217861
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGGCGGTATACGGG"	-0.792705575854141	9.14471433246461	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGGCGGTATACGGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2504.47227916987	42.6975959374508	0.0170485400427763	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2497.36165129682	2497.36165129682
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGAGGCACCTTCCA"	-2.6368650001591	8.99873063648073	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGAGGCACCTTCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2450.00187300784	40.8272334547735	0.0166641641806789	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2440.11304922499	2440.11304922499
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGAGGCACGCTATA"	4.25657381591145	-8.4564886323181	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGAGGCACGCTATA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2382.18670737604	43.4040470653699	0.0182202540762135	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2377.83240030189	2377.83240030189
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGACTTGTTTCACTT"	-2.15118847313579	8.96095368945924	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACTTGTTTCACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2659.00344387047	42.4424677680658	0.0159617949596508	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2651.57823331957	2651.57823331957
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAACCCAGTCGTGGTC"	-0.468546668917495	8.79323384845582	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAACCCAGTCGTGGTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2367.45227313719	30.849448480409	0.0130306527529399	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.45230774924	2357.45230774924
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACGTCAAGTCCAT"	-2.89129505577739	9.17525384509889	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACGTCAAGTCCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.86006240395	36.2070167290747	0.0142555163825857	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2528.33547417393	2528.33547417393
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATGAGTTGCATGT"	-3.62137947502788	9.62740991199342	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATGAGTTGCATGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2587.82225210436	36.5264980023703	0.0141147630880242	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2584.37106216424	2584.37106216424
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCCGAGTCTCAGTCC"	1.3357763486797	-6.46680691158446	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCCGAGTCTCAGTCC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2714.41486145808	41.9156639888244	0.0154418783156488	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2711.77027171446	2711.77027171446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACTGCAGAGGAAA"	-4.04226670685466	9.64995000446168	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACTGCAGAGGAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.94141803602	39.629864528293	0.0158968294407472	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2489.44174997831	2489.44174997831
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGACGAGGTCGTGA"	-2.88447461548503	8.83407018268434	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGACGAGGTCGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2255.66511022943	45.5544718753168	0.0201955829651873	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2252.87733831611	2252.87733831611
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTACTGGTATCCCAA"	-0.540518323809463	8.88258645618287	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACTGGTATCCCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2331.46688555478	40.92213630088	0.0175520984468722	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2321.80274362763	2321.80274362763
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTAGTCCAACGGCCT"	-4.42630038681682	10.850634551886	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTAGTCCAACGGCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2431.84207780014	41.06494094643	0.0168863518405676	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2422.09407052861	2422.09407052861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGGAGTCTCTCGCA"	-2.73056493225749	8.87344071948854	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGAGTCTCTCGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2662.74519868037	43.7502943202485	0.0164305222827669	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2653.13582992836	2653.13582992836
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTAGTCGTGCGTGCT"	-3.21423802796062	9.39086053455202	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTAGTCGTGCGTGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2260.54036704423	41.9165968782095	0.0185427331841977	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2255.37437086531	2255.37437086531
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGATATCCAATCTT"	10.1961666541988	7.71202371204225	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGATATCCAATCTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2400.1019853227	44.5007371104565	0.0185411859090118	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2390.9176460121	2390.9176460121
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTATGCTCGCATAGT"	-2.17628393593486	9.41922280872194	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTATGCTCGCATAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2459.45133118171	40.5215606550968	0.0164758538383547	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.37063931415	2452.37063931415
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGGGCTCACACGAT"	-3.93748507919963	9.61271474445192	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGGCTCACACGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2722.69680292936	35.8670158668482	0.0131733418969966	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2710.63943037861	2710.63943037861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCACAAGCTCGACC"	-0.371520857245284	8.70370767200319	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCACAAGCTCGACC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1841.12957498168	44.3625090923293	0.0240952672180994	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1833.39766107901	1833.39766107901
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCTCAATCGATTTCT"	-3.42922602120097	-7.21138479625853	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	40	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.8	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTCAATCGATTTCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3020.91525010844	32.9137874443	0.0108953031512945	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3014.6455126413	3014.6455126413
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGTCCAGCACTCGC"	-0.999060253531295	8.37719056690065	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTCCAGCACTCGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2510.83410995649	42.5737280497317	0.0169560099095792	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2502.28234660058	2502.28234660058
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGGCAGTGTACATC"	0.000992097973269192	9.3593129881653	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGCAGTGTACATC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2198.17509792938	46.6051319099628	0.0212017377295665	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2194.59338099483	2194.59338099483
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACAACATCCTTGACC"	-3.1431282562321	9.62120435321657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAACATCCTTGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2609.13890241141	44.1846311229406	0.0169345645347223	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2602.47234548334	2602.47234548334
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCCTCAGAAATTCG"	-4.06261287155803	10.4708680876526	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCCTCAGAAATTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.99161965975	40.5192533783848	0.0156445499942227	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2586.61992574815	2586.61992574815
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCCTCGTACTCAAC"	-4.17114005509074	9.93308732593385	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCCTCGTACTCAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2565.80620451207	44.0301688636132	0.0171603641717696	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.21963625447	2562.21963625447
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTTCGGTTAGT"	-3.86595426026042	9.69632241809694	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTTCGGTTAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2748.68409532508	40.3788586647752	0.0146902507761627	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2745.64699297004	2745.64699297004
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAAGACAGATGGTCG"	-2.85219989243205	8.90585897052614	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGACAGATGGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2456.70837559054	40.9271524168299	0.0166593450095565	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2453.37199915749	2453.37199915749
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAAGTCCACACCTTC"	3.90712084349934	-8.44309904491576	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAAGTCCACACCTTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2811.95267789432	45.0921089469185	0.0160358704829574	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2807.31279847173	2807.31279847173
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAAGCAGTGTGTCGC"	-4.87078986588176	-4.86011888897093	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MEP"	"MEP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCAGTGTGTCGC"	"MEP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1702.06951059123	26.7261396022614	0.0157021434412381	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1685.04103899426	1685.04103899426
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCATGGTCGAAGCCC"	-2.74987206879314	8.79653356159059	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATGGTCGAAGCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2436.30669799671	43.0656672836261	0.017676619827478	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2435.02420887004	2435.02420887004
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTCGATTCTGTCAGA"	-2.35530076447185	8.69214150989381	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCGATTCTGTCAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2282.90381025773	41.9707935760751	0.0183848278615544	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2278.44515602339	2278.44515602339
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGCCTTCGGTTGTA"	-3.72413788262065	10.2807826765808	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCCTTCGGTTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.40819802329	46.331856349679	0.0178514718359009	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2583.48501733563	2583.48501733563
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCCATTTCGCAGATT"	0.811208506196183	-7.16297438060912	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCCATTTCGCAGATT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2669.67747335116	42.8324605676689	0.0160440581288281	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2666.65139756249	2666.65139756249
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCGTGCAATGTTGC"	-4.24554286423381	10.3630094298157	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCGTGCAATGTTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2653.6951878668	40.8585410265816	0.0153968478419807	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2646.63144142658	2646.63144142658
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAATCGTCGGCACTG"	-0.233616898686248	8.51350019061891	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATCGTCGGCACTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2403.33310741	37.4072311824952	0.0155647301105121	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2387.67649080406	2387.67649080406
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGATTCTTCAACCGAT"	-4.25840316239055	10.4954843291077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATTCTTCAACCGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2818.45016975273	38.8156872222547	0.0137719969786303	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2812.51220304381	2812.51220304381
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAACCCATCCTATT"	-4.03152165833171	9.75016591632692	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCCATCCTATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2894.42101824321	44.5977664217313	0.0154081822031545	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2889.85263642081	2889.85263642081
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAACCAGCTGGCCT"	-2.69530401650127	8.64631650531618	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAACCAGCTGGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2412.69912734864	43.9680559524673	0.0182235967402967	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2409.83477047668	2409.83477047668
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTACAACAGAGCTGCA"	-0.0660072145169557	-6.54405929958495	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTACAACAGAGCTGCA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2971.69642283961	44.691997459325	0.0150392203980982	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2959.34683575589	2959.34683575589
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAACCTCTTACCGC"	-4.22773681107219	11.8393974074158	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCTCTTACCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2733.57608475083	45.4577528002662	0.0166294082882313	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2719.89754849498	2719.89754849498
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAGAGAGTTTCGGT"	9.93551315841023	7.61706636035768	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGAGAGTTTCGGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2363.16627198017	50.6578342757536	0.021436424036852	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2356.45916210178	2356.45916210178
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTTGGAGTCTCTTAAC"	-3.70022807541545	9.4725074538025	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGAGTCTCTTAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2687.37036595256	37.1889909002437	0.0138384315654466	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2682.47330907657	2682.47330907657
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTCTAGTGGTCTCG"	-0.820147852331954	8.61232278430787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCTAGTGGTCTCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2674.07731156865	38.9582866560353	0.0145688707231811	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2668.0508585941	2668.0508585941
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACAAGATCGTCACCT"	-2.82198224487956	9.00076100910035	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAGATCGTCACCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2416.13779249125	40.2199304383531	0.0166463728034662	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2411.04702959271	2411.04702959271
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTTACTCTCTCTAA"	-4.52565036240275	10.4214324721131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTACTCTCTCTAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2975.71456239238	36.5026842435178	0.0122668634636014	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2964.12107910163	2964.12107910163
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAGGAGTTACCCAA"	-4.29309306564982	10.068896270636	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGGAGTTACCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2760.89462058224	36.7763690463867	0.0133204537298244	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2751.21221337176	2751.21221337176
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACCGTTGTAACATCC"	-0.788012425333816	8.55235192859498	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTGTAACATCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2436.62003246825	40.4570176328159	0.0166037449802273	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2431.7198851944	2431.7198851944
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGAAATCTGAGGTT"	-0.273779819638091	8.73289868915407	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGAAATCTGAGGTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2360.65723222224	37.6442390162661	0.015946507820972	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2348.17014996402	2348.17014996402
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAGAGTCTACTGCC"	-3.9445985359257	10.6436872252258	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGAGTCTACTGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.00507477657	41.0897063375302	0.0177569646607182	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2307.00217836008	2307.00217836008
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTGATGTAGTCGGA"	-4.00846896591838	9.65491674030153	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTGATGTAGTCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2756.97549431783	41.6943449895278	0.0151232192942812	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2746.58017603252	2746.58017603252
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATTCGACATCAGCGC"	-0.318461934954482	8.73359773242799	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCGACATCAGCGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2522.16724070882	34.999480221346	0.0138767483997254	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2509.46734582768	2509.46734582768
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACTGTCAAGTTCGT"	1.32009079036061	-7.08360435878905	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACTGTCAAGTTCGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2689.87343782263	38.1394540700555	0.0141789028189104	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2684.24541040305	2684.24541040305
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGGGCGCAGACCTAT"	-1.15114734593089	8.85715768421022	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGCGCAGACCTAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2492.87986869065	39.0464369228246	0.0156631843408215	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2485.95433183286	2485.95433183286
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGGTAGTCCCTAAA"	-0.634838501841384	8.13747785175172	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGGTAGTCCCTAAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2212.8535898736	33.7759545315223	0.015263528814598	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2203.33047646247	2203.33047646247
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACATTTCAACGCTA"	4.11917986449544	-8.27497961437377	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACATTTCAACGCTA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2888.01902743344	34.0945620006666	0.0118055184805919	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2881.48658906692	2881.48658906692
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATAGCTGTCCAGCAC"	-1.69384775582011	8.6930417784485	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATAGCTGTCCAGCAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2798.59913971035	39.7314700902355	0.0141969135652445	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2791.83459996284	2791.83459996284
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATCCCGTATCTTCT"	-1.80234191837962	9.35421273792116	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCCCGTATCTTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2636.14686369954	42.3930683325918	0.0160814516506481	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2627.74671096179	2627.74671096179
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGGTCACACTGTCGG"	-4.36605678024943	10.2071933516297	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGTCACACTGTCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2473.36322619759	41.0724552684121	0.016605913289798	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2473.36322619759	2473.36322619759
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTCCATCACGGTCTG"	10.2832485633785	7.74041316593019	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATCACGGTCTG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2259.75906561742	47.0216710330462	0.0208082674602298	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2256.06207822461	2256.06207822461
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTGAGAGTCGCCAC"	-3.32614217224773	13.0521249541077	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGAGAGTCGCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2738.89929697175	37.9482916943963	0.0138553073989809	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2730.88122417082	2730.88122417082
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACTCGCAACCAGAG"	-4.68018899384196	-4.2886910668579	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.010989010989011	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTCGCAACCAGAG"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3796.73362226027	39.833733344677	0.0104915796860574	5587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	3789.98258026523	3789.98258026523
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGATGATCAGCAATC"	-3.37433133545573	9.40106008136598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGATGATCAGCAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2620.39770731343	39.3361984976885	0.015011537518867	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2616.7254799301	2616.7254799301
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGGAGAGTCAGTTTG"	-2.90967760506328	8.98568818652955	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAGAGTCAGTTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2562.08870357399	45.4105115263034	0.0177240200399611	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2559.57826101217	2559.57826101217
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCTTTGTCGACTGC"	-1.73168776455577	8.52311322772828	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCTTTGTCGACTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2410.61516539374	35.1302933521613	0.0145731653299473	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2405.77648599609	2405.77648599609
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTATTGGCACTGGCCA"	-7.05414185944255	1.63386640632478	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTGGCACTGGCCA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2734.81704584464	51.0159425341548	0.0186542432926802	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2727.12233185656	2727.12233185656
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACTCGCAGCTATTG"	-3.68193016472514	9.40529058063356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTCGCAGCTATTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3046.16859467104	44.3236551304526	0.0145506244165186	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3039.34311549652	3039.34311549652
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCGTGAGCAGGCTA"	1.7262690263683	-7.6162410012451	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCGTGAGCAGGCTA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2156.62040348461	36.7607338144498	0.017045528158341	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2152.91026453762	2152.91026453762
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTACGAAGGGCCAAT"	1.70314170893971	-5.56567337429198	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACGAAGGGCCAAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2881.27622850924	32.922587980805	0.0114263907275003	2791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2877.05685958099	2877.05685958099
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCCCTTCAATCGGT"	-4.32994685593303	10.7413034209046	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCCCTTCAATCGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2660.41484133024	38.8416338832179	0.0145998410773399	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2650.54493381577	2650.54493381577
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACCGGTGATTCAC"	-3.99353537979777	12.2847575911316	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACCGGTGATTCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2870.80643141897	35.8052785085018	0.0124722022762099	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2859.99442604513	2859.99442604513
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCAACCAATGAGCG"	-4.26070914688762	10.2647638090881	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCAACCAATGAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2276.24775623594	38.4841552460888	0.0169068393985931	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2270.52289248849	2270.52289248849
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACCGGTTATGTCG"	-3.85732303085979	9.4935731657776	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACCGGTTATGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2799.94014596044	35.4771746130719	0.0126706903589549	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2796.95012748225	2796.95012748225
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGGGCCATGACCCG"	-3.47524438324626	9.70502469623414	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGGCCATGACCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2753.80638017405	45.1302069414958	0.0163883006686343	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2743.09357643323	2743.09357643323
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCAAGCGAGCTAGCCC"	-4.14233479920085	10.5536737211975	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAAGCGAGCTAGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2244.08554750008	37.5843846335456	0.0167481960192715	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2236.39450673957	2236.39450673957
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACGCAGCTCAGAG"	4.39253201064412	-8.54127981578978	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCAGCTCAGAG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2824.42301160748	31.039786867166	0.0109897797672666	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2823.18539435339	2823.18539435339
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGACTCAGCATCAGG"	-0.360072712332565	8.64905831897584	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGACTCAGCATCAGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2273.23048323356	48.5245856385485	0.0213460913868816	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2264.85969409842	2264.85969409842
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGCTAGTCTTCGAA"	-2.46838484230693	8.6613034971985	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGCTAGTCTTCGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.20861490139	36.0131115981838	0.0143523784289251	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2506.319114013	2506.319114013
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCGTAGTGCAACG"	-4.31807599487956	10.4262752302918	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCGTAGTGCAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2523.72383484713	38.6361391670855	0.0153091786960223	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2522.51439311294	2522.51439311294
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGACTCGTCAGCTTA"	-1.10206339779552	8.72557447040407	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGACTCGTCAGCTTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2320.3673780342	39.1723631446757	0.0168819659832756	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2310.3200048868	2310.3200048868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCTCAGTCATCGCG"	-4.37345204773601	10.5636653670105	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTCAGTCATCGCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2697.48913547297	41.8230630066363	0.0155044416886236	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2692.11324069276	2692.11324069276
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATACTCGGAAACG"	-3.09028087082561	8.86366746509401	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATACTCGGAAACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2754.90636528515	34.7549713962135	0.0126156633975529	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2750.50655634428	2750.50655634428
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCACAATCATTACTC"	10.4646097618038	7.528368926886	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCACAATCATTACTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2560.9290404124	42.174050736662	0.0164682621311016	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2553.19039366689	2553.19039366689
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCAACATGGCTAT"	14.2047954994137	1.83537623966066	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCAACATGGCTAT"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1298.10689782883	23.1420421850708	0.0178275319419205	2979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1275.9379841929	1275.9379841929
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCATTGCATATGGCT"	-4.01721749725993	9.76001832568971	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCATTGCATATGGCT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2894.30432454065	38.7723383457949	0.0133960820971887	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2880.54922503565	2880.54922503565
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCATCTCCAACCGG"	-3.00159726563151	8.92341802203981	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCATCTCCAACCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2622.37059147898	41.0226075751159	0.0156433296302258	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2614.27686401698	2614.27686401698
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGGATAGTCTGCATA"	-3.97075448456462	10.1321706541809	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGATAGTCTGCATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2617.38128524709	39.2376339339284	0.0149911799840138	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2605.9684397121	2605.9684397121
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATCAGTTAATCGC"	-2.13761935654338	8.74716756427614	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATCAGTTAATCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2460.67046263777	47.3474646012837	0.019241692587527	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2453.23707173551	2453.23707173551
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGAGTATGACA"	-0.574065009981948	8.22918508136598	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGAGTATGACA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2159.61171089951	38.1382852022183	0.0176597881043779	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2145.54571782643	2145.54571782643
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGAATAGATGCCGA"	-0.209246109158355	8.35378739917604	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATAGATGCCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2339.15897433343	38.7494913369269	0.0165655655567271	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2329.63818083446	2329.63818083446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATTGCAAAGACTA"	-2.28959737244304	8.6116266020569	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATTGCAAAGACTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2126.98086371741	39.0364393050557	0.0183529809651555	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2119.72384788589	2119.72384788589
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTCATAGTCTCCTC"	1.08965255793874	-7.12447168743285	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCATAGTCTCCTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3026.78697912916	43.321592160793	0.0143127324319523	2493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3016.34247557314	3016.34247557314
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGTCTAGCACCCAC"	0.578509767621201	-7.26580383693846	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGTCTAGCACCCAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2328.30235309751	43.9714768378034	0.018885638619617	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2323.66813853588	2323.66813853588
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGCAATAGTAGCATA"	-5.52297292175944	2.15119669521181	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.9	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAATAGTAGCATA"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1817.6294040318	45.7082903722629	0.0251472001227943	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	1803.48369920765	1803.48369920765
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCGTTGTCGGATTT"	-3.71977267685588	9.51789758289186	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGTTGTCGGATTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2621.82598319324	32.9973760604954	0.0125856469010603	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2617.19104497819	2617.19104497819
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCGTTGTGAATTGA"	5.31692232665364	-9.48925974285277	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGTTGTGAATTGA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2631.48163976704	42.0647211686122	0.0159851851264811	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2620.65718200222	2620.65718200222
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGAGAGTCCTACACC"	-3.72256384316142	9.70085332477418	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGAGTCCTACACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2313.93315193741	47.168624146802	0.0203846096881877	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2306.50701638717	2306.50701638717
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATCATTCCGGCTTT"	0.653966863721055	-6.15676643764647	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCATTCCGGCTTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3412.38286878942	31.9831795318744	0.00937268201185783	3492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3402.04488693497	3402.04488693497
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTCATGTCCTAGCGG"	-3.39307198944743	9.22826383197633	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCATGTCCTAGCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2640.59676081914	41.2422506216264	0.015618534125912	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2630.58937662406	2630.58937662406
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGCAGGTGACGTCC"	-0.656712333590347	8.64255902850953	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGCAGGTGACGTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2801.01303700152	35.8923444086752	0.0128140583190923	3375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2790.8009649177	2790.8009649177
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGAACTCCGTTGAA"	-2.58848915520366	8.5148830183777	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGAACTCCGTTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2822.42580172222	45.3736880677088	0.0160761314044189	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2810.19288954569	2810.19288954569
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAACATAGCATGTTC"	-2.89596257630046	8.8181695708069	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACATAGCATGTTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2754.26154681786	39.4850613307442	0.0143359883074152	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2752.02825228814	2752.02825228814
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTCCCATCTCGTCGT"	-3.8503078025883	9.61777970874635	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCCATCTCGTCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2367.03723533189	41.6396839376096	0.0175914782057795	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2363.18789585276	2363.18789585276
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTAAAGTAAGAGG"	-3.83594475212749	9.63124463641969	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTAAAGTAAGAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2692.22947949126	43.7122331812875	0.0162364440008835	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.29898402304	2689.29898402304
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTTGGGAGGGCAACT"	5.05036749419515	-10.1065235367981	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTGGGAGGGCAACT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2101.88783885321	48.094932461371	0.0228817787383039	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2093.77281722495	2093.77281722495
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCGTAACACAGCATT"	-4.09252868118938	9.80280397022096	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTAACACAGCATT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2550.31983351708	38.0706922325752	0.0149278109091411	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2546.36900228494	2546.36900228494
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGTTCGGTTACGCCG"	-4.39539227905925	9.99933145130006	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTTCGGTTACGCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2626.31911077655	34.5565277040687	0.0131577794801375	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2619.13018862448	2619.13018862448
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGGTGCGTGCT"	2.24083795127217	-7.49265768444213	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGGTGCGTGCT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.456853583	36.9351890678006	0.0145904872980643	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2528.86036242621	2528.86036242621
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGCACGCAGGTGTTT"	1.92877854880635	-6.44583275234374	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGCACGCAGGTGTTT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2769.90181799928	41.7451964806318	0.0150710022316909	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2767.85665892371	2767.85665892371
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGCACGGTTGTCTAG"	-2.86648331108745	9.75470349872438	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGCACGGTTGTCTAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2333.64851072179	48.9184569538905	0.020962221486714	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2328.1370512463	2328.1370512463
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCGAGGCAAATCGGG"	-4.11184392395671	11.3125419386658	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCGAGGCAAATCGGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2791.14105210924	39.7633264953018	0.0142462619240447	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2784.17162988467	2784.17162988467
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTCCCAAGGGAGGCA"	-4.13069663468059	10.8001775511536	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCCCAAGGGAGGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2466.37832629908	35.0260477875524	0.0142014091731461	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2459.338327361	2459.338327361
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTCCGTGGAGGTT"	-4.44447932663615	10.0743236311707	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTCCGTGGAGGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2718.68103949862	40.3942390426762	0.014858028012777	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2716.37197948102	2716.37197948102
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTTCCGCATAA"	-4.19459042969401	9.99658010089723	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTTCCGCATAA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2889.05106015443	44.3642624588266	0.0153559980544114	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2880.66484866486	2880.66484866486
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGCGGAGCACACAG"	-3.89506135407146	9.80338475787965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGCGGAGCACACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2761.50074457357	40.8223208647034	0.01478265792429	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2753.42924736611	2753.42924736611
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGTAGCTAGGTAAAGG"	-4.13871226730998	10.4971084364685	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGCTAGGTAAAGG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2149.95755048146	47.0181533533091	0.0218693403238496	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2145.74120451215	2145.74120451215
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGAGAAGAAATCCA"	-4.33413205567058	10.618342376593	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAGAAGAAATCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2772.57490956164	42.6637909742808	0.0153877865759905	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2766.48707998899	2766.48707998899
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGTCGGTATGATCC"	-0.35299320045169	8.48818967426149	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTCGGTATGATCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2269.53729713198	37.7669200771626	0.0166408016845058	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2262.41773925867	2262.41773925867
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGCGGTCAGGCGAA"	-0.526668230921584	8.69323728168336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGCGGTCAGGCGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2527.90671886419	34.6794928720021	0.0137186600333037	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2521.09518587814	2521.09518587814
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGGCGAGAAGAGCA"	1.72453047808949	-5.52909328853758	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGGCGAGAAGAGCA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2680.18970919511	42.470674190233	0.0158461447876343	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2672.18766531407	2672.18766531407
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTAGTCTGTTGTATGC"	0.714419205754441	9.6714877852234	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00485436893203883	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGTCTGTTGTATGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2118.0805209671	42.8021648265281	0.020207997006169	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2103.69421401589	2103.69421401589
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTTGGTACCTATG"	-3.73557863655742	9.81082723224489	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTTGGTACCTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2888.51877946251	40.3801248938633	0.0139795265244483	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2878.11891505891	2878.11891505891
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTTAGGTATTTCCT"	-4.25438294830974	10.1479472883972	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTAGGTATTTCCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2794.57765537112	38.9981092767529	0.0139549205948166	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2792.41265049419	2792.41265049419
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGACAGTTCCACTTCG"	-3.77940760079082	9.89734647357789	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACAGTTCCACTTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2638.3955882387	43.2849372624418	0.0164057798820598	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.98362647564	2628.98362647564
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTTCCGTCTTGAAC"	3.19577064093892	-7.8613901368347	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTCCGTCTTGAAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2663.19803494754	46.2415721722751	0.0173631744862661	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2662.01617249555	2662.01617249555
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTGTGAAGTACCATC"	-4.26413140717204	10.2227535017761	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGTGAAGTACCATC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2712.26233958244	47.0812915894349	0.0173586791005929	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2707.65280130626	2707.65280130626
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATAAGCCAGTTGTTG"	0.908666034310502	-7.29076340114745	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATAAGCCAGTTGTTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2842.6519330224	35.2633859315926	0.0124051015609567	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2841.67518108958	2841.67518108958
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGCCATCGCCTATC"	-4.33296761933024	9.97614190662233	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGCCATCGCCTATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2732.07815002129	41.1235117284649	0.0150520993435508	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2727.25795999897	2727.25795999897
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAGCCACAGCATTGT"	1.3762238222057	-5.79556896602782	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCCACAGCATTGT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3351.43608810408	40.5570604074095	0.0121013975326478	3489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3340.38310621845	3340.38310621845
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGGAAGTTGGGTTT"	0.206689466803712	-6.4347396126953	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGGAAGTTGGGTTT"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2934.22062790205	42.7790976036024	0.0145793732062299	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2929.30935196236	2929.30935196236
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTACTTCGGAGCAA"	-3.62134466591533	9.73895452106325	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTACTTCGGAGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.53809671569	39.6182435869699	0.0147909949966917	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2667.24433984756	2667.24433984756
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAGAAATCATTACGG"	-4.49510465088542	-4.79880812084349	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGAAATCATTACGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3593.78065963127	39.7999901250067	0.0110746853785702	4203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3586.45559558757	3586.45559558757
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGGCTAGATTCGCT"	2.33277668532674	-7.76667168056639	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGGCTAGATTCGCT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2532.18336385593	42.3981062279532	0.0167436951182677	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2527.7868227735	2527.7868227735
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACGGGAGCGCGTTC"	2.75377549704854	-7.80921747600707	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGAGCGCGTTC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1961.57945376366	48.3581445003788	0.0246526565149296	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1959.6330486124	1959.6330486124
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGATCTACACTCCTTG"	-3.9156895679539	9.6370000609192	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATCTACACTCCTTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2787.64898824101	43.3522954579228	0.0155515617786864	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2779.98482813195	2779.98482813195
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTACAGTGAAGCTG"	-4.70813165131267	8.66703698718873	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTACAGTGAAGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3421.12559948057	38.1868706024161	0.0111620779454031	3103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3406.65800881848	3406.65800881848
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCCATGGGTCC"	5.54955877837483	-4.33892633831175	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	14	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.230769230769231	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCCATGGGTCC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2240.38376450167	47.6711646065943	0.0212781244722142	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2234.04533240153	2234.04533240153
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTACATCGGAATGG"	-0.576641957194167	9.17430875385133	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTACATCGGAATGG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2314.98407570858	43.7695155226042	0.0189070482090496	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2308.06263656127	2308.06263656127
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAACCAAGCCACCGT"	-4.02200017395671	10.0673703917297	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAACCAAGCCACCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2522.09920916858	47.8419158416695	0.0189690856203237	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2514.50925014358	2514.50925014358
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACTATCAAGTTGGG"	-3.87060199204143	9.9951772459778	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACTATCAAGTTGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2623.05750818116	38.2506689186447	0.0145824743831743	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2611.61020702751	2611.61020702751
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAGTTATCGATACAC"	-3.81403003159221	9.76944730365602	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGTTATCGATACAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2687.7777838662	46.6487495927932	0.0173558803383261	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2682.98606922162	2682.98606922162
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTAGTTCGTGGGAA"	-0.0351801020210564	9.38355062091676	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTAGTTCGTGGGAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2057.27672859151	41.629677959386	0.020235332165492	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2048.16828564917	2048.16828564917
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGTTGAGAGTAGAATC"	-3.98617158356364	9.7897624739441	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGAGAGTAGAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2569.22456791083	38.6215445609307	0.015032373986808	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.52171344049	2562.52171344049
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCATGAGTAAACTG"	-0.697131852537948	8.78245732868043	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGAGTAAACTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.06987012684	38.7246269727896	0.0165202528586292	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2337.89062605369	2337.89062605369
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTGATGTATTAAGG"	-3.5399673980778	9.6467885741028	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTGATGTATTAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2446.17401339432	38.1830201292366	0.0156092820544086	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2441.22989266246	2441.22989266246
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCATGCACTACGGC"	-3.80424437943156	9.60432813251344	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGCACTACGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2554.78599671766	40.6649349721092	0.0159171590201115	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2549.73549134252	2549.73549134252
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGGTCCAGCAC"	-4.18989978256877	10.0005330809387	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGGTCCAGCAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2688.36144462716	45.7492635622383	0.0170175270344212	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2680.47065465556	2680.47065465556
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGATGTTCCTACTGC"	-0.40234468403514	8.48770902240602	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGATGTTCCTACTGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2355.57730367808	33.7633736160063	0.0143333753315109	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2343.01337764371	2343.01337764371
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCAAGTCGTAGTGT"	-3.81168590012248	9.58104322040407	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCAAGTCGTAGTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.14616884752	41.6562812826534	0.0170223919653608	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2440.63130859223	2440.63130859223
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACCAAAGCGGTATG"	-3.50529227677043	9.7904481657776	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAAGCGGTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.11749688104	41.9703455678327	0.0181995694601843	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2302.23873357066	2302.23873357066
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCATTAGCAAGCGCTC"	-4.2999132675236	10.1674585112366	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATTAGCAAGCGCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.06494281574	40.6707079396838	0.0160179864854427	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2533.26829231279	2533.26829231279
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGCTACTCCCTCGTA"	-0.561892191798049	8.83175275409547	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCTACTCCCTCGTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2484.07007082918	34.84615964461	0.0140278489136896	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2477.70330848906	2477.70330848906
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAATCCTCAGTGTCA"	-4.11634335938151	9.79875753009645	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAATCCTCAGTGTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2833.37697260683	41.9145496395347	0.0147931426156017	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2828.57104575757	2828.57104575757
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCCAGTGGGCTCT"	-4.22610364380534	10.406262374762	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCCAGTGGGCTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2587.9148644008	38.2401653947923	0.0147764387155164	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.49037218991	2585.49037218991
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGAGACAGTTTCAG"	-1.78899000111278	8.49551866138307	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGAGACAGTTTCAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.34359611536	43.5886212578029	0.0171315781894996	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2535.23764957627	2535.23764957627
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCGATCGTCGGTGTC"	-1.01299701157268	8.82793138110963	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGATCGTCGGTGTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2052.44676226998	40.2946914976036	0.019632514829782	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2047.74076157329	2047.74076157329
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCAACGTCCGCTGTT"	5.30344786223714	-9.31591989910277	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAACGTCCGCTGTT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2918.21834726694	42.955863944357	0.0147198937271391	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2911.47219987151	2911.47219987151
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGGAAGTCAAGATAG"	-1.77606723728831	8.62013433063356	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGAAGTCAAGATAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2486.64693392596	42.3198639238231	0.0170188470853833	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2481.01243609693	2481.01243609693
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGGTACAATCGTCA"	-4.11232505264934	10.2896423109802	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGGTACAATCGTCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2723.47090432546	41.2134731049672	0.0151327018179307	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2716.94087289096	2716.94087289096
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCTATCTACACAG"	-2.68846378746684	9.09517762744752	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTATCTACACAG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2624.11842443804	39.3572543710284	0.0149982767563003	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2617.2011340591	2617.2011340591
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACCATCAAATCCCA"	-3.57442174378093	9.33009717548219	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCATCAAATCCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2857.21777581329	37.2393324869227	0.0130334246140278	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2852.8591758496	2852.8591758496
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACCATTCGTGTGGC"	-2.29754100266154	8.77780912006227	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"MAIT"	"MAIT"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCATTCGTGTGGC"	"MAIT"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2543.86599581773	34.9998738377067	0.0137585367685439	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2536.6297898905	2536.6297898905
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACTGAAGAGAGTGA"	-3.53362474861797	10.087508178595	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACTGAAGAGAGTGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2587.15271396608	45.8993389182469	0.0177412561193126	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2574.44468458959	2574.44468458959
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTCGAAGGCGTCCT"	-4.26363597336467	9.91441533649293	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCGAAGGCGTCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2389.47012099174	38.2097118123577	0.0159908724016599	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2379.1008187772	2379.1008187772
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTACCGCCAGGACAGT"	10.544151921838	-0.803583704587542	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.181818181818182	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCGCCAGGACAGT"	"Ery"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1728.65383863184	34.5165210474186	0.0199672833716304	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	19	TRUE	"Ery_AML-1371"	1724.86540845615	1724.86540845615
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGAAACAAGGATGC"	-3.83659468117412	9.69647405231325	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAACAAGGATGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2457.86554132017	42.5979603442224	0.0173312818085818	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2450.28864109081	2450.28864109081
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATGGTCAAAGGTA"	5.20412554320638	-9.31198980724486	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGTCAAAGGTA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2782.12062838804	33.0277885260376	0.0118714437429601	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2776.22156919331	2776.22156919331
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATGCGGTCCACCCTA"	-3.1436816257542	-5.08961441433104	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"DC precursor"	"DC precursor"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCGGTCCACCCTA"	"DC precursor"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2711.2804618589	40.3482305391958	0.0148816144647509	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2709.34790921157	2709.34790921157
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTCCACTCTCATTTG"	-4.05542407456096	10.1998452910217	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCACTCTCATTTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.75200382827	39.6477197341914	0.0159307635606939	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2487.52271950434	2487.52271950434
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACAAGGTACGACTT"	-0.331834535033065	8.62382505023805	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACAAGGTACGACTT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2371.32622082969	34.918084515353	0.0147251290052938	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2362.8420461927	2362.8420461927
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTTGCAGGTTGACG"	-3.97447715225871	12.5157565840515	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTTGCAGGTTGACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2612.87788799876	43.1161096036128	0.0165013871492617	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2600.8192902008	2600.8192902008
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTGTCGTTCGAGCC"	-3.13012514534648	9.02761647785035	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGTCGTTCGAGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2355.01053171181	41.0594290613024	0.0174349237544416	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2352.47572504352	2352.47572504352
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCACGCAAAGACTA"	-0.290685783058959	8.87012384021608	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCACGCAAAGACTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2584.10195391544	45.9860843424565	0.0177957701215226	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2575.15041916727	2575.15041916727
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTTTCAGCGAAACC"	1.64285900172536	-5.48693039333495	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTTTCAGCGAAACC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3113.08320226667	38.2062105064292	0.0122727881087826	3116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3105.67948172211	3105.67948172211
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGTACAACGACTT"	-2.31548605385478	8.78031537616578	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGTACAACGACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2644.92242591689	41.1563105073038	0.0155604981469491	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.3766861048	2639.3766861048
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCAGTACAAGCCATT"	-3.48047838631328	9.83095452869264	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGTACAAGCCATT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2302.34057647891	40.109041926562	0.0174209855554485	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2298.1165204071	2298.1165204071
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAGGGTAGAGGTATT"	-4.82965646210368	-5.25643112575682	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGGTAGAGGTATT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3163.23069166975	42.5342278481541	0.0134464514270699	2734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3155.83905826082	3155.83905826082
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTAGGGTAGATCCGAG"	-3.60967216911967	9.47530076587526	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGGTAGATCCGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2523.33448932286	39.1444180019137	0.0155129722862934	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2520.05374425136	2520.05374425136
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGGTATCTAGACCA"	-3.60226855698283	9.71830556476442	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGTATCTAGACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2359.87488724664	39.4559944908311	0.016719528100435	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.47462716127	2357.47462716127
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCGTACAGGTG"	-4.21479354324992	11.1331844099793	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCGTACAGGTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2388.68110957004	44.2911215368511	0.0185420822224459	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2379.39349033849	2379.39349033849
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGAACGAGTTCTACG"	-4.46046815338786	10.3007287749085	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAACGAGTTCTACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2988.83706449148	42.8723627830052	0.0143441619124526	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2978.21154631401	2978.21154631401
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTTCCAGTAAGAGG"	0.333896686404389	-7.20791294490965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTCCAGTAAGAGG"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2516.40652028403	46.0630610214859	0.0183050952420385	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2511.56472469212	2511.56472469212
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCTGTTTCCTACCGT"	-3.08663926544841	9.07624814594118	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCTGTTTCCTACCGT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2733.29258344513	44.0927852498888	0.0161317472988248	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2729.94451917536	2729.94451917536
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGCGGCAGTGACCC"	-4.11351476135905	10.2137965925964	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGCGGCAGTGACCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.65713117756	38.4300574395325	0.0150963210908751	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.34567123118	2539.34567123118
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAAGCGGTACACTCA"	10.4989553886348	7.8676662215027	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAAGCGGTACACTCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2322.32776776041	40.9502302964036	0.0176332690264023	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2315.62780908915	2315.62780908915
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTGGACACCTTCCA"	-2.60172448578532	8.76927850330202	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTGGACACCTTCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2857.12738297882	37.9552704894317	0.0132844166191358	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2849.94612681291	2849.94612681291
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGAAGCGTCTCCGATC"	-3.97171292725261	9.71829221332399	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAAGCGTCTCCGATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2400.0447225226	42.8750400146657	0.0178642671164899	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.16616160817	2397.16616160817
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCAGTCGTTAGGACG"	-4.37879786911662	10.2995624312195	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCAGTCGTTAGGACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2572.56774875491	40.6651555065763	0.0158072243291776	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2568.86119482923	2568.86119482923
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTAATCAACTGAC"	4.29701485213582	-8.45893671428832	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTAATCAACTGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3182.01792201403	41.0610716264875	0.0129040981643806	3227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3173.88011365945	3173.88011365945
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCACGGCACATTCTT"	-3.04891548577006	8.92823503101198	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCACGGCACATTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2672.80336172252	37.5306387412041	0.0140416759716349	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2670.51598810925	2670.51598810925
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGGAAATCCATCTGC"	-4.45403085175212	10.8023814924988	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGGAAATCCATCTGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2943.52597131738	39.9342532424864	0.0135668085254277	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2933.58485040847	2933.58485040847
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATGGATCGGTTGTA"	-2.8025885623997	9.74047753894655	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGGATCGGTTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2169.5183167488	45.2389783066522	0.0208520840582008	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2164.53699368345	2164.53699368345
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATTTCTCAACCGAT"	-4.3035753768986	12.3684949644837	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCTCAACCGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2672.94473917064	44.9123530657587	0.0168025744818406	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2661.0406850542	2661.0406850542
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGCTACTCTCTGCCA"	-4.02546296539958	9.85226152026979	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCTACTCTCTGCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2456.06299026131	41.367801289884	0.0168431353161193	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2449.83956332393	2449.83956332393
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTGTAGAGACC"	-3.93270144882854	9.95095441425172	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTGTAGAGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2476.63672386191	38.5994862435163	0.0155854453225287	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2472.65016274527	2472.65016274527
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGACCACATTCAGCA"	-4.41329417648967	10.4327993162903	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGACCACATTCAGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2902.25965549417	43.0160163201852	0.0148215602414322	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2893.75262859663	2893.75262859663
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATGACTGTCTGTCCT"	5.40746893462483	-9.73185732280882	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGACTGTCTGTCCT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2099.61103059644	35.5894861629709	0.0169505139972812	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2097.98952014963	2097.98952014963
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTAGTGGTCACCACG"	-0.361712287098724	8.29000566089479	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGTGGTCACCACG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2384.80409857286	39.6890253103641	0.0166424677541083	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2375.19926810574	2375.19926810574
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTCATTCCCTTCCC"	-3.80119977417644	10.4272956618103	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCATTCCCTTCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2174.05612467339	42.6741488885127	0.0196288165720302	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2167.93664081579	2167.93664081579
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCACGCCATGAGATA"	-2.19143209877666	8.67019174182741	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCCATGAGATA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2457.82499453155	44.2501237044489	0.0180037731746164	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2455.4683710052	2455.4683710052
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCAACACAGCTAACT"	-4.21121297302898	9.82277486408082	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACACAGCTAACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2857.29793695857	35.8743116017429	0.0125553275833493	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2852.67504545411	2852.67504545411
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCATGAGACGAAGA"	-4.29339347305949	10.1494817503723	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCATGAGACGAAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2495.76552407383	41.2162907268587	0.0165144883721214	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2491.97733614752	2491.97733614752
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCAGGAGTATGCGGA"	-4.41513905945476	10.0578050383362	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAGGAGTATGCGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2675.39915516361	39.6003670614434	0.0148016668783846	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2669.71437470944	2669.71437470944
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTCTGTCAATCGGT"	-4.02729735794719	10.2383575209412	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCTGTCAATCGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2692.16706554789	44.6684132644907	0.0165919915729302	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2677.85536066849	2677.85536066849
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTGAGAGTCTCCTC"	-4.45625243607219	10.3727693327698	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTGAGAGTCTCCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2693.32014080641	42.329009185624	0.0157162932635814	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2685.29054055133	2685.29054055133
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGACCCGGTGGCAGAT"	-2.43012652817424	8.55545899951784	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCCGGTGGCAGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2371.82451952125	43.1631364155385	0.0181982840890147	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2367.7133325607	2367.7133325607
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCTATCAACTGCTA"	-1.18539987030681	8.76999089801637	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATCAACTGCTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2504.06156188333	41.2962251195711	0.0164916972282869	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2501.85627767833	2501.85627767833
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCATTTCGCGATCG"	-4.3919771713322	9.96906087482301	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTTCGCGATCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3012.03539457	32.9754192218095	0.0109478856992373	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3007.50842313616	3007.50842313616
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCTTGGTATGAGCG"	-3.51399240914043	10.0098113783631	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTTGGTATGAGCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2483.30940155577	38.8699546348483	0.0156524815677405	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2479.53273137862	2479.53273137862
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCATCTCCTGGCTT"	-2.09276996079143	9.13547990405885	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCATCTCCTGGCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2260.98620901373	49.5791160604234	0.0219280930873304	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2249.41169577374	2249.41169577374
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTAGTTCTGCTTAT"	-4.42429862442668	10.6338939436707	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAGTTCTGCTTAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2746.40753911678	43.2726883068961	0.0157561060004999	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2735.45304819756	2735.45304819756
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTCTCTCACGTAGT"	10.4689156013424	7.58498952472535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTCTCTCACGTAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2548.65172690347	43.1790198867835	0.0169419067466094	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2534.92972942717	2534.92972942717
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTCTCTCTGGACCG"	-4.39420733872111	10.6021594771179	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTCTCTCTGGACCG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2916.35566250529	43.9481060991783	0.015069528954992	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2903.78292349486	2903.78292349486
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCACGCACCAGCTG"	-3.94187460365947	9.5568866499695	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCACGCACCAGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2735.97203132251	37.3016129991784	0.013633769852957	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2732.55347056804	2732.55347056804
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTCGCTGTTAGTCGT"	5.12221064147298	-9.24051191723021	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCGCTGTTAGTCGT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2999.97628608932	41.7211732429025	0.0139071676787449	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2995.4412451006	2995.4412451006
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGAATTCTGCTCTG"	-8.01724563065227	-1.10428395187529	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00862068965517241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATTCTGCTCTG"	"GMP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3328.4975033059	41.8793640844927	0.0125820626402446	3060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	3312.15304018596	3312.15304018596
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCTGAAAGAACCCGA"	-0.561778764159042	9.28893373096315	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGAAAGAACCCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2461.25405407544	41.3154007740538	0.0167863210649231	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2452.81637356429	2452.81637356429
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCGGTTCCGATTAG"	14.3330961662227	1.87092611873475	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGGTTCCGATTAG"	"Plasma cell"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	2117.79265133385	24.6897408169929	0.011658242746967	4584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2096.18590656032	2096.18590656032
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCCTCAAGTCAACAA"	9.87323345717732	7.98649022662965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCAAGTCAACAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2659.1892017821	36.1034088738065	0.0135768484805862	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2640.81122223915	2640.81122223915
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCGTGATCACTACTT"	-3.93038998070415	9.77900788867799	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGTGATCACTACTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2787.67936042826	37.419073437604	0.0134230191494675	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2779.90396618861	2779.90396618861
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCTGAATCGCAGTTA"	4.83868469771687	-8.74811365520629	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGAATCGCAGTTA"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2992.30058496212	35.3619971913913	0.0118176620922055	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2986.06002900129	2986.06002900129
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCATCACAGATACGAT"	5.31144489821736	-9.71556093609007	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACAGATACGAT"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3025.68937653801	48.2759724917793	0.0159553630541601	2826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3021.4493235303	3021.4493235303
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAATTCCCACGCGCAT"	-4.1896518272465	10.4967679747376	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAATTCCCACGCGCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.14055694372	43.9057812951653	0.0173188745590093	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2532.80553114333	2532.80553114333
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACCGCTCGATACGT"	-3.72882185402568	10.1073388823303	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCTCGATACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2493.25709261293	45.0896056850841	0.0180846194396384	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2488.04474807797	2488.04474807797
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGCTCCAGATCATC"	-3.31328044357951	9.10539910877077	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGCTCCAGATCATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2619.51052440561	40.4263550613289	0.0154327897081086	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2616.46469313298	2616.46469313298
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCTCCGTCATTGCA"	-3.60971985283549	9.80152318561403	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTCCGTCATTGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2749.30163144362	44.5458599198932	0.0162026092046156	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2741.37172013643	2741.37172013643
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCGATAGTGCCTGCA"	-4.32810721817668	10.4619998701843	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGATAGTGCCTGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2463.33901011339	35.9694716013232	0.0146019169321187	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2457.63281925241	2457.63281925241
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTATGGGTCTAGTGT"	-3.89561353150066	9.54625127399293	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATGGGTCTAGTGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2334.03162830801	39.9914473786132	0.0171340640347723	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2326.21746414279	2326.21746414279
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCAATGTACCTATG"	-2.39138064804729	8.61186692798463	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCAATGTACCTATG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2708.74686116064	39.0798151674482	0.0144272673566489	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2700.43586066517	2700.43586066517
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGAAGGACACTAGGCC"	-0.298390756279784	9.80663297260133	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0151878497202238	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAAGGACACTAGGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2118.12257928734	40.7703376279239	0.0192483371956884	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2113.46413000362	2113.46413000362
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCAATTCTAATTCC"	-3.87624655190166	9.83808419788209	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCAATTCTAATTCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.92576688374	45.5922302339358	0.017018847926858	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.41746072813	2674.41746072813
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGCTGGGTTCTATCT"	-1.92319891873057	8.52752492511598	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTGGGTTCTATCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.23513093103	40.6825197747293	0.0167746703220118	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2421.43064962853	2421.43064962853
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCCGTAGCTCATAC"	1.31001545962636	-6.4250583878723	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTAGCTCATAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3086.92178365268	41.6057400976323	0.0134780674774342	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3081.15834945008	3081.15834945008
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTACTCTGCAGCG"	1.35622074183766	-7.48877718364867	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTACTCTGCAGCG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2880.43828360487	39.8229516273006	0.0138253097988485	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2877.56224610825	2877.56224610825
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTTACTCAGCTACCG"	-4.48899922791179	10.2410678633484	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTACTCAGCTACCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2762.35555814872	39.1136941207312	0.0141595436566263	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2759.04308782841	2759.04308782841
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGAAGAGACGTCGA"	-3.01273498955424	12.3825330504212	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000793650793650794	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGAAGAGACGTCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2151.19928804237	46.480896393389	0.0216069690296743	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2148.00605257827	2148.00605257827
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCCTTCGTGCTCCGA"	-4.48562083664592	10.7502012022766	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTTCGTGCTCCGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2785.42554104976	40.4471930388031	0.0145210103241745	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2779.37164414122	2779.37164414122
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCTAGACAGACGATG"	10.6610657173092	7.43786046588746	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTAGACAGACGATG"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2711.08514578858	42.3914719183418	0.0156363484135469	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2699.46120416586	2699.46120416586
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCGAAGGTTTCCCAC"	0.667693634598893	-6.31334640895995	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGAAGGTTTCCCAC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3346.27917646435	43.5787957686174	0.0130230603815496	3010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3340.93002496343	3340.93002496343
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGCCACGGTAGACGTG"	-2.47863064232524	8.56749341571657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCACGGTAGACGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2532.10157443778	42.2759035164617	0.0166959745782902	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2522.87970376811	2522.87970376811
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGAAGAGAGATGCC"	-4.48249087753947	10.2635831602844	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGAAGAGAGATGCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3163.15889112542	43.4990588548326	0.0137517780016912	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	3155.81945329057	3155.81945329057
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGACAAAGAACTTCC"	-4.10478244248088	10.0473031767639	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACAAAGAACTTCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2645.32363957227	45.0833972029132	0.0170426773225385	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2640.84826578591	2640.84826578591
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTACCAGGGAGGTG"	-3.18567405167277	9.36338136279909	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTACCAGGGAGGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2552.46518759046	41.6512272756895	0.0163180393128137	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2542.00993706421	2542.00993706421
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAATCGTCTGCTGAA"	-2.93906507912334	8.85579202258912	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGTCTGCTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2477.75020131099	42.0302978971984	0.0169630892875965	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2476.54330077349	2476.54330077349
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTAACGTCCTCCTA"	-3.76495156708415	9.64637563312379	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAACGTCCTCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2832.15798357286	45.9002457496939	0.0162068097951899	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2824.50617849501	2824.50617849501
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTAACGTTGGCCTG"	3.5696882205898	-8.06616880809935	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAACGTTGGCCTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2823.52653547475	33.8585390455202	0.0119915781276082	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2822.51818488281	2822.51818488281
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGGTCAGTCTA"	-4.30980763855632	9.96231935108034	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGGTCAGTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2746.07228660846	40.827343569601	0.01486754145865	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2741.53823469068	2741.53823469068
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTAGTCAGTCCCGA"	-3.70593796196635	9.68123910510866	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAGTCAGTCCCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2638.35202000177	38.4559773051445	0.0145757567654367	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2628.07952807906	2628.07952807906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTAACCAGGAACCA"	-0.302417884499389	8.6672677763733	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTAACCAGGAACCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2517.77429605724	37.9526314265146	0.0150738815174765	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2508.8340660987	2508.8340660987
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATAGGCTGTCTAACGT"	-1.61303148689922	8.69690892780153	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGGCTGTCTAACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2319.34418176504	41.230505430288	0.0177767947312206	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2318.12320809639	2318.12320809639
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AGGTCTAAGCACACCC"	-4.36788783493693	10.0881204375061	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCTAAGCACACCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2617.74309294498	41.9245558651942	0.0160155349003437	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2612.07568241104	2612.07568241104
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTTTCATGGGATG"	1.18431284007375	-7.30066540157469	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTTTCATGGGATG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2937.31287991339	40.288592708918	0.0137161393273521	2454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2933.19786754314	2933.19786754314
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTGTAAGCTTAAGA"	-3.80203853073772	9.47525498950807	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTGTAAGCTTAAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.30046627561	34.2880622799082	0.0130955414481826	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2611.19934413374	2611.19934413374
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTCTGTAGTACCACGC"	-3.7406726879185	9.61329457843629	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTGTAGTACCACGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2495.22165066804	40.5331320267823	0.0162443011890068	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2491.19923953432	2491.19923953432
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGAGCGCGTCATAACC"	-4.15400252762492	10.1476402052673	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGCGCGTCATAACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.51870412506	39.7457209975012	0.0163662404287805	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2416.47693854819	2416.47693854819
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGTCATTTCCA"	-3.78921971741374	9.87802884662477	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGTCATTTCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2462.22696871995	42.6217500210106	0.0173102441661455	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2453.72641952223	2453.72641952223
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAATACGTCAGCTTCC"	-0.563688735396224	8.27567288959352	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATACGTCAGCTTCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2680.17340644321	37.2307223998081	0.0138911617846459	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2672.60609430946	2672.60609430946
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCAGGGTACCTAAC"	1.75950362262074	-7.4818644753662	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCAGGGTACCTAAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2774.6763283722	35.0467873390007	0.0126309461686154	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2771.26123822698	2771.26123822698
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGATGTTGTTGGCCTG"	-3.50618420067485	9.76451871478883	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATGTTGTTGGCCTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2931.61349511221	51.2817190871956	0.0174926603294384	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2916.14141610708	2916.14141610708
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTACCGCAGTCATACC"	1.10165335711781	-7.64639522945555	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCAGTCATACC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2908.75603040773	36.1915099854466	0.0124422638430675	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2904.35652737125	2904.35652737125
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGAACGGTCACAGTT"	1.99035014685933	-7.71191503917845	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAACGGTCACAGTT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.45988177803	35.7790504718697	0.0132149882303604	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2707.45988177803	2707.45988177803
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCACGTAGCCTGTCG"	-3.9684775871342	10.0918311842713	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCACGTAGCCTGTCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2249.4452390863	26.8053376564759	0.0119164215206074	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2242.8836205185	2242.8836205185
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGAGACTTCGTAACTG"	-4.03930936279948	9.67255113208619	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTTCGTAACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2732.41805488633	41.3951353349223	0.0151496346837909	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2727.91818352965	2727.91818352965
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTTAGTAGAGCTGAC"	-4.32771668854411	12.6152171858582	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTAGTAGAGCTGAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2609.42787009248	40.5980908628282	0.0155582345571366	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2603.53576405432	2603.53576405432
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCATGCAATCGTCA"	3.78908147391621	-8.24110510265502	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGCAATCGTCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3027.74662561799	36.0803850509045	0.0119165800551557	3262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3026.70662772915	3026.70662772915
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCAGGTTCAGGAAAT"	-1.59158418598827	8.87321279132692	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Activated"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCAGGTTCAGGAAAT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2296.06490991358	40.8324490433257	0.0177836649421477	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2282.33891362276	2282.33891362276
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTACATAGTTAACAG"	-4.37925849381145	10.4524173506531	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACATAGTTAACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2780.5391945956	45.0402223700365	0.016198377083689	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2777.21702899154	2777.21702899154
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAACAGTGTCCACATA"	-2.67753920975383	8.97396562183229	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACAGTGTCCACATA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2342.52105759173	43.6053882587836	0.0186147262657322	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2337.84451259484	2337.84451259484
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACTATGGTGTTGATC"	4.75681461867635	-8.50810625469359	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTATGGTGTTGATC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.23079531127	40.6736502647308	0.0151077873173307	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2689.38126997278	2689.38126997278
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCTGTGAGTCTAGCT"	-2.86721716347392	8.88704679096071	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTGTGAGTCTAGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2690.12081838244	40.7355572395188	0.0151426497134106	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2686.64211303709	2686.64211303709
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATAGAGGTACCGGAA"	-2.60926399651225	10.4482736357483	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATAGAGGTACCGGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1972.50616388143	45.8348704576626	0.0232368705847135	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1967.64592678488	1967.64592678488
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGATTTCTCCGCGAGT"	-2.42648277702983	8.98860929096071	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTTCTCCGCGAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2467.57177216989	41.280076572843	0.0167290277180237	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2458.3117732639	2458.3117732639
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTAACGGTACGAGCA"	-2.88827095452006	9.45315835559694	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAACGGTACGAGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2313.32884325705	43.5351903386089	0.0188192830714519	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2307.6324507705	2307.6324507705
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGATCTCATGGCTGC"	-2.59408364716228	9.03342053974	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGATCTCATGGCTGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2573.63445738377	43.4656260620454	0.0168888110498141	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2568.3956320722	2568.3956320722
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCCGGTCAGGTCAAG"	-2.88016472283061	8.87623689258424	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCGGTCAGGTCAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2406.35018868261	44.833052784491	0.0186311422981355	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2400.93381420245	2400.93381420245
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATCCCAGTGACTGAG"	-4.21327672424968	10.2490091093811	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCCAGTGACTGAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2682.82509376739	39.9419861256523	0.0148880321040845	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2680.44466413743	2680.44466413743
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCCGTCCTCTCGA"	-0.917899350554305	8.90043447101442	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCCGTCCTCTCGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2181.44888315477	41.2388548321861	0.0189043415826216	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2178.71204202669	2178.71204202669
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGAACAGTCGGAAAC"	5.48201765593831	-10.0407066575256	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGAACAGTCGGAAAC"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2703.7316328404	49.4994951849073	0.0183078433464588	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2697.34533392446	2697.34533392446
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCTCTCAGACCCGT"	-3.65262709084209	9.63090608203737	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCTCTCAGACCCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2777.39032571917	39.4048455241326	0.0141877233312279	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2767.62439538705	2767.62439538705
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGAGTCAGTCATCCA"	-4.15856633606608	9.81132600391237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGAGTCAGTCATCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2699.6215147243	41.5459996081864	0.0153895645673239	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2690.22829199061	2690.22829199061
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCCACCAGTTA"	-4.35699782791789	10.3995160826477	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCCACCAGTTA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2935.24091574841	44.1537690647748	0.0150426388607072	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2923.05086442717	2923.05086442717
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCACTCCAAATCCCA"	-3.26643739166911	9.42808625781862	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCACTCCAAATCCCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2488.29256233655	42.3812183887397	0.0170322489526485	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2482.88549251028	2482.88549251028
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCAGTGCGCTC"	1.26635160025899	-5.85617973720702	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCAGTGCGCTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2939.61876624727	44.4656165343524	0.015126320815783	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2933.03242973682	2933.03242973682
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGATAGAGAGTGACC"	-4.04181657257732	9.78739926898805	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGATAGAGAGTGACC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.6132601223	45.0559178009838	0.0190623053953643	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2356.65377251869	2356.65377251869
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGGGTAAGCGGTATG"	-4.00545773926433	10.7619533308777	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGGTAAGCGGTATG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2364.82454978759	44.8135936019009	0.0189500712033483	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2363.35640517836	2363.35640517836
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGACTCAGTGAGCCA"	1.90403630313222	-5.46033146297606	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACTCAGTGAGCCA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2659.63634836549	37.5413553740542	0.0141152212019984	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2658.91218921459	2658.91218921459
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGTGAATCTCCCAAC"	10.5119883018428	7.54474065387575	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGAATCTCCCAAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2380.46388513835	42.0739468008688	0.0176746839401949	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2368.82746283987	2368.82746283987
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACACACCAGAGGACT"	1.63430800017659	-5.60015442287596	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACACACCAGAGGACT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2967.57550442627	39.8894382039293	0.0134417601656411	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2959.98438901494	2959.98438901494
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACGCTCGTTGAGTCT"	-4.44660745087321	10.7556142576965	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGCTCGTTGAGTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2288.99366315223	46.860441679237	0.0204720713882206	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2285.96414601161	2285.96414601161
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTGAGGTCATAGTC"	-4.93056378784831	8.75553319537965	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"Treg"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTGAGGTCATAGTC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3689.50685133768	34.5743965055845	0.00937100753534288	4249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3677.71358536283	3677.71358536283
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATGACAAGTGGCA"	-4.07864127579387	10.5824317702088	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATGACAAGTGGCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2628.25467907623	43.1353643661436	0.0164121706733933	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2619.98077942732	2619.98077942732
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGCTACACGACAAG"	4.97695602950398	-8.97855093395384	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGCTACACGACAAG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3263.76116623679	39.2096194743293	0.0120136301270902	3281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3257.26183518987	3257.26183518987
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTTATCACAAACGG"	-1.15668759766276	8.80081746661989	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTATCACAAACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2487.9726502347	33.3721430665266	0.013413388231329	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2482.21636880845	2482.21636880845
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGATTGAGTGCGACA"	1.59543182429616	-6.06307699596556	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATTGAGTGCGACA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2837.41685718322	36.791085792243	0.0129664013587226	2236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2832.84712549566	2832.84712549566
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGCCGCATGGCCAC"	-4.36852298203166	12.5733022459778	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGCCGCATGGCCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2861.73628535341	42.0390679232223	0.014690056571034	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2851.31922292285	2851.31922292285
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAGAATCGTAGGGA"	-3.61815319481547	10.3016175993714	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGAATCGTAGGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2340.43384386275	43.0631854064233	0.0183996593278407	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2333.46782779309	2333.46782779309
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGTGGGTCAACACT"	3.43974008139912	-7.99526693737181	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGTGGGTCAACACT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2902.25907789813	38.9459848100262	0.0134191964827039	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2899.08004174889	2899.08004174889
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGTTTGCAGACACAG"	-4.02518258515056	10.2044887312683	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTTGCAGACACAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2502.59658888919	37.3509027819942	0.0149248596229298	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2497.43109263251	2497.43109263251
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCACAGTAGGGTAC"	4.10470451888387	-7.55970957195433	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCACAGTAGGGTAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2750.19048547884	41.2822836049024	0.0150106997398454	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2743.31878720402	2743.31878720402
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGGGCAGGCCTTGC"	-2.84743104401286	9.24177548969118	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGGCAGGCCTTGC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2576.25293873862	41.0307411010307	0.0159265188926364	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2570.88882062562	2570.88882062562
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAATCGACAGAGTTCT"	-3.65829191628154	9.73603055560914	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATCGACAGAGTTCT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2377.75875142569	48.6645144088573	0.0204665483324068	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2370.64785446658	2370.64785446658
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGCCTGTCGCTCATC"	-3.22581515732463	9.0817022093567	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCCTGTCGCTCATC"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2683.97855759417	35.4232221543318	0.0131980272547647	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.24233929385	2674.24233929385
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCCTCAGTTAAGACA"	-2.67262397232707	8.95473191821901	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCAGTTAAGACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2788.70323781546	40.5795054345118	0.01455138893384	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2782.11748919939	2782.11748919939
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATCCGGTCAAAGCG"	-0.432545761496383	8.67434690082399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCCGGTCAAAGCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2247.07458813249	34.5735640934725	0.0153860331455246	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2243.46709177575	2243.46709177575
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCTGAGTTGCATCA"	1.67842235144917	-6.99672462856444	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCTGAGTTGCATCA"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2576.17311786955	39.3982732691347	0.0152933329658049	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2572.49741914673	2572.49741914673
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACCTTTGTCGAAGCA"	-2.84926448288615	8.76155278766481	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCTTTGTCGAAGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2669.10641827919	40.8089756680272	0.0152893775192138	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2665.4561328904	2665.4561328904
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCATCGGGTCGAACGA"	-0.322448621422607	8.50748059833375	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCGGGTCGAACGA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2335.39040436795	34.9865860212393	0.01498104383567	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2325.53761545079	2325.53761545079
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCATAACATCGATCA"	-3.62915907326396	12.6125230559143	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATAACATCGATCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2363.95796972686	38.2434779563577	0.0161777317727762	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2355.4276519764	2355.4276519764
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCCATGTCATAGAGA"	-4.25687394562419	9.91911504352418	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGTCATAGAGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2668.49359643634	43.5424407983098	0.0163172363825264	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2656.99006046359	2656.99006046359
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATGGATCCGCAAAT"	-3.71078238907512	9.51073072040407	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGGATCCGCAAAT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2255.44384115532	40.6230170044414	0.0180110966467837	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2253.94072494564	2253.94072494564
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAAGTCCAACTTGCA"	9.72354378279988	8.00746438587037	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAAGTCCAACTTGCA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2606.33415085758	42.8127743055796	0.0164264333840281	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2596.84472705524	2596.84472705524
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAAGCACAGGATCTT"	-4.44944129410441	10.7021655806336	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCACAGGATCTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2897.6507129885	39.6048306896552	0.0136679105290812	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2887.82948298026	2887.82948298026
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCGTTCAGCCATTCA"	-3.30895052376445	9.68610665881959	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTTCAGCCATTCA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2157.19690282669	42.8450142043514	0.0198614295005752	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2154.17026309826	2154.17026309826
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTTTGACATTGACCA"	-3.72665844383891	9.87284944141237	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTTGACATTGACCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2636.62495491844	38.0823609812856	0.0144436018138437	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2629.90273493601	2629.90273493601
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GATCGTATCACCGACG"	-2.78133497658427	8.86233518207399	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCGTATCACCGACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2596.1595083034	40.7265710340973	0.0156872375922358	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2589.34059255388	2589.34059255388
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTCGGTTCTTCGCTG"	-3.31871352616008	9.60617158496705	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCGGTTCTTCGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2360.00563574145	46.7299712284086	0.0198007879814776	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2352.86476144486	2352.86476144486
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTGTGTGCCTATA"	5.18426527556722	-9.38023855602416	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTGTGTGCCTATA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.26216448963	37.4771851808965	0.0127984391682458	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2922.24064403656	2922.24064403656
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGGAGCAGACCTGC"	0.778465111821335	-7.1645660630432	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGAGCAGACCTGC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2814.4014512109	39.6944336882716	0.0141040410816989	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2812.0468916314	2812.0468916314
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTGATCTTTCCAA"	4.97700562056844	-9.34866239940795	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTGATCTTTCCAA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2302.9048548634	44.67229458896	0.019398237184927	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2297.94691028261	2297.94691028261
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGGAGTCCGATAGT"	1.6610481935436	-7.41075613414916	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGAGTCCGATAGT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3309.13074918708	37.3500371640738	0.011286963252585	3521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3302.93914937464	3302.93914937464
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTACGTAGGTTGCCC"	-4.2677186531132	10.3190536268982	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACGTAGGTTGCCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2869.88371159981	38.2707193706578	0.0133352857525101	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2859.82493583045	2859.82493583045
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGATTTCGCTATTT"	-4.03194079819377	10.3125715025696	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGATTTCGCTATTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2835.70433772646	38.7923857385333	0.013679982508203	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2823.1401930365	2823.1401930365
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACGCGTCAGGGTAG"	-0.411924908787566	8.18264482105104	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACGCGTCAGGGTAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2176.31333912446	41.9158923258594	0.0192600447611658	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2169.35054618214	2169.35054618214
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACGCGTCCGCTGTT"	-3.59521327439006	12.3177909621033	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACGCGTCCGCTGTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2417.52483765882	42.8465052658613	0.0177232947510706	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2408.46530073091	2408.46530073091
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCGTTCGTTTACT"	-0.491407553583938	8.62779901111452	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCGTTCGTTTACT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2387.70212975923	33.9475372009773	0.0142176600581248	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2378.59082311257	2378.59082311257
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCATTTCAAGACCTT"	-4.04592881622966	10.1566219099793	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCATTTCAAGACCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2432.10696064927	39.0267473392398	0.0160464765615494	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2429.67471919062	2429.67471919062
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTTTCAATCGCACGGT"	-3.94864783707317	9.67362020099489	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCAATCGCACGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2668.80984018773	43.2203296677772	0.0161946081796285	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2661.22959977703	2661.22959977703
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACCCAGCAGAGTGAC"	-2.74390302124675	9.0625953444275	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCAGCAGAGTGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2304.68436913254	48.7232484861335	0.0211409636558921	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2297.53328989947	2297.53328989947
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGATCGGTACGGGAT"	-3.14187345925029	9.30582044208375	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGGTACGGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2771.35403590882	39.1149363674333	0.014114016419633	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2761.29624467258	2761.29624467258
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AACACACCAGGTAGTG"	3.1616071659023	-7.71629812633666	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACACACCAGGTAGTG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2830.56972201163	45.2029707668995	0.0159695662733136	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2820.73448287104	2820.73448287104
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGAAAGTATCCCAA"	-4.09927688065227	10.3265361555847	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAAGTATCCCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2362.79185071215	45.032362523579	0.0190589630271521	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2357.82992003322	2357.82992003322
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGAGCCCATCATCTT"	-4.35442099991496	10.0016031035217	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGCCCATCATCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2638.57966943246	35.1686979903207	0.0133286473771267	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2627.07625286656	2627.07625286656
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGAACCATTGCTTT"	9.94923367080037	7.44642827594606	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGAACCATTGCTTT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2280.06314013553	41.5828710602166	0.0182375962876822	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2275.68007680065	2275.68007680065
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGAACGTACTAACC"	0.706162293522996	-7.13052036678465	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGAACGTACTAACC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.39708743487	42.887878507862	0.0163233333526047	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2626.21668398422	2626.21668398422
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGGTTATGTCTGTGTA"	-3.62828169289287	9.43640515888063	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTATGTCTGTGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2762.84564905361	33.8663540791798	0.012257779977966	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2752.76541766821	2752.76541766821
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:GAAACCTGTGCCGTAC"	-5.04259858551677	-5.39253714000853	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0322108345534407	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAACCTGTGCCGTAC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3343.34998703933	50.0837513249488	0.0149801102245057	3664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3334.74023801013	3334.74023801013
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGTAGATCCGCAGTG"	-2.17785320702251	8.72304532611696	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTAGATCCGCAGTG"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2406.7191909745	43.3211838838401	0.0180000990752473	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2394.22023224237	2394.22023224237
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATATCAGAGATCGC"	-3.62812576714213	12.5167131193909	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATATCAGAGATCGC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2769.69084165692	39.1255005167671	0.014126306058535	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2760.35176035174	2760.35176035174
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTAACTGTGAGATCG"	-0.531637768179733	8.49819657886354	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAACTGTGAGATCG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2444.97588632279	39.5729150937422	0.0161854009747554	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2437.13506540429	2437.13506540429
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACATCCCGTAGCGAGT"	-0.546173135668594	8.5301475294861	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCCCGTAGCGAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2203.38551793204	39.1432741635364	0.0177650591986616	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2198.0999390386	2198.0999390386
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCACGGGCAACCAATC"	-4.22643313828166	10.0675887831482	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACGGGCAACCAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2508.82646625052	41.4372377063327	0.016516581861583	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2504.96812785699	2504.96812785699
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGTACATCTCGGTCT"	-3.8313401741093	9.77403638446657	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTACATCTCGGTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2516.17492232093	37.6203114258161	0.0149513895445373	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2514.88352928965	2514.88352928965
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTTCTCAGGGATCTG"	-4.20457730713542	10.7664403685364	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTCTCAGGGATCTG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2862.84600200026	38.8668964694771	0.0135763140742886	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2853.84713673258	2853.84713673258
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCAGTTAGTGCATTAC"	0.949569721787614	-7.28036692058715	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGTTAGTGCATTAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.54702871438	41.3762607293018	0.0152987765751555	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2703.46521763693	2703.46521763693
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCATCAGACGCCCT"	4.56893553313558	-8.61674215709838	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCATCAGACGCCCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.87644296787	43.3921606182679	0.0165563549303113	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2619.17482474317	2619.17482474317
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATGAGGTGCGTTTA"	-3.3530641597813	9.51182267749635	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGAGGTGCGTTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2591.57342388784	43.3223472575327	0.0167166196636409	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2585.25474876035	2585.25474876035
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGATCAGTCTCACGG"	-2.58293018761333	8.74305150592653	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGATCAGTCTCACGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2359.34603043376	46.1657268588957	0.0195671708445447	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2352.51840073807	2352.51840073807
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTAACTTCGGCTTGG"	-3.74123750153239	9.48589894855348	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTAACTTCGGCTTGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2758.29833272845	36.3898176625618	0.0131928505451279	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2753.85271667186	2753.85271667186
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGCTCAGCAATAGT"	-1.58895335617717	8.5705528029236	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGCTCAGCAATAGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2580.53157928264	43.4157521554053	0.0168243444505626	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2571.57649255377	2571.57649255377
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGCATGGAGGAGTCTG"	-4.17275557938274	10.1413964995178	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATGGAGGAGTCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2517.45487011025	28.3191193054481	0.0112491070412745	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2512.93908292249	2512.93908292249
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTAGAGGTTGTGTTG"	14.3972488838131	2.03893981063691	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Plasmablast"	"Plasmablast"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0474452554744526	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAGAGGTTGTGTTG"	"Plasmablast"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1744.16590739736	35.2110086394016	0.0201878780510871	3606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	1728.35729387432	1728.35729387432
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTAGAGGTTTACCTT"	-3.93564329567607	9.70914170825807	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAGAGGTTTACCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2693.96407647903	39.1374320304611	0.0145278225393462	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2689.51601979951	2689.51601979951
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCCATTCTCTGCTG"	4.13493027266805	-8.23944666301879	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCATTCTCTGCTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.5931827207	34.9436575438744	0.0142186500961846	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2447.21002260199	2447.21002260199
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACAGGTTCAGAACCT"	1.63234116610829	-7.55620195781859	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+ IFN+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACAGGTTCAGAACCT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3201.32634317914	45.763763992462	0.0142952511198891	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3195.78892048868	3195.78892048868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGCCTGTAGTGCGA"	-4.25345693054851	10.5213756331238	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCCTGTAGTGCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.41011508748	38.4600635289677	0.0148184918080553	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2592.83471024629	2592.83471024629
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGGAAGGTGAGTAAT"	-4.19115672531779	10.1469259032044	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGAAGGTGAGTAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.87104337113	37.9046923472972	0.0154406042833293	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2446.33562356137	2446.33562356137
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTATCCGTCGCATGAT"	-4.24910436096843	9.9388913878235	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCCGTCGCATGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.20032481306	42.6567927801557	0.0168258075555829	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2529.9411044145	2529.9411044145
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAACCCCAACAGCCC"	-3.13141427460368	9.06883618915407	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAACCCCAACAGCCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2719.94661080226	41.8587396851085	0.0153895446031428	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2712.97561086732	2712.97561086732
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCAACGTATGATCC"	-3.69022188606914	10.3576669462952	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACGTATGATCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2469.80527390604	43.768048700255	0.017721254854653	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2461.39218775922	2461.39218775922
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCCATCACTACTT"	2.5209866958553	-6.92857363140257	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCATCACTACTT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1882.44677627066	40.9205665324042	0.0217379673349769	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1880.38639036573	1880.38639036573
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCAGCTCAGACCTA"	-2.6686147255009	8.98489949786989	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCAGCTCAGACCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2646.00410377548	41.5281603311535	0.0156946696612823	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2639.78785314108	2639.78785314108
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAATCTAGGTTTGAA"	-2.50488815727885	8.6125449904236	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATCTAGGTTTGAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2828.13111463	44.4732400341855	0.0157253105431089	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2817.97624370624	2817.97624370624
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCGTTTCCAAGTAGTA"	-1.29985485497172	8.746067024115	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTTTCCAAGTAGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2612.75275936804	47.4540508275355	0.0181624727626404	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2603.2964675945	2603.2964675945
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGAGTCTCACCTCAC"	-4.43803821030315	10.4633331068787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGAGTCTCACCTCAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2830.79609233957	38.5973333834497	0.0136347981714042	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2820.27753717503	2820.27753717503
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGGAACCTCCTCTAAT"	2.3437246280605	-5.49641659176024	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAACCTCCTCTAAT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2868.77125598012	39.5132577978257	0.013773582580158	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2864.37185459577	2864.37185459577
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTTCGGCTGGT"	-2.5662137073582	8.69652841174928	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTTCGGCTGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.27319612066	38.1419038897124	0.0151100538358247	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2521.09130822802	2521.09130822802
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TTTGTTGGTAGCGCTC"	-2.84555993500407	8.84753320300905	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGTTGGTAGCGCTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2398.77279335481	41.9647429561888	0.0174942550092453	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.45390899989	2397.45390899989
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCACTAATCGTTTACT"	-4.3381966156071	9.98122785175172	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACTAATCGTTTACT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3090.04538576665	39.8791581234252	0.0129056868572599	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3080.83266142489	3080.83266142489
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGCCAGTACAGTCT"	-2.06663761559184	8.68173692310182	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGCCAGTACAGTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2613.60877667482	46.3264430755706	0.0177250870478441	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2600.86617331675	2600.86617331675
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACAAAGTTTATGCG"	1.27653374251668	-7.43243124401244	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAAGTTTATGCG"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2942.51173510993	41.9626088770304	0.0142608127527018	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2936.27869633522	2936.27869633522
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCTTGCAGATCACT"	10.4474779563839	7.15157935703126	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTTGCAGATCACT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2155.53744941624	43.4564562547089	0.0201603810068239	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2147.36842149545	2147.36842149545
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAGAGGTAGAAACT"	1.96521558341328	-5.25272657787474	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGAGGTAGAAACT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2838.61059220844	31.2835662763636	0.011020731889831	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2836.40941732814	2836.40941732814
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTTCGGTGGTCCGT"	-4.11545119705852	10.9448413618836	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTTCGGTGGTCCGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.13621131355	39.2395374433126	0.0166754211909428	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2347.74243580306	2347.74243580306
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGTGCTTGTGATGTAA"	-3.89601097527202	10.0064372786316	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGCTTGTGATGTAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2202.89165358689	44.6361649779883	0.020262533068891	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2194.38521959043	2194.38521959043
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATCTTGTCCCATTTA"	-1.59132001820262	8.83187959277955	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTTGTCCCATTTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2524.50329473134	40.6594735743386	0.0161059300889784	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2519.79976727823	2519.79976727823
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGATCCGTATATGGA"	-4.04656205597575	9.93851468646852	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGATCCGTATATGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.85314451424	37.6050095486847	0.0144642821953356	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2596.06413223619	2596.06413223619
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGGATAGGTCATAA"	0.503731240599793	-7.18018247997435	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGATAGGTCATAA"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2272.3735396626	31.9311662170291	0.014051900209052	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2269.01915981042	2269.01915981042
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGACGGTATTAAGG"	-2.70268664780315	8.70990274036256	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGACGGTATTAAGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2687.17170954487	35.7237934204394	0.0132941982432861	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2669.44980121966	2669.44980121966
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAAGGGCAGCGTGAAC"	-4.47468028488811	10.2960376509461	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGGCAGCGTGAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2662.73247182845	34.6796038484857	0.0130240661483622	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2650.24220124959	2650.24220124959
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCCCATGTCTTCTAT"	-4.31292090836223	10.0401515730652	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCCATGTCTTCTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2785.18582811381	37.5261814783772	0.0134734928993197	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2775.23382590254	2775.23382590254
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTGCATAGCTGTCCG"	-3.09248218956645	9.79822156513063	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGCATAGCTGTCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2402.8596123075	41.6847414389938	0.0173479720685652	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.79187025346	2397.79187025346
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATTCATAGCCAACCC"	-4.31839833679851	10.5698270567688	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56bright NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTCATAGCCAACCC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2723.82226490807	43.0942392661674	0.0158212376120737	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2716.42186482145	2716.42186482145
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGTCGGTGTTTACG"	-3.91875300827678	9.91206357562868	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGTCGGTGTTTACG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2148.99639190806	44.7869340014337	0.0208408604919378	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2142.21323734592	2142.21323734592
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTTCCCATGTGCCG"	-1.74263129654582	8.5364780195984	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTCCCATGTGCCG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.25091945662	43.6117978605499	0.0171345769987426	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2539.29343118577	2539.29343118577
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGCATCCAGAGAAAG"	-4.075835565955	9.92556474292604	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCATCCAGAGAAAG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2500.05894359222	41.6713493110388	0.0166681467322379	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2495.73604465414	2495.73604465414
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATTCCATCTGCAGCG"	4.45757355269734	-8.73738672649535	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTCCATCTGCAGCG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2820.91261009984	40.649130668702	0.014409921995869	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2820.91261009984	2820.91261009984
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTGATAGCTTGTTG"	5.42722143706624	-9.5311374894348	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTGATAGCTTGTTG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.44129154446	40.1847847085838	0.0156212640656446	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2571.29292759194	2571.29292759194
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTGTCCTCCAT"	-4.096503118903	9.65753743732301	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTGTCCTCCAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2887.51712871417	39.7070410885643	0.013751274648281	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2882.58455875835	2882.58455875835
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAGACAGTTCAAGTC"	10.2639738517696	7.58185670459596	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGACAGTTCAAGTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2404.80856099845	43.7133655606092	0.0181774825113147	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2394.03097959484	2394.03097959484
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTGTAGAGTGATCGG"	-3.68290553513225	9.59988019550172	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTAGAGTGATCGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2571.96017621059	43.0381871390399	0.0167336133495078	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2568.84084906653	2568.84084906653
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACCAAAGACCATGG"	5.23618473586385	-9.39982988750609	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAAGACCATGG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2848.11175342189	45.5244632870533	0.0159840860290533	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2842.53145776321	2842.53145776321
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATACCGACATCTGGGC"	10.6376520591671	7.72950122440187	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCGACATCTGGGC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2743.92492123526	44.1991773916997	0.0161080126681462	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2732.39358754829	2732.39358754829
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACCGTTAGACATACA"	1.44783331927602	-5.76121857082518	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTAGACATACA"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3065.93451855908	39.9914895734146	0.0130438172541956	3009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3060.13873877252	3060.13873877252
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GAGGCAATCCGGACGT"	-4.4635571044987	10.8471078642639	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCAATCCGGACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2651.69305244057	45.0817624123906	0.0170011240067542	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2644.2197970432	2644.2197970432
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCATCTCGTGATAGAT"	-3.55241499367412	10.1432218321594	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCTCGTGATAGAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2484.98884097794	43.6411299040095	0.0175619017616333	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2479.92189087007	2479.92189087007
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCTGAAGTCTTTATC"	2.6248537498409	-8.77877523815306	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.347826086956522	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTGAAGTCTTTATC"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1732.26092647759	40.2252753518325	0.0232212565306933	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	1729.9603773512	1729.9603773512
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTTTGACAGAACGCA"	-3.93690405312236	9.78748605335084	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTTGACAGAACGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2598.59602054137	35.9315517646522	0.0138272942314314	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2582.51069724099	2582.51069724099
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTGGTAGGTGCAGT"	10.3768726783687	7.51750991428224	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTGGTAGGTGCAGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2187.33153652267	44.2516355024462	0.0202308771046184	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2185.27235964317	2185.27235964317
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCATTGTGTCAGTCGC"	-2.45003614845927	8.87227056110231	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTGTGTCAGTCGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2528.89167746193	39.6102997955581	0.0156631065492343	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2521.95803717939	2521.95803717939
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTAAGTGTCTGATTCT"	-4.19153104248698	9.86072633350221	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAAGTGTCTGATTCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.28201273873	37.36587316152	0.0152371843725222	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2448.41992714423	2448.41992714423
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCACGGGTTACCGTA"	-3.87060294571574	9.62685678088991	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCACGGGTTACCGTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2694.19248543169	37.1668269492755	0.0137951639128413	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2685.24349113983	2685.24349113983
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTTATGGTCTGAGGCC"	1.32193257388417	-7.17285873806151	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTATGGTCTGAGGCC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3143.90379891118	44.4047681525763	0.0141240861657265	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3138.8829450386	3138.8829450386
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGGGCGTCTGCAAT"	-3.54298458519633	11.9876537092957	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGGCGTCTGCAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2586.27159800158	40.4603948233094	0.0156442946110429	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2578.36219581076	2578.36219581076
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCGCAAGGTCCAGCGT"	-0.0045943324571431	8.99196431720582	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGCAAGGTCCAGCGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1943.17603235448	34.2256065020519	0.017613230058515	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1934.07714559636	1934.07714559636
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCATGCATCTATCT"	-2.63846192780193	9.13406751239625	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGCATCTATCT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2365.00184750348	49.0045659131033	0.0207207304995694	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2353.17041303096	2353.17041303096
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGAACACATTCATCT"	1.08685423907582	-7.49663355266722	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGAACACATTCATCT"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2833.30313027473	41.6998264454956	0.0147177426940026	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2827.84929406109	2827.84929406109
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTCGAGTGGCTCTG"	-4.35551772537883	9.96783826434938	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCGAGTGGCTCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2653.42095754833	41.7823570805158	0.0157465994838306	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2649.09055558551	2649.09055558551
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCATTTCAATAGGAT"	-3.59362969818767	9.97087857807008	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCATTTCAATAGGAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2345.75512591193	44.7195135034293	0.0190640161069857	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2344.45591287044	2344.45591287044
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACAGAAACAGGTCCGT"	10.331388135522	7.53740069949952	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAACAGGTCCGT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2169.63448290096	46.5199155360097	0.0214413607004481	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2165.31256557681	2165.31256557681
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATCCTCAATCTTC"	0.918877382844132	-6.05828239833983	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATCCTCAATCTTC"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3103.75603541738	49.0274502209438	0.0157961675020475	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3091.52994885043	3091.52994885043
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTCAGAAGCTG"	-4.00642762604411	9.77797505939332	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTCAGAAGCTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2540.73596125623	38.0301925963678	0.0149681797621994	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2538.33638596395	2538.33638596395
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTACGAGTCTTGCTC"	-4.39300570908244	11.1501264342102	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTACGAGTCTTGCTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3008.085367753	35.8696767672871	0.0119244211456942	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2997.07839714514	2997.07839714514
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACCTGCATGTTCGA"	-3.50881753388103	10.0576953657898	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCTGCATGTTCGA"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2338.61939861769	42.7822803821637	0.0182938191684596	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2328.69606078074	2328.69606078074
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGAGCCTCGATACGT"	-3.6702221435612	12.2387285002503	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0482822655524605	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGCCTCGATACGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2562.94350517837	42.3707721321858	0.0165320741743143	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2554.71860102229	2554.71860102229
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTGATCTGTCCCA"	-0.399382303387481	8.87868688190309	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTGATCTGTCCCA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2438.38808785251	38.8166667905576	0.0159189863926638	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2428.58749154145	2428.58749154145
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCCACTCAGGATTCT"	-0.193420152098495	8.80714700305787	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCACTCAGGATTCT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2476.1908607204	39.2877965130148	0.0158662230509908	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2465.1777400052	2465.1777400052
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AAGCGAGGTCACCGAC"	-3.88578019562419	9.96769807422487	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGAGGTCACCGAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2241.55088413659	43.4120278971017	0.0193669607075742	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2237.398992131	2237.398992131
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CACGGGTCAGGTCCGT"	-7.03808579865153	1.76686272704927	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.354166666666667	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGGGTCAGGTCCGT"	"MPP"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2153.19540038583	37.3690640140665	0.017355166190384	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"HSPC_AML-1371"	2151.31160793597	2151.31160793597
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGCGTGTCGGAGCAA"	-1.0362585586613	8.73033616626588	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCGTGTCGGAGCAA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2555.22088370635	42.2625513640566	0.0165396861122843	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2544.90435513873	2544.90435513873
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGAGTAAGGGA"	-4.28920350495036	10.482922531012	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGAGTAAGGGA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2598.46627566597	43.6005009989236	0.0167793214817649	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2594.70898240184	2594.70898240184
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGCACTGAGGA"	-2.67555962029155	8.73845670307008	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGCACTGAGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2651.25492149115	40.7522120886566	0.0153709142633996	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2643.04687536323	2643.04687536323
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:AATGACCCAATAAGGT"	-3.93854365769084	10.7727994688782	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGACCCAATAAGGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2518.63021884861	43.3133440109689	0.0171971826935236	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2506.77893567323	2506.77893567323
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACTACGACACGGTCTG"	-0.0960461598938287	8.82601926410524	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTACGACACGGTCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.09146975498	35.505450349926	0.0163462040362099	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2161.00491987358	2161.00491987358
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCATGGTACGCGTC"	10.393854756921	7.74766490543214	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGGTACGCGTC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2236.55696221957	45.3415013262089	0.0202729025426706	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2227.53211281799	2227.53211281799
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGGGCGTTCTCGACCT"	0.0935883159631908	-6.41979887401732	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCGTTCTCGACCT"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3178.97060095473	35.5594578333251	0.0111858404172236	3982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	3168.92990768693	3168.92990768693
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCGATAGTGGCCTCA"	5.00182070311849	-9.12220861828002	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGATAGTGGCCTCA"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2696.88377773002	40.0796292202879	0.0148614595672429	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2691.90503956662	2691.90503956662
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTGGCTAGGCTTTCA"	-3.39202986183818	9.27800366962282	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGGCTAGGCTTTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2698.80039302604	37.9510284796297	0.0140621842866552	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2695.37959014945	2695.37959014945
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGCGTGTGTGTGGA"	-3.54982052269633	9.40548226917116	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCGTGTGTGTGGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2472.18774555518	35.807190706863	0.0144840094653984	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2471.03887616631	2471.03887616631
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACAGCCCAAGAAATC"	-2.36034927788432	8.64093587482301	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACAGCCCAAGAAATC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2299.69399888801	47.4499782878635	0.0206331704612906	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2292.63748558055	2292.63748558055
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGCAGTCGTCGAGTGA"	-3.93703422966655	9.62010476672975	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCAGTCGTCGAGTGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2568.87856195016	36.4683159176795	0.0141962008083382	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2562.34041163243	2562.34041163243
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTAACACGTAGATTAG"	5.25237812575643	-9.74036314403685	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0399201596806387	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAACACGTAGATTAG"	"CD16+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2097.69083908102	50.3476292681192	0.0240014535650906	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2096.22897577775	2096.22897577775
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGGTAAGAGTGTTA"	-0.26086605611499	8.65305993640748	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGTAAGAGTGTTA"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2351.82276958013	36.794433862011	0.0156450708522479	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2345.86309924438	2345.86309924438
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTCTAAGCTGTGCC"	-0.477369527251083	8.58181474292604	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCTAAGCTGTGCC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2430.5286053802	38.6500643082745	0.0159019170655795	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2415.56911963783	2415.56911963783
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCACAAAGTACTTCCC"	10.7843224006588	7.63757608020631	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAAGTACTTCCC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2580.7937755303	38.8177272303638	0.0150410031202077	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2572.16901119038	2572.16901119038
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCGTGACAATACGAA"	10.2324558692867	7.63692472064821	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGTGACAATACGAA"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2146.83307429083	45.0757840911265	0.0209964084450378	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2137.80677274395	2137.80677274395
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACACCAAGTCAGACTT"	0.938960035412949	-6.21656849300536	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAGTCAGACTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2806.52435909476	46.0987866242591	0.016425578660977	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	2799.7693486018	2799.7693486018
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCCGATCGTGGCTG"	-0.67235908928569	8.83668611133424	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGATCGTGGCTG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2603.95438092874	36.5634220764606	0.0140414987083682	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2598.68735168232	2598.68735168232
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATACTTGTGTCATGT"	-4.0455359024113	10.8929681547913	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACTTGTGTCATGT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2562.92718350649	43.1880193852831	0.0168510520561084	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2557.37541937132	2557.37541937132
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCAGAGTAGGGTC"	-4.18503079834636	9.7691383131775	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCAGAGTAGGGTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2823.03753208157	35.1511167533109	0.0124515229974262	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2817.36768560562	2817.36768560562
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGATCTAGTACGTTCA"	-2.88815937462505	8.76264855945436	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATCTAGTACGTTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2952.4659792441	37.9776385185012	0.0128630232441237	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2944.33689928842	2944.33689928842
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGCTCCACAGGTCCCA"	-1.61927745762523	11.0945777663025	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00224592925322852	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCACAGGTCCCA"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2603.87993880523	51.2987115086265	0.0197008743545082	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2599.06623059453	2599.06623059453
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGAGGAAGGTAAGAG"	-1.95231495323833	8.74876115405885	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGGAAGGTAAGAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2459.66212449128	43.9725833893881	0.0178774893313782	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2455.01258892944	2455.01258892944
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CATACAGGTTGTTGTG"	1.38552822646443	-7.40765621578368	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACAGGTTGTTGTG"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.35621470401	42.2546277924285	0.0154872107845392	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2723.51380178388	2723.51380178388
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAGAGTCGTGCATTAC"	0.0839239182764709	8.32019708240358	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGAGTCGTGCATTAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1745.00777997886	44.1007741210363	0.025272537249989	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	1734.7573772702	1734.7573772702
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCAGCGATCGA"	-3.61673508110698	9.6971168288025	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCAGCGATCGA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2399.68433863146	40.2344624979356	0.0167665646061104	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2397.15479813724	2397.15479813724
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGCACGTAGCGCCT"	-3.80099425736125	9.80044744098512	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCACGTAGCGCCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2541.47203894839	37.9241315108023	0.0149221124331136	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2537.85024049853	2537.85024049853
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGTGGCAGACTCTAC"	-4.40599379959758	10.6493730315003	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTGGCAGACTCTAC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2761.70443218769	37.5394511094619	0.0135928561622812	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2758.37536902759	2758.37536902759
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TACCGGGTCAGTCACA"	-4.26094518128093	10.1087579497131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGGGTCAGTCACA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.54573301297	44.3350428541728	0.0165519081148196	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2673.02134900672	2673.02134900672
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCGCTTGGTATTTCCT"	10.326113362878	7.39146087253419	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTTGGTATTTCCT"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2227.42169969527	48.4709292614323	0.021761002538524	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2219.17671840438	2219.17671840438
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAACCAGTCTTGGT"	-3.77774963799174	9.94674680316774	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAACCAGTCTTGGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2476.88533122345	39.7782285448406	0.0160597779975516	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2469.96902461051	2469.96902461051
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATCCGTGCATGTT"	-3.78913245621379	10.2284192808899	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATCCGTGCATGTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2680.77166662574	36.0138210491386	0.0134341247699282	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2674.89420656868	2674.89420656868
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTGCCATCTCCCAAC"	-0.587575058371383	9.26847646320192	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGCCATCTCCCAAC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2797.41080297194	37.8946141080582	0.0135463172115441	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2784.26160638702	2784.26160638702
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TATGTTCTCATTACTC"	-2.25964889946635	8.62989804828493	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATGTTCTCATTACTC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2505.47483604627	39.7473409338806	0.0158641948272781	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2496.37872838836	2496.37872838836
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAGCAACAATCCAGT"	-0.53731600466426	8.61247918689577	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGCAACAATCCAGT"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2623.90296639746	37.8953502800786	0.01444235963196	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2616.64450868075	2616.64450868075
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGCGTCACATTCTT"	-4.10769639435466	9.73036096179811	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCGTCACATTCTT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2567.079070685	39.5451733459577	0.0154047352095803	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2565.95552089354	2565.95552089354
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTCATGATCTGCCCTA"	-4.27355609360393	10.1020183333191	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATGATCTGCCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2682.57187570342	41.7051150498768	0.0155466906320789	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2675.54751385641	2675.54751385641
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGGGAGTTGCCAAT"	-4.44458423081096	10.4953231581482	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGGGAGTTGCCAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2433.93843541877	46.9638342717215	0.0192954076357487	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2433.93843541877	2433.93843541877
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACCGTTCGTCTTGAAC"	-4.29170451584514	10.0675868757996	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCGTTCGTCTTGAAC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2579.11358124612	29.668315422135	0.0115032992877346	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2573.40182756767	2573.40182756767
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGGTGCAACAG"	-0.673667232424575	9.04567716205446	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGGTGCAACAG"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2405.24689911655	38.4996902099186	0.016006543953579	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2400.0373396893	2400.0373396893
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GCCATGGCAGAACGCA"	-3.89655933800395	10.1599445112976	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGCAGAACGCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2707.24722555916	40.4319911310457	0.014934724375863	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2704.127998217	2704.127998217
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATGACAATCTCTT"	0.419115622609299	-6.38877394115599	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"cDC2"	"cDC2"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATGACAATCTCTT"	"cDC2"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3307.7321299324	41.239956478266	0.0124677437163296	3052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"DC_AML-1371"	3304.1557852907	3304.1557852907
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGGAACTTCAAGCCTA"	-3.42284331741984	9.86735723102418	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTTCAAGCCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2442.00227144845	45.0851396464706	0.0184623659746756	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2432.12428957173	2432.12428957173
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GTGAGCCCATTCACAG"	-4.14354215088542	10.6186980971131	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGCCCATTCACAG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2629.10551210603	47.6617647028381	0.0181285096712071	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2621.67448433927	2621.67448433927
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATCCTATAGAGTCAAT"	-4.39062104645427	10.7696218260559	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATAGAGTCAAT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2679.83879896564	35.8998618636878	0.0133962766258718	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2673.32954638879	2673.32954638879
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TTCAGGAAGCATCAAA"	-2.10741386833842	8.84127042377321	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGAAGCATCAAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2053.73281063695	51.1743575102365	0.0249177289495439	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2050.36677638884	2050.36677638884
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCAACCGTAGGACTG"	-0.794087867171127	8.64937970722047	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAACCGTAGGACTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.14998880574	35.6772209085131	0.0146329065366436	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2430.94084537371	2430.94084537371
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGGTGTCCGTG"	-4.25656400147136	10.080259300116	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGGTGTCCGTG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.20833689909	33.423526350728	0.0133203472422833	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2500.65319266078	2500.65319266078
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCTCAGTCCTGTTAT"	-3.69741425934489	9.5039081343445	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCAGTCCTGTTAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2896.30257192321	38.8609343712231	0.0134174290862914	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2886.60049391315	2886.60049391315
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCCTTTCTCCGCAACG"	-4.31225715103801	10.4254750975403	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTTTCTCCGCAACG"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2772.06204214061	51.5790592306263	0.0186067477735082	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2762.61029787777	2762.61029787777
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAAGCACCAGACAAAT"	-4.40305886688884	10.0187282332214	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCACCAGACAAAT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3183.11080730628	36.364071615459	0.0114240671521681	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3171.08246855869	3171.08246855869
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CGATGCGAGTTACGGG"	-3.70602903786357	9.5463018187317	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGCGAGTTACGGG"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.15312746698	47.1647347040772	0.0195935747360236	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2400.39232861204	2400.39232861204
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCCACACAGCC"	-4.33830819550212	9.92448899829713	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCCACACAGCC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2726.56929028407	37.8214310370829	0.0138714358633235	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2720.71625166865	2720.71625166865
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAGGCTCACCACAA"	-2.0842686695164	9.12315080249635	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAGGCTCACCACAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2303.53991384783	45.1449428755628	0.0195980727766739	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2296.65334651325	2296.65334651325
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CCTCAGTTCCCGTTCA"	-3.7376278442448	10.0080194243225	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCAGTTCCCGTTCA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2350.82955247669	42.2238548711963	0.0179612574747122	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2341.89096922274	2341.89096922274
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TAACTTCGTATCCCTC"	0.344991345971268	-6.51395943081053	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACTTCGTATCCCTC"	"Granulocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2960.94526282659	43.7438640681927	0.014773614567408	2766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	64	TRUE	"Gran_AML-1371"	2954.65267423906	2954.65267423906
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTGAATGTCATCTGTT"	-3.08749423447307	9.28891179645387	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGAATGTCATCTGTT"	"gd T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2658.58122730686	36.243272020091	0.0136325614759589	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2646.85491457217	2646.85491457217
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CTACCTGGTTAAGCAA"	-4.93163333359416	8.93383309924928	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.150943396226415	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCTGGTTAAGCAA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3806.60568445761	49.706399249094	0.0130579322812566	5259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	3794.70754939139	3794.70754939139
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAGTTCCAGTGGACGT"	-2.10848627510722	8.87660024249879	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTCCAGTGGACGT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2656.3689140372	42.7853842879221	0.0161067177310459	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2648.33005227099	2648.33005227099
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GACCGTGGTCTTTCTA"	-4.16546330872233	9.89561364734498	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCGTGGTCTTTCTA"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2604.08100160242	35.9132448642516	0.0137911396927179	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2599.16168864531	2599.16168864531
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ATTATCCAGCTCGCAC"	10.3296410041744	7.78225991809694	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0313443231947992	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTATCCAGCTCGCAC"	"B"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2444.72812834817	40.3240237628643	0.0164942773371328	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	149	TRUE	"B_AML-1371"	2433.75113939189	2433.75113939189
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:TGTTCCGAGCTCCGAC"	3.76773538169209	-7.38252737438353	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"HLA-II+ monocyte"	"HLA-II+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCCGAGCTCCGAC"	"HLA-II+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.07946179283	36.7780715215499	0.0149135792626943	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	2461.02418462352	2461.02418462352
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGGTTCTCGCT"	-2.2839814228123	8.73790452564088	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.191825613079019	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGGTTCTCGCT"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2775.1585265235	39.3124024810391	0.0141658222783714	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2764.44753295027	2764.44753295027
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:ACGTAACCACGCGGTT"	-3.88255534592326	10.2172117003235	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAACCACGCGGTT"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2324.35515969239	43.6709559434456	0.0187884178376703	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2322.81797163202	2322.81797163202
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TCAGTGAAGCAACTTC"	-4.21217236939128	9.82052896106569	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.361592632719393	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTGAAGCAACTTC"	"NK"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2533.82674646814	34.2075499665709	0.0135003508090094	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	507	TRUE	"NK_AML-1371"	2529.68064120109	2529.68064120109
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:GGAGGATTCTACACTT"	1.17469241198842	-7.49636938488158	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD14+ monocyte"	"CD14+"	56	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.965753424657534	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGGATTCTACACTT"	"CD14+ monocyte"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3173.87064534617	38.2241443908806	0.0120433844545393	2888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	334	TRUE	"Mono_AML-1371"	3164.10276338217	3164.10276338217
"AML-1371"	"2020-09-11-AML4340_AML1371-c2:CAAGGGACACGTTGGC"	-0.345415661961395	8.57483193958131	"2020-09-11-AML4340_AML1371-c2"	"AML1371"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGGGACACGTTGGC"	"CD4+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2248.46668677382	35.1415178533019	0.0156291031839676	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2239.69086732986	2239.69086732986
"AML-1371"	"2020-09-11-AML4340_AML1371-c1:TGCATGAGTATGAGGC"	-0.801851550967056	8.86534020984498	"2020-09-11-AML4340_AML1371-c1"	"AML1371"	"CD8+ T"	"CD8+ TRM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.123603351955307	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATGAGTATGAGGC"	"CD8+ T"	"U-18-1371"	"M"	78	"CITE-seq"	"OSU"	"AML1371"	"AML"	NA	"46,XY (17 metas), -Y in 3 metas"	631	"Blasts, defined by CD45 faint 
staining and low side scatter represent 72.4 % of the total events 
analyzed and express CD33+, CD117+ and are negative for the 
remaining markers. "	""	"x"	"x"	""	""	""	NA	NA	"0"	"0,48"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,42"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0,47"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.69792891905	43.8320961513951	0.0181747869937597	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1882	TRUE	"T_AML-1371"	2403.87499543147	2403.87499543147
"AML-2123"	"2020-07-29-AML2123-c2:AAATGGAAGTGAGTTA"	-3.60161314430888	10.1542577513489	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAATGGAAGTGAGTTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2017.87984379927	40.5060648823351	0.0200735762373592	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2014.71486371457	2014.71486371457
"AML-2123"	"2020-07-29-AML2123-c2:AACAACCCACACAGAG"	12.0218464332515	-3.23375465786131	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAACCCACACAGAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2277.14371967223	41.8829735208541	0.0183927668504308	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2274.64769110066	2274.64769110066
"AML-2123"	"2020-07-29-AML2123-c2:AACAAGACACAATGTC"	11.8890024619991	-3.07769634639891	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAAGACACAATGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2123.40630875255	45.6553013130989	0.0215009728118969	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2116.16422127009	2116.16422127009
"AML-2123"	"2020-07-29-AML2123-c2:AACAAGACATCACGGC"	12.0923372703487	-2.66732337391051	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAAGACATCACGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1450.8236050582	43.7347068243221	0.0301447444553865	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1446.86374542466	1446.86374542466
"AML-2123"	"2020-07-29-AML2123-c2:CTGGCAGGTTTAGTCG"	-0.104408035904723	11.1537914046082	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGGCAGGTTTAGTCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1947.14592004934	44.2866700691902	0.0227444022623985	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1939.46775045877	1939.46775045877
"AML-2123"	"2020-07-29-AML2123-c2:CTGGTCTAGTAGATCA"	11.3980566459591	-2.69872023975524	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGGTCTAGTAGATCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2223.23812952263	45.1461293262598	0.0203064749235627	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2209.8056392432	2209.8056392432
"AML-2123"	"2020-07-29-AML2123-c2:CTGGTCTTCACTTGTT"	-7.65332875672038	2.72407553279725	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGGTCTTCACTTGTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2724.85764402514	40.8077523109037	0.0149761043114982	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2712.50060110487	2712.50060110487
"AML-2123"	"2020-07-29-AML2123-c2:CTGTACCGTGAGACGT"	-7.5110424560612	2.52836606586305	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGTACCGTGAGACGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2691.67229045304	50.3240901908814	0.0186962173550523	2899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2682.29720902941	2682.29720902941
"AML-2123"	"2020-07-29-AML2123-c2:CTGTACCTCTAGAACC"	1.47843422469441	11.1161737211975	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGTACCTCTAGAACC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1997.77656049696	39.3946407641212	0.0197192426536036	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1993.41272311869	1993.41272311869
"AML-2123"	"2020-07-29-AML2123-c2:CTGTATTTCGCGTTTC"	-2.08746729317363	3.84398624980775	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGTATTTCGCGTTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3262.51369478293	33.7641563870354	0.0103491232668318	4891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3254.48836475434	3254.48836475434
"AML-2123"	"2020-07-29-AML2123-c2:CTTCAATTCCAGTTCC"	12.0562778907711	-2.1543486348358	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTCAATTCCAGTTCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1712.70549523062	10.0510961863436	0.00586854903795952	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1711.03400008964	1711.03400008964
"AML-2123"	"2020-07-29-AML2123-c2:CTTCAATTCTCCTGAC"	-5.67255435410197	3.90383789623109	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTCAATTCTCCTGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2736.96684260524	42.4160163455365	0.0154974534894847	3632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2723.19234074258	2723.19234074258
"AML-2123"	"2020-07-29-AML2123-c2:CTTCCTTCAATATCCG"	-1.80231211605724	4.01677749240724	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTCCTTCAATATCCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3075.99793812668	24.3110363151471	0.00790346313754449	5677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3072.474504616	3072.474504616
"AML-2123"	"2020-07-29-AML2123-c1:TTTGTTGAGCTCATAC"	11.2421146827633	-2.69503285801085	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTGTTGAGCTCATAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2131.37083760054	37.9839178237179	0.0178213556991704	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2121.59971429471	2121.59971429471
"AML-2123"	"2020-07-29-AML2123-c1:TTTGTTGCAGAACTCT"	8.09000649031941	8.31633470142213	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTGTTGCAGAACTCT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2021.84935899292	34.3675149210601	0.0169980591126623	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2011.94253497035	2011.94253497035
"AML-2123"	"2020-07-29-AML2123-c2:AAACCCAGTTACCTGA"	-1.80832837048228	3.96856973255006	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAACCCAGTTACCTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3122.17468191299	34.772941676723	0.0111374106894677	5293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3117.51215884808	3117.51215884808
"AML-2123"	"2020-07-29-AML2123-c2:AAACGCTAGAGTTGCG"	11.8684116798336	-2.22710683262023	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAACGCTAGAGTTGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1659.98590999981	35.5186764295369	0.0213969746463336	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1659.98590999981	1659.98590999981
"AML-2123"	"2020-07-29-AML2123-c2:AAACGCTCATCATCTT"	-7.64843736115153	2.7801737555298	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAACGCTCATCATCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3078.31618966644	45.0433650070675	0.0146324686067899	3113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3072.7428649077	3072.7428649077
"AML-2123"	"2020-07-29-AML2123-c2:AAACGCTTCTTAGGAC"	0.574471791356248	9.30981538379518	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAACGCTTCTTAGGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1878.39505323349	39.2894199902584	0.0209164839540144	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1871.26343929343	1871.26343929343
"AML-2123"	"2020-07-29-AML2123-c2:AAAGAACAGATCCTAC"	11.2311665016109	-1.01911594783934	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAAGAACAGATCCTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1332.54813289696	42.6386271433077	0.0319978138805473	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1330.46181790175	1330.46181790175
"AML-2123"	"2020-07-29-AML2123-c2:AAAGTCCGTAACACCT"	-7.70909915390666	2.79321286762086	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAAGTCCGTAACACCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2313.71291499918	44.0026432195449	0.0190181949256917	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2303.93514891703	2303.93514891703
"AML-2123"	"2020-07-29-AML2123-c2:AAAGTGACACTTGGGC"	-7.62619910660441	2.83006188953248	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAAGTGACACTTGGGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2409.10205708052	41.3282594562215	0.0171550471823121	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2401.59075582905	2401.59075582905
"AML-2123"	"2020-07-29-AML2123-c2:CTCAAGATCGCGCTGA"	-3.80473099175151	10.0306348570618	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAAGATCGCGCTGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2092.59840566485	44.0947036903812	0.0210717467675656	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2089.56805716285	2089.56805716285
"AML-2123"	"2020-07-29-AML2123-c2:CTCAATTCACTAAACC"	-7.49936042252238	2.10853741252748	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAATTCACTAAACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2902.94888286247	44.6143226243819	0.015368621503383	3041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2896.8227543853	2896.8227543853
"AML-2123"	"2020-07-29-AML2123-c2:CTCAATTCAGAAGCGT"	-2.74900970879253	3.96241972530214	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAATTCAGAAGCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3543.54760830056	40.0992491171322	0.0113161310499122	4953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3535.23288208038	3535.23288208038
"AML-2123"	"2020-07-29-AML2123-c2:CTCAGGGTCCTCTCTT"	-7.39331040802653	2.20972654903261	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAGGGTCCTCTCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2576.46628886643	42.2096718051666	0.0163827766687907	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2563.02489760319	2563.02489760319
"AML-2123"	"2020-07-29-AML2123-c2:CTCATCGAGTGGAATT"	11.138724942773	-2.66573264515074	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCATCGAGTGGAATT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1931.57496984717	40.6587565508037	0.0210495358375972	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1924.21629771994	1924.21629771994
"AML-2123"	"2020-07-29-AML2123-c2:CTCCAACAGGGATGTC"	-7.53526387634929	2.60029122913209	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCAACAGGGATGTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2617.45149637424	44.68994065806	0.0170738371732831	3041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2604.13328188566	2604.13328188566
"AML-2123"	"2020-07-29-AML2123-c2:CTCCATGTCGTCTCAC"	1.37311329421346	11.2516937025818	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCATGTCGTCTCAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2094.88745592685	46.7726073287263	0.0223270263022471	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2084.97822987089	2084.97822987089
"AML-2123"	"2020-07-29-AML2123-c2:CTCCCAAAGGCCCGTT"	-7.22019467774089	3.13498280132142	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCCAAAGGCCCGTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2425.79141141889	0	0	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2402.10433453875	2402.10433453875
"AML-2123"	"2020-07-29-AML2123-c2:CTCCCAAGTAGGTCAG"	-1.70521340790446	3.37332413280336	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCCAAGTAGGTCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3034.67505096687	42.7884135596785	0.0140998337024736	3942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3024.68814663867	3024.68814663867
"AML-2123"	"2020-07-29-AML2123-c2:CTCCCAATCATACGAC"	-2.9130052131718	10.1816549071106	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCCAATCATACGAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2068.14442837643	40.9693425128224	0.0198097105553624	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2058.61160634993	2058.61160634993
"AML-2123"	"2020-07-29-AML2123-c2:CTCCCTCTCTCCTGTG"	8.73598064956014	8.02541921222535	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCCTCTCTCCTGTG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2170.84992012672	38.7273386581615	0.0178397125932597	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2163.05734894311	2163.05734894311
"AML-2123"	"2020-07-29-AML2123-c2:CTCCTCCCACACTTAG"	11.4356771903927	-1.43775322353514	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCCTCCCACACTTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1479.8672080455	26.4467500657386	0.0178710291855629	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1466.23840453058	1466.23840453058
"AML-2123"	"2020-07-29-AML2123-c2:CTCGAGGTCTCATAGG"	12.3003202873165	-2.19235088741454	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCGAGGTCTCATAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1275.3580011966	31.6650966933559	0.0248283985074358	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1273.92450618088	1273.92450618088
"AML-2123"	"2020-07-29-AML2123-c2:CTGAATGAGTTGCTGT"	8.83232559737508	7.66832349384157	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAATGAGTTGCTGT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1830.08423976058	41.8597895823327	0.0228731490457559	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1826.86596561141	1826.86596561141
"AML-2123"	"2020-07-29-AML2123-c2:CTGAATGCAACCGACC"	-7.42674861374553	3.24883577907411	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAATGCAACCGACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2287.52460577013	43.397691657967	0.018971464415508	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2280.69115251645	2280.69115251645
"AML-2123"	"2020-07-29-AML2123-c2:CTGAATGCAGGTAGTG"	-2.5808301967686	9.97294614398805	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"Activated NK"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAATGCAGGTAGTG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	1946.83775204522	40.1852590781122	0.0206412984522702	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	1940.716337778	1940.716337778
"AML-2123"	"2020-07-29-AML2123-c2:CTGAGCGGTGATTCTG"	-7.86683879318889	3.8792400130066	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAGCGGTGATTCTG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2418.33999323102	44.9511222035608	0.0185875941056178	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2403.94866038762	2403.94866038762
"AML-2123"	"2020-07-29-AML2123-c2:CTGAGGCCAATCAAGA"	-5.1314939064091	3.63389418208925	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAGGCCAATCAAGA"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2837.40547211185	45.5562923409974	0.0160556158746992	3364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2829.14831986933	2829.14831986933
"AML-2123"	"2020-07-29-AML2123-c2:CTGAGGCCATACTTTC"	-7.60781608048137	2.72072265231935	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGAGGCCATACTTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2242.64783650729	42.0731433104572	0.0187604770689196	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2235.95523101375	2235.95523101375
"AML-2123"	"2020-07-29-AML2123-c2:CTGATCCTCTTTCCGG"	-7.72953830185588	1.57592926109163	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGATCCTCTTTCCGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2391.4271387447	40.8960912481884	0.0171011236703015	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2385.19872194628	2385.19872194628
"AML-2123"	"2020-07-29-AML2123-c2:CTGCTCACAGCTGAGA"	-1.7221476835316	3.52055261218873	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGCTCACAGCTGAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2665.77977675494	32.2770533187163	0.0121079218921854	4229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2662.18499949059	2662.18499949059
"AML-2123"	"2020-07-29-AML2123-c2:CTGGACGCAGCAGAAC"	-1.4313282770222	3.70939586246339	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTGGACGCAGCAGAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2583.92999098135	44.7850424267384	0.0173321423502381	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2578.19044455347	2578.19044455347
"AML-2123"	"2020-07-29-AML2123-c1:AAACGCTCAGTCGTTA"	8.61339153823201	7.8343205221924	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAACGCTCAGTCGTTA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1689.21953445624	44.7181461578633	0.0264726669599272	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1687.26500950637	1687.26500950637
"AML-2123"	"2020-07-29-AML2123-c1:AAAGTCCAGCTTTCCC"	-6.32602868500407	2.03110716426698	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAAGTCCAGCTTTCCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2334.29233404282	52.3243628051825	0.0224155141333822	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2325.55067506518	2325.55067506518
"AML-2123"	"2020-07-29-AML2123-c1:AACAACCCAATTTCTC"	-7.63430438461955	2.65139744365541	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACAACCCAATTTCTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2598.03980141119	46.9759460382628	0.0180813034552999	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2587.80959749383	2587.80959749383
"AML-2123"	"2020-07-29-AML2123-c1:AACAAGATCTGTCCGT"	-7.19790254059489	2.30822537029115	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACAAGATCTGTCCGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2421.58306829904	42.3262950609337	0.0174787706500873	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2413.91966032442	2413.91966032442
"AML-2123"	"2020-07-29-AML2123-c1:AACACACAGCATCTTG"	-7.56241450730022	2.54503581607667	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACACACAGCATCTTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2662.73377474652	46.5568515354727	0.0174846062257594	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2648.08032223058	2648.08032223058
"AML-2123"	"2020-07-29-AML2123-c1:AACAGGGCAAGGCGTA"	-4.30106959763225	10.3893117674622	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACAGGGCAAGGCGTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2928.1536895153	41.0662378704511	0.0140246183175067	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2923.25366229967	2923.25366229967
"AML-2123"	"2020-07-29-AML2123-c1:AACAGGGCACTTGTCC"	9.3133884864742	7.62933347308961	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACAGGGCACTTGTCC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1827.83565750375	44.5552065083746	0.0243759368220353	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1816.99491847091	1816.99491847091
"AML-2123"	"2020-07-29-AML2123-c1:AACCAACCAACGCCCA"	0.530556072562379	11.9760436781677	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACCAACCAACGCCCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2037.48779685065	46.7388821373878	0.0229394660471745	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2024.23118275146	2024.23118275146
"AML-2123"	"2020-07-29-AML2123-c1:AACCACATCGTTGCCT"	-4.46570716324504	10.8200492628845	"2020-07-29-AML2123-c1"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACCACATCGTTGCCT"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2406.51809007509	46.4906954026575	0.0193186561091701	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2388.45589877198	2388.45589877198
"AML-2123"	"2020-07-29-AML2123-c1:AACCATGCAAATGCGG"	-7.46776376190837	3.00895807826845	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACCATGCAAATGCGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2613.25987674552	47.4510115766671	0.0181577852240862	3058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2599.54438521929	2599.54438521929
"AML-2123"	"2020-07-29-AML2123-c1:AACCTGAAGTGTAGTA"	-7.6007059616154	2.5439734228882	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACCTGAAGTGTAGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2467.70290808923	50.5347690377828	0.0204784655689823	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2457.9667134007	2457.9667134007
"AML-2123"	"2020-07-29-AML2123-c1:AACCTTTGTCGCTTAA"	-2.94542322579082	9.89911935413209	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACCTTTGTCGCTTAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2408.07022809348	46.8133273276789	0.0194401835883092	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2397.05149420037	2397.05149420037
"AML-2123"	"2020-07-29-AML2123-c1:AACGGGAGTAACTGCT"	-7.89592919769939	2.69399449909059	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AACGGGAGTAACTGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2260.64390036305	42.7416630409488	0.0189068535004937	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2252.55976985071	2252.55976985071
"AML-2123"	"2020-07-29-AML2123-c1:AAGATAGAGGTCCTGC"	-0.89338324490245	11.3643216856751	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGATAGAGGTCCTGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2121.70285503539	41.0529550946989	0.0193490596467214	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2112.5189889668	2112.5189889668
"AML-2123"	"2020-07-29-AML2123-c1:AAGATAGAGTACCATC"	-7.49820361557658	2.63263676250306	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGATAGAGTACCATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2499.86244674297	42.4297197733584	0.0169728217761099	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2487.25421101285	2487.25421101285
"AML-2123"	"2020-07-29-AML2123-c1:AAGATAGTCCCACAGG"	-7.69603619995769	2.76122734630433	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGATAGTCCCACAGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2654.14280204149	47.6126191908436	0.0179389817135013	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2643.52985080351	2643.52985080351
"AML-2123"	"2020-07-29-AML2123-c1:AAGCATCTCCCATACC"	-2.93345628204997	10.1868428953919	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGCATCTCCCATACC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2023.18319374284	35.0393113122367	0.0173189019267281	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2018.34999328474	2018.34999328474
"AML-2123"	"2020-07-29-AML2123-c1:AAGCATCTCTATTTCG"	-7.71603331986125	2.84207151019899	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGCATCTCTATTTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2160.09208225268	46.5969090603208	0.0215717234664027	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2152.10309682936	2152.10309682936
"AML-2123"	"2020-07-29-AML2123-c1:AAGCCATCAGCCTTCT"	-7.49746833267863	2.64205453479616	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGCCATCAGCCTTCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2469.13327670358	40.4641468851242	0.0163879962523311	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2457.48027370324	2457.48027370324
"AML-2123"	"2020-07-29-AML2123-c1:AAGCGAGGTAGCGTAG"	-7.51979623261149	2.89082954013673	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGCGAGGTAGCGTAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1966.82392184264	44.5378341723307	0.0226445456950742	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1956.43749630838	1956.43749630838
"AML-2123"	"2020-07-29-AML2123-c1:AAGGAATAGGAATGTT"	10.2616478401119	7.89507482135621	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGGAATAGGAATGTT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2552.8377416868	36.986791892916	0.0144885008901807	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2546.31657029132	2546.31657029132
"AML-2123"	"2020-07-29-AML2123-c1:AAGGTAATCGAGCTGC"	11.5975643592769	-2.26420977031859	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGGTAATCGAGCTGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2468.41066632435	50.0667966381025	0.020283009355431	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2462.12728531431	2462.12728531431
"AML-2123"	"2020-07-29-AML2123-c1:AAGTACCAGCCTGGAA"	11.5020729499752	-2.39402820980223	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGTACCAGCCTGGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1657.13164021474	44.5062419986612	0.0268573967925045	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1654.37858243392	1654.37858243392
"AML-2123"	"2020-07-29-AML2123-c1:AAGTACCCAATTGCAC"	-3.261302570731	10.430091834906	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGTACCCAATTGCAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2076.87358992308	37.8388816626164	0.0182191549096726	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2068.46954718192	2068.46954718192
"AML-2123"	"2020-07-29-AML2123-c1:AAGTCGTAGAATTGCA"	-7.61213336411174	2.74567720973817	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AAGTCGTAGAATTGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2643.46800953237	46.4727378869997	0.0175802157315385	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2627.93280171787	2627.93280171787
"AML-2123"	"2020-07-29-AML2123-c1:AATAGAGTCAGGAGAC"	1.52081479605977	10.7907104262146	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AATAGAGTCAGGAGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1891.49468571894	49.0977221165002	0.0259571028600795	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1887.14575720667	1887.14575720667
"AML-2123"	"2020-07-29-AML2123-c1:AATGAAGCACCAAAGG"	-0.989218692213851	11.090736366156	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AATGAAGCACCAAAGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2096.82932712162	45.9063238613899	0.0218932095557853	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2095.46342833691	2095.46342833691
"AML-2123"	"2020-07-29-AML2123-c1:AATGCCACATGGACAG"	-7.5468638938969	2.53950522029725	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AATGCCACATGGACAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2846.3307909663	45.01584141889	0.0158153934749121	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2837.92948580236	2837.92948580236
"AML-2123"	"2020-07-29-AML2123-c1:AATTCCTGTAGGTACG"	11.6192623573238	-2.8844580880371	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AATTCCTGTAGGTACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1676.93097579905	26.0896145553509	0.0155579537451858	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1671.89838595215	1671.89838595215
"AML-2123"	"2020-07-29-AML2123-c1:AATTTCCGTGTTGATC"	-7.5815785926884	2.53457067096559	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AATTTCCGTGTTGATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2569.06349005416	40.149744264901	0.0156281635001767	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2556.69533443184	2556.69533443184
"AML-2123"	"2020-07-29-AML2123-c1:ACAACCACAGTATGAA"	-5.55728564682658	2.2600571879181	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.833333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACAACCACAGTATGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2075.21797907677	48.9729951193077	0.0235989643560697	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2060.71590185229	2060.71590185229
"AML-2123"	"2020-07-29-AML2123-c1:ACAAGCTAGCGACAGT"	11.9579512077266	-2.74502804195555	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACAAGCTAGCGACAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1842.7957112564	37.1688134058225	0.0201697959132329	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1834.4784608477	1834.4784608477
"AML-2123"	"2020-07-29-AML2123-c1:ACAGGGACAGGCTACC"	11.61519398269	-2.2167699567047	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACAGGGACAGGCTACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1582.51543680625	39.317013993568	0.0248446322096646	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1574.98625172829	1574.98625172829
"AML-2123"	"2020-07-29-AML2123-c1:ACAGGGATCCTAACAG"	11.9493252235347	-2.00861408626708	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACAGGGATCCTAACAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1507.56992125411	42.4920139267227	0.0281857665954059	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1507.56992125411	1507.56992125411
"AML-2123"	"2020-07-29-AML2123-c1:ACATCCCCAGGCCCTA"	11.9278818565303	-3.08402349865111	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACATCCCCAGGCCCTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1753.17845477172	48.2830006681994	0.0275402658165146	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1750.12058748114	1750.12058748114
"AML-2123"	"2020-07-29-AML2123-c1:ACATCGAAGGTAACTA"	-7.52598557892497	2.5821277865204	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACATCGAAGGTAACTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2593.70650558179	39.3626448039866	0.0151762139314052	2703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2583.53508276052	2583.53508276052
"AML-2123"	"2020-07-29-AML2123-c1:ACATTTCAGCATATGA"	-7.64181886139567	2.64308593356935	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACATTTCAGCATATGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2540.58631466071	47.4994377607993	0.0186962503445362	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2529.68062425995	2529.68062425995
"AML-2123"	"2020-07-29-AML2123-c1:ACCAACAAGGCTTAAA"	-9.02635798874553	4.40203282916871	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCAACAAGGCTTAAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1883.68920512632	47.2512671234793	0.0250844284688198	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1871.43190240508	1871.43190240508
"AML-2123"	"2020-07-29-AML2123-c1:ACCAACAGTTACCCAA"	11.4762798744137	-1.58207299625548	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCAACAGTTACCCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1299.56693029687	41.1306068444524	0.0316494717475279	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1292.39791937017	1292.39791937017
"AML-2123"	"2020-07-29-AML2123-c1:ACCATTTTCGGAACTT"	-2.39818702164348	3.44790718639223	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCATTTTCGGAACTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3116.99860907768	37.4917632915	0.0120281617009107	4862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3110.02218795015	3110.02218795015
"AML-2123"	"2020-07-29-AML2123-c1:ACCATTTTCTTCCTAA"	11.7515856223995	-2.29350783741149	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCATTTTCTTCCTAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1570.95864958179	27.7308103615782	0.0176521580430907	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1569.23901671129	1569.23901671129
"AML-2123"	"2020-07-29-AML2123-c1:ACCCTTGAGAGTCAAT"	-0.617758194834548	12.5754070051941	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCCTTGAGAGTCAAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2068.37551540059	38.7703017845475	0.0187443244690695	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2063.99306401833	2063.99306401833
"AML-2123"	"2020-07-29-AML2123-c1:ACCTACCCACACGTGC"	-3.61543665352519	3.49469635570375	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCTACCCACACGTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3515.31552606422	43.0575977218521	0.0122485726821967	5004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3509.21127742417	3509.21127742417
"AML-2123"	"2020-07-29-AML2123-c1:ACCTACCCATCCAATG"	-3.07823548737224	10.2262897261414	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCTACCCATCCAATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2085.15794182384	46.2108144840392	0.0221617813965783	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2080.47324250401	2080.47324250401
"AML-2123"	"2020-07-29-AML2123-c1:ACCTACCTCCTTCAGC"	11.8669105964595	-2.27143361484679	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACCTACCTCCTTCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1505.8479431247	4.88255380704069	0.00324239497708458	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1501.65524800302	1501.65524800302
"AML-2123"	"2020-07-29-AML2123-c1:ACGATCACACGAGAAC"	-4.22168765488322	9.98924062335817	"2020-07-29-AML2123-c1"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGATCACACGAGAAC"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2467.4810205292	39.3369260684235	0.0159421392671896	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2457.20148449385	2457.20148449385
"AML-2123"	"2020-07-29-AML2123-c1:ACGATGTTCGAGGCAA"	11.4276119666988	-2.58259799396666	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGATGTTCGAGGCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2324.5929856412	47.0580149676698	0.0202435502723887	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2317.59376829651	2317.59376829651
"AML-2123"	"2020-07-29-AML2123-c1:ACGCACGAGATGCGAC"	-7.57681022110637	2.59341428363649	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGCACGAGATGCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2549.77628989391	45.3608828666329	0.0177901422357803	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2537.97846121039	2537.97846121039
"AML-2123"	"2020-07-29-AML2123-c1:ACGCACGGTCACCACG"	0.304191370576066	11.121651626471	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGCACGGTCACCACG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1941.32937430497	36.2390574041516	0.0186671349456739	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1937.32536815983	1937.32536815983
"AML-2123"	"2020-07-29-AML2123-c1:ACGCACGGTTGGATCT"	-7.51865230026897	2.67931006038514	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGCACGGTTGGATCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2504.28182939138	49.7162009249792	0.0198524783997901	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2494.73832958139	2494.73832958139
"AML-2123"	"2020-07-29-AML2123-c1:ACGGTCGCAAGTCCCG"	0.71458919820134	10.3088264235291	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGGTCGCAAGTCCCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2068.46863309056	44.3418039693291	0.0214370202477166	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2067.41387431218	2067.41387431218
"AML-2123"	"2020-07-29-AML2123-c1:ACGGTCGCACGTGTGC"	8.7855450111324	8.02214810932008	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGGTCGCACGTGTGC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1796.58724680622	43.9556497727929	0.0244661926944725	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1787.11767961759	1787.11767961759
"AML-2123"	"2020-07-29-AML2123-c1:ACGGTCGCATCATCCC"	11.7568127113277	-1.99318697368773	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGGTCGCATCATCCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1269.99009058962	44.9737863537381	0.0354127065139997	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1268.34483296748	1268.34483296748
"AML-2123"	"2020-07-29-AML2123-c1:ACGGTCGGTCGCGGTT"	8.72963299331014	7.96497533405153	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGGTCGGTCGCGGTT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2036.76397513935	45.2268202487836	0.0222052337928302	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2033.44808344942	2033.44808344942
"AML-2123"	"2020-07-29-AML2123-c1:ACGTAACCATTCCTCG"	-5.41784749451335	2.14847276294557	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.833333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGTAACCATTCCTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2079.69121151898	47.3248605290155	0.0227557150152354	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2065.27283236557	2065.27283236557
"AML-2123"	"2020-07-29-AML2123-c1:ACGTTCCAGTTCAACC"	10.8420282798702	-2.65957977687987	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACGTTCCAGTTCAACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2705.00588752481	45.6889160993291	0.0168905052332941	2702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2700.56065757655	2700.56065757655
"AML-2123"	"2020-07-29-AML2123-c1:ACTACGACATCCTATT"	11.8564754920894	-3.29439928447875	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTACGACATCCTATT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2693.59504725763	13.6168143889717	0.00505525669229126	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2686.49274901186	2686.49274901186
"AML-2123"	"2020-07-29-AML2123-c1:ACTATCTGTCTAGGTT"	-3.65827689591106	9.81537339771119	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTATCTGTCTAGGTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2071.27510384709	52.2165131207415	0.0252098395928947	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2058.60624762851	2058.60624762851
"AML-2123"	"2020-07-29-AML2123-c1:ACTATCTTCAAACCCA"	10.9473806816036	-0.570956312772356	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTATCTTCAAACCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1159.81806095019	8.75964420467837	0.00755260199819788	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1151.85176854825	1151.85176854825
"AML-2123"	"2020-07-29-AML2123-c1:ACTATGGTCATTGTTC"	11.3444858985836	-2.51415231144103	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTATGGTCATTGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2369.33284175617	41.8248695661276	0.017652593518742	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2359.07266155114	2359.07266155114
"AML-2123"	"2020-07-29-AML2123-c1:ACTCCCAGTGGTCTTA"	11.4540382820064	4.32962462985841	"2020-07-29-AML2123-c1"	"AML2123"	"Pre-B"	"Pre-B"	48	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00140056022408964	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTCCCAGTGGTCTTA"	"Pre-B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1692.76554317398	49.1373002073767	0.0290278239686064	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1692.76554317398	1692.76554317398
"AML-2123"	"2020-07-29-AML2123-c1:ACTCTCGAGGTGAGCT"	-8.73245082321819	3.35869453037111	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTCTCGAGGTGAGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2666.05327338943	45.5306396561326	0.0170779181761241	2817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2653.33999164614	2653.33999164614
"AML-2123"	"2020-07-29-AML2123-c1:ACTGTCCCATGGCACC"	-7.62973533096965	2.19383761966554	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTGTCCCATGGCACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2765.30296276928	43.0196450394332	0.0155569373839428	3106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2750.90395108875	2750.90395108875
"AML-2123"	"2020-07-29-AML2123-c1:ACTTATCCAGCTACTA"	0.630664964287919	11.4489974745545	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTTATCCAGCTACTA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2227.23807092849	44.3010995876682	0.0198905991083387	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2218.77207061704	2218.77207061704
"AML-2123"	"2020-07-29-AML2123-c1:ACTTATCTCCATCTGC"	-7.46077523651774	4.38832995975343	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTTATCTCCATCTGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2026.04321943383	42.4716853363666	0.0209628723262059	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2016.80842166333	2016.80842166333
"AML-2123"	"2020-07-29-AML2123-c1:ACTTCGCTCAGCAGAG"	11.8154484229976	-2.01940348064574	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTTCGCTCAGCAGAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1575.83801996755	33.3816109182179	0.0211834024152465	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1566.6800694624	1566.6800694624
"AML-2123"	"2020-07-29-AML2123-c1:ACTTTCATCGTCGATA"	11.7106424766475	-2.26875331318053	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ACTTTCATCGTCGATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1773.70441327737	36.1411270658928	0.0203760710044763	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1767.40652717634	1767.40652717634
"AML-2123"	"2020-07-29-AML2123-c1:AGAACAACACCGAATT"	-7.76076112213786	2.97471187198488	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAACAACACCGAATT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2444.9965030819	49.8512264234231	0.0203890788230519	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2437.64570268497	2437.64570268497
"AML-2123"	"2020-07-29-AML2123-c1:AGAACAATCGGCTGGT"	11.9412085014278	-2.33842828190001	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAACAATCGGCTGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1363.32658619635	42.4539479931904	0.0311399692656445	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1356.47900193235	1356.47900193235
"AML-2123"	"2020-07-29-AML2123-c1:AGAACCTAGATTGATG"	-7.72813973847087	2.52734754169313	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAACCTAGATTGATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2466.77838660667	47.4954341060428	0.019254033667523	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2461.82082873124	2461.82082873124
"AML-2123"	"2020-07-29-AML2123-c1:AGAACCTAGTCCGCGT"	-3.04149518433269	11.7867078551087	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAACCTAGTCCGCGT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2158.43038255525	45.4681658694244	0.021065384474248	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2153.75448936273	2153.75448936273
"AML-2123"	"2020-07-29-AML2123-c1:AGAAGCGGTGTAGCAG"	11.708606381982	-2.82496001636656	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAAGCGGTGTAGCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2038.25387868601	31.8264902765465	0.0156145859008809	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2035.32828164477	2035.32828164477
"AML-2123"	"2020-07-29-AML2123-c1:AGACAAATCCACTGAA"	-2.04954848709758	4.19692847812501	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGACAAATCCACTGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3049.71749543736	27.17656708013	0.00891117525501576	5739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3045.38143967041	3045.38143967041
"AML-2123"	"2020-07-29-AML2123-c1:AGACAAATCTTCACAT"	12.4078318077022	-2.55482723629149	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGACAAATCTTCACAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1629.36137990368	44.218849730113	0.027138761404009	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1619.40506753543	1619.40506753543
"AML-2123"	"2020-07-29-AML2123-c1:AGACCCGCAACTGATC"	10.8350511985714	-2.87942793285521	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGACCCGCAACTGATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2190.38126996355	42.6574027426182	0.0194748755970361	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2179.83817344854	2179.83817344854
"AML-2123"	"2020-07-29-AML2123-c1:AGACTCATCCTGGGAC"	-7.61375699463542	2.28088638866273	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGACTCATCCTGGGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2484.68170194821	42.661518133558	0.0171698121735704	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2472.78697239395	2472.78697239395
"AML-2123"	"2020-07-29-AML2123-c1:AGAGAGCCATGGCACC"	0.15464068677966	11.3470878371033	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAGAGCCATGGCACC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2245.08182641342	32.4202358204284	0.0144405586642784	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2238.63063576674	2238.63063576674
"AML-2123"	"2020-07-29-AML2123-c1:AGAGCCCAGCTCCACG"	-7.6011360687321	-1.5112183324066	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGAGCCCAGCTCCACG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3145.00144774185	29.6735697061404	0.00943515295595379	4521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3136.30775320353	3136.30775320353
"AML-2123"	"2020-07-29-AML2123-c1:AGATAGATCGATGCTA"	0.613072534173173	8.77102468097535	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGATAGATCGATGCTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2310.42517137527	45.0222835028641	0.0194865793797013	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2302.9917021613	2302.9917021613
"AML-2123"	"2020-07-29-AML2123-c1:AGATGAATCCGCTAGG"	-7.39130769196208	2.39141271198121	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGATGAATCCGCTAGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2928.11714490519	43.7855335753201	0.0149534774083425	3196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2915.8263992308	2915.8263992308
"AML-2123"	"2020-07-29-AML2123-c1:AGCCAATAGGGATCGT"	-1.76807628098186	4.02346799457399	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCCAATAGGGATCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3201.86955706152	38.7247195553011	0.0120944088649384	5269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3198.0196061576	3198.0196061576
"AML-2123"	"2020-07-29-AML2123-c1:AGCCAATTCCCGTTCA"	8.81978191909139	8.23327348316041	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCCAATTCCCGTTCA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2074.45374247952	45.0991749303816	0.0217402654042679	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2064.35342194877	2064.35342194877
"AML-2123"	"2020-07-29-AML2123-c1:AGCCACGCACGACAAG"	-7.5382641357487	2.8634371527466	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCCACGCACGACAAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2489.3049011154	44.5936567679076	0.0179140999352576	2789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2480.00196904539	2480.00196904539
"AML-2123"	"2020-07-29-AML2123-c1:AGCCAGCTCCTTATAC"	10.6831709342891	-2.42012455379637	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCCAGCTCCTTATAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1799.79092643131	32.9744648864691	0.0183212752115892	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1793.81085772885	1793.81085772885
"AML-2123"	"2020-07-29-AML2123-c1:AGCGCCAAGCTACTGT"	-3.02394471588786	9.63227365100709	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCGCCAAGCTACTGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2575.48416684014	48.8776451409604	0.0189780413990774	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2566.69484819334	2566.69484819334
"AML-2123"	"2020-07-29-AML2123-c1:AGCGCCACAGCTACTA"	-8.26215587082561	0.715341187361158	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCGCCACAGCTACTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2669.82786080068	49.0891677893649	0.0183866415172711	3382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2658.62899501114	2658.62899501114
"AML-2123"	"2020-07-29-AML2123-c1:AGCGCTGAGATGCGAC"	-7.76984248581584	3.42643854701845	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCGCTGAGATGCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2712.95894897603	32.9992808833018	0.0121635754554107	3460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2697.73143294109	2697.73143294109
"AML-2123"	"2020-07-29-AML2123-c1:AGCGCTGCAAGGTTGG"	11.4077545600826	-2.63698103344115	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCGCTGCAAGGTTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1759.23706727862	43.7974782457977	0.0248957227314158	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1758.34110845717	1758.34110845717
"AML-2123"	"2020-07-29-AML2123-c1:AGCTACAAGGACAACC"	-1.75501296940501	3.91440532291261	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCTACAAGGACAACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3052.60625908348	0	0	5444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3048.80947901855	3048.80947901855
"AML-2123"	"2020-07-29-AML2123-c1:AGCTACACAGAGAATT"	9.1623178916866	7.81970546329347	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCTACACAGAGAATT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2073.74803435554	35.4840862195571	0.0171110885371301	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2061.11850369652	2061.11850369652
"AML-2123"	"2020-07-29-AML2123-c1:AGCTCAAAGAAACACT"	-1.99126372757609	3.46536395633546	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGCTCAAAGAAACACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3170.8269204565	44.551087235533	0.0140503055994993	4896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3158.79027548551	3158.79027548551
"AML-2123"	"2020-07-29-AML2123-c1:AGGAAATTCACGGGCT"	10.9836183982784	-0.904401921388231	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGAAATTCACGGGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1327.16682477496	39.9836160470253	0.0301270460507519	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1325.72751951787	1325.72751951787
"AML-2123"	"2020-07-29-AML2123-c1:AGGAATAAGGGCCTCT"	-7.62441478195842	2.77651379192201	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGAATAAGGGCCTCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2653.29442946251	47.4523884611715	0.0178843282276758	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2640.54098443885	2640.54098443885
"AML-2123"	"2020-07-29-AML2123-c1:AGGACGACATTCGGGC"	7.41575541076009	6.28380916202394	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV+"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGACGACATTCGGGC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1488.50709547819	41.4744790291672	0.0278631382780498	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1471.02869418122	1471.02869418122
"AML-2123"	"2020-07-29-AML2123-c1:AGGAGGTGTCTGTGCG"	-7.38712726059611	2.49137065494386	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGAGGTGTCTGTGCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2397.10378860743	45.8808968043239	0.0191401377872661	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2384.75373889511	2384.75373889511
"AML-2123"	"2020-07-29-AML2123-c1:AGGCCACAGAGGCCAT"	-1.0086192888325	12.256583190802	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGCCACAGAGGCCAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2002.94113811396	50.0926546844437	0.0250095490732257	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1995.1883169237	1995.1883169237
"AML-2123"	"2020-07-29-AML2123-c1:AGGCCACCAGTCGAGA"	-0.554975609213668	12.6701993712219	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGCCACCAGTCGAGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2174.58335603469	40.916840752451	0.0188159449666082	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2164.44711113037	2164.44711113037
"AML-2123"	"2020-07-29-AML2123-c1:AGGGCCTGTAGTGTGG"	-7.56622062149699	2.68205497348634	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGCCTGTAGTGTGG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2472.067324549	45.8737744593998	0.0185568467346531	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2460.38701036948	2460.38701036948
"AML-2123"	"2020-07-29-AML2123-c1:AGGGCCTTCACCTCAC"	10.842470784753	-2.27138950740965	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGCCTTCACCTCAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1764.21721169065	45.89519117081	0.0260144787539108	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1747.09590563697	1747.09590563697
"AML-2123"	"2020-07-29-AML2123-c1:AGGGTCCGTGCTCCGA"	-7.77456460419353	2.59103486621705	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGTCCGTGCTCCGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2100.71004829273	49.7366118598539	0.0236760955660089	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2092.18565172696	2092.18565172696
"AML-2123"	"2020-07-29-AML2123-c1:AGGGTGAAGTAAGACT"	-2.53884563866313	3.41171023929445	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGTGAAGTAAGACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3228.7205446741	13.7484492305614	0.00425817256102886	3966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3221.77441173945	3221.77441173945
"AML-2123"	"2020-07-29-AML2123-c1:AGGGTTTCATAAGCAA"	10.7764460044796	-0.59886964475783	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGTTTCATAAGCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1174.76713318392	34.4006226234013	0.029282929060304	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1168.65721206598	1168.65721206598
"AML-2123"	"2020-07-29-AML2123-c1:AGGGTTTGTCCAGCAC"	-2.57010088387187	3.42174170101014	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGGTTTGTCCAGCAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3256.95858436164	43.0391773852582	0.0132145301422965	4538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3249.26512880509	3249.26512880509
"AML-2123"	"2020-07-29-AML2123-c1:AGGTCATCACTCTCGT"	-2.31779275360759	3.41114018047181	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTCATCACTCTCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3184.24138620235	16.2974865859141	0.0051181693248925	5366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3177.15075023838	3177.15075023838
"AML-2123"	"2020-07-29-AML2123-c1:AGGTCATGTCGCTGCA"	-2.36878810349162	13.3631486662659	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTCATGTCGCTGCA"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2267.40777786959	47.1849841787882	0.020810100697071	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2267.40777786959	2267.40777786959
"AML-2123"	"2020-07-29-AML2123-c1:AGGTGTTAGGAATGTT"	-7.96528373184856	1.39746151054231	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTGTTAGGAATGTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2430.61432870645	46.5541801331327	0.0191532566821938	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2422.75373187961	2422.75373187961
"AML-2123"	"2020-07-29-AML2123-c1:AGGTGTTCAAAGGCGT"	11.7599216895992	-3.43046071445616	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTGTTCAAAGGCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3129.97007137516	25.7352669396149	0.00822220863227233	3908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3120.42847023517	3120.42847023517
"AML-2123"	"2020-07-29-AML2123-c1:AGGTGTTGTTACACTG"	11.9920736747677	-2.83125450527342	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTGTTGTTACACTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1897.46990868863	10.9835385252491	0.00578851789688721	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1887.7175860368	1887.7175860368
"AML-2123"	"2020-07-29-AML2123-c1:AGGTTGTAGGCTCTCG"	-7.59213767471965	2.42040846431581	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTTGTAGGCTCTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2268.70692652631	50.0722965538715	0.0220708527701014	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2259.91241672091	2259.91241672091
"AML-2123"	"2020-07-29-AML2123-c1:AGGTTGTTCGAAGAAT"	11.1910911994869	-2.60252549564513	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGGTTGTTCGAAGAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1986.41850807066	28.675983392604	0.0144360230616538	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1983.39433235034	1983.39433235034
"AML-2123"	"2020-07-29-AML2123-c1:AGTAACCAGCTTTCTT"	-3.22230492058452	9.94223878467409	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTAACCAGCTTTCTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1615.77375798909	41.7830814861588	0.0258594876167316	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1611.93995476558	1611.93995476558
"AML-2123"	"2020-07-29-AML2123-c1:AGTACCATCCTTCACG"	10.9844385581905	-2.8955219022003	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTACCATCCTTCACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2258.54102084134	49.8372309932534	0.0220661172559479	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2254.102600581	2254.102600581
"AML-2123"	"2020-07-29-AML2123-c1:AGTACTGCAGGTCTCG"	11.837250371545	-1.95558860218199	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTACTGCAGGTCTCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1390.38201477034	46.7436345631939	0.0336192744631516	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1388.35717383273	1388.35717383273
"AML-2123"	"2020-07-29-AML2123-c1:AGTAGCTAGTTTCGAC"	-7.84585366669353	2.5406226881775	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTAGCTAGTTTCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2289.33776839736	40.9654119475028	0.0178940008385834	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2277.5997844596	2277.5997844596
"AML-2123"	"2020-07-29-AML2123-c1:AGTCTCCTCATCACCC"	10.8947035270626	-2.44496967708739	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTCTCCTCATCACCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1359.15416929511	41.9145279093868	0.0308386854532658	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1357.34494172269	1357.34494172269
"AML-2123"	"2020-07-29-AML2123-c1:AGTGCCGGTACGTACT"	10.8942257362301	-2.62124850666197	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTGCCGGTACGTACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1718.6475115382	33.0532069954366	0.019232103600961	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1711.88978581433	1711.88978581433
"AML-2123"	"2020-07-29-AML2123-c1:AGTGTTGCACTACGGC"	-7.64731297913249	2.62900445545045	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTGTTGCACTACGGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2525.04011738797	43.8837718349868	0.0173794354920517	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2516.57690030755	2516.57690030755
"AML-2123"	"2020-07-29-AML2123-c1:AGTGTTGGTATACCTG"	12.4258486228878	-2.5053065053192	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTGTTGGTATACCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1353.16287204631	37.4589767163212	0.0276825336329795	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1351.55199811864	1351.55199811864
"AML-2123"	"2020-07-29-AML2123-c1:AGTTAGCCACTTGGGC"	1.36115827140157	-8.65287687694701	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTTAGCCACTTGGGC"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	1742.23429357053	34.7298914420964	0.0199341107968442	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	1742.23429357053	1742.23429357053
"AML-2123"	"2020-07-29-AML2123-c1:AGTTCCCAGATCCTAC"	1.24150373515431	11.6119861372742	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTTCCCAGATCCTAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2064.65580237448	43.0323824978527	0.02084240019492	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2050.95142532679	2050.95142532679
"AML-2123"	"2020-07-29-AML2123-c1:AGTTCGACAACTCGTA"	8.9334827857906	7.8441705473694	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTTCGACAACTCGTA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1877.26146594644	33.03921929464	0.0175996897043764	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1872.43254028599	1872.43254028599
"AML-2123"	"2020-07-29-AML2123-c1:AGTTCGAGTACCTAGT"	12.2885509925777	-2.65049889003905	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.AGTTCGAGTACCTAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1449.46810385284	38.2578572494363	0.0263944112655827	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1445.74083464261	1445.74083464261
"AML-2123"	"2020-07-29-AML2123-c1:ATACCTTAGCGTGAAC"	-1.19251285019572	10.687602973822	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATACCTTAGCGTGAAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2093.34680433236	41.4941063827196	0.0198218977843729	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2086.11578250017	2086.11578250017
"AML-2123"	"2020-07-29-AML2123-c1:ATACTTCGTCGCATGC"	-1.65527270260509	3.84176943385927	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATACTTCGTCGCATGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2979.85610875751	32.8270332161089	0.0110163148883711	5236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2975.22692401561	2975.22692401561
"AML-2123"	"2020-07-29-AML2123-c1:ATACTTCTCGTTGTTT"	11.9814402061397	-2.0089161626068	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATACTTCTCGTTGTTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1348.03240371451	25.5504340359806	0.0189538722997876	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1346.39901431595	1346.39901431595
"AML-2123"	"2020-07-29-AML2123-c1:ATAGGCTAGACGGAAA"	-7.92637191239055	4.24655864322511	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATAGGCTAGACGGAAA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2681.63520806272	50.063064377245	0.0186688570565911	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2672.68126935177	2672.68126935177
"AML-2123"	"2020-07-29-AML2123-c1:ATAGGCTTCATTTGTC"	0.763541896908921	9.67426393115846	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	70	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.833333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATAGGCTTCATTTGTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2608.03533958213	50.699582769513	0.0194397606504966	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2599.66257049839	2599.66257049839
"AML-2123"	"2020-07-29-AML2123-c1:ATCACGACAACTCCAA"	-3.25304899635966	3.62396118724672	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCACGACAACTCCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2944.14356205467	42.3089070870842	0.0143705312581828	4084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2935.52527361307	2935.52527361307
"AML-2123"	"2020-07-29-AML2123-c1:ATCACGACATGTGACT"	-7.66300807419475	2.56408975208131	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCACGACATGTGACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3086.40012574366	41.1061448204612	0.0133184756174661	4072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3069.35497055984	3069.35497055984
"AML-2123"	"2020-07-29-AML2123-c1:ATCACGAGTCGAACGA"	11.5965448814327	-1.87443723594817	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCACGAGTCGAACGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1163.84312972243	35.4717493348742	0.0304781189397355	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1161.92162436672	1161.92162436672
"AML-2123"	"2020-07-29-AML2123-c1:ATCACTTCACGGGCTT"	0.881954093545121	11.7392663725647	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCACTTCACGGGCTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2144.23455043983	35.5711040254141	0.0165891851794467	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2136.64067177157	2136.64067177157
"AML-2123"	"2020-07-29-AML2123-c1:ATCCACCAGCCACTCG"	11.0341469245845	-2.44605996524962	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCCACCAGCCACTCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2644.95156555669	47.9413412044252	0.0181256026872972	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2629.8790329095	2629.8790329095
"AML-2123"	"2020-07-29-AML2123-c1:ATCCCTGAGATGCGAC"	-1.60441003266032	3.73616812312929	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCCCTGAGATGCGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2566.81307074312	13.6179927728952	0.00530540884652445	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2561.41526893339	2561.41526893339
"AML-2123"	"2020-07-29-AML2123-c1:ATCCGTCGTCATCTAG"	-7.66344485703166	2.76739595020143	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCCGTCGTCATCTAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2467.60105375457	43.0481417794248	0.0174453409775965	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2452.23784343539	2452.23784343539
"AML-2123"	"2020-07-29-AML2123-c1:ATCGATGGTGTGTGGA"	11.5626999336178	-1.89881267463835	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGATGGTGTGTGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1475.99752167398	49.867927749516	0.0337859156382315	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1469.41505276473	1469.41505276473
"AML-2123"	"2020-07-29-AML2123-c1:ATCGCCTAGAAACCCG"	1.49889733371083	9.43314454639284	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGCCTAGAAACCCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1946.59193010299	42.2294163680936	0.0216940262183555	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1941.38454170003	1941.38454170003
"AML-2123"	"2020-07-29-AML2123-c1:ATCGCCTCACCCTTAC"	-1.86942134323772	10.3662652739319	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGCCTCACCCTTAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1968.22892244576	49.4909202539991	0.0251449004176306	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1966.77596239528	1966.77596239528
"AML-2123"	"2020-07-29-AML2123-c1:ATCGCCTTCTCTCTTC"	10.6904150443966	-1.02246966278227	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGCCTTCTCTCTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2158.15713489765	44.0029937875408	0.0203891519648904	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2149.38770128591	2149.38770128591
"AML-2123"	"2020-07-29-AML2123-c1:ATCGGATGTCGAGATG"	1.32013573226277	9.63992307269899	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGGATGTCGAGATG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1976.4829832809	29.8420362636008	0.0150985546124278	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1967.90120246775	1967.90120246775
"AML-2123"	"2020-07-29-AML2123-c1:ATCGGCGCATCCTTGC"	12.1057411628658	-3.12163164531859	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGGCGCATCCTTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2171.47572353762	21.0639690347783	0.00970030141551036	2947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2164.21257464089	2164.21257464089
"AML-2123"	"2020-07-29-AML2123-c1:ATCGGCGTCAGTGCGC"	1.98474695262257	-9.16801645671996	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGGCGTCAGTGCGC"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2559.40744810296	40.8246131172348	0.0159508065616884	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2554.64769076631	2554.64769076631
"AML-2123"	"2020-07-29-AML2123-c1:ATCGTAGCACATTGTG"	10.9979797798092	-2.79851772701415	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGTAGCACATTGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1838.1323000332	32.7033378882088	0.0177916126535713	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1836.45260631723	1836.45260631723
"AML-2123"	"2020-07-29-AML2123-c1:ATCGTAGCACCCTGAG"	-7.26881299439128	2.14453861797181	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGTAGCACCCTGAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2238.06299539912	46.6660929911384	0.0208511078942245	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2225.35952501191	2225.35952501191
"AML-2123"	"2020-07-29-AML2123-c1:ATCGTAGGTAGTGATA"	-7.95195613327678	-0.458186053392016	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCGTAGGTAGTGATA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2184.35198446828	47.0472670604343	0.0215383177230416	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2176.59056993089	2176.59056993089
"AML-2123"	"2020-07-29-AML2123-c1:ATCTCTACACGCGTGT"	-0.542022804648238	8.73311421954957	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCTCTACACGCGTGT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1956.84133099665	33.370987797089	0.0170534970150557	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1955.27817378338	1955.27817378338
"AML-2123"	"2020-07-29-AML2123-c1:ATCTTCAGTGTTACAC"	11.1439672904903	-1.06382539188536	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATCTTCAGTGTTACAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1193.27240597419	40.6126527595939	0.0340346869300457	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1188.75498712246	1188.75498712246
"AML-2123"	"2020-07-29-AML2123-c1:ATGAAAGCATGTACGT"	0.815758128731888	10.7880658873352	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGAAAGCATGTACGT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2007.0830922155	44.5182355354472	0.022180564276642	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2002.93922281013	2002.93922281013
"AML-2123"	"2020-07-29-AML2123-c1:ATGAAAGTCATGCGGC"	11.0508104759151	-0.878808282968126	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGAAAGTCATGCGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1172.14756991744	21.3448171896638	0.0182100084814127	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1168.0102871278	1168.0102871278
"AML-2123"	"2020-07-29-AML2123-c1:ATGACCACACGAAGAC"	-3.17046723786052	10.0969524153504	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGACCACACGAAGAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2137.82828356079	46.8820114519696	0.0219297367391371	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2132.25493483092	2132.25493483092
"AML-2123"	"2020-07-29-AML2123-c1:ATGAGTCGTGTGGACA"	8.60594906386678	8.0520243414673	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGAGTCGTGTGGACA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1651.59988741044	38.1354150417423	0.023089984040587	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1650.29489502492	1650.29489502492
"AML-2123"	"2020-07-29-AML2123-c1:ATGCATGCACATAGCT"	1.12301768836324	-9.27122023021849	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	17	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGCATGCACATAGCT"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	1766.61589017373	43.6825886156645	0.024726704236408	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	1763.29526492537	1763.29526492537
"AML-2123"	"2020-07-29-AML2123-c1:ATGCCTCAGTTGTAGA"	12.0111576515133	-2.7236628762451	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGCCTCAGTTGTAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1774.6570160539	41.4364491236578	0.023348990114042	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1766.28325246051	1766.28325246051
"AML-2123"	"2020-07-29-AML2123-c1:ATGCCTCCAGCTCATA"	-7.47729001465495	2.57609126651613	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGCCTCCAGCTCATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2539.80566684171	43.0779412870356	0.0169611170844436	2931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2529.07512576174	2529.07512576174
"AML-2123"	"2020-07-29-AML2123-c1:ATGCCTCTCATCGACA"	8.72363533553426	7.94957778537599	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGCCTCTCATCGACA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2064.6019067474	48.8596276979664	0.0236653989024646	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2059.89297245721	2059.89297245721
"AML-2123"	"2020-07-29-AML2123-c1:ATGCGATGTTGTTTGG"	-1.60194192352946	3.25782773578493	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGCGATGTTGTTTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2391.67326199642	45.0558314605233	0.0188386232251949	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2375.98019400511	2375.98019400511
"AML-2123"	"2020-07-29-AML2123-c1:ATGGAGGTCGCATTGA"	1.3924009996349	11.11056897724	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGGAGGTCGCATTGA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1875.09717221348	30.2465959207441	0.0161306818488981	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1871.02120280793	1871.02120280793
"AML-2123"	"2020-07-29-AML2123-c1:ATGGATCGTTTGACAC"	12.5545422035152	-2.53541638767394	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGGATCGTTTGACAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1617.71987579752	42.2362893591638	0.0261085308965136	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1615.76847573561	1615.76847573561
"AML-2123"	"2020-07-29-AML2123-c1:ATGGATCTCACCCTCA"	1.09242047843282	10.7423248060974	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGGATCTCACCCTCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2082.0881191246	31.0652783745984	0.0149202514962045	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2076.30153047215	2076.30153047215
"AML-2123"	"2020-07-29-AML2123-c1:ATGGGTTGTATCGTAC"	11.8895012336666	-2.1709513894287	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATGGGTTGTATCGTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1685.51662013496	27.9734896444151	0.0165963890894029	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1679.930489894	1679.930489894
"AML-2123"	"2020-07-29-AML2123-c1:ATTATCCAGAGAGCAA"	-2.49046478691753	3.49447772586671	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTATCCAGAGAGCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3215.18964816941	42.1140756446491	0.0130984732638173	5107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3206.70922304286	3206.70922304286
"AML-2123"	"2020-07-29-AML2123-c1:ATTCACTGTTGCATCA"	10.6817575889522	6.3301152952942	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCACTGTTGCATCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2628.51038506911	41.1667083382428	0.015661611448098	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2611.48098369956	2611.48098369956
"AML-2123"	"2020-07-29-AML2123-c1:ATTCACTTCTTGGAAC"	-7.63488851013835	2.42021081531373	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCACTTCTTGGAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2475.86152609038	39.5498917331448	0.0159741937569497	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2466.97723200118	2466.97723200118
"AML-2123"	"2020-07-29-AML2123-c1:ATTCAGGCAAACACCT"	-3.20357070389445	3.32355187023012	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCAGGCAAACACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3522.4374212643	39.0525716091808	0.0110868035223075	4186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3514.82675338516	3514.82675338516
"AML-2123"	"2020-07-29-AML2123-c1:ATTCATCTCAGAGTGG"	-4.95242057266887	8.91888997638551	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"Treg"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCATCTCAGAGTGG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1786.073421377	38.2907321641097	0.0214384983874789	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1775.50842783755	1775.50842783755
"AML-2123"	"2020-07-29-AML2123-c1:ATTCCATTCTCCGTGT"	-7.15668998184856	2.66657230937806	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCCATTCTCCGTGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2585.92242226802	45.9599189766551	0.0177731236563336	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2569.04734830491	2569.04734830491
"AML-2123"	"2020-07-29-AML2123-c1:ATTCCCGCACATTGTG"	-2.21957693520244	9.57311246478883	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCCCGCACATTGTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2332.08379240799	38.5255827138985	0.0165198106686034	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2325.6765109388	2325.6765109388
"AML-2123"	"2020-07-29-AML2123-c1:ATTCTACAGGTAGTCG"	1.49864139136617	-9.86165239727172	"2020-07-29-AML2123-c1"	"AML2123"	"Granulocyte"	"Granulocytes"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCTACAGGTAGTCG"	"Granulocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Gran"	"Gran"	2653.1020589834	27.631937679337	0.0104149546700532	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"Gran_AML-2123"	2650.98477324802	2650.98477324802
"AML-2123"	"2020-07-29-AML2123-c1:ATTCTTGGTTTGTTCT"	11.5300499397213	-2.45556356823119	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTCTTGGTTTGTTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1704.89294594226	12.2021968892741	0.00715716310417963	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1693.68283803787	1693.68283803787
"AML-2123"	"2020-07-29-AML2123-c1:ATTGGGTAGCGACCCT"	-7.51125798645671	-1.59532859241637	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTGGGTAGCGACCCT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2394.300886611	47.8858616569183	0.0199999348138312	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2389.30246295088	2389.30246295088
"AML-2123"	"2020-07-29-AML2123-c1:ATTTACCGTCCACATA"	-7.55803714218791	2.43155214870302	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTTACCGTCCACATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2579.22862664513	40.9376920768541	0.015872067971773	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2565.2946625717	2565.2946625717
"AML-2123"	"2020-07-29-AML2123-c1:ATTTCTGCACGTTGGC"	-7.61007056656535	2.78440806949464	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTTCTGCACGTTGGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2402.41922892918	44.7014710545927	0.0186068570032705	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2393.34652224876	2393.34652224876
"AML-2123"	"2020-07-29-AML2123-c1:ATTTCTGGTAGGTAGC"	-2.0155054134434	10.0919093855652	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.ATTTCTGGTAGGTAGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2000.1143273317	42.258716140796	0.0211281503078737	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1987.81140602105	1987.81140602105
"AML-2123"	"2020-07-29-AML2123-c1:CAACCAAGTAGAAACT"	-6.22458253327067	3.09806869113771	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAACCAAGTAGAAACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2177.53659251939	34.5259573884511	0.015855511915189	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2175.57978760675	2175.57978760675
"AML-2123"	"2020-07-29-AML2123-c1:CAACCTCCATACTGTG"	11.1740042167598	-3.05570890819701	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAACCTCCATACTGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2164.85426906737	33.0245131631581	0.0152548435407549	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2160.84742693981	2160.84742693981
"AML-2123"	"2020-07-29-AML2123-c1:CAACGATGTAGACACG"	-7.60303245011027	2.55422542178956	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAACGATGTAGACACG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2279.63920490371	46.6877370717237	0.0204803185395716	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2271.93055305505	2271.93055305505
"AML-2123"	"2020-07-29-AML2123-c1:CAACGGCAGGTGGCTA"	-3.5763340992039	9.75236413562623	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAACGGCAGGTGGCTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2134.01181140155	40.8051255106993	0.0191213213032312	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2132.57253477877	2132.57253477877
"AML-2123"	"2020-07-29-AML2123-c1:CACAGATTCAATCTTC"	-5.01449952545817	3.7065858610901	"2020-07-29-AML2123-c1"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACAGATTCAATCTTC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3018.40616523319	24.7307827730447	0.00819332502626734	4024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3005.54315319476	3005.54315319476
"AML-2123"	"2020-07-29-AML2123-c1:CACAGGCGTGGCTCTG"	-2.63441167298015	3.70322630489198	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACAGGCGTGGCTCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3075.55000710323	38.9580027374757	0.0126670035107538	5308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3071.02424051066	3071.02424051066
"AML-2123"	"2020-07-29-AML2123-c1:CACCAAATCCACGTAA"	11.4929558235103	-2.32814767276915	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACCAAATCCACGTAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1585.18037097867	17.8036703259523	0.0112313214646738	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1580.50184472576	1580.50184472576
"AML-2123"	"2020-07-29-AML2123-c1:CACGTGGTCTACAGGT"	1.6073520379955	-10.0018511048523	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACGTGGTCTACAGGT"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2565.85033600721	34.5436462320246	0.0134628453371832	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2562.86724981726	2562.86724981726
"AML-2123"	"2020-07-29-AML2123-c1:CACTAAGGTAACAGTA"	-7.98320994797404	2.62248728359071	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACTAAGGTAACAGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2554.19858047046	38.8433245143521	0.0152076368734014	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2540.83523393214	2540.83523393214
"AML-2123"	"2020-07-29-AML2123-c1:CACTGAATCAGTGCGC"	12.3516127067501	-2.76423861896666	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACTGAATCAGTGCGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1698.3052332541	27.8229371999814	0.0163827659805713	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1697.12397113582	1697.12397113582
"AML-2123"	"2020-07-29-AML2123-c1:CACTTCGAGATACTGA"	12.0526129203731	-2.16486408626708	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACTTCGAGATACTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1248.1837484735	33.8358486859996	0.0271080670032598	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1246.0492978872	1246.0492978872
"AML-2123"	"2020-07-29-AML2123-c1:CACTTCGCACGACAAG"	11.9546476798946	-2.17637207424315	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACTTCGCACGACAAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1276.50966357909	43.3534542403003	0.033962495919338	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1274.79305194057	1274.79305194057
"AML-2123"	"2020-07-29-AML2123-c1:CACTTCGTCCGTTGAA"	10.8110357719356	-2.65939166462096	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CACTTCGTCCGTTGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2054.98915277063	44.5433407061025	0.0216757059987627	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2052.82402843729	2052.82402843729
"AML-2123"	"2020-07-29-AML2123-c1:CAGATACAGCGTCTGC"	-8.00900588455852	2.67438361728517	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGATACAGCGTCTGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2127.24858720421	42.7298028703866	0.0200868874128836	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2119.06942052455	2119.06942052455
"AML-2123"	"2020-07-29-AML2123-c1:CAGATACAGTCACGAG"	-7.73147283020671	3.23892233455507	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGATACAGTCACGAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2557.68373407911	47.8565615155573	0.0187108988018755	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2548.98257938691	2548.98257938691
"AML-2123"	"2020-07-29-AML2123-c1:CAGATCAAGGCTCTAT"	-7.63923011246379	2.85148570621339	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGATCAAGGCTCTAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2423.55229075692	48.0915477177092	0.019843412457459	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2416.74100708882	2416.74100708882
"AML-2123"	"2020-07-29-AML2123-c1:CAGATCACAAGACGGT"	11.2240368324215	-2.87680652057799	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGATCACAAGACGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1826.33877265222	42.0632496263196	0.0230314606776021	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1824.21321657409	1824.21321657409
"AML-2123"	"2020-07-29-AML2123-c1:CAGCACGTCGTAGCCG"	-1.93308041516002	3.46425149524537	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGCACGTCGTAGCCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3190.17758328931	26.5153175852043	0.0083115490887078	3499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3186.32124062928	3186.32124062928
"AML-2123"	"2020-07-29-AML2123-c1:CAGCCAGGTGTCTTCC"	-7.68520675125774	2.04695985401002	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGCCAGGTGTCTTCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3006.37792366574	45.3729544449667	0.0150922324461598	3141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2986.60290608455	2986.60290608455
"AML-2123"	"2020-07-29-AML2123-c1:CAGCGTGGTAATCAGA"	8.66305985030476	8.00409934604494	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGCGTGGTAATCAGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1736.87642845487	28.1169041003412	0.0161882006340279	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1728.02452651986	1728.02452651986
"AML-2123"	"2020-07-29-AML2123-c1:CAGGCCAGTGCATGTT"	1.15323998507802	11.4173793562683	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGGCCAGTGCATGTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1998.69239151691	39.4969913499148	0.0197614157724084	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1991.02014056628	1991.02014056628
"AML-2123"	"2020-07-29-AML2123-c1:CAGGCCATCTGTGCTC"	8.86814274367635	8.01616475665895	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CAGGCCATCTGTGCTC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2104.21698699128	45.7546295118692	0.0217442544161245	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2094.98070045363	2094.98070045363
"AML-2123"	"2020-07-29-AML2123-c1:CATACAGTCCTGGGAC"	-7.65599570694621	2.5990636118683	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATACAGTCCTGGGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2323.91976465409	46.0459827203711	0.0198139296462436	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2312.96761411689	2312.96761411689
"AML-2123"	"2020-07-29-AML2123-c1:CATACCCCACGCTGAC"	-3.68896160546001	10.2998695143494	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATACCCCACGCTGAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2015.14366667193	43.1552444648749	0.0214154678788471	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2003.01199712077	2003.01199712077
"AML-2123"	"2020-07-29-AML2123-c1:CATACTTGTTCCCAAA"	10.8954874473507	-2.49465372478636	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATACTTGTTCCCAAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2350.06447614917	43.6896351110494	0.018590824019705	2774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2346.21306860931	2346.21306860931
"AML-2123"	"2020-07-29-AML2123-c1:CATCCCACATCGTTCC"	-4.75705562058147	2.66670558536378	"2020-07-29-AML2123-c1"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCCCACATCGTTCC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2999.90909846511	41.3359483402271	0.013779066959521	4109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2988.75657983297	2988.75657983297
"AML-2123"	"2020-07-29-AML2123-c1:CATCCCAGTTGCAACT"	-7.22503076019939	2.62218091571657	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCCCAGTTGCAACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2636.61247600384	36.4692084740765	0.0138318424895534	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2623.05835867813	2623.05835867813
"AML-2123"	"2020-07-29-AML2123-c1:CATCCGTTCTACGGGC"	-1.88331447067912	3.4010438689026	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCCGTTCTACGGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2944.52401827635	32.5070564382454	0.0110398340229108	3414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2939.40226585719	2939.40226585719
"AML-2123"	"2020-07-29-AML2123-c1:CATCGCTCAAAGGTTA"	10.7605282264644	-2.71717479145201	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCGCTCAAAGGTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1910.48387175247	29.488528309096	0.0154351097882059	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1906.53251027337	1906.53251027337
"AML-2123"	"2020-07-29-AML2123-c1:CATCGCTTCCGGCAGT"	-2.91884503784831	3.47501347148744	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCGCTTCCGGCAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3347.49626678967	41.295833528395	0.0123363344533312	5820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3342.242605218	3342.242605218
"AML-2123"	"2020-07-29-AML2123-c1:CATCGTCGTACGACTT"	-7.42039714279826	2.62908790195314	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATCGTCGTACGACTT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2572.10284345427	47.1017525252593	0.0183125463451542	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2557.17832199631	2557.17832199631
"AML-2123"	"2020-07-29-AML2123-c1:CATGAGTAGGAGTACC"	11.3385321098262	-2.51006033336791	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGAGTAGGAGTACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1965.19037982617	16.0346895930511	0.0081593568529831	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1956.55667698138	1956.55667698138
"AML-2123"	"2020-07-29-AML2123-c1:CATGAGTGTTTGGAAA"	-7.56905255737956	2.79738781535951	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGAGTGTTTGGAAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2363.22591563635	49.5196730605488	0.0209542696417218	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2347.94315853408	2347.94315853408
"AML-2123"	"2020-07-29-AML2123-c1:CATGCAATCTCCTGTG"	12.3648430305416	-2.62737038051756	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGCAATCTCCTGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1487.21660438938	43.9277315876761	0.0295368754343029	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1485.1045062746	1485.1045062746
"AML-2123"	"2020-07-29-AML2123-c1:CATGCCTCAGAACTCT"	11.2789770561153	-2.80703618442687	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGCCTCAGAACTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2238.29163845662	47.52697921165	0.0212335954774962	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2231.99518253975	2231.99518253975
"AML-2123"	"2020-07-29-AML2123-c1:CATGCGGCACGCAAAG"	12.1267172294552	-2.7831807366577	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGCGGCACGCAAAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1839.44954973221	39.5718134926847	0.0215128561141813	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1834.41702619811	1834.41702619811
"AML-2123"	"2020-07-29-AML2123-c1:CATGCTCTCGCTTTAT"	9.73097672042195	7.68399331653444	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATGCTCTCGCTTTAT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2448.14447469552	41.9058656074833	0.0171173989283027	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2439.45506003974	2439.45506003974
"AML-2123"	"2020-07-29-AML2123-c1:CATTCATGTCTCTCTG"	-7.61655030670817	2.51412079418031	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTCATGTCTCTCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2729.28021989081	40.921283071298	0.0149934340831207	2537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2713.91364316103	2713.91364316103
"AML-2123"	"2020-07-29-AML2123-c1:CATTCATGTTGGGCCT"	-4.52642045441325	3.21619794452516	"2020-07-29-AML2123-c1"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTCATGTTGGGCCT"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2973.10468832714	33.2954501939638	0.0111988825434526	4238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2964.93476896492	2964.93476896492
"AML-2123"	"2020-07-29-AML2123-c1:CATTCCGTCTTGAACG"	11.3117748695308	-2.67049624836119	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTCCGTCTTGAACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2140.99088458296	14.1246104051072	0.00659723051920351	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2132.79169850241	2132.79169850241
"AML-2123"	"2020-07-29-AML2123-c1:CATTCTAGTGGACCAA"	8.61678661879842	8.04637239063112	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTCTAGTGGACCAA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1856.2460983521	40.2674259217125	0.0216929349817679	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1854.9396672998	1854.9396672998
"AML-2123"	"2020-07-29-AML2123-c1:CATTCTATCGCGGACT"	0.200977047055405	10.8747720488342	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTCTATCGCGGACT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1883.78875470717	43.4874438651986	0.0230850957977816	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1881.11897905383	1881.11897905383
"AML-2123"	"2020-07-29-AML2123-c1:CATTGCCCAGAAGCTG"	10.9225965934688	-0.979291700479113	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTGCCCAGAAGCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1367.26491122678	24.1569624898536	0.0176680921827933	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1361.20851842506	1361.20851842506
"AML-2123"	"2020-07-29-AML2123-c1:CATTTCAAGTCATCCA"	-3.18385968628581	10.3917636641297	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTTCAAGTCATCCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2122.47025689573	46.0942073011641	0.0217172453425002	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2114.81623120563	2114.81623120563
"AML-2123"	"2020-07-29-AML2123-c1:CATTTCACACCCTTAC"	10.9420219856197	-0.989192747232042	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTTCACACCCTTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1494.91548928568	12.9783934231405	0.00868169038059942	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1489.82175661328	1489.82175661328
"AML-2123"	"2020-07-29-AML2123-c1:CATTTCATCAACTCTT"	-3.29340467873271	9.55871484363405	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CATTTCATCAACTCTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2345.777247279	46.1633842959911	0.019679355467165	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2343.1703199318	2343.1703199318
"AML-2123"	"2020-07-29-AML2123-c1:CCAAGCGCAGCCCAGT"	11.2980505424434	-2.59954502498778	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCAAGCGCAGCCCAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1783.47074712893	35.7060319772744	0.0200205313346209	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1780.09826275055	1780.09826275055
"AML-2123"	"2020-07-29-AML2123-c1:CCACAAACAGAGTAAT"	11.9862381416256	-2.35258581554564	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCACAAACAGAGTAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1744.96405223341	38.7247773295025	0.0221923066437604	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1733.63027363135	1733.63027363135
"AML-2123"	"2020-07-29-AML2123-c1:CCACGAGCATTCTTCA"	11.733228345483	-2.58878853237303	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCACGAGCATTCTTCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2199.74146723443	1.08955037620075	0.000495308377111497	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2189.2257266549	2189.2257266549
"AML-2123"	"2020-07-29-AML2123-c1:CCATAAGAGCTCCCTT"	12.5362087684566	-2.45298817073973	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCATAAGAGCTCCCTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1408.54424228485	19.5124275523982	0.0138529035628631	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1404.64694297865	1404.64694297865
"AML-2123"	"2020-07-29-AML2123-c1:CCATCACCAGTCTACA"	9.06517853316609	7.92806098544923	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCATCACCAGTCTACA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1881.41512974288	43.2039321308641	0.0229635296580019	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1873.57386968346	1873.57386968346
"AML-2123"	"2020-07-29-AML2123-c1:CCATCACTCACACCCT"	-7.4346698326176	3.46685955608217	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCATCACTCACACCCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1997.78121496554	45.7704112676929	0.0229106225070208	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1990.07819511828	1990.07819511828
"AML-2123"	"2020-07-29-AML2123-c1:CCCAACTAGATTGAGT"	-1.91799781742747	4.17137096011964	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCAACTAGATTGAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3319.88081900378	8.22740724476866	0.00247822367528167	5856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3315.09557438274	3315.09557438274
"AML-2123"	"2020-07-29-AML2123-c1:CCCAACTCACGCCAGT"	-3.57400951805766	9.31819245899049	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCAACTCACGCCAGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2602.69817405807	44.4234581707905	0.0170682327338504	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2594.08518723543	2594.08518723543
"AML-2123"	"2020-07-29-AML2123-c1:CCCAACTTCGTTTACT"	11.2345358329708	-1.07262649452361	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCAACTTCGTTTACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1393.95034223983	17.9790122289928	0.0128978857310683	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1389.42087860906	1389.42087860906
"AML-2123"	"2020-07-29-AML2123-c1:CCCATTGGTGTACAGG"	-1.76866481724437	9.23660276019899	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCATTGGTGTACAGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2140.94956996715	40.5331061519342	0.0189323030866888	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2131.3015148302	2131.3015148302
"AML-2123"	"2020-07-29-AML2123-c1:CCCTAACCATCCAACA"	11.1187530952388	-2.68117954647215	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCTAACCATCCAACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1571.41274165227	6.25869458771896	0.00398284576790323	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1570.22756961961	1570.22756961961
"AML-2123"	"2020-07-29-AML2123-c1:CCCTCAAAGACGCCCT"	11.4576364952022	-3.13239290630492	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCTCAAAGACGCCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2254.81620510629	43.7125671307009	0.0193863105257576	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2248.04767053971	2248.04767053971
"AML-2123"	"2020-07-29-AML2123-c1:CCCTCAAAGAGAGCAA"	-7.56794629517253	2.31768772685853	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCTCAAAGAGAGCAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2894.40305540746	46.6117476704561	0.0161040970376858	3252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2878.80377969344	2878.80377969344
"AML-2123"	"2020-07-29-AML2123-c1:CCCTGATCAGTAGATA"	-6.61562667313274	0.974277294519819	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCCTGATCAGTAGATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2528.81631860533	38.8945122846448	0.0153805209174289	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2520.21263648565	2520.21263648565
"AML-2123"	"2020-07-29-AML2123-c1:CCGATCTGTGAGACGT"	-8.02381835404094	3.09771726215211	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGATCTGTGAGACGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2881.01560646139	45.6766076402942	0.0158543423152076	2719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2867.08896710257	2867.08896710257
"AML-2123"	"2020-07-29-AML2123-c1:CCGCAAGCAGACCAAG"	-7.49843583527263	2.58092973316041	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGCAAGCAGACCAAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2659.37877147802	46.8133170056752	0.0176031024642862	2414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2650.68653710505	2650.68653710505
"AML-2123"	"2020-07-29-AML2123-c1:CCGGACATCATTCGTT"	11.0923515754635	-2.56511046802672	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGGACATCATTCGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1875.00652250466	31.6811756729097	0.0168965682479811	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1871.90810435639	1871.90810435639
"AML-2123"	"2020-07-29-AML2123-c1:CCGGTAGGTTCCTAAG"	-3.29434786263164	10.1140022047791	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGGTAGGTTCCTAAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1948.9044810401	45.6813790790356	0.023439516673827	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1947.43564638022	1947.43564638022
"AML-2123"	"2020-07-29-AML2123-c1:CCGGTAGTCTCATTGT"	-2.1537369293278	3.6931490668091	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGGTAGTCTCATTGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3320.90219441083	43.5485108670426	0.0131134578249055	5338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3314.10726681469	3314.10726681469
"AML-2123"	"2020-07-29-AML2123-c1:CCGTAGGGTACCCGAC"	-7.46709952774699	1.6743318804535	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGTAGGGTACCCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2516.76651459548	42.9545133719541	0.0170673414171907	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2507.79422431833	2507.79422431833
"AML-2123"	"2020-07-29-AML2123-c1:CCGTTCATCTTTCAGT"	-7.57372556152995	3.11779329860536	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCGTTCATCTTTCAGT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2681.83141458268	43.2725225008829	0.0161354372484359	2965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2670.62176798795	2670.62176798795
"AML-2123"	"2020-07-29-AML2123-c1:CCTAAGAAGGATTCAA"	-8.49195704880412	1.51775119388429	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTAAGAAGGATTCAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2836.47416768552	49.6396822452376	0.0175004880392555	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2828.55621936255	2828.55621936255
"AML-2123"	"2020-07-29-AML2123-c1:CCTCAACCACAGTGAG"	11.816028256982	-1.78398897564086	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCAACCACAGTGAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1558.72091769239	38.1993661956346	0.024506866984365	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1547.0398622331	1547.0398622331
"AML-2123"	"2020-07-29-AML2123-c1:CCTCAACTCGTCAAAC"	-2.75744138184245	3.66752073848573	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCAACTCGTCAAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3220.54073455839	29.3909189274397	0.00912608203090151	5809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3213.58657674188	3213.58657674188
"AML-2123"	"2020-07-29-AML2123-c1:CCTCACAAGTCATGGG"	-3.2247077030247	9.10003659808961	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCACAAGTCATGGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2796.04518367353	43.8015014810902	0.015665519905348	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2786.72095408448	2786.72095408448
"AML-2123"	"2020-07-29-AML2123-c1:CCTCACAGTCGTCATA"	-2.78046546402629	9.13501069629518	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCACAGTCGTCATA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2250.41277403567	40.8172938624013	0.0181376920418042	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2244.32698405899	2244.32698405899
"AML-2123"	"2020-07-29-AML2123-c1:CCTCCTCGTTCCGCAG"	-7.59190593186076	-1.61066975509795	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCCTCGTTCCGCAG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3159.1471499338	42.0028498934813	0.0132956294531457	3547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3149.31379107372	3149.31379107372
"AML-2123"	"2020-07-29-AML2123-c1:CCTCTCCTCTACGGTA"	0.783285220235032	10.6760453947815	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTCTCCTCTACGGTA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2334.690388762	41.4177144621826	0.0177401314801938	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2325.62952531081	2325.62952531081
"AML-2123"	"2020-07-29-AML2123-c1:CCTGCATAGACATATG"	-5.93749175491984	3.64275143230287	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTGCATAGACATATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2438.69952421204	36.796074034564	0.015088400054719	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2430.61713694331	2430.61713694331
"AML-2123"	"2020-07-29-AML2123-c1:CCTGCATGTTATCTTC"	-8.36504683914836	0.976070679071821	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTGCATGTTATCTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2485.52387870953	38.4401125604109	0.0154655977718342	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2474.55691049468	2474.55691049468
"AML-2123"	"2020-07-29-AML2123-c1:CCTTCAGGTACCTAAC"	10.9004150825435	-0.647524439450823	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTTCAGGTACCTAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1257.1258414652	45.4586608846147	0.0361607878743722	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1252.34824643834	1252.34824643834
"AML-2123"	"2020-07-29-AML2123-c1:CCTTGTGTCTCATAGG"	-0.867039362818557	11.6798763045105	"2020-07-29-AML2123-c1"	"AML2123"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CCTTGTGTCTCATAGG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2176.31583878036	41.2776495361466	0.0189667551008034	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2163.49678143905	2163.49678143905
"AML-2123"	"2020-07-29-AML2123-c1:CGAAGGAAGGCTCCCA"	10.9671579795772	-1.07865371620329	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAAGGAAGGCTCCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1770.38475615256	35.4731360015938	0.0200369642126183	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1761.9322020401	1761.9322020401
"AML-2123"	"2020-07-29-AML2123-c1:CGAAGGACAGCTCTGG"	-7.64686236801799	2.77395746791688	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAAGGACAGCTCTGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2323.59710128185	48.798007508785	0.0210010623106152	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2315.69162543832	2315.69162543832
"AML-2123"	"2020-07-29-AML2123-c1:CGAAGGACATCCGAAT"	-7.68851409378703	2.42517707431642	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAAGGACATCCGAAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2482.84383638677	50.4430589850405	0.0203166458742927	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2472.72690702603	2472.72690702603
"AML-2123"	"2020-07-29-AML2123-c1:CGACAGCAGAAGAACG"	12.1975685554439	-2.52968432819518	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGACAGCAGAAGAACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1569.9523570615	44.9564246145387	0.0286355343283691	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1568.15981345678	1568.15981345678
"AML-2123"	"2020-07-29-AML2123-c1:CGAGAAGCAGAGAATT"	8.45894970473592	7.61302373493043	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAGAAGCAGAGAATT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1817.74247522825	44.3598235476227	0.0244037998518203	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1814.13889516557	1814.13889516557
"AML-2123"	"2020-07-29-AML2123-c1:CGAGAAGTCAAGTTGC"	-7.57643256607707	1.66075942600099	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAGAAGTCAAGTTGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2752.79771324897	36.016102950433	0.0130834542535003	2878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2743.58144391656	2743.58144391656
"AML-2123"	"2020-07-29-AML2123-c1:CGAGTTACAGGCATGA"	8.40467037734334	8.25308415973512	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAGTTACAGGCATGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1931.42394160298	45.8303726745095	0.0237288001289209	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1921.16099977709	1921.16099977709
"AML-2123"	"2020-07-29-AML2123-c1:CGAGTTATCATTCATC"	2.3637134033138	-8.91893103038939	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0588235294117647	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGAGTTATCATTCATC"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	1794.7547360114	45.6950560820957	0.0254603345879152	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	1793.01479068637	1793.01479068637
"AML-2123"	"2020-07-29-AML2123-c1:CGCAGGTAGCACCGAA"	12.582292218774	-2.68220426952513	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGCAGGTAGCACCGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1466.00659505848	40.2903780218386	0.0274830810159019	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1460.2400974981	1460.2400974981
"AML-2123"	"2020-07-29-AML2123-c1:CGCAGGTTCAGGAAGC"	-2.40960989418681	10.3143968352112	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGCAGGTTCAGGAAGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2127.16159079106	40.9308361787489	0.0192419966381244	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2124.18619988598	2124.18619988598
"AML-2123"	"2020-07-29-AML2123-c1:CGCCATTGTATGGAAT"	-7.81506333771403	2.60815332019655	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGCCATTGTATGGAAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2492.70774644867	47.9294211212143	0.0192278542037263	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2484.79469503733	2484.79469503733
"AML-2123"	"2020-07-29-AML2123-c1:CGGAGAACAGTATGAA"	11.0963522392208	-0.906219505426012	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGGAGAACAGTATGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1139.97898268819	8.32064001718094	0.00729894159764243	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1129.85485666767	1129.85485666767
"AML-2123"	"2020-07-29-AML2123-c1:CGTAATGGTTAGAAGT"	-7.56484828415568	3.18074033344118	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTAATGGTTAGAAGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1844.34838398276	46.3441248580969	0.0251276414264097	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1840.50281336363	1840.50281336363
"AML-2123"	"2020-07-29-AML2123-c1:CGTAGTACAAATCGGG"	9.25968422469441	7.77754256809083	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTAGTACAAATCGGG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1882.35761961894	43.7157227201015	0.0232239199737993	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1877.35065783266	1877.35065783266
"AML-2123"	"2020-07-29-AML2123-c1:CGTCCATAGCTAGAGC"	-7.64920459213908	3.7246112593445	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTCCATAGCTAGAGC"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2381.15882537015	42.5426042680212	0.0178663446615779	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2367.48086137452	2367.48086137452
"AML-2123"	"2020-07-29-AML2123-c1:CGTCCATTCGTGGGTC"	-1.58957109871562	8.45310781085817	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTCCATTCGTGGGTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2148.85172120955	40.6708340521205	0.0189267754730083	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2144.03409076305	2144.03409076305
"AML-2123"	"2020-07-29-AML2123-c1:CGTGATATCATGCAGT"	-1.96786389771159	10.3814935454163	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTGATATCATGCAGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1912.35479142193	43.1248778257934	0.0225506679091321	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1907.50723656064	1907.50723656064
"AML-2123"	"2020-07-29-AML2123-c1:CGTGTCTCAGGGTTGA"	-3.42285380783733	11.059338546637	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTGTCTCAGGGTTGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1663.90469952578	40.3043403835942	0.0242227456867459	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1663.90469952578	1663.90469952578
"AML-2123"	"2020-07-29-AML2123-c1:CGTTAGATCTACAGGT"	11.4012752967769	-1.87266411697539	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTTAGATCTACAGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1979.38748458032	44.2671457348418	0.0223640626606405	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1969.0089913131	1969.0089913131
"AML-2123"	"2020-07-29-AML2123-c1:CGTTCTGAGAATCGAT"	11.4888063865596	-2.65055062687071	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CGTTCTGAGAATCGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1835.89122465182	45.9838012828225	0.0250471273381371	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1830.88985594581	1830.88985594581
"AML-2123"	"2020-07-29-AML2123-c1:CTAACTTCACGTCATA"	-7.45009980621989	-1.53800597107085	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTAACTTCACGTCATA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2762.52498807054	40.2632356402159	0.014574795092926	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2754.23046139115	2754.23046139115
"AML-2123"	"2020-07-29-AML2123-c1:CTAACTTGTAGGTGCA"	-1.70708296719249	9.77454755390016	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTAACTTGTAGGTGCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1962.04995552476	50.0810491337805	0.0255248593404882	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1957.54149188861	1957.54149188861
"AML-2123"	"2020-07-29-AML2123-c1:CTAACTTTCACCGGTG"	-2.67739067497905	9.96881864154664	"2020-07-29-AML2123-c1"	"AML2123"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTAACTTTCACCGGTG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2172.19025655319	39.8923687941498	0.0183650436115346	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2166.37382511869	2166.37382511869
"AML-2123"	"2020-07-29-AML2123-c1:CTAAGTGAGGTTGGTG"	11.1866165595943	-2.15297605907591	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTAAGTGAGGTTGGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1169.00847819338	35.921974383477	0.030728583285377	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1163.10383646777	1163.10383646777
"AML-2123"	"2020-07-29-AML2123-c1:CTACAGAAGCCTTTGA"	11.1074987846309	-0.774103604909502	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTACAGAAGCCTTTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1126.60599285683	11.7030803179469	0.0103879088094236	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1115.46521333743	1115.46521333743
"AML-2123"	"2020-07-29-AML2123-c1:CTACAGATCGCCCAGA"	12.4994207817012	-2.67536022579344	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTACAGATCGCCCAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1663.48701373939	18.4748367896088	0.0111060901810582	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1658.59540485166	1658.59540485166
"AML-2123"	"2020-07-29-AML2123-c1:CTACATTGTCCACGCA"	-7.5807879966801	2.74269435489503	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTACATTGTCCACGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2404.76622181955	41.7327942095635	0.0173542001009922	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2398.4321787214	2398.4321787214
"AML-2123"	"2020-07-29-AML2123-c1:CTACGGGAGAATCCCT"	12.4063459831173	-2.18444087421569	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTACGGGAGAATCCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1194.61286697983	15.4520011870576	0.0129347352721244	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1188.89871452038	1188.89871452038
"AML-2123"	"2020-07-29-AML2123-c1:CTAGGTACAATACGCT"	-7.75980029526408	2.61293075168458	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTAGGTACAATACGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2386.11195668861	44.2806600402382	0.0185576623578426	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2374.15227628352	2374.15227628352
"AML-2123"	"2020-07-29-AML2123-c1:CTATCCGAGAGCCGTA"	-6.72229657593425	1.65521392906038	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTATCCGAGAGCCGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2409.98189210735	49.6530497286475	0.0206030800029081	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2399.70808878155	2399.70808878155
"AML-2123"	"2020-07-29-AML2123-c1:CTATCCGGTTAAGAAC"	-7.67050681534465	2.49690959537355	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTATCCGGTTAAGAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2525.5751021551	43.8435786933946	0.0173598396088014	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2508.13082036894	2508.13082036894
"AML-2123"	"2020-07-29-AML2123-c1:CTATCTAGTGTTAAAG"	-7.38269935074504	2.7397935160431	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTATCTAGTGTTAAAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2287.23217346127	42.6850711382342	0.0186623254226259	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2276.69119944122	2276.69119944122
"AML-2123"	"2020-07-29-AML2123-c1:CTATCTAGTTCACCGG"	0.1961723017389	11.4208774336609	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTATCTAGTTCACCGG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1921.99714553558	37.7821282930149	0.0196577442275476	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1915.28721373511	1915.28721373511
"AML-2123"	"2020-07-29-AML2123-c1:CTCAACCAGAAATTGC"	10.9095665412838	-1.06818392192992	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCAACCAGAAATTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1591.99089945447	25.5571945032481	0.0160536059044092	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1582.3376472308	1582.3376472308
"AML-2123"	"2020-07-29-AML2123-c1:CTCAATTAGGTTCTAC"	-7.57289586487468	2.18871829593507	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCAATTAGGTTCTAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2586.25175989644	27.3798115542999	0.0105866768188864	2743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2577.21317105521	2577.21317105521
"AML-2123"	"2020-07-29-AML2123-c1:CTCAGAAGTCAAAGTA"	-2.77790937843974	8.8643646010193	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCAGAAGTCAAAGTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2790.76118261204	40.509009796728	0.0145153981820878	2665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2783.28855160224	2783.28855160224
"AML-2123"	"2020-07-29-AML2123-c1:CTCATGCAGAACAGGA"	12.3811623054439	-2.97459914600524	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCATGCAGAACAGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1870.29811384123	26.647244136497	0.0142475918353832	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1865.12249824611	1865.12249824611
"AML-2123"	"2020-07-29-AML2123-c1:CTCCAACCACGCTTAA"	-0.939549605280715	11.1766528853211	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCCAACCACGCTTAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2267.4762085249	46.1497708290472	0.0203529239493409	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2260.39887139409	2260.39887139409
"AML-2123"	"2020-07-29-AML2123-c1:CTCCAACTCAGGACAG"	11.2384211021358	-2.34152295505675	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCCAACTCAGGACAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1721.74851295482	19.9604934563499	0.0115931527201346	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1714.49533711077	1714.49533711077
"AML-2123"	"2020-07-29-AML2123-c1:CTCCCAACAGCGAACA"	-3.81744847717937	9.60285565936891	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCCCAACAGCGAACA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2476.68754761154	43.1984676691861	0.0174420336997478	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2470.20555267669	2470.20555267669
"AML-2123"	"2020-07-29-AML2123-c1:CTCCGATAGGTCCCTG"	-6.00526652756389	3.1499624022278	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCCGATAGGTCCCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2280.71821835091	41.854196074888	0.0183513227272552	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2273.93884608029	2273.93884608029
"AML-2123"	"2020-07-29-AML2123-c1:CTCCTCCTCTTGATTC"	8.72008480605428	7.91195628726808	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCCTCCTCTTGATTC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1700.86776572511	42.7828708113368	0.0251535549520499	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1689.96109013747	1689.96109013747
"AML-2123"	"2020-07-29-AML2123-c1:CTCGAGGGTACATACC"	-0.550956825644332	11.0591382750305	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTCGAGGGTACATACC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2151.00410456216	50.1155377559104	0.0232986713738101	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2138.70030051425	2138.70030051425
"AML-2123"	"2020-07-29-AML2123-c1:CTGAGCGAGAAGCCTG"	-7.53055701676066	2.89866659725038	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGAGCGAGAAGCCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2504.25148342856	50.4687634719917	0.0201532329344556	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2494.1104841959	2494.1104841959
"AML-2123"	"2020-07-29-AML2123-c1:CTGATCCCACAAAGCG"	-7.3345550102299	4.28064296329347	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGATCCCACAAAGCG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2301.81710708885	39.8530157679349	0.0173137195154213	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2288.37913705276	2288.37913705276
"AML-2123"	"2020-07-29-AML2123-c1:CTGCATCGTGCCCACA"	11.9118591743404	-3.19320299541625	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGCATCGTGCCCACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2257.90187846536	42.9110214921797	0.0190048212021265	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2250.99070290702	2250.99070290702
"AML-2123"	"2020-07-29-AML2123-c1:CTGCATCTCACCATCC"	-2.11714754524882	4.19861886585084	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGCATCTCACCATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3224.64602104792	29.982679615502	0.00929797547383462	4822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3216.62073098347	3216.62073098347
"AML-2123"	"2020-07-29-AML2123-c1:CTGCCTAGTTCGTAAC"	12.5036932426387	-2.6873977414337	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGCCTAGTTCGTAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1375.86561735919	42.5841939180087	0.0309508380620369	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1375.86561735919	1375.86561735919
"AML-2123"	"2020-07-29-AML2123-c1:CTGCGAGGTGACTAAA"	12.6341902213985	-2.62001874363097	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGCGAGGTGACTAAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1398.0084709088	14.3237479591919	0.0102458234390243	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1396.79939159531	1396.79939159531
"AML-2123"	"2020-07-29-AML2123-c1:CTGGACGTCCAAGCAT"	12.565693517297	-2.71330668842467	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGGACGTCCAAGCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1559.97876514599	46.6975353453984	0.0299347250031498	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1557.38377433733	1557.38377433733
"AML-2123"	"2020-07-29-AML2123-c1:CTGGCAGAGTCGAAGC"	-4.25926862183269	10.0097398527893	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGGCAGAGTCGAAGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2247.39952567581	41.8079689121496	0.0186028200302203	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2243.156684909	2243.156684909
"AML-2123"	"2020-07-29-AML2123-c1:CTGTATTAGAGTCAGC"	-7.47691855850871	2.55583069408265	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGTATTAGAGTCAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2490.47489921319	45.8986126421294	0.0184296628151643	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2480.52982617498	2480.52982617498
"AML-2123"	"2020-07-29-AML2123-c1:CTGTGAAGTTGCCATA"	11.9657017188961	-1.93411757862242	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGTGAAGTTGCCATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1178.03939958281	13.8402887584255	0.0117485788364352	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1178.03939958281	1178.03939958281
"AML-2123"	"2020-07-29-AML2123-c1:CTGTGAATCGCCTAGG"	-3.79017029228862	10.6460389860901	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTGTGAATCGCCTAGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1912.42901444768	45.2852077816122	0.0236794189167282	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1902.31356649284	1902.31356649284
"AML-2123"	"2020-07-29-AML2123-c1:CTTCCGACAAGCCCAC"	-2.69841180267985	13.3844566115173	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTCCGACAAGCCCAC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2005.26881130348	42.3351138702104	0.0211119395223084	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	1998.19502681693	1998.19502681693
"AML-2123"	"2020-07-29-AML2123-c1:CTTCGGTAGGTCTACT"	12.5688625770504	-2.56261947071227	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTCGGTAGGTCTACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1327.17047140168	44.0723117034718	0.0332077247446028	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1325.29588755668	1325.29588755668
"AML-2123"	"2020-07-29-AML2123-c1:CTTCGGTGTTCAGTAC"	11.8270126777584	-2.17730095302733	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTCGGTGTTCAGTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1488.50298077103	38.8568166279264	0.0261046280255341	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1486.07495557382	1486.07495557382
"AML-2123"	"2020-07-29-AML2123-c1:CTTGAGAAGCCATATC"	-2.02301345291789	3.76129434192506	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTGAGAAGCCATATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3405.60472613004	37.1311258946169	0.0109029464311353	5310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3400.18413749581	3400.18413749581
"AML-2123"	"2020-07-29-AML2123-c1:CTTGATTTCATGGATC"	12.148945470422	-2.14563848888548	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTGATTTCATGGATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1472.83668441828	46.5874413043668	0.0316310978652512	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1463.4760007345	1463.4760007345
"AML-2123"	"2020-07-29-AML2123-c1:CTTTCAAAGTCACACT"	10.6769653755123	-0.666218423005663	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTTCAAAGTCACACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1486.61124536674	7.20216616686613	0.00484468699487699	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1477.05787293973	1477.05787293973
"AML-2123"	"2020-07-29-AML2123-c1:CTTTCGGTCGTAATGC"	10.9177853065426	0.122613868955053	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTTCGGTCGTAATGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1857.08978269198	35.8109349060893	0.0192833621938185	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1851.6217708726	1851.6217708726
"AML-2123"	"2020-07-29-AML2123-c1:CTTTCGGTCTAGGCAT"	-2.90193996849712	3.33441851222841	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.CTTTCGGTCTAGGCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3367.12264238998	30.5980733814542	0.00908730587839111	5602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3360.92470393599	3360.92470393599
"AML-2123"	"2020-07-29-AML2123-c1:GAAACCTAGCGACTGA"	8.7911192375118	7.92826459491578	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAACCTAGCGACTGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1917.12799304339	36.8203018359011	0.0192059695385543	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1911.83390962322	1911.83390962322
"AML-2123"	"2020-07-29-AML2123-c1:GAACTGTAGCATCAGG"	-7.5440915626591	2.73159811580507	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAACTGTAGCATCAGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2342.24238391542	48.3589285605171	0.0206464236547874	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2331.18714048272	2331.18714048272
"AML-2123"	"2020-07-29-AML2123-c1:GAACTGTTCCTCTAGC"	11.1625124412471	-0.861239277478777	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAACTGTTCCTCTAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1127.8177375911	3.93916569956737	0.00349273252962045	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1125.81381800966	1125.81381800966
"AML-2123"	"2020-07-29-AML2123-c1:GAAGCCCAGATACTGA"	11.9703556495601	-2.59145691311034	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAGCCCAGATACTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1554.59304942486	43.646887016256	0.0280760852702922	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1547.70638049701	1547.70638049701
"AML-2123"	"2020-07-29-AML2123-c1:GAAGCCCCACTGTGAT"	-2.29823718491252	3.80484650218812	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAGCCCCACTGTGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3125.40530363764	37.654452896435	0.0120478623532792	5641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3120.67678868271	3120.67678868271
"AML-2123"	"2020-07-29-AML2123-c1:GAAGGACGTGTCCAAT"	-7.69666181030925	2.49470589244691	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAGGACGTGTCCAAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2579.87310862992	42.7897676953117	0.0165859970213945	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2571.15125474845	2571.15125474845
"AML-2123"	"2020-07-29-AML2123-c1:GAAGGGTCATATGAAG"	9.75145496901814	7.22412679279176	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAGGGTCATATGAAG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1908.08157628785	47.0907734795909	0.024679643713769	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1902.78243016469	1902.78243016469
"AML-2123"	"2020-07-29-AML2123-c1:GAAGTAACAGAAGTGC"	-7.69807801666911	2.85296151721803	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAAGTAACAGAAGTGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2304.49126550496	35.3043653522313	0.0153198087060206	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2295.66555147246	2295.66555147246
"AML-2123"	"2020-07-29-AML2123-c1:GACCCAGCAGTCGAGA"	11.7359377342159	-2.09813144123229	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACCCAGCAGTCGAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1345.11177096876	43.0985758590593	0.0320408881917815	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1340.34934635351	1340.34934635351
"AML-2123"	"2020-07-29-AML2123-c1:GACCCAGTCCAACCAA"	12.5338007408077	-2.36521460926207	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACCCAGTCCAACCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1347.04007843705	35.0922582570814	0.02605138393343	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1343.53198612466	1343.53198612466
"AML-2123"	"2020-07-29-AML2123-c1:GACCTTCAGAACAGGA"	-4.76341042938884	9.36737248981325	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0625	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACCTTCAGAACAGGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2636.79192350475	43.1720510593754	0.0163729457279254	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2627.8247121267	2627.8247121267
"AML-2123"	"2020-07-29-AML2123-c1:GACTATGCAACCTAAC"	-7.35137114945109	2.56775782192079	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACTATGCAACCTAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2255.93865571705	44.2675185393606	0.0196226605839555	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2242.96935980141	2242.96935980141
"AML-2123"	"2020-07-29-AML2123-c1:GACTATGCAGTCGTTA"	-8.1727536720341	0.889722622278608	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACTATGCAGTCGTTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2928.69590186685	43.6111125207985	0.0148909664854584	3142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2915.86918914562	2915.86918914562
"AML-2123"	"2020-07-29-AML2123-c1:GACTATGGTATGGGAC"	12.2293831306392	-2.28142478382262	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACTATGGTATGGGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1505.07222439237	39.5027102067669	0.0262463884234626	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1493.72602560887	1493.72602560887
"AML-2123"	"2020-07-29-AML2123-c1:GACTCTCTCTGGTGCG"	1.35756434974019	9.5521554716858	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GACTCTCTCTGGTGCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1994.63513210219	37.9523751977869	0.0190272268782252	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1985.53569233321	1985.53569233321
"AML-2123"	"2020-07-29-AML2123-c1:GAGACCCAGGCCCGTT"	-3.26071725311931	10.2376432188782	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGACCCAGGCCCGTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1971.7924234763	39.9537265573729	0.0202626433095497	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1968.64966132114	1968.64966132114
"AML-2123"	"2020-07-29-AML2123-c1:GAGACCCGTAGATTAG"	12.0437103706295	-2.97073748027953	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGACCCGTAGATTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2071.84981403325	42.7291233330588	0.0206236586472832	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2064.46541192781	2064.46541192781
"AML-2123"	"2020-07-29-AML2123-c1:GAGACTTAGATGGTCG"	11.0361715751583	-1.888827466127	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGACTTAGATGGTCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1335.62591388839	13.4474577737818	0.010068281570423	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1333.4490959386	1333.4490959386
"AML-2123"	"2020-07-29-AML2123-c1:GAGATGGGTAGGTAGC"	12.0230652290279	-2.21901633655699	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGATGGGTAGGTAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1747.29818017591	31.0655017020801	0.017779164457753	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1743.35123037107	1743.35123037107
"AML-2123"	"2020-07-29-AML2123-c1:GAGATGGTCATACGGT"	9.22486939009969	7.91248605335084	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGATGGTCATACGGT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2155.548654028	49.1393208783457	0.0227966651490425	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2148.00988229949	2148.00988229949
"AML-2123"	"2020-07-29-AML2123-c1:GAGCCTGCAAGAGGTC"	8.91054977950398	8.01830337131349	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGCCTGCAAGAGGTC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1817.2040431096	45.5009185779369	0.0250389705825636	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1812.40238340905	1812.40238340905
"AML-2123"	"2020-07-29-AML2123-c1:GAGCTGCAGTACAGCG"	11.355823178857	-2.16494514858397	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGCTGCAGTACAGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1572.32202004054	24.5541673587071	0.0156165003388263	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1568.23191640413	1568.23191640413
"AML-2123"	"2020-07-29-AML2123-c1:GAGGGTAAGCCACTCG"	-7.26410422745402	-1.48663856899413	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.117647058823529	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGGGTAAGCCACTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1993.18782841628	1.67118231004162	0.000838446977357615	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1987.59627445532	1987.59627445532
"AML-2123"	"2020-07-29-AML2123-c1:GAGGGTAGTTGTGCCG"	1.44597365435902	11.3712615736756	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGGGTAGTTGTGCCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1900.84270190261	45.604887261316	0.0239919311659343	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1897.36439140598	1897.36439140598
"AML-2123"	"2020-07-29-AML2123-c1:GAGTCTAGTGCCCAGT"	-7.50380645218547	-1.65838279640349	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGTCTAGTGCCCAGT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2398.83715353232	46.996177674471	0.0195912330294153	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2396.51476769013	2396.51476769013
"AML-2123"	"2020-07-29-AML2123-c1:GAGTGAGAGACCCGCT"	11.890644689172	-3.13500549709471	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGTGAGAGACCCGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2534.27221154444	44.5377378690034	0.0175741728398865	2737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2525.40116679263	2525.40116679263
"AML-2123"	"2020-07-29-AML2123-c1:GAGTGAGCACTTTATC"	12.5280195671016	-2.52123739635619	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GAGTGAGCACTTTATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1304.31882097063	30.1345002925333	0.0231036306522881	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1295.21578167097	1295.21578167097
"AML-2123"	"2020-07-29-AML2123-c1:GATCAGTTCACAAGGG"	8.60660996016805	7.75701901996461	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GATCAGTTCACAAGGG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1842.99626261239	41.3111137367784	0.0224151912702314	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1835.00883007141	1835.00883007141
"AML-2123"	"2020-07-29-AML2123-c1:GATGACTCAAAGCACG"	11.4184843498165	-1.84472718155058	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GATGACTCAAAGCACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1411.25700256895	21.8332002876131	0.0154707471763609	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1407.51270036431	1407.51270036431
"AML-2123"	"2020-07-29-AML2123-c1:GATGTTGTCTGACAGT"	-2.65694461289104	3.5479857691559	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GATGTTGTCTGACAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3124.33567627618	31.1407032694984	0.00996714389748744	4523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3119.74599053473	3119.74599053473
"AML-2123"	"2020-07-29-AML2123-c1:GATTCGATCGCTTACC"	-7.97348437729533	2.67587134921876	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GATTCGATCGCTTACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2120.03311708573	38.0624020914298	0.0179536827914046	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2107.24121490245	2107.24121490245
"AML-2123"	"2020-07-29-AML2123-c1:GCACATATCTATACGG"	-7.49892220917399	2.54184959018556	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCACATATCTATACGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2545.04184569465	45.6402318785892	0.0179329986089608	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2530.98800612207	2530.98800612207
"AML-2123"	"2020-07-29-AML2123-c1:GCACTAACACAGTATC"	-0.0897329104250253	7.81176135623781	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCACTAACACAGTATC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2041.80901630006	33.1934726351705	0.0162568939456052	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2032.53804509903	2032.53804509903
"AML-2123"	"2020-07-29-AML2123-c1:GCAGCCAGTTACTCAG"	-7.56225524368938	2.60386393153993	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCAGCCAGTTACTCAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2540.75379450703	43.057565886237	0.0169467683092022	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2522.28561594552	2522.28561594552
"AML-2123"	"2020-07-29-AML2123-c1:GCAGCTGGTAGAAACT"	-7.70539460602458	2.5374488600525	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCAGCTGGTAGAAACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2521.04264729159	49.3497978347406	0.0195751539101324	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2514.60905103515	2514.60905103515
"AML-2123"	"2020-07-29-AML2123-c1:GCAGCTGGTGTCATGT"	-3.65329537811931	9.99855706775514	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCAGCTGGTGTCATGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1912.94091410019	39.7032621775827	0.0207550907008847	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1909.3565116675	1909.3565116675
"AML-2123"	"2020-07-29-AML2123-c1:GCAGTTAAGAGAGCAA"	-7.62640700760539	2.50458166683046	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCAGTTAAGAGAGCAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2564.02679108735	41.293267631374	0.0161048502983319	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2555.70934660289	2555.70934660289
"AML-2123"	"2020-07-29-AML2123-c1:GCAGTTACACGGATCC"	-2.06776962700542	4.08050534808961	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCAGTTACACGGATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3361.17778055548	44.7509555458498	0.0133140697896837	5126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3352.45945747416	3352.45945747416
"AML-2123"	"2020-07-29-AML2123-c1:GCATCTCAGTAGGATT"	8.67935242232625	7.5980653532776	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCATCTCAGTAGGATT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1595.9469926759	38.7780791759702	0.0242978490851701	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1590.6322122034	1590.6322122034
"AML-2123"	"2020-07-29-AML2123-c1:GCATCTCTCCACGTCT"	11.2761064964229	-1.12354960357817	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCATCTCTCCACGTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1447.65083137403	28.6096658142582	0.0197628220798958	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1439.79187073806	1439.79187073806
"AML-2123"	"2020-07-29-AML2123-c1:GCCAGGTAGTGATAAC"	11.8103929954464	-2.53790404712828	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCCAGGTAGTGATAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2044.43624531195	38.9135915514139	0.0190338982889028	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2040.97696255311	2040.97696255311
"AML-2123"	"2020-07-29-AML2123-c1:GCCCGAACAATGACCT"	0.940477986901444	9.98107144916383	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCCCGAACAATGACCT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1987.67116809053	38.0661796279927	0.0191511454405012	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1985.58573726896	1985.58573726896
"AML-2123"	"2020-07-29-AML2123-c1:GCCTGTTGTAGTGATA"	12.0098930793697	-2.87580182468566	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCCTGTTGTAGTGATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1726.24004200436	48.0228998815219	0.0278193638850839	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1717.22547924369	1717.22547924369
"AML-2123"	"2020-07-29-AML2123-c1:GCGTGCATCTGCTGAA"	-7.64270148697551	2.4080281027588	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCGTGCATCTGCTGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2451.79860013482	42.1297967216746	0.0171832208075157	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2442.30624018526	2442.30624018526
"AML-2123"	"2020-07-29-AML2123-c1:GCTACAAGTGTTCGAT"	12.3515459495479	-2.32711484348448	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTACAAGTGTTCGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1273.92799039316	43.9293786782783	0.0344834080180002	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1268.54409032867	1268.54409032867
"AML-2123"	"2020-07-29-AML2123-c1:GCTACCTAGGTTCAGG"	2.05661787566487	-10.5665636292663	"2020-07-29-AML2123-c1"	"AML2123"	"CD11c+"	"CD11c+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.166666666666667	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTACCTAGGTTCAGG"	"CD11c+"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2816.61513870378	25.0596985332245	0.00889709715355613	2818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2812.09554082611	2812.09554082611
"AML-2123"	"2020-07-29-AML2123-c1:GCTCAAAAGCTAGCCC"	11.9694858985836	-2.20922090923461	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTCAAAAGCTAGCCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1414.32710458537	34.9559069000095	0.0247155744853361	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1411.68774694147	1411.68774694147
"AML-2123"	"2020-07-29-AML2123-c1:GCTCAAAGTATTAAGG"	12.1399704414303	-2.41097023403319	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTCAAAGTATTAAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1455.58151113124	29.5486434394057	0.0203002327340921	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1453.2039229807	1453.2039229807
"AML-2123"	"2020-07-29-AML2123-c1:GCTCAAATCGGATACT"	-2.09286294403728	4.14082000339357	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTCAAATCGGATACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2851.03117980272	34.8149769950217	0.012211363117197	3923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2846.6828430135	2846.6828430135
"AML-2123"	"2020-07-29-AML2123-c1:GCTGCAGCAAGACGAC"	1.4256463247234	10.003336883429	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTGCAGCAAGACGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2052.48165027602	44.2975280750442	0.0215824234380303	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2041.30368368287	2041.30368368287
"AML-2123"	"2020-07-29-AML2123-c1:GCTGCAGGTAGTACGG"	-3.18808684769328	10.2253131636414	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTGCAGGTAGTACGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1864.80209812126	44.533358351061	0.0238810104278236	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1861.03066975948	1861.03066975948
"AML-2123"	"2020-07-29-AML2123-c1:GCTGGGTGTACACTCA"	0.537354548543137	12.1390628584656	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTGGGTGTACACTCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1830.83342076177	43.9633085915926	0.0240127299911864	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1825.14726251196	1825.14726251196
"AML-2123"	"2020-07-29-AML2123-c1:GCTTCACGTTACGCCG"	8.8246771293575	7.85187432849733	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTTCACGTTACGCCG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1795.23816228367	39.172301535334	0.0218201140986798	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1792.31772728803	1792.31772728803
"AML-2123"	"2020-07-29-AML2123-c1:GCTTGGGGTTGGGTAG"	10.9907862144405	-2.6739232770172	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTTGGGGTTGGGTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1953.97583281604	44.7182418771414	0.0228857701953735	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1950.49674603372	1950.49674603372
"AML-2123"	"2020-07-29-AML2123-c1:GCTTTCGAGGATGCGT"	-7.71628795090373	2.31806895816652	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTTTCGAGGATGCGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2729.45207309025	46.0477548359826	0.016870695510637	2968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2717.90626914004	2717.90626914004
"AML-2123"	"2020-07-29-AML2123-c1:GCTTTCGTCACCATGA"	12.399937291711	-2.65275885975035	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GCTTTCGTCACCATGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1596.46842235053	39.4046234321571	0.0246823694602995	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1587.02326875567	1587.02326875567
"AML-2123"	"2020-07-29-AML2123-c1:GGAGGATCAGTGTGCC"	0.361703951924485	9.36454007709352	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGAGGATCAGTGTGCC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1895.31272887362	41.5503145918263	0.0219226695198314	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1892.40967764044	1892.40967764044
"AML-2123"	"2020-07-29-AML2123-c1:GGAGGATTCCGTTGGG"	-3.34068284454997	3.58162472331849	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGAGGATTCCGTTGGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3136.48161629828	45.8647758987547	0.014623001665441	5001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3123.18786346079	3123.18786346079
"AML-2123"	"2020-07-29-AML2123-c1:GGCTGTGTCTACACTT"	-1.94802031937297	3.80724284732667	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGCTGTGTCTACACTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3551.13568347225	34.5297897322067	0.0097235906509897	4218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3544.35931425131	3544.35931425131
"AML-2123"	"2020-07-29-AML2123-c1:GGGAAGTAGGCACAAC"	-3.09467540207561	10.582040763739	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGAAGTAGGCACAAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1922.84480654065	44.7348774966616	0.0232649443909846	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1921.15440645957	1921.15440645957
"AML-2123"	"2020-07-29-AML2123-c1:GGGAAGTAGTCACGAG"	8.76845612105672	8.10841939533082	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGAAGTAGTCACGAG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1680.09010911855	23.1213225372005	0.0137619538450417	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1677.44883984966	1677.44883984966
"AML-2123"	"2020-07-29-AML2123-c1:GGGACTCTCAGGCGAA"	-7.63169465485271	2.70275328243104	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGACTCTCAGGCGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2435.81365590228	40.812157968318	0.0167550411212389	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2426.47239452823	2426.47239452823
"AML-2123"	"2020-07-29-AML2123-c1:GGGAGATCACTTGGGC"	10.7009760337764	-0.70761957084807	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGAGATCACTTGGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2076.37344790251	30.4435276348702	0.0146618748499328	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2069.44353622555	2069.44353622555
"AML-2123"	"2020-07-29-AML2123-c1:GGGATCCTCTAGTACG"	0.551823099225205	9.84473798358766	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGATCCTCTAGTACG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2000.85076510875	28.9463631686601	0.014467027563191	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1994.92150199497	1994.92150199497
"AML-2123"	"2020-07-29-AML2123-c1:GGGATGATCGGCTCTT"	-3.76785741272624	10.3844060667786	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGATGATCGGCTCTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1839.07100366588	39.0348584867392	0.0212253134375616	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1837.20673818536	1837.20673818536
"AML-2123"	"2020-07-29-AML2123-c1:GGGCGTTCATTGACTG"	-1.40607903423961	8.89310262286989	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGCGTTCATTGACTG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2425.90210518985	43.0522992687558	0.0177469235780999	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2417.83580884723	2417.83580884723
"AML-2123"	"2020-07-29-AML2123-c1:GGGCTACCACGGTGCT"	-3.18343840065654	9.64920804584352	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGCTACCACGGTGCT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2129.08175117525	33.1195829733834	0.0155558061380694	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2126.11175217519	2126.11175217519
"AML-2123"	"2020-07-29-AML2123-c1:GGGCTACTCTTAGGAC"	1.43771721896474	11.0607938536438	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGCTACTCTTAGGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1933.75179943045	40.9676186523668	0.0211855620066821	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1921.95465380745	1921.95465380745
"AML-2123"	"2020-07-29-AML2123-c1:GGGCTCACACTTGTCC"	-7.56891189041789	2.51869127834169	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGCTCACACTTGTCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2723.2592048086	49.3626406279678	0.0181263100261649	2735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2705.8979420756	2705.8979420756
"AML-2123"	"2020-07-29-AML2123-c1:GGGCTCATCGCTCTCA"	-7.5317419570988	2.41322181308595	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGCTCATCGCTCTCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2617.01921395216	41.9963358280293	0.0160473930050393	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2611.79306819186	2611.79306819186
"AML-2123"	"2020-07-29-AML2123-c1:GGGTAGAGTTATGACC"	-2.83034477654155	13.6290502318176	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGTAGAGTTATGACC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2248.25657178006	45.1110962294784	0.0200649235481881	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2242.2990313922	2242.2990313922
"AML-2123"	"2020-07-29-AML2123-c1:GGGTATTTCCATATGG"	10.7888037162716	-2.34696438228758	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGTATTTCCATATGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1666.78809910459	29.7745749655375	0.0178634434584292	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1661.93031431523	1661.93031431523
"AML-2123"	"2020-07-29-AML2123-c1:GGGTGTCCACATCATG"	-2.67159567299541	9.14543531024782	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGGTGTCCACATCATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1844.49397007908	48.5506726660441	0.0263219470779633	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1839.97791903539	1839.97791903539
"AML-2123"	"2020-07-29-AML2123-c1:GGTAGAGTCTTGGGCG"	8.87572350081746	7.83973929965822	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTAGAGTCTTGGGCG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1766.92371768349	38.6454366432359	0.0218715931290467	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1764.01013756938	1764.01013756938
"AML-2123"	"2020-07-29-AML2123-c1:GGTCTGGTCCACTTCG"	-7.39386735382732	1.81916389549104	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTCTGGTCCACTTCG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2715.96654792263	47.0138258791779	0.01731016382184	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2697.633816822	2697.633816822
"AML-2123"	"2020-07-29-AML2123-c1:GGTGAAGAGCGGCTCT"	-2.06337914887126	3.39608953082887	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTGAAGAGCGGCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2625.96135998704	44.9528652734413	0.0171186316594024	3922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2622.57810494437	2622.57810494437
"AML-2123"	"2020-07-29-AML2123-c1:GGTGATTAGTCCTGCG"	-7.56823859635051	2.65286085689393	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTGATTAGTCCTGCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2485.80177463445	48.3991347321722	0.01947023098384	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2476.57396274809	2476.57396274809
"AML-2123"	"2020-07-29-AML2123-c1:GGTGTCGGTCCTTAAG"	11.8261429267818	-1.96284439479979	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTGTCGGTCCTTAAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1209.09369231226	26.5937953647398	0.0219948177166338	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1206.24724475402	1206.24724475402
"AML-2123"	"2020-07-29-AML2123-c1:GGTGTTAGTATGATCC"	10.8425308662349	-0.555429064389788	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTGTTAGTATGATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1166.40070541712	44.9460418222493	0.0385339631684945	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1161.42408022864	1161.42408022864
"AML-2123"	"2020-07-29-AML2123-c1:GGTGTTATCCCTGTTG"	8.4753061729366	7.5937027701172	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTGTTATCCCTGTTG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1649.61385160057	43.3524964706287	0.0262803906675281	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1645.73308755532	1645.73308755532
"AML-2123"	"2020-07-29-AML2123-c1:GGTTAACAGTGCACTT"	11.0142446952755	-2.35375049030455	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTTAACAGTGCACTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1272.46151782388	39.0145921247474	0.0306607245706486	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1268.68703721646	1268.68703721646
"AML-2123"	"2020-07-29-AML2123-c1:GGTTAACCATGGAACG"	0.210008819668931	11.4105348356995	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GGTTAACCATGGAACG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2178.68205310182	49.414245464349	0.0226807970414945	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2169.56726355622	2169.56726355622
"AML-2123"	"2020-07-29-AML2123-c1:GTAAGTCCAGGCATTT"	-2.59914598885234	9.88321206653444	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAAGTCCAGGCATTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2317.70082644549	44.4584981304468	0.0191821557049837	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2314.00444872618	2314.00444872618
"AML-2123"	"2020-07-29-AML2123-c1:GTAATGCCATGTCGTA"	-7.6086143058842	2.50853631580202	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAATGCCATGTCGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2452.36700828734	39.8334520530604	0.0162428592125283	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2437.20048602967	2437.20048602967
"AML-2123"	"2020-07-29-AML2123-c1:GTAATGCGTCCGGACT"	-7.6320141357487	2.68528673732606	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAATGCGTCCGGACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2722.81334982865	44.5625444016849	0.016366360332591	3050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2709.82002128593	2709.82002128593
"AML-2123"	"2020-07-29-AML2123-c1:GTACAGTTCAAAGGAT"	9.11577858504597	7.16056678378908	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTACAGTTCAAAGGAT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1933.11767557006	40.446015419158	0.020922686668431	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1926.63611152624	1926.63611152624
"AML-2123"	"2020-07-29-AML2123-c1:GTACAGTTCTGAGAAA"	-7.54065738144572	2.44069311702577	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTACAGTTCTGAGAAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2828.38041708852	37.5395507560006	0.0132724546278124	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2818.26514378251	2818.26514378251
"AML-2123"	"2020-07-29-AML2123-c1:GTAGATCAGGCTAAAT"	0.823743899434251	11.2303905257019	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAGATCAGGCTAAAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2100.00484692781	44.1196552438449	0.0210093111491573	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2095.48448233854	2095.48448233854
"AML-2123"	"2020-07-29-AML2123-c1:GTAGCTAAGAAGTATC"	-8.26170669022258	0.831080830934919	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAGCTAAGAAGTATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3069.54826013137	39.3730526537018	0.0128269860308424	3930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3058.05400295062	3058.05400295062
"AML-2123"	"2020-07-29-AML2123-c1:GTAGTACAGCTGCGAA"	-3.26015625420268	10.4701823958191	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAGTACAGCTGCGAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1729.86211481062	44.4089071169952	0.0256719346222904	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1726.46868281956	1726.46868281956
"AML-2123"	"2020-07-29-AML2123-c1:GTAGTACAGCTTAGTC"	12.0815149742061	-2.83446409618529	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTAGTACAGCTTAGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1593.04686481845	39.3252077938113	0.0246855310175028	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1582.73273297356	1582.73273297356
"AML-2123"	"2020-07-29-AML2123-c1:GTCAAGTTCACGTAGT"	-0.456270913512069	9.1465968855652	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCAAGTTCACGTAGT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2315.75586154421	38.8488561666002	0.0167758859263751	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2310.17848233195	2310.17848233195
"AML-2123"	"2020-07-29-AML2123-c1:GTCACTCTCCGACGGT"	-7.54026351395305	1.43996510589448	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCACTCTCCGACGGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2766.18385737432	42.9026711214254	0.0155096961494631	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2754.6980551168	2754.6980551168
"AML-2123"	"2020-07-29-AML2123-c1:GTCATCCGTGCATCTA"	-0.449804524809676	11.3924073942932	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCATCCGTGCATCTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1710.40251884797	49.2341484324499	0.0287851239049923	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1710.40251884797	1710.40251884797
"AML-2123"	"2020-07-29-AML2123-c1:GTCATGATCCAGTGCG"	-7.51729331436809	2.19680283153383	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCATGATCCAGTGCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2549.56824811707	44.2680859580043	0.017362973511573	2762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2537.39587149537	2537.39587149537
"AML-2123"	"2020-07-29-AML2123-c1:GTCCACTTCACGGTCG"	-7.31394563141521	2.60431192005006	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCCACTTCACGGTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2681.61556327671	46.7730341057648	0.0174421101765281	3059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2666.42556447083	2666.42556447083
"AML-2123"	"2020-07-29-AML2123-c1:GTCCCATGTACTCGAT"	-7.62082324448283	1.90200088107911	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCCCATGTACTCGAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2866.43577322587	46.6758622792027	0.0162835890882962	3587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2853.54469908153	2853.54469908153
"AML-2123"	"2020-07-29-AML2123-c1:GTCCCATGTGGCCACT"	-7.77175031128581	2.93083236301271	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCCCATGTGGCCACT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2361.7120553013	45.8235367809013	0.019402677256121	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2352.43621724484	2352.43621724484
"AML-2123"	"2020-07-29-AML2123-c1:GTCTACCGTGCATGAG"	-7.68002877655681	2.77343223178712	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCTACCGTGCATGAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2303.47727079594	42.9945649000654	0.0186650701724567	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2298.03439044472	2298.03439044472
"AML-2123"	"2020-07-29-AML2123-c1:GTCTGTCAGCGTATAA"	8.09014763411824	7.66224668109743	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTCTGTCAGCGTATAA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1808.82055740862	36.273161865857	0.0200534882895312	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1804.88588247013	1804.88588247013
"AML-2123"	"2020-07-29-AML2123-c1:GTGAGGAAGCAAGTCG"	-2.10565147820171	10.1980523833069	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGAGGAAGCAAGTCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2061.66781616981	43.2293763257566	0.0209681579091964	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2054.19205930679	2054.19205930679
"AML-2123"	"2020-07-29-AML2123-c1:GTGAGTTAGGATATAC"	-1.84617135945018	10.2909364470276	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGAGTTAGGATATAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2080.34960583965	45.8710391515194	0.0220496781035058	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2073.17001640319	2073.17001640319
"AML-2123"	"2020-07-29-AML2123-c1:GTGATGTCAAAGGGCT"	0.486448456614655	10.0422887572083	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGATGTCAAAGGGCT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1895.54430152442	27.5432284195003	0.0145305115777826	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1891.2627967504	1891.2627967504
"AML-2123"	"2020-07-29-AML2123-c1:GTGATGTGTTTGAACC"	-7.61912284317668	2.71275875652162	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGATGTGTTTGAACC"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2388.12144035577	40.2014377351018	0.0168339168418139	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2375.75489353089	2375.75489353089
"AML-2123"	"2020-07-29-AML2123-c1:GTGCACGGTAACTTCG"	10.8837553459102	-2.2777400246826	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGCACGGTAACTTCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1414.80882521598	44.2760181229948	0.0312947002689469	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1410.46151283107	1410.46151283107
"AML-2123"	"2020-07-29-AML2123-c1:GTGCAGCTCAGACAAA"	0.955625732510728	10.1582546004089	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGCAGCTCAGACAAA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1970.50110866257	39.3674113228527	0.0199783756272902	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1962.17504409675	1962.17504409675
"AML-2123"	"2020-07-29-AML2123-c1:GTGCTGGCAGTTCTAG"	10.764722486108	-0.629422151204668	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGCTGGCAGTTCTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1321.45973212374	24.4367812341925	0.0184922632450704	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1317.52934165349	1317.52934165349
"AML-2123"	"2020-07-29-AML2123-c1:GTGCTGGCATCGAAGG"	0.976009924977463	11.0580634840759	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGCTGGCATCGAAGG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1918.7855493362	33.5871164251435	0.0175043617754798	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1915.87898749751	1915.87898749751
"AML-2123"	"2020-07-29-AML2123-c1:GTGGAAGAGTCGAATA"	10.661430020898	-0.974780463334642	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGGAAGAGTCGAATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1766.54210065142	22.4949353021043	0.0127338801004569	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1759.9747707347	1759.9747707347
"AML-2123"	"2020-07-29-AML2123-c1:GTGGAAGGTAGCACAG"	-2.46784124794658	12.790066696051	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGGAAGGTAGCACAG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2482.59627367966	49.4702758766124	0.0199268307944765	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2472.05323439347	2472.05323439347
"AML-2123"	"2020-07-29-AML2123-c1:GTGGAGATCATCGACA"	-1.82802746716197	3.74357411945192	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGGAGATCATCGACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3172.06860772604	13.7509136386161	0.0043349988096486	5286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3166.5234887564	3166.5234887564
"AML-2123"	"2020-07-29-AML2123-c1:GTGGAGATCGCGATCG"	-3.06896839562114	9.91656587207643	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGGAGATCGCGATCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1926.14303374161	34.3628721217716	0.017840249410253	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1922.96605162399	1922.96605162399
"AML-2123"	"2020-07-29-AML2123-c1:GTGGGAAGTGTGACCC"	-7.70776496353801	2.8727988966736	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGGGAAGTGTGACCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2174.72248401784	44.6962114191586	0.0205526046415732	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2167.56111658679	2167.56111658679
"AML-2123"	"2020-07-29-AML2123-c1:GTGTAACTCATGAGTC"	-7.36161551895793	2.26549742305604	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGTAACTCATGAGTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2461.45133165901	43.9123341030007	0.0178400172037543	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2449.16879203116	2449.16879203116
"AML-2123"	"2020-07-29-AML2123-c1:GTGTGGCGTTCGGCCA"	0.193731253116769	11.1655511626038	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGTGGCGTTCGGCCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2132.07958180245	40.621809663044	0.019052670458343	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2129.01313188734	2129.01313188734
"AML-2123"	"2020-07-29-AML2123-c1:GTGTGGCTCCACATAG"	-2.25046978417094	3.39811012828676	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGTGGCTCCACATAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3292.23652191325	2.06634718174188	0.000627642384740038	5573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3284.97437308677	3284.97437308677
"AML-2123"	"2020-07-29-AML2123-c1:GTGTTCCCATATCTCT"	11.342133184045	-1.98029496585997	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTGTTCCCATATCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1452.82888781751	41.8243100865834	0.0287881872650628	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1448.35366244249	1448.35366244249
"AML-2123"	"2020-07-29-AML2123-c1:GTTACGATCGCGGTAC"	-0.428534428507644	11.5178279646668	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTACGATCGCGGTAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2048.19311090961	43.7147321679703	0.021343071576174	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2043.7487019773	2043.7487019773
"AML-2123"	"2020-07-29-AML2123-c1:GTTAGTGGTACGCTTA"	11.2560488182003	-2.69782569324645	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTAGTGGTACGCTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1497.55339610872	50.1475727811135	0.0334863337169935	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1495.08652427996	1495.08652427996
"AML-2123"	"2020-07-29-AML2123-c1:GTTAGTGGTGCAATAA"	-1.94963488999065	3.86443946445314	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTAGTGGTGCAATAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3069.86878662168	42.3887625364739	0.0138080046682131	5431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3064.3415848351	3064.3415848351
"AML-2123"	"2020-07-29-AML2123-c1:GTTCATTAGATCCTAC"	0.96916695412938	8.72274873340455	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTCATTAGATCCTAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2040.62355541164	33.4187416282763	0.0163767303085625	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2033.63724532917	2033.63724532917
"AML-2123"	"2020-07-29-AML2123-c1:GTTCATTAGTGATTCC"	11.4674698310787	-1.89716961300047	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTCATTAGTGATTCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1224.82371839424	44.1975597739249	0.0360848333602393	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1224.82371839424	1224.82371839424
"AML-2123"	"2020-07-29-AML2123-c1:GTTCATTCATCGTCCT"	-7.43913159790691	-0.23275407468947	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTCATTCATCGTCCT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3051.46953499346	42.9209154629371	0.0140656542596055	2782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3040.22150550593	3040.22150550593
"AML-2123"	"2020-07-29-AML2123-c1:GTTGCGGGTCGTTCAA"	10.9011532264644	-2.54517939006957	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTGCGGGTCGTTCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2052.40861215744	42.3665646755592	0.0206423635257623	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2049.23199571903	2049.23199571903
"AML-2123"	"2020-07-29-AML2123-c1:GTTGTCCCATCGATGT"	10.3786913352901	-0.208134495374285	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTGTCCCATCGATGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1201.36924888069	0	0	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1197.53240732513	1197.53240732513
"AML-2123"	"2020-07-29-AML2123-c1:GTTTACTGTATGCTTG"	12.5311542945797	-2.49650385296019	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.GTTTACTGTATGCTTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2074.60661402096	47.8235149144416	0.0230518473195027	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2067.90708140564	2067.90708140564
"AML-2123"	"2020-07-29-AML2123-c1:TAACGACAGCGTCTGC"	-7.50031075897868	-0.104053982254587	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	11	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACGACAGCGTCTGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2729.40721923508	40.8243132522419	0.0149572086438911	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2728.08394048265	2728.08394048265
"AML-2123"	"2020-07-29-AML2123-c1:TAACGACGTACAGTCT"	-1.90701101246532	3.36382434451906	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACGACGTACAGTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3136.85122592958	46.9800156072352	0.0149768070665554	4294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3129.46350432547	3129.46350432547
"AML-2123"	"2020-07-29-AML2123-c1:TAACGACGTACCGGAA"	-7.32460771027263	0.859586156252302	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACGACGTACCGGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3058.37414073732	45.7746701481137	0.0149669948939204	3330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3045.83109284158	3045.83109284158
"AML-2123"	"2020-07-29-AML2123-c1:TAACGACTCCAATCTT"	-7.58793912354167	2.53984544360963	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACGACTCCAATCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2367.82724065314	44.3695268375666	0.0187384983481006	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2352.26222001	2352.26222001
"AML-2123"	"2020-07-29-AML2123-c1:TAACTTCCAGGACGAT"	11.1251036125118	-2.77153947269591	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACTTCCAGGACGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1735.61529319793	38.3707677706731	0.0221078760489449	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1728.82208028281	1728.82208028281
"AML-2123"	"2020-07-29-AML2123-c1:TAACTTCGTCCACACG"	-7.41022906723674	2.68217036807863	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACTTCGTCCACACG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2638.47915899298	48.1079835922103	0.0182332247833905	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2620.00273402147	2620.00273402147
"AML-2123"	"2020-07-29-AML2123-c1:TAACTTCTCCTGTAGA"	11.8494297462398	-2.89377906238707	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAACTTCTCCTGTAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2081.76507176585	45.0758935355897	0.0216527283250814	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2076.31925503745	2076.31925503745
"AML-2123"	"2020-07-29-AML2123-c1:TAAGCACTCAAGTCTG"	-0.953510264784652	10.9141578444275	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAAGCACTCAAGTCTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2106.40241854593	35.6941936386445	0.016945571902298	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2098.15659335334	2098.15659335334
"AML-2123"	"2020-07-29-AML2123-c1:TAAGCCAAGTTCCAGT"	-7.61996589127238	2.49629542911378	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAAGCCAAGTTCCAGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2673.06180723329	44.4362702210733	0.0166237346629356	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2655.09311127876	2655.09311127876
"AML-2123"	"2020-07-29-AML2123-c1:TAAGCCATCTCCACTG"	-2.86952147904094	9.82780835712282	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAAGCCATCTCCACTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2212.17535993339	40.6775857723757	0.0183880475793748	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2206.05953752842	2206.05953752842
"AML-2123"	"2020-07-29-AML2123-c1:TAAGCGTCAGTTTGGT"	-2.27076731148418	3.40616843784181	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAAGCGTCAGTTTGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3414.39473538747	28.3032634562031	0.00828939406532653	3896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3407.98520499031	3407.98520499031
"AML-2123"	"2020-07-29-AML2123-c1:TAAGTCGAGTCTCCTC"	12.3834492164547	-2.97389295017394	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAAGTCGAGTCTCCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1949.0780395304	40.8656618012927	0.0209666626848552	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1938.950848729	1938.950848729
"AML-2123"	"2020-07-29-AML2123-c1:TAATTCCCATCATCCC"	12.6216484504635	-2.53495337879332	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAATTCCCATCATCCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1510.43252074585	6.1616979731082	0.00407942618321377	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1504.4513612574	1504.4513612574
"AML-2123"	"2020-07-29-AML2123-c1:TACAGGTAGCATACTC"	8.40117229995076	7.89188144290773	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACAGGTAGCATACTC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1985.20712232385	32.0581349385549	0.0161485089278887	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1982.80761755357	1982.80761755357
"AML-2123"	"2020-07-29-AML2123-c1:TACATTCCATACAGAA"	-7.60811076584514	1.7620047100815	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACATTCCATACAGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2737.81402534553	40.820819244058	0.014910004429138	2997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2724.51480480499	2724.51480480499
"AML-2123"	"2020-07-29-AML2123-c1:TACCGAAAGGAGTACC"	-2.30423579636272	10.0452089079651	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACCGAAAGGAGTACC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1955.88760324547	48.4310095858606	0.0247616527174145	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1949.89270315052	1949.89270315052
"AML-2123"	"2020-07-29-AML2123-c1:TACCGAAGTCACATTG"	0.882336874573868	9.89061353290407	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACCGAAGTCACATTG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1918.40761238997	35.6918797851728	0.0186049510826885	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1911.3259298741	1911.3259298741
"AML-2123"	"2020-07-29-AML2123-c1:TACCGGGCAAGGTCAG"	0.477851261466187	4.42619416797487	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACCGGGCAAGGTCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1458.14683313209	42.7661699674216	0.0293291244720261	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1437.94310454599	1437.94310454599
"AML-2123"	"2020-07-29-AML2123-c1:TACGCTCTCAAATAGG"	-7.75128302994426	2.565234161261	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACGCTCTCAAATAGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2816.68604494128	39.4152990241455	0.0139935010133397	2715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2797.61746350059	2797.61746350059
"AML-2123"	"2020-07-29-AML2123-c1:TACGGGCGTTCAAAGA"	10.9681965309078	-2.61345841800841	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACGGGCGTTCAAAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1481.72009049539	25.3334563813982	0.0170973293430396	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1478.29982728843	1478.29982728843
"AML-2123"	"2020-07-29-AML2123-c1:TACGGGCTCCTCTCGA"	-7.61196122589763	2.54687593067018	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACGGGCTCCTCTCGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2565.62092121177	43.0696076774852	0.0167872062943511	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2556.64990293951	2556.64990293951
"AML-2123"	"2020-07-29-AML2123-c1:TACGGTAAGATCACTC"	0.433542599051636	11.234688735846	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Naive"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACGGTAAGATCACTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2068.9565353778	45.4696686049583	0.0219771019001399	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2065.73851008205	2065.73851008205
"AML-2123"	"2020-07-29-AML2123-c1:TACGGTAAGCCTCTTC"	-7.51919875565227	2.40043828571168	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACGGTAAGCCTCTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1955.97875377037	46.2450777670959	0.0236429346064999	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1947.42105106924	1947.42105106924
"AML-2123"	"2020-07-29-AML2123-c1:TACTGCCTCGGTGTAT"	-7.28098712387736	3.95172903621522	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACTGCCTCGGTGTAT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1710.22593337374	42.8573085557252	0.0250594425680243	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1702.31628707246	1702.31628707246
"AML-2123"	"2020-07-29-AML2123-c1:TACTTGTGTGCGAACA"	8.80111851271931	7.63855979526369	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACTTGTGTGCGAACA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1897.37980545532	24.9357373812474	0.0131421960482306	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1887.74236120422	1887.74236120422
"AML-2123"	"2020-07-29-AML2123-c1:TACTTGTTCAGTCTTT"	-2.68461881104167	9.78210160816041	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TACTTGTTCAGTCTTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2624.78582947408	42.6716753769193	0.0162572027392686	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2613.58282683221	2613.58282683221
"AML-2123"	"2020-07-29-AML2123-c1:TAGACCAAGCTTGTTG"	12.4446732002193	-2.54921152507933	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAGACCAAGCTTGTTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1576.80705644174	22.0618182958843	0.0139914507648574	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1561.80982985064	1561.80982985064
"AML-2123"	"2020-07-29-AML2123-c1:TAGGTACAGACCAGCA"	11.1391540962154	-2.62788464939269	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAGGTACAGACCAGCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1577.82659456852	44.2123060107338	0.0280210171148904	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1571.45419289714	1571.45419289714
"AML-2123"	"2020-07-29-AML2123-c1:TAGGTTGAGGCGTTAG"	-7.4855469268864	3.86083862865297	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAGGTTGAGGCGTTAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2254.27093041501	43.134690824739	0.0191346524691236	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2239.99675808134	2239.99675808134
"AML-2123"	"2020-07-29-AML2123-c1:TAGGTTGTCCTATTGT"	-3.18396315994914	10.0479850539002	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAGGTTGTCCTATTGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2235.28136090336	48.7167253746621	0.0217944488898587	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2225.56453269742	2225.56453269742
"AML-2123"	"2020-07-29-AML2123-c1:TAGTGCACAACTCCCT"	-7.69157205048259	2.59342525089113	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TAGTGCACAACTCCCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2462.56126314924	42.5895908788217	0.0172948350630498	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2451.28056688245	2451.28056688245
"AML-2123"	"2020-07-29-AML2123-c1:TATCAGGTCCAATGCA"	-7.55899081650432	2.64840147579042	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCAGGTCCAATGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2277.54061097667	43.9712320563792	0.0193064535685812	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2262.85921603774	2262.85921603774
"AML-2123"	"2020-07-29-AML2123-c1:TATCCTAAGCGTCAGA"	-1.17512188378032	10.7192640074524	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCCTAAGCGTCAGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1932.46615491381	35.4436563138116	0.0183411524303733	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1925.91281738338	1925.91281738338
"AML-2123"	"2020-07-29-AML2123-c1:TATCCTACACAACGCC"	0.597183604806107	11.1625413664612	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCCTACACAACGCC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1875.94360280205	38.5304225371046	0.0205392222237133	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1871.24702777355	1871.24702777355
"AML-2123"	"2020-07-29-AML2123-c1:TATCCTATCTGAGAGG"	11.243518491357	-2.26359894191893	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCCTATCTGAGAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1496.29455628384	39.4755051862928	0.0263821752344895	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1492.50822619518	1492.50822619518
"AML-2123"	"2020-07-29-AML2123-c1:TATCGCCAGTCACTGT"	-7.66232142868693	2.80726096713869	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCGCCAGTCACTGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2335.9464763971	40.0144023158176	0.0171298455337619	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2330.14809617539	2330.14809617539
"AML-2123"	"2020-07-29-AML2123-c1:TATCGCCTCAGAGTTC"	0.0709129004621923	11.1812343367371	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCGCCTCAGAGTTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2239.63489280758	48.78864051445	0.0217841937858403	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2232.70600548357	2232.70600548357
"AML-2123"	"2020-07-29-AML2123-c1:TATCTGTAGCGCCCAT"	-7.64233479920085	2.03548607910005	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCTGTAGCGCCCAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2813.27851108956	40.4318162036485	0.0143717787073949	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2798.13025724892	2798.13025724892
"AML-2123"	"2020-07-29-AML2123-c1:TATCTTGCAATGGCAG"	-7.61833463135417	2.55938289249269	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCTTGCAATGGCAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2578.95177241162	45.0466209087301	0.0174670272591435	2750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2569.68673140683	2569.68673140683
"AML-2123"	"2020-07-29-AML2123-c1:TATCTTGTCCACATAG"	-7.51416621628459	3.82901904666749	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATCTTGTCCACATAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2245.10343847812	50.8471688300084	0.0226480294665069	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2234.78265526414	2234.78265526414
"AML-2123"	"2020-07-29-AML2123-c1:TATGTTCGTCAGACGA"	-7.4598277610844	2.62742469394533	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATGTTCGTCAGACGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2646.18058193458	46.3277472485274	0.0175074020136063	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2639.71428865835	2639.71428865835
"AML-2123"	"2020-07-29-AML2123-c1:TATTGGGTCAGACAAA"	-8.2354510826176	4.02560613239137	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TATTGGGTCAGACAAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2463.8928226488	43.0071049677953	0.0174549414538091	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2455.64223865988	2455.64223865988
"AML-2123"	"2020-07-29-AML2123-c1:TCAAGACTCACCGGTG"	-4.12173734131511	10.8568954237732	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAAGACTCACCGGTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2105.56339659803	43.5037950219788	0.0206613560495343	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2103.79276165797	2103.79276165797
"AML-2123"	"2020-07-29-AML2123-c1:TCAAGTGCATAATCCG"	12.3149076896602	-2.24698617374571	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAAGTGCATAATCCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1321.0292142664	35.2527927172824	0.0266858539815557	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1317.07563382727	1317.07563382727
"AML-2123"	"2020-07-29-AML2123-c1:TCAATTCGTAAGCTCT"	10.8124815421993	-1.01142611419829	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAATTCGTAAGCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1412.90710482219	21.0136847553237	0.014872658424326	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1406.67929285853	1406.67929285853
"AML-2123"	"2020-07-29-AML2123-c1:TCACAAGTCAAGGCTT"	0.72783793982808	9.10776803577272	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCACAAGTCAAGGCTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2182.09862257969	33.2185335802121	0.0152232045043596	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2174.31577139289	2174.31577139289
"AML-2123"	"2020-07-29-AML2123-c1:TCACGCTGTAATCAGA"	-7.12478814545329	2.55443093860475	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCACGCTGTAATCAGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2788.37857153273	46.5680209768756	0.0167007527070751	2891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2775.21090236343	2775.21090236343
"AML-2123"	"2020-07-29-AML2123-c1:TCACTATCAATCACGT"	-1.38270531120952	3.66133663738099	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCACTATCAATCACGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2605.92799555941	47.0263638465137	0.0180459183548617	3077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2598.49018292417	2598.49018292417
"AML-2123"	"2020-07-29-AML2123-c1:TCAGCCTAGTACAGAT"	-1.60566852513011	3.75653050029603	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGCCTAGTACAGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2935.31020494801	38.4010754826929	0.0130824590252713	4543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2928.75924918365	2928.75924918365
"AML-2123"	"2020-07-29-AML2123-c1:TCAGCCTCAATCTAGC"	-6.80747542801555	1.59035620773164	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGCCTCAATCTAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2161.04433976471	38.1846110920378	0.0176695176445085	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2150.67778077215	2150.67778077215
"AML-2123"	"2020-07-29-AML2123-c1:TCAGCCTTCTACAGGT"	-7.38733754578288	2.87375805461732	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGCCTTCTACAGGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2329.65812689285	46.7548685981179	0.0200694119271812	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2323.74261036856	2323.74261036856
"AML-2123"	"2020-07-29-AML2123-c1:TCAGGGCGTCGATTTG"	-1.77526448193248	10.1736659773621	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGGGCGTCGATTTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1849.80108027412	41.5062515626074	0.0224382243070464	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1843.96264129308	1843.96264129308
"AML-2123"	"2020-07-29-AML2123-c1:TCAGGTAGTACCCGCA"	-7.70031676712688	2.24125216091005	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGGTAGTACCCGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2774.28314621147	45.253749097945	0.0163118711079448	3283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2767.63792825878	2767.63792825878
"AML-2123"	"2020-07-29-AML2123-c1:TCAGTTTCATGCCGCA"	0.127329466014546	9.90365598285524	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCAGTTTCATGCCGCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2290.94510961862	37.0068135695002	0.016153513855101	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2287.6731371073	2287.6731371073
"AML-2123"	"2020-07-29-AML2123-c1:TCATCATAGTTCCATG"	1.3801552253658	9.9715890654358	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCATCATAGTTCCATG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2102.79131822359	33.3325454618805	0.0158515708016331	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2099.05942307976	2099.05942307976
"AML-2123"	"2020-07-29-AML2123-c1:TCATCATCAGAGGAAA"	-3.51929984512981	9.77321050250856	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCATCATCAGAGGAAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2252.40548969413	47.4472293193908	0.0210651366001749	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2245.4977944113	2245.4977944113
"AML-2123"	"2020-07-29-AML2123-c1:TCATGAGCAGCCCACA"	11.066326757043	-1.07259788429412	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCATGAGCAGCCCACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1133.09041031794	41.7383483775279	0.0368358499881896	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1128.5557952462	1128.5557952462
"AML-2123"	"2020-07-29-AML2123-c1:TCATTCAAGACCAGAC"	8.49863400039021	8.23623082721559	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCATTCAAGACCAGAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1881.8349974445	32.8391513662442	0.0174506008288927	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1876.81288751313	1876.81288751313
"AML-2123"	"2020-07-29-AML2123-c1:TCATTCAGTGGGCTCT"	-2.12468872490581	4.19863603198854	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCATTCAGTGGGCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3207.55293639969	35.7480024217882	0.0111449454243188	4343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3202.28786056054	3202.28786056054
"AML-2123"	"2020-07-29-AML2123-c1:TCCACCAGTATGAGCG"	1.25665845450703	9.57940766895143	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCACCAGTATGAGCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1951.36041639409	34.9157768628088	0.017893043524645	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1947.77084169359	1947.77084169359
"AML-2123"	"2020-07-29-AML2123-c1:TCCACGTAGACTCTAC"	12.2403513389522	-2.54203083431395	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCACGTAGACTCTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1590.57719059057	33.0374925569018	0.0207707571517703	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1580.70833923582	1580.70833923582
"AML-2123"	"2020-07-29-AML2123-c1:TCCAGAAGTCGAGATG"	10.726995130151	-2.63355543529662	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCAGAAGTCGAGATG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1900.75808603263	40.7957089971341	0.021462862263701	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1897.85036419851	1897.85036419851
"AML-2123"	"2020-07-29-AML2123-c1:TCCCACAGTGTTCATG"	10.1362005668575	-1.343705915567	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	72	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0294117647058824	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCCACAGTGTTCATG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1892.38681249216	36.1610379559395	0.0191086926400199	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1881.85379240775	1881.85379240775
"AML-2123"	"2020-07-29-AML2123-c1:TCCGATCCACAATTCG"	12.3893915611202	-2.93314077770384	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCGATCCACAATTCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2063.69102057107	38.1532592180828	0.0184878738327431	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2059.93056784096	2059.93056784096
"AML-2123"	"2020-07-29-AML2123-c1:TCCGATCCAGGGTTGA"	12.2706953483516	-2.39714624797972	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCGATCCAGGGTTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1834.19984498138	49.1306986283567	0.0267859027263495	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1826.69712040405	1826.69712040405
"AML-2123"	"2020-07-29-AML2123-c1:TCCTAATCAGCGTGCT"	-0.905932704836685	10.8113059767517	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCTAATCAGCGTGCT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1994.27284106479	44.2847115567015	0.0222059442644051	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1987.59313213411	1987.59313213411
"AML-2123"	"2020-07-29-AML2123-c1:TCCTCCCTCAAGCCGC"	-2.28011069718059	3.42281792247621	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCTCCCTCAAGCCGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3587.0328262287	19.1176476108136	0.00532965504832399	5800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3580.78405112176	3580.78405112176
"AML-2123"	"2020-07-29-AML2123-c1:TCCTGCATCTACCACC"	-0.48320565643962	11.5314235457214	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCTGCATCTACCACC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2389.56220822471	47.9516187068733	0.0200671146128053	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2377.02494975431	2377.02494975431
"AML-2123"	"2020-07-29-AML2123-c1:TCCTTCTGTATGCTTG"	-8.12038932266887	0.630604780558027	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCCTTCTGTATGCTTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2801.65516235667	43.9980500912735	0.0157043060410988	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2782.70973856877	2782.70973856877
"AML-2123"	"2020-07-29-AML2123-c1:TCGCACTTCTACTGAG"	-0.247877280146438	-6.84249689495238	"2020-07-29-AML2123-c1"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGCACTTCTACTGAG"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2214.07129149658	47.3547212361545	0.021388074276572	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2212.84271472047	2212.84271472047
"AML-2123"	"2020-07-29-AML2123-c1:TCGCTTGCACTCTGCT"	-7.38865266266521	2.40352223003236	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGCTTGCACTCTGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2359.07441235188	43.4146661801792	0.0184032627173031	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2348.59176788332	2348.59176788332
"AML-2123"	"2020-07-29-AML2123-c1:TCGCTTGGTCGACTTA"	-7.69956098023112	3.01969955051271	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGCTTGGTCGACTTA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2589.44434329944	40.7456063396435	0.0157352701729538	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2576.69499055799	2576.69499055799
"AML-2123"	"2020-07-29-AML2123-c1:TCGCTTGGTTAAACCC"	11.8626324134762	-2.83261659061583	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGCTTGGTTAAACCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1825.01533949273	45.9539186528848	0.0251800177557181	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1823.92701490121	1823.92701490121
"AML-2123"	"2020-07-29-AML2123-c1:TCGGATACAGTTTCAG"	-6.48734364929851	2.8435373076233	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	47	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGGATACAGTTTCAG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2495.08694951532	9.9995935166401	0.00400771344605147	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2474.49227097325	2474.49227097325
"AML-2123"	"2020-07-29-AML2123-c1:TCGGGTGAGAGAATCT"	10.7697407203609	-2.42406775867613	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGGGTGAGAGAATCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2153.75890459216	35.48942443241	0.016477900268568	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2147.36636439415	2147.36636439415
"AML-2123"	"2020-07-29-AML2123-c1:TCGGGTGCATCAGCAT"	8.70230736312215	7.70013520801393	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGGGTGCATCAGCAT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2275.55693895581	48.2577177547109	0.0212069919801062	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2270.52645614368	2270.52645614368
"AML-2123"	"2020-07-29-AML2123-c1:TCGTCCAGTCGCACAC"	-1.85391304913219	3.37900493228761	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCGTCCAGTCGCACAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2745.130070822	34.3710476647882	0.0125207355491524	4035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2739.99918368114	2739.99918368114
"AML-2123"	"2020-07-29-AML2123-c1:TCTAACTGTTCCTTGC"	-7.66487107697185	1.78622732246248	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTAACTGTTCCTTGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2348.37913844011	47.9660940622559	0.0204251916894974	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2339.60798576065	2339.60798576065
"AML-2123"	"2020-07-29-AML2123-c1:TCTATACCACTCCTGT"	11.600867887109	-1.58732905304106	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTATACCACTCCTGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1844.40708852947	29.1967084392092	0.01582986132551	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1842.62168594866	1842.62168594866
"AML-2123"	"2020-07-29-AML2123-c1:TCTGTCGAGCCTGCCA"	10.9552723365719	-2.58324649250182	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTGTCGAGCCTGCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1599.25708758937	39.3461604610314	0.0246027738544148	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1595.26319707786	1595.26319707786
"AML-2123"	"2020-07-29-AML2123-c1:TCTTAGTAGGTACAGC"	-7.82563958588298	3.13531181896058	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTTAGTAGGTACAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2273.37471500615	46.0137897907559	0.020240301560067	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2263.40662898795	2263.40662898795
"AML-2123"	"2020-07-29-AML2123-c1:TCTTAGTAGTAATACG"	9.59281029280965	7.84772584522096	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTTAGTAGTAATACG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2082.55435305575	43.8520410447947	0.0210568530806653	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2075.88756120898	2075.88756120898
"AML-2123"	"2020-07-29-AML2123-c1:TCTTGCGTCAGTGGGA"	9.76805271682088	7.42756364429323	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TCTTGCGTCAGTGGGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1960.60007505117	40.583875341572	0.0206997214057094	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1947.9807958179	1947.9807958179
"AML-2123"	"2020-07-29-AML2123-c1:TGAATGCAGATGACCG"	-2.2118104499882	9.15487382495729	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGAATGCAGATGACCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2097.00865920511	49.1648485305859	0.023445229143318	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2091.86510213827	2091.86510213827
"AML-2123"	"2020-07-29-AML2123-c1:TGACGCGAGCGCTGAA"	-1.97028027001079	3.93540308559266	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGACGCGAGCGCTGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2987.61704167928	39.6985427256063	0.0132876945645257	4316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2983.53949751732	2983.53949751732
"AML-2123"	"2020-07-29-AML2123-c1:TGACGCGAGTTTGAGA"	11.1183296638424	-2.36673476612242	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGACGCGAGTTTGAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1140.99333529966	45.6301077684791	0.0399915638039158	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1136.9683643278	1136.9683643278
"AML-2123"	"2020-07-29-AML2123-c1:TGACTCCAGCCATTGT"	12.3618294197017	-2.4639451733795	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGACTCCAGCCATTGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2086.86190429257	40.8616392974923	0.0195804232246714	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2081.19057461284	2081.19057461284
"AML-2123"	"2020-07-29-AML2123-c1:TGAGACTAGTCGGGAT"	-7.56141887131389	3.85920426929323	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGAGACTAGTCGGGAT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2467.88731881405	37.6749917606301	0.0152660907462886	2493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2447.32692263153	2447.32692263153
"AML-2123"	"2020-07-29-AML2123-c1:TGAGCATAGTATGATG"	8.80252708968465	8.17335221851198	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGAGCATAGTATGATG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1909.91098920134	43.0574216152217	0.0225442032946398	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1907.31705035663	1907.31705035663
"AML-2123"	"2020-07-29-AML2123-c1:TGAGCATCACAATGCT"	-2.43023167076762	12.7040033110413	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGAGCATCACAATGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2306.64445541274	50.7520360181083	0.0220025396194088	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2299.99687530341	2299.99687530341
"AML-2123"	"2020-07-29-AML2123-c1:TGAGCATGTCGCAGTC"	12.4043604331905	-2.53519918834838	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGAGCATGTCGCAGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1783.99326287527	44.3650829739735	0.0248684139661324	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1774.07278718695	1774.07278718695
"AML-2123"	"2020-07-29-AML2123-c1:TGATCAGGTGCCGAAA"	10.9948946433956	-2.50478699123534	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGATCAGGTGCCGAAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2331.36614239453	42.3442376438431	0.0181628431818743	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2327.1975490184	2327.1975490184
"AML-2123"	"2020-07-29-AML2123-c1:TGATTCTCACTAGAGG"	11.9917236762935	-2.21498849308165	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGATTCTCACTAGAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1369.41681600595	40.6332982002726	0.0296719725691583	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1367.77708645632	1367.77708645632
"AML-2123"	"2020-07-29-AML2123-c1:TGCAGATAGTTGGAGC"	-1.41947339001353	9.91192910755006	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCAGATAGTTGGAGC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2214.84078407793	45.5686604504435	0.0205742375605633	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2213.04962350434	2213.04962350434
"AML-2123"	"2020-07-29-AML2123-c1:TGCAGGCGTAGGAGGG"	-2.92185554924663	3.841277337912	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCAGGCGTAGGAGGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3418.94827734956	22.8873746024859	0.00669427342733265	5725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3413.39114350372	3413.39114350372
"AML-2123"	"2020-07-29-AML2123-c1:TGCAGGCTCCCTTGGT"	-4.16870580139812	12.0879335173401	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCAGGCTCCCTTGGT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	1584.66700069268	45.3342967776227	0.0286080903797494	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	1580.0941263694	1580.0941263694
"AML-2123"	"2020-07-29-AML2123-c1:TGCAGTATCCTCCACA"	10.9801336723262	-2.90589406406554	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCAGTATCCTCCACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1518.80559624203	30.403120911098	0.0200177830436787	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1517.1532732868	1517.1532732868
"AML-2123"	"2020-07-29-AML2123-c1:TGCATGACAATTCGTG"	12.4158188301021	-2.37890245830687	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCATGACAATTCGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1188.25504573158	45.0937489438785	0.0379495539327717	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1182.76667246296	1182.76667246296
"AML-2123"	"2020-07-29-AML2123-c1:TGCATGAGTACAGAGC"	11.2145754295284	-2.68100764667662	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCATGAGTACAGAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2516.16006251942	37.9397155396697	0.0150784189387701	3598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2510.56555389996	2510.56555389996
"AML-2123"	"2020-07-29-AML2123-c1:TGCATGAGTTGAGGAC"	8.75708927687947	7.11718890750734	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCATGAGTTGAGGAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1732.90581197172	46.0346203797676	0.0265649870072217	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1731.13108384433	1731.13108384433
"AML-2123"	"2020-07-29-AML2123-c1:TGCGACGCAATTGTGC"	12.0885492759639	-2.28223493015441	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCGACGCAATTGTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1383.70163055738	25.7950225793579	0.0186420410366701	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1382.19631813568	1382.19631813568
"AML-2123"	"2020-07-29-AML2123-c1:TGCGACGCACAACGTT"	12.0208527046138	-2.84013535892638	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCGACGCACAACGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1988.3972115202	41.6193796336477	0.0209311194928845	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1983.1355754259	1983.1355754259
"AML-2123"	"2020-07-29-AML2123-c1:TGCGGCATCGCGATCG"	8.90882839736287	7.63828418338624	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCGGCATCGCGATCG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1731.52990779285	33.3874013161128	0.0192820240446618	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1725.23427626648	1725.23427626648
"AML-2123"	"2020-07-29-AML2123-c1:TGCGGGTCAAGGTCGA"	-2.9223350090092	8.93573949420778	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCGGGTCAAGGTCGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2255.89652263837	45.1515268918274	0.0200148927216842	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2251.13599558385	2251.13599558385
"AML-2123"	"2020-07-29-AML2123-c1:TGCGGGTCAGTGACCC"	-2.34759483757671	4.05458710277406	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCGGGTCAGTGACCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3388.3805254648	36.7645593869355	0.0108501861318815	5472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3383.14910281404	3383.14910281404
"AML-2123"	"2020-07-29-AML2123-c1:TGCTGAACAATCAAGA"	10.6986271339351	-2.63994147693785	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCTGAACAATCAAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1720.6663873345	34.2079739795446	0.019880654513474	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1712.16953129822	1712.16953129822
"AML-2123"	"2020-07-29-AML2123-c1:TGCTGAACATACCACA"	11.9596067863399	-2.6630053750244	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCTGAACATACCACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1753.68824900539	11.2911837838692	0.00643853534986794	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1746.16169101591	1746.16169101591
"AML-2123"	"2020-07-29-AML2123-c1:TGCTTCGAGCCTGCCA"	-3.31567702713664	3.66604111278383	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCTTCGAGCCTGCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3434.47274492047	2.45654632386325	0.000715261557249636	4714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3427.79967285589	3427.79967285589
"AML-2123"	"2020-07-29-AML2123-c1:TGCTTCGAGGCGCTCT"	12.299128194421	-2.9834034672943	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCTTCGAGGCGCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2323.9723606522	35.1930221244069	0.0151434770569002	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2312.67853230489	2312.67853230489
"AML-2123"	"2020-07-29-AML2123-c1:TGCTTCGGTATGACAA"	-6.02275500717815	3.84349963748781	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGCTTCGGTATGACAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2341.70408136385	44.7672436580345	0.0191173786706479	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2307.86914174058	2307.86914174058
"AML-2123"	"2020-07-29-AML2123-c1:TGGAGGATCATCGTAG"	-7.65603337708171	2.47372577274171	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGAGGATCATCGTAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2501.54832964465	48.359800207328	0.0193319471921606	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2494.46094305186	2494.46094305186
"AML-2123"	"2020-07-29-AML2123-c1:TGGATCAGTTTACTTC"	-1.82804105702098	3.56340644443361	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGATCAGTTTACTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3179.16759815888	40.8997173826887	0.0128649138870107	4732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3169.44148846122	3169.44148846122
"AML-2123"	"2020-07-29-AML2123-c1:TGGATGTCAAATTAGG"	-3.56484137001689	11.8352117308411	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"Activated NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGATGTCAAATTAGG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2094.33084735328	41.6384080526054	0.019881485346609	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2088.51354811542	2088.51354811542
"AML-2123"	"2020-07-29-AML2123-c1:TGGCGTGAGCACAAAT"	11.5362755256588	-2.07965090191039	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGCGTGAGCACAAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1665.37580308073	40.2092160550286	0.0241442297772351	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1662.71542615574	1662.71542615574
"AML-2123"	"2020-07-29-AML2123-c1:TGGGCGTCAACTGATC"	-7.46052966538127	2.62153313243715	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGGCGTCAACTGATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2382.95344891806	40.5860155418509	0.0170318121658139	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2373.49551759153	2373.49551759153
"AML-2123"	"2020-07-29-AML2123-c1:TGGGCGTGTGTCCTAA"	12.312366147607	-2.24393465435179	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGGCGTGTGTCCTAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1271.91839297498	39.6584722964235	0.0311800446596763	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1270.31107201272	1270.31107201272
"AML-2123"	"2020-07-29-AML2123-c1:TGGGTTAGTATGGTTC"	-2.02554974976237	3.38253424251405	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGGTTAGTATGGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3770.82176741186	41.7893455789114	0.0110822913827598	5034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3761.96016061044	3761.96016061044
"AML-2123"	"2020-07-29-AML2123-c1:TGGTACAGTATAGGAT"	-2.05184350434001	3.41787264430848	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGTACAGTATAGGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2972.40035507496	43.3150052590674	0.014572399436406	4524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2965.5210531211	2965.5210531211
"AML-2123"	"2020-07-29-AML2123-c1:TGGTACAGTGTATACC"	-4.35071692887004	12.462695098761	"2020-07-29-AML2123-c1"	"AML2123"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGTACAGTGTATACC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2291.4130462169	42.9937695882031	0.0187629941529684	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2281.06907712621	2281.06907712621
"AML-2123"	"2020-07-29-AML2123-c1:TGGTGATCAAAGACGC"	-2.07914028587993	3.74572393977968	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGTGATCAAAGACGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3039.49266138005	36.4190354382443	0.0119819455072179	3675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3033.60363145202	3033.60363145202
"AML-2123"	"2020-07-29-AML2123-c1:TGGTGATGTCAATCTG"	-4.89838967743571	-5.67561914837035	"2020-07-29-AML2123-c1"	"AML2123"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00451807228915663	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGTGATGTCAATCTG"	"Granulocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Gran"	"Gran"	1711.64362391585	28.6502144457354	0.0167384226748032	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"Gran_AML-2123"	1711.64362391585	1711.64362391585
"AML-2123"	"2020-07-29-AML2123-c1:TGGTTAGTCCAGGACC"	11.2943788963253	-2.65447904979857	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGGTTAGTCCAGGACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1879.61838596963	28.5710512764456	0.0152004531822596	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1875.86474183633	1875.86474183633
"AML-2123"	"2020-07-29-AML2123-c1:TGTAACGAGAAGGCTC"	-3.89624748650249	9.72397611224977	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTAACGAGAAGGCTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2238.77870675505	43.8577452619466	0.0195900314442043	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2232.89100683076	2232.89100683076
"AML-2123"	"2020-07-29-AML2123-c1:TGTAGACCACTCCGGA"	-3.07372627678569	3.30961916530458	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTAGACCACTCCGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3198.78292218656	28.9139681256039	0.00903905292386626	3743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3192.77660697099	3192.77660697099
"AML-2123"	"2020-07-29-AML2123-c1:TGTAGACTCTCCTGCA"	-5.82361112061198	3.86538693988649	"2020-07-29-AML2123-c1"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTAGACTCTCCTGCA"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2618.18832832061	31.355828385534	0.0119761546739637	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2608.89997145038	2608.89997145038
"AML-2123"	"2020-07-29-AML2123-c1:TGTCAGAGTCAGACTT"	-6.73596082153972	3.90186617458192	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_MEP"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTCAGAGTCAGACTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1538.67439442234	49.4066217815746	0.0321098615539926	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1532.71765672037	1532.71765672037
"AML-2123"	"2020-07-29-AML2123-c1:TGTCAGATCAGAGCAG"	-2.65228019180949	8.92415235126344	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTCAGATCAGAGCAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2299.93695678057	43.9997947828512	0.0191308699367315	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2294.90176929859	2294.90176929859
"AML-2123"	"2020-07-29-AML2123-c1:TGTCCACTCCCAAGTA"	-6.29104743424113	3.07201907718507	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTCCACTCCCAAGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2490.71221038579	48.2615040978038	0.0193765879078935	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2479.32205229606	2479.32205229606
"AML-2123"	"2020-07-29-AML2123-c1:TGTCCTGCAACGAGGT"	9.06109680709187	7.77572057330934	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTCCTGCAACGAGGT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2030.62441534422	33.593774542807	0.0165435687116529	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2024.3069269782	2024.3069269782
"AML-2123"	"2020-07-29-AML2123-c1:TGTCCTGCAGCCGGTT"	0.848882873624009	9.16349027240602	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTCCTGCAGCCGGTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1894.56383655571	44.444706313858	0.0234590703444746	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1889.47138029213	1889.47138029213
"AML-2123"	"2020-07-29-AML2123-c1:TGTGCGGCAATCGCAT"	12.2051683860714	-2.48540832912596	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTGCGGCAATCGCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1517.76606930615	24.9109976772153	0.016412936209994	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1516.79589431246	1516.79589431246
"AML-2123"	"2020-07-29-AML2123-c1:TGTGTGAGTTCTCCAC"	9.04543079909627	8.00415656650392	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Activated NFkB"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTGTGAGTTCTCCAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2108.53133991907	41.3835285094983	0.0196267078065278	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2098.25246374927	2098.25246374927
"AML-2123"	"2020-07-29-AML2123-c1:TGTTCATTCACCACAA"	-7.33688054505046	2.73712275112001	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTTCATTCACCACAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2476.32908299268	49.4725761490623	0.0199781913029403	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2461.30932456787	2461.30932456787
"AML-2123"	"2020-07-29-AML2123-c1:TGTTGAGTCTAGGAAA"	-2.25149093094524	3.44857738101808	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTTGAGTCTAGGAAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2352.42274135992	12.7670207873093	0.0054271796318075	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2346.8980064534	2346.8980064534
"AML-2123"	"2020-07-29-AML2123-c1:TGTTTGTAGATTGAGT"	-2.3995283645695	3.50460980022279	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TGTTTGTAGATTGAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3250.80429065132	40.9062847582323	0.0125834350827796	4673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3243.91290171747	3243.91290171747
"AML-2123"	"2020-07-29-AML2123-c1:TTAATCCCATAGGTAA"	-7.41469846192058	2.56436083400575	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTAATCCCATAGGTAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2687.40123606487	47.4594084753134	0.0176599637740763	2712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2672.36390492047	2672.36390492047
"AML-2123"	"2020-07-29-AML2123-c1:TTACCGCAGTATGACA"	11.4631744819576	-2.45961835300597	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTACCGCAGTATGACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1856.14270851386	39.746175602255	0.0214133188250801	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1849.9506607416	1849.9506607416
"AML-2123"	"2020-07-29-AML2123-c1:TTACGTTGTATTGGCT"	12.1185642677242	-2.47875645076903	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTACGTTGTATTGGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1662.56993323693	29.8476456739086	0.0179527158991724	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1657.60987871761	1657.60987871761
"AML-2123"	"2020-07-29-AML2123-c1:TTAGGCACACCGCTAG"	10.802021642297	-2.27666594898375	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTAGGCACACCGCTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1795.89362857087	21.8115585115199	0.0121452396536854	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1795.89362857087	1795.89362857087
"AML-2123"	"2020-07-29-AML2123-c1:TTAGGCATCGACACTA"	-8.12205062332805	2.7589642771515	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTAGGCATCGACACTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2348.85813352786	46.895972180403	0.0199654340596415	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2338.22834765189	2338.22834765189
"AML-2123"	"2020-07-29-AML2123-c1:TTATTGCCATTCTGTT"	11.0982862907345	-2.73878123676451	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTATTGCCATTCTGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1997.68470900801	42.4251108305183	0.0212371404953013	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1992.35395760331	1992.35395760331
"AML-2123"	"2020-07-29-AML2123-c1:TTATTGCGTTCCACGG"	-2.37195668640788	3.35088965976564	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTATTGCGTTCCACGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3158.44642995061	40.0228772553802	0.0126716973496385	4954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3154.83108132162	3154.83108132162
"AML-2123"	"2020-07-29-AML2123-c1:TTCACCGGTTCGTAAC"	-8.20466266098674	-0.492667161580645	"2020-07-29-AML2123-c1"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCACCGGTTCGTAAC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2991.50228261273	45.9349439903212	0.0153551425507195	3652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2978.7215060733	2978.7215060733
"AML-2123"	"2020-07-29-AML2123-c1:TTCATGTCATTCAGCA"	-7.71282277527507	2.30434701526491	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCATGTCATTCAGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2632.76957961192	43.2210221462361	0.0164165609026093	2761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2627.09241887724	2627.09241887724
"AML-2123"	"2020-07-29-AML2123-c1:TTCATTGCATAGACTC"	12.4525305229122	-2.80974652683409	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCATTGCATAGACTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1605.27163005409	43.6634900362043	0.0272000633529748	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1596.11197268489	1596.11197268489
"AML-2123"	"2020-07-29-AML2123-c1:TTCCAATGTAGTCGGA"	10.9381720024044	-0.668898724671923	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCAATGTAGTCGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1240.31830124594	5.17144164592304	0.00416944718200816	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1235.31969414704	1235.31969414704
"AML-2123"	"2020-07-29-AML2123-c1:TTCCAATTCACTTATC"	11.0098749595577	-2.76514007961424	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCAATTCACTTATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1810.53583318149	37.7380182369547	0.0208435632950943	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1808.11083150961	1808.11083150961
"AML-2123"	"2020-07-29-AML2123-c1:TTCCACGCATTGCTTT"	-7.55438743057902	2.45502421939699	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCACGCATTGCTTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2904.41057580857	40.0185095062239	0.0137785304321456	3338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2892.6145320159	2892.6145320159
"AML-2123"	"2020-07-29-AML2123-c1:TTCCGGTTCTGCGGAC"	-2.12973533096965	9.19490048969118	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCGGTTCTGCGGAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2016.72528055832	42.033289481854	0.0208423476846669	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2008.13033250118	2008.13033250118
"AML-2123"	"2020-07-29-AML2123-c1:TTCCGTGTCACATACG"	11.1883503395015	-2.71785666858824	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCGTGTCACATACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1776.27765287905	12.4230575355982	0.00699387143415473	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1773.10887878883	1773.10887878883
"AML-2123"	"2020-07-29-AML2123-c1:TTCCTCTAGAGGATCC"	12.6447159248287	-2.62699892437132	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCTCTAGAGGATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1389.14456346533	44.8511693005416	0.0322868983402684	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1386.56219690681	1386.56219690681
"AML-2123"	"2020-07-29-AML2123-c1:TTCCTTCAGACGGTTG"	-2.41480026665385	4.1102347143921	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCTTCAGACGGTTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3547.89716197602	31.9123935253924	0.00899473464659797	5857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3544.3781472302	3544.3781472302
"AML-2123"	"2020-07-29-AML2123-c1:TTCCTTCCAATCGCGC"	-2.35617695275005	10.3523883589539	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCTTCCAATCGCGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2327.77301824685	48.3237260016124	0.0207596383422329	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2324.93185867242	2324.93185867242
"AML-2123"	"2020-07-29-AML2123-c1:TTCCTTCCAGACAATA"	11.2066799598629	-1.00960829174193	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCCTTCCAGACAATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1204.59176362872	18.1901639285497	0.0151006876169845	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1200.99672040987	1200.99672040987
"AML-2123"	"2020-07-29-AML2123-c1:TTCGATTCACAACCGC"	12.5055080848629	-2.66671016132506	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCGATTCACAACCGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1620.13451936686	38.0366007288689	0.0234774336786142	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1613.88875494833	1613.88875494833
"AML-2123"	"2020-07-29-AML2123-c1:TTCGCTGAGTCATGCT"	-7.49154506149943	2.44743821704713	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCGCTGAGTCATGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2568.4674982008	42.639356979407	0.0166010887851513	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2560.07864288452	2560.07864288452
"AML-2123"	"2020-07-29-AML2123-c1:TTCGGTCGTACCCAGC"	11.0276867347652	-2.49930169498595	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCGGTCGTACCCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1680.99286928042	47.2427376675556	0.0281040678582882	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1672.22031566563	1672.22031566563
"AML-2123"	"2020-07-29-AML2123-c1:TTCGGTCGTCGCGGTT"	-3.04028878632243	10.0271892317566	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCGGTCGTCGCGGTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1934.12650989524	43.4823631551453	0.022481654086578	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1923.0714111889	1923.0714111889
"AML-2123"	"2020-07-29-AML2123-c1:TTCTAGTGTGGACTAG"	8.81613506850545	7.92287299716798	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCTAGTGTGGACTAG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1883.18811949254	42.0609529745937	0.0223349714981889	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1874.61278203002	1874.61278203002
"AML-2123"	"2020-07-29-AML2123-c1:TTCTGTATCTCCTGAC"	1.54381908950154	11.1432685622009	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTCTGTATCTCCTGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1909.23735457115	36.6268655520551	0.0191840294054388	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1898.25617275795	1898.25617275795
"AML-2123"	"2020-07-29-AML2123-c1:TTGAACGCAGCTCCTT"	-7.52803979340251	2.61214134776918	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGAACGCAGCTCCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2671.04441605403	48.3565854873268	0.0181039990187676	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2661.06111887422	2661.06111887422
"AML-2123"	"2020-07-29-AML2123-c1:TTGAACGTCTTGATTC"	0.520598133176011	11.4755649336609	"2020-07-29-AML2123-c1"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGAACGTCTTGATTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1530.27376709159	28.5732150577381	0.0186719629338245	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1530.27376709159	1530.27376709159
"AML-2123"	"2020-07-29-AML2123-c1:TTGATGGGTCCTGGGT"	0.636235733597916	9.7606687315735	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGATGGGTCCTGGGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1913.02830135001	47.1089883398548	0.0246253483582079	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1910.65555398535	1910.65555398535
"AML-2123"	"2020-07-29-AML2123-c1:TTGCATTTCTGAGCAT"	-2.88537464562114	10.2053336867127	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGCATTTCTGAGCAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1523.72587975132	45.0179680436909	0.0295446632769919	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1519.23987887549	1519.23987887549
"AML-2123"	"2020-07-29-AML2123-c1:TTGCGTCAGGAAAGTG"	-7.6483887237614	2.2695307501587	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGCGTCAGGAAAGTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2747.45940072931	39.5195520937038	0.0143840349681649	2983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2735.81890151566	2735.81890151566
"AML-2123"	"2020-07-29-AML2123-c1:TTGGGTACAGGCGATA"	11.0393673377926	-0.169961296674334	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGGGTACAGGCGATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2560.48960728934	44.796487937738	0.0174952820781654	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2553.54184705728	2553.54184705728
"AML-2123"	"2020-07-29-AML2123-c1:TTGGGTATCTCTCTTC"	-6.96584639969524	2.40395567500917	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGGGTATCTCTCTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2427.41424711793	37.3541546005552	0.0153884548732899	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2415.09645850918	2415.09645850918
"AML-2123"	"2020-07-29-AML2123-c1:TTGGTTTTCATCTCTA"	10.9330564933712	0.0199304067525043	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGGTTTTCATCTCTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1978.31683795508	49.172916688118	0.0248559359879615	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1971.8260683994	1971.8260683994
"AML-2123"	"2020-07-29-AML2123-c1:TTGTGGATCACGTCCT"	-1.57294569435771	10.5436258085999	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGTGGATCACGTCCT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2136.77051159868	39.7660083577745	0.0186103318732261	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2128.18674282938	2128.18674282938
"AML-2123"	"2020-07-29-AML2123-c1:TTGTTCAAGTGTACAA"	12.5629345374996	-2.41328790104064	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGTTCAAGTGTACAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1358.09934343489	29.0150492928257	0.0213644527796038	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1355.92177637267	1355.92177637267
"AML-2123"	"2020-07-29-AML2123-c1:TTGTTGTGTCTAGGTT"	-2.76158652725871	10.895854926947	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGTTGTGTCTAGGTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1785.70601448425	44.590072191971	0.0249705560883434	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1776.12657980418	1776.12657980418
"AML-2123"	"2020-07-29-AML2123-c1:TTGTTTGGTGTTATCG"	-7.66628680649455	2.3495940932068	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTGTTTGGTGTTATCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2611.43130069612	41.1737035268205	0.0157667190080187	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2603.52791808818	2603.52791808818
"AML-2123"	"2020-07-29-AML2123-c1:TTTACCAGTACCCACG"	9.71210636672322	7.92459342563478	"2020-07-29-AML2123-c1"	"AML2123"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTACCAGTACCCACG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2673.84941340606	43.394858093189	0.016229357523134	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2664.54084654333	2664.54084654333
"AML-2123"	"2020-07-29-AML2123-c1:TTTAGTCGTACCTGTA"	-7.93424878540691	2.54737017238466	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTAGTCGTACCTGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2247.93423313093	41.3960299030483	0.0184151427977463	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2239.72832859597	2239.72832859597
"AML-2123"	"2020-07-29-AML2123-c1:TTTAGTCGTCTCTCTG"	-7.67492900314982	2.72706554019777	"2020-07-29-AML2123-c1"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTAGTCGTCTCTCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2830.84709659582	47.148463888815	0.0166552492169261	2797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2823.50474983252	2823.50474983252
"AML-2123"	"2020-07-29-AML2123-c1:TTTCACAAGGCTCACC"	10.9043623405391	0.0121442147525921	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-3"	55	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.105263157894737	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTCACAAGGCTCACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1657.2891395288	43.6803005267957	0.0263564754543765	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1646.57716422701	1646.57716422701
"AML-2123"	"2020-07-29-AML2123-c1:TTTCATGTCCTGCTAC"	11.0659948783809	-2.5161342850891	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTCATGTCCTGCTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1615.88790636765	30.7551932766633	0.019032999229382	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1612.67300782192	1612.67300782192
"AML-2123"	"2020-07-29-AML2123-c1:TTTGGAGCAATCAAGA"	-2.24243174019511	3.42798206889955	"2020-07-29-AML2123-c1"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTGGAGCAATCAAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3098.26141223571	18.2970423170576	0.00590558377185302	5745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3091.37690666993	3091.37690666993
"AML-2123"	"2020-07-29-AML2123-c1:TTTGGAGCACCCTGTT"	-7.57683072510417	2.73267314517824	"2020-07-29-AML2123-c1"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTGGAGCACCCTGTT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2397.20033958223	45.6239961067968	0.0190321999181545	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2386.40721495979	2386.40721495979
"AML-2123"	"2020-07-29-AML2123-c1:TTTGGTTCACGTTCGG"	-2.15658030930217	9.61751172626344	"2020-07-29-AML2123-c1"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613772"	"2020-07-29"	"2020.07.29.AML2123.c1.TTTGGTTCACGTTCGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1992.41457189467	43.8990537886143	0.0220330921123855	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1983.10298815399	1983.10298815399
"AML-2123"	"2020-07-29-AML2123-c2:GAGTGAGTCGGTCATA"	-3.60169873657878	10.3562974699768	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTGAGTCGGTCATA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2070.0101818745	41.2015889579289	0.0199040513513894	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2065.36707829911	2065.36707829911
"AML-2123"	"2020-07-29-AML2123-c2:GAGTGTTCACGTATAC"	-2.90459523621257	3.39780709827272	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTGTTCACGTATAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3293.68385044649	0	0	4672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3288.0308586861	3288.0308586861
"AML-2123"	"2020-07-29-AML2123-c2:GAGTTACAGCAAGGAA"	-2.94493565979655	3.53265831554262	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTTACAGCAAGGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2843.32748745945	46.3292543683875	0.0162940268304385	4895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2840.06350034364	2840.06350034364
"AML-2123"	"2020-07-29-AML2123-c2:GAGTTGTAGAGTCAGC"	-1.84965095940288	3.87160656535951	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTTGTAGAGTCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3221.10882688537	42.5350021449017	0.0132050807442078	4477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3213.10356026058	3213.10356026058
"AML-2123"	"2020-07-29-AML2123-c2:GAGTTTGGTTACGCCG"	10.8311087089473	-0.565773271676622	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTTTGGTTACGCCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1131.7303473341	30.6429893233378	0.0270762283573293	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1128.2305943869	1128.2305943869
"AML-2123"	"2020-07-29-AML2123-c2:GATAGCTAGGACGGAG"	-3.33969984474834	10.0739145048889	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATAGCTAGGACGGAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2040.66034623375	48.454354641582	0.0237444485707823	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2035.51047113547	2035.51047113547
"AML-2123"	"2020-07-29-AML2123-c2:GATAGCTCAACCGCTG"	-7.34810338440593	2.63320753658143	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATAGCTCAACCGCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2440.78692243187	46.5340533400645	0.0190651846387723	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2428.15352818945	2428.15352818945
"AML-2123"	"2020-07-29-AML2123-c2:GATCATGCACAATGTC"	10.8006073432857	-2.45011618053588	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATCATGCACAATGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2377.72647585762	35.5084486722825	0.0149337819269035	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2373.4942326294	2373.4942326294
"AML-2123"	"2020-07-29-AML2123-c2:GATCGTACAAGACAAT"	11.4298721748287	-2.29330065166625	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATCGTACAAGACAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1587.34045574713	30.7058584848847	0.0193442171612971	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1581.57328769809	1581.57328769809
"AML-2123"	"2020-07-29-AML2123-c2:GATGAGGCAAACACCT"	12.5227934318477	-2.69184877788695	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATGAGGCAAACACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2536.04491441035	34.7780357822107	0.0137134936312028	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2533.6837894141	2533.6837894141
"AML-2123"	"2020-07-29-AML2123-c2:GATGATCAGAATCGCG"	-7.47212586823161	2.90989134395448	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATGATCAGAATCGCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1975.70523464311	44.4312458147318	0.0224888030034287	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1967.81742252277	1967.81742252277
"AML-2123"	"2020-07-29-AML2123-c2:GATTGGTAGAGTGGCT"	12.4124609428341	-2.36197569286498	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATTGGTAGAGTGGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1540.10412774535	38.6800479175819	0.0251152160563377	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1532.57864542599	1532.57864542599
"AML-2123"	"2020-07-29-AML2123-c2:GATTTCTCAGCTCATA"	-7.7318848175114	2.23045823657838	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GATTTCTCAGCTCATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2602.33742937107	45.6837593445441	0.017554894622403	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2592.64426395886	2592.64426395886
"AML-2123"	"2020-07-29-AML2123-c2:GCAACATAGGGAGTGG"	12.1377159553463	-3.21186497127684	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCAACATAGGGAGTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2092.28181879555	28.8729167124795	0.0137997264293491	2879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2086.22197668867	2086.22197668867
"AML-2123"	"2020-07-29-AML2123-c2:GCAACCGCAATTGCTG"	-7.64064488831218	0.707834101560987	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCAACCGCAATTGCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2938.93192265322	43.2324975845319	0.0147102752708549	4332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2926.79284711027	2926.79284711027
"AML-2123"	"2020-07-29-AML2123-c2:AACACACCAACGTATC"	-4.67555270615275	3.92495796764223	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACACACCAACGTATC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3047.33652600144	44.2135784550565	0.0145089254428592	3341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3039.39392391954	3039.39392391954
"AML-2123"	"2020-07-29-AML2123-c2:AACACACGTCGAGATG"	-3.61934719505962	10.3276576765808	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACACACGTCGAGATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1952.72288794309	35.283006934515	0.0180686195426738	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1951.01637347309	1951.01637347309
"AML-2123"	"2020-07-29-AML2123-c2:AACACACGTCGGTAAG"	-2.84718952599223	8.83561227405397	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACACACGTCGGTAAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2223.03926374818	45.4069487953237	0.0204256170980826	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2220.04110995629	2220.04110995629
"AML-2123"	"2020-07-29-AML2123-c2:AACAGGGGTGCATGTT"	-7.35981212082561	1.83477578246919	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAGGGGTGCATGTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2548.49426271299	47.891160840602	0.018791943753336	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2537.52198203177	2537.52198203177
"AML-2123"	"2020-07-29-AML2123-c2:AACAGGGTCACATTGG"	-3.2518302005833	10.4229497679505	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAGGGTCACATTGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1964.75556392156	41.1014707058747	0.0209193812505807	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1959.98199301386	1959.98199301386
"AML-2123"	"2020-07-29-AML2123-c2:AACAGGGTCTCTATGT"	11.3772999244625	-2.54174950039061	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACAGGGTCTCTATGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1652.25786462979	32.4244814860924	0.0196243468893142	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1646.02562135943	1646.02562135943
"AML-2123"	"2020-07-29-AML2123-c2:AACCAACCACAAGGTG"	-7.55283914032634	2.49758718097535	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACCAACCACAAGGTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2666.81442270321	49.3750135697221	0.018514604221944	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2652.81243257437	2652.81243257437
"AML-2123"	"2020-07-29-AML2123-c2:AACGTCACAAGTATAG"	-3.57300768318828	10.1236600645813	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AACGTCACAAGTATAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2148.39658289619	42.8282316937351	0.0199349747782598	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2146.92790392697	2146.92790392697
"AML-2123"	"2020-07-29-AML2123-c2:AAGACAACACCAATTG"	-2.14423308792766	4.09177825534669	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGACAACACCAATTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2448.14061373147	43.4193230201487	0.017735632821339	3125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2446.28873901162	2446.28873901162
"AML-2123"	"2020-07-29-AML2123-c2:AAGCATCCAACTTGGT"	-3.27649817887004	10.1448402174744	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGCATCCAACTTGGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2038.47394997539	47.4607476306029	0.0232824891537985	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2035.32234473679	2035.32234473679
"AML-2123"	"2020-07-29-AML2123-c2:AAGCGAGAGCTGGCCT"	-7.62361703339274	2.65045688236085	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGCGAGAGCTGGCCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2418.13378738585	44.568385845546	0.018430901581226	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2407.50882874124	2407.50882874124
"AML-2123"	"2020-07-29-AML2123-c2:AAGCGAGCAGGGAATC"	12.0259987312252	-2.59929706966551	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGCGAGCAGGGAATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1753.29285752799	40.501680537322	0.0231003510699441	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1740.74020993679	1740.74020993679
"AML-2123"	"2020-07-29-AML2123-c2:AAGCGAGGTGGTCAAG"	-7.581610540778	2.49401972377626	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGCGAGGTGGTCAAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2369.63485418515	43.7946328077438	0.0184815954788965	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2360.58160699898	2360.58160699898
"AML-2123"	"2020-07-29-AML2123-c2:AAGGAATAGTCAACAA"	-3.10894880715068	3.23297855937806	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGGAATAGTCAACAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3582.88954646793	23.8909198889412	0.00666805927983274	5358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3577.0856940449	3577.0856940449
"AML-2123"	"2020-07-29-AML2123-c2:AAGTACCAGATGAACT"	-3.07097826424297	-11.3065138093201	"2020-07-29-AML2123-c2"	"AML2123"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0192307692307692	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGTACCAGATGAACT"	"Granulocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Gran"	"Gran"	2209.45973705052	51.1526206808731	0.0231516419254412	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"Gran_AML-2123"	2209.45973705052	2209.45973705052
"AML-2123"	"2020-07-29-AML2123-c2:AAGTCGTGTAACTGCT"	-9.60279403153117	4.11425540531007	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGTCGTGTAACTGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1904.09155731301	41.3019123798719	0.0216911378138537	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1896.28351831709	1896.28351831709
"AML-2123"	"2020-07-29-AML2123-c2:AAGTGAAGTGTATCCA"	-2.77491317215617	3.28689763629762	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGTGAAGTGTATCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3251.30202713161	16.8791931037945	0.00519151803275741	3743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3244.23385558071	3244.23385558071
"AML-2123"	"2020-07-29-AML2123-c2:AAGTTCGAGGTGCATG"	-3.71810923042949	9.59563062274782	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AAGTTCGAGGTGCATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1811.9897948541	44.9071290201371	0.0247833233651037	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1803.02038221513	1803.02038221513
"AML-2123"	"2020-07-29-AML2123-c2:AATGACCGTTGCTCAA"	-4.13799939575847	11.2864408263001	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AATGACCGTTGCTCAA"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2316.01063082088	45.5106379444261	0.0196504443195476	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2310.64306121176	2310.64306121176
"AML-2123"	"2020-07-29-AML2123-c2:AATGACCTCCTAGAGT"	-1.92548201504405	3.90740845287172	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AATGACCTCCTAGAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2890.5007204945	38.9154728364839	0.0134632289002946	4166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2886.30297136873	2886.30297136873
"AML-2123"	"2020-07-29-AML2123-c2:AATTCCTGTTCCACGG"	-7.66754470291789	2.36465070331422	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AATTCCTGTTCCACGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2292.19305754326	45.2066993991911	0.0197220296302803	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2284.92619598283	2284.92619598283
"AML-2123"	"2020-07-29-AML2123-c2:AATTTCCGTGTAAATG"	12.480485578149	-2.87715008175048	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AATTTCCGTGTAAATG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1794.72268646958	39.7645026453572	0.0221563492483501	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1788.70629531716	1788.70629531716
"AML-2123"	"2020-07-29-AML2123-c2:AATTTCCTCCGAAGGA"	-0.856420854956466	11.5425920256409	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AATTTCCTCCGAAGGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2055.99354254106	43.1533447529303	0.0209890468330926	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2054.57837086638	2054.57837086638
"AML-2123"	"2020-07-29-AML2123-c2:ACAACCAAGCTGTACT"	12.2570702033931	-2.42880895054015	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAACCAAGCTGTACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1518.58715492426	37.2598521588102	0.0245358668009203	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1510.69372521666	1510.69372521666
"AML-2123"	"2020-07-29-AML2123-c2:ACAACCAGTGGCTTAT"	10.876460691064	-1.14774265205535	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAACCAGTGGCTTAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2030.27387777262	26.6240338905035	0.0131135184183684	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2018.53641617554	2018.53641617554
"AML-2123"	"2020-07-29-AML2123-c2:ACAAGCTGTAAGATTG"	-7.60728488388713	2.80620167339174	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAAGCTGTAAGATTG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2279.51160930827	50.3149050919743	0.0220726689377303	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2268.35761273384	2268.35761273384
"AML-2123"	"2020-07-29-AML2123-c2:ACAAGCTGTCTGTCCT"	-1.06978474083598	11.3334626921448	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAAGCTGTCTGTCCT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2064.2217556695	33.1718618520831	0.0160699119467057	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2059.87206919	2059.87206919
"AML-2123"	"2020-07-29-AML2123-c2:ACACAGTTCGACATTG"	-3.00561390343364	10.0597800978455	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACAGTTCGACATTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1850.76262056643	47.6732427362393	0.0257587019569526	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1849.19960996971	1849.19960996971
"AML-2123"	"2020-07-29-AML2123-c2:ACACCAATCTGGTGGC"	-7.31493792954143	0.177817768696226	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACCAATCTGGTGGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2377.74965587614	45.2394170455522	0.0190261480781847	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2367.98559306913	2367.98559306913
"AML-2123"	"2020-07-29-AML2123-c2:ACACGCGCAACGACAG"	-7.50515590134318	2.60389349544374	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACGCGCAACGACAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2506.11470911962	48.1578782790962	0.0192161508425182	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2494.39529162286	2494.39529162286
"AML-2123"	"2020-07-29-AML2123-c2:ACACGCGGTTAGAGAT"	11.5697914558345	-2.10934975063475	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACGCGGTTAGAGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1414.52945216322	33.0017297710596	0.0233305356212912	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1412.87067038655	1412.87067038655
"AML-2123"	"2020-07-29-AML2123-c2:ACACTGAGTGCCGAAA"	-6.87303147736247	2.65995690906373	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACTGAGTGCCGAAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2418.82616988188	44.884741246307	0.0185564145969609	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2408.83816461074	2408.83816461074
"AML-2123"	"2020-07-29-AML2123-c2:ACACTGATCCGCGATG"	-2.98297272148784	9.68231389606325	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACTGATCCGCGATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1662.1484184204	45.3268822683071	0.0272700570935675	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1658.09014717017	1658.09014717017
"AML-2123"	"2020-07-29-AML2123-c2:ACACTGATCGTACACA"	-7.47806964340861	2.515837884787	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACACTGATCGTACACA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2582.05326183956	44.0709761991334	0.017068190207562	2874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2571.90926640635	2571.90926640635
"AML-2123"	"2020-07-29-AML2123-c2:ACAGAAAAGACAACTA"	-7.82293734970744	2.58226821506349	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAGAAAAGACAACTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2548.11773423152	46.1102366567419	0.0180958030460269	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2539.26349494094	2539.26349494094
"AML-2123"	"2020-07-29-AML2123-c2:ACAGGGATCTCCACTG"	10.8688608604366	-2.2763550511566	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAGGGATCTCCACTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1671.99771377999	33.8434392251548	0.0202413190797031	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1665.53284482842	1665.53284482842
"AML-2123"	"2020-07-29-AML2123-c2:ACAGGGATCTGTCAGA"	-2.48398981514629	4.15780208194581	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACAGGGATCTGTCAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3074.65634921091	46.6986363031621	0.0151882457742463	5326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3067.17642676508	3067.17642676508
"AML-2123"	"2020-07-29-AML2123-c2:ACATGCATCTCCGAAA"	1.71176018294637	-9.91146471416625	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACATGCATCTCCGAAA"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2362.75678669375	31.018890384202	0.0131282621042038	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2361.62984729648	2361.62984729648
"AML-2123"	"2020-07-29-AML2123-c2:ACATTTCCACGCGCTA"	-7.54633412781413	1.32350931251375	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACATTTCCACGCGCTA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2607.71561125483	47.7875052430759	0.018325428216492	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2602.68286971573	2602.68286971573
"AML-2123"	"2020-07-29-AML2123-c2:ACCAACAAGCAACAGC"	11.5078922706539	-1.97647693073424	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCAACAAGCAACAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1463.34572699167	29.2133991814285	0.0199634294497755	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1460.34092189964	1460.34092189964
"AML-2123"	"2020-07-29-AML2123-c2:ACCACAACATACCATG"	-8.91815982285197	3.3778824576172	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	16	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCACAACATACCATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1692.04558424782	41.6934658873627	0.0246408644515905	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1682.80235747526	1682.80235747526
"AML-2123"	"2020-07-29-AML2123-c2:ACCCAAAGTGTTGATC"	10.6658894020015	-0.71111580049666	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCCAAAGTGTTGATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1392.14197217326	46.5503539168707	0.0334379358192911	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1387.222856131	1387.222856131
"AML-2123"	"2020-07-29-AML2123-c2:ACCGTTCGTACCTGTA"	11.3219114738399	-2.57633902942809	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCGTTCGTACCTGTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1486.7335163147	39.9926289309394	0.0268996619044903	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1485.0894914419	1485.0894914419
"AML-2123"	"2020-07-29-AML2123-c2:ACCGTTCTCTGTCCCA"	12.4393297630245	-2.65105798160704	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCGTTCTCTGTCCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2445.45515632087	39.1649806266713	0.0160154155865177	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2436.76412656565	2436.76412656565
"AML-2123"	"2020-07-29-AML2123-c2:ACCTGTCAGGGCTAAC"	-1.97981796684917	3.56090853298036	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACCTGTCAGGGCTAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2920.65460610986	40.5318948809534	0.0138776748185707	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2915.83089153801	2915.83089153801
"AML-2123"	"2020-07-29-AML2123-c2:ACGATCAAGTTACTCG"	12.1469484764034	-2.13049390232237	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGATCAAGTTACTCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1370.38434809803	37.5698682782415	0.0274155701868495	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1363.97693913951	1363.97693913951
"AML-2123"	"2020-07-29-AML2123-c2:ACGATGTAGGTATTGA"	11.5536142784053	-2.22279717838439	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGATGTAGGTATTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1658.71750920413	39.2877137780617	0.0236855965889649	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1658.71750920413	1658.71750920413
"AML-2123"	"2020-07-29-AML2123-c2:ACGCACGCAGTCAGCC"	-7.58480058136638	2.46206281268922	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGCACGCAGTCAGCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2493.0410682822	41.2709517031184	0.0165544612273698	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2485.21977012386	2485.21977012386
"AML-2123"	"2020-07-29-AML2123-c2:ACGGTCGGTTGCCAAT"	12.2969719367916	-2.22377946293028	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGGTCGGTTGCCAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1328.76408744673	19.4625105895015	0.0146470775161447	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1328.76408744673	1328.76408744673
"AML-2123"	"2020-07-29-AML2123-c2:ACGTAACGTCGCAGTC"	10.9386240440303	-2.6016896001068	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTAACGTCGCAGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1726.84653149143	22.2344184529679	0.0128757350740165	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1714.95726865697	1714.95726865697
"AML-2123"	"2020-07-29-AML2123-c2:ACGTAGTGTACCCGCA"	-7.59356294098552	2.61262772167055	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTAGTGTACCCGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2368.74268011313	47.3867504250754	0.0200050224209294	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2357.67152813686	2357.67152813686
"AML-2123"	"2020-07-29-AML2123-c2:ACGTAGTTCACGGGAA"	-7.68266234818156	2.67689750278322	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTAGTTCACGGGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2085.31256684156	47.1566526346764	0.0226137095150683	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2075.85758759165	2075.85758759165
"AML-2123"	"2020-07-29-AML2123-c2:ACGTCCTGTGGCCTCA"	10.8868366676265	-2.4570100537506	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTCCTGTGGCCTCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1694.76428295106	42.7183298180234	0.02520605977348	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1689.08639652395	1689.08639652395
"AML-2123"	"2020-07-29-AML2123-c2:ACGTCCTTCCCATACC"	10.6068531471187	-1.20378746902617	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTCCTTCCCATACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2362.16135535581	35.1243075948059	0.0148695632138623	2524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2355.45740585448	2355.45740585448
"AML-2123"	"2020-07-29-AML2123-c2:ACGTTCCTCTCGACGG"	11.163196225732	-2.4527364007202	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACGTTCCTCTCGACGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1685.25475602701	30.4316889872167	0.0180576194064329	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1682.4680453563	1682.4680453563
"AML-2123"	"2020-07-29-AML2123-c2:ACTACGAGTTGCAACT"	-0.336171190172988	11.2755336531433	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTACGAGTTGCAACT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2168.12542644305	42.3984556318319	0.0195553518789682	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2161.4990110507	2161.4990110507
"AML-2123"	"2020-07-29-AML2123-c2:ACTACGAGTTGCTGAT"	-7.64575944367107	2.61639592731325	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTACGAGTTGCTGAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2447.02141627653	47.1764647518751	0.0192791384816159	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2440.3113809771	2440.3113809771
"AML-2123"	"2020-07-29-AML2123-c2:ACTACGATCGTTCCCA"	-7.76196608963664	2.53298399532167	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTACGATCGTTCCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2498.94853409923	39.7404803341986	0.0159028806683781	2745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2489.51604029763	2489.51604029763
"AML-2123"	"2020-07-29-AML2123-c2:ACTCCCAAGTTGTCAC"	1.07479216632192	9.95015237415162	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTCCCAAGTTGTCAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2157.05960959631	47.8685988916086	0.0221915976167979	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2144.03772778448	2144.03772778448
"AML-2123"	"2020-07-29-AML2123-c2:ACTGCAAAGCCTGCCA"	1.43108918246571	10.8020515211853	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTGCAAAGCCTGCCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1879.11640589828	38.1382590495527	0.0202958469894904	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1876.43271432355	1876.43271432355
"AML-2123"	"2020-07-29-AML2123-c2:ACTGCAAGTCAAGGCA"	10.888519902795	-2.33830358898314	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTGCAAGTCAAGGCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1561.60643958766	24.4641606848419	0.0156660219019728	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1553.75759055205	1553.75759055205
"AML-2123"	"2020-07-29-AML2123-c2:ACTGTCCCATCATCTT"	0.60195549306218	11.7091760405335	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTGTCCCATCATCTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2366.15935130263	34.4866440582189	0.0145749456980711	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2359.13081374985	2359.13081374985
"AML-2123"	"2020-07-29-AML2123-c2:ACTGTGACAGCGTTGC"	8.9440561729366	7.58348367297975	"2020-07-29-AML2123-c2"	"AML2123"	"Plasmablast"	"Plasmablast"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTGTGACAGCGTTGC"	"Plasmablast"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"Plasma"	1932.03126818706	40.7640799838496	0.02109907880637	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1927.64294286122	1927.64294286122
"AML-2123"	"2020-07-29-AML2123-c2:ACTGTGATCTTCCAGC"	12.5540453391964	-2.67349603092345	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTGTGATCTTCCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1826.4956626721	38.2863706005853	0.020961654266714	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1822.40046339546	1822.40046339546
"AML-2123"	"2020-07-29-AML2123-c2:ACTTATCAGCCAAGTG"	-1.27265487137492	10.8497848280701	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTATCAGCCAAGTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2113.51171752683	36.5646282817395	0.0173004142719049	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2107.57851932464	2107.57851932464
"AML-2123"	"2020-07-29-AML2123-c2:ACTTATCAGCGACATG"	-2.36913476410564	3.58613464916078	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTATCAGCGACATG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2941.621270416	33.3333471290857	0.0113316243203435	3806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2937.24200307587	2937.24200307587
"AML-2123"	"2020-07-29-AML2123-c2:ACTTATCAGCTCATAC"	1.08817746218984	10.080596900824	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTATCAGCTCATAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2169.72095381401	32.9361803609344	0.0151799153264562	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2161.09670460075	2161.09670460075
"AML-2123"	"2020-07-29-AML2123-c2:ACTTATCAGTTTCGGT"	0.438330044119996	11.6394538649353	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTATCAGTTTCGGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1979.47455406074	34.8937523319185	0.0176277852424709	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1968.78893758818	1968.78893758818
"AML-2123"	"2020-07-29-AML2123-c2:ACTTATCTCGTGCATA"	-4.93825517121013	-4.51214172756346	"2020-07-29-AML2123-c2"	"AML2123"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00451807228915663	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTATCTCGTGCATA"	"Granulocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Gran"	"Gran"	3051.73943528567	44.3900152163996	0.0145458077787183	3037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"Gran_AML-2123"	3046.31871457204	3046.31871457204
"AML-2123"	"2020-07-29-AML2123-c2:ACTTCCGAGAATCGTA"	-2.1719745201176	3.67383859241334	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTCCGAGAATCGTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3163.61006055413	31.688923213634	0.0100166969402302	5098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3159.74372281394	3159.74372281394
"AML-2123"	"2020-07-29-AML2123-c2:ACTTCCGGTACTTCCC"	-5.50453982773479	2.22024843776552	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.833333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTCCGGTACTTCCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1739.48489219992	38.3625661844448	0.0220539806677641	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1734.95424325134	1734.95424325134
"AML-2123"	"2020-07-29-AML2123-c2:ACTTTCAGTGTCCTAA"	-6.78477178040202	2.9208078154358	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTTCAGTGTCCTAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2135.81205969152	47.3384227605197	0.0221641330966906	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2130.80752472616	2130.80752472616
"AML-2123"	"2020-07-29-AML2123-c2:ACTTTGTGTTAGGGAC"	12.5323864417965	-2.47822382366332	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ACTTTGTGTTAGGGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1545.30603837323	31.9764597191777	0.0206926388204889	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1540.79386564097	1540.79386564097
"AML-2123"	"2020-07-29-AML2123-c2:AGAAATGAGGCTCTCG"	1.26335134085957	11.2813091048035	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAATGAGGCTCTCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1898.31180883706	37.9334975093586	0.0199827537988068	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1898.31180883706	1898.31180883706
"AML-2123"	"2020-07-29-AML2123-c2:AGAACAAAGGATCATA"	-2.22609863701518	4.02639458263246	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAACAAAGGATCATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3282.10838030967	36.7068711627736	0.0111839302391685	5660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3275.73347198042	3275.73347198042
"AML-2123"	"2020-07-29-AML2123-c2:AGAACCTAGTGCCCGT"	-3.00058541718181	8.96204755390016	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAACCTAGTGCCCGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2589.02314265826	50.3951991114643	0.0194649473313404	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2582.96047628819	2582.96047628819
"AML-2123"	"2020-07-29-AML2123-c2:AGAAGCGAGGCCTTCG"	-7.5568450492924	2.56309411609498	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAGCGAGGCCTTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2523.6554466396	51.0613322580188	0.020233083849069	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2504.86493250186	2504.86493250186
"AML-2123"	"2020-07-29-AML2123-c2:AGAAGCGCAAACCATC"	-7.73187575760539	1.58094904506532	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAGCGCAAACCATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2358.77709573899	42.5646182033126	0.0180452058315317	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2348.82404259075	2348.82404259075
"AML-2123"	"2020-07-29-AML2123-c2:AGAAGCGCAATCTGCA"	-7.73849616470988	2.56768772685853	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAGCGCAATCTGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2342.2452281054	48.3813386067244	0.0206559663463843	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2335.93062355147	2335.93062355147
"AML-2123"	"2020-07-29-AML2123-c2:AGAAGTAGTTAAACAG"	-2.58335195007976	3.95294473255006	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAGTAGTTAAACAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3107.39486353506	46.6125740978574	0.0150005313598381	4831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3102.20855901217	3102.20855901217
"AML-2123"	"2020-07-29-AML2123-c2:AGAAGTATCCATGCAA"	12.4962297874386	-2.37241580402526	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAAGTATCCATGCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1550.91316100378	40.4952474187871	0.0261105833885489	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1546.85548662906	1546.85548662906
"AML-2123"	"2020-07-29-AML2123-c2:AGACAAATCATTACTC"	12.2818438011104	-2.40612389957579	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGACAAATCATTACTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1543.74762596996	40.2412463230935	0.0260672441830051	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1537.253454495	1537.253454495
"AML-2123"	"2020-07-29-AML2123-c2:AGACACTCACCCTTAC"	-7.59811864319499	2.35929343784181	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGACACTCACCCTTAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2702.22776837487	25.4159595352892	0.00940555782630212	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2690.56607592087	2690.56607592087
"AML-2123"	"2020-07-29-AML2123-c2:AGACACTTCGAAGAAT"	10.7764040428096	-2.49113752758177	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGACACTTCGAAGAAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1734.85608038182	39.9622330116383	0.0230348980895539	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1727.98622600997	1727.98622600997
"AML-2123"	"2020-07-29-AML2123-c2:AGACCATCACACCTTC"	0.796169002621812	11.7735595473084	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGACCATCACACCTTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2070.13847961647	42.4192837136571	0.0204910367742722	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2068.87434250556	2068.87434250556
"AML-2123"	"2020-07-29-AML2123-c2:AGAGAATCATCTGTTT"	-1.70589576187785	3.36907122218934	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAGAATCATCTGTTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2657.31487006498	33.8754872972622	0.0127480140493979	3824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2652.01012805288	2652.01012805288
"AML-2123"	"2020-07-29-AML2123-c2:AGAGAGCTCAGTCCGG"	-3.7039979499882	10.9358443983826	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAGAGCTCAGTCCGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1936.29878162892	42.0292481548599	0.0217059725253262	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1929.59189943973	1929.59189943973
"AML-2123"	"2020-07-29-AML2123-c2:AGAGCAGTCTGTCCCA"	-7.47517619553264	2.35500118816224	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGAGCAGTCTGTCCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2219.33418578853	47.8889391216556	0.0215780658128512	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2212.88336502062	2212.88336502062
"AML-2123"	"2020-07-29-AML2123-c2:AGATAGATCCAGCCTT"	-7.58974204483684	2.66977975452272	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGATAGATCCAGCCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2309.43566706713	46.7438076948224	0.0202403593056934	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2296.2908134662	2296.2908134662
"AML-2123"	"2020-07-29-AML2123-c2:AGATCCATCGAAGTGG"	-1.53279982033427	3.68310139263002	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGATCCATCGAAGTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2584.00077439401	40.1644960199741	0.015543530953234	3670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2578.6659364402	2578.6659364402
"AML-2123"	"2020-07-29-AML2123-c2:AGATGAAAGTGCAACG"	-1.61896810951884	3.65893385494081	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGATGAAAGTGCAACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3303.63784011498	46.5895430951023	0.0141024971107247	5462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3292.92345921016	3292.92345921016
"AML-2123"	"2020-07-29-AML2123-c2:AGATGAAGTATGACAA"	-3.2392877143925	9.43369290912477	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGATGAAGTATGACAA"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2783.21996036406	42.1080937404691	0.0151292726913905	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2777.91505797307	2777.91505797307
"AML-2123"	"2020-07-29-AML2123-c2:AGCATCAAGACCATAA"	11.5101353126461	-1.93652644073638	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCATCAAGACCATAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1413.90815060235	9.05922531571338	0.00640722334888159	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1406.39463484035	1406.39463484035
"AML-2123"	"2020-07-29-AML2123-c2:AGCCAATAGCAGGGAG"	2.26806463774983	-10.12930967724	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCCAATAGCAGGGAG"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2145.08880086946	43.391839916683	0.0202284585603613	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2139.77978100729	2139.77978100729
"AML-2123"	"2020-07-29-AML2123-c2:AGCCACGAGTAGACCG"	0.688404520123643	10.7990321882996	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCCACGAGTAGACCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2227.44198294853	39.9610723033601	0.01794034260343	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2219.65861233806	2219.65861233806
"AML-2123"	"2020-07-29-AML2123-c2:AGCCAGCTCCACGTAA"	-7.46727834168132	0.874781406763472	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCCAGCTCCACGTAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3063.76124146476	47.7306427395721	0.0155790999943431	2983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3049.54485280275	3049.54485280275
"AML-2123"	"2020-07-29-AML2123-c2:AGCGCTGTCAAAGGTA"	11.313270230859	-2.54264333164366	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCGCTGTCAAAGGTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2539.4722775394	46.2726377646622	0.0182213596793022	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2535.08933525902	2535.08933525902
"AML-2123"	"2020-07-29-AML2123-c2:AGCGTATTCGTTCCCA"	-1.02516184273418	10.9004878767761	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGCGTATTCGTTCCCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2070.83012363562	45.6145050708937	0.0220271593262374	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2062.84577772569	2062.84577772569
"AML-2123"	"2020-07-29-AML2123-c2:AGGACTTTCTACGGTA"	-7.45233521881755	0.162387467268385	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGACTTTCTACGGTA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3052.37114482375	39.652374822707	0.0129906793575709	3200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3041.36642798738	3041.36642798738
"AML-2123"	"2020-07-29-AML2123-c2:AGGAGGTAGGTGCTGA"	12.4812971549923	-2.81960847294005	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGAGGTAGGTGCTGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2019.31377621204	35.8265920853761	0.0177419638826918	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2008.74939460081	2008.74939460081
"AML-2123"	"2020-07-29-AML2123-c2:AGGAGGTCAATACAGA"	11.3506275611812	-1.25115778362425	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGAGGTCAATACAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1140.03432237835	41.2431586160574	0.0361771201151343	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1125.75128822768	1125.75128822768
"AML-2123"	"2020-07-29-AML2123-c2:AGGATAATCGACCCAG"	-7.4749325317448	2.36677930438844	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGATAATCGACCCAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2483.4417086212	51.9784987170604	0.0209300256722831	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2467.78094953074	2467.78094953074
"AML-2123"	"2020-07-29-AML2123-c2:AGGATCTTCCTATTGT"	-2.77030549469646	3.4890999563965	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGATCTTCCTATTGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3106.04301309566	40.0397594038283	0.0128909223842082	5655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3097.86748083467	3097.86748083467
"AML-2123"	"2020-07-29-AML2123-c2:AGGATCTTCTCATGGA"	11.389348645776	-2.05080082332762	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGATCTTCTCATGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1490.26855220478	31.2242245268058	0.0209520790602546	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1487.05431506534	1487.05431506534
"AML-2123"	"2020-07-29-AML2123-c2:AGGCCACAGCATTTCG"	0.0370761855388105	10.9896840819153	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGCCACAGCATTTCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1805.83577166153	38.6109639370897	0.0213812155806196	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1802.0135584775	1802.0135584775
"AML-2123"	"2020-07-29-AML2123-c2:AGGCTGCCACAAAGCG"	10.2678019004757	7.57240626895753	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Memory"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGCTGCCACAAAGCG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2139.57805923963	44.7007776283956	0.020892333156698	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2129.54947795712	2129.54947795712
"AML-2123"	"2020-07-29-AML2123-c2:AGGGAGTCAAAGGTTA"	-2.55315051499065	3.50727675044862	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGGAGTCAAAGGTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3211.62037017234	25.1654025018623	0.00783573386679944	4235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3207.75646774043	3207.75646774043
"AML-2123"	"2020-07-29-AML2123-c2:AGGGTGATCGCTAAAC"	-7.55714688721355	2.84882280910341	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGGTGATCGCTAAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2262.83462913147	48.9401384657308	0.0216278016235394	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2244.96462883741	2244.96462883741
"AML-2123"	"2020-07-29-AML2123-c2:AGGTCATCATGTCAGT"	10.7041899162227	-0.782623075601183	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGTCATCATGTCAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1374.79168299631	23.30854847753	0.0169542402429507	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1365.76567077743	1365.76567077743
"AML-2123"	"2020-07-29-AML2123-c2:AGGTGTTTCTGTGCTC"	-1.77692816677745	12.2098436125549	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGTGTTTCTGTGCTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1715.22133574862	49.6690098131143	0.0289577845015762	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1711.36508987577	1711.36508987577
"AML-2123"	"2020-07-29-AML2123-c2:AGGTTACGTTCTCCTG"	11.3312603431637	-2.69694521343382	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGTTACGTTCTCCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1982.38419970787	40.0885831724806	0.0202224085413858	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1971.71263076033	1971.71263076033
"AML-2123"	"2020-07-29-AML2123-c2:AGGTTGTAGCTTCGTA"	12.5518337684566	-2.42726375972899	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGGTTGTAGCTTCGTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1175.46719350163	36.6420620019093	0.0311723391384114	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1172.32254569261	1172.32254569261
"AML-2123"	"2020-07-29-AML2123-c2:AGTACTGGTGTAGCAG"	11.3317791419918	-1.99667169963988	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTACTGGTGTAGCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1363.36159660144	43.7485325488286	0.0320887229461973	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1357.92747023232	1357.92747023232
"AML-2123"	"2020-07-29-AML2123-c2:AGTACTGGTTCCACGG"	12.4195162254268	-2.36839749729308	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTACTGGTTCCACGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1513.19573036684	32.7462804805989	0.0216404790361523	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1508.99438839285	1508.99438839285
"AML-2123"	"2020-07-29-AML2123-c2:AGTACTGTCTGTAAGC"	11.8259960609371	-2.0382073155609	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTACTGTCTGTAAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1582.2498553861	45.9063501971114	0.0290133382163649	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1574.37030638726	1574.37030638726
"AML-2123"	"2020-07-29-AML2123-c2:AGTAGCTGTAACACCT"	-2.82994876328166	3.90097520435182	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTAGCTGTAACACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3518.17284165265	39.0242188069076	0.0110921835177876	5810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3510.67941816768	3510.67941816768
"AML-2123"	"2020-07-29-AML2123-c2:AGTAGTCAGGATTCCT"	11.5164143043453	-1.77973785316619	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTAGTCAGGATTCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1347.23273031281	34.4500277095025	0.025570955139654	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1341.63176332973	1341.63176332973
"AML-2123"	"2020-07-29-AML2123-c2:AGTAGTCCAGGATGAC"	12.3490873771602	-2.30140449916991	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTAGTCCAGGATGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1733.32770413584	48.9109350087669	0.0282179387614137	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1725.93383054567	1725.93383054567
"AML-2123"	"2020-07-29-AML2123-c2:AGTAGTCGTCCGAAGA"	12.5452848869259	-2.69928719913634	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTAGTCGTCCGAAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1430.08611916163	46.2692023040911	0.0323541370579946	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1427.10444331553	1427.10444331553
"AML-2123"	"2020-07-29-AML2123-c2:AGTCAACAGACTGAGC"	-3.48529873314555	10.9187516936096	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"Activated NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTCAACAGACTGAGC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2196.43620771925	45.9140242592387	0.0209038733280195	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2192.32053303648	2192.32053303648
"AML-2123"	"2020-07-29-AML2123-c2:AGTCATGCAGAGTCAG"	-2.12161431732829	3.76177547061769	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTCATGCAGAGTCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2848.68386005389	47.1072872618752	0.0165365093411889	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2843.06004618182	2843.06004618182
"AML-2123"	"2020-07-29-AML2123-c2:AGTCTCCAGAGTTGCG"	12.5297132926876	-2.42029955303343	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTCTCCAGAGTTGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1336.25952241183	49.9149767463881	0.0373542533536419	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1336.25952241183	1336.25952241183
"AML-2123"	"2020-07-29-AML2123-c2:AGTCTCCGTCCTTAAG"	11.0961004692012	-3.0593414536682	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTCTCCGTCCTTAAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2565.58943748001	40.111789375156	0.0156345316944222	3094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2557.67901008815	2557.67901008815
"AML-2123"	"2020-07-29-AML2123-c2:AGTGACTAGCATTTGC"	1.28259672698323	10.6838636168274	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTGACTAGCATTTGC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1912.07481029462	23.8052654162851	0.0124499654972271	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1911.02615589684	1911.02615589684
"AML-2123"	"2020-07-29-AML2123-c2:AGTGACTCACGTAACT"	-7.69882569733317	2.56258080089418	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTGACTCACGTAACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2396.96467879226	29.4328718241936	0.0122792263418015	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2388.40952406873	2388.40952406873
"AML-2123"	"2020-07-29-AML2123-c2:AGTGCCGTCATAAGGA"	-7.3041184944218	2.42228791797487	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTGCCGTCATAAGGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2493.21848027076	41.2808467055935	0.0165572520147173	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2484.95339923768	2484.95339923768
"AML-2123"	"2020-07-29-AML2123-c2:AGTTCGAGTATTAAGG"	11.7221580940181	-2.00339987194213	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.AGTTCGAGTATTAAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1515.08011680554	44.7832020086783	0.0295583061990814	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1511.71391075117	1511.71391075117
"AML-2123"	"2020-07-29-AML2123-c2:ATACCGATCCTACAAG"	-7.69843039932902	2.72800109470216	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATACCGATCCTACAAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2658.15030311198	44.0586085088132	0.0165749124333686	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2642.94672227694	2642.94672227694
"AML-2123"	"2020-07-29-AML2123-c2:ATACCTTGTCTGTGAT"	12.5623489814693	-2.56616928493651	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATACCTTGTCTGTGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1586.39737158525	31.3357815894794	0.0197527946974385	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1576.73528955415	1576.73528955415
"AML-2123"	"2020-07-29-AML2123-c2:ATACTTCAGCTGGCTC"	-4.58025155487712	-5.30617287075194	"2020-07-29-AML2123-c2"	"AML2123"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00451807228915663	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATACTTCAGCTGGCTC"	"Granulocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Gran"	"Gran"	3081.88288972628	42.0355514625025	0.0136395680713993	3148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	5	TRUE	"Gran_AML-2123"	3079.35533927207	3079.35533927207
"AML-2123"	"2020-07-29-AML2123-c2:ATAGAGAGTCCTCATC"	12.4901873069698	-2.44834997570189	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATAGAGAGTCCTCATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1361.18766125105	33.9795871951002	0.0249631907211603	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1357.97454729552	1357.97454729552
"AML-2123"	"2020-07-29-AML2123-c2:ATCATTCAGCCTTTCC"	-7.56876454773601	2.45226357066957	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCATTCAGCCTTTCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2690.94841894705	43.6315730802802	0.0162141989690582	2881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2679.96568188432	2679.96568188432
"AML-2123"	"2020-07-29-AML2123-c2:ATCATTCAGGTAAAGG"	12.4793573814327	-2.71965029155882	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCATTCAGGTAAAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1635.28633302497	29.6392383891604	0.0181248004038127	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1629.22815662763	1629.22815662763
"AML-2123"	"2020-07-29-AML2123-c2:ATCCACCAGTCGTCTA"	-7.59260497513469	2.60330555522767	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCCACCAGTCGTCTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2729.7100333914	43.4532607667585	0.015918636131755	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2712.30706771461	2712.30706771461
"AML-2123"	"2020-07-29-AML2123-c2:ATCCATTGTGTTCATG"	-7.82256541672404	1.43525586212007	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCCATTGTGTTCATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2822.28019383455	43.1803980964933	0.0152998267821968	2703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2808.53914717214	2808.53914717214
"AML-2123"	"2020-07-29-AML2123-c2:ATCCCTGTCCATTCGC"	-8.16499076309856	0.588023103121199	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCCCTGTCCATTCGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3074.02943873299	43.1218558528972	0.0140277953456004	4438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3063.6991420635	3063.6991420635
"AML-2123"	"2020-07-29-AML2123-c2:ATCCTATAGGTCCTGC"	-1.69187043133433	3.93101713741151	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCCTATAGGTCCTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2860.85709846617	44.9836158767258	0.0157238248288751	3146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2857.68019512772	2857.68019512772
"AML-2123"	"2020-07-29-AML2123-c2:ATCCTATGTAACATCC"	11.3605705696041	-2.13348057186278	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCCTATGTAACATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1363.26070350668	43.3915088695972	0.0318292082783451	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1363.26070350668	1363.26070350668
"AML-2123"	"2020-07-29-AML2123-c2:ATCGCCTCACCTGTCT"	8.69582428511922	8.14784238422243	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCGCCTCACCTGTCT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2092.967429615	38.4336198578927	0.0183632192809434	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2084.78101165059	2084.78101165059
"AML-2123"	"2020-07-29-AML2123-c2:ATCGGATAGGAACGAA"	1.02901222285573	11.6995744475159	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCGGATAGGAACGAA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2083.53791337327	38.4879216203594	0.0184723884184316	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2072.80948539408	2072.80948539408
"AML-2123"	"2020-07-29-AML2123-c2:ATCGGATTCTTCCTAA"	-7.61073909226115	2.99583695018617	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCGGATTCTTCCTAA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2476.99913151038	45.2537235327234	0.0182695758577555	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2464.53657884582	2464.53657884582
"AML-2123"	"2020-07-29-AML2123-c2:ATCGTAGTCCAGTGCG"	-2.77138791504558	3.98321530902711	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATCGTAGTCCAGTGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3496.59038133192	42.6500918486734	0.0121976231692393	5190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3492.50069258351	3492.50069258351
"AML-2123"	"2020-07-29-AML2123-c2:ATGAGTCAGATCACTC"	12.1429707008297	-2.45153310215148	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGAGTCAGATCACTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1602.33758194148	35.0932691055628	0.0219012956452296	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1595.89865731776	1595.89865731776
"AML-2123"	"2020-07-29-AML2123-c2:ATGCCTCAGACGTCGA"	-8.09279380264934	0.992453313711561	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGCCTCAGACGTCGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2750.76764816221	43.8846390522266	0.0159535972009654	2904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2739.93327558494	2739.93327558494
"AML-2123"	"2020-07-29-AML2123-c2:ATGCCTCTCCACAGGC"	-1.38361785832103	3.65747807109681	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGCCTCTCCACAGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2914.92845274927	28.0397526549652	0.00961936222774835	3208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2908.28859191716	2908.28859191716
"AML-2123"	"2020-07-29-AML2123-c2:ATGCGATCATCTCCCA"	11.730901380151	-2.33839824115904	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGCGATCATCTCCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1961.83540433238	21.2546566458882	0.0108340672203952	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1952.00656172454	1952.00656172454
"AML-2123"	"2020-07-29-AML2123-c2:ATGGAGGTCTTCTTCC"	8.40133442458455	6.73099563205568	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGGAGGTCTTCTTCC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1578.1324653447	37.956238560557	0.0240513641244092	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1576.13277864267	1576.13277864267
"AML-2123"	"2020-07-29-AML2123-c2:ATGGGAGAGCCAGAGT"	-2.97857675972636	13.1027421721253	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGGGAGAGCCAGAGT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2404.35954823153	47.4167112099565	0.019721139978766	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2398.20616159287	2398.20616159287
"AML-2123"	"2020-07-29-AML2123-c2:ATGTCTTTCCGATAGT"	-2.59498892250713	3.39068768108217	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATGTCTTTCCGATAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3559.2704795769	40.7227223540549	0.0114413115237299	3693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3547.62722961773	3547.62722961773
"AML-2123"	"2020-07-29-AML2123-c2:ATTACCTAGGCACAAC"	-7.55372701111491	2.34601709926454	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTACCTAGGCACAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2717.69936292047	39.7345755571024	0.0146206663250652	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2703.14770326265	2703.14770326265
"AML-2123"	"2020-07-29-AML2123-c2:ATTACTCAGTTTCGAC"	10.9219023185665	-2.49024321949156	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTACTCAGTTTCGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1711.63345821899	35.518935114503	0.0207514844629537	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1706.58792391808	1706.58792391808
"AML-2123"	"2020-07-29-AML2123-c2:ATTATCCGTCGTTGGC"	-2.33442411842998	13.635718322638	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTATCCGTCGTTGGC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2132.94169629003	42.0646342183632	0.0197214177450463	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2131.34943006496	2131.34943006496
"AML-2123"	"2020-07-29-AML2123-c2:ATTATCCTCTGGAAGG"	11.9517418342525	-1.98468449031981	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTATCCTCTGGAAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1568.73626759089	25.0140975342379	0.0159453810375991	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1568.73626759089	1568.73626759089
"AML-2123"	"2020-07-29-AML2123-c2:ATTCACTTCTGCAGCG"	10.4820915656978	-0.275088720676027	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTCACTTCTGCAGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1114.69177594186	43.4008972837019	0.0389353346103502	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1107.88019845301	1107.88019845301
"AML-2123"	"2020-07-29-AML2123-c2:ATTCATCCATCATTGG"	-7.58568845215495	2.54965469920961	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTCATCCATCATTGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2567.49480533603	41.6558883938814	0.0162243321027594	2608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2560.69063435205	2560.69063435205
"AML-2123"	"2020-07-29-AML2123-c2:ATTCGTTAGAAGAGCA"	-1.23017106476482	10.6300830611023	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTCGTTAGAAGAGCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2084.095290798	47.847742044235	0.0229585193419415	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2078.87675386387	2078.87675386387
"AML-2123"	"2020-07-29-AML2123-c2:ATTCTTGTCCGGCAAC"	-7.0397199195927	2.47470924938051	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTCTTGTCCGGCAAC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2197.72709641155	49.2480169315098	0.0224086134315411	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2186.18924240453	2186.18924240453
"AML-2123"	"2020-07-29-AML2123-c2:ATTGTTCAGTCTCCTC"	-7.59561715546306	2.31488607013551	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTGTTCAGTCTCCTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2727.34252303223	38.1531856088266	0.0139891433828445	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2714.93998478523	2714.93998478523
"AML-2123"	"2020-07-29-AML2123-c2:ATTTCACTCGAGAAAT"	1.0878150659496	9.87178514087526	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.ATTTCACTCGAGAAAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2042.54894738445	39.4379405973208	0.019308198536844	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2037.6757981739	2037.6757981739
"AML-2123"	"2020-07-29-AML2123-c2:CAAAGAAAGTGCGACA"	-2.09973321381267	3.46006796443788	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAAAGAAAGTGCGACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3001.30553948567	38.350326007081	0.0127778813261555	3714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2997.53906669762	2997.53906669762
"AML-2123"	"2020-07-29-AML2123-c2:CAACCTCCAAGACCTT"	-7.44598899307902	3.81651637637941	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAACCTCCAAGACCTT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2254.29650486381	50.4066957043205	0.0223602776278828	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2235.17445049986	2235.17445049986
"AML-2123"	"2020-07-29-AML2123-c2:CAACGATGTGGAACAC"	-2.61357365074809	3.40095589244691	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAACGATGTGGAACAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2979.38493395898	41.8712965139222	0.0140536712919079	4897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2976.19986339395	2976.19986339395
"AML-2123"	"2020-07-29-AML2123-c2:CAAGACTCATAGGAGC"	-7.06948028031047	2.59584448421327	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAAGACTCATAGGAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2282.37926119895	49.7209281642481	0.0217846915319978	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2270.91913164699	2270.91913164699
"AML-2123"	"2020-07-29-AML2123-c2:CAAGACTTCCTTACCG"	12.4860474067623	-2.51860716259154	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAAGACTTCCTTACCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1424.35944067718	41.3862325963739	0.0290560313741436	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1422.71569469421	1422.71569469421
"AML-2123"	"2020-07-29-AML2123-c2:CAAGGGACATAGTCGT"	-7.85965619507487	1.20920167053071	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAAGGGACATAGTCGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2755.30422207736	35.9390863644487	0.0130436000774363	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2745.60982590023	2745.60982590023
"AML-2123"	"2020-07-29-AML2123-c2:CACAGATCAGTCTACA"	12.3831917243892	-2.42566826259764	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACAGATCAGTCTACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1401.97938305731	44.2326681624992	0.0315501559416948	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1395.40500482509	1395.40500482509
"AML-2123"	"2020-07-29-AML2123-c2:CACAGATGTACCTATG"	0.786355455487412	8.83079431140748	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACAGATGTACCTATG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2011.14110202501	43.9193060633831	0.0218380033201851	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2000.61059113285	2000.61059113285
"AML-2123"	"2020-07-29-AML2123-c2:CACAGATTCGTCCTTG"	-7.55431590500529	2.55021283710328	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACAGATTCGTCCTTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2605.69453543379	46.971306374647	0.0180264055267811	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2595.28723865742	2595.28723865742
"AML-2123"	"2020-07-29-AML2123-c2:CACAGGCCACTCTAGA"	9.33834614333455	7.46685073459474	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACAGGCCACTCTAGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1913.48704631871	40.5038720152481	0.0211675705321194	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1908.29114533616	1908.29114533616
"AML-2123"	"2020-07-29-AML2123-c2:CACATGATCACAATGC"	-8.92706046524699	5.09643218601076	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACATGATCACAATGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2089.4739565316	50.8711695655523	0.0243464003973495	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2082.37082231565	2082.37082231565
"AML-2123"	"2020-07-29-AML2123-c2:CACGTGGCACTTCCTG"	-7.54778943482097	1.40704605663148	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACGTGGCACTTCCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2729.42839376826	50.0001127280281	0.018318895209776	2920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2716.17822218679	2716.17822218679
"AML-2123"	"2020-07-29-AML2123-c2:CACGTGGGTGACACGA"	-3.39395485344585	9.57715985858766	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACGTGGGTGACACGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2250.83110156977	43.2893762757775	0.0192326186738697	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2245.3123037607	2245.3123037607
"AML-2123"	"2020-07-29-AML2123-c2:CACGTGGGTTGCTGAT"	-2.62782631340678	3.41547772968141	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACGTGGGTTGCTGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3195.95483073122	32.7196245866546	0.0102378244748749	5670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3186.35872429724	3186.35872429724
"AML-2123"	"2020-07-29-AML2123-c2:CACTGAAAGAATTTGG"	-7.59176717224773	2.57227799976198	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACTGAAAGAATTTGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2504.93635635693	44.8824718865671	0.0179176096720645	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2497.22359923667	2497.22359923667
"AML-2123"	"2020-07-29-AML2123-c2:CACTGAATCGCCGAAC"	-1.9604266685551	3.46086309039918	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACTGAATCGCCGAAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2935.67669461511	32.7046243938896	0.0111404040008491	5294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2926.73198512503	2926.73198512503
"AML-2123"	"2020-07-29-AML2123-c2:CACTGAATCTGATGGT"	12.1379181343013	-2.41874697124632	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACTGAATCTGATGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1484.86010037283	43.0611731355291	0.0290001550480864	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1480.37341459421	1480.37341459421
"AML-2123"	"2020-07-29-AML2123-c2:CACTGTCGTCACCCTT"	-7.00858674469646	2.67933127963869	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CACTGTCGTCACCCTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2727.00293929918	47.3685027057549	0.0173701692884601	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2709.966235067	2709.966235067
"AML-2123"	"2020-07-29-AML2123-c2:CAGAGCCTCCCATACC"	0.803542216389817	4.66726396167604	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	25	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.111111111111111	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGAGCCTCCCATACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2254.12914849983	44.3088190939342	0.0196567348962338	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2235.5062294743	2235.5062294743
"AML-2123"	"2020-07-29-AML2123-c2:CAGAGCCTCTCCGTGT"	-5.01415715637858	3.75099275195924	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGAGCCTCTCCGTGT"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2563.85679360957	36.986297637636	0.0144260388216006	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2558.4946977678	2558.4946977678
"AML-2123"	"2020-07-29-AML2123-c2:CAGCAATAGGGACTGT"	1.81004323539082	-10.0995779267517	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCAATAGGGACTGT"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2415.0802155955	46.8741650966271	0.0194089474933109	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2412.2102887091	2412.2102887091
"AML-2123"	"2020-07-29-AML2123-c2:CAGCACGAGGACTAAT"	-1.34915850582774	11.9535455473694	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCACGAGGACTAAT"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2175.08293660893	41.3507988466905	0.0190111366103393	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2171.29780055824	2171.29780055824
"AML-2123"	"2020-07-29-AML2123-c2:CAGCACGAGTGAGTTA"	-1.97591457787212	3.48983976924745	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCACGAGTGAGTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2780.35121831422	44.764045194417	0.0161001404784962	4940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2774.90943889945	2774.90943889945
"AML-2123"	"2020-07-29-AML2123-c2:CAGCAGCCATGCCGAC"	9.12119831618611	7.3013295897278	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCAGCCATGCCGAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1939.17784565281	41.0166999421433	0.0211515926886712	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1935.10049587445	1935.10049587445
"AML-2123"	"2020-07-29-AML2123-c2:CAGCAGCTCATAGAGA"	-7.56109748306926	2.78297231281129	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCAGCTCATAGAGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2413.21462686046	42.3096376825141	0.0175324802077626	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2401.54946597908	2401.54946597908
"AML-2123"	"2020-07-29-AML2123-c2:CAGCCAGAGAGCACTG"	8.95976891097371	7.65446660602418	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00286806883365201	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCCAGAGAGCACTG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1800.12838281474	44.5120822717073	0.0247271709599438	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1791.07305625687	1791.07305625687
"AML-2123"	"2020-07-29-AML2123-c2:CAGCCAGCAGCGATTT"	-7.60644565048869	2.03294394100038	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCCAGCAGCGATTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2790.90677836056	47.4710949124278	0.0170092011960046	2857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2772.32856538704	2772.32856538704
"AML-2123"	"2020-07-29-AML2123-c2:CAGCGTGCAAGGAGTC"	-4.13173852387126	10.4830379256043	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGCGTGCAAGGAGTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2114.52591894085	40.2277173866359	0.0190244617132835	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2109.55650508576	2109.55650508576
"AML-2123"	"2020-07-29-AML2123-c2:CAGTTCCGTCTAGGTT"	8.65363850173299	8.25452039325563	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CAGTTCCGTCTAGGTT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2104.28304460639	43.4468048509507	0.0206468445213736	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2099.33456052858	2099.33456052858
"AML-2123"	"2020-07-29-AML2123-c2:CATAAGCCAGCGGATA"	8.37462009963338	8.23054883563844	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATAAGCCAGCGGATA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1775.2628683277	35.5611872647824	0.0200315051360709	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1766.57791087161	1766.57791087161
"AML-2123"	"2020-07-29-AML2123-c2:CATACAGCAGCTGAGA"	-2.63121662560161	4.12345836246339	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATACAGCAGCTGAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3134.41585626576	38.0202184943554	0.0121299215668375	5349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3128.53451985428	3128.53451985428
"AML-2123"	"2020-07-29-AML2123-c2:CATACAGTCAAGCCGC"	-5.98715291443523	3.42674300754396	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATACAGTCAAGCCGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2047.31554656997	31.7034895431362	0.0154853948118802	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2038.69788398106	2038.69788398106
"AML-2123"	"2020-07-29-AML2123-c2:CATAGACCAGCTGTCG"	-7.60449061814006	2.70668933475343	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATAGACCAGCTGTCG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2187.17977551599	41.6301207572675	0.0190336986576452	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2180.46410494752	2180.46410494752
"AML-2123"	"2020-07-29-AML2123-c2:CATCCGTTCCCTTGTG"	-4.00843558731731	11.1283578642639	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATCCGTTCCCTTGTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1573.06555659054	44.8576102874711	0.028516046327208	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1564.10328457857	1564.10328457857
"AML-2123"	"2020-07-29-AML2123-c2:CATCGCTTCTCGCGTT"	-1.48821387711223	3.71933267200319	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATCGCTTCTCGCGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3034.05663791369	39.9702796580893	0.0131738739345268	3309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3025.25430532575	3025.25430532575
"AML-2123"	"2020-07-29-AML2123-c2:CATCGGGCAGCCATTA"	12.1395002799923	-2.21175076877745	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATCGGGCAGCCATTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1236.51877940814	37.7540322868178	0.030532518321225	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1232.98878920832	1232.98878920832
"AML-2123"	"2020-07-29-AML2123-c2:CATGAGTGTCACTGAT"	-2.19019208374675	9.72322557056276	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGAGTGTCACTGAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2001.66268951066	45.2451574870067	0.022603787203561	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1997.13247631888	1997.13247631888
"AML-2123"	"2020-07-29-AML2123-c2:CATGCCTTCGGTATGT"	-7.22097907486613	2.06321785533754	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGCCTTCGGTATGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2236.34091171902	33.3866954148496	0.0149291618464316	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2220.92668311659	2220.92668311659
"AML-2123"	"2020-07-29-AML2123-c2:CATGCTCGTGCGGCTT"	8.43801369246785	8.13984105670778	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGCTCGTGCGGCTT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1805.13003947355	45.1695682025216	0.0250228887752014	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1802.32128714311	1802.32128714311
"AML-2123"	"2020-07-29-AML2123-c2:CATGCTCTCGTGTGAT"	-7.57323584976848	2.79098699176637	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGCTCTCGTGTGAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2327.43195748885	44.5812140862433	0.0191546798791676	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2316.6442948468	2316.6442948468
"AML-2123"	"2020-07-29-AML2123-c2:CATGGATCATCTGTTT"	-7.71645245972331	2.79217836940614	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGGATCATCTGTTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2168.14674206431	39.5003816175445	0.0182185000909744	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2153.238938912	2153.238938912
"AML-2123"	"2020-07-29-AML2123-c2:CATGGTAGTAAGATCA"	11.0546194511348	-2.72405364429625	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATGGTAGTAAGATCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1812.56663148464	31.4621003916561	0.0173577621065914	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1805.68216244837	1805.68216244837
"AML-2123"	"2020-07-29-AML2123-c2:CATTCATGTATTGCCA"	-7.52837024155315	2.64685914600221	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTCATGTATTGCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2653.16516974489	42.7079455281026	0.0160969795680715	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2637.35748077688	2637.35748077688
"AML-2123"	"2020-07-29-AML2123-c2:CATTCATGTCGGAACA"	-7.32623515549357	2.50705621326295	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTCATGTCGGAACA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2355.24108012064	46.2058865865369	0.0196183256892625	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2344.85712017453	2344.85712017453
"AML-2123"	"2020-07-29-AML2123-c2:CATTCATTCACGGACC"	11.8336235481197	-1.89352145111235	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTCATTCACGGACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1725.68704805594	42.659680204718	0.0247204035359574	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1715.90925331143	1715.90925331143
"AML-2123"	"2020-07-29-AML2123-c2:CATTCATTCGTGTGAT"	-7.6885851425236	2.38602778995363	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTCATTCGTGTGAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3193.77285773567	34.7057037159362	0.0108666787720596	3581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3179.70329856518	3179.70329856518
"AML-2123"	"2020-07-29-AML2123-c2:CATTCTAGTGTGTTTG"	-3.52287540856059	9.4562253721985	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTCTAGTGTGTTTG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2394.35960854304	38.6147556816454	0.0161273835157712	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2386.47231899807	2386.47231899807
"AML-2123"	"2020-07-29-AML2123-c2:CATTGTTAGTTCCGGC"	-7.51173005524333	2.47004435146181	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTGTTAGTTCCGGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2573.34411515304	42.0468408955689	0.0163393774847203	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2563.53584725977	2563.53584725977
"AML-2123"	"2020-07-29-AML2123-c2:CATTGTTCAAGGGTCA"	-1.79598257961925	3.45093844020692	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTGTTCAAGGGTCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2997.1607421704	45.687854536278	0.0152437117881082	3026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2987.62267178711	2987.62267178711
"AML-2123"	"2020-07-29-AML2123-c2:CATTGTTGTATTGCCA"	-7.4618276161259	2.65231630885927	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CATTGTTGTATTGCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2453.84339902616	49.0733046977063	0.0199985478768456	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2444.40661494215	2444.40661494215
"AML-2123"	"2020-07-29-AML2123-c2:CCAAGCGGTTATAGAG"	-7.69634805145915	1.07354221427766	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCAAGCGGTTATAGAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2555.12636488342	50.2957648041686	0.0196842573014832	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2538.9278038034	2538.9278038034
"AML-2123"	"2020-07-29-AML2123-c2:CCAATGATCGCACGAC"	-7.67152820053752	2.56550095165101	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCAATGATCGCACGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2340.69741770043	48.919760280696	0.020899651493082	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2334.95063382412	2334.95063382412
"AML-2123"	"2020-07-29-AML2123-c2:CCACAAACAAATTAGG"	12.551473279565	-2.56804969226988	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCACAAACAAATTAGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1296.89726293866	30.3507332296446	0.0234025732777571	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1291.91608248453	1291.91608248453
"AML-2123"	"2020-07-29-AML2123-c2:CCACAAACAAGAAACT"	-2.46091781082805	3.45227763736574	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCACAAACAAGAAACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3435.81834328973	45.6221964251378	0.0132784076068048	4669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3427.01327789705	3427.01327789705
"AML-2123"	"2020-07-29-AML2123-c2:CCACAAATCTGCTTTA"	-3.26850829544719	3.45129726016847	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCACAAATCTGCTTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3217.42571484637	42.9234791477375	0.0133409386733229	5374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3208.76165008298	3208.76165008298
"AML-2123"	"2020-07-29-AML2123-c2:CCACGTTCATCCCACT"	-2.22701297226604	3.68024370754091	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCACGTTCATCCCACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3100.50691527911	32.7096154657463	0.0105497637513902	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3092.25347813343	3092.25347813343
"AML-2123"	"2020-07-29-AML2123-c2:CCACGTTGTCGTGATT"	-7.18869100037273	2.67907617175905	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCACGTTGTCGTGATT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2238.96518755323	51.4428732137371	0.0229761827024897	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2231.94848304373	2231.94848304373
"AML-2123"	"2020-07-29-AML2123-c2:CCATAAGTCCGATCTC"	-2.27603183212932	3.45803377712098	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCATAAGTCCGATCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3125.02734782751	32.7272097258602	0.0104726154632253	4776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3122.19873212191	3122.19873212191
"AML-2123"	"2020-07-29-AML2123-c2:CCCATTGGTTGTGCAT"	1.14179625090901	11.8313970335755	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCCATTGGTTGTGCAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2067.92433683692	45.741453684248	0.0221195006361857	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2065.40514569612	2065.40514569612
"AML-2123"	"2020-07-29-AML2123-c2:CCCGGAATCATCCTAT"	-8.3391412300175	0.500801659468092	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCCGGAATCATCCTAT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2748.3541116736	43.1691119299569	0.0157072597547007	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2744.55384358205	2744.55384358205
"AML-2123"	"2020-07-29-AML2123-c2:CCCTAACAGCATTGAA"	-2.7115047973698	3.45054957950441	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCCTAACAGCATTGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3725.95362988106	36.1804461729121	0.009710385519228	4634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3711.01902790512	3711.01902790512
"AML-2123"	"2020-07-29-AML2123-c2:CCCTTAGTCTAGCCAA"	-2.12866673889812	3.44369194591371	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCCTTAGTCTAGCCAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3322.12864210921	42.1402777764647	0.0126847218504188	3485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3312.48780092026	3312.48780092026
"AML-2123"	"2020-07-29-AML2123-c2:CCGAACGCACCATATG"	8.41246094283406	8.14256093585817	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCGAACGCACCATATG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2013.32342879717	43.4456470389111	0.0215790699186703	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2007.6029973462	2007.6029973462
"AML-2123"	"2020-07-29-AML2123-c2:CCGGACACAGCCGTCA"	-2.11628685417827	3.88530228221742	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCGGACACAGCCGTCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2982.02249480396	42.1468007209026	0.0141336293721263	3581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2972.4236439397	2972.4236439397
"AML-2123"	"2020-07-29-AML2123-c2:CCGTAGGAGTAATTGG"	11.6387726264888	-2.04280736362609	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCGTAGGAGTAATTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1402.17058809275	41.7412653128763	0.0297690349999804	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1400.06216378742	1400.06216378742
"AML-2123"	"2020-07-29-AML2123-c2:CCTAACCCATAGGAGC"	12.2777592140133	-2.20772864734801	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTAACCCATAGGAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1302.53088217407	46.667241861373	0.0358281269949471	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1302.53088217407	1302.53088217407
"AML-2123"	"2020-07-29-AML2123-c2:CCTATCGCATGAAAGT"	11.4867674308712	-1.93002929603728	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTATCGCATGAAAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1427.73680185537	21.9443381797736	0.0153700164843104	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1422.91414833694	1422.91414833694
"AML-2123"	"2020-07-29-AML2123-c2:CCTCAACCAATGGCCC"	12.4327227073604	-2.85166766559752	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTCAACCAATGGCCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1879.56485331396	46.4455272178468	0.0247107872526752	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1866.86675029387	1866.86675029387
"AML-2123"	"2020-07-29-AML2123-c2:CCTCTCCGTCGCATGC"	10.6753708320553	-0.434202813264452	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTCTCCGTCGCATGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1494.70098895521	49.39619650319	0.0330475438687692	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1488.31082870679	1488.31082870679
"AML-2123"	"2020-07-29-AML2123-c2:CCTTCAGTCGCTCCTA"	-7.16741548004802	3.37162921512452	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTTCAGTCGCTCCTA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2366.57357631915	43.9885204339434	0.0185874298919372	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2347.75914799341	2347.75914799341
"AML-2123"	"2020-07-29-AML2123-c2:CCTTGTGAGACGTCCC"	1.12793125685994	9.40225408161012	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTTGTGAGACGTCCC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1839.11052265637	31.0267252342257	0.0168705060691031	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1830.16378050269	1830.16378050269
"AML-2123"	"2020-07-29-AML2123-c2:CCTTGTGGTAACGCGA"	9.03574528273885	8.01325366580812	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CCTTGTGGTAACGCGA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2413.58369000121	30.3481213757026	0.0125738840138116	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2402.44918165088	2402.44918165088
"AML-2123"	"2020-07-29-AML2123-c2:CGAAGGACACACGCCA"	11.8890339332515	-2.59603979503783	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGAAGGACACACGCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1663.87088206736	37.5078278741574	0.0225425111277588	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1654.77561516891	1654.77561516891
"AML-2123"	"2020-07-29-AML2123-c2:CGAAGGAGTAGCGTAG"	10.5150686698848	-0.435236655828081	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGAAGGAGTAGCGTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1386.47660803455	30.9515757597871	0.0223239076522637	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1376.97266064018	1376.97266064018
"AML-2123"	"2020-07-29-AML2123-c2:CGACAGCCAGCGCTTG"	-4.80538926544841	2.95399377429811	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGACAGCCAGCGCTTG"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3480.40754388475	33.1866707936045	0.00953528297337338	4554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3467.04139720003	3467.04139720003
"AML-2123"	"2020-07-29-AML2123-c2:CGAGAAGTCTCGGTAA"	-7.60252891007121	2.65347549999086	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGAGAAGTCTCGGTAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2379.86036512635	40.2045125099204	0.0168936434670973	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2369.32589547928	2369.32589547928
"AML-2123"	"2020-07-29-AML2123-c2:CGAGGCTCAGGCATTT"	-7.55015311661418	2.6325633295807	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGAGGCTCAGGCATTT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3041.1196830513	37.6332545448264	0.0123748022001775	2799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3029.58109648088	3029.58109648088
"AML-2123"	"2020-07-29-AML2123-c2:CGATGGCAGTAGTCTC"	-1.7946666282719	10.1479100950989	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGATGGCAGTAGTCTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2109.00840418768	46.6468161505152	0.0221178901221506	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2102.4153684909	2102.4153684909
"AML-2123"	"2020-07-29-AML2123-c2:CGCATAAAGGTGCGAT"	-2.81284676018413	13.6701450117859	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCATAAAGGTGCGAT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2122.48167473194	26.6042723637575	0.0125345121611556	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2120.88406497068	2120.88406497068
"AML-2123"	"2020-07-29-AML2123-c2:CGCATAACAACACAGG"	-0.0192215395277322	10.907651878241	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCATAACAACACAGG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1960.01971915507	49.7287746529035	0.0253715685443923	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1950.12013737241	1950.12013737241
"AML-2123"	"2020-07-29-AML2123-c2:CGCATAATCCTTATGT"	-7.52998433533366	2.36745450580446	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCATAATCCTTATGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2645.04589412599	42.0160118949773	0.015884795038258	2616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2636.62632782665	2636.62632782665
"AML-2123"	"2020-07-29-AML2123-c2:CGCCAGATCCTACGGG"	-7.79717956009563	2.82178423488466	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCCAGATCCTACGGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2285.17785465913	41.3786110314831	0.0181073919244922	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2273.97285668625	2273.97285668625
"AML-2123"	"2020-07-29-AML2123-c2:CGCGTGAAGCTGGCTC"	-1.08573899689372	12.1755685576233	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCGTGAAGCTGGCTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2090.11799162467	38.9423450716136	0.0186316491354363	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2083.88347571238	2083.88347571238
"AML-2123"	"2020-07-29-AML2123-c2:CGCGTGAGTACCGTGC"	-2.41093335571941	3.7843401201996	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGCGTGAGTACCGTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2920.7301665592	40.0130447886148	0.0136996718309492	3403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2918.24122909371	2918.24122909371
"AML-2123"	"2020-07-29-AML2123-c2:CGGAACCAGTGTCATC"	-2.02705560150798	3.73412320697633	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGAACCAGTGTCATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3374.49389488893	35.6035872796118	0.0105507932118466	5686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3368.38004275763	3368.38004275763
"AML-2123"	"2020-07-29-AML2123-c2:CGGACACAGTTTGCTG"	-7.53972230377849	1.62912581050722	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGACACAGTTTGCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2636.97306855283	42.7598909660765	0.0162155205436144	2917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2623.19672060874	2623.19672060874
"AML-2123"	"2020-07-29-AML2123-c2:CGGACACGTACTAACC"	-3.28571305695232	10.4545039900574	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGACACGTACTAACC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2143.49413143423	45.4934311523882	0.0212239588087644	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2140.76926474047	2140.76926474047
"AML-2123"	"2020-07-29-AML2123-c2:CGGCAGTAGGTGCGAT"	-2.99712024155315	9.22436616504518	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGCAGTAGGTGCGAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2520.16179958696	46.8700171416107	0.0185980190435758	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2516.41889289427	2516.41889289427
"AML-2123"	"2020-07-29-AML2123-c2:CGGGACTGTGTGTACT"	0.583344002335709	10.2832040556702	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGGACTGTGTGTACT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1866.40364633488	50.6826673813902	0.027155255231588	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1859.53214944633	1859.53214944633
"AML-2123"	"2020-07-29-AML2123-c2:CGGGTCATCGCACGGT"	-7.73090348663982	2.70164082134096	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGGTCATCGCACGGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2222.29625978708	46.065396721095	0.020728737907118	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2212.08416627639	2212.08416627639
"AML-2123"	"2020-07-29-AML2123-c2:CGGGTCATCTGGGCGT"	-3.45203242722209	3.3102133044037	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGGGTCATCTGGGCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3132.44533813977	37.3860387221803	0.0119350969247503	4692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3128.54299384042	3128.54299384042
"AML-2123"	"2020-07-29-AML2123-c2:CGTAGTACACCGGCTA"	0.591734667390031	11.4765805968079	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGTAGTACACCGGCTA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2043.29736817938	42.8876242395745	0.0209894188224734	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2039.62269217884	2039.62269217884
"AML-2123"	"2020-07-29-AML2123-c2:CGTGAATAGTGTCATC"	-8.16352496567424	1.21438071811525	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGTGAATAGTGTCATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2572.39444669256	42.3847178680492	0.0164767568685063	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2562.0455927351	2562.0455927351
"AML-2123"	"2020-07-29-AML2123-c2:CGTGAATGTTGTGGCC"	-7.35989795151408	2.6433317431244	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGTGAATGTTGTGGCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2421.66714968917	41.9371896845591	0.0173174871244968	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2414.10930259668	2414.10930259668
"AML-2123"	"2020-07-29-AML2123-c2:CGTGATAGTTGCTCAA"	0.730964441865128	11.6786851652893	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGTGATAGTTGCTCAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1967.41824082596	49.2159822327419	0.0250155158732696	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1964.70830776295	1964.70830776295
"AML-2123"	"2020-07-29-AML2123-c2:CGTTGGGCACAGTGTT"	-7.55763516846355	2.48301766002504	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CGTTGGGCACAGTGTT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2465.0682171259	47.2961036424043	0.0191865293275933	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2457.43709019198	2457.43709019198
"AML-2123"	"2020-07-29-AML2123-c2:CTAACTTCAACCGATT"	12.3510958152706	-2.24642040645751	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTAACTTCAACCGATT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1372.8941033132	32.7588571215647	0.0238611682011801	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1369.12336181358	1369.12336181358
"AML-2123"	"2020-07-29-AML2123-c2:CTAAGTGTCGATCCCT"	8.86691250380818	7.62851522052614	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTAAGTGTCGATCCCT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1824.82763247244	41.1997042056414	0.022577312767793	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1820.19007057439	1820.19007057439
"AML-2123"	"2020-07-29-AML2123-c2:CTACAGAGTGCGTTTA"	11.7513767677242	-2.84807612812194	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTACAGAGTGCGTTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1862.68670066426	42.5356110536816	0.0228356228873663	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1856.63193963216	1856.63193963216
"AML-2123"	"2020-07-29-AML2123-c2:CTACCTGCAACCGCCA"	-2.10549340668376	9.93117330158082	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTACCTGCAACCGCCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2430.09232918029	50.6178204820048	0.0208295873676039	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2419.18311509257	2419.18311509257
"AML-2123"	"2020-07-29-AML2123-c2:CTAGGTAGTAGCGATG"	-3.40447602692302	10.8371715315613	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTAGGTAGTAGCGATG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2061.78908964435	44.2789741504191	0.0214759959555596	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2049.31133287037	2049.31133287037
"AML-2123"	"2020-07-29-AML2123-c2:CTATAGGGTTTCGTGA"	-5.44514356079753	3.76158759677736	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTATAGGGTTTCGTGA"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2375.56603753372	43.3982952224054	0.0182686124219308	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2361.31939655659	2361.31939655659
"AML-2123"	"2020-07-29-AML2123-c2:CTATCTACACGGCGTT"	-3.08648810806926	9.99586579883424	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTATCTACACGGCGTT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2105.87932656351	44.3735498183109	0.0210712690222009	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2098.78595222783	2098.78595222783
"AML-2123"	"2020-07-29-AML2123-c2:CTCAACCAGATTGACA"	-2.02956829491313	3.77474877918092	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAACCAGATTGACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3325.1912565556	35.4130413124342	0.0106499261486441	4155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3319.56658187239	3319.56658187239
"AML-2123"	"2020-07-29-AML2123-c2:CTCAACCTCGGAATGG"	-7.53353915634807	2.64805338466493	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAACCTCGGAATGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2546.37574710094	45.1489548023058	0.0177306726447218	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2535.10311633624	2535.10311633624
"AML-2123"	"2020-07-29-AML2123-c2:CTCAAGAGTAGCCAGA"	-7.70380435410197	2.56775043094484	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAAGAGTAGCCAGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2507.6358333024	43.5535501015125	0.0173683712455788	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2500.49893391475	2500.49893391475
"AML-2123"	"2020-07-29-AML2123-c2:CTCAAGAGTCGTTATG"	-7.57376084747966	2.51393554294435	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAAGAGTCGTTATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2561.91801620372	48.8492161667927	0.0190674392614554	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2553.59273802879	2553.59273802879
"AML-2123"	"2020-07-29-AML2123-c2:CTCAAGAGTGTTCCTC"	10.9274908500606	-2.27837946331175	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAAGAGTGTTCCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1478.58264077767	46.0414708827966	0.0311389229205211	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1475.52027064681	1475.52027064681
"AML-2123"	"2020-07-29-AML2123-c2:CTCAAGATCCATAAGC"	-7.33333049240764	2.54821679675905	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTCAAGATCCATAAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2843.61889621429	45.9241143438831	0.0161498836588201	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2834.02062477402	2834.02062477402
"AML-2123"	"2020-07-29-AML2123-c2:TTGGGATGTCGTAATC"	-7.65918288651164	2.65145847881166	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGGGATGTCGTAATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2298.85846699871	46.8377673994258	0.0203743588706334	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2289.19654217042	2289.19654217042
"AML-2123"	"2020-07-29-AML2123-c2:TTGTGTTTCCTGGGTG"	10.5985990959102	-0.534351908322893	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGTGTTTCCTGGGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1140.8899497679	24.2548089703749	0.0212595517870144	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1136.85992629928	1136.85992629928
"AML-2123"	"2020-07-29-AML2123-c2:TTGTTCACATGCCGGT"	8.90973057326619	7.94385907733766	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGTTCACATGCCGGT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1990.17889035615	41.5580316242555	0.0208815558368317	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1980.20465153377	1980.20465153377
"AML-2123"	"2020-07-29-AML2123-c2:TTGTTTGCAGAGATGC"	-7.89927421036418	2.89351294124452	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGTTTGCAGAGATGC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2154.99267327841	49.1444756763137	0.022804938636543	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2149.42548270394	2149.42548270394
"AML-2123"	"2020-07-29-AML2123-c2:TTTACCAAGAACTGAT"	1.25366880473439	11.4319019087586	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTACCAAGAACTGAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2016.04462160104	48.0323013627975	0.0238250189743581	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2007.16917621125	2007.16917621125
"AML-2123"	"2020-07-29-AML2123-c2:TTTACGTCACCCAAGC"	-1.81081102314647	3.77105066860048	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTACGTCACCCAAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2820.35934985925	47.232955843628	0.0167471410499464	4648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2814.64551454872	2814.64551454872
"AML-2123"	"2020-07-29-AML2123-c2:TTTACGTTCCTGTAAG"	-2.92003713074382	11.545588470343	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTACGTTCCTGTAAG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2331.88243575936	40.385288909578	0.0173187499893951	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2326.14740534436	2326.14740534436
"AML-2123"	"2020-07-29-AML2123-c2:TTTACTGAGCAGCCCT"	12.5179830985958	-2.70464708721312	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTACTGAGCAGCCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1715.74599541482	42.8155793880361	0.0249544976368628	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1709.25629499764	1709.25629499764
"AML-2123"	"2020-07-29-AML2123-c2:TTTATGCAGGATTTCC"	-2.32377610626872	3.93584797466127	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTATGCAGGATTTCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2910.63667149603	38.3325838977851	0.013169827850098	3882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2902.73312174639	2902.73312174639
"AML-2123"	"2020-07-29-AML2123-c2:TTTCATGTCCGAGCTG"	0.812514563172501	9.53820893848268	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCATGTCCGAGCTG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1863.53463919983	35.9616616816979	0.0192975547248959	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1860.38852608695	1860.38852608695
"AML-2123"	"2020-07-29-AML2123-c2:TTTCCTCAGACGGATC"	12.1592318015987	-2.41729881679686	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCCTCAGACGGATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1324.1976975722	32.8162418208892	0.0247819807276926	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1322.1498608552	1322.1498608552
"AML-2123"	"2020-07-29-AML2123-c2:TTTCCTCAGTTTCGAC"	1.06816699084584	11.5055904158386	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCCTCAGTTTCGAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2262.12062630047	37.984562781555	0.0167915726243459	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2246.83341088179	2246.83341088179
"AML-2123"	"2020-07-29-AML2123-c2:TTTCCTCGTTCTCCCA"	12.3167358833248	-2.52835681354674	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCCTCGTTCTCCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2259.62384933659	37.6533619573404	0.0166635530813658	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2248.80986420671	2248.80986420671
"AML-2123"	"2020-07-29-AML2123-c2:TTTCGATAGGAATTAC"	-2.58586941185649	3.72280786121217	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCGATAGGAATTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3100.48328974535	41.180910023801	0.0132820938464671	5347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3095.43538977556	3095.43538977556
"AML-2123"	"2020-07-29-AML2123-c2:TTTCGATGTCACCACG"	-2.45535407486613	10.4633950957092	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTTCGATGTCACCACG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2400.49270225178	43.3369276637746	0.0180533469746116	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2392.59587333728	2392.59587333728
"AML-2123"	"2020-07-29-AML2123-c2:GGTTGTAGTTCACCGG"	-7.48447499695476	2.4707038172516	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTTGTAGTTCACCGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2651.75899145709	47.1138731782545	0.0177670268414425	3136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2638.38417982826	2638.38417982826
"AML-2123"	"2020-07-29-AML2123-c2:GTAACCAAGGAACTAT"	-1.92875287953075	10.0892877348694	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAACCAAGGAACTAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2070.81829222727	48.2850357068723	0.0233168868017576	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2059.13176502416	2059.13176502416
"AML-2123"	"2020-07-29-AML2123-c2:GTAACCATCCTCAGAA"	-5.86174378815349	3.58637878978578	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAACCATCCTCAGAA"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2599.22933751186	35.3362280062476	0.0135948865674445	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2591.12976537619	2591.12976537619
"AML-2123"	"2020-07-29-AML2123-c2:GTAAGTCTCTACGGTA"	-2.5407272380894	10.0536317595276	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAAGTCTCTACGGTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2074.58081408076	44.4515149511048	0.0214267454173874	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2069.10549103338	2069.10549103338
"AML-2123"	"2020-07-29-AML2123-c2:GTAATGCCATGAGTAA"	11.7732378440792	-1.92170681869658	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAATGCCATGAGTAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1258.18688310295	36.6376505884951	0.0291194027536983	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1258.18688310295	1258.18688310295
"AML-2123"	"2020-07-29-AML2123-c2:GTACAACCAGTTTCAG"	-2.60288916054423	3.90984580600587	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTACAACCAGTTTCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3151.78393064056	44.6727844188243	0.0141738093098739	5447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3143.7796678917	3143.7796678917
"AML-2123"	"2020-07-29-AML2123-c2:GTACAACGTATACGGG"	-3.25195513191875	9.8184022673401	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTACAACGTATACGGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2020.04923044883	40.1207638258763	0.0198612802208598	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2016.9007070994	2016.9007070994
"AML-2123"	"2020-07-29-AML2123-c2:GTACAACGTCACCACG"	-1.05909476700481	10.9326495894226	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTACAACGTCACCACG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2010.3182243519	35.4598132605861	0.0176389055379617	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2008.71431510851	2008.71431510851
"AML-2123"	"2020-07-29-AML2123-c2:GTACAGTCACTCTGCT"	-1.5545782846516	14.1076059111389	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTACAGTCACTCTGCT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	1562.56466887795	46.4933765959929	0.0297545295385304	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	1560.31441098755	1560.31441098755
"AML-2123"	"2020-07-29-AML2123-c2:GTACAGTTCCTCACTG"	-7.00954757157024	-2.42585995113524	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	70	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.833333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTACAGTTCCTCACTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2285.01914384434	6.60884379351974	0.00289224876357095	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2271.50495460572	2271.50495460572
"AML-2123"	"2020-07-29-AML2123-c2:GTAGAAACACCTAAAC"	8.68903221663777	8.02670810306398	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAGAAACACCTAAAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1814.75498134092	34.6297411355721	0.0190823232291029	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1810.62809673525	1810.62809673525
"AML-2123"	"2020-07-29-AML2123-c2:GTAGGAGAGATACCAA"	-7.36481557312663	2.26807568157045	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAGGAGAGATACCAA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2584.5188198594	46.4340791247696	0.0179662375711761	3017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2575.50292514155	2575.50292514155
"AML-2123"	"2020-07-29-AML2123-c2:GTAGGAGTCTCGCCTA"	-3.05300531807597	13.6115302809509	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAGGAGTCTCGCCTA"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2316.6400509186	48.5828027200837	0.02097123491447	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2308.48604479276	2308.48604479276
"AML-2123"	"2020-07-29-AML2123-c2:CTTCGGTAGAACCCGA"	-2.84267459335979	3.52532265270082	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTCGGTAGAACCCGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2814.9971146084	8.67571934404709	0.003081963849634	3069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2814.00192058326	2814.00192058326
"AML-2123"	"2020-07-29-AML2123-c2:CTTCTAACAATGTTGC"	11.3742796379024	-2.84166886722716	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTCTAACAATGTTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2176.2007392885	50.5967384105979	0.0232500327277438	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2171.28868795117	2171.28868795117
"AML-2123"	"2020-07-29-AML2123-c2:CTTGATTCACAGTCAT"	11.2849575477535	-3.06259896671446	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTGATTCACAGTCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1890.05898793214	29.3901014362897	0.0155498329014824	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1878.4154628486	1878.4154628486
"AML-2123"	"2020-07-29-AML2123-c2:CTTTCAAAGCGCTGAA"	-2.74214611473735	3.23436901653139	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTTCAAAGCGCTGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3444.60711595217	17.9770565993747	0.00521889899028598	4149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3436.29702389592	3436.29702389592
"AML-2123"	"2020-07-29-AML2123-c2:CTTTCGGGTCGACTTA"	-2.94370851936992	3.53104970538942	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTTCGGGTCGACTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2909.97037740253	44.3771073739517	0.0152500203158643	3421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2904.25477454519	2904.25477454519
"AML-2123"	"2020-07-29-AML2123-c2:CTTTCGGGTTCTCGTC"	11.4056221443111	-1.9692044488159	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.CTTTCGGGTTCTCGTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1359.18078618956	41.1264374179443	0.0302582539687319	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1357.14243619887	1357.14243619887
"AML-2123"	"2020-07-29-AML2123-c2:GAAACCTCAGGAAGTC"	-5.01340613785441	2.47935245120851	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAACCTCAGGAAGTC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3127.73055789392	44.6145719100062	0.014264199260197	4922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3116.7869841792	3116.7869841792
"AML-2123"	"2020-07-29-AML2123-c2:GAAATGAAGCTGTACT"	-2.36457381668742	3.28438422763673	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAATGAAGCTGTACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3251.89401487866	34.9461221101239	0.0107463902421887	5742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3241.78614314157	3241.78614314157
"AML-2123"	"2020-07-29-AML2123-c2:GAACACTCAAGAGGCT"	-8.47298751297649	0.175207949522413	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAACACTCAAGAGGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2325.8634820189	51.522139690833	0.0221518331102179	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2320.08883410147	2320.08883410147
"AML-2123"	"2020-07-29-AML2123-c2:GAACACTTCATCAGTG"	-7.66228423538859	2.74151656711427	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAACACTTCATCAGTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2646.60510523069	38.01286878192	0.0143628789602167	2691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2637.75507325761	2637.75507325761
"AML-2123"	"2020-07-29-AML2123-c2:GAACGTTGTCTACAGT"	-1.1332108778065	11.5652122267517	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAACGTTGTCTACAGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2123.41332340001	43.7033036769472	0.0205816282658383	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2115.77795321608	2115.77795321608
"AML-2123"	"2020-07-29-AML2123-c2:GAACGTTGTTGCGAAG"	-3.68061004105266	9.88588903034059	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAACGTTGTTGCGAAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1824.04579156185	41.6100180115377	0.0228119371805403	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1817.30664697532	1817.30664697532
"AML-2123"	"2020-07-29-AML2123-c2:GAAGAATCAGGATGAC"	-7.63587413254436	2.26599619472352	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAGAATCAGGATGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3135.91805761257	43.8836578500107	0.0139938789993193	3160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3120.02157469729	3120.02157469729
"AML-2123"	"2020-07-29-AML2123-c2:GAAGAATTCTCGAACA"	10.8713528114254	-1.06371714985045	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAGAATTCTCGAACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1897.55475981274	30.6835192463024	0.0161700309767769	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1889.46475375952	1889.46475375952
"AML-2123"	"2020-07-29-AML2123-c2:GAAGCCCGTACGATTC"	-4.86142144623454	3.7882611521515	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAGCCCGTACGATTC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2326.74640606289	44.5147089884049	0.019131740731354	2528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2316.35999424713	2316.35999424713
"AML-2123"	"2020-07-29-AML2123-c2:GAAGTAAGTCGGTAAG"	11.0073782401973	-1.10359158432158	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAAGTAAGTCGGTAAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1591.6315607763	30.2100994649707	0.0189805858400018	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1583.88723389964	1583.88723389964
"AML-2123"	"2020-07-29-AML2123-c2:GAATAGAAGCATGTTC"	-2.00028310242351	3.72022960269777	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAATAGAAGCATGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3294.5615273461	37.2703294542505	0.0113126827788441	4903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3290.022670391	3290.022670391
"AML-2123"	"2020-07-29-AML2123-c2:GAATAGAAGGTGGTTG"	-4.01100430908855	11.6953277357849	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAATAGAAGGTGGTTG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2100.43197464168	48.4108297127793	0.0230480350219568	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2098.88992531456	2098.88992531456
"AML-2123"	"2020-07-29-AML2123-c2:GAATAGAGTCGCGGTT"	11.4900032478267	-3.15259816562804	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAATAGAGTCGCGGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2652.41023151559	36.7190645334837	0.0138436596636495	3249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2642.95676166824	2642.95676166824
"AML-2123"	"2020-07-29-AML2123-c2:GAATCACGTCTCGCGA"	-2.13602934303935	3.70626518810121	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAATCACGTCTCGCGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2740.05453565441	39.9374259346268	0.014575412793778	4428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2737.78182940619	2737.78182940619
"AML-2123"	"2020-07-29-AML2123-c2:GACCAATAGTATAACG"	11.036035199731	-2.48424365436705	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACCAATAGTATAACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1382.91204403098	28.5134711770244	0.0206184271082866	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1381.06516658676	1381.06516658676
"AML-2123"	"2020-07-29-AML2123-c2:GACCAATGTTGTAGCT"	-4.22827468338664	13.1709604033264	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACCAATGTTGTAGCT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2280.6807482774	39.6711893623535	0.0173944509297574	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2275.93884079012	2275.93884079012
"AML-2123"	"2020-07-29-AML2123-c2:GACCCTTAGGAACGAA"	11.112095494836	-2.27540256893309	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACCCTTAGGAACGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1243.14634181502	43.2095659886437	0.034758229610809	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1239.13630366906	1239.13630366906
"AML-2123"	"2020-07-29-AML2123-c2:GACCCTTTCTCCATAT"	9.46128716048543	8.01714942539064	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACCCTTTCTCCATAT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2578.91086264238	43.5685031184986	0.0168941485142522	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2574.02024005076	2574.02024005076
"AML-2123"	"2020-07-29-AML2123-c2:GACTATGAGATACAGT"	11.97163929519	-3.15681865131529	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTATGAGATACAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2528.89611153122	45.2061841735212	0.017875856571328	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2516.34775584208	2516.34775584208
"AML-2123"	"2020-07-29-AML2123-c2:GACTATGAGATCCCAT"	-2.28842935982402	11.030940032843	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTATGAGATCCCAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2235.67754520809	42.1560306165769	0.0188560424140473	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2232.95517651854	2232.95517651854
"AML-2123"	"2020-07-29-AML2123-c2:GACTATGTCATGCATG"	-8.25898871842082	0.231103307846464	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTATGTCATGCATG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3348.73481922634	47.3876647593779	0.0141509158883849	4464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3334.41211756189	3334.41211756189
"AML-2123"	"2020-07-29-AML2123-c2:GACTCTCCAAGGTTGG"	-7.68549523773845	2.37588808620302	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTCTCCAAGGTTGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2620.97267825996	38.1505502197558	0.0145558748231911	2805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2609.2597601756	2609.2597601756
"AML-2123"	"2020-07-29-AML2123-c2:GACTGATGTGAGCTCC"	0.505273719399613	11.5658607252869	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTGATGTGAGCTCC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2153.68669957126	39.6749378471536	0.0184218706718353	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2145.44540235979	2145.44540235979
"AML-2123"	"2020-07-29-AML2123-c2:GACTTCCGTAAGTAGT"	-1.9701648754185	3.91717550838319	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GACTTCCGTAAGTAGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3116.8245759201	41.452951031909	0.0132997382503222	5807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3106.05776401682	3106.05776401682
"AML-2123"	"2020-07-29-AML2123-c2:GAGAAATAGGGTTGCA"	-2.44976387444194	3.67955730045167	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGAAATAGGGTTGCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2972.143829472	42.6368642778503	0.0143454915791961	3090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2964.9466751881	2964.9466751881
"AML-2123"	"2020-07-29-AML2123-c2:GAGACCCGTTAGGGAC"	12.5022617774898	-2.68526651775511	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGACCCGTTAGGGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1649.75943644382	37.8535728864002	0.0229449046025743	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1646.02829827134	1646.02829827134
"AML-2123"	"2020-07-29-AML2123-c2:GAGACTTGTAATGATG"	-3.0612293285435	9.70764253223268	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGACTTGTAATGATG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2370.50020121443	33.3325650735167	0.0140614057136296	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2366.45156205076	2366.45156205076
"AML-2123"	"2020-07-29-AML2123-c2:GAGACTTTCCGATGCG"	11.1279560523922	-0.815135919210039	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGACTTTCCGATGCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1303.36593240155	44.1855715253874	0.0339011250999726	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1301.08650496643	1301.08650496643
"AML-2123"	"2020-07-29-AML2123-c2:GAGAGGTCAGAGTCAG"	-7.50003371658977	2.40775535190431	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGAGGTCAGAGTCAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2502.67511456516	48.8606240325544	0.0195233587245079	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2494.96621716278	2494.96621716278
"AML-2123"	"2020-07-29-AML2123-c2:GAGCCTGCAGATCCAT"	-2.70663366738017	3.54597470844118	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGCCTGCAGATCCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3115.43880223559	39.271466651033	0.0126054367117892	4751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3108.13255989599	3108.13255989599
"AML-2123"	"2020-07-29-AML2123-c2:GAGCCTGGTATCGTGT"	-7.79834638062175	2.80474898898927	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGCCTGGTATCGTGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2415.92129982457	43.2523755822089	0.0179030565214809	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2411.94645566482	2411.94645566482
"AML-2123"	"2020-07-29-AML2123-c2:GAGTGAGCAAGGTACG"	-2.2459114593571	3.84469769084779	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GAGTGAGCAAGGTACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2884.51559639791	36.4222657600895	0.012626822266301	4571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2882.25142500133	2882.25142500133
"AML-2123"	"2020-07-29-AML2123-c2:TACACCCAGTCGAAAT"	1.27412428435628	10.7403592833313	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACACCCAGTCGAAAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2383.96344541323	46.1509785162827	0.0193589287642298	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2377.17771207589	2377.17771207589
"AML-2123"	"2020-07-29-AML2123-c2:TACCGGGTCAAATGCC"	-7.06506190720256	2.59536168659059	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACCGGGTCAAATGCC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2311.85007903486	45.3736454425283	0.0196265518486694	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2302.00026627818	2302.00026627818
"AML-2123"	"2020-07-29-AML2123-c2:TACCTCGGTATACCCA"	-2.62506328049358	3.59699318492738	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACCTCGGTATACCCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2876.07749852094	33.4276559850303	0.0116226548144898	3777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2871.11707767679	2871.11707767679
"AML-2123"	"2020-07-29-AML2123-c2:TACCTGCTCTTCCCGA"	-3.4149194759434	3.57139656627504	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACCTGCTCTTCCCGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3456.57360493824	32.8128968846606	0.00949289690744105	5421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3449.9572972146	3449.9572972146
"AML-2123"	"2020-07-29-AML2123-c2:TACGCTCTCACCTTGC"	1.04387231644933	11.9013213881287	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACGCTCTCACCTTGC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1922.56297090701	34.5144610679894	0.0179523176043001	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1921.10505712725	1921.10505712725
"AML-2123"	"2020-07-29-AML2123-c2:TACGGGCTCGTGGCTG"	-7.62098536911662	2.56739089572755	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACGGGCTCGTGGCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2488.94993737479	45.089362186531	0.0181158172406187	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2472.37867724015	2472.37867724015
"AML-2123"	"2020-07-29-AML2123-c2:TACGTCCAGGCCACCT"	0.45339055833165	10.4590635069641	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACGTCCAGGCCACCT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1928.31234301654	37.5677796283286	0.0194822066893788	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1921.8071479239	1921.8071479239
"AML-2123"	"2020-07-29-AML2123-c2:TACGTCCCATACAGCT"	-7.5644510788029	2.75033590877382	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACGTCCCATACAGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2710.55409407046	42.7144610199222	0.0157585716932797	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2697.18525568366	2697.18525568366
"AML-2123"	"2020-07-29-AML2123-c2:TACGTCCGTAGTGCGA"	-3.81284318390544	13.3000621565613	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACGTCCGTAGTGCGA"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	3047.40249529732	46.4343033416563	0.0152373384918181	2500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	3037.84585958107	3037.84585958107
"AML-2123"	"2020-07-29-AML2123-c2:TACTGCCGTTGATCGT"	-2.24155841293986	3.8364526995453	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACTGCCGTTGATCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2595.23170602902	42.5921300134969	0.0164116868311028	2754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2591.69030799439	2591.69030799439
"AML-2123"	"2020-07-29-AML2123-c2:TACTTACGTAGTAAGT"	-2.89709768715556	9.93055627429811	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACTTACGTAGTAAGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1886.58414333767	42.7974734806619	0.0226851654784644	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1879.44999315819	1879.44999315819
"AML-2123"	"2020-07-29-AML2123-c2:TACTTGTGTTCGTAAC"	0.351348479359788	10.6776876219544	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACTTGTGTTCGTAAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2118.32568322436	40.1193782421311	0.0189391926651544	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2101.60239757115	2101.60239757115
"AML-2123"	"2020-07-29-AML2123-c2:TAGACCAGTATGCTAC"	11.3257538276607	-2.24245932018431	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAGACCAGTATGCTAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1857.63229847456	44.6100663361055	0.0240144760471372	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1851.99648180755	1851.99648180755
"AML-2123"	"2020-07-29-AML2123-c2:TAGCACAGTGCCCACA"	-7.55695376816447	2.31042358959047	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAGCACAGTGCCCACA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2462.16300275715	48.4236550068158	0.0196671199074109	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2446.34314691242	2446.34314691242
"AML-2123"	"2020-07-29-AML2123-c2:TAGGAGGTCACATTGG"	10.9488302665645	-2.62250568782958	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAGGAGGTCACATTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1791.58008300073	45.1167273850348	0.0251826462088529	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1783.03782173596	1783.03782173596
"AML-2123"	"2020-07-29-AML2123-c2:TAGGTACTCCTAGCCT"	-1.32518933239635	3.63982102954713	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAGGTACTCCTAGCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2105.66875648378	48.0115403704254	0.0228010888334588	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2103.98917282196	2103.98917282196
"AML-2123"	"2020-07-29-AML2123-c2:GCATCGGGTTACCGTA"	-2.96944008293803	9.42910573566285	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCATCGGGTTACCGTA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2041.99891998641	38.6518952339494	0.018928460174801	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2040.49536801169	2040.49536801169
"AML-2123"	"2020-07-29-AML2123-c2:GCATCTCCAGCCGTCA"	-2.80612597885783	3.98828909480897	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCATCTCCAGCCGTCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3044.410542782	40.4521185604944	0.0132873401901732	3756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3037.82446372608	3037.82446372608
"AML-2123"	"2020-07-29-AML2123-c2:GCATGATCAATGGGTG"	-8.00507102432903	2.84415743434755	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCATGATCAATGGGTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2208.85889613313	45.5063218300494	0.0206017332794384	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2204.89986890057	2204.89986890057
"AML-2123"	"2020-07-29-AML2123-c2:GCCATGGTCAGACAAA"	9.11383213576619	7.54338262164918	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCATGGTCAGACAAA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1985.95844250387	39.6489249225592	0.0199646297092553	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1981.93251564865	1981.93251564865
"AML-2123"	"2020-07-29-AML2123-c2:GCCATTCTCCTGTTGC"	-2.20135722580608	3.87835500324098	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCATTCTCCTGTTGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3049.25100194107	33.1204428106158	0.0108618289506283	4067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3042.7124730832	3042.7124730832
"AML-2123"	"2020-07-29-AML2123-c2:GCCCAGAGTACTTGTG"	-2.50880823555644	4.10541675174562	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCCAGAGTACTTGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3269.35854374089	25.7350005399452	0.0078715748657223	5581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3264.29467499553	3264.29467499553
"AML-2123"	"2020-07-29-AML2123-c2:GCCGATGCAAGAGGCT"	-2.94557295265849	9.76469323718873	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCGATGCAAGAGGCT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2747.0685204786	48.6186923377846	0.0176983908393061	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2733.15656079107	2733.15656079107
"AML-2123"	"2020-07-29-AML2123-c2:GCCGATGTCTACTCAT"	0.896677930920762	11.33420178974	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCGATGTCTACTCAT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2028.01405331624	32.0599993422189	0.0158085686288978	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2022.91128297546	2022.91128297546
"AML-2123"	"2020-07-29-AML2123-c2:GCCGTGATCCACGGGT"	-7.45143638077434	2.16664741123048	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCGTGATCCACGGGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2287.06593423666	45.939202859058	0.0200865231611221	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2278.98066981664	2278.98066981664
"AML-2123"	"2020-07-29-AML2123-c2:GCCGTGATCGTGGTAT"	-2.52859411659892	9.3973350294861	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCGTGATCGTGGTAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2175.75307785997	44.4039140726853	0.0204085263739395	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2172.97523290241	2172.97523290241
"AML-2123"	"2020-07-29-AML2123-c2:GCCTGTTGTTAAGGAT"	-3.16891775551494	13.4991502531799	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCCTGTTGTTAAGGAT"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2611.84774104726	40.8353624987823	0.015634664248234	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2600.14210021589	2600.14210021589
"AML-2123"	"2020-07-29-AML2123-c2:GCGTTTCAGACATCCT"	11.6706444221431	-2.257271074411	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCGTTTCAGACATCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1552.3083777213	35.9731698805729	0.0231739842397678	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1549.7112241099	1549.7112241099
"AML-2123"	"2020-07-29-AML2123-c2:GCGTTTCAGGGAGTTC"	8.72273983535115	8.1286411055359	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCGTTTCAGGGAGTTC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1970.07220199131	37.0707338884625	0.0188169417603031	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1965.76659484162	1965.76659484162
"AML-2123"	"2020-07-29-AML2123-c2:GCTACCTGTCCTGGTG"	0.210588921874207	10.5418863066467	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTACCTGTCCTGGTG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2111.50786121228	40.2363168914353	0.0190557267773251	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2108.76800878377	2108.76800878377
"AML-2123"	"2020-07-29-AML2123-c2:GCTGAATAGCAACTCT"	-9.16916976395305	-4.55366279995116	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	11	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	1	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTGAATAGCAACTCT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2144.09697388401	44.11907585288	0.0205769964653039	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2139.4613357322	2139.4613357322
"AML-2123"	"2020-07-29-AML2123-c2:GCTGAATAGCGTATGG"	-7.61670098725017	2.53198382938234	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTGAATAGCGTATGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2423.09126622123	46.1399387296944	0.0190417667600481	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2409.68689935605	2409.68689935605
"AML-2123"	"2020-07-29-AML2123-c2:GCTGGGTGTGTTCCTC"	0.423553993075532	4.43041703784791	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	54	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTGGGTGTGTTCCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1620.77133918233	34.2530260456167	0.0211337806990696	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1587.39587262464	1587.39587262464
"AML-2123"	"2020-07-29-AML2123-c2:GCTTGGGCATGTGGCC"	0.844417949288529	10.2209243544373	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTTGGGCATGTGGCC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1928.68737223808	32.9045980926523	0.0170606177892217	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1923.47161403473	1923.47161403473
"AML-2123"	"2020-07-29-AML2123-c2:GCTTGGGTCGTGCGAC"	-2.22008357468303	3.33122251117555	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GCTTGGGTCGTGCGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3043.16072647639	32.7895387596447	0.01077482975985	4996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3036.83785350381	3036.83785350381
"AML-2123"	"2020-07-29-AML2123-c2:GGAATGGCATAACGGG"	10.8896995979244	-2.57888224041136	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGAATGGCATAACGGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1778.2423577022	20.2377707301284	0.0113807719417274	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1774.67101939819	1774.67101939819
"AML-2123"	"2020-07-29-AML2123-c2:GGACGTCTCGGATTAC"	-7.06592927399333	0.165749638620295	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGACGTCTCGGATTAC"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2215.62556731659	47.2508452358183	0.0213261870294471	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2205.80293973375	2205.80293973375
"AML-2123"	"2020-07-29-AML2123-c2:GGAGATGAGAAGGCTC"	10.9487663703853	-2.39254643833312	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGAGATGAGAAGGCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1463.33558313858	32.6771547071479	0.0223305953081941	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1458.50094559026	1458.50094559026
"AML-2123"	"2020-07-29-AML2123-c2:GGAGGATTCTAACACG"	-7.71420226517375	2.96057818019716	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGAGGATTCTAACACG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2310.16407419912	44.2929542386357	0.0191730772430053	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2299.39855683419	2299.39855683419
"AML-2123"	"2020-07-29-AML2123-c2:GGATCTACATCAGCAT"	-7.88390145722087	1.88172981822816	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGATCTACATCAGCAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2347.38350781807	44.3543691590381	0.0188952376172508	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2343.47106827969	2343.47106827969
"AML-2123"	"2020-07-29-AML2123-c2:GGATCTACATTGGGAG"	11.1413370567257	-2.74716594135436	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGATCTACATTGGGAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1780.74024456014	28.4489446293334	0.015975909297406	3567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1771.49195477425	1771.49195477425
"AML-2123"	"2020-07-29-AML2123-c2:GGCACGTGTGGTCTTA"	-7.59490380707439	2.94992134654848	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGCACGTGTGGTCTTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2182.65553299015	45.7757933198667	0.020972522978537	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2175.00321984411	2175.00321984411
"AML-2123"	"2020-07-29-AML2123-c2:GGCGTCAAGCCGGATA"	11.3669449287349	-2.31776859676512	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGCGTCAAGCCGGATA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1579.45666926352	35.81974341108	0.022678522373002	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1577.33953813975	1577.33953813975
"AML-2123"	"2020-07-29-AML2123-c2:GGCGTCACATAACCCA"	-7.96240649643596	2.61459539020387	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGCGTCACATAACCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2315.93168870605	47.2762237636223	0.0204134793759985	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2311.97068584146	2311.97068584146
"AML-2123"	"2020-07-29-AML2123-c2:GGGAAGTAGGGCTTCC"	-4.10030732575114	12.658158279303	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00340301409820126	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGAAGTAGGGCTTCC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2815.66790810277	51.0909051272076	0.018145216976825	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2806.79695882635	2806.79695882635
"AML-2123"	"2020-07-29-AML2123-c2:GGGACAAAGATTAGCA"	-0.569182853133041	12.6843614348206	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGACAAAGATTAGCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2204.24690327538	44.4552605770584	0.0201680040974541	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2194.65879081858	2194.65879081858
"AML-2123"	"2020-07-29-AML2123-c2:GGGACAACATACCACA"	11.2252546745235	-2.20013787662657	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGACAACATACCACA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1646.42356318198	36.5369960524442	0.0221917353890578	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1643.84725042558	1643.84725042558
"AML-2123"	"2020-07-29-AML2123-c2:GGGACAATCCTTACCG"	0.690456946461838	11.0084094771179	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGACAATCCTTACCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1903.09514656277	45.3414767329869	0.0238251234127097	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1900.07843019129	1900.07843019129
"AML-2123"	"2020-07-29-AML2123-c2:GGGACCTCATCACAGT"	-8.31510959091838	-0.776055239793383	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGACCTCATCACAGT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3111.7922349213	34.3011961374976	0.0110229711844387	4663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3096.96456200546	3096.96456200546
"AML-2123"	"2020-07-29-AML2123-c2:GGGACCTGTAGTTACC"	8.67188133773152	7.89723155582277	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGACCTGTAGTTACC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1992.84464772847	35.7059212564807	0.0179170620736442	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1987.04953150004	1987.04953150004
"AML-2123"	"2020-07-29-AML2123-c2:GGGATCCGTGTTACTG"	10.9354578452999	-2.59876754200133	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGATCCGTGTTACTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1627.08359694354	41.7380057046545	0.0256520352015465	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1612.40302704463	1612.40302704463
"AML-2123"	"2020-07-29-AML2123-c2:GGGCGTTAGATGCGAC"	-8.14921222153361	0.931569612863935	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGCGTTAGATGCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2678.98194349466	36.9484231678371	0.0137919642413263	3326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2669.47507941266	2669.47507941266
"AML-2123"	"2020-07-29-AML2123-c2:GGGCTCATCTTCCCAG"	-2.69972453537639	3.29689190471498	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGCTCATCTTCCCAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3412.54110788315	45.404676523609	0.013305239435423	5790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3406.04003215512	3406.04003215512
"AML-2123"	"2020-07-29-AML2123-c2:GGGTATTGTACAGTTC"	12.5889107185299	-2.69948317920836	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGTATTGTACAGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1532.17823419072	40.2601526186812	0.0262764159679806	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1526.41529802858	1526.41529802858
"AML-2123"	"2020-07-29-AML2123-c2:GGGTCACCAAGACCGA"	-0.730008463293868	11.7575549849304	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGTCACCAAGACCGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2097.80173820544	46.4057432795075	0.0221211291965108	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2088.33835886355	2088.33835886355
"AML-2123"	"2020-07-29-AML2123-c2:GGGTGAATCGCGGACT"	-7.60563073578532	2.58000276172487	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGTGAATCGCGGACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2677.95592260704	42.8770621342003	0.0160111157066613	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2663.43059113757	2663.43059113757
"AML-2123"	"2020-07-29-AML2123-c2:GGGTGAATCTGGACTA"	-3.17225656929668	3.56919429385988	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGTGAATCTGGACTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2987.20407638979	39.8994866796785	0.0133567997563458	4448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2980.34786298614	2980.34786298614
"AML-2123"	"2020-07-29-AML2123-c2:GGGTTATTCGGCTATA"	-5.13793788376506	-2.72795178806456	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	43	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGGTTATTCGGCTATA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2517.85372569559	41.131958379324	0.0163361191158794	2854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2513.58585588383	2513.58585588383
"AML-2123"	"2020-07-29-AML2123-c2:GGTAATCAGGTCACCC"	-3.740954498679	10.9107932814392	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTAATCAGGTCACCC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1837.1146844016	44.904373511055	0.0244428798552017	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1837.1146844016	1837.1146844016
"AML-2123"	"2020-07-29-AML2123-c2:GGTAATCCAAGTACCT"	11.4389683204586	-1.61587848579558	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTAATCCAAGTACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1372.94324273802	47.6337692341657	0.0346946383152527	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1371.19487657538	1371.19487657538
"AML-2123"	"2020-07-29-AML2123-c2:GGTAGAGGTGTTCCTC"	-7.87038646164592	2.68041679942933	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTAGAGGTGTTCCTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2516.46209875347	44.3470870528394	0.0176227915671	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2507.15116273695	2507.15116273695
"AML-2123"	"2020-07-29-AML2123-c2:GGTGTCGTCTGGGTCG"	-2.88069091263469	9.63537404620973	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTGTCGTCTGGGTCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1901.49686456245	48.1637532753488	0.025329388742606	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1896.52304777816	1896.52304777816
"AML-2123"	"2020-07-29-AML2123-c2:GGTTAACAGTAACCTC"	-2.98038301888164	3.63324377620546	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTTAACAGTAACCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3352.77588429654	37.0079782419934	0.0110380113431764	5238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3343.29207256956	3343.29207256956
"AML-2123"	"2020-07-29-AML2123-c2:GGTTAACGTACACGTT"	12.407864232629	-2.36888744747313	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GGTTAACGTACACGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1353.65885574829	43.3554620292582	0.0320283517853482	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1350.74943671497	1350.74943671497
"AML-2123"	"2020-07-29-AML2123-c2:TCGAACATCTGCGGAC"	-1.70059023323711	3.94004962528077	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGAACATCTGCGGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3153.62261237494	15.4391770818196	0.0048956958328608	4986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3149.73275748263	3149.73275748263
"AML-2123"	"2020-07-29-AML2123-c2:TCGACGGAGATGACAT"	-2.01056228104289	3.75114629352418	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGACGGAGATGACAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2764.01672860522	47.819626883542	0.0173007733233484	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2757.44737817938	2757.44737817938
"AML-2123"	"2020-07-29-AML2123-c2:TCGACGGCACAGTCGC"	-3.65618071976359	9.82189748370973	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGACGGCACAGTCGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1853.34627592624	42.6967680177793	0.0230376635884953	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1848.30372876964	1848.30372876964
"AML-2123"	"2020-07-29-AML2123-c2:TCGCACTAGGGTATAT"	-7.57417760315593	2.51578352535097	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGCACTAGGGTATAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2661.42494669638	42.2297977936711	0.0158673637767208	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2652.10718448641	2652.10718448641
"AML-2123"	"2020-07-29-AML2123-c2:TCGCAGGGTGTCTCCT"	-7.71910415116008	2.21853587711183	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGCAGGGTGTCTCCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2297.99341447284	45.9900347168209	0.0200131272906068	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2286.41029957966	2286.41029957966
"AML-2123"	"2020-07-29-AML2123-c2:TCGCAGGTCAATCAGC"	12.3873096900875	-2.71333768283995	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGCAGGTCAATCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1515.19423708363	43.4560331180598	0.0286801731781279	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1501.25343999881	1501.25343999881
"AML-2123"	"2020-07-29-AML2123-c2:TCGCTCAAGGTGGCTA"	1.8886122899944	-10.2889480820862	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGCTCAAGGTGGCTA"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2402.13063156784	48.9039199207894	0.0203585597211549	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2399.29491711513	2399.29491711513
"AML-2123"	"2020-07-29-AML2123-c2:TCGCTTGAGTCATGCT"	-7.76925406876262	3.08049461925355	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGCTTGAGTCATGCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2541.85399071441	46.4290985841877	0.0182658401126881	3066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2531.73236527329	2531.73236527329
"AML-2123"	"2020-07-29-AML2123-c2:TCGGGTGAGGTTACCT"	12.4729649024898	-2.48127558147582	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGGGTGAGGTTACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1276.08178309453	41.0659502138384	0.0321812839567794	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1273.996791136	1273.996791136
"AML-2123"	"2020-07-29-AML2123-c2:TCGTCCAGTTCTCACC"	-6.96443162384685	-2.67326214229735	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	66	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.117647058823529	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCGTCCAGTTCTCACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1635.47075889088	44.1381203553801	0.0269880217151134	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1625.26645140534	1625.26645140534
"AML-2123"	"2020-07-29-AML2123-c2:TCTACATAGCCAGACA"	-3.13101182404216	9.81896779620973	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTACATAGCCAGACA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2162.68849312233	43.8544442880827	0.0202777443110953	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2153.50166800911	2153.50166800911
"AML-2123"	"2020-07-29-AML2123-c2:TCTACATAGTGCCGAA"	-8.77153430405315	1.20832560146181	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTACATAGTGCCGAA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2683.0725050649	39.5025005037497	0.0147228598665075	3261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2675.78268243028	2675.78268243028
"AML-2123"	"2020-07-29-AML2123-c2:TCTACATGTAACGTTC"	-1.4362977546757	10.3270005949768	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTACATGTAACGTTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2095.58258500958	34.0949155413597	0.0162698983019101	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2089.20994888035	2089.20994888035
"AML-2123"	"2020-07-29-AML2123-c2:GTAGGTTGTCTTGAGT"	-3.94809327545818	10.9899167784485	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAGGTTGTCTTGAGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2464.94700711154	39.8399716562625	0.0161626077726302	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2458.09317986626	2458.09317986626
"AML-2123"	"2020-07-29-AML2123-c2:GTAGTACGTTCGATTG"	-4.05467830124553	9.74861619556276	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTAGTACGTTCGATTG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2623.44182576589	44.7911151491958	0.0170734165740914	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2614.19101954572	2614.19101954572
"AML-2123"	"2020-07-29-AML2123-c2:GTATTGGAGCTCCGAC"	-0.431499372155029	11.5927772291931	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTATTGGAGCTCCGAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2267.75718881648	47.9379953039106	0.0211389453598994	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2259.0490141051	2259.0490141051
"AML-2123"	"2020-07-29-AML2123-c2:GTCAGCGTCTCATGCC"	-2.58813629570659	4.15623900974122	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTCAGCGTCTCATGCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3040.47342675854	46.2611886141057	0.0152151267651186	3832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3037.05559506047	3037.05559506047
"AML-2123"	"2020-07-29-AML2123-c2:GTCGAATCATAATCGC"	-7.61446414414104	1.29536256873933	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTCGAATCATAATCGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2923.26083328473	41.7365941392363	0.0142774102344945	3054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2913.34131382654	2913.34131382654
"AML-2123"	"2020-07-29-AML2123-c2:GTCGTAAAGAGAATCT"	-8.66172156754192	3.87070987308351	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.333333333333333	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTCGTAAAGAGAATCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2399.79758234091	46.8180105984012	0.0195091498311837	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2387.16327516465	2387.16327516465
"AML-2123"	"2020-07-29-AML2123-c2:GTCGTTCGTAGTGATA"	-7.52262340012248	0.139855734351553	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTCGTTCGTAGTGATA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2818.19806594277	49.009682913897	0.0173904323852063	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2806.36564155588	2806.36564155588
"AML-2123"	"2020-07-29-AML2123-c2:GTCTTTAAGCCTTCTC"	-2.73297033730205	3.99496862972108	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTCTTTAAGCCTTCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3376.02868827076	28.5407939439945	0.00845395480291768	5583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3371.55438994707	3371.55438994707
"AML-2123"	"2020-07-29-AML2123-c2:GTGAGTTGTTAGGGAC"	-7.44603572312053	2.38388583743898	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGAGTTGTTAGGGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2679.19500356462	42.2101601474561	0.0157547920518276	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2672.51414020114	2672.51414020114
"AML-2123"	"2020-07-29-AML2123-c2:GTGATGTGTATGCTTG"	11.9638811546261	-2.01465752041014	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGATGTGTATGCTTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1328.09887753866	40.9222299268341	0.0308126379887275	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1323.11863058669	1323.11863058669
"AML-2123"	"2020-07-29-AML2123-c2:GTGCTGGTCCGTGTGG"	-1.94503972950633	3.80649468982545	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGCTGGTCCGTGTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2553.02714236135	44.2507099257178	0.0173326437433757	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2547.86001274339	2547.86001274339
"AML-2123"	"2020-07-29-AML2123-c2:GTGGAAGGTTGCTGAT"	-7.58114610138591	2.5946223505768	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGGAAGGTTGCTGAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2946.5693110442	40.8222080798743	0.0138541482553512	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2935.34666728048	2935.34666728048
"AML-2123"	"2020-07-29-AML2123-c2:GTGGAGACACCCGTAG"	-8.29676566544231	-0.659012400266253	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGGAGACACCCGTAG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2626.01930748175	44.834048694642	0.0170730080189837	2917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2615.05780259764	2615.05780259764
"AML-2123"	"2020-07-29-AML2123-c2:GTGGCGTTCTGCCTCA"	-7.54780755463298	2.46399257266847	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGGCGTTCTGCCTCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2794.89818342906	45.8988179931375	0.0164223578036837	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2781.2556401451	2781.2556401451
"AML-2123"	"2020-07-29-AML2123-c2:GTGGTTAAGGGCAATC"	11.9076649146969	-2.1065027943817	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGGTTAAGGGCAATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1483.07043461338	36.530138160322	0.0246314249868011	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1474.19076483755	1474.19076483755
"AML-2123"	"2020-07-29-AML2123-c2:GTGGTTAGTGTTACAC"	9.16297115859334	7.90765092456666	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGGTTAGTGTTACAC"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	2149.85142654781	39.5764871981147	0.0184089405944046	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	2142.5301752241	2142.5301752241
"AML-2123"	"2020-07-29-AML2123-c2:GTGTCCTGTGGGTTGA"	-7.49015746536906	5.26865432346193	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	1	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTCCTGTGGGTTGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1484.53867420085	40.2288828573862	0.0270985751712007	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1480.18065642645	1480.18065642645
"AML-2123"	"2020-07-29-AML2123-c2:GTGTGATAGCCTCTCT"	-7.58464703980144	1.75177333438722	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTGATAGCCTCTCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2828.00024790556	47.1318245992364	0.0166661317070756	4030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2815.72982288175	2815.72982288175
"AML-2123"	"2020-07-29-AML2123-c2:GTGTGATTCCCATGGG"	-7.62651048126872	2.41610596263734	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTGATTCCCATGGG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2626.14358208225	44.4316302535491	0.016918964582401	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2613.22780434404	2613.22780434404
"AML-2123"	"2020-07-29-AML2123-c2:GTGTGGCAGCGACTGA"	-7.67232499542888	2.80599472606508	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTGGCAGCGACTGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2626.27286722383	49.6471192134419	0.0189040216776571	3144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2616.79786482709	2616.79786482709
"AML-2123"	"2020-07-29-AML2123-c2:GTGTGGCGTATGAGGC"	-3.65192637863811	13.4474887617859	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTGGCGTATGAGGC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2285.01082861482	21.3413425202831	0.00933971176548875	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2283.37950562221	2283.37950562221
"AML-2123"	"2020-07-29-AML2123-c2:GTGTTCCTCGGACGTC"	-3.4183443588322	9.91520021045534	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTGTTCCTCGGACGTC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2112.29053159279	40.2021535407812	0.0190324924244519	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2101.49059610586	2101.49059610586
"AML-2123"	"2020-07-29-AML2123-c2:GTTATGGTCCAGCAAT"	-1.46504555168803	10.3854179152283	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTATGGTCCAGCAAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2146.22583178304	47.1131826293978	0.0219516427077281	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2141.80673273521	2141.80673273521
"AML-2123"	"2020-07-29-AML2123-c2:GTTCATTTCACTCCGT"	-3.10078559342082	3.71655438030092	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTCATTTCACTCCGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3149.53660127006	36.2559961194031	0.0115115335077493	4820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3142.66511508787	3142.66511508787
"AML-2123"	"2020-07-29-AML2123-c2:GTTGAACAGCTATCTG"	-2.43546805802043	13.4206332930359	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGAACAGCTATCTG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2321.49396454291	45.172514593784	0.019458381233689	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2318.36744257357	2318.36744257357
"AML-2123"	"2020-07-29-AML2123-c2:GTTGAACTCGTGGACC"	10.9132477241451	-2.58471300518187	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGAACTCGTGGACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1765.53290632544	44.8295061898753	0.0253914871987166	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1760.95389125156	1760.95389125156
"AML-2123"	"2020-07-29-AML2123-c2:GTTGCGGCAGACATCT"	-7.36043010178264	3.1259555586609	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGCGGCAGACATCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1985.53408585562	47.8932445640094	0.0241210890838829	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1980.31613707077	1980.31613707077
"AML-2123"	"2020-07-29-AML2123-c2:GTTGCGGTCCCTCAAC"	0.436413486569566	8.93550012195436	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGCGGTCCCTCAAC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1954.92920487329	34.8818281132019	0.0178430134586193	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1948.67721004231	1948.67721004231
"AML-2123"	"2020-07-29-AML2123-c2:GTTGTCCGTAAGATTG"	8.75333752211873	7.64027879321901	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGTCCGTAAGATTG"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1964.17116952457	36.0152696968538	0.0183361156378094	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1957.16346457284	1957.16346457284
"AML-2123"	"2020-07-29-AML2123-c2:GTTGTCCGTGATCGTT"	8.39893211898152	8.00819346988527	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.GTTGTCCGTGATCGTT"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1908.24339541133	39.2169530844768	0.0205513369933731	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1904.42368724892	1904.42368724892
"AML-2123"	"2020-07-29-AML2123-c2:TAACTTCCATCGCTCT"	-2.51168737831767	3.42842648113099	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAACTTCCATCGCTCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3333.94226771434	38.1836957306151	0.0114530164785345	5101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3326.23375376805	3326.23375376805
"AML-2123"	"2020-07-29-AML2123-c2:TAACTTCTCTTGATTC"	-7.50672231140788	2.40975401485292	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAACTTCTCTTGATTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2377.89664888003	48.6070801865424	0.0204412080774982	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2367.71387258534	2367.71387258534
"AML-2123"	"2020-07-29-AML2123-c2:TAAGCGTCAAACGAGC"	-2.44116959992107	13.6203946837219	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAAGCGTCAAACGAGC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2235.77970132824	46.0377247818045	0.0205913510863589	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2229.86645553725	2229.86645553725
"AML-2123"	"2020-07-29-AML2123-c2:TAATCTCCAAATTGCC"	11.3932606178219	-2.49995925342711	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAATCTCCAAATTGCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2080.77477545022	47.0277273388597	0.022601065667323	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2065.8674996602	2065.8674996602
"AML-2123"	"2020-07-29-AML2123-c2:TAATCTCCACACCTTC"	-4.81032262268718	2.71048877322999	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAATCTCCACACCTTC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3178.98860316023	43.3656194971576	0.0136413258776857	4326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3162.89990839799	3162.89990839799
"AML-2123"	"2020-07-29-AML2123-c2:TAATCTCTCCCAATAG"	-7.47265944901164	2.62214396083681	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAATCTCTCCCAATAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2498.03539381505	44.4939501566052	0.0178115771565002	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2489.72288519068	2489.72288519068
"AML-2123"	"2020-07-29-AML2123-c2:TAATTCCGTAGTTACC"	-2.21899805489238	4.09787747943727	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAATTCCGTAGTTACC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3168.47813964142	44.3414684946896	0.0139945634908839	5882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3163.08238825928	3163.08238825928
"AML-2123"	"2020-07-29-AML2123-c2:TACAACGGTACCTGTA"	-7.54946599426921	2.67718694293825	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TACAACGGTACCTGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2327.23683798587	46.0393867473984	0.0197828540679356	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2316.41091239425	2316.41091239425
"AML-2123"	"2020-07-29-AML2123-c2:TGGATGTTCATCGCTC"	1.066218872636	11.8385133513245	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGATGTTCATCGCTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2060.56032051689	34.6538071551268	0.016817662074767	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2056.07920734073	2056.07920734073
"AML-2123"	"2020-07-29-AML2123-c2:TGGGAGAAGGTCTGGA"	11.9327036338741	-3.01646473323973	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGGAGAAGGTCTGGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2032.55546660983	41.1655774950092	0.0202531139598718	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2025.78085161315	2025.78085161315
"AML-2123"	"2020-07-29-AML2123-c2:TGGGCGTTCCCGAATA"	-7.64453874054607	2.10645482623903	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGGCGTTCCCGAATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2841.19224834052	46.5426337704829	0.0163813743324365	3258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2829.75750139464	2829.75750139464
"AML-2123"	"2020-07-29-AML2123-c2:TGGGCTGTCGCGTGAC"	-4.57440553131755	4.09445998752443	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGGCTGTCGCGTGAC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2894.67017855073	45.8430411862651	0.0158370516703279	3431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2884.61829285279	2884.61829285279
"AML-2123"	"2020-07-29-AML2123-c2:TGGGTTAAGAGTACCG"	-2.02695832672771	4.21671674335328	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGGTTAAGAGTACCG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2943.55764781006	34.7948493034557	0.0118206787386489	5403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2937.90726115642	2937.90726115642
"AML-2123"	"2020-07-29-AML2123-c2:TGGTACATCCGGGACT"	10.9001509147579	-2.95631053363951	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGTACATCCGGGACT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1801.15390190699	40.6281174206228	0.0225567162126498	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1797.69548882697	1797.69548882697
"AML-2123"	"2020-07-29-AML2123-c2:TGGTGATGTAGGGAGG"	-0.993676762015182	12.4331636198792	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGTGATGTAGGGAGG"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2506.51622869847	45.8136303447905	0.0182778111788167	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2502.99592600954	2502.99592600954
"AML-2123"	"2020-07-29-AML2123-c2:TGGTTAGTCCCTATTA"	-7.33830628815349	2.4142741926941	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGTTAGTCCCTATTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2362.0356908674	40.2123054709489	0.0170244275420673	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2349.69279444378	2349.69279444378
"AML-2123"	"2020-07-29-AML2123-c2:TGTAACGAGTAACGTA"	-7.5465272468632	2.46623561466066	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTAACGAGTAACGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2571.38967076556	48.4936861131353	0.018858941009395	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2556.83541434724	2556.83541434724
"AML-2123"	"2020-07-29-AML2123-c2:TGTAGACAGCCTCGTG"	-6.27191195908244	4.66714284503785	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	67	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.5	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTAGACAGCCTCGTG"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2778.83791623575	40.6863661953053	0.0146415039026168	3185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2768.32025257524	2768.32025257524
"AML-2123"	"2020-07-29-AML2123-c2:TGTAGACCAAGCGGAT"	12.0099102455074	-2.24627664005431	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTAGACCAAGCGGAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1983.22603107866	26.4819801904677	0.013352981342255	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1978.95038413907	1978.95038413907
"AML-2123"	"2020-07-29-AML2123-c2:TGTCAGAAGAAGATCT"	-7.59838710251506	2.50948832118837	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTCAGAAGAAGATCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2470.61925726839	45.1590475381526	0.0182784325853925	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2462.35439962814	2462.35439962814
"AML-2123"	"2020-07-29-AML2123-c2:TGTCCACCAGCGTATT"	-7.37529836121257	2.40982935512391	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTCCACCAGCGTATT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2185.65773107222	47.1924324010959	0.0215918676241886	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2174.28746572819	2174.28746572819
"AML-2123"	"2020-07-29-AML2123-c2:TGTCCCACATCCTATT"	-7.49507508698161	2.39818451488344	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTCCCACATCCTATT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2334.59662409547	51.1806184202621	0.0219226815853432	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2325.18744696531	2325.18744696531
"AML-2123"	"2020-07-29-AML2123-c2:TAGTGCAGTCACCTTC"	-7.51935134354289	2.39481041515199	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TAGTGCAGTCACCTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2591.36178886426	44.5936148657792	0.0172085638745656	2526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2581.02352193201	2581.02352193201
"AML-2123"	"2020-07-29-AML2123-c2:TATCTTGAGCGACCCT"	-7.47716126862224	2.33052537525026	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TATCTTGAGCGACCCT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2538.3864887373	47.485963377679	0.0187071447111667	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2527.41045636111	2527.41045636111
"AML-2123"	"2020-07-29-AML2123-c2:TATGTTCTCTACAGGT"	-7.55660472336467	2.82614967906801	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TATGTTCTCTACAGGT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2286.87155272245	51.4095864494628	0.0224803121925503	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2277.3083687645	2277.3083687645
"AML-2123"	"2020-07-29-AML2123-c2:TATTCCACACGGTGCT"	-1.91982541504558	3.93686149204103	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TATTCCACACGGTGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3158.11712048379	41.1712827370933	0.0130366548061354	5517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3150.9745518929	3150.9745518929
"AML-2123"	"2020-07-29-AML2123-c2:TATTGCTTCTGTACAG"	11.8502394157345	-2.05468895351561	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TATTGCTTCTGTACAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1213.49287631498	25.0773768466394	0.0206654504003287	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1211.72008782777	1211.72008782777
"AML-2123"	"2020-07-29-AML2123-c2:TATTTCGCAATACCTG"	-1.97598920288737	3.76067540729371	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TATTTCGCAATACCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3023.64811315327	34.5782001651235	0.0114359207391574	5477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3017.91648580254	3017.91648580254
"AML-2123"	"2020-07-29-AML2123-c2:TCAAGTGGTATAATGG"	11.7219606834346	-2.07349064266356	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAAGTGGTATAATGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2644.09623634878	37.0865986211133	0.0140261909197095	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2635.89712988162	2635.89712988162
"AML-2123"	"2020-07-29-AML2123-c2:TCAATCTGTTACTCAG"	-7.56637320938762	2.79104278171388	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAATCTGTTACTCAG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2303.75453890626	42.8820887128069	0.0186140007490407	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2293.39252368318	2293.39252368318
"AML-2123"	"2020-07-29-AML2123-c2:TCAATTCCATGATCTG"	-3.8824294609135	3.30412361705629	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAATTCCATGATCTG"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3102.83373157847	38.9290804296648	0.0125462992210868	5187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3094.61139159446	3094.61139159446
"AML-2123"	"2020-07-29-AML2123-c2:TCAATTCGTACTCCCT"	12.0279909568721	-3.09195330059203	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAATTCGTACTCCCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2172.91365072314	39.5921911223917	0.0182207843874585	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2165.91522155158	2165.91522155158
"AML-2123"	"2020-07-29-AML2123-c2:TCACACCAGTTCATCG"	1.28658713874165	10.1996278532776	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACACCAGTTCATCG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2014.64213554306	36.4467327739325	0.0180909215244364	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2011.02975988191	2011.02975988191
"AML-2123"	"2020-07-29-AML2123-c2:TCACACCCACGCTGCA"	-7.53606543961223	2.44973037326661	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACACCCACGCTGCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2454.9121413406	50.0464661992443	0.0203862555227392	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2447.77172492005	2447.77172492005
"AML-2123"	"2020-07-29-AML2123-c2:TCACACCCAGATACCT"	-1.8909424346989	3.88919017398683	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACACCCAGATACCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3045.96056022726	38.9261744311987	0.012779605533794	3326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3042.81520167218	3042.81520167218
"AML-2123"	"2020-07-29-AML2123-c2:TCACGCTGTCCACAGC"	-7.61551652374919	2.52904293620912	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACGCTGTCCACAGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2502.21865216725	34.5198133022103	0.0137956821928058	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2493.31509925778	2493.31509925778
"AML-2123"	"2020-07-29-AML2123-c2:TCACGGGGTTAAAGTG"	11.0421711402828	-2.69481136715087	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACGGGGTTAAAGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1918.68027155572	46.2397580507033	0.0240997725031127	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1909.79167071748	1909.79167071748
"AML-2123"	"2020-07-29-AML2123-c2:TCACGGGGTTTGCCGG"	11.0339275794918	-0.794833981153093	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACGGGGTTTGCCGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1191.73443132966	44.1623996673574	0.0370572490870166	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1181.8165288271	1181.8165288271
"AML-2123"	"2020-07-29-AML2123-c2:TCACGGGTCCATCTCG"	-3.19702015343364	10.0071983107361	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACGGGTCCATCTCG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2088.85465338185	37.5983726222595	0.0179995159363472	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2087.23967484828	2087.23967484828
"AML-2123"	"2020-07-29-AML2123-c2:TCACTCGAGCGTATAA"	9.19309200820271	7.1369476088318	"2020-07-29-AML2123-c2"	"AML2123"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0166414523449319	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCACTCGAGCGTATAA"	"B"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"B"	"B"	1881.93224239355	46.5943774023944	0.0247587964926585	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	71	TRUE	"B_AML-2123"	1874.88556051546	1874.88556051546
"AML-2123"	"2020-07-29-AML2123-c2:TCAGCCTCATAGCACT"	-7.46772370758708	2.59534833515016	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAGCCTCATAGCACT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2638.01931388689	50.7950100811063	0.0192549803611044	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2628.843854521	2628.843854521
"AML-2123"	"2020-07-29-AML2123-c2:TCAGGTATCTTGAGCA"	-3.12797913971599	3.44225189769594	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAGGTATCTTGAGCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3447.23785126313	44.4879726203303	0.012905396882907	4736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3440.25018057249	3440.25018057249
"AML-2123"	"2020-07-29-AML2123-c2:TCAGTCCCAAGTTCCA"	-7.4815276664799	2.37277314746705	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCAGTCCCAAGTTCCA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2707.97582371172	41.6928928351778	0.0153963312634125	3006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2696.76888122751	2696.76888122751
"AML-2123"	"2020-07-29-AML2123-c2:TCATACTGTCCCTCAT"	-7.32303176346477	2.23118374431459	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATACTGTCCCTCAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2537.56529802417	39.8514884178802	0.0157046159359564	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2525.24657320125	2525.24657320125
"AML-2123"	"2020-07-29-AML2123-c2:TCATCATCAGTTGAAA"	-0.832566718489486	11.07137391651	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATCATCAGTTGAAA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2142.56704411663	43.8144260758403	0.0204495006100987	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2137.09113535139	2137.09113535139
"AML-2123"	"2020-07-29-AML2123-c2:TCATCATTCATGCATG"	12.1533743339473	-2.307324432489	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATCATTCATGCATG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1608.30946843897	41.4163390633411	0.025751473753083	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1595.78086449175	1595.78086449175
"AML-2123"	"2020-07-29-AML2123-c2:TCATCCGCAGCGTAGA"	11.4295622306759	-2.73048117077025	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATCCGCAGCGTAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1813.57930286869	32.5032810717293	0.0179221724797565	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1811.45033118916	1811.45033118916
"AML-2123"	"2020-07-29-AML2123-c2:TCATCCGGTAGTGGCA"	-2.82275233689006	3.62503287875978	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATCCGGTAGTGGCA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3150.54315225725	33.2480696993818	0.010553123094207	4379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3145.35824549204	3145.35824549204
"AML-2123"	"2020-07-29-AML2123-c2:TCATCCGTCTTAGTTC"	10.988581319421	-2.92469980632933	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATCCGTCTTAGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2722.94891650879	43.108193139451	0.0158314366009928	3166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2709.25173568141	2709.25173568141
"AML-2123"	"2020-07-29-AML2123-c2:TCATGAGAGTATAGGT"	9.93617214736287	-1.0223119488922	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.483870967741935	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATGAGAGTATAGGT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2227.82259708062	49.3408457886789	0.0221475650051024	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2220.64439023993	2220.64439023993
"AML-2123"	"2020-07-29-AML2123-c2:TCATGTTCAGTTGCGC"	-7.58850608292277	2.74718091571657	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATGTTCAGTTGCGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2285.16572199035	48.1291745870465	0.0210615685872999	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2278.4644569161	2278.4644569161
"AML-2123"	"2020-07-29-AML2123-c2:TCATTACGTCTGTTAG"	-0.287161092192489	11.8818788298401	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATTACGTCTGTTAG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2084.49566582344	48.9230903622317	0.0234699890071038	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2078.6998799036	2078.6998799036
"AML-2123"	"2020-07-29-AML2123-c2:TCATTTGAGACGAAGA"	11.3301168876583	-2.33759190952452	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATTTGAGACGAAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1407.32845389468	35.7341106791737	0.0253914504324005	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1399.56725054944	1399.56725054944
"AML-2123"	"2020-07-29-AML2123-c2:TCATTTGTCCTCATAT"	10.8302875953609	-0.39665605938109	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCATTTGTCCTCATAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1247.81833172263	35.4672698666997	0.0284234242798282	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1243.76014946422	1243.76014946422
"AML-2123"	"2020-07-29-AML2123-c2:TCCACCATCTTACGTT"	-2.53514991226848	3.54710791194764	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCACCATCTTACGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3287.19353248524	36.3737119043998	0.0110652784951484	3528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3280.08011676809	3280.08011676809
"AML-2123"	"2020-07-29-AML2123-c2:TCCAGAAGTAGTGTGG"	-7.54390178147014	2.69742462718812	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCAGAAGTAGTGTGG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2350.13148565351	49.8275217483309	0.02120201446281	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2343.15799053515	2343.15799053515
"AML-2123"	"2020-07-29-AML2123-c2:TCCAGAAGTTGTATGC"	11.7445246177608	-1.99891116535338	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCAGAAGTTGTATGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2184.33278220138	39.0184256605492	0.017862857701209	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2170.30076757976	2170.30076757976
"AML-2123"	"2020-07-29-AML2123-c2:TCCATCGCATTGCCGG"	11.9895616966182	-3.14690639888915	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCATCGCATTGCCGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2106.03100858843	37.6662214448405	0.0178849320315024	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2100.5435680302	2100.5435680302
"AML-2123"	"2020-07-29-AML2123-c2:TCCCAGTTCGATGGAG"	-3.39296923103984	3.44627211177675	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCCAGTTCGATGGAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3334.93120172563	33.9234363488238	0.010172154775268	4720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3329.54406261288	3329.54406261288
"AML-2123"	"2020-07-29-AML2123-c2:TCCGAAACATCCGCGA"	-7.62988171997722	2.42385361278383	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGAAACATCCGCGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2467.06844442884	44.7648960728642	0.0181449753345728	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2460.03589433738	2460.03589433738
"AML-2123"	"2020-07-29-AML2123-c2:TCCGAAATCAGGGTAG"	-7.68301616135295	1.31599197471467	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGAAATCAGGGTAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2656.71451516194	43.430755828053	0.0163475433962485	2969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2652.29566344478	2652.29566344478
"AML-2123"	"2020-07-29-AML2123-c2:TCCGATCAGGGAGGAC"	-7.52581010285075	2.5959262617859	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGATCAGGGAGGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2533.1926528074	49.3504562518953	0.0194815251012207	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2521.06642042311	2521.06642042311
"AML-2123"	"2020-07-29-AML2123-c2:TCCGATCTCGTTATCT"	-2.81094680252727	3.76321480357973	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-1"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGATCTCGTTATCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3414.08290371018	34.335597689823	0.0100570486008145	4965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3407.46995547091	3407.46995547091
"AML-2123"	"2020-07-29-AML2123-c2:TCCGGGAGTTTGGGTT"	1.19147982177083	11.638699508551	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGGGAGTTTGGGTT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2057.65147183037	48.3514503565136	0.0234983674438815	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2049.6904414356	2049.6904414356
"AML-2123"	"2020-07-29-AML2123-c2:TCCGTGTTCCACCCTA"	-1.20979760113414	8.35036275470582	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCGTGTTCCACCCTA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2293.28451992204	37.1032619045933	0.0161790922941627	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2283.05441320264	2283.05441320264
"AML-2123"	"2020-07-29-AML2123-c2:TCCTCCCCAGTTCCAA"	-7.13084016266521	3.41014382922975	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTCCCCAGTTCCAA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2766.30565704422	40.5717981405156	0.0146664191056408	3445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2748.65147152071	2748.65147152071
"AML-2123"	"2020-07-29-AML2123-c2:TCCTCCCGTCTTGAGT"	-7.57633624497111	2.93010304057924	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTCCCGTCTTGAGT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1818.76942696365	50.4066132424059	0.0277146803190756	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1814.33577903453	1814.33577903453
"AML-2123"	"2020-07-29-AML2123-c2:TCCTCTTAGTTTCGAC"	11.0996452766353	-2.72344567691954	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTCTTAGTTTCGAC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1763.68906253127	35.9053646902384	0.0203581036210014	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1755.82898515279	1755.82898515279
"AML-2123"	"2020-07-29-AML2123-c2:TCCTGCAGTAGATCGG"	-3.74239478531535	9.96993730151979	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTGCAGTAGATCGG"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2100.17152900651	42.6514928075623	0.0203085758560581	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2097.0165877083	2097.0165877083
"AML-2123"	"2020-07-29-AML2123-c2:TCCTTCTCAACCTAAC"	-7.52714047852214	2.56503508174745	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTTCTCAACCTAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2792.26028228588	38.5962360482592	0.0138225781790881	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2776.73386588885	2776.73386588885
"AML-2123"	"2020-07-29-AML2123-c2:TCCTTCTTCAAGCCTA"	-7.85983214798625	1.33644113624422	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTTCTTCAAGCCTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2516.93816185334	42.8838970949837	0.0170381210571364	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2511.91366135718	2511.91366135718
"AML-2123"	"2020-07-29-AML2123-c2:TCCTTCTTCTTGCAGA"	0.881087620824021	9.84094140613405	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTTCTTCTTGCAGA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1867.27062410821	37.5222208414972	0.0200946881277144	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1859.31935744762	1859.31935744762
"AML-2123"	"2020-07-29-AML2123-c2:TCCTTTCGTGGAGAAA"	12.4502827125484	-2.68645932590636	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCCTTTCGTGGAGAAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1685.74883197242	34.0918957337746	0.0202235914907235	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1676.39181342236	1676.39181342236
"AML-2123"	"2020-07-29-AML2123-c2:TGATGCATCGGCCTTT"	-2.48563895645793	3.90820739353029	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGATGCATCGGCCTTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3061.76773955886	39.3503625246823	0.0128521709913737	4970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3055.79326170433	3055.79326170433
"AML-2123"	"2020-07-29-AML2123-c2:TGATGGTCACCAGACC"	-7.50204787674602	2.58532807910768	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGATGGTCACCAGACC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2624.58295264705	41.2569051251816	0.0157194136628723	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2614.40126088466	2614.40126088466
"AML-2123"	"2020-07-29-AML2123-c2:TGCAGGCGTGTTTCTT"	10.8682371574337	-2.50236966526183	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCAGGCGTGTTTCTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2022.83892521701	26.8494071979865	0.0132731315693394	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2017.54068197347	2017.54068197347
"AML-2123"	"2020-07-29-AML2123-c2:TGCAGTACACTGGCCA"	-0.301312188536483	12.9409761198792	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.017146017699115	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCAGTACACTGGCCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1959.91062650184	35.0787026565308	0.0178981134048654	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1955.50120599724	1955.50120599724
"AML-2123"	"2020-07-29-AML2123-c2:TGCATGAAGGCCCGTT"	12.6134544807369	-2.55039145862731	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCATGAAGGCCCGTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1434.98729357624	21.1453315043663	0.0147355531293022	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1433.54700863691	1433.54700863691
"AML-2123"	"2020-07-29-AML2123-c2:TGCATGATCCCGAGTG"	12.2799231010372	-2.20004823124083	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCATGATCCCGAGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1232.7332002617	30.2283354657166	0.0245213931605795	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1227.91421580656	1227.91421580656
"AML-2123"	"2020-07-29-AML2123-c2:TGCGATAAGAGGTTTA"	-2.27260218086894	3.69594285571901	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCGATAAGAGGTTTA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3279.58406101979	36.7517609761208	0.0112062262446454	5123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3273.99371887887	3273.99371887887
"AML-2123"	"2020-07-29-AML2123-c2:TGCGGCATCCCGAACG"	10.9135004478389	-2.64719536220702	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCGGCATCCCGAACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1711.58840466438	38.5995116870066	0.022551865613144	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1700.69044271445	1700.69044271445
"AML-2123"	"2020-07-29-AML2123-c2:TGCTCCAAGGTCATTC"	-8.39113460007365	0.728297091368116	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.444444444444444	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCTCCAAGGTCATTC"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1692.33482572961	43.922164215944	0.025953590003685	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1684.41540605485	1684.41540605485
"AML-2123"	"2020-07-29-AML2123-c2:TGCTCCATCTTCCAGC"	11.8608061271602	-2.90211346065673	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCTCCATCTTCCAGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2552.64770972925	44.663072608818	0.0174967632386512	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2544.92943917793	2544.92943917793
"AML-2123"	"2020-07-29-AML2123-c2:TGCTGAAGTCTAGGCC"	-1.60664854469951	13.7322969206604	"2020-07-29-AML2123-c2"	"AML2123"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00237717908082409	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCTGAAGTCTAGGCC"	"NK"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"NK"	"NK"	2231.83927659035	37.2196634540627	0.0166766773237024	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	26	TRUE	"NK_AML-2123"	2227.14104013137	2227.14104013137
"AML-2123"	"2020-07-29-AML2123-c2:TGCTTCGCATTGACCA"	0.420734574168366	10.7974529036316	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGCTTCGCATTGACCA"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1998.7427332777	34.0927210712888	0.0170570831871798	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1991.56815348106	1991.56815348106
"AML-2123"	"2020-07-29-AML2123-c2:TGGATGTGTCGAAACG"	0.40300696071927	10.4710197218689	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGGATGTGTCGAAACG"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	1934.84166449044	44.3363315901879	0.0229147079080831	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1923.16685809272	1923.16685809272
"AML-2123"	"2020-07-29-AML2123-c2:TCTACATGTAATGCTC"	10.9929491477901	-0.824013256188951	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-3"	58	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.732673267326733	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTACATGTAATGCTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1170.04544856978	25.8984830645433	0.0221345957938649	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1163.50789454212	1163.50789454212
"AML-2123"	"2020-07-29-AML2123-c2:TCTATCAGTATCGCGC"	11.7963739829952	-3.02744295513304	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTATCAGTATCGCGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1793.64110654478	43.5416709955515	0.0242755759982714	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1789.42028636448	1789.42028636448
"AML-2123"	"2020-07-29-AML2123-c2:TCTCAGCAGACGTCGA"	-7.20298705521281	4.04866383159486	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.022508038585209	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCAGCAGACGTCGA"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2429.45050628426	40.3419211964841	0.0166053686181841	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2422.41625285415	2422.41625285415
"AML-2123"	"2020-07-29-AML2123-c2:TCTCAGCTCATTCATC"	-7.56035170975383	2.39158651912538	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCAGCTCATTCATC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2858.68042815892	34.7397290348542	0.0121523653685305	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2846.35566372347	2846.35566372347
"AML-2123"	"2020-07-29-AML2123-c2:TCTCCGAAGCCTATCA"	-2.14284835282024	9.68338773334352	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCCGAAGCCTATCA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2164.20924222445	44.6644903423208	0.020637787451833	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2162.80696093388	2162.80696093388
"AML-2123"	"2020-07-29-AML2123-c2:TCTCCGACAAACTCTG"	-7.59921346131023	2.07023379886476	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCCGACAAACTCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2370.9267641193	44.8759029414536	0.0189275787091311	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2362.19718931631	2362.19718931631
"AML-2123"	"2020-07-29-AML2123-c2:TCTCTGGGTAGAGCTG"	-7.61597667160686	2.69451449001161	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCTGGGTAGAGCTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2362.80160848395	42.9038550839256	0.0181580437942287	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2355.14946607629	2355.14946607629
"AML-2123"	"2020-07-29-AML2123-c2:TCTCTGGTCTTAGCTT"	11.4415108161861	-2.27799799358519	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTCTGGTCTTAGCTT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1461.86655013636	11.9312330823519	0.00816164312757475	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1457.98033569638	1457.98033569638
"AML-2123"	"2020-07-29-AML2123-c2:TCTGCCAGTTATCTGG"	11.9279180961544	-2.99624850666197	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTGCCAGTTATCTGG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2429.57711043039	20.510043285191	0.00844181614863738	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2418.22152412357	2418.22152412357
"AML-2123"	"2020-07-29-AML2123-c2:TCTGGCTTCGGACCAC"	-3.44406733933147	9.68790052020875	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTGGCTTCGGACCAC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1964.98619028849	43.2656376458004	0.0220182909476063	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1958.26282074415	1958.26282074415
"AML-2123"	"2020-07-29-AML2123-c2:TCTTAGTAGACGCTCC"	-2.43356309357341	4.21070859515993	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTTAGTAGACGCTCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3272.12087191158	36.7240306478626	0.0112233111444958	5680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3264.72007159985	3264.72007159985
"AML-2123"	"2020-07-29-AML2123-c2:TCTTAGTGTCCACACG"	-7.52894483032878	2.9468669661316	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTTAGTGTCCACACG"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2110.89770031736	44.2632819231193	0.0209689374887587	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2105.85901327448	2105.85901327448
"AML-2123"	"2020-07-29-AML2123-c2:TCTTCCTTCTCTGCTG"	11.9583965736324	-2.16539528286131	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTTCCTTCTCTGCTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1877.72542548814	19.4613056151322	0.0103642978632369	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1869.80492834989	1869.80492834989
"AML-2123"	"2020-07-29-AML2123-c2:TCTTGCGCACACCGAC"	-7.90833983841594	2.46357295596925	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTTGCGCACACCGAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2648.42369471674	39.5695670930824	0.0149407993788979	2560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2640.37487065082	2640.37487065082
"AML-2123"	"2020-07-29-AML2123-c2:TCTTTGACAGCTACTA"	-7.6220568222111	1.70265386188356	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TCTTTGACAGCTACTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2951.16964518729	41.6888465781333	0.0141262114992673	3980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2932.4849188624	2932.4849188624
"AML-2123"	"2020-07-29-AML2123-c2:TGAACGTTCCGTGTAA"	-1.96934853020366	3.91484615886537	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAACGTTCCGTGTAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3309.73966138315	30.4690583132717	0.00920587763103357	5858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3303.95026058072	3303.95026058072
"AML-2123"	"2020-07-29-AML2123-c2:TGACGCGGTCCGGATC"	11.2295528846676	-2.24331118976744	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGACGCGGTCCGGATC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1449.45247803437	28.6786010643305	0.0197858167128198	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1449.45247803437	1449.45247803437
"AML-2123"	"2020-07-29-AML2123-c2:TGACTCCTCAGCATTG"	11.347148557275	-2.60375072872313	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGACTCCTCAGCATTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2505.96692667348	44.9394594371492	0.0179329818597421	2708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2495.22484633198	2495.22484633198
"AML-2123"	"2020-07-29-AML2123-c2:TGAGACTCACGGCCAT"	-7.72834763947185	2.77748391712037	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAGACTCACGGCCAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2457.39203739243	49.8514998738886	0.0202863438618393	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2450.18208797056	2450.18208797056
"AML-2123"	"2020-07-29-AML2123-c2:TGAGACTCAGCTCATA"	-7.47956071320232	2.14153072917787	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAGACTCAGCTCATA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2687.84010742427	42.3839103028249	0.0157687617599549	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2678.62922199097	2678.62922199097
"AML-2123"	"2020-07-29-AML2123-c2:TGAGACTGTAACATCC"	11.1072832542354	-2.84843447124632	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAGACTGTAACATCC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2134.10194826764	43.5292870707144	0.0203970045133267	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2125.44362957757	2125.44362957757
"AML-2123"	"2020-07-29-AML2123-c2:TGAGCATTCGCACTCT"	-0.875462691218215	9.35785005176393	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00278108859753675	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAGCATTCGCACTCT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2525.48965246443	50.0415686818146	0.0198146005599282	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2514.26373128614	2514.26373128614
"AML-2123"	"2020-07-29-AML2123-c2:TGAGGTTTCCTACTGC"	-7.57280002060588	2.6542348631653	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGAGGTTTCCTACTGC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2549.61728807856	51.5682311363153	0.020225871301327	2758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2541.11014329838	2541.11014329838
"AML-2123"	"2020-07-29-AML2123-c2:TGATCTTAGACTGTTC"	-7.58471808853801	2.28329012477723	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGATCTTAGACTGTTC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2547.29953846707	40.417036804948	0.0158666211784698	2665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2538.57847914405	2538.57847914405
"AML-2123"	"2020-07-29-AML2123-c2:TGATGCAAGAGAGGGC"	12.2787262397701	-2.11907460605773	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGATGCAAGAGAGGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1193.85217219093	41.3260357067437	0.0346157059218671	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1189.29241765101	1189.29241765101
"AML-2123"	"2020-07-29-AML2123-c2:TTACGCCGTTTAGAGA"	-7.60852132263835	2.82646606052247	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACGCCGTTTAGAGA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2850.45813864372	44.3972383771311	0.015575474614146	2927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2834.05585128306	2834.05585128306
"AML-2123"	"2020-07-29-AML2123-c2:TTACGCCTCCATCAGA"	11.2394348579342	-2.87641098415526	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACGCCTCCATCAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2289.80238929304	44.3169141743977	0.0193540343837619	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2285.85352922881	2285.85352922881
"AML-2123"	"2020-07-29-AML2123-c2:TTACGTTCAGTTTCAG"	-7.89840970459636	2.69664666736452	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACGTTCAGTTTCAG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2836.92168630275	45.5461120610541	0.0160547653750755	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2821.37986448902	2821.37986448902
"AML-2123"	"2020-07-29-AML2123-c2:TTACGTTTCTGCCTGT"	-2.58597503128703	9.59691045368043	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACGTTTCTGCCTGT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2257.8256584605	36.6729346689451	0.0162425892059135	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2249.58548229338	2249.58548229338
"AML-2123"	"2020-07-29-AML2123-c2:TTACTGTCATCCGAAT"	-7.19878707352336	2.00496003711549	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACTGTCATCCGAAT"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2648.3979630531	46.156574729871	0.0174281113993387	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2638.26008629303	2638.26008629303
"AML-2123"	"2020-07-29-AML2123-c2:TTCAATCTCGTGGGAA"	10.9425255256588	-2.42489054119261	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCAATCTCGTGGGAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1538.61500554963	37.5624488625167	0.0244131564602143	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1532.40953445637	1532.40953445637
"AML-2123"	"2020-07-29-AML2123-c2:TTCAGGACATCACGGC"	-1.8736883205479	4.09289405429689	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCAGGACATCACGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2995.60926382008	32.0817358923414	0.0107095862867742	5643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2989.43727104226	2989.43727104226
"AML-2123"	"2020-07-29-AML2123-c2:TTCAGGAGTATCATGC"	-2.7418831390446	9.88153836810914	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCAGGAGTATCATGC"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1923.71398187532	42.996152010386	0.0223505949509561	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1916.86585281259	1916.86585281259
"AML-2123"	"2020-07-29-AML2123-c2:TTCCAATTCGCCAGTG"	11.1480041938717	-2.897092842218	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCCAATTCGCCAGTG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2211.13960931495	46.3565760572581	0.0209650154436065	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2206.10531245975	2206.10531245975
"AML-2123"	"2020-07-29-AML2123-c2:TTCCGTGTCCATAGGT"	12.2466751533443	-2.1862774125305	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCCGTGTCCATAGGT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1213.36021763337	41.9847960030826	0.0346020871567496	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1207.61447123505	1207.61447123505
"AML-2123"	"2020-07-29-AML2123-c2:TTCCTAATCGAATGCT"	-3.87476764145549	2.8311671980652	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCCTAATCGAATGCT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3269.3056331046	38.0875598531882	0.0116500456450196	5148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3259.90614014555	3259.90614014555
"AML-2123"	"2020-07-29-AML2123-c2:TTCCTTCAGACGCCCT"	1.55482806739156	11.033212638739	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCCTTCAGACGCCCT"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2382.98934524519	36.1517408965254	0.0151707522187036	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2373.73580941623	2373.73580941623
"AML-2123"	"2020-07-29-AML2123-c2:TTCCTTCTCCAGCACG"	-2.02032194557841	3.76237437808839	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCCTTCTCCAGCACG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2941.58090753413	37.3924669321426	0.0127116907906123	3512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2935.31686898332	2935.31686898332
"AML-2123"	"2020-07-29-AML2123-c2:TTCGATTAGGTCGTAG"	-2.27438364449199	3.84326551044313	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-4"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCGATTAGGTCGTAG"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2920.39041802811	40.1245127268448	0.0137394344534035	3099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2913.41257579243	2913.41257579243
"AML-2123"	"2020-07-29-AML2123-c2:TTCGGTCGTCATCGCG"	1.85386933860127	-9.8026275864807	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCGGTCGTCATCGCG"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2075.81907550269	34.7247898285658	0.0167282352486123	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2072.29531634282	2072.29531634282
"AML-2123"	"2020-07-29-AML2123-c2:TTCTAACCACATATGC"	12.5825993019039	-2.50952150737914	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCTAACCACATATGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1518.05814551386	48.8802779590189	0.032199213253767	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1516.06405268068	1516.06405268068
"AML-2123"	"2020-07-29-AML2123-c2:TTCTAACTCTTCTAAC"	-8.14588771286662	0.484726495388426	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCTAACTCTTCTAAC"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3334.42059884721	41.5504958129232	0.0124610841917448	4400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3320.47868990861	3320.47868990861
"AML-2123"	"2020-07-29-AML2123-c2:TTCTCTCGTCCTCCAT"	11.9310356574947	-3.16556408321532	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCTCTCGTCCTCCAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2405.98939674974	47.1747859906192	0.0196072293811218	3249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2398.9861718703	2398.9861718703
"AML-2123"	"2020-07-29-AML2123-c2:TTCTTGAGTAGTCACT"	-7.70301137390788	2.7022917040619	"2020-07-29-AML2123-c2"	"AML2123"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.882539682539683	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTCTTGAGTAGTCACT"	"HSC"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2525.51952349982	37.6731871025375	0.0149170048981964	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2511.14582954279	2511.14582954279
"AML-2123"	"2020-07-29-AML2123-c2:TTGAACGAGCTCCATA"	-7.61588082733806	1.64239654624788	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.162162162162162	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGAACGAGCTCCATA"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2399.25578157573	45.0754365370603	0.0187872576501438	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2391.81472434615	2391.81472434615
"AML-2123"	"2020-07-29-AML2123-c2:TTGAACGCAAACTAGA"	11.7652355628902	-2.12202217495116	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGAACGCAAACTAGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1742.48242166545	29.4797456578436	0.0169182456541898	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1736.9356696127	1736.9356696127
"AML-2123"	"2020-07-29-AML2123-c2:TTGAACGCACTTACAG"	-4.43729291382487	10.6414527663025	"2020-07-29-AML2123-c2"	"AML2123"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0320328542094456	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGAACGCACTTACAG"	"gd T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"gd_T"	2309.81542272708	48.9143611773164	0.0211767402260938	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2305.35274241319	2305.35274241319
"AML-2123"	"2020-07-29-AML2123-c2:TTGCATTCAGTCTCTC"	1.29521157321278	10.6370630034241	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0268987341772152	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGCATTCAGTCTCTC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2012.08487045869	47.3080849905098	0.0235119729217611	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2002.14000965294	2002.14000965294
"AML-2123"	"2020-07-29-AML2123-c2:TTGCCTGCACGTACAT"	-0.825193445116836	11.1501073607239	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGCCTGCACGTACAT"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	2026.99194485315	47.5474847123487	0.0234571651027422	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2022.90511708133	2022.90511708133
"AML-2123"	"2020-07-29-AML2123-c2:TTGGATGAGGCCTAAG"	-2.10816488686259	3.63876435840455	"2020-07-29-AML2123-c2"	"AML2123"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0377358490566038	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTGGATGAGGCCTAAG"	"MEP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	1951.26063142224	41.1910174367465	0.0211099515735748	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	1951.26063142224	1951.26063142224
"AML-2123"	"2020-07-29-AML2123-c2:TGTGAGTCAATAGGGC"	12.4319311576778	-2.3401134244171	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTGAGTCAATAGGGC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1458.93727414219	30.457520300276	0.0208765111702174	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1457.80891914372	1457.80891914372
"AML-2123"	"2020-07-29-AML2123-c2:TGTGATGCAGCTACTA"	1.5838186937267	-9.86043741619261	"2020-07-29-AML2123-c2"	"AML2123"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.00297324083250743	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTGATGCAGCTACTA"	"CD14+ monocyte"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Mono"	"Mono"	2623.85856879174	44.7373207016196	0.0170502027943605	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	13	TRUE	"Mono_AML-2123"	2617.45861344249	2617.45861344249
"AML-2123"	"2020-07-29-AML2123-c2:TGTCCTGTCCTCTCGA"	-2.65760336342509	3.35860250079957	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTCCTGTCCTCTCGA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	3264.17454786301	38.1953305475159	0.0117013750298745	4606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	3256.91590536669	3256.91590536669
"AML-2123"	"2020-07-29-AML2123-c2:TGTCCTGTCTCATTTG"	-8.5092433494633	0.220350674632467	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTCCTGTCTCATTTG"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2790.6047645604	42.1930989427556	0.0151196971633502	3460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2783.09209894634	2783.09209894634
"AML-2123"	"2020-07-29-AML2123-c2:TGTTGGAGTCGCTCGA"	-2.78671155396159	9.21843621814577	"2020-07-29-AML2123-c2"	"AML2123"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0175554819476648	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTTGGAGTCGCTCGA"	"CD8+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD8_T"	1925.87260853659	44.5712999608587	0.0231434310677106	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	1920.35108282854	1920.35108282854
"AML-2123"	"2020-07-29-AML2123-c2:TGTTGGATCCGTAGTA"	-8.23408446732219	0.569413221720137	"2020-07-29-AML2123-c2"	"AML2123"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.103603603603604	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTTGGATCCGTAGTA"	"MPP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	2662.35068293764	51.4239091032052	0.0193152274915429	2830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	2650.37681432526	2650.37681432526
"AML-2123"	"2020-07-29-AML2123-c2:TGTGATGGTATAGGAT"	-8.27558169785197	-0.73817309057387	"2020-07-29-AML2123-c2"	"AML2123"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0612244897959184	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTGATGGTATAGGAT"	"GMP"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"HSPC"	"HSPC"	3079.41025963413	43.881423995957	0.0142499440789584	4074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	394	TRUE	"HSPC_AML-2123"	3065.5782673526	3065.5782673526
"AML-2123"	"2020-07-29-AML2123-c2:TGTGTGATCCGCATAA"	11.6866451698238	-2.83803203022154	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TGTGTGATCCGCATAA"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2048.20283195959	40.7266348556972	0.0198840828750991	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2044.18909442756	2044.18909442756
"AML-2123"	"2020-07-29-AML2123-c2:TTACCGCCACGACTAT"	11.9561535316402	-2.26790907299193	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Erythrocytes"	34	"CNV+"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.845070422535211	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACCGCCACGACTAT"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	1733.20010322423	46.0872166697542	0.0265908227122877	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	1728.26612007272	1728.26612007272
"AML-2123"	"2020-07-29-AML2123-c2:TTACCATCAGTAGTTC"	-1.44896672192271	3.67154667461244	"2020-07-29-AML2123-c2"	"AML2123"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.180252583237658	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACCATCAGTAGTTC"	"Ery"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"Ery"	"Ery"	2876.73813071094	42.3674719431731	0.0147276081513553	4282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	505	TRUE	"Ery_AML-2123"	2872.75901053931	2872.75901053931
"AML-2123"	"2020-07-29-AML2123-c2:TTACCGCAGTTGCGCC"	-0.0126401138609231	11.2595996626648	"2020-07-29-AML2123-c2"	"AML2123"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"female"	"Inflammation_high"	0.0314465408805031	"GSM5613773"	"2020-07-29"	"2020.07.29.AML2123.c2.TTACCGCAGTTGCGCC"	"CD4+ T"	"U-16-2123"	"F"	71	"CITE-seq"	"OSU"	"AML2123"	"AML"	"Intermediate"	"46,XX"	1807	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "	""	""	"x"	""	""	""	NA	NA	"0,25"	"0"	"0"	"0"	"0"	0	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	0	0	"0"	0	0	0	"0"	NA	""	""	""	""	""	"AML"	"case"	"T"	"CD4_T"	2076.1907425468	43.6031789312426	0.0210015284423029	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	251	TRUE	"T_AML-2123"	2066.63680181071	2066.63680181071
"AML-3133"	"2019-07-01-count-1:CAGGTATGTGATTCAC"	1.32803990420644	-10.1487093201843	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGGTATGTGATTCAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.90713683888	44.7286573282601	0.0168984611155185	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2642.08973698373	2642.08973698373
"AML-3133"	"2019-07-01-count-3:GTGATGTTCCCTCTCC"	-2.53319392624553	13.7698488005432	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGATGTTCCCTCTCC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2166.72675599466	38.3058156613372	0.0176791169238839	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2159.77998701292	2159.77998701292
"AML-3133"	"2019-07-01-count-2:TACTGCCAGGTTTACC"	1.40938558158223	10.3464727171692	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACTGCCAGGTTTACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1649.95907709558	38.3499916032317	0.0232429956206788	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1647.86900907165	1647.86900907165
"AML-3133"	"2019-07-01-count-1:TCAGCAAAGCGTGTCC"	8.6777454811031	7.24271724307863	"2019-07-01-count-1"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGCAAAGCGTGTCC"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	1777.58501851785	36.3640651906989	0.020457004763136	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	1777.58501851785	1777.58501851785
"AML-3133"	"2019-07-01-count-2:AACCCAACATTGCCGG"	3.96687378463094	-10.8065567246643	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCCAACATTGCCGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2069.48877463188	45.1706342556841	0.0218269530182492	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2067.74223265475	2067.74223265475
"AML-3133"	"2019-07-01-count-2:TAACACGAGCCTCTCT"	0.568112989037675	12.5947093733582	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACACGAGCCTCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1602.72673086939	40.3784890089624	0.0251936204914105	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1597.95096222267	1597.95096222267
"AML-3133"	"2019-07-01-count-3:GATTCTTCAAACTGCT"	-2.36596880379375	13.6884031065735	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTCTTCAAACTGCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2128.58667115169	41.4682212386396	0.0194815751694071	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2126.83367815055	2126.83367815055
"AML-3133"	"2019-07-01-count-1:CGCCATTGTGCACGCT"	1.20644475993459	-9.90961840068968	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCCATTGTGCACGCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.95868253131	40.609377834783	0.0154645913147564	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2619.1139792306	2619.1139792306
"AML-3133"	"2019-07-01-count-3:CTGCTCATCCCTCGTA"	-8.62864623490031	4.46826217258302	"2019-07-01-count-3"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCTCATCCCTCGTA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2125.11429487012	34.4033795202121	0.0161889549203351	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2121.70901642149	2121.70901642149
"AML-3133"	"2019-07-01-count-1:GGTCTGGTCCAAGCCG"	1.41577889499013	11.009871459845	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTCTGGTCCAAGCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2071.7779038606	28.7753446021392	0.013889203349702	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2062.28399753195	2062.28399753195
"AML-3133"	"2019-07-01-count-1:CTTCGGTGTCTCAAGT"	-8.30535731735881	5.52801082218019	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCGGTGTCTCAAGT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1456.86253774888	49.9029889569192	0.0342537388833049	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1447.71272247356	1447.71272247356
"AML-3133"	"2019-07-01-count-1:ATGGAGGCAAGTTCGT"	0.0636626501450359	13.4001140364441	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGAGGCAAGTTCGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2027.02449743994	42.0416266247874	0.0207405616843233	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2025.29948549947	2025.29948549947
"AML-3133"	"2019-07-01-count-1:CTACATTCACGATAGG"	-5.97306857529338	3.37766335094301	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACATTCACGATAGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2066.79137531415	40.0848098035397	0.0193947053787405	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2059.8545093842	2059.8545093842
"AML-3133"	"2019-07-01-count-2:TTTCCTCGTCGTGTTA"	-1.19905779781993	11.0119533308777	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCCTCGTCGTGTTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1560.3237271272	34.8330424222713	0.0223242406794675	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1560.3237271272	1560.3237271272
"AML-3133"	"2019-07-01-count-2:TACAGGTGTTCAAAGA"	1.00239427861516	9.45856378162233	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACAGGTGTTCAAAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1859.67883981128	25.624895723328	0.0137792048684753	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1852.25219417986	1852.25219417986
"AML-3133"	"2019-07-01-count-3:CCAAGCGGTACGGCAA"	1.35336305674855	11.4361676939758	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCAAGCGGTACGGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1760.91577613864	43.0698440042992	0.0244587757051864	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1757.65075371428	1757.65075371428
"AML-3133"	"2019-07-01-count-3:TCATCCGTCCATCCGT"	-1.17960892143901	10.1866788634094	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATCCGTCCATCCGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1450.07379286833	49.7350593947616	0.0342982954656278	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1445.4685293391	1445.4685293391
"AML-3133"	"2019-07-01-count-1:TCATGCCCAGGAACCA"	-0.284022430807906	11.1531696089539	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGCCCAGGAACCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1574.60851428754	47.7264623006281	0.0303100496838243	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1570.39156918214	1570.39156918214
"AML-3133"	"2019-07-01-count-3:ACGTACAAGCCAAGTG"	-1.31030509892161	14.2358398207459	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTACAAGCCAAGTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1769.7698590404	42.326377194983	0.0239163171294674	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1769.7698590404	1769.7698590404
"AML-3133"	"2019-07-01-count-2:GATTCTTAGTGCACAG"	0.131584179669064	11.1157979735169	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCTTAGTGCACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1737.85540426204	37.299475291239	0.0214629336823784	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1734.22975543335	1734.22975543335
"AML-3133"	"2019-07-01-count-1:TACCGAACATGCCGCA"	-1.75505242767985	13.6975536116394	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCGAACATGCCGCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2332.2655404198	39.9467746810301	0.0171278844491437	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2332.2655404198	2332.2655404198
"AML-3133"	"2019-07-01-count-1:GACAGCCCAGAAGTTA"	1.09500338610951	11.0674352415833	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACAGCCCAGAAGTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1917.60356857767	38.139796720731	0.0198893021194262	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1913.69732291226	1913.69732291226
"AML-3133"	"2019-07-01-count-2:CTCAGGGGTCTGTCAA"	1.01757999238316	10.2149696120056	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAGGGGTCTGTCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1528.91894478289	43.2918600718133	0.0283153402078884	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1527.20745711665	1527.20745711665
"AML-3133"	"2019-07-01-count-2:ACTTCGCTCCGGACGT"	0.969064314931077	10.8635539778504	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTCGCTCCGGACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1825.14178574492	40.8619057555806	0.0223883459765856	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1823.58038199564	1823.58038199564
"AML-3133"	"2019-07-01-count-2:TAGCACAGTGTCATTG"	8.7619101005489	7.04522845828859	"2019-07-01-count-2"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGCACAGTGTCATTG"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	1685.16122335673	34.6103102132811	0.0205382783163854	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	1685.16122335673	1685.16122335673
"AML-3133"	"2019-07-01-count-1:CAATGACTCCTCTTTC"	-0.561357657343704	12.231322265509	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATGACTCCTCTTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2502.99143815521	28.2488426572397	0.0112860324756285	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2497.02807550826	2497.02807550826
"AML-3133"	"2019-07-01-count-2:AGCGTATTCTGAGCAT"	-1.79578767243083	10.5245084532532	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGTATTCTGAGCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2027.18685464597	36.7996111966517	0.0181530435205384	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2022.22588630155	2022.22588630155
"AML-3133"	"2019-07-01-count-3:TCTCACGCATTGTCGA"	-2.44657621803935	11.088162399176	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCACGCATTGTCGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1917.2313045785	35.3262132652533	0.0184256397133155	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1913.51985956809	1913.51985956809
"AML-3133"	"2019-07-01-count-2:GTTCATTCAGAATCGG"	-0.736146728426772	12.2770528563294	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCATTCAGAATCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2156.53226298685	41.1900257727342	0.0191001203551135	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2152.78223869309	2152.78223869309
"AML-3133"	"2019-07-01-count-2:GGGAAGTAGACTCTTG"	0.541227896779221	10.8040551909241	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAAGTAGACTCTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2039.40298209139	35.9913610961371	0.017647988853693	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2028.87639464356	2028.87639464356
"AML-3133"	"2019-07-01-count-3:AGGACGAGTTGGATCT"	-1.98735032501872	10.9502811201843	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGACGAGTTGGATCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1703.57430841522	38.9860166585086	0.0228848348240095	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1701.52535945655	1701.52535945655
"AML-3133"	"2019-07-01-count-1:GACTTCCGTACCTAAC"	-0.0416019288008988	13.3056468733582	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTTCCGTACCTAAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2270.16691990834	34.6576261074008	0.0152665541037838	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2267.45731226451	2267.45731226451
"AML-3133"	"2019-07-01-count-3:ATCGTCCCAGACGATG"	1.0530684190685	9.87333772266237	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGTCCCAGACGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1767.06088281328	31.1933115440967	0.0176526524057478	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1761.38941476959	1761.38941476959
"AML-3133"	"2019-07-01-count-1:AGCTTCCGTTGGAGGT"	-8.10354457321819	2.70018217647401	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTTCCGTTGGAGGT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2363.47219494987	42.7090161661805	0.0180704542483888	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2355.60207869957	2355.60207869957
"AML-3133"	"2019-07-01-count-2:ATCCCTGGTACTCAAC"	0.612509925931138	10.5865258940491	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCCTGGTACTCAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1858.90154903269	36.6771615808745	0.0197305562524062	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1858.90154903269	1858.90154903269
"AML-3133"	"2019-07-01-count-1:ACCTACCAGAATTTGG"	4.01038970526997	-10.9355306855408	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCTACCAGAATTTGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.58724815798	43.9654597155151	0.0177381126075707	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2470.31506542284	2470.31506542284
"AML-3133"	"2019-07-01-count-1:TCACTCGCATCTAACG"	-1.88960574093516	8.46689603412477	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACTCGCATCTAACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2380.63618146361	34.8406505863847	0.0146350168319145	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2368.26083918395	2368.26083918395
"AML-3133"	"2019-07-01-count-1:TTCGGTCCAAATGGAT"	8.92059483107869	6.86711595142213	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGGTCCAAATGGAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1833.5276388767	33.7259988134338	0.0183940498623167	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1827.43154050093	1827.43154050093
"AML-3133"	"2019-07-01-count-2:GGGACCTTCACACGAT"	1.42428805407826	11.1484145888123	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACCTTCACACGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1897.94128862987	40.8411638671894	0.0215186655729865	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1895.23467365309	1895.23467365309
"AML-3133"	"2019-07-01-count-2:ATACTTCCAACTTCTT"	7.68999447402303	6.85081813419191	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATACTTCCAACTTCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1766.00856714959	42.047493222286	0.0238093370578334	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1760.02897650563	1760.02897650563
"AML-3133"	"2019-07-01-count-2:TATCAGGCACTATCGA"	-6.05713973465617	3.26153729045717	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCAGGCACTATCGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2689.40293139789	40.9546146021532	0.0152281438099221	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2678.26558122525	2678.26558122525
"AML-3133"	"2019-07-01-count-1:TATTGCTGTGCAATGG"	-5.83656011048015	3.60106060588685	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTGCTGTGCAATGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2392.21838550617	49.9621119731312	0.0208852637684915	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2383.57886816957	2383.57886816957
"AML-3133"	"2019-07-01-count-3:GGCGTCAGTCGAGTGA"	-6.90567861023601	2.35688803279725	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCGTCAGTCGAGTGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2270.29553110891	40.8900778007657	0.0180109052942518	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2267.4460812053	2267.4460812053
"AML-3133"	"2019-07-01-count-2:TTTACTGAGTGTCATC"	8.41965069350545	7.08611438358156	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACTGAGTGTCATC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1732.72863894677	41.2052460003317	0.0237805534427931	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1727.48065595327	1727.48065595327
"AML-3133"	"2019-07-01-count-1:CATTTCAGTATGGGAC"	1.18529774722401	10.7930106886658	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTTCAGTATGGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1967.38966261426	40.4437479808908	0.0205570603269051	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1959.39461829933	1959.39461829933
"AML-3133"	"2019-07-01-count-1:TTGTGTTTCATGAGTC"	1.09279300746266	10.882297492865	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGTTTCATGAGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1987.39178846717	44.2078206883241	0.0222441397538532	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1984.53216009668	1984.53216009668
"AML-3133"	"2019-07-01-count-2:CATTGTTCACTTGAGT"	8.65500034865681	7.24741170490114	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGTTCACTTGAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1916.97053573352	48.6595731796817	0.0253835790757536	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1910.17472769763	1910.17472769763
"AML-3133"	"2019-07-01-count-2:ACTGTGAAGGAATTAC"	0.63661434230153	10.7111968764099	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTGTGAAGGAATTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1775.44510701926	39.3560062865492	0.022166839251157	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1772.41916324752	1772.41916324752
"AML-3133"	"2019-07-01-count-1:ACGATGTTCAAGTCGT"	8.58666290816609	7.4375805624756	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGATGTTCAAGTCGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1980.36854972638	40.0217942661548	0.0202092657307068	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1974.47571385078	1974.47571385078
"AML-3133"	"2019-07-01-count-1:ACTATTCCACAATGTC"	-7.77196536484416	1.34483871543733	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATTCCACAATGTC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2815.00859446011	39.2088623869106	0.0139285053921586	3095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2805.88988001905	2805.88988001905
"AML-3133"	"2019-07-01-count-1:CAATGACTCATCTATC"	-8.03136954727824	3.73913023555604	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATGACTCATCTATC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2441.3100606111	31.1378646441772	0.0127545718778478	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2430.74062786812	2430.74062786812
"AML-3133"	"2019-07-01-count-3:ATCAGGTTCAAGAATG"	7.71639313277547	6.86554429614869	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCAGGTTCAAGAATG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1709.56496467221	41.4082295956163	0.0242215010551271	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1706.11263427768	1706.11263427768
"AML-3133"	"2019-07-01-count-1:GCTTTCGAGTTGGCTT"	3.86452426490132	-10.8975553742615	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTTCGAGTTGGCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2387.21925956191	42.9235806772121	0.0179805774041422	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2384.34203880063	2384.34203880063
"AML-3133"	"2019-07-01-count-2:TGTTTGTAGTCTGGAG"	0.0529752914676487	10.4042739638123	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTTGTAGTCTGGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1657.20617889693	35.9476591820204	0.0216917240834499	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1650.02398921849	1650.02398921849
"AML-3133"	"2019-07-01-count-3:TGCTCCAGTAACACCT"	-8.53849158707317	0.0635018500494733	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTCCAGTAACACCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3297.94895666484	42.940705149859	0.0130204274578234	3642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3289.15475438454	3289.15475438454
"AML-3133"	"2019-07-01-count-2:GATTCTTGTACCAATC"	1.2434901195461	-10.2151317826477	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCTTGTACCAATC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.61859980904	41.9844614472782	0.0177103400144841	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2368.17378816993	2368.17378816993
"AML-3133"	"2019-07-01-count-1:TGGTACACAGCAGTTT"	1.20237006720845	10.2178640135559	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTACACAGCAGTTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2103.02939035802	33.263042750205	0.0158167274802291	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2095.36163749081	2095.36163749081
"AML-3133"	"2019-07-01-count-1:TCGAACAGTCACGCTG"	-7.90320430222209	5.57625148380128	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGAACAGTCACGCTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1748.86180463888	46.5686529859512	0.0266279776151708	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1742.71136929693	1742.71136929693
"AML-3133"	"2019-07-01-count-1:ATCACTTCAAATGAAC"	1.54398896273915	10.7865085371765	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCACTTCAAATGAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2084.04875347698	26.6490127498876	0.0127871349964472	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2078.8950738468	2078.8950738468
"AML-3133"	"2019-07-01-count-1:ATCACTTAGGCTCACC"	8.77372707900349	7.51644132221071	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCACTTAGGCTCACC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2070.65492544832	38.4983577874527	0.0185923580574959	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2067.82166897309	2067.82166897309
"AML-3133"	"2019-07-01-count-2:GAAGAATGTGCCAAGA"	-0.862831274897415	11.9763469466004	"2019-07-01-count-2"	"AML3133"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGAATGTGCCAAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2169.04181469683	38.709312653672	0.0178462731291709	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2163.74280873563	2163.74280873563
"AML-3133"	"2019-07-01-count-2:ACATGCAAGGAACATT"	-3.69666276398357	13.2764653929505	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATGCAAGGAACATT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1965.75231335688	42.0496477229222	0.0213911220845086	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1963.857615691	1963.857615691
"AML-3133"	"2019-07-01-count-2:TTGGGTAGTAGATCCT"	1.49668373641316	10.8024949797424	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGGTAGTAGATCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1769.73298298482	35.7800995654244	0.0202177955145967	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1766.97598249641	1766.97598249641
"AML-3133"	"2019-07-01-count-1:CGGGCATCAGCAGGAT"	8.6096006828243	6.80455825412599	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGCATCAGCAGGAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1697.90248208606	43.661805311465	0.0257151431087029	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1691.94466039182	1691.94466039182
"AML-3133"	"2019-07-01-count-1:ATCACTTAGGAACTAT"	11.2346645790035	-1.10820176517638	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCACTTAGGAACTAT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1467.74282388961	3.34212618192145	0.00227705162479664	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1461.35277046879	1461.35277046879
"AML-3133"	"2019-07-01-count-1:TATTGCTGTTACAGCT"	0.3092383640701	9.98794839465944	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTGCTGTTACAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2094.35364580056	37.0423676462817	0.0176867778374279	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2089.71587676574	2089.71587676574
"AML-3133"	"2019-07-01-count-1:GAGGGTATCCGAGTGC"	-3.18083153191264	13.5317573317322	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGGTATCCGAGTGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2295.31455961142	31.3591021947022	0.0136622242312666	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2293.69347916928	2293.69347916928
"AML-3133"	"2019-07-01-count-3:TCGTAGATCAAGTTGC"	-0.65044073286708	10.6984319456848	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTAGATCAAGTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1548.07474439206	42.0023534347407	0.0271319931979352	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1548.07474439206	1548.07474439206
"AML-3133"	"2019-07-01-count-3:AGGCATTCAGCCTACG"	8.21826614913289	7.73945853793947	"2019-07-01-count-3"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCATTCAGCCTACG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1996.44210581357	45.4518560928586	0.0227664283179083	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1990.33833108759	1990.33833108759
"AML-3133"	"2019-07-01-count-2:GAGGCAAAGTCATCCA"	1.1270703273708	10.8102645643982	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGGCAAAGTCATCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1672.72866574804	36.334130949038	0.0217214732389305	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1669.49727984599	1669.49727984599
"AML-3133"	"2019-07-01-count-3:CATGCCTCATACTGAC"	9.02611031112019	6.26014134967653	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGCCTCATACTGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1829.54095386057	39.8618630270504	0.021787904196917	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1826.20205223485	1826.20205223485
"AML-3133"	"2019-07-01-count-2:GGAGATGGTCCTTGTC"	8.34141888198201	6.66293761813966	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGATGGTCCTTGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1595.30855827979	34.8202285477327	0.0218266418537108	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1591.63828677044	1591.63828677044
"AML-3133"	"2019-07-01-count-1:TTCGGTCAGACCGCCT"	0.622063954442185	10.7795495756897	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGGTCAGACCGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1924.30503192544	36.0232568662857	0.0187201385791946	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1921.81559750156	1921.81559750156
"AML-3133"	"2019-07-01-count-3:TGCGATACAAGTAGTA"	1.44751586493794	10.2424001463684	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGATACAAGTAGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1778.82216889155	41.125829635884	0.023119697041729	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1777.26188095205	1777.26188095205
"AML-3133"	"2019-07-01-count-3:ACACCAAAGTACGAGC"	-8.16677031937297	4.19754788959352	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACACCAAAGTACGAGC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1996.75088656511	38.5978227814321	0.0193303145831224	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1986.64137388728	1986.64137388728
"AML-3133"	"2019-07-01-count-1:TTTGATCTCCGGTTCT"	1.41834892806355	9.4275216826233	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGATCTCCGGTTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1970.58573622267	36.9809210503643	0.0187664613473005	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1966.48062769344	1966.48062769344
"AML-3133"	"2019-07-01-count-2:ATCAGGTAGACGAGCT"	1.44951667365376	10.5924863585266	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCAGGTAGACGAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1802.43672077423	37.3331791208924	0.0207126156999598	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1794.94739090643	1794.94739090643
"AML-3133"	"2019-07-01-count-2:TTAGGGTAGATTTGCC"	-1.56949112835582	9.36954019153444	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTAGGGTAGATTTGCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1792.41426124843	34.3857898860877	0.0191840639909536	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1787.55150267457	1787.55150267457
"AML-3133"	"2019-07-01-count-3:CACTGTCGTTTCGTGA"	9.65267147597615	6.29574821079103	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACTGTCGTTTCGTGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1561.13228214452	40.8345894637425	0.0261570335395589	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1559.21933679779	1559.21933679779
"AML-3133"	"2019-07-01-count-1:CAACAACTCGCCAACG"	1.3971070247585	11.0692424544129	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACTCGCCAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2071.91050782716	40.4543507636388	0.0195251438760566	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2070.80123284873	2070.80123284873
"AML-3133"	"2019-07-01-count-1:CTTCTCTTCAACCTTT"	1.21755435046498	-10.0677185288635	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCTCTTCAACCTTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.62043328707	40.4574440313342	0.0164352893257838	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2460.52818453971	2460.52818453971
"AML-3133"	"2019-07-01-count-2:AAGCGTTCACCCTTAC"	3.01208748397176	-9.41234114086302	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCGTTCACCCTTAC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.65316053101	46.106119421703	0.0180267286171556	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2550.69985856823	2550.69985856823
"AML-3133"	"2019-07-01-count-1:TACGCTCTCATGCTAG"	-1.07209060612376	14.174214340094	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGCTCTCATGCTAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2310.95244956671	27.258057855523	0.011795161713792	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2305.08669481824	2305.08669481824
"AML-3133"	"2019-07-01-count-3:TGAACGTCAATCTCTT"	0.272023250430268	11.2444638975891	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAACGTCAATCTCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1884.47867687477	41.7386475757484	0.0221486441252645	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1881.21127772554	1881.21127772554
"AML-3133"	"2019-07-01-count-3:GTGGGAAGTATGGTAA"	0.093748458742541	11.3595151671204	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGGAAGTATGGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1623.83290364142	41.4069847994099	0.0254995355165889	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1622.06088160438	1622.06088160438
"AML-3133"	"2019-07-01-count-1:TCCCATGGTTGCCGAC"	0.414548833935899	-9.79785826122435	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCCATGGTTGCCGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2557.22857522852	44.6340976355398	0.0174540899737722	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2551.64242884371	2551.64242884371
"AML-3133"	"2019-07-01-count-3:GGGTTTAGTGTACATC"	2.2323645549709	-9.41731169140013	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTTTAGTGTACATC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1637.74885898551	48.1567473272558	0.0294042319510979	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1633.43079529844	1633.43079529844
"AML-3133"	"2019-07-01-count-1:ATGTCCCAGGGTCAAC"	-2.26521430435832	13.4745216139588	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGTCCCAGGGTCAAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2048.99905347771	38.2624314643438	0.0186737184672692	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2042.06268347791	2042.06268347791
"AML-3133"	"2019-07-01-count-3:AGACAGGAGGTCCGAA"	3.9891435104305	-10.746723198053	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACAGGAGGTCCGAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2142.64688960564	37.8753866532723	0.0176769148649796	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2139.72951103609	2139.72951103609
"AML-3133"	"2019-07-01-count-2:GTATTGGAGAAGTGTT"	4.0587326484615	-10.8487692109314	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTATTGGAGAAGTGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1999.19192339576	46.3989153692917	0.0232088349429104	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1999.19192339576	1999.19192339576
"AML-3133"	"2019-07-01-count-3:CTCTCAGGTGGTCTTA"	7.96151508864705	7.60597846591798	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCTCAGGTGGTCTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1783.21000835954	34.7424320414924	0.0194830849303351	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1776.84571306498	1776.84571306498
"AML-3133"	"2019-07-01-count-2:GCAACATTCCCTCAAC"	3.97515477713887	-10.7103357545105	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAACATTCCCTCAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1945.56414474321	50.6352659560996	0.0260260069517177	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1940.48594882086	1940.48594882086
"AML-3133"	"2019-07-01-count-1:TCTATCAAGTGCGACA"	4.02945031699483	-10.8029585114685	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTATCAAGTGCGACA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.76578115929	40.9663441074832	0.0164803717301063	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2485.76578115929	2485.76578115929
"AML-3133"	"2019-07-01-count-1:TCAGGTAAGAACCGCA"	0.216956426470917	-9.95817472850951	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGGTAAGAACCGCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.01929279051	52.3390873021407	0.0243435430917504	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2145.45123816975	2145.45123816975
"AML-3133"	"2019-07-01-count-2:TTTGTTGGTCGGTGTC"	0.594132979481858	9.76719853961793	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGTTGGTCGGTGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1644.57773085579	34.6355854677771	0.0210604733470116	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1641.1868199826	1641.1868199826
"AML-3133"	"2019-07-01-count-1:TTTCAGTGTTGCATCA"	-7.61676917496379	1.49679062450258	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTCAGTGTTGCATCA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2724.29171787784	39.0318150436993	0.0143273258100657	2807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2711.97439922342	2711.97439922342
"AML-3133"	"2019-07-01-count-2:TGAATGCGTCCATAGT"	8.91686882552449	7.20838735187379	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAATGCGTCCATAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1630.3703740671	34.5841780532467	0.0212124671812905	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1627.16560249033	1627.16560249033
"AML-3133"	"2019-07-01-count-1:GCCCGAAAGGTACAAT"	8.58477081832234	7.71513316715089	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCCGAAAGGTACAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2019.48073564013	39.4815153060811	0.0195503302454462	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2014.20867368124	2014.20867368124
"AML-3133"	"2019-07-01-count-1:TTAATCCGTTGTGTAC"	0.783914406865281	10.9280242689881	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAATCCGTTGTGTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1744.4576129247	43.9802884453223	0.0252114400025957	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1741.57295700146	1741.57295700146
"AML-3133"	"2019-07-01-count-1:TATTGGGTCTGGGATT"	8.35910763320271	6.91813705051271	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTGGGTCTGGGATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1849.2962832848	38.5908335642015	0.0208678479013946	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1834.46072401795	1834.46072401795
"AML-3133"	"2019-07-01-count-2:GTAATCGAGTTGCCTA"	1.48609413680379	-10.3908128968445	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAATCGAGTTGCCTA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.13234689021	35.1878754447077	0.0150495653043373	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2335.64958618397	2335.64958618397
"AML-3133"	"2019-07-01-count-2:GTACAGTGTGAATGTA"	-7.35467801514323	1.53177270973054	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTACAGTGTGAATGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2767.25625609895	38.7271217714959	0.0139947725065731	2652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2760.84196160206	2760.84196160206
"AML-3133"	"2019-07-01-count-1:TCCCATGGTTGATGTC"	0.533105601638001	11.0053090819153	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCCATGGTTGATGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2124.93813441069	36.9372765046199	0.0173827538347905	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2123.40886515342	2123.40886515342
"AML-3133"	"2019-07-01-count-2:CTCATTAGTAGCTGCC"	1.22812010821645	11.1992454298767	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCATTAGTAGCTGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2069.85068658973	36.7219320371632	0.0177413435061183	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2059.36730382315	2059.36730382315
"AML-3133"	"2019-07-01-count-2:CAGTTAGAGGAACTAT"	-2.18971405449565	13.6664905318054	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGTTAGAGGAACTAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2048.98419799997	38.0053054624287	0.0185483643551404	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2048.98419799997	2048.98419799997
"AML-3133"	"2019-07-01-count-2:AGTTCCCTCATGAGAA"	2.66822733458821	-10.0052128068176	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTCCCTCATGAGAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2345.31466657941	38.8323329325968	0.016557408473138	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2343.2312817491	2343.2312817491
"AML-3133"	"2019-07-01-count-1:CACGAATGTGTCGATT"	-7.86087403717692	-0.75997575437697	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACGAATGTGTCGATT"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3117.13238404184	43.8068758633142	0.0140535820960263	3527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3112.06053016999	3112.06053016999
"AML-3133"	"2019-07-01-count-3:ACCTACCAGCAGGTCA"	1.3918260532314	11.0924186476502	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCTACCAGCAGGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.3176471304	32.7194950361	0.0174753974499185	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1865.23678065446	1865.23678065446
"AML-3133"	"2019-07-01-count-1:GGGAAGTTCCCATACC"	9.28742947158162	7.44830176914064	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAAGTTCCCATACC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2097.69038343526	35.1777501023185	0.0167697532391363	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2095.06512072149	2095.06512072149
"AML-3133"	"2019-07-01-count-2:CAGCGTGAGCGACTAG"	-0.512107829481918	-9.75709631359252	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCGTGAGCGACTAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2263.50090390512	50.9686496694702	0.0225176184297237	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2257.53175846101	2257.53175846101
"AML-3133"	"2019-07-01-count-2:CATGGATAGCAATTCC"	-7.61446938934978	1.15852449024049	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGGATAGCAATTCC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2707.6804725276	39.2635998414778	0.0145008246873478	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2703.00991688396	2703.00991688396
"AML-3133"	"2019-07-01-count-2:AGCTACATCGCAGTCG"	1.51196386393849	10.9270553358826	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCTACATCGCAGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1698.06126499913	40.2146032915915	0.0236826574638414	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1692.28545585961	1692.28545585961
"AML-3133"	"2019-07-01-count-2:AGAAATGCAGCATACT"	-8.2901967567509	-0.457396291848742	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAATGCAGCATACT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2884.97040657612	40.1075145119386	0.0139022273575201	3043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2880.81226537056	2880.81226537056
"AML-3133"	"2019-07-01-count-2:GTAACCAAGAATTCAG"	2.27955259856526	-10.2361507645813	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAACCAAGAATTCAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2136.18258546805	44.6422040577913	0.0208981218934569	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2134.65252234328	2134.65252234328
"AML-3133"	"2019-07-01-count-1:TTACTGTTCCCATACC"	1.4428754049236	11.1832065352234	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACTGTTCCCATACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2178.36159079024	33.0073003272778	0.0151523514125604	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2169.93278890942	2169.93278890942
"AML-3133"	"2019-07-01-count-1:CACAACAGTCCACAGC"	1.35282983359639	10.2835464247498	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACAACAGTCCACAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2049.0204280853	34.9641703052138	0.0170638466195703	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2037.98626694629	2037.98626694629
"AML-3133"	"2019-07-01-count-3:TAGAGTCAGCCATATC"	1.4442513185436	-10.1043558350769	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGAGTCAGCCATATC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2351.42449018526	43.59346274418	0.018539171862051	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2349.43350946027	2349.43350946027
"AML-3133"	"2019-07-01-count-3:TCACACCGTCGGATTT"	0.595777590840501	10.2630910643372	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACACCGTCGGATTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1594.22088530334	49.0880912641132	0.0307912734782501	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1592.26918809849	1592.26918809849
"AML-3133"	"2019-07-01-count-3:ATTCCTAAGGTTTACC"	-0.900147716433364	10.010133720282	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCCTAAGGTTTACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1902.40661862509	33.7992532037833	0.0177665767522459	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1897.28541119569	1897.28541119569
"AML-3133"	"2019-07-01-count-2:TTTCGATCATTGTGCA"	1.36506654795949	11.513253188971	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATCATTGTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1881.92343960898	38.2390381656504	0.020319125295339	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1877.57038272184	1877.57038272184
"AML-3133"	"2019-07-01-count-3:AACCCAACACCTCTAC"	1.45233931121175	11.5441436537537	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCCAACACCTCTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2140.85452312878	31.3560187165649	0.014646496703914	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2137.39826427779	2137.39826427779
"AML-3133"	"2019-07-01-count-2:TCATTTGGTACGTTCA"	8.49944843825642	7.26620385730592	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATTTGGTACGTTCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1899.40247805479	41.7374593672618	0.021973994374276	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1889.14460536066	1889.14460536066
"AML-3133"	"2019-07-01-count-2:ATTCGTTTCGCATTAG"	0.960426588624161	12.9232873686585	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCGTTTCGCATTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1885.09011659312	43.9999237590111	0.0233410187511518	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1881.94316482121	1881.94316482121
"AML-3133"	"2019-07-01-count-1:ATCGCCTCAATCGTCA"	0.226169799535912	10.7376966246399	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGCCTCAATCGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2047.32417796152	41.4555925258381	0.0202486704216597	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2043.59060359491	2043.59060359491
"AML-3133"	"2019-07-01-count-2:TGGGCTGGTTTGATCG"	1.03232940015141	11.704376197699	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCTGGTTTGATCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1734.81165722977	37.7419226121026	0.0217556311976659	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1731.02044721819	1731.02044721819
"AML-3133"	"2019-07-01-count-1:TCGGATAGTACCTAGT"	-1.56078658524211	11.4697055586609	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGATAGTACCTAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1831.71170022229	34.4177848098608	0.0187899573965074	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1828.30175043797	1828.30175043797
"AML-3133"	"2019-07-01-count-3:GACTCTCCACATAGCT"	1.21745576438252	10.1720447310242	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCTCCACATAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1870.08968053844	36.9793223334346	0.0197740903649003	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1870.08968053844	1870.08968053844
"AML-3133"	"2019-07-01-count-2:AGTGACTAGCGGCTCT"	0.324314375489396	9.90784738147584	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGACTAGCGGCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1341.68051494301	48.966401388742	0.0364963199833173	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1339.34291618207	1339.34291618207
"AML-3133"	"2019-07-01-count-2:GGGCTACAGGGTGGGA"	8.69245400008504	7.92442462528077	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGCTACAGGGTGGGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1716.23390743076	37.4522675765608	0.0218223561569341	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1713.29827792343	1713.29827792343
"AML-3133"	"2019-07-01-count-1:TCGCTTGTCGTGGACC"	-7.6064113182133	1.20453772628633	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGCTTGTCGTGGACC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2379.39936098257	43.171779933809	0.0181439823182861	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2375.86394311788	2375.86394311788
"AML-3133"	"2019-07-01-count-1:TTCATGTGTAGAGGAA"	-1.50983021679576	11.3749828108582	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATGTGTAGAGGAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1985.32632846269	35.918524224965	0.0180920001462823	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1983.74700354969	1983.74700354969
"AML-3133"	"2019-07-01-count-1:TTCGCTGGTGTCTAAC"	8.96048798140828	7.75398919666139	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGCTGGTGTCTAAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1976.89925988915	34.5725753054718	0.0174882838022866	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1976.89925988915	1976.89925988915
"AML-3133"	"2019-07-01-count-2:CTTGATTGTACTCGTA"	-7.40670667114909	1.58397231185762	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTGATTGTACTCGTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2885.79869477021	42.7812599692745	0.0148247554643381	2949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2880.156299371	2880.156299371
"AML-3133"	"2019-07-01-count-2:TCTCACGGTGCGCTCA"	-8.35822997513469	4.36767957294313	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCACGGTGCGCTCA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1895.87525935362	34.5293089839938	0.0182128591074954	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1891.71702300435	1891.71702300435
"AML-3133"	"2019-07-01-count-3:TGGGATTAGTTACGAA"	0.975017805665177	9.97809312427369	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGATTAGTTACGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1729.87008082253	39.1860372621457	0.0226525897502738	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1726.40378382843	1726.40378382843
"AML-3133"	"2019-07-01-count-3:ACTTTCAGTAGGTGCA"	0.84342666444127	9.36105249011842	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTTTCAGTAGGTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1664.86877571915	33.0171750582673	0.0198316981733322	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1663.04200593193	1663.04200593193
"AML-3133"	"2019-07-01-count-2:GTCAGCGCATGCGGTC"	8.05536140975301	7.21602103793947	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCAGCGCATGCGGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1850.16904521305	33.6205209683374	0.0181715941336949	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1850.16904521305	1850.16904521305
"AML-3133"	"2019-07-01-count-3:TACATTCTCGGACGTC"	-2.81386313858684	12.1416606673035	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACATTCTCGGACGTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1844.06949358692	40.2803887023604	0.0218432053902755	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1840.50613942234	1840.50613942234
"AML-3133"	"2019-07-01-count-3:AGTGATCTCTGGGAGA"	1.15872742709462	10.4919271239075	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTGATCTCTGGGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1436.07769723183	45.1108206747373	0.031412520897506	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1430.41563511452	1430.41563511452
"AML-3133"	"2019-07-01-count-1:GTAATCGAGCGAGTCA"	3.76824607428853	-10.8213405839172	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAATCGAGCGAGTCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2165.9931410054	47.6381036508835	0.0219936539728704	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2160.92197515768	2160.92197515768
"AML-3133"	"2019-07-01-count-2:CAAAGAAGTGTTACAC"	0.408124794333619	10.6452283629212	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAAGAAGTGTTACAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1798.64035550265	37.2999184018408	0.0207378413854264	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1791.1596466774	1791.1596466774
"AML-3133"	"2019-07-01-count-2:CAATTTCGTACAGTCT"	1.39869823035542	11.1852321394714	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATTTCGTACAGTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1994.70146944736	34.5819144963126	0.0173368872615779	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1989.06208538511	1989.06208538511
"AML-3133"	"2019-07-01-count-1:AAGATAGTCCTAACAG"	1.06778707084004	11.1499929198059	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGATAGTCCTAACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1810.45803987552	31.7586869414514	0.0175417967398102	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1809.1143860584	1809.1143860584
"AML-3133"	"2019-07-01-count-3:ACCCAAACAGAAATCA"	-2.02669916573222	13.6598911055359	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCAAACAGAAATCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2081.40585919921	31.0423473972017	0.0149141251140442	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2075.95522902377	2075.95522902377
"AML-3133"	"2019-07-01-count-3:TTTAGTCGTATCGCTA"	-2.57536015930827	10.7452087172302	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTAGTCGTATCGCTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1869.37518360442	41.8044081699233	0.022362770478914	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1869.37518360442	1869.37518360442
"AML-3133"	"2019-07-01-count-1:GTCCACTCAGGCACTC"	-2.34979997101482	13.7153959044251	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCACTCAGGCACTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2297.02360675828	38.1153602427626	0.0165933689713158	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2292.50281792614	2292.50281792614
"AML-3133"	"2019-07-01-count-1:ATTCAGGGTAGCTGTT"	8.34891190108601	7.27956388080446	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCAGGGTAGCTGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1871.13201140969	40.4548040353589	0.0216204969979006	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1866.60959387148	1866.60959387148
"AML-3133"	"2019-07-01-count-3:CGGAACCTCGCAGTGC"	-1.95394478264506	11.4588308104309	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAACCTCGCAGTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1832.13693346981	41.1945048881887	0.0224844028498307	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1830.37449384185	1830.37449384185
"AML-3133"	"2019-07-01-count-1:TCGAAGTCATATAGCC"	-2.10409818115886	10.3760843046936	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGAAGTCATATAGCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2155.81835015905	31.6796413392073	0.0146949492923975	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2151.27615472247	2151.27615472247
"AML-3133"	"2019-07-01-count-2:ACCCTCATCTAACGCA"	1.22974898394887	-9.97661688244017	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCCTCATCTAACGCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2478.62399205198	39.3196680537576	0.0158635065987584	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2473.6240341036	2473.6240341036
"AML-3133"	"2019-07-01-count-2:TACGTCCTCTTCCGTG"	0.869913895695847	10.3489942320618	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACGTCCTCTTCCGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1610.62862878585	41.7898488096399	0.025946297031329	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1608.77757877444	1608.77757877444
"AML-3133"	"2019-07-01-count-3:CTCCCAATCGATGCTA"	1.24285747584645	10.631658531073	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCCAATCGATGCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1785.95014611223	37.221991618156	0.0208415625145994	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1784.29850248414	1784.29850248414
"AML-3133"	"2019-07-01-count-1:GTAATGCCATCGATCA"	-7.60166488114055	1.18123791301576	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAATGCCATCGATCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2782.37208659345	47.5283159374979	0.0170819410410663	2766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2775.36254093199	2775.36254093199
"AML-3133"	"2019-07-01-count-2:CATTCATAGTGCCAGA"	1.28251304206197	10.8651695021423	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCATAGTGCCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1715.43029640458	36.9975319302456	0.0215674935949247	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1713.81274233294	1713.81274233294
"AML-3133"	"2019-07-01-count-1:AGACTCAAGCCGAATG"	3.9375499683315	-10.980233215448	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACTCAAGCCGAATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.74764651482	43.1814989805186	0.0173228521711341	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2473.18969445606	2473.18969445606
"AML-3133"	"2019-07-01-count-1:CTGCGAGTCCGTCCTA"	0.41430284556691	9.49727246845094	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCGAGTCCGTCCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1979.56965762135	33.0690441569303	0.0167051682316984	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1974.94053766728	1974.94053766728
"AML-3133"	"2019-07-01-count-1:TCGGGCACATGGTACT"	8.68105473098103	6.65035436237184	"2019-07-01-count-1"	"AML3133"	"Plasmablast"	"Plasmablast"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGCACATGGTACT"	"Plasmablast"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1864.59941290945	38.3330156859472	0.0205583115711346	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1859.97734218382	1859.97734218382
"AML-3133"	"2019-07-01-count-1:GGTAATCAGCAACAAT"	8.5344988304073	7.52184388721315	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTAATCAGCAACAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1977.55404032804	34.2163562590211	0.0173023621915006	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1974.54123125517	1974.54123125517
"AML-3133"	"2019-07-01-count-3:AGATCCAAGACATCAA"	1.97806753691975	-9.13417436992797	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATCCAAGACATCAA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1707.7395455661	49.9576329831309	0.0292536605554628	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1707.7395455661	1707.7395455661
"AML-3133"	"2019-07-01-count-2:TTTACTGAGCTTAAGA"	-2.03669581833537	13.5437307127747	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACTGAGCTTAAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1949.49783210827	40.6067432867625	0.0208293349281895	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1946.98899922212	1946.98899922212
"AML-3133"	"2019-07-01-count-2:CCACTTGGTGACGTCC"	0.878303130238694	10.2334146269592	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACTTGGTGACGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1552.73001828028	29.2692733027992	0.0188502012315163	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1550.78228513918	1550.78228513918
"AML-3133"	"2019-07-01-count-2:GTCATTTTCCAGTGCG"	-1.06733224812205	10.6232270964417	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCATTTTCCAGTGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1910.47643740415	45.1815856420157	0.0236493812524618	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1905.30575037232	1905.30575037232
"AML-3133"	"2019-07-01-count-3:ACGTAACAGCTACAAA"	0.673937578766984	11.3358793028626	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTAACAGCTACAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1868.69987956491	46.5704717801182	0.0249213221927115	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1865.48455003401	1865.48455003401
"AML-3133"	"2019-07-01-count-2:TTTCAGTTCGTTCCTG"	0.671370704739731	11.9170293577942	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCAGTTCGTTCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1899.65334463741	28.793304283925	0.0151571360981236	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1896.62052454828	1896.62052454828
"AML-3133"	"2019-07-01-count-1:CGCCATTCACCCTATC"	11.0090261894161	-0.791258656140886	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCCATTCACCCTATC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1597.59753186118	12.1414303076879	0.00759980537372469	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1592.80759392936	1592.80759392936
"AML-3133"	"2019-07-01-count-3:GAAATGACAGGAGGTT"	-0.747935692698318	11.0544023283753	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAATGACAGGAGGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1819.24975705773	33.846447962816	0.0186046186520072	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1817.39721288776	1817.39721288776
"AML-3133"	"2019-07-01-count-2:GACCTTCGTACCAATC"	-1.44818983498271	3.62297127330629	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-5"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACCTTCGTACCAATC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2911.62385619809	37.9112880129556	0.0130206681512972	4277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2908.1303516976	2908.1303516976
"AML-3133"	"2019-07-01-count-2:TGCAGATTCCGCGAGT"	-2.28306470337566	13.2974281080994	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCAGATTCCGCGAGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1947.17194630072	32.2764484066586	0.0165760648246695	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1942.24615059403	1942.24615059403
"AML-3133"	"2019-07-01-count-3:TGCAGTATCAGTCATG"	-1.60121486607249	13.4433984526428	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCAGTATCAGTCATG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1476.42027888199	44.2080153745153	0.0299427039894031	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1476.42027888199	1476.42027888199
"AML-3133"	"2019-07-01-count-3:CCTCCTCAGTCTGGTT"	1.08113708075826	12.290931678656	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCCTCAGTCTGGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2039.24604216666	35.9742542364742	0.0176409582230951	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2037.79210688721	2037.79210688721
"AML-3133"	"2019-07-01-count-3:CACAACAGTATAATGG"	-1.47440741482432	11.25483510578	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAACAGTATAATGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1912.33642211483	36.5444487047995	0.0191098429555535	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1907.21618795493	1907.21618795493
"AML-3133"	"2019-07-01-count-2:ACCTGTCCACATGACT"	4.03012122687642	-10.8885898820129	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTGTCCACATGACT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.05878622804	40.2121509818061	0.0164194306841199	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2445.47625468194	2445.47625468194
"AML-3133"	"2019-07-01-count-3:GAGACCCAGTATGAGT"	3.61279620703999	-10.7955913773743	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGACCCAGTATGAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2743.59247112409	44.4784105861215	0.0162117410126505	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2738.46400531629	2738.46400531629
"AML-3133"	"2019-07-01-count-2:CCAATGATCCCACAGG"	11.1244389015133	-0.747754835244738	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCAATGATCCCACAGG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1918.24910913142	38.8593365250103	0.0202577112326176	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1909.7782441283	1909.7782441283
"AML-3133"	"2019-07-01-count-2:ATTCCCGAGCTGGCTC"	1.27471746978108	10.2818164595398	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCCGAGCTGGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1741.85673034247	35.6826346019214	0.02048540157198	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1734.56561684578	1734.56561684578
"AML-3133"	"2019-07-01-count-2:TGAGACTCAGGTCAAG"	3.86219157752339	-10.731677078363	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGACTCAGGTCAAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2014.70918176012	40.8644452141782	0.0202830490793106	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2010.61874500483	2010.61874500483
"AML-3133"	"2019-07-01-count-3:CGTCAAACAATAGTCC"	0.938432534306687	9.28232667529909	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTCAAACAATAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1626.27223035952	43.1391591162035	0.0265264070251428	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1616.51606175334	1616.51606175334
"AML-3133"	"2019-07-01-count-1:CAATCGACAATGGCAG"	2.94348659095113	-10.5444612733093	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATCGACAATGGCAG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.58966493331	34.6848300478618	0.0139824939764047	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2477.02360077948	2477.02360077948
"AML-3133"	"2019-07-01-count-3:CGAGAAGTCCTCTTTC"	9.37987961348836	6.44672725284425	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGAAGTCCTCTTTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1590.92798687866	43.8013007264301	0.0275319191614491	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1587.00319961506	1587.00319961506
"AML-3133"	"2019-07-01-count-2:GCCTGTTCACATCATG"	-4.07311377945598	13.0049113997254	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCTGTTCACATCATG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2026.34833943064	31.4886878104912	0.0155396222839647	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2024.83366305716	2024.83366305716
"AML-3133"	"2019-07-01-count-2:AAGGAATCAATGCTCA"	-7.53549895706828	1.08049020850984	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGAATCAATGCTCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2148.82560562512	42.9387397076644	0.0199824218378918	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2143.22024764773	2143.22024764773
"AML-3133"	"2019-07-01-count-1:TCGAACAGTCCCGTGA"	1.33580805835072	10.4477004774841	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGAACAGTCCCGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1666.05929065877	45.6687167196606	0.0274112193819962	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1661.03347826009	1661.03347826009
"AML-3133"	"2019-07-01-count-3:TCTCACGTCCTACGGG"	10.1811100440914	6.54614017093507	"2019-07-01-count-3"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCACGTCCTACGGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1701.36061515264	36.750512444579	0.0216006601523933	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1697.42287512515	1697.42287512515
"AML-3133"	"2019-07-01-count-2:TTTCGATGTTCGGACC"	1.48625089701955	11.0436601408753	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATGTTCGGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1788.40717164981	27.8621240312476	0.015579295628492	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1783.9867046238	1783.9867046238
"AML-3133"	"2019-07-01-count-2:ACGTAGTGTGATAGTA"	-2.58647427979167	-8.31684877788695	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAGTGTGATAGTA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2375.3845518865	43.6748855355283	0.0183864484177277	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2374.15284494867	2374.15284494867
"AML-3133"	"2019-07-01-count-2:CTGTACCTCACCACAA"	-0.318240742117721	9.86773297870485	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTACCTCACCACAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1864.5218002187	43.437637626813	0.0232969320185573	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1864.5218002187	1864.5218002187
"AML-3133"	"2019-07-01-count-2:GGAGGTATCTAATTCC"	1.31923880156819	10.8022298582825	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGTATCTAATTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1976.70624695936	27.3052409874268	0.0138135046769993	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1969.36674302881	1969.36674302881
"AML-3133"	"2019-07-01-count-3:GTTACCCCACGTAGTT"	1.40948869761769	10.9632901915344	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTACCCCACGTAGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1799.77019251575	34.4681087837203	0.0191513943986038	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1798.23690701479	1798.23690701479
"AML-3133"	"2019-07-01-count-2:GAGGGTACAAGCCATT"	1.11265101012532	11.0999126204285	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGGGTACAAGCCATT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1908.6788886772	46.7434572988781	0.0244899535360154	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1907.43035934096	1907.43035934096
"AML-3133"	"2019-07-01-count-1:AATGGAAAGACCAACG"	1.22031476077382	9.58349416339723	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGAAAGACCAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1875.70403249717	31.5569263452887	0.0168240435583412	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.48261258625	1874.48261258625
"AML-3133"	"2019-07-01-count-1:TCTAACTCAGTCGGAA"	-2.18220625343974	13.525981880072	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTAACTCAGTCGGAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2181.06358922416	41.9715571406121	0.019243619190187	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2176.11558008628	2176.11558008628
"AML-3133"	"2019-07-01-count-1:GAAGCGATCAGTCAGT"	0.212163989513558	10.0794706114563	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGCGATCAGTCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1344.49192349315	40.9985006627002	0.0304936756750321	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1339.81358998267	1339.81358998267
"AML-3133"	"2019-07-01-count-3:CACAGATAGCTACTAC"	-2.73998580399211	13.8248510130676	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAGATAGCTACTAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2140.75042435295	35.5801475882015	0.0166204089853004	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2140.75042435295	2140.75042435295
"AML-3133"	"2019-07-01-count-1:AACCTTTCAACCGTAT"	1.18438841876332	11.9824666746887	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCTTTCAACCGTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2065.84696653524	41.3843847837536	0.0200326478457221	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2065.84696653524	2065.84696653524
"AML-3133"	"2019-07-01-count-1:GTAACACAGTGAGGCT"	4.09145655211751	-10.9054260483948	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAACACAGTGAGGCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2231.58270614003	42.0691534580598	0.0188517115419069	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2227.51802220439	2227.51802220439
"AML-3133"	"2019-07-01-count-1:TCTTAGTAGATGTTCC"	-3.95444283905681	11.4089555510315	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTAGTAGATGTTCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1984.36685279044	30.1267096062161	0.0151820262285936	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1981.0606019396	1981.0606019396
"AML-3133"	"2019-07-01-count-1:TCGACCTGTAATACCC"	2.73958816108052	-10.4708280793396	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGACCTGTAATACCC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2928.76698550693	45.8444445102292	0.0156531553165859	3036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2923.12005226223	2923.12005226223
"AML-3133"	"2019-07-01-count-2:ACCTGAAAGAGCTGCA"	-2.03024206581767	13.8474120863709	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTGAAAGAGCTGCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2372.90342161766	42.4769758595347	0.0179008447931595	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2360.88641268223	2360.88641268223
"AML-3133"	"2019-07-01-count-3:CAACCAACACGGAAGT"	-0.561445931822616	12.5021667250427	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACCAACACGGAAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1747.38576951352	40.4633238311717	0.0231564915642164	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1745.55032339426	1745.55032339426
"AML-3133"	"2019-07-01-count-1:CTAGGTATCTGAACGT"	8.59639133986775	7.08242318713991	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGGTATCTGAACGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1868.12782709862	40.4462631318318	0.0216506935687847	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1863.27848064169	1863.27848064169
"AML-3133"	"2019-07-01-count-3:TTCATGTCACGTAACT"	3.96336736258809	-10.8828640214172	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCATGTCACGTAACT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2217.60283595807	45.7096760281331	0.0206122012864333	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2213.64643238876	2213.64643238876
"AML-3133"	"2019-07-01-count-1:TGTTGGACACAGTCGC"	3.84042157706563	-10.6161213151184	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTGGACACAGTCGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2337.08609418723	44.3686255147025	0.0189845918064617	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2330.43058516789	2330.43058516789
"AML-3133"	"2019-07-01-count-2:TCCGAAAAGCCGAACA"	-3.39953694763835	13.4273452528748	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCGAAAAGCCGAACA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2415.72961289116	35.2056060494006	0.0145734878032423	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2406.47606150136	2406.47606150136
"AML-3133"	"2019-07-01-count-1:CGTAGTATCTTTCAGT"	8.04574598845784	7.34762332523195	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTAGTATCTTTCAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1751.89363854559	38.4785726691324	0.0219639890359309	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1750.09366885216	1750.09366885216
"AML-3133"	"2019-07-01-count-3:AGTGATCGTCAGGTAG"	-0.200913826853591	-9.92819597637328	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTGATCGTCAGGTAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1899.03679033167	41.2719757363038	0.0217331101463788	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1894.01974245198	1894.01974245198
"AML-3133"	"2019-07-01-count-2:CAAGAGGTCATGAGTC"	1.41326703605	9.66724679553834	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGAGGTCATGAGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1582.30222990328	39.2955632850448	0.0248344232488674	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1574.1071088759	1574.1071088759
"AML-3133"	"2019-07-01-count-2:TATCTTGTCGCAATTG"	1.28611828860585	10.529568649176	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCTTGTCGCAATTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1973.90252316987	40.6259427716571	0.0205815344449818	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1967.46077817342	1967.46077817342
"AML-3133"	"2019-07-01-count-3:ATCGGCGTCTCGTTTA"	2.16526569899861	-3.63229753887328	"2019-07-01-count-3"	"AML3133"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGGCGTCTCGTTTA"	"cDC2"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2309.08363197861	43.1392719269763	0.0186824207358878	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	2306.61361248123	2306.61361248123
"AML-3133"	"2019-07-01-count-2:CCCTGATTCCATAGAC"	-8.20035968247111	-3.41140105640563	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTGATTCCATAGAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1988.48431504507	49.1054119483247	0.0246948952912468	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1988.48431504507	1988.48431504507
"AML-3133"	"2019-07-01-count-3:CAGGTATAGTCATGGG"	1.24472572383229	11.5389575728211	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGTATAGTCATGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1782.09095384164	37.9575367925443	0.0212994385672177	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1775.21387179151	1775.21387179151
"AML-3133"	"2019-07-01-count-2:GGTGTCGGTCGAGATG"	4.19470514830892	-10.7791977158752	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGTCGGTCGAGATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2013.97682287745	43.0621419082235	0.0213816472061972	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2010.93329078004	2010.93329078004
"AML-3133"	"2019-07-01-count-1:TCCACGTTCTTCACAT"	1.09504415568654	10.8985595473084	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCACGTTCTTCACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2142.06168072561	36.8839581198674	0.0172189057167453	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2131.98937833911	2131.98937833911
"AML-3133"	"2019-07-01-count-3:TTCCTCTGTGAATAAC"	1.09789504584615	10.1459226378235	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTCTGTGAATAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1661.33889223082	39.3041894120333	0.0236581407898399	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1654.36774968317	1654.36774968317
"AML-3133"	"2019-07-01-count-2:TCTTGCGCAGATAAAC"	2.38275851783101	-10.4227905503479	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTTGCGCAGATAAAC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.29229489521	41.8769120073286	0.0169797035387924	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2457.42504577862	2457.42504577862
"AML-3133"	"2019-07-01-count-2:AGGTGTTGTTGTGTTG"	-0.28788391771968	-10.0091819993225	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTGTTGTTGTGTTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.79490622452	46.6257043036317	0.0200299881140536	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2323.77203092967	2323.77203092967
"AML-3133"	"2019-07-01-count-2:TCTTGCGTCATGCCCT"	4.54807009276692	-9.98438646709593	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTTGCGTCATGCCCT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2009.72512124274	50.6258780243627	0.0251904489271933	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2004.55298305078	2004.55298305078
"AML-3133"	"2019-07-01-count-3:CGGAGAATCTTTCGAT"	0.570289869874161	9.39642045581666	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGAGAATCTTTCGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1745.18935858373	37.3965225101057	0.0214283466296483	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1741.20953160903	1741.20953160903
"AML-3133"	"2019-07-01-count-2:AACACACCATGTGTCA"	1.18615915355031	10.4412488707337	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACACACCATGTGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1953.2264933791	34.7673742250307	0.0177999706346819	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1946.11086484167	1946.11086484167
"AML-3133"	"2019-07-01-count-3:ATTTCACCAAGGTCAG"	1.03863473710362	11.9179715880188	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTTCACCAAGGTCAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1890.59182215696	36.6099955433743	0.0193643044015743	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1889.19749403664	1889.19749403664
"AML-3133"	"2019-07-01-count-3:CAGGTATTCTCTCCGA"	-0.560474852949935	-9.94756128704222	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGTATTCTCTCCGA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.72722956496	38.7452031013902	0.0164962549135886	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2345.0274367392	2345.0274367392
"AML-3133"	"2019-07-01-count-1:GCGTTTCGTGGTCAAG"	1.28145958957021	10.4241695174011	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGTTTCGTGGTCAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1882.05504302297	33.4840683771135	0.0177912269363446	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.51399966493	1876.51399966493
"AML-3133"	"2019-07-01-count-3:GTCAAGTAGGTGCCTC"	-1.29133258286174	8.54591748798219	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCAAGTAGGTGCCTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1901.68532479804	46.6813447951764	0.0245473550152857	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1901.68532479804	1901.68532479804
"AML-3133"	"2019-07-01-count-1:CTGTGAATCACCTCAC"	1.44504274901692	10.6384143599304	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTGAATCACCTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2082.09277721356	33.9233332641308	0.016292901851151	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2070.88596076663	2070.88596076663
"AML-3133"	"2019-07-01-count-3:GACTGATAGTGTTCAC"	-2.98424468460734	13.1857013472351	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTGATAGTGTTCAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1909.57723074927	38.1283488929703	0.0199669059093303	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1909.57723074927	1909.57723074927
"AML-3133"	"2019-07-01-count-3:TGCGGCAAGTGCTAGG"	9.07430233535115	7.17465541446535	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCAAGTGCTAGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1544.9607904098	34.2395982353847	0.0221621146943817	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1544.9607904098	1544.9607904098
"AML-3133"	"2019-07-01-count-2:CTCCGATAGTGGATTA"	-3.7074342769688	13.1941203841004	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCGATAGTGGATTA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1881.85894101555	33.3070761584331	0.01769902909963	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1875.46699078653	1875.46699078653
"AML-3133"	"2019-07-01-count-1:ATCCGTCAGGTAGTAT"	1.33587684211079	11.4342756041321	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCCGTCAGGTAGTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1989.18072936653	35.806163069303	0.0180004574449631	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1983.00886664534	1983.00886664534
"AML-3133"	"2019-07-01-count-3:TGTTCATCATCACGGC"	1.41424085673634	10.9543647536072	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCATCATCACGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1818.90704845508	38.093203278474	0.0209429081661039	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1814.62729405394	1814.62729405394
"AML-3133"	"2019-07-01-count-2:CATGCCTAGCCTCTGG"	1.41578342494313	11.4139594801697	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCCTAGCCTCTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1967.76676105835	37.7174839142774	0.0191676598368758	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1963.98976375466	1963.98976375466
"AML-3133"	"2019-07-01-count-2:AGCCACGTCTTTGCGC"	8.21734299239461	6.17957685077516	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCCACGTCTTTGCGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1892.71657163476	40.868763211938	0.0215926482730793	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1889.81840968423	1889.81840968423
"AML-3133"	"2019-07-01-count-2:TTGGTTTGTGAGTAGC"	8.75271572646443	6.27416751468507	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGTTTGTGAGTAGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1604.78641531009	41.3885948961211	0.025790718628512	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1594.12092311854	1594.12092311854
"AML-3133"	"2019-07-01-count-2:CGGAGAATCGGCGATC"	-6.19679913941081	2.78856704318849	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAGAATCGGCGATC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2118.82454286736	50.0590074428246	0.0236258389640327	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2113.2508244483	2113.2508244483
"AML-3133"	"2019-07-01-count-3:ACACTGACATGGGAAC"	1.35152091559712	10.330391860846	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACACTGACATGGGAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1789.15916111455	38.3307006418456	0.0214238629379219	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1783.96152763344	1783.96152763344
"AML-3133"	"2019-07-01-count-2:CCCATTGCACAAGCAG"	0.656023164361161	12.8450174101624	"2019-07-01-count-2"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCATTGCACAAGCAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1583.91125171637	49.9059176608131	0.0315080264798508	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1579.49269404229	1579.49269404229
"AML-3133"	"2019-07-01-count-1:CATCGTCAGATAGCAT"	-7.66911206665691	1.26817116821138	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGTCAGATAGCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2887.66403936301	40.0749937134652	0.0138779972902614	3132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2883.59765771547	2883.59765771547
"AML-3133"	"2019-07-01-count-1:CGACAGCTCTTAGGAC"	8.55833305892293	7.09692618930665	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGACAGCTCTTAGGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1898.26504978482	36.7538612912535	0.0193618174108088	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1893.69216697466	1893.69216697466
"AML-3133"	"2019-07-01-count-2:AAAGGATAGGAGTCTG"	1.46234740790669	11.3945722349915	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGATAGGAGTCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1683.94460416874	29.3216165717013	0.0174124591148149	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1679.71498515761	1679.71498515761
"AML-3133"	"2019-07-01-count-1:ATGATCGCACCAATTG"	-1.18839786472972	11.592972732428	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGATCGCACCAATTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2143.87280050695	34.8402879931152	0.0162510984722959	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2139.56876239235	2139.56876239235
"AML-3133"	"2019-07-01-count-3:AGACAGGGTCGCACAC"	3.67150606688802	-10.7700252763	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACAGGGTCGCACAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1885.36945021288	50.2839795027253	0.0266706238912738	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1882.11440276368	1882.11440276368
"AML-3133"	"2019-07-01-count-2:AGAAATGTCTAACGGT"	1.43768968161885	11.0659217604431	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAATGTCTAACGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.03596138809	39.0825406711057	0.0203233540380051	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1917.76097668911	1917.76097668911
"AML-3133"	"2019-07-01-count-1:ATTTCTGTCGGTGAAG"	-0.207874308258849	12.5611705549988	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTCTGTCGGTGAAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1998.67486032715	35.8425605588269	0.0179331622517932	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.51914977828	1995.51914977828
"AML-3133"	"2019-07-01-count-3:AATAGAGCATGGTGGA"	2.85778536376302	-10.6894140473572	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATAGAGCATGGTGGA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.96508901793	43.9546755865711	0.0195617972888854	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2243.02099538842	2243.02099538842
"AML-3133"	"2019-07-01-count-2:GGTGTCGTCTGAACGT"	7.10791363295857	-10.3347521058288	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGTCGTCTGAACGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1766.83611307432	51.9095074855776	0.0293799221679108	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1766.83611307432	1766.83611307432
"AML-3133"	"2019-07-01-count-2:TGGTGATAGTCCCGAC"	-7.63288197937663	1.01658330047456	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTGATAGTCCCGAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2749.84714199619	39.6681658181295	0.0144255894127021	2846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2747.48494519583	2747.48494519583
"AML-3133"	"2019-07-01-count-1:TGACGCGGTCTCTCAC"	-1.78064701977428	10.4028863676819	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACGCGGTCTCTCAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2152.89767478578	34.8296511518878	0.0161780337076882	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2150.1513142961	2150.1513142961
"AML-3133"	"2019-07-01-count-2:AAAGGATAGGTCGAGT"	2.14740600165669	-9.74564649974974	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	24	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.25	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGATAGGTCGAGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2164.32898558354	46.0959563055234	0.0212980358404686	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2154.70168074837	2154.70168074837
"AML-3133"	"2019-07-01-count-2:CTTCCTTCAGGTTCAT"	-7.5649975341862	1.49813184821931	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCCTTCAGGTTCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2710.039836129	40.7964668331453	0.0150538255155019	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2707.8970493443	2707.8970493443
"AML-3133"	"2019-07-01-count-1:AATTTCCAGTAGACCG"	-1.76256809654887	13.8432550200256	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATTTCCAGTAGACCG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1975.26622403081	38.0955530249108	0.0192862878742347	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1971.93450223455	1971.93450223455
"AML-3133"	"2019-07-01-count-1:TCTCCGACAGCTCGGT"	0.97912092980687	-9.94567015087279	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCCGACAGCTCGGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.47920447646	45.7028235178955	0.0195773101898952	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2328.37978379302	2328.37978379302
"AML-3133"	"2019-07-01-count-1:CATCCCACACATACTG"	1.36293854293172	11.4190416106018	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCCACACATACTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2024.8104124443	43.9044616345691	0.0216832456830211	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2021.34131433249	2021.34131433249
"AML-3133"	"2019-07-01-count-2:TTTGATCGTCAACCAT"	-2.81945953789409	11.7603578337464	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGATCGTCAACCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1808.83815805109	34.3737492857638	0.0190032199026581	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.83815805109	1808.83815805109
"AML-3133"	"2019-07-01-count-1:CAAAGAAAGGCTGAAC"	0.604107876389664	9.95656297290651	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAAGAAAGGCTGAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2019.03636202098	34.7950879406446	0.0172335122809853	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2011.86998527999	2011.86998527999
"AML-3133"	"2019-07-01-count-3:CTTCCGAAGCAGGTCA"	1.41259457644765	10.9346875914368	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCCGAAGCAGGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1762.767851802	41.7034808086169	0.0236579540329064	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1756.78620731777	1756.78620731777
"AML-3133"	"2019-07-01-count-1:CCGATCTCATTCCTAT"	1.20511140403096	-10.4131078950134	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGATCTCATTCCTAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2421.23172029427	35.6637727599113	0.0147295991792049	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2421.23172029427	2421.23172029427
"AML-3133"	"2019-07-01-count-2:GAAGTAAAGGGATCTG"	8.31089272078816	6.99725005710451	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGTAAAGGGATCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1954.47770185938	36.9181856444829	0.0188890288230768	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1951.38227849619	1951.38227849619
"AML-3133"	"2019-07-01-count-1:TGCTCGTCACCGTCTT"	1.22774197634999	11.0842790373596	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTCGTCACCGTCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.7242180353	33.6046066873302	0.0160271944198836	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2086.47298506101	2086.47298506101
"AML-3133"	"2019-07-01-count-3:CGTTAGAAGAACAAGG"	2.57591404494588	-10.5107879868713	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTTAGAAGAACAAGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2082.09942145528	45.5556631419512	0.0218796771530295	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2077.14264578755	2077.14264578755
"AML-3133"	"2019-07-01-count-1:GAGGGTATCTGCCTCA"	0.687863607972306	9.8372764357361	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGGTATCTGCCTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.53697176009	36.2899594049008	0.0193801030111519	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1867.55441362667	1867.55441362667
"AML-3133"	"2019-07-01-count-3:GCAGTTACACCAGCGT"	1.62182988700215	-9.7085867158142	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGTTACACCAGCGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2074.54536452577	47.1503568448211	0.0227280432865345	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2064.9725441489	2064.9725441489
"AML-3133"	"2019-07-01-count-2:AGCGTATTCTGCGGCA"	-1.693147401244	12.6296605833801	"2019-07-01-count-2"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGTATTCTGCGGCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1537.07121532691	45.1177001451249	0.0293530317237313	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1530.53400276087	1530.53400276087
"AML-3133"	"2019-07-01-count-3:TGTCAGATCCTTGACC"	-3.92806396904643	12.8454370268616	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTCAGATCCTTGACC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1859.13237655097	38.7158107471796	0.0208246659761822	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1853.0516287016	1853.0516287016
"AML-3133"	"2019-07-01-count-1:TAAGTCGAGCGCTGAA"	8.71723904189412	8.05454776370851	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAAGTCGAGCGCTGAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1872.89624504399	43.6630069553989	0.0233130943964135	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1864.44779074852	1864.44779074852
"AML-3133"	"2019-07-01-count-3:TTGCTGCGTGAGCCAA"	-5.81094727936442	-5.53371908580931	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00601503759398496	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCTGCGTGAGCCAA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3045.78562638917	49.4751234777639	0.0162437970187736	2500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	3045.78562638917	3045.78562638917
"AML-3133"	"2019-07-01-count-1:TGCGGGTAGAGGCCAT"	0.399776836007279	11.3095903166565	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCGGGTAGAGGCCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1699.02021461849	44.0411030809295	0.0259214709171772	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1694.10298761361	1694.10298761361
"AML-3133"	"2019-07-01-count-2:GGCTGTGCACTAAACC"	0.765724022954148	10.5058126219544	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCTGTGCACTAAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1677.5709069361	33.9943747353869	0.0202640464226182	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1674.66823109785	1674.66823109785
"AML-3133"	"2019-07-01-count-2:TCAGCCTCAGATGCGA"	1.32728566703145	11.4792985686096	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGCCTCAGATGCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2041.53535080343	28.9060003056762	0.0141589516411266	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2038.95915039702	2038.95915039702
"AML-3133"	"2019-07-01-count-1:GACTCAACACACACTA"	-7.61481604996379	1.70505580985872	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTCAACACACACTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2770.0590585233	36.6977552064551	0.0132480046205291	2817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2764.49707705342	2764.49707705342
"AML-3133"	"2019-07-01-count-3:TGGAACTCACCGGAAA"	1.25742735442464	10.5561265715393	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAACTCACCGGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1823.95468238474	39.2932678013585	0.0215428969704359	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1820.94943399383	1820.94943399383
"AML-3133"	"2019-07-01-count-1:ACAGAAAAGACTTCAC"	0.95690562304799	11.2631921538147	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGAAAAGACTTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2064.32643013049	37.0446341634763	0.0179451435697283	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2059.79868203658	2059.79868203658
"AML-3133"	"2019-07-01-count-2:GTAACCACAAATGGTA"	1.10734524306599	-10.1464796296326	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAACCACAAATGGTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2375.52922407217	36.7495936570948	0.0154700659056082	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2367.19237865863	2367.19237865863
"AML-3133"	"2019-07-01-count-2:GGGAGTAAGATCCCAT"	-0.648887316614944	11.7007331618103	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAGTAAGATCCCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1702.54709836664	43.3454808040291	0.0254591963098191	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1700.92500233324	1700.92500233324
"AML-3133"	"2019-07-01-count-1:TACGTCCAGACTAGAT"	1.50288309630696	11.0770158537659	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGTCCAGACTAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1918.24803217399	36.1168803254982	0.0188280554546256	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1912.66569794959	1912.66569794959
"AML-3133"	"2019-07-01-count-3:CCGGTGAAGTGGTTGG"	8.44013180312459	7.08611152255861	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGGTGAAGTGGTTGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1514.28731515339	37.0412486798556	0.0244611760986081	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1510.61346901365	1510.61346901365
"AML-3133"	"2019-07-01-count-3:CAGTTAGTCGAAACAA"	4.23171581801717	-10.6040725938049	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGTTAGTCGAAACAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1915.3263035741	49.2342083382421	0.0257053893356805	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1909.94286021515	1909.94286021515
"AML-3133"	"2019-07-01-count-3:AACCATGAGGTAGTCG"	1.43704607066457	10.7473411330017	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCATGAGGTAGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1720.80727283281	38.9779247407151	0.0226509530474899	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1715.91794950732	1715.91794950732
"AML-3133"	"2019-07-01-count-1:TGCAGGCAGTCCGCCA"	3.87283505973164	-10.8413963547912	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGGCAGTCCGCCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.48219545106	46.9667151625872	0.0194440328523377	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2409.37647953356	2409.37647953356
"AML-3133"	"2019-07-01-count-2:AATGGAAAGTGATCGG"	-0.941356579691726	10.4199695357117	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGGAAAGTGATCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1851.06133079123	41.4603389965537	0.022398144408771	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1847.41276190754	1847.41276190754
"AML-3133"	"2019-07-01-count-1:ACGTAGTGTATCGAGG"	-7.52287946167644	4.31391093814699	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	67	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.666666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTAGTGTATCGAGG"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2169.03470454043	29.8103967686973	0.0137436236987335	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2161.11482169158	2161.11482169158
"AML-3133"	"2019-07-01-count-2:CCAAGCGCACAACGAG"	1.24308933791463	10.567729926947	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCAAGCGCACAACGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1774.24968039322	30.8609316602653	0.017393792993907	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.5814996862	1771.5814996862
"AML-3133"	"2019-07-01-count-1:TACGTCCCATAGGTAA"	1.26427390155141	11.1353626021179	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGTCCCATAGGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1950.85545289177	33.8779697117836	0.0173656995763402	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1947.13811238955	1947.13811238955
"AML-3133"	"2019-07-01-count-2:ACCCTTGAGCCGATAG"	1.40718712386433	11.1724433668884	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCCTTGAGCCGATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1763.69562346573	32.0568186431249	0.0181759359248916	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1753.24177890092	1753.24177890092
"AML-3133"	"2019-07-01-count-2:CAGCAGCTCGCTGTCT"	-7.63422904434856	1.50535473907319	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAGCTCGCTGTCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2547.62424994622	39.6964861686245	0.0155817664906677	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2543.96012089213	2543.96012089213
"AML-3133"	"2019-07-01-count-3:TCACTATGTTAAGACA"	4.16358055648152	-10.1771211854187	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACTATGTTAAGACA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1989.47039404065	44.3621640825949	0.0222984791407197	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1979.86602599315	1979.86602599315
"AML-3133"	"2019-07-01-count-2:ACGGAAGAGGAGGGTG"	1.15283681926076	10.8735828169617	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGAAGAGGAGGGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1739.96812563948	40.1344817288421	0.0230662166377856	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1736.42732821259	1736.42732821259
"AML-3133"	"2019-07-01-count-1:GCATCTCCATCCGTTC"	-0.687115470797378	12.442090965155	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATCTCCATCCGTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2375.97885235605	37.8643563771702	0.0159363187679989	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2369.99621092976	2369.99621092976
"AML-3133"	"2019-07-01-count-2:CCCGAAGGTGGACCAA"	1.31331779536549	10.8482370146546	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGAAGGTGGACCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1803.86552379694	28.0046730828716	0.0155248119737467	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1801.22830246827	1801.22830246827
"AML-3133"	"2019-07-01-count-1:TAAGCCACAGAATGTA"	-0.508667568594772	9.15476892078248	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAAGCCACAGAATGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1925.30806822725	43.0643657467753	0.022367519493349	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1922.44096441894	1922.44096441894
"AML-3133"	"2019-07-01-count-2:GCCGTGACAACATACC"	-2.75054750862773	10.4672546156677	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGTGACAACATACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1979.07672829035	34.4190584167616	0.017391472460239	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1975.4004143007	1975.4004143007
"AML-3133"	"2019-07-01-count-3:TTGGGCGGTCATACCA"	8.07673992690389	7.54369590366212	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGCGGTCATACCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1641.65016806061	37.1367155094679	0.0226215768937787	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1639.84830575848	1639.84830575848
"AML-3133"	"2019-07-01-count-3:TTTCACAGTATCGGTT"	1.12128760394399	11.365394569281	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTCACAGTATCGGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1413.46768686612	43.0105086724674	0.0304290710513718	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1411.03197739759	1411.03197739759
"AML-3133"	"2019-07-01-count-3:TGCGATACAAGCCTGC"	-1.14994035187419	11.763648010138	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGATACAAGCCTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1983.164227885	34.687697439107	0.0174910866943685	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1981.50703082698	1981.50703082698
"AML-3133"	"2019-07-01-count-1:TTAGTCTGTGAGCGAT"	1.35204150256459	11.005645728949	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGTCTGTGAGCGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1873.9959309612	33.6505988063839	0.0179566018529848	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1871.17028017513	1871.17028017513
"AML-3133"	"2019-07-01-count-1:CTCTCAGTCTCGTGGG"	1.24425389346425	10.2352456816467	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCTCAGTCTCGTGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2031.08074134756	33.7627662166326	0.0166230546769066	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2023.51535404882	2023.51535404882
"AML-3133"	"2019-07-01-count-3:TCAGTTTCAGAGCGTA"	-7.25999484482463	-1.81464841282042	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.032258064516129	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTTTCAGAGCGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3330.85174236425	42.0635342137993	0.0126284618672167	3831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3321.64654828695	3321.64654828695
"AML-3133"	"2019-07-01-count-2:GTAATCGCACCTGAAT"	-4.86701951447185	2.94179842555848	"2019-07-01-count-2"	"AML3133"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAATCGCACCTGAAT"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2887.90403919301	39.3527302240566	0.0136267444104733	2905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2884.12554120204	2884.12554120204
"AML-3133"	"2019-07-01-count-1:GTGGAAGAGCCAGAGT"	-0.224384616047698	11.5134639509949	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAAGAGCCAGAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1916.31062903658	44.6461030797535	0.0232979467959218	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.16365015095	1909.16365015095
"AML-3133"	"2019-07-01-count-2:TATCAGGCAGAGTGAC"	11.0817114311153	-2.53599216854247	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCAGGCAGAGTGAC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2446.97548790334	38.8551396922774	0.0158788430388282	2944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2439.99600538383	2439.99600538383
"AML-3133"	"2019-07-01-count-3:CTGAGCGGTGTACGCC"	7.79995359954183	6.57736442172853	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGAGCGGTGTACGCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1508.43728199232	44.5391875503026	0.0295267082576187	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1506.49496725591	1506.49496725591
"AML-3133"	"2019-07-01-count-3:CACACAAAGTGGGAAA"	4.10018314894978	-10.7370786896911	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACACAAAGTGGGAAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2175.85604109558	43.1860455004145	0.0198478413483042	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2173.14142149222	2173.14142149222
"AML-3133"	"2019-07-01-count-1:GACTTCCGTGCTCCGA"	1.40090801295583	11.1094274290833	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTTCCGTGCTCCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1895.38947123104	32.8712221632763	0.0173427270026601	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1889.09880850234	1889.09880850234
"AML-3133"	"2019-07-01-count-1:AGTGTTGCAATCAGCT"	-0.68100349131282	13.1558665999207	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTGTTGCAATCAGCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1516.28589030904	50.0940607796517	0.0330373454635535	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1516.28589030904	1516.28589030904
"AML-3133"	"2019-07-01-count-3:GCTTCACTCAACTGGT"	1.03342982110326	10.2369251021179	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTTCACTCAACTGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1960.40596499408	35.0428728105756	0.017875314315666	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.73699817026	1955.73699817026
"AML-3133"	"2019-07-01-count-1:TATTGGGTCGGCATCG"	3.91273536261861	-10.81445887005	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATTGGGTCGGCATCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2251.81868290096	51.0334571659377	0.0226632177596966	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2243.9813177889	2243.9813177889
"AML-3133"	"2019-07-01-count-1:CACTGGGGTTCTCACC"	1.64038826999013	-10.2532472840515	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGGGGTTCTCACC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2468.42832743446	40.9254205920644	0.0165795458337653	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2461.4939049646	2461.4939049646
"AML-3133"	"2019-07-01-count-3:TACTTACCACGCCACA"	-1.13744543018993	10.6678514250549	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACTTACCACGCCACA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1814.0344280014	33.0483728668396	0.0182181618808913	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.76400053955	1808.76400053955
"AML-3133"	"2019-07-01-count-2:TGGTTAGTCTAAGCCA"	0.416869868605775	10.7110366591248	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTTAGTCTAAGCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2153.8422742751	31.3207450482856	0.0145418006798232	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2146.4186491207	2146.4186491207
"AML-3133"	"2019-07-01-count-1:CTTCTAAGTCATACCA"	9.83225502547566	7.32583854282228	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCTAAGTCATACCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2073.39838543501	33.4901883428505	0.0161523171707419	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2065.97359128449	2065.97359128449
"AML-3133"	"2019-07-01-count-1:TCTACCGAGTTCGGTT"	-0.122347365052062	14.2488899000916	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTACCGAGTTCGGTT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1956.07810979534	42.6803449980978	0.0218193459577968	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1944.00225401365	1944.00225401365
"AML-3133"	"2019-07-01-count-3:CCACCATTCTGAATCG"	1.33980753001515	11.5482330092224	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACCATTCTGAATCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1886.80044032961	34.4046773444941	0.0182344017995268	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1883.47945060015	1883.47945060015
"AML-3133"	"2019-07-01-count-3:GGGACCTCAACTTGCA"	1.06517984446828	12.3933105238709	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGACCTCAACTTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1829.46769322814	34.3603416200215	0.0187816061181118	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1820.48386337842	1820.48386337842
"AML-3133"	"2019-07-01-count-2:GAGTCTAAGTAGATCA"	3.85777439650838	-10.7977771989075	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTCTAAGTAGATCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2153.22781331691	37.5203236619581	0.01742515280079	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2150.91680635769	2150.91680635769
"AML-3133"	"2019-07-01-count-1:CTCTGGTTCCGAGGCT"	-2.29195676270183	13.4505471953186	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCTGGTTCCGAGGCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2360.72195219015	37.9218689355179	0.0160636744621009	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2352.49143248722	2352.49143248722
"AML-3133"	"2019-07-01-count-2:CAACGGCTCGTGTCAA"	0.925035138695878	12.2926673659119	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACGGCTCGTGTCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1830.05631385646	37.0102202661248	0.0202235417489058	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1826.94574851346	1826.94574851346
"AML-3133"	"2019-07-01-count-2:CTATCCGGTGCGAACA"	-8.29036651077922	-1.07454349910887	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTATCCGGTGCGAACA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2951.60471484747	39.0008051731016	0.0132134242017285	3330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2947.50027414639	2947.50027414639
"AML-3133"	"2019-07-01-count-3:TGGATGTTCACTGGTA"	1.25412180003468	11.0609369047913	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGATGTTCACTGGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1961.79186728032	35.0917837001782	0.0178876180931603	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1960.22249060689	1960.22249060689
"AML-3133"	"2019-07-01-count-1:GACCTTCGTCACCTTC"	1.47026981887166	10.9333657988342	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCTTCGTCACCTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2065.3657752111	34.5858748609692	0.0167456415110946	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2058.50474243981	2058.50474243981
"AML-3133"	"2019-07-01-count-1:TTGCATTGTATCCCTC"	1.3551707464153	11.3420543440613	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCATTGTATCCCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2351.62475655135	39.4804698947343	0.0167885925612691	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2343.22441876378	2343.22441876378
"AML-3133"	"2019-07-01-count-3:CGTTGGGAGACCATAA"	3.89253964003865	-10.274929069635	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTTGGGAGACCATAA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1865.21921108233	51.8782219038544	0.0278134717869173	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1863.44394443049	1863.44394443049
"AML-3133"	"2019-07-01-count-1:TTGTGGAAGGTACTGG"	8.59346165236775	7.25767276370851	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGGAAGGTACTGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1840.84509715624	36.6835228824484	0.0199275446582212	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1828.96440139921	1828.96440139921
"AML-3133"	"2019-07-01-count-3:CTTCAATAGACCATTC"	3.40291490134541	-9.45754339611205	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCAATAGACCATTC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1654.69766233822	50.0250639727649	0.0302321476069987	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1650.72407742748	1650.72407742748
"AML-3133"	"2019-07-01-count-2:TTGTGTTTCAGTAGGG"	3.66669477996175	-10.7328472367493	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTGTTTCAGTAGGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2029.54534897362	47.424658435791	0.0233671341513874	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2026.4545335852	2026.4545335852
"AML-3133"	"2019-07-01-count-1:GTGTGGCTCACGTCCT"	-7.64486632767375	1.34309897506563	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGGCTCACGTCCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2881.18312522649	40.3000776941082	0.0139873364317793	3160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2872.39436099855	2872.39436099855
"AML-3133"	"2019-07-01-count-1:CAATCGACACCGGTCA"	0.754413087933701	11.4151382216248	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATCGACACCGGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1957.22357145718	32.4410076331014	0.0165750137624536	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1951.33409275748	1951.33409275748
"AML-3133"	"2019-07-01-count-2:CCCGAAGGTCTAGATC"	8.48045219954793	6.58762738788453	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGAAGGTCTAGATC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1689.69041741922	40.1577728292287	0.0237663493946805	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1686.39440092709	1686.39440092709
"AML-3133"	"2019-07-01-count-1:CTGAGGCCATCGTGCG"	-2.19624886933025	3.97178409183351	"2019-07-01-count-1"	"AML3133"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAGGCCATCGTGCG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3450.25342268384	40.8816660506852	0.0118488879054237	5291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	3440.49343711787	3440.49343711787
"AML-3133"	"2019-07-01-count-3:GAGTCATTCGTTGTTT"	1.06462564048116	12.2947158583435	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTCATTCGTTGTTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1769.97622283157	36.0321969561527	0.0203574468918623	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1766.71023328639	1766.71023328639
"AML-3133"	"2019-07-01-count-3:TCATCATTCTCCCATG"	1.33403350886647	10.8358287581238	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATCATTCTCCCATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1924.82962229168	40.3065715275947	0.0209403321004621	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1920.74630240708	1920.74630240708
"AML-3133"	"2019-07-01-count-1:TGAATCGAGACAGCTG"	1.41173400458638	11.1365489729675	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAATCGAGACAGCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1809.30782468034	31.0969405478702	0.0171872028207053	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.19857850835	1804.19857850835
"AML-3133"	"2019-07-01-count-2:GATGAGGTCTGACCCT"	4.00274767455403	-10.8942680588928	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGAGGTCTGACCCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.12478603748	35.4743671948579	0.0150307167674881	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2351.00595432211	2351.00595432211
"AML-3133"	"2019-07-01-count-1:GAGCCTGGTGGCTCTG"	1.35952164706532	11.1065253981384	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGCCTGGTGGCTCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1957.19216585581	42.564319610825	0.0217476445866587	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1952.99366659019	1952.99366659019
"AML-3133"	"2019-07-01-count-3:TTGACCCAGTCTGGAG"	4.07526793059651	-10.6391525498596	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGACCCAGTCTGGAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1872.60305056249	40.3291201487639	0.0215363956267453	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1872.60305056249	1872.60305056249
"AML-3133"	"2019-07-01-count-2:TCGCTCACAAGTATAG"	1.3789915042812	10.3456954726013	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCTCACAAGTATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1740.95866692337	36.6320894492752	0.0210413320805666	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1735.89987147127	1735.89987147127
"AML-3133"	"2019-07-01-count-1:AATTTCCTCCATCTAT"	1.38640095767323	11.2842368849548	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATTTCCTCCATCTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2152.13515269774	40.5081525272832	0.0188223088482642	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2148.39166496424	2148.39166496424
"AML-3133"	"2019-07-01-count-3:CAGGTATCACTAGAGG"	8.08204712447469	-9.7325649491516	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.2	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGTATCACTAGAGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.44796298034	41.1560881199809	0.0186273172346929	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2200.76657436436	2200.76657436436
"AML-3133"	"2019-07-01-count-1:ATTCTTGTCGTTTACT"	-1.92628596249278	3.44584891879884	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCTTGTCGTTTACT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3330.15199876684	43.9596167754735	0.0132004835790534	4386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	3325.24441264243	3325.24441264243
"AML-3133"	"2019-07-01-count-2:TTTCCTCGTCCGGTGT"	1.30310322818105	10.5045585402283	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCCTCGTCCGGTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1769.76053418495	24.3892764683404	0.0137811167088618	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1767.10540957687	1767.10540957687
"AML-3133"	"2019-07-01-count-2:ATATCCTCACCTGTCT"	0.820488889783066	10.9377269514832	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATATCCTCACCTGTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2067.91493482408	34.9301291319658	0.0168914729246043	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2061.2720378279	2061.2720378279
"AML-3133"	"2019-07-01-count-2:GCGGAAACACACTTAG"	1.05993344363515	10.1024455794129	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGGAAACACACTTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1815.6164915866	34.4265848197959	0.0189613748163919	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1811.03668537833	1811.03668537833
"AML-3133"	"2019-07-01-count-1:GCATTAGCAGGACTAG"	-7.49645982208903	-1.41957309162291	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATTAGCAGGACTAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2606.7786251014	48.1011132654702	0.0184523199639168	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2601.90589399177	2601.90589399177
"AML-3133"	"2019-07-01-count-2:ACTTCGCGTTAAGGGC"	1.53698100623433	10.595302558783	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTCGCGTTAAGGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1665.99644751788	40.7559329974973	0.0244633973008876	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1664.44392338325	1664.44392338325
"AML-3133"	"2019-07-01-count-1:CCGTTCATCTTGTTAC"	-7.484367231757	0.71580127561418	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGTTCATCTTGTTAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1785.10318771463	42.2211092367199	0.023651915209884	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1779.38153770194	1779.38153770194
"AML-3133"	"2019-07-01-count-2:ACCATTTGTTGCTCGG"	-4.8661654991215	3.31770441615907	"2019-07-01-count-2"	"AML3133"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCATTTGTTGCTCGG"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3058.87958147015	40.9576813330416	0.0133897658414381	3765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3057.92718499976	3057.92718499976
"AML-3133"	"2019-07-01-count-3:GCTTCACTCAGGACAG"	11.0412203269893	-1.16595735466155	"2019-07-01-count-3"	"AML3133"	"Ery"	"Erythrocytes"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTTCACTCAGGACAG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1924.73845697917	39.1442832376056	0.0203374557699863	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1913.12067228067	1913.12067228067
"AML-3133"	"2019-07-01-count-1:CATTGAGTCCACGGAC"	3.82478394088094	-10.3134651414123	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTGAGTCCACGGAC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1975.08673391421	41.0799736830766	0.0207990732648306	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1971.39221020011	1971.39221020011
"AML-3133"	"2019-07-01-count-3:CTGCCATGTGTCACAT"	-7.99594054642375	-3.56995632564696	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCCATGTGTCACAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1609.67953838448	47.5711283976715	0.0295531671138811	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1603.93133355496	1603.93133355496
"AML-3133"	"2019-07-01-count-1:ATGTCTTGTCGCATGC"	-2.60435114327129	9.89371488178102	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGTCTTGTCGCATGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1956.64458245086	37.4063634077093	0.0191176076346246	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.23852986752	1955.23852986752
"AML-3133"	"2019-07-01-count-2:GTGGAAGAGAAGGATG"	-0.833621422678787	10.6300086745056	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGAAGAGAAGGATG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1716.7502299199	33.9318517649764	0.0197651651204728	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1714.96867959947	1714.96867959947
"AML-3133"	"2019-07-01-count-1:TGACAGTAGTTCGCAT"	-7.8369439643925	-0.852149032708727	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACAGTAGTTCGCAT"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3118.92291789526	39.8028425659809	0.0127617269210491	3565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3111.4962719321	3111.4962719321
"AML-3133"	"2019-07-01-count-1:CCAATGATCACGGGAA"	1.45391084727589	10.9858093031677	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCAATGATCACGGGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1783.5562651708	36.6966514892504	0.0205749895340343	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1780.58996987998	1780.58996987998
"AML-3133"	"2019-07-01-count-2:AGCGCTGAGTACAGAT"	0.637723405926865	11.2981433638367	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGCTGAGTACAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1810.02365263769	37.5719189223674	0.0207576949989659	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1800.59770030424	1800.59770030424
"AML-3133"	"2019-07-01-count-2:ACTCTCGCAAGAATAC"	-7.28103862229045	-1.29136207019957	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.032258064516129	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTCTCGCAAGAATAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3565.01549484953	40.3071700605138	0.0113063099217231	4954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3556.27619861103	3556.27619861103
"AML-3133"	"2019-07-01-count-2:AACAGGGGTCTGATCA"	0.867822368710679	10.6122627028259	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAGGGGTCTGATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1629.36529864096	51.2947787058236	0.0314814478672206	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1623.10447136927	1623.10447136927
"AML-3133"	"2019-07-01-count-1:TCGACCTGTCCAATCA"	1.18662478503529	9.2054929503235	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGACCTGTCCAATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1806.03672932112	42.3761902763751	0.0234636370281928	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1803.41356806884	1803.41356806884
"AML-3133"	"2019-07-01-count-1:CATTCATGTCAATCTG"	1.36153258857076	11.1197147139343	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTCATGTCAATCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1992.46015943997	26.5594876301224	0.0133299968404827	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1990.12316972258	1990.12316972258
"AML-3133"	"2019-07-01-count-2:CAATCGAGTCCCGTGA"	0.880562146275681	10.1771964796814	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATCGAGTCCCGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1792.12214672011	35.8733198946382	0.0200172292721746	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1781.09929266306	1781.09929266306
"AML-3133"	"2019-07-01-count-3:TCCCAGTCATAGATCC"	0.906391580670518	12.3428668745789	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCCAGTCATAGATCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1707.89715767003	42.1454300885705	0.024676796198939	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1698.79887357084	1698.79887357084
"AML-3133"	"2019-07-01-count-2:ACGTAACCACCGGCTA"	3.66210021552388	-10.9615974656311	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAACCACCGGCTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.78152898465	41.0238244406058	0.0177225469993275	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2310.75467713767	2310.75467713767
"AML-3133"	"2019-07-01-count-1:CATCAAGTCCAACTAG"	1.57196404513661	9.9118442305359	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCAAGTCCAACTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1827.14867133888	29.8122941269747	0.0163162935751305	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1823.20375238966	1823.20375238966
"AML-3133"	"2019-07-01-count-1:AGGACGAAGTGATAGT"	0.981333692639512	10.02329919422	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGACGAAGTGATAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1879.57229409147	38.8619105517858	0.0206759328566133	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1875.94102841678	1875.94102841678
"AML-3133"	"2019-07-01-count-2:CTCAACCAGTCGCTAT"	-2.71613798561748	10.4048175581726	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCAGTCGCTAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2020.09556436628	34.2370351243983	0.0169482254841438	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2016.6540097369	2016.6540097369
"AML-3133"	"2019-07-01-count-1:CAATACGTCATTGAGC"	1.40891053256337	11.1183395155701	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATACGTCATTGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1987.90804967819	31.2481684720256	0.0157191216550907	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1981.29254663473	1981.29254663473
"AML-3133"	"2019-07-01-count-1:TATCCTACAACGACAG"	-7.62475285950358	0.962194181326307	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCCTACAACGACAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2891.16354971143	37.0119215299427	0.0128017391245946	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2885.7971013284	2885.7971013284
"AML-3133"	"2019-07-01-count-3:ATGTCTTTCCATTTAC"	8.92864384230916	7.56422135913698	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCTTTCCATTTAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1967.1550623021	41.918558016821	0.0213092291604939	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1962.61693286505	1962.61693286505
"AML-3133"	"2019-07-01-count-1:CTGATCCGTAACATGA"	0.984977980225724	12.2107486494812	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGATCCGTAACATGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1926.46113874564	36.2715973387686	0.0188280970787637	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1920.19328565176	1920.19328565176
"AML-3133"	"2019-07-01-count-3:AGTACCATCTGACAGT"	8.26476254042928	7.30302665317384	"2019-07-01-count-3"	"AML3133"	"Plasmablast"	"Plasmablast"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTACCATCTGACAGT"	"Plasmablast"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1602.61281682214	36.8228299001412	0.0229767474174818	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1597.27113369689	1597.27113369689
"AML-3133"	"2019-07-01-count-2:CGTTCTGCACAGGATG"	0.978139896958512	10.207061744574	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTTCTGCACAGGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1755.83865620333	42.7292113863831	0.0243354998680671	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1753.07395647824	1753.07395647824
"AML-3133"	"2019-07-01-count-2:AGGCTGCTCGACCAAT"	1.89974095401112	-10.2385864487854	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGCTGCTCGACCAAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2143.10547924285	48.9020128175083	0.0228182948954921	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2136.2006819753	2136.2006819753
"AML-3133"	"2019-07-01-count-1:ACCATTTAGGGCAGAG"	1.23137607154195	11.0004462965759	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCATTTAGGGCAGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2001.77438502796	32.6748937207223	0.0163229652477874	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1989.99328810387	1989.99328810387
"AML-3133"	"2019-07-01-count-1:ACCATTTGTGGATCGA"	-0.575553278357345	12.4276695021423	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCATTTGTGGATCGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2091.8489977119	30.386110767046	0.0145259580401276	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2086.77872699044	2086.77872699044
"AML-3133"	"2019-07-01-count-1:ACCATTTGTCGTGGAA"	0.771907766431016	10.9333705672058	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCATTTGTCGTGGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1988.28179533974	37.7052516406134	0.018963736291802	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1985.7322920951	1985.7322920951
"AML-3133"	"2019-07-01-count-1:GTCGAATCACTCGATA"	1.13186730918233	10.5657338866028	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGAATCACTCGATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2169.85725486428	32.4495162444825	0.0149546778580659	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2168.68514316745	2168.68514316745
"AML-3133"	"2019-07-01-count-3:TCTTTGAGTATGGTAA"	1.05524303492848	11.8226680525574	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTTGAGTATGGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1787.50695033031	43.884598788322	0.0245507290364452	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1784.33418815652	1784.33418815652
"AML-3133"	"2019-07-01-count-1:AAGACTCTCAACTTTC"	1.12392534789388	10.9701919325623	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGACTCTCAACTTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2142.5473803093	35.6505927493526	0.0166393485983054	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2130.61166055979	2130.61166055979
"AML-3133"	"2019-07-01-count-1:CTACAGAGTAGAAACT"	8.28395332869832	6.82300660693971	"2019-07-01-count-1"	"AML3133"	"Plasmablast"	"Plasmablast"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACAGAGTAGAAACT"	"Plasmablast"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1849.07831825098	34.8500297281367	0.0188472437236195	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1839.31527627761	1839.31527627761
"AML-3133"	"2019-07-01-count-3:CTACTATTCCCGATCT"	1.16923799094502	10.7332296141419	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACTATTCCCGATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1995.51453481681	34.7984892070649	0.0174383541687705	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1990.41246126306	1990.41246126306
"AML-3133"	"2019-07-01-count-2:ATTCATCGTAGTGTGG"	8.22339596328084	6.7908348807129	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCATCGTAGTGTGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1616.36433430627	39.2383972847076	0.0242757133722258	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1611.02812768077	1611.02812768077
"AML-3133"	"2019-07-01-count-3:CACCAAAGTGGTCAAG"	1.07172753390614	10.3684615858826	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAAGTGGTCAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1606.3317278052	34.1814577614323	0.0212792022779354	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1606.3317278052	1606.3317278052
"AML-3133"	"2019-07-01-count-1:GCGTGCACACGGTGAA"	11.3920456367428	-3.07110478794249	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-5"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGTGCACACGGTGAA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2862.27336754796	32.2043082721036	0.0112513041686484	5257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2851.44977235282	2851.44977235282
"AML-3133"	"2019-07-01-count-2:CCCTAACCACCGCTGA"	-7.38216100159343	1.01912645185319	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTAACCACCGCTGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2124.45944022215	48.8180915435013	0.0229790649890668	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2114.32545894988	2114.32545894988
"AML-3133"	"2019-07-01-count-1:CTGCTCAAGGAAGAAC"	1.2418256002361	11.2534332045349	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCTCAAGGAAGAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1910.52997575954	38.0685969819928	0.019925673747599	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.19879884743	1909.19879884743
"AML-3133"	"2019-07-01-count-3:TCATTACGTGTTCAGT"	1.29020490226094	10.6163215407166	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTACGTGTTCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1733.58623973812	39.0396084177977	0.0225195652358749	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1730.25873295347	1730.25873295347
"AML-3133"	"2019-07-01-count-2:ACCATTTCAGTGTACT"	3.88909878310506	-10.8468599549499	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCATTTCAGTGTACT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2525.77076274199	43.7335578571829	0.0173149355049567	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2522.59812593606	2522.59812593606
"AML-3133"	"2019-07-01-count-1:CGTTCTGCAGGTCCGT"	-1.79930839958842	9.5586833723816	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTCTGCAGGTCCGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2088.63173203426	33.1696458321938	0.0158810408381029	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2086.95086579552	2086.95086579552
"AML-3133"	"2019-07-01-count-1:CTACATTCAATTGCAC"	8.22414555129353	7.30697963321535	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACATTCAATTGCAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2006.94601730787	36.9811889496993	0.0184265987379701	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2002.8409296137	2002.8409296137
"AML-3133"	"2019-07-01-count-2:AAGGAATCAGGGAGAG"	-3.51986728134807	10.2094659575256	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGAATCAGGGAGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2016.08711349785	42.3405817520571	0.0210013652032116	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2014.3658430137	2014.3658430137
"AML-3133"	"2019-07-01-count-3:ATCATTCTCCTCTAGC"	8.50448765334431	7.14005324924318	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCATTCTCCTCTAGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1739.38160009486	39.4055654496327	0.022654928307557	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1733.76752463373	1733.76752463373
"AML-3133"	"2019-07-01-count-3:AGGGTCCGTCGAAACG"	-7.23397431793864	1.72560057723848	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTCCGTCGAAACG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2194.39539113233	38.3187701456741	0.0174621083787007	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2190.89525996414	2190.89525996414
"AML-3133"	"2019-07-01-count-1:TTTCCTCTCGAGTCCG"	-5.18306765976604	-4.81712677395018	"2019-07-01-count-1"	"AML3133"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00601503759398496	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTCCTCTCGAGTCCG"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3089.00576629096	45.2897081222196	0.0146615809580051	3358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	3084.78470654919	3084.78470654919
"AML-3133"	"2019-07-01-count-2:GATCACAAGTCAACAA"	-7.51392255249675	0.728510237577833	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCACAAGTCAACAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2749.56996827376	40.320248895446	0.0146642018063501	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2746.46190552387	2746.46190552387
"AML-3133"	"2019-07-01-count-3:GGGACCTCAAACTAGA"	-8.06534038010295	2.8652202852997	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGACCTCAAACTAGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2398.07303102833	40.2076007537769	0.0167666289698172	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2396.04978273653	2396.04978273653
"AML-3133"	"2019-07-01-count-2:GACGTTAGTTGGGTAG"	1.02435930547063	12.8047818907532	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACGTTAGTTGGGTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1645.89630133382	39.8682115048707	0.0242227967050912	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1644.2780931828	1644.2780931828
"AML-3133"	"2019-07-01-count-3:TCTTCCTGTGCGTTTA"	1.02303632077519	12.3146199950012	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTCCTGTGCGTTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1629.36524851838	44.4686256429389	0.0272919934209811	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1623.41269363975	1623.41269363975
"AML-3133"	"2019-07-01-count-1:GTCGTAATCTTAGGAC"	0.264922876923722	10.8124322661194	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCGTAATCTTAGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1843.036741137	40.2950209535838	0.0218633845187075	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.46380533659	1841.46380533659
"AML-3133"	"2019-07-01-count-3:TCATTGTAGCACACCC"	1.24888255175893	11.0395049818787	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTGTAGCACACCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1658.63695312544	40.7972525754161	0.0245968549648795	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1658.63695312544	1658.63695312544
"AML-3133"	"2019-07-01-count-3:CTGGCAGGTGCATTAC"	0.940870423882645	10.6071491011414	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGGCAGGTGCATTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1887.47709154775	40.3602790665795	0.0213831888330277	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1884.31700160083	1884.31700160083
"AML-3133"	"2019-07-01-count-2:TCGTAGAAGCAGGGAG"	-3.69908056679423	10.462056136969	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGAAGCAGGGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1703.99197630529	34.6286374949762	0.0203220660522477	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1702.07822376614	1702.07822376614
"AML-3133"	"2019-07-01-count-2:GACTATGAGCGTCTCG"	3.65357961234395	-10.8095960847107	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACTATGAGCGTCTCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.59335169748	44.370453675473	0.018844210888256	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2347.21368331461	2347.21368331461
"AML-3133"	"2019-07-01-count-1:TGATTTCCACCATTCC"	-1.35319707813914	-9.59376718914183	"2019-07-01-count-1"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATTTCCACCATTCC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2555.97118813012	44.7667774832257	0.0175145861154937	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2547.83706080323	2547.83706080323
"AML-3133"	"2019-07-01-count-2:CATGCTCCACCCTAGG"	1.17034306105916	10.8342542418274	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCTCCACCCTAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2095.28277895629	33.5538225924605	0.0160139828998043	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2082.81488668634	2082.81488668634
"AML-3133"	"2019-07-01-count-1:TGGTTAGAGTCATGCT"	0.337487627833527	10.1291894682678	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTTAGAGTCATGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1788.12852676775	38.7976906098333	0.0216973724366249	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1786.38120675193	1786.38120675193
"AML-3133"	"2019-07-01-count-1:GGGCGTTCAGGGATAC"	1.44038583812062	11.1294488676819	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCGTTCAGGGATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1798.21193316881	35.6743471867901	0.0198387890374661	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1793.73389213947	1793.73389213947
"AML-3133"	"2019-07-01-count-3:GAATCGTCATGAGTAA"	-0.942376057535964	11.3190879591736	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAATCGTCATGAGTAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1773.2501343998	40.4829792315827	0.0228298187865556	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.29062105056	1771.29062105056
"AML-3133"	"2019-07-01-count-2:TGAACGTTCGGTCATA"	-8.27794871750529	5.62438104236452	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAACGTTCGGTCATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1479.2581752487	46.3929782718915	0.0313623267717225	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1479.2581752487	1479.2581752487
"AML-3133"	"2019-07-01-count-3:TCTCCGACACGTTGGC"	1.22108246859853	11.1917304762634	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCCGACACGTTGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1800.92094059368	39.6267957030274	0.0220036287045251	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1796.40390676245	1796.40390676245
"AML-3133"	"2019-07-01-count-2:TGCATGAAGAACAAGG"	2.87218179282491	-10.3276148072449	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCATGAAGAACAAGG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2242.56427321624	48.9690395777225	0.0218361810908064	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2239.50573247281	2239.50573247281
"AML-3133"	"2019-07-01-count-3:TCATTTGTCATTCATC"	3.76321496543233	-10.8540067902771	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTTGTCATTCATC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2166.01952160458	41.3625245966044	0.0190960996353178	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2161.8312259885	2161.8312259885
"AML-3133"	"2019-07-01-count-2:TCTGCCAAGGCTTAAA"	3.06733216819112	-10.5661926499573	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGCCAAGGCTTAAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.64806818395	36.3060240796429	0.0146180227966798	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2481.60116742875	2481.60116742875
"AML-3133"	"2019-07-01-count-2:CGATGCGTCGCTCTCA"	0.411639680236024	11.4486093291077	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATGCGTCGCTCTCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1330.6542924689	39.8602630561892	0.0299553860696849	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1330.6542924689	1330.6542924689
"AML-3133"	"2019-07-01-count-3:ATCTTCATCGTAACAC"	0.684016187756699	10.484966255072	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCTTCATCGTAACAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1775.95124356115	34.3639529411314	0.0193496038056903	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.5211854712	1771.5211854712
"AML-3133"	"2019-07-01-count-2:AGGAATACAGTTGCGC"	1.10293438014333	11.2763252028259	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAATACAGTTGCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1716.75185471199	36.8727087970595	0.0214781820074081	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1712.43541684087	1712.43541684087
"AML-3133"	"2019-07-01-count-2:ATCCCTGAGCAACTCT"	3.8258282142574	-10.7954302064148	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCCTGAGCAACTCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2144.37987289164	45.6728471511109	0.0212988602105849	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2144.37987289164	2144.37987289164
"AML-3133"	"2019-07-01-count-1:AGACAGGTCAACCTTT"	4.11960711058919	-10.9016275635925	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACAGGTCAACCTTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.48038976693	43.1089707019584	0.0185696036425647	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2318.79535271456	2318.79535271456
"AML-3133"	"2019-07-01-count-3:TGGTTAGGTTTAGAGA"	0.971836169331711	11.3802356489929	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGTTAGGTTTAGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2299.92543594836	38.7382736076694	0.0168432737001737	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2291.6648565932	2291.6648565932
"AML-3133"	"2019-07-01-count-3:TGGTTAGTCCCGAACG"	-3.74961266937907	10.3445052870545	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGTTAGTCCCGAACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1959.55783343639	34.7052412535404	0.0177107512018052	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1954.58806220027	1954.58806220027
"AML-3133"	"2019-07-01-count-2:CTCAGGGCATGTTCAG"	7.74425949630086	6.35247371280519	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAGGGCATGTTCAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1653.23728229955	41.3132964738291	0.0249893326966138	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1648.30519401324	1648.30519401324
"AML-3133"	"2019-07-01-count-2:ATTCGTTGTAGGTAGC"	-7.89667354050334	4.28009173953859	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCGTTGTAGGTAGC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2015.61163758738	35.7323667244172	0.017727803341713	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2008.33805457087	2008.33805457087
"AML-3133"	"2019-07-01-count-2:CGGCAGTTCTCTAGGA"	-0.879087964922744	12.3357133635315	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGCAGTTCTCTAGGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1776.42979310322	37.5717570624048	0.0211501502667162	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1774.70843953021	1774.70843953021
"AML-3133"	"2019-07-01-count-1:CAACGATAGCGGCTCT"	8.78578438338582	7.25781486118165	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACGATAGCGGCTCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1856.92407435158	32.1867472552317	0.0173333674218592	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1853.67612075578	1853.67612075578
"AML-3133"	"2019-07-01-count-2:CCCTTAGGTTGACTAC"	1.46775462207143	10.7139615782532	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTTAGGTTGACTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1892.95207349859	34.1022110761524	0.0180153589483774	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1883.01890637249	1883.01890637249
"AML-3133"	"2019-07-01-count-1:GTCTCACCACTGGATT"	0.263588463037652	-9.81924440776976	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTCACCACTGGATT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2174.38663412823	45.5738473611503	0.0209594037444137	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2169.99822009648	2169.99822009648
"AML-3133"	"2019-07-01-count-3:CAACGGCGTTTACGTG"	-0.948806027800399	11.8764581450256	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGGCGTTTACGTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1705.2380456263	32.9158118469782	0.0193027665148585	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1703.27674225844	1703.27674225844
"AML-3133"	"2019-07-01-count-2:CGGACACCAACGACAG"	8.69840874251668	6.20361039722291	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGACACCAACGACAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1628.65949145157	35.6860573778685	0.0219113065469952	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1625.05586568684	1625.05586568684
"AML-3133"	"2019-07-01-count-3:TTTACTGAGCTTGTTG"	1.32288779792134	11.0339383848938	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTACTGAGCTTGTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1680.78391278359	28.9861453401793	0.0172456108841348	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1673.00836407924	1673.00836407924
"AML-3133"	"2019-07-01-count-3:AACCACAAGCATACTC"	1.34995128688161	-10.0851135483948	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCACAAGCATACTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2321.75058570816	44.4744285365511	0.0191555582284847	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2321.75058570816	2321.75058570816
"AML-3133"	"2019-07-01-count-1:AGTTAGCCAATACCCA"	8.54159702834431	7.63608119571535	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTAGCCAATACCCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1781.46944286479	42.1356558678984	0.023652191193434	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1778.1197601581	1778.1197601581
"AML-3133"	"2019-07-01-count-2:CCGAACGGTACAGAGC"	1.32055952128713	10.4555167921814	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGAACGGTACAGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1834.30833546067	38.1387066300502	0.0207918733687006	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1828.04475548957	1828.04475548957
"AML-3133"	"2019-07-01-count-1:ATCTCTACACAAATAG"	8.70453514632527	7.5357889899048	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTCTACACAAATAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1803.66137153556	18.0611577162624	0.010013607876342	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1800.42193573752	1800.42193573752
"AML-3133"	"2019-07-01-count-1:AGGTGTTGTACAAAGT"	1.06083788451497	12.8216733702454	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTGTTGTACAAAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1844.31683942014	39.0639476557143	0.0211807140838101	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.50467290257	1841.50467290257
"AML-3133"	"2019-07-01-count-3:GTAGCTAAGCCAGAGT"	1.17333592948262	11.0747213133606	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGCTAAGCCAGAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1668.90152918777	39.5256413324235	0.023683627009234	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1665.98502342249	1665.98502342249
"AML-3133"	"2019-07-01-count-3:CTATCTACATAGAGGC"	8.5002256828243	7.4719929465088	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATCTACATAGAGGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1572.38436154755	39.2668629706891	0.0249728144917713	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1567.0613404283	1567.0613404283
"AML-3133"	"2019-07-01-count-1:AAGGTAAGTCGCGTCA"	1.44624831256215	10.7105741270813	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGGTAAGTCGCGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1931.5424873451	33.2455440567469	0.0172119144541536	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1928.05635816087	1928.05635816087
"AML-3133"	"2019-07-01-count-3:TAGGGTTTCAAGCGTT"	-3.26466188851054	10.1132411726746	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGGGTTTCAAGCGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1700.0200717686	40.168882233525	0.0236284752754335	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1696.5097180437	1696.5097180437
"AML-3133"	"2019-07-01-count-1:TTCACCGCAACACAGG"	1.04171737012212	12.3145875700745	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCACCGCAACACAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2025.69248462812	32.5670163566407	0.0160769794052029	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2022.01470149646	2022.01470149646
"AML-3133"	"2019-07-01-count-1:CTATAGGTCAATCAGC"	3.81389655646626	-11.1818475953308	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTATAGGTCAATCAGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2086.7774168824	49.0937234144968	0.0235260948375805	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2080.74404690148	2080.74404690148
"AML-3133"	"2019-07-01-count-2:ATTCTTGAGTCTCGTA"	2.96258987960164	-10.2460394135681	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTTGAGTCTCGTA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2307.6896866767	37.9880902876639	0.0164615244878831	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2305.12399583331	2305.12399583331
"AML-3133"	"2019-07-01-count-2:TACCGGGCACACGCCA"	1.03454693135564	10.7126941450867	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCGGGCACACGCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1737.54950541727	44.5440220971972	0.0256361168175753	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1737.54950541727	1737.54950541727
"AML-3133"	"2019-07-01-count-3:AGCGATTCATCGGATT"	-0.227045993239242	8.67404553974	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGATTCATCGGATT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1699.25990467639	37.0867426695307	0.0218252326012445	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1695.84214599123	1695.84214599123
"AML-3133"	"2019-07-01-count-3:GCCGATGAGAGAGCCT"	-3.14556489411052	13.2027635344299	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCGATGAGAGAGCCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1964.3671223752	37.6171513124369	0.0191497561143013	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1964.3671223752	1964.3671223752
"AML-3133"	"2019-07-01-count-2:GTCATGAGTAACCCTA"	4.14558138427083	-10.7012768021789	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCATGAGTAACCCTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2365.77031700328	43.5416270833329	0.0184048412351742	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2357.87473804381	2357.87473804381
"AML-3133"	"2019-07-01-count-2:CAGTTCCCAAACCGGA"	-7.43693957749065	1.3978723057541	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGTTCCCAAACCGGA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1443.16428658741	42.1731959966431	0.0292227270232472	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	1443.16428658741	1443.16428658741
"AML-3133"	"2019-07-01-count-3:CACTGGGCAACAGATA"	1.05300476130788	10.4869546660217	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACTGGGCAACAGATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1651.70190618623	44.1699923473312	0.0267421089616101	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1647.84415205938	1647.84415205938
"AML-3133"	"2019-07-01-count-2:TCCTTTCCAACTTGCA"	1.21401311930959	10.1967410811218	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTTCCAACTTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1871.3488564411	33.3203152846554	0.0178055070651142	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1868.52380408211	1868.52380408211
"AML-3133"	"2019-07-01-count-1:GTGACGCCATCAGTCA"	-1.22558985176738	9.09655091846315	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGACGCCATCAGTCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1694.00426312627	26.9600899336684	0.0159150071345829	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1692.26128326546	1692.26128326546
"AML-3133"	"2019-07-01-count-2:GAGACCCGTCCTTAAG"	1.17629053172414	9.77839944446412	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGACCCGTCCTTAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1805.31176584306	35.2231439249706	0.0195108371813673	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1801.9809055201	1801.9809055201
"AML-3133"	"2019-07-01-count-3:TACACCCGTGCCTACG"	-7.53099141541179	-0.598209344503008	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACACCCGTGCCTACG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3312.59555223559	44.6951069595754	0.0134924732750461	3167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3280.00380033902	3280.00380033902
"AML-3133"	"2019-07-01-count-1:AACGAAAGTTCGGCCA"	-7.9516376060551	0.212416551354803	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00995024875621891	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACGAAAGTTCGGCCA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2654.93835605903	40.628917756365	0.0153031491912582	2956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2649.00075411003	2649.00075411003
"AML-3133"	"2019-07-01-count-1:GTTCATTCATGTTTGG"	0.28753768381421	-10.0273761979309	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCATTCATGTTTGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2377.27558875913	52.5703524247028	0.0221136971553824	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2370.13020638466	2370.13020638466
"AML-3133"	"2019-07-01-count-2:GTCACTCGTTAAGTCC"	1.14210106906239	10.637406326178	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACTCGTTAAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1870.53157653137	36.20476626971	0.019355335522775	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1863.40845602555	1863.40845602555
"AML-3133"	"2019-07-01-count-3:TCCAGAAGTTTCGCTC"	3.81197323378865	-10.8915624848572	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCAGAAGTTTCGCTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2407.48365242679	41.260115152283	0.0171382742768334	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2402.73140318031	2402.73140318031
"AML-3133"	"2019-07-01-count-1:TCGCTTGTCGCACGGT"	1.33578016337697	11.3516044386658	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGCTTGTCGCACGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2091.18736182501	35.040794591277	0.0167564108462746	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2083.64082728763	2083.64082728763
"AML-3133"	"2019-07-01-count-1:GCGAGAAAGGCTGTAG"	-1.96145925942119	11.0020503767761	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGAGAAAGGCTGTAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2122.28048093678	35.0686738516599	0.0165240523892395	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2116.42288615567	2116.42288615567
"AML-3133"	"2019-07-01-count-3:ACGATCATCGTAACAC"	-0.0407508191769898	11.0861606367859	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGATCATCGTAACAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2041.81610273869	37.4031513927886	0.0183185700919	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2038.58949699082	2038.58949699082
"AML-3133"	"2019-07-01-count-1:CCCTCAAAGGTCTGGA"	-7.67511401596721	1.556236363295	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTCAAAGGTCTGGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2740.6632376407	31.78101002607	0.0115961018448325	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2733.92845113086	2733.92845113086
"AML-3133"	"2019-07-01-count-2:ACGGAAGGTTAAACAG"	-3.39786515656169	10.3183946379456	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGAAGGTTAAACAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1664.5589275963	40.7476030117014	0.0244795196710414	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1660.97313958464	1660.97313958464
"AML-3133"	"2019-07-01-count-1:CCCTCAAAGTGATGGC"	-0.846352736384231	12.8577117689881	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTCAAAGTGATGGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2153.28028425184	42.592261306435	0.0197801752135736	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2151.89375237986	2151.89375237986
"AML-3133"	"2019-07-01-count-1:AGAGAATCATCGGATT"	-2.14480553093608	10.9296169050964	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAGAATCATCGGATT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2032.83587160038	28.8591797941728	0.0141965124668196	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2028.10954245844	2028.10954245844
"AML-3133"	"2019-07-01-count-1:GCTTTCGGTCCTGGTG"	8.32383694228474	7.28678081119386	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTTCGGTCCTGGTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1858.33977817537	31.666723347908	0.0170403301483437	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1847.91010267868	1847.91010267868
"AML-3133"	"2019-07-01-count-1:ACGGAAGCATCCGTGG"	1.23220016536061	10.8327598341736	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGAAGCATCCGTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2120.17718316248	41.2642383961993	0.0194626367663523	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2116.56543710798	2116.56543710798
"AML-3133"	"2019-07-01-count-2:CCTCAGTCAAATGCTC"	0.492133935063523	11.7883634337219	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCAGTCAAATGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.49112003339	37.038500706917	0.0157980980991685	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2337.94329251147	2337.94329251147
"AML-3133"	"2019-07-01-count-3:ATTTCACAGGCGTTAG"	-7.53836713257487	1.62383339488832	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTTCACAGGCGTTAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2382.90897585509	38.5440258372209	0.0161751985609898	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2377.98374743072	2377.98374743072
"AML-3133"	"2019-07-01-count-1:ACGGGTCCACGGATCC"	-1.71188137951549	3.90833232486574	"2019-07-01-count-1"	"AML3133"	"Ery"	"Heat shock proteins"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGGTCCACGGATCC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2489.04363306103	29.9813559267918	0.0120453315998807	2823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2487.03478016833	2487.03478016833
"AML-3133"	"2019-07-01-count-2:TTTCGATCAACTTGCA"	0.875043471425217	10.7197999724182	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATCAACTTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1747.30708825979	42.7393223390556	0.0244601092882999	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1742.67341355392	1742.67341355392
"AML-3133"	"2019-07-01-count-3:CGTAAGTAGTAGGCCA"	10.9774166541988	-0.712261878606401	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTAAGTAGTAGGCCA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1571.36184883764	34.1230575873833	0.0217155950506402	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1564.23256976769	1564.23256976769
"AML-3133"	"2019-07-01-count-3:TTCCTTCGTGTGAATA"	3.69910683211629	-10.9995479813782	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTTCGTGTGAATA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.78715988756	47.8787433066593	0.0200096122669386	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2387.59039932006	2387.59039932006
"AML-3133"	"2019-07-01-count-3:CTGTGGGTCGGCTGTG"	0.955080767243546	10.7093105086121	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTGGGTCGGCTGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1504.00495620334	45.5469867747059	0.0302838009853925	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1498.23325472759	1498.23325472759
"AML-3133"	"2019-07-01-count-1:TTCATGTGTTGTGGCC"	1.38673235949818	10.839777923468	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATGTGTTGTGGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.94594843685	30.809910589965	0.0158982300898621	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1933.15486977122	1933.15486977122
"AML-3133"	"2019-07-01-count-3:CTCACTGGTCTGTAAC"	1.14360894736592	10.7250365980896	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCACTGGTCTGTAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1682.50007093048	36.6988960671533	0.0218121215572119	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1679.24685179384	1679.24685179384
"AML-3133"	"2019-07-01-count-1:CAAGCTATCCGCAACG"	4.07473673400227	-10.9105978242126	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGCTATCCGCAACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2497.48810034722	44.3371203899885	0.0177526853416537	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2496.25452755751	2496.25452755751
"AML-3133"	"2019-07-01-count-3:AGCTACAAGAGCAGTC"	-4.31775746765788	9.15370938861696	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTACAAGAGCAGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1646.66292323186	33.3421979516677	0.0202483443826062	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1644.14814620226	1644.14814620226
"AML-3133"	"2019-07-01-count-2:CGAGAAGTCGGTCTGG"	-7.47442660751994	0.930078662279524	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAGAAGTCGGTCTGG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2138.69586810974	44.7261102348052	0.0209127959247127	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2136.40727221201	2136.40727221201
"AML-3133"	"2019-07-01-count-2:AGCGCTGAGTCAACAA"	8.62719883498494	7.30198237979738	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGCTGAGTCAACAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1739.24734732679	48.3850357821749	0.0278195254151414	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1730.99628748702	1730.99628748702
"AML-3133"	"2019-07-01-count-2:TAGGGTTGTATAGCTC"	-7.57276616516765	0.0504423853005244	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGGTTGTATAGCTC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2265.532808824	39.0420774611111	0.0172330664597072	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2260.73910652155	2260.73910652155
"AML-3133"	"2019-07-01-count-2:ACACGCGGTAATCAGA"	0.697423358529252	10.277711845282	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACGCGGTAATCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1909.24647911777	23.074823412974	0.0120858274012041	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1906.04544213387	1906.04544213387
"AML-3133"	"2019-07-01-count-3:GTGAGCCCAACTGTGT"	8.15222324904744	7.22087810123292	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGCCCAACTGTGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1588.06983621892	38.9829683374432	0.0245473891943309	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1586.2536377446	1586.2536377446
"AML-3133"	"2019-07-01-count-3:TCAGCCTAGAGTAACT"	-4.67289529267009	8.65756318652955	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTAGAGTAACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3088.7503781675	39.4719320220031	0.0127792560710008	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	3081.142204735	3081.142204735
"AML-3133"	"2019-07-01-count-2:TGAGGTTCACAGTGAG"	-0.267404387623626	13.1696796187195	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGGTTCACAGTGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1800.91662837544	29.7862583266857	0.0165394987515636	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1797.6703855765	1797.6703855765
"AML-3133"	"2019-07-01-count-3:TACTTGTCAGCAGTTT"	1.26041152056996	-10.3705482712952	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACTTGTCAGCAGTTT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2064.12826055894	48.2528613917342	0.0233768716381355	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2062.41345420564	2062.41345420564
"AML-3133"	"2019-07-01-count-1:AATCACGAGCTGAAGC"	1.09354271468465	11.5743846663269	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATCACGAGCTGAAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1930.31884321659	39.3344486002469	0.0203771769303676	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1921.72891669919	1921.72891669919
"AML-3133"	"2019-07-01-count-2:TGCGATAGTCGCATCG"	-1.94335971298869	11.0592374571594	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGATAGTCGCATCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1975.27747449289	35.8165158795214	0.0181323972667265	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1969.81525195825	1969.81525195825
"AML-3133"	"2019-07-01-count-3:TGCAGGCCAGCGTAGA"	4.21546234664266	-10.6943578950134	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCAGGCCAGCGTAGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2233.74851113139	49.3016355710356	0.0220712561532115	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2226.9915618662	2226.9915618662
"AML-3133"	"2019-07-01-count-3:CTTAGGATCTCATAGG"	-7.06912455979045	1.94452915275422	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTAGGATCTCATAGG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2450.58523718478	39.7329513004178	0.0162136581488848	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2447.23954336055	2447.23954336055
"AML-3133"	"2019-07-01-count-3:ACCGTTCCACATTGTG"	3.87509455260579	-10.8716650239197	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCGTTCCACATTGTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2144.10101211485	43.4502664644933	0.0202650277290975	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2144.10101211485	2144.10101211485
"AML-3133"	"2019-07-01-count-1:ACGGTTACAGTGGGTA"	1.31928612765614	10.1695451506409	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTTACAGTGGGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1891.29323058559	29.6044544197023	0.0156530219327947	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1887.36137486463	1887.36137486463
"AML-3133"	"2019-07-01-count-2:ATCGGCGCAAATTGGA"	-7.43397078934367	4.23558137500612	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGCGCAAATTGGA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2236.55215053894	36.9494419353318	0.0165207155694662	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2223.81633843187	2223.81633843187
"AML-3133"	"2019-07-01-count-1:TCTCCGAAGGACAGCT"	1.08839227732961	10.4620866545471	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCCGAAGGACAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2077.68223485856	32.7496378853306	0.0157625826201282	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2073.67582601151	2073.67582601151
"AML-3133"	"2019-07-01-count-2:AATCGTGTCCTAACAG"	-1.737048248679	8.74826047504274	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCGTGTCCTAACAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2242.01908505472	37.6383220525456	0.0167876903026573	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2235.83682574164	2235.83682574164
"AML-3133"	"2019-07-01-count-1:CCGAACGCAGCTCATA"	-7.4535325569218	4.09748313510744	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGAACGCAGCTCATA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2245.49960667965	34.6685408241666	0.0154391213078099	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2235.50235640521	2235.50235640521
"AML-3133"	"2019-07-01-count-1:ACGGTTAGTCAAAGAT"	1.02475257691686	10.4866704710755	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTTAGTCAAAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1583.37785535502	48.2231140209929	0.0304558471990126	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1583.37785535502	1583.37785535502
"AML-3133"	"2019-07-01-count-3:TGTCCTGGTGTCTTAG"	2.27785696563069	-10.2852421036926	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTCCTGGTGTCTTAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2128.44194308318	46.7380687894774	0.0219588177828212	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2124.21563653514	2124.21563653514
"AML-3133"	"2019-07-01-count-1:ATGCATGAGAGAGCGG"	-7.25841985169108	1.73844525897828	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCATGAGAGAGCGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3077.6098544723	42.3035308723997	0.0137455794830282	3611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3071.03062983813	3071.03062983813
"AML-3133"	"2019-07-01-count-2:TTCGGTCTCAAGAATG"	0.100350883870763	11.1208581694397	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGGTCTCAAGAATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2069.66282496231	41.7803241934108	0.0201870196872149	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2068.21566461277	2068.21566461277
"AML-3133"	"2019-07-01-count-2:CCGGTGACATTCATCT"	1.52785696563069	11.0688981779846	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTGACATTCATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1940.46449997032	43.5998825034872	0.0224687864705353	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1939.01559151683	1939.01559151683
"AML-3133"	"2019-07-01-count-2:CCGGTGAGTCCTATAG"	0.932021518319291	10.4687366255554	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTGAGTCCTATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1841.44888324628	36.5890437692321	0.019869703743679	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.48796602724	1834.48796602724
"AML-3133"	"2019-07-01-count-2:GTTATGGGTTGCATGT"	-7.73219666901286	4.33291099155275	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTATGGGTTGCATGT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1926.40111314701	32.4843409283113	0.016862708761232	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1916.65705757655	1916.65705757655
"AML-3133"	"2019-07-01-count-3:TACCGAAGTTCAGGTT"	-2.29247007790263	10.9821347960266	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGAAGTTCAGGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1925.5465601769	33.4465647616645	0.0173699070452972	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1923.65471598914	1923.65471598914
"AML-3133"	"2019-07-01-count-1:GTTGCGGAGTTCATGC"	1.42686929282491	11.3284158476624	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCGGAGTTCATGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1880.77618869719	37.0875688405228	0.0197192888039556	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.6257641016	1874.6257641016
"AML-3133"	"2019-07-01-count-3:TACCGAAGTTGAGTCT"	-2.12549529495891	13.5909719237122	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGAAGTTGAGTCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1981.98832508854	43.139495827615	0.0217657668723593	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1977.0467149021	1977.0467149021
"AML-3133"	"2019-07-01-count-1:TCATGCCAGCTTAAGA"	1.05929090556447	12.6946820982727	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATGCCAGCTTAAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1943.65677973326	37.2256820149876	0.0191523948071204	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1936.31722840373	1936.31722840373
"AML-3133"	"2019-07-01-count-2:TACTGCCAGAGGTCGT"	0.620066781609696	11.5148038634094	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACTGCCAGAGGTCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1875.62965236768	31.9498290829017	0.0170341885150782	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1873.99673158125	1873.99673158125
"AML-3133"	"2019-07-01-count-1:GCAACCGCATAATCCG"	2.4045897918636	-9.74113848125609	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACCGCATAATCCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1983.00455381948	41.5783563959258	0.02096735295733	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1979.38641093144	1979.38641093144
"AML-3133"	"2019-07-01-count-2:TTGCTGCCAAGTGGAC"	3.89360584792439	-10.9141369096008	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGCTGCCAAGTGGAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.40288510718	43.3694956103441	0.0181431740567865	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2387.43309829183	2387.43309829183
"AML-3133"	"2019-07-01-count-3:AAAGTCCCAAAGCTCT"	-1.68432221832927	11.8984794386658	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGTCCCAAAGCTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1747.11171872012	42.8550103386722	0.0245290612383199	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1743.08677344634	1743.08677344634
"AML-3133"	"2019-07-01-count-2:CTCCGATAGAGCAGCT"	-0.700372199446517	11.2220906981262	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCGATAGAGCAGCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1855.44960224415	37.5451869668715	0.0202350885313516	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1848.43303928829	1848.43303928829
"AML-3133"	"2019-07-01-count-1:TGTGCGGCATCCGATA"	-4.96252093735393	9.0282411345276	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGCGGCATCCGATA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2875.32493964511	33.5880841957745	0.0116814916229677	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2874.189710572	2874.189710572
"AML-3133"	"2019-07-01-count-1:CATCGCTGTAATGTGA"	1.31809033927266	11.4160508879456	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGCTGTAATGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1935.8716192547	40.6929039695921	0.0210204558839799	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1933.35864484011	1933.35864484011
"AML-3133"	"2019-07-01-count-1:AGTCACAGTTACCCAA"	1.13685454901997	11.4207811125549	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTCACAGTTACCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.48418033958	36.0740193658752	0.0187545183550751	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1917.4589952661	1917.4589952661
"AML-3133"	"2019-07-01-count-2:CGTCCATAGTTACGGG"	0.927932818501633	11.5766744383606	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATAGTTACGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1871.31742421079	24.8225808639465	0.0132647623234819	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1860.45351596689	1860.45351596689
"AML-3133"	"2019-07-01-count-3:CTTCCTTCACAGACGA"	3.92857207831685	-10.8611440888611	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTCCTTCACAGACGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2176.40642225423	47.2516773498264	0.0217108702063492	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2167.05334777712	2167.05334777712
"AML-3133"	"2019-07-01-count-3:AAGGTAATCTTCTGGC"	1.52015819129292	11.0714111098084	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGTAATCTTCTGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1921.04617203091	35.1510324339035	0.0182978592319529	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1919.73957609358	1919.73957609358
"AML-3133"	"2019-07-01-count-2:GAATAGATCCTGTAGA"	-1.4930559200352	12.9320897825989	"2019-07-01-count-2"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATAGATCCTGTAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2223.86060581987	30.3019006536414	0.0136258093579881	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2220.95189667203	2220.95189667203
"AML-3133"	"2019-07-01-count-2:GAATAGATCGCTGACG"	10.9717499214107	-1.22713556205901	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATAGATCGCTGACG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2302.55821248329	40.1095593105697	0.017419563637139	3308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2294.21413190995	2294.21413190995
"AML-3133"	"2019-07-01-count-1:TACGGTAGTTTCGTTT"	2.31679596480672	-10.5019989243713	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGGTAGTTTCGTTT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2827.42161934613	45.2030284241442	0.0159873674710735	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2819.3557114365	2819.3557114365
"AML-3133"	"2019-07-01-count-2:TCTCCGACAAAGTGTA"	-0.473821799189407	12.9881725081238	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCCGACAAAGTGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1552.79074806068	35.0696985706141	0.0225849481743845	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1552.79074806068	1552.79074806068
"AML-3133"	"2019-07-01-count-2:CTCCGATTCGCAGAGA"	-8.00833735886272	4.45011661136476	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCGATTCGCAGAGA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1938.27841068464	32.1185681618398	0.0165706680654276	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1928.64700828791	1928.64700828791
"AML-3133"	"2019-07-01-count-3:GATTGGTTCTTTCCGG"	9.12030663070027	7.895631767157	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTGGTTCTTTCCGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1876.38595592373	35.4385117931129	0.0188865791076904	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1873.0048907598	1873.0048907598
"AML-3133"	"2019-07-01-count-1:AAGCCATCAGAATCGG"	-2.4331673187321	8.52083203876344	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGCCATCAGAATCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2551.62152985119	34.5820051462283	0.0135529524036604	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2543.28487612134	2543.28487612134
"AML-3133"	"2019-07-01-count-2:CGTCCATTCTACCAGA"	1.4010452228481	9.55706498706666	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATTCTACCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1742.836621881	30.2408431778814	0.0173515077651072	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1738.15263464393	1738.15263464393
"AML-3133"	"2019-07-01-count-3:TACCCGTCAATAGTCC"	0.528707821934861	10.676094985846	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCCGTCAATAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1873.72058945247	40.6132077209224	0.0216751675514172	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1869.14941810273	1869.14941810273
"AML-3133"	"2019-07-01-count-3:CTCATTAGTTGGGAAC"	0.944787104695481	10.0943174132141	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATTAGTTGGGAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1597.84025914174	42.4523838281074	0.0265686032037459	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1592.16355272664	1592.16355272664
"AML-3133"	"2019-07-01-count-1:GTCAAGTGTTAAGTCC"	1.4907497363979	11.1296605833801	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCAAGTGTTAAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2030.78128045148	32.7091304215814	0.0161066731983612	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2030.78128045148	2030.78128045148
"AML-3133"	"2019-07-01-count-2:AGAAGTACACCAGGTC"	1.20591690120046	10.9204063185486	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAGTACACCAGGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1755.42984781748	31.9726769861845	0.018213588555496	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1751.45663671792	1751.45663671792
"AML-3133"	"2019-07-01-count-1:TCGACGGTCACCTTAT"	1.46601535853688	11.1023444899353	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGACGGTCACCTTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2089.8250605942	40.995098788586	0.0196165217661472	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2079.4446039309	2079.4446039309
"AML-3133"	"2019-07-01-count-3:CTGGTCTGTACGCTTA"	0.137289111583871	13.6189794310364	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGGTCTGTACGCTTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1894.61166704588	32.0686474619839	0.0169262377191977	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1894.61166704588	1894.61166704588
"AML-3133"	"2019-07-01-count-1:TCGTGGGCAGCCGTCA"	-2.14527616921123	11.3276405104431	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGTGGGCAGCCGTCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1720.94986242975	35.8243613054396	0.0208166211506362	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1720.94986242975	1720.94986242975
"AML-3133"	"2019-07-01-count-1:ACCGTTCCAAATGGTA"	0.641515453427476	10.5964431532654	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCGTTCCAAATGGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2030.61618716412	39.8493536434391	0.0196242667104369	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2024.89008649928	2024.89008649928
"AML-3133"	"2019-07-01-count-3:GATCGTATCGCGTGCA"	-1.47821257534679	11.3833045729431	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCGTATCGCGTGCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1575.27347063479	44.4370914629043	0.0282091283140808	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1575.27347063479	1575.27347063479
"AML-3133"	"2019-07-01-count-2:TTTCACAAGCCTTCTC"	0.555708249180955	12.8223933943543	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCACAAGCCTTCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1667.78203189968	50.4233416548876	0.0302337719740589	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1657.36719899556	1657.36719899556
"AML-3133"	"2019-07-01-count-1:ATCGTCCCAAACTCGT"	1.10776664790456	12.019148803595	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGTCCCAAACTCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.47516107782	34.065577669581	0.0162489774751576	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2094.01267137181	2094.01267137181
"AML-3133"	"2019-07-01-count-1:TCATTACTCTACAGGT"	0.953671117394608	10.7951926955017	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTACTCTACAGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2166.09425403145	40.9747142583115	0.0189164041140181	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2158.13426664656	2158.13426664656
"AML-3133"	"2019-07-01-count-3:ACGTCCTTCCGCAAAT"	0.839957316487473	12.5353631743225	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTTCCGCAAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1455.01848478295	28.1360153143971	0.0193372219038126	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1455.01848478295	1455.01848478295
"AML-3133"	"2019-07-01-count-1:AATGCCATCCTTATCA"	-3.39216981354411	10.001962638739	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGCCATCCTTATCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2211.82775034728	29.405689853255	0.0132947467761167	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2208.70445617184	2208.70445617184
"AML-3133"	"2019-07-01-count-3:ATGAAAGGTACCGTCG"	4.12290825423543	-10.8660831681457	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGAAAGGTACCGTCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2194.96031251767	42.7103369363276	0.0194583640955849	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2193.46751196924	2193.46751196924
"AML-3133"	"2019-07-01-count-3:AGCCAATCAGAGCGTA"	8.21454205092732	6.81848142230836	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCCAATCAGAGCGTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1604.02234101887	38.2946663780907	0.0238741477589184	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1604.02234101887	1604.02234101887
"AML-3133"	"2019-07-01-count-3:CAACGATTCCTGTTGC"	1.52116884764974	-10.0774908295837	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGATTCCTGTTGC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2711.33849517869	42.981284464466	0.0158524229051059	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2706.20713047679	2706.20713047679
"AML-3133"	"2019-07-01-count-2:GCATGATTCCCTCGTA"	1.53319015082662	11.0065183409485	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCATGATTCCCTCGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1864.91658527421	39.2119159892625	0.0210260964478992	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1861.85529509649	1861.85529509649
"AML-3133"	"2019-07-01-count-1:TCTAACTTCCCAATAG"	11.8920399146969	-2.21423699772032	"2019-07-01-count-1"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTAACTTCCCAATAG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1661.76614328262	24.8320689382573	0.0149431790018326	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1658.75899125852	1658.75899125852
"AML-3133"	"2019-07-01-count-2:TTGGGTATCATTGCCC"	8.15148129042928	6.76078841770021	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGGTATCATTGCCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1596.71247180503	45.0480044993092	0.0282129721504486	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1589.82170464502	1589.82170464502
"AML-3133"	"2019-07-01-count-3:GAAGCCCCATGAGAAT"	0.615256507962388	10.5643262633118	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGCCCCATGAGAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1511.22617063321	43.2160525018605	0.0285966808553565	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1509.15184110298	1509.15184110298
"AML-3133"	"2019-07-01-count-1:GTCTCACAGGCACTAG"	8.55852760848347	7.32080648029176	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTCACAGGCACTAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1850.42468643876	33.6330685114185	0.018175864577416	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1845.73737069552	1845.73737069552
"AML-3133"	"2019-07-01-count-3:TTCTAGTAGTCGCGAA"	0.77099378880803	10.082007385138	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTAGTAGTCGCGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1451.21214951582	39.6424085054933	0.0273167562156364	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1445.32058442577	1445.32058442577
"AML-3133"	"2019-07-01-count-2:TGTCAGACAGCTGTCG"	2.55487646636311	-9.82082369243773	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCAGACAGCTGTCG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1817.00266841053	51.1492555448816	0.0281503469610343	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1813.46015512806	1813.46015512806
"AML-3133"	"2019-07-01-count-3:TACGGTACAGAATGTA"	-3.60013041916545	10.1737174757752	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACGGTACAGAATGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1848.77647890368	33.8471118910297	0.0183078442836426	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.40061715782	1841.40061715782
"AML-3133"	"2019-07-01-count-1:CGGAGAACATAGGCGA"	0.757424553006333	11.5618753203186	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGAGAACATAGGCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1931.12657471841	34.6118033567863	0.0179231148335439	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1926.29877918231	1926.29877918231
"AML-3133"	"2019-07-01-count-3:TGTAACGTCCCATAGA"	-3.43730054321941	13.5043887862	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGTCCCATAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1848.36008280163	42.5319342204185	0.0230106322984162	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1846.443693651	1846.443693651
"AML-3133"	"2019-07-01-count-2:CAGTGCGCATTGGGAG"	-7.38526139679607	0.444252259376921	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGTGCGCATTGGGAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2561.85734943413	48.5404385330991	0.0189473619769738	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2556.3259654302	2556.3259654302
"AML-3133"	"2019-07-01-count-2:ATCTTCATCCGACGGT"	1.33328320559804	9.54462525928346	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCTTCATCCGACGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1868.39384425747	37.1718695840697	0.0198950931562517	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1864.01551452819	1864.01551452819
"AML-3133"	"2019-07-01-count-1:ATGGATCCATGAAGGC"	-7.83849177780803	1.6456705101761	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGATCCATGAAGGC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2390.30076182117	35.9197868425675	0.015027308452682	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2385.6430635831	2385.6430635831
"AML-3133"	"2019-07-01-count-1:CCGGTGAGTGGCTGCT"	1.18328156050984	12.2893638380798	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTGAGTGGCTGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1856.02308126665	45.7591212219039	0.0246543923315197	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1853.20952279926	1853.20952279926
"AML-3133"	"2019-07-01-count-1:CATGCCTGTAGCTCGC"	1.29336406764333	11.1466703184876	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCCTGTAGCTCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.89124337603	37.7914870693136	0.020178153538265	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1870.22557847245	1870.22557847245
"AML-3133"	"2019-07-01-count-2:TTGGTTTTCCACGGAC"	1.27173997935597	10.4800548323425	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGTTTTCCACGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1750.47486745769	36.6026160061923	0.0209101065583148	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1747.25405442934	1747.25405442934
"AML-3133"	"2019-07-01-count-3:GCTTCACTCGTCCTTG"	0.917436500161332	10.7224941023621	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTTCACTCGTCCTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1746.24489086056	44.4857306789196	0.0254750813655906	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1742.82570381216	1742.82570381216
"AML-3133"	"2019-07-01-count-2:GGTGGCTCAAGTCCAT"	-7.52311120453532	1.11478290641633	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGGCTCAAGTCCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2494.30432175125	50.1748371166241	0.0201157640144713	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2488.7607093299	2488.7607093299
"AML-3133"	"2019-07-01-count-3:CGTAAGTGTGTCCAAT"	1.59561481055562	-10.0922203294006	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTAAGTGTGTCCAAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.92733765133	47.0103386426726	0.0209034493269879	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2246.02512956374	2246.02512956374
"AML-3133"	"2019-07-01-count-2:GTCGTTCAGCTCCCTT"	8.0336352783138	6.82005021655885	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGTTCAGCTCCCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1560.6558651267	35.9561123649283	0.0230391037309235	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1556.87669600039	1556.87669600039
"AML-3133"	"2019-07-01-count-3:AGGTGTTAGGCCATAG"	-2.60595212402995	13.0256023176941	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTGTTAGGCCATAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1728.40301546969	40.2427864305761	0.023283219289941	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1728.40301546969	1728.40301546969
"AML-3133"	"2019-07-01-count-1:GGTGATTAGACGCCCT"	1.42518939551656	11.3587827452454	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGATTAGACGCCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2011.85318753835	32.171908953056	0.0159911812414208	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2009.64863409587	2009.64863409587
"AML-3133"	"2019-07-01-count-3:AGCGATTCAGATTCGT"	11.8284374671871	-2.86049749767455	"2019-07-01-count-3"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGATTCAGATTCGT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1922.49003472376	27.0044621722178	0.0140466071004098	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1915.79570071248	1915.79570071248
"AML-3133"	"2019-07-01-count-1:ACGATCATCTGCATAG"	8.70923771437947	7.3942250975403	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGATCATCTGCATAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1988.14870994069	35.723589012121	0.0179682680845271	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1983.72397912177	1983.72397912177
"AML-3133"	"2019-07-01-count-2:TGCTCGTGTCTTACAG"	-1.6628089946812	13.9731025465759	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTCGTGTCTTACAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1798.75275054818	30.8084445121779	0.0171276705499346	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1792.71467662705	1792.71467662705
"AML-3133"	"2019-07-01-count-1:GACGTTAAGGCGTCCT"	1.20462884482686	10.7124023207459	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACGTTAAGGCGTCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1855.19897620825	38.3691366914663	0.0206819522776404	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1852.45380772037	1852.45380772037
"AML-3133"	"2019-07-01-count-1:ACTATGGGTGCCCTTT"	1.98339500006978	-10.3975105515686	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATGGGTGCCCTTT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2763.25704500242	40.4108945180538	0.0146243703933155	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2756.23116275326	2756.23116275326
"AML-3133"	"2019-07-01-count-2:TGCAGATGTCATCAGT"	1.20268263396565	11.3408860930237	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCAGATGTCATCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1787.41383881896	41.8790104627702	0.0234299464137762	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1785.84248088072	1785.84248088072
"AML-3133"	"2019-07-01-count-2:AAACCCAGTTAAGCAA"	0.178145294159096	10.802653289679	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAACCCAGTTAAGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1915.5298417322	37.6767219978478	0.0196690864203802	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1910.53945245782	1910.53945245782
"AML-3133"	"2019-07-01-count-1:CTTGATTAGGTAGTCG"	8.43856873092	8.41905305469362	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTGATTAGGTAGTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1925.9726566594	44.9105132883683	0.0233183545639042	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1922.94807602347	1922.94807602347
"AML-3133"	"2019-07-01-count-3:AACCATGTCGTTAGAC"	0.468024213879746	10.0997028120789	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCATGTCGTTAGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1413.16182840765	30.908133451698	0.0218716164209766	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1406.4501727323	1406.4501727323
"AML-3133"	"2019-07-01-count-1:TCCACGTGTTCATCTT"	0.0386181958833754	10.0525846251282	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCACGTGTTCATCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1506.84786474712	46.2984624615458	0.0307253728426761	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1504.61485505175	1504.61485505175
"AML-3133"	"2019-07-01-count-1:ACTATGGTCTGGCCTT"	-1.90368078175243	3.44581887805787	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-6"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATGGTCTGGCCTT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3269.5020465127	38.8770341460614	0.0118908119930765	5467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	3263.37705852799	3263.37705852799
"AML-3133"	"2019-07-01-count-3:GTCCACTCAAAGTATG"	1.46443464335744	10.9745683440003	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCCACTCAAAGTATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1780.50879137079	42.1261095743813	0.023659590886911	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1780.50879137079	1780.50879137079
"AML-3133"	"2019-07-01-count-1:CCGTTCAAGTATTGCC"	-1.0337886613911	10.8088540800842	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGTTCAAGTATTGCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2005.91401095812	36.8283953724267	0.0183599073396151	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2003.02120190306	2003.02120190306
"AML-3133"	"2019-07-01-count-2:TGGGCTGCATCGGTTA"	2.98565234717671	-9.25902750408324	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCTGCATCGGTTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1516.02923178916	53.493888218925	0.0352855255672039	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1511.60202127639	1511.60202127639
"AML-3133"	"2019-07-01-count-3:TGTTCTATCCAAGCCG"	-2.12978849831279	8.62822625720827	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCTATCCAAGCCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2070.22599796267	36.7173150616485	0.0177358969976139	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2065.40601410413	2065.40601410413
"AML-3133"	"2019-07-01-count-3:AACCCAACATCCCGTT"	1.19013347205464	11.7710609205994	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCCAACATCCCGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2128.50763571811	33.9746777662452	0.0159617363809846	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2121.64765307172	2121.64765307172
"AML-3133"	"2019-07-01-count-3:CTACATTTCGCTACGG"	3.80313410338704	-10.4810629121033	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACATTTCGCTACGG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2156.54542943222	48.389124041173	0.0224382586059933	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2153.54037219945	2153.54037219945
"AML-3133"	"2019-07-01-count-1:AGTTCGATCTCGCCTA"	3.8805967765743	-10.5370598069397	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTCGATCTCGCCTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.96470801518	44.6446557899877	0.0186722353702363	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2389.82853024845	2389.82853024845
"AML-3133"	"2019-07-01-count-2:TTGTTCAGTCGAGCAA"	1.32230665263478	11.3457555540833	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTCAGTCGAGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2064.20970024538	37.6571208294549	0.0182428756269184	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2058.86317501192	2058.86317501192
"AML-3133"	"2019-07-01-count-2:GGTGTTATCTACTCAT"	-2.10823617401775	8.72749612415162	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGTTATCTACTCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2461.67493494203	40.2126080753114	0.016335466354439	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2449.97770343077	2449.97770343077
"AML-3133"	"2019-07-01-count-2:CCCAACTCACCCAACG"	1.14400519904439	10.7143440016541	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCAACTCACCCAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1952.9668221952	41.1683918000307	0.0210799238021648	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1945.38932619578	1945.38932619578
"AML-3133"	"2019-07-01-count-3:AACCCAATCCCTCATG"	0.013376054435414	8.99523446643678	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCCAATCCCTCATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1954.21767513507	42.2581236092858	0.0216240617137827	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1950.99496031096	1950.99496031096
"AML-3133"	"2019-07-01-count-3:TCTACCGAGGTAGCCA"	3.90655126151387	-10.866047882196	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTACCGAGGTAGCCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2460.99967930614	46.5946318090409	0.0189332132794824	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2459.95100858977	2459.95100858977
"AML-3133"	"2019-07-01-count-1:TTTAGTCCAACTAGAA"	-8.15987334671672	2.80566237056581	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTAGTCCAACTAGAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2431.17825466493	41.244863042325	0.0169649687196669	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2421.46383639016	2421.46383639016
"AML-3133"	"2019-07-01-count-2:TTCACGCCATGACTTG"	0.81176127967183	10.3393955000672	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCACGCCATGACTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1793.23982330815	29.0444141125727	0.0161966144935327	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1791.81401885698	1791.81401885698
"AML-3133"	"2019-07-01-count-2:TTCACGCGTTCCATTT"	8.80368008193318	7.53592965686647	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCACGCGTTCCATTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2037.37403113737	40.9301500995499	0.0200896592741493	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2034.25168865601	2034.25168865601
"AML-3133"	"2019-07-01-count-1:GAGGCAACAGTCTCTC"	-0.352012286812621	8.75731847369996	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCAACAGTCTCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1859.29393422255	30.6614326187597	0.0164909012256744	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1855.09501497817	1855.09501497817
"AML-3133"	"2019-07-01-count-2:AACAGGGAGACTTCAC"	-7.3348163169926	0.631719566229261	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAGGGAGACTTCAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2192.5807853448	51.4449939169625	0.0234632147927322	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2182.84147123373	2182.84147123373
"AML-3133"	"2019-07-01-count-1:TCCATCGAGGAGTACC"	1.68219294127766	-9.68487741863402	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATCGAGGAGTACC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2852.82894679106	41.0171328477237	0.0143777049422682	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2848.23046200072	2848.23046200072
"AML-3133"	"2019-07-01-count-2:CTATCCGCACGCGCTA"	1.22891714152638	10.7402753599915	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTATCCGCACGCGCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1853.84668330867	35.468354667163	0.0191323020325826	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1847.9042344686	1847.9042344686
"AML-3133"	"2019-07-01-count-2:GTTGTCCGTCGCCTAG"	3.0072246986324	-10.2781248322693	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGTCCGTCGCCTAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1955.43987100024	48.9594659039139	0.0250375716635411	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1953.77409324646	1953.77409324646
"AML-3133"	"2019-07-01-count-3:CTTACCGTCCGTAATG"	4.124031205743	-10.72732164776	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTACCGTCCGTAATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1751.14964178157	39.7530831263932	0.0227011342594055	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1751.14964178157	1751.14964178157
"AML-3133"	"2019-07-01-count-3:AGATAGAAGCGACAGT"	8.40917839583699	6.78522584522096	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATAGAAGCGACAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1644.59300840296	44.1688802836516	0.0268570278834782	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1640.85695760034	1640.85695760034
"AML-3133"	"2019-07-01-count-2:CCCATTGCAATAGGAT"	-0.542091886431533	13.0963916548523	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCATTGCAATAGGAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1771.27977914785	43.8073716029771	0.0247320452244154	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.27977914785	1771.27977914785
"AML-3133"	"2019-07-01-count-3:CAAGGGAGTCAATCTG"	-2.021383146674	11.0991134413513	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAAGGGAGTCAATCTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1634.0257151701	37.6639712830151	0.0230498032762564	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1631.66162392948	1631.66162392948
"AML-3133"	"2019-07-01-count-1:GTGTGATAGTGCTACT"	1.19500019130055	10.6955966719422	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGATAGTGCTACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1896.56925673701	39.5921612511417	0.0208756738571513	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1891.22733497083	1891.22733497083
"AML-3133"	"2019-07-01-count-1:TCATCCGGTGTCTTAG"	8.57119335707967	6.98556087100831	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCCGGTGTCTTAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1962.09700144762	39.7317862758439	0.0202496544495661	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1951.85521215003	1951.85521215003
"AML-3133"	"2019-07-01-count-1:TCGGGACTCGCTACGG"	0.496755172579926	-9.79768469249877	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGACTCGCTACGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.79938617416	48.3579516757219	0.0188913052862306	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2553.32533737739	2553.32533737739
"AML-3133"	"2019-07-01-count-3:CTCAGAATCCGATCTC"	1.48183466967885	10.8288173445496	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCAGAATCCGATCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.08338472893	44.0614509689216	0.0235360515072898	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1868.89656112908	1868.89656112908
"AML-3133"	"2019-07-01-count-3:TTCGGTCCAGAGATTA"	-7.53103814545329	2.02650091731874	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCGGTCCAGAGATTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2421.13501217924	34.8664270038746	0.0144008602694534	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2412.32926250887	2412.32926250887
"AML-3133"	"2019-07-01-count-1:GTCCTCACAGGTACGA"	0.854394693940324	9.02885625446168	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCTCACAGGTACGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1533.25642967993	52.8638817725848	0.0344781738718162	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1528.78063454573	1528.78063454573
"AML-3133"	"2019-07-01-count-3:GCTACAATCTACACAG"	-1.11205587807353	10.6627731093201	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTACAATCTACACAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1705.73167707869	39.7271388309773	0.023290379937726	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1705.73167707869	1705.73167707869
"AML-3133"	"2019-07-01-count-1:TTCTCTCCATTGCCTC"	7.93156113204305	6.91112134540407	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTCTCCATTGCCTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2104.34267602085	37.1704655932602	0.0176636942342236	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2092.31161369411	2092.31161369411
"AML-3133"	"2019-07-01-count-2:CAATGACCAGTAACGG"	-1.74556682530101	9.78950879657594	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATGACCAGTAACGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1940.71081379357	41.7037007852052	0.0214888794810627	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.54918739247	1937.54918739247
"AML-3133"	"2019-07-01-count-1:TTGGGATCAAGTACCT"	1.15165628966634	11.786329246405	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGATCAAGTACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2023.85838695333	42.6521939447946	0.0210746928835284	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2014.10576031593	2014.10576031593
"AML-3133"	"2019-07-01-count-3:TGCAGGCTCCTACACC"	0.344462026923341	10.3505687483582	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCAGGCTCCTACACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1980.59959137353	34.1508848301141	0.0172427001292224	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1977.17766912635	1977.17766912635
"AML-3133"	"2019-07-01-count-1:AACAACCCAGCATGCC"	8.93320049819295	7.44172093952028	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAACCCAGCATGCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2214.7550397066	31.7863486379114	0.0143520832182517	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2210.11297147727	2210.11297147727
"AML-3133"	"2019-07-01-count-2:GGCTTTCTCATACGAC"	2.02866937693898	-10.0337944260803	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCTTTCTCATACGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2294.23334219106	52.5456364758012	0.0229033531635533	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2286.0624465631	2286.0624465631
"AML-3133"	"2019-07-01-count-2:CCCGAAGGTCCACGCA"	-7.49678550186809	0.94034675443498	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGAAGGTCCACGCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2491.21565099851	35.281286593606	0.0141622771916453	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2487.21998480985	2487.21998480985
"AML-3133"	"2019-07-01-count-1:GAGGGATGTTACACTG"	-2.8055776161259	13.2690887221131	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGGATGTTACACTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2209.70702700551	37.8836205795448	0.0171441825167578	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2205.30444640365	2205.30444640365
"AML-3133"	"2019-07-01-count-2:TCATGAGTCCCTGGTT"	-7.64542231980022	1.34797999942628	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATGAGTCCCTGGTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2495.25231430681	34.389253149154	0.0137818740621857	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2488.91897431166	2488.91897431166
"AML-3133"	"2019-07-01-count-2:AATGAAGAGAAGCCAC"	4.0734621482784	-10.7381820908752	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGAAGAGAAGCCAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2255.02449327835	41.6540627445952	0.0184716675445235	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2251.36895230712	2251.36895230712
"AML-3133"	"2019-07-01-count-1:CCGATCTAGCTAGATA"	2.68717612799947	-8.83625986492308	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGATCTAGCTAGATA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1716.27787009678	35.7846654960195	0.0208501584268529	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1714.27735423595	1714.27735423595
"AML-3133"	"2019-07-01-count-2:AAAGGATTCGCCTCTA"	0.952864010899705	12.1775226362976	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAAGGATTCGCCTCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1911.022381097	43.0048954947501	0.0225036064046846	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1907.96969554307	1907.96969554307
"AML-3133"	"2019-07-01-count-2:CGAGTGCCACAGCCTG"	1.11002256450002	10.8809184798035	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAGTGCCACAGCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1793.96447099992	35.6452332681136	0.0198695313337202	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1788.50431889627	1788.50431889627
"AML-3133"	"2019-07-01-count-1:TCTCTGGGTAGTAAGT"	3.90271606025044	-10.882649444696	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCTGGGTAGTAAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.93532979752	46.8575231198342	0.0217948523708605	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2144.50953127605	2144.50953127605
"AML-3133"	"2019-07-01-count-3:ATGCGATCATAAGCAA"	1.25537027892415	10.20405385578	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGCGATCATAAGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1678.402773714	35.4598366481001	0.0211271318204712	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1677.01971333141	1677.01971333141
"AML-3133"	"2019-07-01-count-1:GCCAGTGAGATGTAGT"	-1.51113675060924	14.2216958769592	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAGTGAGATGTAGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1875.49897499397	41.831120542862	0.0223039954170044	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1870.71883963575	1870.71883963575
"AML-3133"	"2019-07-01-count-1:GTGCACGGTCTCACGG"	3.91295756873433	-10.7292833558288	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCACGGTCTCACGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1943.3206068513	50.2634260146051	0.025864711071039	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1941.56395336934	1941.56395336934
"AML-3133"	"2019-07-01-count-1:ACTGTCCGTATAGCTC"	3.12619294699971	-10.45792295849	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGTCCGTATAGCTC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.45472373612	43.1389886472412	0.0172524574181387	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2496.26723022808	2496.26723022808
"AML-3133"	"2019-07-01-count-2:TAGGTTGGTCGCATGC"	0.928250094025773	10.4340638884339	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGTTGGTCGCATGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1839.34627604669	38.2600278539739	0.0208008836357916	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1837.67594596751	1837.67594596751
"AML-3133"	"2019-07-01-count-2:CTGCATCAGTGAATAC"	1.58880796012227	-10.1822071305481	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCATCAGTGAATAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2683.6619923031	39.6538724730995	0.014776030881247	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2676.64237138413	2676.64237138413
"AML-3133"	"2019-07-01-count-2:TCGGGCACACCTGCTT"	3.85968222197835	-10.6343689194885	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGGGCACACCTGCTT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1989.37519391336	47.86932457239	0.0240624919416155	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1983.16979960528	1983.16979960528
"AML-3133"	"2019-07-01-count-2:GTGACGCGTCCAGGTC"	0.610876818268937	13.978585220221	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGACGCGTCCAGGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2018.16126137296	37.7804073124104	0.018720212321739	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2004.11711507847	2004.11711507847
"AML-3133"	"2019-07-01-count-2:GGGAAGTGTATCACCA"	3.72876586493794	-10.7845325700012	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAAGTGTATCACCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2081.52467226673	48.2084037555453	0.0231601404479378	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2075.10335792209	2075.10335792209
"AML-3133"	"2019-07-01-count-2:AACCCAAAGGCCCACT"	-1.21187804165538	9.25233934009401	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCCAAAGGCCCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1920.52938937519	39.6015429479421	0.0206201181648284	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1917.71578142871	1917.71578142871
"AML-3133"	"2019-07-01-count-1:AACACACTCCGAACGC"	1.5103768306667	11.3275213011536	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACACACTCCGAACGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1942.82604702863	35.8770596485517	0.0184664292016376	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1936.81313439572	1936.81313439572
"AML-3133"	"2019-07-01-count-1:AACACACTCACCTTAT"	0.397320170968217	10.1699151762756	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACACACTCACCTTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2024.32133800558	39.4812791645235	0.0195034644071981	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2014.51224719676	2014.51224719676
"AML-3133"	"2019-07-01-count-3:CGAAGTTGTAAGTTGA"	0.911960621445817	11.3939571150574	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAAGTTGTAAGTTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1640.3437783492	43.541502054055	0.0265441321683641	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1640.3437783492	1640.3437783492
"AML-3133"	"2019-07-01-count-2:CCCTAACTCTTCGCTG"	1.13902916487996	10.7633056410584	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTAACTCTTCGCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1964.8161633899	35.8736071874155	0.0182579967815018	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1956.7622432183	1956.7622432183
"AML-3133"	"2019-07-01-count-3:TCAGTCCAGGCTCCCA"	2.38192429122273	-9.62638571178588	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTCCAGGCTCCCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1676.78247685821	48.4525907880993	0.0288961695728625	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1674.72192318604	1674.72192318604
"AML-3133"	"2019-07-01-count-2:GCTCAAAGTTACGCCG"	1.38130952891652	-10.1626568070618	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTCAAAGTTACGCCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.10566432762	36.9423220389129	0.0147115760852718	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2502.38713202247	2502.38713202247
"AML-3133"	"2019-07-01-count-1:TCAGCCTAGTAGGAAG"	1.46980609473531	10.5762691267761	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGCCTAGTAGGAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1815.73261047979	32.9899421668649	0.018168942924998	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.11952402504	1808.11952402504
"AML-3133"	"2019-07-01-count-1:GTGTTCCTCAGTCAGT"	2.86253656920735	-10.5379991761413	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTTCCTCAGTCAGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.26054337425	39.7551338788519	0.0168721298629909	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2353.1157848032	2353.1157848032
"AML-3133"	"2019-07-01-count-3:CGGGCATGTGGATCGA"	3.94431557235066	-10.6163816682068	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGGCATGTGGATCGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2275.15142699001	42.6183524511813	0.0187320949039268	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2273.72842900238	2273.72842900238
"AML-3133"	"2019-07-01-count-2:CTGCCATGTCTTCCGT"	3.66643609580342	-10.9163065186706	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCCATGTCTTCCGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.63303090724	51.0384281989799	0.020599672171908	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2470.19183147194	2470.19183147194
"AML-3133"	"2019-07-01-count-3:TGGAGAGAGGTTACAA"	-1.27372680130656	11.1651544340881	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGAGAGAGGTTACAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1616.40081922774	39.5312812561929	0.0244563605672259	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1616.40081922774	1616.40081922774
"AML-3133"	"2019-07-01-count-1:CCGCAAGGTTTGAACC"	3.72045292434041	-10.817861580011	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGCAAGGTTTGAACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2268.80847549585	47.0171695948396	0.0207232871803178	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2262.96626408223	2262.96626408223
"AML-3133"	"2019-07-01-count-2:ATGGAGGTCGTTACCC"	3.92240657386128	-10.5569801560608	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGAGGTCGTTACCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2062.91266030804	45.1058167946965	0.0218651122088519	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2059.1875752438	2059.1875752438
"AML-3133"	"2019-07-01-count-1:TCTTAGTAGAGTCTGG"	-7.97172007980998	5.49449536884157	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTAGTAGAGTCTGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1573.79788350798	48.8259365043935	0.0310242738384937	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1562.53507415702	1562.53507415702
"AML-3133"	"2019-07-01-count-3:CCCTAACTCCGTGACG"	0.513103445141953	-9.79146768963011	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTAACTCCGTGACG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2237.8601070723	47.8910149334445	0.0214003613461336	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2235.25781384727	2235.25781384727
"AML-3133"	"2019-07-01-count-3:AGACAGGGTAACCCTA"	0.824895759194535	9.81437299335328	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACAGGGTAACCCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1633.93402634886	37.2179521583913	0.0227781241826253	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1630.54443004995	1630.54443004995
"AML-3133"	"2019-07-01-count-1:TCATTACAGTAGGGTC"	-7.48853002014812	0.646254516485609	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTACAGTAGGGTC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2287.71364123702	29.9717508965524	0.0131011811777046	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2282.49411945079	2282.49411945079
"AML-3133"	"2019-07-01-count-2:TCAATCTAGCATCAGG"	1.3387836414272	11.3985728987488	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAATCTAGCATCAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1878.98856225915	32.810040943192	0.0174615437274103	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1872.15617836994	1872.15617836994
"AML-3133"	"2019-07-01-count-2:GTCCTCACAGTACTAC"	0.450256903737229	9.60744950855104	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCCTCACAGTACTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2221.88026540909	30.8956817583832	0.0139051965307837	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2214.70522500657	2214.70522500657
"AML-3133"	"2019-07-01-count-1:ACGTCCTAGATGCGAC"	1.15018965777699	11.5301360853943	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTCCTAGATGCGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1924.28947825576	37.2977331971537	0.0193825999770896	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1922.86964460931	1922.86964460931
"AML-3133"	"2019-07-01-count-2:CACACAATCATACGGT"	-0.901024917990524	10.1176080473694	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACACAATCATACGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2100.2613894265	34.3369393754772	0.0163488885470838	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2092.1449326818	2092.1449326818
"AML-3133"	"2019-07-01-count-3:CTAACCCCAGGAATAT"	0.41103826937024	11.1449794539246	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTAACCCCAGGAATAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1840.26826108393	42.4131703889796	0.0230472759248687	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1838.63050283716	1838.63050283716
"AML-3133"	"2019-07-01-count-2:AGGAATAAGTAGATCA"	-2.1284843486851	13.354727722052	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAATAAGTAGATCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1831.41618226277	45.7571433565569	0.0249845686631547	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1829.55140225125	1829.55140225125
"AML-3133"	"2019-07-01-count-1:CTACTATGTGTCCCTT"	1.45357861098592	11.4523916014465	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACTATGTGTCCCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1945.05862454512	37.1109480886886	0.019079603884622	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1940.07482227687	1940.07482227687
"AML-3133"	"2019-07-01-count-3:TGTGTGACAAATACGA"	8.27687134322469	7.41658685291139	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGTGACAAATACGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1546.55949633122	41.4993305776599	0.0268333230477751	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1542.86468978598	1542.86468978598
"AML-3133"	"2019-07-01-count-1:TCTTAGTTCCCATGGG"	1.25998940047566	11.0369004973206	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTAGTTCCCATGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2064.28189121628	29.1627934720236	0.0141273309600371	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2060.45235900969	2060.45235900969
"AML-3133"	"2019-07-01-count-1:ACAGCCGTCCTGGCTT"	8.75479569014851	7.24227187717286	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGCCGTCCTGGCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1905.85089157152	30.7203718414544	0.016118979704715	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1899.37008874335	1899.37008874335
"AML-3133"	"2019-07-01-count-1:AACCATGCAACCGTAT"	3.96016969260518	-10.8986959687439	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCATGCAACCGTAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.36372497051	43.4141063057539	0.0178852908853951	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2423.91551554699	2423.91551554699
"AML-3133"	"2019-07-01-count-1:CCTCATGCATTAGGAA"	-2.29192576828654	11.4983415373596	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCATGCATTAGGAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1961.51051182756	37.8242060150971	0.0192832033206164	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1958.63285769918	1958.63285769918
"AML-3133"	"2019-07-01-count-1:TTGTGTTTCAGACCGC"	3.84713449057881	-10.1206951371399	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGTTTCAGACCGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1959.83020518229	50.8017031329768	0.0259214818705437	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1954.59952798996	1954.59952798996
"AML-3133"	"2019-07-01-count-1:CCTCCAACAACTGTGT"	8.1741758781368	-10.0542106858459	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCAACAACTGTGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1874.20431257254	49.0267853619591	0.026158719747403	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1856.20083984161	1856.20083984161
"AML-3133"	"2019-07-01-count-3:AAGACAAGTCATCGCG"	-0.857219378382522	10.9793557890686	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGACAAGTCATCGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1586.86595584371	50.8220852989157	0.0320267033971968	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1584.57801651869	1584.57801651869
"AML-3133"	"2019-07-01-count-2:TGTAGACTCAGACCTA"	-7.37130151215251	1.84615299785463	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTAGACTCAGACCTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2323.49876748326	38.8523634357529	0.0167214908737983	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2320.33631188762	2320.33631188762
"AML-3133"	"2019-07-01-count-3:AGGACGAGTGGCGCTT"	1.15979232367818	11.0668306120667	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGACGAGTGGCGCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2021.17356507323	47.1427242579275	0.0233244314454605	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2015.14884554432	2015.14884554432
"AML-3133"	"2019-07-01-count-1:AACCCAAAGTCCTGTA"	-7.29429374161418	0.848177469614424	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCCAAAGTCCTGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2195.4930739157	40.9923253827222	0.0186711248920552	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2188.93642825575	2188.93642825575
"AML-3133"	"2019-07-01-count-1:AATGGAACAGCTGGTC"	-7.48256669464763	0.873530305269636	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGAACAGCTGGTC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2550.88622746239	38.2112885946454	0.0149796130392917	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2545.19711629552	2545.19711629552
"AML-3133"	"2019-07-01-count-3:GTCATCCGTTTGGCTA"	-2.16963110390361	11.096842742804	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCATCCGTTTGGCTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1630.21900544552	38.1701141810842	0.0234141020645584	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1628.25415336111	1628.25415336111
"AML-3133"	"2019-07-01-count-2:GAGTCATGTCGTCATA"	1.18132342871968	10.7356309660706	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTCATGTCGTCATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1838.97794298411	38.1121471142075	0.0207246352571053	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1831.62881485677	1831.62881485677
"AML-3133"	"2019-07-01-count-1:GTTTACTCACCACTGG"	2.56889524039571	-10.4678468934265	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTTACTCACCACTGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2587.27537699386	38.7474511950586	0.0149761604580642	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2578.84412412954	2578.84412412954
"AML-3133"	"2019-07-01-count-2:AATTTCCCACAGTGTT"	1.49736489829366	-10.1621484986511	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATTTCCCACAGTGTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2564.78225704902	40.4916281757786	0.0157875500208612	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2563.71933410887	2563.71933410887
"AML-3133"	"2019-07-01-count-2:GCATTAGTCTAGATCG"	-3.05621204796489	13.4484967955383	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCATTAGTCTAGATCG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1899.50505295714	37.9333465051167	0.0199701213987624	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1895.77461991273	1895.77461991273
"AML-3133"	"2019-07-01-count-3:TACGGTACAATGAACA"	0.739332576363724	9.77330300891725	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACGGTACAATGAACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1432.1777036429	36.6126123682325	0.0255642943435751	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1428.15982812168	1428.15982812168
"AML-3133"	"2019-07-01-count-3:TCGATTTTCGCCTATC"	11.851036687463	-2.74409820949706	"2019-07-01-count-3"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGATTTTCGCCTATC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2029.23090028937	43.5322177552131	0.0214525699115884	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2026.1390350898	2026.1390350898
"AML-3133"	"2019-07-01-count-3:TCATATCGTCATATGC"	8.16669144210164	7.45754907214967	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATATCGTCATATGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1794.3329323537	41.0719255944333	0.0228898020282989	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1787.50569539264	1787.50569539264
"AML-3133"	"2019-07-01-count-3:CCCTTAGAGTAGATCA"	-0.40855516019519	10.4544505842957	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTTAGAGTAGATCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1803.42655787442	34.1775896888891	0.0189514729832813	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1795.20749468388	1795.20749468388
"AML-3133"	"2019-07-01-count-3:AAGATAGCAAGGCTTT"	-1.566194276244	11.661461807135	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGATAGCAAGGCTTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1889.55111212334	39.6791921751381	0.020999269043614	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1889.55111212334	1889.55111212334
"AML-3133"	"2019-07-01-count-1:TTGTTTGGTGAGATCG"	-8.20737967911418	-0.906175278779589	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTTGGTGAGATCG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2833.28724008275	43.7101350715355	0.0154273574712668	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2824.85249480328	2824.85249480328
"AML-3133"	"2019-07-01-count-3:TCATATCGTAGTGCGA"	2.65862931784932	-10.1911621323791	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATATCGTAGTGCGA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1936.32297424822	42.6048981197324	0.0220029915909425	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1931.65755264313	1931.65755264313
"AML-3133"	"2019-07-01-count-3:AAGACTCTCTATCCAT"	1.28350081023518	11.0187482603821	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGACTCTCTATCCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1827.93136318384	36.9032600522687	0.0201885370509709	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1822.51000906972	1822.51000906972
"AML-3133"	"2019-07-01-count-3:GTTGTCCCAGGATTCT"	-1.46226654473003	10.3924302824768	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTCCCAGGATTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1680.4417772174	40.1132446008391	0.0238706542200239	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1678.49641607021	1678.49641607021
"AML-3133"	"2019-07-01-count-3:ATGTCCCAGCTATCCA"	0.969400544732255	10.552481628302	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCCCAGCTATCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1941.49970162938	40.9154947361527	0.0210741699840669	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1939.95789367554	1939.95789367554
"AML-3133"	"2019-07-01-count-1:ATGGGTTAGTGCACAG"	4.04079594191853	-10.9149170151916	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGGTTAGTGCACAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2337.44063172466	33.2049887086485	0.0142057035622541	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2334.95114301986	2334.95114301986
"AML-3133"	"2019-07-01-count-3:ACTATCTTCGAACTCA"	1.41212369975392	10.1484441527161	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATCTTCGAACTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1878.92889495801	34.7918986139381	0.0185168787958395	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.3194257219	1874.3194257219
"AML-3133"	"2019-07-01-count-1:GTAGATCAGCTACTGT"	0.660731692879838	12.2616281279358	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGATCAGCTACTGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1688.81632236667	44.8729076845255	0.026570626473838	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1684.55857244772	1684.55857244772
"AML-3133"	"2019-07-01-count-2:GCCAGCACAGTAACGG"	1.67157520827596	-10.0833969346252	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAGCACAGTAACGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2328.35819875782	37.4142242229258	0.0160689297045817	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2324.1170775551	2324.1170775551
"AML-3133"	"2019-07-01-count-3:CCACGAGTCGTTCAGA"	4.24946989592854	-10.4892444840637	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACGAGTCGTTCAGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1730.58110798424	46.607298912137	0.0269315888733031	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1726.55853699684	1726.55853699684
"AML-3133"	"2019-07-01-count-1:CTGTATTCAATTGCGT"	-2.2613550228184	9.87749765003053	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTATTCAATTGCGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1974.25926523659	37.3233797042263	0.0189050042015397	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1972.6932386784	1972.6932386784
"AML-3133"	"2019-07-01-count-1:AGACTCAGTCGAAGCA"	8.4747072654659	7.08495519244996	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACTCAGTCGAAGCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1867.5176187868	36.85356219316	0.0197339836703127	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1862.87187872718	1862.87187872718
"AML-3133"	"2019-07-01-count-2:GGAACCCGTGCCTTTC"	1.08473457869832	12.5601415404114	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCGTGCCTTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1768.29031670388	37.1770740710553	0.0210243045046776	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1765.22499005523	1765.22499005523
"AML-3133"	"2019-07-01-count-3:GGGATGATCTCGCCTA"	0.932654400437516	10.7040290602478	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATGATCTCGCCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1868.57813360174	39.2142375407758	0.0209861374462246	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1865.5840206813	1865.5840206813
"AML-3133"	"2019-07-01-count-3:GTTAGTGAGCAACTTC"	1.25712754306142	10.8644075163635	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTAGTGAGCAACTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1787.24625737949	35.7914592043138	0.0200260367347431	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1787.24625737949	1787.24625737949
"AML-3133"	"2019-07-01-count-1:CCACAAAAGGAGGGTG"	1.04031928357427	11.424271560553	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACAAAAGGAGGGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2209.18425189963	30.2387434887888	0.0136877417367009	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2201.84617683444	2201.84617683444
"AML-3133"	"2019-07-01-count-1:GGGAGTAAGCGGGTTA"	-7.77631602707561	1.39032075488893	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAGTAAGCGGGTTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2656.7635328201	39.2301827075835	0.0147661552196712	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2653.31167415526	2653.31167415526
"AML-3133"	"2019-07-01-count-1:ATCCATTAGGAAACGA"	1.44025899943654	10.3224801787171	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCCATTAGGAAACGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1850.97932092057	38.1774416924428	0.0206255365799849	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1847.66903947956	1847.66903947956
"AML-3133"	"2019-07-01-count-3:GAAGGGTTCGCCTTGT"	1.5587086873943	10.8980693587097	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGGGTTCGCCTTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1708.54237285054	35.9611694103966	0.0210478651169761	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1708.54237285054	1708.54237285054
"AML-3133"	"2019-07-01-count-1:CCACAAAGTTCGGTCG"	4.33237852629964	-10.7266636124817	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACAAAGTTCGGTCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2331.15237610541	52.8002630141325	0.0226498548766445	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2326.86958264336	2326.86958264336
"AML-3133"	"2019-07-01-count-2:ACCACAAAGCGAAACC"	1.26224865493123	11.7096652754578	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCACAAAGCGAAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1912.26184787331	42.7230983667763	0.0223416570352486	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1908.04075484021	1908.04075484021
"AML-3133"	"2019-07-01-count-3:CGAGTGCGTAACTTCG"	1.19056894358937	10.2556495436463	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGTGCGTAACTTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1726.73653742977	49.5288831269153	0.028683520649096	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1723.95363429798	1723.95363429798
"AML-3133"	"2019-07-01-count-2:CATGAGTCATACTGAC"	9.14895596083943	7.51455590808717	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGAGTCATACTGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1974.8015423253	40.7940146907532	0.0206572730557618	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1969.00840670456	1969.00840670456
"AML-3133"	"2019-07-01-count-1:GTGTAACAGGGTAATT"	8.50508465346639	7.33975265109865	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTAACAGGGTAATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1800.80628353069	39.5366279561635	0.0219549589079883	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1796.1753191759	1796.1753191759
"AML-3133"	"2019-07-01-count-1:GTCATTTCATTGCTGA"	0.860836108296555	12.3080882796082	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATTTCATTGCTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1967.16013471733	38.2663570998988	0.0194525887468726	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1967.16013471733	1967.16013471733
"AML-3133"	"2019-07-01-count-2:CCGCAAGGTAATCAGA"	-1.43613360348399	8.48707673633424	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGCAAGGTAATCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2629.36746459982	36.8876374563327	0.0140290917693951	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2627.25037967205	2627.25037967205
"AML-3133"	"2019-07-01-count-1:TGAATCGCATCGATCA"	7.67106833037679	6.40764377200929	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAATCGCATCGATCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1505.11063250045	37.5003524313157	0.0249153461689498	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1502.79268151039	1502.79268151039
"AML-3133"	"2019-07-01-count-2:ATATCCTCAGCCCAGT"	1.21183743056599	11.5542039641174	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATATCCTCAGCCCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2366.24230616137	34.5881712335105	0.0146173412348548	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2358.35175266913	2358.35175266913
"AML-3133"	"2019-07-01-count-1:GCGAGAATCCTGGGTG"	8.24792065200154	8.10637662494508	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGAGAATCCTGGGTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1944.70182890981	41.9492306067463	0.0215710346867226	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1940.53502523988	1940.53502523988
"AML-3133"	"2019-07-01-count-3:AGAACAACACTGCATA"	1.31473269042317	9.36677835071412	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAACAACACTGCATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1688.04098309992	35.3278028361424	0.0209282850297073	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1686.38820297934	1686.38820297934
"AML-3133"	"2019-07-01-count-2:GTCTAGACAAGTTCGT"	-7.58037124100383	4.21457097614137	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTAGACAAGTTCGT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2053.40745756839	35.7391583561524	0.0174048059601741	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2044.14788816375	2044.14788816375
"AML-3133"	"2019-07-01-count-2:ATCGCCTCATAGTCAC"	1.10580792006795	10.3272256621155	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGCCTCATAGTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1892.06996791995	26.2546313261226	0.013876141882314	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1888.39108226806	1888.39108226806
"AML-3133"	"2019-07-01-count-2:CATGCAATCTTCACAT"	0.841337938874406	11.0007915266785	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCAATCTTCACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1849.48267660385	39.2400248078319	0.0212167571528095	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1844.35611352818	1844.35611352818
"AML-3133"	"2019-07-01-count-1:CCACACTGTCCACAGC"	1.13287128981892	10.2955207594666	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACACTGTCCACAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.07981778046	38.3493715428424	0.0183746549682157	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2079.36695578267	2079.36695578267
"AML-3133"	"2019-07-01-count-3:ATCACGAAGGTATTGA"	4.16199745711629	-10.8028650513855	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCACGAAGGTATTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1935.77477308403	47.1206621333392	0.024342016844381	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1934.00473832311	1934.00473832311
"AML-3133"	"2019-07-01-count-2:ACTTTCAAGCTCCACG"	2.98691501197163	-10.5120735398498	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTTCAAGCTCCACG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2166.47742985648	44.6663021697482	0.0206170170776749	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2165.19220261584	2165.19220261584
"AML-3133"	"2019-07-01-count-1:GATCATGAGCCATTGT"	-2.44489107552226	13.4467973479065	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATCATGAGCCATTGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2434.56892908803	37.1240839711838	0.0152487298788826	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2431.75392264885	2431.75392264885
"AML-3133"	"2019-07-01-count-1:CTGCATCAGTTACGAA"	7.56427254256551	-10.2769718400207	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCATCAGTTACGAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1382.64734471159	46.6561665929865	0.0337440828794407	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1376.49030757984	1376.49030757984
"AML-3133"	"2019-07-01-count-1:CCACCATCAGGTGTTT"	14.1803108650142	1.86300776088563	"2019-07-01-count-1"	"AML3133"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0150943396226415	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACCATCAGGTGTTT"	"Plasma cell"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1235.52310915334	29.6402293199103	0.0239900242256268	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1220.64167167399	1220.64167167399
"AML-3133"	"2019-07-01-count-3:GGTAATCTCGCTGATA"	4.36651863631551	-10.0213461152283	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTAATCTCGCTGATA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1758.46100389954	48.7548089944669	0.0277258403151102	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1756.51483058203	1756.51483058203
"AML-3133"	"2019-07-01-count-1:TCTCAGCCAGGTCAGA"	0.937322397797745	11.6274919279846	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCAGCCAGGTCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2179.04498985388	34.5123292801496	0.0158382821102119	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2170.49749813881	2170.49749813881
"AML-3133"	"2019-07-01-count-2:TTTGACTCACCGGAAA"	-1.21284196797069	11.4590377577576	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTGACTCACCGGAAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1823.67316136398	38.1818758696793	0.0209367976009045	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1821.97574144201	1821.97574144201
"AML-3133"	"2019-07-01-count-1:GTGTGATGTACTGGGA"	1.07542492923085	8.99404237354127	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGATGTACTGGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1927.27520014167	30.9133253605271	0.0160399123893955	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1919.96107182577	1919.96107182577
"AML-3133"	"2019-07-01-count-3:TCCTGCACAACTTGGT"	-2.14670095863994	13.3495321043762	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTGCACAACTTGGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2088.98258615126	38.8598997985991	0.0186023091126837	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2088.98258615126	2088.98258615126
"AML-3133"	"2019-07-01-count-2:AACCAACAGGCGATAC"	0.666487892239731	10.9518403776917	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCAACAGGCGATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1911.37133794235	37.7302081435154	0.0197398628903441	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1906.91503218417	1906.91503218417
"AML-3133"	"2019-07-01-count-1:ATTACCTTCAAGGTGG"	8.71666874465291	7.28582236850587	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTACCTTCAAGGTGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1848.81624537384	37.1337313506434	0.0200851390415681	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1847.22576333661	1847.22576333661
"AML-3133"	"2019-07-01-count-2:ATGATCGCAGGACAGT"	-1.68567738953288	8.46838376605836	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGATCGCAGGACAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2812.61406480571	41.5153200801509	0.0147604040666769	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2801.91777695497	2801.91777695497
"AML-3133"	"2019-07-01-count-3:GGGCTCACACGGAAGT"	-7.7000392479008	1.27927885139314	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGCTCACACGGAAGT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2683.38323438966	41.6872926177127	0.0155353480946953	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2678.17597542038	2678.17597542038
"AML-3133"	"2019-07-01-count-2:AGTGTTGCACAACGCC"	-2.69793854180034	13.8030175932678	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGTTGCACAACGCC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2056.42603322921	26.9215548258896	0.013091428717042	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2056.42603322921	2056.42603322921
"AML-3133"	"2019-07-01-count-1:ATGAGTCCATCTCAAG"	8.08195080336873	6.96335456455079	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGAGTCCATCTCAAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1999.14154361709	37.3381013244854	0.0186770673860985	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1996.0253562392	1996.0253562392
"AML-3133"	"2019-07-01-count-3:CCTCAACTCGTAATGC"	1.30731298503224	10.9970874556336	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCAACTCGTAATGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1770.55795100941	31.9725676482309	0.0180579052100514	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1767.75575199733	1767.75575199733
"AML-3133"	"2019-07-01-count-2:CTCCATGGTCGGTGTC"	3.57620348510091	-10.7991390458313	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCATGGTCGGTGTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2046.76887099671	41.8617176653406	0.0204525866396216	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2043.65132547309	2043.65132547309
"AML-3133"	"2019-07-01-count-1:ATGATCGCACCAAAGG"	-0.219648043543655	10.5769157179627	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGATCGCACCAAAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1485.06966436333	44.8186978823931	0.0301795255521615	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1482.80077351496	1482.80077351496
"AML-3133"	"2019-07-01-count-3:ACAGAAAAGCACACCC"	-0.217832813889343	10.970956779364	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACAGAAAAGCACACCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2101.69613228546	43.3152018805985	0.0206096405732526	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2100.23328213533	2100.23328213533
"AML-3133"	"2019-07-01-count-2:CTCAACCAGCCATATC"	0.668135126202744	10.0814456709656	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCAGCCATATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2106.4242182377	28.850945239586	0.0136966452387846	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2101.86077410445	2101.86077410445
"AML-3133"	"2019-07-01-count-1:GTGTGGCCAACACAGG"	1.12350060519521	11.9881925352844	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGGCCAACACAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2097.78535523545	36.3678383788335	0.0173363010129088	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2092.12950944643	2092.12950944643
"AML-3133"	"2019-07-01-count-3:ATTCAGGCAAGTCCCG"	-2.10429606857951	10.7896184691223	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCAGGCAAGTCCCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1800.53031582503	42.5712005534164	0.0236437010692096	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1796.91248894576	1796.91248894576
"AML-3133"	"2019-07-01-count-3:CACCAAACATCCTGTC"	1.76610233363454	-10.1367702714172	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAACATCCTGTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2199.0804462589	41.1432369539375	0.0187092914331219	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2195.40713473746	2195.40713473746
"AML-3133"	"2019-07-01-count-2:CTGTCGTAGCACTGGA"	-4.61921248856242	9.1234731444153	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTCGTAGCACTGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2893.23877703739	40.7371636457592	0.0140801250035343	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2885.79595682126	2885.79595682126
"AML-3133"	"2019-07-01-count-2:GTTTACTAGTGCACCC"	1.3541370826656	9.93317601764528	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTTACTAGTGCACCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1750.59815458033	33.0613343720089	0.0188857358757668	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1744.44629551316	1744.44629551316
"AML-3133"	"2019-07-01-count-2:GTAGCTAAGTCAACAA"	-2.5413797897404	10.152708984259	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGCTAAGTCAACAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1866.98355930964	36.1220366720685	0.0193478065149248	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1861.91798103456	1861.91798103456
"AML-3133"	"2019-07-01-count-1:ATCGATGCAACTTGCA"	0.963692207902116	9.46038529956666	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGATGCAACTTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2166.22962316367	45.0126303786641	0.020779251607189	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2160.36892063868	2160.36892063868
"AML-3133"	"2019-07-01-count-3:CACCAAACATGACAGG"	1.07524706897084	10.4575443037781	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAACATGACAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1817.03120930167	28.9565196036435	0.0159361707467712	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1817.03120930167	1817.03120930167
"AML-3133"	"2019-07-01-count-2:CACGTTCGTACGATGG"	0.738041599362534	9.96393773639528	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTTCGTACGATGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1788.30658754107	38.9688280253755	0.0217909100692616	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1779.55904875594	1779.55904875594
"AML-3133"	"2019-07-01-count-2:GTAGCTACAGAGGACT"	0.792696137993973	10.2525233992371	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGCTACAGAGGACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1571.07486227294	34.1115433420545	0.0217122329184899	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1557.4302641721	1557.4302641721
"AML-3133"	"2019-07-01-count-2:CACGTTCGTAAGGCTG"	8.02088989791219	6.92301366412965	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTTCGTAAGGCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1639.05755853601	41.5362225662703	0.0253415277272935	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1639.05755853601	1639.05755853601
"AML-3133"	"2019-07-01-count-3:ATTCAGGTCGCCAACG"	3.82914509352986	-10.7610607377258	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCAGGTCGCCAACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.2233349018	39.7886987175982	0.016772745690593	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2367.14708927297	2367.14708927297
"AML-3133"	"2019-07-01-count-1:GTGTTAGTCAGGACGA"	-3.3712674182957	13.4451837309631	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTTAGTCAGGACGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2302.30936317404	31.984946226544	0.0138925492543055	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2288.0061365624	2288.0061365624
"AML-3133"	"2019-07-01-count-1:TCGAACAGTTGCTTGA"	-1.02958736839946	11.6039943465027	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGAACAGTTGCTTGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2151.20186828891	38.6205931971923	0.0179530307064634	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2148.45164690249	2148.45164690249
"AML-3133"	"2019-07-01-count-2:ATCAGGTTCATATGGC"	0.728167672722977	10.5465545424256	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCAGGTTCATATGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1813.8144066063	37.9121393606892	0.0209018845713239	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1810.76621186944	1810.76621186944
"AML-3133"	"2019-07-01-count-1:GATGACTCACACCAGC"	3.30091847953145	-9.57927896892699	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGACTCACACCAGC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1837.7520795774	42.8235155742909	0.0233021178700766	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1827.87752111064	1827.87752111064
"AML-3133"	"2019-07-01-count-2:GCTCAAAAGAACTGAT"	3.05156173285787	-10.3659620515076	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTCAAAAGAACTGAT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.76433194069	40.3514832497068	0.0183185657514965	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2200.18522677178	2200.18522677178
"AML-3133"	"2019-07-01-count-2:CACGTTCTCTGGCTGG"	-7.95129237595256	5.48913285816041	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTTCTCTGGCTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1436.62031907625	46.4665871935679	0.0323443755991466	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1436.62031907625	1436.62031907625
"AML-3133"	"2019-07-01-count-2:TGCCGAGGTGTGATGG"	4.10381950911824	-10.719677948114	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCCGAGGTGTGATGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1957.80231404011	50.7218182670452	0.0259075279987671	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1950.73437197823	1950.73437197823
"AML-3133"	"2019-07-01-count-1:GATGACTGTTACAGCT"	-7.73880086365398	1.81598982894746	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGACTGTTACAGCT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2635.6517906752	38.6006607374379	0.0146455843954824	2561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2630.23674884178	2630.23674884178
"AML-3133"	"2019-07-01-count-3:TAAGCACTCACCTCAC"	1.38674952563588	10.5735177763733	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAAGCACTCACCTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1712.70125321544	39.5010900676663	0.0230636195270522	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1706.39995018442	1706.39995018442
"AML-3133"	"2019-07-01-count-1:GACATCAAGGCGAAGG"	-8.44367442551311	5.54107234561769	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACATCAAGGCGAAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1204.47029446138	4.574858881914	0.00379823305145089	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1185.97275823052	1185.97275823052
"AML-3133"	"2019-07-01-count-2:AGGGCTCAGGTTCCAT"	-7.59241948548015	1.46532306754915	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGCTCAGGTTCCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2552.7002802698	44.7610133323379	0.0175347704069696	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2549.68899456642	2549.68899456642
"AML-3133"	"2019-07-01-count-1:GGCTGTGTCTAGACAC"	-0.88906035843547	10.8764524229797	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTGTGTCTAGACAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2181.93567886354	35.3082614042897	0.0161820816930222	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2173.77475792774	2173.77475792774
"AML-3133"	"2019-07-01-count-3:CCCTAACCAGATCCAT"	1.47412397441213	11.0659436949524	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCTAACCAGATCCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1839.09448826616	38.3762530239489	0.0208669284089524	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1833.0878320028	1833.0878320028
"AML-3133"	"2019-07-01-count-1:AACAGGGGTTCCTAAG"	-7.71104798737224	1.26763758743135	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAGGGGTTCCTAAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2780.06745987286	42.6613949233593	0.0153454531370654	2753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2776.81704785697	2776.81704785697
"AML-3133"	"2019-07-01-count-1:GTGCGTGCACCGTGAC"	0.0910183573955714	-10.2472458115784	"2019-07-01-count-1"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCGTGCACCGTGAC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2555.29295453154	42.9627992724384	0.0168132578287153	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2553.00213090982	2553.00213090982
"AML-3133"	"2019-07-01-count-1:CGACAGCGTCATCCGG"	-0.644211749464828	-10.0366821519104	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGACAGCGTCATCCGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1910.54367489977	43.1103810384518	0.0225644572300675	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1908.74604985413	1908.74604985413
"AML-3133"	"2019-07-01-count-3:TCGGGTGTCGGTCAGC"	3.4665216403896	-9.57932665264281	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGTGTCGGTCAGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1449.45734847603	46.0675056579736	0.0317825879501796	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1444.25472647785	1444.25472647785
"AML-3133"	"2019-07-01-count-1:CGACAGCTCCTCACCA"	7.95777048644368	7.60498139942018	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGACAGCTCCTCACCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2063.02839770682	39.6968436158683	0.0192420248116767	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2054.19541651866	2054.19541651866
"AML-3133"	"2019-07-01-count-2:TCCGAAAGTCAGACTT"	0.735101540654343	12.4073228606018	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCGAAAGTCAGACTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1901.70990562651	38.5346971935895	0.0202631837167059	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1900.12757474541	1900.12757474541
"AML-3133"	"2019-07-01-count-2:GTGTAACAGAATTTGG"	-1.77188764038737	13.9339456328186	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTAACAGAATTTGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2042.65225769452	36.9985524896575	0.0181129961550169	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2040.81154129263	2040.81154129263
"AML-3133"	"2019-07-01-count-1:AAGCCATGTTATCTTC"	0.933997650712174	10.3788757094177	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGCCATGTTATCTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1940.54025218036	42.3082166963856	0.021802287609777	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.09464227871	1937.09464227871
"AML-3133"	"2019-07-01-count-1:TTTCGATTCATCCCGT"	-0.713178078562576	11.5813636549744	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTCGATTCATCCCGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1951.36661798444	45.2243923058481	0.023175753796875	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1946.64840681294	1946.64840681294
"AML-3133"	"2019-07-01-count-3:CGCATAACAGTAGATA"	0.750344772904557	10.7110595473084	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCATAACAGTAGATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1794.57129618412	42.5005824873095	0.0236828609583138	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1792.96012674717	1792.96012674717
"AML-3133"	"2019-07-01-count-2:AAGGTAATCAACCCGG"	-0.0889954817598641	11.951392150763	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGGTAATCAACCCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2043.38380666064	30.0860318408897	0.0147236323116689	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2036.66890242027	2036.66890242027
"AML-3133"	"2019-07-01-count-1:CACTTCGGTACCGTGC"	4.26588882979695	-10.7293100587097	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTTCGGTACCGTGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1957.5137207008	41.6260411278793	0.0212647506312124	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1952.36110342726	1952.36110342726
"AML-3133"	"2019-07-01-count-2:TCGTAGACAGCTTCCT"	0.346934666007203	10.0721282728943	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGACAGCTTCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1502.4798218605	16.2610302982985	0.0108227944639966	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1500.10795896469	1500.10795896469
"AML-3133"	"2019-07-01-count-2:TCCGATCAGGTCGTAG"	3.87840809401814	-10.7601080170837	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCGATCAGGTCGTAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2014.31617220512	43.2287839854041	0.0214607739251185	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2009.37645845322	2009.37645845322
"AML-3133"	"2019-07-01-count-3:TGGTTAGAGCAAATGT"	1.2535420852596	11.1089343794617	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGTTAGAGCAAATGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1699.25483744226	45.1321956511929	0.0265599924488822	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1697.77255888799	1697.77255888799
"AML-3133"	"2019-07-01-count-1:CCCAACTAGTAATACG"	-7.7381480735844	0.589731551054396	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCAACTAGTAATACG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3176.73415837148	38.891894384183	0.0122427286783482	3773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3165.32091312698	3165.32091312698
"AML-3133"	"2019-07-01-count-3:ATCCATTGTGTCATGT"	-1.58670518818553	9.16526506030885	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCCATTGTGTCATGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1981.05571903677	33.9910396243216	0.0171580432078148	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1979.24165795554	1979.24165795554
"AML-3133"	"2019-07-01-count-1:GAAGAATTCACAAGGG"	0.553820808499497	11.2577800520691	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGAATTCACAAGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1969.57323253032	40.0278220808218	0.0203230940691644	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1966.80027038799	1966.80027038799
"AML-3133"	"2019-07-01-count-3:GACCAATTCGTGGACC"	0.772942205041093	10.9859647520813	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCAATTCGTGGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1807.43415014342	36.2018097781816	0.0200293934776594	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.09914007563	1804.09914007563
"AML-3133"	"2019-07-01-count-2:AGACAAAAGTGAGTGC"	2.31048359450642	-10.4846706620422	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACAAAAGTGAGTGC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.07324091915	36.99405104477	0.015242247502494	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2420.3291817675	2420.3291817675
"AML-3133"	"2019-07-01-count-2:TGCGGCACAGCTACAT"	2.74589576300923	-10.5552292100159	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGGCACAGCTACAT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2112.31201178764	48.9814090690095	0.0231885293439943	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2108.25215467889	2108.25215467889
"AML-3133"	"2019-07-01-count-2:GTGTGATAGGAGACCT"	-1.73298714581187	13.8319434889588	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTGATAGGAGACCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1879.37782146198	42.7823897688697	0.0227641239990738	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1877.65586467744	1877.65586467744
"AML-3133"	"2019-07-01-count-3:TAATCTCCATACAGCT"	4.02908362922017	-10.9192829362121	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAATCTCCATACAGCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.85453904768	43.9021423127218	0.0209972245762815	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2087.45049765601	2087.45049765601
"AML-3133"	"2019-07-01-count-2:CGGCAGTTCTACGCGG"	-0.944622139365035	11.3619346388611	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGCAGTTCTACGCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1787.32274644835	41.1037845523024	0.0229974047127085	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1779.99006498381	1779.99006498381
"AML-3133"	"2019-07-01-count-2:CGGCAGTTCGTACACA"	0.39744802293126	11.7378387221131	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGCAGTTCGTACACA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2118.3980417161	41.9436047718804	0.0197996806765843	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2113.31841651519	2113.31841651519
"AML-3133"	"2019-07-01-count-1:TACTGCCGTGCTCTTC"	3.75595106658284	-10.8949976197449	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTGCCGTGCTCTTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.7341906738	45.8866783395962	0.0196370980159985	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2326.49265180307	2326.49265180307
"AML-3133"	"2019-07-01-count-1:CGAGGAATCTGGGCCA"	-2.75050435486491	10.0278243788513	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGGAATCTGGGCCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2184.07647909773	38.1038522048979	0.0174462078455417	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2184.07647909773	2184.07647909773
"AML-3133"	"2019-07-01-count-1:GGGTATTCACTGCGAC"	4.13264860686604	-10.7778902283874	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTCACTGCGAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2206.76000428355	47.7473140498043	0.0216368404163216	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2200.29959096506	2200.29959096506
"AML-3133"	"2019-07-01-count-2:GACACGCTCGGATTAC"	1.12435569342915	9.99988648975221	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACACGCTCGGATTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1780.66121708367	39.3140928772334	0.0220783675749514	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1775.88694755071	1775.88694755071
"AML-3133"	"2019-07-01-count-3:GCACATACAGTTCCAA"	-0.0959199172561944	9.32859513843385	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCACATACAGTTCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1827.54805104161	36.3353848409629	0.0198820407596142	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1821.50593738791	1821.50593738791
"AML-3133"	"2019-07-01-count-1:GTGGAAGTCTAGTGAC"	-2.30558548393901	13.1639251478943	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAAGTCTAGTGAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1711.12507844114	35.3910201936072	0.0206828949207202	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1708.90507589621	1708.90507589621
"AML-3133"	"2019-07-01-count-1:AGTGTTGCAACTTGGT"	10.4741608100826	-0.473405741807543	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTGTTGCAACTTGGT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1152.3392328474	3.98740670033463	0.00346027158207732	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1143.85151736173	1143.85151736173
"AML-3133"	"2019-07-01-count-1:TGAGGGACATCGTCCT"	1.08594729480092	11.0258216627869	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGGGACATCGTCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2009.29254485006	36.4103974903497	0.0181210036257148	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2003.72273070254	2003.72273070254
"AML-3133"	"2019-07-01-count-1:CTGGTCTTCTGCCTCA"	-1.00291464749034	-9.70688631450804	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGTCTTCTGCCTCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.97865964262	49.3725707896123	0.0201440231212831	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2445.48843029926	2445.48843029926
"AML-3133"	"2019-07-01-count-1:CCTCCTCCAGTGGCTC"	1.54753400859181	11.3941154249939	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCTCCAGTGGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2215.3347342677	23.8537916854702	0.0107675789651514	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2213.10042830145	2213.10042830145
"AML-3133"	"2019-07-01-count-1:GTTAGACAGGTCACTT"	4.05210675772969	-10.6512527695862	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTAGACAGGTCACTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2057.69209716259	40.8258914183605	0.0198406221585127	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2051.62182796345	2051.62182796345
"AML-3133"	"2019-07-01-count-1:CTGTACCGTGGATCAG"	-1.54982231083568	9.85495278919069	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTACCGTGGATCAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2083.07810166112	46.2790408656055	0.0222166614053985	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2079.89218483892	2079.89218483892
"AML-3133"	"2019-07-01-count-3:ATTGGGTAGTACTGTC"	-2.9471803707188	13.3214931257996	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTGGGTAGTACTGTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1918.94286631136	37.9383573599054	0.019770446544264	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1915.08647072609	1915.08647072609
"AML-3133"	"2019-07-01-count-2:ATTCTACCAGTTTCGA"	0.877008755772752	13.703456855658	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTACCAGTTTCGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1889.07828047805	31.814963249496	0.0168415272031209	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1887.50734303644	1887.50734303644
"AML-3133"	"2019-07-01-count-3:AGACTCACAGAACTCT"	0.957731624215287	12.4398870238098	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACTCACAGAACTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1826.56506546251	35.7184222052293	0.0195549684380857	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1822.93724532855	1822.93724532855
"AML-3133"	"2019-07-01-count-1:AAGGTAATCGACGTCG"	-1.51650402966197	10.7818097838196	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGGTAATCGACGTCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1784.30013484607	37.0034445077772	0.0207383521332129	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1784.30013484607	1784.30013484607
"AML-3133"	"2019-07-01-count-2:TCTGTCGGTTTGAAAG"	-1.69873319092448	8.40294644916383	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGTCGGTTTGAAAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2161.31474054173	32.9749249784033	0.015256882470592	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2158.07270712977	2158.07270712977
"AML-3133"	"2019-07-01-count-3:AATCACGGTACCTAAC"	-1.67335663262065	13.5816840895447	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATCACGGTACCTAAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2088.21311320636	37.1547364363437	0.0177925979879008	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2088.21311320636	2088.21311320636
"AML-3133"	"2019-07-01-count-2:AAGTTCGAGGACACTG"	3.67455734786336	-10.8359680405823	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGTTCGAGGACACTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.44332838631	45.7094468887902	0.0176250031718378	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2586.6661402899	2586.6661402899
"AML-3133"	"2019-07-01-count-1:CAACGGCGTACCTGTA"	-7.42272458496745	-1.26698496257933	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACGGCGTACCTGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3070.26861744832	38.1550856708569	0.0124272793116608	3916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3061.87039127015	3061.87039127015
"AML-3133"	"2019-07-01-count-3:CTACAGAAGTTACTCG"	0.498464902012986	10.4341449507507	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACAGAAGTTACTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1574.19002982595	41.3166001131528	0.0262462595559197	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1574.19002982595	1574.19002982595
"AML-3133"	"2019-07-01-count-1:GTCATCCTCCGGTAAT"	1.14142014560048	10.937286353949	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATCCTCCGGTAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1941.35146335509	39.300859790747	0.0202440725095837	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1941.35146335509	1941.35146335509
"AML-3133"	"2019-07-01-count-3:GGGATGAGTGTTATCG"	3.94887318190877	-10.7436580888	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATGAGTGTTATCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2104.39014286197	44.0114129927395	0.0209140938727664	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2097.26556506618	2097.26556506618
"AML-3133"	"2019-07-01-count-2:ATCCTATCATTGAAGA"	0.370996733277482	10.7793349989685	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCTATCATTGAAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1908.04099505747	38.0756333878728	0.0199553539397228	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1904.73836064196	1904.73836064196
"AML-3133"	"2019-07-01-count-3:CTGTCGTGTGTTCCAA"	0.655091126530808	10.3482236632141	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTCGTGTGTTCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1595.07122008636	36.2518201792656	0.0227273990795865	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1595.07122008636	1595.07122008636
"AML-3133"	"2019-07-01-count-2:ATGACCAGTTCCATTT"	1.31317843970601	11.2586993941101	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGACCAGTTCCATTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2089.55770604729	28.8721748162198	0.013817361795112	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2084.12005433556	2084.12005433556
"AML-3133"	"2019-07-01-count-1:TAACACGCACAAACGG"	-1.61536798897441	11.5612382658753	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACACGCACAAACGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2039.27169668278	30.8047924779571	0.015105781406208	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2034.80198908222	2034.80198908222
"AML-3133"	"2019-07-01-count-3:CATCCCATCGTGTGGC"	-1.38902101936992	11.5574245222839	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCCCATCGTGTGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1425.96985568074	47.2887436309866	0.0331625128277425	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1423.50495938517	1423.50495938517
"AML-3133"	"2019-07-01-count-1:TGTCAGACATTGACTG"	-2.21521840515788	13.884928680304	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCAGACATTGACTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2454.23565551384	36.162406425948	0.0147346919782146	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2446.27483985872	2446.27483985872
"AML-3133"	"2019-07-01-count-3:GACCTTCTCCCTCGTA"	1.33183445510213	9.99283406818239	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCTTCTCCCTCGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1840.35919971763	36.6267938944765	0.0199019810372324	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1835.63980486942	1835.63980486942
"AML-3133"	"2019-07-01-count-3:TGTACAGCATAGCACT"	1.1822598176891	9.87119004810182	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTACAGCATAGCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1932.47222707618	38.3190017945197	0.0198290051766985	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1926.25646643857	1926.25646643857
"AML-3133"	"2019-07-01-count-1:TGATCAGAGGTTACCT"	1.16390289840047	10.8248367079529	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATCAGAGGTTACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2070.56480773696	39.7842551188596	0.0192142042452378	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2069.36638873973	2069.36638873973
"AML-3133"	"2019-07-01-count-2:TGCTCGTTCTTGGTCC"	1.29283012923543	11.1324987181458	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTCGTTCTTGGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1903.73865607021	32.4540537361572	0.01704753624279	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1898.94419282321	1898.94419282321
"AML-3133"	"2019-07-01-count-3:GCGGATCAGTTGTCGT"	-7.49726615372356	1.60730311954347	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCGGATCAGTTGTCGT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2320.76872081408	41.0480616678893	0.0176872694378139	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2312.47171366753	2312.47171366753
"AML-3133"	"2019-07-01-count-1:TTCGCTGGTCCAATCA"	1.43812515315358	11.0600948103699	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGCTGGTCCAATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2174.85502721981	28.8162008451732	0.013249711123049	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2168.94865900316	2168.94865900316
"AML-3133"	"2019-07-01-count-2:TACCTCGCAATAAGGT"	4.38310017165486	-10.7636547318664	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCTCGCAATAAGGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2050.52767534829	38.3086563391662	0.0186823405505412	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2049.23556931243	2049.23556931243
"AML-3133"	"2019-07-01-count-1:CAAGAGGCACCATTCC"	-8.50632319870647	-1.05269458210143	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	1	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGAGGCACCATTCC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2775.77407334058	40.4741538799349	0.014581213315832	2906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2773.15459766741	2773.15459766741
"AML-3133"	"2019-07-01-count-1:GTTCCGTCAAAGAACT"	0.277120922773522	11.1833448179993	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCCGTCAAAGAACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2211.79098009139	32.2605087222159	0.0145856950374592	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2209.18432434813	2209.18432434813
"AML-3133"	"2019-07-01-count-2:ACGGGTCTCACTGCTC"	-6.94502482834514	2.07490727985231	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGGTCTCACTGCTC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2990.95274971846	43.1335951621811	0.0144213562605565	3112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2975.82067944275	2975.82067944275
"AML-3133"	"2019-07-01-count-1:CCCTCTCAGGTTGGTG"	-7.67557034912761	1.815349436644	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTCTCAGGTTGGTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2737.33790076841	39.392287474394	0.0143907288403584	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2731.3818840495	2731.3818840495
"AML-3133"	"2019-07-01-count-1:CGATGGCGTGAAAGTT"	9.0059343772823	6.58298871600953	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGATGGCGTGAAAGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1851.93151090883	37.3834486854524	0.0201861939630297	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1847.6546512443	1847.6546512443
"AML-3133"	"2019-07-01-count-3:GACGTTACACTGTTCC"	4.06096615371053	-10.8359585038391	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACGTTACACTGTTCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2059.13500717516	42.3403670691332	0.0205622103075301	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2059.13500717516	2059.13500717516
"AML-3133"	"2019-07-01-count-1:GACTATGTCCGTGGCA"	-7.66159711304362	1.41801641071168	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTATGTCCGTGGCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2630.77215365568	37.5109739276471	0.0142585414991269	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2624.9623192892	2624.9623192892
"AML-3133"	"2019-07-01-count-2:TCTTTGAGTATGACAA"	-1.87034378472026	13.7110938795838	"2019-07-01-count-2"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTTTGAGTATGACAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1986.06882349416	38.697926058767	0.0194846853245923	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1986.06882349416	1986.06882349416
"AML-3133"	"2019-07-01-count-2:GCACTAACATCGTGGC"	-1.61339459839519	11.0648460158142	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACTAACATCGTGGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1767.06321218901	36.7743095135051	0.020810975668465	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1765.20174560353	1765.20174560353
"AML-3133"	"2019-07-01-count-2:CATTGTTGTTGTGTAC"	4.02235307273213	-10.8705606690613	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGTTGTTGTGTAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.34023032599	46.6395997700804	0.0177990625913025	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2615.18427573379	2615.18427573379
"AML-3133"	"2019-07-01-count-1:AGTACTGAGTAATTGG"	-1.45121822777446	8.70103356921998	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTACTGAGTAATTGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2533.17317509588	38.623829502326	0.0152472124219711	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2524.58718924296	2524.58718924296
"AML-3133"	"2019-07-01-count-3:AAAGTCCGTATGGAAT"	0.449452121823472	9.76808927142946	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGTCCGTATGGAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1693.05973376526	41.2000757171379	0.024334685242033	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1684.62259549475	1684.62259549475
"AML-3133"	"2019-07-01-count-1:CAAGCTAGTGATTCTG"	3.99964537200276	-10.907271408197	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGCTAGTGATTCTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2405.8707483356	44.7449847277748	0.0185982496186587	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2399.73653845098	2399.73653845098
"AML-3133"	"2019-07-01-count-3:TACCCACCATGACAAA"	3.93393125113789	-10.8167324296203	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCCACCATGACAAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2451.98542154295	42.288870907352	0.0172467872507745	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2446.98516881004	2446.98516881004
"AML-3133"	"2019-07-01-count-3:AGATAGAAGGGAGAAT"	1.3321781354839	-9.97235968029173	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATAGAAGGGAGAAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2168.84567220075	36.7949394511695	0.0169652179142066	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2168.84567220075	2168.84567220075
"AML-3133"	"2019-07-01-count-2:CCTCATGGTTTGTGGT"	0.521676053374451	10.8362188109192	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCATGGTTTGTGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1887.71402430774	32.869544418273	0.0174123537755285	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1882.35483621487	1882.35483621487
"AML-3133"	"2019-07-01-count-2:TGCTTCGTCTACCTTA"	-2.35180101814922	13.7425136336121	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTCGTCTACCTTA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1899.39386333548	28.5637135626275	0.0150383309717909	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1895.55719695791	1895.55719695791
"AML-3133"	"2019-07-01-count-3:ATTCACTAGGGCCCTT"	-2.13933859291728	10.6916942366394	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCACTAGGGCCCTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1846.94643090428	38.1845643836886	0.0206744298290196	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.35622416694	1841.35622416694
"AML-3133"	"2019-07-01-count-3:TACTTCATCCTCTTTC"	-0.523268262774307	-9.78223516857298	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACTTCATCCTCTTTC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.35946645682	41.3559041199503	0.018634162128758	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2217.8182044075	2217.8182044075
"AML-3133"	"2019-07-01-count-1:CTGCATCTCCTTCACG"	-2.06508026543315	8.46981713855592	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCATCTCCTTCACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2818.85629527144	42.525542500924	0.0150860980647575	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2809.02538251236	2809.02538251236
"AML-3133"	"2019-07-01-count-2:AATCGACGTTCTCGTC"	-1.85220799866374	12.9899034270081	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATCGACGTTCTCGTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1877.80079132546	41.8301150241436	0.0222761196061791	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1877.80079132546	1877.80079132546
"AML-3133"	"2019-07-01-count-2:TGCTTGCCAATAGTAG"	1.2314473586971	10.5966224440369	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTGCCAATAGTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1808.63021460641	33.511867251423	0.0185288661998361	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.6301361293	1804.6301361293
"AML-3133"	"2019-07-01-count-1:CATCAAGGTTGGGTAG"	-7.65630994263347	1.51034042919008	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCAAGGTTGGGTAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2532.89437169688	38.2454064342178	0.0150994873144259	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2526.98835682558	2526.98835682558
"AML-3133"	"2019-07-01-count-3:CCTCAACCAGGTCTCG"	-4.69044051590617	8.87581155383912	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCAACCAGGTCTCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2374.25132356858	33.8115224141693	0.014240919686358	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2369.05276654962	2369.05276654962
"AML-3133"	"2019-07-01-count-3:GACTCAAGTCGCTCGA"	-0.243807057768661	-9.88200762188109	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCAAGTCGCTCGA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2168.91263464761	38.5370359623718	0.0177679060681174	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2164.32990109377	2164.32990109377
"AML-3133"	"2019-07-01-count-1:GTGTGGCAGGTCGTAG"	-7.70654235306438	1.43142352187959	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTGGCAGGTCGTAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2435.30505007414	41.0322190020231	0.0168489031798189	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2428.60269341197	2428.60269341197
"AML-3133"	"2019-07-01-count-1:CTCCGATAGTACCGGA"	8.57952560958211	7.38976953113405	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCGATAGTACCGGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1818.19439931404	37.220385599412	0.0204710704275925	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1813.46538119222	1813.46538119222
"AML-3133"	"2019-07-01-count-2:GGACGTCGTCACGTGC"	-2.75299201431926	13.0620298155579	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGACGTCGTCACGTGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2091.27449283885	40.5462506486502	0.0193882968436199	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2082.11394340148	2082.11394340148
"AML-3133"	"2019-07-01-count-1:CATCCACAGCGAGTCA"	1.40475120124165	11.1596259840759	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCACAGCGAGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1731.02894140341	33.2608309572999	0.0192144857672537	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1729.53309625894	1729.53309625894
"AML-3133"	"2019-07-01-count-1:GGAAGTGGTTCCGGTG"	-8.25438056412395	5.54098794544069	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAAGTGGTTCCGGTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1497.19311819324	43.5811471584946	0.0291085676449587	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1489.95411561508	1489.95411561508
"AML-3133"	"2019-07-01-count-1:CATCCACGTTCTCTAT"	1.33579423007314	11.612651801947	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCACGTTCTCTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1972.06575018341	33.8957795166313	0.0171879560879139	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1969.12390108076	1969.12390108076
"AML-3133"	"2019-07-01-count-2:AGTAACCGTAGCTGTT"	1.09666099128072	9.65329835498659	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTAACCGTAGCTGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1524.89971093675	37.5378979633947	0.0246166339295422	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1521.01304767481	1521.01304767481
"AML-3133"	"2019-07-01-count-1:TAGATCGGTATCTTCT"	-0.673815409571487	-9.76573755657347	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGATCGGTATCTTCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1419.41452652841	30.8942115525691	0.0217654610229543	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1419.41452652841	1419.41452652841
"AML-3133"	"2019-07-01-count-1:CAATCGAAGTCAAGCG"	-2.59917531433757	13.6213178404602	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATCGAAGTCAAGCG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2112.55528942085	43.7161267512526	0.0206934828973102	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2109.26548722698	2109.26548722698
"AML-3133"	"2019-07-01-count-1:TCCTTCTGTGTGAGCA"	3.20237459716145	-9.66981031810912	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	29	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00537634408602151	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTTCTGTGTGAGCA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2815.537499164	34.7673894552511	0.0123484022022702	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2806.09687345333	2806.09687345333
"AML-3133"	"2019-07-01-count-1:TAGATCGGTTCGGCTG"	10.9554001289303	-1.19877233421477	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGATCGGTTCGGCTG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1926.62733092989	24.4315723072842	0.0126810057736969	2639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1918.40826085773	1918.40826085773
"AML-3133"	"2019-07-01-count-2:AGTACCACACTTCTCG"	4.10472311553304	-10.7191229096619	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTACCACACTTCTCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1875.75902369299	49.5959460934935	0.0264404678143832	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1875.75902369299	1875.75902369299
"AML-3133"	"2019-07-01-count-2:CCTCTAGCAAAGCACG"	-0.854581872851211	11.2076396712097	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCTAGCAAAGCACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2028.14821653577	40.3536945203524	0.0198968172993192	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2028.14821653577	2028.14821653577
"AML-3133"	"2019-07-01-count-2:AATGAAGGTGATACAA"	0.476778616278809	11.4546756514343	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGAAGGTGATACAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1838.98197445546	35.5609329934739	0.0193372928541096	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1835.52442161305	1835.52442161305
"AML-3133"	"2019-07-01-count-2:CTCCCTCGTACAATAG"	-7.58224091950114	1.35427889907686	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCCTCGTACAATAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2594.5209538388	44.6812246848052	0.0172213774641889	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2587.59852984515	2587.59852984515
"AML-3133"	"2019-07-01-count-3:TCTCACGCAGAGTAAT"	14.2895828681881	2.13621709430543	"2019-07-01-count-3"	"AML3133"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0150943396226415	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCACGCAGAGTAAT"	"Plasma cell"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1225.40301316895	17.5946376525676	0.0143582457881077	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1215.41616141312	1215.41616141312
"AML-3133"	"2019-07-01-count-1:CATCCGTGTGTAAACA"	0.186875169246834	10.5182313689026	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCGTGTGTAAACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1597.89591587535	48.9054662765528	0.0306061651392117	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1597.89591587535	1597.89591587535
"AML-3133"	"2019-07-01-count-3:TGTGAGTGTGTATTGC"	-1.98825560036357	11.9874477156433	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGAGTGTGTATTGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1861.32273920257	39.4990831260245	0.0212209748981774	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1859.52557567482	1859.52557567482
"AML-3133"	"2019-07-01-count-2:ATCGTAGAGCCTCAAT"	1.23761310157124	10.6861696013245	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGTAGAGCCTCAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1736.09835669735	37.0013712794815	0.0213129464334444	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1731.81333586638	1731.81333586638
"AML-3133"	"2019-07-01-count-2:TCAGCCTAGCCTCCAG"	1.46844245967214	10.8749322661194	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGCCTAGCCTCCAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1897.73943851431	32.5000999576292	0.0171256913873659	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1893.77796799366	1893.77796799366
"AML-3133"	"2019-07-01-count-3:AGATCGTTCTGGGAGA"	-1.75607107105907	11.2972545393738	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATCGTTCTGGGAGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1511.19408371954	46.1006162541598	0.0305060857177863	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1509.0816697948	1509.0816697948
"AML-3133"	"2019-07-01-count-1:TTCTTCCAGACTCATC"	-2.30292497101482	13.8224162825379	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTTCCAGACTCATC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2497.05380352237	30.7311951263308	0.0123069815648269	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2494.07335238669	2494.07335238669
"AML-3133"	"2019-07-01-count-1:AGATCGTCAGAGTAAT"	-1.93462977829631	12.9771880873474	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATCGTCAGAGTAAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1931.81195996281	47.1376526849757	0.0244007458603182	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1927.84014116654	1927.84014116654
"AML-3133"	"2019-07-01-count-3:AACAACCAGCGCCTAC"	1.38586010512654	11.3188171156677	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAACCAGCGCCTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1778.15399505031	35.7735235501731	0.0201183495072714	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.67156057384	1771.67156057384
"AML-3133"	"2019-07-01-count-1:GGTGAAGAGCGCTGAA"	0.520632137625855	9.65103623950807	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGAAGAGCGCTGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1690.61701006519	37.5763822000531	0.0222264309280812	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1688.75257735815	1688.75257735815
"AML-3133"	"2019-07-01-count-1:CAATTTCGTCCCGCAA"	1.1012131172115	9.87740132892457	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCGTCCCGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1920.61794929186	29.3521569636187	0.0152826630483386	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1912.73663079076	1912.73663079076
"AML-3133"	"2019-07-01-count-2:CAGCGTGTCATCCCGT"	1.06196429309193	10.7351541289124	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCGTGTCATCCCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1741.11833350135	34.6621392780552	0.0199079744386761	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1733.21301271302	1733.21301271302
"AML-3133"	"2019-07-01-count-3:AGTAGTCTCCTTCACG"	1.14648022231404	10.8666038283142	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTAGTCTCCTTCACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1825.2947311369	43.4896693411568	0.0238261079700093	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1825.2947311369	1825.2947311369
"AML-3133"	"2019-07-01-count-2:ATTCCATTCTTCTTCC"	2.212414641946	-10.0695381394592	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCATTCTTCTTCC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.08583033304	51.7741459176905	0.021071362375108	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2452.34909476984	2452.34909476984
"AML-3133"	"2019-07-01-count-2:GTAGGTTCATCCGGTG"	1.27989449080769	9.62439439380494	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGTTCATCCGGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1698.80064935151	37.4827031963641	0.0220642152513142	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1698.80064935151	1698.80064935151
"AML-3133"	"2019-07-01-count-3:CTGGCAGGTGTCCGGT"	8.33678879317586	7.38201139057008	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGGCAGGTGTCCGGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1569.71609776754	44.1568102585258	0.028130443665148	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1564.1395621632	1564.1395621632
"AML-3133"	"2019-07-01-count-2:ATCGTCCTCACTCACC"	4.34148850020711	-10.6529073945251	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGTCCTCACTCACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2245.10575059092	49.4385503591622	0.0220205887166562	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2240.50404627585	2240.50404627585
"AML-3133"	"2019-07-01-count-2:GTTCCGTCAACCCTAA"	1.3024990755016	10.8299016722473	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCCGTCAACCCTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1899.88155503454	31.8013436580743	0.0167385927684825	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1894.59190365377	1894.59190365377
"AML-3133"	"2019-07-01-count-1:CGGAACCAGCTCACTA"	-7.38905702057536	-1.08545412933501	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGAACCAGCTCACTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3237.3933012867	40.7293258071121	0.0125809013662085	3839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3227.1786358821	3227.1786358821
"AML-3133"	"2019-07-01-count-2:CCTGCATCACCCTAGG"	-5.70499310913737	2.68337748134462	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	70	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTGCATCACCCTAGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2351.11719357936	51.2697260185121	0.0218065378274311	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2349.4516806199	2349.4516806199
"AML-3133"	"2019-07-01-count-2:CCTGCATCAGCGTGAA"	-2.6241491836613	13.1073713072571	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTGCATCAGCGTGAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1929.74146003678	41.095801743131	0.0212960143077134	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1929.74146003678	1929.74146003678
"AML-3133"	"2019-07-01-count-3:GTCACGGCACCGGTCA"	-0.406948815018493	-9.98185636913451	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCACGGCACCGGTCA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2212.39232314675	43.3187642956713	0.0195800554189492	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2212.39232314675	2212.39232314675
"AML-3133"	"2019-07-01-count-1:TGTGTGACACGGGTAA"	4.1497241455013	-10.6846294633118	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGTGACACGGGTAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.95760634783	43.967617315532	0.0183891245912521	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2386.09303679729	2386.09303679729
"AML-3133"	"2019-07-01-count-2:CATTCATAGCCGCACT"	-2.47959695282634	10.7004842528137	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCATAGCCGCACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2103.5770322429	32.1749593646027	0.0152953558968538	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2103.5770322429	2103.5770322429
"AML-3133"	"2019-07-01-count-1:GGAGAACGTACCATAC"	9.05418552932088	6.60528848255006	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGAACGTACCATAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1758.39042590329	35.3328347272288	0.0200938507209389	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1752.07447015224	1752.07447015224
"AML-3133"	"2019-07-01-count-2:CTCACTGTCTATACTC"	1.35919596728627	9.82767007434694	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCACTGTCTATACTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1905.93762930822	35.3889763325462	0.0185677515299338	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1897.52687906161	1897.52687906161
"AML-3133"	"2019-07-01-count-2:AGAAGTACAAGACGGT"	-0.958073000342208	12.3232984312805	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAGTACAAGACGGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2062.17021145282	45.6791155811233	0.0221509918664483	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2058.98301389986	2058.98301389986
"AML-3133"	"2019-07-01-count-1:AAACGCTCAGTTAGGG"	1.21163394030873	10.4675884016785	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAACGCTCAGTTAGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1848.11378536175	47.2427058943477	0.0255626608429309	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1843.03365975021	1843.03365975021
"AML-3133"	"2019-07-01-count-2:AGATCGTTCGCCTAGG"	3.18963064727132	-10.6797285309997	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATCGTTCGCCTAGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2403.87327328589	46.7775998506867	0.0194592620045839	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2397.98771463732	2397.98771463732
"AML-3133"	"2019-07-01-count-2:GGAGGATGTTGTCATG"	-7.25771556320842	1.16731891715852	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATGTTGTCATG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2031.04458341385	44.8968324402038	0.0221052914381326	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2025.85794308475	2025.85794308475
"AML-3133"	"2019-07-01-count-2:GGAGGATTCTAGATCG"	-7.36556230011638	1.32221398437349	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATTCTAGATCG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2640.71295616615	46.8798884494762	0.017752739213859	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2633.4298904653	2633.4298904653
"AML-3133"	"2019-07-01-count-1:GTTACCCCACTCATAG"	0.919506152241868	11.7642364271912	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACCCCACTCATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1869.5634068228	38.6436901429987	0.0206699007917956	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1864.10808962129	1864.10808962129
"AML-3133"	"2019-07-01-count-2:CACTGTCCAGAGTCAG"	-0.0985503447359383	10.9456176527771	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACTGTCCAGAGTCAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1814.27981316617	38.36986916309	0.021148815571138	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.18397872832	1808.18397872832
"AML-3133"	"2019-07-01-count-2:AATGGCTGTCACTCAA"	1.30525328692738	10.8768558272156	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AATGGCTGTCACTCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2089.56859234747	38.6718651217147	0.0185071048939675	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2085.63682970195	2085.63682970195
"AML-3133"	"2019-07-01-count-1:CCGGTAGAGACAGCTG"	10.9355389076168	-0.577404045220934	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTAGAGACAGCTG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1233.70952035276	12.0666275342198	0.00978076875889676	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1231.18521222175	1231.18521222175
"AML-3133"	"2019-07-01-count-2:GTCGAATAGGCTCTAT"	8.52161278304402	6.48843190753785	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCGAATAGGCTCTAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1588.98084517464	36.6373537887609	0.0230571399900885	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1586.91939593322	1586.91939593322
"AML-3133"	"2019-07-01-count-1:GGTGGCTAGACGACGT"	-7.72815356674846	1.3793575533661	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGGCTAGACGACGT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2561.03298833083	36.465864111584	0.014238732682374	2541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2553.30401336518	2553.30401336518
"AML-3133"	"2019-07-01-count-2:GAAACCTTCGCGGTAC"	8.26124920424764	7.70515439594118	"2019-07-01-count-2"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAACCTTCGCGGTAC"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	1897.35254165221	34.1417260304188	0.0179944028750125	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	1895.95803563058	1895.95803563058
"AML-3133"	"2019-07-01-count-1:AGCCAATAGCGTACAG"	0.889725347130936	11.3368863829407	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCCAATAGCGTACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.23798518187	33.3126915683044	0.0171959727318566	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1936.03549413351	1936.03549413351
"AML-3133"	"2019-07-01-count-2:AGATGCTAGCGTGAGT"	2.83234848555867	-10.2664041749206	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATGCTAGCGTGAGT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2068.44700462489	47.2318960304698	0.0228344723963741	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2059.78492347821	2059.78492347821
"AML-3133"	"2019-07-01-count-3:GCAACCGAGCGCCGTT"	1.77202357825581	-8.79975225841673	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAACCGAGCGCCGTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1860.10793182327	47.7560502128347	0.0256738060172801	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1851.80004374289	1851.80004374289
"AML-3133"	"2019-07-01-count-1:ACGTTCCTCAGGGATG"	1.3556373315746	11.5649919279846	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTTCCTCAGGGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1867.7509742511	43.333893360475	0.0232011086905471	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1864.76287336044	1864.76287336044
"AML-3133"	"2019-07-01-count-2:TTGGTTTAGAATCGTA"	1.41429903086964	9.38656709277955	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGTTTAGAATCGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1747.21567982457	41.3337203257336	0.0236569078465939	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1740.86558233973	1740.86558233973
"AML-3133"	"2019-07-01-count-3:CAACGGCCAAAGGTTA"	9.2563063102657	6.34881875598756	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGGCCAAAGGTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1657.60824957948	37.4972527733042	0.0226212995638848	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1655.89048365015	1655.89048365015
"AML-3133"	"2019-07-01-count-3:CCACCATAGCACAAAT"	-0.42524696412738	-9.97209741985472	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACCATAGCACAAAT"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2474.44216257014	41.4638996443955	0.0167568675767018	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2468.05918522912	2468.05918522912
"AML-3133"	"2019-07-01-count-3:TTACTGTGTTATGACC"	-6.83520160141643	2.61081740939943	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACTGTGTTATGACC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2334.41821595652	37.6441626660818	0.0161257149249314	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2330.99594348435	2330.99594348435
"AML-3133"	"2019-07-01-count-2:CGTGTCTAGGTGAGCT"	0.968855698674363	10.963520980719	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTGTCTAGGTGAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1643.67407125442	36.0248663047589	0.0219172808860247	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1643.67407125442	1643.67407125442
"AML-3133"	"2019-07-01-count-2:CAACGATGTTGTCAGT"	1.08592345294301	10.5449790724548	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACGATGTTGTCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1755.20901987635	42.6724673971212	0.024311900698942	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1748.74774287136	1748.74774287136
"AML-3133"	"2019-07-01-count-3:GACCCTTCAAGCCTGC"	7.82984604415242	7.29285905444948	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCCTTCAAGCCTGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1697.67750891244	41.2874175705517	0.0243199414222086	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1693.97913933073	1693.97913933073
"AML-3133"	"2019-07-01-count-1:CTCATTAAGTGAGGTC"	4.02779950675313	-10.3692140809265	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCATTAAGTGAGGTC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2055.52180397711	44.7635068838834	0.0217771987615373	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2047.73646213878	2047.73646213878
"AML-3133"	"2019-07-01-count-2:GTTGAACTCACGATAC"	1.47264256057088	11.2783250578674	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGAACTCACGATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.53683773315	34.0496605088081	0.0177015900298197	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1922.19978721592	1922.19978721592
"AML-3133"	"2019-07-01-count-1:CACAGGCCAGCTGCCA"	1.2859819131786	11.2470750578674	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACAGGCCAGCTGCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2131.78713531419	40.0656448237709	0.0187943928172105	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2128.02399485189	2128.02399485189
"AML-3133"	"2019-07-01-count-1:CACATGAAGGCGACAT"	-7.18347058716472	4.35576818073121	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACATGAAGGCGACAT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2179.90158467808	35.9072451647855	0.0164719569989615	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2170.93091992665	2170.93091992665
"AML-3133"	"2019-07-01-count-3:CCACCATTCTAGACCA"	-0.30513827028926	13.2612447508606	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACCATTCTAGACCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2138.38182555834	32.7732104634718	0.0153261733109402	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2133.45670286212	2133.45670286212
"AML-3133"	"2019-07-01-count-3:CCACGAGAGACGCATG"	7.15810074385945	-10.0257702103821	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACGAGAGACGCATG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1686.19297483003	48.570403713105	0.028804771718374	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1680.20851551249	1680.20851551249
"AML-3133"	"2019-07-01-count-1:TGCATGATCAAGTCTG"	0.600102980702561	11.1426868208679	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCATGATCAAGTCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1956.21505622352	32.8712056267337	0.0168034723596248	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1953.46149004311	1953.46149004311
"AML-3133"	"2019-07-01-count-1:ACTATCTCATTCAGCA"	1.32539894160573	11.1984605559143	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATCTCATTCAGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1797.85847974659	33.7597141097472	0.0187777372301882	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1794.40427782394	1794.40427782394
"AML-3133"	"2019-07-01-count-3:TGCGGCACATCGTGCG"	-7.56278357926066	1.68837652290193	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCACATCGTGCG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2430.54384244	42.5058643499183	0.0174882113244446	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2428.16713086256	2428.16713086256
"AML-3133"	"2019-07-01-count-1:ATGGGAGTCGGTGTAT"	-4.23271689835246	10.6099500426087	"2019-07-01-count-1"	"AML3133"	"gd T"	"gd T"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGGAGTCGGTGTAT"	"gd T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"gd_T"	2123.23005243339	39.5049539294949	0.0186060638526753	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2118.69785040813	2118.69785040813
"AML-3133"	"2019-07-01-count-3:GATGATCCAGCTTTGA"	3.8513158756191	-10.6593742600647	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGATCCAGCTTTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2185.05989211663	48.3447444194028	0.0221251346902771	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2185.05989211663	2185.05989211663
"AML-3133"	"2019-07-01-count-3:AGCGATTAGGGAGGTG"	-1.42754314366038	12.7056627043518	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGATTAGGGAGGTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1757.74518727539	40.3003325601822	0.0229272893772789	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1755.7008923485	1755.7008923485
"AML-3133"	"2019-07-01-count-1:ACTATCTTCATCACTT"	0.963635881512803	12.7694892653259	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATCTTCATCACTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2060.44318389296	39.8148259833664	0.0193234282287469	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2053.4203564767	2053.4203564767
"AML-3133"	"2019-07-01-count-2:GTTGCGGTCTTGAACG"	0.266561930149239	10.282989478949	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGCGGTCTTGAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1557.30831957252	38.5398293602381	0.0247477194309328	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1551.47389498553	1551.47389498553
"AML-3133"	"2019-07-01-count-2:GGTGTCGCAATCCAGT"	3.82608689841573	-10.6503353348938	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTGTCGCAATCCAGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2106.33483742907	37.0206716357715	0.0175758720683544	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2101.81359795138	2101.81359795138
"AML-3133"	"2019-07-01-count-2:ATTCTTGTCCTATTGT"	0.295122181146783	11.1033324965271	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTTGTCCTATTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2398.10581382366	36.5295097722793	0.0152326513541264	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2391.49921728242	2391.49921728242
"AML-3133"	"2019-07-01-count-2:TCACACCTCGGACTTA"	-7.78524814072307	1.64505407893983	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCACACCTCGGACTTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2496.61977945303	39.0618375768553	0.0156458896538155	2227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2490.3091064469	2490.3091064469
"AML-3133"	"2019-07-01-count-2:TGCTCGTAGGTCGTCC"	1.05208470401112	11.7121839293274	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTCGTAGGTCGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1730.60277510365	38.9817578715941	0.0225249597610632	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1722.57192564964	1722.57192564964
"AML-3133"	"2019-07-01-count-3:TATTCCATCCCAAGCG"	-1.9586218399113	11.0953502424988	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTCCATCCCAAGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1889.71944316895	40.3833276139967	0.0213700122311682	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1886.43005564432	1886.43005564432
"AML-3133"	"2019-07-01-count-1:TAACACGAGGCGACAT"	1.42190303382222	11.013530708197	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACACGAGGCGACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2044.08272967719	30.3309969813223	0.014838439042099	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2032.66578040968	2032.66578040968
"AML-3133"	"2019-07-01-count-1:AGCGCCAAGCCATTCA"	1.02580346640889	10.4367646940979	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCGCCAAGCCATTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2101.19343656445	32.7404149181949	0.0155818185743655	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2095.28717736541	2095.28717736541
"AML-3133"	"2019-07-01-count-1:AAAGTCCCAGCGATTT"	1.33053233203236	10.2609119185242	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGTCCCAGCGATTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2065.87617019791	29.7557587006098	0.0144034570560728	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2061.43210314572	2061.43210314572
"AML-3133"	"2019-07-01-count-2:TCGCAGGTCCGATGCG"	1.08789529380147	10.8128518828186	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCAGGTCCGATGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1743.47920692281	41.7906364948744	0.0239696787486406	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1741.79496742271	1741.79496742271
"AML-3133"	"2019-07-01-count-2:CGAAGTTCATGACAAA"	0.247843985527199	11.2602405318054	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAAGTTCATGACAAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2064.09146938151	38.4269647734748	0.0186168904544667	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2064.09146938151	2064.09146938151
"AML-3133"	"2019-07-01-count-2:GTTGCTCTCTGAGGCC"	1.06499125537221	12.150493598822	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGCTCTCTGAGGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1823.94742244701	38.3768311590492	0.0210405358656461	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1821.00873685849	1821.00873685849
"AML-3133"	"2019-07-01-count-3:GAGATGGGTGTAGCAG"	4.24436106261556	-10.6491508713928	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGATGGGTGTAGCAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2038.1129357381	45.0455887979071	0.0221016156700826	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2034.94109582975	2034.94109582975
"AML-3133"	"2019-07-01-count-1:AGTTCGAGTGATTAGA"	1.0339216190273	10.2927407988342	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTCGAGTGATTAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1762.03932721983	36.9249727091338	0.0209558164444573	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1757.78423868155	1757.78423868155
"AML-3133"	"2019-07-01-count-3:TCTGTCGTCGCTGTTC"	1.48081566867177	11.0049056776795	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGTCGTCGCTGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1816.56889172585	34.6507417024398	0.0190748293996819	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1816.56889172585	1816.56889172585
"AML-3133"	"2019-07-01-count-3:GTCTTTACACATACGT"	0.990296383469742	12.9210052260193	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCTTTACACATACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1654.10930912437	36.5688700056009	0.022107892026168	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1649.20003390852	1649.20003390852
"AML-3133"	"2019-07-01-count-3:ATATCCTGTGGACTGA"	1.37108101424519	11.5632734068665	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATATCCTGTGGACTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2034.3508861307	31.6914800487304	0.0155781779164985	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2026.44637617944	2026.44637617944
"AML-3133"	"2019-07-01-count-3:TGCTCCACATGGACAG"	0.764706988900345	11.8879651793274	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTCCACATGGACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1731.22982307279	39.3283138230831	0.0227169803216991	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1729.55188559766	1729.55188559766
"AML-3133"	"2019-07-01-count-1:CGGGCATGTACTCGCG"	-0.169220815331298	10.2722158201965	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGGGCATGTACTCGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1372.45441677451	44.7009536602113	0.0325700825571066	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1370.17901363583	1370.17901363583
"AML-3133"	"2019-07-01-count-2:CGAATTGGTTGCTAGT"	1.11900271949117	11.7210416563782	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAATTGGTTGCTAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1692.77808517726	30.6196941778503	0.0180884278015945	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1686.42711931023	1686.42711931023
"AML-3133"	"2019-07-01-count-3:CAGGTATTCGACATTG"	-1.16808948937114	11.354803062323	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGTATTCGACATTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1982.8790237226	40.1908237746423	0.0202689237688284	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1975.7140719907	1975.7140719907
"AML-3133"	"2019-07-01-count-1:CTCCATGGTCAGTCCG"	-7.48243365708049	2.02726624095765	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCATGGTCAGTCCG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2685.8403767547	38.0474924104747	0.014165954440095	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2670.00701354498	2670.00701354498
"AML-3133"	"2019-07-01-count-3:TTGAGTGAGCAACAGC"	-2.37023053589519	13.4599036940369	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGAGTGAGCAACAGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1927.3724904776	31.7309806251459	0.016463335853301	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1925.43698757869	1925.43698757869
"AML-3133"	"2019-07-01-count-1:TAACCAGGTGTCTTCC"	9.20658554610555	7.55129716480104	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACCAGGTGTCTTCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1910.94466389011	37.4981780125488	0.0196228486994562	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1907.97236804898	1907.97236804898
"AML-3133"	"2019-07-01-count-2:CCCAACTGTATGGAAT"	0.24462035772149	12.3203868635925	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCAACTGTATGGAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1833.70252424453	32.0440172109171	0.0174750357744744	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1826.79477577333	1826.79477577333
"AML-3133"	"2019-07-01-count-2:CTGAATGTCCAAAGGG"	10.9659820991451	-1.27485730564269	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGAATGTCCAAAGGG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2299.39823793923	39.8740992172124	0.0173411019280195	3616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2288.8884450859	2288.8884450859
"AML-3133"	"2019-07-01-count-1:TAACGACGTTCTTCAT"	1.52206601676289	10.7083539732727	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACGACGTTCTTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1751.31748895924	46.1797550331326	0.0263685798401842	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1738.00898348679	1738.00898348679
"AML-3133"	"2019-07-01-count-1:TTGCTGCGTCGTTCAA"	0.601471920579117	10.4344300993714	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCTGCGTCGTTCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1692.90657630852	37.3956190477665	0.022089594057405	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1684.16716510075	1684.16716510075
"AML-3133"	"2019-07-01-count-1:GGCACGTCATGACTCA"	-1.52406154099162	14.0650644072327	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCACGTCATGACTCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2197.50881936264	32.6154781291846	0.0148420237688258	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2194.64189233451	2194.64189233451
"AML-3133"	"2019-07-01-count-2:GAGTTGTAGTGTAGTA"	-1.75838957253154	8.55475232684938	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTGTAGTGTAGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2486.59791164806	31.4880601143631	0.0126631088873929	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2478.389414359	2478.389414359
"AML-3133"	"2019-07-01-count-1:TCCATCGCACCAGGTC"	3.02145995673482	-10.4888067475525	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATCGCACCAGGTC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.05170391692	36.7942731083436	0.0147587284493678	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2488.66760709453	2488.66760709453
"AML-3133"	"2019-07-01-count-3:AACCTGAGTTGGGCCT"	2.26625742492024	-10.4223184815613	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCTGAGTTGGGCCT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2202.80508776584	42.9071418762146	0.0194784105568471	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2202.80508776584	2202.80508776584
"AML-3133"	"2019-07-01-count-3:ACACGCGCAGTGTGCC"	0.776344318955582	-10.2721052399841	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACACGCGCAGTGTGCC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.67049102807	47.6073228178292	0.0191065885273563	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2489.42835856245	2489.42835856245
"AML-3133"	"2019-07-01-count-3:CGTGAATTCGTAGCCG"	8.04566158828084	7.07706544483034	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTGAATTCGTAGCCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1660.23749492001	40.2628192280398	0.0242512407720195	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1658.4062147165	1658.4062147165
"AML-3133"	"2019-07-01-count-1:AGCGTATTCACCCATC"	1.41355707225148	11.1950511702332	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCGTATTCACCCATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1955.2452992442	37.8963070672235	0.0193818683936345	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1952.57634285842	1952.57634285842
"AML-3133"	"2019-07-01-count-1:AGAACAAAGTTGCTGT"	8.19391407546346	7.44645593250123	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAACAAAGTTGCTGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1749.87524117945	39.7646229040793	0.0227242616892375	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1746.84614465465	1746.84614465465
"AML-3133"	"2019-07-01-count-3:TGCAGGCTCCACGTGG"	0.941242237656754	10.509943939093	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCAGGCTCCACGTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1770.70807487458	39.9568402189533	0.0225654588612996	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1767.35265367758	1767.35265367758
"AML-3133"	"2019-07-01-count-1:TATCTTGCACTTCTCG"	-7.97039161148723	0.248433254006781	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCTTGCACTTCTCG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2990.80322054884	39.7982343118242	0.0133068715582434	3414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2983.10468439388	2983.10468439388
"AML-3133"	"2019-07-01-count-3:AGTTAGCAGCAACAAT"	1.47148444232289	11.0843543776306	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTTAGCAGCAACAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1755.06232840872	39.3277441839215	0.0224081752239416	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1752.41861324021	1752.41861324021
"AML-3133"	"2019-07-01-count-3:GTCCTCACATGGCACC"	1.96346714076344	-9.58572962200316	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCCTCACATGGCACC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2266.95031592152	41.5774420506313	0.0183406939969613	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2261.4040100833	2261.4040100833
"AML-3133"	"2019-07-01-count-2:TTCAGGAGTCGTACAT"	-1.54853604260142	11.1626519926819	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCAGGAGTCGTACAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1918.97062653816	44.6509733862747	0.0232681901269252	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1917.19443770848	1917.19443770848
"AML-3133"	"2019-07-01-count-3:CAGATACGTACGAGCA"	0.217834209173363	11.4831800230774	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGATACGTACGAGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1349.64359682985	43.2832687218863	0.0320701471288816	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1347.30939726502	1347.30939726502
"AML-3133"	"2019-07-01-count-3:ATCGGCGCAGACCGCT"	1.05491401728932	10.7267713316712	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGGCGCAGACCGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1933.78760667473	37.4268831297565	0.0193541850204089	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1929.84454623185	1929.84454623185
"AML-3133"	"2019-07-01-count-3:GCCATGGTCCCATTTA"	-1.71030877056773	10.5181655653748	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATGGTCCCATTTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1839.54595210817	39.4813625840839	0.0214625584856074	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.00565656743	1834.00565656743
"AML-3133"	"2019-07-01-count-2:GTCTTTAAGGTGATAT"	2.94498409804646	-9.67488481914672	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTTTAAGGTGATAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1281.51121411548	45.3521737247205	0.0353896034815609	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1277.03588706714	1277.03588706714
"AML-3133"	"2019-07-01-count-3:CTCCTTTAGCATGGGT"	1.40015043792073	10.6936664351257	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCTTTAGCATGGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1688.97268802912	47.3184380450373	0.0280161061101903	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1687.15094518234	1687.15094518234
"AML-3133"	"2019-07-01-count-1:ATAGAGAAGCTCCACG"	4.05365051802937	-10.8015909424988	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATAGAGAAGCTCCACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.7980614848	43.9725204842137	0.0187932972541697	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2337.54067975941	2337.54067975941
"AML-3133"	"2019-07-01-count-1:GGCGTCAAGCGTGCCT"	3.01910247382466	-10.6180143586365	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCGTCAAGCGTGCCT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2651.00467368482	42.6473678285926	0.0160872473186982	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2642.19385841584	2642.19385841584
"AML-3133"	"2019-07-01-count-1:GTAACCACAAGCAGGT"	0.897057016461533	10.4429044493469	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAACCACAAGCAGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1891.53827959215	34.5570535686508	0.0182692858725026	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1885.93409171769	1885.93409171769
"AML-3133"	"2019-07-01-count-3:TCAGCCTTCCAGCAAT"	-1.61517463150676	13.9032878645691	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTTCCAGCAAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2320.77928830252	40.586587796087	0.0174883445404122	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2317.39281660496	2317.39281660496
"AML-3133"	"2019-07-01-count-1:ACTGATGGTTGTACGT"	4.35338892516438	-10.3149614564148	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGATGGTTGTACGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2008.44587222783	49.4035045454628	0.024597877009582	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2003.40795869138	2003.40795869138
"AML-3133"	"2019-07-01-count-2:GGAGATGAGCGTGAAC"	-1.52659736099895	12.0051269301209	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGATGAGCGTGAAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1943.47409264282	30.2912316903289	0.0155861257965819	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1937.77947301413	1937.77947301413
"AML-3133"	"2019-07-01-count-1:TTGGGATGTTCGGTTA"	8.71906055983846	7.73148677432863	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGATGTTCGGTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1887.06723573201	37.4992043611498	0.0198716842998992	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1884.51103016888	1884.51103016888
"AML-3133"	"2019-07-01-count-2:AACCACATCCAACCAA"	1.35133459147755	-10.2109737626282	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCACATCCAACCAA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2418.81896270357	44.3803603993384	0.0183479462843856	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2418.81896270357	2418.81896270357
"AML-3133"	"2019-07-01-count-3:AGTTCCCAGGTAAGTT"	1.05881645259206	11.5122289427551	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTTCCCAGGTAAGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1476.29569750382	39.7763720455608	0.0269433637941344	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1476.29569750382	1476.29569750382
"AML-3133"	"2019-07-01-count-1:CACTGAAGTACAAGCG"	1.48759367045705	10.7761344679627	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGAAGTACAAGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1868.58843819616	42.6103084631031	0.0228034743189554	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1867.20558339773	1867.20558339773
"AML-3133"	"2019-07-01-count-2:TGGTTAGAGACCATAA"	4.44488586959187	-10.6686172715393	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGTTAGAGACCATAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2271.03935705937	44.5856409259093	0.0196322625529663	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2265.07045697465	2265.07045697465
"AML-3133"	"2019-07-01-count-1:CACTGAATCGATACGT"	-1.80295501175578	13.5519227751526	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGAATCGATACGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2091.77671541183	38.2805759002793	0.0183005077063125	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2090.10031223101	2090.10031223101
"AML-3133"	"2019-07-01-count-3:GGTCTGGCATCCGATA"	0.592644770711106	11.9252872237	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTCTGGCATCCGATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1912.86575558525	41.6359593651129	0.0217662735837801	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1911.34324625476	1911.34324625476
"AML-3133"	"2019-07-01-count-2:GATAGAAGTCTCTCAC"	1.08531584319417	10.078643775824	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATAGAAGTCTCTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1801.61085312905	31.1200097305491	0.0172734359789739	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1798.62716681688	1798.62716681688
"AML-3133"	"2019-07-01-count-1:ATAGAGATCCTAACAG"	-7.57652364197429	1.15273783290712	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATAGAGATCCTAACAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2381.87684129127	43.178077454794	0.0181277540073761	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2374.30793892909	2374.30793892909
"AML-3133"	"2019-07-01-count-3:TGCTTGCGTGTTACAC"	-7.77282224121745	2.88240287387697	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTTGCGTGTTACAC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2212.17335029625	35.5185345647829	0.0160559454167669	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2203.84075952049	2203.84075952049
"AML-3133"	"2019-07-01-count-1:GTGCACGTCCGAGAAG"	1.03692670640294	8.53472611987916	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCACGTCCGAGAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1791.74015157719	34.4086970623583	0.0192040665227431	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1785.71322189806	1785.71322189806
"AML-3133"	"2019-07-01-count-3:ACAGCCGGTGATTCTG"	7.97487415847127	7.30751702869264	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACAGCCGGTGATTCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1666.61077465819	34.0772647830903	0.0204470445656871	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1659.31909416882	1659.31909416882
"AML-3133"	"2019-07-01-count-3:TCGAACACAGCACCCA"	-7.58452401581462	1.23744926536409	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGAACACAGCACCCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2616.86981635696	38.2742679503279	0.0146259732567098	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2614.48523230334	2614.48523230334
"AML-3133"	"2019-07-01-count-1:TGCTGAAAGGTCGCCT"	8.61492218550984	7.38769910419313	"2019-07-01-count-1"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTGAAAGGTCGCCT"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	1786.55334971675	40.020678765882	0.0224010543946124	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	1786.55334971675	1786.55334971675
"AML-3133"	"2019-07-01-count-1:GTGCAGCAGAAGCGGG"	3.94293155249898	-10.7719831696716	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCAGCAGAAGCGGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.17366886419	45.9700309576355	0.0213697441647784	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2149.59406801062	2149.59406801062
"AML-3133"	"2019-07-01-count-1:GTGCAGCCAAGAGTGC"	1.06631412085835	12.6247949370178	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGCAGCCAAGAGTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1710.01888485802	47.4726942167588	0.0277615028916482	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1702.31384431454	1702.31384431454
"AML-3133"	"2019-07-01-count-1:ATTCAGGAGGTAAGTT"	3.96296443518941	-10.1992283097473	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCAGGAGGTAAGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1533.71656919054	50.6761661825345	0.0330414153439577	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1525.9394925698	1525.9394925698
"AML-3133"	"2019-07-01-count-2:AGCTCAAAGCTTCGTA"	0.259779040783089	11.1446256407532	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCTCAAAGCTTCGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1615.60408826256	40.6363108201709	0.0251523941511387	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1615.60408826256	1615.60408826256
"AML-3133"	"2019-07-01-count-3:TTGCTGCGTGTCTTGA"	-1.66645846787151	12.9546432265076	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCTGCGTGTCTTGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1701.93215135544	40.6647272348883	0.0238932716574526	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1696.22906407245	1696.22906407245
"AML-3133"	"2019-07-01-count-1:CATTGCCAGTCATTGC"	1.53312744674031	11.1907243498596	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTGCCAGTCATTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2174.56438740556	32.4109400931194	0.0149045667632718	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2173.33201732841	2173.33201732841
"AML-3133"	"2019-07-01-count-1:GAACTGTAGGTCCAGA"	3.06912793692891	-10.829089187738	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACTGTAGGTCCAGA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2123.02376426384	44.1112509047403	0.0207775587100109	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2105.9525489516	2105.9525489516
"AML-3133"	"2019-07-01-count-1:CGACAGCCACCCTTAC"	8.65581192550008	6.32682416522828	"2019-07-01-count-1"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGACAGCCACCCTTAC"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2040.4914042028	35.274371876544	0.0172871945472985	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	2037.56498961193	2037.56498961193
"AML-3133"	"2019-07-01-count-2:TTCCAATGTGTGGTCC"	1.42883946475331	11.2756480940613	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCAATGTGTGGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1895.86997969106	36.6218716576052	0.0193166578140411	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1892.72567997374	1892.72567997374
"AML-3133"	"2019-07-01-count-3:CGTTCTGAGCTAGCCC"	8.46431793746297	7.07306192005006	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTTCTGAGCTAGCCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1674.23599233296	41.1214686246455	0.0245613335353906	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1672.431921809	1672.431921809
"AML-3133"	"2019-07-01-count-2:GCCCGAACAGCGGTCT"	1.09628500518147	10.7085466154846	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCGAACAGCGGTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1886.78093807762	36.7110244073281	0.0194569616781966	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1879.3277149159	1879.3277149159
"AML-3133"	"2019-07-01-count-1:GAACTGTGTTTAGAGA"	8.24452557143514	7.23525903308717	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACTGTGTTTAGAGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1875.7957749805	37.6988884011141	0.0200975441484327	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1873.67113052607	1873.67113052607
"AML-3133"	"2019-07-01-count-1:CCTCACAGTCTCAAGT"	3.71080746230428	-10.7059068909851	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCACAGTCTCAAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.76391416884	38.9325758851772	0.014923763577733	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2603.06571202837	2603.06571202837
"AML-3133"	"2019-07-01-count-1:TGCTTCGTCTGAGGTT"	-2.44048510018047	10.3711642988953	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTTCGTCTGAGGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1910.95627755879	37.198698707637	0.0194660124590384	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.34931813895	1909.34931813895
"AML-3133"	"2019-07-01-count-3:TGAATCGTCTTGCAAG"	2.85376872596089	-9.78337767040404	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAATCGTCTTGCAAG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2005.01174175153	45.24194806715	0.0225644304843959	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2001.63269750428	2001.63269750428
"AML-3133"	"2019-07-01-count-2:GCCCGAATCATTTGGG"	8.60359444197957	7.22267816150514	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCGAATCATTTGGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1589.8021286777	33.3532140981402	0.0209794750532139	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1586.01094707395	1586.01094707395
"AML-3133"	"2019-07-01-count-1:ACTTATCAGCGCCATC"	-1.89062688770946	8.56658456409303	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTATCAGCGCCATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.88114557341	35.6712312930885	0.0140113498051985	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2541.53789040768	2541.53789040768
"AML-3133"	"2019-07-01-count-1:TCGTGCTTCTCTCGAC"	-7.62368283692058	1.49006400192109	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGTGCTTCTCTCGAC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2556.92215256769	38.0490516308984	0.0148808017454459	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2549.96821616024	2549.96821616024
"AML-3133"	"2019-07-01-count-2:AGGAAATAGAGTATAC"	10.9147125678951	-2.99473764812621	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAAATAGAGTATAC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2036.94606112362	27.1263344207128	0.0133171589265105	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2033.21861685813	2033.21861685813
"AML-3133"	"2019-07-01-count-2:TAACGACGTTACACTG"	1.33945967730824	10.1277532347473	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAACGACGTTACACTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1810.0666424413	31.4447137420865	0.0173721303982907	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1803.22145897204	1803.22145897204
"AML-3133"	"2019-07-01-count-2:TGTACAGAGAAGCGGG"	8.57256950911824	7.53923127734987	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTACAGAGAAGCGGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1657.41312880564	40.4250174968322	0.0243904291538725	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1650.50232193345	1650.50232193345
"AML-3133"	"2019-07-01-count-3:TTGGGATGTATCGCAT"	1.03100492533986	9.71463201129762	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGATGTATCGCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1793.18992002123	35.1446954426316	0.0195989811509846	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1786.14642433274	1786.14642433274
"AML-3133"	"2019-07-01-count-2:GCCGTGACAAATAGCA"	1.50923862037007	10.9152374037537	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGTGACAAATAGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1817.00833652925	36.2025884504488	0.0199242830770942	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1813.94678828709	1813.94678828709
"AML-3133"	"2019-07-01-count-3:GAGTCATTCCCTTCCC"	1.40455462512318	11.4630260237488	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTCATTCCCTTCCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1899.77018999181	39.9160461230768	0.0210109866621546	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1895.51689187473	1895.51689187473
"AML-3133"	"2019-07-01-count-2:AACCTTTGTGCTGATT"	8.43184628066365	6.86890504443971	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCTTTGTGCTGATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1754.76457975328	41.9415847307195	0.023901545093084	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1747.92397257078	1747.92397257078
"AML-3133"	"2019-07-01-count-2:GGGACCTGTCGGTAAG"	8.4458404975826	7.55778834903566	"2019-07-01-count-2"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACCTGTCGGTAAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1757.64961023785	35.3190195994429	0.020094459893325	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1753.30122231398	1753.30122231398
"AML-3133"	"2019-07-01-count-1:ACAGCCGGTCCTCATC"	1.68309619006459	-10.5813751450744	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAGCCGGTCCTCATC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2503.86655209426	47.9235436941167	0.019139815440257	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2500.45511682581	2500.45511682581
"AML-3133"	"2019-07-01-count-3:CGACAGCTCCTTTGAT"	7.76068224486653	6.59988305652467	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGACAGCTCCTTTGAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1509.65403754044	39.3068198540041	0.0260369719661358	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1509.65403754044	1509.65403754044
"AML-3133"	"2019-07-01-count-3:ATGGGTTAGATCCCAT"	1.1560067134792	10.9052543410095	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGGTTAGATCCCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1719.30629641828	36.0561549112949	0.0209713388396287	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1716.1897752793	1716.1897752793
"AML-3133"	"2019-07-01-count-3:GAGTCATTCTGCTTTA"	8.22256626662556	6.98265502536622	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTCATTCTGCTTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1628.0590837895	39.1557228082585	0.0240505539375874	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1628.0590837895	1628.0590837895
"AML-3133"	"2019-07-01-count-1:ATTCCATCAGTATACC"	1.2148595052654	9.64128778064577	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCATCAGTATACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1997.48741043453	43.8297841138832	0.0219424582527649	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.98934775204	1995.98934775204
"AML-3133"	"2019-07-01-count-3:ACATCGATCTTGGAAC"	-8.29190955582317	-0.9119906059471	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACATCGATCTTGGAAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2998.31813577184	36.6433905253583	0.0122213150393147	3131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2993.1183811592	2993.1183811592
"AML-3133"	"2019-07-01-count-2:GATCCCTAGTGGCGAT"	1.24486662921254	9.96025083148805	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCCCTAGTGGCGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1716.92060564264	31.2477964475059	0.0181999076397653	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1715.39570489641	1715.39570489641
"AML-3133"	"2019-07-01-count-1:TACACCCTCAAAGCCT"	0.584179838269395	11.0890006789002	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACACCCTCAAAGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2211.25767754503	35.8413253001239	0.0162085702015133	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2207.4170312691	2207.4170312691
"AML-3133"	"2019-07-01-count-2:ACATGCACATCTCAAG"	8.07016720351521	7.12329814517824	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATGCACATCTCAAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1799.84441501749	36.8458421429706	0.0204716817940137	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1798.23384674865	1798.23384674865
"AML-3133"	"2019-07-01-count-1:ACTACGAGTGGAAATT"	7.96969809111897	7.04708383167116	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTACGAGTGGAAATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1839.02126274803	37.1301543708731	0.0201901713280846	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1833.35839698562	1833.35839698562
"AML-3133"	"2019-07-01-count-1:ACTTCCGGTTGACTGT"	8.30912842330281	7.75552413547365	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGGTTGACTGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1830.08370482081	40.7521404488858	0.0222679106652534	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1828.51302286177	1828.51302286177
"AML-3133"	"2019-07-01-count-1:GCAGTTAGTCTTAGTG"	1.32022633132283	11.5633992918762	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAGTTAGTCTTAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1881.20497882737	40.6594057135422	0.0216134903804511	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1881.20497882737	1881.20497882737
"AML-3133"	"2019-07-01-count-3:GCAACCGGTCGCAACC"	-1.73888216438945	8.49910638416139	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAACCGGTCGCAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2562.05958620928	41.099242970119	0.0160414859948389	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2550.76508708894	2550.76508708894
"AML-3133"	"2019-07-01-count-2:CTGCTCAAGTATAACG"	-3.55923448029216	10.3650989302429	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCTCAAGTATAACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2082.62139629539	38.7118155685265	0.0185880235540593	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2079.49557440456	2079.49557440456
"AML-3133"	"2019-07-01-count-1:TCATTGTTCTAGCCTC"	1.29455723342244	11.3554868468079	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTGTTCTAGCCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2246.14273919796	33.3838241871554	0.014862734947591	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2240.68825533051	2240.68825533051
"AML-3133"	"2019-07-01-count-1:CCTCCTCCATGAAAGT"	4.06049456176106	-10.8913231126037	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCTCCATGAAAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2496.93068496669	34.6888122728102	0.0138925811924463	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2493.75184811553	2493.75184811553
"AML-3133"	"2019-07-01-count-3:CACACAAGTTTAGACC"	0.0426158524001062	13.016930557135	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACACAAGTTTAGACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1739.85784777791	43.2637748852247	0.0248662699314658	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1736.17536604447	1736.17536604447
"AML-3133"	"2019-07-01-count-3:CACACAATCTCCCATG"	8.1739317375118	6.50760696018068	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACACAATCTCCCATG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1767.20505287904	39.3325841335759	0.0222569441330519	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1765.44863399782	1765.44863399782
"AML-3133"	"2019-07-01-count-1:CGTGATAGTGGTCTCG"	8.16458572921101	7.67341182315675	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGATAGTGGTCTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1654.17910658832	30.9842259474008	0.0187308773421184	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1648.75458310618	1648.75458310618
"AML-3133"	"2019-07-01-count-1:GTGGCGTCACGATAGG"	1.26652576503102	11.226195312384	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGCGTCACGATAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1816.04529430535	33.3877560430416	0.0183848696658266	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1816.04529430535	1816.04529430535
"AML-3133"	"2019-07-01-count-1:TGGATCACATCTCAAG"	-3.60652194443401	13.2892627486023	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGATCACATCTCAAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2279.97920973677	36.3175561636851	0.0159288979516081	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2273.67981227451	2273.67981227451
"AML-3133"	"2019-07-01-count-1:GTAGAAAAGTCACTAC"	1.01110144433324	10.3842811354431	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGAAAAGTCACTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1920.60629148431	38.8182811346268	0.0202114724432287	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1912.92835106498	1912.92835106498
"AML-3133"	"2019-07-01-count-2:CGCATAACAACACAAA"	-7.60379729691203	5.2010493048462	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCATAACAACACAAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1490.15515301237	52.5042568857656	0.035234087389912	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1490.15515301237	1490.15515301237
"AML-3133"	"2019-07-01-count-2:TTCCTAAGTTAGTTCG"	7.88494886931722	6.39674708927003	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTAAGTTAGTTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1662.93441211843	37.2173966221995	0.022380555932322	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1659.52381483202	1659.52381483202
"AML-3133"	"2019-07-01-count-1:AGGATAAGTGGCGCTT"	3.97421230849568	-10.5923671952453	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGATAAGTGGCGCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1784.52267499075	47.3951282615206	0.0265589946968683	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1784.52267499075	1784.52267499075
"AML-3133"	"2019-07-01-count-1:ATGGGAGTCTCAATCT"	1.50461043891255	10.9653568037781	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGGAGTCTCAATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2077.87314487881	33.2264847017597	0.0159906223263199	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2071.28852501883	2071.28852501883
"AML-3133"	"2019-07-01-count-3:TTAGGCATCGTAACAC"	-2.10558090630229	11.0461358794006	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGGCATCGTAACAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1831.96669233629	42.6109319574196	0.0232596652197199	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1828.57925728336	1828.57925728336
"AML-3133"	"2019-07-01-count-1:TACATTCTCGACGCTG"	1.31984605368916	11.1018113859924	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACATTCTCGACGCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1945.42565077171	33.2920567079049	0.017112993598444	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1940.33033949739	1940.33033949739
"AML-3133"	"2019-07-01-count-3:TCCTCCCGTCAAAGTA"	1.17416526851003	10.3954229124817	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCCCGTCAAAGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1769.49922921543	38.277099495914	0.0216315999826038	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1767.86349831394	1767.86349831394
"AML-3133"	"2019-07-01-count-2:GTCACGGAGTTCGCAT"	-6.05198607865031	3.14928362453309	"2019-07-01-count-2"	"AML3133"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACGGAGTTCGCAT"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2528.26994303015	40.4681928910616	0.0160062785236296	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2523.53952146949	2523.53952146949
"AML-3133"	"2019-07-01-count-1:ACTATGGGTGAATATG"	1.55910708483998	-8.62873270427855	"2019-07-01-count-1"	"AML3133"	"Granulocyte"	"Granulocytes"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATGGGTGAATATG"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2431.09217482945	29.4496903581432	0.0121137695489515	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2427.89286783794	2427.89286783794
"AML-3133"	"2019-07-01-count-3:TCACGGGCATGCCGAC"	0.504302223294419	9.88991639697877	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACGGGCATGCCGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1922.4859211024	33.2412314117121	0.0172907541464079	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1915.13155844865	1915.13155844865
"AML-3133"	"2019-07-01-count-2:GAACTGTTCGCCGAAC"	-4.14599070969279	10.7482442625794	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAACTGTTCGCCGAAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2098.4225949253	41.3136985172961	0.0196879783019906	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2095.12233817529	2095.12233817529
"AML-3133"	"2019-07-01-count-1:TCACACCAGTTTGTCG"	-0.695043424994308	9.0074367293152	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACACCAGTTTGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2051.92245523172	36.6221647442409	0.017847733305353	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2046.10825361702	2046.10825361702
"AML-3133"	"2019-07-01-count-2:AACTTCTGTGCACAAG"	3.56520976599995	-10.6583910218445	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACTTCTGTGCACAAG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2170.24404721388	51.3228997308189	0.0236484462642375	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2160.75202235416	2160.75202235416
"AML-3133"	"2019-07-01-count-2:CACCAAACATACAGAA"	8.42812218245808	7.08396241748659	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCAAACATACAGAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1909.17274568426	37.669540176759	0.019730818105335	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1904.50096385644	1904.50096385644
"AML-3133"	"2019-07-01-count-2:TTCCTCTTCGGAGTAG"	0.387325664132279	-9.01753809368285	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTCTTCGGAGTAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1798.68162476316	46.6802638785791	0.0259524883314054	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1796.73204707332	1796.73204707332
"AML-3133"	"2019-07-01-count-3:TCATCCGCATTCTGTT"	8.4081617790157	7.58936498248903	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATCCGCATTCTGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1878.5809556229	33.8964201435977	0.0180436302423594	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1875.35785140258	1875.35785140258
"AML-3133"	"2019-07-01-count-3:TCATCCGAGATGTTCC"	1.07973386821095	10.3827113875183	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATCCGAGATGTTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1780.95897928066	34.7812206812619	0.0195294900589514	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1777.86032424917	1777.86032424917
"AML-3133"	"2019-07-01-count-3:GTTTACTCAACCACAT"	3.83820857581441	-10.3318100205627	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTTACTCAACCACAT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.20994653801	41.3457184655898	0.0182524884851312	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2257.87379843405	2257.87379843405
"AML-3133"	"2019-07-01-count-2:AGGATAACAGACCCGT"	8.49631084975545	7.45189712131349	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGATAACAGACCCGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1719.68737123355	41.9864927197567	0.0244151893082981	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1716.33165686999	1716.33165686999
"AML-3133"	"2019-07-01-count-3:AAGCATCCATTAGGAA"	1.31408478793446	11.4339580305847	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCATCCATTAGGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1751.45110786061	39.4092126261003	0.0225008922311502	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1748.49790403028	1748.49790403028
"AML-3133"	"2019-07-01-count-2:CGGGTGTAGCTAGATA"	10.9479528861934	-0.855135463830553	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGGTGTAGCTAGATA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1758.2043169684	18.4963177335505	0.0105200047315564	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1747.29604163742	1747.29604163742
"AML-3133"	"2019-07-01-count-3:GCGGATCGTATGAAGT"	-0.85278014364894	12.9077615507874	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCGGATCGTATGAAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1844.75107926485	38.1392358337915	0.0206744618623507	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.00968489519	1841.00968489519
"AML-3133"	"2019-07-01-count-2:TCTACATCACCCTTGT"	1.08272172984425	12.5278854140076	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTACATCACCCTTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1888.91258344101	34.8257240973731	0.0184369167756464	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1885.94909842243	1885.94909842243
"AML-3133"	"2019-07-01-count-3:ATATCCTTCCAGCCTT"	1.56559087809865	11.1006355055603	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATATCCTTCCAGCCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1773.56984509425	37.5803321545153	0.0211890906120577	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1768.44392491496	1768.44392491496
"AML-3133"	"2019-07-01-count-2:TGTCCTGAGTACCGGA"	7.85993589934651	-9.88033583080443	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTCCTGAGTACCGGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1589.19652014095	46.0616017063909	0.0289842075052528	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1584.73325448916	1584.73325448916
"AML-3133"	"2019-07-01-count-2:CCGGACAAGCGGCTCT"	-7.68788991394694	1.34039554679719	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGACAAGCGGCTCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2459.94800607782	40.1354359316875	0.0163155626999125	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2455.18546169911	2455.18546169911
"AML-3133"	"2019-07-01-count-3:AGGCATTGTAGTGTGG"	-1.86802194538768	13.8347701796326	"2019-07-01-count-3"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCATTGTAGTGTGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1937.85767185646	41.7848507068154	0.0215623940362894	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1934.11033255587	1934.11033255587
"AML-3133"	"2019-07-01-count-2:GTAGAAAGTAAGTCAA"	0.86355092105214	10.4849233397278	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGAAAGTAAGTCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1892.15747467922	37.745074696831	0.0199481677407585	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.39615274996	1890.39615274996
"AML-3133"	"2019-07-01-count-2:TCCAGAAAGCCTCACG"	0.946884532540482	10.8956880339417	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCAGAAAGCCTCACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2186.42692864892	38.3863849762467	0.0175566740755279	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2186.42692864892	2186.42692864892
"AML-3133"	"2019-07-01-count-1:CCTGTTGCACAAATCC"	1.369770069688	10.912254310492	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTGTTGCACAAATCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2153.15430906607	30.7188411496217	0.0142669018287621	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2147.04039377418	2147.04039377418
"AML-3133"	"2019-07-01-count-3:CTACCCATCACGATAC"	1.18283226069753	11.8120879896912	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCCATCACGATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1716.62725481731	40.6779961654484	0.0236964641283046	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1711.9827568555	1711.9827568555
"AML-3133"	"2019-07-01-count-2:CATGCCTAGCCATGCC"	4.20746292647664	-10.7636327973572	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCCTAGCCATGCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.73100989169	52.1800061936627	0.0225425788010264	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2310.80038290713	2310.80038290713
"AML-3133"	"2019-07-01-count-3:TGGGATTTCCCATAAG"	8.18881477889363	6.89041612232057	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGATTTCCCATAAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1643.42360510512	46.0634618291132	0.0280289644654135	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1632.32944499256	1632.32944499256
"AML-3133"	"2019-07-01-count-2:ATTACTCGTCGCATGC"	1.02424772557561	-10.1196699372497	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTACTCGTCGCATGC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2139.82901541718	45.032691251882	0.0210449951502795	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2135.07900036916	2135.07900036916
"AML-3133"	"2019-07-01-count-3:CGAGTTACATGGGCAA"	-7.40550933304484	0.377498722914137	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGTTACATGGGCAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1923.89179671871	48.545072473345	0.0252327457064586	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1920.59710441049	1920.59710441049
"AML-3133"	"2019-07-01-count-1:TACCTCGAGGACGCTA"	-7.7197769683903	1.927379108313	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCTCGAGGACGCTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2769.46185702896	30.7112788651406	0.0110892586540575	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2766.68399665344	2766.68399665344
"AML-3133"	"2019-07-01-count-1:GCGATCGTCAGCTTCC"	1.22712661799733	11.5117749937805	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGATCGTCAGCTTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1763.04883987772	37.792722310469	0.0214360041852784	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1755.03273596689	1755.03273596689
"AML-3133"	"2019-07-01-count-2:GCGTGCAAGTACCGGA"	1.102924366563	11.2702970274719	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGTGCAAGTACCGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1576.99379964894	40.1019828966275	0.0254293852680681	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1573.04033918346	1573.04033918346
"AML-3133"	"2019-07-01-count-3:TAACCAGTCGAATGCT"	-2.70367227020915	10.2076940306458	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAACCAGTCGAATGCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2082.43856838693	39.3121451178129	0.0188779374885783	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2077.18858239007	2077.18858239007
"AML-3133"	"2019-07-01-count-2:GAAGCGAGTTACAGCT"	8.12552322921101	7.70073602283327	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGCGAGTTACAGCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1839.16423447271	38.7720595940684	0.0210813470963263	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1835.80626811864	1835.80626811864
"AML-3133"	"2019-07-01-count-1:TCACGGGAGAACTGAT"	1.40597130832021	10.8910035856995	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACGGGAGAACTGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1865.30204814953	35.6471382863136	0.0191106519835098	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1861.05112684825	1861.05112684825
"AML-3133"	"2019-07-01-count-1:TACCTGCCATAACCCA"	-0.431604693562347	9.08195684039918	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCTGCCATAACCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2412.92472131437	41.1465977356139	0.0170525824416107	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2409.73126421827	2409.73126421827
"AML-3133"	"2019-07-01-count-3:ATCACTTAGTTCTCTT"	3.91776980933492	-10.6581878892151	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCACTTAGTTCTCTT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1944.38096705825	45.172147337045	0.0232321484844547	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1944.38096705825	1944.38096705825
"AML-3133"	"2019-07-01-count-2:TACAACGAGTAAACAC"	1.80530550059621	-10.3664713135925	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACAACGAGTAAACAC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.57547304707	44.9618453618848	0.0196978570447285	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2278.68218449309	2278.68218449309
"AML-3133"	"2019-07-01-count-3:AATGAAGGTTACCTGA"	-7.55967173996623	0.868843353632368	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGAAGGTTACCTGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2372.10667351035	49.1308439493477	0.0207119032621925	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2370.66628814836	2370.66628814836
"AML-3133"	"2019-07-01-count-2:ATCACTTAGTATGAAC"	8.4914947944576	7.11268994891969	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCACTTAGTATGAAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1749.25647943499	38.7369514646541	0.0221448094776623	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1744.11581716008	1744.11581716008
"AML-3133"	"2019-07-01-count-1:CCCTTAGAGAAACCCG"	1.41725053366963	-9.94007685100707	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTTAGAGAAACCCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1705.42174452028	51.7711900790642	0.0303568253690978	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1700.68896638983	1700.68896638983
"AML-3133"	"2019-07-01-count-1:CTAAGTGAGCAGCGAT"	-7.48414836350139	1.04883418166963	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAAGTGAGCAGCGAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2497.18677941793	43.5067247915163	0.0174222950201816	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2493.03104041089	2493.03104041089
"AML-3133"	"2019-07-01-count-3:TCATGTTCACTAACGT"	-1.38279197636302	11.2039308317932	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGTTCACTAACGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1561.98793506745	41.503977985653	0.0265712538835077	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1558.01087000604	1558.01087000604
"AML-3133"	"2019-07-01-count-3:TTGTTTGGTAGCTTTG"	3.00713386115376	-8.83584406292113	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTTTGGTAGCTTTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1426.39687008734	47.6585010092623	0.0334118098607046	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1426.39687008734	1426.39687008734
"AML-3133"	"2019-07-01-count-1:GGGCCATCAGCTGTGC"	-0.257489303976852	11.7469634779724	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCCATCAGCTGTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2086.6385660471	37.3280893244453	0.0178891016066856	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2081.199967264	2081.199967264
"AML-3133"	"2019-07-01-count-2:CGGAACCGTGATAGAT"	1.35693826255147	11.2544955977234	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAACCGTGATAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1837.63444348928	31.7474912987111	0.0172762822394802	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1835.03465572342	1835.03465572342
"AML-3133"	"2019-07-01-count-3:TGAGGAGGTGCACAAG"	-5.70083365860637	3.88306567752687	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGAGGTGCACAAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2398.82109279153	47.9083501940737	0.0199716228684326	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2390.44946210747	2390.44946210747
"AML-3133"	"2019-07-01-count-1:ATTTCTGAGGATCATA"	1.15409137782399	11.7482175596985	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTCTGAGGATCATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1935.20885994127	32.3814523204356	0.0167327945787817	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1935.20885994127	1935.20885994127
"AML-3133"	"2019-07-01-count-2:TTCGGTCTCCTTATCA"	1.3006280857021	11.658836341742	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGGTCTCCTTATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1914.34968026461	30.7799384285183	0.0160785350481338	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1910.3323763516	1910.3323763516
"AML-3133"	"2019-07-01-count-1:GGGCGTTCACAAGCCC"	11.0059839683468	-1.12474276935729	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCGTTCACAAGCCC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2050.97808133443	15.376024565624	0.00749692290988303	2861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2045.84322936765	2045.84322936765
"AML-3133"	"2019-07-01-count-1:CCACGTTCACTGGCGT"	1.50967313823048	-10.1730270615784	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACGTTCACTGGCGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.35335417034	42.8033312179498	0.017511106217488	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2437.47281109293	2437.47281109293
"AML-3133"	"2019-07-01-count-3:AGGGCCTAGGAACTAT"	-3.15565143051799	12.8935565718445	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGCCTAGGAACTAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2161.63385251442	31.7053528485718	0.0146673095499925	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2158.03152101423	2158.03152101423
"AML-3133"	"2019-07-01-count-1:TGGGCTGTCATTTGCT"	1.36464609679524	10.4692058333191	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGCTGTCATTTGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1726.72058426697	30.1966656868401	0.0174878703375504	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1725.19844158593	1725.19844158593
"AML-3133"	"2019-07-01-count-2:ACCCTTGCACTAGTAC"	-7.88898454132732	4.67581555927125	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCCTTGCACTAGTAC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2038.57603326367	25.7096961222037	0.0126115953992864	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2030.31359275258	2030.31359275258
"AML-3133"	"2019-07-01-count-1:TACGCTCGTTGCCAAT"	0.764269610016984	10.2116479643616	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACGCTCGTTGCCAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1566.6895552141	28.9643360994204	0.018487604007459	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1562.24503183128	1562.24503183128
"AML-3133"	"2019-07-01-count-2:TGCCGAGAGAGGGTCT"	4.05932678756062	-10.6079769364563	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCCGAGAGAGGGTCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1714.83425062222	47.0696645161213	0.0274485213361246	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1712.89435692339	1712.89435692339
"AML-3133"	"2019-07-01-count-1:TGACTCCGTCACTCTC"	2.16603889045064	-9.34964563762816	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACTCCGTCACTCTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1722.96427990822	38.6973378369971	0.022459744690156	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1722.96427990822	1722.96427990822
"AML-3133"	"2019-07-01-count-2:AGAACAACATAAGATG"	-2.33805308762248	13.5705909498963	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAACAACATAAGATG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1909.09718975406	31.9021857321567	0.0167106137410775	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1899.87342768437	1899.87342768437
"AML-3133"	"2019-07-01-count-2:CTCAAGAAGATTGTGA"	1.05753972110097	10.8581495054993	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAAGAAGATTGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1761.44968245673	31.9801718784031	0.0181555977425365	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1751.50731031675	1751.50731031675
"AML-3133"	"2019-07-01-count-1:AGGGTCCTCTCGAACA"	8.82324375685994	7.67874095523683	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTCCTCTCGAACA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2008.51611942613	35.5416619895422	0.0176954825733224	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2003.98657139124	2003.98657139124
"AML-3133"	"2019-07-01-count-3:AAGGAATTCTAAACGC"	1.11367156085317	10.760528541449	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGAATTCTAAACGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1851.9414091559	40.1638295778689	0.0216874191479823	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1845.17533407288	1845.17533407288
"AML-3133"	"2019-07-01-count-3:ATTCATCCATCGTGGC"	8.16924156722371	7.0734653242859	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCATCCATCGTGGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1685.36184137206	36.2734249668761	0.0215226333458136	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1681.97689972676	1681.97689972676
"AML-3133"	"2019-07-01-count-2:ATTCCATCACAGTCGC"	1.05604805526082	11.7244996794495	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCATCACAGTCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1950.00505518912	37.2219834895444	0.0190881471771028	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1950.00505518912	1950.00505518912
"AML-3133"	"2019-07-01-count-1:TGAGACTAGAACCCGA"	1.3553441959316	10.2295217283997	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGACTAGAACCCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1769.00936038087	29.1247066615903	0.0164638510761299	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1765.38490811885	1765.38490811885
"AML-3133"	"2019-07-01-count-1:CAACAACGTTTGGCTA"	8.80936398085896	7.69139525974122	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACGTTTGGCTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1890.40780598488	38.8273542599848	0.0205391419444315	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1887.23932965654	1887.23932965654
"AML-3133"	"2019-07-01-count-1:ACCCTCAAGAAGCCTG"	-8.28302035751994	-3.56080701267394	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCCTCAAGAAGCCTG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2432.81112306724	52.369676382772	0.0215264045310453	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2427.58242662001	2427.58242662001
"AML-3133"	"2019-07-01-count-1:AGGGTGAAGTCCCTAA"	0.976296265690964	10.9258785017761	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTGAAGTCCCTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1754.70248568732	34.6166849969649	0.0197279511936209	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1750.19908169501	1750.19908169501
"AML-3133"	"2019-07-01-count-3:TGAGGTTCACAGCTTA"	-3.57094893875774	10.0497455366882	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGGTTCACAGCTTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2126.08559314007	37.026673114123	0.0174154197900553	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2124.33064034345	2124.33064034345
"AML-3133"	"2019-07-01-count-3:TTCATGTCAAACGGCA"	-7.62210641327556	1.31342873657075	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCATGTCAAACGGCA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2554.83299416979	39.6865467241045	0.0155339103630924	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2551.86575053164	2551.86575053164
"AML-3133"	"2019-07-01-count-2:AGGGCTCCATCTGCGG"	1.12219204482381	12.4223537215027	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGCTCCATCTGCGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1691.5978149334	37.8761859924251	0.0223907749572946	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1685.90893299079	1685.90893299079
"AML-3133"	"2019-07-01-count-3:TTGGATGAGCTATCTG"	-7.90122781220134	4.03930041873781	"2019-07-01-count-3"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGATGAGCTATCTG"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2066.66877303825	35.2273208386627	0.0170454604522205	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2055.95828823401	2055.95828823401
"AML-3133"	"2019-07-01-count-2:TCTCCGAAGGGTAGCT"	1.1553085046703	9.95583245838014	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTCCGAAGGGTAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1804.6723424874	34.854885990812	0.0193136921147532	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1800.46978766952	1800.46978766952
"AML-3133"	"2019-07-01-count-1:GATGAGGAGATGGTAT"	0.661556740372819	10.7624492415222	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGAGGAGATGGTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1926.04614996823	35.889942824807	0.0186339994113843	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1920.23076440337	1920.23076440337
"AML-3133"	"2019-07-01-count-2:GGGTAGACATTGACAC"	1.15713109549825	11.3321704634461	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTAGACATTGACAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1792.64195588079	36.5288878651027	0.0203771242468521	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1792.64195588079	1792.64195588079
"AML-3133"	"2019-07-01-count-1:AGGGTTTGTAGAGGAA"	0.757586439221543	12.503352142218	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTTTGTAGAGGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1933.23405031035	38.1732283464868	0.0197457872937624	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1928.0908564213	1928.0908564213
"AML-3133"	"2019-07-01-count-2:GTGGTTAGTGTCTAAC"	0.161686343222302	11.0654182204041	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGTTAGTGTCTAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1700.39640925813	38.6312725629767	0.0227189803228479	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1700.39640925813	1700.39640925813
"AML-3133"	"2019-07-01-count-1:AGGGTTTGTTCTCTAT"	-2.05025301399882	11.5637168654236	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTTTGTTCTCTAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2076.30993859428	34.1875987003737	0.0164655565457244	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2071.7397040322	2071.7397040322
"AML-3133"	"2019-07-01-count-1:TTCCGTGAGACTTCCA"	1.03765120086018	11.3035030134949	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCGTGAGACTTCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.79349876193	38.8728097418117	0.0178907060261187	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2170.12616989043	2170.12616989043
"AML-3133"	"2019-07-01-count-2:TGCGATACACATTCTT"	8.11142220076863	6.3400668867859	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCGATACACATTCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1713.74643427402	31.4030589076099	0.0183242154612639	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1707.02844542767	1707.02844542767
"AML-3133"	"2019-07-01-count-2:AGAAGTACAACTGCCG"	-0.0254968208378136	11.418526626471	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAAGTACAACTGCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.51374133459	36.8045432673527	0.0191340162934404	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1921.94671254426	1921.94671254426
"AML-3133"	"2019-07-01-count-1:GTTACAGCAGCGAACA"	2.61246766623799	-8.83676531231078	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACAGCAGCGAACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1392.94772401355	46.7814333917122	0.0335844860400929	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1385.80624009015	1385.80624009015
"AML-3133"	"2019-07-01-count-2:TTCTCTCTCGATGCTA"	1.70232631739919	-10.2891445389953	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCTCTCTCGATGCTA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2440.90534866728	44.9276152904814	0.0184061275931947	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2438.38677233546	2438.38677233546
"AML-3133"	"2019-07-01-count-1:TCAGCCTGTGCGAGTA"	2.26755442199056	-10.2876882783142	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGCCTGTGCGAGTA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2267.98545447441	35.1243523809922	0.0154870271816324	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2261.08570443293	2261.08570443293
"AML-3133"	"2019-07-01-count-1:TGGTTAGAGAGCAGTC"	-6.95647225800212	2.7224983938965	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTTAGAGAGCAGTC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2350.50887284959	37.1693186492166	0.0158133071006684	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2347.53224857127	2347.53224857127
"AML-3133"	"2019-07-01-count-2:GATTTCTTCGCCAGTG"	4.40283312377278	-10.6765146485535	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTTCTTCGCCAGTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2331.40243762805	50.2392527480582	0.0215489406450013	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2324.16513387541	2324.16513387541
"AML-3133"	"2019-07-01-count-2:CATTCATTCAAGTGTC"	8.75316776809041	7.5430493124756	"2019-07-01-count-2"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTCATTCAAGTGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1712.9753269261	34.4140179262668	0.0200902005915182	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1709.64994229936	1709.64994229936
"AML-3133"	"2019-07-01-count-3:ATTCGTTGTCAGGAGT"	-0.539014558226425	11.2282686003479	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCGTTGTCAGGAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1541.46135596719	38.0571211598535	0.0246889881556418	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1539.3658962966	1539.3658962966
"AML-3133"	"2019-07-01-count-1:GCTCAAACACCTCTAC"	8.72698177871053	6.85511968219606	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTCAAACACCTCTAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1737.58105366465	38.8190821740043	0.0223408756052749	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1735.52039360492	1735.52039360492
"AML-3133"	"2019-07-01-count-2:GTAGTACCAGCCTTCT"	-7.66781602326091	1.55912218177644	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGTACCAGCCTTCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2359.02776050338	39.6076137240111	0.0167898039977111	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2354.94139143361	2354.94139143361
"AML-3133"	"2019-07-01-count-1:GTTACCCCACTCCTGT"	1.02980967339818	10.4644708403381	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACCCCACTCCTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1955.38833435788	33.3647182051888	0.0170629626959216	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1951.83535532934	1951.83535532934
"AML-3133"	"2019-07-01-count-3:GCCGTGATCCATTCAT"	-0.513679127127487	11.2952165373596	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCGTGATCCATTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1704.59381217284	43.3092218328028	0.0254073560067642	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1704.59381217284	1704.59381217284
"AML-3133"	"2019-07-01-count-3:GATGACTAGAGTCTGG"	3.56451477584187	-10.7994661561218	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGACTAGAGTCTGG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.4830924362	47.5936861544474	0.0222662281273076	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2130.10380982657	2130.10380982657
"AML-3133"	"2019-07-01-count-2:GACTCAATCGGTCTAA"	1.9204498725826	-3.89002087032469	"2019-07-01-count-2"	"AML3133"	"DC precursor"	"DC precursor"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACTCAATCGGTCTAA"	"DC precursor"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2292.72134085991	40.9494961761676	0.0178606512036081	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	2287.009813678	2287.009813678
"AML-3133"	"2019-07-01-count-1:ACCGTTCCATTGGCAT"	1.55188836631123	10.6078910597595	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCGTTCCATTGGCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2042.51974683127	38.6795452209841	0.0189371707573407	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2031.48974730742	2031.48974730742
"AML-3133"	"2019-07-01-count-3:TCCACCACACTTCAGA"	4.18095840987508	-10.8552351227966	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCACCACACTTCAGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.88732361843	39.3137433753864	0.0156760405482108	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2503.01477632924	2503.01477632924
"AML-3133"	"2019-07-01-count-1:GTTACCCTCGGTCATA"	1.57005395469014	-10.1498871079651	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACCCTCGGTCATA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2529.72852274076	40.8339019586707	0.0161416142450062	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2523.31929480742	2523.31929480742
"AML-3133"	"2019-07-01-count-2:ATTCGTTCACGAGGTA"	0.994721849530381	10.5845584639343	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCGTTCACGAGGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1712.28350024945	45.3855385246567	0.0265058552033264	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1708.72172015617	1708.72172015617
"AML-3133"	"2019-07-01-count-2:CACTTCGAGTTCATGC"	1.32351591166798	11.0145578154358	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACTTCGAGTTCATGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1752.55313096736	40.064331839578	0.0228605519180258	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1746.22956271346	1746.22956271346
"AML-3133"	"2019-07-01-count-2:TCTGGCTCATCGTGGC"	3.92402424392049	-10.8363504639831	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTGGCTCATCGTGGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2036.8876843147	48.2377064541029	0.0236820649589877	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2035.23272990081	2035.23272990081
"AML-3133"	"2019-07-01-count-3:GAAGCCCGTAGGATAT"	8.36685432967488	7.02170560443727	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGCCCGTAGGATAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1557.01836506854	45.5140358336543	0.0292315343574324	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1553.26757545794	1553.26757545794
"AML-3133"	"2019-07-01-count-2:CAGAGCCAGCGGGTTA"	-7.73285851898845	1.52553484523622	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGAGCCAGCGGGTTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2252.63713764957	37.6378713623127	0.0167083596080568	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2250.53319672052	2250.53319672052
"AML-3133"	"2019-07-01-count-1:ACTTCCGTCGAGAGAC"	1.38267495211903	11.2841224440369	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGTCGAGAGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2029.09390681656	31.9459263369885	0.0157439368526361	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2018.79824212106	2018.79824212106
"AML-3133"	"2019-07-01-count-3:GTCTAGATCCCGTGAG"	-2.40423617783244	11.9870967634949	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCTAGATCCCGTGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1468.49329818099	37.914797908695	0.0258188429975539	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1466.33019557857	1466.33019557857
"AML-3133"	"2019-07-01-count-2:GTGTGGCCAAAGTGTA"	0.743674655526322	10.6354703673157	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTGGCCAAAGTGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1444.91997551465	47.8472291875985	0.0331141032018443	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1440.83249411808	1440.83249411808
"AML-3133"	"2019-07-01-count-1:GGGTATTTCCTACTGC"	-7.68047128143962	1.35122904861299	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTTCCTACTGC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2797.1322458358	38.3896048879994	0.0137246299116359	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2792.00570510728	2792.00570510728
"AML-3133"	"2019-07-01-count-1:TCAGTCCCATCGCCTT"	2.04886688765828	-10.6401071778503	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCAGTCCCATCGCCTT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2783.11099401981	45.6291434291581	0.0163950138989079	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2777.18330649309	2777.18330649309
"AML-3133"	"2019-07-01-count-1:CGAGTGCAGTTCCAGT"	1.06135799464528	11.6516294249329	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGTGCAGTTCCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2025.533779989	36.2873023721349	0.0179149332045857	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2019.40220404785	2019.40220404785
"AML-3133"	"2019-07-01-count-2:AGGTAGGTCTACCTTA"	1.3449487882549	10.6493768461975	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTAGGTCTACCTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1774.38350612238	44.8544096126909	0.0252788697921976	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1770.53102703037	1770.53102703037
"AML-3133"	"2019-07-01-count-1:GATGTTGAGCGGTAGT"	1.02410658177678	10.188525176886	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGTTGAGCGGTAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1828.56300576009	35.4195899040194	0.0193701774521553	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1817.31972784162	1817.31972784162
"AML-3133"	"2019-07-01-count-1:CCCGAAGCACGTCTCT"	4.08074726638143	-10.6624269715515	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCGAAGCACGTCTCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2309.0901692004	43.0634620608435	0.0186495367895294	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2301.48931222034	2301.48931222034
"AML-3133"	"2019-07-01-count-3:GTAGATCTCCTGGGAC"	0.739996333687943	10.6951808699402	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGATCTCCTGGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1812.17424547896	34.6262389154751	0.0191075659539148	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1809.06166695464	1809.06166695464
"AML-3133"	"2019-07-01-count-3:TGATGCACAAATGCGG"	0.461367656558198	-9.89353563701781	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGATGCACAAATGCGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2491.73306943849	39.5241981305518	0.0158621317087783	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2481.79680528471	2481.79680528471
"AML-3133"	"2019-07-01-count-3:TGTAACGTCTATTCGT"	4.36009468612019	-10.6287584534851	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGTCTATTCGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2114.81117122811	39.4811973696096	0.0186688995720985	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2113.09448889145	2113.09448889145
"AML-3133"	"2019-07-01-count-3:TCGTGGGCAATTTCTC"	0.997677822678727	9.65016172015993	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTGGGCAATTTCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1502.0416654334	44.3136524154825	0.0295022790880412	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1499.98868381611	1499.98868381611
"AML-3133"	"2019-07-01-count-2:AGACAGGCATCGCTAA"	2.7239269214565	-10.2343712083069	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACAGGCATCGCTAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1979.79427337139	49.9267023712247	0.0252181264703854	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1976.26785482765	1976.26785482765
"AML-3133"	"2019-07-01-count-2:CGGGCATCAGGCGAAT"	-3.33230386200603	10.7628249892029	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGGCATCAGGCGAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1675.97711323876	35.9462294027929	0.021447923792544	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1675.97711323876	1675.97711323876
"AML-3133"	"2019-07-01-count-2:GTGTTAGCAATGAACA"	-1.95452056351359	13.573363281134	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTTAGCAATGAACA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1834.80048788564	29.6004140704133	0.0161327698928856	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1834.80048788564	1834.80048788564
"AML-3133"	"2019-07-01-count-3:AAAGGATAGATTCGAA"	3.75257100638692	-10.64897348797	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGGATAGATTCGAA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2053.65596237044	43.688704077084	0.0212736236631652	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2053.65596237044	2053.65596237044
"AML-3133"	"2019-07-01-count-2:TCACACCGTACCATAC"	0.536888291209382	-10.2710857621399	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCACACCGTACCATAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.94479280632	45.6936241944073	0.017581606319951	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2592.92497387661	2592.92497387661
"AML-3133"	"2019-07-01-count-1:CTATAGGTCCTAAACG"	1.5831194120342	-10.3868799439636	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTATAGGTCCTAAACG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2475.2808040276	42.5112767278052	0.0171743248922037	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2467.31114626892	2467.31114626892
"AML-3133"	"2019-07-01-count-3:AACCATGGTAAGCAAT"	-2.29423771324809	11.9371728667053	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCATGGTAAGCAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1932.01069515876	37.6779769840125	0.019501950521509	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1926.62622391296	1926.62622391296
"AML-3133"	"2019-07-01-count-1:TCTTTGATCGACATAC"	0.603203554719132	13.6414842375549	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTTGATCGACATAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1939.10631502812	43.0288241840809	0.0221900283912267	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.39284831955	1937.39284831955
"AML-3133"	"2019-07-01-count-2:ATTCTTGGTAAGCGGT"	-5.87057385864909	3.6090528734955	"2019-07-01-count-2"	"AML3133"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTTGGTAAGCGGT"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2652.57788753149	41.1359798295354	0.0155079253366682	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2638.52088756795	2638.52088756795
"AML-3133"	"2019-07-01-count-1:GCCTGTTCAGTAGAGC"	1.20453860339467	10.8476791151795	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCTGTTCAGTAGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1839.8613174209	38.1365370017059	0.0207279410902368	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.43746252207	1834.43746252207
"AML-3133"	"2019-07-01-count-2:GTGTTCCCAATGCAGG"	0.138080884783906	13.0744514235291	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTTCCCAATGCAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1859.68708320268	39.5997685265643	0.0212937804882567	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1856.47354825615	1856.47354825615
"AML-3133"	"2019-07-01-count-1:GATTCGAAGTTCTCTT"	-3.45531354370769	13.2551517256531	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTCGAAGTTCTCTT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2248.23970505709	39.2449250499824	0.0174558455496122	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2241.65062081612	2241.65062081612
"AML-3133"	"2019-07-01-count-2:GGGTGAAGTTACCGTA"	-8.54637656632121	-3.05198886310729	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTGAAGTTACCGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2014.3766420802	50.6547445517026	0.0251466103674597	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2011.10544799782	2011.10544799782
"AML-3133"	"2019-07-01-count-1:TACTTGTAGAGTCTTC"	-0.478567759425002	-9.85014822399291	"2019-07-01-count-1"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTTGTAGAGTCTTC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2559.55387878382	41.1091948290604	0.0160610781315506	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2555.15738640954	2555.15738640954
"AML-3133"	"2019-07-01-count-2:CTCATTAAGCTTGTGT"	-3.50853524628337	13.1796731718811	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCATTAAGCTTGTGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1772.15428579473	36.5408644438479	0.020619460019228	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1772.15428579473	1772.15428579473
"AML-3133"	"2019-07-01-count-3:TTCCTCTCACGCTTAA"	1.0486669736797	12.2701892622742	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCTCTCACGCTTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1789.42457979749	43.1272273090451	0.0241011707316136	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1785.95401720984	1785.95401720984
"AML-3133"	"2019-07-01-count-2:GAGACTTGTAAGCAAT"	0.550036092370194	11.4863662489685	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGACTTGTAAGCAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2534.28568834466	31.9125907746451	0.0125923414717658	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2509.13638514594	2509.13638514594
"AML-3133"	"2019-07-01-count-2:TCCTCTTGTGCTGATT"	10.2482134300167	6.90517566287843	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00191387559808612	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTCTTGTGCTGATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2095.61389089074	40.0036810285711	0.0190892421559429	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2088.57128578348	2088.57128578348
"AML-3133"	"2019-07-01-count-2:GCACGTGGTATACCCA"	1.25368108329121	10.2992610701355	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACGTGGTATACCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1660.08735333143	46.301843850327	0.0278912093134192	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1654.37438328558	1654.37438328558
"AML-3133"	"2019-07-01-count-3:GCACGTGTCAGTCATG"	2.87301363524739	-10.0280742875305	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCACGTGTCAGTCATG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2052.68091958664	43.6715305720156	0.0212753624566306	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2046.00254630576	2046.00254630576
"AML-3133"	"2019-07-01-count-2:TGAGCGCTCACGACTA"	-1.63258789005931	13.4809579619202	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGCGCTCACGACTA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2035.31893164012	35.5503776368383	0.0174667355981359	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2031.78735052111	2031.78735052111
"AML-3133"	"2019-07-01-count-2:TGCTGAAGTCAGACGA"	10.8056456046993	-3.01907589351805	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTGAAGTCAGACGA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2850.71391219355	50.9569831584532	0.0178751655648402	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2844.27133769452	2844.27133769452
"AML-3133"	"2019-07-01-count-1:TAGACCAAGGATCACG"	1.26549448546712	11.0881280669006	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGACCAAGGATCACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1862.36470617473	49.66549939035	0.0266679771291211	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1859.44037368502	1859.44037368502
"AML-3133"	"2019-07-01-count-1:GCTTTCGGTAGTGGCA"	1.0581679540569	11.3833188780579	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTTTCGGTAGTGGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2097.24267069521	38.5479342699753	0.0183802927570595	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2087.93810114726	2087.93810114726
"AML-3133"	"2019-07-01-count-2:CCTCACATCTGCAGCG"	-7.33309827271159	4.16286561572877	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCACATCTGCAGCG"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2263.11526966808	38.1495746290956	0.0168571062819486	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2253.5832137786	2253.5832137786
"AML-3133"	"2019-07-01-count-2:ATCGCCTAGTGGATAT"	0.9408783513004	12.999298072699	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGCCTAGTGGATAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1855.06998884956	34.7371087315762	0.0187254976579718	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1853.46047267013	1853.46047267013
"AML-3133"	"2019-07-01-count-2:CCTCACATCTATTTCG"	1.31201316890065	11.4482736357483	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCACATCTATTTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1717.08800504521	38.7861579998691	0.0225883343695292	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1707.99623910394	1707.99623910394
"AML-3133"	"2019-07-01-count-1:AGAGAGCCACAGTCAT"	1.44273473796193	11.3704843291077	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAGAGCCACAGTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1906.70145672974	33.7244578206109	0.0176873299706043	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1901.26171526686	1901.26171526686
"AML-3133"	"2019-07-01-count-1:TCATATCGTGAGCAGT"	1.24390437182729	10.8109397658142	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATATCGTGAGCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1841.36039526123	40.3609555961221	0.0219190961747584	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.68814238179	1834.68814238179
"AML-3133"	"2019-07-01-count-2:GGAATCTTCGTTCCCA"	1.51128258284871	10.6725587614807	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAATCTTCGTTCCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1844.77423889937	33.5596691897994	0.0181917486064971	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1839.87187161339	1839.87187161339
"AML-3133"	"2019-07-01-count-2:ACGGTCGAGTAAAGCT"	-3.78478393974956	10.1547384032044	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGTCGAGTAAAGCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2056.12155932072	34.3458702639255	0.0167042021947731	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2051.14358250506	2051.14358250506
"AML-3133"	"2019-07-01-count-3:TCCATGCCAAATACAG"	7.99691309508626	7.32347343051759	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCATGCCAAATACAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1783.9407776943	44.6958679887322	0.0250545693823426	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1779.35938755136	1779.35938755136
"AML-3133"	"2019-07-01-count-1:TCATCATAGGTAAGGA"	-5.38340316239055	3.53716299617616	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCATAGGTAAGGA"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2427.15530711477	39.8967199493767	0.0164376460922903	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2423.60849236486	2423.60849236486
"AML-3133"	"2019-07-01-count-1:CTCAACCGTTCCACAA"	0.936141033738297	8.95245931232301	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAACCGTTCCACAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2098.9946075721	39.2043193698031	0.0186776655968405	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2087.71644985115	2087.71644985115
"AML-3133"	"2019-07-01-count-1:CGCAGGTGTGATTAGA"	1.36656465110127	10.0422944792542	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCAGGTGTGATTAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1915.82327956024	31.4589399127645	0.016420585472782	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1913.20289980613	1913.20289980613
"AML-3133"	"2019-07-01-count-1:GGTAACTAGATTAGTG"	2.71755542334859	-10.0063886872497	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTAACTAGATTAGTG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1840.70247895725	49.4470067055532	0.0268631173537424	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1835.09385507846	1835.09385507846
"AML-3133"	"2019-07-01-count-2:ATCGGATCATCTCCCA"	1.20272221144978	11.4307288893494	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCGGATCATCTCCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1993.42561713214	41.0363465369561	0.0205858428748364	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1986.28616390487	1986.28616390487
"AML-3133"	"2019-07-01-count-2:TGCTTCGTCATCGCCT"	1.0128913122112	10.7546758421692	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTCGTCATCGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1819.79126741499	36.3566083497894	0.019978449727058	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1813.84466941547	1813.84466941547
"AML-3133"	"2019-07-01-count-3:CACATGAAGGTCCAGA"	-1.85563347759898	13.579825378302	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACATGAAGGTCCAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1890.81097677692	35.4656858576178	0.0187568648020399	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1883.26133949042	1883.26133949042
"AML-3133"	"2019-07-01-count-1:CAGCCAGTCCTTATAC"	8.53972496566121	7.39676044071046	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGTCCTTATAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1936.67716634007	35.5981697773148	0.0183810551371286	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1929.2527492954	1929.2527492954
"AML-3133"	"2019-07-01-count-1:TTCTAGTCAAGACCTT"	1.3198729949886	10.5173883208069	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTAGTCAAGACCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1954.8190152591	41.1313884285618	0.0210410212441636	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1950.77142239314	1950.77142239314
"AML-3133"	"2019-07-01-count-1:CCCTGATTCTACTGCC"	0.646592696278733	-9.75171949779662	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTGATTCTACTGCC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2591.2444308429	44.3856984924941	0.0171291052145382	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2589.54719116137	2589.54719116137
"AML-3133"	"2019-07-01-count-1:TTCTAGTCAACCGTGC"	0.610244949429673	-9.81981089031371	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTAGTCAACCGTGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2621.46008370365	40.4533878029981	0.0154316245570464	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2619.60928143527	2619.60928143527
"AML-3133"	"2019-07-01-count-3:AAATGGACAACACAGG"	0.49072571572606	8.97258756244508	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAATGGACAACACAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1953.17069270963	37.3331898878107	0.0191141460534708	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1950.4747951289	1950.4747951289
"AML-3133"	"2019-07-01-count-1:TAGAGTCTCGTAGGAG"	-1.89693818512614	13.4082498320374	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGAGTCTCGTAGGAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1951.00944278963	41.3682041810875	0.0212034874223558	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1947.84606475843	1947.84606475843
"AML-3133"	"2019-07-01-count-1:TCATCCGGTGTAACGG"	-0.18403727832492	10.4018811949524	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATCCGGTGTAACGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1447.76750842235	46.1034831003756	0.0318445350045293	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1445.41980405187	1445.41980405187
"AML-3133"	"2019-07-01-count-2:ACCCTCACACCGTGGT"	3.95939697799031	-10.8760748139587	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCCTCACACCGTGGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2188.98201607719	41.9272713133762	0.01915377604998	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2184.76844322088	2184.76844322088
"AML-3133"	"2019-07-01-count-2:GGAGAACAGTAGACCG"	4.23212542113606	-10.5406046143738	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGAACAGTAGACCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1898.27611587887	50.2781692657927	0.0264862254996633	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1888.75600953878	1888.75600953878
"AML-3133"	"2019-07-01-count-1:TAACTTCTCTGAGAAA"	-7.79576764527019	1.69023380363313	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACTTCTCTGAGAAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2490.39414042383	36.284498234465	0.0145697814034729	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2483.3286775992	2483.3286775992
"AML-3133"	"2019-07-01-count-1:TAAGCACGTAACAAGT"	-7.63772235336955	1.45038745487062	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAAGCACGTAACAAGT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2630.41908717405	42.8468888924001	0.0162889971036638	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2622.01723747335	2622.01723747335
"AML-3133"	"2019-07-01-count-1:AGTAGCTTCGCCGTGA"	1.66514613208119	-10.4484863511291	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAGCTTCGCCGTGA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2308.62238354865	45.2292979429093	0.0195914664369606	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2298.56060892049	2298.56060892049
"AML-3133"	"2019-07-01-count-3:GACTCAATCAAATGCC"	7.83839191970174	6.96623895252077	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCAATCAAATGCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1616.01791530788	46.3245117913	0.0286658404913007	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1616.01791530788	1616.01791530788
"AML-3133"	"2019-07-01-count-2:TGAACGTTCACAGAGG"	1.49586548384969	10.8188180693421	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAACGTTCACAGAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1927.00689595581	33.6241213170483	0.0174488847899895	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1923.72514450226	1923.72514450226
"AML-3133"	"2019-07-01-count-1:CTCACTGAGAATCGAT"	4.36478437957112	-10.7539501420227	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCACTGAGAATCGAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2155.23109208233	43.4679769998874	0.02016859220321	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2153.20770999984	2153.20770999984
"AML-3133"	"2019-07-01-count-3:CATTGTTTCGTTAGAC"	-6.9524167579716	2.30485746944276	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGTTTCGTTAGAC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2584.56272398403	38.8673613554286	0.0150382735906349	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2576.31414452645	2576.31414452645
"AML-3133"	"2019-07-01-count-1:GCAACATGTCGTTGGC"	-7.60130391541179	1.6302668818268	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACATGTCGTTGGC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2650.26195005849	32.3030955870975	0.0121886425552707	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2642.27664453905	2642.27664453905
"AML-3133"	"2019-07-01-count-1:CATCCCAGTATACCTG"	-6.65918956223186	-2.90495850956114	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	57	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.032258064516129	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCCAGTATACCTG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3228.64734277294	31.1526936176677	0.00964883751934088	3754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3215.14480430873	3215.14480430873
"AML-3133"	"2019-07-01-count-3:ATCGTAGAGTCATACC"	-1.26761208000835	10.8572101362976	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCGTAGAGTCATACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1735.55097664586	31.883054378619	0.0183705663548047	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1735.55097664586	1735.55097664586
"AML-3133"	"2019-07-01-count-2:CAGCAGCTCTCTGACC"	1.17721607264821	10.43647573078	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAGCTCTCTGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1983.61265256994	30.8874341885204	0.0155713032725936	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1977.24532645244	1977.24532645244
"AML-3133"	"2019-07-01-count-1:GGAATCTCATTCTCTA"	8.38923611220662	7.56806323612062	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAATCTCATTCTCTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1938.34608900833	39.5865625920667	0.0204228557616971	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1933.65527730464	1933.65527730464
"AML-3133"	"2019-07-01-count-2:TCCTTTCTCATTACGG"	9.11571564254109	7.68205974185792	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTTCTCATTACGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1852.88506886968	38.7717936760368	0.0209250936970898	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1849.73610257636	1849.73610257636
"AML-3133"	"2019-07-01-count-2:TACGTCCTCCTTATAC"	-7.44049249115642	0.603121138456739	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACGTCCTCCTTATAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2434.67075114741	44.5179418891507	0.0182849947444312	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2430.06356241958	2430.06356241958
"AML-3133"	"2019-07-01-count-1:ATGCATGCACCGTACG"	4.06335510787312	-10.7196903458801	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCATGCACCGTACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2154.52542654427	51.3371951740002	0.0238276116594001	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2149.47307527335	2149.47307527335
"AML-3133"	"2019-07-01-count-3:TCTCACGGTCAGACGA"	-1.01192710819896	10.9553470381531	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCACGGTCAGACGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1890.590216332	39.3508173019729	0.0208140383685676	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.590216332	1890.590216332
"AML-3133"	"2019-07-01-count-2:TGGAGAGAGAAGATCT"	0.293605764477891	11.6407785185608	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGAGAGAGAAGATCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2080.31200276471	36.8177314846716	0.0176981776943753	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2075.74434579847	2075.74434579847
"AML-3133"	"2019-07-01-count-2:CTGCATCAGTAAACAC"	11.4460169273311	-2.64605905925902	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCATCAGTAAACAC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1783.57843800334	18.373444904713	0.0103014504510839	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1779.59452387069	1779.59452387069
"AML-3133"	"2019-07-01-count-2:TAGTGCAAGGTCTTTG"	-1.22065172615703	11.20063588703	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGTGCAAGGTCTTTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1751.51330262535	42.9462948579961	0.0245195367877729	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1747.39507661401	1747.39507661401
"AML-3133"	"2019-07-01-count-3:CAGATTGCAACTCATG"	1.2913769679958	10.9119224318298	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGATTGCAACTCATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1908.10401605824	40.6435039181851	0.0213004655805643	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1904.88466309075	1904.88466309075
"AML-3133"	"2019-07-01-count-2:TCGAACAAGCTCGACC"	4.13583960112874	-10.6918573609558	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGAACAAGCTCGACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1813.24829040768	44.0487601817272	0.0242927349854683	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1813.24829040768	1813.24829040768
"AML-3133"	"2019-07-01-count-2:CTCCCTCTCGTTCCTG"	1.0044952231342	11.5221118696961	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCCTCTCGTTCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1935.74907006455	38.4923484865706	0.0198849887528485	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1930.19358455105	1930.19358455105
"AML-3133"	"2019-07-01-count-2:TGGAGGACAAAGAGTT"	0.997198899357957	9.96830556476442	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGAGGACAAAGAGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1519.52886419893	36.6620748311381	0.0241272645060716	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1515.78670652655	1515.78670652655
"AML-3133"	"2019-07-01-count-1:GTTGCTCCAGGTGTTT"	-7.68919501724895	1.36608193004457	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCTCCAGGTGTTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2908.12819110287	42.3250820721859	0.0145540634012198	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2899.59370709769	2899.59370709769
"AML-3133"	"2019-07-01-count-1:GCAACCGTCACCCTGT"	1.51309587535207	11.2626876601013	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACCGTCACCCTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1863.46361202744	34.2139722619396	0.0183604187605869	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1855.55552209409	1855.55552209409
"AML-3133"	"2019-07-01-count-3:TCCGAAACACGGCACT"	1.48926355418507	11.290313697699	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCGAAACACGGCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.71717725651	41.3151301211102	0.0214767173727852	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1923.71717725651	1923.71717725651
"AML-3133"	"2019-07-01-count-2:CCTCTCCTCGCAACAT"	1.37602259692494	10.6756896742615	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCTCCTCGCAACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2051.02487733552	41.2350679753564	0.0201046161999384	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2041.65238098488	2041.65238098488
"AML-3133"	"2019-07-01-count-3:CGCAGGTGTGCTGCAC"	1.4492538171703	-9.98120405590209	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCAGGTGTGCTGCAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.01887076977	41.3848587872073	0.0175655888416912	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2352.88567727966	2352.88567727966
"AML-3133"	"2019-07-01-count-2:TCAGGGCCATAACAGA"	8.2183014350826	6.97877833927003	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGGGCCATAACAGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1708.54025307626	37.4475954433484	0.021917888897217	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1703.27352837441	1703.27352837441
"AML-3133"	"2019-07-01-count-2:TGGATCATCAGGCGAA"	-7.40557084503825	0.128455496672071	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGATCATCAGGCGAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2029.09893893744	46.5064162677103	0.0229197381040787	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2023.85480903895	2023.85480903895
"AML-3133"	"2019-07-01-count-1:GCACGGTCAACCCTCT"	1.27030434188191	11.1785068281922	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCACGGTCAACCCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2077.13324213348	39.978094129585	0.0192467643955871	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2071.43721505817	2071.43721505817
"AML-3133"	"2019-07-01-count-3:ACGTACATCCGCAGTG"	1.35829152640645	11.3572854765686	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTACATCCGCAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2015.87044553498	36.0114269354952	0.0178639589737813	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2011.86437745997	2011.86437745997
"AML-3133"	"2019-07-01-count-3:TGCCGAGTCAAGTTGC"	8.59707703170125	7.22388265216676	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCCGAGTCAAGTTGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1678.72532283453	39.0998792970722	0.0232914097173753	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1671.64981798178	1671.64981798178
"AML-3133"	"2019-07-01-count-2:GGTCACGGTTGTGTAC"	-0.756127814680892	10.8490638502869	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTCACGGTTGTGTAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1655.87085582547	38.9450698492746	0.0235193884307239	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1654.2528617583	1654.2528617583
"AML-3133"	"2019-07-01-count-1:TTGAACGAGAAGTCAT"	-7.53737292710002	-1.45587041294249	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAACGAGAAGTCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2705.85965946345	34.1017288207125	0.0126029185221951	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2697.34672349641	2697.34672349641
"AML-3133"	"2019-07-01-count-3:CCTCATGTCCTCTAGC"	-3.17563782158549	13.3589410551819	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCATGTCCTCTAGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1969.49817825324	36.9342522239645	0.0187531284018357	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1967.66680460315	1967.66680460315
"AML-3133"	"2019-07-01-count-2:AGTCAACAGGAATTAC"	1.41208829459493	11.0675954588684	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCAACAGGAATTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1802.02567370423	37.5083357040178	0.0208145401318928	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1800.58146612751	1800.58146612751
"AML-3133"	"2019-07-01-count-2:TGACCCTGTCTGATCA"	1.03767844018285	-9.78587343609007	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGACCCTGTCTGATCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2336.78476301703	41.0445060962046	0.0175645214509239	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2334.44961772039	2334.44961772039
"AML-3133"	"2019-07-01-count-2:GTTCGCTCAGGAATCG"	1.28732444819753	10.4304914244446	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCGCTCAGGAATCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1765.72817910133	34.0599959407854	0.0192894899361692	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1761.6859615712	1761.6859615712
"AML-3133"	"2019-07-01-count-2:AGTAGTCTCTTCCACG"	-7.67509446564372	1.48573312843172	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTAGTCTCTTCCACG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2472.91115711224	37.5707919232877	0.0151929404399474	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2466.14627165786	2466.14627165786
"AML-3133"	"2019-07-01-count-1:CTCAGTCGTTCCGTTC"	-1.10500703278239	11.7808294066223	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCAGTCGTTCCGTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.39506872525	34.1866696627064	0.0148225558258765	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2302.1791542172	2302.1791542172
"AML-3133"	"2019-07-01-count-3:ACGTCCTAGATACAGT"	1.17583896693532	10.9955348738464	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTCCTAGATACAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1835.22051435284	36.483974671504	0.0198798860334064	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1835.22051435284	1835.22051435284
"AML-3133"	"2019-07-01-count-3:TCACACCAGCGCCGTT"	-0.0834445905988992	10.7956228026184	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACACCAGCGCCGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1656.14459333614	40.7013396671419	0.0245759578184856	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1654.38656904836	1654.38656904836
"AML-3133"	"2019-07-01-count-3:GGGTCTGCATTGACCA"	-5.66470370712932	-5.50608160411986	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00601503759398496	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTCTGCATTGACCA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2719.77323367984	49.2294185555924	0.0181005599827105	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2716.407705066	2716.407705066
"AML-3133"	"2019-07-01-count-1:AGATGCTCACATTCGA"	-0.33189837160762	12.3413591154846	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATGCTCACATTCGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2053.60590093823	36.7322283680473	0.0178866979059933	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2043.64556308905	2043.64556308905
"AML-3133"	"2019-07-01-count-1:TTGACCCTCTCAGGCG"	1.1226542192394	11.1670245894226	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGACCCTCTCAGGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1875.27507129457	43.4668990729355	0.0231789457121769	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1873.88119731744	1873.88119731744
"AML-3133"	"2019-07-01-count-2:TACTTGTCATAACAGA"	10.9539905982906	-1.20017149364623	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACTTGTCATAACAGA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2072.35557770328	35.7679027833913	0.0172595394189214	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2064.93548385917	2064.93548385917
"AML-3133"	"2019-07-01-count-2:AGTCAACTCCCTTCCC"	1.47336973723714	11.0024194487366	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCAACTCCCTTCCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1895.52940757884	39.7568858082711	0.0209740274402035	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.07763083258	1890.07763083258
"AML-3133"	"2019-07-01-count-1:TCATTACTCAGTGTGT"	8.5846926170284	7.22580812061159	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTACTCAGTGTGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1995.42112958215	31.1175913949255	0.0155944982909154	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1993.98528658656	1993.98528658656
"AML-3133"	"2019-07-01-count-2:CGTGCTTAGGTCGAGT"	-2.80813918533977	12.3020915755066	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTGCTTAGGTCGAGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1952.2991005071	34.0089085465288	0.017419927375726	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1952.2991005071	1952.2991005071
"AML-3133"	"2019-07-01-count-3:TGTGTGAGTGATCATC"	1.21454526957814	10.5895986326965	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGTGAGTGATCATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1854.7946453593	34.5354555378298	0.0186195574934603	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1847.54507558347	1847.54507558347
"AML-3133"	"2019-07-01-count-1:AGTGATCTCTGAGAAA"	3.789478679269	-10.589327835199	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTGATCTCTGAGAAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2259.22625619079	43.0450690220271	0.0190530137935826	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2255.5654611618	2255.5654611618
"AML-3133"	"2019-07-01-count-1:TGTTCCGAGTGCCTCG"	1.38016905364339	11.4938211210999	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTCCGAGTGCCTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1936.2456966861	34.5971428915462	0.017868157409341	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1930.57891742308	1930.57891742308
"AML-3133"	"2019-07-01-count-2:ATCTCTACAGTCTCTC"	-2.11613903465922	13.6590652235779	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCTCTACAGTCTCTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2323.42712315936	36.3174174719712	0.0156309690585807	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2320.28865604983	2320.28865604983
"AML-3133"	"2019-07-01-count-1:TGCATCCGTGATTGGG"	-7.45464501801189	0.865926719549574	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCATCCGTGATTGGG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2311.96205248768	44.4078054976751	0.0192078435932338	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2304.67037386282	2304.67037386282
"AML-3133"	"2019-07-01-count-1:TCTAACTTCATTACTC"	-0.419666747481185	13.3559198149475	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTAACTTCATTACTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1801.92407384078	41.2129022673439	0.0228716086685601	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1796.1346026614	1796.1346026614
"AML-3133"	"2019-07-01-count-2:CAGGTATTCCGATGCG"	0.817285855382127	10.6077050932678	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGTATTCCGATGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1636.7822979404	48.5192215554722	0.0296430512576567	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1635.19530285998	1635.19530285998
"AML-3133"	"2019-07-01-count-3:GCTTCACAGCGTGCCT"	1.50027443942372	11.3022470244202	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTTCACAGCGTGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1843.79792935155	53.2869304300998	0.0289006347072102	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1842.44457342992	1842.44457342992
"AML-3133"	"2019-07-01-count-2:CCACGTTTCGTCTCAC"	2.17237534102742	-10.223545097467	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACGTTTCGTCTCAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2284.31563521837	45.2189053481091	0.01979538407519	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2281.92085699582	2281.92085699582
"AML-3133"	"2019-07-01-count-1:GTTGTGAGTTGTTGAC"	1.4379184442455	-10.3820667496887	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGAGTTGTTGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2484.09045486282	43.9589689204196	0.0176962029842215	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2475.57344176659	2475.57344176659
"AML-3133"	"2019-07-01-count-1:AATGGAAGTTGACTGT"	3.82372011718099	-10.727378868219	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGAAGTTGACTGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2330.31093580004	46.4619771427279	0.0199381020055921	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2328.48428192693	2328.48428192693
"AML-3133"	"2019-07-01-count-1:TGCATGAAGCGCCTAC"	-8.04838309708293	0.243874422553457	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCATGAAGCGCCTAC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2903.39392764621	40.4898236203659	0.0139456872299761	3225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2896.18494909886	2896.18494909886
"AML-3133"	"2019-07-01-count-2:TCAGTGATCTCGTGGG"	3.8846193748409	-10.8407774201599	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAGTGATCTCGTGGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.98305405796	39.6110393893917	0.0172148331642576	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2297.269429045	2297.269429045
"AML-3133"	"2019-07-01-count-3:TTCTTCCTCTCTAGGA"	-1.97676001015361	8.50131700122682	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTTCCTCTCTAGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2601.21190826988	40.7309615449626	0.0156584557434437	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2595.18952279493	2595.18952279493
"AML-3133"	"2019-07-01-count-3:TCACATTGTTGTTGTG"	0.745887597172898	8.67541596973268	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACATTGTTGTTGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1733.84977720424	40.3411884685813	0.0232668302634787	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1730.79979987771	1730.79979987771
"AML-3133"	"2019-07-01-count-2:CGTGTCTAGTGGAATT"	-0.0455512580579102	-9.60743429577025	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTGTCTAGTGGAATT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1976.1673467339	43.689695103718	0.0221082972431084	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1971.15286244383	1971.15286244383
"AML-3133"	"2019-07-01-count-1:ACTATCTAGTAGCTCT"	0.927849014371079	10.3104152449402	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATCTAGTAGCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1991.33473701922	38.9060399956482	0.0195376695200354	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1988.89528682569	1988.89528682569
"AML-3133"	"2019-07-01-count-3:TGCGGCACAGGCCTGT"	-9.13300261917766	2.64850542629091	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCACAGGCCTGT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2852.96510236992	39.9643246739971	0.0140079963266285	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2844.26954457671	2844.26954457671
"AML-3133"	"2019-07-01-count-1:TCCTAATAGAGCCGTA"	3.72885217246358	-10.7592811814514	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTAATAGAGCCGTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2200.8803976326	45.6396396021614	0.0207369921833346	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2196.84633463284	2196.84633463284
"AML-3133"	"2019-07-01-count-2:TCGCACTCACACCAGC"	1.28634681281392	9.65832231128541	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCACTCACACCAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1803.88641669117	45.1226843276517	0.0250141493999491	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1802.50819832088	1802.50819832088
"AML-3133"	"2019-07-01-count-2:ACTACGATCGACATCA"	1.10210003432576	10.191475845221	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTACGATCGACATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1811.52153930027	36.2344806864162	0.0200022356346987	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.62747391826	1804.62747391826
"AML-3133"	"2019-07-01-count-1:ATGGGAGTCCAGTGTA"	0.648837466805619	9.35059354389039	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGGGAGTCCAGTGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2120.09750386245	42.5518441112299	0.0200707014812799	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2114.26990646595	2114.26990646595
"AML-3133"	"2019-07-01-count-2:CGAAGGAAGGTTCTAC"	1.50236119803731	-10.2369356385437	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAAGGAAGGTTCTAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.66240171257	41.6997672513973	0.0157556049552882	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2640.70382990774	2640.70382990774
"AML-3133"	"2019-07-01-count-1:AATTCCTAGGCAGTCA"	1.21157433566396	9.92424581134645	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATTCCTAGGCAGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1896.94404948619	30.2816834261715	0.015963403577651	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.2668953515	1890.2668953515
"AML-3133"	"2019-07-01-count-1:GTCTGTCTCACTCCGT"	1.25305094298665	11.1298312910828	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTGTCTCACTCCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1951.41942188004	37.2879844176563	0.0191081343147299	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1947.31379814059	1947.31379814059
"AML-3133"	"2019-07-01-count-1:AGCGATTCAATGCAAA"	3.42898740348164	-9.55737402355345	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCGATTCAATGCAAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1948.66584944342	50.6514349607105	0.0259928786534528	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1934.56526494568	1934.56526494568
"AML-3133"	"2019-07-01-count-3:TGTACAGAGCACTCCG"	-9.90541873398479	5.27517268741456	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTACAGAGCACTCCG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2739.68003921992	39.6465645084605	0.0144712389552429	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2725.20213745169	2725.20213745169
"AML-3133"	"2019-07-01-count-1:TATCAGGGTGCATTTG"	1.34522463855092	11.1483936079773	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCAGGGTGCATTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1967.8326136844	36.5784574669877	0.0185881955673563	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1963.95927361605	1963.95927361605
"AML-3133"	"2019-07-01-count-3:TCTAACTCACACCGCA"	1.0767637687618	10.9267196425232	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTAACTCACACCGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2126.5954292586	42.0654276926201	0.0197806442701165	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2122.37676627342	2122.37676627342
"AML-3133"	"2019-07-01-count-3:CTTGATTAGGTAAGTT"	-1.98647151413615	9.16847989642946	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTGATTAGGTAAGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2014.28541379494	35.5298773223897	0.0176389488197955	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2010.78217796292	2010.78217796292
"AML-3133"	"2019-07-01-count-1:CATGCTCAGCGTGCTC"	1.2007723051006	11.4737062224182	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGCTCAGCGTGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1944.50895294347	36.090755722151	0.0185603443314155	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1943.36246702913	1943.36246702913
"AML-3133"	"2019-07-01-count-3:ACTATGGGTCAAGTTC"	-1.85558436337169	13.3866319426331	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTATGGGTCAAGTTC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1886.26243254983	40.892604086351	0.0216791700776613	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1886.26243254983	1886.26243254983
"AML-3133"	"2019-07-01-count-1:AATTCCTTCCTGGCTT"	0.996767719357651	11.2900542982849	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATTCCTTCCTGGCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2127.45008031514	37.0475778513048	0.0174140762192723	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2119.7276820473	2119.7276820473
"AML-3133"	"2019-07-01-count-1:TCCACGTAGAAGGCTC"	4.02553047713582	-10.9120455018249	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCACGTAGAAGGCTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1965.57415118433	49.5733279128798	0.0252207874645737	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1963.73219975713	1963.73219975713
"AML-3133"	"2019-07-01-count-1:AGTTCGAAGGTAACTA"	-3.40573988381084	10.1916932829651	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTTCGAAGGTAACTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2003.50011350684	35.609659764432	0.0177737248550001	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.50182058114	1995.50182058114
"AML-3133"	"2019-07-01-count-3:TCACTATAGGATATGT"	-1.64888844910319	3.78348586643068	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-7"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACTATAGGATATGT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3389.18950622864	42.9733782049979	0.012679544217289	5227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	3370.2064081141	3370.2064081141
"AML-3133"	"2019-07-01-count-3:ATGATCGAGAATAACC"	4.03352751311604	-10.8422298661438	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGATCGAGAATAACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2055.74127524303	43.5059327385136	0.021163136267413	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2052.15180578019	2052.15180578019
"AML-3133"	"2019-07-01-count-1:CTTGATTCAGCGGTCT"	-7.49551473084148	1.68107781493989	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTGATTCAGCGGTCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2446.64310928539	38.799952008912	0.0158584437025817	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2441.74200487646	2441.74200487646
"AML-3133"	"2019-07-01-count-1:CGTTAGAAGACGGTCA"	-3.66018758240398	13.3650541075501	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56bright NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTAGAAGACGGTCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2038.66207412734	29.9402547249411	0.0146862273571049	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2035.47979431031	2035.47979431031
"AML-3133"	"2019-07-01-count-3:AGGATCTTCCGTATAG"	-2.54084620896037	13.4891366728577	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGATCTTCCGTATAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1940.49917428163	33.6826837287701	0.017357741850748	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1934.93018268177	1934.93018268177
"AML-3133"	"2019-07-01-count-1:GATAGCTCAAATGGCG"	8.45209374007527	7.45883128726808	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGCTCAAATGGCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1868.38987349083	39.5326070006608	0.0211586497880121	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1861.17154470474	1861.17154470474
"AML-3133"	"2019-07-01-count-3:AAGCATCGTGCGGATA"	-2.13567862930949	13.5261106261047	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCATCGTGCGGATA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1771.61829368438	35.1238615490821	0.0198258629831802	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1767.6441585407	1767.6441585407
"AML-3133"	"2019-07-01-count-1:GCATGATGTGAATGTA"	3.26125635680501	-10.5837736359802	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATGATGTGAATGTA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.67552561982	45.9696615506595	0.019885862458285	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2304.51559128753	2304.51559128753
"AML-3133"	"2019-07-01-count-1:TCCAGAAGTGTTAGCT"	2.9385789829189	-10.7271728745666	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCAGAAGTGTTAGCT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.11469937517	42.3952298872128	0.016355460619637	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2583.75859596838	2583.75859596838
"AML-3133"	"2019-07-01-count-2:CATACAGAGTACTGTC"	0.0568791088530838	10.0435838469299	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATACAGAGTACTGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1387.96927539709	43.8421226854624	0.0315872429329673	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1380.56910181319	1380.56910181319
"AML-3133"	"2019-07-01-count-3:TGCTCCATCTGCATGA"	-0.589215139777023	-9.84507849132689	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTCCATCTGCATGA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.01848827276	37.9673180966573	0.015396201722417	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2463.46582016316	2463.46582016316
"AML-3133"	"2019-07-01-count-3:CCACTTGTCTCTGCCA"	1.41860892352406	9.84095380390016	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCACTTGTCTCTGCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1725.88424694147	32.6777901207131	0.0189339407776756	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1722.97517810362	1722.97517810362
"AML-3133"	"2019-07-01-count-2:AGCGATTAGATCGCCC"	1.20036687430684	9.90573594653932	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGATTAGATCGCCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1734.30909178489	40.9692235060227	0.0236227923269771	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1728.28923732265	1728.28923732265
"AML-3133"	"2019-07-01-count-2:TCGCTCATCATGGCCG"	1.27558602866475	10.5074558028015	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCTCATCATGGCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1837.73000612583	33.7819044932758	0.0183824089396529	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1831.7803937051	1831.7803937051
"AML-3133"	"2019-07-01-count-2:AACACACTCTGATGGT"	-0.652312020689803	12.6666993864807	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACACACTCTGATGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2173.2499198691	42.0555472780404	0.0193514546548671	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2161.4149402465	2161.4149402465
"AML-3133"	"2019-07-01-count-3:GTTCATTCACAGCGCT"	2.55882324752156	-10.4152984849182	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTCATTCACAGCGCT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2167.0052104972	41.8483813331726	0.0193116200784634	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2163.00245868476	2163.00245868476
"AML-3133"	"2019-07-01-count-1:TATCTGTAGCTCAGAG"	1.01791544732396	10.842650390509	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATCTGTAGCTCAGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2061.94526864108	36.2655759649723	0.0175880400496144	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2052.75828695697	2052.75828695697
"AML-3133"	"2019-07-01-count-1:TAACGACGTTCCAAAC"	3.95139731940572	-10.636935257074	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACGACGTTCCAAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2394.84394788001	45.502356222218	0.0190001341266926	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2388.18748561313	2388.18748561313
"AML-3133"	"2019-07-01-count-2:GAGTTGTGTGCAACGA"	0.815496702759904	11.9450568922791	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTGTGTGCAACGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1701.57225002419	50.0647588218055	0.0294226465088943	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1697.83952108713	1697.83952108713
"AML-3133"	"2019-07-01-count-2:AGTGCCGCACAAATAG"	8.97718109664265	6.54487035358278	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGCCGCACAAATAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1646.19906181294	41.0810399664835	0.0249550864895047	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1644.5186121155	1644.5186121155
"AML-3133"	"2019-07-01-count-1:GAAACCTCAACCGATT"	-7.43374095383342	4.47174832904664	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAACCTCAACCGATT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2280.64704502175	32.5483691193726	0.0142715503437587	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2262.90258740536	2262.90258740536
"AML-3133"	"2019-07-01-count-1:TTGCTGCTCTGAGAAA"	1.53303100642506	10.8744945296082	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCTGCTCTGAGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1726.39821494767	35.0287802994997	0.0202900929786709	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1721.63908184631	1721.63908184631
"AML-3133"	"2019-07-01-count-2:TTGTTGTCATCATTTC"	1.23801722106282	10.3408260115418	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTGTCATCATTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1901.6565057771	41.3797043525779	0.0217598205705758	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1898.82172887307	1898.82172887307
"AML-3133"	"2019-07-01-count-3:GCTACAACATCACCAA"	0.894155462353867	10.898712135199	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCTACAACATCACCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1976.44858249576	41.2925922546699	0.0208923179790125	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1968.65524278903	1968.65524278903
"AML-3133"	"2019-07-01-count-3:AGTGTTGGTCCCTGAG"	-3.22073231163676	10.9604711302551	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTGTTGGTCCCTGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1756.24068968658	36.069396701969	0.0205378436530849	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1756.24068968658	1756.24068968658
"AML-3133"	"2019-07-01-count-1:GCCAACGGTGTACATC"	0.683141310780686	13.2106408842835	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAACGGTGTACATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1930.52291950497	36.1991714429525	0.0187509669412445	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1926.53691158428	1926.53691158428
"AML-3133"	"2019-07-01-count-3:CCATCACAGCAACCAG"	1.22568621215169	9.13673780048219	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCATCACAGCAACCAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1604.72893520805	29.2574783956614	0.018232037669258	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1600.96487602053	1600.96487602053
"AML-3133"	"2019-07-01-count-2:GTTGTCCTCACATCAG"	8.9883209663326	7.2993478544983	"2019-07-01-count-2"	"AML3133"	"Pre-B"	"Pre-B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGTCCTCACATCAG"	"Pre-B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1764.30523378986	37.1420844197964	0.0210519606859707	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1758.62800205817	1758.62800205817
"AML-3133"	"2019-07-01-count-3:TCAGCCTAGCGCCCAT"	4.14262594756429	-10.8953895798889	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTAGCGCCCAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2358.49598724006	40.3428193903277	0.0171053161033941	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2352.94780525443	2352.94780525443
"AML-3133"	"2019-07-01-count-3:TTCGCTGGTGATAGAT"	1.36706866797749	11.6176242598328	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCGCTGGTGATAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1749.92735051263	36.7350009191564	0.0209923005708752	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1745.01341364999	1745.01341364999
"AML-3133"	"2019-07-01-count-1:GGCGTCAAGACCATGG"	-7.64800057831462	1.62966046417085	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCGTCAAGACCATGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2433.91195025036	40.1395391549545	0.0164917794790504	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2428.83439914347	2428.83439914347
"AML-3133"	"2019-07-01-count-3:AGAAGCGCACTGTGTA"	4.21096195754353	-10.6460266343323	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAAGCGCACTGTGTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2015.34562690846	44.832133837996	0.0222453822507698	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2010.25289674604	2010.25289674604
"AML-3133"	"2019-07-01-count-3:AGAAGCGAGTTGGCGA"	9.50639786300008	7.4749488600525	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAAGCGAGTTGGCGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1778.30922704221	40.990181277644	0.0230500863709858	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1776.71963633932	1776.71963633932
"AML-3133"	"2019-07-01-count-2:AGTGTTGGTCTCCTGT"	1.96984996375386	-8.76920130169066	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGTTGGTCTCCTGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1687.67011949521	41.8140750592269	0.0247762134176635	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1683.62339683172	1683.62339683172
"AML-3133"	"2019-07-01-count-3:GCAGCTGTCAACTACG"	1.03658523139302	10.278706527594	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCTGTCAACTACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1559.8567297048	38.7006660599557	0.0248103978544746	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1557.75435462189	1557.75435462189
"AML-3133"	"2019-07-01-count-1:GTGATGTAGTTACGGG"	3.67812480506245	-11.334200882074	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGATGTAGTTACGGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2542.39049464746	46.3720588419919	0.0182395501161682	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2538.29160237843	2538.29160237843
"AML-3133"	"2019-07-01-count-1:TCTCCGAAGCCTGAAG"	1.57295383986775	-10.3933782807556	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTCCGAAGCCTGAAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2681.57211868465	42.6067997065807	0.0158887390757478	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2678.47460857181	2678.47460857181
"AML-3133"	"2019-07-01-count-3:AGCTACACAGGGTCTC"	1.75962259349172	-10.1862526169983	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTACACAGGGTCTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.24120857101	49.7061669632015	0.0204028101931487	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2431.69974626521	2431.69974626521
"AML-3133"	"2019-07-01-count-2:TTCATGTCAGGTGTGA"	-7.70674548569377	1.29805884445039	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCATGTCAGGTGTGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2543.64685284306	39.8354750770484	0.0156607726550264	2334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2540.65066486503	2540.65066486503
"AML-3133"	"2019-07-01-count-1:TTACGTTAGGTCATAA"	1.32508589801137	11.2456817396912	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACGTTAGGTCATAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2002.35918915181	38.3803384963026	0.0191675592991687	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1997.91506731815	1997.91506731815
"AML-3133"	"2019-07-01-count-3:GGTCACGTCCGAGTGC"	-1.27856324139293	12.5331048735413	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTCACGTCCGAGTGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1670.0337118235	36.2908788352721	0.0217306265007347	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1668.03249031986	1668.03249031986
"AML-3133"	"2019-07-01-count-2:ACAGAAACAGCGATTT"	1.18076946315114	10.6855401762756	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAGAAACAGCGATTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1804.48271091361	37.8992930818755	0.0210028574131847	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1800.96397089366	1800.96397089366
"AML-3133"	"2019-07-01-count-2:TTTACCATCTGAACGT"	1.12459947642629	11.1776160963806	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACCATCTGAACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1806.37766566805	38.7194695850364	0.021434869529743	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.76771312779	1804.76771312779
"AML-3133"	"2019-07-01-count-2:GTTTACTCAGGACATG"	-1.82286892357524	10.2725171812805	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTTACTCAGGACATG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1992.0770405335	40.6632041488241	0.0204124656433639	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1982.5163604413	1982.5163604413
"AML-3133"	"2019-07-01-count-1:ATTCACTCAAAGACGC"	1.38605274733846	11.4079160460266	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCACTCAAAGACGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1746.92571032612	50.1552757811367	0.0287105945517131	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1731.46720162573	1731.46720162573
"AML-3133"	"2019-07-01-count-3:ACTGCAAAGCGATGGT"	8.1403509574825	7.36086366260377	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACTGCAAAGCGATGGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1652.58214759291	41.141751602117	0.0248954350995759	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1650.73950127948	1650.73950127948
"AML-3133"	"2019-07-01-count-3:AACGAAATCCTTTAGT"	-2.98359642449077	13.2759828337464	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACGAAATCCTTTAGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1948.53787733174	45.0140996046778	0.023101475279669	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1946.73321226439	1946.73321226439
"AML-3133"	"2019-07-01-count-3:TTTACGTCAACCGTAT"	-1.81281695786174	10.5644855269226	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTACGTCAACCGTAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2030.27242810341	37.1294728001644	0.0182879264310598	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2026.88660889793	2026.88660889793
"AML-3133"	"2019-07-01-count-3:CTCGAGGCACCATAAC"	1.34956254538838	11.4867286452088	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCGAGGCACCATAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1777.72060295702	39.0020383796263	0.021939352176462	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.87412897608	1771.87412897608
"AML-3133"	"2019-07-01-count-1:GGGCTACAGAAATGGG"	-7.68669448319133	1.45410010898439	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCTACAGAAATGGG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2746.30285681114	38.8924816737119	0.0141617599010445	2995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2741.82931402784	2741.82931402784
"AML-3133"	"2019-07-01-count-1:CTACAGATCAGCTGTA"	1.6766081052715	-8.02713110363158	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACAGATCAGCTGTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1582.72709198775	42.6388481265502	0.0269401138973366	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1580.47815953773	1580.47815953773
"AML-3133"	"2019-07-01-count-3:GAGGCCTGTCGAGCAA"	0.982221444218796	12.524857498053	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGGCCTGTCGAGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1718.62998626943	47.8582867073896	0.027846765790043	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1714.85621984267	1714.85621984267
"AML-3133"	"2019-07-01-count-3:CCCGAAGGTAGACGTG"	-2.59396086159404	9.92615888202516	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCGAAGGTAGACGTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1938.27752466667	34.7562507945613	0.0179315141161421	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1938.27752466667	1938.27752466667
"AML-3133"	"2019-07-01-count-3:CAATCGATCGATAACC"	0.618881960480851	10.3022165068421	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAATCGATCGATAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1793.15683228374	43.5404064377731	0.0242814268411317	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1789.93058525362	1789.93058525362
"AML-3133"	"2019-07-01-count-2:GCCCAGAGTATCCTTT"	-8.26011977616008	-0.851663314458452	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCAGAGTATCCTTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3162.18605342782	38.7815629002624	0.0122641622741404	3731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3155.9604831813	3155.9604831813
"AML-3133"	"2019-07-01-count-2:TTTACGTTCAAGTTGC"	1.3606616455013	10.1566133269104	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTACGTTCAAGTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1643.03068350936	38.8940131358629	0.0236721161243252	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1641.3702025396	1641.3702025396
"AML-3133"	"2019-07-01-count-1:CTCCTCCGTAGCGATG"	-0.135412777692634	10.8137950667175	"2019-07-01-count-1"	"AML3133"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCGTAGCGATG"	"MAIT"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	1920.32633516636	32.1353028788187	0.0167342926513763	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1914.40918271735	1914.40918271735
"AML-3133"	"2019-07-01-count-1:TTACTGTGTTGCATTG"	-6.7863167327946	3.93282315814821	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACTGTGTTGCATTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2484.90811631132	39.1859588507391	0.015769580610855	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2476.31704486434	2476.31704486434
"AML-3133"	"2019-07-01-count-2:GAATAGAGTAGCGCCT"	-2.65424595299419	13.4424009093079	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAATAGAGTAGCGCCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1923.73505831314	32.4555113213686	0.0168710920878199	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1923.73505831314	1923.73505831314
"AML-3133"	"2019-07-01-count-2:AGCTCAACACGACGCT"	-2.09688148918803	13.4445647963318	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCTCAACACGACGCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2099.63478740414	36.7628706291815	0.0175091739047784	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2097.89478844035	2097.89478844035
"AML-3133"	"2019-07-01-count-2:ACAGCCGGTCCGAAAG"	-2.5151392025059	13.2067003020081	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAGCCGGTCCGAAAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2118.0446179579	33.9577127025068	0.0160325766580153	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2111.06441541276	2111.06441541276
"AML-3133"	"2019-07-01-count-1:GTAATCGTCCGGTAGC"	-2.04967961731609	13.5328101881775	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAATCGTCCGGTAGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2011.06501979549	47.5841388112881	0.0236611637828234	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2009.28094982659	2009.28094982659
"AML-3133"	"2019-07-01-count-3:ATGGATCTCAAACTGC"	8.09306969222371	6.76529882037965	"2019-07-01-count-3"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGATCTCAAACTGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1649.76319557771	41.3787563537568	0.0250816338154924	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1649.76319557771	1649.76319557771
"AML-3133"	"2019-07-01-count-2:CGATCGGCAGCTGTGC"	-0.0371256646817506	13.314616180304	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATCGGCAGCTGTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1444.67106246827	38.7247021610183	0.0268052037360366	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1442.62409118893	1442.62409118893
"AML-3133"	"2019-07-01-count-1:TAATCTCAGTTCCGTA"	3.87073125418965	-10.8770075074402	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAATCTCAGTTCCGTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2486.70190445482	37.6061061931384	0.0151228847035379	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2481.26068784741	2481.26068784741
"AML-3133"	"2019-07-01-count-3:ATGGGAGAGCACTTTG"	1.99353553828542	-7.96883871471556	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGGAGAGCACTTTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1962.85723369022	43.0771793300816	0.0219461602151754	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1961.18822203458	1961.18822203458
"AML-3133"	"2019-07-01-count-3:CGAATTGGTTAGGGAC"	0.978346605866593	10.3763751753601	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAATTGGTTAGGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1436.51052977511	41.5126379160893	0.0288982482589865	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1432.31357708209	1432.31357708209
"AML-3133"	"2019-07-01-count-2:GCCCGAATCCTAAACG"	-7.67996106568034	1.56780169093934	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCGAATCCTAAACG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.78832141148	39.3944849863932	0.0147777993736331	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2661.36145855226	2661.36145855226
"AML-3133"	"2019-07-01-count-1:AGGACGAAGCATCAGG"	1.25487925586049	11.38658044422	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGACGAAGCATCAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1853.21375937991	37.987842019162	0.0204983595804257	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1849.25165442562	1849.25165442562
"AML-3133"	"2019-07-01-count-1:CTCCTTTAGTCTTGGT"	1.58362307128255	10.812021232489	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTTTAGTCTTGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.11820591217	35.9436773919756	0.0185552318295672	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1932.57770447216	1932.57770447216
"AML-3133"	"2019-07-01-count-2:CTACATTGTTTAGAGA"	-7.34176001969035	3.82273337924806	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACATTGTTTAGAGA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2127.15495156291	33.7928495853564	0.0158864071282289	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2118.35663322128	2118.35663322128
"AML-3133"	"2019-07-01-count-1:TTGTGGACAGGTATGG"	7.90687288817708	-10.2155857316223	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGGACAGGTATGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1865.22243449106	50.6033658164833	0.0271299362911056	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1863.26887251369	1863.26887251369
"AML-3133"	"2019-07-01-count-3:CGTTGGGCAGCTAACT"	1.01532842692677	10.9209375151428	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTTGGGCAGCTAACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1711.82750649386	39.50091852121	0.0230752913896769	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1707.1420349298	1707.1420349298
"AML-3133"	"2019-07-01-count-2:AGGAAATGTACGGCAA"	-7.66449914398845	1.64554057205049	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAAATGTACGGCAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2541.53413975561	37.771502307014	0.0148616938549746	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2533.12667497073	2533.12667497073
"AML-3133"	"2019-07-01-count-3:GTTGCGGTCGGAGCAA"	-7.10516200485881	2.59369752490846	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGCGGTCGGAGCAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2503.84607778537	35.9480492872552	0.0143571322559296	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2493.62947640772	2493.62947640772
"AML-3133"	"2019-07-01-count-1:AACCACATCCCGGTAG"	0.841814358800095	11.3229655989441	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCACATCCCGGTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2051.20446242859	38.5957755261279	0.0188161522817824	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2047.45813576821	2047.45813576821
"AML-3133"	"2019-07-01-count-1:ATTCCATAGCCACCGT"	4.06634869155232	-10.9119148484436	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCATAGCCACCGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2598.61131696003	42.6919495241737	0.0164287553300263	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2587.39230062689	2587.39230062689
"AML-3133"	"2019-07-01-count-1:CTCTCAGGTAGGACTG"	-7.8220628303593	-1.26287462627562	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCTCAGGTAGGACTG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3295.39446810686	38.7022200424689	0.0117443360474847	4355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3285.0572037587	3285.0572037587
"AML-3133"	"2019-07-01-count-2:CATCCGTTCGATACGT"	-1.37574909153636	11.5982370146546	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCCGTTCGATACGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2131.62300369536	38.0049337191721	0.0178291065790185	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2126.97521454169	2126.97521454169
"AML-3133"	"2019-07-01-count-1:CCTCATGAGGATTCCT"	8.58253349837605	7.88030765140382	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCATGAGGATTCCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2067.66864510406	32.2462433283517	0.0155954598454188	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2059.09083761325	2059.09083761325
"AML-3133"	"2019-07-01-count-2:CTGCCTATCATTTCGT"	1.4109044271404	10.1690644987854	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCCTATCATTTCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1823.53888932578	34.7265358558684	0.0190434852029439	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1817.19028837387	1817.19028837387
"AML-3133"	"2019-07-01-count-2:TGTACAGTCGAGAGCA"	-5.86948190155681	3.50705764377443	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTACAGTCGAGAGCA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2346.995737629	37.6767538343843	0.0160531837490452	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2335.6354258699	2335.6354258699
"AML-3133"	"2019-07-01-count-3:GCATCTCTCGGAATGG"	-3.82573447647746	10.8941859968933	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCTCTCGGAATGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1524.84677290075	37.153950585704	0.0243656944723864	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1522.51162979551	1522.51162979551
"AML-3133"	"2019-07-01-count-1:GTACAACGTTGTCTAG"	1.03862400826756	12.0238218077454	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTACAACGTTGTCTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2015.37164021024	36.0625029710553	0.0178937235453474	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2008.26775485255	2008.26775485255
"AML-3133"	"2019-07-01-count-1:CATTTCACACTAGAGG"	8.79655613478963	7.88919780338136	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTTCACACTAGAGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1925.95179718283	36.5000392070987	0.0189516888535262	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1924.35601577248	1924.35601577248
"AML-3133"	"2019-07-01-count-2:TGTAGACAGCTGTTCA"	0.818901558488053	10.7749709852966	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTAGACAGCTGTTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1757.11524428075	39.5121470390782	0.0224869411199331	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1750.63524024713	1750.63524024713
"AML-3133"	"2019-07-01-count-1:GGGAAGTGTAAGACCG"	-7.70699868622478	4.2957610853943	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	67	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.666666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAAGTGTAAGACCG"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2144.22845174399	36.2926073207206	0.0169257185684679	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2133.71383261826	2133.71383261826
"AML-3133"	"2019-07-01-count-1:TACACCCCAATCGTCA"	4.17105545577351	-10.5622768632141	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACACCCCAATCGTCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.25715884637	46.3404095089605	0.0203402892114364	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2275.78434369634	2275.78434369634
"AML-3133"	"2019-07-01-count-2:GCCGTGAGTTCTTGCC"	0.325016995042008	10.8993911513123	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGTGAGTTCTTGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1798.21262183986	35.1334778065288	0.019537999778125	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1795.01888243198	1795.01888243198
"AML-3133"	"2019-07-01-count-1:CAGATACTCCACGTAA"	0.782419522374314	10.8620118864807	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGATACTCCACGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1998.21837546282	28.7249982237393	0.0143753048097589	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1992.42689296592	1992.42689296592
"AML-3133"	"2019-07-01-count-2:TCATTCATCTAGGAAA"	0.384458501904649	10.7676353224548	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATTCATCTAGGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1869.18017322276	38.8198965632735	0.0207684080536452	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1867.72178754923	1867.72178754923
"AML-3133"	"2019-07-01-count-3:TTACTGTGTCGTACAT"	-1.19342551651652	11.0740194090637	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACTGTGTCGTACAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1693.56751365025	40.0691550525737	0.0236596148246905	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1691.68013146416	1691.68013146416
"AML-3133"	"2019-07-01-count-2:CATCGCTGTCAGTTTG"	3.7428249317104	-10.5423212281433	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCGCTGTCAGTTTG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1799.73138734911	50.845858669277	0.0282519152728506	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1795.86173518072	1795.86173518072
"AML-3133"	"2019-07-01-count-1:ATTCCTACAGGTTTAC"	1.46424676951711	11.3499793776306	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCCTACAGGTTTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2091.05910689027	30.9996161182571	0.014824839726486	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2083.73021489808	2083.73021489808
"AML-3133"	"2019-07-01-count-2:TTTCAGTAGGTTGGTG"	3.97942246970479	-10.6551075211731	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCAGTAGGTTGGTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1934.04117060806	47.0940348483879	0.024350068428782	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1930.82408410639	1930.82408410639
"AML-3133"	"2019-07-01-count-3:CTAAGTGAGGTGCAGT"	-3.28622947159465	10.621160484198	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTAAGTGAGGTGCAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1712.58150923566	36.0346002733652	0.0210411008638343	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1706.84857295733	1706.84857295733
"AML-3133"	"2019-07-01-count-2:AGGACGATCGCTTGCT"	-9.84496818009074	4.87077901447145	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACGATCGCTTGCT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2594.3764953428	36.407902623803	0.0140333921037133	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2588.68667842012	2588.68667842012
"AML-3133"	"2019-07-01-count-1:GTGGCGTAGCTACAAA"	1.27068080481831	11.5298099287781	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGCGTAGCTACAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1953.80525311354	28.355119192182	0.0145127663808846	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1947.08529818673	1947.08529818673
"AML-3133"	"2019-07-01-count-2:ATAGACCCAGTTGTCA"	1.02831937846486	11.6438846358093	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATAGACCCAGTTGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1830.20857266084	43.389830388879	0.0237075877782589	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1830.20857266084	1830.20857266084
"AML-3133"	"2019-07-01-count-3:CTGTAGATCTCCGATC"	-1.46001873436626	11.3455743559631	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTAGATCTCCGATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1755.31947968523	32.0516469802285	0.0182597227178133	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1747.92006129289	1747.92006129289
"AML-3133"	"2019-07-01-count-1:TCCTAATGTAGTGCGA"	1.14780189570729	11.958788848761	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTAATGTAGTGCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1930.58486528489	38.3329893556037	0.0198556354837822	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1926.46770021199	1926.46770021199
"AML-3133"	"2019-07-01-count-1:CCAATGATCTCGCTCA"	1.24146320399587	10.5104112395081	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCAATGATCTCGCTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1875.84996285227	43.8539840814262	0.0233781938587164	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1870.79171226953	1870.79171226953
"AML-3133"	"2019-07-01-count-1:GCCGATGTCGGTGAAG"	-7.65594039383586	1.62710163677064	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCGATGTCGGTGAAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2474.43943753727	37.5265795383472	0.0151656892341226	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2468.65653628982	2468.65653628982
"AML-3133"	"2019-07-01-count-1:TCTTTGAAGTCTGTAC"	1.48172785815541	10.4494161375794	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTTGAAGTCTGTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1893.58159031823	34.4003045725688	0.0181667928904968	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1884.83850505438	1884.83850505438
"AML-3133"	"2019-07-01-count-2:TTCCTAAGTTGCTCCT"	-0.0795182240312875	11.0981378325256	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTAAGTTGCTCCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1780.08577167557	47.1685954138919	0.0264979340683638	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1780.08577167557	1780.08577167557
"AML-3133"	"2019-07-01-count-1:GTGGCGTGTCACTCAA"	4.10835423049275	-10.833091758844	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGCGTGTCACTCAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2324.84214000018	42.0430134898977	0.0180842444166529	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2316.99594477889	2316.99594477889
"AML-3133"	"2019-07-01-count-2:TGCACGGTCTACGCAA"	1.35404707965199	10.8983344801697	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCACGGTCTACGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1888.76506966141	34.0387545929934	0.0180216984842352	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1884.71335539703	1884.71335539703
"AML-3133"	"2019-07-01-count-2:TTCCTAATCCATGCAA"	0.252129529684228	11.2503070601257	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTAATCCATGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1985.84485902915	36.2333852262218	0.0182458287521694	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1985.84485902915	1985.84485902915
"AML-3133"	"2019-07-01-count-1:CTCCAACCATCCTAAG"	1.05357100543324	10.9945754774841	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCAACCATCCTAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2025.04671183586	38.624706256418	0.0190734890364093	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2021.19541260399	2021.19541260399
"AML-3133"	"2019-07-01-count-1:GATAGAATCAAGGAGC"	-2.19375143471416	10.4149961241516	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGAATCAAGGAGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2116.95437690783	37.6841690416356	0.0178011247916829	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2108.06805591801	2108.06805591801
"AML-3133"	"2019-07-01-count-3:TTGAACGCAAACAGGC"	0.557446797459763	13.2043618925842	"2019-07-01-count-3"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGAACGCAAACAGGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1369.860726159	48.6895658424602	0.03554344241913	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1369.860726159	1369.860726159
"AML-3133"	"2019-07-01-count-1:ATTCTACAGCTGCCTG"	4.2159182029659	-10.648614906427	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTCTACAGCTGCCTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2008.66405000644	49.7913618568155	0.0247882974042653	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2003.4290346674	2003.4290346674
"AML-3133"	"2019-07-01-count-3:TCATCATGTAGCTTAC"	0.315581430762452	10.7381276854309	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATCATGTAGCTTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1758.92142311186	29.0591069514653	0.016520980738329	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1754.23000821585	1754.23000821585
"AML-3133"	"2019-07-01-count-1:TTCACGCAGAAGTCCG"	-0.450385193259078	11.5659961470398	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCACGCAGAAGTCCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1788.106744038	30.4126800332252	0.0170083134771617	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1788.106744038	1788.106744038
"AML-3133"	"2019-07-01-count-1:ACATGCATCGTGTGAT"	1.42944528636281	10.9186076887879	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACATGCATCGTGTGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1789.01847885736	36.2839553248882	0.0202814871694688	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1783.48376147368	1783.48376147368
"AML-3133"	"2019-07-01-count-3:GCCAGCATCATAGCAC"	1.26034607467	10.8391732939514	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCAGCATCATAGCAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1824.51771066071	38.2071536824993	0.0209409607038911	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1824.51771066071	1824.51771066071
"AML-3133"	"2019-07-01-count-2:GTGCGTGTCAACACGT"	0.851060231297654	12.6540946730408	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCGTGTCAACACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1678.29555303144	35.9337859211121	0.0214108807332572	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1672.93253674439	1672.93253674439
"AML-3133"	"2019-07-01-count-3:AGGATCTGTCTAGGCC"	1.23671378669087	9.84858605945436	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGATCTGTCTAGGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1743.1187562889	32.6939218557267	0.0187559922339038	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1743.1187562889	1743.1187562889
"AML-3133"	"2019-07-01-count-3:TGGGAAGGTTTCGTGA"	1.09474732455556	10.4176387556824	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGGAAGGTTTCGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1752.7783985244	31.9399303117049	0.0182224577497041	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1749.04397682502	1749.04397682502
"AML-3133"	"2019-07-01-count-1:GTGGTTAGTTACCCAA"	1.16347291049306	11.4466314085755	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGTTAGTTACCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1933.58920586628	38.8470539857346	0.0200906448318377	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1923.65950622792	1923.65950622792
"AML-3133"	"2019-07-01-count-3:GGGCCATGTATACAGA"	-3.21839461746867	12.5636281737122	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGCCATGTATACAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1688.5679328952	41.5900583806873	0.0246303732118004	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1684.19541171044	1684.19541171044
"AML-3133"	"2019-07-01-count-2:CAGATCATCCTGTTGC"	1.52727903899495	-10.3239612809387	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGATCATCCTGTTGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2647.55239509952	40.6478165056723	0.0153529790688597	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2644.55930148456	2644.55930148456
"AML-3133"	"2019-07-01-count-3:TCTACATGTAAGACCG"	4.20061411437337	-10.4820089570251	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTACATGTAAGACCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1904.33320164708	45.5987583318044	0.0239447373455263	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1900.98625641431	1900.98625641431
"AML-3133"	"2019-07-01-count-3:GGGCCATGTCTGATCA"	-2.14375982704814	10.9862527617249	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGCCATGTCTGATCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1725.86185572608	35.7825004007602	0.0207331196770128	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1721.8556612265	1721.8556612265
"AML-3133"	"2019-07-01-count-2:CTGGTCTAGTAGTGCG"	3.94543256339375	-10.9399185410705	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGGTCTAGTAGTGCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.41414563786	44.6380524087994	0.0179889570176223	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2476.69905168479	2476.69905168479
"AML-3133"	"2019-07-01-count-3:GTTTGGACACTGATTG"	-1.2667455476826	9.95623776996461	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTTGGACACTGATTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1795.51106682616	41.5444375858094	0.023137945709934	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1790.94848206011	1790.94848206011
"AML-3133"	"2019-07-01-count-1:CGTTAGAGTCGTGTTA"	0.31237949904744	11.2476777800354	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTTAGAGTCGTGTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1752.81623873934	39.5479397719696	0.0225625133416229	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1749.70200613799	1749.70200613799
"AML-3133"	"2019-07-01-count-1:TTCAGGAAGTCGCTAT"	1.04101576384847	10.8687085875305	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCAGGAAGTCGCTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1834.11698469094	35.1217459542174	0.019149130751949	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1826.03507698003	1826.03507698003
"AML-3133"	"2019-07-01-count-3:TCGCTCATCATACAGC"	1.44391681727712	-9.90739824688109	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCTCATCATACAGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2356.30609254476	43.8524359624385	0.0186106703628979	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2350.11000701924	2350.11000701924
"AML-3133"	"2019-07-01-count-1:TACCGAAGTTCGGGTC"	2.60640492019002	-8.14122965252074	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACCGAAGTTCGGGTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1453.81682696006	5.2792546825707	0.00363130663001725	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1449.59691212182	1449.59691212182
"AML-3133"	"2019-07-01-count-3:GTGACGCAGTACCGGA"	4.0017839866573	-10.6813078156677	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGACGCAGTACCGGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2211.01964463693	40.1774297203642	0.0181714485521732	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2207.02019390068	2207.02019390068
"AML-3133"	"2019-07-01-count-2:TCTACATTCTTGCAAG"	-8.44758925858195	0.107088937703051	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTACATTCTTGCAAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2812.96576350266	41.8342853104005	0.0148719496885412	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2800.92979720015	2800.92979720015
"AML-3133"	"2019-07-01-count-1:TCCTCTTGTTAACCTG"	3.68464126166646	-10.7477398148743	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTCTTGTTAACCTG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2224.62427184938	47.8399051284094	0.0215047123839204	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2220.57121925717	2220.57121925717
"AML-3133"	"2019-07-01-count-2:TCTACCGAGGCTTTCA"	0.977002282708329	10.0873155363831	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTACCGAGGCTTTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1886.06851895786	33.5848519542637	0.0178068037384033	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1884.67038487096	1884.67038487096
"AML-3133"	"2019-07-01-count-2:CGCCATTAGGAGAATG"	4.08021940764729	-10.8755445710388	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCCATTAGGAGAATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2325.43882388078	44.9206114811373	0.0193170471825925	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2317.10244491701	2317.10244491701
"AML-3133"	"2019-07-01-count-3:CTACCCATCTTGAACG"	-7.41800389710124	1.38455877387849	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACCCATCTTGAACG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2947.07293881637	42.2871758881271	0.0143488731925009	2760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2938.31348436592	2938.31348436592
"AML-3133"	"2019-07-01-count-1:TGGGAAGGTACAGTCT"	-0.248370240361053	12.7120475539002	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGGAAGGTACAGTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2088.97501280915	29.8169607687889	0.0142734884744708	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2080.47124973856	2080.47124973856
"AML-3133"	"2019-07-01-count-3:GTGAGCCAGACTTGTC"	-0.47457198324855	10.8170032271179	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGCCAGACTTGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1807.68743227418	39.7430896248574	0.0219855982374443	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1803.81116653719	1803.81116653719
"AML-3133"	"2019-07-01-count-1:CTGCATCCACAAAGTA"	4.1408974128658	-10.8404150239197	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCATCCACAAAGTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2292.78824435966	39.7398377452802	0.0173325372908037	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2291.54809486641	2291.54809486641
"AML-3133"	"2019-07-01-count-3:TGAGCGCAGTTGTCGT"	-2.12000785294231	13.1294841536316	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGCGCAGTTGTCGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1564.20082158629	47.4243654030675	0.0303185912886642	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1559.62412335786	1559.62412335786
"AML-3133"	"2019-07-01-count-3:GATAGAAGTCCAAAGG"	0.843980987637681	10.0050353773865	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATAGAAGTCCAAAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1711.60053341843	39.8151683496288	0.023261951356202	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1710.03210992432	1710.03210992432
"AML-3133"	"2019-07-01-count-2:AGTGCCGGTTGAGGAC"	1.22313894805257	11.0201787718567	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGCCGGTTGAGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1824.67278112647	30.1770165835767	0.0165383168399908	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1822.01673464217	1822.01673464217
"AML-3133"	"2019-07-01-count-1:ACCAACATCCTCTTTC"	-0.800557474524337	11.4509563216004	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCAACATCCTCTTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2075.49664100493	41.7316158071102	0.0201068096101106	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2068.20864825181	2068.20864825181
"AML-3133"	"2019-07-01-count-2:CGCGTGAAGTAACGAT"	0.944261928170365	12.2890157469544	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCGTGAAGTAACGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1786.91124618767	38.5812703050681	0.0215910389435291	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1786.91124618767	1786.91124618767
"AML-3133"	"2019-07-01-count-3:TGAGCGCTCGTTCTAT"	-7.50942264023479	1.33821926200715	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGCGCTCGTTCTAT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2106.19663286776	30.5787721657214	0.0145184792761186	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2099.56139582502	2099.56139582502
"AML-3133"	"2019-07-01-count-3:TCATGCCTCTCTCGAC"	-2.00910864296611	13.3472966917786	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGCCTCTCTCGAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2215.32771648857	42.5401231996764	0.0192026321356667	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2212.12715016	2212.12715016
"AML-3133"	"2019-07-01-count-2:CGCGTGAGTTTGACAC"	1.61397900161092	-10.1979246369568	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCGTGAGTTTGACAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.64518040778	44.2002301228933	0.0193720875193196	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2280.31768429272	2280.31768429272
"AML-3133"	"2019-07-01-count-2:GACCGTGTCAACGCTA"	-7.69430528107341	1.59962079608766	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GACCGTGTCAACGCTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2717.28920125018	36.5909215086704	0.0134659650845539	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2709.92456398738	2709.92456398738
"AML-3133"	"2019-07-01-count-1:CCACGAGGTACACTCA"	1.62390186366383	11.3531312712464	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCACGAGGTACACTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2058.64166754052	38.5401392337799	0.0187211498928923	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2057.46050824379	2057.46050824379
"AML-3133"	"2019-07-01-count-2:GGTAACTGTAGGTGCA"	0.596313436597031	10.8518790968689	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTAACTGTAGGTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1710.72017281178	38.4061887768518	0.0224503044900245	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1707.14712315318	1707.14712315318
"AML-3133"	"2019-07-01-count-3:TGTTTGTTCCATTCGC"	1.56989159163777	10.9674262770447	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTTGTTCCATTCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1757.04469289068	37.3134549440733	0.021236485955679	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1755.62330235849	1755.62330235849
"AML-3133"	"2019-07-01-count-3:GCCATGGCATATCTGG"	1.1355068880016	10.3057374724182	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATGGCATATCTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1798.07795995194	40.8668128959523	0.0227280539588198	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1791.06083825416	1791.06083825416
"AML-3133"	"2019-07-01-count-2:TGCATCCTCCGATGTA"	0.611732740967911	10.914861656073	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCATCCTCCGATGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1645.6514553098	51.0869512422807	0.0310436034783947	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1643.70410268497	1643.70410268497
"AML-3133"	"2019-07-01-count-3:GATAGCTTCCGCGATG"	0.781336327164811	10.3713397749695	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATAGCTTCCGCGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1671.97295786786	35.5828414955397	0.0212819479693714	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1665.65659754321	1665.65659754321
"AML-3133"	"2019-07-01-count-2:ACTTTGTGTACGGGAT"	8.16035809096639	6.72178313815919	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTTGTGTACGGGAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1535.57341393003	38.4315368468764	0.0250274825666053	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1533.65471725641	1533.65471725641
"AML-3133"	"2019-07-01-count-2:AGGCTGCTCCAAGCCG"	-2.0678735775059	13.3373079069885	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGCTGCTCCAAGCCG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1988.40455059443	41.3252441529439	0.0207831168665299	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1988.40455059443	1988.40455059443
"AML-3133"	"2019-07-01-count-2:CATGCGGTCCGTGGGT"	0.278725092380685	11.1507501372131	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCGGTCCGTGGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1869.5995688467	42.6037546801457	0.0227876361281078	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1860.87456620747	1860.87456620747
"AML-3133"	"2019-07-01-count-2:GCGTTTCCAGGAGACT"	8.50421585616414	7.4850134619507	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGTTTCCAGGAGACT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1803.19770733124	33.1842194766949	0.0184029845101168	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1797.85802468736	1797.85802468736
"AML-3133"	"2019-07-01-count-1:AGAAGCGCACAGTATC"	-7.54257951203044	4.0515610941681	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAGCGCACAGTATC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2174.52801593836	43.2542188992235	0.0198913136929892	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2163.17143069723	2163.17143069723
"AML-3133"	"2019-07-01-count-3:AGAAGTACAAAGGGCT"	3.71192969855611	-10.749595665094	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAAGTACAAAGGGCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2067.97916262193	48.3866166679823	0.0233980194494002	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2065.0224908757	2065.0224908757
"AML-3133"	"2019-07-01-count-3:TATCAGGAGAAACCCG"	-7.54754100266154	-1.58721890365752	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCAGGAGAAACCCG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2917.05932275424	45.8476805545711	0.0157170888493562	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2911.03758053874	2911.03758053874
"AML-3133"	"2019-07-01-count-3:GAATCGTCAGCATTGT"	3.84474625167195	-10.5007496110168	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAATCGTCAGCATTGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.4012716819	45.5266647330208	0.0173606782549422	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2615.81991679847	2615.81991679847
"AML-3133"	"2019-07-01-count-3:TTTACGTAGTTTCGGT"	0.264989902346772	-10.0670585862366	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTACGTAGTTTCGGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1873.99720795938	44.8663111859967	0.0239415037522132	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1872.04057043183	1872.04057043183
"AML-3133"	"2019-07-01-count-1:AGAAGCGGTGGGCTTC"	8.913910527795	7.53794906223146	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAGCGGTGGGCTTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1538.14108424555	39.0955920004261	0.0254174291297878	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1534.10188283048	1534.10188283048
"AML-3133"	"2019-07-01-count-1:AGGGCTCTCGTTATCT"	-7.89948783341106	4.16186521137086	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCTCTCGTTATCT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2150.57184179856	28.6111284777878	0.0133039631235289	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2141.34745924685	2141.34745924685
"AML-3133"	"2019-07-01-count-1:CATCCGTAGGCCTGCT"	3.74312176284139	-10.8727779618469	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCCGTAGGCCTGCT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.5731564974	37.502336645866	0.0143765707902252	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2599.7609882152	2599.7609882152
"AML-3133"	"2019-07-01-count-2:TGCCGAGCACCTCTAC"	3.35376705703084	-10.7735433808533	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCCGAGCACCTCTAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.62698159143	46.3867641435261	0.0178367618546895	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2593.6985311301	2593.6985311301
"AML-3133"	"2019-07-01-count-3:TGCTTGCCATAGGTAA"	0.55723657187764	-9.97823908245238	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTTGCCATAGGTAA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2104.11611219741	41.0749803768833	0.0195212517687473	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2104.11611219741	2104.11611219741
"AML-3133"	"2019-07-01-count-3:TTGCTGCAGAACTCCT"	0.95054449614827	12.8448152312073	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCTGCAGAACTCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1663.47471687663	31.7643793631183	0.0190951981661373	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1656.00415304717	1656.00415304717
"AML-3133"	"2019-07-01-count-1:CAACAACAGCCGATTT"	3.80844821509663	-10.7989435425964	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACAGCCGATTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2474.82068740319	46.8622146455293	0.0189356000150061	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2471.29761436135	2471.29761436135
"AML-3133"	"2019-07-01-count-3:GATCAGTTCTTGATTC"	4.23967947539632	-10.6925525895325	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCAGTTCTTGATTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1809.88803129729	50.3535408992171	0.0278213569173806	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1806.28482924459	1806.28482924459
"AML-3133"	"2019-07-01-count-2:CGGACACAGGAATGTT"	0.936433454125565	-9.9192219010559	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGACACAGGAATGTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.15961752199	41.0527825760343	0.0153574003987424	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2668.4281227701	2668.4281227701
"AML-3133"	"2019-07-01-count-1:AGGGTGAAGAGGTATT"	1.60741831836049	10.7226257094177	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGTGAAGAGGTATT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1906.68566531405	33.8476345587271	0.01775207899995	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1901.71019532226	1901.71019532226
"AML-3133"	"2019-07-01-count-2:ATTCCATGTATCTCTT"	3.79957475241963	-10.6655264130798	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCCATGTATCTCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2059.25213438555	48.0980514426147	0.0233570482407034	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2057.16830323818	2057.16830323818
"AML-3133"	"2019-07-01-count-3:TCATTACGTTTCTTAC"	-1.98932109299358	10.3513135679993	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTACGTTTCTTAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2000.53572907625	40.2040255827436	0.0200966296169615	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.45685973535	1995.45685973535
"AML-3133"	"2019-07-01-count-3:CCGGTAGGTCGTTGGC"	3.87003697928731	-10.792603515741	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGGTAGGTCGTTGGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1786.89650394166	45.727906171076	0.0255906853419917	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1783.14922711479	1783.14922711479
"AML-3133"	"2019-07-01-count-2:GGGCTCACATATCGGT"	8.18089737471883	7.74966666782228	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGCTCACATATCGGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1653.11501253139	38.6769213037696	0.0233963886423995	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1651.47099806552	1651.47099806552
"AML-3133"	"2019-07-01-count-3:TGGTACATCCGTATAG"	6.53874077376668	-10.3413000336853	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGTACATCCGTATAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1554.73847485284	42.8063595182809	0.0275328360432662	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1554.73847485284	1554.73847485284
"AML-3133"	"2019-07-01-count-2:AGGGTCCAGTCCCGAC"	8.60978855666463	6.74987504566041	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGGTCCAGTCCCGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1779.09830727827	38.5392660979477	0.0216622465100911	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1772.74154950955	1772.74154950955
"AML-3133"	"2019-07-01-count-3:CCGGTGAAGGACTAAT"	3.88419141349141	-10.8768549195495	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGGTGAAGGACTAAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1995.25448049465	45.0362846770157	0.0225716995587704	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1995.25448049465	1995.25448049465
"AML-3133"	"2019-07-01-count-1:TGGTAGTAGGCTCTAT"	-1.51703284207042	11.2766914137634	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTAGTAGGCTCTAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1708.92612266872	50.4108047079861	0.0294985277826187	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1705.17891280262	1705.17891280262
"AML-3133"	"2019-07-01-count-3:TCATTCAGTGTTAAAG"	10.9065920310909	-0.648664497491442	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTCAGTGTTAAAG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1381.27728479283	11.8108237718203	0.00855065373321602	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1374.28658878483	1374.28658878483
"AML-3133"	"2019-07-01-count-3:AATGGCTAGCCGTAAG"	8.1727463203365	6.98726222598878	"2019-07-01-count-3"	"AML3133"	"Pre-B"	"Pre-B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGGCTAGCCGTAAG"	"Pre-B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1691.11032436993	44.653025317829	0.0264045607636307	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1689.00174964622	1689.00174964622
"AML-3133"	"2019-07-01-count-2:CATGGTAGTGATATAG"	1.35428955134694	11.2505254515442	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGGTAGTGATATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1660.57632676131	48.0629641891089	0.0289435441265432	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1655.00346776945	1655.00346776945
"AML-3133"	"2019-07-01-count-3:CTAGGTATCCTAAGTG"	1.21012224730794	10.9249009856018	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTAGGTATCCTAAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1314.41473403498	34.4217006035098	0.0261878535839615	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1310.05484949083	1310.05484949083
"AML-3133"	"2019-07-01-count-3:GATCCCTTCCTACCAC"	1.20044793662373	11.2443256148132	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCCCTTCCTACCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1892.96238484665	35.6171572526229	0.0188155652419413	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1891.58056383653	1891.58056383653
"AML-3133"	"2019-07-01-count-3:GATCCCTTCGTACACA"	-1.92671952667888	13.0320787199768	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCCCTTCGTACACA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1805.72371963582	44.3757704529106	0.0245750609411391	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1803.85991215325	1803.85991215325
"AML-3133"	"2019-07-01-count-3:CTATAGGCAAATCAGA"	-3.43396125260051	13.3980273970398	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATAGGCAAATCAGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2103.16480491654	37.6845531893884	0.0179180219739764	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2090.23778654593	2090.23778654593
"AML-3133"	"2019-07-01-count-1:GGGCTCAGTATCATGC"	1.36900450763051	9.72089288318483	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGCTCAGTATCATGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1794.37467498148	36.1182646571962	0.0201286081222524	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1791.90192369855	1791.90192369855
"AML-3133"	"2019-07-01-count-2:GTAGGTTTCATCGCTC"	1.81454112109486	-10.2316923371521	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGTTTCATCGCTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2327.55511643117	45.7812265960376	0.0196692341559816	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2322.41013034351	2322.41013034351
"AML-3133"	"2019-07-01-count-3:AGACAGGCAGATGCGA"	-7.38315949860271	2.54752991283265	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGACAGGCAGATGCGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2335.81590421653	37.3469397356366	0.0159888198672761	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2333.50784984714	2333.50784984714
"AML-3133"	"2019-07-01-count-1:CCATCACCATGAGTAA"	6.60895123061482	-10.180877708551	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCATCACCATGAGTAA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1898.49760157938	33.3055849411429	0.017543127214612	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1896.73077725966	1896.73077725966
"AML-3133"	"2019-07-01-count-3:TCGTAGAAGGTTCACT"	-1.34285316887553	11.4469461210999	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTAGAAGGTTCACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1747.78404134757	33.4949933018081	0.0191642631523188	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1741.68731683785	1741.68731683785
"AML-3133"	"2019-07-01-count-3:GGGACTCTCGGAGATG"	0.747295935719651	9.87585256183473	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGACTCTCGGAGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1585.23557232516	39.5131050851995	0.0249256992304577	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1579.84988497236	1579.84988497236
"AML-3133"	"2019-07-01-count-3:TGAGTCAGTGTCTTCC"	8.68865360793416	7.19720552051393	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGTCAGTGTCTTCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1510.62960331737	44.840830455566	0.0296835374846983	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1508.61245534688	1508.61245534688
"AML-3133"	"2019-07-01-count-2:ACCTGAAGTGGTAACG"	-0.935445885092574	10.9931316145691	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACCTGAAGTGGTAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1857.67419533203	40.2396891889088	0.0216613275298883	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1854.70750188717	1854.70750188717
"AML-3133"	"2019-07-01-count-3:AGGGTTTTCCTATTTG"	1.27664424952809	-10.107804321405	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTTTTCCTATTTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.1565861294	46.2262328723305	0.0221161577936767	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2088.59755371125	2088.59755371125
"AML-3133"	"2019-07-01-count-2:GCTGCAGGTTGGGTAG"	4.11363615569417	-10.8579693070618	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTGCAGGTTGGGTAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2150.07092713623	44.4741782975404	0.0206849819400039	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2142.96151423403	2142.96151423403
"AML-3133"	"2019-07-01-count-3:GTGCTGGAGGAAAGGT"	-0.277974168688613	11.3025741347107	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCTGGAGGAAAGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1564.72378790056	42.3532594631012	0.0270675628443841	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1562.76883641569	1562.76883641569
"AML-3133"	"2019-07-01-count-1:CTGGCAGTCTCATGGA"	11.5222670036251	-2.99598767673644	"2019-07-01-count-1"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGGCAGTCTCATGGA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2085.55475649074	9.32671103399869	0.00447205282190351	2940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2080.33923396799	2080.33923396799
"AML-3133"	"2019-07-01-count-3:GGGAGATGTTCCAGGC"	-8.03205047074016	4.00625608051149	"2019-07-01-count-3"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGAGATGTTCCAGGC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2074.20214913629	33.5700967060405	0.0161845829347054	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2064.00996151756	2064.00996151756
"AML-3133"	"2019-07-01-count-1:GTCACGGCAGCGACAA"	-2.15576897087749	11.064462638739	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCACGGCAGCGACAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1969.17929611155	41.3599265676686	0.0210036367177637	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1964.35141171236	1964.35141171236
"AML-3133"	"2019-07-01-count-1:CAGTTAGTCGGATAAA"	-2.34159670296367	13.7407693632874	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGTTAGTCGGATAAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2157.59946676527	38.082338365799	0.0176503280392876	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2156.1024464139	2156.1024464139
"AML-3133"	"2019-07-01-count-3:GATGACTCAGTTTCGA"	1.27496566352193	10.4322023161682	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGACTCAGTTTCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1612.91913371213	43.7491809073975	0.02712422463903	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1611.27127929555	1611.27127929555
"AML-3133"	"2019-07-01-count-2:GTGTGATCAGGGACTA"	-8.22032103958781	-0.725734078046404	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTGATCAGGGACTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3275.35664102054	43.397600250343	0.0132497327792741	4021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3265.96229663393	3265.96229663393
"AML-3133"	"2019-07-01-count-3:AAACGCTTCATCGCTC"	1.1042409139568	10.3704719313416	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAACGCTTCATCGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2054.35215541526	41.7923130327379	0.0203433052714812	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2048.84600893412	2048.84600893412
"AML-3133"	"2019-07-01-count-3:GGGAGTATCTCATAGG"	7.77120508727376	-10.4921541444031	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGAGTATCTCATAGG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1625.76272333802	45.6354572046205	0.02807018302826	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1621.74743687795	1621.74743687795
"AML-3133"	"2019-07-01-count-1:AGGTCTAGTACCAATC"	1.8627573448116	-8.72998335277709	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTCTAGTACCAATC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.78834700928	37.3914004106671	0.0141591810843203	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2636.8749307573	2636.8749307573
"AML-3133"	"2019-07-01-count-3:CTATCCGGTGTTCCAA"	-6.97811971131023	2.33066437328187	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATCCGGTGTTCCAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2286.08508176689	43.934814831317	0.0192183638228199	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2283.270850456	2283.270850456
"AML-3133"	"2019-07-01-count-2:CAGAGCCAGGCGATAC"	4.00056161460225	-10.9148702851501	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGAGCCAGGCGATAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2278.46249189072	41.0064685995491	0.017997429734084	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2277.13832867945	2277.13832867945
"AML-3133"	"2019-07-01-count-3:CCGTTCAGTCAGTTTG"	4.04451765593831	-10.8552437058655	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGTTCAGTCAGTTTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.30923289118	44.0661887960463	0.0206176009151643	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2132.90235183647	2132.90235183647
"AML-3133"	"2019-07-01-count-3:TTTCAGTGTCCGGTCA"	8.20147575911824	7.16623208606569	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTCAGTGTCCGGTCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1652.4752527755	41.089946382295	0.0248656954549124	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1648.80410632184	1648.80410632184
"AML-3133"	"2019-07-01-count-2:CTTCAATCAGACATCT"	-1.31465242329295	11.5418700941834	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCAATCAGACATCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1675.77508771844	41.1490943596067	0.0245552608229968	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1675.77508771844	1675.77508771844
"AML-3133"	"2019-07-01-count-1:GTCAGCGGTACGGGAT"	0.175472048192662	11.5277747877869	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCAGCGGTACGGGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1791.76779204333	40.5839322448287	0.0226502186416393	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1788.67445808142	1788.67445808142
"AML-3133"	"2019-07-01-count-2:GCAACCGCAGTCGAGA"	0.990341086953324	12.3058318861756	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAACCGCAGTCGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1567.61103621224	42.1370314098547	0.026879774661238	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1567.61103621224	1567.61103621224
"AML-3133"	"2019-07-01-count-2:CTCAGTCTCATGTCTT"	1.23523535308186	9.66387078845827	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAGTCTCATGTCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1535.33408404257	34.3748398897782	0.0223891596278958	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1526.71814272123	1526.71814272123
"AML-3133"	"2019-07-01-count-3:CGCCATTGTGGATACG"	0.933472235768479	10.3179454573425	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCCATTGTGGATACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1687.83344687971	40.1515805899837	0.0237888286099625	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1684.4638057608	1684.4638057608
"AML-3133"	"2019-07-01-count-1:GCTGGGTGTGAGTAGC"	1.35344423827474	11.6952934035095	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGGGTGTGAGTAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1984.13877935889	32.3841035808706	0.016321491176809	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1979.61640981612	1979.61640981612
"AML-3133"	"2019-07-01-count-1:GTCTCACGTATCGAGG"	0.0481345281818926	10.54465100849	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTCACGTATCGAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1788.48935619684	38.6674355450057	0.0216201653149508	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1788.48935619684	1788.48935619684
"AML-3133"	"2019-07-01-count-3:CACTAAGAGCTGCCTG"	1.09595229205434	9.54599473560182	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACTAAGAGCTGCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1729.76119950455	36.2623609473086	0.0209637960186036	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1726.24291408599	1726.24291408599
"AML-3133"	"2019-07-01-count-1:GATGTTGCATAATGCC"	0.69940092143361	10.2292308577332	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGTTGCATAATGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1804.57310301815	38.9428047926391	0.0215800649624596	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1798.00048031942	1798.00048031942
"AML-3133"	"2019-07-01-count-1:TTTGTTGAGAGAGCGG"	1.29257585582082	10.9049510725769	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTGTTGAGAGAGCGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1794.67471214208	36.9885107739769	0.0206101476349596	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1789.73912406833	1789.73912406833
"AML-3133"	"2019-07-01-count-1:ATCTCTAGTGTGTCGC"	0.509193499653977	9.00444219196168	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTCTAGTGTGTCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1944.44580493538	40.7152681647308	0.0209392661196252	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.84960205302	1937.84960205302
"AML-3133"	"2019-07-01-count-1:AGGTTACAGTACAGCG"	1.46601368960683	11.2032890089783	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGTTACAGTACAGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1850.47188184439	41.5514783250321	0.0224545310483817	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1844.03040761971	1844.03040761971
"AML-3133"	"2019-07-01-count-1:ACCTGTCAGTAGGTTA"	7.9745155769283	6.86085269534913	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCTGTCAGTAGGTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2050.23446794605	43.7475553027733	0.0213378303734208	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2045.77898691753	2045.77898691753
"AML-3133"	"2019-07-01-count-2:GCACATACAGGTGTGA"	4.02400483664815	-10.6011657944885	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACATACAGGTGTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1635.91186308801	49.1869906335032	0.0300670175107454	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1633.75308581623	1633.75308581623
"AML-3133"	"2019-07-01-count-1:ACGATCAAGATGCGAC"	8.13842453536336	7.45152089679567	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGATCAAGATGCGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1674.44546142101	34.3376053004793	0.0205068520245138	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1671.35371517451	1671.35371517451
"AML-3133"	"2019-07-01-count-1:TTCGCTGAGGACATCG"	0.0982508669490039	11.1801252135071	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGCTGAGGACATCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2067.8272294704	45.8618667670126	0.0221787710856087	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2064.49036495363	2064.49036495363
"AML-3133"	"2019-07-01-count-3:CATTCCGAGACAGCGT"	8.01049294051472	6.49440047824708	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTCCGAGACAGCGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1564.58042709087	43.5710704988486	0.0278484057095507	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1560.8267835431	1560.8267835431
"AML-3133"	"2019-07-01-count-2:TTGAACGGTATTCCTT"	-1.32253632965739	11.7013959654602	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAACGGTATTCCTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1844.49484481572	33.5572365200465	0.0181931853126969	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.15126514163	1841.15126514163
"AML-3133"	"2019-07-01-count-1:GTCATGACACAACGTT"	-2.22976551476176	13.7956752547058	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATGACACAACGTT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2143.73985072677	34.449158161478	0.0160696542305724	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2140.58855460256	2140.58855460256
"AML-3133"	"2019-07-01-count-3:AGGTGTTGTCCAAGAG"	7.98837246474568	6.89817760074464	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGTGTTGTCCAAGAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1782.49125578998	34.1171316572646	0.0191401397041605	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1780.65177277733	1780.65177277733
"AML-3133"	"2019-07-01-count-2:TTGAACGTCAAGGTGG"	-2.62084637108501	10.7297744520935	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAACGTCAAGGTGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1910.98175298245	38.1215233853324	0.0199486590208601	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.36442438317	1909.36442438317
"AML-3133"	"2019-07-01-count-1:GTTCATTCACACCTAA"	-1.38692591610606	11.3162927397522	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTCATTCACACCTAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2046.52297378592	39.2430253485027	0.0191754628954426	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2040.69689991792	2040.69689991792
"AML-3133"	"2019-07-01-count-2:ATTGTTCAGAAACTCA"	3.84508194503133	-10.9528637162414	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTGTTCAGAAACTCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.49306795471	40.8334970142444	0.0177808056919638	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2293.91630457179	2293.91630457179
"AML-3133"	"2019-07-01-count-3:GTGGCGTCATCACAGT"	-2.01117644730266	11.1515741118225	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGGCGTCATCACAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1973.16903157682	35.2459777772499	0.0178626246475619	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1969.69060205299	1969.69060205299
"AML-3133"	"2019-07-01-count-2:GTCACTCGTAGTAAGT"	1.9826623397762	-10.3095255128113	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCACTCGTAGTAAGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.76234225251	38.3639736312828	0.0161889540344443	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2368.59636090335	2368.59636090335
"AML-3133"	"2019-07-01-count-2:TACCTCGTCTATACTC"	3.49673046645467	-10.6911077729431	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCTCGTCTATACTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.4339299041	44.5340296154315	0.0192169576188411	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2313.36821112351	2313.36821112351
"AML-3133"	"2019-07-01-count-1:AGCGCCATCAGTGTGT"	-3.61378059807475	13.3098668822083	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCGCCATCAGTGTGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1986.51652419424	36.0498187166576	0.0181472533843029	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1981.61947367326	1981.61947367326
"AML-3133"	"2019-07-01-count-1:GGTTAACGTATCTTCT"	4.42787136611287	-10.2776031724182	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTTAACGTATCTTCT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1515.79606260924	28.528333101773	0.0188206934992728	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1515.79606260924	1515.79606260924
"AML-3133"	"2019-07-01-count-2:GGCGTCAAGATGCCGA"	1.31717648085896	10.1687602766785	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCGTCAAGATGCCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1745.10795384471	41.980961503035	0.0240563693555721	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1743.06661337999	1743.06661337999
"AML-3133"	"2019-07-01-count-3:TTGTGTTCACTACAGT"	1.16450633582417	10.4774923094544	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTGTTCACTACAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1597.97235813254	33.623078703413	0.0210410890603305	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1596.19871617979	1596.19871617979
"AML-3133"	"2019-07-01-count-3:TATTGCTGTGAGTAGC"	8.59986939009969	7.26159713352052	"2019-07-01-count-3"	"AML3133"	"Pre-B"	"Pre-B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTGCTGTGAGTAGC"	"Pre-B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1699.56748856552	36.9465752864139	0.0217388103355624	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1690.12930105687	1690.12930105687
"AML-3133"	"2019-07-01-count-2:GAGACTTTCATTGCGA"	-7.663069109351	1.19484422290651	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGACTTTCATTGCGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2698.57081139268	42.0789613026649	0.0155930543401041	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2694.49636891671	2694.49636891671
"AML-3133"	"2019-07-01-count-2:CATTGTTCAGTAGGAC"	-7.38190541687663	-0.00997860049875835	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGTTCAGTAGGAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1528.26133982528	54.3716461538258	0.0355774531076222	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1523.7594968402	1523.7594968402
"AML-3133"	"2019-07-01-count-1:TCATATCTCACTGCTC"	3.9776779609615	-10.8502035371033	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATATCTCACTGCTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.90420306361	43.4203964816137	0.0176584335524398	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2452.29171716221	2452.29171716221
"AML-3133"	"2019-07-01-count-2:GGAATCTGTCCTGGTG"	0.914504368870896	10.2343339690003	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAATCTGTCCTGGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1869.17692956469	30.9572434400031	0.0165619652962509	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1865.35449686377	1865.35449686377
"AML-3133"	"2019-07-01-count-2:GTTACCCAGTTCATCG"	4.24561562117879	-10.805371307489	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTACCCAGTTCATCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2072.56579495408	42.3418605545589	0.0204296822120897	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2068.54226005587	2068.54226005587
"AML-3133"	"2019-07-01-count-3:CATTGAGCAGCTCCTT"	-7.47137437287028	1.50925467098085	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGAGCAGCTCCTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2382.62975771856	41.4941350104839	0.017415267678943	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2379.44566783374	2379.44566783374
"AML-3133"	"2019-07-01-count-3:TCTACCGAGCACTCGC"	10.9753033119137	-1.1156181327072	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTACCGAGCACTCGC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1845.24242428805	4.6508127871351	0.00252043456508406	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1836.90712431631	1836.90712431631
"AML-3133"	"2019-07-01-count-2:TACGCTCCAGCTCATA"	-3.42980800095256	10.6293897398743	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACGCTCCAGCTCATA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.77740327489	35.9330755123683	0.016057484296598	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2231.58393473069	2231.58393473069
"AML-3133"	"2019-07-01-count-1:CATAGACCATGAATCC"	1.09821857985799	10.6266383894714	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATAGACCATGAATCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2005.37442411844	24.4209247900233	0.012177738229986	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2000.05326693827	2000.05326693827
"AML-3133"	"2019-07-01-count-3:TTCGATTCAGAGGGTT"	-3.356757025153	12.5238275297913	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCGATTCAGAGGGTT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1668.26539089456	45.9958463358572	0.0275710606878881	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1668.26539089456	1668.26539089456
"AML-3133"	"2019-07-01-count-1:CGCAGGTAGCACTGGA"	3.90665711936299	-10.7974157563415	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGCAGGTAGCACTGGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2192.99885375095	41.20447011252	0.0187890978793915	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2188.38676522255	2188.38676522255
"AML-3133"	"2019-07-01-count-2:ACGGTCGGTATTCCTT"	-7.10719237747844	1.83872959697572	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGGTCGGTATTCCTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2431.42479747648	41.5329449734619	0.0170817312616734	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2427.7003828122	2427.7003828122
"AML-3133"	"2019-07-01-count-1:TGATGGTAGTATGGCG"	-2.31061516228374	10.765746093634	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATGGTAGTATGGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2156.98148031738	44.3117075148803	0.0205433880259187	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2155.51535391466	2155.51535391466
"AML-3133"	"2019-07-01-count-2:TTACAGGGTCAACCTA"	0.197023307054681	11.5010928877625	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTACAGGGTCAACCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1971.25756964376	39.556652603854	0.0200667092991824	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1965.29580715412	1965.29580715412
"AML-3133"	"2019-07-01-count-2:GGAATGGTCTGGAGAG"	1.4107104736263	10.7997131117615	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAATGGTCTGGAGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1781.50538926975	29.1426845321817	0.0163584599337797	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1775.46454482278	1775.46454482278
"AML-3133"	"2019-07-01-count-2:CACGGGTGTACCGCGT"	0.644861658185166	10.0180196532044	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGGGTGTACCGCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1696.24547324086	41.2361737655789	0.0243102631170433	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1689.60623068301	1689.60623068301
"AML-3133"	"2019-07-01-count-2:CATTTCATCTTTCGAT"	-0.603906492621261	13.1610555418762	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTTCATCTTTCGAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1943.05618497549	35.7101512359797	0.018378342073742	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1935.21436580446	1935.21436580446
"AML-3133"	"2019-07-01-count-3:TGCAGGCCAAGAGGCT"	0.821465213864487	11.2321195372376	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCAGGCCAAGAGGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1612.36795467303	37.5729630555909	0.0233029706071096	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1608.89328598337	1608.89328598337
"AML-3133"	"2019-07-01-count-1:TGTCCTGAGCAGCACA"	1.01842453059499	12.5741319426331	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCCTGAGCAGCACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1829.27058718747	29.0646398632802	0.0158886498623298	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1827.50508372067	1827.50508372067
"AML-3133"	"2019-07-01-count-2:GAGATGGTCGCCACTT"	-8.45827517929729	-3.25882198726805	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGATGGTCGCCACTT"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2490.92150179307	47.3240578203186	0.0189986146838641	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2486.95533048857	2486.95533048857
"AML-3133"	"2019-07-01-count-3:GATGTTGCAGGTGACA"	1.41493417796437	11.0626954802307	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGTTGCAGGTGACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1841.38568487283	39.4754006358839	0.021437877442069	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.89216005907	1834.89216005907
"AML-3133"	"2019-07-01-count-3:CATTGCCTCACCATAG"	3.51029934462849	-10.7623243561951	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGCCTCACCATAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2045.63535429549	42.2602248015045	0.0206587282101696	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2042.68674099151	2042.68674099151
"AML-3133"	"2019-07-01-count-1:TTCTAGTTCCAGCTCT"	1.56776001033131	11.2104654082092	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCTAGTTCCAGCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2092.53227456433	33.0222958858319	0.0157810210562737	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2087.49063872605	2087.49063872605
"AML-3133"	"2019-07-01-count-1:CAAGGGATCCTTTGAT"	1.23510171946828	11.4959430464539	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGGGATCCTTTGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2389.18662905399	43.2528203150612	0.0181035754131051	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2378.87897553582	2378.87897553582
"AML-3133"	"2019-07-01-count-1:CCTACGTCAGACAATA"	1.12290944632832	10.2985172041687	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTACGTCAGACAATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2005.86816822874	39.6112693175413	0.0197476932656645	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1998.96464237069	1998.96464237069
"AML-3133"	"2019-07-01-count-3:GATAGCTCAAAGGGTC"	1.61288930949513	-9.70978357708129	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATAGCTCAAAGGGTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2249.63844613198	40.0039729975189	0.0177824010192845	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2246.10372172483	2246.10372172483
"AML-3133"	"2019-07-01-count-3:GGAATGGGTACTGGGA"	0.0574710961313963	11.7574214705261	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAATGGGTACTGGGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1698.4758231368	42.4477264448691	0.0249916577360962	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1694.87418485756	1694.87418485756
"AML-3133"	"2019-07-01-count-2:ATGCATGAGAGTGGCT"	3.45664610442464	-10.3854017487732	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGCATGAGAGTGGCT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2106.84552464138	41.3629597914346	0.0196326495263459	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2101.50341453523	2101.50341453523
"AML-3133"	"2019-07-01-count-3:TACTTGTGTTTACCAG"	4.19218792495076	-10.2293806306091	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACTTGTGTTTACCAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1680.54782605959	51.9733487854887	0.0309264324284965	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1678.51541459255	1678.51541459255
"AML-3133"	"2019-07-01-count-1:TTCATTGTCGAGAATA"	1.23014201697652	11.2213916548523	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCATTGTCGAGAATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1960.59459115672	32.8558154929832	0.0167580873889889	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1956.05333476673	1956.05333476673
"AML-3133"	"2019-07-01-count-1:ATGATCGTCCCTTGTG"	4.29317774352376	-10.7335767976013	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGATCGTCCCTTGTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2235.95429091322	45.2424035751784	0.0202340467151054	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2231.68937747534	2231.68937747534
"AML-3133"	"2019-07-01-count-3:TTTGTTGCATCGAGCC"	4.09175219115559	-10.8354635468689	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGTTGCATCGAGCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2276.38091943723	40.5824612266128	0.0178276231715409	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2273.96567242104	2273.96567242104
"AML-3133"	"2019-07-01-count-1:GTTGAACTCTACTATC"	4.59697641906087	-10.2394752732483	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGAACTCTACTATC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1563.94067434061	47.2013040397462	0.0301810067441639	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1561.73264130938	1561.73264130938
"AML-3133"	"2019-07-01-count-1:TCGGGCAGTGGTCTTA"	0.986262996762437	11.7306556471619	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGCAGTGGTCTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1830.11364281216	40.4688156941922	0.0221127337382216	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1823.42776361299	1823.42776361299
"AML-3133"	"2019-07-01-count-3:CCTCACACAGCTGTGC"	-1.7739819091862	13.98872182453	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCACACAGCTGTGC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2331.42702538193	36.6967288058166	0.0157400289206157	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2328.00806206075	2328.00806206075
"AML-3133"	"2019-07-01-count-3:TTCTAACGTATGCTAC"	1.540011425584	-10.2998161545959	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTAACGTATGCTAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2347.0071270444	41.0499876687888	0.0174903549272487	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2343.26808576749	2343.26808576749
"AML-3133"	"2019-07-01-count-1:TGTGATGAGACGGTCA"	1.16296710547749	11.2816257246765	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGATGAGACGGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1914.25330497644	42.8036879591521	0.0223605140698341	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.04940680858	1909.04940680858
"AML-3133"	"2019-07-01-count-1:ACGGTTATCTCCCTAG"	1.03546227988545	-10.5221939316955	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTTATCTCCCTAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2135.95782249062	48.3157064843029	0.0226201594317835	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2130.74154869961	2130.74154869961
"AML-3133"	"2019-07-01-count-1:GACTTCCCACGACCTG"	3.93296017226521	-10.7178411713806	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTTCCCACGACCTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2266.65977843302	38.8464170157545	0.0171381772356722	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2261.15192314257	2261.15192314257
"AML-3133"	"2019-07-01-count-1:TCCCAGTAGAATTGCA"	1.12068559703175	9.51285359943239	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCCAGTAGAATTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1954.33594524445	37.8438784508254	0.0193640599728578	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1945.73774720045	1945.73774720045
"AML-3133"	"2019-07-01-count-3:TCATGTTTCATTGAGC"	-0.478563467890579	8.93129060352174	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGTTTCATTGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1962.0577231452	32.8775021752776	0.0167566436947505	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.0224892791	1955.0224892791
"AML-3133"	"2019-07-01-count-2:TCAAGACCAGCTCTGG"	-0.0505413142150224	10.3292007216248	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAAGACCAGCTCTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2008.55756648406	30.3941889167631	0.0151323464280725	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2000.8155453682	2000.8155453682
"AML-3133"	"2019-07-01-count-2:CATGCTCGTGGCGCTT"	-7.48639998856242	1.15458152377931	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATGCTCGTGGCGCTT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2695.35270965878	41.9049253152841	0.0155471026723583	2579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2689.84377829198	2689.84377829198
"AML-3133"	"2019-07-01-count-2:CTGCATCAGCAATAAC"	8.00713409957234	6.24799630725709	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCATCAGCAATAAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1812.3762549867	35.2585598066059	0.019454326721393	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1812.3762549867	1812.3762549867
"AML-3133"	"2019-07-01-count-3:CATAAGCTCCGATCGG"	-0.149037818343002	11.5364703902039	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATAAGCTCCGATCGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1701.59716320456	42.9506771182339	0.0252413897055084	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1698.18952052467	1698.18952052467
"AML-3133"	"2019-07-01-count-2:GCAGGCTTCTAAACGC"	-7.41211638870891	1.60327062690584	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGGCTTCTAAACGC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2513.06922073383	34.8936884514666	0.0138848895062578	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2509.43369123198	2509.43369123198
"AML-3133"	"2019-07-01-count-2:ACGTAGTAGAAGCCAC"	0.85740884122197	9.07261273944703	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACGTAGTAGAAGCCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1617.63997374495	30.3635698722506	0.0187702890414835	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1609.77323693468	1609.77323693468
"AML-3133"	"2019-07-01-count-1:CAATTTCGTCATCAGT"	1.37023629721944	11.329903579596	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCGTCATCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2189.78351136983	32.743695157266	0.0149529371224386	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2183.45270712169	2183.45270712169
"AML-3133"	"2019-07-01-count-3:GACTGATCATGGAAGC"	-3.89227161827739	11.1913470991882	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTGATCATGGAAGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1869.819725857	44.7643389576809	0.0239404571139413	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1869.819725857	1869.819725857
"AML-3133"	"2019-07-01-count-3:CGGGACTCAGGACTTT"	-0.331182817847091	-10.0719232789245	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGGGACTCAGGACTTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2508.3659232512	41.4122181111226	0.0165096398923513	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2504.20914946324	2504.20914946324
"AML-3133"	"2019-07-01-count-1:TGCACGGTCGCCTTTG"	0.657016475766343	12.8073320158753	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCACGGTCGCCTTTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1758.65197672825	51.4957840094973	0.0292813954613684	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1752.71498060794	1752.71498060794
"AML-3133"	"2019-07-01-count-3:TGTGATGTCCCTTGTG"	0.919578691094559	11.3547973402771	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGATGTCCCTTGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1821.24232959777	40.4178651503226	0.0221924696639623	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1819.72213460091	1819.72213460091
"AML-3133"	"2019-07-01-count-3:CAGCAATAGCTTTGTG"	-4.72978625717815	-4.25467731868895	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes (cycling)"	49	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	1	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCAATAGCTTTGTG"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3011.42391353947	38.4851078239647	0.0127797045281251	3028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	3008.93321199138	3008.93321199138
"AML-3133"	"2019-07-01-count-3:CAGCAATCACGTAGAG"	-0.965883592993575	-9.37123587047728	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCAATCACGTAGAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1705.7217173713	53.5542470060261	0.0313968254379495	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1701.58981587797	1701.58981587797
"AML-3133"	"2019-07-01-count-3:GACTTCCGTTCTATCT"	1.33988132056538	10.3073119887146	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTTCCGTTCTATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1807.43608542737	30.2226388876998	0.0167212766920904	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1804.08152446279	1804.08152446279
"AML-3133"	"2019-07-01-count-1:GGAGAACAGCATGTTC"	0.581821401684922	11.5731181868347	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGAACAGCATGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2010.00974676282	40.0523545392373	0.0199264479208336	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2007.32522395262	2007.32522395262
"AML-3133"	"2019-07-01-count-2:GCAGTTATCTCCAAGA"	0.100152378051919	12.9900140532288	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGTTATCTCCAAGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1857.12880982755	39.7396084977913	0.0213984125858677	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1850.83060527639	1850.83060527639
"AML-3133"	"2019-07-01-count-3:TTACCGCCAGACCATT"	1.06616665896718	10.1804809340271	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACCGCCAGACCATT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1650.91655560581	39.3764892336441	0.0238512898183364	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1649.35692143522	1649.35692143522
"AML-3133"	"2019-07-01-count-3:CAACCAACAAAGCAAT"	-2.46891818466838	13.5146732100281	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACCAACAAAGCAAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1844.34094207536	31.3716663419648	0.0170096892750554	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1844.34094207536	1844.34094207536
"AML-3133"	"2019-07-01-count-2:GGAGGATAGGTTCTAC"	11.5321518379146	-2.99511721050414	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATAGGTTCTAC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2153.14127833545	37.9386343879229	0.0176201323943092	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2149.36942726276	2149.36942726276
"AML-3133"	"2019-07-01-count-2:GGAGGATCAAACTCGT"	-1.20049820366557	11.6813888319763	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATCAAACTCGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1930.59441600374	35.8854245312062	0.0185877594142677	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1923.7201717282	1923.7201717282
"AML-3133"	"2019-07-01-count-1:AATGACCAGCGCACAA"	-1.56171343746837	10.0400590666565	"2019-07-01-count-1"	"AML3133"	"MAIT"	"MAIT"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGACCAGCGCACAA"	"MAIT"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2283.61349056715	39.8683922059603	0.0174584676306404	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2281.15935006551	2281.15935006551
"AML-3133"	"2019-07-01-count-2:TTAGGCAAGAGCATTA"	0.11874790218417	13.287854171637	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTAGGCAAGAGCATTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1814.61454938356	42.7383885964989	0.0235523233355633	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1814.61454938356	1814.61454938356
"AML-3133"	"2019-07-01-count-2:TGACCCTCAGTGCCTG"	10.6738974052364	-0.560482226964556	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-3"	55	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0555555555555556	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGACCCTCAGTGCCTG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1780.27956272493	37.2124640955361	0.020902595791516	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1767.11203977725	1767.11203977725
"AML-3133"	"2019-07-01-count-3:TCTCCGAAGTAAGAGG"	0.0483861179905057	13.3726930388245	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCCGAAGTAAGAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1620.87723752543	34.7386730101446	0.0214320197766364	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1617.06800635615	1617.06800635615
"AML-3133"	"2019-07-01-count-3:CAACCTCCAGTAACCT"	0.799509962170762	-10.2261896363464	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACCTCCAGTAACCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.68811762976	43.8663352174893	0.0185349032222385	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2358.48656635311	2358.48656635311
"AML-3133"	"2019-07-01-count-3:GAGAAATGTTTCGGCG"	1.1772196489269	10.1894035109314	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGAAATGTTTCGGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1826.82599263374	36.884680341479	0.0201905821847335	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1822.11881831491	1822.11881831491
"AML-3133"	"2019-07-01-count-3:CCTCCAAAGGCGTTGA"	1.43996264514272	10.9980754622254	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCCAAAGGCGTTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1805.26504747886	38.739241720384	0.0214590327190377	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1802.44538425664	1802.44538425664
"AML-3133"	"2019-07-01-count-1:GAGACCCGTACAGAGC"	-0.0859294337337792	10.0221757658753	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGACCCGTACAGAGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1396.59868604224	40.9161553000286	0.029297002574146	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1394.25894036989	1394.25894036989
"AML-3133"	"2019-07-01-count-3:TGTGTGAAGTATTGCC"	4.00049652633016	-10.8015852204529	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGTGAAGTATTGCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1792.20218039993	46.2842590127756	0.0258253558214326	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1786.5590763295	1786.5590763295
"AML-3133"	"2019-07-01-count-3:ATCTTCAAGGTCACAG"	3.86693801459615	-10.7631988755432	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCTTCAAGGTCACAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2090.38842336824	42.6243499919095	0.0203906362642541	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2084.62455627184	2084.62455627184
"AML-3133"	"2019-07-01-count-2:CCACGAGCATCCCGTT"	7.99828638610188	7.32129952991334	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACGAGCATCCCGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1737.74802667862	41.0501074921934	0.0236225890416651	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1731.21712463852	1731.21712463852
"AML-3133"	"2019-07-01-count-1:GGAGATGAGCAGGGAG"	8.11410679396931	6.8096303709778	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGATGAGCAGGGAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1689.55804954996	36.6582728051677	0.0216969596368306	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1687.83761464351	1687.83761464351
"AML-3133"	"2019-07-01-count-1:ATGCGATCAGTTGTTG"	0.581635733216447	11.1699199446472	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCGATCAGTTGTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1919.57817684209	48.2557289236565	0.0251387151124225	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1918.23052944596	1918.23052944596
"AML-3133"	"2019-07-01-count-1:TTGAGTGCAACCGACC"	1.47171392020528	11.3919086226257	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAGTGCAACCGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2056.08591070332	38.6402313355052	0.0187931015597921	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2051.35643314843	2051.35643314843
"AML-3133"	"2019-07-01-count-1:TGTTCATGTAGACTGG"	-2.33017478409465	12.9827003248963	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTCATGTAGACTGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2094.91175407088	43.6145892061227	0.020819296622576	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2093.18821249666	2093.18821249666
"AML-3133"	"2019-07-01-count-2:TGGGAAGCATAACAGA"	1.29700340804402	10.8856410750183	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGAAGCATAACAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1869.13273736414	34.9063431390039	0.0186751547609342	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1867.48031404312	1867.48031404312
"AML-3133"	"2019-07-01-count-3:CCTCCTCGTAATGTGA"	3.85356487807576	-10.6422071686951	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCCTCGTAATGTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.71973270015	39.8455844481791	0.0173564672902445	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2292.77277262545	2292.77277262545
"AML-3133"	"2019-07-01-count-1:GGTGGCTCACCGCTGA"	1.0157142477924	11.4529065855774	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGGCTCACCGCTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2001.04243556657	44.5553010165249	0.0222660450496192	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.65623975684	1995.65623975684
"AML-3133"	"2019-07-01-count-2:AGTCACATCAGAGCGA"	0.946121473878068	10.2297916182312	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTCACATCAGAGCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1556.2810584192	39.423780328488	0.0253320440515628	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1550.10011110344	1550.10011110344
"AML-3133"	"2019-07-01-count-3:ATGACCAAGACTTAAG"	-2.49494276467021	13.382957435492	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGACCAAGACTTAAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1944.70732893266	40.7790515652876	0.0209692486671858	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1937.50360197925	1937.50360197925
"AML-3133"	"2019-07-01-count-2:GCATGATTCCGATGCG"	14.3346306281978	1.97423324668733	"2019-07-01-count-2"	"AML3133"	"Plasma cell"	"Plasma cell"	69	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0150943396226415	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCATGATTCCGATGCG"	"Plasma cell"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	1289.31280364366	21.3912218432799	0.0165911808079678	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1281.99547528343	1281.99547528343
"AML-3133"	"2019-07-01-count-1:GCAGGCTCACATATCG"	-1.33267734471019	11.5901145705017	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAGGCTCACATATCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2202.04285015518	34.7667605609381	0.0157884123637685	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2200.51186288541	2200.51186288541
"AML-3133"	"2019-07-01-count-3:TGCGATAGTGATACTC"	-4.80747781220134	8.6490850218567	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.117647058823529	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGATAGTGATACTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	3112.15796110599	41.7288148278381	0.0134083216049254	2497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	3101.52219436065	3101.52219436065
"AML-3133"	"2019-07-01-count-2:AACAAAGAGCACTGGA"	-2.11760840836223	11.9051465758118	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAAGAGCACTGGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1794.77616867002	33.3399826240193	0.0185761228647944	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1792.94350652664	1792.94350652664
"AML-3133"	"2019-07-01-count-1:AGTGCCGTCTTCGGTC"	1.22167040881459	10.613158203009	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTGCCGTCTTCGGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1835.4566505774	36.1271020766739	0.0196828958424646	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1825.96522012511	1825.96522012511
"AML-3133"	"2019-07-01-count-1:TCATTGTGTCGTCATA"	0.95339604195897	-9.93377592479857	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCATTGTGTCGTCATA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2339.86707766872	49.7476376183351	0.0212608819078305	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2330.49489833432	2330.49489833432
"AML-3133"	"2019-07-01-count-2:AACAAAGAGGTAGACC"	0.863638957112473	11.4572753676209	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAAGAGGTAGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2128.63348107364	35.4328266530714	0.0166458091391101	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2124.0659808985	2124.0659808985
"AML-3133"	"2019-07-01-count-1:TCTACATGTAGCACAG"	-3.04752288284953	13.4527625807556	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTACATGTAGCACAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2430.68912707467	33.3540461493175	0.013722053461217	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2422.93683508452	2422.93683508452
"AML-3133"	"2019-07-01-count-3:TCTCTGGCAGCTCATA"	8.03354610976521	6.84412763202516	"2019-07-01-count-3"	"AML3133"	"Pre-B"	"Pre-B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCTGGCAGCTCATA"	"Pre-B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1734.67544915108	29.8648392602523	0.0172163843529737	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1729.57814237861	1729.57814237861
"AML-3133"	"2019-07-01-count-2:TCGATTTGTCTGCGCA"	-3.86047039452251	11.2810678252014	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGATTTGTCTGCGCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2049.5704978857	35.2661026733764	0.0172065819203371	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2046.30443884321	2046.30443884321
"AML-3133"	"2019-07-01-count-1:CTCATTAGTTATGACC"	0.248334993689698	10.554323173407	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCATTAGTTATGACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1721.26983884102	48.801064549406	0.0283517804403435	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1712.89986737564	1712.89986737564
"AML-3133"	"2019-07-01-count-1:TACATTCAGTCAGCGA"	0.92745997485463	11.1269864805969	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACATTCAGTCAGCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2092.98874137439	31.3033609190784	0.0149562968497014	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2091.59345007183	2091.59345007183
"AML-3133"	"2019-07-01-count-1:TCTTGCGTCCTCAGGG"	8.69329704818074	7.65551517093507	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTGCGTCCTCAGGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1887.01211074737	39.0138030163478	0.0206749086527568	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1884.01604153731	1884.01604153731
"AML-3133"	"2019-07-01-count-2:CAACGGCGTGCCTACG"	-7.42706857147868	1.79007587516633	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACGGCGTGCCTACG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2477.81185062458	37.8233406013129	0.0152648154426167	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2473.1833325654	2473.1833325654
"AML-3133"	"2019-07-01-count-3:TGTTCATTCAGATGCT"	0.510229994624299	-10.0333166352478	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCATTCAGATGCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2011.94724812123	51.4241343846781	0.0255593850349199	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2008.78024628176	2008.78024628176
"AML-3133"	"2019-07-01-count-3:CAACGGCTCTACGGTA"	0.34485020217244	11.0691833266052	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGGCTCTACGGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1894.41757872877	41.398349288131	0.0218528109921314	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1892.85199379083	1892.85199379083
"AML-3133"	"2019-07-01-count-2:GGCACGTCACAAGCTT"	3.93638028678243	-10.8868255845276	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCACGTCACAAGCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.99502720563	38.6147569376174	0.0158127909792692	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2435.96964620287	2435.96964620287
"AML-3133"	"2019-07-01-count-2:TAGAGTCAGCATTTCG"	10.7644440132076	-2.1312773457733	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGAGTCAGCATTTCG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2506.7753417637	34.5706856650371	0.0137908990443133	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2498.67534647091	2498.67534647091
"AML-3133"	"2019-07-01-count-3:AGCGATTAGCGATTCT"	-2.41510472717937	8.69773385608522	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCGATTAGCGATTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2260.68364098405	37.1624609299789	0.0164385941740183	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2249.20822278548	2249.20822278548
"AML-3133"	"2019-07-01-count-1:TATATCCGTACTCCCT"	2.2434410053188	-10.3820352784363	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATATCCGTACTCCCT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2140.28355093957	46.4510542974372	0.0217032244522206	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2137.38083388642	2137.38083388642
"AML-3133"	"2019-07-01-count-2:CGAAGGACAATCCTAG"	8.44673504409139	7.4237112768921	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAAGGACAATCCTAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1765.86396776273	44.8702871900291	0.0254098209200552	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1760.99307116555	1760.99307116555
"AML-3133"	"2019-07-01-count-1:CACCAAACACAGCTTA"	7.9509936767513	6.89134261691896	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACCAAACACAGCTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1928.50181473726	36.4901027699962	0.0189214770196976	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1922.66290552865	1922.66290552865
"AML-3133"	"2019-07-01-count-2:ACAACCAAGGCCATAG"	0.211778064339799	10.7792548903259	"2019-07-01-count-2"	"AML3133"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAACCAAGGCCATAG"	"MAIT"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2037.45742807857	40.2745270695275	0.0197670520691608	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2022.36648869117	2022.36648869117
"AML-3133"	"2019-07-01-count-1:GCATCGGTCCTTGACC"	1.30098785933797	10.9887285002503	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATCGGTCCTTGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1918.03828471849	33.6440779928185	0.0175408792727808	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1909.42861970968	1909.42861970968
"AML-3133"	"2019-07-01-count-2:TCGCAGGCAGCTCGGT"	1.44393517550771	10.6404790648255	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGCAGGCAGCTCGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1650.62442720721	48.5775976879244	0.0294298308489931	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1649.17590918191	1649.17590918191
"AML-3133"	"2019-07-01-count-1:ACTATGGCAACAGTGG"	1.41709770736043	11.0644407042297	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTATGGCAACAGTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1800.89941103852	36.4284510931296	0.0202279210431429	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1800.89941103852	1800.89941103852
"AML-3133"	"2019-07-01-count-1:CTTGAGATCAGCCTCT"	2.6842905479366	-10.7190122834411	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTGAGATCAGCCTCT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2280.79959119179	46.791175309561	0.0205152506560698	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2276.41193807229	2276.41193807229
"AML-3133"	"2019-07-01-count-1:GGGAGTACAGTAGTTC"	1.20250966128651	-10.0485878220764	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAGTACAGTAGTTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.7334235392	39.2011850114777	0.0160809974679527	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2434.11982558539	2434.11982558539
"AML-3133"	"2019-07-01-count-3:TACTGCCAGAATTCAG"	0.664450426667374	9.76560018146364	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACTGCCAGAATTCAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2045.21489974777	32.8854909225485	0.0160792349628413	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2041.96133452461	2041.96133452461
"AML-3133"	"2019-07-01-count-2:ATGACCATCAAAGGTA"	1.2778750854427	9.66991612994996	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGACCATCAAAGGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1694.73134906159	31.9510482870326	0.0188531641340822	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1690.52704844901	1690.52704844901
"AML-3133"	"2019-07-01-count-2:TCATATCCAGCGTGAA"	3.35854353484456	-10.7584486237732	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATATCCAGCGTGAA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.09880525423	39.9511208496372	0.0179870975370969	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2214.48954037632	2214.48954037632
"AML-3133"	"2019-07-01-count-2:TTCAATCGTCCCTCAT"	-0.38762209835704	12.811424232367	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCAATCGTCCCTCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2147.08080371242	38.6625769938577	0.0180070432966509	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2143.99235038915	2143.99235038915
"AML-3133"	"2019-07-01-count-3:ATGTCTTTCAGACTGT"	1.21920051154439	11.0014095076355	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGTCTTTCAGACTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1939.92762515064	37.3036495300044	0.0192294027088292	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.0510594345	1937.0510594345
"AML-3133"	"2019-07-01-count-3:GCCAGGTAGCCTCAAT"	0.0497600923640698	10.1038703688416	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCAGGTAGCCTCAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1926.92714034726	29.0415451064617	0.0150714287522194	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1920.37687446634	1920.37687446634
"AML-3133"	"2019-07-01-count-3:CATCCGTAGGTTGTTC"	-0.104252736002761	11.6327981718811	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCCGTAGGTTGTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1876.46379549669	37.4118283716047	0.019937410176199	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.46379549669	1876.46379549669
"AML-3133"	"2019-07-01-count-1:AGTAACCGTGCGTTTA"	-7.8719085258549	0.223110235575117	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAACCGTGCGTTTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2714.84512843176	37.5240973211107	0.0138218187579586	2963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2705.9327465114	2705.9327465114
"AML-3133"	"2019-07-01-count-3:GGTTGTAGTCATCAGT"	-3.67136488381084	10.9163675078186	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTTGTAGTCATCAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1937.31075176656	40.0625379481075	0.0206794588382768	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1931.69112486419	1931.69112486419
"AML-3133"	"2019-07-01-count-1:TCACATTAGTCCCAGC"	1.62432231482808	-10.1564970246521	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACATTAGTCCCAGC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.62554069139	39.3744523785647	0.0153289966773305	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2566.68847408249	2566.68847408249
"AML-3133"	"2019-07-01-count-1:CATGGATGTCAAAGAT"	2.71501817282979	-10.4943142167297	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGGATGTCAAAGAT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2129.36633803015	49.5084737975044	0.0232503317598719	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2128.06812163338	2128.06812163338
"AML-3133"	"2019-07-01-count-3:CTTTCAATCCATTCGC"	1.01848628100697	12.2945260771546	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTTCAATCCATTCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1734.7738534162	37.627975881833	0.0216904213812851	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1733.0202037649	1733.0202037649
"AML-3133"	"2019-07-01-count-1:TTGCCTGTCTAGTGTG"	1.2296060520107	11.1601981886658	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCCTGTCTAGTGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1942.54318916188	29.1338488107328	0.0149977869080495	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1934.18072959282	1934.18072959282
"AML-3133"	"2019-07-01-count-2:ATGAGTCAGAATAACC"	1.29346468028371	10.8176412352356	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGAGTCAGAATAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1875.86839183167	34.8399180972743	0.0185726878543197	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1868.08840755206	1868.08840755206
"AML-3133"	"2019-07-01-count-2:GCCAGTGAGACGGAAA"	0.757755954831284	10.9233188399109	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAGTGAGACGGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1827.12279576131	34.6888516800519	0.0189855064807497	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1820.38204088311	1820.38204088311
"AML-3133"	"2019-07-01-count-3:CAAGCTAAGACTACGG"	0.783477147191209	-10.3082399598328	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAAGCTAAGACTACGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2216.82944085986	45.1548076203382	0.0203690941612647	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2211.90399790782	2211.90399790782
"AML-3133"	"2019-07-01-count-1:GCATTAGGTTACCCAA"	-7.51666627350505	0.822102702501692	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCATTAGGTTACCCAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2469.13867443228	48.1759765719817	0.0195112478172408	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2464.74157760362	2464.74157760362
"AML-3133"	"2019-07-01-count-1:ATGTCTTCATTAGGAA"	8.59883656081502	7.43896291339723	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGTCTTCATTAGGAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1658.02088583005	30.869609116452	0.0186183475614047	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1654.59688616334	1654.59688616334
"AML-3133"	"2019-07-01-count-3:CAGTGCGGTTACCTGA"	3.76821126517598	-11.27139952099	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGTGCGGTTACCTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1838.99128219083	46.3872610572441	0.0252242963337934	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1837.13679353983	1837.13679353983
"AML-3133"	"2019-07-01-count-3:CTTTCGGGTTGCGTAT"	1.07602109488789	12.2586745985779	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTTCGGGTTGCGTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1729.53626593156	40.3805913797349	0.0233476407376663	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1721.65281809803	1721.65281809803
"AML-3133"	"2019-07-01-count-2:AGTGCCGAGCACACCC"	0.742884953587693	10.8581809767517	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGCCGAGCACACCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1904.57770850087	36.9056927449165	0.0193773625408887	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1900.29788214801	1900.29788214801
"AML-3133"	"2019-07-01-count-2:TGAGGGACACAAATAG"	2.12366690215413	-9.65846636211547	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAGGGACACAAATAG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2219.59231581058	48.1344816814544	0.0216861814390793	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2210.80601171107	2210.80601171107
"AML-3133"	"2019-07-01-count-2:GTCTCACTCTTAGGAC"	4.26482023772542	-10.6997585526672	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTCACTCTTAGGAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2105.89434682956	53.008407921935	0.025171446991982	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2104.30739416973	2104.30739416973
"AML-3133"	"2019-07-01-count-3:ACACGCGAGTATTAGG"	-2.40464029732402	13.9007205733093	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACACGCGAGTATTAGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1965.53282359431	34.2894943337112	0.0174453939013886	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1965.53282359431	1965.53282359431
"AML-3133"	"2019-07-01-count-3:TCTTCCTCATCAGCTA"	1.00260283526723	10.5677890547547	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTCCTCATCAGCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1774.46712042733	39.6469159777332	0.0223429983691021	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1769.64593450745	1769.64593450745
"AML-3133"	"2019-07-01-count-3:CAAGGGATCGGCCTTT"	-0.993320683867294	11.0107135542664	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAAGGGATCGGCCTTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1542.2009234628	44.4884010021426	0.0288473442891281	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1542.2009234628	1542.2009234628
"AML-3133"	"2019-07-01-count-2:CTGAGCGTCAGTCACA"	-8.23589930954631	-0.109633766767107	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGAGCGTCAGTCACA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2340.98316877584	45.4921497272828	0.0194329247360936	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2340.00791073563	2340.00791073563
"AML-3133"	"2019-07-01-count-1:CTCCCAATCAGCCTCT"	0.80785890397374	11.2730121382507	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCCAATCAGCCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2445.94145674802	39.6864072160587	0.016225411735252	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2442.05748805257	2442.05748805257
"AML-3133"	"2019-07-01-count-2:GAAGCGAGTCGCTGCA"	-0.0896963578766168	11.0881528624329	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAGCGAGTCGCTGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1846.08261118598	41.6401883164616	0.0225559723406477	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1844.5097342008	1844.5097342008
"AML-3133"	"2019-07-01-count-3:TGTTTGTAGGATTTGA"	1.47413172301595	11.0770807036194	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTTGTAGGATTTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1802.15679927515	43.8979161270225	0.0243585442424759	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1797.45033930768	1797.45033930768
"AML-3133"	"2019-07-01-count-3:TTGATGGTCTTTGCTA"	3.70308913764302	-9.70191767131957	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGATGGTCTTTGCTA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1731.27567124567	47.7582307426642	0.027585572613229	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1727.23431372775	1727.23431372775
"AML-3133"	"2019-07-01-count-1:GCCAACGTCCGGGACT"	-0.758299629122573	12.2227239378723	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAACGTCCGGGACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2062.66533130059	30.3732199736493	0.0147252293005273	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2061.09607336232	2061.09607336232
"AML-3133"	"2019-07-01-count-2:TCATGAGCAAGCTCTA"	4.04736103591268	-10.754364036676	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATGAGCAAGCTCTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1769.76813545548	52.3749484594801	0.0295942431159212	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1769.76813545548	1769.76813545548
"AML-3133"	"2019-07-01-count-2:TCCATGCGTCAGTTTG"	-2.55903468552287	12.8123817213806	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCATGCGTCAGTTTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1984.61240041846	35.3289070255517	0.0178014140283022	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1978.10026156879	1978.10026156879
"AML-3133"	"2019-07-01-count-3:GACTCAAGTAGTTAGA"	-7.5961254638737	-1.4254405728546	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACTCAAGTAGTTAGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2957.86996110489	41.9615770313658	0.0141864171120259	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2951.22709578192	2951.22709578192
"AML-3133"	"2019-07-01-count-2:CCGGTAGCACAAGTGG"	-2.69450459900554	13.3407611616882	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTAGCACAAGTGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2005.56739776555	35.8131634409824	0.0178568735615082	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2000.24590651444	2000.24590651444
"AML-3133"	"2019-07-01-count-3:CGATCGGTCCATATGG"	0.879712899296921	9.76404378497926	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGATCGGTCCATATGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1785.90862092467	42.2170374551341	0.0236389683998926	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1782.42732315853	1782.42732315853
"AML-3133"	"2019-07-01-count-2:GTGGAGAGTCTGTAAC"	4.38839258727376	-10.663263343927	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGAGAGTCTGTAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2172.91238045071	42.4612678816659	0.0195411781274211	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2164.06457632195	2164.06457632195
"AML-3133"	"2019-07-01-count-3:ATGCCTCAGCTAGCCC"	9.4483114677364	6.33369538867799	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGCCTCAGCTAGCCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1808.34982427274	38.6656815785558	0.0213817487410689	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1804.9685626324	1804.9685626324
"AML-3133"	"2019-07-01-count-2:AAGCCATAGGTCCAGA"	3.5452045398647	-10.7542562714783	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCCATAGGTCCAGA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2102.73597073353	51.4303429542598	0.0244587735550643	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2099.81883181147	2099.81883181147
"AML-3133"	"2019-07-01-count-2:GGCTTTCGTGACGTCC"	0.574335237115067	10.0604753264221	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCTTTCGTGACGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1881.87991056654	37.8689000678977	0.0201229099982779	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.60973915259	1876.60973915259
"AML-3133"	"2019-07-01-count-3:GAAATGAAGGATTCAA"	-7.68927417221721	1.33005759799806	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAATGAAGGATTCAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2621.01634102773	40.2595889780905	0.0153602968237521	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2614.77722028845	2614.77722028845
"AML-3133"	"2019-07-01-count-2:ATTCAGGGTAAGCGGT"	-2.35156331482585	10.8318490752014	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCAGGGTAAGCGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1934.04313835519	35.6093367464324	0.0184118627140429	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1930.65761307715	1930.65761307715
"AML-3133"	"2019-07-01-count-2:CCCGAAGTCCGGCAGT"	4.10747971114461	-10.8889446488586	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGAAGTCCGGCAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.87073066725	48.0881533119969	0.0219794307944927	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2181.89732798702	2181.89732798702
"AML-3133"	"2019-07-01-count-3:CGTGTCTCACGACGTC"	1.29683186587636	9.61950585925905	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTGTCTCACGACGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1590.63663917684	34.4220546200342	0.0216404260861536	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1583.29366052848	1583.29366052848
"AML-3133"	"2019-07-01-count-3:GGTCACGTCCCTATTA"	-7.64938435974773	1.51612613284913	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTCACGTCCCTATTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2570.76337560076	45.3011424472513	0.0176216694532086	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2562.27806137305	2562.27806137305
"AML-3133"	"2019-07-01-count-1:TTGGGATTCTTTCAGT"	4.00822248038594	-10.7260866395203	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGGATTCTTTCAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2203.19920676045	47.5510042190248	0.021582707579558	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2200.25780717275	2200.25780717275
"AML-3133"	"2019-07-01-count-1:GAGGGTAGTGATGAAT"	-7.69377313080485	1.72884807670442	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGGTAGTGATGAAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2579.38642523262	44.9984634143966	0.0174454137519695	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2570.35680460976	2570.35680460976
"AML-3133"	"2019-07-01-count-1:ACTGCAATCGGCCTTT"	-7.59795508804973	1.27064476096956	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGCAATCGGCCTTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2841.93856542173	34.7814705958502	0.0122386426712531	2870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2836.68919863437	2836.68919863437
"AML-3133"	"2019-07-01-count-3:ATCAGGTCACTGGCCA"	-0.732504705817062	11.1632051237854	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCAGGTCACTGGCCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1759.13544814327	41.0139550157166	0.0233148363072361	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1755.43100067863	1755.43100067863
"AML-3133"	"2019-07-01-count-1:GCAACATTCCTCACTG"	0.194275741546792	-10.3337965241638	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAACATTCCTCACTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2084.81526650957	45.232692688331	0.0216962593352745	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2081.78726578898	2081.78726578898
"AML-3133"	"2019-07-01-count-1:AGGGCTCTCCAAGCTA"	0.905162711709183	10.5456886061463	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCTCTCCAAGCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1605.27581736504	49.3369045868205	0.0307342227753758	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1605.27581736504	1605.27581736504
"AML-3133"	"2019-07-01-count-1:CAATCGAGTCATCCGG"	-0.672695915133315	8.78752133930055	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATCGAGTCATCCGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2056.53197860892	37.5526134711363	0.0182601651040397	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2050.76015155064	2050.76015155064
"AML-3133"	"2019-07-01-count-2:GATTCGACAATAACCC"	0.979461868374985	9.56374547565309	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCGACAATAACCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1582.59439223422	30.58337545752	0.019324834971988	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1578.59705995934	1578.59705995934
"AML-3133"	"2019-07-01-count-2:CGGAATTTCATTATCC"	-2.72567878189738	-8.08150484478148	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAATTTCATTATCC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2571.93029436257	43.5655515529811	0.0169388539216917	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2566.1163991984	2566.1163991984
"AML-3133"	"2019-07-01-count-1:GGCTGTGCAGCTGTAT"	-7.71265540543254	1.75395498359529	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTGTGCAGCTGTAT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2851.62553955991	32.7524621765409	0.0114855410439323	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2844.20813740415	2844.20813740415
"AML-3133"	"2019-07-01-count-3:TGCTTGCTCCTACAAG"	9.40993752059285	6.53315970981447	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTTGCTCCTACAAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1770.30469564075	41.2033780538502	0.0232747380466824	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1764.69930663273	1764.69930663273
"AML-3133"	"2019-07-01-count-2:TGATCTTAGTGATAGT"	1.43785097178761	10.024161315802	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATCTTAGTGATAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1691.00804665868	28.8081341863617	0.0170360716161491	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1686.26430588661	1686.26430588661
"AML-3133"	"2019-07-01-count-2:CCGTAGGGTATCACCA"	1.03691156682317	11.4477967985901	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGTAGGGTATCACCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1693.4274404079	43.8433392829841	0.0258902969426451	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1688.42231056396	1688.42231056396
"AML-3133"	"2019-07-01-count-2:GTGACGCTCGACCACG"	1.45392181453053	-10.3921299210754	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGACGCTCGACCACG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.86989960512	46.8200423333656	0.0184340317355014	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2534.77546171879	2534.77546171879
"AML-3133"	"2019-07-01-count-1:TTGGTTTAGACCAAAT"	8.16748871383015	7.00548741901246	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGGTTTAGACCAAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1656.73282687567	34.2961661642152	0.0207010844523991	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1653.32732027761	1653.32732027761
"AML-3133"	"2019-07-01-count-2:CTACAGATCTGGCCTT"	-2.52892313423808	11.0374297865662	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACAGATCTGGCCTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1990.9303562849	36.3635525784353	0.0182646030101676	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1988.9570276919	1988.9570276919
"AML-3133"	"2019-07-01-count-3:CATACCCCAAAGGCAC"	0.794595141976517	10.0106115111145	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATACCCCAAAGGCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1754.32709238921	38.3052460826201	0.021834722982276	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1745.99197569288	1745.99197569288
"AML-3133"	"2019-07-01-count-1:GAACGTTTCGGTGCAC"	0.413748522370499	11.5610046156677	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACGTTTCGGTGCAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2342.05944750065	39.1464586138801	0.0167145452501881	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2329.13724297016	2329.13724297016
"AML-3133"	"2019-07-01-count-2:TGTAACGGTAGGTACG"	-7.91108594361003	4.18432614887086	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTAACGGTAGGTACG"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1997.44172293701	31.6794284900681	0.0158600013839138	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1987.26344824824	1987.26344824824
"AML-3133"	"2019-07-01-count-1:TCTGTCGCACAAACGG"	8.05535950240437	8.19755933368532	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTGTCGCACAAACGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2034.91616976382	29.9072895165158	0.0146970621988753	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2033.66312805151	2033.66312805151
"AML-3133"	"2019-07-01-count-2:CCCTCAACACCGTGGT"	8.46600403365437	6.90693090045778	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCTCAACACCGTGGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1523.97298754131	25.4877808518627	0.0167245620888485	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1519.39245107746	1519.39245107746
"AML-3133"	"2019-07-01-count-3:GTAATGCGTGACCGTC"	1.36292316493337	10.551902747992	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAATGCGTGACCGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1659.80730476856	32.1250215762329	0.0193546693546529	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1658.19144325896	1658.19144325896
"AML-3133"	"2019-07-01-count-2:ATGGAGGGTAAGAACT"	1.16771544989888	9.77617642963258	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGAGGGTAAGAACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1568.21895972328	44.0360501452942	0.0280802944462964	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1561.49589898458	1561.49589898458
"AML-3133"	"2019-07-01-count-3:TCAGTCCTCACCGGGT"	2.58866061744038	-10.3111591569153	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTCCTCACCGGGT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1785.32106454625	47.4714553668535	0.0265898701973355	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1783.36736522987	1783.36736522987
"AML-3133"	"2019-07-01-count-1:GAGTGAGGTATCGTGT"	2.60939135131184	-8.76925184642943	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTGAGGTATCGTGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1973.62496777608	46.0891214992501	0.0233525225165672	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1964.95578159165	1964.95578159165
"AML-3133"	"2019-07-01-count-3:CTCTCGATCATGCAGT"	-1.73811409893687	8.73204801166383	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCTCGATCATGCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2602.24999157459	41.513606257476	0.0159529662376353	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2596.62804544516	2596.62804544516
"AML-3133"	"2019-07-01-count-2:GGGACAACAAATAAGC"	1.13586272773091	10.7839383848938	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACAACAAATAAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1832.19828134968	39.516976713126	0.0215680677770399	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1827.58388236448	1827.58388236448
"AML-3133"	"2019-07-01-count-1:CCTCACATCTTCGCTG"	1.40857078608815	11.3018255003723	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCACATCTTCGCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2007.53857096993	35.7577548289257	0.0178117398818642	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1998.76902332969	1998.76902332969
"AML-3133"	"2019-07-01-count-2:GTGAGGAGTCGTTGGC"	4.05060162123982	-10.6758661500183	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGGAGTCGTTGGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1993.47862938918	49.8037853029181	0.0249833555116557	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1990.39594040574	1990.39594040574
"AML-3133"	"2019-07-01-count-1:GGCTTTCCAGTCAACT"	1.2847099500591	10.405828452948	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCTTTCCAGTCAACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1941.11644115768	35.4803799016835	0.018278336708396	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.76551926105	1937.76551926105
"AML-3133"	"2019-07-01-count-2:ACTGCAATCTCGGTCT"	0.0872721756691157	13.0684451826843	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTGCAATCTCGGTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1901.54048681752	42.6015272731628	0.0224036919374049	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1899.95807693725	1899.95807693725
"AML-3133"	"2019-07-01-count-2:CGATGCGCATTGTACG"	-2.4281784099644	13.8819522627625	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATGCGCATTGTACG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2010.69118381141	32.6440766949772	0.0162352513194483	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2008.86921889923	2008.86921889923
"AML-3133"	"2019-07-01-count-3:CACAACAAGATCGACG"	-0.180935676128227	11.4160690077576	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAACAAGATCGACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1741.66661465244	33.3356808173595	0.0191401043901917	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1739.87448248691	1739.87448248691
"AML-3133"	"2019-07-01-count-2:ACATCGAGTAATTGGA"	3.95328869399373	-10.8094949952331	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATCGAGTAATTGGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2376.57532319159	46.9706646825139	0.0197640126210834	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2371.80506363715	2371.80506363715
"AML-3133"	"2019-07-01-count-2:GCCGATGCAAATCGTC"	0.857682068913621	11.777995086554	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGATGCAAATCGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1788.14905370208	34.4785743399029	0.0192817115936283	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1788.14905370208	1788.14905370208
"AML-3133"	"2019-07-01-count-2:ATGGGAGAGTTGAATG"	3.48368610915486	-10.8546180955139	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGGAGAGTTGAATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1968.98375765086	48.9837902603995	0.0248777015402304	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1963.93191805153	1963.93191805153
"AML-3133"	"2019-07-01-count-2:GGGACCTCAATTGAGA"	-7.49424109879191	1.48932025516359	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACCTCAATTGAGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2490.51256095292	41.3150108364636	0.0165889590296448	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2477.7244856126	2477.7244856126
"AML-3133"	"2019-07-01-count-3:ATGGGTTAGAGACAAG"	-1.86255011978801	11.5652570494446	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGGGTTAGAGACAAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1908.1350059009	38.2512226357872	0.0200463921669564	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1904.60494799738	1904.60494799738
"AML-3133"	"2019-07-01-count-1:ATCACGATCCGTCACT"	-7.63858638230022	1.61823937976686	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCACGATCCGTCACT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2678.58203577532	34.7742653661452	0.0129823409929947	2977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2672.6522501851	2672.6522501851
"AML-3133"	"2019-07-01-count-3:GCATCTCCATTACTCT"	8.6075550514156	7.13702199542848	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCTCCATTACTCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1702.82359658931	34.4262930664109	0.0202171811192688	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1699.17392765813	1699.17392765813
"AML-3133"	"2019-07-01-count-2:TACCCACTCCTTGACC"	-7.5420335334843	0.636247969511427	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCCACTCCTTGACC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2455.04541230958	46.4744949291546	0.0189301976640154	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2447.54982060413	2447.54982060413
"AML-3133"	"2019-07-01-count-2:TCATTACTCTCTAAGG"	0.416895260184449	10.7711553343567	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATTACTCTCTAAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1914.12720987651	42.3616442798374	0.0221310496299619	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1912.47387735587	1912.47387735587
"AML-3133"	"2019-07-01-count-3:GTTGCTCCACAATTCG"	1.34572281417195	10.1087188490662	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGCTCCACAATTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1977.38614793236	31.421040512136	0.015890189452875	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1975.73722767754	1975.73722767754
"AML-3133"	"2019-07-01-count-3:TACGCTCAGGTAAGAG"	1.35322405871693	-10.1759176484314	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACGCTCAGGTAAGAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1973.35564853701	42.0303542987193	0.0212989251734118	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1968.54587128006	1968.54587128006
"AML-3133"	"2019-07-01-count-1:CAGTTCCTCCACTTTA"	1.21163537082021	11.5970144041809	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGTTCCTCCACTTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1650.34157738852	26.5191816112468	0.0160689047495309	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1648.37187203845	1648.37187203845
"AML-3133"	"2019-07-01-count-1:AGACCATAGACTTGTC"	1.22189118441884	11.3148498305115	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATAGACTTGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2309.01612928292	31.8621597154724	0.0137990199857839	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2307.01662974832	2307.01662974832
"AML-3133"	"2019-07-01-count-1:TTATTGCAGAAGTGTT"	8.25309624251668	7.08890292728273	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTATTGCAGAAGTGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1976.63134853163	41.4288859077406	0.0209593386943482	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1968.55793582533	1968.55793582533
"AML-3133"	"2019-07-01-count-3:TTACTGTAGAGCCCAA"	1.05059339579884	11.668921447638	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTACTGTAGAGCCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1661.39325379111	36.2228888951182	0.021802718177928	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1654.88150046569	1654.88150046569
"AML-3133"	"2019-07-01-count-3:TCATACTTCCCTATTA"	2.74681295928304	-9.26468279277953	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.127118644067797	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATACTTCCCTATTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1703.37005348825	51.4733910975212	0.0302185605483149	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1697.3079477963	1697.3079477963
"AML-3133"	"2019-07-01-count-1:GTGGAAGTCCTTCTTC"	1.29940988597218	11.6355161436829	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGAAGTCCTTCTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1852.04327360236	38.8530025489011	0.0209784528810329	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1844.00136361329	1844.00136361329
"AML-3133"	"2019-07-01-count-1:CCTCCAATCACCCTCA"	1.36983348903005	10.9416131743225	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCCAATCACCCTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2192.3517806319	32.0305699119556	0.0146101415817143	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2184.40168250021	2184.40168250021
"AML-3133"	"2019-07-01-count-3:GTCTAGAGTGCATTTG"	0.869664509862107	9.5021180876526	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCTAGAGTGCATTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1738.34808781684	38.5130065607656	0.0221549451635623	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1738.34808781684	1738.34808781684
"AML-3133"	"2019-07-01-count-2:TAAGCACGTTGCATCA"	1.18105818805043	11.4067592390808	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAAGCACGTTGCATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1901.35907468026	34.9555174127911	0.0183844902723961	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1898.44432802742	1898.44432802742
"AML-3133"	"2019-07-01-count-3:GGATCTACAATCGCCG"	-0.0115096298163712	13.312286353949	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGATCTACAATCGCCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1594.7432670775	36.3403525713765	0.0227875880222233	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1594.7432670775	1594.7432670775
"AML-3133"	"2019-07-01-count-2:GCCTGTTTCATTTGGG"	0.825915475457352	10.2970103987488	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCTGTTTCATTTGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1817.26894169919	35.9291807280098	0.0197709760528979	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1810.77685258301	1810.77685258301
"AML-3133"	"2019-07-01-count-1:TTCAATCAGTGCAAAT"	-3.39708671990092	13.3071698912415	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCAATCAGTGCAAAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2112.28899716475	41.9285374851289	0.0198498110539837	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2107.34323173213	2107.34323173213
"AML-3133"	"2019-07-01-count-1:ACATCCCTCACGGTCG"	1.99570419368092	-8.77917768871459	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACATCCCTCACGGTCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2058.30519302766	51.8033162349303	0.0251679471102778	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2052.93929245067	2052.93929245067
"AML-3133"	"2019-07-01-count-2:CCTACGTCATATACCG"	1.30814256247823	10.9492330321106	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTACGTCATATACCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1881.17514201922	37.0196245957632	0.0196789888239896	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1878.0660965908	1878.0660965908
"AML-3133"	"2019-07-01-count-3:GGGATCCTCGCATTGA"	-7.65865359726604	1.6601741083893	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATCCTCGCATTGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2500.57198305119	39.8703769210114	0.015944502774266	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2496.15567251634	2496.15567251634
"AML-3133"	"2019-07-01-count-1:TTGTTTGGTGGTCAAG"	4.2940751510555	-10.6720857850281	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTTGGTGGTCAAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2034.02638605527	48.5081620849288	0.0238483445531914	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2030.70893777733	2030.70893777733
"AML-3133"	"2019-07-01-count-2:ATGTCCCAGGCATCAG"	1.43613483485524	-8.83721735393675	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGTCCCAGGCATCAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2311.9262145406	46.5562261681733	0.0201374186924147	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2307.05720750033	2307.05720750033
"AML-3133"	"2019-07-01-count-3:AAGACTCTCCCTTGTG"	-7.67095313492473	1.51347241485444	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGACTCTCCCTTGTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2669.75008660964	41.4273173859718	0.0155173016357427	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2667.4257423844	2667.4257423844
"AML-3133"	"2019-07-01-count-2:TGCACGGGTCATACCA"	8.74278606948201	6.80434987628785	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCACGGGTCATACCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1641.16988044751	38.7192225607337	0.0235924525681497	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1630.24300503636	1630.24300503636
"AML-3133"	"2019-07-01-count-1:TTGTTTGTCATACGAC"	-4.49905476990398	4.02553365314332	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTTTGTCATACGAC"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2998.10747719702	48.6114643924713	0.0162140499505772	3052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2988.44040681788	2988.44040681788
"AML-3133"	"2019-07-01-count-2:ACTTATCAGGTCTGGA"	-2.54268846932109	13.2068643339905	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCAGGTCTGGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1900.56891719651	40.3755365955029	0.021243921349119	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1898.62457235189	1898.62457235189
"AML-3133"	"2019-07-01-count-3:TAGGGTTTCGACGATT"	0.202482526271981	-9.81617929851683	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAGGGTTTCGACGATT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2239.33597384215	45.8944891784614	0.020494686690411	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2236.05506890449	2236.05506890449
"AML-3133"	"2019-07-01-count-1:GGGAGATCAGTCGGTC"	1.08610906180684	10.6128930815491	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAGATCAGTCGGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1911.66402594768	32.8780709214965	0.0171986659136914	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1902.17477653854	1902.17477653854
"AML-3133"	"2019-07-01-count-3:CGAGTGCAGAGGTGCT"	-3.5374780696934	13.4602002867493	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGAGTGCAGAGGTGCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1964.18692344854	42.704335257552	0.0217414823140028	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1962.21967266566	1962.21967266566
"AML-3133"	"2019-07-01-count-1:TCTTTGATCCAGCTCT"	-0.930543999106246	10.4102239378723	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTTGATCCAGCTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2063.2120041823	41.9204833537441	0.0203180687533651	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2058.46152349668	2058.46152349668
"AML-3133"	"2019-07-01-count-2:AGGAGGTAGCCGGAAT"	1.26804055747334	10.1566133269104	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGAGGTAGCCGGAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1507.77019472644	49.5788284561724	0.0328822181454301	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1503.39958753486	1503.39958753486
"AML-3133"	"2019-07-01-count-3:ACCAAACGTCCGGATC"	-4.23630938950236	10.5190772780213	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCAAACGTCCGGATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1829.55825350425	40.6235796813307	0.0222040372879749	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1827.65954309945	1827.65954309945
"AML-3133"	"2019-07-01-count-1:CACCAAATCGGCCTTT"	-7.258537153632	4.12980601871339	"2019-07-01-count-1"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACCAAATCGGCCTTT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2084.9942584526	34.9685963442549	0.0167715552225104	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2074.53576998769	2074.53576998769
"AML-3133"	"2019-07-01-count-3:CACAGATGTTGCACGC"	1.27018656310384	10.3650645979675	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAGATGTTGCACGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1702.88851849054	40.5455159781694	0.0238098475254913	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1698.99500250105	1698.99500250105
"AML-3133"	"2019-07-01-count-2:CTAGACAAGCCACAAG"	-7.56522403183635	1.47268328750459	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAGACAAGCCACAAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2622.97754139264	37.0392115411116	0.0141210555395934	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2615.22257780721	2615.22257780721
"AML-3133"	"2019-07-01-count-1:TTCACGCAGAGCAGCT"	-7.54680858078654	1.18385813320009	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCACGCAGAGCAGCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2446.47908788037	40.6538618266112	0.0166172938195167	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2443.09501144277	2443.09501144277
"AML-3133"	"2019-07-01-count-2:ATGTCTTCAACAAAGT"	0.950451512902421	10.0050382384094	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGTCTTCAACAAAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1360.63567419672	43.2663473270744	0.0317986277646422	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1360.63567419672	1360.63567419672
"AML-3133"	"2019-07-01-count-1:CCCTAACTCTCCGATC"	4.11108555373494	-10.8566169968811	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCTAACTCTCCGATC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2717.64106136126	45.5176478044401	0.016748954985851	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2710.07634345198	2710.07634345198
"AML-3133"	"2019-07-01-count-2:GGGTGTCGTGAATTAG"	-2.41844830933269	10.4256496199402	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTGTCGTGAATTAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1824.55858253665	39.2239605749352	0.021497780860729	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1822.75332314371	1822.75332314371
"AML-3133"	"2019-07-01-count-2:CCTCAACGTTCTATCT"	0.708789189427537	11.1892518767151	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCAACGTTCTATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2180.62483935864	29.5463644120472	0.0135494945663085	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2169.96703731462	2169.96703731462
"AML-3133"	"2019-07-01-count-2:CAAGAGGTCCTGGGAC"	1.02541222152058	10.6629819639954	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGAGGTCCTGGGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1879.50132264908	34.6215581737064	0.0184206085712718	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1878.19473895446	1878.19473895446
"AML-3133"	"2019-07-01-count-2:GGGTGTCTCGCAGTCG"	3.97619595107381	-10.8850708237854	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTGTCTCGCAGTCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.72081317731	49.1490902173911	0.0218564660981398	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2243.68511151319	2243.68511151319
"AML-3133"	"2019-07-01-count-1:CAAGAGGAGTGGAAGA"	11.2015282112056	-0.822448515054308	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-3"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGAGGAGTGGAAGA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1390.75041586681	36.147505008551	0.0259913673914105	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1382.34828994779	1382.34828994779
"AML-3133"	"2019-07-01-count-1:GATAGCTGTGGGATTG"	1.15630926665608	10.568781829718	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATAGCTGTGGGATTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1906.45785579229	43.2188855518258	0.0226697303696046	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1900.96403257516	1900.96403257516
"AML-3133"	"2019-07-01-count-3:AGGCATTAGCATTGAA"	8.00176729735677	7.30166242206422	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGCATTAGCATTGAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1681.23573675235	35.2017713652035	0.0209380342064361	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1675.92203709724	1675.92203709724
"AML-3133"	"2019-07-01-count-3:AAGCATCGTGTCTAAC"	-7.3679498237675	1.38089177692262	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGCATCGTGTCTAAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2222.58481766603	45.2421319764336	0.0203556380016773	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2212.01120969135	2212.01120969135
"AML-3133"	"2019-07-01-count-1:GCGAGAATCAAGGAGC"	3.64647187766377	-10.685627960321	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGAGAATCAAGGAGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2118.76558417559	52.8101521785541	0.0249249622388513	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2116.49974279873	2116.49974279873
"AML-3133"	"2019-07-01-count-3:AGAACAACACGGATCC"	1.24799730357472	11.3054580458435	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAACAACACGGATCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1757.37333402768	38.2630479379371	0.0217728624857662	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1753.36662460912	1753.36662460912
"AML-3133"	"2019-07-01-count-2:ATTACTCCAGCGGATA"	-2.24295936051067	13.6995086439881	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTACTCCAGCGGATA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2009.17384761008	38.5486046374375	0.019186296239766	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2007.3762774169	2007.3762774169
"AML-3133"	"2019-07-01-count-2:CTAGGTATCACTACGA"	-7.5507701438969	0.947776771429457	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAGGTATCACTACGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2592.3947460842	42.882015424255	0.0165414682655981	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2585.13297279988	2585.13297279988
"AML-3133"	"2019-07-01-count-2:GTGCTGGTCGTTCTAT"	4.05186881598775	-10.7985697022644	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGCTGGTCGTTCTAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.79108539551	46.3070015558317	0.0221374887191835	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2081.67306048032	2081.67306048032
"AML-3133"	"2019-07-01-count-1:GTAGCTATCAAGAGTA"	11.046515126794	-0.69792022621306	"2019-07-01-count-1"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGCTATCAAGAGTA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1514.46502458469	30.8073530377004	0.0203420696665799	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1507.59200314742	1507.59200314742
"AML-3133"	"2019-07-01-count-1:TGATGCAGTGTCTTCC"	1.31137623366658	10.9898862608704	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATGCAGTGTCTTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1898.15579546401	29.2813427046104	0.0154262062021376	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1895.94215546178	1895.94215546178
"AML-3133"	"2019-07-01-count-2:CACGAATTCTCTTGCG"	1.51804949817006	-10.2687034836975	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGAATTCTCTTGCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2243.63633615469	44.0610118560921	0.0196382146010378	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2240.06148458474	2240.06148458474
"AML-3133"	"2019-07-01-count-2:CTGTACCCATCGCTCT"	-1.85380051556285	9.69577500903932	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTACCCATCGCTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2145.4788322938	37.1932463582518	0.0173356389251752	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2142.13007135764	2142.13007135764
"AML-3133"	"2019-07-01-count-1:AGAAATGTCCAGGACC"	-0.692317108542281	9.41321847522584	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAATGTCCAGGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2280.35634357287	46.5544253623974	0.0204154168683373	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2272.48038095482	2272.48038095482
"AML-3133"	"2019-07-01-count-1:TTTAGTCTCAAGAGTA"	4.22900785979573	-10.767659210321	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTAGTCTCAAGAGTA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2171.40749415304	39.1772439000116	0.0180423269264311	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2168.80934540714	2168.80934540714
"AML-3133"	"2019-07-01-count-1:AGAAATGTCGAACGCC"	1.43425609645192	11.1051559218201	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAATGTCGAACGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1951.05532490185	41.7183135420645	0.0213824349364174	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1945.75636392642	1945.75636392642
"AML-3133"	"2019-07-01-count-1:GGGATGATCAGACATC"	-7.69158730927165	2.07864759052125	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGATGATCAGACATC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2447.10158117943	40.0406116568203	0.0163624640532993	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2437.01211373669	2437.01211373669
"AML-3133"	"2019-07-01-count-3:TCGCTTGTCCTTATAC"	0.484961410134476	9.76658723438112	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGCTTGTCCTTATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1886.30864121245	31.9788298298047	0.0169531269332732	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1885.01228703247	1885.01228703247
"AML-3133"	"2019-07-01-count-2:TCCATCGCAGTTTGGT"	-7.18581138077434	4.29608724201051	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0193548387096774	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCATCGCAGTTTGGT"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2206.94449817907	34.9487025710532	0.0158357868083629	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2194.32889532513	2194.32889532513
"AML-3133"	"2019-07-01-count-3:TCATGCCGTCGTGATT"	8.50688709792439	6.85226342761842	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATGCCGTCGTGATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1671.59607523904	43.3775894725745	0.0259498033736239	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1669.9746115985	1669.9746115985
"AML-3133"	"2019-07-01-count-2:AAGCATCAGGACGCAT"	0.786569495766801	10.4077367552551	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGCATCAGGACGCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1579.2380765924	51.6700242929062	0.0327183247787422	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1572.58301458337	1572.58301458337
"AML-3133"	"2019-07-01-count-3:GGCTGTGTCCGTGGGT"	4.45941557463948	-10.6325454941955	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGCTGTGTCCGTGGGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1803.23772243425	45.7398866772092	0.0253654224887573	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1799.66970589572	1799.66970589572
"AML-3133"	"2019-07-01-count-2:CTGTAGACAGGCAATG"	-1.13441870632823	-8.77172472393187	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGTAGACAGGCAATG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2054.47095100737	46.5220458773236	0.0226442948022762	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2047.3876336832	2047.3876336832
"AML-3133"	"2019-07-01-count-2:TCCATGCGTACTAGCT"	1.27347983893697	11.00154969776	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCATGCGTACTAGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1884.1432597118	37.2072085650933	0.0197475475250139	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1879.50577877391	1879.50577877391
"AML-3133"	"2019-07-01-count-1:ATTTCACCACCCTTGT"	11.3420025306637	-3.10489466106566	"2019-07-01-count-1"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATTTCACCACCCTTGT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2032.49977958631	31.0669318560868	0.0152850849816131	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2024.21839997972	2024.21839997972
"AML-3133"	"2019-07-01-count-1:TGTCCTGCAGTCAGAG"	-6.54376111450847	4.25983903491823	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCCTGCAGTCAGAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1664.21162712218	47.2790431188213	0.0284092734050766	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1656.09903370617	1656.09903370617
"AML-3133"	"2019-07-01-count-3:CCCAACTAGGAAAGTG"	1.21922590312306	10.8638820418152	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCCAACTAGGAAAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1797.99555331033	37.7866166894797	0.0210159678203374	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1797.99555331033	1797.99555331033
"AML-3133"	"2019-07-01-count-2:TTCAGGATCAGCATTG"	3.85350479659383	-10.7970123521057	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCAGGATCAGCATTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2062.40201944296	48.3479700485001	0.0234425536790148	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2060.81413065159	2060.81413065159
"AML-3133"	"2019-07-01-count-3:AGTTAGCCACTGTGTA"	3.76312579688374	-10.2762499085632	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTTAGCCACTGTGTA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1637.5740721603	39.8974394920527	0.0243637464529588	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1635.57860919948	1635.57860919948
"AML-3133"	"2019-07-01-count-2:CATAGACGTATATGGA"	-7.52656398239787	1.40387127483217	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATAGACGTATATGGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3118.24134521471	43.1199313368997	0.013828285422189	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3105.54587321676	3105.54587321676
"AML-3133"	"2019-07-01-count-3:CATCGTCCAGTGTATC"	0.57375212487523	10.0498103865418	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGTCCAGTGTATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1665.09958738122	37.8426047976034	0.0227269318210092	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1657.37263836054	1657.37263836054
"AML-3133"	"2019-07-01-count-2:CCGGTAGCACTAGAGG"	2.03374566611592	-10.2627516022888	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGGTAGCACTAGAGG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2560.29034613655	48.5071033556303	0.0189459384670285	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2550.88361114416	2550.88361114416
"AML-3133"	"2019-07-01-count-2:GAGCCTGGTTCCAGGC"	9.26274075087849	7.14788625324098	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGCCTGGTTCCAGGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1772.57852365033	36.7495594750902	0.0207322603680263	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1771.24265585601	1771.24265585601
"AML-3133"	"2019-07-01-count-3:CACCAAACACATCATG"	-2.54137955132182	10.8864154585632	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAACACATCATG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1697.26768035277	35.5147346609168	0.0209246514689628	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1695.23931455628	1695.23931455628
"AML-3133"	"2019-07-01-count-3:CGCATGGAGCGTACAG"	7.92007364806477	7.69742915714113	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCATGGAGCGTACAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1646.48168672008	41.1657509143964	0.0250022525281782	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1644.77663897796	1644.77663897796
"AML-3133"	"2019-07-01-count-3:CGCATGGCAACGATTC"	1.23219670829121	11.3789853819641	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGCATGGCAACGATTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1887.82243432039	34.9159912888305	0.0184953789371616	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1886.19115593734	1886.19115593734
"AML-3133"	"2019-07-01-count-2:CGGAATTCAAATCAGA"	-8.20525012436565	-0.761276148912035	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGGAATTCAAATCAGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2897.54455528926	42.1604435103956	0.0145504038698679	2903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2889.27976751742	2889.27976751742
"AML-3133"	"2019-07-01-count-1:ATCGATGAGTTAGTGA"	0.782004793255967	11.2888612517151	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCGATGAGTTAGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1980.61732883649	28.5620511174085	0.0144207821983398	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1978.01766410357	1978.01766410357
"AML-3133"	"2019-07-01-count-3:ACCCAAATCCGGCAAC"	1.21172751960103	9.94037435138551	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCCAAATCCGGCAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1807.62055431211	34.6694019705628	0.0191795794133113	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1802.01655279127	1802.01655279127
"AML-3133"	"2019-07-01-count-3:TATCAGGAGCGAAACC"	-7.81602750244792	-1.56893064891966	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATCAGGAGCGAAACC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2877.17938865948	42.1626173597821	0.0146541496598953	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2866.95273822571	2866.95273822571
"AML-3133"	"2019-07-01-count-2:CAGCCAGCACAAGCCC"	1.02709676799123	13.2036523588928	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCCAGCACAAGCCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1864.28508492185	50.1166978198907	0.0268825289786576	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1854.26607168411	1854.26607168411
"AML-3133"	"2019-07-01-count-3:GTTCTATCACATTACG"	0.69900663670842	11.6279725798401	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTCTATCACATTACG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2175.22914204682	37.2764696849593	0.0171368013440108	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2163.09147726981	2163.09147726981
"AML-3133"	"2019-07-01-count-1:TGTGAGTTCTGTCCCA"	3.83197631415669	-10.7604475251404	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGAGTTCTGTCCCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1991.39912281239	46.9412326277408	0.0235719861930275	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1988.75146620479	1988.75146620479
"AML-3133"	"2019-07-01-count-2:AGGTAGGCAATAGTAG"	4.00230946120564	-10.9900493851868	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGTAGGCAATAGTAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2346.69635977599	49.5799477860158	0.0211275513252803	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2340.87680797608	2340.87680797608
"AML-3133"	"2019-07-01-count-2:GTAGCTACAGGACTAG"	1.00262584266011	10.7650565871033	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGCTACAGGACTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1754.76299755864	37.130988007354	0.0211601156731784	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1751.76917310592	1751.76917310592
"AML-3133"	"2019-07-01-count-2:AACCATGGTAGACAAT"	-0.373557458550292	11.4847392805847	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCATGGTAGACAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1878.25459463935	36.4821084681193	0.0194234096763247	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.87447944009	1874.87447944009
"AML-3133"	"2019-07-01-count-2:GATTCGATCACGACTA"	1.15842392024342	-9.88902189647826	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCGATCACGACTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2435.58943371793	43.1052990493765	0.017698097410275	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2430.47006468861	2430.47006468861
"AML-3133"	"2019-07-01-count-1:CAACAACAGGCCCAAA"	1.29612495478932	11.6711530455383	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAACAACAGGCCCAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1967.18267614832	34.8215081168589	0.0177012071827708	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1962.63949994752	1962.63949994752
"AML-3133"	"2019-07-01-count-2:GTAGGAGAGATCGCTT"	4.10552515563313	-10.8479700318542	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGAGAGATCGCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2058.77312970056	43.217851639532	0.0209920418214405	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2056.01605703786	2056.01605703786
"AML-3133"	"2019-07-01-count-2:GCTACCTCAGTTCACA"	0.330992003052872	13.8223972090515	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTACCTCAGTTCACA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1898.55492816361	33.2099696386333	0.0174922353554216	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1888.36000683044	1888.36000683044
"AML-3133"	"2019-07-01-count-1:CGAATTGCAGTGGTGA"	1.4291168647701	11.488308883551	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAATTGCAGTGGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1901.43978837679	40.264408716168	0.0211757474321817	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1896.68594770374	1896.68594770374
"AML-3133"	"2019-07-01-count-3:AAGGTAACATGGTACT"	0.285781060426873	11.3585338362488	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAGGTAACATGGTACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1954.81199108107	39.3342890787423	0.0201217760368808	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1953.35059464237	1953.35059464237
"AML-3133"	"2019-07-01-count-3:GTAATGCAGTTGTACC"	1.99754585799519	-10.3321466675964	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAATGCAGTTGTACC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2146.11514722345	43.6931075608609	0.0203591627492072	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2146.11514722345	2146.11514722345
"AML-3133"	"2019-07-01-count-2:GTGGGAATCTTTCCAA"	1.33978559550588	10.8219613798889	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGGGAATCTTTCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1778.65693681241	34.939045528359	0.0196434988699813	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1770.76268530514	1770.76268530514
"AML-3133"	"2019-07-01-count-2:CCGTGAGTCACTAGCA"	8.38012280043904	6.57901141727296	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCGTGAGTCACTAGCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1623.46933387559	38.8952774070843	0.0239581226423492	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1621.66763040424	1621.66763040424
"AML-3133"	"2019-07-01-count-3:TTCAGGATCGGACTTA"	0.679856558411759	9.64100358569948	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCAGGATCGGACTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1614.26415040246	36.4748941067412	0.0225953689782725	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1614.26415040246	1614.26415040246
"AML-3133"	"2019-07-01-count-2:CTCAAGATCTTCTGTA"	-7.43004165116008	1.61846063220827	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAAGATCTTCTGTA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2429.50761560953	45.411620061502	0.0186916969388091	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2425.18261474502	2425.18261474502
"AML-3133"	"2019-07-01-count-1:TGAGACTGTGAAAGTT"	8.62699665602986	7.43403098666994	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGACTGTGAAAGTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1769.05795752364	39.3842814326335	0.0222628553604679	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1759.25763202599	1759.25763202599
"AML-3133"	"2019-07-01-count-1:GCACATATCAGTAGGG"	1.02626450833623	10.0550498732361	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCACATATCAGTAGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1857.18451900337	35.0251778398295	0.0188592880682772	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1851.75367125512	1851.75367125512
"AML-3133"	"2019-07-01-count-3:GTCACGGAGGTACATA"	9.10976090010945	6.92317245090333	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCACGGAGGTACATA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1616.04910725746	43.8684998731205	0.0271455240290119	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1606.63847255202	1606.63847255202
"AML-3133"	"2019-07-01-count-1:TGCAGGCAGATCGACG"	4.19091333922688	-10.7484874955383	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGGCAGATCGACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.68961764502	50.892585314317	0.0220917717927395	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2301.30027655941	2301.30027655941
"AML-3133"	"2019-07-01-count-2:TGTTACTCAGATCACT"	1.25885393199269	11.5338325270447	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTACTCAGATCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1839.71827540503	33.8057950440443	0.0183755281968928	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1839.71827540503	1839.71827540503
"AML-3133"	"2019-07-01-count-3:ATTCCCGGTGCAGTGA"	8.46730866011922	6.7479791411194	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTCCCGGTGCAGTGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1593.23190181526	42.8479534230516	0.0268937330304725	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1586.16926734453	1586.16926734453
"AML-3133"	"2019-07-01-count-3:GTGCGTGAGCAGAAAG"	0.712680478661698	10.9076900252136	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGCGTGAGCAGAAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1985.59038516431	42.2873031355477	0.0212970930215541	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1982.63332755004	1982.63332755004
"AML-3133"	"2019-07-01-count-3:TTCATTGAGCCAGAGT"	1.37436928328816	10.7829179533753	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCATTGAGCCAGAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1685.01288861574	33.3994196017063	0.0198214623919847	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1683.57037429475	1683.57037429475
"AML-3133"	"2019-07-01-count-3:TCGGTCTCACAAATGA"	3.99273862418477	-10.8196735612121	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGTCTCACAAATGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1850.80465080356	49.1172750880972	0.0265383356729583	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1848.94044644041	1848.94044644041
"AML-3133"	"2019-07-01-count-3:TTCATTGCATATGAAG"	-5.85771594467815	3.22383043849794	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCATTGCATATGAAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2201.18458407893	44.7215819338472	0.0203170521260763	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2196.69559145746	2196.69559145746
"AML-3133"	"2019-07-01-count-1:TGAGCGCAGTCATGCT"	-7.60628638687785	1.03872088277666	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGCGCAGTCATGCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2500.76650623072	39.1123680946354	0.0156401519282932	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2491.02131882067	2491.02131882067
"AML-3133"	"2019-07-01-count-1:AGGACGACACTGGCCA"	9.1573015647823	7.3333267935547	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGACGACACTGGCCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2012.95355059655	40.9640827366751	0.0203502374530873	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2006.1112012803	2006.1112012803
"AML-3133"	"2019-07-01-count-3:CTATAGGGTTCGGTCG"	7.84622063216512	6.62307021701661	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTATAGGGTTCGGTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1418.61829324444	36.9522050612095	0.0260480252067654	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1412.56990002873	1412.56990002873
"AML-3133"	"2019-07-01-count-3:TGAGTCAGTCATCGGC"	4.24707903441731	-10.7598562470642	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGTCAGTCATCGGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2190.49435001363	39.2741291483793	0.0179293451033713	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2189.10920807178	2189.10920807178
"AML-3133"	"2019-07-01-count-1:CCATCACGTTTACGAC"	-7.50856719437297	1.36446783626405	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCATCACGTTTACGAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2917.56395903876	45.2260807729619	0.0155013159635624	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2910.8195840718	2910.8195840718
"AML-3133"	"2019-07-01-count-1:CTACGGGTCTGGCCAG"	-1.9640978378361	13.7338571318421	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTACGGGTCTGGCCAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2510.53181894975	37.3867503781678	0.0148919643622792	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2501.18782716343	2501.18782716343
"AML-3133"	"2019-07-01-count-2:CTTCCTTCAATTGGTC"	1.27048601683919	9.88195798480836	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCCTTCAATTGGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1940.09901288041	28.335332766494	0.0146050962236331	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.29163071045	1937.29163071045
"AML-3133"	"2019-07-01-count-1:GTCATGATCAGCGCAC"	1.33277132090871	10.9179935225281	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCATGATCAGCGCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1957.88275333998	36.6034953825466	0.018695448090599	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1953.00887813614	1953.00887813614
"AML-3133"	"2019-07-01-count-3:CACGTGGCATGCGGTC"	2.56709374961202	-10.3149233094421	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACGTGGCATGCGGTC"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2048.6745960217	46.968093666693	0.0229260878022795	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2045.97234829158	2045.97234829158
"AML-3133"	"2019-07-01-count-2:AGACAAAAGCACCGTC"	1.11772241172139	11.2284688719544	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACAAAAGCACCGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1625.94435051478	39.0418439648851	0.0240117959464753	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1621.10313811891	1621.10313811891
"AML-3133"	"2019-07-01-count-1:GAGACCCGTTCGGCCA"	1.27155210551564	-9.94989778911742	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGACCCGTTCGGCCA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.57978916931	38.9819949115329	0.0160117959924549	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2431.88739424765	2431.88739424765
"AML-3133"	"2019-07-01-count-2:CTTAGGAGTAGCTGCC"	1.26956464824025	11.1048755415711	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTAGGAGTAGCTGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1741.51304066733	45.3893341508941	0.0260631606488007	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1737.73878876069	1737.73878876069
"AML-3133"	"2019-07-01-count-2:GCAACATCAACTAGAA"	1.10843839225118	10.9243354567322	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAACATCAACTAGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2012.26174765576	35.9602108988474	0.0178705434025868	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2006.46367984826	2006.46367984826
"AML-3133"	"2019-07-01-count-1:TGGTTAGGTTGATGTC"	0.103382204740685	13.4514741667542	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTTAGGTTGATGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2127.12636168843	34.5905450357055	0.0162616314943551	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2121.84919307503	2121.84919307503
"AML-3133"	"2019-07-01-count-3:CTCCAACGTGCCTTTC"	0.35613047060315	11.0926246413025	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACGTGCCTTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1890.09751141802	41.4264660710253	0.0219176343129226	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1887.56788638004	1887.56788638004
"AML-3133"	"2019-07-01-count-3:GCAACATTCGTGGACC"	1.27616991576497	10.1025037535462	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAACATTCGTGGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.87093001866	34.258370632296	0.0182919015310653	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1866.8685261434	1866.8685261434
"AML-3133"	"2019-07-01-count-3:CTGTGGGCAAGACCGA"	-2.57632646980937	13.2805347212586	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTGGGCAAGACCGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1958.15952130255	37.4130616555068	0.0191062378976254	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1956.4512942283	1956.4512942283
"AML-3133"	"2019-07-01-count-1:AGACCATCAGAGTAAT"	-7.53500924530681	1.43935940349428	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATCAGAGTAAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2459.28832458766	41.7647658256438	0.0169824600914357	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2452.84267033056	2452.84267033056
"AML-3133"	"2019-07-01-count-2:GGGTCACTCTACGCAA"	0.105693225830239	10.076992011908	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTCACTCTACGCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1451.27363127966	48.5006393382594	0.0334193623400255	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1439.44047749931	1439.44047749931
"AML-3133"	"2019-07-01-count-3:CATGGTAAGAATTGTG"	-2.26127133789714	13.2229366072449	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGGTAAGAATTGTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1639.47636515798	49.4231321663929	0.0301456813997013	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1635.27670771735	1635.27670771735
"AML-3133"	"2019-07-01-count-1:GTCAGCGCAAATCAGA"	1.08717753466908	12.4766359099182	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCAGCGCAAATCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1866.95302222839	35.7103473559245	0.0191276089600266	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1860.98988820996	1860.98988820996
"AML-3133"	"2019-07-01-count-3:GGGATCCCACAATTCG"	0.776212473481339	10.9488630064758	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATCCCACAATTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.77189630655	46.2151470694834	0.0238496322284222	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1934.43753034616	1934.43753034616
"AML-3133"	"2019-07-01-count-1:GGGTATTTCACGACTA"	1.31137432631795	-10.0253448716369	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTATTTCACGACTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2574.33216281861	29.6600864784011	0.0115214683275085	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2572.38348678515	2572.38348678515
"AML-3133"	"2019-07-01-count-3:TTCCGGTAGCACAAAT"	-7.57276235047038	1.62532863700715	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCGGTAGCACAAAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2615.74722536676	41.1117861122224	0.0157170332490587	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2610.9568009556	2610.9568009556
"AML-3133"	"2019-07-01-count-1:AGACCATGTCTTCCGT"	1.39861359175984	10.8109683760437	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATGTCTTCCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1891.2658144334	39.1415610880059	0.0206959597055543	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1887.04672693637	1887.04672693637
"AML-3133"	"2019-07-01-count-1:GACCGTGCAAGGTTGG"	0.339189042418641	10.6253814467224	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACCGTGCAAGGTTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2233.78242819558	38.667772164834	0.0173104469248016	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2227.38256310446	2227.38256310446
"AML-3133"	"2019-07-01-count-2:TACCGAAGTCCGTACG"	3.87954439696614	-10.9080867997375	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCGAAGTCCGTACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2357.35185283421	39.541182072518	0.0167735597148886	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2352.18168440344	2352.18168440344
"AML-3133"	"2019-07-01-count-3:TGACCCTAGGTAGACC"	0.985182245343369	12.7570724257263	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGACCCTAGGTAGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1786.42537223734	32.7809646306045	0.0183500330548649	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1783.73174668595	1783.73174668595
"AML-3133"	"2019-07-01-count-1:AACCTGACATTGCTTT"	1.16225840625111	11.5227412947449	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACCTGACATTGCTTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2224.63378253488	28.6338697426469	0.0128712734506889	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2216.94924686037	2216.94924686037
"AML-3133"	"2019-07-01-count-1:CGTGATATCCTACCGT"	4.10024752196614	-10.9468946686951	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGATATCCTACCGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2295.7884786495	45.2705487986414	0.0197189546073826	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2291.41781118827	2291.41781118827
"AML-3133"	"2019-07-01-count-3:GATGATCAGATCACCT"	-7.69512877884563	1.35631904685823	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATGATCAGATCACCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2513.04377261091	37.0814581608563	0.0147555958097502	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2508.95096101065	2508.95096101065
"AML-3133"	"2019-07-01-count-3:TTTCATGGTGATGGCA"	0.82948668774907	11.0952653654846	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTCATGGTGATGGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1779.84403061756	32.2123438260772	0.0180984082155223	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1775.02022145985	1775.02022145985
"AML-3133"	"2019-07-01-count-3:GGGATGACACCATAAC"	0.940098424523514	9.99538610065309	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGATGACACCATAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1686.4826532726	37.2921225073676	0.0221123664895116	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1682.24532880275	1682.24532880275
"AML-3133"	"2019-07-01-count-2:GCACATACACCCAATA"	2.62100710448567	-10.3416137925354	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACATACACCCAATA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2452.3282165897	40.9925065357939	0.0167157504686708	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2448.20449861424	2448.20449861424
"AML-3133"	"2019-07-01-count-1:GGAGGTACAATCCAGT"	1.18971778926198	11.0864639052185	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGGTACAATCCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1764.08010564614	41.5099526498417	0.0235306506303112	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1756.73777097164	1756.73777097164
"AML-3133"	"2019-07-01-count-3:CTGTATTCAAGATTGA"	-0.106484035879928	10.810743308905	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTATTCAAGATTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1775.19652173928	40.9635701373276	0.0230755128436106	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.68410115696	1771.68410115696
"AML-3133"	"2019-07-01-count-1:ATCTCTATCCTAAGTG"	-7.51166615906413	1.41611180389253	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCTCTATCCTAAGTG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2501.45674904962	43.4980199680938	0.0173890753796243	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2496.89666809503	2496.89666809503
"AML-3133"	"2019-07-01-count-1:ACGATCACAGCGCGTT"	-9.06174598160442	-1.3785325518814	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	1	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGATCACAGCGCGTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2923.14404860225	42.501755253997	0.0145397402753107	3187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2918.11189242615	2918.11189242615
"AML-3133"	"2019-07-01-count-2:CTCATGCCAACCACAT"	1.41066231307332	10.872251487616	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCATGCCAACCACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2041.99070021705	34.576376475552	0.0169326806786518	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2037.08533973047	2037.08533973047
"AML-3133"	"2019-07-01-count-2:CATTGAGGTGTATACC"	3.88483848151509	-10.6925859681335	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATTGAGGTGTATACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2380.66904317096	36.9995905241265	0.0155416775087916	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2378.3635836826	2378.3635836826
"AML-3133"	"2019-07-01-count-1:GACGCTGGTCCGGCAT"	1.10563196715657	10.7900810011658	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACGCTGGTCCGGCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1971.5450869244	35.2060733627792	0.0178570977637141	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1962.68519310976	1962.68519310976
"AML-3133"	"2019-07-01-count-1:TTCGATTTCTCGTGAA"	4.02443804320638	-10.6823578110901	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCGATTTCTCGTGAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1805.43838136229	48.0717994746479	0.0266261091881604	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1799.15792834765	1799.15792834765
"AML-3133"	"2019-07-01-count-3:CAGGGCTAGCGTACAG"	1.03979881581609	9.53717801654664	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGGGCTAGCGTACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1680.03616174145	38.6097261053914	0.0229814851517066	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1675.15548008223	1675.15548008223
"AML-3133"	"2019-07-01-count-3:CCGAACGGTCATACCA"	0.891290803521317	12.5985984572205	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGAACGGTCATACCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1636.40498031653	38.7856884939701	0.0237017663478804	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1634.4875591591	1634.4875591591
"AML-3133"	"2019-07-01-count-2:CTCATGCTCCACAGCG"	1.05128737267796	10.7554273375305	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCATGCTCCACAGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2049.33294167922	33.6692241867725	0.0164293578178585	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2037.82755892223	2037.82755892223
"AML-3133"	"2019-07-01-count-3:TTTGTTGAGGGACTGT"	9.08691372451131	6.62677905643312	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGTTGAGGGACTGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1556.34218320279	40.2606354045272	0.0258687554954496	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1550.69038417356	1550.69038417356
"AML-3133"	"2019-07-01-count-2:TGACCCTGTTAGGCTT"	-7.46008286896403	0.106194812152065	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGACCCTGTTAGGCTT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2093.35590866557	47.5752533765376	0.0227267867731412	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2084.52701009357	2084.52701009357
"AML-3133"	"2019-07-01-count-1:CTTGATTAGTGAGTGC"	-7.6923807663029	1.65711221778718	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTGATTAGTGAGTGC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2669.4389598489	40.7282826560311	0.015257244413012	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2665.3619835648	2665.3619835648
"AML-3133"	"2019-07-01-count-3:GTTAGTGCACACCGCA"	0.706405182450455	9.87363240802614	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTAGTGCACACCGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1696.2694993043	33.2271144489639	0.0195883463462566	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1694.68675650365	1694.68675650365
"AML-3133"	"2019-07-01-count-2:GAGACCCAGGCTTAAA"	4.18247761306111	-10.8327121964661	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGACCCAGGCTTAAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2418.49894783034	47.2585023825166	0.0195404271004181	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2417.28411626438	2417.28411626438
"AML-3133"	"2019-07-01-count-1:GTAGCTAAGCAAGTCG"	0.946858723729294	11.3005990752014	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGCTAAGCAAGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1920.26929336851	41.0122656714421	0.0213575594907832	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1914.75948495188	1914.75948495188
"AML-3133"	"2019-07-01-count-3:GACGCTGGTACTGTTG"	-4.28341613236125	13.2738847502503	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACGCTGGTACTGTTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1990.21785380583	40.1349449818595	0.0201661063913736	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1988.30239130106	1988.30239130106
"AML-3133"	"2019-07-01-count-1:GGGAGTAGTAGATTGA"	1.36170377311055	11.321223235968	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGAGTAGTAGATTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1980.4407677598	36.0730248913986	0.0182146446784183	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1973.4443815364	1973.4443815364
"AML-3133"	"2019-07-01-count-1:AGTAACCTCAAGTGGG"	1.40144016322438	10.7417878874573	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAACCTCAAGTGGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1995.26906822232	34.8586888902671	0.0174706707207787	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1992.26402506627	1992.26402506627
"AML-3133"	"2019-07-01-count-1:CTGTCGTTCTACCCAC"	-1.59825036945995	13.6687354811463	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTCGTTCTACCCAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1988.07282216238	39.617692560263	0.0199276868123833	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1981.87406614988	1981.87406614988
"AML-3133"	"2019-07-01-count-3:GGGTAGAAGCGAGGAG"	-7.02923903885539	2.06433556163637	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTAGAAGCGAGGAG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2443.86040774668	43.469894983347	0.0177873886927231	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2434.87741031523	2434.87741031523
"AML-3133"	"2019-07-01-count-2:AGACCCGAGCGCGTTC"	0.337190230458421	10.7751693495545	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACCCGAGCGCGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1704.79780956904	38.1308368058526	0.0223667795628455	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1704.79780956904	1704.79780956904
"AML-3133"	"2019-07-01-count-1:GACTATGGTCCGTACG"	1.10375752028767	12.2704753645691	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTATGGTCCGTACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2008.29518386092	34.6332894606316	0.0172451190138541	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1999.8983459692	1999.8983459692
"AML-3133"	"2019-07-01-count-1:ATACCGAGTCACTCTC"	-2.88450155678447	10.4401178129944	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATACCGAGTCACTCTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2364.00801740523	35.952731269349	0.0152083795844361	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2356.49299234557	2356.49299234557
"AML-3133"	"2019-07-01-count-2:TTGAGTGTCATGCCCT"	-7.67681298676189	1.49343345249025	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAGTGTCATGCCCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2337.85242058041	42.4752038105572	0.0181684709593482	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2335.11113275365	2335.11113275365
"AML-3133"	"2019-07-01-count-1:AAGTTCGAGTAGATCA"	3.90472473677937	-10.8329601517883	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGTTCGAGTAGATCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2221.4608630864	45.0008375816266	0.0202573173038504	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2213.81382802897	2213.81382802897
"AML-3133"	"2019-07-01-count-2:CAGCAATAGTGTTCAC"	-7.5267952484196	1.41097078407136	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAATAGTGTTCAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2247.50758949104	39.2922825451276	0.017482602830287	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2240.6778259622	2240.6778259622
"AML-3133"	"2019-07-01-count-3:ATGCATGAGCCGCTTG"	1.44437470015828	10.839554763678	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGCATGAGCCGCTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1692.62840109664	43.717657248505	0.0258282663933682	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1691.0581682523	1691.0581682523
"AML-3133"	"2019-07-01-count-2:AGTGATCGTGCCGTAC"	1.20509137687032	10.8958272703919	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGATCGTGCCGTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1957.68277086928	36.2864828143114	0.0185354253274645	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.18948038086	1955.18948038086
"AML-3133"	"2019-07-01-count-1:GATTGGTAGAGAGTTT"	0.409525235264939	11.587809539679	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTGGTAGAGAGTTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1995.40638458041	38.3803871849134	0.0192343712446244	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1992.32673432703	1992.32673432703
"AML-3133"	"2019-07-01-count-2:GAGAGGTTCTCAGGCG"	1.30039276656453	10.860379196051	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGAGGTTCTCAGGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1742.13036172452	30.9911040337585	0.0177891991980902	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1740.6409262774	1740.6409262774
"AML-3133"	"2019-07-01-count-1:GGGTTTAGTAAGTCAA"	-8.22814021530803	-0.448539995309435	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGTTTAGTAAGTCAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2791.78346743465	39.8629086601505	0.0142786534575979	2970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2784.24968535037	2784.24968535037
"AML-3133"	"2019-07-01-count-2:CAGCAATTCAGCTAGT"	-0.0962687832420648	9.96628282153932	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAATTCAGCTAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1751.79837033674	51.939274468929	0.0296491167867367	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1747.49550973748	1747.49550973748
"AML-3133"	"2019-07-01-count-3:CTTACCGGTTGCCGAC"	8.35033478316609	6.95618436420289	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTACCGGTTGCCGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1634.85656073095	42.2628782466131	0.0258511231271063	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1631.0805679408	1631.0805679408
"AML-3133"	"2019-07-01-count-1:ACGGTCGAGGTGTGAC"	0.828852792351884	11.271888709906	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTCGAGGTGTGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1912.2097642089	37.2670615569808	0.0194890028565452	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1910.86090659413	1910.86090659413
"AML-3133"	"2019-07-01-count-1:ACGGTCGAGACTAAGT"	1.16287066516225	10.6555995711121	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTCGAGACTAAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1797.79543204049	33.5051373200229	0.0186367907732387	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1796.10912985559	1796.10912985559
"AML-3133"	"2019-07-01-count-1:TCGGGACTCGGCTGAC"	1.32903267916982	11.3114814528259	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGACTCGGCTGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1962.26847920081	34.6855145638368	0.0176762328557423	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.18355377589	1955.18355377589
"AML-3133"	"2019-07-01-count-3:TTTGGTTCATCTATCT"	1.42768480357472	11.4856958159241	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGGTTCATCTATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1949.65582799766	28.1613583103972	0.0144442716021932	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1943.71121106612	1943.71121106612
"AML-3133"	"2019-07-01-count-2:GCAGCTGCAATTTCTC"	0.10108726945464	9.48131749713746	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGCTGCAATTTCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1864.96880226189	29.6024694983474	0.0158729033228034	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1852.48621790779	1852.48621790779
"AML-3133"	"2019-07-01-count-2:TGCTTGCAGCCTCCAG"	1.70494153079335	-10.1114778748718	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCTTGCAGCCTCCAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1996.81537654859	40.5790695223383	0.0203218935505582	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1993.64549783117	1993.64549783117
"AML-3133"	"2019-07-01-count-1:ACGGTCGCATCTATCT"	1.36333932456319	11.5069379576477	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTCGCATCTATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1964.1505695966	52.0322095275721	0.0264909474522915	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1960.91965770461	1960.91965770461
"AML-3133"	"2019-07-01-count-2:GGACGTCTCCGTATAG"	1.71262218531911	-10.1306839219299	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGACGTCTCCGTATAG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2343.99039397681	46.3718465780822	0.0197832920720327	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2340.39931354567	2340.39931354567
"AML-3133"	"2019-07-01-count-1:GCCAGCAAGCATGCAG"	-7.77288184586223	-0.0924345037904606	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCAGCAAGCATGCAG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2481.51602491947	48.2294105324517	0.0194354620514759	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2475.41141204427	2475.41141204427
"AML-3133"	"2019-07-01-count-3:TCGGATACAGTAGGAC"	-0.954480389983016	10.7422446974548	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGATACAGTAGGAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1649.95698275924	34.1576861780246	0.0207021677140348	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1649.95698275924	1649.95698275924
"AML-3133"	"2019-07-01-count-1:AGAACAATCGGCTGAC"	0.705865820019883	11.2806882628235	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAACAATCGGCTGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2060.19914507137	39.4099725300446	0.0191292053607174	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2057.44249241005	2057.44249241005
"AML-3133"	"2019-07-01-count-2:CACGTGGAGAGCACTG"	4.28781857070271	-10.8544302216736	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGTGGAGAGCACTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2230.53172146101	41.8861820798178	0.0187785637284647	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2230.53172146101	2230.53172146101
"AML-3133"	"2019-07-01-count-3:CTACGGGGTCAGGCAA"	3.90255822715108	-10.7632875672546	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTACGGGGTCAGGCAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1756.09713764732	46.8542134444412	0.0266808779764956	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1754.16360524046	1754.16360524046
"AML-3133"	"2019-07-01-count-2:CTGATCCCACCCTCTA"	0.852701624005479	10.3334264525208	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGATCCCACCCTCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1535.54653148933	34.409195518292	0.022408435571743	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1535.54653148933	1535.54653148933
"AML-3133"	"2019-07-01-count-1:AGCTACAAGCTAAATG"	1.20959248122517	11.3881091841492	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCTACAAGCTAAATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2127.14968301116	27.4352607497511	0.012897663464338	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2124.73706465068	2124.73706465068
"AML-3133"	"2019-07-01-count-1:AGGGCTCAGCATAGGC"	-0.296180407435256	11.088297820929	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGCTCAGCATAGGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1890.02058424266	42.7774994153399	0.0226333510714017	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.02058424266	1890.02058424266
"AML-3133"	"2019-07-01-count-3:CTCCAACAGCCGATCC"	-1.45254610005077	11.6099424132141	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACAGCCGATCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1988.0434972442	42.4027543270179	0.0213288866092699	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1982.94911824282	1982.94911824282
"AML-3133"	"2019-07-01-count-3:GGGTTATGTGTTTACG"	1.41556336459462	10.7486209639343	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTTATGTGTTTACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1821.81425513951	36.5061640620424	0.0200383567968332	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1820.34935994746	1820.34935994746
"AML-3133"	"2019-07-01-count-1:TGTTCATAGCAACTTC"	4.10450853881184	-10.9278793565002	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTCATAGCAACTTC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2372.9998138999	40.4267090222812	0.0170361197609375	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2368.24188068428	2368.24188068428
"AML-3133"	"2019-07-01-count-2:TTGCCTGTCCAGCAAT"	1.06085528907124	11.4981736906799	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGCCTGTCCAGCAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1623.7750803724	7.20006716185788	0.0044341530110233	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1621.8186776022	1621.8186776022
"AML-3133"	"2019-07-01-count-1:GGTAGAGGTCTGTAAC"	3.92868985709493	-10.8189048997131	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTAGAGGTCTGTAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.42609622908	43.2203877309378	0.0169863010739403	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2540.12398106909	2540.12398106909
"AML-3133"	"2019-07-01-count-3:AATGACCTCGTGTGAT"	1.06032266196553	10.6366023787293	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AATGACCTCGTGTGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1638.36486344586	41.634646018454	0.0254123162351558	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1634.60899697356	1634.60899697356
"AML-3133"	"2019-07-01-count-3:AGATCCATCAGATGCT"	1.09479202803914	10.6720399626526	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATCCATCAGATGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1663.51183867745	38.7673237665993	0.0233045072870781	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1661.81808431575	1661.81808431575
"AML-3133"	"2019-07-01-count-1:GAACACTTCACCCTTG"	-2.38862429085429	10.0385522612366	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAACACTTCACCCTTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2109.84559805437	34.5389582246449	0.0163703724369668	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2105.69737044995	2105.69737044995
"AML-3133"	"2019-07-01-count-1:TCCTTTCGTGGCTTAT"	1.10907806929891	9.2237977751526	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTTTCGTGGCTTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2027.97987382388	32.0625161188817	0.0158100760923361	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2023.63947344818	2023.63947344818
"AML-3133"	"2019-07-01-count-3:GTAGAAAAGTGTAGAT"	0.809230704873246	11.593910194281	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGAAAAGTGTAGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1585.63289927647	44.3169470638811	0.0279490587538282	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1583.96433993323	1583.96433993323
"AML-3133"	"2019-07-01-count-3:TACGCTCTCATGCGGC"	1.05206527289693	12.3919181593689	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACGCTCTCATGCGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1658.33533394741	42.434677544133	0.0255887194076267	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1653.31724085324	1653.31724085324
"AML-3133"	"2019-07-01-count-1:TAGCACAAGCATTGTC"	8.14883484420125	7.07894322955934	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGCACAAGCATTGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2020.57729274359	40.0296045528639	0.0198109741689271	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2016.25780204275	2016.25780204275
"AML-3133"	"2019-07-01-count-3:AACCAACCATAATGAG"	1.30654062804524	10.6625804671082	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACCAACCATAATGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1720.72221674356	40.1224358302845	0.0233172068331956	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1714.81439282407	1714.81439282407
"AML-3133"	"2019-07-01-count-3:GTCGAATTCATACGGT"	1.19193353232686	11.2259073027405	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCGAATTCATACGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2003.09196942102	32.0684533799315	0.0160094762844067	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1995.16483814916	1995.16483814916
"AML-3133"	"2019-07-01-count-2:CGAGTTAAGCGATGCA"	-7.81062112274821	4.43831775272218	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGAGTTAAGCGATGCA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2063.83913529958	30.2881136555492	0.0146756174633507	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2052.92382872089	2052.92382872089
"AML-3133"	"2019-07-01-count-3:TCGGGCATCGCGCCAA"	-7.84688172760661	0.0050213889214172	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00995024875621891	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGCATCGCGCCAA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2307.47043376458	42.1753750282072	0.0182777531668734	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2302.01322029563	2302.01322029563
"AML-3133"	"2019-07-01-count-2:GATAGCTAGATTGACA"	11.0033489662105	-1.18524100696715	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATAGCTAGATTGACA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1948.16434208409	4.37587366233016	0.00224615222022233	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1943.67508673681	1943.67508673681
"AML-3133"	"2019-07-01-count-3:TCCCATGGTGTGCCTG"	8.27769913253133	7.80242965305177	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCCATGGTGTGCCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1660.96794940329	35.79395975586	0.0215500604745078	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1654.11734181941	1654.11734181941
"AML-3133"	"2019-07-01-count-2:GCAGTTAAGAGAGGTA"	7.94785704192464	6.74884984577028	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGTTAAGAGAGGTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1689.70844164894	34.0085458579771	0.0201268721986079	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1682.79873581579	1682.79873581579
"AML-3133"	"2019-07-01-count-2:GTTCATTGTAGAGTTA"	8.15212978896443	7.04218814456788	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCATTGTAGAGTTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1498.96042550005	37.6839490502023	0.02514005600757	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1496.89329476937	1496.89329476937
"AML-3133"	"2019-07-01-count-2:TCGAACATCAGGAGAC"	3.84826483306233	-10.7825861207214	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGAACATCAGGAGAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2187.7309387307	42.1069467227918	0.019246858001296	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2182.08980138257	2182.08980138257
"AML-3133"	"2019-07-01-count-2:GCAGTTAGTCTACAGT"	3.28028478202168	-9.53931906139525	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAGTTAGTCTACAGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1453.90648478004	48.7032601269446	0.0334982068219558	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1453.90648478004	1453.90648478004
"AML-3133"	"2019-07-01-count-3:AACAACCTCCAAGCCG"	4.02575125274007	-10.8852968445984	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACAACCTCCAAGCCG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2180.97179143695	46.0810617609405	0.0211286830677346	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2176.8135386216	2176.8135386216
"AML-3133"	"2019-07-01-count-1:GTTGCTCTCGCGTGCA"	4.04215826567952	-10.7423477402893	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCTCTCGCGTGCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.28783481231	46.3547644943691	0.0190189947335206	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2430.43908392725	2430.43908392725
"AML-3133"	"2019-07-01-count-2:CAGGCCACAGCAGAAC"	-4.74205956879314	-5.05380680477294	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00601503759398496	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGCCACAGCAGAAC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2965.1845996228	46.6302475945632	0.0157259172331109	2632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2962.10544209306	2962.10544209306
"AML-3133"	"2019-07-01-count-2:GGGACAAAGACATGCG"	0.188762043684167	13.4267253645691	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACAAAGACATGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1758.22184405173	39.6145125023367	0.0225310091763205	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1758.22184405173	1758.22184405173
"AML-3133"	"2019-07-01-count-2:CAATTTCGTATGCTAC"	0.528255035250825	11.4762668379578	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATTTCGTATGCTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1963.82671647525	42.4228869129697	0.0216021538749162	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1959.45069092379	1959.45069092379
"AML-3133"	"2019-07-01-count-3:GCATCGGCACCAACAT"	1.38380922850911	11.0862111815247	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGCACCAACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1748.42853517164	39.3370102041742	0.0224984947413436	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1747.12875808858	1747.12875808858
"AML-3133"	"2019-07-01-count-2:GGTCACGGTTCGATTG"	4.43273462828938	-10.6699495545593	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTCACGGTTCGATTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2369.6160455232	42.9128627415018	0.0181096270100698	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2366.21487844606	2366.21487844606
"AML-3133"	"2019-07-01-count-3:TCACAAGAGGTGATCG"	-2.12564669075664	13.5816201933655	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACAAGAGGTGATCG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1786.74399549585	40.4111842198042	0.0226172212256908	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1784.59253295385	1784.59253295385
"AML-3133"	"2019-07-01-count-1:CTTCCGAAGCCAAGGT"	1.38152184066121	11.3990001448425	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCCGAAGCCAAGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1956.63233712308	39.347798431583	0.020109960203069	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.54570068842	1955.54570068842
"AML-3133"	"2019-07-01-count-2:AGATCGTCACGTAACT"	4.01627244529073	-10.76589586651	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATCGTCACGTAACT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2268.73041872625	44.514122577654	0.019620719240255	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2261.85633143404	2261.85633143404
"AML-3133"	"2019-07-01-count-2:GGAGGATCAGATAAAC"	-0.724063376814681	11.2880363234314	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGGATCAGATAAAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1925.81060427048	42.100872957184	0.0218613776784827	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1921.04522082306	1921.04522082306
"AML-3133"	"2019-07-01-count-1:CATCGTCCACTCCACT"	1.04718418893163	11.7873124846253	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGTCCACTCCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2026.58786829177	37.1699840426441	0.0183411657713983	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2022.62874069271	2022.62874069271
"AML-3133"	"2019-07-01-count-1:TGCAGTAAGCCGAATG"	4.04078425940816	-10.7846412888733	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCAGTAAGCCGAATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2449.45218976086	39.450533827921	0.0161058599113839	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2445.35010544053	2445.35010544053
"AML-3133"	"2019-07-01-count-2:GGGTATTCATAAGATG"	4.37374510344808	-10.7501096955505	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGTATTCATAAGATG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2215.9832709148	43.0313451785189	0.0194186236617006	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2213.21431382518	2213.21431382518
"AML-3133"	"2019-07-01-count-3:TCACAAGTCGCTGTCT"	1.06439616259877	12.4339656599793	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCACAAGTCGCTGTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1758.84194962206	40.144497260795	0.0228243915090956	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1751.32373699483	1751.32373699483
"AML-3133"	"2019-07-01-count-3:GAGAAATCAGGCATTT"	0.617439349263352	11.2786035307678	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGAAATCAGGCATTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2000.32461389402	45.7778949208325	0.0228852330281118	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1998.93175402619	1998.93175402619
"AML-3133"	"2019-07-01-count-3:TTCTCTCTCTGTTCAT"	0.70378871735875	11.6940841444763	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCTCTCTCTGTTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1970.91875673479	38.095240229105	0.0193286710063165	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1968.02296923089	1968.02296923089
"AML-3133"	"2019-07-01-count-2:TTCCTCTTCAGAGTTC"	1.05497493323628	11.2132158049378	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCCTCTTCAGAGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2034.57124884347	45.2472920089936	0.0222392270778003	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2026.62174250373	2026.62174250373
"AML-3133"	"2019-07-01-count-1:CCTCTCCCAGTTAGGG"	3.94583787497823	-10.8112287751404	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCTCCCAGTTAGGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.80343312685	38.368880142035	0.015101081666446	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2535.02209562023	2535.02209562023
"AML-3133"	"2019-07-01-count-2:TTGGGCGCATACGCAT"	4.12345327910726	-10.8004770508972	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGGGCGCATACGCAT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.84893692626	35.3619037014835	0.0142539528203988	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2473.9936431865	2473.9936431865
"AML-3133"	"2019-07-01-count-1:AAAGAACCACCTTCGT"	0.482063998549622	10.9199466475281	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGAACCACCTTCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1454.68593344205	48.966031901326	0.033660895988362	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1452.29120545343	1452.29120545343
"AML-3133"	"2019-07-01-count-2:TCCGGGATCGAGATAA"	3.48099484023396	-10.6676960221496	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCGGGATCGAGATAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2123.08124836816	40.8169513694022	0.0192253364777136	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2118.43619924668	2118.43619924668
"AML-3133"	"2019-07-01-count-2:ATCTCTAAGTCTTGGT"	1.00406869229619	12.0544852980408	"2019-07-01-count-2"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCTCTAAGTCTTGGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1657.01574580127	38.329405338944	0.0231315878778264	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1654.70425695923	1654.70425695923
"AML-3133"	"2019-07-01-count-3:TGTGTGACAATTCTTC"	7.63302578505818	5.91360519016115	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTGTGACAATTCTTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1460.75966385973	50.4697586287652	0.0345503506685078	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1460.75966385973	1460.75966385973
"AML-3133"	"2019-07-01-count-2:CAGGTATCACCAAATC"	0.497345467179459	13.7417344816956	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGTATCACCAAATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2009.54761139825	30.9464485426948	0.0153997090525077	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2000.47169390947	2000.47169390947
"AML-3133"	"2019-07-01-count-2:CGTGCTTCATCTGGGC"	4.70303787764851	-10.6005773774353	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTGCTTCATCTGGGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2209.8987684706	40.0700166043338	0.0181320597920714	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2207.15917153568	2207.15917153568
"AML-3133"	"2019-07-01-count-2:GCGGAAAAGAGGCGGA"	0.566531200974625	4.39307591998903	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGGAAAAGAGGCGGA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1466.66433211485	48.0738283926825	0.0327776624412504	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1463.90001547101	1463.90001547101
"AML-3133"	"2019-07-01-count-3:TTGACCCGTGCTGTCG"	0.970181723206681	10.2872094877991	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGACCCGTGCTGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1767.52623789124	38.950287536311	0.0220366106603209	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1764.38704309488	1764.38704309488
"AML-3133"	"2019-07-01-count-1:GAGACTTTCACCGACG"	1.44787897643391	10.8731994398865	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGACTTTCACCGACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1984.25900358324	32.7361423427034	0.0164979180054556	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1979.21763394478	1979.21763394478
"AML-3133"	"2019-07-01-count-2:CTGGTCTCATGGCCAC"	1.40555324134175	11.0565051802429	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGGTCTCATGGCCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1847.53100030048	36.7163083288264	0.0198731757804632	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1843.41696975858	1843.41696975858
"AML-3133"	"2019-07-01-count-1:CTTCGGTTCTGTTGGA"	0.924836118786973	-9.90111162578734	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTCGGTTCTGTTGGA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.57944009345	42.3138922592408	0.0167144240425964	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2530.6964643847	2530.6964643847
"AML-3133"	"2019-07-01-count-3:GTTACCCGTTCCACAA"	-0.253519217402297	10.1682739027771	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTACCCGTTCCACAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1754.677024525	39.5699544800875	0.0225511327309932	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1748.60094227051	1748.60094227051
"AML-3133"	"2019-07-01-count-1:GTTGTGATCAGGTAAA"	-1.41301534596141	12.6569127806458	"2019-07-01-count-1"	"AML3133"	"NK"	"IFN+ NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGATCAGGTAAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1672.66889075374	47.5633359428605	0.0284355954760584	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1666.52134386403	1666.52134386403
"AML-3133"	"2019-07-01-count-3:CCTCCTCTCTTTGATC"	-6.35891232910808	2.64034650409547	"2019-07-01-count-3"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCTCCTCTCTTTGATC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2339.85154101143	40.9763613688627	0.0175123765976837	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2338.59631150773	2338.59631150773
"AML-3133"	"2019-07-01-count-1:GGTGTCGAGGACAACC"	0.433557112782639	10.845091796759	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTGTCGAGGACAACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2005.82613708633	40.4249900256716	0.020153785653822	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2002.42915550208	2002.42915550208
"AML-3133"	"2019-07-01-count-3:TTGGGTATCACTCCGT"	1.51781990107839	10.6963271864685	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGTATCACTCCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1810.32675599062	39.4747184447745	0.0218053002388366	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1805.69210191669	1805.69210191669
"AML-3133"	"2019-07-01-count-1:GTTGTGATCTCCGCAT"	8.73606266555135	6.5407242544922	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGTGATCTCCGCAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1868.19049599084	39.5014984393202	0.0211442561794907	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1865.05093470145	1865.05093470145
"AML-3133"	"2019-07-01-count-3:TTGGTTTAGAAAGCGA"	8.11389221724812	7.44820687854616	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGTTTAGAAAGCGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1615.79395611125	39.650901437331	0.0245395777644565	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1615.79395611125	1615.79395611125
"AML-3133"	"2019-07-01-count-1:CGAGTGCAGAGCAAGA"	1.51668622073476	10.9584197768006	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGAGTGCAGAGCAAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1878.34840653294	29.1044274247718	0.01549469061413	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.79869474208	1874.79869474208
"AML-3133"	"2019-07-01-count-3:TGTAACGGTTCGGCTG"	8.61125340041463	6.76275441730348	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGGTTCGGCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1560.14236127649	37.1222588216022	0.0237941483694022	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1551.09459877258	1551.09459877258
"AML-3133"	"2019-07-01-count-2:GCAACCGTCTCCTGAC"	1.24116005477254	-10.0949249497619	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCAACCGTCTCCTGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2527.62586623463	41.472858588456	0.0164078312152414	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2526.43847134721	2526.43847134721
"AML-3133"	"2019-07-01-count-2:GGGAGATTCTACTTCA"	1.32088865813557	10.109574294928	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAGATTCTACTTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1666.92445538372	34.7448613943987	0.0208436928753322	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1662.38816846761	1662.38816846761
"AML-3133"	"2019-07-01-count-1:GAGTTTGGTCGTATGT"	0.999427755444688	11.4162635573181	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTTTGGTCGTATGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1964.47189887283	31.9367318901315	0.0162571589384689	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1961.94200575027	1961.94200575027
"AML-3133"	"2019-07-01-count-2:CATCGGGCAGTAACCT"	0.553639073937577	9.90019319141237	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCGGGCAGTAACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1882.77607590534	30.6361393998346	0.0162717913149088	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.49037652604	1876.49037652604
"AML-3133"	"2019-07-01-count-1:TTGATGGTCCTGTACC"	1.3251813846523	10.5035848387512	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGATGGTCCTGTACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1933.1092035197	29.559666456226	0.0152912553529854	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1931.74663958827	1931.74663958827
"AML-3133"	"2019-07-01-count-2:CGCATAAGTCCAGCAC"	-2.045881609351	13.7735194929871	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGCATAAGTCCAGCAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2123.51506287899	34.6584166279927	0.0163212483084551	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2118.17570055645	2118.17570055645
"AML-3133"	"2019-07-01-count-3:GAGAGGTTCACTACGA"	1.43013658103291	10.7594709166321	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGAGGTTCACTACGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1802.80679859452	47.7998226304755	0.0265141126979	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1798.62203084017	1798.62203084017
"AML-3133"	"2019-07-01-count-1:TATATCCCACCAGGTC"	8.57829918441121	7.38355538928834	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATATCCCACCAGGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1969.89014464032	37.3903921889046	0.0189809529686904	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1964.0356747738	1964.0356747738
"AML-3133"	"2019-07-01-count-2:ACAAAGATCCATTCAT"	0.505290885537308	9.8089561232361	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAAAGATCCATTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2085.47220285205	38.6845488186235	0.0185495394116111	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2080.20677869106	2080.20677869106
"AML-3133"	"2019-07-01-count-2:TAGAGTCAGTCATACC"	4.41910423812215	-10.011950515863	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGAGTCAGTCATACC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2132.93873705479	45.598595857283	0.0213782960875128	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2120.5716448007	2120.5716448007
"AML-3133"	"2019-07-01-count-2:TCATACTGTGTCCCTT"	9.53876652297322	6.91122577274171	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00191387559808612	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATACTGTGTCCCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1846.00791123533	36.8741867507785	0.0199750968164067	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1844.23086548114	1844.23086548114
"AML-3133"	"2019-07-01-count-3:TCTGGCTCACTGGAAG"	-2.78111753884013	13.3887758024964	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGGCTCACTGGAAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1924.34000813367	37.224182826185	0.0193438699340284	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1916.80272298452	1916.80272298452
"AML-3133"	"2019-07-01-count-2:TGGGCGTAGCCAAGCA"	1.23226334628407	11.1764640578064	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCGTAGCCAAGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1806.39179221319	33.7032090946162	0.0186577514578513	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1803.16517965125	1803.16517965125
"AML-3133"	"2019-07-01-count-1:TTCACCGTCCTGGTCT"	-2.72418055954631	10.6491307982239	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCACCGTCCTGGTCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2202.16324069867	38.7671843671987	0.0176041374457323	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2196.63700568591	2196.63700568591
"AML-3133"	"2019-07-01-count-3:TGTTCCGGTCCTTAAG"	1.0319473343784	11.3907441862854	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTTCCGGTCCTTAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1764.42734969148	41.2388282435593	0.0233723583182783	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1764.42734969148	1764.42734969148
"AML-3133"	"2019-07-01-count-1:GGTTAACAGGATACAT"	1.42841186103169	11.0915355452332	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTTAACAGGATACAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1927.37781977777	36.4762408732447	0.0189253194152927	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1922.46680687681	1922.46680687681
"AML-3133"	"2019-07-01-count-1:TGACCCTGTATGCTTG"	-2.55758176270183	9.6417083510193	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACCCTGTATGCTTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2105.05366742608	39.1690620664767	0.0186071560419503	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2098.138461934	2098.138461934
"AML-3133"	"2019-07-01-count-3:TCAGTGAGTTGCGGAA"	3.98782052573506	-10.6507988206116	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGTGAGTTGCGGAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2153.62001436254	41.9597231293544	0.0194833456457147	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2147.22819265106	2147.22819265106
"AML-3133"	"2019-07-01-count-3:TTGGGATTCGCGAAGA"	3.9538594680721	-10.8435478440491	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGGGATTCGCGAAGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2190.60367107852	43.4025984257824	0.0198130766412957	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2189.04593355295	2189.04593355295
"AML-3133"	"2019-07-01-count-3:TTGTGTTAGGCTCTCG"	2.04338695582692	-9.70710089122923	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGTGTTAGGCTCTCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1640.17274811954	47.363572346518	0.0288771852847942	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1638.0136716068	1638.0136716068
"AML-3133"	"2019-07-01-count-2:GCGATCGCAGTTGCGC"	1.06543364104573	10.6675910719666	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCGATCGCAGTTGCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.27130228109	39.0652086472601	0.0203118554313824	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1917.71513620438	1917.71513620438
"AML-3133"	"2019-07-01-count-2:AGTTAGCGTAGAGACC"	0.994862516492051	11.5685386427673	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTAGCGTAGAGACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1625.39090702525	34.9379724376136	0.0214951199041442	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1625.39090702525	1625.39090702525
"AML-3133"	"2019-07-01-count-3:TGCTTGCAGCAATTCC"	-2.46069179001506	11.4709806212219	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTTGCAGCAATTCC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1688.73972859958	34.1749450907261	0.0202369521554789	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1684.62026656385	1684.62026656385
"AML-3133"	"2019-07-01-count-3:TTGCCTGTCAAGAATG"	-7.55284343186076	1.29352948749391	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGCCTGTCAAGAATG"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2403.22730801768	40.8413999548098	0.0169943974165715	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2399.57054254773	2399.57054254773
"AML-3133"	"2019-07-01-count-2:CCCGAAGTCTAAGGAA"	-7.57356915894206	4.81789205158082	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCGAAGTCTAAGGAA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2074.68227803609	39.4022719149508	0.0189919547354736	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2066.40727261926	2066.40727261926
"AML-3133"	"2019-07-01-count-2:ACTTCCGTCCGTGTAA"	1.39174201068227	11.2372894057068	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTCCGTCCGTGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1676.25602707491	37.3092451108783	0.0222574860333141	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1674.88764690808	1674.88764690808
"AML-3133"	"2019-07-01-count-1:GTTGCGGAGGTCACCC"	1.13315047797505	12.2106780775818	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTGCGGAGGTCACCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2057.45535183603	31.7960016048168	0.015454042089634	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2049.59215481801	2049.59215481801
"AML-3133"	"2019-07-01-count-3:TCCCAGTTCTATGCCC"	1.21162142333333	9.86970994556276	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCCAGTTCTATGCCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1758.49720214705	37.5196707465679	0.0213362129327007	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1757.00944467122	1757.00944467122
"AML-3133"	"2019-07-01-count-1:GTAGCTAGTATCCCTC"	-2.02744255486186	8.73800275409547	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGCTAGTATCCCTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2048.05315968173	39.7272510259137	0.0193975682897252	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2039.54956364669	2039.54956364669
"AML-3133"	"2019-07-01-count-1:GAGTTACGTGTCTCCT"	-0.693237821490127	12.8999957808289	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTTACGTGTCTCCT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2016.20010494358	37.5789928702221	0.0186385234174332	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2007.9167625164	2007.9167625164
"AML-3133"	"2019-07-01-count-2:CACCGTTTCGGACAAG"	1.46121718463246	11.2103242644104	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCGTTTCGGACAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1836.93382929212	37.4035517800337	0.020361948363947	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1834.27251115723	1834.27251115723
"AML-3133"	"2019-07-01-count-1:TGCGGCAAGGAATTAC"	8.08203281935994	7.22904203021852	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCGGCAAGGAATTAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1923.7014910211	37.0058401808645	0.0192367892594509	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1923.7014910211	1923.7014910211
"AML-3133"	"2019-07-01-count-3:CTTTCGGGTAGGGTAC"	0.929904301732224	10.8850183256897	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTTTCGGGTAGGGTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1491.36234477156	42.6876099865434	0.0286232317291624	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1491.36234477156	1491.36234477156
"AML-3133"	"2019-07-01-count-3:TCTTAGTGTCAGCTTA"	1.12367488917653	10.2472209700379	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTTAGTGTCAGCTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1735.23008738888	36.4896839896532	0.0210287294202936	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1730.43159664499	1730.43159664499
"AML-3133"	"2019-07-01-count-2:CAGCAATAGTGGAAGA"	0.874543328850907	10.2348994978699	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAATAGTGGAAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1828.16156175525	39.1512381802093	0.0214156336065941	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1824.97575188224	1824.97575188224
"AML-3133"	"2019-07-01-count-2:CCCAACTTCATTACCT"	-4.06514058533366	13.1390781172547	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCAACTTCATTACCT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2067.97753294608	37.8227088054618	0.0182897097298629	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2066.3148107629	2066.3148107629
"AML-3133"	"2019-07-01-count-2:ATGAGTCCAACCGCCA"	4.26687111434285	-10.5659609070984	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGAGTCCAACCGCCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2317.99819189699	40.9435765283067	0.0176633341093332	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2311.02460192043	2311.02460192043
"AML-3133"	"2019-07-01-count-1:TCCATCGAGATTGACA"	1.12476326999013	10.2400254973206	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATCGAGATTGACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1929.76723331168	30.0202125158808	0.0155563904276492	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1921.47945396536	1921.47945396536
"AML-3133"	"2019-07-01-count-3:CAGTTAGCACCCTTGT"	0.62322094020192	9.62873361194459	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGTTAGCACCCTTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1580.72410062809	47.6479202772761	0.0301430972415386	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1578.69405047967	1578.69405047967
"AML-3133"	"2019-07-01-count-2:GTCTCACGTTTACGAC"	1.43942298468892	11.0554589995178	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTCACGTTTACGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1935.42063571144	34.0573523994256	0.0175968736568247	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1935.42063571144	1935.42063571144
"AML-3133"	"2019-07-01-count-2:TTCACGCTCTTTCTAG"	0.353720803826493	10.6258430250916	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCACGCTCTTTCTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2250.43264791325	39.2184425307124	0.0174270678871809	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2245.66265144637	2245.66265144637
"AML-3133"	"2019-07-01-count-2:AGTGCCGGTCTACACA"	8.53850998458211	7.58805034244386	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGCCGGTCTACACA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1764.97889176275	32.6096728425074	0.0184759562817994	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1760.00249710348	1760.00249710348
"AML-3133"	"2019-07-01-count-2:TCATCCGAGTCGTTAC"	3.64820398864095	-10.7754593125549	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCATCCGAGTCGTTAC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2148.58973816186	37.1057067669488	0.017269796140185	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2141.85456117178	2141.85456117178
"AML-3133"	"2019-07-01-count-2:ACACGCGCATTGACCA"	4.05416264113728	-10.6058273545471	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACACGCGCATTGACCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.14752480437	52.1381500044938	0.0230480768529907	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2255.09169592079	2255.09169592079
"AML-3133"	"2019-07-01-count-3:TCAGCAATCGTTGCCT"	1.21413852748219	10.7483157881531	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCAATCGTTGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1735.23850610287	37.0616904176263	0.0213582687839623	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1728.46398206697	1728.46398206697
"AML-3133"	"2019-07-01-count-2:GTTGTCCGTTCTTGCC"	1.16047050532643	11.0647439726624	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGTCCGTTCTTGCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1801.89833106792	32.7641482271711	0.0181831281278522	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1797.26161897234	1797.26161897234
"AML-3133"	"2019-07-01-count-2:AGTGCCGTCTGGTGGC"	8.40003838118855	7.21068427646486	"2019-07-01-count-2"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTGCCGTCTGGTGGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1882.38465794597	36.2314325456426	0.0192476242263777	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1880.36930929785	1880.36930929785
"AML-3133"	"2019-07-01-count-3:GGTAGAGGTCCTTTGC"	0.635793288319749	10.2500018843445	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTAGAGGTCCTTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1406.19614789512	45.7126041935084	0.0325079856476167	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1406.19614789512	1406.19614789512
"AML-3133"	"2019-07-01-count-1:GTAGGTTCAGTGCGCT"	1.22493435916249	10.3500003584656	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGGTTCAGTGCGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1552.00151197894	42.3943249273044	0.0273159043983454	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1549.82346066117	1549.82346066117
"AML-3133"	"2019-07-01-count-1:ACAAGCTGTTCGTGCG"	1.3882860141689	10.8798465498718	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAAGCTGTTCGTGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2045.84564913118	36.6551010250925	0.0179168457995152	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2041.68357055758	2041.68357055758
"AML-3133"	"2019-07-01-count-1:AGAGCCCAGTTGCCCG"	1.28657342967336	9.11374566638795	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAGCCCAGTTGCCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1855.78413019956	29.0924010614263	0.0156766083877966	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1854.25545357197	1854.25545357197
"AML-3133"	"2019-07-01-count-1:CTCCCTCAGCAGCGAT"	3.61382903632466	-10.6912088624206	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCCTCAGCAGCGAT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2211.03902164807	48.8837897068622	0.0221089674258327	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2205.85333609	2205.85333609
"AML-3133"	"2019-07-01-count-3:GCCATGGCAGATCACT"	0.973146458237809	9.99738118732301	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATGGCAGATCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1655.5310396003	39.1242941403256	0.0236324739340262	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1653.91466978704	1653.91466978704
"AML-3133"	"2019-07-01-count-3:GCCATGGCAGCAGGAT"	1.11292888697926	10.514187789801	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCATGGCAGCAGGAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1706.92474908782	35.983526530315	0.0210809097176338	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1699.11409231719	1699.11409231719
"AML-3133"	"2019-07-01-count-2:GATGTTGCAGTTACCA"	1.0454966026241	12.3898553618225	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGTTGCAGTTACCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1952.40963502643	40.507454158163	0.0207474156198858	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1950.87109009575	1950.87109009575
"AML-3133"	"2019-07-01-count-1:CCTCAGTTCGCCATAA"	-3.4059501689976	13.421733833197	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCTCAGTTCGCCATAA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2377.02015284101	34.3459688717432	0.0144491702481752	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2374.22569070265	2374.22569070265
"AML-3133"	"2019-07-01-count-1:CTGAGGCAGACTAAGT"	-7.52047334137614	0.758490599039473	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAGGCAGACTAAGT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2551.7485752767	41.3157392330083	0.0161911481535865	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2547.26507079641	2547.26507079641
"AML-3133"	"2019-07-01-count-2:GATGAGGAGTATGAAC"	-7.85214267197307	4.43737933719484	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATGAGGAGTATGAAC"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2173.52886527199	34.8958487662683	0.0160549276910116	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2166.57264658255	2166.57264658255
"AML-3133"	"2019-07-01-count-2:TGATTCTCAATCACGT"	-2.22159800949748	10.1349582442078	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATTCTCAATCACGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2061.70240832007	37.2150096774587	0.0180506214317237	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2055.75462106642	2055.75462106642
"AML-3133"	"2019-07-01-count-2:CTAAGTGGTTTCGATG"	8.52630772170369	7.7571344145569	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAAGTGGTTTCGATG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1851.56854522269	30.9881401654697	0.0167361560798943	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1839.85574646379	1839.85574646379
"AML-3133"	"2019-07-01-count-1:TTGTGGATCCGTCCTA"	-2.57785926285442	9.86703965747682	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGTGGATCCGTCCTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2123.00997644169	45.502666536913	0.0214330912439604	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2114.31460832995	2114.31460832995
"AML-3133"	"2019-07-01-count-3:CTCCAACCATAAGATG"	-2.1619602245396	13.692561126593	"2019-07-01-count-3"	"AML3133"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCAACCATAAGATG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2035.48337431437	37.4965134581172	0.0184214294900579	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2028.84079855932	2028.84079855932
"AML-3133"	"2019-07-01-count-3:CACGTGGGTAATGTGA"	0.948895474045914	10.1356868513855	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACGTGGGTAATGTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1379.03888201158	47.1587613718415	0.0341968322916696	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1374.20454669473	1374.20454669473
"AML-3133"	"2019-07-01-count-2:ACTGTCCTCCATTGTT"	3.92278375205342	-10.8647690049377	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTGTCCTCCATTGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2793.16502902332	47.9233830770713	0.0171573761589835	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2788.58008128767	2788.58008128767
"AML-3133"	"2019-07-01-count-2:TCAAGACAGGTCACCC"	3.45809402045552	-10.7578592530456	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCAAGACAGGTCACCC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2370.53975256838	45.4518892219768	0.0191736456529495	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2365.10834487192	2365.10834487192
"AML-3133"	"2019-07-01-count-3:GACCAATTCTTGCAAG"	1.04345103082005	12.270782447699	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACCAATTCTTGCAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1702.30962836445	39.7282699824374	0.0233378636415325	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1700.75317673546	1700.75317673546
"AML-3133"	"2019-07-01-count-3:GTTACAGTCTCCTGAC"	1.55374099788014	-10.1905594102112	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTACAGTCTCCTGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2404.75172933236	42.7482005547786	0.0177765546577429	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2402.49390256607	2402.49390256607
"AML-3133"	"2019-07-01-count-2:TACCCGTAGGGTTTCT"	0.850568075745743	10.5269965895447	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACCCGTAGGGTTTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1766.12432478494	36.6503366510129	0.0207518441010521	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1760.63724500799	1760.63724500799
"AML-3133"	"2019-07-01-count-2:AAACGAATCAAGGAGC"	4.43331160125081	-5.56300785457762	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAACGAATCAAGGAGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1808.62104970433	50.4805827762379	0.0279110888289674	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1800.68494002163	1800.68494002163
"AML-3133"	"2019-07-01-count-2:TCGTAGATCTGGCTGG"	8.33244194564168	6.95453546130983	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGTAGATCTGGCTGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1639.80948376057	37.0949920246318	0.0226215254832909	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1639.80948376057	1639.80948376057
"AML-3133"	"2019-07-01-count-3:CACCAAATCACCGGGT"	-0.373755375773269	10.7548494108948	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACCAAATCACCGGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1898.96708801755	48.8030696544608	0.025699797517507	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1893.95195467329	1893.95195467329
"AML-3133"	"2019-07-01-count-3:TAAGCACAGCTTAGTC"	8.71709026870076	6.9107661017212	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAAGCACAGCTTAGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1678.74386697631	39.7071076637784	0.0236528683409563	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1676.97419821851	1676.97419821851
"AML-3133"	"2019-07-01-count-1:CTCCTCCCATAATCGC"	1.41610540923421	10.6791848906311	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCTCCCATAATCGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1880.19041498823	38.5205349602767	0.0204875711806656	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.46000718057	1876.46000718057
"AML-3133"	"2019-07-01-count-2:GCCTGTTAGCAACAGC"	3.20946278151814	-9.77010729229125	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00326397388820889	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCTGTTAGCAACAGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1731.85825956942	54.5049637886417	0.0314719541783938	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1731.85825956942	1731.85825956942
"AML-3133"	"2019-07-01-count-3:TAAGCACGTGATGAAT"	0.668461938470048	10.8694686659607	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAAGCACGTGATGAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1740.34504675694	40.0214995777899	0.0229963015968404	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1738.64255451841	1738.64255451841
"AML-3133"	"2019-07-01-count-1:TCTGGCTCACACGCCA"	-1.33393857899364	13.3118066557678	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTGGCTCACACGCCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2363.44340766087	37.2465883715633	0.0157594585302242	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2360.78944642541	2360.78944642541
"AML-3133"	"2019-07-01-count-2:GTGACGCTCACTCACC"	1.01599134978597	12.6008634337219	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGACGCTCACTCACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1949.33563907916	40.9495730251478	0.0210069380583899	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1947.83104726112	1947.83104726112
"AML-3133"	"2019-07-01-count-1:ACTGTGAGTGAACGGT"	1.37584747847859	11.5367393263611	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTGTGAGTGAACGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1941.89381497754	38.3507351624233	0.0197491412077374	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1939.26529197448	1939.26529197448
"AML-3133"	"2019-07-01-count-2:AGTTCCCTCGGTGTAT"	1.38440432128255	10.9022531279358	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTTCCCTCGGTGTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1861.99765185667	36.687809122654	0.0197034669115028	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1858.09678126901	1858.09678126901
"AML-3133"	"2019-07-01-count-1:CACTGTCAGTTATGGA"	-5.09946380081828	3.69490430438844	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CACTGTCAGTTATGGA"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2811.38064391805	38.858524435496	0.013821865253131	3372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2803.77703157701	2803.77703157701
"AML-3133"	"2019-07-01-count-1:TCCCATGTCATCCCGT"	1.38561238822286	11.1839017638001	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCCATGTCATCCCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1945.91525273427	33.1027346849311	0.0170113958654763	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1943.19724971443	1943.19724971443
"AML-3133"	"2019-07-01-count-3:CATACCCGTCCTGTTC"	0.847210188477677	10.2858342894348	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATACCCGTCCTGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1448.38530044005	42.7399926475172	0.0295087174901126	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1446.18320051293	1446.18320051293
"AML-3133"	"2019-07-01-count-1:GATGAGGAGACGACGT"	-8.04232154312785	5.59434077823488	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGAGGAGACGACGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1534.18176187088	48.5770617812365	0.0316631725057131	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1531.95708774593	1531.95708774593
"AML-3133"	"2019-07-01-count-1:GGACGTCGTCGCCTAG"	3.88942946967427	-10.9393673173157	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGACGTCGTCGCCTAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2131.47833284206	45.3018100362455	0.0212537042193815	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2124.08909543583	2124.08909543583
"AML-3133"	"2019-07-01-count-3:CAACAGTCAGGTAGTG"	1.49511911448781	10.9696836241516	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACAGTCAGGTAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1797.44416557168	38.4020772795277	0.0213648234616032	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1794.38721786511	1794.38721786511
"AML-3133"	"2019-07-01-count-3:AACTTCTCATCCTTGC"	1.08548082885091	11.4891862639221	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AACTTCTCATCCTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.1470821507	37.9467015882376	0.0173896168130142	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2177.87271343533	2177.87271343533
"AML-3133"	"2019-07-01-count-2:ATGGAGGGTTCAGTAC"	1.32718994197194	11.3877105482849	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGAGGGTTCAGTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1811.78956395274	41.5376172220501	0.0229262923512091	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1807.34647283232	1807.34647283232
"AML-3133"	"2019-07-01-count-2:CACAACAGTTTAGAGA"	1.24480249461476	11.3268270262512	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACAACAGTTTAGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1733.83547191884	39.9005022224683	0.0230128537965084	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1729.23988454368	1729.23988454368
"AML-3133"	"2019-07-01-count-1:GTTACAGCAGCATACT"	3.40497984465901	-10.8052940598694	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTTACAGCAGCATACT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2578.10405202043	33.9831864364976	0.013181464266295	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2571.44012173873	2571.44012173873
"AML-3133"	"2019-07-01-count-2:TGATGGTGTTACCCAA"	8.04458918151204	7.06736943805543	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATGGTGTTACCCAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1601.06769586506	38.3945457828851	0.0239805886297272	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1601.06769586506	1601.06769586506
"AML-3133"	"2019-07-01-count-2:CGATGCGAGACTGGGT"	-3.53341732445415	-5.09435894405516	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.001230012300123	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGATGCGAGACTGGGT"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2766.38724633696	43.3820837495117	0.0156818550284147	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2761.30061032359	2761.30061032359
"AML-3133"	"2019-07-01-count-2:AACCTTTAGTGAGTGC"	1.52709796008412	-10.0498552552429	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACCTTTAGTGAGTGC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.81171624319	38.9995730089067	0.0166749519587457	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2337.63615731691	2337.63615731691
"AML-3133"	"2019-07-01-count-1:CATTGTTAGAGCCTGA"	2.08551849898641	-10.4200268021789	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATTGTTAGAGCCTGA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2572.87602970686	43.0844619326584	0.0167456423998662	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2567.14675593481	2567.14675593481
"AML-3133"	"2019-07-01-count-2:ATGGATCGTAGCCAGA"	1.20360245284383	11.1001348265442	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGGATCGTAGCCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1705.46328160867	37.2913766855381	0.0218658338104841	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1702.00992594313	1702.00992594313
"AML-3133"	"2019-07-01-count-3:GAAGAATCAGAGAATT"	8.5050445991451	7.06122443759767	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGAATCAGAGAATT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1582.38857237298	37.962496411343	0.0239906285182619	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1578.78349048147	1578.78349048147
"AML-3133"	"2019-07-01-count-2:AGCCAATGTTTGCCGG"	3.85567369040791	-10.7960682145325	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCCAATGTTTGCCGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2193.99640554979	42.0870689139555	0.0191828340317672	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2192.47191302272	2192.47191302272
"AML-3133"	"2019-07-01-count-1:AACAACCAGGCGCTTC"	0.94232209500615	11.5612678297791	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACAACCAGGCGCTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2034.56025845147	38.8317459303765	0.0190860633245298	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2026.50218269321	2026.50218269321
"AML-3133"	"2019-07-01-count-3:TTCCAATAGTGTTGTC"	0.952221711247605	11.1227197417053	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTCCAATAGTGTTGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1786.87478971829	37.7551097911957	0.0211291300366647	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1785.44760503862	1785.44760503862
"AML-3133"	"2019-07-01-count-1:CTATCCGGTGAAAGTT"	-1.62233207646068	10.6572723158631	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTATCCGGTGAAAGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1997.43570548853	34.0889680268935	0.0170663656072755	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1997.43570548853	1997.43570548853
"AML-3133"	"2019-07-01-count-2:GCCGATGGTGCACATT"	-0.176043311983901	10.9307613142761	"2019-07-01-count-2"	"AML3133"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCGATGGTGCACATT"	"MAIT"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2016.00158408455	40.3348609324378	0.0200073557733605	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2006.50125562033	2006.50125562033
"AML-3133"	"2019-07-01-count-2:AGACCATTCAACACGT"	1.17521037635152	10.6441039809021	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACCATTCAACACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1960.348989369	37.3463811054578	0.0190508839538203	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1955.26697852715	1955.26697852715
"AML-3133"	"2019-07-01-count-1:CTGCCTACATCGGAGA"	-0.171005721122581	13.0320110091004	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCCTACATCGGAGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1941.53504604138	37.8515710040184	0.0194956928957808	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.15770587018	1937.15770587018
"AML-3133"	"2019-07-01-count-2:TACACCCAGTCTCCTC"	2.58641686019246	-10.2680235139099	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TACACCCAGTCTCCTC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.11004568103	41.2243893506288	0.0160837375750191	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2559.90452891732	2559.90452891732
"AML-3133"	"2019-07-01-count-2:CAGCAGCTCTCCGAAA"	1.03834297236745	12.4858617552551	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGCAGCTCTCCGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1851.9029556747	38.5869006581572	0.0208363513541124	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1851.9029556747	1851.9029556747
"AML-3133"	"2019-07-01-count-2:GGGACCTTCATGGGAG"	-1.88448725166972	11.8661107786926	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGACCTTCATGGGAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1920.97955096634	33.5837688736604	0.0174826269528826	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1913.7989048319	1913.7989048319
"AML-3133"	"2019-07-01-count-1:TAGCACAAGTTCCTGA"	1.4358147579128	10.1752786406311	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGCACAAGTTCCTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1949.88523455108	38.8273060748019	0.0199126109510445	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1945.96425487379	1945.96425487379
"AML-3133"	"2019-07-01-count-3:GACGCTGTCCAGCAAT"	-7.579573015601	1.69748256290285	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GACGCTGTCCAGCAAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2396.51866877422	38.5089694115978	0.0160687124675288	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2390.82517400357	2390.82517400357
"AML-3133"	"2019-07-01-count-2:ACTTCCGTCACTGTCC"	11.1864191490108	-1.91551353847655	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTCCGTCACTGTCC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1907.92231807007	13.5813263700679	0.00711838539831429	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1903.51114994896	1903.51114994896
"AML-3133"	"2019-07-01-count-2:CAGGTATGTATCCCAA"	0.957223852246445	11.5819625624451	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGGTATGTATCCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1831.39995943444	38.7690841151343	0.0211690973975487	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1827.11434695372	1827.11434695372
"AML-3133"	"2019-07-01-count-2:AGACCCGAGGTAGATT"	3.94504346427266	-10.7402372590271	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGACCCGAGGTAGATT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2281.04481699284	45.6846593181775	0.0200279534088264	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2276.29425645104	2276.29425645104
"AML-3133"	"2019-07-01-count-1:GAGTTACTCCATTTAC"	-7.38749585571941	0.772544778231062	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTTACTCCATTTAC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2562.60631490087	47.3071037408756	0.0184605428722303	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2554.48701220814	2554.48701220814
"AML-3133"	"2019-07-01-count-1:AAGGAATGTAACCCTA"	2.41685142096822	-10.3506222001282	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGGAATGTAACCCTA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2517.87090795389	45.2754540902063	0.0179816423261345	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2514.11881918376	2514.11881918376
"AML-3133"	"2019-07-01-count-1:TCCGGGATCGTTCCCA"	-7.68241296234782	1.51490173423616	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGGGATCGTTCCCA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2655.54036969001	36.5161923580439	0.0137509460503162	2671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2652.42447639075	2652.42447639075
"AML-3133"	"2019-07-01-count-2:TTCGATTCAAAGTGTA"	-3.67532954636272	10.384515739325	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCGATTCAAAGTGTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1837.67728479729	37.1192074523325	0.0201989803973808	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1837.67728479729	1837.67728479729
"AML-3133"	"2019-07-01-count-3:TGGATCAGTTGGGTAG"	-2.3309784931248	8.73637769306032	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGGATCAGTTGGGTAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2177.20866847113	39.3297817956688	0.0180643143513142	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2177.20866847113	2177.20866847113
"AML-3133"	"2019-07-01-count-2:GGATCTACAGGCGTTC"	0.52275170859639	11.4509792097839	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGATCTACAGGCGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1877.92056125938	43.6882291796789	0.0232641518927619	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.38738849394	1876.38738849394
"AML-3133"	"2019-07-01-count-3:GAAGCCCTCGTCGACG"	3.71727051314656	-11.1484937897888	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAAGCCCTCGTCGACG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2086.27812811329	50.2689705870022	0.0240950474961181	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2084.59636630361	2084.59636630361
"AML-3133"	"2019-07-01-count-1:GATGGAGTCGCGGTAC"	-2.0612395805424	13.8926458128723	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGGAGTCGCGGTAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2257.41580947694	41.8316714670824	0.018530778109849	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2254.52997186241	2254.52997186241
"AML-3133"	"2019-07-01-count-1:GCCGATGGTTTCGTGA"	9.56164230880086	6.77494094455568	"2019-07-01-count-1"	"AML3133"	"pDC"	"pDC"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCGATGGTTTCGTGA"	"pDC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	1859.87914129286	43.3549967696892	0.0233106527231397	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	1859.87914129286	1859.87914129286
"AML-3133"	"2019-07-01-count-2:AACGGGAGTCCAAGAG"	1.2763612466747	10.0375356444153	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACGGGAGTCCAAGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1843.96235384883	35.340844830505	0.0191657084304024	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1839.91275984187	1839.91275984187
"AML-3133"	"2019-07-01-count-3:GGTGTTAAGATCCGAG"	1.00663413581197	9.77954099262086	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTGTTAAGATCCGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1420.49662055851	47.4285655591156	0.0333887211505422	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1416.49420253236	1416.49420253236
"AML-3133"	"2019-07-01-count-3:GAGTGAGTCCACAAGT"	8.55630745467488	6.70105598056642	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTGAGTCCACAAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1661.73464594365	39.1149579935088	0.0235386306044648	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1661.73464594365	1661.73464594365
"AML-3133"	"2019-07-01-count-3:TGTAACGTCGTAGTGT"	3.86090960082356	-10.747211479303	"2019-07-01-count-3"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGTAACGTCGTAGTGT"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2040.05203694487	43.9205168887132	0.0215291159702414	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2038.3908363664	2038.3908363664
"AML-3133"	"2019-07-01-count-1:TTCCTTCGTCTTAGTG"	0.880783279507798	10.3687314757141	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCTTCGTCTTAGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1859.02132113889	39.7469171785013	0.0213805601509461	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1854.74728027272	1854.74728027272
"AML-3133"	"2019-07-01-count-2:GATCGTAGTCGCATTA"	1.19843616065328	10.8592252501282	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCGTAGTCGCATTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1707.49042975471	31.0401907363377	0.0181788373131888	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1705.97765068084	1705.97765068084
"AML-3133"	"2019-07-01-count-2:CCTATCGCATATGGCT"	8.44156326827351	7.71071670139161	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTATCGCATATGGCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1803.80232832986	40.5780985528133	0.0224958677098419	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1799.03446438366	1799.03446438366
"AML-3133"	"2019-07-01-count-2:GGGAGTAAGCGCAATG"	-3.09553609314616	10.6995467909607	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ NK-like"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAGTAAGCGCAATG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1947.8248621849	37.7543500712706	0.0193828258403689	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1942.87126333335	1942.87126333335
"AML-3133"	"2019-07-01-count-1:AATGGCTTCTTCCGTG"	0.209988732903641	10.8437642821106	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGCTTCTTCCGTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2132.40534227781	39.9474819116751	0.018733531153605	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2120.4165164451	2120.4165164451
"AML-3133"	"2019-07-01-count-2:CACATGATCCGACAGC"	1.43732943114583	11.3568076857361	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACATGATCCGACAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1862.56354601289	35.7786697148757	0.0192093686099814	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1855.73757482327	1855.73757482327
"AML-3133"	"2019-07-01-count-2:GATCGTATCAGTGTGT"	2.85832967337911	-9.72523119365843	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCGTATCAGTGTGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1791.69855726077	48.7731386171266	0.0272217323720422	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1785.62008823188	1785.62008823188
"AML-3133"	"2019-07-01-count-2:TTTCATGAGGTGCCTC"	1.21325339850728	11.0021428831848	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCATGAGGTGCCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1776.92870198191	41.1329988604098	0.0231483676382355	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1774.24255717932	1774.24255717932
"AML-3133"	"2019-07-01-count-1:TCACAAGCAAACAGGC"	-5.84454665604289	3.39000747287599	"2019-07-01-count-1"	"AML3133"	"MEP"	"MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCACAAGCAAACAGGC"	"MEP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2561.36170135582	35.5307346548916	0.0138718146039601	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2553.08701404374	2553.08701404374
"AML-3133"	"2019-07-01-count-1:AACGAAAAGTAACCGG"	-1.78651497784312	14.048988319281	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AACGAAAAGTAACCGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2094.19736426555	36.0712096315591	0.0172243601520382	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2087.21756682582	2087.21756682582
"AML-3133"	"2019-07-01-count-2:GGAACCCGTGACACAG"	-1.3478014272755	10.9286784895691	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCGTGACACAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1779.13514024186	36.8138173401814	0.0206919735929542	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1777.35773964809	1777.35773964809
"AML-3133"	"2019-07-01-count-2:ATAGAGAGTTCTTCAT"	-7.57824979248698	1.00122234905092	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATAGAGAGTTCTTCAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2565.95657613686	39.9837006308692	0.0155823761799843	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2562.78756175717	2562.78756175717
"AML-3133"	"2019-07-01-count-2:CAATCGATCTGATGGT"	-1.66881416264232	9.17694852435914	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAATCGATCTGATGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1835.23712624718	37.9096386277838	0.020656534289552	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1833.67975501192	1833.67975501192
"AML-3133"	"2019-07-01-count-3:AGGGTTTGTGACTGAG"	-1.95956812325175	8.7051095732483	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGTTTGTGACTGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2325.83214314499	41.223434505495	0.0177241657902933	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2321.64863932481	2321.64863932481
"AML-3133"	"2019-07-01-count-1:TGTTACTCATCATCTT"	2.28420629081075	-9.76525499736937	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTTACTCATCATCTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1685.69595755547	48.6267286846882	0.0288466781134155	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1676.9153727339	1676.9153727339
"AML-3133"	"2019-07-01-count-3:CTCTGGTGTTGGGCCT"	-3.40144310417827	-5.87912990963133	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCTGGTGTTGGGCCT"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1698.60850797891	46.9821157269972	0.0276591783841345	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	1698.60850797891	1698.60850797891
"AML-3133"	"2019-07-01-count-2:GCACGTGAGGTGCCAA"	1.02503802356068	10.2272376784119	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCACGTGAGGTGCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1854.64095727476	32.300608419739	0.0174160978668357	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1850.80234152886	1850.80234152886
"AML-3133"	"2019-07-01-count-2:GCTGCAGCAATAGGGC"	-0.895915071398574	8.75337503040162	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTGCAGCAATAGGGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2386.03547149065	33.8139588824008	0.0141716077931045	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2376.90129041213	2376.90129041213
"AML-3133"	"2019-07-01-count-2:CTTAGGACATGCGGTC"	1.06983151015584	10.1762723692688	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTAGGACATGCGGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1690.84855800961	32.3117142909272	0.0191097624549907	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1685.31049791955	1685.31049791955
"AML-3133"	"2019-07-01-count-2:GTAAGTCGTTCGTTCC"	-2.10509238663371	-8.91448976909789	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAAGTCGTTCGTTCC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2024.16976726546	46.4825799800934	0.0229637754361329	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2022.80390361131	2022.80390361131
"AML-3133"	"2019-07-01-count-2:TGACGCGAGTGCGCTC"	-3.14744172516521	10.4235172041687	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGACGCGAGTGCGCTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1772.42518126139	35.1506336026401	0.0198319421176494	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1767.50760765881	1767.50760765881
"AML-3133"	"2019-07-01-count-2:CTCAACCGTCCACAGC"	-1.31790051880534	10.5977754362854	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCAACCGTCCACAGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2069.99134066377	38.6016625064945	0.0186482241486655	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2065.17142766798	2065.17142766798
"AML-3133"	"2019-07-01-count-1:GGTAGAGCAGCATTGT"	1.27527882632558	10.0427226790222	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGTAGAGCAGCATTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1821.98563656305	41.6750125892419	0.022873403474166	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1821.98563656305	1821.98563656305
"AML-3133"	"2019-07-01-count-2:GTTTACTCAGAACATA"	1.08154024657552	10.8041410216126	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTTACTCAGAACATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1847.36814966505	34.1515391150505	0.0184865908407279	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1845.62570690175	1845.62570690175
"AML-3133"	"2019-07-01-count-1:ATGCGATGTGTCATGT"	1.2458481985027	9.51237962329713	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCGATGTGTCATGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1733.75311092234	33.4480936093534	0.019292304883917	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1733.75311092234	1733.75311092234
"AML-3133"	"2019-07-01-count-3:TTTGACTGTGGACTGA"	1.0190245109493	10.5045890578064	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGACTGTGGACTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1719.61259518319	38.143708979676	0.0221815710622965	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1711.62415737861	1711.62415737861
"AML-3133"	"2019-07-01-count-1:TTCCTAATCCCTCATG"	1.25359382209126	11.4090099104675	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCCTAATCCCTCATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2253.17449291815	38.5853795243826	0.0171248962943875	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2251.962921631	2251.962921631
"AML-3133"	"2019-07-01-count-1:AAGTGAATCAGACCGC"	-0.880838612944442	12.4902057417664	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGTGAATCAGACCGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1925.6138633092	42.3417651425916	0.0219887101715329	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1925.6138633092	1925.6138633092
"AML-3133"	"2019-07-01-count-3:GAGTTTGTCAAACGAA"	8.04732098159139	6.49522683704225	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGTTTGTCAAACGAA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1650.78535267641	40.7244237032158	0.024669726828621	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1650.78535267641	1650.78535267641
"AML-3133"	"2019-07-01-count-2:TCCAGAAAGACCATGG"	3.93227018889729	-10.8722563019958	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCAGAAAGACCATGG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2396.26644477796	45.9016262406364	0.0191554767795823	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2391.05981043567	2391.05981043567
"AML-3133"	"2019-07-01-count-2:ATTCGTTTCTTTCGAT"	-1.95911941948588	13.4679384001526	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCGTTTCTTTCGAT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2102.81665144849	36.1346714698692	0.0171839382406347	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2093.65538445913	2093.65538445913
"AML-3133"	"2019-07-01-count-1:CATGGTAAGGTATTGA"	-7.71474299851115	1.69980464065401	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGGTAAGGTATTGA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2645.93431637792	35.7464497340676	0.013509953558863	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2639.94033277294	2639.94033277294
"AML-3133"	"2019-07-01-count-1:TAACCAGGTTGCATTG"	-2.85502324524577	10.1842021712097	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAACCAGGTTGCATTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2170.38233205058	30.4501213257674	0.0140298420587483	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2167.274361246	2167.274361246
"AML-3133"	"2019-07-01-count-1:GTAGCTATCATCTACT"	11.5464130836422	-2.40258004581603	"2019-07-01-count-1"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGCTATCATCTACT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1729.90577640863	20.889871933423	0.0120757281802893	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1725.33694484971	1725.33694484971
"AML-3133"	"2019-07-01-count-2:CTTCGGTCACATTCGA"	-1.16729603233989	13.5539235838684	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTCGGTCACATTCGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2312.49894948395	37.9492249314335	0.0164104831009338	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2303.13674879885	2303.13674879885
"AML-3133"	"2019-07-01-count-1:AGGGAGTAGACTCAAA"	0.82417650994603	11.1178397902283	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGGAGTAGACTCAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2042.27358487458	44.3904660119198	0.0217358077491101	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2039.60870246744	2039.60870246744
"AML-3133"	"2019-07-01-count-3:CTGCCATGTTCTGACA"	8.98282494124715	6.46223399722902	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCCATGTTCTGACA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1655.84104014339	42.3297979024491	0.0255639260510076	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1655.84104014339	1655.84104014339
"AML-3133"	"2019-07-01-count-2:ATTTACCTCTTTCGAT"	10.9784943061763	-3.00349190151366	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-5"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTTACCTCTTTCGAT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	2614.35788483091	43.882202150158	0.0167850784335122	2659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	2609.93638586824	2609.93638586824
"AML-3133"	"2019-07-01-count-2:AAGATAGGTGCCCTTT"	-1.36715767803844	12.1253595122131	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AAGATAGGTGCCCTTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1874.28491130366	41.5949602723902	0.0221924425798524	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1872.4550684141	1872.4550684141
"AML-3133"	"2019-07-01-count-3:GATAGAAGTACATACC"	-1.12273548069652	10.8780278929505	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATAGAAGTACATACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2056.00680554096	34.7914789259052	0.0169218695347417	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2052.72947622742	2052.72947622742
"AML-3133"	"2019-07-01-count-1:GATCATGAGTTCCATG"	-8.64840541306194	1.10208544814912	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.523809523809524	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATCATGAGTTCCATG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2755.82773578449	42.5981734019619	0.0154574877264001	2701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2749.92529825758	2749.92529825758
"AML-3133"	"2019-07-01-count-3:CACAGGCTCTCATGCC"	-7.41482625427898	0.520967818144239	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CACAGGCTCTCATGCC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2137.00036262669	51.8316057712569	0.0242543738773859	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2132.4142730606	2132.4142730606
"AML-3133"	"2019-07-01-count-2:CACGGGTAGGTTGTTC"	1.33642448958699	11.3142623671326	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGGGTAGGTTGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1881.39546240444	35.8210985845605	0.0190396433394076	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1877.27149874282	1877.27149874282
"AML-3133"	"2019-07-01-count-2:TAATTCCTCATGTCAG"	-2.57639275017436	13.6233205565247	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAATTCCTCATGTCAG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1831.56179533899	38.5550248203435	0.0210503543579362	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1829.64213482412	1829.64213482412
"AML-3133"	"2019-07-01-count-1:CTAACCCTCCATTTCA"	8.48572792586629	8.17424104297487	"2019-07-01-count-1"	"AML3133"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAACCCTCCATTTCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2133.94439894811	34.9879804681345	0.0163959194463461	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2126.84251040821	2126.84251040821
"AML-3133"	"2019-07-01-count-3:ACCATTTGTAGTGATA"	1.50164188918416	10.7839908369812	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACCATTTGTAGTGATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1902.13944223414	42.4595392489562	0.0223219908626077	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1890.38316662037	1890.38316662037
"AML-3133"	"2019-07-01-count-1:GTCCCATCATCCAACA"	8.83833088454549	5.94028184497682	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCCCATCATCCAACA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1452.47406138815	25.6769471195326	0.0176780761888393	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1452.47406138815	1452.47406138815
"AML-3133"	"2019-07-01-count-3:GTGAGGAAGTATGTAG"	-2.11219034615214	-8.97472860729369	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGAGGAAGTATGTAG"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2309.07065254484	48.1473067082368	0.0208513787376638	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2306.2594750713	2306.2594750713
"AML-3133"	"2019-07-01-count-2:GTCTGTCGTTTCACAG"	1.26562978801076	9.69523236835328	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCTGTCGTTTCACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1747.92334779053	32.3607851073872	0.0185138468161622	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1740.196289958	1740.196289958
"AML-3133"	"2019-07-01-count-3:GTAACCAAGGAGACCT"	1.41336776789967	10.4569587477478	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAACCAAGGAGACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1703.20575453087	34.729451032837	0.0203906374438025	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1697.68813085893	1697.68813085893
"AML-3133"	"2019-07-01-count-2:ACTCTCGGTCGTTCAA"	4.01830281791036	-10.9071111909119	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTCTCGGTCGTTCAA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2374.94721682285	41.1473740482646	0.0173255951781996	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2365.51249796814	2365.51249796814
"AML-3133"	"2019-07-01-count-3:TAACGACCACTATCGA"	-7.56896243515666	0.627784169557966	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAACGACCACTATCGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2610.48195165574	44.1789425935165	0.0169236728740818	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2606.854133325	2606.854133325
"AML-3133"	"2019-07-01-count-1:TGCTTGCAGACTTGTC"	-0.975834111601669	-4.93490173732909	"2019-07-01-count-1"	"AML3133"	"cDC2"	"cDC2"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTTGCAGACTTGTC"	"cDC2"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2647.67180350108	30.9459816067931	0.0116879975704967	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	9	TRUE	"DC_AML-3133"	2644.11903188107	2644.11903188107
"AML-3133"	"2019-07-01-count-3:CATCCCAAGTTCTCTT"	2.69259562072102	-10.4451236954895	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCCCAAGTTCTCTT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2296.65916437272	39.4114390186082	0.0171603342933877	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2292.71229262581	2292.71229262581
"AML-3133"	"2019-07-01-count-1:CTGAATGTCACTTATC"	-0.697029988200027	12.8519201048645	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGAATGTCACTTATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1957.77431320812	51.922821823349	0.02652135206446	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1951.78589286794	1951.78589286794
"AML-3133"	"2019-07-01-count-2:GGAACCCTCCGACAGC"	1.36403348025624	10.7710008391174	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCTCCGACAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1872.42210427543	41.813067456531	0.0223310050447794	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1868.17706137927	1868.17706137927
"AML-3133"	"2019-07-01-count-1:TCCGATCAGGTGGTTG"	3.64861144599263	-10.485113166925	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCGATCAGGTGGTTG"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1982.46428949961	51.3439039984186	0.025899030953732	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1980.71775009525	1980.71775009525
"AML-3133"	"2019-07-01-count-1:ACTTTCAGTAGGCAGT"	-2.15258322182353	8.52131269061891	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTTCAGTAGGCAGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2374.13191992593	35.3326971250262	0.0148823647197029	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2364.25515039863	2364.25515039863
"AML-3133"	"2019-07-01-count-3:TCTAACTTCGCTCTAC"	1.42729570445363	10.7350387343201	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTAACTTCGCTCTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2035.5083411634	36.711251006166	0.0180354215523301	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2026.62091873905	2026.62091873905
"AML-3133"	"2019-07-01-count-2:TAGGTACGTTGCTCGG"	1.32711674746816	11.2293367155823	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAGGTACGTTGCTCGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1913.44724716651	33.4122680600632	0.0174618182495185	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1905.38863887216	1905.38863887216
"AML-3133"	"2019-07-01-count-3:TTTGTTGGTTCGAACT"	-1.36869345131572	11.5221767195496	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGTTGGTTCGAACT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1697.84879751743	44.7373172050837	0.0263494118383793	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1695.17583699849	1695.17583699849
"AML-3133"	"2019-07-01-count-1:AGACAGGGTGAGCAGT"	4.08503927764241	-10.5602464905945	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACAGGGTGAGCAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1921.66322135117	46.7502962553088	0.0243280381993456	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1915.10747314741	1915.10747314741
"AML-3133"	"2019-07-01-count-1:ACGGTTATCCCATTTA"	1.17150499400441	11.3458909758362	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGGTTATCCCATTTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1973.00439693095	36.8464794541701	0.0186753154283314	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1971.86999481639	1971.86999481639
"AML-3133"	"2019-07-01-count-1:CTCACTGTCAAATAGG"	1.06334187564198	12.1072664030823	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCACTGTCAAATAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.59908155173	39.4516190671331	0.0188980822111727	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2084.79837568342	2084.79837568342
"AML-3133"	"2019-07-01-count-3:ATCAGGTAGCTAGTTC"	-1.75652227822002	11.7386531599793	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATCAGGTAGCTAGTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1828.34489249271	32.6913659601361	0.0178803058954406	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1826.50483080619	1826.50483080619
"AML-3133"	"2019-07-01-count-1:ATGCATGAGGGCTAAC"	1.55108847197835	10.907630897406	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGCATGAGGGCTAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.94585846412	41.4284825295234	0.0213775231896089	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1929.80931883373	1929.80931883373
"AML-3133"	"2019-07-01-count-2:GAGTTACAGGTTGTTC"	0.854079981415909	10.8131065138611	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTACAGGTTGTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1896.37396248081	32.7655699243181	0.0172780108631394	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1893.24514905321	1893.24514905321
"AML-3133"	"2019-07-01-count-3:TCGTCCAAGTAATCCC"	11.7889887290889	-2.43679788028868	"2019-07-01-count-3"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGTCCAAGTAATCCC"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1748.05092498682	36.9519504118105	0.0211389438852242	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1748.05092498682	1748.05092498682
"AML-3133"	"2019-07-01-count-1:TTACGTTGTGCAACAG"	1.01891394433324	10.7897577055725	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTACGTTGTGCAACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1871.60043705196	40.7831956879754	0.0217905461446754	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1865.0449267598	1865.0449267598
"AML-3133"	"2019-07-01-count-2:GGGCTACGTCTTCAAG"	1.10254051265065	10.7575912245545	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGCTACGTCTTCAAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1712.53878934171	41.3514065750048	0.0241462598291862	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1712.53878934171	1712.53878934171
"AML-3133"	"2019-07-01-count-2:GGAATCTCAGCGGTCT"	1.16853608664815	11.5682143934998	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAATCTCAGCGGTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2083.96723536143	37.5614940527962	0.0180240329192517	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2079.85925983824	2079.85925983824
"AML-3133"	"2019-07-01-count-1:AGACCATCAGCAGTCC"	1.52807750281636	10.9146528013977	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGACCATCAGCAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2015.5765018485	33.5608726129727	0.0166507560403655	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2008.36685265197	2008.36685265197
"AML-3133"	"2019-07-01-count-3:CTGTAGAAGTAGATCA"	1.04257502135579	10.1634645231995	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGTAGAAGTAGATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1724.99632680964	39.0016217474864	0.0226096839403823	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1724.99632680964	1724.99632680964
"AML-3133"	"2019-07-01-count-2:AGAACCTCACGGCTAC"	1.1111829477245	10.3320379027161	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAACCTCACGGCTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1937.11680120031	40.1096018460536	0.0207058251836958	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1934.75182153129	1934.75182153129
"AML-3133"	"2019-07-01-count-2:GATTCTTCATGATCTG"	8.58089413222615	7.13776061618654	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTCTTCATGATCTG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1718.44507623415	36.2202714176191	0.0210773517981694	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1712.88165766639	1712.88165766639
"AML-3133"	"2019-07-01-count-2:GTAGGAGCAGATAAAC"	1.3624892431194	11.104745841864	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAGGAGCAGATAAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1877.71873811373	38.9823205352008	0.0207604684045283	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1876.4216704066	1876.4216704066
"AML-3133"	"2019-07-01-count-2:TGAATGCTCTGTGCGG"	10.7268711524898	-0.613100551721178	"2019-07-01-count-2"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGAATGCTCTGTGCGG"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1297.52748236673	3.55824658090872	0.0027423284895811	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1293.28538570054	1293.28538570054
"AML-3133"	"2019-07-01-count-3:GATCATGTCTCGTCGT"	8.04675831374471	6.47498223865358	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATCATGTCTCGTCGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1633.63047138046	42.7942744709275	0.0261958106319878	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1627.92817518538	1627.92817518538
"AML-3133"	"2019-07-01-count-1:AAGCATCGTCTATGAC"	0.523377616971177	11.4278468855652	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAGCATCGTCTATGAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1933.40293661115	36.692874264499	0.018978389641227	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1927.73486579152	1927.73486579152
"AML-3133"	"2019-07-01-count-1:GTATTTCTCTTAGCTT"	8.32380737838094	7.15140006625978	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTATTTCTCTTAGCTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1920.9808599217	37.3898928978011	0.0194639591043739	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1915.33346048512	1915.33346048512
"AML-3133"	"2019-07-01-count-2:CCACAAATCGGATAAA"	11.5460621314937	-2.87991955196532	"2019-07-01-count-2"	"AML3133"	"Ery"	"Erythrocytes"	34	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.225352112676056	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCACAAATCGGATAAA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1880.20603624911	23.9082925877718	0.0127157833380151	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1878.36283681802	1878.36283681802
"AML-3133"	"2019-07-01-count-2:ACAGCCGGTGCCCAGT"	0.982286174863022	12.9123906859192	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACAGCCGGTGCCCAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1852.32705255527	44.5426922345376	0.0240468831749184	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.99354490897	1841.99354490897
"AML-3133"	"2019-07-01-count-2:CGTCCATCAGGTCTCG"	8.12765945967976	6.11668346011964	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CGTCCATCAGGTCTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1636.52656824341	37.5839187165919	0.0229656636475711	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1631.10896143859	1631.10896143859
"AML-3133"	"2019-07-01-count-3:GATTGGTTCCCTCTAG"	1.33986165103261	10.0420493849548	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GATTGGTTCCCTCTAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1716.48208540471	32.1840196968228	0.0187499886951832	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1705.14683414471	1705.14683414471
"AML-3133"	"2019-07-01-count-3:TGAGTCAAGAGGTTAT"	-7.71244702759441	-2.40771748935851	"2019-07-01-count-3"	"AML3133"	"GMP"	"GMP"	41	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.75	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGAGTCAAGAGGTTAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1451.12885045428	44.3566654705206	0.0305670068213685	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1446.87993412286	1446.87993412286
"AML-3133"	"2019-07-01-count-1:GATGAGGAGTTCACTG"	1.45120396193807	-10.0663986436096	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGAGGAGTTCACTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2469.79997665136	29.8392727172041	0.012081655599358	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2464.67052646003	2464.67052646003
"AML-3133"	"2019-07-01-count-2:GTTCCGTGTATCACCA"	-2.22464881363567	13.831817603949	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCCGTGTATCACCA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2147.96218418031	39.8044676938556	0.0185312702369783	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2143.18959306691	2143.18959306691
"AML-3133"	"2019-07-01-count-3:ACGTAGTCATCAGTGT"	1.30211057242696	9.27481553638307	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTAGTCATCAGTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1903.08668707785	38.0781608066006	0.0200086318007241	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1901.59140555411	1901.59140555411
"AML-3133"	"2019-07-01-count-1:TGTGTGACAGTGGTGA"	-1.25706944885905	10.996669746283	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTGTGACAGTGGTGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1886.81313010167	37.2760748123382	0.0197561031443159	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1883.50627879255	1883.50627879255
"AML-3133"	"2019-07-01-count-1:TGGTGATGTAAGATTG"	3.73637713965718	-10.758231186029	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGTGATGTAAGATTG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2241.02917133409	48.37882952909	0.0215877732195204	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2236.97540931999	2236.97540931999
"AML-3133"	"2019-07-01-count-2:GGTCACGTCATTATCC"	1.25778915461842	11.0412778624329	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTCACGTCATTATCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1890.37883254159	37.2639142547074	0.0197124055841265	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1883.06534085233	1883.06534085233
"AML-3133"	"2019-07-01-count-1:GAGTGTTAGCGTTCAT"	0.615273912518662	10.2859458693298	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTGTTAGCGTTCAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1580.33987027174	45.8113877175455	0.0289883135769195	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1573.29515586655	1573.29515586655
"AML-3133"	"2019-07-01-count-1:GATTCGAAGACAGTCG"	0.283927966921967	9.39638516986696	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATTCGAAGACAGTCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1984.58315029412	31.0638509373034	0.0156525822224681	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1973.90009642074	1973.90009642074
"AML-3133"	"2019-07-01-count-1:CTCCCTCCAAATCGTC"	1.35033096846883	10.5997628935608	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCCTCCAAATCGTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2038.95310564177	36.643827419586	0.0179718833739691	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2032.7906601277	2032.7906601277
"AML-3133"	"2019-07-01-count-1:AGGATCTGTACCAATC"	1.56345870074574	11.3697175749573	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGATCTGTACCAATC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1993.49428312639	32.4391771676	0.0162725207903409	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1989.23353810969	1989.23353810969
"AML-3133"	"2019-07-01-count-3:GGTGATTTCAAGGACG"	1.53630747374837	-10.078980468866	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGTGATTTCAAGGACG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2154.87627335904	43.7687250002316	0.0203114793834565	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2152.30195334329	2152.30195334329
"AML-3133"	"2019-07-01-count-3:ATTGTTCCAACATCGT"	8.90904678878133	6.89372823322145	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTGTTCCAACATCGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1651.02487428635	39.2792053360113	0.0237908016697746	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1645.36084159831	1645.36084159831
"AML-3133"	"2019-07-01-count-1:GCCATTCGTTCTCTAT"	1.25970353659932	11.259925819281	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCCATTCGTTCTCTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2036.15621328988	37.7479279609925	0.0185388172649101	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2031.99448944274	2031.99448944274
"AML-3133"	"2019-07-01-count-1:TCTTAGTGTGACAACG"	1.39406027373616	11.2992610701355	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCTTAGTGTGACAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1947.42337376896	36.3020001676013	0.0186410416227797	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1941.04226898383	1941.04226898383
"AML-3133"	"2019-07-01-count-2:CTCCTTTAGCCGTCGT"	-2.3633590740269	12.8343992003235	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTCCTTTAGCCGTCGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2012.8176381739	40.8081320376872	0.0202741327697772	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2011.02065717682	2011.02065717682
"AML-3133"	"2019-07-01-count-1:GAGTGTTTCCGCACTT"	1.1910215812618	11.2286844023499	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGTGTTTCCGCACTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2054.82475811563	35.9301296889703	0.0174857391352049	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2050.34035373084	2050.34035373084
"AML-3133"	"2019-07-01-count-1:GTGATGTGTTCTCACC"	0.982670684426469	11.4479703673157	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGATGTGTTCTCACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2018.46001808908	38.1235995292863	0.0188874682617587	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2011.46300215158	2011.46300215158
"AML-3133"	"2019-07-01-count-1:CATGAGTCACGATTCA"	8.49304832991902	6.90414378726808	"2019-07-01-count-1"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATGAGTCACGATTCA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1844.68480495429	41.7276191642852	0.0226204601741267	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1841.48988769123	1841.48988769123
"AML-3133"	"2019-07-01-count-3:ATGCGATCACCTGAAT"	8.6910158592159	7.049205280188	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGCGATCACCTGAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1685.17839755525	40.9061560580624	0.024274080487506	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1681.73445385166	1681.73445385166
"AML-3133"	"2019-07-01-count-1:AGTAGTCGTCGATTTG"	-7.03490338745769	2.1591381796631	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTAGTCGTCGATTTG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2699.47761510427	45.4824002363216	0.0168485932173825	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2688.16231109654	2688.16231109654
"AML-3133"	"2019-07-01-count-1:TGAGGGAGTGTTACAC"	2.28013910826985	-9.87141611492308	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGAGGGAGTGTTACAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2137.87563584666	48.2255719138736	0.0225577068680961	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2124.04913466051	2124.04913466051
"AML-3133"	"2019-07-01-count-3:CAACGATAGACCATGG"	-0.27367208424266	11.0700540312561	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACGATAGACCATGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1750.02598817771	35.7015857011042	0.0204006031580593	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1748.28035603944	1748.28035603944
"AML-3133"	"2019-07-01-count-2:CACCGTTCATCTCCCA"	2.38671698149983	-10.0789928666321	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCGTTCATCTCCCA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2513.41135301437	41.2357145921949	0.0164062737055517	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2502.62878087935	2502.62878087935
"AML-3133"	"2019-07-01-count-1:TACTGCCTCTTTCCAA"	1.28762855109517	11.3378114470276	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TACTGCCTCTTTCCAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2288.10952874508	33.8780034657933	0.0148061109139184	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2280.98515910941	2280.98515910941
"AML-3133"	"2019-07-01-count-1:AATGGAAAGTTGGAAT"	-7.35067162934001	-1.33426954662474	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0980392156862745	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATGGAAAGTTGGAAT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3243.90139832831	41.0221688525512	0.012645935808558	3794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	3226.46980480169	3226.46980480169
"AML-3133"	"2019-07-01-count-3:AGCTCAAGTATGAGCG"	1.37271489676778	10.8072519072327	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGCTCAAGTATGAGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1671.20565351904	38.4327898615606	0.0229970439488599	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1667.13508150243	1667.13508150243
"AML-3133"	"2019-07-01-count-2:GAGAGGTCAATAGTCC"	1.31617345389668	9.89826104724733	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGAGGTCAATAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1711.91842193969	35.5827340235629	0.0207852976914904	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1707.59872000741	1707.59872000741
"AML-3133"	"2019-07-01-count-2:TATTCCAAGTCCGTCG"	-2.14334927025493	11.2685985335144	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATTCCAAGTCCGTCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1770.75913203812	35.1037605236417	0.0198241307293092	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1768.87078048206	1768.87078048206
"AML-3133"	"2019-07-01-count-1:CGTGAATTCCTAACAG"	1.10437061366383	11.131941772345	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CGTGAATTCCTAACAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1695.46476675932	39.8661485006919	0.0235134042784571	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1686.26144651141	1686.26144651141
"AML-3133"	"2019-07-01-count-1:CTAGGTAGTACAGTAA"	-1.13841650906261	10.9447631605896	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGGTAGTACAGTAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1850.85385848747	37.2358007547737	0.0201181744220492	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1849.13405297018	1849.13405297018
"AML-3133"	"2019-07-01-count-1:AGGATAACAATGTTGC"	0.093332969664973	13.1140193709168	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGATAACAATGTTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1702.95977833419	37.4444390313381	0.0219878587314409	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1702.95977833419	1702.95977833419
"AML-3133"	"2019-07-01-count-3:AGGACTTAGTTTGAGA"	1.43132426318471	10.7892064818176	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGACTTAGTTTGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1831.57751356622	39.9391753155971	0.0218058886505068	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1828.70264476381	1828.70264476381
"AML-3133"	"2019-07-01-count-1:TGGAGAGTCTCAGTCC"	1.03464742478673	12.2549762495789	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGAGAGTCTCAGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1882.55299803082	46.6906594487788	0.024801776894259	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1882.55299803082	1882.55299803082
"AML-3133"	"2019-07-01-count-3:AGTGACTGTTAGAGTA"	1.15210809287373	10.5904140242371	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGTGACTGTTAGAGTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1764.94618395592	37.0759136271627	0.0210068238704374	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1763.42486005753	1763.42486005753
"AML-3133"	"2019-07-01-count-2:ATTCTACCAGGAGACT"	1.22468699988667	10.5134410628113	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTCTACCAGGAGACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1890.01996123211	39.8142228085193	0.021065503870427	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1886.98721297694	1886.98721297694
"AML-3133"	"2019-07-01-count-2:TGTTCTAAGCTGGCTC"	7.52591147002522	-10.4723186722961	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.407407407407407	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTTCTAAGCTGGCTC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1843.57859995337	24.3611302759057	0.0132140448346069	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1843.57859995337	1843.57859995337
"AML-3133"	"2019-07-01-count-3:CTCACTGTCGTGTGGC"	0.496226568787736	12.5374879606995	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ IFN+"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCACTGTCGTGTGGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1748.32017402739	42.2788350377002	0.0241825471477045	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1744.57772497828	1744.57772497828
"AML-3133"	"2019-07-01-count-2:CAGAGCCCAGCGCTTG"	-1.19403455677684	10.4422960051331	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGAGCCCAGCGCTTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1389.13287940274	42.9643882004902	0.0309289261218572	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1389.13287940274	1389.13287940274
"AML-3133"	"2019-07-01-count-1:GGAGGATTCTTACGGA"	0.772291799157304	10.2646131285462	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAGGATTCTTACGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1939.07006363946	36.4591804153092	0.018802404873849	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1934.44363298937	1934.44363298937
"AML-3133"	"2019-07-01-count-2:GCCAACGCAGGTTACT"	1.42961706694905	10.5628356703552	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCAACGCAGGTTACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1865.58130940842	28.3422265302634	0.0151921689970461	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1858.74808265649	1858.74808265649
"AML-3133"	"2019-07-01-count-1:TATATCCCAAGAGGTC"	8.65043892440144	7.50860450351564	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TATATCCCAAGAGGTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1953.92799324558	38.9445716091076	0.0199314262059466	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1949.64496394808	1949.64496394808
"AML-3133"	"2019-07-01-count-3:TCCTCCCAGTCTAGCT"	10.8607260185177	-0.697331928369127	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-7"	58	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.490566037735849	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCTCCCAGTCTAGCT"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	1432.50681533122	5.08942073427761	0.00355280734430631	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	1428.06341198723	1428.06341198723
"AML-3133"	"2019-07-01-count-2:CAGATACAGTACGAGC"	0.875439782708329	11.5635967024597	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGATACAGTACGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1950.12595707481	33.3198285139613	0.0170859879040537	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1943.2165155435	1943.2165155435
"AML-3133"	"2019-07-01-count-1:CTATAGGTCCTGTTGC"	1.04255231198613	11.570116973761	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTATAGGTCCTGTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1983.03888486949	38.4685794014623	0.0193988023608493	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1977.11816228357	1977.11816228357
"AML-3133"	"2019-07-01-count-2:TTGAACGAGAGTTGCG"	8.45234932479207	7.01554296100465	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGAACGAGAGTTGCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1742.04944293195	39.5429902404539	0.0226991205105529	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1740.32181044456	1740.32181044456
"AML-3133"	"2019-07-01-count-2:CAGATACAGTGTAGTA"	8.97910370406453	6.8597316511902	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAGATACAGTGTAGTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1770.07049141594	39.7816245469792	0.0224745990286277	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1766.00917020884	1766.00917020884
"AML-3133"	"2019-07-01-count-2:CCAATGACACCAGCCA"	-0.974576334387618	8.9142970808777	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCAATGACACCAGCCA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2388.87530809196	35.3385692313399	0.0147929735435063	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2380.22325192982	2380.22325192982
"AML-3133"	"2019-07-01-count-1:GAGGCCTGTGATGTAA"	1.22895934161488	10.9419488676819	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGGCCTGTGATGTAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1703.5447312946	37.811560434457	0.0221958130830661	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1698.30856922127	1698.30856922127
"AML-3133"	"2019-07-01-count-2:ACTGCAATCCTCTCTT"	0.0530481034306854	10.8064927824768	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTGCAATCCTCTCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1888.73439862351	37.3890764913632	0.0197958360469381	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1885.32461499833	1885.32461499833
"AML-3133"	"2019-07-01-count-2:TGGGCGTAGGCCACCT"	1.08249821242635	12.1214761503967	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGGGCGTAGGCCACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1600.37978711557	40.7809918033468	0.025482071275624	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1596.97540242914	1596.97540242914
"AML-3133"	"2019-07-01-count-3:ATACTTCCAGAAGCGT"	0.441697289317292	10.0878381499085	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATACTTCCAGAAGCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1551.52500748004	40.3054915743108	0.0259779838417005	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1547.70432362857	1547.70432362857
"AML-3133"	"2019-07-01-count-1:CTCGAGGTCCTCATAT"	0.994268079369706	-9.64517977153929	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCGAGGTCCTCATAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.87132703485	42.0263827481374	0.0169401702902373	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2479.61874320343	2479.61874320343
"AML-3133"	"2019-07-01-count-2:ACTTATCTCGCCCAGA"	4.26923241195027	-10.6585731736389	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCTCGCCCAGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1581.10636210633	51.2214405759522	0.0323959486872949	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1573.1183770604	1573.1183770604
"AML-3133"	"2019-07-01-count-3:AAAGGGCAGTGGATAT"	8.67021908339803	6.44989774310914	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AAAGGGCAGTGGATAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1673.28100666089	44.5551466483067	0.0266274143260722	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1668.13470632817	1668.13470632817
"AML-3133"	"2019-07-01-count-2:TTTAGTCTCTGCGGGT"	-2.65831122818645	10.9342164763245	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTAGTCTCTGCGGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1897.97988079305	37.0183280661813	0.0195040676883854	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1897.97988079305	1897.97988079305
"AML-3133"	"2019-07-01-count-2:GATCAGTGTCGGTACC"	0.921016653149766	10.3869676359924	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATCAGTGTCGGTACC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1600.25638565327	44.4213801828806	0.0277589144971582	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1598.13100765192	1598.13100765192
"AML-3133"	"2019-07-01-count-3:GGGAGATCAGGACAGT"	1.18283237990682	10.5092525252136	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGAGATCAGGACAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1780.77170976742	39.7365833881875	0.0223142490248665	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1777.54286470035	1777.54286470035
"AML-3133"	"2019-07-01-count-1:CTCGAGGCAGTTGGTT"	4.25087227401082	-10.7421121827331	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCGAGGCAGTTGGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2248.00390227636	48.6841766290764	0.0216566246080703	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2239.84780702952	2239.84780702952
"AML-3133"	"2019-07-01-count-1:GGAACCCCAGAAGCTG"	-0.443136851221877	11.1759118803772	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGAACCCCAGAAGCTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1939.56890800761	38.1662448159625	0.0196776946972037	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1931.57202355261	1931.57202355261
"AML-3133"	"2019-07-01-count-1:CATAGACTCCGTGGCA"	3.97555555877034	-10.9250431290832	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATAGACTCCGTGGCA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2408.61582248609	45.4430117657927	0.0188668576123892	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2404.3117962086	2404.3117962086
"AML-3133"	"2019-07-01-count-2:ATGAGTCGTCGAAGCA"	-7.61939034882243	4.60944840991823	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	39	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0298913043478261	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGAGTCGTCGAAGCA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1706.10764018207	49.0598930754196	0.0287554500782753	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1701.84672922059	1701.84672922059
"AML-3133"	"2019-07-01-count-1:GATCAGTAGTAGAATC"	-1.47194645825084	12.0525083311829	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATCAGTAGTAGAATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1562.63560784804	36.1308903743426	0.0231217631243535	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1562.63560784804	1562.63560784804
"AML-3133"	"2019-07-01-count-1:GTCTAGAAGAGGCGTT"	1.2868547635967	10.3922433623108	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTAGAAGAGGCGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1803.92964628834	37.511816553913	0.0207945008449166	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1799.85499348715	1799.85499348715
"AML-3133"	"2019-07-01-count-1:GCGAGAAGTAGGCAGT"	3.88084497031514	-10.7579622498718	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCGAGAAGTAGGCAGT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.30011255413	42.506485891489	0.0174614812989883	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2431.42503654547	2431.42503654547
"AML-3133"	"2019-07-01-count-2:ATTACCTTCGAGATAA"	0.736215670674485	10.549214340094	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTACCTTCGAGATAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1913.37924902165	38.8688940131649	0.0203142654719599	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1908.99634077171	1908.99634077171
"AML-3133"	"2019-07-01-count-2:CACAGATAGACGACGT"	8.5722938972408	5.91477058017579	"2019-07-01-count-2"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACAGATAGACGACGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1645.87531306764	31.6470784845105	0.0192281142035757	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1642.27453333607	1642.27453333607
"AML-3133"	"2019-07-01-count-3:GGGTGAAGTTTACTGG"	0.889670391648453	12.9972285994324	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTGAAGTTTACTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1738.8054914522	42.1092064248346	0.0242173185165559	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1736.99991314407	1736.99991314407
"AML-3133"	"2019-07-01-count-3:CAGCCAGCATGTACGT"	0.172622357576531	10.1769552000794	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGCCAGCATGTACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1704.48628514464	46.5670341700187	0.027320275074004	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1697.07446137559	1697.07446137559
"AML-3133"	"2019-07-01-count-1:GGATGTTGTCTCTCAC"	1.47616388377492	11.0970048674378	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGATGTTGTCTCTCAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1916.47967291263	39.594501465681	0.0206600163963681	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1911.41113837702	1911.41113837702
"AML-3133"	"2019-07-01-count-1:ACAAAGAGTCGGAACA"	1.44298412379567	10.185782409552	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAAAGAGTCGGAACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1685.02677377885	35.6187147911287	0.0211383672624085	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1682.62281818249	1682.62281818249
"AML-3133"	"2019-07-01-count-1:GAGCTGCGTGGATTTC"	8.07391705092732	7.8041987189087	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAGCTGCGTGGATTTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1819.60046570179	40.216147469434	0.022101636170951	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1815.0729292334	1815.0729292334
"AML-3133"	"2019-07-01-count-1:CAGCGTGAGTGATTCC"	-3.2466758293217	13.4356174238953	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCGTGAGTGATTCC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2059.71374890941	38.8927073206204	0.018882578873503	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2059.71374890941	2059.71374890941
"AML-3133"	"2019-07-01-count-3:TCAGCCTCAGCATCTA"	1.43431200560872	10.9421376951965	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAGCCTCAGCATCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1981.72621781316	35.463013024332	0.0178950112813593	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1974.63119525632	1974.63119525632
"AML-3133"	"2019-07-01-count-2:CACGGGTGTTGTGTAC"	8.17079701003377	6.93478915775148	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACGGGTGTTGTGTAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1806.08999588687	39.1922408702396	0.0217000487016122	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1801.73011450275	1801.73011450275
"AML-3133"	"2019-07-01-count-2:CCTCATGGTCTTAGTG"	-0.631583551794845	11.0572995909485	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTCATGGTCTTAGTG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2398.80993864171	28.1417704763923	0.0117315548943937	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2397.21987506862	2397.21987506862
"AML-3133"	"2019-07-01-count-1:TCGGGACCACGGGTAA"	-3.85813126984294	10.4521903761658	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCGGGACCACGGGTAA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1959.42356894534	34.7157299133842	0.0177173177171028	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1956.50468988446	1956.50468988446
"AML-3133"	"2019-07-01-count-3:GCATCGGCAAGTCGTT"	-3.59218869629558	13.3776149519714	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATCGGCAAGTCGTT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1720.24895901185	39.0736625630329	0.0227139579758721	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1711.81135272573	1711.81135272573
"AML-3133"	"2019-07-01-count-3:TCCCACAGTCGAATGG"	-2.32442913475688	12.1273412474426	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCCCACAGTCGAATGG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2023.80498010271	41.7131337276453	0.0206112417637832	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2022.01738758992	2022.01738758992
"AML-3133"	"2019-07-01-count-1:CTGTGGGAGGGACCAT"	0.768851240246934	11.3870172270569	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGTGGGAGGGACCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1935.40702335061	40.9189750006304	0.0211423098639948	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1932.37266097133	1932.37266097133
"AML-3133"	"2019-07-01-count-1:CAAGGGAGTAGATCCT"	-1.56744943085368	9.55467317188112	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAAGGGAGTAGATCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2080.24575263936	46.7532439992379	0.022474865741184	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2077.33568455608	2077.33568455608
"AML-3133"	"2019-07-01-count-3:CATTGTTAGTAGAGTT"	1.47876169261281	10.5770864256653	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGTTAGTAGAGTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1695.71342459046	42.0723923174231	0.0248110274456217	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1692.63284984014	1692.63284984014
"AML-3133"	"2019-07-01-count-2:TTGTTGTTCATGGAGG"	0.65481855449025	10.3573121794495	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTTGTTCATGGAGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1663.13063399488	33.6503349266228	0.0202331279568784	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1657.85136315254	1657.85136315254
"AML-3133"	"2019-07-01-count-1:TGATTCTGTTTCTATC"	-3.60604105415996	10.4129209288391	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGATTCTGTTTCTATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2559.24953199255	39.5283965617953	0.0154453077230886	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2554.43587698353	2554.43587698353
"AML-3133"	"2019-07-01-count-1:ACGTAACTCAACCCGG"	8.82523407515828	7.71074864948121	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACGTAACTCAACCCGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1900.41737508347	35.7119928445321	0.0187916577235902	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1897.20710205177	1897.20710205177
"AML-3133"	"2019-07-01-count-2:TGTGTGATCCGATCGG"	-5.74674163284953	3.51796839320985	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGTGTGATCCGATCGG"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2567.4697097536	42.5027595988048	0.016554337306236	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2558.17490642787	2558.17490642787
"AML-3133"	"2019-07-01-count-2:GCTACCTTCGTCCTTG"	0.642914553254288	10.5018939741882	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCTACCTTCGTCCTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1863.46711232244	40.267173583842	0.0216087385270014	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1858.8981571903	1858.8981571903
"AML-3133"	"2019-07-01-count-2:TGATGGTGTGGCATCC"	8.09023632582967	7.19447848880617	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGATGGTGTGGCATCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1744.44374209731	38.0091701622242	0.0217887050438935	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1740.09618376925	1740.09618376925
"AML-3133"	"2019-07-01-count-2:GGGAGTAGTACTAACC"	-0.760470549494582	10.7357454069885	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGAGTAGTACTAACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1730.09402859349	39.3159155545159	0.022724727618694	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1724.72861232172	1724.72861232172
"AML-3133"	"2019-07-01-count-3:TCTGGCTAGTCTTCGA"	8.45696510848347	7.73369309985963	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTGGCTAGTCTTCGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1758.93821557637	39.8147266876015	0.0226356595899844	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1752.5062937823	1752.5062937823
"AML-3133"	"2019-07-01-count-3:CGTAATGCAAGACAAT"	-0.305316965014297	8.33860681140748	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00515259611573524	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGTAATGCAAGACAAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2046.96439107081	38.7726726613584	0.0189415472152281	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2038.59482930497	2038.59482930497
"AML-3133"	"2019-07-01-count-1:TTCACCGTCCTGTTAT"	1.1203211742336	12.049422241095	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTCACCGTCCTGTTAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1903.32116853883	41.8473675302218	0.0219864982441969	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1898.64767564198	1898.64767564198
"AML-3133"	"2019-07-01-count-1:TCCTCCCAGGGCTAAC"	1.10299350795094	12.6750850447449	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCTCCCAGGGCTAAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.88259409079	34.9126416330554	0.0166497836986402	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2085.21786450386	2085.21786450386
"AML-3133"	"2019-07-01-count-2:GGTTAACAGAAGATCT"	1.31162502345387	10.1104764708313	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTTAACAGAAGATCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1557.75005578515	40.083352752556	0.0257315688121435	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1555.88692125972	1555.88692125972
"AML-3133"	"2019-07-01-count-2:TTCACGCCATAAGATG"	-0.287417451769668	8.77163884723512	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTCACGCCATAAGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1749.77053513961	31.4669808373473	0.0179834899522048	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1744.1339446307	1744.1339446307
"AML-3133"	"2019-07-01-count-2:CATCAAGAGAACTCCT"	9.4316221671993	7.52045056903688	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CATCAAGAGAACTCCT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2182.18047127207	42.7057917358925	0.0195702382539414	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2173.66590116994	2173.66590116994
"AML-3133"	"2019-07-01-count-2:CAAGACTTCAGGTAAA"	1.25627674636189	10.5512780913147	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAAGACTTCAGGTAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1913.08829792411	39.9393569787465	0.02087690203431	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1908.97538310454	1908.97538310454
"AML-3133"	"2019-07-01-count-2:TATACCTTCGTAACCA"	1.04767956313435	10.4425983198914	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATACCTTCGTAACCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1708.6460455546	34.1082891169447	0.0199621736787935	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1700.35411633928	1700.35411633928
"AML-3133"	"2019-07-01-count-2:GTCCCATTCTGCCCTA"	8.48728718337361	7.74286935413209	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCCCATTCTGCCCTA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2063.47974759047	39.4914968060341	0.0191383011401727	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	2057.7617962116	2057.7617962116
"AML-3133"	"2019-07-01-count-2:GGAGCAAGTTCCTTGC"	1.09949113902394	11.7617597349915	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAGCAAGTTCCTTGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1789.90839499996	40.3369012633125	0.0225357349996191	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1787.21514429287	1787.21514429287
"AML-3133"	"2019-07-01-count-2:AGAGCAGCACGGTCTG"	1.12710299071614	10.7437095412048	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGAGCAGCACGGTCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1745.53222894554	42.0234212705375	0.0240748469570931	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1739.1837308661	1739.1837308661
"AML-3133"	"2019-07-01-count-3:TTAGTCTCAATATCCG"	1.25263180312459	9.43427178943483	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTAGTCTCAATATCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1797.50380012712	31.1933580641524	0.0173537091058981	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1789.75798304971	1789.75798304971
"AML-3133"	"2019-07-01-count-1:GCAGGCTCAACAGAGC"	0.660951455205125	11.0745019682678	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCAGGCTCAACAGAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2211.10273810255	33.9666000592145	0.0153618370932699	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2207.29501060544	2207.29501060544
"AML-3133"	"2019-07-01-count-3:ATGACCACACGCCAGT"	1.53254212912862	-10.2541284791199	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGACCACACGCCAGT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.51524823898	36.7685080968871	0.0142485141763758	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2577.69441256648	2577.69441256648
"AML-3133"	"2019-07-01-count-2:TATCAGGTCCAGTTCC"	1.58191635188405	11.1419782408508	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCAGGTCCAGTTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2047.14719651215	35.5829719444955	0.0173817359128452	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2043.45014865828	2043.45014865828
"AML-3133"	"2019-07-01-count-3:GGAGCAAGTAACTGCT"	1.20509948310201	10.8289317854675	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGAGCAAGTAACTGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1738.35153493805	35.2457059081862	0.0202753615708933	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1736.69509614936	1736.69509614936
"AML-3133"	"2019-07-01-count-2:GTGAGCCCACTGAATC"	0.608773966401261	10.509570098761	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGAGCCCACTGAATC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1711.61431745922	44.5665408968575	0.026037723827301	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1706.6191430768	1706.6191430768
"AML-3133"	"2019-07-01-count-3:TACCTCGAGAATAACC"	-2.20537362518962	11.4635858305725	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCTCGAGAATAACC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1750.52821883654	32.0634315283069	0.0183164322535841	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1750.52821883654	1750.52821883654
"AML-3133"	"2019-07-01-count-1:TAGGGTTAGGCGTTGA"	3.92130937156026	-10.7952776185242	"2019-07-01-count-1"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGGGTTAGGCGTTGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2075.41953180274	47.8429995677263	0.0230522064742106	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2070.43838073386	2070.43838073386
"AML-3133"	"2019-07-01-count-1:TGGAACTAGAAGTCTA"	1.45297493514363	11.2478542097839	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGAACTAGAAGTCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2002.80701071277	31.3989460557825	0.0156774696153116	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1999.16508859995	1999.16508859995
"AML-3133"	"2019-07-01-count-2:AGGACGAGTCTAACGT"	1.48204543170277	10.6429004439148	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGACGAGTCTAACGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1844.53101384861	28.8437873916923	0.0156374640356465	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1838.14257270226	1838.14257270226
"AML-3133"	"2019-07-01-count-1:AGGATAAAGCATATGA"	1.18143107470815	10.8344878920349	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGATAAAGCATATGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1775.21950779303	40.80086286675	0.0229835593218971	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1770.76012078661	1770.76012078661
"AML-3133"	"2019-07-01-count-2:GAGGGATAGGCCTTGC"	3.80085529860799	-10.8230915299621	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGGGATAGGCCTTGC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2238.94760492569	48.8691313538365	0.0218268311622497	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2235.54133948294	2235.54133948294
"AML-3133"	"2019-07-01-count-1:TAGGGTTTCTGCACCT"	0.735649724572343	11.4717511900696	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TAGGGTTTCTGCACCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1887.22271490297	42.3300348358423	0.0224298035952893	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1880.42521592169	1880.42521592169
"AML-3133"	"2019-07-01-count-1:CAATTTCTCTCGTCAC"	-1.6373373073643	13.7702884444031	"2019-07-01-count-1"	"AML3133"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCTCTCGTCAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2294.76947073874	39.3579435148933	0.0171511535327438	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2294.76947073874	2294.76947073874
"AML-3133"	"2019-07-01-count-3:GCATTAGCATGGGAAC"	1.54694308814351	-10.3877210847107	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCATTAGCATGGGAAC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2246.97989882539	44.5564585863726	0.0198294869525377	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2242.02784454973	2242.02784454973
"AML-3133"	"2019-07-01-count-3:GTAATGCGTAATGCTC"	-0.460636059672195	11.5886554487976	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAATGCGTAATGCTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1989.50660256708	41.4880445244631	0.0208534339473569	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1989.50660256708	1989.50660256708
"AML-3133"	"2019-07-01-count-2:GCCCGAAAGTTGGAGC"	-2.77265582504924	-7.59276058590087	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GCCCGAAAGTTGGAGC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2286.59856252756	45.5190952217784	0.0199069027540464	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2279.06238688375	2279.06238688375
"AML-3133"	"2019-07-01-count-2:CTGCCTACAATAGGGC"	-7.3511041206425	1.25186500633088	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	47	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.288461538461538	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGCCTACAATAGGGC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2508.3900376401	43.0314246320116	0.0171549974231662	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2506.32836243651	2506.32836243651
"AML-3133"	"2019-07-01-count-1:CTAGACATCTATCACT"	1.43405808982198	10.7831153639588	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGACATCTATCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2303.03766444609	29.2462909493792	0.0126990067947557	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2299.14015077049	2299.14015077049
"AML-3133"	"2019-07-01-count-1:CTAGACAGTCGATTAC"	-1.96092615547832	13.8667468794617	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTAGACAGTCGATTAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2150.03734613521	41.3283580436677	0.0192221582187664	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2145.29732287433	2145.29732287433
"AML-3133"	"2019-07-01-count-2:ATCCACCTCTCATTAC"	1.4493987756664	9.93594930255739	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCACCTCTCATTAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1857.33262931113	44.280490722457	0.0238409049750449	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1849.79277380524	1849.79277380524
"AML-3133"	"2019-07-01-count-2:CCTTGTGAGGGCAAGG"	8.15146412429158	7.22083280170289	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCTTGTGAGGGCAAGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1713.36424946812	46.553645397603	0.0271708980808108	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1708.70450854885	1708.70450854885
"AML-3133"	"2019-07-01-count-2:ATCACGAAGCTTGTGT"	1.46823896941487	10.5097760924133	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCACGAAGCTTGTGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1759.20048413573	32.2355394275751	0.0183239714394531	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1759.20048413573	1759.20048413573
"AML-3133"	"2019-07-01-count-2:GAACGTTGTCGATGCC"	0.10706521671955	13.2724618681702	"2019-07-01-count-2"	"AML3133"	"NK"	"IFN+ NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAACGTTGTCGATGCC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1499.27118091272	45.2109747314838	0.0301553016606111	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1499.27118091272	1499.27118091272
"AML-3133"	"2019-07-01-count-1:ACAACCAGTAGAATAC"	0.0210179994696796	10.5469045408997	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAACCAGTAGAATAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2088.03192851035	45.2259134033588	0.0216595890062007	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2081.05856682684	2081.05856682684
"AML-3133"	"2019-07-01-count-3:GTTGTGAAGAGAGCCT"	0.521280189126176	9.1433648833069	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTTGTGAAGAGAGCCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1536.86696602276	44.4375426002027	0.0289143716291868	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1535.10626206069	1535.10626206069
"AML-3133"	"2019-07-01-count-2:GTTCCGTGTTCTATCT"	1.20225920256917	-9.99332716381224	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTCCGTGTTCTATCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.16098840716	40.2206650748576	0.0152804730607291	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2626.65734022957	2626.65734022957
"AML-3133"	"2019-07-01-count-1:ATCATTCCATGTGGTT"	1.50477685508077	-10.2082061997619	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATCATTCCATGTGGTT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2672.04227938699	36.1838568483127	0.0135416483217525	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2667.00533171313	2667.00533171313
"AML-3133"	"2019-07-01-count-3:CTGATCCCATGTGACT"	1.49306335028951	10.7213315733704	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGATCCCATGTGACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1732.00611834628	36.9586630011582	0.0213386445981185	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1726.27983288083	1726.27983288083
"AML-3133"	"2019-07-01-count-2:TCGACCTCAACTACGT"	-1.0065452856129	11.064649558905	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCGACCTCAACTACGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1510.89522376309	36.9404627637765	0.0244493874775586	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1506.58891881867	1506.58891881867
"AML-3133"	"2019-07-01-count-1:AGTGCCGAGTTGAAGT"	1.46410872515981	11.328981376532	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGTGCCGAGTTGAAGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1861.952330005	34.4102560070214	0.0184807395186798	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1856.35858236516	1856.35858236516
"AML-3133"	"2019-07-01-count-3:CTGCCTAGTATGCGGA"	0.833406885235947	10.8954047926697	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTGCCTAGTATGCGGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1639.07718586863	31.2405152355948	0.0190598194550788	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1636.08790725578	1636.08790725578
"AML-3133"	"2019-07-01-count-1:GAAGCGATCAGGAAAT"	8.71196426925008	7.53601739490358	"2019-07-01-count-1"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GAAGCGATCAGGAAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1813.01194080892	37.0394597716066	0.0204297936146413	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1809.80773005535	1809.80773005535
"AML-3133"	"2019-07-01-count-2:GGCGTCATCAACTGAC"	2.97240151938741	-9.97419264232787	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGCGTCATCAACTGAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1731.78038862644	47.2123698329588	0.0272623308030444	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1729.76489897412	1729.76489897412
"AML-3133"	"2019-07-01-count-3:GAGCTGCAGGTACAAT"	8.51275887069051	7.38300225818483	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGCTGCAGGTACAAT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1734.47215291424	36.8498384666292	0.0212455636169855	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1730.93227007222	1730.93227007222
"AML-3133"	"2019-07-01-count-2:GAGTTACGTGGCCACT"	1.29288842257802	11.6948604353699	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGTTACGTGGCCACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1814.4215657827	33.6239957441162	0.0185315234222382	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1814.4215657827	1814.4215657827
"AML-3133"	"2019-07-01-count-1:TGTCCCAAGCAGGCTA"	1.52240004119222	10.8586416014465	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGTCCCAAGCAGGCTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1805.39129796727	35.0024558590684	0.019387739321929	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1801.63929407408	1801.63929407408
"AML-3133"	"2019-07-01-count-3:TGCGGCAGTTCGGCTG"	0.987467547028702	12.6007871397766	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCGGCAGTTCGGCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1627.47062788122	32.5128508927086	0.0199775346698801	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1625.64300445568	1625.64300445568
"AML-3133"	"2019-07-01-count-3:CAGAGCCAGGTCACAG"	2.01390578326527	-10.347740196344	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAGAGCCAGGTCACAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2000.99902909411	45.1926599747344	0.0225850484271319	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1997.84979420147	1997.84979420147
"AML-3133"	"2019-07-01-count-2:ACATTTCAGTCGAGGT"	-2.4761053127354	9.82595155322877	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATTTCAGTCGAGGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1780.64729882579	35.4114898694764	0.0198868635539603	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1775.92039848763	1775.92039848763
"AML-3133"	"2019-07-01-count-1:GATGTTGGTTTACTGG"	0.935875375836533	11.4999704130921	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGTTGGTTTACTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1982.61535831261	34.8415746188669	0.0175735421763909	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1979.85526371602	1979.85526371602
"AML-3133"	"2019-07-01-count-3:AGAGCCCAGCACGTCC"	0.689153571694535	9.69276998126832	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGAGCCCAGCACGTCC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1804.81722822932	40.052195700068	0.0221918292188304	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1803.41501634941	1803.41501634941
"AML-3133"	"2019-07-01-count-1:GATGCTAGTCATCCCT"	-9.18288360062297	-1.65428450023802	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	60	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	1	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GATGCTAGTCATCCCT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2825.62892730537	52.9810802302235	0.0187501903446141	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2821.72535702406	2821.72535702406
"AML-3133"	"2019-07-01-count-2:TTTCGATTCGCGTGCA"	-7.77537427368816	4.04798600757448	"2019-07-01-count-2"	"AML3133"	"HSC"	"HSC"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.466666666666667	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTTCGATTCGCGTGCA"	"HSC"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2171.89467255636	32.1377656450542	0.0147971105832805	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2166.00899910939	2166.00899910939
"AML-3133"	"2019-07-01-count-1:AGGACGAAGTCAGGGT"	1.02213664826695	12.8555364378723	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGGACGAAGTCAGGGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2047.99654698204	37.4705175427855	0.0182961819921048	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2044.11074122587	2044.11074122587
"AML-3133"	"2019-07-01-count-1:GCTGCAGCAGTGCGCT"	-6.02216134491618	3.49994871700136	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.5	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTGCAGCAGTGCGCT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1876.29613563249	43.2624974810695	0.023057393051916	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	1872.56154597035	1872.56154597035
"AML-3133"	"2019-07-01-count-1:TCCATCGGTTAGTCGT"	1.377897520631	10.6420001753601	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TCCATCGGTTAGTCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1841.71893601748	36.5218116697369	0.0198302851512791	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1841.71893601748	1841.71893601748
"AML-3133"	"2019-07-01-count-1:ACTTCCGTCACAACCA"	1.51565875586812	10.7963580855164	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACTTCCGTCACAACCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1946.08964814505	40.7135718990193	0.0209207072951784	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1941.27970161652	1941.27970161652
"AML-3133"	"2019-07-01-count-2:CTACATTCATGAAAGT"	7.68669714507405	6.69495771015016	"2019-07-01-count-2"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTACATTCATGAAAGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1825.95256136987	41.305023490453	0.0226210824773373	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1824.14575924618	1824.14575924618
"AML-3133"	"2019-07-01-count-1:CAGCCAGGTGCACAAG"	1.61876442012135	-10.4882612458435	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGGTGCACAAG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2747.29618903966	39.4563839115042	0.0143618966418384	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2738.46285073073	2738.46285073073
"AML-3133"	"2019-07-01-count-3:TGCTCGTGTTATGTGC"	1.29018392142598	10.864683128241	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TGCTCGTGTTATGTGC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1881.1862505039	41.6353605305385	0.0221325031050944	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1874.99109969353	1874.99109969353
"AML-3133"	"2019-07-01-count-3:GTCATTTGTATGGTTC"	-3.61751804772075	-4.13671018993529	"2019-07-01-count-3"	"AML3133"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCATTTGTATGGTTC"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2138.3595273777	52.6621534684041	0.0246273616733592	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2136.71615362463	2136.71615362463
"AML-3133"	"2019-07-01-count-2:GGGCCATTCGACGAGA"	1.09530999240224	10.0882787474426	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGCCATTCGACGAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1760.93252197217	33.2293563985344	0.0188703178480223	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1750.87418186507	1750.87418186507
"AML-3133"	"2019-07-01-count-3:GTGTAACAGTAAACTG"	-2.42370710793193	13.3064641722473	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTAACAGTAAACTG"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2130.85251245242	33.6417847620985	0.015787946169667	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2127.2447657068	2127.2447657068
"AML-3133"	"2019-07-01-count-3:CTCCGATTCCGGCAAC"	3.86405863341634	-10.6755008927551	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCGATTCCGGCAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2298.90105961677	39.0908154556957	0.0170041312966345	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2296.09472289481	2296.09472289481
"AML-3133"	"2019-07-01-count-1:TTGCTGCTCACTTGTT"	0.836202879517716	-10.4767837754455	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGCTGCTCACTTGTT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2151.70368181371	49.4625693856364	0.0229876305941641	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2145.69211749749	2145.69211749749
"AML-3133"	"2019-07-01-count-1:TTAGGGTCACCGTCGA"	1.42818238314931	11.0628213652405	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTAGGGTCACCGTCGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1885.3740778973	34.6711068078036	0.01838951071528	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1877.91719916483	1877.91719916483
"AML-3133"	"2019-07-01-count-1:CAATTTCTCTCAGTCC"	1.76742114600484	-10.4849596253601	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAATTTCTCTCAGTCC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2734.89939526106	38.5320568685627	0.0140890216785779	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2730.96485211157	2730.96485211157
"AML-3133"	"2019-07-01-count-3:ACGTACAGTCTGTAAC"	1.79970659789388	-9.90451242839965	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ACGTACAGTCTGTAAC"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2183.93385190723	42.007188579888	0.0192346432760329	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2173.11028949354	2173.11028949354
"AML-3133"	"2019-07-01-count-1:GTGTAACCATATGCGT"	1.2062437730724	11.1024293669495	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGTAACCATATGCGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2022.41106851273	36.4130723315655	0.0180047829536176	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2020.08757059017	2020.08757059017
"AML-3133"	"2019-07-01-count-3:AGATGCTCAATCTCGA"	4.07798304137532	-10.7770586243835	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGATGCTCAATCTCGA"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2116.84738813738	42.916745827943	0.0202738969603782	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2111.59680177346	2111.59680177346
"AML-3133"	"2019-07-01-count-2:GGGATGACACACCAGC"	0.0470204028183639	10.0409011610779	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGGATGACACACCAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1382.56948495693	47.7110138502943	0.0345089446638414	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1372.523011556	1372.523011556
"AML-3133"	"2019-07-01-count-1:CCGGTAGTCGTTCTGC"	8.10739960250203	6.58392856204835	"2019-07-01-count-1"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCGGTAGTCGTTCTGC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2002.01544418643	45.4005473750622	0.0226774211492218	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1995.35187470948	1995.35187470948
"AML-3133"	"2019-07-01-count-3:CGATCGGCAACTGGTT"	1.1173868375713	11.24946401203	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CGATCGGCAACTGGTT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1736.14185485028	41.5236718252565	0.0239172114359499	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1729.79992716809	1729.79992716809
"AML-3133"	"2019-07-01-count-3:TCGGGTGAGTAGATCA"	-3.09658465805705	3.49364826763002	"2019-07-01-count-3"	"AML3133"	"Ery"	"Ery-2"	53	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0110803324099723	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGTGAGTAGATCA"	"Ery"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Ery"	"Ery"	3341.5542595908	45.4145341280165	0.0135908414468116	4550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	46	TRUE	"Ery_AML-3133"	3336.39190925527	3336.39190925527
"AML-3133"	"2019-07-01-count-3:AGGGCTCCATCGCTGG"	1.13850297507588	10.0003061064514	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.AGGGCTCCATCGCTGG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1700.49545839386	35.0461453462981	0.0206093730937686	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1700.49545839386	1700.49545839386
"AML-3133"	"2019-07-01-count-2:ACTTATCTCCTGGCTT"	3.71408094939534	-10.1939048997131	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACTTATCTCCTGGCTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2507.14412032507	43.5047002673492	0.0173522933582727	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2500.12606735348	2500.12606735348
"AML-3133"	"2019-07-01-count-2:AGCGATTTCATCCTGC"	3.66792025145833	-10.6141662827698	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGCGATTTCATCCTGC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2389.25712684886	38.908748216469	0.0162848727243455	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2383.54121790162	2383.54121790162
"AML-3133"	"2019-07-01-count-1:GGGACTCCAGTTGTTG"	1.50383557853047	11.3456754454407	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGGACTCCAGTTGTTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2014.31053295864	34.8620368554022	0.0173071809360975	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2010.70271440797	2010.70271440797
"AML-3133"	"2019-07-01-count-1:GCTACAAGTGTCATGT"	0.322150637477082	9.92771241748659	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GCTACAAGTGTCATGT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1893.49714986226	24.4705456177696	0.0129234657784141	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1888.94645204611	1888.94645204611
"AML-3133"	"2019-07-01-count-2:TTGTGGAGTAGTCTGT"	-2.76426396790202	11.090923286322	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTGTGGAGTAGTCTGT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1629.65604465333	32.7859443655355	0.0201183215765691	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1629.65604465333	1629.65604465333
"AML-3133"	"2019-07-01-count-3:CCGCAAGCAATTGCTG"	-0.643074135214645	-9.80447676098021	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CCGCAAGCAATTGCTG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2091.8240624048	43.1517086282028	0.020628746654054	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2084.30827369964	2084.30827369964
"AML-3133"	"2019-07-01-count-3:TTGATGGGTGTAGTGG"	3.78365554389302	-10.8059787980286	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTGATGGGTGTAGTGG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2575.26483704888	45.5098124030061	0.0176718960117352	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2571.08999457127	2571.08999457127
"AML-3133"	"2019-07-01-count-1:AGCCAATCACTACAGT"	-7.60995088043864	1.3126067885193	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGCCAATCACTACAGT"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2754.95596993629	48.2417587488037	0.0175109000925047	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2748.17333034268	2748.17333034268
"AML-3133"	"2019-07-01-count-2:TGCATCCAGAGCTTTC"	-1.48418341103252	11.50656507099	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGCATCCAGAGCTTTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1757.76546217138	34.7405142627786	0.019764021429721	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1756.00653334152	1756.00653334152
"AML-3133"	"2019-07-01-count-2:ATTATCCGTACGCGTC"	-2.80569777908977	10.2763376005921	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTATCCGTACGCGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1775.50466654883	34.857437078154	0.0196324108490848	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1771.99559210876	1771.99559210876
"AML-3133"	"2019-07-01-count-1:AAAGGATTCAGCTTCC"	-7.41123376312907	1.73677477920381	"2019-07-01-count-1"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGGATTCAGCTTCC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2740.74988761993	36.562016317915	0.01334015062194	2766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2730.71363708185	2730.71363708185
"AML-3133"	"2019-07-01-count-1:GTAGGTTAGTTCTCTT"	1.1807859140331	10.5706090697083	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGGTTAGTTCTCTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2009.24896348993	36.6373660645126	0.0182343585739002	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1999.6283962464	1999.6283962464
"AML-3133"	"2019-07-01-count-1:ACCACAACAAAGGAGA"	-1.07088742676433	11.0576276549133	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACCACAACAAAGGAGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1942.38186848483	46.7918855694386	0.0240899517899325	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1937.07339198889	1937.07339198889
"AML-3133"	"2019-07-01-count-3:CTCCCTCGTAGTTAGA"	9.58475460585896	6.80103871906129	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	2	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00191387559808612	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCCTCGTAGTTAGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1800.62249249339	41.0004066030891	0.022770129093697	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1798.89231791174	1798.89231791174
"AML-3133"	"2019-07-01-count-1:CATACCCAGTAGATCA"	1.48238994654958	10.7698077925476	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATACCCAGTAGATCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1583.23281571678	45.1016278966365	0.0284870471663496	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1572.73333422801	1572.73333422801
"AML-3133"	"2019-07-01-count-2:GATTGGTAGCCGATTT"	7.58725227889363	6.64705751026002	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GATTGGTAGCCGATTT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1878.64440368955	34.9286043442917	0.0185924511715436	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1869.73635911785	1869.73635911785
"AML-3133"	"2019-07-01-count-2:GTGTGGCCAAGTGACG"	1.3260678249294	10.7038135298523	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTGTGGCCAAGTGACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1814.72436488549	32.6175300461103	0.0179738205301324	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1809.45844753488	1809.45844753488
"AML-3133"	"2019-07-01-count-3:TAACCAGAGTGAGGCT"	1.9603177505428	-9.94434931194457	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	66	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.375	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TAACCAGAGTGAGGCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1693.80503935512	45.8732601625176	0.0270829635623135	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1687.85386853661	1687.85386853661
"AML-3133"	"2019-07-01-count-2:GGAACCCCACCGGTCA"	1.22244240817372	10.9553508528504	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGAACCCCACCGGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1936.57872396089	38.5772688659298	0.0199203205057565	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1929.42842220456	1929.42842220456
"AML-3133"	"2019-07-01-count-2:GTCATCCCATATCTCT"	1.24472059783284	10.0871047743591	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTCATCCCATATCTCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1731.21070317312	31.5236767347287	0.0182090352589371	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1731.21070317312	1731.21070317312
"AML-3133"	"2019-07-01-count-1:CATCGGGAGGAGCAAA"	0.243621592491311	11.2232751616272	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CATCGGGAGGAGCAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1959.43526865989	44.0997458244871	0.0225063550349627	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1958.11668917973	1958.11668917973
"AML-3133"	"2019-07-01-count-3:GAGACCCCATGAAGCG"	-1.56463227692302	-6.64986898815306	"2019-07-01-count-3"	"AML3133"	"CD11c+"	"CD11c+"	24	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.25	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGACCCCATGAAGCG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.26708430988	47.0740929329371	0.0204379653812669	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2299.27222290479	2299.27222290479
"AML-3133"	"2019-07-01-count-3:GTCACTCTCTGTAAGC"	1.48884656009023	10.8063363798889	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTCACTCTCTGTAAGC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1829.39074473884	40.667453618685	0.0222300532216208	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1824.80493015225	1824.80493015225
"AML-3133"	"2019-07-01-count-3:TTTGGTTCATGGGATG"	0.714864988892716	9.70475957477418	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TTTGGTTCATGGGATG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1418.41000443013	42.9163797209	0.0302566814862128	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1413.83790165189	1413.83790165189
"AML-3133"	"2019-07-01-count-1:AGAAGTAGTCTGTGAT"	1.30549587783162	9.73610684955446	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGAAGTAGTCTGTGAT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1876.68284376029	38.8025223152109	0.0206761214044365	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1872.810042136	1872.810042136
"AML-3133"	"2019-07-01-count-2:TATCCTAGTAACGCGA"	-1.13405905190166	11.8532113798889	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TATCCTAGTAACGCGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1976.95600113778	46.1769903738381	0.023357621690752	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1970.30075260769	1970.30075260769
"AML-3133"	"2019-07-01-count-2:ACATCCCGTCAGACGA"	-7.53782926026042	1.31254599178163	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATCCCGTCAGACGA"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2476.19295528416	40.1308474927518	0.0162066721848607	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2466.23682248495	2466.23682248495
"AML-3133"	"2019-07-01-count-2:CTTTCAAAGAGGCGGA"	0.98368533429448	-9.78850653087767	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTTTCAAAGAGGCGGA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2161.61925416934	45.246679211346	0.0209318450157557	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2161.61925416934	2161.61925416934
"AML-3133"	"2019-07-01-count-2:ATGCGATTCGTTCAGA"	1.08188345012013	11.1072530516419	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATGCGATTCGTTCAGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1822.26327661877	38.4941591433659	0.0211243675034665	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1812.65935475543	1812.65935475543
"AML-3133"	"2019-07-01-count-2:ATCCTATAGGAAAGTG"	2.16580571708028	-10.375780128595	"2019-07-01-count-2"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATCCTATAGGAAAGTG"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.96967468676	43.5688605292427	0.0169398811183685	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2567.51004986962	2567.51004986962
"AML-3133"	"2019-07-01-count-2:GAGATGGAGCGTTCAT"	1.53883399543111	-10.343511604425	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAGATGGAGCGTTCAT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.69049392646	42.9846490079819	0.0164585539932636	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2607.80585903039	2607.80585903039
"AML-3133"	"2019-07-01-count-3:CTCATGCCACAGAGAC"	7.87189259108846	6.82302472675172	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCATGCCACAGAGAC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1696.00961353573	40.3800178866921	0.0238088378535252	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1688.73730048128	1688.73730048128
"AML-3133"	"2019-07-01-count-3:CAACAGTCACTTCCTG"	1.52340282973592	10.7658281096253	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CAACAGTCACTTCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.57687087913	35.0167764418539	0.0167018805407172	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2087.90270611963	2087.90270611963
"AML-3133"	"2019-07-01-count-3:GGGACAATCTCACTCG"	8.30542339858357	6.76610181415407	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGACAATCTCACTCG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1561.36566138432	39.560496597906	0.0253371119759553	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1557.22475482057	1557.22475482057
"AML-3133"	"2019-07-01-count-3:GGGCTACGTTGGATCT"	1.00700445946996	-9.95223143016966	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGCTACGTTGGATCT"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2299.10685367313	43.4896853282992	0.0189159043472984	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2299.10685367313	2299.10685367313
"AML-3133"	"2019-07-01-count-2:AGTAGTCCACTTCCTG"	1.45961119708363	11.0111560591492	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGTAGTCCACTTCCTG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1710.88878776805	37.2858487409248	0.0217932626641187	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1709.43606071986	1709.43606071986
"AML-3133"	"2019-07-01-count-1:TGGCGTGTCGAGTGGA"	-2.09982881966289	8.51471135700075	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGGCGTGTCGAGTGGA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2481.89239454477	34.3235482050407	0.0138295875681332	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2470.96700651137	2470.96700651137
"AML-3133"	"2019-07-01-count-2:AACAAAGTCCTCTCGA"	-3.76251421395	13.0403766402039	"2019-07-01-count-2"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AACAAAGTCCTCTCGA"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1980.03810697313	34.5783305211918	0.0174634671925842	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1976.44411189204	1976.44411189204
"AML-3133"	"2019-07-01-count-1:TTGAACGAGAGTTGCG"	0.975091894238633	11.7657232054505	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTGAACGAGAGTTGCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1862.05233382225	42.7676311074577	0.0229680070375188	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1858.58942582357	1858.58942582357
"AML-3133"	"2019-07-01-count-3:GAGCCTGCACCATTCC"	4.24097170409505	-10.8006639710632	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GAGCCTGCACCATTCC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1822.17176475061	48.8360098065403	0.0268009914055628	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1818.42333349143	1818.42333349143
"AML-3133"	"2019-07-01-count-2:ATTTCACGTAGAGTTA"	-2.99143467369731	10.4777145155701	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ATTTCACGTAGAGTTA"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1812.48769613649	37.6083834608487	0.0207495937991827	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.96582299002	1808.96582299002
"AML-3133"	"2019-07-01-count-3:CATTGCCGTAGGTACG"	0.683260520070237	8.86120603168336	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATTGCCGTAGGTACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1743.19851525647	38.6450943415216	0.0221690725429719	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1739.91444994821	1739.91444994821
"AML-3133"	"2019-07-01-count-3:ATTATCCGTGACAGCA"	1.0828855234081	10.7431525954041	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTATCCGTGACAGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1846.74795518624	40.5056526380195	0.0219335034454848	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1837.56344837365	1837.56344837365
"AML-3133"	"2019-07-01-count-3:CATCGGGTCGGCTGGT"	8.0520416694576	7.20894000614015	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATCGGGTCGGCTGGT"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1550.29434144075	37.8947565355377	0.0244435882416501	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1546.52947475213	1546.52947475213
"AML-3133"	"2019-07-01-count-1:CTGCTCACAAGTCCAT"	0.372852702706498	11.1113528975281	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTGCTCACAAGTCCAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2168.18656420537	40.9779920807628	0.0188996614762166	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2162.18891334243	2162.18891334243
"AML-3133"	"2019-07-01-count-3:ATGCATGCAAATCAGA"	7.77941145476643	6.48732326114503	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATGCATGCAAATCAGA"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1530.57631193921	32.7456372483178	0.0213943185928637	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1530.57631193921	1530.57631193921
"AML-3133"	"2019-07-01-count-3:TATTTCGCACTCCCTA"	0.0527735679584134	-10.102378868219	"2019-07-01-count-3"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TATTTCGCACTCCCTA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.42627032534	42.7540354465922	0.0164919002464925	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2583.45062008723	2583.45062008723
"AML-3133"	"2019-07-01-count-2:TCCTTCTAGTGATCGG"	8.13521446761433	7.30861089313356	"2019-07-01-count-2"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCTTCTAGTGATCGG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1686.50929691706	37.9982097661046	0.0225306850282802	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1686.50929691706	1686.50929691706
"AML-3133"	"2019-07-01-count-2:CTAACCCCATGACCCG"	0.981662471860093	8.79988572681276	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTAACCCCATGACCCG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1761.90709019384	35.1317944318446	0.0199396407605009	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1759.21061964117	1759.21061964117
"AML-3133"	"2019-07-01-count-2:GTAACCAAGCAGCCCT"	-7.68736205521281	1.80827579582063	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTAACCAAGCAGCCCT"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2697.09487681113	38.3611255912252	0.0142231279741189	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2690.77960760358	2690.77960760358
"AML-3133"	"2019-07-01-count-2:ACATGCATCTACTGAG"	0.326946844428223	11.166440940741	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.ACATGCATCTACTGAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1793.23150240259	37.8066217188602	0.0210829564772905	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1791.55465770519	1791.55465770519
"AML-3133"	"2019-07-01-count-1:AAAGGATGTAGAATAC"	0.0650969623470723	10.1058568724426	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGGATGTAGAATAC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1393.8246282738	41.0653091187856	0.0294623213607894	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1386.54596047251	1386.54596047251
"AML-3133"	"2019-07-01-count-1:GACTCTCCAGATCCTA"	-7.68434033814128	0.765719867590345	"2019-07-01-count-1"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GACTCTCCAGATCCTA"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2730.03684121069	38.9733895963129	0.0142757742342515	2849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2720.09135391094	2720.09135391094
"AML-3133"	"2019-07-01-count-1:AAAGGATCAAAGCAAT"	-0.587778667837936	11.3959607847962	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AAAGGATCAAAGCAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2091.28965749215	39.1601585219501	0.0187253632616873	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2087.46726282647	2087.46726282647
"AML-3133"	"2019-07-01-count-1:CTTTCGGAGCACAAAT"	-0.248839626938659	11.5590028532776	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTTTCGGAGCACAAAT"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1617.08795346503	33.8303677920594	0.0209205490150174	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1612.60417917091	1612.60417917091
"AML-3133"	"2019-07-01-count-3:TCTCCGATCTCATTGT"	-1.75491879406627	12.7100066908631	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCTCCGATCTCATTGT"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2199.03957712353	34.1266423296239	0.0155188850099112	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2197.30030880974	2197.30030880974
"AML-3133"	"2019-07-01-count-1:CAGCCAGTCAACTTTC"	1.32988383349721	11.4299325712952	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CAGCCAGTCAACTTTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2019.82219646687	34.1373300285142	0.0169011559969131	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2016.14094037179	2016.14094037179
"AML-3133"	"2019-07-01-count-1:AATAGAGCAACCCGCA"	1.27815475043599	11.1193876036438	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AATAGAGCAACCCGCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2004.62550875466	36.8528862071095	0.0183839255991528	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2000.79722212084	2000.79722212084
"AML-3133"	"2019-07-01-count-2:GGTAACTAGCCTCATA"	1.27404441413228	10.7407178648743	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTAACTAGCCTCATA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1988.44781107324	41.2782138705154	0.0207590129550527	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1985.66808588146	1985.66808588146
"AML-3133"	"2019-07-01-count-2:TTACGTTTCGCATTGA"	0.968076427548569	10.1048793562683	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TTACGTTTCGCATTGA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1766.56449096015	33.978263999213	0.0192340920317862	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1761.1182768914	1761.1182768914
"AML-3133"	"2019-07-01-count-3:TCGGGTGGTGATCATC"	7.79693283614461	6.59073970401613	"2019-07-01-count-3"	"AML3133"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCGGGTGGTGATCATC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1521.23809142378	43.4304100030841	0.0285493837210165	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1521.23809142378	1521.23809142378
"AML-3133"	"2019-07-01-count-2:TCCGAAAAGACTTCCA"	1.43420328673665	11.5527496107849	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCCGAAAAGACTTCCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1964.38540207944	39.3617011426093	0.0200376673034437	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1961.44457593104	1961.44457593104
"AML-3133"	"2019-07-01-count-2:CACCGTTGTCCTATAG"	0.420476933091325	9.82835099780885	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CACCGTTGTCCTATAG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1848.47573575335	39.0252517275616	0.0211121255057518	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1845.32195442936	1845.32195442936
"AML-3133"	"2019-07-01-count-1:TTTAGTCTCTCCGAAA"	1.13658537444417	10.7866458662781	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TTTAGTCTCTCCGAAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.35718630617	39.8408038022833	0.0190867207891652	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2082.25659226001	2082.25659226001
"AML-3133"	"2019-07-01-count-3:GTGTCCTCACTAAACC"	8.41654743727986	5.76639411533204	"2019-07-01-count-3"	"AML3133"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTGTCCTCACTAAACC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1567.10700974751	36.4597188780723	0.0232656217165072	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1565.11673248553	1565.11673248553
"AML-3133"	"2019-07-01-count-1:ACAAAGAGTTTGACAC"	2.35443892058675	-10.495348953363	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ACAAAGAGTTTGACAC"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2776.27269715905	43.7679922375556	0.0157650191504398	2607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2764.06817571784	2764.06817571784
"AML-3133"	"2019-07-01-count-1:GTGGGAACAACATCGT"	3.09768833693807	-10.8006820908752	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.00740009866798224	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTGGGAACAACATCGT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.78064376345	38.5193849453306	0.0154091060115335	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2489.87811659132	2489.87811659132
"AML-3133"	"2019-07-01-count-1:AGATGAATCGCTTGCT"	0.914443810551804	11.7329873808655	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.AGATGAATCGCTTGCT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1898.47566090729	39.5375279666209	0.0208259335533044	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1895.80429879074	1895.80429879074
"AML-3133"	"2019-07-01-count-2:GAAATGACAAGTGCAG"	-3.15824399414714	9.99455926502077	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GAAATGACAAGTGCAG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1645.62936278769	41.0904429089479	0.02496943955797	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1643.68636551639	1643.68636551639
"AML-3133"	"2019-07-01-count-1:GTCTACCTCGGATTAC"	-1.67601714554484	10.8379821547302	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTACCTCGGATTAC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.39358330767	40.0297827700119	0.0166278514022674	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2397.39925968712	2397.39925968712
"AML-3133"	"2019-07-01-count-2:GTTAGACGTAGTCGTT"	3.7675367790157	-10.711301826593	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTAGACGTAGTCGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2282.53516169768	44.4914791907636	0.0194921331059243	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2281.37528083492	2281.37528083492
"AML-3133"	"2019-07-01-count-1:TGACAGTGTCGTATGT"	3.68807186660115	-10.8123140565124	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGACAGTGTCGTATGT"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2239.63489815715	47.3548861813433	0.0211440204920492	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2237.22949440517	2237.22949440517
"AML-3133"	"2019-07-01-count-1:CCCATTGTCAATGCAC"	-3.00990877571757	13.200376487616	"2019-07-01-count-1"	"AML3133"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0422213769494104	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CCCATTGTCAATGCAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1842.58605115588	47.6425673912244	0.0258563595232568	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	1840.71695764697	1840.71695764697
"AML-3133"	"2019-07-01-count-3:CTCCCTCGTACAAGCG"	0.316364188759965	10.0415477522644	"2019-07-01-count-3"	"AML3133"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CTCCCTCGTACAAGCG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1450.15939463314	43.3969484583272	0.0299256403254249	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1450.15939463314	1450.15939463314
"AML-3133"	"2019-07-01-count-2:CTGAGCGGTCCCTGTT"	4.33294786986653	-10.7024812928406	"2019-07-01-count-2"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CTGAGCGGTCCCTGTT"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1824.6428223732	43.3084073197404	0.023735279468785	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1819.38403373257	1819.38403373257
"AML-3133"	"2019-07-01-count-2:CAACGATAGCTGTCCG"	1.25926484641377	-10.1087379685608	"2019-07-01-count-2"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACGATAGCTGTCCG"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2207.84452475191	48.2833386214045	0.0218689939803755	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2198.62053821823	2198.62053821823
"AML-3133"	"2019-07-01-count-3:TCAAGACCAGAGGTAC"	-3.68167791786845	13.2986268767151	"2019-07-01-count-3"	"AML3133"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0101400289715113	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCAAGACCAGAGGTAC"	"NK"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2283.84962038147	40.5266093351538	0.0177448676889613	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	150	TRUE	"NK_AML-3133"	2282.24934506376	2282.24934506376
"AML-3133"	"2019-07-01-count-2:TCTTTGATCCTAGCTC"	1.40102710303609	11.3223981627258	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TCTTTGATCCTAGCTC"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1968.81456700378	36.0867022802981	0.018329152417445	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1967.44380433875	1967.44380433875
"AML-3133"	"2019-07-01-count-2:TGACTCCAGGAACGAA"	0.636643667786759	11.2524909743103	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TGACTCCAGGAACGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1811.50373077232	36.0814534700896	0.0199179570304867	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.6147795981	1808.6147795981
"AML-3133"	"2019-07-01-count-2:CAACAGTCAGCCGTCA"	1.0310056405956	11.9015397795471	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"CD4+ Activated"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0849639546858908	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CAACAGTCAGCCGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1796.89423869142	39.2581498267379	0.0218477798979017	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1794.02590058198	1794.02590058198
"AML-3133"	"2019-07-01-count-2:GGTTCTCAGCTAGTTC"	-7.60778222504314	0.729420281294264	"2019-07-01-count-2"	"AML3133"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GGTTCTCAGCTAGTTC"	"MPP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2645.93899122196	36.781505921573	0.0139011164065376	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2642.08690657741	2642.08690657741
"AML-3133"	"2019-07-01-count-3:CATGGATGTTTCGACA"	1.26330806788747	11.5915069350037	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.CATGGATGTTTCGACA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1678.28561270795	38.6130422697226	0.0230074320946002	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1676.50504122469	1676.50504122469
"AML-3133"	"2019-07-01-count-1:ATGTCCCTCGCTACAA"	2.94203223761861	-10.736300491449	"2019-07-01-count-1"	"AML3133"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.ATGTCCCTCGCTACAA"	"CD11c+"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.74815523068	47.2533462448148	0.0198231286057323	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2381.16853624942	2381.16853624942
"AML-3133"	"2019-07-01-count-1:CTCCCAATCGAGTGAG"	8.25379814681355	7.95970342243043	"2019-07-01-count-1"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.CTCCCAATCGAGTGAG"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1855.12306950274	38.8868319217242	0.020961861000493	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1852.0586419099	1852.0586419099
"AML-3133"	"2019-07-01-count-3:GCAGCCAGTAATGCTC"	8.14710487899129	8.13533399188844	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCCAGTAATGCTC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1922.93470513736	39.1354512559927	0.0203519397468034	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1916.5504647407	1916.5504647407
"AML-3133"	"2019-07-01-count-2:TAATTCCCAAATGGTA"	1.79975440081899	-10.2153082123962	"2019-07-01-count-2"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.TAATTCCCAAATGGTA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2462.76222423096	42.0993518696038	0.0170943631729409	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2456.7427979793	2456.7427979793
"AML-3133"	"2019-07-01-count-1:GTAGGAGTCGGTCTAA"	3.38782705840413	-9.33104517376097	"2019-07-01-count-1"	"AML3133"	"HLA-II+ monocyte"	"HLA-II+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.310810810810811	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTAGGAGTCGGTCTAA"	"HLA-II+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1688.26451444893	44.380903113047	0.0262878848268238	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	1686.30511569611	1686.30511569611
"AML-3133"	"2019-07-01-count-3:GCCTGTTGTACGTACT"	1.26935591277425	10.8319778212341	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCCTGTTGTACGTACT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1814.57257404183	38.1773294349739	0.0210392959648545	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1808.74494832243	1808.74494832243
"AML-3133"	"2019-07-01-count-1:GTCACTCAGATAGTCA"	1.39613999900166	9.92744443500368	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCACTCAGATAGTCA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1768.26265057401	26.42223527011	0.014942483381376	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1763.47702588096	1763.47702588096
"AML-3133"	"2019-07-01-count-2:GTTACGATCACAGAGG"	0.0199852633172691	10.4635095366272	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTACGATCACAGAGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1639.12721593601	40.1342292621458	0.0244851216378758	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1636.81620588889	1636.81620588889
"AML-3133"	"2019-07-01-count-2:CCCATTGAGTCAGCCC"	-7.27544246140178	2.07440660083619	"2019-07-01-count-2"	"AML3133"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.584821428571429	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.CCCATTGAGTCAGCCC"	"GMP"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2359.01666273797	39.643375460596	0.0168050425784548	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	250	TRUE	"HSPC_AML-3133"	2358.10290995689	2358.10290995689
"AML-3133"	"2019-07-01-count-1:TGCTTCGAGCTGACTT"	-0.475174407393295	10.2366971739563	"2019-07-01-count-1"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.TGCTTCGAGCTGACTT"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2108.87484901297	36.0138275312085	0.01707727110884	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2106.96486554265	2106.96486554265
"AML-3133"	"2019-07-01-count-3:ATTTCACTCCCTCAAC"	4.50499643859212	-10.3763656846252	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.ATTTCACTCCCTCAAC"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2076.83766182328	41.4127440015642	0.0199402893942165	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2076.83766182328	2076.83766182328
"AML-3133"	"2019-07-01-count-3:TCATTACTCGGCATTA"	-1.96801004830058	8.56347749317018	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TCATTACTCGGCATTA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2402.96852472428	41.3285801319866	0.0171989685702307	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2401.53412107398	2401.53412107398
"AML-3133"	"2019-07-01-count-2:AGGATAAGTTCGGTTA"	-3.22634587708171	-6.52276232158812	"2019-07-01-count-2"	"AML3133"	"Granulocyte"	"Granulocytes"	56	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285714285714286	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGGATAAGTTCGGTTA"	"Granulocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2748.12240757023	43.7352016878613	0.0159145755543437	2520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	23	TRUE	"Gran_AML-3133"	2744.43722647085	2744.43722647085
"AML-3133"	"2019-07-01-count-1:GGCACGTTCGAAGTGG"	-0.0759216052597344	11.794596649054	"2019-07-01-count-1"	"AML3133"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.193189259986902	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GGCACGTTCGAAGTGG"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2111.79809283577	20.3841724626809	0.00965251959069091	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2102.29860911672	2102.29860911672
"AML-3133"	"2019-07-01-count-1:GTCTACCTCGCCATAA"	1.2204415994579	-10.1772175065246	"2019-07-01-count-1"	"AML3133"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.965034965034965	"GSM5613744"	"2019-07-01-count-1_metadata.csv"	"2019.07.01.count.1.GTCTACCTCGCCATAA"	"CD14+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2609.33568423301	41.4252616751124	0.0158757885868905	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2605.82110080306	2605.82110080306
"AML-3133"	"2019-07-01-count-3:GGGTATTCATCTAACG"	0.153988924890202	9.97418687427369	"2019-07-01-count-3"	"AML3133"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.285506825442928	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GGGTATTCATCTAACG"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1365.96234227376	48.4728203010355	0.0354862054398573	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1363.41236956776	1363.41236956776
"AML-3133"	"2019-07-01-count-2:GTTGAACAGAAGCGAA"	-1.68127856674846	8.45582578265993	"2019-07-01-count-2"	"AML3133"	"CD4+ T"	"Treg"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0119920053297801	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.GTTGAACAGAAGCGAA"	"CD4+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2525.93641121324	34.655880554324	0.0137200130614841	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	2517.37729196182	2517.37729196182
"AML-3133"	"2019-07-01-count-3:TACCGGGCATATAGCC"	7.92327179488484	6.87906978214113	"2019-07-01-count-3"	"AML3133"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.TACCGGGCATATAGCC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1667.42870995749	38.1765940150492	0.0228954879972185	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1660.11414154313	1660.11414154313
"AML-3133"	"2019-07-01-count-3:GTAGAGGAGCACACAG"	4.18932976302449	-10.7376356354919	"2019-07-01-count-3"	"AML3133"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.348251748251748	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GTAGAGGAGCACACAG"	"CD16+ monocyte"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2128.93958824579	46.1814498122039	0.0216922312249623	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	474	TRUE	"Mono_AML-3133"	2126.017315349	2126.017315349
"AML-3133"	"2019-07-01-count-2:AGATAGAAGGAACGTC"	-3.37370143356975	10.9220237501892	"2019-07-01-count-2"	"AML3133"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.014219991635299	"GSM5613745"	"2019-07-01-count-2_metadata.csv"	"2019.07.01.count.2.AGATAGAAGGAACGTC"	"CD8+ T"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1688.01393638264	36.8838198645547	0.0218504237847677	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1256	TRUE	"T_AML-3133"	1686.01628073164	1686.01628073164
"AML-3133"	"2019-07-01-count-3:GCAGCCACAACATACC"	8.37398685988728	6.81298921192018	"2019-07-01-count-3"	"AML3133"	"B"	"Naive B"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_younger60"	"male"	"Inflammation_low"	0.0784499054820416	"GSM5613746"	"2019-07-01-count-3_metadata.csv"	"2019.07.01.count.3.GCAGCCACAACATACC"	"B"	"U-16-3133"	"M"	57	"CITE-seq"	"OSU"	"AML3133"	"AML"	"Favorable"	"46,XY[19]/nonclonal[1]"	170	"11/4/2016: The amended report includes staining results for cMPO, cCD3, cCD79a, and TdT. The blasts are positive for cMPO. This does not alter the previous diagnosis.   
SAMPLE TYPE: Bone Marrow 
LABORATORY INTERPRETATION: 
Immunophenotypic analysis demonstrates an abnormal myeloid 
blast population (approximately 8% of total events) with aberrant CD7 expression, consistent with a myeloid neoplasm. Correlation with bone marrow morphology and cytogenetic studies is 
recommended. The B cells are unremarkable. The T cells have a mildly elevated CD4:CD8 ratio with no significant loss of T cell antigens as can be seen in reactive T cells. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone marrow was performed using a ten color technique with a gating strategy based on CD45 staining and light side scatter characteristics. Lymphocytes represent 22.6 % of the total events analyzed. Of the lymphocytes: 11.1 % are B cells (CD19+) with a Kappa:Lambda ratio of 8:5 , 81.6 % are T cells (CD3+) with a 
CD4:CD8 ratio of 4.7 and 6.6 % are NK cells (positive for CD56 and/or CD16 and negative for CD3). Blasts, defined by CD45 faint staining and low side scatter represent 7.8 % of the total events 
analyzed and express CD117+, CD13+, HLA DR+, CD7+, CD33+, MPO+ with subpopulatios sexpressing CD4+ (20%), CD34+ (24%), CD65+ (32%) and are negative for the remaining markers 
analyzed. The monocytes show aberrant expression of CD56/CD16. "	"x"	"x"	"x"	""	""	""	NA	NA	"0,3"	"0"	"0"	"0"	"0"	0	"0"	"0,44"	"0"	"0"	"0"	"0"	"0"	"0"	"0,44"	"0"	"0"	"0.05
0.08"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1727.86652758674	38.8652047076755	0.0224931753044359	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	240	TRUE	"B_AML-3133"	1726.13418102735	1726.13418102735
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGAGGTGGCGCTT"	-7.83014426651652	2.67431948268739	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGAGGTGGCGCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2624.49293445159	42.2743251963658	0.0161076163099671	2924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2617.44127699937	2617.44127699937
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAACTGTAGTATGTAG"	-2.43548379364665	13.038960433844	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACTGTAGTATGTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2267.73548707215	43.9855536818895	0.0193962452555165	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2267.73548707215	2267.73548707215
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGGTACTCGTA"	-2.1955660385197	13.7486829527649	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGGTACTCGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3003.10545903588	31.3586627653167	0.0104420784394911	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2999.85422612319	2999.85422612319
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCAATCGTGTGTTTG"	-0.347203115851241	11.6249608763489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAATCGTGTGTTTG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2589.6743509308	44.5664645175418	0.0172092929373623	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2579.69282526998	2579.69282526998
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGTAAAGGCCATAG"	-7.76261840286906	3.10397861087648	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGTAAAGGCCATAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2448.32971009093	47.0255044666513	0.0192071779682422	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2443.42108864388	2443.42108864388
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGATTTCGTTAGAC"	-2.17860136452373	12.9033403166565	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGATTTCGTTAGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2269.95362887607	39.9633595232546	0.0176053638342567	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2269.95362887607	2269.95362887607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAACTGTAGAATCGCG"	-7.20480523529704	0.709945059660353	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACTGTAGAATCGCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2490.27382582415	37.6487838075011	0.0151183309309535	3123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2487.19942405553	2487.19942405553
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCAGCAGAACAGGA"	-1.8730026287144	11.8814830549988	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCAGCAGAACAGGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.96359360127	41.3833417694034	0.0184915169700372	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2232.45431397329	2232.45431397329
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGGATCATGGCACC"	-0.805419186980087	10.9067764052185	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGATCATGGCACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2199.50017171671	32.9494215527556	0.014980413266819	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2199.50017171671	2199.50017171671
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATGACTCATGAGAA"	-0.0600225505536378	9.02693269336549	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATGACTCATGAGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2287.22517383102	41.5730171415882	0.0181761802979611	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2280.7184250012	2280.7184250012
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACACACAGACATGCG"	1.26020993766133	10.3922471770081	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACACACAGACATGCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2363.84898144765	28.9089893586232	0.0122296261671162	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2353.46142624611	2353.46142624611
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAGATGCATGGGCAA"	-2.32844982567485	13.5593909987244	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGATGCATGGGCAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2824.22586043953	45.2084143689441	0.0160073650631852	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2815.61865118181	2815.61865118181
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTGTTTCCTTATAC"	-2.39752636376079	13.2722949751648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTGTTTCCTTATAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2237.59712149449	40.1830146701768	0.0179581097437856	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2234.78103686566	2234.78103686566
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCGTGTCCGGACT"	-2.14627943459209	13.0599450835022	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCGTGTCCGGACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2794.06443366822	40.5702791944604	0.0145201659294583	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2782.59035139683	2782.59035139683
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCTACGTACCCACG"	-0.323561291128951	11.4311885603699	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACGTACCCACG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2507.7419793518	44.4636985542403	0.0177305715342107	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2499.20449434844	2499.20449434844
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTTAGCTCTACCAGA"	1.41336800631825	11.0564765700134	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTTAGCTCTACCAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2383.48331134556	38.9531001142273	0.0163429296646667	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2370.09973209055	2370.09973209055
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTACAAAGTACGAGC"	0.140067775815171	11.3863630064758	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACAAAGTACGAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2350.67152156625	45.3022976855879	0.0192720664158993	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2337.23413322789	2337.23413322789
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACAGGCAAAGGAGA"	-6.97729716721232	0.116630523744501	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACAGGCAAAGGAGA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2477.53837092383	44.0248646520326	0.0177695995221324	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2473.82313375263	2473.82313375263
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCGTCATAAAG"	-1.37537894669231	11.8554696806702	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCGTCATAAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2589.83373125854	44.3848995643543	0.0171381270653175	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2580.70723809734	2580.70723809734
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCATCCTGTTGC"	1.42433394965474	10.7342738875183	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCATCCTGTTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2345.18126521033	38.690249802394	0.016497765173356	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2335.00492926161	2335.00492926161
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCAGCGTTACT"	-2.71671185913737	13.2094516524109	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCAGCGTTACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2181.33779283444	40.6119353894337	0.0186179029780905	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2175.30312539855	2175.30312539855
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGCTGCAACAGTGG"	-8.22995887222942	2.54999158466188	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGCTGCAACAGTGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2218.61318373298	42.4819657256542	0.019147982188664	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2214.372570553	2214.372570553
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGGCTGTACAAACA"	-8.0450967353886	2.27024290645448	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGGCTGTACAAACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2523.35055948259	46.4303101489347	0.0184002614993199	3465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2519.56002342628	2519.56002342628
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTATCGTGTGTCGC"	6.7381760078365	-9.95565988933715	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTATCGTGTGTCGC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.70727232375	40.5757958053566	0.0160143976569729	2593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2531.44170769316	2531.44170769316
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCACGTGCGGCTT"	-1.61367128315623	11.7310027846131	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCACGTGCGGCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2457.9218636069	41.4049566125828	0.0168455137755366	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2449.91380736404	2449.91380736404
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAATCACCATGTGCCG"	0.819527705281418	11.4000921019348	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATCACCATGTGCCG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2191.00265587529	36.8338464437789	0.0168114111340792	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2185.93893851042	2185.93893851042
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCCATAGTGTGTTC"	-0.662235180765945	11.6832103499207	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCCATAGTGTGTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.87550988299	39.0333364612412	0.0165124332047305	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2358.15184080558	2358.15184080558
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTGTGAGGTCGTAG"	6.49795927581136	-9.99313928997191	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTGTGAGGTCGTAG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2500.82447020915	42.8102378218933	0.017118449668046	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2498.6506888732	2498.6506888732
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGAAAGGACTAAT"	1.46929587897603	11.3602533110413	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGAAAGGACTAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2233.64177226167	39.4533970999617	0.0176632607743601	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.40754357978	2230.40754357978
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGACGCCAACCGTAT"	1.29171218451802	11.2185210951599	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGACGCCAACCGTAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2108.9943966604	37.4269839038491	0.0177463647903071	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2106.85306349548	2106.85306349548
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGAAGTAGGCTCC"	-2.14890537682231	12.7354879149231	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGAAGTAGGCTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2541.21623678461	46.1874393578949	0.0181753282893925	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2535.76444415032	2535.76444415032
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAAGAAGGACACTG"	1.24298121508901	11.5676202544006	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAAGAAGGACACTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2456.67040948136	35.7404914579124	0.0145483461354744	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2448.87550128965	2448.87550128965
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGACTCACGATAGG"	-2.97935281220134	13.1917342909607	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGACTCACGATAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2700.00770705976	41.9414369054967	0.0155338211797809	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2692.05883934118	2692.05883934118
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCAATCAGGATACAT"	7.99824728545491	8.58568093860475	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAATCAGGATACAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2374.85842903264	37.7572806459996	0.0158987500831279	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2368.49886215171	2368.49886215171
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCAGCGTGCTC"	-7.47314010086711	2.81040475452272	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCAGCGTGCTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2911.25100970339	44.1898444822262	0.0151789881171148	2947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2903.06561254622	2903.06561254622
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCATAAAGCTGGCTC"	1.30194367942159	10.2244539030823	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATAAAGCTGGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1947.93936879997	40.1592505690115	0.0206162733872727	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1946.26576440799	1946.26576440799
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCCATGTGATAGAT"	-1.99334488335307	12.9070138701233	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCCATGTGATAGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2452.37299816897	38.4943315830534	0.0156967686448165	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2443.83693024602	2443.83693024602
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATAGACCGTTTCGTAG"	-2.6832209629124	13.1117028960022	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCGTTTCGTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.42484642643	41.8724887438185	0.0159488430228017	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2622.81931278096	2622.81931278096
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCACGTCACTTCAAG"	-1.80644367161449	11.0041169890198	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACGTCACTTCAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2726.65598533996	40.3106821066675	0.0147839266571949	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2718.1652529636	2718.1652529636
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGGGTCACTAGGCC"	-6.89448008957561	0.128427534643091	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGGGTCACTAGGCC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2071.68837609497	34.6337709203798	0.0167176547013614	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2067.58083163299	2067.58083163299
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCTCAAGTCAGCGTC"	1.24637844142262	10.631170249823	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTCAAGTCAGCGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2433.64303972148	36.9563686645909	0.0151856159927302	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2427.91483332852	2427.91483332852
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGTCCATACTT"	1.3081565099651	11.6039323576721	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGTCCATACTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2112.89636907	41.9552455736825	0.0198567455497826	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2109.51098222446	2109.51098222446
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCATTAGTCGCTTTAT"	-7.02064452591594	0.0862818409684076	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATTAGTCGCTTTAT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2618.64686181921	42.2968543968636	0.0161521795907522	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2611.38469753955	2611.38469753955
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATGTTCAGGGTAATT"	6.39409222182576	-10.0590563050476	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATGTTCAGGGTAATT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.45075672394	39.5611743901287	0.0154992899611922	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2549.67389957199	2549.67389957199
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATGTTCCACCACATA"	7.3172513442928	-9.85427668010863	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATGTTCCACCACATA"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2477.47071514604	42.7653855786633	0.0172617118407159	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2473.8273646297	2473.8273646297
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTGAGGTTTCACTT"	8.20374931868855	8.0712737807068	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTGAGGTTTCACTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2429.68768247522	46.4915570339857	0.0191347873100393	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2429.68768247522	2429.68768247522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGCACAAGTGTTGAA"	6.52040400084798	-10.0236101380554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGCACAAGTGTTGAA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.77864947363	37.3129775471609	0.0152373827480003	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2446.50511114067	2446.50511114067
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCTATCATAACGGG"	8.55852474746053	8.15026853168336	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCTATCATAACGGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2384.64341885272	42.4055923520874	0.0177827812816095	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2373.98633196141	2373.98633196141
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGGAATCCATTCAT"	-7.6066554588383	3.19429872119752	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGGAATCCATTCAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2714.67936310159	41.4905563832151	0.0152837778734248	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2700.20328131674	2700.20328131674
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGAGCCAGTAGCAAT"	-2.56062851372417	12.855571723822	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGAGCCAGTAGCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2278.89375970705	46.8705355307093	0.020567231504787	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2276.24529640483	2276.24529640483
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGGTAAGATACGAT"	-0.734383146197158	10.6362886198792	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGGTAAGATACGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2334.03920165347	40.6545969918499	0.0174181294654561	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2330.34061493294	2330.34061493294
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTAGGTCGTGTGAT"	1.318003197282	10.9559745558533	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTAGGTCGTGTGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2096.13412558974	43.3773769744024	0.0206939892084426	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2093.29010903459	2093.29010903459
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGGAATGTTCTCGCT"	-1.85088227215465	13.1424827345642	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGGAATGTTCTCGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2494.34943808133	46.3545462203676	0.0185838221031387	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2489.72366227127	2489.72366227127
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACCAAACAGGAAGTC"	-0.252038846642333	11.755814529303	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACCAAACAGGAAGTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2255.98507324522	42.8308408172538	0.0189854273971955	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2251.43573194866	2251.43573194866
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGCCCAGCTAACT"	-0.124475414783317	11.1839637526306	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCCAGCTAACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2297.55418053609	46.2940031627725	0.0201492541742675	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2290.03257794799	2290.03257794799
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGTCGTCATTCAGCA"	-0.681486646563369	10.6532869108948	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTCGTCATTCAGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.13313523403	40.4838165779801	0.0165433649665769	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2443.0585367557	2443.0585367557
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGAATTCTCACCCA"	-2.08910785141643	13.0274228819641	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGAATTCTCACCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2487.74427854569	41.1122116830113	0.0165258994011415	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2483.72070643518	2483.72070643518
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCTCTACACAG"	8.2459885078365	-9.26797201549681	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCTCTACACAG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1961.83235788282	31.2212197910343	0.015914315851497	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1960.24806755931	1960.24806755931
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATCCCTCCAGTGTA"	-7.04126630249675	2.8963937529358	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCTCCAGTGTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2515.43172399586	37.973155900316	0.0150960789506122	2440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2501.34411259871	2501.34411259871
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCCAAGTAATGCGG"	-2.31214580956157	13.4420060881409	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCCAAGTAATGCGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2607.84629841162	46.9640498694361	0.0180087491728484	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2606.62328049459	2606.62328049459
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATCCCTCATCGCAA"	-0.125771189958411	11.6555967100891	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCTCATCGCAA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2549.5179167892	40.905590824913	0.016044441404212	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2541.11622922562	2541.11622922562
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATTCTTGTGACTGTT"	6.97322382506673	-10.0302267304626	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCTTGTGACTGTT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.62485173478	39.5837618920534	0.0167612404074154	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2360.75838413552	2360.75838413552
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGTTGTCACGTCGTG"	-2.39680300179179	12.6137294539246	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTGTCACGTCGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2115.77396469032	46.0151290574046	0.0217486035017638	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2112.52150595021	2112.52150595021
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAGGGAAGTAAACTG"	-8.73596988144572	0.45977327907411	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGAAGTAAACTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2777.34339941567	46.8769091815221	0.0168783266741105	4353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2768.78987884578	2768.78987884578
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCTTCAGCGCCTCA"	1.32668067988698	10.7038898237976	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCTTCAGCGCCTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2254.10705316403	37.7549537833148	0.0167494058147412	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2247.18117056392	2247.18117056392
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGGCGGTGGTTTAC"	-2.05663643303569	13.4496383436951	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGGCGGTGGTTTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2387.2250121602	39.0531883427432	0.0163592406010374	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2380.09102548631	2380.09102548631
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACGTTGTTATAGAG"	6.79139675673787	-0.92315193330916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACGTTGTTATAGAG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2473.95920089705	39.9210991139446	0.0161365228252226	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2470.25897024771	2470.25897024771
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTGTCATCCCT"	-2.38504229012187	12.8124170073303	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTGTCATCCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1809.45779357032	43.145521893231	0.0238444477934458	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1803.48361727862	1803.48361727862
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCATGTCGTAGCCG"	1.48683597621266	11.5583448179993	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGTCGTAGCCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1973.52241265873	37.6138537832438	0.0190592483480188	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1969.60730749922	1969.60730749922
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAACCAGTTAGAAC"	8.36967720565144	7.69548080051271	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCAGTTAGAAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2131.73631851918	43.321890593703	0.0203223495407709	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2120.22328078126	2120.22328078126
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGGAGCAGTACTAC"	1.48404147204701	11.0774659880432	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGGAGCAGTACTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2032.47551904023	36.0462326579221	0.0177351374322795	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2030.74796188829	2030.74796188829
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGAATGGTGGAACAC"	-2.64931760254558	12.5871400603089	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAATGGTGGAACAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2595.28403524811	45.8646973071589	0.0176723228302733	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2584.23608878866	2584.23608878866
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACCATAGGGCGAAG"	-2.35821876946147	12.8794421919617	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCATAGGGCGAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2474.82495963312	42.8638023177752	0.0173199329313899	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2466.36801225685	2466.36801225685
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGATTGTGCTCTCT"	6.48079313811604	-10.0971269837585	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGATTGTGCTCTCT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2552.27574561329	40.9564507247779	0.016047032063511	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2548.24769874268	2548.24769874268
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGACCACTATCGA"	-2.89709077301677	13.1420402296814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACCACTATCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2776.76780097488	40.746389949106	0.0146740357385304	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2770.70089446293	2770.70089446293
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCACCGGTGTGAGCA"	7.77040447768514	-9.34815027630004	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACCGGTGTGAGCA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2348.27719861255	41.7042824799798	0.0177595228129883	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2342.80867294041	2342.80867294041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACACTCATGTCTAG"	1.33663608607594	11.6757087477478	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACACTCATGTCTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2333.38026106091	37.4991819699301	0.0160707547739692	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2320.65277177047	2320.65277177047
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTCTCTCGGACCAC"	-1.33404527130778	11.5370654829773	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCTCTCGGACCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.68580986871	39.4615795436202	0.0158500238814075	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2486.6432445969	2486.6432445969
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGCTGCAGCTATCTG"	-2.59981189194377	13.313317275885	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCTGCAGCTATCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2591.82645841646	40.4087105165256	0.0155908241407545	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2582.57354229205	2582.57354229205
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGATCGTTGTTGCA"	0.39208753880803	11.463032699469	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGATCGTTGTTGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2222.11291394745	39.4745049081697	0.0177644010168888	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2216.73134763756	2216.73134763756
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGATCGTTACAGCT"	0.53399102863614	11.5305137404236	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGATCGTTACAGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2367.30383604129	38.9259293038209	0.0164431488308296	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2365.23523483222	2365.23523483222
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTCACGAGGGTCAAC"	-0.283260921866256	10.985135055426	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCACGAGGGTCAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.83534463476	36.9225850107178	0.0159849424317109	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.70414051751	2297.70414051751
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCCACAGTACCGGA"	8.12589993056599	8.13944909656373	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCCACAGTACCGGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2317.51266532336	42.1314247261603	0.0181795876918247	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2310.60086078059	2310.60086078059
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGTTGGTGTTGAGG"	-3.19226155701335	13.1407069929871	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGTTGGTGTTGAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2311.64359674873	47.8982721364373	0.0207204398652998	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2308.49932787895	2308.49932787895
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGATCGCATCCAATG"	-2.16160903397258	12.701316810492	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGATCGCATCCAATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2628.07501520684	45.4327017655494	0.0172874448037678	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2618.68761496799	2618.68761496799
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATAGACTCCCGAGAC"	6.6070634323055	-10.024311088678	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATAGACTCCCGAGAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2600.00811937987	39.4971593181085	0.0151911676827875	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2593.57265147662	2593.57265147662
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGATCAGTTGTCAGT"	0.0541056742308706	11.6487083205017	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATCAGTTGTCAGT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2505.02770842953	40.7753222676926	0.0162773937112479	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2494.48474136361	2494.48474136361
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGCACAAGCACCGTC"	1.25641741332356	11.4175557860169	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGCACAAGCACCGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2577.54934568786	39.5532355780278	0.0153452874313343	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2575.91020150307	2575.91020150307
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGGTGGTTTAC"	-1.54241881790813	11.8580188521179	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGGTGGTTTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.42232629028	40.8486502250711	0.0177724736476094	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2292.98799873374	2292.98799873374
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGATGTCCATAGAC"	8.38227905806844	8.04228255832521	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGTCCATAGAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2182.6060899071	43.4289092037844	0.0198977311593742	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2175.81699263423	2175.81699263423
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACTTCAGGTCCAGA"	1.35904206809346	11.6184034117493	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACTTCAGGTCCAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.4076257773	43.9986698687414	0.0187674998942018	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2337.48698249292	2337.48698249292
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGAAAGCTACGTT"	8.16716541823689	8.0589332350525	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGAAAGCTACGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2048.11479845818	43.9663732641444	0.0214667523994467	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2039.47114420689	2039.47114420689
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTGATTCTAGAGCT"	-2.95654306832011	13.3056344755921	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTGATTCTAGAGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2325.71762364087	41.9262807456526	0.0180272447177047	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2321.12534440987	2321.12534440987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTATTGCAGTGGTTAA"	-2.6014646095341	13.1871423491272	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTATTGCAGTGGTTAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2828.10641339661	40.4300196881211	0.0142957915220608	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2819.43539282841	2819.43539282841
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGAGAAGTCATAGA"	-2.19160447540935	13.0633477934631	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAGAAGTCATAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2433.63512148025	40.9992986424515	0.0168469374396248	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2426.54845512222	2426.54845512222
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTACCTAGAGGCTGT"	-0.0375652340358079	10.7676849135193	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACCTAGAGGCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2456.69854204082	42.7070515376646	0.0173839202518463	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2444.46246522899	2444.46246522899
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATTTCCCAAAGGCTG"	-1.42622743073161	11.8385095366272	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCCAAAGGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2706.68445150566	42.6995902028044	0.0157756070084385	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2700.49196771493	2700.49196771493
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGCTGTCAGGAAAT"	-0.252269904047805	11.6899032362732	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGCTGTCAGGAAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.34485691461	44.8152010395081	0.018962616017882	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2359.9560761327	2359.9560761327
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGATGCGGTGGCGCTT"	8.02666344222371	6.62430188739625	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGCGGTGGCGCTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1984.45710116255	40.4248933495306	0.0203707569822742	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1973.47641828041	1973.47641828041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGATGGTCCACTTC"	0.852482755749863	11.6789798506531	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGGTCCACTTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2280.0517246255	41.0643451817752	0.0180102691260305	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2264.49833331081	2264.49833331081
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCACGTTCTACCTTA"	1.08954753455464	11.0399799116882	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACGTTCTACCTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2279.97541834107	33.539896395802	0.0147106394770721	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.63125265311	2274.63125265311
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGCCTGCAGCGAGTA"	-2.87007937851604	12.8843192824158	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCCTGCAGCGAGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1749.58695244577	46.4999139697616	0.0265776524594898	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1747.32222327773	1747.32222327773
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGTTGCATGTGTCA"	-2.37975440445598	12.6850385435852	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGTTGCATGTGTCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2667.0914263959	44.1439946084673	0.016551361596224	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2662.42521033525	2662.42521033525
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCTTCAGATCGACG"	-8.05675445023235	2.43640849674074	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCTTCAGATCGACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2772.43127750346	35.6961951059158	0.0128754120600096	3059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2765.50574187535	2765.50574187535
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATAGACCTCTCGGTAA"	-1.79160604897197	11.7587585219177	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCTCTCGGTAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2743.0190192041	39.2703897109225	0.0143164846601453	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2733.97706095335	2733.97706095335
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACTAATCCCTTTGG"	5.95910515364949	-10.1810846558777	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACTAATCCCTTTGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2585.14710267077	38.5504996307027	0.014912304058394	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2581.16499416585	2581.16499416585
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCATGCAGCAAATCA"	-2.16956148567851	12.8250980147156	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATGCAGCAAATCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2667.34143490837	37.6243550229228	0.0141055638886423	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2658.94419776698	2658.94419776698
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGATGTCTACCCAC"	-1.46416733685191	11.8901433714661	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGATGTCTACCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2416.56560296595	42.5633714492892	0.0176131661383616	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2412.49464660085	2412.49464660085
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCAGGGTACCTTCC"	-2.16045890274699	13.5690335997376	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCAGGGTACCTTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2733.94406579632	42.7665991539792	0.0156428215518457	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2729.973320949	2729.973320949
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTACCACACGATAGG"	-2.77187667313274	13.2528390654358	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACCACACGATAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.8017264998	41.7373062186344	0.0153400763503365	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2714.30014658797	2714.30014658797
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAATCGGCTGTG"	-8.03989921036418	2.9983544119629	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAATCGGCTGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2464.2710596339	47.1611719708384	0.0191379806967521	3526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2455.12067638502	2455.12067638502
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTGAGAGTCCTGCG"	-2.52233515206035	12.9454021223816	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTGAGAGTCCTGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2219.8245760124	41.1575096246586	0.0185408838470435	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2218.37181452236	2218.37181452236
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCCGTCTTTGGAG"	1.37423755702321	9.99204728687135	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCCGTCTTTGGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2375.89702598348	35.5218006043391	0.0149509007401679	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2372.2093568298	2372.2093568298
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGATCGCAGTGGCTC"	0.914233108132523	10.7533864744934	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGATCGCAGTGGCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.03480701843	40.1232551761697	0.017339088873891	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2302.64790773647	2302.64790773647
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATTTCCATTGAGCT"	-7.58090672913249	3.08909175479738	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCCATTGAGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2486.34374556362	42.6840040552886	0.0171673784574034	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2478.04047393697	2478.04047393697
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGAATCATCGGGC"	1.01925500211064	10.7054528960022	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGAATCATCGGGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2184.38174662926	39.8407634237412	0.0182389197699623	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2178.74769262999	2178.74769262999
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTCAGAAATTG"	-3.45999823036845	11.286934829596	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTCAGAAATTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.78993963172	43.7407493441614	0.017249358340192	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2534.3713072228	2534.3713072228
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACCAATCTCTGAGA"	-0.0713210878079713	11.5370721586975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAATCTCTGAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.48448848544	44.5399255268812	0.0171341378354721	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2591.3560778888	2591.3560778888
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACCACATCGCTAA"	1.37309624728505	10.4860505827698	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACCACATCGCTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2221.86573433921	37.8293134399076	0.0170259223387133	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2212.5858112991	2212.5858112991
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACACGCTCAATCTTC"	0.310713996260804	10.5954026945862	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACACGCTCAATCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2375.12421089454	43.0872521145558	0.0181410521255762	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2368.90485794407	2368.90485794407
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGATCTGTACTGGGA"	1.66842915591542	-8.15483095562132	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGATCTGTACTGGGA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1671.56100974487	44.2962485164549	0.0264999292626571	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1660.5013582321	1660.5013582321
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCAATCAGACGCTC"	-8.11146293106731	3.62757418239442	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCAATCAGACGCTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2631.36040806034	42.6574934964613	0.0162111937862231	2643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2615.56888978644	2615.56888978644
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTAGTCATAATGCC"	0.205421348183793	11.5046577223572	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAGTCATAATGCC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2496.25837639531	38.92225328903	0.0155922374290578	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2490.08501185573	2490.08501185573
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCATCGTTGTAGCT"	1.06297280368153	10.3856706389221	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCGTTGTAGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2463.10880987931	36.4424526425904	0.0147953076601501	2379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2452.31250953415	2452.31250953415
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAATCTCCATCCTAAG"	6.3995381790096	-10.0033464661804	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATCTCCATCCTAAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2551.63306411108	36.3741915054866	0.0142552595108961	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2545.09749939663	2545.09749939663
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTCACAGACGA"	-1.70586488667186	11.9625682600769	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTCACAGACGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2439.89857659745	37.5540338043814	0.0153916372445088	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2429.58707800137	2429.58707800137
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGGACTCGTGGCGT"	-3.08741388741191	12.9303855665955	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGACTCGTGGCGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2661.48188116782	41.6363555044	0.015644049955407	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2660.30648093162	2660.30648093162
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACCAAGTCGACTTA"	-0.291393021971542	11.3799628981384	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAAGTCGACTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.98056978661	42.2929157607114	0.0186890317687083	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2254.05180730585	2254.05180730585
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAATCGTCTAGTGAC"	-7.59089312973674	3.79905650699464	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATCGTCTAGTGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2223.83105302814	38.1510289406513	0.0171555428586636	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2215.86865612751	2215.86865612751
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCGGTCAACTCGTA"	1.38509716567342	11.6566562422547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGGTCAACTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2212.81358800993	37.6387233472386	0.0170094415323473	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2198.70873313807	2198.70873313807
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGTTAGTACACGCC"	1.64019848880116	-4.81758072292479	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGTTAGTACACGCC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2457.78141997492	40.2909958629172	0.0163932380379572	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2453.38694070001	2453.38694070001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTCTACAGTGAGCA"	-2.18086920204814	13.1066865690979	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTACAGTGAGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.14256439515	41.0556439851847	0.0156393959482518	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2616.96239979533	2616.96239979533
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGGAATGTTGCAACT"	1.05100615796391	10.8242044218811	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGGAATGTTGCAACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2235.95240292848	39.196500758449	0.0175301141057888	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2228.42303450697	2228.42303450697
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCACAGTGGCGAT"	1.27662636813466	10.5381107100281	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCACAGTGGCGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2132.26212392415	32.5462587912432	0.0152637231727148	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2128.10965317875	2128.10965317875
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACTGCCAGTCGTCTA"	1.34077145633046	11.6542358168396	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTGCCAGTCGTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2239.58283876988	44.093926254897	0.0196884551406529	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2227.51204087106	2227.51204087106
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGCCAAGAACGTGC"	-0.56648168984111	10.5011081465515	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGCCAAGAACGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2303.59711245237	38.6591358922637	0.016782073429111	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.15272495761	2297.15272495761
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCATTGTCCCAAGCG"	0.295557533472222	11.1775169142517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGTCCCAAGCG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2576.16506187181	40.4106260690398	0.0156863497091596	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2570.24691832007	2570.24691832007
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTTCGGAGCCAGAGT"	-2.26244221153911	13.0452098616394	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCGGAGCCAGAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2470.0450131241	45.565633450111	0.0184472886963626	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2465.40924080201	2465.40924080201
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAAGAACAGCTGTCCG"	0.627312560647172	11.4613246687683	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGAACAGCTGTCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2300.07756974294	42.6707689928535	0.0185518825774308	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2291.34568754828	2291.34568754828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATGGAGAAATTGC"	1.41595735129659	10.4992599257263	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATGGAGAAATTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2222.85857716479	42.4358025228131	0.0190906443436177	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2216.74727079519	2216.74727079519
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCTGGTAGCACAG"	-0.367746810347396	11.2677993544373	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCTGGTAGCACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2423.3536625923	41.8030619332795	0.0172500871740537	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2417.38185214892	2417.38185214892
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATGAAGTCCGAGTGC"	1.39383294162099	10.3728608855042	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGAAGTCCGAGTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1744.85106858985	32.3432249625203	0.0185363814395112	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1743.30839101326	1743.30839101326
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGGCTTCGAGTTGT"	0.767601926892441	10.727117515448	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGGCTTCGAGTTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2036.10347931408	42.9624830939788	0.0211003436369806	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2033.71582556904	2033.71582556904
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGCGTGTGGCTTGC"	-2.54153070870097	12.700584388617	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGCGTGTGGCTTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2250.1885741718	45.0809136954604	0.0200342825543201	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2242.99233483768	2242.99233483768
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCATTCTCAGCCTTC"	-2.38288555565532	13.4883394011292	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCATTCTCAGCCTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2923.73714497086	41.7411987074429	0.0142766591652202	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2915.70301214829	2915.70301214829
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAAGTATTCCGA"	1.46706237372701	10.9650392302307	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAGTATTCCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2170.17749987676	23.6925199395551	0.0109173189478282	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2167.33620418851	2167.33620418851
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTTCCAAGGGA"	-1.5832590860432	11.5778674849304	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTTCCAAGGGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.89610645183	44.2192617046951	0.0176179649791188	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2504.20589179069	2504.20589179069
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTAGTCCGCGAGT"	1.51539685305898	11.1859063872131	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTAGTCCGCGAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2242.67025771404	38.2460286028083	0.0170537904407724	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2235.08595761314	2235.08595761314
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCTTCTCTCATAGG"	-2.35041914406474	13.3279676207337	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCTTCTCTCATAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2701.57027739438	37.5761893436287	0.0139090178989792	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2690.1316521785	2690.1316521785
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTGCAGCATATAGCC"	-0.458111445338088	10.7121820219788	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGCAGCATATAGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2356.64709939112	37.5294235734368	0.0159249229904355	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2351.7190324744	2351.7190324744
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTGAGCAAGAATGT"	-2.06016169014629	13.4287700423035	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTGAGCAAGAATGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2427.19164824323	39.9666724228765	0.0164662203134243	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2420.83738692394	2420.83738692394
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACAAAGGTATAATGG"	-7.00044761124309	0.194278634432234	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAAAGGTATAATGG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2563.75222921262	39.7916816406641	0.015520876466633	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2560.8959016419	2560.8959016419
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACAAAGGTCAGACTT"	-2.05597553673442	13.6373967894348	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAAAGGTCAGACTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2651.72285151409	42.4175858474686	0.0159962364932855	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2643.9348946937	2643.9348946937
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTGCAGGTCTGTCAA"	-2.0577326816624	13.6793975600037	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGCAGGTCTGTCAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2298.11341374276	41.1997268577189	0.0179276299469572	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2293.70840071854	2293.70840071854
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGGACGTTTACGTG"	-7.85011706772502	3.10316107356874	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGGACGTTTACGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2348.19604143235	47.3193659459333	0.0201513694389287	2868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2340.74424579155	2340.74424579155
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGGCGAGTTAACAG"	0.166364898055237	10.7919807204041	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGGCGAGTTAACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.242593683	39.0100225630018	0.0168419416296861	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.35631803377	2309.35631803377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACTCACAGGCGTTC"	-2.28752575340922	12.9140376814636	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACTCACAGGCGTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2354.58720575088	40.5435390438558	0.0172189583570452	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2348.50693715737	2348.50693715737
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTAACGAGACCATAA"	-2.55552277985271	13.6087798842224	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAACGAGACCATAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2547.1541751831	43.0219972868586	0.0168902211362082	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2541.129347279	2541.129347279
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCGATGTGGCTGAA"	-7.76946340027507	2.89926836574403	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCGATGTGGCTGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2511.49567925711	42.64288241779	0.0169790785506761	3235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2505.80036859518	2505.80036859518
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCCCGTTTACTTC"	-2.01319251480754	13.6753482588562	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"IFN+ NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCCCGTTTACTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2617.87372719034	43.2465140767585	0.0165197097276244	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2609.19847407895	2609.19847407895
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCCCTCAGTCGCAC"	-2.26431928101237	12.5935601958069	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCCCTCAGTCGCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2592.20809851179	45.2703769305019	0.0174640211009649	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2589.66747002573	2589.66747002573
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTACACACTCATAG"	8.0525013404781	8.19976613605348	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTACACACTCATAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2030.85719224288	39.799774891726	0.0195975251454147	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2022.5893737402	2022.5893737402
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGATGTGTAGCACGA"	1.43017961558644	11.2013749846253	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGATGTGTAGCACGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1998.73489425041	35.8800714631271	0.0179513909355064	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1991.16002559156	1991.16002559156
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGATCAGGGCTTCC"	-0.424756656319457	11.2365131148132	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGATCAGGGCTTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2436.17823522834	39.1984909339319	0.0160901572664521	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2430.84192278664	2430.84192278664
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACTGTAGAGTTCGG"	1.27737345275227	9.39196012103883	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACTGTAGAGTTCGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1943.43148390018	39.1919607530234	0.0201663712241457	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1937.08185343326	1937.08185343326
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGAGGTTGAGC"	6.71626867827718	-1.08813419258269	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGAGGTTGAGC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2845.17528641505	39.055055374413	0.0137267659960673	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2827.8786731267	2827.8786731267
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCTCAACACAGCCTG"	-2.37617454949077	12.5686750181946	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTCAACACAGCCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2687.37293824301	39.5948968910267	0.0147336814803656	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2680.98403399051	2680.98403399051
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTTTCCACACCTTC"	-2.83071003380473	13.1734533079895	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTTTCCACACCTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2872.15716255572	40.9830608462275	0.0142690871448551	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2865.92920989379	2865.92920989379
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGCGAGGTGCATACT"	-7.66182933273967	3.41510150516359	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCGAGGTGCATACT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2421.59590778411	41.252410456923	0.017035216455528	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2413.79544667012	2413.79544667012
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGAGGTTGGAC"	1.65994503077809	-8.61949732219847	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGAGGTTGGAC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1816.6916936925	33.2616102331783	0.0183088910180311	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1807.58374011554	1807.58374011554
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCCTGTTCCACGG"	3.70060481604878	-10.5856104127136	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTGTTCCACGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2994.99114699701	39.0726481061887	0.0130459978639221	2739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2990.32137283485	2990.32137283485
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGACCCAGTTGTAGA"	1.18491949614827	10.5368423231873	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACCCAGTTGTAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.52776309271	33.3192477802799	0.0152663569021755	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2177.29232563686	2177.29232563686
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTGTGAGCATCTTG"	-0.832339267165023	10.5528163679871	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTGTGAGCATCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2424.13844126408	42.5844045480969	0.0175668203693396	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.23988553499	2415.23988553499
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCATTTTCGCGATCG"	1.62126733836476	-8.41634848034056	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTTCGCGATCG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1324.30776747345	43.8711253366232	0.0331275904394352	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1311.3817509643	1311.3817509643
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGCAAGCTACT"	-2.826239447028	13.1319446333679	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGCAAGCTACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2613.9278286823	40.3720831588599	0.0154449876985363	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2611.18802881767	2611.18802881767
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCTGTCCATCCTCAC"	-7.41835294190105	3.17744634235231	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGTCCATCCTCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2545.98487121968	42.3247743151734	0.0166241264013864	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2534.00330370279	2534.00330370279
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGTCGTCAGACCAGA"	1.39099468764607	10.315306640509	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTCGTCAGACCAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1758.56260184113	35.2143952308618	0.0200245332147937	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1754.69067548845	1754.69067548845
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATCGATCGTGTGAT"	-8.0200608772343	2.63670156085817	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGATCGTGTGAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2428.30130278162	41.7381781135087	0.0171882204509373	3123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2422.22500467825	2422.22500467825
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTTCTGGCCGA"	1.03070964392964	11.3400678404602	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTTCTGGCCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2306.29886198907	36.0971646663715	0.015651555512298	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2301.03907255834	2301.03907255834
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACAGATCACGAAAGC"	-8.08873687210735	2.33112881267396	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGATCACGAAAGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2778.545768359	42.2883636171183	0.0152196030379207	3542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2771.32679397274	2771.32679397274
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGTCTTTCCGTCAAA"	-2.09744034233745	13.8332242735657	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCTTTCCGTCAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2421.96306262125	39.7467329781915	0.0164109575375498	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2419.10330474772	2419.10330474772
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACAGGTGTAATTGGA"	6.53508009490315	-10.0803919068542	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAGGTGTAATTGGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.26221823215	39.6357051695426	0.015178753360272	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2602.35055161252	2602.35055161252
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGTGTTGTGGATGAC"	0.397434731095475	11.4343871840271	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTGTTGTGGATGAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2399.79574362509	40.5469995856399	0.0168960211273608	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2391.83706638618	2391.83706638618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGACTTCTATTCGT"	1.28719200667683	11.7547254332337	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTTCTATTCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2330.04465355154	38.0094824499556	0.0163127699686013	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2326.05437100135	2326.05437100135
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACAAATCCGATGCG"	8.02826656874959	8.42199704730836	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACAAATCCGATGCG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2067.07977668552	38.6961608488368	0.0187202067792877	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2059.99602577095	2059.99602577095
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCAGCCAATTCGTG"	1.05122675475423	11.227304435614	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCAGCCAATTCGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2214.11382045944	42.9950619735339	0.0194186322203672	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2209.29812920877	2209.29812920877
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGGAACATCTCGTC"	-2.32213221016582	13.4227514036926	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGGAACATCTCGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2703.14291946422	44.0560928836557	0.0162980997291804	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2690.98291120181	2690.98291120181
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGGGATCGATACTG"	-7.67399106445964	2.66906092250673	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGATCGATACTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2660.13030925344	45.9908987216365	0.0172889645900631	3536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2653.41392930056	2653.41392930056
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCATGCAGTGGATTA"	1.37625505503957	11.2825002440247	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATGCAGTGGATTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2283.46957861111	41.5089052058989	0.0181779979005221	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.48363356938	2274.48363356938
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACTTCTCACACACTA"	1.33041526851003	10.9534997710022	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACTTCTCACACACTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2170.1249962951	34.9622774646897	0.0161107205918453	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.64644547778	2163.64644547778
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAATCGCAGTTA"	0.909639139741105	11.676860786322	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAATCGCAGTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2352.98242165834	42.1111751189648	0.0178969357065088	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.77992483686	2345.77992483686
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGTTAAGAAGCGGG"	-1.06239400330241	10.8930797346863	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGTTAAGAAGCGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2361.19302161963	42.8938016272682	0.0181661563601631	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2355.29558214001	2355.29558214001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCACGCCACGCGGTT"	-7.92807422104533	2.86903140628663	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCCACGCGGTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2552.10559084247	41.3420880342795	0.0161992075024734	3207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2546.89518013566	2546.89518013566
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGTTATCAAGAGTA"	-2.21612296524699	11.1410751112732	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGTTATCAAGAGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.33369549225	40.4470067207009	0.0176290863008151	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2288.10812098193	2288.10812098193
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTCAACAGCGTGAA"	-1.91490886631663	11.702664352301	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCAACAGCGTGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2334.50448595939	41.9044121662185	0.0179500242634991	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2329.00142584209	2329.00142584209
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACACACCAAACACGG"	1.11035539683644	11.0941018828186	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACACACCAAACACGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2451.6210247881	39.6868566683543	0.0161880063301319	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2436.43273047404	2436.43273047404
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGCCTCAGAAACCG"	1.41685368594472	10.3350105055603	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCCTCAGAAACCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.83716956196	36.6334149330837	0.0156230101640393	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2337.07797291015	2337.07797291015
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTAACCAATGGCAG"	0.0745720966601789	11.7418794401917	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAACCAATGGCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2251.99511743338	41.5669873523434	0.0184578496776306	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.03750540762	2246.03750540762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTTCACTCCGTCAAA"	-0.547885517508346	11.3906764754089	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTCACTCCGTCAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2446.30487992003	41.3643417066543	0.0169089069993624	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2441.76364149811	2441.76364149811
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACAGGGCAAACGAGC"	-1.43679247322734	11.3234033354553	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAGGGCAAACGAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2383.29302598677	39.5318734068485	0.0165870805544278	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2379.05848030531	2379.05848030531
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGATGCAGTCAACT"	-0.995276789099532	11.9594135054382	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGCAGTCAACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2601.90756845578	44.1520965341922	0.0169691256789711	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2594.12521252332	2594.12521252332
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCATCCATCAGCGC"	-1.41398415985759	12.3932828673157	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCCATCAGCGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2020.85489337603	49.313737431422	0.0244024138462702	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2011.72236614457	2011.72236614457
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTTAGCAGGTCAAG"	-2.18228373947795	12.1023034819397	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTTAGCAGGTCAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2267.87965942627	35.7098422934568	0.0157459158580269	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2262.2860327147	2262.2860327147
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGAAAGTTCCTACC"	-2.40150747719463	13.4463081129822	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGAAAGTTCCTACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2365.0476009774	40.1083617896088	0.0169587968432573	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2363.67948613766	2363.67948613766
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCATAAGCAGCTACTA"	6.79190125045125	-9.94109442150267	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATAAGCAGCTACTA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2652.5007897153	34.1915721730252	0.012890315548858	3036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2647.10085495357	2647.10085495357
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCCTTGAGCCTGACC"	1.36065389689748	11.3083600767883	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCCTTGAGCCTGACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2046.69999698038	34.392633065259	0.0168039444549766	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2045.49011759127	2045.49011759127
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGGATGTGCTATTG"	0.915207822888535	10.6591195830139	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGATGTGCTATTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2076.26780251891	36.792560146475	0.0177205272373047	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2074.35398002818	2074.35398002818
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGGCTTCGACATTG"	6.43997349318807	-10.2101011506286	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGCTTCGACATTG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2450.72903456812	37.5213043183452	0.0153102622889345	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2447.47705640784	2447.47705640784
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCACCTCTGTGCTC"	-0.0869593423908532	11.5392560728821	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCACCTCTGTGCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2318.22146353216	38.2097120496894	0.0164823390046053	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.85969770587	2314.85969770587
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAATTCCGTGACTCTA"	1.38671125945393	11.1136369475159	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAATTCCGTGACTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2064.57244502199	32.8591084036885	0.0159156964837523	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2058.87478196685	2058.87478196685
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAATCTGTGACCTGC"	1.38864292678182	11.0763749846253	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATCTGTGACCTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2126.7839667267	38.5194428445609	0.0181115917023982	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2122.16580667051	2122.16580667051
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCGGTCATCGCTAA"	7.46587767180745	-9.23273661052855	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGGTCATCGCTAA"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2569.87986885826	42.5961512999317	0.0165751527206041	2484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2565.57131841565	2565.57131841565
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTCTAAGCATGTTC"	-2.82736454430278	13.1467456587586	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTCTAAGCATGTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2647.74022206887	36.211088600725	0.0136762240868293	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2642.139255685	2642.139255685
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCCAAGTGTGGACA"	8.02626289901082	7.48696897113649	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCCAAGTGTGGACA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2185.21678293385	46.6013181468116	0.0213257185789344	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2178.96280393469	2178.96280393469
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCCTCGTACTGCCG"	-1.93519316139873	12.8605632551941	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCCTCGTACTGCCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2612.22339811071	43.9025898409682	0.0168065984987045	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2600.43076937249	2600.43076937249
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAACAAGTCTCACAA"	6.79545177993123	-10.0170545808044	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAACAAGTCTCACAA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2437.06824940085	42.5004313276511	0.0174391633628232	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2434.40567441779	2434.40567441779
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATACCTAGTGCACCC"	-2.18509922447856	13.1928071745667	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATACCTAGTGCACCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2513.75438548647	46.497101312739	0.0184970741696949	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2506.04659994246	2506.04659994246
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAACGCTTCATATGGC"	-0.0788696062868417	11.325373626593	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGCTTCATATGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2338.52845690191	39.6082547743291	0.0169372558445589	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2329.94627628907	2329.94627628907
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAACGTTCACGGGAA"	-1.95808229866679	11.901696182135	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAACGTTCACGGGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2752.59027229759	40.4644860734661	0.0147005119071682	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2742.91132448773	2742.91132448773
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCCTCAGTCTCAAGT"	-2.39879308167155	13.3712472685608	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCTCAGTCTCAAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2805.8272263942	40.6943231484517	0.014503502840675	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2802.24527222025	2802.24527222025
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTAAGTAGGAGTC"	0.23666282471959	11.3826904066834	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTAAGTAGGAGTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2159.63749904275	44.7091623397449	0.0207021605985088	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2154.95867760146	2154.95867760146
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGCCCCAAAGCGTG"	-1.32716522637065	11.5873670347962	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGCCCCAAAGCGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2324.60554985398	45.0838872829	0.0193942096050368	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2318.24336452707	2318.24336452707
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGTAGCACGTTCGG"	-7.83804593506511	4.2588171728882	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTAGCACGTTCGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2209.16915062781	42.7347076869678	0.019344244271573	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2201.14510166136	2201.14510166136
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGTGTTTCGAACGCC"	-7.52632556381877	3.1281311281952	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTGTTTCGAACGCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2397.64042800733	46.151710059936	0.0192488037492312	2515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2389.33282363377	2389.33282363377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGGGAGTCCCTCAT"	-2.6214841407841	13.3532895811829	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGAGTCCCTCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2331.22918988082	41.8751250365641	0.0179626804684548	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2327.01788323512	2327.01788323512
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGATGGCTCCCTTCCC"	1.46360590037648	11.5798158415589	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGGCTCCCTTCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2127.57642709516	35.8397284368589	0.0168453306684695	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.35113950495	2121.35113950495
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGAGGCACCAA"	0.497987617819947	10.7255296477112	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGAGGCACCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2265.19689901406	41.1065332341402	0.0181470022548733	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2260.28783230263	2260.28783230263
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATGCTGTCGTATTG"	-2.05792818489726	12.0590228804382	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGCTGTCGTATTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2302.10532813956	43.9613969254249	0.0190961709649281	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2295.23782424184	2295.23782424184
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATGCTGTTGCCATA"	-0.419470081955749	11.5639629133972	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGCTGTTGCCATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.18544164277	41.1089609684243	0.0167642137785814	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2441.09287200514	2441.09287200514
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCATAATCCCTCTCC"	-8.02401671829875	0.259071401599325	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATAATCCCTCTCC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2833.92142361615	42.1431519681048	0.0148709669989118	3406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2826.82004710568	2826.82004710568
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCCGAGTTCACGAT"	0.668567498295945	11.4307574995789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCCGAGTTCACGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2471.10081062419	42.2194522135349	0.0170852811961445	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2464.95561983629	2464.95561983629
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGTAACAAATGAAC"	1.46122541007344	10.8024654158386	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGTAACAAATGAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1929.15015724417	36.4998871519013	0.0189201898125141	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1923.43947447508	1923.43947447508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCATGGAGCTACTAC"	1.42456247386281	11.5616760023865	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGAGCTACTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.41867085348	38.8373640458773	0.0176821316269297	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2188.90550420339	2188.90550420339
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCCACGAGGTGGGTT"	-2.00394521179851	12.8591708906922	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCACGAGGTGGGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2175.31585370523	42.9857025454276	0.01976067175358	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2172.30184836041	2172.30184836041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCGCTGTCTTTCAGT"	0.587799866765183	11.5373639830383	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGCTGTCTTTCAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2239.9351163481	40.0894352325242	0.017897587720257	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2232.30718431863	2232.30718431863
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGGTTGTTACCTTT"	-2.4129789871281	12.9563035734924	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGTTGTTACCTTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2649.14871468354	37.9043687671949	0.0143081317243916	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2641.87987968685	2641.87987968685
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGGTTATCTTGGCTC"	6.49021830138509	-10.1859951249328	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTTATCTTGGCTC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2708.29373605859	43.3006140986709	0.0159881528071201	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2700.89779718083	2700.89779718083
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTTAACGTCTGTAAC"	0.0870634178513705	11.5767698057922	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTTAACGTCTGTAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2197.80365955253	41.3332964419852	0.0188066373728764	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2194.27617765261	2194.27617765261
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAAGTGGTTTGGCTA"	-7.83620391312297	2.4477762945923	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAAGTGGTTTGGCTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3101.39440412952	42.799371627288	0.0138000415459254	4128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3093.70122102193	3093.70122102193
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAATTCGTTGAATCC"	1.47754432734792	11.0161647566589	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATTCGTTGAATCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2431.14299181816	32.5227204078374	0.0133775432038718	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2422.08017578355	2422.08017578355
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGCTGTGGTGTAGGAC"	-2.46108923378642	12.7471294173035	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTGTGGTGTAGGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2355.77016391362	41.5286893330051	0.0176284978768955	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2347.22274863522	2347.22274863522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAACCCACAGATCCAT"	-2.03024564209636	12.7892846831116	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAACCCACAGATCCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2500.60574571474	43.3479424746016	0.0173349767546869	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2493.83177415762	2493.83177415762
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGAAGAGAATACAC"	8.16192497786824	-8.9511289826599	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGAAGAGAATACAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2658.98410100347	33.4768376135168	0.0125900856650038	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2655.35877794112	2655.35877794112
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCCATTCATTGTAGC"	0.0691922913188159	11.5556344755921	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCATTCATTGTAGC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2695.73960428332	36.8041096610102	0.0136526946454811	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2683.26771131309	2683.26771131309
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCCTCATCCACACAA"	1.04048331555669	10.538077331427	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCCTCATCCACACAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2181.59285184595	37.3018741666868	0.0170984581908232	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2170.35757498772	2170.35757498772
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGGTTCATTGTAGC"	1.40034057673756	11.1138467558655	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGGTTCATTGTAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1984.01768795262	37.0491937951029	0.0186738223253116	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1976.47787927429	1976.47787927429
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGGTAGTATCGAAA"	-0.386351386935073	11.5573377379212	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTAGTATCGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2346.56492288249	41.1904147181368	0.0175534946067203	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2341.73886286295	2341.73886286295
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATGACCAATTCTCT"	0.848258395760697	11.6895179518494	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATGACCAATTCTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2351.64295309168	38.4092380975451	0.0163329378071824	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.57254129575	2345.57254129575
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATTTCCAGTGTACAA"	-2.27554402771648	13.4028510817322	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATTTCCAGTGTACAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2274.24752354732	44.2159960087878	0.0194420332663793	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2269.58526360226	2269.58526360226
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCCCGAGCAGGGAG"	-0.227399240166503	11.6868152388367	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCCGAGCAGGGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.29508318836	43.7366070331509	0.0180558542750219	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2411.8992711627	2411.8992711627
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGGTATCATAGACC"	-0.890031377703506	11.1401977309021	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGGTATCATAGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2390.24003647389	38.7510145299377	0.0162121853615605	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2384.96779241591	2384.96779241591
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTCTACAGCGAACA"	6.30294146117513	-0.734809838887774	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTACAGCGAACA"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2497.73647537025	41.3020626424042	0.0165357967302303	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2490.66364404529	2490.66364404529
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGCCATCGGATACT"	6.76929010924642	-1.1833501092163	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGCCATCGGATACT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2400.7439329804	32.3353349948374	0.0134688812707712	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2390.02161276954	2390.02161276954
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGCCCTCTGAATCG"	-0.257217029959518	9.25270269000856	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGCCCTCTGAATCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2128.78794782346	38.0000533151942	0.017850558273804	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.00521272796	2121.00521272796
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTACATCATGGAGAC"	-0.217506806284744	11.4237212904724	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTACATCATGGAGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.99836986145	37.5249828265197	0.0154678516245923	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.50782032676	2416.50782032676
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTAAGTCCCAGGAC"	8.15899910506551	8.35714814746705	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTAAGTCCCAGGAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2403.48907744963	37.5057840696931	0.0156047241577195	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2394.51862006455	2394.51862006455
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAATGGTCTGAATCG"	-0.593017856509048	11.3303050764832	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAATGGTCTGAATCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2244.10953091748	39.2382731377565	0.0174850080163932	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.49766153568	2230.49766153568
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTCTCGTAACGCGA"	-7.28134618225749	0.0723418139847889	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTCTCGTAACGCGA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2780.75216751449	31.4205734528293	0.0112993073672271	3371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2774.31315450362	2774.31315450362
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCACACAAAGGCAC"	-2.08518109741862	13.4433297880921	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"IFN+ NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCACACAAAGGCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2441.15722564465	42.613213768267	0.01745615289364	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2436.80917637266	2436.80917637266
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCCAGTCTAGAACC"	1.36291243609731	11.3717164763245	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCAGTCTAGAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2608.48253628617	40.016129741894	0.0153407696563946	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2600.12163628342	2600.12163628342
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCACATCGTACCTC"	-0.712522665888625	11.8092107542786	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCACATCGTACCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2837.70324003689	37.4702344864673	0.0132044231961268	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2830.51013383553	2830.51013383553
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGTGAAGTCTCCTC"	-8.14581237259563	2.33896086299745	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTGAAGTCTCCTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2731.905162813	46.4845774982165	0.0170154433363829	4141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2724.88070519908	2724.88070519908
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACGGCAGGAATTAC"	-2.72689781609233	13.3204288252625	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCAGGAATTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2429.67601896507	41.3402503071684	0.0170147171822428	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2425.83679237827	2425.83679237827
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGCGACAGCCCACA"	-8.26201091232951	2.4807820090088	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGCGACAGCCCACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2519.15799938463	46.0232078844762	0.0182692819964919	3199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2514.03300597136	2514.03300597136
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGATGTCATTCGGA"	1.31751241263692	10.9088487395081	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGTCATTCGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2082.85859627407	36.1656433027854	0.0173634654639928	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2079.63070661699	2079.63070661699
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCATTAGCACCCAC"	-2.392805437476	13.3498668440613	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCATTAGCACCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2709.67857165653	41.9005001960927	0.0154632732584504	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2703.81532628996	2703.81532628996
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAATGGAGTTTCGCTC"	0.355476518242997	11.4236612089905	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAATGGAGTTTCGCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2219.55840866446	39.9959054867957	0.0180197580431604	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2218.47756378218	2218.47756378218
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTTCCCGGTAG"	1.45946719226186	11.5012387999329	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTTCCCGGTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2145.6032868042	40.5578528719597	0.0189027734630147	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2142.85968875112	2142.85968875112
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAAGCACTACAGT"	-7.46543012085612	3.17002389514772	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAAGCACTACAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2512.64679676528	37.3525175656776	0.0148658050999306	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2504.05419819058	2504.05419819058
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCCTGCATGGGCAA"	0.17523612555806	10.6993102797302	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCCTGCATGGGCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2089.16068648651	42.3309267114175	0.0202621689108119	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2079.08646547202	2079.08646547202
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATCTGTTTGTTGG"	3.21373762664143	-10.9394779435364	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTGTTTGTTGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2818.60742672966	34.1351453660877	0.0121106419582856	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2813.48324488064	2813.48324488064
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCGTCAGCAGATAT"	0.964423735707444	11.1423883208069	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCGTCAGCAGATAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2437.14769292313	41.0256585655543	0.0168334724582685	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2430.24561357535	2430.24561357535
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACTTTCCACAAGT"	-6.92654166641887	0.224264464620031	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACTTTCCACAAGT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2563.20641864084	41.2671132188681	0.016099800983157	2956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2558.33611307931	2558.33611307931
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGACTAGTAAAGCT"	0.742726822465104	10.717559791449	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGACTAGTAAAGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2220.61316570227	42.1324982933902	0.0189733623776232	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2210.96183968935	2210.96183968935
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAAGTAGCCTTCTC"	-7.5125506919926	3.02614185893861	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAAGTAGCCTTCTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2744.18454054006	40.3570140398157	0.0147063775936415	2602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2735.35865745769	2735.35865745769
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGACTGTGGGCTTC"	-1.79304323616679	11.497435546759	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGACTGTGGGCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2598.37175835712	40.0691145440055	0.0154208551625192	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2589.93132568756	2589.93132568756
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAACCGTTCGTAAC"	1.3476011949474	10.7684001692566	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCGTTCGTAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2190.15275001575	38.4850755829594	0.0175718682556195	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2181.56934484151	2181.56934484151
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCATGGTCTGTAAGC"	-2.3931556743687	12.9862890013489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGTCTGTAAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2424.48038785954	42.8324263676907	0.0176666417192615	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2421.70079019335	2421.70079019335
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGTTGAGTATTGCC"	-2.85219750824626	12.9121675261292	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGTTGAGTATTGCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2487.38041872623	39.6162058583282	0.0159268785586948	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2487.38041872623	2487.38041872623
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTGTCAGAACTCT"	-2.2337568801945	13.4008769758972	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTGTCAGAACTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2571.36452468753	45.4110238565697	0.0176602824767087	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2566.47061201024	2566.47061201024
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTGTTCCGCTAGG"	-1.76967153969463	11.2158746489319	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTGTTCCGCTAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2440.03325177156	44.9019920526637	0.0184022049781752	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2431.21877008644	2431.21877008644
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACCAATCGCTGTCT"	1.14672519740407	11.3846969374451	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAATCGCTGTCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1886.1700900976	35.3000169583285	0.0187151822328505	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1882.53222387693	1882.53222387693
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGCAACGTTAC"	0.40746514972989	11.5756616362366	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGCAACGTTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2501.64159352182	36.1069953591425	0.0144333206853628	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2497.02391785964	2497.02391785964
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGATCGTGTCATTG"	6.48608555373494	-10.1101656190124	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGATCGTGTCATTG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2586.70270614265	37.0373461603177	0.0143183621652248	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2581.52071700836	2581.52071700836
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGGGTGTCTTCCTAA"	-0.30292851749118	11.2040843733582	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGTGTCTTCCTAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2254.43706372335	37.0023640554198	0.0164131279825164	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2251.61643294058	2251.61643294058
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAACCCCATCAGTGT"	-7.38849196854289	3.07656905734865	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAACCCCATCAGTGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2387.1010282163	42.5122088149465	0.0178091368201172	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2380.8806800929	2380.8806800929
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAGGGCAAGCTACT"	-0.247942875058013	11.8544349440369	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAGGGCAAGCTACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2250.5051040224	39.6374821288592	0.0176127048359116	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.3793997382	2246.3793997382
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCATGAGCCAGTAG"	-1.47770319405254	11.5945663222107	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCATGAGCCAGTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2523.87599466855	37.3444020539309	0.0147964488480485	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2515.62913464236	2515.62913464236
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTTTCACATGAGTAA"	8.85610355910603	7.79819390857545	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTCACATGAGTAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2159.93238940035	38.7876264541342	0.0179577965701522	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2156.56300957738	2156.56300957738
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTGTCCAGTCACTAC"	-2.32236419144328	13.1488713988098	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTCCAGTCACTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2581.20507534253	34.9509392136858	0.0135405510966802	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2575.24677377655	2575.24677377655
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTCTACACTTGGGC"	0.25645444270913	11.2806825407776	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCTACACTTGGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2167.60823731294	41.2019375388705	0.0190080185291906	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2157.06485474446	2157.06485474446
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCATGGTCGTTCAA"	1.0685963827068	11.061439491156	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCATGGTCGTTCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2475.62599812736	35.441955302988	0.0143163609243874	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2471.21407971717	2471.21407971717
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTCAGAGGAGTCTG"	-7.46517739716228	3.00567720020143	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTCAGAGGAGTCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2536.95885355077	44.3311918132323	0.017474146950072	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2528.39446138909	2528.39446138909
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGCGTGTCGAGAAAT"	-7.91391168060954	2.7350601919922	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGCGTGTCGAGAAAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2612.33985521461	44.7441085305594	0.0171279814306104	3042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2607.31772489978	2607.31772489978
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTAAGGTGACACGA"	-6.82937512818034	0.0378625032487287	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTAAGGTGACACGA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2722.2556885448	39.3279845189164	0.0144468371154142	3579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2716.29030199432	2716.29030199432
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGAATGTTCAGCGC"	6.58859648284261	-10.0939445725647	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGAATGTTCAGCGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2432.01247833647	44.3811604950646	0.0182487388080435	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2428.30624076836	2428.30624076836
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTTTGAGTGCGGTAA"	-2.82367811623271	13.0380859144959	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTTGAGTGCGGTAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2345.0212133701	40.51360610175	0.0172764348018527	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2343.52447547409	2343.52447547409
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATCCAAGGATCATA"	0.206262369721574	10.7950076826843	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATCCAAGGATCATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2141.6794798112	37.0520361664469	0.0173004581291096	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2133.67421946851	2133.67421946851
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACCTGAGTTCCGGTG"	-7.61830411377605	3.10950586879579	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCTGAGTTCCGGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2395.56683991014	43.4999919108803	0.0181585381740015	2750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2391.32876598144	2391.32876598144
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGACCCTCAGTAGGG"	-1.9222026866978	11.2766275175842	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGACCCTCAGTAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2404.03260158527	43.7020243409871	0.018178632150067	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2394.73581383757	2394.73581383757
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGAAGCATACGCAT"	1.49394502219502	11.3496284254822	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGAAGCATACGCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2347.70331349508	38.9479134505749	0.0165897936194469	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.29170303223	2345.29170303223
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGACGTCCAGGTGACA"	-2.84820161286052	13.2226972349915	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGACGTCCAGGTGACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2637.86125432644	42.1047974868184	0.0159617180083907	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2627.49768859519	2627.49768859519
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGTCTGAACGT"	1.3275896507198	10.5477275618347	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGTCTGAACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2090.28293805484	32.530963972943	0.0155629476664127	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2084.69322201873	2084.69322201873
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACGAAACACCGTCTT"	-2.87132463875468	13.2393846281799	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGAAACACCGTCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2507.97937972702	40.6559758561118	0.0162106499697525	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2503.95205267801	2503.95205267801
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGTCTCAGCGATTT"	-1.86796210232432	10.8667812117371	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGTCTCAGCGATTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2267.56790620365	39.5374198953243	0.0174360466944153	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2267.56790620365	2267.56790620365
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGATGGTCGTTGTTT"	1.43402339991872	10.4856223830017	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGATGGTCGTTGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2072.9439996739	41.9530200755525	0.0202383759918996	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2066.66476514497	2066.66476514497
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTGTCCGTTTC"	-0.761029402643997	11.4672469862732	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTGTCCGTTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2408.64498267488	44.312759936634	0.0183973812061848	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2407.42754268186	2407.42754268186
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACGTCACAGACGATG"	1.08219005641286	10.9196243056091	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGTCACAGACGATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.54842124081	39.2624473034069	0.0162070846382906	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.75313769217	2416.75313769217
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACGTCATCTGAGATC"	1.25743164595906	11.0990686186585	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGTCATCTGAGATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2200.27159913711	34.1930109969564	0.0155403592040028	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2193.18735241172	2193.18735241172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGACTCCAAAGGG"	1.41180362281148	10.2935085066589	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACTCCAAAGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1946.6625892437	44.6993100096376	0.0229620224155043	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1943.69169860123	1943.69169860123
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGACTCCCGTTGT"	-7.40006862106975	1.02468869769899	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACTCCCGTTGT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2728.1126860048	40.2037951459767	0.0147368528258462	3095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2726.56377387505	2726.56377387505
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGCTGCAGGTCAAG"	0.403505970805329	11.4603433378967	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCTGCAGGTCAAG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2307.3470228714	44.147451109717	0.019133424956068	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2299.82661250847	2299.82661250847
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCATAGTATTGCC"	6.66422619399373	-9.93345644390257	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCATAGTATTGCC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2320.17596693852	33.1222588325932	0.0142757529189901	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2319.03634986358	2319.03634986358
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATATCCTCACGTTGGC"	-0.428964833647567	11.9008111723694	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATATCCTCACGTTGGC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2736.79708340131	40.8008854150183	0.0149082610700208	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2727.2882935278	2727.2882935278
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATAATCAGTGATC"	0.958475430577439	11.4490270384583	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAATCAGTGATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2106.64319942137	43.3778139801407	0.0205909638575983	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2101.87974323789	2101.87974323789
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGAATGTCGAACGA"	1.40697218951527	11.5067224272522	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGAATGTCGAACGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2173.28538888927	39.406104132903	0.0181320430047352	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2167.08300194627	2167.08300194627
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATCTAGGCCTTCG"	-2.51507244530376	13.1133241423401	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATCTAGGCCTTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2548.55880706216	43.2370764034138	0.0169653045806132	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2536.57010620041	2536.57010620041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGAGACGGAAA"	-1.75868473473247	11.0839862593445	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGAGACGGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2433.69681990926	44.7153380531686	0.0183734217374027	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2426.40571861638	2426.40571861638
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGTGATGTATCGCGC"	-2.95504150810893	13.1303481825623	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTGATGTATCGCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2632.04666004086	46.1978906143619	0.0175520788881625	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2627.12407703327	2627.12407703327
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTAGTCTCATATGGC"	1.27334191378896	11.427803970221	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTAGTCTCATATGGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2147.0287038052	37.5220207991987	0.0174762548505747	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2141.74072139879	2141.74072139879
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCATTAGGGTACAC"	6.33378281173055	-10.0226583710876	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTAGGGTACAC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.15378785735	41.7778941686605	0.0146890419030871	2605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2840.05894574396	2840.05894574396
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGGGTCATGGACAG"	0.540779520838898	11.6177329787048	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGGGTCATGGACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2258.47019559386	40.5800997407565	0.0179679589396069	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2252.17847788687	2252.17847788687
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTATGCGTGCGAACA"	-7.93161521378215	3.17737720096437	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTATGCGTGCGAACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2389.91116516523	40.6873577642913	0.017024631859686	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2383.15226109035	2383.15226109035
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGCCATCTACCCAC"	-2.27501426163371	13.3504352339539	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCATCTACCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2688.41043122991	41.6937470129674	0.0155086985709593	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2674.54228999384	2674.54228999384
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGGGTTCTGTGTGA"	-9.53365073624309	3.24461267078248	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGGGTTCTGTGTGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2289.94385507632	46.154074407475	0.0201551117968073	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2284.64997288751	2284.64997288751
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCACACAGGTAGTG"	0.583676536648911	11.0431813963684	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCACACAGGTAGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2432.30399864826	40.127883715163	0.0164978899584361	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2424.90410278143	2424.90410278143
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGACTCTCTTTGGAG"	1.4184875684673	10.7049712904724	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGACTCTCTTTGGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2006.62392205497	40.2539923937703	0.0200605564158462	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2000.88513699725	2000.88513699725
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTGATTCACCCTCA"	0.359140624373597	10.2094421156677	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTGATTCACCCTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2073.76026206968	49.2129249928095	0.0237312508552427	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2070.15893986198	2070.15893986198
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTCATGTTACACTG"	0.537941177457017	11.0756158598694	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTCATGTTACACTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2389.57034960749	38.1141526472203	0.0159502115740099	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2379.25529362421	2379.25529362421
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTCCAGTCCACAGC"	7.95886911925618	8.36543176257936	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTCCAGTCCACAGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2192.68485476827	40.51997927087	0.0184796183467743	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2187.75507389912	2187.75507389912
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTGTGTTCGTAAC"	-0.204197267920333	11.2698955305847	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTGTGTTCGTAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2445.47379870102	45.5219013739608	0.0186147573521913	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.4821405512	2437.4821405512
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACGGGTCCCGAAAT"	-2.36959371987041	13.0075349577698	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACGGGTCCCGAAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2378.90264606061	44.6495173517796	0.0187689552683957	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2374.60192971154	2374.60192971154
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGCCATTCTACACAG"	-1.25337646427806	10.612467742804	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCCATTCTACACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.97723094719	40.4143007762154	0.0155440979617703	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2591.894250133	2591.894250133
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCACAGTCGTCTA"	1.07738854464833	11.6772355803284	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCACAGTCGTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2436.19997613174	38.7953338298643	0.015924527629076	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2424.86004274579	2424.86004274579
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGAATCATGGGTTT"	-7.82321582260783	2.95372650707094	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGAATCATGGGTTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2531.34251033239	44.3360698343119	0.0175148442588633	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2522.03776417997	2522.03776417997
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTTGTCACTGAATC"	-0.274926285178024	11.457640624884	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTGTCACTGAATC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2328.01944839078	43.768686632826	0.0188008251662505	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2313.11802673771	2313.11802673771
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACCATGGTGACAACG"	7.19175829467122	-10.0242872468201	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCATGGTGACAACG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2473.34847548259	36.0885068081052	0.0145909511602742	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2469.2689546737	2469.2689546737
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCGTTTCTCTCTCGAC"	-0.204179833561736	11.5993137129578	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTTTCTCTCTCGAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2496.70317345966	40.4612226686876	0.0162058602315232	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2486.78976863925	2486.78976863925
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACGCTTCCGTCCTA"	0.973267098038834	11.4575242766174	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTTCCGTCCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2482.34669169826	39.3723030619072	0.0158609203112444	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2475.01209959563	2475.01209959563
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCGATGTCCGTACG"	1.42551722106282	10.628915763739	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCGATGTCCGTACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2158.04202080454	37.8920868633035	0.0175585491376007	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2152.91341211828	2152.91341211828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGTTTGTGATACTC"	1.24163438853566	11.7233180769714	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGTTTGTGATACTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2248.67402168125	41.3791986201786	0.0184015994409189	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.04819995608	2246.04819995608
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATCCACATTACGGT"	-7.68071685257609	3.40490815723268	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATCCACATTACGGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2446.75921117521	39.889369462588	0.0163029403467245	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2437.64885636027	2437.64885636027
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCTCCAGTTACCA"	-7.84940705719646	2.95051238620607	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCTCCAGTTACCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2711.21305111084	43.4707329632712	0.0160336838690933	3610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2698.36726018915	2698.36726018915
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGGTACATAACGGG"	-0.226380149752456	11.0772237547669	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTACATAACGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2277.85830203369	49.3553998317869	0.0216674583259731	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2264.7441524268	2264.7441524268
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTAGACCATTC"	6.51790489730184	-10.0228109589783	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTAGACCATTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.9253388641	37.1630561858826	0.0141685528120967	2747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2617.00179219847	2617.00179219847
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCATGGGTTGGGAAC"	6.71674122390096	-9.9681720963684	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCATGGGTTGGGAAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2728.19928215682	39.2690391398775	0.0143937575956082	2883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2725.5446642835	2725.5446642835
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATAGAGTCTGTCTCG"	-0.666083137423354	11.0812587507996	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATAGAGTCTGTCTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2293.16020856227	42.4496808045753	0.0185114326709819	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2286.40112521556	2286.40112521556
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCTACCCAAGTGCTT"	0.239079420536202	11.4786748656067	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTACCCAAGTGCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2209.75960638014	41.4483035187525	0.0187569287623326	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2206.22230786458	2206.22230786458
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGCTAAGTATTGCC"	8.33116306838338	7.93543717944948	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTAAGTATTGCC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2251.69440360482	40.5934267300672	0.018027946716517	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2239.83125635131	2239.83125635131
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGATGGTTCAGCGC"	-2.46030197563823	12.5422954329285	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGATGGTTCAGCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2537.82159568982	42.7382367339188	0.0168405205497914	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2532.26513434711	2532.26513434711
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGAGTGGACGT"	-7.63113627854045	3.21726725185243	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGAGTGGACGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2230.77814423851	43.2652523365116	0.0193946907935484	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2226.40522110839	2226.40522110839
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTGCAGTAAGATAC"	-7.65408025208171	3.14288709247438	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCAGTAAGATAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2552.31202983024	41.3763708045904	0.0162113293049605	2749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2542.31507997418	2542.31507997418
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGCTAGCGAAACC"	-0.0866778594559014	11.1597213515076	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGCTAGCGAAACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2169.18777792814	41.8546057435643	0.019295058809312	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.63998145041	2163.63998145041
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGAATCGTAGCCG"	-2.58930526199992	13.4872884520325	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGAATCGTAGCCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2556.50776546983	37.0698144734448	0.0145001767544532	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2544.76354677337	2544.76354677337
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATCGTGGTGGAAGTC"	-2.22151050987895	13.0310344466004	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCGTGGTGGAAGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2170.73507985067	45.6253045281185	0.0210183660602459	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2164.46703156827	2164.46703156827
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCTGAATCGGTGCAC"	-7.60482964935954	3.07398936832277	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGAATCGGTGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2648.19085702079	43.3860135471361	0.0163832653647726	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2645.01730478475	2645.01730478475
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGCTCAAAGGCAC"	-0.453030924231368	11.038451171759	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGCTCAAAGGCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2435.11333511224	42.2648515404317	0.0173564207180869	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2426.58483888713	2426.58483888713
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGGTTTCGAGTGGA"	-1.82757924023326	11.6382426985535	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGTTTCGAGTGGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.6727233844	42.5133423435713	0.0167068016067028	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2533.71392924473	2533.71392924473
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGCTTCCGCCTAT"	1.53215612944905	11.0137004622254	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGCTTCCGCCTAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1963.59159327444	40.2624273045642	0.0205044814015646	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1959.65522137381	1959.65522137381
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAATTAGGGTGGGA"	8.68577351149861	8.03532598102418	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAATTAGGGTGGGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2157.24989879249	43.5942025084644	0.0202082301790192	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2145.06570162563	2145.06570162563
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCGATTGTTAAGGGC"	-2.27110038223918	13.2799396284851	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGATTGTTAAGGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2375.23442389626	44.2328760464342	0.0186225307285148	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2373.82577133035	2373.82577133035
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCGAGAACATCTATCT"	-2.33523164215739	13.4288673170838	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAACATCTATCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2549.38903734137	45.2796782085612	0.0177609919652675	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2547.01139743965	2547.01139743965
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTACAAGATACTGA"	-1.6735055250233	11.345486617926	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTACAAGATACTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.17089901697	43.6208725583004	0.0171791794617637	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2533.32164231033	2533.32164231033
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCACTGGTGATAGAT"	-2.24305472794231	13.067543006781	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCACTGGTGATAGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2638.09069067356	42.449470770788	0.0160909823611673	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2635.52509572561	2635.52509572561
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCACTGGTTTACGTG"	8.3031345802242	-8.60084249889525	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.555555555555556	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCACTGGTTTACGTG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2679.22640152547	39.0242967263729	0.0145655091724065	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2675.23384952642	2675.23384952642
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGCACGTCGGCTGGT"	-0.244741122156936	11.1356086500916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGCACGTCGGCTGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2398.16030540826	38.4682564304873	0.0160407360357583	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.81341208816	2395.81341208816
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGAACACAGCATT"	0.213812907307786	11.7247171171936	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAACACAGCATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2547.55111695263	41.7910982131492	0.0164044198897722	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2538.96284500159	2538.96284500159
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGGGATCCACACCT"	-0.305813739926177	11.5573615797791	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGGGATCCACACCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2496.6525525284	30.3238218870152	0.0121457917147125	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2493.13558817276	2493.13558817276
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTCCATCACCGCTAG"	-7.65764127197917	3.29951665485231	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTCCATCACCGCTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2532.80449512453	40.9666958481647	0.0161744405961939	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2527.68384759264	2527.68384759264
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCATTTAGACTCAAA"	-7.45593438568767	2.92960808360902	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTAGACTCAAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2845.63725315786	38.7403989971484	0.0136139625506229	3026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2835.62379508592	2835.62379508592
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGCGAGAGTGATAAC"	1.44875707206075	11.4856452711853	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCGAGAGTGATAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1976.97865952854	42.346417619119	0.0214197646570537	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1974.05702911904	1974.05702911904
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTTCCGTGGGTATG"	-0.0474079576438248	11.3777179487976	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTTCCGTGGGTATG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2590.3218222014	40.3591136386135	0.0155807333639779	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2584.36260746385	2584.36260746385
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGTGAAGTCCCTAA"	1.03535344180409	10.6398553618225	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTGAAGTCCCTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2398.31601893403	42.8492422150491	0.0178663870302188	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2388.67515332458	2388.67515332458
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGGGTCGAAGAAT"	-1.22267828407939	11.9496545561585	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGGGTCGAAGAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.13291230863	43.5549225993384	0.0169862187682477	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2555.13315201455	2555.13315201455
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACGCTCATAATGAG"	1.1723014312679	11.6520271071228	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTCATAATGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2220.23011921151	40.562680809206	0.0182695840661829	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2212.23746215565	2212.23746215565
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGTCTCGTTATCT"	-7.32880483093913	3.1003219851288	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGTCTCGTTATCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2602.60583313222	39.7541894893583	0.0152747638475529	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2586.09773598529	2586.09773598529
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTCATTCCACTTTA"	1.36259736594502	11.0714778670105	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTCATTCCACTTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2122.93365349403	44.0385782157148	0.0207442084415752	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.02832480218	2121.02832480218
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTGGGGTTGGCTAT"	-2.00626311722453	12.1183824309143	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGGGGTTGGCTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2470.3376890331	43.9919403539984	0.0178080675161528	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2462.98737238336	2462.98737238336
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGGCCAGTATGCGTT"	-0.524450878531295	12.087074256781	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGCCAGTATGCGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.18917069854	45.6027257210599	0.0201586703321448	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2259.64812253018	2259.64812253018
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAAGCTAGACTCATC"	6.29874863204305	-10.0440674058166	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAGCTAGACTCATC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2544.10007139878	36.2613114801755	0.0142530995096583	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2534.78103694593	2534.78103694593
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAATGATCGATACTG"	-2.68435059014018	13.1986722716126	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAATGATCGATACTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2585.97765764589	37.2047295518744	0.0143871040191984	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2579.69768993196	2579.69768993196
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATATCTCCCTCTAG"	8.47594036635701	7.9767446287903	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATATCTCCCTCTAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1939.0602068078	40.8698788814354	0.0210771582738619	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1931.83493881836	1931.83493881836
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAATTTTCTTTGCAT"	-1.73394451561626	9.27411649310914	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00168293503870751	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAATTTTCTTTGCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.12222036289	42.0498986259502	0.0175784908764282	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2387.6175560744	2387.6175560744
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGTCACAGCGTTGC"	-0.075018192560035	11.0967912443909	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTCACAGCGTTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2376.61707048594	39.344373874841	0.0165547804749195	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2368.33905395942	2368.33905395942
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATTCGACACAAGGTG"	-1.68399653855022	11.8103179701599	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCGACACAAGGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2501.94133555331	43.9604033516	0.0175705172327224	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2494.14036610123	2494.14036610123
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCCTCTCGTTTACT"	-2.27791510048564	12.7368554838928	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCCTCTCGTTTACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2768.82028161038	44.948831713556	0.0162339289451511	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2763.89264708472	2763.89264708472
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTATTCACCGGTG"	-7.85361276093181	-0.0250664434400425	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATTCACCGGTG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2773.38860636821	44.1232561745094	0.0159095108681107	3422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2769.36717943175	2769.36717943175
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATTCTTGTAACGCGA"	-7.73562846604045	3.00221107089845	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTCTTGTAACGCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2331.4644272666	45.7825411000732	0.0196368173430587	2825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2328.62952021648	2328.62952021648
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCACATCCATCTAT"	-1.48419592800792	12.0521716841492	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCACATCCATCTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2568.43939105781	43.9899689460464	0.0171271197207146	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2564.17119247381	2564.17119247381
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCATGAGAGTGTTA"	-1.95708404007609	12.0444669493469	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGAGAGTGTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2547.42540767957	41.095749918821	0.0161322682088874	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2537.73201514905	2537.73201514905
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAAGCTGTTGCAACT"	-2.2020095390385	13.0606775053772	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAGCTGTTGCAACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.54469634183	41.9973769993656	0.017619714479792	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2378.67019708631	2378.67019708631
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGACTTCCCATGGG"	-1.98154960098918	12.2627725371155	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTTCCCATGGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2831.72490937517	44.8632833067183	0.0158430937829401	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2822.59303181464	2822.59303181464
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGTCAGGTATCGTAC"	8.2389255958492	8.25754354083864	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGTCAGGTATCGTAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2221.49094254341	39.8071587217874	0.0179191181739466	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2213.5408042246	2213.5408042246
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCATGGTGTCCAAT"	0.804528256028336	11.7280854948792	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGGTGTCCAAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2593.59326994169	38.7640520570189	0.0149460798291979	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2576.09959985522	2576.09959985522
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATCTGTTGTGTTG"	-3.00170431557353	12.8880462416443	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTGTTGTGTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2552.08096234641	36.4602997554508	0.0142864980748608	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2547.8782959136	2547.8782959136
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCCAACATGGAAGC"	7.78826918181722	7.44423911655275	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCAACATGGAAGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2165.12110773198	43.5044284470086	0.020093300227709	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2161.89540334001	2161.89540334001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCCAAGTAGGCAGT"	1.19685365733449	11.1070260771546	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCAAGTAGGCAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2224.88676945728	34.4273476479734	0.0154737526963547	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2220.12999075936	2220.12999075936
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATGGAGTTAACGA"	1.51157786425893	11.335853553656	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATGGAGTTAACGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2475.41804802225	37.1363314484387	0.0150020443933133	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2468.0189677389	2468.0189677389
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTATGTCAATCCAG"	-0.417664776474792	9.89105317676393	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTATGTCAATCCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.38786405876	42.8440369046167	0.0191491326081008	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2237.38786405876	2237.38786405876
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACCGCCACCAATTG"	1.31212069567983	11.4550637968811	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCGCCACCAATTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2055.51183887102	35.4716535901601	0.0172568471362552	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2052.97062955509	2052.97062955509
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGGACATTGAAGA"	-2.80172882500346	12.8592900999817	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGGACATTGAAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2471.65642567839	40.8958155754666	0.0165459143716717	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2463.96144078925	2463.96144078925
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAGAAAAGGTAGATT"	-2.1658185524052	13.4581603773865	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAAAGGTAGATT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2695.39782106529	41.166706092835	0.0152729611084143	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2692.07836679335	2692.07836679335
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAACCGTCCATCCGT"	-1.53662167015727	10.4786643751892	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACCGTCCATCCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2582.46734421857	45.0620072580133	0.0174492069992268	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2575.4324399663	2575.4324399663
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTCCCACAGGTCTCG"	-2.55168114128764	12.9162072905335	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCCCACAGGTCTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2775.01713870312	42.4677074579552	0.0153035838466216	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2763.08160887574	2763.08160887574
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAACCCAGACTTCAC"	-2.76625547829326	13.4032268294129	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAACCCAGACTTCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2393.44191748589	41.0570614133282	0.0171539827699079	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2388.05005520369	2388.05005520369
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGTTGTCGGTAAGG"	-0.678764979273635	10.8863324888977	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGTTGTCGGTAAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2481.57184605633	44.5128173687003	0.0179373478303436	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2473.16986106533	2473.16986106533
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTAGAGTCCGTCCTA"	-1.54576132717784	11.4590387114319	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAGAGTCCGTCCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2397.85038739385	45.6585685428802	0.0190414584591765	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2392.96364393872	2392.96364393872
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACGGTAGGCTGTAG"	-8.10530124130901	2.79087493503419	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTAGGCTGTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2382.71887675086	43.9973709769827	0.0184651959600785	2983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2375.77614376865	2375.77614376865
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGATAGTCCATATGG"	1.40334119376485	11.6490344771179	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGATAGTCCATATGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2081.8395315824	31.806897840885	0.0152782658597652	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2073.43767759386	2073.43767759386
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCTTCACAACCCTAA"	1.21311940726582	11.0162782439026	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCTTCACAACCCTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2417.31854420047	42.4631276342775	0.0175662110135022	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2398.02648888482	2398.02648888482
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGTACCAACCACGC"	0.93045206841771	11.7997941740784	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGTACCAACCACGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2210.0871186184	40.4133164313854	0.0182858476894111	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2201.82906495852	2201.82906495852
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGTCCAGTATGATCC"	-7.9111512703007	1.7871591814789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTCCAGTATGATCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2506.85724522845	41.9347793116238	0.0167280284473488	2872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2503.36829034703	2503.36829034703
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACCAACTCCGATGCG"	-2.90403232994731	12.9257812269959	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCAACTCCGATGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2341.59459410324	42.3158524829936	0.0180713828899145	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2338.74212272758	2338.74212272758
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACCGATCAAGCTGT"	0.235148673027199	11.3659896620545	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCGATCAAGCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2251.70399707941	42.2081510949148	0.0187449820889696	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2250.23348154803	2250.23348154803
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTCAGGTATTAAGG"	-7.96794639053996	2.82378408992616	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTCAGGTATTAAGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2590.46503436571	46.154098386437	0.0178169161807421	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2583.23881901518	2583.23881901518
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGTTGAGTATCTGC"	-2.40569029274638	13.4612531431946	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGTTGAGTATCTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2550.40947666092	42.2012201228416	0.0165468410108375	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2545.20585542731	2545.20585542731
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCAGTAGTCAA"	1.47940303859059	11.1994809874329	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCAGTAGTCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2241.82120234396	40.2707687221181	0.0179634168327128	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.46481777344	2230.46481777344
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGACACAGTGAGCA"	-2.25654230538066	13.3375491865906	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGACACAGTGAGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2821.56117568315	39.1369714167162	0.0138706797336196	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2812.68833342614	2812.68833342614
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACTAAGTCGAGTTT"	7.49658693847005	-9.37845518505248	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACTAAGTCGAGTTT"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2281.50466219416	40.068951204059	0.0175625112093894	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2274.94024156837	2274.94024156837
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGCTTCTCCTTGAAG"	1.24469174918477	10.4433002241882	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTTCTCCTTGAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2130.24077722014	40.6793594342386	0.0190961321693049	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2126.90088084391	2126.90088084391
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCCATCCTGTC"	-7.99908767166789	3.29136607730714	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCCATCCTGTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2494.95158131009	42.1438500990201	0.0168916504892213	3432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2486.85214731227	2486.85214731227
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGAATGAGGTCGTGA"	1.06711639937703	10.9419831999573	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAATGAGGTCGTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1915.92283607028	35.0321041579904	0.0182847155942064	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1907.99471849356	1907.99471849356
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATGCACAAGCTACT"	8.10310711440389	8.24789998615114	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATGCACAAGCTACT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2046.39534632654	46.1059052517443	0.0225303020428133	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2043.69471229142	2043.69471229142
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATTTCAGCGTGCTC"	-7.67432389679607	2.82580134952394	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCAGCGTGCTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2520.55246298308	46.4772683780073	0.0184393179910254	3417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2516.07579591167	2516.07579591167
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCACCAGCATCTTG"	0.150104832916897	11.3119144209656	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCAGCATCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2538.66578653631	41.1937291973811	0.0162265271056356	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2528.06416411741	2528.06416411741
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCACCAGCCGGAAT"	0.101781071245116	11.5381488570007	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCAGCCGGAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2243.8253531897	45.5014498161597	0.0202785166641768	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2237.95848266452	2237.95848266452
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCACCAGGCTCTCG"	-7.66544804993327	3.25626251781312	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCAGGCTCTCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2363.23854475409	37.5325897686536	0.0158818456359255	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2357.12261336284	2357.12261336284
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGAAGTCTTTGCGC"	-0.113584349781829	11.7657785185608	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGAAGTCTTTGCGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.01855659731	43.7440693548015	0.0179424677619575	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2427.672472775	2427.672472775
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAGTTACAAGAAATC"	-8.16802440109904	2.65409061992494	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAGTTACAAGAAATC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2345.52555345503	45.6432039859737	0.0194596916323251	3033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2340.43713887611	2340.43713887611
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTGATCTTCGCTG"	-7.39203725281413	3.16814491832582	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTGATCTTCGCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2589.65401520101	42.1281756534771	0.0162678780277941	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2579.16210560896	2579.16210560896
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTAGGGTAGTGATA"	1.44940199431722	11.3945245512756	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTAGGGTAGTGATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.60716375784	36.4902332668964	0.0168033306741134	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2165.19871621343	2165.19871621343
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCAGGCACTACTTT"	6.02134670790975	-10.1350298157898	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCAGGCACTACTTT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2625.05177050246	43.3079344393148	0.0164979353649186	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2616.73944739464	2616.73944739464
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCAACAAGGGATCTG"	6.54682316359822	-10.0903005830017	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACAAGGGATCTG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2424.05780776371	39.7355976336171	0.0163921823589986	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2421.78031569158	2421.78031569158
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCATTTCTCTGCTG"	1.38822187957112	10.886297202948	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCATTTCTCTGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2222.55913760977	35.1847619845412	0.0158307427636686	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2216.07406423596	2216.07406423596
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCATCGGAGCCAGTAG"	-7.94795928421672	2.72195265376893	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATCGGAGCCAGTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2338.78637319835	47.8535815891395	0.0204608604434866	2716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2335.7357813303	2335.7357813303
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTCAAGTTGAAGTA"	-0.319225232035476	11.0152158507141	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCAAGTTGAAGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2540.78411336597	39.3838340503118	0.0155006613285759	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2532.85003124066	2532.85003124066
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGTTAAGGATTTGA"	-2.37426910820659	13.1400689848694	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGTTAAGGATTTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2420.55509204692	39.6896245981217	0.0163969102494414	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2420.55509204692	2420.55509204692
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCAGGACAATTGCTG"	2.07565679129903	-4.20451834118041	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAGGACAATTGCTG"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2441.47736837992	42.3509177201142	0.0173464305951019	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2436.02516897943	2436.02516897943
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGAGTAGAGGACTC"	-2.53148255768474	12.7766923674378	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTAGAGGACTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2859.94794250208	36.8256690201325	0.0128763424231823	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2852.83354952552	2852.83354952552
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCTCGAGTATAGAC"	-2.58855376663859	12.7309169539246	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCTCGAGTATAGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2660.41220912944	42.9369473800924	0.0161392085154137	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2652.12534795897	2652.12534795897
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGAGTAGGGTTGCA"	0.159982492297333	11.4003581770691	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTAGGGTTGCA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2458.64750236294	39.1009532685422	0.0159034400949967	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2449.31649417292	2449.31649417292
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGCATCCAGGATCTT"	-3.11518464508708	13.1662235029968	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCATCCAGGATCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2452.31572043828	40.8274345472864	0.0166485229479301	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2448.14581985943	2448.14581985943
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAACACGTTTGTTGG"	-1.51135061207469	12.0188693770203	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAACACGTTTGTTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.88129066373	40.7726187216829	0.0157491264156147	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2580.56005520539	2580.56005520539
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTAACGGTTTCCCAC"	1.31440856036488	11.2390098341736	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAACGGTTTCCCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2118.70622230672	43.9121034847295	0.0207259048103991	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2115.62777474498	2115.62777474498
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAAGTGTCGGCAGTC"	-2.40588531914409	13.5217857130798	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAAGTGTCGGCAGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2767.85731010175	39.0764150608675	0.0141179297495762	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2764.13778835518	2764.13778835518
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCGAGGTATGTCCA"	-2.18141828003581	13.0274438627991	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCGAGGTATGTCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2549.88299718457	43.1373881267284	0.0169173990235466	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2545.95379399321	2545.95379399321
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCGAGTCGAACACT"	8.0732122856075	8.44093701923219	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCGAGTCGAACACT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2193.3458312928	42.4894987022407	0.0193720014856009	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2187.76341300204	2187.76341300204
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCTCAAGCATCAGG"	0.985438664525193	11.1969699629578	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCTCAAGCATCAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2655.13675317974	41.3935306042082	0.0155899806496355	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2642.21320189656	2642.21320189656
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCTCCGTAAGGAGA"	-0.0104534131592095	11.7713470228943	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCTCCGTAAGGAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2381.17081288609	45.3531404075895	0.0190465716118111	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2374.55677732831	2374.55677732831
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGGAGAGGCTTCCG"	8.01853670653645	8.5841550596985	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGGAGAGGCTTCCG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2076.06450146337	42.4359034707422	0.020440551553591	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2068.35110702779	2068.35110702779
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTCTCGGTGTTCGTA"	1.32092465934102	11.1039275893006	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCTCGGTGTTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2035.24029549759	28.4993426147455	0.014002937480057	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2030.27845292313	2030.27845292313
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACGGGCAAGAATAC"	0.664527555077714	11.3605432280335	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACGGGCAAGAATAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.86059182852	44.7110230951805	0.0189144077488068	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2355.71859305296	2355.71859305296
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGTGTGTTTGAAAG"	0.690932949155015	11.6181125410828	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGTGTGTTTGAAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2209.59360996635	38.5674235756329	0.0174545325446611	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2205.84988811685	2205.84988811685
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCTACCCATTGACTG"	-2.25633178177531	13.3126020201477	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTACCCATTGACTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2460.37396163245	45.7429660316295	0.0185918753591747	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2451.14826111872	2451.14826111872
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGGCGAGGAAAGAC"	1.01035418090169	10.6596812971863	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGGCGAGGAAAGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2173.79661068562	40.6164341752778	0.0186845604485818	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2171.7768530072	2171.7768530072
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCTGAAAGACGCCAA"	-2.37499390068706	13.3196553953919	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGAAAGACGCCAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2733.70209222699	37.4229636241818	0.0136894812827595	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2727.50973430527	2727.50973430527
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCGGTTCCGTTTCG"	1.4456498819286	11.3326711424622	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGGTTCCGTTTCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2381.47832445166	34.6865569348579	0.0145651365283136	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2379.14202461639	2379.14202461639
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCCATCCGAAT"	-7.77536998215373	2.89512918079225	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCCATCCGAAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2587.27544652204	43.9355431047217	0.0169813937529467	3188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2579.33171743379	2579.33171743379
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGACAAGGATCATA"	1.48506667193715	11.4706506499085	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGACAAGGATCATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2345.19484168017	39.5032413695682	0.016844332363134	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2336.72953667186	2336.72953667186
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGGTGTTTACTGG"	6.72372068938558	-10.2750711671081	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGGTGTTTACTGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2364.57745190245	39.5454711704372	0.0167241175114059	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2356.66637530952	2356.66637530952
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCCAAACAGAGGTTG"	-2.43784223023112	13.5468358763489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCAAACAGAGGTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2486.57408743102	36.9332920207735	0.0148530832873477	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2482.65280106618	2482.65280106618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCTGAGAATTGCA"	-1.44337866726573	11.7393655546936	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCTGAGAATTGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2648.94733671249	45.6045532271394	0.0172161041463881	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2646.31954405718	2646.31954405718
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTGAGGTGTCACAT"	-2.85576496544536	13.3711471327576	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGAGGTGTCACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2344.01499870287	43.9661724125551	0.0187567794732052	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2337.40801358685	2337.40801358685
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTACCAGAATCCCT"	5.7127534347469	-10.0492210618225	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTACCAGAATCCCT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.77110383779	39.5151108297691	0.0150776657953471	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2616.74505048361	2616.74505048361
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTAGACCATACGCAT"	-1.43257317963298	-6.69626858150633	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTAGACCATACGCAT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	1498.91518830141	34.3862188292868	0.0229407368059654	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	1498.91518830141	1498.91518830141
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGTCATTGGTG"	-0.129429574043113	11.7834443815979	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGTCATTGGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2574.34978206467	37.1927550726732	0.0144474365262222	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2568.67540390524	2568.67540390524
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACCAAGTTCCAGT"	-1.52826152268108	11.9999742277893	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACCAAGTTCCAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2504.20324769182	45.5432446340755	0.0181867205371823	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2502.05897667252	2502.05897667252
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACAAATCCCTAGGG"	-2.55935059014018	12.5086717375549	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAAATCCCTAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2662.22411846792	40.9513203399089	0.015382371474974	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2657.78654300823	2657.78654300823
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTAGATCGCCTTGT"	6.7296744781429	-1.02635946190032	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTAGATCGCCTTGT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2528.25193800111	40.218361599976	0.0159075766918124	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2522.12558310029	2522.12558310029
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGGAAGGTACTTCCC"	1.17422666129414	11.1318521269592	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGAAGGTACTTCCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2355.3487903935	37.0710416022528	0.0157390878809331	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.87564188348	2345.87564188348
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTATTGTTCTCCAC"	0.569618542760056	10.9268884428772	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTATTGTTCTCCAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2689.21190559945	41.1474825171551	0.0153009446490543	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2678.15713863875	2678.15713863875
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTTTGCAACTTGGT"	0.631264944642228	11.3801250227722	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTTGCAACTTGGT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2239.38724449912	46.2880993179584	0.0206699843591864	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.24431609772	2230.24431609772
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGGAGAGGTCGTAG"	-8.86632953110393	5.08475730502931	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGAGAGGTCGTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1967.92413678342	44.8811480462407	0.022806340553147	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	1961.87598900478	1961.87598900478
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGTTCGGTACAATAG"	-1.52077935162242	11.74484632099	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTTCGGTACAATAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2695.03709828352	42.6151012018746	0.0158124358395721	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2690.69281780883	2690.69281780883
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCCGAACAGAGGGTT"	-2.62602482262309	13.1289453276428	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCGAACAGAGGGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2025.75791055077	38.5501649059749	0.0190299959857956	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2022.2671414691	2022.2671414691
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTGAAAGGCTGGAT"	3.93745507773702	-10.75200083172	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGAAAGGCTGGAT"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2901.36904335309	42.6184484173731	0.0146890822162076	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2897.63988884625	2897.63988884625
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGGTCGGTGAGCCAA"	-0.00770538944061402	11.6890001066956	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTCGGTGAGCCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2179.22882613035	45.7897599834405	0.0210119100088949	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2172.64450697543	2172.64450697543
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCCGAAGTGATACAA"	-3.02536068382915	12.7321796187195	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCGAAGTGATACAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2294.21714824529	43.4973138751169	0.0189595452672758	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2286.30044526922	2286.30044526922
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTTCTCATCCAATG"	6.79059519347493	-9.8564548722473	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTTCTCATCCAATG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2338.78173418909	35.7036581052894	0.0152659213911933	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2337.66875293181	2337.66875293181
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTACCGCAACCAATC"	0.246567790477914	11.205391860846	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTACCGCAACCAATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2263.01955240117	37.5542793253659	0.0165947657347985	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2254.15852369023	2254.15852369023
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGAACAAGACGTCCC"	-2.55814896050151	13.4608096846375	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAACAAGACGTCCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2540.04329422406	41.4102947006155	0.0163029877462249	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2534.7636711943	2534.7636711943
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCGATGGTAAGATTG"	-9.39744601669963	2.17026159847108	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCGATGGTAAGATTG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2569.10667814178	44.2812204099463	0.0172360380309216	3066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2564.76494102942	2564.76494102942
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGATCGGTCCGAAAG"	0.148462195962113	11.4828386076721	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGGTCCGAAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2206.44375215991	44.0762734370393	0.0199761600058431	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2205.20219270269	2205.20219270269
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGAGTCTGCTCTG"	-1.39008245888408	12.0289134749207	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGAGTCTGCTCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2627.97815275276	37.2218829275608	0.0141636957250088	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2615.2793602871	2615.2793602871
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGATCGTCACTGGTA"	-3.15697060051616	13.2991037138733	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGTCACTGGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2637.17170978277	44.5895008147242	0.0169080764249504	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2629.36709308539	2629.36709308539
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCGAGAAAGGCCTGCT"	8.08167805251424	8.30926702106325	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGAGAAAGGCCTGCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2138.2156948622	39.8116990571844	0.0186191220805486	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2133.99883200688	2133.99883200688
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAGAGCAGGGTATAT"	-1.79365573349651	12.0159330138001	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAGAGCAGGGTATAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2536.57156012795	44.4231105688194	0.0175130523684412	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2532.05922217774	2532.05922217774
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACAACTCGCATGAT"	-2.06445203247722	13.5474738844666	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAACTCGCATGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2725.08029600725	40.119376225113	0.0147222730588509	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2717.1230546502	2717.1230546502
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTTAGTAGCGTCAAG"	8.1046368080074	8.38757798755494	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTAGTAGCGTCAAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2337.94836229228	43.2705554207912	0.0185079175052291	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2327.04390000856	2327.04390000856
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGGTAAGTTCCGTA"	0.432496120303315	11.3765372999939	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTAAGTTCCGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2144.88765467343	43.3162394894127	0.0201951087717962	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2137.6029363462	2137.6029363462
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGCTCACACTGGACC"	-2.44123468819316	13.3348178633484	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGCTCACACTGGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2539.86697231847	33.6112624413137	0.0132334735667799	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2530.72980794945	2530.72980794945
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTTCAAGTTCATCG"	6.99929441985433	-9.84019472515257	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCAAGTTCATCG"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2423.11949457159	40.1022084235311	0.0165498269950658	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2420.74110131	2420.74110131
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCGTACATAGGCGA"	-8.73193011704143	3.28376720035402	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCGTACATAGGCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2152.84164893982	47.0929531504777	0.0218747872950474	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2150.97606422172	2150.97606422172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTTCCGTCGACTTA"	1.35087027129475	11.3035430678162	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTTCCGTCGACTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2325.63953402267	40.2184559767315	0.0172935037388041	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.86486080262	2319.86486080262
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTTCCGTTCAGCTA"	-2.43520555916484	12.8606891402039	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTTCCGTTCAGCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2496.03409561895	39.9452612002022	0.0160034918073893	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2493.30372951505	2493.30372951505
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGTGAGTTGATCGT"	-7.93881020966228	2.95809099757997	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTGAGTTGATCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2601.92526071691	45.5605603671594	0.0175103263168313	3095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2597.0468138918	2597.0468138918
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGGGCGTCACGCTG"	1.15503396567647	10.6489543684754	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGGCGTCACGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.85831352727	38.4056075246826	0.0179813460852924	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2129.90662183859	2129.90662183859
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGACGGTCTGCAAT"	-2.20706282082255	13.3567266234192	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGGTCTGCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2840.21185413017	40.0715114598114	0.014108634678621	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2831.45871864849	2831.45871864849
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATTTCCAGGAGAGTA"	1.39741112765614	11.0847530134949	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCAGGAGAGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2208.44820609764	36.1198126173783	0.0163552907954326	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2200.84958373022	2200.84958373022
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAAGCGTCACTTGGA"	-7.47910056534465	-0.0638788721528874	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00245700245700246	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAAGCGTCACTTGGA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2887.13212661398	34.360665874354	0.0119013139570623	3109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2879.56626191331	2879.56626191331
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAAGAACAGCAGGTCA"	-2.20190892639812	12.1400232085022	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGAACAGCAGGTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2520.20602538667	40.6719800220434	0.0161383552028463	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2511.4531576567	2511.4531576567
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGATGAACAATTGGTC"	-2.78973684731181	13.0913429030213	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATGAACAATTGGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2511.04655010814	40.0531291010263	0.0159507712428913	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2507.32280640987	2507.32280640987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTTCAATCGCAGTCG"	-1.75739417496379	12.6958074339661	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCAATCGCAGTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2736.65616385325	42.6158409302924	0.0155722306269885	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2731.91673098764	2731.91673098764
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGATGCTTCGGTGCAC"	-7.88520036163982	3.0440418490204	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATGCTTCGGTGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2371.08779610124	47.8121291528252	0.0201646388764862	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2367.56090691927	2367.56090691927
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATGGCAAAGCAAT"	-7.37848744812663	2.9412541159424	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATGGCAAAGCAAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2604.72372232127	40.75364633709	0.0156460533560048	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2600.03531252933	2600.03531252933
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTTCGGGTTCTTGTT"	-2.55715523186381	13.2052821882996	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCGGGTTCTTGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2452.85987097352	38.2062463354777	0.0155762042453383	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2448.95657796381	2448.95657796381
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCAGGTCTCCGAGG"	-2.31594596329387	12.8693332442078	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCAGGTCTCCGAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2424.47493249705	41.8099034503941	0.0172449312178834	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2419.22104372143	2419.22104372143
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTTGTTCATTTCCA"	1.15845479544942	10.9486131438049	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTTGTTCATTTCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.23770686665	40.4356872082681	0.0174574859429987	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.76176046563	2309.76176046563
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCCTCGTGGCAACA"	0.0843650187248408	11.6874303587708	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCCTCGTGGCAACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2399.12655291559	36.9591958394295	0.0154052714703666	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2389.04900537762	2389.04900537762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAACGACAGATCGCCC"	-3.08264766159709	12.8803787001404	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACAGATCGCCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2504.0713619297	42.934661162858	0.0171459415317028	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2496.26824816128	2496.26824816128
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTCAAAGTCCTGTTC"	8.2767445045406	-9.98122312938841	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTCAAAGTCCTGTTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2073.45561182341	42.4283684385229	0.0204626364782466	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2067.2050085068	2067.2050085068
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCTCAGTAGTGTGG"	1.1496031480724	10.7303514250549	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCAGTAGTGTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1897.15354070035	42.9123226873256	0.0226193198213594	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1890.96015925184	1890.96015925184
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGTCAGCAAAGCAAT"	-2.96084962311443	13.0705127486023	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGTCAGCAAAGCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2657.93827754754	46.2564616090063	0.0174031361073165	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2652.7328984212	2652.7328984212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATCTGTAGACGTG"	-2.62031636658366	13.3040132292542	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTGTAGACGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.51488768594	40.3072485429107	0.0155715730029833	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2583.39209487114	2583.39209487114
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCAGAAGGCTC"	0.966844041913193	10.6977395781311	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCAGAAGGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2273.9485801827	37.3612796593058	0.016430133902282	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2265.92820359655	2265.92820359655
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAACGTTGTTTGCCGG"	6.77270760115926	-1.07840373432311	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAACGTTGTTTGCCGG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2843.87725306074	40.1858943219593	0.0141306711739084	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2836.4107399126	2836.4107399126
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCTAACATGAGAAT"	-8.22682128372844	2.41520021045534	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTAACATGAGAAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2361.7141695766	39.7718228686912	0.0168402355293577	2990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2356.7965658778	2356.7965658778
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCCAGCCATCAACCA"	-7.22033439102824	2.98073384845582	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAGCCATCAACCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.93985947621	41.387351250801	0.0155244879601045	2712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2658.44873722672	2658.44873722672
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGTCCCATACTGTG"	6.41120304641072	-10.0445051423279	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTCCCATACTGTG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2398.02227454639	42.1595028626026	0.0175809471455295	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2394.3621097762	2394.3621097762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTACTCTCTGCGGGT"	6.94671597060506	-9.77958776867064	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTACTCTCTGCGGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.1990135584	39.7966922114684	0.0163961389194553	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2423.55761373579	2423.55761373579
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAAGCACCATTGTCGA"	0.903878887265366	10.6436881789002	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCACCATTGTCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2239.58134716721	37.141150173407	0.0165839701336975	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2233.85984791033	2233.85984791033
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTTCACTCTCCGATC"	-1.76228402081187	13.2379426726135	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTTCACTCTCCGATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2675.41024974633	40.6033487148216	0.0151764944156402	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2670.61318543627	2670.61318543627
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGGGACATGGCCCA"	-2.5868857902592	10.7416677244934	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGGGACATGGCCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2720.47813933834	40.9297013910679	0.0150450396197716	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2713.38663635639	2713.38663635639
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCGATTCAGTCAGCC"	8.01698507842366	8.52828500354616	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGATTCAGTCAGCC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2185.79855311367	40.7961335383903	0.0186641781239521	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2176.56632481557	2176.56632481557
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCCCCAGATCATC"	-8.24977908554729	2.68059084499208	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCCCCAGATCATC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2743.19278208759	45.9961432478532	0.0167673754277123	3648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2735.68462534357	2735.68462534357
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCCCCAGTCGCTG"	-0.040641407400924	11.7420663603577	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCCCCAGTCGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2432.79087991309	40.0023911040059	0.0164430043840986	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2426.19864628682	2426.19864628682
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACTTGTCTCACCCA"	8.13755192336385	8.16013619983522	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACTTGTCTCACCCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2067.62878566857	36.5079699728845	0.0176569267297561	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2060.77801713588	2060.77801713588
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTCTCGAGTCTCGTA"	1.33842756327931	11.6662139662537	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCTCGAGTCTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2168.81216601383	37.4375824678655	0.0172617910644949	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2166.09349385791	2166.09349385791
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGTCATACGGT"	-1.00921235504802	12.0505008467468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGTCATACGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2600.84463110346	43.5711281882334	0.0167526839808757	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2591.89275439759	2591.89275439759
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCGACATGCACTA"	1.3971971469814	10.6713065871033	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCGACATGCACTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1917.62077924492	33.8496727555603	0.0176519117449744	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1913.99807724682	1913.99807724682
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGGGTCGTGTGATGG"	-2.02949748459514	13.7914170988831	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGGTCGTGTGATGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3146.34353867821	40.9624443536716	0.0130190628741323	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3140.64930137701	3140.64930137701
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGGACAGCTGCGAA"	-8.24879203262981	4.31733129108278	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGACAGCTGCGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2075.1620919837	39.8709693582565	0.0192134241042071	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2071.16800024062	2071.16800024062
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGGACAGGTAAGAG"	0.455565680831116	11.2858400114807	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGACAGGTAAGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2370.92238705449	36.7808463009411	0.015513306762705	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2366.07778046943	2366.07778046943
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGATGCATGGAATA"	7.28967918929402	-9.89918424999388	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGATGCATGGAATA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2270.17414802714	44.9643417173907	0.0198065605479942	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2269.20548628968	2269.20548628968
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCATCTCGAGCACC"	1.55491795119588	11.1728839644226	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCATCTCGAGCACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2038.52954795459	35.6426589421964	0.0174844946338695	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2029.34853317443	2029.34853317443
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTAACGTACAATAG"	-1.67046294632609	13.4384584196839	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTAACGTACAATAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2576.82717719465	33.6892041339191	0.0130739090429014	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2572.90666087596	2572.90666087596
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTAGTAGTTGCGCC"	4.53473486480061	-10.57719614422	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTAGTAGTTGCGCC"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2765.56274607511	48.6556629433912	0.0175934040955836	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2757.18493502909	2757.18493502909
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCTTTAGTCGCTAT"	-2.19221601906474	13.5312604674133	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCTTTAGTCGCTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2861.58219163545	43.8891228523413	0.0153373623097849	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2853.77474546104	2853.77474546104
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGTAAAGGCGTCCT"	-2.63388667526897	13.3875140913757	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGTAAAGGCGTCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2550.63022805524	39.1517527693266	0.0153498348520626	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2544.36248872473	2544.36248872473
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGAAAAGACTTAAG"	-2.76147089424785	13.084090209845	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGAAAAGACTTAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2728.59143739705	42.1984153701199	0.0154652744239259	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2720.70681088336	2720.70681088336
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTACCGAGCGACCCT"	3.45021166381184	-9.51479246532591	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTACCGAGCGACCCT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2260.12947236935	46.9192248609936	0.0207595296794245	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2254.84343659633	2254.84343659633
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGAATAGTAGCGCCT"	-2.49789009514506	13.3586063154968	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAATAGTAGCGCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2549.2485662669	36.0868608682748	0.0141558815981292	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2545.55043480667	2545.55043480667
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGAATATCGAGATGG"	-2.51957807961162	12.7712783583435	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAATATCGAGATGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2308.25796582219	41.3356556954183	0.0179077279521896	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.83066838828	2306.83066838828
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATAGATCTAAACGC"	-1.80357954922374	11.8924150236878	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATAGATCTAAACGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2482.30662414476	37.1582488376561	0.0149692421058008	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2477.97076664772	2477.97076664772
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTTGGTCCAGTTCC"	-2.00516162338908	13.4678029783997	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTTGGTCCAGTTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2834.5028783275	44.5706076834568	0.015724312021075	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2828.10626820451	2828.10626820451
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACAAAAGGAGGGTG"	-2.69148478928264	13.1367892988953	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAAAAGGAGGGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2435.48951125395	46.7543234239117	0.0191970949609385	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2429.71866960285	2429.71866960285
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAAGGAAGTGAGTGC"	-8.15119109574016	0.229308656695761	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAAGGAAGTGAGTGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3028.73821900701	42.3652912423277	0.0139877692223322	4574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3022.13994466998	3022.13994466998
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCTAAGCGCACAA"	8.02698149260823	8.46814820850221	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCTAAGCGCACAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2316.05094299842	36.4924601016223	0.0157563287681307	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2305.97686400286	2305.97686400286
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTTGATCCTTACCG"	-2.02117762985881	12.413095451239	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTGATCCTTACCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2169.52617467442	42.1380918436028	0.0194227165062558	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2166.92020710505	2166.92020710505
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGGGATCCTGGGTG"	-2.71512399140056	13.4103879698547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGATCCTGGGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2585.3172189155	41.6795688685134	0.0161216459487309	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2579.98565246756	2579.98565246756
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCTAGTTGCTTGA"	-1.55686209622081	11.5950288542542	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCTAGTTGCTTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2863.91451924712	40.3910761793537	0.0141034503327187	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2857.20444996291	2857.20444996291
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCGTTAGGTGCTGA"	1.41863252696339	10.9644231566223	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCGTTAGGTGCTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1822.8374659428	39.4172071451546	0.0216240931413857	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1817.64376974631	1817.64376974631
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACATGAGTTCGGACC"	7.93708004531209	8.15574834430543	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACATGAGTTCGGACC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2350.33368958531	43.7320019335435	0.0186067204530688	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2342.40634791005	2342.40634791005
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGTTTGAGATGATTG"	-1.78394697132762	11.9481000670227	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTTTGAGATGATTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2413.97599721038	42.2886959148665	0.0175182752288075	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2407.62297492275	2407.62297492275
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGACCCCAGTGGGTA"	1.00651641663854	10.9272546538147	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGACCCCAGTGGGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2283.70941980404	40.6578592276361	0.0178034293133164	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.15283981045	2276.15283981045
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTACCAGTCATCAGT"	-1.76854596558269	11.2277993925842	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACCAGTCATCAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2661.19180140428	40.8999352834337	0.0153690294934214	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2652.45658344382	2652.45658344382
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGATGTTAGAGAAGGT"	-2.48845229569133	13.4190397032532	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGATGTTAGAGAAGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2444.41287496909	40.288164393313	0.01648173465533	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2440.31460242052	2440.31460242052
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATAAGTTTGACAC"	8.26504101332967	8.1257285841736	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAAGTTTGACAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2203.35454667442	41.9971455231496	0.0190605481929982	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2195.43283357043	2195.43283357043
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCCACATCCTAAACG"	0.834907849400681	11.671492553595	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCACATCCTAAACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2481.30003270862	37.8067725021433	0.0152366791616381	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2473.27641204738	2473.27641204738
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATAATCATGTCAG"	0.232095067470711	11.2271318205628	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAATCATGTCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2248.90528465601	34.5106415094793	0.0153455291091808	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2244.38747418254	2244.38747418254
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGCACGTCAGACACAG"	-7.63675151291545	3.23383758151857	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCACGTCAGACACAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2012.81280266998	39.8349209955903	0.0197906735006601	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2011.82163377562	2011.82163377562
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTGTTCCACTCGATA"	-0.052691469818908	11.5678920515808	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGTTCCACTCGATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2478.14909669518	42.8217486391045	0.0172797305441432	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2472.17631752967	2472.17631752967
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTCATCAAGACTGG"	-2.76595125618632	13.0239972838196	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTCATCAAGACTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2202.59756215902	43.5795823462867	0.019785540080036	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2199.51235775479	2199.51235775479
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCAATAGTGCCAGA"	0.627316256135148	10.8843631514343	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCAATAGTGCCAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2667.28647600035	32.4601538704856	0.0121697291095482	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2661.14027002044	2661.14027002044
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGAAAAGAAGGTAG"	1.40499867972676	10.682291961554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGAAAAGAAGGTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2161.00859346156	40.7149150940607	0.0188407002254639	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2153.14473978278	2153.14473978278
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTTACCGTGTTCATG"	-1.46580074253734	12.1768445738587	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTACCGTGTTCATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2753.25840000054	46.012146536724	0.0167118881891779	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2744.82945751265	2744.82945751265
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCATTAGGTAGACC"	1.55265690860097	11.1396207579407	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTAGGTAGACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2149.4265763584	38.5759455438526	0.0179470868966404	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2143.3795416287	2143.3795416287
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGGCTGTTGTATGC"	8.41141380843465	7.48056218707887	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGGCTGTTGTATGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2073.55712409271	42.8000836188876	0.0206408992169024	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2070.3686084498	2070.3686084498
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAAATGTCGTAATGC"	-8.06408343735393	2.69368455493776	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAATGTCGTAATGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2827.42885005748	37.3794809563509	0.0132203082512902	3486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2820.61806004648	2820.61806004648
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCGAGTGAATTGA"	-2.20917187157329	13.6003303297791	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCGAGTGAATTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2658.30609120605	39.5482374414737	0.0148772323745198	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2655.75759474964	2655.75759474964
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTTCTGCAATGCAAA"	-2.70606384697612	13.2367858656677	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCTGCAATGCAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2738.87768377426	43.8785183898907	0.0160206199239335	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2732.36776177637	2732.36776177637
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGATAGTCGTCGATA"	-2.32965813103374	13.099281288031	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGATAGTCGTCGATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2552.04091433481	46.7997864386638	0.0183381803072943	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2543.24780724696	2543.24780724696
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGAAGTGTATCTCGA"	-7.14437280121501	2.8113016852173	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGAAGTGTATCTCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2687.2378666552	38.176390883504	0.0142065543795801	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2679.7943244687	2679.7943244687
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGAAGTGTTGTGTTG"	-3.42867026749309	13.0458545454773	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGAAGTGTTGTGTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2231.18406728367	39.8337992784837	0.0178532107066267	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2229.6031942287	2229.6031942287
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGACAACAATCCTAG"	-7.37049804154094	3.1216671236786	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACAACAATCCTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2376.03623701722	39.4399930208923	0.0165990705050878	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2367.09947411624	2367.09947411624
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGTGCAGGTACAGC"	1.31638195094411	11.5078916319641	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGTGCAGGTACAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2345.96413135154	39.5228220714711	0.0168471553095322	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2339.7260065828	2339.7260065828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAAGAAGTAACAAGT"	1.3305102783138	10.4365825423035	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAAGTAACAAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2280.40054346781	41.5956432266752	0.0182404987342358	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.07710343819	2276.07710343819
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGACCTAGTTGCATC"	-2.2361503643101	13.3630323179993	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACCTAGTTGCATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2594.59802726367	43.9304922445053	0.0169315214853669	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2587.76903512233	2587.76903512233
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGGAATCACATATGC"	-1.55239794674571	11.918957687262	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGGAATCACATATGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2675.47050493616	38.014257775088	0.0142084383681124	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2666.44966326627	2666.44966326627
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAAGAATCACTTATC"	-2.30190883103068	12.9550809630188	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAATCACTTATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2533.75911000231	43.5987429197716	0.0172071381007218	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2529.63263823231	2529.63263823231
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAAGAATCTACACTT"	1.46227111396138	11.41987416828	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAATCTACACTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2152.31852978731	41.7350615886672	0.019390745845036	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2143.88611234391	2143.88611234391
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGATCGGTCTATCCAT"	-2.08581386032756	13.3455333479675	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATCGGTCTATCCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2341.56319151642	41.7549393044051	0.017832078782108	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2340.00219496388	2340.00219496388
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACTTACCACTCAAGT"	8.59609665450398	8.17628572070924	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTACCACTCAAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2169.56781053098	38.0145563808871	0.0175217184714698	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2162.2952009987	2162.2952009987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTAGGGTGATGAAT"	-2.79406629028972	13.109200454596	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTAGGGTGATGAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2759.00319881441	38.5898566785382	0.0139868836306971	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2746.48917292172	2746.48917292172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATCCATCATCGGGC"	1.21530999717061	10.4472503432068	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATCCATCATCGGGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1954.4517047607	46.6364651970143	0.0238616616022878	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1947.06715963021	1947.06715963021
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAACGTTCTCCTACG"	-1.29746590080913	11.5117416151795	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAACGTTCTCCTACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.99069677386	39.6025780641061	0.0152965316227111	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2575.44943332971	2575.44943332971
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTAGAGTCACTAGT"	0.884118993848008	10.6328277357849	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTAGAGTCACTAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2443.52445972846	40.5885557436493	0.0166106607126657	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.87041141905	2437.87041141905
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGACTTCATGCCGG"	-1.52994368496593	11.5854987868103	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGACTTCATGCCGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2817.85538829851	41.5197024989776	0.0147345043579572	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2811.30333819205	2811.30333819205
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTGGATCTCTGGTC"	7.95170702513997	7.65568206394044	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGGATCTCTGGTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2169.74494448796	41.7458338552647	0.0192399728646984	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2161.10365305119	2161.10365305119
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATGCTCAGACGGAT"	6.81533970412557	-9.95514204418334	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGCTCAGACGGAT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2388.74421445109	41.8568274903621	0.0175225238588303	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2386.34643770374	2386.34643770374
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTGTTCAGGGAATC"	-7.7063869041508	3.09594009006349	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGTTCAGGGAATC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2544.8468644569	44.3510359422292	0.017427781829102	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2538.1788971057	2538.1788971057
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTGTTGTGGATACG"	-2.81961164894755	13.3576278456482	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGTTGTGGATACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2240.7220637893	41.3527316192653	0.0184550919043183	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2236.12694413722	2236.12694413722
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTGTTAGGATAATC"	0.759296317666215	11.072856880072	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTGTTAGGATAATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2114.6226430489	41.4419247799662	0.0195977873008181	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2106.75597069305	2106.75597069305
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCCAGAGTGTAAACA"	-2.48466859284099	13.322462058905	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCAGAGTGTAAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2633.51775919594	41.1444354823914	0.0156233749853099	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2632.13101576025	2632.13101576025
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAACCTCGTAGTCTGT"	-1.96189079704936	11.2504186400208	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCTCGTAGTCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2240.13778640839	37.8062130097296	0.0168767355468541	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2237.43970685263	2237.43970685263
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAACGATAGTAGGGTC"	0.421810497611207	11.8136491545471	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACGATAGTAGGGTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2169.33112998658	42.4252615455637	0.0195568398752596	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2151.4562463385	2151.4562463385
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCGTTCATCCTCAC"	-1.53543649140056	11.4466619261536	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCGTTCATCCTCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2406.03267251497	40.1524556301583	0.0166882420545802	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2396.6218656257	2396.6218656257
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGAGTCTCCTACTGC"	1.42032231864278	11.2884597548279	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGAGTCTCCTACTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2420.49975056841	39.5932496593287	0.0163574690102864	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2412.91073164875	2412.91073164875
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATCACGCAGATAAAC"	-7.91439710083659	2.80568502033082	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCACGCAGATAAAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2555.4612383738	42.8641590673647	0.0167735508657693	3403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2546.91165310082	2546.91165310082
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCATGGTCTGGTCAA"	1.4086500602657	11.1453161009583	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCATGGTCTGGTCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2105.83250811699	36.6730319735209	0.0174149804565005	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2100.10061166864	2100.10061166864
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAGACTCATGATGCT"	-0.222504834563094	11.5040187605652	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGACTCATGATGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2380.35606519157	42.5918408539485	0.0178930545210348	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2376.83183371633	2376.83183371633
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTTTGGTCTGTCCT"	-2.72301111641582	13.5998553999695	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTTGGTCTGTCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2412.62526403263	43.6887195430968	0.0181083735607048	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2408.44506826914	2408.44506826914
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTAACCGTGAGTTGG"	8.28259911116902	8.055468536261	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAACCGTGAGTTGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2048.33690061651	41.2971329540363	0.0201612991210609	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2043.46347428933	2043.46347428933
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATCGACGTAATGCGG"	1.37417771395985	11.3836555250916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCGACGTAATGCGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2329.23252984453	40.2378533161034	0.0172751551425349	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2324.12770460586	2324.12770460586
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAATCGTTCGGTAGAG"	-7.87255464020427	2.96787498081056	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAATCGTTCGGTAGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2551.34604677453	44.9006261371127	0.0175987989531554	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2544.46022629178	2544.46022629178
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTACCACACGTGAGA"	-1.51994774761851	11.9507169493469	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACCACACGTGAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2400.82320502421	44.3919047285225	0.0184902847638357	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2396.04023961243	2396.04023961243
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTACTGCACTATCGA"	1.42867388305013	10.8768491514954	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTACTGCACTATCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2491.62733306093	36.4504641711809	0.0146291797683893	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2485.75665437277	2485.75665437277
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCAATAGCTACTGT"	6.60034622725789	-10.1340065232483	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAATAGCTACTGT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2705.67854011379	45.9542408598791	0.0169843683122631	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2701.44102134499	2701.44102134499
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACACGCTCCGCTAGG"	-2.0713714164799	13.0490550764832	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACACGCTCCGCTAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2485.63388018148	42.6113303891775	0.0171430437639779	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2480.55149965818	2480.55149965818
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGCCTCAAAGCACG"	-7.83100066605266	3.11646554553834	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGCCTCAAAGCACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2526.05920932872	50.5443966441531	0.0200091891977405	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2514.89713740418	2514.89713740418
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCGTATTCTGGTTGA"	-2.82882771912273	13.0171308287415	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGTATTCTGGTTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2364.9631555751	39.8474305854429	0.0168490703508457	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2362.05186687853	2362.05186687853
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCAGCCACGAGGTA"	-2.79492268982585	13.226740814093	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAGCCACGAGGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2803.2728362094	40.5896994704344	0.0144793967059303	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2799.61573795294	2799.61573795294
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTATCGAGCGCGTTC"	-8.29717574539836	3.30857513034669	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTATCGAGCGCGTTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2323.26844285827	45.4853131048702	0.0195781564737782	2721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2319.90792562131	2319.90792562131
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGCCAGTACGATTC"	-1.65706739845927	11.9808959730896	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGCCAGTACGATTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2774.52130883858	44.0202340838655	0.0158658843035855	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2763.75495966957	2763.75495966957
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTAGTCCACTACCGG"	6.48365320739095	-10.0439768067566	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGTCCACTACCGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2666.92259533126	39.2305788029585	0.014710055279308	3280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2662.15068976412	2662.15068976412
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTCACCATCATTGG"	0.217403267591637	10.9573182829651	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACCATCATTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2359.40775958483	41.9351496084137	0.0177735914608472	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2358.23900941545	2358.23900941545
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATGGAGAGCGTATGG"	-7.69297585907634	3.00774786556093	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGGAGAGCGTATGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2433.31996298927	43.4371868650666	0.017850996796864	2598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2425.11195152148	2425.11195152148
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATACTAGAAGCGGG"	0.178367813199204	11.6454820402893	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATACTAGAAGCGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2170.85950910088	44.8917034470635	0.0206792301661459	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2162.85334540312	2162.85334540312
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATACTCACAGACGA"	-7.78943095627482	3.78116295421449	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATACTCACAGACGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2209.16517722349	41.2593168610327	0.0186764291264486	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2200.55019449546	2200.55019449546
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTCACTCTCTGAGA"	1.22556390342061	11.7390594252381	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACTCTCTGAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2531.94030953637	35.7216916690346	0.0141084256743698	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2520.74637408105	2520.74637408105
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAATGACGTTCGGTCG"	1.335501452058	10.8940467604431	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATGACGTTCGGTCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2105.57960557599	41.7287088006317	0.0198181577605168	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2101.63058784289	2101.63058784289
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGACTGTTGCGAAG"	-2.07230983200725	13.5565213927063	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGACTGTTGCGAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2712.18350416526	36.4284928135524	0.0134314262871989	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2702.23867589629	2702.23867589629
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACAACACAGTATGAA"	-0.0363816049998582	10.791534400824	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAACACAGTATGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2168.96921860529	42.9560524534966	0.0198048234548569	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2161.18341460675	2161.18341460675
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGTCCTCGCCACTT"	-0.563261489302474	11.636634803656	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTCCTCGCCACTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2244.17450059425	45.843024878743	0.0204275669590773	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2238.71236757591	2238.71236757591
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCCTTGTTGATGTC"	8.29754986342732	8.13708207691041	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCTTGTTGATGTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2123.12769865653	40.9843138923765	0.0193037441498741	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2118.61339869109	2118.61339869109
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACACAAAGGTCACAG"	1.42730691012685	11.4409169920715	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACACAAAGGTCACAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2068.13527242973	44.2265134208112	0.0213847295244146	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2062.03205320767	2062.03205320767
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCGTGAGCACTAGG"	-7.13045630875285	0.341462350729383	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCGTGAGCACTAGG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2583.0722643425	37.0353363558909	0.0143377081884769	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2577.36318795212	2577.36318795212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACGGCCATCTAACG"	1.29172231730763	11.2079686888489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCCATCTAACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2402.08301909006	37.0143763918912	0.01540928273408	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2392.49475730918	2392.49475730918
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCATGGTCCGTTTC"	0.685087283223313	10.4958152540955	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGGTCCGTTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2515.52057379295	40.8156120183849	0.0162255130980075	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2509.70844818875	2509.70844818875
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACAGGCAGTGTTGAA"	7.00279535826985	-10.4201259843078	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAGGCAGTGTTGAA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1845.68615222772	48.4884279780192	0.0262712205536647	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1845.68615222772	1845.68615222772
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCATGTCGGATTAC"	8.18529858168904	8.37481973255006	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGTCGGATTAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2528.48785869817	38.2721413652895	0.0151363753769395	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2517.06580357553	2517.06580357553
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTTCCGGACTG"	-2.24815020981486	13.1467447050842	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTTCCGGACTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2530.37985942685	43.0339585451588	0.0170069163271424	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2527.6852295859	2527.6852295859
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAAGTCCCAGGTGTGA"	-2.2208870452946	13.6288814314636	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGTCCCAGGTGTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2791.31752982659	37.5504854685602	0.0134526026033638	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2784.12626752361	2784.12626752361
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTAGTCGGTTGTA"	-3.02346454086955	13.3853149184021	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTAGTCGGTTGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2664.02125904685	38.5588576748588	0.0144739301700072	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2655.79018195722	2655.79018195722
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAAGCTGTCCTCCAT"	6.62219538268392	-10.0569105378357	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAGCTGTCCTCCAT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2483.51195597691	43.162081714508	0.0173794539666429	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2481.23079626433	2481.23079626433
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCTCCGTGTTGAGG"	6.71873869475667	-1.11416675960692	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCTCCGTGTTGAGG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2497.86644584002	42.7523922926839	0.0171155637099351	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2493.68920411683	2493.68920411683
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCAGTTGGGAC"	1.3351739841396	11.3338660963806	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCAGTTGGGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2046.85393263503	36.2248150002577	0.0176978016959048	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2038.4988682408	2038.4988682408
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGACTGTCGTGGTC"	-1.84111116352733	11.9575538405213	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTGTCGTGGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2418.6104266349	49.6839894893959	0.020542369677337	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2415.86522086537	2415.86522086537
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCAAACAATAGTAG"	1.59095062789266	-9.47505953228148	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCAAACAATAGTAG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2083.78648433518	29.0189855254678	0.0139260839551544	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2072.96023730955	2072.96023730955
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACCAAAGGTTTACC"	1.38159706172292	10.9234037169251	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAAAGGTTTACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2205.85278453613	38.7758672787748	0.0175786287963586	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2201.58989405894	2201.58989405894
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCAAAGTCCCAAAT"	0.460804869502228	11.3420648344788	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCAAAGTCCCAAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.94752347797	43.3709382752497	0.0188984444443947	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2291.52242169899	2291.52242169899
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAATGCAAGAGGCT"	1.4169018464977	11.5145416029724	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAATGCAAGAGGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2211.81453076131	28.3944794055811	0.0128376403223139	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2207.72725482701	2207.72725482701
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAATGGTAGTCTTG"	-1.18322966519054	11.6808585890564	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAATGGTAGTCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2473.68640766867	40.8763568143928	0.0165244699925068	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2472.63416461784	2472.63416461784
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTCAATCTGAATGC"	-0.116542394191581	9.61662480914918	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTCAATCTGAATGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2551.04031810261	31.3328127475112	0.0122823667368831	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2544.08873662416	2544.08873662416
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGCCGGTACTAAGA"	-2.0186906856602	13.7817392119202	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGCCGGTACTAAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2836.21345601759	41.0575818232328	0.0144761959774646	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2806.82795055695	2806.82795055695
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAGTACACGGTGTC"	0.778188486664933	10.3648948439392	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAGTACACGGTGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2241.97206053813	36.7377795736876	0.0163863681534325	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2234.64277244038	2234.64277244038
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGGTTCAAGGG"	-7.7111853164738	3.44093535030214	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGGTTCAAGGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2493.11841468197	41.2049366316744	0.0165274687271244	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2487.75889960603	2487.75889960603
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGCGAAGGCCATAG"	-7.62816939774211	3.32425377452699	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGCGAAGGCCATAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2572.44418191892	39.8805909250654	0.0155029956355813	2804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2563.02572165138	2563.02572165138
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACCCCACTACGGC"	6.70375933226888	-10.1076202622619	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACCCCACTACGGC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2794.0541754578	40.4771321462907	0.0144868816438244	3012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2787.43278792377	2787.43278792377
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGTTGGTGCATCTA"	-0.960327963263351	11.8376550444397	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGTTGGTGCATCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2382.73913086028	45.03102482849	0.0188988480716442	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2380.19639454842	2380.19639454842
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACGAATCATGGGTCC"	6.28337444838826	-10.092685722467	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGAATCATGGGTCC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2535.31953225798	42.7076432814313	0.0168450732690863	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2531.74312992167	2531.74312992167
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACGAATGTCCTTGTC"	1.23308243331258	10.8232936629089	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGAATGTCCTTGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2275.57079497164	32.7651057158938	0.0143986316700387	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.6448227044	2269.6448227044
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGATGTCAAGCACCC"	-2.6776524585789	12.996482826117	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTCAAGCACCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2873.91279726561	42.6459695016862	0.0148389921720178	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2863.93560203099	2863.93560203099
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGGACAGTAAGCAT"	8.64509644088094	7.76976726138917	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGGACAGTAAGCAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2272.64551404552	42.9955348383548	0.0189187159073562	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2262.19830327531	2262.19830327531
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTTCCTCAGGAACG"	1.36320175704305	11.3401040800842	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTTCCTCAGGAACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2185.23899914435	30.6941006911503	0.0140461069490197	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2174.69457804683	2174.69457804683
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCAAGGTTCGGTTA"	8.1001955467159	8.48833844745485	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGGTTCGGTTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2196.16010188351	37.9214686698592	0.0172671694733623	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2192.49908108529	2192.49908108529
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGCGTGCATGTCTAG"	-0.0233868536656678	11.092128730658	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGCGTGCATGTCTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2263.27817777281	40.4746565398057	0.0178832001020904	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2256.46843253199	2256.46843253199
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTCTGGTCAGAGCGA"	1.07184578952138	11.1306380995545	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCTGGTCAGAGCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2304.02108824121	40.069125997646	0.0173909545368932	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2298.98090981621	2298.98090981621
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACCTTCAAGTGGCA"	-0.110968063504058	11.0377349623474	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCTTCAAGTGGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.98256546076	40.013902435116	0.0157288430268266	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2542.96392626117	2542.96392626117
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGATACATCTGTTT"	1.14498343047444	10.480875945929	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGATACATCTGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2103.21409314817	41.7088480263549	0.0198310044432631	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2101.48992053095	2101.48992053095
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGATAGTGGAGGTT"	-1.49729977074321	11.4583482512268	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGATAGTGGAGGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.34039374218	35.9167138065672	0.0147784704969922	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2423.84174422592	2423.84174422592
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGAAGCATGAGTAA"	1.03141697224919	10.8415136107239	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAAGCATGAGTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2287.32653095412	36.296215590151	0.0158684014280246	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.87722897958	2276.87722897958
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACCTTTCTTGGGCG"	1.5154832797939	11.4218454130921	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCTTTCTTGGGCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.22410031112	39.0936076357864	0.0180053305553234	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2162.64282415524	2162.64282415524
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGAATCCACTTTA"	-1.67662070217784	11.3646945723328	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGAATCCACTTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2380.53613768728	46.1506257333328	0.0193866520246018	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2372.64357106043	2372.64357106043
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATAGACCGTGAAGCGT"	-7.56968198242839	1.28709790790407	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGACCGTGAAGCGT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2396.15557428285	46.7215147638963	0.0194985314248136	2956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2390.62520466481	2390.62520466481
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGTCAGAGCAG"	6.45012869414632	-10.0410261384216	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGTCAGAGCAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2593.41038804121	40.9712528461593	0.0157982142105572	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2587.01912678074	2587.01912678074
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGATGGAGACGTCCC"	-0.0265850153868974	11.8384418257507	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGATGGAGACGTCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2221.98962184494	47.1092343185591	0.02120137459483	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2215.58229464197	2215.58229464197
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGTCAGACATCCT"	-1.68012307110484	13.1042699583801	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGTCAGACATCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2504.27521375436	43.5735651386146	0.0173996711301111	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2499.38548551125	2499.38548551125
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGTCGTACGAGCA"	1.35864152488057	10.5537929304871	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGTCGTACGAGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2098.16553001468	37.634524594823	0.017936871069729	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2095.45796725694	2095.45796725694
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACGGGATCATCTATC"	1.57597090777699	10.8557395705017	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACGGGATCATCTATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2146.81397005621	34.0315532702683	0.0158521202791396	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2141.83278610386	2141.83278610386
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATCCCTCTGACAGT"	9.29077877578084	7.54506490314332	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATCCCTCTGACAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2394.32856666458	41.4294739394463	0.0173031698807986	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2385.90787542632	2385.90787542632
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTTCGAGCTATCTG"	8.13114132460896	8.04282424533693	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTTCGAGCTATCTG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2401.24689208145	38.4390653189107	0.0160079604665687	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2393.6358998191	2393.6358998191
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTTGGGGTTATGTGC"	1.15618052062337	10.724263168219	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTGGGGTTATGTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2193.83440413825	36.1922199571997	0.0164972433146868	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2188.14888188106	2188.14888188106
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTTCGGTCACCACG"	-0.28225670281108	11.1026515730652	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTTCGGTCACCACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2293.74074904491	39.8377685142058	0.0173680345221201	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2288.02332418583	2288.02332418583
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTTGGGTCCTGGGAC"	0.472026576369447	11.6636380919251	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTGGGTCCTGGGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2508.02549301902	40.2314966563454	0.0160411035566935	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2502.63744876759	2502.63744876759
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTTCGGTTTGGAAA"	-1.58717868748363	12.1019429930481	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTTCGGTTTGGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2520.89602727748	40.2819784049015	0.0159792303883335	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2510.71701970067	2510.71701970067
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATAGAGATCGCGTGCA"	7.98354115065877	7.37768695438234	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGAGATCGCGTGCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2095.05195954227	41.3776485391804	0.0197501777226664	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2093.85216700854	2093.85216700854
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATTTCCACGCGCAT"	7.52409853514974	-9.37521936809691	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATTTCCACGCGCAT"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2540.94788144062	41.0606404126039	0.0161595760041029	2688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2538.44579868959	2538.44579868959
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGTTATCTTACTGT"	1.13760568675343	11.8339957960877	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGTTATCTTACTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2348.72939121782	41.3803684845201	0.0176181933258238	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2340.01720518359	2340.01720518359
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGTACATCTTAAGGC"	1.27534522589986	10.700524307135	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTACATCTTAAGGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2308.14992255485	41.7197374618211	0.0180749686379307	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2302.83134789965	2302.83134789965
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATATCCTGTCATGACT"	7.69277252730672	-9.44424250042113	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATATCCTGTCATGACT"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2616.71247308851	41.3265254724839	0.0157933001418784	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2614.95969079098	2614.95969079098
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATATCCTGTCCAAAGG"	-2.88083539429362	13.2492742308411	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATATCCTGTCCAAAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2495.48849258942	41.9611177569754	0.0168147911246967	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2489.4616069422	2489.4616069422
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGTGATCAGTGTGCC"	-7.81018624725993	3.63875529849855	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTGATCAGTGTGCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2438.25208746972	43.2109055178184	0.0177220828559447	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2428.59252982797	2428.59252982797
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGCTGTGGTAGACTGG"	-0.128181199461776	11.4627141722473	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTGTGGTAGACTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2029.39017828486	43.3840432469688	0.0213778718903798	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2024.17749233243	2024.17749233243
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGCTCAGTCATCGT"	6.312920709222	-10.0952272645203	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGCTCAGTCATCGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.71589273	39.2539779501354	0.014470360886422	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2707.84710781661	2707.84710781661
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCACGACACGTCGGT"	8.29643692550008	7.78446052158204	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACGACACGTCGGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2125.73074969113	37.2600833638304	0.0175281292653099	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2112.55592346172	2112.55592346172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGATCAGTGCCGGTT"	8.7232481437618	7.15992353046266	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATCAGTGCCGGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1991.61189335431	38.1969259788772	0.0191789003200545	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1985.83110669684	1985.83110669684
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGGATTCTGTGTGA"	-0.68890212002452	10.5900001295838	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGATTCTGTGTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2282.01673245684	44.8139439270199	0.0196378682459408	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2272.30083967676	2272.30083967676
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCATTTCGCAACAT"	-2.5399149459904	13.1837701567444	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTTCGCAACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2697.94339146551	41.429874600375	0.0153560948429946	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2691.88649837593	2691.88649837593
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTTCACGTGCATCTA"	0.102078964083832	11.6257486113342	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCACGTGCATCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2501.39317858532	39.0839217011122	0.0156248613915291	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2495.329366986	2495.329366986
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCAGGTGTGGCCCAT"	0.876696308224839	11.5698013075623	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCAGGTGTGGCCCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2285.45566864388	42.2092471246481	0.0184686352501835	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2271.44407561627	2271.44407561627
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCACAATCCAAACCA"	0.198286091058892	11.6120576628479	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAATCCAAACCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2402.89423008908	44.4775452120686	0.0185099887690103	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2390.27664986212	2390.27664986212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTACAGTCCTGTAAG"	1.40803446349446	11.5982331999573	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTACAGTCCTGTAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2258.7963029393	37.1727562173116	0.0164568873115916	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2255.47794486796	2255.47794486796
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTAGACTCTACAGGT"	6.43132271346394	-10.0362205735412	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTAGACTCTACAGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.35071437629	35.8529600354511	0.0146857064920354	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2438.97502232007	2438.97502232007
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCATTCACGTAACT"	1.82400443133656	-10.1837539902893	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCATTCACGTAACT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1995.39332867708	34.736344967506	0.0174082695718622	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1981.38902189064	1981.38902189064
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCAGACACTACCGG"	-0.947517494589645	11.5199451216492	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCAGACACTACCGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.97347089338	45.1401646540148	0.0181287733309941	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2485.16254782673	2485.16254782673
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACGCTCAAGAGATT"	8.45233311232869	8.00453517520753	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTCAAGAGATT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2097.08792745339	40.9709266026689	0.019537057109676	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2091.32448168703	2091.32448168703
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCACGGTTCTCCCA"	1.44737054881398	11.5443563231262	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCACGGTTCTCCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2190.72466625681	35.4255927031376	0.0161707188716086	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2184.35691039282	2184.35691039282
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCATTTCTGCAGCG"	-2.76028595390971	13.1533603438172	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCATTTCTGCAGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2576.19684624265	40.0359193289428	0.0155407065990841	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2570.14482129342	2570.14482129342
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTACAACCAGGCACAA"	-0.469259898096877	10.5010318526062	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTACAACCAGGCACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2451.92535789761	43.1725347871593	0.0176076056508414	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2442.23040180812	2442.23040180812
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCCAGTTTGAAAG"	-1.17721507969554	11.5911502608093	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCCAGTTTGAAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2526.17514629961	39.8158260316559	0.0157613085893822	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2518.30752661836	2518.30752661836
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGAAAGTATTTCTC"	-0.774626473814803	11.5031890639099	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAAAGTATTTCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2231.34010242321	41.4227128233223	0.0185640516111092	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2228.61437691653	2228.61437691653
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCGTCAGGGTTGCA"	-8.06070743027385	2.38058207118837	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCGTCAGGGTTGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3176.89989828354	40.8692533479494	0.0128645077454379	4237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3169.06034308984	3169.06034308984
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCTATAGGCAGCTA"	-2.29011736336406	13.6745900877747	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCTATAGGCAGCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2496.67570179858	39.9419061244727	0.0159980353458396	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2494.03449709763	2494.03449709763
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTGAGGTTTGGGTT"	-2.52003894272502	13.3486509093079	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTGAGGTTTGGGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2372.94485383327	46.4645075607277	0.0195809470606401	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2365.83091614716	2365.83091614716
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCCAGTCAAACGAA"	-2.1389630836552	12.0848579176697	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCCAGTCAAACGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2535.53325186875	40.8964623321958	0.0161293338598711	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2527.25205575996	2527.25205575996
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACTATGTCGAGTTT"	0.900314767926377	11.1089229353699	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATGTCGAGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2291.07843035775	44.7276054087513	0.0195225116766374	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2284.78847299716	2284.78847299716
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGAGTAGCGCTGCT"	-1.22405336323436	9.65573880756227	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00168293503870751	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGAGTAGCGCTGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2729.30642627048	39.7733115039398	0.0145726808544136	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2721.95272351947	2721.95272351947
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTATAGGTCCCGAGGT"	6.69638647612874	-10.0309019318786	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATAGGTCCCGAGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2415.79804082586	48.1922524529988	0.0199487919265486	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2411.52217716981	2411.52217716981
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCGTGTCTTACCGC"	0.138564345508259	11.3476037749085	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCGTGTCTTACCGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2149.6129409958	40.4563666008412	0.018820302869083	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2144.43900182382	2144.43900182382
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCTACCGTAACGCGA"	-2.28388772431071	13.7087669142517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTACCGTAACGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2726.50027632853	46.6127297350976	0.0170961764206625	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2720.68688929412	2720.68688929412
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGGCCACATGTCAGT"	1.04748066243474	10.910955406073	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGCCACATGTCAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2349.72739492801	42.0166727098726	0.0178815094893848	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2341.13452361551	2341.13452361551
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGATGTCGCTGTTC"	-1.89380631867107	11.8082856901917	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGTCGCTGTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2610.77782365366	36.6915676616271	0.0140538836086324	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2600.38672870543	2600.38672870543
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTGTTGTACGTTCA"	-1.87340162220653	11.0994300612244	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTGTTGTACGTTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2536.12004808469	40.848795444547	0.0161068067244674	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2528.78610669026	2528.78610669026
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGGAGAGTGACCTT"	-2.16711364212688	13.5058278807434	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGGAGAGTGACCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2229.00185464751	43.0194769522773	0.0192998838751887	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2227.44579664953	2227.44579664953
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGAACATCCGTGG"	0.605981608002824	9.82423493945924	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGAACATCCGTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2047.69733121246	38.9335274577758	0.0190133213851107	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2046.38901079623	2046.38901079623
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAACCAGGAGAGTA"	1.47832204875295	11.0057420500549	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAACCAGGAGAGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2047.02113270288	38.4688620985984	0.0187926062335294	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2043.24395867698	2043.24395867698
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGCGGGTTCGGCCA"	-3.49460468712505	13.0073575743469	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGCGGGTTCGGCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2894.35097088788	42.0855669459639	0.0145405886740313	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2893.21081185279	2893.21081185279
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGTGCGTCCCATGGG"	1.25821234759633	11.5660857924256	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTGCGTCCCATGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2241.88549633882	38.3306721025323	0.01709751553553	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2234.1815571567	2234.1815571567
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGAGGTGCCCGTA"	-1.50490007820781	11.749521232489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGAGGTGCCCGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2372.50050909631	41.8245351278675	0.0176288835207873	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2367.41205488752	2367.41205488752
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGGATGTCCTGTCT"	-2.17350516739543	13.4406509169373	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGATGTCCTGTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2510.34504806578	42.7631022349147	0.0170347507677734	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2505.40286195846	2505.40286195846
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGGATGTCTGTGCG"	-0.118460665375549	11.5522603758606	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGGATGTCTGTGCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2169.73078961891	40.0527318615577	0.0184597702411701	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2164.16965746398	2164.16965746398
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATGACCCAAGCGGAT"	1.23323931273763	10.418487525824	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGACCCAAGCGGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2064.12359014975	33.9995744923958	0.0164716757536448	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2060.19221448843	2060.19221448843
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGTTCCCAAGGATGC"	-0.252222190529662	11.3432502516541	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGTTCCCAAGGATGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2372.42101674302	36.5025170037201	0.0153861885163337	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2365.85509183801	2365.85509183801
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCAGTTCGTAGTGT"	-2.30217824402507	13.0637473830017	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCAGTTCGTAGTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2359.41044782469	36.4250951794956	0.0154382189894422	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2351.76790236384	2351.76790236384
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGTAGGTCTACGTA"	-0.12275324288066	11.8476962813172	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTAGGTCTACGTA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2551.13124761318	36.0465149566325	0.0141296199442335	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2539.40189224344	2539.40189224344
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGTGAAGTGGTTGG"	-2.62355099144633	13.2381648787293	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGTGAAGTGGTTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2484.93476406956	41.5859834454959	0.0167352415229568	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2475.29889432286	2475.29889432286
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCCCTCACATTCGA"	6.62821116027181	-10.4457826844421	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCCCTCACATTCGA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2466.91601448487	43.1205845898861	0.0174795511224124	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2462.91302198837	2462.91302198837
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCATGGTACTGCCG"	6.55995621260945	-10.1792059174744	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCATGGTACTGCCG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.30348687769	40.6287961415212	0.0158749426747696	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2555.95697889406	2555.95697889406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGAACACTAAACC"	-2.56872330132182	12.9478683241638	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAACACTAAACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2842.48180501389	40.2149727565719	0.0141478382326445	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2835.99754483125	2835.99754483125
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGTCCTCTAACGGT"	6.59361662444417	-9.99627497112425	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTCCTCTAACGGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.74881028816	41.0255931579241	0.0157988300583342	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2589.02430042394	2589.02430042394
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGGAAGTCCTGGTCT"	-2.58795128288921	12.8547343977722	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGAAGTCCTGGTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2620.68873205379	44.0245752367855	0.0167988569944681	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2614.40990496455	2614.40990496455
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTATTTCCGTTGGG"	6.79382242736165	-10.0666399232117	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTATTTCCGTTGGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2392.58535080634	41.0907835033392	0.0171742184618371	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2386.78968234899	2386.78968234899
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGTGATCTAGCCTC"	1.2665819126064	11.6198014982971	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTGATCTAGCCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2404.14658515035	35.9972302789399	0.0149729764820845	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2400.29776975222	2400.29776975222
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATACCCGTATACAGA"	-2.41138825836833	13.4503612288269	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACCCGTATACAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2844.29340825909	37.52161034904	0.0131918916100874	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2831.202772686	2831.202772686
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATACCCGTTTGATCG"	-1.51233420792277	13.5093097456726	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACCCGTTTGATCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2158.77607118321	35.6261444503451	0.0165029365138454	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2151.05332335919	2151.05332335919
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAATCGAAGTTCTCTT"	-3.41579876366313	12.9250144728455	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATCGAAGTTCTCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2564.06145438626	41.4846039026035	0.0161792549206015	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2556.00556661075	2556.00556661075
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGAGAACACAAATGA"	-8.02575049820598	2.89108345592348	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGAGAACACAAATGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2684.46382034653	40.1643294653204	0.0149617697064495	3228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2676.02927081447	2676.02927081447
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCAACTCTGTTCAT"	-1.3750253719395	11.7985305556091	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCAACTCTGTTCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2616.1226172825	51.5272818517138	0.0196960499906682	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2606.35138656872	2606.35138656872
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGTAGTCATGACACT"	0.266267572611016	10.5734100111756	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTAGTCATGACACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.09672007353	39.3388589967139	0.0170143656427413	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.00082792865	2308.00082792865
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTGAGAGGTGCATG"	-2.35901222649272	12.6414537199768	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGAGAGGTGCATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2668.57171859919	47.3642213194596	0.0177489032763648	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2654.29289445234	2654.29289445234
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGTCGGTGTAT"	1.32550682601277	11.6305351027283	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGTCGGTGTAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2192.73211781357	37.2234564838876	0.016975834020712	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2184.31477201038	2184.31477201038
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGTCGTTAGTG"	1.3620420890743	9.45288083637086	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGTCGTTAGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2025.76291697459	39.1743006786523	0.0193380480758122	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2020.86182597651	2020.86182597651
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTGAGCAGGCGTTC"	7.47502865371053	-9.22158815776976	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGAGCAGGCGTTC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2493.16333728677	41.6739073148729	0.0167152736010571	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2489.64657363476	2489.64657363476
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAAGCTTCCGCGATG"	-1.58755097809489	11.6898040541443	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAGCTTCCGCGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2262.74534718561	45.5397993142415	0.0201259056264921	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2258.3494807404	2258.3494807404
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAAAGAAACTGT"	-0.220408718020278	10.6920280226502	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAAGAAACTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.26047612325	40.3516945108748	0.0167346891430622	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2403.08420206739	2403.08420206739
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTGGAGTAGGCAGT"	8.44660152968709	7.93517825687257	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGGAGTAGGCAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2136.96389782191	45.7640049085632	0.021415431938372	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2128.49090458447	2128.49090458447
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAATGGAAGGTGCAGT"	-7.85173259201701	2.91366407955018	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAATGGAAGGTGCAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2440.86534714005	47.7240821348676	0.0195521158882384	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2433.60392359983	2433.60392359983
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTACGATCACACCGG"	-1.43833265724834	11.4275636442932	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTACGATCACACCGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.28431502498	41.0537159996152	0.0171608849925459	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2385.20571148573	2385.20571148573
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATCCACAGGTGCTGA"	8.11618771132771	7.97532270038453	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCACAGGTGCTGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2320.00602918543	42.7337373233397	0.0184196664947219	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2314.9756868525	2314.9756868525
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCGCGAAGATGACCG"	6.39983238753621	-10.0346727601257	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCGCGAAGATGACCG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2149.40756509927	41.5106436540086	0.0193125977260117	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2144.86512544063	2144.86512544063
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATCCCAAGTTGCTGT"	1.38702716407124	11.4322585829529	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCCAAGTTGCTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2422.31140516826	36.3524216213416	0.0150073279363586	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.35585480164	2416.35585480164
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTTACAAATCAAG"	-0.471689562231857	11.2379178770813	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTTACAAATCAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2276.8335663163	39.9404224270547	0.0175420913579004	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.18920928293	2274.18920928293
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGACTAGAGCAGAA"	-7.43406997147258	2.74240825260011	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTAGAGCAGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2830.12921800361	36.3229076665199	0.0128343636875147	2610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2821.96854310444	2821.96854310444
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAGTCGTGCAACAG"	-2.58918676796611	12.6557149657044	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGTCGTGCAACAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2425.79810367246	43.3562560250555	0.0178729861975808	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2421.52590455212	2421.52590455212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACAGGAGATACCAA"	-0.153332660824615	11.5471944578919	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACAGGAGATACCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.57480958834	37.6255165147358	0.01553120934215	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.12610523245	2415.12610523245
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCTAGACAGTCTGGC"	-1.5215849680012	11.4480905302796	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCTAGACAGTCTGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2333.67468972731	44.110858655894	0.0189018884466062	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2332.38496077334	2332.38496077334
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATCCGTTCGCTACAA"	-1.58205805245097	11.4978112944397	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCCGTTCGCTACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2542.00877734005	40.7246708497071	0.0160206649216692	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2535.96630513757	2535.96630513757
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATCGGGGTCAAGTTC"	1.14570858058278	11.0147828825745	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATCGGGGTCAAGTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2179.8207296336	38.3521227012097	0.0175941636758616	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2172.65784387319	2172.65784387319
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGAGTCACAGAGAC"	-0.0335324731772721	11.0075979002747	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGAGTCACAGAGAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2296.69758104561	41.5470249569383	0.0180898979908462	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2292.23899514337	2292.23899514337
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCCTCCATCGTCCT"	1.32810427722279	11.7689962157044	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCTCCATCGTCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2348.09213388193	33.6601436254511	0.014335103439831	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2342.95936054556	2342.95936054556
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGAGGATCGAGAAGC"	6.64177002486531	-10.0908117524353	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGAGGATCGAGAAGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.61206581792	43.3044144989366	0.0179640743996042	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2406.65167044705	2406.65167044705
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGAGCCGTTACCCAA"	0.99944301423375	10.611205078009	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGAGCCGTTACCCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1884.69582791089	38.8634168602985	0.0206205246940972	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1881.87547064279	1881.87547064279
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGCATGGTAGCACAG"	1.41195430335347	11.6003684767517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCATGGTAGCACAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2254.12608808673	36.7900351117036	0.0163211966296573	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2248.37159877296	2248.37159877296
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACCGCTCTCCGAAA"	1.23143996772115	11.815535522345	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCGCTCTCCGAAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2654.50912840335	41.3290803404814	0.0155693871602318	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2637.71364376377	2637.71364376377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACGCCTCCCGAAAT"	-2.36360917511638	13.2556991347107	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACGCCTCCCGAAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2902.17468736431	35.5743015033365	0.0122578084834874	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2893.89667723018	2893.89667723018
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGTTGTCGCTCTCA"	6.87779583510701	-9.88666155254515	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGTTGTCGCTCTCA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2300.52196087377	43.9892301885066	0.0191214128518029	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2296.67128564449	2296.67128564449
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGAGGGTTATCTTC"	-7.5457652610844	3.06481144512025	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGAGGGTTATCTTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2423.7722739371	44.2836563073184	0.0182705515627445	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2418.52103926157	2418.52103926157
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACGTTGTCGGAACA"	-2.14692626419719	12.3837728270325	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACGTTGTCGGAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2449.62684752298	41.0172221848965	0.0167442736130903	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2438.29863866988	2438.29863866988
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGCTCAGGCACTCC"	0.0385493143344342	11.2291898497376	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCTCAGGCACTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2401.50480990207	41.9923771938705	0.0174858601243371	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.54229993274	2395.54229993274
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGCTCTCGTCCATC"	-0.2249892455643	11.0045709379944	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGCTCTCGTCCATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2363.57914716138	48.1775613717964	0.0203833078446545	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2352.72518835852	2352.72518835852
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGGATTCACCCATC"	-1.30427883091624	11.6421298750672	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGGATTCACCCATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.49973298906	47.1342105456854	0.0194327832341584	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2412.89622488015	2412.89622488015
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTGCTCACCCTGTT"	-8.00837359848674	2.08043406093446	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGCTCACCCTGTT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2355.87508694136	38.2519053941527	0.0162368139152128	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2354.04910120793	2354.04910120793
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGGTACATGACGAG"	-1.87397525730785	11.2344789274964	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGGTACATGACGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2272.43751893788	40.2706279646157	0.0177213356270574	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2268.49528837551	2268.49528837551
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTTGAGTCCTGTA"	8.90730537947957	-8.93412306224974	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.555555555555556	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTTGAGTCCTGTA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2562.67595648868	37.8781698502743	0.0147807098881803	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2544.99051085477	2544.99051085477
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACGTGTCCACATAG"	-2.81029425087627	13.1839332350525	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGTGTCCACATAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2361.48965418346	47.4469083550355	0.0200919399629728	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2357.1128589063	2357.1128589063
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCTCGACACGGTCTG"	-0.0826998305624307	11.7483882674011	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTCGACACGGTCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2617.39418616633	38.8093448484479	0.0148274742312665	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2614.41573499785	2614.41573499785
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAGGGTAGGAGTACC"	1.21057822284047	11.3718471297058	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGGTAGGAGTACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2380.53832466908	33.4703696264307	0.0140600003283222	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2374.31825379412	2374.31825379412
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCCAATGCAGG"	6.68653215941731	-9.99869825756224	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCCAATGCAGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2834.35279754874	40.126867379604	0.0141573298194591	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2830.00806442309	2830.00806442309
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAGGGTGTTGATCGT"	-2.16230736199077	13.5150995024475	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGGTGTTGATCGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2451.71014791825	41.6267881999356	0.0169786743491195	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2450.33619823808	2450.33619823808
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCTGGTGTAGGTACG"	1.0888098674709	11.2324037321839	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTGGTGTAGGTACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.36845719222	39.0176218865362	0.016961466222746	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2293.03787934331	2293.03787934331
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTGAGGTCAAAGAT"	-3.49688444557841	13.242932296637	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGAGGTCAAAGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2315.09222697561	45.2588281491412	0.0195494709116908	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2308.53452506975	2308.53452506975
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGTCCCCATGCTGCG"	-2.72945342484172	13.5063247450623	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCCCCATGCTGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2726.10350920535	42.1654828649295	0.0154673080910345	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2717.4895158709	2717.4895158709
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCTCCATAAGC"	-7.38579163971599	3.18790385806886	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCTCCATAAGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2620.65731723031	36.2955643983873	0.0138497941565084	2459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2609.86988510845	2609.86988510845
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGAATGGTAGCTTGT"	-2.28838763657268	13.1631221541199	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAATGGTAGCTTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2680.58826119586	44.3784256848076	0.0165554801262204	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2677.30329259952	2677.30329259952
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCAATCAGATAGCAT"	-1.39244399491008	11.8447475203308	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCAATCAGATAGCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2652.00431120565	43.504581592444	0.0164044158633611	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2642.56039465438	2642.56039465438
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTGCCCAGAGAGGG"	-1.64357624474223	11.2542810210022	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGCCCAGAGAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2293.23092970265	49.6298659587807	0.0216418962939838	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2287.88133391099	2287.88133391099
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGTCTTTCGGTGAAG"	-7.27634416046794	2.91053364360658	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGTCTTTCGGTGAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2710.99554922101	40.9200809045105	0.0150941158558038	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2698.74380273023	2698.74380273023
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCACCCATCCTAAG"	8.02080692824666	8.19310376727907	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCCATCCTAAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2131.16414885473	40.2431561239939	0.0188831799491467	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2128.15092880589	2128.15092880589
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCACCGGTAGCCAGA"	8.3050295310909	8.13365838611452	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACCGGTAGCCAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2206.18132348224	40.9761559941015	0.018573340077698	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2198.4820254048	2198.4820254048
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTACTCAGACAGCGT"	-2.1571835083073	11.7587957152161	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTACTCAGACAGCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2529.80589528532	36.1211591282507	0.0142782334390034	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2524.84316192888	2524.84316192888
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTTCACATCTATCT"	1.30915381488149	11.3987893828186	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTTCACATCTATCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.08340954268	39.2714003626342	0.0179972040440309	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2178.96642496504	2178.96642496504
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTTCAGTTGAGTCT"	6.28868021544759	-10.0392961732117	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTTCAGTTGAGTCT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2344.60973629979	38.2044868517954	0.0162946038567974	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2339.9821478126	2339.9821478126
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCATTTCTCGAACA"	-0.279437283903915	11.4189014204773	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCATTTCTCGAACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2318.39949668713	42.9951568892	0.0185451890196827	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2311.98146000263	2311.98146000263
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTATCCCAGATTAAG"	-8.0242808860844	1.93371484363405	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTATCCCAGATTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2664.06217144462	38.0402337590029	0.0142790337878545	4326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2657.22253273034	2657.22253273034
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCAAGCGCAAGCTCTA"	1.33317353305165	10.1603994139465	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCAAGCGCAAGCTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.16569698754	35.8191135697753	0.0164900466016248	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2162.36641905965	2162.36641905965
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTATCCGTTGTTGAC"	-7.72133288803752	3.38596723163453	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTATCCGTTGTTGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2452.46785514975	45.7699410293877	0.0186628097625333	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2445.98043433689	2445.98043433689
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTATCCTCGGACGTC"	-1.67834566059764	11.3407382735047	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTATCCTCGGACGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.48885154094	41.7547652146917	0.0171795748777942	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2427.85549138926	2427.85549138926
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTCGCCACTGGCCA"	-2.26977239075359	13.5484285124573	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCGCCACTGGCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2654.1975496514	41.4889804569247	0.0156314591061143	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2650.58002144284	2650.58002144284
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGTCGATACTG"	-2.89504752579387	12.6894931563172	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGTCGATACTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.61820114927	47.601963764863	0.0183889473324915	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2579.15049567249	2579.15049567249
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACAAACATCGTGCG"	-2.71687326851543	13.0797462233338	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAACATCGTGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2478.69393688034	42.6778396506245	0.0172178739035197	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2473.45689861155	2473.45689861155
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCATGTGTGGTTCTA"	1.11531140384023	11.097141242865	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCATGTGTGGTTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2554.77874856738	39.0566163716861	0.0152876707595863	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2544.45340683838	2544.45340683838
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGATCAAGCGGTATG"	-2.36075315895732	13.3995370634827	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATCAAGCGGTATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2528.93277029578	41.9997950774582	0.0166077151479776	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2523.32951143834	2523.32951143834
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAAGTGTCCTCACGT"	0.00761210274640915	10.9475030669006	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAAGTGTCCTCACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2193.68573845795	44.8086692083665	0.020426202542514	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2186.18221699573	2186.18221699573
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCACGAAGCGGGTTA"	-7.86634431305583	3.71459887111513	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACGAAGCGGGTTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2168.74682847519	40.7281366694754	0.0187795717484049	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2164.47892091249	2164.47892091249
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCATGATTCCTCACGT"	-1.28053436699565	10.827856994513	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATTCCTCACGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2540.39526767763	39.8581328174533	0.0156897366817608	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2535.56799587078	2535.56799587078
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACACTCACAGTCCG"	8.51965775069539	7.86356780612794	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACACTCACAGTCCG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2034.74583672036	44.1425431916074	0.0216943769560709	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2033.52327219359	2033.52327219359
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTCCTTCAACTTTC"	1.18957354602162	11.4365424879822	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTCCTTCAACTTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2270.70314666332	44.0884826467113	0.0194162247546523	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2263.66072150918	2263.66072150918
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACCATCACGCCAGT"	-1.94506655159648	13.3646964796814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACCATCACGCCAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2934.5705358489	36.2935935171347	0.0123675996449122	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2924.73837728004	2924.73837728004
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACCTGCAGGAATAT"	6.80626120147054	-1.18911340152892	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACCTGCAGGAATAT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2790.50716589977	46.2019473986013	0.0165568280788499	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2778.14015436085	2778.14015436085
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACGAGAGTCAGGGT"	0.938986082642716	10.9894189604553	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACGAGAGTCAGGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2344.02241114673	38.8614547777368	0.01657896041989	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2338.94536329582	2338.94536329582
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACGTTAGACCGCCT"	-1.28465590897258	11.2390098341736	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACGTTAGACCGCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2577.22507498991	41.7765529647978	0.0162098969819162	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2566.32903857035	2566.32903857035
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCATCTCGGTAACT"	4.06977524337117	-10.7831831208435	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCTCGGTAACT"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2653.71420620072	46.2934758003635	0.0174447857618553	2609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2647.72023063152	2647.72023063152
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACAATCACCATCC"	1.08232237872426	9.96737382495729	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAATCACCATCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2464.37040278342	36.414903522259	0.0147765544826904	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2462.82499221866	2462.82499221866
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGCATCACTTATC"	1.24165417727773	11.4170703657898	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGCATCACTTATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2271.00183503775	41.8525102362004	0.0184290957367301	2323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2264.97449740001	2264.97449740001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCCATTCGCTAAAC"	-2.14946470680888	13.1800699003967	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCATTCGCTAAAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2878.15596381095	40.6258388466489	0.0141152318906501	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2862.68057728851	2862.68057728851
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACTTGGTTGTGTAC"	-7.96371779862102	2.73528239810792	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGGTTGTGTAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2281.52061520879	40.3998617895748	0.0177074278971079	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2275.86105904638	2275.86105904638
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGCACTACCCT"	0.0362365088308274	11.9147281416687	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGCACTACCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.92229973063	47.8302077083561	0.0191864013224658	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2487.06713241051	2487.06713241051
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCCCGCACGCTGAC"	-3.21073041382487	12.9689779051575	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCCGCACGCTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2734.55013348644	42.3556412982918	0.0154890710466844	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2729.6485592012	2729.6485592012
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACCTTCGGAGTAG"	-2.62673697891887	13.2273988493714	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACCTTCGGAGTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2672.13742744052	35.0248320478248	0.0131074216797948	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2665.05365387779	2665.05365387779
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCATAAGCACTCTGCT"	-2.42705617371257	13.0489358671936	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATAAGCACTCTGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2064.71737015705	45.2476939513521	0.0219147155951472	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2060.18734286177	2060.18734286177
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCGTGGTTAGGACG"	1.07694234427754	10.7913818129334	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCGTGGTTAGGACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2137.75959651609	33.5672123051685	0.0157020519799668	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2130.56886697652	2130.56886697652
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCATCACAGCGTGTTT"	1.37716593322102	10.9929122694763	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACAGCGTGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2092.6611085228	38.2134078147697	0.0182606766375777	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2087.48524235916	2087.48524235916
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCTACCAACACGAG"	1.16963316973988	11.2750825651917	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCTACCAACACGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2603.06965455745	37.4914971472792	0.0144028021231161	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2588.84380450542	2588.84380450542
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCGTTTCACCATAG"	1.21550454673116	11.4285630949768	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCGTTTCACCATAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2370.78421224087	34.7905991604826	0.0146747219678836	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2360.95880184853	2360.95880184853
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGGTAGCGTTT"	-7.87926898422893	2.70679328525392	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGGTAGCGTTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2543.32080849801	45.1598841801903	0.017756267329429	2854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2539.59904763004	2539.59904763004
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCATCACTCTGGCTGG"	1.4665136533672	10.9665546187195	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACTCTGGCTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2363.5567584438	35.5288645332126	0.0150319489499399	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2359.08599373424	2359.08599373424
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCTACCAGACGCTC"	6.75170912322347	-1.03159644519957	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCTACCAGACGCTC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3006.50513165166	39.753868796016	0.0132226179751028	3915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2994.7864257384	2994.7864257384
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCTACCAGGCATTT"	0.491817970841569	11.2268810042175	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCTACCAGGCATTT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2284.40474776095	38.645037447976	0.0169168959598135	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2282.04989771874	2282.04989771874
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTCTAGGCGAACT"	1.2127911048824	10.9082956084046	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTCTAGGCGAACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2214.74362137699	37.5128997310407	0.0169378068725253	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2201.05609889079	2201.05609889079
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTATTAGGCTTAGG"	1.32648005065266	10.7276334532532	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTATTAGGCTTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2218.18562188078	37.6346276590804	0.0169664014083593	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2212.379136447	2212.379136447
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCAACTGTCCGGTGT"	1.1983491378719	11.5655870207581	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCAACTGTCCGGTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2090.13784547321	39.6455792420855	0.0189679256456455	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2082.79362985908	2082.79362985908
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCCAGAAGCGCCTAC"	0.054591755231288	11.2955932387146	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCCAGAAGCGCCTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2255.94104636481	39.3410198480596	0.0174388510335645	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2252.43270555618	2252.43270555618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCATTCTGTCTCG"	-1.69681153717693	11.0550231703552	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCATTCTGTCTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2618.09630449467	42.4667487048939	0.0162204685259241	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2612.80173351877	2612.80173351877
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTTCCATTGACAC"	1.64469923552815	-4.7731971970764	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTTCCATTGACAC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	3076.21332883622	38.3559753884363	0.0124685681025077	3780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	3069.81628673167	3069.81628673167
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTTCGTCACAGTT"	8.3067099052364	8.09206388080446	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTTCGTCACAGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2227.72919675381	41.1124532017449	0.0184548702156676	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2220.09917311116	2220.09917311116
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCGAAGGTAGGATAT"	-0.834625403315383	11.2995357283386	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGAAGGTAGGATAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2249.85808699483	46.8138243918826	0.0208074565513652	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2239.80641195348	2239.80641195348
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCATTTCCTAGCCT"	-7.22271953049357	2.85901448810426	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCATTTCCTAGCCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2664.04743734411	38.3601802939183	0.0143992106732758	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2653.01295280084	2653.01295280084
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCGCTGGTAAGCAAT"	6.71622004088704	-10.203694366571	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGCTGGTAAGCAAT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2521.57411596513	40.739978364778	0.0161565658954208	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2518.43627641405	2518.43627641405
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTTACCAGGTATTGA"	6.56559576567952	-10.0623302689758	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTACCAGGTATTGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2265.34123860607	48.0254767061539	0.0212001070248054	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2262.43358802552	2262.43358802552
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTTACCGTAGGGAGG"	0.439884920685929	11.5142888792786	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTACCGTAGGGAGG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2422.98024678124	37.6832018990447	0.0155524181218994	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2411.69199934237	2411.69199934237
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCGGTCAGTCTAGCT"	-0.224061678082305	11.5837173231873	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCGGTCAGTCTAGCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2389.36392660352	44.7699856439618	0.0187371982750247	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2384.33363785015	2384.33363785015
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTTCTGAGCTCACTA"	-7.43435893479045	3.04327509487001	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTCTGAGCTCACTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2698.96832314895	38.8535485647586	0.0143957038070855	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2691.98234708011	2691.98234708011
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCGGAACAGTCACGC"	1.48256434974019	-7.3826098672119	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCGGAACAGTCACGC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1423.41341757193	35.7669800824913	0.0251276120071306	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1418.16738499187	1418.16738499187
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTAACCAGTAACAA"	-1.49893532219585	11.316530204657	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAACCAGTAACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2508.86209958878	44.1007672909223	0.0175779957368525	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2501.7679397962	2501.7679397962
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAAGAATCTCCCTAG"	1.14797391471211	10.2595147856506	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAAGAATCTCCCTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2399.2253226593	38.4591283055218	0.0160298109320111	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2392.48094238771	2392.48094238771
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTAACTCCTCTTTC"	-1.08412442627605	11.7490577467713	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAACTCCTCTTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2453.40542511301	43.9333545008339	0.0179070911196058	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2447.78302727468	2447.78302727468
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACAACCAACAAGTA"	-1.83934603157695	13.4024448164734	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAACCAACAAGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2683.33404783503	38.3169414541394	0.0142796017085738	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2675.05893134519	2675.05893134519
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCAATTCACTACTT"	1.09744920310323	11.4564609297547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATTCACTACTT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2453.24189464848	37.8744038864287	0.0154385117786584	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2450.2347764956	2450.2347764956
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCAATTCACTGGGC"	-1.66208539429362	10.8070049055847	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATTCACTGGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2549.99701629154	46.1105946637395	0.0180826073007717	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2542.74708717454	2542.74708717454
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCCTTAGGTTTGAA"	-2.54856000366862	12.9125556715759	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCCTTAGGTTTGAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2540.88608885918	42.7868175940928	0.0168393293118084	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2534.32422389708	2534.32422389708
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACAGTCAGCAGTTT"	-1.4559215110844	11.7580775984558	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAGTCAGCAGTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.83355739119	42.4265227529892	0.0172969432129401	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2447.27259098116	2447.27259098116
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCTTCAAGATCCCGC"	-2.19942675057109	12.6958913573059	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCTTCAAGATCCCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2717.72468596454	43.2810561912347	0.0159254748704885	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2708.87881825564	2708.87881825564
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCTAAGTACGAGTG"	-2.21008024635966	13.4132442244324	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCTAAGTACGAGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2580.16559864373	37.9621930240959	0.0147130839369577	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2575.96653464352	2575.96653464352
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCCAGGCGATA"	-1.5302998823231	11.8169860609802	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCCAGGCGATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.5731572452	36.7974354258561	0.015034253549043	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2433.73312460648	2433.73312460648
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTCTCCATATGCGT"	-1.34863183918651	11.7676381834778	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCTCCATATGCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2498.26073706488	39.3615409148587	0.0157555776028019	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2491.31217486576	2491.31217486576
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATACTTCATTACGGT"	-6.92062745514567	0.127512841764368	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACTTCATTACGGT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2825.39429725485	40.0542149922046	0.014176504508104	2757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2815.7650733194	2815.7650733194
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCTTCATCGCTAAAC"	6.65100159224812	-10.0131006470886	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCTTCATCGCTAAAC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2551.37616613915	44.9868635888973	0.0176323915641861	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2544.10454934369	2544.10454934369
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATGCTATCAGCTTCC"	-7.6108869117802	3.22488591754762	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATGCTATCAGCTTCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2709.1566457128	42.6398670687739	0.0157391663329069	3069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2703.76282791114	2703.76282791114
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTGATTAGCCTGGAA"	-0.126280899078208	11.366711593512	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTGATTAGCCTGGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2627.37336136771	42.1389605552386	0.0160384363999575	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2620.61668587992	2620.61668587992
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTGATTTCGTTCATT"	6.67322029647176	-1.01578595554503	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTGATTTCGTTCATT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3001.26656772508	36.391054939653	0.0121252325038349	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2997.34660768685	2997.34660768685
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCTCTCCTTTAGT"	0.572166045277756	11.4973764189514	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCTCCTTTAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2582.57050233491	41.4993983339078	0.0160690282400376	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2572.21873256525	2572.21873256525
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTGATTCCACGGGT"	-2.32939682427104	13.5143327482971	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTGATTCCACGGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2577.39715433401	39.791575675933	0.0154386667219764	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2573.3665602635	2573.3665602635
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCTCTCTTCGTGC"	8.10241665419881	8.3106536635193	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCTCTTCGTGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2377.52719124656	44.3387396428124	0.0186490988645919	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2364.02598595344	2364.02598595344
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGAGCTTTCTT"	-1.0822733444279	11.8141107329163	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGAGCTTTCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2366.60998321215	48.1094802204087	0.0203284362703104	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2357.68637049653	2357.68637049653
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGGTTGCATCTCCCA"	2.20628704604451	-9.09275247966918	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGTTGCATCTCCCA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1678.52327501548	23.7625771633723	0.0141568350687024	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1671.6490824939	1671.6490824939
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGAGTGAGTCTAGAA"	-6.9933594268864	0.00764115834561726	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAGTGAGTCTAGAA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2425.62620066221	36.8206050669466	0.0151798348224035	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2416.87099199287	2416.87099199287
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCCAAGTAGATCCT"	6.82320942458455	-1.10889222538146	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCCAAGTAGATCCT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2533.12494133106	43.5010031511226	0.0171728612518672	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2524.78637499411	2524.78637499411
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACGGCCAGAATGTA"	-2.2684317630833	13.699041343573	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCCAGAATGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2677.98928266088	36.3544218939268	0.0135752678807604	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2672.01604555602	2672.01604555602
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGATGGCAGGACATG"	-7.64077029648479	2.93198940837709	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGATGGCAGGACATG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2525.69508813605	46.1862754227004	0.0182865602580656	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2518.76794899598	2518.76794899598
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGAACGAGGTTGAGC"	-0.904693464667159	11.2112922438416	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGAACGAGGTTGAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2400.60101196332	42.5114488845746	0.0177086690677543	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2391.56382582192	2391.56382582192
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAACCTGTCACTCAA"	6.14514889296834	-10.2944927445618	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAACCTGTCACTCAA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2687.3207814457	34.8798124737734	0.012979400417917	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2683.15497938731	2683.15497938731
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCCAATTCGATAACC"	0.990429480641526	11.5975818403992	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATTCGATAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2129.69933165219	38.0407131538482	0.0178620111245172	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2126.06888085595	2126.06888085595
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCCTGCATCGAAGG"	1.11496641215627	11.4790563353333	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCCTGCATCGAAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.42823122001	37.9428952328683	0.017274816765487	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2192.77873788368	2192.77873788368
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACGGCTCCCGTTGT"	-2.95323739472087	13.1966275938782	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGGCTCCCGTTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2486.56611581499	40.8217099214931	0.016416901067645	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2481.54496439997	2481.54496439997
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCCACGTCAACTCTT"	-2.0992628139561	13.4219741591248	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCACGTCAACTCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2756.71045958069	39.9224524243085	0.0144819171290049	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2747.76551943221	2747.76551943221
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGCAAGCATAACTCG"	-0.579090575606185	11.6120233305725	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGCAAGCATAACTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.47745800023	42.793495356514	0.0177752423867181	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2397.51608204982	2397.51608204982
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGACTTCCTAACAG"	7.09462656554524	-9.85208036815795	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTTCCTAACAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2498.29814124648	42.8408447505632	0.0171480112974781	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2490.38281086358	2490.38281086358
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCTGCAGTGCGTCC"	7.01416887816731	-9.74508478557738	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCTGCAGTGCGTCC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.99304696653	35.3040980176639	0.014808809137504	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2382.15755891243	2382.15755891243
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCTAAGTGCCGAAA"	-0.0876796943252862	11.435447669867	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTAAGTGCCGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2284.08732705084	41.5148551850049	0.0181756864955807	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2279.48234021002	2279.48234021002
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGACTTCTTCCAGC"	-2.69304333153422	13.3685836561951	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGACTTCTTCCAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2837.16298864913	40.7535109199519	0.0143641768495493	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2830.75995890815	2830.75995890815
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAAGCACCAAAGCTCT"	-1.95369062843974	12.7056112059387	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCACCAAAGCTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2497.02582608501	46.2115886947347	0.0185066522788785	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2492.95099769399	2492.95099769399
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGCATAGAACTTCC"	-2.31248102608379	13.2949008711609	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATAGAACTTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2872.92428901756	33.1240103099595	0.0115297191912032	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2860.27226274735	2860.27226274735
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGTGACACGAGGAT"	6.42616476592366	-10.1074724427429	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTGACACGAGGAT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2584.73776338785	40.2291729011654	0.0155641216184487	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2579.70648782833	2579.70648782833
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGGGAAGAGCCGAT"	0.488322545855683	10.7730130919251	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGGGAAGAGCCGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2245.39470792804	38.5808231647876	0.017182200986119	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2242.98866226838	2242.98866226838
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAAGCCATCGATCCCT"	-7.8898323577946	2.23085210407106	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCCATCGATCCCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2784.43215577926	36.1502086028908	0.0129829733965178	3244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2778.92238586739	2778.92238586739
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGAGGAGACCT"	1.30745758590047	10.8209533461365	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGAGGAGACCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2424.4760207659	38.4412474199928	0.0158554867487817	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2417.18627373822	2417.18627373822
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTCCCATCGTGGACC"	0.752767046063584	10.5946874388489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTCCCATCGTGGACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2129.20134512724	40.0230879136053	0.0187972302409069	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2115.98244180305	2115.98244180305
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCGTACGAAAT"	1.32593121108357	10.84179112995	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCGTACGAAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2136.20908692486	37.4380270723659	0.0175254507161839	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2132.21168486235	2132.21168486235
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTTCGCAGTTGCCCG"	1.41736020621602	11.1811475523743	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTCGCAGTTGCCCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2304.82576500816	32.2712703655263	0.0140016095166361	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.68826848097	2297.68826848097
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGGATCATCATCCC"	-0.0670461160248101	11.3658542403015	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGATCATCATCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2434.27527046473	45.2767236438615	0.0185996728444017	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2422.03637702129	2422.03637702129
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGGTGATCTATCGCC"	-1.76949439469035	11.3527440794739	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGTGATCTATCGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2343.22393492512	42.0637589438483	0.0179512330498589	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2342.13233673526	2342.13233673526
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTAGGAGTAAGCAT"	1.16499807414357	11.295588470343	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTAGGAGTAAGCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2340.1523416455	39.3743102680296	0.0168255329225033	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2335.65567729073	2335.65567729073
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATACGTCTGCAGCG"	-2.38404450836833	-5.71755173122557	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"DC precursor"	"DC precursor"	63	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00245700245700246	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATACGTCTGCAGCG"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2950.70381187653	35.2199761219188	0.0119361272318011	2842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2948.79798931092	2948.79798931092
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTAGGTCTTCTGTA"	1.39899041232411	10.5982007750305	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTAGGTCTTCTGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2213.45047686458	32.1424425649785	0.014521419340951	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2206.85983781639	2206.85983781639
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGGCGGTAGTCGGA"	1.02589406546895	10.7259549864563	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGCGGTAGTCGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2263.61884043725	35.02251718707	0.0154719145120319	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2259.57789408122	2259.57789408122
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTGAGAGCAGCGAT"	-2.57610760155376	13.1748237379822	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTGAGAGCAGCGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1972.28754818285	48.2608571813437	0.0244694832788497	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1970.47277668853	1970.47277668853
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTGAGAGGTCTTTG"	-2.32004723969157	13.4760379561218	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTGAGAGGTCTTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2328.98035517232	36.7438186907318	0.015776783436206	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2325.89217006669	2325.89217006669
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACAACGAGTTCCTGA"	0.564753552048844	11.6126031645569	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAACGAGTTCCTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2484.52357878498	38.8563562433587	0.0156393590204368	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2474.99408509101	2474.99408509101
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTCACCACATA"	-2.86556635323222	13.3812675246033	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTCACCACATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2674.49892564828	39.6498657692401	0.0148251567383334	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2670.77730556317	2670.77730556317
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATTTCGTATGGAAT"	-1.74579189243968	13.6591663130554	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATTTCGTATGGAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2795.61897230699	39.7079598544123	0.014203637994932	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2784.20179668801	2784.20179668801
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTTCATCGGATTAC"	-2.85658154907878	13.3683547743591	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTTCATCGGATTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2556.60933056404	38.7419091918611	0.0151536289603206	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2549.70606910576	2549.70606910576
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCATTCGCTGACG"	8.33344234999959	7.50347468936769	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATTCGCTGACG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1928.30701734203	41.5226128927675	0.0215331959689708	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1923.37763954532	1923.37763954532
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTTCGGCCTTT"	0.416879137128037	11.6350173720154	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTTCGGCCTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2442.79340176885	44.6190116946786	0.0182655691072235	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.69322680415	2437.69322680415
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTAAGAAGTATGAGT"	6.27104725417439	-10.0482664338318	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTAAGAAGTATGAGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2701.10373354637	35.9993084337479	0.0133276289935312	2531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2694.05808979795	2694.05808979795
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCCGGTTGGTAGG"	1.41877069052998	11.1134509810242	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCCGGTTGGTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2086.06268930079	43.6706755370825	0.0209344981630059	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2077.28293921702	2077.28293921702
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGTGTTGTCTGGTTA"	-2.76743302765544	13.4351529845032	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGTGTTGTCTGGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.95912569328	37.5958149729274	0.0143169840707257	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2619.96606328437	2619.96606328437
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTACGTGTCCTCCTA"	-2.48944411698039	13.1814851530823	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTACGTGTCCTCCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2597.95937413073	39.0525850256407	0.0150320229848504	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2597.95937413073	2597.95937413073
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTATCGAGACGAAGA"	0.0936060148173987	11.3173818358215	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTATCGAGACGAAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2268.24179122342	44.2236354227258	0.0194968788573783	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2266.95807710227	2266.95807710227
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCAGCAGCTGTTAC"	8.49153389510457	7.92895743930665	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCAGCAGCTGTTAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2143.99624690452	40.95152608361	0.0191005586613015	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2136.86295185901	2136.86295185901
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCTACATCCTGTC"	-2.05288420143779	13.4178571471008	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCTACATCCTGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2491.84559374103	41.6969734596136	0.0167333696615662	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2484.55656552778	2484.55656552778
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCCACGTACAACGG"	-2.63522372666057	12.9195165404114	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCACGTACAACGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2622.249823198	45.1501533786872	0.0172180975966752	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2615.24101857344	2615.24101857344
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACAGGCCAGGAGGTT"	0.54954152283017	11.0510120161804	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGGCCAGGAGGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2167.95490718777	48.9945285005682	0.0225994223118427	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2159.90732373651	2159.90732373651
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACTTCTCAAGGGCAT"	-2.18906054917033	13.2559060820374	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACTTCTCAAGGGCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2571.35056906342	40.2450605365985	0.0156513316467996	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2567.49586110595	2567.49586110595
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACAGGTCTGGGCAC"	-9.01727137985881	2.15890381419984	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAGGTCTGGGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2736.81625977812	42.5883243407065	0.0155612654625777	3524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2731.74445173338	2731.74445173338
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACATGACATGTCTAG"	-7.59096513214763	3.11490223491517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACATGACATGTCTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3035.28806277862	41.4692701824355	0.0136623837094635	3271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3026.50028315842	3026.50028315842
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCAGTAGGTGATCG"	-0.610996941954452	11.7070178755554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCAGTAGGTGATCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2498.91765990281	43.7085512633236	0.0174909929865491	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2493.62240272125	2493.62240272125
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCAGTGTGTTAACC"	-2.9978805584019	12.1519174345764	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCAGTGTGTTAACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2468.84713834374	40.6593819044134	0.0164689750422095	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2459.74714226551	2459.74714226551
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCAGTTCACCGGGT"	-2.15062461319621	13.515767074469	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCAGTTCACCGGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2724.25579999282	37.2550545145255	0.0136753143792972	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2719.69854539537	2719.69854539537
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGATGTTTCGTCAGAT"	6.46423162993733	-10.0350055924621	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGATGTTTCGTCAGAT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2314.63651334818	40.9828121609007	0.0177059386752774	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2309.30218968137	2309.30218968137
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACCGTTTCGAAGCAG"	1.02491946992223	10.9176873930725	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACCGTTTCGAAGCAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2748.37552035343	42.1854098422767	0.0153492161205292	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2738.63290141557	2738.63290141557
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGCCACACATGACT"	1.46869482573811	11.0223626860413	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCACACATGACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.63239516518	39.8979610741113	0.017342171290797	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2293.53076142832	2293.53076142832
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTACTGGTTCAGCGC"	1.36944438990895	11.3907327421936	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTACTGGTTCAGCGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2156.60247489012	37.5010100468707	0.017388930265779	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2149.15872135437	2149.15872135437
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGTGATTCAATGCAC"	-2.28556428375896	13.5224437483582	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGTGATTCAATGCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2742.46148407615	38.1510779062891	0.0139112538600122	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2737.40897743603	2737.40897743603
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCAGGTCCATTGTT"	0.58421947535817	11.5547590025696	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCAGGTCCATTGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2479.48710870211	40.2494249749523	0.0162329640003738	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2473.9684487807	2473.9684487807
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCATTAGCTGTTAC"	-2.00294647637065	13.4321441420349	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCATTAGCTGTTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2699.99669027889	44.2782259780504	0.0163993630575439	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2692.34419202896	2692.34419202896
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTATGCCAGCAGACA"	1.00752009925191	11.0601920851502	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTATGCCAGCAGACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1940.04862169756	44.5610042594995	0.022969014158268	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1931.65838068371	1931.65838068371
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGGGTAGGCCCACT"	-2.71941099587138	13.134307838324	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGGGTAGGCCCACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2223.21245852984	46.6136506498883	0.0209667998535385	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2221.8792551826	2221.8792551826
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCTAGAGAGCAGTC"	-3.0867043537205	13.0787143477234	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTAGAGAGCAGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2351.6304030805	46.0620198881049	0.0195872701032298	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2345.67976154965	2345.67976154965
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCATCGTCAGTCTA"	1.43198134478871	11.460871673468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCATCGTCAGTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2291.35012473359	39.0459771196734	0.0170405983346666	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2283.14221967895	2283.14221967895
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTAGTTACGGG"	8.04577745971028	8.14046762073366	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTAGTTACGGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2072.07780281701	42.5406601684367	0.0205304357348948	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2060.3661826119	2060.3661826119
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGTGGGTACACGCC"	-2.3906765979832	13.4110021361145	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGGTACACGCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2690.05604690383	41.1865364317793	0.0153106610842491	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2687.36179151037	2687.36179151037
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCTCCCAATTGCAC"	1.39825250682179	11.0515212782654	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTCCCAATTGCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2269.50172079393	35.7033369649314	0.0157317955028655	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2260.81315435355	2260.81315435355
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTCACCAGCTG"	-1.60740254345592	11.7136583098206	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTCACCAGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2732.49005922994	38.1394503719515	0.0139577636314256	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2726.41799363455	2726.41799363455
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTTCCTAAGTG"	-1.631779174239	11.660376525763	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTTCCTAAGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2274.38656986334	44.0661091880369	0.0193749425765756	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2270.09820058962	2270.09820058962
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTTCGAGTACT"	7.83172192153279	-10.1328678361145	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTTCGAGTACT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2459.95999547441	44.3282052805834	0.0180198886819842	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2452.64880829996	2452.64880829996
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAAGAACACAAGCAG"	-8.12510619583781	2.69136045062868	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAAGAACACAAGCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2171.21600763558	43.1008275910841	0.0198510085774562	2929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2165.18671903009	2165.18671903009
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGTCCAGCAGGGAG"	-2.80555043640788	12.9564466246399	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGTCCAGCAGGGAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2329.68744787971	44.5696344318694	0.0191311647716662	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2324.01654498885	2324.01654498885
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTGCATGTGTTCGAT"	-1.23172579231914	11.6448507078919	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGCATGTGTTCGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2449.27198606905	39.7086388663937	0.0162124251990993	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2444.60506529526	2444.60506529526
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGTCCCACGACAGA"	-2.16217956963237	12.5347013243469	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGTCCCACGACAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2580.21948596655	44.5442619775044	0.0172637491576877	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2571.44701879122	2571.44701879122
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTGTTGCACCACTGG"	-2.1620114845341	13.1971969374451	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGTTGCACCACTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2500.1381415236	38.941779167604	0.0155758509983263	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2494.68647512873	2494.68647512873
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTGTTGGTCAGACTT"	-1.40388367596324	11.783348060492	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTGTTGGTCAGACTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2046.51751544839	46.1364671093265	0.0225438906635588	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2037.43408030946	2037.43408030946
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTTGTGCACGGCTAC"	-3.04713259163554	12.8236016997131	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTGTGCACGGCTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2585.46625019333	38.2744381385897	0.0148036889422663	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2582.96863183474	2582.96863183474
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGGTTTGTTCCGCTT"	8.21210732039754	7.93582389438478	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTTTGTTCCGCTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2340.47234113635	40.8686352615602	0.0174617040087377	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2335.79824071423	2335.79824071423
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTTTGGAGAGCCTGA"	-2.07345018807109	12.9416293867859	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTTGGAGAGCCTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2705.48728896242	39.7385295515276	0.0146881228064345	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2696.34960297205	2696.34960297205
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTTTGGCACTCCGAG"	-8.15257392349895	2.92398927295534	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTTGGCACTCCGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2592.97048108803	45.5774626993289	0.0175773164529834	3279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2585.51173454604	2585.51173454604
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGATGCGTCACTCCGT"	-1.39929852905925	11.4059676893982	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATGCGTCACTCCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2345.4121526382	42.7261743843671	0.0182169152386745	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2338.40123929338	2338.40123929338
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACTTGTTCCAACCAA"	-0.311837385327178	11.1276273497376	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTGTTCCAACCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2552.91864001134	41.8016049576006	0.0163740451036916	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2542.15223477599	2542.15223477599
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATGAATCGTGGACC"	-2.90461144867595	13.4250144728455	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGAATCGTGGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2282.58763191218	42.0621663499476	0.0184274048285766	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2276.01331240981	2276.01331240981
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGTCTCATGAGAA"	-0.145895595580894	11.6869544752869	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGTCTCATGAGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2611.13398112653	45.7445595566233	0.0175190395771601	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2606.545359508	2606.545359508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGTCTCTCGTTTA"	-2.09290800514873	12.4410171278748	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGTCTCTCGTTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2660.52714191969	42.1534172895679	0.0158440094917251	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2656.20105184248	2656.20105184248
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTTCGCAAGAGGTC"	-2.78165231171306	12.8387231596741	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTTCGCAAGAGGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2421.65471034447	39.3553422238975	0.0162514259591944	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2420.16750955321	2420.16750955321
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGACAGCTCAACCTTT"	-1.65829525414165	10.9400090941223	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGACAGCTCAACCTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2326.60017667956	39.3014781725157	0.0168922355316784	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2322.37828465173	2322.37828465173
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTTCGTCCTAGCCT"	-1.40575752678569	11.6339530714783	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTTCGTCCTAGCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2506.34840066713	44.5403637617133	0.0177710184864394	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2500.70885917215	2500.70885917215
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGAGCCAGAAGCGAA"	-8.24343715134319	2.42500231349794	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGAGCCAGAAGCGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2589.68723151159	43.5977447792567	0.01683513910435	3986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2585.18589990883	2585.18589990883
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGAAGGTTATGTGC"	0.997911472886246	11.3265781172547	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGAAGGTTATGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2337.56599432136	37.9719880775846	0.0162442421603624	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2335.23030238339	2335.23030238339
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGAGCCGTACTGCCG"	-2.87616906586345	13.2254724272522	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGAGCCGTACTGCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2551.05257048467	39.5191503028128	0.0154913116099777	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2549.70995444558	2549.70995444558
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGAGCCGTTCCGCTT"	1.46150602874104	10.7559346922669	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGAGCCGTTCCGCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2217.65060654318	47.315569659661	0.0213358991358045	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2215.69044517896	2215.69044517896
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTTACAGCCAAGCA"	0.568429489701432	11.0790605315003	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTACAGCCAAGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2143.79241379189	43.6759854360025	0.0203732344395927	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2138.11299778766	2138.11299778766
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTTACAGCCGATCC"	0.834337075322312	9.97744367206422	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTACAGCCGATCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2275.20523075942	36.2487071585369	0.0159320603998602	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2260.14539099245	2260.14539099245
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGGAACATATCTGG"	-0.984303812414962	11.2377567061218	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGAACATATCTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2231.55438859339	44.4031244135079	0.0198978454840603	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2224.59580486988	2224.59580486988
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGATCACAGTAGTTC"	-7.97204719010051	2.51390717113344	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATCACAGTAGTTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2923.47779618787	39.4966356899492	0.0135101541531978	3829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2913.96491296381	2913.96491296381
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGGAATCGCCAGTG"	-3.06974063339885	12.2302207716736	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGAATCGCCAGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2261.80826032295	38.8526664222526	0.0171777011799864	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2259.0204493738	2259.0204493738
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGATCAGTCGTGGTC"	-1.07125113430675	11.9959869154724	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATCAGTCGTGGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2541.32535127903	40.067020114538	0.0157661906982404	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2532.95727541167	2532.95727541167
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGGCTTCAAAGCCT"	1.32825340804402	10.2637319334778	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGGCTTCAAAGCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1923.67548923138	34.9184988690343	0.0181519695315067	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1920.59954523232	1920.59954523232
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGATTGCAGCTTCGG"	-2.4614409011906	12.8773364790711	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATTGCAGCTTCGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2487.24001144042	46.0816249519284	0.0185272127900683	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2479.72563027828	2479.72563027828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAACCCAAGGTTCAGG"	-2.18320165100749	13.6603822478089	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAACCCAAGGTTCAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2785.33271577463	45.7039874511465	0.0164088071749215	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2775.40578416145	2775.40578416145
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGATTGGTCCCTCAT"	1.38764049586598	11.2961950072083	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGATTGGTCCCTCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2245.61469168168	34.5627244230789	0.0153912087194245	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2237.49216145884	2237.49216145884
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGAAGCACAAGCAG"	-0.187816555530387	11.4274539717468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGAAGCACAAGCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2396.77991775402	40.2513133460303	0.0167939129695934	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2392.22531389205	2392.22531389205
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGGTTAGGACTAAT"	1.18852700766866	11.3661956557068	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGGTTAGGACTAAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2243.58289390463	41.2223195496295	0.0183734328076856	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2240.72073914566	2240.72073914566
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCGTGAGTAGACAAT"	0.166949679225129	11.2312631377014	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCGTGAGTAGACAAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2238.50476855502	40.165841298386	0.017943156459887	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2229.71040666198	2229.71040666198
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAGGGAGTTAATCGC"	1.44212510165517	10.8665714033875	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGGGAGTTAATCGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2418.5518696921	36.0380128115261	0.014900657398807	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2410.78088636844	2410.78088636844
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCAGCAGATCACCT"	-2.31616840782817	13.4470243223938	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAGCAGATCACCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2590.21001159902	44.6044429540627	0.0172203963208863	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2574.16707521054	2574.16707521054
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGGTTTCGTTATCT"	7.98559631881062	7.82306382739869	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGGTTTCGTTATCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2128.62896748608	39.4049784407519	0.0185119055705088	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2120.0702765892	2120.0702765892
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGATCGGTCAGCTAGT"	-3.50916371765788	12.6481446989807	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATCGGTCAGCTAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2262.35370529263	46.6498511272313	0.0206200520361149	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2257.58127222915	2257.58127222915
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGTACTCTTCCGTG"	1.36135448989217	11.0378255614075	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGTACTCTTCCGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2221.46261000516	40.9003877700762	0.0184114680057483	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2211.06542228857	2211.06542228857
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGGATGTGTTCCAA"	8.19355263289754	7.97731492603151	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGATGTGTTCCAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2329.86098086802	43.4608066263863	0.018653819684209	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2325.69641864521	2325.69641864521
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGATGCGCAGCGACAA"	0.140557517378968	11.1472558745178	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGCGCAGCGACAA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2125.42485838208	41.2779370756242	0.0194210286535586	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2120.40475761753	2120.40475761753
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCCAGCATTGGCAT"	8.02787413176839	8.28517053211061	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCCAGCATTGGCAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2068.36065434554	39.0698551051997	0.0188892855910383	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2059.87611968139	2059.87611968139
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCAATCATGGGTCC"	8.04717220839803	7.59526441181032	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCAATCATGGGTCC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2195.85214955925	50.0288472113242	0.0227833405001178	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2194.58983660327	2194.58983660327
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGATGGCAGCGAGTCA"	1.28763665732686	11.1453056105408	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGGCAGCGAGTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2296.74249091681	42.1987035197919	0.0183732846353825	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2290.83057496984	2290.83057496984
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGGGCTCCTCACTG"	1.23670675334279	10.6641120680603	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGGGCTCCTCACTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2119.34701103733	36.7746940127743	0.0173518984013735	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2115.39544576127	2115.39544576127
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGTGCATCCAGTACA"	-2.56357465210612	12.9785489805969	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGTGCATCCAGTACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2618.99008938322	42.4647066404145	0.0162141532388979	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2613.52939863683	2613.52939863683
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCAGGTAGGCTCACC"	1.04932477053944	11.0319280394348	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCAGGTAGGCTCACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2304.0781753556	39.7293902054072	0.0172430738810655	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2301.59211814093	2301.59211814093
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGCATGTCTAATCG"	0.435258020728272	11.4358052977356	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGCATGTCTAATCG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2581.31969206222	43.9584748426782	0.0170294578303704	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2573.02862599458	2573.02862599458
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCAGTTCAGGGTAG"	-1.98557267609294	10.6419629820618	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCAGTTCAGGGTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.9658946477	40.2932655144158	0.0178528464297886	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.84497044973	2246.84497044973
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGTGAAGAAAGTCT"	1.24975575980489	10.2825879820618	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTGAAGAAAGTCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2117.32192521221	40.4435991639195	0.019101298995837	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2108.76444027003	2108.76444027003
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCATAAGTCATCGGC"	0.834875484078568	11.4812621840271	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATAAGTCATCGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2210.15662158334	43.8456427599291	0.0198382514305789	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2208.07455167495	2208.07455167495
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTATGTAGGTTTC"	0.0590946209499657	11.8278016814026	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATGTAGGTTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2197.05836872711	45.4365393338614	0.0206806245935949	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2192.47488533694	2192.47488533694
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGGTATAGATGACAT"	-2.39006743851359	13.4222240217957	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGTATAGATGACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2604.4557791601	42.6806204614056	0.0163875389257596	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2596.6283809753	2596.6283809753
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGGTATTCCGGACGT"	1.3387094932491	11.5229787596497	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGTATTCCGGACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2761.68002541829	44.065403763269	0.0159560134981947	2532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2744.63684362167	2744.63684362167
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCATGGTCATCAGTG"	0.634739299386185	11.5388002165589	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATGGTCATCAGTG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2417.27912602741	44.5887463676524	0.018445840981935	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2411.71003298394	2411.71003298394
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGTTAGCACCCTATC"	0.936774213879746	11.6463861235413	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTAGCACCCTATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2107.79632685936	36.3187316918268	0.0172306646657565	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2105.26877591271	2105.26877591271
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTTCTTCGGAA"	-2.01179275932963	10.0296706923279	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00127118644067797	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTTCTTCGGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.79499368541	37.6835213324201	0.0162794206118546	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.15973283194	2306.15973283194
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAAGCAGTCACGC"	1.48243739184682	10.9057206877503	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAAGCAGTCACGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.14167661653	35.7662105826935	0.0164658737354579	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2168.02404890658	2168.02404890658
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGACTCATCACCAA"	7.19876398619954	-10.0884533158508	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTCATCACCAA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2049.68523122866	46.9119358881822	0.0228873854255472	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2043.07471490628	2043.07471490628
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAAGTCTTAGCTT"	-1.18495653095897	12.3658065565857	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAAGTCTTAGCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2523.49543811752	41.171892762711	0.0163154219107384	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2518.07145709738	2518.07145709738
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCGTGACAATCCAGT"	-2.04758415642436	11.4815912016663	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCGTGACAATCCAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2288.09368907767	44.4363741171952	0.0194206969449348	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2279.67198043237	2279.67198043237
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCAGTAGTCCT"	1.24792875823323	11.242519355658	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCAGTAGTCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2762.49329993564	37.1070725730583	0.0134324570394154	2526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2756.98096521296	2756.98096521296
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCGTGATCCATCTGC"	-3.24958072128947	11.374900794867	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00127118644067797	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCGTGATCCATCTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2024.05589486125	49.6661415689508	0.0245379298541335	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2018.99593244979	2018.99593244979
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCAAAGTAGTATAG"	-7.96689734879191	3.05510661685792	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCAAAGTAGTATAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.9589874175	47.5534219595112	0.01783726688368	3052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2656.5260785269	2656.5260785269
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCGTGTCTTGA"	6.51917328414266	-10.0449028245178	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCGTGTCTTGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2361.33190045747	41.2646313184933	0.0174751509139816	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2358.31797976558	2358.31797976558
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGTTCCTCGTTAGAC"	6.40082420882527	-10.0747690430847	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGTTCCTCGTTAGAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2731.12042338122	43.1915794745765	0.0158146008886359	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2725.36021901692	2725.36021901692
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTGTCACTTTATC"	0.561871011822861	10.9588813551697	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTGTCACTTTATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2252.32258531689	37.4757093300997	0.0166386953513708	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.67898430258	2246.67898430258
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGATCGTTGTGTTG"	-2.08950481835063	11.1889476546082	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGATCGTTGTGTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.85221659041	39.7585305091073	0.0163692670297247	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2427.57764778736	2427.57764778736
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAGACAGCTGCCA"	6.30374207076375	-10.0578890076843	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAGACAGCTGCCA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.02622830762	40.7751175163446	0.0153230799014999	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2658.51251187677	2658.51251187677
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATAAGCGTTACACTG"	-1.77935252609904	13.0831737288269	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATAAGCGTTACACTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2044.86669738941	42.2940529902235	0.0206830367202999	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2033.38111258969	2033.38111258969
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCACTGTCGCATTA"	1.48758091506307	10.896400428656	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTGTCGCATTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2236.99638170292	40.80257478077	0.0182398930612972	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2231.19140298529	2231.19140298529
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTTGCACGTGTGC"	-0.0771374655073464	11.6078481444153	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTTGCACGTGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2196.0564602525	37.8007331614822	0.0172130060613906	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2191.41194163778	2191.41194163778
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTGATGTGACCTGC"	-7.57505212250407	3.24023554408876	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTGATGTGACCTGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2341.02385697113	37.4499584753205	0.0159972562277832	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2336.09417328971	2336.09417328971
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACAGTCGGCTATA"	1.3802213865215	11.1586370238098	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACAGTCGGCTATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2232.02315259801	37.8752883178373	0.0169690391758489	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.07500107188	2230.07500107188
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGACACTCATCGACA"	-7.72624764862712	2.91215465152589	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGACACTCATCGACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2616.74295311199	42.6181954640238	0.0162867336332518	3582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2606.79587610489	2606.79587610489
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGAGAACATTAAAGG"	-1.38651953163798	11.8384561308655	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGAGAACATTAAAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2605.23740714695	39.357084986314	0.0151069092123219	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2598.13351367847	2598.13351367847
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATGTTCCAGACCATT"	-10.0977195304936	3.08660695636598	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATGTTCCAGACCATT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2934.30942718827	46.7577707040585	0.0159348466357425	3793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2924.75657909373	2924.75657909373
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACTTCAAGTGCTT"	6.70268406447713	-9.8915643922058	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACTTCAAGTGCTT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.46649656213	38.2219162589493	0.0147605370873475	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2582.98129355279	2582.98129355279
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGGCATAGGGTAGCT"	-1.02029047432597	11.7462634810242	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGCATAGGGTAGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2441.08303582106	43.2427120726428	0.0177145600694808	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.628090378	2437.628090378
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACCGAAGCACGGAT"	-2.96824059906657	13.0636462935242	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACCGAAGCACGGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2595.03992298761	40.3746821849929	0.0155584050277386	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2591.21936152226	2591.21936152226
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGGCATGTTTCGTGA"	0.81790324029271	10.7962817915711	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGCATGTTTCGTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1986.42393813803	49.7905460486771	0.0250654178560434	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1976.47769939004	1976.47769939004
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGGTCAAGCCATTCA"	8.27396740493123	8.12772653186647	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGTCAAGCCATTCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1954.16212133314	39.8406773790899	0.0203876008772038	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1952.30788539874	1952.30788539874
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACCACATCTCGACGG"	-2.53041086617168	13.5071582564148	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCACATCTCGACGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2529.23764137017	49.8822263266516	0.0197222378438227	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2521.86608058707	2521.86608058707
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCAAGTCTACGGTA"	1.34123041209523	11.6526441344055	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGTCTACGGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2404.94580509998	42.1095267169979	0.017509553282947	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.5911469291	2395.5911469291
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGGTCATCTATTTCG"	-8.60520968857463	3.5078291662964	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGTCATCTATTTCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2684.65098103318	41.5374695629051	0.0154722047135227	2928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2678.25484566442	2678.25484566442
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCACAGCAAATCA"	1.47223462638203	10.7610072859558	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCACAGCAAATCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2358.74660514223	41.3345940806189	0.0175239654783208	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2347.57214793292	2347.57214793292
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGTCAGGTCGTGGTC"	6.42159857329671	-10.0050316086975	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGTCAGGTCGTGGTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2290.40055165549	41.8613998858494	0.0182768904135969	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2284.40200154835	2284.40200154835
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGTCAGTCGTCACCT"	-8.03363452377971	2.62583992565004	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGTCAGTCGTCACCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2818.36079561233	46.6159712513583	0.0165401006584859	3572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2812.76081621735	2812.76081621735
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGCTTAGCCTGACC"	-1.57256195965465	11.5686263808045	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGCTTAGCCTGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.61611273196	36.2009630335184	0.0136833771382409	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2638.96906284067	2638.96906284067
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGGGCACTTGTCC"	6.63598694381062	-10.0067568055359	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGGGCACTTGTCC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2426.68389952983	43.2451138927215	0.0178206621394324	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2423.26681453078	2423.26681453078
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCACAGAGAAAG"	-8.15000472489055	2.4567923315796	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCACAGAGAAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2476.17587492736	41.5658521195913	0.0167863084930551	2843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2472.21763164074	2472.21763164074
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCAGTGCCAAGA"	8.09836163100545	8.0930194624695	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCAGTGCCAAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2252.66714926112	41.3653693761934	0.018362841305588	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2242.44332044865	2242.44332044865
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCATCATTGCTT"	-0.604041497141677	11.582941985968	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCATCATTGCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2419.82449666046	43.1903934951075	0.0178485644536261	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.40038468628	2415.40038468628
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGTCTCCTCTAGC"	1.26089765605275	11.6923265227112	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGTCTCCTCTAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2292.87466275843	44.815000053869	0.0195453335421111	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2284.9422395869	2284.9422395869
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCATCTTTCAGT"	8.14452042159383	7.20165679538576	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCATCTTTCAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1964.34474095383	40.5408165566688	0.0206383409752116	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1961.09500270596	1961.09500270596
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCGTAGGATTACA"	-0.312927882105666	12.1291646727356	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCGTAGGATTACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2610.78924786083	39.4986486634361	0.0151290069452369	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2600.11859219792	2600.11859219792
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCGTGTATAATGG"	6.57172169265096	-10.0569906464783	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCGTGTATAATGG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2434.99921273529	45.5834677737747	0.018720116021134	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2429.05713744195	2429.05713744195
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTCAAACATGTCTAG"	-2.52390799942668	12.8280448683533	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCAAACATGTCTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2772.12514964444	42.2823238006322	0.0152526749400385	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2764.07018934689	2764.07018934689
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCGCTAGATACGAT"	-1.76370022717174	12.3376083143982	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGCTAGATACGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2548.52715965291	38.6054852831336	0.0151481553323494	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2546.20603735146	2546.20603735146
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCGCTAGCAGGTCA"	0.879044433205765	10.7427596815857	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGCTAGCAGGTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2165.90130154944	38.325917150347	0.0176951355645474	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2161.94581635774	2161.94581635774
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGAGCCTCCTCACCA"	-1.26071999493297	10.6568498381409	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGAGCCTCCTCACCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2236.745531116	39.0280699701554	0.0174485963768453	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2233.75799096454	2233.75799096454
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCGCTTCCTCTCTT"	1.3667582469875	10.1776551970276	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGCTTCCTCTCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2317.66635277313	35.8989133485646	0.0154892499110628	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.2556533532	2306.2556533532
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGCAACAAATGAAC"	1.38977660712544	10.6870946654114	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGCAACAAATGAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1953.12036739753	31.5428773935411	0.0161499915315362	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1947.03717820964	1947.03717820964
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGAATAGAGCAGCT"	-1.17739758911784	11.4597282179627	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGAATAGAGCAGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2405.09588117425	44.7691287577553	0.0186142802489427	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2394.5166706603	2394.5166706603
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGATAGAGAGGTATT"	-1.79775069180186	11.8568296202454	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGATAGAGAGGTATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2569.81016664499	45.0244770387343	0.0175205459232484	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2563.94819678228	2563.94819678228
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGAATGTAAGGCTG"	-2.16973052445109	13.446937538031	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGAATGTAAGGCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2291.14710791581	41.4478182612974	0.0180904220938485	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2291.14710791581	2291.14710791581
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCCAAAGCTTTCTT"	-1.35895119133647	11.3478564986023	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCCAAAGCTTTCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2697.09891862795	43.3371193824345	0.016068049667411	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2691.37325403619	2691.37325403619
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGCATTAGAATTCAG"	-7.89366755905803	3.12677309596864	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCATTAGAATTCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2385.89399984076	44.4262016923784	0.0186203585303217	2716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2378.6744084899	2378.6744084899
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGCATCGTCCGCAGT"	-7.76705727997478	2.53789589488832	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCATCGTCCGCAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2662.79704377027	40.31795275037	0.0151412038122453	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2658.19430288899	2658.19430288899
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGATAGTCGTGGTC"	-2.24024591866191	13.4348668822083	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGATAGTCGTGGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2494.74176667716	39.8805544336159	0.0159858446939517	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2484.05419381746	2484.05419381746
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGAGTTCGAACCAT"	0.773943741887253	11.4993037947449	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTTCGAACCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2245.12343456643	36.4514655732015	0.0162358403159428	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2227.68872920547	2227.68872920547
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCACTTGTCGACGCT"	1.26019110259358	11.6431646117005	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCACTTGTCGACGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2157.12926131084	37.010712543466	0.0171573920985038	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2146.78016759682	2146.78016759682
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCTAGAGCTAGAGC"	-2.57272634926494	13.4152736433777	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTAGAGCTAGAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2269.49466526859	45.5707909621192	0.0200797083419123	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2263.27024499125	2263.27024499125
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGCGAGAGGCTTTCA"	-2.27041778984721	13.2998409041199	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGAGAGGCTTTCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2450.52023545514	42.566330148462	0.0173703238735167	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2446.37902911126	2446.37902911126
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACCTGGTAGCGAGT"	-2.37539325180705	12.8254089125427	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACCTGGTAGCGAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2661.4406014039	45.9324515453764	0.0172584920817497	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2646.29948778568	2646.29948778568
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCAGGTCAGAATCGG"	-2.46622929993327	12.9405450590881	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCAGGTCAGAATCGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2595.88028428447	42.2884399721256	0.0162905971543222	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2591.96148242083	2591.96148242083
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGCGAGGTAGGACCA"	-0.644997696310836	10.0427074202332	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGAGGTAGGACCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2149.08478240392	45.7276520470875	0.0212777329314749	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2145.91852738088	2145.91852738088
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCAATCTTCCCGA"	1.50393750247304	11.4755687483582	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAATCTTCCCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2356.42626089437	39.6144415111479	0.0168112374949142	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2352.93044204335	2352.93044204335
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCAGAAGGTCATCT"	-1.45033679428752	10.9829053648743	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCAGAAGGTCATCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2198.78885078971	45.010549497913	0.020470610209683	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2196.23573451932	2196.23573451932
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCCTCAGGACATG"	-8.06647906723674	1.05612645233003	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTCAGGACATG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3180.98967415103	39.1055140826807	0.0122935055088217	4632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3176.19275356334	3176.19275356334
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCACGGTAGAGCTG"	-2.36356745186504	12.3820237883362	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCACGGTAGAGCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2158.12942848253	44.7828894333964	0.0207507894764612	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2150.29918398833	2150.29918398833
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTTAGATCTCATGCC"	1.35973550853078	10.7195863493714	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTAGATCTCATGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2103.82931074006	33.2092805925751	0.0157851591966333	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2099.25072543813	2099.25072543813
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCCTGTTAAACAG"	-0.0704031017726243	11.2532939680847	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTGTTAAACAG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2423.33147628743	42.5412202729201	0.017554849878851	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.44939943465	2415.44939943465
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTTCTGCACCAGTAT"	-0.273450354964095	11.7099475630554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTCTGCACCAGTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.35929637001	34.0884393772151	0.0151077177433824	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2249.33038458388	2249.33038458388
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACGCTTCACAACCA"	1.36865105208699	11.3238878020081	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACGCTTCACAACCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2278.74425234927	31.6999929658029	0.0139111674919736	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2277.72116190565	2277.72116190565
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGTACCGTTTGGGTT"	1.38321663913075	10.6790723570618	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTACCGTTTGGGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2190.52215622546	33.6606722421972	0.0153665061759515	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2184.03318932371	2184.03318932371
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCGGAGGCCTAGA"	6.21906628188435	-10.094117187616	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCGGAGGCCTAGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2632.66533555114	40.1248774003562	0.0152411614414166	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2629.29436207215	2629.29436207215
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGTGAAAGGATTTGA"	-7.24898276749309	0.762923396471418	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGTGAAAGGATTTGA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2452.47987539657	38.1939133635351	0.0155735888994233	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2448.1577758143	2448.1577758143
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGAGGAGGGACAGG"	-7.7052677673405	2.78059551799623	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAGGAGGGACAGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2564.61327354598	42.7810933076139	0.0166813038631989	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2560.21319054325	2560.21319054325
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCTCCAAGATGTA"	6.82813324508016	-10.0244598618713	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCTCCAAGATGTA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2458.72264275344	39.5832565144892	0.0160991141604167	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2451.64559113881	2451.64559113881
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCCAGTCAGCTAGT"	8.06121697005574	8.37886235797731	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCCAGTCAGCTAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2026.07401776113	40.0759902923394	0.0197801215261743	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2023.44078732927	2023.44078732927
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCTCGTGCCGTAC"	-8.09939322891887	3.29564282977907	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCTCGTGCCGTAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2335.84372748153	45.1563431823972	0.0193319196190766	2630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2330.16035888805	2330.16035888805
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGATGGTGGACCTC"	1.1531648832256	11.452965713385	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGATGGTGGACCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2286.92621110953	32.3625217517658	0.0141511001074515	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2285.84388580479	2285.84388580479
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGGATCACAGCTGC"	8.96714176711385	7.94976184451906	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGGATCACAGCTGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2316.79780984935	39.9222447259584	0.0172316481637879	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2313.82479471212	2313.82479471212
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGGCCACACATTCTT"	6.15799393233601	-10.0267820588318	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGCCACACATTCTT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2589.23817160563	38.7440103351913	0.0149634787406079	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2582.02691635006	2582.02691635006
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGGTACAACAGATA"	-7.20137582245524	-0.054770149942957	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGGTACAACAGATA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2423.08933074538	48.9672236069211	0.0202085919762018	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2421.02288699318	2421.02288699318
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCATAGGTACCTT"	-2.70447574082072	13.4405002363953	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCATAGGTACCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2896.28096269914	39.5062690627487	0.0136403441418651	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2885.01360328605	2885.01360328605
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGGGCTCATCAGTCA"	0.374561687081498	11.4276981123718	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGGCTCATCAGTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2072.76411376809	44.4763975935184	0.0214575297295478	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2065.74785915135	2065.74785915135
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATCGTGAGAGCAAGA"	-2.68106661263164	12.4840659865173	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATCGTGAGAGCAAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2415.54682158869	46.4823653967378	0.0192429991343188	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2415.54682158869	2415.54682158869
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGGTATTCCGTAATG"	-2.49525270882304	13.0507087477478	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGTATTCCGTAATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2562.56442739088	42.9211549800305	0.0167492978991094	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2554.63029252235	2554.63029252235
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGCCTTCCGTATGA"	-0.0643591609900773	11.3303670653137	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGCCTTCCGTATGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.00385304629	43.7034365631238	0.0193720575894012	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2253.76391661128	2253.76391661128
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACAGAGTGGTACAG"	-3.01945577088054	13.0880574950012	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGAGTGGTACAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2529.93277314829	38.4968666285783	0.0152165571501223	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2524.04787084179	2524.04787084179
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCCGCAACCAACT"	-0.803080002695876	11.3089313277039	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCCGCAACCAACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2843.6972674976	44.4370687444897	0.0156265117431411	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2835.28254215685	2835.28254215685
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACAGATCAGACATC"	-1.47880301895793	11.6263112791809	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGATCAGACATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2342.91478753496	40.9630884346727	0.0174838148841815	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2337.85579616099	2337.85579616099
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACATTCAAAGCGTG"	0.943092842667741	10.6830777891907	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACATTCAAAGCGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1958.67152179836	39.5083609199753	0.0201709988021373	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1952.94550412999	1952.94550412999
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATGAAGTCCGAGCTG"	1.42076935347859	11.5465755232605	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGAAGTCCGAGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2271.03784683898	43.413260091152	0.019116044301762	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2266.10459576901	2266.10459576901
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCTAAGGTAAAGG"	6.92195858535115	-9.57396604931029	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCTAAGGTAAAGG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2470.77674335381	41.7079615850974	0.0168805059774374	3117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2467.10055692172	2467.10055692172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACCCAAGATGCTAA"	6.05310549315755	-10.1024837723938	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCCAAGATGCTAA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2272.61575969336	37.0691623518567	0.0163112317573906	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2271.52065941104	2271.52065941104
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACCCAAGTGCTCAT"	-2.58746467056926	13.2762946852478	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCCAAGTGCTCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.32050248117	40.6947089108039	0.0157224381106566	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2584.08511553216	2584.08511553216
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGAGTCACGAGGA"	-2.3993390602177	12.8654145964417	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGAGTCACGAGGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2534.25209954686	44.7557955276969	0.0176603564955907	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2522.96048545325	2522.96048545325
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACCCACAGAAGTGC"	-1.04151282730754	11.7866744765076	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCCACAGAAGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2255.4356008452	44.4243386124551	0.019696567082566	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2250.22266186736	2250.22266186736
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCATGAGTGCACAG"	6.70837225493733	-0.931181394216143	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCATGAGTGCACAG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2277.02613954232	40.0023224881106	0.0175677923908906	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2271.32871469649	2271.32871469649
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGTCCGTTCCGCTT"	-8.06238208237346	2.97390792453615	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTCCGTTCCGCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2761.310755844	48.4273624463974	0.0175378169023195	3843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2753.6760378072	2753.6760378072
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGCACGGTCGACTGC"	-1.98720441284831	11.5916328200134	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGCACGGTCGACTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2514.88515203893	44.440593448176	0.0176710230334558	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2510.18607908895	2510.18607908895
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATGGAATCGGACGTC"	-1.17961368981059	10.9600028761658	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGGAATCGGACGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2315.38905558361	44.4554931617524	0.0192000100607486	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.54364936037	2306.54364936037
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AATGGAATCTGGTCAA"	-7.89736018601115	3.1253566511902	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AATGGAATCTGGTCAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2536.22525122378	41.7641000322168	0.0164670310778054	2792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2527.89990511798	2527.89990511798
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGAAGTCTGCATA"	8.44481911238972	8.10474679553834	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAAGTCTGCATA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2223.21115424189	36.2008934795575	0.0162831557454568	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2215.53154146193	2215.53154146193
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGTCCGTAGTGTGG"	1.15445735034291	11.1318883665833	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGTCCGTAGTGTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.62648856081	41.6023306543928	0.0194801529561606	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2128.58340475019	2128.58340475019
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACGGGGTAATTGGA"	-2.71307835999187	13.2876558073792	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGGTAATTGGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2355.3970157307	34.2781812139064	0.0145530375494988	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2350.99966909125	2350.99966909125
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACGGGGTATACCCA"	-7.559562544257	3.36992213809816	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGGTATACCCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2614.21540553403	41.4875394656748	0.015869977423379	3338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2606.31981643281	2606.31981643281
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTTCACAGCGAACA"	-2.14705954018291	13.5632285841736	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTTCACAGCGAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3279.96597878287	41.8561740586795	0.0127611610393018	2995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3264.36903246431	3264.36903246431
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAAAGAGTGTCATGT"	1.37885632094685	11.369376159552	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAAGAGTGTCATGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2225.03513402229	37.4839544586308	0.0168464550898437	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2221.31777303159	2221.31777303159
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATACTTGTAGTGCGA"	-2.74835119667705	13.076500869635	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACTTGTAGTGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2351.16335375333	39.8808502223173	0.0169621775359219	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2349.53843042174	2349.53843042174
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAAGCGAGCTTCATG"	-2.12430057945903	11.9394149550232	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAAGCGAGCTTCATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2574.31204190647	38.4260216112878	0.014926714782731	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2571.1970380953	2571.1970380953
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCCCATAGGAATCGC"	0.0284756860578477	12.4778756865296	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCCATAGGAATCGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2124.50146849363	47.9131268556107	0.0225526447339118	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2101.44679683609	2101.44679683609
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAACCATCTCTAGGA"	3.58140267905537	-6.60499288952025	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000263088660878716	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAACCATCTCTAGGA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2858.91738360932	38.3376243577403	0.0134098398846839	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2852.9794044232	2852.9794044232
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAAGCGGTTGTACGT"	-1.86332152310069	13.5009555586609	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAAGCGGTTGTACGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2560.62496598032	43.5822158835321	0.017020147996115	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2553.96636733385	2553.96636733385
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAAGCTGTCAACATC"	1.31119026717488	11.2126388319763	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAAGCTGTCAACATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2364.9848705362	36.0377356679051	0.0152380406813066	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2355.7983045208	2355.7983045208
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGTCTGGAAGG"	-7.53203998032268	3.00601813876954	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGTCTGGAAGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2642.53539976517	42.1636791703904	0.0159557670160775	2646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2636.66309424281	2636.66309424281
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGACCAAGATGACAT"	-0.482226352125961	11.2709340819153	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGACCAAGATGACAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.54590348958	49.1645885280951	0.0202694941610312	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2420.66344225896	2420.66344225896
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTAGGTACACTTTAGG"	0.193339427083176	11.2181377180847	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGGTACACTTTAGG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2231.51118983119	39.363842136347	0.0176399931650465	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2221.41472519432	2221.41472519432
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATCATGTGTTAACC"	-2.05885825577434	11.10799501026	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCATGTGTTAACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.04995614667	33.9935030360796	0.0133619636493175	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2540.49752552851	2540.49752552851
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAGGGCATAACGGG"	6.61534227904622	-10.1884746781555	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAGGGCATAACGGG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2622.92723259599	40.8543914087517	0.0155758767917922	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2618.69882174692	2618.69882174692
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACAAAAGGCGAACT"	-0.274262557656127	10.7679509886536	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACAAAAGGCGAACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2416.15485542215	47.5833113944306	0.0196938169288478	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2412.0972076071	2412.0972076071
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATCCGCAGCGCGTT"	1.36009909686391	11.2140569456848	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCCGCAGCGCGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.28791767341	36.0263347269354	0.0165085158723437	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2177.97365538227	2177.97365538227
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTATCCGCAGTAACCT"	1.27450694617574	11.611376739386	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCCGCAGTAACCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2315.90171446486	33.8404715297808	0.0146122226683529	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2310.38537475548	2310.38537475548
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCATGCACGCGCAT"	6.58800997313802	-10.117850326654	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGCACGCGCAT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2685.2924462957	37.9744385923216	0.0141416398220262	2403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2681.91674350512	2681.91674350512
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCATGGTCGTCGGT"	6.76920284804646	-10.0095501176086	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCATGGTCGTCGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2254.23831517758	38.585238520214	0.0171167521465779	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2249.8859763817	2249.8859763817
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGAGAGTTGGAAT"	-1.1010790866917	11.3440913924011	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGAGAGTTGGAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2446.51706515533	39.4762761540221	0.0161357043922829	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2441.84975695497	2441.84975695497
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACACTGTCCACATA"	3.52874459800069	-10.3058700791565	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACACTGTCCACATA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2617.67919156471	39.6248268161095	0.0151373884713596	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2612.37091883248	2612.37091883248
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACCATCACTGTCCT"	0.2778353440458	11.2856445082459	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACCATCACTGTCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2653.13276247514	47.2673422593341	0.0178156716949354	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2648.22461212347	2648.22461212347
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTATCTAGTTCTGAGT"	-2.30856523934062	13.5866927870545	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTAGTTCTGAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2729.44885379218	35.7880753773582	0.0131118322029137	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2721.98341149962	2721.98341149962
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTATCTATCAGCAGAG"	-8.2547439140385	2.48920295322267	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTATCTATCAGCAGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2228.08411999261	44.2241515052973	0.0198485107040949	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2225.34530509928	2225.34530509928
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGCCCATTGACCA"	6.75576891478841	-9.96795656597289	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCCATTGACCA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2354.38269405219	44.5186264875241	0.0189088318564311	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2347.47412009879	2347.47412009879
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGAGTCAGCAGATG"	-2.64060173454936	13.3519830473694	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGAGTCAGCAGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2695.17531151756	45.9915978491374	0.0170644179072868	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2692.38166215386	2692.38166215386
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAACATAGCTGAAGC"	-1.49431000176128	11.7943715819153	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACATAGCTGAAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2417.55104522485	35.3560168379696	0.0146247240188805	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2410.81869713087	2410.81869713087
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAACCTCAGGACAG"	-4.99200663986857	8.95822808826295	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0425531914893617	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAACCTCAGGACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3302.3135438417	41.7271763881572	0.0126357403178665	2608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	3289.26660463923	3289.26660463923
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAAGAAGCAGTCTT"	8.25038017806355	8.44916341388551	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAAGAAGCAGTCTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2427.62587615235	48.0938913238954	0.0198110803630588	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2413.66634978288	2413.66634978288
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACGTTAGCTACTAC"	-7.76099334183391	3.03334138477174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGTTAGCTACTAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2679.25722997517	41.0023921858426	0.0153036415194157	3373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2675.00909713128	2675.00909713128
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACGTTAGCTGGTGA"	-7.63734946671184	3.10487744891969	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGTTAGCTGGTGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2454.68545469205	46.4430976089878	0.0189201828365477	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2450.63416235998	2450.63416235998
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACGTTCAACTCCCT"	1.56325759467427	11.3759221800598	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACGTTCAACTCCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2349.47308242863	40.9885375006685	0.0174458425624094	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2344.0068818158	2344.0068818158
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACGTTAGTGGCAGT"	-2.68966279450114	12.3147506483826	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACGTTAGTGGCAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2076.4851920404	42.1128920735975	0.0202808535476319	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2073.31347220916	2073.31347220916
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTACTCCATAAGC"	-1.26969037476237	11.8862495192322	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTACTCCATAAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2466.16842886328	38.6158840280221	0.0156582509029285	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2458.97866932486	2458.97866932486
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAATTTCTCAACCC"	-8.34995208206828	2.97199318492738	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAATTTCTCAACCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2577.85870040368	43.8812149918156	0.0170223507537259	2877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2575.12630744674	2575.12630744674
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCACTGAGTTACTCG"	-2.45746622505839	12.8995427855286	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCACTGAGTTACTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2662.33820109364	39.3911074707997	0.0147956812754362	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2659.69153509118	2659.69153509118
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAGCCGAGCTGACCC"	-1.92135677757915	13.3558416136536	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGCCGAGCTGACCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2446.24039376009	40.8082282507397	0.0166820188051975	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2443.48229852791	2443.48229852791
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCATAAGTCAGACCTA"	0.300374408333939	11.7406701811585	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATAAGTCAGACCTA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2421.7464178455	35.0936888242324	0.0144910666804881	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2413.11414335297	2413.11414335297
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGGTACAATGCAAA"	-2.53491411629375	13.1829595335755	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGGTACAATGCAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2796.71855611578	42.2794613922822	0.0151175245359698	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2787.61050567855	2787.61050567855
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTCATCGCGTGAC"	-2.38872967186626	13.2614202269348	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTCATCGCGTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2340.40997301758	41.1540288510218	0.0175841110427163	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2338.92699837093	2338.92699837093
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAGCCGTCCCTTCCC"	-7.92922721329387	2.8275325068268	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGCCGTCCCTTCCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2475.29431491606	45.5687010082104	0.0184094072101304	3057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2468.41523749622	2468.41523749622
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCAACTAGATGCTAA"	1.3850517469341	11.0264940031799	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCAACTAGATGCTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2372.80804931096	34.6928507464974	0.0146210102231286	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2364.77735155807	2364.77735155807
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCAGTGCCGAA"	-2.43402038040813	13.4130277403626	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCAGTGCCGAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2436.00949121235	39.1667491599873	0.016078241608367	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2424.11497755837	2424.11497755837
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCCACAGAGAC"	-0.279528568417388	11.2522496947083	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCCACAGAGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.04429121632	35.9030926836379	0.0159141790005732	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2254.85873082878	2254.85873082878
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAGGGTCATTGTCGA"	0.661626298993272	10.9263505705628	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGGTCATTGTCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2304.90072303651	40.4399375596002	0.0175451971338375	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2301.13862712696	2301.13862712696
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATCGACAACACAGG"	1.36748399314229	10.8983306654724	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGACAACACAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2458.82778113686	37.6752308891695	0.0153224358282425	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2451.46697184539	2451.46697184539
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATCGACAGAGTTGG"	-0.0114590478246987	11.8385152586731	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGACAGAGTTGG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2317.51514389099	47.4351559238645	0.0204681104453209	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.40182048848	2309.40182048848
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATCGACATGATGCT"	0.963030417531174	9.77956578815309	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATCGACATGATGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1950.89803168581	37.1326543786944	0.0190336213249481	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1947.33358146466	1947.33358146466
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCATTGGTTCCTACC"	-7.61436973038371	3.28198382938234	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCATTGGTTCCTACC"	"HSC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2525.83401861931	44.7678421836228	0.0177239841785384	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2517.41902726247	2517.41902726247
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATCGGTACAGGTG"	1.34055687960927	11.3716840513977	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATCGGTACAGGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2320.61857909456	43.4600376381617	0.018727781475885	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2312.25134622148	2312.25134622148
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATGCCAAGACTGG"	1.26740827140157	11.5295381315979	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATGCCAAGACTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2128.07463392017	34.5703567757945	0.0162448986632164	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2120.76219926801	2120.76219926801
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATGCGTTAATCGC"	-2.03081283989604	13.6008329161438	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATGCGTTAATCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3036.00002989172	38.983432280678	0.0128403925878974	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3020.8678942899	3020.8678942899
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATGCTCCATTTGT"	-1.0323717397755	11.6980790861878	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATGCTCCATTTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2628.74096722934	46.9567554723137	0.0178628309360604	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2618.98812225963	2618.98812225963
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGAAGCATCGCTAA"	-1.54378793659862	11.8970098265442	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGAAGCATCGCTAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2178.71219768473	42.3131835755063	0.0194211900132893	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2175.28378795726	2175.28378795726
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATTTCGTAAGCGGT"	-2.2834726375645	13.1218623884949	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCGTAAGCGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2434.50346442062	39.6580698703209	0.0162900034647349	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2429.95987378425	2429.95987378425
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGAAGTCGGTGTTA"	-1.71186469021495	11.3702993162903	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGAAGTCGGTGTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.94695070522	43.0601303351016	0.0166451539809748	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2583.29628141802	2583.29628141802
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCAACAGAAACCAT"	-2.77548203888591	13.4586000212464	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACAGAAACCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2626.47461653809	37.9403355751676	0.0144453463727649	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2623.84025219107	2623.84025219107
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACATTTCTCATGAGTC"	-2.4167951149052	13.252074218634	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACATTTCTCATGAGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2304.77631590221	46.9583291894209	0.0203743542769958	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2303.28985038716	2303.28985038716
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCAACAGGTTGCCC"	-2.59453998032268	13.1612033613953	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACAGGTTGCCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2646.02255676844	38.4467990188621	0.0145300344929096	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2637.97077580799	2637.97077580799
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCAACCACATATGC"	1.53182425078694	11.2542810210022	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACCACATATGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2108.97623407109	42.7910191991813	0.020289948510505	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2101.17127641403	2101.17127641403
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCGGAATCGATTGGT"	-6.79429612579997	2.86922714794008	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCGGAATCGATTGGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2647.87744691707	40.9615395197604	0.0154695752884832	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2643.62397624883	2643.62397624883
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTAACTCAACCTCC"	0.185159270733041	11.5298766859802	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTAACTCAACCTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2771.91419686073	37.291326521261	0.0134532759215615	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2754.45652786912	2754.45652786912
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCAACACAAGACAAT"	-1.56223390522655	11.5343866118225	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACACAAGACAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2476.00871062062	47.8349352858918	0.0193193727795496	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2463.85753254832	2463.85753254832
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCAACACAAGGATGC"	-1.61814747276958	10.8688239821228	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACACAAGGATGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.14247802085	41.6105676863145	0.0170665037262678	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.01992737802	2437.01992737802
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCATCTCGTGCTATTG"	-2.47908029976543	13.1947030791077	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATCTCGTGCTATTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1800.75858211069	40.4499538876737	0.022462730034729	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1796.57460339576	1796.57460339576
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCACGCTCTAACGCA"	-7.13037000122722	3.12728426540223	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCACGCTCTAACGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2578.39857359422	39.8116802519368	0.0154404678390899	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2569.91166423284	2569.91166423284
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCAACAGTGTACGCC"	0.53102078017537	-9.92089273845824	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCAACAGTGTACGCC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2381.24062479741	32.8861041529214	0.013810491812737	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2380.13177075417	2380.13177075417
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCCAGTTCGCCAACG"	-0.383599261671859	11.0634660490784	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCAGTTCGCCAACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2366.71867413324	43.1375894853921	0.0182267499542126	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2362.00192724761	2362.00192724761
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGAGTAGATTCGAA"	0.82451101121251	10.2004842528137	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTAGATTCGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2117.18379872982	32.7927488132999	0.0154888530853928	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2112.98941433348	2112.98941433348
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGATACAGAGTGAC"	-0.827961723238784	11.6947984465393	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGATACAGAGTGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2180.12659060278	45.9425019305551	0.0210733184616828	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2174.08657868089	2174.08657868089
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCAGGGTCCGGACT"	1.56755282458608	11.0966109999451	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCAGGGTCCGGACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2214.20169866163	33.7840075329691	0.0152578726470086	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2206.2815207909	2206.2815207909
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCCAAAGTTAACAG"	7.59229769286458	-9.38318636333617	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCAAAGTTAACAG"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2949.08814328816	34.5576516734275	0.0117180802995249	3151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2943.03429260085	2943.03429260085
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTGATTCCGCAGTG"	1.46483935889546	11.2705507048401	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTGATTCCGCAGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2189.00737689592	39.9930926031884	0.0182699670294852	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2181.62988627143	2181.62988627143
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCCAAATCCCTTTGG"	1.37910177287404	11.1386613615784	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCCAAATCCCTTTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2056.37065718824	38.980186332925	0.0189558172290905	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2052.82586137653	2052.82586137653
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCCAAGTCATGACT"	-2.1113363308018	12.7769508131775	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCAAGTCATGACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2385.19458076403	41.1548937731844	0.0172543129625934	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2378.84075818498	2378.84075818498
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGAACGAGCTGAAAT"	-1.03542397442515	11.1218862303528	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGAACGAGCTGAAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2626.78798412657	39.3618514846641	0.0149847843535618	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2622.88441573006	2622.88441573006
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCGTTCAGCTAATGA"	-0.88336549225505	11.9061641463074	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCGTTCAGCTAATGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2607.41234054732	38.1485937811831	0.014630825047478	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2595.02848535979	2595.02848535979
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCCAAGACTGG"	-3.18813715401347	13.0880861052307	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCCAAGACTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2522.03532548637	41.401842907433	0.0164160440137565	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2516.45049288406	2516.45049288406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGACGAGCACTCGC"	1.35690440711324	11.4425239332947	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGAGCACTCGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2319.13468619831	33.1211671106032	0.0142816919205748	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2312.40601021871	2312.40601021871
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGATGGTCCAAGCTA"	0.971554895013016	10.6415643461975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGATGGTCCAAGCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2203.70863359368	39.312524313305	0.0178392568391387	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2198.43129786307	2198.43129786307
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCCTCGTTGCAACT"	-2.56096134606059	13.0514268645081	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCTCGTTGCAACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2522.37830379571	46.0318274107232	0.0182493749416786	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2519.68656126822	2519.68656126822
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGAGATACGAT"	-8.01102481308635	2.24860689723817	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGAGATACGAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2545.49946029249	46.4480186921613	0.0182471139423555	3101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2541.90788106043	2541.90788106043
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCGATAGAATCGCG"	-1.30725882473643	9.90991113269655	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATAGAATCGCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2377.40361649557	37.6262231563609	0.0158266029778419	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2373.53421116262	2373.53421116262
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCTGAATCCTGTAGA"	-8.40959773483928	3.00149891460267	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGAATCCTGTAGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2928.24289959455	43.344371603178	0.0148021776503512	3469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2921.82605117776	2921.82605117776
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCGATCAGAACGCA"	6.50549711760823	-9.9827394715515	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATCAGAACGCA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2217.05850408052	38.6463602793281	0.0174313669252296	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2215.41557963853	2215.41557963853
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGGTTGCCATA"	1.45682122287099	11.0867957838806	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGGTTGCCATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2313.22535168818	40.2449536474204	0.0173977661182253	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2307.63739310223	2307.63739310223
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCGATGTCTACACA"	-2.54901681366618	13.2051563032898	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATGTCTACACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2434.13009906769	34.637808877476	0.0142300565161833	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2428.94480973924	2428.94480973924
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCTGTCGTTCGGTCG"	6.82282938536946	-10.0959053269592	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCTGTCGTTCGGTCG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2649.93741432685	41.7253779600819	0.0157457975175166	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2648.59028029423	2648.59028029423
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCCTATCAAACTGC"	6.79088367995564	-10.1697578660217	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCTATCAAACTGC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.30862874368	43.3785590945909	0.0173354152226897	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2493.70031646284	2493.70031646284
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGATGTCATAGGTTC"	0.0435508536988914	11.9722308882507	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGATGTCATAGGTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.11354838336	40.9102297689106	0.0158314365847059	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2577.33403741612	2577.33403741612
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCATCACTCCTGTTAT"	-0.918654779822189	12.3011369475159	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCATCACTCCTGTTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2585.8618576265	48.2834176936547	0.018672079311295	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2582.0044465408	2582.0044465408
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGGTATCGTCAGAT"	-2.8799708885258	13.3377370604309	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGGTATCGTCAGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2385.48170480381	37.5959106360138	0.015760301393343	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2380.03276741737	2380.03276741737
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGCACGCACATCCCT"	-2.29418645325359	13.4509620436463	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGCACGCACATCCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2815.85178057924	37.1390143494744	0.0131892646500856	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2811.92340992361	2811.92340992361
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCTTTTCATTTGGG"	6.56537737426106	-10.0306062928406	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTTTTCATTTGGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2686.68601541481	28.5767739639125	0.0106364397625751	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2681.36296005655	2681.36296005655
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCTTTTCCGTTGGG"	1.44555725631062	11.0148439177307	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTTTTCCGTTGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2377.05640905261	37.0993449650909	0.0156072631780232	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2372.22989877411	2372.22989877411
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTATGGCATCTGGGC"	-7.79686055603679	2.67449829662172	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTATGGCATCTGGGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2549.90947616578	45.367926825674	0.0177919754602004	3606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2544.24322002021	2544.24322002021
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCGAGGTCGCACTCT"	6.39363207396809	-10.1560058823791	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCGAGGTCGCACTCT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.55609210601	31.7896665740242	0.0116721174446026	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2716.59374383337	2716.59374383337
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTGGGTGTCGAAACG"	-2.73301825943645	13.4304008253845	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGGGTGTCGAAACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2575.87825234259	39.9802112959604	0.015521001918317	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2571.03668403195	2571.03668403195
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTAGGGTCGTATGT"	7.43930019912068	-9.85984518444213	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTAGGGTCGTATGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2514.14540406119	40.8394583169913	0.016243872868698	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2507.63394192187	2507.63394192187
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGTGATCTAGTGTG"	-7.4994662803715	3.11049888217775	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGATCTAGTGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2775.26297701424	36.7757452336515	0.0132512650290231	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2769.45536522251	2769.45536522251
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGAAGAAATTGC"	-1.33492527428325	11.3154878386292	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGAAGAAATTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2339.21321599108	43.4703129063707	0.018583305108403	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2334.44622201202	2334.44622201202
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGAAGCAACTCT"	-7.39737830582316	3.19503948772279	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGAAGCAACTCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2636.98423174772	42.6530381142934	0.0161749310446291	2576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2622.17944595607	2622.17944595607
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGGTCGGTCTGTGCG"	-7.85851130905803	3.07079193675844	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTCGGTCTGTGCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2510.65963220473	45.9307136989056	0.0182942813552834	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2503.91827623113	2503.91827623113
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGAAGTGGTTGG"	-2.01757655564006	11.1709918745789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGAAGTGGTTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2292.37414149716	47.2382684563838	0.020606700974882	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2281.46031814604	2281.46031814604
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGACAATTGCCA"	7.11449493941609	-9.88724901592406	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGACAATTGCCA"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2899.58623681534	42.4335211160378	0.0146343366433699	3261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2893.70536713642	2893.70536713642
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGGTTACAGACCCGT"	6.89807858046834	-9.88355066692504	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGGTTACAGACCCGT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2475.64506816328	38.7534365751009	0.0156538742461385	2657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2469.93724558084	2469.93724558084
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGAGTAACACCT"	7.18015303191487	-9.52033426677855	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGAGTAACACCT"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2692.9977806343	36.979350177958	0.0137316675282399	2460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2685.40321601704	2685.40321601704
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCTCGATCAAACGTC"	8.52219357070271	7.83563993060914	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCTCGATCAAACGTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2169.37869372972	35.8655506849264	0.0165326371041583	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2159.31526593866	2159.31526593866
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTTCAAGACATACA"	1.08840908583943	11.4717483290466	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCAAGACATACA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2451.75389717971	35.4123157813832	0.0144436665613618	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2445.43696899705	2445.43696899705
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTTCTGGTTGCTCAA"	-1.90730009499248	13.4584522017273	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTCTGGTTGCTCAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2886.26294769365	43.2745877525907	0.0149932935899588	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2878.28865501166	2878.28865501166
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTTCAAGTAACGTA"	-6.97968993607219	0.0841195595446005	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCAAGTAACGTA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2717.44295426646	32.3920245916788	0.0119200384835392	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2710.48126673607	2710.48126673607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTTCACATCCTTGC"	8.27810062941853	7.99241540515748	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCACATCCTTGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2255.60479987605	41.3193334949788	0.0183185163895951	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2248.25901495931	2248.25901495931
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTTCACATCTCAAG"	8.27590908583943	7.65341708743898	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCACATCTCAAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2458.47008958601	47.6434968192407	0.0193793274203566	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2449.86089444084	2449.86089444084
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGTTCATCTTACACT"	1.47092105922047	11.4652824171814	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGTTCATCTTACACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2050.64781628073	40.6811703544567	0.0198382043135229	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2046.51341837899	2046.51341837899
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTCTCCAGGCTCTG"	-3.00397072258647	13.3127040632996	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTCTCCAGGCTCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2622.32196396099	43.331946613666	0.0165242663598079	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2616.23056302855	2616.23056302855
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTAGTTCTTCGCTG"	-3.42777405205424	12.6592197188172	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTAGTTCTTCGCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2361.32050513176	44.7869778377679	0.0189669203060043	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2354.28707965298	2354.28707965298
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTCCTCACGAGGAT"	1.16795303401296	10.7624826201233	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTCCTCACGAGGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2174.2964794437	35.7228454056274	0.016429611022857	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2170.96460423992	2170.96460423992
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCGATCGGTTAAGGAT"	-8.10267100754436	2.42458055103151	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGATCGGTTAAGGAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2632.19305612063	43.9191447857006	0.0166853812958649	2924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2625.82051753816	2625.82051753816
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGACGGAGCGCGTTC"	6.65851463851277	-9.97025682842406	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGAGCGCGTTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2252.83991818378	45.2393226891752	0.0200810196605744	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2247.02045188687	2247.02045188687
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGACGGCATGGCCAC"	-7.38129554215129	3.28137109363405	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGACGGCATGGCCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2537.03457781813	43.3861856450918	0.0171011408454686	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2531.01194672789	2531.01194672789
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGATCCTCAGGACGA"	5.97718014296834	-10.086057685968	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGATCCTCAGGACGA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.26707925059	43.1461333633286	0.0159784688317953	2826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2695.95218235614	2695.95218235614
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTTGAAGGTTCCAT"	-2.14644203606303	13.1831702955994	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTTGAAGGTTCCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2826.4282681474	37.9303296545681	0.013419880519179	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2814.62414351622	2814.62414351622
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCAATCAGACCCG"	1.38592412051503	10.7738437422547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAATCAGACCCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2151.96110431354	38.1426199658158	0.0177245861411529	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2147.53209811606	2147.53209811606
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTTGACAACTGCTA"	0.888524492352647	12.0913772352966	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTTGACAACTGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2384.06668290488	33.8962502382143	0.0142178280839499	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2381.34013247493	2381.34013247493
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAACGAAGTTCAAACC"	1.25644769248311	11.6189203032288	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGAAGTTCAAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2505.02650108537	39.4425955859944	0.0157453805653971	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2498.10699501694	2498.10699501694
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCTCTCACTTTGT"	0.0756703290039718	11.621760345343	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCTCTCACTTTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2584.27626889908	35.3138300477911	0.0136648819140514	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2578.88120110675	2578.88120110675
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTACGATCATGCTAG"	6.39164604720418	-10.0211944810119	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTACGATCATGCTAG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2787.69347117121	40.9587148733784	0.0146926896005428	3084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2780.44819730792	2780.44819730792
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCACACAGTTAGAA"	-2.19083462181743	13.430151916388	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCACACAGTTAGAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2805.42369292125	37.47155096101	0.0133568241601294	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2792.79136922818	2792.79136922818
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCATCTCACTGTTT"	-2.7925365966862	13.0322303541931	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCATCTCACTGTTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2481.19557816015	41.5669070847362	0.0167527733204969	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2476.59699145142	2476.59699145142
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATCTCAGCAGTCC"	8.03874983367268	7.93275353992311	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATCTCAGCAGTCC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2182.97752249221	43.5692147561369	0.0199586181292402	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2174.93922053057	2174.93922053057
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCACAGTTCAGTAC"	0.725212772458237	11.7867393263611	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCACAGTTCAGTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.76163084672	44.7119122417951	0.0183941986225199	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2424.17083228286	2424.17083228286
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCAGTTCATCTCTA"	-2.52345190468486	13.2132138975891	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCAGTTCATCTCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2803.05411740731	42.1248249938866	0.0150281882651806	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2793.52569798627	2793.52569798627
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGCACTTTATC"	-0.549703041941482	10.2894019850525	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGCACTTTATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2307.90942008741	46.178991705972	0.0200090139171159	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2303.65168459182	2303.65168459182
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATTCGTATTCCGA"	-2.61850462380107	13.4773282774719	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATTCGTATTCCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2596.01721570659	42.8966035072566	0.0165240057915336	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2590.54976119461	2590.54976119461
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCCTAAGTTACGGG"	1.52838661250417	11.1160678633484	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCTAAGTTACGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2302.65476322023	37.9111517365269	0.0164641058408203	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2295.7582686112	2295.7582686112
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATTCTCAGGAGAC"	-0.869352678686935	10.9707441099915	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00168293503870751	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATTCTCAGGAGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2052.16414838633	40.5078769138982	0.0197391017408381	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2046.34926002677	2046.34926002677
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGAACGGTCATAGTC"	-7.98025832596477	2.94767830455629	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGAACGGTCATAGTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2460.12691345854	47.8663511841184	0.0194568625391875	2884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2454.37623499209	2454.37623499209
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTCCCAGTTCCCACT"	-2.80314598503764	12.9599971541199	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCCCAGTTCCCACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2272.43818912117	41.0881536458889	0.0180810874604159	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2272.43818912117	2272.43818912117
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTCCCATCCGAGTGC"	-1.13150594654735	11.4386949309143	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTCCCATCCGAGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2422.96333812278	43.6785891108058	0.0180269294312337	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.68606757393	2415.68606757393
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTAGTCCCGATCT"	-1.34779820862468	11.5169639357361	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTAGTCCCGATCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2917.05755969362	36.977730206324	0.0126763800335184	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2905.66935163524	2905.66935163524
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGCCTGTCTCGAGTA"	-4.72098002854045	-5.96296884929808	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	62	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.142857142857143	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGCCTGTCTCGAGTA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2647.72783411264	35.8723565764803	0.0135483549760327	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2644.42602715334	2644.42602715334
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGGCAGGTAGCCAGA"	-0.396506409079391	10.5990352400574	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGCAGGTAGCCAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2337.26712859702	40.201562191372	0.0172002428389534	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2334.02426208333	2334.02426208333
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGGCAGGTTCTCGTC"	8.03549351271931	8.2709111937317	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGCAGGTTCTCGTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2135.97589080653	42.3718284628787	0.0198372222482715	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2123.93741821824	2123.93741821824
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCAGTGTTGTC"	-7.38175187531169	3.00966856563417	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCAGTGTTGTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2756.45127098711	38.0144980514703	0.0137911010622934	2807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2750.28117771779	2750.28117771779
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGCAACAGGCATGA"	-1.24462924423869	11.7117595442566	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGCAACAGGCATGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2552.72400625137	40.0516479403262	0.0156897682014364	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2546.11154688618	2546.11154688618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTCCGTGTTTACG"	-2.06672869148906	13.5791263350281	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTCCGTGTTTACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2303.69808046584	37.9673097389982	0.0164810267721023	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2299.36402905176	2299.36402905176
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGTCCGTGAATGTA"	0.336606611579102	11.491524673346	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTCCGTGAATGTA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2252.68092531553	38.4828852226013	0.0170831495886223	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2242.31153170466	2242.31153170466
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAAGCTAGTACGTACT"	6.38417973098103	-10.0182991257873	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAAGCTAGTACGTACT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2595.5907549992	38.3920129454429	0.014791242753311	2542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2593.24912323077	2593.24912323077
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACACACCAGATACTC"	6.13566269454305	-10.0459633103577	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACACACCAGATACTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2740.6637710469	40.8692706123832	0.0149121796858619	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2734.78365479848	2734.78365479848
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGTCGTAGCAAATCA"	-1.49688814106639	11.725839591864	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTCGTAGCAAATCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2249.30070552653	44.1058051366636	0.0196086743885759	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2249.30070552653	2249.30070552653
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGTGAGTTCGTAAC"	-2.91319928589519	12.8440255888733	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTGAGTTCGTAAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2382.41862217891	41.6286959954466	0.0174732918924945	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2379.35056445105	2379.35056445105
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTTAGGCATTCTTCA"	0.226841216056985	11.5473842390808	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTAGGCATTCTTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2271.77384995602	38.0046560026867	0.0167290665853129	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2262.58054376254	2262.58054376254
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGATGTCATGGCCG"	7.45347656783406	-9.50311090862425	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGATGTCATGGCCG"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2454.80254567087	37.1260834182967	0.0151238573072893	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2451.9249597962	2451.9249597962
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGGTAGAGGAGCTGT"	-2.33022222939189	13.0977153548035	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGTAGAGGAGCTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2798.59531128553	43.1527610781894	0.0154194359235052	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2791.08789858372	2791.08789858372
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCGCTGAGACCGTTT"	1.23960794982259	11.087261176947	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCTGAGACCGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2385.36521174516	39.5504276133326	0.0165804495758522	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2374.37025726318	2374.37025726318
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGGTATCGTGT"	-1.95640001717265	11.3286895521912	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGGTATCGTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2288.95053752159	43.1614772658475	0.0188564482099214	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2284.76681761002	2284.76681761002
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGGTCGTATTG"	-2.98710689964946	12.7364291914734	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGGTCGTATTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2396.56909828903	38.4445663228018	0.0160415013071179	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2392.18080778561	2392.18080778561
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGTGGGGTTCCTTGC"	-0.438288132578689	11.1161784895691	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTGGGGTTCCTTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2240.03625873534	41.4211760238227	0.0184912971217742	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2236.50052451901	2236.50052451901
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGTAGAGTTGGAGAC"	6.10919394072835	-10.0545158616272	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGTAGAGTTGGAGAC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2479.73902145154	38.8116124622012	0.0156514907925603	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2475.4367792286	2475.4367792286
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGGTACCTTCC"	-1.35101697865184	11.6159772642883	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGGTACCTTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2391.82396925958	43.0579484639325	0.0180021393787025	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2387.21047281894	2387.21047281894
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCATGAGCGACATG"	-1.13081870499309	10.433865524176	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCATGAGCGACATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2219.19203982367	44.5948555866195	0.020095086313559	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2213.96474571154	2213.96474571154
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTACCGCATAGGCGA"	1.11912431296651	10.6914205321106	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTACCGCATAGGCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2326.93528142176	36.9838022498025	0.0158937820682341	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2318.99737591981	2318.99737591981
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCCAACACTTCAAG"	1.16564704951589	11.4221734770569	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCCAACACTTCAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2282.18307266334	36.2972991861468	0.0159046395624113	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2275.53550871918	2275.53550871918
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTTTGTGTATGGAAT"	1.35682465609853	11.2387199171814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTTTGTGTATGGAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1898.88068570438	46.9181274529753	0.0247083072708021	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1895.26601402633	1895.26601402633
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTCAGAGTCAGCGA"	0.74405594643895	11.4203147658142	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTCAGAGTCAGCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.95919499186	41.6919137415297	0.0174227432832056	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2388.39429944237	2388.39429944237
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCAATAGTACGAGC"	1.16423465785329	11.6587657698425	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCAATAGTACGAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2343.58544573239	37.2199536023284	0.0158816285832911	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2339.48262790496	2339.48262790496
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTCAGGTCGACTGC"	-7.97734961929973	2.74989125812379	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTCAGGTCGACTGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3048.84388289994	40.9586494144831	0.0134341576635682	4164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3042.12772128708	3042.12772128708
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCAATCATGCGGTC"	1.51354231414143	11.1312894591126	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCAATCATGCGGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1992.33877338764	39.3006486673258	0.0197258865772619	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1990.39979754003	1990.39979754003
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCAATCATTAAGCC"	-1.48331258717235	13.4575786360535	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCAATCATTAAGCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2643.84107009384	37.918626473419	0.0143422488221174	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2634.14225879213	2634.14225879213
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCAATTCGATCCAA"	1.10092153128926	11.3325576552185	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCAATTCGATCCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2098.13000236687	38.470490835991	0.0183356087528385	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2093.98545329985	2093.98545329985
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTGTGGTAGATGTA"	0.17213494059388	11.3447322615418	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTGTGGTAGATGTA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2386.03000487232	41.8117423146715	0.0175235609901347	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2375.20457900943	2375.20457900943
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAAGTAAGTCGTTAC"	1.30381228503529	10.3585529097351	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAAGTAAGTCGTTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2012.33912943431	40.1982746724962	0.0199758947607387	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2005.90190150496	2005.90190150496
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTTGGCATCACAGT"	0.421886821358842	10.6441745528015	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTTGGCATCACAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2599.69912051886	41.4998347771914	0.0159633222358858	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2593.1606722426	2593.1606722426
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCCGAGTGAGACGT"	1.46480848368947	11.0272264250549	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCGAGTGAGACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2283.96415679507	38.0831810025045	0.0166741587818717	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2278.72536712593	2278.72536712593
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGGGACATGTCTAG"	1.45361318167989	11.3423537977966	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGGGACATGTCTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2217.95510756555	39.0753912516047	0.0176177557058376	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2214.70043842311	2214.70043842311
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCCTTCATCAACCA"	-2.26294169846233	13.6636857756409	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCTTCATCAACCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2962.4954447962	30.6859095963308	0.0103581288707911	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2951.15044180673	2951.15044180673
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACAAATCCGTCAAA"	-2.03877649727519	11.9555473097595	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACAAATCCGTCAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2356.22558874386	38.8207812062969	0.0164758338046031	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2350.79215484626	2350.79215484626
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCCTTTCGATCCCT"	0.531187196343583	10.4395255812439	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCTTTCGATCCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2415.02246448509	42.2624184781698	0.0174998034592529	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2412.34205802028	2412.34205802028
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCCTTTCTTGGATG"	0.787093480199021	10.5214814909729	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCTTTCTTGGATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2179.89330439786	41.6462064781371	0.0191046994796109	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2172.99367683238	2172.99367683238
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGTCATCACCCTCA"	-1.67571292343791	11.6844692000183	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGTCATCACCCTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2688.34078623631	40.1735924730206	0.0149436383507255	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2681.74335701039	2681.74335701039
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGAGGTCAGAGGTTG"	-2.70172152939494	13.2284126051697	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAGGTCAGAGGTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2432.577523617	45.4700837656505	0.0186921416991641	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2429.69859803018	2429.69859803018
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAATTGGTTCTTAGG"	0.381303836672944	11.1650981673035	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAATTGGTTCTTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2566.01652323071	37.727817014377	0.0147028737628221	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2556.99214889888	2556.99214889888
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAATTGTCGAAACAA"	0.392742415040177	11.356849647406	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAATTGTCGAAACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.45972387047	41.5671038139458	0.0180220375772234	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.84797282692	2297.84797282692
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCATGTCGCATTA"	-1.42497013035472	11.5882549055847	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCATGTCGCATTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2612.53952390889	44.5300119968582	0.0170447228029807	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2606.88649227618	2606.88649227618
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCATGTGATACTC"	-8.40444217148479	2.54083774173585	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCATGTGATACTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2756.15348796323	43.2883598364906	0.0157060773376886	3864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2748.47931224337	2748.47931224337
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGAACAGTGTGCCTG"	-2.42345104637797	13.5024213560852	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGAACAGTGTGCCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3280.00681804366	43.6313239391547	0.0133022052573593	3011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3269.60278464008	3269.60278464008
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCATTCTTTGCTA"	0.768919308751267	10.5270128020081	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCATTCTTTGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2318.05590440405	41.7009500549937	0.0179896222415372	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.85485528598	2309.85485528598
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGCCAAGGAAAGAC"	-8.12789473953899	2.44267675960389	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCAAGGAAAGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2618.64567952044	45.1883636960872	0.017256387165889	3888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2610.55626170551	2610.55626170551
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTTCAACAGTCTGGC"	-0.238427261740524	10.8867978819641	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCAACAGTCTGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2381.61463167964	37.5641293172298	0.0157725472532631	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2378.06643375995	2378.06643375995
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGAACATCTTGGCTC"	-1.57933102074321	12.7676782377991	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGAACATCTTGGCTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2724.59955513698	40.3649679368486	0.0148150093692646	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2712.77921186501	2712.77921186501
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCCAAGTACTCAAC"	7.5202394920284	-9.35885336315306	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCCAAGTACTCAAC"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2585.61715812243	43.7393671215773	0.0169164127737066	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2579.43967903942	2579.43967903942
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGAATTCGACTCCT"	0.327792544930619	11.6162767180237	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGAATTCGACTCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2768.57184695932	37.9481470202674	0.01370675897826	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2757.18438205708	2757.18438205708
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGGTACGCGTC"	3.61303486403767	-10.2876034013	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGGTACGCGTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2477.59526537271	44.9689561282367	0.0181502430024509	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2471.92006251683	2471.92006251683
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGTCATGCCGG"	7.01727356490437	-9.96424963390502	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGTCATGCCGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2533.8571137797	43.0076602536678	0.0169731986937157	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2530.82100306828	2530.82100306828
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGAAGTCGGCATTA"	-3.31303892555888	13.1478204497131	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGAAGTCGGCATTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2607.23715367576	44.2986856414416	0.0169906621570608	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2600.42918923468	2600.42918923468
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTTCGGCAATACCCA"	-2.67398271980937	13.4284524687561	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCGGCAATACCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2313.10317282955	43.8036149566536	0.0189371643561709	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2308.77229915951	2308.77229915951
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGAATCACATTACG"	1.20454647120778	9.57327458942262	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGAATCACATTACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2221.22052889635	38.7219194001343	0.0174327217385182	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2216.2589659062	2216.2589659062
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGAGCCAAAGTATG"	-1.38736544075664	11.7816343077454	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGAGCCAAAGTATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.85906903752	44.9339163579163	0.0193943243930598	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.28270942783	2314.28270942783
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGAGCCACTATGTG"	-2.87720356407817	12.6763257750305	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGAGCCACTATGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2253.19022174641	40.7835517537412	0.0181003589311383	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2243.63451311941	2243.63451311941
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGAGCCAGCCTACG"	0.306642551987809	11.0325679549011	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGAGCCAGCCTACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2201.79745605208	44.5237982953427	0.020221568597493	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2197.10901693361	2197.10901693361
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGAGCGTTCGGTCG"	4.44951786574666	-9.92253782665404	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGAGCGTTCGGTCG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2373.75867258791	43.3085075358726	0.018244696917171	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2371.69139126467	2371.69139126467
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGCCATCATGGGATG"	1.33193304118459	10.5857524641785	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGCCATCATGGGATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1984.16270205703	43.9482153205199	0.0221495017898269	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1978.75891524173	1978.75891524173
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGGCTTCAGCGGAA"	1.48958172377889	11.2135181196961	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGCTTCAGCGGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2283.43202959826	38.7588450672771	0.0169739429791988	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.82295189473	2276.82295189473
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGAGCCCCAAGTGATA"	-7.96595416489299	3.54772422397462	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGAGCCCCAAGTGATA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2201.47145505162	42.8114987715698	0.0194467653320383	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2196.8307057976	2196.8307057976
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAATGAGTAATACCC"	-8.03561149063762	3.78502175891725	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAATGAGTAATACCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2386.79361279313	42.3018457736623	0.0177232943589785	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2379.3609581496	2379.3609581496
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAATGAGTGCCGTAC"	1.40048660811726	11.3519172438416	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAATGAGTGCCGTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2127.94703902948	33.2554465857868	0.0156279484290897	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.81521928717	2121.81521928717
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATAGACAGCCATTA"	0.545572658150834	10.5594777830872	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATAGACAGCCATTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2148.71597871819	36.8943198039653	0.0171704032405318	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2145.66411818971	2145.66411818971
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATAGAGTCACTCTC"	1.12662448462788	10.9457511671814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATAGAGTCACTCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2062.06672096439	49.7173769168262	0.024110459866	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2054.98643963079	2054.98643963079
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAACACTGTATACGGG"	-0.074784736067611	11.428081489447	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACACTGTATACGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.77629556581	41.5534472817392	0.0177899944273874	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2331.88776225651	2331.88776225651
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGAACATCTTTCA"	-7.23087487641032	2.7631637820038	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGAACATCTTTCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2823.16210640147	44.3167832643222	0.0156975694607953	3403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2811.20930128672	2811.20930128672
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAACGTTTCGTGCACG"	-2.77855644646342	13.3982639082703	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACGTTTCGTGCACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2267.56897506959	42.4207628734768	0.0187075953763104	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2264.72887039677	2264.72887039677
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGATCGGTCTTTGATC"	-1.77026663246806	11.8872289427551	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGATCGGTCTTTGATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2658.90842288782	44.6653950575842	0.0167983954141127	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2651.64247877956	2651.64247877956
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAACTGTTCCGAGGCT"	1.48018040236775	11.0443944700989	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACTGTTCCGAGGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2187.58019594305	36.3980324930601	0.0166384905845106	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2180.68035048006	2180.68035048006
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAGTCGTTCTCAATCT"	1.41582049903218	11.3969735869202	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAGTCGTTCTCAATCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2183.54244099812	37.1769645976757	0.017025986717566	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2179.66844050908	2179.66844050908
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATATCCGTCGAGCAA"	1.21842660483662	11.2596044310364	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATATCCGTCGAGCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2059.61682897461	39.8802826823883	0.0193629621400223	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2058.63580895236	2058.63580895236
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATATCCTCTGCGAGC"	-1.90678332272227	11.1524734267029	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATATCCTCTGCGAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2368.7342582241	43.8740634212296	0.0185221551420982	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2365.23639187786	2365.23639187786
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAATCGAGTCCTACA"	1.38857914981191	10.6904115446839	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATCGAGTCCTACA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1995.77419501337	33.1695112856638	0.0166198718114208	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1987.53139625094	1987.53139625094
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCAGGGTGACTGTT"	1.49478532847707	10.7283220061096	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCAGGGTGACTGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2365.73969479338	44.4849990891154	0.0188038435450104	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2361.04880489212	2361.04880489212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCAGGGTGTGATGG"	-1.60381613197978	11.2535018690857	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCAGGGTGTGATGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2475.28773797449	43.0133175657766	0.0173770979857776	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2472.83597828386	2472.83597828386
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCAGGTCCTAGCCT"	-7.93731627884563	-1.32174804126891	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCAGGTCCTAGCCT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3459.61890364457	37.5430932667229	0.0108518002451579	5324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3447.86993045751	3447.86993045751
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCCTAGTAACGATA"	0.230383013456505	11.4394140013489	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCCTAGTAACGATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.8601434705	41.3453769427002	0.0171425267151714	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2403.2731730322	2403.2731730322
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGGGTGTGTTCCAA"	1.24456467208211	11.3436450728211	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGGGTGTGTTCCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2324.22261961062	37.9010742127981	0.0163069896545227	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2322.33289047837	2322.33289047837
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAATGCAGTCATCGT"	-7.78007398071941	2.69893834674684	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAATGCAGTCATCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2558.18760412673	44.6396210274025	0.0174497057820905	3480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2550.48993982925	2550.48993982925
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCCAATGTCCAGCCA"	0.972345014184159	11.2023887404236	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAATGTCCAGCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2281.27823120132	43.7847987595095	0.0191930989217622	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.40396009731	2274.40396009731
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCGCCTCGCCTAGG"	1.33831038054768	10.8949851759705	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCTCGCCTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2311.51951461837	35.2567787396425	0.015252641613741	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.44373872304	2308.44373872304
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCGCCTCGGCTTCT"	-1.71705542030986	12.9823474653992	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCTCGGCTTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2615.08922175089	46.2115333813827	0.017671111561709	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2610.5980435584	2610.5980435584
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACAGTCATCGTCCT"	1.17501463469807	10.364041305426	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACAGTCATCGTCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2071.9293292188	34.1051582503523	0.0164605798901506	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2065.02055640486	2065.02055640486
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCCAGCGTAGGACCA"	-8.35671267929729	3.16126368129579	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCCAGCGTAGGACCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2478.31798795961	46.0236926080669	0.0185705356744628	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2473.74449101256	2473.74449101256
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACAGTTCATAGCAC"	7.05095877227132	-10.053978942987	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACAGTTCATAGCAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2630.75046744154	40.8009727358588	0.0155092522992265	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2627.11416999102	2627.11416999102
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATCGACCATATTCGG"	9.34281506118123	7.90814778888551	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATCGACCATATTCGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2458.77388479917	47.0555900832699	0.0191378273432058	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2443.16687022954	2443.16687022954
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACCCTAGTATTGCC"	0.355807651847047	11.1059551008972	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACCCTAGTATTGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2000.12367035893	44.4085095037394	0.0222028818326869	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1996.90623889997	1996.90623889997
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACGCGAGCATTTCG"	-3.1113694709843	12.9903125532898	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACGCGAGCATTTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2442.20200312125	42.5665307257402	0.0174295699828835	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2438.11782974656	2438.11782974656
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCGCCAGTTTCCAAG"	7.4900242286617	-9.86106970226439	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGCCAGTTTCCAAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2436.56214860665	45.0075210638267	0.0184717312010959	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2431.18748606444	2431.18748606444
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGCCAGATCTACTGCC"	-1.99777350845988	11.1657304533753	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGCCAGATCTACTGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2685.68514622185	47.4016302805539	0.0176497346858537	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2683.62527432323	2683.62527432323
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCGTATAGCGACCCT"	-0.694137792021591	11.4270829924378	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGTATAGCGACCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2319.64106900792	39.6500264579045	0.0170931731584069	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2313.79087093458	2313.79087093458
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACTCCAGACCAACG"	0.341564943164033	11.3019685515198	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACTCCAGACCAACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2292.74141333684	41.9100537009982	0.0182794507296846	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2287.56998684638	2287.56998684638
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGTTACAGTGGGTA"	1.49959554251973	11.1910714873108	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTTACAGTGGGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2279.77560243233	37.4180407110141	0.0164130367353226	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.05954072194	2274.05954072194
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCAATGTGCCGGTT"	1.25209011611287	11.200753188971	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCAATGTGCCGGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2366.25333458252	39.9095768594307	0.0168661471179594	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2356.93452425059	2356.93452425059
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGCATTCGCTCATC"	1.58335711535756	11.1718225249085	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGCATTCGCTCATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2103.70801632767	40.8131715090699	0.0194005875303529	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2096.3503016812	2096.3503016812
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGACCGTTTGATCG"	-2.20020065727885	13.0579509505066	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGACCGTTTGATCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2757.80292321372	42.4583797425884	0.015395726571031	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2750.63438600568	2750.63438600568
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCTACAAGGAAGTAG"	1.43755783614461	11.1290464171204	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTACAAGGAAGTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1898.79131572821	39.9045642328512	0.0210157714027396	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1894.84292056183	1894.84292056183
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACATCATCATGAGTC"	1.28464045104329	10.9812259444031	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACATCATCATGAGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2152.7316575624	36.3950338708503	0.0169064424462738	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2148.16630642349	2148.16630642349
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCTACATCCGCTTAC"	-2.95538196983989	12.8329877623352	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTACATCCGCTTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2605.09400273941	38.6655686379622	0.0148422930601748	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2599.95676895324	2599.95676895324
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACATCATCCAAGCTA"	-2.46788249436076	13.0526923903259	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACATCATCCAAGCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2567.32789060459	44.8456923614243	0.0174678476113402	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2561.23475131071	2561.23475131071
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCAATAGAACTTCC"	0.0583936544949233	11.3328027495178	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCAATAGAACTTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.31039169467	39.140042407597	0.0159604765123346	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2451.09243530189	2451.09243530189
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCCAGGTCACGTGC"	-2.84113798561748	13.2351608046326	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCCAGGTCACGTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2813.35425098511	37.6972987720991	0.0133994141544383	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2801.60934677303	2801.60934677303
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCTCAAGTATCTCGA"	-1.30276737633403	11.7714109190735	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTCAAGTATCTCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2554.54088692062	41.5855097440006	0.0162790542742614	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2549.89075246296	2549.89075246296
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCAATGTTTGGAAA"	-1.97122536125835	11.1347903975281	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCAATGTTTGGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2537.9907870125	41.6224829238494	0.0163997769955831	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2529.89896900643	2529.89896900643
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGTCAGTCCATACA"	-2.32440004769023	12.6286659010681	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGTCAGTCCATACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2167.33629295194	44.1303207978045	0.0203615474632681	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2163.85643826928	2163.85643826928
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATTTCCAGAGACAAG"	-2.30976591530498	13.535635925177	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCAGAGACAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2486.28360549057	42.7044286562645	0.0171760086266741	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2481.94614933731	2481.94614933731
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGAATAGTCAACATC"	-0.709250609309036	11.6147861250672	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGAATAGTCAACATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2324.49191997363	41.352068520908	0.0177897234942323	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.58044497343	2319.58044497343
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCATAAAGTGTACCT"	-1.53271685066875	12.0359020003113	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCATAAAGTGTACCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.64386093637	40.2001133784081	0.017211576666612	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2331.5820196984	2331.5820196984
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCCTTGTGGAGGTT"	1.63015260276143	-10.2783231965271	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCCTTGTGGAGGTT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2547.51834546364	36.1247300528228	0.0141803611020702	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2545.22618616627	2545.22618616627
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAAGCATGCAG"	-7.66134772720988	3.47702286327211	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAAGCATGCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2451.61683085301	46.2263546068177	0.018855456539974	2428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2443.02360300191	2443.02360300191
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATTTCCTCGCGTAGC"	-0.340990195900756	10.9705753096375	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCTCGCGTAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2227.39386129854	41.0372885266281	0.0184239030373837	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2227.39386129854	2227.39386129854
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCGTGCAAAGCGTG"	-0.157623509795028	11.7504806288513	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCGTGCAAAGCGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2278.93652140304	46.6360665425382	0.0204639603185728	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2272.33309112687	2272.33309112687
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACCGTGCACCAAAGG"	1.31421472606007	11.1951389082703	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACCGTGCACCAAAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1931.9349012449	32.0645116992101	0.0165970973859152	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1926.46780514167	1926.46780514167
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGGGTGTCATGATCTG"	6.08053555068318	-10.0887336960998	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGGGTGTCATGATCTG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2633.24758675143	41.1568961486066	0.0156297100036008	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2629.26761470312	2629.26761470312
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTTAGGCTT"	-2.52804384651836	13.1630725630554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTTAGGCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2465.4152086142	42.3380431505841	0.0171727841227937	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2461.18646866851	2461.18646866851
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCCATTCAAAGACGC"	-7.65553746643718	3.22778818691102	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCCATTCAAAGACGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2687.76538848408	44.7383260365501	0.016645175292544	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2681.2872687572	2681.2872687572
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTTTCCAAG"	1.42311193522755	11.324532485846	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTTTCCAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2354.03542850973	37.9715536489037	0.0161304087394056	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2341.87834600247	2341.87834600247
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATGGTGTTGAGTCT"	1.23562409457509	11.1714668043884	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGGTGTTGAGTCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1942.4267792085	43.1687799992155	0.0222241478861849	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1937.38283421474	1937.38283421474
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATGGTGTTGCAACT"	-2.10365662995036	12.3351611861023	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGGTGTTGCAACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2212.60642854064	40.7332426650829	0.0184096195959935	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2207.35523470907	2207.35523470907
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATGGTTCACCGCTT"	1.1323285299236	11.9278592833313	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGGTTCACCGCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.59067382877	43.2097469417214	0.0202331595990037	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2128.15478133414	2128.15478133414
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACTTTCCGAGCTG"	1.2472001510555	10.5123195418152	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACTTTCCGAGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2084.02299460711	37.9885184926655	0.0182284545760625	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2079.00449222834	2079.00449222834
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGAGGTAGCAGCCTC"	1.26229669627492	10.6275167235169	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGAGGTAGCAGCCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2218.40400735211	36.8836021770863	0.016626188040974	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2213.04639509726	2213.04639509726
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTATGGTCTCGGGT"	3.86611213263814	-10.852282547113	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTATGGTCTCGGGT"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2581.21884431217	41.4549075489159	0.0160602064564435	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2575.02681703647	2575.02681703647
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACCAAAGGGTCAAC"	-1.0111394924229	11.8890123137268	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACCAAAGGGTCAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.82454404315	39.8107244940894	0.0171315534970742	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2321.35949212762	2321.35949212762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GACTATGGTTTGGGAG"	0.760727305977982	11.2062597044739	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GACTATGGTTTGGGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2009.34152543405	38.9344816159135	0.0193767366687468	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1997.33987764255	1997.33987764255
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCACGGGTCCCAAAT"	-2.32259498062785	13.3085775145325	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCACGGGTCCCAAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2332.53031689775	42.6218119352344	0.0182727794046086	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2331.10736517422	2331.10736517422
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAGACACGGTGAA"	1.27668728408162	11.3162603148255	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAGACACGGTGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2179.9511442598	38.6450935794131	0.0177275044356716	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.61340471511	2163.61340471511
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGATCTCAATACGCT"	-2.7626989883488	13.2807979353699	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGATCTCAATACGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2585.19723431961	44.8078757661308	0.0173324786098666	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2572.34628931488	2572.34628931488
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCAGATAGGGATCTG"	-1.69218872013744	11.6654348143372	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGATAGGGATCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2317.67683635838	46.1133463137204	0.0198963658739306	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.0341058753	2314.0341058753
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCATTAGTCTCGTA"	1.26241077956502	10.1446857222351	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCATTAGTCTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2041.09161644905	34.0257286808609	0.0166703583546419	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2035.89708485259	2035.89708485259
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAGTACATCATTTC"	0.927122254937333	10.6200456389221	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAGTACATCATTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2037.4924453613	34.6615216384578	0.0170118528377226	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2034.70687085732	2034.70687085732
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACAGGTTGTGCAT"	1.12086917933766	11.2186717757019	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACAGGTTGTGCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2199.06007261656	34.9660126441011	0.0159004354085228	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2191.73910511187	2191.73910511187
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTAGTATCCCAGTGG"	6.24884047087972	-10.1433792344299	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTAGTATCCCAGTGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.84427130474	44.3428183658132	0.0184773732596012	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2394.56875008644	2394.56875008644
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTCAAAGTACCTTCC"	1.32071055945699	11.1361789473328	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTCAAAGTACCTTCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2295.46589582563	37.1321264549095	0.0161762919337793	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2290.15480811849	2290.15480811849
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCCACCATCTTAGG"	1.39451827582662	10.5310983427796	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCCACCATCTTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2134.43124747016	35.2610286428323	0.0165201051496156	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2128.4562205395	2128.4562205395
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCAGTAAGTCCCTAA"	0.312704046338242	11.2787742384705	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGTAAGTCCCTAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2157.08617234545	43.9616639398886	0.020380114852847	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2149.06972727559	2149.06972727559
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCTGCAGGGAGTGG"	-1.59288416329082	11.3301553496155	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCTGCAGGGAGTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2278.45008506556	44.5431469513835	0.0195497576371535	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2272.50796697148	2272.50796697148
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCTGCCATCCTGTC"	-0.0994446230238259	11.1700601347717	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCTGCCATCCTGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2327.37977050845	44.0839485087518	0.0189414504101842	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2318.06045222779	2318.06045222779
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCAAGAGTCACAGG"	-1.51279149475749	11.9147462614807	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCAAGAGTCACAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2626.42670159698	41.5167145798662	0.0158072999161265	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2623.09083673501	2623.09083673501
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTGAATCAACTCGTA"	1.57035579261128	10.8081502684387	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTGAATCAACTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.69991269269	38.8697810842558	0.0182000199809199	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2131.41488675925	2131.41488675925
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGTCAGTAGGG"	6.76949419555013	-1.39691927349242	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGTCAGTAGGG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2778.14250388017	40.9243398877025	0.0147308281812557	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2767.33001450168	2767.33001450168
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCATGATCACTGATG"	8.77740730819051	7.82087705219118	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCATGATCACTGATG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2211.7811808935	41.7002132124851	0.0188536793660752	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2201.08021818756	2201.08021818756
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTCAACGTATC"	6.94810785826985	-9.65343859111937	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTCAACGTATC"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2643.06566494595	39.8828639314292	0.0150896228044507	2544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2639.36986373006	2639.36986373006
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCATGATCCGAGTGC"	0.959214945405167	11.2381295927796	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCATGATCCGAGTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2251.83772759556	39.1950669266904	0.0174058132370584	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2245.93636106196	2245.93636106196
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGAGTGTTAGAGAT"	1.1520731645519	10.7276201018128	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGAGTGTTAGAGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2159.43235736146	36.1843905833798	0.016756436227339	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2154.01047921775	2154.01047921775
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAGGGACAGATACCT"	1.05006106671636	10.2566089400086	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGGGACAGATACCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2215.85654793368	40.4930201770971	0.0182742065206602	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2211.56019524778	2211.56019524778
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGCCTAGGTATAGT"	1.12795700606648	10.7211417921814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCCTAGGTATAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2181.95569619773	40.4124264092922	0.0185211947610645	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2174.48167226182	2174.48167226182
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTGAATCCGCTGTT"	1.41144706782643	11.1347560652527	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTGAATCCGCTGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2395.82333779032	36.6190017672249	0.015284516679347	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2389.17415452328	2389.17415452328
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGCCTGTTGCTGAT"	-2.82658491554912	13.3072280653748	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCCTGTTGCTGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2517.36404154041	45.1667953603306	0.0179420992017874	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2507.52123399748	2507.52123399748
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACCTTTGTGTGACCC"	-2.29952750626262	13.564818359259	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACCTTTGTGTGACCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2486.27486595537	39.754256191813	0.0159894856100462	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2474.56660742733	2474.56660742733
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGCCTTCTTGGCTC"	1.23368813571278	10.9916639097962	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCCTTCTTGGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2293.81495366556	39.1436886268832	0.0170648851008364	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2290.9483895196	2290.9483895196
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGCTCCAAGGTACG"	1.23763360556905	10.0350293883118	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCTCCAAGGTACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2045.87049674185	37.6690925886545	0.0184122566157753	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2038.14132650596	2038.14132650596
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGCTCTCTATCCAT"	-1.05913875523265	11.6928405531677	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGCTCTCTATCCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2248.47663797293	38.8364275055347	0.0172723286734021	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2248.47663797293	2248.47663797293
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTAGTAAGCCTGAAG"	4.44952740248982	-10.679451965448	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTAGTAAGCCTGAAG"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2627.54025769047	44.9768851277919	0.0171174865907955	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2619.26542334954	2619.26542334954
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCGGGTTCGAGATAA"	-2.82743034783061	13.204466796759	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGGTTCGAGATAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2361.48387503858	45.9127138967558	0.0194423152247888	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2352.54009207148	2352.54009207148
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGCCTGCAGTTTGGT"	6.39247622069661	-9.98184301769408	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGCCTGCAGTTTGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2422.03885541432	46.0573897791166	0.0190159582601898	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2420.40156256637	2420.40156256637
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGTGAAGTAAACAC"	-0.902952114970046	11.940216041449	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTGAAGTAAACAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2359.16373706987	46.114135667626	0.0195468143830071	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2352.38387502141	2352.38387502141
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGTTGGGTCACTGAAC"	-0.35831374946292	11.8188676604065	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGTTGGGTCACTGAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2526.9572659226	40.9230940991334	0.0161946126477894	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2523.62090012159	2523.62090012159
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATGCAGTGCATGTT"	6.65309967574422	-1.03884079372557	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATGCAGTGCATGTT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2703.36056584178	44.076082157444	0.0163041818077714	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2700.74754232367	2700.74754232367
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAACCCAGACCATGG"	1.31772448596303	10.6119737395081	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACCCAGACCATGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2298.86659522484	39.671236464358	0.0172568676002176	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2293.05546877302	2293.05546877302
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCGCTAGCTGGCTC"	1.40524794635121	11.0466632612976	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCGCTAGCTGGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1999.99398068299	44.9440560213779	0.0224720956440227	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1993.05546093509	1993.05546093509
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACATTTCCAACGGCTC"	1.17420031604115	11.4626283415589	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACATTTCCAACGGCTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2083.70937865404	34.1145127418578	0.0163720109394017	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2075.51658860069	2075.51658860069
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATATCCTGTAACTAAG"	1.08512820777242	10.6404742964539	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATATCCTGTAACTAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2242.27318106044	35.8747149448656	0.0159992614851234	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2238.38114007064	2238.38114007064
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCAAACCAGAAACCG"	6.6534649330074	-0.963750385400377	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAAACCAGAAACCG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2441.31931671943	42.5851279105524	0.0174434895176994	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2436.45360273998	2436.45360273998
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAACTTCAACACAGG"	1.44406177577321	11.2910394438538	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACTTCAACACAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2560.49254415406	36.6465270461866	0.0143122959408163	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2554.49129958536	2554.49129958536
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAACTTCACCATTCC"	-1.65802333775218	11.6327543028626	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACTTCACCATTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2910.42310473588	36.2402441978702	0.0124518817002585	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2904.51791314442	2904.51791314442
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAACTTTCTGCTTTA"	1.13559557971303	11.379328704718	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACTTTCTGCTTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2648.22293140002	31.4850691861701	0.0118891309386574	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2638.34677357256	2638.34677357256
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCAACACAGTATGAA"	7.02692331847493	-9.96448805248412	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAACACAGTATGAA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2693.69886934425	35.9678087840399	0.0133525722542237	2965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2686.27886881799	2686.27886881799
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTGAATCACATTGG"	0.205931504338425	11.1970042952332	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTGAATCACATTGG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2363.47626330766	35.4681574475514	0.0150067754003648	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2359.04911793642	2359.04911793642
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTGAATCACCTTGC"	-8.16875110092815	2.43331239307252	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTGAATCACCTTGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2647.33569803177	45.7852778386621	0.0172948515266509	3677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2640.63705986686	2640.63705986686
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCAACATCACCGACG"	1.49995173987691	11.146756149176	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAACATCACCGACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2295.63572797636	39.9388224030016	0.0173977177285912	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2284.79291766208	2284.79291766208
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGCTTAGGATTACA"	-1.56807420674022	11.7750711210999	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGCTTAGGATTACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2188.2135381465	45.8068614478622	0.0209334512602743	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2181.18495309374	2181.18495309374
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCACAAGTCACCTTC"	-0.222626070410568	11.0320949324402	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCACAAGTCACCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2220.40038266188	41.0829461207325	0.0185024946138232	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2217.78051220758	2217.78051220758
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGGATTCGTTCTGC"	1.37648155268971	11.4075898894104	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGATTCGTTCTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1959.79485771791	37.8650908889019	0.0193209461387168	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1956.79057885776	1956.79057885776
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGCGAGAGTATAGGT"	1.22819401797597	10.7980403670105	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGCGAGAGTATAGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1910.8762702943	32.0305728305557	0.0167622432328508	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1905.45009898468	1905.45009898468
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTGTTCATTGCCTC"	-2.82287130776103	13.1994066008362	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTGTTCATTGCCTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2545.48502801056	39.9235224105926	0.0156840531259361	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2540.29260143471	2540.29260143471
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGGGTAAGCGGACAT"	-2.62027440491374	13.2224855192932	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGGGTAAGCGGACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2177.9607710549	40.5924215152204	0.0186378111372316	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2173.25375735741	2173.25375735741
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTGTTTCTCCTGCA"	-7.35737548294719	3.35851190173952	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTGTTTCTCCTGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2107.18285681974	42.166868385709	0.0200110152990468	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2098.37293058312	2098.37293058312
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTTACCAATAACGA"	-0.0750157785719216	11.2989978560242	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTACCAATAACGA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2376.95334940658	45.4313313561893	0.0191132616748795	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2369.04596596221	2369.04596596221
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCATTTAGTACAACA"	-7.44331441345866	2.96958944881288	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTAGTACAACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2867.39553758787	38.6250835137046	0.0134704413839596	3037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2852.34024837209	2852.34024837209
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTTACTCCAGCAAT"	-1.17629538002666	11.6829766997131	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTACTCCAGCAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2525.08410515152	45.656773409609	0.0180812881901489	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2520.85614842983	2520.85614842983
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCATTTTCAACGAGG"	-2.3443652195042	12.9772357710632	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTTCAACGAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2770.59645682646	43.6440134873186	0.0157525695883225	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2759.08435167156	2759.08435167156
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGAGGAAGGATTCCT"	-1.36148140850719	11.3696670302185	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGGAAGGATTCCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2263.15517673101	42.0873004689684	0.0185967364950029	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2258.67118233224	2258.67118233224
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGAGGACACTGCTTC"	-1.06435082379039	11.7960567244324	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGGACACTGCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2404.12975558881	44.4569761826739	0.0184919204461931	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.18767739233	2395.18767739233
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCATTTTCGCCGAGT"	7.20014061507527	-9.98370745098265	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCATTTTCGCCGAGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2461.11289721194	38.0805054609901	0.0154728803803066	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2455.19353528877	2455.19353528877
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGACAGTAACCCGC"	-2.25272474709209	13.3969468840393	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGACAGTAACCCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2617.41652256142	41.0535425749224	0.0156847571722162	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2611.93383240757	2611.93383240757
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGACAGTATCGCTA"	-7.53370843353923	3.11004040325014	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGACAGTATCGCTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2541.0080353452	42.6503163676479	0.0167848018480799	2866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2531.42203624713	2531.42203624713
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGGTAAGAATCGAT"	-7.24846587601359	3.20807049358217	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTAAGAATCGAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2123.51873523375	32.2351640276079	0.0151800704617092	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2113.4593851558	2113.4593851558
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTAACCGTACTTGTG"	-1.73696349087413	11.3674087294373	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAACCGTACTTGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2558.81958393535	47.3452252811289	0.0185027602486589	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2553.60935745946	2553.60935745946
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTAACCTCGGTCACG"	1.42769732055013	10.376305557135	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAACCTCGGTCACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1844.26656055786	39.9370832187207	0.0216547239281075	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1841.53123630835	1841.53123630835
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTAACCTCTCTATAC"	0.0697794753009498	11.2478542097839	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAACCTCTCTATAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2269.0377027192	40.6596192782302	0.0179193229048173	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2263.53041985617	2263.53041985617
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAGGTAGTACAGCGA"	-2.47184119644817	13.0748862990173	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAGGTAGTACAGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2336.52787363552	42.1967425000815	0.0180595930295603	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2324.24617911174	2324.24617911174
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGTTACAGCTACTAC"	1.13545252856557	11.5285463103089	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGTTACAGCTACTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2372.86333503398	38.8737345921917	0.0163826268534909	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2369.64113163038	2369.64113163038
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCCTTGTCGTCGCTT"	-0.199202041060287	11.0268888243469	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCTTGTCGTCGCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2260.72306445539	40.698088456457	0.0180022441033754	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2257.39227539421	2257.39227539421
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTATCCGCAGGACTAG"	-2.23641262474712	13.5864772566589	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCCGCAGGACTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3182.84826572395	44.0165658139211	0.0138293007203438	2715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3169.57957916429	3169.57957916429
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTACTGAGAGGTATT"	0.284966607659501	-9.93218614971312	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACTGAGAGGTATT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2384.89001175664	37.4433827774579	0.0157002556062861	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2378.48771196277	2378.48771196277
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTACTGGTTAGCTAC"	-2.32684097710307	13.703438735846	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"IFN+ NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACTGGTTAGCTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2580.09062337469	40.5269552670111	0.0157075704627782	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2572.13068216592	2572.13068216592
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTATCCGTCTGAGGCC"	-1.18511889401134	11.7784356840881	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCCGTCTGAGGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.25945675343	41.9352701345554	0.0163537546967455	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2555.67513918206	2555.67513918206
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGGTATAGTGTGTTC"	6.44192900237386	-10.2418937913147	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGGTATAGTGTGTTC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2844.18143961022	37.7822780310334	0.0132840603995402	2906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2843.03644079977	2843.03644079977
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACAGAGTACACTCA"	8.17504372176472	8.47750756824342	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACAGAGTACACTCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2431.54897073076	45.8560627282777	0.0188587864280177	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2424.50889692204	2424.50889692204
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTATCTAGTAGTATAG"	8.60738434371297	-9.83598711406859	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCTAGTAGTATAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2924.54479884118	41.9830149988523	0.0143554015706949	3404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2908.90799296819	2908.90799296819
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTAGTCAGCTAGAAT"	-1.87036583843883	11.9423732527527	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAGTCAGCTAGAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2117.58556759015	43.68432437511	0.0206293077567692	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2116.0449006556	2116.0449006556
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGATTTCGTACACA"	1.00164755162541	11.1632241972717	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGATTTCGTACACA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2219.15847690422	39.716858303075	0.0178972609286025	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2217.91076207699	2217.91076207699
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAAGAGTACACGCC"	-0.535563628107864	11.76411244953	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAAGAGTACACGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.66625788577	44.1140359891706	0.0183223218104607	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.59928984073	2395.59928984073
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCTGTCTCAGATTGC"	1.20454206046407	11.8405503996643	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCTGTCTCAGATTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2169.68362350972	41.8023190819522	0.019266550491049	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.08325994917	2163.08325994917
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATAGCTGTGGCATCC"	-0.456185023218948	11.3135347136292	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATAGCTGTGGCATCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.20578003847	38.9569366812687	0.0158735412483048	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2449.60716832713	2449.60716832713
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGATCACAAAGGATT"	-1.38553533974345	11.7195367583069	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATCACAAAGGATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2465.2324844194	37.5985661897384	0.0152515295929963	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2459.32380858803	2459.32380858803
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCAGTAGCCTATTG"	-1.12872658196147	11.5295190581116	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCAGTAGCCTATTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2408.41148028173	45.7276826791878	0.0189866569951072	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2399.11250911125	2399.11250911125
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCACTGAGACGGAAA"	-2.12855992737468	12.9797935255798	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCACTGAGACGGAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2119.52140196276	41.4516919055392	0.0195570999505611	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2116.3593821504	2116.3593821504
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCACTGGTAGTCTTG"	-6.95809207382854	3.13168690288392	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCACTGGTAGTCTTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2324.81611871265	41.7183003017931	0.0179447741978382	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2315.41848141413	2315.41848141413
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTCACATCAGTGCGC"	7.13584770736043	-9.91751387035521	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACATCAGTGCGC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2145.55892568237	38.9365277563897	0.0181474986728721	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2143.6668182945	2143.6668182945
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGATGTCACATGACT"	8.21399464186971	7.98182580554811	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATGTCACATGACT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2159.4252473441	42.0589252197418	0.0194769072332883	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2148.13533615241	2148.13533615241
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGATGTTCACTGAAC"	-7.99293647232707	2.33981297099916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATGTTCACTGAAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2905.19376501036	41.7561781852795	0.0143729408648	3792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2899.54521410671	2899.54521410671
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTACTCACGCACCA"	-7.53202758255656	3.59841296756593	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTACTCACGCACCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2137.49575815248	41.8689229678311	0.0195878390907404	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2127.1629554376	2127.1629554376
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGGTATCACGT"	1.31130244311635	10.8596248396668	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGGTATCACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2098.63545809727	35.5800699533241	0.016953906795029	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2089.22331291346	2089.22331291346
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTCTCCAGATGGTCG"	-2.75998816910442	13.1590442427429	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCTCCAGATGGTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2220.44547169112	41.8092828613122	0.0188292319691462	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2217.38557879416	2217.38557879416
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATCCCTGTCCCTAAA"	-1.951896528632	13.5941524275574	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATCCCTGTCCCTAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2330.41473624257	43.0675666071646	0.0184806446412214	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2328.88301262141	2328.88301262141
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTCTCCTCACCTGGG"	1.25202526625935	10.9255561598572	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCTCCTCACCTGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2290.34762549871	34.1366680329353	0.0149045793978555	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2285.33919670528	2285.33919670528
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGAATCGTCTAAG"	-6.85708413544353	2.80498907649843	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGAATCGTCTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2832.77987301515	46.1419502293222	0.0162885759916847	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2820.76621839257	2820.76621839257
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGGGAGTGCGACA"	1.19446410712544	10.9069871672424	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGGGAGTGCGACA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2339.1088049089	38.9881781182778	0.0166679626174107	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2336.13477756745	2336.13477756745
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGGTTAAGTTGAAGT"	1.08369030532185	11.5660524138245	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGTTAAGTTGAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2271.44874944938	43.262158696141	0.0190460641943289	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2260.97698561456	2260.97698561456
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGGTTACATGAGATA"	7.13747467574422	-9.99940779125365	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGGTTACATGAGATA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2634.1562753255	40.5779319932008	0.0154045272003411	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2629.27858907194	2629.27858907194
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGTACACATCGCTGG"	-2.18813786926921	13.262442565802	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTACACATCGCTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2820.32292116848	33.9033419070377	0.012021085122051	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2815.49171168643	2815.49171168643
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAGTCAGCGCTGAA"	-1.53753707829173	11.7799653776917	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAGTCAGCGCTGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2688.04133870081	39.4764936198912	0.0146859696878661	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2683.09374571823	2683.09374571823
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAAGCGGTCTGATAC"	-7.92259726944621	1.24384102905122	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAAGCGGTCTGATAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2981.62721754163	42.2940280555279	0.0141848812643988	4936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2974.88924591445	2974.88924591445
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCATCGGTGACCTGC"	-1.43536065045055	12.4609794386658	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCATCGGTGACCTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2515.36027299453	35.2096952287293	0.0139978736273879	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2510.84361632051	2510.84361632051
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGTCCGTATGA"	1.42070235785787	10.9612340697083	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGTCCGTATGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1924.4917053244	39.936923171226	0.0207519331264117	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1920.44779348689	1920.44779348689
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGTCCTAGAAACTGT"	-1.32674155655559	11.8074874647888	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTCCTAGAAACTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2351.82458259766	40.7031804643618	0.0173070648064253	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2350.63783275109	2350.63783275109
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGTCCTAGCTGGAGT"	0.928185601800126	11.6794786223206	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTCCTAGCTGGAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2307.53217632484	41.155729514023	0.0178353870582082	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2300.94161667503	2300.94161667503
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCAATGAGTATGAAAC"	-1.61435685578044	11.9911517866882	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCAATGAGTATGAAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2797.98982900428	39.6688854626082	0.0141776374779479	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2787.83584039597	2787.83584039597
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGTTCCCAGATCCTA"	-6.8142241043156	-0.394136809465014	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGTTCCCAGATCCTA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1915.48178049551	42.6060591328066	0.0222429988980553	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	1913.76444268739	1913.76444268739
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTTCGATCAAGCCGC"	-7.59958205643352	3.2811662920746	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTTCGATCAAGCCGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2360.71585242003	42.2898361850694	0.0179139883106715	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2352.52652242494	2352.52652242494
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAAAGCCTATTG"	1.16944791850392	11.5357236632141	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAAGCCTATTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2268.30644514751	38.125965433519	0.0168081193416702	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2264.18662832841	2264.18662832841
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTACGAGTCCCACGA"	-2.21949730339702	13.0891198881897	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTACGAGTCCCACGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2506.2127487919	47.0883089043694	0.0187886319415891	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2503.53714127431	2503.53714127431
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATACCGATCACAACCA"	-2.2618387741154	13.0880183943543	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCGATCACAACCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2430.31481568601	40.1733430379642	0.0165300983965834	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2428.87044637508	2428.87044637508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTACGATCCATTCAT"	0.458364297717255	11.4110317000183	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTACGATCCATTCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2403.5780154274	40.5834912650963	0.0168846157705765	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2394.45509655939	2394.45509655939
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATACCTTTCAATGCAC"	-7.41686187210734	3.0858378180298	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATACCTTTCAATGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2525.31421979523	37.674607065577	0.0149187799166759	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2521.33384548375	2521.33384548375
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAATCCTCGCCATAA"	-2.50605712357219	12.9694881209168	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAATCCTCGCCATAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2863.20675711379	44.994089567208	0.0157145792756383	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2860.84781394049	2860.84781394049
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GATTGGTGTTGGAGAC"	1.28311576422994	11.561665511969	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GATTGGTGTTGGAGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1953.5297990583	36.9010116078463	0.0188894029799978	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1942.68248194425	1942.68248194425
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTAGACCACACACTA"	5.93833651122395	-9.91545870220336	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAGACCACACACTA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.92971931301	40.5171631222803	0.0162073208735702	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2494.68740891371	2494.68740891371
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATCTGTTCGAAGG"	-2.20199833336528	13.4198312529358	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTGTTCGAAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2720.16826161661	40.4208035261429	0.0148596702992632	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2713.22439818081	2713.22439818081
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTAGACGTGGCTTAT"	-1.46703765812572	11.5873622664246	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAGACGTGGCTTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.49923143353	40.0464580330535	0.0174228720572934	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2294.11882523479	2294.11882523479
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATAGACCCAAAGGCGT"	-7.59640679779704	3.10760185802308	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGACCCAAAGGCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2358.58831941519	45.9424310898213	0.0194787834365315	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2353.56536285821	2353.56536285821
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATGGAGCGGTATG"	-7.48409161987956	3.07055828655092	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATGGAGCGGTATG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2555.99405066329	42.61923847913	0.0166742322690736	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2542.31380527245	2542.31380527245
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCCAAGTGTTGACT"	-7.66454110565837	3.23459479892579	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCCAAGTGTTGACT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2774.63312528811	46.7511355612324	0.0168494836795326	3239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2765.02633976365	2765.02633976365
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATAGAGAGTCTTCATT"	-2.04933939400371	12.9610996016297	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGAGAGTCTTCATT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2515.4653727801	46.391542765891	0.0184425288727465	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2511.01048419102	2511.01048419102
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATGGCAGTCACGC"	-2.98909984055217	13.1558398970398	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATGGCAGTCACGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2936.13448403667	38.6837848513022	0.0131750725525756	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2925.05416810003	2925.05416810003
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAACCGCAGGTCCGT"	8.90082039412801	7.74989507282106	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACCGCAGGTCCGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2095.23817938719	40.9183044757722	0.019529189988195	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2090.83815235931	2090.83815235931
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAACCGGTAGGATAT"	8.28974117812459	8.30658719623414	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACCGGTAGGATAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2123.95383305417	40.3138139638598	0.0189805509594763	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2117.99790866225	2117.99790866225
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCAACCGGTGCACGCT"	9.02863277968709	7.6116847761902	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCAACCGGTGCACGCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2523.31368956381	42.009598233365	0.0166485833319546	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2512.98833484236	2512.98833484236
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCACGTCGATTCA"	-6.84215913239177	-0.0443170077172146	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCACGTCGATTCA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2352.7135475273	46.2839187544953	0.0196725686402153	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2348.948127278	2348.948127278
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCACTTGCAGAGAGGG"	1.32200207289998	11.421154952887	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCACTTGCAGAGAGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2166.07066364347	29.6910075013142	0.013707312508158	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.48670836558	2163.48670836558
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCCGATTCTCGTGGG"	-1.9059901041096	11.2591876753601	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCCGATTCTCGTGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2346.82900446154	37.561164969621	0.0160050710546928	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.74254892329	2345.74254892329
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACAGGTGATAGTA"	-2.46744141998943	13.3125209578308	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACAGGTGATAGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2753.86904502827	41.0179243462353	0.0148946531863189	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2741.8891013927	2741.8891013927
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACGAAGCAAATCA"	-8.8210748237675	0.236477620247282	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGAAGCAAATCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3337.98147445059	39.0019264491391	0.0116842848732582	4820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3329.34684713098	3329.34684713098
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACGAAGGGCTGAT"	-2.24193416062053	13.0152282484802	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGAAGGGCTGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2502.27873202839	43.696242515886	0.0174625799902256	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2496.8056471703	2496.8056471703
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACGGTAGGGTTAGC"	-2.47173271599467	12.9615964659485	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTAGGGTTAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2176.36491674239	41.6015976747004	0.0191151756558226	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2174.80764476682	2174.80764476682
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCGAGGAGTATGAAC"	0.895951409905595	10.8198194273743	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCGAGGAGTATGAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2320.41117643161	37.1093778703115	0.0159925871100911	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.23711296711	2314.23711296711
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCACGGTGTTCCACGG"	-1.89664051953014	11.9144353636536	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCACGGTGTTCCACGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2958.78286597802	40.6890691037016	0.0137519618528181	2444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2953.39310576836	2953.39310576836
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCGAGGGTCGCTTAA"	-8.08158908310588	3.53625938976137	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCGAGGGTCGCTTAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2230.1079091985	48.5627187728491	0.02177595020068	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2220.68659573802	2220.68659573802
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGCAATCACTCTTA"	-0.0526410293882668	11.503035522345	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGCAATCACTCTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2378.95806639379	41.4141659349105	0.017408531289368	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2368.63640032539	2368.63640032539
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCGAGGTCCGGCAAC"	-1.30779633942302	11.0973224409851	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCGAGGTCCGGCAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.302314464	52.1428562767909	0.0243623790547781	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2136.29269855773	2136.29269855773
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACTTCATGAAAGT"	3.35950460013692	-10.4607630006042	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.375	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACTTCATGAAAGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2673.89046753675	47.2118063400847	0.0176565969748108	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2666.67140453446	2666.67140453446
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCTCGACAGGCGAAT"	0.619731684296769	11.3531551131043	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCTCGACAGGCGAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2352.88900445418	40.5683003938916	0.0172419099741182	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2347.63213426645	2347.63213426645
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCAGGTGTTACTCAG"	-7.80103335800822	2.61972234332887	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCAGGTGTTACTCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2752.96277240232	40.0261189510742	0.0145392881270771	3099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2746.0942664142	2746.0942664142
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCAGGTTCCGCAGTG"	1.46303107318227	10.7841624983582	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCAGGTTCCGCAGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2012.49943731976	38.13260266962	0.0189478824006057	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2008.65101124862	2008.65101124862
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCAGGTTCGGAGCAA"	-0.401858876377898	11.6892738112244	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCAGGTTCGGAGCAA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2245.1705870826	41.1150381503503	0.0183126566804777	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2238.66308309255	2238.66308309255
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGGTACCCGCA"	1.30713703212087	11.062569595221	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGGTACCCGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1919.79113166563	35.3946516208288	0.0184367200353301	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1908.88017852161	1908.88017852161
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCGTCCTCATC"	0.146674935787362	11.7228507765564	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCGTCCTCATC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2589.66876647655	40.09409424836	0.0154823252947948	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2581.00045916429	2581.00045916429
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTGTCCGTCCTGGGT"	-0.116934831172782	11.3595819243225	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTGTCCGTCCTGGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2604.43093515481	34.7840866403716	0.0133557339420498	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2593.66042877197	2593.66042877197
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCACCAGATGACCG"	1.2477066713268	11.4507808455261	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCACCAGATGACCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2257.86726769925	41.4035299914441	0.0183374508252799	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2249.48213674848	2249.48213674848
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGCGGGTTCGAGCC"	6.92504705962483	-10.1059217683044	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGCGGGTTCGAGCC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.15407519331	44.7891071446068	0.0180517234267756	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2480.32881937101	2480.32881937101
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGGCGAGTGACACG"	-2.38926754418071	13.6429567106995	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGGCGAGTGACACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2545.43451272586	45.7111547904906	0.0179580949979103	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2540.06187026395	2540.06187026395
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGGCGGTAACACCT"	-2.6225257915562	13.4438266524109	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGGCGGTAACACCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2398.32651136694	41.1701490249685	0.0171661985262813	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2391.32820131327	2391.32820131327
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGTGACACGGAAGT"	-0.93525586548503	11.0653972395691	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGTGACACGGAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.22269371135	39.7686852905783	0.0172440785527868	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.02959041812	2297.02959041812
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGAGGCCAGACACCC"	6.44538321074788	-10.0430250397888	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGAGGCCAGACACCC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2635.6810984308	36.7955365329193	0.0139605419467576	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2631.16828975679	2631.16828975679
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGATCCTCATTCGTT"	-0.372871617705184	11.7214708098206	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGATCCTCATTCGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.0331217035	42.326853788726	0.018220512395315	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2318.85667050019	2318.85667050019
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCATTCAGCACCCA"	-0.584593216807205	9.32435319507448	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCATTCAGCACCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2553.50984339777	36.4840944746741	0.0142878221397915	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2549.96173165359	2549.96173165359
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCATTTCCTGTTAT"	1.40629639205281	11.4635686644348	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCATTTCCTGTTAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2094.67809703367	36.8057582281529	0.0175710808645369	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2084.54625119248	2084.54625119248
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTACTTCAGAATAG"	-2.75092516365703	13.0567531355652	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTACTTCAGAATAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2602.55689889849	40.3934339679467	0.0155206727603315	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2587.15063526472	2587.15063526472
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTCATCACATCATG"	0.00962862846199867	10.297861076239	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCATCACATCATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2162.05029834008	45.80690202574	0.0211867883281478	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2156.44773974365	2156.44773974365
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGAGAGGTTTA"	8.56033482131306	7.79090116107789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGAGAGGTTTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2534.06287713213	51.0261080507571	0.0201360860108194	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2522.53768503737	2522.53768503737
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTCCGCAATCTGCA"	0.122562629252118	10.9726886519226	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCCGCAATCTGCA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2534.84678925361	52.1933684836117	0.0205903444361543	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2528.83041939964	2528.83041939964
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCCAGGACAGT"	0.321868171065491	11.4607229002747	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCCAGGACAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.57468620862	43.4273482878944	0.018150885127315	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2387.19954861021	2387.19954861021
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCATGCACTATCCC"	-2.47779498520549	12.8254232176575	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGCACTATCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.95751198319	39.0827944043658	0.0168973248327659	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.93015668009	2305.93015668009
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTCCGTCATTACTC"	8.00536837157552	7.48344276035158	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCCGTCATTACTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2003.72812696245	42.4104518735089	0.0211657715948725	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1993.37475625769	1993.37475625769
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGTCTGGGCCA"	-0.488852481276351	10.8720903166565	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGTCTGGGCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.11091454806	48.451181024151	0.0209372769125084	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.5275813673	2305.5275813673
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACAAAGTGTTCGTA"	-2.41031036797221	13.3563594588074	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAAGTGTTCGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2143.44767307664	39.4058394755249	0.018384325388715	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2143.44767307664	2143.44767307664
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTCTCTCTGAACGT"	0.694767971604508	11.5285072096619	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTCTCTCTGAACGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2512.36854297265	40.1186727731202	0.0159684664438807	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2506.3107081521	2506.3107081521
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACAAATCCTCTCTT"	-2.84891066971477	13.298728919867	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAATCCTCTCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2715.97772197738	38.0008879503996	0.0139916051751459	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2706.77040967896	2706.77040967896
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCCATGTCGCTTTAT"	-7.47262607041057	2.87827918613283	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCATGTCGCTTTAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2435.64118970122	46.4064368219942	0.019053067840295	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2428.11272740063	2428.11272740063
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCTATCAACTTGCA"	-2.25843940201457	13.2125673064026	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCTATCAACTTGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2587.08083884573	40.1473890113155	0.0155184130346804	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2582.98949890195	2582.98949890195
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAATCCCACATCCCT"	1.64835586127583	10.9722184904846	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAATCCCACATCCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2317.60156421958	35.3025926081689	0.0152323821113991	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2312.48453925716	2312.48453925716
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAATCCGTACGGGAT"	-0.284914801747161	11.4758701094422	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAATCCGTACGGGAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2310.54066983073	41.0582251230806	0.0177699642595292	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.05760320894	2305.05760320894
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGATGAGAATAACC"	-0.0397399542039216	10.6001233824524	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGATGAGAATAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2125.90741057105	43.4726126513864	0.0204489680195946	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.77843373667	2121.77843373667
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGATGCATAGCTGT"	6.73171248015706	-1.22471036827239	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGATGCATAGCTGT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2641.72381464329	44.105767887511	0.0166958285506718	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2627.34170680977	2627.34170680977
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACAGGAGTATTGCC"	1.4672038751537	11.3467693098816	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACAGGAGTATTGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2102.34264125735	39.2138022590716	0.018652431573009	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2097.40760084554	2097.40760084554
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGCCTGTAGAGATT"	0.377693881362122	10.8766784437927	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGCCTGTAGAGATT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2350.93424580997	40.901749807047	0.0173980832853771	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2347.90135818104	2347.90135818104
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGACGAGATCACCT"	-2.68623552742656	13.1259088286194	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGAGATCACCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2821.58553224859	38.4410424014812	0.0136239153348815	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2814.468354792	2814.468354792
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACAAGTCGATTTG"	-2.74964986267741	13.0403566130432	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAAGTCGATTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2537.17402566805	43.9738175113923	0.017331809748373	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2534.77423006263	2534.77423006263
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACAATCAAGGACG"	-6.77764687958415	0.0614732837299778	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAATCAAGGACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2789.27117998545	41.3591024491861	0.0148279244936671	2876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2784.81955541748	2784.81955541748
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCGCAGATAGTCA"	-7.31095681610759	0.0415330438869967	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCAGATAGTCA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2529.3321198243	36.963282176752	0.0146138507818102	2520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2526.74918666046	2526.74918666046
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGACGCACGCACCA"	-6.81970344010051	2.93379423702089	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGACGCACGCACCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2538.76022244763	43.5699763624822	0.0171619107536183	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2530.37721576353	2530.37721576353
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACAATCGCCTATC"	-1.95237074318584	13.6617069014343	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAATCGCCTATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2603.26061569092	44.5353797165005	0.0171075379268858	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2600.82746202509	2600.82746202509
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGTAGCAATCGCCG"	-2.18857679787334	13.3689031370911	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTAGCAATCGCCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2295.28607624192	44.5148295371683	0.0193940223826272	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2288.10972245722	2288.10972245722
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGTAGTCCGATAGT"	-2.23975024643596	13.2120122679505	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTAGTCCGATAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2367.0673956108	40.386748472996	0.0170619343360837	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2358.125748455	2358.125748455
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCGTCCTCCTGTACC"	6.98384966430013	-9.84178736126097	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCGTCCTCCTGTACC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.05230358872	38.744774399367	0.0141092630860427	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2742.93956378564	2742.93956378564
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGCAGCATGCGGTC"	-0.43161583963092	11.446524597052	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGCAGCATGCGGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2759.02332600237	41.6854049438629	0.0151087540837366	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2747.05206008804	2747.05206008804
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGCAGAGTCTT"	-0.0906056267326653	11.8717288740906	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGCAGAGTCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2166.76132874557	42.1708731816532	0.0194626296040033	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2162.82886420394	2162.82886420394
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCCAGTGGTACATACC"	-7.96726165238078	3.03808329189149	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCCAGTGGTACATACC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2464.96437076685	46.2631612735589	0.01876828802161	3099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2460.03966110188	2460.03966110188
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACGCCGTGCTTCAA"	-8.04785762253459	1.66276357257692	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACGCCGTGCTTCAA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2554.14221760608	40.5361672007819	0.0158707557164829	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2547.96477168953	2547.96477168953
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAAGTAGTATCTTCT"	-2.26108966293986	11.1360234984192	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAAGTAGTATCTTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2453.30129492517	41.7252265883683	0.0170077872924455	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2447.62170668022	2447.62170668022
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACAAACATCTTAGG"	1.50007190284078	11.1799354323181	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACAAACATCTTAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.83432327192	39.0441566127974	0.0169695645696359	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2294.45154813419	2294.45154813419
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCTCTATCGGTGTTA"	-3.22296534004863	12.6003217467102	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTCTATCGGTGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2481.13926353728	42.8133736669459	0.0172555302703599	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2479.76701660276	2479.76701660276
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCTTCAGTTGAGTCT"	-2.84838185730632	13.3898935087952	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTTCAGTTGAGTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2401.21428761657	40.1848964377083	0.0167352396014583	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2395.2949840843	2395.2949840843
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCTTCATCCCTTGGT"	-2.7194336456364	13.5247211226257	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCTTCATCCCTTGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2959.84731395517	46.2281291794025	0.0156184168559793	2541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2956.51425354206	2956.51425354206
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACTGTTCCACGTCT"	6.73202719268147	-10.0725412598816	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACTGTTCCACGTCT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.96242149853	43.5435376196164	0.0159036286538163	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2730.11826223926	2730.11826223926
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGCACACGTCTCT"	-2.22980151596721	13.4569635161194	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCACACGTCTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2518.87715361868	38.7992808870286	0.0154034033899941	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2516.05179746122	2516.05179746122
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTCGTCAGGACATG"	-2.33112965050395	13.3260564574036	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTCGTCAGGACATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2434.67386997792	38.8630239671078	0.0159623120148984	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2426.11452756777	2426.11452756777
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGAGGGGTCCGTTTC"	-2.23719273033794	13.4533595808777	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGGGGTCCGTTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2684.75286899728	39.4153542062531	0.0146811852447984	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2681.16245158134	2681.16245158134
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGAGGGGTCCTACAA"	8.00288548049275	-8.60149481212767	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	35	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.375	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGGGGTCCTACAA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2199.52506389254	49.847076581426	0.0226626544974262	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2193.78920808463	2193.78920808463
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGAGGGTCAGACTGT"	1.51215972480122	10.8266954191956	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGGGTCAGACTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2164.62237954268	37.1049886581914	0.0171415527294098	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2152.32498113407	2152.32498113407
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGAGGGTCTCGAGTA"	8.17604889449422	8.29304788196412	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGGGTCTCGAGTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2106.94785363081	41.9318623213461	0.0199017086488813	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2097.39181462746	2097.39181462746
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGTGAACACAAGCTT"	-7.87007270279582	3.7816967734131	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGTGAACACAAGCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2433.0220515591	40.5673301377104	0.0166736384948564	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2430.75524282854	2430.75524282854
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACCATTCAAGTGGG"	-2.03137264671977	13.5063419112	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACCATTCAAGTGGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2470.6157608294	41.0561290195893	0.016617771840736	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2468.02500614322	2468.02500614322
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACCATTCGAAATCC"	-8.77586398544963	4.20585057819215	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACCATTCGAAATCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2997.18529254891	45.8968419973672	0.0153133148329094	3804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2984.01790826462	2984.01790826462
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGATCGAGAGTCTTC"	-1.49157128754314	11.854447341803	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGAGAGTCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2614.97071724879	43.55977267286	0.0166578433882767	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2608.1275227438	2608.1275227438
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTACCGGTAGACACG"	1.16213120993916	11.3568143614563	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTACCGGTAGACACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2189.20334440693	41.5272940832996	0.0189691351373984	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2180.52786698128	2180.52786698128
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGATCGGTACAACGG"	-2.65553412857707	13.1848249205383	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGGTACAACGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2307.56298280643	43.3499073006625	0.0187860126131599	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2301.6017764433	2301.6017764433
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTATTGCTCGAGTCTA"	8.07168640670125	8.12621400440065	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTATTGCTCGAGTCTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2078.89854441804	41.6723177561673	0.0200453831034996	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2072.36874543268	2072.36874543268
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGATCGGTTCGGCTG"	1.46753694590871	10.4064569243225	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGATCGGTTCGGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1982.08886820288	30.7992304742329	0.0155387737494122	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1975.73109292241	1975.73109292241
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAATCAGGGCCAAT"	-2.1515670818394	13.5715369948181	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCAGGGCCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2487.72635934538	44.1999519154213	0.0177672080972169	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2481.92995735509	2481.92995735509
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGACTCATCCTGGGAC"	-1.98168096962627	11.1448659666809	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGACTCATCCTGGGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.72483164893	42.5910698581617	0.0170110825757603	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2499.41783942293	2499.41783942293
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCAATGTGGTTTGT"	1.17168023166005	10.2477922209534	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCAATGTGGTTTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2601.8851374505	32.7931767661843	0.0126036220024367	2566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2588.42589105448	2588.42589105448
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGCATGCATCAGCTA"	1.26017810878102	11.5977353819641	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCATGCATCAGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2621.03871041206	36.74624201173	0.0140197250295297	2688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2612.43622764013	2612.43622764013
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAATCTCATTCACT"	-1.77979979935344	12.3527450331482	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCTCATTCACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2656.76352201538	46.6159803763779	0.0175461534269395	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2650.92818862551	2650.92818862551
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGCCTCGTCGCATTA"	-1.89906368675883	11.8985938795838	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCCTCGTCGCATTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2280.15378787874	42.6560478649668	0.0187075310848442	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2270.27452787262	2270.27452787262
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCCTTCACGTCTCT"	1.34430100497548	11.2366342314514	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCCTTCACGTCTCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2292.71820238076	35.9720824919183	0.0156897094699928	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2287.74067745501	2287.74067745501
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCACCGAGGTAGACC"	1.334977765649	10.5129861601624	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCACCGAGGTAGACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1940.77854020795	34.1371461571557	0.0175894082966818	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1934.19229865087	1934.19229865087
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGCGATTCCGTCAAA"	-1.96893034401591	13.5917205580506	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGCGATTCCGTCAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2908.03795358712	41.3965751737309	0.0142352252049074	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2901.83585030963	2901.83585030963
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTCTAAGTTCAATCG"	-2.20842729035075	12.8032426604065	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTCTAAGTTCAATCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2499.89585167193	38.896729690469	0.0155593400678892	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2490.65340565091	2490.65340565091
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCAGGAGTTGGCGA"	-2.80778656426128	12.9696254500183	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCAGGAGTTGGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2249.75343752782	42.5077262867468	0.0188943933044756	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2245.43060865912	2245.43060865912
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAGGAAGACGATAT"	-2.23062787476237	13.6033000716004	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGAAGACGATAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3049.93132296817	40.3814419994017	0.013240115177447	2764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3042.3437453959	3042.3437453959
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTGAGACAAGTGACG"	1.37022473391835	11.4348172911438	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTGAGACAAGTGACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2008.46526863593	41.0931726451907	0.0204599866808249	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2007.54945038112	2007.54945038112
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCGTGCAGTGTGCTTA"	6.73597445067708	-1.04689218914183	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCGTGCAGTGTGCTTA"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2365.7113445792	37.8333419508089	0.0159923745716063	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2364.3301271702	2364.3301271702
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGGGAGTCGTAGCCG"	1.37503518637959	10.8170060881409	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGAGTCGTAGCCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2244.93984908834	37.52271259125	0.0167143509909577	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2241.24790960018	2241.24790960018
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGATCGTCACCTATCC"	-1.91895208779033	13.4803027876648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCGTCACCTATCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.60447370722	42.4882553579453	0.0161822756563002	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2619.41752034932	2619.41752034932
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGGGTTAGTAGGAAG"	6.37751497802083	-10.0817089310852	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGGTTAGTAGGAAG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2457.95782029799	40.0252506993888	0.0162839453016067	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2452.99707914731	2452.99707914731
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAGGATCCCATTCG"	4.8861195045406	-10.3149261704651	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	50	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000692520775623269	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGATCCCATTCG"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2746.62610523784	42.5441664642046	0.0154896097372236	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2742.22976774751	2742.22976774751
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGGTTGAGTGCACAG"	-2.69763384285625	13.3923568495545	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGGTTGAGTGCACAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2392.79064944525	38.7776002249509	0.0162060146105725	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2391.2947265188	2391.2947265188
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTTCAATCGGATAAA"	1.40181269225423	11.0359563597473	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCAATCGGATAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2096.70710036452	40.6071000970248	0.0193670828366848	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2088.81559876549	2088.81559876549
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCAATCAAGACAAT"	0.303898383944672	11.0324868925842	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCAATCAAGACAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2377.76050921607	43.3439628489269	0.0182289018094666	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2371.79054911116	2371.79054911116
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCATCATCCTGGTCT"	7.97835030135457	8.49810502612916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCATCATCCTGGTCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2506.88997349146	37.8330786138497	0.0150916390483456	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2492.46036278841	2492.46036278841
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTATTCAGCACTCTA"	1.46992780741994	11.4742460020813	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTATTCAGCACTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2281.47821048874	39.6715556592571	0.0173885314691472	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.20290897799	2274.20290897799
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCCAATAGTAATTGG"	-1.43197212639506	11.4374027022156	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATAGTAATTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2553.59854036328	44.4864636377937	0.0174210875102806	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2549.84155340962	2549.84155340962
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTACCTCATCCCACT"	-0.603647629649001	11.301094985846	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTACCTCATCCCACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2365.97551807305	42.6612806789646	0.0180311589672364	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2363.66883690363	2363.66883690363
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCCTATCGGCTCTT"	-8.18281302872356	2.23620007121889	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCTATCGGCTCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2733.0002657614	44.1337372104486	0.0161484569772455	4087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2724.1471567443	2724.1471567443
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTGTATTTCTC"	0.0634132857317149	11.573739982489	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTGTATTTCTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2425.5255543959	40.5379317626301	0.0167130507815765	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2420.4655434062	2420.4655434062
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCGGTAGACCTGGA"	8.05794968184773	8.18697354877321	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCGGTAGACCTGGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2061.45380435197	44.6323260491969	0.0216508979997383	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2058.43007324244	2058.43007324244
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTCAAATCACCCTGT"	-2.77406368675883	13.40819737995	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTCAAATCACCCTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2483.01362935507	37.4614478227819	0.0150870890839661	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2475.82052294315	2475.82052294315
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAAGTGAAGAAAGTCT"	-7.95316443863566	2.63394448840944	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAAGTGAAGAAAGTCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2404.26902035343	37.0635553450773	0.0154157272049485	2579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2400.38730663078	2400.38730663078
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCTGAATCACAGACGA"	8.1869875389034	8.23827836597291	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCTGAATCACAGACGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2385.17099877285	45.0379630247042	0.0188824881100248	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2378.52258901176	2378.52258901176
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTACCTGTAGACGTG"	-0.219231943518478	11.3504094847473	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTACCTGTAGACGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2264.98714943951	46.1689841642528	0.020383773115745	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2254.04053721237	2254.04053721237
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATCGCAATTTCTC"	1.27290691909139	11.5755014189514	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGCAATTTCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2143.84518036843	51.3603054283242	0.0239570962953107	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2142.88101932561	2142.88101932561
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATCGGTCTTTATC"	6.73062719878499	-1.05053081428679	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGGTCTTTATC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2610.22397682511	40.041464293067	0.0153402407795559	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2605.99365180536	2605.99365180536
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTACTCCATTGAGCT"	1.49185695227925	10.567151046637	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTACTCCATTGAGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.88499917373	41.047546910324	0.0188908050476362	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2171.89617070358	2171.89617070358
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATCGTCATTCGTT"	1.41984822329823	10.4491109617981	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGTCATTCGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.55600258643	37.4708565879079	0.0172553028995238	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2165.119008353	2165.119008353
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCTCTAGACGCTCC"	1.34611334380452	11.5156984099182	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTCTAGACGCTCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2101.90340232887	39.9527147837595	0.0190078738820693	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2098.85845106711	2098.85845106711
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAAGAATAGCTACAAA"	-2.23500070992168	11.3065871962341	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAAGAATAGCTACAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2603.4708722461	44.4420155957822	0.0170702949165091	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2596.23501169019	2596.23501169019
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATGCAGTGGATAT"	6.72515978392903	-0.97869803821715	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCAGTGGATAT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2401.6950010451	46.3660776671318	0.0193055644646617	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2394.72877424933	2394.72877424933
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATGCCACTTGTGA"	0.778423448174637	10.6851310499939	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCCACTTGTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2428.06065513123	36.6815678659469	0.0151073523589403	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.86790857103	2415.86790857103
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCACTAGAGCCGAT"	-2.415754656226	13.3500222929749	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCACTAGAGCCGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2352.32786738858	43.0329942131212	0.0182937909335292	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2349.45107134492	2349.45107134492
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATGCCATGAGAAT"	0.250152190297288	11.1137780913147	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATGCCATGAGAAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2338.61220588928	37.4192161432595	0.0160006075607693	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2333.13597138542	2333.13597138542
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCTTCCAATTGCCA"	-0.186673591763336	9.74184224689332	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCTTCCAATTGCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2554.37317114101	33.0914685030723	0.0129548293401041	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2552.07556689041	2552.07556689041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGCATTCGCTTGAA"	1.483526011079	11.1189365156922	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGCATTCGCTTGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1968.28427513503	33.9767470364178	0.0172621137432432	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1967.43460474031	1967.43460474031
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGACAGTAGCATCCCG"	-0.326446185738403	11.144109702948	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACAGTAGCATCCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2196.11095718085	41.9286684148563	0.0190922358807773	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2188.65190763794	2188.65190763794
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGACCCTGTTTACCTT"	0.903029997914475	11.4838847883972	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGACCCTGTTTACCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2469.41821043996	43.6583718500996	0.0176796184888915	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2459.83630780114	2459.83630780114
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCGTATAGGAACTAT"	-2.55985079231914	13.5246848830017	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGTATAGGAACTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2458.60244451083	36.5342106579784	0.014859747146004	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2451.65173965746	2451.65173965746
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCGATTTCACCTCTG"	-7.70257745209392	3.89776489818422	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGATTTCACCTCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2146.32474751969	43.4922520747625	0.0202635934403787	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2139.90025811993	2139.90025811993
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCAGGAGGCATCTT"	1.18539180335347	10.4459275969299	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCAGGAGGCATCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2309.00271814163	32.5288037518861	0.0140878152703374	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.76863819154	2297.76863819154
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCTACAAGGTAGCCA"	-2.0226198238438	13.261619544867	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTACAAGGTAGCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2626.63810950595	41.8589195041884	0.0159363101268875	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2623.04723437366	2623.04723437366
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCTACATCAGCTCTC"	6.64185299453084	-9.96350576793822	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTACATCAGCTCTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2498.50459881934	39.9557016967409	0.0159918463690729	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2493.79705023431	2493.79705023431
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCGGTCGTTACCTGA"	-1.54495392265971	11.5465001829895	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCGGTCGTTACCTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2553.19819261316	44.7781907232234	0.0175380786547532	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2545.14770944345	2545.14770944345
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCATCAATACGCT"	-2.64345608177837	13.3583602675232	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCATCAATACGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2675.73836680574	42.4237336423639	0.0158549633135503	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2675.73836680574	2675.73836680574
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGACTAGTTCCTGA"	0.787358482449692	11.5558805235657	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTAGTTCCTGA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2395.99509877178	41.7035413066022	0.0174055202900791	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2386.89612227267	2386.89612227267
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGACTCAGAACTTC"	0.996326406567734	11.6464404829773	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGACTCAGAACTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2186.79780676242	37.122810459345	0.0169758769395812	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2174.17200825803	2174.17200825803
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCTTCCGTTATCTTC"	-0.147222648293334	11.331612563971	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCTTCCGTTATCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2852.54504501638	37.3533350120915	0.0130947397578701	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2839.87156671337	2839.87156671337
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATAGAAGATCGACG"	6.76186432418172	-1.20032098209532	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATAGAAGATCGACG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2403.84795584902	47.9706105861433	0.0199557590443362	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2391.99753273394	2391.99753273394
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTCTCAGTCTTCGA"	-3.41189895096477	13.2187461622986	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTCTCAGTCTTCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2769.09678165757	46.0909121164229	0.0166447458325501	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2761.71636652508	2761.71636652508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGCATCAGTCGCTG"	-1.28647110882457	11.7397603758606	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCATCAGTCGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2699.18440298278	40.646501278103	0.0150588085916568	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2694.40577835692	2694.40577835692
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGCATCATGCACTA"	-8.23725161972697	2.41721198642579	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCATCATGCACTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2615.4339895608	44.7386922660742	0.0171056476457228	3423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2610.49524150242	2610.49524150242
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTGTAAGATGTTCC"	-8.76768145981486	4.78779599750368	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTGTAAGATGTTCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2468.02844621468	43.0251250220019	0.0174329939705482	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2457.60531361178	2457.60531361178
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGCATTCATCGCTC"	1.35732676562611	11.573269821051	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGCATTCATCGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2373.34528658201	39.5771688407718	0.0166756894011698	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2368.54411778917	2368.54411778917
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGACGACAGAAGTTA"	1.5340379672939	11.3209533461365	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACGACAGAAGTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2069.13431474652	39.07602072918	0.0188852025944807	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2060.9934218048	2060.9934218048
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGACGATCCCGATCT"	0.362144966691178	11.6730880507263	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGACGATCCCGATCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2535.71204021186	36.9733509752863	0.0145810527334946	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2522.70503758628	2522.70503758628
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATCGTTCACAAGAA"	-2.77813921395	13.3151740797791	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATCGTTCACAAGAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2592.85500114659	38.0557140877299	0.0146771470332515	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2591.56726521424	2591.56726521424
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTCCTACACGCTATA"	-2.73539338532146	13.0459899672302	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTCCTACACGCTATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2519.96538149875	42.2395395517977	0.0167619523116923	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2514.377624522	2514.377624522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAGGATCAGTTTCAG"	1.38967563685719	11.3520450362	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGATCAGTTTCAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2152.50682150751	37.2449176279568	0.0173030427851896	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2145.23674587918	2145.23674587918
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAGGATGTCGCACGT"	6.64194454726521	-9.95529272472533	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGATGTCGCACGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2444.32294132293	42.9969413753239	0.0175905321872293	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2440.53374427823	2440.53374427823
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGAGGATGTCTGCAAT"	0.824299235909623	11.6863412627014	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGAGGATGTCTGCAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.71965707789	38.2298948040691	0.0176035128104465	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2166.14875726513	2166.14875726513
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACACTTCTCTGCCA"	-0.0737009895151437	11.6680612334046	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACACTTCTCTGCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2372.294259164	44.1640455014853	0.0186165967104978	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2364.37262874146	2364.37262874146
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACACGCGTTGAATCC"	-0.553602973849136	10.6971483000549	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACACGCGTTGAATCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2316.23368096391	42.6243727175041	0.0184024492294602	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2312.68118413476	2312.68118413476
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATAACATAGATGA"	-2.49849734726604	13.4707889326843	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAACATAGATGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2757.24293299677	41.540281116368	0.01506587635759	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2749.89970586957	2749.89970586957
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGATAAGTGTGTGGA"	5.98481430587117	-10.0470552674499	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGATAAGTGTGTGGA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2723.76185279946	38.9144627023063	0.0142870283106103	2836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2717.78750482357	2717.78750482357
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTGGGTAGCGGACAT"	-2.43293366852458	12.8795947798523	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGGGTAGCGGACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2240.78372784217	44.2081567843557	0.0197288815672217	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2236.19572073535	2236.19572073535
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACAGCCTCAGCCTCT"	6.83054556426351	-1.03229310428771	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACAGCCTCAGCCTCT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2473.76487601439	35.9730429357375	0.0145418197519626	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2467.39771237865	2467.39771237865
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTGGGTTCAACCGAT"	-7.42036281052287	3.11123654926149	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTGGGTTCAACCGAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2421.7825879889	40.6286119374968	0.0167763250669151	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2414.88355055843	2414.88355055843
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACATCACAGCAATTC"	1.39097716388051	11.113628364447	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACATCACAGCAATTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2306.46465436624	37.8468389944379	0.0164090262223582	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2298.72162886334	2298.72162886334
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACATCAGTATCTCGA"	1.51247050341908	11.1227159270081	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACATCAGTATCTCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2273.36046599476	40.1298506079087	0.0176522162711002	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2270.41817635641	2270.41817635641
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACATCATCAAGTAAG"	-9.0018085044926	1.72681710803834	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACATCATCAAGTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2758.33475116707	45.0510443323568	0.0163326964986013	3730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2751.54003227118	2751.54003227118
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCAGCACAAATCC"	1.10933806475942	11.628318763617	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCAGCACAAATCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2332.01261166646	38.4192026776666	0.0164746976433426	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2320.0830363696	2320.0830363696
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGATGGTCATCTCTA"	-2.29613743248637	13.4944305189881	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGATGGTCATCTCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2513.30942657386	45.4414606464189	0.0180803287354732	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2510.4282549201	2510.4282549201
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGCAGTCGTATGGTAA"	6.59046616133992	-10.080873512384	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCAGTCGTATGGTAA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2499.02544903678	41.8933884460829	0.0167638902846028	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2495.74868281656	2495.74868281656
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCAGTCTTCCACG"	1.54094996032063	10.9640111693176	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCAGTCTTCCACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2195.37940322475	41.8927661631474	0.0190822443271591	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2191.08376314536	2191.08376314536
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCTTCAAGTGGGT"	-1.65133724632915	12.9171209105286	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCTTCAAGTGGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2265.71896482153	37.0401328207484	0.0163480702575423	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2265.71896482153	2265.71896482153
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGCTTGGGTGATGAAT"	8.31799091872517	7.77259204471437	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGCTTGGGTGATGAAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1970.90130207483	40.3673040554719	0.0204816466522073	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1962.77310775658	1962.77310775658
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCTTTCACCTTAT"	-7.3673337501591	3.09725854480592	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCTTTCACCTTAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2676.24578504431	37.410185676466	0.0139786061076773	3408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2663.75945591423	2663.75945591423
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCTTTCAGGACAG"	1.30315365371053	11.2864169844422	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCTTTCAGGACAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2333.64769904346	36.75577135428	0.0157503514216588	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2328.72560741631	2328.72560741631
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACCCTTTCTACCTTA"	0.658792694180649	11.5930423506531	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACCCTTTCTACCTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2636.6153717359	40.6593369412844	0.0154210346253557	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2623.41855284568	2623.41855284568
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATTTCTGCACCTTCCA"	8.08322872695271	8.5272006758484	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATTTCTGCACCTTCCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2180.20439629529	37.3752286008332	0.0171429929525613	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2172.03386236118	2172.03386236118
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGCTGCCAAATGATG"	-2.81254754486735	13.092430091742	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGCTGCCAAATGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2519.96430937079	41.7048542005274	0.0165497797113407	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2516.05433719406	2516.05433719406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGAGCAAACAT"	-1.15614507618602	11.6004752882752	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGAGCAAACAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2336.53120333708	40.0911237100037	0.0171583943123656	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2330.99316556643	2330.99316556643
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGAGCTGTTAC"	-8.3611367744511	4.53910110080568	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HSC"	"HSC"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGAGCTGTTAC"	"HSC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2398.90778389251	36.5083589220673	0.015218742115559	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2390.31541122089	2390.31541122089
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGCAGATAAAC"	1.43516089495961	11.5463704832825	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGCAGATAAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2036.27183796157	41.9426559938707	0.020597768535589	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2030.88526439602	2030.88526439602
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGCAGTCAACT"	6.76378740844075	-10.1003484955994	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGCAGTCAACT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2322.59956906348	30.7481917202114	0.013238696902286	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2320.64027370057	2320.64027370057
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGGTCCTCCCATGGG"	-7.48140941086467	2.90145371044008	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGGTCCTCCCATGGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2860.79486591344	44.8399523789286	0.0156739488430994	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2854.69321691533	2854.69321691533
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGGCGGTAATACCC"	0.973061104386491	11.0364722975525	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGGCGGTAATACCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2194.81269977123	31.6720002086348	0.0144303886212869	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2186.12084481684	2186.12084481684
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGTCAATCTTC"	-2.6241069835728	13.2154235609802	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGTCAATCTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2644.23661321975	39.8499974449285	0.0150705111810721	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2635.753674313	2635.753674313
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGTCTTGCAAG"	1.34099700030629	10.3263072737488	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGTCTTGCAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2006.44060204933	38.0167606200544	0.0189473640940206	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2004.59642748206	2004.59642748206
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATCCAAGTAAGCAT"	1.45750834521596	9.41687581622926	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATCCAAGTAAGCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1867.08828759616	35.4472941891554	0.0189853337009538	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1860.81099697543	1860.81099697543
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACTATGAGACAAGCC"	0.37850653108899	10.118285156134	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTATGAGACAAGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2233.96772420411	27.8229900936503	0.0124545174902036	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2229.80401640844	2229.80401640844
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGACTCTCGGATAAA"	-0.3483743769234	11.6501111754212	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGACTCTCGGATAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2157.08646387402	40.1353033864765	0.0186062561972576	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2148.95773654943	2148.95773654943
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACTATGAGTTGCTCA"	-7.66895661774333	2.95103237712709	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTATGAGTTGCTCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2586.52736899944	42.8501823262051	0.016566684288665	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2572.02600202379	2572.02600202379
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGATGAAAGCCTTGAT"	-2.91590032997783	13.0755977400574	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGATGAAAGCCTTGAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2264.69115849681	43.7774791413702	0.0193304411407812	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2261.64863699741	2261.64863699741
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTCATCATGCAGCC"	-8.22986731949504	2.7905611761841	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCATCATGCAGCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2524.98936791345	42.1058063462039	0.0166756370863449	3479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2518.71073776823	2518.71073776823
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTCATTCTTGGAAC"	0.374436129897279	11.5903148421082	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCATTCTTGGAAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2408.4539948347	38.4578874210878	0.0159678729606489	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2400.9789997783	2400.9789997783
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTCTACAGACGGAT"	0.273307864635628	11.1417140730652	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCTACAGACGGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2457.0470709085	38.4699546084696	0.0156569872282687	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2448.90525910855	2448.90525910855
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTCTATCCTTCACG"	-2.11893186989482	13.2155570753845	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCTATCCTTCACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2979.13521002303	38.4682836605373	0.0129125672212239	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2976.8775833936	2976.8775833936
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAACCAATCGCTGACG"	-1.03719828549083	11.310912109259	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAACCAATCGCTGACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2515.08046544738	42.6105107078411	0.0169420069430111	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2512.59033854407	2512.59033854407
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCCATAGTGGGAAA"	1.29488517817799	11.1896991499695	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCCATAGTGGGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.29652245397	42.7591395227344	0.0185160888205454	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2303.12341577969	2303.12341577969
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACTGATCAGCTACTA"	-2.13512859764751	11.0985030897888	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACTGATCAGCTACTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2762.37917502314	37.3801150453765	0.0135318552150117	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2748.75362806967	2748.75362806967
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCCATCAGAGGTTG"	6.63787474211995	-10.0289745560852	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCCATCAGAGGTTG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2531.06066033128	49.4587945579251	0.019540738526374	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2525.22211828419	2525.22211828419
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCCATTCCTACCAC"	1.06767668303792	10.7422990568909	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCCATTCCTACCAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2275.75818090245	37.9400053221395	0.0166713694102132	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2271.70784981532	2271.70784981532
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCGTTAGTAAGACT"	-1.25564573231395	11.7425756224426	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCGTTAGTAAGACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2627.34163884695	47.3679643520734	0.0180288561075223	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2617.3183526677	2617.3183526677
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGAAATAGCTCATAC"	-1.64091418209727	11.8652162321839	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAAATAGCTCATAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2304.04452323793	37.7985481601754	0.0164053028398323	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2300.63729180411	2300.63729180411
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCGTTTCTCACTCG"	-7.69126687470134	2.96430490100709	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCGTTTCTCACTCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2636.20732946984	50.0066539860422	0.0189691658266115	3005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2629.20482781315	2629.20482781315
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTTACGTGTAAATG"	1.38997759398763	11.0190305479797	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTACGTGTAAATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2031.60656328882	37.2384877304412	0.0183295764068406	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2019.16227833442	2019.16227833442
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACCCAGAGCTGCA"	1.43430664119069	9.70407960498659	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACCCAGAGCTGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2008.41592100475	38.571654141254	0.0192050131339119	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2001.73930116424	2001.73930116424
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTTGTAGGTGAGCT"	-3.07545957985576	13.0007858046326	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTGTAGGTGAGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2555.90098535869	38.5310421542243	0.0150753266166987	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2545.97675076419	2545.97675076419
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACCCCAGAAATCA"	-1.11284826222118	11.7407436140808	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACCCCAGAAATCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2173.26805436246	23.3740685195026	0.0107552625515216	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2173.26805436246	2173.26805436246
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAGACTGTTCATCGA"	-7.44133029404338	2.94306991184083	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGACTGTTCATCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2661.19961931318	44.217921266958	0.0166157852068122	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2655.29356263844	2655.29356263844
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGCTACTCCGTGGGT"	-1.84055755558665	10.2932338484558	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGCTACTCCGTGGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.53087411799	37.446785664328	0.0163200182166746	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2293.22945247224	2293.22945247224
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACTTCAGTATACC"	-2.27757416191753	13.6139287718567	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACTTCAGTATACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2659.52458328736	40.2646088469947	0.0151397768984804	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2653.57782204986	2653.57782204986
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAGCTAAGAGAGGTA"	6.54644646224324	-10.0231981507507	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGCTAAGAGAGGTA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2262.28727347088	43.3557844575444	0.0191645795677516	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2257.06702826846	2257.06702826846
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAAGCTACAACCCTAA"	0.81133004006688	10.5836448439392	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAAGCTACAACCCTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2248.47192807683	39.7686545057674	0.0176869695410351	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2247.45523512529	2247.45523512529
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGAAGCATAATCCG"	-7.27291093292888	0.682756520155348	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGAAGCATAATCCG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2461.20223874284	36.5800428491369	0.0148626725074903	3326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2456.35814457251	2456.35814457251
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCGTATGTGGTAACG"	-2.57825050774272	13.0639238127503	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCGTATGTGGTAACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2284.89776400301	40.7222829648893	0.017822365449536	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2278.93673866763	2278.93673866763
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTATTAGCTAATGA"	-2.04418454590495	12.8941612013611	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTATTAGCTAATGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2505.93575458642	45.951303178717	0.0183369837373588	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2495.48472903865	2495.48472903865
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTATTCAATCCTAG"	-1.28813145580943	11.7228584059509	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTATTCAATCCTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2600.25441842244	44.7171805905447	0.0171972328068091	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2589.26775454025	2589.26775454025
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTAGCTCAAGTTCGT"	0.888819952576798	10.048427558783	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGCTCAAGTTCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2425.98798647396	36.1113025988641	0.0148851943209125	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.85899436633	2416.85899436633
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAATACGGTGGATCGA"	-1.55756745758708	11.9220590361389	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATACGGTGGATCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2284.40797895745	46.660938152082	0.0204258339937059	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2278.12935670523	2278.12935670523
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGATGGTCATGGTAC"	-1.21920941296275	11.5561265715393	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGTCATGGTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2439.10005616077	44.3302162919087	0.0181748248416205	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2431.94236647403	2431.94236647403
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTAGCTTCGCTGACG"	-8.26165614548381	2.48272130573121	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTAGCTTCGCTGACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2205.20271706342	40.6848717052171	0.0184494928245851	2910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2202.04616408136	2202.04616408136
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGCCTGGTGGCAACA"	-2.66313205185588	12.8188476332459	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCCTGGTGGCAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2535.69246548341	42.9163367952362	0.0169248981804481	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2530.28150851665	2530.28150851665
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCTCAAGTACAGTTC"	6.23476662215535	-10.1340790024963	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTCAAGTACAGTTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2737.11071502422	41.278382441283	0.0150810057535132	2645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2731.85359666613	2731.85359666613
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAATGACAGCACTCCG"	0.115738098591012	11.1850814589295	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATGACAGCACTCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2207.33217696796	47.8559760749715	0.0216804595947618	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2201.08033497028	2201.08033497028
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAATGACCAGAGATTA"	0.232612972229165	11.356286025885	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAATGACCAGAGATTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1921.49559585446	40.5419884989889	0.0210991836704994	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1918.61997568041	1918.61997568041
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCGTGAGTTGG"	-1.43395183506663	11.390788055304	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCGTGAGTTGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2436.62660862526	46.1478677373102	0.0189392447632125	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2432.24909239618	2432.24909239618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCACAAGGCCCAAA"	-2.59812269631084	12.7097606428894	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCACAAGGCCCAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2069.43088638573	42.7714249238475	0.0206682065128292	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2061.40773878178	2061.40773878178
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCTCACCTTGC"	-8.13899741593059	3.07122299754945	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCTCACCTTGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2779.12781549565	42.396903823314	0.0152554710103366	3601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2775.10065100668	2775.10065100668
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATTTCCAGTGTTCCA"	6.61178459700887	-9.97062113201293	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATTTCCAGTGTTCCA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2493.87426662784	45.0221527085383	0.0180530964656114	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2488.42974994781	2488.42974994781
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACAACATCGGAAACG"	1.02170731601064	10.6442689665589	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAACATCGGAAACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2120.56781677563	40.2711089596758	0.0189907196747468	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2114.3651351481	2114.3651351481
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTGAATCGCCGAAC"	-7.3581956428593	3.39724037731019	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTGAATCGCCGAAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2248.01363974437	41.3852955783783	0.018409717292945	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2237.44648950385	2237.44648950385
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCATGAGGTAAACT"	-4.9913481277531	-6.23969223415526	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00601503759398496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGAGGTAAACT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2917.29479871963	45.1847084729801	0.0154885644374409	3090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2910.89799397175	2910.89799397175
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCATGAGTATTCCG"	1.45071878012959	11.4588193663391	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCATGAGTATTCCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2305.43809727556	41.8217482321293	0.0181404776304998	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2301.28949857351	2301.28949857351
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGGCCTAGGTACAGC"	-2.43305025520976	12.7929610976013	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCCTAGGTACAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2269.03123209402	40.9075975451071	0.0180286621737484	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2263.03391540373	2263.03391540373
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGGCCTAGGTAGCAC"	-7.59164319458659	3.18534276569215	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCCTAGGTAGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2416.92764869894	42.0955998791275	0.0174169880102899	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2410.0714155331	2410.0714155331
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGGCCTGTACGTGAG"	-8.09605441513713	2.91160414302675	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGCCTGTACGTGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2521.27832535648	47.0071454522653	0.0186441714821861	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2514.52361200532	2514.52361200532
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTTCACCGG"	0.239226718514603	11.3015565642151	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTTCACCGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2244.99436289038	44.3550139193383	0.0197572941173145	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2239.6301828671	2239.6301828671
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTCTCCAGAGCTGAC"	-2.31640921059306	12.6399173506531	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTCTCCAGAGCTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2201.79928898615	42.9142467574199	0.0194905352963305	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2201.79928898615	2201.79928898615
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTATTCTAAGCGT"	1.11790539798085	10.7281656035217	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATTCTAAGCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2169.44789967565	41.023746000426	0.018909763173644	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.59679868527	2163.59679868527
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGGGATCATGACTTG"	0.275309805839699	10.9834251173767	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGGGATCATGACTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.01788037722	42.4198881809563	0.0183952989011591	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2299.28366445157	2299.28366445157
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTTATCGTAGTCA"	-7.25194440308269	0.0735898104491605	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTTATCGTAGTCA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2881.96159779181	44.5489198023411	0.0154578464322616	2974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2878.02491549186	2878.02491549186
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTAACTAGTGGTTCT"	4.01817955550496	-10.8806305161682	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTAGTGGTTCT"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2579.40138355301	43.012368344454	0.0166753296399362	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2573.01005693758	2573.01005693758
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCAAACAACCACAT"	7.0769268470699	-9.71124079143675	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCAAACAACCACAT"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2728.8877024043	40.314914105387	0.0147733869993505	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2723.20936558099	2723.20936558099
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTCATGTATCGTTG"	1.15458466586415	11.5365895994934	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCATGTATCGTTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2374.15562195622	40.5674629657622	0.0170871119780834	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2365.34352445447	2365.34352445447
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTCTACACGTTGGC"	-0.607165913016158	10.8915347822937	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCTACACGTTGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2391.11685861244	39.3335802820482	0.0164498778637165	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2386.08633407635	2386.08633407635
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTAACTCACTGGAAG"	-1.52890739861186	11.2953643568787	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAACTCACTGGAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2272.6429759325	40.3339715582683	0.0177476057548013	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2268.35826287613	2268.35826287613
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCAAATCCTCAGGG"	1.35417308387105	10.8115348585877	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCAAATCCTCAGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2362.749896857	35.5989098481928	0.0150667279239109	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2357.78332443171	2357.78332443171
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGATAATCTCTCAAT"	-3.00591264191325	13.3726844557556	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGATAATCTCTCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2519.8079482484	35.3204924163292	0.0140171366793575	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2515.50764122957	2515.50764122957
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTGAGGTCCGTTTC"	-7.64319119873698	2.91647360408632	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTGAGGTCCGTTTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2370.21430099103	40.7560319907551	0.0171950831507996	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2368.12207454031	2368.12207454031
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGTGCCGAGGTGATAT"	7.07560171660726	-9.8272972336975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGTGCCGAGGTGATAT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.18484571431	39.4670836405961	0.0143820791453729	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2741.12302505089	2741.12302505089
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCGTTCAATTTCGG"	-1.32942293110545	11.6777734526428	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTCAATTTCGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2626.80593383126	41.3841575586259	0.0157545546192163	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2623.5226214871	2623.5226214871
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGGTTGTCGAGATG"	-8.13411746445354	2.53562328899232	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGTTGTCGAGATG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2391.24696558372	47.4896876012825	0.0198598004659423	2969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2387.04112122637	2387.04112122637
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTTACTCTTCACGC"	-0.28219179335292	11.2977094420227	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTACTCTTCACGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2500.17269962335	38.1173592249131	0.015245890506146	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2492.79298751182	2492.79298751182
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGTTGGTAGAGACC"	7.23272289809529	-9.97173502361449	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGTTGGTAGAGACC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2485.27695873447	37.813597181658	0.0152150435583297	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2480.4323977049	2480.4323977049
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTTGTGTCGTATGT"	-3.61366949501689	13.2111854323181	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTGTGTCGTATGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2403.26277568035	43.995610401716	0.0183066166741841	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2400.45867828904	2400.45867828904
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTTGTGTTACGGAG"	-2.48007712784465	13.6263971098694	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTGTGTTACGGAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2557.19441547705	46.2525959787274	0.0180872426823671	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2548.58248922825	2548.58248922825
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTTGTTCTCATGGA"	8.27698292311971	-8.82106401836547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.555555555555556	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTTGTTCTCATGGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2480.04567511534	44.1473893505973	0.0178010388250386	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2472.06607173068	2472.06607173068
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACGGGTAGACTTAAG"	0.102953487157267	11.4325866469177	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGGGTAGACTTAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2482.77318796917	36.4009615751201	0.014661412388175	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2481.77025696477	2481.77025696477
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTCACGAGGTTTACC"	6.61892714080159	-10.034411453363	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCACGAGGTTTACC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.05047871372	41.3547466197976	0.0160847665038794	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2567.99254415268	2567.99254415268
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAGCCGCAGCGACCT"	8.0763336616451	8.35626790607301	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAGCCGCAGCGACCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1977.84579474495	41.6059839197033	0.021036010001512	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1977.84579474495	1977.84579474495
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATAGAACACCCAACG"	-2.68612966957744	13.0936279066834	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATAGAACACCCAACG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2631.51016398902	40.08264569481	0.0152318034880967	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2624.86243171875	2624.86243171875
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACGTTCTCAAGATAG"	1.31858553466145	10.5869865187439	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGTTCTCAAGATAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1930.25486172144	34.272908882094	0.0177556391965405	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1926.73578813352	1926.73578813352
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACGTTCTCATTCATC"	0.0672941627794921	11.6658572920593	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACGTTCTCATTCATC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2559.64246243622	44.4339634620364	0.0173594414509537	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2550.68282388301	2550.68282388301
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATAGCTGTTTCCCAC"	-2.84264908257182	13.1272859343323	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATAGCTGTTTCCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2550.09325483343	38.8288279198106	0.0152264345024303	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2543.2272273288	2543.2272273288
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGAAGAGCTTCATG"	6.73943676528279	-0.836385392304979	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGAAGAGCTTCATG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2507.38817417498	39.3031678837152	0.0156749434684748	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2504.9996746064	2504.9996746064
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCACAAGGTCACTT"	0.911880095570725	10.5954541929993	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCACAAGGTCACTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.96278651052	33.6397550022134	0.0137139279842348	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2446.08086919825	2446.08086919825
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGAAGAGTACAACA"	-2.36819897118266	13.0815047987732	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGAAGAGTACAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2318.99561715362	47.8041116629464	0.0206141448950309	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2318.99561715362	2318.99561715362
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCAGTCAAGCTCTA"	-6.87024579468425	0.0779386659148111	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCAGTCAAGCTCTA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2935.54119163103	38.9775444363002	0.0132778053148843	3666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2927.82680235485	2927.82680235485
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCAGTGTCTGTCAA"	-2.08478699150737	10.5453414686951	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCAGTGTCTGTCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2516.75926762652	33.3715435126745	0.0132597280725011	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2508.57211714201	2508.57211714201
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCAGTGTTCCTACC"	3.18353118476216	-10.4641103974548	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCAGTGTTCCTACC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2648.74741052538	43.8792472307785	0.0165660368581824	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2645.0826791568	2645.0826791568
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATACTTCGTTCCGCGA"	8.38933243331258	8.19697568500368	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATACTTCGTTCCGCGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2400.3274708269	41.7670559345664	0.017400565732049	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2390.39536912571	2390.39536912571
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCATGGTCAGTTTG"	-7.61520467224773	3.18264458263246	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCATGGTCAGTTTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2687.31942803863	39.8045981338557	0.014812008471545	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2675.74928517513	2675.74928517513
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCCCTCACTTCAGA"	-7.55995116654094	3.79499242389528	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCCCTCACTTCAGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2177.28690263779	37.8658405845403	0.0173912958088645	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2174.17343265376	2174.17343265376
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCCCTGTGAGGAAA"	-2.23926959458049	13.6982049711975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCCCTGTGAGGAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2550.84572164953	41.5659321226306	0.0162949612239785	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2547.04021116093	2547.04021116093
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGGCGTGTCCATAGT"	1.4946686225826	11.269935584906	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGGCGTGTCCATAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2153.08012105613	37.2218179906672	0.0172877068654599	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2146.89267034139	2146.89267034139
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGATTTCAACCGAT"	-1.30784688416179	11.424458480719	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGATTTCAACCGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2430.15792498034	45.4150910159342	0.0186881233310389	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2428.57149937314	2428.57149937314
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATCGTAAGAGTGACC"	-2.42233548584636	13.207155204657	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATCGTAAGAGTGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2600.04916864616	41.8244254834561	0.016086013290754	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2594.27931149563	2594.27931149563
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACTTCGAGTGAATAC"	6.38193239745442	-10.1728382340637	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACTTCGAGTGAATAC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2764.54189668557	33.3455290739116	0.0120618642509596	2688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2763.29233200366	2763.29233200366
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGGCTCACTCATAG"	0.0755341919953048	11.1936015852722	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGGCTCACTCATAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2649.37601958129	42.1473471174344	0.0159084051512233	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2646.25023171957	2646.25023171957
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATAGAGATCCTAGCGG"	1.46269824084584	10.7835492857727	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATAGAGATCCTAGCGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1986.30302696449	37.8040105431979	0.0190323480506249	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1981.61248226261	1981.61248226261
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGACTGTGGCTGCT"	-0.89880202236827	11.3621577986511	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGACTGTGGCTGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2586.47639858705	43.9231391454065	0.0169818441681513	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2582.68704882515	2582.68704882515
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGACTTCGTGTGGC"	8.07483543929402	8.19875714862672	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGACTTCGTGTGGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2170.96487172101	38.0976398919745	0.0175487131957934	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2167.94050763142	2167.94050763142
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGAGGGTGTAAATG"	-7.57576928559001	2.97644612872926	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGAGGGTGTAAATG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2819.18743073795	43.8863743531405	0.0155670296606185	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2807.75806901423	2807.75806901423
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGATACAGGTGCATG"	1.33794297751729	11.3554286726746	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATACAGGTGCATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1942.39462480858	39.9998888810191	0.0205930805049262	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1939.55777203987	1939.55777203987
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGTCGAGTAAACGT"	-2.11395202103313	12.2867564924988	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGTCGAGTAAACGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2417.38867111709	45.3642151612837	0.0187657929001217	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2414.30587226582	2414.30587226582
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGGAGAGAACGCGT"	-1.88906190815623	13.0644454726013	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGGAGAGAACGCGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2162.471479552	43.0874247952819	0.0199250834994634	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2159.2156551289	2159.2156551289
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGGAGCAAAGGCTG"	0.00472174313609001	11.6729097136292	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGGAGCAAAGGCTG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2520.05147545881	42.8509057519377	0.0170039803429556	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2505.47411603291	2505.47411603291
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTGTTATCGACACCG"	-2.37443075600322	13.0404052504334	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTGTTATCGACACCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2239.67557130293	45.1171119243818	0.0201444854346181	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2236.59278617914	2236.59278617914
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTTAACAGACTACGG"	0.997848530381364	11.3778943785462	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTTAACAGACTACGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2129.79378117592	46.9799811356842	0.0220584647917157	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2123.31022757596	2123.31022757596
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTTAACCAAGACCTT"	-7.55211911621745	3.40202305400697	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTTAACCAAGACCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2302.52152644616	42.4991801478843	0.0184576689771409	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2293.77603615082	2293.77603615082
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGTTGCATTCGATG"	-2.83390031281169	13.0514182814392	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGCATTCGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2692.9400446715	44.7056683581184	0.0166010633792524	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2691.72211324873	2691.72211324873
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGTTGGTATGACAA"	-1.60154555264171	11.6860503920349	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGGTATGACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2446.55409291671	42.1483355015364	0.0172276327850525	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2444.11408778937	2444.11408778937
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGTTGGTGCCGAAA"	-0.1585790020531	11.5189838179382	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGGTGCCGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2772.6963015612	42.0745795493001	0.0151746080252675	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2767.03754671849	2767.03754671849
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGATTGAGAGCTGCA"	-7.23379836502727	2.93444249713746	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGATTGAGAGCTGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2196.20804065664	38.5331235302764	0.017545297538732	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2189.37199210034	2189.37199210034
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATTCGAAGATACATG"	7.03061308440511	-9.61828710949095	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCGAAGATACATG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2465.40770088101	36.899364686048	0.0149668408486199	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2460.64362819436	2460.64362819436
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGAACTGTCGCAACC"	-1.38403175297435	11.8331641920838	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAACTGTCGCAACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2408.53017657052	42.8462626923707	0.0177893817188452	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2401.24223515798	2401.24223515798
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTACAGCACTGTGAT"	-0.385151307017165	10.9529847868714	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTACAGCACTGTGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2489.62373262279	40.569857603988	0.0162955779511502	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2479.99870890653	2479.99870890653
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATTCGATCATTGAGC"	-2.57561121407207	13.2400359877381	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCGATCATTGAGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2630.1932867732	37.9421780896958	0.0144256235009422	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2626.20867356745	2626.20867356745
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCAATAGTAAACAC"	-2.42581353607829	13.3804321059021	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCAATAGTAAACAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2612.3582729933	42.7357200472821	0.016359057824911	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2607.52719230273	2607.52719230273
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATTCTTAGGCTGAAC"	1.30383624610249	11.2782506712708	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTCTTAGGCTGAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2137.99803113784	38.5521838380264	0.0180319080170102	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2131.2851712832	2131.2851712832
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCACCGTTGCGGCT"	-1.64363847199138	11.9199628599915	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCACCGTTGCGGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2550.59523214714	38.8301920475428	0.0152239726469083	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2547.37812603908	2547.37812603908
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CAGCACGGTACAACGG"	1.06690420684163	11.0600394972595	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CAGCACGGTACAACGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2473.18675874413	39.1895447324906	0.015845768458016	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2467.21294333618	2467.21294333618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATTGGTCACCGTGCA"	-1.4398994249409	10.2055063017639	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00168293503870751	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTGGTCACCGTGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2633.28390677608	44.8959331865344	0.0170494085620643	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2627.44120670205	2627.44120670205
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAATCGTCGGACCAC"	-2.50932393494304	13.170157409552	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAATCGTCGGACCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2148.64262221433	42.3256765390541	0.019698797790502	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2144.04434295019	2144.04434295019
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAATGCGTAGTCCTA"	0.600222309201401	10.6647901304993	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAATGCGTAGTCCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2102.97563922195	41.2917698900475	0.0196349254456054	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2096.86609715714	2096.86609715714
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCCAAGCTCGGCT"	-7.65229354324992	3.07937166774598	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCCAAGCTCGGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2220.85053871629	43.3256468731168	0.0195085829135356	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2217.80308066982	2217.80308066982
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATTTCTTCGATTGAC"	-0.14172905209716	11.5475711592468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATTTCTTCGATTGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2452.71989472616	42.2632700718371	0.0172311849236073	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2446.97337205305	2446.97337205305
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTCCCATCTAATTCC"	0.309041549533051	11.2367639311585	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTCCCATCTAATTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2063.2106180093	42.3835632039765	0.0205425286366888	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2059.7791901607	2059.7791901607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACATGTGATGGCA"	-2.60122380676921	13.5109042891297	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACATGTGATGGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2600.65269806533	31.6806442342151	0.0121818050744657	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2598.21822129263	2598.21822129263
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGAGGAGACTCCGC"	7.75934090194051	-10.0835180512634	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGAGGAGACTCCGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2410.7655029499	47.257789335398	0.0196028146568265	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2405.31157656513	2405.31157656513
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCCTATGTTACGGAG"	7.07339539107625	-9.83081724559935	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCCTATGTTACGGAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.97684698175	43.3978649211044	0.0163028709172698	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2656.24956785482	2656.24956785482
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACATTCTGCCTGT"	-0.997410039336044	11.7637061842713	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACATTCTGCCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2596.58743386056	49.4218034322449	0.01903336771478	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2588.81215989252	2588.81215989252
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACCGAGTCACGCC"	0.849348981946152	11.5226115950379	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGAGTCACGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2431.07405190018	38.6495112269173	0.0158981217362376	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2420.30072738287	2420.30072738287
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACCGCAAAGCACG"	1.43518425998036	11.4257383116516	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGCAAAGCACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2133.16265496823	32.4986665276	0.0152349688158609	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2127.22913216266	2127.22913216266
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACCGGTGTTGAGG"	-1.89585993710216	11.7715778120789	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGGTGTTGAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2439.34197753238	43.1270078486682	0.0176797711210198	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2433.3454221228	2433.3454221228
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGATCCACTGAGTT"	6.62750639495198	-9.93877794658812	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGATCCACTGAGTT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2558.74583706983	35.6331036368943	0.0139260035602832	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2552.77875503799	2552.77875503799
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACCGTCAGTGGGA"	7.99069513854329	7.59161565387575	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGTCAGTGGGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1944.86468174719	45.7989454043773	0.0235486539676547	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1939.64805787323	1939.64805787323
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAACCGTCCTTCAGC"	8.2136045890743	7.7762093313965	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAACCGTCCTTCAGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2086.91445062017	46.2825008510348	0.0221774787353075	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2079.8619053958	2079.8619053958
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACATACAAGTAGTA"	-2.34659419480022	13.5263852843079	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACATACAAGTAGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2784.57128743602	44.8322154280177	0.0161002218295867	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2779.31203734699	2779.31203734699
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCATTCAACTGAC"	-1.74052379551585	13.1159696348938	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCATTCAACTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2510.74680456739	48.4166714829115	0.0192837730171896	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2501.15862859493	2501.15862859493
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACATAGTGATCATC"	-2.29305968704875	13.4293107756409	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACATAGTGATCATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2515.27555309672	41.2992918545924	0.0164193906324682	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2507.11484925853	2507.11484925853
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACATATCAGGGATG"	-2.097808222205	11.2419690855774	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACATATCAGGGATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.41842774808	45.1212905445529	0.0194035146561766	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.03702640439	2315.03702640439
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACGGTAGTCTCGTA"	-0.00725965473111275	11.296565032843	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGGTAGTCTCGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2376.43842695227	43.2704283403546	0.0182080999236525	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2373.8195873106	2373.8195873106
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACGGTGTCGAGTGA"	-2.08146748963054	13.3510703810486	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGGTGTCGAGTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2509.71887429765	43.4343426677103	0.017306457353661	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2505.74716604508	2505.74716604508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCACGGTTCATGGAGG"	0.594605584710282	10.0688905485901	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCACGGTTCATGGAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2538.16138582516	33.9271069490118	0.0133668044666049	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2529.04389509328	2529.04389509328
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGGTTAGGTGATAT"	-2.40735326233562	13.3518495329651	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGGTTAGGTGATAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2647.34905123256	41.7694675335993	0.0157778467158126	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2639.79221715017	2639.79221715017
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGGTTTCACGGAGA"	1.35865237292592	11.2769679793152	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGGTTTCACGGAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.27793889688	36.3044536776048	0.0165299905966543	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2189.38011739654	2189.38011739654
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGTACAGGAACGAA"	8.10543121871297	6.98944232547609	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGTACAGGAACGAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2206.41074641336	45.2446878918176	0.0205060132005636	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2200.91652120473	2200.91652120473
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTATTGGAGCAATAGT"	-2.67566190186198	13.1524390944275	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTATTGGAGCAATAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2372.39110156715	37.4721714055885	0.0157951070465722	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2369.40574953255	2369.40574953255
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTATTGGCAACTTGGT"	0.110735607414883	-10.2134962311951	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTATTGGCAACTTGGT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2448.21955791104	45.0982604934862	0.01842083989067	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2445.37649214039	2445.37649214039
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTGTGAAGCTGGCTC"	-0.340959976345855	11.2097434767517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTGTGAAGCTGGCTC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2445.80902877938	39.1940140991789	0.0160249690952933	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2435.10298342513	2435.10298342513
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTATTGGTCCTGTACC"	-6.67437968674357	0.00383939528790852	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTATTGGTCCTGTACC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3041.41002206371	41.709834430833	0.0137139794135785	3395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3034.55145107621	3034.55145107621
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGCCAAGGTCTTTG"	-2.07346067848857	13.4382791289124	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCCAAGGTCTTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2767.25479535093	39.9948993783389	0.0144529153750249	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2760.91415141103	2760.91415141103
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATCGTCCAGAAACTGT"	-2.13917551460918	13.9382800825867	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATCGTCCAGAAACTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2358.36055497803	41.2760699299927	0.017502018443646	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2353.19049030131	2353.19049030131
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTCATGAGGTGCTAG"	-2.21708712998088	13.3592052229675	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCATGAGGTGCTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2217.90567849138	39.9104138177789	0.0179946398103485	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2211.77066905536	2211.77066905536
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGCCATCCATCTCG"	-1.71050153198894	10.5993242033753	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCCATCCATCTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2481.97069680288	39.6985816500091	0.0159947825738419	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2477.44538656341	2477.44538656341
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGCCATCGTAGCCG"	-0.412603597075301	10.9742688902649	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCCATCGTAGCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2267.92687268044	44.2249920274977	0.019500184313804	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2261.42322164171	2261.42322164171
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGCTGAGGAGGCAG"	8.02956451949422	8.50839803302614	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCTGAGGAGGCAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2156.871737514	42.5292494063552	0.0197180243343419	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2148.2372196052	2148.2372196052
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATACCCAGAGTTGCG"	-2.14152679863628	13.078248954657	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATACCCAGAGTTGCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2509.16897017657	39.0039075695257	0.0155445520142794	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2507.76419468268	2507.76419468268
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGGCTAGACCTCAT"	1.15704693373982	10.4494085081848	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGGCTAGACCTCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2008.83031237181	30.7964389848151	0.0153305327957014	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2005.43977036195	2005.43977036195
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGGCTGTCAGACTT"	-2.27578888359721	13.214591003302	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGGCTGTCAGACTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2568.45873928017	45.7699684802446	0.0178200131387246	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2559.23564851126	2559.23564851126
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGGCTTCAGACCTA"	-2.64034376564677	13.3919410475525	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGGCTTCAGACCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2390.78351904749	42.4296778659915	0.0177471851917801	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2383.92603912497	2383.92603912497
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGGCTTCGGTCAGC"	0.641493638127488	11.6063880690369	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGGCTTCGGTCAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2151.51857127661	41.1595569071393	0.0191304678735435	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2144.82735232195	2144.82735232195
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCATTTAGATAGTCA"	-0.393408308655578	11.0469903715881	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCATTTAGATAGTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2275.76069684169	42.2414607125617	0.0185614685986908	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2273.20730684343	2273.20730684343
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGTTAAGCAGGCAT"	-7.95159755173381	2.79853508556215	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGTTAAGCAGGCAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2550.9689147333	48.9735859033479	0.0191980331945629	2985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2541.12630877157	2541.12630877157
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTAGTTCGTCCTTG"	-0.380664626986343	11.0898265608582	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTAGTTCGTCCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2180.63268145558	44.0426509340655	0.0201971892417327	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2175.02374280221	2175.02374280221
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGGTAGGTCAG"	0.153280091553372	11.4092006453308	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGGTAGGTCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2429.18110784725	46.1631452815671	0.0190035831961813	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2419.42937793166	2419.42937793166
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCATCGGAGTCTGGTT"	-2.32407389107402	13.4946603544983	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCGGAGTCTGGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2604.03209175212	43.0325122022961	0.0165253386617604	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2595.46308600997	2595.46308600997
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCATCGGCAGTCCCGA"	-9.31512198868449	4.22806928241578	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCGGCAGTCCCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2121.89486692035	49.5788081930037	0.0233653462129162	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2116.77465452328	2116.77465452328
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGAAAGTCTCTCCGA"	-2.51498613777812	12.9728879698547	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGAAAGTCTCTCCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2867.54747107045	42.8637703640497	0.014947885186378	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2861.12873767662	2861.12873767662
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTTCGAAGCACCGAA"	-2.34076843681987	13.4133615263733	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTTCGAAGCACCGAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2517.97921535095	40.3777958588664	0.0160357939464717	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2510.80473959239	2510.80473959239
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCCTCAGTCGACTTA"	1.22853495654408	11.1897039183411	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCTCAGTCGACTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2100.58150522757	37.6149964591525	0.017906944513004	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2091.73976398221	2091.73976398221
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCATCTCCAGAATCGG"	6.1612454849178	-10.0194092026916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCTCCAGAATCGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2707.81364641542	43.0473580286725	0.0158974595927819	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2705.01812328435	2705.01812328435
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGTTGGATCAACGTGT"	-0.168444643647033	11.506525970343	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGTTGGATCAACGTGT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2408.91141537959	42.5332026851078	0.0176566072183296	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2400.59691015031	2400.59691015031
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCATCTCGTTTCCATT"	-0.138307834894019	11.317506767157	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATCTCGTTTCCATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.51366903296	41.8480113644856	0.0167894811909784	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2487.61955720765	2487.61955720765
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCATTAGAGTATGAAC"	0.497758318751496	11.6722001799378	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCATTAGAGTATGAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2319.91875439114	41.408562594552	0.0178491434306369	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2316.97173316252	2316.97173316252
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAATCCCATTCAGCA"	0.861482580273789	11.217840171698	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAATCCCATTCAGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2441.90466453491	41.3692249620535	0.0169413759525017	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2433.44157163666	2433.44157163666
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAACGCAGTCGAGA"	8.19216599044148	8.20140264118043	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAACGCAGTCGAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2265.36207967309	37.0802770696014	0.0163683666299175	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2261.44457771928	2261.44457771928
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAAGTTGCTGAT"	0.223685030906838	11.7669954069885	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAAGTTGCTGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.2432038661	43.7316039168346	0.0180169848028327	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.09941494221	2416.09941494221
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAACGTCTGAGGCC"	0.774554212659043	11.6382369765076	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAACGTCTGAGGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.52310275089	43.8031245693409	0.0189253347772936	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.55839376343	2309.55839376343
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGCACATGAAAGT"	-8.10872016373332	2.98277947986452	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGCACATGAAAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2440.21064805992	45.6392763595989	0.0187030068063527	3124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2435.46809965369	2435.46809965369
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGCATCCATAGGT"	-0.0511043173378289	11.4950189360413	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGCATCCATAGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2517.79750359521	43.4795258794957	0.0172688732185215	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2505.32827031253	2505.32827031253
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGGTTCATTATCC"	-7.15047250214274	2.83879230106202	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGGTTCATTATCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2776.39964044543	42.409662474906	0.0152750568963847	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2767.89913077163	2767.89913077163
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGTGCATCTATCT"	-2.8401759666508	12.6828822859558	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGTGCATCTATCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2787.31823328115	42.2565491819955	0.0151602887239224	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2778.10666359423	2778.10666359423
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGTGGTAGTGCGA"	-7.81205068054851	3.08128831470338	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGTGGTAGTGCGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2590.18133100252	47.247685049489	0.0182410723465457	2908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2579.6472415518	2579.6472415518
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCTCACAGTATTGCC"	1.34604301032369	11.2276153334412	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCTCACAGTATTGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2424.5422037527	37.2151407903391	0.015349347490317	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2417.8147985263	2417.8147985263
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCAGTGTCGCAAGAG"	0.870565136044663	10.7210149534973	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCAGTGTCGCAAGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2181.89880786801	37.8315196555365	0.0173388057773874	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2180.17568728801	2180.17568728801
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATGAGTTCTCAAAGC"	1.50235857543294	10.708373046759	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATGAGTTCTCAAAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2050.97173772803	35.4752898890549	0.0172968204468545	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2043.67846626358	2043.67846626358
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTACCGCCAAGAAATC"	1.25459422644917	11.1200656660828	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTACCGCCAAGAAATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2083.72403114449	35.5062880609869	0.0170398227069854	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2081.37764863623	2081.37764863623
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCATGGCAGGGATAC"	-2.27497706833537	13.6444787749085	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGCAGGGATAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2507.0314861231	34.1080291917597	0.0136049464797527	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2503.03719205987	2503.03719205987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCATGGCATCCGAAT"	8.39275230941121	7.88237235629884	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCATGGCATCCGAAT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2328.55132463663	39.7441787407631	0.0170681995798247	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2321.39079208946	2321.39079208946
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGCCTCCACATTACG"	-0.191825221211273	11.5190477141174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCCTCCACATTACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2230.21972592338	39.5077452323734	0.0177147322181522	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2225.55592399116	2225.55592399116
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGCCTCGTCTGCGCA"	0.927607138722581	11.0231542357239	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGCCTCGTCTGCGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2340.22708677566	38.5528258522273	0.0164739678769145	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2331.93907680606	2331.93907680606
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGAGTTTCTCTTAAC"	0.951445658772629	10.9224128493103	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGAGTTTCTCTTAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2332.66849101465	46.0104535196524	0.0197243859111927	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.25274601049	2319.25274601049
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATGGAGGCACTACACA"	0.845687945454758	10.9512643584046	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATGGAGGCACTACACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.41027306434	38.4598800760956	0.0165389654125053	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.26011206722	2315.26011206722
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGATGTCATCACCAA"	-0.389772246510345	10.7199563750061	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGATGTCATCACCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2334.30633117927	36.9631363231576	0.0158347410660897	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2330.84526358587	2330.84526358587
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCCGAATCTCGTCGT"	1.45310403880422	11.1761722334656	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCCGAATCTCGTCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1950.67622453514	29.2528474331374	0.0149962597919645	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1949.6920875169	1949.6920875169
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGCACGAGATACTGA"	1.49232604083363	11.3162212141785	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCACGAGATACTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1989.55964983922	39.7289506733392	0.0199687155278555	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1983.90491377957	1983.90491377957
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCGATGGTCTTACAG"	-2.98968897286113	13.3696784743103	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGATGGTCTTACAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2437.14878604106	43.3003371468741	0.0177668008596273	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2433.02932906181	2433.02932906181
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCGATGTCTAGAGCT"	-1.91076157513316	11.8840398558411	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCGATGTCTAGAGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2484.34230667061	43.2161325832679	0.0173954017798715	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2477.44234480001	2477.44234480001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTAGGCATCCCATTCG"	-2.50920806351359	13.3482208021912	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTAGGCATCCCATTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2885.45491678127	40.8856790166759	0.014169578176007	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2881.91719210928	2881.91719210928
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGCTGGAGGCACTCC"	-1.90596185150798	12.1479215391907	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTGGAGGCACTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.58524138033	39.4633588098353	0.017198471470206	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2287.32298629229	2287.32298629229
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTCATTCCGCAAAT"	1.03518112477605	11.2051877745422	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTCATTCCGCAAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2402.9093330494	42.1506278047688	0.017541497394443	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2393.27016457474	2393.27016457474
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTCCGGTGGACAGT"	-2.39401278916057	12.5392036207947	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTCCGGTGGACAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2263.33108711516	41.0754143671947	0.0181482128712991	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2257.72552742505	2257.72552742505
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTCCGTCTAGAGCT"	8.18070091780965	7.61933372104494	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTCCGTCTAGAGCT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1963.607900672	39.1793251703522	0.0199527233298175	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1962.22024771736	1962.22024771736
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTCTAAGTTTGTCG"	-7.8219932121342	2.73717019641725	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTCTAAGTTTGTCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2450.51575675375	47.6164718158677	0.0194312040984165	2716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2443.4020529271	2443.4020529271
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGCTTCGTGTCCCTT"	-7.57585797730144	2.84057900989381	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGCTTCGTGTCCCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2424.9514870918	45.5590759730286	0.0187876236764088	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2421.64112760515	2421.64112760515
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCCTGTTTCGCCGTGA"	6.67900290068929	-10.1356840363708	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCCTGTTTCGCCGTGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2419.76006701865	42.7650593205253	0.0176732643469133	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2413.02761242089	2413.02761242089
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGAGAAGTCATCGGC"	-2.5562461418217	13.3255939253601	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGAGAAGTCATCGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2534.54783564333	41.955174546065	0.0165533173041951	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2527.38400676082	2527.38400676082
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTATTGCGTCCAAATC"	-3.15996418419536	9.76003263080446	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	9	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00127118644067797	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTATTGCGTCCAAATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2395.49050559301	36.3564655665282	0.0151770443179143	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2389.54554462986	2389.54554462986
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTGCCAGCGTGCCT"	1.31130911883656	10.7236099013123	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGCCAGCGTGCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2263.75324961532	38.3306235750104	0.0169323328775007	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2256.4894200062	2256.4894200062
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGAAGTCCTCTCTT"	-1.63954983177837	11.4931316145691	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGAAGTCCTCTCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2323.11750713495	42.6221723766165	0.0183469722240531	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2318.25093710105	2318.25093710105
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGATCGTCTGTCTCG"	-2.19182167473491	12.9760532149109	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGATCGTCTGTCTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2552.31241821182	42.5547644778217	0.016673023323546	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2543.52888803909	2543.52888803909
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGGAAAGTCAGCTTA"	8.1614462333614	7.75192163074342	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGGAAAGTCAGCTTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2174.26517955096	46.4248685092466	0.0213519808650178	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2169.91840053148	2169.91840053148
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CATTGTTTCATGAGAA"	1.68165947970693	-7.76393177425536	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CATTGTTTCATGAGAA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1411.19132278172	52.9646069059432	0.0375318399786785	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1408.78554800955	1408.78554800955
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTACCTGTCACGCTG"	-1.31763301315959	10.7314014204773	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTACCTGTCACGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2513.56483824516	41.5276448367837	0.0165214138123352	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2507.21447021261	2507.21447021261
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGGATCCAAGAGTGC"	7.33305468138997	-9.19311525737914	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGGATCCAAGAGTGC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2865.46973428469	43.2260557824619	0.0150851552418342	3042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2859.90873600218	2859.90873600218
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGCGTTCCCATTTA"	1.20892288264577	10.7013282545838	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGCGTTCCCATTTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1883.35838701603	40.6898506777893	0.0216049430412753	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1881.33068708841	1881.33068708841
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGGAAAGCATTGAA"	-8.00273929062541	2.47858736598817	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGGAAAGCATTGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3065.85734635717	43.9133974915179	0.0143233662008754	4422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3058.2382729117	3058.2382729117
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGGAACAATTTCGG"	-2.51968584480937	13.4760207899841	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGGAACAATTTCGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2380.18486424978	42.7800613210473	0.0179734196127372	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2377.30182301303	2377.30182301303
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGGAAGTTTACCTT"	1.00840951976125	11.3261117705139	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGGAAGTTTACCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.52588221219	39.8409330287534	0.0178057976202553	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2233.22113770406	2233.22113770406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGTGCATCGGTGAAG"	-2.72078118744548	12.8126916655335	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTGCATCGGTGAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1816.35001820786	44.6731609458736	0.0245950177543156	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1816.35001820786	1816.35001820786
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGGAATCCGATCGG"	6.73432888564412	-9.96882822429808	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGGAATCCGATCGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.89033696845	37.37490514721	0.0142603849615627	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2617.48779996799	2617.48779996799
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCGTTTCAGTTCTCTT"	0.233441029756707	11.0582952269348	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCGTTTCAGTTCTCTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2457.95224022381	35.24326630968	0.0143384666849633	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2453.02190903673	2453.02190903673
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCCCTGGTGTTATCG"	6.56367315825765	-10.0441990128723	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCCCTGGTGTTATCG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2534.55457330338	44.4485082658635	0.0175370097507635	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2529.93848249418	2529.93848249418
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACAAACACCATAAC"	-0.0695140463417352	11.4218177565369	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACAAACACCATAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.34503940155	40.3338209718241	0.0171389321567911	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2346.77040331449	2346.77040331449
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTACAAAGTCAGGGT"	0.215082143514794	11.3929166563782	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTACAAAGTCAGGGT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2441.6211910449	38.6967933804039	0.0158488112416175	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2432.99746043271	2432.99746043271
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGGTTATCAAGTCGT"	-2.25915108147319	13.5724639662537	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGGTTATCAAGTCGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2067.78780908382	45.9059259003945	0.0222005012790622	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2066.16462946749	2066.16462946749
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTACAATCGAGTCTA"	0.186776672571343	11.3865327605042	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTACAATCGAGTCTA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2450.52045828801	42.2145247173285	0.0172267587379461	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2443.59449597522	2443.59449597522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GCATGATTCACAAGGG"	-7.87117324295695	3.16647503459779	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GCATGATTCACAAGGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2546.41429213423	39.990379321333	0.0157045848528504	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2537.55279424713	2537.55279424713
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTAACCACCGTGAC"	-2.73826084557231	12.592598892096	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTAACCACCGTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2176.87297782151	46.2035443836095	0.0212247314631317	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2173.54264373349	2173.54264373349
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTCAAACAGTAGAGC"	-7.24733148041423	0.649071312788404	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTCAAACAGTAGAGC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2559.18543636061	35.2089746112172	0.0137578833135622	2742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2557.02990320318	2557.02990320318
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTCCTCAAGTGGTG"	-1.61470292034801	11.4192857512268	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTCCTCAAGTGGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2342.37633483383	42.5190880741387	0.0181521164818099	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2338.89157845531	2338.89157845531
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCAATCACAGCGCT"	-2.69265566292461	13.1141538389954	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCAATCACAGCGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2589.10860631651	43.4114347038201	0.016766942336027	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2583.92243804632	2583.92243804632
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTCAAATCATCCTAT"	0.912250180810136	10.5346784361633	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTCAAATCATCCTAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2561.18037432222	34.8943307373427	0.0136243159939787	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2549.63000000376	2549.63000000376
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTGATGTCGCAGTC"	1.16648509082143	11.1257438429627	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTGATGTCGCAGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2459.62786381619	36.629039965112	0.014892106445843	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2455.33496101508	2455.33496101508
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTGAATCAATGGCAG"	7.00596537169759	-9.64111902630004	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATCAATGGCAG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2366.27476786254	40.8258477353399	0.0172532151759442	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2362.47382229614	2362.47382229614
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTGAATCACGGCGTT"	-1.30089579048808	10.6607331999573	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATCACGGCGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2355.52866545464	41.664151445337	0.0176878133798025	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2351.72734812919	2351.72734812919
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTGAATGTGGTACAG"	6.60804714736287	-10.0723610154358	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGAATGTGGTACAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2817.60221769504	38.3555776242093	0.0136128433542994	3241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2806.03988688341	2806.03988688341
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACGTTTCACACCGG"	6.41876234587972	-10.0936718217102	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACGTTTCACACCGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2608.6902557469	41.0394334829169	0.015731815378429	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2600.47243225122	2600.47243225122
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACTTGAGAGTGACC"	0.198172126978081	11.7070426710877	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGAGAGTGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2047.67813203324	41.360545555931	0.0201987533630894	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2043.34701697804	2043.34701697804
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTTAGTCTAGCAAC"	1.25322415408437	11.1023187407288	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTTAGTCTAGCAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2097.44126783273	43.9150414410302	0.0209374355861737	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2085.58693862616	2085.58693862616
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTTCCCATAATGCC"	-1.18389270725902	11.3441657789978	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTTCCCATAATGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2039.11644525183	40.4748721305138	0.0198492205900066	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2039.11644525183	2039.11644525183
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACTTGGTTGTTGTG"	-2.03506694260295	13.729483581427	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGGTTGTTGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2468.23021553998	37.7238084740504	0.0152837479407477	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2458.88233709431	2458.88233709431
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTGGGTCAGAAATTG"	7.02551903304402	-9.69900419628295	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTGGGTCAGAAATTG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2306.38263110163	39.1812408401916	0.0169881789395357	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2305.60892130056	2305.60892130056
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCACTTGTCGAGAAAT"	-2.1044171852177	13.5149392851624	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCACTTGTCGAGAAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2496.20608152836	36.754857750358	0.0147242881997363	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2494.91074369027	2494.91074369027
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTACAGGTTTGATCG"	1.39743663844411	11.0513143309387	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACAGGTTTGATCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2140.87814214548	41.4136509553022	0.0193442354985228	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2134.0533473079	2134.0533473079
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCCTACAAGTGGAC"	-0.274991731077987	11.4646367796692	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCCTACAAGTGGAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2329.23527482617	40.3737460796268	0.0173334770067999	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2321.28951344753	2321.28951344753
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTACCCCACACGCCA"	1.08123101767842	10.592936492804	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACCCCACACGCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2275.55160471645	35.5008001021804	0.0156009646314323	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2272.45302619407	2272.45302619407
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTACCCTCGTAGGAG"	-1.33782682839091	10.1332130202088	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACCCTCGTAGGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2202.44692170311	43.0135470820466	0.0195298904405765	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2198.30518648932	2198.30518648932
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCCTAACACGACCTG"	6.17146362838094	-10.077609085199	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCCTAACACGACCTG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2851.7627014401	36.1723756436816	0.0126842165462838	3048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2845.82148240135	2845.82148240135
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTTCACCATAGTCAC"	1.48007978972737	11.274914718512	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTCACCATAGTCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2204.00396252606	36.4147490060049	0.0165220887190552	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2199.98714503199	2199.98714503199
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTACGATCTCATAGG"	8.26252808150594	7.67157552326051	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTACGATCTCATAGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2062.71799380893	47.4074035415994	0.0229829786155396	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2051.62258187026	2051.62258187026
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTTCACGTCTGCGCA"	6.51015295562093	-0.904941820260607	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTCACGTCTGCGCA"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2414.76572463385	38.2680567540814	0.0158475235770062	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2408.85639406331	2408.85639406331
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTAGACGTAGAGACC"	6.32939829406087	-10.0345010987488	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTAGACGTAGAGACC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2511.6241744704	35.8642220035133	0.0142792947957971	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2507.99431892565	2507.99431892565
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCAACTCAAGCCTGC"	-0.301551143557388	11.0231599577698	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCAACTCAAGCCTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.97753659796	47.6260489259947	0.0206175376909233	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2303.06967125377	2303.06967125377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCTTGGTAAGGTCG"	-2.2808190387791	13.4914388426575	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCTTGGTAAGGTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2665.50907468259	43.059510538376	0.0161543289975493	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2661.58243433482	2661.58243433482
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCTTTCGTCCTTCTTC"	8.04238905486409	8.50015828693239	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCTTTCGTCCTTCTTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2363.49238570946	40.6099554671479	0.0171821816362475	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2353.3947916644	2353.3947916644
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGAGGGCAAACACCT"	-3.35240517082866	12.9429721602234	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGAGGGCAAACACCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2638.60935003802	38.3086702340088	0.0145185077258431	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2634.45254022373	2634.45254022373
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTGGGTTCAAGGAGC"	1.36016156253163	10.8985509642395	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGGGTTCAAGGAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2216.10793029714	38.632001416899	0.0174323645923325	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2212.86008957987	2212.86008957987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAACCCCAGGCTTGC"	1.30568399009053	11.4821090468201	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAACCCCAGGCTTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2292.95784173002	34.1561281882127	0.0148960995124281	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2285.99132983005	2285.99132983005
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAACCCGTTAGTTCG"	-2.11436400833781	13.279761291388	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAACCCGTTAGTTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2743.09717363503	41.5968980460296	0.0151642087075272	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2736.10367823417	2736.10367823417
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAAGTGTCAATGCAC"	0.965114613145035	11.7524823912415	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAAGTGTCAATGCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2229.46526569394	38.8205385438735	0.0174124886093663	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2225.67798043752	2225.67798043752
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTGTTCGTTTCCATT"	-2.2976807159489	11.3646249541077	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTGTTCGTTTCCATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2276.40761654448	40.4349716402338	0.0177626235944566	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.87067709574	2274.87067709574
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAATCTGTATGTCAC"	1.38576855239217	11.5433597334656	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAATCTGTATGTCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2276.57971690483	35.6499969937442	0.0156594547201768	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.82712620487	2269.82712620487
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCCGTAGGCACAAC"	-0.360620031983215	11.724356628302	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCCGTAGGCACAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2297.56534645094	37.2527544936514	0.0162140130426305	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2293.73170917906	2293.73170917906
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGACGTCTCAAAGCCT"	-2.21128592911418	13.4837703474793	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGACGTCTCAAAGCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2758.38868071194	45.1617152727215	0.0163724987665862	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2751.1404196185	2751.1404196185
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTTCACCAGCTATAC"	8.12066711959187	8.3143157728943	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTTCACCAGCTATAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1919.7903815121	45.2186471696816	0.0235539502672504	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1915.02875968882	1915.02875968882
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCGCTGTATGAAGT"	-1.69731173935588	11.6855945357117	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCGCTGTATGAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2281.02782948861	40.9642382093039	0.017958675330361	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2277.40377034688	2277.40377034688
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCTATAGTTGTCGT"	-1.98293219032939	13.4210462340149	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCTATAGTTGTCGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.92055706473	45.8663833097494	0.0192398958823626	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2380.98602295505	2380.98602295505
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAGAACGTTCTCCTG"	-2.02314601364787	13.3186855086121	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGAACGTTCTCCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2996.18508692138	37.1172602045296	0.0123881733363368	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2979.94972870262	2979.94972870262
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAGATGAGATTAGTG"	-1.86046121540721	13.2199058302673	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGATGAGATTAGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2632.48739994594	45.5704075177809	0.0173107789684831	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2624.21237814417	2624.21237814417
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTCTATTCCAAGCAT"	-0.107907603413421	11.4771499403748	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTCTATTCCAAGCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2088.43409594914	43.27141775757	0.0207195514771101	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2085.31409364588	2085.31409364588
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAGATGCACCACTGG"	-2.23462686958964	13.5829620131287	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGATGCACCACTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2526.26856376554	47.404859854583	0.0187647744719285	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2521.40221480459	2521.40221480459
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTAGTTCTCTGACC"	-2.96341119232829	13.0377654799256	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTAGTTCTCTGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2714.12529216053	41.4488230858101	0.0152715216226497	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2706.42362808568	2706.42362808568
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACAACCAGCACCCA"	0.0274211737209975	11.5557203062805	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACAACCAGCACCCA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2399.81632053028	42.1749830671079	0.0175742546236991	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2385.48944414402	2385.48944414402
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTCAATCGAAGAAT"	0.840621431439561	10.7956933745178	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTCAATCGAAGAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2172.15066381432	35.5207039624899	0.0163527809346867	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2158.29438929307	2158.29438929307
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGAGGTATCAGCAGAG"	-9.24267135086711	3.44807837093202	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGAGGTATCAGCAGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2128.11471560798	39.518073300798	0.0185695221272449	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2123.06385916519	2123.06385916519
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGATCTAAGGCCCAAA"	8.33805718001668	8.0043473013672	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATCTAAGGCCCAAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2106.07922815421	40.7153514374662	0.0193322980888756	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2090.23745954171	2090.23745954171
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCAAAGCGATGAC"	-7.89621053162273	2.75917980754701	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAAAGCGATGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2535.55862537924	41.6461325183604	0.0164248351828708	3276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2526.65016581522	2526.65016581522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTGTCCAGTAGGTTA"	-2.28512940827068	13.1210651167664	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTGTCCAGTAGGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2552.27123076242	42.8530799672851	0.0167901747474088	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2548.50617082027	2548.50617082027
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGATCTACAGCACAAG"	1.26388969001119	10.4294070967468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATCTACAGCACAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1932.36481303035	40.2016807556917	0.0208043949489263	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1928.84186532306	1928.84186532306
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTCTTCCTCATGAGAA"	-0.130377183586913	11.3249645003113	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTCTTCCTCATGAGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2336.82040808185	41.7295176127041	0.0178573918082807	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2334.36724724324	2334.36724724324
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGATGTTGTACCGTCG"	-2.10417256775554	13.4992055662903	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATGTTGTACCGTCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2267.25869401006	46.8055795316207	0.0206441283719753	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2264.20341782214	2264.20341782214
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACCAATCGGCCTTT"	7.01708426055257	-9.91881754314574	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACCAATCGGCCTTT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2567.93205981754	44.4640514342159	0.0173151198701788	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2561.04372313996	2561.04372313996
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGATGTTTCCACTGAA"	-8.04263148728069	3.25703046405641	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATGTTTCCACTGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2529.08726322395	49.4890738201871	0.0195679581878487	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2521.37868030281	2521.37868030281
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGATGTTTCTCTCCGA"	6.70348705825154	-1.10550429737242	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGATGTTTCTCTCCGA"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2804.27141163007	38.7799231534284	0.0138288765461851	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2791.08710939108	2791.08710939108
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGAACGTCAGTAGGG"	0.677981634705704	11.7342920073303	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGAACGTCAGTAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2242.57593425357	47.9616819472198	0.0213868708812233	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.42518824237	2230.42518824237
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTTACTGTAGGCAAC"	-2.94262347641643	12.9950608977112	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTACTGTAGGCAAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2519.088387046	33.8335681473649	0.0134308777418643	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2514.73449971686	2514.73449971686
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTTGGAAGCGTGAAC"	-2.87856636467631	12.2989072569641	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTTGGAAGCGTGAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.86801306252	40.2138664160653	0.0173270802948423	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.99819314972	2314.99819314972
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCAGTCGTACGTGAG"	1.28798820552174	10.569517112616	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCAGTCGTACGTGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2127.41602276258	36.3561510823567	0.0170893472143478	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2117.3306807634	2117.3306807634
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAACGATGTAAGATCA"	-0.050046238035518	11.6504544981751	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAACGATGTAAGATCA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2389.12735790332	38.3164843244591	0.0160378575875023	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2383.2733166138	2383.2733166138
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGCACGTGAGA"	-0.0598244917696297	11.0948848494324	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGCACGTGAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2140.64393727011	38.1850581850342	0.0178381175496801	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2133.08547670793	2133.08547670793
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTTTCGGTCACCCTGT"	1.52983452853505	11.266348815802	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTTTCGGTCACCCTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2122.16734647626	37.2972106490431	0.0175750563267185	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2113.97482200551	2113.97482200551
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGCAGTAGTTC"	1.31554319438283	10.7456397780213	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGCAGTAGTTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2323.66032083025	36.85757860034	0.0158618616800112	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2313.98276095172	2313.98276095172
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCCTTAGCATGGGAAC"	-2.81357083740886	13.4386262663635	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCCTTAGCATGGGAAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2721.90932956621	41.3187642387881	0.0151800663563518	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2715.56945963504	2715.56945963504
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCTTGGAGGGCTGAT"	-0.379527340561706	9.16180131519166	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTGGAGGGCTGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2819.72515557905	36.066844623563	0.012790907848661	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2809.97925916773	2809.97925916773
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCTTGGGTCAAATCC"	0.924983878701371	11.3032340773377	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTGGGTCAAATCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.27951280067	41.8386954941404	0.0195940134503815	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2130.91968055944	2130.91968055944
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCTTGGTCCTCGATC"	7.50736012038533	-9.32339861309203	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTGGTCCTCGATC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2616.35402843753	35.7214818108611	0.0136531529841142	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2610.95099555246	2610.95099555246
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAACGACCATTACGGT"	0.684173067181748	10.8377971419129	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACCATTACGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2095.95814421727	41.0215878229147	0.0195717590716651	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2085.72504238623	2085.72504238623
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCTTTCGTCCGGCAT"	6.32478394088094	-10.0371389619079	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTTCGTCCGGCAT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2744.32285721512	42.10053937012	0.0153409571543061	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2741.69263362089	2741.69263362089
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCTTTCGTCTACGTA"	0.870639582245988	10.6459626921448	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCTTTCGTCTACGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2226.51262701937	37.3567235041657	0.0167781323361167	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2218.36441835612	2218.36441835612
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAACGACGTTGACGGA"	0.265217696397942	11.3891277083191	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACGACGTTGACGGA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2351.19355877813	40.949198386505	0.0174163450872098	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2340.58424262926	2340.58424262926
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAAGTCAGCCTACG"	-7.27630935135539	3.15300200069276	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAAGTCAGCCTACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2470.58374085033	49.7467466859101	0.020135624574615	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2462.8032256158	2462.8032256158
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGCAAGGTAAGAACT"	-3.54759273949321	12.4322728880676	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGCAAGGTAAGAACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2572.1568798313	43.5073339828891	0.0169147279950291	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2563.40719619649	2563.40719619649
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAAGTTCACCTCTG"	8.07915939864461	8.27083299243776	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAAGTTCACCTCTG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2129.83838684599	42.2445558401611	0.0198346297545701	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2119.6631803278	2119.6631803278
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAACTTCTCCAACTGA"	8.41612972792928	8.10175416553346	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAACTTCTCCAACTGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2268.19716020627	39.5243745807409	0.0174254581013348	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2255.83795457293	2255.83795457293
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGGACACACTTGGGC"	-2.84031329575236	13.230722404364	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGACACACTTGGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2515.59640008883	43.1688910542361	0.017160499614609	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2510.28309014745	2510.28309014745
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACAAGTACCAATC"	-2.89713821831401	13.2330627211365	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACAAGTACCAATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2675.86143834843	43.7460553869856	0.0163484008402117	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2672.20684742487	2672.20684742487
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACCTAGAGCAAGA"	-1.31499693813975	11.3696107634339	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACCTAGAGCAAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2507.07065923806	38.6887807949	0.0154318669289753	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2497.88189885136	2497.88189885136
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACCTCAAGATGTA"	0.366177578538102	10.9383668669495	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACCTCAAGATGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2193.91438734603	40.0061836192949	0.0182350705433361	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2189.22932719022	2189.22932719022
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGGGTACATCTAACG"	-7.21554313126262	4.05008528316347	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0065359477124183	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGGTACATCTAACG"	"HSC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2530.27868787088	38.1701888894867	0.0150853694782551	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2521.17679436173	2521.17679436173
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACTCCACGGCTAC"	1.1667626100475	11.1571054228577	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACTCCACGGCTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2638.74600552296	38.6482655545162	0.014646451562077	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2627.36139681169	2627.36139681169
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACTCGTGGATCAG"	-2.56322036209758	13.4141940840515	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACTCGTGGATCAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2470.77942435263	46.156128455856	0.0186807968371962	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2465.77706920284	2465.77706920284
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCGCCATCAGGAAAT"	1.47945298728291	10.7893523939881	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCGCCATCAGGAAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2101.23436221743	41.4637160076698	0.0197330277636965	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2098.47307000065	2098.47307000065
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGGTAGGTAATGCGG"	6.53090443190877	-10.1754427186218	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGGTAGGTAATGCGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2166.67008917259	43.8122003676942	0.0202209836128883	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2164.90179479527	2164.90179479527
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAAGCGTGTGACGTCC"	1.50166334685628	11.1792993315491	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGCGTGTGACGTCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2074.98316487577	37.2178603263636	0.0179364637537152	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2064.50903941643	2064.50903941643
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAGATGTTTACGAC"	-1.39370534840282	11.634775138739	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGATGTTTACGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.03084119712	44.4460487444973	0.0173547495131772	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2555.61083901878	2555.61083901878
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAAGTCGTCCCGTTCA"	0.405789186328095	11.4530858763489	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAAGTCGTCCCGTTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2270.94369969336	38.0239271705645	0.0167436679190677	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2263.22658097479	2263.22658097479
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAGATTCGAACTCA"	-1.05114040795024	11.80565831745	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGATTCGAACTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2645.92249686875	38.8934551480965	0.0146993931961816	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2638.25330558025	2638.25330558025
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAGTACAGCGACAA"	-2.55220828476604	13.0312747725281	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGTACAGCGACAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2219.95967777426	44.9915205992682	0.0202668188299604	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2216.89707125712	2216.89707125712
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAATCGACATTGAGCT"	-0.705579082400161	11.7984208830628	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAATCGACATTGAGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2659.44966722806	42.4324810855926	0.0159553615954762	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2657.49749792757	2657.49749792757
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAGTATCATCCCGT"	1.28747930106465	10.7846431502136	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGTATCATCCCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2207.57023178516	38.1733587843875	0.0172920246136489	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2199.419453315	2199.419453315
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGAGTATCCCATTTA"	-2.80829010430034	12.9282197722229	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGAGTATCCCATTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2716.6481765883	46.5240526312328	0.0171255347056607	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2710.61556676215	2710.61556676215
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGGTACAATCTCGA"	-0.885486404330093	10.7283181914124	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGGTACAATCTCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2570.77273243303	39.5331866864789	0.0153779391650323	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2561.47957637631	2561.47957637631
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGATCCAGTCAGCCC"	-0.83368549767192	11.1028032072815	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGATCCAGTCAGCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2721.29692294004	38.1483863682105	0.0140184579075611	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2713.64871853904	2713.64871853904
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCGTTCACACGTAGTT"	0.0576901632243812	11.6137618788513	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCGTTCACACGTAGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.3149376563	38.5090335055179	0.0150055758708581	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2558.03505655304	2558.03505655304
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACAACGCAATTGCCA"	1.59173013743703	11.1384649046692	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACAACGCAATTGCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2236.49842737751	38.8944884594491	0.0173907962479796	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2230.05386749712	2230.05386749712
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTGGTTTTCGGAGTGA"	-2.58959160271342	13.1594133147034	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTGGTTTTCGGAGTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2510.63003959122	43.3478296065071	0.0172657177373552	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2505.79458693905	2505.79458693905
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTAAGAAGGCCCAAA"	-1.74360332909282	11.9128770598206	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTAAGAAGGCCCAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2361.95603101244	42.1012783007617	0.0178247510740982	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2360.64228507784	2360.64228507784
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGCCATGTACGCGTC"	-1.82495568218883	11.7565526732239	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCCATGTACGCGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2509.26177225366	40.3486712996777	0.0160798971816476	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2506.08377873971	2506.08377873971
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACACCCCATCCTATT"	1.59755816039388	11.4082774885925	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACACCCCATCCTATT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2347.1390250707	28.4361957507286	0.0121152583835003	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2340.63164263191	2340.63164263191
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGCCATTCGTTGTTT"	1.31056286868398	10.8715848692688	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCCATTCGTTGTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2216.89243918444	38.171692356772	0.0172185585922313	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2216.12363793133	2216.12363793133
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACAACAGTTTCCAAG"	6.65004648742024	-10.2123270264831	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAACAGTTTCCAAG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.72302278244	31.7525026912286	0.0131007142287969	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2415.84777652365	2415.84777652365
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGCTACGTATGAGCG"	7.46568073806111	-9.82574846660765	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCTACGTATGAGCG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2411.39053454346	43.7323284185481	0.0181357303149686	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2405.33641678788	2405.33641678788
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGCTACGTTGGCCGT"	6.69840540465657	-9.96717646038207	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGCTACGTTGGCCGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2454.41881894279	36.6833183029756	0.01494582669423	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2447.40532914427	2447.40532914427
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACAGATTCTACAGGT"	1.31401469287221	10.5932426222595	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGATTCTACAGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2305.07515934017	39.2868940287018	0.0170436499085556	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2295.22512621309	2295.22512621309
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACAGGCAGACAAGCC"	-2.81696353378947	13.0461082228455	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACAGGCAGACAAGCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2706.74772344512	38.0839018194311	0.0140699857210772	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2693.20709020761	2693.20709020761
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCCACAGATGCTAA"	-1.31048021736797	10.900047279242	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCACAGATGCTAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2202.74340432416	39.0021309864279	0.0177061617389768	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2197.52582861758	2197.52582861758
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTAGAGTCCGATCG"	-1.80346975746806	11.9718236693176	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTAGAGTCCGATCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2566.18885974981	39.7422026195665	0.0154868580574546	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2557.97186227991	2557.97186227991
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCACACAAATAAGC"	1.07640637931172	10.0497751005921	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCACACAAATAAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2295.87602894124	40.9680366720871	0.0178441850324906	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2283.51228445196	2283.51228445196
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTATTAGACTTCAC"	7.21613802489583	-9.72992899334105	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTATTAGACTTCAC"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2683.23776936352	45.4158997673443	0.0169257828306872	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2676.09607107226	2676.09607107226
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCCGTTCTATTGTC"	-1.30001161518748	11.6214637526306	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCGTTCTATTGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2629.28147405119	41.3894758778133	0.0157417440035587	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2624.49640738598	2624.49640738598
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCCGTTCTCGACGG"	1.29059125956838	11.0734061964783	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCCGTTCTCGACGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2315.22445931433	38.3534560685273	0.0165657614380448	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2314.19193933606	2314.19193933606
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTCACAGGGCTAAC"	6.353767533868	-10.2743883362976	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCACAGGGCTAAC"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2571.06935055404	34.8960459529126	0.0135725805861257	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2568.09502447299	2568.09502447299
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTCACCACGCTGCA"	-7.32324061814006	2.99914643848268	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTCACCACGCTGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2665.01697635755	45.8806834705795	0.01721590664435	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2653.203089119	2653.203089119
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGGGCAACAGATA"	1.309458275407	10.8897104033264	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGGGCAACAGATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2308.09797959313	37.5176850955518	0.016254806090236	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2304.39226472632	2304.39226472632
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGGGCACGCCAGT"	-7.39937863770183	2.9272479780945	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGGGCACGCCAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2506.28236502832	43.5609824355392	0.0173807161728351	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2496.22761473324	2496.22761473324
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCATGCAAGCTCTA"	-1.96605453911479	13.7312726744446	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCATGCAAGCTCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2672.40457690394	34.0128267984073	0.0127274242427066	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2668.41259990426	2668.41259990426
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGGGGTGTTACAC"	-6.30886731568034	3.44313142383424	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	54	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0588235294117647	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGGGGTGTTACAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2579.93962567787	45.3170393818332	0.0175651549868832	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2570.626722016	2570.626722016
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACCGGGTCTCCAATT"	8.92202724990193	7.9062723883423	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACCGGGTCTCCAATT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2523.97856499626	39.515573569735	0.0156560654348479	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2522.35493261105	2522.35493261105
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTGAAAGTAGCATA"	-2.70552025261577	12.9998941191467	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAAAGTAGCATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2473.69764332739	43.9309149730488	0.017759209615431	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2468.64398487106	2468.64398487106
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTGAACAACGATTC"	6.78410114821736	-9.92127897655638	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAACAACGATTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2502.02799350547	43.2881978997186	0.0173012444353468	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2495.37368852558	2495.37368852558
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCCTCTCACTTTGT"	1.3150198656017	11.5677747496399	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCCTCTCACTTTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2271.4238924866	35.1898055934726	0.0154923991553815	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2265.4978890787	2265.4978890787
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTGAATCTACCAGA"	6.43645920333211	-10.0962209931579	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGAATCTACCAGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2657.3856014049	41.2605310021319	0.0155267383778697	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2649.63180089639	2649.63180089639
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGCTCGTACTCGTA"	-1.14406369152721	11.6803064116272	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGCTCGTACTCGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.01646234256	33.5408718160876	0.0138311934524713	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2419.74054182144	2419.74054182144
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTGTCGTGAATTAG"	-8.91579661789592	1.79644880378572	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	16	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.04	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTGTCGTGAATTAG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2700.73658292044	43.7854416802148	0.016212407369573	3274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2696.69250736125	2696.69250736125
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGTGGAGTATAACG"	-0.928187469870406	10.2425813444885	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGAGTATAACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.25127498965	51.0512432438493	0.0216939192964312	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2346.09008060824	2346.09008060824
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTCAGTCAAACTAAG"	-1.95910940590556	13.5291299589905	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTCAGTCAAACTAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2563.86849934817	44.4005515301326	0.017317795956158	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2561.26998169576	2561.26998169576
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTTATGTCTCACGG"	-1.29083846035655	11.0387868651184	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTATGTCTCACGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2529.56932596077	38.9827084823261	0.0154108085049299	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2522.06722985265	2522.06722985265
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGTGGGTGAATTGA"	-9.37855754318889	3.04421660983888	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTGGGTGAATTGA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2441.16713275377	39.2526414466494	0.0160794567975239	3147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2433.67830887129	2433.67830887129
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTTATTCCTCACTG"	1.48383810099904	10.9388913878235	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTATTCCTCACTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2098.21772586468	40.7740998342577	0.0194327306130514	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2093.41909567	2093.41909567
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTCTCCTCAAAGGTA"	-2.53432379189189	13.4324807890686	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTCTCCTCAAAGGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2738.6153094499	40.2356166516279	0.0146919563740078	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2729.6829418451	2729.6829418451
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGTTTAGTCGTTGGC"	-2.8406265777653	13.2907981642517	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGTTTAGTCGTTGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3059.24967869389	44.2043044612283	0.0144493941665137	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3050.96612977185	3050.96612977185
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACGTTCAGCCTGACC"	-2.23914919319804	13.6453180083069	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACGTTCAGCCTGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3342.16742084447	40.4514289052897	0.01210335205023	2810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3335.26788136149	3335.26788136149
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAACTTCAGGAAAT"	4.03454818305318	-10.0350256196228	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAACTTCAGGAAAT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1988.06448148831	48.6682737636888	0.0244802289950146	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1985.07945176618	1985.07945176618
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACGTCCAGCGATGGT"	8.45806088027303	8.11715982044069	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACGTCCAGCGATGGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1971.19956411365	39.5356596481784	0.0200566499546461	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1967.36756909047	1967.36756909047
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAATCAGCACTCGC"	-0.438612054020721	10.5865335234436	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAATCAGCACTCGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2399.90319045085	41.4320384581855	0.0172640457427793	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.50873461233	2395.50873461233
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAATCCACGAAGAC"	-0.802248458296615	11.5785331496033	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAATCCACGAAGAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2679.32216552682	42.9105913037689	0.0160154653501072	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2666.13431504742	2666.13431504742
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAATCGTAGGTGCA"	-1.91855035248454	12.1649131544861	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAATCGTAGGTGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2491.81256863863	40.4394568995741	0.0162289320667756	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2490.61597375125	2490.61597375125
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAATCGTTACGTAC"	-2.73266730728801	13.3807763823303	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAATCGTTACGTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2420.83631098269	40.3427846359951	0.0166648130866885	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2416.70743172567	2416.70743172567
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAATCTCCCTCTAG"	-0.248958985239822	11.8962659605774	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAATCTCCCTCTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2447.20233608337	37.3427570531644	0.0152593663803581	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2441.72003790148	2441.72003790148
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTAGAGAGCACACCC"	-2.76378307762797	13.2729577788147	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTAGAGAGCACACCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2617.53443610888	42.3061759221668	0.016162605289372	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2614.89281313708	2614.89281313708
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CACTGGGGTCAAACGG"	-2.71497903290446	13.1542815932068	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CACTGGGGTCAAACGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2616.7726699486	35.4114934767785	0.0135325066191073	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2614.16798324385	2614.16798324385
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CCTTTGGTCTCGTCAC"	-1.54661534252818	11.4250926741394	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CCTTTGGTCTCGTCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2704.42341013499	41.5328463063614	0.0153573756796789	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2700.69084740997	2700.69084740997
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACTTCAAGACTCGAG"	1.4667840200359	10.9214639433655	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTCAAGACTCGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2019.94831894902	35.9940561815457	0.017819295594787	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2014.96193291893	2014.96193291893
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TACTTCACAAAGGCAC"	-1.92497871342357	11.4036750563416	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TACTTCACAAAGGCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2332.03060044007	41.3693089395652	0.0177396081045242	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2329.6196164388	2329.6196164388
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTCACGAGTAACAGT"	-2.6014874977177	13.2449846037659	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTCACGAGTAACAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2767.02529413294	37.024035955227	0.0133804472383143	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2756.05740888741	2756.05740888741
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTCACGTCGTGCATA"	-1.51083562794383	11.8428754576477	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTCACGTCGTGCATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2277.75536462321	41.4505066626066	0.0181979624793743	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2267.16516438794	2267.16516438794
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACCACAGTCGGAA"	-6.88245950165446	-0.0134550339547024	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACCACAGTCGGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2307.4522645768	32.1194483165559	0.0139198755309665	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2304.16351533585	2304.16351533585
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGAAGCAAGTATAG"	-0.164918775588828	11.6065492399964	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGAAGCAAGTATAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2288.08174305997	49.6349047807161	0.0216928022485494	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2279.58584597227	2279.58584597227
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACCATCTTCTGTA"	1.37523295459096	11.3003825911316	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACCATCTTCTGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2410.35561179474	33.8156806074658	0.0140293326188026	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2406.04877892956	2406.04877892956
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACTGAGAAGTCTA"	8.27986492690389	-9.00439741527709	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACTGAGAAGTCTA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2455.14501508929	38.2950300987557	0.0155978689093292	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2448.95384049341	2448.95384049341
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGACTGGTAGACGGT"	1.50380732592885	11.195755935553	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGACTGGTAGACGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2159.12633311681	37.0387832537626	0.0171545234225805	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2150.61243198776	2150.61243198776
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGATTGTACAAACA"	-2.20820246163066	13.8100747832092	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGATTGTACAAACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3000.69918599404	33.5729381122254	0.0111883717864587	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2994.39340451363	2994.39340451363
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGAAGTCGTCTAAG"	-7.85018477860149	2.54537198627321	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGAAGTCGTCTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2709.65097741067	43.4823256048163	0.0160472053291409	2765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2705.38617540211	2705.38617540211
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TTTGGTTCACAGCCAC"	1.01618917760198	10.3567056425842	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TTTGGTTCACAGCCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2490.12026560528	38.3166153193263	0.015387455717932	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2481.22843908914	2481.22843908914
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGAGTCCAAACTCTG"	-1.3606085580891	11.6311826475891	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGAGTCCAAACTCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2592.49823816555	42.9684068572407	0.0165741315556863	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2587.53790117956	2587.53790117956
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTAGCTGGTGA"	0.945387561886948	10.6940822371277	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTAGCTGGTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2372.33705645193	37.1888812575635	0.0156760529269745	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2364.96773347141	2364.96773347141
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTCACGACGAA"	-0.168667609721977	11.454092956427	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTCACGACGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2642.4280391204	41.7649764959641	0.0158055303219787	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2631.45855730823	2631.45855730823
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTGTCACTAGT"	-1.38167891922649	11.6832132109436	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTGTCACTAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2513.255425797	44.6405985992872	0.0177620619619794	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2505.06038845406	2505.06038845406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGGCTTCAGAGCGA"	-0.437511811882812	9.22013661945192	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGGCTTCAGAGCGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2758.64329611993	36.045423964863	0.0130663591104952	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2751.00964227205	2751.00964227205
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGCACATCCAAAGGG"	-0.0100430091028989	11.2512492903504	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGCACATCCAAAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2270.96261840818	39.3662974572208	0.0173346303184921	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.6255586293	2269.6255586293
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGTGCAGGCCTAAG"	0.424743105738801	11.2126340636047	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTGCAGGCCTAAG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2316.84163623048	44.7277602830184	0.0193054888100988	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.23997830622	2309.23997830622
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGAGGAGTGTGTTC"	-1.85181878033336	12.2733983763489	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGAGGAGTGTGTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2503.35223220829	40.9942343139167	0.0163757356182172	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2494.0952686137	2494.0952686137
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGAGTGCTCCGTGCGA"	-2.59463606301005	13.3163785704407	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGAGTGCTCCGTGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2343.92975922637	42.6285442953333	0.0181867840226591	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2342.42074295586	2342.42074295586
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGGTTGCCAAT"	-1.5131176513737	12.5328969725403	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGGTTGCCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2445.11895427857	45.1374161706402	0.0184602127809188	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2440.94427789239	2440.94427789239
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGTCCAATCCC"	-2.59651575508769	13.2123737105164	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGTCCAATCCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2595.78320997724	46.8425163565471	0.0180456195943104	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2590.41766853426	2590.41766853426
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGTCCGCGATG"	7.78293861922566	-9.4059047929016	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGTCCGCGATG"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2688.16803001128	40.1669775927257	0.0149421379706525	2853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2682.97094692108	2682.97094692108
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTCGTCGCAGTTA"	-2.41388521614726	13.0941238173279	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTCGTCGCAGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2625.85266965692	43.8093425910321	0.0166838540095077	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2616.07219529392	2616.07219529392
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGATCGGAGGGCCAAT"	-1.60997674885448	11.1291742094788	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATCGGAGGGCCAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.31385575077	40.5067768837765	0.017457455931396	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2311.15378320638	2311.15378320638
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTTAGTAATACCC"	6.40641464766805	-10.0240259400574	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTTAGTAATACCC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.5264058758	40.362157909655	0.0150463226834397	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2679.53534956375	2679.53534956375
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTGTTATCAACGTGT"	-0.786292652518112	11.5088453062805	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTGTTATCAACGTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2486.92724243229	30.9024558784483	0.0124259589710493	2643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2482.04034480234	2482.04034480234
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGATGCGCAAATGAAC"	6.2393294769222	-10.0587988129822	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGATGCGCAAATGAAC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2592.61402033786	40.5406762000057	0.0156369887233436	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2590.21804149532	2590.21804149532
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTTAACCACGACCTG"	1.13172449645345	11.7104282149109	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTAACCACGACCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2761.37223993539	39.9637506409245	0.0144724242762213	2885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2753.0667189674	2753.0667189674
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGTTGGTGTCCATA"	-2.52803264084514	13.049796081427	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGTTGGTGTCCATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2424.70166515661	43.6545181093183	0.0180040780837665	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2419.10044111529	2419.10044111529
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGGTTGTCGAGCTGC"	1.24712564524953	11.0777854689392	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGGTTGTCGAGCTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2107.12515605543	44.7494046447108	0.0212371839974054	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2102.12469700438	2102.12469700438
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGTGCAAGCATCTTG"	0.23503484305684	11.4948568114075	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGTGCAAGCATCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2271.02197725631	42.442783841761	0.0186888476935998	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2264.57520915678	2264.57520915678
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGCGTGCAGAGGCAT"	-7.19116292420085	2.6775924929413	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGCGTGCAGAGGCAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2775.38377641735	35.9015741274384	0.0129357152090089	2903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2764.43756418863	2764.43756418863
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TAGTGCAGTCGCGTCA"	-2.72439799729045	13.2492236861023	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TAGTGCAGTCGCGTCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2178.03918413381	43.0331956979531	0.0197577692869043	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2176.5448648707	2176.5448648707
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGTTGTATCTAACGCA"	1.03091682967488	10.2613601454529	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGTTGTATCTAACGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2591.07863331589	35.1737745684371	0.0135749545058862	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2581.31961204062	2581.31961204062
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGCTGCTCATCCTAT"	-2.8390089077061	13.245503402594	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGCTGCTCATCCTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2683.33970300239	41.4833060405253	0.0154595804601667	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2680.72314631267	2680.72314631267
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAACCACAACAAGTA"	0.749288161366624	11.237971282843	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAACCACAACAAGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2386.96366483388	37.2681233540518	0.0156131925689139	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2376.17411737551	2376.17411737551
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAACCACACTCAAGT"	-1.52485893192943	11.736433959845	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAACCACACTCAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2351.54602310322	44.2476301547022	0.0188163998152631	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2348.0271378453	2348.0271378453
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAAGTCAGACTCTTG"	-2.67522798004802	13.455539680365	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAAGTCAGACTCTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2733.85487790898	37.6626873121185	0.0137764032818469	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2725.21229428061	2725.21229428061
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAAGTGATCTCTTAAC"	6.99802460250203	-9.73304273998412	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAAGTGATCTCTTAAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2360.20022587265	49.3678565541877	0.0209168086728467	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2353.85001207694	2353.85001207694
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAAGTCCAAGGAGTC"	6.34090866622273	-10.1066313019958	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAAGTCCAAGGAGTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2427.8373533916	42.1995283375867	0.0173815302242696	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2419.41799235427	2419.41799235427
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CAGGTATTCCATACAG"	0.147940342395943	11.2275533446106	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CAGGTATTCCATACAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2407.31824256646	42.7596485612588	0.0177623580485447	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2400.07727386248	2400.07727386248
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAAGTCCAGGAGGAG"	1.01163484629933	10.798988319281	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAAGTCCAGGAGGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2246.9784722165	38.8429012755665	0.0172867260438194	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2239.88796948568	2239.88796948568
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAATCGAGAACTTCC"	-2.52240572395976	13.4044828184876	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATCGAGAACTTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2643.79695460087	48.6113905590524	0.0183869606455429	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2640.27385139061	2640.27385139061
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCCTAAGTTCATGC"	1.28861906108205	9.83888719165651	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCCTAAGTTCATGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2165.97409146434	30.6998648999923	0.0141736990396026	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2159.5728014871	2159.5728014871
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAATCGCAGCACGAA"	-0.390305171639282	10.7702388533386	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATCGCAGCACGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2241.67273142408	45.9785440922243	0.0205108191966163	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2233.34351463906	2233.34351463906
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAAAGTCGGAAACG"	8.18395103987996	8.02452037418214	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAAAGTCGGAAACG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1981.84653180325	42.4256616352804	0.0214071377144819	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1974.29368735475	1974.29368735475
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGCGTGAAGGCCTTGC"	-2.78532658043559	13.1281614073547	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGCGTGAAGGCCTTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2132.43560548229	43.8602591677482	0.020568151767391	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2127.30451457091	2127.30451457091
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAATGCGTGAAAGTT"	-0.359523306519347	11.0860519179138	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATGCGTGAAAGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2678.20308907351	39.9373204005079	0.0149119835472685	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2663.25725363147	2663.25725363147
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAATGCTCGGTGTAT"	-2.13071213188823	12.9954175719055	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATGCTCGGTGTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2406.33580451203	37.7616072050872	0.0156925758800089	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2395.21134340146	2395.21134340146
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAATGCTCTGAGGTT"	8.13066925582234	7.53136060321657	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAATGCTCTGAGGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2091.30376254375	48.0043724426028	0.0229542801492466	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2087.62827968828	2087.62827968828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AACAACCGTAGTCACT"	-2.21733174744304	12.4302539595398	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AACAACCGTAGTCACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2473.49912020083	43.0870605653419	0.0174194768105855	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2468.28143710026	2468.28143710026
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTACAACAGCGTCAGA"	7.70202364501302	6.9354734190735	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTACAACAGCGTCAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2055.10645638308	42.6487640072177	0.020752581392926	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2050.2827236192	2050.2827236192
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCGCCTCTTACCAT"	6.55714335021321	-9.9623651734558	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCGCCTCTTACCAT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2580.00331898251	43.0493782505913	0.0166857840584364	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2576.32093703277	2576.32093703277
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTGTCACGGATCC"	7.0548583465511	-9.77000238811644	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTGTCACGGATCC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2770.37996898729	39.2073561792156	0.0141523388914582	3017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2766.25716752447	2766.25716752447
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGAAAAGTAAGAGG"	-0.63958309117015	11.2989234694275	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGAAAAGTAAGAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2167.22567469	42.7568359018995	0.0197288341501471	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.19825087979	2163.19825087979
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGAAAGTGGTTCTA"	-0.559097031981307	10.9390697249207	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGAAAGTGGTTCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2493.34310816475	44.4276190481784	0.0178184939339856	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2488.62733136434	2488.62733136434
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGAAAGTTGTAAAG"	-8.19889769974406	2.25725147807924	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGAAAGTTGTAAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2631.35692527045	45.8399771790225	0.0174206610812826	4076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2624.50964621542	2624.50964621542
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACAGAGGTATTGA"	0.0855183425242126	11.0502900847229	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACAGAGGTATTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2545.24087127515	43.4842139753463	0.0170845181947596	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2538.07994993637	2538.07994993637
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATACAGCAATACCTG"	-2.12790475311931	13.6446103819641	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATACAGCAATACCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2611.09932410888	41.6428986281507	0.0159484161493407	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2607.10214587709	2607.10214587709
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTTGAGTAGCCAG"	1.24611272391621	11.4601039656433	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTTGAGTAGCCAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2319.86969132612	36.5227625634795	0.0157434543414384	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2313.95633662785	2313.95633662785
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGATCTCGGAACTT"	-2.2991500896519	13.5070333250794	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGATCTCGGAACTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2455.02550901275	43.4630074295091	0.0177036887274491	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2450.84740448012	2450.84740448012
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATCTTGGTGCATACT"	0.575244267552537	10.611961341742	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATCTTGGTGCATACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2383.18928788895	39.9269389991669	0.0167535743812169	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2380.02272566333	2380.02272566333
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGCTAAGCAATAAC"	-0.10420903089698	10.9518604048523	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGCTAAGCAATAAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2311.9383542318	41.3189303059277	0.0178719861757114	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2303.93585845458	2303.93585845458
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGCTAAGCGCCGTT"	-7.71968875351604	3.0732416876587	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGCTAAGCGCCGTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2268.86552290351	45.2008231981792	0.019922213433053	2692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2262.46132914618	2262.46132914618
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGCTAGTACTCGAT"	6.77556957778279	-1.02619912540587	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGCTAGTACTCGAT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2418.67985087748	36.5331534217919	0.0151045841840283	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2416.77806263983	2416.77806263983
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGGAGCAACAAGTA"	-1.74786315384563	11.030264831427	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGAGCAACAAGTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2712.43473300681	42.6991322608267	0.0157419943570379	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2699.45526994416	2699.45526994416
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTGCTAGCAAATGT"	-7.90811143341716	3.63035771930543	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGCTAGCAAATGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2362.37471409087	37.9082408503215	0.0160466672049146	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2349.36522703116	2349.36522703116
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGGAGTCGCTTTAT"	-2.29188714447673	13.6189746626648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGAGTCGCTTTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2386.31255535383	39.2696411715044	0.0164562018849545	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2380.53917205888	2380.53917205888
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGGAGTCGTGGCTG"	-8.07511268082317	3.1169178255829	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGAGTCGTGGCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2614.26656039622	39.8968105974854	0.0152611869049186	2668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2606.33195815481	2606.33195815481
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGGGTCACACTAGGTT"	-1.72249255600627	11.8165902861389	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGGGTCACACTAGGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2595.980790735	41.6428176250497	0.0160412657033796	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2592.44181388912	2592.44181388912
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGGTTCAACCGCCA"	1.06098391589467	10.6433543928894	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGTTCAACCGCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2319.3575858506	30.4362753956714	0.0131227179376522	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.49458950205	2315.49458950205
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGGTTGTATACCTG"	1.03167011317555	10.5754365690979	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGGTTGTATACCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2598.69007288706	41.0571540400324	0.0157991730019653	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2586.95363406036	2586.95363406036
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTGGGGTTCCAGGC"	8.31634487685506	7.79859922015993	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTGGGGTTCCAGGC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1917.37891326551	40.3820962328334	0.0210610933256058	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1915.90831037096	1915.90831037096
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTAGTACTCCTATTTG"	-6.8945725959843	2.88162753665773	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTAGTACTCCTATTTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2694.99987521736	41.99737677341	0.015583442938016	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2683.98204078912	2683.98204078912
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTTCGAGATGTTGA"	-2.18506083908733	13.0172605284485	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTTCGAGATGTTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2532.14496538721	44.0184904618711	0.0173838745662573	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2518.31858467345	2518.31858467345
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATCCCAAGTGGAATT"	0.401204784482163	11.0326604613098	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATCCCAAGTGGAATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2153.55336516532	37.3083979659291	0.0173241111965967	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2147.04434454243	2147.04434454243
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTATTGGTCAACCTTT"	0.565162797539872	10.800923324469	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTGGTCAACCTTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2384.58590465722	41.5519955174751	0.0174252457989967	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2373.27182826539	2373.27182826539
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TATTTCGTCATGAGAA"	2.96044578131978	-10.9835968247619	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TATTTCGTCATGAGAA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2813.85475956619	36.0716175525122	0.0128192890659621	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2808.88487655721	2808.88487655721
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTATTTCAGATGGTCG"	1.82172967967336	-9.93256475841673	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCAGATGGTCG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1876.4419638607	20.8546301617589	0.0111139222866512	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1871.66478226724	1871.66478226724
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTATTTCAGTATAGGT"	6.61187042769734	-0.935826861020647	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCAGTATAGGT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2649.78775395957	43.1215209982559	0.0162735754717786	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2646.08476473785	2646.08476473785
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGACCACGGGTAA"	1.48653306540791	10.8482398756775	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACCACGGGTAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2129.00953714786	41.0781309304501	0.0192944795284856	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2123.34561388607	2123.34561388607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTATTTCTCAAGCTTG"	-1.9271424812382	13.3654317625794	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTATTTCTCAAGCTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2665.82371057592	39.9725592664327	0.0149944495983934	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2660.92405331015	2660.92405331015
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGACGTGGAAGTC"	0.710004349320573	10.8901929625305	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGACGTGGAAGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.82688292838	36.8844295375105	0.0164822533051548	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2222.90066619154	2222.90066619154
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCAAACTCCGATGCG"	1.39048149165456	11.3563880690369	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAAACTCCGATGCG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2136.96542697254	42.6974941651449	0.0199804328260167	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2131.1704736417	2131.1704736417
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCAAACTCTCCGATC"	8.85135616835896	7.76164434039918	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAAACTCTCCGATC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2684.6651081151	45.2212581052424	0.0168442827258228	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2668.90435753991	2668.90435753991
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCAAGTCAACCGCTG"	-2.04846630516704	13.2733134993347	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAAGTCAACCGCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2532.69207936403	35.0826399503683	0.0138519167948666	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2527.43383838378	2527.43383838378
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCAAGTGTCCTTGTC"	6.81672634658162	-0.974831723329149	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAAGTGTCCTTGTC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2338.73750274842	33.9205917632615	0.014503804605433	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2335.53612846004	2335.53612846004
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAAGCAAGGCAGCTA"	-2.66906819763835	13.1142225035462	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAAGCAAGGCAGCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2561.27762554033	40.9214496596068	0.0159769676084895	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2555.78664035398	2555.78664035398
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCACGGAGTCCCGAC"	-7.62670169296916	3.79427883708803	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCACGGAGTCCCGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2578.3950956772	41.5045232783161	0.0160970377844343	2947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2569.20769577186	2569.20769577186
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGACTCAGCGCACAA"	0.210006584494752	11.4368448027405	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGACTCAGCGCACAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2322.47630137998	45.0555310740185	0.019399780762993	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.12773349765	2315.12773349765
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTCCATTCTAGTGTG"	-1.7907706302708	11.3048906096253	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTCCATTCTAGTGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2366.74295372448	42.418773408515	0.01792284765938	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2365.42335146654	2365.42335146654
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCAGCGTCTCTGAGA"	6.94870771941487	-9.8278494111267	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCAGCGTCTCTGAGA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2521.45878620455	40.2146809764669	0.0159489741400852	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2517.09534112364	2517.09534112364
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAATCTGTTAAAGTG"	-0.852446238428909	11.7131633528504	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATCTGTTAAAGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2420.70318569301	43.914524619473	0.0181412264333022	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.98535794786	2416.98535794786
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCATCCCAGACCGCT"	1.26069106635396	11.2680473097595	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATCCCAGACCGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2298.47230909211	36.5025085626812	0.0158812044061995	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2294.10791851278	2294.10791851278
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAATTCAGATCCCAT"	0.976283391087693	10.4171590575012	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATTCAGATCCCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1880.13094831963	40.0696651439915	0.0213121672082489	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1874.33447983213	1874.33447983213
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAATTCAGATGGTAT"	-8.24295077744182	3.7443752058777	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAATTCAGATGGTAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2585.49924915064	43.219354294883	0.0167160575695703	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2576.52202149539	2576.52202149539
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCATCCTCATGGTAC"	-2.26210079613383	12.7596225508484	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATCCTCATGGTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2910.93493564299	37.9786486871082	0.0130468902695412	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2902.67856884669	2902.67856884669
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCATGAAGAAACCAT"	-1.78691051426585	11.8324699171814	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATGAAGAAACCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2385.34230959593	42.3491286301289	0.0177538999160681	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2381.54753198607	2381.54753198607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGAGTGTGTATCCA"	-2.68116150322612	13.2351779707703	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGAGTGTGTATCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.13603785304	38.3287144280839	0.0160833094793086	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2375.98012802538	2375.98012802538
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GATGTTGGTTACCTTT"	-0.20279554548915	11.7498950728211	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GATGTTGGTTACCTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.14870695508	39.7192275666788	0.0171636452952674	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2310.21866731729	2310.21866731729
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCAACATACCACA"	-4.64349494400676	-5.50810720836791	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00601503759398496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCAACATACCACA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2878.67718415937	36.3085099581616	0.0126129147644474	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2877.37730068191	2877.37730068191
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGCTTCATGGAGAC"	-9.47777972641643	2.40263507449952	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGCTTCATGGAGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2322.04942465912	42.7588985987297	0.0184142930570941	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2317.5856060323	2317.5856060323
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCACTCAAAGGATT"	0.255945791571778	11.2180957564148	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCACTCAAAGGATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2318.6558652866	39.7014042840527	0.0171225945507637	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.76298744453	2308.76298744453
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTGCTTTCTGTGTGA"	-2.7906006378239	12.9723710783753	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTGCTTTCTGTGTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2464.09817867143	42.7156223398504	0.01733519496487	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2461.35895523665	2461.35895523665
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCACTGTGCTCTTC"	-2.32662187042888	13.4589671858582	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCACTGTGCTCTTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2811.15306739687	38.2493682364603	0.0136062915534796	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2807.38974551765	2807.38974551765
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACATTCATACGCAT"	6.96932186660115	-10.1952476731506	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTCATACGCAT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2342.74300776902	39.1478128100283	0.0167102463566025	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2338.34703096212	2338.34703096212
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCCTCAGATACTC"	-1.12773821774181	11.1746053465637	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCCTCAGATACTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2333.77996928547	39.6979862741038	0.0170101666809053	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2331.56164419377	2331.56164419377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCTCAAGACGTCCC"	-1.0697537464207	11.010546661261	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCAAGACGTCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2429.43148721484	41.8929605939366	0.0172439357991378	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2422.59638896809	2422.59638896809
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACATTTCCGTAGTA"	1.32996227320973	10.9947118529114	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACATTTCCGTAGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2234.77705552902	32.7601943772478	0.0146592673735379	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2226.94136297027	2226.94136297027
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCTCACAACACGAG"	-0.16198125007804	10.9380712279114	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCACAACACGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2491.77150794274	41.7840351942035	0.0167688068753548	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2479.36105057885	2479.36105057885
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCTCACAGATACCT"	-0.0994456214016259	11.0822410353455	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCACAGATACCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2326.96455421396	35.5943697410401	0.015296481279262	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2320.62619445143	2320.62619445143
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCCTCAGTGTACGCC"	1.24850692328755	11.6507396467957	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCCTCAGTGTACGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.41028467487	39.5079605379904	0.0179875139055993	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2190.89795666375	2190.89795666375
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AAGGTAATCTTAGCCC"	-2.74385533753093	13.3681506880554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AAGGTAATCTTAGCCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2487.60501220983	40.8956073510103	0.0164397511462968	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2480.49119591386	2480.49119591386
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGCGAGTACCGTCG"	7.46913017806355	-9.29204847728881	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGCGAGTACCGTCG"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2564.85038842131	41.9093454234254	0.0163398791651239	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2559.59306823302	2559.59306823302
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGCGAGTACTGCGC"	-2.44540558281596	13.1136626967224	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGCGAGTACTGCGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2366.25130779403	43.183823892838	0.018249889075855	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2363.49678494388	2363.49678494388
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATGCGGGTTAGTCGT"	0.777747650712174	10.1679687269959	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATGCGGGTTAGTCGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2278.51107492797	39.6030043600476	0.0173810892542181	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2272.15785775737	2272.15785775737
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCACTATAGAAACACT"	-7.62791238251384	1.327774263266	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCACTATAGAAACACT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3132.43760937234	42.6779782097281	0.0136245261779626	3759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3126.81137698061	3126.81137698061
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGTAACACTATCCC"	-0.0672559541767419	10.9987506636414	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTAACACTATCCC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2520.78013522021	40.0739390962331	0.0158974352964474	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2514.75463027501	2514.75463027501
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CGTTGGGTCTTAGCCC"	-1.9673641723698	11.2177800902161	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CGTTGGGTCTTAGCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2622.59876268939	41.2540200183524	0.0157302064674383	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2614.97144961708	2614.97144961708
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGTTCCAGAAATTG"	-8.01143393936809	2.37191746318666	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTTCCAGAAATTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2843.1332709917	37.970128392125	0.0133550293894175	3151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2835.85140549551	2835.85140549551
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGTTCGTTTACGAC"	8.46994938430135	7.62941167438356	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTTCGTTTACGAC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2419.17231032169	45.195184886545	0.0186820858909943	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2410.31364057118	2410.31364057118
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCGTTCTCTTCGACC"	-1.48325572434123	9.03567502582399	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	15	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00168293503870751	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCGTTCTCTTCGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2483.26591345411	38.8955439577453	0.0156630603863295	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2478.23852743113	2478.23852743113
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTACCCAAATAGCA"	8.23092903670613	8.29051492297975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTACCCAAATAGCA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2256.84318459502	41.6650334267863	0.0184616431089176	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2253.88303049964	2253.88303049964
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTACCGTCCTACGG"	1.46278109130208	11.1140041121277	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTACCGTCCTACGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2116.45305960235	35.8672060150982	0.0169468469203078	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2108.90393237008	2108.90393237008
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTAGAAGGATACCG"	3.12362565573995	-7.11577846920165	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	3	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.000263088660878716	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTAGAAGGATACCG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2704.5659206127	41.366596134903	0.0152950962739084	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2694.36189689895	2694.36189689895
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTAGCTAGTAGTTAGA"	-2.99149976196941	12.970115638617	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTAGCTAGTAGTTAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2462.29539015902	43.9003882706803	0.0178290502618555	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2459.38331900606	2459.38331900606
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTAGACAGTTGTCA"	7.31518568572347	-9.77299215709838	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTAGACAGTTGTCA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2399.12738113247	39.5476681054643	0.0164841885497537	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2395.7450417677	2395.7450417677
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTAGAGTTCGTACA"	-8.17407069626506	2.97359106624452	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTAGAGTTCGTACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2498.2731261797	40.4910722589116	0.0162076243124104	3449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2492.5041383454	2492.5041383454
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCCGAGACTAGAT"	-1.73007963123973	11.3936233290466	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCCGAGACTAGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2663.06413976892	37.8632581039601	0.014217929466485	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2660.05221670511	2660.05221670511
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTCACTCAACTGAC"	0.896659632294816	10.4786824950012	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTCACTCAACTGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2338.09163154991	45.8721128553706	0.0196194675334269	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2330.6053239759	2330.6053239759
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGCAACAGAGGACT"	6.18519939956014	-10.0943718186584	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGCAACAGAGGACT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.14516636786	36.2220276444421	0.0142823163771487	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2532.92562200718	2532.92562200718
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTGTCAGCTTTGTG"	-8.27562938156779	3.10479018771974	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTGTCAGCTTTGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2238.2565121643	44.6840767185851	0.0199637872047907	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2232.90247776314	2232.90247776314
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTGTCAGTATGAGT"	1.27482726153676	11.1805791624817	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTGTCAGTATGAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2435.14759212726	35.1393838872284	0.0144300838277042	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2425.46078804242	2425.46078804242
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTCTAAGCTACAAA"	1.21704151210133	11.176468826178	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTCTAAGCTACAAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2274.25128293953	38.6574579926654	0.0169978833397423	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.00860515328	2269.00860515328
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTTTAAGATGTTCC"	1.11803962764089	10.9452914961609	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTTTAAGATGTTCC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2443.52514639625	42.4779990849371	0.0173839009381935	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2435.15923036031	2435.15923036031
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCTTTAGTATCAGGG"	-1.94115887108501	13.2208595045838	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCTTTAGTATCAGGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2307.71751951152	40.871195900351	0.0177106580657248	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2303.32180378304	2303.32180378304
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGACGCCAAAGACGC"	-2.01662025871928	13.1744384535584	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGACGCCAAAGACGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2491.29133345274	45.8340202725518	0.0183976958684432	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2485.36929143096	2485.36929143096
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCCAATCTCTT"	0.982622225850266	11.3312463530335	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCCAATCTCTT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2426.28657256853	39.1259605283823	0.0161258612114242	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.61547932709	2415.61547932709
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCAGGGCGTTCGATTG"	-2.64356646958049	13.1034459837708	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCAGGGCGTTCGATTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2367.00519722428	42.6274895959774	0.0180090392898019	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2364.08486645836	2364.08486645836
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACCCAGTCTCGGGT"	-2.06652198258098	11.0061406859192	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACCCAGTCTCGGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2308.33935250747	41.676297432359	0.0180546666100405	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.33921014335	2305.33921014335
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GCAGCCAGTCCAGGTC"	-0.398449758917648	11.5582494505676	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GCAGCCAGTCCAGGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2261.93267525882	41.2190156358057	0.0182229188722822	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2257.34319121747	2257.34319121747
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGAGCCTCCATTGTT"	8.02050365981404	8.41069219196168	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGCCTCCATTGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2239.46982216821	40.7219707798266	0.0181837550909261	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2230.30056407312	2230.30056407312
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGTTCAGCCGTCA"	-7.58386741104777	0.966091311815657	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGTTCAGCCGTCA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2856.28629354097	38.6518918366817	0.0135322190650449	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2849.15949364253	2849.15949364253
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CATTGTTGTAGGAGTC"	1.24930002269093	10.6455411680969	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CATTGTTGTAGGAGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2138.29747862794	38.3069671186902	0.0179147043391129	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2129.83877052724	2129.83877052724
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGAGGAGTAACATCC"	0.836127122014207	11.3842859038147	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGGAGTAACATCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2303.82476842987	37.2015767431738	0.0161477458064347	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2298.5123855608	2298.5123855608
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGAGTTGTTGTCAGT"	-8.01401839676555	3.63065717304078	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGTTGTTGTCAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2348.19240180124	44.2903315097546	0.0188614576368532	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2343.80924463846	2343.80924463846
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGAGTTTCGACGCGT"	-0.324905346066314	11.1976442106995	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGAGTTTCGACGCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2163.66006929941	41.9900883438127	0.0194069710578007	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2162.24353811995	2162.24353811995
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGATGTAGAGGTGCT"	1.41553117808644	10.6085595854553	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGATGTAGAGGTGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2144.20068359538	36.6615266848654	0.0170979922566724	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2137.92394790881	2137.92394790881
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGATGTGTTGCTAGT"	1.28188266333882	10.3990554579529	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGATGTGTTGCTAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2081.49652520023	42.0634160727189	0.0202082566862189	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2077.72390220795	2077.72390220795
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTACGGGGTCGGAACA"	-1.39967058125194	11.4284705885681	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTACGGGGTCGGAACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2221.47447106692	42.4475993929884	0.0191078492892164	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2213.4282408814	2213.4282408814
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCACGGTTACGTAC"	1.05328073081319	11.2341718443665	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCACGGTTACGTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2270.63830256463	42.1511448032128	0.018563566357356	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2261.64397079007	2261.64397079007
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCAGCGTGTTCAGT"	-1.42406986180003	11.6525468596253	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCAGCGTGTTCAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2562.40734465338	41.025851971699	0.0160106674909834	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2553.93667076805	2553.93667076805
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCAGCTCCAAATGC"	-2.84117446366008	13.0866775282654	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCAGCTCCAAATGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2520.16226526302	38.6826167486967	0.0153492563879253	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2512.99330459893	2512.99330459893
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCAGCTCCAGTTCC"	-7.11013064804729	4.05483863437501	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HSC"	"HSC"	65	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0065359477124183	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCAGCTCCAGTTCC"	"HSC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2728.25176374462	39.2318601122295	0.0143798532941778	2809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2713.40263203224	2713.40263203224
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCGTGCAACGCCCA"	-3.15473494949992	13.2808389433655	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCGTGCAACGCCCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2379.32132160937	36.0994934318686	0.0151721808668747	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2369.87837482489	2369.87837482489
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTAGACAGTGGACCAA"	-0.168037961155731	11.8053798445496	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGACAGTGGACCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2311.92476651373	49.9276771519998	0.0215957188032932	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2309.01964786091	2309.01964786091
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTCCCATGTCGTCAGC"	1.07493223723714	10.3353137739929	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTCCCATGTCGTCAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2181.54821326775	38.7875338377919	0.0177798196720539	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2178.76317400632	2178.76317400632
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCTGGCATCTGCGG"	0.953697999089402	11.3629598387512	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTGGCATCTGCGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2148.76375031772	38.5741243380664	0.0179517754487262	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2143.86230828781	2143.86230828781
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCTGGGTACTCGTA"	1.37204231795613	11.3120488890442	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTGGGTACTCGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1926.37287735648	39.6241367036682	0.0205692974446586	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1923.00814514959	1923.00814514959
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTAGGTATCACCGCTT"	-2.2628484767979	13.3522605665955	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGGTATCACCGCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2631.05676480176	42.0522222314659	0.0159830159478275	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2629.69039771083	2629.69039771083
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTAGGTATCCAATCCC"	-1.55383799496349	11.8592500456604	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTAGGTATCCAATCCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.94145084901	41.3661835645828	0.0171505753383946	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2407.43014924882	2407.43014924882
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGCTTCGTTTCTATC"	-0.0863977325266183	11.5130901106629	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGCTTCGTTTCTATC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2378.853031948	38.7029171188835	0.0162695705027184	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2373.87182168731	2373.87182168731
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAACAAGTTGGG"	6.75737919387166	-1.08537473594817	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAACAAGTTGGG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2721.21231594309	39.1792007485139	0.0143977008037815	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2717.15247338636	2717.15247338636
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGAAGAGTTGGCTT"	4.34107508239095	-10.3396568528381	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGAAGAGTTGGCTT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2643.79325082611	39.9249879420657	0.0151014032317354	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2641.5608171588	2641.5608171588
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTATCTAGGCAGCTA"	-1.4707387489384	11.9246215590271	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTATCTAGGCAGCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2748.58893264242	45.2412363053071	0.0164598044356576	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2742.90449312075	2742.90449312075
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATCCGTCCACTGAA"	-7.30705342713054	3.03780839526979	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATCCGTCCACTGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2238.98325619718	39.10583278922	0.017465888894426	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2232.23079070564	2232.23079070564
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACACCAATCAGCAGAG"	-7.88817677918132	2.82914922321168	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACACCAATCAGCAGAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2453.24015388303	44.1282387817452	0.0179877370390739	2767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2444.80243987911	2444.80243987911
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGAGACATAACTCG"	-1.22413561764415	11.6323270567688	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGAGACATAACTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2527.18444411061	41.1921177777688	0.016299608789443	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2514.68935944285	2514.68935944285
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGAGTCTACGCAA"	1.1963218646938	10.7967509993347	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGAGTCTACGCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2217.90176068987	36.7734112811007	0.0165802705660248	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2215.4770990489	2215.4770990489
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGGAAAGATGGCAC"	-7.70699868622478	3.08080480182496	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGGAAAGATGGCAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2447.53639350608	42.7377328693831	0.0174615311064534	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2439.9976682828	2439.9976682828
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGGAAGTAGTGGCA"	-7.66038880768474	3.05503127658693	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGGAAGTAGTGGCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2678.97054877277	43.9234681829759	0.0163956517562677	3007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2668.53697488732	2668.53697488732
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGCCCATGGCCAC"	-2.19928274574931	12.6333093413147	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCCATGGCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2714.73202746448	41.6442785624806	0.0153401065523863	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2705.65816547643	2705.65816547643
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGGAATCTCTAGGA"	-2.56820736351665	13.2042102583679	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGGAATCTCTAGGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2690.85597879557	41.1651518154046	0.0152981624211007	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2680.37047348123	2680.37047348123
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGTTAAGCCTTTGA"	1.85851361331288	-4.6310138932434	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	45	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.055045871559633	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGTTAAGCCTTTGA"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2396.1261302823	42.8162577047283	0.0178689498702157	2692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2394.17225963072	2394.17225963072
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATGCCTCGGTCACG"	0.163506102829617	11.5986337431702	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATGCCTCGGTCACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.82313425581	49.153076514297	0.0210431499686114	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2328.76359914724	2328.76359914724
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGTTAGTTTGGAAA"	1.43856360492055	10.7272605665955	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGTTAGTTTGGAAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2301.61740733304	37.9253632936049	0.0164777009301255	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2294.9054658889	2294.9054658889
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGGTTATCCCAGGCA"	-1.27746329727824	11.6735334166321	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGGTTATCCCAGGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2414.92233901344	39.0723016093144	0.016179527174889	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2406.61460444865	2406.61460444865
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTAACGTACTGCCG"	-1.95882115784343	13.0200462111267	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTAACGTACTGCCG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2376.97585743529	38.8952153000797	0.0163633194583839	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2375.47346384159	2375.47346384159
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTAACGTTGGGTTT"	8.09816803511922	8.27214620197145	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTAACGTTGGGTTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	1948.84872961844	37.3355581207322	0.019157750703433	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	1942.32633253663	1942.32633253663
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTAACTCTCCTGCA"	0.947469790547532	10.2325324782166	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTAACTCTCCTGCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2286.8975194163	37.788768185293	0.016524032172171	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.97854254295	2276.97854254295
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACAGAAATCATAGACC"	-7.22403083267863	2.95529911601869	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACAGAAATCATAGACC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2484.15632580964	42.7612730452348	0.0172135998853848	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2476.33960704654	2476.33960704654
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTCCTGTCCGATCG"	-7.68613849106486	3.1185903319153	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTCCTGTCCGATCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2571.35573312017	44.9505397851758	0.0174812606463561	2953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2565.31415953001	2565.31415953001
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTACTCGCAGATT"	-2.20380411568339	11.8770236738953	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTACTCGCAGATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2647.97695345067	36.5853367593573	0.0138163350370862	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2641.6850753456	2641.6850753456
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAGAACAAGCCATT"	-1.48327598992046	11.770707107428	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGAACAAGCCATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.83024000724	44.4690676272984	0.0184378928871731	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2408.10807155925	2408.10807155925
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCATAAGGTACGATGG"	6.28453030165975	-10.0931997529236	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCATAAGGTACGATGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2540.69402198302	31.7303388462794	0.0124888469732037	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2536.08141850794	2536.08141850794
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAGAAGTCGAAACG"	1.13863339003865	11.2962255247864	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGAAGTCGAAACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2212.25162343634	44.900617974605	0.0202963431008178	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2205.08082285221	2205.08082285221
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTAGGTATGCGGA"	-8.14780841293986	2.33329293811647	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTAGGTATGCGGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2666.93509153883	35.3892135164864	0.0132696193577275	3770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2663.12212417421	2663.12212417421
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTAGTCACTTGTT"	-2.80060325089152	13.4566287764343	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTAGTCACTTGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2884.02921413399	40.6227590260001	0.0140854187006557	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2873.13790771255	2873.13790771255
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTAGTCCAAAGGG"	8.11620964583699	7.53741405093995	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTAGTCCAAAGGG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2203.23097755	43.5589741737803	0.0197704982444546	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2196.68294758604	2196.68294758604
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTAGTCGCCACTT"	6.94200481948201	-9.6201496354309	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTAGTCGCCACTT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2417.24001801865	36.4769943455473	0.0150903485270969	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2415.20455982363	2415.20455982363
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTAGTCGTTCATT"	-1.37132320824321	11.7794255980286	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTAGTCGTTCATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2548.58335749155	42.2121425096045	0.0165629828765546	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2542.00839743209	2542.00839743209
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCATTTGGTTACCCTC"	8.73414864119832	7.97703502261964	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCATTTGGTTACCCTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2003.69023585835	38.7296211878309	0.0193291460400014	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2000.21226559498	2000.21226559498
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTGTTCCCAGACCAGA"	-2.35245953026469	13.0562915571961	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTGTTCCCAGACCAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2252.42301142069	37.7584398461109	0.0167634763340014	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2251.04144006184	2251.04144006184
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCAGTCGTCGTATTG"	-1.53802524033244	11.3833446272644	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCAGTCGTCGTATTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2270.42338854875	44.6975005585473	0.0196868569906328	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2267.72014191474	2267.72014191474
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATCGAGCTACAAA"	0.185841311782044	11.8103933104309	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATCGAGCTACAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2498.31145038491	49.6128422814427	0.019858549771206	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2489.03277620444	2489.03277620444
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCACCACAGGCGAAT"	-0.0987936210935891	11.1785392531189	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCACCACAGGCGAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2368.27651460451	46.4509051156565	0.0196138013568967	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2357.27829604211	2357.27829604211
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACAGGTGCTCTTC"	0.0974597307736098	11.0352706679138	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACAGGTGCTCTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2499.90783249396	42.8308067156738	0.0171329543269381	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2491.13523119371	2491.13523119371
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACAGTCTGCCCTA"	-1.37903259220775	12.1809692152771	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACAGTCTGCCCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2611.4656538058	40.6521250926013	0.015566785277592	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2604.47582054762	2604.47582054762
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACCCAGGGACAGG"	1.46443202075307	11.3830270537171	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACCCAGGGACAGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2179.08334101207	36.3504542206823	0.0166815346327229	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2173.62225639597	2173.62225639597
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACCCAGGTCATCT"	0.52872939881627	11.5470218428406	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACCCAGGTCATCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2399.47427286048	37.7609364139466	0.0157371707798853	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2393.6321721905	2393.6321721905
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACCCGTATGCTAC"	0.389685590832871	11.6477136381897	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACCCGTATGCTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2401.90704893646	35.7294933273903	0.014875468783528	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2395.73177643255	2395.73177643255
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCATTACAGTTGTTG"	-2.2734833759373	13.6558656462464	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCATTACAGTTGTTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2473.01011144582	39.4220847883085	0.0159409315011901	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2471.06642119182	2471.06642119182
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTACGAAGTAGTCAA"	-7.61539540711101	2.76811835849611	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTACGAAGTAGTCAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2641.25382727401	45.3171047770446	0.0171574213387191	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2631.45145608653	2631.45145608653
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCATCGAGTAACGTA"	-1.59476147118266	12.2700614699158	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATCGAGTAACGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2200.97182445615	42.0982935976012	0.0191271388074236	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2197.03355634592	2197.03355634592
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCATCGCACCGTCGA"	1.84300734576527	-8.29792597210082	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATCGCACCGTCGA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1629.59950707273	38.9319900044187	0.0238905263750066	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1627.46574764438	1627.46574764438
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTAGACCAGCTCTGG"	6.68398108062093	-10.007878326532	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGACCAGCTCTGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2682.92587820785	40.1381394992691	0.0149605845712297	2557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2676.69182845408	2676.69182845408
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTAGACCATCAGCGC"	1.49344553527181	11.2665767439636	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGACCATCAGCGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2175.29725715341	41.4318927369859	0.0190465429957851	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2171.69341366582	2171.69341366582
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTAGACCATCCAACA"	-1.58210645142253	11.76375672901	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGACCATCCAACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2468.21790941553	38.2624138218999	0.0155020404300366	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2465.97511769023	2465.97511769023
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCATGCCACATTCGA"	-2.65114865723308	13.1139182814392	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCATGCCACATTCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2592.11291329698	43.5736845213814	0.0168101027921499	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2588.03082130389	2588.03082130389
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCAACTCGTTCTCG"	-8.65072474899944	4.48685119235841	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCAACTCGTTCTCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2354.48439426901	37.5743957108362	0.0159586514152717	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2345.96574841399	2345.96574841399
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTAGTGTCCACGTGG"	-2.64955769005473	13.3118200072083	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTAGTGTCCACGTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2813.23724552516	35.4693212384906	0.0126080092586963	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2806.10185067207	2806.10185067207
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ATTCACTCACTACCCT"	-1.97759113732036	13.3364305266174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ATTCACTCACTACCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2879.95436562146	40.5997519620311	0.0140973594743992	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2875.02477824058	2875.02477824058
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCATTAGAGAATCT"	1.51075830039327	11.1140727766785	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTAGAGAATCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1981.18909538544	36.4919257565043	0.0184192038213318	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1976.9584432975	1976.9584432975
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCATGCATAGGAGC"	0.788937290280503	9.82259461963502	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGCATAGGAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2122.17652425984	33.173334488148	0.0156317507563222	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2110.63292279801	2110.63292279801
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCATTAGTGATAGT"	1.37120582637135	11.3092708357605	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTAGTGATAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2276.92390670438	35.6424886988168	0.0156537900075922	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2267.56505517352	2267.56505517352
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCATTCAGCAGTCC"	0.963291664689225	10.9698333510193	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCATTCAGCAGTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2265.26798637926	43.3731732450553	0.0191470384545459	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2262.5231398733	2262.5231398733
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTGTAACCAAAGCAAT"	-2.6400068801945	13.2447604903015	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTGTAACCAAAGCAAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2204.70286250261	40.2250755788959	0.0182451233057481	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2204.70286250261	2204.70286250261
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCATGTCACTCCGT"	-0.205140869051772	11.1456012495789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCATGTCACTCCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2062.59674232864	48.5951649339582	0.0235601869898694	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2057.9395320055	2057.9395320055
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCCTGATAGTTAGTGA"	6.40806164321248	-10.1406107178894	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCCTGATAGTTAGTGA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2536.99038960227	46.3206728196946	0.0182581191515497	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2532.42529695412	2532.42529695412
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTCAAGGATGC"	-7.47874389115031	3.0324988135132	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTCAAGGATGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2738.60291394288	38.5656402662935	0.0140822315166418	2670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2726.7543769459	2726.7543769459
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTCAGCTGGTC"	8.13534798201863	8.40519902789918	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTCAGCTGGTC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2244.80592643771	44.0013328608533	0.0196013973157489	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2238.70091260831	2238.70091260831
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCCAACACGAGAAC"	-7.44873605194743	3.19793078983156	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCCAACACGAGAAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2533.17945847441	43.3505246166628	0.0171130886410907	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2525.8856864306	2525.8856864306
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTTCCCTTGTG"	0.212974478572053	11.5397119292053	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTTCCCTTGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2453.76607908858	40.0381776548923	0.0163170311938471	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2447.14489405573	2447.14489405573
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCCGTTCCGTGACG"	6.98183216628377	-10.2101097336975	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCCGTTCCGTGACG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1868.6835296169	36.1921338212903	0.0193677170305611	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1865.06011519097	1865.06011519097
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGATCTCCGAGTGC"	-1.76391992989238	12.1788463362488	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGATCTCCGAGTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2341.00628101158	42.5331159607198	0.0181687320985489	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2335.72519585325	2335.72519585325
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCGCTGTGATCATC"	-7.70396886292155	3.40173122966615	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCGCTGTGATCATC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2336.0488764112	45.3245469786578	0.0194022254569812	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2328.85694870799	2328.85694870799
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACCGTTCTCAATCGGT"	-2.06910191002544	13.5943679579529	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACCGTTCTCAATCGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2298.81633162133	39.0436468929458	0.0169842393913257	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2293.38329000365	2293.38329000365
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCTATCAAATGCGG"	-7.39074120941814	3.0153484114441	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCTATCAAATGCGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2720.83119142096	43.6372021338684	0.0160381879888251	3370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2712.08239919498	2712.08239919498
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGTGTGTTGATCGT"	-8.02483020249065	3.02863261783449	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGTGTGTTGATCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2362.84712565876	45.3285569782836	0.0191838720694408	2804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2356.05313551399	2356.05313551399
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTCTATGTAGAATGT"	-7.54160104218181	3.12617132747499	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTCTATGTAGAATGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2742.63274686171	39.8106381226234	0.0145154826756069	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2734.61820982462	2734.61820982462
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCGTGTTCACTCCGT"	-7.63488088074382	1.50236032092897	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCGTGTTCACTCCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2487.12542728019	46.6909042094979	0.0187730396293511	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2481.74913794228	2481.74913794228
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGCAACACGAG"	-0.684576670557815	9.37942407214967	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGCAACACGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2358.74820492419	37.9363199201292	0.0160832427305858	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2347.90037526799	2347.90037526799
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTAATCATAGAGGC"	-7.82378182831462	2.65706274593202	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTAATCATAGAGGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2667.27954180643	39.6200926045292	0.0148541208311808	3970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2661.81844372695	2661.81844372695
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGCAAGGTCGCACAC"	-2.57583985748943	13.2582521208557	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGCAAGGTCGCACAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2717.27921562479	42.7156865463693	0.0157200210787126	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2710.9930614843	2710.9930614843
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTGCGGCACTTCAAG"	-1.41136179390605	11.6763505705628	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGCGGCACTTCAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2802.67320607629	47.0180963271807	0.0167761607829425	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2798.86078377478	2798.86078377478
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCGATGTTACTCAG"	-1.21828673306163	11.8191070326599	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCGATGTTACTCAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2327.46464065741	40.5935994612339	0.0174411240248823	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.97864110982	2319.97864110982
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGACATCGAGATGG"	0.871659834950608	11.6989125975403	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGACATCGAGATGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2364.52033630456	47.8979795324432	0.020256953935656	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2356.16719928498	2356.16719928498
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCTCCCATATGAAG"	-1.45847855034526	11.4078120955261	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCTCCCATATGAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2532.91645598495	44.2958794263224	0.0174880933485418	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2528.36192021137	2528.36192021137
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGATGTTCCCTATTA"	1.48993780192677	11.1804189451965	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGATGTTCCCTATTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2110.78656571241	39.7921616415384	0.0188518168003917	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2107.33808375922	2107.33808375922
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTCGACACCCATAA"	-1.4230252307957	11.540931678656	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCGACACCCATAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2695.23428421273	41.4222248800336	0.0153686917395877	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2691.59785962251	2691.59785962251
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGTAGAGGTTGCCC"	-7.66955457153972	3.79986903751222	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTAGAGGTTGCCC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2230.98583584979	39.8104955523905	0.0178443515474972	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2220.97334549195	2220.97334549195
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTGTCCCACGGTAGA"	-0.664370576769668	11.0047893294129	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTCCCACGGTAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2368.23213864524	40.7852037802316	0.017221793047519	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2358.60913863886	2358.60913863886
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTGTCCCAGAAACCG"	-8.04792724075969	3.42349479282228	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTGTCCCAGAAACCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2377.21493547003	44.2875069360811	0.0186299969242472	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2369.44994834549	2369.44994834549
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGTGACACCCAAGC"	-7.50098309937175	3.02864263141481	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGACACCCAAGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2384.15461116681	46.5065619718634	0.0195065209924045	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2378.42921425199	2378.42921425199
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTCTTGTCATTCCC"	0.395411630242509	11.4431752928528	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTCTTGTCATTCCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2558.05927776699	42.7859550447118	0.0167259435371885	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2548.7052953462	2548.7052953462
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GTTATGGGTATGTGTC"	3.13047256049458	-10.95938780224	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GTTATGGGTATGTGTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.61880519124	38.927124972619	0.0163311033156142	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2379.15186232415	2379.15186232415
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTTACTAGGTAAGTT"	0.349352230399293	11.5474738844666	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTACTAGGTAAGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2252.31511920568	44.3368320440379	0.0196850039614679	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2246.81837658853	2246.81837658853
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCGGTGACATCCTTGC"	-0.221907625824767	11.5100049742493	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCGGTGACATCCTTGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2609.65475745223	40.4207830553054	0.0154889388873675	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2598.87767169458	2598.87767169458
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTTACTTCTGCTCTG"	6.5218616920406	-9.96500208294066	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTACTTCTGCTCTG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.60703242832	40.9715918888165	0.0167805839943326	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2437.45109991379	2437.45109991379
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTTGGACAGGGAATC"	1.22655810889546	11.4689044722351	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTGGACAGGGAATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2607.55331920637	39.4485705471109	0.0151285767606537	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2603.328461093	2603.328461093
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTTTGGACATGCCGGT"	1.20797576484029	10.6522454985413	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTTTGGACATGCCGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2248.17654415285	39.7959517226419	0.0177014353370712	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2241.54134612933	2241.54134612933
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTGCATCAAGCTGT"	1.31186821040456	11.1222467192444	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTGCATCAAGCTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2254.81870242563	32.9380814116979	0.0146078624309194	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2251.33815664333	2251.33815664333
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTTCTAGCCTAACT"	-2.27646408501323	13.4788512953552	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTTCTAGCCTAACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2747.9714049641	43.470856160038	0.0158192534614842	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2739.6299369817	2739.6299369817
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCTTCTCAACCAATC"	1.34171380576436	11.7683057554993	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCTTCTCAACCAATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2518.68385924272	38.3321479697678	0.0152191184412056	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2503.31173576654	2503.31173576654
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACACGCAGAATGTA"	6.85825171050374	-9.74529364025267	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACACGCAGAATGTA"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2408.85447002488	43.9927793606195	0.0182629461049032	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2405.42034623434	2405.42034623434
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACCAGGTACCGGCT"	-3.01148496094401	13.2126674422058	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACCAGGTACCGGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2782.35801029303	37.1401475518786	0.0133484430883742	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2780.01493272159	2780.01493272159
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACCAGGTCCTTGTC"	1.3060653406078	11.021364189032	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACCAGGTCCTTGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2072.17249774379	38.0271045725299	0.0183513219164593	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2064.00184495	2064.00184495
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACGACTCATTATCC"	4.8843900161678	-10.0236225358215	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACGACTCATTATCC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2700.11288262854	40.7776694639938	0.015102209143307	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2696.08149908638	2696.08149908638
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGAACATCGAAGGAC"	-9.46968493881877	4.08365771854249	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAACATCGAAGGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2425.32570422017	45.3029609681004	0.0186791245766585	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2422.71893853053	2422.71893853053
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACGACTCGCACGGT"	6.60800375518147	-10.0424070588318	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACGACTCGCACGGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2665.21237326853	39.7971929914152	0.014932090737148	2434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2662.44100465025	2662.44100465025
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGAAGTCACACTGGC"	1.56379677829091	11.1981296309265	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAAGTCACACTGGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2211.16194826839	36.3663148884751	0.0164466989480143	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2204.68510397195	2204.68510397195
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAACTTCAGCTGCCAC"	-6.76703057709392	-0.00585272973450283	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAACTTCAGCTGCCAC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2870.24817787728	48.9324178793483	0.0170481487477285	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2862.41589338842	2862.41589338842
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGAAGTGTATTCTCT"	0.92416008290593	11.3106078871521	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGAAGTGTATTCTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2044.09217244104	41.4840512277506	0.0202946089159036	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2034.67506272019	2034.67506272019
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTAACCTCGTTCCCA"	-8.05913100662883	3.06831977451173	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTAACCTCGTTCCCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2599.56500372155	44.9540415274863	0.0172929091840865	3248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2594.84178921138	2594.84178921138
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTAAGAAGATGACAT"	-7.88051543656047	2.57677481258241	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTAAGAAGATGACAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2706.42530791725	39.4350917523626	0.0145709144963288	3184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2697.71066533707	2697.71066533707
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTCCTGTGCTTATG"	-2.72129044953044	13.2915534743103	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTCCTGTGCTTATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2889.41911470116	46.1341339957605	0.0159665774207118	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2879.39650374403	2879.39650374403
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAAGCCATCAATGTCG"	-1.47520027580913	11.7701377638611	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCCATCAATGTCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2344.58796834407	40.1076954915021	0.0171065006018219	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2343.39491327426	2343.39491327426
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAAGCGTAGACTCGAG"	0.406091888516587	11.5898027190003	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCGTAGACTCGAG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2358.94013402386	42.7803438846622	0.0181354088930133	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2351.37708210445	2351.37708210445
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAAGCGTAGGTACATA"	1.41559567031209	10.7920465239319	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCGTAGGTACATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2232.33889427677	41.5709934052301	0.01862216956028	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2228.55339622926	2228.55339622926
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAAGCGTCAAGCAATA"	-1.14230928841289	10.9604282149109	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAAGCGTCAAGCAATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2477.05069185311	42.7486189285352	0.0172578700424393	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2474.78842886097	2474.78842886097
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACGTTCCTCAGGACAG"	-2.41967306557353	12.8493737944397	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACGTTCCTCAGGACAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2646.74126965218	41.619568366234	0.0157248344760587	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2640.08837116429	2640.08837116429
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCAACCAAGTGCTT"	-2.39400539818462	12.7231054075989	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCAACCAAGTGCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2532.62804414458	45.3608419842453	0.0179105818910595	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2530.06192225523	2530.06192225523
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCAGGGTTTAGACC"	0.145687003701371	11.5256404646668	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCAGGGTTTAGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2206.76003289936	38.0705908843498	0.0172518036926429	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2198.50547148828	2198.50547148828
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGATTTGTGACTCTA"	1.4242568212444	10.3167571791443	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGATTTGTGACTCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2115.54458087282	34.7596045608795	0.0164305705845908	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2104.52508995646	2104.52508995646
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGATTTTCTTCTCAA"	-1.45021710816081	11.5611924895081	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGATTTTCTTCTCAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2542.45122384686	48.6654603200353	0.0191411578965916	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2539.11571240051	2539.11571240051
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AAACGCTCATACTGAC"	-2.12664590302165	13.5034246214661	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AAACGCTCATACTGAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2844.02217035492	34.7098105454442	0.0122044795948664	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2837.34756696762	2837.34756696762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCACTCACGGTGTC"	-2.07287583771403	11.0224666365418	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCACTCACGGTGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2492.4451518376	38.8024700913426	0.0155680336888195	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2487.24034924492	2487.24034924492
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACACCCAGTTGTACC"	6.82944740828816	-9.94666769420775	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACACCCAGTTGTACC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2736.92891076459	39.8132397605932	0.0145466839142238	2973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2732.96590305453	2732.96590305453
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACACCCGTCGAACGA"	-1.22970102253612	11.4541377791199	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACACCCGTCGAACGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2576.47542501842	42.6204377467151	0.0165421479797	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2571.87996043644	2571.87996043644
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACAGGTAGATGGCGT"	-0.188249195844489	11.2731103667053	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACAGGTAGATGGCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2290.79998531787	36.850143870032	0.0160861463707923	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2286.05527668646	2286.05527668646
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGCAGTCGTTGCACGC"	-5.20911107483562	-5.30039360439452	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00601503759398496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGCAGTCGTTGCACGC"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2163.09801534064	32.8580761704827	0.0151902853858004	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2157.96190750461	2157.96190750461
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGCCTAAGGTACCTT"	-2.06503115120586	13.4941015013489	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGCCTAAGGTACCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2813.258278558	40.7713835062188	0.0144925845653664	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2807.20669735489	2807.20669735489
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCAGGTCAATCTTC"	8.01963629302327	-8.83636476909789	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCAGGTCAATCTTC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2409.25458510361	42.7657295373906	0.0177506062671046	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2405.58350353174	2405.58350353174
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCCACGTAGCGTTT"	0.5813932615215	10.8224363096985	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCACGTAGCGTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2168.3862002108	38.0295888747953	0.0175381990860753	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2163.34679795488	2163.34679795488
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCCACTCGCCAATA"	1.21398307856862	10.5927753218445	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCACTCGCCAATA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2537.66738888572	33.6349263424518	0.013254269054236	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2530.98393850347	2530.98393850347
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTCTAGCACATAACC"	-1.38025079193767	12.4693431624207	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTCTAGCACATAACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2952.72213521995	46.8486691726137	0.0158662640868928	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2939.30104480988	2939.30104480988
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCTCACAGCGGATA"	-1.87041376057323	11.9179906615051	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCACAGCGGATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2275.07539442341	40.1725751740259	0.0176576896187685	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2267.44767353835	2267.44767353835
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCCGTCAATCTAGC"	-1.16423819485362	11.3189906843933	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTCAATCTAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2441.56400281271	45.1591806025454	0.0184960052452123	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2437.11234842212	2437.11234842212
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGGCAGGTAACGCGA"	-2.79205594483073	12.9093589552673	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGCAGGTAACGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2274.16750276018	37.2518186698919	0.0163804199227537	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2269.59184074332	2269.59184074332
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGCTCAGTTGCGAAG"	-2.73151932182963	13.0484599837097	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGCTCAGTTGCGAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2351.56089628464	41.6474045891868	0.0177105362888912	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2347.24242861237	2347.24242861237
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCCGTTCATTGGTG"	0.708146651356858	11.2958268889221	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCCGTTCATTGGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2441.80041472011	40.5379325197461	0.0166016568247626	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2436.41943272301	2436.41943272301
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCGAAAGCCTCTCT"	-0.00887700069006089	11.4031018980774	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGAAAGCCTCTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2412.03439659241	43.4892434450223	0.0180301091503759	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2405.03036961067	2405.03036961067
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGGTCTGTAATGCTC"	-2.3218129676884	12.5451326140198	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGTCTGTAATGCTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2385.66987627228	40.5138061715361	0.016982151040462	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2378.26231574237	2378.26231574237
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCGAATCCGATAGT"	7.01921619948689	-10.1020355454651	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGAATCCGATAGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2646.06010334761	39.0322948803943	0.0147510991269674	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2642.02154173909	2642.02154173909
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGGTCTGTTCCTAAG"	6.57964767989461	-10.031578086969	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGGTCTGTTCCTAAG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2423.98965083421	41.1372238984314	0.0169708743947294	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2416.86267018421	2416.86267018421
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ACTGTCCGTTCTTCAT"	-2.18682799759563	13.2855376967224	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ACTGTCCGTTCTTCAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3100.03641234478	40.665985291106	0.0131179056894843	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3091.029540452	3091.029540452
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCGGGTCTCTGGTC"	-1.87579844418224	12.6537027128967	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCGGGTCTCTGGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2740.3214227946	43.8929616523557	0.0160174501017451	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2739.08830309163	2739.08830309163
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGGGCAAGCCTGAAG"	1.4603519636089	11.021306968573	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGGCAAGCCTGAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2196.8520650655	36.2161850478223	0.0164854910459082	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2188.17139099412	2188.17139099412
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTGTCGTTCTATACGG"	1.34702887114827	10.7587785490784	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTGTCGTTCTATACGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2281.23519686171	30.8727965989433	0.01353336851957	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2273.93861636582	2273.93861636582
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACCTGCCAGTATACC"	7.63540329512898	-9.82250692760619	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACCTGCCAGTATACC"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2537.19841604785	48.3680337227942	0.0190635597976355	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2532.92467173139	2532.92467173139
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACAGGGCATGGTACT"	1.08128084716145	10.9107064970764	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACAGGGCATGGTACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2171.01750914252	38.805894622246	0.0178745194171985	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2164.52755320921	2164.52755320921
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GGGACTCTCCGTGTCT"	-2.71516166153606	13.2156133421692	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GGGACTCTCCGTGTCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2495.98508442014	41.3684034082113	0.0165739786132664	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2490.61400369787	2490.61400369787
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACCAACGTCGAAGCA"	-2.26070461693462	12.8616466292175	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACCAACGTCGAAGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2231.22872356019	46.9534744589921	0.0210437746534888	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2224.4702723812	2224.4702723812
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACGGGCCAGTCACGC"	-7.49585137787517	3.33663628185121	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCCAGTCACGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2221.68990068711	42.1043382509247	0.0189514919421936	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2213.88241292645	2213.88241292645
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACGGGCGTACTAACC"	-7.3910997909611	0.891661799791731	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCGTACTAACC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2778.13578938536	41.0601916916763	0.0147797641312416	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2768.66602417513	2768.66602417513
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCGGTCTCAGCTTTGA"	-6.87783465805705	2.85323331439821	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCGGTCTCAGCTTTGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2565.00020541479	41.1011361216142	0.0160238334620202	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2559.74063804182	2559.74063804182
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACGGGCTCCGGTAGC"	1.23502721366231	11.1535024412903	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCTCCGGTAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2679.49357080701	37.047080003491	0.0138261499886089	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2670.86525478184	2670.86525478184
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACGGGCTCCTGGGAC"	-7.4155777496403	2.8048639067444	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGGCTCCTGGGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2890.42570915944	41.8996462404766	0.0144960121644716	3543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2882.79843022328	2882.79843022328
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTACCGAGTTCGGTT"	-1.20811818066295	11.4153270491394	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTACCGAGTTCGGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2336.97975926156	46.7817600288207	0.0200180424513402	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2336.97975926156	2336.97975926156
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACGGTACAACTTCTT"	-8.00764594498332	3.53001210773317	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACGGTACAACTTCTT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2780.89940105375	46.0679892135269	0.0165658596625504	3106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2771.1009692939	2771.1009692939
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTGTTGGTTAACCTG"	1.35731818255727	9.53588769519655	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTGTTGGTTAACCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2016.50343033252	37.0160225724438	0.0183565383602347	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2013.11918051747	2013.11918051747
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTAGGACAAAGGTTA"	-2.75391135636027	13.3877105482849	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTAGGACAAAGGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2454.90344806277	38.1657784975321	0.0155467533876535	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2453.58454366107	2453.58454366107
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTGCCAGACGGTCA"	-0.267176995903808	11.8564481505188	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTGCCAGACGGTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2547.31967063822	39.5647949115833	0.0155319316093808	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2538.9113784183	2538.9113784183
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTAACTCATGGTGGA"	6.32525839385335	-10.026674293634	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTAACTCATGGTGGA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2758.16722936366	38.9061832191761	0.0141058101209303	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2752.11603486924	2752.11603486924
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTACAGTTCCAGT"	-7.67708764496501	3.06093523586122	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTACAGTTCCAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2742.60461765975	42.3360496944426	0.0154364392963677	3761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2735.11708363081	2735.11708363081
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTACCAGCTGGTC"	0.361104478209656	11.6727752455506	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTACCAGCTGGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2248.392728848	42.0298049883151	0.0186932667274057	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2245.36890286489	2245.36890286489
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTACCATAGACTC"	-2.87212286415752	13.077965713385	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTACCATAGACTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2800.02545424573	47.2772185829124	0.0168845674282086	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2788.86053686177	2788.86053686177
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTACGTAAGGAGA"	6.39405741271321	-10.1629028550354	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTACGTAAGGAGA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2867.11538347312	40.5610401663874	0.0141469856428495	2872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2862.62606671638	2862.62606671638
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTATACCAAAGGGTC"	1.33970965918843	10.7555799254212	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTATACCAAAGGGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2173.58223990225	39.0810811021424	0.0179800333222727	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2170.02938940801	2170.02938940801
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCCGAGTCAGCTTA"	6.51278461989705	-10.0103121033874	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCCGAGTCAGCTTA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2433.38754573797	41.131863346832	0.0169031288990008	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2426.19537268218	2426.19537268218
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTATACTCCTTGACC"	-2.32339201393779	13.4251308211121	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTATACTCCTTGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2871.89880919157	43.7188455876642	0.0152229756312239	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2858.33284132085	2858.33284132085
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTATCAGTTCGGCCA"	-0.259658436209518	11.3619174727234	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTATCAGTTCGGCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2290.81575748607	42.5721010760134	0.0185838171127004	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.58221530399	2276.58221530399
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CCTTTGGTCTGGTTGA"	6.89729656752889	-9.804225944635	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CCTTTGGTCTGGTTGA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2539.1444370914	37.9133236103553	0.014931534833751	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2535.12198323567	2535.12198323567
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCACGCATCTTAGG"	-1.60621343079265	12.00620935047	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCACGCATCTTAGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2405.17098868662	39.2600948776244	0.0163232032409733	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2403.12331434033	2403.12331434033
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTGTGTTAGGGAC"	0.963693161576432	11.5332431563172	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTGTTAGGGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2423.4049841601	40.1745497958679	0.0165777284681914	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.7361251149	2416.7361251149
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTGTTCCCGAGTG"	-0.698081592947799	10.6167039641174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTTCCCGAGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2331.16209014054	41.4319938018463	0.0177731072314017	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2321.67426326293	2321.67426326293
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TACTTGTTCCGTGGCA"	-2.1951085132664	13.1735429533753	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TACTTGTTCCGTGGCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2617.80566941804	46.0606209789397	0.0175951261459295	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2612.70717599222	2612.70717599222
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AACGTCAGTCGTCTCT"	0.850785751908463	11.6439084776672	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AACGTCAGTCGTCTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2257.63033194268	41.9987038681105	0.0186030030133281	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2248.28059688348	2248.28059688348
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTCTAAAGCCTTCTC"	1.54195620593373	11.3994712599548	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTCTAAAGCCTTCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2350.49883838773	33.4486396512433	0.0142304429617104	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2341.18495688299	2341.18495688299
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTCCGACATGGGATG"	-2.62072287026103	13.2224778898987	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTCCGACATGGGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2616.66075561471	45.7619889990998	0.0174886977231977	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2611.53189999896	2611.53189999896
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGACTGAGAGTATAC"	1.52863397177998	11.101143813971	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGACTGAGAGTATAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2174.07854698373	37.6649714414568	0.0173245679157786	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2169.22359765933	2169.22359765933
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGACTGCAGGGATAC"	-1.31783686104472	11.4731244810852	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGACTGCAGGGATAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2320.82071004476	40.2853096247924	0.0173582170524562	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.03249373033	2315.03249373033
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGACAGCCAGCAGTAG"	8.50555576857869	8.21100804889528	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGACAGCCAGCAGTAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2190.71092388108	39.6400978227569	0.018094627360752	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2185.66565211909	2185.66565211909
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCATGTGATTCTG"	6.82852949675862	-9.73100187694701	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCATGTGATTCTG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2563.06871877804	44.1655465436641	0.0172315108916472	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2558.1519525329	2558.1519525329
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGACAGCGTGTCGCTG"	-1.21691022339519	11.6305007704529	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGACAGCGTGTCGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2345.60306655739	38.7377204369723	0.0165150365759996	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2338.69420966187	2338.69420966187
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGAGTCTCGTGGAAG"	-2.04205570641215	12.7447662123474	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGAGTCTCGTGGAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2344.7536808686	46.8527765745652	0.0199819609867117	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2341.96657820012	2341.96657820012
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGATCGCAACTGAAA"	-2.7484806579655	13.3803119429382	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGCAACTGAAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2690.07421133541	44.670918555744	0.0166058313066272	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2679.3318862005	2679.3318862005
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGATCGCATGAAGGC"	-7.64298377457316	0.941398418787397	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGCATGAAGGC"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2720.68870785275	41.0044147730033	0.0150713364063488	4329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2715.10789975723	2715.10789975723
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTTTCAAGTAGACGGT"	-8.17610583725627	2.322149968985	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTTTCAAGTAGACGGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2537.49839003063	43.9910607013479	0.0173363896009474	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2534.00676997066	2534.00676997066
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGACCCGTCATTCACT"	-0.160203675658065	11.0069446333679	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGACCCGTCATTCACT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2369.81572882086	37.7873089568919	0.0159452519861929	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2366.58220883235	2366.58220883235
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGCCAGTAGCCCTG"	-2.11707220497783	12.5028371580872	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGCCAGTAGCCCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2505.60839434901	43.8253509288345	0.0174909020211121	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2499.00679487616	2499.00679487616
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGATCGTCTCGGGAC"	0.600266237824601	11.3936509856018	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGATCGTCTCGGGAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2374.68655197593	40.1525509329906	0.0169085687959872	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2368.56741198552	2368.56741198552
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGCACAAGGGCGAGA"	7.97862877425496	8.32985303485719	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGCACAAGGGCGAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2105.72222335316	43.1788240152238	0.0205054700645491	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2102.09747291762	2102.09747291762
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTGGCTAGTTTCGGT"	6.47510828551595	-10.0205869904724	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTGGCTAGTTTCGGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2645.12116209929	43.714420213323	0.0165264339644197	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2640.8836234267	2640.8836234267
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGAGGCACTACAGT"	3.96491446074788	-10.3510523072449	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGAGGCACTACAGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2611.64096634498	40.6319987079894	0.0155580339072619	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2609.62860523162	2609.62860523162
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGAGGTCAGGACGA"	-2.06338534775432	11.749690032843	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGAGGTCAGGACGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2423.37344562901	41.4129378628058	0.0170889624698585	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2417.47332160876	2417.47332160876
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGGTTAGACGAGCT"	-7.27254758301433	3.19770500743715	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGGTTAGACGAGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2562.47226930468	40.0803281969627	0.0156412729523268	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2549.90476235827	2549.90476235827
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAACCTCACGGTCTG"	-1.7013078731602	11.9395446547302	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAACCTCACGGTCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2161.90644058282	36.8107253521571	0.0170269742765711	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2155.68895578228	2155.68895578228
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGGTTCACAAGCTT"	2.12605299529378	-9.22653009807738	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGGTTCACAAGCTT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1504.4874098858	26.2837763528898	0.0174702534432541	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1504.4874098858	1504.4874098858
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CGAGGCTGTACAGTCT"	-1.37023673477824	11.8141650923523	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CGAGGCTGTACAGTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2561.71904332676	41.5829173536648	0.0162324269954536	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2558.77337876674	2558.77337876674
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGTACAGGCGATAC"	-1.99617252770122	11.0864333876404	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTACAGGCGATAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2414.68879574016	41.2809211849957	0.0170957521556487	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2405.9850410212	2405.9850410212
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAATGAAGCCATTGT"	7.36192192611043	-10.00248911297	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAATGAAGCCATTGT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2492.15354415203	39.9489936606302	0.0160299086524475	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2486.23730440368	2486.23730440368
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGGTACGTTTCGTGA"	1.45060874995534	11.166835761908	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGGTACGTTTCGTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1971.89909830049	34.3069054893862	0.0173979010989731	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1967.72815590057	1967.72815590057
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTTGCGGTCCGAAAG"	-2.81530700150188	13.0342445143494	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTGCGGTCCGAAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2271.85838184806	43.7590002610316	0.0192613239498826	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2271.85838184806	2271.85838184806
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCTTGCGGTCTACATG"	-0.797902147204238	11.3831424483093	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCTTGCGGTCTACATG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2410.54547260533	44.6280707601091	0.0185136813502526	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2403.68614578238	2403.68614578238
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGTGCAAGCGTCAGA"	-2.51354728165324	13.4626350172791	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGTGCAAGCGTCAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2601.19546811764	39.9982049663266	0.0153768547794954	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2596.15937235942	2596.15937235942
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGTGCACAGATGCGA"	-2.00524030152019	12.8774461516174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGTGCACAGATGCGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2383.88209054222	42.7311830810548	0.0179250405255301	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2374.39502273496	2374.39502273496
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAACGTTAGAATCCCT"	1.4414459663326	11.3365926512512	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAACGTTAGAATCCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2085.11245536649	33.4407996985483	0.0160378878426826	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2075.1331925128	2075.1331925128
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TAGTGCATCCAAGCCG"	6.80937876281087	-1.00412955200347	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TAGTGCATCCAAGCCG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2609.06374221935	37.1661363723135	0.0142450089550893	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2600.54981356489	2600.54981356489
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATACCTGTATGCGGA"	1.43232860144917	11.4423856505188	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATACCTGTATGCGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2420.31194580512	34.4498821730982	0.0142336537374063	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2415.41876384176	2415.41876384176
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATACCTGTGACACAG"	1.36139275607411	10.1937703856262	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATACCTGTGACACAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1961.97841557458	40.7636710834603	0.0207768193369866	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1957.37374938409	1957.37374938409
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAAGAATCATTCTCTA"	6.71307339248006	-10.0068769684997	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAAGAATCATTCTCTA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2727.67078403864	41.6774461144493	0.0152795001355482	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2721.12553610386	2721.12553610386
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGATCCCAGCTACAT"	-1.40876660767253	11.5161456831726	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATCCCAGCTACAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2604.93183302805	42.2835467294617	0.0162321125617748	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2590.04445471522	2590.04445471522
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGTTTTCTTTCGAT"	-0.0124190476840318	11.4266175993714	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGTTTTCTTTCGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2335.80476611199	36.5701741138174	0.0156563487858145	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2329.58325624757	2329.58325624757
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCACGGGTAAGCGGT"	-2.481184343726	12.9179906615051	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCACGGGTAAGCGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2499.96926377791	38.6802200803628	0.0154722782558974	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2489.40447908478	2489.40447908478
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCACGGTCAGAGTGG"	6.58867897567098	-0.981417321321093	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCACGGTCAGAGTGG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2760.80879678139	40.4797171525395	0.0146622675209278	3056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2754.26235708709	2754.26235708709
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGATGATCGTAGGGA"	1.41329278525655	10.4556274184021	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGATGATCGTAGGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1897.24693201457	34.6868822334404	0.0182827451968039	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1894.3179614711	1894.3179614711
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCAGATCACTGAGGA"	1.30751671370808	11.2209691771301	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGATCACTGAGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2118.09594076702	35.3997525539756	0.0167130071271259	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2113.32340836444	2113.32340836444
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCAGATTCCGTTGAA"	-1.93145118179973	11.9604520567688	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGATTCCGTTGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.12575829857	40.2621986739856	0.0173984488654531	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.8218567865	2306.8218567865
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTGTTGTTAGAGTA"	-3.17355261269267	13.2635164030823	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTGTTGTTAGAGTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2505.09176566351	45.4843182611813	0.0181567473433988	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2499.11439182243	2499.11439182243
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCAGGCCAGTTGCGC"	6.44000353392903	-10.0420503846374	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGGCCAGTTGCGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	3032.31450247439	39.5894463264302	0.0130558509990059	3022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	3028.02187055608	3028.02187055608
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCAGGCCAGTTGTTG"	0.829150040715378	11.3321151503357	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCAGGCCAGTTGTTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2368.23649375566	42.7843288536295	0.0180659021877414	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2363.35930733002	2363.35930733002
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTTCAGTAGCCCTG"	1.36332060870473	11.2746038206848	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTCAGTAGCCCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2277.57882875811	33.3549340198541	0.0146449087068664	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2270.47760180289	2270.47760180289
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTTCAGTGAATTAG"	1.4706629711086	10.9349822768006	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTCAGTGAATTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2238.83874211169	39.3195434780559	0.0175624723382129	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2229.7194121123	2229.7194121123
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTTGTAGAATCTAG"	-0.959940294653732	11.1332998045715	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTGTAGAATCTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2264.05202361581	38.833756764633	0.0171523252820902	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2262.88532951494	2262.88532951494
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTTACGTCTCTCCA"	6.75456966933553	-9.87717153942259	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTTACGTCTCTCCA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2441.22028981349	45.1759149543959	0.0185054643134428	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2435.52833112963	2435.52833112963
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCGCCTCTATCGTT"	8.45872368392293	8.21646401965944	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCTCTATCGTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2571.99662631602	40.771212212402	0.0158519695536305	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2556.53674943591	2556.53674943591
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCGCCTCTCTATGT"	-2.20713625374492	13.435031867865	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCTCTCTATGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2825.60149269274	41.3190864070976	0.0146231117565419	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2817.61266543076	2817.61266543076
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCGCCTCTTTGATC"	1.32751562175099	10.6396827467713	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCGCCTCTTTGATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2316.02768103099	36.3042464193446	0.0156752212923394	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.27274687101	2308.27274687101
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTGTAGACGGATC"	8.08733810958211	8.4814243086609	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTAGACGGATC"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2090.01663472733	46.163180435905	0.0220874703429945	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2084.53136913273	2084.53136913273
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTGTAGGGACTGT"	1.41382028636281	11.210232711676	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTAGGGACTGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2165.01729237242	37.0183878803044	0.0170984259621039	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2152.72560721149	2152.72560721149
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGACGCGCAGGCCTGT"	-1.34865234318431	11.23654553974	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGACGCGCAGGCCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2519.80869127295	40.8741929586548	0.0162211492881255	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2512.05676393934	2512.05676393934
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTGTCACGGATCC"	0.861965079873246	11.7444181212219	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTCACGGATCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2222.59683913814	40.91950772614	0.0184106748491586	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2218.20715490972	2218.20715490972
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTGTTCCGGTAGC"	-0.978823284537155	11.6290826567444	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTTCCGGTAGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2564.8077094939	43.9401637929477	0.0171319524774893	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2551.78473993552	2551.78473993552
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTGTTCGCTTTAT"	-4.98528705063518	-5.02786686336669	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes (cycling)"	38	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00601503759398496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTGTTCGCTTTAT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	3132.56886848084	40.7581239247003	0.0130110863115569	3959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	3128.75212623266	3128.75212623266
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTTGGTCGACTTA"	0.153552484779996	11.5999259718689	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTTGGTCGACTTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2456.78973414538	46.010624901449	0.0187279457667769	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2449.69438888653	2449.69438888653
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGCATCAGTAACCT"	-2.6013551754063	13.3666915663513	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGCATCAGTAACCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2371.6768384896	39.5585877697963	0.0166795859907242	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2361.41294944332	2361.41294944332
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATCTTGGTTCAGCTA"	1.2700306373531	10.9459438093933	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATCTTGGTTCAGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2655.55717614214	35.7687644459491	0.0134694009857141	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2640.77126577662	2640.77126577662
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGCGCAGATGGCGT"	-0.413960347802001	11.3254174956116	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGCGCAGATGGCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2226.04875069487	45.8028944424961	0.0205758721268788	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2218.02691094132	2218.02691094132
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGCCAAGGAACGTC"	-0.563173036009628	11.8213987120422	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGCCAAGGAACGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2493.92474471666	43.3254790021308	0.0173724083270416	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2490.83473545531	2490.83473545531
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATGTTCCAAAGGCAC"	0.211015244095963	11.5394582518372	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATGTTCCAAAGGCAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2313.52480332852	40.4019436270876	0.0174633717213494	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.40855846138	2308.40855846138
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGCCATCGACGCTG"	1.30121030387227	11.5696792372498	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGCCATCGACGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2563.50773766031	32.4669554382875	0.0126650506886786	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2557.69312809533	2557.69312809533
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGCTCAAAGGCTCAAG"	-7.21875319901164	-0.0184558711019383	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGCTCAAAGGCTCAAG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2616.87944029833	33.7340677849433	0.0128909522026347	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2614.66949539698	2614.66949539698
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATTCCACACTCCACT"	6.50487007674519	-10.0910501710144	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTCCACACTCCACT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2445.4348841561	39.9908655797351	0.0163532735379031	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2439.59775625167	2439.59775625167
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGGTTCAACCGTGC"	0.915086587041062	10.9299373396668	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGTTCAACCGTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2323.76823975831	35.94152915677	0.0154669164255847	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.24794483982	2319.24794483982
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AATGGCTGTTCAGCTA"	-2.6427780193394	13.4644317396912	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AATGGCTGTTCAGCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2661.041891731	37.6347604332612	0.0141428665780154	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2645.00073085705	2645.00073085705
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGGTTTCACAACCA"	-2.61429534378703	13.1586055525574	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGGTTTCACAACCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2771.1214007217	43.66863256238	0.0157584696762138	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2760.11235994887	2760.11235994887
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATTGCTGTGCTCGTG"	-2.36614809456523	13.3464078673157	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTGCTGTGCTCGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2397.36497399806	39.9783786371543	0.0166759667679981	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2393.03763482813	2393.03763482813
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGAGTCATCTTTGCTA"	1.35998680171315	10.7314319380554	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGAGTCATCTTTGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2524.98645405709	44.1029506485715	0.0174666088119831	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2515.33067766413	2515.33067766413
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATTGGGGTCCCTGTT"	-2.50642619553264	13.233091331366	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTGGGGTCCCTGTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2421.67691546839	41.0922278270137	0.0169685012746904	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2420.26052077055	2420.26052077055
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAAGAATAACC"	1.01054652509038	11.0795135268006	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAAGAATAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2340.31595043875	34.23963298651	0.0146303463769885	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2332.3125626723	2332.3125626723
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATCTTCATATAGCC"	-0.787855128676254	10.2441558607849	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATCTTCATATAGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2409.23521180057	42.717221082126	0.0177306146252946	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2404.17068285654	2404.17068285654
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TATTTCGGTGGAACAC"	6.95580591735188	-9.88746836101683	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TATTTCGGTGGAACAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2384.0825444283	40.7790034004244	0.0171046944224841	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2380.11472854586	2380.11472854586
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACAAAGAAGAGGTTAT"	-2.15896401825603	13.2877988585266	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACAAAGAAGAGGTTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2551.04896838304	42.8962608602365	0.0168151460014607	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2543.13828629016	2543.13828629016
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGACGAGTGATCATC"	-7.94691501084025	2.8725912340912	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGACGAGTGATCATC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2370.07121566046	48.8760389450929	0.0206221815708069	2806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2361.72152828089	2361.72152828089
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGCACATAGACTC"	-2.0702522796696	13.3999442824158	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCACATAGACTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2894.06402053898	44.2650547325704	0.0152951193955712	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2884.20155486705	2884.20155486705
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATGCACACCAACAT"	-2.29423389855083	13.0651368864807	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGCACACCAACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2393.56851572981	42.7360568354831	0.0178545366696774	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2389.37349284565	2389.37349284565
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATGGTGTATACCCA"	1.42650904235188	11.3476056822571	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATGGTGTATACCCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2293.67881389194	39.7899890442735	0.0173476725700567	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2287.77118433149	2287.77118433149
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGCAGTTCGTACA"	-2.06594977799113	12.2294435271057	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCAGTTCGTACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2534.26919100561	45.5258850843076	0.0179641078563729	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2529.45322776229	2529.45322776229
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGCATCCTTCACG"	-7.83569560471232	2.74803230846254	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGCATCCTTCACG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2545.41511516592	44.1808773711143	0.0173570421216873	3322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2540.06683186211	2540.06683186211
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGTGCAGGCCTGT"	-1.00221178951915	11.6444234617981	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGTGCAGGCCTGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2438.06832883195	43.6688485834797	0.0179112488633167	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2434.91171431956	2434.91171431956
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGTGGTACCGGAA"	1.52632536467854	11.0938968428406	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGTGGTACCGGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2010.62207876848	37.0198840090497	0.0184121543277415	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2008.13714041399	2008.13714041399
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAAGTGTCCTAGAGT"	1.35195364531819	11.5029115446839	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAAGTGTCCTAGAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2284.44735200029	35.7946946842224	0.0156688639170783	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2279.63485692533	2279.63485692533
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATCTAGGAACGTC"	1.42885961112325	11.2944421538147	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATCTAGGAACGTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2128.63935673536	40.9147217947274	0.0192210679865834	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2121.2707707265	2121.2707707265
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACAGTTCCTAGAGT"	1.28819658335988	11.4753341444763	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACAGTTCCTAGAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2409.41820606302	36.0318465488033	0.014954583831953	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2404.5672381715	2404.5672381715
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGATTTCCATTGAAAG"	0.0518270526895344	11.3504428633484	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGATTTCCATTGAAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2141.95578056885	36.8658452138355	0.0172113007879392	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2140.46420086202	2140.46420086202
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGATAAGTCAGGTAG"	1.43970253047292	10.7009963759216	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGATAAGTCAGGTAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2135.3966282982	38.3790893577916	0.0179728153773371	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2124.80118709369	2124.80118709369
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATTCAGGGTTAGC"	1.51848949965779	11.004253364447	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATTCAGGGTTAGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2223.65525765914	35.0591583931505	0.0157664540276165	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2215.94666763829	2215.94666763829
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATTCAGTAATTGG"	-2.04223976555522	12.4007091292175	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATTCAGTAATTGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2564.67880800205	47.3034099706376	0.0184441848324423	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2558.71971244955	2558.71971244955
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATTCCAGCTGAGA"	-2.91679988327678	13.0375718840393	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATTCCAGCTGAGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2376.38501661857	41.7876730622107	0.0175845550152776	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2367.09149177119	2367.09149177119
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATTCCAGCTGTGC"	-2.34124646607097	13.5095205076965	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATTCCAGCTGTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2826.35085099003	39.6506922420818	0.0140289349527122	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2817.89484791047	2817.89484791047
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAATTCTCATACGGT"	-7.89994798126872	3.23531553829042	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAATTCTCATACGGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2356.58495152301	46.2316641749039	0.0196180766345917	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2351.32305701432	2351.32305701432
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCATTGTATCAGGG"	1.48054577884023	11.1319818266663	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCATTGTATCAGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2249.19402979098	41.2051747061603	0.0183199733595192	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2242.69458095625	2242.69458095625
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCATTGTTATTCCT"	6.32719482955281	-10.230079673883	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCATTGTTATTCCT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2541.54922966232	38.8477694947999	0.0152850745684597	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2537.0490129135	2537.0490129135
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACACTGATCCGTTGAA"	0.678715904324692	11.1283817061218	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACACTGATCCGTTGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2480.68141864353	34.8849053402526	0.0140626301620497	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2476.67570772852	2476.67570772852
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCAGGCGTATACAGA"	1.31792642649953	11.5322742232117	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCAGGCGTATACAGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.74941570762	37.4976793939706	0.0171791040804445	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2175.5179466152	2175.5179466152
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACACCAGCAATAGT"	8.13683189925496	8.29839227283327	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACACCAGCAATAGT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2299.32449809386	39.1056436255612	0.0170074487780997	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2294.22498285442	2294.22498285442
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACACCGTCCTATAG"	8.07553829726521	8.47345445239869	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACACCGTCCTATAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2209.4403517483	39.7453619813323	0.0179888820940028	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2205.5572969718	2205.5572969718
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACATTAGAGGGTCT"	-1.76790402355846	11.5481939085755	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACATTAGAGGGTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2467.58278269314	41.5672158539103	0.0168453176709815	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2458.23307101935	2458.23307101935
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACATTAGCGTGAGT"	-7.9112642807072	2.62942431056825	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACATTAGCGTGAGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2593.51830384113	45.2790259967105	0.0174585334252895	3579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2586.88523380048	2586.88523380048
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACATTCATGGAATA"	-2.73591838303264	13.1281690367493	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACATTCATGGAATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2695.10855063838	38.4394961477178	0.0142626893965413	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2690.25600238605	2690.25600238605
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGCTGCTCTATACGG"	6.50908054885213	-10.1062937012878	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGCTGCTCTATACGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2350.21656785415	48.8553403048389	0.0207875908003857	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2342.74300746947	2342.74300746947
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCATCCTCAATCCAG"	1.17293967780415	10.7109002836975	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCATCCTCAATCCAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2529.06254276576	38.3488678563602	0.0151632738249416	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2523.6821221871	2523.6821221871
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCATGACATGGGATG"	1.42484798011128	10.1691961058411	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCATGACATGGGATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2024.33193479347	30.3065170831904	0.0149711203791696	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2018.96119999352	2018.96119999352
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACGGGGTTACCGTA"	-7.26949534836467	0.803491152170576	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACGGGGTTACCGTA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2803.46112376439	39.6229188919334	0.0141335717324766	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2801.9394367497	2801.9394367497
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACTATCAAGCGATG"	-2.29523168030437	12.9016361006531	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTATCAAGCGATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2694.45419372221	41.5522596217099	0.0154214013801096	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2691.92968822101	2691.92968822101
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACTATCAATCGTCA"	0.231232007115525	11.1713094481262	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTATCAATCGTCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2497.16410612365	41.6720642661327	0.0166877555880059	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2485.93100709434	2485.93100709434
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCCGAGAGAAGTCCG"	-1.6113272708958	11.2204484709534	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCCGAGAGAAGTCCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2271.71869448079	39.094888767889	0.0172093881442589	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.0628166502	2269.0628166502
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCGACGAGGAACGAA"	-1.96522293511088	11.359143234137	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGACGAGGAACGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2464.69062899554	44.6275162457533	0.0181067415604777	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2459.64154464711	2459.64154464711
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGAGGTAGCTGGCTC"	0.947893579571885	10.9536294707092	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGAGGTAGCTGGCTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2257.79765064193	43.00191622522	0.0190459566706493	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2251.89404134155	2251.89404134155
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACTCGCAGGTTACT"	8.05026831206624	8.4018230208191	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTCGCAGGTTACT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2300.29701083894	41.5145322109706	0.0180474660512774	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2297.70772489978	2297.70772489978
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GAGAGGTTCCAAGCAT"	-0.875553945929366	11.5309362181458	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GAGAGGTTCCAAGCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2454.19493594479	45.705104432825	0.0186232575755967	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2445.73763141496	2445.73763141496
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCACTCGTCCGGCAAC"	0.247032885521096	9.61016843402711	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCACTCGTCCGGCAAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2769.15591393009	33.1113870433566	0.0119572129820468	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2756.93363058211	2756.93363058211
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCGGCATCGAATGCT"	1.16020562228505	10.7757358320984	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGCATCGAATGCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2150.98728523644	41.2905066849392	0.0191960719472131	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2147.15432735856	2147.15432735856
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGCAAGTAGTCGGA"	-1.69198439541515	11.2628755339417	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCAAGTAGTCGGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2262.97229014759	36.8592564474958	0.0162879839969635	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2259.22361241132	2259.22361241132
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGCAATCATTCGTT"	0.0178659307653129	11.4587936171326	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ GZMK+"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCAATCATTCGTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2569.21846049056	41.8379172235265	0.0162842972938697	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2556.33617962707	2556.33617962707
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCGGGTTCAGCCCAG"	-9.29065356674846	2.2045221098694	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGGTTCAGCCCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2556.56134163613	42.6202601372578	0.0166709319440706	3521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2553.94146802025	2553.94146802025
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGCCTAGAGGTTAT"	-2.62378082695659	13.4800071486267	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGCCTAGAGGTTAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2607.60634931311	38.0400856244044	0.0145881243288216	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2594.31983287067	2594.31983287067
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCGGGTTCGGCCCAA"	6.60269274291341	-9.95343210613402	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCGGGTTCGGCCCAA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2334.11775064383	43.2400679450174	0.0185252299002868	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2329.20379153243	2329.20379153243
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTCCAAGCGGCTCT"	1.42240430888478	11.4206771620545	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCAAGCGGCTCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2174.48991762842	34.9667612525407	0.0160804430358899	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2167.83015607612	2167.83015607612
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTCCAAGCTGTTAC"	-2.41473565521892	13.056107498053	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCCAAGCTGTTAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2843.37610149157	38.9255429210859	0.013689902964531	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2834.81318332724	2834.81318332724
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGGGCGTAACCCTA"	-2.52126465264018	13.3396777876648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGGCGTAACCCTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2767.75243917247	37.518234847937	0.0135554879536678	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2759.82993402406	2759.82993402406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAACCCCACAGCCAC"	-2.85888729515727	13.2296666868958	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAACCCCACAGCCAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3091.07073444537	40.7962153626265	0.0131980853456421	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3079.01755310149	3079.01755310149
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGGGCGTTGGTGTT"	1.78197362002675	-9.18310263073119	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	51	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0192307692307692	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGGCGTTGGTGTT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2716.70877554133	35.4162020867264	0.0130364367375628	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2711.71560289413	2711.71560289413
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGGTTTGTGTGCCTG"	-8.0463117164677	2.29934594714967	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGGTTTGTGTGCCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2569.65178433637	40.7993516328187	0.0158773853646304	3577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2567.00340674361	2567.00340674361
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGGTACACGACAAG"	-2.07212624970134	13.4542379149231	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGGTACACGACAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2805.02500041346	43.2765002140683	0.0154282048137501	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2795.93221406655	2795.93221406655
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCAGGATTCCT"	0.753528435795945	11.0614661940369	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCAGGATTCCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2594.48197356266	44.9180974129776	0.0173129348635626	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2583.63280827089	2583.63280827089
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTCGTGTCTCAAGT"	-0.855116228491622	11.0917434462341	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTCGTGTCTCAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2309.12996838631	46.2630688228667	0.0200348483871597	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.1951582443	2305.1951582443
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCAAACTCTTTGGAG"	1.47845294055287	11.5465268858704	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCAAACTCTTTGGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2000.5185649931	34.9504029166204	0.0174706716189564	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1998.89929651739	1998.89929651739
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTAAGTGGTGTGAATA"	-2.19181929054912	13.5054006346497	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTAAGTGGTGTGAATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2396.07988914215	39.5697943019815	0.0165143885566137	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2394.63293587581	2394.63293587581
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGCTGAAGTGCAATGG"	-3.00890026512797	13.1985578306946	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGCTGAAGTGCAATGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2636.70307071582	40.2234596153787	0.0152552102138898	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2628.80550822257	2628.80550822257
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTCCTCTCAATCT"	1.43147053298299	11.5129623183045	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTCCTCTCAATCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2461.50269965681	35.4208425989199	0.0143899263664664	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2453.06701398821	2453.06701398821
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTGAAGATTGACA"	1.39200045642201	10.6937951811585	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTGAAGATTGACA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2182.24477842439	40.8167940531746	0.0187040401960063	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2175.92777745113	2175.92777745113
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GTCATGAGTCGTTGGC"	6.89136948165242	-10.2875137559143	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GTCATGAGTCGTTGGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2189.78941711793	48.0797323272072	0.0219563269195477	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2186.30721378355	2186.30721378355
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACAGAGTCAGTCTA"	-1.94763861122783	10.7981509932312	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACAGAGTCAGTCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2345.61313238209	36.2688385348613	0.0154624128054862	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2338.91074505565	2338.91074505565
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTACCCAAGGCCTAAG"	-8.0649016899174	3.93101403796998	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTACCCAAGGCCTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2181.44619022719	40.9534921053388	0.0187735513664326	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2175.59996507314	2175.59996507314
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTTTTCATAGACC"	-2.79528198662456	13.4164981612	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTTTTCATAGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2530.28748870598	43.1618779947899	0.0170580924845277	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2523.4004129566	2523.4004129566
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTTTTCGCGTTTC"	0.0497739702345848	11.3777236708435	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTTTTCGCGTTTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2552.1297859225	41.0304527880202	0.0160769460136171	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2550.18566346788	2550.18566346788
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCAGTTTTCGGCTTCT"	0.613100190728348	11.1900977858338	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCAGTTTTCGGCTTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2593.65726388259	33.3562853776099	0.012860714421333	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2582.67435945546	2582.67435945546
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGAACTTCTCTTCAA"	0.911291440098923	11.0228872069153	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAACTTCTCTTCAA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2304.88185320531	39.7046790768829	0.0172263402662775	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.62486993354	2297.62486993354
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATACTGTCGGTGAA"	8.17951454696004	8.01839826190797	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATACTGTCGGTGAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2116.1665747087	36.9661849439364	0.0174684665119167	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2106.95935698458	2106.95935698458
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTTACCACATACGT"	-0.581627349287826	11.9047746428284	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTACCACATACGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.13235996491	42.633217759241	0.018335824012997	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2319.23869289517	2319.23869289517
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATATCAGCACGGAT"	1.33939840373341	10.7233447798523	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATATCAGCACGGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.99149155972	34.4953821311136	0.0165208442038936	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2085.52928795918	2085.52928795918
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATCATTCAAGCTGT"	-7.87404237213786	2.74521491611329	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCATTCAAGCTGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2904.37431710121	49.5612392789275	0.0170643429075607	3423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2890.66503414552	2890.66503414552
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGAGAGTCTCGAACA"	7.15247025069539	-9.90898420726927	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGAGAGTCTCGAACA"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2225.07484891046	46.5182877422178	0.0209063923242834	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2221.88289304838	2221.88289304838
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATCCGAGACGCTCC"	-0.426645706326324	11.1552085646423	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCCGAGACGCTCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2314.81436361762	40.4761258493983	0.0174856897752016	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.9760324145	2308.9760324145
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATCCGCACTAAACC"	1.3061441379482	11.4298448332581	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATCCGCACTAAACC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2480.23652647175	40.0327868726128	0.0161407133736399	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2477.0509138798	2477.0509138798
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGGTTGTTCGGTGCAC"	1.30984546717946	10.727943397406	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGGTTGTTCGGTGCAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1981.70820715252	39.3047533324858	0.0198337743117903	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1975.93065784257	1975.93065784257
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCCAAAAGCCGATCC"	7.73781599578206	-9.36160757457884	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"DC precursor"	"DC precursor"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.555555555555556	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCAAAAGCCGATCC"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2927.90161960931	39.7042741199262	0.0135606585460424	3416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2921.96455313277	2921.96455313277
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTAACCAGTGAGTTA"	-2.69455395165141	13.1106567152771	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTAACCAGTGAGTTA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2355.03193269262	36.1556630634847	0.0153525149963237	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2347.79930954186	2347.79930954186
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGATCAGTACAAGTA"	1.20779575881307	10.5621881254944	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGATCAGTACAAGTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2046.92031506289	38.612815952646	0.0188638588754539	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2038.82520926542	2038.82520926542
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATGCCCACTGAGGA"	1.38678445395772	11.2588529356751	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGCCCACTGAGGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2187.38187495688	39.3272052116017	0.0179791218268081	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2180.71551219219	2180.71551219219
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATGCCTCAGGAAGC"	-1.05713150921519	11.7370805510315	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGCCTCAGGAAGC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2794.66009063987	45.9463880029538	0.0164407786681613	2834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2788.55093671861	2788.55093671861
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACCCTCATCGCTGACG"	3.73343219336812	-10.6370516053406	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACCCTCATCGCTGACG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2640.74077444922	41.9628151474935	0.0158905469077122	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2635.72574925836	2635.72574925836
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTACCAGTCCCACGA"	-1.35784516754802	11.7568835982117	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTACCAGTCCCACGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2366.80155568721	39.378554943221	0.0166378777505017	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2364.36775366104	2364.36775366104
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATGTTAGGACAGCT"	-2.51958570900615	13.2662038573059	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGTTAGGACAGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2364.89442112035	40.0483858954944	0.0169345343867494	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2359.17423005943	2359.17423005943
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATGTTGTCTACATG"	-2.02132139626201	12.9397735365662	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATGTTGTCTACATG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2609.31377533281	37.7497693035581	0.0144673169093063	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2601.1261770005	2601.1261770005
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGCATGGACAG"	1.23620595511739	10.9885892638001	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGCATGGACAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2279.6562764667	40.8018798608347	0.0178982596113457	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2273.00398157448	2273.00398157448
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGGTAGTCACT"	-7.56479821625407	3.09561297977296	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGGTAGTCACT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2399.85098749113	47.0419705887299	0.0196020381406718	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2390.81607507281	2390.81607507281
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATTGTAGCATGGGT"	-3.49078760567363	13.0576123961243	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	26	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00388726919339164	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTGTAGCATGGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2523.63506864264	41.9740020211472	0.0166323580388837	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2516.8511750238	2516.8511750238
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTATCTACAGTCAACT"	6.8167835670406	-1.20969345485839	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTATCTACAGTCAACT"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3561.29115574114	41.3901682457065	0.011622236552881	4089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	3545.71320542309	3545.71320542309
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGAAGTCCAAATGC"	6.69811501082723	-10.0216427079407	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGAAGTCCAAATGC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2712.34596243907	43.6153611228863	0.016080308974916	2670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2706.71009968452	2706.71009968452
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGATTCAGCAGACA"	6.63543905791585	-10.0212249985901	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGATTCAGCAGACA"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2383.93105205255	37.9914206170572	0.0159364594812198	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2380.49769505934	2380.49769505934
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATTTGAGCGACTGA"	-7.9966290992802	5.05710170352785	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTTGAGCGACTGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1935.21722551828	32.8214483634268	0.0169600848579863	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	1920.06909552942	1920.06909552942
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGATTCAGTGCCTG"	-1.43001614037212	11.4674949415955	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGATTCAGTGCCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.48423107923	42.6364078061453	0.0183344213804272	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2322.98598098572	2322.98598098572
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCATTTGCACTTCAGA"	-2.10573587837871	10.9369268187317	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCATTTGCACTTCAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2725.06839769743	44.9574678469331	0.0164977392438738	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2715.67931696969	2715.67931696969
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTCAAGATCTGAACGT"	-7.53921971741374	1.14538357341615	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTCAAGATCTGAACGT"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2773.93290359003	34.6118206542553	0.0124775262622469	3437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2770.03578457831	2770.03578457831
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTCACAAGCAGGGAG"	0.593336005776566	11.4482879408631	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTCACAAGCAGGGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2162.71878251237	36.6202489723142	0.0169325060976136	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2152.47816493349	2152.47816493349
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCACCAGTCGATTAC"	-1.15949318829234	11.4965238341126	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACCAGTCGATTAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2409.32158556336	45.7101098370571	0.0189721912221896	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2407.23412533522	2407.23412533522
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCACCAGTTGAAGTA"	6.70177473601643	-10.0486259690491	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACCAGTTGAAGTA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2559.07887857547	39.2049043998124	0.015319928091328	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2555.39157122682	2555.39157122682
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCACGTAGGCTGAAC"	-2.28417096558269	13.3963508375916	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACGTAGGCTGAAC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2825.96836360688	31.6061687894525	0.0111841905933839	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2818.41954257805	2818.41954257805
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACGATCATCCCAACTC"	1.28208198127095	11.642418838385	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACGATCATCCCAACTC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2436.45291129817	37.9702075679896	0.0155842156406621	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2429.29894160438	2429.29894160438
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCACGTGTTCTCAGA"	-1.21326563778575	11.5828046568665	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACGTGTTCTCAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2539.77102074968	44.7897032236583	0.0176353312396002	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2530.98869908422	2530.98869908422
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCACGTTCTCAGTCC"	-2.25145039978679	13.3510694273743	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCACGTTCTCAGTCC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2723.06270617631	37.2794434270938	0.0136902625644788	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2717.91195360066	2717.91195360066
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGAGTGTACAA"	-2.67793856087382	13.4896812208923	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGAGTGTACAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2893.46551742588	41.0372517351525	0.0141827339873262	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2884.60356599269	2884.60356599269
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGCACTTGGGC"	-2.7013729614323	13.0426177748474	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGCACTTGGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2557.15173300705	37.6446939850945	0.0147213376113691	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2547.12723502669	2547.12723502669
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCATCGAGCAAACAT"	-2.54216156426128	13.550414062384	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCATCGAGCAAACAT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2660.03976750148	38.1453162407853	0.0143401300637751	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2654.31422434125	2654.31422434125
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCATGCAGATAGCTA"	1.22694768485371	11.2025213011536	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCATGCAGATAGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2558.55238533815	36.969500221672	0.0144493817807002	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2551.81271394317	2551.81271394317
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGGCTGGTTGGAGGT"	-2.50158153000529	13.292679763678	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGGCTGGTTGGAGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2373.24449439263	39.3584553302845	0.0165842396024845	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2367.20533372895	2367.20533372895
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCACAAGCGTTAGG"	6.71803202208821	-10.2891845933166	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCACAAGCGTTAGG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2834.11266281892	40.6489377545309	0.0143427388359713	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2831.29143507392	2831.29143507392
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTGACTAGGGAGGGT"	-2.75676570358928	13.3612117537293	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGACTAGGGAGGGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2696.17695554747	42.8272868390597	0.0158844495540032	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2688.21830070972	2688.21830070972
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCACAGTGTCTTGA"	-2.78070459786113	13.2151584395203	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCACAGTGTCTTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2684.70734645203	41.2498860417485	0.0153647607424557	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2677.63160129334	2677.63160129334
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTACAGTTGAGTCT"	6.91143860396687	-9.80260851299437	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTACAGTTGAGTCT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2596.604971921	38.8881366496414	0.0149765316904833	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2594.43341241935	2594.43341241935
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCAGTCAGGTGTTT"	-1.38055167618449	11.7233524092468	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCAGTCAGGTGTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2486.842967131	40.2678585062005	0.0161923607716399	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2481.96317315915	2481.96317315915
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCAGTGTCTTCCGT"	-2.09887586060222	10.5255412825379	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCAGTGTCTTCCGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2658.37000050773	38.1348254796621	0.014345191027727	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2652.80092973078	2652.80092973078
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:AGTGCCGAGGTGCTTT"	-2.62869940224345	13.5381517180237	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.AGTGCCGAGGTGCTTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2643.63614752225	40.721174756806	0.0154034717655725	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2638.73989694481	2638.73989694481
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTAGTGTCTACACA"	-2.78368912163432	12.9415235289368	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTAGTGTCTACACA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2287.80882253652	40.6075290751036	0.0177495290144399	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2279.87730415936	2279.87730415936
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCAGTTCTAGTCAG"	-7.91585622254069	2.60732815349428	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCAGTTCTAGTCAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2756.56917851878	40.582289105133	0.0147220281723311	3958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2748.83553510984	2748.83553510984
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTGATAGACAAGCC"	0.10266669568364	11.0017623671326	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTGATAGACAAGCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2281.89512881141	38.6308797077548	0.0169292967148218	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2271.85435494252	2271.85435494252
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCATGAGTTTGCTG"	1.24677743491475	11.5488872298035	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGAGTTTGCTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2559.34446164567	38.2676421585843	0.0149521265042916	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2553.39102840365	2553.39102840365
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTGATAGCTAGATA"	-1.18138633194621	11.5311355360779	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTGATAGCTAGATA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2411.29868306708	43.0315366918323	0.017845792806181	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2406.52131758424	2406.52131758424
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGGTTAGAGAGATGCC"	1.38770999488179	10.6951875456604	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGGTTAGAGAGATGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1958.70787052248	39.5217645752341	0.020177467589739	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1955.77134649359	1955.77134649359
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCATGCAGCGGTTC"	6.44753517684285	-10.0312643281189	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGCAGCGGTTC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2481.75648162463	25.2691300687115	0.0101819538926598	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2479.94408703209	2479.94408703209
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTAACGAGATCGACG"	1.26000406321828	11.444683051947	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAACGAGATCGACG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1834.64022255893	37.5405050130541	0.020462052750971	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1830.56382102261	1830.56382102261
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCATGTCCACAGCG"	0.156535406678361	11.6219949492249	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGTCCACAGCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2274.84686221323	38.395289341365	0.0168781863865815	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2273.6043022098	2273.6043022098
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCCATGTCTCAAAGC"	-8.25083098831828	3.67226097667543	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCCATGTCTCAAAGC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2272.60487480295	50.0134353591444	0.0220070967521272	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2267.77261011904	2267.77261011904
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTAAGCTCTCCAAGA"	-7.65173802796062	3.16369769656984	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTAAGCTCTCCAAGA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2164.88049943903	45.01892031299	0.0207951063925493	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2160.35234130052	2160.35234130052
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGAAAGTAGATCCT"	1.3081017929012	10.963541961554	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGAAAGTAGATCCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2097.47434248976	42.9235373573941	0.0204643920966598	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2090.88275956909	2090.88275956909
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTACAGAGTCGGCCT"	-0.212238828570205	11.6993913420471	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTACAGAGTCGGCCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2343.77812631951	38.9172407649915	0.0166044901298333	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2337.18825170055	2337.18825170055
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGATCCACCTTCGT"	-7.34966359558757	2.83818838680116	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGATCCACCTTCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3061.97086096557	32.7305680751544	0.0106893793446594	3296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3053.51870908155	3053.51870908155
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTACAGTCCTACGGG"	-2.66039047661479	13.3463477858338	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTACAGTCCTACGGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2557.42426209262	45.0250236231687	0.0176056136991235	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2554.79863976235	2554.79863976235
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGATCGTGTCCCTT"	-2.05069718781169	13.3598174818787	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGATCGTGTCCCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2448.15841563851	44.2612128847671	0.0180793908605065	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2446.7245170365	2446.7245170365
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGGGAGTGCTTCAA"	-7.61066756668742	3.12943241679994	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGGGAGTGCTTCAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2140.46121520742	49.6406117396606	0.0231915492731085	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2136.90462288778	2136.90462288778
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGGGATCGCTGATA"	-6.85453639450725	0.0463730155485644	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGGGATCGCTGATA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2502.45896252138	37.8468465222052	0.01512386300396	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2498.27360222026	2498.27360222026
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGGGATCTTGGATG"	0.0825368455493867	11.4196481474671	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGGGATCTTGGATG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2424.79454966162	40.8751221553602	0.0168571486442281	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.13875524618	2416.13875524618
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCAGAAGTGTACAA"	-7.71187386933024	3.14373991573182	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCAGAAGTGTACAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2292.49654687119	33.5510124355911	0.0146351419727902	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2287.40746240911	2287.40746240911
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCGTGTGTATACCCA"	-1.42323587361034	11.6284684904846	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCGTGTGTATACCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2548.62784790643	39.9408735008749	0.0156715204747073	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2544.0385079243	2544.0385079243
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTAATGTTCGTACA"	-7.30760178986247	3.52785060489503	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTAATGTTCGTACA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2634.95531250481	35.314361011576	0.0134022618311526	2625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2625.17408881553	2625.17408881553
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTAATTCGCACGGT"	0.782013674348038	11.6710071333679	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTAATTCGCACGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2543.1849767068	39.8681649560403	0.0156764707723565	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2530.24818796966	2530.24818796966
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATAGAGATCACTGTTT"	0.460045267909211	11.0659789809021	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGAGATCACTGTTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.92101440699	41.0959692709651	0.0178761988834861	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2294.26929920924	2294.26929920924
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATAGAGATCTCCTGCA"	-1.46011016789134	11.4818200835022	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATAGAGATCTCCTGCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2264.11357146343	40.2353193668012	0.0177708927122391	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2262.79373025643	2262.79373025643
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCACAGTACAGAT"	-0.804711739451248	11.762141204718	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCACAGTACAGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2419.20052161324	40.6709229701791	0.0168117204865092	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2416.72387928335	2416.72387928335
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCACCAGGTGTGA"	3.94574989852254	-10.8453464738098	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCACCAGGTGTGA"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2768.34123897281	44.9174230565925	0.0162253924567692	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2763.62190113505	2763.62190113505
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTCTTAGCTTCTAG"	-0.292874167591888	11.4525718458923	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCTTAGCTTCTAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.6203890322	43.1278546355908	0.0187952023967593	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2291.27545413602	2291.27545413602
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTCTTGTTAATGAG"	-6.8161338371342	0.0248805482867136	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTCTTGTTAATGAG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2435.72161724192	37.6782063106795	0.015469011747469	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2433.06583399351	2433.06583399351
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCCAGTCCTTTGC"	-2.70401440087016	13.0504007109436	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCCAGTCCTTTGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2542.06806814087	45.7179349294521	0.0179845439634068	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2539.27141981246	2539.27141981246
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTTCTAGCTACAAA"	-7.43489823761638	3.00147984111635	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTTCTAGCTACAAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2895.50597330747	38.7859206807012	0.0133952134923061	3096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2886.04519279717	2886.04519279717
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCTGGTGCCCAGT"	-2.12749824944194	12.9499568709168	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCTGGTGCCCAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2486.03551141092	44.951901034958	0.0180817614344721	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2477.0076387205	2477.0076387205
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCCTTCTGTGGTCCCA"	-1.36922679367717	11.5102147825989	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCCTTCTGTGGTCCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2882.60728730783	38.2757829707942	0.0132781815751744	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2875.07512330741	2875.07512330741
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTCCTGTCGCTTACC"	-2.97727141800578	13.0286531218323	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTCCTGTCGCTTACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2445.21474759353	36.9984649502915	0.0151309675302358	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2438.0564889484	2438.0564889484
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACGAGTCTTCTAT"	-0.0788649571245492	11.4437694319519	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACGAGTCTTCTAT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2297.44385761425	42.0070851329884	0.018284270579134	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2290.60652666247	2290.60652666247
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGAACAAGACTCCGC"	3.04867925223653	-10.7078056565491	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGAACAAGACTCCGC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2816.30150770252	37.9297617599893	0.0134679336201228	3141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2812.33004875407	2812.33004875407
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACTTAGGGCAGAG"	-0.144434790045577	11.1736345061096	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACTTAGGGCAGAG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2313.33502145111	39.7911447082856	0.0172007704631236	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2307.98758604009	2307.98758604009
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATCACTTCAGTATGAA"	1.10475458678548	10.4546975859436	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATCACTTCAGTATGAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1913.14993873686	44.5579693131901	0.0232903696730686	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1909.64940164726	1909.64940164726
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGAGATGGGCT"	0.606688340275925	11.3331327208313	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGAGATGGGCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2228.67198966889	41.8875286683031	0.0187948378507356	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2223.06830767812	2223.06830767812
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGAAGTTCGGCAGTC"	-7.43518386307414	2.99665162647096	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGAAGTTCGGCAGTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2767.69116494287	42.6079461679715	0.0153947617811075	3226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2754.78544241647	2754.78544241647
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGAGTCAGCGA"	-0.892745832831222	10.9174489744934	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGAGTCAGCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2194.97912499302	45.9511623518585	0.0209346694137716	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2192.26555565432	2192.26555565432
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGAGTTGAAGT"	-1.22769616070445	11.3397254713806	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGAGTTGAAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2173.7879956904	37.8338104884676	0.0174045539691424	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2169.48428304616	2169.48428304616
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGCAGGGACTA"	-7.3510082763737	2.97501013362733	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGCAGGGACTA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2536.14081327639	43.1023207137956	0.0169952395735127	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2530.84804836981	2530.84804836981
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGACCTTCACAAGGG"	-0.205607692629653	11.3289232023987	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACCTTCACAAGGG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2306.85327773533	42.4892996887302	0.0184187265392286	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2296.15991603702	2296.15991603702
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGACCTTCCCGAGAC"	-0.132059971720535	9.63910958850709	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACCTTCCCGAGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2702.53171111951	37.3543866283309	0.0138219975272213	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2694.69057469414	2694.69057469414
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGATGTCCGGACGT"	1.11174525794331	11.8529777296814	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGATGTCCGGACGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2218.85749162632	42.9486268748859	0.0193561898576039	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2209.98410580331	2209.98410580331
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGACGGGTCCGGACT"	1.18054105815236	11.5412521132263	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACGGGTCCGGACT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.9083139492	37.8552060108852	0.0164522878992565	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2295.10262888397	2295.10262888397
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGCGGGTCCTTAAG"	-7.34715733948405	3.10016033733217	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGCGGGTCCTTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2077.73783569913	47.0393181419212	0.0226396792384989	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2074.93100318377	2074.93100318377
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGACGGTCTGGACTA"	0.22652200338189	11.8933267363342	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGACGGTCTGGACTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2600.75579771127	36.6904251759277	0.0141076010320601	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2594.85094556531	2594.85094556531
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGATTTAGTTACGAA"	-8.18993411484416	2.91230652416078	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGATTTAGTTACGAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2271.93965115085	50.3307506689214	0.0221532075658023	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2266.88963639395	2266.88963639395
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGATTTCAACTGCCG"	8.48674168166463	8.04255435550538	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGATTTCAACTGCCG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2201.91391086921	40.4250905408724	0.0183590695082691	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2191.73147693199	2191.73147693199
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGATTTGTACGCTTA"	-8.36700568619426	4.02198741519777	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HSC"	"HSC"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGATTTGTACGCTTA"	"HSC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2414.87509257304	43.2619937547821	0.0179147956297345	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2404.2483712001	2404.2483712001
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTGTGACATCGTGGC"	-2.40516910973247	13.3774947890076	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTGTGACATCGTGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2321.09601553491	37.0386317256253	0.0159573888704857	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2311.90075404152	2311.90075404152
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGATTTTCGAGTGAG"	1.27369942244832	11.4652375944885	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGATTTTCGAGTGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2404.4568233493	37.5807932226408	0.0156296394502491	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2398.17788634327	2398.17788634327
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTACTAGGGCCTCT"	0.334741820662659	11.5300845869812	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTACTAGGGCCTCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2259.21175042513	44.6109564092141	0.0197462483987255	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2251.7863322072	2251.7863322072
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTACTCAACCAGAG"	1.20141484317128	11.5044698485169	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTACTCAACCAGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2212.14448400541	43.2947743796664	0.0195714044415738	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2203.89941232312	2203.89941232312
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGCACTCATGACGAG"	0.855439324944657	10.2358503111633	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCACTCATGACGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2273.63557492303	36.4458859341153	0.0160297834605043	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.69294959129	2269.69294959129
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGCAGGGTCCTGGTG"	-7.53164945069011	3.17073581302492	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCAGGGTCCTGGTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2329.13704051941	35.4465366324101	0.0152187423993332	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2322.72123351281	2322.72123351281
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGCTCACAGTAACGG"	-6.96139131012614	2.65519282901613	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTCACAGTAACGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2755.55917779537	38.6702947389272	0.0140335562562173	2918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2744.47198040602	2744.47198040602
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CTCCACATCCCTGGTT"	1.28431882438008	10.6424693831238	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CTCCACATCCCTGGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2141.99796544993	33.7750941553971	0.0157680327900324	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2137.22294644141	2137.22294644141
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGCTCAGTGCCGAAA"	-1.24561748924907	10.7417831190857	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTCAGTGCCGAAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.48059744302	41.9244934485942	0.0167464822740846	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2494.16144209093	2494.16144209093
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTCCGCAGGTATGG"	-0.993861774832565	11.7156591185364	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"Activated NK"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTCCGCAGGTATGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2477.73050346175	42.6454668915889	0.0172115033624548	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2470.21507883987	2470.21507883987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGCTTGCAACGTTAC"	1.23129143294637	10.677146888617	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGCTTGCAACGTTAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2288.361594408	38.0485420211322	0.0166269798069109	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2280.6881824886	2280.6881824886
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTCGCTCGGTGCAC"	-0.774313370615798	11.4358052977356	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTCGCTCGGTGCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2713.90888900712	40.4469506793732	0.0149035772141086	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2704.9831571734	2704.9831571734
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TCCCATGAGCTGGAGT"	-1.47528467598613	11.5584783324036	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TCCCATGAGCTGGAGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2410.96773327142	37.1707543160041	0.0154173586825932	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2408.40727180607	2408.40727180607
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:ACTTTCACAGAACATA"	-2.15413794937785	13.030903793219	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.ACTTTCACAGAACATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2566.04087360422	44.8903694920975	0.0174940196603514	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2560.40224170388	2560.40224170388
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGGATAAGCACCGTC"	-2.76247892800029	13.3037900694641	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGATAAGCACCGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2327.08949882843	45.6753139745635	0.0196276567779446	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2325.75242736488	2325.75242736488
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TGTTTGTCAGGTAGTG"	-1.27398167076762	11.6171512373718	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TGTTTGTCAGGTAGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2225.67911386269	45.3882477653183	0.0203929881367968	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2220.19204532797	2220.19204532797
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGGATATCTCCACTG"	-0.0636703399127305	11.3174371489319	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGATATCTCCACTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2515.04236294284	39.9082709185462	0.0158678324892507	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2508.69425129926	2508.69425129926
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGGGACTCTAGCAAC"	-0.451785544783431	10.9657983549866	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGGACTCTAGCAAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2376.44134052785	37.902651868315	0.0159493319788386	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2369.94668115505	2369.94668115505
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGGGCAGTGTCATTG"	6.83780397948567	-0.992850922700487	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGGGCAGTGTCATTG"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2495.5131440532	36.2029278221882	0.0145072078295639	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2490.65142871814	2490.65142871814
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAATCCGTATCGGTT"	1.84324647960011	-10.2519417039123	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	33	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.555555555555556	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAATCCGTATCGGTT"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1886.72004548459	42.1694253417726	0.0223506531574173	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1886.72004548459	1886.72004548459
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACAGGAGGTCCCTG"	-0.916480283171493	11.5077123411926	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACAGGAGGTCCCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2464.2155414352	36.4637375857798	0.0147973003873447	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2459.24698482539	2459.24698482539
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGTAGAGTTACCTGA"	-1.62244186821635	11.187979675177	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTAGAGTTACCTGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2453.42434516655	38.9579136652544	0.0158789953079274	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2444.09694552301	2444.09694552301
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGAACAAGTCGATTCA"	1.12865223464314	10.6069221266541	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGAACAAGTCGATTCA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2300.7635380689	37.5471890835551	0.0163194472018926	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2296.58439856948	2296.58439856948
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACAGGGTCAACATC"	-2.05165944519694	13.0850076445374	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACAGGGTCAACATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2466.23846461992	43.2720396093712	0.0175457646250117	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2460.92394509414	2460.92394509414
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCATGTATGCTAC"	-7.89103970947917	2.76329634273378	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCATGTATGCTAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2499.17618225192	51.2956613399627	0.0205250280889529	2998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2496.70502801758	2496.70502801758
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCGCAGAGAGCAA"	-2.8009663623875	12.9926624068054	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCAGAGAGCAA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2371.16276057184	40.5596306199985	0.017105376018227	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2369.70425921805	2369.70425921805
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCGTGGGTCCACTTCG"	-7.91838584366496	-0.236096077319704	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	27	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0386473429951691	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCGTGGGTCCACTTCG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2851.87393326496	40.5145414088317	0.014206287639948	3050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2846.32578289846	2846.32578289846
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCGCCACGACCTG"	0.414554317563218	11.5797977217468	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCCACGACCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2353.60623087065	51.187506474779	0.0217485430669699	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2345.80081829392	2345.80081829392
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTAACTGTCTTCAAG"	-1.97531948509868	13.5126733549866	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTAACTGTCTTCAAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2877.10184039393	38.8041262093933	0.0134872272036364	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2863.03873286822	2863.03873286822
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCGCCATACCGTA"	7.99937882003133	8.09835240924684	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCCATACCGTA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2184.07220479298	38.893524702491	0.0178078016913262	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2178.84261649614	2178.84261649614
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACCGCGTCTTCAAG"	-2.98268518868144	13.0987844237122	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACCGCGTCTTCAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2276.85264934852	43.4167563697663	0.0190687598436329	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2272.16725185458	2272.16725185458
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTAACTTCACTTATC"	-2.64401278916057	13.1896676787171	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTAACTTCACTTATC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2826.11411864568	41.3618656991595	0.0146355964277128	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2819.09817586067	2819.09817586067
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGCAGGTACTTGTG"	-2.61017666283305	12.9016666182312	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGCAGGTACTTGTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2690.63429860583	38.9340384324766	0.0144702081782911	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2686.81302948487	2686.81302948487
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:CTGGCAGGTCAGGTGA"	1.23448791083638	11.5302486189636	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.CTGGCAGGTCAGGTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2272.54992076884	44.8712022927691	0.0197448697970025	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2269.93561556751	2269.93561556751
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTACATCACGGCGTT"	-0.0685769644683183	11.1108646162781	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACATCACGGCGTT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2507.22046442328	45.6621263747774	0.0182122501880906	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2496.99284219651	2496.99284219651
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTACATGTAATGTGA"	-8.64741740647014	0.16146064484445	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MEP"	"MEP"	37	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0254237288135593	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACATGTAATGTGA"	"MEP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	1898.91517357614	34.8470758665257	0.018351043981022	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	1897.96729755791	1897.96729755791
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTACATGTCGCATCG"	-1.24516365948375	11.6517295607361	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACATGTCGCATCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2576.58263024794	38.840942535499	0.0150745961257068	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2572.44556856715	2572.44556856715
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACGTTGTTAACAGA"	-1.31938801232036	11.8009223707947	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACGTTGTTAACAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2427.98012646768	39.0071335358594	0.0160656724948604	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2422.97726662074	2422.97726662074
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTACTGTCAGCACAAG"	-2.54805288735088	13.4289483794006	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTACTGTCAGCACAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2432.24755275374	42.9998798144731	0.0176790720853186	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2429.35783212788	2429.35783212788
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTACCGGTTTGGAGG"	7.47414030608479	-9.29248812114867	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTACCGGTTTGGAGG"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2637.01829172143	39.5245019247362	0.0149883305886873	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2633.0710130558	2633.0710130558
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTATACTCCAGTACA"	-0.144009719521362	11.6809863814148	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTATACTCCAGTACA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2358.69580162022	44.2459863765827	0.0187586658466894	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2349.9480257108	2349.9480257108
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTATCAAGGCCTGCT"	-7.70234761658366	3.14403460109559	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTATCAAGGCCTGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2811.09054746823	43.9536588203424	0.015635803286354	2863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2800.78816047072	2800.78816047072
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTATCAAGTCATGCT"	-0.367336432368118	11.3667621382507	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTATCAAGTCATGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2433.46248292047	42.513131783762	0.0174702228130268	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2424.38784751327	2424.38784751327
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCACGAGGTTCCAT"	-1.91673479500468	11.9049958952698	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCACGAGGTTCCAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2774.59451558936	38.7113107863151	0.0139520605871638	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2764.11692486131	2764.11692486131
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGCAGTACTGGGA"	0.745402951806229	11.4521264799866	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCAGTACTGGGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2294.36664313233	36.2057628450536	0.0157802864478646	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2286.56033001844	2286.56033001844
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGCAGTCCAAGAG"	1.45238246497456	11.285563445929	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCAGTCCAAGAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2087.28355277839	32.556996638174	0.0155977833461282	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2081.19341223358	2081.19341223358
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGCAGTCTCCCTA"	1.40017773684804	10.0448732146057	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCAGTCTCCCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	1984.30276902285	40.0570570573665	0.0201869682805977	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1982.42915747865	1982.42915747865
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGCATCTGGTTGA"	-2.16986451569255	12.4215192564758	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGCATCTGGTTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2656.11769408485	49.4289943678133	0.0186094895109095	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2650.87216501352	2650.87216501352
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGGGTAGTCATGCT"	-8.13600860062297	2.88360521877138	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGGGTAGTCATGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2643.12409599795	48.0857462381791	0.0181927690459133	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2636.01585921635	2636.01585921635
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTAGTCTCAAATTAGG"	-3.19684467735942	13.3980655440125	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTAGTCTCAAATTAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2620.2253984557	41.2790882825318	0.0157540218894377	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2614.93199713244	2614.93199713244
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCCGAAGTGTTCAC"	7.00362839278523	-10.0008087388244	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGAAGTGTTCAC"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2303.51179502728	36.8031133706405	0.0159769589415993	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2300.9701972047	2300.9701972047
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCCGACATACACCA"	-0.133736873895484	10.4894733198914	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGACATACACCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2459.78717152177	38.6430257124926	0.0157099061902115	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2450.72001469614	2450.72001469614
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCCGAGTAGACTGG"	6.8423453765804	-9.99734213268431	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGAGTAGACTGG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2831.50947635936	44.1050153353209	0.0155765028171579	3286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2825.03494170847	2825.03494170847
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCCGAGTAGTTCCA"	6.20015062865559	-10.3387680283752	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD14+ monocyte"	"CD14+"	13	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00346706290242694	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGAGTAGTTCCA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2366.20312140987	46.1742055930609	0.019514049818998	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2361.73142170873	2361.73142170873
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCCGAGTTTGCCGG"	0.194977586239022	11.6956472166809	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCCGAGTTTGCCGG"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2481.95717456343	44.644845694681	0.017987758270863	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2469.00473941152	2469.00473941152
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAATCAGACATGCG"	-7.99239097061809	3.27182624423829	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCAGACATGCG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2457.74821640901	37.9730397087755	0.015450337611986	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2451.25619538157	2451.25619538157
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGAGAATTGTG"	-0.840343336493331	11.566735244635	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGAGAATTGTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2556.7369705865	38.1799906817227	0.0149330928918216	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2550.30464883588	2550.30464883588
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGAGATAGTCA"	-6.9464615387028	0.101274586561598	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGAGATAGTCA"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2466.40490496802	40.2996603808501	0.0163394340887319	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2463.7687706919	2463.7687706919
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAATCCACATACGT"	-1.86868427220042	10.4806957014832	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCCACATACGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2501.47061353068	37.3654680131935	0.0149374003480514	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2495.89353042811	2495.89353042811
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGCAGCAGACA"	1.3349344926769	11.5463971861633	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGCAGCAGACA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2399.14668956176	39.2467913260059	0.01635864597057	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2390.86840961199	2390.86840961199
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGCAGTAACCT"	1.4062280851299	11.4572229155335	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGCAGTAACCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2486.81992395625	39.2008213628407	0.0157634338478665	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2479.76486211945	2479.76486211945
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGGTACCGGCT"	-2.03764543953593	12.6942767866882	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGGTACCGGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2315.99731430049	39.6044142242391	0.0171003713949474	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2313.19353412748	2313.19353412748
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAATCTCGTCCTTG"	0.776017387478989	10.5327310332092	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAATCTCGTCCTTG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2242.4926206974	42.9717300585755	0.0191624844880031	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2235.57605941778	2235.57605941778
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTCTGGTCACTGAAC"	0.0161349112981975	11.8742961653504	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTCTGGTCACTGAAC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2680.69521461887	42.0515756179563	0.0156868171318518	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2674.45074012711	2674.45074012711
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTGCCAAGTAACAGT"	-2.5672803920811	12.7991666563782	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGCCAAGTAACAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2639.49214420236	48.7182184497789	0.0184574212720384	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2633.08074295179	2633.08074295179
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCACGCTCACCTCAC"	3.76774038848225	-10.3113804093567	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCACGCTCACCTCAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2692.13337448822	38.9452697211433	0.0144663225418937	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2689.97428407453	2689.97428407453
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTGCCATCTCCGAGG"	3.63182630118672	-10.5178747407165	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGCCATCTCCGAGG"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2887.25146482165	34.1342022124278	0.0118223863173402	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2883.18376281182	2883.18376281182
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGATCCATCCGTATAG"	-1.03301570835765	11.9148549803528	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGATCCATCCGTATAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2560.47333434826	41.5195916243623	0.0162155922763909	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2547.40363343636	2547.40363343636
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAGGACACACAGAG"	0.723108430474442	10.8761024245056	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGACACACAGAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2177.19595930088	46.5428188696947	0.0213774137651074	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2172.27170659992	2172.27170659992
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTGTCGGTAACAGGC"	-0.1127045256203	10.9650010832581	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGTCGGTAACAGGC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2325.77760783444	39.5030753216357	0.0169848893499398	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.60553866737	2315.60553866737
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTGTCGTCGAGATAA"	1.31632890281026	10.8764219054016	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTGTCGTCGAGATAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2463.07104275023	38.8573522002595	0.0157759770326689	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2457.44400626455	2457.44400626455
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCAGGAGTGTTCGAT"	-0.942938069731551	11.7261905440125	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCAGGAGTGTTCGAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2330.65578746815	39.6036555102307	0.0169924944400534	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2326.92369421157	2326.92369421157
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTTAGTAGAGGTATT"	-2.00877747955974	11.3684148558411	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTAGTAGAGGTATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2380.9447923992	41.8628070818135	0.0175824350129638	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2375.77616319535	2375.77616319535
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCATTGAGACGGATC"	0.929072816937607	10.5589647063049	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCATTGAGACGGATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1969.23763907319	39.4599527603437	0.0200381873560548	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1968.31050686202	1968.31050686202
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTTAGTGTTCAGCTA"	1.3445483642513	11.4237174757752	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTAGTGTTCAGCTA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2337.88483478887	29.0083582798787	0.0124079500616199	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2330.68578304623	2330.68578304623
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTTAGTTCAAGTAAG"	1.42732276496236	11.3344182738098	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTAGTTCAAGTAAG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2288.32885229274	35.5743218896015	0.0155459831981573	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2276.90800172575	2276.90800172575
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCAATCACTGGATT"	-0.0827647996252358	11.5578193434509	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCAATCACTGGATT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2503.40516652496	42.3430902088895	0.0169141978194713	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2495.63500453406	2495.63500453406
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTTGCGTCGGACGTC"	-2.29816613617595	13.3741073378357	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTGCGTCGGACGTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2513.03978133923	39.753943090536	0.0158190663696341	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2503.63393265333	2503.63393265333
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TCTTTGACAAACTCGT"	-7.46970305863078	3.34297535503236	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TCTTTGACAAACTCGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2368.38928520599	40.0516116745025	0.0169109073093189	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2359.49519615566	2359.49519615566
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGCCAATTCATCGCCT"	-2.71046529236491	13.0198383101257	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGCCAATTCATCGCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2591.39134868177	39.7714082186117	0.0153475113818078	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2590.06201004538	2590.06201004538
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCCACGTCGTTGTTT"	3.83951224860494	-10.885148071405	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD16+ monocyte"	"CD16+"	61	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0210084033613445	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCCACGTCGTTGTTT"	"CD16+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2439.73231584315	46.4750422582655	0.0190492382940807	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2437.0573323127	2437.0573323127
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAACGTAGTATGGCG"	-0.391402552754241	11.8347692259583	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ NK-like"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAACGTAGTATGGCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2217.3464520843	44.3931058286645	0.0200208252467426	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2207.85780898767	2207.85780898767
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAACGTGTGACTAAA"	1.44626476344411	11.0390281447205	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAACGTGTGACTAAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2180.14621143383	39.4504677854005	0.0180953312115039	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2174.24824088157	2174.24824088157
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:ATGTCTTGTTTAGACC"	6.97064222869222	-9.78706552898558	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"DC precursor"	"DC precursor"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.ATGTCTTGTTTAGACC"	"DC precursor"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	2242.53453623923	44.003334420695	0.0196221434763227	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2236.91401150922	2236.91401150922
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAACGTTCTAAGGAA"	-4.57186065140422	11.4097604521546	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	78	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0425531914893617	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAACGTTCTAAGGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	3311.45938413128	41.6572750885477	0.0125797330591376	2637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	3299.51770233058	3299.51770233058
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAACGTTCTCCAATT"	-2.47834716263469	12.9066123732361	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAACGTTCTCCAATT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2791.97892716936	42.1479532510086	0.0150960857336198	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2783.12906453315	2783.12906453315
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAATCGCAAACGTGG"	8.65172066268269	7.65631625736085	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"Plasma cell"	"Plasma cell"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAATCGCAAACGTGG"	"Plasma cell"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"Plasma"	2210.20865248235	36.7279362915506	0.0166174068001681	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2204.16531840948	2204.16531840948
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTCATCAAAGGCTG"	-1.67673430863078	13.0078544386658	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCATCAAAGGCTG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2852.58287074426	41.9515188491559	0.0147065031061518	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2843.80183081789	2843.80183081789
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGAACTGTATCTTCT"	0.346048970788163	11.532202697638	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTGTATCTTCT"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2329.47955275571	43.2233948936382	0.0185549578413368	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2326.56405892132	2326.56405892132
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGACTTCAGACATC"	1.48152997073476	11.0639896162781	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ Naive"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTTCAGACATC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2164.79872405651	33.2964998263151	0.0153808755780872	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2161.05478669081	2161.05478669081
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGACTTCCCATAAG"	-2.37615404549297	13.3084125288757	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGACTTCCCATAAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2474.74270908463	41.8558173053384	0.0169131995628023	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2473.40952187693	2473.40952187693
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGTCTAGTCTCTCAC"	-0.512242357165176	11.2094545134339	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGTCTAGTCTCTCAC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2661.81733259122	39.7130842852482	0.0149195377905923	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2648.17022522948	2648.17022522948
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGAACTTCATGAGAA"	0.253721018403214	11.7857560881409	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTTCATGAGAA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2372.35708224522	35.661733179789	0.0150321945404772	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2361.07436077092	2361.07436077092
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGGAGTCGAGAAAT"	-1.02041147175487	11.2769813307556	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGAGTCGAGAAAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2298.80264909739	45.0821906421519	0.0196111617758284	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2297.46044089528	2297.46044089528
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGAGAGCATCATTTC"	-7.63361058655437	3.03192088687745	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGAGCATCATTTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2442.9118323381	38.656507120065	0.0158239469015412	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2435.23512610279	2435.23512610279
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTAATCTCTCCGTGT"	-8.11144290390666	2.88045642459718	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTAATCTCTCCGTGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2692.77351617228	47.3544114592429	0.017585738709491	3100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2683.8696324807	2683.8696324807
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACCGTTCACTGCGAC"	1.28622283515279	11.2291440733704	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACCGTTCACTGCGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2610.96718128146	45.4326832306545	0.0174007101875391	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2604.99818247592	2604.99818247592
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGAGGAGTCACGTGC"	0.317474325268906	10.7120713957581	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAGGAGTCACGTGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2062.32474976273	42.1278350987478	0.0204273527258956	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2059.50719225672	2059.50719225672
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTGGTTTCCTGTAAG"	-7.68142114105876	1.28104219520418	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTGGTTTCCTGTAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3109.85871725698	40.9923351126453	0.0131814139610825	3730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3103.09089148686	3103.09089148686
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGATCAGTCTGTGCG"	-0.393004636198837	11.8197297819885	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATCAGTCTGTGCG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2417.61998815441	38.9687835480292	0.0161186554292917	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2404.40602435591	2404.40602435591
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGATGTCAAACTAGA"	-1.64537511292155	12.0570583113464	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTCAAACTAGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2522.35780067631	43.4433399260708	0.0172233058745363	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2518.72482642903	2518.72482642903
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGATGTCAAATCGGG"	1.2302334505016	11.4351424940857	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGATGTCAAATCGGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2312.57700102155	39.7521729038718	0.0171895564499309	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2308.7049247466	2308.7049247466
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGTCACGAGGTGCTGA"	-2.20456085625346	13.4875898131165	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGTCACGAGGTGCTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2373.46381162998	45.3406244974767	0.0191031454852218	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2366.93455526272	2366.93455526272
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGCTGCAGCACTCGC"	1.40308835086171	11.3682012327942	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"Treg"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCTGCAGCACTCGC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2131.22185147236	35.4088190938954	0.016614328099833	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2126.65208633547	2126.65208633547
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATGCACAAAGGAGA"	8.13385738906209	7.76222465122072	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated AP-1"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGCACAAAGGAGA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2255.01126828709	40.3242671847775	0.0178820690396851	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2251.92772943619	2251.92772943619
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGCTGCGTTTACTGG"	1.29151417788808	11.116467452887	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCTGCGTTTACTGG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2016.44391472117	34.5288862520009	0.0171236531796995	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2010.49303046696	2010.49303046696
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATGGTCACGCGTGT"	-8.87807498398479	3.71163222873536	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	1	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.583333333333333	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTCACGCGTGT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2734.72474964769	48.0234951250442	0.0175606320640609	3554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2728.49392842302	2728.49392842302
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGATGCATGCCGGT"	1.19091918048207	11.0743160017761	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGATGCATGCCGGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2311.52803635128	40.2602620358847	0.017417163626289	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2305.68843712047	2305.68843712047
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGATGTCGTCAGAT"	1.46824397620503	10.8689164885315	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGATGTCGTCAGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2122.68681803536	34.6040335841392	0.0163019967383444	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2116.65842507298	2116.65842507298
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACGCTGGTTGCTTGA"	1.461557884782	11.5294465788635	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACGCTGGTTGCTTGA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2133.76345926207	37.7146229419733	0.0176751658100923	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2131.88062722126	2131.88062722126
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATGGTTCAAGCCAT"	1.00005145844762	10.9434957274231	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATGGTTCAAGCCAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2564.6620257191	33.2481315978581	0.0129639427201078	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2559.65704580093	2559.65704580093
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATTCTAGGAGATAG"	-2.60820923271831	13.2664146193298	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTCTAGGAGATAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2650.57744736987	39.806405129477	0.0150180124595025	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2649.18574882672	2649.18574882672
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATTCTCACTTGTCC"	6.73573603209798	-1.16126623069914	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTCTCACTTGTCC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3066.23422800918	39.3393689841471	0.0128298642761186	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	3054.63835327176	3054.63835327176
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATTCTCAGGTCAAG"	-7.61315761032756	3.32142732227174	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTCTCAGGTCAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2664.15764093414	46.9623201381206	0.0176274554540452	2642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2654.50908199183	2654.50908199183
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGGTTTAGTCACTGT"	7.19851889190022	-9.7957802048889	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGGTTTAGTCACTGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2568.2977671069	39.4346004772071	0.0153543724494333	2364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2557.81643629209	2557.81643629209
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATTTCGTTCAGCTA"	1.07828177985494	11.4192390211853	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATTTCGTTCAGCTA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2588.6499618784	34.6638586502641	0.0133907091189382	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2582.30109377912	2582.30109377912
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATCACAGAGTTGAT"	1.13550390776936	9.95722482288209	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATCACAGAGTTGAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2159.8683442211	42.5591515432724	0.0197045119241378	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2155.61901308481	2155.61901308481
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATCACCATCTCAAG"	-7.92916808548625	2.23229429805604	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATCACCATCTCAAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	3078.60968723005	40.8397201845135	0.0132656375226503	4148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	3067.76885231989	3067.76885231989
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTTGACAAGACAAT"	-7.54137883606608	3.03468892658082	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTGACAAGACAAT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2494.61189075205	44.1573308127928	0.0177010824715827	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2485.96027505688	2485.96027505688
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAATCGTTCTTTCCAA"	0.323320170014542	11.4477376707825	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MAIT"	"MAIT"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAATCGTTCTTTCCAA"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2660.01538317834	38.1086935791488	0.0143264936812562	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2654.86448292001	2654.86448292001
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGAGTCCGTTGGG"	-7.38763604584392	2.85218069637147	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGAGTCCGTTGGG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2827.21786958541	41.50303221586	0.0146798139125889	3143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2817.40938353313	2817.40938353313
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGAGTCGTGCGAC"	-7.7809341949528	3.12435791576234	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_MEP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGAGTCGTGCGAC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2349.44357724944	47.6073430604804	0.0202632416975153	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2338.78056411839	2338.78056411839
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTCTTGATCGACGCTG"	-1.89828894558604	11.7581023939881	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTCTTGATCGACGCTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2544.00825576061	43.9117000697657	0.0172608323775416	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2533.24809746367	2533.24809746367
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGAGGTAGCAAGGAA"	8.22832836684529	7.97160098636476	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGAGGTAGCAAGGAA"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2210.11931204454	43.4627438311856	0.0196653382441054	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2205.96777854106	2205.96777854106
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGGACATGTCTAG"	-7.66265473786052	3.17823717677919	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGGACATGTCTAG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2720.06428336055	42.384362161384	0.0155821178273844	2784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2704.68636551369	2704.68636551369
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGACCCCAAGGTACG"	-0.204805145890075	11.6800279387268	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGACCCCAAGGTACG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2425.95655724482	42.9465117041232	0.0177029187006127	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2410.29524141597	2410.29524141597
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGGATCTTGCGCT"	-1.92817399922069	12.980309463385	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGGATCTTGCGCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2426.10979380356	37.5113746301385	0.0154615321721816	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2421.49731151652	2421.49731151652
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GACAGCCGTCATGACT"	-3.45321188393291	13.2259988554749	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GACAGCCGTCATGACT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2571.09299791611	42.7419854829837	0.0166240526957315	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2567.4321152761	2567.4321152761
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGTTAGTCGAATA"	-2.6900466484135	13.1359081038269	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGTTAGTCGAATA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2744.64960955582	41.8151391550959	0.0152351465955842	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2737.27860931052	2737.27860931052
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGTTGTCTTACTT"	8.09243168410603	8.30921361530153	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Activated NFkB"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGTTGTCTTACTT"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2306.47382424179	40.8815903338828	0.0177247146289734	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2305.51787978269	2305.51787978269
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGAGTGCAAAGCGTG"	0.798814852803391	11.0795707472595	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGAGTGCAAAGCGTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2016.8069865151	41.7236709180955	0.0206879841239499	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2011.7179468214	2011.7179468214
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGGTTTCGTTCGCT"	-0.42540199580844	11.911877609137	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGGTTTCGTTCGCT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2278.35587017594	44.2171059195402	0.0194074624154855	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2274.93153850569	2274.93153850569
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGATGGAGTAGGGTC"	0.375653137534302	11.1611394652161	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGATGGAGTAGGGTC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2196.02415334237	44.5051132273578	0.0202662220994339	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2193.11209893146	2193.11209893146
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGATGGGTATTCCGA"	-1.59234724465068	11.9134988554749	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGATGGGTATTCCGA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2417.8416908584	38.5085678510205	0.0159268359035322	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2414.17972205485	2414.17972205485
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGATGGGTCCATCTC"	-2.62098250809367	13.5302390822205	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGATGGGTCCATCTC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2224.01590578436	45.8149824912797	0.0206001145819692	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2216.38330852286	2216.38330852286
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGAGTCATCGTCGCTT"	-2.53997073593791	13.4967288740906	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGAGTCATCGTCGCTT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2668.77594701644	36.4092138491945	0.0136426641171951	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2665.26723084254	2665.26723084254
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATCAGAGAGGACTC"	-9.08404860916789	3.8135661848816	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCAGAGAGGACTC"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2708.47102377363	44.2966487697041	0.0163548542261999	3240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2701.62747883676	2701.62747883676
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATCAGCAAGACCTT"	-0.56064740839656	11.2037563093933	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCAGCAAGACCTT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2324.74660409936	41.0467827249434	0.0176564545368357	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2315.90604281032	2315.90604281032
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATCTTAGATGGGCT"	-7.5389121574467	3.24788448894349	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCTTAGATGGGCT"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2470.93628670045	44.2200537459521	0.0178960720209428	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2459.77669558856	2459.77669558856
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGATCTTAGGCACCAA"	1.42314114150349	11.5118779906067	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGATCTTAGGCACCAA"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2243.84778058626	36.3015764814989	0.0161782705563094	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2234.93790285123	2234.93790285123
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGCGTCCAGACATCT"	1.526499291032	11.2920341261658	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCGTCCAGACATCT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2137.65138212337	35.9052530865194	0.0167965896529181	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2135.17894149662	2135.17894149662
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGCGTCTCTACGGGC"	-2.33626137200053	13.5971164473328	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGCGTCTCTACGGGC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2588.99343605984	41.350689391561	0.0159717243062973	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2583.09340050649	2583.09340050649
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGATGGCATGATCTG"	-8.53241000595744	2.98241398418275	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGCATGATCTG"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2544.28390538089	44.3859223720192	0.0174453496632776	3356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2539.95042447641	2539.95042447641
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGATGGGTGAGCAGT"	-0.286219338805038	9.23971746051637	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	18	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00317712470214456	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGGTGAGCAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2498.4979039273	33.8533616054014	0.0135494856938597	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2493.62398274673	2493.62398274673
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGACGTCCGCATAA"	-7.93953071060832	2.52350113475648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGACGTCCGCATAA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2630.31059144758	43.1790325949643	0.0164159444650226	2869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2623.28200205599	2623.28200205599
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGACGTCGACGACC"	-2.18156919899638	13.0291614302429	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"Activated NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGACGTCGACGACC"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2230.50845048857	50.5985380044131	0.0226847551253751	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2230.50845048857	2230.50845048857
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTAGTCGTCGATTCA"	-8.31677470627483	2.57702992046205	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MPP"	"MPP_GMP"	47	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.882165605095541	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTAGTCGTCGATTCA"	"MPP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2530.81085885432	42.0969968787164	0.0166337981091852	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2524.98323495447	2524.98323495447
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTCACGTATGCGTT"	1.4460469680721	11.4617557295593	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCACGTATGCGTT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1969.794378756	40.8065322784145	0.0207161380489802	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1965.51463823856	1965.51463823856
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTATGCGTACCTAGT"	6.59544672545735	-9.98621466076048	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTATGCGTACCTAGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2661.47640650102	41.2938997510568	0.01551541078861	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2652.94888855781	2652.94888855781
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGATATCTCTGACC"	-1.3365846675938	11.8078059920105	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGATATCTCTGACC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2591.48604368451	44.8635847690801	0.0173119144818137	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2585.18698997453	2585.18698997453
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGGCAAGCACTCCG"	6.29741873320882	-10.0592880479065	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGCAAGCACTCCG"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2849.25418831399	38.721455128158	0.0135900318360402	2579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2845.75159058037	2845.75159058037
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTCTGTCTGAGGCC"	1.37297167357747	11.2205295332703	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTCTGTCTGAGGCC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1804.89919079151	41.9224027921918	0.023227005145815	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1796.92656649724	1796.92656649724
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCACAAGCTTGTGT"	-2.93587217751201	12.8122329481873	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCACAAGCTTGTGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	1906.41242594332	43.5473114353899	0.0228425448988783	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	1903.0784734759	1903.0784734759
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTAGGTTCAGG"	-2.59683523598369	13.2439746626648	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTAGGTTCAGG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2551.51118925034	40.4369611111361	0.0158482397731585	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2546.28271333378	2546.28271333378
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTGAAGTCGCTGCA"	6.5502630668575	-10.1045894852844	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTGAAGTCGCTGCA"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2620.54319102401	46.8419695716842	0.017874908428195	2350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2612.2839569929	2612.2839569929
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:AGGTCATAGTTTCGAC"	6.76464190062825	-1.19892301475676	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"pDC"	"pDC"	32	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0608108108108108	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.AGGTCATAGTTTCGAC"	"pDC"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"pDC"	3035.45892195754	39.3661245139437	0.0129687554752205	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	3025.47947518282	3025.47947518282
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTTCAATCGGT"	-1.43228528919871	11.7047576674256	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTTCAATCGGT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2392.49849977102	38.3914697758399	0.016046601399965	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2391.39480667333	2391.39480667333
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTTATCAACGACAG"	1.93471004542653	-8.85021498119506	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD14+ monocyte"	"CD14+"	8	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.003060599877576	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTTATCAACGACAG"	"CD14+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	1871.86719275959	33.6656346941607	0.0179850551494144	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	1869.99892507949	1869.99892507949
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCTCCAAGCACGATG"	1.47012164172475	11.4025134810242	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTCCAAGCACGATG"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2210.93761191466	41.5185444032567	0.0187787046452667	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2206.21636015472	2206.21636015472
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCTCCATCGACTCCT"	-2.27920327606853	12.3948297270569	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56bright NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTCCATCGACTCCT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2565.19082537333	44.6861680301729	0.0174202120123634	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2563.12864952408	2563.12864952408
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCGATCACGGAAGT"	1.19945885714833	10.4102077254089	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCGATCACGGAAGT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	1820.82250964409	33.9758948353989	0.0186596412640131	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	1817.05823315109	1817.05823315109
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:CACAGGCGTCTACAAC"	6.59659876403157	-9.95941641246947	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.CACAGGCGTCTACAAC"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2390.45392817165	42.379365594839	0.017728584975178	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2385.7995767817	2385.7995767817
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTCGATTCATTTCCA"	-0.595508198172408	11.133105255011	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTCGATTCATTTCCA"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2312.87174387357	36.9548926918064	0.0159779256198248	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2306.88151636633	2306.88151636633
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCTTCGCAGCTGTAT"	-0.906896273524123	11.7114877470764	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ Cytotoxic"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTTCGCAGCTGTAT"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2597.17258128716	44.4379178552962	0.0171101135810054	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2586.94460850987	2586.94460850987
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCTTCGTCACGTCCT"	6.71600737151448	-10.0025482407776	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD11c+"	"CD11c+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTTCGTCACGTCCT"	"CD11c+"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2245.9642654584	52.6318000403253	0.0234339436516294	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2242.2968131739	2242.2968131739
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCTTGCTCTGAGGCC"	1.8391361432964	-4.35127308284911	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"cDC2"	"cDC2"	36	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.00281056773468241	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCTTGCTCTGAGGCC"	"cDC2"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"DC"	"cDC"	2785.46177790188	42.7409118131816	0.0153442822846328	2699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	62	TRUE	"DC_AML-4340"	2772.31990969275	2772.31990969275
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGGAACTAGATTAGTG"	-7.58708796921428	0.859309233072676	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"GMP"	"GMP"	42	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.321167883211679	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGGAACTAGATTAGTG"	"GMP"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"HSPC"	"HSPC"	2812.51833841026	31.4972651403626	0.0111989545846538	4067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	352	TRUE	"HSPC_AML-4340"	2804.70091855436	2804.70091855436
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTACGTTCATTCTTG"	0.0660499363089025	11.7226905592713	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACGTTCATTCTTG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2256.47246838428	35.4922198829114	0.0157290728693558	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2253.82091832308	2253.82091832308
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTACGTTCTGCCTCA"	-2.62775693360026	13.2493438490662	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACGTTCTGCCTCA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	3293.80145203732	38.551514046322	0.0117042616586609	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	3280.75852736679	3280.75852736679
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCGGGTCAGTTCTAG"	-2.66747937622722	13.5345363386902	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCGGGTCAGTTCTAG"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2568.32352560374	42.5873910463309	0.0165817859867634	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2564.5836301978	2564.5836301978
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTGTTGTGTTGTGGCC"	0.543172081082505	10.6623277434143	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"MAIT"	"MAIT"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTGTTGTGTTGTGGCC"	"MAIT"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"MAIT"	2263.24812970118	44.4541825270252	0.0196417626258658	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2259.6641634316	2259.6641634316
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACCCAGCCTCAAT"	1.15717866000478	11.1048698195252	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	4	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.200779727095517	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACCCAGCCTCAAT"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2461.16640927506	40.4647753631996	0.0164413000318489	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2455.51193987408	2455.51193987408
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCATCCCACAAATCC"	0.142288376658601	11.4611520537171	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATCCCACAAATCC"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2237.94000364021	42.2163182242284	0.0188639186732262	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2225.9959192328	2225.9959192328
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACTTAGAAACTGT"	6.79216589507405	-9.97467520153197	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"HLA-II+ monocyte"	"HLA-II+"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACTTAGAAACTGT"	"HLA-II+ monocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Mono"	"Mono"	2448.87175070996	38.8130213874477	0.0158493483279373	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Mono_AML-4340"	2444.08954421756	2444.08954421756
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGACTTCACTGCGAC"	1.01549257811849	12.0719823607239	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD4+ T"	"CD4+ TCM"	22	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0039237668161435	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGACTTCACTGCGAC"	"CD4+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD4_T"	2104.69954139204	35.6344283496574	0.0169308861663404	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2100.12804474442	2100.12804474442
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:TTTACCAAGACCGTTT"	0.175863963633221	-10.0867185822693	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"Granulocyte"	"Granulocytes"	10	"CNV-"	"malignant"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.934959349593496	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.TTTACCAAGACCGTTT"	"Granulocyte"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"Gran"	"Gran"	2423.40001564943	44.0027528471744	0.0181574451444338	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	21	TRUE	"Gran_AML-4340"	2419.96404338577	2419.96404338577
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:TGCATGACAACGACAG"	8.14614834365193	8.16249845111696	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"B"	"Atypical memory"	0	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.0329779320605009	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.TGCATGACAACGACAG"	"B"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"B"	"B"	2090.37946894383	45.1510089788367	0.0215994318972379	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	132	TRUE	"B_AML-4340"	2083.26329959213	2083.26329959213
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGAGGTTCCGTATAG"	-0.422551582485992	11.3588399657044	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"CD8+ T"	"CD8+ TRM"	5	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.428040854224698	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGAGGTTCCGTATAG"	"CD8+ T"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"T"	"CD8_T"	2429.59283703093	36.6028443996157	0.0150654232436518	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1366	TRUE	"T_AML-4340"	2423.24096387218	2423.24096387218
"AML-4340"	"2020-09-11-AML4340_AML1371-c2:GGGTAGACAGCCCAGT"	-2.39132271233256	13.263382888678	"2020-09-11-AML4340_AML1371-c2"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613778"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c2.GGGTAGACAGCCCAGT"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2419.78766477179	45.0144224843695	0.0186026332556806	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2413.8813773407	2413.8813773407
"AML-4340"	"2020-09-11-AML4340_AML1371-c1:GAGATGGCAAGATTGA"	-2.21582875672038	13.4166154631409	"2020-09-11-AML4340_AML1371-c1"	"AML4340"	"NK"	"CD56dim NK"	6	"CNV-"	"microenvironment"	"AML"	"adult_AML"	"adult_60up"	"male"	"Inflammation_high"	0.209915280828365	"GSM5613777"	"2020-09-11"	"2020.09.11.AML4340_AML1371.c1.GAGATGGCAAGATTGA"	"NK"	"U-18-4340"	"M"	80	"CITE-seq"	"OSU"	"AML4340"	"AML"	"Intermediate"	"46,XY"	455	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright  with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	"x"	""	"x"	""	""	""	NA	NA	"0,37"	"0"	"0"	"0"	"0"	0	"0,34"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0,24"	"0"	0	0	"0"	0	0	0	"0"	0	"0"	"0"	"0"	"0"	"0"	"AML"	"case"	"NK"	"NK"	2507.59373394948	46.0384622413057	0.0183596176757049	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	613	TRUE	"NK_AML-4340"	2502.56044446565	2502.56044446565
"healthy-1"	"2019-08-01-count-2:TGTAGACGTCACTTAG"	1.62567593631093	-9.50816347515257	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACGTCACTTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.95154986064	42.395011480907	0.0184651159052029	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2294.90741069832	2294.90741069832
"healthy-1"	"2019-08-01-count-3:TAAGTCGGTTCTAACG"	0.181040410965127	13.2073745497498	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGGTTCTAACG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.30921759188	40.1588006038284	0.0221222920121023	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1813.67526265231	1813.67526265231
"healthy-1"	"2019-08-01-count-4:CTACTATAGAGTTGTA"	2.9284037548	-10.7378540269104	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATAGAGTTGTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.31331483118	44.009767498334	0.0183886360492832	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2390.74923791508	2390.74923791508
"healthy-1"	"2019-08-01-count-3:AGAGAATCACAGCCAC"	2.42633952674214	-10.6783294907776	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATCACAGCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.77436372339	35.1068633369891	0.0139992113504441	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2502.02095503084	2502.02095503084
"healthy-1"	"2019-08-01-count-4:CCTCTCCTCGACGACC"	1.45034517821614	9.70742032611696	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCTCGACGACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.10624525023	34.3042337849369	0.0178657998065447	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1915.03333417669	1915.03333417669
"healthy-1"	"2019-08-01-count-3:GACATCACACGTCTCT"	2.13709225234334	-10.6615648499695	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCACACGTCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2015.53373930235	51.0683894823935	0.0253374024391525	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2015.53373930235	2015.53373930235
"healthy-1"	"2019-08-01-count-2:ACATTTCCACGTATAC"	1.86224331435506	-10.4327745667663	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATTTCCACGTATAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.0743865063	39.4219463002029	0.0167533786973621	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2348.47539378436	2348.47539378436
"healthy-1"	"2019-08-01-count-3:ATCCATTAGTTCGCAT"	-9.35881076279338	3.61404464328615	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCATTAGTTCGCAT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2253.08548899789	44.9901770240947	0.0199682512020905	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2249.63362328849	2249.63362328849
"healthy-1"	"2019-08-01-count-3:TGGGCGTCAGTTAAAG"	2.02086677131001	-10.3266620866028	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTCAGTTAAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.05018101718	38.7049416750804	0.0167768096218936	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2303.3621417565	2303.3621417565
"healthy-1"	"2019-08-01-count-4:TTACCATGTTCTAACG"	-1.83160124245341	12.9649400481018	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATGTTCTAACG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1855.44508740292	38.3168158029726	0.0206510104034418	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1849.56540321721	1849.56540321721
"healthy-1"	"2019-08-01-count-2:ATTTACCGTAATCAGA"	0.45795296606366	9.64110181415407	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCGTAATCAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2172.02031016969	38.255751927463	0.0176129807572906	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2166.25516902126	2166.25516902126
"healthy-1"	"2019-08-01-count-2:TTCCTTCTCCATTTGT"	0.620226879685563	9.17350576007692	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCTCCATTTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.73407439416	37.8868037542394	0.0199432142976758	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1889.72341465141	1889.72341465141
"healthy-1"	"2019-08-01-count-4:GGATGTTTCACAAGGG"	1.31114854392354	11.6234454878601	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTTCACAAGGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.79513296418	35.2233947240216	0.0187678421077267	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1868.53709071746	1868.53709071746
"healthy-1"	"2019-08-01-count-2:AGTAGTCAGAAATGGG"	-3.03872857514079	-5.04391100322875	"2019-08-01-count-2"	"Control1"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGTCAGAAATGGG"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2531.0306944598	47.1748333031312	0.0186385860141454	2593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2526.30216616654	2526.30216616654
"healthy-1"	"2019-08-01-count-2:TGCTCCAGTCATAGTC"	1.35700025138203	10.6557845839295	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCAGTCATAGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.79613243095	37.7854265003324	0.0208092890085331	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1814.53567794032	1814.53567794032
"healthy-1"	"2019-08-01-count-2:ACGTAACTCAACGAGG"	1.13329948958699	9.61583039844362	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCAACGAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1661.21539021401	33.6797494694633	0.0202741617179	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1654.49827395274	1654.49827395274
"healthy-1"	"2019-08-01-count-2:TCGGGCAAGAGCCATG"	1.31652524051015	9.30592820728151	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAAGAGCCATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.02084305711	34.7194259981499	0.0208397308730187	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1660.64299326772	1660.64299326772
"healthy-1"	"2019-08-01-count-3:GACATCAAGAAATTCG"	1.95029606398885	-10.5322704545227	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCAAGAAATTCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.08621765666	44.4436155629735	0.0189034392823206	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.10657551656	2350.10657551656
"healthy-1"	"2019-08-01-count-4:AGCGCTGCATGGGTCC"	1.28922142562215	9.05301759326784	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGCATGGGTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.4623420836	29.8100524991406	0.0160229271105564	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1853.022207796	1853.022207796
"healthy-1"	"2019-08-01-count-3:GTCATGAGTGGAAGTC"	-7.84294972840007	1.03660658681718	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATGAGTGGAAGTC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2499.31646437325	45.8284577364726	0.018336396526706	2907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2494.73146733618	2494.73146733618
"healthy-1"	"2019-08-01-count-2:GGGTTTAGTGGCTTAT"	1.48640479621236	10.3374490507874	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTTAGTGGCTTAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1732.57345605713	36.9496292094734	0.0213264430897843	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1728.70602805137	1728.70602805137
"healthy-1"	"2019-08-01-count-2:TCGGGCAAGGTAGGCT"	0.978427250950974	13.1716441878113	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Activated"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAAGGTAGGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1637.04778820132	44.5370149080933	0.0272056901631612	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1632.32378452894	1632.32378452894
"healthy-1"	"2019-08-01-count-1:CAAGAGGGTTCATCGA"	1.41828598555867	10.7028913267883	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAAGAGGGTTCATCGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.5909054201	43.7170926186045	0.0224007462307752	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1938.07503864141	1938.07503864141
"healthy-1"	"2019-08-01-count-2:AGAAATGCAGTAACGG"	1.15637232837026	10.6239232786926	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGCAGTAACGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2073.37420238211	36.4958039494213	0.0176021308201342	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2062.48679184085	2062.48679184085
"healthy-1"	"2019-08-01-count-3:TCAATTCCATGTTTGG"	1.9033451276714	-9.92765810405882	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCCATGTTTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.30694621465	41.2228066982713	0.0169549989409819	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2429.47146780349	2429.47146780349
"healthy-1"	"2019-08-01-count-2:ATCCACCCAGCCCACA"	1.50894608077351	10.1039981612	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCCAGCCCACA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.77851845156	34.8822225731774	0.0190844909386114	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1823.13236785797	1823.13236785797
"healthy-1"	"2019-08-01-count-4:AGCGCTGCACTAAACC"	1.35137452658955	9.72458551013795	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGCACTAAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.91975427414	35.0734780005321	0.0193891840241448	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1806.41308918053	1806.41308918053
"healthy-1"	"2019-08-01-count-2:TTCCTTCTCGAAACAA"	-0.295405755669433	11.8856019743714	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCTCGAAACAA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1745.1528532775	36.9377120961013	0.0211658892954449	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1737.76674766536	1737.76674766536
"healthy-1"	"2019-08-01-count-3:CGGAGAACACTATCCC"	1.30873598632161	9.43180844867555	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAACACTATCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.39369643074	41.2533408993605	0.022674224375016	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1811.55566679376	1811.55566679376
"healthy-1"	"2019-08-01-count-4:CTTTCGGGTCCACGCA"	6.94782795485799	-1.14604809200438	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGGTCCACGCA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2436.18619180777	36.2143664870931	0.0148651883049301	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2427.38854390348	2427.38854390348
"healthy-1"	"2019-08-01-count-3:CCGTAGGAGGATTCCT"	2.27363791045491	-10.7626362076965	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTAGGAGGATTCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.17917602193	41.2470185941821	0.0173439491061298	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2371.27201973017	2371.27201973017
"healthy-1"	"2019-08-01-count-3:CATCCGTTCTGAGAGG"	1.53502239760701	-9.41088201915892	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCGTTCTGAGAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2508.24627494134	45.7610211159054	0.0182442296727723	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2505.5408327342	2505.5408327342
"healthy-1"	"2019-08-01-count-2:AGGCTGCTCTATCGGA"	2.78732385215108	-10.8460321656433	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCTCTATCGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.554026192	41.726355522491	0.0174255226927777	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.5058229194	2388.5058229194
"healthy-1"	"2019-08-01-count-4:CACTGGGAGGAATGTT"	1.95521726188008	-10.2749033204285	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGAGGAATGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.46336861363	38.4297856517346	0.0168369780563343	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2277.3350852238	2277.3350852238
"healthy-1"	"2019-08-01-count-2:ACACAGTTCTCGACCT"	1.84641065177266	-10.2176056138244	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTTCTCGACCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.35826958925	39.0326125505161	0.0163155381226482	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.11776857576	2388.11776857576
"healthy-1"	"2019-08-01-count-2:CACGTTCTCGCTCTCA"	1.39993133124654	10.1150502928528	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCTCGCTCTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2040.4230394624	37.0826778124391	0.0181740144544778	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2029.1392666737	2029.1392666737
"healthy-1"	"2019-08-01-count-3:TTGGATGTCTATTGTC"	2.2907690006191	-10.5385399094787	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGTCTATTGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.94244585378	43.6471207182893	0.0182628333975201	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2385.87664202736	2385.87664202736
"healthy-1"	"2019-08-01-count-2:GTTGTCCGTGGTCTCG"	8.58814968642537	7.54283616626588	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTCCGTGGTCTCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1834.05421003983	43.3310529250306	0.0236258299715631	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1828.62678394286	1828.62678394286
"healthy-1"	"2019-08-01-count-2:CATGGATAGCCTAGGA"	0.971930940716904	11.3417844542297	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATAGCCTAGGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2087.0565486628	39.2754717146846	0.0188185948961703	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2085.65364854127	2085.65364854127
"healthy-1"	"2019-08-01-count-4:CATTCCGCAGCCCACA"	-4.97388205948527	-5.3136139146057	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGCAGCCCACA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2523.65312615086	41.8635655287867	0.0165884784620294	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2519.35243546329	2519.35243546329
"healthy-1"	"2019-08-01-count-4:ATACCGAGTCCTCATC"	7.92996134337727	7.5279068716797	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGAGTCCTCATC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1894.54376241602	44.6409909639897	0.0235629241454213	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1889.45930621752	1889.45930621752
"healthy-1"	"2019-08-01-count-2:AAGACTCAGCAATAGT"	-7.76850209656413	3.91168878162233	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCAGCAATAGT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2254.13001533261	42.8273607438897	0.0189995077713254	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2244.93010221068	2244.93010221068
"healthy-1"	"2019-08-01-count-3:GAACTGTGTTTCGCTC"	1.27945603904073	10.6197852858338	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACTGTGTTTCGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.69067789913	33.7238573338075	0.0179030759824217	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1874.22452570615	1874.22452570615
"healthy-1"	"2019-08-01-count-2:TTCCTTCGTAACCAGG"	2.72768320617024	-10.5442323914734	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCGTAACCAGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.31735202588	43.583585823678	0.0174661494612273	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2492.93058448235	2492.93058448235
"healthy-1"	"2019-08-01-count-3:GCCGTGACACCAGACC"	2.82507910308186	-10.5131511918274	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGTGACACCAGACC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.56297492669	38.7870183458826	0.0166713812451627	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2318.440151493	2318.440151493
"healthy-1"	"2019-08-01-count-3:TCCAGAACAGAGTGAC"	-4.94226870957072	-4.21670868312987	"2019-08-01-count-3"	"Control1"	"DC precursor"	"DC precursor"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCAGAACAGAGTGAC"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2706.56209156077	43.337507326836	0.0160120129746755	3103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2701.11809816228	2701.11809816228
"healthy-1"	"2019-08-01-count-2:TTGATGGAGCGATCGA"	2.55366935309712	-10.6729698411194	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGAGCGATCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.03811171384	39.2792236537519	0.0161242237815884	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2428.9594777352	2428.9594777352
"healthy-1"	"2019-08-01-count-2:GTACAGTCACGAGGTA"	-3.62182150307353	3.50288341129152	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAGTCACGAGGTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2868.91866054613	44.5581049318473	0.0155313238902929	4724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2864.27550596734	2864.27550596734
"healthy-1"	"2019-08-01-count-2:ATTTACCGTTGAAGTA"	1.28067268904988	10.0436649092468	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCGTTGAAGTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1810.74877568083	33.8492522561465	0.0186935110550714	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1801.67871855152	1801.67871855152
"healthy-1"	"2019-08-01-count-2:CCTGTTGGTACTTCCC"	1.5366276699001	9.76060865009157	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGTTGGTACTTCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.10699129775	33.857150135799	0.0177345482941131	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1903.80609698456	1903.80609698456
"healthy-1"	"2019-08-01-count-3:GTGACGCCACTCATAG"	-1.73158846321757	12.6287393339905	"2019-08-01-count-3"	"Control1"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCCACTCATAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2334.92359539408	42.2971193205632	0.018114990744879	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2323.78809341445	2323.78809341445
"healthy-1"	"2019-08-01-count-2:CAACCTCTCTAGTACG"	1.40501119670216	11.2176618346008	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCTCTAGTACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.73489112485	36.9264217492737	0.0194172289321738	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1898.25508535973	1898.25508535973
"healthy-1"	"2019-08-01-count-4:TCCTCGAAGGGCAACT"	1.7389688688213	-10.2978515855041	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCGAAGGGCAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.02908889124	43.4230148790175	0.017723469111409	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2443.72225147696	2443.72225147696
"healthy-1"	"2019-08-01-count-2:ACGATCAAGGTAGTCG"	1.38031842288319	10.2792215117249	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATCAAGGTAGTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1733.98952592503	36.7908433339832	0.0212174541909971	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1733.98952592503	1733.98952592503
"healthy-1"	"2019-08-01-count-3:GGTCACGGTTACGATC"	-4.8162878555363	-5.2834477654663	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCACGGTTACGATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2435.57865401939	39.931779053728	0.0163951917495374	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2430.31438084925	2430.31438084925
"healthy-1"	"2019-08-01-count-3:TACGCTCCACCCTGAG"	1.35030200061147	10.2597818144592	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCCACCCTGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1904.86045983918	36.331306547652	0.0190729490761331	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1901.07857258261	1901.07857258261
"healthy-1"	"2019-08-01-count-3:ATCACAGAGGAAGTGA"	2.68392123755757	-10.7692995301453	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGAGGAAGTGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.6371601454	36.3012537597613	0.0148858773880067	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2436.85449718825	2436.85449718825
"healthy-1"	"2019-08-01-count-3:CATGCCTAGTGGTGAC"	10.8640037971431	4.85600993717042	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTAGTGGTGAC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.66790622776	36.0716026232157	0.0186159880685848	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1934.24384179982	1934.24384179982
"healthy-1"	"2019-08-01-count-2:CTATCTACACGCCAGT"	7.81329741057698	7.00829360568849	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTACACGCCAGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1911.1675986984	38.8782785176344	0.020342683992818	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1906.05822636019	1906.05822636019
"healthy-1"	"2019-08-01-count-3:TGGTACAGTACAGTTC"	1.46692218360249	-8.45375158703002	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTACAGTACAGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.3906617035	40.9652301532685	0.0166161212458568	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2459.88569853479	2459.88569853479
"healthy-1"	"2019-08-01-count-2:GTTGTGAGTCCAGTTA"	2.02080919322316	-9.92971231853636	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTGAGTCCAGTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.65955053789	40.4433282068771	0.0182698952948975	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2211.51285363842	2211.51285363842
"healthy-1"	"2019-08-01-count-3:CCCAACTGTTCGTTCC"	1.38623668727223	9.4731874235901	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTGTTCGTTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1754.80417373625	37.4864224583639	0.021362168508267	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1744.84160962153	1744.84160962153
"healthy-1"	"2019-08-01-count-2:CAGGTATCATCATTGG"	1.44821621951405	9.80914781177369	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATCATCATTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.27601425462	34.7399120683241	0.0192435460251035	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.55921670227	1802.55921670227
"healthy-1"	"2019-08-01-count-3:AAACGCTCACTTGAAC"	3.75140633162801	-10.3909797898498	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTCACTTGAAC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.79876417758	41.6291999008581	0.0162817662790323	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2549.36883699894	2549.36883699894
"healthy-1"	"2019-08-01-count-3:AATTTCCTCAAGGCTT"	11.1060768562252	3.88467071140138	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCTCAAGGCTT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1740.49284692031	37.5523348585502	0.0215756904287177	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1730.4096629436	1730.4096629436
"healthy-1"	"2019-08-01-count-3:CATACAGTCAACCCGG"	8.74313129958455	6.44747350299684	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGTCAACCCGG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.78535490123	35.7805333139585	0.0196080778585026	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1817.64792638756	1817.64792638756
"healthy-1"	"2019-08-01-count-2:GGTAACTAGGTATAGT"	2.34261169013326	-9.76001646434935	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTAGGTATAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.20352271834	40.329861492357	0.0184305806446452	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2186.90146286564	2186.90146286564
"healthy-1"	"2019-08-01-count-4:AGCATCATCCTAGCTC"	0.716012497513932	9.01043984973756	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCATCCTAGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1936.12279620219	42.6055551999462	0.0220056058859073	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1928.92807180954	1928.92807180954
"healthy-1"	"2019-08-01-count-4:CTACGGGAGTTAGTGA"	2.62864293631856	-10.382649444696	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGAGTTAGTGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.9933294634	41.7768871692982	0.0181797251687643	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2294.92828394404	2294.92828394404
"healthy-1"	"2019-08-01-count-3:TCATTACAGGCACTCC"	7.66504158553426	7.02418134296266	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACAGGCACTCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.96658512112	39.5654874988808	0.0206611894987078	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1905.74921051466	1905.74921051466
"healthy-1"	"2019-08-01-count-2:TACAACGTCATGACAC"	1.15128697928731	-8.4974632493225	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAACGTCATGACAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2275.34629987948	47.9367489277208	0.0210678914810726	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2270.66477425353	2270.66477425353
"healthy-1"	"2019-08-01-count-2:AGAGCAGAGTGGTTAA"	2.58321251448933	-10.6401415101257	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCAGAGTGGTTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.60099375038	38.6126461421518	0.0152221994067197	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2529.37005560203	2529.37005560203
"healthy-1"	"2019-08-01-count-4:CTCAGAAGTGTCCTAA"	8.85753025588338	7.83920476520387	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAAGTGTCCTAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.92252848852	40.6548511078062	0.01991008500107	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2036.29112443139	2036.29112443139
"healthy-1"	"2019-08-01-count-4:CTACCCATCTAATTCC"	10.9011808830196	4.17848107898561	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCATCTAATTCC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2028.7981052722	35.5438841530343	0.0175196753489995	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2027.21049132537	2027.21049132537
"healthy-1"	"2019-08-01-count-4:AGGACGACAGAGTTCT"	2.39668073233907	-10.8413934937683	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGACAGAGTTCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.95505674373	37.6822322139555	0.0161038273386301	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2329.16195079392	2329.16195079392
"healthy-1"	"2019-08-01-count-3:CACAGGCTCAAGAAAC"	2.00299467620198	-9.96216299450072	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCTCAAGAAAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2331.48923153484	43.3569532427141	0.0185962485506192	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2328.13228772162	2328.13228772162
"healthy-1"	"2019-08-01-count-4:CTAACCCTCAGCCTTC"	-5.32774339142497	-5.53797581112059	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACCCTCAGCCTTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2960.75129611687	40.0557829260981	0.0135289252355079	3370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2955.41260907352	2955.41260907352
"healthy-1"	"2019-08-01-count-3:AGCGATTCAATGAGCG"	1.07028092917745	10.1154460676941	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTCAATGAGCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1810.4996285143	40.5926213167321	0.0224206736513073	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1804.59781451832	1804.59781451832
"healthy-1"	"2019-08-01-count-1:AATTCCTGTCAAGGCA"	1.91595508632008	-10.5232753983703	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATTCCTGTCAAGGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.95503168934	44.9254968921798	0.0184199775348307	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2433.38690708014	2433.38690708014
"healthy-1"	"2019-08-01-count-2:TGGGCTGGTTGGAGAC"	2.21373309668843	-10.3952493897644	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGGTTGGAGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.35293826905	43.9924238212254	0.0190496753840491	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2305.48238869305	2305.48238869305
"healthy-1"	"2019-08-01-count-2:TATCGCCAGCCTTTGA"	8.56215157088582	7.82371614063112	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCAGCCTTTGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2278.40428907933	43.2051878205589	0.0189629154174466	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2270.36737470606	2270.36737470606
"healthy-1"	"2019-08-01-count-4:ATCCGTCTCCTTGAAG"	-4.98381743851359	-5.39588310634764	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCGTCTCCTTGAAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2796.25441653568	39.4086999219417	0.014093388530349	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2791.83002216683	2791.83002216683
"healthy-1"	"2019-08-01-count-4:GAAGGACTCAATGTCG"	2.77617110785787	-10.8688831559387	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGACTCAATGTCG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.81431608794	44.300746231828	0.0173197663150091	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2548.06346372487	2548.06346372487
"healthy-1"	"2019-08-01-count-2:ATTTACCGTATCCCTC"	0.892978747456711	9.06129930103151	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCGTATCCCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1971.07624867287	49.020813512832	0.024870074684243	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1959.51472037891	1959.51472037891
"healthy-1"	"2019-08-01-count-3:CTGAGCGGTCTTCAAG"	2.7895893054897	-10.3393392792908	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGCGGTCTTCAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.49225990264	42.5866782131764	0.0184959050481139	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2295.78115643122	2295.78115643122
"healthy-1"	"2019-08-01-count-4:CCTTCAGGTCAGTTTG"	2.61752023276631	-10.8447208634582	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTCAGGTCAGTTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.75761857365	39.7078470924296	0.0167560795168283	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.68922491356	2366.68922491356
"healthy-1"	"2019-08-01-count-4:AGTCATGAGTCATCGT"	2.30017675933186	-10.411252998468	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCATGAGTCATCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.9827317885	37.3701798838055	0.0158148340997484	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.52550800521	2359.52550800521
"healthy-1"	"2019-08-01-count-2:TTCTTCCTCTCATTAC"	8.2583815055782	8.25249765003053	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCTCTCATTAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2156.43728778063	47.3989128242877	0.0219801953401899	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2146.46825445591	2146.46825445591
"healthy-1"	"2019-08-01-count-3:GTTGCGGAGATGCTGG"	3.3568021255428	-10.336449646112	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGAGATGCTGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.42331167071	36.5307633011968	0.0154763610071874	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.89455725872	2357.89455725872
"healthy-1"	"2019-08-01-count-3:TCCATGCAGGAACGAA"	1.7916428047115	-10.1416349641052	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCAGGAACGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.97611284082	43.6686326456933	0.0181954447013239	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.17270669952	2393.17270669952
"healthy-1"	"2019-08-01-count-3:AAGGAATGTTCGGTAT"	2.72468580779378	-10.5425348511902	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATGTTCGGTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.05745872299	37.7000283765959	0.0156557843917016	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.57321270714	2405.57321270714
"healthy-1"	"2019-08-01-count-2:CATTGAGCATCCAACA"	-4.85136590424235	3.26382753932802	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGAGCATCCAACA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2750.79391003826	41.9538102981119	0.0152515279843441	3714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2744.72327223467	2744.72327223467
"healthy-1"	"2019-08-01-count-3:TACGCTCAGTCGGGAT"	-3.20417318764384	3.61807272518007	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCAGTCGGGAT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3145.6551815192	42.8308864235011	0.0136158872959546	4862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3137.42493774061	3137.42493774061
"healthy-1"	"2019-08-01-count-2:GACGTTAAGCCAAGTG"	-5.47930512848552	-5.53287889873656	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTAAGCCAAGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2388.01551335408	42.3912905768854	0.0177516814023309	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2381.75910615566	2381.75910615566
"healthy-1"	"2019-08-01-count-4:CACCGTTCAATCTCTT"	2.57281364974324	-10.6345415345398	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCGTTCAATCTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.1582405949	44.9253290195673	0.0185170646612694	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2415.01604066005	2415.01604066005
"healthy-1"	"2019-08-01-count-2:CAAGACTAGGAGGTTC"	2.66816081580464	-10.8749408951965	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGACTAGGAGGTTC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.87455860618	37.0748980472392	0.0153336730870817	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2413.79178066991	2413.79178066991
"healthy-1"	"2019-08-01-count-2:CATCCGTCAATTCTCT"	3.00402321395223	-10.6969757310119	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCAATTCTCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.46839717096	39.2797540653103	0.01556578006261	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2517.12557743254	2517.12557743254
"healthy-1"	"2019-08-01-count-3:AATCGACAGCTAGATA"	-0.871040086180526	13.4262094267639	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACAGCTAGATA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2002.10471881347	40.8075882296104	0.0203823445627733	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1996.89959074219	1996.89959074219
"healthy-1"	"2019-08-01-count-4:ACATGCACAACTTGCA"	1.88313021239583	-10.1942243806091	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATGCACAACTTGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.79340562728	35.8819795693946	0.0152184578529043	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2354.2230462685	2354.2230462685
"healthy-1"	"2019-08-01-count-3:CTGCCTACACCAAATC"	14.2983995872432	2.11950538242189	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTACACCAAATC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1358.85561046526	24.6953468101773	0.0181736356828389	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1337.18705048726	1337.18705048726
"healthy-1"	"2019-08-01-count-2:GGTTGTACAAAGGGTC"	2.35845770415608	-10.6956234208313	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTACAAAGGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.79017375135	40.0881098819474	0.01707482650287	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2341.27694875334	2341.27694875334
"healthy-1"	"2019-08-01-count-3:CCTACGTGTACTCCGG"	2.87535085257832	-10.4179325333801	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTGTACTCCGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2471.64193092956	42.4243181196513	0.017164427253302	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2467.06559924942	2467.06559924942
"healthy-1"	"2019-08-01-count-4:GTAGAGGTCAACACCA"	0.695009489625138	8.5128488310608	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGTCAACACCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.78766718073	41.8735411408718	0.0220760298400243	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1889.16260073348	1889.16260073348
"healthy-1"	"2019-08-01-count-3:TTCATTGCACCTAAAC"	1.30476047572438	9.27059266651002	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATTGCACCTAAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.16770111318	34.4249163219441	0.0201413332931129	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1704.75128331431	1704.75128331431
"healthy-1"	"2019-08-01-count-1:GTGAGGATCATCACTT"	1.99847044524495	-9.93871500408324	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGAGGATCATCACTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2662.09664829756	36.196073919922	0.0135968293799813	2796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2654.18881568144	2654.18881568144
"healthy-1"	"2019-08-01-count-4:GTCCCATCAGAAATCA"	6.86281218108479	-1.10565843498381	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCCATCAGAAATCA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2220.20918962533	41.9118633483312	0.0188774389116929	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2216.43082775519	2216.43082775519
"healthy-1"	"2019-08-01-count-2:GCTGGGTAGCAACAGC"	1.39406992968861	9.91562554920045	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTAGCAACAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.23015639122	36.3557461585395	0.0196705729710234	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1845.6826932583	1845.6826932583
"healthy-1"	"2019-08-01-count-3:TTCCTTCCAGAAGTGC"	-1.0236875814503	13.4263334044251	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCCAGAAGTGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2279.15833678407	43.198885463479	0.0189538764228348	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2274.75642576306	2274.75642576306
"healthy-1"	"2019-08-01-count-2:CCATCACCATTCATCT"	1.42219020900075	10.4474572905335	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACCATTCATCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1862.76880023446	35.2479166695801	0.0189223250170089	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1854.13691275243	1854.13691275243
"healthy-1"	"2019-08-01-count-3:CTCTGGTTCTCTAGGA"	-2.46489701691325	3.97957203471986	"2019-08-01-count-3"	"Control1"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTTCTCTAGGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3242.09598716425	43.4289467000129	0.0133953303270329	5719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3238.36134574885	3238.36134574885
"healthy-1"	"2019-08-01-count-2:TTACGCCTCGATTGAC"	10.8995338874752	4.11138103092042	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCTCGATTGAC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.17569375284	32.1834160524488	0.0166050044669237	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1934.85304855997	1934.85304855997
"healthy-1"	"2019-08-01-count-2:CTCAGAAAGCGTCGAA"	-7.67526994171794	4.43126294696657	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAAGCGTCGAA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1961.99816290152	40.2091284287209	0.0204939684394288	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1955.35204626146	1955.35204626146
"healthy-1"	"2019-08-01-count-3:TCCATGCCACAGGATG"	1.59800900992696	-9.73961069500121	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCCACAGGATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.97432431802	41.5477339417132	0.0176350537919126	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2346.70534655658	2346.70534655658
"healthy-1"	"2019-08-01-count-4:TCCCATGCACCATTCC"	2.54324187812154	-10.4723978272644	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGCACCATTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.22310899658	41.696767684852	0.0172498630886252	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2412.4052976621	2412.4052976621
"healthy-1"	"2019-08-01-count-2:TATCCTAGTTATGACC"	-0.153995643288451	13.1049432524475	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTAGTTATGACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.79487301938	46.2636384040716	0.024782389898706	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1857.8247936939	1857.8247936939
"healthy-1"	"2019-08-01-count-4:TGACAGTAGTGCGTCC"	2.23889507827107	-10.4412269822327	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTAGTGCGTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.9139123095	41.207157568745	0.0170494933058535	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2410.08741751916	2410.08741751916
"healthy-1"	"2019-08-01-count-4:TCATGGATCAGAATAG"	1.64283778247182	-9.46111395275267	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGGATCAGAATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.79541209353	37.7080099468807	0.0163111362491774	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2307.14360550043	2307.14360550043
"healthy-1"	"2019-08-01-count-3:GAAGTAAAGAGACAAG"	2.89755000647847	-10.6951294175354	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAAAGAGACAAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.29373661636	44.4110977251914	0.019744463340746	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2246.39623074174	2246.39623074174
"healthy-1"	"2019-08-01-count-2:CGTGATAAGGACTGGT"	1.08877374705617	-8.47471144115599	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGATAAGGACTGGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2300.97247465077	44.5892185544272	0.0193784232734877	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2300.97247465077	2300.97247465077
"healthy-1"	"2019-08-01-count-4:ATACCGACAATTTCGG"	-5.05628333512004	-5.47799112713011	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGACAATTTCGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2710.85149595209	37.9638961652383	0.0140044175130681	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2704.79963271375	2704.79963271375
"healthy-1"	"2019-08-01-count-3:TTCTGTATCGTTTACT"	2.51267876204793	-10.222755455133	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTATCGTTTACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.13031379592	42.8048514020867	0.0180906567793453	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2363.30684925002	2363.30684925002
"healthy-1"	"2019-08-01-count-4:ACTATGGAGCGTTAGG"	1.01451994952504	11.7535867460999	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATGGAGCGTTAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2237.14234405764	36.4719336768798	0.0163029115128761	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2231.3324420512	2231.3324420512
"healthy-1"	"2019-08-01-count-4:GAAGAATGTGGACTGA"	1.97612573680226	-10.3355283967224	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATGTGGACTGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.79801216529	40.6181950611012	0.0168066155535729	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2415.26640222022	2415.26640222022
"healthy-1"	"2019-08-01-count-4:TCCTCGAAGGAATTAC"	-5.2897666496342	-5.47436621105345	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCGAAGGAATTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2791.09270465453	41.6968205762044	0.0149392460188332	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2783.7216845769	2783.7216845769
"healthy-1"	"2019-08-01-count-2:TTTCATGAGCAGTAAT"	2.23921837386433	-10.5205040208069	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCATGAGCAGTAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.47083124237	43.0450399381603	0.0208908756607858	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2057.78063446892	2057.78063446892
"healthy-1"	"2019-08-01-count-3:AGTTAGCTCTGTCCGT"	6.95750011977498	-1.15497329151305	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTAGCTCTGTCCGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2347.77108280748	42.0629856826331	0.017916135857817	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2330.65062912885	2330.65062912885
"healthy-1"	"2019-08-01-count-4:AATTCCTGTCGCTTGG"	1.11429192599599	11.5713844069275	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTCCTGTCGCTTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1946.45387630426	36.7578946673023	0.0188845444090844	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1941.68570610562	1941.68570610562
"healthy-1"	"2019-08-01-count-3:TCGTAGAAGGATCATA"	-2.77415166321452	4.02931783283082	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTAGAAGGATCATA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3066.16188474403	45.7835764644457	0.0149318849380543	5969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3063.56761266049	3063.56761266049
"healthy-1"	"2019-08-01-count-3:GGGTCACCACAGTGTT"	1.81660034236256	-9.57520105755004	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACCACAGTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.48373907431	44.6243689226192	0.0196109372949301	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2271.32248454876	2271.32248454876
"healthy-1"	"2019-08-01-count-4:GCATTAGCAGCTGTCG"	-2.7206269306248	-5.87344744121703	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATTAGCAGCTGTCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2421.22331665362	42.2866528493983	0.017464994888552	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2419.43418981338	2419.43418981338
"healthy-1"	"2019-08-01-count-4:TGAGCATCAATGTCTG"	1.95364596423451	-8.64860918438109	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCATCAATGTCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.68506736359	40.2308685217616	0.0173208452093019	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2321.72471988946	2321.72471988946
"healthy-1"	"2019-08-01-count-4:TTCCTTCTCCGCATAA"	2.18382801589314	-10.4016571274963	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTTCTCCGCATAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.76014925996	39.1212416968131	0.0162682509974445	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.77611793017	2403.77611793017
"healthy-1"	"2019-08-01-count-3:AATTTCCCACATATGC"	2.70405854758565	-10.6602916947571	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCCACATATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.61008137446	41.0977420549634	0.0156884959128727	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2615.027180986	2615.027180986
"healthy-1"	"2019-08-01-count-3:GGCACGTCACACCTGG"	1.32091309603993	9.41567609393922	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTCACACCTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1736.25219016695	32.6287157332921	0.0187926131457635	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1732.1019602143	1732.1019602143
"healthy-1"	"2019-08-01-count-2:TTGTTTGTCTCCTGAC"	1.55613829669301	-9.22321035778197	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGTCTCCTGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.23192188428	40.4530804221665	0.0185629991998229	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2171.98912582163	2171.98912582163
"healthy-1"	"2019-08-01-count-3:TCGCTCACACTAACGT"	1.46535172042195	9.780153251532	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCACACTAACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1695.81212402632	36.8943131373192	0.0217561324244587	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1691.04661717711	1691.04661717711
"healthy-1"	"2019-08-01-count-2:ACTTTGTCATGACACT"	1.13271798667256	10.0787658461365	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTGTCATGACACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2009.96954370745	32.379809208556	0.0161096019140819	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2005.31587301851	2005.31587301851
"healthy-1"	"2019-08-01-count-3:CTTGATTCATAATGCC"	3.25802840766255	-10.5378074876037	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTCATAATGCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.04752569103	36.2718624280871	0.0145258999097541	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2492.41312527016	2492.41312527016
"healthy-1"	"2019-08-01-count-3:CTGCCATCATATAGCC"	-1.11533294144328	13.123695350531	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATCATATAGCC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1957.6523097018	34.5539360818772	0.0176507012561084	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1952.18849247987	1952.18849247987
"healthy-1"	"2019-08-01-count-4:GGTGTCGCATGTTCAG"	2.6208037334377	-10.5066223374573	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGCATGTTCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.31237236916	40.4603319268703	0.0170912518344076	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.56742037508	2362.56742037508
"healthy-1"	"2019-08-01-count-3:CTCCCTCCATGAATAG"	1.77534403380696	-10.1591501466003	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCCATGAATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.38655546222	41.3121367563678	0.01788104967054	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2304.4830995703	2304.4830995703
"healthy-1"	"2019-08-01-count-3:ATGGAGGTCTTTGCGC"	1.86862315711324	-10.3102092972961	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGAGGTCTTTGCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.77004198158	45.0655639910993	0.0197589249076357	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2277.96458883323	2277.96458883323
"healthy-1"	"2019-08-01-count-4:TGCTTGCTCCGTCACT"	-8.41011462631877	-0.581560813542925	"2019-08-01-count-4"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCTCCGTCACT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2844.12045660257	44.8533294250418	0.0157705449222151	4142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2836.27932149245	2836.27932149245
"healthy-1"	"2019-08-01-count-2:TCATGAGCAGTCAGTT"	2.15306605872456	-10.6157789460388	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGCAGTCAGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.99203212007	42.7647516142368	0.018585354063497	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2293.97439987353	2293.97439987353
"healthy-1"	"2019-08-01-count-2:TGTGCGGTCACCGGGT"	1.20636822757069	11.0585345991882	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGTCACCGGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1715.70460743206	37.7014181284479	0.0219743060461186	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1710.69340691209	1710.69340691209
"healthy-1"	"2019-08-01-count-4:CACCAAATCAAGAGGC"	11.387187619775	3.64018604839174	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCAAATCAAGAGGC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.9136460145	32.732461891799	0.0168818564762189	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1932.46506751978	1932.46506751978
"healthy-1"	"2019-08-01-count-4:ATTCCATCAAGAAACT"	1.66449322280232	-5.03589918529662	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATCAAGAAACT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2381.99110368277	35.54773505983	0.014923538129454	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2377.46051870119	2377.46051870119
"healthy-1"	"2019-08-01-count-2:GAGATGGCAACAGTGG"	2.26280011710469	-10.1959276429382	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	51	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGCAACAGTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.6639295727	44.5001988882977	0.0189228564203829	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.36852265517	2344.36852265517
"healthy-1"	"2019-08-01-count-2:CTTTCAATCCATTGTT"	2.60814823684041	-10.5093136063782	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCCATTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.21107526465	40.2121018044118	0.0166771388108352	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2404.81684897466	2404.81684897466
"healthy-1"	"2019-08-01-count-4:CGGAACCCAAGGACAC"	7.03894152221028	-1.05249812519225	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAACCCAAGGACAC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2387.96942200545	39.2264630236974	0.0164267023950225	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2381.66684923229	2381.66684923229
"healthy-1"	"2019-08-01-count-3:CTCCGATGTCACGACC"	-0.405683378607589	12.7767257460388	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCGATGTCACGACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.4765129143	43.8571508636804	0.0212746303869743	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2052.77948128806	2052.77948128806
"healthy-1"	"2019-08-01-count-3:GCAGCCATCTCTTCAA"	-7.56122909012492	-1.20701851761016	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCATCTCTTCAA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2845.46022184045	40.5646732545844	0.0142559270177908	4377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2838.81978230055	2838.81978230055
"healthy-1"	"2019-08-01-count-3:TACCGGGTCTGCTGAA"	-7.41843972626384	0.285316801908888	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	62	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCGGGTCTGCTGAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2426.0171046686	47.8174616865677	0.0197102739278088	2704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2421.78764649412	2421.78764649412
"healthy-1"	"2019-08-01-count-2:TTTGACTCAGCTGTCG"	3.35726060447041	-10.5270252457825	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTCAGCTGTCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.04139144159	45.8284079458431	0.0191107660232225	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2391.81471977589	2391.81471977589
"healthy-1"	"2019-08-01-count-2:CGGACACCACGTCATA"	-0.827526013285476	14.0289268263611	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGACACCACGTCATA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1872.50192883822	48.0873670389442	0.0256808104164569	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1868.91642230378	1868.91642230378
"healthy-1"	"2019-08-01-count-4:CTCCAACTCTCGGTCT"	-4.52291093292888	3.63771221721498	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCAACTCTCGGTCT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2736.85283738693	47.2891195986851	0.0172786490207619	3576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2730.82800267178	2730.82800267178
"healthy-1"	"2019-08-01-count-2:GAGGCCTTCGATCCCT"	9.78697647628133	7.59182689273683	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCGATCCCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2302.4970464725	42.1099882319235	0.0182888348527688	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2296.5561665274	2296.5561665274
"healthy-1"	"2019-08-01-count-2:CCTTGTGGTTACACTG"	1.94239201125447	-10.4639454117981	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGGTTACACTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.49794008142	42.4786462731514	0.0166550404160669	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2545.7786359016	2545.7786359016
"healthy-1"	"2019-08-01-count-2:CAGATCACAGAGCGTA"	1.79310144957845	-10.2097473374573	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCACAGAGCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.34578965158	39.2685372162513	0.018051629953756	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2174.1796529758	2174.1796529758
"healthy-1"	"2019-08-01-count-4:CCTCTCCGTGATACCT"	-1.40013847771342	14.0885429152283	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCGTGATACCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2086.99994994402	44.8442546743965	0.0214874248921756	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2085.2678727851	2085.2678727851
"healthy-1"	"2019-08-01-count-3:ATGTCCCCAGCGCTTG"	10.963450093835	3.96251986110536	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCCAGCGCTTG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1712.7621652198	42.6607270053669	0.0249075603558139	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1708.59519321668	1708.59519321668
"healthy-1"	"2019-08-01-count-2:CTCCAACTCGAAGCCC"	1.21772720393483	9.17708966815797	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACTCGAAGCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.69705388938	24.2344154012727	0.0141746839571034	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1704.54408073622	1704.54408073622
"healthy-1"	"2019-08-01-count-3:GCTTGGGAGTCTTCGA"	2.52148975905721	-10.4850168458191	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGAGTCTTCGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.80607062759	40.5232917358995	0.0174834694970521	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2314.67468438043	2314.67468438043
"healthy-1"	"2019-08-01-count-2:CTCATTATCGCTATTT"	10.9829241233761	4.04172561252443	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATTATCGCTATTT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.72798933144	33.1348622175676	0.016830594372166	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1965.30484182441	1965.30484182441
"healthy-1"	"2019-08-01-count-4:TCACTATGTTACCCAA"	2.43463792380635	-10.3681431046692	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTATGTTACCCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.41482804197	40.6548173539555	0.0167689196105064	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2422.48913857393	2422.48913857393
"healthy-1"	"2019-08-01-count-3:GGAGAACCATGTTACG"	1.51235928115193	-9.3761663666931	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACCATGTTACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.02347183809	41.9540583003159	0.0175025646570514	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2392.87167324667	2392.87167324667
"healthy-1"	"2019-08-01-count-3:CGCATGGCACTTGACA"	8.01239695128743	6.66810557926027	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCATGGCACTTGACA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1644.56217224751	40.1886172028032	0.0244372744801007	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1638.28538875489	1638.28538875489
"healthy-1"	"2019-08-01-count-1:TTCAATCCACGCGCAT"	0.821978886693162	8.97161576831666	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCAATCCACGCGCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2107.36056705751	38.0140915224149	0.0180387220472164	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2088.62046045412	2088.62046045412
"healthy-1"	"2019-08-01-count-3:TGATTCTAGACCTTTG"	2.41415037688557	-10.5379142991272	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTCTAGACCTTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.92524808374	40.5512754753571	0.0158222622784947	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2555.34838352169	2555.34838352169
"healthy-1"	"2019-08-01-count-3:AGACTCACAGTTAGGG"	1.77000965651814	-9.13995268261107	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCACAGTTAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.3458475999	38.5113035007943	0.0158329883633921	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2431.54628101326	2431.54628101326
"healthy-1"	"2019-08-01-count-4:TACAACGAGTTGCATC"	2.58677639540974	-10.779869102594	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAACGAGTTGCATC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.95227083504	45.4153484872821	0.0193260727253597	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.30400889572	2344.30400889572
"healthy-1"	"2019-08-01-count-2:GCGTGCAGTTTGACAC"	2.99008931693379	-10.4449329606262	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTGCAGTTTGACAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.00256581305	43.3338103674281	0.0188080564711248	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2301.95283854126	2301.95283854126
"healthy-1"	"2019-08-01-count-4:AGGGCCTTCTTCACAT"	-5.57308135452922	-5.07560541546019	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTTCTTCACAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2532.34063982515	45.3158992181567	0.0178948671065381	2490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2528.66944640055	2528.66944640055
"healthy-1"	"2019-08-01-count-3:ACTGTGATCACAGTGT"	2.07158937033955	-10.4449825516907	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTGATCACAGTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.62971296734	42.2314577089754	0.018206120344506	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2315.68760611444	2315.68760611444
"healthy-1"	"2019-08-01-count-3:CAAAGAACACGGATCC"	-4.52537045899089	-5.27142956173094	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAAGAACACGGATCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2709.87400664663	45.6855969515449	0.016858937662596	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2702.78130390204	2702.78130390204
"healthy-1"	"2019-08-01-count-3:CTTCTCTTCCTGATAG"	-1.51837346974071	8.63333127582399	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTTCCTGATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2541.61575735854	39.5573917728167	0.0155638757189356	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2528.08314460283	2528.08314460283
"healthy-1"	"2019-08-01-count-2:GCTGGGTAGCACCTGC"	2.66376628455464	-10.8658266297546	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTAGCACCTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.50302696517	37.9045200300348	0.0152933119780965	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2472.00430259414	2472.00430259414
"healthy-1"	"2019-08-01-count-2:TGTAGACGTAACACGG"	3.07425179061238	-10.3475418320862	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACGTAACACGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.66318788795	41.0713901237321	0.0171799149005247	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.84323106722	2383.84323106722
"healthy-1"	"2019-08-01-count-2:ACATCCCCAAATCGGG"	2.30048813399617	-10.7943268052307	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCCAAATCGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.43770777141	38.3650002465117	0.0155611314476045	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2463.48533570678	2463.48533570678
"healthy-1"	"2019-08-01-count-3:CTCCCTCGTTCATCGA"	3.30732574042622	-10.4230995408264	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCGTTCATCGA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.67545799912	41.2875986117233	0.0169651209967283	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2427.13104517333	2427.13104517333
"healthy-1"	"2019-08-01-count-4:AGGCCACTCCCTCAAC"	2.53978600081746	-10.6080522767273	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACTCCCTCAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.90672940176	48.8038881587076	0.0206105618742161	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.33789140255	2362.33789140255
"healthy-1"	"2019-08-01-count-3:TTGACCCAGGCGATAC"	-5.12301621857341	-4.46569731151732	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGACCCAGGCGATAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2897.14433406768	45.1521111674279	0.0155850402882872	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2892.34783195994	2892.34783195994
"healthy-1"	"2019-08-01-count-3:ACCTACCAGAGAGGTA"	10.7645231681759	4.26481435382692	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTACCAGAGAGGTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.44765211474	30.8104288071041	0.0163065797417674	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1884.43759196496	1884.43759196496
"healthy-1"	"2019-08-01-count-2:AGCCAGCCACTCATAG"	-4.8458436531132	9.08589551532594	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	78	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCCACTCATAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	3323.64488106843	43.0062553710978	0.012939485688156	4188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	3314.21344232825	3314.21344232825
"healthy-1"	"2019-08-01-count-3:CGGGCATAGACCACGA"	-3.62699017944987	-5.56627180492552	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATAGACCACGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2481.79300437346	45.660940189061	0.0183983676755461	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2477.84371282076	2477.84371282076
"healthy-1"	"2019-08-01-count-3:TCACGGGAGTAAATGC"	-3.58618340912517	3.6867375143799	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGGGAGTAAATGC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2861.98960236778	45.5155772313251	0.0159034740006285	4353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2857.65364075112	2857.65364075112
"healthy-1"	"2019-08-01-count-4:GACTATGCAGCCCAGT"	1.33596159991567	9.55096814716188	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGCAGCCCAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.51616743418	30.1458269349568	0.0160050799967504	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1880.93569724686	1880.93569724686
"healthy-1"	"2019-08-01-count-2:GCAGTTACATCGGATT"	0.131543551653069	13.4841184386047	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTACATCGGATT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1602.9544230219	47.7036195154764	0.0297598102792875	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1598.37670922577	1598.37670922577
"healthy-1"	"2019-08-01-count-3:TGTTGGAAGCTAAACA"	-0.515805224806625	12.4989175566467	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGGAAGCTAAACA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1602.04884234028	43.0267240488542	0.0268573110330398	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1599.86127135639	1599.86127135639
"healthy-1"	"2019-08-01-count-3:TCAATTCCAATCTCGA"	2.90362324294392	-10.4332761994568	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCCAATCTCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.54328463558	37.326054345817	0.0155231367987097	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.01867255469	2401.01867255469
"healthy-1"	"2019-08-01-count-3:TACTTACTCGATAACC"	1.09214260157887	9.18279168689577	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTACTCGATAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.68706465087	38.9298163024757	0.0213350645470402	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1822.13959753286	1822.13959753286
"healthy-1"	"2019-08-01-count-4:CATCCACAGCATAGGC"	1.50720896300618	9.77084634387819	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACAGCATAGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.49322301475	40.132634891375	0.0205020555982138	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1951.0141944562	1951.0141944562
"healthy-1"	"2019-08-01-count-3:TTCATGTGTACAAACA"	3.01619758185689	-10.6523447266785	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATGTGTACAAACA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.46653943346	46.4445770081688	0.0199979531328354	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2316.75576048741	2316.75576048741
"healthy-1"	"2019-08-01-count-2:CAGAGCCAGTTGCGCC"	1.88809885558431	-9.98257543956908	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGAGCCAGTTGCGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.88531801363	39.5549310536072	0.0155063541172476	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2547.31677427313	2547.31677427313
"healthy-1"	"2019-08-01-count-4:TTGGGTACAATGACCT"	6.94195999678914	-1.14954235469969	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGTACAATGACCT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2325.26975483071	41.8679261569934	0.0180056210983751	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2317.98469653579	2317.98469653579
"healthy-1"	"2019-08-01-count-2:GTACAGTAGCCTCTGG"	0.982801874249619	11.6639184721741	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAGTAGCCTCTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.06546236321	38.2095195202827	0.0214652327839426	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1771.28600157145	1771.28600157145
"healthy-1"	"2019-08-01-count-3:GCGTTTCCAAAGGCTG"	1.43771733817403	-9.6492548218933	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTTTCCAAAGGCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.3216807782	42.7271380704591	0.0172612466501834	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2471.17565205192	2471.17565205192
"healthy-1"	"2019-08-01-count-3:AACGAAATCCGACGGT"	1.65734424170796	-9.31460001384886	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGAAATCCGACGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.40252986841	43.2798367695133	0.018405966745275	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2348.3342245758	2348.3342245758
"healthy-1"	"2019-08-01-count-3:CGAAGTTCATTGCAAC"	1.63749458369557	-9.45402433788451	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTCATTGCAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.03913686551	45.5725724020629	0.0201466772432648	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2258.21757068601	2258.21757068601
"healthy-1"	"2019-08-01-count-3:GAAGGACCAGCAATTC"	1.11742140826527	11.309956527594	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGACCAGCAATTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2494.10486281118	36.5249962882979	0.0146445311233343	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2488.22485177283	2488.22485177283
"healthy-1"	"2019-08-01-count-3:CAAGACTAGGTCCCGT"	1.69571699675862	-4.77177479183348	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTAGGTCCCGT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2201.15957903887	39.3563561122671	0.017879828653519	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2195.20425412373	2195.20425412373
"healthy-1"	"2019-08-01-count-3:ACCCTTGAGACAACTA"	10.2222506004268	5.01220748508302	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGAGACAACTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.45592264864	42.6424958291838	0.024072005001076	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1765.91607613441	1765.91607613441
"healthy-1"	"2019-08-01-count-3:GCACTAATCTACACTT"	3.36317004737203	-10.4770918122497	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAATCTACACTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.38906758985	41.1912568997224	0.0161573050670779	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2545.56234947891	2545.56234947891
"healthy-1"	"2019-08-01-count-2:ACTTTGTCAACGTAAA"	1.42359711703603	10.2333554991516	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTGTCAACGTAAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1642.6207647958	32.8641605534817	0.0200071503160178	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1634.82755891793	1634.82755891793
"healthy-1"	"2019-08-01-count-3:CTGCCATGTTGAATCC"	-2.08619056168254	11.2554454573425	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATGTTGAATCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1816.83108084977	45.2352680844972	0.0248978942298476	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1808.92971687123	1808.92971687123
"healthy-1"	"2019-08-01-count-3:AGAAGCGAGTCTTCCC"	3.7451602416927	-10.7007351151672	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGCGAGTCTTCCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.6919592053	40.0858164469908	0.0164509167010443	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.14148651067	2432.14148651067
"healthy-1"	"2019-08-01-count-1:TCAGGTATCACGAGGA"	7.94522585448567	7.63850209796754	"2019-08-01-count-1"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGGTATCACGAGGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.84028165573	41.3175070811758	0.02013680472626	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2044.48143824096	2044.48143824096
"healthy-1"	"2019-08-01-count-2:TATTGCTTCTCTATAC"	8.05245651778523	7.75304410541383	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTTCTCTATAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.25513481032	37.3725523066597	0.0198868964699845	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1874.3022645294	1874.3022645294
"healthy-1"	"2019-08-01-count-4:TTACCATTCACATCAG"	0.709382494061631	9.82068822467653	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATTCACATCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1644.66155781765	10.9343109024352	0.00664836534328937	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1635.19837045875	1635.19837045875
"healthy-1"	"2019-08-01-count-1:GTCAAGTAGCGCCTTG"	1.84868659552876	-10.2578010789123	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTCAAGTAGCGCCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.02552589418	38.1462173119977	0.0147167598971998	2443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2586.66793638645	2586.66793638645
"healthy-1"	"2019-08-01-count-2:TTTGACTCACTGGATT"	7.79098190841023	7.02281425083009	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTCACTGGATT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1741.60153241678	32.7648244778719	0.0188130429768312	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1736.9050975872	1736.9050975872
"healthy-1"	"2019-08-01-count-3:TCACGGGAGGGCAACT"	2.54510607299153	-10.6930904618469	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGGGAGGGCAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.76396385159	39.5196514771696	0.0150050088085253	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2628.19893116986	2628.19893116986
"healthy-1"	"2019-08-01-count-2:AATCACGAGGATTACA"	-1.37453339520152	13.5247831114563	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGAGGATTACA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1984.122472175	46.2145708188436	0.0232921966597067	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1977.2401387532	1977.2401387532
"healthy-1"	"2019-08-01-count-2:AGCCAATCATCTCAAG"	-1.88862619820293	13.2646016844544	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATCATCTCAAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1972.31842695192	43.1072641575697	0.0218561382221576	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1968.73985637952	1968.73985637952
"healthy-1"	"2019-08-01-count-3:ACCCTTGGTCTGCCTT"	2.43729676780049	-10.6874437562195	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGGTCTGCCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.6105052041	38.319062115928	0.0160022108115917	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.99212644789	2388.99212644789
"healthy-1"	"2019-08-01-count-3:CCTACGTAGAGAATCT"	2.51241268691365	-10.6215706101623	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTAGAGAATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.84411294156	35.5971027563818	0.0141211043450218	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.31738361185	2516.31738361185
"healthy-1"	"2019-08-01-count-4:CTTTCGGCAGGTTTAC"	1.51040329512898	-9.54632093822631	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGCAGGTTTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.37650293491	42.0976719392601	0.0175452547308712	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.88970210806	2393.88970210806
"healthy-1"	"2019-08-01-count-3:TATTGCTGTTCGAGCC"	-1.37290404263194	11.6432027586731	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGCTGTTCGAGCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.43891220979	41.7558022441285	0.0211589028602724	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1971.66440942529	1971.66440942529
"healthy-1"	"2019-08-01-count-2:GTGAGTTAGGTTCTTG"	1.12458231028859	11.6343765028748	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTAGGTTCTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1730.38072898136	33.1462736440856	0.019155480114251	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1729.0710052712	1729.0710052712
"healthy-1"	"2019-08-01-count-2:TAGCACAAGATGAATC"	2.09960045394246	-10.6785249940124	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGCACAAGATGAATC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.94119515404	42.7369912363235	0.0182719391684018	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2331.46521990244	2331.46521990244
"healthy-1"	"2019-08-01-count-3:CGTAAGTAGCCTGAAG"	6.98167910155599	-10.5685148469177	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTAGCCTGAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.28763903326	42.6800553084992	0.0184899206610031	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2305.26190983606	2305.26190983606
"healthy-1"	"2019-08-01-count-4:CTTCTAATCGTCCTCA"	0.293499459593934	13.1697044142517	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAATCGTCCTCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.26651439108	37.1121440556118	0.0188074665966062	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1971.54583836114	1971.54583836114
"healthy-1"	"2019-08-01-count-3:AACCCAAAGAGAGCCT"	1.33183540877644	-8.89632704174193	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAAAGAGAGCCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2377.54370322294	39.1629781691884	0.0164720329288164	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2376.72404683307	2376.72404683307
"healthy-1"	"2019-08-01-count-3:TTCTGTAAGCAAGGAA"	1.35158671912495	9.50243852222291	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTAAGCAAGGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1642.81565078787	29.2543955626956	0.0178074731322809	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1639.00445346772	1639.00445346772
"healthy-1"	"2019-08-01-count-2:CACGTGGTCCCAACTC"	6.33828272399251	-10.2054157487121	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGTCCCAACTC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.41105182656	41.2594547248948	0.0177352384448571	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2321.68262648567	2321.68262648567
"healthy-1"	"2019-08-01-count-4:AGTCTCCCACGGTGAA"	1.29027773913686	10.7372379072937	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCTCCCACGGTGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1852.31829954391	34.4561461462936	0.0186016335069289	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1843.80599150162	1843.80599150162
"healthy-1"	"2019-08-01-count-2:CACGTTCTCGACCCAG"	2.7820266681606	-10.640669845697	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCTCGACCCAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.57153481713	40.3030069355871	0.0154680101455804	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2602.55281556649	2602.55281556649
"healthy-1"	"2019-08-01-count-3:AGACACTTCTTAGCAG"	0.442306299775285	11.4260244139465	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTTCTTAGCAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.65540517284	44.7992304840703	0.0225728004807811	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1983.04610430667	1983.04610430667
"healthy-1"	"2019-08-01-count-3:GTATTGGGTGTTTCTT"	-2.42747269097026	12.777446723822	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTGGGTGTTTCTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1678.90514408631	47.4268342572961	0.0282486681420627	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1678.90514408631	1678.90514408631
"healthy-1"	"2019-08-01-count-4:ATAGGCTAGTGCCCGT"	-3.01709828797038	3.34981629932252	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTAGTGCCCGT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3206.10030371109	46.4625382932933	0.0144919166251637	5351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3200.3773498476	3200.3773498476
"healthy-1"	"2019-08-01-count-2:ATTCATCTCATATGGC"	1.40315844592397	10.332191444281	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCTCATATGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.54176882891	30.7980362924475	0.0160947813076983	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1907.88747258674	1907.88747258674
"healthy-1"	"2019-08-01-count-2:CATCCCACAGCTACCG"	1.19911791858022	11.4333371886047	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCACAGCTACCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2042.59162772038	34.1606295544509	0.0167241601751671	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2037.23838313118	2037.23838313118
"healthy-1"	"2019-08-01-count-2:ACGATGTAGCGTGCTC"	1.18505241450612	9.45155427539674	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTAGCGTGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1707.58875095597	38.6773835393662	0.022650291832687	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1695.86617147086	1695.86617147086
"healthy-1"	"2019-08-01-count-3:TGTTTGTCACTAGTAC"	1.52717544612233	-9.73785784160765	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTTGTCACTAGTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.19356492373	42.9125846055612	0.0194245471682074	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2207.06754977604	2207.06754977604
"healthy-1"	"2019-08-01-count-3:GTCTGTCTCGCGATCG"	8.221039434045	7.95929620349733	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTGTCTCGCGATCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.50567058351	40.9543112833798	0.0202593106115593	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2016.62905689465	2016.62905689465
"healthy-1"	"2019-08-01-count-4:AGTAGTCTCTTTGATC"	1.16544200953786	10.7744092711243	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCTCTTTGATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.91705150377	28.9099630597414	0.0160440032661964	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1798.66661640228	1798.66661640228
"healthy-1"	"2019-08-01-count-4:TCGACCTCAGAGATTA"	1.65416147288625	-9.88173391735228	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACCTCAGAGATTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.24614092518	43.826887871889	0.0183357216319677	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2385.44292229107	2385.44292229107
"healthy-1"	"2019-08-01-count-4:GGTAACTAGGATTTCC"	1.33130409297292	9.83836171710817	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTAGGATTTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.73929877076	35.635323363648	0.0196041992312903	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1815.07331062838	1815.07331062838
"healthy-1"	"2019-08-01-count-2:CAGGGCTCAGGCACTC"	-2.95446501198466	-5.85828449642333	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGGCTCAGGCACTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2701.57793898384	43.7754170740205	0.0162036476691418	2529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2696.80923060719	2696.80923060719
"healthy-1"	"2019-08-01-count-2:CGGAGAACATATGGCT"	1.32190622863118	10.9996547468933	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAACATATGGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.40377908238	33.3470569948953	0.0186567005089444	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1780.47354464683	1780.47354464683
"healthy-1"	"2019-08-01-count-1:TGCGGCACATTGACTG"	1.71168782290761	-9.50221350109252	"2019-08-01-count-1"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCGGCACATTGACTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2559.85528387533	40.3971995452323	0.0157810481708464	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2556.96448889988	2556.96448889988
"healthy-1"	"2019-08-01-count-4:GAACTGTCACGGTCTG"	1.71376897868459	-9.93573191082152	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTCACGGTCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.95269213158	43.0832243075023	0.0179891755060752	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2389.247862642	2389.247862642
"healthy-1"	"2019-08-01-count-4:AATCACGGTTTCGCTC"	1.8027329641277	-10.1208820573059	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCACGGTTTCGCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.84969549948	40.9021369432835	0.0170578402057696	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.30621636706	2393.30621636706
"healthy-1"	"2019-08-01-count-2:TACCTGCAGCCTTTGA"	-1.50679645958598	13.9015445479187	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTGCAGCCTTTGA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2159.65029790607	50.1167376623048	0.0232059503850676	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2153.96351535764	2153.96351535764
"healthy-1"	"2019-08-01-count-1:TCCTCTTTCATCGCTC"	1.10541929778401	9.28600976550905	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCTCTTTCATCGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2079.75801308432	41.828197949161	0.020112050385674	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2067.37012233715	2067.37012233715
"healthy-1"	"2019-08-01-count-3:ACTTAGGCACTCTGCT"	2.29791464385335	-10.4975967637268	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTAGGCACTCTGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.23551232984	37.8861248984394	0.0161682958025716	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2342.31447637357	2342.31447637357
"healthy-1"	"2019-08-01-count-4:CAACCTCAGAGTGTGC"	3.03037180480306	-10.8429212800232	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCAGAGTGTGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.84208433944	41.891416880325	0.0175583359667006	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.28936794322	2377.28936794322
"healthy-1"	"2019-08-01-count-3:GTTAGTGTCGGTTCAA"	3.54138125953023	-10.7598600617615	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGTGTCGGTTCAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.6912798226	39.4722364663823	0.0182177483400469	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2161.96781466431	2161.96781466431
"healthy-1"	"2019-08-01-count-2:CCTAACCGTTACCCAA"	1.70604517039601	-10.0764675370422	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCGTTACCCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.08896783452	40.0127432043877	0.0157897941675584	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2527.98738478189	2527.98738478189
"healthy-1"	"2019-08-01-count-3:TGTAGACGTCGCACGT"	-3.28538284722026	-5.61398174678954	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACGTCGCACGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2235.43240634871	50.8343124084634	0.022740259228636	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2235.43240634871	2235.43240634871
"healthy-1"	"2019-08-01-count-2:TGCGGGTTCATTTCGT"	1.00753184136693	10.1387462385925	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTTCATTTCGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.29801279405	33.9906292515061	0.0179152821656361	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1890.62702519272	1890.62702519272
"healthy-1"	"2019-08-01-count-4:CGAATTGCAACACAGG"	1.83052410659139	-9.90341761028441	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAATTGCAACACAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.36129126333	41.8187438150122	0.0176497961578137	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2365.55451920618	2365.55451920618
"healthy-1"	"2019-08-01-count-2:CGAGTTACAGCAGTCC"	0.954765577881974	11.6814479597839	"2019-08-01-count-2"	"Control1"	"MAIT"	"MAIT"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTTACAGCAGTCC"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2042.07514058559	33.6709058975124	0.0164885734262731	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2040.5140637405	2040.5140637405
"healthy-1"	"2019-08-01-count-4:CGACAGCCACAAGCTT"	6.86914600905721	-0.987032198068224	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCCACAAGCTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2440.682216176	42.3727121944473	0.017361011570296	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2432.37549668727	2432.37549668727
"healthy-1"	"2019-08-01-count-3:ATTCCTATCACTTGTT"	8.60705914077107	7.04214665973512	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTATCACTTGTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.76766545654	37.0464131722793	0.020114596356048	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1840.10388984217	1840.10388984217
"healthy-1"	"2019-08-01-count-4:GTTTGGAAGCACTGGA"	2.09896435317342	-10.3288126221863	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGAAGCACTGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.01690524762	42.057666112654	0.0175239041111315	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.27672004719	2397.27672004719
"healthy-1"	"2019-08-01-count-4:GTCTAGATCGACGCGT"	-2.94369636002238	-6.00663044368895	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTAGATCGACGCGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2530.90406020917	48.7454955343169	0.0192601119499916	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2526.783304139	2526.783304139
"healthy-1"	"2019-08-01-count-3:ATCAGGTAGAAGAACG"	0.331837912171525	12.2267064818176	"2019-08-01-count-3"	"Control1"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTAGAAGAACG"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1787.98413128141	37.3527462207133	0.0208909830726201	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1779.14903260245	1779.14903260245
"healthy-1"	"2019-08-01-count-4:AACCACACAAGTGGAC"	1.8012556034023	-10.0007524720398	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACACAAGTGGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.88198185176	39.812256121385	0.0159129233153988	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2498.59746429086	2498.59746429086
"healthy-1"	"2019-08-01-count-4:CATTTCACACGACGAA"	1.4742337661678	-4.6839604607788	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTTCACACGACGAA"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2801.22963973398	45.300218044212	0.0161715474524659	3156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2796.03577691253	2796.03577691253
"healthy-1"	"2019-08-01-count-2:AACCTGATCTCTGACC"	1.39182819899861	10.3204288252625	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTGATCTCTGACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1800.99055036087	32.5112137349375	0.0180518513705822	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1797.67839655393	1797.67839655393
"healthy-1"	"2019-08-01-count-3:CAACGGCCACGACCTG"	1.85454036769215	-10.3552808991638	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGGCCACGACCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.54696599087	41.0315356335587	0.0178977950036563	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2289.76514897324	2289.76514897324
"healthy-1"	"2019-08-01-count-3:AAAGTGAGTCAAGCGA"	3.17149390754048	-10.5649433366028	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTGAGTCAAGCGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.6869995024	42.2023943310506	0.0180530560079403	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.96031612472	2330.96031612472
"healthy-1"	"2019-08-01-count-3:AGTACTGAGCGCCTCA"	2.91894092139546	-10.3880129090515	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGAGCGCCTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.45918077365	44.6970792206877	0.0196950355394587	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2269.45918077365	2269.45918077365
"healthy-1"	"2019-08-01-count-3:TAAGCGTAGTGCTCAT"	1.42258741435353	-8.65659811412963	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCGTAGTGCTCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.19707242919	40.0394305359383	0.017683721537976	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2259.69863852798	2259.69863852798
"healthy-1"	"2019-08-01-count-3:ATTCTACGTTCCTTGC"	2.88176073607747	-10.6762132874695	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTACGTTCCTTGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.20968232833	40.5408096174187	0.0166409360866972	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.99662041695	2432.99662041695
"healthy-1"	"2019-08-01-count-4:AGTCTCCAGACGGTCA"	0.981791337102097	-8.46565344249877	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCTCCAGACGGTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2135.16617510323	46.3292416370028	0.0216981901349026	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2132.71091847657	2132.71091847657
"healthy-1"	"2019-08-01-count-3:TACTTGTAGCGTCGAA"	2.09073915061299	-10.4705114594665	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTAGCGTCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.93587130353	38.0214240834229	0.0158294917602395	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.33126740622	2399.33126740622
"healthy-1"	"2019-08-01-count-3:GCTTTCGAGGCCTAGA"	0.984018107026261	-8.0049677125183	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTTCGAGGCCTAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2320.86055176679	42.0537176152762	0.0181198812583816	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2315.82435489228	2315.82435489228
"healthy-1"	"2019-08-01-count-3:GCAGCCATCACGATCA"	10.9209200340206	4.42755124652711	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCATCACGATCA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1702.44977994603	32.0602110388201	0.0188318101458689	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1696.47630542912	1696.47630542912
"healthy-1"	"2019-08-01-count-1:GGTTAACGTGTTAGCT"	2.61004628714864	-10.6399030915466	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTTAACGTGTTAGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.13867844376	40.8891234572035	0.0164799830869794	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2476.35424219254	2476.35424219254
"healthy-1"	"2019-08-01-count-1:AAGCCATAGTGTTGTC"	1.07042243060414	9.38856694782106	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAGCCATAGTGTTGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.81074986751	40.3083716274665	0.0211947332983971	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1891.0092975468	1891.0092975468
"healthy-1"	"2019-08-01-count-2:TCCTGCATCCCTAGGG"	1.94365241107289	-10.5054064027038	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCATCCCTAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.03551999099	42.0064875281827	0.0177689747776475	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.25359083158	2359.25359083158
"healthy-1"	"2019-08-01-count-4:AACCTTTGTTGGACCC"	-4.72934852066691	-4.38464357769164	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTGTTGGACCC"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2905.08262084938	41.5866298288482	0.0143151280897785	3474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2899.28639871837	2899.28639871837
"healthy-1"	"2019-08-01-count-3:TAAGCGTGTACATTGC"	14.1287695365841	1.72613105857698	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCGTGTACATTGC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1659.95861426333	47.34202670701	0.028520004233973	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1644.83177657893	1644.83177657893
"healthy-1"	"2019-08-01-count-4:AGTAGTCGTCTGTAAC"	11.1524549919063	3.77367422664491	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCGTCTGTAAC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1833.07661539038	34.167141279326	0.0186392325298687	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1829.37587321017	1829.37587321017
"healthy-1"	"2019-08-01-count-3:TTACCGCCAGTCTACA"	1.23910178717915	10.2324657210144	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCCAGTCTACA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.82153312621	39.1410900040394	0.0231081546895903	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1689.239592406	1689.239592406
"healthy-1"	"2019-08-01-count-3:CCATAAGAGTTCATGC"	-4.30877147141154	3.68133208835451	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATAAGAGTTCATGC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2834.65849096943	43.286830982543	0.015270562969206	3633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2828.81110948015	2828.81110948015
"healthy-1"	"2019-08-01-count-3:ACTTAGGGTGTTGACT"	1.83452274379079	-10.4452028504578	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTAGGGTGTTGACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.86601343794	37.6186289694388	0.0173608468341581	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2159.24971435758	2159.24971435758
"healthy-1"	"2019-08-01-count-3:GTTGAACCAATTCTCT"	-1.28020272675212	13.2156438597473	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGAACCAATTCTCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1827.86157598696	31.2171077862579	0.0170784856995542	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1821.91972991851	1821.91972991851
"healthy-1"	"2019-08-01-count-1:CTGGCAGTCTCCCATG"	1.31986834582631	10.8434362181458	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGGCAGTCTCCCATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2219.438014559	35.8937080034298	0.0161724309343065	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2212.37009822538	2212.37009822538
"healthy-1"	"2019-08-01-count-2:ACCTACCTCCACACAA"	1.46514882621114	9.88287351215211	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCTCCACACAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1857.10296662549	43.7946507735701	0.0235822415669006	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1848.73990571904	1848.73990571904
"healthy-1"	"2019-08-01-count-1:AAGACAATCTGCCCTA"	1.26091911372487	9.54935071552125	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAGACAATCTGCCCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2030.57168186569	37.7187270732238	0.0185754225817666	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2015.75878173348	2015.75878173348
"healthy-1"	"2019-08-01-count-2:CATTGCCTCGCTACAA"	7.82203402098958	7.4424199827942	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCTCGCTACAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.69398206812	42.6234292131539	0.0216616148657197	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1958.50560672222	1958.50560672222
"healthy-1"	"2019-08-01-count-2:TACTTACGTTGTTTGG"	1.76246394690816	-8.86124422466429	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACGTTGTTTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.07444774624	38.3877998466373	0.0169252820976767	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2264.71850647246	2264.71850647246
"healthy-1"	"2019-08-01-count-3:TCAGTCCTCCGGTAGC"	1.91843368586842	-9.93440153515013	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTCCTCCGGTAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.12330130572	45.7555575278044	0.0202178809706946	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2254.00315968191	2254.00315968191
"healthy-1"	"2019-08-01-count-2:GCAGGCTGTATCGCAT"	-4.87165055695232	-4.57238342678221	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTGTATCGCAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2637.55257989752	43.9893051578528	0.0166780770526144	2989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2632.75030417106	2632.75030417106
"healthy-1"	"2019-08-01-count-2:CTACAGATCCCTCAAC"	1.61132182654683	-9.26976873790892	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGATCCCTCAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.91712370651	42.0264746716442	0.0178994710875057	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2345.02461107217	2345.02461107217
"healthy-1"	"2019-08-01-count-2:TAGATCGGTGATGTAA"	6.66196264800374	-0.987339281198107	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGATCGGTGATGTAA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2302.26266873353	43.1353014260477	0.0187360469384566	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2294.38069132229	2294.38069132229
"healthy-1"	"2019-08-01-count-4:CTTTCAAGTTGCACGC"	2.65983285483662	-10.6872215501037	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAAGTTGCACGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.37810049043	43.5949237383145	0.0177476438703026	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2452.02446892775	2452.02446892775
"healthy-1"	"2019-08-01-count-4:TCATGGACAGCTATTG"	1.26108517226521	9.46086881244508	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGGACAGCTATTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1852.54260673624	34.9188141501182	0.0188491287720703	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1843.36784951637	1843.36784951637
"healthy-1"	"2019-08-01-count-2:CGTTGGGGTCAGGAGT"	1.77365591105763	-10.005436920282	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGGTCAGGAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.0032036707	41.2453168134373	0.0184377549150389	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2235.12597562623	2235.12597562623
"healthy-1"	"2019-08-01-count-4:AGAAATGTCACCCTCA"	0.962007482617539	11.1014737852844	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAATGTCACCCTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.8433002564	43.2727707189161	0.0229704724979124	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1874.40800952721	1874.40800952721
"healthy-1"	"2019-08-01-count-3:CTCAACCTCAATCGGT"	-5.26721892777141	3.6707553633484	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCTCAATCGGT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2365.53531760211	41.2119207673123	0.0174218158827101	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2358.76776755496	2358.76776755496
"healthy-1"	"2019-08-01-count-4:TAACACGGTATTTCCT"	2.73361863669698	-10.94900133526	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGGTATTTCCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.13763472943	39.0453869611373	0.0158261891884355	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2456.67361185648	2456.67361185648
"healthy-1"	"2019-08-01-count-4:CATTGTTCAGTAACCT"	1.60464801368062	-9.98862459575804	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGTTCAGTAACCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.6772147118	39.6856404684268	0.0159017521314389	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2490.95574481083	2490.95574481083
"healthy-1"	"2019-08-01-count-4:AGGCCACAGCCTTTCC"	-6.2974775833195	4.05490181529848	"2019-08-01-count-4"	"Control1"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACAGCCTTTCC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2196.09405630356	41.0300662760342	0.0186832008211413	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2191.61723679118	2191.61723679118
"healthy-1"	"2019-08-01-count-4:CTGAATGTCAACTGAC"	1.39461054381673	11.311629272345	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGTCAACTGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.18447025536	38.3337069116663	0.0200890990935149	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1899.61715878273	1899.61715878273
"healthy-1"	"2019-08-01-count-4:CCACGTTAGCCGATCC"	1.27140619334523	9.6490211256775	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGTTAGCCGATCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1851.07353240025	37.8128924938101	0.0204275474917405	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1846.04516373291	1846.04516373291
"healthy-1"	"2019-08-01-count-2:TCCTTCTAGTCACTGT"	1.34196152266805	10.9347219237122	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTAGTCACTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.5705333552	36.9966679643938	0.0203438180075074	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1813.22751699418	1813.22751699418
"healthy-1"	"2019-08-01-count-3:CTCAACCGTACCTTCC"	1.01462038335149	11.368022895697	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCGTACCTTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.72281192517	35.3491158073895	0.0186369434611852	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1889.44947873558	1889.44947873558
"healthy-1"	"2019-08-01-count-3:TGCAGATCAAGCACAG"	11.1301294761593	3.84933135593263	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGATCAAGCACAG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1712.69241140264	36.8087993824999	0.0214917746686077	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1707.06905850643	1707.06905850643
"healthy-1"	"2019-08-01-count-2:GACAGCCGTATCCTCC"	2.28459157523457	-10.0177107087341	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACAGCCGTATCCTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.93294780074	43.0008994121927	0.0170575339775327	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2514.94213497075	2514.94213497075
"healthy-1"	"2019-08-01-count-4:AAGGTAACATTCGGGC"	1.34998240050618	-9.15715696727904	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGTAACATTCGGGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2370.14480953406	39.7905744955722	0.0167882461592693	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2365.96919172167	2365.96919172167
"healthy-1"	"2019-08-01-count-3:GTAGAAAGTAAGAACT"	-4.39823518219646	3.57777760112611	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAAAGTAAGAACT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2765.74396148294	43.6114475361499	0.0157684327050889	3812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2760.80958569969	2760.80958569969
"healthy-1"	"2019-08-01-count-2:GTCTCACCAATAGTAG"	0.607291300862473	9.80495355213014	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACCAATAGTAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.72233216728	42.625436591129	0.0230567002136868	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1839.64555380155	1839.64555380155
"healthy-1"	"2019-08-01-count-2:GGTAACTAGGTTGAGC"	3.7038480239803	-10.4718094102112	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTAGGTTGAGC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.48135083648	46.4392940543306	0.0217771161450553	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2130.68834066915	2130.68834066915
"healthy-1"	"2019-08-01-count-3:ATCACGACAGCGTACC"	1.47756340083424	9.94378659808961	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGACAGCGTACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.19323129661	35.2297251212944	0.0202563605281684	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1736.4188243425	1736.4188243425
"healthy-1"	"2019-08-01-count-4:CTTTCGGCATATGCGT"	-5.39423928681071	-5.04499914562377	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGCATATGCGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3016.21140661776	43.7502755797279	0.0145050428109041	4363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3011.98138970066	3011.98138970066
"healthy-1"	"2019-08-01-count-1:CATGCCTGTTACACTG"	0.858703692525071	9.89959905231325	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATGCCTGTTACACTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.6742789102	29.929797401325	0.0153119103905188	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1941.8290500822	1941.8290500822
"healthy-1"	"2019-08-01-count-4:ATAGGCTAGATAACAC"	0.991495688527268	10.1504449614319	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTAGATAACAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1724.9784974247	39.9706706972768	0.0231716921439606	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1719.25443248861	1719.25443248861
"healthy-1"	"2019-08-01-count-2:AGTAGCTGTAGTGATA"	1.84325697001759	-4.52690603649291	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTGTAGTGATA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2471.4465927359	40.5959792763172	0.0164259990062651	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2467.91538161656	2467.91538161656
"healthy-1"	"2019-08-01-count-3:GTAGAAAAGCCTCTCT"	2.49744023856465	-10.557906173822	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAAAAGCCTCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.29117593347	38.200989935797	0.0159550310003141	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2390.83305418715	2390.83305418715
"healthy-1"	"2019-08-01-count-3:GTGGAAGTCGCAATTG"	1.24900307235066	9.30074117267457	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGTCGCAATTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1658.90901641331	39.7400340845535	0.0239555235949435	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1653.730022002	1653.730022002
"healthy-1"	"2019-08-01-count-4:CAGATACAGATCACTC"	0.820494850247544	9.5702333220276	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATACAGATCACTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1683.48787277275	37.5127560628405	0.0222827598995744	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1675.62410435271	1675.62410435271
"healthy-1"	"2019-08-01-count-3:TCACGCTCATTGACCA"	8.74312367019002	8.15302655780641	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTCATTGACCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2545.5530901183	44.4174589121806	0.0174490404794961	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2537.76432129693	2537.76432129693
"healthy-1"	"2019-08-01-count-4:CTCATGCTCACTTGGA"	-5.11168895188029	-5.21994354641112	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCTCACTTGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2906.16329274623	40.7306072780964	0.0140152507533764	3639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2900.91613781116	2900.91613781116
"healthy-1"	"2019-08-01-count-3:TTCTCTCCAAACGGCA"	2.93250503119771	-10.5476265183655	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTCTCCAAACGGCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.80115918421	41.7191247778501	0.0173627037836183	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.01290732039	2399.01290732039
"healthy-1"	"2019-08-01-count-2:TGTGAGTGTTTGTGGT"	-5.10786662522014	3.74086735332338	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTGTTTGTGGT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2389.71128661301	43.8392580056078	0.0183450018632762	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2386.13270763384	2386.13270763384
"healthy-1"	"2019-08-01-count-2:ATGTCCCCAAACTAAG"	1.00828226384465	11.2658147581848	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCCAAACTAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1971.06088614812	34.4403800020907	0.0174730168124815	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1965.62909058567	1965.62909058567
"healthy-1"	"2019-08-01-count-2:TGCGGCACAACAAGAT"	-2.46510229530986	3.69786975467531	"2019-08-01-count-2"	"Control1"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGCACAACAAGAT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3116.22968388612	43.3345466839175	0.0139060823751209	5350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3111.248923705	3111.248923705
"healthy-1"	"2019-08-01-count-2:TTGACCCTCGGCATAT"	1.98181678828542	-10.4720316163269	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCTCGGCATAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.50476150329	46.4786006632409	0.0192417756338079	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.69569679034	2405.69569679034
"healthy-1"	"2019-08-01-count-4:AACAACCCACGTAACT"	7.79608597335164	-8.47787859356078	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	33	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAACCCACGTAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2138.50510239505	48.9861427129025	0.0229067223912816	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2134.90123321466	2134.90123321466
"healthy-1"	"2019-08-01-count-4:GAAACCTGTCTGTGAT"	1.44182028350179	9.64505574786989	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAACCTGTCTGTGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1742.43958752385	37.5410557137854	0.0215451117976115	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1732.84186066056	1732.84186066056
"healthy-1"	"2019-08-01-count-3:GTGGAAGTCTACCTTA"	6.93484367904012	-1.11005809223326	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGTCTACCTTA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2015.11961054261	43.9744541956418	0.0218222550986941	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2001.54523900328	2001.54523900328
"healthy-1"	"2019-08-01-count-2:ACTTCGCTCATTACGG"	2.74134029921834	-10.1961975327698	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCTCATTACGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.27653022633	39.8998631278214	0.0161847414026849	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2461.42197545984	2461.42197545984
"healthy-1"	"2019-08-01-count-1:CTTCAATTCAACGTGT"	1.42787661132161	9.93320272052614	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTTCAATTCAACGTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.93791232356	39.0859983243718	0.0201169569426071	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1931.54611881628	1931.54611881628
"healthy-1"	"2019-08-01-count-3:GCGTGCAGTCCTTTGC"	11.2157856422359	3.72690818393556	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTGCAGTCCTTTGC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1684.42729195837	34.2181489832181	0.0203144114005865	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1680.33817624053	1680.33817624053
"healthy-1"	"2019-08-01-count-3:TGCGATAAGATCCCGC"	8.87196983870808	7.38768861377565	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGATAAGATCCCGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1852.67454258478	36.9311349199339	0.0199339571365886	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1849.32250388946	1849.32250388946
"healthy-1"	"2019-08-01-count-4:TTCCACGTCACTCGAA"	7.70482077178304	6.28726575458375	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGTCACTCGAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.62737002154	38.2076399609219	0.0197187759380676	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1930.96426027296	1930.96426027296
"healthy-1"	"2019-08-01-count-4:GCCGTGAAGGATCATA"	1.69565143164937	-8.86992361461791	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGTGAAGGATCATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1727.64605883054	41.6978377854695	0.0241356367945499	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1724.04993071763	1724.04993071763
"healthy-1"	"2019-08-01-count-2:TTACCGCTCCGTCACT"	1.74610652503316	-10.0891523591247	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCTCCGTCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.90485702657	42.9876452492155	0.017912228946641	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.15590504201	2397.15590504201
"healthy-1"	"2019-08-01-count-4:AGGACTTAGTCACTAC"	1.83690096911733	-9.22711470043334	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACTTAGTCACTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2386.35000893694	43.8996710229229	0.0183961576711369	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2386.35000893694	2386.35000893694
"healthy-1"	"2019-08-01-count-4:TCATGCCTCTCCAATT"	1.1425996023113	10.0510940321716	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGCCTCTCCAATT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.21614544517	35.1435262820764	0.0183304977717659	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1913.30441000807	1913.30441000807
"healthy-1"	"2019-08-01-count-2:CGAAGTTAGGAACTCG"	8.79802670058553	8.02314422214357	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTAGGAACTCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2136.56826161061	41.7660079772157	0.0195481739234164	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2129.8241750353	2129.8241750353
"healthy-1"	"2019-08-01-count-2:TGTAAGCCAAGACCTT"	2.30280007895772	-10.5140714875427	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAAGCCAAGACCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.73652832502	41.549104220796	0.0167960911540281	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2469.21074778222	2469.21074778222
"healthy-1"	"2019-08-01-count-2:AAGTGAAGTGGCCCAT"	8.54890789565389	8.08451745593873	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAAGTGGCCCAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2211.47280293686	42.9701100532848	0.0194305396820708	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2208.44936288557	2208.44936288557
"healthy-1"	"2019-08-01-count-3:CTCCAACTCTTGTGCC"	6.86546721038167	-1.17360653793486	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACTCTTGTGCC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2564.44521996974	40.5085093715967	0.015796207716254	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2558.42689170528	2558.42689170528
"healthy-1"	"2019-08-01-count-4:GTAGGAGAGAGGCGTT"	-0.21184347096141	13.6002349623474	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGAGAGGCGTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1636.41274537954	40.7192704263896	0.0248832518210101	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1634.14601644571	1634.14601644571
"healthy-1"	"2019-08-01-count-2:GACGCTGTCAAAGCCT"	1.1388735967571	10.3527087935242	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGCTGTCAAAGCCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.71974590343	38.4106136818216	0.021271636292931	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1799.62963658028	1799.62963658028
"healthy-1"	"2019-08-01-count-4:TTCCGGTCAAGGTTGG"	-2.14918671074565	13.0896053084168	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTCAAGGTTGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1798.44883390051	47.2788784953509	0.0262886981292715	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1790.3368197176	1790.3368197176
"healthy-1"	"2019-08-01-count-3:CTCCACACATGTCAGT"	1.32507171210591	9.80115315997926	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACACATGTCAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.64943041596	36.1666095075557	0.0193751482834655	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1857.70860371208	1857.70860371208
"healthy-1"	"2019-08-01-count-4:GCGAGAAAGCTAGAGC"	1.60549976405446	-4.88997700130614	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAAAGCTAGAGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2303.2928996611	40.7502543191216	0.0176921720746491	2057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2299.03843265427	2299.03843265427
"healthy-1"	"2019-08-01-count-1:GCGATCGGTCGCTTGG"	8.18530811843221	7.27973315799562	"2019-08-01-count-1"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCGATCGGTCGCTTGG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1823.77358500886	42.6663951277305	0.0233945679871897	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1812.99726602968	1812.99726602968
"healthy-1"	"2019-08-01-count-4:CGTGAATAGAGAGCCT"	2.86814488944356	-10.3747015229431	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGAATAGAGAGCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.85732848976	41.5979377325176	0.0182779198026977	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2267.17837518795	2267.17837518795
"healthy-1"	"2019-08-01-count-3:TGGATGTTCGCCACTT"	1.54141833361928	-9.32441522991332	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATGTTCGCCACTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.70435818287	47.7163000081484	0.0203767396347059	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2336.37082388674	2336.37082388674
"healthy-1"	"2019-08-01-count-2:CCTAAGAAGTGCCTCG"	-7.55412612381633	4.35246894443361	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAAGAAGTGCCTCG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2043.64168116623	42.6948225507152	0.0208915403048301	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2032.81463777476	2032.81463777476
"healthy-1"	"2019-08-01-count-3:ATCGGCGAGAAGCGGG"	6.96583809432332	-1.12022330677184	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGAGAAGCGGG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2350.36465585373	43.6066637321915	0.0185531481779163	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2345.03616619482	2345.03616619482
"healthy-1"	"2019-08-01-count-4:GCCGTGATCATCGCTC"	2.53782357749287	-10.2953529587952	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGTGATCATCGCTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.75256441131	39.9572311408593	0.0156281181437123	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2554.19906222534	2554.19906222534
"healthy-1"	"2019-08-01-count-4:GAAGGGTCAATCGCAT"	6.71142830428426	-0.83575894748839	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGGTCAATCGCAT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1457.05157375758	45.8559656112839	0.0314717518838584	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	1452.64183807807	1452.64183807807
"healthy-1"	"2019-08-01-count-4:CACTTCGCAGAACGCA"	-2.37649307671245	13.303587890509	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTTCGCAGAACGCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2144.59143882126	41.1799784256653	0.0192017825308018	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2141.31679343642	2141.31679343642
"healthy-1"	"2019-08-01-count-4:TTGGATGTCGGCTCTT"	-4.89225373688396	-5.2988434067932	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGATGTCGGCTCTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2753.73596047648	40.5555076421316	0.0147274496263303	2808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2750.85051778683	2750.85051778683
"healthy-1"	"2019-08-01-count-2:AGCGCCACACTTGGCG"	-4.42413793030437	9.09525296771852	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCCACACTTGGCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2959.34570529561	42.7457798458324	0.0144443346951121	3013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2953.1578086864	2953.1578086864
"healthy-1"	"2019-08-01-count-4:CTCGAGGCAAGCGAGT"	1.35897054251973	11.0817832716736	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGCAAGCGAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1829.09045689138	36.9577504514156	0.0202055345661947	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1820.15707874532	1820.15707874532
"healthy-1"	"2019-08-01-count-4:AACAGGGCACCACTGG"	-4.62118087235149	3.68076942050783	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGCACCACTGG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2676.548818683	46.8015031680453	0.0174857648182461	3671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2669.91249511266	2669.91249511266
"healthy-1"	"2019-08-01-count-4:AACAGGGAGCTTCTAG"	11.0267340141231	4.0372652777466	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGAGCTTCTAG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1853.59847871779	33.7199430995776	0.0181916113369401	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1848.40685258707	1848.40685258707
"healthy-1"	"2019-08-01-count-3:GACCTTCCATCTCATT"	-7.51643691483195	1.40116272056428	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCCATCTCATT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2647.44864373277	43.1773202920603	0.0163090303542895	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2639.75086842385	2639.75086842385
"healthy-1"	"2019-08-01-count-4:GTAGAAATCTCTCCGA"	2.29407801207845	-10.2964592210022	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAAATCTCTCCGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2236.51414588323	45.9283049419896	0.0205356648544031	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2233.84659501224	2233.84659501224
"healthy-1"	"2019-08-01-count-3:TACCGAAGTGACAGGT"	1.15667845782582	10.7852830656799	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCGAAGTGACAGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.83930111594	28.4608402014842	0.0168722890097804	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1679.9677888481	1679.9677888481
"healthy-1"	"2019-08-01-count-4:AATTCCTCATGACTTG"	-7.2684248489445	4.42186591708986	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTCCTCATGACTTG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2441.62941338709	39.7760224244554	0.0162907696828885	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2432.09772821618	2432.09772821618
"healthy-1"	"2019-08-01-count-3:TGCTTGCCAGATCCAT"	1.10176863250081	9.58741948688356	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCCAGATCCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1581.1583814812	38.507725043768	0.0243541225817585	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1574.80961612656	1574.80961612656
"healthy-1"	"2019-08-01-count-4:TGCAGTAGTATCACCA"	-1.50568566742595	11.1505861052307	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTAGTATCACCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.61454364844	39.6396613769411	0.0197250072170435	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2004.7408018376	2004.7408018376
"healthy-1"	"2019-08-01-count-3:GTCATGACACAGCCAC"	2.10794772681538	-10.5058269730774	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATGACACAGCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.3806283397	43.2668527756293	0.0183693676746114	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2351.88275269763	2351.88275269763
"healthy-1"	"2019-08-01-count-1:GGTTAACCAAATACAG"	1.53941990908925	9.85953710162965	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTTAACCAAATACAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1875.04920613592	35.5012256597183	0.0189334901417754	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1869.75666895316	1869.75666895316
"healthy-1"	"2019-08-01-count-2:TTGTTGTGTGGCATCC"	1.8451929288799	-10.1744919053284	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTGTGTGGCATCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2418.61620122298	44.0543620892672	0.0182146973409799	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2414.55692563989	2414.55692563989
"healthy-1"	"2019-08-01-count-3:TGCTTGCTCTTGATTC"	11.0948883491451	3.86923167789308	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCTCTTGATTC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2017.57979389758	44.9597284196888	0.0222839902320964	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2014.37182071998	2014.37182071998
"healthy-1"	"2019-08-01-count-4:CCTAACCAGCACTAAA"	-5.60438762131389	-4.54921200191649	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCAGCACTAAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3006.91710649177	42.69408699595	0.0141986245326736	4098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3003.31736521538	3003.31736521538
"healthy-1"	"2019-08-01-count-2:TGGAGGACAATGCAAA"	1.31324424323384	11.4351844557556	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGACAATGCAAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1729.27709627005	34.9964075315307	0.0202375938517985	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1724.46322545559	1724.46322545559
"healthy-1"	"2019-08-01-count-2:TTGTTTGCAACGGGTA"	-1.01597581329997	12.4456214674744	"2019-08-01-count-2"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGCAACGGGTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1917.3215090732	37.0067575804566	0.0193012791049035	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1917.3215090732	1917.3215090732
"healthy-1"	"2019-08-01-count-3:GATGATCAGCCATGCC"	1.81895091113393	-10.0079584351745	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGATCAGCCATGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.74670208597	39.2042311814984	0.0165296872330498	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.21530147311	2369.21530147311
"healthy-1"	"2019-08-01-count-3:GCTTGGGTCATAGGCT"	10.8773542838985	4.12849996173707	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGTCATAGGCT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.43703356642	40.4548500533233	0.0206567019311582	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1951.76561025158	1951.76561025158
"healthy-1"	"2019-08-01-count-2:GACTTCCGTTACACAC"	-0.0388706875150979	11.4403648146423	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCGTTACACAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.58868251042	43.0591077894541	0.0219623361970648	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1952.72273321449	1952.72273321449
"healthy-1"	"2019-08-01-count-3:AAGGAATAGTCATCGT"	-0.98710940304454	10.919895149115	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATAGTCATCGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1885.81881920262	43.7435652720954	0.0231960593598231	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1882.18775288657	1882.18775288657
"healthy-1"	"2019-08-01-count-4:CGTCAAAGTCCAGTTA"	-0.713575283915359	10.856099105719	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCAAAGTCCAGTTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1779.52255866758	34.220611109085	0.0192302204557091	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1775.3498077025	1775.3498077025
"healthy-1"	"2019-08-01-count-4:ACAAAGAGTATCAAGA"	3.10875310477559	-10.6904287568298	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGAGTATCAAGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.17807152682	38.1427651711042	0.0162643364417404	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2336.01544931086	2336.01544931086
"healthy-1"	"2019-08-01-count-3:CTACGGGTCATGCGGC"	-1.02871344509776	13.1667871245178	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGTCATGCGGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1898.40356315886	30.8859013704814	0.0162694076064041	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1896.43755276834	1896.43755276834
"healthy-1"	"2019-08-01-count-2:GAAGCGACATTGCCGG"	1.74754275855367	-10.1106176606384	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGACATTGCCGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2498.31472833581	40.1190047444229	0.0160584270225822	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2494.34867320124	2494.34867320124
"healthy-1"	"2019-08-01-count-4:GCAGCCACATTGTACG"	-3.018941740424	-5.34035780346068	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCACATTGTACG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2651.90860638042	42.3464795636749	0.0159683027770227	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2651.24937294649	2651.24937294649
"healthy-1"	"2019-08-01-count-3:GAGAGGTGTAGACGTG"	-4.47352443161662	-5.39326670086058	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTGTAGACGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2474.54170849887	41.9894109510874	0.016968560605333	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2473.61570510688	2473.61570510688
"healthy-1"	"2019-08-01-count-2:TGGATGTCAGTCAGCC"	14.1264921623165	1.79771945560304	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATGTCAGTCAGCC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1282.85145056316	23.2792794443104	0.0181465121578114	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1270.11820654553	1270.11820654553
"healthy-1"	"2019-08-01-count-3:AGACACTCATTCACCC"	8.10429729995076	7.41431138599244	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTCATTCACCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.73385456665	39.9457023883538	0.0203832282099279	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1956.0508305198	1956.0508305198
"healthy-1"	"2019-08-01-count-2:GTCTAGAAGTGGTTGG"	1.68526293811147	-9.73362829601439	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTAGAAGTGGTTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.9872566423	40.6109893410805	0.0171066585245784	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2368.89922493893	2368.89922493893
"healthy-1"	"2019-08-01-count-4:AAGACAAAGCGTTCAT"	1.51444425162618	-8.85494425213011	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGACAAAGCGTTCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2066.25793920675	43.9468353361096	0.0212688041034127	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2063.9850750152	2063.9850750152
"healthy-1"	"2019-08-01-count-1:TACGGGCCATTCTCCG"	2.44944920119588	-10.4742117158142	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACGGGCCATTCTCCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.26664167653	44.9600512863035	0.0175196336016476	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2561.42939295595	2561.42939295595
"healthy-1"	"2019-08-01-count-3:TTGGTTTTCCACAGCG"	1.25314750251119	-9.14693071758422	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGTTTTCCACAGCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2424.11666691284	39.558329245628	0.0163186573425141	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2421.05832420768	2421.05832420768
"healthy-1"	"2019-08-01-count-3:TAGAGTCAGGAATGTT"	6.8286096054012	-1.04702653801116	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGAGTCAGGAATGTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1806.05607619734	46.4191152039201	0.0257019235535897	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	1797.49798001214	1797.49798001214
"healthy-1"	"2019-08-01-count-4:TGGGTTAAGGTGAGCT"	2.94076528128926	-10.4094610444275	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGTTAAGGTGAGCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.3111536962	42.6745832478497	0.0181184482487081	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2352.37672854284	2352.37672854284
"healthy-1"	"2019-08-01-count-4:TCATCATCAAGTAGTA"	1.82427205619161	-10.0468063584534	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCATCAAGTAGTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2527.90965196122	47.500870965615	0.0187905730447141	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2523.41021924794	2523.41021924794
"healthy-1"	"2019-08-01-count-2:TAAGCGTGTACTCGAT"	3.14861931380574	-10.7099914780823	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCGTGTACTCGAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.86351943185	41.5307328000538	0.0165338333387825	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2508.23726247079	2508.23726247079
"healthy-1"	"2019-08-01-count-2:TGTTCATTCCCGAAAT"	-3.4163592857426	3.60144374454347	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATTCCCGAAAT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2968.87501805964	47.1542004347385	0.0158828512981853	4071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	2963.69663124829	2963.69663124829
"healthy-1"	"2019-08-01-count-4:GTTACGATCCACGAAT"	2.49922384795491	-8.02916147625121	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGATCCACGAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.86425658258	45.4655012852865	0.0221150307661182	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2049.61906955779	2049.61906955779
"healthy-1"	"2019-08-01-count-3:ATGGTTGTCCGGGACT"	2.99684681472127	-10.848267578241	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGTTGTCCGGGACT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.11796783911	42.3559752907349	0.0168271713252663	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2513.37918926586	2513.37918926586
"healthy-1"	"2019-08-01-count-3:CCACTTGTCCCGAGTG"	11.0316244560177	4.14958283984987	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGTCCCGAGTG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.51024615458	29.9525485589412	0.0153013495677897	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1950.43743805593	1950.43743805593
"healthy-1"	"2019-08-01-count-4:TCATGCCTCGGCATTA"	1.42159988459889	-9.2740164033142	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGCCTCGGCATTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2438.69446206889	46.785119328744	0.0191844940218765	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2431.76604718579	2431.76604718579
"healthy-1"	"2019-08-01-count-2:GTCCTCAGTGACAACG"	2.35473122176473	-10.2202205888	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCAGTGACAACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.44267068875	39.2686329632936	0.0158504709020679	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2472.71311737677	2472.71311737677
"healthy-1"	"2019-08-01-count-4:CGATCGGGTTAAACCC"	2.18519773063008	-10.7800026169983	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATCGGGTTAAACCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.45272288731	34.8160260767032	0.013885017954242	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2497.76160656992	2497.76160656992
"healthy-1"	"2019-08-01-count-4:CCGTGAGTCCCGATCT"	1.96822549876515	-10.4115677109924	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTGAGTCCCGATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2176.81544149835	25.1455557295972	0.0115515331480233	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2170.65278908216	2170.65278908216
"healthy-1"	"2019-08-01-count-3:TCTATCATCGTTTACT"	2.59543742713277	-10.6615591279236	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATCATCGTTTACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.28774619502	39.6365812501823	0.0157083080635382	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.11138728637	2516.11138728637
"healthy-1"	"2019-08-01-count-4:TGTACAGTCTTCGTAT"	2.24714173850362	-10.3224277726379	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGTCTTCGTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2164.08013703606	40.9300500490799	0.0189133707890957	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2157.86517337102	2157.86517337102
"healthy-1"	"2019-08-01-count-3:TACACCCGTGATACTC"	2.91498102721516	-10.5441694489685	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCGTGATACTC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.69531299912	40.1588619868439	0.0170042518888036	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.12563183355	2359.12563183355
"healthy-1"	"2019-08-01-count-4:ACACCAAAGTTAACGA"	4.37961544570271	-10.8049698106018	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAAAGTTAACGA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2603.22159441434	44.0756468505814	0.0169311928516394	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2596.57157290072	2596.57157290072
"healthy-1"	"2019-08-01-count-3:TTGTTCAGTACAGTAA"	1.88056470927541	-10.2539224854675	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTCAGTACAGTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.26090524527	38.4279493498062	0.0160970882006959	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.86441962405	2383.86441962405
"healthy-1"	"2019-08-01-count-4:AAGCCATGTAGACGTG"	11.3493153053219	3.60366175258485	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATGTAGACGTG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.69057391281	37.9831702571179	0.0193329019650519	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1959.84413225166	1959.84413225166
"healthy-1"	"2019-08-01-count-3:TAGGAGGAGCCTGGAA"	-5.1648772758549	2.31617829883424	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGAGCCTGGAA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2296.27363171622	46.526097553193	0.020261565046331	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2289.60712339837	2289.60712339837
"healthy-1"	"2019-08-01-count-2:TTTCAGTAGTAAACTG"	-8.16790423813518	3.81466219508973	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCAGTAGTAAACTG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1975.80434935878	45.5845475309468	0.0230713873798995	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1967.3697856975	1967.3697856975
"healthy-1"	"2019-08-01-count-2:TTGAGTGCAACGACAG"	2.4595169025356	-10.5417900315491	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAGTGCAACGACAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.47993209868	40.2241600344273	0.0167567158119336	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2394.70521329386	2394.70521329386
"healthy-1"	"2019-08-01-count-4:GGAACCCCACGACAAG"	2.98761643943135	-10.6065483323303	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCCACGACAAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.55185561799	40.1172750715801	0.0159667451168736	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2508.84411547735	2508.84411547735
"healthy-1"	"2019-08-01-count-4:CCTCATGGTATCTCTT"	-1.15071974220927	13.646439529303	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGGTATCTCTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1854.27435801408	20.7927008283308	0.0112133896143609	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1850.11491693886	1850.11491693886
"healthy-1"	"2019-08-01-count-3:ACCAACAAGGGAGGGT"	2.69673981246297	-10.6499691239563	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACAAGGGAGGGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.65283934169	39.6862933009135	0.0183592353862887	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2156.97020683175	2156.97020683175
"healthy-1"	"2019-08-01-count-3:CCGGTAGCAATACCTG"	14.0725065666134	1.71163091743318	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTAGCAATACCTG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1285.80684039622	32.6089944120709	0.0253607255674753	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1271.56540474864	1271.56540474864
"healthy-1"	"2019-08-01-count-3:TGGGCTGAGCTTTCTT"	1.85116245326344	-10.373899482843	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCTGAGCTTTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.72834894641	42.0340956412356	0.0169647716462176	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2475.21666294015	2475.21666294015
"healthy-1"	"2019-08-01-count-4:GCCAACGTCACCATGA"	-4.56872449341472	3.66399738872377	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGTCACCATGA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2625.28569129862	41.3976119655593	0.0157688026498486	3266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2619.29090558584	2619.29090558584
"healthy-1"	"2019-08-01-count-4:GTAAGTCTCAGTCAGT"	1.73688818988149	-9.95660974895629	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAAGTCTCAGTCAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.78349599638	40.3039279905273	0.0165533929636046	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2429.814164409	2429.814164409
"healthy-1"	"2019-08-01-count-3:GTTATGGAGCGCTGAA"	3.21866979178731	-10.6522188416687	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTATGGAGCGCTGAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.64648104813	38.828982421223	0.0158962759132307	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2436.04878517749	2436.04878517749
"healthy-1"	"2019-08-01-count-1:TCCCAGTGTTCATCTT"	8.033699174493	6.75580213153688	"2019-08-01-count-1"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCCAGTGTTCATCTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1795.95754507596	36.8018369750258	0.0204914849328853	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1787.03985330236	1787.03985330236
"healthy-1"	"2019-08-01-count-3:GTCTTTACAGGCCCTA"	-2.78596744957622	9.36933610523073	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTTTACAGGCCCTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2215.73453975052	40.5927976189548	0.0183202440954526	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2212.01889774057	2212.01889774057
"healthy-1"	"2019-08-01-count-2:CGCCATTGTCTGCATA"	2.24180593070332	-10.0518398514953	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCATTGTCTGCATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1834.21828207196	43.0475062227945	0.0234691294070885	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1829.49216521426	1829.49216521426
"healthy-1"	"2019-08-01-count-4:CTTTCGGTCTCGTGGG"	1.81651224669759	-10.1746378174988	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGTCTCGTGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.52119074811	38.3837804772858	0.0168311439652504	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.57683327168	2272.57683327168
"healthy-1"	"2019-08-01-count-2:TCGGTCTGTGCCGTAC"	1.45756878432576	9.90515801990358	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGTCTGTGCCGTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.68907417134	37.5784434671763	0.021138929193618	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1772.7941486727	1772.7941486727
"healthy-1"	"2019-08-01-count-2:ACTGTGATCTCTCAAT"	2.39799274977986	-10.3683948746887	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTGATCTCTCAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.2954525218	42.8995915639959	0.0166194038431692	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2574.27463413791	2574.27463413791
"healthy-1"	"2019-08-01-count-3:ATCACAGTCTGGGATT"	7.85202517089192	7.71418521488038	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGTCTGGGATT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1777.75980201693	38.3381367896302	0.0215654200000103	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1774.13761521069	1774.13761521069
"healthy-1"	"2019-08-01-count-4:TGCGGCATCAGCCTCT"	-4.44536958161052	-5.57515194332274	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGCATCAGCCTCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2384.08417901188	53.3492609549438	0.0223772555619472	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2382.43120406262	2382.43120406262
"healthy-1"	"2019-08-01-count-3:GAGCTGCAGGTGTGAC"	2.82675828513448	-10.7631120911804	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCAGGTGTGAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.35160440236	48.3650228585662	0.0217629932017767	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2216.80682450521	2216.80682450521
"healthy-1"	"2019-08-01-count-2:CATTTCATCATCTGTT"	-7.28513656082805	0.0847786639812364	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCATCATCTGTT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2403.50197178866	31.4647384500342	0.0130912055905735	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2398.67450510311	2398.67450510311
"healthy-1"	"2019-08-01-count-4:GGCAGTCGTGCTGATT"	3.22643985328023	-10.6256809464661	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCAGTCGTGCTGATT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.08822971912	43.802866493696	0.0199822552303511	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2189.61921944847	2189.61921944847
"healthy-1"	"2019-08-01-count-4:GGCAGTCGTACTTCCC"	11.2812153297359	3.80765626514284	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCAGTCGTACTTCCC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1699.30511659741	18.2474537640402	0.0107381856182355	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1688.4163236407	1688.4163236407
"healthy-1"	"2019-08-01-count-3:GTGAGTTCACAGCATT"	-0.887548665434676	13.1633844145569	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGTTCACAGCATT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2039.68987398495	48.4987504248799	0.0237775119852548	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2032.73208634356	2032.73208634356
"healthy-1"	"2019-08-01-count-3:GAACACTAGACTACCT"	2.54686870154683	-10.3222103348938	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTAGACTACCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.34385677902	38.1479094946926	0.0157939870083611	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2412.35882157622	2412.35882157622
"healthy-1"	"2019-08-01-count-4:TATCCTACAAGGCGTA"	2.66777004775349	-10.5002613297668	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCCTACAAGGCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.9875270436	42.8999823239509	0.0183884319254439	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2327.87799421776	2327.87799421776
"healthy-1"	"2019-08-01-count-3:GTTACAGTCACCGGTG"	1.85520579394643	-10.1646442643371	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGTCACCGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.07339686666	38.8061711149746	0.0173779201209533	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2228.27957715592	2228.27957715592
"healthy-1"	"2019-08-01-count-2:GAGGCAATCAGTGTCA"	-6.7334774536198	1.76786420429078	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	52	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCAATCAGTGTCA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1384.30061708593	44.6304733369524	0.0322404489213501	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1383.25611884745	1383.25611884745
"healthy-1"	"2019-08-01-count-3:GTGAGGAGTGCTCTTC"	8.10960259017293	7.23600146854249	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGAGTGCTCTTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1828.24063100822	39.8057536249624	0.0217727103040099	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1814.57367950607	1814.57367950607
"healthy-1"	"2019-08-01-count-2:CGGAATTCAACATACC"	-7.91854033890422	-0.562546931859575	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTCAACATACC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2773.35169056575	43.6347151956409	0.0157335672010424	4319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2766.30017013864	2766.30017013864
"healthy-1"	"2019-08-01-count-2:GGTGTTACACGGTGTC"	1.95757236060445	-9.61780359661254	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTACACGGTGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.13813955476	44.1571253211436	0.0196678879322323	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2237.99563172362	2237.99563172362
"healthy-1"	"2019-08-01-count-2:CAGATTGTCGCAGTTA"	1.31329097327535	-8.82039072429808	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGTCGCAGTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.4309457877	41.9748524353474	0.017334730320667	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2419.68091240844	2419.68091240844
"healthy-1"	"2019-08-01-count-3:TGTAACGCATGGTACT"	-1.68295071545299	12.4776534804138	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAACGCATGGTACT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.69709598072	39.879236083329	0.0205277684132209	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1940.9262962085	1940.9262962085
"healthy-1"	"2019-08-01-count-2:CCACTTGCAAGACGGT"	1.84692897376363	-10.2718286744324	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGCAAGACGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.21907730504	36.4880048294699	0.0146761020227636	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2483.55332235711	2483.55332235711
"healthy-1"	"2019-08-01-count-3:TATACCTGTCGAATGG"	-7.77714238587077	1.66060350025026	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTGTCGAATGG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2588.75723562849	31.4370388262694	0.0121436797524343	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2578.60158417947	2578.60158417947
"healthy-1"	"2019-08-01-count-2:CGGACACAGGGTGAAA"	-3.69000826302226	-5.49134399807128	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGACACAGGGTGAAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2805.61478131569	40.6672524855028	0.0144949523207288	3008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2801.33567644715	2801.33567644715
"healthy-1"	"2019-08-01-count-2:TTACCATTCCACGTGG"	1.10832049426381	10.2502984770569	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATTCCACGTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.21964411891	35.4098874921399	0.0188128349434562	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1878.10356900154	1878.10356900154
"healthy-1"	"2019-08-01-count-1:TGCTGAAGTAGCTCGC"	0.542086263268632	8.54100987994996	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCTGAAGTAGCTCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.19178836571	34.5756346073523	0.0194661605992253	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1769.17405364318	1769.17405364318
"healthy-1"	"2019-08-01-count-4:CCTCTCCCATGCAGGA"	1.23573185977284	9.58658216083375	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCCATGCAGGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1958.47415663211	38.6415517849172	0.0197304374193873	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1954.03663302909	1954.03663302909
"healthy-1"	"2019-08-01-count-4:CTCATTATCGCTTAAG"	1.30008186873738	10.5480985411438	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATTATCGCTTAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.31291534565	48.4352441508774	0.0251832365729072	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1915.26099926793	1915.26099926793
"healthy-1"	"2019-08-01-count-1:CTTCTCTCACAAACGG"	1.19745959815328	10.3550004729065	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTTCTCTCACAAACGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2083.78747295886	35.1830250276397	0.016884171483036	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2079.33360232386	2079.33360232386
"healthy-1"	"2019-08-01-count-2:TTACGCCCAGCTGTGC"	2.44160236892049	-10.4230804673401	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCCAGCTGTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.16448426321	38.3765440902841	0.0163154168626542	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2346.35768056276	2346.35768056276
"healthy-1"	"2019-08-01-count-4:CATAGACAGACCTCAT"	-0.916607479483444	13.5645761259827	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAGACAGACCTCAT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2470.60414863922	45.4254160860033	0.0183863595109007	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2462.89991614738	2462.89991614738
"healthy-1"	"2019-08-01-count-4:CTGTCGTCAGTTGGTT"	1.65708901461903	-10.1108227006164	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTCGTCAGTTGGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.49837873633	40.3265188837092	0.0166123772674574	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2424.62086473726	2424.62086473726
"healthy-1"	"2019-08-01-count-4:GTTAGTGCACGATTCA"	-3.73846779289897	-5.49011900341185	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGCACGATTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2452.24346549608	41.7125100300492	0.0170099382940392	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2450.5959273007	2450.5959273007
"healthy-1"	"2019-08-01-count-4:CCGATCTGTTACGGAG"	7.84477676925008	-10.4766092530456	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATCTGTTACGGAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.56007753154	46.6512337570619	0.022454818159815	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2073.69952310267	2073.69952310267
"healthy-1"	"2019-08-01-count-2:ATCGTAGTCCCGTGAG"	1.81100120124165	-9.75310900127562	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTAGTCCCGTGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.70076151998	40.5656378040861	0.0174123812268575	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2324.20451074252	2324.20451074252
"healthy-1"	"2019-08-01-count-2:TACCTGCAGCGAATGC"	2.29673304137532	-10.6876259080139	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTGCAGCGAATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.72105741488	41.6206104951669	0.018775754556915	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2211.58471995811	2211.58471995811
"healthy-1"	"2019-08-01-count-4:TCGCAGGGTACGAGTG"	11.138312001794	3.7912273176941	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCAGGGTACGAGTG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1583.68182614617	38.9952446799588	0.0246231560128794	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1579.68324580428	1579.68324580428
"healthy-1"	"2019-08-01-count-2:CGGGACTTCTTGGTCC"	-7.67649207535441	3.38606951320497	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGACTTCTTGGTCC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2415.66180185217	46.9622821202145	0.0194407520474128	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2404.22121397099	2404.22121397099
"healthy-1"	"2019-08-01-count-3:ATTACTCCAGACCAAG"	-0.953244428068954	12.9843683012756	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCCAGACCAAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1863.21728423833	42.4098131328239	0.022761603540062	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1857.92043152316	1857.92043152316
"healthy-1"	"2019-08-01-count-2:TACCTGCTCAGTCCGG"	1.0599260526592	9.9533710249695	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTGCTCAGTCCGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.80104531279	39.9615365926988	0.0225033861187191	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1772.0782191936	1772.0782191936
"healthy-1"	"2019-08-01-count-4:TTGCTGCCATACCACA"	6.77558149871175	-1.69148864662322	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCCATACCACA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2909.59354276709	43.3656740211025	0.0149043752619346	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2900.31527902655	2900.31527902655
"healthy-1"	"2019-08-01-count-2:AGCCAGCAGCCTCACG"	2.5903660255367	-10.7701101533142	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCAGCCTCACG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.35967030097	41.4225870565138	0.0167746268616532	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2462.55289419044	2462.55289419044
"healthy-1"	"2019-08-01-count-3:AAACGCTCACCACTGG"	14.0661837058956	1.7280862101349	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTCACCACTGG"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1514.94024075267	37.0744767301789	0.0244725671236769	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1499.08645078548	1499.08645078548
"healthy-1"	"2019-08-01-count-4:TATACCTGTGCAACAG"	3.55547346648518	-10.758776687738	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTGTGCAACAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.86191425901	41.939424717502	0.0182833257995174	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2287.56539742895	2287.56539742895
"healthy-1"	"2019-08-01-count-4:TCATCATCAGCCTTCT"	1.74896909770314	-9.21934320842894	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCATCAGCCTTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.7649414822	42.905142376719	0.0178640056050785	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.10032022316	2397.10032022316
"healthy-1"	"2019-08-01-count-2:TAAGCGTTCTCGTGGG"	14.1516376930172	1.69829235160676	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCGTTCTCGTGGG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1194.47371924724	31.8648946929772	0.0266769324259879	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1182.9734854405	1182.9734854405
"healthy-1"	"2019-08-01-count-4:CGTGAATTCTCCGAGG"	1.68171133574788	-9.75469686901244	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGAATTCTCCGAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.76306052278	44.919667385311	0.0194477382347365	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2306.91141640296	2306.91141640296
"healthy-1"	"2019-08-01-count-2:CTGTACCAGCACTAGG"	0.99896397170369	9.13541028583375	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCAGCACTAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1717.64822768894	35.6696659715251	0.0207665722215531	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1712.54975239538	1712.54975239538
"healthy-1"	"2019-08-01-count-3:CCTTCAGTCGGCATAT"	2.1211642223293	-10.5865659943786	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTCAGTCGGCATAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.36002364354	38.100871707501	0.017644520270044	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2156.01194012459	2156.01194012459
"healthy-1"	"2019-08-01-count-3:GGAATCTCATGGAATA"	8.22632755812947	-10.3134737244812	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATCTCATGGAATA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.96411218484	39.0588925587876	0.018141915296094	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2149.2843132957	2149.2843132957
"healthy-1"	"2019-08-01-count-2:TCGACCTTCACAGAGG"	-8.11510405960735	0.756971038225569	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTTCACAGAGG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2519.15048929391	39.8281846988059	0.0158101649218937	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2516.0353514548	2516.0353514548
"healthy-1"	"2019-08-01-count-4:CGAGTGCTCAGGGATG"	2.62747826155965	-10.4305076829162	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCTCAGGGATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.18562418574	39.9376353902177	0.0165772346428125	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.41939946014	2403.41939946014
"healthy-1"	"2019-08-01-count-3:TCGCACTAGGTCCGAA"	2.16148557242696	-10.3948936692444	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTAGGTCCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.49468873919	31.1285810637978	0.014249785648032	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2179.6255129185	2179.6255129185
"healthy-1"	"2019-08-01-count-2:CATTCTAAGAGCAGTC"	2.57400049743001	-10.4901762238708	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCTAAGAGCAGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.17180157853	42.5422106191123	0.0190757548763735	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2224.53683096797	2224.53683096797
"healthy-1"	"2019-08-01-count-3:ACACCAAAGAGAAGGT"	-7.67469869080241	1.77248034561006	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAAAGAGAAGGT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2495.630293242	43.4886865329342	0.0174259331002267	2822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2487.7244273448	2487.7244273448
"healthy-1"	"2019-08-01-count-4:CAGAGCCGTGGCTAGA"	2.05050613459889	-10.5228204957214	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCGTGGCTAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.94996717371	38.4808436237116	0.0172409078114056	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2230.91359497916	2230.91359497916
"healthy-1"	"2019-08-01-count-3:TTCAATCCACAAATAG"	2.50842346724812	-10.3716278306213	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAATCCACAAATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.0689027225	44.3345032067577	0.0188732238357824	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2343.45159964731	2343.45159964731
"healthy-1"	"2019-08-01-count-4:TCGACCTCAAGACCTT"	1.35609414157216	11.3949680098328	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACCTCAAGACCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.63713813639	40.8640266080348	0.021013702662902	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1937.61572982965	1937.61572982965
"healthy-1"	"2019-08-01-count-3:ACGGGTCAGTGAACAT"	8.50222935256306	7.58442733371583	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGGTCAGTGAACAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1859.96152440436	48.9370179355398	0.0263107689559393	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1856.04589721048	1856.04589721048
"healthy-1"	"2019-08-01-count-3:TTTGGTTGTTATTCTC"	1.00362851199452	9.81926915729371	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTGTTATTCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1651.11828467022	37.2265682071718	0.022546275789446	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1649.23064344873	1649.23064344873
"healthy-1"	"2019-08-01-count-3:TGCTTCGGTGACACGA"	1.18646325644795	-8.82732298290404	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTCGGTGACACGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2531.48657652761	42.4502708510784	0.0167689101118232	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2529.72094205549	2529.72094205549
"healthy-1"	"2019-08-01-count-4:AGGCATTTCTGAGGTT"	3.07288899001424	-10.6130647889343	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTTCTGAGGTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.76255688678	41.1986744975705	0.017608057867371	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2336.22690912718	2336.22690912718
"healthy-1"	"2019-08-01-count-4:TTGGGTAAGTAGATCA"	1.71770896491353	-4.9681229821411	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGTAAGTAGATCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2424.65418780285	41.8141961529013	0.0172454267347675	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2414.55468054051	2414.55468054051
"healthy-1"	"2019-08-01-count-3:CTGTAGATCAAGGCTT"	1.70741393145863	-9.36041643535765	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGATCAAGGCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.08286436486	39.3103388281468	0.0177146781940467	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2215.40508682471	2215.40508682471
"healthy-1"	"2019-08-01-count-3:GGGACCTCAACTCGAT"	-3.06332431259807	-5.62644865429076	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTCAACTCGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2537.39029477255	42.5663495310846	0.0167756413425157	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2534.34551536902	2534.34551536902
"healthy-1"	"2019-08-01-count-4:TTGGTTTCAGAAGTGC"	-5.31785855713542	3.27010271632997	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTCAGAAGTGC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2561.87272801156	41.4752373045364	0.0161894214537067	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2555.16423543262	2555.16423543262
"healthy-1"	"2019-08-01-count-4:ATCGTCCGTCACTACA"	3.11791290816609	-10.5627145997253	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTCCGTCACTACA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.38373890746	39.97328072479	0.0158852086455404	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2508.42899482419	2508.42899482419
"healthy-1"	"2019-08-01-count-4:TACCTCGGTGGTCTTA"	-2.21174536171611	10.7071857222351	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTCGGTGGTCTTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.8615254313	40.8957328555208	0.0222397022777062	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1837.13198045323	1837.13198045323
"healthy-1"	"2019-08-01-count-3:CATTCATTCGTACCTC"	2.26007976111714	-10.3808737031189	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATTCGTACCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.9548605377	45.6728542003165	0.0182402865643148	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2498.80790657963	2498.80790657963
"healthy-1"	"2019-08-01-count-4:TACCTCGTCCTCATAT"	1.74560799178426	-4.53849031841429	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTCGTCCTCATAT"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2770.96704643679	40.850280513436	0.0147422469588607	2942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2764.29737300477	2764.29737300477
"healthy-1"	"2019-08-01-count-3:ATTCCTATCATGTCTT"	8.09949364241902	7.72330854022828	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTATCATGTCTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.80026337854	42.7554725574312	0.0219281294399592	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1945.50163525619	1945.50163525619
"healthy-1"	"2019-08-01-count-2:GTCTACCCAACCAGAG"	1.15379931506459	9.32699773395387	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTACCCAACCAGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1650.25130096485	38.9991536003424	0.0236322513895556	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1646.76689263738	1646.76689263738
"healthy-1"	"2019-08-01-count-1:GTCGTAACAGGGAATC"	0.858038743107957	10.7757110365662	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTCGTAACAGGGAATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.16533247517	38.479280916251	0.0211521626040971	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1812.0968820137	1812.0968820137
"healthy-1"	"2019-08-01-count-2:TGTGGCGCACTGCATA"	2.59511818465535	-10.4189386597839	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGCACTGCATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.74690762683	38.4563666478177	0.0166064635652381	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.93643627288	2313.93643627288
"healthy-1"	"2019-08-01-count-3:GGGAGATGTGGACTGA"	2.30526842650716	-10.5551796189514	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGATGTGGACTGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.44056296701	42.2542981218241	0.0180308810855123	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2342.5634005016	2342.5634005016
"healthy-1"	"2019-08-01-count-2:CCCTCAATCCGCACTT"	-5.53984580460246	3.48312470996705	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAATCCGCACTT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2938.24529363451	44.488314339798	0.0151411165147371	3356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2930.96291463364	2930.96291463364
"healthy-1"	"2019-08-01-count-3:TTCATGTAGCACGTCC"	11.0692841010982	3.76487538898317	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATGTAGCACGTCC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1581.72334745937	33.6615876103194	0.0212815898964809	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1576.97306268795	1576.97306268795
"healthy-1"	"2019-08-01-count-2:CTCCTTTTCGAACTCA"	10.9515043693477	4.03983995998231	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTTCGAACTCA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1495.29772055434	33.9344940962801	0.0226941388526292	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1490.40404168388	1490.40404168388
"healthy-1"	"2019-08-01-count-2:TAGACCAAGGATTTAG"	-4.14178882065471	-5.18276741420897	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAAGGATTTAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2667.94306042824	45.3139248620969	0.0169845921879695	2997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2665.32846310771	2665.32846310771
"healthy-1"	"2019-08-01-count-2:GGATGTTAGCGTGCCT"	2.19689287719075	-9.8619709244934	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTAGCGTGCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.86427525474	43.3203019044694	0.0178724123898879	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2417.7739648474	2417.7739648474
"healthy-1"	"2019-08-01-count-3:AGTACTGAGCATGTTC"	-5.87593493881877	-3.2082340947357	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGAGCATGTTC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3086.5497327932	41.6514227652438	0.0134944926766338	2809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3078.34360430423	3078.34360430423
"healthy-1"	"2019-08-01-count-3:GCCAGTGCAAGCGAAC"	1.76051654395406	-9.87934496318968	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGCAAGCGAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.92604253779	39.9092916230934	0.017566281153463	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2268.21909340762	2268.21909340762
"healthy-1"	"2019-08-01-count-2:TTCTTGACACAAGCCC"	2.19913925704305	-10.4229917756286	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGACACAAGCCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.77127333743	40.3655358020157	0.0159121700195343	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2533.29428855101	2533.29428855101
"healthy-1"	"2019-08-01-count-4:CGTGATATCGGAATGG"	1.52454211291615	-9.45242597973021	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGATATCGGAATGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2465.10652043981	45.9545525950215	0.018642014944986	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2460.76947997081	2460.76947997081
"healthy-1"	"2019-08-01-count-2:GCATCGGAGATTAGTG"	1.76534905013387	-9.32896521007689	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCGGAGATTAGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.29596998422	40.2503267396672	0.017437246896871	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2300.24906375322	2300.24906375322
"healthy-1"	"2019-08-01-count-3:GTAACACTCAGTGATC"	14.0722843604976	1.73370883548585	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACACTCAGTGATC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1313.80224961442	39.6342783374746	0.030167613390148	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1296.88620618604	1296.88620618604
"healthy-1"	"2019-08-01-count-2:TTAGGCAGTATGCTTG"	1.83791198310201	-10.0782881013122	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCAGTATGCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.15772727909	41.449307540239	0.0186779457046796	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2214.84801445987	2214.84801445987
"healthy-1"	"2019-08-01-count-4:TATCAGGTCGCATTAG"	2.5583094554836	-10.4964132539001	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCAGGTCGCATTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.27300079858	37.9410079378907	0.0163801969477733	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2314.30858117681	2314.30858117681
"healthy-1"	"2019-08-01-count-4:ACTTCGCCAGCGCGTT"	1.54393353041951	-9.5238657227722	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCCAGCGCGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.74107083176	39.3566945904212	0.0164966328792336	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2382.08417810683	2382.08417810683
"healthy-1"	"2019-08-01-count-3:TCGCACTCACCCTCTA"	2.51463021811787	-10.5152073136536	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTCACCCTCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.57592841612	42.5832556466222	0.0174838547013866	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2429.78260721757	2429.78260721757
"healthy-1"	"2019-08-01-count-2:ATCGTGAGTCTGTTAG"	1.23026980933492	9.47777555072633	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTGAGTCTGTTAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.88183789115	34.1683026097787	0.0192401892292302	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1770.04908193465	1770.04908193465
"healthy-1"	"2019-08-01-count-2:ATCTCTAGTCACAATC"	1.72013845023457	-10.1425457230774	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTAGTCACAATC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.32759465474	39.0480923076754	0.0167564819629837	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2326.40319678275	2326.40319678275
"healthy-1"	"2019-08-01-count-4:TATTTCGGTGATACAA"	2.28675212439839	-9.65291216289672	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTTCGGTGATACAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2059.8335847058	41.6539649346627	0.020222004944449	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2053.90575449863	2053.90575449863
"healthy-1"	"2019-08-01-count-3:TAATTCCCAATTAGGA"	1.70396115359609	-9.57545950328978	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCCAATTAGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.81116192301	35.6917961985508	0.0161296168478893	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2211.03240567575	2211.03240567575
"healthy-1"	"2019-08-01-count-4:CGTTCTGTCCTAGCCT"	-5.1009501022404	-6.36559059536131	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	33	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTCTGTCCTAGCCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2829.58712754589	39.1777751554521	0.0138457567798702	3021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2816.03304374378	2816.03304374378
"healthy-1"	"2019-08-01-count-1:CATGCCTGTTCCTTGC"	1.96976306018178	-10.4118767014709	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATGCCTGTTCCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.47382550406	43.2605561276215	0.0163095129202266	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2649.17366539119	2649.17366539119
"healthy-1"	"2019-08-01-count-2:CCTGCATTCAAGTCTG"	3.34751953658406	-11.1018944016662	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATTCAAGTCTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2744.00820477485	43.763366870876	0.0159487011717834	2932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2736.59220510002	2736.59220510002
"healthy-1"	"2019-08-01-count-2:AGTACTGTCAGCCCAG"	1.30908026274983	10.7197713621887	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACTGTCAGCCCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.40442067572	38.1014897720116	0.0211041300972061	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1800.89250718624	1800.89250718624
"healthy-1"	"2019-08-01-count-2:AGTAGCTAGTAGGAAG"	0.0472977385738909	11.4736213454041	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTAGTAGGAAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.5351612889	38.2239341709856	0.021312062900131	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1787.06891663044	1787.06891663044
"healthy-1"	"2019-08-01-count-2:CTCAATTCAAAGCACG"	2.38712729987447	-10.4156389466492	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAATTCAAAGCACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.29116142259	38.7907925453488	0.0155705576072442	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2487.95322141095	2487.95322141095
"healthy-1"	"2019-08-01-count-2:ATTGGGTCACGCGTCA"	7.73066200789754	6.50766751849977	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTCACGCGTCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1583.77553071566	31.1676403398099	0.0196793293843391	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1583.77553071566	1583.77553071566
"healthy-1"	"2019-08-01-count-4:AAGCCATGTTTACCAG"	6.99344601210896	-1.10790421878966	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATGTTTACCAG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2497.69299034415	41.8487963772121	0.0167549801112449	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2486.07050787042	2486.07050787042
"healthy-1"	"2019-08-01-count-4:GGGATGAAGTGATTCC"	-8.00724158707317	4.20629928195802	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATGAAGTGATTCC"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2219.56967450703	43.0394777085296	0.0193909108611734	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2203.46187628152	2203.46187628152
"healthy-1"	"2019-08-01-count-2:CCAATTTTCCTTCTAA"	1.72841932353322	-9.77710440075072	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTTCCTTCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.55687026393	40.5325359252134	0.0187342133143322	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2161.33989223864	2161.33989223864
"healthy-1"	"2019-08-01-count-2:ATGCGATAGGATGCGT"	1.31308366832082	9.75973126972047	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCGATAGGATGCGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1589.71159353326	41.8366011151315	0.0263171013442421	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1584.97949792341	1584.97949792341
"healthy-1"	"2019-08-01-count-3:TGTTGAGTCACGTCCT"	1.13373364981953	10.896722770575	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGTCACGTCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1941.37989370673	34.6817602810155	0.0178644892704625	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1936.43622425014	1936.43622425014
"healthy-1"	"2019-08-01-count-2:ATCCACCCAGAAGTGC"	1.252529044717	-8.87275125896605	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCCAGAAGTGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2534.74779754539	47.2987410183233	0.0186601369430626	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2532.12162883336	2532.12162883336
"healthy-1"	"2019-08-01-count-3:AACCATGCAACTTGGT"	1.62298359450642	-9.60212900554808	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGCAACTTGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.77956746442	42.6927082844669	0.0179851191195776	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.61939254325	2369.61939254325
"healthy-1"	"2019-08-01-count-2:CCGGGTAAGCAGCCCT"	1.34201933917348	10.8277072676453	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGGTAAGCAGCCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1704.57139497076	33.7480008253513	0.0197985258493266	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1700.41636703453	1700.41636703453
"healthy-1"	"2019-08-01-count-4:CTGCGAGGTCGCGTCA"	1.79647614535634	-8.72231390392455	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	51	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCGAGGTCGCGTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.15890024229	47.2871946989051	0.0196934882960614	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2398.55829572986	2398.55829572986
"healthy-1"	"2019-08-01-count-4:GTGTAACCACGGCTAC"	2.91387714919392	-11.0357389680115	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACCACGGCTAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.42725083	37.8319390060374	0.015714675902665	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.10033757694	2401.10033757694
"healthy-1"	"2019-08-01-count-4:GTGTCCTAGCGTTAGG"	1.05303813990895	-8.51358129894408	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTCCTAGCGTTAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2421.80739279556	40.3701378733625	0.0166694254850556	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2420.81409307779	2420.81409307779
"healthy-1"	"2019-08-01-count-3:GTTAGACGTTGACTAC"	1.27659072455708	10.871256805304	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGACGTTGACTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1749.4063265982	23.6892279035698	0.0135412954345687	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1747.90516452864	1747.90516452864
"healthy-1"	"2019-08-01-count-3:ATCCACCTCTTCCCAG"	2.156422038644	-10.6167946091858	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCACCTCTTCCCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.68239529259	40.7548532022098	0.0163629265936262	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2485.87815474018	2485.87815474018
"healthy-1"	"2019-08-01-count-2:TCCTCCCCAAGGTCAG"	1.67283024367635	-9.81563856517943	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCCAAGGTCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.48957180964	39.1836606654079	0.015733316496859	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2485.38388053878	2485.38388053878
"healthy-1"	"2019-08-01-count-4:CTGCTCATCCCTTCCC"	-0.52473739805873	12.4546661146912	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCATCCCTTCCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2092.21780751051	45.6450438138001	0.0218165831731029	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2085.24980687979	2085.24980687979
"healthy-1"	"2019-08-01-count-3:GCACATAGTGGTCTTA"	2.97246732291524	-10.2821464768616	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACATAGTGGTCTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.28673908331	41.2342258584058	0.0150474128383366	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2733.65808156757	2733.65808156757
"healthy-1"	"2019-08-01-count-4:TCAAGTGGTCACGTGC"	1.27753831919972	-8.88089277660521	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGGTCACGTGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2192.59136005532	45.4330252796061	0.0207211549344333	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2192.59136005532	2192.59136005532
"healthy-1"	"2019-08-01-count-4:TCCTTCTGTCCTTGTC"	-2.58598075333293	3.38938615405885	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTCTGTCCTTGTC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3383.22975138315	46.1529962660647	0.0136416973299541	5914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3376.9554014136	3376.9554014136
"healthy-1"	"2019-08-01-count-4:GTGTGGCTCGCTGTCT"	1.67810775813405	-4.84633638775023	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGGCTCGCTGTCT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2340.80285616492	39.7939705162887	0.0170001375431871	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2334.6629276721	2334.6629276721
"healthy-1"	"2019-08-01-count-2:GTTACAGCACTTCAGA"	2.83907069739644	-10.8329181901184	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGCACTTCAGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.7451158937	42.6546785988819	0.0172989001677174	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2455.97550038141	2455.97550038141
"healthy-1"	"2019-08-01-count-2:ACCGTTCAGTCAACAA"	3.34574570235555	-9.79363253032836	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCAGTCAACAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.84487265045	37.5196600585925	0.0156472424411344	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.85610116779	2393.85610116779
"healthy-1"	"2019-08-01-count-3:TTGGTTTAGTAAATGC"	2.316502948373	-10.236035369989	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGTTTAGTAAATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.41422550699	40.1908758219204	0.0167363361951582	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.14195340909	2399.14195340909
"healthy-1"	"2019-08-01-count-4:GTGGAGAGTAACATCC"	1.45813264426534	9.73169419849244	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGAGAGTAACATCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1689.84979613294	36.0493073428864	0.021332847111845	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1679.46581553129	1679.46581553129
"healthy-1"	"2019-08-01-count-2:GTCTCACGTAGTCTTG"	1.38958611068074	-9.16210844432982	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACGTAGTCTTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2469.13470535861	44.0818554188699	0.0178531593773324	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2466.54756632794	2466.54756632794
"healthy-1"	"2019-08-01-count-4:GGTCACGAGGCGACAT"	1.92309214648549	-10.2059889069763	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGAGGCGACAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.74989003607	42.4593092440267	0.0179399223478488	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.21016229909	2360.21016229909
"healthy-1"	"2019-08-01-count-2:GCCTGTTGTGCTCTCT"	0.971698840230149	11.5828399428162	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCTGTTGTGCTCTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2258.16949333022	38.2331516525584	0.0169310371809931	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2251.47477920128	2251.47477920128
"healthy-1"	"2019-08-01-count-4:GCTGGGTGTCGGATTT"	11.0876757102901	3.74261400783388	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTGTCGGATTT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1656.08983891416	33.6103971746146	0.020295032542831	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1649.87219768089	1649.87219768089
"healthy-1"	"2019-08-01-count-3:TCAAGCATCGTACACA"	4.59041895446126	-10.7185440293518	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGCATCGTACACA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.30167258394	43.2035305661453	0.0190718662723914	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2261.19622859039	2261.19622859039
"healthy-1"	"2019-08-01-count-1:TGAATGCTCGCATGAT"	1.34947194632832	9.86102292621461	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGAATGCTCGCATGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.35153799861	32.2953462265028	0.0174536273585258	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1848.19575539606	1848.19575539606
"healthy-1"	"2019-08-01-count-4:CTGTACCCATTCAGCA"	1.76928057250325	-10.1122999421326	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTACCCATTCAGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.35111697001	41.5811462103766	0.0167709792799305	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2472.54130333813	2472.54130333813
"healthy-1"	"2019-08-01-count-2:AACAGGGTCAAAGCCT"	2.66573299941365	-10.6491928330627	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGTCAAAGCCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.36087896841	37.3195587676855	0.0159870562876197	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.41733880384	2330.41733880384
"healthy-1"	"2019-08-01-count-4:TGTGCGGAGCCGAACA"	3.55743755873982	-10.846215271112	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGAGCCGAACA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.48773350332	41.8507344332408	0.0183839050908638	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.51881650492	2272.51881650492
"healthy-1"	"2019-08-01-count-2:AGGCTGCGTGGATGAC"	2.31911100920979	-10.3685522309509	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCGTGGATGAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.93822011756	37.5500429189057	0.0156397372511597	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.80373604165	2393.80373604165
"healthy-1"	"2019-08-01-count-4:TCTGCCACATTGCTGA"	0.640854080289048	9.98804090106813	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCACATTGCTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1598.39800179462	23.1312375603163	0.0144715130614186	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1594.40010631606	1594.40010631606
"healthy-1"	"2019-08-01-count-3:AACCTTTTCAAAGAAC"	2.14280499991719	-10.330122970697	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTTCAAAGAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.5161985419	42.6104888985125	0.0180819842973614	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2354.88877258169	2354.88877258169
"healthy-1"	"2019-08-01-count-4:ACGTCCTTCGTAGTGT"	1.48146142539327	10.0945777663025	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTCCTTCGTAGTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1604.89999974047	33.7100168224512	0.0210044344369758	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1604.89999974047	1604.89999974047
"healthy-1"	"2019-08-01-count-4:TCACGCTCAAGCGATG"	11.2948290306026	3.87291619861452	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGCTCAAGCGATG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.52296376067	38.6178064984998	0.0208798740297755	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1840.16948322773	1840.16948322773
"healthy-1"	"2019-08-01-count-3:TCACGCTTCCTTCTAA"	1.43634571608846	-8.72907068645629	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTTCCTTCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.71056113562	41.5456308272908	0.0176137045010255	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2356.6406705036	2356.6406705036
"healthy-1"	"2019-08-01-count-4:AGTAGTCGTGAGACGT"	3.16930379447286	-10.2374229661194	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCGTGAGACGT"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.79540444721	39.9914496367911	0.0159978890935014	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2498.85547997102	2498.85547997102
"healthy-1"	"2019-08-01-count-3:TTACCGCTCGCTATTT"	2.39330186423604	-10.5183449021545	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCTCGCTATTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.98444710933	37.8199357022924	0.0155895210900287	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2420.4247565689	2420.4247565689
"healthy-1"	"2019-08-01-count-4:TTTCCTCGTCTAACTG"	1.15573157843892	11.2629556425842	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCGTCTAACTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2200.66754403042	42.0299290081906	0.019098718078613	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2191.87098122765	2191.87098122765
"healthy-1"	"2019-08-01-count-2:ATCGGCGAGAAATCCA"	1.74818422374074	-9.92488577282103	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGAGAAATCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.19975550421	34.7420905758628	0.0149608536016401	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2314.74874156203	2314.74874156203
"healthy-1"	"2019-08-01-count-2:CTCCACAAGGCGATAC"	3.57312979277913	-11.1010017625061	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCACAAGGCGATAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.41467889747	43.7375400054777	0.0193151636107453	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2259.78565577549	2259.78565577549
"healthy-1"	"2019-08-01-count-3:AATTTCCCACAAGCAG"	1.47676600989644	10.1785373457703	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCCACAAGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.9085020266	38.1669250353308	0.0203025439771062	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1876.44179944348	1876.44179944348
"healthy-1"	"2019-08-01-count-2:TGTAGACCAACGCATT"	3.15362157401387	-10.7749033204285	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACCAACGCATT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.49488459705	40.0337272152655	0.0175164370242394	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2281.29915387802	2281.29915387802
"healthy-1"	"2019-08-01-count-2:GGAATCTTCTCGTCGT"	-1.62988100472148	11.7929343947205	"2019-08-01-count-2"	"Control1"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTTCTCGTCGT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1817.89126444725	35.0495128961352	0.0192803131747224	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1813.93444469501	1813.93444469501
"healthy-1"	"2019-08-01-count-4:TCTGGCTGTCGCATTA"	0.183452968567055	13.3852548369202	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTGTCGCATTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1885.34232151101	43.2420713613239	0.0229359256767055	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.53909842977	1883.53909842977
"healthy-1"	"2019-08-01-count-2:CAGTGCGAGTTGCGCC"	1.3005356985027	9.54102513873903	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTGCGAGTTGCGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1744.47095314574	39.2009676509016	0.0224715508046791	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1742.17810311902	1742.17810311902
"healthy-1"	"2019-08-01-count-4:ACTATTCAGAAGGATG"	1.15938927707021	10.6440133818421	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCAGAAGGATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2110.10563276249	38.7980115665278	0.0183867627118433	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2097.7757735409	2097.7757735409
"healthy-1"	"2019-08-01-count-2:CCTACGTCAAGACAAT"	-4.95258269730266	-5.31886246120604	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTCAAGACAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2566.46318101043	47.8753872922037	0.0186542272051434	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2564.62899021985	2564.62899021985
"healthy-1"	"2019-08-01-count-2:AGGGCCTGTGAGATCG"	2.79958953437154	-10.7381620637146	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTGTGAGATCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.7470528225	43.3786318985811	0.0180763351068858	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2392.76477635763	2392.76477635763
"healthy-1"	"2019-08-01-count-2:CAGTTAGTCCGTGTCT"	2.40508927878682	-10.5818071595398	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTAGTCCGTGTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.85546477671	43.3244612426169	0.0185000577081933	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2339.91630792131	2339.91630792131
"healthy-1"	"2019-08-01-count-4:CTGTGGGAGCTATCCA"	1.70256139811818	-9.87303354656371	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGGGAGCTATCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.27658629018	43.0991674095066	0.0178222655149732	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2416.4480993007	2416.4480993007
"healthy-1"	"2019-08-01-count-2:GAAATGACAACTGAAA"	2.33045877990071	-10.6927051774231	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGACAACTGAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.53591225396	45.2161346159747	0.0190661817020516	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2367.06688305058	2367.06688305058
"healthy-1"	"2019-08-01-count-2:CTACCTGGTATTGGCT"	3.02684869345967	-10.8003425828186	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGGTATTGGCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.03071600071	38.2491110101314	0.0149759792513477	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2546.07478739621	2546.07478739621
"healthy-1"	"2019-08-01-count-2:ATTATCCTCATGGCCG"	0.332459230988663	13.4109248884949	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCTCATGGCCG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1766.97794535757	41.2325014544326	0.0233350402379181	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1761.5492224711	1761.5492224711
"healthy-1"	"2019-08-01-count-3:GGTCTGGTCCTTCGAC"	1.29366459426228	10.0890722044739	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCTGGTCCTTCGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.94229905895	37.4808292169882	0.0206398789413141	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1814.66045875296	1814.66045875296
"healthy-1"	"2019-08-01-count-3:GTTGTGAAGCGCCGTT"	3.54666819152181	-10.4564123383728	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGAAGCGCCGTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.9004448172	41.6559653204006	0.0181042015156419	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2292.68629572942	2292.68629572942
"healthy-1"	"2019-08-01-count-2:AGCGATTTCTTCGCTG"	1.86828782138173	-9.7170448533264	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTTCTTCGCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.14152175997	40.8669872781164	0.0183166271074906	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2229.05990878568	2229.05990878568
"healthy-1"	"2019-08-01-count-3:CTAGACAAGGCCTAGA"	-8.32008586350139	-0.750314556714617	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAAGGCCTAGA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2701.76265574455	42.3455290485838	0.0156732971930557	4026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2699.15969436036	2699.15969436036
"healthy-1"	"2019-08-01-count-2:ATCTCTAGTAAGAACT"	-2.81351051750835	-5.73672392284545	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTAGTAAGAACT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2430.19009661816	44.3948016462375	0.0182680366066906	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2426.54036554687	2426.54036554687
"healthy-1"	"2019-08-01-count-2:GGAGCAACAAGGGCAT"	2.48454751548116	-10.649479889032	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGCAACAAGGGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.3210082183	41.0404542462271	0.0173950276809597	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.88245567548	2355.88245567548
"healthy-1"	"2019-08-01-count-2:TTCACCGGTACCTATG"	1.00275804576222	9.34999463641969	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCACCGGTACCTATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.27189713228	40.9491225813872	0.0235438304090949	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1733.41210186665	1733.41210186665
"healthy-1"	"2019-08-01-count-4:TCCGGGAGTCGAGTGA"	2.76314725455586	-11.0590267411438	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGAGTCGAGTGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.13491892065	42.9814232264592	0.0173933939815932	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.085380438	2457.085380438
"healthy-1"	"2019-08-01-count-2:GGAACCCTCGAGCACC"	2.41910543021504	-10.3638305894104	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAACCCTCGAGCACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.25946640732	43.3365549381775	0.0183221145729111	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.56632107582	2362.56632107582
"healthy-1"	"2019-08-01-count-4:TAGGAGGGTATCGCTA"	2.86355056342427	-9.99511148845824	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGAGGGTATCGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.86659882294	40.2091817332778	0.0183866641682305	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2185.76278419892	2185.76278419892
"healthy-1"	"2019-08-01-count-2:TATCTGTCAAGCCCAC"	6.92515434798543	-1.14781656181487	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTGTCAAGCCCAC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2478.18277435228	40.1443726415803	0.0161991169727474	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2470.99023255139	2470.99023255139
"healthy-1"	"2019-08-01-count-3:CGGAATTAGCGGTAAC"	-0.218731860548812	12.5466270216736	"2019-08-01-count-3"	"Control1"	"MAIT"	"MAIT"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAATTAGCGGTAAC"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1776.17092378215	41.3583802029481	0.0232851352587623	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1774.3364595387	1774.3364595387
"healthy-1"	"2019-08-01-count-2:CGTAAGTAGCGACCCT"	-1.26037548008617	13.5450982817444	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAAGTAGCGACCCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2026.18008649732	40.8186895025765	0.0201456374853334	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2022.80147954262	2022.80147954262
"healthy-1"	"2019-08-01-count-3:GTGGAAGTCATGCCCT"	2.70170344886128	-10.5087814561096	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGTCATGCCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.47659904916	42.820095023023	0.0180639180493066	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.71194682256	2366.71194682256
"healthy-1"	"2019-08-01-count-4:TACCCGTAGCCAAGTG"	1.7885385948116	-9.39194776928099	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCGTAGCCAAGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.09483320991	37.5993975096825	0.0153837719383016	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2438.27276966798	2438.27276966798
"healthy-1"	"2019-08-01-count-2:GAACTGTAGCGAATGC"	1.58780850943868	-8.39426424419554	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTAGCGAATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.86772089787	48.1788854240159	0.0193811138939501	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2484.98575915907	2484.98575915907
"healthy-1"	"2019-08-01-count-2:CTCCGATTCCGTGCGA"	7.81477179107015	7.0570964583191	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATTCCGTGCGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.83998513364	44.1037437250865	0.0254958516996468	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1726.11738424978	1726.11738424978
"healthy-1"	"2019-08-01-count-2:CTCCGATCACCAATTG"	2.04016520556752	-10.0949812165466	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATCACCAATTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.4111455772	42.0150790121701	0.0178756295855857	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.74209770658	2344.74209770658
"healthy-1"	"2019-08-01-count-4:CGGTCAGCAGTTAGGG"	1.82750906524007	-9.87598135387572	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGTCAGCAGTTAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.10409812122	46.5147562147546	0.0204181873221316	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2277.0929848103	2277.0929848103
"healthy-1"	"2019-08-01-count-3:ATAGACCAGCCATGCC"	2.10986842688863	-10.5775041810242	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGACCAGCCATGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.12305560941	45.8544714399721	0.019544785313088	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2339.15237645543	2339.15237645543
"healthy-1"	"2019-08-01-count-4:TGAACGTAGCTTGTGT"	1.71318521079366	-9.8003664246765	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAACGTAGCTTGTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.29005771828	46.2225913838912	0.0203687453821425	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2266.60299778698	2266.60299778698
"healthy-1"	"2019-08-01-count-2:CTAGACATCTCAGTCC"	0.479106147854966	11.4216422804627	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACATCTCAGTCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.93375600368	45.7196623570515	0.0218761299135507	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2083.38814946444	2083.38814946444
"healthy-1"	"2019-08-01-count-4:GGTCTGGTCAACCTCC"	1.17257906970326	11.0219192274841	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCTGGTCAACCTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2104.55142969375	41.6618483801452	0.0197960704558347	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2098.90108032453	2098.90108032453
"healthy-1"	"2019-08-01-count-4:CAGATCATCGCTTAAG"	2.94908442076985	-10.6381588212219	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATCATCGCTTAAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.86961600481	42.8990413297808	0.0189410644333045	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2260.91259043594	2260.91259043594
"healthy-1"	"2019-08-01-count-2:CTGTCGTCAAACTAAG"	2.16334523734395	-9.74604990398558	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTCGTCAAACTAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.56374661832	36.6963366545112	0.0166004426294643	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2209.55589718453	2209.55589718453
"healthy-1"	"2019-08-01-count-4:CCACGAGAGGCACTCC"	-1.62700281563457	12.0512132414612	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGAGGCACTCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2169.04042623465	46.9348068903781	0.0216385118150402	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2159.78386579042	2159.78386579042
"healthy-1"	"2019-08-01-count-3:TATTGCTAGCGACATG"	1.11140372332875	9.94071195209352	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGCTAGCGACATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.42262300824	36.638167774128	0.0218029484205226	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1673.46354350341	1673.46354350341
"healthy-1"	"2019-08-01-count-2:CTGTGAAGTCGGAAAC"	2.72314180907552	-10.7979917756286	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAAGTCGGAAAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.09206263132	39.1484365526448	0.017367718560237	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2247.9001428141	2247.9001428141
"healthy-1"	"2019-08-01-count-2:GGGTGTCTCGCTATTT"	10.9074617820675	4.12586495960084	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCTCGCTATTT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1575.24997551051	36.0763523007966	0.0229019856287285	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1566.44711108376	1566.44711108376
"healthy-1"	"2019-08-01-count-2:CTATAGGTCTCTTCAA"	3.39452089843099	-10.7051935425964	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGTCTCTTCAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.61572020025	45.8559580824791	0.0192460570513759	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2379.539708529	2379.539708529
"healthy-1"	"2019-08-01-count-4:ATTCCCGCAATGCTCA"	7.00367464598958	-1.11486508762511	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCCGCAATGCTCA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2287.65492803115	36.1878371783891	0.0158187481577625	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2280.93164080179	2280.93164080179
"healthy-1"	"2019-08-01-count-3:TCTACCGCACTTACAG"	8.07910503920857	7.93476674640504	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGCACTTACAG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.2045730744	40.3163766620222	0.0207901617095018	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1929.12271758025	1929.12271758025
"healthy-1"	"2019-08-01-count-4:GGTGGCTGTAAGAACT"	1.40211405333821	10.1675252684387	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGGCTGTAAGAACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.11094643476	32.1280305912564	0.0178082343853337	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1800.86515080923	1800.86515080923
"healthy-1"	"2019-08-01-count-2:GCAGGCTGTATCATGC"	-6.39673028412517	4.05423710429994	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTGTATCATGC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2140.92695822778	39.7755160585396	0.0185786422585221	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2135.20822956249	2135.20822956249
"healthy-1"	"2019-08-01-count-2:TATTGCTTCTCCGAAA"	-7.66390214386638	2.24357483470765	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTTCTCCGAAA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2578.3083761032	39.6059099274058	0.0153611997286629	2796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2572.46530394168	2572.46530394168
"healthy-1"	"2019-08-01-count-2:TCCCATGAGCTTAGTC"	2.24879517134969	-10.6650810471741	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCATGAGCTTAGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.77419266653	42.1170677991194	0.0172133039188302	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2444.25101767944	2444.25101767944
"healthy-1"	"2019-08-01-count-2:GCAGGCTTCGACCACG"	3.15827717360799	-10.9105358353821	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTTCGACCACG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.49650511141	37.9516062080506	0.0169692222282995	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2233.73622668127	2233.73622668127
"healthy-1"	"2019-08-01-count-2:AGGTTGTAGGGTCACA"	-2.40764866295512	13.1324386366638	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTAGGGTCACA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1779.43962442956	47.3221881455948	0.0265938711805213	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1775.63118930928	1775.63118930928
"healthy-1"	"2019-08-01-count-4:CTTCTCTCACGGCACT"	2.48323478278462	-10.6969633332458	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTCACGGCACT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.40529186112	38.1696566082409	0.0145885871454914	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2612.16674173026	2612.16674173026
"healthy-1"	"2019-08-01-count-2:CATCAAGAGTCTTGGT"	1.20971335944478	9.39905545795289	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGAGTCTTGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.19195032707	42.6058156358632	0.0253426240992733	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1673.78718184551	1673.78718184551
"healthy-1"	"2019-08-01-count-4:CCAATTTTCATGCCCT"	2.26768579062764	-10.4848089448181	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTTCATGCCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.68929382049	37.6171879874228	0.0143211410941981	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2622.43577447171	2622.43577447171
"healthy-1"	"2019-08-01-count-3:CGGAACCGTCAGGTAG"	2.8616541820461	-10.610547088739	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAACCGTCAGGTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.66341943542	41.5550412941748	0.0172666609541617	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2400.43548180179	2400.43548180179
"healthy-1"	"2019-08-01-count-4:ATTCACTAGTAGATCA"	1.94535531577412	-10.4439926377502	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTAGTAGATCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.49623147618	39.1745718220737	0.0168747083415094	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2318.82427274633	2318.82427274633
"healthy-1"	"2019-08-01-count-4:AGTGACTTCTATGTGG"	-1.19324157658275	8.80135819995729	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTTCTATGTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2805.64137856762	40.5100752645301	0.0144387930595791	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2799.75986670628	2799.75986670628
"healthy-1"	"2019-08-01-count-4:AGCCAGCTCTCATTAC"	-3.58595810356792	-5.58492472088011	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCTCTCATTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2714.75954268808	40.3547023316735	0.0148649269657656	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2714.01399793785	2714.01399793785
"healthy-1"	"2019-08-01-count-2:CCTCTAGTCCCTGGTT"	4.34871496733968	-10.41641905224	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTAGTCCCTGGTT"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.21397039893	38.8645893182733	0.0152636776681357	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2541.73291315162	2541.73291315162
"healthy-1"	"2019-08-01-count-2:CGTGTCTCAGCTGTCG"	11.1412960487301	3.83884070003358	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGTCTCAGCTGTCG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1602.54344912523	33.6831215200391	0.0210185387100896	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1593.94804136187	1593.94804136187
"healthy-1"	"2019-08-01-count-4:GCATCTCTCCGATAGT"	2.80187286910359	-10.194603942987	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATCTCTCCGATAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.89469521731	41.6285264780713	0.0176699436365221	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.95687634928	2349.95687634928
"healthy-1"	"2019-08-01-count-3:GGGCTCAAGAAGGTAG"	1.64929892596547	-9.12473966991576	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTCAAGAAGGTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.41972379666	42.7036342096796	0.0179621771377767	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2372.77166669763	2372.77166669763
"healthy-1"	"2019-08-01-count-4:AAAGTCCTCCAATCTT"	0.342214544385117	12.3420724638733	"2019-08-01-count-4"	"Control1"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCTCCAATCTT"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2303.11503953533	39.3053411660413	0.0170661649510879	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2300.53481702533	2300.53481702533
"healthy-1"	"2019-08-01-count-2:CGTTCTGCAGGTTCGC"	1.69413067874257	-9.37796022808226	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTCTGCAGGTTCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.31110103937	40.9244562384123	0.0199115628858896	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2054.06316705884	2054.06316705884
"healthy-1"	"2019-08-01-count-3:AGACCCGGTGAGATCG"	0.0312728649819314	12.8736457594666	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGGTGAGATCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2298.34279720615	36.9219172845767	0.0160645824154077	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2289.89089575939	2289.89089575939
"healthy-1"	"2019-08-01-count-2:GTCTTTAGTGTATTGC"	2.43506588515584	-10.6229582062927	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTTTAGTGTATTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.63184264269	44.6795575632908	0.0203957400296853	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2183.00889038048	2183.00889038048
"healthy-1"	"2019-08-01-count-3:TAATTCCCACCCAAGC"	1.68925668773	-9.19012358104857	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCCACCCAAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.00541261029	41.4064688714377	0.0161806882734185	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2554.24407153979	2554.24407153979
"healthy-1"	"2019-08-01-count-2:TTCATGTTCTTGTGCC"	6.97652306136434	-1.04958536541136	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATGTTCTTGTGCC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2514.18438926795	36.7536922144181	0.0146185348900045	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2508.13077289219	2508.13077289219
"healthy-1"	"2019-08-01-count-3:ATGATCGGTAGATGTA"	2.76759781417195	-10.7906875840393	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGATCGGTAGATGTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.27016578859	39.6870586101135	0.0174351266412018	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.5751285451	2272.5751285451
"healthy-1"	"2019-08-01-count-4:TCATGGACAAGATCCT"	0.319584121077698	13.303156829718	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGGACAAGATCCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1816.05747342187	43.8125487040302	0.024125089291077	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1812.49261861942	1812.49261861942
"healthy-1"	"2019-08-01-count-2:AAGCCATTCTGATTCT"	1.40949573096578	9.68301675403444	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATTCTGATTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1716.06921228303	39.7610732688631	0.0231698540969485	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1709.4657335825	1709.4657335825
"healthy-1"	"2019-08-01-count-3:TACACCCGTCACAGTT"	1.36285056647603	-9.15106775676879	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCGTCACAGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.59384601816	37.3890555163294	0.0150000593061149	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2489.82945114683	2489.82945114683
"healthy-1"	"2019-08-01-count-2:AAGCGAGAGTTGGGAC"	2.25166477736775	-10.6068220368591	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGAGAGTTGGGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.58946769791	43.2859518210548	0.0182981672907002	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.91542415927	2360.91542415927
"healthy-1"	"2019-08-01-count-2:ATTGTTCTCGCCGAAC"	0.307030339806718	12.0337238081726	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGTTCTCGCCGAAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.68436377484	40.1262559940805	0.0220633424872005	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1815.15858971101	1815.15858971101
"healthy-1"	"2019-08-01-count-4:GTAACCAGTCTCGCGA"	2.13197173651997	-10.6403360596863	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAACCAGTCTCGCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.82220145636	38.5285694211835	0.0154558032252257	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2488.55223997558	2488.55223997558
"healthy-1"	"2019-08-01-count-4:CACATGATCGCTTGAA"	3.12448300895039	-10.6490717164245	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGATCGCTTGAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.7408560745	42.8852991194646	0.0175418588898314	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2442.46252213096	2442.46252213096
"healthy-1"	"2019-08-01-count-3:TGCACGGAGGTCGCCT"	3.08044352111165	-9.49466707622679	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCACGGAGGTCGCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.63043413906	41.4254674149803	0.0169593675883193	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2440.61184345886	2440.61184345886
"healthy-1"	"2019-08-01-count-2:TCCTAATTCATGCTAG"	2.66824521598164	-10.4850187531677	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTAATTCATGCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.9801190622	40.3240476132747	0.0159070468876862	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2526.02403876566	2526.02403876566
"healthy-1"	"2019-08-01-count-3:TGGGTTATCACAAGGG"	1.78169550475423	-9.59651091015013	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGTTATCACAAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.53612699947	41.5975943646895	0.0195520037647285	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2124.31084235595	2124.31084235595
"healthy-1"	"2019-08-01-count-2:CTCAGAAGTGGTCAAG"	1.70223667201344	-9.65285017406615	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAGTGGTCAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.13395979454	41.0558086996285	0.01793508349477	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2289.13395979454	2289.13395979454
"healthy-1"	"2019-08-01-count-4:CTAACTTTCGTGACTA"	3.45932759818379	-11.0674772492615	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTTCGTGACTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.47278651232	40.9717652588649	0.0182301496617655	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2239.17121875323	2239.17121875323
"healthy-1"	"2019-08-01-count-2:TCGGGTGCAGCGACAA"	-3.43388400498088	3.09626529300538	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGCAGCGACAA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3106.2481648322	44.653316483435	0.0143753216465392	3336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3102.32238159569	3102.32238159569
"healthy-1"	"2019-08-01-count-4:CACCGTTGTGGTTCTA"	2.93549384650533	-10.0407428971496	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCGTTGTGGTTCTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2347.04323719591	44.0279423591777	0.0187588970077003	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2342.81574632387	2342.81574632387
"healthy-1"	"2019-08-01-count-2:AGTCACATCTAGGCCG"	1.04190667447392	-8.13330747997435	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCACATCTAGGCCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2198.30612267863	48.6951730195397	0.0221512247621841	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2196.22325805039	2196.22325805039
"healthy-1"	"2019-08-01-count-4:AGAAGCGTCCGGTAAT"	1.5213175016338	-9.42726232921752	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAGCGTCCGGTAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.40362955822	44.2607712578197	0.0198888734924038	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2222.41251249556	2222.41251249556
"healthy-1"	"2019-08-01-count-4:CACGAATGTGTTAACC"	1.15844859656636	9.88714692676393	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATGTGTTAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1687.98778172396	31.608409303544	0.018725496502861	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1677.86409126982	1677.86409126982
"healthy-1"	"2019-08-01-count-4:CCCTAACAGGGAGTTC"	-1.7681397003239	13.7343330153259	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTAACAGGGAGTTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1533.3170897407	45.2506176500517	0.0295115850157935	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1528.87114688286	1528.87114688286
"healthy-1"	"2019-08-01-count-2:CGCGTGATCCTACGGG"	1.03016223487203	9.83383176410524	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGATCCTACGGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1618.98047953716	34.0213327609009	0.0210140475385022	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1617.59840117048	1617.59840117048
"healthy-1"	"2019-08-01-count-2:TTTGACTTCCACCTCA"	1.38128449496571	-9.19033720409545	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTTCCACCTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.4151525809	40.9291494746647	0.0162907588869697	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2508.52931248545	2508.52931248545
"healthy-1"	"2019-08-01-count-3:CTCAGGGAGTCATACC"	3.21247567710225	-10.6183710328308	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGGGAGTCATACC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.55203042838	39.6123814037343	0.016710192771671	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2365.2628235768	2365.2628235768
"healthy-1"	"2019-08-01-count-3:GTTCGCTGTGAATGTA"	2.70004095610921	-10.6829138032165	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCGCTGTGAATGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.22425805574	40.1425895301048	0.017036828898124	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.74665856204	2350.74665856204
"healthy-1"	"2019-08-01-count-2:ACTATTCCACAGTCGC"	2.59027423438374	-10.486915611383	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCCACAGTCGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.01956293164	40.1878954046434	0.0165177033579703	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2429.13145861026	2429.13145861026
"healthy-1"	"2019-08-01-count-4:CGTGAATTCGGCTATA"	11.0679937797481	3.94962880695192	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGAATTCGGCTATA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.73824745239	35.2129149095092	0.0190882988186203	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1837.66813933895	1837.66813933895
"healthy-1"	"2019-08-01-count-2:TATTTCGAGATGTTCC"	1.19504632529561	9.21999452197877	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGAGATGTTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.36526087853	37.7246421515836	0.0212369848602682	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1773.63378518748	1773.63378518748
"healthy-1"	"2019-08-01-count-4:CCATAAGTCCACCTGT"	3.36439432677571	-10.6018676987854	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGTCCACCTGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.95983006703	39.2874000287278	0.0150933562534909	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2597.68767314509	2597.68767314509
"healthy-1"	"2019-08-01-count-1:TGATGGTCAAACAGGC"	2.24803199347798	-10.5051422349182	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGATGGTCAAACAGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.8124502471	41.9536573090136	0.0168840337647381	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2474.92717742786	2474.92717742786
"healthy-1"	"2019-08-01-count-1:CTACCTGTCGTGCTCT"	0.384136815636796	8.9713620909485	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTACCTGTCGTGCTCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.34401033382	43.7665329893989	0.022000484964918	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1973.51196593654	1973.51196593654
"healthy-1"	"2019-08-01-count-2:GGTGTCGGTCGAGTTT"	2.97540058669392	-10.3593225709167	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGGTCGAGTTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2118.9344925253	42.6411113090886	0.0201238459515895	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2115.94176123759	2115.94176123759
"healthy-1"	"2019-08-01-count-4:GTAGAAACATTCCTAT"	2.54376449164693	-10.6738119355408	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAAACATTCCTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.16641866152	44.0189330429196	0.0182411510049668	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.90800167594	2405.90800167594
"healthy-1"	"2019-08-01-count-3:TTCTCTCCAGCATACT"	1.4674070077831	11.2114934691223	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTCTCCAGCATACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2053.60397640226	33.5861326857473	0.0163547271390599	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2047.68609854033	2047.68609854033
"healthy-1"	"2019-08-01-count-1:CTGAATGGTGACTGAG"	1.83591248568837	-9.3869199982849	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGAATGGTGACTGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.01828181564	43.5101302095933	0.0185621974654102	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.01828181564	2344.01828181564
"healthy-1"	"2019-08-01-count-2:CTCATCGTCAGTGATC"	14.0958391624386	1.73841056907503	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGTCAGTGATC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1312.30300305074	33.2561424767314	0.0253418169427488	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1297.53956371931	1297.53956371931
"healthy-1"	"2019-08-01-count-3:TCCACCACAGATACTC"	9.53341831740681	7.28623197162477	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCACAGATACTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2250.67605047105	42.7427893271282	0.0189910890632983	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2236.59750653813	2236.59750653813
"healthy-1"	"2019-08-01-count-2:TCACACCAGCTGAGTG"	6.80527319487874	-1.00780227100524	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCAGCTGAGTG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2324.82194009981	42.0203584916606	0.0180746567153683	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2315.52267252981	2315.52267252981
"healthy-1"	"2019-08-01-count-4:TTCATTGAGTGGGAAA"	11.0420443015987	4.03524897182313	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATTGAGTGGGAAA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1901.8022105436	34.4091636448014	0.0180929244135047	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1896.3233455968	1896.3233455968
"healthy-1"	"2019-08-01-count-3:TCCACCAGTCCTGTCT"	1.03037919577901	11.55832288349	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCAGTCCTGTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.64871159307	36.2429302850197	0.0184946057273482	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1958.4439545307	1958.4439545307
"healthy-1"	"2019-08-01-count-4:TGATCTTTCGACCACG"	14.2851530509884	1.92248330200044	"2019-08-01-count-4"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTTCGACCACG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1155.24639742733	26.3144584597006	0.022778221614282	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1142.96944765475	1142.96944765475
"healthy-1"	"2019-08-01-count-3:CACTGGGCAACATACC"	2.32909144934956	-9.8347263566223	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGCAACATACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.38001546349	41.150470709088	0.0168623208059145	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2436.68252284161	2436.68252284161
"healthy-1"	"2019-08-01-count-3:TCCACGTAGTAACCTC"	2.1885425048763	-10.5989361039368	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTAGTAACCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.35189186694	41.7296787108061	0.0172482882093703	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2414.9283053202	2414.9283053202
"healthy-1"	"2019-08-01-count-2:TTGGGATCACTACGGC"	2.94931377944295	-10.5165510407654	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATCACTACGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.14506965974	44.2609255128522	0.0186507458303838	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2367.72271771682	2367.72271771682
"healthy-1"	"2019-08-01-count-3:CATCGTCCATGTGCTA"	-2.43159804764445	12.2365865477356	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCGTCCATGTGCTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1887.48116184399	45.2704934857693	0.0239846067875676	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1887.48116184399	1887.48116184399
"healthy-1"	"2019-08-01-count-2:GTCATGAAGCCAAGGT"	2.70955004271809	-10.6642885438171	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATGAAGCCAAGGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.49121022176	42.4158160143975	0.0191364693073399	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2211.83707694791	2211.83707694791
"healthy-1"	"2019-08-01-count-4:AGGACGAGTTTACGTG"	0.314334889023942	11.4265842207703	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGAGTTTACGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.97792886271	33.089988151656	0.0189521228216269	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1741.95281412092	1741.95281412092
"healthy-1"	"2019-08-01-count-4:ACTATGGCACGCTTAA"	3.6025456386501	-10.5603971711365	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATGGCACGCTTAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.16773099315	43.1380582291944	0.0179654497569614	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.64681388042	2396.64681388042
"healthy-1"	"2019-08-01-count-4:CTACGGGCATAATCCG"	-5.00119862976726	3.67854044521181	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGCATAATCCG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2763.40035779595	42.1756122983349	0.0152622156899385	3308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2753.69823076383	2753.69823076383
"healthy-1"	"2019-08-01-count-3:TTCTTGAAGTATAGAC"	1.58224811133687	-9.29496099865111	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTGAAGTATAGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.59683380796	42.3110864600081	0.0189176188665038	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2234.34925690687	2234.34925690687
"healthy-1"	"2019-08-01-count-3:CCTATCGGTATTAAGG"	1.93638755854909	-10.0155954591003	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGGTATTAAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.67810837993	40.7692615324356	0.0178446413886047	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2279.58056275233	2279.58056275233
"healthy-1"	"2019-08-01-count-2:GTTGCTCGTACGGTTT"	2.80865468558614	-10.5197849503723	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCTCGTACGGTTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.11777436527	41.0100750692757	0.016170414277996	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2532.13402458846	2532.13402458846
"healthy-1"	"2019-08-01-count-3:GACTATGCAGAGGCTA"	-5.00523457947429	3.37392876231996	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGCAGAGGCTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2882.35856830357	44.2268501594244	0.0153439792834153	3146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2874.41652833132	2874.41652833132
"healthy-1"	"2019-08-01-count-4:TCCATGCAGCGCCCAT"	1.73344912108724	-10.24343492901	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCAGCGCCCAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2545.8024548572	45.1757546989488	0.0177451925277065	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2538.92165958246	2538.92165958246
"healthy-1"	"2019-08-01-count-3:GACTATGCATCGCTAA"	8.27982868727986	6.96179864490358	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGCATCGCTAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.95226768945	39.6943894000316	0.0208484162516338	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1897.61951369509	1897.61951369509
"healthy-1"	"2019-08-01-count-3:ACAAAGAAGGAAGTCC"	2.54456653174703	-10.5924301377502	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAAGAAGGAAGTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.70353679944	42.9599631951244	0.0171243682503561	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2504.04968833934	2504.04968833934
"healthy-1"	"2019-08-01-count-2:AGTTCGATCCTCACTG"	1.25942458686177	9.48254296863405	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCGATCCTCACTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1649.90300253261	32.3667168948032	0.0196173452894626	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1645.12906915352	1645.12906915352
"healthy-1"	"2019-08-01-count-1:TTGTTGTGTTCAAGTC"	1.47440352019612	9.63516423786012	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTGTTGTGTTCAAGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1829.37312791282	37.9623939419159	0.020751586083058	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1822.18985146016	1822.18985146016
"healthy-1"	"2019-08-01-count-3:ATTCACTTCAGACATC"	2.3985194164211	-10.751190208551	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTTCAGACATC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2805.91890592888	39.7656220350401	0.0141720496451326	2941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2797.55215634957	2797.55215634957
"healthy-1"	"2019-08-01-count-3:GGGAAGTAGCTAATGA"	1.87453975257222	-9.49073603069457	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTAGCTAATGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.57210959764	41.1260936398712	0.0181446217685842	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2262.4601145551	2262.4601145551
"healthy-1"	"2019-08-01-count-3:CGCCATTCATCCAACA"	1.58198525485341	-9.51830103313597	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCATTCATCCAACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.48635221031	39.2163487268133	0.0178703999171898	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2191.40937310283	2191.40937310283
"healthy-1"	"2019-08-01-count-4:AGATCCAAGTTGTAAG"	1.05492176589314	9.94124505603639	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCAAGTTGTAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1829.04059755882	39.1828055281919	0.0214226002312296	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1815.92875017391	1815.92875017391
"healthy-1"	"2019-08-01-count-4:GCGATCGTCTGAATGC"	11.1160866218502	3.95571563327638	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGATCGTCTGAATGC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1588.65570631632	38.4149937932032	0.0241808175556663	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1583.96213093377	1583.96213093377
"healthy-1"	"2019-08-01-count-3:TACCCGTCAGTAGAGC"	3.02749003943745	-10.4101000062195	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTCAGTAGAGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.47764004744	41.1817242914518	0.0169160412952691	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2430.45160320895	2430.45160320895
"healthy-1"	"2019-08-01-count-2:CAAGCTACATGTGGTT"	-4.8870771926945	-5.45049431240233	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTACATGTGGTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2829.98862271877	43.7841313036327	0.0154714866880169	3742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2826.93358071352	2826.93358071352
"healthy-1"	"2019-08-01-count-4:ATCGCCTTCTTCCCGA"	0.840906043618363	9.14799687946168	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGCCTTCTTCCCGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1870.85365906482	39.1761367227606	0.020940246466067	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1866.04981867866	1866.04981867866
"healthy-1"	"2019-08-01-count-3:ATTCAGGCAGTTTCGA"	-5.02587304535564	-5.33642818843993	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCAGGCAGTTTCGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2567.73864511692	41.6685425189359	0.0162277195142805	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2564.09901064627	2564.09901064627
"healthy-1"	"2019-08-01-count-2:CGGTCAGAGACGTCCC"	3.14939274367635	-10.6107778779236	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGTCAGAGACGTCCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.78673688061	39.8738945981975	0.0173154960290467	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2297.69068943961	2297.69068943961
"healthy-1"	"2019-08-01-count-2:CATTGAGAGGGTGGGA"	2.32873668250386	-10.5760221711365	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGAGAGGGTGGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.46878870073	41.19418755077	0.0163568386217809	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.86320465301	2516.86320465301
"healthy-1"	"2019-08-01-count-4:AGGCATTGTATGCTTG"	0.0854573073679626	12.1963824995789	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTGTATGCTTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1727.74022381932	38.5563441203197	0.0223160539928205	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1722.23194416557	1722.23194416557
"healthy-1"	"2019-08-01-count-2:ATCTTCACAATTCTTC"	1.83448972281758	-9.86845877086791	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTTCACAATTCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.40013846338	37.7995705241399	0.0151355683624642	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2492.80329939909	2492.80329939909
"healthy-1"	"2019-08-01-count-4:TTCCTCTGTTGAAGTA"	-0.853384534746963	13.4979905852112	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTGTTGAAGTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2251.52304830305	37.0524913212925	0.0164566342544078	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2242.41064505638	2242.41064505638
"healthy-1"	"2019-08-01-count-4:TTAATCCAGACATCAA"	3.21000995215718	-10.6645450822082	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCAGACATCAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.0888447309	38.7620038652313	0.0158141978201067	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2444.85136064403	2444.85136064403
"healthy-1"	"2019-08-01-count-3:CATGGTACAGCAGAAC"	1.71700336512868	-10.0126600495544	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTACAGCAGAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.05780602575	40.9949652439339	0.0175562956677749	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2327.84693615339	2327.84693615339
"healthy-1"	"2019-08-01-count-3:AGGTTGTCAGTACTAC"	2.23903121527974	-10.4538669816223	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTCAGTACTAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.72860446406	39.8179790673236	0.0159544507347882	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2489.6925158801	2489.6925158801
"healthy-1"	"2019-08-01-count-2:ATAGACCTCACTGGGC"	0.0303061111712873	11.5732421644959	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCTCACTGGGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.04753515745	44.4153271981393	0.0246198208930581	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.20229000799	1802.20229000799
"healthy-1"	"2019-08-01-count-3:ACACGCGAGGGTCACA"	-3.4163592857426	-5.55511858379515	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACGCGAGGGTCACA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2349.16965027259	49.4255766621229	0.0210395944185587	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2346.97367156828	2346.97367156828
"healthy-1"	"2019-08-01-count-2:TCAGCCTTCCACGTCT"	6.53544296798055	-10.4989805451599	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTTCCACGTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2134.00756866672	46.5868580513044	0.0218306901696749	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2129.84518208242	2129.84518208242
"healthy-1"	"2019-08-01-count-3:TACTTACTCATGACAC"	10.924128194421	4.10331294620363	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTACTCATGACAC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.64700469071	34.5018169100383	0.0168002664680118	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2052.0041928026	2052.0041928026
"healthy-1"	"2019-08-01-count-4:GTCAAACGTTCCACGG"	2.05111314830129	-10.6028471223083	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACGTTCCACGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.1179192867	37.1658840928531	0.0160535598568146	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2309.51707968129	2309.51707968129
"healthy-1"	"2019-08-01-count-3:AGAAGTATCTGAGCAT"	-2.68508801880534	-5.86182787334593	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGTATCTGAGCAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2193.10906245232	45.3439666487403	0.020675655135015	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2190.53815666641	2190.53815666641
"healthy-1"	"2019-08-01-count-4:GCGTTTCAGCGTGTTT"	1.22149600562398	-8.73491575634154	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTTTCAGCGTGTTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2438.8072979998	41.9383374963978	0.0171962489741578	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2435.79353282663	2435.79353282663
"healthy-1"	"2019-08-01-count-4:TGCATCCAGCCACAAG"	8.18355621871297	7.66022870624391	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATCCAGCCACAAG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.08830333367	44.3965282767356	0.0225926377972019	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1955.08251657713	1955.08251657713
"healthy-1"	"2019-08-01-count-4:CGACAGCAGCAACTCT"	-3.32272730293925	3.28091595256654	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCAGCAACTCT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3181.36552996996	43.9892536595497	0.0138271610870081	5473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3175.81643686183	3175.81643686183
"healthy-1"	"2019-08-01-count-4:GGGAAGTCATGACGTT"	-3.65600524368938	3.49403951251832	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAAGTCATGACGTT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2640.57137651979	26.1804666221834	0.00991469757454108	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2636.83969475258	2636.83969475258
"healthy-1"	"2019-08-01-count-2:TCTGCCAAGGGATCGT"	1.85166086730306	-10.2576170197693	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCAAGGGATCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.79872063928	42.4640349758247	0.0187082821880633	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2263.73884047456	2263.73884047456
"healthy-1"	"2019-08-01-count-2:AAGACAAAGCCTGCCA"	3.3006190257961	-10.7134151688782	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAAAGCCTGCCA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.29708049048	41.3436863265966	0.0165156931028322	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2497.32514748321	2497.32514748321
"healthy-1"	"2019-08-01-count-2:AATGGCTTCTTACGGA"	8.03449501571004	7.70956561649171	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTTCTTACGGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.08983367087	41.5646193079036	0.0221904035571244	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1866.75331582582	1866.75331582582
"healthy-1"	"2019-08-01-count-4:ACAAAGATCCCAGGAC"	1.54135562953297	-9.23826696788939	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGATCCCAGGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.68709700252	43.4578146313383	0.0184951497102645	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2345.97474772528	2345.97474772528
"healthy-1"	"2019-08-01-count-2:AAGACAACAGAGGCAT"	2.37216367301289	-10.7494793168274	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAACAGAGGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.03471023373	40.2999411395018	0.0173181521368257	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2320.85351836957	2320.85351836957
"healthy-1"	"2019-08-01-count-2:CCTCCAATCATGGAGG"	2.62057032164876	-10.7521915665832	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCAATCATGGAGG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.8864111383	40.0174276628273	0.0166469711203526	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.73779772987	2396.73779772987
"healthy-1"	"2019-08-01-count-2:GTAGATCAGTCTAGCT"	1.25902118262593	9.48428056323854	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGATCAGTCTAGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2124.78046585244	37.5710797152409	0.017682334866613	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2119.16995340663	2119.16995340663
"healthy-1"	"2019-08-01-count-2:CCTCCTCAGTAATCCC"	7.78553070601766	7.57607600772706	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCAGTAATCCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1891.0257745964	44.9728583253026	0.0237822556040523	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1886.05610105554	1886.05610105554
"healthy-1"	"2019-08-01-count-2:TCGCTCATCAGGTGTT"	1.50689734992329	-8.90662100231322	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCATCAGGTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.98462250704	38.0063691920913	0.0162213481159871	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.4186395106	2337.4186395106
"healthy-1"	"2019-08-01-count-4:CAGCACGTCTTCACAT"	1.73820664462392	-9.80872728740843	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGTCTTCACAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.06298588406	38.5739704200092	0.0163306273585977	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2356.61643308115	2356.61643308115
"healthy-1"	"2019-08-01-count-2:GTGTTCCAGCCGATAG"	1.3113167482311	9.82241628253785	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTTCCAGCCGATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.53819744856	37.7511430975942	0.0225442113862284	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1668.08183518589	1668.08183518589
"healthy-1"	"2019-08-01-count-4:AAAGGTAAGAAATTCG"	1.41913499411885	9.52092454517213	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTAAGAAATTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1811.57679229019	44.8653779760798	0.0247659266595931	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1803.14627038156	1803.14627038156
"healthy-1"	"2019-08-01-count-4:CTCAATTCAGCTGAGA"	-7.68830333176311	3.30830261791078	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAATTCAGCTGAGA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2424.54329046999	39.2333392604447	0.0161817441720496	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2417.41756841341	2417.41756841341
"healthy-1"	"2019-08-01-count-2:TTTACTGCACTTGTGA"	1.3585635620052	9.80450246417848	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGCACTTGTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.77437316055	32.1390229713786	0.0190535399889666	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1685.37839682773	1685.37839682773
"healthy-1"	"2019-08-01-count-3:TTGGGTAAGGACTAAT"	2.45533551749532	-10.2856312028137	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGTAAGGACTAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.12292301669	39.7029387780748	0.0164870897571701	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.31686558652	2401.31686558652
"healthy-1"	"2019-08-01-count-2:CCTCAACAGGTGCCAA"	1.2119126516277	-8.64531042492064	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACAGGTGCCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.22359824099	38.1738376968756	0.0168894076349722	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2256.9055712881	2256.9055712881
"healthy-1"	"2019-08-01-count-2:CTCTCAGTCCTGCTAC"	1.41240539130513	9.47519586170045	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGTCCTGCTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1672.69989904245	33.5206146457253	0.020039825831827	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1666.88808736434	1666.88808736434
"healthy-1"	"2019-08-01-count-2:TGCACGGGTGGATCGA"	2.97042002257649	-10.651020073053	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCACGGGTGGATCGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.62579918565	41.2016621509718	0.0184626213615234	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2229.87855137035	2229.87855137035
"healthy-1"	"2019-08-01-count-2:CTCTCAGTCTTGGCTC"	2.80613102492635	-10.634545349237	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGTCTTGGCTC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.79000435297	39.8212000159051	0.0159298180833442	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2498.05705356799	2498.05705356799
"healthy-1"	"2019-08-01-count-2:GGTAATCTCAATCCGA"	8.37174477156941	-8.7036457291809	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCTCAATCCGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.21495433056	42.9311190436881	0.0200686326340322	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2130.24803171434	2130.24803171434
"healthy-1"	"2019-08-01-count-3:TTCCTAACATCCTTGC"	1.70643033561055	-4.60696747219237	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAACATCCTTGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2700.90640654554	39.9108478788048	0.0147768348366617	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2693.79300407844	2693.79300407844
"healthy-1"	"2019-08-01-count-3:TGATGCAGTTTCGTAG"	2.08172716674153	-10.5709285966125	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGCAGTTTCGTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.62569920352	46.3581393807358	0.0209421761761331	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2209.85736890065	2209.85736890065
"healthy-1"	"2019-08-01-count-4:GGTTAACTCGATCCCT"	1.209689159959	11.6958837279114	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACTCGATCCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1961.64168045864	33.5919302549786	0.017124396667145	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1954.33557568071	1954.33557568071
"healthy-1"	"2019-08-01-count-3:AGACCATCATTCAGGT"	8.08163132247273	6.81411454761354	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATCATTCAGGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1755.99030314577	47.1804402253207	0.0268682806168117	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1755.99030314577	1755.99030314577
"healthy-1"	"2019-08-01-count-2:AAGCCATGTTAGCTAC"	1.01284309205357	9.19667527759401	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATGTTAGCTAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.08438004116	42.9400217534274	0.0246345055036368	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1739.61002344085	1739.61002344085
"healthy-1"	"2019-08-01-count-3:GAATCGTTCTCGCTTG"	2.25081600722615	-10.6644544831482	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCGTTCTCGCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.17783048657	40.6919285116059	0.0165402386800461	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2453.68627082104	2453.68627082104
"healthy-1"	"2019-08-01-count-4:AGGTAGGTCTCCCAAC"	1.35496713694875	-8.95863535320433	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTAGGTCTCCCAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.09892039317	38.8108159089575	0.0156931918852592	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2471.48313326699	2471.48313326699
"healthy-1"	"2019-08-01-count-3:CACGAATAGAATCGAT"	11.0628868537838	3.93127248370973	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATAGAATCGAT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1848.19988152671	36.986149510457	0.0200119856516301	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1844.56759265281	1844.56759265281
"healthy-1"	"2019-08-01-count-2:ACACAGTTCATCCTAT"	-0.687420110136825	12.8086738356384	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTTCATCCTAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.73977310422	45.1178162567095	0.0248071862307726	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1816.8261420831	1816.8261420831
"healthy-1"	"2019-08-01-count-2:GTTAGACAGACCACGA"	2.54331030425374	-10.6413326493469	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACAGACCACGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.72158818028	41.8043533529258	0.0176783404701335	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.9477027921	2359.9477027921
"healthy-1"	"2019-08-01-count-4:GTGGGAATCCTTCTAA"	-2.40372238579448	3.3779771097931	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAATCCTTCTAA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3107.16512565269	45.335270479546	0.0145905571948072	5350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3101.89045924435	3101.89045924435
"healthy-1"	"2019-08-01-count-3:CGAAGGATCGCTTACC"	1.68464364585225	-9.63466932689818	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGATCGCTTACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.40341730432	41.610815448423	0.0207597009110993	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2003.18250066768	2003.18250066768
"healthy-1"	"2019-08-01-count-3:CATACAGGTTCCGTTC"	2.79049148139302	-9.07706262981566	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGGTTCCGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1684.02367490856	39.8845083405086	0.0236840544077709	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1679.6294707426	1679.6294707426
"healthy-1"	"2019-08-01-count-3:CGAAGTTAGAACAAGG"	1.11154212531392	-8.00396730816039	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTAGAACAAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2456.22728686313	45.639640763594	0.0185811960512338	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2455.35117463335	2455.35117463335
"healthy-1"	"2019-08-01-count-2:CACAGGCCATGGCACC"	2.38775386390035	-10.7417841187683	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCCATGGCACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.75230810423	42.9749253897508	0.0180131546949648	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2380.18924338511	2380.18924338511
"healthy-1"	"2019-08-01-count-4:TGCTTCGCACTTCATT"	14.0517498451168	1.70446608150331	"2019-08-01-count-4"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGCACTTCATT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1422.42525380341	44.3766756031569	0.0311978963284703	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1406.82409825884	1406.82409825884
"healthy-1"	"2019-08-01-count-2:TGTTGAGCACCGTACG"	0.906394560902756	9.20198724353639	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGAGCACCGTACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1578.18744111103	32.2167093238009	0.0204137407791819	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1570.86994925708	1570.86994925708
"healthy-1"	"2019-08-01-count-1:TCAGCAACAAGATGGC"	2.45047893103902	-10.4607477418152	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGCAACAAGATGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.72397106298	35.2493127590293	0.012965388591931	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2710.74613131041	2710.74613131041
"healthy-1"	"2019-08-01-count-3:GTCTGTCTCATTTGCT"	0.963012238114518	11.7365979918274	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTGTCTCATTTGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.71320948695	28.7347811825764	0.0151417933115114	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1897.71320948695	1897.71320948695
"healthy-1"	"2019-08-01-count-4:GTAAGTCCACGCAAAG"	1.44560756263081	9.98604867542116	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAAGTCCACGCAAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.35317202573	32.2074943856079	0.0178399965639238	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.77023972858	1802.77023972858
"healthy-1"	"2019-08-01-count-4:GTAAGTCGTGTGCTTA"	1.95090045508687	-10.2800960770813	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAAGTCGTGTGCTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.48524631881	36.726409430346	0.0162112772484495	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2262.49457024814	2262.49457024814
"healthy-1"	"2019-08-01-count-3:TGGGCTGCATGGGATG"	6.89868702468221	-1.02466955101164	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCTGCATGGGATG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2400.25466830743	40.6292269107554	0.0169270483866637	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2392.02138025161	2392.02138025161
"healthy-1"	"2019-08-01-count-3:GAGTCATTCGCCTTTG"	1.74689592894856	-4.86227896129759	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATTCGCCTTTG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2430.53662947445	41.0137626684089	0.0168743651797081	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2428.51435792152	2428.51435792152
"healthy-1"	"2019-08-01-count-2:ATCCATTTCAGACCCG"	8.30401768264119	7.90896270358888	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTTCAGACCCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1807.16177016595	37.0162063279545	0.0204830618592354	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1801.36453917284	1801.36453917284
"healthy-1"	"2019-08-01-count-3:ACCACAAAGTAAGAGG"	3.34332432326619	-10.5614652863708	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAAAGTAAGAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.8206978161	39.7233645722974	0.0169916215599448	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2334.40421987896	2334.40421987896
"healthy-1"	"2019-08-01-count-2:ACACGCGGTGATCGTT"	-6.2715838951176	3.96217105472413	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACGCGGTGATCGTT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2241.15689187228	43.2355273962342	0.0192916112000151	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2232.40747483835	2232.40747483835
"healthy-1"	"2019-08-01-count-2:AGTCATGGTTGCGTAT"	1.89939751204793	-4.45164587413939	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCATGGTTGCGTAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2614.32602997145	39.2718832549548	0.0150218001904619	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2609.25943037894	2609.25943037894
"healthy-1"	"2019-08-01-count-4:TGAGGGAAGCTACGTT"	1.65396930751149	-4.83643486416014	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGAAGCTACGTT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2365.95398635438	40.0637394138777	0.0169334398069214	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2358.76071562181	2358.76071562181
"healthy-1"	"2019-08-01-count-3:CCACGTTTCCCTAGGG"	1.47567560252492	-8.65906526958617	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGTTTCCCTAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.54139119821	45.8972485768213	0.0212237549596175	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2160.25844818579	2160.25844818579
"healthy-1"	"2019-08-01-count-3:TTTACGTGTGCGGCTT"	2.39493884620015	-10.7553749314514	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACGTGTGCGGCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.27996390298	44.0026684000324	0.0193564669106943	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2267.07022908135	2267.07022908135
"healthy-1"	"2019-08-01-count-3:CTGAGGCGTTACGGAG"	-1.79779205742534	13.8580569990906	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCGTTACGGAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1724.94326354804	41.5691486490423	0.0240988498158129	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1722.90066044611	1722.90066044611
"healthy-1"	"2019-08-01-count-4:AGTACTGTCCTCATAT"	2.06495799598042	-5.03149273311766	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGTCCTCATAT"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2672.15099989874	42.3216647408321	0.0158380513460639	2813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2664.85719891627	2664.85719891627
"healthy-1"	"2019-08-01-count-1:TCGCTCATCATTACGG"	1.08832420882527	11.6104326018128	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGCTCATCATTACGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2152.06782576957	32.6331423945574	0.0151636217055045	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2140.57981510994	2140.57981510994
"healthy-1"	"2019-08-01-count-2:ACAAAGAGTAACTGCT"	-8.73014674606975	4.4845776327881	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_MEP"	1	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGAGTAACTGCT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2001.14363658195	42.3845541474654	0.0211801658674838	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1997.77619647035	1997.77619647035
"healthy-1"	"2019-08-01-count-3:ATGGGTTGTCGATGCC"	0.899960895150345	9.0039491423401	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTGTCGATGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1774.02242041608	38.0976305581871	0.0214752813266315	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1771.48182025124	1771.48182025124
"healthy-1"	"2019-08-01-count-1:TCGCACTTCGCGTTTC"	2.54827632483785	-10.535803817865	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGCACTTCGCGTTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.86303053474	40.3684981777815	0.016579371271211	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2431.86742775444	2431.86742775444
"healthy-1"	"2019-08-01-count-2:TTTGATCCAGCTCATA"	1.95094980773274	-10.1947431794372	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCCAGCTCATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.46513196223	46.8367618174095	0.0182282145940784	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2565.00941481392	2565.00941481392
"healthy-1"	"2019-08-01-count-4:TTGATGGAGCTTTGTG"	-3.11785588684734	-4.70566179668578	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGAGCTTTGTG"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2638.97412685033	38.258033578991	0.0144973128723519	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2635.46012708071	2635.46012708071
"healthy-1"	"2019-08-01-count-3:GTGAGGACAGGTAGTG"	-3.59786901894267	-5.63158895885619	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGACAGGTAGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2483.46998576029	43.9836024586259	0.0177105431959391	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2477.74068108914	2477.74068108914
"healthy-1"	"2019-08-01-count-3:GAGTGTTAGCAATTAG"	1.38121356543843	10.9185075529846	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTAGCAATTAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1778.3029492654	40.2092111967913	0.0226110018056267	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1773.49665184859	1773.49665184859
"healthy-1"	"2019-08-01-count-2:CGGAATTAGTCCCAGC"	1.29964305934255	-9.13120176708373	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTAGTCCCAGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2519.80585365928	43.3943812262749	0.0172213193184138	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2515.7964359001	2515.7964359001
"healthy-1"	"2019-08-01-count-4:TGGATGTAGCGCCTAC"	-2.96085772934611	-5.64907505428465	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATGTAGCGCCTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2500.58425886209	40.2326616504511	0.0160893045326772	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2497.20790727078	2497.20790727078
"healthy-1"	"2019-08-01-count-3:CATCCCATCAAGAAAC"	2.62540735778157	-10.7797317734924	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCATCAAGAAAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.06776153951	38.8771530371797	0.0167858443879629	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2311.42575115801	2311.42575115801
"healthy-1"	"2019-08-01-count-4:TGGATGTCAACTCCAA"	8.51430191573445	7.9088506468567	"2019-08-01-count-4"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATGTCAACTCCAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.31433006277	43.7726544204183	0.0201688086440236	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2158.51383387242	2158.51383387242
"healthy-1"	"2019-08-01-count-3:GTGATGTCACAATCTG"	2.48813476142232	-10.1935291520325	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGATGTCACAATCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.36705336166	39.8938200346327	0.0177434640731749	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2244.80373877957	2244.80373877957
"healthy-1"	"2019-08-01-count-4:CTCATTACAAGTGGAC"	1.33692957934682	9.88788125598756	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATTACAAGTGGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.06278025261	31.0092609212887	0.016389128968093	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1886.91653143771	1886.91653143771
"healthy-1"	"2019-08-01-count-3:ACCCTCATCAAGCCCG"	8.13768543776814	6.94022796237794	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCATCAAGCCCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.98112054179	37.8899403646725	0.0209802527466653	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1802.56551333247	1802.56551333247
"healthy-1"	"2019-08-01-count-2:CTGCCTACAACACACT"	10.7120357948238	4.68006274783937	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTACAACACACT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.96270609995	36.2745290745361	0.0190321295156726	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1898.77563672529	1898.77563672529
"healthy-1"	"2019-08-01-count-2:CCATAAGGTACCGGCT"	0.047273064113599	13.4560775526795	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGGTACCGGCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1528.19747155647	43.3038787553625	0.0283365727017318	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1519.21589395863	1519.21589395863
"healthy-1"	"2019-08-01-count-2:CTGCCTAGTATTGACC"	1.80869354781453	-9.95538713848265	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTAGTATTGACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.74721872451	43.485222851691	0.0180007338990752	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2413.69251609493	2413.69251609493
"healthy-1"	"2019-08-01-count-2:CTCCAACTCTTGTGCC"	0.375090618699235	10.3903283842835	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACTCTTGTGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2188.36547400652	24.8443962586177	0.0113529465501628	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2182.083504062	2182.083504062
"healthy-1"	"2019-08-01-count-4:CACTGAAAGTCGTTAC"	-7.0396445793217	3.82282922351686	"2019-08-01-count-4"	"Control1"	"MPP"	"MPP_MEP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAAGTCGTTAC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2423.85166274309	39.0314108137637	0.0161030525975305	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2418.55554630046	2418.55554630046
"healthy-1"	"2019-08-01-count-2:AGGGCCTGTGGGACAT"	0.956130226224106	10.1724271544251	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTGTGGGACAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.20485471366	37.1947109316455	0.0195843596541635	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1896.49202397936	1896.49202397936
"healthy-1"	"2019-08-01-count-3:TGCGATACAATTCTCT"	1.41103829917256	-8.36671259319457	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGATACAATTCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.20621518597	42.2386190030889	0.0204030973790186	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2068.82409846096	2068.82409846096
"healthy-1"	"2019-08-01-count-2:ACATCGAAGTCACTGT"	2.79020204123799	-10.7780828705994	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCGAAGTCACTGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.41839649395	41.7694824103727	0.0182605344410952	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2283.20503730118	2283.20503730118
"healthy-1"	"2019-08-01-count-4:GGAGGTAAGCCTGGAA"	14.0753504234249	1.7377708920273	"2019-08-01-count-4"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGTAAGCCTGGAA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1274.37655778633	37.0673278204787	0.0290866365941846	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1251.15501366305	1251.15501366305
"healthy-1"	"2019-08-01-count-4:TCGCACTGTTTCGCTC"	0.610881765454453	11.3794898756775	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCACTGTTTCGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2005.44303786528	35.6318914495599	0.017767590889786	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2000.60974462642	2000.60974462642
"healthy-1"	"2019-08-01-count-3:TCGCTTGGTCGACTTA"	14.3254829841549	2.09553907001344	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGGTCGACTTA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1150.61825203358	31.4528287349915	0.0273355899573142	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1142.21023630839	1142.21023630839
"healthy-1"	"2019-08-01-count-4:GTGACGCTCCACAAGT"	11.3930736976558	3.59105870807496	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGACGCTCCACAAGT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.2669558458	24.2772319922515	0.0124545444734723	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1944.06547043863	1944.06547043863
"healthy-1"	"2019-08-01-count-2:CCCAACTAGCCATCCG"	8.04413809356038	6.5144381293091	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCAACTAGCCATCCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.72558306684	39.3476623414825	0.0201707829553463	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1946.21615914791	1946.21615914791
"healthy-1"	"2019-08-01-count-3:CTGCGAGCAGATTCGT"	7.77551283416097	-10.6012964478699	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGCAGATTCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1918.71556757678	46.532246939379	0.024251769113515	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1916.44912383873	1916.44912383873
"healthy-1"	"2019-08-01-count-4:CCTTCAGAGAACAGGA"	3.08618893203084	-10.5083008042541	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTCAGAGAACAGGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.32490985362	40.7319452092031	0.0183533042090217	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2214.62960153524	2214.62960153524
"healthy-1"	"2019-08-01-count-2:TCATTGTGTCTGTGAT"	11.0188394981319	3.96132443034974	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTGTGTCTGTGAT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1402.07892970859	46.3932831296991	0.0330889239875686	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1397.21553843548	1397.21553843548
"healthy-1"	"2019-08-01-count-3:ATTACTCCATCAGCAT"	7.65581812438313	6.82128284061281	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCCATCAGCAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.28775725321	41.0107440993944	0.0207619087137071	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1965.45052129019	1965.45052129019
"healthy-1"	"2019-08-01-count-2:CACGTTCTCCTACAAG"	1.11866142329518	11.4019670256409	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCTCCTACAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.04587997421	31.5124576945917	0.016860184135783	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1869.04587997421	1869.04587997421
"healthy-1"	"2019-08-01-count-3:CATGCGGAGAGCTGAC"	11.0456816154415	3.84817812526552	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCGGAGAGCTGAC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.87771978602	45.5768951589578	0.0241546628491254	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1876.52037364631	1876.52037364631
"healthy-1"	"2019-08-01-count-2:CGGGTGTCACAGTGAG"	2.605068107217	-10.6387691727844	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTCACAGTGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.67692173408	42.730728673607	0.0178888690575142	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.8283265061	2383.8283265061
"healthy-1"	"2019-08-01-count-3:AAAGGATCACCTCAGG"	3.0448965030605	-10.4564151993957	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATCACCTCAGG"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.84015357134	41.4517058289041	0.0176627733958891	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2341.67774660871	2341.67774660871
"healthy-1"	"2019-08-01-count-4:CCACAAAGTAGGTCAG"	1.86090125617329	-9.68391039287718	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAAGTAGGTCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.42712106786	37.6474971754246	0.0144274951660723	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2602.11997392441	2602.11997392441
"healthy-1"	"2019-08-01-count-3:CTGGACGGTACTCCCT"	3.03165759620015	-10.8581209412781	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGACGGTACTCCCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2826.551731969	41.8672782046514	0.0148121393750279	3296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2820.76176400095	2820.76176400095
"healthy-1"	"2019-08-01-count-3:GTGCTTCCATCATTGG"	2.56571259078328	-10.5462703934875	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCCATCATTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.65939643	43.6564830495154	0.0196503942592043	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2214.11153359686	2214.11153359686
"healthy-1"	"2019-08-01-count-4:TCGGGACCACCCAACG"	2.88753952559773	-10.7766218415466	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACCACCCAACG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.24198665767	40.937067413608	0.0176739164773885	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2307.96413231248	2307.96413231248
"healthy-1"	"2019-08-01-count-4:TATCAGGAGTCAACAA"	-4.30180154267009	3.63016603076784	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCAGGAGTCAACAA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2813.4993919703	44.3549561810016	0.0157650491439914	3886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2808.55497211135	2808.55497211135
"healthy-1"	"2019-08-01-count-4:GTGAGTTGTGCCTATA"	1.99138428744618	-10.1046791306702	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGTTGTGCCTATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.05617925297	37.7887880555491	0.0162388808626356	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2324.42809954407	2324.42809954407
"healthy-1"	"2019-08-01-count-4:ATTCACTAGATACTGA"	-4.98993192139323	-5.36712934887084	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTAGATACTGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2396.35612389983	42.6524579655842	0.0177988812014183	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2394.64586550949	2394.64586550949
"healthy-1"	"2019-08-01-count-2:GCCTGTTTCAACCCGG"	1.06842209872548	10.9637613066467	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCTGTTTCAACCCGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.66057150484	35.8050016497535	0.018957880621834	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.11141634929	1883.11141634929
"healthy-1"	"2019-08-01-count-4:ATTCACTCATGAAGCG"	-4.9151123565739	-5.56368019497069	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTCATGAAGCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2557.87864285252	44.9737170952103	0.0175824280095854	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2548.7835493572	2548.7835493572
"healthy-1"	"2019-08-01-count-4:TCAGGTAAGCTGGCCT"	1.30956961688344	11.5032157667908	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTAAGCTGGCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2239.3705507834	43.4163783728267	0.019387759813863	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2233.73603542419	2233.73603542419
"healthy-1"	"2019-08-01-count-4:ACCCTCACACAAAGCG"	-2.1626025241917	13.1097545393738	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTCACACAAAGCG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1869.58968849551	43.5459034032788	0.0232916899741359	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1867.7248395732	1867.7248395732
"healthy-1"	"2019-08-01-count-3:GATCGTAAGATGCTAA"	-3.28081307831462	3.61709759319154	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAAGATGCTAA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2947.81011408197	43.607688345731	0.014793248770473	4338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	2942.80115600462	2942.80115600462
"healthy-1"	"2019-08-01-count-4:TCGGGCAGTAGCTGTT"	-2.70132122460063	3.34569428050844	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCAGTAGCTGTT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3233.3897384439	44.8562670876696	0.0138728302853021	5606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3229.73332480612	3229.73332480612
"healthy-1"	"2019-08-01-count-2:TAACACGGTGGAAATT"	1.6643862920696	-4.8296895257202	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACACGGTGGAAATT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2266.86398935506	42.8892347212058	0.0189200741299914	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2263.26026780715	2263.26026780715
"healthy-1"	"2019-08-01-count-4:CGAAGTTCAGCATACT"	-7.46949849548991	4.00816533649293	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTCAGCATACT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2242.22137879112	36.4717271132199	0.0162658903613181	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2232.79670095174	2232.79670095174
"healthy-1"	"2019-08-01-count-4:CTCGAGGTCTAAACGC"	2.22904266890828	-10.4207124940124	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGTCTAAACGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.70320581374	39.9835025595976	0.0160918625878712	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2483.92047179766	2483.92047179766
"healthy-1"	"2019-08-01-count-4:CTCTCAGCACTGCTTC"	2.49926867064778	-10.7948885194031	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCAGCACTGCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.81819207532	42.4051977758038	0.018723444523795	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2261.53074306476	2261.53074306476
"healthy-1"	"2019-08-01-count-2:TTAGGGTGTTCTCCTG"	-4.92326388779338	-4.55919649517211	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTGTTCTCCTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2810.00692873803	43.7392583719307	0.015565533993745	3411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2802.86119359659	2802.86119359659
"healthy-1"	"2019-08-01-count-3:TCGGTCTTCATCGTAG"	2.93629207190816	-10.9170532456604	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTTCATCGTAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.13392669741	39.172150717593	0.0165483457762127	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.26888706314	2357.26888706314
"healthy-1"	"2019-08-01-count-3:GTGGTTAAGCACCAGA"	1.2756538587505	9.57937429035035	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGTTAAGCACCAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1586.23682746275	32.0753071766557	0.0202210077469714	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1579.9128476631	1579.9128476631
"healthy-1"	"2019-08-01-count-2:CGAGTGCGTAACAGTA"	1.4333459335262	-8.79695799266966	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCGTAACAGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.66948558048	43.3051695294494	0.0208632298303209	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2074.46967143585	2074.46967143585
"healthy-1"	"2019-08-01-count-2:CACTGTCGTACTTCCC"	2.67762865599934	-10.5458631745544	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCGTACTTCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.55393334029	39.9497063136307	0.0158558647167626	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2513.79247483816	2513.79247483816
"healthy-1"	"2019-08-01-count-2:ACCACAATCGCCGATG"	1.33751442012135	9.97058675372926	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAATCGCCGATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.83101699306	32.7407887029838	0.0193866576191136	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1686.39789264585	1686.39789264585
"healthy-1"	"2019-08-01-count-4:TACCTCGCAAGGATGC"	1.76636650142018	-10.1585197678772	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTCGCAAGGATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.64419263727	36.9229224291247	0.014402514410996	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2562.75457247745	2562.75457247745
"healthy-1"	"2019-08-01-count-2:TCAGGGCTCACACCGG"	1.3354375558788	9.82297132099	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCTCACACCGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.53157015503	37.6620062735376	0.0215762389620903	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1740.35972205157	1740.35972205157
"healthy-1"	"2019-08-01-count-2:TACTTCACACACGCCA"	1.20511200007741	9.57738015735475	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCACACACGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1774.47709098114	41.9124058423733	0.0236195812588368	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1762.35894607134	1762.35894607134
"healthy-1"	"2019-08-01-count-3:GAGACTTAGTGGATAT"	1.62457086619679	-9.29594805156859	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACTTAGTGGATAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.90757725658	42.6771211568166	0.018419863431648	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2312.82883397989	2312.82883397989
"healthy-1"	"2019-08-01-count-2:GGATCTATCACTGGGC"	0.802413960068864	9.48001954639284	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTATCACTGGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1915.46681141427	40.9832462445029	0.0213959573720013	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1910.40090035147	1910.40090035147
"healthy-1"	"2019-08-01-count-2:TGATCAGGTACAAGTA"	2.09558739241902	-10.2717352143494	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCAGGTACAAGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.21040694854	43.3648671397065	0.0204241967719205	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2118.73983932047	2118.73983932047
"healthy-1"	"2019-08-01-count-4:GTGCTGGAGTGAGTTA"	1.55198874053304	-4.69146873867186	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGAGTGAGTTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2392.17557146182	45.9195377245665	0.0191957222004846	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2389.27394390917	2389.27394390917
"healthy-1"	"2019-08-01-count-4:ACGATCATCATTTCGT"	1.46301295337026	-8.67041113292845	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATCATCATTTCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.61716979564	42.8802257461661	0.0186710376940976	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2292.07603575738	2292.07603575738
"healthy-1"	"2019-08-01-count-4:AAACGCTGTAATCAAG"	-1.3344865840977	13.441382385138	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGCTGTAATCAAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1860.28419514415	46.1202469278755	0.0247920436287433	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1854.2094439424	1854.2094439424
"healthy-1"	"2019-08-01-count-4:TATTCCACACCTCTAC"	1.77064587649648	-10.0558185807434	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTCCACACCTCTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.22200304747	38.0390291240746	0.0167114758899382	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2271.94162512075	2271.94162512075
"healthy-1"	"2019-08-01-count-3:GTGTTAGAGGCCTGAA"	1.69960906085317	-9.35786631023558	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGAGGCCTGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.44930290334	46.0080657431662	0.0186914537256154	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.66888369974	2457.66888369974
"healthy-1"	"2019-08-01-count-2:CTCTCAGCATCACGGC"	8.17240871962849	7.61826989734498	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGCATCACGGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2015.65181322909	40.7918259985417	0.020237535932951	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2013.33355290693	2013.33355290693
"healthy-1"	"2019-08-01-count-3:CGGGACTTCTGAGGCC"	2.30280293998067	-10.5913448563782	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGACTTCTGAGGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.47816404533	40.5998831777537	0.0164340182271729	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2469.67886450263	2469.67886450263
"healthy-1"	"2019-08-01-count-2:CAGATACGTTCCGCAG"	1.2212516265804	10.9428682097229	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATACGTTCCGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1991.9655312562	35.0792753872417	0.0176103827284198	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1988.62403590796	1988.62403590796
"healthy-1"	"2019-08-01-count-4:AAGAACAGTGCATCTA"	0.589841683476609	8.9492559202942	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGAACAGTGCATCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1782.15105531574	29.7219209681605	0.0166775542844737	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1770.19545553019	1770.19545553019
"healthy-1"	"2019-08-01-count-2:CGTGATATCGCCAGAC"	2.35030879554097	-10.1948557130066	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGATATCGCCAGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.06667990223	43.0416132185833	0.0195726730853367	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2195.9623166889	2195.9623166889
"healthy-1"	"2019-08-01-count-3:CATTGCCAGACCAAAT"	2.03585662421529	-10.4853716126648	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGCCAGACCAAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.50769623886	43.1976376032181	0.0194978503918322	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2210.93971718001	2210.93971718001
"healthy-1"	"2019-08-01-count-3:TATTTCGTCTTTGCGC"	2.52961816367452	-10.4475450745788	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTTCGTCTTTGCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.36584600281	41.0154561592698	0.0181054447482029	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2265.36584600281	2265.36584600281
"healthy-1"	"2019-08-01-count-3:CGGGCATTCGTGCGAC"	1.48132206973378	9.74544999683229	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATTCGTGCGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1639.44864117807	37.1731703316481	0.0226741902112508	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1638.16225333743	1638.16225333743
"healthy-1"	"2019-08-01-count-3:TCTATACAGCTGAGCA"	2.37577786025349	-10.7355947724548	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATACAGCTGAGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.32133546579	39.6165707893297	0.0168701660164714	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2341.81036737602	2341.81036737602
"healthy-1"	"2019-08-01-count-4:TTTACCACATCGCCTT"	1.65451087531392	-10.0850191346374	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCACATCGCCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.59534673154	40.9804007983096	0.0173235041466119	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2361.81023869641	2361.81023869641
"healthy-1"	"2019-08-01-count-2:GGCAGTCAGGCACCAA"	1.24855794486348	9.25294301593629	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCAGTCAGGCACCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.42718463108	36.853649602153	0.0207342668778874	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1768.96853951884	1768.96853951884
"healthy-1"	"2019-08-01-count-2:CTTAGGATCATCACAG"	-4.99494300308879	-4.47509958660277	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTAGGATCATCACAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2769.4290497452	45.902362769938	0.0165746664548641	2938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2765.6380889447	2765.6380889447
"healthy-1"	"2019-08-01-count-3:CTCTCAGTCATCCTGC"	2.33958949622456	-10.5440998307434	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGTCATCCTGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.59180166846	38.2126333109416	0.0152024021106279	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2504.07446901781	2504.07446901781
"healthy-1"	"2019-08-01-count-3:GTTACCCAGGCAGGGA"	1.75957932051961	-10.1949253312317	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACCCAGGCAGGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.25728516339	38.42257835989	0.0161829885076022	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.28532806963	2366.28532806963
"healthy-1"	"2019-08-01-count-2:ATGCCTCAGTTCCGGC"	2.32275642928426	-10.7001314393249	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCAGTTCCGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.58758384442	39.4750705584168	0.0180532766444289	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2180.50045394051	2180.50045394051
"healthy-1"	"2019-08-01-count-3:TCTCACGAGCATGCGA"	2.24630846556966	-10.3874016038147	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGAGCATGCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.4244884536	42.2955915976231	0.0178883241161512	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.47712268782	2360.47712268782
"healthy-1"	"2019-08-01-count-4:TCATGCCGTAGGGAGG"	2.67561544951741	-10.4221868745056	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGCCGTAGGGAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.08621471608	48.2379698330702	0.02169865006303	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2221.99726667918	2221.99726667918
"healthy-1"	"2019-08-01-count-3:CCAAGCGAGTATGAGT"	1.38450219210927	-8.79067900097045	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCAAGCGAGTATGAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.50049784596	44.2019772721409	0.0199422365639427	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2215.45296226684	2215.45296226684
"healthy-1"	"2019-08-01-count-4:CGTTCTGCAACCAATC"	-4.23621735993083	3.67974112117616	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTCTGCAACCAATC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2724.89772739968	42.2080473063068	0.015489773022265	3689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2720.49749003561	2720.49749003561
"healthy-1"	"2019-08-01-count-2:AGAGAGCCACAGCGCT"	1.37790503081624	9.92067525470582	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCCACAGCGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1797.46417459933	32.0574924090743	0.0178348435880343	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1793.47051423253	1793.47051423253
"healthy-1"	"2019-08-01-count-3:GCCATTCAGCCTCAAT"	-2.75473199310954	-5.80014803325804	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATTCAGCCTCAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2636.225599176	48.9556925934832	0.0185703729638257	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2630.85889420044	2630.85889420044
"healthy-1"	"2019-08-01-count-3:TCAATTCAGAGCATCG"	11.1365248161251	3.75294206226198	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCAGAGCATCG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1769.31912837517	27.2063766725901	0.0153767493021876	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1769.31912837517	1769.31912837517
"healthy-1"	"2019-08-01-count-4:TCAAGACTCGCGTAGC"	2.46756400641744	-10.1585779420105	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACTCGCGTAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.86340279588	38.7451745754608	0.0170094372331126	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2271.7639453814	2271.7639453814
"healthy-1"	"2019-08-01-count-4:AGGTGTTCAGGTTCAT"	-0.883650104433853	8.75853440845338	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTGTTCAGGTTCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2794.84287929783	45.1078143378586	0.0161396601833987	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2782.25479160763	2782.25479160763
"healthy-1"	"2019-08-01-count-3:GTTACGATCTTCTCAA"	10.8149601417476	4.38863465869752	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGATCTTCTCAA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.28432675724	37.1967580819327	0.0198882905394527	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1866.98647599784	1866.98647599784
"healthy-1"	"2019-08-01-count-4:AGGTGTTCAGGCGTTC"	-4.84424672547038	-5.49056723034056	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTGTTCAGGCGTTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2744.15846495085	40.9125503912006	0.0149089605843638	2839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2735.27955976451	2735.27955976451
"healthy-1"	"2019-08-01-count-4:CGATGCGTCAGACCGC"	2.31413616713826	-10.696656250116	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGCGTCAGACCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.04863123104	43.5084510691066	0.019606803770213	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2213.10970820941	2213.10970820941
"healthy-1"	"2019-08-01-count-3:TGTTGGACAACTGCCG"	1.85014345225636	-4.41801693355712	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGGACAACTGCCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2633.01115073123	42.9108945015278	0.0162972703285403	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2628.24222210138	2628.24222210138
"healthy-1"	"2019-08-01-count-3:GCAACCGTCCGTGTAA"	-2.5864556831425	12.9587478407654	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACCGTCCGTGTAA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1930.58635521615	44.5356395351879	0.0230684524496195	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1926.91806111464	1926.91806111464
"healthy-1"	"2019-08-01-count-4:CTGCTCACAGATTCGT"	1.77187122878377	-10.1921749345032	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACAGATTCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.35868451285	40.9777652280912	0.0171788693642356	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2382.81563499254	2382.81563499254
"healthy-1"	"2019-08-01-count-3:CAACAACTCGCGCCAA"	-0.0495768961613953	11.8761224516663	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACTCGCGCCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2221.29018398309	43.9966693409103	0.0198068085197306	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2218.31829344963	2218.31829344963
"healthy-1"	"2019-08-01-count-3:TCACAAGCAGTCAGCC"	1.7499758201534	-4.68074371730956	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACAAGCAGTCAGCC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2569.85247874446	40.0776480687206	0.015595310781536	2520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2564.36794227023	2564.36794227023
"healthy-1"	"2019-08-01-count-2:AGGATAAAGAGGTATT"	2.22430743750874	-10.388153099176	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAAAGAGGTATT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.28895426838	34.6479096054039	0.0141288038447088	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2448.15596188916	2448.15596188916
"healthy-1"	"2019-08-01-count-3:AGTCTCCGTCAGGAGT"	2.03416766700093	-10.5993490449158	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCGTCAGGAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.49421828637	46.9556908802249	0.0192797381852391	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2430.24175882854	2430.24175882854
"healthy-1"	"2019-08-01-count-3:CGTAATGCAGCCATTA"	1.04169638928716	10.1438331373963	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGCAGCCATTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.95232957685	33.9358651644393	0.0190870500855981	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1775.13200049541	1775.13200049541
"healthy-1"	"2019-08-01-count-2:AACAAGATCCATACAG"	3.2622717815334	-10.4933700791565	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAGATCCATACAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.78287447835	40.2973453900279	0.0172743660933464	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2326.3443258524	2326.3443258524
"healthy-1"	"2019-08-01-count-2:GCTTGGGCAAAGGAGA"	1.15796436843221	8.77937028491823	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTGGGCAAAGGAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.82078750867	36.252614499174	0.0217234916837862	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1667.46997312212	1667.46997312212
"healthy-1"	"2019-08-01-count-4:GGGCTACGTTCTTGTT"	10.8378702598507	4.37768075549928	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACGTTCTTGTT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1828.20703831547	37.3755685119736	0.0204438379946354	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1824.53086281758	1824.53086281758
"healthy-1"	"2019-08-01-count-3:GCACGTGCATTGAAGA"	11.0752769905025	3.85031936252443	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGTGCATTGAAGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.31404818568	34.5011481767064	0.0194777138543249	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1760.47542820716	1760.47542820716
"healthy-1"	"2019-08-01-count-3:GTTCCGTCAGTGACCC"	2.91384901580159	-10.4083175889221	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCCGTCAGTGACCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.04009353917	44.5327506710852	0.0191042405467475	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2321.25627614084	2321.25627614084
"healthy-1"	"2019-08-01-count-4:CGCATGGTCAAAGACA"	1.78396620330159	-4.8623028031555	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGTCAAAGACA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2480.75337288972	43.9589397523973	0.0177199959628358	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2471.78842230201	2471.78842230201
"healthy-1"	"2019-08-01-count-4:GTGTTAGGTGTGTTTG"	3.05485786971394	-10.7628717652527	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTAGGTGTGTTTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.43222742008	38.6525060872937	0.0150666642736317	2766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2560.41688365843	2560.41688365843
"healthy-1"	"2019-08-01-count-2:TCATGTTAGCGAGTCA"	3.1591772037441	-10.6071043244568	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTAGCGAGTCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.41543646529	38.4684375513837	0.0162697455608277	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.32148855257	2359.32148855257
"healthy-1"	"2019-08-01-count-3:AACCTTTAGTTCGCAT"	3.23889030989949	-10.5420036545959	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTAGTTCGCAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.83120105438	39.5775300587056	0.0172840382472217	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2287.82282222466	2287.82282222466
"healthy-1"	"2019-08-01-count-3:GTTCGCTGTGAGATAT"	1.32322337207143	11.5768747099671	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCGCTGTGAGATAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2103.47613107534	28.66898947056	0.0136293390959012	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2097.28902806093	2097.28902806093
"healthy-1"	"2019-08-01-count-3:AACCTTTGTAACGGTG"	3.45495762404744	-10.6051845780578	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTGTAACGGTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.64791332525	43.6485574323248	0.0197625692936315	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2203.3177328178	2203.3177328178
"healthy-1"	"2019-08-01-count-2:ACGGTCGAGATGGCAC"	0.887351413338822	9.15812108600465	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGAGATGGCAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1661.04477216196	33.8439602502412	0.0203751041618168	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1657.24899645726	1657.24899645726
"healthy-1"	"2019-08-01-count-4:CGCCATTAGTGAGGCT"	-7.8826678794926	4.28424975955812	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTAGTGAGGCT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2213.46403794396	41.2037386172725	0.0186150476858643	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2206.94443688134	2206.94443688134
"healthy-1"	"2019-08-01-count-4:CAACAGTGTATGTCAC"	-3.9358905357426	-5.42576601421507	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAGTGTATGTCAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2662.11119693085	39.3058624797473	0.0147649213620615	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2659.12727932782	2659.12727932782
"healthy-1"	"2019-08-01-count-2:CTAAGTGCATACAGCT"	1.20589496669118	11.0918550261292	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAAGTGCATACAGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1905.02671963087	39.0393836848661	0.0204928273617236	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1902.27116500072	1902.27116500072
"healthy-1"	"2019-08-01-count-4:CATTGTTAGGCCTGAA"	1.50373246249501	10.4452438124451	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGTTAGGCCTGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.75808023862	34.6237572130841	0.017453618744136	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1977.01660128533	1977.01660128533
"healthy-1"	"2019-08-01-count-3:CTTCTCTGTAACACCT"	3.40109266814534	-10.858407043573	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTGTAACACCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.95837122799	41.8727730423359	0.0164856139048026	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2527.61545549896	2527.61545549896
"healthy-1"	"2019-08-01-count-3:GTTGAACCACTGTGAT"	-1.60240600529369	10.5573558577332	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGAACCACTGTGAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.73508798327	45.7607426985472	0.0224017019963785	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2034.39965619686	2034.39965619686
"healthy-1"	"2019-08-01-count-3:CAACGGCAGTATGTAG"	-5.04198632660564	-4.44089414989623	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGGCAGTATGTAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2721.92871684345	43.1066893333555	0.0158368178661729	3248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2716.02189589727	2716.02189589727
"healthy-1"	"2019-08-01-count-2:GATTGGTAGATCCAAA"	1.8751286464626	-9.86902525341185	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTAGATCCAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.53345750537	43.8494471072768	0.0189452638781633	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2309.60209703588	2309.60209703588
"healthy-1"	"2019-08-01-count-2:TATATCCCATCTTCGC"	8.09890427169148	6.61962745273439	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCCATCTTCGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.7588953495	39.8248447726985	0.0216467738644269	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1830.72062151721	1830.72062151721
"healthy-1"	"2019-08-01-count-3:TCTTGCGGTTCTTGCC"	1.42718901213948	10.8381194838318	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTGCGGTTCTTGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1834.46269243664	36.2699569427742	0.0197714333969901	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1830.05144077763	1830.05144077763
"healthy-1"	"2019-08-01-count-4:CAACCTCCATTCAGCA"	0.37954999980275	11.9949950941834	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCCATTCAGCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.89721633319	40.6905623592072	0.02068769126384	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1963.61206995231	1963.61206995231
"healthy-1"	"2019-08-01-count-2:AGGGAGTAGCCGATCC"	-8.24572596970256	0.289208538177885	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGAGTAGCCGATCC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2670.19103964874	43.2294633670996	0.0161896518732931	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2662.15081947496	2662.15081947496
"healthy-1"	"2019-08-01-count-3:CATCGGGAGGCCCGTT"	10.7655579048092	4.3926906355652	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCGGGAGGCCCGTT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.32743022844	36.8530988646023	0.0195369575154507	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1882.80959263559	1882.80959263559
"healthy-1"	"2019-08-01-count-3:TTTCATGAGGACAAGA"	1.82114603099172	-9.29265310680541	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGAGGACAAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.3887437063	45.8861607098323	0.0196566063958049	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2331.8974415	2331.8974415
"healthy-1"	"2019-08-01-count-4:TAATTCCCACAAGCTT"	1.60830881175343	-8.83385183727416	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATTCCCACAAGCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.98943512389	40.493949783778	0.0169431501196904	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2384.61736538688	2384.61736538688
"healthy-1"	"2019-08-01-count-3:TATATCCCATCAACCA"	7.9771577316219	6.86308238590089	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCCATCAACCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1920.26634338202	44.4149893082929	0.023129598381685	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1915.5235458455	1915.5235458455
"healthy-1"	"2019-08-01-count-2:AACCCAAAGCAAACAT"	8.17744698104207	7.55358979785768	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCCAAAGCAAACAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.51119194854	42.5787030775098	0.022738824344864	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1871.14145760217	1871.14145760217
"healthy-1"	"2019-08-01-count-4:GATTCGATCTATCGCC"	7.68934979018514	6.82289407337037	"2019-08-01-count-4"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCGATCTATCGCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1670.32584056027	39.5727242586546	0.0236916195018458	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1664.23146138595	1664.23146138595
"healthy-1"	"2019-08-01-count-3:CGTGCTTTCAGAATAG"	2.08088721808736	-10.2318878403869	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTTCAGAATAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.66485691053	37.9057344060568	0.0160776601877708	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2352.02448410161	2352.02448410161
"healthy-1"	"2019-08-01-count-3:GTTGCTCTCTCGGCTT"	8.17287125167195	7.05878017032472	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCTCTCTCGGCTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1853.32484067267	39.7925355642051	0.0214708909581994	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1849.77864519809	1849.77864519809
"healthy-1"	"2019-08-01-count-2:GGGCTACCACGCGGTT"	1.96195318278615	-9.71611597454222	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTACCACGCGGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.46881835403	40.0776464088257	0.0184734834950209	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2167.12431954571	2167.12431954571
"healthy-1"	"2019-08-01-count-4:GTTAGTGTCAGCGCAC"	-0.886624912649947	12.9997005232605	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGTCAGCGCAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2062.87533475277	42.9052464171221	0.0207987587491632	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2061.26536501967	2061.26536501967
"healthy-1"	"2019-08-01-count-3:CCCAACTTCCCGGTAG"	13.9994903999263	1.66742036426393	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTTCCCGGTAG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1182.15292076771	30.1638621716208	0.0255160408113967	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1169.00551592241	1169.00551592241
"healthy-1"	"2019-08-01-count-4:TCACTCGTCGATGCTA"	2.46358146247212	-10.6920309296814	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTCGTCGATGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.73037612489	40.2424543505927	0.0175982506598735	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2279.34182433188	2279.34182433188
"healthy-1"	"2019-08-01-count-2:GGGCTCAGTCGTCGGT"	-8.02176318588908	4.12379644000856	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	1	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTCAGTCGTCGGT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2094.80875729802	41.6932036235077	0.0199031073735273	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2088.78652889429	2088.78652889429
"healthy-1"	"2019-08-01-count-3:CAAGCTATCCCACAGG"	2.92854322966878	-10.6646099320618	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTATCCCACAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.32837956917	40.2543885232758	0.0175681446981618	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2289.42098760368	2289.42098760368
"healthy-1"	"2019-08-01-count-3:CGTTCTGTCAAGAAAC"	1.55251004275624	-9.14479830181273	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTCTGTCAAGAAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.920863878	40.6823647772989	0.0169092697054569	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.46409183383	2401.46409183383
"healthy-1"	"2019-08-01-count-1:TTCTTGAAGACGAAGA"	2.2504788833553	-10.4854383698669	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCTTGAAGACGAAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.38195798795	36.0656847752994	0.0142869365157583	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2513.03875748436	2513.03875748436
"healthy-1"	"2019-08-01-count-4:TATATCCGTTGTCAGT"	1.35678066787068	11.1595391997131	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATATCCGTTGTCAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.5784362379	40.4941174576254	0.0217642624836095	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1858.2359189443	1858.2359189443
"healthy-1"	"2019-08-01-count-3:GTGCTTCCATATGCGT"	8.99106373366658	-9.35393812572631	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCCATATGCGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.04133087116	40.4686102052251	0.0191337207526609	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2102.70504857417	2102.70504857417
"healthy-1"	"2019-08-01-count-2:TCGACCTAGCACCTGC"	0.718515296548051	9.36226079547731	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTAGCACCTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1774.65099052083	39.0404788163138	0.0219989614999489	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1769.46062883591	1769.46062883591
"healthy-1"	"2019-08-01-count-2:CCTCAACCAGAGCCCT"	1.25311138209645	9.30078408801881	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACCAGAGCCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1870.94060798302	38.3188973127563	0.0204810869726464	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1859.39364017095	1859.39364017095
"healthy-1"	"2019-08-01-count-2:TTCTAACAGCATGCAG"	1.40750541266744	9.72730729663698	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACAGCATGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1697.98373833135	30.3645945752012	0.0178827357940666	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1693.5044774854	1693.5044774854
"healthy-1"	"2019-08-01-count-2:CTACTATCAATTGGTC"	1.30140342292134	10.4970330961975	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCAATTGGTC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.97822868177	41.0682287378329	0.0218218405037549	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1876.19339389371	1876.19339389371
"healthy-1"	"2019-08-01-count-3:GAAATGACATGGCCCA"	1.59537949141805	-4.85088732158812	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAATGACATGGCCCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2548.68317417542	38.6657568844122	0.0151708761905731	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2540.87549553755	2540.87549553755
"healthy-1"	"2019-08-01-count-4:TCTTCCTAGCTAGCCC"	8.14884151992146	7.0219311484131	"2019-08-01-count-4"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTCCTAGCTAGCCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1785.29001478939	47.5651751056602	0.0266428281744865	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1777.86569972693	1777.86569972693
"healthy-1"	"2019-08-01-count-3:TATCTTGCAGGTTCCG"	7.95499195632283	8.18276593768922	"2019-08-01-count-3"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGCAGGTTCCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1742.78808183234	42.3483497009109	0.0242991962949313	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1736.70600945724	1736.70600945724
"healthy-1"	"2019-08-01-count-4:CGGGTGTAGAACGCGT"	3.35616411742513	-10.4500847092834	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTAGAACGCGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.23049959971	41.8018277714794	0.017525278072075	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2381.5059172008	2381.5059172008
"healthy-1"	"2019-08-01-count-2:TGAGGAGTCAAACGTC"	1.94664456424062	-4.65296699916991	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGAGTCAAACGTC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2490.03158678944	42.1351972983415	0.0169215513256477	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2485.46256777351	2485.46256777351
"healthy-1"	"2019-08-01-count-2:GTAAGTCGTAATGTGA"	-0.904795686632949	11.6272115477356	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAAGTCGTAATGTGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.3974188022	37.9233694394948	0.0183169516611139	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2064.85455830722	2064.85455830722
"healthy-1"	"2019-08-01-count-2:CTACTATTCACATTGG"	1.45457567748372	9.4534873732361	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATTCACATTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.93366782842	40.8255957995979	0.0224324636228703	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1814.04853220803	1814.04853220803
"healthy-1"	"2019-08-01-count-4:TCTTGCGAGCACCTGC"	2.58313359793965	-10.481999420282	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGAGCACCTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.91696376822	41.9560167984118	0.0171675295930353	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2442.09854238369	2442.09854238369
"healthy-1"	"2019-08-01-count-4:AACCTTTAGTTCATGC"	1.85985900935475	-10.0830440751282	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTAGTTCATGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2234.33596425277	45.1536289628541	0.0202089702199082	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2232.4271103138	2232.4271103138
"healthy-1"	"2019-08-01-count-4:TCGGGCATCAACTCTT"	2.26323403891866	-10.0292005768982	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCATCAACTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.88890843761	41.5548555840071	0.0176312321871607	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.69857546403	2349.69857546403
"healthy-1"	"2019-08-01-count-4:CAATACGAGGTCCCGT"	1.26060070571248	10.4441957243714	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATACGAGGTCCCGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1766.66282614723	37.0452202148015	0.0209690381585661	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1761.78513521828	1761.78513521828
"healthy-1"	"2019-08-01-count-3:GCCAACGAGGTTACCT"	0.471932162612122	12.8141889342102	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ TRM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAACGAGGTTACCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.52586902799	36.1336171462908	0.0193276903758906	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1861.50167568875	1861.50167568875
"healthy-1"	"2019-08-01-count-2:AACTTCTGTGAGCGAT"	3.12909640845601	-10.8587398759094	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTGTGAGCGAT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.05010207001	42.2066859108955	0.0179141716357445	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.61959771609	2349.61959771609
"healthy-1"	"2019-08-01-count-4:TCAGGTACAAAGAACT"	-3.14379320564922	-5.74988510524901	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTACAAAGAACT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2568.32372906416	43.8253698073637	0.0170638028654326	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2561.72159432878	2561.72159432878
"healthy-1"	"2019-08-01-count-2:ATTCATCGTATCGCAT"	13.9898086982662	1.7228839167389	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCGTATCGCAT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1179.96034379881	31.0477837628154	0.0263125654400037	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1172.76639292386	1172.76639292386
"healthy-1"	"2019-08-01-count-3:CCCTCAACAAACTGCT"	1.76750328120534	-9.77479460155638	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAACAAACTGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.61640008946	41.9043091298752	0.0165982876164436	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.92706240599	2516.92706240599
"healthy-1"	"2019-08-01-count-2:ATGAAAGGTAGCACGA"	1.2253244119579	9.41834924304811	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGGTAGCACGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1711.11801775251	37.1410834009876	0.0217057403496756	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1706.12880178104	1706.12880178104
"healthy-1"	"2019-08-01-count-2:ACTACGACAGCCTACG"	1.35384084758107	9.42202088916627	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGACAGCCTACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.24651431352	35.4040732187763	0.0202860013920166	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1739.41616516062	1739.41616516062
"healthy-1"	"2019-08-01-count-4:CTTCCTTAGTAACAGT"	6.94083418425862	-1.10192873394164	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTAGTAACAGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2590.06991620879	40.3051911983134	0.0155614298077752	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2580.38319977523	2580.38319977523
"healthy-1"	"2019-08-01-count-3:TTTGTTGCAGAATTCC"	11.026233335107	4.04479906642763	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGTTGCAGAATTCC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1833.63779557803	33.9036608905429	0.0184898353275136	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1831.71180702981	1831.71180702981
"healthy-1"	"2019-08-01-count-2:GTCGCGAGTGTGAATA"	6.97545542296712	-1.17819764530333	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGCGAGTGTGAATA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2081.91374033298	39.0842547002717	0.0187732344251788	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2078.0855735858	2078.0855735858
"healthy-1"	"2019-08-01-count-2:TCGCACTTCCATTGCC"	8.54062141951863	7.78756473148195	"2019-08-01-count-2"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCACTTCCATTGCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.53714776416	37.7203584765507	0.0192006338589628	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1957.96501074976	1957.96501074976
"healthy-1"	"2019-08-01-count-4:AGGCTGCGTAGGACCA"	2.14816679534261	-10.5960073701111	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCTGCGTAGGACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.2233764079	40.4245642959327	0.017612474982369	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2292.75735751222	2292.75735751222
"healthy-1"	"2019-08-01-count-2:AGGTGTTGTGTGTTTG"	-2.87893591347392	-5.90585281765135	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTGTGTGTTTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2618.8078441029	48.2656535108137	0.0184303913780843	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2612.83956783426	2612.83956783426
"healthy-1"	"2019-08-01-count-3:ATATCCTAGCCATTGT"	1.22691347178761	11.5446376570496	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTAGCCATTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.89695087596	35.2709443681515	0.0175661128190689	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2003.90623682921	2003.90623682921
"healthy-1"	"2019-08-01-count-4:TGAATCGCATGACGAG"	7.07426609572713	-9.9712763062683	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCATGACGAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2293.30443561652	44.7422324059962	0.0195099402029316	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2290.37358792017	2290.37358792017
"healthy-1"	"2019-08-01-count-3:CATTCCGTCGAATGCT"	1.15273358401601	9.98818967426149	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGTCGAATGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1768.94414779688	30.6970343296046	0.0173533089599443	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1765.05743260076	1765.05743260076
"healthy-1"	"2019-08-01-count-4:CGTAGTATCCGAAGGA"	-2.66996512833293	10.5928087004456	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAGTATCCGAAGGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1888.10719159523	44.7579264443972	0.0237051829703493	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1886.31755907947	1886.31755907947
"healthy-1"	"2019-08-01-count-3:TCATATCAGATTAGCA"	6.83753075179402	-0.998968147393785	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATATCAGATTAGCA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1823.97281475132	47.8565382763114	0.0262375282620844	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	1821.96095935663	1821.96095935663
"healthy-1"	"2019-08-01-count-2:GAAGCGACAGAACGCA"	3.02877845343892	-10.243395828363	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGACAGAACGCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.77753539325	42.4369874444985	0.0170719168711873	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2482.46091793224	2482.46091793224
"healthy-1"	"2019-08-01-count-3:CGGGACTAGGAATCGC"	1.50635935839955	9.67020795429078	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGACTAGGAATCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.99491450741	38.5399212959366	0.020968459157171	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1835.0564306998	1835.0564306998
"healthy-1"	"2019-08-01-count-3:AGACACTCACCGCTGA"	7.81912531432454	6.88202521884767	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTCACCGCTGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1684.07235759483	44.5598734328389	0.0264595955345284	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1678.39696522437	1678.39696522437
"healthy-1"	"2019-08-01-count-2:ACTATCTTCTCGCTTG"	1.23800625380818	10.6071500548157	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTTCTCGCTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1728.9976725306	32.7165582922275	0.0189222685559448	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1721.43222247693	1721.43222247693
"healthy-1"	"2019-08-01-count-3:TAGACTGCAACACGTT"	1.1612831550533	10.1058616408142	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGCAACACGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1783.24890575307	41.2272888558648	0.0231192004228117	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1770.96214472679	1770.96214472679
"healthy-1"	"2019-08-01-count-3:ATCACAGTCACGAGGA"	1.12179925021474	11.1247138747009	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGTCACGAGGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.86130846647	37.1312129628065	0.0198896472889611	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1860.37049790294	1860.37049790294
"healthy-1"	"2019-08-01-count-2:TTCTTGACAATCTCGA"	7.0945369201595	-1.08706989204558	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGACAATCTCGA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2311.79468761455	33.3959787524824	0.0144459103273321	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2299.36873299473	2299.36873299473
"healthy-1"	"2019-08-01-count-4:ACTTCGCCACCGTCTT"	1.50652839717214	10.0718965300354	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCCACCGTCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.07450390783	34.9777791764979	0.0188045043910946	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1855.23071988635	1855.23071988635
"healthy-1"	"2019-08-01-count-2:AAGATAGTCTCTTAAC"	1.28070761737172	9.39138982379762	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGATAGTCTCTTAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1699.52011662124	40.4305220171508	0.0237893753782271	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1691.96075979058	1691.96075979058
"healthy-1"	"2019-08-01-count-3:CACCAAAAGTTGGCGA"	2.23212661322896	-10.6179981461731	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAAAGTTGGCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.12134379612	37.9077549480249	0.0159402105560829	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.62010903728	2366.62010903728
"healthy-1"	"2019-08-01-count-3:GTAACCACAACAACAA"	-1.07306967201884	13.2752475508484	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCACAACAACAA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1638.78641602432	46.4844507004654	0.0283651672029576	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1636.67156963374	1636.67156963374
"healthy-1"	"2019-08-01-count-2:CTATCTATCCATTGTT"	7.93183674392049	7.33695790851442	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTATCCATTGTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.50493563827	40.6498979732482	0.0214341113536662	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1891.336112637	1891.336112637
"healthy-1"	"2019-08-01-count-2:GGTAATCCACCATTCC"	3.44042744216267	-11.0340242615906	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCCACCATTCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.69857861266	39.8037972724476	0.0174908037674802	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2270.96733241109	2270.96733241109
"healthy-1"	"2019-08-01-count-2:TCCGATCGTAGCTGCC"	1.47824170169179	-9.29754640972289	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCGTAGCTGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.24106686018	43.5029775045426	0.0187736088949469	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2311.61975097086	2311.61975097086
"healthy-1"	"2019-08-01-count-3:TTCCTAACAAACTCTG"	-7.67792592468913	4.16640756213991	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAACAAACTCTG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2329.71799410274	41.4086701991312	0.0177741127054647	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2317.4511836482	2317.4511836482
"healthy-1"	"2019-08-01-count-1:CAGTGCGGTAGGAGTC"	0.720656116574448	9.31620309436647	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAGTGCGGTAGGAGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1708.60902186302	40.3521251292436	0.0236169449024942	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1705.36464753371	1705.36464753371
"healthy-1"	"2019-08-01-count-2:TTGAACGTCCCGTGTT"	1.98108639296834	-9.8136778107849	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAACGTCCCGTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.95649060306	38.4779170326821	0.0154843423529497	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2477.35639278274	2477.35639278274
"healthy-1"	"2019-08-01-count-4:CCCAACTGTAGGTCAG"	2.30651130256001	-10.0599861375061	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTGTAGGTCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.43966174809	41.5951731368002	0.0171283535646335	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2423.37354587907	2423.37354587907
"healthy-1"	"2019-08-01-count-4:TGTAGACAGCTGACCC"	6.87767901000325	-0.950748108979784	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAGACAGCTGACCC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2307.183604124	38.7825077343114	0.0168094587985929	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2297.4841292243	2297.4841292243
"healthy-1"	"2019-08-01-count-2:CTCAAGAGTCTTAGTG"	1.90878297862355	-4.63465597545775	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAAGAGTCTTAGTG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2557.25496684696	42.1349281732141	0.0164766238484094	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2551.27310946308	2551.27310946308
"healthy-1"	"2019-08-01-count-2:GATCCCTCAGACAAGC"	-5.58554206314738	-5.41519024288329	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTCAGACAAGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2895.21780809918	42.8271925774814	0.0147923905613163	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2891.08475412916	2891.08475412916
"healthy-1"	"2019-08-01-count-4:CTTGATTGTCTGTGCG"	1.63899983939473	-4.98998691951903	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTGTCTGTGCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2265.16691310997	39.3437980495868	0.0173690502990659	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2260.89083715328	2260.89083715328
"healthy-1"	"2019-08-01-count-3:ATGATCGCAGAGGTTG"	-7.65925441208537	1.03263667905656	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGATCGCAGAGGTTG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2500.38293844616	43.564361470969	0.0174230758021576	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2493.73150568272	2493.73150568272
"healthy-1"	"2019-08-01-count-4:CACATGACAGGCTACC"	-5.5183461708134	3.80893347347108	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGACAGGCTACC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2819.87513747184	38.5983387166064	0.0136879602233777	2707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2812.87851073433	2812.87851073433
"healthy-1"	"2019-08-01-count-2:ACTCTCGTCATCGGGC"	2.73705520209615	-10.4679794541565	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCTCGTCATCGGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.13352160927	43.9223348442221	0.0195546410850738	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2243.16437052691	2243.16437052691
"healthy-1"	"2019-08-01-count-3:AGACTCACAAGATCCT"	10.5407682853634	4.34651563251344	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCACAAGATCCT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.49399985558	39.9687691603599	0.0203766971315246	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1952.41003482672	1952.41003482672
"healthy-1"	"2019-08-01-count-3:TCATGTTAGTAATCCC"	0.47132103618924	11.6307735213074	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGTTAGTAATCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2251.70853986912	45.8267942408901	0.020352009787001	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2239.81082735769	2239.81082735769
"healthy-1"	"2019-08-01-count-2:CCTGTTGAGGATGTTA"	11.0257402854854	3.88067648494569	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGTTGAGGATGTTA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2070.13004881555	36.6611866235149	0.0177096055605255	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2065.40749155529	2065.40749155529
"healthy-1"	"2019-08-01-count-4:CACATGATCCAAATGC"	1.21737625178639	9.85144422138063	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGATCCAAATGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.55607046635	40.7467208719946	0.0225424381228085	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.29845210853	1802.29845210853
"healthy-1"	"2019-08-01-count-1:CCCGGAAGTACTCAAC"	2.9058526950771	-10.8874712220398	"2019-08-01-count-1"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCCGGAAGTACTCAAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.47298042054	30.3364634599808	0.0128846088752152	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.59079162457	2344.59079162457
"healthy-1"	"2019-08-01-count-4:CTTTCAATCTTTGGAG"	-4.90556035462077	-5.08987190639647	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAATCTTTGGAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3129.61950427522	42.0259060382141	0.0134284394575138	3915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3125.18858428828	3125.18858428828
"healthy-1"	"2019-08-01-count-4:TAACACGTCCTGTTGC"	-3.58961878243144	10.7980727919373	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGTCCTGTTGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.13822653093	44.9895597538567	0.0219553562426197	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2044.14890663333	2044.14890663333
"healthy-1"	"2019-08-01-count-2:TGGGCTGTCTAGACAC"	0.10003719207589	13.5694951781067	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGTCTAGACAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.30367362359	45.5303033604014	0.0229567987827176	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1981.52182443248	1981.52182443248
"healthy-1"	"2019-08-01-count-2:GTTAGTGTCTAACGCA"	1.04964931783025	9.3602609404358	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGTCTAACGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.87064299555	33.9011571615848	0.0187002626428807	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1808.07507753799	1808.07507753799
"healthy-1"	"2019-08-01-count-2:CATCGCTAGTTCCTGA"	2.45826353606526	-10.6839685670105	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGCTAGTTCCTGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.03563201097	35.9570635851676	0.0152876355680142	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2348.97411952588	2348.97411952588
"healthy-1"	"2019-08-01-count-3:AGAGAATCACCTGCAG"	-6.05420670929607	-2.85618688976439	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATCACCTGCAG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2954.56058126847	42.9958002891996	0.0145523502079421	2860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2943.76551200979	2943.76551200979
"healthy-1"	"2019-08-01-count-2:AGTCACAAGAGAGAAC"	2.18076505240743	-10.3149309388367	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCACAAGAGAGAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.74254627519	41.4773197467715	0.0181302392676585	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2283.66552460305	2283.66552460305
"healthy-1"	"2019-08-01-count-3:CCGGTGAAGTCGAAGC"	6.91093649443929	-1.11194434082183	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTGAAGTCGAAGC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2083.27603029563	46.97739605087	0.022549770346181	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2072.78218780342	2072.78218780342
"healthy-1"	"2019-08-01-count-2:CATCGCTCATGTTACG"	-8.07064853134807	3.37211797321168	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGCTCATGTTACG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2404.32180847308	39.6941875898769	0.0165095152612227	2759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2396.7632020254	2396.7632020254
"healthy-1"	"2019-08-01-count-3:CCGGTGACAACCGCTG"	1.9477490383083	-7.99591543590697	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTGACAACCGCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.64711084743	42.0694706656496	0.0208301095967194	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2019.64711084743	2019.64711084743
"healthy-1"	"2019-08-01-count-3:TACCCACAGACTTCCA"	1.80074014243428	-9.84946062481078	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACAGACTTCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.31374025797	39.9320949535948	0.0163836498740487	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2433.89481480617	2433.89481480617
"healthy-1"	"2019-08-01-count-2:ATCCCTGTCGTGTCAA"	3.41438259658162	-10.8480901948181	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGTCGTGTCAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.98148848165	41.0245623133134	0.0182009313399237	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2247.86885384665	2247.86885384665
"healthy-1"	"2019-08-01-count-2:GTTCATTAGTCATGCT"	-5.12117991867717	-4.41738321697386	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCATTAGTCATGCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2999.42959648553	43.5471049245548	0.0145184621021209	3555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2993.6441562143	2993.6441562143
"healthy-1"	"2019-08-01-count-3:CACGTTCCAGTTACCA"	2.49356259879414	-10.8868980637756	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTTCCAGTTACCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.62796119037	39.3100851509419	0.0161994692963393	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2423.36168730877	2423.36168730877
"healthy-1"	"2019-08-01-count-2:AAGTACCAGCTGAAAT"	0.91395409879033	10.9460601576599	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCAGCTGAAAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2062.72843744404	36.4205558369088	0.0176564957246811	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2056.80751306423	2056.80751306423
"healthy-1"	"2019-08-01-count-4:ACGTAGTAGTTGCCCG"	-5.13030848923381	-5.51731684124144	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTAGTTGCCCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2728.12085168013	40.0491019821496	0.0146801055229958	2541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2723.22579778123	2723.22579778123
"healthy-1"	"2019-08-01-count-3:TAGGTTGCATCGTCCT"	8.660492559045	7.37308690631715	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGCATCGTCCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.78339678108	42.9160554213716	0.0228060548811211	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1877.19654646457	1877.19654646457
"healthy-1"	"2019-08-01-count-3:CACGTTCTCTCTCTAA"	2.63836946067159	-10.6011524430481	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTTCTCTCTCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.81044020846	40.9932804198489	0.016070688661796	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2540.11933673183	2540.11933673183
"healthy-1"	"2019-08-01-count-4:ATCACTTTCAATCCAG"	1.20411576804463	10.6220683821472	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACTTTCAATCCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.40345249763	39.8974884853695	0.0220135800505057	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1807.86069449715	1807.86069449715
"healthy-1"	"2019-08-01-count-3:AATGCCAGTGCCGTAC"	1.58497633513753	-9.2166433564392	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCAGTGCCGTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2412.62222551387	42.5743057810967	0.0176464866031932	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2407.02987173496	2407.02987173496
"healthy-1"	"2019-08-01-count-2:ACAGGGAGTTGCGTAT"	8.13705219802205	-10.2473917237488	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGGGAGTTGCGTAT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.93291961423	42.7794649386106	0.0203330935790741	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2099.80934784899	2099.80934784899
"healthy-1"	"2019-08-01-count-3:TGCATCCGTCGACGCT"	2.92119230803792	-10.6431999436584	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATCCGTCGACGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.95461345638	38.0232978550335	0.0157645163150667	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2406.39216244389	2406.39216244389
"healthy-1"	"2019-08-01-count-4:GTACAGTGTACTAGCT"	-2.9856096309727	-5.60397436535033	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAGTGTACTAGCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2432.94491623695	41.5807453226047	0.0170907056074734	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2430.69772292084	2430.69772292084
"healthy-1"	"2019-08-01-count-3:ATCGATGAGGCACCAA"	2.53285851058308	-10.5794058076111	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGAGGCACCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.67442305793	36.7271635286838	0.0151472557220134	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2421.21803634176	2421.21803634176
"healthy-1"	"2019-08-01-count-1:CTGAATGTCCCAGTGG"	1.19620515879933	9.32102296436159	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGAATGTCCCAGTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1996.71689523573	42.2346702124488	0.0211520573162991	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1988.86236462256	1988.86236462256
"healthy-1"	"2019-08-01-count-3:GCGGATCCACCGTGGT"	2.84680976447408	-10.6742553940979	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGATCCACCGTGGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.72647616273	38.6102173571535	0.01670912492476	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2307.87888825742	2307.87888825742
"healthy-1"	"2019-08-01-count-4:CACGTTCAGACTTAAG"	-5.65651069107707	-4.5415020219055	"2019-08-01-count-4"	"Control1"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCAGACTTAAG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3116.79372250473	40.016947868908	0.0128391390100559	3943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3113.99718380819	3113.99718380819
"healthy-1"	"2019-08-01-count-4:GCCCGAACACATAGCT"	1.441374083131	9.95693204486696	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCGAACACATAGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.33566252816	28.6653151222513	0.01482686926944	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1926.44855786785	1926.44855786785
"healthy-1"	"2019-08-01-count-2:GCCATTCGTAGTATAG"	1.71870626982991	-9.64145853435668	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATTCGTAGTATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.48098813092	43.0723384506355	0.0177582667773566	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2420.94187775362	2420.94187775362
"healthy-1"	"2019-08-01-count-4:GAACTGTGTAACGATA"	14.0432230430538	1.70134077155916	"2019-08-01-count-4"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTGTAACGATA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1229.99068553599	22.0756423902602	0.0179478126540774	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1218.58083374783	1218.58083374783
"healthy-1"	"2019-08-01-count-2:TGTAACGTCGCACGGT"	14.1207577186519	1.81142160976259	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGTCGCACGGT"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1341.94889184931	35.3901242926679	0.0263721848928967	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1318.8957329035	1318.8957329035
"healthy-1"	"2019-08-01-count-3:TGCGACGTCAAAGGTA"	1.46173598346059	-9.25479891216429	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGACGTCAAAGGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.86335450121	46.4844611636491	0.0196313951458745	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.0582723584	2366.0582723584
"healthy-1"	"2019-08-01-count-2:GGTTAACGTAACAGTA"	-1.0782165330952	13.265938735846	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACGTAACAGTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2099.4442445884	51.5434638750639	0.0245510039182627	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2094.89783426757	2094.89783426757
"healthy-1"	"2019-08-01-count-2:AGTGTTGAGAGTTGCG"	3.23353590545003	-10.1985712281433	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGTTGAGAGTTGCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2361.57676796095	41.3168017463533	0.0174954303018603	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2357.15506762441	2357.15506762441
"healthy-1"	"2019-08-01-count-4:TTGCCTGCAGTTGGTT"	2.42624153670613	-10.7513084641662	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCCTGCAGTTGGTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.27961387902	41.7918002305836	0.0170768391129374	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2438.71326260295	2438.71326260295
"healthy-1"	"2019-08-01-count-2:GTGCTTCTCGTCGACG"	1.80154134806935	-8.62074949657591	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCTCGTCGACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.54221936769	44.348201422895	0.0183519249394696	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2413.74701548211	2413.74701548211
"healthy-1"	"2019-08-01-count-2:CAACGATCACCCAACG"	3.060559173196	-10.7438802949158	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGATCACCCAACG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.30176420664	41.7143492597588	0.0172923428895629	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2410.70705126378	2410.70705126378
"healthy-1"	"2019-08-01-count-4:CACTAAGGTTCCTTGC"	1.36125101622884	-8.89991953289183	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTAAGGTTCCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.34553004826	44.9524179654189	0.0169354055289861	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2648.93115168365	2648.93115168365
"healthy-1"	"2019-08-01-count-3:AGCATCATCAACTTTC"	7.02339424666707	-1.12621512329253	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCATCATCAACTTTC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2267.82432932187	41.644206668186	0.0183630654851641	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2261.12050775701	2261.12050775701
"healthy-1"	"2019-08-01-count-2:CGACAGCCAGTCAACT"	1.74111666259114	-10.0248022309509	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCCAGTCAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.60759653944	42.4830383810412	0.017905631948159	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.76314211614	2369.76314211614
"healthy-1"	"2019-08-01-count-4:GAAGAATCATACTGAC"	2.25493778762166	-10.5894470444885	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATCATACTGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.90654591731	43.5302732262173	0.0180256554026119	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2406.25143693713	2406.25143693713
"healthy-1"	"2019-08-01-count-2:GTTGCTCGTTGTCTAG"	7.95910801467244	7.281618095282	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCTCGTTGTCTAG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.97048574989	40.7635586741875	0.0233338565286005	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1734.03709416656	1734.03709416656
"healthy-1"	"2019-08-01-count-3:TGCGGCAAGGTCCGAA"	1.74216451224629	-9.79024698650511	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAAGGTCCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.73017999779	41.3817884619546	0.0183859392963733	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2246.40757282479	2246.40757282479
"healthy-1"	"2019-08-01-count-4:TGATGGTTCACTCACC"	8.01338734206502	7.56881949985353	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTTCACTCACC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.5882204818	31.1407205625441	0.0159402683923146	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1950.53293455697	1950.53293455697
"healthy-1"	"2019-08-01-count-3:CCTCAACCAGCGTTTA"	2.25249447402303	-10.3218164674011	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACCAGCGTTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.27916325709	40.6934506232627	0.0172336465998926	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.33624639001	2355.33624639001
"healthy-1"	"2019-08-01-count-2:AGAAATGAGGCATCTT"	1.30959834632222	-8.82629587566527	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGAGGCATCTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2488.38368656442	48.985257191256	0.0196855723881101	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2485.4964763322	2485.4964763322
"healthy-1"	"2019-08-01-count-1:GAGTTTGTCTGCGAGC"	1.02689256247823	10.2535953291687	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAGTTTGTCTGCGAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2033.87591778609	42.0051249056955	0.0206527470719152	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2023.79519854886	2023.79519854886
"healthy-1"	"2019-08-01-count-2:CATGGATAGACCACGA"	14.1272665458614	1.71558675849763	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATAGACCACGA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1461.26038570164	30.7014866318476	0.0210102777932394	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1446.67347664548	1446.67347664548
"healthy-1"	"2019-08-01-count-4:TACACCCGTTAGGCCC"	2.75813426551167	-9.89579012310179	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCGTTAGGCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.19455080167	39.1101909478388	0.0188920364671493	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2066.38556134203	2066.38556134203
"healthy-1"	"2019-08-01-count-2:TGTCCCATCTTCCAGC"	2.10858764228169	-10.6257391205994	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCCATCTTCCAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.8106439402	39.6226845979686	0.0174410154753247	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2270.90304371473	2270.90304371473
"healthy-1"	"2019-08-01-count-4:CGGGCATAGATCCCGC"	1.77432741698567	-4.93806412136229	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATAGATCCCGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2463.20069138467	40.1152846300407	0.0162858368667841	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2457.89714035842	2457.89714035842
"healthy-1"	"2019-08-01-count-1:GCTTTCGTCCCTATTA"	1.29893424090688	10.8472451933655	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCTTTCGTCCCTATTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.12040819962	35.3428926559841	0.0180309803969883	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1949.00662177329	1949.00662177329
"healthy-1"	"2019-08-01-count-2:AATCGTGCACCGTACG"	1.65309788760487	-4.74008371746215	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGCACCGTACG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2227.17269758506	36.3093906820585	0.0163029075928548	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2221.42744036728	2221.42744036728
"healthy-1"	"2019-08-01-count-3:TGCTCGTAGTCCCAAT"	2.88186039504353	-10.362108253595	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTAGTCCCAAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.32665267442	41.7105181381502	0.0182674336540046	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2279.8633826137	2279.8633826137
"healthy-1"	"2019-08-01-count-2:GACTATGTCCCGAGGT"	1.89758112010304	-10.0207538834778	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTATGTCCCGAGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.57618070901	42.5326913796826	0.0180715167532286	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.30089899386	2349.30089899386
"healthy-1"	"2019-08-01-count-1:GCTACAAAGATCGACG"	1.22699954089467	11.3017139204773	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCTACAAAGATCGACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2029.77555652132	39.8398501849304	0.0196277120674411	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2018.99955353791	2018.99955353791
"healthy-1"	"2019-08-01-count-3:AGCCACGCAGGTGTGA"	1.89936198767964	-5.09462501918944	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGCAGGTGTGA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2446.19586252717	38.9271933195101	0.0159133591532177	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2444.66272849944	2444.66272849944
"healthy-1"	"2019-08-01-count-1:GGATGTTAGCACTCTA"	0.548055340617341	9.05755422199098	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGATGTTAGCACTCTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.21664310654	33.1518384893128	0.0168607251929951	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1962.03114026939	1962.03114026939
"healthy-1"	"2019-08-01-count-2:AATGACCCATCCGAAT"	1.77415659007375	-4.82401516353758	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGACCCATCCGAAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2635.68047254152	40.1623791413979	0.0152379545092089	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2631.47458765279	2631.47458765279
"healthy-1"	"2019-08-01-count-3:GACTGATCACCATTCC"	1.18484415587727	9.34882352435914	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATCACCATTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1561.50824856716	30.0191388552329	0.0192244510285351	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1554.147062422	1554.147062422
"healthy-1"	"2019-08-01-count-2:AGAAGCGAGGGATCTG"	-4.60633454743083	-5.37961389934691	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGCGAGGGATCTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2498.39351625376	42.0455233545222	0.0168290235629365	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2495.38539397207	2495.38539397207
"healthy-1"	"2019-08-01-count-2:AGAAGCGCAGATCACT"	1.48492481288258	10.4026679762634	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGCGCAGATCACT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1695.5482188574	33.869979487024	0.0199758279418608	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1695.34059804666	1695.34059804666
"healthy-1"	"2019-08-01-count-2:TGTGATGAGATTCGCT"	-4.00339160385783	-4.97947313701781	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGAGATTCGCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2768.83400288003	41.5011432378211	0.0149886714749434	3089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2764.83446982159	2764.83446982159
"healthy-1"	"2019-08-01-count-2:AACTTCTCACGTCATA"	2.37481250342671	-10.5348968735901	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTCACGTCATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.90302837295	35.4206463132238	0.0151118224109345	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2339.62421709052	2339.62421709052
"healthy-1"	"2019-08-01-count-3:TACTGCCTCCCTTCCC"	-0.899450461298782	12.1463832625183	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTGCCTCCCTTCCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2076.91199392049	44.7624079599636	0.0215523855083853	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2068.89764604847	2068.89764604847
"healthy-1"	"2019-08-01-count-3:TACTGCCAGTACTGTC"	2.02450015124623	-10.4005394211975	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTGCCAGTACTGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.5750605239	41.8299898280286	0.0181429746288648	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2304.47322154406	2304.47322154406
"healthy-1"	"2019-08-01-count-3:TACTGCCTCGGTGAAG"	2.25648679313008	-10.5604372254578	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTGCCTCGGTGAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.47811249082	36.6720584819202	0.0146836355836352	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2496.52081833093	2496.52081833093
"healthy-1"	"2019-08-01-count-4:AGATGAAAGTCGAGGT"	2.82618369635884	-10.4539280167786	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGAAAGTCGAGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.60878717022	42.130413609771	0.017689896777644	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.65259757499	2377.65259757499
"healthy-1"	"2019-08-01-count-2:CTCCGATAGAGGTATT"	2.3350039916927	-10.4988126984802	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATAGAGGTATT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.4641054929	42.5660000974711	0.0174847515728119	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2430.26625122761	2430.26625122761
"healthy-1"	"2019-08-01-count-4:GACACGCGTGAACTAA"	1.68532743033711	-4.74623396312865	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCGTGAACTAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2415.74452485983	40.643062774714	0.0168242388035929	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2409.47075936539	2409.47075936539
"healthy-1"	"2019-08-01-count-2:GCGGATCGTATGGTTC"	3.69627751883809	-10.7474384537903	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCGTATGGTTC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.88048041811	42.0958142559485	0.0187519178072715	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2239.30738834869	2239.30738834869
"healthy-1"	"2019-08-01-count-4:CAGATCATCTGGAAGG"	-5.1120003265446	3.39615104282228	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATCATCTGGAAGG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2562.48876780991	41.5089434579418	0.0161986830847335	3303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2557.47129226997	2557.47129226997
"healthy-1"	"2019-08-01-count-2:TGTGCGGAGACTGGGT"	1.09805168685262	11.0060214766297	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGAGACTGGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1731.23288072239	37.7566467924005	0.0218091091111011	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1725.68783992106	1725.68783992106
"healthy-1"	"2019-08-01-count-2:TGTGATGTCCTTCTGG"	1.09986545619313	10.3428735502991	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGTCCTTCTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.34537295022	41.0941573484764	0.0215452103909809	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1903.48899443012	1903.48899443012
"healthy-1"	"2019-08-01-count-2:TCAGGGCGTCACCGAC"	1.34595467624013	-8.93249704754027	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCGTCACCGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2551.48921076016	41.2394321861094	0.0161628871531943	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2550.80885174227	2550.80885174227
"healthy-1"	"2019-08-01-count-2:AGACACTGTCACGTGC"	0.775297542184037	11.4479884871277	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTGTCACGTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.99887738201	36.8278269476211	0.0210926979534154	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1739.01574276056	1739.01574276056
"healthy-1"	"2019-08-01-count-3:CCTCTCCGTTCTCTCG"	1.46235634860341	10.1209144362244	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCGTTCTCTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.08067109482	38.1226059714262	0.0199690911697114	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1902.37877298374	1902.37877298374
"healthy-1"	"2019-08-01-count-4:TTCGATTGTATCCCTC"	2.06204022940938	-10.5752659074036	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTGTATCCCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.6331829246	42.7591328285824	0.0170924870682255	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2496.42534759308	2496.42534759308
"healthy-1"	"2019-08-01-count-4:GACCAATCACTCTAGA"	-5.53248534622844	-5.42270519649657	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATCACTCTAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2592.82179676508	45.7703195843383	0.0176527054969391	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2589.9490476261	2589.9490476261
"healthy-1"	"2019-08-01-count-3:AGCGCTGCATGGGATG"	1.16313721713368	-8.60233690654906	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGCATGGGATG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2676.35814723684	42.885966033291	0.0160240011515529	2516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2672.39258217988	2672.39258217988
"healthy-1"	"2019-08-01-count-3:AGACACTCAACACGTT"	1.5049658018047	9.50822351062623	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTCAACACGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.59992052846	29.8501167897639	0.0152249913290408	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1952.04082550562	1952.04082550562
"healthy-1"	"2019-08-01-count-4:CAGCAATGTACAGTTC"	8.02646936950032	8.00539634311525	"2019-08-01-count-4"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAATGTACAGTTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.11183483371	44.640951352311	0.0238452375128948	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1869.95891560872	1869.95891560872
"healthy-1"	"2019-08-01-count-4:ACAAAGATCGATGCTA"	1.98639418658559	-4.43639852916869	"2019-08-01-count-4"	"Control1"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGATCGATGCTA"	"cDC1"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2753.83863465792	41.3336267839278	0.0150094585295344	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2746.21491077037	2746.21491077037
"healthy-1"	"2019-08-01-count-4:TACGGGCCAGCCGGTT"	1.42864896830861	9.84526631915895	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCCAGCCGGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.26145832175	39.2025811626029	0.022372563738376	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1751.06661951201	1751.06661951201
"healthy-1"	"2019-08-01-count-3:ACAGCCGAGGTTCTAC"	-4.91792092743571	3.66644499385682	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGCCGAGGTTCTAC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2445.72878470668	43.5798755975325	0.0178187687326741	2833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2439.99653787317	2439.99653787317
"healthy-1"	"2019-08-01-count-2:ATTCGTTAGAGCATCG"	1.72089066085164	-9.96394827282103	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCGTTAGAGCATCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1993.41637071614	39.6989281365514	0.0199150206247626	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1991.89168708485	1991.89168708485
"healthy-1"	"2019-08-01-count-3:GAGATGGAGCTAGATA"	1.80625404891316	-10.2732706299988	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGATGGAGCTAGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.33006902341	40.4256953536853	0.0175053778132205	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2305.04274325155	2305.04274325155
"healthy-1"	"2019-08-01-count-4:ATTCCTACAGAACATA"	2.24936928328816	-10.3989897004333	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCTACAGAACATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.2980350947	45.652554872424	0.0191712898594016	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2376.16891778363	2376.16891778363
"healthy-1"	"2019-08-01-count-3:CAGTGCGGTCTCACAA"	2.53402127799336	-10.409354232904	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGGTCTCACAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.7787286636	47.8067239108717	0.0223419007164023	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2136.4767805692	2136.4767805692
"healthy-1"	"2019-08-01-count-4:CAGCAGCCACAATTCG"	1.93950297412221	-10.3601083985535	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCCACAATTCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.17970977991	46.3608391025596	0.0194370423798538	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2379.19643397844	2379.19643397844
"healthy-1"	"2019-08-01-count-3:ACAGGGATCAACTTTC"	1.67596830901448	-4.7360730401245	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGGGATCAACTTTC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2555.8590124961	39.3712660698589	0.0154043184218554	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2551.56064041666	2551.56064041666
"healthy-1"	"2019-08-01-count-4:ACAAGCTCACTATGTG"	0.811997492879075	8.90212533557741	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTCACTATGTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.18786563025	37.7172272676685	0.0201892047162742	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1864.37982645025	1864.37982645025
"healthy-1"	"2019-08-01-count-2:TGTTACTTCGTGGGTC"	1.87974991378133	-10.2539806596008	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTACTTCGTGGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.9664617277	38.5832559805423	0.0163560002257446	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.44625604678	2355.44625604678
"healthy-1"	"2019-08-01-count-3:CCTTCAGAGTCTTCCC"	1.89007618007008	-10.4645185700622	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTCAGAGTCTTCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.05484740626	38.2471906947295	0.0144763045825022	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2637.94864373763	2637.94864373763
"healthy-1"	"2019-08-01-count-4:GACCTTCCAGTCCCGA"	1.44135393676106	11.0882711180481	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCCAGTCCCGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1927.69225416993	36.8705452478895	0.0191267797897368	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1926.6874363038	1926.6874363038
"healthy-1"	"2019-08-01-count-3:AGCTTCCCAAGGTACG"	2.31933869895284	-10.6452207795349	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCCAAGGTACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.72629704021	41.802663456951	0.0186309103352287	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2238.91868864583	2238.91868864583
"healthy-1"	"2019-08-01-count-2:GAGACCCCAGTTCTAG"	2.4666391807491	-10.1438875428406	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACCCCAGTTCTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.8989574552	43.6063167057687	0.0180273411468352	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2413.098284044	2413.098284044
"healthy-1"	"2019-08-01-count-2:CTCAACCTCACTGCTC"	7.88891281661336	8.04572484577028	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAACCTCACTGCTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1848.59397759524	39.8113568679877	0.0215360199970881	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1846.94302096019	1846.94302096019
"healthy-1"	"2019-08-01-count-2:GTAGGTTAGTTAACGA"	2.0893038707668	-10.4463463059631	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGTTAGTTAACGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.91470263099	40.8316766918063	0.0160570374812653	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2541.42168668832	2541.42168668832
"healthy-1"	"2019-08-01-count-4:GTCATGATCGGCTGAC"	2.19828929480855	-10.6886749497619	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATGATCGGCTGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.51984828609	38.82158483842	0.0158616016395557	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2442.91297089918	2442.91297089918
"healthy-1"	"2019-08-01-count-2:TTTATGCCAATGGCAG"	1.07575192031209	9.34350392902223	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCCAATGGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1782.56788004113	39.3998911110165	0.0221028840203872	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1777.2998754904	1777.2998754904
"healthy-1"	"2019-08-01-count-2:AGTACTGGTGGACTGA"	1.93642761287038	-10.2149381867615	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACTGGTGGACTGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2528.65289002884	37.4586848482943	0.0148136919052844	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2527.9610132906	2527.9610132906
"healthy-1"	"2019-08-01-count-2:CATCCCACAAAGGCTG"	-7.61896501007732	0.78381279790727	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCACAAAGGCTG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2611.20389505847	45.2031132238371	0.0173112154548257	3622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2606.24977145885	2606.24977145885
"healthy-1"	"2019-08-01-count-3:CATACAGAGCGTTAGG"	14.0640131431514	1.71622047508088	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGAGCGTTAGG"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1281.17998653282	45.361345517115	0.0354059117328811	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1264.10597544458	1264.10597544458
"healthy-1"	"2019-08-01-count-2:CAGCAATAGATCGCCC"	1.28765465792958	10.0587405928406	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATAGATCGCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1890.96944785809	35.8892008501312	0.018979260024948	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1887.9040493909	1887.9040493909
"healthy-1"	"2019-08-01-count-4:ACGGGTCCATGGAGAC"	1.77592708644215	-9.29392721569213	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCCATGGAGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.23380292089	46.366284116645	0.020902343141463	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2215.94037514411	2215.94037514411
"healthy-1"	"2019-08-01-count-3:TAGGAGGAGCAAGCCA"	2.22634567794148	-10.6014394990173	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGAGCAAGCCA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.58179331713	42.0069573824195	0.0176234595767575	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2379.02369146511	2379.02369146511
"healthy-1"	"2019-08-01-count-2:TTTCACATCGCGTGAC"	-0.338600586087066	12.6361293562683	"2019-08-01-count-2"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACATCGCGTGAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1874.55796525529	39.4581041003656	0.0210492845949375	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1871.14785012283	1871.14785012283
"healthy-1"	"2019-08-01-count-2:GAGATGGAGATGCTTC"	0.843432565301102	-7.87235166942748	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGAGATGCTTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2252.18449057961	35.2053111195391	0.0156316284331036	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2249.91833724634	2249.91833724634
"healthy-1"	"2019-08-01-count-4:TTCTGTATCAAGGCTT"	0.462551732628983	11.8830699690613	"2019-08-01-count-4"	"Control1"	"MAIT"	"MAIT"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTGTATCAAGGCTT"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1773.4270268302	39.5851506413064	0.0223212740318164	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1762.36736442091	1762.36736442091
"healthy-1"	"2019-08-01-count-2:GCTGCAGGTTGTGTAC"	-8.93841681900676	1.45319352233735	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	1	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGCAGGTTGTGTAC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2269.51196114822	44.863412935347	0.0197678680277363	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2266.85703247687	2266.85703247687
"healthy-1"	"2019-08-01-count-4:TGCTTCGGTATGACAA"	1.5857490497524	-8.88510134136351	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGGTATGACAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.34609442983	44.956970932254	0.0191522549823119	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2343.17741928763	2343.17741928763
"healthy-1"	"2019-08-01-count-3:GGAGAACGTATAGCTC"	2.58772553977315	-10.8101635209289	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACGTATAGCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.7914352114	37.5829149461191	0.0154041507006367	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.62704917715	2432.62704917715
"healthy-1"	"2019-08-01-count-2:ACACGCGAGGCAGGGA"	1.22560777243916	-8.85021498119506	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACGCGAGGCAGGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2487.10772231485	49.2331378487032	0.0197953379369028	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2483.66535338437	2483.66535338437
"healthy-1"	"2019-08-01-count-4:ATGCCTCTCCGCAGTG"	1.47847070273702	10.3211517103943	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCCTCTCCGCAGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1816.39739754178	34.5606450794978	0.0190270285160452	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1809.4097822212	1809.4097822212
"healthy-1"	"2019-08-01-count-2:CACATGAGTATGGTTC"	2.68501867827718	-9.49594976818236	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGAGTATGGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.24513666601	43.4134093367429	0.0174474004578634	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2480.98541244219	2480.98541244219
"healthy-1"	"2019-08-01-count-2:ATCCATTTCTATTCGT"	8.54034962233846	7.22741506183473	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTTCTATTCGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.15330716252	41.9113079600532	0.0210170942271679	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1992.62165829622	1992.62165829622
"healthy-1"	"2019-08-01-count-3:GAGTCATTCGGCTTCT"	1.63756050643269	-9.66116907512816	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATTCGGCTTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.03194568152	42.6547915194843	0.018050873834963	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.15908602802	2359.15908602802
"healthy-1"	"2019-08-01-count-3:GTCTTTATCTGCGGAC"	1.07342376288716	10.0790672072205	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTTTATCTGCGGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.97866373521	27.7750550265609	0.0155953889802974	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1776.42316427833	1776.42316427833
"healthy-1"	"2019-08-01-count-1:TCCACGTCAGCGATTT"	0.546533634036225	9.27304551685182	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCACGTCAGCGATTT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.79625709537	35.1326733806604	0.0170563827658387	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2051.08783975788	2051.08783975788
"healthy-1"	"2019-08-01-count-3:CATACTTCATGGGATG"	2.17052616652791	-10.4146518937317	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACTTCATGGGATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.65028602435	43.3031548496663	0.0186518853034578	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2316.3227381836	2316.3227381836
"healthy-1"	"2019-08-01-count-2:CGCGTGAAGCACCCAC"	2.1956316429073	-10.2715740433899	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGAAGCACCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.98716806807	42.5727730675502	0.019229006238866	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2212.95849929696	2212.95849929696
"healthy-1"	"2019-08-01-count-2:CTGCAGGAGGCTAACG"	7.8746448951656	7.98184011066285	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGAGGCTAACG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.99219366412	43.8514700438946	0.0237807243406812	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1838.06539247606	1838.06539247606
"healthy-1"	"2019-08-01-count-3:CCGTAGGTCATCTGTT"	1.05353750762288	10.6396922835144	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTAGGTCATCTGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2211.15816221942	33.8662146698807	0.0153160525775722	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2208.82021461891	2208.82021461891
"healthy-1"	"2019-08-01-count-4:GACTGATGTCCTGGGT"	1.50060381469075	-7.61191322719725	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTGATGTCCTGGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.94407455128	43.6698232588369	0.0209052141657826	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2087.44698696506	2087.44698696506
"healthy-1"	"2019-08-01-count-4:GACTGATGTCTCAAGT"	1.49424411830251	-9.29391004955443	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTGATGTCTCAAGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2419.2859270801	42.8337268012146	0.0177051113809073	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2416.51737083203	2416.51737083203
"healthy-1"	"2019-08-01-count-2:AAGTACCTCGCATAGT"	0.77323736724202	8.95348832691041	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCTCGCATAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1703.21210800488	36.207190350096	0.0212581804579282	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1698.50104283877	1698.50104283877
"healthy-1"	"2019-08-01-count-3:CGTCCATCAAGCGAGT"	3.47879161414449	-10.7644644013611	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCCATCAAGCGAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.67534215091	39.5563929897041	0.0184182367853086	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2141.88090998954	2141.88090998954
"healthy-1"	"2019-08-01-count-2:TTTGATCCACCAGCCA"	0.839160581200761	9.57833192432252	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCCACCAGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.6789261689	38.7492837097499	0.0205819925910583	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1870.60299037715	1870.60299037715
"healthy-1"	"2019-08-01-count-3:ACCATTTCAAATCAAG"	-3.51417432251628	2.89138839328615	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTCAAATCAAG"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3144.69879233577	44.6389621859814	0.0141949881797185	5356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3139.246805584	3139.246805584
"healthy-1"	"2019-08-01-count-4:AGCTTCCTCACTCCGT"	2.77864398536031	-10.5936136475769	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCTCACTCCGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.69451413717	40.6887989686783	0.0155200381849483	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2614.68731868646	2614.68731868646
"healthy-1"	"2019-08-01-count-4:ACAGGGATCGTGTGAT"	1.61422361907307	-4.89519359981688	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGATCGTGTGAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2228.42134335885	37.5485168547222	0.0168498282277831	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2221.20958562737	2221.20958562737
"healthy-1"	"2019-08-01-count-4:TGGAGGATCCATACTT"	3.59974135932271	-10.8473491898743	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGGATCCATACTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2177.57426607046	42.8737959854461	0.0196887870386226	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2169.87093679183	2169.87093679183
"healthy-1"	"2019-08-01-count-3:CGAGTGCTCGTCGATA"	11.1224781471187	3.84138653362123	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTGCTCGTCGATA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1793.53489892024	40.8853538016765	0.0227959622231442	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1791.74183217422	1791.74183217422
"healthy-1"	"2019-08-01-count-2:GGAAGTGGTACGTGAG"	-4.66703782501872	-5.30803205883177	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAAGTGGTACGTGAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2369.03625055938	51.6113404811984	0.0217857960041818	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2366.0898439179	2366.0898439179
"healthy-1"	"2019-08-01-count-2:TTTGATCTCACGAACT"	1.70834483680074	-9.72242071544798	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCACGAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.35282256192	45.1133289117639	0.0204655663331302	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2200.78668830987	2200.78668830987
"healthy-1"	"2019-08-01-count-2:GTCACTCAGTTAGTGA"	1.52015854892079	9.74120805347291	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCAGTTAGTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.42045190779	38.5089802062793	0.0214484468890617	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1794.04161134929	1794.04161134929
"healthy-1"	"2019-08-01-count-3:GGATCTACAACCCTCT"	-5.06130872193034	-5.15450289165648	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATCTACAACCCTCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2583.7565411265	39.0166069989472	0.015100728872054	2622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2582.00459186693	2582.00459186693
"healthy-1"	"2019-08-01-count-4:TTGATGGCAGAGATGC"	1.73732425746266	-4.81243231212767	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGCAGAGATGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2292.98009060116	40.709353081674	0.0177539060406761	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2290.65032812512	2290.65032812512
"healthy-1"	"2019-08-01-count-4:TGGATGTAGGTCACCC"	2.35198082503621	-10.6503753892151	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATGTAGGTCACCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.03147968358	41.931424573615	0.0181597457386597	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2308.12942944105	2308.12942944105
"healthy-1"	"2019-08-01-count-3:TCGCAGGGTATCCCTC"	1.9398111301357	-9.84634878551634	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCAGGGTATCCCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.38515499283	41.4731221821793	0.0172848957141703	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2395.61331938211	2395.61331938211
"healthy-1"	"2019-08-01-count-3:AGGGCCTAGGATATGT"	8.21933712539021	7.84273383701173	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCCTAGGATATGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.86838179754	37.4151507586359	0.0180325417683707	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2071.63145130722	2071.63145130722
"healthy-1"	"2019-08-01-count-3:CATCCGTTCTGCTAGA"	10.4297005134517	-0.1960522166458	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-3"	58	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCGTTCTGCTAGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1228.21814424114	46.1922395052717	0.0376091492556574	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	1222.07632345253	1222.07632345253
"healthy-1"	"2019-08-01-count-3:ATGTCCCTCTTAGCTT"	1.46354856070821	10.5499772795471	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCTCTTAGCTT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.02346925945	39.6278516149993	0.021202436602201	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1866.85691371506	1866.85691371506
"healthy-1"	"2019-08-01-count-4:GAGACCCCAATCGTCA"	1.43512548980061	9.29437730396119	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCCAATCGTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.5674584698	45.477234620683	0.0251593567961119	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1800.49508512555	1800.49508512555
"healthy-1"	"2019-08-01-count-2:TCTAACTTCGCTTGCT"	1.36110570010487	10.1798171767029	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTAACTTCGCTTGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1911.79028258851	34.7872707552239	0.0181961751098153	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1902.29586671324	1902.29586671324
"healthy-1"	"2019-08-01-count-2:GTTGCGGGTTTCGATG"	0.96825941380803	9.9390773543152	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCGGGTTTCGATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1797.26544436134	37.4157048859462	0.0208181295664102	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1794.86461118853	1794.86461118853
"healthy-1"	"2019-08-01-count-3:AGGGTCCTCGCTATTT"	2.25871171531026	-10.5416336289612	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTCCTCGCTATTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.15248564773	41.0453412452948	0.017630005550893	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2325.22793015881	2325.22793015881
"healthy-1"	"2019-08-01-count-3:GGCACGTTCCCTCATG"	-3.1434362930363	-4.87504770671996	"2019-08-01-count-3"	"Control1"	"DC precursor"	"DC precursor"	62	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTTCCCTCATG"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2525.40487205842	43.6673822269943	0.0172912401928652	2759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2523.23684282958	2523.23684282958
"healthy-1"	"2019-08-01-count-4:TCGACGGGTGTTGACT"	-3.43143711510356	-5.73210813915404	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACGGGTGTTGACT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2265.36782603775	43.8966616925961	0.0193772778036553	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2263.09943347921	2263.09943347921
"healthy-1"	"2019-08-01-count-4:AGGACTTGTAGTGATA"	-5.27451167526897	-5.36567594921263	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACTTGTAGTGATA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2419.73531183752	48.12045822435	0.019886661978664	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2413.97558534375	2413.97558534375
"healthy-1"	"2019-08-01-count-3:CATGAGTTCCGTGGCA"	1.22200085696523	11.4867019423279	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGAGTTCCGTGGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2046.5859857252	37.1652485430593	0.01815963209085	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2033.36398433607	2033.36398433607
"healthy-1"	"2019-08-01-count-1:TTAGGCACAACCGTGC"	0.871047695248765	9.22913453662721	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTAGGCACAACCGTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.57913619571	34.7926890956153	0.0184715833951562	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1876.5852747323	1876.5852747323
"healthy-1"	"2019-08-01-count-3:AGGGTGAGTTGCTCAA"	1.90593649920766	-10.3215351334778	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTGAGTTGCTCAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2084.13533106621	46.261531140144	0.0221969900181469	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2081.81338454684	2081.81338454684
"healthy-1"	"2019-08-01-count-3:TTTCGATAGCAAGGAA"	1.86192264136617	-5.19498827373656	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCGATAGCAAGGAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2566.24977744985	43.2998738213243	0.0168728212669745	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2560.51782740965	2560.51782740965
"healthy-1"	"2019-08-01-count-4:CATCCACAGTTGGCTT"	8.3260256248409	7.1458472975525	"2019-08-01-count-4"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACAGTTGGCTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2211.54256611299	40.9744955330436	0.0185275635933431	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2205.72958460069	2205.72958460069
"healthy-1"	"2019-08-01-count-2:CCCAACTGTCTGATCA"	1.2476701932842	9.58217904651491	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCAACTGTCTGATCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1928.04683261483	40.7708901999028	0.0211462136241831	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1924.18490102562	1924.18490102562
"healthy-1"	"2019-08-01-count-4:ATTACTCCATAAGCAA"	0.994021375744981	9.66636178577272	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACTCCATAAGCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.90015820694	34.8877862229486	0.0187578812061518	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1857.19880024771	1857.19880024771
"healthy-1"	"2019-08-01-count-2:CCCATTGTCGGCTTCT"	0.770553429692429	12.7618131407532	"2019-08-01-count-2"	"Control1"	"MAIT"	"MAIT"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCATTGTCGGCTTCT"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2052.32003884764	42.3703122640339	0.0206450804270392	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2045.48262093282	2045.48262093282
"healthy-1"	"2019-08-01-count-3:GATAGCTTCGCAAGAG"	14.3146759468013	1.91220030868379	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTTCGCAAGAG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1759.4763393974	41.6328843204106	0.0236620881953261	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1746.7147272124	1746.7147272124
"healthy-1"	"2019-08-01-count-3:ACCTACCTCACTGTTT"	3.48137964782063	-11.020236038324	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTACCTCACTGTTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.14469759621	40.4853615651814	0.0174720903736312	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2308.77994698081	2308.77994698081
"healthy-1"	"2019-08-01-count-4:CATCCCACACTTGACA"	-5.78320060196574	-4.91713669216307	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCACACTTGACA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3267.73930763368	41.4386816562333	0.0126811467363475	4542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3259.2128177642	3259.2128177642
"healthy-1"	"2019-08-01-count-4:CTCCGATGTCACAATC"	1.25566210326497	10.4065599211487	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATGTCACAATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1969.58076723641	37.4620120653445	0.0190202974605143	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1961.22023521348	1961.22023521348
"healthy-1"	"2019-08-01-count-4:CATCCCAGTTCCCAAA"	10.1359926658565	4.69362781131593	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCAGTTCCCAAA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1803.13473859042	52.871813446274	0.0293221645142314	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1791.45441195435	1791.45441195435
"healthy-1"	"2019-08-01-count-3:AGGTCATTCATTTCGT"	11.0685440498287	4.19621608341066	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCATTCATTTCGT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2015.13178028805	36.497283670348	0.0181116113731931	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2005.43561712849	2005.43561712849
"healthy-1"	"2019-08-01-count-2:CCCGAAGCACTACGGC"	2.03419210490529	-10.5035553208557	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGCACTACGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.8634425277	38.4590994092232	0.0161602126920253	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.04054009197	2377.04054009197
"healthy-1"	"2019-08-01-count-1:TTTGGAGCAATCACGT"	-0.0309413624113381	11.7227153548035	"2019-08-01-count-1"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTTGGAGCAATCACGT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1355.24290446101	48.6939852109322	0.0359300794349468	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1343.92868951209	1343.92868951209
"healthy-1"	"2019-08-01-count-3:AGGTCATTCTGTTGGA"	2.31732811507527	-10.8484077683655	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCATTCTGTTGGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.31472879212	41.9549326997773	0.0179270472401082	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2333.02365982231	2333.02365982231
"healthy-1"	"2019-08-01-count-4:GAGGCAACAGGTGACA"	2.13309373435323	-10.4921350709167	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCAACAGGTGACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.50991252577	39.9195223028671	0.0188343173423973	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2117.28959191565	2117.28959191565
"healthy-1"	"2019-08-01-count-3:GGGAAGTGTTAATCGC"	1.89054288443868	-9.4771766892639	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTGTTAATCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.77925436602	44.2219808328074	0.018621512189609	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2370.97127977662	2370.97127977662
"healthy-1"	"2019-08-01-count-4:ACCCAAATCACGATAC"	8.40872921523396	7.70255515659181	"2019-08-01-count-4"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCAAATCACGATAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.88698263204	48.4327988294916	0.0250313321988492	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1932.63554689577	1932.63554689577
"healthy-1"	"2019-08-01-count-2:CATTCCGTCACGTAGT"	7.05866255339925	-1.09882225906523	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCCGTCACGTAGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2289.01917529602	39.6947787247157	0.0173413919608525	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2282.23193651981	2282.23193651981
"healthy-1"	"2019-08-01-count-3:CGGACACAGAGTACCG"	1.84329094466512	-9.85540296947631	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGACACAGAGTACCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.88816432025	36.8602789612536	0.0147921080444268	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2485.41595894844	2485.41595894844
"healthy-1"	"2019-08-01-count-2:GTCCTCACACGCACCA"	1.56636883792226	-4.73809292232665	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCACACGCACCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2175.4291593373	46.958457978188	0.0215858364206596	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2171.3556410099	2171.3556410099
"healthy-1"	"2019-08-01-count-3:TCGGGTGTCTTTCCGG"	2.33463182029073	-10.5065956345764	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGTCTTTCCGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.70697161158	37.3632881411592	0.0153967036721975	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2421.42205282036	2421.42205282036
"healthy-1"	"2019-08-01-count-2:TTAGGGTAGGTTCCGC"	1.43320431289021	10.1604184874329	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTAGGTTCCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.60394065814	38.5506158180674	0.0215655240745745	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1783.11132756804	1783.11132756804
"healthy-1"	"2019-08-01-count-3:GGGACAACATGGCCCA"	-7.09443221512492	-0.214698427077852	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAACATGGCCCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2588.18202813456	45.9996617103277	0.017772962338156	2857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2584.46382224041	2584.46382224041
"healthy-1"	"2019-08-01-count-2:CACTGGGTCATTTACC"	1.21118487891499	11.5335941084656	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGGGTCATTTACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.3024690207	39.9628126656308	0.0204172902748268	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1950.16509723866	1950.16509723866
"healthy-1"	"2019-08-01-count-4:ACCGTTCGTGAACCGA"	-3.34898291054423	3.53037235820619	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCGTTCGTGAACCGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3087.4490843788	45.4969120542032	0.0147360849720238	4776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3080.49409424973	3080.49409424973
"healthy-1"	"2019-08-01-count-4:AGGCCACCACTCCGAG"	1.15827943858449	9.75583646381227	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACCACTCCGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.29048873772	28.9057615730418	0.0161008827008077	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1793.08589816793	1793.08589816793
"healthy-1"	"2019-08-01-count-2:TCCATGCAGTGTTCAC"	1.84562267836873	-4.96486904537352	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCAGTGTTCAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2661.96428871227	41.1762675278662	0.0154683771313045	2857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2654.72863892012	2654.72863892012
"healthy-1"	"2019-08-01-count-2:GAGTTTGAGCCTTTCC"	2.83429970321004	-10.7883901826111	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTTGAGCCTTTCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.14321787461	39.325506601457	0.0168263144084167	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2332.71124563688	2332.71124563688
"healthy-1"	"2019-08-01-count-4:GAGTCATAGGTGCAGT"	-7.41493258896525	4.04676268184511	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCATAGGTGCAGT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2267.14056304036	41.2135293691979	0.0181786387844997	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2259.09328734767	2259.09328734767
"healthy-1"	"2019-08-01-count-3:GGGACCTCAACCAGAG"	3.6047338443691	-10.8946743241516	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTCAACCAGAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2197.67123943749	38.6622043273572	0.0175923512277719	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2191.84425900964	2191.84425900964
"healthy-1"	"2019-08-01-count-2:ATGAAAGCAGAACTTC"	1.72302748736684	-9.91847517406615	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGCAGAACTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.67795555088	50.2950263454005	0.021756934708241	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2306.86833645409	2306.86833645409
"healthy-1"	"2019-08-01-count-3:GGGACCTGTACGAGCA"	2.62401070174519	-10.5132484666077	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTGTACGAGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.88476929089	42.1633760549475	0.0177016859079627	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.56457601998	2377.56457601998
"healthy-1"	"2019-08-01-count-2:TACTTCAGTCCGGTCA"	-3.12563548508342	3.15018246257631	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCAGTCCGGTCA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3101.01570110355	47.940773917383	0.0154597004782409	4620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3096.82454138625	3096.82454138625
"healthy-1"	"2019-08-01-count-2:AAAGAACAGGACGCAT"	3.15569676932637	-10.622395538446	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACAGGACGCAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.55919723161	39.3534757033623	0.0154354037929747	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2544.73904002862	2544.73904002862
"healthy-1"	"2019-08-01-count-4:AAACGAAAGAATGTTG"	1.83832754668538	-9.58857252514037	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGAAAGAATGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.0132410336	45.2624700057058	0.0212798252180654	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2122.5200221123	2122.5200221123
"healthy-1"	"2019-08-01-count-3:TATTCCATCTTCTCAA"	-0.560088376433212	12.5283107527527	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCATCTTCTCAA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.93622157283	40.8778035983615	0.0212138850994226	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1913.42345759759	1913.42345759759
"healthy-1"	"2019-08-01-count-2:CCCTCAATCATGCCAA"	1.85396911677663	-5.02147200023802	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAATCATGCCAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2624.47469502064	39.0684285898097	0.0148861898588443	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2620.27809380885	2620.27809380885
"healthy-1"	"2019-08-01-count-3:GGGAGATCAGATTAAG"	10.9466835456783	4.18230197513429	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGATCAGATTAAG"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.33831112516	39.4188537733903	0.0213728975511778	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1837.10183213816	1837.10183213816
"healthy-1"	"2019-08-01-count-2:AGCTACATCGAACGGA"	2.72213878211324	-10.5407381287781	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTACATCGAACGGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.41693544065	38.9783511066966	0.0160509303562503	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2422.45301490668	2422.45301490668
"healthy-1"	"2019-08-01-count-4:TTGTTCACATAGTCAC"	0.13821736451928	12.7129478224548	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCACATAGTCAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1813.45795080396	41.5822894969691	0.0229298338450773	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1811.79761114792	1811.79761114792
"healthy-1"	"2019-08-01-count-3:TCTAACTCAAGCACAG"	-0.0973275852506936	11.9345845946106	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTAACTCAAGCACAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2057.91519239571	42.0718288976661	0.0204439080158053	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2053.35766177739	2053.35766177739
"healthy-1"	"2019-08-01-count-2:CAGAGCCGTCAAGCCC"	1.23680951175038	-9.01890947734984	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGAGCCGTCAAGCCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2388.65941657905	38.1949706210964	0.0159901283355824	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2387.75358324056	2387.75358324056
"healthy-1"	"2019-08-01-count-2:ACCCTCAGTACCACGC"	1.32385553893391	9.67402837360231	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTCAGTACCACGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.083552368	41.2268946104686	0.0234632522482539	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1750.9284084614	1750.9284084614
"healthy-1"	"2019-08-01-count-2:AAAGGATGTGTTTCTT"	1.86655201491658	-10.3120756379333	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATGTGTTTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.83233532773	43.7884539566881	0.0195411558760303	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2234.09582327127	2234.09582327127
"healthy-1"	"2019-08-01-count-3:AACAACCGTATGAGGC"	-2.60921917381938	3.69035861575929	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAACCGTATGAGGC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2996.10942475823	40.240926050343	0.0134310602002096	5102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	2992.45637610559	2992.45637610559
"healthy-1"	"2019-08-01-count-4:AACTTCTCACATGACT"	2.54270782050435	-10.6631088486877	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTCACATGACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.57974187625	37.4547909302029	0.0165248061818457	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2261.44731239803	2261.44731239803
"healthy-1"	"2019-08-01-count-3:TGTTCATTCGAGAGAC"	-2.79765186730083	-5.81000950252684	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCATTCGAGAGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2222.61926423996	46.2937948642396	0.0208284862860082	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2218.45201381823	2218.45201381823
"healthy-1"	"2019-08-01-count-4:ATTCCTAGTAACGATA"	1.25605465945546	-8.54930117046507	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCTAGTAACGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.21439877546	47.3592080726248	0.0199305281951959	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2374.14943448242	2374.14943448242
"healthy-1"	"2019-08-01-count-3:CTGTGGGCAGAGTGTG"	1.6214974122936	-9.89134600078734	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGCAGAGTGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2627.76165048391	42.3815827773572	0.016128396869462	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2624.93778901584	2624.93778901584
"healthy-1"	"2019-08-01-count-4:TTGTTTGCACTGCGAC"	-3.8242531818455	-5.5276761285034	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTTGCACTGCGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2698.92340356727	39.0394764510791	0.014464833051386	2620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2695.12619209618	2695.12619209618
"healthy-1"	"2019-08-01-count-4:TGTACAGAGACATAGT"	1.86737753924672	-10.3230896226135	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGAGACATAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.26128414535	40.0106001409692	0.0183597076826244	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2178.1854782499	2178.1854782499
"healthy-1"	"2019-08-01-count-2:ACCGTTCCAAACTCTG"	8.09817757186238	7.77706763828126	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCCAAACTCTG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2196.20152036875	45.3190334916046	0.0206351890167143	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2190.87257557348	2190.87257557348
"healthy-1"	"2019-08-01-count-2:TTCACCGGTGCTCTCT"	2.4357770877773	-10.4908657304016	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCACCGGTGCTCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.84701568186	36.8927649630257	0.0146875047455909	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2509.29625950698	2509.29625950698
"healthy-1"	"2019-08-01-count-3:AACAGGGCAAGTCATC"	4.08076157149617	-10.8618097535339	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGCAAGTCATC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.68957210066	45.0354284300563	0.0182278781351579	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2464.74237220317	2464.74237220317
"healthy-1"	"2019-08-01-count-4:GTGGCGTAGTTGAAGT"	2.97407712516133	-10.5373745194641	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGCGTAGTTGAAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.31278643503	41.804844945926	0.0178248484328911	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2338.26437391372	2338.26437391372
"healthy-1"	"2019-08-01-count-4:TATTGGGTCATGCCAA"	1.35948004302327	10.3297405012879	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGGGTCATGCCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1846.63194840263	38.4308133696588	0.0208113010299114	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1840.17306086324	1840.17306086324
"healthy-1"	"2019-08-01-count-2:ACCGTTCGTCTATGAC"	1.42322828349416	9.83238313281862	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCGTCTATGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1742.33492335665	34.6778030291579	0.0199030637360756	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1736.30963191214	1736.30963191214
"healthy-1"	"2019-08-01-count-2:CGTTAGAGTTACAGCT"	-2.32087741318401	13.4930724867615	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTAGAGTTACAGCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1769.25602581327	48.3289099428587	0.0273159504547361	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1763.25758005974	1763.25758005974
"healthy-1"	"2019-08-01-count-2:CCGAACGTCACCTTAT"	1.82165779647176	-10.1064987412659	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGAACGTCACCTTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.51508130324	40.6137926845311	0.0165062157078994	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.16985771693	2457.16985771693
"healthy-1"	"2019-08-01-count-3:CTTACCGTCCAGCTCT"	1.27214457568471	9.9256324538025	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGTCCAGCTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.92320585206	44.4335143570814	0.0243615050318546	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1816.5575429302	1816.5575429302
"healthy-1"	"2019-08-01-count-4:GGGATCCAGGGCGAAG"	1.57396032389943	-9.37595369732054	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATCCAGGGCGAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2072.14153613727	37.3326633528869	0.0180164639827063	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2070.94596989591	2070.94596989591
"healthy-1"	"2019-08-01-count-4:CATGCTCCACGAGAAC"	8.2529407936031	7.29529998386232	"2019-08-01-count-4"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCCACGAGAAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1947.32715536187	44.3332979756667	0.0227662300366927	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1946.21563828138	1946.21563828138
"healthy-1"	"2019-08-01-count-3:CGGGTGTTCGCCTATC"	1.68247177180592	-4.87891819393309	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTTCGCCTATC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2154.67878133369	36.5858456370443	0.0169797215037309	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2150.51908662328	2150.51908662328
"healthy-1"	"2019-08-01-count-4:TCTACATCAGATAAAC"	1.45068552073781	10.3514146574768	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATCAGATAAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.46641539074	34.8207986119419	0.0184386644783075	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.87238906802	1883.87238906802
"healthy-1"	"2019-08-01-count-2:AAGCCATAGGTTCAGG"	3.68332495269124	-10.892960571405	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATAGGTTCAGG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.12164060626	41.1114738993346	0.0174339920347642	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.99905077988	2350.99905077988
"healthy-1"	"2019-08-01-count-4:GTTTACTCATTGACAC"	1.96317436274831	-4.61936142360839	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTCATTGACAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2584.53946376181	42.4120548681018	0.0164099080175665	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2582.31982731026	2582.31982731026
"healthy-1"	"2019-08-01-count-2:CCGCAAGAGCGATGAC"	2.30389298972432	-10.5861282578674	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGCAAGAGCGATGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.98553280086	44.8079820087175	0.0209286710826575	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2139.02858373586	2139.02858373586
"healthy-1"	"2019-08-01-count-4:GATCATGCATTGACCA"	0.980282922356766	-8.3891172639099	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGCATTGACCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2600.9333019592	43.6255672758046	0.0167730434467285	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2598.58423847122	2598.58423847122
"healthy-1"	"2019-08-01-count-2:CTTCCGATCCAAATGC"	-4.47488246384318	3.68979022586671	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGATCCAAATGC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2815.61514205402	43.3715289902269	0.0154039266029046	3607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2807.23465932501	2807.23465932501
"healthy-1"	"2019-08-01-count-3:ACTATGGTCCGTGCGA"	2.03662612017934	-10.5217628709045	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATGGTCCGTGCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.58678401358	39.2022326450781	0.0162423132678446	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2408.31996567876	2408.31996567876
"healthy-1"	"2019-08-01-count-4:AAATGGAGTAGCGAGT"	2.04104187068288	-10.4559231034485	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAGTAGCGAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.44508950309	42.9784882302954	0.0170519438845497	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2517.0877080111	2517.0877080111
"healthy-1"	"2019-08-01-count-2:TCCGGGATCTTGGCTC"	4.37993111190144	-10.3669624558655	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGATCTTGGCTC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.20374148726	46.9822325170561	0.0195417017727427	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.82977299209	2396.82977299209
"healthy-1"	"2019-08-01-count-2:GTGAGCCCACAAGTTC"	1.35483922538106	10.4891242750916	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGCCCACAAGTTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.03481092909	32.7731545321989	0.0187700464658891	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1741.2729784791	1741.2729784791
"healthy-1"	"2019-08-01-count-2:AGGACTTCATCATTGG"	0.697717626660508	9.34620759570924	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTCATCATTGG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.80770604497	35.3626180559282	0.0192312757553037	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1835.33797102843	1835.33797102843
"healthy-1"	"2019-08-01-count-3:TCTCTGGCACCGTACG"	-3.2427421611851	3.68125197971193	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGCACCGTACG"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3134.55829850781	41.2241699538177	0.013151508451268	4819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3126.14254080112	3126.14254080112
"healthy-1"	"2019-08-01-count-3:GTTAGACGTAACGTTC"	2.08099093016927	-10.584252380487	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGACGTAACGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.46383428852	43.704712909225	0.0192323029523189	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2266.21466598452	2266.21466598452
"healthy-1"	"2019-08-01-count-3:AACCATGGTACACGTT"	-4.1391957801884	-5.49565365230712	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGGTACACGTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2674.02541617764	45.764654395251	0.0171145173558854	2857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2670.69613858901	2670.69613858901
"healthy-1"	"2019-08-01-count-2:AACAACCGTATCGTGT"	3.38523020324056	-10.8870344392029	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCGTATCGTGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.42616491178	40.5732746826021	0.0171164473642705	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2364.85137711093	2364.85137711093
"healthy-1"	"2019-08-01-count-2:CAGCCAGAGCTACTAC"	-0.860653261572677	12.1821441420349	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGAGCTACTAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2382.84946008082	47.1138079123054	0.0197720454865442	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2371.90996727639	2371.90996727639
"healthy-1"	"2019-08-01-count-4:GTGTCCTTCACACGAT"	2.13716830787007	-10.6209211579529	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTCCTTCACACGAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.86149645826	38.5536938012548	0.0163789134829151	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.42793441337	2349.42793441337
"healthy-1"	"2019-08-01-count-3:AGTCTCCGTAGACAGC"	1.66269590434377	-9.84754469310912	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCGTAGACAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.99499976697	40.4427891184635	0.0173723694090888	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2326.86146252753	2326.86146252753
"healthy-1"	"2019-08-01-count-4:TTTATGCCACCGTACG"	1.2832713323528	9.73491380298463	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCCACCGTACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1667.66716798801	34.6934603233271	0.0208035877837565	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1662.04698756388	1662.04698756388
"healthy-1"	"2019-08-01-count-4:CTGGACGCATGAGAAT"	-5.57873855057414	-4.96204330837401	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGACGCATGAGAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3082.99051408852	37.8175393028865	0.0122665117294619	3124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3073.77546568801	3073.77546568801
"healthy-1"	"2019-08-01-count-3:ACTCCCAGTTGGCCTG"	6.8556076484615	-1.10082855140837	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCAGTTGGCCTG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2428.48339700673	41.9493903095478	0.0172739045122784	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2427.54863305607	2427.54863305607
"healthy-1"	"2019-08-01-count-2:ACGCACGCAAACTGCT"	1.0330534177715	9.41971108997194	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGCAAACTGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.84324995118	34.8253030630008	0.0188260832716069	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1847.37965071873	1847.37965071873
"healthy-1"	"2019-08-01-count-4:CAACAACCAATTGCTG"	3.47164668616597	-10.943181060907	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACCAATTGCTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.12905803542	42.5029770103312	0.0182327858956685	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2324.21613348711	2324.21613348711
"healthy-1"	"2019-08-01-count-2:CAGCGTGAGCCTCCAG"	1.83902277526204	-8.95843794262084	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCGTGAGCCTCCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.10559245909	38.9922680578296	0.0184003421993623	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2117.76273547852	2117.76273547852
"healthy-1"	"2019-08-01-count-2:ATGGGAGAGAGGGTGG"	-5.03867278519328	-5.3512287369934	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGAGAGAGGGTGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2849.78881689329	40.5907566916985	0.0142434261974362	3029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2848.19081498707	2848.19081498707
"healthy-1"	"2019-08-01-count-2:TGCGACGGTATGGTTC"	-0.366461197764236	14.1032924422058	"2019-08-01-count-2"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGGTATGGTTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1828.43065216509	50.1925049501688	0.0274511395281711	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1828.43065216509	1828.43065216509
"healthy-1"	"2019-08-01-count-4:TCTCAGCGTGGCTTGC"	1.7667838531429	-9.18858816539916	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCAGCGTGGCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.92193689701	42.6910195188273	0.0185056194733013	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2304.91045337973	2304.91045337973
"healthy-1"	"2019-08-01-count-2:CTAACTTCAAGGGCAT"	1.1579176383907	11.2314052351746	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTCAAGGGCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1921.56199385913	40.0484461848288	0.0208416102695695	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1917.66055744869	1917.66055744869
"healthy-1"	"2019-08-01-count-3:TTACCATAGTAACGTA"	-7.14955029907878	0.768842376116194	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATAGTAACGTA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2665.05702814822	41.2288135538841	0.0154701430845296	3592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2659.438472723	2659.438472723
"healthy-1"	"2019-08-01-count-3:GTTCTATAGACACACG"	14.0572191673214	1.67545209014741	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATAGACACACG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1388.12698009041	28.9364723665533	0.0208456955174724	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1369.23468043079	1369.23468043079
"healthy-1"	"2019-08-01-count-3:CTTCTAACATTCGATG"	2.44113864478413	-10.4644479981628	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAACATTCGATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.51528511904	45.4587380171556	0.0188741745996056	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.57239217803	2403.57239217803
"healthy-1"	"2019-08-01-count-3:ACTGTGAAGCTTCATG"	-3.10369811478313	-5.87453129207762	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTGAAGCTTCATG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2790.00485345894	41.3289152353913	0.0148132054982461	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2786.0357351436	2786.0357351436
"healthy-1"	"2019-08-01-count-4:GATGCTAAGTTAACGA"	2.44208731231038	-10.8269987336365	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGCTAAGTTAACGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2195.68555710537	43.458772958156	0.0197928035813328	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2189.45876468129	2189.45876468129
"healthy-1"	"2019-08-01-count-2:ACGGAAGCATGATCTG"	1.26530696925465	9.15088365161744	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGAAGCATGATCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1760.48038615366	37.2787781873628	0.0211753442302248	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1756.78843563828	1756.78843563828
"healthy-1"	"2019-08-01-count-2:CTTTCAAAGAACCCGA"	11.1843401390011	3.74672052944032	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAAAGAACCCGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.85608944481	34.0490758011447	0.0187303472474236	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1807.83052660584	1807.83052660584
"healthy-1"	"2019-08-01-count-4:TTTCAGTTCCATGAGT"	10.3572575050289	4.50410411441652	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTTCCATGAGT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1745.75563764429	34.6209738574906	0.0198315119888187	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1743.81536739424	1743.81536739424
"healthy-1"	"2019-08-01-count-4:AGTAGTCAGTTCCGGC"	1.41661395606343	11.6046037443909	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCAGTTCCGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.2029504929	33.2768103832538	0.0170196195616751	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1955.2029504929	1955.2029504929
"healthy-1"	"2019-08-01-count-4:ACGTCCTAGTGCTACT"	7.96026196059529	8.05198857868043	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTCCTAGTGCTACT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.49778128064	41.6912097079177	0.0210296375116174	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1974.9432147763	1974.9432147763
"healthy-1"	"2019-08-01-count-4:ACGTTCCGTATTGAGA"	10.2009216743404	4.84400651538698	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTTCCGTATTGAGA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1731.79064148404	33.3428278125217	0.0192533826051565	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1727.99266280295	1727.99266280295
"healthy-1"	"2019-08-01-count-2:TAGTGCATCATTACCT"	1.75386311587636	-9.69840052044066	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCATCATTACCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.94349204924	39.1572676259061	0.0166772615092753	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2343.1946981152	2343.1946981152
"healthy-1"	"2019-08-01-count-2:TGCGGCACAATTCTCT"	2.76767887648885	-10.8604383698669	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGCACAATTCTCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.56912284209	40.1417782947299	0.017055703996599	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2347.11762511703	2347.11762511703
"healthy-1"	"2019-08-01-count-4:TGTGCGGCAATGTGGG"	-3.10359034958537	13.0452985533508	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGCAATGTGGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1840.60497076325	43.1463846564628	0.0234414148292619	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1836.69686197201	1836.69686197201
"healthy-1"	"2019-08-01-count-4:GATGGAGTCCGGTAGC"	1.01691313561742	9.81740472400514	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGTCCGGTAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1747.98878580564	34.1459915040785	0.0195344454045458	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1738.51340000865	1738.51340000865
"healthy-1"	"2019-08-01-count-3:TCTTGCGTCTACCCAC"	1.62636091288869	-4.71853639995726	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTGCGTCTACCCAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2523.27965314423	38.589497406702	0.0152933890457271	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2519.63377183084	2519.63377183084
"healthy-1"	"2019-08-01-count-4:GATGTTGCATGGGAAC"	3.2179659801418	-10.7201347581116	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGTTGCATGGGAAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.14996676412	41.4194361552238	0.0170439835901881	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2423.32490066985	2423.32490066985
"healthy-1"	"2019-08-01-count-3:CGTGCTTCAGTCTGGC"	-7.56370530548747	4.25648257816163	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTCAGTCTGGC"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1996.59875415268	37.5933328189939	0.0188286869060718	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1990.31215415562	1990.31215415562
"healthy-1"	"2019-08-01-count-3:CGCAGGTTCGAAGCAG"	1.65922119197194	-9.8754863969055	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCAGGTTCGAAGCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.5895009931	41.3061979094386	0.0178383076498332	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.00586715389	2313.00586715389
"healthy-1"	"2019-08-01-count-2:ACATCGAGTATGGAAT"	2.48103537139241	-10.5503416291443	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCGAGTATGGAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.88018107948	41.9360054163372	0.0183939514735732	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.34150567225	2275.34150567225
"healthy-1"	"2019-08-01-count-4:AGTCAACTCTACGCAA"	1.49077238616292	-9.22371580516966	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCAACTCTACGCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.61862702067	32.3400587456329	0.0129795380380115	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2488.81063502986	2488.81063502986
"healthy-1"	"2019-08-01-count-4:AACCAACGTCGCATCG"	6.86943115767781	-1.0928389064041	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCAACGTCGCATCG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2592.7225641733	38.924318636662	0.0150129131340642	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2585.48638672178	2585.48638672178
"healthy-1"	"2019-08-01-count-3:GGTAATCTCTCTCAAT"	1.58051755008046	-9.36474230205687	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCTCTCTCAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.18282689216	40.4722038242	0.0166883104133079	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2420.52088887787	2420.52088887787
"healthy-1"	"2019-08-01-count-2:GTGCTGGTCTCATGCC"	1.74528541144673	-10.0602760544983	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGTCTCATGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.22496804492	45.2789579548117	0.018840915252161	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.54663728847	2401.54663728847
"healthy-1"	"2019-08-01-count-3:ACTTCCGAGCAGCCTC"	2.86049499091451	-10.6610336533752	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCCGAGCAGCCTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2628.89957584762	41.4066007645446	0.0157505448838585	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2619.9890738646	2619.9890738646
"healthy-1"	"2019-08-01-count-2:CCTAAGAGTACCGCGT"	10.5405937629635	4.76002452457277	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAAGAGTACCGCGT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.37585283348	39.3784004913473	0.0208530523371503	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1888.37585283348	1888.37585283348
"healthy-1"	"2019-08-01-count-4:CGGAGAAAGACAGCGT"	1.22415520724599	9.8929872282776	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAGAAAGACAGCGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.60525081483	37.5245102032129	0.020991496968421	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1786.52492101169	1786.52492101169
"healthy-1"	"2019-08-01-count-4:TTTCGATCACCTGCAG"	0.215732340782326	13.3725461729797	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATCACCTGCAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1790.49995938143	43.3562448688477	0.0242146025425358	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1790.49995938143	1790.49995938143
"healthy-1"	"2019-08-01-count-2:CTACCCATCAACCTCC"	1.1286869245464	-8.70571043407591	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCATCAACCTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2483.38125135694	41.6567731773928	0.0167742158617937	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2482.49175071731	2482.49175071731
"healthy-1"	"2019-08-01-count-4:TCTGTCGGTCATCAGT"	1.52191688594167	-9.21512701427611	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTCATCAGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2458.28078222253	45.7303318188712	0.0186025665373857	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2456.42408775147	2456.42408775147
"healthy-1"	"2019-08-01-count-3:TTACTGTTCCGCGGAT"	2.78141822394673	-10.4527797929016	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTTCCGCGGAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.05946142616	42.2476587827676	0.0172505647364583	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2445.40637258102	2445.40637258102
"healthy-1"	"2019-08-01-count-3:AGTTCCCGTGGTCTGC"	1.98653461512868	-10.1694774857727	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTGGTCTGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2364.55900583956	38.3967817447194	0.0162384536185792	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2362.78315708323	2362.78315708323
"healthy-1"	"2019-08-01-count-4:TGTTCATCACCGGAAA"	-5.21520457688029	-4.46878340160521	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATCACCGGAAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2716.60890231309	41.7738753312693	0.0153772135899652	2752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2711.36639287576	2711.36639287576
"healthy-1"	"2019-08-01-count-4:TCTGTCGGTGGATTTC"	-7.99907718125041	4.35822579944459	"2019-08-01-count-4"	"Control1"	"MPP"	"MPP_GMP"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTGGATTTC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2045.31177573566	39.2563951000796	0.0191933550502147	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2038.83923739374	2038.83923739374
"healthy-1"	"2019-08-01-count-4:CGGGACTTCGACGATT"	7.64966072615926	7.10898826206056	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTTCGACGATT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1622.38628161054	33.5014207395355	0.0206494723970907	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1617.7130141717	1617.7130141717
"healthy-1"	"2019-08-01-count-2:GAAATGATCCGTATAG"	1.63404573973958	-9.82459165966185	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGATCCGTATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.97378249588	42.3261564674945	0.01769507541313	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2387.46109587914	2387.46109587914
"healthy-1"	"2019-08-01-count-4:GTTATGGTCGACTCCT"	-0.938799600035507	13.325262046698	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGTCGACTCCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2253.48144118837	41.8774892423645	0.0185834631148683	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2241.4556393929	2241.4556393929
"healthy-1"	"2019-08-01-count-3:AAGACAATCTTCGTAT"	2.12537087973897	-7.79674436962279	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAATCTTCGTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1391.96357508859	36.1722973885746	0.0259865258228991	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1391.96357508859	1391.96357508859
"healthy-1"	"2019-08-01-count-3:CTAACCCAGAAACCAT"	2.42999424514119	-10.7206707230774	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACCCAGAAACCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.6618406814	43.462308990953	0.0182717476892397	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.71523329183	2375.71523329183
"healthy-1"	"2019-08-01-count-2:CATAAGCCACAGCCAC"	8.40188087996785	7.88913962924806	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAAGCCACAGCCAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.83846603003	38.7505977551008	0.0192517176162326	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2007.41911950209	2007.41911950209
"healthy-1"	"2019-08-01-count-1:ACTATGGGTCACATTG"	2.02593829211537	-10.5977335206238	"2019-08-01-count-1"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTATGGGTCACATTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2677.42729401777	45.6362636733034	0.0170448190228244	2431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2670.37130635128	2670.37130635128
"healthy-1"	"2019-08-01-count-4:GCAACATGTGGCACTC"	1.76981594142262	-4.82958652889403	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACATGTGGCACTC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2486.31542200087	41.0109565250682	0.0164946716583789	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2480.3595794752	2480.3595794752
"healthy-1"	"2019-08-01-count-3:GTTGTGAGTGCATCTA"	0.345401723950547	12.5672921904358	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Activated"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGAGTGCATCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1854.30139976383	38.4061526066343	0.020711925586383	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1846.44478787339	1846.44478787339
"healthy-1"	"2019-08-01-count-2:AACGTCAGTACGATCT"	-7.07384190979655	-0.171564259287439	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCAGTACGATCT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2316.14172997685	43.8709376633308	0.0189413873492833	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2312.44653329637	2312.44653329637
"healthy-1"	"2019-08-01-count-4:CATCCGTGTAACTTCG"	3.42994346198384	-10.5847654572693	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTGTAACTTCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.72020348712	46.1803122482813	0.0192120165156022	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.87292659922	2399.87292659922
"healthy-1"	"2019-08-01-count-4:AGTGCCGCACAGTCAT"	3.06745543059651	-10.6004638901916	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGCACAGTCAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.14238376401	42.0165892970108	0.0179164342378108	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2339.56994636771	2339.56994636771
"healthy-1"	"2019-08-01-count-3:AGAACCTAGGGACAGG"	1.29647638377492	9.60447499835817	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTAGGGACAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.18494967116	33.6558179783592	0.020019104968161	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1673.5236808089	1673.5236808089
"healthy-1"	"2019-08-01-count-2:GCACGGTAGGTGCTTT"	1.37979533252065	11.0777072676453	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGGTAGGTGCTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1991.92287438523	37.5529459628065	0.0188526104327189	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1982.85968501873	1982.85968501873
"healthy-1"	"2019-08-01-count-4:CCACACTAGATAGTCA"	1.31364836272542	9.57766435230104	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTAGATAGTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1679.62983803035	35.41428852928	0.0210845793087418	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1678.29476420331	1678.29476420331
"healthy-1"	"2019-08-01-count-4:GTTCGCTCAAGACCTT"	0.713034172623795	9.32131574237672	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCGCTCAAGACCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1753.17092695712	43.9080274671132	0.0250449210581662	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1750.60282895934	1750.60282895934
"healthy-1"	"2019-08-01-count-3:TCAGTCCAGTGCCAGA"	1.62937130507771	-8.32654096996459	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTCCAGTGCCAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.31465732321	43.2021961458844	0.0182340475598514	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2367.11729366175	2367.11729366175
"healthy-1"	"2019-08-01-count-4:AGTTAGCAGACTCAAA"	3.14187182959859	-10.9145136109558	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCAGACTCAAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.3730336755	43.4780636720911	0.0197325023986357	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2196.42671058791	2196.42671058791
"healthy-1"	"2019-08-01-count-2:GAACTGTTCGTCGCTT"	1.67262556132619	-10.0231065980163	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTTCGTCGCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.22205740914	41.6878056304255	0.0176776421454669	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2354.45381014957	2354.45381014957
"healthy-1"	"2019-08-01-count-3:AAGATAGTCATCACTT"	-7.46431909027751	-0.120401897188746	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGTCATCACTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2582.61925539565	38.6304642197418	0.0149578626965761	3290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2579.68285535936	2579.68285535936
"healthy-1"	"2019-08-01-count-3:TGAGCATCAAACCACT"	2.33932890471761	-10.7132044068542	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCATCAAACCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.18214519532	41.162706340582	0.0172287853495644	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2381.16771736847	2381.16771736847
"healthy-1"	"2019-08-01-count-2:AGGTCTAGTGCTGATT"	2.12837900695149	-10.6918764344421	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTAGTGCTGATT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.33270065383	43.9348824635339	0.0199040599772386	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2207.33270065383	2207.33270065383
"healthy-1"	"2019-08-01-count-4:CAATGACGTCACGACC"	2.24224867400472	-10.3495474091736	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATGACGTCACGACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.4768105972	38.9152517963899	0.0164304972808991	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.59185973587	2362.59185973587
"healthy-1"	"2019-08-01-count-2:CCTCAGTTCTAACACG"	1.63865818557088	-9.81808950817259	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTTCTAACACG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2626.66196598953	44.7741103226498	0.0170460115928097	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2625.1363399222	2625.1363399222
"healthy-1"	"2019-08-01-count-2:TTCTCTCCACGACAGA"	-4.31278882446941	-5.44792177593382	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCCACGACAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2507.00599232014	41.3881503791148	0.0165089953936694	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2503.82232509976	2503.82232509976
"healthy-1"	"2019-08-01-count-3:CTACCCAAGCATCAAA"	-4.65819869461711	-5.34922888195189	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCCAAGCATCAAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2841.35856409258	44.3879298687306	0.0156220796733222	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2836.89808621906	2836.89808621906
"healthy-1"	"2019-08-01-count-4:CGTAATGTCAAGTTGC"	6.93559612807576	-1.15425612842711	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAATGTCAAGTTGC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2504.61763823175	42.9749827567911	0.0171583007724609	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2501.62698624741	2501.62698624741
"healthy-1"	"2019-08-01-count-4:GCACGTGGTCGCGTTG"	1.5451463657314	-4.84302809154662	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGGTCGCGTTG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2291.81069955395	39.4852487935524	0.017228843901129	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2289.40509183569	2289.40509183569
"healthy-1"	"2019-08-01-count-4:CGTCAAAAGCCAGAGT"	3.13717736777608	-9.66645815288695	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCAAAAGCCAGAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.8640043425	42.536573465451	0.0182885041369715	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2320.88938370155	2320.88938370155
"healthy-1"	"2019-08-01-count-2:AAGACAAAGATGATTG"	1.16109528121297	9.61096761310426	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAAAGATGATTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1860.3293804414	39.2503229535	0.0210985878985511	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1853.63069760567	1853.63069760567
"healthy-1"	"2019-08-01-count-4:AGTTCGAAGCCTTCTC"	8.79707874831502	7.8450979956421	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCGAAGCCTTCTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.89576076391	42.7287096460031	0.0231605007473759	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1844.89576076391	1844.89576076391
"healthy-1"	"2019-08-01-count-3:TCATACTTCTACAGGT"	1.30694069442098	10.5139150389465	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATACTTCTACAGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1785.0034240797	34.5938730787865	0.0193802838762745	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1782.3912865177	1782.3912865177
"healthy-1"	"2019-08-01-count-3:TAAGCCAGTGACAGGT"	-0.0826820683782876	11.9312915571961	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCAGTGACAGGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.00290854923	49.152489743436	0.0230114339014736	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2131.77787003573	2131.77787003573
"healthy-1"	"2019-08-01-count-2:GAAGCGAAGCAACCAG"	6.91880430754964	-1.08765449440154	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGAAGCAACCAG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2232.89586020125	44.4757807285207	0.019918430376109	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2224.16689770047	2224.16689770047
"healthy-1"	"2019-08-01-count-2:AAGACAAAGGTTCTTG"	1.25374772128407	9.81157968128053	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAAAGGTTCTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1749.11756396038	28.8113070533872	0.0164719099773672	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1745.16047430276	1745.16047430276
"healthy-1"	"2019-08-01-count-4:TCATACTAGCAACCAG"	2.33457889136617	-9.72194197094115	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	51	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTAGCAACCAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2462.76611567086	46.3346430652252	0.0188140655218506	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2457.10130062118	2457.10130062118
"healthy-1"	"2019-08-01-count-4:GTTGCGGTCCCTCATG"	2.12794723090474	-10.2374353638855	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGTCCCTCATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.83021039304	38.1566226303348	0.016019875163158	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2372.24804027435	2372.24804027435
"healthy-1"	"2019-08-01-count-3:CACAGATGTCTTCAAG"	1.37436070021932	-8.64999201213988	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGATGTCTTCAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.3595155906	44.8420470390267	0.0177006251039631	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2530.21205945965	2530.21205945965
"healthy-1"	"2019-08-01-count-2:CATACTTCAAATGAGT"	3.59375967559163	-10.9631929627624	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTCAAATGAGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.90163522207	37.855400479556	0.0162197926031935	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2332.68276210804	2332.68276210804
"healthy-1"	"2019-08-01-count-3:GGAACCCGTATCTCTT"	1.23317172107045	10.9519843825134	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAACCCGTATCTCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.08069409684	34.5593593481509	0.0197925327649457	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1738.60961889208	1738.60961889208
"healthy-1"	"2019-08-01-count-2:CAATTTCCACGCTGTG"	1.26644970950429	-9.09434320842894	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCCACGCTGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2553.96110997173	45.2958931203012	0.0177355453626318	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2548.32279641939	2548.32279641939
"healthy-1"	"2019-08-01-count-3:GTAACACAGAGTACCG"	14.1259657340938	1.67047319496004	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACACAGAGTACCG"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1528.95221442524	35.9260014532029	0.0234971381801544	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1515.0584315586	1515.0584315586
"healthy-1"	"2019-08-01-count-4:CACAACACAATACCCA"	6.88849558409993	-1.18652810966643	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACACAATACCCA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2376.20832440942	46.3304764933183	0.0194976492664351	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2371.42033010196	2371.42033010196
"healthy-1"	"2019-08-01-count-4:TCATATCCATCTTCGC"	2.19087924537007	-10.6280851594177	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATATCCATCTTCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.6417168432	43.805946351298	0.0172217439512918	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2540.60281757479	2540.60281757479
"healthy-1"	"2019-08-01-count-3:TAAGTCGTCTTGTTAC"	-5.47369227829631	3.79942462528077	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGTCTTGTTAC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2219.09529359308	42.9019840809766	0.0193330967826583	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2215.11613806468	2215.11613806468
"healthy-1"	"2019-08-01-count-4:GCAGCTGTCGGCTTGG"	12.2843796211178	-2.98306133663329	"2019-08-01-count-4"	"Control1"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCTGTCGGCTTGG"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1898.46525624954	42.463815772446	0.0223674442461666	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	1897.2532027198	1897.2532027198
"healthy-1"	"2019-08-01-count-2:CTATCTAGTTCTGAGT"	-2.65830431404765	3.41355106914369	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTAGTTCTGAGT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3186.2002392634	47.588569513083	0.0149358376559801	5400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3179.44787475462	3179.44787475462
"healthy-1"	"2019-08-01-count-4:GCAGCTGTCGACGTCG"	2.65412344512288	-10.756901764032	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCTGTCGACGTCG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.37555833646	40.0312724759798	0.0166909941759688	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2391.52551855427	2391.52551855427
"healthy-1"	"2019-08-01-count-3:AGACAGGCAACTGAAA"	1.82314123687093	-9.6010198823181	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAGGCAACTGAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.00672655802	48.4439986691076	0.022140699149182	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2183.3161873064	2183.3161873064
"healthy-1"	"2019-08-01-count-3:TAATCTCCAGCGAGTA"	-6.01704822006877	4.04811666095582	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCAGCGAGTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2208.18441560019	39.3547078511024	0.0178222016119092	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2205.61920818636	2205.61920818636
"healthy-1"	"2019-08-01-count-3:CACCAAACATTCACCC"	1.43653060969655	9.21103761279909	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAACATTCACCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.99572932567	34.1985822071937	0.017747098079538	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1919.91058038969	1919.91058038969
"healthy-1"	"2019-08-01-count-3:AAGTACCGTCGGAACA"	-7.6458571952885	3.86326739871827	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCGTCGGAACA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2295.63093068194	40.1164339053206	0.0174751234482642	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2287.44519239131	2287.44519239131
"healthy-1"	"2019-08-01-count-3:GTAAGTCAGCAACAAT"	-4.93131146851237	3.05958554828493	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAAGTCAGCAACAAT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2746.1968003416	47.7777765094684	0.0173977977483352	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2740.24336328569	2740.24336328569
"healthy-1"	"2019-08-01-count-4:ATAGACCTCGACGAGA"	1.83161224898641	-9.63359739696654	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGACCTCGACGAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.08213729289	43.683256244168	0.0173340605045093	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2515.80654519065	2515.80654519065
"healthy-1"	"2019-08-01-count-2:TCGGGACAGCAGGCAT"	1.46031381663625	-8.99349501049193	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACAGCAGGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.34906190327	40.5268353432373	0.0167165842493907	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2423.36631603833	2423.36631603833
"healthy-1"	"2019-08-01-count-2:ACTCCCAGTCCGACGT"	10.6704946952755	4.44420955264894	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCAGTCCGACGT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.52587985805	42.5907007594606	0.0226965698776732	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1867.20703311062	1867.20703311062
"healthy-1"	"2019-08-01-count-3:CTAGGTATCAGTGGGA"	2.61050333556477	-10.7317714921203	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGGTATCAGTGGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.62579864487	46.0831224584522	0.0193575666048331	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2374.48041993643	2374.48041993643
"healthy-1"	"2019-08-01-count-4:TGCTCGTCAGGTGTGA"	10.9437815147335	3.93964502895204	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCGTCAGGTGTGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1715.79473295965	32.6901603525542	0.0190524890446339	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1708.7942648772	1708.7942648772
"healthy-1"	"2019-08-01-count-2:CACAGATGTTCTCTAT"	1.72758760032002	-9.68289091503295	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATGTTCTCTAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.76390266948	38.9317230096792	0.0162910331711809	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2387.12922837785	2387.12922837785
"healthy-1"	"2019-08-01-count-2:GAGAGGTTCCTCGATC"	3.32800235328023	-10.3744802705017	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTTCCTCGATC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.19659104481	50.2217909660144	0.0221514936836025	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2260.68526606434	2260.68526606434
"healthy-1"	"2019-08-01-count-4:GACTATGAGACCTTTG"	4.1296783882076	-10.6436767808166	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGAGACCTTTG"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.75232506161	46.3495017263535	0.0201804527290988	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2295.86200342168	2295.86200342168
"healthy-1"	"2019-08-01-count-3:ATCAGGTAGCCATATC"	1.57762875136678	-4.9247822991577	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTAGCCATATC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2464.92710206283	39.294450321533	0.0159414249162373	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2458.96885269466	2458.96885269466
"healthy-1"	"2019-08-01-count-1:CATTCATTCTTTCTAG"	1.2477408843929	11.4956369169983	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATTCATTCTTTCTAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2214.50402438487	31.3192335521889	0.0141427756316174	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2210.54444772915	2210.54444772915
"healthy-1"	"2019-08-01-count-4:GCATTAGAGGTTAAAC"	9.43352951583211	5.08631894672243	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATTAGAGGTTAAAC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1694.32499753942	31.5801745040396	0.0186387939444333	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1692.21303380907	1692.21303380907
"healthy-1"	"2019-08-01-count-2:GTTAGACTCGCTTTAT"	0.773436327546281	9.05359933460084	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACTCGCTTTAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.86709043424	39.0429078473996	0.0220224674810996	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1772.86709043424	1772.86709043424
"healthy-1"	"2019-08-01-count-1:CCACCATCATGTCTAG"	2.35339870032613	-10.2866363755432	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCACCATCATGTCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2715.49461390821	43.0576194095779	0.015856271336001	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2708.46744359063	2708.46744359063
"healthy-1"	"2019-08-01-count-2:TCGGGCAAGGTACCTT"	7.99689545211141	7.35722730243532	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAAGGTACCTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.27040637595	36.8294486746733	0.0207926743099756	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1768.07536621023	1768.07536621023
"healthy-1"	"2019-08-01-count-2:ACTGATGTCCATTTCA"	-7.26957784119304	1.84300158107606	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGATGTCCATTTCA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2576.37392854355	41.1352565654047	0.0159663378478057	2572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2570.14141291681	2570.14141291681
"healthy-1"	"2019-08-01-count-4:AGAACAACAGGCTTGC"	2.02807857569997	-10.2054491273132	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACAACAGGCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.07317270524	41.7554599247924	0.0177752912978466	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2342.34599763171	2342.34599763171
"healthy-1"	"2019-08-01-count-2:AGTAGTCTCTTAGCTT"	1.40477134761159	11.2413844832214	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGTCTCTTAGCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1935.61074223408	41.5188242896741	0.0214499864997407	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1922.77185776482	1922.77185776482
"healthy-1"	"2019-08-01-count-4:TCATGTTTCGGAACTT"	-2.13119326058086	13.5878448256287	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTTCGGAACTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2005.13951008346	42.9931822903237	0.0214414917636001	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2001.53434552425	2001.53434552425
"healthy-1"	"2019-08-01-count-2:AGTCAACTCGGCCCAA"	1.08980919894521	9.32410237872926	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCAACTCGGCCCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1523.6745766383	33.2012624946672	0.0217902582373721	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1522.31053098146	1522.31053098146
"healthy-1"	"2019-08-01-count-3:GTACAGTCACAACGAG"	-7.25336728516276	-0.354637645837389	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAGTCACAACGAG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2229.6018251856	47.9195404911748	0.0214924207317537	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2225.75322644198	2225.75322644198
"healthy-1"	"2019-08-01-count-4:TAACCAGGTGCCGAAA"	2.0177387195522	-10.2627649537292	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACCAGGTGCCGAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1947.73037731054	40.8328813927318	0.0209643397609861	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1935.27266421706	1935.27266421706
"healthy-1"	"2019-08-01-count-3:CTCAATTAGATGGGCT"	2.23337640342061	-10.7047357789245	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAATTAGATGGGCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.60685202036	37.5275026124273	0.0151161681447416	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2474.45893114102	2474.45893114102
"healthy-1"	"2019-08-01-count-2:CCTTGTGCAAGAAACT"	2.50402226027791	-10.6313667527405	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGCAAGAAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.98382030528	46.7720547774083	0.0209459891075314	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2221.83496982614	2221.83496982614
"healthy-1"	"2019-08-01-count-3:TGCAGGCCACTGCTTC"	1.66373052176778	-9.84060194408568	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCCACTGCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.52482785881	41.6754995012379	0.0175584847531736	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2371.66546317472	2371.66546317472
"healthy-1"	"2019-08-01-count-4:CTAAGTGTCACGATAC"	1.51987530764882	-9.56472780620726	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGTCACGATAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.54250446674	35.2356821347147	0.0144435614752352	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2437.7953653604	2437.7953653604
"healthy-1"	"2019-08-01-count-4:CCCGGAACACTGCGTG"	2.82459535178487	-10.5389089814392	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGGAACACTGCGTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.31834623355	42.6141956215955	0.0186551036950953	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2279.82090791737	2279.82090791737
"healthy-1"	"2019-08-01-count-4:GCCAGTGAGGATACAT"	3.1048592525417	-10.557436012384	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGTGAGGATACAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.5900289948	41.7980172813017	0.0176170416171775	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2363.58836799015	2363.58836799015
"healthy-1"	"2019-08-01-count-3:GTAGAGGAGTCAGGGT"	1.98745836791341	-9.76553251659545	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAGGAGTCAGGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.35933160689	43.4411827193521	0.01873789887836	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2314.99650350063	2314.99650350063
"healthy-1"	"2019-08-01-count-3:ATCCCTGTCCCTTGGT"	1.44758238372151	-8.74083330547484	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCCTGTCCCTTGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.41110491662	40.8050299653013	0.0181888330123149	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2240.94475505736	2240.94475505736
"healthy-1"	"2019-08-01-count-2:CTCAGTCTCTAGTGTG"	3.20813169059102	-10.2035875550476	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCTCTAGTGTG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2551.07368260149	44.8999718032561	0.0176004213870721	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2544.57396618942	2544.57396618942
"healthy-1"	"2019-08-01-count-4:CTACATTGTCGTTCAA"	1.83125104483907	-10.2882738343445	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTGTCGTTCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.06296000063	41.3299902337383	0.0192226883596591	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2143.77596987172	2143.77596987172
"healthy-1"	"2019-08-01-count-2:TCACAAGAGACAACAT"	7.98178305205647	7.69173429096071	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGAGACAACAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.3619662493	39.8276281025979	0.0213740694636832	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1856.02436857047	1856.02436857047
"healthy-1"	"2019-08-01-count-2:TGGTTAGAGACCAACG"	1.9091155725414	-10.0623693696228	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGAGACCAACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.78407774287	31.9286139161801	0.0142108065623537	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2238.98020679074	2238.98020679074
"healthy-1"	"2019-08-01-count-3:ATCCTATGTATTGACC"	7.93124737319295	7.550425983313	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATGTATTGACC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1785.29117916398	27.8841020917637	0.0156187978841756	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1781.91503207227	1781.91503207227
"healthy-1"	"2019-08-01-count-2:CAACCAAAGAGCATTA"	1.18172492560689	9.15065476978151	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCAAAGAGCATTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1679.97887784161	42.0973744907692	0.0250582760569316	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1671.19083208471	1671.19083208471
"healthy-1"	"2019-08-01-count-3:GTAGATCTCTCCGATC"	1.66443469104115	-4.7520437470642	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGATCTCTCCGATC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2413.82178008233	43.3486627608505	0.0179585183622678	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2407.01284539493	2407.01284539493
"healthy-1"	"2019-08-01-count-3:CTCATCGGTCCACAGC"	3.10825242575948	-10.5855159989563	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATCGGTCCACAGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.80674857423	39.3187773971328	0.0180460141418519	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2176.59875079553	2176.59875079553
"healthy-1"	"2019-08-01-count-4:AGACACTTCTGGGATT"	1.32094552096669	11.4059295424256	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTTCTGGGATT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2031.53530245819	30.5889139802775	0.0150570427908708	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2028.00616778659	2028.00616778659
"healthy-1"	"2019-08-01-count-2:GGTGTTAGTAGACACG"	1.69957317885701	-9.60311701213988	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTAGTAGACACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.53613247435	44.2768267866336	0.0197793665888665	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2233.93733824029	2233.93733824029
"healthy-1"	"2019-08-01-count-2:AGTCTCCTCGTGCGAC"	2.80248369750325	-10.439425491449	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCTCGTGCGAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.62516847251	37.7622500125498	0.0159561600694557	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.45977363644	2362.45977363644
"healthy-1"	"2019-08-01-count-2:GCCATGGCATTGACAC"	1.76915540274922	-10.3843956223694	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATGGCATTGACAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.41677148871	42.4736243646817	0.0160313110499469	2474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2644.33593739705	2644.33593739705
"healthy-1"	"2019-08-01-count-4:GAACTGTAGTGTTCAC"	-5.01538930359538	-5.56857683574828	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTAGTGTTCAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2717.76912765594	41.4951753962024	0.0152681016845577	2715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2711.85041924445	2711.85041924445
"healthy-1"	"2019-08-01-count-4:ATCCATTCAACCGCTG"	1.49353017386739	10.1079816588196	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCATTCAACCGCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1754.0661926872	38.5650121574433	0.0219860643333889	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1744.21359946006	1744.21359946006
"healthy-1"	"2019-08-01-count-3:ATCGATGGTAAGTTAG"	2.84590615805928	-10.8436346284119	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGGTAAGTTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.03571618287	44.7143576625144	0.0195683408122869	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2281.96087948883	2281.96087948883
"healthy-1"	"2019-08-01-count-2:TCACACCGTAGTCACT"	11.095008512109	3.90107462489931	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTAGTCACT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.39867027949	35.4062084748926	0.0187294929009117	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1880.93519734589	1880.93519734589
"healthy-1"	"2019-08-01-count-2:GGTGTTATCGCGATCG"	-3.21671948853191	-4.57165720379027	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTATCGCGATCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2581.65220889164	41.2674603955707	0.0159849030994332	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2577.49634779246	2577.49634779246
"healthy-1"	"2019-08-01-count-4:AATAGAGGTAGATGTA"	-3.06607494774516	-5.73480083858641	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGGTAGATGTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1959.52563472687	44.9057212777647	0.0229166286380448	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	1958.19315670729	1958.19315670729
"healthy-1"	"2019-08-01-count-4:TGATGCACACTCACTC"	-2.65700588646587	3.35401699626771	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCACACTCACTC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3156.95465753229	45.1296158781813	0.0142953006215991	5675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3153.50096809983	3153.50096809983
"healthy-1"	"2019-08-01-count-2:CAGTGCGAGTTTGGCT"	2.65102519568745	-10.5632658234802	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTGCGAGTTTGGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.18523804416	45.2626581313588	0.0201061455834186	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2245.83508618523	2245.83508618523
"healthy-1"	"2019-08-01-count-4:GCCGATGCACCGTGAC"	1.51208223876302	-9.66769697582396	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGCACCGTGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2561.18832639602	46.244751059183	0.0180559744797277	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2557.91598799959	2557.91598799959
"healthy-1"	"2019-08-01-count-4:TAATTCCAGCCTCATA"	-0.367055664688903	12.1405915983948	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATTCCAGCCTCATA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.6329877124	40.7328884247505	0.0197863770122589	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2053.32483848996	2053.32483848996
"healthy-1"	"2019-08-01-count-3:CTCCAACAGAAATCCA"	1.31380321559255	9.21329782092897	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACAGAAATCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1840.43754912488	37.6931257135173	0.0204805241728741	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1827.10404363465	1827.10404363465
"healthy-1"	"2019-08-01-count-2:GCCCAGAGTTCAGCGC"	1.65462281283681	-9.44846632396849	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGAGTTCAGCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.32256899257	39.4563244322718	0.0178509349656849	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2204.58108796945	2204.58108796945
"healthy-1"	"2019-08-01-count-4:AGAGAGCAGCTTTCTT"	3.05991758879964	-10.7565527192322	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAGCAGCTTTCTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.46823575212	38.3008229185418	0.0154596625562443	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2472.76029559778	2472.76029559778
"healthy-1"	"2019-08-01-count-3:ATCGCCTTCAGTCACA"	2.57735862311665	-10.3457317582336	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	51	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGCCTTCAGTCACA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.91314302428	42.4821042182372	0.0162523013940263	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2608.64947221046	2608.64947221046
"healthy-1"	"2019-08-01-count-3:ATCGGATGTGCTTATG"	1.87332429465596	-10.0067444077698	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGATGTGCTTATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.75239358973	41.2207796581349	0.0190594077159784	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2158.42926490467	2158.42926490467
"healthy-1"	"2019-08-01-count-2:GACGCTGAGAATACAC"	2.26416577872578	-10.6687441102234	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGCTGAGAATACAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.67702103228	39.2020232734472	0.016081713424384	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2430.86893977414	2430.86893977414
"healthy-1"	"2019-08-01-count-2:AGTTCCCCATTCACAG"	2.85685553130452	-10.2666054002014	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCCCCATTCACAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.79937612864	40.4503263659331	0.0164112043997134	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.28446821896	2457.28446821896
"healthy-1"	"2019-08-01-count-3:TCCATCGGTATCTCTT"	0.823450406163377	11.0253658064636	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATCGGTATCTCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1875.84339546065	36.6538988813188	0.0195399567842484	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1872.81558262188	1872.81558262188
"healthy-1"	"2019-08-01-count-2:GGTTGTAAGTATGAGT"	-2.01371465149577	10.3925409086975	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTAAGTATGAGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.40903288161	44.1257221617425	0.0228109574612615	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1929.13562143814	1929.13562143814
"healthy-1"	"2019-08-01-count-3:ATCGTAGCAAATCAAG"	10.7417026954586	4.3037914999756	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGCAAATCAAG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1742.84959939909	43.8905339492005	0.0251832022478206	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1731.42372642948	1731.42372642948
"healthy-1"	"2019-08-01-count-2:CGAGAAGGTTATGGTC"	-7.47118411484416	4.31730172717897	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGAAGGTTATGGTC"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1997.31844027275	31.6606398983607	0.0158515734196282	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1986.24487223817	1986.24487223817
"healthy-1"	"2019-08-01-count-2:GACGTTAGTCGCATGC"	1.13098945197408	10.4865360029968	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTAGTCGCATGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1763.26163555834	44.1369183706047	0.0250314062760338	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1763.26163555834	1763.26163555834
"healthy-1"	"2019-08-01-count-4:ATCGATGTCAAGCGTT"	1.73500730571095	-9.18167784130248	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGTCAAGCGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.20047240257	42.9461424279735	0.0190262863015714	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2253.79236631122	2253.79236631122
"healthy-1"	"2019-08-01-count-4:AGATAGACAGAACTAA"	1.90953352031056	-10.4857893220154	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATAGACAGAACTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.33037423392	36.1188551507294	0.0146626110441893	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2458.6398069584	2458.6398069584
"healthy-1"	"2019-08-01-count-4:AGAGCCCTCGAAATCC"	3.14873637732808	-10.3534784547058	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCCCTCGAAATCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.72659565624	41.6419493720096	0.0177371374712266	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2345.86868836902	2345.86868836902
"healthy-1"	"2019-08-01-count-3:CCTCATGCATACATCG"	8.45783772048299	7.93434808338014	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCATGCATACATCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2081.8793500372	39.8171336392928	0.0191255721128034	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2075.20044826535	2075.20044826535
"healthy-1"	"2019-08-01-count-3:CTCCATGCAAGGCCTC"	11.1472670036251	3.87025401676027	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGCAAGGCCTC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2147.15999677434	33.8929729068949	0.0157850243846812	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2137.04704895019	2137.04704895019
"healthy-1"	"2019-08-01-count-4:ATCGCCTAGGATATAC"	1.83094551142995	-9.9359169236389	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGCCTAGGATATAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2351.53616813789	44.9843466867817	0.019129770273703	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2343.90264437139	2343.90264437139
"healthy-1"	"2019-08-01-count-4:TCCCACAGTCGAGCAA"	1.75255086001698	-4.8522896996704	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACAGTCGAGCAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2406.29311733162	38.607723971531	0.0160444809044477	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2402.52338657797	2402.52338657797
"healthy-1"	"2019-08-01-count-3:TCCCATGCACGCTATA"	-7.46654973450358	3.90134546840516	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGCACGCTATA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2353.38111940112	42.0020369228533	0.0178475286372408	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2347.51923071915	2347.51923071915
"healthy-1"	"2019-08-01-count-4:TCCCACAGTGGAAGTC"	6.94757761534993	-1.18790533458861	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACAGTGGAAGTC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2043.77127679847	46.0217289359842	0.0225180427274017	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2025.19734417832	2025.19734417832
"healthy-1"	"2019-08-01-count-3:GCTGAATGTAGGGTAC"	3.41617145118062	-10.8877811661926	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATGTAGGGTAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.99177345327	41.2436096878195	0.0165637533936991	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2484.8610421225	2484.8610421225
"healthy-1"	"2019-08-01-count-4:CCGGTGAAGAAACCAT"	0.69715460118596	-8.12408926403197	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTGAAGAAACCAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2332.43350765615	36.626916226834	0.0157033056276233	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2331.48209401955	2331.48209401955
"healthy-1"	"2019-08-01-count-3:TGCTGAAAGGCATTTC"	2.5446044403011	-10.633029007074	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAAAGGCATTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.50635017607	40.5015002993877	0.0171217043219407	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.57124833775	2362.57124833775
"healthy-1"	"2019-08-01-count-2:TGTGAGTGTTTCGTTT"	-4.98345933380778	-4.55649378215941	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTGTTTCGTTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2746.04399157263	44.4356196709235	0.0161816852924762	3118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2739.85727296462	2739.85727296462
"healthy-1"	"2019-08-01-count-2:CATTCTACAACTCGAT"	-1.08325848999675	12.2371139296326	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCTACAACTCGAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.66751453401	45.946225319594	0.0235661849915859	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1941.09708160394	1941.09708160394
"healthy-1"	"2019-08-01-count-3:CCTCCTCGTCCTCCAT"	1.05613567408864	-8.32834818279418	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCTCGTCCTCCAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2418.28333226849	38.0675778952459	0.0157415706370256	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2416.60181242758	2416.60181242758
"healthy-1"	"2019-08-01-count-3:TCCGAAACAAATGGAT"	1.20221712168996	9.34834859454957	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGAAACAAATGGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1743.87192369989	31.3634078226919	0.0179849261843437	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1739.93642947699	1739.93642947699
"healthy-1"	"2019-08-01-count-3:CCTCTAGAGCGACATG"	1.95925774154012	-9.9096718064514	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGAGCGACATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.21993714049	39.4445105677127	0.0172305464965431	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2284.46865669128	2284.46865669128
"healthy-1"	"2019-08-01-count-2:AATGCCATCCGGCTTT"	2.99962033805196	-10.5068035355774	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGCCATCCGGCTTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.42045672469	40.1279961417617	0.0161518538591749	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2478.99305931516	2478.99305931516
"healthy-1"	"2019-08-01-count-2:TAACGACAGTCCGCGT"	7.98278393325154	-9.6946707001892	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACGACAGTCCGCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.7439055755	44.768965841354	0.0211699230924941	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2109.05320679435	2109.05320679435
"healthy-1"	"2019-08-01-count-2:GCGGATCGTATCGCGC"	2.18641438063924	-9.70973589336547	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCGTATCGCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.09120701628	39.6232483001106	0.0194032706100354	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2042.09120701628	2042.09120701628
"healthy-1"	"2019-08-01-count-3:TTGCGTCAGCTAATGA"	2.43840064582173	-10.6044330826965	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCGTCAGCTAATGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.71637063706	42.6757011720339	0.0200194086604872	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2128.33141633304	2128.33141633304
"healthy-1"	"2019-08-01-count-4:TTCCTCTTCAAATGCC"	-1.18759463253673	13.321376777533	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTTCAAATGCC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2298.6449181479	42.7543713706292	0.0185998154969833	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2292.55923245526	2292.55923245526
"healthy-1"	"2019-08-01-count-2:CATTGAGGTGTACATC"	14.0116182762081	1.65838394248811	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGAGGTGTACATC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1350.94762334505	36.3071099980675	0.0268752906261224	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1333.5494708507	1333.5494708507
"healthy-1"	"2019-08-01-count-2:ATAGAGAAGACGCTCC"	-4.48242412033732	-5.28340818798216	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGAAGACGCTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2504.35317588799	39.5126028233521	0.0157775681177004	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2500.48934757148	2500.48934757148
"healthy-1"	"2019-08-01-count-2:CTCCGATTCTTTCTAG"	1.86377741870229	-9.60523226177367	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATTCTTTCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.96736032806	43.120181557653	0.0177014611360991	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2431.81904819111	2431.81904819111
"healthy-1"	"2019-08-01-count-4:TGCATGAAGACTCAAA"	2.23378910598103	-10.6682586899963	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGAAGACTCAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.3889914886	36.8905436428128	0.0155172518148634	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2367.09435387434	2367.09435387434
"healthy-1"	"2019-08-01-count-3:CCTCTAGGTGCGTGCT"	1.78543021258656	-10.2375688782898	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	51	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGGTGCGTGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.22632082963	41.1100051855946	0.0185161327022882	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2217.00665481234	2217.00665481234
"healthy-1"	"2019-08-01-count-2:GTAGAGGAGCGGATCA"	1.95448054847066	-9.90617372905882	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGAGCGGATCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.3075017046	42.4214995062287	0.0176146523964248	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.33445460333	2403.33445460333
"healthy-1"	"2019-08-01-count-3:CTCCGATGTGGCTACC"	1.34035017070119	11.0798806914124	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCGATGTGGCTACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.04928328735	41.2479914077566	0.0221163010422183	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1858.15461547944	1858.15461547944
"healthy-1"	"2019-08-01-count-4:CCTAACCCATGCCATA"	-1.64928183975871	13.0966462858948	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCCATGCCATA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2041.64753846955	39.6776065694391	0.0194341118247971	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2039.80179063986	2039.80179063986
"healthy-1"	"2019-08-01-count-2:TCAGGTAAGTGAGTGC"	3.03728570517842	-10.2109766236511	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTAAGTGAGTGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.36631692887	40.8833355235602	0.0172549661196131	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.79561016639	2362.79561016639
"healthy-1"	"2019-08-01-count-4:CCTACGTAGACAACAT"	-1.77729354324992	10.1184549101624	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTACGTAGACAACAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2086.8525375034	48.8835685385112	0.0234245437375239	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2074.62928020506	2074.62928020506
"healthy-1"	"2019-08-01-count-3:ATGAAAGTCGTTCCCA"	2.39294137534444	-10.7602453461853	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGTCGTTCCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.93801765596	45.9833245666094	0.0206116549194513	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2227.66724351926	2227.66724351926
"healthy-1"	"2019-08-01-count-3:TGGAGGATCTTTGATC"	-5.96976409378703	-3.10421183025511	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGGATCTTTGATC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2784.11026922751	44.7237244622249	0.0160639199375656	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2777.55825007578	2777.55825007578
"healthy-1"	"2019-08-01-count-4:GTCAGCGTCAAACTGC"	10.9859901863033	3.98635480487672	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGTCAAACTGC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1605.02481677215	27.4812772287639	0.0171220263646959	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1605.02481677215	1605.02481677215
"healthy-1"	"2019-08-01-count-4:GTCAGCGGTTCGAACT"	1.73476817187611	-10.0646229020325	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGGTTCGAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.81086920934	44.7430635215697	0.0197209314045477	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2264.55437142488	2264.55437142488
"healthy-1"	"2019-08-01-count-3:ACGTACAGTACGTACT"	1.06077553805653	9.29995439136354	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACAGTACGTACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1695.92283362594	37.4948426716236	0.0221088141088697	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1687.46483213449	1687.46483213449
"healthy-1"	"2019-08-01-count-3:ATTCGTTGTGGTACAG"	1.27591647681538	-8.8296108475891	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCGTTGTGGTACAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.63380270823	43.2585254066224	0.0195418616004592	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2212.54652616069	2212.54652616069
"healthy-1"	"2019-08-01-count-3:CTCCTTTCAAGACTGG"	2.74431886252705	-10.8102007142273	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTTTCAAGACTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.54945158233	42.9160095618511	0.01812676374433	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2367.54945158233	2367.54945158233
"healthy-1"	"2019-08-01-count-4:AGCCACGGTTCGTACA"	-7.75424848023112	3.29190466487733	"2019-08-01-count-4"	"Control1"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGGTTCGTACA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2413.23915428859	38.7543686307634	0.0160590667368763	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2404.67783905159	2404.67783905159
"healthy-1"	"2019-08-01-count-4:CCTCAACGTCCGAAGA"	11.1545931297237	3.95287964427797	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAACGTCCGAAGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1960.32703937647	39.9042165882076	0.0203558976572093	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1951.92623198248	1951.92623198248
"healthy-1"	"2019-08-01-count-2:TCAGTGAAGGAGAGGC"	-1.99861679497417	13.6129808195862	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTGAAGGAGAGGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1827.26244908711	39.0621972908459	0.0213774421459606	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1819.37697395938	1819.37697395938
"healthy-1"	"2019-08-01-count-4:TCCGGGAAGCACTCGC"	-4.90348468247111	-5.14287378704222	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGAAGCACTCGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2591.71278162058	47.793935555752	0.018441061793069	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2587.40820494156	2587.40820494156
"healthy-1"	"2019-08-01-count-3:ATGACCATCGCATTAG"	2.30661572989766	-10.4729585877624	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCATCGCATTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.37765588841	39.0366764935061	0.0162695007172817	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2394.84019511864	2394.84019511864
"healthy-1"	"2019-08-01-count-4:GCTGGGTGTCCGTTTC"	1.66252162036244	-9.79330160534056	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTGTCCGTTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.74099053546	38.9383236702191	0.0160323080237693	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2427.7218021004	2427.7218021004
"healthy-1"	"2019-08-01-count-4:GCTGAATGTATGCTAC"	1.35342516478841	11.2810535200867	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGAATGTATGCTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.7194545472	28.1633340377936	0.0146324358967002	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1921.00906202437	1921.00906202437
"healthy-1"	"2019-08-01-count-4:TGCGGCATCATTGCCC"	2.94816460189168	-10.610528968927	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGCATCATTGCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.95136281683	38.9125056362784	0.0167874556215843	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2310.35225253028	2310.35225253028
"healthy-1"	"2019-08-01-count-2:TGTTCATGTATTGCCA"	3.04704322394673	-10.5675382844177	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATGTATTGCCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.28599384557	38.6653728865986	0.0176692502695456	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2182.5113364503	2182.5113364503
"healthy-1"	"2019-08-01-count-2:TAAGTCGCAATCGCGC"	-3.50574646416362	-5.4910984269348	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGCAATCGCGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2751.6420756225	39.0749062423609	0.0142005773892381	2514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2750.22053169823	2750.22053169823
"healthy-1"	"2019-08-01-count-3:GAGGCAACAAGGCCTC"	8.59864868697469	7.56269071185914	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAACAAGGCCTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.05505072467	39.9511669089066	0.0192902486560787	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2061.3113109755	2061.3113109755
"healthy-1"	"2019-08-01-count-2:ACAACCAGTGAGCAGT"	2.18448128279988	-10.4282961121765	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCAGTGAGCAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.5643667281	41.8553399309789	0.0174866155733231	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.3918628121	2388.3918628121
"healthy-1"	"2019-08-01-count-4:TGCTCCAAGTGCTACT"	3.08527054366414	-10.1330795518127	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCCAAGTGCTACT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.31658688099	47.8655876447776	0.022270142954714	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2147.11319472313	2147.11319472313
"healthy-1"	"2019-08-01-count-3:AGGAAATCACTACCCT"	-0.322744200856048	10.9764146574768	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATCACTACCCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.7366445906	36.9092731159684	0.0194798961751983	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1892.83532013914	1892.83532013914
"healthy-1"	"2019-08-01-count-4:CTCACTGTCGCATGAT"	2.0249670940334	-10.3842115632263	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGTCGCATGAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.29793736083	36.6375896860477	0.0141934757533285	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2576.51705982722	2576.51705982722
"healthy-1"	"2019-08-01-count-3:TAGCACAGTCATCCCT"	2.99231233176534	-10.2925663224426	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACAGTCATCCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.46813871077	41.771711831609	0.0173292943228657	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.94434498072	2405.94434498072
"healthy-1"	"2019-08-01-count-4:ATTCTTGGTGGCTAGA"	1.2821442085201	10.3000116118225	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGGTGGCTAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2014.47083836447	43.3493272680484	0.0215189649025862	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2011.17852477393	2011.17852477393
"healthy-1"	"2019-08-01-count-4:CATGGATAGCACTAGG"	6.93595375594441	-1.17603566562804	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGATAGCACTAGG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2532.94135187262	41.091259904232	0.0162227443102277	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2521.66235580085	2521.66235580085
"healthy-1"	"2019-08-01-count-2:GGCTGTGGTGGTCTTA"	-5.83985171738322	3.80287931049196	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	54	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTGTGGTGGTCTTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2313.21109168585	47.0314614531547	0.020331677304417	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2309.44361751907	2309.44361751907
"healthy-1"	"2019-08-01-count-2:ATGCCTCTCAGTGTCA"	1.17821683463399	9.21275994861452	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCTCAGTGTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.19242005339	34.7612743503591	0.0200100310990827	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1730.15552608201	1730.15552608201
"healthy-1"	"2019-08-01-count-2:TCATACTTCTCTAGGA"	1.73498823222463	-10.0054826966492	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTTCTCTAGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2502.95570627991	40.6052197723005	0.0162229078486775	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2497.71170431811	2497.71170431811
"healthy-1"	"2019-08-01-count-2:TTTCACAGTTCAGCGC"	8.42079701003377	7.66852567279664	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACAGTTCAGCGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2224.17524944396	45.2615251311992	0.0203498016365907	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2221.33805856814	2221.33805856814
"healthy-1"	"2019-08-01-count-4:AGCGCTGCAATTCGTG"	-4.30745873871501	3.64933679187623	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGCAATTCGTG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2810.06521989804	43.0551499224831	0.0153217617931463	3814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2806.08687395271	2806.08687395271
"healthy-1"	"2019-08-01-count-2:GTAGTACTCGACATAC"	1.34605922278706	-8.86593725597533	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACTCGACATAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.44021994335	40.2194875920676	0.0156713128478618	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2563.00006589661	2563.00006589661
"healthy-1"	"2019-08-01-count-2:GCTGCAGTCACCGCTT"	6.8188005882198	-1.03790798103484	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGCAGTCACCGCTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2022.47621929128	51.827243840251	0.0256256381884245	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2011.64571937652	2011.64571937652
"healthy-1"	"2019-08-01-count-4:CTCAGAAGTATCCCTC"	-0.286669473082381	14.0853900679382	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAAGTATCCCTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2226.41895801621	38.8164471630609	0.0174344756737282	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2221.63113649744	2221.63113649744
"healthy-1"	"2019-08-01-count-2:CGCCAGATCTCGGCTT"	2.81538810309712	-10.3857040635315	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGATCTCGGCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.40505714139	40.361432483221	0.0178479447349611	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2255.88019119507	2255.88019119507
"healthy-1"	"2019-08-01-count-4:GGAACCCTCGCACGAC"	2.66806640204732	-10.7760238877502	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCTCGCACGAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.6333020825	43.1648092968968	0.0176497471064616	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2440.10606274164	2440.10606274164
"healthy-1"	"2019-08-01-count-4:AGCGCTGTCTTCACGC"	6.93353237685506	-1.22528960621031	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGTCTTCACGC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2563.78685025733	36.6112290422295	0.0142801376169609	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2552.44236590799	2552.44236590799
"healthy-1"	"2019-08-01-count-4:TGCTTGCCAGACACAG"	3.17035808142964	-10.6896562806335	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCCAGACACAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.17455396871	40.9651297752436	0.0157184904260773	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2600.59771550765	2600.59771550765
"healthy-1"	"2019-08-01-count-1:TCATTGTCATACAGAA"	1.37201680716817	9.4057521590027	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCATTGTCATACAGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.82279622294	35.4192405002001	0.0191473694521015	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1837.77619017643	1837.77619017643
"healthy-1"	"2019-08-01-count-3:CATACCCTCAGGGATG"	-7.55610547486003	0.956240452173628	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCTCAGGGATG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2483.23593857061	45.33161796459	0.0182550587563918	2783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2478.46007857633	2478.46007857633
"healthy-1"	"2019-08-01-count-4:ATGCGATCATGGCCAC"	1.93581523474995	-10.5319471589294	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCGATCATGGCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.05070171397	40.8777726780013	0.0172914111564377	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.0065081558	2360.0065081558
"healthy-1"	"2019-08-01-count-3:GTCTTTACAACACACT"	1.57475771483724	-9.51443293010863	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTTTACAACACACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.87046020773	45.9809975469157	0.0190328903408844	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2412.02641739396	2412.02641739396
"healthy-1"	"2019-08-01-count-4:GACTCAATCCAACTAG"	1.9625823694164	-10.2924776307312	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAATCCAACTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.27465392648	45.3024784816741	0.0191288955470451	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2361.97371317915	2361.97371317915
"healthy-1"	"2019-08-01-count-2:CGCCATTGTGATATAG"	0.69070984896962	9.93484971607057	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCATTGTGATATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1619.17726261587	39.0954409262712	0.0241452506954738	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1619.17726261587	1619.17726261587
"healthy-1"	"2019-08-01-count-4:CCTCCTCAGCGGCTCT"	0.958144922822159	10.0769796141419	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCAGCGGCTCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.86877868562	37.4931122020214	0.0192581609056025	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1944.46546372272	1944.46546372272
"healthy-1"	"2019-08-01-count-4:CAGTTCCCAAATTGGA"	2.14557113227193	-10.3865242234436	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCCAAATTGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.57661647338	41.7368856671401	0.0178242665106554	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.65249010431	2337.65249010431
"healthy-1"	"2019-08-01-count-2:GCTTTCGCATGTGTCA"	-3.42000947418864	3.56715843761293	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTTCGCATGTGTCA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3133.7497199643	44.6043628925695	0.0142335434793681	4893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3124.51828754188	3124.51828754188
"healthy-1"	"2019-08-01-count-3:GTGAGCCCATTGCAAC"	1.76634552058522	-10.2419738999573	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGCCCATTGCAAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2422.87958056096	39.3190935087638	0.0162282491561799	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2418.4264535818	2418.4264535818
"healthy-1"	"2019-08-01-count-1:TCGAACATCTGGACTA"	1.30638660964314	11.2933597334656	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGAACATCTGGACTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2124.3253196194	37.6916560829103	0.0177428832273502	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2102.5838969657	2102.5838969657
"healthy-1"	"2019-08-01-count-2:TTAATCCCATGATCTG"	2.40401949462239	-10.2661638489929	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCCATGATCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.72332108706	44.4718081956616	0.0179849511736359	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2467.66687383919	2467.66687383919
"healthy-1"	"2019-08-01-count-4:TGGAGGACACCTCTGT"	1.8341427045757	-10.3285064927307	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGGACACCTCTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.10212746302	40.7233548133961	0.0174023835692785	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.44846237725	2337.44846237725
"healthy-1"	"2019-08-01-count-3:AGGCTGCAGGATTTCC"	-5.2296818298405	2.8335881003174	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCTGCAGGATTTCC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2860.53537352393	42.1199684848547	0.0147245053757076	3418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2851.75536407272	2851.75536407272
"healthy-1"	"2019-08-01-count-4:TGGAGAGTCGTTAGTG"	2.74575056609456	-10.66335680401	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGAGTCGTTAGTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.04149406113	34.912922961812	0.015041921073425	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2315.97577526096	2315.97577526096
"healthy-1"	"2019-08-01-count-4:TCGAACACACTAGGCC"	2.74860801276509	-10.7360697022644	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACACACTAGGCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.45648064673	41.2608049278443	0.0166949348495294	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2467.18374090392	2467.18374090392
"healthy-1"	"2019-08-01-count-2:GAGGCCTAGTATAGGT"	1.83865787562672	-9.35170652782591	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTAGTATAGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.31594437803	43.5541014509452	0.0184448428236135	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.29007346041	2357.29007346041
"healthy-1"	"2019-08-01-count-3:CTGCAGGTCTGGGCCA"	2.6200930076534	-10.4329586259094	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCAGGTCTGGGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.98655257124	40.1650778573469	0.0161241648678865	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2486.13305938174	2486.13305938174
"healthy-1"	"2019-08-01-count-3:TTTAGTCAGTCGCGAA"	2.89570011672322	-10.8099403611389	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCAGTCGCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.58242865654	37.1375093928027	0.0150075863154677	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2471.92223884449	2471.92223884449
"healthy-1"	"2019-08-01-count-2:CACGGGTGTCAACCTA"	14.1575285392696	1.81089518153993	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGGGTGTCAACCTA"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1128.30638950465	23.3911538686424	0.0207312074860372	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1117.54148597716	1117.54148597716
"healthy-1"	"2019-08-01-count-3:TAGTGCATCACTCGAA"	0.195206646888894	12.2347535856995	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCATCACTCGAA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1523.88709772478	45.0995411075408	0.0295950672296367	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1511.8590852087	1511.8590852087
"healthy-1"	"2019-08-01-count-4:ATGGTTGCAAACGAGC"	0.849064429371995	13.3469400175842	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ TRM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGCAAACGAGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1654.49146490899	44.2613238252758	0.0267522225191476	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1647.55403323367	1647.55403323367
"healthy-1"	"2019-08-01-count-4:CCTCTAGTCGTTCTCG"	2.59337462958638	-10.5148248902527	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGTCGTTCTCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.55594101981	35.9234095301046	0.0156218898132886	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2293.24128344559	2293.24128344559
"healthy-1"	"2019-08-01-count-3:TCGCACTTCGTTCCTG"	1.19429554519002	9.45113275134889	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTTCGTTCCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1779.29144492457	37.7091310235459	0.0211933413894116	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1765.69713721793	1765.69713721793
"healthy-1"	"2019-08-01-count-3:ATGTCCCCACAGCGCT"	8.44265904006306	6.96144149387208	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCCACAGCGCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.00128234994	36.3447961369568	0.019487812947325	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1856.20684869792	1856.20684869792
"healthy-1"	"2019-08-01-count-3:CATCCCACAAGACAAT"	-3.73008141937907	-5.54094746029051	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCACAAGACAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2482.47510816523	39.9230616803766	0.0160819585054705	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2478.44416775892	2478.44416775892
"healthy-1"	"2019-08-01-count-2:CCACTTGTCAAAGGAT"	1.23266341265981	10.6856155165466	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGTCAAAGGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.86960989003	30.5877917032612	0.0161937020655661	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1882.37563212797	1882.37563212797
"healthy-1"	"2019-08-01-count-2:GGAATCTCATTCTCCG"	1.35777785357777	9.72994992816774	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTCATTCTCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.20478514378	42.119493872886	0.0225816994511083	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1856.24310296087	1856.24310296087
"healthy-1"	"2019-08-01-count-3:GAGTTACGTTTAGTCG"	-4.12709603729899	-5.24651768123778	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTACGTTTAGTCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3002.08089871768	40.7224054677625	0.0135647262154584	2995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2997.0873543131	2997.0873543131
"healthy-1"	"2019-08-01-count-2:TTTGGTTAGGTTCACT"	10.7152401405269	4.28566882694093	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGTTAGGTTCACT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1683.60073342676	33.8089355076082	0.0200813261935295	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1673.84986725735	1673.84986725735
"healthy-1"	"2019-08-01-count-2:TTGGGATAGCGTATAA"	-4.70879540863689	-5.31403877651366	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATAGCGTATAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2271.94338845128	44.8597703932815	0.0197451092405349	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2268.12782534996	2268.12782534996
"healthy-1"	"2019-08-01-count-3:CTGCCTAGTAGATTAG"	-1.53807220879253	12.7997131117615	"2019-08-01-count-3"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTAGTAGATTAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2044.29871044214	44.9407854305459	0.0219834729636092	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2039.84969207451	2039.84969207451
"healthy-1"	"2019-08-01-count-1:TGGTAGTAGACTCGAG"	1.2392027574474	10.7267856367859	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGTAGTAGACTCGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.51369611491	33.2901738854654	0.0177593655114188	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1866.68370506107	1866.68370506107
"healthy-1"	"2019-08-01-count-4:TTGCATTTCCATAGGT"	2.65472068366353	-10.5638237229553	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTTCCATAGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.9748225965	40.2730245620242	0.0173368321388043	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2319.14682651277	2319.14682651277
"healthy-1"	"2019-08-01-count-1:TGGGCGTGTCGAGTTT"	1.1898191171581	10.6202239760193	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGGCGTGTCGAGTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.56723008143	35.6888837109346	0.0191714181117023	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1850.46045054493	1850.46045054493
"healthy-1"	"2019-08-01-count-3:CTGCGAGAGGTTGGAC"	1.96892048892323	-10.4965496293274	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGAGGTTGGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.45285719559	38.2517549148665	0.0168476323098442	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2265.39031824384	2265.39031824384
"healthy-1"	"2019-08-01-count-4:GTGACGCAGTCAAGCG"	-5.3052319091862	3.51809928500978	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGACGCAGTCAAGCG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2465.90848122994	44.9432522633351	0.0182258395254468	2803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2461.82142129866	2461.82142129866
"healthy-1"	"2019-08-01-count-1:TGTTTGTTCGAACCTA"	1.14175107058827	10.2609939345154	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGTTTGTTCGAACCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1790.65806075305	34.2548561223735	0.0191297584241001	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1787.29953799137	1787.29953799137
"healthy-1"	"2019-08-01-count-3:GTGCTGGAGATAGCTA"	0.504981150000733	-8.05404188549193	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGAGATAGCTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2353.46374149296	46.6654367465536	0.0198284069237245	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2351.39211136405	2351.39211136405
"healthy-1"	"2019-08-01-count-2:TTACGTTAGTTGTAAG"	1.98929121074025	-10.3132629624573	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTAGTTGTAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.23163918284	38.8629975382791	0.0160112438017505	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2422.94054737927	2422.94054737927
"healthy-1"	"2019-08-01-count-3:ATTACTCAGGCGTCCT"	-7.62321553650554	2.83371636951295	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCAGGCGTCCT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2469.9414326768	46.5804904003842	0.0188589453110646	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2460.75079780338	2460.75079780338
"healthy-1"	"2019-08-01-count-1:TTAGGCAGTTCTCTAT"	1.56696035441701	9.72635934436647	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTAGGCAGTTCTCTAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1976.82149371866	31.3448269303592	0.0158561746874755	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1967.65935627479	1967.65935627479
"healthy-1"	"2019-08-01-count-4:TTGCTGCAGACTCGAG"	1.97361805018727	-9.99462892925414	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCAGACTCGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.55385265513	42.2771418792777	0.0182974059793914	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2308.44624252817	2308.44624252817
"healthy-1"	"2019-08-01-count-4:TATACCTGTCGCGGTT"	1.56007721003835	-9.14713194286498	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTGTCGCGGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.30371086873	41.6110825188718	0.0174887646031867	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2378.83015446667	2378.83015446667
"healthy-1"	"2019-08-01-count-3:GATAGCTCACAGCCTG"	1.91854943808858	-10.3291120759216	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTCACAGCCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.77100700023	43.3350542993298	0.0193739341951893	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2231.21959772517	2231.21959772517
"healthy-1"	"2019-08-01-count-2:GTCCCATAGTGGTTCT"	6.97020735320393	-1.1136228076187	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATAGTGGTTCT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2300.82502925116	45.3797906670224	0.019723268866643	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2295.21725358599	2295.21725358599
"healthy-1"	"2019-08-01-count-3:AAACGCTTCCGCATAA"	1.22641124305074	9.92264649951784	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTTCCGCATAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.43434260612	36.6669570493812	0.0208401962843747	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1752.43982411332	1752.43982411332
"healthy-1"	"2019-08-01-count-1:TTGTTTGAGACGCTCC"	8.01426996764485	8.09998223865358	"2019-08-01-count-1"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTGTTTGAGACGCTCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2178.96550180893	37.659717908214	0.0172833015836872	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2166.94003774938	2166.94003774938
"healthy-1"	"2019-08-01-count-3:TGTCCACTCGCACTCT"	1.05825473841969	11.7442121275696	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCACTCGCACTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1941.54406248498	34.3634430891167	0.0176990281874597	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1939.04975882672	1939.04975882672
"healthy-1"	"2019-08-01-count-1:TTCTTCCGTCTTGTCC"	0.633572359650773	11.4489621886047	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCTTCCGTCTTGTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.53033614379	36.0842395145827	0.0190666637281533	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1885.89619144345	1885.89619144345
"healthy-1"	"2019-08-01-count-4:GGCACGTGTTAGTTCG"	0.314465274184388	12.3952655562195	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCACGTGTTAGTTCG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1669.08471843808	34.701796076977	0.0207909135429931	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1659.8876261588	1659.8876261588
"healthy-1"	"2019-08-01-count-4:TTGGATGGTACCTTCC"	1.81660391864125	-10.4122266999451	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGATGGTACCTTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.27130874723	39.1061005179719	0.0160846304471557	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2427.22129499373	2427.22129499373
"healthy-1"	"2019-08-01-count-4:TCGGGACAGTTTGCTG"	1.95321251925771	-10.0113163224426	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACAGTTTGCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.44698696706	41.4190357204574	0.017465722804721	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.97781242643	2366.97781242643
"healthy-1"	"2019-08-01-count-1:TTTATGCCAACAAGAT"	1.86707903918568	-10.5042972794739	"2019-08-01-count-1"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTTATGCCAACAAGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2515.27950370861	38.3361587723074	0.0152413116378451	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2508.8767371026	2508.8767371026
"healthy-1"	"2019-08-01-count-2:ATCTCTAAGAATCGAT"	14.1171881156856	1.66928694331972	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTAAGAATCGAT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1409.93769579189	36.9745638683233	0.0262242537231808	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1391.70157289902	1391.70157289902
"healthy-1"	"2019-08-01-count-3:AAAGGATGTATCGCTA"	2.05085207995717	-10.5735264054504	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATGTATCGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.17519017423	43.0609632126428	0.0178663208335199	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.83957922131	2405.83957922131
"healthy-1"	"2019-08-01-count-2:TCCACGTCACCCAAGC"	1.18405296382253	11.8442458876404	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACGTCACCCAAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.2200766721	34.6580010578716	0.0177622204036474	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1943.09379611924	1943.09379611924
"healthy-1"	"2019-08-01-count-4:GGCGTCACAATGTGGG"	2.19911613044087	-10.8013248673645	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCGTCACAATGTGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.70839403022	48.2023884375481	0.022412331012119	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2139.97753354211	2139.97753354211
"healthy-1"	"2019-08-01-count-4:TATCGCCAGCAAGCCA"	2.56944908675496	-10.7436647645203	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCGCCAGCAAGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.05054688418	39.1487155852715	0.0163525016780548	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2386.61842037211	2386.61842037211
"healthy-1"	"2019-08-01-count-2:AAACGAATCCTCAGAA"	8.0594879585201	8.46319673145143	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGAATCCTCAGAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.65405393796	45.1029432595755	0.0222110423841567	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2022.92041090156	2022.92041090156
"healthy-1"	"2019-08-01-count-3:GTGGAGAAGAATAACC"	2.87694706496541	-10.3965645066467	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAGAAGAATAACC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.20996711534	40.5734061692617	0.0179352963513811	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2257.42540013361	2257.42540013361
"healthy-1"	"2019-08-01-count-2:GGAGGATGTAGACAGC"	-1.37956128540691	13.3112306364807	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATGTAGACAGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1842.0505630342	41.7403717345896	0.0226597318077064	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1837.95992351117	1837.95992351117
"healthy-1"	"2019-08-01-count-2:GGAGGATGTGCTGTCG"	-9.14605746689494	1.98697934234468	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATGTGCTGTCG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2416.36976662544	44.1760394523701	0.0182819864999651	2861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2403.20831945825	2403.20831945825
"healthy-1"	"2019-08-01-count-3:GATCGTAGTAGTGTGG"	1.50238015231435	10.8432559737	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAGTAGTGTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.6829699922	35.1406086647607	0.0199812071102938	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1757.37136459245	1757.37136459245
"healthy-1"	"2019-08-01-count-3:ACGGAAGCAAGAGTTA"	1.9702818590099	-9.86803343212279	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGAAGCAAGAGTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.74661074989	42.9732667432877	0.018280688589222	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2342.72888804565	2342.72888804565
"healthy-1"	"2019-08-01-count-2:GGAGGTACACGCAAAG"	0.985885043709916	9.60678384387819	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTACACGCAAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1702.75305943944	39.1536455659065	0.0229943181419368	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1696.31268634494	1696.31268634494
"healthy-1"	"2019-08-01-count-2:AAACGCTTCGCCAATA"	8.33342327651326	7.55027721011964	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTTCGCCAATA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.20940827762	40.1144119636617	0.0197199028774657	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2029.46279600168	2029.46279600168
"healthy-1"	"2019-08-01-count-4:GGCTTTCGTTATGACC"	1.96446897563283	-10.306908630487	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTTCGTTATGACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.35847912634	40.1711287408729	0.0161371409854041	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2486.96130923229	2486.96130923229
"healthy-1"	"2019-08-01-count-4:AAACCCAAGCTCTTCC"	1.3809400993282	-9.09054186260375	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCAAGCTCTTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.6821960847	43.8695966906523	0.0171924218297897	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2547.74233036109	2547.74233036109
"healthy-1"	"2019-08-01-count-4:CGAATTGAGCCTCATA"	-2.15028844299968	9.99139688098756	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAATTGAGCCTCATA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2482.70392995259	37.4237866877592	0.0150738016870477	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2476.03933112556	2476.03933112556
"healthy-1"	"2019-08-01-count-3:CTGTATTGTTCCCAAA"	1.80195929583852	-9.73712351238402	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTATTGTTCCCAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.72008155832	44.5134258731131	0.0192972811174565	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2304.07967115974	2304.07967115974
"healthy-1"	"2019-08-01-count-4:ACCTGAACAAGAGTTA"	1.84504248675649	-9.73704531109007	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAACAAGAGTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.07039632665	34.9231733562719	0.0157235778812009	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2220.00395138319	2220.00395138319
"healthy-1"	"2019-08-01-count-2:AAACGCTTCGTGACTA"	-6.06197438660319	-5.01565649425658	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTTCGTGACTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2620.34285877976	46.1830101366137	0.0176247966871481	2649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2616.72887671119	2616.72887671119
"healthy-1"	"2019-08-01-count-2:TCCCACAGTAATCAAG"	-3.90357480469401	-5.40152981197508	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCACAGTAATCAAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2636.28980912202	38.8828146839582	0.0147490668701965	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2634.90224078982	2634.90224078982
"healthy-1"	"2019-08-01-count-3:CTGTCGTCACACCTAA"	2.46164526519124	-9.64614775097045	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTCGTCACACCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.53122080071	45.7625704415858	0.0204614047038441	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2233.1247842185	2233.1247842185
"healthy-1"	"2019-08-01-count-2:GGATCTAGTCGATTTG"	2.61235847052876	-10.5286913148132	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTAGTCGATTTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.98410725461	46.5412239002514	0.0187743131406334	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2473.98758344348	2473.98758344348
"healthy-1"	"2019-08-01-count-2:CGTGAATGTATACAGA"	2.09790911254231	-10.5595264664856	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATGTATACAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.54563032989	42.6660923474016	0.0183704000430517	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2317.05859631743	2317.05859631743
"healthy-1"	"2019-08-01-count-4:AAACGCTAGGTACATA"	1.8747624355251	-10.1344394913879	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGCTAGGTACATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.01450028634	37.7544598063126	0.0154036052426054	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2448.48664378065	2448.48664378065
"healthy-1"	"2019-08-01-count-2:GGATCTATCAGACTGT"	6.86579145964925	-0.933811508771502	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTATCAGACTGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2049.08304397794	44.0352957677503	0.0214902445741113	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2035.25239276707	2035.25239276707
"healthy-1"	"2019-08-01-count-2:GATAGCTTCTGTTGGA"	1.75581445273702	-9.99910547649535	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGCTTCTGTTGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.23331378811	40.9046352723249	0.0185910444206028	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2197.64762108161	2197.64762108161
"healthy-1"	"2019-08-01-count-2:TGATTCTTCTATCGCC"	1.90950920161549	-10.4747963181702	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTCTTCTATCGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.94579676198	38.8965371922806	0.0156844303787071	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2478.17270374173	2478.17270374173
"healthy-1"	"2019-08-01-count-4:TGCCGAGTCGACATAC"	1.86586310443227	-10.3440408936706	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCCGAGTCGACATAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.58745104572	37.9038781088661	0.0184753899179613	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2041.25251010768	2041.25251010768
"healthy-1"	"2019-08-01-count-1:TAACGACAGGTAAGAG"	7.8737641769344	7.09851119602052	"2019-08-01-count-1"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAACGACAGGTAAGAG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1637.60061568234	35.6430277205096	0.021765397117696	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1633.59616739536	1633.59616739536
"healthy-1"	"2019-08-01-count-2:TGATTTCCACAAGGTG"	1.36963500556294	9.77270219409791	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCCACAAGGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1573.90907542611	35.8609344191909	0.0227846290355001	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1569.55246333532	1569.55246333532
"healthy-1"	"2019-08-01-count-3:GATGTTGAGAGAGCGG"	6.99173941191976	-1.18297269260558	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGTTGAGAGAGCGG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2344.69547757395	42.3718141027552	0.0180713506329603	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2335.6461346733	2335.6461346733
"healthy-1"	"2019-08-01-count-2:CTGTGGGTCCCATAAG"	-4.04675898972209	-5.14195206081542	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGGGTCCCATAAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2752.75517508889	42.7878434321743	0.0155436428998059	2920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2748.23271289118	2748.23271289118
"healthy-1"	"2019-08-01-count-3:AACAAGACATAAGATG"	-7.7432259124821	1.99510238254396	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAGACATAAGATG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2420.86813314443	42.4304685713698	0.0175269639805856	3004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2414.61125377937	2414.61125377937
"healthy-1"	"2019-08-01-count-2:AGGAAATAGAGGTCGT"	1.69802250441853	-4.79918243801268	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATAGAGGTCGT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2244.48029314225	41.7292035146007	0.0185919224339369	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2239.05728079471	2239.05728079471
"healthy-1"	"2019-08-01-count-2:TTCAATCGTAGCTGAG"	-0.126917789608794	12.9741315611633	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCGTAGCTGAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1797.83396512432	43.8675421931598	0.024400218843416	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1792.77043530024	1792.77043530024
"healthy-1"	"2019-08-01-count-3:GATTCTTAGTGGCCTC"	7.01378359374349	-1.06515326416167	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTAGTGGCCTC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2414.22936336226	32.0903614157014	0.0132921759227589	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2406.98266691369	2406.98266691369
"healthy-1"	"2019-08-01-count-2:GATCATGCACATACTG"	11.0351101356441	3.97071287715761	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGCACATACTG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.10559477471	34.7389362544278	0.0183793626929973	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1883.15513491115	1883.15513491115
"healthy-1"	"2019-08-01-count-4:ACGCACGTCAAGCCGC"	3.03503527221028	-10.5109215012756	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGTCAAGCCGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.04483297919	38.6703279091835	0.0158612045956226	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2434.7194934875	2434.7194934875
"healthy-1"	"2019-08-01-count-3:TGTTCCGGTATGAGCG"	11.1724134880001	3.91516659343568	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGGTATGAGCG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1707.8111756159	36.847256667958	0.0215757205445558	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1701.40200649245	1701.40200649245
"healthy-1"	"2019-08-01-count-2:AAAGGTAGTTGGGCCT"	3.35471286353413	-10.6852236024109	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGTAGTTGGGCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.83957334485	42.3981593140808	0.0170764795958857	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2480.45540226041	2480.45540226041
"healthy-1"	"2019-08-01-count-2:TTCAGGAAGTGCGCTC"	1.26305796679799	9.39081475818483	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGAAGTGCGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.68145493628	37.5006666545998	0.021756146733032	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1713.12147664656	1713.12147664656
"healthy-1"	"2019-08-01-count-2:CTTCAATTCCAGTTCC"	-7.72263179245647	0.16051603788463	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATTCCAGTTCC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3057.97374489232	38.2943188097689	0.0125227755384529	4569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3050.08117092439	3050.08117092439
"healthy-1"	"2019-08-01-count-4:AGGGTTTTCGACATTG"	2.10770287093465	-10.3101825944153	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTTTTCGACATTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.40989971039	42.0459806338815	0.0195981106638677	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2140.58408038276	2140.58408038276
"healthy-1"	"2019-08-01-count-2:GGCGTCAGTGGGCTTC"	1.51367475566213	-9.77033331310423	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCAGTGGGCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.02457122283	50.0100798065686	0.0220597872830258	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2265.35784129464	2265.35784129464
"healthy-1"	"2019-08-01-count-3:TTCCTAAGTCCGCAGT"	1.57864167270009	-9.57061293041381	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAAGTCCGCAGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2378.6859473843	40.5624961867844	0.0170524806906051	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2375.70082519368	2375.70082519368
"healthy-1"	"2019-08-01-count-3:GCCATGGCAGCAATTC"	11.0722156959469	3.92112968051759	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGCAGCAATTC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.31493052731	32.2642735474141	0.017474956744351	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1843.01275649176	1843.01275649176
"healthy-1"	"2019-08-01-count-3:CCGCAAGCACATGGTT"	8.49203266677205	7.88238093936769	"2019-08-01-count-3"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGCAAGCACATGGTT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2078.92659945846	44.5797751200095	0.021443650358614	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2075.56203893469	2075.56203893469
"healthy-1"	"2019-08-01-count-4:CCTCAGTAGTACTGTC"	2.10043658789937	-10.4028835526672	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTAGTACTGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.24538135118	39.647131968425	0.0159916127167765	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2475.80161330072	2475.80161330072
"healthy-1"	"2019-08-01-count-3:AACCAACGTGCAACAG"	1.78687765178029	-4.97429182445677	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACGTGCAACAG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2541.98620991585	39.5718304296562	0.015567287609702	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2537.95090179145	2537.95090179145
"healthy-1"	"2019-08-01-count-3:TGTTCTAGTGTTGATC"	0.279672597616357	13.3541717299256	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCTAGTGTTGATC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.45218796979	44.4621968306151	0.0234449342370256	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1889.42507123979	1889.42507123979
"healthy-1"	"2019-08-01-count-3:AACCACACAGCGAACA"	2.67171325263326	-10.6326952210632	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCACACAGCGAACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.50343508372	40.6032783375191	0.0172449433424061	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.24836383029	2349.24836383029
"healthy-1"	"2019-08-01-count-2:AACAAAGAGCAAACAT"	8.06437363204305	6.9381441839966	"2019-08-01-count-2"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGAGCAAACAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.98785431483	41.4713745555934	0.0214767661344553	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1926.00031140527	1926.00031140527
"healthy-1"	"2019-08-01-count-4:CGATGCGGTTTACACG"	1.76510657843892	-10.3699150315491	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGCGGTTTACACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.763509598	37.0944164286287	0.0151916499213865	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2436.40600401431	2436.40600401431
"healthy-1"	"2019-08-01-count-3:TCAATTCAGTAAATGC"	1.31133272227589	9.53795240009157	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCAGTAAATGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.48550978424	35.5138365662081	0.0205106172506367	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1730.2844446609	1730.2844446609
"healthy-1"	"2019-08-01-count-4:TGTCCACAGAGAATCT"	2.01324774798695	-10.1954260102478	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCACAGAGAATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.58687688441	43.0596064204757	0.0177668920520935	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2421.08520166201	2421.08520166201
"healthy-1"	"2019-08-01-count-2:GGCTTTCGTTACACTG"	0.751523871987504	9.91909501636354	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCGTTACACTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.84378668533	37.3771650485667	0.0210357068689156	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1771.96753570375	1771.96753570375
"healthy-1"	"2019-08-01-count-3:AACCATGCAGAGTGTG"	1.10184146937672	10.8023690947327	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGCAGAGTGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.09626450612	33.5451947433764	0.018961769020942	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1764.50602762807	1764.50602762807
"healthy-1"	"2019-08-01-count-2:CTTCCTTAGTTGCTCA"	10.6175953346187	4.37531278217164	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTAGTTGCTCA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1705.31130044743	19.9760628842774	0.0117140271568225	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1698.94901575777	1698.94901575777
"healthy-1"	"2019-08-01-count-3:TCACAAGAGAGGCGGA"	2.60987271842305	-10.3226375809875	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACAAGAGAGGCGGA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.55980244931	39.9855186128585	0.0171423337446147	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.15470599366	2330.15470599366
"healthy-1"	"2019-08-01-count-3:CCACCATTCACTTATC"	1.30847730216328	11.4578418501648	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACCATTCACTTATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2132.29485940684	41.0510122843899	0.0192520336028055	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2121.51488706404	2121.51488706404
"healthy-1"	"2019-08-01-count-2:GATGATCTCGGAAACG"	2.25931157645528	-10.7432880631653	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGATCTCGGAAACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.92906972546	40.804835929982	0.0174161635779966	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2335.75029615367	2335.75029615367
"healthy-1"	"2019-08-01-count-4:TTTAGTCTCGTCTAAG"	-6.95675597611125	0.142168819251932	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	62	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTAGTCTCGTCTAAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2389.48143200956	40.1278656241516	0.0167935456984924	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2383.51359095638	2383.51359095638
"healthy-1"	"2019-08-01-count-2:CTTCCTTCATGCCGGT"	-2.89401398125346	-5.82110550319823	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTCATGCCGGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2602.15595944942	44.5307109138233	0.0171130061409714	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2598.86974785478	2598.86974785478
"healthy-1"	"2019-08-01-count-4:ACGTAACAGCACCAGA"	-4.33482871475871	-5.36187889492186	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACAGCACCAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2472.57392478558	45.72355153553	0.0184922889775662	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2469.54196835879	2469.54196835879
"healthy-1"	"2019-08-01-count-2:TCCTCCCGTACAAACA"	7.66300072249715	6.74358222568361	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCGTACAAACA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.50907837773	39.9073219457433	0.0207040902652095	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1918.74262983564	1918.74262983564
"healthy-1"	"2019-08-01-count-2:ACGATGTTCCATCTGC"	8.24844326552693	7.43909356677858	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTTCCATCTGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.23000229945	32.2208955779695	0.0184516905193135	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1738.83985916816	1738.83985916816
"healthy-1"	"2019-08-01-count-4:AGTACCAGTGTGGACA"	-0.375099430710632	13.5926437147888	"2019-08-01-count-4"	"Control1"	"NK"	"CD56bright NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCAGTGTGGACA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1761.9820676506	38.3715837313	0.0217775109269212	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1756.42097372004	1756.42097372004
"healthy-1"	"2019-08-01-count-3:TTAATCCGTGCTATTG"	10.7594076591427	4.44571063602296	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAATCCGTGCTATTG"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.8469206658	22.6810377614577	0.0125320199749898	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1801.53129156684	1801.53129156684
"healthy-1"	"2019-08-01-count-3:CCACGTTGTGTTAGCT"	3.1236478286678	-10.430148147699	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGTTGTGTTAGCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.34936111866	42.4496915439773	0.0182238406365935	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2319.12049172346	2319.12049172346
"healthy-1"	"2019-08-01-count-3:CTTCGGTTCTCCGTGT"	-3.58209596100505	-5.66797497188719	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTTCTCCGTGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2475.09492823235	40.0508996437994	0.0161815610330561	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2471.69574746509	2471.69574746509
"healthy-1"	"2019-08-01-count-2:AACAGGGCACACCGCA"	14.1746555763179	1.80149588668672	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGCACACCGCA"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1166.64887085003	29.0400450077931	0.0248918468387445	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1149.39419195892	1149.39419195892
"healthy-1"	"2019-08-01-count-2:TGCCGAGTCGCGGTAC"	1.97342803057973	-9.66063120281371	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGTCGCGGTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.92597458725	38.9992969452695	0.0178492532007345	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2184.92597458725	2184.92597458725
"healthy-1"	"2019-08-01-count-2:CTTCTCTAGCCGATTT"	-7.83525071564372	3.49250314319459	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTCTAGCCGATTT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2458.03053130201	42.1996966114851	0.0171680929402989	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2453.71332781061	2453.71332781061
"healthy-1"	"2019-08-01-count-2:CCGTGAGAGGGACCAT"	-0.864257733256179	13.6071004637512	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGAGGGACCAT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1803.93926413117	47.014362749947	0.0260620541305145	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1802.02400568147	1802.02400568147
"healthy-1"	"2019-08-01-count-4:TCTCCGAGTGGCGTAA"	4.37299694594685	-10.6178102723328	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGAGTGGCGTAA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.46160644965	48.1341588351675	0.0219543907603989	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2192.46160644965	2192.46160644965
"healthy-1"	"2019-08-01-count-2:CTTGATTAGAGTACCG"	2.26312007483785	-10.6726894608703	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGATTAGAGTACCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.97889836472	40.1652912182081	0.016638625650546	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2408.86531181895	2408.86531181895
"healthy-1"	"2019-08-01-count-2:AACAGGGGTTTGTTCT"	-0.701957563788253	13.5705537565979	"2019-08-01-count-2"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGGTTTGTTCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2237.01743219953	42.1747974394695	0.0188531375895455	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2231.41310862871	2231.41310862871
"healthy-1"	"2019-08-01-count-4:CGCATGGTCGGATACT"	1.5642235475475	-9.95755960857543	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGTCGGATACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.7155678708	39.2576332873745	0.0167501696133882	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2340.44725115319	2340.44725115319
"healthy-1"	"2019-08-01-count-4:TTTCAGTTCGAACGCC"	3.39322342452351	-10.42960264599	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTTCGAACGCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1969.85036735125	27.7472518807075	0.0140859693409189	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1962.0021082008	1962.0021082008
"healthy-1"	"2019-08-01-count-4:TCACACCTCATTGCGA"	1.89917399463002	-10.1395521393982	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACACCTCATTGCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.07553014819	42.4411282897451	0.0181444026679448	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.13000029659	2337.13000029659
"healthy-1"	"2019-08-01-count-4:TCACACCCAATTGTGC"	1.60250510749165	-9.83552076732787	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACACCCAATTGTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.98546307409	40.0619871628781	0.0155944779519847	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2567.2398845384	2567.2398845384
"healthy-1"	"2019-08-01-count-2:AACCAACCAGGCTACC"	2.48598422583882	-10.6592588654724	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCAACCAGGCTACC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.34257263304	40.7865298037103	0.0157699642094154	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2581.85835634947	2581.85835634947
"healthy-1"	"2019-08-01-count-2:ATGGTTGTCGTTCTCG"	1.16029419478719	9.32040021503297	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGTTGTCGTTCTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1584.07692777465	36.9419327789293	0.0233207946730379	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1582.83204770915	1582.83204770915
"healthy-1"	"2019-08-01-count-4:TCTCTGGCAGTGTATC"	-3.38026605072673	-5.69126274501952	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCTGGCAGTGTATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2250.91525055102	42.4214286508086	0.0188463020277746	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2242.5290505253	2242.5290505253
"healthy-1"	"2019-08-01-count-3:AGTGCCGGTTGCTCCT"	2.44926275786702	-10.6110849610535	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGGTTGCTCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.47612143649	37.8502704169436	0.0146000459190231	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2589.93023854958	2589.93023854958
"healthy-1"	"2019-08-01-count-2:AAGTGAAGTGCCGTAC"	4.52086081084554	-10.694703125116	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAAGTGCCGTAC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.49864510043	43.9359732127545	0.0188445201566317	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2326.93956133492	2326.93956133492
"healthy-1"	"2019-08-01-count-3:GGGTTTATCGCTCTAC"	10.9948603111202	3.98741362178651	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTTTATCGCTCTAC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1720.11398406947	40.8334328799106	0.0237387947880676	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1716.18285489163	1716.18285489163
"healthy-1"	"2019-08-01-count-2:GGGATGAAGGCTCAAG"	-3.24383674088176	-5.42868235027465	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATGAAGGCTCAAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2615.60447664929	43.6770032265494	0.016698626882036	2752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2613.91185506402	2613.91185506402
"healthy-1"	"2019-08-01-count-2:AACCATGCATAATGAG"	-7.85236154022868	1.5867789753708	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGCATAATGAG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2737.04778427744	41.6000079089882	0.0151988606658434	3646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2727.69380724413	2727.69380724413
"healthy-1"	"2019-08-01-count-4:TCGACGGAGGGTGGGA"	0.637816389172715	-7.9021001092163	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACGGAGGGTGGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2220.0528996012	41.649433295582	0.018760558950223	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2218.90582754499	2218.90582754499
"healthy-1"	"2019-08-01-count-3:GTTGCTCAGTTGCGCC"	1.77981903132741	-10.2215814820495	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCTCAGTTGCGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.97036577342	41.0682019048727	0.0178017899640876	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2305.11779757073	2305.11779757073
"healthy-1"	"2019-08-01-count-4:TCTGGCTCAACGATCT"	3.08499302443807	-10.4475984803406	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTCAACGATCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.53841865509	43.8499841630297	0.0179159533631039	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2444.19901630449	2444.19901630449
"healthy-1"	"2019-08-01-count-3:CAAGACTGTAGTAAGT"	1.59110059317891	-9.91142179882201	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTGTAGTAAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.01654351463	42.6460531211573	0.0178284942204023	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2385.99424733504	2385.99424733504
"healthy-1"	"2019-08-01-count-4:CAACCTCTCGCTGATA"	1.96204080161397	-10.2486791840759	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCTCGCTGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.89466418729	44.8565530990808	0.0182797386349658	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2452.26792755193	2452.26792755193
"healthy-1"	"2019-08-01-count-4:GATGTTGTCTTACACT"	-1.63582621040996	11.8833780058655	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGTTGTCTTACACT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.12855862802	46.3841088649593	0.0231673978501882	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1998.86540372121	1998.86540372121
"healthy-1"	"2019-08-01-count-3:TGAACGTTCAAGAAAC"	1.70529367503468	-9.8780088654724	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAACGTTCAAGAAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.73875800336	47.4152004965977	0.0201703402112068	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2346.85677347868	2346.85677347868
"healthy-1"	"2019-08-01-count-2:TCCTTTCCACACCTTC"	1.50319768962209	-9.75588705455931	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCCACACCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.40250770759	40.7549010845267	0.0166048156146123	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2447.55657379983	2447.55657379983
"healthy-1"	"2019-08-01-count-3:GTGCAGCCAAAGCTAA"	2.30231918868367	-10.6333513489929	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCCAAAGCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.13865105288	40.2369893784747	0.0175543435646845	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2285.27346476718	2285.27346476718
"healthy-1"	"2019-08-01-count-4:CTCCACATCCCATACC"	2.08772697028462	-10.4714641801086	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACATCCCATACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.04290662912	40.1761595183541	0.0164115422199342	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2446.16448697223	2446.16448697223
"healthy-1"	"2019-08-01-count-4:GGGTGTCGTATACCCA"	-3.4021135372227	-5.29896404659423	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGTCGTATACCCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2682.99719229508	38.8639490881346	0.0144852738570664	2864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2679.15529642451	2679.15529642451
"healthy-1"	"2019-08-01-count-3:CCCAACTGTTCCTTGC"	2.15109266814534	-10.5044260255066	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTGTTCCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.27649411804	41.5717291734752	0.0165408498709823	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2509.03457732003	2509.03457732003
"healthy-1"	"2019-08-01-count-4:CAACGGCGTATCTCTT"	2.67802347716634	-10.2699003449646	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCGTATCTCTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.63664783344	44.3780018129842	0.0192226012935518	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2306.21323708653	2306.21323708653
"healthy-1"	"2019-08-01-count-2:ACGTAACTCCGACGGT"	-1.82550869408305	12.9751033552918	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCCGACGGT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1816.37744946767	42.7808478249969	0.0235528402081488	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1810.54407315194	1810.54407315194
"healthy-1"	"2019-08-01-count-2:TATCGCCGTACTAGCT"	2.06019463118855	-10.4250440827576	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCGTACTAGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.73823397508	41.7735072279527	0.0171502449012262	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.31777724893	2432.31777724893
"healthy-1"	"2019-08-01-count-4:CGGGACTGTCTCAGGC"	1.20676781710927	11.3307027586731	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTGTCTCAGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.9683668444	38.4249247227187	0.0199717029577474	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1917.46179029788	1917.46179029788
"healthy-1"	"2019-08-01-count-3:GCATCGGGTGCCGTTG"	3.59761251982991	-11.0698795548645	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCGGGTGCCGTTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.93812523348	39.8805310319401	0.0171607542382108	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2317.57761986903	2317.57761986903
"healthy-1"	"2019-08-01-count-4:CAAGACTTCCTTCGAC"	0.578683813183945	10.4448423155579	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTTCCTTCGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2454.86838546138	39.2117605883686	0.0159730602343469	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2444.04714201931	2444.04714201931
"healthy-1"	"2019-08-01-count-3:TGACCCTAGTCCCAGC"	1.12189378318135	11.6656961210999	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTAGTCCCAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.53658544363	34.7547352509327	0.0177090890986251	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1957.60298099599	1957.60298099599
"healthy-1"	"2019-08-01-count-3:TTAGGCACATGGAGAC"	3.15584435042683	-10.6490879288879	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCACATGGAGAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.4276133044	42.3041087575528	0.0181140740635916	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.03060881143	2330.03060881143
"healthy-1"	"2019-08-01-count-4:TTTGATCGTCCACGCA"	1.95647563514058	-8.78754808818968	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCGTCCACGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.57541475108	41.1079085782906	0.0183880661359249	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2228.85716270663	2228.85716270663
"healthy-1"	"2019-08-01-count-2:CCTCAACAGCAGCGAT"	6.70545925673787	-1.02930345451506	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACAGCAGCGAT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2568.48074775985	42.1432108615817	0.0164078359934517	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2562.74094078917	2562.74094078917
"healthy-1"	"2019-08-01-count-4:AGTGACTAGGATTTCC"	1.43299367007558	10.3769569166931	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTAGGATTTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1814.87149799462	38.8713109024705	0.0214182166315478	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1807.10249787051	1807.10249787051
"healthy-1"	"2019-08-01-count-3:TTAGTCTAGAAGGCTC"	13.9048735099727	1.63777062976686	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGTCTAGAAGGCTC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1605.13122579869	36.4275599746017	0.0226944435377711	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1590.6049334246	1590.6049334246
"healthy-1"	"2019-08-01-count-4:GCAACATGTTATGGTC"	1.47029079970662	-8.7120514146057	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACATGTTATGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.52048115026	40.0415113873621	0.0169773854869531	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.51437447059	2357.51437447059
"healthy-1"	"2019-08-01-count-4:TCTTCCTAGGATTCCT"	1.0841803747112	9.28778550708619	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTCCTAGGATTCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1695.58110413418	39.6493406231247	0.0233839245592271	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1688.99915733302	1688.99915733302
"healthy-1"	"2019-08-01-count-2:GGGTCACTCTGCAGCG"	-7.16044841232951	0.420377410295881	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	62	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACTCTGCAGCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2516.99101964319	40.9495397626875	0.0162692434907823	2893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2511.040383633	2511.040383633
"healthy-1"	"2019-08-01-count-3:CTAAGTGCATGGATCT"	2.61380137976949	-10.5947637788025	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAAGTGCATGGATCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.42486143205	41.7575432382219	0.0164891538833688	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2524.42799073944	2524.42799073944
"healthy-1"	"2019-08-01-count-4:CTTCAATCAGTGAGCA"	-0.710075120360214	13.7493619688782	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATCAGTGAGCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1741.86881731486	47.8015381798968	0.0274426740433784	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1739.7643482964	1739.7643482964
"healthy-1"	"2019-08-01-count-2:AACGTCAGTTGGAGAC"	-1.60859201374705	13.266912437323	"2019-08-01-count-2"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCAGTTGGAGAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2234.2359224589	42.8036036013096	0.01915805003896	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2228.4269499602	2228.4269499602
"healthy-1"	"2019-08-01-count-2:GGGTCTGAGAGGCTGT"	6.98016657409017	-1.16807701503905	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGAGAGGCTGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2251.24140311033	45.3709942809765	0.0201537668142971	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2236.65980710541	2236.65980710541
"healthy-1"	"2019-08-01-count-3:GAACGTTCATCGCTCT"	2.01203419741933	-10.3925791016785	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACGTTCATCGCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.90431418474	41.4014480998433	0.0168373563220861	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2454.23821505174	2454.23821505174
"healthy-1"	"2019-08-01-count-4:AGTGTTGCAGCGCGTT"	-2.55689559403117	3.30309007251588	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-7"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGTTGCAGCGCGTT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3164.06067802518	26.0610080272048	0.00823657024285341	5073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3158.78798371158	3158.78798371158
"healthy-1"	"2019-08-01-count-2:TGGAACTTCTACCTTA"	1.31195988234822	11.3036803969177	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTTCTACCTTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.92127142918	38.2109980532568	0.0199023775723953	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1913.96228286991	1913.96228286991
"healthy-1"	"2019-08-01-count-4:GGTCACGTCTACGCGG"	2.06128229674641	-10.5509453049866	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGTCTACGCGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.58747533091	39.6613130958817	0.016072910683972	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2461.22825762093	2461.22825762093
"healthy-1"	"2019-08-01-count-3:CCCTCAAAGACCGCCT"	4.25008501586263	-10.7926130524841	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAAGACCGCCT"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.2950058923	45.6547754422028	0.0181508631533289	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2510.58780647348	2510.58780647348
"healthy-1"	"2019-08-01-count-3:CAATGACGTCTACAGT"	2.46670260009114	-9.95639994060668	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATGACGTCTACAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.36504246623	39.1505105900752	0.0154235147171887	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2536.50688712293	2536.50688712293
"healthy-1"	"2019-08-01-count-4:TCAGGTAGTCGACTGC"	1.47541465339009	-9.22695257579955	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTAGTCGACTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.90535427604	38.9805876167903	0.015937079310384	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2443.65730856075	2443.65730856075
"healthy-1"	"2019-08-01-count-4:AGTTAGCAGATTGAGT"	11.0549408393795	3.90271756732789	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCAGATTGAGT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1722.91010848097	38.7746311059628	0.0225053129093015	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1717.03992677491	1717.03992677491
"healthy-1"	"2019-08-01-count-4:GGTGAAGAGGGAGGTG"	2.2624839740688	-9.12653448497923	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	45	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGAGGGAGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.17619714213	45.7169197232036	0.0201558061409895	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2267.2309744801	2267.2309744801
"healthy-1"	"2019-08-01-count-3:CCCTCAAGTGTTTGCA"	1.83921565589253	-9.89329340374144	"2019-08-01-count-3"	"Control1"	"DC precursor"	"DC precursor"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAGTGTTTGCA"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2682.78115433039	42.2120329090731	0.0157344302351822	2552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2676.97161579134	2676.97161579134
"healthy-1"	"2019-08-01-count-4:GTTGAACCAAGAGAGA"	-3.56865463677104	-4.67584707653197	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACCAAGAGAGA"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2884.58826033963	40.6501558110965	0.0140921865245026	3522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2880.25762095331	2880.25762095331
"healthy-1"	"2019-08-01-count-4:GCACGTGGTCTACTGA"	0.923323233693284	10.6418809660706	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGGTCTACTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1999.45114364204	32.8708015688895	0.0164399123596562	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1992.83282456823	1992.83282456823
"healthy-1"	"2019-08-01-count-3:CACAACACATACCGTA"	1.80054750022237	-10.2539291611877	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAACACATACCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.28982593634	37.8955130589588	0.0158473107893228	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2387.20658672145	2387.20658672145
"healthy-1"	"2019-08-01-count-2:CTATAGGTCATCTGTT"	1.87935306605641	-10.286273979303	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGTCATCTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.70953496428	41.3786643242341	0.017439414186388	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.68437853381	2369.68437853381
"healthy-1"	"2019-08-01-count-2:TATTGCTCAGTATTCG"	1.57880248603169	-4.80570366298827	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTCAGTATTCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2436.09107621534	42.8823829245755	0.0176029473377476	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2429.80253985778	2429.80253985778
"healthy-1"	"2019-08-01-count-4:ACTTATCAGGGTCACA"	2.04200377044026	-10.6151094666687	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCAGGGTCACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.16741575248	40.7052084607505	0.0163463742249837	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2487.49181701257	2487.49181701257
"healthy-1"	"2019-08-01-count-4:AGTTCCCTCTTTCCGG"	2.44775571402852	-10.1653681031433	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCCCTCTTTCCGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.08987178453	40.0064461069651	0.0158561320206439	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2519.45325513822	2519.45325513822
"healthy-1"	"2019-08-01-count-4:CTTCGGTCAAATGAAC"	-0.885633508593398	12.4594526060852	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCGGTCAAATGAAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.17568538711	47.4225872578044	0.0262849054235144	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1804.17568538711	1804.17568538711
"healthy-1"	"2019-08-01-count-4:GGTGATTTCGCTAGCG"	1.70710506018941	-10.2310600510803	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTTCGCTAGCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.82100903074	38.0087686434705	0.0157986685213891	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2404.13553916374	2404.13553916374
"healthy-1"	"2019-08-01-count-4:GGTGATTTCCTTCTTC"	2.20294513282124	-10.5427379838196	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTTCCTTCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.22402456233	41.9901662451004	0.0162235439616557	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2580.73442581442	2580.73442581442
"healthy-1"	"2019-08-01-count-4:TTACCATCATCCGGTG"	1.79862000521962	-10.1921615830627	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATCATCCGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.31266367767	37.3865832989864	0.015832966076063	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.63200440483	2359.63200440483
"healthy-1"	"2019-08-01-count-2:ATGACCAGTCCTACAA"	2.11254896697347	-10.6043987504211	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCAGTCCTACAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.76504513098	40.0674416279337	0.0154535566973866	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2584.2539439547	2584.2539439547
"healthy-1"	"2019-08-01-count-2:ATGACCACACCTGATA"	1.91021933135335	-10.1750116578308	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCACACCTGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.10265149956	37.5207519234945	0.015383014692074	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2436.57551517328	2436.57551517328
"healthy-1"	"2019-08-01-count-3:CCTGCATTCGCCACTT"	0.93841983851735	9.53621289813844	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGCATTCGCCACTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.71051635855	34.0798120689363	0.0199330891065241	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1704.42092052069	1704.42092052069
"healthy-1"	"2019-08-01-count-2:GAGAAATAGGACCCAA"	1.61369564112965	-4.80063249981078	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATAGGACCCAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2330.04765004944	39.4550062850626	0.0169331327984754	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2327.27134708962	2327.27134708962
"healthy-1"	"2019-08-01-count-4:GCAGCCATCGAACGCC"	1.38513757762257	9.47529122913209	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCATCGAACGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1797.5830694838	30.9011004214093	0.0171903601819542	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1796.39026334674	1796.39026334674
"healthy-1"	"2019-08-01-count-3:GCCAGTGTCGCTATTT"	0.713425834744614	-8.36195185100707	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGTCGCTATTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2356.27328127292	45.0323139231527	0.0191116685322787	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2354.11981653596	2354.11981653596
"healthy-1"	"2019-08-01-count-4:ACTTCCGCATTGGATC"	1.76179410991017	-4.65095283901366	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGCATTGGATC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2556.28185284634	45.3896897307034	0.0177561365857068	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2550.80895663292	2550.80895663292
"healthy-1"	"2019-08-01-count-2:GGTAACTGTACATTGC"	0.932773013680619	10.4206590422424	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTGTACATTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1970.83761981231	30.9659783555782	0.0157120901510532	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1960.69580319645	1960.69580319645
"healthy-1"	"2019-08-01-count-2:ACTATTCGTCAACATC"	8.19486202773396	7.60309264743654	"2019-08-01-count-2"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCGTCAACATC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1941.46289464546	45.8609215576273	0.0236218377822782	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1933.45374089783	1933.45374089783
"healthy-1"	"2019-08-01-count-2:GGTAACTGTAGGAGGG"	3.06272663649861	-10.8834858170715	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTGTAGGAGGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.32628177752	34.0557934409013	0.0152352673157944	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2233.36226356025	2233.36226356025
"healthy-1"	"2019-08-01-count-2:CTATCTACATTAGGCT"	1.43534817275349	9.83880612933961	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTACATTAGGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1784.04662786268	37.967738728646	0.0212818085220855	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1778.54143018946	1778.54143018946
"healthy-1"	"2019-08-01-count-2:TCGGATAAGAGGACTC"	1.29408707198445	10.3569936522278	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATAAGAGGACTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1782.11097105818	38.4757151422539	0.0215899659264248	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1777.06871646138	1777.06871646138
"healthy-1"	"2019-08-01-count-4:ATACCTTTCGTCCATC"	1.18830813941304	9.11179254138795	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTTCGTCCATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1764.07816238927	37.0449711958547	0.0209996200767436	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1761.15927565673	1761.15927565673
"healthy-1"	"2019-08-01-count-2:AAGCATCAGCTGACAG"	-5.02506814423259	3.7864243754181	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCATCAGCTGACAG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2764.63022923902	45.0399337166473	0.0162914856534158	3168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2753.5727551063	2753.5727551063
"healthy-1"	"2019-08-01-count-1:CATCGTCAGGTTGCCC"	1.41385449942891	9.75075337970582	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATCGTCAGGTTGCCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1973.52300308824	25.2934764792059	0.0128164082403021	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1964.95950657359	1964.95950657359
"healthy-1"	"2019-08-01-count-3:AAGTACCAGGAAGAAC"	-5.5630181831425	3.47248647296754	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCAGGAAGAAC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2387.95317438407	47.7803435279515	0.0200089114143855	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2381.09021345872	2381.09021345872
"healthy-1"	"2019-08-01-count-2:GAAGTAAAGGTAATCA"	8.26378883895222	7.36299846256105	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAAAGGTAATCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1926.00155362053	42.9767151840766	0.0223139566545459	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1921.03207820603	1921.03207820603
"healthy-1"	"2019-08-01-count-4:AAGCCATCACCAGTTA"	6.90360798415486	-1.05566480075987	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATCACCAGTTA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2368.40911337866	46.4314262971125	0.0196044788186428	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2354.85809894581	2354.85809894581
"healthy-1"	"2019-08-01-count-3:AAGTCGTAGCCATTTG"	2.73340668258016	-10.533681892511	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTCGTAGCCATTTG"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.00017355338	39.5098924476123	0.0166778765526004	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2366.97791234135	2366.97791234135
"healthy-1"	"2019-08-01-count-4:CTCACTGGTTGGGCCT"	1.7915766435558	-9.85028555309447	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGGTTGGGCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.77665200948	38.0688201570392	0.0157128888151801	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2418.11882428222	2418.11882428222
"healthy-1"	"2019-08-01-count-2:TGTTCTACAATTTCGG"	1.04830833253209	8.97799584949342	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCTACAATTTCGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1697.33732450535	38.3176668624225	0.0225751630564003	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1692.80985964703	1692.80985964703
"healthy-1"	"2019-08-01-count-2:CTCTGGTAGGTGCCTC"	7.85988344725911	6.70439384067384	"2019-08-01-count-2"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTAGGTGCCTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2103.54730063383	44.0872799526204	0.020958539862325	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2094.59928867363	2094.59928867363
"healthy-1"	"2019-08-01-count-4:CTAACCCCAAGTGTCT"	2.44853367385213	-10.8154669038025	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACCCCAAGTGTCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.61811858293	32.3604191153417	0.0126972412537562	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2546.04414972706	2546.04414972706
"healthy-1"	"2019-08-01-count-2:ATTGTTCAGCTGACCC"	5.95148052748982	-1.44232883369597	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGTTCAGCTGACCC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2683.11012376638	45.3314921236325	0.0168951291719622	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2675.01941827282	2675.01941827282
"healthy-1"	"2019-08-01-count-2:GGTCACGGTGGAACAC"	1.26687659797017	9.2794732817444	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCACGGTGGAACAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1626.80808063567	34.4086413710739	0.0211510145423109	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1618.78343223096	1618.78343223096
"healthy-1"	"2019-08-01-count-2:GTTAGACGTCCTGGGT"	1.6927156644756	-9.72477438366088	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACGTCCTGGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.29828618892	43.16218168106	0.0182326755917803	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2361.40225252916	2361.40225252916
"healthy-1"	"2019-08-01-count-3:CACGAATCAACGGCTC"	0.998832305043381	9.8043584593567	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATCAACGGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.40713501184	31.4951816703824	0.018148583715583	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1729.48029431296	1729.48029431296
"healthy-1"	"2019-08-01-count-4:TAACACGCACCGTGGT"	1.67138030108754	-4.79540588771971	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGCACCGTGGT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2501.79133007075	38.8499712954649	0.0155288615914926	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2494.61256588887	2494.61256588887
"healthy-1"	"2019-08-01-count-4:GCATTAGGTAGGAGGG"	1.26573254641835	-8.50871374523314	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATTAGGTAGGAGGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2379.03480473657	40.2516639222004	0.0169193253676074	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2373.83903048445	2373.83903048445
"healthy-1"	"2019-08-01-count-2:GTTAGTGCAGATGCGA"	2.89796652373616	-10.6711960068909	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGCAGATGCGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.12257251834	41.8840968021898	0.0183210197500702	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2281.94848293126	2281.94848293126
"healthy-1"	"2019-08-01-count-3:TGATTTCTCGACGATT"	2.76654877242391	-10.5205059281555	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTTCTCGACGATT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.83058276714	38.733253428185	0.016234704051476	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.42335948939	2377.42335948939
"healthy-1"	"2019-08-01-count-3:GACATCAGTTCCTAGA"	-1.96450958672221	13.2805652388367	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCAGTTCCTAGA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1897.67412103907	44.8732279702052	0.0236464351137565	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1897.67412103907	1897.67412103907
"healthy-1"	"2019-08-01-count-2:GGTGAAGCACTGAATC"	1.32473351535146	-9.29155161296996	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGAAGCACTGAATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2550.39075298239	44.2657299799438	0.0173564501550126	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2547.93467297408	2547.93467297408
"healthy-1"	"2019-08-01-count-2:AAGGAATAGCCTCTGG"	1.6682411628658	-4.79954483425292	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGAATAGCCTCTGG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2036.07054367713	41.8656944080111	0.0205620058391503	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2030.97110987526	2030.97110987526
"healthy-1"	"2019-08-01-count-2:GGTGAAGCATGGATCT"	1.09478272971455	-8.79094507610472	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGAAGCATGGATCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2374.55644079012	41.7306226776291	0.0175740706604319	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2372.15081506586	2372.15081506586
"healthy-1"	"2019-08-01-count-3:GACCAATAGTGATAAC"	1.31998719748799	11.3800163039002	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATAGTGATAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.09291011711	38.9437505985313	0.0201875971832622	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1925.05840727422	1925.05840727422
"healthy-1"	"2019-08-01-count-2:ATTTCTGAGCCTAGGA"	2.26157488402669	-10.6719131699768	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCTGAGCCTAGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.1776541323	43.4304749383536	0.0201423453466923	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2153.47205983615	2153.47205983615
"healthy-1"	"2019-08-01-count-4:ATATCCTTCATGCCCT"	0.909611840813798	8.46104810321657	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATATCCTTCATGCCCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1955.85693715227	38.7418849800607	0.0198081384400584	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1954.54195698525	1954.54195698525
"healthy-1"	"2019-08-01-count-3:CTCAATTCAAGAGATT"	11.0827471214229	3.93739650333253	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAATTCAAGAGATT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1679.22818631508	39.1970006818958	0.0233422717658821	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1673.27099547853	1673.27099547853
"healthy-1"	"2019-08-01-count-3:GTAGAAACAATAGTGA"	-7.56750808182414	0.236279717925467	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAAACAATAGTGA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2645.88181048062	39.1524672873089	0.014797511790671	3415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2643.48763246377	2643.48763246377
"healthy-1"	"2019-08-01-count-4:CTACATTAGCGGGTTA"	2.99566187438313	-10.8388147584167	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTAGCGGGTTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.20605729746	36.6742049184437	0.0171759558254824	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2129.33697591382	2129.33697591382
"healthy-1"	"2019-08-01-count-4:TGAGGGACATGAGATA"	2.66549934920613	-10.7337227097717	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGACATGAGATA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.5051971652	43.9390517772869	0.017405015377519	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2518.14674185175	2518.14674185175
"healthy-1"	"2019-08-01-count-3:TTCGGTCTCGTCGCTT"	-4.88222966614421	3.6803669699463	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGGTCTCGTCGCTT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2459.87144293332	44.9857981133587	0.0182878655071968	2624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2457.59314443611	2457.59314443611
"healthy-1"	"2019-08-01-count-2:ACTTAGGGTTATAGAG"	2.18063010749165	-10.1529445878235	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTAGGGTTATAGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.97924576601	40.1354598857482	0.0180629319388227	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2218.84791600366	2218.84791600366
"healthy-1"	"2019-08-01-count-2:AGTCTCCAGTCGGGAT"	0.981223841279191	-8.66052439129027	"2019-08-01-count-2"	"Control1"	"DC precursor"	"DC precursor"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCAGTCGGGAT"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2330.76014348811	43.818348583548	0.0188000248356622	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2328.70091455105	2328.70091455105
"healthy-1"	"2019-08-01-count-2:GGTGGCTTCTTAGCAG"	1.21806945380513	10.6080541380676	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGGCTTCTTAGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.26087416097	30.350586339261	0.0170867842560555	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1771.97143432919	1771.97143432919
"healthy-1"	"2019-08-01-count-3:CACTAAGTCATAGAGA"	-7.18630776825603	-0.121836670395456	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTAAGTCATAGAGA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2322.14823369443	36.6682830458771	0.0157906728406995	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2320.28168975133	2320.28168975133
"healthy-1"	"2019-08-01-count-3:AATGCCACATCCGTTC"	2.75484695014302	-10.5886421433655	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCACATCCGTTC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.62785102294	39.5847496609905	0.0166069336889157	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.73515972075	2375.73515972075
"healthy-1"	"2019-08-01-count-4:GAACACTGTAGGACTG"	1.41708435592	10.5743074187073	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACACTGTAGGACTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1828.78863180815	37.339630573012	0.0204176851953054	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1825.27977439338	1825.27977439338
"healthy-1"	"2019-08-01-count-2:TCGTCCACAGCACAGA"	1.65891959246938	-9.21763613140257	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCACAGCACAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.689903793	38.8070335894445	0.0198940044309383	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1949.27680216433	1949.27680216433
"healthy-1"	"2019-08-01-count-2:AAGTCGTAGAGTCACG"	1.70068587836568	-10.2789211503235	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTAGAGTCACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.84900487102	44.7319410337168	0.0210716546165443	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2115.58832467448	2115.58832467448
"healthy-1"	"2019-08-01-count-3:TACCCGTGTGTCCGTG"	0.843116183846635	-8.54550268566283	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTGTGTCCGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2475.81773866592	44.4499901662531	0.017953660106743	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2472.908615107	2472.908615107
"healthy-1"	"2019-08-01-count-3:CACTGAACAATCAGCT"	-5.98271928253825	-3.12859275257262	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGAACAATCAGCT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3013.5776338437	40.6999436854128	0.0135055235439552	3443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3001.72411196459	3001.72411196459
"healthy-1"	"2019-08-01-count-3:CTCATGCCAGAACCGA"	0.847154517739457	-7.93622782146605	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCCAGAACCGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2194.40273267239	51.6911637503117	0.0235559147738397	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2190.96343106824	2190.96343106824
"healthy-1"	"2019-08-01-count-2:TCACAAGCATCCAATG"	0.471381266682786	11.797240234259	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGCATCCAATG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1880.10140688429	36.1529044685404	0.019229231112833	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1876.09382063802	1876.09382063802
"healthy-1"	"2019-08-01-count-4:ATCATTCTCGACGCTG"	0.928085942834061	9.47156617725221	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCATTCTCGACGCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1585.80332271246	19.0486905720099	0.0120120132800755	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1582.37424879101	1582.37424879101
"healthy-1"	"2019-08-01-count-2:GCCATGGCATGTCTAG"	1.58898999270741	-9.23156931316527	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATGGCATGTCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.75924894129	47.3951241243916	0.0203783448978936	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2321.81715733641	2321.81715733641
"healthy-1"	"2019-08-01-count-2:GTTGAACAGCTGTGCC"	2.3871714073116	-10.4555549851623	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACAGCTGTGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.65131469587	28.4565349961057	0.0138835980501045	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2045.19281662086	2045.19281662086
"healthy-1"	"2019-08-01-count-4:GCCCAGATCGAGTCCG"	1.90480055388753	-10.1069536439148	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGATCGAGTCCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.77866281309	39.4116512290163	0.0182818634903769	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2152.03459481404	2152.03459481404
"healthy-1"	"2019-08-01-count-2:ATCGCCTCAATGCTCA"	1.86460461196248	-10.3474893799988	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTCAATGCTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.49853367309	40.4916353721915	0.0153989952280481	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2619.09483722651	2619.09483722651
"healthy-1"	"2019-08-01-count-2:TTGGATGGTGCATTAC"	3.38134040412251	-10.7323608628479	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGATGGTGCATTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.2813541748	42.1904215236794	0.0190194185441252	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2213.39961049386	2213.39961049386
"healthy-1"	"2019-08-01-count-4:CCCTGATTCTCGCTCA"	-1.04531655731853	13.3851146467957	"2019-08-01-count-4"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATTCTCGCTCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2359.5591645501	44.6505761546939	0.0189232704250531	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2354.49194139911	2354.49194139911
"healthy-1"	"2019-08-01-count-4:CACGTTCGTGTCCATA"	-3.00596294823344	3.4086920985016	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCGTGTCCATA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3120.0558862422	43.3149506886615	0.0138827483442388	4870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3112.38310852262	3112.38310852262
"healthy-1"	"2019-08-01-count-3:GTAGTACGTGAGGCAT"	2.67584337767903	-10.9057283631531	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACGTGAGGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.42257433144	39.3264605819993	0.0161942410673011	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2427.46415124554	2427.46415124554
"healthy-1"	"2019-08-01-count-2:CAACGATAGTCGAATA"	1.88147558745686	-10.2532778016296	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGATAGTCGAATA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2506.69990856611	42.3636834235312	0.0169001815010893	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2504.07574587866	2504.07574587866
"healthy-1"	"2019-08-01-count-2:TCACATTAGACCAAGC"	-5.15277848663982	-5.33311130916747	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTAGACCAAGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2572.416138413	46.3190775254348	0.0180060592972373	2515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2568.00130437577	2568.00130437577
"healthy-1"	"2019-08-01-count-2:TGTACAGTCAAGCTTG"	8.39982666549031	7.35877273166505	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTACAGTCAAGCTTG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.51928783615	39.5095806180671	0.0216547892266598	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1820.46982705277	1820.46982705277
"healthy-1"	"2019-08-01-count-3:AATTTCCCAAGACGAC"	1.57024778899495	-9.44502642070922	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCCAAGACGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.43019564904	44.3967282753096	0.0187531308660774	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2365.07810349222	2365.07810349222
"healthy-1"	"2019-08-01-count-4:GCCGATGTCTTCGCTG"	14.0347010093624	1.69721112335054	"2019-08-01-count-4"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGTCTTCGCTG"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1253.90578256759	41.1604893862373	0.0328258230869261	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1235.46743564178	1235.46743564178
"healthy-1"	"2019-08-01-count-2:GACCTTCAGCAGCCTC"	-5.28175292435344	3.37745640361635	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCAGCAGCCTC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2547.48110116126	42.3840914562678	0.0166376470612273	2904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2539.02747685556	2539.02747685556
"healthy-1"	"2019-08-01-count-2:TGCTCCACAACAAGAT"	3.61694588240926	-10.6994571915832	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCACAACAAGAT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.5787020318	40.6294486569231	0.0169885476160185	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.28431507045	2388.28431507045
"healthy-1"	"2019-08-01-count-3:ACCGTTCAGTGATCGG"	6.9124514060909	-1.14152254974516	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCAGTGATCGG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2220.82886728892	33.0937193027961	0.0149015170823114	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2213.38875361136	2213.38875361136
"healthy-1"	"2019-08-01-count-4:GCCGTGATCCCTCTCC"	1.7395484643871	-9.67353155529173	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGTGATCCCTCTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2471.67599678677	45.372342912765	0.0183569136779052	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2470.84205600898	2470.84205600898
"healthy-1"	"2019-08-01-count-3:TTGAACGGTTAGAAGT"	0.779865999787491	9.56493375385133	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAACGGTTAGAAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1658.35803384055	35.6450431820778	0.0214941782502348	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1649.89492510855	1649.89492510855
"healthy-1"	"2019-08-01-count-2:GCCCGAACATACAGGG"	2.44719113883321	-10.5947780839172	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAACATACAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.72020399721	42.618333442758	0.0175332123264019	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2425.94097335221	2425.94097335221
"healthy-1"	"2019-08-01-count-2:TGTCAGACAAGCGATG"	1.01232381638829	9.39545819843141	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCAGACAAGCGATG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1834.10604325863	41.1832371534825	0.0224541199811505	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1831.72313886724	1831.72313886724
"healthy-1"	"2019-08-01-count-4:GCCTGTTGTAAGGCCA"	3.39543332633321	-10.3809938660828	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCTGTTGTAAGGCCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.35356132879	42.7010527866791	0.0190259919481659	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2238.5091657757	2238.5091657757
"healthy-1"	"2019-08-01-count-4:AGAGCAGGTCATCTAG"	1.69248809394185	-9.9800424805847	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGGTCATCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.6708629727	43.0740052034217	0.0183397366921405	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2343.21851460946	2343.21851460946
"healthy-1"	"2019-08-01-count-2:AGTTCGAGTGCAATAA"	-1.09724650803264	8.84665486896364	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCGAGTGCAATAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2607.92730180509	36.2199233951931	0.0138883945768439	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2601.09235443143	2601.09235443143
"healthy-1"	"2019-08-01-count-4:TCCATGCAGGTTCACT"	0.596054037182969	9.19664666736452	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCAGGTTCACT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.78861069155	40.2798381362646	0.0201319809204344	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1996.18445879256	1996.18445879256
"healthy-1"	"2019-08-01-count-2:AGAACAACAGACTGCC"	2.70045079764668	-10.3039922944275	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACAACAGACTGCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.44433672837	41.0460963840657	0.0162530196318797	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2519.87339801412	2519.87339801412
"healthy-1"	"2019-08-01-count-2:CTCCATGTCTACACTT"	1.65091349658315	-8.54477026378783	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGTCTACACTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.81635114966	38.18763971311	0.0147624085088755	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2585.88125670972	2585.88125670972
"healthy-1"	"2019-08-01-count-2:CAAGAGGCACTAGTAC"	1.36801030215566	9.72124097431032	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGAGGCACTAGTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1825.09080674693	42.5940235501335	0.0233380297531901	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1821.1299483942	1821.1299483942
"healthy-1"	"2019-08-01-count-3:TGCTCCATCCACGTGG"	-0.982636432082015	12.8373517760071	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCCATCCACGTGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2268.1902164439	37.7230908463264	0.0166313612380664	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2265.05293999246	2265.05293999246
"healthy-1"	"2019-08-01-count-4:AGATAGAGTTCTTGTT"	-3.18537888947185	3.63067576968995	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATAGAGTTCTTGTT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3117.92189365104	37.1581184757728	0.0119175911851535	4898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3111.65110206754	3111.65110206754
"healthy-1"	"2019-08-01-count-2:AGAACCTCAAGAAATC"	0.985463102429551	10.5181646117005	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCAAGAAATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.91838600305	38.3118892475102	0.0211210656130622	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1809.30237623289	1809.30237623289
"healthy-1"	"2019-08-01-count-4:CTAGACATCAGATGCT"	6.91677345809285	-1.05805494701537	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACATCAGATGCT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2133.02054592773	51.0915754271894	0.0239526879029512	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2117.30534750695	2117.30534750695
"healthy-1"	"2019-08-01-count-3:GACTCTCTCGTTCATT"	1.38378562506978	-9.68085291301879	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCTCGTTCATT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2563.7775305344	36.0589677210567	0.0140647803062462	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2559.80364725972	2559.80364725972
"healthy-1"	"2019-08-01-count-3:TACGGTATCGGAATGG"	-1.43170009079631	12.2576904066834	"2019-08-01-count-3"	"Control1"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGTATCGGAATGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1985.30949165051	38.9757620948613	0.0196320836921292	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1981.98451319512	1981.98451319512
"healthy-1"	"2019-08-01-count-4:CCGGTAGGTGGAACCA"	7.67108501967732	6.48538158023683	"2019-08-01-count-4"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTAGGTGGAACCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1452.11787238777	28.5249808733451	0.0196437089686393	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1452.11787238777	1452.11787238777
"healthy-1"	"2019-08-01-count-3:TACGTCCCAATCACGT"	8.14988865432088	8.2004823454651	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCCAATCACGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.2859267886	43.33030842221	0.0225293118504541	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1915.04639462818	1915.04639462818
"healthy-1"	"2019-08-01-count-3:ACACAGTGTCACCACG"	-3.68979297104533	-5.59214546596678	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACAGTGTCACCACG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2669.14471398383	43.5769149874797	0.0163261717355291	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2666.71491384565	2666.71491384565
"healthy-1"	"2019-08-01-count-4:TTCCTCTAGGGTTTCT"	2.68613113936726	-10.7037773362366	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTAGGGTTTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.19360277438	38.3705283554574	0.0162918786422728	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.90098964326	2350.90098964326
"healthy-1"	"2019-08-01-count-4:TTCCTCTAGTCTTCCC"	6.98047508773152	-1.1621680489746	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTAGTCTTCCC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2557.47498423657	40.8421393221701	0.0159697121472966	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2546.838995624	2546.838995624
"healthy-1"	"2019-08-01-count-4:TACCCGTTCTAGAGCT"	3.00106396254842	-11.0516214600769	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCGTTCTAGAGCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.39387251349	43.5242339420986	0.0179083046720679	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2424.48789987169	2424.48789987169
"healthy-1"	"2019-08-01-count-1:GGTCTGGAGTTCCTGA"	1.09215631064717	9.19593236530153	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTCTGGAGTTCCTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.39669417042	34.2037416152184	0.0187171957377026	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1815.22558523998	1815.22558523998
"healthy-1"	"2019-08-01-count-2:TCTCAGCTCTGTAAGC"	1.42515518245046	9.99476525867311	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCAGCTCTGTAAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.81139264126	37.5898035564111	0.0207356395204704	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1803.92692412098	1803.92692412098
"healthy-1"	"2019-08-01-count-2:CTCCCTCTCAGGACAG"	1.40121914920155	10.5669879683289	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCTCTCAGGACAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.40210420812	39.6777544210989	0.0208128989857469	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1902.88524076259	1902.88524076259
"healthy-1"	"2019-08-01-count-2:TTGTTCATCTGCGGGT"	2.34675230559651	-10.133273147699	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCATCTGCGGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.70755406684	43.0999191457557	0.0194344466504246	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2212.76477451388	2212.76477451388
"healthy-1"	"2019-08-01-count-4:CCGTAGGGTGAACCGA"	3.35172094878499	-10.1887016526428	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTAGGGTGAACCGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.68086654746	52.8400969366427	0.0213522873397256	2198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2469.4531136661	2469.4531136661
"healthy-1"	"2019-08-01-count-2:TTGTTCATCGATCCCT"	7.89445557174031	7.75105617130128	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCATCGATCCCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.08038077336	44.7768395052408	0.0227515298372344	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1962.17550873018	1962.17550873018
"healthy-1"	"2019-08-01-count-2:TTGTTGTAGGCTAAAT"	11.0161186653072	4.02203557575075	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTGTAGGCTAAAT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.31889628331	33.9486812208738	0.0177712115432265	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1899.25927756601	1899.25927756601
"healthy-1"	"2019-08-01-count-2:GTAGAAAGTCCTCCAT"	1.92255200919453	-4.29358341610106	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAAAGTCCTCCAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2318.34865387377	42.8385855198649	0.0184780599968366	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2313.87271016184	2313.87271016184
"healthy-1"	"2019-08-01-count-3:AGCGCCAAGAAGGCTC"	-7.24604640427287	-0.269873314258181	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCCAAGAAGGCTC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2024.85149705784	53.9389510931049	0.0266384725850166	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2020.70622780663	2020.70622780663
"healthy-1"	"2019-08-01-count-4:AATTTCCAGACATAGT"	1.92926230010335	-10.2531805268494	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTTCCAGACATAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.39210864431	38.6148950884802	0.01599363042574	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2411.62569240069	2411.62569240069
"healthy-1"	"2019-08-01-count-4:CTCAACCAGCGGGTTA"	-7.71608958664592	1.39137802207796	"2019-08-01-count-4"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCAGCGGGTTA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2705.78444928216	42.5055454768525	0.0157091395392302	3154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2701.82737335498	2701.82737335498
"healthy-1"	"2019-08-01-count-3:CCTCTCCAGACCAAAT"	1.24659337577168	-8.40428163921507	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCAGACCAAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.54033144193	44.5151495370451	0.0187547474746309	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2372.44405488206	2372.44405488206
"healthy-1"	"2019-08-01-count-3:GAGACCCTCTATACGG"	1.89576115187947	-10.4614515534607	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACCCTCTATACGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.27606896956	39.8792102220861	0.0154613965918034	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2573.17502108188	2573.17502108188
"healthy-1"	"2019-08-01-count-4:ATCGTCCTCTCTATGT"	3.31608213958089	-10.6340885392395	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTCCTCTCTATGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.37251724515	42.5922854120846	0.0184033836794705	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2307.66620312895	2307.66620312895
"healthy-1"	"2019-08-01-count-4:GACCAATGTCACAGAG"	2.98246445235555	-10.7052679291931	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATGTCACAGAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.32579576618	43.5511477009218	0.018404544200483	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2359.34976787667	2359.34976787667
"healthy-1"	"2019-08-01-count-4:TGCATGACATACTGTG"	1.45668162879292	-9.29101755535277	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGACATACTGTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2431.35410847662	44.7181958957928	0.018392300710081	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2427.66497573577	2427.66497573577
"healthy-1"	"2019-08-01-count-3:TTGGGATAGTCGAAAT"	1.70857288417165	-5.08832218563231	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGATAGTCGAAAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2441.33744115869	42.3435151135434	0.0173443926266279	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2434.03919057483	2434.03919057483
"healthy-1"	"2019-08-01-count-3:GAGAGGTAGGTTCTTG"	1.70625903186147	-9.61050798809203	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTAGGTTCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.10111760314	40.3047820123401	0.0173048656873333	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2320.88075489513	2320.88075489513
"healthy-1"	"2019-08-01-count-3:ACAGCCGAGACGACGT"	1.2689024406368	9.92998406970827	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGCCGAGACGACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2010.86025364315	30.5406576372302	0.0151878568298809	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1998.36676068547	1998.36676068547
"healthy-1"	"2019-08-01-count-2:TCTGGCTTCCCGAACG"	2.60633887824361	-10.6189375153747	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTTCCCGAACG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.94384160837	34.2428370332295	0.0132214592776516	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2582.69919234979	2582.69919234979
"healthy-1"	"2019-08-01-count-3:TTGGGCGAGACGGATC"	8.19766106185262	7.88557574832765	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGAGACGGATC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.48436279769	39.3197060616094	0.0194798170282136	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2016.43909955673	2016.43909955673
"healthy-1"	"2019-08-01-count-3:GGAACCCCAATGAACA"	-3.38737926903422	9.74201963031618	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAACCCCAATGAACA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2274.67173728678	44.1087821672313	0.0193912736700391	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2273.15373878439	2273.15373878439
"healthy-1"	"2019-08-01-count-4:GTGCTGGGTCGTCGGT"	3.27400173720662	-10.7120352021423	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTCGTCGGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.73855474365	39.837282078799	0.0170555398839025	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.86392444932	2330.86392444932
"healthy-1"	"2019-08-01-count-4:GTGCTGGGTCTTCATT"	-3.40791140022929	3.50309155071107	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTCTTCATT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3144.41832653962	46.9180007508936	0.0149210429016059	4689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3138.60498281851	3138.60498281851
"healthy-1"	"2019-08-01-count-4:TTCGGTCCACACACTA"	2.54077472266499	-10.8731975785461	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCCACACACTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.73418654104	39.8312533552061	0.0156401298438235	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2544.46505427617	2544.46505427617
"healthy-1"	"2019-08-01-count-4:ACAAGCTAGATCCCGC"	0.781976600258988	9.89604375446168	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTAGATCCCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1698.27428937396	36.5746262760949	0.021536348106393	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1695.04427791708	1695.04427791708
"healthy-1"	"2019-08-01-count-2:CATTTCACAGCCGTCA"	-5.60871444168742	-5.45487263118895	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCACAGCCGTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2514.31069674257	43.5319860946823	0.0173136860735153	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2508.30761135483	2508.30761135483
"healthy-1"	"2019-08-01-count-4:ATGAAAGTCCATCAGA"	2.99985041198079	-10.5743103257385	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGTCCATCAGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.55768373834	37.4391475067015	0.0154863512703483	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2416.67571021361	2416.67571021361
"healthy-1"	"2019-08-01-count-2:TCTGTCGTCGTTCTAT"	-2.42165074768718	11.0788430937561	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGTCGTCGTTCTAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.58649611618	41.4224194024454	0.0203791668800292	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2030.72984777725	2030.72984777725
"healthy-1"	"2019-08-01-count-4:GTCATCCCAGAGAATT"	2.86709346350972	-10.764428161737	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCCAGAGAATT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.09937980875	42.315130780629	0.0177712577389473	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2376.95967351919	2376.95967351919
"healthy-1"	"2019-08-01-count-3:AGCTTCCAGGTTGACG"	1.50545682486836	-9.04784204876097	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCAGGTTGACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.30554419313	43.8495339543299	0.020468384667718	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2138.69573809244	2138.69573809244
"healthy-1"	"2019-08-01-count-3:CTTACCGCACGGCACT"	2.54304565963094	-10.5080318680969	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGCACGGCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.37593087951	42.6671271521046	0.0190872266998586	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2234.50861549324	2234.50861549324
"healthy-1"	"2019-08-01-count-3:TGGGAAGCAGAGCCCT"	1.27712871608083	9.78721711719362	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAAGCAGAGCCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.11620187519	31.8727079143889	0.018139214629274	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1750.42427411222	1750.42427411222
"healthy-1"	"2019-08-01-count-1:TAGTGCAAGTGAGGCT"	-1.04868791523631	11.2010774382385	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAGTGCAAGTGAGGCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2092.46547921666	44.2397615207696	0.0211424092584463	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2083.38601182603	2083.38601182603
"healthy-1"	"2019-08-01-count-3:ATGAGTCAGCATCAAA"	1.37262429770772	-9.67819693004759	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCAGCATCAAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2554.02869767692	42.7703076893203	0.0167462126514956	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2549.89113526417	2549.89113526417
"healthy-1"	"2019-08-01-count-2:GAGACTTCAGGCCTGT"	2.10169710692708	-10.028461479303	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACTTCAGGCCTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.3034359835	43.6215165232859	0.0186233413882902	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.57676423898	2337.57676423898
"healthy-1"	"2019-08-01-count-2:CGCATAAAGCGAATGC"	8.31204189833943	7.21851060474244	"2019-08-01-count-2"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAAAGCGAATGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.14032858935	45.6103661266513	0.0237908333816189	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1909.83783531833	1909.83783531833
"healthy-1"	"2019-08-01-count-4:TCCGTGTCAAGAGTGC"	-5.41374240341838	-4.64266922390135	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGTGTCAAGAGTGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2792.1421171336	40.9952878448305	0.0146823786630589	3270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2788.87114615085	2788.87114615085
"healthy-1"	"2019-08-01-count-3:CATAAGCGTATCCTCC"	2.20630898055379	-10.593270324823	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCGTATCCTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.83086274237	38.137236039451	0.015663197236007	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2433.05028005568	2433.05028005568
"healthy-1"	"2019-08-01-count-4:CTGCAGGGTTATCTGG"	-1.89138863506969	10.8715228804382	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGGTTATCTGG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1792.87607758513	38.1061421304049	0.0212541974355143	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1791.00889289769	1791.00889289769
"healthy-1"	"2019-08-01-count-2:ACCTACCAGACTTAAG"	1.44499160823171	9.85073278034059	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCAGACTTAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.05479631559	36.4536885682554	0.0189857542806626	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1911.53756555569	1911.53756555569
"healthy-1"	"2019-08-01-count-4:TCAAGACAGGGCCTCT"	2.01557924327199	-10.5235224000183	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACAGGGCCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.92262240841	42.7250058067402	0.0182202198906071	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2336.69722508286	2336.69722508286
"healthy-1"	"2019-08-01-count-2:AGAGAGCAGAACAGGA"	-7.24669537964519	-0.110587575193964	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCAGAACAGGA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2136.05538952081	51.7442432698927	0.0242242048234061	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2134.69895902956	2134.69895902956
"healthy-1"	"2019-08-01-count-4:TGCTGAAAGTACAACA"	6.88333239135091	-1.16984643852385	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTGAAAGTACAACA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2435.01788136702	37.0465698962605	0.015214085358364	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2428.95310509373	2428.95310509373
"healthy-1"	"2019-08-01-count-3:TCCTTTCAGGCGTTGA"	14.1795679527218	1.70029268348543	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCAGGCGTTGA"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1496.45206108652	40.2268538756941	0.0268814851619683	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1472.25499045943	1472.25499045943
"healthy-1"	"2019-08-01-count-3:GGAGAACAGGCGACAT"	2.27387489852254	-10.0660829774109	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACAGGCGACAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.51380720942	43.2946171270351	0.0190682025317637	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2266.21557464775	2266.21557464775
"healthy-1"	"2019-08-01-count-3:AGGAATACATCTCCCA"	1.25927640971486	10.4777898558411	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAATACATCTCCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1814.72783012857	43.3449057388318	0.0238850724715898	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1808.29938202045	1808.29938202045
"healthy-1"	"2019-08-01-count-4:ATTTACCCACACACGC"	-3.03225717964824	-5.65837719356688	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTACCCACACACGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2597.84547963376	38.3833181679464	0.0147750582045232	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2593.88597487185	2593.88597487185
"healthy-1"	"2019-08-01-count-4:ATGATCGGTGACACGA"	-2.93834171715434	-5.80029823696288	"2019-08-01-count-4"	"Control1"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGATCGGTGACACGA"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2583.45245686945	40.5839199742685	0.0157091801191677	2587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2577.93158230425	2577.93158230425
"healthy-1"	"2019-08-01-count-4:TGCTTCGCACGGCACT"	1.65643872794453	-9.31963827526244	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGCACGGCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.84348881573	44.331942032736	0.0185268874625297	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2389.79582244812	2389.79582244812
"healthy-1"	"2019-08-01-count-2:AGAGAGCTCGGCTGGT"	8.19002403792683	7.0590142973694	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCTCGGCTGGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1765.57166658395	36.9909804941425	0.0209512766851958	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1757.97369241495	1757.97369241495
"healthy-1"	"2019-08-01-count-2:CACATGAGTTATGGTC"	10.8193432289058	4.17093942249147	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGAGTTATGGTC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.90009077521	34.9938943423517	0.01804832260767	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1938.90009077521	1938.90009077521
"healthy-1"	"2019-08-01-count-4:CTCAGGGCAGGTGTTT"	1.2253301340038	10.2173404463562	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGGGCAGGTGTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1794.86872841773	37.9017114096046	0.0211167038622468	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1786.42649365474	1786.42649365474
"healthy-1"	"2019-08-01-count-2:TTTCATGGTTCGGTTA"	-7.76095090332683	1.88878402793733	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCATGGTTCGGTTA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2500.60441923513	45.5310109723627	0.01820800228222	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2494.52798435775	2494.52798435775
"healthy-1"	"2019-08-01-count-2:GTATTTCTCCAAGCAT"	1.55297054824178	10.2355375059876	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTTCTCCAAGCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.17613619786	38.1053314037811	0.0218346621944989	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1742.4495172433	1742.4495172433
"healthy-1"	"2019-08-01-count-3:GGAGATGCAGTCAGCC"	8.03139032897298	-10.0206718674866	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGCAGTCAGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.94793968045	42.9094722220404	0.0196386703054884	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2179.81142362582	2179.81142362582
"healthy-1"	"2019-08-01-count-2:CCACACTTCCTGTTAT"	1.07922746714894	11.3282270201477	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACACTTCCTGTTAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1863.37857025553	36.7603516268391	0.0197277956361804	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1855.60470752013	1855.60470752013
"healthy-1"	"2019-08-01-count-3:TTTACCAGTCCGGACT"	-8.21831736984904	0.893863595369734	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCAGTCCGGACT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2721.91653498274	47.6599791340776	0.0175097136600406	3422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2710.28996435052	2710.28996435052
"healthy-1"	"2019-08-01-count-2:TCATCCGAGCACCGAA"	2.82342233237569	-10.8458013764587	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCCGAGCACCGAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.77153928074	40.4049056753871	0.0166565173270057	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2420.57012149737	2420.57012149737
"healthy-1"	"2019-08-01-count-3:TTTACGTCAGACAATA"	2.25645341452901	-10.570131324884	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACGTCAGACAATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.50168703602	46.3935433122637	0.0209593440041091	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2210.31663751785	2210.31663751785
"healthy-1"	"2019-08-01-count-4:GTCGCGACAGTTGTCA"	4.34969772872273	-10.6788349381653	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGCGACAGTTGTCA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.96814813023	44.7645548142395	0.0209378960361915	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2132.86345357945	2132.86345357945
"healthy-1"	"2019-08-01-count-2:GAGCTGCAGGAAGTCC"	1.58172204074208	-4.82242872631224	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCAGGAAGTCC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2309.40301962659	38.3201867065116	0.0165931136232374	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2302.83101922847	2302.83101922847
"healthy-1"	"2019-08-01-count-3:ACCACAAGTAAGCGGT"	6.81709398803059	-1.01547565376433	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAAGTAAGCGGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2216.24785928297	37.9191572411354	0.0171096193425782	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2212.63417489563	2212.63417489563
"healthy-1"	"2019-08-01-count-4:CAGTTCCCACTGGCCA"	2.30550016936604	-10.5825109711853	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCCACTGGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.51046480475	45.5704400141963	0.0190630581564588	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2386.52492297418	2386.52492297418
"healthy-1"	"2019-08-01-count-1:TCGAAGTCATGACGAG"	1.35529210147206	9.79253861987916	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGAAGTCATGACGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2031.02493860253	29.6558815238943	0.0146014364276095	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2024.30043384778	2024.30043384778
"healthy-1"	"2019-08-01-count-2:TCATGCCGTGGTCTTA"	-0.0841660303180993	12.1840171583923	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGCCGTGGTCTTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1995.28753843235	41.3822989314766	0.0207400177339802	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1987.3137812504	1987.3137812504
"healthy-1"	"2019-08-01-count-3:TCGACGGTCATGCTAG"	-0.359305421740371	13.3446702727112	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACGGTCATGCTAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1747.08445395725	48.5378067592323	0.0277821754118934	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1740.52006357131	1740.52006357131
"healthy-1"	"2019-08-01-count-3:GTGAGGACAATGCTCA"	1.83267046984975	-10.3304891816345	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGACAATGCTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.47387627228	39.3819190103076	0.0172767582117285	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.71923581907	2275.71923581907
"healthy-1"	"2019-08-01-count-4:GTCGTTCGTTCGGACC"	-5.03970513764079	-5.21049311077269	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTTCGTTCGGACC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2776.7233378425	41.3044648379139	0.0148752539639067	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2772.95383725556	2772.95383725556
"healthy-1"	"2019-08-01-count-3:CTGCAGGGTTTCGCTC"	1.37296893176381	10.045552230719	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCAGGGTTTCGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1647.44610646512	29.7205647424229	0.0180403866480304	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1637.52363801546	1637.52363801546
"healthy-1"	"2019-08-01-count-3:TAGGTTGTCGACGAGA"	0.108107009052676	12.3307733305725	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGTCGACGAGA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1984.25739667257	35.6907524627711	0.0179869569959127	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1979.71580475417	1979.71580475417
"healthy-1"	"2019-08-01-count-2:CGGAATTAGGTAACTA"	11.0928961234981	4.02753923023073	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTAGGTAACTA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.47400422318	38.1708640790755	0.0201166730053319	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1893.66386023291	1893.66386023291
"healthy-1"	"2019-08-01-count-3:GAGTGAGTCTCTTGCG"	8.07743897017781	6.71361205661622	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGAGTCTCTTGCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1327.39401750988	44.9129367554353	0.0338354220095774	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1319.93502907407	1319.93502907407
"healthy-1"	"2019-08-01-count-4:CATAAGCCATACTTTC"	10.6960789161617	4.43249080264894	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCCATACTTTC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.8821552892	35.323366182823	0.0188503669150803	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1865.68551427542	1865.68551427542
"healthy-1"	"2019-08-01-count-4:ACATCCCGTATCGAGG"	3.29995216903035	-10.8121729127136	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCCCGTATCGAGG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.61541130784	43.4160513037995	0.0190536986137912	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.22788775965	2275.22788775965
"healthy-1"	"2019-08-01-count-3:TTTATGCTCTAGTGAC"	8.59158196029012	8.05040452564088	"2019-08-01-count-3"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTATGCTCTAGTGAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2144.11900815228	45.0104376882291	0.020992509052479	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2137.35179578758	2137.35179578758
"healthy-1"	"2019-08-01-count-3:TTTATGCTCCTACAAG"	8.23088516768758	7.98852870548097	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTATGCTCCTACAAG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2138.51558963364	37.8244930129322	0.0176872655014931	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2131.19047282389	2131.19047282389
"healthy-1"	"2019-08-01-count-3:AGGGAGTTCCATTCGC"	1.99087574061696	-10.5869179002014	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTTCCATTCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.36502686479	42.2886665695316	0.0183435881418929	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2299.93145970354	2299.93145970354
"healthy-1"	"2019-08-01-count-3:AGTGCCGAGTCTACCA"	3.10778011855428	-10.5475540391174	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGAGTCTACCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.86150593851	41.5645430125055	0.0173340048662391	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2393.64189556898	2393.64189556898
"healthy-1"	"2019-08-01-count-3:TATACCTTCTTGCAAG"	2.75494207915608	-10.9150972596374	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTTCTTGCAAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.47471136775	41.7086580541643	0.0177447805979133	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2338.80856066867	2338.80856066867
"healthy-1"	"2019-08-01-count-4:TCGAAGTTCAGCGTCG"	1.78282441672627	-9.25693132793578	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTTCAGCGTCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.24286419351	43.3046794866271	0.019066512071136	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2269.3291456927	2269.3291456927
"healthy-1"	"2019-08-01-count-3:ACCCTCAGTGTCTAAC"	8.04558386382405	7.35059831226198	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCAGTGTCTAAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1915.18375924867	37.5171351486177	0.0195893135410337	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1902.52445059241	1902.52445059241
"healthy-1"	"2019-08-01-count-4:GTCTGTCAGGCCCACT"	1.38101472434346	9.18567369067994	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCAGGCCCACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.3245893483	34.8585706048686	0.0194923062695077	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1783.51436889928	1783.51436889928
"healthy-1"	"2019-08-01-count-4:GTCTGTCGTAGCGTAG"	-2.93074331703838	-5.66709949886473	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCGTAGCGTAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2407.05013252102	48.0913405932276	0.0199793680835635	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2406.1293477477	2406.1293477477
"healthy-1"	"2019-08-01-count-2:TGACGCGGTATTCCTT"	-2.46408544006999	13.6698140867981	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGGTATTCCTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2202.69734378263	43.1263802003186	0.0195788950860852	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2195.70888842718	2195.70888842718
"healthy-1"	"2019-08-01-count-4:ATGTCTTTCAAAGGAT"	11.1458794074947	3.73256990993348	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCTTTCAAAGGAT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.88418588194	31.7806975403294	0.017936103157053	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1764.29287893401	1764.29287893401
"healthy-1"	"2019-08-01-count-2:TCATTACTCTCGCCTA"	2.21361031112019	-9.81499102031859	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACTCTCGCCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.39542623184	36.9938675968844	0.0165491380910823	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2229.22504268537	2229.22504268537
"healthy-1"	"2019-08-01-count-3:AGGGCTCCATCTGGGC"	1.93152608451192	-9.66598226940306	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCTCCATCTGGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.28016122305	34.1187648298524	0.013828492348003	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2462.45686481485	2462.45686481485
"healthy-1"	"2019-08-01-count-4:CCTGCATCAAGCGGAT"	1.43123545226399	-9.49428465282591	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATCAAGCGGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2519.27977413217	46.0440720452836	0.0182766807077411	2169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2515.37952503271	2515.37952503271
"healthy-1"	"2019-08-01-count-2:TTGGGATTCCGGACGT"	2.03009607371632	-10.2542877427307	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATTCCGGACGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.12413293308	41.984976431603	0.0180338220963795	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2324.32451629317	2324.32451629317
"healthy-1"	"2019-08-01-count-4:ATTACCTGTCTCCTGT"	3.22512998160664	-10.6760711899963	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTGTCTCCTGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.19974739165	38.768030097526	0.0149903464094859	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2576.43302554764	2576.43302554764
"healthy-1"	"2019-08-01-count-2:GGACGTCTCTAGCCTC"	-1.23750887337382	13.2626704939636	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGACGTCTCTAGCCTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1887.79488632352	38.0054953090817	0.0201322164735266	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1883.93354284275	1883.93354284275
"healthy-1"	"2019-08-01-count-3:TTTCCTCCACGTCTCT"	2.14833440360371	-4.86762621318968	"2019-08-01-count-3"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCCTCCACGTCTCT"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2618.89204219125	45.6126898185867	0.0174167888877245	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2616.3061473094	2616.3061473094
"healthy-1"	"2019-08-01-count-2:CCCAACTCATAGGTTC"	1.14836897429768	10.8412465819153	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCAACTCATAGGTTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1816.07024556017	33.6826481577859	0.0185469963180838	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1806.08312297158	1806.08312297158
"healthy-1"	"2019-08-01-count-3:TATCGCCCATAGAATG"	-0.0253939208691895	13.9095401533875	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCGCCCATAGAATG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1928.25612494398	43.9821305609783	0.0228092782862319	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1921.33740893464	1921.33740893464
"healthy-1"	"2019-08-01-count-3:ACCGTTCTCCTGTTAT"	6.85704340514485	-1.16034819996031	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCTCCTGTTAT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2637.13786269989	38.8606877048731	0.0147359333216989	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2628.58880955945	2628.58880955945
"healthy-1"	"2019-08-01-count-3:TATCCTACAATACGCT"	2.2657650905544	-10.2130031815735	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCCTACAATACGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.34055841826	38.4503121591012	0.0149534109875954	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2563.53937662553	2563.53937662553
"healthy-1"	"2019-08-01-count-4:GTGAGGAGTGGTAATA"	-3.20467005196269	-5.86536505138548	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGAGTGGTAATA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2517.37712128111	44.6458903189141	0.0177350822574385	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2515.41180739786	2515.41180739786
"healthy-1"	"2019-08-01-count-2:ACATTTCTCAGACCGC"	1.40505101260487	9.38611505115358	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATTTCTCAGACCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.47910858627	36.0184318651563	0.0214206835405998	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1672.92689435063	1672.92689435063
"healthy-1"	"2019-08-01-count-3:GGCTTTCAGTGGGAAA"	8.48730816420857	7.09196088397828	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCAGTGGGAAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.38650293965	39.6722987892499	0.0185785096677513	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2128.78968461245	2128.78968461245
"healthy-1"	"2019-08-01-count-4:CTCCGATCAGTATGAA"	1.77755870398824	-10.0653724900452	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATCAGTATGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.24802304321	49.0585800789403	0.0201369399235712	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2431.42105308534	2431.42105308534
"healthy-1"	"2019-08-01-count-3:ACCTGAACACAACCGC"	3.28900374945943	-10.6200828782287	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGAACACAACCGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.28261390907	39.9720885992034	0.0157601082702673	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2533.83764540404	2533.83764540404
"healthy-1"	"2019-08-01-count-3:TCGGGACCAAATGCTC"	1.83305503901784	-4.98662331020506	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACCAAATGCTC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2444.54502107984	41.2346449920882	0.0168680243712073	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2436.75154910097	2436.75154910097
"healthy-1"	"2019-08-01-count-3:CATGCTCAGATTGGGC"	14.0140310722286	1.7071540125641	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCAGATTGGGC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1247.16279333478	31.3741601063122	0.0251564272715521	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1228.85092009402	1228.85092009402
"healthy-1"	"2019-08-01-count-4:CTCCTCCGTAGTGATA"	2.4262339073116	-10.3802328339783	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTCCGTAGTGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.25889132585	41.009975881715	0.0171356204004306	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.79977431382	2383.79977431382
"healthy-1"	"2019-08-01-count-4:ATTATCCTCGAGTTGT"	3.09503712233846	-10.6355886689392	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCTCGAGTTGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.39634953348	41.1133413306281	0.0170708369237447	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.53535564868	2403.53535564868
"healthy-1"	"2019-08-01-count-2:GTCCTCAAGTCGCCAC"	1.45956148680989	-9.41922953045043	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCAAGTCGCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.82665148566	41.6334240480971	0.017568130572756	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2368.93487255762	2368.93487255762
"healthy-1"	"2019-08-01-count-2:CTGTACCAGATGGTCG"	1.25278534468953	9.96478746021119	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCAGATGGTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.55815302143	37.6244749427881	0.0218548963197991	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1714.8522600812	1714.8522600812
"healthy-1"	"2019-08-01-count-3:ACGATCAAGAGGGTGG"	10.9706770378048	3.95915911281434	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGATCAAGAGGGTGG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1680.11246879654	29.4281003686754	0.0175155538187004	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1671.83363045825	1671.83363045825
"healthy-1"	"2019-08-01-count-4:GTGATGTAGGTTCATC"	1.4169337945873	-9.17022707378539	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGATGTAGGTTCATC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.48503490025	42.7909229206569	0.0180059719679459	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2372.07093979033	2372.07093979033
"healthy-1"	"2019-08-01-count-3:TCGGGTGTCCTACTGC"	2.56323089179341	-10.2489919892517	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGTCCTACTGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2235.9165242898	45.8386859050976	0.0205010721138874	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2233.08632766092	2233.08632766092
"healthy-1"	"2019-08-01-count-3:GGGACAACAATTGTGC"	1.67156400260274	-4.64332392131957	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAACAATTGTGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2417.02016703817	37.7032992952473	0.0155990834538419	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2416.34282218281	2416.34282218281
"healthy-1"	"2019-08-01-count-4:TGGTACACAGCGATTT"	-0.870025317103225	10.1516885527405	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTACACAGCGATTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2207.88387669647	36.3635887238886	0.0164698828175228	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2201.88217500644	2201.88217500644
"healthy-1"	"2019-08-01-count-2:GTCGAATAGGTAGCCA"	-8.3683799308842	-1.08256878769072	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGAATAGGTAGCCA"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2722.41112071199	44.3933076730963	0.0163066141389718	3169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2716.9140320376	2716.9140320376
"healthy-1"	"2019-08-01-count-2:CTGTAGAGTGGTTCTA"	3.01112832602803	-10.4397659531799	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTAGAGTGGTTCTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2740.10980524891	41.1689971002599	0.0150245793148133	2919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2737.48349928719	2737.48349928719
"healthy-1"	"2019-08-01-count-4:TATCGCCCAGAAGTTA"	-4.96054015579875	-5.38737394725951	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCGCCCAGAAGTTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2802.35532678736	36.3130740185541	0.0129580548445952	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2800.07482417659	2800.07482417659
"healthy-1"	"2019-08-01-count-2:CCCTAACCAGGCTACC"	8.62185062941853	7.54699227893678	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACCAGGCTACC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.67582913042	38.5483893074084	0.0194034621764544	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1982.00831460874	1982.00831460874
"healthy-1"	"2019-08-01-count-4:TTGGGCGTCGACACTA"	1.75904037532155	-10.1910505524841	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGTCGACACTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.83824343107	39.5792399145596	0.0170318394692232	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2317.61126067797	2317.61126067797
"healthy-1"	"2019-08-01-count-2:GGAGGATTCGCGCCAA"	1.80889405783955	-4.75232698833617	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATTCGCGCCAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2375.76005762712	42.7356362192131	0.0179881954332951	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2370.30153640169	2370.30153640169
"healthy-1"	"2019-08-01-count-2:AGGTCTAGTAGAATGT"	-2.94707737389262	-5.71280577098998	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTAGTAGAATGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2586.51844644945	39.910305614198	0.0154301260325374	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2583.89480961251	2583.89480961251
"healthy-1"	"2019-08-01-count-3:CCCTCAACAAGAGGTC"	7.52904047545735	-10.4353418580261	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAACAAGAGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2024.82503233776	39.1873896039628	0.0193534695482893	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2020.33228365442	2020.33228365442
"healthy-1"	"2019-08-01-count-3:AGGTTGTGTGATTCTG"	2.14023580130879	-10.5884618989197	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTGTGATTCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.44140096666	39.8739499893327	0.0175082221533376	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.48400298314	2272.48400298314
"healthy-1"	"2019-08-01-count-3:GATGACTTCGCTAATG"	-4.95855699005778	-5.22304584896239	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGACTTCGCTAATG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2687.82711100804	45.6519587177401	0.0169847080308	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2683.3027810622	2683.3027810622
"healthy-1"	"2019-08-01-count-2:GAGTTTGCACCGTGCA"	2.53038777884786	-10.1551923981872	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTTGCACCGTGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.84816286725	44.9999757823342	0.0195750100024909	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2297.25421110569	2297.25421110569
"healthy-1"	"2019-08-01-count-4:TCGGTCTAGTGCTAGG"	1.64261259612386	-9.27747824108275	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTAGTGCTAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.77713894706	40.6432738020253	0.0172819410176859	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2346.89137310452	2346.89137310452
"healthy-1"	"2019-08-01-count-2:TTAGTCTCAAATACGA"	1.75908853587453	-9.96750166332396	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTCAAATACGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.23584569119	40.3656882840731	0.0157479415528337	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2560.76133111037	2560.76133111037
"healthy-1"	"2019-08-01-count-3:TATTCCATCGACCACG"	-7.51716123047526	1.86218020999757	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCATCGACCACG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2455.361735717	42.6844947835754	0.0173841980848133	2604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2447.95914792424	2447.95914792424
"healthy-1"	"2019-08-01-count-2:ACCCAAACACATAACC"	0.93379702147786	11.5023059614929	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCAAACACATAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1885.96588601765	38.9212009307525	0.0206372772802044	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1873.95421882072	1873.95421882072
"healthy-1"	"2019-08-01-count-3:AGTAACCGTCGTTATG"	2.34085239943807	-10.7682924500671	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCGTCGTTATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2197.91276322191	36.5860962944519	0.0166458364074562	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2195.99049087837	2195.99049087837
"healthy-1"	"2019-08-01-count-4:ATTCCATCATAATGCC"	13.9875933128292	1.68641970241395	"2019-08-01-count-4"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATCATAATGCC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1373.30696955369	32.8591202830186	0.0239270032203342	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1359.35998111072	1359.35998111072
"healthy-1"	"2019-08-01-count-3:GATGCTACATCGCTAA"	1.39946152743642	10.976891494635	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGCTACATCGCTAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2172.94004689515	39.7655220098687	0.0183003309579059	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2164.15466493506	2164.15466493506
"healthy-1"	"2019-08-01-count-4:GAGTGAGTCAACTTTC"	-3.00193081322368	3.65340564334718	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGAGTCAACTTTC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2933.89551857644	43.1476879396604	0.0147066204868114	4704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	2927.83627895825	2927.83627895825
"healthy-1"	"2019-08-01-count-4:TGTAACGTCACCTGGG"	6.85387053069417	-10.1003456345764	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	10	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGTCACCTGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.59520892736	42.3436224347081	0.0170287557390468	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2474.81483282333	2474.81483282333
"healthy-1"	"2019-08-01-count-3:CATTCTAAGGAGAGTA"	2.42922272261922	-10.3041496506897	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCTAAGGAGAGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.47284909971	40.1313319031327	0.0165185348410064	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2425.64196218226	2425.64196218226
"healthy-1"	"2019-08-01-count-4:ACGATCAAGTGAGTTA"	2.22793283042256	-10.7190141907898	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATCAAGTGAGTTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.70928399735	38.8480864027592	0.0168779292297471	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2299.56397201994	2299.56397201994
"healthy-1"	"2019-08-01-count-4:ATCTTCATCGACACCG"	1.74514724788014	-9.45510389721068	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCTTCATCGACACCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.66175188251	35.0682935790309	0.0162982371873039	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2145.12250574069	2145.12250574069
"healthy-1"	"2019-08-01-count-2:TCTGGCTAGGGCCTCT"	3.06858148154561	-10.5859947434631	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTAGGGCCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.79113074799	40.1707647107418	0.0160439759600638	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2500.5409284943	2500.5409284943
"healthy-1"	"2019-08-01-count-3:GGGATCCAGAAACTAC"	0.952935000031632	9.16369721973268	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATCCAGAAACTAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1910.74265573826	39.7151831897236	0.0207852078198248	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1904.1961138975	1904.1961138975
"healthy-1"	"2019-08-01-count-4:TTGTTGTAGCAAGTGC"	1.5819488960201	-8.94867899334105	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTGTAGCAAGTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.68336917277	40.048399857349	0.0167029560167347	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2394.52295877314	2394.52295877314
"healthy-1"	"2019-08-01-count-2:CAGATCAAGAATCCCT"	2.52856673774068	-10.6490478745666	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCAAGAATCCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.64630657202	42.8993727184728	0.0172241930157947	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2485.93291983996	2485.93291983996
"healthy-1"	"2019-08-01-count-4:GTGCTTCCAACGCATT"	1.1594988304073	9.65113351428834	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTTCCAACGCATT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1605.5762649121	12.7577728855284	0.00794591522329639	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1596.00431607725	1596.00431607725
"healthy-1"	"2019-08-01-count-2:ACCGTTCAGCTAGATA"	-8.14338717880901	0.466248936298765	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCAGCTAGATA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2535.71379494306	42.7511746462999	0.0168596214334433	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2533.83893796176	2533.83893796176
"healthy-1"	"2019-08-01-count-2:GATCAGTAGGCTCACC"	1.37890686568562	9.52094361865846	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCAGTAGGCTCACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1733.75939377083	35.7851233573256	0.0206401900320753	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1729.18618632641	1729.18618632641
"healthy-1"	"2019-08-01-count-4:ATTCTACGTACTGCCG"	0.932492216199082	9.11166474902955	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTACGTACTGCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1877.68391260068	41.0255145681621	0.0218489993405439	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1871.69460039465	1871.69460039465
"healthy-1"	"2019-08-01-count-4:CACAACATCTAGACCA"	-2.95123920860942	-5.82058765804442	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACATCTAGACCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2719.23556825961	44.6748761092944	0.0164292040861644	2494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2714.9423536836	2714.9423536836
"healthy-1"	"2019-08-01-count-3:GATTCTTCAATAAGGT"	3.23822941359822	-10.7427559128967	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTCAATAAGGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.03939473401	41.5249775003752	0.0199731556821643	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2076.03087682366	2076.03087682366
"healthy-1"	"2019-08-01-count-2:GTCTGTCAGGTTCCAT"	1.16447498378102	10.3611068495545	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCAGGTTCCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1614.8219659582	46.929255709608	0.0290615663515335	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1609.37655580122	1609.37655580122
"healthy-1"	"2019-08-01-count-4:TGTACAGCAACTTGCA"	1.88203980502431	-10.4480285874573	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGCAACTTGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.22691175214	37.4786333768542	0.0160423772144401	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2333.06508991826	2333.06508991826
"healthy-1"	"2019-08-01-count-4:CATGCTCAGCAGGCAT"	3.15358628806416	-10.3031854859558	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCAGCAGGCAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.44990825674	38.680308652511	0.016597785910552	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2325.07944691439	2325.07944691439
"healthy-1"	"2019-08-01-count-4:AAAGTCCAGGTGATAT"	2.55949606475179	-10.5821161500183	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCAGGTGATAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.74748187583	38.2524657529856	0.015545059391395	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2456.09825831428	2456.09825831428
"healthy-1"	"2019-08-01-count-3:ATTGTTCTCGATGCAT"	2.25777639922444	-10.490487121698	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGTTCTCGATGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.07541522274	41.1353295273326	0.018265520439183	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2249.72875316617	2249.72875316617
"healthy-1"	"2019-08-01-count-4:CTGCAGGTCCTGTTAT"	1.75942518290822	-4.61496307766112	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGTCCTGTTAT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2613.44585868895	41.6152078828124	0.0159235010530078	2764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2608.30038006218	2608.30038006218
"healthy-1"	"2019-08-01-count-2:ACTCCCACAGGTTACT"	-3.58618054810222	-5.41578771984252	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCACAGGTTACT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2010.69341611789	40.2173634267505	0.020001738258237	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2003.20989577812	2003.20989577812
"healthy-1"	"2019-08-01-count-4:CACAGATAGCTCCCTT"	2.03918745097463	-10.5626144639221	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAGATAGCTCCCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.58360985774	41.6962620101691	0.0175372432066286	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.31732417679	2375.31732417679
"healthy-1"	"2019-08-01-count-3:AGACCCGGTCGCGTTG"	2.38590063628499	-10.7372036210266	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGGTCGCGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.19293276964	41.3939173206021	0.0178638199414521	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2312.52413641782	2312.52413641782
"healthy-1"	"2019-08-01-count-2:GGCGTCACATTGAAAG"	-1.58038959923442	10.5800704726013	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCACATTGAAAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.45166633581	47.9350706420117	0.0253698316268505	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.58179184307	1883.58179184307
"healthy-1"	"2019-08-01-count-3:CGAAGGACAACTCATG"	-1.4455009502476	11.3024282225403	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGACAACTCATG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.86293507995	51.6078031815427	0.0263189243155532	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1954.3947923354	1954.3947923354
"healthy-1"	"2019-08-01-count-4:ATTGGGTTCTCATGCC"	1.8474381166393	-10.3784284821716	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGGGTTCTCATGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.69031309928	37.2868862146638	0.0147806038739867	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.96488567612	2516.96488567612
"healthy-1"	"2019-08-01-count-2:TGCAGTAAGAAGTATC"	1.99463488635365	-9.87591173565062	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTAAGAAGTATC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.70934929095	41.5789648527056	0.0184164382655206	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2254.60003648591	2254.60003648591
"healthy-1"	"2019-08-01-count-2:TGCAGTACAGGGTTGA"	1.61257674273793	-4.49691822445067	"2019-08-01-count-2"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTACAGGGTTGA"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2735.01108272348	43.2700688632936	0.0158208020203728	2869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2729.3002825657	2729.3002825657
"healthy-1"	"2019-08-01-count-4:ACGGGTCTCGTCCTTG"	1.4351872402126	-8.81697561657103	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCTCGTCCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.88214333158	37.6921592788439	0.0147012058946928	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2561.24140586692	2561.24140586692
"healthy-1"	"2019-08-01-count-2:GAATAGAGTAGTATAG"	1.03492804345433	9.19722840869752	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATAGAGTAGTATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.16848316003	36.432974584633	0.02019377620477	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1797.10510862489	1797.10510862489
"healthy-1"	"2019-08-01-count-2:GGCTTTCAGAGTGAAG"	1.07019784030263	9.18842218005983	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCAGAGTGAAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1490.80365641349	32.5441597457251	0.021829943605061	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1482.79975260318	1482.79975260318
"healthy-1"	"2019-08-01-count-3:TCTCAGCGTACCACGC"	2.46671142157857	-10.6038284531799	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCAGCGTACCACGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.80198172898	37.5442912958828	0.0168677589489424	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2219.95572040613	2219.95572040613
"healthy-1"	"2019-08-01-count-3:AGTCACAAGTATGATG"	-8.39221129837688	-0.81232818281325	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACAAGTATGATG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3119.29897892072	43.4655984346676	0.0139344124203531	5221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3110.4155357236	3110.4155357236
"healthy-1"	"2019-08-01-count-2:CCGGGTATCCGACAGC"	3.05925955352132	-10.7880277863708	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGGTATCCGACAGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.74580507706	38.650521998238	0.0159334592756351	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2414.01451496791	2414.01451496791
"healthy-1"	"2019-08-01-count-2:TTCATTGCACGCAAAG"	-7.58344636383708	0.387289739492811	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGCACGCAAAG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3011.94776582697	41.9817115209022	0.0139383929552894	4213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3006.21705305094	3006.21705305094
"healthy-1"	"2019-08-01-count-3:ACTATTCTCTGAACGT"	1.22057487544362	11.1814422377381	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATTCTCTGAACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.96778622412	32.8696118758797	0.0171735449846442	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1906.58132430467	1906.58132430467
"healthy-1"	"2019-08-01-count-3:GCACATAGTATGTCTG"	-0.183377216488677	10.7438316115173	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACATAGTATGTCTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.19596413834	39.1387578729981	0.0208606982538591	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1872.64349906873	1872.64349906873
"healthy-1"	"2019-08-01-count-3:AGTCTCCCACCCAATA"	-7.46635661545451	4.32884595477907	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCCACCCAATA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2172.26472266883	40.3858871333442	0.0185916047486728	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2163.03628968879	2163.03628968879
"healthy-1"	"2019-08-01-count-4:AAATGGATCCTCACCA"	-5.03257165375407	-5.18549492275389	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGATCCTCACCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2634.67753489186	47.3270369222922	0.0179631231129903	3250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2632.12530443272	2632.12530443272
"healthy-1"	"2019-08-01-count-2:TAGGGTTCAAGATGGC"	3.27395834502522	-10.613289856073	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTCAAGATGGC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.86469159104	41.8796244401353	0.0176122823927855	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2376.29616269897	2376.29616269897
"healthy-1"	"2019-08-01-count-2:GTGAGTTTCATTACCT"	1.33223380622212	10.7514514693054	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTTCATTACCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.62657635318	35.2471489459358	0.0179500264308891	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1959.54248463373	1959.54248463373
"healthy-1"	"2019-08-01-count-4:CTGGACGCACTCTAGA"	1.67824830588643	-9.14584162151488	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGACGCACTCTAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.67897094969	44.1292840179299	0.0194429628959664	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2267.57545731876	2267.57545731876
"healthy-1"	"2019-08-01-count-3:GGGTCACCAGGCTTGC"	-1.52533052387889	13.2337684401306	"2019-08-01-count-3"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACCAGGCTTGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2178.0938013392	40.343941411471	0.0185225913533501	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2174.34380719342	2174.34380719342
"healthy-1"	"2019-08-01-count-2:GGGACCTCACGGGCTT"	2.88369168814961	-10.8062639466492	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTCACGGGCTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.02481836862	36.7402381716694	0.0164752597679818	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2218.20874250004	2218.20874250004
"healthy-1"	"2019-08-01-count-4:CTGGACGTCACCGCTT"	3.45721950110738	-10.377992653009	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGACGTCACCGCTT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.8959055681	38.0987885066528	0.0150356565251685	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2530.55965356748	2530.55965356748
"healthy-1"	"2019-08-01-count-4:GTGTTAGAGTGCAAAT"	-3.59268532219585	-5.51287653362425	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTAGAGTGCAAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2480.48091461125	39.7418534275587	0.0160218339893122	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2478.73470922847	2478.73470922847
"healthy-1"	"2019-08-01-count-2:CCGGTGATCTCTATGT"	-3.79566107216533	-5.52898838436278	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTGATCTCTATGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2389.37954511946	44.4084320122562	0.0185857588439495	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2387.31601065212	2387.31601065212
"healthy-1"	"2019-08-01-count-4:ACGTAGTAGCTACTGT"	3.15528525885884	-10.323757194635	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTAGCTACTGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.36536956832	38.3677734586935	0.0157157031622341	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2438.20712771307	2438.20712771307
"healthy-1"	"2019-08-01-count-2:TAGGTTGTCCGATAAC"	2.82282795485799	-10.8231840363708	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGTCCGATAAC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.82713327571	40.4700116860285	0.0168286572976672	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.07407576878	2399.07407576878
"healthy-1"	"2019-08-01-count-2:TTCCGGTCATCGGATT"	-6.97419248047526	-0.298949115630709	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTCATCGGATT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2295.45344440215	37.6403995747489	0.0163978057000203	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2293.0825438376	2293.0825438376
"healthy-1"	"2019-08-01-count-2:ATGGGTTTCCTGTTAT"	0.950515766709489	9.69844243610231	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGTTTCCTGTTAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.47544737753	41.0567316250503	0.0216034001816253	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1894.26504762986	1894.26504762986
"healthy-1"	"2019-08-01-count-3:GCACTAACATCAGTGT"	2.28845562514607	-10.6481189957825	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAACATCAGTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.21202549769	41.7820983024357	0.0178692513111776	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2332.63836763924	2332.63836763924
"healthy-1"	"2019-08-01-count-2:ACGCACGTCTAGGAAA"	-7.57380996170695	4.79389760578004	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_MEP"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGTCTAGGAAA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1937.61548935098	39.7239321389544	0.0205014526139344	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1932.39793507686	1932.39793507686
"healthy-1"	"2019-08-01-count-2:TAGGTTGTCGCTGTCT"	1.27403404292409	11.3008270033631	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGTCGCTGTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1790.20874676132	32.5202112782689	0.0181655973567895	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1787.49771028575	1787.49771028575
"healthy-1"	"2019-08-01-count-2:TGCGATATCCATCAGA"	1.23736562308614	9.66387937152711	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGATATCCATCAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.76907398493	41.4058227943424	0.021980307122652	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1873.13756715592	1873.13756715592
"healthy-1"	"2019-08-01-count-3:TCACATTGTATCGTTG"	10.6546484428341	5.20039317691652	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTGTATCGTTG"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1812.80634111229	33.0214627502739	0.0182156593351349	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1807.74804551085	1807.74804551085
"healthy-1"	"2019-08-01-count-3:CCACTTGAGTGGGAAA"	1.99617650088612	-10.126395248529	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGAGTGGGAAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.61983920762	38.3905630756451	0.0170124193754874	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2254.15820531022	2254.15820531022
"healthy-1"	"2019-08-01-count-3:AGTGATCGTTTCCCAC"	2.1239022212917	-10.2129812470642	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCGTTTCCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.92591512616	38.714364447581	0.0175820467807896	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2198.96701491172	2198.96701491172
"healthy-1"	"2019-08-01-count-3:TCTTCCTAGCGGGTTA"	-2.33751855316814	13.1632375487122	"2019-08-01-count-3"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTCCTAGCGGGTTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2198.50791680114	46.0525705715898	0.0209471934213441	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2198.50791680114	2198.50791680114
"healthy-1"	"2019-08-01-count-2:CCACTTGAGCTGCGAA"	1.58141078528706	-4.78847029125365	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGAGCTGCGAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2468.39182732265	41.5360292921975	0.0168271620544335	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2462.22453593767	2462.22453593767
"healthy-1"	"2019-08-01-count-4:TCTCCGATCCTCTTTC"	0.192865003913087	12.4249629744324	"2019-08-01-count-4"	"Control1"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGATCCTCTTTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1996.24845292765	41.4454049038138	0.020761646599165	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1996.24845292765	1996.24845292765
"healthy-1"	"2019-08-01-count-2:CATGCAACATATGCGT"	0.667159517377061	8.66955087268678	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCAACATATGCGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1751.15566718884	38.3131001024934	0.0218787517411277	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1750.03690233919	1750.03690233919
"healthy-1"	"2019-08-01-count-2:AAGTGAACACTTGACA"	-3.23432479324992	3.06541988933412	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAACACTTGACA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3049.73247428532	43.6817782653206	0.0143231508447498	5493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3046.91636380787	3046.91636380787
"healthy-1"	"2019-08-01-count-4:CTGTATTAGTTTGAGA"	-7.77540336075481	4.09812734210817	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTAGTTTGAGA"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2115.81962923762	42.544797595901	0.0201079510786234	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2113.70594171753	2113.70594171753
"healthy-1"	"2019-08-01-count-3:CCATCACCAAACGGCA"	0.252135207026643	11.3978223570618	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACCAAACGGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2268.80277840478	42.5142069675584	0.0187386084732542	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2260.6172504185	2260.6172504185
"healthy-1"	"2019-08-01-count-2:ACGGTCGCAGTCTGGC"	7.04473366317098	-1.06311895763548	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGCAGTCTGGC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2305.27904466313	44.4951976760199	0.0193014367518888	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2289.94943766394	2289.94943766394
"healthy-1"	"2019-08-01-count-3:CCATCACTCTTCACAT"	8.30760349807088	7.34196946704713	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACTCTTCACAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.52763540108	29.4649413847908	0.0155280697024277	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1894.35055380639	1894.35055380639
"healthy-1"	"2019-08-01-count-2:CTACCCAAGCACTCTA"	0.709096689789933	8.88255689227907	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAAGCACTCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.60239111656	39.4769754515358	0.0222832028504179	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1769.25960805277	1769.25960805277
"healthy-1"	"2019-08-01-count-4:AACCAACCAAGACGGT"	2.33477987822835	-10.575351738092	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCAACCAAGACGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.78440834101	43.7023092112062	0.0178101666400077	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2449.22178506677	2449.22178506677
"healthy-1"	"2019-08-01-count-3:ACTTATCGTAACATGA"	2.52515544471089	-10.4263849488464	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTATCGTAACATGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.76598960406	45.4067615843904	0.0184748107738709	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2453.7234915123	2453.7234915123
"healthy-1"	"2019-08-01-count-2:TATCAGGTCCTCCACA"	7.95500626143758	7.6348256834778	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCAGGTCCTCCACA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1904.1014590048	41.5795560008007	0.0218368384752631	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1899.2258693731	1899.2258693731
"healthy-1"	"2019-08-01-count-2:CGAATTGAGCATCTTG"	2.28997029837911	-10.4123306504455	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAATTGAGCATCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.00959973741	40.9624302711675	0.0180212306520393	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2268.65018497706	2268.65018497706
"healthy-1"	"2019-08-01-count-4:GTAGATCGTGTTATCG"	2.96886362609212	-10.8875284424988	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGATCGTGTTATCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.310798363	39.4283048084204	0.016263717026317	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2417.5810078568	2417.5810078568
"healthy-1"	"2019-08-01-count-4:AGGACTTGTGGCCCAT"	1.71552886542622	-9.91039659893187	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACTTGTGGCCCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.37407568648	43.1761650857864	0.0188346943649923	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2287.9175599352	2287.9175599352
"healthy-1"	"2019-08-01-count-4:TCCAGAATCTTCGACC"	1.41042007979695	10.0153064497742	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCAGAATCTTCGACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1781.64273871779	32.0159649308548	0.0179699129545444	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1772.66730994762	1772.66730994762
"healthy-1"	"2019-08-01-count-4:TCTGTCGAGCACACAG"	2.04133286055867	-10.3883590928284	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGAGCACACAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.83334118991	43.988002849747	0.018648202940678	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2358.83334118991	2358.83334118991
"healthy-1"	"2019-08-01-count-3:GCAGTTAGTGTGAATA"	2.12586702880208	-9.77074530040892	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGTTAGTGTGAATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.18456762065	46.362585985331	0.0207607497640592	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2229.93078675198	2229.93078675198
"healthy-1"	"2019-08-01-count-2:ATTACTCCAAGTGACG"	1.3738782602245	10.1082896956238	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCCAAGTGACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1707.75258243524	30.6604936010968	0.0179537094052437	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1701.83568280866	1701.83568280866
"healthy-1"	"2019-08-01-count-4:ACTATTCTCTCAGAAC"	1.33024634894673	9.6754522093567	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCTCTCAGAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1855.4296881736	36.1093950892218	0.0194614731667716	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1847.09323001355	1847.09323001355
"healthy-1"	"2019-08-01-count-4:AGTCATGCAGGCATGA"	1.70358492907826	-9.59616854107054	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCATGCAGGCATGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.49120849583	38.5161350190847	0.0163446970988998	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2353.83638048904	2353.83638048904
"healthy-1"	"2019-08-01-count-2:AGGGCTCTCCCAAGCG"	2.03592361983601	-10.1334581605163	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCTCTCCCAAGCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.56747285071	42.2038069004096	0.0179014205898327	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.24146050867	2355.24146050867
"healthy-1"	"2019-08-01-count-2:GCAACATCAACACTAC"	1.45242740687672	9.66102693164674	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACATCAACACTAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.9973984595	40.4095024518921	0.021563264967769	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1872.80338387495	1872.80338387495
"healthy-1"	"2019-08-01-count-4:GATTGGTGTGAGAACC"	0.846164007752579	12.3872670897278	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Activated"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTGTGAGAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1755.76969412938	38.4138108470144	0.0218786159571244	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1747.67784476226	1747.67784476226
"healthy-1"	"2019-08-01-count-4:AGTCTCCTCACTGGGC"	1.87528457221333	-5.00916149532469	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCTCCTCACTGGGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2404.69645486618	37.6842881992354	0.015671120620225	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2398.96654530477	2398.96654530477
"healthy-1"	"2019-08-01-count-4:CCAATTTCATGTGCTA"	2.37875237044637	-10.5803222886291	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTCATGTGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.00532299025	42.2499220540734	0.017849525577196	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2365.31504766068	2365.31504766068
"healthy-1"	"2019-08-01-count-2:TCGAAGTTCTTACACT"	1.86686911162679	-8.93059542095336	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTTCTTACACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.04379031372	42.1549780017131	0.0166617582522103	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2523.52238373324	2523.52238373324
"healthy-1"	"2019-08-01-count-3:CCCGGAAAGCGACAGT"	2.51442350920979	-10.6940202943054	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGGAAAGCGACAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.37975063957	40.5934551971206	0.0172197352531375	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2353.01015383885	2353.01015383885
"healthy-1"	"2019-08-01-count-4:GTTCATTGTGGCTGCT"	-0.836615900427657	13.4966335066589	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTGTGGCTGCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2008.49188984644	42.3519425204129	0.0210864393998877	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2003.22477507775	2003.22477507775
"healthy-1"	"2019-08-01-count-3:CAATACGGTAGCGATG"	3.39834179457967	-10.7391062012878	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGGTAGCGATG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.25922164846	52.5601217534776	0.0213376332022025	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.02147012852	2457.02147012852
"healthy-1"	"2019-08-01-count-2:GGGTCACAGTCATCGT"	-5.31963096085246	-5.53546335613402	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACAGTCATCGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2709.55010346218	39.3039154134985	0.0145056979619152	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2707.2006991994	2707.2006991994
"healthy-1"	"2019-08-01-count-2:ATTCACTTCCATTGGA"	1.19506599482839	10.4071540602478	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTTCCATTGGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1561.26511364841	34.0219821001457	0.0217912907953488	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1555.50675284263	1555.50675284263
"healthy-1"	"2019-08-01-count-3:TTAGTCTTCTCCTGCA"	1.70873941954915	-9.98187639629515	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGTCTTCTCCTGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.18282541988	41.4802727472754	0.0170617661138304	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2426.02342856921	2426.02342856921
"healthy-1"	"2019-08-01-count-4:ACTGCAATCCCAACTC"	6.94317974623982	-1.20183303272399	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAATCCCAACTC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2135.39232285511	39.9173934946214	0.018693236398476	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2131.83967422032	2131.83967422032
"healthy-1"	"2019-08-01-count-4:GTTCGCTAGGCTAGCA"	-2.0110207599705	13.0694255598816	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCGCTAGGCTAGCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1965.76698234728	47.6564471206649	0.0242431822024803	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1964.01294952118	1964.01294952118
"healthy-1"	"2019-08-01-count-4:TGTTTGTAGCCGCTTG"	-4.50269828262981	3.59863112056581	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTTGTAGCCGCTTG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2467.87066701193	36.2916735129779	0.0147056626581325	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2463.50475697187	2463.50475697187
"healthy-1"	"2019-08-01-count-2:TTCTAACGTGCCCGTA"	1.88525845584218	-8.31122400676879	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACGTGCCCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1831.48993922066	39.721296943521	0.0216879689551685	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1831.48993922066	1831.48993922066
"healthy-1"	"2019-08-01-count-2:TGGAACTGTCCCTGAG"	1.1679308610851	9.9318113096985	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTGTCCCTGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.07420872514	30.5411100494434	0.0152623575459007	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1996.83154196263	1996.83154196263
"healthy-1"	"2019-08-01-count-4:CTTCAATTCCATTCGC"	1.14482237872426	10.0141401060852	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATTCCATTCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1773.46502073672	26.2520783076356	0.0148027043108695	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1771.81314838954	1771.81314838954
"healthy-1"	"2019-08-01-count-4:CCACACTCACACACTA"	1.31491353091542	-8.44250013744506	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTCACACACTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.97333752078	47.0242481242705	0.0208443279635336	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2251.66497919833	2251.66497919833
"healthy-1"	"2019-08-01-count-2:CATACAGTCTATTTCG"	2.88947906073872	-10.9578733674255	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGTCTATTTCG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.40001860981	40.5891930332673	0.0178226015199754	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2267.44867098336	2267.44867098336
"healthy-1"	"2019-08-01-count-2:GGGTCTGCAGTTCTAG"	2.9099072414333	-10.6994028321472	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGCAGTTCTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.96846913488	37.6552069604146	0.0159693428700639	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.70449885898	2350.70449885898
"healthy-1"	"2019-08-01-count-3:ATCGTGATCACTCACC"	3.28675951537434	-10.0832195512024	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTGATCACTCACC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.27966690535	43.3871492568599	0.0173390488004557	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2499.40123330542	2499.40123330542
"healthy-1"	"2019-08-01-count-2:AAACGCTAGAGGTGCT"	-7.86501012268718	1.41939542377321	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTAGAGGTGCT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2545.86372976958	42.0551533679935	0.0165190119471947	2977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2535.78941767638	2535.78941767638
"healthy-1"	"2019-08-01-count-2:CCTCAGTCAGACATCT"	2.48603643950765	-10.0199337235657	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTCAGACATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.42428334581	39.4651322098745	0.0158149988654276	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2487.15260989939	2487.15260989939
"healthy-1"	"2019-08-01-count-2:TATTCCAGTTCCTACC"	6.9512435394222	-1.12683453476103	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCAGTTCCTACC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2534.19969859101	39.2201386860642	0.0154763409954907	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2524.4628814235	2524.4628814235
"healthy-1"	"2019-08-01-count-4:TGAATCGCAAACTGCT"	2.59072818335835	-10.6739769211975	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCAAACTGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.99226773335	38.4635415810873	0.0175954609487115	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2175.89680272305	2175.89680272305
"healthy-1"	"2019-08-01-count-2:TATTCCACAGACCGCT"	0.981435556977433	12.107753730658	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCACAGACCGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2503.96258771492	36.0666068435414	0.0144038121897241	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2491.07195222357	2491.07195222357
"healthy-1"	"2019-08-01-count-3:GAAGCGAAGTCATCCA"	11.1099001365596	3.75597927654115	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGAAGTCATCCA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1737.68952378747	47.0125237558296	0.0270546165539176	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1737.68952378747	1737.68952378747
"healthy-1"	"2019-08-01-count-2:GGGTGTCCAGTCTACA"	2.81175055083577	-10.6473589173523	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCCAGTCTACA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.80574373612	43.7727182924516	0.0182173354656583	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.54159302942	2397.54159302942
"healthy-1"	"2019-08-01-count-3:TAAGCACTCATGCAGT"	1.30588998374287	9.69937703693239	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCACTCATGCAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1784.06211572148	38.8437373068369	0.0217726372666842	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1780.45358200054	1780.45358200054
"healthy-1"	"2019-08-01-count-2:TATTGCTCAGGATTCT"	1.83361782607381	-10.2801618806091	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTCAGGATTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.58505131622	42.627791462645	0.0178539363191042	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2386.06253749376	2386.06253749376
"healthy-1"	"2019-08-01-count-4:TCAGTGACACGCTGAC"	-2.73000965538676	13.3652486571106	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTGACACGCTGAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1918.76147246056	51.1723193879651	0.0266694532501444	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1911.92297725705	1911.92297725705
"healthy-1"	"2019-08-01-count-2:GAAGCCCTCACTCCGT"	1.04488434371297	9.71024320209352	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCCCTCACTCCGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.67503045906	32.3263502718596	0.0189078916729454	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1702.90907931022	1702.90907931022
"healthy-1"	"2019-08-01-count-2:GTGTGGCGTACTGTTG"	3.73648776587788	-10.5034408799377	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGGCGTACTGTTG"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.93006386414	46.7556870772919	0.0217779274063259	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2142.5018018576	2142.5018018576
"healthy-1"	"2019-08-01-count-4:GTTGCTCAGAAATTCG"	1.34271289882008	10.7215137251648	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCTCAGAAATTCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.44924517242	34.1349290512521	0.0179049765618937	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1906.44924517242	1906.44924517242
"healthy-1"	"2019-08-01-count-2:CTATAGGTCTAGTGTG"	1.22683813151662	9.36346910083619	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGTCTAGTGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1512.93027993527	32.9918090674058	0.0218065627378529	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1507.33557723462	1507.33557723462
"healthy-1"	"2019-08-01-count-4:CAATTTCGTCCCTCAT"	-0.203258464962798	13.7824458845886	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCGTCCCTCAT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2239.19917746276	44.431185282119	0.0198424444459041	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2236.14534920721	2236.14534920721
"healthy-1"	"2019-08-01-count-1:GTGGAAGAGAGAGTTT"	0.54703321036641	10.981626487616	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGGAAGAGAGAGTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1843.39141465468	42.4280642651126	0.0230163078377255	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1835.8531236803	1835.8531236803
"healthy-1"	"2019-08-01-count-3:ATTCGTTCAACTAGAA"	2.89477338370625	-10.6060323945251	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCGTTCAACTAGAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.55393186055	37.5727035906076	0.015420427637289	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.12517655324	2432.12517655324
"healthy-1"	"2019-08-01-count-4:AGCCACGCACTCTAGA"	2.33743562278096	-10.4828644028869	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGCACTCTAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.41721270988	39.0176660474686	0.0161602832526514	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2411.78741364196	2411.78741364196
"healthy-1"	"2019-08-01-count-4:GACCCAGAGAGTTCGG"	-5.56378493729289	-5.47083141719969	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCCAGAGAGTTCGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2736.20305442903	42.0927342936693	0.0153836295977868	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2735.02752261089	2735.02752261089
"healthy-1"	"2019-08-01-count-3:GGTTGTATCTGACAGT"	2.95392622527425	-10.8012438050476	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTATCTGACAGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.74833477989	40.5075422163234	0.0160441900914671	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2522.34375986798	2522.34375986798
"healthy-1"	"2019-08-01-count-4:GTTGTCCAGAAGCGCT"	1.59205081042592	-9.32564356243285	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCAGAAGCGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.22299249143	41.752192042645	0.0188648826549757	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2209.85542679514	2209.85542679514
"healthy-1"	"2019-08-01-count-4:ACTTCCGTCGTAGTCA"	3.40218867835347	-10.5807085267273	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGTCGTAGTCA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.5809194515	44.9009658133066	0.0199242749287366	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2251.0142750197	2251.0142750197
"healthy-1"	"2019-08-01-count-3:CTAGACAAGATGCTTC"	-3.73445306244548	-5.44776871120604	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAAGATGCTTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2887.70514354963	39.8899438270588	0.0138137177599875	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2884.71549132215	2884.71549132215
"healthy-1"	"2019-08-01-count-3:TGGATCATCGTTCCTG"	2.93513884124104	-10.8263588181702	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCATCGTTCCTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.4423619492	40.9414875355319	0.0170416107308041	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.29062242558	2397.29062242558
"healthy-1"	"2019-08-01-count-4:CTTCTCTTCACTTGGA"	-1.74529335919078	12.3679981001648	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTTCACTTGGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.50327705962	41.9552880790365	0.0207750532299819	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2019.50327705962	2019.50327705962
"healthy-1"	"2019-08-01-count-3:TCATGAGTCAGCTTCC"	2.01799931105916	-10.2000408402649	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGTCAGCTTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.34931911245	41.0072361765562	0.0183366864139234	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2232.88171746331	2232.88171746331
"healthy-1"	"2019-08-01-count-3:TCATGAGCAGAGTCTT"	-7.58960423889812	-1.08482780372771	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGCAGAGTCTT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2832.45305827289	46.3720482411804	0.0163716917057952	3667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2827.10262276033	2827.10262276033
"healthy-1"	"2019-08-01-count-3:TAATCTCCATTAGGCT"	1.76386930522267	-9.29246618663939	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCATTAGGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.21669867235	41.1267338216336	0.0179811269502825	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2281.2691977034	2281.2691977034
"healthy-1"	"2019-08-01-count-2:GAAGGGTTCCTGTAAG"	3.15428223189656	-10.7193804017273	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTTCCTGTAAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.09940821665	40.6225333761885	0.0175240687401926	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.90097155252	2313.90097155252
"healthy-1"	"2019-08-01-count-1:CATCCGTAGTCACTCA"	1.55279781398122	-9.87048914348754	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATCCGTAGTCACTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.48646982455	39.9765386106593	0.0151685615040629	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2629.3873648329	2629.3873648329
"healthy-1"	"2019-08-01-count-4:ACTTTCAAGAACAAGG"	-7.43467221680339	4.41418502414552	"2019-08-01-count-4"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTCAAGAACAAGG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2009.60705092584	37.8018141402886	0.0188105501137016	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2004.45403479776	2004.45403479776
"healthy-1"	"2019-08-01-count-4:CAGCCAGTCGGCATCG"	1.40675618228261	10.6476402052673	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGTCGGCATCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.09035613717	38.6346243817959	0.0216066398709619	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1783.00631851377	1783.00631851377
"healthy-1"	"2019-08-01-count-3:TAGCACACAAAGGTTA"	4.26798595961873	-10.7605104676453	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACACAAAGGTTA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.90757377445	45.3262884067982	0.0181529700509822	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2489.08429285071	2489.08429285071
"healthy-1"	"2019-08-01-count-4:TGCTCGTAGACAACTA"	2.66072263297383	-10.3802824250427	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCGTAGACAACTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.13603228799	43.3869557842534	0.0183599061549775	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2356.41719802014	2356.41719802014
"healthy-1"	"2019-08-01-count-2:CATCCACAGGATATGT"	1.7702245908672	-4.59034683620604	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACAGGATATGT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2437.08167919524	37.6760291882975	0.01545948562575	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2433.57366546005	2433.57366546005
"healthy-1"	"2019-08-01-count-4:GATCATGCACCCATAA"	-5.06400189819987	-5.08489086544188	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGCACCCATAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2461.57288740853	37.5962870957525	0.0152732780280712	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2457.95373522464	2457.95373522464
"healthy-1"	"2019-08-01-count-3:CGAAGGACATGCCGCA"	1.62341727790181	-9.96208956157836	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGACATGCCGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.2464356214	41.826869988942	0.0162608331028117	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2566.58196197207	2566.58196197207
"healthy-1"	"2019-08-01-count-3:TCATGGAAGGCACAAC"	-4.9285982650822	8.91416452014772	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGGAAGGCACAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	3303.55156731615	44.4631784572229	0.0134592052072447	5114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	3296.10535151705	3296.10535151705
"healthy-1"	"2019-08-01-count-3:AGACTCAAGATTCGAA"	1.44020940837209	-9.1060190430847	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCAAGATTCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.58266527739	44.8463882508876	0.0182111199283684	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2458.21119831495	2458.21119831495
"healthy-1"	"2019-08-01-count-2:TGGGCGTGTGGTCTAT"	14.1660248237545	1.77616999233095	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCGTGTGGTCTAT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1445.72962632773	36.1719605132087	0.0250198653015698	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1434.1209790615	1434.1209790615
"healthy-1"	"2019-08-01-count-3:CTCTCGATCGGCAGTC"	-1.18770657005962	13.0134591826233	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCGATCGGCAGTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1778.08515768194	37.7144790810517	0.0212107271230021	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1776.13456506165	1776.13456506165
"healthy-1"	"2019-08-01-count-2:CATCCCAGTTGGTACT"	1.3480781513149	9.789524055365	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCAGTTGGTACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1796.36186238098	37.5102696688145	0.0208812436148564	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1791.86586512038	1791.86586512038
"healthy-1"	"2019-08-01-count-2:TCAAGTGAGCAAGCCA"	-2.43321857872661	12.9330158003601	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGAGCAAGCCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.00339229951	47.3268173335073	0.0274995491265545	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1721.00339229951	1721.00339229951
"healthy-1"	"2019-08-01-count-2:TGGGCTGGTCCCGCAA"	-6.94815621796306	-0.361871950980745	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGGTCCCGCAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2518.12592939832	47.7392463359042	0.0189582442158923	2721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2512.00090582032	2512.00090582032
"healthy-1"	"2019-08-01-count-1:CCGGACAAGAAGAACG"	1.39824809607808	9.89264581287233	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCGGACAAGAAGAACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.36625557347	28.5384945056833	0.0158426940758907	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1793.4375794974	1793.4375794974
"healthy-1"	"2019-08-01-count-4:CCTCATGTCCCTCTTT"	0.611529489129227	11.3459300764832	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGTCCCTCTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2337.72133660082	34.9822321096903	0.0149642438394974	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2330.52075449117	2330.52075449117
"healthy-1"	"2019-08-01-count-4:CCCATTGTCCGGCTTT"	1.19113745269124	9.65296552265016	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGTCCGGCTTT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.30983483484	34.4273308436025	0.0180786394177229	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1898.54309964425	1898.54309964425
"healthy-1"	"2019-08-01-count-3:TGATTTCTCGAGCCAC"	0.643992562859696	9.33728597247926	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTTCTCGAGCCAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1517.43786717547	36.0775178616843	0.0237752850657657	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1513.38952210339	1513.38952210339
"healthy-1"	"2019-08-01-count-2:GAATCGTTCTCGGTAA"	1.24773337420766	9.78318116748659	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCGTTCTCGGTAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1653.7943738082	38.3582920368287	0.0231941120639447	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1650.3093702023	1650.3093702023
"healthy-1"	"2019-08-01-count-4:TAACACGTCGACCAAT"	3.46538748320882	-10.8625011674133	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGTCGACCAAT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.83082220294	43.4419604803913	0.0178492112451228	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2426.27760022472	2426.27760022472
"healthy-1"	"2019-08-01-count-2:GTTATGGGTGGCTGAA"	1.98838915404622	-10.5735607377258	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTATGGGTGGCTGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.66328233919	43.668625549092	0.0185534718907167	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2348.05886771404	2348.05886771404
"healthy-1"	"2019-08-01-count-2:TGGGTTACAATTCACG"	0.608001430600327	-8.42128660595091	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGTTACAATTCACG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2343.7075891021	47.0276153553546	0.0200654789761428	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2341.95234417996	2341.95234417996
"healthy-1"	"2019-08-01-count-2:GCCAACGTCAGAGTTC"	2.05953754958455	-10.2814979783264	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGTCAGAGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.17195532543	37.7940707122148	0.0156940913744291	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2406.52333748679	2406.52333748679
"healthy-1"	"2019-08-01-count-3:GACCAATCAGAAGTGC"	2.65101756629292	-10.787681602594	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATCAGAAGTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.88887140722	41.4130877834827	0.0180222326235131	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2294.45811793465	2294.45811793465
"healthy-1"	"2019-08-01-count-1:CGAGAAGCATCTTAGG"	1.04959591206853	9.27225015247194	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGAGAAGCATCTTAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1872.61689189614	41.0043699815966	0.0218968279945809	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1866.44991783637	1866.44991783637
"healthy-1"	"2019-08-01-count-2:TCGGTCTAGGTCCTGC"	1.77122189578359	-9.28615667736205	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGTCTAGGTCCTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.4290750014	40.9114287486762	0.0179638651309706	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.6683491825	2272.6683491825
"healthy-1"	"2019-08-01-count-2:CCTTGTGCACAAGCTT"	1.21771242198293	9.1443824538025	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGCACAAGCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1712.44255770066	36.3672698402316	0.0212370743045903	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1706.66877624799	1706.66877624799
"healthy-1"	"2019-08-01-count-4:AAGTACCAGCCTATCA"	8.18366589125935	8.50381085956422	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCAGCCTATCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2379.41830600677	50.653644421696	0.0212882469189307	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2370.88922082945	2370.88922082945
"healthy-1"	"2019-08-01-count-1:CGGGTGTGTACCGGCT"	3.4388436275417	-11.0517750016418	"2019-08-01-count-1"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGGGTGTGTACCGGCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.459825709	32.4191635008213	0.0137400786178166	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2343.35799834752	2343.35799834752
"healthy-1"	"2019-08-01-count-3:TTCTAGTAGCACCCAC"	2.15948571738545	-10.0879221192566	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTAGCACCCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.03629029739	44.9281475210602	0.0187353909958921	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.22244463964	2396.22244463964
"healthy-1"	"2019-08-01-count-3:TTCTAACGTCGAGCAA"	2.64770116385762	-10.7886724702087	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAACGTCGAGCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2195.09544733177	44.0451366311885	0.020065248955223	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2191.36797657867	2191.36797657867
"healthy-1"	"2019-08-01-count-4:TAAGCACGTACAGGTG"	1.53831114348714	-9.49351599132689	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCACGTACAGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.40336989325	42.3713327308396	0.0178225257301382	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.53572283859	2375.53572283859
"healthy-1"	"2019-08-01-count-2:CTCAGTCTCCTCACGT"	8.19922318038289	7.53538320148317	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCTCCTCACGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.35540847091	42.7452130430177	0.0220979106816815	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1928.47371751378	1928.47371751378
"healthy-1"	"2019-08-01-count-3:TCATTGTTCTCTAGGA"	1.31766714629475	-8.94142916118773	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTTCTCTAGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2460.66275852139	42.6610676853071	0.0173372265409267	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2459.77069389205	2459.77069389205
"healthy-1"	"2019-08-01-count-4:TCATTTGAGGGACACT"	10.2413383918697	4.7511906393799	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTTGAGGGACACT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1757.65617859851	32.7596810914383	0.0186382760691909	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1753.81799520531	1753.81799520531
"healthy-1"	"2019-08-01-count-3:CCTAACCAGCACCGTC"	1.09182490882222	9.249973274115	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAACCAGCACCGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.19643888731	40.1331810424831	0.0222197210549295	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1803.47554242038	1803.47554242038
"healthy-1"	"2019-08-01-count-4:CACGGGTTCCCAACTC"	0.38705145296399	11.8352575072083	"2019-08-01-count-4"	"Control1"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTTCCCAACTC"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1854.4720215153	41.6355912793574	0.0224514529183011	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1851.00130756783	1851.00130756783
"healthy-1"	"2019-08-01-count-2:ACTTCCGAGGATTCCT"	0.0154678906196773	13.1012611159119	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCCGAGGATTCCT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2011.72028582865	45.307176617648	0.0225216084645612	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2005.19423675266	2005.19423675266
"healthy-1"	"2019-08-01-count-2:ACTTCCGCATCTATCT"	1.74889328059499	-10.1937437287536	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCCGCATCTATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.28399959277	41.2832649321011	0.0168690127255238	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2445.82288751196	2445.82288751196
"healthy-1"	"2019-08-01-count-1:CTCAACCTCCCATAAG"	1.41421474990193	11.2913532027039	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTCAACCTCCCATAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2116.56773862682	21.7188011515377	0.0102613305282771	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2109.73762472975	2109.73762472975
"healthy-1"	"2019-08-01-count-2:GACCCTTAGAGAGCAA"	2.29343595084493	-10.5615768662659	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTAGAGAGCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.8930568336	47.7897209901588	0.0191014243632945	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2495.47740109041	2495.47740109041
"healthy-1"	"2019-08-01-count-2:TGTAACGAGCCAAGTG"	8.36890091475789	7.51461646640626	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGAGCCAAGTG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.10671038927	45.4201973043945	0.0231368967687895	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1958.84957748266	1958.84957748266
"healthy-1"	"2019-08-01-count-2:TCCTGCACACCTTCGT"	14.0661770301754	1.67126998985139	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCACACCTTCGT"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1482.48838001762	42.7854540946884	0.0288605662421314	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1451.5040741177	1451.5040741177
"healthy-1"	"2019-08-01-count-2:GAGGCCTCACGCTATA"	-6.18214879456218	1.48763284767	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTCACGCTATA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2450.26878175145	43.1238506238528	0.017599640882266	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2440.9704143711	2440.9704143711
"healthy-1"	"2019-08-01-count-2:TCATGTTTCGTCGCTT"	0.286524598568124	10.244451499823	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTTCGTCGCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.13320310267	38.4660629769844	0.0202119656754837	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1890.36380955068	1890.36380955068
"healthy-1"	"2019-08-01-count-3:AGGGAGTGTCTCCTGT"	-7.89794288101848	1.50146577442018	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTGTCTCCTGT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2390.07050960885	43.8961519188468	0.0183660489271635	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2386.24826887421	2386.24826887421
"healthy-1"	"2019-08-01-count-4:TTGATGGAGGGTACGT"	1.36487950858418	10.7932176359924	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGAGGGTACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.30023710715	37.354177344302	0.0206114729664926	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1807.56733069508	1807.56733069508
"healthy-1"	"2019-08-01-count-2:AGTGATCAGATCGCCC"	2.09422936019246	-10.4446592560974	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGATCAGATCGCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.58094244553	46.9310742548805	0.01977226620573	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2368.20717563411	2368.20717563411
"healthy-1"	"2019-08-01-count-4:GCCGATGAGTTAACAG"	1.80594517764394	-9.7229099503723	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGAGTTAACAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.64252310965	46.3741542696931	0.0205591771721706	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2251.67541999929	2251.67541999929
"healthy-1"	"2019-08-01-count-3:GACCTTCTCTTGATTC"	-5.00775990906413	2.45187113368837	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCTCTTGATTC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2653.08855751057	40.5610120393507	0.0152882239548799	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2643.98628864546	2643.98628864546
"healthy-1"	"2019-08-01-count-2:GCCCAGAAGCTCCCTT"	1.02078964289967	8.66960046375123	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGAAGCTCCCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.80204707624	39.4641723133328	0.0224508626434779	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1753.72026082252	1753.72026082252
"healthy-1"	"2019-08-01-count-3:AGATGCTTCTAGCCAA"	1.29000415381734	11.460217452887	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGCTTCTAGCCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.97988934493	32.0168267936239	0.0166669245061914	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1913.54273930581	1913.54273930581
"healthy-1"	"2019-08-01-count-2:TGTACAGGTCTCCTGT"	-5.64617810669597	-5.33244039928588	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTACAGGTCTCCTGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2900.17590301884	42.7175211116044	0.0147292862709255	2885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2898.34221773831	2898.34221773831
"healthy-1"	"2019-08-01-count-2:CGAATTGCATATACCG"	0.895116050809067	10.0402259596619	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAATTGCATATACCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1660.28423415674	30.2121150187397	0.0181969535078339	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1652.96653044633	1652.96653044633
"healthy-1"	"2019-08-01-count-3:CCTATCGAGATGCTAA"	1.67336394366567	-9.84888460552367	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGAGATGCTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.8225492712	40.3391610417055	0.017115909322142	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.12251428767	2355.12251428767
"healthy-1"	"2019-08-01-count-2:TCACACCGTATGCTTG"	0.922113199799699	12.8845958479675	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Activated"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTATGCTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.55641527984	41.4708234525893	0.0214479511044353	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1923.66978924436	1923.66978924436
"healthy-1"	"2019-08-01-count-3:CTCATTAGTCCGCAGT"	-1.12163267555888	13.136505103949	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTAGTCCGCAGT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2007.43939591432	41.9524655085399	0.02089849665894	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2001.22634403435	2001.22634403435
"healthy-1"	"2019-08-01-count-2:AGTGCCGAGTGATAGT"	1.22173919257466	11.5194215544495	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGAGTGATAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.03342075116	36.5934028961126	0.0202842156221673	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.83666818666	1802.83666818666
"healthy-1"	"2019-08-01-count-2:TCTCTGGTCCGGCTTT"	1.84456994113271	-9.47104456340941	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGTCCGGCTTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.20739061008	37.8543464518367	0.0170499146214601	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2213.22568527021	2213.22568527021
"healthy-1"	"2019-08-01-count-2:TCATTCATCCTACCAC"	3.10783376273457	-10.6034012070862	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCATCCTACCAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.64493642605	39.1869024755992	0.0144941008886324	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2699.726212876	2699.726212876
"healthy-1"	"2019-08-01-count-2:TCACGCTAGCACGGAT"	-1.28409169140514	8.76142976367799	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGCTAGCACGGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2621.71901617133	42.1276006573409	0.0160686940123975	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2614.82126393722	2614.82126393722
"healthy-1"	"2019-08-01-count-2:TCTACCGCAAATGCGG"	7.96665920790975	7.69455716693727	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACCGCAAATGCGG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.51943576538	34.8827996647152	0.0180878652388956	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1927.27481672925	1927.27481672925
"healthy-1"	"2019-08-01-count-3:CTCCACAAGACCCTTA"	1.36560740050618	9.55170629108278	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACAAGACCCTTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1703.06675160615	43.416466079787	0.0254931088513361	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1699.62969704703	1699.62969704703
"healthy-1"	"2019-08-01-count-4:TCCATCGAGAACAGGA"	1.83780767497365	-10.0146513215271	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATCGAGAACAGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2378.87555287885	41.7827166704178	0.0175640615667572	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2372.84261003223	2372.84261003223
"healthy-1"	"2019-08-01-count-4:TCCATCGGTCGCACGT"	3.42721428450887	-10.6462764970032	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATCGGTCGCACGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.27204032936	48.2901291107881	0.021574736332623	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2231.76493363009	2231.76493363009
"healthy-1"	"2019-08-01-count-4:TTCCGTGAGGGTCTTT"	1.90385343608205	-10.2690077058044	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGAGGGTCTTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.26737252984	39.8232843510108	0.0172077283825153	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2307.82883810709	2307.82883810709
"healthy-1"	"2019-08-01-count-3:TTGACCCGTGCTGATT"	-2.66412077370341	3.67219874942628	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGACCCGTGCTGATT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3150.96372506108	45.1303293369815	0.014322706725577	5418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3147.12696549799	3147.12696549799
"healthy-1"	"2019-08-01-count-4:TACAGGTTCGTAGGGA"	1.52200879630391	-9.2329950562683	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAGGTTCGTAGGGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2397.8538449984	41.3420956655734	0.0172412908951091	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2394.91538035197	2394.91538035197
"healthy-1"	"2019-08-01-count-4:TGATTTCGTCCCTGAG"	-1.15591214123424	13.188449836615	"2019-08-01-count-4"	"Control1"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCGTCCCTGAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2062.86847658832	44.7329085669856	0.0216848088352037	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2061.2267812947	2061.2267812947
"healthy-1"	"2019-08-01-count-2:ATACCGACAGTATGAA"	10.0934044319088	4.77517030322877	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGACAGTATGAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1722.10961996884	32.1442128164426	0.0186656020288791	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1714.97771720248	1714.97771720248
"healthy-1"	"2019-08-01-count-4:GCGATCGCATGTGTCA"	-5.37519965592082	-5.54838659679564	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGATCGCATGTGTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2475.93549455862	44.0097978198737	0.0177750179342694	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2475.93549455862	2475.93549455862
"healthy-1"	"2019-08-01-count-3:TTGATGGCACCAAATC"	-3.59672508660014	-5.5507531396118	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGATGGCACCAAATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2591.3107002329	42.3133941382369	0.0163289543528817	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2583.69610034129	2583.69610034129
"healthy-1"	"2019-08-01-count-2:GCCTGTTGTGATGGCA"	1.77918972548787	-10.4436950913635	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCTGTTGTGATGGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.5880176158	43.9147622139557	0.019323679379436	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2266.51518743944	2266.51518743944
"healthy-1"	"2019-08-01-count-3:GCTGAATAGCCTCAGC"	0.683137078850907	-8.10188391124877	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATAGCCTCAGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2363.01983319285	42.0029467797585	0.0177751139409631	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2357.6355682316	2357.6355682316
"healthy-1"	"2019-08-01-count-4:CCGGTAGCATTGACCA"	1.77586903151814	-10.0318842164245	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTAGCATTGACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.98408788281	40.9953679363073	0.0179805500197045	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.47467998592	2275.47467998592
"healthy-1"	"2019-08-01-count-2:GTTTGGACAGAGTGAC"	1.89692713794057	-10.3454075089661	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGACAGAGTGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.56086824434	37.9388137307038	0.0178993744879471	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2118.26973485287	2118.26973485287
"healthy-1"	"2019-08-01-count-3:TTGCATTGTTATGACC"	0.973525424569291	9.91581151569215	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCATTGTTATGACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.56330036102	36.0945769239696	0.0185713410606513	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1935.03111176833	1935.03111176833
"healthy-1"	"2019-08-01-count-1:GGATCTAAGAAGCCTG"	0.210729156702203	11.3522357710632	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Naive"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGATCTAAGAAGCCTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.47802034476	42.9576109164524	0.0215815550221508	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1984.77836499504	1984.77836499504
"healthy-1"	"2019-08-01-count-3:TCCCATGGTTGTCCCT"	2.46056952056233	-10.7248163453308	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGGTTGTCCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.73785525755	36.7321338007437	0.0138887616886955	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2641.77670452376	2641.77670452376
"healthy-1"	"2019-08-01-count-2:GTTTGGATCGTGACTA"	1.46247698840443	11.4350166090759	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGATCGTGACTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.09392543688	33.7315225070276	0.018853969614139	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1784.62664521402	1784.62664521402
"healthy-1"	"2019-08-01-count-4:TGCAGATTCGTTCTAT"	3.46795715865437	-9.99811079418334	"2019-08-01-count-4"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATTCGTTCTAT"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.57227722437	45.7093511768188	0.0193636736387352	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.35966814309	2357.35966814309
"healthy-1"	"2019-08-01-count-4:GAATCGTGTTAGAAGT"	2.30905952033345	-10.6215286484924	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCGTGTTAGAAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.80897612845	43.4195088025328	0.018446487902323	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.34058503376	2350.34058503376
"healthy-1"	"2019-08-01-count-1:GGTAATCTCGATACTG"	1.26329793509786	9.51080701434938	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTAATCTCGATACTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1887.68737996383	37.4000354850997	0.0198126214552625	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.51959913967	1883.51959913967
"healthy-1"	"2019-08-01-count-2:ATACTTCAGTCCGCCA"	-0.0601594922250092	11.7823467024597	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACTTCAGTCCGCCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1867.75409879682	43.3234177790865	0.0231954612263974	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1864.34679177918	1864.34679177918
"healthy-1"	"2019-08-01-count-4:TCCCAGTGTATGACAA"	1.75589670714681	-4.88523962413939	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTGTATGACAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2368.73905461806	41.9720042477163	0.017719133800698	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2364.9680827277	2364.9680827277
"healthy-1"	"2019-08-01-count-2:GTACAACTCCATCAGA"	1.18183579024617	10.9159221419129	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAACTCCATCAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1878.4365538003	39.9865991045757	0.0212871704522988	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1867.40562721681	1867.40562721681
"healthy-1"	"2019-08-01-count-4:CTCTCAGCACAAGGTG"	3.63691057738606	-10.9171343079773	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCAGCACAAGGTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.22007719929	41.8447273911843	0.0175139694289845	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2377.57448082306	2377.57448082306
"healthy-1"	"2019-08-01-count-4:GCACGGTAGAATACAC"	-2.52946720543559	3.39658210361329	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTAGAATACAC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3200.44291466912	43.5080894992416	0.0135943963567742	5857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3194.76704840659	3194.76704840659
"healthy-1"	"2019-08-01-count-3:GATGACTAGCAACTTC"	1.44824614104573	9.76808068836061	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGACTAGCAACTTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1803.37952805309	33.1887898843767	0.0184036634375056	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1795.1440656954	1795.1440656954
"healthy-1"	"2019-08-01-count-3:AGCGCCAAGCTTAGTC"	-3.34477458420451	-5.71183779155882	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCCAAGCTTAGTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2156.22978218572	46.682087685441	0.021649866851445	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2154.06773754636	2154.06773754636
"healthy-1"	"2019-08-01-count-2:CAATCGAGTCATCAGT"	2.78493966636006	-10.5791025391785	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATCGAGTCATCAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.25734545726	40.0534281102846	0.0168627741271437	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2371.78404748021	2371.78404748021
"healthy-1"	"2019-08-01-count-3:CAGCGTGTCATAGGCT"	1.34960128840749	9.53140637958375	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCGTGTCATAGGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.48034604412	39.6815528459619	0.0228254250537008	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1732.63930621779	1732.63930621779
"healthy-1"	"2019-08-01-count-4:TGCAGTAGTTGTTGTG"	0.733429928391617	9.41676328265993	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTAGTTGTTGTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1697.32248731114	37.5982727084336	0.0221515198140077	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1693.52298297894	1693.52298297894
"healthy-1"	"2019-08-01-count-2:CTCCTCCCACTCTCGT"	1.19784071025197	9.83261964404909	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTCCCACTCTCGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.32708330102	33.6025936317774	0.018571873456109	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.7358150291	1802.7358150291
"healthy-1"	"2019-08-01-count-2:TAACTTCCACAAATGA"	1.40032853659932	9.72051141345827	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCCACAAATGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.54145435749	40.7664891552223	0.0219346676715993	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1856.38088681037	1856.38088681037
"healthy-1"	"2019-08-01-count-2:TCTCTGGTCGATACGT"	1.57699062403981	-10.0180511704651	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGTCGATACGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.92039391143	43.9643931359922	0.0185197419630207	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2368.92811424945	2368.92811424945
"healthy-1"	"2019-08-01-count-2:TGAACGTCAAGGTTGG"	-1.63076303425487	14.0079011687073	"2019-08-01-count-2"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAACGTCAAGGTTGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1847.14108223141	39.410211489637	0.0213357885159633	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1843.38102416592	1843.38102416592
"healthy-1"	"2019-08-01-count-1:GTGCTGGTCCTCTAAT"	1.71017660674397	-10.1896591416565	"2019-08-01-count-1"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGCTGGTCCTCTAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2526.55720511196	47.5449318131321	0.0188180705811588	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2520.68154067363	2520.68154067363
"healthy-1"	"2019-08-01-count-4:ACAAAGACAGGACATG"	1.91437675532643	-10.0532436600891	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGACAGGACATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.13484046979	39.5974799016218	0.0169863532620197	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2327.27811342153	2327.27811342153
"healthy-1"	"2019-08-01-count-2:GCGTTTCTCCTTTGAT"	2.68589534339253	-10.5244436494079	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCTCCTTTGAT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.20365037739	36.4501814414568	0.0143155012114032	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2543.11389280419	2543.11389280419
"healthy-1"	"2019-08-01-count-3:GTCCACTTCTCGACCT"	6.83859791335408	-1.0889258614746	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCACTTCTCGACCT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2383.12458226679	41.2032889613827	0.0172896076302443	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2376.30667125451	2376.30667125451
"healthy-1"	"2019-08-01-count-2:TCAGGTAAGAGTACCG"	1.86826827105824	-9.91085245525511	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTAAGAGTACCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2010.52078472827	41.3309296523216	0.0205573252294965	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2005.59631097733	2005.59631097733
"healthy-1"	"2019-08-01-count-2:ACCCAAATCTCTGGTC"	1.36333789405171	11.4190311201843	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCAAATCTCTGGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1995.46452908931	37.8084467998787	0.0189471906158781	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1989.00816010333	1989.00816010333
"healthy-1"	"2019-08-01-count-2:CGATCGGTCACGGACC"	-7.47743926468547	0.0290199679317846	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGTCACGGACC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2088.79335307988	53.1955893536473	0.0254671383721188	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2085.28755729722	2085.28755729722
"healthy-1"	"2019-08-01-count-2:TTTACGTGTTTGACAC"	1.4881897169048	10.5530776747498	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACGTGTTTGACAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.41965739673	32.1229497282642	0.0186390758573491	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1719.33191564797	1719.33191564797
"healthy-1"	"2019-08-01-count-3:CATTCTAGTCCAGCAC"	7.71537079390828	6.58104178989259	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCTAGTCCAGCAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.68853487702	46.0715211733881	0.0242777043369626	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1891.81299987709	1891.81299987709
"healthy-1"	"2019-08-01-count-2:GTCTACCTCTACTCAT"	0.240358715027016	12.05708119953	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTACCTCTACTCAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2120.80729221156	42.4493522289275	0.0200156574266875	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2119.34185160978	2119.34185160978
"healthy-1"	"2019-08-01-count-3:GTCCCATTCCCTTGGT"	1.27975120124165	9.4218654402527	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATTCCCTTGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.10344977365	37.4295948213127	0.0221070926447623	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1691.78643278967	1691.78643278967
"healthy-1"	"2019-08-01-count-2:ATCACAGTCATGGTAC"	2.97196521338765	-10.7988596192566	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACAGTCATGGTAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.13303245023	42.6876609797293	0.0188788807943209	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2257.13182385114	2257.13182385114
"healthy-1"	"2019-08-01-count-4:TTCGGTCCAGGAACCA"	1.85190310057942	-4.43855192577513	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCCAGGAACCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2647.65440165812	40.4584216581315	0.0152808544924874	2597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2642.53289408601	2642.53289408601
"healthy-1"	"2019-08-01-count-2:TAAGCGTCAGTCTGGC"	1.15637936171834	-8.78874113475951	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCGTCAGTCTGGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2283.55669702951	43.9927621316748	0.0192650185514997	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2277.24117744973	2277.24117744973
"healthy-1"	"2019-08-01-count-4:CTCAATTGTTCAACGT"	1.56161238726918	-9.41068079387816	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAATTGTTCAACGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.28283022069	39.9979512397903	0.0167827127911993	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2381.48437759344	2381.48437759344
"healthy-1"	"2019-08-01-count-3:AACACACTCCGGCAAC"	-0.396088073880035	13.3061313399109	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACACACTCCGGCAAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.17045249723	41.8085496887947	0.020583476702998	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2029.52517081764	2029.52517081764
"healthy-1"	"2019-08-01-count-3:TCTATACAGCGATGAC"	8.11954845961873	6.95378635013429	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATACAGCGATGAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.37094996571	43.8907706744395	0.0253796160247227	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1721.86833011006	1721.86833011006
"healthy-1"	"2019-08-01-count-4:TCGTGGGGTCTGTCCT"	2.57695235785787	-10.6470518342224	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTGGGGTCTGTCCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.79896438876	38.6659723037123	0.0169083390826387	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2282.26444767316	2282.26444767316
"healthy-1"	"2019-08-01-count-4:TTCTAACCAGGTAGTG"	8.22376217421834	8.03364274585573	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAACCAGGTAGTG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.98747365618	45.7660696891496	0.0245002015990891	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1863.65477457668	1863.65477457668
"healthy-1"	"2019-08-01-count-2:CTCTCGACACTAGGCC"	2.15212406691853	-10.4243126145569	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGACACTAGGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.35916553842	39.8839613691497	0.0164377813209279	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2422.70881150698	2422.70881150698
"healthy-1"	"2019-08-01-count-3:CATAAGCGTCCTGTCT"	2.90284170684163	-10.8118381730286	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCGTCCTGTCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.76336031657	35.3827937159342	0.0152593379391261	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2314.71462510121	2314.71462510121
"healthy-1"	"2019-08-01-count-4:TGCTCCACAGCCGTTG"	1.94387604770009	-10.4576063386169	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCCACAGCCGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.7665054193	41.5730860527019	0.017280598910598	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2401.82875708254	2401.82875708254
"healthy-1"	"2019-08-01-count-4:TCCGTGTCACCGTACG"	2.00367261943166	-10.0981216660705	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGTGTCACCGTACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.36754799191	37.4770048907479	0.0166685402145303	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2247.16584060953	2247.16584060953
"healthy-1"	"2019-08-01-count-3:GGGCTACAGAGAGCGG"	2.85452951964681	-10.0969848862854	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTACAGAGAGCGG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2591.80184642605	45.3080787876732	0.0174813050813088	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2586.43289765103	2586.43289765103
"healthy-1"	"2019-08-01-count-2:GATCATGTCTGAGTCA"	-4.95989022675212	-5.12437107479247	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGTCTGAGTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2658.7837493998	48.8405511826367	0.0183695086874448	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2654.25779905252	2654.25779905252
"healthy-1"	"2019-08-01-count-4:GATCACAAGCGTGTCC"	1.49922420558278	-8.83124735271605	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCACAAGCGTGTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.43986871616	46.5571531699923	0.02157981496731	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2154.1211170103	2154.1211170103
"healthy-1"	"2019-08-01-count-2:CCAATTTGTCAACCAT"	0.916678388684434	9.26950643146364	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTGTCAACCAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.83605513035	36.7867093944555	0.0192819028110579	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1899.0224138255	1899.0224138255
"healthy-1"	"2019-08-01-count-3:TGGGAGATCACCCTGT"	1.29131187972371	10.3797006377014	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAGATCACCCTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2089.41426658777	37.3830618398328	0.0178916466866493	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2085.49425204826	2085.49425204826
"healthy-1"	"2019-08-01-count-2:GATCCCTGTCACTAGT"	1.43219818648641	9.6907863386902	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTGTCACTAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.74280172606	32.7510365954925	0.0184852093450505	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1765.88922800594	1765.88922800594
"healthy-1"	"2019-08-01-count-2:TAATTCCTCGTTATCT"	1.22020568427388	9.0340251692566	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATTCCTCGTTATCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.47504684583	41.2762661046494	0.0229124828439446	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1792.54954814275	1792.54954814275
"healthy-1"	"2019-08-01-count-3:ACATTTCCACAATGCT"	1.83831121501271	-10.2409067383972	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATTTCCACAATGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.95738761443	38.4713450244798	0.0154444011028721	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2487.03195878998	2487.03195878998
"healthy-1"	"2019-08-01-count-2:TCATATCCATGTCGTA"	10.3083054023678	4.49534986102907	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCCATGTCGTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1598.55286333987	38.1391425064341	0.0238585431743243	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1593.97797051475	1593.97797051475
"healthy-1"	"2019-08-01-count-3:GTTACGAGTCAATCTG"	1.22751297530476	10.841580367926	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGAGTCAATCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1798.07737767808	34.8874328705299	0.0194026315572588	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1793.17072330606	1793.17072330606
"healthy-1"	"2019-08-01-count-4:CTGCCATCAAGTATAG"	1.34502234038655	11.1365203627381	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCCATCAAGTATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.05717803336	31.7892384246737	0.0167394846202547	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1896.79167676174	1896.79167676174
"healthy-1"	"2019-08-01-count-4:GTGTAACAGAGGCGGA"	2.93689860877339	-10.724786781427	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACAGAGGCGGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.10762789725	41.922750395296	0.0168222070050277	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2486.70355784236	2486.70355784236
"healthy-1"	"2019-08-01-count-4:GTGTAACAGTCTAGAA"	2.85672726210896	-10.644184135553	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACAGTCTAGAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.17943259135	41.9409091249847	0.0171384691152675	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2442.61318489845	2442.61318489845
"healthy-1"	"2019-08-01-count-4:CTGCGAGCAATGGCAG"	4.02820577201192	0.899080551508345	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCGAGCAATGGCAG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2398.59489683007	43.1811420806882	0.0180026823778185	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2393.33846357193	2393.33846357193
"healthy-1"	"2019-08-01-count-4:GGGCCATCAGGATGAC"	1.92878415164296	-9.86912443554076	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCCATCAGGATGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.95228631623	40.6903950340618	0.0176764719564096	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2297.69408763746	2297.69408763746
"healthy-1"	"2019-08-01-count-3:GGAGAACGTTCCGCAG"	1.31485976752583	11.5474424132141	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACGTTCCGCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.29211742835	31.2818885379151	0.0162647619955633	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1921.93140383579	1921.93140383579
"healthy-1"	"2019-08-01-count-3:AGTAACCCAACGAGGT"	-5.30653939667399	-4.84505178844603	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCCAACGAGGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2766.06239572001	40.8346195277449	0.0147627253784764	4018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2756.59074501545	2756.59074501545
"healthy-1"	"2019-08-01-count-4:ACACGCGGTGTTACAC"	1.37150504168813	10.7388581999573	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACGCGGTGTTACAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.80051725405	33.8515278348639	0.0182114904319436	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1852.61318864402	1852.61318864402
"healthy-1"	"2019-08-01-count-2:GCTGGGTCAGGTACGA"	1.67809500274007	-9.52039720928343	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTCAGGTACGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.37149284082	39.695220348498	0.0175847087971077	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2255.15331073525	2255.15331073525
"healthy-1"	"2019-08-01-count-2:ATCCATTCAGCTGAGA"	1.49589969691579	10.2666492232117	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTCAGCTGAGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.1938270494	38.4232583815644	0.021063144613154	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1820.26454359318	1820.26454359318
"healthy-1"	"2019-08-01-count-2:GAGCCTGCAAAGGGTC"	7.06436123427693	-1.02372684394988	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGCAAAGGGTC"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2099.83799182156	40.3788713470268	0.019229517469583	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2089.88043361699	2089.88043361699
"healthy-1"	"2019-08-01-count-3:TTTACCACACTTCATT"	-7.80542884293254	3.11317679965822	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCACACTTCATT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2632.35430879356	46.2304623448151	0.0175624011518431	2730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2623.95066575227	2623.95066575227
"healthy-1"	"2019-08-01-count-4:CCTCCTCCAAGGTCTT"	1.65260436114613	-9.54609682476195	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCCAAGGTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.32958835082	38.3963273321664	0.0166122250697976	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2309.14835778567	2309.14835778567
"healthy-1"	"2019-08-01-count-2:CACCAAAGTCGGCACT"	2.01455750045125	-10.1663313142029	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAAGTCGGCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.42334784538	41.4549277471124	0.017689901308369	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2334.1021638495	2334.1021638495
"healthy-1"	"2019-08-01-count-2:GAGCTGCAGCCTATCA"	2.55578484114949	-10.3418112031189	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCAGCCTATCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2353.97820760816	44.5699541153869	0.0189338856117422	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2350.16647430919	2350.16647430919
"healthy-1"	"2019-08-01-count-4:GACTCTCAGCGATGCA"	-5.51926932755168	3.42814824664918	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCTCAGCGATGCA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2470.48997789943	42.1743876089609	0.0170712643994696	2846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2463.45555251659	2463.45555251659
"healthy-1"	"2019-08-01-count-2:GAGCTGCAGACCTCAT"	1.25870372828786	11.1311359175476	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCAGACCTCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2010.14851961673	35.6187923293386	0.0177194829047408	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2002.00596776584	2002.00596776584
"healthy-1"	"2019-08-01-count-3:CTGAGGCGTACCCACG"	0.623787661164445	11.6729640730652	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCGTACCCACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.07922153789	36.596495044395	0.01957995927764	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1864.6267026941	1864.6267026941
"healthy-1"	"2019-08-01-count-2:GAGCTGCCAGTTAAAG"	1.17799963530843	9.79197404468385	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCCAGTTAAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.58053946322	37.539935790415	0.0196896669264147	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1902.91975137181	1902.91975137181
"healthy-1"	"2019-08-01-count-3:GAGTCTAGTCCCGGTA"	2.91464342650716	-10.6976289979187	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTAGTCCCGGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.97988739282	37.642297057519	0.0156909598347772	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.15185886138	2388.15185886138
"healthy-1"	"2019-08-01-count-2:ATCCGTCTCATGGCCG"	1.17661919173543	9.49299810016481	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCGTCTCATGGCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.90807570154	33.7696787387402	0.0192649456105821	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1751.48574847998	1751.48574847998
"healthy-1"	"2019-08-01-count-3:CGAGGCTAGCAATAGT"	2.22720326957051	-10.4306888810364	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGCTAGCAATAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.79704302499	38.7867154250891	0.0170506267994402	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2270.04275144787	2270.04275144787
"healthy-1"	"2019-08-01-count-3:TGGTAGTTCAGCGGAA"	1.40535904940907	-8.860378288385	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTTCAGCGGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.94039471907	45.6889003667096	0.0195926535987699	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2327.91239507413	2327.91239507413
"healthy-1"	"2019-08-01-count-2:CTGCATCAGACTAGAT"	-4.6712478202885	3.65227696979371	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCAGACTAGAT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2628.40288006056	37.2690460090383	0.0141793506207768	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2625.3680483167	2625.3680483167
"healthy-1"	"2019-08-01-count-3:CATCAAGTCGCAATTG"	-4.6519058746403	3.30534360492555	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCAAGTCGCAATTG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2634.22982057948	46.0443909037413	0.0174792611274944	3549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2629.37809427372	2629.37809427372
"healthy-1"	"2019-08-01-count-3:CGAGTGCTCCCTCGTA"	10.9015613990719	4.46934268558351	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTGCTCCCTCGTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.16877073752	39.5666466190078	0.020520323334494	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1918.80199616329	1918.80199616329
"healthy-1"	"2019-08-01-count-4:ATGGGAGTCAAACCCA"	1.63858642157857	-9.50971891796263	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGGAGTCAAACCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.75641413355	39.4271635624459	0.0160158671004511	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2457.52794959775	2457.52794959775
"healthy-1"	"2019-08-01-count-4:CCTCTAGGTCAGGAGT"	1.73782732066457	-9.75850965892943	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGGTCAGGAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.55192133064	39.2579567324148	0.0174747604805689	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2242.27678797448	2242.27678797448
"healthy-1"	"2019-08-01-count-2:ATCGATGCAATTGCCA"	3.13596715506856	-10.4597807160583	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGATGCAATTGCCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.84204413365	42.7519092408623	0.0178890104246871	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2384.3621717387	2384.3621717387
"healthy-1"	"2019-08-01-count-2:GTCACGGTCTCACCCA"	10.3100305992061	4.84554956043092	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGTCTCACCCA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.608384414	37.7907163376874	0.0205428050110379	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1830.27367623483	1830.27367623483
"healthy-1"	"2019-08-01-count-2:CCACGTTTCGACGATT"	0.967698176472825	9.10432813251344	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTTCGACGATT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.62661736961	37.8529273455756	0.022523103558136	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1673.77704593921	1673.77704593921
"healthy-1"	"2019-08-01-count-2:GAGTGTTCAAGGAGTC"	1.31425251540486	-8.85823442852172	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGTTCAAGGAGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.67246333025	43.8724861614343	0.0180050814467993	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2431.95302076512	2431.95302076512
"healthy-1"	"2019-08-01-count-3:CTGCCATAGCGATTCT"	-5.10298476639445	3.39053342426149	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATAGCGATTCT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2378.53652957226	45.666006741848	0.0191992034488788	2645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2372.5042511857	2372.5042511857
"healthy-1"	"2019-08-01-count-3:TGGTTAGCAACCACGC"	1.9968886571819	-10.3512058488098	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGCAACCACGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.04671468724	37.9194808793839	0.0155851840618105	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2429.92441184294	2429.92441184294
"healthy-1"	"2019-08-01-count-2:TGACCCTGTAGTAAGT"	1.95103540000264	-10.2152023545471	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTGTAGTAAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.49342860281	42.1100764022481	0.0175935625721896	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2391.65343939953	2391.65343939953
"healthy-1"	"2019-08-01-count-2:TTGCTGCTCCTTCTGG"	1.22823025759999	10.3877811201843	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCTCCTTCTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2023.4587289007	38.9773887394793	0.0192627545018696	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2019.15766733999	2019.15766733999
"healthy-1"	"2019-08-01-count-3:CATCCGTTCCCTCGTA"	1.70156099376027	-4.88487007534178	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCGTTCCCTCGTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2616.08840383299	41.4188468269285	0.0158323574869424	2652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2607.46558623837	2607.46558623837
"healthy-1"	"2019-08-01-count-3:TCGCAGGCATCACCAA"	8.26707233962361	7.3389944800171	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCAGGCATCACCAA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2329.02551047828	40.6290858374956	0.0174446718830281	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2326.54550313852	2326.54550313852
"healthy-1"	"2019-08-01-count-4:CCTCTCCCAGCAATTC"	2.58080520209615	-10.2832346192566	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCCAGCAATTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.16202569387	40.8106691197199	0.0162065302801454	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2513.80625633716	2513.80625633716
"healthy-1"	"2019-08-01-count-2:TACCGGGCACTGCGAC"	-8.42614207688029	-0.554474734422289	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGCACTGCGAC"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2770.3219358348	48.1315047245058	0.0173739752416182	3620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2760.01623441526	2760.01623441526
"healthy-1"	"2019-08-01-count-3:CGCAGGTAGTCAGCCC"	2.0323289829189	-10.3780985108581	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCAGGTAGTCAGCCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.55213662144	41.133038844756	0.0196381069373163	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2087.47469935483	2087.47469935483
"healthy-1"	"2019-08-01-count-2:TTACGCCGTGGAACCA"	1.8806047635967	-10.4290828934875	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCGTGGAACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.09695276644	37.7597216754218	0.0153864017608825	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2449.94483096502	2449.94483096502
"healthy-1"	"2019-08-01-count-2:TACCTCGGTGATAGTA"	1.63782455500905	-4.77812054073485	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTCGGTGATAGTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2410.55406294275	41.9836574114392	0.0174166006300586	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2407.98107778178	2407.98107778178
"healthy-1"	"2019-08-01-count-3:GGCACGTTCCCTCGAT"	11.0768228965694	4.21831271732179	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTTCCCTCGAT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2196.28846609836	35.0188393474233	0.0159445536813446	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2190.06763164742	2190.06763164742
"healthy-1"	"2019-08-01-count-3:TGTAAGCTCGCGCCAA"	-1.97433791580852	13.38937757099	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAAGCTCGCGCCAA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1592.01778784678	37.9769002080801	0.023854570280552	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1589.83424931571	1589.83424931571
"healthy-1"	"2019-08-01-count-4:GTTAGACAGGAACGCT"	-2.46498737755473	3.4143175848755	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACAGGAACGCT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3203.27337167043	43.4310193106037	0.0135583243361947	5389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3197.75306837808	3197.75306837808
"healthy-1"	"2019-08-01-count-4:TCAAGCACAGCAGTCC"	-1.77873001518901	-6.68523743068846	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCACAGCAGTCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.10653233108	38.8964396879648	0.0171417424143617	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2261.92500197991	2261.92500197991
"healthy-1"	"2019-08-01-count-2:CTGTCGTAGGTGAGAA"	1.68434097346608	-4.98724367534789	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTCGTAGGTGAGAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2450.88362754711	39.1242471387875	0.0159633230639938	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2450.15733639155	2450.15733639155
"healthy-1"	"2019-08-01-count-4:TGGGAAGTCTCGGCTT"	1.73576917228047	-4.74936916744383	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAAGTCTCGGCTT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2261.87887888865	40.4235136219327	0.0178716526332278	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2257.31840669169	2257.31840669169
"healthy-1"	"2019-08-01-count-3:GATAGAACAAAGACTA"	2.80337776717488	-10.5714740983215	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGAACAAAGACTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.00968977976	38.0110500997518	0.0156940123981123	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2419.28093735285	2419.28093735285
"healthy-1"	"2019-08-01-count-4:GGATCTAAGTGACCTT"	7.03675379332845	-1.10757257854613	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATCTAAGTGACCTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2222.17013553941	35.5393337376539	0.0159930750437464	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2215.82540990828	2215.82540990828
"healthy-1"	"2019-08-01-count-3:TATCGCCTCAGCATTG"	2.74013366278951	-10.2665186158386	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCGCCTCAGCATTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.94505819388	40.2678765812878	0.0165715173046826	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2425.71235165195	2425.71235165195
"healthy-1"	"2019-08-01-count-3:TTTCGATAGTATCCTG"	1.05007918652837	11.0344705351624	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCGATAGTATCCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.9406861881	38.0347911065055	0.0194259158997074	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1956.68825425807	1956.68825425807
"healthy-1"	"2019-08-01-count-2:GAGTCATAGCGCATCC"	2.3130473094875	-9.76074125682982	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATAGCGCATCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.24288046832	40.8998926023846	0.017175859269904	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2376.72087051191	2376.72087051191
"healthy-1"	"2019-08-01-count-3:GCAGTTAGTGCATCTA"	1.7671203809673	-10.1437816849914	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGTTAGTGCATCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.10770809958	39.3137924485731	0.0169229314299568	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2318.74743390163	2318.74743390163
"healthy-1"	"2019-08-01-count-2:ACCAAACAGGGCCCTT"	1.17752446708028	9.81159684741823	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACAGGGCCCTT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.38409226977	40.4219890300036	0.0226151666028718	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1783.36512996889	1783.36512996889
"healthy-1"	"2019-08-01-count-2:AGCCAGCCATCCGAAT"	1.39374830302541	-9.19992258464965	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCCATCCGAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2526.0161041678	42.0152428168767	0.0166330067126467	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2520.62706449401	2520.62706449401
"healthy-1"	"2019-08-01-count-2:TTACTGTAGACGAGCT"	-4.01224074783977	-5.54050829326781	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACTGTAGACGAGCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2032.83171537828	48.1291833685713	0.0236759309708109	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2028.90145626519	2028.90145626519
"healthy-1"	"2019-08-01-count-4:TCGGATAAGCCATTGT"	2.50438918647115	-10.5434017411438	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGATAAGCCATTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.62079442241	39.5126083672667	0.0159929878581404	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2467.95868335999	2467.95868335999
"healthy-1"	"2019-08-01-count-4:GAGCCTGTCGGCTGGT"	3.07587208327596	-10.5355291596619	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGTCGGCTGGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.91589994838	37.4538377803594	0.016277795195035	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2290.69667608089	2290.69667608089
"healthy-1"	"2019-08-01-count-2:AGCGATTCACATTGTG"	1.09785189208333	9.62413213336793	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTCACATTGTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1819.01544815966	40.8461700762271	0.0224550979583774	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1808.88852603388	1808.88852603388
"healthy-1"	"2019-08-01-count-2:GAGTCTATCTAGTTCT"	2.43265595015828	-10.7118091813293	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCTATCTAGTTCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.6632606315	39.9562673066597	0.0153579703842846	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2593.96896867984	2593.96896867984
"healthy-1"	"2019-08-01-count-1:ACTACGAGTGTACATC"	2.99179091033284	-10.8633661500183	"2019-08-01-count-1"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTACGAGTGTACATC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.10893216548	46.8945907645346	0.020794822855632	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2251.75220766236	2251.75220766236
"healthy-1"	"2019-08-01-count-3:CTGGCAGAGGACACTG"	-8.34956012192424	-1.04203667556914	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGCAGAGGACACTG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2903.58881707027	45.2130689937662	0.0155714434247568	4386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2897.50026613413	2897.50026613413
"healthy-1"	"2019-08-01-count-4:TCGGGACTCAAGCCTA"	-4.87221703949626	3.36433122241823	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACTCAAGCCTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2582.223625214	41.9213420687871	0.0162345900871823	2994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2577.61208798542	2577.61208798542
"healthy-1"	"2019-08-01-count-3:AGGTCTAAGGGTCAAC"	1.28004803237264	-8.40086557781371	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTAAGGGTCAAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2357.50121177968	41.6449296859828	0.0176648603520951	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2352.36236548438	2352.36236548438
"healthy-1"	"2019-08-01-count-4:TCGGGACCAGGGCTTC"	-0.517102519900161	13.3794173964295	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACCAGGGCTTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.11662701166	37.7093121801737	0.0202290519990827	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1862.29625135108	1862.29625135108
"healthy-1"	"2019-08-01-count-3:CGGAACCTCGCAATTG"	13.9715572791988	1.99239990794984	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAACCTCGCAATTG"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1287.86801253066	46.4545301427584	0.0360708781418333	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1273.8752220706	1273.8752220706
"healthy-1"	"2019-08-01-count-4:GAGGCAATCCTGATAG"	1.71490683135335	-9.37651350414427	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCAATCCTGATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.2446134684	35.0252798360316	0.0182971808250616	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1912.59172117871	1912.59172117871
"healthy-1"	"2019-08-01-count-4:TTGGGATGTGCAGATG"	-4.98146710816081	-5.47133591091307	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGATGTGCAGATG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2746.59467105246	46.3923481035402	0.0168908607420269	2648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2740.1602311941	2740.1602311941
"healthy-1"	"2019-08-01-count-3:TCGGGTGAGGAGAGTA"	1.8901684480602	-5.10325529491576	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGAGGAGAGTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2335.59003997312	38.8062464657511	0.016615178949041	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2332.92934415351	2332.92934415351
"healthy-1"	"2019-08-01-count-3:AGACCATCACTGGCCA"	1.48308684405629	10.4769773253235	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATCACTGGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.6042506615	36.5167512678821	0.0197323394533591	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1846.04148046202	1846.04148046202
"healthy-1"	"2019-08-01-count-4:GAGGGATGTCTAATCG"	3.27359547194783	-10.4705648652283	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATGTCTAATCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.79414469634	41.3964886458579	0.018391947901323	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2243.78184836051	2243.78184836051
"healthy-1"	"2019-08-01-count-4:CATCGCTAGATCCCGC"	1.8208222585613	-9.80779650127562	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTAGATCCCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.0319187255	42.3816617434006	0.0195124488632143	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2167.29053434884	2167.29053434884
"healthy-1"	"2019-08-01-count-2:TCCAGAAGTCGTTCAA"	10.7579580741817	4.15762326801149	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCAGAAGTCGTTCAA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1548.05004708183	24.6577102708305	0.0159282384424921	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1542.96781853559	1542.96781853559
"healthy-1"	"2019-08-01-count-2:TCCAGAATCGCTCTAC"	0.693979878991288	-9.06498243724974	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCAGAATCGCTCTAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1407.93441106704	34.7088656817955	0.0246523313933996	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1379.1658648537	1379.1658648537
"healthy-1"	"2019-08-01-count-2:TCGACGGAGGTCCGAA"	1.83683588084523	-10.0267820588318	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACGGAGGTCCGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.18908421659	39.5217807091237	0.0186671001677432	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2114.45962993284	2114.45962993284
"healthy-1"	"2019-08-01-count-2:TTGTTCATCCATCACC"	1.21496142920796	9.90093419635621	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCATCCATCACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1827.91970285037	41.1363787135482	0.0225044779863153	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1823.24840317714	1823.24840317714
"healthy-1"	"2019-08-01-count-3:CTACATTTCCGACATA"	1.31409420546834	9.71619603717653	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACATTTCCGACATA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.78778604598	38.4131118111961	0.0201138116453904	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1899.24031329887	1899.24031329887
"healthy-1"	"2019-08-01-count-4:GGCTTGGTCGCTGATA"	-5.59913287583049	-4.5670786133972	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTGGTCGCTGATA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3006.989098737	42.5080589512713	0.0141364193734941	3901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	3004.41731828172	3004.41731828172
"healthy-1"	"2019-08-01-count-2:GAGTTTGCAAGGGTCA"	0.999863167374772	8.98652074420778	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTTGCAAGGGTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1701.98909671028	37.0218451191696	0.0217521047524498	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1692.91155128057	1692.91155128057
"healthy-1"	"2019-08-01-count-4:CTCTCGACAGGATCTT"	11.1377569633419	3.9041697748932	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCGACAGGATCTT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1748.65062941888	32.8912279812927	0.0188094908313523	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1735.20042713796	1735.20042713796
"healthy-1"	"2019-08-01-count-2:AGCGTATGTCACCGCA"	1.68153609809224	-9.68713381206664	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATGTCACCGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2014.78372272592	47.7961792340689	0.023722734452809	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2013.41451156015	2013.41451156015
"healthy-1"	"2019-08-01-count-2:AAACGCTTCGGTGCAC"	1.71655048903767	-9.67919924175414	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTTCGGTGCAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2338.01512978416	45.2855688047361	0.0193692368487439	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2333.83074942263	2333.83074942263
"healthy-1"	"2019-08-01-count-4:CATCGGGTCTGCGGAC"	-5.03271422806438	-5.45760633861693	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGTCTGCGGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2693.70113442342	48.0719362362694	0.0178460541230604	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2688.78515211035	2688.78515211035
"healthy-1"	"2019-08-01-count-2:GCAGCCATCCTAAGTG"	0.877002080052537	9.89002225482789	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCCATCCTAAGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1947.43535382101	38.0737994650642	0.0195507385600044	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1944.87309887923	1944.87309887923
"healthy-1"	"2019-08-01-count-3:CTTCCGATCTTGGTGA"	11.1718021827633	3.9245760210785	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCGATCTTGGTGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.88525610259	36.4905596992497	0.0192370938525952	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1880.38997251523	1880.38997251523
"healthy-1"	"2019-08-01-count-4:GAGTGAGAGATTAGCA"	14.0812231498653	1.6957877644333	"2019-08-01-count-4"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGAGAGATTAGCA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1123.1128489373	19.9042979227194	0.0177224380805126	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1111.4405482854	1111.4405482854
"healthy-1"	"2019-08-01-count-3:TCGTGGGTCGCGTGAC"	3.12833752211873	-10.515386604425	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTGGGTCGCGTGAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.38149355877	37.9318343323457	0.017631384506148	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2148.00461532238	2148.00461532238
"healthy-1"	"2019-08-01-count-2:CGTGAATCAGACCAAG"	-0.155592511326629	11.9458789595398	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATCAGACCAAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1834.39286621406	35.8063158495253	0.0195194369259758	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1825.6406314745	1825.6406314745
"healthy-1"	"2019-08-01-count-2:CCCTCAATCTTGTGCC"	1.13664974746053	11.7148990401062	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAATCTTGTGCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2027.27268849604	36.413479342057	0.0179618062970457	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2019.73401215733	2019.73401215733
"healthy-1"	"2019-08-01-count-4:TCGTAGAGTATGTGTC"	3.23588885840718	-10.2691726914612	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGAGTATGTGTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.28120371296	42.6294975081691	0.017242980872947	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2469.59586767027	2469.59586767027
"healthy-1"	"2019-08-01-count-2:GTGTGGCCATGGAATA"	1.75335516509358	-4.82548715984496	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGGCCATGGAATA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2275.86614478872	41.6223357693916	0.0182885693276375	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2268.07059925332	2268.07059925332
"healthy-1"	"2019-08-01-count-4:TATGTTCGTGGTTCTA"	1.76190259036366	-4.86294414913329	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCGTGGTTCTA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2388.18326935035	42.0624801546643	0.0176127522098028	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2382.08102513397	2382.08102513397
"healthy-1"	"2019-08-01-count-4:AGGGCCTAGTGAATAC"	1.44489779052083	11.1835517653259	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTAGTGAATAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.71879724986	37.0801953977281	0.0189598808631744	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1950.50014250548	1950.50014250548
"healthy-1"	"2019-08-01-count-2:TAAGCCACAAGTCATC"	-2.56899676743205	3.48856303775636	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCCACAAGTCATC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3250.69185961529	43.7314932611981	0.0134529802115337	5622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3243.41762532569	3243.41762532569
"healthy-1"	"2019-08-01-count-4:GACCCAGCAGGTATGG"	2.76323499259297	-10.855890297052	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCCAGCAGGTATGG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.12507362137	39.5064102532862	0.0167604217083782	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.39825587954	2349.39825587954
"healthy-1"	"2019-08-01-count-4:TATTGCTGTAACGTTC"	1.94775344905202	-10.3373270264831	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTGTAACGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.58216707596	39.1025778477872	0.0162955777819587	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2395.72041032935	2395.72041032935
"healthy-1"	"2019-08-01-count-2:TGATTTCAGAATCGCG"	-5.19158015671428	-4.51551725780638	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCAGAATCGCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2810.92975564751	40.1345790560848	0.0142780441152787	3200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2805.73308366547	2805.73308366547
"healthy-1"	"2019-08-01-count-4:CATGCAATCAGTGATC"	14.220304151147	1.82107112491456	"2019-08-01-count-4"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCAATCAGTGATC"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1349.62953218025	34.7185627264867	0.0257245132080066	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1337.76845031104	1337.76845031104
"healthy-1"	"2019-08-01-count-4:TTGTTTGTCGTCCATC"	3.08869781073872	-10.3880329362121	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTTGTCGTCCATC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.20025836827	42.8025368731149	0.0180738671579263	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.62088778811	2362.62088778811
"healthy-1"	"2019-08-01-count-3:AACAGGGAGGATCACG"	1.30739953097646	9.47635934436647	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGAGGATCACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1785.46827549003	29.8988176784509	0.0167456448758492	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1779.52786953358	1779.52786953358
"healthy-1"	"2019-08-01-count-3:AAGGTAAGTGATGAAT"	1.27452888068501	9.35649583423463	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAAGTGATGAAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1613.67897796525	39.2316029852957	0.0243119006450491	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1608.54114501485	1608.54114501485
"healthy-1"	"2019-08-01-count-3:CACAGGCTCTGGCCTT"	1.22764398631398	9.44748303974	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCTCTGGCCTT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.93676060827	39.5811632410342	0.0209209758302432	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1885.64086156593	1885.64086156593
"healthy-1"	"2019-08-01-count-3:CACATGAAGATAACGT"	3.41094412383382	-10.5739164582458	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACATGAAGATAACGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.41750230596	41.7632094239413	0.0177987120292523	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2340.35743509924	2340.35743509924
"healthy-1"	"2019-08-01-count-2:CTTACCGTCCATATGG"	1.3369046646053	11.2232208021912	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTACCGTCCATATGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.10458776003	37.0759953299966	0.0200616326454413	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1845.0214044461	1845.0214044461
"healthy-1"	"2019-08-01-count-2:ATGAGTCAGTTCAACC"	1.66011704978291	-10.0760488740173	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGTCAGTTCAACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.6822660764	36.7558573931967	0.0162300283548724	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2259.64540519274	2259.64540519274
"healthy-1"	"2019-08-01-count-4:TATTGGGGTCGTGGTC"	-3.05578194084819	-5.708203338739	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGGGGTCGTGGTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2305.88902006951	45.3084249139388	0.0196490050126406	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2300.44008586144	2300.44008586144
"healthy-1"	"2019-08-01-count-2:TTCAGGAAGAGATCGC"	2.45589031752889	-10.1519947282043	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGAAGAGATCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.8436371284	41.117318967435	0.0176632649683279	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2324.94417848878	2324.94417848878
"healthy-1"	"2019-08-01-count-4:GATCAGTCAAACGAGC"	1.35209312018697	10.8749999769959	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCAGTCAAACGAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1994.33209607773	34.7575692405037	0.0174281752316286	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1986.50495308679	1986.50495308679
"healthy-1"	"2019-08-01-count-3:CCACGTTTCGTAGTCA"	1.98758699473683	-10.5079202882019	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGTTTCGTAGTCA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.74460339037	41.1697548860111	0.0174986077225231	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.60816935301	2344.60816935301
"healthy-1"	"2019-08-01-count-4:CACACAACATATGCGT"	1.77691986140553	-10.406427406427	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAACATATGCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.41626519535	39.550716130989	0.0164286985606869	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.22752375506	2403.22752375506
"healthy-1"	"2019-08-01-count-3:CACCAAATCCGTATAG"	2.08066238936726	-10.4336605302063	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAATCCGTATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.57856397979	42.1540599086441	0.0190778733084368	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2204.04976645689	2204.04976645689
"healthy-1"	"2019-08-01-count-3:GCCATGGCAACAAAGT"	2.14983191069905	-10.2866850129333	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGCAACAAAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.84496118761	40.97502960936	0.0164568598640036	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2484.98273374795	2484.98273374795
"healthy-1"	"2019-08-01-count-2:CAGATTGCAGCCTACG"	1.06478609618489	10.7078723677429	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGCAGCCTACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1932.54622062659	33.7505805598704	0.0174643070368208	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1928.60299128619	1928.60299128619
"healthy-1"	"2019-08-01-count-2:AGGACGAGTACCATAC"	8.52847160872762	7.73383281314699	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGAGTACCATAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2160.54782479624	44.6954477738179	0.0206870902189046	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2150.48835911615	2150.48835911615
"healthy-1"	"2019-08-01-count-4:GACGTTACAGAGGCTA"	-5.29565129700358	-5.22233345424803	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTACAGAGGCTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2415.87624189151	44.4869876862102	0.0184144315486041	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2413.5705386034	2413.5705386034
"healthy-1"	"2019-08-01-count-2:CTTCCGACACTCTGCT"	13.9977709251339	1.64621934974519	"2019-08-01-count-2"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGACACTCTGCT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1436.49265239911	31.2534135735251	0.0217567514329629	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1423.4180532311	1423.4180532311
"healthy-1"	"2019-08-01-count-2:GCATGATCAATTTCCT"	-7.92172370377238	4.25027606571046	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATGATCAATTTCCT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2404.99185899416	43.4275323558246	0.0180572471351264	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2396.46279983927	2396.46279983927
"healthy-1"	"2019-08-01-count-3:GGAGAACAGCCGGAAT"	14.344574590295	2.05080375755159	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACAGCCGGAAT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1136.09483870959	18.2924903539416	0.01610120012051	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1125.49419341977	1125.49419341977
"healthy-1"	"2019-08-01-count-3:CCACAAAAGCCAAGGT"	1.53627206858937	-9.73228456890257	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACAAAAGCCAAGGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.10062498637	46.9194581383855	0.0194517001705311	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2407.94081021401	2407.94081021401
"healthy-1"	"2019-08-01-count-2:TTCATTGAGACTCGAG"	1.1596608358318	9.64197061145631	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGAGACTCGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1716.16566029125	36.389007230008	0.0212036681958969	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1710.44109782472	1710.44109782472
"healthy-1"	"2019-08-01-count-4:CCCATTGCATGGATCT"	1.8202369409496	-9.8093586198059	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGCATGGATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.09140394082	36.9585624773809	0.0162520127437862	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2268.41570982626	2268.41570982626
"healthy-1"	"2019-08-01-count-4:TTAGGGTTCAACCTCC"	-4.99246917191203	-5.65542461788329	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTTCAACCTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2623.95646732716	45.4733012581374	0.0173300517079302	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2622.295359554	2622.295359554
"healthy-1"	"2019-08-01-count-3:GCAACATCACCTCTAC"	-0.512999991804916	12.5344619520935	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACATCACCTCTAC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1890.47736287622	49.1295138769193	0.0259878879491963	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1888.75664347877	1888.75664347877
"healthy-1"	"2019-08-01-count-2:GAAGCCCAGGGATCAC"	2.39262380179707	-10.2074623337952	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCCCAGGGATCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.38669377764	45.8382592750467	0.0193951583952514	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2358.65702051071	2358.65702051071
"healthy-1"	"2019-08-01-count-3:CCACACTTCGAAGCCC"	-0.609326104552108	11.4888381727966	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACACTTCGAAGCCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.64458002835	39.8341176879336	0.0198610053269611	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2005.64458002835	2005.64458002835
"healthy-1"	"2019-08-01-count-2:AGGACTTTCCTGTTGC"	1.03035809573476	11.4319076308045	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTTCCTGTTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.96894057846	45.2682578769216	0.0238007345499311	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1894.78639723658	1894.78639723658
"healthy-1"	"2019-08-01-count-4:GATCCCTTCCGTGTCT"	7.81151356276814	7.15088651264039	"2019-08-01-count-4"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCCCTTCCGTGTCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1758.83441729732	37.5585608437368	0.0213542335050791	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1751.23413472349	1751.23413472349
"healthy-1"	"2019-08-01-count-2:TGCAGTATCGCCTAGG"	0.248279188841027	12.2412652739319	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTATCGCCTAGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2267.27667314829	36.6320539809958	0.016156852145499	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2255.15236557692	2255.15236557692
"healthy-1"	"2019-08-01-count-4:TGAGGAGCAATGCTCA"	-5.12337766113933	-5.25303604519042	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGCAATGCTCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2792.44329773394	43.5773651129761	0.0156054610485158	3297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2787.99396026301	2787.99396026301
"healthy-1"	"2019-08-01-count-2:AAGGAATTCGATGCTA"	1.25318016585652	9.54839322650758	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGAATTCGATGCTA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.90470841336	40.6742537838988	0.0209671400906934	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1936.67014842492	1936.67014842492
"healthy-1"	"2019-08-01-count-2:TCAATCTTCGACGAGA"	3.13057937201802	-10.8983927003113	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATCTTCGACGAGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.25147345589	48.1782517998931	0.0229611428417309	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2088.72733519783	2088.72733519783
"healthy-1"	"2019-08-01-count-4:AACAACCCACTTGGGC"	1.80209328707997	-10.2953052750793	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAACCCACTTGGGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.17134018955	41.6605757188376	0.0167704115432146	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2480.96659401143	2480.96659401143
"healthy-1"	"2019-08-01-count-4:TCTATCAGTTCCTTGC"	2.02596892890279	-10.4114265671936	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATCAGTTCCTTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.41436391734	38.4092471726426	0.0155100243853717	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2471.09854854055	2471.09854854055
"healthy-1"	"2019-08-01-count-2:AACAAGAGTGCTGCAC"	4.3864127593929	-10.6907692185608	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAGAGTGCTGCAC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.71335658657	43.2106961123042	0.020194619049926	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2131.43132824107	2131.43132824107
"healthy-1"	"2019-08-01-count-2:TGCCGAGTCCACCCTA"	2.10851587828938	-10.2484207383362	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGTCCACCCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.90738799769	40.0923736789958	0.0188855971323415	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2121.70858962083	2121.70858962083
"healthy-1"	"2019-08-01-count-2:AGGCATTAGTAGCCAG"	1.30360354956929	11.3817682036194	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTAGTAGCCAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.51382912691	42.5777909399534	0.0239670472820799	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1774.31231667602	1774.31231667602
"healthy-1"	"2019-08-01-count-4:AGTACCATCTGGGCAC"	1.8287019926006	-10.321201347467	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCATCTGGGCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.83777909502	40.820924319138	0.0169603970295359	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.15915597443	2403.15915597443
"healthy-1"	"2019-08-01-count-2:GGGACCTTCCTGATAG"	-1.01991413059886	8.95694348895875	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTTCCTGATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2822.93207829613	36.2718228879128	0.0128489888817324	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2815.13128019896	2815.13128019896
"healthy-1"	"2019-08-01-count-4:CGCATGGAGAATAACC"	1.64705099639241	-9.9420433274475	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGAGAATAACC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.42283898253	42.5597967082815	0.018068856259654	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2352.21373867639	2352.21373867639
"healthy-1"	"2019-08-01-count-4:AGTACTGGTGGTCTAT"	2.35074963149373	-10.4665184251037	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGGTGGTCTAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2321.8118764847	43.7018362092685	0.0188222985039747	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2319.73236484117	2319.73236484117
"healthy-1"	"2019-08-01-count-4:CATTGCCAGCTGTCCG"	3.09974422034566	-10.7233925095764	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCAGCTGTCCG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.87968838855	37.3772288031649	0.0155681390383423	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.77676478275	2396.77676478275
"healthy-1"	"2019-08-01-count-3:TCTTAGTCAAACTCTG"	6.91465153273885	-1.24665679847869	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTCAAACTCTG"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2518.49750300606	38.7411431270078	0.0153826410710222	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2509.44177849709	2509.44177849709
"healthy-1"	"2019-08-01-count-3:TCTTAGTAGACCAAAT"	2.77894773063008	-10.7202034226623	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTAGACCAAAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.47439887919	41.4275745484395	0.0169682608867239	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2437.46488955641	2437.46488955641
"healthy-1"	"2019-08-01-count-3:TCTGTCGCAGACAAAT"	10.567981381982	4.62539956653444	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGTCGCAGACAAAT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.73453800653	38.7061136435219	0.0206792752164232	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1861.85745924746	1861.85745924746
"healthy-1"	"2019-08-01-count-2:GTGCACGTCGAACACT"	1.18780602988545	10.0914773710999	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCACGTCGAACACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1647.65003435225	38.483529755326	0.0233566163645033	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1643.82464438049	1643.82464438049
"healthy-1"	"2019-08-01-count-2:GATTCTTAGAAGCGAA"	6.68833126601521	-0.916523539182268	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCTTAGAAGCGAA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2464.84191814312	43.156517215822	0.0175088377466145	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2457.75364346661	2457.75364346661
"healthy-1"	"2019-08-01-count-2:TGGTTAGCACACGTGC"	1.57122923907582	-7.87603809749755	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGCACACGTGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2141.26761182347	36.1551944605362	0.016884949018468	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2141.26761182347	2141.26761182347
"healthy-1"	"2019-08-01-count-2:TATCTTGCATGTTCAG"	2.38111724433247	-10.4420891038147	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTTGCATGTTCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.08440673955	39.1628947814658	0.01634453889492	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2390.7335947518	2390.7335947518
"healthy-1"	"2019-08-01-count-2:CCTCACAAGCGATTCT"	2.26729526099507	-10.4790868989197	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACAAGCGATTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.75243052022	39.9626891182629	0.0166597805633473	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2396.58323081173	2396.58323081173
"healthy-1"	"2019-08-01-count-2:AACGTCAGTGAGCTCC"	1.70882799205129	-9.93968393718871	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCAGTGAGCTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2557.31979106547	45.1816790223838	0.0176675905689368	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2553.89833619148	2553.89833619148
"healthy-1"	"2019-08-01-count-4:TTGATGGAGGAGAGTA"	10.8547646003658	4.20534417713014	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGAGGAGAGTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1626.91308657616	35.0834138980945	0.0215644057372035	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1614.36243955505	1614.36243955505
"healthy-1"	"2019-08-01-count-3:GGATCTAAGACTCTTG"	2.60696711119954	-10.642945312616	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATCTAAGACTCTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.59781053838	40.3075952436353	0.0171259486489814	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2348.16335692611	2348.16335692611
"healthy-1"	"2019-08-01-count-2:CGGAATTTCGTAACCA"	1.7226742702419	-10.1307039490906	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTTCGTAACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.42307973024	40.3710256503925	0.0169524793784083	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.33382400636	2375.33382400636
"healthy-1"	"2019-08-01-count-4:AGACCATCAACAACAA"	1.38821675357167	10.0112886198792	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATCAACAACAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1706.05078271404	31.0238959103777	0.0181846262870464	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1702.32385722705	1702.32385722705
"healthy-1"	"2019-08-01-count-4:TTTCCTCCAAGGGCAT"	0.546812643378419	9.9490756758484	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCCAAGGGCAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.60413751379	37.3547970395388	0.0194090807098616	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1923.57336958498	1923.57336958498
"healthy-1"	"2019-08-01-count-4:AGTAGTCTCACTCTTA"	-3.50156341019328	3.70818350398866	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCTCACTCTTA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3003.75868191508	44.251050688013	0.0147318927297449	4935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	2996.56870199028	2996.56870199028
"healthy-1"	"2019-08-01-count-4:TCTGGCTAGACTCATC"	2.68107404288594	-10.751621269342	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTAGACTCATC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.40416595568	37.6182754395451	0.0145446237423783	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2584.8386394359	2584.8386394359
"healthy-1"	"2019-08-01-count-3:TCACTATCAACCGCCA"	1.41999699649159	-8.75384046947631	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTATCAACCGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.9123221223	39.0378651027497	0.0157734335692643	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2472.95959368515	2472.95959368515
"healthy-1"	"2019-08-01-count-2:TTCCTCTCACAGCGCT"	2.99866475638692	-10.7634039155212	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTCTCACAGCGCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.57202749208	36.6687658874919	0.0141875581324283	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2582.8336260117	2582.8336260117
"healthy-1"	"2019-08-01-count-4:TCACGGGGTGGGAGAG"	2.37913169440572	-10.7523594132629	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGGGGTGGGAGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.74469527	39.4119163071308	0.0159320872450943	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2470.01405242217	2470.01405242217
"healthy-1"	"2019-08-01-count-2:AACCATGGTGACACGA"	2.40153302726094	-10.8224697343078	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGGTGACACGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.9066976032	41.0975935179583	0.0178459655185907	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2295.7108335982	2295.7108335982
"healthy-1"	"2019-08-01-count-3:GACGCTGTCGGACTTA"	1.7707984643871	-9.9034109345642	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGCTGTCGGACTTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2407.18818597984	40.786565311099	0.0169436546542775	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2404.75815955643	2404.75815955643
"healthy-1"	"2019-08-01-count-3:TTGTTTGTCACTGAAC"	-7.64524875107463	3.01101658428041	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTTGTCACTGAAC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2280.0961094696	40.8936390695682	0.0179350505883197	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2276.29210379662	2276.29210379662
"healthy-1"	"2019-08-01-count-2:GGGTGTCGTGATGTAA"	1.28003718432729	11.4873647459778	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCGTGATGTAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.48425251292	34.1046207351194	0.0174494221129029	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1951.24796585056	1951.24796585056
"healthy-1"	"2019-08-01-count-2:CTATAGGAGAGTGGCT"	-8.71551928940471	2.94197223270265	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	1	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGAGAGTGGCT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2362.78040873103	45.4628435209207	0.0192412478759874	2657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2358.9134819145	2358.9134819145
"healthy-1"	"2019-08-01-count-2:AGTTAGCAGGAAGTAG"	2.46917309340779	-10.6125164262024	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTAGCAGGAAGTAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.56785773377	45.9181303660458	0.0196687923265678	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2332.17311302683	2332.17311302683
"healthy-1"	"2019-08-01-count-3:CAGAGCCAGCGAGTAC"	2.83763684806172	-10.55202867901	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGAGCCAGCGAGTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.21163222808	37.5950314393172	0.0147708862254438	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2542.48546056801	2542.48546056801
"healthy-1"	"2019-08-01-count-3:CTTTCAACAGACACCC"	0.273771067231339	10.7951411970886	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAACAGACACCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1993.31428234295	44.8802387258639	0.0225153851168474	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1982.63738652462	1982.63738652462
"healthy-1"	"2019-08-01-count-3:ACTTCGCGTTCCACGG"	-7.84603820267375	1.90940377796022	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCGTTCCACGG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2243.41226269336	43.191253224256	0.019252481562351	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2238.35406294442	2238.35406294442
"healthy-1"	"2019-08-01-count-4:GGGTTTATCATCCTGC"	2.6597589450771	-10.8853044739929	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTTATCATCCTGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.41284433523	40.044899554402	0.0164698067001248	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2428.00217251584	2428.00217251584
"healthy-1"	"2019-08-01-count-4:CCAATTTAGTCACTCA"	1.06934728202168	10.9756765135559	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTAGTCACTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1891.33581103626	34.1308726319692	0.0180459083113691	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1889.05500690066	1889.05500690066
"healthy-1"	"2019-08-01-count-3:TCAGCCTAGGGAACAA"	0.882762034505051	-8.36862757122191	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTAGGGAACAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2532.32014337444	45.4244105466062	0.0179378625034653	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2529.92699530995	2529.92699530995
"healthy-1"	"2019-08-01-count-2:GAAATGACAGGATCTT"	1.847788353532	-4.64995100414427	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGACAGGATCTT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2645.35680504019	37.4896108409044	0.0141718541595128	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2643.27417837907	2643.27417837907
"healthy-1"	"2019-08-01-count-3:GCATCGGTCGGCTTCT"	-3.04873261871989	-5.95992615139159	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCGGTCGGCTTCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2642.0781707467	42.2939808667513	0.0160078461474129	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2639.25033130292	2639.25033130292
"healthy-1"	"2019-08-01-count-2:ATTATCCGTGCGGATA"	1.65143813666646	-9.61081602489623	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCGTGCGGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.90339106152	41.2210444655003	0.0182806255154439	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2251.45556412806	2251.45556412806
"healthy-1"	"2019-08-01-count-3:CGTTGGGAGCAAACAT"	1.98622729358022	-9.581419014093	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTGGGAGCAAACAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.94600268309	40.9285664155005	0.0172407318318285	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.48035798263	2369.48035798263
"healthy-1"	"2019-08-01-count-3:TGACCCTCAGCCCAGT"	1.71929647502248	-9.56316378032836	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTCAGCCCAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.76169159223	45.2675359621501	0.0204021622212456	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2214.22400668741	2214.22400668741
"healthy-1"	"2019-08-01-count-3:CTCCATGAGCCTCTCT"	7.67734350737874	7.24638745868532	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGAGCCTCTCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.11009098631	35.7863939388984	0.0177326272232297	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2008.98997266766	2008.98997266766
"healthy-1"	"2019-08-01-count-3:ATACCGACAAGACGGT"	-3.48664007607158	-5.64625885402831	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCGACAAGACGGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2665.90165207562	41.0589769222351	0.01540153474539	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2659.47595324999	2659.47595324999
"healthy-1"	"2019-08-01-count-2:TATCTGTAGCTGACAG"	0.679260333150071	11.9325132139954	"2019-08-01-count-2"	"Control1"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTGTAGCTGACAG"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1989.40718917669	40.6466665769699	0.0204315470448216	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1983.34747014918	1983.34747014918
"healthy-1"	"2019-08-01-count-2:GTGGTTACAACTCGTA"	2.56912817534749	-10.6417494050232	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGTTACAACTCGTA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.39239877486	34.7137849886668	0.0156622920236757	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2214.43245071172	2214.43245071172
"healthy-1"	"2019-08-01-count-3:CAATACGGTATTTCCT"	1.25330164012257	10.1963824995789	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGGTATTTCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1953.00478199903	38.6978312058857	0.0198145091924843	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1950.70916379195	1950.70916379195
"healthy-1"	"2019-08-01-count-2:AGGTCATCATGTAACC"	0.965322812169236	9.47828004443971	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCATCATGTAACC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1875.0434794336	38.2156364743008	0.0203812001660061	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1867.2838334849	1867.2838334849
"healthy-1"	"2019-08-01-count-3:GGTGGCTCAAGGATGC"	-1.5560898584431	13.7014674910339	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTCAAGGATGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2224.6048148759	47.8466092691936	0.0215079141019762	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2221.74353770176	2221.74353770176
"healthy-1"	"2019-08-01-count-2:AGGTAGGTCCTACAAG"	2.1800819831783	-10.5286131135193	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTAGGTCCTACAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.29566573536	38.2112195264633	0.0164540717576389	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2320.33782712774	2320.33782712774
"healthy-1"	"2019-08-01-count-4:CCCAACTCAAGCGCTC"	-1.27487371388133	13.4100227125916	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTCAAGCGCTC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2265.03426276871	40.7484675308662	0.0179902212521308	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2253.52939154268	2253.52939154268
"healthy-1"	"2019-08-01-count-4:CCTCACACACAGAGAC"	1.76530625399892	-4.86073639309081	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACACACAGAGAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2627.77430096048	41.2784252413519	0.0157085124191466	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2623.39205121704	2623.39205121704
"healthy-1"	"2019-08-01-count-4:ACTGTCCTCAGCTTCC"	10.9131914573604	4.00103423679201	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTCCTCAGCTTCC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.44725067881	31.8872902071665	0.0154534070093997	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2056.49905699777	2056.49905699777
"healthy-1"	"2019-08-01-count-2:TTCTAGTAGGCATGCA"	7.69654144820516	7.09090278232423	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTAGGCATGCA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.61502847424	36.1271088030762	0.0197673515703339	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1825.99166236718	1825.99166236718
"healthy-1"	"2019-08-01-count-2:CTAGACACAGACTCTA"	1.44570793685262	9.60552690112916	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACACAGACTCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1682.55744626669	33.3390692122255	0.0198145206193103	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1681.14908351466	1681.14908351466
"healthy-1"	"2019-08-01-count-3:TTCAATCGTGATGGCA"	2.15173568305318	-10.4871568909851	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAATCGTGATGGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.83159372777	39.0390826181461	0.0161932018477415	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2409.90325010554	2409.90325010554
"healthy-1"	"2019-08-01-count-4:TACCGGGAGTACCCTA"	1.36622597750966	10.7534179457459	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGGGAGTACCCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.8217001312	48.6404348384346	0.0245680885481815	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1973.47831958291	1973.47831958291
"healthy-1"	"2019-08-01-count-4:AGATCCAGTCGTCATA"	2.46876444396321	-10.7947635880676	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCAGTCGTCATA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.40409796405	39.4318943360652	0.0155770840253357	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2527.59794128063	2527.59794128063
"healthy-1"	"2019-08-01-count-3:GATCGTAGTTGTTGTG"	-7.81913934174235	1.09682724559633	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAGTTGTTGTG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2683.69305793053	41.5222569702825	0.0154720588658904	2972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2676.89222209812	2676.89222209812
"healthy-1"	"2019-08-01-count-3:GAACTGTGTCACTTCC"	-6.09975276413615	4.24837825382081	"2019-08-01-count-3"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACTGTGTCACTTCC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2218.0993898569	41.3457805609678	0.0186401839115222	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2210.36331458269	2210.36331458269
"healthy-1"	"2019-08-01-count-4:TTAATCCGTAGGCAGT"	3.39042939719502	-10.5979337922302	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCGTAGGCAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.68469650605	37.9604175406148	0.0157860269979554	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2397.40040586291	2397.40040586291
"healthy-1"	"2019-08-01-count-3:ATAGAGAAGCTAATCC"	1.10557927665059	10.071452117804	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGAGAAGCTAATCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1651.62528795176	39.0971759084401	0.0236719407202379	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1644.51447414999	1644.51447414999
"healthy-1"	"2019-08-01-count-3:AAGCGAGCAGCTTTGA"	6.88712372359578	-1.16107060825499	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGAGCAGCTTTGA"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2490.37692468979	40.1005645448267	0.0161022069178632	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2479.16035091163	2479.16035091163
"healthy-1"	"2019-08-01-count-3:TGAGGAGGTAAGATTG"	3.36249365386311	-10.9897585145203	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGGTAAGATTG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.40764026765	44.5502794245951	0.0197351504575014	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2252.41373621914	2252.41373621914
"healthy-1"	"2019-08-01-count-4:GTGCGTGAGGCCTGAA"	-0.902948181063491	13.280150390509	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGAGGCCTGAA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2004.19687053526	37.5342434547829	0.0187278226039534	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1999.10250290968	1999.10250290968
"healthy-1"	"2019-08-01-count-2:CAATACGTCCATTGTT"	1.48683514174764	-9.3426552048889	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGTCCATTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.93811531176	43.7913837586378	0.0185247589499027	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.33044588324	2360.33044588324
"healthy-1"	"2019-08-01-count-4:GCCAACGGTATCTCGA"	-5.27073750916179	-4.45570232784423	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGGTATCTCGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2847.45426120078	40.9730264708661	0.0143893536866111	3446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2840.28195923372	2840.28195923372
"healthy-1"	"2019-08-01-count-2:CGCCAGATCGGAATGG"	1.58335270461385	-4.85200884258422	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGATCGGAATGG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2365.29832638915	42.0688733438536	0.0177858635735288	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2363.67532398633	2363.67532398633
"healthy-1"	"2019-08-01-count-2:GCAGCTGTCGTAACCA"	1.47730924662892	-8.73086550151976	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCTGTCGTAACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.14851422456	42.9286646358346	0.0174638205899356	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2452.16930352721	2452.16930352721
"healthy-1"	"2019-08-01-count-2:GTGTGGCAGTCAGGGT"	-5.14306674423869	-5.4115462533203	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGGCAGTCAGGGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.80933971467	41.8671768457812	0.0151593291556131	2765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2760.03210966079	2760.03210966079
"healthy-1"	"2019-08-01-count-4:ATACCGACAATCACGT"	1.22728826579396	9.54806706989137	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGACAATCACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1820.18121864938	40.0451274055488	0.0220006266382988	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1815.76315867127	1815.76315867127
"healthy-1"	"2019-08-01-count-4:GTTGCGGGTGAACTAA"	1.78171147879903	-10.0064993134704	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGGTGAACTAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.74197887461	41.3508687271485	0.0203224139259264	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2032.17038956183	2032.17038956183
"healthy-1"	"2019-08-01-count-3:CGGCAGTTCCATTCGC"	-3.62897644463237	-4.5926141968933	"2019-08-01-count-3"	"Control1"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTTCCATTCGC"	"DC precursor"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2640.70883568968	42.2510498327602	0.015999889598478	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2633.97225419485	2633.97225419485
"healthy-1"	"2019-08-01-count-4:GCTACCTTCATGCGGC"	-2.61889062348064	3.85835549915162	"2019-08-01-count-4"	"Control1"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACCTTCATGCGGC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3159.10927232446	40.906309192406	0.0129486844759591	4974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3153.13206178617	3153.13206178617
"healthy-1"	"2019-08-01-count-2:TCTGGCTAGACCAAGC"	8.15337051925008	7.76564214313356	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTAGACCAAGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.02123694391	46.4408203180251	0.024927692393999	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1858.09891323435	1858.09891323435
"healthy-1"	"2019-08-01-count-2:TGATTCTGTGACGTCC"	1.41115822371785	-8.72286703502806	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTCTGTGACGTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.25915804735	39.2188674961118	0.0162783930342711	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2406.79022079351	2406.79022079351
"healthy-1"	"2019-08-01-count-2:ACCCTTGAGCAGGTCA"	2.76647772368733	-10.3945160142151	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGAGCAGGTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.97369931109	40.7320984427493	0.0171217102797499	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2371.9956648139	2371.9956648139
"healthy-1"	"2019-08-01-count-2:TTTACGTAGCAAACAT"	2.68139423903767	-10.6158085099426	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACGTAGCAAACAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.5968119851	39.5408425902587	0.0165678770673333	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.33688207438	2383.33688207438
"healthy-1"	"2019-08-01-count-2:CATTGTTGTCTGTTAG"	1.70246686515157	-10.2515964738098	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGTTGTCTGTTAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.4118919798	36.7778762859376	0.0149417805308301	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2454.43288212754	2454.43288212754
"healthy-1"	"2019-08-01-count-3:CCTGTTGCACAAATAG"	1.09392358836476	11.3884153136047	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGTTGCACAAATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2319.28756940466	33.6220154884043	0.0144966997331145	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2304.11239365262	2304.11239365262
"healthy-1"	"2019-08-01-count-4:CACAACACAATGAAAC"	10.6089130836422	4.32567594135133	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACACAATGAAAC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.00490746668	32.2296330957032	0.0184590736016121	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1744.22686507115	1744.22686507115
"healthy-1"	"2019-08-01-count-2:ATTCTTGAGGGTACAC"	0.00453275543395874	11.389037109259	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGAGGGTACAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1761.99797844567	27.1166187838897	0.0153896991458585	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1761.99797844567	1761.99797844567
"healthy-1"	"2019-08-01-count-4:ACAAGCTAGGCGACAT"	1.29014744338338	11.4457139738831	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTAGGCGACAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1934.38549949474	27.7584696462606	0.0143500195041325	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1930.64193454702	1930.64193454702
"healthy-1"	"2019-08-01-count-3:GAGCCTGCACTAGAGG"	2.50488962706868	-10.765049003717	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCCTGCACTAGAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.40566107779	39.9993479544301	0.0166983607847169	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2390.53180383968	2390.53180383968
"healthy-1"	"2019-08-01-count-3:ACGTAGTTCTAGTACG"	2.19758905944173	-10.5569858781067	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAGTTCTAGTACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.99861990547	41.8881164286841	0.0179623247077145	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2326.10606671596	2326.10606671596
"healthy-1"	"2019-08-01-count-2:ACTATTCGTTCCTTGC"	3.74433626708333	-10.1693105927673	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCGTTCCTTGC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.82320923886	36.4671336489752	0.0183729883242143	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	1984.82320923886	1984.82320923886
"healthy-1"	"2019-08-01-count-4:GTTGTCCTCCCGATCT"	-3.31683049622234	-5.64034988796385	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCTCCCGATCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2569.24692365137	38.5447194589231	0.015002341388092	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2566.57856596519	2566.57856596519
"healthy-1"	"2019-08-01-count-4:TGACGCGGTTTCGTTT"	1.39029433306996	9.47767827594606	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACGCGGTTTCGTTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.52360525783	36.1586030333899	0.020655878575293	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1747.72859138391	1747.72859138391
"healthy-1"	"2019-08-01-count-2:CCTGCATAGGTCCCGT"	10.5719286399776	4.42834565723268	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATAGGTCCCGT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1656.42531395917	41.666794915559	0.0251546475198254	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1652.1220237034	1652.1220237034
"healthy-1"	"2019-08-01-count-3:TGCAGTACACCTCTAC"	2.84711660918538	-10.2954588166443	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGTACACCTCTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.9926342079	42.9545454987138	0.0178680021259163	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2403.18284073062	2403.18284073062
"healthy-1"	"2019-08-01-count-2:CTTGAGAAGCACACAG"	1.49066557463948	10.0132703551087	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGAGAAGCACACAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1720.98518125945	31.551044033343	0.0183331294057125	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1715.37273878004	1715.37273878004
"healthy-1"	"2019-08-01-count-4:TACCCACTCAGCCCAG"	2.59263934668843	-10.7476845017639	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCACTCAGCCCAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.70792318637	39.0963592305763	0.0149011857932325	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2616.69401180909	2616.69401180909
"healthy-1"	"2019-08-01-count-4:TTCTAGTTCCTATTGT"	1.23384453830068	10.4657220610413	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAGTTCCTATTGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.80774871101	40.0200257653177	0.0208784766193845	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1909.57528138848	1909.57528138848
"healthy-1"	"2019-08-01-count-2:CCAATGAGTCCCTAAA"	2.86172356185262	-10.9174118272034	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGAGTCCCTAAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.43868265029	46.7507200066831	0.0188782061652543	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2465.78997627781	2465.78997627781
"healthy-1"	"2019-08-01-count-3:TTGTGTTGTGCGCTCA"	1.85612620887105	-10.0344696274963	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTGTGCGCTCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.49071037752	40.7940449936567	0.0168605917016691	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2418.53988864792	2418.53988864792
"healthy-1"	"2019-08-01-count-2:ATGCCTCAGTAGTCCT"	-2.46052751961406	3.59241340244142	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCAGTAGTCCT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3060.86256675292	43.360504129087	0.0141661061819857	5315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3056.81524792918	3056.81524792918
"healthy-1"	"2019-08-01-count-3:CTCTCAGTCTGGCCGA"	3.42974891242329	-10.417543434259	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGTCTGGCCGA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.59033793267	43.2614634696977	0.0181192991035289	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2385.74088040082	2385.74088040082
"healthy-1"	"2019-08-01-count-2:AAATGGAAGCATAGGC"	-2.91132841530498	3.43566558444826	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAATGGAAGCATAGGC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3055.42988555432	45.8966930257623	0.0150213537030438	5392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3050.21977536928	3050.21977536928
"healthy-1"	"2019-08-01-count-4:TCATGGAAGGATTCAA"	2.64639892157857	-10.6033048859802	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGGAAGGATTCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.92159355868	38.7499023118183	0.0170860855251237	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2265.09394232754	2265.09394232754
"healthy-1"	"2019-08-01-count-3:CGAAGGATCAAACGTC"	2.33555473861043	-9.65739252483519	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGATCAAACGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.08975729747	50.9422399746612	0.0234747156440673	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2166.01674413335	2166.01674413335
"healthy-1"	"2019-08-01-count-4:ATTGTTCTCATCGCCT"	1.35903992232625	10.7463311919006	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGTTCTCATCGCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1937.37484869499	36.1062434693923	0.0186366843224549	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1929.75353407878	1929.75353407878
"healthy-1"	"2019-08-01-count-3:ATCGCCTCATTGCTTT"	-3.30938253822978	3.7230767973694	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGCCTCATTGCTTT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3268.83967903105	41.9180180227326	0.0128235160297485	5002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3263.19799093352	3263.19799093352
"healthy-1"	"2019-08-01-count-4:TCCACGTGTTCAGCGC"	1.89404704150502	-9.61505606090697	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTGTTCAGCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.34193326377	36.9365610074597	0.0154913020201342	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2383.52026421007	2383.52026421007
"healthy-1"	"2019-08-01-count-3:AATTCCTGTGCAGTGA"	4.46220793303792	-10.5489044419494	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTGTGCAGTGA"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.61922722011	48.3625448211328	0.019897211492252	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2417.58807187438	2417.58807187438
"healthy-1"	"2019-08-01-count-4:AGTCAACCAAATTAGG"	0.645523031323594	10.5920963057312	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCAACCAAATTAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2009.38167481912	34.136515934415	0.0169885673599009	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2005.45627300463	2005.45627300463
"healthy-1"	"2019-08-01-count-2:GGGCGTTCAATACGAA"	1.07048239287679	10.1546611555847	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTCAATACGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1733.57107898876	37.4895273957756	0.0216256073086109	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1731.04418420059	1731.04418420059
"healthy-1"	"2019-08-01-count-3:GAGACCCTCCTACAAG"	2.03250302848164	-10.2776241532532	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACCCTCCTACAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.0083305746	37.8711944366988	0.0153822365125223	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2459.29479647947	2459.29479647947
"healthy-1"	"2019-08-01-count-3:AGCGCTGCACCGTGCA"	1.46048976954762	9.36646554553834	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGCACCGTGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.52408142804	41.6182727834453	0.0246477223755361	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1686.15130102686	1686.15130102686
"healthy-1"	"2019-08-01-count-4:CCCATTGTCTAGGCAT"	1.41607095774953	-9.1263466111389	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGTCTAGGCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.10518748882	39.5349065094486	0.0165966250008992	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2376.97161945506	2376.97161945506
"healthy-1"	"2019-08-01-count-2:ATTTCACAGTATGAAC"	1.08580436286275	9.59351346576539	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCACAGTATGAAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.61632596944	41.5738011413852	0.0239671450792731	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1733.32866621286	1733.32866621286
"healthy-1"	"2019-08-01-count-4:CCCGAAGCATCGTGCG"	2.14428748664204	-10.457205795404	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGAAGCATCGTGCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.31817088789	39.7607525583072	0.0154752155684038	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2565.45297507596	2565.45297507596
"healthy-1"	"2019-08-01-count-3:CGACAGCAGCCAAGTG"	2.89274086531941	-10.1601515046326	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCAGCCAAGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.76088910881	41.0004624377319	0.0179060017282807	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2285.16074389429	2285.16074389429
"healthy-1"	"2019-08-01-count-2:GAGCCTGGTGTCTTGA"	3.32615294036214	-10.6741094819275	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGGTGTCTTGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.02404067632	41.3800338454452	0.0178900145946369	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2309.35147548103	2309.35147548103
"healthy-1"	"2019-08-01-count-4:GACTCAATCAACGTGT"	1.65764715251271	-9.31846907055052	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAATCAACGTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.82760618711	43.5655174076393	0.0189182712985505	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2298.80903683156	2298.80903683156
"healthy-1"	"2019-08-01-count-3:TACATTCCATCATGAC"	1.36818136748616	11.2383565672669	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACATTCCATCATGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2087.98675936563	34.5069577764778	0.0165264255731974	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2081.35072962208	2081.35072962208
"healthy-1"	"2019-08-01-count-2:CCACCATCACACTGGC"	1.37485565718953	10.8141050108704	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATCACACTGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2064.23327610072	39.6030668634051	0.0191853640389976	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2064.23327610072	2064.23327610072
"healthy-1"	"2019-08-01-count-1:CCTTGTGTCTTTGCGC"	1.08139493045155	9.29469583118287	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCTTGTGTCTTTGCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.97952848334	41.8137418791513	0.0222415942544248	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1867.97794455297	1867.97794455297
"healthy-1"	"2019-08-01-count-2:AGTCATGGTCGATTTG"	3.25163831290547	-10.7074403992859	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCATGGTCGATTTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.89379485481	41.9493283652044	0.0178820236692773	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2342.42646710078	2342.42646710078
"healthy-1"	"2019-08-01-count-2:GGTGATTTCCTGTACC"	9.71879543837849	5.03978250110475	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGATTTCCTGTACC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.49216903536	37.7629018146193	0.0201671881138351	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1865.36809471619	1865.36809471619
"healthy-1"	"2019-08-01-count-2:AGTCATGTCCTCGATC"	9.43402733382527	7.67949149692384	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCATGTCCTCGATC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2236.72150556332	40.9938334934103	0.018327643111334	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2227.16529534039	2227.16529534039
"healthy-1"	"2019-08-01-count-2:TGGTGATCAGTCGGAA"	2.62273921546285	-10.7245455018249	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTGATCAGTCGGAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.8017787515	44.193463949381	0.0193423623705029	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2278.81575421171	2278.81575421171
"healthy-1"	"2019-08-01-count-1:CGTGAATAGTTCCAGT"	2.64296426352803	-10.5154524079529	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGTGAATAGTTCCAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.59529346282	43.4401203286132	0.0177408330582797	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2441.61289561401	2441.61289561401
"healthy-1"	"2019-08-01-count-4:CCCTCAAAGTAGGCCA"	0.784090359776658	9.67904851520387	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAAAGTAGGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1857.06089173699	36.2845564215151	0.0195387004179366	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1846.35552508912	1846.35552508912
"healthy-1"	"2019-08-01-count-4:CTACATTCATACTGTG"	1.32656588134114	9.85691545093385	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTCATACTGTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1930.52029484052	37.2292159129411	0.0192845503942327	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1921.47035136397	1921.47035136397
"healthy-1"	"2019-08-01-count-3:CACTAAGGTTGCAAGG"	3.04172505912129	-10.6023321381775	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTAAGGTTGCAAGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.5831983113	39.154385997537	0.01619567261424	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2413.43818721278	2413.43818721278
"healthy-1"	"2019-08-01-count-2:TCACAAGAGCTATCCA"	1.46494926986043	9.9562139281067	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGAGCTATCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.56600356015	39.1022804491491	0.0206065456357179	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1892.49866813158	1892.49866813158
"healthy-1"	"2019-08-01-count-4:GCCATGGTCCACAAGT"	1.15844037112538	11.26522157276	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGTCCACAAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2301.68825582567	44.3572401330722	0.0192716107495453	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2296.88328603696	2296.88328603696
"healthy-1"	"2019-08-01-count-2:CCTTTGGGTGTATTGC"	1.45535041865651	9.89320371234743	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGGTGTATTGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.09651372177	37.6476756358475	0.0198973336522851	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1888.15301873788	1888.15301873788
"healthy-1"	"2019-08-01-count-4:GCCATGGTCGGTAGAG"	1.40719904479329	-9.08314993297728	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGTCGGTAGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.78146987016	43.0704535123859	0.0185906414016682	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.98733217567	2313.98733217567
"healthy-1"	"2019-08-01-count-3:TTGCATTGTATCAGCT"	10.8886381584102	4.09712455356447	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCATTGTATCAGCT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.81653359682	34.1898660002409	0.0173745191264085	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1964.35052321997	1964.35052321997
"healthy-1"	"2019-08-01-count-2:GCGAGAAAGAGCCGTA"	2.62648191031758	-10.741539024469	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGAGAAAGAGCCGTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.37873802114	45.1004439680375	0.020468766077203	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2199.90728261183	2199.90728261183
"healthy-1"	"2019-08-01-count-2:GACTCAACACAGCTGC"	8.13487782058064	7.57985732639161	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCAACACAGCTGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.36708426737	37.5495303803127	0.0198112179387282	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1886.40210783751	1886.40210783751
"healthy-1"	"2019-08-01-count-4:CCGTAGGCAGGATCTT"	-4.56420741501506	-5.30716516887816	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTAGGCAGGATCTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2624.6544222356	43.1955986469323	0.0164576327767141	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2622.74108873155	2622.74108873155
"healthy-1"	"2019-08-01-count-1:GGGCCATCAAGGGTCA"	1.24160220202748	9.14718530261842	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGGCCATCAAGGGTCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.78603627622	39.5350123768153	0.022750218698691	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1729.0735707185	1729.0735707185
"healthy-1"	"2019-08-01-count-2:AGATGAAGTGTCATCA"	1.5187974172527	10.4663839110169	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATGAAGTGTCATCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.35713171148	39.7704665324204	0.0220413497048099	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.05752635169	1802.05752635169
"healthy-1"	"2019-08-01-count-4:TTGATGGCAAGCGCAA"	1.88066293773	-10.4074592820373	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGCAAGCGCAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.91190782304	38.4449202250896	0.0166795616329651	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2299.60853760013	2299.60853760013
"healthy-1"	"2019-08-01-count-2:TCGTGCTTCTGTCGCT"	7.0413028198177	-1.09945645248564	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTTCTGTCGCT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2083.10498095674	39.4690821810182	0.0189472362371726	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2083.10498095674	2083.10498095674
"healthy-1"	"2019-08-01-count-2:GATTGGTAGGTCATCT"	1.84923483905141	-10.1182136765686	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTAGGTCATCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.74507423355	43.5038624772193	0.0168767124849048	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2572.46994535122	2572.46994535122
"healthy-1"	"2019-08-01-count-3:CATCCCATCGCTTACC"	11.1001764732296	4.01971981609193	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCATCGCTTACC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1781.83929123581	35.3732624258828	0.0198521059670592	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1762.80511002211	1762.80511002211
"healthy-1"	"2019-08-01-count-1:TGGATGTTCCGATCTC"	0.639164527028245	10.1258964308533	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGATGTTCCGATCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.82984749469	36.6426513852308	0.0195967838647601	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1859.82921626329	1859.82921626329
"healthy-1"	"2019-08-01-count-3:TCCGGGACATCGAACT"	2.59021915969197	-10.4111871949402	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGGGACATCGAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.8813682143	40.5149515096594	0.0174642341909256	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.52579378925	2313.52579378925
"healthy-1"	"2019-08-01-count-4:ATTCATCAGTAAACTG"	2.82372178611104	-10.6426344147888	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCATCAGTAAACTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.20950612088	36.3027214275971	0.0139239755540819	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2603.0003648977	2603.0003648977
"healthy-1"	"2019-08-01-count-3:TTGCGTCCAAACTAAG"	13.9591118293697	1.75726816737977	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCGTCCAAACTAAG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1279.79059040263	39.4182657243598	0.0308005591070635	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1261.0398058336	1261.0398058336
"healthy-1"	"2019-08-01-count-4:TGGTAGTCAAAGAACT"	1.86615147170369	-10.493263267633	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTCAAAGAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.98439986492	40.5926934650757	0.0180172989513418	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2247.74905811111	2247.74905811111
"healthy-1"	"2019-08-01-count-2:ATTCCATCATACCGTA"	1.66799070414845	-9.4028415909973	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCATCATACCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.93621148367	24.2118983594552	0.0115463208784612	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2095.60403793379	2095.60403793379
"healthy-1"	"2019-08-01-count-2:TGCAGTACAGGTGACA"	2.23029460486714	-10.168088935968	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTACAGGTGACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.16087936783	35.6869987650184	0.0166983211743865	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2134.58716037674	2134.58716037674
"healthy-1"	"2019-08-01-count-3:TAGGAGGTCAGCAATC"	1.17998828467671	-8.54312612926634	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGTCAGCAATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2477.1207322947	42.9595106254006	0.0173425178939925	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2477.1207322947	2477.1207322947
"healthy-1"	"2019-08-01-count-2:TGGATCACAATAACGA"	3.57682981070821	-11.0538053742615	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCACAATAACGA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.73725377231	39.9328896347907	0.0176636579806688	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2257.87427803882	2257.87427803882
"healthy-1"	"2019-08-01-count-4:TGGGAGAAGCTTCGTA"	2.29426731643025	-10.1644287339416	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGAAGCTTCGTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.20777683556	41.5423095658272	0.018585435321203	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2231.82612055619	2231.82612055619
"healthy-1"	"2019-08-01-count-2:CGGGACTGTTGAATCC"	-5.63774142685588	3.70804522121278	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGACTGTTGAATCC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2451.88306388844	45.8076804104325	0.0186826529719513	2660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2444.74368597293	2444.74368597293
"healthy-1"	"2019-08-01-count-2:GCCCGAACAACACACT"	11.1105095344478	3.982634759787	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAACAACACACT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2156.58261520026	33.48321551345	0.0155260527825134	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2154.94076576992	2154.94076576992
"healthy-1"	"2019-08-01-count-4:AATCGACGTTCCGTTC"	1.8710011440212	-10.2862663499084	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCGACGTTCCGTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.75089074636	37.7231547333994	0.0156154986335303	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2410.59385181984	2410.59385181984
"healthy-1"	"2019-08-01-count-2:GAAACCTTCCATAAGC"	1.29081298884694	10.4881105192932	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTTCCATAAGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.51099098141	34.174241150062	0.0189697655585464	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1797.34630004588	1797.34630004588
"healthy-1"	"2019-08-01-count-2:TCCTTTCGTCATATGC"	11.2556034522945	3.74980137431947	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCGTCATATGC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.26500610191	36.4096036954838	0.0187170403936091	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1943.41742565334	1943.41742565334
"healthy-1"	"2019-08-01-count-3:TGCGGCAGTACTGTTG"	1.80709161338155	-9.99239923870238	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAGTACTGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.74287441211	42.2250653332271	0.0178863466203376	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2355.0641272707	2355.0641272707
"healthy-1"	"2019-08-01-count-3:CTCCACACATTGACAC"	14.0677343803341	1.66459224307863	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACACATTGACAC"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1734.19069342099	38.6587900544229	0.0222921217378706	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1704.76277985305	1704.76277985305
"healthy-1"	"2019-08-01-count-4:TGATTCTTCCGATCGG"	-0.495467464358169	14.2442264326843	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTCTTCCGATCGG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1932.86757643811	44.3190120821281	0.0229291507718285	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1929.58125778084	1929.58125778084
"healthy-1"	"2019-08-01-count-3:GTCAAGTAGGAAAGAC"	2.7187839942867	-10.7092132798401	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAGTAGGAAAGAC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.65313115162	41.1036767024486	0.0185514944214595	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2209.23316354312	2209.23316354312
"healthy-1"	"2019-08-01-count-1:GCCTGTTAGTTGTACC"	1.46885706958119	9.91540620410768	"2019-08-01-count-1"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCCTGTTAGTTGTACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2355.44827660806	44.3762276763827	0.018839822600684	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2346.97752647917	2346.97752647917
"healthy-1"	"2019-08-01-count-1:GCCATTCCACAATGCT"	1.33424403247182	11.0933723219666	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCCATTCCACAATGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2062.54158664977	33.5986644181158	0.0162899330784844	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2049.07964274625	2049.07964274625
"healthy-1"	"2019-08-01-count-2:TCTATCACACAACGCC"	0.391774674027604	11.4420947798523	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATCACACAACGCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.09940149457	42.3784180397056	0.0221748894937457	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1907.17054117161	1907.17054117161
"healthy-1"	"2019-08-01-count-2:TCATTTGGTATCGTGT"	2.13357080993001	-10.6829662553039	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTTGGTATCGTGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.65080682985	44.1360950492239	0.0190434619914095	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.77452716924	2313.77452716924
"healthy-1"	"2019-08-01-count-4:AATGCCAGTCGTGCCA"	2.02527942237203	-10.2475233308044	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGCCAGTCGTGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.75482100492	43.4188525758305	0.0195690177953801	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2213.91253141419	2213.91253141419
"healthy-1"	"2019-08-01-count-2:TCTCACGAGTCATCCA"	14.1505314308101	1.82343778694002	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGAGTCATCCA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1372.92663236008	27.5630980296345	0.0200761623964225	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1355.3261723098	1355.3261723098
"healthy-1"	"2019-08-01-count-2:GCCGTGACACATAACC"	0.33274464783017	11.9488897093567	"2019-08-01-count-2"	"Control1"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGTGACACATAACC"	"MAIT"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1905.33261210678	44.3677048824971	0.0232860680600215	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1895.4869454536	1895.4869454536
"healthy-1"	"2019-08-01-count-3:GTCACGGCAGCAGTAG"	1.16275789317433	9.37322614276735	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACGGCAGCAGTAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1729.82137774083	39.2154303767156	0.0226702195274818	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1723.57636783026	1723.57636783026
"healthy-1"	"2019-08-01-count-2:CATTCATGTCTAGGTT"	1.47709180888478	9.64060113513795	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCATGTCTAGGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1684.77712191954	38.2265547928066	0.022689383833307	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1677.98065798685	1677.98065798685
"healthy-1"	"2019-08-01-count-3:TCCCAGTTCTTAGGAC"	-4.57069955292399	-5.32951548015746	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCAGTTCTTAGGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2929.51844382564	42.9972781901041	0.0146772512324429	2962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2922.25941559022	2922.25941559022
"healthy-1"	"2019-08-01-count-4:AGCGATTAGAATAGTC"	2.23704161223714	-10.2395582429138	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGATTAGAATAGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.91131155349	43.5890680455921	0.0183231160547668	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2375.50243935803	2375.50243935803
"healthy-1"	"2019-08-01-count-4:GACGCTGAGATCCCGC"	2.29304589804952	-10.5753431550232	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGCTGAGATCCCGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.91103191624	43.0444062338197	0.0184351376328432	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2328.42083872078	2328.42083872078
"healthy-1"	"2019-08-01-count-3:TCATTGTGTTCGGGTC"	3.14496554908101	-10.6156502000061	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTGTTCGGGTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.06293384755	40.7685009820365	0.0166262049881674	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2447.96372550932	2447.96372550932
"healthy-1"	"2019-08-01-count-4:AAAGTCCCAAGCACAG"	2.81198873099629	-10.7326784363953	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCCAAGCACAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.90357813293	39.1649341008472	0.016773683704817	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2331.77295719529	2331.77295719529
"healthy-1"	"2019-08-01-count-2:GGCGTCAAGACGCCCT"	1.68642570552174	-4.58411457454833	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCAAGACGCCCT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2604.8377642664	41.2065443893328	0.0158192364048967	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2601.75462074152	2601.75462074152
"healthy-1"	"2019-08-01-count-2:TGCAGGCCATCAACCA"	2.26513971862141	-10.8059272996155	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGGCCATCAACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.2435358231	38.8288491575739	0.0154620006397934	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2505.53078603955	2505.53078603955
"healthy-1"	"2019-08-01-count-4:AGATCGTCAGCGGTCT"	1.69653167304341	-9.1468191376892	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCGTCAGCGGTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.3852549687	37.349044468836	0.0159516868868875	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2337.79623772696	2337.79623772696
"healthy-1"	"2019-08-01-count-2:GCGAGAAGTCTTCAAG"	3.00994886931722	-10.819477104303	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGAGAAGTCTTCAAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.53935151977	37.353092760425	0.0152241669722101	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2448.54396390035	2448.54396390035
"healthy-1"	"2019-08-01-count-2:CCCTAACAGCTTAGTC"	2.37729014930074	-10.5663442841736	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACAGCTTAGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.19979054695	35.2908066847557	0.0143039922506366	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2463.06118393531	2463.06118393531
"healthy-1"	"2019-08-01-count-2:TATCTTGTCCTCTTTC"	1.53083278712575	-9.32209303295287	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTTGTCCTCTTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.34379367095	43.2698840328449	0.0184650174463137	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2338.82597542747	2338.82597542747
"healthy-1"	"2019-08-01-count-3:TGCTGAATCCTGGCTT"	1.40274514731709	-8.58373930370482	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCCTGGCTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2758.95891659255	40.2576275258225	0.0145916009418301	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2752.30424492229	2752.30424492229
"healthy-1"	"2019-08-01-count-2:CTGTAGATCGTGGTAT"	-5.50592980805095	3.60260078990785	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTAGATCGTGGTAT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2625.20912545811	39.5084701300035	0.0150496468059889	2881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2621.78975153932	2621.78975153932
"healthy-1"	"2019-08-01-count-3:CCGGACATCCGTCACT"	2.61386408385579	-10.5311336747375	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACATCCGTCACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.62806554675	38.9387709749805	0.0172095323875386	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2258.47057106692	2258.47057106692
"healthy-1"	"2019-08-01-count-3:GTGCACGCATCGAACT"	8.36534466323201	6.72526214206544	"2019-08-01-count-3"	"Control1"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCACGCATCGAACT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1834.84802425102	41.523741928815	0.0226306164761329	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1833.0709454479	1833.0709454479
"healthy-1"	"2019-08-01-count-2:CGGAGAAGTCCAGAAG"	0.907900293439072	11.8022575148377	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAAGTCCAGAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1940.15850466726	35.9085113529494	0.0185080297648711	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1937.00540147836	1937.00540147836
"healthy-1"	"2019-08-01-count-3:TTACGCCCAGGGATAC"	1.94486190852467	-10.3556137315002	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGCCCAGGGATAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.39446546049	45.333248096162	0.0199232479397754	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.46532534677	2272.46532534677
"healthy-1"	"2019-08-01-count-2:GCCATTCTCTGTGCTC"	1.1359324651653	10.9998388060364	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATTCTCTGTGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.20880773498	41.1554159683386	0.0219940264273102	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1866.63533800047	1866.63533800047
"healthy-1"	"2019-08-01-count-2:TTAGTCTCAACTGCTA"	1.86854543265645	-9.8026218644348	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTCAACTGCTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2523.53067856082	38.3086019153364	0.0151805572410096	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2520.19960880481	2520.19960880481
"healthy-1"	"2019-08-01-count-2:GAGTTTGCAGCTTTGA"	1.10046078738515	9.11893746936647	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTTGCAGCTTTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1816.29077466586	35.8277915741626	0.0197258016579166	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1814.99567581087	1814.99567581087
"healthy-1"	"2019-08-01-count-4:TCAAGCAGTAAGATAC"	-2.41570744934734	4.11420819843141	"2019-08-01-count-4"	"Control1"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCAGTAAGATAC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3305.3667167597	43.4732072765455	0.01315230986508	5051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3292.32542985919	3292.32542985919
"healthy-1"	"2019-08-01-count-2:TCCCAGTCATAGATGA"	2.8835309940273	-10.6421470872131	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTCATAGATGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.6758894791	38.7562507865881	0.0155107154752542	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2488.27000311624	2488.27000311624
"healthy-1"	"2019-08-01-count-4:GCTACAATCGCGGTAC"	-4.81775508347209	-5.29191877758177	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAATCGCGGTAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2883.54687301338	45.6994597169257	0.0158483498723808	3184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2879.8658112537	2879.8658112537
"healthy-1"	"2019-08-01-count-2:CAATTTCAGGGAGTGG"	2.37621440467183	-10.3827171555725	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCAGGGAGTGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.83427825761	44.411235187205	0.0198279112067849	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2239.83427825761	2239.83427825761
"healthy-1"	"2019-08-01-count-4:TCCGAAAGTCTTTATC"	1.32184388217275	9.254931426886	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAAGTCTTTATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1676.20886777324	37.3775313649142	0.0222988507479789	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1667.43314305937	1667.43314305937
"healthy-1"	"2019-08-01-count-2:GATAGCTTCGCGATCG"	1.95539333400075	-10.3035850754944	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGCTTCGCGATCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.7160461533	39.9966480214767	0.0173017131961476	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2309.8946664202	2309.8946664202
"healthy-1"	"2019-08-01-count-3:CTGTGAAAGTGGTTGG"	1.55340327796285	-9.88304617321166	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAAAGTGGTTGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2398.79725113263	41.9798437863711	0.017500371807809	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2395.45982883093	2395.45982883093
"healthy-1"	"2019-08-01-count-3:TCCTCCCAGGTACCTT"	2.07252873954121	-9.91786577617797	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCCCAGGTACCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.03560796526	41.6192101799949	0.0179622661114576	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2313.59952823571	2313.59952823571
"healthy-1"	"2019-08-01-count-3:GATGGAGAGATCCAAA"	3.19726838645284	-10.7507190934387	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGGAGAGATCCAAA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.44877237064	40.7807075801594	0.0176505569254913	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2306.81049328502	2306.81049328502
"healthy-1"	"2019-08-01-count-2:TGTGGCGTCCGTGTGG"	10.3546492057735	7.89010856235353	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGTCCGTGTGG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2351.70319993731	42.0804532443047	0.0178936071717836	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2338.26678558761	2338.26678558761
"healthy-1"	"2019-08-01-count-3:GGGAGTAAGGTGATAT"	1.3627847629482	-9.2065000764099	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGTAAGGTGATAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.3557070201	43.011151946248	0.0173687293082806	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2475.47198813581	2475.47198813581
"healthy-1"	"2019-08-01-count-4:ATTCGTTAGGGCAATC"	1.82313932952229	-4.84034969722899	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCGTTAGGGCAATC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2677.37678466613	42.8555237418919	0.016006534450935	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2672.73888585415	2672.73888585415
"healthy-1"	"2019-08-01-count-3:GATTCGACATCAGCTA"	2.1777991252834	-10.5564499131409	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCGACATCAGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.56845558404	40.4513107987191	0.0164934482079874	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2446.71792783572	2446.71792783572
"healthy-1"	"2019-08-01-count-2:GAGAAATAGTGTACCT"	1.40342082557027	10.8711871870789	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATAGTGTACCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1902.02051553375	36.5697998121298	0.0192268167001698	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1895.64266111259	1895.64266111259
"healthy-1"	"2019-08-01-count-2:CGTGCTTCAGGGTTGA"	-4.82083163681682	3.33927104556886	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTCAGGGTTGA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2575.75394035256	41.556692773082	0.0161337976124357	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2569.73724236359	2569.73724236359
"healthy-1"	"2019-08-01-count-3:ATGAGGGAGTATGACA"	1.99098064479176	-10.5790024033752	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGGGAGTATGACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.84188313383	43.7074063219676	0.0179213776113296	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2432.55578743518	2432.55578743518
"healthy-1"	"2019-08-01-count-3:CCTTGTGGTTGTGCAT"	7.84442247924153	7.42552230441896	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTGTGGTTGTGCAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1604.48529645012	40.648097531245	0.0253340417772465	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1598.13482553357	1598.13482553357
"healthy-1"	"2019-08-01-count-4:GTCTACCCAATTGCAC"	-2.73638067665752	3.1594712504181	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCCAATTGCAC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3214.2891494036	45.9355015527426	0.0142910296546487	5108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3209.03551748961	3209.03551748961
"healthy-1"	"2019-08-01-count-3:AGGCTGCCACCACATA"	1.31448616561238	9.9635324248108	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCTGCCACCACATA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1741.24979171678	33.0659314314508	0.0189897690663035	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1735.56916229975	1735.56916229975
"healthy-1"	"2019-08-01-count-4:CTCCTCCTCTGCTCTG"	-5.14330516281779	-5.28423120891722	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTCCTCTGCTCTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2790.20533209136	40.9406646617626	0.0146729934857791	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2786.08143917868	2786.08143917868
"healthy-1"	"2019-08-01-count-3:CAATCGAAGTCCCAAT"	-3.47484503212627	3.71363470638124	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATCGAAGTCCCAAT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3138.99542394137	38.5429413686736	0.0122787504163604	4776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3132.94465393894	3132.94465393894
"healthy-1"	"2019-08-01-count-3:AGAACAAGTACGTAGG"	-7.84112487259563	4.00725624645082	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	47	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAAGTACGTAGG"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1975.73215777837	37.5657216615307	0.0190135699890474	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1966.07236701602	1966.07236701602
"healthy-1"	"2019-08-01-count-2:TCCAGAAAGGCATTTC"	2.50666536864583	-10.4162540665832	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCAGAAAGGCATTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.811002913	39.1356512886406	0.0158008226072207	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2473.98000174578	2473.98000174578
"healthy-1"	"2019-08-01-count-4:AAGCCATAGAGCAAGA"	-0.559470335871536	14.124126411322	"2019-08-01-count-4"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATAGAGCAAGA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1872.14388257846	48.5777440576954	0.0259476552575598	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1868.73740725315	1868.73740725315
"healthy-1"	"2019-08-01-count-4:AGGTCTAGTCCTATAG"	1.74956907805745	-10.0626144639221	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTAGTCCTATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.37485745926	41.8154113600407	0.0168245893509954	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2482.23630377892	2482.23630377892
"healthy-1"	"2019-08-01-count-4:ACAAGCTTCGTACACA"	-3.40829596939738	-5.26042463695677	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTTCGTACACA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2069.29951038897	46.1135010366558	0.0222845947651085	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2064.171772928	2064.171772928
"healthy-1"	"2019-08-01-count-3:AGGAAATTCACCACAA"	1.96200432357137	-10.2434101334778	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATTCACCACAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.1416222453	46.4569182076331	0.0205276230842074	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2257.58623731678	2257.58623731678
"healthy-1"	"2019-08-01-count-4:GGGATCCGTCGTATGT"	10.2332350212032	7.70809934223024	"2019-08-01-count-4"	"Control1"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATCCGTCGTATGT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2246.0139697039	43.3371277638063	0.0192951283243887	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2238.62745357528	2238.62745357528
"healthy-1"	"2019-08-01-count-3:TCTTGCGCAATAACCC"	1.58815409716908	-9.2214565507141	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTGCGCAATAACCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.66017718391	39.7131140732015	0.0178112855400951	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2225.12669704244	2225.12669704244
"healthy-1"	"2019-08-01-count-3:TATTCCACATCATGAC"	2.17031278189961	-10.4291830292908	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCACATCATGAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.83022310399	43.1728899227215	0.0182254048861932	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.93568001424	2360.93568001424
"healthy-1"	"2019-08-01-count-1:AGTACCACAACGACAG"	1.01568510112111	9.33555982196657	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGTACCACAACGACAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.25760715448	32.7735985334967	0.0172469240013059	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1887.43147256704	1887.43147256704
"healthy-1"	"2019-08-01-count-2:ACCACAAGTATGTCTG"	2.41437234458272	-10.6023435822693	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAAGTATGTCTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.78372235023	42.5455083655786	0.0175244227786453	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2423.19350973826	2423.19350973826
"healthy-1"	"2019-08-01-count-4:CCACCATCACCCATAA"	1.50171436843221	-9.07538034832152	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACCATCACCCATAA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.03665830753	39.7514379209892	0.015668452322446	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2532.39849858941	2532.39849858941
"healthy-1"	"2019-08-01-count-2:CATGCGGGTGAGATAT"	-3.31785140457805	-5.61003878032836	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCGGGTGAGATAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2155.9533292773	47.5515016460818	0.0220559049216625	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2150.70088686005	2150.70088686005
"healthy-1"	"2019-08-01-count-2:TGATCAGAGGATGAGA"	-3.07478199425395	-5.48713066494139	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCAGAGGATGAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2488.86492560417	44.4223772742729	0.0178484484301572	2661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2485.48177368815	2485.48177368815
"healthy-1"	"2019-08-01-count-4:GGAACCCTCCATATGG"	1.77585913714711	-9.49031450664672	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCTCCATATGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.92578224137	41.4309919512261	0.0161781306738866	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2557.34853310214	2557.34853310214
"healthy-1"	"2019-08-01-count-3:TCGAACATCGCCAACG"	2.91826905783955	-10.1854553452698	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAACATCGCCAACG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2652.21304575499	40.8691740354635	0.0154094612048141	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2647.15714231387	2647.15714231387
"healthy-1"	"2019-08-01-count-3:AGGAGGTTCGTGCACG"	2.74393238601033	-10.6181097260681	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAGGTTCGTGCACG"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.18633169366	46.5522096224222	0.0216805635054982	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2142.69436304444	2142.69436304444
"healthy-1"	"2019-08-01-count-2:GGTGAAGCACGGGCTT"	1.07994737204854	9.7602443465027	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGAAGCACGGGCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.86311217556	39.1211787267272	0.0222676305601764	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1750.57965428193	1750.57965428193
"healthy-1"	"2019-08-01-count-3:GCCGATGGTTGGCCGT"	2.62648453292195	-10.0329151383606	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGGTTGGCCGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.52572788692	36.7237905081619	0.0159562806807634	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2297.3418758688	2297.3418758688
"healthy-1"	"2019-08-01-count-3:GACATCAGTTGCCGAC"	-2.51591000977214	4.03959343517152	"2019-08-01-count-3"	"Control1"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCAGTTGCCGAC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3207.57527072086	42.5240790542377	0.0132573908529607	5637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3203.21956369407	3203.21956369407
"healthy-1"	"2019-08-01-count-4:GATGACTGTCTTACTT"	1.17439415034596	9.95041749561159	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTGTCTTACTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1673.88885184929	40.5567037293246	0.0242290303113723	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1664.89259477234	1664.89259477234
"healthy-1"	"2019-08-01-count-2:GAGCCTGTCAGTGTTG"	1.73227693614308	-10.2237472764221	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGTCAGTGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.88799607585	42.73419358431	0.0178737747876309	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2388.27952111729	2388.27952111729
"healthy-1"	"2019-08-01-count-2:AGGATCTAGGTCTACT"	2.1209896999294	-10.6745176545349	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATCTAGGTCTACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.96112767071	40.8912939443534	0.018077805778414	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2255.64371169243	2255.64371169243
"healthy-1"	"2019-08-01-count-4:TTTATGCTCATTGAGC"	2.84508313712422	-10.4430446854797	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCTCATTGAGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.97011572652	41.3947426927093	0.0181717672268528	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2272.21683207642	2272.21683207642
"healthy-1"	"2019-08-01-count-2:CTGCAGGCAACTAGAA"	-8.87587962570842	4.19415090167848	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_GMP"	1	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGCAACTAGAA"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2277.8005909414	43.7609535049121	0.0192119335111885	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2271.92780781617	2271.92780781617
"healthy-1"	"2019-08-01-count-3:TGGTAGTAGCTACTGT"	0.875045021145981	-7.30516579067381	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTAGCTACTGT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2630.73154791205	47.9230236321844	0.0182166149450786	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2627.57818196319	2627.57818196319
"healthy-1"	"2019-08-01-count-2:CCACGAGGTCCCACGA"	0.373460848897141	11.8035278090271	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGAGGTCCCACGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.24496131236	37.6657723287696	0.0196048776117757	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1918.00233424852	1918.00233424852
"healthy-1"	"2019-08-01-count-2:TTTGATCAGAAACACT"	-3.40288529816325	3.5151431330475	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCAGAAACACT"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3066.3874783988	45.248859211234	0.0147564062043659	4732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3059.67238324617	3059.67238324617
"healthy-1"	"2019-08-01-count-3:TCGACGGCACATCCCT"	3.03994049605672	-10.538637184259	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACGGCACATCCCT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.43134436459	38.0091934918077	0.0145660829796858	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2606.39120573387	2606.39120573387
"healthy-1"	"2019-08-01-count-4:CATAAGCAGACAAGCC"	-4.1773251098698	3.69061014736024	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCAGACAAGCC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2831.51953557289	43.0104342523141	0.0151898772768354	4227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2824.16726542212	2824.16726542212
"healthy-1"	"2019-08-01-count-3:AACCTGACATAAGCAA"	-3.00931487503703	-5.69707777416381	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTGACATAAGCAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2358.05125815573	46.8903920953376	0.0198852302014891	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2354.59070945286	2354.59070945286
"healthy-1"	"2019-08-01-count-3:CAACGATAGAAACCAT"	-8.13905463638957	0.508270628097929	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATAGAAACCAT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2464.86680563486	46.944427597312	0.0190454216390085	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2456.6008258376	2456.6008258376
"healthy-1"	"2019-08-01-count-2:CGGGTGTTCCGCACTT"	1.31711163100545	11.2072047957214	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTTCCGCACTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1762.1217939961	30.8798466235081	0.0175242407923912	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1759.81355383454	1759.81355383454
"healthy-1"	"2019-08-01-count-2:TCACTCGTCGGTATGT"	1.50834765013997	-9.00110342418822	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTCGTCGGTATGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.80895653255	42.0924218233719	0.0197634730074104	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2127.6605955349	2127.6605955349
"healthy-1"	"2019-08-01-count-4:CATGCTCAGACATCAA"	1.73117842253987	-9.25730421459349	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCAGACATCAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2571.70806368432	40.4843309123106	0.0157421954241226	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2568.93261181442	2568.93261181442
"healthy-1"	"2019-08-01-count-3:CCGATGGGTAACATGA"	-2.73122773590739	4.07702395999757	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATGGGTAACATGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3109.96683216786	45.5065532803544	0.0146324882984791	5728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3105.23063783517	3105.23063783517
"healthy-1"	"2019-08-01-count-2:CCTCTCCAGTAGGGTC"	2.47359218177144	-10.2038316956726	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCAGTAGGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.38019115517	47.2688284695053	0.0210422210165582	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2240.13478346753	2240.13478346753
"healthy-1"	"2019-08-01-count-2:TTGAACGTCACCTACC"	1.80049659785573	-5.01941444790038	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAACGTCACCTACC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2323.7386609174	41.9231545840406	0.0180412519226622	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2318.26029110708	2318.26029110708
"healthy-1"	"2019-08-01-count-2:TGAGGGACAGGAGGAG"	-0.605105857283431	12.6496972807678	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGGACAGGAGGAG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.17903021016	46.4092881696358	0.0243212441992534	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1899.38724472966	1899.38724472966
"healthy-1"	"2019-08-01-count-2:TCATGTTGTCAAGCCC"	0.919913669198197	11.4822158583435	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTGTCAAGCCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.02829382073	35.7700073482294	0.0196104454461631	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1821.63163346401	1821.63163346401
"healthy-1"	"2019-08-01-count-4:CCTCTCCCAGACAATA"	1.20033289965932	10.2173118361267	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCCAGACAATA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2014.54385403237	37.0805503958628	0.0184064250185675	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2006.36988055054	2006.36988055054
"healthy-1"	"2019-08-01-count-2:TCATGTTGTCGCACAC"	1.59151687201802	-4.87839605724486	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTGTCGCACAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2355.4631362869	42.3070806370147	0.0179612578032984	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2353.12727326055	2353.12727326055
"healthy-1"	"2019-08-01-count-3:TGAGACTGTCCGGATC"	1.63528146323506	-9.74128916179808	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGACTGTCCGGATC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.90730953935	44.3925813899144	0.0188350985251901	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2351.74137349293	2351.74137349293
"healthy-1"	"2019-08-01-count-2:CCGTTCAGTTCTCGTC"	0.150157448917073	11.8535737761292	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTTCAGTTCTCGTC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1586.85072553445	38.0525754321579	0.0239799338525317	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1582.42004921074	1582.42004921074
"healthy-1"	"2019-08-01-count-2:AGGTCTACACCTGATA"	1.7326361137325	-9.24409868633422	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTACACCTGATA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.8152291244	38.5428171664018	0.016500798815688	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2332.65678390551	2332.65678390551
"healthy-1"	"2019-08-01-count-2:GAGAGGTGTGTTGCCG"	-0.617606083781082	13.8618306883606	"2019-08-01-count-2"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTGTGTTGCCG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1633.33141816358	42.9845694738646	0.0263171142095545	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1633.33141816358	1633.33141816358
"healthy-1"	"2019-08-01-count-3:GCAGCTGGTAGAATGT"	2.50644745406453	-10.3899727097717	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCTGGTAGAATGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.62290521205	38.2250396420387	0.0162755117295373	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2344.69389467811	2344.69389467811
"healthy-1"	"2019-08-01-count-2:TGACCCTTCGAGAATA"	2.9407545524532	-9.96230032360228	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTTCGAGAATA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.62562141266	40.750553171741	0.0181466370810758	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2240.65857467009	2240.65857467009
"healthy-1"	"2019-08-01-count-2:AGTGCCGGTCGAAACG"	-1.23988352242168	13.5324287184509	"2019-08-01-count-2"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGGTCGAAACG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1750.02521149732	44.0555668396223	0.025174246948093	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1741.98720786376	1741.98720786376
"healthy-1"	"2019-08-01-count-4:ATTCATCCAGTTCTAG"	-5.23660169068034	-4.46442367946776	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCATCCAGTTCTAG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3004.89726321919	43.9971190358153	0.0146418047546426	3813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2999.10662795229	2999.10662795229
"healthy-1"	"2019-08-01-count-4:CGGAATTGTCGGCACT"	-5.1147645515507	3.66789505565492	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAATTGTCGGCACT"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2386.94227820568	42.0729275086606	0.0176262861036957	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2380.5238007586	2380.5238007586
"healthy-1"	"2019-08-01-count-3:AAGCGAGGTCTGTTAG"	3.00853957709615	-10.734947227594	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGAGGTCTGTTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.26600401886	41.2162019112699	0.0180831029983321	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2274.29667356392	2274.29667356392
"healthy-1"	"2019-08-01-count-2:CAATCGAGTCGATGCC"	3.11452378806416	-10.4226560822693	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATCGAGTCGATGCC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.05736637478	42.242151505696	0.0178760584092382	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2361.66413684312	2361.66413684312
"healthy-1"	"2019-08-01-count-3:CCCTCTCCACTGTCCT"	1.3684638935024	9.46804521167604	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCTCCACTGTCCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1950.97802462208	32.3964431478803	0.0166052322163679	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1945.71783424381	1945.71783424381
"healthy-1"	"2019-08-01-count-4:TCGCACTCAGTTTCGA"	1.82273592528645	-10.2834358445373	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCACTCAGTTTCGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.31950088532	41.1589188688963	0.017445250146685	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2356.38132488497	2356.38132488497
"healthy-1"	"2019-08-01-count-1:TGTGTGATCATTTGTC"	1.45469631728474	9.8863200911316	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGTGTGATCATTTGTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1839.12105173457	30.710639079886	0.0166985414314742	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1831.28788517761	1831.28788517761
"healthy-1"	"2019-08-01-count-2:TGACTCCCAGTAGTGG"	8.34194054183308	7.74306771838991	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACTCCCAGTAGTGG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2052.46311243288	44.8822564307816	0.0218675094129124	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2039.37337397543	2039.37337397543
"healthy-1"	"2019-08-01-count-2:TTGGGCGTCAGCTGAT"	1.13173927840535	9.87296483600465	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGCGTCAGCTGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1603.72389534299	39.2589215700786	0.0244798507299676	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1601.16446528549	1601.16446528549
"healthy-1"	"2019-08-01-count-3:CCCTCTCGTTCCCACT"	1.44251133975331	11.0433883436951	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCTCGTTCCCACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1988.01550030898	34.0620230608311	0.0171336808267024	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1981.91142529537	1981.91142529537
"healthy-1"	"2019-08-01-count-2:TCCTTTCTCTCTGAGA"	9.85175194320027	6.80820891940919	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCTCTCTGAGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2235.75301804872	35.8714801227465	0.016044473532257	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2234.55110475728	2234.55110475728
"healthy-1"	"2019-08-01-count-2:CTGCTCAGTCTTGAGT"	1.66781880435292	-4.72341110622557	"2019-08-01-count-2"	"Control1"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCTCAGTCTTGAGT"	"cDC1"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2438.29520503295	42.7775797987894	0.0175440527916764	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2434.23566319172	2434.23566319172
"healthy-1"	"2019-08-01-count-4:TTGCTGCGTCGTTATG"	-5.553046087653	4.06385419452516	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCGTCGTTATG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2260.92928983411	36.7808805279224	0.0162680366401999	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2253.40850879084	2253.40850879084
"healthy-1"	"2019-08-01-count-2:CGGGTCATCCAAACCA"	-0.876232783228713	13.376419998053	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCATCCAAACCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1569.69848063349	46.6700429056968	0.0297318519967363	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1569.69848063349	1569.69848063349
"healthy-1"	"2019-08-01-count-2:GAGTCATCATTACGGT"	1.08257844027821	10.7469367750916	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATCATTACGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.92650695618	32.3309181864169	0.0176968904131142	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1820.0053632545	1820.0053632545
"healthy-1"	"2019-08-01-count-4:CCTTTGGCAACGTATC"	2.40782036361043	-10.390799545404	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGCAACGTATC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.61658300206	38.7320686292995	0.0159877006130716	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2421.60652075099	2421.60652075099
"healthy-1"	"2019-08-01-count-3:CTGCTCATCGAAGCCC"	3.24863972243611	-10.846441291925	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCATCGAAGCCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.39229373006	36.3442973750085	0.0158543096983941	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2290.3167833315	2290.3167833315
"healthy-1"	"2019-08-01-count-4:GGTAACTCACGACGAA"	-4.36242185059245	3.63870880687562	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTCACGACGAA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2859.01896480702	43.2072979952316	0.0151126307754828	3785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2852.37807951352	2852.37807951352
"healthy-1"	"2019-08-01-count-3:CAATACGAGAGCACTG"	3.27590622481648	-10.2828998795715	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGAGAGCACTG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.50975411998	41.1152857001178	0.0185830980512316	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2209.31001632602	2209.31001632602
"healthy-1"	"2019-08-01-count-4:ATTATCCGTATCAGGG"	2.50290264663045	-10.6159677735535	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCGTATCAGGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.48991418396	41.9197340189343	0.0180650360782439	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2318.22022706327	2318.22022706327
"healthy-1"	"2019-08-01-count-3:GATCAGTTCCGATAGT"	1.25577678260152	9.28301999652711	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCAGTTCCGATAGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.47131141789	29.8539751370997	0.0182764000374061	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1628.66841047818	1628.66841047818
"healthy-1"	"2019-08-01-count-2:TCCACGTCACAACGTT"	1.43501474437062	10.4489536055359	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACGTCACAACGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1864.95154363356	29.3211123914674	0.0157221845744795	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1858.88934580692	1858.88934580692
"healthy-1"	"2019-08-01-count-2:TCCACCATCATTACGG"	1.68067659911458	-9.897412323114	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCATCATTACGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.18216159797	40.1302798210318	0.0177161380225253	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2264.05966399746	2264.05966399746
"healthy-1"	"2019-08-01-count-4:TCTAACTAGACCTCAT"	-5.58934388580974	-5.45293524181517	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTAACTAGACCTCAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2862.93417983044	42.49637881912	0.0148436450682345	3349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2861.97341418609	2861.97341418609
"healthy-1"	"2019-08-01-count-2:ACCGTTCCATGTCAGT"	3.21097650107686	-10.5444393388	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCCATGTCAGT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.48677764171	49.3323934817398	0.0212046739125449	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2321.0085133227	2321.0085133227
"healthy-1"	"2019-08-01-count-1:CTAACTTAGACGACGT"	1.03667541322057	9.96581552112428	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTAACTTAGACGACGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.82689467122	40.0739255155451	0.0212613294243848	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1873.91251968297	1873.91251968297
"healthy-1"	"2019-08-01-count-2:GAACGTTGTAATACCC"	8.14587273177449	8.21375749194948	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTGTAATACCC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.43422523608	37.2821397662643	0.0202133202996124	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1838.97771093221	1838.97771093221
"healthy-1"	"2019-08-01-count-4:GAATCGTAGTCACGAG"	1.70475794848744	-10.1221380463806	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCGTAGTCACGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.41921102811	39.4796452691362	0.017342871241763	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.40744796784	2275.40744796784
"healthy-1"	"2019-08-01-count-4:GTATTTCAGACGGATC"	0.834268887608689	9.15570542896119	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTTCAGACGGATC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1710.77434908948	37.5949850207545	0.0219754201018759	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1702.13836798878	1702.13836798878
"healthy-1"	"2019-08-01-count-2:GTTACCCAGTGAGGTC"	2.2426766353542	-10.2619571915832	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCAGTGAGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.65825569074	37.0045882449405	0.0158365427014493	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2330.7844100807	2330.7844100807
"healthy-1"	"2019-08-01-count-2:GTCCTCATCTCCGAAA"	10.8440586524898	4.6999506720337	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCATCTCCGAAA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1837.41679575498	35.3652717354941	0.0192472779269239	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1832.05761053041	1832.05761053041
"healthy-1"	"2019-08-01-count-2:CACTGGGCACAATGAA"	-0.252075950533706	12.1508655318054	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGGGCACAATGAA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1834.4518912189	35.3961290989633	0.0192952070688779	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1827.39787807606	1827.39787807606
"healthy-1"	"2019-08-01-count-4:CGGGTGTCAATGACCT"	3.46635140952412	-10.8913498154846	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTCAATGACCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.51011130014	39.2756817440693	0.0170060661574497	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2303.56389966101	2303.56389966101
"healthy-1"	"2019-08-01-count-1:TATTGGGGTTAAACAG"	1.92758156832997	-10.3360662690369	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TATTGGGGTTAAACAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.72015035383	42.6426218828362	0.0171343579456989	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2482.03189169303	2482.03189169303
"healthy-1"	"2019-08-01-count-2:GCTGAATGTCGCTGCA"	1.12222244319264	9.93348023975221	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGAATGTCGCTGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1786.31290000465	36.4898910688898	0.0204274912132106	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1780.912359526	1780.912359526
"healthy-1"	"2019-08-01-count-2:TTTATGCTCTTGAACG"	1.87809242781941	-10.2839927903381	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCTCTTGAACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.44773496006	36.3752964607679	0.0170580014058113	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2127.34475238834	2127.34475238834
"healthy-1"	"2019-08-01-count-2:GTCAGCGTCAGTGATC"	-5.17867169800456	-5.15286352550658	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAGCGTCAGTGATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2767.05784501995	44.0152030449429	0.0159068604670335	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2764.04297272213	2764.04297272213
"healthy-1"	"2019-08-01-count-3:CTACATTGTATGCTTG"	1.74442185935323	-9.8891811600891	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACATTGTATGCTTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2428.93888737316	42.7207149226886	0.0175882214018526	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2422.53048347026	2422.53048347026
"healthy-1"	"2019-08-01-count-2:GTCTACCCATCCCACT"	1.25331558760945	-8.73975660717162	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTACCCATCCCACT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2543.62005805259	44.2745131283261	0.0174061031592206	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2540.52103871791	2540.52103871791
"healthy-1"	"2019-08-01-count-4:GCTCAAAAGATCACCT"	-0.399855355650741	13.6593084105286	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAAAGATCACCT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1975.6915823222	34.2686953586244	0.0173451644301412	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1975.6915823222	1975.6915823222
"healthy-1"	"2019-08-01-count-4:GTTAGACCAGTGCGCT"	2.1680084663326	-10.4398737183777	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACCAGTGCGCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.46686052824	37.3157601706056	0.0153596497967838	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2426.28745101102	2426.28745101102
"healthy-1"	"2019-08-01-count-3:ATCGATGTCATACAGC"	-0.843328813940841	13.060315109137	"2019-08-01-count-3"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGTCATACAGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1945.82136855914	52.8858480073221	0.027179189653202	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1940.61104177755	1940.61104177755
"healthy-1"	"2019-08-01-count-2:TTCTCTCAGGACAACC"	3.06015243110005	-10.5799637070862	"2019-08-01-count-2"	"Control1"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCAGGACAACC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.92129587096	45.5415323553719	0.0199838109538429	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2277.73754233974	2277.73754233974
"healthy-1"	"2019-08-01-count-4:CAGGTATGTCCTCAGG"	1.35028852996175	9.66291711414186	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGTATGTCCTCAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.47220302991	32.8619489658762	0.0182013042963098	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.92456464231	1802.92456464231
"healthy-1"	"2019-08-01-count-3:TCTCCGAGTGGGTCAA"	1.24076213416402	9.56735322559205	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCCGAGTGGGTCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.76500156189	35.1197862068776	0.0199911690952709	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1749.82697249172	1749.82697249172
"healthy-1"	"2019-08-01-count-4:TCGTAGAAGGAGATAG"	1.5065436559612	-8.71310141002806	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGAAGGAGATAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.72864993459	41.4039723413526	0.0172392382222198	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2399.09054754247	2399.09054754247
"healthy-1"	"2019-08-01-count-2:TACTTCAGTTCAATCG"	3.2223023372585	-10.7721262208191	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCAGTTCAATCG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.06459981637	41.7168695104317	0.0172736039912157	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2409.32971086623	2409.32971086623
"healthy-1"	"2019-08-01-count-3:ATTCCTACAGTTGAAA"	14.1580711799556	1.75552830779878	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTACAGTTGAAA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1445.24525579893	28.0789714251537	0.019428516587402	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1428.65884924592	1428.65884924592
"healthy-1"	"2019-08-01-count-2:GCCAACGTCATACGAC"	1.35180582579915	9.87277886951295	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGTCATACGAC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.30412226182	39.905003838812	0.0221780205720028	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1795.81644717065	1795.81644717065
"healthy-1"	"2019-08-01-count-3:ATGAAAGCATAGTCGT"	2.74776019629781	-10.7966337434021	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGCATAGTCGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.1021929077	39.1730366297949	0.0164516402305095	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2378.5233343623	2378.5233343623
"healthy-1"	"2019-08-01-count-4:ATCACTTTCATGGCCG"	1.46474268016164	10.4523715742859	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACTTTCATGGCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.13191735409	37.2084772421207	0.0215935163566903	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1713.57566811699	1713.57566811699
"healthy-1"	"2019-08-01-count-2:GTCCTCACAACTCGTA"	9.8542705970699	5.9167818793091	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCACAACTCGTA"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1603.92307365058	42.8398450496761	0.0267094137826519	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1603.92307365058	1603.92307365058
"healthy-1"	"2019-08-01-count-1:GTGTGATTCCAATCTT"	0.862801809876603	9.34514329517213	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGTGATTCCAATCTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1623.08923475579	32.1135033604363	0.0197854207105675	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1615.96847057376	1615.96847057376
"healthy-1"	"2019-08-01-count-4:CCCGGAACAACTCGAT"	1.30135073241536	-8.89273073589476	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGGAACAACTCGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2588.1448300932	37.2853300300356	0.014406199219034	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2586.4809407518	2586.4809407518
"healthy-1"	"2019-08-01-count-2:CTAACTTAGGCGACAT"	-3.098615984351	-5.55091574108275	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTAGGCGACAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2141.04352403821	44.6157470885821	0.0208383185991627	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2141.04352403821	2141.04352403821
"healthy-1"	"2019-08-01-count-3:ACGTACATCGTTGCCT"	1.84562315520589	-10.0739135972229	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACATCGTTGCCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.78103534451	38.7579729329738	0.0164174365825155	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2357.61015336384	2357.61015336384
"healthy-1"	"2019-08-01-count-2:CCTCTAGGTACTTCCC"	-3.20856390419658	-5.49426414882811	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTAGGTACTTCCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2470.40812091438	44.4661511316738	0.01799951625613	2565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2467.54159911337	2467.54159911337
"healthy-1"	"2019-08-01-count-2:CCTCTAGCATCACGGC"	1.47988845881764	9.8699855574402	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTAGCATCACGGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1862.61453978191	36.8787303053138	0.0197994429430535	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1860.00019098017	1860.00019098017
"healthy-1"	"2019-08-01-count-2:AAAGGTACACAGCGCT"	8.61236347731892	8.00363872135011	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGTACACAGCGCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.56805044439	40.3384379023355	0.0208945951908041	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1928.57080231401	1928.57080231401
"healthy-1"	"2019-08-01-count-4:GTTGTCCTCAGACATC"	-7.24279771271403	-0.207010947820269	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCTCAGACATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2704.08218426632	39.9435844308053	0.0147715867007359	3295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2700.92024945525	2700.92024945525
"healthy-1"	"2019-08-01-count-2:TCCTCTTCACGGCCAT"	2.43171920356099	-10.7535104981628	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCTTCACGGCCAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.10247567831	40.7318719390206	0.0164102297701828	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2479.08497911156	2479.08497911156
"healthy-1"	"2019-08-01-count-3:AACCAACCATGTCTAG"	1.82607211646382	-5.23943188106688	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACCATGTCTAG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2490.81592967793	40.233503268085	0.0161527404689785	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2487.25627130036	2487.25627130036
"healthy-1"	"2019-08-01-count-3:ACATCGAGTATAATGG"	1.59139813956563	-8.86879255687865	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCGAGTATAATGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.91741300155	41.1250830613581	0.018492180879079	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2219.30010851258	2219.30010851258
"healthy-1"	"2019-08-01-count-2:ATCACTTGTGACCGAA"	1.85333861884419	-10.0929241410461	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTGTGACCGAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2435.21595265693	42.1308949197109	0.0173006812285967	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2434.41651580187	2434.41651580187
"healthy-1"	"2019-08-01-count-4:TCCGGGATCTGCTCTG"	1.39319290694539	10.2838687666687	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGATCTGCTCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.02941741949	38.0258271953657	0.0212787919575918	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1781.0455993496	1781.0455993496
"healthy-1"	"2019-08-01-count-4:GCAACCGCACTCCTTG"	-0.392685572535354	12.388892150763	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACCGCACTCCTTG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2190.71571865139	44.336569747571	0.0202383948634215	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2179.26379359214	2179.26379359214
"healthy-1"	"2019-08-01-count-2:TTTAGTCGTAGAGACC"	0.414323707192582	13.1396198042664	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTAGTCGTAGAGACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1600.7326596784	46.6962605636091	0.0291718047240885	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1598.73978754098	1598.73978754098
"healthy-1"	"2019-08-01-count-2:TGTTCCGCAGCTGCCA"	3.03917779502217	-10.6915216675964	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCCGCAGCTGCCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.26231094526	41.78882869449	0.0172235411257777	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2421.42763769874	2421.42763769874
"healthy-1"	"2019-08-01-count-2:TTTCACAAGGCATTTC"	1.8555460172588	-10.2688207856384	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACAAGGCATTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.08304165705	45.2183722265695	0.0184558529069232	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2446.46619439448	2446.46619439448
"healthy-1"	"2019-08-01-count-4:CCGGTGACAGAGATTA"	2.17562760886495	-10.085665725824	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTGACAGAGATTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.89309312593	41.2439560190363	0.0178321929974265	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2308.30954423776	2308.30954423776
"healthy-1"	"2019-08-01-count-3:GAACGTTCAATTTCCT"	8.29599442061726	7.41522834384767	"2019-08-01-count-3"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACGTTCAATTTCCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.74779065602	41.6213181235173	0.0198031934700053	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2097.8954883678	2097.8954883678
"healthy-1"	"2019-08-01-count-3:ACGTTCCTCACTTCTA"	-0.6640342277592	12.6904716261658	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTTCCTCACTTCTA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1965.22124521361	38.3366100717098	0.0195075288164528	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1958.03300389375	1958.03300389375
"healthy-1"	"2019-08-01-count-4:GCGGATCCAGCACAGA"	-4.22798333588298	3.65224955165712	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCCAGCACAGA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2655.10350131533	41.0814192049793	0.015472624394728	3582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2650.76563825233	2650.76563825233
"healthy-1"	"2019-08-01-count-2:TCGGGTGCAGCATACT"	-8.97212539139445	2.88413093173829	"2019-08-01-count-2"	"Control1"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGCAGCATACT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2328.48394173563	44.4448086926322	0.0190874447944457	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2320.39709207225	2320.39709207225
"healthy-1"	"2019-08-01-count-2:GAACGTTAGGCCACTC"	3.27553190764729	-10.6936226121155	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTAGGCCACTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.59690684022	39.9017926093199	0.0176666285553107	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2254.90855247468	2254.90855247468
"healthy-1"	"2019-08-01-count-2:TGCCGAGCAAATGCGG"	3.31901230391805	-9.93531420147093	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGCAAATGCGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.29039686626	44.3021970829459	0.0178689019805596	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2475.4103742436	2475.4103742436
"healthy-1"	"2019-08-01-count-3:AAAGTCCAGCTTGTTG"	2.64684667167012	-10.4911775819031	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTCCAGCTTGTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.36496087861	46.063774277748	0.0190396137096321	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2416.84975697802	2416.84975697802
"healthy-1"	"2019-08-01-count-4:GCACGGTTCCTTCGAC"	-5.0090745491093	-5.25080397045287	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTTCCTTCGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2937.13755915873	43.9655126119923	0.0149688299326999	3003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2930.09970863196	2930.09970863196
"healthy-1"	"2019-08-01-count-2:AGTGCCGGTGTGTTTG"	13.978571553796	1.73245725715486	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGGTGTGTTTG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1472.83074066358	34.6051075513738	0.0234956445407858	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1455.10136039855	1455.10136039855
"healthy-1"	"2019-08-01-count-2:CCTCATGAGCCAGACA"	1.80175962027852	-10.1783361664978	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCATGAGCCAGACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.55395903183	40.6021167375941	0.0165415458023213	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2451.35217647021	2451.35217647021
"healthy-1"	"2019-08-01-count-3:CGGAGAAGTATCATGC"	2.34964646872823	-10.4948740235535	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAAGTATCATGC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.56959484132	39.9937147654638	0.0182073515263936	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2188.34953552012	2188.34953552012
"healthy-1"	"2019-08-01-count-3:ACTATTCAGTAAACTG"	14.1812559562618	1.72801981056062	"2019-08-01-count-3"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATTCAGTAAACTG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1483.83811430679	28.5955065645078	0.0192713115324354	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1464.24608907059	1464.24608907059
"healthy-1"	"2019-08-01-count-4:AAGGAATGTACCCAGC"	-0.854139904410201	13.8933553465637	"2019-08-01-count-4"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGAATGTACCCAGC"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.08433604959	46.3654173028779	0.0241350243884769	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1908.60171432103	1908.60171432103
"healthy-1"	"2019-08-01-count-2:GAGATGGGTTGCTGAT"	1.91680314120595	-10.2031564942566	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGGTTGCTGAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.5707659817	41.5819699727619	0.0171219923072545	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2425.03564465	2425.03564465
"healthy-1"	"2019-08-01-count-3:CTTGATTTCGAGAAAT"	1.01607628640477	9.35120675647584	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTTCGAGAAAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.66275651754	37.4852785718607	0.0207368760775246	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1803.93184548864	1803.93184548864
"healthy-1"	"2019-08-01-count-2:GGACGTCAGAGATCGC"	-6.84278235855754	3.98757050121156	"2019-08-01-count-2"	"Control1"	"MPP"	"MPP_MEP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGACGTCAGAGATCGC"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2117.87387397709	39.9874290891363	0.0188809303426767	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2112.08909797731	2112.08909797731
"healthy-1"	"2019-08-01-count-3:ATACCTTAGCACTAAA"	0.744803388684434	12.7854842909607	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTAGCACTAAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2338.77470772259	48.0434745793588	0.0205421558650862	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2329.34680982037	2329.34680982037
"healthy-1"	"2019-08-01-count-2:TTCAGGAGTGAGCTCC"	2.40205564078633	-10.4176197282043	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGAGTGAGCTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.03893065829	42.4833465270056	0.0173682217378169	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2440.9807746093	2440.9807746093
"healthy-1"	"2019-08-01-count-4:TGACGCGCAATTAGGA"	1.4226870733196	10.8637437590393	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACGCGCAATTAGGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1767.87307456545	42.5837234441151	0.0240875456823066	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1762.4618936347	1762.4618936347
"healthy-1"	"2019-08-01-count-3:AATGAAGAGACGGAAA"	11.3155886131221	3.57091949069826	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGAGACGGAAA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1757.88208320062	34.9453143172075	0.0198792141129181	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1749.66744687642	1749.66744687642
"healthy-1"	"2019-08-01-count-3:TCAGCCTAGCACTCAT"	-7.51961884918864	1.1512526043686	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTAGCACTCAT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2592.79126778732	45.7140323261037	0.0176312042137954	3602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2587.42375558658	2587.42375558658
"healthy-1"	"2019-08-01-count-2:CAGCGTGAGACGACTG"	1.41594399985616	-9.1941709748474	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCGTGAGACGACTG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2430.90238722649	42.9682780661685	0.0176758549795957	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2427.83383188445	2427.83383188445
"healthy-1"	"2019-08-01-count-4:GTGTTAGAGAGGATGA"	-2.54401479187663	3.34444735133973	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTAGAGAGGATGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3093.96738590193	41.4301111262554	0.0133906101644889	4983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3088.51389545189	3088.51389545189
"healthy-1"	"2019-08-01-count-2:AAGGTAATCACATACG"	1.82106473025624	-10.1209955445495	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAATCACATACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2570.37240104438	38.0751036806256	0.0148130689798704	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2561.18352747702	2561.18352747702
"healthy-1"	"2019-08-01-count-4:GATGAGGCAGCCGGTT"	0.93143798884694	11.7870063551697	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGCAGCCGGTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.96149287198	36.1678744833875	0.0190260952781032	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1895.13282586819	1895.13282586819
"healthy-1"	"2019-08-01-count-4:TAAGCCACATCGCTCT"	1.49465157565419	10.2315797575745	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCCACATCGCTCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.43530066611	34.2788097804661	0.0175389841601731	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1946.57639431911	1946.57639431911
"healthy-1"	"2019-08-01-count-4:TTCAGGAAGCGCATCC"	2.49693240699117	-10.680519127008	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAGGAAGCGCATCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.96200437374	41.2439510221978	0.0175062038121286	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2352.09349534976	2352.09349534976
"healthy-1"	"2019-08-01-count-3:GACCCTTGTTTCTATC"	4.26056303557698	-10.5725164643494	"2019-08-01-count-3"	"Control1"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCTTGTTTCTATC"	"CD16+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.3288351071	50.4094393908248	0.0220868433222329	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2278.86119198003	2278.86119198003
"healthy-1"	"2019-08-01-count-2:GCTCAAAAGTCATAGA"	-2.49134836617168	3.34649918163148	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGTCATAGA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3141.74058246599	43.8429202367078	0.0139549778493471	5287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3133.76720586351	3133.76720586351
"healthy-1"	"2019-08-01-count-2:CGTCCATTCGTTGTGA"	1.68472196635548	-4.71232368862303	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCCATTCGTTGTGA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2515.45125203691	43.9626030326759	0.0174770244492223	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2507.06314514292	2507.06314514292
"healthy-1"	"2019-08-01-count-3:CATGCAACACTCCCTA"	1.23256971415822	9.50526425922243	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCAACACTCCCTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1664.46732331661	30.1215962877196	0.0180968384694387	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1661.38894522193	1661.38894522193
"healthy-1"	"2019-08-01-count-4:ACTCTCGGTATTAAGG"	-5.01837096634563	-5.52850725567015	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCTCGGTATTAAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2720.10446585784	42.2893131690884	0.015546944501542	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2711.52158488923	2711.52158488923
"healthy-1"	"2019-08-01-count-3:TGAGACTAGATGCTTC"	10.8245769935543	4.06750152194826	"2019-08-01-count-3"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGACTAGATGCTTC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.77165678986	32.2381095455227	0.0161532054209933	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1992.15418472447	1992.15418472447
"healthy-1"	"2019-08-01-count-2:CGCAGGTGTCGCATTA"	-6.13410172882732	4.39914605701295	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCAGGTGTCGCATTA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1773.28603748906	50.5705204723424	0.0285179713837647	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	1765.85942817504	1765.85942817504
"healthy-1"	"2019-08-01-count-2:TCGACGGCACCTGATA"	-5.5166052383488	3.30334398830263	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACGGCACCTGATA"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2568.84259498306	39.401195531108	0.0153381120384949	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2561.08858246327	2561.08858246327
"healthy-1"	"2019-08-01-count-3:TTCAATCGTTTGAAAG"	1.45429720458333	9.88777158344118	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAATCGTTTGAAAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1754.83770994726	36.4305876385795	0.0207600893416373	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1751.08245087191	1751.08245087191
"healthy-1"	"2019-08-01-count-4:TGTACAGGTGCAGTGA"	1.85841455039327	-10.3319921723572	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGGTGCAGTGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.54463906979	38.0891302163224	0.0158076051378018	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2405.97272974432	2405.97272974432
"healthy-1"	"2019-08-01-count-4:TACGTCCTCTCGCTCA"	-1.81013462963756	11.0824136503967	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCTCTCGCTCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.96146347092	43.1339860877863	0.0209901678715333	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2051.54339156403	2051.54339156403
"healthy-1"	"2019-08-01-count-3:CAATCGACACCTGCGA"	0.783427258103532	9.38982198322145	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATCGACACCTGCGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.15721543253	39.9515050727571	0.0222799789828357	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1789.47000891592	1789.47000891592
"healthy-1"	"2019-08-01-count-4:GCACGTGGTACCATAC"	1.62024917182271	-4.97374584591063	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGGTACCATAC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2373.67930427867	40.1904085344704	0.0169316926941332	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2365.35439397987	2365.35439397987
"healthy-1"	"2019-08-01-count-3:TCATGAGAGAATCGAT"	2.26244201239888	-10.172314666864	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGAGAATCGAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.36501857168	44.5774162636256	0.0179576395615157	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2477.86765300263	2477.86765300263
"healthy-1"	"2019-08-01-count-3:ATTCTTGCAACTCGTA"	2.97149505194966	-10.804018043634	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTTGCAACTCGTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.12497201705	44.0695539314416	0.0183384361798097	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2398.8906661027	2398.8906661027
"healthy-1"	"2019-08-01-count-2:GCCCGAAGTCACTCTC"	1.41432430323903	-9.44886686718138	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAAGTCACTCTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.1130367592	48.4780836317727	0.0185305768331122	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2605.96736581639	2605.96736581639
"healthy-1"	"2019-08-01-count-3:GAGAGGTAGTTCCGGC"	-2.71706996384318	3.3200359114441	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTAGTTCCGGC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3232.42498242353	44.5035000172232	0.0137678369209535	5631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3226.79042169767	3226.79042169767
"healthy-1"	"2019-08-01-count-4:GGAGCAAGTCTTCAAG"	10.7541176277095	4.30551097476808	"2019-08-01-count-4"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGCAAGTCTTCAAG"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.07727336702	30.7798796210554	0.0166912092381334	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1836.67661665766	1836.67661665766
"healthy-1"	"2019-08-01-count-2:CACTGGGTCGCCAATA"	1.10877492007558	9.60616300189821	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGGGTCGCCAATA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1722.99619652323	36.2123146893246	0.021017060143485	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1721.70531642939	1721.70531642939
"healthy-1"	"2019-08-01-count-2:TCTGCCAAGCAGTAAT"	2.2398861843044	-10.3730907670227	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCAAGCAGTAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.29017584547	42.1816313449293	0.0190497306112209	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2212.21118518414	2212.21118518414
"healthy-1"	"2019-08-01-count-4:ACTTAGGCAAGAGTGC"	0.178853725164574	13.3719720610413	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTAGGCAAGAGTGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1854.02907416524	44.6168541934571	0.0240648082682012	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1850.55366297326	1850.55366297326
"healthy-1"	"2019-08-01-count-4:AACGTCACATCCGTGG"	1.24934496459309	9.94030664050905	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCACATCCGTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.45868912463	40.2884298534728	0.02388936658412	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1685.31467655484	1685.31467655484
"healthy-1"	"2019-08-01-count-2:CGGCAGTTCTTGAGCA"	-1.30910811844524	13.6560477980408	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGCAGTTCTTGAGCA"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1965.4690124647	43.9418466931765	0.0223569267256335	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1961.79824503645	1961.79824503645
"healthy-1"	"2019-08-01-count-3:CCCTCTCCACCCTGTT"	0.574110110371751	-8.32367994701537	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCTCCACCCTGTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2685.75296215106	43.804924722487	0.0163101094329253	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2682.34062440635	2682.34062440635
"healthy-1"	"2019-08-01-count-2:GCAACCGTCTCAGTCC"	10.924839635461	4.3870000609192	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGTCTCAGTCC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.58754106534	43.0222888646629	0.0223772847507498	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1904.90684619934	1904.90684619934
"healthy-1"	"2019-08-01-count-1:TATTCCAGTAGGGTAC"	7.78015055236165	7.59964702213136	"2019-08-01-count-1"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TATTCCAGTAGGGTAC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.9091666856	36.9582342625058	0.0194936734902314	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1892.34417305847	1892.34417305847
"healthy-1"	"2019-08-01-count-4:GTATTTCTCTGGCTGG"	1.34068061885182	9.73122594440309	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTTCTCTGGCTGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.45319313774	34.9150741014307	0.0197098485224926	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1764.01909921422	1764.01909921422
"healthy-1"	"2019-08-01-count-4:GTGAGCCCAATTGCCA"	-3.06254086914714	-5.48457243358763	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGCCCAATTGCCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2535.49701068773	46.0514783247079	0.0181627026695712	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2528.67546374844	2528.67546374844
"healthy-1"	"2019-08-01-count-4:CACACAAAGAGTCTTC"	-5.56256280365642	-5.44736101543578	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAAAGAGTCTTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2678.0026918403	45.0982431513666	0.0168402531068315	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2676.47514544598	2676.47514544598
"healthy-1"	"2019-08-01-count-3:TCACAAGTCTGAATCG"	-7.48664937439616	1.77069959724275	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACAAGTCTGAATCG"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2297.00550891134	44.1014541804834	0.0191995421906433	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2292.59800280118	2292.59800280118
"healthy-1"	"2019-08-01-count-3:TCAGCCTCACCGTGCA"	1.60649456557576	-9.26481535350951	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCACCGTGCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.44013799532	40.428919485123	0.0160979029017965	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2505.33351246944	2505.33351246944
"healthy-1"	"2019-08-01-count-4:GGTAACTCAAGGTACG"	1.22158398207967	10.0658063658508	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTCAAGGTACG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.21824016512	38.254578992891	0.0233513325971973	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1634.57272301121	1634.57272301121
"healthy-1"	"2019-08-01-count-3:TCCCACACAAAGCAAT"	1.10701527175252	9.50121877277223	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCACACAAAGCAAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1872.5656380171	35.7398239486661	0.019086019321871	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1861.56993083401	1861.56993083401
"healthy-1"	"2019-08-01-count-4:GTTCATTCAAGAAACT"	1.7679212289745	-9.57007315075072	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTCAAGAAACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.51414768848	43.8201453269257	0.0188189302480408	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2325.55626122801	2325.55626122801
"healthy-1"	"2019-08-01-count-3:GTTGTGACAACACAGG"	-4.75895390930827	-5.52616598522338	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGACAACACAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2403.79728105773	42.7191599527567	0.0177715318547824	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2398.83932952403	2398.83932952403
"healthy-1"	"2019-08-01-count-4:GATTTCTGTCGAGCTC"	8.3419939475948	7.12369773471681	"2019-08-01-count-4"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTTCTGTCGAGCTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.29604063804	41.2631418807766	0.0212226641511011	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1934.65150213685	1934.65150213685
"healthy-1"	"2019-08-01-count-4:TTCTAGTGTTAAGCAA"	0.264704589813393	13.7224988707337	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAGTGTTAAGCAA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1717.20874471787	45.1388928181983	0.0262862001821534	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1713.59080702808	1713.59080702808
"healthy-1"	"2019-08-01-count-3:CCCTCAATCAGATTGC"	7.94924606856648	7.51548001849977	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAATCAGATTGC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2128.51159922904	38.3808519290848	0.0180317795510189	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2124.6223828059	2124.6223828059
"healthy-1"	"2019-08-01-count-1:AGTTCGAAGCAGGGAG"	1.22451510009114	9.48155400836793	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGTTCGAAGCAGGGAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.86588606512	27.8867658755773	0.0154081946570122	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.08576487422	1802.08576487422
"healthy-1"	"2019-08-01-count-2:ATGACCAAGAAGGTAG"	2.69204535064046	-10.3567581406799	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCAAGAAGGTAG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.51295534015	39.5704967475428	0.015933275750568	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2476.04164920074	2476.04164920074
"healthy-1"	"2019-08-01-count-3:TCAGCCTTCACTCGAA"	1.22884645041768	9.43074224078981	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTTCACTCGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1660.1175771814	32.6348578995664	0.0196581605713584	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1655.69403275202	1655.69403275202
"healthy-1"	"2019-08-01-count-2:CGATCGGCACAGCTGC"	2.97518004950826	-10.6538219681946	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGCACAGCTGC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.50397974291	40.5270123122352	0.0172933405117072	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2333.68727044932	2333.68727044932
"healthy-1"	"2019-08-01-count-2:TGTTCATCAAGACGGT"	1.45551087436025	11.0123643645081	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATCAAGACGGT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2000.66214645711	37.1376623559599	0.0185626855697377	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1993.49047250769	1993.49047250769
"healthy-1"	"2019-08-01-count-2:TGCTTGCTCCGCAACG"	-2.97115002098735	13.4445934065613	"2019-08-01-count-2"	"Control1"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCTCCGCAACG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2085.29565020648	41.8317488080968	0.0200603443468339	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2081.71419007085	2081.71419007085
"healthy-1"	"2019-08-01-count-4:ACGGGTCAGCATACTC"	1.90485384043996	-9.98090174114379	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCAGCATACTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2391.3577863928	40.2164740664053	0.0168174224263903	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2388.6250073717	2388.6250073717
"healthy-1"	"2019-08-01-count-1:AGCTTCCTCTTACCAT"	0.989022214978379	9.09769628131715	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGCTTCCTCTTACCAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.60116811723	34.9776162723091	0.0174573746656263	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1997.56956665786	1997.56956665786
"healthy-1"	"2019-08-01-count-3:GTCATCCCAAATCAAG"	-1.35758314552959	13.6672982939514	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCCAAATCAAG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2123.8700435646	47.7806759203745	0.0224969866047838	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2113.31984361275	2113.31984361275
"healthy-1"	"2019-08-01-count-4:CATCCGTTCTGTGCTC"	0.97027345475499	9.40960214221803	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTTCTGTGCTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1689.13304183476	32.1524350859373	0.0190348742755117	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1686.44755755009	1686.44755755009
"healthy-1"	"2019-08-01-count-4:AGAAATGTCTCCCATG"	2.16314138945882	-10.5807113877502	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAATGTCTCCCATG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.21024584844	39.1278446572692	0.015718979432343	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2483.85037215059	2483.85037215059
"healthy-1"	"2019-08-01-count-3:ATTCTTGCAATGGGTG"	2.60915722426717	-10.724952720758	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTTGCAATGGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.86313198684	42.5740043236925	0.0180868648415241	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2349.22492648633	2349.22492648633
"healthy-1"	"2019-08-01-count-2:GTGCACGCACTGTGAT"	2.35077180442159	-10.7625799409119	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCACGCACTGTGAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.11598965803	43.9376529348164	0.0182456547456653	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2402.78838409929	2402.78838409929
"healthy-1"	"2019-08-01-count-3:GTAGATCTCATTGCCC"	0.0341324667329013	13.5980481871399	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGATCTCATTGCCC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1757.78697700507	42.4727012987217	0.0241625986847889	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1755.97083039357	1755.97083039357
"healthy-1"	"2019-08-01-count-4:AGCCAATCATCGAGCC"	2.27805938300435	-10.5095005265442	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATCATCGAGCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.76831488882	39.1844423664475	0.0154040924785086	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2538.29945190023	2538.29945190023
"healthy-1"	"2019-08-01-count-4:GCTGGGTGTGACTGAG"	11.2076174217159	3.67825958812562	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTGTGACTGAG"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1932.51565919717	34.8277110531374	0.0180219554172233	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1926.82561958757	1926.82561958757
"healthy-1"	"2019-08-01-count-4:CATTCTACATAATCCG"	1.24347450312917	9.65042302692262	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCTACATAATCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.27382200644	37.6294187051975	0.0220148569648285	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1703.02487476629	1703.02487476629
"healthy-1"	"2019-08-01-count-2:AATCGACAGCATCCCG"	1.04178484258	10.5189103850159	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACAGCATCCCG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2105.18584189902	36.3178608776279	0.0172516174842154	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2105.18584189902	2105.18584189902
"healthy-1"	"2019-08-01-count-2:TCGGTCTTCATGAGTC"	0.964000363915604	-8.47844221508177	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGTCTTCATGAGTC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2348.63319742395	41.1635293479229	0.0175265892490459	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2346.42947225369	2346.42947225369
"healthy-1"	"2019-08-01-count-3:TTGTTTGGTTATAGAG"	1.75080349025075	-8.3559255830017	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTTGGTTATAGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.90771504774	40.6473161393067	0.0169088504874238	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2400.89607450964	2400.89607450964
"healthy-1"	"2019-08-01-count-3:TTCCTTCTCTAGCAAC"	2.39434494551961	-10.4736919633118	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCTCTAGCAAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.48733040586	41.2404008215923	0.0167202970447881	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2463.27722694295	2463.27722694295
"healthy-1"	"2019-08-01-count-2:TAAGCCATCTACCTTA"	8.14335789260213	7.70459601962892	"2019-08-01-count-2"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCCATCTACCTTA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.15865155707	39.6718546059533	0.0200245722748017	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1975.40765567442	1975.40765567442
"healthy-1"	"2019-08-01-count-4:CCACACTAGTATTAGG"	1.05909850177113	11.4467410811218	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTAGTATTAGG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.41265350791	35.065152699494	0.017617026618925	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1989.31275734346	1989.31275734346
"healthy-1"	"2019-08-01-count-2:GATCATGTCCACTGAA"	-2.98190961304362	-5.63877489483031	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGTCCACTGAA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2164.47957922407	43.091987668484	0.0199087060382116	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2161.99395240591	2161.99395240591
"healthy-1"	"2019-08-01-count-4:TACTTCATCCACACCT"	1.34501256522481	11.3806476362976	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTCATCCACACCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2274.04549525206	37.1975822215902	0.0163574485643556	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2268.18879918019	2268.18879918019
"healthy-1"	"2019-08-01-count-1:GCTCAAAGTAGGAAAG"	2.60630645331685	-10.5179338685242	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCTCAAAGTAGGAAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.54319158191	41.5358099807384	0.0166240111920742	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2493.12628072599	2493.12628072599
"healthy-1"	"2019-08-01-count-3:CAAGAGGGTCCGGTCA"	1.55625094947163	-4.72385027324828	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGGTCCGGTCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2127.67240154658	40.3495282555866	0.0189641639503605	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2123.81201525735	2123.81201525735
"healthy-1"	"2019-08-01-count-3:GCACGTGTCTTACACT"	1.67187346991841	-9.71195795452269	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGTGTCTTACACT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.38928041796	38.920087457421	0.0159679406855958	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2435.59115563141	2435.59115563141
"healthy-1"	"2019-08-01-count-4:ATCACTTGTCACTTCC"	2.14593710479085	-10.1778173676697	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACTTGTCACTTCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.52499470849	39.062514576557	0.0154977691784702	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2516.5212021126	2516.5212021126
"healthy-1"	"2019-08-01-count-4:TGCAGGCCAGCGGATA"	1.79715802249257	-4.65742494976195	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGGCCAGCGGATA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2698.63805788888	43.9404570895017	0.0162824566121609	2720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2695.00492965527	2695.00492965527
"healthy-1"	"2019-08-01-count-3:CCTGTTGCAGGTGTGA"	0.846657236188096	9.13910577380983	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGTTGCAGGTGTGA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1770.54379749363	32.3885989821795	0.018293023323133	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1766.72376991191	1766.72376991191
"healthy-1"	"2019-08-01-count-2:GAGAAATGTTCCTACC"	8.09155525740926	8.01804683292238	"2019-08-01-count-2"	"Control1"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATGTTCCTACC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.17192125658	10.3489168444454	0.00533677119135438	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1931.57368929136	1931.57368929136
"healthy-1"	"2019-08-01-count-2:TTTACTGCAATGCAGG"	-7.29632363739665	0.0100649216207637	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGCAATGCAGG"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2428.80153741291	46.0092722022279	0.0189431995548042	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2427.01167564224	2427.01167564224
"healthy-1"	"2019-08-01-count-3:ACGTCCTTCTGTCCGT"	14.0893026786739	2.41141698444215	"2019-08-01-count-3"	"Control1"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTTCTGTCCGT"	"Plasmablast"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1379.05856183976	39.1425558423892	0.028383534191739	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1366.70719448065	1366.70719448065
"healthy-1"	"2019-08-01-count-3:TTTCATGGTGCATGAG"	2.46407665786092	-10.6637821427551	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGGTGCATGAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.12195129795	40.5294710591472	0.0174311162631803	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2323.36576040063	2323.36576040063
"healthy-1"	"2019-08-01-count-3:CATACCCAGCAACAAT"	0.677879055112046	13.6723031767639	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCAGCAACAAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.00015295169	38.520964371995	0.019088682582928	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2016.44524228957	2016.44524228957
"healthy-1"	"2019-08-01-count-3:ATCGTCCAGCCTGCCA"	1.11719049987141	11.8007144697937	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCAGCCTGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2041.11552153806	39.2503872220089	0.0192298705329683	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2041.11552153806	2041.11552153806
"healthy-1"	"2019-08-01-count-3:CGAATTGTCATATGGC"	3.00574912604634	-10.6232710114685	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAATTGTCATATGGC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.89023022541	40.6400780654075	0.0162762774163839	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2494.23751454762	2494.23751454762
"healthy-1"	"2019-08-01-count-4:CTGGTCTCAGGTTCGC"	-4.8615964454716	3.22095892513124	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTCAGGTTCGC"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2631.67359313325	43.5542399683504	0.0165500159601841	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2628.35041553275	2628.35041553275
"healthy-1"	"2019-08-01-count-2:TCAATCTAGCTAATGA"	8.61299862441365	7.9608640440735	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATCTAGCTAATGA"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.69293425778	41.2555820135949	0.0195182475869333	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	2111.55779128946	2111.55779128946
"healthy-1"	"2019-08-01-count-2:GGTGAAGGTCTTTATC"	-3.29527268829997	3.61652085864869	"2019-08-01-count-2"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGAAGGTCTTTATC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3117.5540630339	45.5290106187701	0.0146040805382098	4715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3109.88416684573	3109.88416684573
"healthy-1"	"2019-08-01-count-2:CATGGATTCGATCCAA"	3.1756829219753	-10.2972641221252	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATTCGATCCAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.51353551399	35.2981315073968	0.0142935566052891	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2467.46430852029	2467.46430852029
"healthy-1"	"2019-08-01-count-4:GTATTTCTCACTCCGT"	2.64205612716023	-10.573473953363	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTTCTCACTCCGT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.58637523586	38.4621095976261	0.0154678357368454	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2482.49283193397	2482.49283193397
"healthy-1"	"2019-08-01-count-4:TCATCCGGTGTGTTTG"	1.3069107728893	10.2201652296814	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCCGGTGTGTTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.85689431046	45.6923701181418	0.0233618166293555	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1945.85804888407	1945.85804888407
"healthy-1"	"2019-08-01-count-2:ATCACTTGTCACAATC"	11.1436420875484	3.86948630893556	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTGTCACAATC"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1847.75739588881	38.024679325562	0.0205788267497483	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1840.60875891603	1840.60875891603
"healthy-1"	"2019-08-01-count-2:GAGCCTGAGACTAGAT"	-3.42187962952312	-5.2559852830139	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGAGACTAGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2461.5838902341	41.675570683168	0.0169303881328232	2499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2458.66190355194	2458.66190355194
"healthy-1"	"2019-08-01-count-2:TACATTCTCGAGATGG"	-1.84300849857982	11.6325559386047	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACATTCTCGAGATGG"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2083.70564516954	43.9638964229752	0.0210988997053843	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2078.23859930531	2078.23859930531
"healthy-1"	"2019-08-01-count-4:ATGGATCAGTTGGAAT"	-1.98481378975566	12.5269775160584	"2019-08-01-count-4"	"Control1"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGATCAGTTGGAAT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1790.50062678815	39.5510166363122	0.0220893620725842	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1788.46693629882	1788.46693629882
"healthy-1"	"2019-08-01-count-2:ATACCTTTCTGGGCAC"	1.6042398410732	-8.88958361065062	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTTCTGGGCAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.43770906111	38.7794446244097	0.0173631189565219	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2224.50847023551	2224.50847023551
"healthy-1"	"2019-08-01-count-4:TCAGCAATCCAACCAA"	0.714379151433152	9.48707959735719	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAATCCAACCAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.48694445491	34.3189020009254	0.0189870815422543	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1802.08884822475	1802.08884822475
"healthy-1"	"2019-08-01-count-2:CATACCCTCAATCTCT"	2.15412249144856	-10.5053835145203	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCTCAATCTCT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2580.88614879371	37.9204103201723	0.0146927869475746	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2576.75065762549	2576.75065762549
"healthy-1"	"2019-08-01-count-2:TTGCATTTCTTGGTCC"	1.35951437529866	9.97554299915162	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTTCTTGGTCC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.90691201741	34.5955311916026	0.0181232154243921	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1905.36003096684	1905.36003096684
"healthy-1"	"2019-08-01-count-1:ACTACGAGTGAGCGAT"	1.51962759074513	9.99134347522584	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTACGAGTGAGCGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1784.7715937803	35.6802342638118	0.0199914848421797	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1776.18691683493	1776.18691683493
"healthy-1"	"2019-08-01-count-4:AGACACTCATTGTAGC"	3.26591267165486	-10.0656128159729	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTCATTGTAGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2398.65666947902	42.2638590993861	0.017619803466315	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2394.8516346772	2394.8516346772
"healthy-1"	"2019-08-01-count-4:TTACCGCTCTGTAACG"	-3.63293848457988	3.70041058147279	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCTCTGTAACG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3063.06791874962	43.7841646984107	0.0142942193447294	4756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	3056.78361270189	3056.78361270189
"healthy-1"	"2019-08-01-count-2:CTCCCAAAGAACGTGC"	-3.08227763596233	10.5240449675354	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAAGAACGTGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.16619774181	39.8890237719384	0.0203706017486866	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1952.77997761618	1952.77997761618
"healthy-1"	"2019-08-01-count-4:AGTTCCCCAATGAACA"	2.13949288901631	-10.6953668824402	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCCCCAATGAACA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.88242377228	40.5442774352242	0.0178697128641046	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2266.41837074072	2266.41837074072
"healthy-1"	"2019-08-01-count-2:TTAGTCTAGCAGCGAT"	1.04433764991109	-8.76344015514525	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTAGCAGCGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2150.82651361953	43.3877515114577	0.0201725946917226	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2144.82817629594	2144.82817629594
"healthy-1"	"2019-08-01-count-3:GACCCTTCACAGAAGC"	0.493937392800492	13.4213933714661	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ IFN+"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCTTCACAGAAGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2135.14642981658	41.0854969077348	0.0192424727100634	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2129.20546461006	2129.20546461006
"healthy-1"	"2019-08-01-count-2:CCTCACACAGAGAAAG"	1.77041604098622	-9.46012785350951	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACACAGAGAAAG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.48464393979	42.8293717914802	0.0187561461843619	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2280.69879645687	2280.69879645687
"healthy-1"	"2019-08-01-count-2:CGAGGCTAGTGAGCCA"	1.63116325911824	-10.0039491883484	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGCTAGTGAGCCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.36018770737	43.601627151084	0.0181343990696583	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2400.14510268912	2400.14510268912
"healthy-1"	"2019-08-01-count-3:CACAACAGTACGCTTA"	1.36899163302724	9.51133916461793	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAACAGTACGCTTA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1702.74029337081	29.9110915515374	0.0175664437307255	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1699.55473164546	1699.55473164546
"healthy-1"	"2019-08-01-count-2:GGGTGAATCCGCACTT"	-0.00526662069614533	13.9451646574768	"2019-08-01-count-2"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAATCCGCACTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.16500297885	43.7208691416857	0.0254019045623269	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1715.4778688829	1715.4778688829
"healthy-1"	"2019-08-01-count-4:ATTCGTTGTATCAGCT"	2.4599367576534	-10.6542978516785	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCGTTGTATCAGCT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.26898780915	42.9139062848258	0.0181894928075481	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2354.38601015138	2354.38601015138
"healthy-1"	"2019-08-01-count-4:CCCGAAGCAGAATCGG"	-3.2721508544987	-5.48278477108153	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGAAGCAGAATCGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2635.72271023106	37.6162459610599	0.0142717008185441	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2633.10131729332	2633.10131729332
"healthy-1"	"2019-08-01-count-3:CGGCAGTTCCAGTTCC"	3.07778873023335	-10.7659225693909	"2019-08-01-count-3"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTTCCAGTTCC"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.90710731505	42.98698630943	0.0173551063673226	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2473.60517467512	2473.60517467512
"healthy-1"	"2019-08-01-count-2:CCGTGAGAGAGTCAAT"	-3.43487105789836	-5.41509392177733	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGAGAGTCAAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2326.41673149525	41.6280198891329	0.0178936212612164	2293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2324.56311688917	2324.56311688917
"healthy-1"	"2019-08-01-count-2:GACCAATAGGGCAAGG"	2.89229168471639	-10.710023903009	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCAATAGGGCAAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.14291188982	40.5136533376139	0.0176135374581258	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2295.0882876275	2295.0882876275
"healthy-1"	"2019-08-01-count-2:TAGAGTCAGATCGGTG"	2.21003951606099	-10.6429739228454	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCAGATCGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.00223258617	42.7447036538266	0.0181351986276763	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2350.68664830659	2350.68664830659
"healthy-1"	"2019-08-01-count-3:TGCAGGCTCTAACGCA"	0.72504367408101	9.26869485462037	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCTCTAACGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1881.47584180143	35.5143587212872	0.0188757984196512	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1872.55674364355	1872.55674364355
"healthy-1"	"2019-08-01-count-2:CGCGTGATCACGATCA"	3.00369181212727	-10.6589308015076	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGATCACGATCA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.96222970404	41.5521898602301	0.0183780999586487	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2255.6367071092	2255.6367071092
"healthy-1"	"2019-08-01-count-2:TCCACGTTCATTCTTG"	1.14815237101857	11.0033302077088	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACGTTCATTCTTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1886.90826282328	39.9763643877831	0.0211861727331505	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1883.34230451939	1883.34230451939
"healthy-1"	"2019-08-01-count-4:ACTGTGATCGACATTG"	2.0510159927303	-10.2993660203186	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGATCGACATTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.20038323947	39.9938783861188	0.0184541672728652	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2159.99237195904	2159.99237195904
"healthy-1"	"2019-08-01-count-3:ACGTAACGTTCATCTT"	1.73844315585439	-10.0117521516052	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACGTTCATCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.69635849626	41.5569867558389	0.0172171560062049	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2409.06444134332	2409.06444134332
"healthy-1"	"2019-08-01-count-4:TCCCACAAGGTCACTT"	1.52311946925465	10.7909478911194	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACAAGGTCACTT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1922.7816275142	39.5763127383106	0.0205828431954988	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1913.96876076856	1913.96876076856
"healthy-1"	"2019-08-01-count-2:CCCTGATCATCACCAA"	14.0382458167965	1.76003275001375	"2019-08-01-count-2"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTGATCATCACCAA"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1211.89063333772	31.1057737693997	0.0256671459566693	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1201.88586554089	1201.88586554089
"healthy-1"	"2019-08-01-count-3:CATACCCAGGCCGCTT"	-0.0559246492689431	13.8412074812683	"2019-08-01-count-3"	"Control1"	"NK"	"IFN+ NK"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCAGGCCGCTT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2139.71390604302	39.6590949468308	0.0185347652482067	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2133.16455616966	2133.16455616966
"healthy-1"	"2019-08-01-count-3:AGTTCGAAGTAGGATT"	1.14834751662557	-8.71684839641722	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCGAAGTAGGATT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2431.95597197549	44.5195549194955	0.0183060694488363	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2423.95590786629	2423.95590786629
"healthy-1"	"2019-08-01-count-3:AGAACAAAGCCTGCCA"	1.34124698218648	9.72212693775026	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAAAGCCTGCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.6017052336	34.4198138979563	0.0198316317586953	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1725.54920380804	1725.54920380804
"healthy-1"	"2019-08-01-count-4:TAAGCACTCATCTGTT"	2.45996536788289	-10.0315323106018	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCACTCATCTGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.24754564645	40.0575756214848	0.0175672047966742	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2275.84406019394	2275.84406019394
"healthy-1"	"2019-08-01-count-1:ACCCTTGGTGGCTGCT"	1.22001554545705	10.1222944029602	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACCCTTGGTGGCTGCT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1751.52518288017	36.4731314314836	0.0208236408976478	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1744.00065016872	1744.00065016872
"healthy-1"	"2019-08-01-count-2:GCACATAGTCACGCTG"	0.959599395363969	9.59448907459108	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACATAGTCACGCTG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1672.2272283348	41.0031910879581	0.024520107311486	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1666.34805551173	1666.34805551173
"healthy-1"	"2019-08-01-count-2:CAAGGGAGTGACTGTT"	6.95656933364217	-1.09329667007598	"2019-08-01-count-2"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGAGTGACTGTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2142.57880123706	40.8253576246462	0.0190543085748234	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2133.01137306465	2133.01137306465
"healthy-1"	"2019-08-01-count-2:GATGAGGCACCAGTTA"	10.8146940666134	4.07130668247072	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGAGGCACCAGTTA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1740.43387341046	35.8275345057213	0.0205854040495751	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1734.38857260482	1734.38857260482
"healthy-1"	"2019-08-01-count-4:TTCCGTGAGTCACTAC"	2.22309841689412	-10.2719116440979	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGAGTCACTAC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.67820492441	40.433570505677	0.0170917457926062	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2362.40655856532	2362.40655856532
"healthy-1"	"2019-08-01-count-3:TGCTCCAGTTCTCTAT"	7.88239683684651	7.7221059569153	"2019-08-01-count-3"	"Control1"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCCAGTTCTCTAT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1855.12264587067	40.0487457842298	0.0215881930358484	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1849.63028927585	1849.63028927585
"healthy-1"	"2019-08-01-count-4:CTTCAATAGCAGTCTT"	1.38240696963612	-9.12466719066771	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATAGCAGTCTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2489.2324059811	40.1652809035781	0.0161356090363717	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2482.41687797609	2482.41687797609
"healthy-1"	"2019-08-01-count-3:GTCATCCCACTTCTCG"	-1.12415931645091	13.1011686095032	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCCACTTCTCG"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2003.54580916505	35.9951734044015	0.017965735167993	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	1994.46965869198	1994.46965869198
"healthy-1"	"2019-08-01-count-3:GACCCAGCATCACAGT"	2.40878190573995	-10.4842014542786	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCAGCATCACAGT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.34574260506	40.2124769227782	0.016431056806863	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2441.48266989576	2441.48266989576
"healthy-1"	"2019-08-01-count-4:CAATGACGTCTCTCCA"	1.08422913131062	9.28723619067994	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATGACGTCTCTCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.34000595439	40.0814560168705	0.0212708194329133	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1878.22512013141	1878.22512013141
"healthy-1"	"2019-08-01-count-4:AACGGGATCATGTCTT"	2.56087841567342	-9.9575872651306	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGGGATCATGTCTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.27835848411	38.9208216704677	0.0153638156423353	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2528.0472398299	2528.0472398299
"healthy-1"	"2019-08-01-count-4:ACAGAAAGTGTCATCA"	-3.09500084343608	-5.40685036098631	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAAGTGTCATCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2186.31206411899	39.3131531622758	0.0179814921243266	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2183.72315598154	2183.72315598154
"healthy-1"	"2019-08-01-count-2:AGTCTCCAGGGTCACA"	3.12865938720052	-10.2000370255676	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCAGGGTCACA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.7714378602	40.4816881731294	0.0175186898668853	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2306.93679714971	2306.93679714971
"healthy-1"	"2019-08-01-count-3:GGAGCAATCCGTGCGA"	2.67240228232686	-10.3005590668884	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAATCCGTGCGA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.05480912029	42.0728007592657	0.0168963352152596	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2489.19740135966	2489.19740135966
"healthy-1"	"2019-08-01-count-4:ACGTAACGTAAGATTG"	1.66501917418782	-9.76814272319945	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACGTAAGATTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2007.99652044328	41.6937990273526	0.0207638801177545	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2003.50586451038	2003.50586451038
"healthy-1"	"2019-08-01-count-2:GAAGAATGTGACAGCA"	0.244837720959824	11.6720494993958	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGAATGTGACAGCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1745.53024065639	35.1487478582842	0.0201364302030465	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1737.05721258021	1737.05721258021
"healthy-1"	"2019-08-01-count-4:TTGCTGCTCAAGCGTT"	2.24998964843099	-10.4061784974304	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCTCAAGCGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.95339206324	42.4542065419797	0.0177413428455349	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2385.20713548787	2385.20713548787
"healthy-1"	"2019-08-01-count-3:AGTAGCTTCTTACTGT"	6.81741346892659	-1.10649623787078	"2019-08-01-count-3"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGCTTCTTACTGT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2285.51066603651	37.4429574599516	0.0163827533235206	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2275.89296473259	2275.89296473259
"healthy-1"	"2019-08-01-count-2:TTGTGTTCATAGCACT"	10.8400541740352	4.19864175403444	"2019-08-01-count-2"	"Control1"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTCATAGCACT"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1828.42689043659	35.8017430505838	0.0195806259675141	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1826.53325367905	1826.53325367905
"healthy-1"	"2019-08-01-count-3:CGTAAGTTCCTGATAG"	1.48370613631551	10.94370935047	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTTCCTGATAG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1843.80512527129	35.6069332933679	0.0193116576178997	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1843.80512527129	1843.80512527129
"healthy-1"	"2019-08-01-count-3:CTCAAGACAACTGCTA"	2.14795198020284	-10.5327139130798	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGACAACTGCTA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.075045098	39.1579129996765	0.0159497825037415	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2449.44528686112	2449.44528686112
"healthy-1"	"2019-08-01-count-3:TTCACGCAGCTCCCTT"	-7.5600884956425	4.34088323200075	"2019-08-01-count-3"	"Control1"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCAGCTCCCTT"	"HSC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2323.21907733208	36.1187028459924	0.0155468346478414	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2317.69399323666	2317.69399323666
"healthy-1"	"2019-08-01-count-2:GGTGTCGAGAGGGCGA"	1.07466675814931	9.27085206592409	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGAGAGGGCGA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1703.546067191	37.6193813942051	0.0220829844984681	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1702.29482790573	1702.29482790573
"healthy-1"	"2019-08-01-count-3:CTGTGGGTCGGACTGC"	1.68324400958363	-4.81245329296263	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGTCGGACTGC"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2293.95581266344	42.4002010225024	0.0184834427884088	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2289.81389948003	2289.81389948003
"healthy-1"	"2019-08-01-count-2:GCCAGGTGTCGTGATT"	2.79834093627278	-10.1733179322449	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGGTGTCGTGATT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.08906282079	37.2140983333116	0.0145135747712179	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2560.81064876723	2560.81064876723
"healthy-1"	"2019-08-01-count-2:AGGGTGACAACCGCCA"	1.84837176379506	-4.40747835552367	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTGACAACCGCCA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2573.29283750206	46.2269001797724	0.0179641040094937	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2567.07606038566	2567.07606038566
"healthy-1"	"2019-08-01-count-4:CACGGGTTCCATTCAT"	11.1516519981319	4.32118270480958	"2019-08-01-count-4"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTTCCATTCAT"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.53985853727	36.9197937227241	0.0197269609590785	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1854.94724218987	1854.94724218987
"healthy-1"	"2019-08-01-count-4:TTTGGAGCAGTCAGAG"	-3.00197945061381	3.29579446399537	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGAGCAGTCAGAG"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3081.27204926315	38.7208464543454	0.0125665133864454	4663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3078.31938846375	3078.31938846375
"healthy-1"	"2019-08-01-count-2:CTCCATGGTTCGGTTA"	-5.06401143494304	-5.29756882106932	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGGTTCGGTTA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2436.56755009507	49.1147249061162	0.0201573417918169	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2434.18290185195	2434.18290185195
"healthy-1"	"2019-08-01-count-1:CAGGCCAAGTCGCCCA"	0.884286006062668	10.4404144057068	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAGGCCAAGTCGCCCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.27347222052	28.1195212947948	0.0155676987606016	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1794.88838754145	1794.88838754145
"healthy-1"	"2019-08-01-count-1:ATCCATTTCAGCGGAA"	1.3527680831844	10.015637374762	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATCCATTTCAGCGGAA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2070.69526617832	38.4177890144976	0.0185530868022901	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2058.92117480728	2058.92117480728
"healthy-1"	"2019-08-01-count-4:TGCTTCGTCCTACGAA"	-3.52631507340129	3.68352005565492	"2019-08-01-count-4"	"Control1"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGTCCTACGAA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3128.42008711525	43.8108663656727	0.0140041507040927	4831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3124.11902452854	3124.11902452854
"healthy-1"	"2019-08-01-count-3:AGTACTGTCCCTCGAT"	1.46107556399648	10.9576272734436	"2019-08-01-count-3"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGTCCCTCGAT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1905.67383223692	40.6409279703604	0.0213262769750348	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1901.44529534466	1901.44529534466
"healthy-1"	"2019-08-01-count-3:GATGTTGGTGTGTGTT"	3.05649413642232	-10.5034313431946	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGTTGGTGTGTGTT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2323.97600368342	41.3744335068887	0.0178032963513012	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2323.05532839187	2323.05532839187
"healthy-1"	"2019-08-01-count-2:AGGCATTCACAAGTTC"	3.07934560355489	-10.7095709077087	"2019-08-01-count-2"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTCACAAGTTC"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.36382020716	40.5305965560094	0.0162293520183405	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2487.28467980949	2487.28467980949
"healthy-1"	"2019-08-01-count-3:GCATCTCGTTATCTTC"	1.73844255980794	-10.0585985413757	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCGTTATCTTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.50838758411	35.1025844368756	0.0146902955516996	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2384.38166027253	2384.38166027253
"healthy-1"	"2019-08-01-count-2:TTCGCTGCATCTCGTC"	8.23059525069539	8.0785283812317	"2019-08-01-count-2"	"Control1"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGCATCTCGTC"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1859.27280725518	35.8862103606414	0.0193012075584647	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1855.21539190267	1855.21539190267
"healthy-1"	"2019-08-01-count-2:GCAACCGCAGAACTTC"	1.43959083136861	10.120693183783	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGCAGAACTTC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1620.42301240692	37.6199654794107	0.0232161387436305	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1616.24768042353	1616.24768042353
"healthy-1"	"2019-08-01-count-3:CTTTCGGCACTGTCGG"	1.69191898879353	-4.81092884456786	"2019-08-01-count-3"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCGGCACTGTCGG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2414.59912855074	43.2230578137763	0.0179007178884054	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2411.30120719129	2411.30120719129
"healthy-1"	"2019-08-01-count-1:ACAACCAAGTCTGCGC"	1.35081996497456	10.1084794768128	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACAACCAAGTCTGCGC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.77354132232	34.8156691102506	0.0187506275458106	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1851.5756830397	1851.5756830397
"healthy-1"	"2019-08-01-count-3:GTAGAGGTCTACTATC"	1.28923966464345	-8.79447557842406	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAGGTCTACTATC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2357.52800295343	39.2026921387161	0.0166287280955324	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2353.31402678988	2353.31402678988
"healthy-1"	"2019-08-01-count-2:GAGCTGCAGGTAGATT"	1.32543327388112	11.5144634016785	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCAGGTAGATT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.72841763397	37.7043950656704	0.0206403944350448	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1825.47436653848	1825.47436653848
"healthy-1"	"2019-08-01-count-3:CTCCTTTCAGTGACCC"	2.18088831481282	-10.5875149003235	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTTTCAGTGACCC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.91502572706	37.2557670788907	0.0155432156246715	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2389.64102731528	2389.64102731528
"healthy-1"	"2019-08-01-count-4:GCACGTGGTATTAAGG"	2.80160989341084	-10.7025614014831	"2019-08-01-count-4"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGGTATTAAGG"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.80824217613	42.6822903434268	0.0190647370057649	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2237.85069733886	2237.85069733886
"healthy-1"	"2019-08-01-count-2:CTAGGTATCCTAGCGG"	-5.10534701767619	3.73683354938356	"2019-08-01-count-2"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGGTATCCTAGCGG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2303.99069721296	48.0013829777965	0.0208340177049593	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2297.15761113945	2297.15761113945
"healthy-1"	"2019-08-01-count-3:TCGAACAGTAGGATAT"	-2.19776068154033	10.9217195280823	"2019-08-01-count-3"	"Control1"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAACAGTAGGATAT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1708.08357673139	43.2689955049717	0.0253318959882348	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1708.08357673139	1708.08357673139
"healthy-1"	"2019-08-01-count-3:CGTTGGGCAGCCCAGT"	-8.46261535111125	-0.768019580003344	"2019-08-01-count-3"	"Control1"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTGGGCAGCCCAGT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2824.81745439313	38.592550579544	0.0136619626586933	3754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2818.50649035438	2818.50649035438
"healthy-1"	"2019-08-01-count-4:TAACTTCTCCTGGGAC"	1.40960087355916	9.99794766986696	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACTTCTCCTGGGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.67047207609	32.471092174461	0.0198761578479143	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1629.73318969794	1629.73318969794
"healthy-1"	"2019-08-01-count-4:GAAATGAGTTAATCGC"	-3.79876766625102	-5.37744381343993	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAATGAGTTAATCGC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2362.78458480992	47.4632918504548	0.0200878624973224	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2359.74712361907	2359.74712361907
"healthy-1"	"2019-08-01-count-2:ACAGAAAGTACCCGCA"	1.46026136454884	9.70824334705202	"2019-08-01-count-2"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAAGTACCCGCA"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1619.07407030668	38.4112666146814	0.0237242182548238	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1616.04044256269	1616.04044256269
"healthy-1"	"2019-08-01-count-4:GGAATCTTCCTTCACG"	1.94793119010274	-10.4275274506775	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTTCCTTCACG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.07868373028	43.7063176104749	0.0208813543180238	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2086.10444054682	2086.10444054682
"healthy-1"	"2019-08-01-count-2:GGTGGCTCAAATTGGA"	10.8308464485103	4.13738868320314	"2019-08-01-count-2"	"Control1"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGGCTCAAATTGGA"	"Pro-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.13516807898	36.2157375800999	0.0198536480266642	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1815.64485989674	1815.64485989674
"healthy-1"	"2019-08-01-count-4:GAGCCTGCAGGACGAT"	0.700214047997636	-7.90467932140502	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGCAGGACGAT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1840.38931724104	49.3720630124939	0.0268269667455516	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	1840.38931724104	1840.38931724104
"healthy-1"	"2019-08-01-count-1:CGGTCAGAGGTGTGAC"	1.37089528617207	10.7258691557678	"2019-08-01-count-1"	"Control1"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGGTCAGAGGTGTGAC"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1733.75211730282	32.9342048126437	0.0189959132473211	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1725.16260776511	1725.16260776511
"healthy-1"	"2019-08-01-count-3:AGCCAGCAGAATAACC"	-2.94391498985942	3.48999235713807	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAGCAGAATAACC"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3187.12210293987	41.6533959738336	0.0130692815111826	5223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3180.19315616362	3180.19315616362
"healthy-1"	"2019-08-01-count-2:GTGGTTAGTCCGAAGA"	1.67053689536397	-9.6333627930847	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGTTAGTCCGAAGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.51934789088	43.4960937099568	0.0191907003796073	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2261.12193998423	2261.12193998423
"healthy-1"	"2019-08-01-count-2:TAGGTTGGTATGAGGC"	1.43848826464955	10.1368503340515	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGGTATGAGGC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1806.70894866549	38.7263251374789	0.0214347336720083	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1805.53198870656	1805.53198870656
"healthy-1"	"2019-08-01-count-2:TGAATGCTCAACTGAC"	0.771507580845994	-8.65007116710814	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCTCAACTGAC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.37756052019	39.7556894873602	0.0143970495218593	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2756.92487720111	2756.92487720111
"healthy-1"	"2019-08-01-count-4:AGGATCTAGTACAGCG"	3.20765699920003	-10.492853187677	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTAGTACAGCG"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2479.168516998	41.342958097169	0.0166761387189729	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2473.85097203826	2473.85097203826
"healthy-1"	"2019-08-01-count-3:AAGCGAGAGGTAGTAT"	3.01302327689473	-10.4914198151794	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGAGAGGTAGTAT"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.1232385891	44.1011246549669	0.018397520805365	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2391.68135563313	2391.68135563313
"healthy-1"	"2019-08-01-count-4:CCTATCGAGTATTAGG"	-2.92526541176494	-5.76646091854247	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTATCGAGTATTAGG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2695.49956869207	43.9934518877033	0.016321075469157	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2688.83926058205	2688.83926058205
"healthy-1"	"2019-08-01-count-2:TCAATTCTCGAGTGGA"	2.86234392699544	-10.385410331842	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCTCGAGTGGA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.25990028764	41.9851335941098	0.0172405144884744	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2433.49612424929	2433.49612424929
"healthy-1"	"2019-08-01-count-4:GTTATGGGTGCCCGTA"	2.88799991187398	-10.784564994928	"2019-08-01-count-4"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGGTGCCCGTA"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.69909449368	40.1939520196168	0.0174703211366553	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2293.79183861573	2293.79183861573
"healthy-1"	"2019-08-01-count-2:CCACGAGTCTGCAGCG"	2.47094668921773	-10.5594301453796	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGAGTCTGCAGCG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.99816464921	42.3764875182442	0.0177233458999587	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2387.81183940017	2387.81183940017
"healthy-1"	"2019-08-01-count-4:AAGTACCAGGCCTAGA"	-5.46770797196086	-5.49944689190062	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCAGGCCTAGA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2548.29429474959	42.2709349462007	0.0165879329688467	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2544.27905351464	2544.27905351464
"healthy-1"	"2019-08-01-count-2:TTGCATTCATCCCGTT"	2.09415998038594	-10.6173382035461	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTCATCCCGTT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.98505938851	41.6283132947045	0.0168673279185161	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2461.08193794079	2461.08193794079
"healthy-1"	"2019-08-01-count-3:TGTCAGAAGGTACCTT"	-6.85625014725383	3.87196776950685	"2019-08-01-count-3"	"Control1"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCAGAAGGTACCTT"	"MPP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2414.67144549655	40.7470362166925	0.0168747745341036	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2408.71335292663	2408.71335292663
"healthy-1"	"2019-08-01-count-2:TTACTGTAGTATTCCG"	8.0829779106075	7.20840928638307	"2019-08-01-count-2"	"Control1"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACTGTAGTATTCCG"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1730.85481780472	35.526677898315	0.0205255100155508	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1722.0393894353	1722.0393894353
"healthy-1"	"2019-08-01-count-1:ACTTAGGCATTGACCA"	1.87484862384145	-10.4180269471374	"2019-08-01-count-1"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTTAGGCATTGACCA"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2572.15078806308	31.5776598438548	0.0122767529766923	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2563.73533759257	2563.73533759257
"healthy-1"	"2019-08-01-count-2:TCTTTGAGTTGCGTAT"	-7.64197478714641	0.0650081786322369	"2019-08-01-count-2"	"Control1"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTTGAGTTGCGTAT"	"GMP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2583.49976389976	42.7571130751423	0.0165500743110582	3471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2578.18672044179	2578.18672044179
"healthy-1"	"2019-08-01-count-3:CGTCAAAGTGATGTAA"	2.71660198745076	-10.6785679093567	"2019-08-01-count-3"	"Control1"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAAGTGATGTAA"	"HLA-II+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.77620217338	40.0032604770412	0.0165249726270136	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2415.28130065153	2415.28130065153
"healthy-1"	"2019-08-01-count-4:TACAGGTGTCGTTCAA"	1.87147416648213	-4.61353924190673	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAGGTGTCGTTCAA"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2499.22318002314	40.2700395504135	0.0161130225872988	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2496.39465541645	2496.39465541645
"healthy-1"	"2019-08-01-count-4:AAGTACCGTAACATCC"	1.28346850451772	-8.74236681377562	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCGTAACATCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2293.22999206408	45.4238387466199	0.019807799001327	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2289.34802891976	2289.34802891976
"healthy-1"	"2019-08-01-count-2:TCACGGGCAGGCTATT"	1.66464485701863	-4.88241197979125	"2019-08-01-count-2"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGCAGGCTATT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2387.63514257921	36.7446491377506	0.0153895578442767	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2385.37144386682	2385.37144386682
"healthy-1"	"2019-08-01-count-2:ATACCGACAAGGGTCA"	0.639177759259385	11.8064164885315	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGACAAGGGTCA"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1749.44718765308	39.7115104921682	0.0226994623058282	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1743.66343298232	1743.66343298232
"healthy-1"	"2019-08-01-count-4:GTAGGAGCATCGTCCT"	-3.16041002693828	-5.53154995357665	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGCATCGTCCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2446.59133832022	43.8965588176334	0.0179419252124762	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2442.18880761204	2442.18880761204
"healthy-1"	"2019-08-01-count-3:GGGTGAAAGTAGGATT"	-0.959139089018661	13.1397342451843	"2019-08-01-count-3"	"Control1"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGAAAGTAGGATT"	"NK"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2061.77501404237	37.0630280196495	0.0179762717887354	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	99	TRUE	"NK_healthy-1"	2060.07195396584	2060.07195396584
"healthy-1"	"2019-08-01-count-4:ATCGATGCATCGAGCC"	-3.30018315735515	-5.80125381862792	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGCATCGAGCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2472.33125199718	40.6568445737866	0.0164447399760625	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2466.87786490399	2466.87786490399
"healthy-1"	"2019-08-01-count-3:TTTACGTGTGCATTTG"	1.34787001189534	-8.59440805828246	"2019-08-01-count-3"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACGTGTGCATTTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.53260678771	42.8438845203339	0.0180278967761544	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2369.83344434134	2369.83344434134
"healthy-1"	"2019-08-01-count-4:GAATCACTCTTCGACC"	-4.92149959030803	-5.46536257183226	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACTCTTCGACC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2804.58018536345	43.4698076917921	0.0154995774122104	2890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2798.27827685566	2798.27827685566
"healthy-1"	"2019-08-01-count-2:TCACGGGTCGTGGGTC"	1.77803840216939	-8.29281237041625	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGTCGTGGGTC"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.82785895716	45.5875589826109	0.0214244581819477	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2125.73947481969	2125.73947481969
"healthy-1"	"2019-08-01-count-2:CCTATCGCAGAGTAAT"	2.60452475127522	-10.857581161615	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGCAGAGTAAT"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.64941320458	39.1520741200846	0.0166842451623903	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2338.40941064174	2338.40941064174
"healthy-1"	"2019-08-01-count-2:TGCTGAACATGACTGT"	0.651197989552659	12.9163598784241	"2019-08-01-count-2"	"Control1"	"CD8+ T"	"CD8+ TRM"	22	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAACATGACTGT"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1792.45414800541	43.4181878544577	0.024222760678577	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1788.94860428163	1788.94860428163
"healthy-1"	"2019-08-01-count-1:ACAACCACACTAGAGG"	2.57696165618245	-10.4265604249206	"2019-08-01-count-1"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACAACCACACTAGAGG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.37033777727	40.7218422725282	0.0163714432282398	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2480.06522968655	2480.06522968655
"healthy-1"	"2019-08-01-count-4:GAGCCTGGTCAGTTTG"	14.1608902412349	1.80249152267305	"2019-08-01-count-4"	"Control1"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGGTCAGTTTG"	"Plasma cell"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1324.5747810894	27.5487793206308	0.0207982061216454	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1311.57773843774	1311.57773843774
"healthy-1"	"2019-08-01-count-4:TAGACCACATCGAACT"	1.20187677916829	9.2958831557068	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCACATCGAACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.84995792446	36.1949393697545	0.0216885521660498	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1663.3967189272	1663.3967189272
"healthy-1"	"2019-08-01-count-4:CTGTGGGGTACGGTTT"	6.98262133178059	-1.0855101577011	"2019-08-01-count-4"	"Control1"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGGGGTACGGTTT"	"pDC"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2369.04469370197	39.8141444032103	0.0168059912542194	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2363.16146011681	2363.16146011681
"healthy-1"	"2019-08-01-count-3:CGAGGAAAGTAGACCG"	-3.1844666999882	-5.53226139461669	"2019-08-01-count-3"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGAAAGTAGACCG"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2559.90012577207	45.5099902900522	0.017778033538057	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2559.14310659888	2559.14310659888
"healthy-1"	"2019-08-01-count-4:ACGTAACTCACGGACC"	0.381778915494126	11.2728976973328	"2019-08-01-count-4"	"Control1"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACTCACGGACC"	"CD8+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2225.50734587986	31.1312273978421	0.0139883732378939	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	2221.40392827008	2221.40392827008
"healthy-1"	"2019-08-01-count-4:TCAAGTGGTTGCTCCT"	-3.13354263725932	-5.8269458047119	"2019-08-01-count-4"	"Control1"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGGTTGCTCCT"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1949.43701062802	44.0205806847863	0.022581176229236	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	1947.73922287256	1947.73922287256
"healthy-1"	"2019-08-01-count-2:TCAATTCTCGTAACCA"	1.55650069293324	-9.55600359356078	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCTCGTAACCA"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.75510554323	43.3528735013161	0.0173359132228578	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2497.07372124945	2497.07372124945
"healthy-1"	"2019-08-01-count-4:GTAATGCAGAGTAACT"	1.34664275225942	9.61192605579225	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATGCAGAGTAACT"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.70203685325	48.8737118907341	0.0260701225741292	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1869.01553249394	1869.01553249394
"healthy-1"	"2019-08-01-count-2:GAGTCATAGGGCCCTT"	3.43364848670308	-11.0016145936218	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATAGGGCCCTT"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.53619266457	46.7946763888781	0.0210925909361322	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2213.51348959647	2213.51348959647
"healthy-1"	"2019-08-01-count-2:GATGCTATCATTGGTG"	2.37189426001851	-10.4654827347961	"2019-08-01-count-2"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTATCATTGGTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.40622545211	39.5288777779792	0.0167183106491866	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2360.40389368341	2360.40389368341
"healthy-1"	"2019-08-01-count-2:AATCGACAGGAAGTCC"	2.65190710601155	-10.7392177811828	"2019-08-01-count-2"	"Control1"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACAGGAAGTCC"	"Granulocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2666.98270948673	42.8299640995183	0.0160593332484563	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	276	TRUE	"Gran_healthy-1"	2662.76267483584	2662.76267483584
"healthy-1"	"2019-08-01-count-4:GTTATGGAGTTCACTG"	2.10204376754109	-10.1257915726868	"2019-08-01-count-4"	"Control1"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGAGTTCACTG"	"CD14+ monocyte"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.61329752224	39.2363554637631	0.0175036236210469	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2237.17873136698	2237.17873136698
"healthy-1"	"2019-08-01-count-3:TCGGATATCTCTTAAC"	9.94104923781697	6.08544252002565	"2019-08-01-count-3"	"Control1"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGATATCTCTTAAC"	"Pre-B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.45991684159	39.2117917985135	0.0200217484469891	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1953.87881507675	1953.87881507675
"healthy-1"	"2019-08-01-count-4:GAAGTAAGTATCGTTG"	-4.09004435959514	3.62005159938661	"2019-08-01-count-4"	"Control1"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGTAAGTATCGTTG"	"MEP"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2877.19160893621	40.3567385489401	0.0140264341184636	4106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	156	TRUE	"HSPC_healthy-1"	2872.3682581176	2872.3682581176
"healthy-1"	"2019-08-01-count-2:GGAGAACTCCAACTAG"	3.24455537375752	-10.9126854172912	"2019-08-01-count-2"	"Control1"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACTCCAACTAG"	"CD11c+"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.46499814625	41.08967522423	0.0193048395252054	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1120	TRUE	"Mono_healthy-1"	2121.72356360909	2121.72356360909
"healthy-1"	"2019-08-01-count-3:AACCCAACATGGGCAA"	-2.81982098046001	3.26307795131532	"2019-08-01-count-3"	"Control1"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAACATGGGCAA"	"Ery"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3103.45114502757	43.9055904042496	0.0141473438286909	5664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	51	TRUE	"Ery_healthy-1"	3100.39180791029	3100.39180791029
"healthy-1"	"2019-08-01-count-4:TGTTCATCACGTCTCT"	1.96530975875203	-5.02450897609862	"2019-08-01-count-4"	"Control1"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATCACGTCTCT"	"cDC2"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2332.93657096655	42.6024667153393	0.0182613051917176	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	173	TRUE	"DC_healthy-1"	2328.38900027559	2328.38900027559
"healthy-1"	"2019-08-01-count-4:GATGAGGAGTGACACG"	1.23612191256825	11.0220746763977	"2019-08-01-count-4"	"Control1"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGAGTGACACG"	"CD4+ T"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1744.21140767997	35.9606817177548	0.0206171577363935	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	667	TRUE	"T_healthy-1"	1736.7769769913	1736.7769769913
"healthy-1"	"2019-08-01-count-3:TTGAGTGGTGGCTGCT"	10.3444105583126	4.62828776920167	"2019-08-01-count-3"	"Control1"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAGTGGTGGCTGCT"	"B"	"1"	"F"	26	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1416.32316590593	48.8043730216092	0.034458500853788	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	290	TRUE	"B_healthy-1"	1398.61950813616	1398.61950813616
"healthy-2"	"2019-08-01-count-3:CAGAGCCGTTTCGCTC"	6.86737837371175	-1.00853183185729	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGAGCCGTTTCGCTC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1931.14425063435	39.1484822509	0.0202721688128892	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1915.98049967838	1915.98049967838
"healthy-2"	"2019-08-01-count-2:GGAGAACCAACCTATG"	1.21462478217427	10.7226619490418	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACCAACCTATG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.81819054884	33.2006333239587	0.0176147670318753	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1882.21959949907	1882.21959949907
"healthy-2"	"2019-08-01-count-3:TCCAGAAGTTCACCGG"	7.86178030547444	7.56868741596071	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCAGAAGTTCACCGG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1672.86151420466	35.3070152182697	0.0211057609482133	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1664.84013524125	1664.84013524125
"healthy-2"	"2019-08-01-count-4:TGTTACTCATCCAACA"	-5.01339135590251	-5.35198595440062	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTCATCCAACA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2605.80610804325	44.1096244964894	0.0169274392136613	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2604.03813114148	2604.03813114148
"healthy-2"	"2019-08-01-count-3:GCTACCTTCTGTGCTC"	-2.98805914345439	-5.91127827083739	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTTCTGTGCTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2523.89112602597	45.554354466946	0.0180492549766496	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2517.40311778962	2517.40311778962
"healthy-2"	"2019-08-01-count-4:GGAATCTCATATGGCT"	2.72137870368306	-10.6959629288879	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTCATATGGCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.79384684662	42.5341648832724	0.0171869527384956	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2469.25654328578	2469.25654328578
"healthy-2"	"2019-08-01-count-3:TCACACCAGATGCTTC"	4.34334482726399	-10.7075510255066	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCAGATGCTTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.60080577088	42.0771918823081	0.0172193395021549	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2439.84892394881	2439.84892394881
"healthy-2"	"2019-08-01-count-1:GAGAGGTGTGCACGCT"	2.3156439262325	-11.0013342133728	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAGAGGTGTGCACGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.79243995804	39.6689620168561	0.0160033415373526	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2474.21932212184	2474.21932212184
"healthy-2"	"2019-08-01-count-3:TCACAAGTCTATCGCC"	1.69014360484425	-9.78329183971556	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACAAGTCTATCGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.34582696572	42.7180134701962	0.018402261728505	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2318.90829560221	2318.90829560221
"healthy-2"	"2019-08-01-count-4:TCGCTTGCACACGCCA"	1.23947228965108	10.7397069700989	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTTGCACACGCCA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.13834421216	43.8669639155387	0.0224482386548862	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1943.66812586791	1943.66812586791
"healthy-2"	"2019-08-01-count-2:CTAACCCTCACTAGCA"	8.78878368911092	7.82851026141969	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCTCACTAGCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.67914713346	37.2941583493082	0.0189823149513862	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1958.12209419631	1958.12209419631
"healthy-2"	"2019-08-01-count-2:CTAACCCTCCCTAGGG"	0.960474987595719	-8.78287985241088	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCTCCCTAGGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2487.34139060193	42.2871968873038	0.0170009621707258	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2487.34139060193	2487.34139060193
"healthy-2"	"2019-08-01-count-2:TCAGGGCTCCGGACGT"	-3.11853299561198	3.14632484996644	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCTCCGGACGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3186.8343543418	43.9910102440338	0.01380398393914	5500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3180.51764013833	3180.51764013833
"healthy-2"	"2019-08-01-count-2:GTCCCATAGTGGAAGA"	4.58269991454427	-10.725217842218	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATAGTGGAAGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.25003596928	49.4755904324618	0.0204846660576102	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2410.01698640242	2410.01698640242
"healthy-2"	"2019-08-01-count-3:AGACTCAGTATGATCC"	3.1302784877712	-10.9804888001648	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCAGTATGATCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.83481829538	41.7398650192694	0.018244265139023	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.83481829538	2287.83481829538
"healthy-2"	"2019-08-01-count-2:GTTGCTCTCAAGCGTT"	3.74571528014485	-9.92107679760131	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCTCTCAAGCGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.49420562828	36.859828829635	0.0144520339424002	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2547.17262857795	2547.17262857795
"healthy-2"	"2019-08-01-count-2:CCATCACAGTGACCTT"	4.48154701766316	-10.7569236985412	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACAGTGACCTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.86508875671	43.7106241669615	0.0175765964806777	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2481.04459152777	2481.04459152777
"healthy-2"	"2019-08-01-count-4:ACTATCTTCAACCTCC"	4.41696371611897	-10.8561296693054	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATCTTCAACCTCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.52286174079	44.0848765148342	0.0168679896243458	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2604.73703434102	2604.73703434102
"healthy-2"	"2019-08-01-count-2:TGCATCCTCTTTGGAG"	-3.63491068306621	-4.52495767986449	"2019-08-01-count-2"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATCCTCTTTGGAG"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2791.53264997177	47.0299806806208	0.0168473690182691	2971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2784.80022860404	2784.80022860404
"healthy-2"	"2019-08-01-count-2:TCACGGGAGCGGCTCT"	-0.926624457270461	12.93319032276	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGAGCGGCTCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1632.86727954844	45.01649333677	0.0275689848774598	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1628.87853890686	1628.87853890686
"healthy-2"	"2019-08-01-count-3:GTGACGCCATACCAGT"	2.87921084937398	-10.8214607468811	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCCATACCAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.87897633877	42.9739848947667	0.0173290653716547	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2475.96337916612	2475.96337916612
"healthy-2"	"2019-08-01-count-3:CCTCAACCAGATCATC"	-0.795949260622817	13.1695251234802	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACCAGATCATC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2134.32762663132	49.9255920456688	0.0233917189763729	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2124.53139514719	2124.53139514719
"healthy-2"	"2019-08-01-count-2:TCATTGTCACTGAATC"	0.150322710245293	11.9134654768738	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTGTCACTGAATC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1697.19202184939	39.0262566498553	0.0229946029367551	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1693.42220704582	1693.42220704582
"healthy-2"	"2019-08-01-count-2:ATTATCCCACAGTGTT"	2.47399463233296	-10.4644108048645	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCCACAGTGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.2128741978	45.7600034720943	0.0194045261870859	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.97420069518	2353.97420069518
"healthy-2"	"2019-08-01-count-4:CCCATTGGTTGACTAC"	2.12709035453145	-10.0766973725525	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGGTTGACTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.7586050948	38.5366850518976	0.0168079993097678	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2286.83112561048	2286.83112561048
"healthy-2"	"2019-08-01-count-3:GGTAGAGTCGATCCAA"	2.45034184035603	-10.7035141221252	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAGAGTCGATCCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.44351477442	40.5837034026211	0.0181709110322945	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2225.41207570335	2225.41207570335
"healthy-2"	"2019-08-01-count-4:TTCCGGTGTAGTTAGA"	1.68285932120625	-4.98504211818846	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTGTAGTTAGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2342.79514374437	43.1160584600475	0.0184036827014834	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2331.91329754997	2331.91329754997
"healthy-2"	"2019-08-01-count-3:CCACCATGTTATGTCG"	2.95467581328694	-10.746195816156	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACCATGTTATGTCG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.58819676681	39.2697491487153	0.0172418127229766	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2271.7847045148	2271.7847045148
"healthy-2"	"2019-08-01-count-3:TGACAGTAGGCGTTGA"	1.33083548125569	9.33587071979371	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTAGGCGTTGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1558.18140479721	38.5829239833319	0.0247615097090401	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1547.89320418513	1547.89320418513
"healthy-2"	"2019-08-01-count-4:TGATTCTTCACTTTGT"	2.38125791129414	-10.6796894303528	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTCTTCACTTTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.33325077333	42.2285794228841	0.0171289538279004	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2460.8134613456	2460.8134613456
"healthy-2"	"2019-08-01-count-4:CATCCACAGCCTGGAA"	-3.80305610123332	-5.62451126491698	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACAGCCTGGAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2272.14434955776	45.2457691806624	0.0199132459121573	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2270.05158065599	2270.05158065599
"healthy-2"	"2019-08-01-count-3:GCTACCTCAACAAGTA"	1.98938550528828	-10.453492187616	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTCAACAAGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.22267918827	39.8050048047075	0.0165907921553054	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.99501756974	2390.99501756974
"healthy-2"	"2019-08-01-count-2:ATGGATCCAAATGGCG"	2.7620026069576	-10.5316038361755	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCCAAATGGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.88415289415	43.5075591057858	0.0187380404192669	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.21335029888	2314.21335029888
"healthy-2"	"2019-08-01-count-2:TCGAAGTAGCCATATC"	1.50353946265523	-9.42880346691283	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTAGCCATATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.00130753432	42.6617658643928	0.0175202229799179	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2431.84969107866	2431.84969107866
"healthy-2"	"2019-08-01-count-4:TACACCCCAGGAGGTT"	2.82469691809956	-10.6893816224304	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCCAGGAGGTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.81761508878	43.8450870479918	0.0181792714232158	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2407.92259741959	2407.92259741959
"healthy-2"	"2019-08-01-count-4:CTAACTTCACCGTGGT"	2.4414652782375	-10.8543167344299	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTCACCGTGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.22534989846	40.1972122579812	0.0163255618579505	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2456.64073381152	2456.64073381152
"healthy-2"	"2019-08-01-count-4:TTCTGTATCTCAACGA"	3.14818491515462	-10.661011718866	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTGTATCTCAACGA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.98428883312	46.6129711935532	0.0209403864292268	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2215.24325166487	2215.24325166487
"healthy-2"	"2019-08-01-count-2:TCGAAGTGTATTCTCT"	1.99795450743977	-10.2686443558899	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTGTATTCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.06104629796	38.9602185798677	0.0179122414270531	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2171.04892377675	2171.04892377675
"healthy-2"	"2019-08-01-count-2:GTCTCACCACTCCTTG"	3.05363859710042	-10.9982738724914	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACCACTCCTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.68875271855	40.6496761241094	0.0160183852651602	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2531.90229394171	2531.90229394171
"healthy-2"	"2019-08-01-count-2:TGTCCACCAACCGCCA"	3.0705415206844	-10.7155876389709	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCACCAACCGCCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.61924358583	38.0796337565186	0.0166096633198277	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2285.89157765233	2285.89157765233
"healthy-2"	"2019-08-01-count-2:TCATCATTCGCGTGCA"	-1.62030647221263	13.1868133314881	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCATTCGCGTGCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1754.90385497252	44.3519850923603	0.0252731709299566	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1750.68993312933	1750.68993312933
"healthy-2"	"2019-08-01-count-2:TTTCAGTAGGAGGTTC"	2.12828578528706	-10.6007518998352	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCAGTAGGAGGTTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.73798509921	39.3440769778848	0.0176372470638388	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2226.62273855081	2226.62273855081
"healthy-2"	"2019-08-01-count-2:CTGAATGGTTGTCCCT"	2.19676436957662	-10.5078659287659	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGGTTGTCCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.93498701951	42.5289728965717	0.0169307617897523	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2500.87174582638	2500.87174582638
"healthy-2"	"2019-08-01-count-3:CACGAATCAGAGAGGG"	-5.15478358689006	3.67097828471986	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATCAGAGAGGG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2640.48497875648	38.0603112570449	0.014414136631434	3034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2632.65741274792	2632.65741274792
"healthy-2"	"2019-08-01-count-4:CCTGTTGGTAACGGTG"	1.73751213130299	-9.83609774028929	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGTTGGTAACGGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.36946807266	41.327764940045	0.0180048421462827	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2293.31346262455	2293.31346262455
"healthy-2"	"2019-08-01-count-3:CAACAACCAGTCCGTG"	2.13853969153706	-10.498881363031	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACCAGTCCGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.61156684298	40.9766400629221	0.0181023284485472	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2259.13220772352	2259.13220772352
"healthy-2"	"2019-08-01-count-3:CAGCCAGGTAAGTTAG"	0.651579399674576	9.63519284808961	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCCAGGTAAGTTAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1844.36561202443	39.0100727699035	0.0211509434547985	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1831.90673713775	1831.90673713775
"healthy-2"	"2019-08-01-count-4:AACTTCTCAGGAAGTC"	3.36157264289204	-10.4574518433777	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTCAGGAAGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.35979932594	39.7034736851875	0.0186720392747143	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2125.16464549815	2125.16464549815
"healthy-2"	"2019-08-01-count-4:TTCCTTCCATATCTCT"	7.02222933348958	-1.16550853168639	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTTCCATATCTCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2468.08587079851	32.7349467621707	0.0132632932871091	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2457.96036747604	2457.96036747604
"healthy-2"	"2019-08-01-count-2:GTTGTCCAGTGGGAAA"	-5.00433383408244	-5.17407419597777	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTCCAGTGGGAAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2480.03783920519	37.3908519733368	0.0150767264040294	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2476.43818682614	2476.43818682614
"healthy-2"	"2019-08-01-count-4:AATCGTGTCCAAAGGG"	1.81926502761189	-4.86273386394652	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCGTGTCCAAAGGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2356.79806420207	37.7328043428446	0.0160101982923258	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2353.32484687645	2353.32484687645
"healthy-2"	"2019-08-01-count-2:GGGACCTAGTATGAGT"	1.47462191161458	-8.84513285076293	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTAGTATGAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.45346580489	43.5180603024486	0.0197678765317611	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2198.05338597743	2198.05338597743
"healthy-2"	"2019-08-01-count-2:CGAGGAAAGCTCGAAG"	2.42191972312276	-10.8079481354919	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAAAGCTCGAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.60379442776	42.4423233225709	0.0176724917828021	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2398.99420105349	2398.99420105349
"healthy-2"	"2019-08-01-count-2:GGTTAACTCGACGATT"	1.18644716319386	10.986750579718	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACTCGACGATT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.91195924979	37.9209943483971	0.0208367191366934	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1812.45296951136	1812.45296951136
"healthy-2"	"2019-08-01-count-4:ATACCGAGTGGTCTCG"	3.04317702826802	-10.9336977235046	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGAGTGGTCTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.76472508465	40.853185710516	0.0185127056120352	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2199.98403396328	2199.98403396328
"healthy-2"	"2019-08-01-count-3:CACTTCGCACAATGCT"	1.95524241504018	-9.00437166607054	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTTCGCACAATGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.19328526566	28.1477050417773	0.0129761166203915	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2165.59157873121	2165.59157873121
"healthy-2"	"2019-08-01-count-4:CGAATTGCACGAAGAC"	2.18073358115498	-10.8183126679626	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAATTGCACGAAGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.00553280162	41.3461434834865	0.0186495445643916	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2212.59403070523	2212.59403070523
"healthy-2"	"2019-08-01-count-3:CACTGGGTCGATCCCT"	1.41938092288319	10.1784953841004	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGTCGATCCCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.93156160254	39.7512488988129	0.0224592011133025	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1765.61765012832	1765.61765012832
"healthy-2"	"2019-08-01-count-2:ACTATGGTCTGTGCTC"	3.08056296881978	-10.9874420396057	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATGGTCTGTGCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.57069728722	42.6642319185411	0.0172132398584542	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.36213899159	2472.36213899159
"healthy-2"	"2019-08-01-count-4:CGGGACTCATAGGAGC"	3.23410453376119	-10.7285909882751	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTCATAGGAGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.5018947624	38.1717253742956	0.017858101304064	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2135.42813660465	2135.42813660465
"healthy-2"	"2019-08-01-count-2:GACCTTCGTACTGAGG"	2.34322013434712	-10.5699568024841	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCGTACTGAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.82385230134	41.4050065577334	0.0180035555837466	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2293.66149138601	2293.66149138601
"healthy-2"	"2019-08-01-count-3:CTCCACAAGAATCGCG"	3.72265781935994	-10.8682260743347	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACAAGAATCGCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.30416584989	41.6318596711329	0.0190160235934925	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2184.35785054372	2184.35785054372
"healthy-2"	"2019-08-01-count-4:ATGGAGGAGTCAGCCC"	1.99510659751241	-10.1598940125671	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGAGTCAGCCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2357.97057940122	42.2628514665688	0.0179234006716492	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2352.59148700644	2352.59148700644
"healthy-2"	"2019-08-01-count-4:TAATTCCTCTCCTACG"	2.88808669623677	-10.9516191712585	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATTCCTCTCCTACG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2675.33487104298	36.4064612395767	0.0136081885051585	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2671.8402681305	2671.8402681305
"healthy-2"	"2019-08-01-count-2:ACTGCAACAAACCATC"	2.68211760100667	-10.8653288117615	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAACAAACCATC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.67411219149	36.5386627532518	0.0168019026613742	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2171.10937425842	2171.10937425842
"healthy-2"	"2019-08-01-count-4:GTGAGCCCAGACCAGA"	-1.94464264336284	13.1681384810242	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGCCCAGACCAGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1653.96623152609	42.5407764530943	0.0257204625114037	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1642.95015078657	1642.95015078657
"healthy-2"	"2019-08-01-count-3:GCTACAATCTGGGTCG"	1.86188389834706	-9.96716406261595	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAATCTGGGTCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2274.58737233442	45.5636960753191	0.0200316315079851	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2271.73436818965	2271.73436818965
"healthy-2"	"2019-08-01-count-4:AATCACGTCCTATTGT"	1.08618702468221	11.2860708006653	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCACGTCCTATTGT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.43950278489	42.1281928100129	0.02254726082767	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1861.00821579804	1861.00821579804
"healthy-2"	"2019-08-01-count-3:TCTTTGACAATCCAGT"	8.46781220015828	6.91762635791627	"2019-08-01-count-3"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTTGACAATCCAGT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1653.88290993345	39.1884091164437	0.0236947905326748	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1645.75496406529	1645.75496406529
"healthy-2"	"2019-08-01-count-3:AACCATGTCTTCGGAA"	-2.07613263550456	13.0409745940003	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGTCTTCGGAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1748.78959426868	45.5611877153806	0.0260529842267467	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1736.45715173086	1736.45715173086
"healthy-2"	"2019-08-01-count-4:TTCAATCCAATTCGTG"	2.35210837897603	-10.6908655396667	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAATCCAATTCGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.90834571006	39.4478903238307	0.0147971667470525	2749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2661.94345061205	2661.94345061205
"healthy-2"	"2019-08-01-count-2:TCGGGCAGTCCCGGTA"	1.73833050307576	-4.9639086953369	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAGTCCCGGTA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2299.6336439844	41.8293837341976	0.0181895859123555	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2293.24753164519	2293.24753164519
"healthy-2"	"2019-08-01-count-2:TCTATACCAGCGACCT"	4.39533104476277	-10.6750030747619	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACCAGCGACCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.657239388	41.1072483251573	0.0163081468129867	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2519.75654308629	2519.75654308629
"healthy-2"	"2019-08-01-count-2:AGAAATGAGCTGAAGC"	2.24281229552571	-10.7235670319763	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGAGCTGAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.62442735583	42.7198009991882	0.0185768599824401	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2297.76468347147	2297.76468347147
"healthy-2"	"2019-08-01-count-2:CAACGGCCAACACACT"	-2.13786540451701	13.3706016310486	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCCAACACACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1996.38543494029	37.9083354845371	0.0189884853000197	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1986.77466442697	1986.77466442697
"healthy-2"	"2019-08-01-count-2:CGCGTGACACTGAGGA"	2.0267319875652	-9.87389471447142	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGACACTGAGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.15106619519	41.5507470900554	0.0176574924096305	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.64347530765	2346.64347530765
"healthy-2"	"2019-08-01-count-3:TGGTACAGTTGCCGAC"	2.40694298323933	-10.9631014100281	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTACAGTTGCCGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.68719553767	40.7909149496165	0.0166787130521199	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2439.23250484598	2439.23250484598
"healthy-2"	"2019-08-01-count-2:CACATGAGTAGTCTGT"	-2.34593687477763	13.0550565489563	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGAGTAGTCTGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1644.60982243121	44.8630767783404	0.0272788573717867	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1642.42328510102	1642.42328510102
"healthy-2"	"2019-08-01-count-3:CGAAGTTTCAGACATC"	2.98803176459615	-10.9951133958069	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTTCAGACATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.44425910454	45.6909287685	0.0202760412572425	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.46666190517	2245.46666190517
"healthy-2"	"2019-08-01-count-3:TTTGACTAGAATTCAG"	0.481715162366074	9.50780770862428	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGAATTCAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2006.22062522871	30.5834814453187	0.0152443261028842	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1995.46211547464	1995.46211547464
"healthy-2"	"2019-08-01-count-1:TCCTTCTTCAAGCCAT"	2.08423771437947	-10.6255588761536	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCTTCTTCAAGCCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.3161685394	35.1799713099776	0.0130425834836513	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2684.91834502447	2684.91834502447
"healthy-2"	"2019-08-01-count-2:TGAGACTTCCTCGATC"	4.4141808944637	-10.7095031968323	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGACTTCCTCGATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.35422482822	39.2756255129094	0.016796268544726	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.6355015442	2334.6355015442
"healthy-2"	"2019-08-01-count-4:TTCTTCCGTATTTCGG"	3.08948888358418	-10.8511333695618	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCGTATTTCGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.74464403213	38.3389032739917	0.0155297160306438	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2464.75094934808	2464.75094934808
"healthy-2"	"2019-08-01-count-2:TGTTGGACAGGTTACT"	3.08026423034016	-11.0828180543152	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGACAGGTTACT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.52549342052	45.0302560769301	0.0187584994203774	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.1358949913	2390.1358949913
"healthy-2"	"2019-08-01-count-3:CCACGAGGTGACCTGC"	7.91654743727986	6.99707601154176	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGAGGTGACCTGC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1753.59012597528	33.587598843222	0.0191536199626705	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1750.34459513646	1750.34459513646
"healthy-2"	"2019-08-01-count-4:TTAGTCTAGTTCTCTT"	0.646109660237473	-8.54101469432982	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGTCTAGTTCTCTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2669.05273034917	42.9459768302406	0.0160903440917116	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2666.26728258334	2666.26728258334
"healthy-2"	"2019-08-01-count-2:CACAACACAGACCATT"	1.73704185065572	-4.77196838771971	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAACACAGACCATT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2628.21235241977	41.4777501316188	0.015781734719202	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2623.52620167442	2623.52620167442
"healthy-2"	"2019-08-01-count-4:CTCAACCCAAACGTGG"	11.0943190055782	3.8159460791382	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCCAAACGTGG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.23052799599	25.5318788193949	0.0135719033044786	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1879.48760237307	1879.48760237307
"healthy-2"	"2019-08-01-count-2:TCAAGTGAGGCAGCTA"	2.68851246413533	-10.6793880692688	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGAGGCAGCTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.99802601961	42.3071648829448	0.0180645604363932	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2339.28591792734	2339.28591792734
"healthy-2"	"2019-08-01-count-3:CTGCTCAAGGGTACAC"	-3.84740004959758	-5.52724316036376	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCAAGGGTACAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2540.78585404409	43.4466125174271	0.0170996750663872	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2538.10634207156	2538.10634207156
"healthy-2"	"2019-08-01-count-4:CTACGGGGTGGATACG"	2.11174168166463	-4.85309984600218	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGGTGGATACG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2639.32961456125	40.6215480805239	0.0153908582908378	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2633.62889723624	2633.62889723624
"healthy-2"	"2019-08-01-count-3:GTCAAACTCATCCTGC"	14.1754671531612	1.89424059474794	"2019-08-01-count-3"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAACTCATCCTGC"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1715.40067858377	33.8765105108549	0.0197484534859945	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1698.30921825641	1698.30921825641
"healthy-2"	"2019-08-01-count-4:GCGTGCATCGCTTTAT"	2.61197914656941	-10.7635250321594	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCATCGCTTTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.49787911282	39.781635886665	0.0181775985557692	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2184.38853263174	2184.38853263174
"healthy-2"	"2019-08-01-count-3:TTCCTTCAGGACTTCT"	1.8330166536266	-10.2569828263489	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCAGGACTTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.69501469685	40.6748413107469	0.0175648524752175	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2309.05638427826	2309.05638427826
"healthy-2"	"2019-08-01-count-1:TGCTTGCCAGGCGATA"	2.21947922286336	-10.7240782014099	"2019-08-01-count-1"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCTTGCCAGGCGATA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.91162843792	39.0365055802077	0.0153330167253917	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2534.07882753377	2534.07882753377
"healthy-2"	"2019-08-01-count-2:CATCGCTTCAAACGAA"	10.2512613731319	4.68077848041383	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGCTTCAAACGAA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1402.45304415038	47.4700653709993	0.0338478821583343	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1393.09835366757	1393.09835366757
"healthy-2"	"2019-08-01-count-1:GATAGAAGTAGCGCCT"	2.17528428611104	-10.4051733247009	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GATAGAAGTAGCGCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2628.73015362203	36.7145840666591	0.0139666614376799	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2624.12167392555	2624.12167392555
"healthy-2"	"2019-08-01-count-2:CGAGTGCCAGGATTCT"	2.97181953963582	-11.0296678773132	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCCAGGATTCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.94151702906	38.2099905978698	0.0166860115482089	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2286.31549196662	2286.31549196662
"healthy-2"	"2019-08-01-count-2:GCCCGAATCCTGCTAC"	2.67884721335713	-10.9795971146789	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAATCCTGCTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.64990742274	37.7781418503521	0.0155168682508209	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2430.42905444512	2430.42905444512
"healthy-2"	"2019-08-01-count-2:TCATATCGTTCTGAGT"	1.76513483104054	-4.7618766061035	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCGTTCTGAGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2454.03084077111	40.2697850405742	0.0164096491256485	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2446.86972868351	2446.86972868351
"healthy-2"	"2019-08-01-count-3:GTCATTTCATTGAGCT"	-7.73923764649089	1.57601127708284	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATTTCATTGAGCT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2621.39180932545	36.2363033154862	0.013823306835162	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2611.74653131215	2611.74653131215
"healthy-2"	"2019-08-01-count-3:CAGGTATAGCAGCACA"	4.66059364852254	-10.5732765427795	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATAGCAGCACA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.22395201099	44.5372627199811	0.0190801155483008	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2329.43258439171	2329.43258439171
"healthy-2"	"2019-08-01-count-2:ATTACTCAGGAGACCT"	0.740272601216477	10.8874082335266	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCAGGAGACCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.3553490971	36.7914513547043	0.0197659470947077	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1857.4181899387	1857.4181899387
"healthy-2"	"2019-08-01-count-2:CAGCCAGCACCTCTGT"	2.7712103324825	-11.1014471284119	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGCACCTCTGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.59972192594	39.3397632187788	0.0156196964830506	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2509.29193911775	2509.29193911775
"healthy-2"	"2019-08-01-count-1:TGGGAAGTCGCAGATT"	2.29541363295857	-10.784523033258	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGGAAGTCGCAGATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.79862043124	41.7479776614868	0.0175205648112769	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2379.77798172695	2379.77798172695
"healthy-2"	"2019-08-01-count-3:CAGATACTCAAGAGGC"	2.9393445449764	-10.8989773026672	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATACTCAAGAGGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.32278396451	39.463670499254	0.0174825110434337	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.37907501589	2256.37907501589
"healthy-2"	"2019-08-01-count-4:AGTAACCAGTTTAGGA"	9.24388947066609	6.14223811710206	"2019-08-01-count-4"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAACCAGTTTAGGA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1590.89303884299	39.3553812093215	0.0247379177910939	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1590.89303884299	1590.89303884299
"healthy-2"	"2019-08-01-count-2:AGTTAGCGTGCTGATT"	2.81862821158711	-10.3844661942688	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTAGCGTGCTGATT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.76723668609	37.819257828398	0.015952328530262	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2366.6039667324	2366.6039667324
"healthy-2"	"2019-08-01-count-3:GTCCACTCAGAAGTTA"	2.2885374027187	-10.8545532456604	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCACTCAGAAGTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.59029486604	40.6379431707999	0.0175194486977912	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2316.40073819125	2316.40073819125
"healthy-2"	"2019-08-01-count-2:CTCATTAAGTGGTCAG"	-1.73009405556377	12.962113357428	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATTAAGTGGTCAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1804.2596601255	40.9870615506972	0.0227168308733602	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1800.387641775	1800.387641775
"healthy-2"	"2019-08-01-count-3:AATTTCCGTCCATCTC"	3.17727984961812	-10.8720674744812	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCGTCCATCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.21507701038	45.415045470527	0.0176149173416474	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2571.776796297	2571.776796297
"healthy-2"	"2019-08-01-count-3:TTTCAGTAGTACAGAT"	-1.28605256500896	13.9118222960266	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCAGTAGTACAGAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1987.31053680474	41.4711674114278	0.0208679854725202	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1985.62767705712	1985.62767705712
"healthy-2"	"2019-08-01-count-2:GAAGCGATCGTCACCT"	2.26776327666585	-10.6351194611755	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGATCGTCACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.46037761953	41.2910945192223	0.0174558385800465	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2360.37154290809	2360.37154290809
"healthy-2"	"2019-08-01-count-1:CGGGCATAGAATCGCG"	2.34887423095052	-10.518225692865	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGGGCATAGAATCGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.11104671302	45.352152741102	0.019281467515949	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.33783302611	2348.33783302611
"healthy-2"	"2019-08-01-count-2:GTTAGACTCTCTTCAA"	2.73406543311421	-10.8479042283264	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACTCTCTTCAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.5738059567	38.9251647822652	0.0170756325943696	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2273.49303357343	2273.49303357343
"healthy-2"	"2019-08-01-count-2:CCTACGTAGCGTGAAC"	1.61281241950337	-9.14702608501586	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTAGCGTGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.29615218908	42.6682822859538	0.0178580969323795	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2388.36924503044	2388.36924503044
"healthy-2"	"2019-08-01-count-2:CTAACCCGTCCTTTGC"	1.23915841159169	9.16532132709352	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCGTCCTTTGC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1749.96477474066	36.1746276427105	0.0206716318893171	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1736.96755008567	1736.96755008567
"healthy-2"	"2019-08-01-count-2:TCATGAGCAGAGTAAT"	2.13493480262105	-10.5382929078308	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGCAGAGTAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.03248913462	39.4320795327398	0.0164572390865123	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.47948232497	2392.47948232497
"healthy-2"	"2019-08-01-count-4:CTGCTCACAGTGTGCC"	4.31026472625081	-10.6815204850403	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACAGTGTGCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.26041062192	42.3693695096815	0.0183953882567022	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.26686725085	2302.26686725085
"healthy-2"	"2019-08-01-count-3:ATGCGATAGCCAGAGT"	2.36722364005391	-10.8659420243469	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCGATAGCCAGAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.37405550076	41.6738087025688	0.0167811242975096	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2475.36534759836	2475.36534759836
"healthy-2"	"2019-08-01-count-3:TACCTGCGTTCCACGG"	1.78394820269887	-9.17753508007201	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCGTTCCACGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.76672180771	43.9470379307012	0.0199780447149354	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2198.70268536365	2198.70268536365
"healthy-2"	"2019-08-01-count-4:GGATCTAGTCCTTGTC"	4.30619635161702	-10.8315506211487	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATCTAGTCCTTGTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.22570541909	44.9833168827657	0.0181440990969242	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.74631757328	2472.74631757328
"healthy-2"	"2019-08-01-count-2:GAGGGTATCTGGGTCG"	1.96438064154927	-9.88132288372191	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTATCTGGGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.57371340532	41.542966509163	0.0191479857321639	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2166.61722384686	2166.61722384686
"healthy-2"	"2019-08-01-count-4:CATTTCAGTTCATCTT"	2.03590919551198	-10.3131904832092	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTTCAGTTCATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.17107096446	43.0576929710494	0.0165277794809494	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2599.57472981423	2599.57472981423
"healthy-2"	"2019-08-01-count-2:GCCCGAACATAATGCC"	1.52364959296529	-9.79712488567504	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAACATAATGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.42039497833	33.2180459250763	0.0124067352244641	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2673.56475369984	2673.56475369984
"healthy-2"	"2019-08-01-count-3:TTTCATGAGCCTGCCA"	2.23170651969258	-10.6659555665222	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGAGCCTGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.86763298174	41.5595990231755	0.0191090245644961	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2174.86763298174	2174.86763298174
"healthy-2"	"2019-08-01-count-2:GAGGGTAAGTGCGTCC"	10.5276495414669	5.3218989142212	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTAAGTGCGTCC"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1615.48434044133	33.4506699470636	0.0207062792932585	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1611.59301584574	1611.59301584574
"healthy-2"	"2019-08-01-count-2:CTATCTAAGTCATGCT"	2.74825110015218	-10.9241390458313	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTAAGTCATGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.68798303696	40.9845004440846	0.016805963177399	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2429.14633956906	2429.14633956906
"healthy-2"	"2019-08-01-count-4:TGTTACTTCACCGCTT"	2.53573574599568	-10.0060110322204	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTTCACCGCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.23137748877	42.3079064758902	0.0188686622177564	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2231.4829339443	2231.4829339443
"healthy-2"	"2019-08-01-count-4:GGGCGTTCATGAATAG"	1.94295646724049	-9.21968653118285	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCGTTCATGAATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.43232952447	42.5795056897689	0.0188702781522113	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2254.29475523117	2254.29475523117
"healthy-2"	"2019-08-01-count-2:CATGCTCTCTACGGTA"	2.57255138930623	-10.6370868912903	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCTCTACGGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.98350755195	40.2085562287812	0.0158489624032205	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2530.40691344874	2530.40691344874
"healthy-2"	"2019-08-01-count-3:TTCCTTCGTGCGTTTA"	2.74558200415913	-10.0036325684753	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCGTGCGTTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.87050495598	42.7505725821003	0.0183646695514571	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2318.62878133883	2318.62878133883
"healthy-2"	"2019-08-01-count-2:GCTTCACAGCACTCAT"	-8.01359019699748	3.4123644598755	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTCACAGCACTCAT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2457.33643926087	45.4528699753065	0.0184968037949977	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2450.78279679966	2450.78279679966
"healthy-2"	"2019-08-01-count-4:GTGTGATCACTTCAAG"	1.31999899920766	10.3496064909729	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGATCACTTCAAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1832.59850972033	30.443076776156	0.0166119728978726	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1825.62229681735	1825.62229681735
"healthy-2"	"2019-08-01-count-4:TCACGGGAGGGAGGGT"	3.14796819266621	-10.9002561799255	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGGGAGGGAGGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.0964784846	41.2111772318662	0.0173294807862998	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2374.4479271772	2374.4479271772
"healthy-2"	"2019-08-01-count-2:TGACGCGGTAGAGATT"	2.0984443622524	-10.0787067643371	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGGTAGAGATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.59544467025	40.8338286929269	0.0177415317654911	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2299.23554311921	2299.23554311921
"healthy-2"	"2019-08-01-count-2:CTAACTTAGAGGGCGA"	1.93598653849904	-9.99358084118041	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTAGAGGGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.26580780318	45.0842627043146	0.0200439905981355	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.65938044318	2243.65938044318
"healthy-2"	"2019-08-01-count-1:TCAGTTTCAAGACGAC"	8.87400402602498	6.25612638080446	"2019-08-01-count-1"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGTTTCAAGACGAC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1713.2059049291	44.3793371019714	0.0259042634480109	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1706.865048181	1706.865048181
"healthy-2"	"2019-08-01-count-2:TCGCTCACATCTTCGC"	6.89300503310506	-1.35691883480223	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCACATCTTCGC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2597.81494242051	42.096932428201	0.0162047464354706	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2595.51080971412	2595.51080971412
"healthy-2"	"2019-08-01-count-4:CCTTCAGAGCCATGCC"	13.9770761924678	1.68155298316804	"2019-08-01-count-4"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTCAGAGCCATGCC"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1331.51482700205	32.4060275280995	0.0243377143618166	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1308.37559255122	1308.37559255122
"healthy-2"	"2019-08-01-count-3:TCCTTTCTCTGCAGCG"	1.79962279376332	-5.16213562404784	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCTCTGCAGCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.8220781386	41.529762671352	0.0190344405657416	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2177.41967012569	2177.41967012569
"healthy-2"	"2019-08-01-count-3:CCGGTAGAGTATGCAA"	2.22162284430806	-10.4241371384827	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTAGAGTATGCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.54299177773	39.109860469508	0.0168682921163005	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2315.23720214152	2315.23720214152
"healthy-2"	"2019-08-01-count-1:TCATTCATCAACCTCC"	1.18237890776936	9.35811898792116	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCATTCATCAACCTCC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2043.94326450211	16.6040211444268	0.0081235235012609	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2033.96445450921	2033.96445450921
"healthy-2"	"2019-08-01-count-2:CAACGGCCATAGGCGA"	1.65968396243398	-9.43766882335814	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCCATAGGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.29699329473	44.246764343797	0.0202660309063248	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2176.93984084072	2176.93984084072
"healthy-2"	"2019-08-01-count-4:TTATTGCTCACATCAG"	4.19286551055257	-10.6510887376037	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTATTGCTCACATCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.85480575384	38.2616898243892	0.0149409836662434	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2556.85176708119	2556.85176708119
"healthy-2"	"2019-08-01-count-4:ATCCTATGTAGGCTGA"	1.89630665358846	-4.83265402233275	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATGTAGGCTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2403.70353051348	42.0112185091928	0.0174777038748279	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2399.98497182372	2399.98497182372
"healthy-2"	"2019-08-01-count-2:ACTTTGTCACCTGCGA"	1.6233682828838	-4.82613661205443	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTGTCACCTGCGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2266.54252639349	40.7015864590858	0.0179575657571491	2079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2257.56655690838	2257.56655690838
"healthy-2"	"2019-08-01-count-4:AGGTTGTAGATGGGCT"	-1.96080336991008	13.0501060255798	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTGTAGATGGGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1652.14048335416	40.2691148614954	0.0243739048024182	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1649.94398112942	1649.94398112942
"healthy-2"	"2019-08-01-count-4:TGCTTGCCAGTTAGAA"	2.92045011100118	-10.7603836289612	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCCAGTTAGAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.27054935406	40.8950005780733	0.0198493351229501	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2056.94182394425	2056.94182394425
"healthy-2"	"2019-08-01-count-3:ACCACAAAGGAGGGTG"	3.35172380980794	-10.5796404114929	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAAAGGAGGGTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.70322572833	45.721539200823	0.0202244764728431	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2259.67332540827	2259.67332540827
"healthy-2"	"2019-08-01-count-3:GGGACCTAGTAATACG"	4.65397991713826	-10.5889597169128	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTAGTAATACG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.82708404392	39.9872773940268	0.0181857307853809	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2192.25324384224	2192.25324384224
"healthy-2"	"2019-08-01-count-3:GTGGGAAGTACCGCGT"	-3.02695761147197	3.74083826625673	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGGAAGTACCGCGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2993.55816904172	44.2022456379309	0.014765788116314	4397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2988.64587316028	2988.64587316028
"healthy-2"	"2019-08-01-count-4:ACCAACAGTCAGTCTA"	2.28558339652364	-10.4661293259827	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAACAGTCAGTCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.99862869608	36.4406822416672	0.0145646291823343	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2497.9233884579	2497.9233884579
"healthy-2"	"2019-08-01-count-2:CGACAGCTCCATAGAC"	3.10550179061238	-10.9453888169494	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCTCCATAGAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.44686566235	43.6849363053235	0.0209274482737371	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2083.47570322906	2083.47570322906
"healthy-2"	"2019-08-01-count-2:AGGGCCTTCACAAGGG"	4.54126705703084	-10.6999435654846	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTTCACAAGGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.73902286127	41.9994717505727	0.0179428254668192	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2337.68568287646	2337.68568287646
"healthy-2"	"2019-08-01-count-4:GAGAGGTCAGTTGAAA"	-2.41015038910564	13.004219985846	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAGGTCAGTTGAAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1559.31376173659	40.9876798430274	0.0262857167356618	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1556.53513231411	1556.53513231411
"healthy-2"	"2019-08-01-count-3:GTCATTTCAATAGTGA"	1.90825619277303	-5.05119659816893	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATTTCAATAGTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2152.25615524844	39.6128407883128	0.0184052630964553	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2145.58998971057	2145.58998971057
"healthy-2"	"2019-08-01-count-4:GATTGGTAGCGTACAG"	0.925649841397446	8.96043870532838	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTAGCGTACAG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1667.2538824215	37.4325991188894	0.0224516490940916	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1657.9089086384	1657.9089086384
"healthy-2"	"2019-08-01-count-2:ACCCAAAGTTCTCGTC"	6.82997622069661	-0.970831655618273	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCAAAGTTCTCGTC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1752.73069689548	48.6019199062336	0.0277292569773096	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1747.00844044727	1747.00844044727
"healthy-2"	"2019-08-01-count-2:TTACGCCGTTAACAGA"	-3.07904563370402	-5.50053169643553	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCGTTAACAGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2097.61282310584	36.8845524708525	0.0175840613027142	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2097.61282310584	2097.61282310584
"healthy-2"	"2019-08-01-count-4:TAAGTCGGTGCGAACA"	1.81412937220876	-5.0803752175537	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGGTGCGAACA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2384.85992021725	36.9202407201506	0.0154810940496611	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2379.92889805173	2379.92889805173
"healthy-2"	"2019-08-01-count-4:CATCGTCTCATTGTGG"	1.73797311362569	-9.77933695232543	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCTCATTGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.22322931813	39.1527083122823	0.0164422670794681	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.09925988792	2378.09925988792
"healthy-2"	"2019-08-01-count-2:ATCCACCTCATGCTAG"	1.00942107018773	-8.94670774852904	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCTCATGCTAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2611.14439443397	43.6004820617361	0.0166978441156594	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2604.83292175834	2604.83292175834
"healthy-2"	"2019-08-01-count-3:CCGAACGGTAGTGATA"	2.63720073279683	-10.8900785676208	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGAACGGTAGTGATA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.73381736174	43.3516005129353	0.0207549665508324	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2083.562189608	2083.562189608
"healthy-2"	"2019-08-01-count-3:GAGTCTAAGATAGCTA"	2.59697737273518	-10.8290033570495	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTAAGATAGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.81834836132	39.4337557168482	0.0167602210958245	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.40623564811	2346.40623564811
"healthy-2"	"2019-08-01-count-2:TGTGCGGAGTGACACG"	-3.20344958725627	-5.39753773128661	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGAGTGACACG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2558.67135784049	35.1923801665302	0.0137541619241919	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2556.63303621706	2556.63303621706
"healthy-2"	"2019-08-01-count-1:TTCACCGTCAACCTTT"	0.924752195447129	10.7684602507385	"2019-08-01-count-1"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCACCGTCAACCTTT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2221.0399093105	29.765572854566	0.0134016380028968	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2209.20113447055	2209.20113447055
"healthy-2"	"2019-08-01-count-4:CCGTTCATCGTCTAAG"	2.42023982581441	-9.84669783031615	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTTCATCGTCTAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.75676258811	36.0248461807081	0.0159419132081493	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.75100202072	2256.75100202072
"healthy-2"	"2019-08-01-count-3:ACTTCCGGTGTAGCAG"	4.50673164901082	-10.7321853867737	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCCGGTGTAGCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.84420879169	40.647653219991	0.0178369600972168	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2274.66745140547	2274.66745140547
"healthy-2"	"2019-08-01-count-4:TGTGCGGGTGTTACAC"	-2.14407883110698	13.0736140974793	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGGTGTTACAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1588.53826230597	47.0270976404464	0.0296040068762212	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1588.53826230597	1588.53826230597
"healthy-2"	"2019-08-01-count-2:TTGGGATTCTGTAAGC"	2.1857918697292	-10.3207435837952	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATTCTGTAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.55382031996	42.9994235915782	0.0180098237893611	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2382.53738657058	2382.53738657058
"healthy-2"	"2019-08-01-count-4:CTGCTCACAAGGACAC"	1.39115693148915	9.98539159381715	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACAAGGACAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1690.0122302933	40.2694990128127	0.0238279334853239	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1682.30547577911	1682.30547577911
"healthy-2"	"2019-08-01-count-4:CACTGAAAGGTTTACC"	1.43019392070119	9.67333791339723	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAAGGTTTACC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1645.19183260853	36.9003692040477	0.022429219786206	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1642.81361879818	1642.81361879818
"healthy-2"	"2019-08-01-count-3:AAGAACACAGCACAGA"	1.5571663576061	-9.53983690654906	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGAACACAGCACAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.83954783783	41.7908224111445	0.0175529772466595	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.71986946962	2377.71986946962
"healthy-2"	"2019-08-01-count-3:TTACGCCAGACGTCGA"	2.76195325431172	-10.9566316834656	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGCCAGACGTCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.22949555169	41.8567570043567	0.0183563790776374	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2276.91745562323	2276.91745562323
"healthy-2"	"2019-08-01-count-3:GTGCTGGAGGCATCTT"	2.59102382239644	-10.6697006455627	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGAGGCATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.13217572713	40.0818882703453	0.0181191199649588	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2206.7737629258	2206.7737629258
"healthy-2"	"2019-08-01-count-3:CTGCCTACAGAACTAA"	3.92512001571004	-10.825294517633	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTACAGAACTAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.35876517922	45.7826462778042	0.0218391274615108	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2083.57669213176	2083.57669213176
"healthy-2"	"2019-08-01-count-3:CATACAGTCGAGAAAT"	2.17703809317891	-10.4169502488342	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGTCGAGAAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.43614310374	41.6288486717648	0.0186305832906643	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2228.05184089608	2228.05184089608
"healthy-2"	"2019-08-01-count-2:CAATTTCGTAGTCCTA"	4.49352755126302	-10.5458469620911	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCGTAGTCCTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.1314527075	41.3993465036098	0.0166722331427399	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2480.48489123336	2480.48489123336
"healthy-2"	"2019-08-01-count-3:GCTACAAGTATGAAAC"	-1.90637944164928	13.0872907408508	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAAGTATGAAAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1860.4767012992	37.6815231668975	0.0202536925835104	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1852.54548878359	1852.54548878359
"healthy-2"	"2019-08-01-count-2:TGGATGTGTACTCCCT"	2.49272837218587	-10.555503868219	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATGTGTACTCCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.49897527009	39.3934122373545	0.0177168564840779	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2217.3544854363	2217.3544854363
"healthy-2"	"2019-08-01-count-4:AGTAGCTTCCATAGAC"	10.2297464805538	4.7058911093506	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGCTTCCATAGAC"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1696.42802177464	27.2067604685521	0.016037674525142	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1692.49385678678	1692.49385678678
"healthy-2"	"2019-08-01-count-2:GCTGCAGGTACCTATG"	-7.29320369187053	1.44202563846437	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGCAGGTACCTATG"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1866.97386479115	46.1674740255239	0.0247285057901378	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	1857.46121929737	1857.46121929737
"healthy-2"	"2019-08-01-count-2:TGGGCTGCATGTTTGG"	4.55461563643758	-10.9623270264831	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGCATGTTTGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.42751035106	43.3792125389234	0.0179221283650968	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2413.17746043316	2413.17746043316
"healthy-2"	"2019-08-01-count-4:CTACCTGGTCCCTGAG"	2.86106123503987	-10.9224424592224	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCTGGTCCCTGAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.20862179591	33.3739158522387	0.013637544243264	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2441.69903847747	2441.69903847747
"healthy-2"	"2019-08-01-count-2:ATGTCCCCATCCGCGA"	2.20726503905599	-10.4896087876526	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCCATCCGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.27365650661	44.1286381351105	0.0188723154846807	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.67025869649	2333.67025869649
"healthy-2"	"2019-08-01-count-2:TATATCCTCGTTCCCA"	2.26326288756673	-10.8235273591247	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCTCGTTCCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.81312488057	42.5500686250042	0.016980543442174	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2499.61860336184	2499.61860336184
"healthy-2"	"2019-08-01-count-2:GACCGTGGTATCGTTG"	1.83391811427419	-5.19464685833129	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCGTGGTATCGTTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2549.3637358269	37.6491052805496	0.0147680398647931	2367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2539.13164775917	2539.13164775917
"healthy-2"	"2019-08-01-count-3:CCTACGTCAGACCAGA"	3.21986283835713	-10.9993925324646	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTCAGACCAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.74635548675	43.3712528226825	0.0181869458455803	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2381.01470335172	2381.01470335172
"healthy-2"	"2019-08-01-count-2:TACGCTCAGGACAAGA"	2.13950814780537	-10.5395698777405	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCAGGACAAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.94501690694	39.8109740468997	0.0175770156669262	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2259.25761145944	2259.25761145944
"healthy-2"	"2019-08-01-count-4:TGCTTGCGTATTCCTT"	1.6758961873943	-4.84821417247923	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCGTATTCCTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2436.44047116444	35.9771893692925	0.0147662911509995	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2430.01377568367	2430.01377568367
"healthy-2"	"2019-08-01-count-2:AGAGCAGTCTGCGGCA"	10.7983890968258	4.19023797595827	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCAGTCTGCGGCA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1634.0907671356	35.7876577051843	0.0219006547401993	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1634.0907671356	1634.0907671356
"healthy-2"	"2019-08-01-count-3:ACAGGGACAATCTCTT"	1.93608035620992	-9.6499347916809	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGGGACAATCTCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.07871039467	39.2895664435936	0.0154678539223254	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2538.26742874837	2538.26742874837
"healthy-2"	"2019-08-01-count-2:TTGATGGAGACGGAAA"	-2.46383009377177	13.0460099943909	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGAGACGGAAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1780.43822496654	41.3182893995129	0.0232068087620897	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1776.30507187851	1776.30507187851
"healthy-2"	"2019-08-01-count-4:AGGCTGCCAGTTCTAG"	3.53468074378316	-10.8291712037292	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCTGCCAGTTCTAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.62413834753	40.4992199024933	0.0188138835670508	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2144.69053283492	2144.69053283492
"healthy-2"	"2019-08-01-count-3:GGAAGTGAGAATACAC"	0.382202615111512	4.4277338751587	"2019-08-01-count-3"	"Control2"	"Ery"	"Erythrocytes"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGAGAATACAC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1598.63411838395	36.5282212904464	0.0228496444998762	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	1563.81834836981	1563.81834836981
"healthy-2"	"2019-08-01-count-4:GTGCTGGGTCTCTCCA"	-5.19529376450236	-5.5218715897766	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTCTCTCCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2823.33633195084	40.3593981449387	0.0142949310318447	2895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2819.28119451682	2819.28119451682
"healthy-2"	"2019-08-01-count-3:CGTTCTGTCTATCACT"	1.23775746402089	-9.09787561809691	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTCTGTCTATCACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2509.33013154058	41.255491433161	0.0164408384989315	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2507.56735244109	2507.56735244109
"healthy-2"	"2019-08-01-count-4:AATTTCCTCATACAGC"	2.32749809798543	-10.6631918183533	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTTCCTCATACAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.35688078987	35.7839901040086	0.014663425003816	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2438.5336531316	2438.5336531316
"healthy-2"	"2019-08-01-count-3:TGTGCGGAGCCAGAGT"	-1.3671500486439	13.0279149779114	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ TRM"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGCGGAGCCAGAGT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1746.15377311479	42.2909193147382	0.0242194702241485	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1733.89135765781	1733.89135765781
"healthy-2"	"2019-08-01-count-2:TGTAAGCCAAGTCCCG"	-4.96901307526286	3.68833396518556	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAAGCCAAGTCCCG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2638.9932655696	40.0600110850179	0.0151800353595716	2911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2631.79336406903	2631.79336406903
"healthy-2"	"2019-08-01-count-4:ATATCCTAGATCCCGC"	1.41236223754231	-8.82215502178343	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATATCCTAGATCCCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.11110889395	36.5910664630011	0.0163930309370364	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2229.8971848349	2229.8971848349
"healthy-2"	"2019-08-01-count-4:TCGACCTCAGATGCGA"	7.00430979308431	-1.15790071403655	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACCTCAGATGCGA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2107.35214026257	41.1790433002453	0.0195406560268159	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2096.73442990705	2096.73442990705
"healthy-2"	"2019-08-01-count-4:TACTTCACAGGCTCTG"	2.12378110465352	-10.6025076142517	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTCACAGGCTCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.25564452281	43.5637004176234	0.0174236984578182	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.10076018953	2493.10076018953
"healthy-2"	"2019-08-01-count-3:CGCCAGATCACTCGAA"	2.45730604705159	-10.8452978364197	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGATCACTCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.13796427517	41.0376735132346	0.017432144647423	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.98466584138	2348.98466584138
"healthy-2"	"2019-08-01-count-2:CCACAAAAGTAGACAT"	8.11908974227254	7.18094441974489	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAAAGTAGACAT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1658.87873011828	36.7858194813655	0.0221751107018791	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1655.28573326123	1655.28573326123
"healthy-2"	"2019-08-01-count-4:GTTTGGATCTACGCAA"	-5.07677874985393	-4.42764332210692	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGATCTACGCAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2949.34730462448	43.6202481342628	0.0147897970733618	3299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2943.68414347112	2943.68414347112
"healthy-2"	"2019-08-01-count-2:CTTTCAAGTCGTGATT"	1.83323087271993	-5.21289589321288	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAAGTCGTGATT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2202.47475261901	43.2208609318561	0.0196237713419694	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2194.28878572873	2194.28878572873
"healthy-2"	"2019-08-01-count-4:GTGGGAACAGTAGTGG"	2.40401877936665	-10.8401251069275	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAACAGTAGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.22368565316	41.6841953104935	0.0183370407292393	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2268.67760504107	2268.67760504107
"healthy-2"	"2019-08-01-count-3:CGTGAATAGCTTTCCC"	2.17166008529012	-10.6043768159119	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATAGCTTTCCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.36168916879	39.2787025363459	0.0171420787569311	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2289.57131315173	2289.57131315173
"healthy-2"	"2019-08-01-count-2:TGATTTCAGGCCGCTT"	-3.1837297481602	-5.87250950252684	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCAGGCCGCTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2345.07116582862	39.3248160973499	0.0167691354831249	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2341.92509034376	2341.92509034376
"healthy-2"	"2019-08-01-count-2:CCTCTAGTCTATCCAT"	4.03303017196004	-10.8675203553406	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTAGTCTATCCAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.48190529653	46.5695508334873	0.0194000840959202	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2387.55711011353	2387.55711011353
"healthy-2"	"2019-08-01-count-2:TGTGGCGCAGTCAGCC"	2.28450240668599	-10.3390550843445	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGCAGTCAGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.56937312015	42.6051966130593	0.0178072983344671	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.15086361324	2390.15086361324
"healthy-2"	"2019-08-01-count-4:TTTCCTCCAATGGCAG"	-1.97246728363689	13.1911058195862	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCCAATGGCAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1892.7259737078	44.6356232943075	0.02358271821402	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1890.74714788244	1890.74714788244
"healthy-2"	"2019-08-01-count-3:CTGAGCGGTGTGAGCA"	-2.22015939179118	13.3084811934265	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGCGGTGTGAGCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1753.37571554588	44.6666562169995	0.0254746634283647	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1743.56007129081	1743.56007129081
"healthy-2"	"2019-08-01-count-2:ATGGATCAGAAACTAC"	0.225854163139504	11.8604030379089	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCAGAAACTAC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1667.85157605029	41.5206997146122	0.0248947210356327	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1657.80890936188	1657.80890936188
"healthy-2"	"2019-08-01-count-2:CCTAACCCAACCGTGC"	4.23445381697957	-10.5107755891052	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCCAACCGTGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.60595646905	41.8146790709385	0.0183348986493388	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2277.13551447266	2277.13551447266
"healthy-2"	"2019-08-01-count-3:GGGTCACAGGCATCTT"	-3.20197234574016	3.22057960117189	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACAGGCATCTT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3227.84407928997	45.1120691979461	0.013975913361921	5495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3222.55816192819	3222.55816192819
"healthy-2"	"2019-08-01-count-4:AACAGGGTCACTGAAC"	2.65116324004475	-10.6706180802551	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGTCACTGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.10050245207	42.919648419622	0.0186842710511825	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.5704732733	2294.5704732733
"healthy-2"	"2019-08-01-count-3:TAGGTACCACCCTAGG"	2.59239520606343	-10.9747228852478	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACCACCCTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.37357588005	37.4449394508296	0.0152315904377654	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2449.19057773093	2449.19057773093
"healthy-2"	"2019-08-01-count-2:CATGCTCAGGTTTACC"	-2.35097418251689	4.17143724048463	"2019-08-01-count-2"	"Control2"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCAGGTTTACC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3160.27088312147	43.7423362988824	0.013841324973914	5769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3156.31017932696	3156.31017932696
"healthy-2"	"2019-08-01-count-1:GACCAATGTGGGAGAG"	2.37218894538228	-10.9439459077087	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GACCAATGTGGGAGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.36416645704	44.1304922873374	0.0181879096705325	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2417.4896623686	2417.4896623686
"healthy-2"	"2019-08-01-count-4:GTGCGTGTCATGACAC"	2.0782102542812	-10.077060722467	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGTCATGACAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.64544450166	32.1353655519252	0.0142277158330246	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.38138102547	2256.38138102547
"healthy-2"	"2019-08-01-count-2:ATTGGGTGTGCGGATA"	0.480131586163682	11.2659797438416	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTGTGCGGATA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1604.86342125406	39.4074232332316	0.0245550011990666	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1600.52748417	1600.52748417
"healthy-2"	"2019-08-01-count-2:AACCACAGTCGTGATT"	2.65302362021748	-10.7538948289123	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCACAGTCGTGATT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.20447749006	35.3265125071085	0.0146025327068508	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2413.21489821552	2413.21489821552
"healthy-2"	"2019-08-01-count-4:AGTCAACAGCATCCCG"	-4.0885742706364	-5.44569828426512	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCAACAGCATCCCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2365.77005272703	44.8539305035154	0.0189595478443952	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2362.68990812454	2362.68990812454
"healthy-2"	"2019-08-01-count-2:CAATGACGTACTCCGG"	1.53923978385274	-9.66507723247679	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATGACGTACTCCGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2210.34084971133	44.996661226086	0.0203573404671784	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2207.14998295839	2207.14998295839
"healthy-2"	"2019-08-01-count-3:CGAATTGGTCATATGC"	3.14082016524617	-10.3757925263611	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAATTGGTCATATGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2555.49739340071	45.7511217613523	0.0179030203198405	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2550.46654257429	2550.46654257429
"healthy-2"	"2019-08-01-count-1:TCAGTTTCATACAGGG"	8.81651653823201	7.2107829817566	"2019-08-01-count-1"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGTTTCATACAGGG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.41404278666	40.0246545185857	0.0208199969557897	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1913.32757471074	1913.32757471074
"healthy-2"	"2019-08-01-count-4:TCGCTTGAGGCAGGTT"	2.28347744521443	-10.8385095826355	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTTGAGGCAGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.63097286162	39.5185575909185	0.0171177455623988	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2303.65206298162	2303.65206298162
"healthy-2"	"2019-08-01-count-4:TCTGGCTAGATTGACA"	2.01092292842214	-10.3545961610046	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTAGATTGACA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2372.91680246495	41.6852153163592	0.0175670783202585	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2371.28395926157	2371.28395926157
"healthy-2"	"2019-08-01-count-3:ACTTTCACAATGACCT"	1.19075240668599	10.9993018873963	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTCACAATGACCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.17382697597	35.5765193968016	0.0181867883652236	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1951.86868334	1951.86868334
"healthy-2"	"2019-08-01-count-4:AGGACGAGTCCTTGTC"	1.00240304049794	9.18777749622194	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGAGTCCTTGTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.16389473485	36.832980658264	0.0195590945436271	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1872.55273150307	1872.55273150307
"healthy-2"	"2019-08-01-count-2:AACCTTTAGGCCTGAA"	-3.84826884689983	-4.6317405930725	"2019-08-01-count-2"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTTTAGGCCTGAA"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2945.69316987302	40.1202860258398	0.0136199813463835	3940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2941.26855886602	2941.26855886602
"healthy-2"	"2019-08-01-count-2:ATTATCCAGATACAGT"	1.5658526616985	-4.74729015743407	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCAGATACAGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2056.64654413662	39.2620049772673	0.0190903026527339	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2032.56932014165	2032.56932014165
"healthy-2"	"2019-08-01-count-3:GGTTGTACAATCACGT"	1.97265686568562	-9.81417467510375	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTACAATCACGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.64059956829	38.6051667779479	0.0161958840543914	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.52790096954	2377.52790096954
"healthy-2"	"2019-08-01-count-2:GAGATGGGTAGGACTG"	2.81588878211324	-10.8178911439148	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGGTAGGACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.15529465879	43.1972921561879	0.0185383747835199	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2325.85058370573	2325.85058370573
"healthy-2"	"2019-08-01-count-3:CTCAACCGTTGCCGAC"	2.17974605140035	-10.5512380830017	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCGTTGCCGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.04886484557	40.1851943548149	0.017899474253795	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2239.55665881084	2239.55665881084
"healthy-2"	"2019-08-01-count-4:CAGGGCTAGCCTATTG"	2.60407080230061	-10.3693552247253	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGGCTAGCCTATTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.64396065849	43.4902574523485	0.0191448388064042	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2267.85093773795	2267.85093773795
"healthy-2"	"2019-08-01-count-2:CAGGGCTGTCCGAAGA"	7.97164263305013	8.2266807326111	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGGCTGTCCGAAGA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1941.5145921657	44.5058821762866	0.0229232797713056	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1937.01361243917	1937.01361243917
"healthy-2"	"2019-08-01-count-3:GTTGCGGTCTGCATGA"	1.78267015990559	-8.74750139629515	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGTCTGCATGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.38626944854	39.6081731014763	0.0183084147573761	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2162.23322812151	2162.23322812151
"healthy-2"	"2019-08-01-count-4:GTTAGTGGTCTCAAGT"	10.5541693168575	4.43482444370119	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGGTCTCAAGT"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1586.51784105301	37.3166411044092	0.0235210976761795	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1579.65496470055	1579.65496470055
"healthy-2"	"2019-08-01-count-4:GTTACGATCTCTGAGA"	0.157997136085671	11.9536676176819	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGATCTCTGAGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1656.148154574	26.2428783059974	0.0158457310920638	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1652.16725064706	1652.16725064706
"healthy-2"	"2019-08-01-count-3:CTACGGGAGGCTTTCA"	2.97395076331441	-10.8675461045471	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGAGGCTTTCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.56038419507	41.3821554418877	0.0186191366210619	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2220.58029847796	2220.58029847796
"healthy-2"	"2019-08-01-count-3:TTCACCGTCCGACGGT"	6.94835295256917	-1.09993710434111	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGTCCGACGGT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2070.9996865003	47.0740482173349	0.0227301088088929	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2058.74098956164	2058.74098956164
"healthy-2"	"2019-08-01-count-2:TTCGATTAGCAAATCA"	-4.22210298004802	-5.39089682018431	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGATTAGCAAATCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2345.62375791234	47.634768519343	0.0203079323180709	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2343.10080443644	2343.10080443644
"healthy-2"	"2019-08-01-count-4:AGTAGTCCACGTTCGG"	1.81583180007283	-9.65371706401976	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCCACGTTCGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2371.84354863224	42.8395485806761	0.0180617092579231	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2368.88541587568	2368.88541587568
"healthy-2"	"2019-08-01-count-3:GCACTAATCCGATGTA"	2.46377124366109	-10.76176645672	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAATCCGATGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.00131420136	41.9720979303645	0.0182249561350857	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2300.93414361862	2300.93414361862
"healthy-2"	"2019-08-01-count-2:ACGGAAGTCGGATAAA"	3.02160610732381	-11.0173263779846	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGAAGTCGGATAAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.15975681876	45.9047403300516	0.0197426177687066	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2313.73781671196	2313.73781671196
"healthy-2"	"2019-08-01-count-2:GACATCAAGGCATGCA"	1.99483027037923	-9.47929479992064	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACATCAAGGCATGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.81645005508	35.5102343171862	0.0154069684448571	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.61869065799	2301.61869065799
"healthy-2"	"2019-08-01-count-4:CTACAGAGTAGCGTAG"	-2.25478349152263	13.3606681593689	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACAGAGTAGCGTAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1616.8413319155	41.1272526133501	0.0254367894990822	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1616.8413319155	1616.8413319155
"healthy-2"	"2019-08-01-count-3:TTCCTTCAGGACGCTA"	-1.00239298763927	13.3210906752381	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCAGGACGCTA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1924.95807190837	37.3753323933857	0.0194161799879269	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1914.02349469487	1914.02349469487
"healthy-2"	"2019-08-01-count-2:CCTAACCGTGCATTAC"	2.60054029998128	-10.6588402024475	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCGTGCATTAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.82489289788	40.0267836935121	0.0157534601480783	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2535.21726925788	2535.21726925788
"healthy-2"	"2019-08-01-count-2:TGTAAGCTCCATACAG"	-3.0589796108311	12.7336168059143	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAAGCTCCATACAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1847.70374350773	39.9944177318032	0.0216454709648836	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1836.1841000345	1836.1841000345
"healthy-2"	"2019-08-01-count-3:TGAATCGCAGGAATAT"	2.03136636790578	-10.1174421540466	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAATCGCAGGAATAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.64244695295	48.7349515491445	0.0227028733258869	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2144.01851841095	2144.01851841095
"healthy-2"	"2019-08-01-count-4:CAGATTGGTATGAGCG"	2.19123758849446	-10.6631613007751	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATTGGTATGAGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.68204156608	38.6497906569951	0.0172568203609694	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2237.49738769655	2237.49738769655
"healthy-2"	"2019-08-01-count-4:CTGCTCACAGTCGTTA"	2.74944963034932	-11.1035709611145	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACAGTCGTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.25022790042	39.3196444176276	0.0154786500895726	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2537.04990720133	2537.04990720133
"healthy-2"	"2019-08-01-count-4:GGTGAAGAGAGGTCGT"	1.93685485896413	-10.1769705048767	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGAGAGGTCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.89726703898	36.7435183038345	0.0158111629222972	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2320.79314974074	2320.79314974074
"healthy-2"	"2019-08-01-count-3:GTGGTTAGTATCGTGT"	1.78675570067708	-5.1852975121704	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGTTAGTATCGTGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2380.83548025108	41.6165009798087	0.0174797886393309	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2371.8709474531	2371.8709474531
"healthy-2"	"2019-08-01-count-4:ATCGTGAGTATCACCA"	2.24212207373921	-10.8659487000671	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTGAGTATCACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.23202850356	39.1463377661589	0.0163844856000349	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.64099853291	2383.64099853291
"healthy-2"	"2019-08-01-count-3:TGGGCGTCAAGGTCGA"	3.28658690032307	-10.8914880982605	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTCAAGGTCGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.80886844646	40.2510795377864	0.0179547329410289	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2235.91548643835	2235.91548643835
"healthy-2"	"2019-08-01-count-2:ACGGGTCGTAGTCTGT"	2.62263311919515	-10.7244653931824	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGGTCGTAGTCTGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.3833962725	39.8818832902547	0.0167403296012952	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2374.57225526229	2374.57225526229
"healthy-2"	"2019-08-01-count-3:TGGTTAGAGCTAGAGC"	-7.52900109711345	0.537623769882597	"2019-08-01-count-3"	"Control2"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGAGCTAGAGC"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2612.45214707678	43.2002904485292	0.0165362992378132	3427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2607.23872839173	2607.23872839173
"healthy-2"	"2019-08-01-count-2:TCAAGACTCTCCTACG"	1.70221569117848	-9.59424402630004	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACTCTCCTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.66585388638	46.724161151511	0.0204512012432934	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.62782661004	2278.62782661004
"healthy-2"	"2019-08-01-count-3:CTTCTCTCATGGGCAA"	-3.4313407939976	3.54773686015931	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTCATGGGCAA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3333.49961828089	41.7637590183815	0.0125285027150894	5349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3324.98351785084	3324.98351785084
"healthy-2"	"2019-08-01-count-2:AAGCGTTCACAGACGA"	4.54225267943684	-10.8039846650329	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGTTCACAGACGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.31368881141	45.0381367906797	0.0192774356484607	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2330.94384765399	2330.94384765399
"healthy-2"	"2019-08-01-count-3:TATACCTTCCTGTTAT"	2.7087034183437	-10.5791807404724	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTTCCTGTTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.26962919937	40.5661002578114	0.017021196326594	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.62668647951	2378.62668647951
"healthy-2"	"2019-08-01-count-3:ACTCCCAAGACGAGCT"	2.32312407073323	-10.70304014599	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCAAGACGAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.29737545853	33.7133785756646	0.0158405394680342	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2122.5796389669	2122.5796389669
"healthy-2"	"2019-08-01-count-4:CCTCATGGTAGACAGC"	-5.04652295532878	-5.31877615368041	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGGTAGACAGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2703.45447781367	45.6657970201842	0.0168916463713178	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2699.82186482985	2699.82186482985
"healthy-2"	"2019-08-01-count-3:TTGGGCGCATCCCACT"	1.08381714400594	11.3803224333557	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGCATCCCACT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.40473125739	38.6237851437005	0.0225948743661718	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1698.6827752662	1698.6827752662
"healthy-2"	"2019-08-01-count-4:CTTCTAAGTGTTGCCG"	1.81890513476674	-8.95065977489623	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAAGTGTTGCCG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2420.86815206305	39.5205797084799	0.0163249616360977	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2419.23218674639	2419.23218674639
"healthy-2"	"2019-08-01-count-2:GAAGCGATCCACAAGT"	4.46518625792806	-9.39984323894652	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGATCCACAAGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.74005717683	39.5503445162785	0.0168031913276425	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2350.11862247407	2350.11862247407
"healthy-2"	"2019-08-01-count-4:TCTCACGGTGACTAAA"	2.39147557792012	-10.9459324113098	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCACGGTGACTAAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.46531280845	41.4665209262014	0.0176945315552835	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2339.65681367603	2339.65681367603
"healthy-2"	"2019-08-01-count-3:GACGCTGCATCTTAGG"	1.15173079547231	10.694480872992	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGCTGCATCTTAGG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.89236212102	36.5429719729985	0.0206470024703682	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1764.86310215504	1764.86310215504
"healthy-2"	"2019-08-01-count-2:CCATAAGTCTCTCGCA"	2.87783875045125	-10.9403314820495	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGTCTCTCGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.72896244971	42.7314962713871	0.017740267559173	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2406.78076798528	2406.78076798528
"healthy-2"	"2019-08-01-count-4:TAGTGCACAGCGAACA"	3.95779814299886	-10.3467684022156	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGTGCACAGCGAACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.54739617753	39.4161176290752	0.0175451974421467	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.77796668783	2243.77796668783
"healthy-2"	"2019-08-01-count-3:CACTTCGCAGCTGTGC"	2.2636350589687	-4.48690750515135	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTTCGCAGCTGTGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2555.76878430498	41.0503887363855	0.0160618554340583	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2548.59902836131	2548.59902836131
"healthy-2"	"2019-08-01-count-2:CCGATGGAGACCATGG"	3.15178098258321	-11.0196552506653	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATGGAGACCATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.44318216433	41.4617088593672	0.0180704883789089	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.75025484997	2291.75025484997
"healthy-2"	"2019-08-01-count-2:TACTTACTCGATGGAG"	8.51044048842732	7.61469791019288	"2019-08-01-count-2"	"Control2"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACTCGATGGAG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.92290934857	42.5331022655496	0.0220960029406806	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1917.69210319591	1917.69210319591
"healthy-2"	"2019-08-01-count-2:AGACACTTCGATTGGT"	-3.33745346489604	13.0719890364441	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTTCGATTGGT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1948.51808466109	46.1266754327371	0.0236726955709832	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1943.14092747669	1943.14092747669
"healthy-2"	"2019-08-01-count-2:TTGACCCTCTAGGAAA"	2.73573269423787	-10.4072227708069	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCTCTAGGAAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.43931978325	40.3980477614103	0.0166148698150574	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.69387941524	2426.69387941524
"healthy-2"	"2019-08-01-count-2:ATTACCTCATGGGAAC"	2.27706088599507	-10.6926937333313	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACCTCATGGGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.25460996585	38.8667793930651	0.0149415513745405	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2596.54147095634	2596.54147095634
"healthy-2"	"2019-08-01-count-4:CTCAGAACATCAACCA"	8.04346909102742	7.61774013126222	"2019-08-01-count-4"	"Control2"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAACATCAACCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.73318590645	42.0965203013667	0.0228198422530582	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1836.70880145444	1836.70880145444
"healthy-2"	"2019-08-01-count-3:TTGTTCACACTTCCTG"	4.33233465728108	-10.8269357911316	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTCACACTTCCTG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.65279762249	44.9278696115307	0.0184686732341911	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2423.39781856773	2423.39781856773
"healthy-2"	"2019-08-01-count-4:CTGTAGAAGATTGATG"	-3.34978685799297	-5.30438377773436	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTAGAAGATTGATG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2418.01264891576	43.6472008615903	0.0180508571289575	2622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2416.48202202098	2416.48202202098
"healthy-2"	"2019-08-01-count-3:CCACTTGGTGCTGTCG"	0.667476852505845	-8.33415605938109	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGGTGCTGTCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2546.21431573822	42.8062648151245	0.0168117289069258	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2540.56878399499	2540.56878399499
"healthy-2"	"2019-08-01-count-4:GTAGGAGAGAGGCCAT"	2.26342930373494	-9.02766420757445	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGAGAGGCCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2056.49319725979	34.2177098729919	0.0166388636337751	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2055.0547235536	2055.0547235536
"healthy-2"	"2019-08-01-count-1:GAGCTGCTCATTTGTC"	0.218755264847916	9.12615106189577	"2019-08-01-count-1"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAGCTGCTCATTTGTC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2043.0765394095	39.4122127741209	0.0192906198147192	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2030.37975422425	2030.37975422425
"healthy-2"	"2019-08-01-count-4:TTCCGGTCAGCTGTCG"	1.24330546435658	9.76893422687379	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTCAGCTGTCG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.72313607301	37.3295180444983	0.02210517357588	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1683.57794181374	1683.57794181374
"healthy-2"	"2019-08-01-count-4:TCCATGCTCCGGTAGC"	2.8826445537502	-10.7176399460998	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCTCCGGTAGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.7102219565	39.8533233920197	0.0163018598417464	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2440.31793842416	2440.31793842416
"healthy-2"	"2019-08-01-count-4:TAGTGCAAGCTAAACA"	1.21463408049886	10.5200729140076	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGTGCAAGCTAAACA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1940.618142048	38.3466792071199	0.0197600333503279	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1939.58053926659	1939.58053926659
"healthy-2"	"2019-08-01-count-4:GAAGAATCACTTCATT"	1.89910509166066	-5.17933800136717	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATCACTTCATT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2448.49009460984	41.7153209968201	0.0170371614280381	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2439.38810665676	2439.38810665676
"healthy-2"	"2019-08-01-count-2:AGCGCTGTCGTACACA"	3.97135343131368	-10.809895538446	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGTCGTACACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.78657420266	43.7332584804533	0.0185013566612735	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2354.45518338329	2354.45518338329
"healthy-2"	"2019-08-01-count-3:GTTAGTGGTTAAACCC"	1.6426782804424	-4.91288950359496	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGTGGTTAAACCC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2143.71050032806	37.8481704814864	0.0176554485671897	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2139.06337404868	2139.06337404868
"healthy-2"	"2019-08-01-count-2:AGGCTGCTCGGTGAAG"	1.66551150855367	-9.80670168316039	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCTCGGTGAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.34600514229	39.5716504435782	0.0170248535958208	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2318.14298321936	2318.14298321936
"healthy-2"	"2019-08-01-count-3:GGTCTGGAGATGGCAC"	-1.87716529789622	13.4548949965271	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCTGGAGATGGCAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1850.19879694611	42.4626153713946	0.0229502988767922	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1846.30083301482	1846.30083301482
"healthy-2"	"2019-08-01-count-4:TCATTACGTCCGGTCA"	3.59647740897481	-10.3246212235657	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTACGTCCGGTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.51015855255	41.4421953072229	0.0168634889109194	1937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2454.94758711277	2454.94758711277
"healthy-2"	"2019-08-01-count-3:CCGGGTAGTGGCTTGC"	1.79314686831776	-5.0972848168579	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGGTAGTGGCTTGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2300.72821558182	36.221214446624	0.0157433695128845	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2292.07605797693	2292.07605797693
"healthy-2"	"2019-08-01-count-3:TTCTGTATCTCGTCGT"	4.49590649184529	-10.3691053620544	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTATCTCGTCGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.43622461169	40.9276759354908	0.0169512350412458	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2406.65258390452	2406.65258390452
"healthy-2"	"2019-08-01-count-3:TATCTTGCATTCACCC"	11.2442776161129	4.2908053168091	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGCATTCACCC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.74238525369	31.971808644624	0.0163142915544408	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1954.32601261585	1954.32601261585
"healthy-2"	"2019-08-01-count-3:TACGTCCAGTTAGTGA"	2.27859177169148	-10.3402223817078	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCAGTTAGTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.42693446241	41.3561142807614	0.0184343486500359	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2240.4831383763	2240.4831383763
"healthy-2"	"2019-08-01-count-3:TGTCCCAGTCTGTAGT"	4.4654389816219	-10.8011913529602	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCCAGTCTGTAGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.34111364761	41.8342726591575	0.0180761048630481	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2310.08297815595	2310.08297815595
"healthy-2"	"2019-08-01-count-2:AAGTCGTGTTATGTGC"	-8.30763087692912	0.029146087634839	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTGTTATGTGC"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2610.97069609071	41.2480789664115	0.0157979861773901	3529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2606.28240010177	2606.28240010177
"healthy-2"	"2019-08-01-count-3:GGGTGTCTCTACGGGC"	3.03967632827107	-10.898367904779	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCTCTACGGGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.03325941681	40.6182362596423	0.0155563840916812	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2607.05074467147	2607.05074467147
"healthy-2"	"2019-08-01-count-2:CTCATTAAGGATTCAA"	3.16827525672261	-10.9718437424866	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATTAAGGATTCAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.16462019739	38.7140696351362	0.016515081450157	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2338.71819774804	2338.71819774804
"healthy-2"	"2019-08-01-count-4:GGATGTTCAATGCAGG"	6.86903061446492	-1.04713501846465	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTCAATGCAGG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1862.96607811207	49.9470097669303	0.0268104773102184	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1844.37366366371	1844.37366366371
"healthy-2"	"2019-08-01-count-2:CCTGCATTCTCCGAGG"	1.46702601489369	10.8143358000549	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATTCTCCGAGG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2310.08364567605	39.2772165933046	0.0170025084012964	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2299.01246162732	2299.01246162732
"healthy-2"	"2019-08-01-count-4:TTCCACGTCTTCACGC"	2.39446534690205	-10.7619829407898	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGTCTTCACGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.30190019384	44.9570828312908	0.018847544131683	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2379.15014116432	2379.15014116432
"healthy-2"	"2019-08-01-count-4:CTACCCATCTTCCAGC"	4.09718050536458	-10.9141082993713	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCATCTTCCAGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.51697468238	43.7382070533795	0.0189136804322861	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2311.17433718394	2311.17433718394
"healthy-2"	"2019-08-01-count-4:GAACTGTGTCAATCTG"	-5.05391107025798	-5.29609014904173	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTGTCAATCTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2832.29070694388	41.7966263144902	0.0147571808967272	2833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2824.62735351635	2824.62735351635
"healthy-2"	"2019-08-01-count-3:TGCAGGCCACATCATG"	2.79283251342122	-11.0085153809753	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCCACATCATG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.58135360729	39.2733570726518	0.0169385288170068	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2312.33592617148	2312.33592617148
"healthy-2"	"2019-08-01-count-3:AGCCAATCACTCCTGT"	3.08786358413045	-10.8907547227112	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATCACTCCTGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.4675907256	40.3903268952491	0.0160887665088618	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2500.77313829505	2500.77313829505
"healthy-2"	"2019-08-01-count-4:GTCAAACTCCGCAGTG"	10.9667965370113	3.94860813701478	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACTCCGCAGTG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1626.23160446473	38.5233136538284	0.0236887006426789	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1621.9376446604	1621.9376446604
"healthy-2"	"2019-08-01-count-3:GCTTCACGTGTTAACC"	3.03137936171834	-10.7709732285705	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTCACGTGTTAACC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.70991575516	42.7310001344813	0.0196580968899138	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2170.1904824397	2170.1904824397
"healthy-2"	"2019-08-01-count-2:TGTGCGGTCGTTGCCT"	-3.44598207894023	-5.70030929958495	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGTCGTTGCCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2072.33274900822	47.4802712854856	0.0229115094128628	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2069.48288731372	2069.48288731372
"healthy-2"	"2019-08-01-count-4:TCCCATGTCCGTCACT"	4.25457014617268	-10.7582216492859	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGTCCGTCACT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.65392627247	42.044655739838	0.0165032837883733	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2543.7989554411	2543.7989554411
"healthy-2"	"2019-08-01-count-4:TTTCATGCAAGTGGGT"	2.3798586326534	-10.2691202393738	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCATGCAAGTGGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1696.13386685228	47.1918414374428	0.0278231820964829	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1689.27434041047	1689.27434041047
"healthy-2"	"2019-08-01-count-4:AACAACCAGGTCACAG"	-2.25967178764995	12.5834007033142	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAACCAGGTCACAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1863.33254430076	47.2599702591974	0.0253631432584312	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1855.63832836112	1855.63832836112
"healthy-2"	"2019-08-01-count-4:GGAGCAACATCCGCGA"	1.4640140729839	-9.52468016063841	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGCAACATCCGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.73750299455	44.480388899286	0.0177585031749264	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2500.8339880975	2500.8339880975
"healthy-2"	"2019-08-01-count-4:CTTTCGGTCTCATTAC"	2.68457092818562	-11.0170335999695	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGTCTCATTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.89883945617	40.2759827826953	0.0171467506842569	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.02677071858	2343.02677071858
"healthy-2"	"2019-08-01-count-3:CTCACTGTCTGAGCAT"	14.1186920600826	1.90071914279786	"2019-08-01-count-3"	"Control2"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCACTGTCTGAGCAT"	"Plasma cell"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1333.02648093102	34.0198440172993	0.0255207563420188	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1324.1688590774	1324.1688590774
"healthy-2"	"2019-08-01-count-3:AATGGCTCACGGTAGA"	2.96402635154073	-11.1402874222961	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGCTCACGGTAGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.12718956936	39.9928742076415	0.0180707527322113	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2209.64786628876	2209.64786628876
"healthy-2"	"2019-08-01-count-4:CAACCTCAGGACAACC"	4.46567549285237	-10.5029602280823	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCAGGACAACC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.70832293249	43.7602488216019	0.0177187923024212	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2460.00409272872	2460.00409272872
"healthy-2"	"2019-08-01-count-4:AAACGCTGTCTTACTT"	4.4115854698116	-10.8059730759827	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGCTGTCTTACTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.36822484227	44.9783428070542	0.017629106754998	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2546.70785100459	2546.70785100459
"healthy-2"	"2019-08-01-count-3:CAGGTATGTATGCGTT"	2.02867331084554	-4.77001621639403	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATGTATGCGTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2575.41411583677	42.8521510641445	0.0166389361620089	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2573.83559594743	2573.83559594743
"healthy-2"	"2019-08-01-count-4:TGCCGAGTCCAGCAAT"	-3.86815391007121	3.59752795780031	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCCGAGTCCAGCAAT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2959.57977308424	42.868100676341	0.0144845227914459	4333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2953.21142101692	2953.21142101692
"healthy-2"	"2019-08-01-count-1:GTTAGTGAGGTGATCG"	8.47292770919148	6.63589284503785	"2019-08-01-count-1"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTTAGTGAGGTGATCG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1570.3788890141	34.6151848993878	0.0220425689249551	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1558.58372613012	1558.58372613012
"healthy-2"	"2019-08-01-count-2:GAAGGACTCCAAGGGA"	2.08612527427022	-10.3826227418152	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGACTCCAAGGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.47499131176	42.0485619835558	0.016931341016382	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2474.40154763999	2474.40154763999
"healthy-2"	"2019-08-01-count-4:CCTAACCAGGTGCCAA"	1.39342870292012	9.90709970081178	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCAGGTGCCAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1669.37126806374	33.9361402131487	0.0203286955169118	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1666.62919067467	1666.62919067467
"healthy-2"	"2019-08-01-count-2:TGCGGGTTCGCCTTTG"	1.92037357863728	-10.3130808106628	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTTCGCCTTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.68230340586	39.1914989559706	0.0168226795982761	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2322.815783296	2322.815783296
"healthy-2"	"2019-08-01-count-3:TCGTAGAAGACTGGGT"	4.58471693572347	-10.7018070450989	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTAGAAGACTGGGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.3641872032	43.0772137178566	0.0181732469425652	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.9712940437	2361.9712940437
"healthy-2"	"2019-08-01-count-2:GCGGATCGTCGGTGTC"	1.84559692916219	-9.69264128124388	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCGTCGGTGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.56192936038	39.2995445118915	0.0166554410049092	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2355.05569972121	2355.05569972121
"healthy-2"	"2019-08-01-count-3:AGCCAATCATGACGTT"	1.73361219939534	-9.86279871380004	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATCATGACGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.10317543446	42.4568396356676	0.0189361667655818	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2233.69796545314	2233.69796545314
"healthy-2"	"2019-08-01-count-3:GTCATGACAGTCAGTT"	2.13839044150655	-10.418275856134	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATGACAGTCAGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.63312957952	42.9303638456566	0.0178606141333918	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2398.80319188144	2398.80319188144
"healthy-2"	"2019-08-01-count-2:GTGCTGGGTATTGGCT"	2.4550482231075	-10.4735460511413	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGGTATTGGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.36902586921	38.8753170572776	0.0161149959398398	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2408.88593954413	2408.88593954413
"healthy-2"	"2019-08-01-count-4:ACTTTGTCACGCGTGT"	6.90398611602132	-1.3599652281967	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTGTCACGCGTGT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2268.05123586995	33.0164599605647	0.0145571931702419	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2256.55766468909	2256.55766468909
"healthy-2"	"2019-08-01-count-3:TAATTCCCAAGCGCAA"	11.1217380958492	3.81381437862245	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCCAAGCGCAA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.63754843971	41.8245432997035	0.0251102308175526	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1657.38481553185	1657.38481553185
"healthy-2"	"2019-08-01-count-3:CACCGTTGTCGCCACA"	3.195897479623	-10.5213871232239	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCGTTGTCGCCACA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2463.2128047883	41.1500002369926	0.0167058242621182	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2457.46107612274	2457.46107612274
"healthy-2"	"2019-08-01-count-4:TGACTCCAGTCTAGCT"	1.77291526374165	-9.49696543132933	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCAGTCTAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.58488741516	45.8629598285892	0.0217505873737012	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2107.2245514292	2107.2245514292
"healthy-2"	"2019-08-01-count-2:GCATCTCAGCGTCAGA"	-5.15300021591838	2.75340530956117	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCAGCGTCAGA"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2735.37224022666	38.9502515686107	0.014239470224858	3097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2731.22245038324	2731.22245038324
"healthy-2"	"2019-08-01-count-2:TGGAACTTCTAAGCGT"	3.02315415915791	-10.9661779633728	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTTCTAAGCGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.18621332821	41.9093697235067	0.0193025220343786	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2165.0263768747	2165.0263768747
"healthy-2"	"2019-08-01-count-2:TTAGTCTTCAGGCGAA"	1.83426715907399	-9.80660631572875	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTTCAGGCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.55971608963	38.7057864334187	0.0165087654487104	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2340.69970659518	2340.69970659518
"healthy-2"	"2019-08-01-count-4:CCCATTGCAACTCGTA"	2.27450146254842	-10.6072731248108	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGCAACTCGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.06360516681	37.4006023464637	0.0151599667994514	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.92518979731	2455.92518979731
"healthy-2"	"2019-08-01-count-2:CACTTCGCAACTGGTT"	2.36815514144246	-10.9006119004455	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTTCGCAACTGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.65318116117	34.7975929159702	0.0139544637477481	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2487.23262835597	2487.23262835597
"healthy-2"	"2019-08-01-count-4:AGAGAGCTCAGGCGAA"	3.24060811576192	-10.2878589860168	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAGCTCAGGCGAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2449.10029843933	40.9670775932032	0.0167273988816665	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2441.57829002649	2441.57829002649
"healthy-2"	"2019-08-01-count-4:GAGGGTATCACAAGAA"	2.58925046500508	-10.6369619599548	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGTATCACAAGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.21936183361	36.0087260043795	0.0154198473140894	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2331.18116451233	2331.18116451233
"healthy-2"	"2019-08-01-count-2:ATTCTACCATCTCGTC"	2.04409672793691	-9.70923139965209	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTACCATCTCGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.79222262858	39.7631885394741	0.0163783326138274	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.12777651143	2425.12777651143
"healthy-2"	"2019-08-01-count-2:ACACAGTGTCCTTGTC"	2.92556132849995	-10.89018442547	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTGTCCTTGTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.84879885526	44.010937114301	0.0200610621558175	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2187.36407488608	2187.36407488608
"healthy-2"	"2019-08-01-count-2:ATTTACCTCGCAATGT"	3.6270772415096	-10.6367359391418	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCTCGCAATGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.86353798892	42.3834083039576	0.0179297187095731	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.21158804505	2361.21158804505
"healthy-2"	"2019-08-01-count-4:TCCTCCCTCCCTCTTT"	4.27552761611287	-10.7974233857361	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCCCTCCCTCTTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.07641678913	41.0786697277883	0.0163005651154528	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2513.52775908198	2513.52775908198
"healthy-2"	"2019-08-01-count-2:TTGAGTGCATACACCA"	-2.75303540650066	3.42245361888734	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAGTGCATACACCA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3345.64654041088	43.8673166693943	0.0131117606535946	5968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3342.03230456112	3342.03230456112
"healthy-2"	"2019-08-01-count-2:AAGCCATTCTACTCAT"	-3.43211684647258	3.7030823000702	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATTCTACTCAT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3180.12493833482	40.5243458865592	0.0127430043386215	5511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3175.28716921079	3175.28716921079
"healthy-2"	"2019-08-01-count-4:GCTTTCGTCAATGTCG"	-0.496302048594314	12.5202703245911	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTTCGTCAATGTCG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1434.32165677951	35.3629883949256	0.0246548521580063	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1434.32165677951	1434.32165677951
"healthy-2"	"2019-08-01-count-4:ATAGAGACAGGAACCA"	-5.01078114929851	-5.33718588268431	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGACAGGAACCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2336.0621728888	40.8228783677911	0.0174750821453134	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2331.01409837259	2331.01409837259
"healthy-2"	"2019-08-01-count-4:TTCTTCCCAGTGTACT"	1.54919304427449	-9.57915785228881	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCCAGTGTACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2398.23118828309	41.8113916097939	0.0174342623071827	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2387.86691160453	2387.86691160453
"healthy-2"	"2019-08-01-count-4:CATCGCTGTGCATTTG"	1.51643480834309	-9.33274843609007	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTGTGCATTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.01800670684	41.6310025866982	0.0162429614141451	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2558.52994306554	2558.52994306554
"healthy-2"	"2019-08-01-count-2:TCTTTGAAGGGTCTTT"	2.72015204009358	-10.9295025101868	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTTGAAGGGTCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.18124521741	43.8422130933433	0.0177198874084468	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.08374686023	2472.08374686023
"healthy-2"	"2019-08-01-count-3:CCTCAACCACACCTTC"	3.12371911582295	-10.8508491746155	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACCACACCTTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.83577298739	47.306953767199	0.018315896915305	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2579.90195942456	2579.90195942456
"healthy-2"	"2019-08-01-count-4:GGGTCTGGTAGTCGGA"	-2.57057581368144	13.1649093397888	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCTGGTAGTCGGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1702.95089019262	44.4779489041672	0.0261181629842164	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1700.8655290315	1700.8655290315
"healthy-2"	"2019-08-01-count-4:AGCTACAGTGTTTGCA"	2.3938704925472	-10.9587917557922	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTACAGTGTTTGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.37975100869	39.9096583408293	0.0162143441394909	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2458.7483539971	2458.7483539971
"healthy-2"	"2019-08-01-count-4:TCCTGCACAACGGTAG"	2.95368446883504	-11.0338955155578	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTGCACAACGGTAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.43123514942	41.3468579831137	0.0184713549980255	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.18638681911	2230.18638681911
"healthy-2"	"2019-08-01-count-2:CTGAGCGCACAACCGC"	-5.22745738449748	2.89528582179872	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGCGCACAACCGC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2554.93022393987	39.593567463458	0.0154969271146678	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2547.57543669347	2547.57543669347
"healthy-2"	"2019-08-01-count-2:TGAATCGAGCGAGAAA"	2.41170539435689	-10.7732630006042	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGAGCGAGAAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.17386503353	39.804471036885	0.0172226207811966	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2309.27946783216	2309.27946783216
"healthy-2"	"2019-08-01-count-4:CCTCCTCCAATTGTGC"	8.60831226882283	7.9010438689026	"2019-08-01-count-4"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCCAATTGTGC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2119.49834782696	37.6090000548746	0.017744293168916	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2113.50848951786	2113.50848951786
"healthy-2"	"2019-08-01-count-2:ACAGAAAAGATAACAC"	4.47509111937825	-10.6447954407898	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAAAGATAACAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.36274637418	40.1810732652928	0.017713689457085	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2262.02369597935	2262.02369597935
"healthy-2"	"2019-08-01-count-4:ATGAAAGAGAGCCGTA"	1.89701702174489	-4.79788353359374	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGAGAGCCGTA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2346.21739181737	42.6359095166756	0.0181721905503607	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2338.41645566137	2338.41645566137
"healthy-2"	"2019-08-01-count-3:GGGTAGAGTATGGTTC"	2.7336856323177	-10.8976040116516	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTAGAGTATGGTTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.44908065604	38.2860861774065	0.0166646070634453	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.00224942835	2292.00224942835
"healthy-2"	"2019-08-01-count-3:TTCCGGTAGGCATCGA"	1.81705369529073	-4.66620781337889	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGGTAGGCATCGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2348.79852797905	36.6161577567226	0.0155893139920468	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2342.52427277068	2342.52427277068
"healthy-2"	"2019-08-01-count-2:CACATGAGTATGTCAC"	0.953031321137589	-8.85735704815062	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGAGTATGTCAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2421.51545012105	41.4665404861146	0.0171242105781492	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2417.61281407575	2417.61281407575
"healthy-2"	"2019-08-01-count-4:CCCATTGTCGATTGGT"	2.62461127814595	-10.7994070283142	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGTCGATTGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.00851398676	40.566450134003	0.0174328756814483	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2320.61312532988	2320.61312532988
"healthy-2"	"2019-08-01-count-2:CATCCCACAGGAATCG"	2.49360861357991	-10.9389848939148	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCACAGGAATCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.59294283017	42.2794087599827	0.0176414642655396	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.83073024592	2392.83073024592
"healthy-2"	"2019-08-01-count-2:CATCCCACAGTTTGGT"	2.45996822890584	-10.5430183640686	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCACAGTTTGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.24711953932	41.6325256770288	0.0176465302562955	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2354.36247961905	2354.36247961905
"healthy-2"	"2019-08-01-count-2:CAAGCTATCTTGCAAG"	0.918292065232438	10.9022187956604	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTATCTTGCAAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1687.83595975284	31.8977766208375	0.0188986236704594	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1679.15332598555	1679.15332598555
"healthy-2"	"2019-08-01-count-3:CATGCTCGTTGGGTAG"	6.9503022628719	-1.15170779144438	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCGTTGGGTAG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2342.39688583301	39.2613512984676	0.0167611866016059	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2337.46749504239	2337.46749504239
"healthy-2"	"2019-08-01-count-3:CAGCAATCAGTAGAAT"	2.53942122039143	-11.0569458237854	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCAATCAGTAGAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.27747015426	37.7568547944129	0.0151556200570766	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2487.49371914936	2487.49371914936
"healthy-2"	"2019-08-01-count-3:TCTTAGTCACAGTACT"	-5.08037743988689	-4.45028068935546	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTCACAGTACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2873.54300246474	43.9334988992257	0.0152889651769757	3452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2868.87940507888	2868.87940507888
"healthy-2"	"2019-08-01-count-3:CTCATCGGTCTTGTCC"	-2.45953164520915	3.32992432201234	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATCGGTCTTGTCC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2873.28579170656	44.330035627563	0.0154283419197342	4539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2867.91855329798	2867.91855329798
"healthy-2"	"2019-08-01-count-2:CCGTGAGTCGGAACTT"	3.28566112098042	-10.7808618775574	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGTCGGAACTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.62044405323	41.0632171144591	0.0191292397443695	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2143.52010620258	2143.52010620258
"healthy-2"	"2019-08-01-count-3:TTTAGTCTCCGCATAA"	2.41527905043904	-10.6206789246765	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCTCCGCATAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.06388446198	39.8226034034091	0.0169237238590802	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2352.13796465444	2352.13796465444
"healthy-2"	"2019-08-01-count-4:CTCATGCTCCAAATGC"	3.06083097037618	-10.9132509461609	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCTCCAAATGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.81541828158	45.494655309129	0.0188242159351486	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2411.81967998658	2411.81967998658
"healthy-2"	"2019-08-01-count-3:CATCCACTCTTGCGCT"	2.02211465415303	-9.7525844804016	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACTCTTGCGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.09692983063	39.0541511853566	0.0167535509508797	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2326.18472369366	2326.18472369366
"healthy-2"	"2019-08-01-count-4:CAACCAATCAAACTGC"	-2.45320640030559	12.7098645933899	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCAATCAAACTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1827.40639308825	36.3728437425854	0.0199040803841758	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1827.40639308825	1827.40639308825
"healthy-2"	"2019-08-01-count-2:CAGGTATAGCACCTGC"	2.43825735625569	-9.98476126110228	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATAGCACCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.88872635347	44.4907699018676	0.0181751602607133	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2441.76246916803	2441.76246916803
"healthy-2"	"2019-08-01-count-4:AAGGAATCAACTAGAA"	1.85684384879414	-9.44666006481322	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGAATCAACTAGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.6232889987	44.1688053634278	0.019774509686111	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2229.31737991063	2229.31737991063
"healthy-2"	"2019-08-01-count-4:AGGAATATCCTCGATC"	1.16349961337392	11.0532789000305	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAATATCCTCGATC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1843.62418566482	35.7134970863407	0.0193713541859738	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1838.74491496545	1838.74491496545
"healthy-2"	"2019-08-01-count-2:AGCATCACACATATGC"	-1.16170845452006	13.0117940672669	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCATCACACATATGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1777.28082629287	41.1205519656283	0.0231367780247759	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1769.48451442776	1769.48451442776
"healthy-2"	"2019-08-01-count-4:CCTCTCCCAGACCTGC"	1.66327013549153	-9.61019327556761	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCCAGACCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.07490358429	43.1070635713084	0.0171462924632242	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2511.76764641211	2511.76764641211
"healthy-2"	"2019-08-01-count-3:AGGGCCTCATCAACCA"	2.0882212119991	-10.1314735642639	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCCTCATCAACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.29831619624	41.3911640182123	0.0163906037368916	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2521.91677235034	2521.91677235034
"healthy-2"	"2019-08-01-count-4:ATGTCCCAGGGATCAC"	-1.5794212621754	13.222554183844	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCAGGGATCAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1834.2065567335	37.6857225510214	0.0205460624991632	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1830.03241662209	1830.03241662209
"healthy-2"	"2019-08-01-count-3:TGCGATACAGGTGAGT"	4.38584866103475	-10.8377886048523	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGATACAGGTGAGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.42921288995	42.8711764963494	0.0183490157800765	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.16259071173	2333.16259071173
"healthy-2"	"2019-08-01-count-2:TACCTCGAGTCATGAA"	3.00228561934773	-10.9036331406799	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTCGAGTCATGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.93585580085	38.229626559538	0.0159228021303327	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2398.43578727879	2398.43578727879
"healthy-2"	"2019-08-01-count-3:GCAGGCTCACTGTGTA"	0.376619120209855	12.0175380476746	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGGCTCACTGTGTA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1538.49703778396	45.9470489355928	0.0298648926888897	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1532.131943113	1532.131943113
"healthy-2"	"2019-08-01-count-2:ATTACCTCAGACACAG"	-1.45180139961894	13.3902415999207	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACCTCAGACACAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2033.2083786414	40.2089224051113	0.0197760951742581	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2021.59933005362	2021.59933005362
"healthy-2"	"2019-08-01-count-4:CAACGATCAGTGTGCC"	-2.2650240463322	13.2994661101135	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGATCAGTGTGCC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1928.83112220499	41.2379412616584	0.021379757298045	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1928.83112220499	1928.83112220499
"healthy-2"	"2019-08-01-count-3:GGGTTTAAGACCCGCT"	-2.54253898087199	12.8979024657044	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTTTAAGACCCGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.8680576809	39.1381743082163	0.0198987289235677	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1964.94087510969	1964.94087510969
"healthy-2"	"2019-08-01-count-4:TAAGCGTGTTCGGGTC"	2.36034597930257	-10.9572773209778	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCGTGTTCGGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.60850444703	39.96921190699	0.0167472846227249	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2382.71241420556	2382.71241420556
"healthy-2"	"2019-08-01-count-4:GAGACTTGTTCATCTT"	3.05569972571675	-9.80950262462767	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACTTGTTCATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.85617885759	37.1619658681098	0.0151135174914442	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2456.94494171792	2456.94494171792
"healthy-2"	"2019-08-01-count-4:TATACCTAGCTGACAG"	1.56092621859853	-9.38766100322875	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTAGCTGACAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2327.95224503294	41.4511778433247	0.0178058540211757	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2323.41684752877	2323.41684752877
"healthy-2"	"2019-08-01-count-4:GGATGTTAGTAGGCCA"	3.08627333220784	-10.7062015763489	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTAGTAGGCCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.640999072	41.1648741206835	0.0168113145766506	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2447.80598833208	2447.80598833208
"healthy-2"	"2019-08-01-count-2:GGAGAACAGTTGTCGT"	3.27030577239339	-10.7845754853454	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACAGTTGTCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.7988874665	42.0315343711899	0.0177064428638473	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.71920593376	2367.71920593376
"healthy-2"	"2019-08-01-count-4:GGATGTTAGTGCGACA"	3.79411449012105	-10.7844562760559	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTAGTGCGACA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.75040480493	41.7562073952357	0.0196153608713286	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2120.51851095934	2120.51851095934
"healthy-2"	"2019-08-01-count-3:ACCGTTCTCGTCTCAC"	2.31375970420186	-10.6831407777038	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCTCGTCTCAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.99905293093	45.9220513766314	0.0192787865805935	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.10727651541	2378.10727651541
"healthy-2"	"2019-08-01-count-4:GTGAGCCTCTGTCCGT"	3.07156433638875	-10.5438652268616	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGCCTCTGTCCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.47685100702	41.3663171459227	0.0171468244881419	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2409.2771985297	2409.2771985297
"healthy-2"	"2019-08-01-count-2:TGAGACTGTTGAGAGC"	1.79301907595937	-5.16595985805663	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGACTGTTGAGAGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2255.4687586381	39.7790971232638	0.0176367315977736	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2248.77114678517	2248.77114678517
"healthy-2"	"2019-08-01-count-2:CATCAAGAGCTCGACC"	1.18296243724172	-9.02798178112181	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGAGCTCGACC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2439.99113416264	45.5955377853973	0.018686763712789	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2435.85191320355	2435.85191320355
"healthy-2"	"2019-08-01-count-2:ACTATTCAGTAAACAC"	1.53435601767842	-4.637158416864	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCAGTAAACAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2479.59211940828	42.0615893481479	0.0169631081736884	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2477.49110754211	2477.49110754211
"healthy-2"	"2019-08-01-count-1:TAGAGTCAGTTACTCG"	1.43403031405751	10.4366283186707	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAGAGTCAGTTACTCG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1991.63067467636	30.6389555695257	0.0153838540242932	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1979.23169077205	1979.23169077205
"healthy-2"	"2019-08-01-count-3:TCGCTTGTCGCCGTGA"	2.10078134116475	-10.1681843033996	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGTCGCCGTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.16829702647	38.4762324951884	0.0167057841777622	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2298.41930419234	2298.41930419234
"healthy-2"	"2019-08-01-count-3:AGGGTGAAGGTACCTT"	8.00194992598836	8.10487840259401	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTGAAGGTACCTT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1691.12331287231	34.4175760609152	0.0203519020753479	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1686.53219637091	1686.53219637091
"healthy-2"	"2019-08-01-count-3:ATCGTGAAGTAATACG"	3.10026111182515	-10.7757702103821	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTGAAGTAATACG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.89066746372	39.6578238348196	0.0185066949224049	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2137.53587146935	2137.53587146935
"healthy-2"	"2019-08-01-count-2:AGCGCTGAGATCGCCC"	1.89859797534291	-8.99639418041381	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGAGATCGCCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.35501385909	39.9103743773982	0.0160195452496259	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2484.43426749512	2484.43426749512
"healthy-2"	"2019-08-01-count-2:GTAACCATCTGTCCGT"	2.33688582953755	-5.31147386943968	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACCATCTGTCCGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2412.03229576102	39.1089591282736	0.0162141108960294	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2409.68746279751	2409.68746279751
"healthy-2"	"2019-08-01-count-2:TGCGATATCTCCGCAT"	2.2678562599117	-10.8672447434631	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGATATCTCCGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.9497925262	39.9179923584453	0.0162602072270361	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.6221979944	2450.6221979944
"healthy-2"	"2019-08-01-count-3:TTTGGAGGTACAGAGC"	2.91566218909566	-10.7793379059997	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGGTACAGAGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.79268690848	41.8094171585103	0.0185096301226888	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2255.77624413166	2255.77624413166
"healthy-2"	"2019-08-01-count-4:ACCCAAATCCGTTGGG"	2.35897674140279	-10.1324854127136	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCAAATCCGTTGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.94670047754	41.2949405406	0.0179313487941501	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2298.53737588811	2298.53737588811
"healthy-2"	"2019-08-01-count-4:AATGGCTTCACCATGA"	2.82761969146077	-10.8305826417175	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGCTTCACCATGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.79484943169	40.6807315357363	0.0158180313428678	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2561.3645597126	2561.3645597126
"healthy-2"	"2019-08-01-count-4:AGGCATTGTCATATGC"	10.8122641044552	4.16762731159059	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTGTCATATGC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1708.97048693703	38.2301705365198	0.022370293009003	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1702.84584332914	1702.84584332914
"healthy-2"	"2019-08-01-count-4:CAATACGAGCCGTTAT"	2.15974607047383	-10.5960531464783	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATACGAGCCGTTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.9456013175	42.6395673436122	0.0190700378929109	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2231.40516052769	2231.40516052769
"healthy-2"	"2019-08-01-count-4:TATCTTGAGCTGACCC"	4.20176090773885	-10.900209449884	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGAGCTGACCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.96196912727	42.4768291825215	0.0179230003417158	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.03466505285	2367.03466505285
"healthy-2"	"2019-08-01-count-3:GGGACCTAGAGCCGTA"	2.15016974982564	-10.4485731354919	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTAGAGCCGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.51886168131	42.2303441834809	0.0195283125302536	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2159.06061070909	2159.06061070909
"healthy-2"	"2019-08-01-count-3:GGGACAACAGAATGTA"	2.62900628623311	-10.9129429093567	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAACAGAATGTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2107.89844318924	40.818942620757	0.0193647577057831	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2096.61738327229	2096.61738327229
"healthy-2"	"2019-08-01-count-3:TGTGAGTAGTTCGGTT"	2.30636896666829	-10.2666931382385	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGAGTAGTTCGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.66921631516	41.9730883793591	0.017970476335505	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.46296582151	2332.46296582151
"healthy-2"	"2019-08-01-count-2:ATGAAAGCAATATCCG"	1.88971330699269	-9.72016432201537	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGCAATATCCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.88083868824	46.8316589938095	0.020622684464968	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2269.12824874226	2269.12824874226
"healthy-2"	"2019-08-01-count-4:TGAATCGAGGCATTTC"	6.98525013503377	-1.16375448619994	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGAGGCATTTC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2351.76109306349	36.643769235245	0.0155814165577132	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2346.19090985246	2346.19090985246
"healthy-2"	"2019-08-01-count-2:TTAGGGTGTTCAGCTA"	2.11607708510701	-4.69327642833861	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTGTTCAGCTA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2692.82225182229	43.3664041871311	0.016104443640045	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2683.57301756807	2683.57301756807
"healthy-2"	"2019-08-01-count-2:TACTTACTCATGCATG"	2.26569284972493	-10.7861423722473	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACTCATGCATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.80108607894	39.3718141561404	0.0153688021954906	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2556.61502219378	2556.61502219378
"healthy-2"	"2019-08-01-count-4:ACCTGAAAGTGATCGG"	-2.42309008064922	12.4873075255188	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAAAGTGATCGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1599.67398600469	37.741481726825	0.0235932334069439	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1597.4035230829	1597.4035230829
"healthy-2"	"2019-08-01-count-2:TTGTTGTTCCCATACC"	2.96882452544515	-10.826632522699	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTGTTCCCATACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.96676111054	35.5145554163334	0.0143960413152652	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2462.96448993152	2462.96448993152
"healthy-2"	"2019-08-01-count-2:AGACACTCAGTGAGCA"	1.65371229228322	-4.92586567318114	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTCAGTGAGCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2362.79673560041	38.8413761212081	0.016438729382	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2358.4539474986	2358.4539474986
"healthy-2"	"2019-08-01-count-2:CGTCAAAAGCAAGTCG"	2.31606974181477	-10.6403789750305	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCAAAAGCAAGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.7675910023	39.7727834634825	0.0170496124932848	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.7675910023	2332.7675910023
"healthy-2"	"2019-08-01-count-2:CACTGTCTCGGCCTTT"	2.75802650031392	-10.6719703904358	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCTCGGCCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.87511681687	40.3040593217137	0.0158000911357854	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2543.73395237482	2543.73395237482
"healthy-2"	"2019-08-01-count-3:CAGGGCTGTAGACTGG"	-1.73799155178722	12.8685464628967	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGGCTGTAGACTGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1738.47441554142	42.7923046168535	0.0246148601522713	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1730.17059701439	1730.17059701439
"healthy-2"	"2019-08-01-count-2:TAACTTCTCTCATTAC"	1.77479996260945	-5.13420107280882	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCTCTCATTAC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2459.78688648891	37.0865101646059	0.0150771232940196	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2449.8355176099	2449.8355176099
"healthy-2"	"2019-08-01-count-3:TATTGCTCACTTCCTG"	3.03243531760518	-11.0593300095764	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGCTCACTTCCTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.27725562793	41.4451418277791	0.01573302192821	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2628.99323873536	2628.99323873536
"healthy-2"	"2019-08-01-count-2:ATTCTACCAGGCATTT"	-1.82149801674541	12.9110765227112	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTACCAGGCATTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1904.6292029722	40.2926641730295	0.021155122535217	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1897.01870875314	1897.01870875314
"healthy-2"	"2019-08-01-count-3:TAAGTCGGTCCCTAAA"	2.61918153342549	-10.9622287980286	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGGTCCCTAAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.49624625111	42.4897321136719	0.0195041566799993	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2176.28644463607	2176.28644463607
"healthy-2"	"2019-08-01-count-1:CAAAGAAGTTGTGGCC"	2.50479116019551	-10.6228695145813	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAAAGAAGTTGTGGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.38601480794	34.6106825851221	0.0145155534255681	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2375.11363304832	2375.11363304832
"healthy-2"	"2019-08-01-count-3:GATGCTATCAGTCCGG"	1.88181163844411	-4.77133467113646	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGCTATCAGTCCGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2489.1065381022	38.774459342049	0.0155776616020672	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2485.16971617784	2485.16971617784
"healthy-2"	"2019-08-01-count-4:CTGAGGCGTATGCTAC"	2.06430091437642	-10.2199497452942	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAGGCGTATGCTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.25731478	37.3057638089955	0.0163316818852295	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.36765130934	2278.36765130934
"healthy-2"	"2019-08-01-count-4:TATTCCAGTACGTACT"	1.19981696185414	10.7137727507385	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTCCAGTACGTACT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2065.41053840779	38.5142340093009	0.0186472535571505	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2062.66572889376	2062.66572889376
"healthy-2"	"2019-08-01-count-3:CTGTGGGCAAATGAAC"	-6.33589063111003	3.35820314967958	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGCAAATGAAC"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2419.18326009159	39.2305255113512	0.0162164339339327	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2412.97405344328	2412.97405344328
"healthy-2"	"2019-08-01-count-2:TCCCAGTTCCGGACGT"	-3.30398831787761	3.70937154376832	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTTCCGGACGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3201.50927443302	40.0611671018795	0.0125132128842495	5148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3194.55407137022	3194.55407137022
"healthy-2"	"2019-08-01-count-3:TGTTACTGTGGAGGTT"	-4.71481357041057	-5.25821688091429	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTGTGGAGGTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2721.08500123625	45.7197243711274	0.0168020199113059	2923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2717.38638889146	2717.38638889146
"healthy-2"	"2019-08-01-count-3:CTACTATTCTCCATAT"	1.4069615798885	-8.95636560833129	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACTATTCTCCATAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.79399866644	40.8457606583051	0.0162099602903738	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2516.90784728442	2516.90784728442
"healthy-2"	"2019-08-01-count-4:CAGCCAGGTCCACATA"	3.09709372100179	-10.8892536393371	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGGTCCACATA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.22880955831	42.4983858206012	0.0171141642916749	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2477.99932972105	2477.99932972105
"healthy-2"	"2019-08-01-count-2:GTAGCTATCCATCTGC"	2.24807467040364	-10.5281543961731	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTATCCATCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.79880051913	41.3487678361609	0.0177477848417415	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.25592337327	2317.25592337327
"healthy-2"	"2019-08-01-count-4:ATTCACTCACCCTGAG"	2.61884750899617	-10.8644409409729	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTCACCCTGAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.69185501964	40.4763736572927	0.016482676185351	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2448.53704957165	2448.53704957165
"healthy-2"	"2019-08-01-count-3:GACTGATAGTCCTGCG"	2.37068523940389	-10.1754932633606	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATAGTCCTGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.53819905184	38.9873590901775	0.0164120110153307	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2365.46034064547	2365.46034064547
"healthy-2"	"2019-08-01-count-2:GCTCAAAAGAAGCTCG"	1.05806948718373	-8.95968439495238	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGAAGCTCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2458.64398589788	42.504437675078	0.0172877561447985	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2455.48855518113	2455.48855518113
"healthy-2"	"2019-08-01-count-4:AGTGACTTCGCAGATT"	1.88314785537068	-4.5396995774475	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTTCGCAGATT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2464.94199564937	42.6952014186536	0.0173209761097871	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2462.55948817651	2462.55948817651
"healthy-2"	"2019-08-01-count-4:GGTTCTCCACGCGCAT"	4.4214469390804	-10.5759983292786	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTCTCCACGCGCAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.31024990983	36.7287802226124	0.0141792977207618	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2588.49504093671	2588.49504093671
"healthy-2"	"2019-08-01-count-4:TACGTCCAGCGAACTG"	2.19791283187215	-10.014937423822	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCAGCGAACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.32665083411	40.0849159237249	0.0162726757777543	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2458.81255649582	2458.81255649582
"healthy-2"	"2019-08-01-count-4:CCCAACTGTACCCGCA"	-4.53006349030192	-5.40115358745726	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTGTACCCGCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2699.23365754078	44.1607753447423	0.0163604863259509	2962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2695.05109028777	2695.05109028777
"healthy-2"	"2019-08-01-count-3:ATTTCACAGGTGAGCT"	-3.63025818291362	2.86034247958986	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACAGGTGAGCT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2977.82679822944	44.4036595374474	0.0149114312369843	5090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2974.3833555243	2974.3833555243
"healthy-2"	"2019-08-01-count-4:GCATCGGGTCTGTGAT"	2.3362304168636	-4.60456612026366	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATCGGGTCTGTGAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2628.62277421393	44.6250041249939	0.0169765721284746	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2622.85443465367	2622.85443465367
"healthy-2"	"2019-08-01-count-2:GATCCCTAGTAAATGC"	2.36514367636983	-10.7571506730286	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTAGTAAATGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.29368898706	38.9375261017728	0.0152141687643452	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2554.22571182386	2554.22571182386
"healthy-2"	"2019-08-01-count-2:AAAGTGAGTGTGAATA"	2.72163500365559	-10.8460111848083	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTGAGTGTGAATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.74695944491	36.2821937669886	0.0150877387013574	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2399.91786028291	2399.91786028291
"healthy-2"	"2019-08-01-count-2:TGCAGGCTCGTTCTGC"	1.79021133956258	-10.2711019746033	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGGCTCGTTCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.93824999633	40.6611720471251	0.0168513106571156	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2410.60677232617	2410.60677232617
"healthy-2"	"2019-08-01-count-4:AAAGTCCGTGGTCTAT"	2.57497276839558	-10.3514290085998	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCGTGGTCTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.7701528205	43.3505284046358	0.0182239248097322	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2371.35579220126	2371.35579220126
"healthy-2"	"2019-08-01-count-4:TCAAGACAGCTACAAA"	1.33791722831075	9.59051988208619	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACAGCTACAAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.50238269175	38.1303914160422	0.0206165678794896	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1844.28883238241	1844.28883238241
"healthy-2"	"2019-08-01-count-4:CTGCATCGTGAAGCGT"	3.30929936942403	-10.8442497483459	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCATCGTGAAGCGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.48520936763	38.4541037397077	0.0180749100254087	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2117.43426814534	2117.43426814534
"healthy-2"	"2019-08-01-count-2:GTAGTACGTTCCGCTT"	-1.45584819737132	13.1056527861389	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACGTTCCGCTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1797.18249695252	38.1782476626507	0.0212433894317297	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1789.39438357897	1789.39438357897
"healthy-2"	"2019-08-01-count-3:CGGTCAGGTCGAAGCA"	2.09079541739766	-9.65015795147093	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGGTCGAAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.64185360951	43.2595809149868	0.0186412137864794	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.76751671316	2317.76751671316
"healthy-2"	"2019-08-01-count-4:ATGATCGAGCAATAAC"	2.05817212638203	-9.76537611400756	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGATCGAGCAATAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.82505994002	30.0800014299617	0.0125499361353951	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2388.14743874396	2388.14743874396
"healthy-2"	"2019-08-01-count-2:CATCCGTCAATTCACG"	2.43888916549031	-10.9087591401306	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCAATTCACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.34892812203	37.2267303764743	0.0148057137019081	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2509.29580439086	2509.29580439086
"healthy-2"	"2019-08-01-count-2:CACAGGCCACGGAAGT"	1.55974831160848	-9.6688556901184	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCCACGGAAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.68848627631	42.2904339183552	0.0177192935573827	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.61946302722	2378.61946302722
"healthy-2"	"2019-08-01-count-2:GTAGTACTCGTCCTTG"	1.4080648618633	9.93943402850953	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACTCGTCCTTG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.6305620173	35.4054148918023	0.0187466069880733	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1881.34618906293	1881.34618906293
"healthy-2"	"2019-08-01-count-2:AACAAAGTCCTTCTGG"	2.3128248649532	-10.7223434678284	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGTCCTTCTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.25764013158	37.596324942188	0.0155468649486588	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2416.55272976269	2416.55272976269
"healthy-2"	"2019-08-01-count-4:ATAGAGATCGCCTAGG"	4.40189756926839	-10.7494983903137	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGATCGCCTAGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.27774357765	47.0400423339544	0.0197209915954691	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.18602286736	2378.18602286736
"healthy-2"	"2019-08-01-count-4:GTAACACCACTCCACT"	2.48291148719136	-11.0920543900696	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAACACCACTCCACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.60768634736	36.0000119045634	0.0144311316370852	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2488.24171120199	2488.24171120199
"healthy-2"	"2019-08-01-count-4:ACGGTTAAGACAACTA"	2.72076310691182	-11.0510969392029	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTAAGACAACTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2671.64057067971	39.3465604655439	0.0147274902535012	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2665.98297359128	2665.98297359128
"healthy-2"	"2019-08-01-count-4:TGTCCACGTGGAGGTT"	4.16340746459309	-10.6106109849182	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCACGTGGAGGTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.49460857842	41.1301526652332	0.0175059574578549	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.87917762969	2342.87917762969
"healthy-2"	"2019-08-01-count-3:CTGAATGTCGCTACGG"	-2.84116731110271	3.79176638210145	"2019-08-01-count-3"	"Control2"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAATGTCGCTACGG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3184.6193380733	45.0966879887436	0.014160778165728	4791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3173.28325160274	3173.28325160274
"healthy-2"	"2019-08-01-count-2:ATGGAGGTCCATCTGC"	7.82198633727376	7.74230525577394	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGTCCATCTGC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2066.65408111977	40.2310865905142	0.0194667733502434	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2061.11374507646	2061.11374507646
"healthy-2"	"2019-08-01-count-4:GTGTCCTTCTAACGCA"	1.14107038554494	-9.07287504589232	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTCCTTCTAACGCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2324.74406071804	43.326260178125	0.0186370022017576	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2321.39466224198	2321.39466224198
"healthy-2"	"2019-08-01-count-4:TGTCCCACAAGCACCC"	8.89354576644246	7.50209138477174	"2019-08-01-count-4"	"Control2"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCACAAGCACCC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2119.14557758876	39.1778635710098	0.01848757536308	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2114.04520598311	2114.04520598311
"healthy-2"	"2019-08-01-count-2:CTAACCCCAAGTTCCA"	6.94553055342976	-1.16062679206999	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCCAAGTTCCA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2364.49122971543	35.6690925792466	0.0150853139698638	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2357.28707484742	2357.28707484742
"healthy-2"	"2019-08-01-count-4:CATTCCGCACCAGGTC"	-3.144842962653	13.0607108839783	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGCACCAGGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2181.12826251706	38.7765573264695	0.0177782104761325	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2179.38197334165	2179.38197334165
"healthy-2"	"2019-08-01-count-2:GTGAGGATCCGATAAC"	2.68531789359395	-10.97829821026	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGATCCGATAAC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.6547038421	37.4108424540555	0.0147133003932958	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2538.16257343816	2538.16257343816
"healthy-2"	"2019-08-01-count-2:CTTCTAAGTCCTCCAT"	2.53064002570454	-10.8052616349426	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTAAGTCCTCCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2227.49041753636	45.3685233228356	0.0203675503901892	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2222.15670369113	2222.15670369113
"healthy-2"	"2019-08-01-count-3:GCACGGTCACGACAGA"	2.23700942572896	-10.4380283585754	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTCACGACAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.56375883551	40.3711240374532	0.0175103047498646	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.47962131431	2301.47962131431
"healthy-2"	"2019-08-01-count-4:GCCAGTGTCACCTGGG"	2.40575375136678	-10.7670755616394	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGTGTCACCTGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.15618041915	39.9387031153912	0.0167657786016213	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2375.25500799141	2375.25500799141
"healthy-2"	"2019-08-01-count-3:GGAGCAACATCCTTCG"	1.18525840815846	-7.68799164211424	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAACATCCTTCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2064.10692631211	52.159330309949	0.0252696842615323	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2062.96557855533	2062.96557855533
"healthy-2"	"2019-08-01-count-3:GAGATGGTCGCATTGA"	1.86023559150044	-4.6844692460266	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGATGGTCGCATTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2055.02317444691	46.0397538862183	0.0224035205338302	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2050.73785483809	2050.73785483809
"healthy-2"	"2019-08-01-count-3:CCTTCAGTCTGCTTTA"	2.33129086074178	-10.8491268388	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTCAGTCTGCTTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.29843150143	43.4882693884354	0.0189137124579508	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.5633577251	2291.5633577251
"healthy-2"	"2019-08-01-count-4:TGACCCTTCTGGTGCG"	3.27366532859151	-10.2092848054138	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACCCTTCTGGTGCG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2473.47913936026	41.2108862869421	0.0166611012121173	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2468.3202833205	2468.3202833205
"healthy-2"	"2019-08-01-count-3:CACATGATCGCCAACG"	2.98073281821553	-11.0806246033874	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACATGATCGCCAACG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.9074395021	37.9179835373099	0.0161290839869649	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2349.18160465552	2349.18160465552
"healthy-2"	"2019-08-01-count-4:GCTGGGTGTCTGCATA"	2.48384131964986	-10.7565393677917	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTGTCTGCATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.48996827961	43.1368918228223	0.019007306674954	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2264.36120087063	2264.36120087063
"healthy-2"	"2019-08-01-count-2:TCCACCAGTAGTCACT"	-4.82034001770671	-5.38718893444213	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCAGTAGTCACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2714.47624708093	44.5300419137662	0.016404653369744	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2710.76405180454	2710.76405180454
"healthy-2"	"2019-08-01-count-2:GAGAAATGTTCGGCGT"	2.20585097846333	-10.5695066682068	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATGTTCGGCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.33718539895	43.8191850707551	0.0199147591385227	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2198.15907525657	2198.15907525657
"healthy-2"	"2019-08-01-count-1:TGATTTCCAACACAAA"	2.82277121123616	-11.0506420365539	"2019-08-01-count-1"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGATTTCCAACACAAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.75074000978	39.9052597048583	0.0150203250549246	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2647.63255448393	2647.63255448393
"healthy-2"	"2019-08-01-count-4:GGAGAACTCTTGGATG"	1.81891574439351	-5.11233951961669	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGAACTCTTGGATG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2301.80269944349	44.4197943883854	0.0192978287839895	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2296.82731289231	2296.82731289231
"healthy-2"	"2019-08-01-count-4:CTACATTTCTCGGTCT"	4.06143202361409	-10.7944307557312	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTTCTCGGTCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.43614534085	42.4431053175005	0.0163845402612369	2074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2586.16855861534	2586.16855861534
"healthy-2"	"2019-08-01-count-4:GTTACAGCAACGTAAA"	2.32258882102315	-10.890389465448	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACAGCAACGTAAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.32665305906	39.6054903131663	0.0161567575107715	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2448.66351985006	2448.66351985006
"healthy-2"	"2019-08-01-count-4:CAACCAAAGTCAGGGT"	2.72959794577901	-11.0240917435852	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCAAAGTCAGGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.42886026347	38.1802407089992	0.015638481763863	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.49478263225	2433.49478263225
"healthy-2"	"2019-08-01-count-4:GGGTATTTCATCACTT"	0.897257228463334	-8.6684608689514	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTATTTCATCACTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2509.96113220249	43.5292817349874	0.017342611874149	2343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2507.19979287659	2507.19979287659
"healthy-2"	"2019-08-01-count-3:CAACGGCCATGATCTG"	2.38954414901082	-10.9033813706604	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGGCCATGATCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.3363515651	40.2131153558536	0.0171752833927396	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.90903123529	2333.90903123529
"healthy-2"	"2019-08-01-count-2:TCATTACAGGCGTTGA"	2.75040258940999	-10.8866415253845	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACAGGCGTTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.46334145571	34.4898463403599	0.0141324992490103	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.44641766246	2433.44641766246
"healthy-2"	"2019-08-01-count-3:AGTGCCGCACGCTGCA"	1.02060427245442	-8.79819967662963	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGCACGCTGCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2450.49995377326	39.0617370549366	0.0159403133204674	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2447.73800085476	2447.73800085476
"healthy-2"	"2019-08-01-count-2:GATTGGTCAAGTGTCT"	6.97497334060018	-1.06985261356505	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTCAAGTGTCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2190.14535420956	39.0848739957924	0.0178457899703641	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2180.886753968	2180.886753968
"healthy-2"	"2019-08-01-count-2:TGCGGCAGTCTTTCAT"	2.16607226905171	-4.77321150219115	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGCAGTCTTTCAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2371.83218986006	42.5720924095941	0.0179490322256339	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2369.42478586973	2369.42478586973
"healthy-2"	"2019-08-01-count-4:AACAGGGGTACGTAGG"	-5.10023055496867	-5.33428528225096	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGGTACGTAGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2589.21015776718	48.0891001222987	0.0185728840812863	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2583.15575047466	2583.15575047466
"healthy-2"	"2019-08-01-count-4:ACTACGACAGGAGACT"	-5.17570004883464	-5.27776195919188	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTACGACAGGAGACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2820.13946224824	42.7930356653049	0.0151740849125206	3866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2816.30765081922	2816.30765081922
"healthy-2"	"2019-08-01-count-3:CGTGCTTCAATACCTG"	2.83813037452046	-10.8899984589783	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTCAATACCTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.96796197619	38.5519324749962	0.0169834698642326	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.88803595065	2265.88803595065
"healthy-2"	"2019-08-01-count-2:AGTGTTGAGGGAGGCA"	3.18994822081868	-10.740014099237	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGTTGAGGGAGGCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.82445290055	43.5656292368753	0.0188528510602316	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2307.7766851249	2307.7766851249
"healthy-2"	"2019-08-01-count-2:ACTTTCACACTCTCGT"	14.1990562873775	1.89534268462984	"2019-08-01-count-2"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTCACACTCTCGT"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1232.941706457	27.2105010224692	0.0220695762662306	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1222.44401311319	1222.44401311319
"healthy-2"	"2019-08-01-count-4:CACTGAAAGTCAGCGA"	2.19293083724324	-10.4952430955139	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAAGTCAGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.53436016261	39.5774635384932	0.0176800786455733	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2233.63858164165	2233.63858164165
"healthy-2"	"2019-08-01-count-4:GCCGATGTCAGCCCAG"	2.7911135154659	-10.961922668573	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGTCAGCCCAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.61683566571	35.5539850759718	0.0145735939169604	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2432.67426831677	2432.67426831677
"healthy-2"	"2019-08-01-count-3:GTAGTACTCGGTCAGC"	1.67769839343373	-4.68617775356444	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACTCGGTCAGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2223.41043728028	40.6931036838732	0.0183021105782204	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2218.73572056195	2218.73572056195
"healthy-2"	"2019-08-01-count-1:AAAGTCCCAATAACCC"	1.45104291018788	11.1182756193909	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAAGTCCCAATAACCC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2133.82662476986	29.798091610346	0.0139646263967485	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2120.34386897879	2120.34386897879
"healthy-2"	"2019-08-01-count-2:AGGGAGTGTGAGACCA"	2.38159932669942	-10.3817672959534	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGAGTGTGAGACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.55255692073	38.5230544801659	0.0189251092285435	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2024.05560482149	2024.05560482149
"healthy-2"	"2019-08-01-count-2:TTCCTTCCAGGGATAC"	1.87429656562154	-10.1712389222351	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCCAGGGATAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.41729992838	45.0672893251426	0.0185430252354074	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.46634593011	2426.46634593011
"healthy-2"	"2019-08-01-count-2:CTACCCAGTCGGCTAC"	10.0847288566524	5.06672713840333	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAGTCGGCTAC"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1835.39327903554	36.6090111009238	0.0199461398922421	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1829.79174735191	1829.79174735191
"healthy-2"	"2019-08-01-count-3:TTACTGTCAAGCGAAC"	1.97843696650807	-10.0804567567078	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTCAAGCGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.92866971547	39.7461597958112	0.0164926706318258	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2403.50098964366	2403.50098964366
"healthy-2"	"2019-08-01-count-3:AAGAACACAGGCGATA"	0.634230216115159	10.0258016356262	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGAACACAGGCGATA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1971.18483001002	38.4755730761469	0.0195190083093077	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1960.2090450346	1960.2090450346
"healthy-2"	"2019-08-01-count-2:TATCGCCAGGCTTAGG"	1.70692755755727	-4.86356403743895	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCAGGCTTAGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2556.60979885636	38.2350524348005	0.0149553727173791	2507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2550.54988653995	2550.54988653995
"healthy-2"	"2019-08-01-count-2:GGGCTCAGTCCAGGTC"	4.30000795897786	-10.8369684449402	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTCAGTCCAGGTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.65154569929	42.9353418463159	0.0191705454934554	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2232.8475923001	2232.8475923001
"healthy-2"	"2019-08-01-count-3:GGTCTGGAGCAAACAT"	-7.58282218399699	3.43152186954347	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCTGGAGCAAACAT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2318.42951208345	39.4211340508015	0.0170033782978271	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2310.00127532655	2310.00127532655
"healthy-2"	"2019-08-01-count-3:AGTTCCCGTCAGCTTA"	3.13665928420369	-10.9382219544617	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTCAGCTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.37439959417	41.7070425270431	0.0168283865964208	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.81473705845	2472.81473705845
"healthy-2"	"2019-08-01-count-3:CTTTCAATCCGCATAA"	2.26576890525166	-10.8538093796936	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAATCCGCATAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.39467793218	38.063368172698	0.0150484100029084	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2524.86953954643	2524.86953954643
"healthy-2"	"2019-08-01-count-4:GTTGTAGAGACCATGG"	-2.13914809647258	13.0986528166565	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTAGAGACCATGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1783.9125495419	46.1633818621944	0.0258776036269541	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1770.5011190744	1770.5011190744
"healthy-2"	"2019-08-01-count-1:TAGCACACACAGTCGC"	0.74352933940236	11.302237487677	"2019-08-01-count-1"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAGCACACACAGTCGC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.01726303202	38.9547897175038	0.021251730959188	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1828.64523435366	1828.64523435366
"healthy-2"	"2019-08-01-count-2:ACTATTCCAGGACAGT"	1.40932812270467	10.4308480986389	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCCAGGACAGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1894.26324896803	35.2686040176691	0.0186186392186423	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1891.47880743356	1891.47880743356
"healthy-2"	"2019-08-01-count-2:GTAGCTATCCCATTCG"	2.11536206778828	-10.6643715134827	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTATCCCATTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.81905602236	38.366857065658	0.0160542937210971	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2384.3109232755	2384.3109232755
"healthy-2"	"2019-08-01-count-4:TTGGGATGTCCCAAAT"	14.1234384971553	1.81420657718507	"2019-08-01-count-4"	"Control2"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGATGTCCCAAAT"	"Plasma cell"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1221.68820988775	18.8344193358823	0.0154167153152872	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1211.09791816827	1211.09791816827
"healthy-2"	"2019-08-01-count-2:TTCACCGGTGCAGTGA"	1.23656882819478	10.3234901198181	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCACCGGTGCAGTGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1862.95509544426	34.6868782721113	0.0186192777039747	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1857.56557745567	1857.56557745567
"healthy-2"	"2019-08-01-count-4:CAAGAGGTCGCTTGCT"	2.30686845359151	-10.8664140931335	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGAGGTCGCTTGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.25594147367	41.9497165378049	0.0182211350971487	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.91321130402	2294.91321130402
"healthy-2"	"2019-08-01-count-3:TACGTCCAGTCTGGTT"	2.41395105895345	-10.3023472062317	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCAGTCTGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.0742636246	40.2335037175873	0.017230074582354	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.88942461027	2332.88942461027
"healthy-2"	"2019-08-01-count-3:AAGACTCGTGTGACCC"	2.39950909194295	-11.0916500321594	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCGTGTGACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.88581958673	41.7412532284067	0.0182684197479752	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.85654339461	2278.85654339461
"healthy-2"	"2019-08-01-count-3:TTATTGCTCTCTGCTG"	2.62870659407918	-10.7960300675598	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTATTGCTCTCTGCTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.97190096406	42.4937036179564	0.0183560343001399	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2307.94689820544	2307.94689820544
"healthy-2"	"2019-08-01-count-4:TATCCTACAAAGCGTG"	13.8910595374996	1.70169923389284	"2019-08-01-count-4"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCCTACAAAGCGTG"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1114.84780549575	51.9701376784948	0.0466163519561172	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1100.74725129241	1100.74725129241
"healthy-2"	"2019-08-01-count-3:GCTGAATGTTGACTGT"	-0.0794808072155297	11.7934322127136	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATGTTGACTGT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1761.27071069104	41.2529365973449	0.0234222577749897	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1755.76854953954	1755.76854953954
"healthy-2"	"2019-08-01-count-3:GCTGAATGTGTGCTTA"	2.37214817580525	-10.771453880426	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATGTGTGCTTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.24494769026	35.0797981353413	0.0146211824553856	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2394.68552200558	2394.68552200558
"healthy-2"	"2019-08-01-count-4:AATGGCTCAGCTACCG"	2.11714925345723	-10.3646412125793	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGCTCAGCTACCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.95727845844	42.7180766579572	0.017114906984442	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2487.66866502022	2487.66866502022
"healthy-2"	"2019-08-01-count-4:CAAGGGACAGGTGGAT"	2.73000278052632	-10.4776373139587	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGGGACAGGTGGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.12533265384	41.8192897006351	0.0175923789655414	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2376.17770055138	2376.17770055138
"healthy-2"	"2019-08-01-count-4:CGAAGTTCAGTTGAAA"	3.4582699733669	-10.3567829362121	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTCAGTTGAAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2358.82039678981	40.7525277938696	0.0172766556747309	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2351.60325326256	2351.60325326256
"healthy-2"	"2019-08-01-count-3:TCAGGTAGTGTCATTG"	1.85673453387563	-10.0131616822449	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGTAGTGTCATTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.17594353636	42.3501372878158	0.0166393751266457	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2543.00397412602	2543.00397412602
"healthy-2"	"2019-08-01-count-4:AGTTAGCCACTGCATA"	3.13861765441243	-10.8819523087707	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCCACTGCATA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.39599531198	40.7033935348328	0.0162787788858837	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2497.69889637497	2497.69889637497
"healthy-2"	"2019-08-01-count-2:AGCGTATAGGTTGAGC"	3.23759331282918	-10.6644516221252	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATAGGTTGAGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.21429039962	42.6896796346271	0.0182262057786965	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.18988904314	2334.18988904314
"healthy-2"	"2019-08-01-count-4:TACCGGGGTGGCTGCT"	2.86581172522847	-11.0769415131775	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGGGGTGGCTGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.82947805208	41.653540326495	0.0165237437475072	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2512.58745862641	2512.58745862641
"healthy-2"	"2019-08-01-count-3:GCCAACGCAAAGGGCT"	2.52297224578206	-10.9125213853088	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAACGCAAAGGGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.80940320275	37.9895882319217	0.0169459491862457	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2238.5654838535	2238.5654838535
"healthy-2"	"2019-08-01-count-4:AGTTAGCCATTCCTAT"	1.25165321406667	10.6022367247376	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCCATTCCTAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.02279538469	50.9983501387881	0.0280979116452249	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1808.81265851178	1808.81265851178
"healthy-2"	"2019-08-01-count-4:TCAGTCCAGGTTGACG"	2.38988627967183	-10.3491630784241	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTCCAGGTTGACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.52007415927	45.3796626320499	0.0201820135624172	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.65269448918	2241.65269448918
"healthy-2"	"2019-08-01-count-3:CTGTATTCACTCCTGT"	4.3727556663448	-10.7957697144714	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTATTCACTCCTGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.47193035	42.6451452967707	0.0192054421917636	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2210.59361415107	2210.59361415107
"healthy-2"	"2019-08-01-count-4:AGGCCACTCTTCTAAC"	2.02819432792012	-9.77657511150511	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACTCTTCTAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.88294207491	40.094610759348	0.0175708446827207	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2279.63938520632	2279.63938520632
"healthy-2"	"2019-08-01-count-2:ATTCCATCATTAGGAA"	-4.66517720642741	-5.65443041240843	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCATCATTAGGAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1928.73271398883	42.5585527082041	0.0220655523699748	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	1918.93085883718	1918.93085883718
"healthy-2"	"2019-08-01-count-4:CTGAATGAGTGCGACA"	-4.4510477584904	3.60727450931398	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGAGTGCGACA"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2766.3173161376	42.0629568648319	0.0152053983899292	3450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2758.41758325337	2758.41758325337
"healthy-2"	"2019-08-01-count-2:ACCCAAAAGCCAGTAG"	0.204932843416375	11.1943197020325	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCAAAAGCCAGTAG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.75549090154	43.0143107835531	0.0246959524504148	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1735.78483384065	1735.78483384065
"healthy-2"	"2019-08-01-count-3:TCCTAATAGTAGTCAA"	-1.45662568035777	12.4764795073303	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATAGTAGTCAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1892.61604124411	39.2701695569371	0.0207491475825825	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1877.30118740711	1877.30118740711
"healthy-2"	"2019-08-01-count-2:AAAGAACCACCGCTAG"	-2.91746149483379	13.1671390303406	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACCACCGCTAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1697.60392676595	39.0185105852096	0.0229844606094558	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1693.20138764281	1693.20138764281
"healthy-2"	"2019-08-01-count-2:AGACACTTCGACCACG"	2.57364453849141	-11.0256538621155	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTTCGACCACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.47340428866	46.2847921095494	0.0179853392043673	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2570.63891054264	2570.63891054264
"healthy-2"	"2019-08-01-count-3:ACAGCCGAGTGCTACT"	-2.49380193176921	13.2782335051331	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGCCGAGTGCTACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1834.59678560344	42.487456342175	0.0231590160168083	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1831.04268375971	1831.04268375971
"healthy-2"	"2019-08-01-count-3:AAGGAATCAGTGAGCA"	2.72129358825032	-11.0790148011413	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATCAGTGAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.7983651968	41.7277504287144	0.0176752708083292	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2357.03684261128	2357.03684261128
"healthy-2"	"2019-08-01-count-4:TGTAACGCAGCTACAT"	-7.59993873062785	3.67489264095155	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGCAGCTACAT"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2248.33601334699	39.800076394379	0.0177020143600024	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2239.59041015727	2239.59041015727
"healthy-2"	"2019-08-01-count-4:GGTGATTCACGACGAA"	2.80160917815511	-10.6105919114319	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTCACGACGAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.83352403813	43.1926815238473	0.0173197934455175	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2489.4775563839	2489.4775563839
"healthy-2"	"2019-08-01-count-3:TGAGGGAGTTCCCACT"	2.82152690467183	-10.8941498032776	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGGAGTTCCCACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.68802916453	39.4594038462801	0.0175790146931762	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.62872917995	2243.62872917995
"healthy-2"	"2019-08-01-count-2:TGGATGTCACAATGAA"	2.9772592979366	-10.6902437440124	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATGTCACAATGAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.63846091942	43.5405774726612	0.0194843945605174	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2228.2971420692	2228.2971420692
"healthy-2"	"2019-08-01-count-3:TTCAGGATCTCGCGTT"	3.03651322898213	-10.855796836969	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAGGATCTCGCGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.25271329225	39.1987442718829	0.0185227142418646	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2116.25271329225	2116.25271329225
"healthy-2"	"2019-08-01-count-3:GAAGCGATCGTCACCT"	1.78069545802419	-5.09276726162108	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGATCGTCACCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2599.84798356067	40.6485956987622	0.0156349894131469	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2591.29244894719	2591.29244894719
"healthy-2"	"2019-08-01-count-4:ACTTCGCCAAAGGTTA"	-3.53154168549235	-4.61091949855956	"2019-08-01-count-4"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCCAAAGGTTA"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2973.07238497241	39.3107645979776	0.0132222695944695	3669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2966.82780941585	2966.82780941585
"healthy-2"	"2019-08-01-count-3:AAAGAACTCACCATCC"	2.15848722037618	-10.2673921815124	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGAACTCACCATCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.55784376261	45.3169927493672	0.0184774409560281	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2449.06240442998	2449.06240442998
"healthy-2"	"2019-08-01-count-3:ACAGGGATCTCGTGGG"	-3.36506066742595	3.60085222804872	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGGGATCTCGTGGG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3209.47885905732	45.8630405880199	0.0142898715343122	5283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3200.55137923648	3200.55137923648
"healthy-2"	"2019-08-01-count-2:CAGATCATCATTTCGT"	2.74057449874226	-10.918146156427	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCATCATTTCGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.76635576198	44.0002040541041	0.0206790580812371	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2127.76635576198	2127.76635576198
"healthy-2"	"2019-08-01-count-2:CGAGGAACAGCAGTTT"	-2.61946354332622	13.1884536513123	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACAGCAGTTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1922.04050585631	38.7250929830264	0.0201479068027099	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1916.21665595417	1916.21665595417
"healthy-2"	"2019-08-01-count-1:CACAACAAGCGACATG"	1.2075443464214	11.2664870985779	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CACAACAAGCGACATG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2106.92264681645	32.9874801592092	0.0156567115594173	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2104.69674925542	2104.69674925542
"healthy-2"	"2019-08-01-count-3:CCGATCTGTCAAGTTC"	11.6606117683345	-2.7164082757202	"2019-08-01-count-3"	"Control2"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATCTGTCAAGTTC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1793.45358461766	50.3186767866985	0.0280568603605237	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	1789.4857701871	1789.4857701871
"healthy-2"	"2019-08-01-count-4:GACCTTCCATCCAATG"	10.0395523506099	4.79640672290651	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCCATCCAATG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1636.38596391868	30.9020716479657	0.0188843416708147	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1629.84973927371	1629.84973927371
"healthy-2"	"2019-08-01-count-3:ACGTCCTGTGGAGGTT"	14.2667566734249	2.06638953769533	"2019-08-01-count-3"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTGTGGAGGTT"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1376.4414123354	33.7349321780496	0.0245088035536593	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1361.06796665317	1361.06796665317
"healthy-2"	"2019-08-01-count-3:AAGTACCAGGAACTAT"	2.34666051444356	-10.3349008790222	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCAGGAACTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.1043610208	44.0517054888768	0.0185785603590691	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2363.91480821181	2363.91480821181
"healthy-2"	"2019-08-01-count-2:CTTAGGATCTTCACGC"	2.18412913855855	-10.8163423768249	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTAGGATCTTCACGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.79995829383	40.0477981323362	0.0176049757633956	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2269.11485363985	2269.11485363985
"healthy-2"	"2019-08-01-count-3:GGGCGTTTCGTTTACT"	4.41092409667317	-10.8658743134704	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCGTTTCGTTTACT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.73332381261	37.6600896054199	0.0172615457601428	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2174.62906912906	2174.62906912906
"healthy-2"	"2019-08-01-count-2:CTCAAGAAGTTGTACC"	3.13620581206624	-10.9692716828552	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAAGAAGTTGTACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.51416787951	43.1253104353136	0.0193082770888607	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2225.42464691334	2225.42464691334
"healthy-2"	"2019-08-01-count-3:TGATGCATCACGGGAA"	3.43007459220235	-10.7899790040222	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGCATCACGGGAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1837.40790340608	19.5869485424587	0.0106600981230948	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1831.66505848321	1831.66505848321
"healthy-2"	"2019-08-01-count-4:CCCATTGAGCGATCGA"	1.43268110331838	-9.39857199108275	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGAGCGATCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.98919800026	43.010184211128	0.0174838914927314	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2453.90235833636	2453.90235833636
"healthy-2"	"2019-08-01-count-4:GGTTCTCCACTTTAGG"	2.41234840926473	-10.9622669450012	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTCTCCACTTTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.70689069245	36.9716484681048	0.0155952001545437	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2363.93652787463	2363.93652787463
"healthy-2"	"2019-08-01-count-3:CACCGTTGTACATTGC"	4.5064660507137	-10.8542146912781	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCGTTGTACATTGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.83902784125	48.6428677788781	0.0211138309539176	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2298.83764998396	2298.83764998396
"healthy-2"	"2019-08-01-count-2:TTGACCCCACGTCGGT"	1.88783933696095	-10.3811722031799	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCCACGTCGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.58824832767	40.9893370012635	0.0165842093758933	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2466.94972629619	2466.94972629619
"healthy-2"	"2019-08-01-count-2:TCAAGCACATCGGTTA"	2.50186171111409	-10.9711599580017	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCACATCGGTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.79949644735	45.224431834578	0.0197159481047153	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2289.5567245698	2289.5567245698
"healthy-2"	"2019-08-01-count-4:ATAGAGACAACACGTT"	2.7167190509731	-11.0216722718445	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGACAACACGTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.89715184224	42.316689370503	0.0174006903780642	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.18040791119	2425.18040791119
"healthy-2"	"2019-08-01-count-2:AGTAGCTTCAGCTGTA"	2.78721036490743	-11.0423860779968	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTTCAGCTGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.80947213549	36.9450684352432	0.016305461200329	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.08465301157	2261.08465301157
"healthy-2"	"2019-08-01-count-4:TTCTCTCGTCGGCACT"	14.1318432289058	1.74917481029359	"2019-08-01-count-4"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTCTCGTCGGCACT"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1359.0651255162	28.0566704522464	0.0206440956547907	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1345.05251649602	1345.05251649602
"healthy-2"	"2019-08-01-count-2:GCATTAGGTGCCGGTT"	1.85069992121999	-5.16723396694335	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATTAGGTGCCGGTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2592.8064853643	35.9134951015859	0.0138512053654246	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2583.63836041936	2583.63836041936
"healthy-2"	"2019-08-01-count-4:CTTTCAATCTATCCAT"	4.47392906722371	-10.8279180756775	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAATCTATCCAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.52341498688	42.2716674760906	0.0171034865458942	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2465.91461282528	2465.91461282528
"healthy-2"	"2019-08-01-count-4:CTTTCAATCGCGTCGA"	1.8906133371288	-4.58382131969603	"2019-08-01-count-4"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAATCGCGTCGA"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2265.78651645643	38.9524032264644	0.0171915592857282	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2261.94233956507	2261.94233956507
"healthy-2"	"2019-08-01-count-4:GTCCCATCACATATCG"	-2.8739107650822	3.69374034488527	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCCATCACATATCG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3098.75958007172	43.6903847923044	0.0140993141492097	4574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3093.62463101023	3093.62463101023
"healthy-2"	"2019-08-01-count-4:TGCTTCGCACCGCTGA"	-1.57847390595134	13.6563768156799	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGCACCGCTGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1867.31323602715	44.2466232155695	0.0236953406433874	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1861.41256701204	1861.41256701204
"healthy-2"	"2019-08-01-count-2:GAATCACTCCACTGAA"	1.61905982074086	-9.82473471080931	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCACTCCACTGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.32116687573	42.5557652326782	0.0167719269394179	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2533.15088670248	2533.15088670248
"healthy-2"	"2019-08-01-count-2:TCAAGTGCAATCTAGC"	-1.51784263077434	13.1047162779602	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGCAATCTAGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2041.08497459592	39.4058611161685	0.0193063305088363	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2035.75255263337	2035.75255263337
"healthy-2"	"2019-08-01-count-2:TCAAGTGAGTCTCGTA"	3.4483925300533	-10.614790939447	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGAGTCTCGTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.62059448688	39.8011251889124	0.01763749089508	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2254.57894675069	2254.57894675069
"healthy-2"	"2019-08-01-count-4:TGAGCGCGTACTCGAT"	-3.62300453606303	3.72113869273988	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCGCGTACTCGAT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2717.62248309912	47.7872487709528	0.0175842115923538	3337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2713.55539868835	2713.55539868835
"healthy-2"	"2019-08-01-count-3:AATCGACCATAAGCAA"	1.76257850703542	-5.19603826915892	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACCATAAGCAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2418.46831326413	41.4092207077513	0.0171220852804404	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2412.58711085782	2412.58711085782
"healthy-2"	"2019-08-01-count-2:ACTGCAATCTACTATC"	-7.77993331375774	3.29958555782167	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAATCTACTATC"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2381.04179947411	39.4268106789398	0.0165586386125804	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2374.71271892009	2374.71271892009
"healthy-2"	"2019-08-01-count-2:GTTATGGTCGGTTAGT"	3.11535038527791	-10.8888273469177	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTATGGTCGGTTAGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.18225030765	41.6480541571444	0.0190593046192284	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2183.47247069933	2183.47247069933
"healthy-2"	"2019-08-01-count-3:GCCGATGTCGACCATA"	2.03418590602223	-9.47534944927367	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGTCGACCATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.90616657774	40.6520481602165	0.0181085734296809	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.75530688594	2241.75530688594
"healthy-2"	"2019-08-01-count-4:TCATTACTCAGGAACG"	-1.75509736958202	13.1148833998474	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTACTCAGGAACG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1771.25790644852	40.1767803740623	0.0226826258490042	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1767.04810459208	1767.04810459208
"healthy-2"	"2019-08-01-count-4:GCCAGGTCATAGGTAA"	-5.16627011719401	-5.28166487133177	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTCATAGGTAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2760.14031805379	40.1099489936527	0.0145318514175883	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2755.41313070986	2755.41313070986
"healthy-2"	"2019-08-01-count-3:GCCGTGACAGAGTGTG"	-1.29524300518687	13.215115524176	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGTGACAGAGTGTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1746.9143087856	41.4954840782739	0.0237535887533718	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1743.01752839888	1743.01752839888
"healthy-2"	"2019-08-01-count-2:CTCAGTCAGTGGGAAA"	-2.53788862648662	3.33063647830812	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCAGTGGGAAA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2988.29727975508	39.9221998928412	0.0133595141833122	5180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2984.27816915038	2984.27816915038
"healthy-2"	"2019-08-01-count-4:GCAGCTGTCATAAGGA"	2.60991825637166	-10.7366647950378	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCTGTCATAAGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.03472132573	43.0203763597873	0.0179623184485501	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2391.27978962982	2391.27978962982
"healthy-2"	"2019-08-01-count-4:CAGCAGCTCAAGTGTC"	2.37007917937581	-10.9295101395813	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCTCAAGTGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.89962015049	38.4216644329198	0.0161442373903527	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.10674839061	2377.10674839061
"healthy-2"	"2019-08-01-count-4:TATCAGGCATGTCGTA"	3.04459728774373	-10.9883661500183	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCAGGCATGTCGTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.36670490025	41.7582314507062	0.017774250126048	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2347.45889786336	2347.45889786336
"healthy-2"	"2019-08-01-count-1:CACGGGTCAAATGAGT"	2.20020713385884	-10.5592832795349	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CACGGGTCAAATGAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.19564383568	42.5341081565374	0.0207160522107271	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2047.06705891966	2047.06705891966
"healthy-2"	"2019-08-01-count-3:TGATCAGAGCTACAAA"	-2.42085180702861	3.39228627765504	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGAGCTACAAA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2912.4064674599	47.2770236759412	0.0162329757896653	4581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2908.25821929769	2908.25821929769
"healthy-2"	"2019-08-01-count-2:CAACCAAAGAATCGCG"	-2.48299322548564	13.2699613341126	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCAAAGAATCGCG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2055.56414757279	44.7139616471417	0.0217526471747135	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2046.36682572714	2046.36682572714
"healthy-2"	"2019-08-01-count-4:CTGTACCGTGTGTCGC"	3.01190247115437	-10.7591696015564	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTACCGTGTGTCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.53640968	36.9627996138085	0.0162793247693473	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2267.36484251055	2267.36484251055
"healthy-2"	"2019-08-01-count-2:ACTTATCCATCCTATT"	-8.31137690964397	-0.502038501855455	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCCATCCTATT"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2928.98701777683	43.3476793670329	0.0147995464315628	4591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2917.23541236469	2917.23541236469
"healthy-2"	"2019-08-01-count-2:AGATCGTCAGTCTACA"	1.28096391734425	9.91966435993043	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCGTCAGTCTACA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1701.79414253959	34.7577752464478	0.0204241948997302	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1693.35666016146	1693.35666016146
"healthy-2"	"2019-08-01-count-3:ATGGTTGAGAGAGTTT"	2.43296041068379	-10.9525461426941	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGTTGAGAGAGTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.34841513207	42.5425812661076	0.0193169168755509	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2189.98015881796	2189.98015881796
"healthy-2"	"2019-08-01-count-3:CGAGTGCCAAGTGATA"	2.87791027602498	-10.8716945878235	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTGCCAAGTGATA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.88563658331	43.3681994012616	0.0218492182128506	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1980.74559723414	1980.74559723414
"healthy-2"	"2019-08-01-count-4:TAAGCGTAGGGCATGT"	0.696688910096329	-8.58074667369994	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCGTAGGGCATGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2390.8165400115	37.9701509125963	0.0158816664838757	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2388.10862112672	2388.10862112672
"healthy-2"	"2019-08-01-count-4:AGACACTGTATGACAA"	-7.66674313965495	3.75827858531801	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTGTATGACAA"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2310.42891287561	40.3045503917781	0.0174446182555836	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2304.14138043997	2304.14138043997
"healthy-2"	"2019-08-01-count-2:CAACCTCGTGGTAATA"	-8.57126841965373	-0.796133302804552	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCGTGGTAATA"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2805.07754877086	43.4061408744418	0.015474132219076	3640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2793.56986469904	2793.56986469904
"healthy-2"	"2019-08-01-count-4:TGATCTTAGCGAAACC"	-2.37801084938701	13.2362499007019	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTAGCGAAACC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2035.00259308819	39.3731357726453	0.0193479536126267	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2026.38070642474	2026.38070642474
"healthy-2"	"2019-08-01-count-3:TTACCGCAGTTGCATC"	3.0544716316158	-10.9403343430725	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCAGTTGCATC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.66724728926	40.6966692875125	0.0162483337184041	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2498.46857014956	2498.46857014956
"healthy-2"	"2019-08-01-count-2:CCGTTCAAGTGAGCCA"	2.71269406852071	-11.0430612794128	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTTCAAGTGAGCCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.97180538972	40.0490767787389	0.0150110569751275	2392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2662.14640943693	2662.14640943693
"healthy-2"	"2019-08-01-count-2:GGGATCCCAATTGAGA"	1.56043042716328	-9.61688139354857	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCCAATTGAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.60733178215	40.4467436052785	0.0172362640555465	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.76928977561	2344.76928977561
"healthy-2"	"2019-08-01-count-2:AGTGACTTCCTGCTAC"	2.46496929702107	-10.7857275239197	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGACTTCCTGCTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.96583266792	40.4509821561531	0.0173463013863606	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.30879233028	2328.30879233028
"healthy-2"	"2019-08-01-count-4:GAACTGTTCCGGTAGC"	1.78997923907582	-5.09231426632079	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTTCCGGTAGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2622.29544962907	37.8971755180897	0.0144519091178114	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2616.86289858511	2616.86289858511
"healthy-2"	"2019-08-01-count-1:CTTACCGTCGAGCTGC"	1.45522572573964	9.70231435382692	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTTACCGTCGAGCTGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.25210397851	32.2514045765912	0.0178356792759326	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1803.80995459924	1803.80995459924
"healthy-2"	"2019-08-01-count-3:GCGTGCACATAGACTC"	2.55962004241292	-10.7891979447571	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTGCACATAGACTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.19472106327	45.8226503383978	0.0191710951139637	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.73582151863	2386.73582151863
"healthy-2"	"2019-08-01-count-4:GCCCGAACACCGTCGA"	11.1530300575191	3.76787636363832	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCGAACACCGTCGA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1792.90783795519	35.4852603549218	0.0197920158547541	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1785.3884219469	1785.3884219469
"healthy-2"	"2019-08-01-count-2:ACTTTCAAGCACTTTG"	-6.29036698761638	4.22341582858888	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	67	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTCAAGCACTTTG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2335.8317991766	36.4372704773496	0.0155992698148017	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2331.4445244036	2331.4445244036
"healthy-2"	"2019-08-01-count-2:TCATTCACAAGATTGA"	2.51729645308797	-10.9344578019348	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCACAAGATTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.5470646348	37.0402714541275	0.0155661016353178	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2375.06650092403	2375.06650092403
"healthy-2"	"2019-08-01-count-2:GAGGGATGTGGCATCC"	1.84624316272084	-10.1088533631531	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGATGTGGCATCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2337.38837201639	45.2008641494331	0.0193381915862103	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2335.02547510178	2335.02547510178
"healthy-2"	"2019-08-01-count-2:AGCCAATCACTATCGA"	1.49828102168385	-9.65336897289427	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATCACTATCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.82794212945	37.4440572020381	0.0146619341829333	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2551.23807671686	2551.23807671686
"healthy-2"	"2019-08-01-count-3:ACCCTTGTCATACGGT"	-1.5079701942509	11.8618039854797	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGTCATACGGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1661.41259471086	51.5615280892455	0.031034752146091	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1653.2766866523	1653.2766866523
"healthy-2"	"2019-08-01-count-3:CTGCGAGCACATATGC"	-2.63359866562541	12.8614463576111	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGCACATATGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1854.63710145063	43.5214105977782	0.0234662676400344	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1850.63731476755	1850.63731476755
"healthy-2"	"2019-08-01-count-3:TTCTTCCTCCGCTAGG"	10.7632986503536	4.26934287631837	"2019-08-01-count-3"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTCCTCCGCTAGG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1515.02498458587	46.2325857453978	0.0305160549930043	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1508.13872929366	1508.13872929366
"healthy-2"	"2019-08-01-count-4:GTAGATCGTTTCGTAG"	2.3827609020168	-10.7589235535828	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGATCGTTTCGTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.17466244706	39.1192401231993	0.0168750184172512	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2312.39147026322	2312.39147026322
"healthy-2"	"2019-08-01-count-2:GCCCGAAAGGTTAGTA"	10.338884015649	4.64896104419557	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAAAGGTTAGTA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1338.43386914395	42.6566380347072	0.0318705608234421	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1331.26084427504	1331.26084427504
"healthy-2"	"2019-08-01-count-2:TCACATTAGGAATCGC"	-3.344869474799	3.67496750438539	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTAGGAATCGC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3224.70212339874	43.9293984460469	0.0136227771635994	4856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3219.93158094361	3219.93158094361
"healthy-2"	"2019-08-01-count-3:TGCGGCAAGTTGAAGT"	4.49143423613851	-10.7003765336243	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAAGTTGAAGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.45657075628	41.1294546484614	0.0172562215536451	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2379.48527261076	2379.48527261076
"healthy-2"	"2019-08-01-count-4:CCGCAAGAGGGTATAT"	2.33971895751302	-10.8529367676941	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGAGGGTATAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.97141806821	39.7149562096453	0.0172376080268152	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2299.07387558013	2299.07387558013
"healthy-2"	"2019-08-01-count-4:AGAGCAGCACTAAACC"	-0.755495826632339	12.3768167265686	"2019-08-01-count-4"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGCACTAAACC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.10494577996	31.1044226502084	0.0166859825787298	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1852.65578944746	1852.65578944746
"healthy-2"	"2019-08-01-count-2:TCACATTGTCACCACG"	-7.54435239258464	0.374908901098646	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTGTCACCACG"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2606.26011336853	41.9133867668567	0.0160818126141234	3512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2600.51991973228	2600.51991973228
"healthy-2"	"2019-08-01-count-2:TTGGGCGCACAACCGC"	1.23003019866292	10.6826944121155	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGCGCACAACCGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.27776237697	36.582762982986	0.0191304650938959	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1904.41486645122	1904.41486645122
"healthy-2"	"2019-08-01-count-2:TCACGGGAGCTCTTCC"	2.75838913497273	-10.9619121781555	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGAGCTCTTCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.58376228348	39.9637531610474	0.0182684447791529	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2182.9383572428	2182.9383572428
"healthy-2"	"2019-08-01-count-2:AATCGACCAACTCCAA"	8.10595764693562	6.28220031345216	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACCAACTCCAA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1497.72698290501	48.0183156636368	0.0320607935970412	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1493.33179754532	1493.33179754532
"healthy-2"	"2019-08-01-count-2:AATTTCCGTGTCCGGT"	3.46313514289204	-10.5989141694275	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCGTGTCCGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.84916148755	45.4239484340183	0.0202889722163495	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2233.74512863351	2233.74512863351
"healthy-2"	"2019-08-01-count-4:ACGATGTGTCGGTACC"	4.56714405593221	-10.6550674668518	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATGTGTCGGTACC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.0571131123	40.5683084963808	0.0169808868418098	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2384.96149723732	2384.96149723732
"healthy-2"	"2019-08-01-count-4:TTCGGTCCACTGGAAG"	3.1974216895992	-10.7620706788269	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCCACTGGAAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.77636096143	42.5366240256417	0.0193985236173339	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2190.72055116074	2190.72055116074
"healthy-2"	"2019-08-01-count-2:GGGACTCCATACCACA"	-3.38732920113261	3.64372489536134	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCCATACCACA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3238.52222075748	44.6321645402233	0.0137816452992513	5397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3232.11567820801	3232.11567820801
"healthy-2"	"2019-08-01-count-2:CAACCAAAGCAATTAG"	2.66132392463033	-10.9515428773132	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCAAAGCAATTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.76312619189	47.2367322203067	0.0209497537331497	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.28083712942	2248.28083712942
"healthy-2"	"2019-08-01-count-4:AGGATCTCATGGAAGC"	-0.437710265547591	10.6833944090637	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTCATGGAAGC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1508.4772438844	45.7709872327625	0.0303425109117988	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1506.11152910702	1506.11152910702
"healthy-2"	"2019-08-01-count-2:AGAACCTCAATTCTCT"	0.481367905705613	8.95250890338746	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCAATTCTCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1994.844219829	37.728835975961	0.0189131740719058	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1988.11759160412	1988.11759160412
"healthy-2"	"2019-08-01-count-2:AATGAAGGTGTCGCTG"	1.44043018397633	-9.18184854900511	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGAAGGTGTCGCTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2502.98589457867	41.8602253771133	0.016724115572437	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2501.16270989344	2501.16270989344
"healthy-2"	"2019-08-01-count-4:AGATCCACACCCTCTA"	-1.12885711613353	10.9258079298767	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCACACCCTCTA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2071.27065588893	43.2528911099484	0.0208822980169076	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2065.64944113459	2065.64944113459
"healthy-2"	"2019-08-01-count-2:TCAGCAACACGACGAA"	2.3953923183376	-10.6116132966247	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAACACGACGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.21063949143	43.8012759600366	0.0186928461410295	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2336.78591408916	2336.78591408916
"healthy-2"	"2019-08-01-count-2:TACTGCCCAGCTACTA"	1.53582539138142	-9.18523790752562	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTGCCCAGCTACTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.61135197225	43.0358777824864	0.0191815207855209	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.44916034944	2241.44916034944
"healthy-2"	"2019-08-01-count-3:TACGTCCCAGACCAAG"	8.0381199317867	7.22016284549562	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCCAGACCAAG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1529.21812818223	45.5025674652617	0.0297554460195619	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1517.89800627098	1517.89800627098
"healthy-2"	"2019-08-01-count-3:TATGTTCAGCAACTCT"	1.77834703502004	-10.1319656602112	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCAGCAACTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.93593254952	41.7629915078836	0.0168948519085645	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2468.36625674688	2468.36625674688
"healthy-2"	"2019-08-01-count-2:ATCTTCACATTGACAC"	2.51444305953328	-10.9695034257141	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTTCACATTGACAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.21279195667	40.0447155163991	0.0163100793738068	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2446.40966867028	2446.40966867028
"healthy-2"	"2019-08-01-count-2:CGTAATGCAATTCACG"	3.83269943770711	-10.4316959611145	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAATGCAATTCACG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.45509332857	40.5955860159	0.0175324436793728	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2313.44429348854	2313.44429348854
"healthy-2"	"2019-08-01-count-2:TGTGATGAGGTCACAG"	3.04755749282185	-10.8248310319153	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGAGGTCACAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2288.52366285621	43.1154598480764	0.0188398575675053	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2287.51636068298	2287.51636068298
"healthy-2"	"2019-08-01-count-3:AAAGGTAGTTAAGAAC"	2.54447354850118	-10.6708488694397	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGTAGTTAAGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2057.96984539217	41.1466334243749	0.0199937980221153	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2052.51159358306	2052.51159358306
"healthy-2"	"2019-08-01-count-4:AACCTTTCAGCGTTGC"	2.29875673827474	-10.797390007135	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTCAGCGTTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.65525930008	40.8379730642646	0.0179692775211501	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2269.62974462866	2269.62974462866
"healthy-2"	"2019-08-01-count-2:CTGTAGAGTTAGGCCC"	2.52168645438496	-10.5907478562561	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTAGAGTTAGGCCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.84158995948	38.4367164232871	0.016800427351252	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2284.80921523517	2284.80921523517
"healthy-2"	"2019-08-01-count-4:ATCGGCGAGGTACAAT"	1.93799080428426	-5.01116659557494	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGCGAGGTACAAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2449.50037966822	39.4883792277934	0.016120993307681	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2445.50098943659	2445.50098943659
"healthy-2"	"2019-08-01-count-4:CAGATACGTAGCGTCC"	2.90803088721578	-10.9401417008606	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATACGTAGCGTCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.3626955975	41.1997516703018	0.0194030684233663	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2117.15919355876	2117.15919355876
"healthy-2"	"2019-08-01-count-2:GTACAGTAGATTGAGT"	1.40760411795918	9.85347554767457	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAGTAGATTGAGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1621.47912135431	35.8696346259509	0.0221215519543609	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1617.12573227405	1617.12573227405
"healthy-2"	"2019-08-01-count-4:GTCAAACGTTTAGACC"	2.54764356192891	-10.7104568711487	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACGTTTAGACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.84447026668	43.9115375703368	0.0196397997062377	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2232.58964602954	2232.58964602954
"healthy-2"	"2019-08-01-count-2:GACTCTCGTCCTCCAT"	-1.74163077297862	12.926279044989	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCTCGTCCTCCAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1724.29340517865	39.982819906412	0.0231879445727333	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1720.19759923856	1720.19759923856
"healthy-2"	"2019-08-01-count-4:CTCAACCAGAGAGAAC"	-5.03685555878337	3.61538193309633	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCAGAGAGAAC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3012.71229615129	40.1846975647777	0.0133383787147924	3782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3004.41404241156	3004.41404241156
"healthy-2"	"2019-08-01-count-3:ACACTGAGTGGATTTC"	1.34374775466267	10.4991941221985	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACTGAGTGGATTTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1616.49335972755	36.7512625580993	0.0227351769414589	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1611.60591514882	1611.60591514882
"healthy-2"	"2019-08-01-count-3:CAGGCCACAGCACAAG"	-5.16144977036174	3.24110219562379	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGCCACAGCACAAG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2523.10186038841	40.9263984962885	0.0162206683522433	2865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2513.52312461198	2513.52312461198
"healthy-2"	"2019-08-01-count-4:TGGTTAGTCGATGCAT"	2.25960959967915	-10.3133030167786	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTTAGTCGATGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.70207208774	41.6648061263515	0.0178153543470194	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.56702331418	2333.56702331418
"healthy-2"	"2019-08-01-count-3:TGGAACTGTACCATAC"	4.59242119368855	-10.6024275056091	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAACTGTACCATAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.8802655788	38.7721613866152	0.0162711328582838	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.1911319823	2377.1911319823
"healthy-2"	"2019-08-01-count-4:CATCGTCAGCATCTTG"	1.77509238299672	-5.35941793834838	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCAGCATCTTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2631.56610861602	38.3739605908943	0.0145821761669805	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2625.64046980396	2625.64046980396
"healthy-2"	"2019-08-01-count-2:CACTTCGTCCGAGATT"	-7.48705182495769	3.95149467075197	"2019-08-01-count-2"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTTCGTCCGAGATT"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2370.39363566622	38.3053322876218	0.0161599034486337	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2357.95177377291	2357.95177377291
"healthy-2"	"2019-08-01-count-3:TCTACATAGGCACCAA"	4.33901943740193	-10.7119302979675	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACATAGGCACCAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.3674578908	41.7386840945727	0.017841867447453	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2336.2772507557	2336.2772507557
"healthy-2"	"2019-08-01-count-2:AATTTCCCAGCAGACA"	13.9329515891964	1.9444130429062	"2019-08-01-count-2"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCCAGCAGACA"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1130.53162778408	41.6785615753608	0.0368663384120034	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1109.5963230966	1109.5963230966
"healthy-2"	"2019-08-01-count-2:CTCCTTTTCCACCCTA"	3.33785309371297	-10.3716345063415	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTTCCACCCTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2721.83217843271	43.2145956889959	0.0158770243189203	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2715.40828116436	2715.40828116436
"healthy-2"	"2019-08-01-count-2:TCAGGTATCCGAGCTG"	-3.77255640450175	3.3835251101288	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTATCCGAGCTG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2951.66199707377	41.9424950946977	0.0142097893106591	4698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2943.65100562074	2943.65100562074
"healthy-2"	"2019-08-01-count-3:GTCCCATCAACCAGAG"	4.17966141280476	-10.790626548883	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATCAACCAGAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.86854460191	44.1713826738724	0.019659086322604	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2244.61962306577	2244.61962306577
"healthy-2"	"2019-08-01-count-2:GTAGCTAAGACTAAGT"	0.245012139051598	11.0149125822815	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTAAGACTAAGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.54861636837	36.2376308324201	0.0208436108666989	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1734.21570727144	1734.21570727144
"healthy-2"	"2019-08-01-count-4:TGCGACGAGCTCAGAG"	1.71303274211232	-4.71892979061278	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGACGAGCTCAGAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2056.41126568149	38.8950042510417	0.0189140202157723	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2046.639688224	2046.639688224
"healthy-2"	"2019-08-01-count-2:TCAGTCCGTAATACCC"	2.8156279521877	-10.9812937012878	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTCCGTAATACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.57589351896	42.6152130722458	0.0171588124942962	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2480.01189234189	2480.01189234189
"healthy-2"	"2019-08-01-count-4:ATTCCTACAGCCGGTT"	3.30651654776875	-10.6500311127869	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCTACAGCCGGTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.12826294516	42.4424427757775	0.0191516183812271	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.26583261356	2214.26583261356
"healthy-2"	"2019-08-01-count-3:ATCACAGGTAGGAGTC"	-2.54492316666301	13.2830171355042	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGGTAGGAGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1760.12199688105	47.9661849718655	0.0272516252037426	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1758.09333704446	1758.09333704446
"healthy-2"	"2019-08-01-count-2:CTCCATGGTTTCTATC"	1.66561104831044	-9.47562982952269	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGGTTTCTATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.02347607587	40.3211171491518	0.0157257207374956	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2561.68777187972	2561.68777187972
"healthy-2"	"2019-08-01-count-3:CGGAACCTCCGCTAGG"	1.22776903685872	-8.91106893932494	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAACCTCCGCTAGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2567.38485978763	40.3020694421685	0.015697712514166	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2564.24480059343	2564.24480059343
"healthy-2"	"2019-08-01-count-2:ATCACGAGTATACCCA"	2.79097094115559	-10.2493572465149	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACGAGTATACCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.48972942123	41.7286689311531	0.0181154134955217	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.61584547119	2301.61584547119
"healthy-2"	"2019-08-01-count-4:ACAAGCTAGTAGGAAG"	1.98384787616078	-9.57724573528441	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTAGTAGGAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.05090236898	40.2069089221341	0.0165593352606015	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.62981858051	2420.62981858051
"healthy-2"	"2019-08-01-count-2:GTAGCTAGTGGACAGT"	3.10342397269551	-10.8130893937317	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTAGTGGACAGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.07210775717	40.9786564643979	0.0175117067241461	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.09482013384	2333.09482013384
"healthy-2"	"2019-08-01-count-4:TCATCATTCTAGTACG"	1.82992972907369	-9.92773344432982	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCATTCTAGTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.82672737899	36.7019725099882	0.0150923468752009	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.31155369244	2426.31155369244
"healthy-2"	"2019-08-01-count-2:TCAGTGAGTAGTGGCA"	1.68458106097524	-9.49430467998656	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTGAGTAGTGGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.36256204006	42.9431972997546	0.0183176433522234	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.93787531182	2341.93787531182
"healthy-2"	"2019-08-01-count-3:TGGATGTTCGTCAGAT"	2.70056571540181	-10.761218093988	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATGTTCGTCAGAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.63452269271	39.3373470963918	0.0166709491313518	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2351.24041177368	2351.24041177368
"healthy-2"	"2019-08-01-count-2:TCAAGACTCAGGTAAA"	-0.65365038338359	12.5263538130554	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACTCAGGTAAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1943.09653589382	36.8831736348845	0.0189816475679724	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1939.59524300844	1939.59524300844
"healthy-2"	"2019-08-01-count-3:GAATCACGTTACCCAA"	-2.36688814583476	3.63770291889039	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCACGTTACCCAA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3272.14039463048	38.5393908176743	0.0117780370551693	5910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3266.87226798216	3266.87226798216
"healthy-2"	"2019-08-01-count-4:CTTGATTAGCTACGTT"	-7.34372983399089	3.83189103687135	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTAGCTACGTT"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2289.18001279247	38.531399352784	0.0168319656547155	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2281.25512072523	2281.25512072523
"healthy-2"	"2019-08-01-count-4:ATTGGGTGTTACGTAC"	1.98325612124745	-9.66628172313841	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGGGTGTTACGTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.09872260279	41.3295994059035	0.0185993533885359	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2217.81508798188	2217.81508798188
"healthy-2"	"2019-08-01-count-2:CTTCAATCAGTTTCAG"	-0.732273916632491	11.2785711058411	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATCAGTTTCAG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.60280857342	40.5266159766356	0.0222599986036445	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1814.635644702	1814.635644702
"healthy-2"	"2019-08-01-count-2:TAGAGTCCACATACTG"	1.34881617602651	10.4085426100525	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCCACATACTG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.20203411342	34.7377870926658	0.0183486952088203	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1889.87356436274	1889.87356436274
"healthy-2"	"2019-08-01-count-3:TAGCACATCGCGCTGA"	2.11522903022115	-9.70017053997191	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACATCGCGCTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.11321532704	37.2661510579837	0.016488621368727	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.57686027925	2256.57686027925
"healthy-2"	"2019-08-01-count-4:CTCACTGTCCGGCTTT"	2.69918264922444	-10.8874187699524	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGTCCGGCTTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.66509065754	41.426652555084	0.0170153392817966	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.88678931176	2425.88678931176
"healthy-2"	"2019-08-01-count-4:GTCCACTCATAATCCG"	7.94828714904134	7.69254729831544	"2019-08-01-count-4"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTCATAATCCG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1706.62510487446	48.1228075245246	0.0281976442202076	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1693.07831835253	1693.07831835253
"healthy-2"	"2019-08-01-count-4:ACACCAAAGAAGCGCT"	2.79285420951192	-10.9538898698059	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAAAGAAGCGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.22373482334	41.1492624346329	0.0179360285616614	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2289.13215963469	2289.13215963469
"healthy-2"	"2019-08-01-count-1:CCAATGACAAGCACCC"	2.79572977599446	-10.9704933396545	"2019-08-01-count-1"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCAATGACAAGCACCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2675.85533505989	39.6448784452652	0.0148157779405432	2631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2667.4356345988	2667.4356345988
"healthy-2"	"2019-08-01-count-4:AGCGCTGAGTAACGAT"	4.51417841491048	-10.8070688477722	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGAGTAACGAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.88204445601	41.0966311802436	0.0185967532897712	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2207.57327670126	2207.57327670126
"healthy-2"	"2019-08-01-count-3:GTCTAGAAGAGTCAGC"	-1.23225162449535	12.9849910506043	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTAGAAGAGTCAGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1324.65996093843	40.6764153800175	0.0307070618720907	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1319.79867492045	1319.79867492045
"healthy-2"	"2019-08-01-count-4:CAGGGCTAGCGACTGA"	1.6054308610851	-4.84248211300048	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGGCTAGCGACTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2109.42948405798	37.941623346338	0.0179866753703226	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2104.85333959881	2104.85333959881
"healthy-2"	"2019-08-01-count-3:GTTACGATCTTGTTAC"	1.38221635398213	10.9229116209778	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGATCTTGTTAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.46772974115	48.7050679003508	0.0280322143926132	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1731.72354380298	1731.72354380298
"healthy-2"	"2019-08-01-count-2:CCGGTAGAGGGAGATA"	4.23618139800374	-10.5031299821106	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGAGGGAGATA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1706.74109773409	39.0268884207102	0.0228663201891156	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1704.73435629105	1704.73435629105
"healthy-2"	"2019-08-01-count-2:AACAAAGCATAGATCC"	-1.71618745747264	13.3124274977478	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGCATAGATCC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1752.75189971615	36.5418940293461	0.0208482980593339	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1748.40707578796	1748.40707578796
"healthy-2"	"2019-08-01-count-2:CTTCCTTAGGGAGATA"	2.63504280623738	-10.4592085114685	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTAGGGAGATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.10792630829	40.0380937192842	0.0178017663140796	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.79942888164	2245.79942888164
"healthy-2"	"2019-08-01-count-3:TGGGCTGAGCCGGAAT"	1.91640927371327	-10.0985861054626	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCTGAGCCGGAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.48107200906	42.2643790277453	0.0186229264253482	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2266.39559032378	2266.39559032378
"healthy-2"	"2019-08-01-count-4:CTCAGGGGTAACACCT"	2.18595470961873	-10.5217304459778	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGGGGTAACACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.36604474548	36.2225852585777	0.0142028966129027	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2547.11988603198	2547.11988603198
"healthy-2"	"2019-08-01-count-2:GTATTTCGTCTTCTAT"	8.29598393019978	7.74932715976564	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTTCGTCTTCTAT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1721.1817644091	32.9042750585878	0.0191172575372271	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1717.49026651351	1717.49026651351
"healthy-2"	"2019-08-01-count-4:GGAAGTGCATCCTATT"	11.4196125465328	-2.27812054073485	"2019-08-01-count-4"	"Control2"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAAGTGCATCCTATT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1407.22837257245	28.2010353911738	0.0200401270616947	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	1402.39594716584	1402.39594716584
"healthy-2"	"2019-08-01-count-3:TCGAAGTTCATACGGT"	1.87891723689381	-10.4225034943786	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAAGTTCATACGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.02317262766	41.1193326339676	0.0171830064599068	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.20337815699	2383.20337815699
"healthy-2"	"2019-08-01-count-3:ATGGAGGGTTAGGGAC"	2.17422904547994	-10.2571869126526	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGAGGGTTAGGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.90968736157	35.323173626996	0.015637266874646	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.83979892095	2256.83979892095
"healthy-2"	"2019-08-01-count-2:TCATCCGCAGTCTACA"	3.53886284407918	-10.9083099595276	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCCGCAGTCTACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.44888768773	41.1549590468831	0.0160733374701531	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2551.67173472438	2551.67173472438
"healthy-2"	"2019-08-01-count-3:GGAGATGGTCTGATCA"	2.01893987235371	-10.1618480912414	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGGTCTGATCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2614.47716921356	39.4271521222362	0.0150803199150123	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2608.7636783644	2608.7636783644
"healthy-2"	"2019-08-01-count-4:GACTCAAGTTTCGACA"	-7.60967956009563	3.58169028842775	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAAGTTTCGACA"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2236.70134281879	40.2941296242711	0.0180149798513066	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2215.95962131806	2215.95962131806
"healthy-2"	"2019-08-01-count-4:GTCGAATTCGTTATCT"	-2.18170962753947	13.1606788405213	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATTCGTTATCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1800.85004109729	38.4101292672386	0.0213288882420408	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1796.83097538164	1796.83097538164
"healthy-2"	"2019-08-01-count-2:GTTCATTTCCACTTTA"	-2.32191214981731	13.1491546400818	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCATTTCCACTTTA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1987.99555798534	43.3396369910355	0.0218006709406114	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1983.99947373214	1983.99947373214
"healthy-2"	"2019-08-01-count-4:CTGGCAGCACCCTGTT"	2.30846871909444	-10.6804781190124	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGCAGCACCCTGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.15503793125	40.1843768943306	0.0166522151551356	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2408.16583417802	2408.16583417802
"healthy-2"	"2019-08-01-count-2:ACTATTCGTATGCAAA"	4.5239073234493	-10.8998165360657	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCGTATGCAAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.19505307523	42.3408804671499	0.0191052138702308	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2210.52830342484	2210.52830342484
"healthy-2"	"2019-08-01-count-4:AGCCACGTCCAGCACG"	-0.256563405424911	11.6796569594177	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGTCCAGCACG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1812.31383711255	38.2922936939439	0.0211289528942474	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1808.52792826213	1808.52792826213
"healthy-2"	"2019-08-01-count-2:CTTCTCTGTCCAACGC"	3.85324778136556	-10.7374096146789	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTCTGTCCAACGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.07147934108	41.9571294104645	0.0173299837565653	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2418.16143828094	2418.16143828094
"healthy-2"	"2019-08-01-count-2:ATGGGAGCATTAGGAA"	2.53643812712972	-10.9171085587707	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGAGCATTAGGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.89848608172	42.0492035952929	0.0192630137697199	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2180.26483674637	2180.26483674637
"healthy-2"	"2019-08-01-count-2:GGGACTCCATGACTTG"	10.5957676368648	4.47984359348146	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCCATGACTTG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1902.11281959572	37.9129977533802	0.0199320447046029	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1902.11281959572	1902.11281959572
"healthy-2"	"2019-08-01-count-2:TCATGGATCGTAGTGT"	1.82929124411885	-9.560667060968	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGGATCGTAGTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.89125375442	43.431768771372	0.019398784419985	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2236.86165220577	2236.86165220577
"healthy-2"	"2019-08-01-count-4:CATAAGCCATAATGCC"	2.53984298285787	-10.9938669434753	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCCATAATGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.77547810708	47.6367857616261	0.0199002731030128	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.49779935534	2390.49779935534
"healthy-2"	"2019-08-01-count-3:ACTGTGAGTTGTGTTG"	6.93356194075887	-1.12404134189757	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTGAGTTGTGTTG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2204.71685854727	32.7342573595507	0.014847374724172	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2194.95197271965	2194.95197271965
"healthy-2"	"2019-08-01-count-4:GTTACCCTCCGATCTC"	1.51805796202962	-9.54829981243285	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACCCTCCGATCTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2425.48618481743	41.6216890495223	0.0171601427004851	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2420.93882162556	2420.93882162556
"healthy-2"	"2019-08-01-count-3:CATCCACTCTCGTTTA"	2.65295328673665	-11.0396118394104	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACTCTCGTTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.32030447784	38.9329010842789	0.0168517330730374	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2307.03855983616	2307.03855983616
"healthy-2"	"2019-08-01-count-4:ACAGGGAAGCGTCTGC"	1.76578809794728	-9.57162954723509	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGAAGCGTCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.57737005076	38.0820850232584	0.0176585758304429	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2151.70264021578	2151.70264021578
"healthy-2"	"2019-08-01-count-3:ATGGGTTTCCAAGCTA"	2.93438162383382	-10.9699249497619	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTTCCAAGCTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.76437882325	38.1389748249934	0.0161827695495112	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2351.72950818483	2351.72950818483
"healthy-2"	"2019-08-01-count-4:GTCTAGAAGACGCATG"	2.1925376850063	-10.3222818604675	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTAGAAGACGCATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.77522326442	41.8373316859886	0.017647110225988	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2366.008416156	2366.008416156
"healthy-2"	"2019-08-01-count-3:GGATGTTTCGGACTGC"	-2.18867431107219	12.3542613753113	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATGTTTCGGACTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2282.9996175921	41.8598754825638	0.018335471964167	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2276.39251566934	2276.39251566934
"healthy-2"	"2019-08-01-count-4:TGATCTTGTACTAGCT"	1.84923770007436	-4.60455944454344	"2019-08-01-count-4"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTGTACTAGCT"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2301.32121544637	35.3980889008488	0.0153816375842096	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2296.26463940638	2296.26463940638
"healthy-2"	"2019-08-01-count-2:CTGCCATTCATTACCT"	-1.80755637112315	12.8858852156433	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATTCATTACCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1946.38352291275	43.0191146427576	0.0221020750208468	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1942.38284930635	1942.38284930635
"healthy-2"	"2019-08-01-count-2:TGACCCTCAGTGCCTG"	-1.79930887642558	12.9577560194763	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTCAGTGCCTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2252.90331931293	38.3440036284366	0.0170198176280953	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2244.46862873873	2244.46862873873
"healthy-2"	"2019-08-01-count-3:AGGGAGTCATTCAGGT"	3.37370624121968	-10.4133453599182	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTCATTCAGGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2202.43893342939	33.0503560520748	0.0150062530908008	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2193.43783502978	2193.43783502978
"healthy-2"	"2019-08-01-count-3:ACCCTCACAGAGATGC"	-6.24896178665813	4.04675672138063	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCACAGAGATGC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2448.8406678977	42.6133030100406	0.0174014191975273	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2439.05241599051	2439.05241599051
"healthy-2"	"2019-08-01-count-3:TATATCCAGTTGCGCC"	2.45869555053059	-10.5847759476868	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCAGTTGCGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.92933166009	40.39580453076	0.018018321969519	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.92933166009	2241.92933166009
"healthy-2"	"2019-08-01-count-3:TTTCACATCCTAACAG"	-2.53506741944011	12.8700713881287	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCACATCCTAACAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1678.66333536236	41.6034812073981	0.0247836956529568	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1672.25019551813	1672.25019551813
"healthy-2"	"2019-08-01-count-2:TACCGGGCACAGACGA"	2.11925091323201	-10.4817257157532	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGCACAGACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.11666166916	45.5470151453002	0.0186659170279768	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2437.11331847601	2437.11331847601
"healthy-2"	"2019-08-01-count-2:TCATTACGTGAACGGT"	2.42777504500691	-10.8552036515442	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACGTGAACGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.07750091433	31.0037190866671	0.0134970278862277	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2286.98116476248	2286.98116476248
"healthy-2"	"2019-08-01-count-3:TTCTTGACAATGTCAC"	-0.187182004482108	11.2907972105774	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTGACAATGTCAC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.89612984867	42.6408070209332	0.0226584275001204	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1874.46562679561	1874.46562679561
"healthy-2"	"2019-08-01-count-2:AATAGAGAGAAACTAC"	4.52788986739461	-10.7707281342712	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATAGAGAGAAACTAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.71093470525	43.9939143806381	0.0187790622090443	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2336.88422922208	2336.88422922208
"healthy-2"	"2019-08-01-count-3:CAAGAGGGTACATACC"	2.16590179976766	-9.52835657512816	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGGTACATACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.02327782687	38.1938121791465	0.017471823180728	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2183.74312623652	2183.74312623652
"healthy-2"	"2019-08-01-count-2:GAAACCTCATGACGGA"	1.73243703421895	-9.53297331249388	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTCATGACGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.62686826903	40.6150441122148	0.0180621537015965	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2244.7790765783	2244.7790765783
"healthy-2"	"2019-08-01-count-4:TAGGTACTCACTGAAC"	1.63492538508717	-9.01695253765257	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTACTCACTGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.32654234973	35.8659561520025	0.0159381118593359	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.06099141469	2245.06099141469
"healthy-2"	"2019-08-01-count-4:CCTGCATGTGTCATCA"	-7.4571364921635	1.04480890119401	"2019-08-01-count-4"	"Control2"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATGTGTCATCA"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2616.23402465669	43.9291584088097	0.0167909896419049	3035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2608.33760353253	2608.33760353253
"healthy-2"	"2019-08-01-count-3:TGTACAGTCATTTGTC"	2.96592201766316	-10.8798504105774	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGTCATTTGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.51627009333	40.6754811626198	0.0177349869687057	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.67317588356	2291.67317588356
"healthy-2"	"2019-08-01-count-3:AAACGAAAGTGGACGT"	1.56034209307973	9.77019212329713	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGAAAGTGGACGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1548.57452651489	32.1434026229384	0.0207567682875928	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1538.71215119789	1538.71215119789
"healthy-2"	"2019-08-01-count-3:AAACGAACAGGCTCTG"	4.05304588851277	-10.5237531892029	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGAACAGGCTCTG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.02282563114	40.470865294794	0.0175729327752985	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2299.94184673961	2299.94184673961
"healthy-2"	"2019-08-01-count-3:GGCGTCAAGCAAATGT"	-4.82096705856975	3.17076299274293	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCGTCAAGCAAATGT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3094.87719023997	42.5545805286467	0.0137500061917957	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3084.12288618545	3084.12288618545
"healthy-2"	"2019-08-01-count-4:GAGATGGAGGGCGAGA"	2.54232039031331	-10.7849703065124	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGATGGAGGGCGAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.97107334955	39.5906506868785	0.0168401266760257	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.92712567533	2348.92712567533
"healthy-2"	"2019-08-01-count-2:AGCCACGTCCAATCTT"	2.64909233626668	-10.4478664628235	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCACGTCCAATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.97508363388	41.8865146689085	0.0178698634475123	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2340.05957996725	2340.05957996725
"healthy-2"	"2019-08-01-count-4:GAGATGGCAAGTTCGT"	-5.20611319962199	-5.51304438030394	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGATGGCAAGTTCGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2824.59360493452	48.8844513421223	0.0173067202505599	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2817.29519223855	2817.29519223855
"healthy-2"	"2019-08-01-count-2:TACGCTCTCCAGCTCT"	2.51845087584798	-10.8506546250549	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCTCCAGCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.81518233103	41.4268946778445	0.0184791748242016	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2237.00363729487	2237.00363729487
"healthy-2"	"2019-08-01-count-2:TACGCTCCAATTAGGA"	1.61613668975179	-4.77567818081053	"2019-08-01-count-2"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCCAATTAGGA"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2066.86913315367	37.7142499463853	0.0182470429992054	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2061.21490449408	2061.21490449408
"healthy-2"	"2019-08-01-count-3:TCAGCCTCATAAGCGG"	-3.22107038918193	3.64094827258912	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCATAAGCGG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2982.48128042178	28.5529463556256	0.0095735542560011	4141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2979.19537638194	2979.19537638194
"healthy-2"	"2019-08-01-count-2:CAGTTCCTCTTAGCAG"	2.19685258445088	-10.7172336808411	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCTCTTAGCAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.92277979086	40.8736277032361	0.0181103350408044	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2247.67215941631	2247.67215941631
"healthy-2"	"2019-08-01-count-2:TCCTCTTAGGTCGTAG"	-0.610679487616378	10.9588260420593	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCTTAGGTCGTAG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.51879466759	33.6544990758525	0.0179728498168836	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1865.11256025746	1865.11256025746
"healthy-2"	"2019-08-01-count-4:GGGTAGACACAGCCAC"	-2.42620191994365	3.35600826824037	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTAGACACAGCCAC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3022.36284912356	42.4036401622077	0.0140299634024763	5136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3018.24163118019	3018.24163118019
"healthy-2"	"2019-08-01-count-2:CCCGAAGCACCAGCTG"	2.26352824744527	-10.7634287110535	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGCACCAGCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.02749489994	41.0439649385229	0.0170943335824788	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2398.17277265797	2398.17277265797
"healthy-2"	"2019-08-01-count-3:TATCTGTTCCGTAGGC"	2.85709847983662	-11.0210266343323	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTTCCGTAGGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.60292501282	40.9318225268913	0.0173985257315228	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.84649482121	2344.84649482121
"healthy-2"	"2019-08-01-count-4:ACCATTTGTACGAGTG"	2.34337272223775	-9.70027162944945	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCATTTGTACGAGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.73332198469	35.0128718305546	0.0152446396346523	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.78353859825	2287.78353859825
"healthy-2"	"2019-08-01-count-3:AGGTCTAGTAACTTCG"	3.53354014930074	-10.8137855759827	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTAGTAACTTCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.83528341057	40.8678866733152	0.0175110415734193	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.61726162517	2328.61726162517
"healthy-2"	"2019-08-01-count-2:AGCGCCATCCGGTTCT"	2.94924654540364	-11.1084966889587	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCCATCCGGTTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.49485326793	40.1947598649655	0.0165717770173002	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.61122935106	2420.61122935106
"healthy-2"	"2019-08-01-count-3:GATCAGTTCGAGAGCA"	2.65940107878987	-10.7859592667786	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCAGTTCGAGAGCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.32654005666	39.5132126238384	0.0169852391499931	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2321.99452641186	2321.99452641186
"healthy-2"	"2019-08-01-count-4:CTAGGTAGTAGATCGG"	2.55049194869344	-10.8053465119568	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGGTAGTAGATCGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.90075310357	39.7368322906487	0.0169895333258243	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.64138115859	2334.64138115859
"healthy-2"	"2019-08-01-count-4:CGAAGTTAGGCGCTCT"	1.90918018397633	-5.35034038936766	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTAGGCGCTCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2497.16808356698	39.154276810177	0.0156794719057311	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2494.21347297073	2494.21347297073
"healthy-2"	"2019-08-01-count-2:CATTCTAAGCTGCGAA"	-1.7527758878773	13.1931161650452	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCTAAGCTGCGAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1789.81075914909	43.2165673219558	0.0241458864301955	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1787.81670012873	1787.81670012873
"healthy-2"	"2019-08-01-count-2:CCTCACAGTATGACAA"	2.55204119262044	-10.751244567987	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACAGTATGACAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2033.47476652856	50.3978512459471	0.0247841045659906	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2031.84911546885	2031.84911546885
"healthy-2"	"2019-08-01-count-3:GGTGGCTTCGCATTGA"	-1.8548962873524	13.4084443815979	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTTCGCATTGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1803.31890962284	47.1321677841062	0.0261363464513128	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1799.50724480197	1799.50724480197
"healthy-2"	"2019-08-01-count-3:GTGGAGATCCACGTGG"	2.89321698722188	-10.867497467157	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAGATCCACGTGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.31204382128	36.751197752267	0.015394383757827	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.40447637452	2386.40447637452
"healthy-2"	"2019-08-01-count-3:GTGGAGAAGGTAGTAT"	-2.6570647758549	13.2839765318665	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAGAAGGTAGTAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1667.07971098783	39.7014474954526	0.0238149665152649	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1665.03067034479	1665.03067034479
"healthy-2"	"2019-08-01-count-4:GTGCACGCACATGACT"	3.59390725669209	-10.6365337601868	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGCACATGACT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.23150086155	39.021983574417	0.0164217937352774	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.24377370261	2367.24377370261
"healthy-2"	"2019-08-01-count-4:CAATACGCAGGGATAC"	2.63778771933858	-10.6443062058655	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATACGCAGGGATAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.60014883153	37.9627153092303	0.0157221539672318	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2409.96107887365	2409.96107887365
"healthy-2"	"2019-08-01-count-3:GGGACAATCCGCGGAT"	2.84827746924703	-10.8924379578796	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAATCCGCGGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.27771688345	41.97802767372	0.0172092039308068	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2435.10341422022	2435.10341422022
"healthy-2"	"2019-08-01-count-3:TGTCCTGTCGTTCGCT"	3.13821949538533	-10.6280918351379	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGTCGTTCGCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2548.58053512817	43.4709146557003	0.0170569122915765	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2541.36562768746	2541.36562768746
"healthy-2"	"2019-08-01-count-2:TCCATGCAGCTGTCCG"	2.53092279013936	-11.067822479364	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCAGCTGTCCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.93793591759	46.0618470118394	0.0180074138488884	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2553.48707572899	2553.48707572899
"healthy-2"	"2019-08-01-count-2:GAGTTGTGTTAGAAGT"	3.19130339202229	-10.7009630433288	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTGTGTTAGAAGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.547700381	42.291965950714	0.0193684644229822	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2177.45663712037	2177.45663712037
"healthy-2"	"2019-08-01-count-3:AAAGTGAAGTTCACTG"	2.80758299407307	-11.0372076264587	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTGAAGTTCACTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.76840344454	43.6468030816305	0.0177876620386668	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2449.64267776747	2449.64267776747
"healthy-2"	"2019-08-01-count-2:CGTAGTACACCGAATT"	2.01699461516682	-9.63374235546263	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTACACCGAATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.76468458654	41.4686567771461	0.0182619789089668	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2267.80940502459	2267.80940502459
"healthy-2"	"2019-08-01-count-2:ATGAAAGCACCAGCCA"	2.53976621207539	-10.7257385483948	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGCACCAGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.21376131838	44.5819074630594	0.0176967544984068	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2513.53181316885	2513.53181316885
"healthy-2"	"2019-08-01-count-3:CTGTCGTAGTACCGGA"	-4.34793696823772	-5.32596208965453	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTCGTAGTACCGGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2563.55664158327	41.6306095917648	0.0162393952669029	2592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2562.41185247834	2562.41185247834
"healthy-2"	"2019-08-01-count-3:CCTCTCCAGGAGTACC"	2.21863045272176	-10.4470854035583	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCAGGAGTACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.18229537394	45.3356940976274	0.0204751407290839	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2212.07006474312	2212.07006474312
"healthy-2"	"2019-08-01-count-4:CATCGGGCATACGCAT"	4.48325695571248	-10.6274576417175	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGCATACGCAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.29575643366	51.3374186815266	0.0233532810729764	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2190.58072134034	2190.58072134034
"healthy-2"	"2019-08-01-count-4:GTCACTCCAACTCGAT"	-5.43849692764934	-5.53162767803343	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCCAACTCGAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2914.69698171323	41.7427665969876	0.0143214772783864	2956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2910.62061742465	2910.62061742465
"healthy-2"	"2019-08-01-count-2:CTATCCGAGTTCGGTT"	2.22779645499532	-10.5588884583679	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGAGTTCGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.25890054931	41.693961451763	0.018578053290357	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2242.27182963284	2242.27182963284
"healthy-2"	"2019-08-01-count-4:ATCTCTACATAGATCC"	-5.32834372940715	-5.5585975877014	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCTCTACATAGATCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2798.24827168111	40.4882039744029	0.01446912498228	2698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2793.30511560567	2793.30511560567
"healthy-2"	"2019-08-01-count-4:TGTAACGAGGATTCCT"	1.93995573100392	-5.28054144298705	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGAGGATTCCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2348.99054268925	40.9099869850662	0.0174159862466837	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2345.09695686845	2345.09695686845
"healthy-2"	"2019-08-01-count-4:GAGTGAGAGTCCTGCG"	1.71548869189565	-9.5999155274597	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGAGAGTCCTGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.16729880979	42.3543507877281	0.0191894609939933	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2203.93044472917	2203.93044472917
"healthy-2"	"2019-08-01-count-2:TTATTGCCATAACGGG"	2.10754456099812	-10.6732206574646	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTATTGCCATAACGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.02129909417	38.2754146454413	0.0153222931523125	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2495.39506719372	2495.39506719372
"healthy-2"	"2019-08-01-count-2:CAGAGCCGTTGCTCAA"	2.79567517813985	-10.7623472443786	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGAGCCGTTGCTCAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.78570870831	40.9767458443166	0.0176033153271031	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2324.99845332214	2324.99845332214
"healthy-2"	"2019-08-01-count-3:AACAACCCAGTCGCTG"	-2.46611891213115	13.4459714659485	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAACCCAGTCGCTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1687.49844730256	48.603982920777	0.0288023867509151	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1683.44398138385	1683.44398138385
"healthy-2"	"2019-08-01-count-4:TGTAAGCAGTTTGAGA"	2.88424839553182	-10.9977112046448	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCAGTTTGAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.74384060893	42.2566650532457	0.0189513540899414	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2225.30675878238	2225.30675878238
"healthy-2"	"2019-08-01-count-4:GTGCTGGGTTCAGCGC"	2.60652055320088	-10.8654976121155	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTTCAGCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.88035728088	38.1150362476361	0.0159351767456152	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2388.34406496292	2388.34406496292
"healthy-2"	"2019-08-01-count-4:GTTGCTCGTGTGGTCC"	4.45671333846394	-10.7799101105896	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCTCGTGTGGTCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.44612536526	38.4012333251361	0.0170033869277822	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2252.62626030333	2252.62626030333
"healthy-2"	"2019-08-01-count-3:ACGTACAGTCCAAAGG"	3.92375793036763	-10.9060344926086	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACAGTCCAAAGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.68821312702	41.1102793026093	0.0186383003082412	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2204.56540128297	2204.56540128297
"healthy-2"	"2019-08-01-count-3:TTTGACTCAGAAGTGC"	1.72312058982198	-8.95178224956664	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTCAGAAGTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.95741847124	42.2470507426292	0.0186854694376309	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2259.10582435201	2259.10582435201
"healthy-2"	"2019-08-01-count-3:CGGGCATCAGTATGAA"	3.10277142104451	-10.9468479386536	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATCAGTATGAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.27783182942	38.2305468425725	0.0161837639618222	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2354.90908949607	2354.90908949607
"healthy-2"	"2019-08-01-count-2:CAGATCAGTTGCTCAA"	1.57260431823079	-9.65396501934203	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCAGTTGCTCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.12550480246	42.8137986508086	0.0182021744007254	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.84560777295	2346.84560777295
"healthy-2"	"2019-08-01-count-2:TGATTTCTCACGATCA"	2.45356835898702	-10.9477892152038	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCTCACGATCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.62621238393	43.8078588883156	0.0187483383761328	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.95538234706	2332.95538234706
"healthy-2"	"2019-08-01-count-4:GTGGAGAGTTATGACC"	2.55491342124287	-10.5820045701233	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGAGAGTTATGACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.13977381705	37.9734000988857	0.0166612862164608	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2277.27209523778	2277.27209523778
"healthy-2"	"2019-08-01-count-3:CTCGAGGTCGGCCCAA"	2.27374090728108	-10.6790504685608	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGTCGGCCCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.36798243839	42.1693642367037	0.0186394806521499	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2255.90786845545	2255.90786845545
"healthy-2"	"2019-08-01-count-4:CTGCAGGGTGTCTTGA"	-1.69065628472026	12.9887180098328	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGGTGTCTTGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1646.42848090939	40.3616695598549	0.0245146813407659	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1646.42848090939	1646.42848090939
"healthy-2"	"2019-08-01-count-3:GATTCTTCACCAGCGT"	5.05596079406087	-10.3138666382995	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTCACCAGCGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.47601964371	44.8539409484663	0.0185847883233113	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2410.24062644865	2410.24062644865
"healthy-2"	"2019-08-01-count-2:CCAAGCGGTGGTACAG"	-0.779950360686141	13.664207435492	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAAGCGGTGGTACAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1673.28492097905	39.4331711473306	0.0235663219413094	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1673.28492097905	1673.28492097905
"healthy-2"	"2019-08-01-count-2:GGCAGTCGTCGGATTT"	2.4040535884792	-10.7502079240051	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCAGTCGTCGGATTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.68916279732	37.9971660456155	0.0156709431578351	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2416.78269463335	2416.78269463335
"healthy-2"	"2019-08-01-count-4:TGACTCCCATCCGGTG"	3.06551923331563	-10.3249311677185	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCCATCCGGTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2544.82627270057	36.0317510269608	0.0141588254622678	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2540.11312449284	2540.11312449284
"healthy-2"	"2019-08-01-count-3:ATCACTTCAACCCTCT"	-2.72662649574931	3.8758117922577	"2019-08-01-count-3"	"Control2"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTCAACCCTCT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3520.74979328539	44.5003904616847	0.0126394640557968	5678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3510.69439471353	3510.69439471353
"healthy-2"	"2019-08-01-count-3:TAATTCCAGAGAGTTT"	2.06488480147664	-10.6400861970154	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCAGAGAGTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.23781561036	43.0814334550438	0.0195448209580391	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2197.91734499255	2197.91734499255
"healthy-2"	"2019-08-01-count-4:ACTTTCACAAGCTGCC"	-2.04116640511211	13.7478761442932	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTCACAAGCTGCC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1927.83941371878	43.4409398530751	0.0225334846584955	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1918.31536552182	1918.31536552182
"healthy-2"	"2019-08-01-count-4:ATTCTTGTCGCCGAGT"	2.90073337134663	-10.7713155976501	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGTCGCCGAGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.01427157658	41.0725141426854	0.0173520348550026	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.53388293475	2361.53388293475
"healthy-2"	"2019-08-01-count-3:TGTTCCGTCTTGGTCC"	2.76133789595906	-10.9610643616882	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGTCTTGGTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.44351052406	44.1523323012494	0.0195845813368754	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.21819316802	2248.21819316802
"healthy-2"	"2019-08-01-count-3:ATTTACCGTATGGTAA"	1.6965934234554	-5.04269602214965	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTACCGTATGGTAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2272.00815658806	38.1221912982694	0.0167790732562856	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2265.69538889164	2265.69538889164
"healthy-2"	"2019-08-01-count-2:CAGCAATAGGTGGTTG"	2.11981453475301	-10.3036298981872	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATAGGTGGTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.82667137574	41.4594669314834	0.0181614607238219	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.24731994737	2278.24731994737
"healthy-2"	"2019-08-01-count-2:GGCTGTGGTGTTGAGG"	2.6478554206783	-10.9718666306702	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTGTGGTGTTGAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.58620309658	36.3836169635097	0.0147985931580046	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2456.65134325913	2456.65134325913
"healthy-2"	"2019-08-01-count-2:CCAATTTGTTTGATCG"	-7.82369695130046	-0.825523339864336	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTGTTTGATCG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2822.5743180057	49.284698376256	0.0174609037083134	2925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2811.63613213454	2811.63613213454
"healthy-2"	"2019-08-01-count-3:CGGTCAGTCTCTCCGA"	1.31183292445485	10.1129770048889	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGTCTCTCCGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.22407708319	35.7080521893039	0.0203787019344836	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1745.53008699403	1745.53008699403
"healthy-2"	"2019-08-01-count-4:ACGGTCGCACTGTCCT"	2.0522731738979	-10.2556791535583	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTCGCACTGTCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.46694846263	45.1045403796322	0.0200958808551523	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2238.24628831239	2238.24628831239
"healthy-2"	"2019-08-01-count-3:GACACGCCAATTGCGT"	2.26689137992207	-10.8009491196838	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACACGCCAATTGCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.75699428955	37.6192231486306	0.015656690725711	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2399.47014112951	2399.47014112951
"healthy-2"	"2019-08-01-count-2:CATCCGTCAATACGCT"	4.42394222792928	-10.7787180176941	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCAATACGCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.85763413586	41.052223305402	0.0162914851812571	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2514.98786175159	2514.98786175159
"healthy-2"	"2019-08-01-count-3:TCATGGATCAGGAAGC"	1.96494342860524	-9.12402346050414	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGGATCAGGAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.34950671595	38.7336708886131	0.0185032030075945	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2090.52660323245	2090.52660323245
"healthy-2"	"2019-08-01-count-3:CGTAAGTCAATTGCGT"	-1.85960839214976	13.3812408217224	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTCAATTGCGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1797.44925274824	41.054137755103	0.0228402207697005	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1787.17378523504	1787.17378523504
"healthy-2"	"2019-08-01-count-3:ATTTCTGGTTGTGCAT"	2.29927267607991	-10.4237461320129	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCTGGTTGTGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.86685872327	38.7574994271218	0.0171049323917294	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2262.34552252959	2262.34552252959
"healthy-2"	"2019-08-01-count-3:TGTTGGATCACGATAC"	3.2803644138271	-9.89036085521849	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGGATCACGATAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.58044072039	41.2898087054885	0.0186193059549513	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.43938617898	2214.43938617898
"healthy-2"	"2019-08-01-count-2:ACGATCACATGGAAGC"	2.58958973464314	-10.5047731629578	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATCACATGGAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.84606861213	40.4345127146724	0.0174298257379046	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.69368644344	2314.69368644344
"healthy-2"	"2019-08-01-count-4:CATTCCGAGCTTGTGT"	4.39385857161824	-10.4712648621765	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGAGCTTGTGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.23391181713	44.1707523344649	0.0195080340877927	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2262.17239926981	2262.17239926981
"healthy-2"	"2019-08-01-count-3:CTTCCTTCAGAGGACT"	4.30207600173299	-10.744429611322	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTCAGAGGACT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.17631552256	37.1272583661119	0.0151714684923239	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2443.61942620155	2443.61942620155
"healthy-2"	"2019-08-01-count-2:GTGAGGATCTTCCACG"	1.6970166164333	-4.84610989010008	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGATCTTCCACG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2305.50707953364	40.7318622867577	0.0176672033013219	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2301.11714238492	2301.11714238492
"healthy-2"	"2019-08-01-count-4:CGCAGGTCAGGAGGTT"	3.17052759703938	-10.6216106644836	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCAGGTCAGGAGGTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.5583847591	41.8437680950821	0.0184369648192697	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2266.00034476352	2266.00034476352
"healthy-2"	"2019-08-01-count-4:ACGGTTATCTCCGTGT"	3.09551133689229	-10.918260597345	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTATCTCCGTGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.2190051159	39.3220184759616	0.0174980802433778	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2240.12876177937	2240.12876177937
"healthy-2"	"2019-08-01-count-3:CTTCCTTTCCGAGCTG"	-3.90648327294047	-4.61540892040404	"2019-08-01-count-3"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTTCCGAGCTG"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3005.69567463697	44.0330486402631	0.0146498692505127	3394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	3000.43638851467	3000.43638851467
"healthy-2"	"2019-08-01-count-3:TGTTTGTGTTATTCTC"	11.0198618369991	3.8999919661316	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTTGTGTTATTCTC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1708.84491900623	39.1119588184692	0.0228879510267172	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1704.79402884566	1704.79402884566
"healthy-2"	"2019-08-01-count-4:GTGTTAGAGACATACA"	2.59682526168172	-10.9099846116272	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTAGAGACATACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2107.30510716304	40.7892098509496	0.019356100695766	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2099.83263810723	2099.83263810723
"healthy-2"	"2019-08-01-count-3:TCGACGGAGAATTGTG"	2.26567902144734	-10.7661237946716	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACGGAGAATTGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.14067911178	40.8681836047866	0.0171921602974111	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2371.84644761652	2371.84644761652
"healthy-2"	"2019-08-01-count-3:AGGCCACTCAAGTGTC"	-3.86566005173381	-5.47697689449462	"2019-08-01-count-3"	"Control2"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCCACTCAAGTGTC"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2777.44161769559	44.8856053563826	0.0161607736668192	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2774.48729673134	2774.48729673134
"healthy-2"	"2019-08-01-count-4:CGAGGAATCCGTGACG"	-8.0646861595219	3.31260845744935	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAATCCGTGACG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2138.18127379408	40.5913179058083	0.0189840395682548	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2126.87946083646	2126.87946083646
"healthy-2"	"2019-08-01-count-4:GGAATGGCAACCAGAG"	-2.48091946068462	13.5728406676087	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATGGCAACCAGAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1951.09954963312	40.1731552851867	0.0205900079740887	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1941.41467997316	1941.41467997316
"healthy-2"	"2019-08-01-count-3:TCACACCTCGGTTGTA"	2.27044310149495	-10.7117853394714	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCTCGGTTGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.72402313085	36.247207840627	0.0145120948130978	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.95924686941	2493.95924686941
"healthy-2"	"2019-08-01-count-3:AATGACCTCTTCTCAA"	1.15698530253713	10.4427804716858	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGACCTCTTCTCAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2245.63237972446	43.3993341624834	0.0193261081173974	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2232.70662750984	2232.70662750984
"healthy-2"	"2019-08-01-count-4:ATCAGGTCAGCTACTA"	10.0684639411861	6.20811030948488	"2019-08-01-count-4"	"Control2"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCAGGTCAGCTACTA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1969.72362554089	31.0114404193375	0.0157440566875577	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1964.45491577301	1964.45491577301
"healthy-2"	"2019-08-01-count-4:TTTCACAGTCGAGTTT"	4.35285915908162	-10.7467870942322	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCACAGTCGAGTTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.47805130547	39.1899951962544	0.0169325413019793	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.02228254332	2308.02228254332
"healthy-2"	"2019-08-01-count-4:CTACATTTCAAGAGTA"	3.07136573371236	-11.0084409943786	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTTCAAGAGTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.4833074164	32.2525037021094	0.0134414369970495	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2394.94273175316	2394.94273175316
"healthy-2"	"2019-08-01-count-4:CCTCTAGCAATCTCTT"	1.67695166644399	-4.70688631450804	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGCAATCTCTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2422.74311615861	41.5468859952487	0.0171486963343945	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2419.08689158074	2419.08689158074
"healthy-2"	"2019-08-01-count-4:ACAGGGATCTATTGTC"	1.432270069688	9.83425805652467	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGATCTATTGTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1598.94422916411	38.8267245593941	0.0242827259708062	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1591.686416379	1591.686416379
"healthy-2"	"2019-08-01-count-3:GTTCTATGTATGAAAC"	-2.00820217552837	13.5318641432556	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATGTATGAAAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1731.02522673811	42.1977808501326	0.0243773344248997	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1726.92604139696	1726.92604139696
"healthy-2"	"2019-08-01-count-4:GTTACAGAGTATTGCC"	-0.789778391749221	11.6938762434754	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACAGAGTATTGCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.815927987	35.9070903002433	0.0192757050016451	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1857.60167143303	1857.60167143303
"healthy-2"	"2019-08-01-count-3:ACTGCAAAGCGGACAT"	2.00718404826466	-9.79659464275511	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGCAAAGCGGACAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.2865876991	42.9082337358282	0.0195367189219055	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2190.10947545955	2190.10947545955
"healthy-2"	"2019-08-01-count-2:GATTCTTCACCTTCCA"	2.50798263129537	-10.7548856965271	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCTTCACCTTCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2148.12501174519	31.2831301849989	0.0145629933146134	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2143.89119342686	2143.89119342686
"healthy-2"	"2019-08-01-count-2:GATTCTTCATGCACTA"	14.1987711387569	1.80642197215883	"2019-08-01-count-2"	"Control2"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCTTCATGCACTA"	"Plasma cell"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1338.52263315563	23.6179392733632	0.0176447814092488	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1325.79248835809	1325.79248835809
"healthy-2"	"2019-08-01-count-3:CTTCTAATCTGTTGGA"	6.95702280577962	-1.24104859745177	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAATCTGTTGGA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2375.06986692862	33.7354586025755	0.0142039857741959	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2367.93522830163	2367.93522830163
"healthy-2"	"2019-08-01-count-4:GATGTTGAGTCATGGG"	-1.57364354553874	13.6231202849182	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGTTGAGTCATGGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1744.18249882982	40.6317450294424	0.0232955812001912	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1742.11836897878	1742.11836897878
"healthy-2"	"2019-08-01-count-3:TCTTGCGAGAGAGCGG"	2.32867111739461	-10.551166557428	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTGCGAGAGAGCGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.28758623226	41.649620614919	0.0185663313391182	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2239.79466743526	2239.79466743526
"healthy-2"	"2019-08-01-count-2:TCCTTCTCAGCTAACT"	1.81663884696309	-8.95827772533568	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTCAGCTAACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.11309674181	38.9243608420142	0.0167049234204305	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.94717113138	2328.94717113138
"healthy-2"	"2019-08-01-count-2:GATTGGTAGCATGCAG"	2.06196679648702	-9.70544340526732	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTAGCATGCAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.22045065472	37.7714686592448	0.0173246098337909	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2180.22045065472	2180.22045065472
"healthy-2"	"2019-08-01-count-4:CGGAACCCATTCAGGT"	-5.21001754227336	-5.15073206340941	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAACCCATTCAGGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2459.19030255662	43.5342156338505	0.0177026623716723	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2453.14936125503	2453.14936125503
"healthy-2"	"2019-08-01-count-3:ATGTCTTCACACAGAG"	1.87759592112843	-5.22321560299071	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCTTCACACAGAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2065.13988258717	45.2498720057102	0.0219112866819568	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2057.61076326809	2057.61076326809
"healthy-2"	"2019-08-01-count-4:GAGACTTAGACTAGAT"	0.843269010155839	11.060423828009	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"Treg"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACTTAGACTAGAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.46144918072	32.1054901603188	0.0165027634825862	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1939.47561702996	1939.47561702996
"healthy-2"	"2019-08-01-count-4:TCCACGTTCTGAGAAA"	0.467530449002427	11.7767009505066	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTTCTGAGAAA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.32635929122	38.5100383818423	0.0193875685139596	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1980.42824657364	1980.42824657364
"healthy-2"	"2019-08-01-count-4:CTACCTGTCCCTTGGT"	-4.60404715958293	-5.33354952251586	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCTGTCCCTTGGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2281.5471009137	46.3083853887024	0.0202969228074043	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2279.25226753713	2279.25226753713
"healthy-2"	"2019-08-01-count-4:CCAAGCGTCTTCCCGA"	1.94004203852956	-9.42225363170775	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAAGCGTCTTCCCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.78381710391	39.3899014514778	0.0182547951000695	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2149.88426742423	2149.88426742423
"healthy-2"	"2019-08-01-count-4:TGTTACTCACCCTAGG"	-3.26090393486674	-5.27733185207518	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTCACCCTAGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2533.77616801024	44.789496055441	0.0176769742414201	2957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2530.42830859657	2530.42830859657
"healthy-2"	"2019-08-01-count-2:CTTTCGGTCGCAGAGA"	-5.06879601898845	-5.30843069469603	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCGGTCGCAGAGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2791.90031422576	40.3391676375384	0.0144486418200519	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2787.29224456654	2787.29224456654
"healthy-2"	"2019-08-01-count-2:AACCCAATCGATTGGT"	-2.16627250137981	12.8737077482971	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCCAATCGATTGGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1711.23920171581	45.8191744679812	0.0267754352647132	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1704.77240629894	1704.77240629894
"healthy-2"	"2019-08-01-count-2:GATTGGTTCAAGATAG"	2.35549606856648	-10.7777452698913	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTTCAAGATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.17327306919	37.9940017346795	0.0147482322450362	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2574.4750425443	2574.4750425443
"healthy-2"	"2019-08-01-count-3:TTACTGTCAGTTCCAA"	2.51416244086568	-9.84724619304808	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTCAGTTCCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.73129434261	35.6646369669508	0.015845799565944	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.45325364721	2248.45325364721
"healthy-2"	"2019-08-01-count-3:GCAGTTAGTACAGTTC"	3.05255689200703	-10.8769960633484	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGTTAGTACAGTTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.16348415057	41.0861967739416	0.0178312854346306	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.98688626175	2294.98688626175
"healthy-2"	"2019-08-01-count-2:ATTACTCAGGCTTTCA"	2.20963158187215	-10.4873600236145	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCAGGCTTTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.16494512978	36.9843331971787	0.0151564890197256	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.45969272687	2433.45969272687
"healthy-2"	"2019-08-01-count-2:CAGTTCCAGCCTCTTC"	-2.15101418915446	13.282784438971	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCAGCCTCTTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2120.58963240895	42.9801464263399	0.0202680168616666	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2113.22777338336	2113.22777338336
"healthy-2"	"2019-08-01-count-4:AGTCATGGTCTAGGTT"	3.71713604506795	-10.78689196026	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCATGGTCTAGGTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.58274528468	36.6883736672211	0.0172522671636319	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2117.80875198638	2117.80875198638
"healthy-2"	"2019-08-01-count-3:GTTGTAGGTAGTGTGG"	2.63868155059163	-10.6484766236511	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTAGGTAGTGTGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.99373296979	43.601948198026	0.0197562628052206	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2205.00830223252	2205.00830223252
"healthy-2"	"2019-08-01-count-4:TTTGACTAGGCGCTCT"	2.12858333167378	-10.4321575394836	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGACTAGGCGCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.41201071045	45.8331787640524	0.0196253074634611	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.36730714962	2332.36730714962
"healthy-2"	"2019-08-01-count-3:AACCTGACAGAGGCAT"	3.09369554099385	-10.8585310212341	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTGACAGAGGCAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.83645545956	42.0901799795362	0.0178891226722833	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2349.27422892231	2349.27422892231
"healthy-2"	"2019-08-01-count-3:ACTTTGTCATCTCGTC"	2.00276019152943	-10.06596567547	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTGTCATCTCGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.70679139965	33.5807920781864	0.014672387133369	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2286.48614150808	2286.48614150808
"healthy-2"	"2019-08-01-count-4:CACTGTCGTACGTGAG"	3.02429737624471	-10.7003040543762	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGTCGTACGTGAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.68945522252	40.9034867790266	0.017982009229926	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2273.66759501072	2273.66759501072
"healthy-2"	"2019-08-01-count-4:TTTGATCTCGCGTGAC"	-5.13319001618083	-5.55502369320067	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCTCGCGTGAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2526.72459266364	48.8339948862038	0.019326995521393	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2523.02055409132	2523.02055409132
"healthy-2"	"2019-08-01-count-4:TCAGCCTAGACGCCAA"	4.3908802467281	-10.5944500199524	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCCTAGACGCCAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.68821215009	49.2718841982555	0.0209161314065769	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2347.55880391551	2347.55880391551
"healthy-2"	"2019-08-01-count-3:GTTTACTCAGAGTTGG"	3.2214147048885	-10.3757219544617	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTTACTCAGAGTTGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2314.83524632644	42.3625227423409	0.0183004482973761	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2303.8469767844	2303.8469767844
"healthy-2"	"2019-08-01-count-2:ATTCACTAGTCCCAGC"	4.20722164687459	-10.8337869874206	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTAGTCCCAGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.85587101308	51.5610286574245	0.0230300794816654	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.68418156673	2230.68418156673
"healthy-2"	"2019-08-01-count-4:CGGGCATGTGGAACAC"	2.96944441375081	-10.9085798493591	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATGTGGAACAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.80794969941	41.1376669482068	0.0164234814701636	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2499.96802164393	2499.96802164393
"healthy-2"	"2019-08-01-count-2:GGAGGATAGCAGTAAT"	3.00276388701741	-10.8745737305847	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATAGCAGTAAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.41382085616	39.4579732721323	0.0178186989714852	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2210.50334344021	2210.50334344021
"healthy-2"	"2019-08-01-count-4:TCTTGCGAGAAGCCAC"	4.6041747528011	-10.6794662705627	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGAGAAGCCAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.81825316823	39.5870637151391	0.0176113276326244	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.07191672446	2245.07191672446
"healthy-2"	"2019-08-01-count-4:CGAAGGAGTAACACCT"	2.43853272971455	-10.7059564820495	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGGAGTAACACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.94021682976	41.4298708455582	0.0175257692857897	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2362.39765876986	2362.39765876986
"healthy-2"	"2019-08-01-count-4:TTCCTCTGTAACGGTG"	-1.74504230442699	12.3050575026306	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTGTAACGGTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1772.57868866685	47.7704258030338	0.0269496785155201	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1766.52299823409	1766.52299823409
"healthy-2"	"2019-08-01-count-3:AGGTTGTAGTGTTGTC"	3.3415638404781	-10.3238487473694	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTAGTGTTGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2121.23899120779	46.8510266224532	0.0220866327729424	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2119.07123531286	2119.07123531286
"healthy-2"	"2019-08-01-count-2:TCGACCTTCGTTCAGA"	11.0877195793087	3.78871343219606	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTTCGTTCAGA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1524.47609311617	33.5486792113513	0.0220066942097954	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1515.87259116778	1515.87259116778
"healthy-2"	"2019-08-01-count-2:ATTCATCCAAGTTCCA"	4.4037262397701	-10.8834295502869	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCCAAGTTCCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.53260520709	49.5158907659269	0.0231649756571221	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2132.55681238759	2132.55681238759
"healthy-2"	"2019-08-01-count-4:CTTCAATTCGAACCAT"	-1.84725294533427	12.8331041106018	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATTCGAACCAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1780.63496868641	40.0478052093748	0.0224907439838264	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1772.63599316684	1772.63599316684
"healthy-2"	"2019-08-01-count-2:CGTAAGTCACCTTCCA"	10.7685400443966	4.27691218936769	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAAGTCACCTTCCA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.71285982312	33.3495904442204	0.0170873447271556	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1940.88496792584	1940.88496792584
"healthy-2"	"2019-08-01-count-3:TAACCAGTCTATTCGT"	2.85801019248311	-10.9431009522644	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACCAGTCTATTCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.39243623577	41.792063980252	0.0171041144928139	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2438.3049455079	2438.3049455079
"healthy-2"	"2019-08-01-count-4:CTTCCGACATATGCGT"	3.15694083747212	-10.5939464799133	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCGACATATGCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.48187339926	26.6624397076205	0.011148919840953	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.07634549666	2380.07634549666
"healthy-2"	"2019-08-01-count-2:GTGTCCTAGCTCTGTA"	2.22943939742391	-10.8164110413757	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTAGCTCTGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.80980260164	38.460521295023	0.0164094037205287	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.49711359735	2341.49711359735
"healthy-2"	"2019-08-01-count-2:ACGTTCCTCGAACACT"	2.54214682158772	-10.6323356858459	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCTCGAACACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2059.56958523707	40.7472373083729	0.019784346011151	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2052.86769730881	2052.86769730881
"healthy-2"	"2019-08-01-count-3:TGAGCGCTCATTGTGG"	3.13799204406087	-10.2777576676575	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCGCTCATTGTGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2472.67616151638	39.1794534867075	0.0158449594396868	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2465.76896625011	2465.76896625011
"healthy-2"	"2019-08-01-count-3:TTCACCGGTGTCTAAC"	10.9192730384762	4.07642982089845	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGGTGTCTAAC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1625.66787453311	32.6354688659271	0.0200751145896267	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1619.38045716816	1619.38045716816
"healthy-2"	"2019-08-01-count-2:TCGATTTGTGAATTGA"	2.99962796744649	-10.5189180604187	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGATTTGTGAATTGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.57420066441	41.0856072897482	0.0164898188778774	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2488.06792486172	2488.06792486172
"healthy-2"	"2019-08-01-count-2:TTCTCTCCAACGACAG"	2.21358050879781	-10.6168880692688	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCCAACGACAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.27188789871	39.5452309401573	0.0160931442446012	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.55834205575	2450.55834205575
"healthy-2"	"2019-08-01-count-2:ATTCCTAAGTGCCGAA"	4.03818454322164	-10.6482219926086	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCTAAGTGCCGAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.59908454497	49.0189354667974	0.0223361687389754	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2191.34160789495	2191.34160789495
"healthy-2"	"2019-08-01-count-4:TCGGTCTCACACCTAA"	2.76644148406331	-10.9598531953064	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTCACACCTAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2535.3984792016	39.8178149730408	0.0157047561950023	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2532.29824015282	2532.29824015282
"healthy-2"	"2019-08-01-count-3:CACACAAGTCCCACGA"	1.7669059234554	-9.195508026239	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACACAAGTCCCACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.78490135867	42.7411043468897	0.0183849715824938	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2320.9614604836	2320.9614604836
"healthy-2"	"2019-08-01-count-4:CATCGTCAGGGTGGGA"	2.66261472281758	-10.8692226639953	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCAGGGTGGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.27718225252	37.372073851371	0.0163534096177054	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2280.02966979194	2280.02966979194
"healthy-2"	"2019-08-01-count-4:AGCCAATAGGTAATCA"	6.90997280654256	-1.12268974697264	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATAGGTAATCA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2154.95956137284	36.9992012315598	0.0171693250744757	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2145.70538186981	2145.70538186981
"healthy-2"	"2019-08-01-count-4:TTGTTCACAGCTATAC"	3.1641489463741	-10.509545349237	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCACAGCTATAC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2428.28386871401	47.2903147270052	0.0194747884859317	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2420.07115994699	2420.07115994699
"healthy-2"	"2019-08-01-count-3:TTCAGGACATGGTGGA"	2.44471134719197	-10.9233360520569	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAGGACATGGTGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.30482064144	39.528503120319	0.017434137113128	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.3726806687	2261.3726806687
"healthy-2"	"2019-08-01-count-2:AAGACAATCCGCACTT"	1.22082163867299	11.2168626555237	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAATCCGCACTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.3639660624	31.4597984724726	0.016072533784179	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1950.65850184378	1950.65850184378
"healthy-2"	"2019-08-01-count-2:CCTCCAAAGTCTGCGC"	2.8364438014919	-11.0519695512024	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCAAAGTCTGCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.93600023062	36.8018553064121	0.0151576710847883	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.39590296839	2420.39590296839
"healthy-2"	"2019-08-01-count-3:GCCAGGTGTAACACGG"	4.2452150779659	-10.7949447861877	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTGTAACACGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.57936578333	42.1199525509883	0.0175603747584282	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.97682197217	2392.97682197217
"healthy-2"	"2019-08-01-count-3:CTACGGGCACCTGCGA"	3.05170478400533	-10.6291160813537	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGCACCTGCGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.26887218891	39.2243494648339	0.0167749525862332	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.79162912115	2334.79162912115
"healthy-2"	"2019-08-01-count-3:CCCTGATGTACCGTCG"	-1.65365121784862	12.3313884505066	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATGTACCGTCG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1389.56339642293	46.3348224161925	0.0333448783520561	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1384.73184440607	1384.73184440607
"healthy-2"	"2019-08-01-count-3:TTGGGCGGTAGACGGT"	2.33717431601827	-8.25379087841185	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGGTAGACGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.62516337961	39.1441475199212	0.0180004113716255	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2173.38566804526	2173.38566804526
"healthy-2"	"2019-08-01-count-3:TCCTCCCGTGGCAGAT"	2.18430699881856	-10.6212511292663	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCCCGTGGCAGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.28014385945	41.592108200634	0.018104935226036	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2289.91990020385	2289.91990020385
"healthy-2"	"2019-08-01-count-4:GCTCAAATCTCTCTAA"	4.42370142516438	-10.8261881104675	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAATCTCTCTAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.49171378645	38.0939289805309	0.0149008615107575	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2552.81156460762	2552.81156460762
"healthy-2"	"2019-08-01-count-3:ATCACAGTCGGTAACT"	1.92401399192159	-10.3541441193786	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGTCGGTAACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.70044513228	38.8970204526179	0.0152316300554207	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2549.72425097367	2549.72425097367
"healthy-2"	"2019-08-01-count-2:CTATCTAGTCGCACAC"	2.28860225257222	-10.8479604951111	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTAGTCGCACAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.64652369602	38.6909526638044	0.0160833905907173	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2401.41263410136	2401.41263410136
"healthy-2"	"2019-08-01-count-4:TGACCCTCAAGCTGTT"	2.02189578589742	-10.3645973435608	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACCCTCAAGCTGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.52133378137	37.7755126267913	0.0164777147632833	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.7134017225	2287.7134017225
"healthy-2"	"2019-08-01-count-2:GCAGTTATCCATTGCC"	1.01447816666905	-8.82586958324584	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTATCCATTGCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2457.58944583394	43.9323200564828	0.0178761835631073	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2455.88940154971	2455.88940154971
"healthy-2"	"2019-08-01-count-2:TCGGATAAGACCAAGC"	2.99029483374898	-10.7691164246765	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATAAGACCAAGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2177.13384675556	41.988279084414	0.0192860347777819	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2169.43500359564	2169.43500359564
"healthy-2"	"2019-08-01-count-3:ACGTCCTAGTTGAAAC"	11.0228506523067	3.85388562763063	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTAGTTGAAAC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1749.15877042644	34.2693100401318	0.0195918807483536	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1747.21157490833	1747.21157490833
"healthy-2"	"2019-08-01-count-4:CGTGCTTAGCATGCAG"	4.50437321242635	-10.7547703019348	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGCTTAGCATGCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.49285496295	33.5849680254319	0.0155522478105203	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2155.71997205446	2155.71997205446
"healthy-2"	"2019-08-01-count-3:CTTACCGGTCTGCCTT"	1.6484509902889	-9.91574194347533	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGGTCTGCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.38649245584	40.9535267142248	0.0167747002945973	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2434.67812562018	2434.67812562018
"healthy-2"	"2019-08-01-count-2:TCCGATCTCGTGCAGC"	-1.89400289478953	12.669352508429	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCTCGTGCAGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1858.69001807627	39.8596561701084	0.0214450262187144	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1854.70207733901	1854.70207733901
"healthy-2"	"2019-08-01-count-4:CTCACTGGTGAATATG"	2.51668967780415	-10.6720447770325	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGGTGAATATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.58062458782	42.051291008401	0.0174807240208822	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2402.52452613196	2402.52452613196
"healthy-2"	"2019-08-01-count-3:AACCAACAGCATTTCG"	2.39448799666707	-10.2505197755066	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACAGCATTTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.00716652598	44.7307168826646	0.0190261933351577	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.56398995562	2343.56398995562
"healthy-2"	"2019-08-01-count-3:CTAGGTATCTGTGCTC"	2.68147172507588	-10.4662885895935	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGGTATCTGTGCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.29608722827	38.3607953435513	0.0150771742078734	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2538.54019829268	2538.54019829268
"healthy-2"	"2019-08-01-count-2:GAAGTAAAGTGAGGTC"	1.66991080817525	-9.47787954723509	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAAAGTGAGGTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2439.57991464195	39.935993836469	0.0163700289532554	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2434.96422837079	2434.96422837079
"healthy-2"	"2019-08-01-count-3:AAGTCGTTCATTGGTG"	0.329077203839463	11.8659076460632	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTCGTTCATTGGTG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1511.00062293247	19.2994360530528	0.0127726195212266	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1507.02446684842	1507.02446684842
"healthy-2"	"2019-08-01-count-2:TCGGGACAGCGATGCA"	2.57763447341267	-11.0339641801086	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACAGCGATGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.63399000042	40.7127271824927	0.018400118305371	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2206.51866320733	2206.51866320733
"healthy-2"	"2019-08-01-count-4:TTAGGCATCGATCCAA"	1.58005227622334	-4.8059873810974	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGCATCGATCCAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2388.52140611453	37.1228216912417	0.0155421766772568	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2382.91558056505	2382.91558056505
"healthy-2"	"2019-08-01-count-2:GTTACGATCACCTACC"	1.87789561328236	-5.1367020837036	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACGATCACCTACC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2416.03507274861	39.3016290942515	0.0162669944395881	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2406.35211251652	2406.35211251652
"healthy-2"	"2019-08-01-count-3:GCCCAGAAGCGCCTAC"	2.13916601714436	-10.3208179703918	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCAGAAGCGCCTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1645.53466737347	3.61974066976572	0.00219973528454639	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1645.53466737347	1645.53466737347
"healthy-2"	"2019-08-01-count-2:GCATTAGGTGACACGA"	2.45365657386128	-10.6575050584045	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATTAGGTGACACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.74835817739	47.9733504744068	0.0222330608166603	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2152.44550556535	2152.44550556535
"healthy-2"	"2019-08-01-count-3:TGATGGTCACAGTCCG"	2.37867345389668	-10.9992656937805	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGGTCACAGTCCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.38185937001	40.5158183221256	0.0172086860765088	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.31045708219	2346.31045708219
"healthy-2"	"2019-08-01-count-2:CGCATAATCCTCACTG"	-2.39255319061931	3.32945010745851	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAATCCTCACTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3260.99799579978	44.7773349220858	0.0137311752352377	5787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3253.89389154328	3253.89389154328
"healthy-2"	"2019-08-01-count-3:CGAAGTTCAGTAGGAC"	2.29527749594991	-8.55326940929564	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTCAGTAGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2064.67036365492	37.2554942306022	0.0180442819766404	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2062.33071167161	2062.33071167161
"healthy-2"	"2019-08-01-count-3:AGGACGACAGGATCTT"	1.06822671469991	-8.91186048900756	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACGACAGGATCTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2508.53960616384	41.9158551843189	0.016709265853856	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2506.86512188154	2506.86512188154
"healthy-2"	"2019-08-01-count-2:GGCTTGGGTCGCACAC"	10.8394943672115	4.13942334735719	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTGGGTCGCACAC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1714.60536262085	38.2603513895757	0.0223143775376352	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1703.6736707782	1703.6736707782
"healthy-2"	"2019-08-01-count-4:AAGCGTTGTCGTGGAA"	4.5848204093868	-10.6843223801819	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGTTGTCGTGGAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.61225218767	46.4986950454727	0.0199855798927178	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2321.4313221867	2321.4313221867
"healthy-2"	"2019-08-01-count-4:CACCGTTAGAGTTGAT"	0.958799441426438	11.2381028898987	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCGTTAGAGTTGAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1798.42412453163	40.8942910551143	0.0227389582342066	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1793.45564312973	1793.45564312973
"healthy-2"	"2019-08-01-count-2:AGTAGTCAGGCTAACG"	4.45050062712972	-10.6814642182556	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGTCAGGCTAACG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.6952603634	40.7276837671472	0.0175346652064788	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2318.16237787788	2318.16237787788
"healthy-2"	"2019-08-01-count-2:AGTAGTCCAACGTATC"	-3.28225837174113	-4.46136763012084	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGTCCAACGTATC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2690.00820288565	40.8873324868805	0.015199705503879	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2684.23460932095	2684.23460932095
"healthy-2"	"2019-08-01-count-3:AATCGTGAGGGTTAAT"	3.09905232962911	-10.7538147202698	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGTGAGGGTTAAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2100.3076322047	41.3779970759854	0.0197009221132767	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2094.77385882894	2094.77385882894
"healthy-2"	"2019-08-01-count-3:CCGGTGAAGTCGTTAC"	4.39472260054891	-10.9015932313171	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTGAAGTCGTTAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.87990283205	42.9315440114297	0.0179638918091888	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2381.39622952785	2381.39622952785
"healthy-2"	"2019-08-01-count-2:GACACGCGTTTACACG"	1.36705615100209	11.3067760237488	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACACGCGTTTACACG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2013.60949484215	34.9821264752778	0.0173728454126207	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2011.1881205092	2011.1881205092
"healthy-2"	"2019-08-01-count-4:TGAGGAGCACAAGTGG"	2.13207425650899	-9.32564451610716	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGCACAAGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.14381616596	40.8229755054281	0.0175874390983921	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.56617491031	2317.56617491031
"healthy-2"	"2019-08-01-count-4:TTCAATCCACAGCCTG"	1.33463587340657	9.50215051257936	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAATCCACAGCCTG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.97650651509	31.9795690144326	0.018284733325637	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1743.6944982218	1743.6944982218
"healthy-2"	"2019-08-01-count-4:TGAGGAGGTCCGATCG"	1.84103943881337	-4.97145893489989	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGGTCCGATCG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2373.49105408696	40.678849279431	0.0171388256169684	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2369.3020671641	2369.3020671641
"healthy-2"	"2019-08-01-count-3:CACGTGGGTTAGGAGC"	14.1777340370113	1.75041685188142	"2019-08-01-count-3"	"Control2"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGGTTAGGAGC"	"Plasma cell"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1552.1227986457	31.3380756209336	0.0201904615074771	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1537.69893293191	1537.69893293191
"healthy-2"	"2019-08-01-count-3:TCATTCATCCATTCGC"	-7.14886889877971	3.9139947661194	"2019-08-01-count-3"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTCATCCATTCGC"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2345.4914729854	39.9251756106877	0.0170220936935959	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2339.35986411413	2339.35986411413
"healthy-2"	"2019-08-01-count-2:GTGATGTAGTCATCGT"	1.81076087531392	-10.319043182489	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGATGTAGTCATCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.76230789998	39.6882844313665	0.0171309263345801	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.92957857964	2308.92957857964
"healthy-2"	"2019-08-01-count-4:CTGGCAGGTGTATTGC"	1.89018501815144	-9.95174982463988	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGCAGGTGTATTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.07972798637	40.1071926508038	0.0173768662167465	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.51845584441	2301.51845584441
"healthy-2"	"2019-08-01-count-4:TGTCCTGCATAAGCAA"	-0.852494041354019	10.5207700499329	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGCATAAGCAA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1855.09275464133	35.1163890149811	0.018929721399171	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1847.72239351354	1847.72239351354
"healthy-2"	"2019-08-01-count-3:ATCCGTCCAGACGGAT"	2.88942994651143	-10.8393297425476	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCCAGACGGAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.43643807381	36.4581289842844	0.0156175290916752	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.77063508084	2332.77063508084
"healthy-2"	"2019-08-01-count-3:AACCCAATCCCAATAG"	2.33380665358846	-10.4841566315857	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAATCCCAATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.17582862231	52.8153508001983	0.0279716274298112	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1885.39318936973	1885.39318936973
"healthy-2"	"2019-08-01-count-4:AACACACAGAGTCACG"	6.87297977980916	-1.39071335708769	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACAGAGTCACG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2447.2948471326	30.6139055900575	0.0125092837203195	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2441.70330147676	2441.70330147676
"healthy-2"	"2019-08-01-count-3:GACCCTTAGGAAAGAC"	-5.10646424713786	-5.23861792003783	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCTTAGGAAAGAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2225.05310463615	44.9338033813111	0.020194485824939	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2220.12528096931	2220.12528096931
"healthy-2"	"2019-08-01-count-3:TACCCACGTCGAAACG"	2.66351332244222	-10.9023876420227	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACGTCGAAACG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.53713580199	40.6513305579149	0.0188328150040426	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2155.02338093154	2155.02338093154
"healthy-2"	"2019-08-01-count-2:GGGAGATAGTCGGGAT"	2.86724128302876	-11.0161237946716	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAGATAGTCGGGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.12974116089	39.3698225685224	0.0173349068769618	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.55858891078	2265.55858891078
"healthy-2"	"2019-08-01-count-4:AAGTGAAAGTAGGAAG"	2.52463306960408	-10.9229488602844	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAAAGTAGGAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.84126336191	40.0252209927992	0.0171499328686745	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2330.2500781264	2330.2500781264
"healthy-2"	"2019-08-01-count-4:AGACACTGTTCGCGTG"	2.09641851958577	-5.23494388973387	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTGTTCGCGTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2278.04191053304	43.2971590950516	0.0190063048861644	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2272.86599260492	2272.86599260492
"healthy-2"	"2019-08-01-count-4:GTACAGTCATCTAACG"	4.29303850707356	-10.8665113679138	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAGTCATCTAACG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.73895540785	41.5966897563068	0.0161619692117203	2131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2570.4274283637	2570.4274283637
"healthy-2"	"2019-08-01-count-2:CAACCTCGTTCGAACT"	4.42215504226033	-10.7754783860412	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCGTTCGAACT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.49884005424	35.2375800744263	0.0143096839280745	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2459.12507753557	2459.12507753557
"healthy-2"	"2019-08-01-count-4:ATCATTCTCTCTTGCG"	2.35291709479634	-10.8512172929016	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCATTCTCTCTTGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.47080882565	38.6710566075299	0.0168834531566709	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2290.47080882565	2290.47080882565
"healthy-2"	"2019-08-01-count-3:GACCGTGTCTATTGTC"	-3.35716138306316	3.55693528735963	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGTCTATTGTC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3186.96780223525	47.2127960646912	0.0148143310489605	4941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3179.60977393845	3179.60977393845
"healthy-2"	"2019-08-01-count-3:ATCCTATTCACGAACT"	2.37945308265035	-10.8531389466492	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATTCACGAACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.19541624766	38.2683381479101	0.0154171335171348	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2477.50259929781	2477.50259929781
"healthy-2"	"2019-08-01-count-4:TTCATTGAGTGATAGT"	2.57031406935994	-11.005756401178	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATTGAGTGATAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.97472261457	35.7534057558983	0.0141151845838371	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2529.56744205484	2529.56744205484
"healthy-2"	"2019-08-01-count-2:GAGGCCTCACGGTGCT"	2.69216336783711	-10.3751373521057	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTCACGGTGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.85615113291	38.8341886543241	0.0141428343354045	2727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2737.96163934143	2737.96163934143
"healthy-2"	"2019-08-01-count-4:GTAGAGGGTCTCTCTG"	2.35920395430867	-10.544327758905	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGGTCTCTCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.20408999109	38.8997300527325	0.0163019291668709	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.29962484794	2383.29962484794
"healthy-2"	"2019-08-01-count-3:CACTGGGCAACAGTGG"	3.27067246016805	-10.7845478287903	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGCAACAGTGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.40603377561	42.1846932552757	0.0182348851171741	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2309.5439877771	2309.5439877771
"healthy-2"	"2019-08-01-count-3:ATCGATGAGTCGCCAC"	4.59993853148763	-10.4013662568298	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGAGTCGCCAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.62712934647	40.9955412555641	0.0171198015562249	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.94707328332	2390.94707328332
"healthy-2"	"2019-08-01-count-3:TACCGGGGTGGAACCA"	3.6776827770168	-9.51952745830687	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCGGGGTGGAACCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.05968030299	46.7683478497405	0.0214233024739156	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2178.92092835566	2178.92092835566
"healthy-2"	"2019-08-01-count-4:ATCCCTGCACATAGCT"	4.64411034163777	-10.0985508195129	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCCTGCACATAGCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.38411770317	43.4981289853244	0.016995545406588	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2551.26393179511	2551.26393179511
"healthy-2"	"2019-08-01-count-2:GCCCAGACACCAAATC"	4.52079548415486	-10.8361101380554	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGACACCAAATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.63981402492	42.7738951723211	0.016915772240506	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2517.61124456757	2517.61124456757
"healthy-2"	"2019-08-01-count-4:GCCGATGCAGTTTGGT"	4.2788540321285	-10.7685718766418	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGCAGTTTGGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.56163339611	44.3320122684481	0.0190711279200115	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.52160928013	2317.52160928013
"healthy-2"	"2019-08-01-count-3:GTGCAGCAGCCGTTAT"	2.98929919776265	-11.0466642609802	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCAGCCGTTAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.50773274109	38.5141418163228	0.0160709441034313	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.65654065485	2390.65654065485
"healthy-2"	"2019-08-01-count-4:TGGGAAGGTATAATGG"	1.99217714843099	-10.0080795518127	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAAGGTATAATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.98204115471	41.5460284153651	0.0183427628389427	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2262.99426593565	2262.99426593565
"healthy-2"	"2019-08-01-count-2:GTTGCGGCATTGAAAG"	1.39493431624715	10.0172900923523	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCGGCATTGAAAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1778.72757242516	37.5285236152014	0.021098522447726	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1769.23816663625	1769.23816663625
"healthy-2"	"2019-08-01-count-3:GTATTGGCAAGTGCTT"	1.28949632224385	11.4365587004456	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTGGCAAGTGCTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.41837351757	30.696718177479	0.0164999005677629	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1852.43965136774	1852.43965136774
"healthy-2"	"2019-08-01-count-4:TCCACGTTCTAGGCAT"	-5.22780833664592	3.15583870494691	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTTCTAGGCAT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2584.97121181042	38.2043926953725	0.0147794267575675	3025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2579.05649165095	2579.05649165095
"healthy-2"	"2019-08-01-count-2:TCTACATCAAACTAGA"	1.49938120421712	11.0716380842957	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACATCAAACTAGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.60556684573	34.2588500765418	0.0178097062448818	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1916.36220890879	1916.36220890879
"healthy-2"	"2019-08-01-count-2:ACATGCACACATGTTG"	-4.93234382095988	-5.16671516811522	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCACACATGTTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2867.6729852758	42.884457376731	0.0149544448048725	3834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2862.42494837362	2862.42494837362
"healthy-2"	"2019-08-01-count-3:CAGAGCCAGCCATCCG"	3.29729785498921	-10.7717857590881	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGAGCCAGCCATCCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.87283416808	40.2281693009512	0.0174686889801641	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2298.53085072223	2298.53085072223
"healthy-2"	"2019-08-01-count-3:TTGAACGAGAAGCGGG"	3.38632406768147	-10.6126375428406	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAACGAGAAGCGGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.66310808846	40.9370195825367	0.0178013116088837	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.01688769323	2294.01688769323
"healthy-2"	"2019-08-01-count-2:GTTGTAGTCCCGAATA"	3.53277196463887	-10.8748226395813	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTAGTCCCGAATA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.1882046607	43.5037784910816	0.0193248074066018	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.78679986395	2241.78679986395
"healthy-2"	"2019-08-01-count-2:CAACGGCGTACCAGAG"	2.4985314804012	-10.8476772538391	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCGTACCAGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.30410445957	40.4182937997058	0.0172557840473201	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2335.2893402274	2335.2893402274
"healthy-2"	"2019-08-01-count-4:AGAGCAGGTAGTCGTT"	2.3839816051418	-10.2581634751526	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGGTAGTCGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.13268274011	34.5366206069099	0.015321467485635	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.08992747848	2248.08992747848
"healthy-2"	"2019-08-01-count-2:TCACGGGTCAGTCAGT"	6.90561022338216	-1.16003253376158	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGTCAGTCAGT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2241.69483023893	34.4914471808507	0.0153863258796803	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2236.28747730073	2236.28747730073
"healthy-2"	"2019-08-01-count-4:CACTGGGTCTTTCTAG"	1.21565975722615	10.9189615019592	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGTCTTTCTAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2041.6138779672	34.0520364296586	0.016678979701864	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2032.12068260096	2032.12068260096
"healthy-2"	"2019-08-01-count-4:TTCCGTGCATCCTAAG"	2.42889132079427	-10.6341400376526	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGCATCCTAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1813.00466828321	48.4268090799006	0.0267108021987376	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1807.77153754116	1807.77153754116
"healthy-2"	"2019-08-01-count-2:GTTTACTCACGCGCTA"	2.22360934790913	-10.3537702790466	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTCACGCGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.87202837312	38.9255026679278	0.0162672730536253	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2391.18421509259	2391.18421509259
"healthy-2"	"2019-08-01-count-4:GGCACGTGTACAGAAT"	2.04479112204854	-8.91611387645873	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCACGTGTACAGAAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2444.61567567244	42.1349275069775	0.0172358084447722	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2441.77253540318	2441.77253540318
"healthy-2"	"2019-08-01-count-2:GCCGATGTCGGATACT"	2.1765886741573	-9.62693788921507	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGTCGGATACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.59142016093	43.2688692824109	0.0186055335891361	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2319.17075176436	2319.17075176436
"healthy-2"	"2019-08-01-count-2:GTTTGGAAGCCATGCC"	1.58574857291524	-4.77979423916014	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAAGCCATGCC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2332.0130584649	37.8451155404949	0.0162285178477548	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2328.52255046896	2328.52255046896
"healthy-2"	"2019-08-01-count-3:ACAAGCTGTTTACACG"	2.45893897589986	-10.6613197556702	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTGTTTACACG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.99636551885	38.8858336539988	0.0165120567587082	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2349.13422756856	2349.13422756856
"healthy-2"	"2019-08-01-count-4:TTCCGTGTCAAACCCA"	2.45835079726521	-10.3847456208435	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGTCAAACCCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2521.18784847934	41.1885548634677	0.0163369638991044	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2518.89343527474	2518.89343527474
"healthy-2"	"2019-08-01-count-2:CAAGCTATCGGCAGTC"	-2.51023922386821	13.3521804579529	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTATCGGCAGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2073.11693426153	42.1418814183461	0.0203277879418595	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2071.53720900231	2071.53720900231
"healthy-2"	"2019-08-01-count-2:CTCCCAACAGCAGTAG"	3.02353729781453	-10.9629879227844	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAACAGCAGTAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.73444335615	41.2439794830245	0.0173095157951933	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.42273171678	2377.42273171678
"healthy-2"	"2019-08-01-count-2:TCAGCAACATCATCTT"	2.17304696616475	-10.7364683381286	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAACATCATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.94269208775	40.9158391750775	0.017396614004552	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.8434204945	2341.8434204945
"healthy-2"	"2019-08-01-count-2:TGTGAGTCAGACATCT"	2.56205834922139	-10.9437637559143	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTCAGACATCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.18274809858	43.079622253145	0.0195533585628901	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2201.16037928702	2201.16037928702
"healthy-2"	"2019-08-01-count-2:ATCTTCAAGATAACAC"	2.20692815360371	-10.2385254136291	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTTCAAGATAACAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.26224147285	43.9529649983559	0.0176145674261525	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.1982974266	2493.1982974266
"healthy-2"	"2019-08-01-count-3:CCCTAACTCATTGCTT"	2.88816871222798	-10.9409799805847	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACTCATTGCTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.186830296	38.9183922001757	0.0163578545848515	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2369.73061267858	2369.73061267858
"healthy-2"	"2019-08-01-count-3:CCTCCTCCACCTTCGT"	2.34013595160787	-10.0616951218811	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCTCCACCTTCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.80422004812	44.716218032139	0.0175165089750972	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2548.95937578262	2548.95937578262
"healthy-2"	"2019-08-01-count-4:AATGGCTTCAGCCCAG"	3.67606343802754	-10.6002216569153	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGCTTCAGCCCAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.17341312155	38.45591523959	0.0169098429423661	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2270.16871558098	2270.16871558098
"healthy-2"	"2019-08-01-count-4:CAGAGCCTCTGGGCCA"	3.1497560935909	-10.5627460709778	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCTCTGGGCCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2382.72846666155	39.1660913112518	0.0164374967014716	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2377.07382509868	2377.07382509868
"healthy-2"	"2019-08-01-count-2:GAACTGTCAAGGGTCA"	1.22486652907674	11.0970935591492	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTCAAGGGTCA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.9587507811	36.5833504887184	0.017767888975357	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2054.30533839091	2054.30533839091
"healthy-2"	"2019-08-01-count-3:GAGAAATCACATATCG"	4.51163878020589	-10.7523451081482	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATCACATATCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.51566191693	43.5674017444532	0.0198981914138535	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2182.9933068591	2182.9933068591
"healthy-2"	"2019-08-01-count-3:ATCTCTATCACCGGGT"	2.70976914939229	-10.8911705247131	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTATCACCGGGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.70536947816	42.5103092585264	0.0181380773420302	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.75458278624	2342.75458278624
"healthy-2"	"2019-08-01-count-2:GACTGATAGGCGTTGA"	2.01884295520131	-8.92070295726927	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATAGGCGTTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.07614325956	42.3404944958034	0.0191579347276954	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2205.85937334009	2205.85937334009
"healthy-2"	"2019-08-01-count-3:GCTGCAGGTCTGCGCA"	2.01525976237599	-10.5661812058655	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGCAGGTCTGCGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.43618917906	40.4557621578526	0.0173448527104579	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.04982704971	2328.04982704971
"healthy-2"	"2019-08-01-count-4:ACCTACCTCCATATGG"	2.15495099601094	-10.6676845780578	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTACCTCCATATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.99807167591	36.5952437901192	0.0158421101033947	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2309.99807167591	2309.99807167591
"healthy-2"	"2019-08-01-count-4:CAGATCATCATCCTAT"	1.45661725577657	-9.17699339306029	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATCATCATCCTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.00437201535	42.0246398886649	0.0176351501416357	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.21539234012	2380.21539234012
"healthy-2"	"2019-08-01-count-3:TCCGTGTCAGCGACCT"	2.12427796897237	-10.5048218003479	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGTGTCAGCGACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.84154060184	39.1708379510451	0.0165638319855783	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2360.53605697094	2360.53605697094
"healthy-2"	"2019-08-01-count-2:TAACGACCAATTGTGC"	1.34363998946492	9.18910405719606	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACGACCAATTGTGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.56558066863	35.9121921683415	0.0215486222593973	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1662.20994391777	1662.20994391777
"healthy-2"	"2019-08-01-count-3:GAGAAATTCTTTGCAT"	2.20671357688252	-10.8988504639831	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATTCTTTGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.66366178749	38.7724446246057	0.016170927241605	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2394.01198558981	2394.01198558981
"healthy-2"	"2019-08-01-count-4:TACCTCGGTTTCACAG"	1.74162687835042	-5.11989834224852	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTCGGTTTCACAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2358.87433145695	38.4764734368616	0.0163113706074782	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2353.00510132438	2353.00510132438
"healthy-2"	"2019-08-01-count-2:CAATGACCATAGGCGA"	2.0922118621761	-10.5301599732605	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATGACCATAGGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.64439566164	43.5087043874161	0.0191867404213179	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.48478552412	2261.48478552412
"healthy-2"	"2019-08-01-count-3:TGTGCGGTCTGTTCAT"	3.19227160987203	-10.8540354005066	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGCGGTCTGTTCAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.07835324792	42.5729916483151	0.0183656396207078	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2311.96409955515	2311.96409955515
"healthy-2"	"2019-08-01-count-4:GCACGTGTCTAAGCGT"	1.60856988009755	-9.66905977642211	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGTCTAAGCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.59883640854	44.0234044692001	0.0180601515768946	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2430.16432312644	2430.16432312644
"healthy-2"	"2019-08-01-count-3:CCTCTCCTCACTCGAA"	2.36638583716695	-11.0025148621765	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCTCACTCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.66123727177	42.7374223669782	0.0169481220297524	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2515.59227830695	2515.59227830695
"healthy-2"	"2019-08-01-count-4:GTCACTCTCAAGGACG"	1.79523911055867	-9.96391394054564	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCTCAAGGACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.11363309707	40.1576191524348	0.0160687447823926	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.47145204228	2493.47145204228
"healthy-2"	"2019-08-01-count-2:AATTTCCGTAGACGGT"	-2.19479976120647	13.5189733275208	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCGTAGACGGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1804.09244987728	46.0593259373491	0.0255304687631071	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1802.04179231824	1802.04179231824
"healthy-2"	"2019-08-01-count-2:CTCCTTTCAGCTGTAT"	1.64126398143117	-9.74143793499144	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTCAGCTGTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.54402445627	39.154012926822	0.0152733920515083	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2561.17503098622	2561.17503098622
"healthy-2"	"2019-08-01-count-3:TAGACCAAGCGGTATG"	2.23354281958882	-10.7700691453186	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACCAAGCGGTATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.54027680382	41.351360367304	0.0180137812371035	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.70607215927	2292.70607215927
"healthy-2"	"2019-08-01-count-4:GTCAGCGAGCTCAGAG"	2.90091027793233	-10.7211618653503	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGAGCTCAGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.0178066256	41.1409654820031	0.016456268980553	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.38941683457	2493.38941683457
"healthy-2"	"2019-08-01-count-4:GGGACAATCGTTCAGA"	2.91356100615804	-10.9841842881409	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAATCGTTCAGA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.30900945968	40.7673565373209	0.0171485307021936	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2372.09034595399	2372.09034595399
"healthy-2"	"2019-08-01-count-3:CTGTGAAGTGGTTTAC"	2.64944567260091	-10.9593153229919	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAAGTGGTTTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.42253567479	44.3098135674509	0.0188679051126202	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.36202626721	2345.36202626721
"healthy-2"	"2019-08-01-count-4:GTGCTGGGTCCATAGT"	-2.04327903214152	13.3236903914246	"2019-08-01-count-4"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTCCATAGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2141.21915929201	37.1499482012989	0.0173499046279702	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2136.44011158823	2136.44011158823
"healthy-2"	"2019-08-01-count-3:GATGGAGCACGGTGCT"	4.48191608962361	-10.4883070222107	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGGAGCACGGTGCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.29548846659	41.218377258934	0.0180442405402653	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.58155520848	2278.58155520848
"healthy-2"	"2019-08-01-count-4:CTCAATTCAGGAGGAG"	2.61107148703877	-10.995406173822	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAATTCAGGAGGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.87368920117	39.8978416300626	0.0156285999573082	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2546.93981795894	2546.93981795894
"healthy-2"	"2019-08-01-count-2:ACAAAGAAGGGTACGT"	2.35537399825398	-10.8338041535583	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGAAGGGTACGT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.41104164222	42.7046753191912	0.0199329981451444	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2135.78311276693	2135.78311276693
"healthy-2"	"2019-08-01-count-2:ACAAAGAAGATACGAT"	2.49903931197469	-10.5480699769226	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGAAGATACGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.34199514921	36.5890713100665	0.0152179146660023	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2401.00585575663	2401.00585575663
"healthy-2"	"2019-08-01-count-4:TCCGGGACACTTCAGA"	1.1782623725826	-9.07166960155638	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGACACTTCAGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2205.80471971492	42.8068289319634	0.0194064454343428	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2203.73083449319	2203.73083449319
"healthy-2"	"2019-08-01-count-4:TTCGGTCTCGTAGTGT"	2.94093622741048	-10.7328205338684	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCTCGTAGTGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.00421506305	40.8323766022731	0.0176077198726278	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.86397204894	2314.86397204894
"healthy-2"	"2019-08-01-count-3:TCCTCTTTCACCTTGC"	2.36969389495198	-10.7550049058166	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCTTTCACCTTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.14086541989	39.9968034817366	0.0163242873282236	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2443.70407394939	2443.70407394939
"healthy-2"	"2019-08-01-count-3:ACATCGAAGACATCCT"	3.1599825817043	-10.7047243348328	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCGAAGACATCCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2080.88175429773	41.896496493857	0.0201340111745064	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2075.58608267158	2075.58608267158
"healthy-2"	"2019-08-01-count-3:ACATCCCTCTGAGAAA"	7.84177984771077	7.42133710468141	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCCCTCTGAGAAA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1717.23005130706	34.0222212919267	0.0198122675910725	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1717.23005130706	1717.23005130706
"healthy-2"	"2019-08-01-count-1:TACGTCCAGGGAGTTC"	2.70846094664876	-10.951105140802	"2019-08-01-count-1"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACGTCCAGGGAGTTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.3732292535	37.7855082897905	0.0141023683737849	2899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2673.51266344165	2673.51266344165
"healthy-2"	"2019-08-01-count-4:GGTGTTATCCTTGGAA"	2.43263425406758	-10.7927084199158	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTATCCTTGGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.69917167004	46.046683171826	0.020568499669152	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2236.13667891731	2236.13667891731
"healthy-2"	"2019-08-01-count-4:GCATCTCCAAGTGGAC"	1.41144492205922	-9.55108358776244	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATCTCCAAGTGGAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2515.06889509618	44.5883776167953	0.017728491535056	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2511.04161186233	2511.04161186233
"healthy-2"	"2019-08-01-count-2:TCCGATCGTGGTAATA"	7.01688494262044	-1.17522027408751	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCGTGGTAATA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2482.81282889624	43.0195066622793	0.0173269229809015	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2471.7428225289	2471.7428225289
"healthy-2"	"2019-08-01-count-2:AGTACTGAGGGAGTTC"	2.17906369742696	-10.7215891114441	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACTGAGGGAGTTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.26713385531	44.2946004203549	0.0203721979377087	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2169.86054022818	2169.86054022818
"healthy-2"	"2019-08-01-count-3:CATACAGCAGCAGTAG"	4.52513088759725	-10.833182357904	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGCAGCAGTAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.89938326463	39.6468016181217	0.0180631521975063	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2188.95974186371	2188.95974186371
"healthy-2"	"2019-08-01-count-4:CAGCCAGTCTGCGTCT"	2.22857274588887	-10.5698261491028	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGTCTGCGTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.52763159044	39.4877987435076	0.0157665654175401	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2502.10721520582	2502.10721520582
"healthy-2"	"2019-08-01-count-3:TTGTTCACACTGCACG"	1.60724546489064	-4.86540510570677	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTCACACTGCACG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2314.67342671803	39.7183663968662	0.0171593823726498	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2309.6794432812	2309.6794432812
"healthy-2"	"2019-08-01-count-3:TTGTGTTTCGGACGTC"	1.98744668540303	-5.40910437023314	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTTCGGACGTC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2354.35830705161	40.3915458258368	0.0171560742070817	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2347.55420036769	2347.55420036769
"healthy-2"	"2019-08-01-count-4:CAGGCCAGTTCGGCGT"	3.20408119735066	-10.3474731675354	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGCCAGTTCGGCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.42267214203	40.0490911384008	0.0182837274502991	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2187.94806440112	2187.94806440112
"healthy-2"	"2019-08-01-count-2:CCAATTTTCATCTACT"	2.47274484214131	-11.0068960419861	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTTCATCTACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.52242536985	25.6915754978769	0.0120588148671643	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2129.01579870108	2129.01579870108
"healthy-2"	"2019-08-01-count-2:TAATTCCAGCCGAACA"	2.48013271865193	-10.4404125443664	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATTCCAGCCGAACA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.72955913937	33.3364142181011	0.0145084150941538	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.42386374434	2294.42386374434
"healthy-2"	"2019-08-01-count-4:CTCACTGTCTGCGAGC"	-6.29359994354899	3.97192952716676	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGTCTGCGAGC"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2418.81610542043	36.2613299750975	0.0149913546109759	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2413.40213277669	2413.40213277669
"healthy-2"	"2019-08-01-count-4:CTCACTGTCTATCGTT"	1.52311636981313	9.75899121845094	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGTCTATCGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.42727835799	33.2925117906389	0.0177709122607731	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1869.30020394827	1869.30020394827
"healthy-2"	"2019-08-01-count-3:ACTATCTTCGACGCGT"	-2.14242182198222	12.972759223822	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATCTTCGACGCGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1682.80513972951	47.1285469460097	0.0280059442613688	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1676.56613276972	1676.56613276972
"healthy-2"	"2019-08-01-count-2:ACCTGTCAGCAACAGC"	-1.44137726250346	12.0004539259705	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCAGCAACAGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1640.28853669181	46.5120068629974	0.0283559909263309	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1635.939780457	1635.939780457
"healthy-2"	"2019-08-01-count-3:TCAATTCAGGGTGAGG"	3.94095577773396	-10.6399622193542	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCAGGGTGAGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.71181392226	40.8954781217309	0.0185997445698797	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2195.42117700848	2195.42117700848
"healthy-2"	"2019-08-01-count-2:ATCATTCAGCGATCGA"	2.13281478461568	-9.47501947796019	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCATTCAGCGATCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.13494184308	40.0030523069152	0.0174067464788787	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2293.34974492853	2293.34974492853
"healthy-2"	"2019-08-01-count-3:AGTCACACATACCGTA"	1.27800824221913	-9.0356540909973	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACACATACCGTA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2443.92075578234	43.9779756263068	0.0179948451774692	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2440.7661587871	2440.7661587871
"healthy-2"	"2019-08-01-count-2:TACAACGTCCAATCTT"	1.80818202075307	-10.0238275757995	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAACGTCCAATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.59857418692	38.6009143936461	0.0160129997615493	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2407.98979450444	2407.98979450444
"healthy-2"	"2019-08-01-count-4:TCCTCTTGTGGACCAA"	-2.40905127945598	13.2894458540711	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCTTGTGGACCAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1828.65492265471	35.8384462713162	0.0195982554320793	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1826.69497085112	1826.69497085112
"healthy-2"	"2019-08-01-count-3:ATGCGATGTGCACAAG"	1.70039548453633	-9.63847162639769	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCGATGTGCACAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.18624921624	38.7163050097953	0.0172595142393203	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2238.41429167341	2238.41429167341
"healthy-2"	"2019-08-01-count-3:ATGGAGGGTCTTAGTG"	6.9932972389156	-1.10190334236296	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGAGGGTCTTAGTG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2103.42735074767	34.6282090773081	0.0164627549722596	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2096.65663371395	2096.65663371395
"healthy-2"	"2019-08-01-count-4:GGAAGTGAGTTGCGAG"	2.55825676497762	-11.0112276307312	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAAGTGAGTTGCGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.32676727568	39.0881605027805	0.0159392137395312	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.35493612573	2450.35493612573
"healthy-2"	"2019-08-01-count-4:AGCGTATCACATAACC"	3.41486110266988	-10.7530393830505	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGTATCACATAACC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.06511275919	43.5605691607478	0.0166766781379097	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2605.83490463546	2605.83490463546
"healthy-2"	"2019-08-01-count-4:TGCTTGCGTTTCGCTC"	2.27540149268453	-10.4516897431579	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCGTTTCGCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2110.35497497333	37.639673183319	0.0178357070870481	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2105.90815225121	2105.90815225121
"healthy-2"	"2019-08-01-count-2:GTCAAACCATAGAATG"	7.8082705932552	6.53375670993654	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAACCATAGAATG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1486.49427663535	46.1858871391102	0.0310703430649266	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1474.84058561214	1474.84058561214
"healthy-2"	"2019-08-01-count-2:TTTCCTCTCTTGATTC"	-3.42694125595744	-5.62869932567748	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCCTCTCTTGATTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2565.85118656209	41.8299919236482	0.0163025790983985	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2552.05152475624	2552.05152475624
"healthy-2"	"2019-08-01-count-2:AGGAGGTTCTCGTGGG"	1.58260430869405	-9.51206781780394	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAGGTTCTCGTGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.07980107628	39.5286310614039	0.0172683499469168	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2288.0369844093	2288.0369844093
"healthy-2"	"2019-08-01-count-3:TAGGTACAGTAAACGT"	-2.60494385185893	13.0886430510315	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACAGTAAACGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.03465394923	41.232536336833	0.0208031359364361	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1970.12931266866	1970.12931266866
"healthy-2"	"2019-08-01-count-2:TCGGTCTCAACGGCTC"	1.50558890876119	-9.31083872234496	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGTCTCAACGGCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.1518026357	46.0049123983579	0.0213663116283964	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2150.10975665678	2150.10975665678
"healthy-2"	"2019-08-01-count-4:CAACAACAGCTGAAAT"	-5.13930163803752	-5.28724243557128	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACAGCTGAAAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2476.45658905781	45.0175116724562	0.0181781953583865	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2471.22753139559	2471.22753139559
"healthy-2"	"2019-08-01-count-4:TCCTTTCAGTTACTCG"	1.64197506484334	-9.54025556957396	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCAGTTACTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.05860878264	49.2656456301469	0.020742917858098	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.54514555998	2367.54514555998
"healthy-2"	"2019-08-01-count-2:TCATGAGGTTACGATC"	2.33163752135579	-10.6861028901306	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGGTTACGATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2133.78016054412	46.3314621250867	0.021713325009673	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2131.62075748621	2131.62075748621
"healthy-2"	"2019-08-01-count-2:CTCATCGAGCACTTTG"	2.75092639502828	-10.3481827012268	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGAGCACTTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.38409832983	41.9683160403758	0.0172327297649506	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2430.45049325031	2430.45049325031
"healthy-2"	"2019-08-01-count-3:TGGTAGTTCTTTGATC"	2.51651157912557	-10.7505674592224	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTTCTTTGATC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.3401881345	38.8091705703159	0.015319367983853	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2527.22724355899	2527.22724355899
"healthy-2"	"2019-08-01-count-4:GGACGTCAGACATCCT"	1.67567815360371	-9.70925333416136	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGACGTCAGACATCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.13670650014	41.3870122159015	0.0184340722309147	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.40196273709	2241.40196273709
"healthy-2"	"2019-08-01-count-4:TAAGCCACAACTGTGT"	1.46596207198445	10.2255182036194	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCCACAACTGTGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1825.6698969702	34.7782253404297	0.0190495693652757	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1817.22707505551	1817.22707505551
"healthy-2"	"2019-08-01-count-4:GGAATGGGTCAGGCAA"	2.20189466056172	-10.1214542618957	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATGGGTCAGGCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.85229075607	42.4980081082387	0.0192485739585801	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2206.71834465651	2206.71834465651
"healthy-2"	"2019-08-01-count-4:ATGGGTTGTGGGTATG"	1.62853791293446	-9.06549646770629	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGGTTGTGGGTATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.14065078888	42.7246790496775	0.0178380668524019	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.84935297196	2392.84935297196
"healthy-2"	"2019-08-01-count-2:AGATCCAGTCGCGTTG"	2.61952628669087	-10.9870014420715	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCCAGTCGCGTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.43683859087	45.9248065881979	0.0197914486722624	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2313.65150204429	2313.65150204429
"healthy-2"	"2019-08-01-count-3:CATCCACGTCAATCTG"	0.997583945363206	10.0835532912048	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACGTCAATCTG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1774.03417900215	36.2363727149442	0.0204259721395708	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1774.03417900215	1774.03417900215
"healthy-2"	"2019-08-01-count-2:CACGAATTCTTAGCAG"	-7.80237565460857	3.15245792949525	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCTTAGCAG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2528.00726170861	41.0795755053824	0.0162497854051328	2595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2514.81118304074	2514.81118304074
"healthy-2"	"2019-08-01-count-4:GTCTACCTCTATCGTT"	1.00662757930104	11.0226449736389	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCTCTATCGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2103.98537813704	34.8406708732229	0.016559369297553	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2100.14566019661	2100.14566019661
"healthy-2"	"2019-08-01-count-4:TCGAAGTAGTCCTACA"	2.33903946456258	-10.6680670014587	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTAGTCCTACA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.33028922542	41.5099802406807	0.0184790190649097	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2241.33507246105	2241.33507246105
"healthy-2"	"2019-08-01-count-3:GGATCTATCATCCTGC"	2.70162667807881	-10.731170677301	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATCTATCATCCTGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.25106374618	42.1379408421526	0.0194609953310672	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2161.04472647034	2161.04472647034
"healthy-2"	"2019-08-01-count-4:GTCTCACGTCCGGCAT"	4.45433678206746	-10.807251953241	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTCACGTCCGGCAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.75028734735	44.6082298380901	0.0199522415765924	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2234.39861977202	2234.39861977202
"healthy-2"	"2019-08-01-count-2:TCACACCCAGTGGCTC"	-1.7075848383015	12.6605958708557	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCCAGTGGCTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1543.95974351237	44.8573642877371	0.0290534545840493	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1534.38647885735	1534.38647885735
"healthy-2"	"2019-08-01-count-2:TTTGATCTCGGTATGT"	-1.31417105618175	13.0577096709046	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCGGTATGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1642.24019882207	42.2004893854645	0.0256969043966489	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1635.61127611868	1635.61127611868
"healthy-2"	"2019-08-01-count-1:TGCATCCAGATCCGAG"	7.85505737838094	6.79160020435182	"2019-08-01-count-1"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCATCCAGATCCGAG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1625.12979255703	39.9084069439995	0.0245570582280732	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1612.96600886981	1612.96600886981
"healthy-2"	"2019-08-01-count-4:CATACAGGTTACGATC"	3.13445009764974	-10.9151468507019	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACAGGTTACGATC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.82871030749	40.6005622303173	0.0166749151833313	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.40571086581	2426.40571086581
"healthy-2"	"2019-08-01-count-2:AGCATCACAACGTTAC"	-2.21478877487834	12.7825040587219	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCATCACAACGTTAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1977.23194680451	41.69158598717	0.0210858346966069	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1972.31920824099	1972.31920824099
"healthy-2"	"2019-08-01-count-2:CTGCCATGTGCTGTCG"	1.74940301951711	-9.4737119904724	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATGTGCTGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.23819454681	40.6424271691318	0.0175467390464493	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2313.9524870716	2313.9524870716
"healthy-2"	"2019-08-01-count-2:CACGTGGGTTCGGGTC"	2.60126485404317	-10.5129966965881	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGGTTCGGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.07292815505	37.8661802697061	0.0164917149648781	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.42665616374	2292.42665616374
"healthy-2"	"2019-08-01-count-2:ACATCCCGTCCCTGTT"	-2.05663309517558	13.1479244002136	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCGTCCCTGTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2028.43423564133	39.9455612401601	0.0196928056814869	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2026.57985715061	2026.57985715061
"healthy-2"	"2019-08-01-count-4:GAAGAATAGGTCATCT"	2.44715656813924	-10.7877979508606	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATAGGTCATCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.3636650209	38.0760637702803	0.0155707162557986	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2439.22215227497	2439.22215227497
"healthy-2"	"2019-08-01-count-2:CAGTTAGAGAGTATAC"	0.932898302643937	-8.75187017833861	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTAGAGAGTATAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2502.00830502526	38.4444926292321	0.0153654536445849	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2498.02497148855	2498.02497148855
"healthy-2"	"2019-08-01-count-2:CCATAAGGTGGATACG"	2.56471933898274	-9.96836283123168	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGGTGGATACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.07643282984	40.1377178535805	0.0174430180940228	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2299.97555712621	2299.97555712621
"healthy-2"	"2019-08-01-count-4:AGGACGAGTGGCAACA"	3.20361842688863	-10.3085413209167	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGAGTGGCAACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.01222646068	39.7781609728551	0.017789777936867	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2231.7122659765	2231.7122659765
"healthy-2"	"2019-08-01-count-2:CCATCACCAGTGGCTC"	1.39375938948933	9.46060369098512	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACCAGTGGCTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.45233634667	30.0332221800341	0.0158115166173629	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1886.79994993322	1886.79994993322
"healthy-2"	"2019-08-01-count-2:CTGCTCAAGCGACTTT"	1.74968208846394	-9.77122595226439	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCTCAAGCGACTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.80120750407	42.2818815910062	0.0173300519160988	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2436.165211935	2436.165211935
"healthy-2"	"2019-08-01-count-2:GATTTCTAGTCCGCCA"	8.21252502974812	7.45400140369264	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTAGTCCGCCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.03364001204	46.3083996008491	0.0245793910561773	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1864.55843343356	1864.55843343356
"healthy-2"	"2019-08-01-count-3:CGCATGGCACGCAAAG"	2.05215265330617	-10.0464363328186	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCATGGCACGCAAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.37574560726	44.0456658288552	0.0183647895495637	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2396.65641299484	2396.65641299484
"healthy-2"	"2019-08-01-count-1:TGTTCCGAGGAAGTCC"	2.44393171843831	-9.83253862774047	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGTTCCGAGGAAGTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.99034161539	46.8702683460051	0.0200386754541427	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.42763808067	2334.42763808067
"healthy-2"	"2019-08-01-count-2:TCATTGTAGCGTGAAC"	3.20243873175923	-10.3906078568664	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTGTAGCGTGAAC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2402.07503282689	43.5460388772112	0.0181285090107963	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2396.80545924319	2396.80545924319
"healthy-2"	"2019-08-01-count-4:AACCACAGTGCACGCT"	4.4215485053951	-10.870948814508	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACAGTGCACGCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.93763609381	39.9403736236679	0.0159829413294604	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2495.35047625382	2495.35047625382
"healthy-2"	"2019-08-01-count-2:CGGGCATCAACAAGAT"	2.68854941901509	-11.1099605790344	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGCATCAACAAGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.93702524522	40.5974343299046	0.0180759450837549	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2238.92039663507	2238.92039663507
"healthy-2"	"2019-08-01-count-3:ACCGTTCGTTCTTAGG"	2.46542825278584	-10.9015455476013	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCGTTCTTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.22466370564	39.7179452819361	0.0159112061744374	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2489.56460757571	2489.56460757571
"healthy-2"	"2019-08-01-count-2:TGAGACTTCATGAGTC"	1.91485609587972	-9.68521501934203	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGACTTCATGAGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.32822522387	44.3700122777762	0.0193558722479383	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.01478095636	2287.01478095636
"healthy-2"	"2019-08-01-count-3:ACCGTTCTCACGATAC"	1.43224110183064	-9.10522367870482	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCTCACGATAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.64105539588	34.3486840694264	0.0135731157906363	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2526.68628100738	2526.68628100738
"healthy-2"	"2019-08-01-count-4:CCAATTTCACGGTGTC"	2.66611256179158	-10.9619131318298	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTCACGGTGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.47212880267	39.9239080437307	0.0162790465892969	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2445.95060687695	2445.95060687695
"healthy-2"	"2019-08-01-count-3:ACCTGAAAGTGGCAGT"	-1.16766927662547	12.8926524885925	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGAAAGTGGCAGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1655.52104962716	43.7497748939844	0.026426589322943	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1653.37098601994	1653.37098601994
"healthy-2"	"2019-08-01-count-3:ATTCACTCATCCTCAC"	1.76252438601796	-5.0212087861267	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTCATCCTCAC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2603.51115910082	38.8934593396167	0.0149388487173028	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2600.80691085264	2600.80691085264
"healthy-2"	"2019-08-01-count-2:CTGGCAGCATTCCTCG"	8.01499809798543	7.09163282001344	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGCATTCCTCG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1644.52427965198	41.2681452798468	0.0250942754634064	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1636.59227193108	1636.59227193108
"healthy-2"	"2019-08-01-count-2:GTCCCATCATGGTACT"	-4.53796897354777	-5.46574118053588	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATCATGGTACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2935.0980242985	41.9733820526286	0.0143005043460722	3226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2934.05908087598	2934.05908087598
"healthy-2"	"2019-08-01-count-2:TACGGTAAGGGCTAAC"	1.98908700522725	-9.6876259080139	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGTAAGGGCTAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.55345494449	44.3187420227973	0.020003463208658	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2213.28183004863	2213.28183004863
"healthy-2"	"2019-08-01-count-3:CTGGACGTCACACCCT"	2.40510906752889	-10.9583530656067	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGACGTCACACCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.29023486497	39.8108337131571	0.0173824404903443	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.03075021134	2287.03075021134
"healthy-2"	"2019-08-01-count-2:CCCGAAGGTCACTTCC"	0.0746191601151645	11.4450559386047	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGGTCACTTCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1774.21741362922	43.9437061738178	0.0247679375911036	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1770.38870762727	1770.38870762727
"healthy-2"	"2019-08-01-count-4:AGGATCTGTGAGCTCC"	2.63054861602132	-10.5181522599426	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTGTGAGCTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.06761353968	42.8743256948783	0.0197207876277008	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2172.96852004272	2172.96852004272
"healthy-2"	"2019-08-01-count-3:ACCTGTCCATATTCGG"	4.32386698302571	-10.7546644440857	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGTCCATATTCGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.43227018142	42.1633064258433	0.0179309040538898	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.96310231304	2345.96310231304
"healthy-2"	"2019-08-01-count-4:GAGGCAAGTGAACTAA"	1.67541899260823	-4.99124815380248	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCAAGTGAACTAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2244.77946231332	43.0779186089401	0.0191902676107642	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2238.25427845005	2238.25427845005
"healthy-2"	"2019-08-01-count-4:GTGAGTTTCTCTGGTC"	3.26590337333028	-11.0330476990906	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGTTTCTCTGGTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.4214005676	38.0944736349814	0.0169051707884668	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2237.92952073157	2237.92952073157
"healthy-2"	"2019-08-01-count-2:CTCCCAATCGCAAGAG"	-2.06923613968547	12.7365226515564	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAATCGCAAGAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1491.83361046746	45.4791894113535	0.0304854302063235	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1489.39542758823	1489.39542758823
"healthy-2"	"2019-08-01-count-3:TCCCATGTCCATGAGT"	1.26703180846516	9.11823747241823	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGTCCATGAGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1605.75421894093	33.8451362945663	0.0210774076725695	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1598.23210556446	1598.23210556446
"healthy-2"	"2019-08-01-count-3:ATTCAGGGTTCAAACC"	-2.11072049561198	13.6415471800598	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCAGGGTTCAAACC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2137.79077573688	42.1461666029909	0.0197148229290415	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2134.26419935249	2134.26419935249
"healthy-2"	"2019-08-01-count-4:AGGCATTGTGGCCTCA"	4.47725214537923	-10.6253938904968	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTGTGGCCTCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.00491513775	46.6709806760421	0.0198346294883578	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2350.797013211	2350.797013211
"healthy-2"	"2019-08-01-count-2:CTGTACCGTGATGTAA"	-1.58599422398265	12.946675277594	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCGTGATGTAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2065.37440400999	44.2880770433685	0.0214431228339916	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2052.66148908269	2052.66148908269
"healthy-2"	"2019-08-01-count-4:GAGGGATGTCAATGGG"	2.99523295935933	-10.8119755021301	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATGTCAATGGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.51980745803	42.0900036769164	0.0189806663892507	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2213.10261167121	2213.10261167121
"healthy-2"	"2019-08-01-count-2:TGAGGGAGTCCGTTTC"	-7.52983890000041	0.0468361045229211	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGGAGTCCGTTTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2752.96138253356	39.1800508480607	0.0142319652925909	3440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2748.60794957232	2748.60794957232
"healthy-2"	"2019-08-01-count-2:TCCATCGAGCTAATGA"	6.76617731627767	-0.995367192384325	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATCGAGCTAATGA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1514.02975494825	41.8247196532575	0.0276247672917677	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1511.87606862625	1511.87606862625
"healthy-2"	"2019-08-01-count-4:ACCCTTGAGGCGAAGG"	2.50949945029561	-10.8545541993347	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTTGAGGCGAAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.31725385483	43.9284748912384	0.0189157940493794	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2315.09125923978	2315.09125923978
"healthy-2"	"2019-08-01-count-3:ACGGGTCGTGACACAG"	10.9180504280025	3.99608061397401	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGGTCGTGACACAG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.57469099508	35.288178969428	0.0204028072063922	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1722.0765734708	1722.0765734708
"healthy-2"	"2019-08-01-count-2:AAACGCTCAACCACAT"	4.43600859221761	-10.8919754258362	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTCAACCACAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.0264051557	37.3480163111098	0.0136804597349599	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2720.55222923027	2720.55222923027
"healthy-2"	"2019-08-01-count-2:GCACGTGTCATTTCGT"	4.4104138809139	-10.8024740449158	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGTGTCATTTCGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.31100178822	42.9075182382267	0.0178016522375716	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2401.89735640308	2401.89735640308
"healthy-2"	"2019-08-01-count-4:AGGCCACGTCCAGGTC"	1.85573591765706	-10.4179229966369	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACGTCCAGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.19743957792	37.7851213474167	0.0155545698887209	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2424.56140294856	2424.56140294856
"healthy-2"	"2019-08-01-count-3:ACGGTCGAGTGCGACA"	-1.77301702919658	12.8646135100159	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGTCGAGTGCGACA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1567.53456379734	43.4639673119749	0.0277275974104735	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1560.31707349947	1560.31707349947
"healthy-2"	"2019-08-01-count-4:ATTCCATAGCTCATAC"	8.32141651686971	6.57616040790407	"2019-08-01-count-4"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATAGCTCATAC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1584.37154592871	35.2072619017687	0.0222215944184553	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1576.4087318805	1576.4087318805
"healthy-2"	"2019-08-01-count-4:TGGTTAGGTAGTATAG"	-3.01891336861308	-5.93052341854247	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTTAGGTAGTATAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2248.50741587662	46.9583589199764	0.0208842357327378	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2246.68726027029	2246.68726027029
"healthy-2"	"2019-08-01-count-4:TCGGTCTCATTAAGCC"	3.42550005492513	-10.0026741257873	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTCATTAAGCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.29213363983	38.5936146582629	0.0160319614387263	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2403.539790195	2403.539790195
"healthy-2"	"2019-08-01-count-3:ATTCCCGAGGACAACC"	3.22946753081624	-11.0710315934387	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCCGAGGACAACC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.09152019006	43.3404104824615	0.0172321405143882	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2510.37453820096	2510.37453820096
"healthy-2"	"2019-08-01-count-3:TCCGTGTGTGCATGTT"	2.1437677341396	-10.5237407914368	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGTGTGTGCATGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.27690233484	40.9200930553508	0.0187339311291577	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2179.77319559475	2179.77319559475
"healthy-2"	"2019-08-01-count-2:TGTGGCGCATACCACA"	1.83579291877095	-5.18948271190795	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGCATACCACA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2478.46443001463	44.4414162718224	0.0179310284761924	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2473.11447612247	2473.11447612247
"healthy-2"	"2019-08-01-count-2:TTAGTCTCATTGACAC"	0.551402737467927	10.7788839110169	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTCATTGACAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.0944426601	35.4321482939773	0.0184245492618481	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1919.34257592638	1919.34257592638
"healthy-2"	"2019-08-01-count-4:ATTCCATGTTGGTAGG"	2.26203765448872	-10.5979356995788	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATGTTGGTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.36964050545	37.6596006577655	0.0145889996019289	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2576.79506937576	2576.79506937576
"healthy-2"	"2019-08-01-count-4:ACCTGTCAGGCGATAC"	1.30238642272298	9.95095155322877	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGTCAGGCGATAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1687.85478974184	36.018954092715	0.021340078726929	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1679.22022080425	1679.22022080425
"healthy-2"	"2019-08-01-count-3:CGGCAGTTCTGGCCTT"	2.53645243224446	-11.056441330072	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTTCTGGCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.09237242898	41.0385954362549	0.0164543205736553	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2492.14845837026	2492.14845837026
"healthy-2"	"2019-08-01-count-3:CATTCTACATATCTGG"	3.13212575492207	-10.6541929475036	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCTACATATCTGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2796.23595728663	40.1629261912117	0.0143632106891953	3002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2790.11603231139	2790.11603231139
"healthy-2"	"2019-08-01-count-2:TGGATCAGTCCCTCAT"	1.22105576571767	11.2898273237976	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCAGTCCCTCAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2189.14977126321	40.6032345183154	0.0185474904692729	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2179.24013473064	2179.24013473064
"healthy-2"	"2019-08-01-count-3:TGGATCAAGTCATCCA"	6.79774822768514	-0.925427102204882	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCAAGTCATCCA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1500.13326182543	49.1869496915454	0.0327883868341754	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1487.0981623802	1487.0981623802
"healthy-2"	"2019-08-01-count-2:ATTCCTATCTCCGATC"	2.88034429129903	-10.7272005311218	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCTATCTCCGATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.57356944755	38.6236786610048	0.0163343104059261	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.74341909621	2361.74341909621
"healthy-2"	"2019-08-01-count-3:ATGACCAAGACGTCGA"	-5.24763284149821	-5.30713798916014	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCAAGACGTCGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2370.89770040097	48.5433828555151	0.0204746846931883	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2368.49944865234	2368.49944865234
"healthy-2"	"2019-08-01-count-2:AGCTTCCCAATCAAGA"	1.38063051280324	10.2957324751648	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCCAATCAAGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1934.83364454573	34.678337557746	0.0179231623635984	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1932.51672788527	1932.51672788527
"healthy-2"	"2019-08-01-count-3:AACAAGATCGTCGATA"	3.02443446692769	-10.8578453294006	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAGATCGTCGATA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.65250039166	42.2165395757019	0.0195207226163503	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2156.01352367514	2156.01352367514
"healthy-2"	"2019-08-01-count-2:TTCAATCGTTGCAAGG"	2.2896532016689	-10.2295017472473	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCGTTGCAAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.4357038261	37.6959060095357	0.0166249062524362	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2267.4357038261	2267.4357038261
"healthy-2"	"2019-08-01-count-2:GGCACGTAGTACTCGT"	1.75404800948445	-9.49088194286498	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCACGTAGTACTCGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2568.12791837177	42.1936750835031	0.0164297404275151	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2562.40973961557	2562.40973961557
"healthy-2"	"2019-08-01-count-4:TATTGCTTCCTGGTCT"	1.38110460814778	-9.3345346680847	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTTCCTGGTCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2663.19194101784	40.9759080699753	0.0153860138425903	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2660.32028949973	2660.32028949973
"healthy-2"	"2019-08-01-count-2:TGCACGGCACCCATAA"	3.08620824393575	-10.3989429703918	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCACGGCACCCATAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.55875964386	42.4501903135869	0.0180826955402927	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.77814609224	2343.77814609224
"healthy-2"	"2019-08-01-count-2:AGGAAATAGTTCAACC"	4.35330261763875	-10.6496391526428	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATAGTTCAACC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.32609773807	42.5447563470457	0.0177467539302173	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2395.30406894649	2395.30406894649
"healthy-2"	"2019-08-01-count-2:CCCTTAGTCTGTAAGC"	1.75737251815144	-9.65393164074095	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTTAGTCTGTAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.73855046076	39.9480027177575	0.0176703328695907	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2258.01230758183	2258.01230758183
"healthy-2"	"2019-08-01-count-4:TATTGGGTCCCGAGTG"	1.92734636840169	-10.1173115006653	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGGGTCCCGAGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.52584272345	38.5845152123063	0.0163318912811668	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2357.79040430537	2357.79040430537
"healthy-2"	"2019-08-01-count-4:GTGGCGTAGAAGTATC"	2.51207794722859	-10.7910566559997	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGCGTAGAAGTATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.71150884727	38.8287012019715	0.0167602660295375	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2312.73089481933	2312.73089481933
"healthy-2"	"2019-08-01-count-3:CATTTCACAACTCCCT"	7.73778547820393	6.8365154036316	"2019-08-01-count-3"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCACAACTCCCT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1674.94819102598	30.3232555358393	0.0181039961106289	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1668.81490850059	1668.81490850059
"healthy-2"	"2019-08-01-count-3:GAATCACCACCTGCTT"	-1.5391495031422	13.4352044829163	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCACCACCTGCTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1945.63295771285	39.5712304715564	0.020338486925136	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1941.81625683966	1941.81625683966
"healthy-2"	"2019-08-01-count-3:ACGTTCCGTACTCAAC"	3.04175843772237	-10.9894724122253	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTTCCGTACTCAAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.98057537004	43.4607821090872	0.0178778812753251	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2424.72239708181	2424.72239708181
"healthy-2"	"2019-08-01-count-4:TTTACCATCTATCGGA"	-3.55296383324321	3.62678358638612	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCATCTATCGGA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3104.94442605606	42.8909850092441	0.0138137689838542	4788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3100.1354441382	3100.1354441382
"healthy-2"	"2019-08-01-count-4:CTGCAGGGTTGGGCCT"	-8.2491811317509	3.72882864559022	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGGTTGGGCCT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2342.06609263791	41.0595278236134	0.0175313275541969	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2336.19575503375	2336.19575503375
"healthy-2"	"2019-08-01-count-4:TGTACAGGTATCAAGA"	-1.97613559189494	13.1090097197327	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGGTATCAAGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1925.80899051202	44.4239815387865	0.0230676986957961	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1920.26367779128	1920.26367779128
"healthy-2"	"2019-08-01-count-3:AGTCAACCAGTTGCGC"	2.55705895003621	-10.9756050339905	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACCAGTTGCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.43225131189	41.7851835036912	0.0187846509953485	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2219.90309471253	2219.90309471253
"healthy-2"	"2019-08-01-count-3:ACTACGAAGCAAATCA"	2.17239942130391	-10.4184112778869	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTACGAAGCAAATCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.8649179602	41.0112935021277	0.0164185393722644	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2492.54840616334	2492.54840616334
"healthy-2"	"2019-08-01-count-4:TGTCAGAAGAAACTGT"	2.53050651130025	-10.8817949525085	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCAGAAGAAACTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.64058685696	36.5117258670598	0.0161940337985125	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2251.12554205406	2251.12554205406
"healthy-2"	"2019-08-01-count-3:CTTAGGATCCGTATAG"	1.82359721240346	-4.99745228206786	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGATCCGTATAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2701.00421026546	38.6302599428095	0.0143021842750156	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2695.05587766895	2695.05587766895
"healthy-2"	"2019-08-01-count-4:CTGCCATGTAAGCAAT"	-4.67063651505168	-5.34840490734252	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCCATGTAAGCAAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2360.6968689465	47.3042568344238	0.0200382596582738	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2356.37892053735	2356.37892053735
"healthy-2"	"2019-08-01-count-3:TCATGGAGTTTCGATG"	2.19208397445027	-10.5638427964416	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGGAGTTTCGATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.00898181992	40.4082424521924	0.0168226858259192	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2395.76402174857	2395.76402174857
"healthy-2"	"2019-08-01-count-3:AGACCCGTCGATACGT"	2.86610498008077	-10.7955761185852	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGTCGATACGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.65988841873	40.3390446299943	0.0174502507190138	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.94496672379	2308.94496672379
"healthy-2"	"2019-08-01-count-4:GGTTCTCCAGGTAGTG"	2.18558039244954	-10.7114086381164	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTCTCCAGGTAGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.5756824419	41.8163739993042	0.0178353696630309	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2340.01502389182	2340.01502389182
"healthy-2"	"2019-08-01-count-4:ATTGTTCTCCATATGG"	1.76668824729268	-10.212989830133	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGTTCTCCATATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.49341106656	37.2213489194657	0.015183132351668	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.19114877912	2450.19114877912
"healthy-2"	"2019-08-01-count-3:AACCATGAGCACCGAA"	1.82278492030446	-10.3699789277283	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGAGCACCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.97520815823	40.0914782511485	0.0179061733712217	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2235.51589029409	2235.51589029409
"healthy-2"	"2019-08-01-count-4:GTGTAACCAAATTAGG"	2.01739086684529	-10.5659017792908	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACCAAATTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.62912049143	36.7260899588155	0.0160542150953762	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2280.75425102719	2280.75425102719
"healthy-2"	"2019-08-01-count-4:AGGTTACGTTCAAGTC"	1.32629587230031	10.6132068403992	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTACGTTCAAGTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2002.02061030748	44.3010289562813	0.0221281582857818	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1992.07743049698	1992.07743049698
"healthy-2"	"2019-08-01-count-2:TCCGTGTTCGTCAACA"	1.35881366309468	-8.82969763195189	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGTGTTCGTCAACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.44998312793	39.7787728750616	0.0175279354781089	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.66352111573	2265.66352111573
"healthy-2"	"2019-08-01-count-4:CGATGGCTCATCGGGC"	2.47725762900655	-10.6131010285583	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGGCTCATCGGGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.45617687241	34.528583678408	0.0144383091826358	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.41798260886	2386.41798260886
"healthy-2"	"2019-08-01-count-2:CAGCAGCCAAAGGCTG"	1.70710553702657	-9.60501863872679	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAGCCAAAGGCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.37810138495	41.6989698771845	0.0169138234227682	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2461.7092044057	2461.7092044057
"healthy-2"	"2019-08-01-count-2:TGCATCCCACTATCGA"	1.54977454718892	-9.00664522564086	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATCCCACTATCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.1346399541	40.2919063258683	0.0184475377977225	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2182.26406261852	2182.26406261852
"healthy-2"	"2019-08-01-count-2:TTCCAATCACCAGCTG"	-5.16474709931071	-5.23665048992308	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATCACCAGCTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2463.09356825645	43.8092591352143	0.0177862748292691	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2459.4031170534	2459.4031170534
"healthy-2"	"2019-08-01-count-2:CCGGTAGCATGAGAAT"	2.63007297095601	-11.065510772821	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGCATGAGAAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.12498775522	41.2721895378874	0.0170678479180685	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2414.72090070085	2414.72090070085
"healthy-2"	"2019-08-01-count-4:GTAATCGCAACACACT"	1.64842691001241	-4.89948513424071	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGCAACACACT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2335.7945132497	41.592730269658	0.0178066735039084	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2331.00281672939	2331.00281672939
"healthy-2"	"2019-08-01-count-2:ATGGATCAGTCTTCGA"	2.25824250754659	-9.3280706635681	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCAGTCTTCGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2611.08655073518	37.9235784606438	0.0145240602805625	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2606.58708677972	2606.58708677972
"healthy-2"	"2019-08-01-count-3:ACCACAACAGGTGGAT"	-2.74525127831157	4.01188037479249	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAACAGGTGGAT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3389.58449508764	41.0691360496854	0.0121162744605437	5709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3378.3828521027	3378.3828521027
"healthy-2"	"2019-08-01-count-2:ATCCCTGGTCCGAAAG"	1.60993780669515	-9.27750303661498	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGGTCCGAAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.36758500588	47.2598252349044	0.0213520002529443	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2212.43592719329	2212.43592719329
"healthy-2"	"2019-08-01-count-4:CAACAACAGAGTACCG"	2.51838078078572	-11.0626306763855	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACAGAGTACCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.52791229078	42.4679206979302	0.0189290806079466	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2237.90905465729	2237.90905465729
"healthy-2"	"2019-08-01-count-4:GGGCTCACACCAGACC"	3.65492143210713	-10.7822628251282	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTCACACCAGACC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.03730275735	38.162244560016	0.017659225276363	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2155.84488784369	2155.84488784369
"healthy-2"	"2019-08-01-count-2:AACACACGTCGCTCGA"	-0.677993158728439	12.7881946333679	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACACACGTCGCTCGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1477.60370428326	28.6262155176333	0.0193734053553412	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1475.1322453684	1475.1322453684
"healthy-2"	"2019-08-01-count-4:ACGTAGTAGGACGCAT"	2.15984191474263	-10.4972152940002	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTAGGACGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.97616367047	41.428319991242	0.0173851172423943	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.03230259979	2377.03230259979
"healthy-2"	"2019-08-01-count-4:TCAATTCGTGCAACAG"	2.47179307517354	-10.6618128052917	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCGTGCAACAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.53342959511	43.1102020587865	0.019104614845667	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2249.62026899283	2249.62026899283
"healthy-2"	"2019-08-01-count-2:CCGTAGGTCAGCTCTC"	-5.09815154495891	-4.32057812130126	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTAGGTCAGCTCTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3010.2799124986	38.3372252159872	0.0127354353516469	3335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	3000.97926180168	3000.97926180168
"healthy-2"	"2019-08-01-count-3:TCTGGCTTCAGGACGA"	8.32682003554646	7.72082994067994	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTTCAGGACGA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1545.28362892423	37.1934638455872	0.0240690208253095	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1545.28362892423	1545.28362892423
"healthy-2"	"2019-08-01-count-4:GGGTAGAGTCATCACA"	4.50070108947102	-10.6980724564758	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTAGAGTCATCACA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.33663284648	38.9228466187133	0.0160088266235451	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.18695933091	2426.18695933091
"healthy-2"	"2019-08-01-count-4:CTGGTCTTCTTTCAGT"	10.8192631202633	4.37401769244996	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTTCTTTCAGT"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.08435880981	44.2464576074163	0.0240589603165626	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1833.76489168603	1833.76489168603
"healthy-2"	"2019-08-01-count-4:TTTCAGTCAAAGCAAT"	2.30596532401387	-10.617964767572	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTCAAAGCAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.36586251181	36.8515926120892	0.0166045595431398	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.08276206719	2214.08276206719
"healthy-2"	"2019-08-01-count-2:ACGGAAGCAGTGAGCA"	1.46007206019704	-9.14631750499877	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGAAGCAGTGAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.38537430976	41.5514930278589	0.017845625336045	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2325.49493891616	2325.49493891616
"healthy-2"	"2019-08-01-count-4:ACGTCCTAGACGTCCC"	1.18181802806203	9.42507073963014	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTCCTAGACGTCCC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1768.73676487728	37.1598119160729	0.021009238148929	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1762.39513506476	1762.39513506476
"healthy-2"	"2019-08-01-count-2:ATGGGTTTCGACACCG"	3.49517311629598	-8.88682367717894	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGTTTCGACACCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1636.99633998777	2.86357428234921	0.00174928569624695	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1634.06050925215	1634.06050925215
"healthy-2"	"2019-08-01-count-3:GTTCTATGTTAAGTCC"	-3.92380724373515	-5.22625257885131	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATGTTAAGTCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2854.61103481511	39.8662866860547	0.0139655757649087	3061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2851.26608345213	2851.26608345213
"healthy-2"	"2019-08-01-count-4:TCACAAGTCGCAGTTA"	4.51581968840901	-10.7948723069397	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACAAGTCGCAGTTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.5232362591	42.4984103996097	0.0189850208884276	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2235.24037790693	2235.24037790693
"healthy-2"	"2019-08-01-count-4:TTGATGGCAGCTGTTA"	-2.60788569870647	13.5084333189758	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGCAGCTGTTA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1816.86190714243	43.4689972100864	0.0239253170751181	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1813.00969598353	1813.00969598353
"healthy-2"	"2019-08-01-count-4:TCCACCAAGGTTGACG"	2.74851979789082	-11.1169624558655	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCAAGGTTGACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.02637090144	37.8525563001049	0.0153870530608313	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.18134158162	2455.18134158162
"healthy-2"	"2019-08-01-count-3:AGTGATCTCGAGAATA"	2.56363429602925	-10.7855177155701	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCTCGAGAATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.32494078593	38.4792966232464	0.0168449312688446	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2281.0479388358	2281.0479388358
"healthy-2"	"2019-08-01-count-4:ACGTTCCGTTCGAGCC"	-1.98151240769084	12.6465711363587	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTTCCGTTCGAGCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1640.34237266927	49.579801117219	0.0302252761029025	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1636.14490054544	1636.14490054544
"healthy-2"	"2019-08-01-count-2:CCGTTCAGTCACGACC"	3.13746966895406	-11.0117006531921	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTTCAGTCACGACC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.89510735877	39.5349283892076	0.015324238677937	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2575.83286574899	2575.83286574899
"healthy-2"	"2019-08-01-count-4:GATGGAGGTGAAGCGT"	2.28786601599995	-10.6458101502624	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGGTGAAGCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.35393644146	40.3948244034582	0.0181113964664767	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2222.14278992572	2222.14278992572
"healthy-2"	"2019-08-01-count-2:GTGCTGGGTTTCGTGA"	-5.02164826813396	-4.48978235637816	"2019-08-01-count-2"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGGTTTCGTGA"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2687.75066599124	41.5068974562272	0.0154429865766285	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2682.84656957902	2682.84656957902
"healthy-2"	"2019-08-01-count-2:CCTAAGAAGGGCGAGA"	4.57423033294026	-10.6967268220154	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAAGAAGGGCGAGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.65723807495	44.2803281424016	0.0199132885159656	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2218.89512122227	2218.89512122227
"healthy-2"	"2019-08-01-count-2:GAGGGTAAGTGGACTG"	2.58164872702901	-10.6688099137512	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTAAGTGGACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.33488481144	43.3673817757271	0.0185225027214421	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2340.64079040309	2340.64079040309
"healthy-2"	"2019-08-01-count-4:GTAGCTAAGGGCAAGG"	3.19611515578572	-10.7155781022278	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGCTAAGGGCAAGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2390.63578015263	38.3586546097606	0.0160453779401359	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2384.07362665651	2384.07362665651
"healthy-2"	"2019-08-01-count-4:CGGACACTCGTAGAGG"	-3.39203129234965	12.8041314848694	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACTCGTAGAGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.85465489453	51.732290665251	0.0268063144206465	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1926.32892660158	1926.32892660158
"healthy-2"	"2019-08-01-count-3:TTACTGTCAAACTCTG"	2.7233678298885	-10.6337576142517	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTCAAACTCTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.45944803172	41.0434664271344	0.0161622846385463	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2531.6143823194	2531.6143823194
"healthy-2"	"2019-08-01-count-1:AACACACGTTATGTGC"	2.48525013503377	-10.9653282395569	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AACACACGTTATGTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.18927729606	24.7793301735059	0.0096862770841167	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2551.3277816177	2551.3277816177
"healthy-2"	"2019-08-01-count-2:CCTAAGAAGGTAGCCA"	1.03420390662495	-8.83826448833617	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAAGAAGGTAGCCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2409.94042821958	40.8931580699189	0.0169685348198129	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2407.75782498766	2407.75782498766
"healthy-2"	"2019-08-01-count-4:GTAGATCCAGGCTCTG"	1.79770769652669	-4.88518907940062	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGATCCAGGCTCTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2322.76295286434	37.8418918924394	0.0162917579883794	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2321.0413386861	2321.0413386861
"healthy-2"	"2019-08-01-count-3:ATTACCTCACTAGGTT"	2.00945987281148	-9.81961920177611	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTCACTAGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.35824272008	46.9496476335056	0.0205346855782537	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2282.5488381844	2282.5488381844
"healthy-2"	"2019-08-01-count-2:TCACATTAGGGATGTC"	4.51365150985066	-10.8666153184143	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTAGGGATGTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.86313058692	40.7826522977149	0.0159877853925982	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2547.87151451435	2547.87151451435
"healthy-2"	"2019-08-01-count-2:CTACCCAAGTGTCATC"	1.68161823329274	-9.59569551860961	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAAGTGTCATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.65647951051	32.4244712227293	0.0152323644208602	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2128.65647951051	2128.65647951051
"healthy-2"	"2019-08-01-count-4:GCCGTGATCGTCCATC"	3.00560822066609	-10.5721349946228	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGTGATCGTCCATC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.87783425116	35.2129461315019	0.015357532619265	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2285.12088403473	2285.12088403473
"healthy-2"	"2019-08-01-count-2:AGGGCCTTCTCAGAAC"	2.5420159297878	-10.8591480485168	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTTCTCAGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.40695681061	37.0121504482392	0.0154836189473036	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2384.1873636784	2384.1873636784
"healthy-2"	"2019-08-01-count-4:CTGTGAATCATCAGTG"	2.37266172942464	-10.2518759003845	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAATCATCAGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.55706760682	45.0726296981129	0.0210959165947293	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2134.50750247473	2134.50750247473
"healthy-2"	"2019-08-01-count-4:TGTTCATAGGAAGTCC"	3.39749970015828	-10.581382774469	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATAGGAAGTCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.97705452723	41.0337677727689	0.0170975667018834	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2393.78145142476	2393.78145142476
"healthy-2"	"2019-08-01-count-3:CAAGCTATCATGCATG"	8.11602367934529	6.95789716327516	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTATCATGCATG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.81407640517	37.7546408240725	0.0213446067213591	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1765.33014403494	1765.33014403494
"healthy-2"	"2019-08-01-count-2:TATCGCCGTTACGGAG"	2.49573626097981	-10.6852512589661	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCGTTACGGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.76611274609	39.7953801889487	0.0170959530560404	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2325.92124989497	2325.92124989497
"healthy-2"	"2019-08-01-count-2:GAAATGATCACGACTA"	-3.38458166542705	3.31177756870119	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGATCACGACTA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3181.74787954664	43.8518596076821	0.0137823175398581	5544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3173.58978037889	3173.58978037889
"healthy-2"	"2019-08-01-count-3:CAAGGGAGTTAGAGTA"	1.7489570575649	-4.8210430375305	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGGGAGTTAGAGTA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2243.9463981303	41.4593274676378	0.0184760774598638	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2242.1880042923	2242.1880042923
"healthy-2"	"2019-08-01-count-2:AACGAAAGTACCTATG"	-0.489139894873458	10.7822704085144	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGAAAGTACCTATG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.47264120718	40.0010036724779	0.0192453837878016	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2074.46706828519	2074.46706828519
"healthy-2"	"2019-08-01-count-3:CGTTGGGGTTAATCGC"	-1.19681797447856	13.5719861754212	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTGGGGTTAATCGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1346.32650426687	39.5718199522051	0.0293924392239115	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1346.32650426687	1346.32650426687
"healthy-2"	"2019-08-01-count-3:AAGACTCCACGGATCC"	-0.203000972897369	12.205711341742	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCCACGGATCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.40655360015	40.819614395532	0.0222886689551752	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1824.51052184151	1824.51052184151
"healthy-2"	"2019-08-01-count-4:CGGGCATCAGAGAAAG"	4.50475658950154	-10.7884578934875	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATCAGAGAAAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.32523139721	40.1083817794721	0.0182449717660657	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2191.61106377675	2191.61106377675
"healthy-2"	"2019-08-01-count-2:GAAATGATCGTCCTTG"	-4.81948981705363	3.72929570758668	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGATCGTCCTTG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3132.05624810883	40.8752376125943	0.0130506077715798	4064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3124.30671571789	3124.30671571789
"healthy-2"	"2019-08-01-count-2:CATACAGCACGACGAA"	2.3190607028896	-10.2305107346741	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGCACGACGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.2619036905	35.4813334249214	0.0140283350542504	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2524.96298458454	2524.96298458454
"healthy-2"	"2019-08-01-count-3:TTAGTCTCAGGTGGAT"	2.1470214324886	-10.3839063874451	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGTCTCAGGTGGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.70503849937	38.6856756072219	0.0170744536247509	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2264.67718165491	2264.67718165491
"healthy-2"	"2019-08-01-count-3:GAACACTCAACTGTGT"	1.8673845725948	-9.791211151239	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTCAACTGTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.89887740968	38.5944830847894	0.0174249413724592	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.89887740968	2214.89887740968
"healthy-2"	"2019-08-01-count-3:GTTTACTGTAGCTTTG"	3.02205934104268	-10.9179821244446	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTTACTGTAGCTTTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.10378970056	37.2984060265447	0.0152045772311564	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2447.6184364865	2447.6184364865
"healthy-2"	"2019-08-01-count-3:CATGCTCTCCAGTTCC"	2.24420823630635	-10.3075638047424	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCTCCAGTTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.32048826708	41.1847231419125	0.0177648963335081	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2313.82260597585	2313.82260597585
"healthy-2"	"2019-08-01-count-4:TGGGTTACACTTGGGC"	2.81703366813008	-11.025381111261	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGTTACACTTGGGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.50260767099	40.9332176418095	0.0177008309119421	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2305.9955947489	2305.9955947489
"healthy-2"	"2019-08-01-count-2:AGGTAGGCATGACTTG"	11.9523922401363	-3.11750247394713	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-5"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTAGGCATGACTTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2035.12596739064	48.619528802988	0.0238901815327559	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2029.7787645407	2029.7787645407
"healthy-2"	"2019-08-01-count-3:GCATGATGTGCAATAA"	-0.00914851847346428	11.2932481535706	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATGATGTGCAATAA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1880.81710606646	37.0035231775667	0.0196741740907258	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1877.34133382421	1877.34133382421
"healthy-2"	"2019-08-01-count-3:CCCTAACTCGGCTCTT"	3.00422324714009	-10.7927379838196	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACTCGGCTCTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.36639555245	44.9998629581551	0.0196732202788555	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2282.78353154742	2282.78353154742
"healthy-2"	"2019-08-01-count-2:TGGAGAGAGGTGATCG"	3.00206722792928	-10.9578228226868	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGAGAGGTGATCG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.86939767833	44.5144985154004	0.0195765414499402	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2269.63078294369	2269.63078294369
"healthy-2"	"2019-08-01-count-3:GAACGTTTCACTCGAA"	2.62132420119588	-10.9618311158386	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACGTTTCACTCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.12347949739	37.449392522479	0.015210200802002	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2454.54856205901	2454.54856205901
"healthy-2"	"2019-08-01-count-2:GTGTAACGTATGTGTC"	-1.80928931656535	13.4538793333801	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTAACGTATGTGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1818.51911075837	46.7929861293718	0.0257313689213075	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1816.4899322419	1816.4899322419
"healthy-2"	"2019-08-01-count-2:GGGTCTGGTCGAGCAA"	2.09938277777974	-10.0609483948913	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGGTCGAGCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.75388531136	42.1410177747902	0.0195390944056218	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2152.48629153604	2152.48629153604
"healthy-2"	"2019-08-01-count-2:ATTCATCCAGCTTCGG"	1.81257094916646	-9.23955347454222	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCCAGCTTCGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2427.97468121951	40.4312960458284	0.0166522725127928	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2425.19044507625	2425.19044507625
"healthy-2"	"2019-08-01-count-2:AGGTCTACAGCTGCCA"	1.77448370036427	-9.71978285228881	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTACAGCTGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.31483675724	40.9550065568643	0.0187238736137232	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2181.63427356655	2181.63427356655
"healthy-2"	"2019-08-01-count-4:GACACGCAGGATATAC"	2.08930482444112	-9.85977651989134	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCAGGATATAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.84144442835	41.9187596589467	0.0180153055805851	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2324.71605412814	2324.71605412814
"healthy-2"	"2019-08-01-count-2:GAAGAATAGTATGACA"	3.20484675940816	-10.9893837205139	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGAATAGTATGACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.1236248259	39.737042803336	0.0165149630689534	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2400.96424023644	2400.96424023644
"healthy-2"	"2019-08-01-count-3:GCCAGCAGTAGGAGGG"	1.5432628589565	-4.60850860988768	"2019-08-01-count-3"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGCAGTAGGAGGG"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2569.74718095984	42.2067322801381	0.0164244687543049	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2566.53744409558	2566.53744409558
"healthy-2"	"2019-08-01-count-2:GAAGAATCACAAGTGG"	2.87615503844563	-11.0557193986145	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGAATCACAAGTGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.23800692451	40.7727475689618	0.0171153123451337	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2379.861015243	2379.861015243
"healthy-2"	"2019-08-01-count-3:TTCACGCCAAACACGG"	-2.43353066864665	12.9450855025086	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCCAAACACGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1701.80311912796	37.8389519701969	0.0222346237028795	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1694.00627765553	1694.00627765553
"healthy-2"	"2019-08-01-count-4:AGTTCCCCACATGACT"	-1.57810829106029	13.0865792998108	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCCCCACATGACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1907.88874221661	39.4418211466434	0.0206730194868802	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1898.62578146472	1898.62578146472
"healthy-2"	"2019-08-01-count-3:CACAACATCGCATAGT"	1.83697189864461	-9.81427957927855	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAACATCGCATAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.44915281434	37.925129240297	0.0175624090017912	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2155.54604107035	2155.54604107035
"healthy-2"	"2019-08-01-count-3:TGTGTGATCTGGTCAA"	2.36263432082478	-10.7820854417053	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGTGATCTGGTCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.75073392384	39.9123189384224	0.0166110942657972	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2400.74260472747	2400.74260472747
"healthy-2"	"2019-08-01-count-4:GTGCGTGTCCGTAGGC"	3.20048727568929	-10.5394277802673	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGTCCGTAGGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2578.87293524572	42.5190202074963	0.0164874428772292	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2576.28207685081	2576.28207685081
"healthy-2"	"2019-08-01-count-3:TAAGCCACAATGACCT"	1.39939071711842	-8.88859655773314	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCACAATGACCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2456.70185568401	44.6218273474221	0.018163305915279	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2455.15518406765	2455.15518406765
"healthy-2"	"2019-08-01-count-2:ACTATCTGTACGCTAT"	1.42592026767079	9.97219274127809	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTGTACGCTAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1803.57227698065	36.9517217199368	0.0204880736921713	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1793.27184893396	1793.27184893396
"healthy-2"	"2019-08-01-count-4:CAATTTCGTTTGATCG"	3.11142100867574	-10.879719757196	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCGTTTGATCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.32827908045	39.8997604091056	0.017188331684354	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2316.1117166933	2316.1117166933
"healthy-2"	"2019-08-01-count-4:CTTCTAACAACCGCCA"	1.80500139769856	-10.0155353776184	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAACAACCGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.38680968251	42.3408230874652	0.0181145982821801	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.09161463406	2334.09161463406
"healthy-2"	"2019-08-01-count-2:GTGTTAGCATCACGGC"	1.13494863089864	-9.0955963364807	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTTAGCATCACGGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2488.94896311872	40.8568192908969	0.0164152901069141	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2487.31217007022	2487.31217007022
"healthy-2"	"2019-08-01-count-2:CATACTTAGAACTCCT"	2.33308090743367	-10.7225151292053	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTAGAACTCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.37790661373	41.9822006724197	0.0175777043306947	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2384.9797564533	2384.9797564533
"healthy-2"	"2019-08-01-count-2:GACTTCCTCCGATGCG"	4.07845606383626	-10.5945854417053	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCTCCGATGCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.47887336158	46.4192327252408	0.018030535501979	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2569.44976853011	2569.44976853011
"healthy-2"	"2019-08-01-count-3:ACGTACACACTACTTT"	1.34229435500447	-9.52933599865111	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACACACTACTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.40849293546	44.3616119584709	0.0185039854864922	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2391.69606443358	2391.69606443358
"healthy-2"	"2019-08-01-count-4:TACGGGCGTCTGTAAC"	2.38361062583272	-10.6007566682068	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCGTCTGTAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.55341679497	41.3552705534057	0.0178674945470351	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.0287319026	2308.0287319026
"healthy-2"	"2019-08-01-count-3:ATTCCTATCGCCGTGA"	2.74938954886739	-11.0195427170959	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTATCGCCGTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.75779898276	40.0113502819157	0.0169989241455547	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.47145397954	2346.47145397954
"healthy-2"	"2019-08-01-count-4:TGCCGAGTCTTTCCAA"	8.51529182967488	6.15710256183473	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCCGAGTCTTTCCAA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1540.94649034102	39.0250375768147	0.0253253684157315	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1534.26146500058	1534.26146500058
"healthy-2"	"2019-08-01-count-4:TTACCATTCTTTCCGG"	4.41878237304036	-10.8859901658264	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATTCTTTCCGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.3379757569	41.8346773300589	0.0168869479011144	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2468.74983835195	2468.74983835195
"healthy-2"	"2019-08-01-count-4:CCACTTGGTTCAGCGC"	3.15033926543538	-10.5391407242981	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACTTGGTTCAGCGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.43200845347	39.6520009583173	0.0176432482981334	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2242.95803996551	2242.95803996551
"healthy-2"	"2019-08-01-count-3:CCGAACGTCAGTCACA"	2.24806823310201	-10.4238538972107	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGAACGTCAGTCACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.83317672311	42.0061655727481	0.0190432195943079	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2204.0937286392	2204.0937286392
"healthy-2"	"2019-08-01-count-4:GTTGTCCAGGATTTCC"	2.43559875068013	-10.8681183091369	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCAGGATTTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.56503939742	39.3273436904198	0.0159960558538076	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2454.47415581722	2454.47415581722
"healthy-2"	"2019-08-01-count-2:ATTCTTGAGATTAGAC"	-2.0628174346989	13.1524657973084	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGAGATTAGAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1749.99479322491	34.4983988403968	0.0197134294193086	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1745.18164605865	1745.18164605865
"healthy-2"	"2019-08-01-count-4:TCATATCGTCTCCTGT"	3.38082971152608	-10.5275955430237	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATATCGTCTCCTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.47556668895	39.0288401817701	0.0162452599822104	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2400.62786842303	2400.62786842303
"healthy-2"	"2019-08-01-count-3:TAATCTCCAATCTAGC"	4.19344915923421	-10.4182386628357	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCAATCTAGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.43098256344	37.80699185948	0.0145611387760261	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2593.77065147947	2593.77065147947
"healthy-2"	"2019-08-01-count-3:TTCCGTGTCACACCCT"	3.13917197760884	-10.9454012147156	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGTGTCACACCCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.99711625673	41.4581682512313	0.0182635334443053	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2264.853727726	2264.853727726
"healthy-2"	"2019-08-01-count-4:CTTGAGATCCATACTT"	2.29007806357686	-10.6208257905212	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGAGATCCATACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.14507596813	53.3229000301839	0.0253418362826763	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2100.81860972409	2100.81860972409
"healthy-2"	"2019-08-01-count-3:GCCATGGAGGGAGAAT"	-4.97579799118693	4.20683143222658	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	12	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGGGAGAAT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1392.06150949199	23.7712002404257	0.0170762571038263	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	1384.63386594446	1384.63386594446
"healthy-2"	"2019-08-01-count-2:GATCATGTCCACTGGG"	3.72935118254964	-10.5737953416077	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGTCCACTGGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.66127696161	43.5275407107652	0.019725519800075	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2204.82682577476	2204.82682577476
"healthy-2"	"2019-08-01-count-4:CGAGTTAAGGAAGTAG"	3.1677471595699	-10.6838426820007	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTTAAGGAAGTAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.44378264289	40.7037785608496	0.0187364013218935	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2169.2887214222	2169.2887214222
"healthy-2"	"2019-08-01-count-3:CCGATGGGTCACGTGC"	1.85211469706838	-5.1971268883911	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATGGGTCACGTGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2280.63851795163	45.0149375699365	0.0197378660474291	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2275.00221522244	2275.00221522244
"healthy-2"	"2019-08-01-count-2:TGGGAGACACACGGTC"	3.26768912848775	-10.5677271119324	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGACACACGGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.80900271876	41.2044340439049	0.0173579399171175	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.82235928673	2367.82235928673
"healthy-2"	"2019-08-01-count-2:AGTAACCTCTATCCAT"	3.15069593962972	-10.9615860215393	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAACCTCTATCCAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.88916620846	39.8617972233489	0.0187683038538728	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2115.25279025269	2115.25279025269
"healthy-2"	"2019-08-01-count-2:GTTACCCCAAGCTGCC"	3.21374072608296	-10.5373697510925	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCCAAGCTGCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.08572216493	42.5522815896	0.017445996753173	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2432.60352663924	2432.60352663924
"healthy-2"	"2019-08-01-count-3:GAATCGTCACACGTGC"	-1.95592961731609	13.1117057570252	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCGTCACACGTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1569.87347933178	39.668991170156	0.0252689096875764	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1567.69473314626	1567.69473314626
"healthy-2"	"2019-08-01-count-4:TTACTGTTCTAACGGT"	1.7940032678539	-4.78020956432494	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTTCTAACGGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2491.96136775869	36.255392329085	0.0145489383576173	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2486.29076824212	2486.29076824212
"healthy-2"	"2019-08-01-count-2:GAAGTAAGTATCTCGA"	1.23618974265401	9.34966561878053	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAAGTATCTCGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.82226998421	45.3411467598907	0.0263026807051902	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1718.05334839183	1718.05334839183
"healthy-2"	"2019-08-01-count-4:TGAGACTCATATCTGG"	4.4889346557552	-10.6487350693909	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGACTCATATCTGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.69119174164	38.8965882885957	0.0164489081806693	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2356.72807674908	2356.72807674908
"healthy-2"	"2019-08-01-count-3:CTCAACCAGGTTCAGG"	8.15749611434285	7.15786931598512	"2019-08-01-count-3"	"Control2"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCAGGTTCAGG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1868.93987287585	47.025651896678	0.0251616719077842	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1863.56228936685	1863.56228936685
"healthy-2"	"2019-08-01-count-4:TCCTAATTCAACACGT"	-1.71229980412181	12.9600476988587	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATTCAACACGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1706.63501768836	49.6591315713829	0.0290976870020201	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1700.33107151284	1700.33107151284
"healthy-2"	"2019-08-01-count-2:CACAGGCAGGATCACG"	2.49612154540364	-10.4682388535705	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCAGGATCACG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.9155434032	46.6370312823764	0.0185589330309194	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2506.25182814101	2506.25182814101
"healthy-2"	"2019-08-01-count-2:TCATATCAGCTGTTAC"	-5.34202466431316	-5.28044178402098	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCAGCTGTTAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3006.24969187418	41.0564138318554	0.0136570205538249	4034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	3002.08823140756	3002.08823140756
"healthy-2"	"2019-08-01-count-2:TCATACTGTGACATCT"	-2.69893680039104	13.3169669874939	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTGTGACATCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1916.0665618431	39.9403504908452	0.0208449702563703	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1916.0665618431	1916.0665618431
"healthy-2"	"2019-08-01-count-2:TGCAGTACACGTTGGC"	3.3401731449062	-10.6442365876404	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTACACGTTGGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.61193072002	39.9949175003218	0.018324337431404	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2176.47336065722	2176.47336065722
"healthy-2"	"2019-08-01-count-4:TGTCAGACACAGTGAG"	-5.07797418060954	-4.44614508068236	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCAGACACAGTGAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2765.18045561699	43.3949869282126	0.0156933652702713	3186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2760.91958864719	2760.91958864719
"healthy-2"	"2019-08-01-count-3:ACCAACACATCTTCGC"	4.29162468489949	-10.8839712372986	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACACATCTTCGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.96024759123	35.800775333155	0.0141787481079389	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2519.55032943964	2519.55032943964
"healthy-2"	"2019-08-01-count-4:GCCAACGCAACATACC"	2.11121787604634	-10.1374435654846	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGCAACATACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.44363549995	42.5960970096613	0.0183016664120037	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2324.72782382891	2324.72782382891
"healthy-2"	"2019-08-01-count-4:CTAACTTGTTCCACAA"	-0.355439166457015	12.5324697264465	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTGTTCCACAA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.52033489052	38.7220638809968	0.0196606570620401	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1961.07118270332	1961.07118270332
"healthy-2"	"2019-08-01-count-3:TTCGATTAGGATTCCT"	4.39599861678426	-10.8142166367737	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGATTAGGATTCCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2760.27247589288	41.5829488851624	0.0150647985835932	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2755.0301703564	2755.0301703564
"healthy-2"	"2019-08-01-count-3:GACATCATCTCAACGA"	2.82722224768941	-9.74736692821654	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCATCTCAACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.82045413384	49.6544585364521	0.0268138622324901	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1847.24409826708	1847.24409826708
"healthy-2"	"2019-08-01-count-4:TAACCAGCACATAGCT"	2.32113160666768	-10.8732462159363	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACCAGCACATAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.12564581002	43.1469412321877	0.016840290913425	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2557.2581488029	2557.2581488029
"healthy-2"	"2019-08-01-count-4:TGAGGAGAGGGTCTTT"	2.78430928763692	-11.0375423661438	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGAGGGTCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.59021567439	43.2877057481524	0.0183066416587563	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2358.93170323245	2358.93170323245
"healthy-2"	"2019-08-01-count-3:GAGTCATAGGCCCAAA"	-7.786453585059	3.21912238681642	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATAGGCCCAAA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2244.50089108561	40.4036596512551	0.0180011778171818	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2235.09324670142	2235.09324670142
"healthy-2"	"2019-08-01-count-4:AGAACCTTCAGTGTTG"	3.22907700118367	-10.7026043168274	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACCTTCAGTGTTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.76398587235	40.1072734899736	0.0181747000344121	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2206.76398587235	2206.76398587235
"healthy-2"	"2019-08-01-count-4:ATCACAGTCTAGACAC"	-2.2667215866154	13.4385747679505	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACAGTCTAGACAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2108.86442031183	42.0922848543379	0.0199596922632484	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2102.01141846611	2102.01141846611
"healthy-2"	"2019-08-01-count-4:TGTCCTGGTTATAGCC"	-4.65767655792888	-5.25208570873412	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGGTTATAGCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2669.48154655457	43.5485506638159	0.0163134863097379	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2667.29334192022	2667.29334192022
"healthy-2"	"2019-08-01-count-4:CACGAATTCGCATGAT"	6.91595329818074	-1.07757904445799	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATTCGCATGAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2558.9036801626	39.4599003254718	0.0154206274473623	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2550.71977616189	2550.71977616189
"healthy-2"	"2019-08-01-count-3:CCGTAGGGTGCGGCTT"	-7.98264823380168	2.97318050945131	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTAGGGTGCGGCTT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2296.98913952014	46.2372926445063	0.0201295216633744	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2290.22915454322	2290.22915454322
"healthy-2"	"2019-08-01-count-4:CTACATTAGGTCCTGC"	-2.04092297974284	13.4828977354797	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTAGGTCCTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2401.74127653634	39.7181009244362	0.0165372104449633	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2396.92427548161	2396.92427548161
"healthy-2"	"2019-08-01-count-3:CCGTGAGGTGCCCAGT"	-3.02132783356364	3.17750094020692	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTGAGGTGCCCAGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3166.3024860326	41.7866972171023	0.0131973168708405	4858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3161.338673746	3161.338673746
"healthy-2"	"2019-08-01-count-3:CCGTGAGTCGAGCCTG"	2.20144738730733	-10.9134807816711	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTGAGTCGAGCCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.41684034827	39.3961627410233	0.016494676337686	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2381.39923993454	2381.39923993454
"healthy-2"	"2019-08-01-count-4:TAAGCACTCTGAATGC"	10.6419731574947	4.37897203052369	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCACTCTGAATGC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.60705495473	33.8549951631926	0.0184736793802362	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1827.31160102923	1827.31160102923
"healthy-2"	"2019-08-01-count-4:TCATTGTAGTTTCTTC"	6.9994965988094	-1.20266809379729	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTAGTTTCTTC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2446.88270978187	37.8666064115152	0.0154754481120556	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2436.83453187452	2436.83453187452
"healthy-2"	"2019-08-01-count-4:GAACACTAGCCTAGGA"	3.75652827796285	-10.8255348435608	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACACTAGCCTAGGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.20582755858	36.5345029473582	0.0142645712243221	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2556.21504739216	2556.21504739216
"healthy-2"	"2019-08-01-count-4:AAGTCGTTCCGTTGAA"	-2.4646729034489	12.4905643233093	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTCGTTCCGTTGAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1583.03477761657	45.1494395404452	0.0285208134267413	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1583.03477761657	1583.03477761657
"healthy-2"	"2019-08-01-count-2:GCCAGTGTCTCGCGTT"	1.68873550471608	-4.71191742336424	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGTGTCTCGCGTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2274.75360407978	42.7067322100446	0.0187742233415742	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2268.64360541571	2268.64360541571
"healthy-2"	"2019-08-01-count-2:TGGTTAGAGTACAGAT"	-1.54750023308452	13.1149043806824	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGAGTACAGAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1810.00897140956	42.2903371634184	0.0233647113530518	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1806.40779197486	1806.40779197486
"healthy-2"	"2019-08-01-count-4:TAAGCCAGTATCACCA"	1.91976167735402	-5.20240166103514	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCCAGTATCACCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2525.23582020162	42.3265988489297	0.0167614440244834	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2518.02479459044	2518.02479459044
"healthy-2"	"2019-08-01-count-2:CTCATCGGTTATGTCG"	2.28918757018391	-10.8282299271789	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGGTTATGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.0061387631	38.0154280800815	0.0154533874859336	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2454.96945866923	2454.96945866923
"healthy-2"	"2019-08-01-count-4:GTAGAAACATTGACTG"	1.87100841578786	-8.86446382915648	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAAACATTGACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.90515592731	38.715018454262	0.016958662673192	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2280.20275234662	2280.20275234662
"healthy-2"	"2019-08-01-count-4:AGACAGGTCTGTACAG"	2.30070700225179	-10.8287067643371	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAGGTCTGTACAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.63114494191	36.3421627639143	0.015984194641582	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2271.54488097587	2271.54488097587
"healthy-2"	"2019-08-01-count-4:TGATCAGCAACGGCCT"	1.55463065680806	-9.56116964733275	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCAGCAACGGCCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2451.94846750088	44.7939726119739	0.0182687251407162	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2447.75172078791	2447.75172078791
"healthy-2"	"2019-08-01-count-1:CTCGAGGAGCCAGAGT"	2.51257314261739	-10.8563595048157	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTCGAGGAGCCAGAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.26110800667	37.7230405002196	0.014260611319631	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2637.77454146487	2637.77454146487
"healthy-2"	"2019-08-01-count-3:TGTAACGAGGGAGGAC"	2.54621567305867	-10.6287040940491	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAACGAGGGAGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.64145229049	42.3289023453104	0.018327044790148	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.6359899443	2308.6359899443
"healthy-2"	"2019-08-01-count-3:AGATCGTGTATCCTTT"	2.42404951628987	-10.8622112504211	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCGTGTATCCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.49827153727	42.0228944463432	0.0188739847605311	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2222.93213469223	2222.93213469223
"healthy-2"	"2019-08-01-count-4:AATAGAGCATGATAGA"	-7.71656117859538	2.16619513118593	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGCATGATAGA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2591.30871594557	42.0930914839304	0.0162439508750584	3110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2581.91761286324	2581.91761286324
"healthy-2"	"2019-08-01-count-3:AATGGCTAGACATACA"	1.3721008497173	-9.01736071026	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGCTAGACATACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.83014224086	40.5450352628666	0.0191265490828461	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2119.83014224086	2119.83014224086
"healthy-2"	"2019-08-01-count-4:TCCACCACACGTGTGC"	2.82232799109761	-10.7833357087341	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCACACGTGTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.77034670006	42.9624887117803	0.0199290656249841	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2152.61420061298	2152.61420061298
"healthy-2"	"2019-08-01-count-3:GTAGTACCAATCCTTT"	2.18585457381551	-10.6295252076355	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACCAATCCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.53763793698	42.4662398598741	0.0192631049382374	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2202.22324232573	2202.22324232573
"healthy-2"	"2019-08-01-count-2:TGTACAGAGGTTAAAC"	2.40164866027181	-10.6140089265076	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTACAGAGGTTAAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.18850546935	37.9684432609185	0.0162523029164937	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.55798900332	2332.55798900332
"healthy-2"	"2019-08-01-count-3:TACCTCGCACCAGGTC"	2.81475438651387	-10.6453829041687	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTCGCACCAGGTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.93799524437	40.0154477343609	0.0179045001783083	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2229.73238670669	2229.73238670669
"healthy-2"	"2019-08-01-count-3:TTTCATGGTAGTCGTT"	0.960780103772324	-8.72111513530882	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGGTAGTCGTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2263.1816936205	45.5640460810683	0.0201327388823907	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2259.94006971607	2259.94006971607
"healthy-2"	"2019-08-01-count-3:AGATGCTGTCCTTGTC"	3.1746937232906	-10.7532224885193	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGCTGTCCTTGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.36106213576	40.9583559976059	0.0164006545223293	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2489.71134185864	2489.71134185864
"healthy-2"	"2019-08-01-count-2:TTGGGATCAGCATACT"	3.23837103423421	-10.6376161805359	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATCAGCATACT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.34160833058	41.7692921287034	0.018905764491651	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2207.56234051955	2207.56234051955
"healthy-2"	"2019-08-01-count-2:AATAGAGGTTCAACGT"	6.80812515792195	-1.11992909824523	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATAGAGGTTCAACGT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2237.84670147134	32.0873308842116	0.0143384847867885	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2230.72854766162	2230.72854766162
"healthy-2"	"2019-08-01-count-3:AAACCCAGTACCTTCC"	2.83297409591023	-10.9248552552429	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACCCAGTACCTTCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.54906327124	43.3618194361453	0.018315066880275	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2360.59000393994	2360.59000393994
"healthy-2"	"2019-08-01-count-4:TTTCCTCTCTCTATAC"	3.16559805449788	-10.7632475129333	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCTCTCTATAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.1404574928	38.9086799809743	0.0151505264704095	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2564.87841618972	2564.87841618972
"healthy-2"	"2019-08-01-count-2:GGACGTCAGTCGAAAT"	1.44440795955006	-9.1014499894348	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGACGTCAGTCGAAAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2320.72876931764	52.6099189094836	0.0226695681137061	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2318.83780170799	2318.83780170799
"healthy-2"	"2019-08-01-count-3:TGCGGCAAGTATAGGT"	4.54962887343709	-10.8165712586609	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAAGTATAGGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.17072959624	42.7311871787416	0.0209039228280026	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2041.49483439569	2041.49483439569
"healthy-2"	"2019-08-01-count-4:ATTACCTCACTGCACG"	1.91774930533711	-9.99521639263304	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTCACTGCACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.4413757887	36.1939659531956	0.0158993621966899	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2273.07448665419	2273.07448665419
"healthy-2"	"2019-08-01-count-2:CTGCTCAGTTAAGACA"	-7.74862943115886	3.60709807956544	"2019-08-01-count-2"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCTCAGTTAAGACA"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2147.46126038545	40.7884994721594	0.018993823183026	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2139.71077554085	2139.71077554085
"healthy-2"	"2019-08-01-count-3:GACTATGCAGGCTATT"	2.25035037574117	-10.3747139207092	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGCAGGCTATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.9505724525	42.1587172613657	0.0182746512928308	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2300.01522866273	2300.01522866273
"healthy-2"	"2019-08-01-count-4:GCGAGAAAGCCTGACC"	2.19802083548848	-9.91785528576048	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAAAGCCTGACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.47095980404	40.397067754906	0.0222883944906205	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1810.63613612377	1810.63613612377
"healthy-2"	"2019-08-01-count-2:CGAGAAGCAAGCTGCC"	-1.36827216568645	13.155153251532	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGAAGCAAGCTGCC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1717.13357850529	42.0846812761838	0.0245086822615264	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1710.89902488628	1710.89902488628
"healthy-2"	"2019-08-01-count-2:TTGGTTTAGGTATTGA"	11.1999441581661	3.90981981838075	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTAGGTATTGA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1433.33812364873	49.8690702659411	0.0347922583256165	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1413.60440233613	1413.60440233613
"healthy-2"	"2019-08-01-count-3:CCTCAGTAGCTCTATG"	2.32335009154622	-10.7356672517029	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAGTAGCTCTATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.34674192143	43.7596075789707	0.0184301672566823	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2366.99867416778	2366.99867416778
"healthy-2"	"2019-08-01-count-4:AGAGCCCCAGGCAATG"	1.87812163409535	-5.01806881343993	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCCCCAGGCAATG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2587.29350817942	41.7944365519136	0.0161537283728288	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2585.92793747821	2585.92793747821
"healthy-2"	"2019-08-01-count-3:CCTCATGCATTCTCCG"	10.2445436912471	5.28305051410524	"2019-08-01-count-3"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCATGCATTCTCCG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.60386821765	34.5527938094718	0.0181037010271486	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1895.31132230609	1895.31132230609
"healthy-2"	"2019-08-01-count-2:TGTCCTGAGGATGCGT"	-7.27352509918864	-0.171775125619494	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGAGGATGCGT"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2070.94733191901	50.4353219149412	0.0243537443650033	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2064.52127416919	2064.52127416919
"healthy-2"	"2019-08-01-count-4:TTCCGTGTCTGCGGGT"	2.32113875922505	-10.6331577531067	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGTCTGCGGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.9760147744	35.4396032945718	0.0155848624015006	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2273.01322952838	2273.01322952838
"healthy-2"	"2019-08-01-count-3:TCCCACAGTCATAAAG"	10.6136051612789	4.31488654697267	"2019-08-01-count-3"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCACAGTCATAAAG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1553.97499996661	36.3780062423472	0.023409647029797	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1543.27355651783	1543.27355651783
"healthy-2"	"2019-08-01-count-3:CTCCATGAGTCGCTAT"	1.78126146373097	-9.4713926545349	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGAGTCGCTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.20581100456	42.4777661264445	0.0187274743413305	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2264.03453766728	2264.03453766728
"healthy-2"	"2019-08-01-count-3:AGCCACGGTCGTTCAA"	1.10364784774129	11.3412961729797	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGGTCGTTCAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.27751727091	30.5600886389082	0.0159227044363875	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1916.89433916581	1916.89433916581
"healthy-2"	"2019-08-01-count-4:TACATTCCATTGGGAG"	2.16983880576436	-10.2370748749939	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACATTCCATTGGGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.91597796198	43.9905689363011	0.0184530702184851	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.2655790886	2380.2655790886
"healthy-2"	"2019-08-01-count-4:GTATTGGAGCGAGTCA"	3.00742735442464	-10.9828844300476	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTGGAGCGAGTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.93468934327	42.561978934845	0.0189001835338561	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.84794320215	2248.84794320215
"healthy-2"	"2019-08-01-count-3:GTCACTCTCGTACCTC"	2.64245762404744	-10.8285846940246	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACTCTCGTACCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.27685195282	39.0711604802958	0.0160702227098956	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2428.24392063553	2428.24392063553
"healthy-2"	"2019-08-01-count-4:AATGGAAGTCCACATA"	1.34645762023274	9.77606484973756	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAAGTCCACATA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1768.08163789975	33.0332292588959	0.0186830905037479	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1760.36630489808	1760.36630489808
"healthy-2"	"2019-08-01-count-2:GTTTGGAGTGGGTTGA"	1.20698847350423	-9.1308050385681	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAGTGGGTTGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2414.19243263378	40.673045198182	0.0168474743969806	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2408.95455940297	2408.95455940297
"healthy-2"	"2019-08-01-count-2:GTTTGGAGTGCCCACA"	3.19957985457723	-10.6838054887024	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAGTGCCCACA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.06507759417	38.6552296898157	0.0192980398501298	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1998.57433868691	1998.57433868691
"healthy-2"	"2019-08-01-count-4:TCCCACATCAGAACCT"	1.32963659343068	-9.12132742321166	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACATCAGAACCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2525.16707436035	40.2610958851185	0.0159439334901502	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2522.40508983476	2522.40508983476
"healthy-2"	"2019-08-01-count-3:CCTCCTCTCTGGACCG"	10.3042742210323	4.5475396879944	"2019-08-01-count-3"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCTCTCTGGACCG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1722.5930046043	38.5513725974085	0.0223798497348851	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1718.78216657564	1718.78216657564
"healthy-2"	"2019-08-01-count-3:TCCGAAACAATCCAGT"	-2.66467986527141	3.28295443141786	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGAAACAATCCAGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3232.39681029603	45.471572126856	0.0140674474068335	5483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3224.69075980233	3224.69075980233
"healthy-2"	"2019-08-01-count-3:ACACCAATCGGCATAT"	6.94878687438313	-1.07637348091277	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAATCGGCATAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2324.55990410777	36.6345890172463	0.0157597956294904	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2317.6416650858	2317.6416650858
"healthy-2"	"2019-08-01-count-4:GTCAAACGTAGGCAGT"	2.72317614135091	-10.8249693146911	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACGTAGGCAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.35244333379	40.6750155569942	0.0167638529467331	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2423.05989268932	2423.05989268932
"healthy-2"	"2019-08-01-count-4:CTATCCGCAGTCTGGC"	1.78845455226247	-7.36962797557982	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCCGCAGTCTGGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2192.19319006231	39.2107317633363	0.0178865311420029	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2189.25199964137	2189.25199964137
"healthy-2"	"2019-08-01-count-3:ATCTCTAAGTTGCGAG"	3.00968613204305	-11.0511913529602	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTAAGTTGCGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.44438375165	40.3741872046999	0.0164964676920711	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2438.5305993224	2438.5305993224
"healthy-2"	"2019-08-01-count-2:GAGTTGTTCCGATGTA"	3.3901113468105	-10.7635793915954	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTGTTCCGATGTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.09629231225	42.4921914135431	0.0178007864828877	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2384.52651727827	2384.52651727827
"healthy-2"	"2019-08-01-count-4:GGCTGTGTCCAAAGGG"	4.39762129363362	-10.7388420335022	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTGTGTCCAAAGGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.44870809696	46.1327066121748	0.0216032847978291	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2131.85057112078	2131.85057112078
"healthy-2"	"2019-08-01-count-3:TGTGATGAGTACCCTA"	-2.71564350548442	13.346387840155	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGATGAGTACCCTA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1575.3391004146	45.2577453964152	0.0287288910587594	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1573.11757764679	1573.11757764679
"healthy-2"	"2019-08-01-count-2:CGAGTGCTCTTGTTAC"	2.01244988021199	-10.3010463944641	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCTCTTGTTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.21886716679	43.0729113482356	0.0177750808776906	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.33189976444	2420.33189976444
"healthy-2"	"2019-08-01-count-4:AATTTCCAGGTGCATG"	-2.18250070038493	12.9593600996765	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTTCCAGGTGCATG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2084.34839074131	43.4032614452386	0.0208234197498058	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2080.59334712092	2080.59334712092
"healthy-2"	"2019-08-01-count-3:TTGCTGCCAGAGTGAC"	4.44592728194539	-10.7211303940979	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCTGCCAGAGTGAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.96919199441	39.9059033386179	0.0171566775157501	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2319.80182896247	2319.80182896247
"healthy-2"	"2019-08-01-count-4:ATCGGCGGTAGTCACT"	2.5224846797878	-10.5911836854187	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGCGGTAGTCACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2328.41628204167	40.4211644692775	0.0173599389340442	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2325.6338416929	2325.6338416929
"healthy-2"	"2019-08-01-count-4:GTCACTCAGGGATCGT"	6.930587430566	-1.09857156192931	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCAGGGATCGT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2015.8267552302	45.4020501502811	0.0225227937036168	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2010.77890742952	2010.77890742952
"healthy-2"	"2019-08-01-count-3:CAGGCCACAGTACTAC"	2.83026399192159	-10.9783659211365	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGCCACAGTACTAC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.01642877492	39.6024955089363	0.0158535768831425	2181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2492.49774091564	2492.49774091564
"healthy-2"	"2019-08-01-count-3:TACTTCATCGTGCATA"	-7.39400372925456	3.83417222583619	"2019-08-01-count-3"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTCATCGTGCATA"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2357.26970708153	41.2849403570209	0.0175138806700802	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2351.6933813381	2351.6933813381
"healthy-2"	"2019-08-01-count-4:TCCGAAACACTCATAG"	2.59043135222737	-10.9823684922424	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAACACTCATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.44887784612	45.6446413656679	0.0187648923606918	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2429.77064515251	2429.77064515251
"healthy-2"	"2019-08-01-count-3:CCTCTCCTCGGTTAGT"	1.96785893019978	-10.5585441819397	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCTCGGTTAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.66953216648	41.9895116511215	0.0170227552185485	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2461.61370049079	2461.61370049079
"healthy-2"	"2019-08-01-count-3:GAGAGGTAGCGCCTTG"	1.77515568312947	-9.68436148082884	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTAGCGCCTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.67195554017	39.0290750847264	0.0167386647131005	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.90724001318	2328.90724001318
"healthy-2"	"2019-08-01-count-3:TGGAGGATCTTCCACG"	3.1653114753658	-10.8531208268371	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGGATCTTCCACG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.67399457141	41.456345592584	0.0172184214665506	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2396.68965774291	2396.68965774291
"healthy-2"	"2019-08-01-count-3:CCTGCATAGCCTCTCT"	2.88035788115804	-10.9285440674988	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGCATAGCCTCTCT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.19351710977	38.9602960183362	0.016996948873436	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2281.87117194692	2281.87117194692
"healthy-2"	"2019-08-01-count-2:GATCACAAGTCACGAG"	-3.21131501618083	-5.46501829540404	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACAAGTCACGAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2234.1496694006	47.058235013474	0.0210631524190138	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2231.28505889266	2231.28505889266
"healthy-2"	"2019-08-01-count-3:GCCAGGTAGCAGCACA"	2.4249915080959	-10.9933490983215	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTAGCAGCACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.42500636342	43.9129879519304	0.0194354704529933	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2257.26045410673	2257.26045410673
"healthy-2"	"2019-08-01-count-4:CTGAGGCCAGAACCGA"	-7.55773435059245	3.68468091571657	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAGGCCAGAACCGA"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2282.63668856642	38.2189032145494	0.0167433141708383	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2274.33402226226	2274.33402226226
"healthy-2"	"2019-08-01-count-3:ATGAAAGTCTCTGCCA"	-0.611680189997512	10.8958825835022	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGTCTCTGCCA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.48431169199	36.165867945411	0.0193972498017916	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1860.92760810717	1860.92760810717
"healthy-2"	"2019-08-01-count-4:TGTAAGCAGTCGCCAC"	3.01034869727437	-11.0023422471252	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCAGTCGCCAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.64883029338	39.6655558873233	0.0161659465680672	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2452.77052633897	2452.77052633897
"healthy-2"	"2019-08-01-count-3:GTCGAATAGACCTCCG"	-3.16991029205974	3.29290316188661	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGAATAGACCTCCG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3093.28522957418	39.644294431609	0.0128162427611198	4597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3085.02797009711	3085.02797009711
"healthy-2"	"2019-08-01-count-3:GGAAGTGAGCGCTGCT"	-2.38183365288432	12.6967344054016	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGAGCGCTGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1846.16153777897	43.0944313137177	0.0233427197088953	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1837.94886621111	1837.94886621111
"healthy-2"	"2019-08-01-count-2:AGACCCGAGCCATATC"	7.78529705581014	6.56004808032838	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGAGCCATATC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.5258895685	39.6492559326948	0.0220699607853789	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1783.69021615478	1783.69021615478
"healthy-2"	"2019-08-01-count-4:GTCATCCCACGACAGA"	1.16553141650502	9.00142095172731	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCCACGACAGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1720.80852271433	31.9640994697958	0.0185750471640952	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1716.84340293636	1716.84340293636
"healthy-2"	"2019-08-01-count-4:TTCGGTCTCACAAGGG"	2.35755338248555	-10.5289354554382	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCTCACAAGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.11634817501	46.4704895644636	0.0203628923659505	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2277.15946381086	2277.15946381086
"healthy-2"	"2019-08-01-count-3:GTCGAATTCCTAACAG"	7.8218113380367	6.92825791919557	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGAATTCCTAACAG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1749.09729031752	36.6179993486282	0.0209353702343114	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1747.32120366413	1747.32120366413
"healthy-2"	"2019-08-01-count-3:TCCTGCAAGCATTTGC"	2.52633800086324	-10.9517431489197	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAAGCATTTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.48661356861	34.3933054489384	0.014291916379263	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2403.50907828067	2403.50907828067
"healthy-2"	"2019-08-01-count-3:TGGATGTCACTTCATT"	-2.57955179634746	12.9427976378235	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATGTCACTTCATT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1801.43239965024	45.7849269617484	0.02541584517445	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1791.08091431285	1791.08091431285
"healthy-2"	"2019-08-01-count-4:CAGCCAGCAGCTTCGG"	-5.00967631760295	-5.43447401439818	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGCAGCTTCGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2634.09652462745	45.2324561746103	0.0171719053389692	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2628.77708686622	2628.77708686622
"healthy-2"	"2019-08-01-count-3:CCTTGTGAGGCACGAT"	2.3614829975063	-10.880192779657	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTGTGAGGCACGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.71346875399	42.1332167213301	0.0183689973901658	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2285.46617036253	2285.46617036253
"healthy-2"	"2019-08-01-count-2:AAGCCATAGAGGTTAT"	1.18445338782613	10.6829442747864	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATAGAGGTTAT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1827.96378939645	37.9307605315156	0.0207502800392121	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1823.1749283997	1823.1749283997
"healthy-2"	"2019-08-01-count-2:GCATCTCAGATGGGCT"	2.50980820235555	-10.9779978028503	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCAGATGGGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.02819669455	39.6362198900828	0.0174760701599077	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2263.24668166705	2263.24668166705
"healthy-2"	"2019-08-01-count-3:AGGAAATCACGGCACT"	-1.8678859275883	13.3654813536438	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATCACGGCACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1829.66649555555	41.6098643788933	0.0227417753344493	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1821.90861050419	1821.90861050419
"healthy-2"	"2019-08-01-count-3:TAGATCGGTGAGGCAT"	2.14553966101949	-10.3825330964294	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGATCGGTGAGGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.48644893876	40.726398302831	0.0183247003923367	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2219.15192434495	2219.15192434495
"healthy-2"	"2019-08-01-count-2:TTTAGTCTCAACCTTT"	7.94845213469808	7.55409095371095	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTAGTCTCAACCTTT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1751.89580522497	31.7205094049215	0.0181063904087882	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1748.40387773374	1748.40387773374
"healthy-2"	"2019-08-01-count-3:GTCTACCAGTTTGTCG"	-3.12005672875102	3.14979384029237	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCAGTTTGTCG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3243.20714956489	43.5693669764897	0.0134340376569332	5466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3237.37320626541	3237.37320626541
"healthy-2"	"2019-08-01-count-2:ACAAGCTGTTAAGACA"	1.17974259433095	11.2077903517517	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTGTTAAGACA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.15018380528	35.3800111348197	0.0180312452261966	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1951.48146824753	1951.48146824753
"healthy-2"	"2019-08-01-count-2:TCTTCCTTCAAGGACG"	11.1546846824581	4.15348050678102	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTTCAAGGACG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.45899784308	38.1631921054122	0.019799742639464	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1914.02623259982	1914.02623259982
"healthy-2"	"2019-08-01-count-2:TTTCACACAGCACAAG"	1.70976569232289	-4.72827150737914	"2019-08-01-count-2"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACACAGCACAAG"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2164.60239530317	38.4130082768313	0.0177459880669915	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2157.9261091254	2157.9261091254
"healthy-2"	"2019-08-01-count-2:AGAGAGCAGTAACGTA"	2.22144808348958	-10.45596983349	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCAGTAACGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.94847991357	41.362795661694	0.0171847449195004	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2403.41435602285	2403.41435602285
"healthy-2"	"2019-08-01-count-4:GATCATGCACTGAATC"	2.95152654227559	-10.8656368485657	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGCACTGAATC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.49265308245	37.8311379454491	0.0157597391089161	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2394.97808162935	2394.97808162935
"healthy-2"	"2019-08-01-count-2:GTGACGCAGCCTCACG"	2.90340294417683	-10.7015695801941	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGACGCAGCCTCACG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.32040243244	35.8420351089567	0.0152563418220208	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.30158500884	2345.30158500884
"healthy-2"	"2019-08-01-count-3:ATTTCTGCAAAGGTTA"	14.2050243812496	2.03052005851594	"2019-08-01-count-3"	"Control2"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCTGCAAAGGTTA"	"Plasma cell"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1113.51881437062	27.0833073100442	0.0243222718471551	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1094.36454738657	1094.36454738657
"healthy-2"	"2019-08-01-count-4:TCTACCGCACTAGTAC"	3.08915986594502	-10.7849045029846	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGCACTAGTAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.61055585788	40.5085288640169	0.0162319111725715	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2491.79730644282	2491.79730644282
"healthy-2"	"2019-08-01-count-2:TTTATGCCAGCTTTGA"	2.71094502982442	-10.0622816315857	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCCAGCTTTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.47127892849	40.1818450638848	0.0167461246220161	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2393.4690473521	2393.4690473521
"healthy-2"	"2019-08-01-count-2:CAGCAATCAGTATGAA"	10.9190956550533	4.06518266284791	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATCAGTATGAA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.47636497335	29.2109027693553	0.0159406709563646	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1832.47636497335	1832.47636497335
"healthy-2"	"2019-08-01-count-2:TTCATTGCAATCACGT"	3.14918865737264	-10.8975649110046	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGCAATCACGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.26189541088	42.4322003836688	0.0183668355816959	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.95001292273	2302.95001292273
"healthy-2"	"2019-08-01-count-3:TCTCCGACAATAACGA"	2.20973696288411	-10.8941517106262	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCCGACAATAACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.65980322745	41.5689011176672	0.0171654586091187	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2419.0265532354	2419.0265532354
"healthy-2"	"2019-08-01-count-2:TGAACGTCAGCGCTTG"	2.81031837043111	-10.8799686661926	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAACGTCAGCGCTTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.27575595479	41.4239444521493	0.0184083858800555	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.39262697396	2243.39262697396
"healthy-2"	"2019-08-01-count-2:GTATTGGCAGAGGCTA"	1.6911971765453	-9.03303911602172	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTGGCAGAGGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.14057909378	38.9090792617987	0.0158673934086512	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.12832632608	2450.12832632608
"healthy-2"	"2019-08-01-count-3:TGGGTTAAGCTAGAAT"	-3.66247568550761	3.58432123744813	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGTTAAGCTAGAAT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3154.72118707975	42.3683663695042	0.0134301460753568	4375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3147.33661418002	3147.33661418002
"healthy-2"	"2019-08-01-count-3:CATACTTGTTAGTTCG"	1.29505362090413	-8.92957117473754	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACTTGTTAGTTCG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2380.00155934181	42.6797547686816	0.0179326583216545	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2374.78713979216	2374.78713979216
"healthy-2"	"2019-08-01-count-4:TTCTTGAAGGATGGCT"	2.30096759375874	-10.7531862488953	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGAAGGATGGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.37341040904	40.1884968275809	0.0181325478093351	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2210.06451407269	2210.06451407269
"healthy-2"	"2019-08-01-count-2:CCACCATAGTCCTGCG"	1.91163148459737	-9.69077970897826	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATAGTCCTGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.91784180283	37.190002762042	0.0153366032122526	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2424.0194649024	2424.0194649024
"healthy-2"	"2019-08-01-count-2:TTCCAATAGAGTACCG"	2.09855331954305	-10.2637691727844	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATAGAGTACCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.46690765645	40.6760590765154	0.0171667555031383	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2364.80295382032	2364.80295382032
"healthy-2"	"2019-08-01-count-3:AGAGAATGTATCGTTG"	9.08398212966267	5.41489980304567	"2019-08-01-count-3"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATGTATCGTTG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1605.6383284105	31.9797005827265	0.0199171258040313	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1599.37587596691	1599.37587596691
"healthy-2"	"2019-08-01-count-4:TTCACCGTCACACCGG"	1.55931963500325	-4.82825424587401	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACCGTCACACCGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2512.95484920102	38.569250189371	0.0153481668011799	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2507.03254960323	2507.03254960323
"healthy-2"	"2019-08-01-count-2:CTGCAGGAGGTCACTT"	2.14688195761983	-10.8724832764831	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGAGGTCACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.07877741362	41.676160736783	0.0172852754240943	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2405.07266944589	2405.07266944589
"healthy-2"	"2019-08-01-count-3:TCGACCTTCGCTGTTC"	-2.13286910477336	12.7331475981506	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACCTTCGCTGTTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1666.42841658106	35.9321656421404	0.0215623817288598	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1664.29074746638	1664.29074746638
"healthy-2"	"2019-08-01-count-2:TTAATCCAGATGTTGA"	8.28209366378133	7.86298654163209	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCAGATGTTGA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1845.09263638073	42.8913003538018	0.0232461500892095	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1837.3861408683	1837.3861408683
"healthy-2"	"2019-08-01-count-2:TTTGACTTCCGCGATG"	1.4186028438503	9.73099801624147	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTTCCGCGATG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1703.36661782624	32.7263737072779	0.019212759816229	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1693.44640882558	1693.44640882558
"healthy-2"	"2019-08-01-count-4:AGCTTCCAGGCATCTT"	2.0032328563625	-9.94463636791381	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCAGGCATCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.96949787648	33.0982326451933	0.0143969864218579	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2296.77784430746	2296.77784430746
"healthy-2"	"2019-08-01-count-2:TTAATCCCATAGCTGT"	2.2469297843868	-10.8102369538513	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCCATAGCTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.38028304743	42.3980444358519	0.0173949238576929	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.00864573788	2433.00864573788
"healthy-2"	"2019-08-01-count-3:GTGAGGAAGTGTTCAC"	-2.31698737564738	12.9708032377991	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGAAGTGTTCAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1775.53863406952	42.1876668567176	0.0237604893789463	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1773.55423859014	1773.55423859014
"healthy-2"	"2019-08-01-count-3:CTGCAGGTCCAAGCTA"	4.56904615935628	-10.6997680894104	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCAGGTCCAAGCTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.33071907747	37.3034994802808	0.0161254502750722	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.03955894679	2308.03955894679
"healthy-2"	"2019-08-01-count-3:ACCATTTAGGAAAGGT"	-5.12779031220134	-4.44748785411986	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTAGGAAAGGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2714.80915243042	42.9044320866627	0.0158038483288053	3088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2709.1988936752	2709.1988936752
"healthy-2"	"2019-08-01-count-2:TTACAGGCAACTACGT"	1.72612084922139	-4.97473051464232	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACAGGCAACTACGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2323.16494775728	41.158802095798	0.0177166938299115	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2317.39098208158	2317.39098208158
"healthy-2"	"2019-08-01-count-3:GAGTGAGGTAGACACG"	2.63434948500935	-10.9298086396423	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGAGGTAGACACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.59171655727	39.9908409862457	0.0173904092184313	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.38744694369	2294.38744694369
"healthy-2"	"2019-08-01-count-4:GACTTCCGTCGTGCCA"	3.0591377216274	-10.3569612733093	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCGTCGTGCCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2472.4815104672	42.3158268510143	0.0171147192291919	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2470.3914282373	2470.3914282373
"healthy-2"	"2019-08-01-count-4:TGGAGGAGTTCGGTAT"	1.88902713832204	-9.97460653698119	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGGAGTTCGGTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.75845377497	42.3696735403082	0.0177668616598208	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.85327910344	2383.85327910344
"healthy-2"	"2019-08-01-count-2:ACAGCCGGTTTCCATT"	1.25346161898915	9.26213834369508	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGCCGGTTTCCATT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.85326943395	36.5978262375256	0.0223997019329679	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1626.88977876992	1626.88977876992
"healthy-2"	"2019-08-01-count-4:TGGATCAGTACCACGC"	1.37579466876332	-8.88702394878539	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATCAGTACCACGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2337.39572436428	39.0111617611513	0.0166900116033033	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2333.09342460812	2333.09342460812
"healthy-2"	"2019-08-01-count-2:CTGCCATCAAACGAGC"	4.58420481261556	-10.7279291382995	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATCAAACGAGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.99794793613	47.0564676427143	0.0213601958580121	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2200.78308956066	2200.78308956066
"healthy-2"	"2019-08-01-count-3:TCGCACTGTGGGTTGA"	6.66007484969441	-0.861567401048265	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTGTGGGTTGA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1606.55024777016	43.7697108288709	0.0272445327431382	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1600.8937720037	1600.8937720037
"healthy-2"	"2019-08-01-count-2:TTGCGTCCAAACTAAG"	-5.30994401398357	3.67257354343263	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCGTCCAAACTAAG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2837.62878651544	41.6565992596963	0.0146800735380366	3111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2828.56691874956	2828.56691874956
"healthy-2"	"2019-08-01-count-3:ACCCAAATCATTTGGG"	4.42264093932454	-10.6649494401184	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCAAATCATTTGGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.62058398274	40.7687540574319	0.0164814096072045	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2470.87041644753	2470.87041644753
"healthy-2"	"2019-08-01-count-3:ATGTCCCCACACAGAG"	2.23574223098103	-10.2014360657898	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCCACACAGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.92014605008	42.5815987129223	0.0196145393880093	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2164.1733147274	2164.1733147274
"healthy-2"	"2019-08-01-count-4:TCGAAGTGTCAAAGCG"	4.73338808593099	-10.5357084504333	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTGTCAAAGCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.01299494493	38.3089583011863	0.0171327082569704	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.38164363436	2230.38164363436
"healthy-2"	"2019-08-01-count-4:ACATCGAGTACGACTT"	-5.1349609893864	-5.29468347942504	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCGAGTACGACTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2858.72733075678	38.6859720418281	0.013532585506008	2634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2855.32338995741	2855.32338995741
"healthy-2"	"2019-08-01-count-3:CGATGCGAGCGTATGG"	2.43842806395833	-10.8651705018249	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGCGAGCGTATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.85523675361	41.4578018269486	0.0181923806121218	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2270.31468585541	2270.31468585541
"healthy-2"	"2019-08-01-count-4:TTGCATTAGCGGTATG"	2.39030637320821	-10.8723707429138	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTAGCGGTATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.11223797869	36.8673246550182	0.0158903194645176	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.55010262678	2314.55010262678
"healthy-2"	"2019-08-01-count-3:ATGTCTTAGGAGCTGT"	-2.13784919205363	13.4418763884339	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCTTAGGAGCTGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1833.43493545517	42.5479393779836	0.0232066808345291	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1833.43493545517	1833.43493545517
"healthy-2"	"2019-08-01-count-4:AGAGAATAGTTATGGA"	1.97032489356343	-10.2863664857117	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAATAGTTATGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.39629870641	43.8127713803262	0.0171855475755406	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2541.66800094607	2541.66800094607
"healthy-2"	"2019-08-01-count-4:TTGCATTTCTGAATCG"	3.04039253768269	-10.7548361054626	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTTCTGAATCG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.51905378788	38.5874728860536	0.0163817281902269	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.82767487259	2353.82767487259
"healthy-2"	"2019-08-01-count-3:CTGCCTAGTGATTGGG"	3.25145568427388	-10.7077369919983	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTAGTGATTGGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1956.90801993525	43.8140419314126	0.022389423256011	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1955.80078145133	1955.80078145133
"healthy-2"	"2019-08-01-count-3:AGGGTCCGTCCGATCG"	6.93134083327596	-1.06214024936827	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTCCGTCCGATCG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2059.06479619986	36.2446857779141	0.0176024988843509	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2054.16070994561	2054.16070994561
"healthy-2"	"2019-08-01-count-3:CATCGTCGTGGAACAC"	-5.30058465424235	-5.06623508846434	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCGTCGTGGAACAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2514.10074384679	42.2408566643151	0.0168015767736034	3062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2510.54027402954	2510.54027402954
"healthy-2"	"2019-08-01-count-3:CCCAACTAGATTACCC"	2.84732069548909	-10.8492927781311	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTAGATTACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.46108543555	43.8203831528197	0.0179557803295188	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2434.3477015799	2434.3477015799
"healthy-2"	"2019-08-01-count-4:GATTCGAAGATGCGAC"	4.3200327354366	-10.6336603394714	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCGAAGATGCGAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.1147347254	36.7519652998798	0.0148007519692577	1956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2480.52564526886	2480.52564526886
"healthy-2"	"2019-08-01-count-3:TATCAGGAGGGTGGGA"	3.29850925978963	-10.5978956452576	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCAGGAGGGTGGGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2367.42690977121	40.4213678429815	0.0170739665398531	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2356.39175057865	2356.39175057865
"healthy-2"	"2019-08-01-count-3:ACCGTTCGTACGATTC"	4.29307045516316	-10.7576904526916	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCGTACGATTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.92839422283	42.0214671247651	0.0172436199702808	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.00246466997	2433.00246466997
"healthy-2"	"2019-08-01-count-4:CGGACACGTTAGAGAT"	-1.69482181492503	12.2187661894592	"2019-08-01-count-4"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACGTTAGAGAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1685.84607270215	42.92620897812	0.0254627095991724	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1683.77349291355	1683.77349291355
"healthy-2"	"2019-08-01-count-4:AGTCACAGTTCGGCCA"	4.59957804259602	-10.6264620057312	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACAGTTCGGCCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.40834561472	43.6307793346219	0.0176828368973324	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2461.463352687	2461.463352687
"healthy-2"	"2019-08-01-count-3:CTTGATTTCGTAGTCA"	-4.9506290954655	3.61847779834596	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTTCGTAGTCA"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2620.27738994248	38.4344897871522	0.0146680996197871	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2613.55787446936	2613.55787446936
"healthy-2"	"2019-08-01-count-3:GATAGCTAGCGACTTT"	1.86278154429738	-5.30349066173705	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTAGCGACTTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2582.88656042104	45.8530920666659	0.0177526542471115	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2577.25143317341	2577.25143317341
"healthy-2"	"2019-08-01-count-4:CTCCATGGTGATACTC"	1.4384112554485	-9.49545099651488	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCATGGTGATACTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.11977447884	47.2603952560835	0.0189183864356316	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.52289812885	2493.52289812885
"healthy-2"	"2019-08-01-count-2:GTCCACTGTGCCTTCT"	2.46450199660603	-10.6069870225159	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCACTGTGCCTTCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.93734986217	39.9682121003367	0.0150259975493061	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2657.15125027041	2657.15125027041
"healthy-2"	"2019-08-01-count-4:ATTATCCAGCGGTATG"	2.3892728286678	-10.6421175233093	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCAGCGGTATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.85809638522	42.4278736513822	0.0187083458700563	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.88579788472	2265.88579788472
"healthy-2"	"2019-08-01-count-3:ACCTACCGTTAGGCTT"	2.54897059974019	-10.5691976777283	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTACCGTTAGGCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.80497141724	38.578475683122	0.0168405762011486	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2283.6854883804	2283.6854883804
"healthy-2"	"2019-08-01-count-2:CCCGAAGAGTGCACCC"	2.86402930793111	-10.8773327103821	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGAGTGCACCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.91579847151	39.8693819881894	0.017230264824038	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2311.00791774754	2311.00791774754
"healthy-2"	"2019-08-01-count-2:TTAGGCACACTCAGAT"	2.56454267081563	-10.7542591325012	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCACACTCAGAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.2953548333	41.8830605545056	0.0168591308891756	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2480.39648195887	2480.39648195887
"healthy-2"	"2019-08-01-count-3:CATGCGGGTCGTCGGT"	2.29756512221639	-10.8274812928406	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCGGGTCGTCGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.27465412702	42.8155401877726	0.0183893855099437	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.41562829375	2317.41562829375
"healthy-2"	"2019-08-01-count-4:GTGAGGATCAGCGCGT"	0.99699362096135	-8.89266683971556	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGATCAGCGCGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2264.45805527966	43.6948615383442	0.0192959465230403	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2264.45805527966	2264.45805527966
"healthy-2"	"2019-08-01-count-3:CGCGTGACACACAGCC"	4.49051107940022	-10.8340158692566	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCGTGACACACAGCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.49529105505	41.6805748560402	0.0166025305861154	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2509.54416244406	2509.54416244406
"healthy-2"	"2019-08-01-count-4:ATTCACTCAACCGATT"	-7.27844891968425	3.83441565120546	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTCAACCGATT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2305.48448005556	39.5638296397828	0.0171607442956325	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2296.62218308241	2296.62218308241
"healthy-2"	"2019-08-01-count-3:TTTGGAGAGAGGTTAT"	3.01984991607015	-10.4545908204285	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGAGAGGTTAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2298.97080209377	44.1613953739399	0.0192092023673029	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2297.56923819972	2297.56923819972
"healthy-2"	"2019-08-01-count-2:CACTGAAAGGATTTCC"	2.87030543860738	-10.8170643082825	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAAGGATTTCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.77535978075	45.0544123423794	0.0186038775893972	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2414.63854560529	2414.63854560529
"healthy-2"	"2019-08-01-count-4:ACCCAAAGTGACTGAG"	1.78705515441243	-10.2477493516174	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCAAAGTGACTGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.3116528775	43.8786187401361	0.0200605243804247	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2186.22241604638	2186.22241604638
"healthy-2"	"2019-08-01-count-4:GAGGCCTCACGTACAT"	-5.10031686249431	-5.43018486416014	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCCTCACGTACAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3034.82227337945	41.246273090718	0.013591001177406	3643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	3029.69410207676	3029.69410207676
"healthy-2"	"2019-08-01-count-4:ACCCTCACAATTTCCT"	1.34306695041005	9.33772180164186	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTCACAATTTCCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.61669663713	39.9525632599141	0.0210762879071443	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1888.47033475513	1888.47033475513
"healthy-2"	"2019-08-01-count-3:TATCTTGTCATTCGTT"	2.11968864974324	-10.3452253571716	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGTCATTCGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.65068233559	40.4361937042982	0.0160930422953625	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2507.80897861781	2507.80897861781
"healthy-2"	"2019-08-01-count-4:TATCGCCCACCCAACG"	2.19887437400166	-10.6620989075867	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCGCCCACCCAACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.83288916467	43.983135721333	0.0206995740444436	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2119.01624229883	2119.01624229883
"healthy-2"	"2019-08-01-count-3:GGGACAAAGCTCCGAC"	4.39431776580159	-10.7986746064392	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAAAGCTCCGAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.26342762232	38.9693668002619	0.0168387774421597	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2304.83553807208	2304.83553807208
"healthy-2"	"2019-08-01-count-2:AAACGAAGTGGCTGAA"	3.10375680503194	-10.7899532548157	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGAAGTGGCTGAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.82200149276	39.6513959459986	0.0164268102293696	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2412.95083729654	2412.95083729654
"healthy-2"	"2019-08-01-count-4:TTGGGCGCATATCTCT"	3.57019629058186	-10.8630523911682	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGCATATCTCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.90610150071	40.2450877136511	0.0186500643775291	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2156.08206271719	2156.08206271719
"healthy-2"	"2019-08-01-count-3:GGGACAAGTATATGGA"	10.7971731620723	4.53914544666139	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAAGTATATGGA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1645.40298925923	33.463792327818	0.0203377485918411	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1641.3267314361	1641.3267314361
"healthy-2"	"2019-08-01-count-4:GGCTTGGCATGTGCCG"	3.16071691092793	-10.7986850968567	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTGGCATGTGCCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.30124044219	40.6386456874564	0.0167354218704991	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.01370385624	2420.01370385624
"healthy-2"	"2019-08-01-count-4:ACCCTTGAGAAGTCAT"	2.68573226508443	-11.0405864945618	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTTGAGAAGTCAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.98479822166	37.3651261403864	0.014084184035066	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2647.67953624792	2647.67953624792
"healthy-2"	"2019-08-01-count-3:TAACCAGTCGGCTTCT"	2.22685255584065	-4.24100639736327	"2019-08-01-count-3"	"Control2"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACCAGTCGGCTTCT"	"cDC1"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2622.6676066597	38.9027048196388	0.0148332578329232	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2618.46953386048	2618.46953386048
"healthy-2"	"2019-08-01-count-3:GTCATCCGTGCGCTCA"	1.80080558833424	-9.94915773784789	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCGTGCGCTCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2346.71115766742	44.079307396371	0.0187834396458851	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2343.6725233171	2343.6725233171
"healthy-2"	"2019-08-01-count-2:TATTCCACAGACCATT"	-1.83028994026836	12.722683883551	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCACAGACCATT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1765.19489597208	44.3492798326039	0.0251242964353696	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1761.27151172788	1761.27151172788
"healthy-2"	"2019-08-01-count-3:GTGGCGTCAGGTAGTG"	2.76666965064351	-11.0268497697082	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGCGTCAGGTAGTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.24908832822	37.9237753935123	0.0168756439108068	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2239.74873552132	2239.74873552132
"healthy-2"	"2019-08-01-count-3:GTGGCGTCAGGCGATA"	2.64129080352132	-11.0310020676819	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGCGTCAGGCGATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.40225726512	39.9505275662083	0.0183141497324273	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2175.40791699448	2175.40791699448
"healthy-2"	"2019-08-01-count-3:CTGTATTTCATGGGAG"	2.6084267097408	-10.6821518174377	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTATTTCATGGGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.32379884501	40.3486967889878	0.0166501467151103	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.92390736196	2420.92390736196
"healthy-2"	"2019-08-01-count-3:CGGCAGTCACCAAAGG"	2.97055615958516	-11.0148535004822	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTCACCAAAGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.57304704939	43.8059093176757	0.0187078978265809	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2332.5440013204	2332.5440013204
"healthy-2"	"2019-08-01-count-4:CTGAATGAGTTCCTGA"	2.35620941695516	-10.9725094071594	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGAGTTCCTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.31523989707	38.5298846253258	0.0165412924645736	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2322.80487326045	2322.80487326045
"healthy-2"	"2019-08-01-count-4:GAGTCTATCTAGACAC"	-3.11400947991069	-5.4627313843933	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCTATCTAGACAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2650.25704929837	45.8299526828782	0.017292644385197	2971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2645.31201585254	2645.31201585254
"healthy-2"	"2019-08-01-count-2:TACTTCATCGATGCTA"	2.10378970679585	-10.5209808579651	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCATCGATGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.60622183742	42.5100842115239	0.0189556614075094	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2238.95858490997	2238.95858490997
"healthy-2"	"2019-08-01-count-2:GGATCTACACTGCATA"	2.50799288329427	-11.1552257767883	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTACACTGCATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.3529304134	39.234850123661	0.0159209541942839	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2459.22453439371	2459.22453439371
"healthy-2"	"2019-08-01-count-4:TTGTTCACAATGGGTG"	-1.86636529389079	13.1261424788269	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCACAATGGGTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1890.42087219594	36.4416901695022	0.019277024870748	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1888.39614270883	1888.39614270883
"healthy-2"	"2019-08-01-count-3:AACAAAGGTCAGTCTA"	3.16274632987325	-10.7521429291931	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAAGGTCAGTCTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.86227277088	36.1678586984012	0.016917768351618	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2128.09211056904	2128.09211056904
"healthy-2"	"2019-08-01-count-4:CTGAGCGGTCGAGATG"	-8.90628276291545	1.85766408527223	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAGCGGTCGAGATG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2299.43784101397	39.1271796960641	0.0170159762521828	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2291.95910388954	2291.95910388954
"healthy-2"	"2019-08-01-count-4:CCACGAGGTCAAAGCG"	2.92947973784749	-10.8935642472473	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGGTCAAAGCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.69700432209	41.6002633857508	0.0174300563961058	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.91120483748	2380.91120483748
"healthy-2"	"2019-08-01-count-4:AGCCAATGTATGGGAC"	1.70516099509541	-9.69254305278929	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATGTATGGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.92913571198	38.7189154199417	0.0168715080642041	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.95027992178	2291.95027992178
"healthy-2"	"2019-08-01-count-2:GTAGATCCAGCTGAAG"	-8.02932486954387	3.40568087184755	"2019-08-01-count-2"	"Control2"	"HSC"	"HSC"	47	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGATCCAGCTGAAG"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2091.21926144016	41.0392149401412	0.0196245394717141	1845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2083.98866417184	2083.98866417184
"healthy-2"	"2019-08-01-count-4:AGGGCCTCATAGAAAC"	-3.32370458069499	-4.52513172542723	"2019-08-01-count-4"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTCATAGAAAC"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2733.30586356725	47.0558517750913	0.017215728544071	2824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2728.00259888852	2728.00259888852
"healthy-2"	"2019-08-01-count-3:CAGTGCGAGCGATGAC"	2.45299853858296	-10.7295198670593	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGAGCGATGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.05134558011	40.5039421196034	0.015996493195253	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2529.27543921136	2529.27543921136
"healthy-2"	"2019-08-01-count-3:TCTACCGCATGAATAG"	2.67385615882222	-10.7626953355041	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGCATGAATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.43561990007	39.407786474993	0.0155305561906414	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2530.11880316203	2530.11880316203
"healthy-2"	"2019-08-01-count-4:CATGCAACACTGATTG"	2.7750424343044	-11.0592260590759	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCAACACTGATTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.13324885558	37.3886103029085	0.0152287499345856	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.40572658629	2450.40572658629
"healthy-2"	"2019-08-01-count-4:CTGATCCGTTTACACG"	1.85844113406484	-9.72207548534545	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCGTTTACACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.35568091095	40.5995154411752	0.0164680154492652	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2462.54531009622	2462.54531009622
"healthy-2"	"2019-08-01-count-2:ATGAGGGGTAATCAGA"	2.26720633086507	-10.7181101075378	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGGGGTAATCAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.01524104527	37.4056454808276	0.0159239688305226	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.50160053948	2343.50160053948
"healthy-2"	"2019-08-01-count-4:TTGTTTGGTCTTGTCC"	1.97267164763753	-10.3289318314758	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTTGGTCTTGTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.69388762725	40.9882202216863	0.0191740363103071	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2132.21645668302	2132.21645668302
"healthy-2"	"2019-08-01-count-2:CCGAACGAGATGGTCG"	2.91175403174703	-11.0502453080383	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGAACGAGATGGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.40698599618	37.9413096843323	0.0161561900942131	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.38739780008	2343.38739780008
"healthy-2"	"2019-08-01-count-2:ATGATCGCATTCACCC"	3.1360613304073	-10.7521839371887	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGATCGCATTCACCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.72282931326	39.2889456301245	0.0161038562077905	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2434.58948409702	2434.58948409702
"healthy-2"	"2019-08-01-count-2:AAAGGTACATGACCCG"	1.55401112613026	-4.93089916622313	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGTACATGACCCG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2456.9375519811	51.6210438257825	0.0210103198529238	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2448.52809980204	2448.52809980204
"healthy-2"	"2019-08-01-count-2:AGGAAATAGTGAGTTA"	4.1599723297054	-10.7581310502258	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATAGTGAGTTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.31497269971	42.756788635269	0.0192397518625937	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2215.76356149922	2215.76356149922
"healthy-2"	"2019-08-01-count-4:TTTACCATCCGTGGTG"	-1.67066452923473	13.2687406309876	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCATCCGTGGTG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2040.15927834525	33.1781747027188	0.0162625413882534	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2034.73380049881	2034.73380049881
"healthy-2"	"2019-08-01-count-4:AGCGATTGTGTCCAAT"	2.55636801299397	-10.9440946809021	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGATTGTGTCCAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.42695913302	42.2011150626685	0.0169046063648201	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.59745760901	2493.59745760901
"healthy-2"	"2019-08-01-count-2:AGGAAATTCTCTATAC"	4.36784138259236	-10.7544794312683	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATTCTCTATAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.40742403045	44.4251682040531	0.0189252056329344	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.82903147648	2342.82903147648
"healthy-2"	"2019-08-01-count-3:CGGGTGTCACCAGTTA"	3.6921714740688	-10.6311197510925	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTCACCAGTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.39246897686	40.6744127649348	0.0170800963280152	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2376.88480474081	2376.88480474081
"healthy-2"	"2019-08-01-count-2:ATGCATGGTTTCCCAC"	1.48354413089101	10.8707275160584	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGGTTTCCCAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2011.15747511217	36.8481712729739	0.0183218727170625	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1995.5893208611	1995.5893208611
"healthy-2"	"2019-08-01-count-4:TTTACCATCGGTGCAC"	2.76764359053914	-10.9276161423889	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCATCGGTGCAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.5268671327	40.8919567995328	0.0176294387355304	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.34657854852	2314.34657854852
"healthy-2"	"2019-08-01-count-4:ACGGGTCAGGATGCGT"	-3.620264629752	3.66887996280519	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCAGGATGCGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2967.6481912048	44.2017588945088	0.0148945414168396	4746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2963.59470809602	2963.59470809602
"healthy-2"	"2019-08-01-count-2:AAAGTCCGTTTCAGAC"	1.33002664622609	10.4868793257507	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTCCGTTTCAGAC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1832.16202747162	40.3401669899871	0.022017794488218	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1824.5018261143	1824.5018261143
"healthy-2"	"2019-08-01-count-4:TTTACGTTCGGCATAT"	4.08085312423055	-10.794345878717	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTTCGGCATAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.89326724137	38.6835920051139	0.0172394973369974	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2235.77963741326	2235.77963741326
"healthy-2"	"2019-08-01-count-4:ACGGGTCCATATCTGG"	1.87349416789357	-5.23564722454222	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCCATATCTGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2649.09092481886	40.9165541453127	0.0154455076501802	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2641.52156748549	2641.52156748549
"healthy-2"	"2019-08-01-count-4:TCAAGACCATTCATCT"	2.55058826979939	-10.9751444092956	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACCATTCATCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.85297900048	39.9841997340926	0.0156994534289076	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2544.05297570738	2544.05297570738
"healthy-2"	"2019-08-01-count-2:ATCAGGTTCCGGACTG"	2.3457576232845	-10.7421226731506	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCAGGTTCCGGACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.93218736718	39.0268881708997	0.0161807568120316	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2407.47425318441	2407.47425318441
"healthy-2"	"2019-08-01-count-3:CACGAATCAAGAGGTC"	2.78038181838338	-10.811758064386	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATCAAGAGGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.1671771211	38.0418597841083	0.0154505592218108	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2457.41141142242	2457.41141142242
"healthy-2"	"2019-08-01-count-2:TCATATCCACCTCAGG"	7.88394131240193	6.88567349994508	"2019-08-01-count-2"	"Control2"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCCACCTCAGG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.60569411851	37.7607333908249	0.0196710884461951	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1909.6076941055	1909.6076941055
"healthy-2"	"2019-08-01-count-3:GTCTACCAGCTCCATA"	4.25194897231404	-10.8040848008362	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCAGCTCCATA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.51834238415	42.9695649963096	0.0188090260424287	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2283.43459416353	2283.43459416353
"healthy-2"	"2019-08-01-count-2:CTTCAATTCCCGGTAG"	2.33604230460469	-10.4653778306213	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATTCCCGGTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.39239740643	43.149364552016	0.0183583662879567	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.66142460568	2342.66142460568
"healthy-2"	"2019-08-01-count-4:TCTACCGTCGACACCG"	7.00138010558431	-1.06209590351256	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGTCGACACCG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2230.96042783176	36.973114760108	0.0165727344594999	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2221.96518973167	2221.96518973167
"healthy-2"	"2019-08-01-count-2:TAGCACAAGTCAGCGA"	4.56605257567708	-10.6999263993469	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGCACAAGTCAGCGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.6854035814	41.469424316657	0.0183356289300845	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.93293589463	2256.93293589463
"healthy-2"	"2019-08-01-count-2:CAGCACGCATCATGAC"	2.01415600356404	-10.2090740433899	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCACGCATCATGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.67054167522	42.2327966030304	0.0170591344413916	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.64844583653	2472.64844583653
"healthy-2"	"2019-08-01-count-3:GTTAGACAGTCATCGT"	3.01919664916341	-10.8667774430481	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGACAGTCATCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.69938088414	43.8584417658086	0.0189888095952209	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2306.75223813878	2306.75223813878
"healthy-2"	"2019-08-01-count-3:ACTATTCTCGTTCATT"	2.23987497863118	-10.5641327134338	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATTCTCGTTCATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.47710452519	41.8523313075335	0.018605359984923	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.65126378995	2243.65126378995
"healthy-2"	"2019-08-01-count-4:TCAAGTGCAAATAGCA"	-7.83576951447185	1.5339876183304	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGCAAATAGCA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2541.69675760107	42.16667424127	0.0165899705050056	3015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2537.41948758562	2537.41948758562
"healthy-2"	"2019-08-01-count-4:TGTCCCAAGGTCTGGA"	3.93734564360921	-10.8104000321594	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCAAGGTCTGGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.03531475324	39.2717322563492	0.017104149924876	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.8668906667	2291.8668906667
"healthy-2"	"2019-08-01-count-4:GATGACTCAACTGCTA"	-2.87959108772929	3.44057128513185	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTCAACTGCTA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3151.96920153108	43.5885056853899	0.0138289757603649	4870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3147.43694598044	3147.43694598044
"healthy-2"	"2019-08-01-count-2:CCGGTAGCACAGTGAG"	3.05936994132344	-10.9480028382507	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGCACAGTGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.69894557075	43.4486318379818	0.0174163828124926	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2491.35265118383	2491.35265118383
"healthy-2"	"2019-08-01-count-4:CACCGTTGTATGGAAT"	-4.67492280426677	-5.53307726299437	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCGTTGTATGGAAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2645.71320505898	46.4073109630265	0.0175405674637331	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2640.45586266567	2640.45586266567
"healthy-2"	"2019-08-01-count-4:CAGTGCGAGAAGCCAC"	-6.06548867645915	-3.1897068253723	"2019-08-01-count-4"	"Control2"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTGCGAGAAGCCAC"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2926.87279898661	39.7329670984689	0.0135752285211117	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2921.83691660141	2921.83691660141
"healthy-2"	"2019-08-01-count-2:CTTCTAAGTATGACAA"	2.02504326876943	-10.4606228104797	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTAAGTATGACAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.00670269472	40.8937362518387	0.0175058300152416	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2329.96303541248	2329.96303541248
"healthy-2"	"2019-08-01-count-3:CTTCGGTAGCGTATAA"	1.18722858008687	11.2643794783386	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTAGCGTATAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2205.17983996938	34.3732067817206	0.0155874845936365	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2196.92711792345	2196.92711792345
"healthy-2"	"2019-08-01-count-3:GGGTGAACATGTCAGT"	2.89024200019185	-10.330478691217	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGAACATGTCAGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.14634583324	40.2201127719703	0.0156307132849632	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2569.89046393738	2569.89046393738
"healthy-2"	"2019-08-01-count-3:CCACGTTAGGTAGACC"	1.49363674697224	10.7974138029846	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGTTAGGTAGACC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1936.62183621742	37.106142955815	0.0191602419542527	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1925.6916227121	1925.6916227121
"healthy-2"	"2019-08-01-count-2:ATGGATCTCAGCTCTC"	2.26457728919331	-11.0416507950989	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCTCAGCTCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.97977046601	38.1538191466253	0.0164103875789757	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2322.36265881843	2322.36265881843
"healthy-2"	"2019-08-01-count-4:TCTCAGCCATGTTCGA"	2.17625536498372	-10.6508283845154	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCAGCCATGTTCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.95788954291	42.9030981353262	0.0194663874200537	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2202.9687762259	2202.9687762259
"healthy-2"	"2019-08-01-count-2:AACACACAGTCGAAAT"	4.51503195342366	-10.8283424607483	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACACACAGTCGAAAT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.92150189535	43.8865506412469	0.0189091059759702	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2317.1662103548	2317.1662103548
"healthy-2"	"2019-08-01-count-3:TTACCATAGGTGCTTT"	8.04519381102864	7.28684375369874	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATAGGTGCTTT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.27866698326	35.4843924487468	0.0188919743765918	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1866.78100831257	1866.78100831257
"healthy-2"	"2019-08-01-count-2:ACGCACGCAAGACTGG"	4.36515583571736	-10.6467857590881	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGCAAGACTGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.40567705177	42.7674130610955	0.0197868514528155	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2157.15681422707	2157.15681422707
"healthy-2"	"2019-08-01-count-4:CGCCAGAAGCCTGACC"	2.53995337065999	-11.0965147248474	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCAGAAGCCTGACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.45137763522	40.0892295092524	0.0171728697771647	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2331.60746322499	2331.60746322499
"healthy-2"	"2019-08-01-count-4:TGTGAGTGTTATGTGC"	-4.16491876068767	-5.32087900554808	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGAGTGTTATGTGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2653.77241815491	45.4009335866121	0.0171080735017127	2871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2650.5012416258	2650.5012416258
"healthy-2"	"2019-08-01-count-3:GCACTAACACTTGTCC"	-5.89646039429362	4.08745286548463	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAACACTTGTCC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2456.79554439502	41.2683390419338	0.0167976285760059	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2451.11458311381	2451.11458311381
"healthy-2"	"2019-08-01-count-3:CCACTTGAGATGCTGG"	2.41570295867268	-10.4925613633362	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGAGATGCTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.48300626215	38.615186035395	0.0178156811028416	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2164.07362825752	2164.07362825752
"healthy-2"	"2019-08-01-count-2:AGGCCACGTCACTTAG"	2.4561890560085	-10.4548473588196	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCCACGTCACTTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.67185187124	43.930903582751	0.0186569111733507	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2349.67455606391	2349.67455606391
"healthy-2"	"2019-08-01-count-2:TAGTGCACATGAGAAT"	3.12568821486775	-10.931031250116	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCACATGAGAAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.65275849546	43.4831723765632	0.0172644570514509	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2515.85171132705	2515.85171132705
"healthy-2"	"2019-08-01-count-4:ACGTAGTTCGGCTCTT"	0.850631375878495	11.1519622572693	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTTCGGCTCTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.51446178599	33.5821205772845	0.0178389708334163	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1876.2567957549	1876.2567957549
"healthy-2"	"2019-08-01-count-3:TGCATGAAGGCGCTCT"	2.11728491362874	-10.6740656129089	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATGAAGGCGCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.46014310364	40.0194884030409	0.0172092772786161	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2319.49270004204	2319.49270004204
"healthy-2"	"2019-08-01-count-4:GAGAAATTCAGAGTTC"	-4.58037648621257	-5.37720873272093	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATTCAGAGTTC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2716.34482218442	36.7717188206543	0.0135372057775358	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2712.85597357817	2712.85597357817
"healthy-2"	"2019-08-01-count-3:GCGGATCGTTCGCGTG"	2.41960491713826	-10.7450371018616	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGATCGTTCGCGTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.40894086176	41.9147862838862	0.0191007179671014	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2190.28397587461	2190.28397587461
"healthy-2"	"2019-08-01-count-2:GACCCAGTCATCACCC"	2.14310731467549	-10.5891247025696	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGTCATCACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.78471233826	41.186556152945	0.0169158923761236	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2428.56973930246	2428.56973930246
"healthy-2"	"2019-08-01-count-2:TCACACCCAGCACCCA"	4.3465916114742	-10.7827978364197	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCCAGCACCCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.57438011399	39.2366062302719	0.0147640670093264	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2650.03298265805	2650.03298265805
"healthy-2"	"2019-08-01-count-2:GATTCTTTCAATCCGA"	2.85509004172627	-10.9228506318298	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCTTTCAATCCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.2163805092	41.5042116924817	0.0189239019283841	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2191.12225585861	2191.12225585861
"healthy-2"	"2019-08-01-count-4:TAAGCGTCAAGGCCTC"	-2.42801175537761	13.3138894804749	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCGTCAAGGCCTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1737.77497545564	33.9422940114634	0.0195320421175727	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1733.54388404044	1733.54388404044
"healthy-2"	"2019-08-01-count-2:AGGCTGCTCAAGCTGT"	2.35999335822408	-10.8914928666321	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCTCAAGCTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.03496329221	36.0723440296026	0.0146395422820649	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2457.40140640382	2457.40140640382
"healthy-2"	"2019-08-01-count-3:CTTGAGATCCATACTT"	2.47561182555501	-10.2524242631164	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGAGATCCATACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.38453591515	38.759848699564	0.0172160055651305	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2249.18151547236	2249.18151547236
"healthy-2"	"2019-08-01-count-2:TTTGGTTCAGCACCCA"	2.95154132422749	-10.9494524232117	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGTTCAGCACCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.37170054135	42.2927582386194	0.0176781719283209	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.48257344297	2386.48257344297
"healthy-2"	"2019-08-01-count-2:TGCTCCATCTACTTCA"	1.52629890021626	-8.6661644211975	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCATCTACTTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.35315929868	20.9615118602398	0.00927355611401163	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.21439623195	2256.21439623195
"healthy-2"	"2019-08-01-count-4:CCAAGCGGTATCTTCT"	2.24473108825032	-10.6811332932678	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAAGCGGTATCTTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.46151622238	43.0184535347978	0.0180411607577339	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.97051321906	2377.97051321906
"healthy-2"	"2019-08-01-count-3:ACTTCGCAGGTAAGAG"	2.55940141257588	-10.9390239945618	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCAGGTAAGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.68533401938	43.1393123088012	0.0174958709100478	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2464.85695826623	2464.85695826623
"healthy-2"	"2019-08-01-count-2:AACCATGGTTTGGAAA"	2.94622244414632	-11.0888176194397	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGGTTTGGAAA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.32659053732	41.1759906144896	0.0169495492186509	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2424.62128116519	2424.62128116519
"healthy-2"	"2019-08-01-count-4:ACATGCACACTCCACT"	4.34948696669881	-10.8511743775574	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATGCACACTCCACT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2715.7956867713	46.0215151375049	0.0169458679685209	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2711.98227481089	2711.98227481089
"healthy-2"	"2019-08-01-count-3:GGTAATCCAGGCAATG"	10.4105059104854	4.67545888507692	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCCAGGCAATG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1635.31167893706	27.9854489979362	0.0171132202860109	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1628.8520335007	1628.8520335007
"healthy-2"	"2019-08-01-count-4:CTCCACAGTCTTGCTC"	2.32691516455953	-10.8630008927551	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACAGTCTTGCTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.59108452154	33.66892127411	0.013540192226897	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2483.10951411089	2483.10951411089
"healthy-2"	"2019-08-01-count-2:TCTACCGAGCTCAGAG"	2.54616012152974	-10.9162616959778	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACCGAGCTCAGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.39385249348	41.4654219792893	0.0183119301148203	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.34709042701	2261.34709042701
"healthy-2"	"2019-08-01-count-4:TGATGGTCACCAGCGT"	2.30379714545552	-10.5558433762756	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTCACCAGCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.43894161406	42.8734018930177	0.0180258576929971	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2374.78465101488	2374.78465101488
"healthy-2"	"2019-08-01-count-4:ACCAAACGTATCAAGA"	2.15324534949605	-10.6200237504211	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACGTATCAAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.03209438712	39.0192779373141	0.0152595964763072	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2553.75793027357	2553.75793027357
"healthy-2"	"2019-08-01-count-4:ACTATTCGTGGGCTTC"	10.4172226386959	4.67297074878541	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCGTGGGCTTC"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.79530832342	34.560168104155	0.0184636471469259	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1868.25158784269	1868.25158784269
"healthy-2"	"2019-08-01-count-3:TGACAGTCACTTACAG"	8.2787090736324	7.66551110828248	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTCACTTACAG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.80803206826	43.0179625385368	0.022268238781718	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1923.15083519168	1923.15083519168
"healthy-2"	"2019-08-01-count-3:CGTTAGAGTGTTCAGT"	-2.31182895126994	12.8431195982727	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGAGTGTTCAGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1492.9211110362	40.187188332157	0.026918494242649	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1492.9211110362	1492.9211110362
"healthy-2"	"2019-08-01-count-2:GCAACATAGGTCCCGT"	2.05884851989095	-10.475461982843	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACATAGGTCCCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.82914068104	41.9684932434598	0.0171732518222465	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2441.71549408144	2441.71549408144
"healthy-2"	"2019-08-01-count-3:AGTTCCCGTGGTCTTA"	2.37437953528706	-10.9748583070007	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTGGTCTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.99428599019	39.028700742836	0.0165236219978722	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2357.4001320857	2357.4001320857
"healthy-2"	"2019-08-01-count-4:AACCCAAGTGACACGA"	4.1654917198116	-10.7968292466369	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAAGTGACACGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.89143260868	41.55081849704	0.0182249110210906	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2277.16803769713	2277.16803769713
"healthy-2"	"2019-08-01-count-2:CAGTTCCTCTGGCTGG"	2.32498445090596	-10.7645368806091	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCTCTGGCTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.97946970823	51.4985346641231	0.0223132550960835	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2297.00985032137	2297.00985032137
"healthy-2"	"2019-08-01-count-4:CGGGACTTCTATCCAT"	2.60300149497334	-10.9463539353577	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTTCTATCCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.97204061141	43.7108522977859	0.0198959529251092	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2188.88321937573	2188.88321937573
"healthy-2"	"2019-08-01-count-4:AACCCAATCAGATGCT"	7.03330959853475	-1.22173561966094	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAATCAGATGCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2305.990161514	31.181756158713	0.0135220681679928	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2298.39368918113	2298.39368918113
"healthy-2"	"2019-08-01-count-4:ACTCTCGTCGCAGTGC"	1.93061842498128	-5.13180115139159	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCTCGTCGCAGTGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2469.25364410813	38.706131558554	0.0156752351670759	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2465.67943726673	2465.67943726673
"healthy-2"	"2019-08-01-count-4:TCAGCAATCGGCTTGG"	3.28214683112447	-10.6525469056335	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAATCGGCTTGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.16159173865	42.710067708085	0.0179065719723215	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.28784128404	2380.28784128404
"healthy-2"	"2019-08-01-count-2:CTACTATCAACCAATC"	1.04378910836522	11.1603069075379	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCAACCAATC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2095.18766310978	43.719988219737	0.0208668602767762	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2086.19791996153	2086.19791996153
"healthy-2"	"2019-08-01-count-2:AACGGGATCACCTTGC"	2.04893483695332	-10.4314995042053	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGGGATCACCTTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.02719246281	40.5661655171467	0.0170659240440227	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2368.65457254365	2368.65457254365
"healthy-2"	"2019-08-01-count-2:AACGGGATCGTGGACC"	-1.82002339783366	12.9989166029724	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGGGATCGTGGACC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1666.07720932038	48.6879727849264	0.029223119140311	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1660.05886226591	1660.05886226591
"healthy-2"	"2019-08-01-count-3:CTAACCCAGGAATGTT"	1.16269101676289	9.38969323718873	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACCCAGGAATGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1601.18602582193	33.6145998836825	0.0209935631098375	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1601.18602582193	1601.18602582193
"healthy-2"	"2019-08-01-count-3:AAGACTCTCCAGCCTT"	0.870742400258225	-8.60292532360228	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCTCCAGCCTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2525.39353662722	47.7397360033777	0.0189038798551517	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2524.45875894381	2524.45875894381
"healthy-2"	"2019-08-01-count-2:GCACATATCGGAGTGA"	2.33437480506245	-10.761199974176	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACATATCGGAGTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.22820146335	39.5276583972021	0.0173197659952924	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.27111706495	2278.27111706495
"healthy-2"	"2019-08-01-count-2:GTGTAACAGGAAAGAC"	2.827973027795	-11.0216694108215	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTAACAGGAAAGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.77687147596	41.3329576588912	0.0185202016326821	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2224.97258817336	2224.97258817336
"healthy-2"	"2019-08-01-count-3:CTAAGTGTCTAGCCAA"	0.867084701626939	-8.76373102581175	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAAGTGTCTAGCCAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2413.41921219222	41.3041482701921	0.0171143695473749	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2409.86320415075	2409.86320415075
"healthy-2"	"2019-08-01-count-2:GCACATAGTACGAGCA"	1.82992472228352	-9.96624090587767	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACATAGTACGAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1581.16218636061	40.4201122706954	0.0255635459912757	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1579.23308977265	1579.23308977265
"healthy-2"	"2019-08-01-count-4:GTTCGCTTCCACCTCA"	4.41289772567098	-10.6114950410095	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCGCTTCCACCTCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.82121190621	42.3059595567285	0.0168427431682619	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2505.70158353634	2505.70158353634
"healthy-2"	"2019-08-01-count-2:GAACTGTAGCGCCTCA"	2.76115407523457	-10.9901218644348	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTAGCGCCTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.52115321272	38.2451330812152	0.0163404347056287	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2336.63094084537	2336.63094084537
"healthy-2"	"2019-08-01-count-4:GTTCTATAGAAGGGAT"	2.69402088698689	-10.9475593796936	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATAGAAGGGAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.85884389026	40.2598249447249	0.017346951130057	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2310.32795719565	2310.32795719565
"healthy-2"	"2019-08-01-count-2:CATACAGTCTCTATGT"	-1.8821761411732	13.2717904814514	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGTCTCTATGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1997.00211143823	40.2038941766193	0.0201321240204722	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1990.80033933473	1990.80033933473
"healthy-2"	"2019-08-01-count-4:GTTCTATAGGAAGTAG"	2.3376645046169	-10.6699810258118	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATAGGAAGTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.00645297275	40.0717072130825	0.0172796876704307	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2311.8069894505	2311.8069894505
"healthy-2"	"2019-08-01-count-3:ATCTCTAAGCTCTTCC"	2.20568456229512	-10.6237964860168	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTAAGCTCTTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.41051816611	41.5570019614337	0.0180965039276256	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.35472125536	2291.35472125536
"healthy-2"	"2019-08-01-count-4:AGGCCACAGGAGATAG"	2.29927672919576	-10.0922832719055	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACAGGAGATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.93091578492	44.3596109483462	0.0213274443933182	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2073.99670184087	2073.99670184087
"healthy-2"	"2019-08-01-count-2:TGAGGTTAGAAAGCGA"	2.98036589202229	-10.9233722916809	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGTTAGAAAGCGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.75639746705	45.6577677183866	0.0197759138939379	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.89822471667	2301.89822471667
"healthy-2"	"2019-08-01-count-3:TGAGGAGAGACCGTTT"	1.48880841311757	-9.22136976635131	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGAGACCGTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.56695156591	41.0138944862005	0.0167913082013604	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2439.30584917533	2439.30584917533
"healthy-2"	"2019-08-01-count-4:ACTGTGATCACCTCTG"	1.63842131671254	-9.38617803966673	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGATCACCTCTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2450.5339841017	41.0318866030985	0.0167440594047259	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2442.80123727397	2442.80123727397
"healthy-2"	"2019-08-01-count-3:TGAGGAGCAGGAACCA"	3.28076877173726	-10.5596037141052	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGCAGGAACCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.02046495994	43.0843314142953	0.0202271912984206	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2126.9990161058	2126.9990161058
"healthy-2"	"2019-08-01-count-2:AGGTGTTAGCTAGAAT"	-7.40576062622722	1.50220320308534	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTAGCTAGAAT"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1999.45344548803	48.7854568184682	0.0243993962092778	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	1992.53530040513	1992.53530040513
"healthy-2"	"2019-08-01-count-2:ATTCCTAAGGCGACAT"	1.57109190997426	-8.91115190899047	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCTAAGGCGACAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1923.77102248041	38.4228339247909	0.0199726648732085	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	1919.66407307872	1919.66407307872
"healthy-2"	"2019-08-01-count-2:TCGCAGGGTGGATACG"	-1.3562949699467	12.2394056090149	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCAGGGTGGATACG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.48631216241	41.5081943363973	0.0216924438249518	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1905.88703155681	1905.88703155681
"healthy-2"	"2019-08-01-count-4:ACTTAGGGTTATCTTC"	2.70300855216328	-10.8476228944031	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTAGGGTTATCTTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.10426059509	39.9661940707869	0.0157775558994946	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2527.5993511869	2527.5993511869
"healthy-2"	"2019-08-01-count-4:GCACGTGTCACTGTTT"	3.13050975379292	-10.852417968866	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGTCACTGTTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.88503748801	35.9953342504013	0.0155360899086421	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2312.19393805281	2312.19393805281
"healthy-2"	"2019-08-01-count-2:CCTCATGCATTGAGGG"	2.43936934050862	-10.7056551209656	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCATGCATTGAGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.56652283848	43.5262356411947	0.0184310859847718	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2356.1331376882	2356.1331376882
"healthy-2"	"2019-08-01-count-4:CAATTTCAGTCGAAAT"	3.05187763747517	-10.926857017633	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCAGTCGAAAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.8699349631	38.8297899197519	0.0166875635532107	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2306.26714344025	2306.26714344025
"healthy-2"	"2019-08-01-count-4:CCACGTTTCATCACAG"	4.61327423629109	-10.6626100770203	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGTTTCATCACAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.19040236022	39.7611875956714	0.0163680819572806	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2421.19239012572	2421.19239012572
"healthy-2"	"2019-08-01-count-2:TTTACCACATTGCTGA"	2.1282865005428	-10.056462310907	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACCACATTGCTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.13100821776	43.1915197745757	0.017766019037468	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2426.88043276805	2426.88043276805
"healthy-2"	"2019-08-01-count-3:TATTGCTAGTAGGGTC"	-2.39391551438029	12.9915656813416	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGCTAGTAGGGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1985.65243445423	46.5928230689236	0.0234647424999783	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1983.788018402	1983.788018402
"healthy-2"	"2019-08-01-count-2:GACTTCCGTTTCGATG"	2.91357411917989	-10.8364153138367	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCGTTTCGATG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.28284169791	41.8971827544698	0.0173971188221941	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2402.74545990079	2402.74545990079
"healthy-2"	"2019-08-01-count-3:CTGTGAACATCGGAAG"	-2.72207627716716	13.5032195814881	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAACATCGGAAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1834.66104706366	39.3119177326016	0.0214273463730641	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1830.65614214201	1830.65614214201
"healthy-2"	"2019-08-01-count-3:CCTGCATGTGACATCT"	6.84189619597737	-1.0274731150833	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGCATGTGACATCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2065.77866917635	46.6770301207823	0.022595368428019	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2051.0348736273	2051.0348736273
"healthy-2"	"2019-08-01-count-4:ATGAAAGCAGTTCACA"	-2.27466688576396	12.8322505720886	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGCAGTTCACA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1897.51817426403	42.4977383721641	0.0223964855507365	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1889.62725874017	1889.62725874017
"healthy-2"	"2019-08-01-count-4:CTTCTCTAGCGCGTTC"	2.89471258696858	-10.934259437677	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTAGCGCGTTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.89067160413	42.6541320851935	0.0181592666703656	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2346.13146788642	2346.13146788642
"healthy-2"	"2019-08-01-count-4:TCATACTGTCTGCGCA"	2.14170255240743	-10.5049009553161	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTGTCTGCGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.25154620304	36.2048512891165	0.0151849964601149	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.82416815039	2378.82416815039
"healthy-2"	"2019-08-01-count-3:GTAACACGTGTTACTG"	2.78526463088338	-10.8880853882995	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACACGTGTTACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.71033194187	40.1600002446953	0.0163737232732655	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2449.05379998059	2449.05379998059
"healthy-2"	"2019-08-01-count-2:AGGTTGTCAAAGGGCT"	10.7618814903194	4.41748187625734	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTCAAAGGGCT"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1733.57807695416	36.4178626944456	0.0210073392012608	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1731.59283675196	1731.59283675196
"healthy-2"	"2019-08-01-count-4:GGTGTTAAGATTGATG"	1.3867470222408	-9.04430773174437	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTAAGATTGATG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2215.97316708426	44.9375312278718	0.020278914878288	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2213.84209563827	2213.84209563827
"healthy-2"	"2019-08-01-count-3:CTAGACAGTGATACCT"	2.11801304396932	-10.4395961991516	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAGTGATACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.2188539015	44.9678425891914	0.0197035628341769	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2280.37777754935	2280.37777754935
"healthy-2"	"2019-08-01-count-3:TTCCGTGCATGAATAG"	0.874250491231126	10.0079297789368	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGTGCATGAATAG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1820.82516150928	40.0175453859473	0.0219776979316217	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1815.92266122527	1815.92266122527
"healthy-2"	"2019-08-01-count-2:TCAAGACAGCTCTATG"	1.75982560691182	-4.43829967891844	"2019-08-01-count-2"	"Control2"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACAGCTCTATG"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2759.54165839703	40.3206813787434	0.0146113689771819	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2753.28216566388	2753.28216566388
"healthy-2"	"2019-08-01-count-3:CTTACCGGTGCATTAC"	-4.50828490677531	-5.38174297725829	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGGTGCATTAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1992.63208027411	43.0679467768176	0.021613597012296	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	1988.33756963919	1988.33756963919
"healthy-2"	"2019-08-01-count-2:CTCAACCGTTGGGAAC"	2.3373040157253	-10.4384804002014	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAACCGTTGGGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.91299904186	36.1907830599375	0.015506483349977	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2329.33270223396	2329.33270223396
"healthy-2"	"2019-08-01-count-2:TCAAGACTCCCTAGGG"	2.55437650260274	-11.0420789948669	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACTCCCTAGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.45578894723	38.8601370805893	0.0159167891782083	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2437.75780723453	2437.75780723453
"healthy-2"	"2019-08-01-count-1:CATACCCGTGTCTTGA"	1.2631924348766	9.19632146442262	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATACCCGTGTCTTGA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1621.76183102783	35.8400556709543	0.0220994568901895	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1609.15159792313	1609.15159792313
"healthy-2"	"2019-08-01-count-3:GCCATGGAGTATGTAG"	2.92246546325032	-10.9809484711853	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGTATGTAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.60519210396	41.5447406857864	0.0193898254512261	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2133.76932938168	2133.76932938168
"healthy-2"	"2019-08-01-count-3:CTCTCGACACACCAGC"	6.87014212188069	-0.977883123513781	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCGACACACCAGC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1874.05318885243	45.0179053063778	0.0240216796268971	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1860.74608073106	1860.74608073106
"healthy-2"	"2019-08-01-count-2:GAAGTAACATTGAGCT"	2.28472055968587	-10.7724905244079	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAACATTGAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.61186138177	38.9956270854329	0.0175528532968756	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2218.37246157178	2218.37246157178
"healthy-2"	"2019-08-01-count-3:CCGCAAGCAGCATTGT"	2.63307179984395	-10.9415140382019	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGCAAGCAGCATTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.72784524741	42.1887111871373	0.0187278331362321	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2250.05378706267	2250.05378706267
"healthy-2"	"2019-08-01-count-2:AGAGAGCAGGATCACG"	2.45824780043904	-10.9502525559631	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCAGGATCACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.29137998574	41.8457911952218	0.0190096556846976	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2193.661637638	2193.661637638
"healthy-2"	"2019-08-01-count-4:TTACTGTTCCCATAGA"	1.39720549163167	-9.47594168102416	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTTCCCATAGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2541.16109260432	41.858850444343	0.0164723324964195	2294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2539.8469112319	2539.8469112319
"healthy-2"	"2019-08-01-count-3:GATTGGTTCTGCACCT"	8.07691826400105	7.47575042331544	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTTCTGCACCT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1826.10848453918	42.3096721963159	0.0231693092467027	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1819.53934540927	1819.53934540927
"healthy-2"	"2019-08-01-count-4:GACGTTAAGAAGCCTG"	3.09321083602254	-10.7195978394714	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTAAGAAGCCTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.26678701968	37.3543162452482	0.0153389010371891	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2432.0594392431	2432.0594392431
"healthy-2"	"2019-08-01-count-3:CTTAGGACAATGGCAG"	3.52910866317098	-10.6487550965515	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGACAATGGCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.08339067148	43.3795670607134	0.0189754963610368	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.58786359913	2278.58786359913
"healthy-2"	"2019-08-01-count-2:CGCATAACAGTAGATA"	4.54302801665608	-10.7428760758606	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAACAGTAGATA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.58194244465	43.3185108797224	0.0181053405575155	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.77239798072	2386.77239798072
"healthy-2"	"2019-08-01-count-4:TCCTAATAGAGAAGGT"	1.4830080467159	10.8567695387634	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATAGAGAAGGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.73347184378	34.8424261841871	0.0178064241684157	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1951.91337068319	1951.91337068319
"healthy-2"	"2019-08-01-count-2:AAAGTGAGTTCGGCCA"	1.67251672324483	-4.84511091625365	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTGAGTTCGGCCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2376.62708131755	38.7493909339707	0.0163043631197238	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2367.6066571171	2367.6066571171
"healthy-2"	"2019-08-01-count-4:CATTCATAGCTGGCTC"	6.82453407821004	-1.15006985580596	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCATAGCTGGCTC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2500.25509512409	42.4789336441641	0.0169898398475439	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2488.12291739224	2488.12291739224
"healthy-2"	"2019-08-01-count-4:GATCCCTCAAAGTATG"	-7.8475755256718	3.47247407520143	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCCCTCAAAGTATG"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2526.29493223651	38.2575215655665	0.0151437273128271	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2513.95743089428	2513.95743089428
"healthy-2"	"2019-08-01-count-2:ACACCAAAGGATGCGT"	3.1073235469753	-10.9995689622131	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACCAAAGGATGCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.64069197393	42.1081775423159	0.018684512439041	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2247.4694129654	2247.4694129654
"healthy-2"	"2019-08-01-count-4:TCCTCGAGTCACCGCA"	3.10895742949788	-11.0544567338196	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCGAGTCACCGCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.4713859876	45.1551249632748	0.0181749426529721	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2478.7716400934	2478.7716400934
"healthy-2"	"2019-08-01-count-3:CTCAACCTCGCATAGT"	4.3080903488094	-10.8848924866882	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCTCGCATAGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.27891377958	44.4060404376405	0.0188859093565636	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.85520372776	2348.85520372776
"healthy-2"	"2019-08-01-count-4:TTCAATCAGGCAGCTA"	6.94239439544026	-1.20986118232878	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAATCAGGCAGCTA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2101.72503438538	43.897511094153	0.0208864196676376	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2085.91839387463	2085.91839387463
"healthy-2"	"2019-08-01-count-4:AAGGAATGTGAGATTA"	1.88183774527852	-10.1520185700622	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGAATGTGAGATTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.09140409115	41.0227120798109	0.017500474601039	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2339.4277542814	2339.4277542814
"healthy-2"	"2019-08-01-count-4:CCCGAAGCAGGTCAAG"	3.34170999106709	-10.8918886414734	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGAAGCAGGTCAAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.67721323879	44.0116751195532	0.0194769743491246	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2254.25124932728	2254.25124932728
"healthy-2"	"2019-08-01-count-4:CCTCCAAAGTAACAGT"	8.27830662307088	6.63995835864869	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCAAAGTAACAGT"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1713.96763689902	33.1362446229074	0.019333063185988	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1707.76976684482	1707.76976684482
"healthy-2"	"2019-08-01-count-3:CGTAATGAGTTGGCGA"	-2.04114852371867	13.2504110106262	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGAGTTGGCGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2008.77953649404	42.0484050276214	0.0209323145042633	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1989.5154624775	1989.5154624775
"healthy-2"	"2019-08-01-count-2:CTCAGAATCTTTGATC"	4.81039537963216	-10.4966392747131	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAATCTTTGATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.13721407306	41.0764506630946	0.018780920739124	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2187.13721407306	2187.13721407306
"healthy-2"	"2019-08-01-count-4:ATCACAGCAAGGTACG"	-5.03224215927775	-5.34002306377562	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACAGCAAGGTACG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2646.98399309347	46.2843544210668	0.0174856948670004	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2644.8123834943	2644.8123834943
"healthy-2"	"2019-08-01-count-3:CACGTGGGTGTCATTG"	2.10818876799886	-10.4402933350769	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGGTGTCATTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.7724433632	42.1044138184104	0.0177597870838589	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2364.83920235749	2364.83920235749
"healthy-2"	"2019-08-01-count-4:AAGGTAATCTTCCGTG"	-2.86448131027873	3.42016909206239	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGTAATCTTCCGTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3264.38939021262	43.6276441109091	0.0133647181435262	5383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3257.62248806066	3257.62248806066
"healthy-2"	"2019-08-01-count-2:GCCAGCATCAAAGCCT"	-1.36783454838451	13.3343505629334	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGCATCAAAGCCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.11207795304	37.1234179374287	0.0192437849317806	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1923.37265832809	1923.37265832809
"healthy-2"	"2019-08-01-count-4:GCCATGGAGCGTGAGT"	-2.62196073952373	13.1805085905823	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGAGCGTGAGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1769.45980188437	45.3016080574334	0.0256019424737368	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1765.29149653706	1765.29149653706
"healthy-2"	"2019-08-01-count-3:CACGTGGTCTTCCCAG"	4.26405920562093	-10.6361742249695	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGTCTTCCCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.15996339973	44.1352294705584	0.0186055030653602	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2368.81632453132	2368.81632453132
"healthy-2"	"2019-08-01-count-2:CCTTGTGTCAGATTGC"	4.80930819091145	-10.4591922990051	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGTCAGATTGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.18459974538	34.1176793416161	0.0162916293748718	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2090.85743969296	2090.85743969296
"healthy-2"	"2019-08-01-count-2:TCAATTCTCTAGTGAC"	0.795907695859116	-8.63571264660033	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCTCTAGTGAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2352.85986413024	51.1081693743398	0.0217217226378386	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2351.16175052273	2351.16175052273
"healthy-2"	"2019-08-01-count-3:GACCCAGGTTAGTTCG"	4.41732372817342	-10.8168182603088	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCAGGTTAGTTCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.35348907111	42.3092387127467	0.0187677925923586	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2253.22953944134	2253.22953944134
"healthy-2"	"2019-08-01-count-2:TCGTAGAGTGACGCCT"	1.78182079371755	-4.83029034053954	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTAGAGTGACGCCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2309.02893535926	39.6673660639377	0.0171792416528405	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2306.70612047525	2306.70612047525
"healthy-2"	"2019-08-01-count-2:TCGTCCACAGTCACGC"	2.45273365554158	-10.9826393357483	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCACAGTCACGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.09137672861	40.2791506296865	0.0173162374585364	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2321.33879952614	2321.33879952614
"healthy-2"	"2019-08-01-count-4:CACGGGTTCCCAAGCG"	2.4256657558376	-10.8830499879089	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTTCCCAAGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.30764907465	44.8729965566621	0.0192562542437179	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2325.81648617978	2325.81648617978
"healthy-2"	"2019-08-01-count-4:CCCTCAATCGGACGTC"	-3.06464109841045	13.4274644621643	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAATCGGACGTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1936.54261813475	43.4023705370007	0.0224122981495782	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1932.71628575618	1932.71628575618
"healthy-2"	"2019-08-01-count-2:TTGCCTGCACGCGTCA"	-2.30213556709941	13.7894820936951	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCCTGCACGCGTCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2463.0035376488	42.1370245120224	0.0171079837555762	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2460.01316100132	2460.01316100132
"healthy-2"	"2019-08-01-count-2:AGTCTCCGTTGCTCGG"	-2.00510416451152	13.2076320418152	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCGTTGCTCGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1962.66989436459	42.4604313297322	0.0216340157107665	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1958.88983694397	1958.88983694397
"healthy-2"	"2019-08-01-count-2:AGTCTCCTCGCTTGCT"	2.10962881621663	-10.7104273072449	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCTCGCTTGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.2065428087	39.6834468013646	0.0162957211652342	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2427.37508994219	2427.37508994219
"healthy-2"	"2019-08-01-count-2:CAACCTCAGCGAACTG"	1.91705622252766	-9.74682333385619	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCAGCGAACTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.88356415927	43.887719072432	0.0175629307831306	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2496.25835971673	2496.25835971673
"healthy-2"	"2019-08-01-count-4:TAAGCCAGTGTATTGC"	3.06136598166768	-11.0632114640442	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCCAGTGTATTGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.0069855089	39.3463762011615	0.0156135980683465	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2514.7203553649	2514.7203553649
"healthy-2"	"2019-08-01-count-4:TCATTTGGTGCCTTCT"	1.02907117184941	-8.22519400036009	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTTGGTGCCTTCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2392.22543914831	40.0995813468629	0.0167624592108424	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2388.26672223218	2388.26672223218
"healthy-2"	"2019-08-01-count-2:CCACTTGCAACCAATC"	2.00693251666371	-10.4935264817444	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGCAACCAATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.59610635638	39.5562660598105	0.0164983025935607	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.72109443753	2390.72109443753
"healthy-2"	"2019-08-01-count-4:GAGAAATCAGCATCTA"	3.62104429778401	-10.9096899262634	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATCAGCATCTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.98238704479	44.4742922476747	0.0194127604381296	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2283.22033463926	2283.22033463926
"healthy-2"	"2019-08-01-count-3:GTGATGTAGGCATTTC"	2.51220240172688	-10.6316452256409	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGATGTAGGCATTTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.10085630468	41.4370370365308	0.018698172927755	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2211.83119757676	2211.83119757676
"healthy-2"	"2019-08-01-count-2:TTGCTGCTCGCCGAAC"	2.2787467437679	-10.7718572846619	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCTCGCCGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.40452045205	42.5315273276162	0.0168815793503399	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2514.70666313775	2514.70666313775
"healthy-2"	"2019-08-01-count-2:GAGTTACGTCAGACTT"	-2.3668192428654	13.0345830687317	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTACGTCAGACTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1703.9648637949	38.4515837667428	0.0225659487374096	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1697.6467099013	1697.6467099013
"healthy-2"	"2019-08-01-count-2:CGAAGTTCACCTAAAC"	2.68068255957906	-10.6382532349792	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTCACCTAAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.1040551082	43.5561141475235	0.0176906065595223	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2456.10809973356	2456.10809973356
"healthy-2"	"2019-08-01-count-2:GCACGGTGTACGACTT"	1.19948210295979	10.0191964873108	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGGTGTACGACTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.83273054938	38.7688028288309	0.0198627690898075	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1949.73338578385	1949.73338578385
"healthy-2"	"2019-08-01-count-3:TGCGACGTCCATCAGA"	3.03340496596639	-10.6281280747619	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGACGTCCATCAGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2197.25314108638	46.9240793565404	0.0213557912281969	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2191.00374894967	2191.00374894967
"healthy-2"	"2019-08-01-count-4:TGATGCACACTACAGT"	1.61338700827901	-4.96256353771361	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCACACTACAGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2243.89241434902	42.4438594597925	0.0189152827418894	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2241.60019270415	2241.60019270415
"healthy-2"	"2019-08-01-count-2:TCTAACTGTGTTACAC"	-5.17273698273357	-5.30455400859984	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTAACTGTGTTACAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2868.1038643062	42.3003410917323	0.0147485387883485	3570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2863.67891825133	2863.67891825133
"healthy-2"	"2019-08-01-count-4:GAAGAATAGGCTCTAT"	-2.08092651787456	12.8687047728333	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATAGGCTCTAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1749.42603526131	47.7759530203922	0.0273095015493215	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1742.64444249928	1742.64444249928
"healthy-2"	"2019-08-01-count-2:GTGCTTCCAGGCATGA"	4.42310776290242	-10.4927349320618	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCCAGGCATGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.98693246089	43.6661102656826	0.0193385132738978	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2255.40281464236	2255.40281464236
"healthy-2"	"2019-08-01-count-1:AAAGGATGTGGTTCTA"	7.98517479476277	7.25519416416017	"2019-08-01-count-1"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAAGGATGTGGTTCTA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.40990112168	42.2705213084707	0.0210992874123284	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1989.26693613822	1989.26693613822
"healthy-2"	"2019-08-01-count-4:CGGAATTGTCTTGCGG"	1.0685371356899	-8.98183538829955	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAATTGTCTTGCGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2164.06888524863	38.8403338103035	0.0179478269268869	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2162.01833890856	2162.01833890856
"healthy-2"	"2019-08-01-count-4:GGGTGAACAGATACCT"	3.03761353072469	-10.8353348008362	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAACAGATACCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.48783507814	45.0217193244221	0.0195790204399547	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.67405762637	2291.67405762637
"healthy-2"	"2019-08-01-count-2:GAGGGTATCGAAGCAG"	3.09644617614095	-10.3652258149353	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTATCGAAGCAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.44377317869	41.4845314532997	0.0175525781167645	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2356.20066195923	2356.20066195923
"healthy-2"	"2019-08-01-count-3:ATTACCTGTCGCTGCA"	9.69407143172566	5.56540772998659	"2019-08-01-count-3"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTGTCGCTGCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.29586974325	39.268065862701	0.0215250533172711	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1818.64840892342	1818.64840892342
"healthy-2"	"2019-08-01-count-2:TCCTTTCCAGATGCGA"	-5.02627835694011	-5.67693188106688	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCCAGATGCGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2075.86175288619	51.2337149883051	0.0246806970247763	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2072.24316517219	2072.24316517219
"healthy-2"	"2019-08-01-count-4:TGGGAGACATGCAGCC"	3.87362684783284	-10.6224670640198	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGACATGCAGCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.17880321307	40.8573095084533	0.0174441462165075	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2336.13285209056	2336.13285209056
"healthy-2"	"2019-08-01-count-2:ATTACTCCACTATCGA"	-7.76683507385905	1.32291791522828	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCCACTATCGA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2611.4788087834	43.8512012068967	0.0167917124425473	3651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2606.92980982605	2606.92980982605
"healthy-2"	"2019-08-01-count-4:CGGGACTAGATCGGTG"	3.14344133910481	-10.9256983033386	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTAGATCGGTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.45670882507	44.9032995924739	0.0188712404079192	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.72511566244	2377.72511566244
"healthy-2"	"2019-08-01-count-4:GCGAGAAAGCATGATA"	2.31082667884175	-10.3975038758484	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAAAGCATGATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.5693527625	41.3295266794103	0.0178254433623767	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.0310202061	2314.0310202061
"healthy-2"	"2019-08-01-count-4:TTCCGTGAGGTTACCT"	3.51965155181233	-10.8485965958801	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGAGGTTACCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.65403679559	41.955438108374	0.0176978325209718	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2370.65403679559	2370.65403679559
"healthy-2"	"2019-08-01-count-3:TTGAGTGGTACCGGAA"	3.17835273322408	-11.0285597077576	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAGTGGTACCGGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.29881778944	37.5991527548617	0.0162886851845589	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.97121578954	2302.97121578954
"healthy-2"	"2019-08-01-count-4:GTAGGTTAGTAGAATC"	2.61462797698323	-10.9138956299988	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGTTAGTAGAATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.51553759349	42.6600105495371	0.0181106895151796	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2354.62026846935	2354.62026846935
"healthy-2"	"2019-08-01-count-4:TGATTTCCAGTTAGAA"	1.82444479045216	-4.87997009670409	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCCAGTTAGAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2562.59996372987	42.815203783233	0.0167077204359729	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2556.56165481914	2556.56165481914
"healthy-2"	"2019-08-01-count-3:ATCGTAGTCATCGACA"	1.15291001376454	-9.0279808274475	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGTCATCGACA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2357.62979550109	40.8114430884134	0.0173103695780785	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2356.55656567515	2356.55656567515
"healthy-2"	"2019-08-01-count-4:AGAGCCCTCCTCGCAT"	8.22166027602498	7.13161466205446	"2019-08-01-count-4"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCCCTCCTCGCAT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1378.10884416781	38.2486757947972	0.0277544665333704	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1373.39490840456	1373.39490840456
"healthy-2"	"2019-08-01-count-4:TGCACGGCAACCAACT"	3.07647933539693	-10.9934702149597	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCACGGCAACCAACT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.53149062143	41.3754654523007	0.0169952475914531	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2428.14090383268	2428.14090383268
"healthy-2"	"2019-08-01-count-2:AATCGTGCAGACGCTC"	-2.47717938843425	13.2363185652527	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGCAGACGCTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1817.89578991468	42.4995691335979	0.023378440815682	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1803.98455068298	1803.98455068298
"healthy-2"	"2019-08-01-count-4:CTAGACATCCTACGGG"	-6.83021388474162	3.42292568767396	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACATCCTACGGG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2555.53844176186	38.7143337482865	0.0151491885684943	2485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2545.20691846274	2545.20691846274
"healthy-2"	"2019-08-01-count-2:TTGTGGAGTACGAGCA"	3.05022706565205	-10.9829883805481	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGGAGTACGAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.68450498936	40.5924936171764	0.0184035810766926	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2203.55394348993	2203.55394348993
"healthy-2"	"2019-08-01-count-3:TGCTCGTCAGCGTACC"	-2.25146756592448	12.9740047224793	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTCAGCGTACC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1907.33546489289	38.4269796397275	0.0201469433914634	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1901.89886632414	1901.89886632414
"healthy-2"	"2019-08-01-count-2:TCTCACGTCCTGTACC"	3.16530885276143	-10.6087846986023	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGTCCTGTACC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2384.15853997876	36.5877215667499	0.0153461780973156	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2382.63023918145	2382.63023918145
"healthy-2"	"2019-08-01-count-4:GCGGAAATCATTCCTA"	2.66152562674825	-10.8228721848694	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGAAATCATTCCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.83134695321	45.2390841726765	0.0188352459593233	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2397.78200150881	2397.78200150881
"healthy-2"	"2019-08-01-count-4:GCGGATCAGCTCCCTT"	2.36748876151387	-10.8291530839172	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCAGCTCCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.93904732995	42.5746499720183	0.0180788755531867	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.7431777199	2348.7431777199
"healthy-2"	"2019-08-01-count-4:CTATAGGCATGGGCAA"	14.0958448844845	1.87489471519319	"2019-08-01-count-4"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATAGGCATGGGCAA"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1152.9356393335	32.0072654278679	0.0277615370155189	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1134.65550183314	1134.65550183314
"healthy-2"	"2019-08-01-count-3:GATCGTAAGGCCTGCT"	-3.56258283081706	3.74918577754823	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAAGGCCTGCT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3157.01976950461	41.0545055615898	0.0130041965394572	5067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3150.21675912344	3150.21675912344
"healthy-2"	"2019-08-01-count-4:CTATCCGAGTATCTGC"	1.83150603350942	-9.9569301835266	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCCGAGTATCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.96189143856	47.0317150264079	0.0200993508477584	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2334.83571144253	2334.83571144253
"healthy-2"	"2019-08-01-count-4:ATCGGATCATTGACCA"	2.5616144138271	-10.6822166672912	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATCATTGACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.18724426963	37.8459249920924	0.0165759181981586	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2283.18724426963	2283.18724426963
"healthy-2"	"2019-08-01-count-2:TAACCAGCAATTGAGA"	3.83079924163167	-10.9000082246033	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACCAGCAATTGAGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.88539905195	42.2614765451728	0.0171802623656616	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.49407292936	2455.49407292936
"healthy-2"	"2019-08-01-count-4:CTATCTACACTTCAAG"	-8.48934874954875	-0.164323650952898	"2019-08-01-count-4"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCTACACTTCAAG"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2950.14834748124	40.1703164595573	0.0136163716966483	4117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2938.1512757267	2938.1512757267
"healthy-2"	"2019-08-01-count-3:TGCTTGCAGAAACCAT"	2.70744909819905	-10.8067751160828	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCAGAAACCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.13986073906	40.9484276123187	0.0176948802045357	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2310.99663718169	2310.99663718169
"healthy-2"	"2019-08-01-count-2:ACAAGCTCACTCCTGT"	-3.59841952744182	3.4340679415497	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTCACTCCTGT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3205.79711898018	44.2377053620692	0.0137992841468839	5547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3200.08454925705	3200.08454925705
"healthy-2"	"2019-08-01-count-4:GCACGGTAGGTGCTTT"	-7.69397244873698	3.23238179767457	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTAGGTGCTTT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2299.15113596886	39.1118693311496	0.0170114390129764	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2292.26468416579	2292.26468416579
"healthy-2"	"2019-08-01-count-4:GGGATGAAGAGCAGTC"	2.3983642059261	-10.6713075867859	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATGAAGAGCAGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.95181920535	36.7536924413609	0.0170475481473921	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2154.80833619413	2154.80833619413
"healthy-2"	"2019-08-01-count-2:CTGTAGATCCTTGACC"	-4.83572612229045	-5.38812734996947	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTAGATCCTTGACC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2837.81487268769	45.2544134845791	0.0159469223733114	2950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2828.42661259198	2828.42661259198
"healthy-2"	"2019-08-01-count-4:GACATCAAGCTTCATG"	-1.06364593926128	13.1995095976624	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACATCAAGCTTCATG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2123.76224200346	41.6743197408083	0.0196228744049497	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2120.57130934578	2120.57130934578
"healthy-2"	"2019-08-01-count-3:TCCGGGAAGGGACACT"	10.989874501794	3.88363287532655	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGGGAAGGGACACT"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1541.90733466884	28.8731330349909	0.0187255954918926	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1537.84864352632	1537.84864352632
"healthy-2"	"2019-08-01-count-2:CTGTATTAGGGACTGT"	1.46493091162984	-8.95165064251097	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTATTAGGGACTGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2348.73974513525	43.2336111162023	0.0184071526893299	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2344.87137795767	2344.87137795767
"healthy-2"	"2019-08-01-count-2:TGAGTCATCGTAGCTA"	2.09602417525594	-10.2691602936951	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGTCATCGTAGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.68681637756	40.9171870132455	0.0164810103083992	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2475.87528136261	2475.87528136261
"healthy-2"	"2019-08-01-count-2:ACCATTTAGGAGCTGT"	-2.67298255387004	13.0496949919495	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCATTTAGGAGCTGT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1854.65503815406	40.8076028890057	0.0220027994691787	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1852.69176368917	1852.69176368917
"healthy-2"	"2019-08-01-count-3:CAGGCCAAGCAGTACG"	2.40674891051595	-10.873037361261	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGCCAAGCAGTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.93645772242	39.7256405135182	0.0170867639765237	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2321.27094103169	2321.27094103169
"healthy-2"	"2019-08-01-count-2:TCCCACAGTGCATCTA"	2.08784236487691	-10.5931062928406	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCACAGTGCATCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.46083756932	38.3135903344599	0.0163004589236556	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2343.74737503185	2343.74737503185
"healthy-2"	"2019-08-01-count-3:TCCTAATAGTAAATGC"	-2.75022945824321	13.5107440718445	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATAGTAAATGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2239.41880907125	40.8756715938741	0.018252803552555	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2236.03921571432	2236.03921571432
"healthy-2"	"2019-08-01-count-2:AATTCCTGTACTTCCC"	4.17818893966023	-10.5723409882751	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTCCTGTACTTCCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.15136463458	41.640975662858	0.0156359778177954	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2656.47394722721	2656.47394722721
"healthy-2"	"2019-08-01-count-4:AGCCAATCACCCATAA"	-2.1134275001591	13.5972499617371	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATCACCCATAA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1998.14636385174	42.5355182385606	0.0212874887486053	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1990.74274671814	1990.74274671814
"healthy-2"	"2019-08-01-count-3:ACAGAAATCACCACAA"	10.9641748863155	4.16261670673219	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAATCACCACAA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1822.38269982237	43.1172546741718	0.0236598244037186	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1820.70597272273	1820.70597272273
"healthy-2"	"2019-08-01-count-4:GAGTGAGTCCGAAGGA"	-1.98626838150676	13.0831975706848	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGAGTCCGAAGGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1807.26229853652	44.7144730089293	0.0247415513758783	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1795.48387735073	1795.48387735073
"healthy-2"	"2019-08-01-count-3:TCAGTTTGTTAAGGAT"	-2.23770556870158	12.7454023131165	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTTTGTTAAGGAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1642.07110995544	47.6209093910292	0.0290005159352212	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1637.8249075531	1637.8249075531
"healthy-2"	"2019-08-01-count-3:TACTTGTTCTGTACAG"	2.82144441184346	-11.0421343079773	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTTCTGTACAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.54423278416	42.1319087456149	0.0164030302487516	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2566.83184874691	2566.83184874691
"healthy-2"	"2019-08-01-count-2:CGTGAATTCACGTCCT"	2.68992962416951	-10.9900074235168	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATTCACGTCCT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.45704091676	37.7640459796057	0.0153671235552984	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2449.85925110143	2449.85925110143
"healthy-2"	"2019-08-01-count-2:AGACAGGTCCCGTTCA"	1.86958803710286	-10.422239326593	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAGGTCCCGTTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.91651602107	39.2120279382716	0.0157673278076132	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2484.18085694297	2484.18085694297
"healthy-2"	"2019-08-01-count-4:GGGACAACAGGACATG"	2.42640175399129	-10.1458521119324	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAACAGGACATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.33918526198	42.0513766641956	0.0186618050843094	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2252.34537296666	2252.34537296666
"healthy-2"	"2019-08-01-count-2:CTGTGGGTCAGAATAG"	2.57846178588216	-10.9303274384704	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGGGTCAGAATAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.90023214012	36.2268743295217	0.0164301648670785	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2203.96443092171	2203.96443092171
"healthy-2"	"2019-08-01-count-2:CGATGCGAGCCGGAAT"	6.84182419356648	-1.0124516717163	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGAGCCGGAAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1688.81870646092	47.163400432717	0.0279268581359762	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1685.29989021202	1685.29989021202
"healthy-2"	"2019-08-01-count-3:ATGACCACACCTTCCA"	2.80366148528401	-10.9089794388977	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCACACCTTCCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.06041259584	42.0320264691969	0.0173466688039229	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2415.02438055453	2415.02438055453
"healthy-2"	"2019-08-01-count-2:TTTACTGAGGACACTG"	1.82659139212911	-5.25696804439696	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGAGGACACTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2344.91548880709	40.6168043513071	0.0173212231081171	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2340.6933311216	2340.6933311216
"healthy-2"	"2019-08-01-count-2:TTTACTGGTCATAAAG"	-4.29054866257365	3.60258982265321	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGGTCATAAAG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2794.85856636272	47.4290406270215	0.0169701040324006	3706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2793.24523767637	2793.24523767637
"healthy-2"	"2019-08-01-count-2:ACAAAGAAGGTAAGGA"	1.68057539042775	-9.65419199382933	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGAAGGTAAGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.16788011094	45.2315705409	0.0195878224924585	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2307.20409088361	2307.20409088361
"healthy-2"	"2019-08-01-count-4:TCCGGGACATGACGGA"	-2.57747064057048	13.3542775877747	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGACATGACGGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2005.02600791489	45.8869253304442	0.0228859501818453	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2001.37168609701	2001.37168609701
"healthy-2"	"2019-08-01-count-4:TGTACAGGTAGACGGT"	3.20415796813313	-10.5026407471863	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGGTAGACGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.82181906333	40.401958875123	0.0182581166396058	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2209.90003775921	2209.90003775921
"healthy-2"	"2019-08-01-count-4:CCTCACAAGAGGTCAC"	-5.11453233185466	-4.50872232830199	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACAAGAGGTCAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2811.70992139133	44.7556247754264	0.0159175825482309	3619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2805.75373405168	2805.75373405168
"healthy-2"	"2019-08-01-count-3:CTTACCGCAAAGGTTA"	3.45009030875508	-10.785800956842	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGCAAAGGTTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.6907754468	41.940094531004	0.0192324812867661	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2173.92167604622	2173.92167604622
"healthy-2"	"2019-08-01-count-2:ACTCCCACAACGGGTA"	-0.660234968096572	11.1488094099793	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCACAACGGGTA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1882.16301009986	47.3724732326025	0.0251691659959299	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1880.2784090852	1880.2784090852
"healthy-2"	"2019-08-01-count-3:TTGTGTTAGAAGAACG"	-0.883128027350265	13.0705566176209	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTAGAAGAACG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1882.32930220997	43.1237175093985	0.0229097626322708	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1873.18590643561	1873.18590643561
"healthy-2"	"2019-08-01-count-2:TCAGTTTTCTGGTCAA"	1.37839915332143	9.47422883594362	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTTTTCTGGTCAA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.1359507354	31.4944719439585	0.0173128742418765	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1816.33950045839	1816.33950045839
"healthy-2"	"2019-08-01-count-3:TGGGAAGGTAAGATAC"	2.34582247313802	-10.6532440415588	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAAGGTAAGATAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.9220338692	42.7250466198087	0.0184086522495467	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2316.96427186554	2316.96427186554
"healthy-2"	"2019-08-01-count-2:CACACAATCCTTCTGG"	0.0823972831362903	11.9530238875183	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAATCCTTCTGG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.79791951545	38.265872112564	0.0190681242692356	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1993.50954682747	1993.50954682747
"healthy-2"	"2019-08-01-count-4:TGTACAGTCCGCGGAT"	2.95409645613973	-10.8785896531311	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGTCCGCGGAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.6348533733	39.0827350874319	0.0169509647333147	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.00058761758	2294.00058761758
"healthy-2"	"2019-08-01-count-3:ATGAGTCTCGTCGCTT"	4.44242062148396	-10.4102268449036	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCTCGTCGCTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.29137820103	40.2542923084518	0.0190121646566445	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2111.38989547007	2111.38989547007
"healthy-2"	"2019-08-01-count-2:TAATCTCTCAAGCTGT"	-5.73809562149699	-4.85827019130858	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATCTCTCAAGCTGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3094.02953727984	41.1557566594084	0.0133016689606625	4874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	3089.07693405633	3089.07693405633
"healthy-2"	"2019-08-01-count-3:CCGCAAGCATCTCCCA"	1.18654920634572	-8.77288153087767	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGCAAGCATCTCCCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2407.80086460037	44.8992529380915	0.0186474112532323	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2407.80086460037	2407.80086460037
"healthy-2"	"2019-08-01-count-4:TTCATGTTCTCGACGG"	3.15902843055074	-10.7067470780578	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTTCTCGACGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.82261363666	38.9355272409157	0.0170708265553519	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2276.99435307986	2276.99435307986
"healthy-2"	"2019-08-01-count-4:ACACAGTGTGAACTAA"	2.18717755851094	-10.5872793427673	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTGTGAACTAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.68954470482	39.4340255959339	0.0165017358356501	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.2929371897	2383.2929371897
"healthy-2"	"2019-08-01-count-4:CCGTAGGGTTCCTTGC"	2.37646641310994	-10.183602356073	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTAGGGTTCCTTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.53538872088	33.1046613796736	0.0150370789174131	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2198.71661529633	2198.71661529633
"healthy-2"	"2019-08-01-count-4:TCCTAATCAGGTTTAC"	2.37507190284078	-10.6782942048279	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATCAGGTTTAC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.98098282016	36.3001543398447	0.0143536683693703	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2522.92151250386	2522.92151250386
"healthy-2"	"2019-08-01-count-3:CCATCACAGACATCCT"	-2.07719622078593	3.84792969310609	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACAGACATCCT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3181.16094381265	40.7566997375894	0.0128118949205827	5696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3177.77976104318	3177.77976104318
"healthy-2"	"2019-08-01-count-2:GCTCAAAAGCTCAGAG"	4.53713049468343	-10.7816467515198	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGCTCAGAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.92052408403	46.0495922022453	0.0189510692822367	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2427.90943944002	2427.90943944002
"healthy-2"	"2019-08-01-count-4:GGAGGATTCGCTCTCA"	2.56039084967915	-10.9371633759704	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGATTCGCTCTCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.51245602047	43.0905145629493	0.0181394605840695	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2369.11563295739	2369.11563295739
"healthy-2"	"2019-08-01-count-3:GCAACATAGGTGCTAG"	-7.82999787750896	1.2568241127762	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACATAGGTGCTAG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2604.03581945667	42.2352282135652	0.0162191425701577	3187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2597.83266495537	2597.83266495537
"healthy-2"	"2019-08-01-count-4:TCTACCGTCAAGGTGG"	2.29041328009908	-10.5934925309387	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGTCAAGGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2111.63852254483	39.5209019122317	0.018715751531471	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2102.03221747369	2102.03221747369
"healthy-2"	"2019-08-01-count-2:GATGACTAGTAAGCAT"	-5.03687701645549	-5.2489223710266	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGACTAGTAAGCAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2217.02708022153	48.0979470099706	0.0216947945467425	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2215.28559535301	2215.28559535301
"healthy-2"	"2019-08-01-count-3:GGGTAGACACAAGTGG"	2.2640618282253	-10.7973528138367	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTAGACACAAGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.50646643878	40.2034370348813	0.017848311484958	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2244.3188117989	2244.3188117989
"healthy-2"	"2019-08-01-count-3:TTGTTTGAGTGCAGCA"	2.12742271003072	-9.93280413067015	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTTGAGTGCAGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.16155067212	40.4576122088279	0.0176120012965525	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.87642767634	2291.87642767634
"healthy-2"	"2019-08-01-count-2:TGAACGTCATCGGAGA"	4.5044375854427	-10.8639736405578	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAACGTCATCGGAGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.18951099734	37.9058873903701	0.0170886604604522	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.30800578585	2214.30800578585
"healthy-2"	"2019-08-01-count-3:CTGAGCGGTAGCTGAG"	3.19286789473836	-10.3692293397156	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGCGGTAGCTGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.33480166068	42.1626739789638	0.0179695898254256	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.07767793424	2341.07767793424
"healthy-2"	"2019-08-01-count-3:CTGAGCGCATACCACA"	1.85972072657887	-8.81695749675902	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGCGCATACCACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.44592771374	41.7498490894514	0.0183802962597809	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2266.75328970359	2266.75328970359
"healthy-2"	"2019-08-01-count-3:CGTAATGAGATCCCAT"	1.71555556830708	-9.73024179851683	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGAGATCCCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.37592706124	39.3463069169071	0.0169131336252308	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2323.09942767664	2323.09942767664
"healthy-2"	"2019-08-01-count-1:CCTCAACCACCGAATT"	1.41220464286153	10.9834871062073	"2019-08-01-count-1"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCTCAACCACCGAATT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2150.14650394351	31.3115476036683	0.0145625182034066	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2140.73353713451	2140.73353713451
"healthy-2"	"2019-08-01-count-3:CTCAAGATCGACCCAG"	-2.85333428803142	-5.91415789043578	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGATCGACCCAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2299.3586256707	43.1552793378439	0.0187683986551928	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2296.1539780141	2296.1539780141
"healthy-2"	"2019-08-01-count-2:TCCTCCCGTATGTCCA"	9.78342594680135	5.0317058333191	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCGTATGTCCA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.96065589192	22.425654861317	0.0115242077446002	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1945.96065589192	1945.96065589192
"healthy-2"	"2019-08-01-count-2:CCACCATCATGCCGCA"	-1.69939337197002	12.7954053648743	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATCATGCCGCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1913.80264112199	41.4004744902238	0.0216325725551054	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1911.90511874321	1911.90511874321
"healthy-2"	"2019-08-01-count-4:TTGAACGGTACAACGG"	2.23661150512044	-10.6947536698547	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAACGGTACAACGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.57520516039	41.6102026590759	0.01816583125729	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2283.98701045942	2283.98701045942
"healthy-2"	"2019-08-01-count-4:GACTCTCCAGTAACGG"	2.43912686881368	-10.733331703302	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCTCCAGTAACGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.15099427463	42.7828160482917	0.0178771904282869	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2387.12076289624	2387.12076289624
"healthy-2"	"2019-08-01-count-3:CTGAGGCCAGCCTACG"	2.83177127417867	-10.2998323670593	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCCAGCCTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.99946498885	41.0936009598999	0.0169948759521704	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2415.03479361469	2415.03479361469
"healthy-2"	"2019-08-01-count-4:CTCAGTCGTTATAGCC"	3.11928953704182	-10.9059248200622	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTTATAGCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.78146376979	40.7021138602954	0.0172045112719067	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2359.22690247368	2359.22690247368
"healthy-2"	"2019-08-01-count-3:TTTACTGTCCAAGCTA"	2.41872920569722	-10.7374515763489	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACTGTCCAAGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.57824783631	43.2975123219852	0.0177917074827904	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2431.48017272086	2431.48017272086
"healthy-2"	"2019-08-01-count-4:CCTCCTCCATTGAAAG"	-2.12556872788127	13.1817397841248	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCCATTGAAAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1723.69419070147	40.6371917563728	0.0235756388665644	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1723.69419070147	1723.69419070147
"healthy-2"	"2019-08-01-count-4:CTCATCGGTACAAGTA"	-3.04325375977214	-5.89470674907836	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATCGGTACAAGTA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2639.27628761638	43.4590961443827	0.0164662928046961	2663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2632.42546527325	2632.42546527325
"healthy-2"	"2019-08-01-count-4:CCTCTAGAGGCTCACC"	2.49463405188863	-11.0383138886658	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGAGGCTCACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.14196355369	41.8907288419286	0.0171322276850731	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2441.44830484889	2441.44830484889
"healthy-2"	"2019-08-01-count-2:ATCCCTGTCTAGTGAC"	2.77005281028096	-10.6570739976135	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGTCTAGTGAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.68363615006	40.8621901037306	0.0161467002512785	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2525.89921700769	2525.89921700769
"healthy-2"	"2019-08-01-count-4:TCCTTTCTCCATTCGC"	6.80059446868245	-1.00238349353942	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCTCCATTCGC"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1953.14008422711	51.8346303857111	0.0265391257925173	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1938.7715633226	1938.7715633226
"healthy-2"	"2019-08-01-count-3:TCGCACTAGAGTGACC"	2.20588054236714	-10.7133836976257	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTAGAGTGACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.29336079611	39.3062728693756	0.0161668161905831	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.23037174983	2425.23037174983
"healthy-2"	"2019-08-01-count-3:AGGCTGCTCTCGGGAC"	-2.08917174759563	12.3784894713196	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCTGCTCTCGGGAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1744.48226022378	42.3767843876012	0.0242918975754819	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1740.25951015363	1740.25951015363
"healthy-2"	"2019-08-01-count-4:GACTTCCCATGCCGAC"	-4.44837413254436	3.66029880130617	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCCATGCCGAC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2724.69786845942	39.6997784664532	0.0145703415141951	4037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2718.2240033184	2718.2240033184
"healthy-2"	"2019-08-01-count-2:TGCGACGGTGCTTCAA"	1.71603276309316	-4.87899496471556	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGGTGCTTCAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2301.88679007136	39.9984364121819	0.0173763699347446	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2297.76302846735	2297.76302846735
"healthy-2"	"2019-08-01-count-2:CACGAATTCTTAATCC"	14.1606890159542	1.79953346336213	"2019-08-01-count-2"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCTTAATCC"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1299.40211854759	18.4520300391032	0.0142004001499767	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1288.02195255813	1288.02195255813
"healthy-2"	"2019-08-01-count-2:CAGGCCACACCTCTGT"	2.46779789504353	-10.6790495148865	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCACACCTCTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.74512963848	42.6672921420428	0.0191957645404818	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2217.75098901272	2217.75098901272
"healthy-2"	"2019-08-01-count-4:CTCATGCGTCTCGGAC"	1.86458112773244	-10.0624666444031	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCGTCTCGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.74751826881	47.0485268883616	0.0197953407026721	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2374.26826863103	2374.26826863103
"healthy-2"	"2019-08-01-count-2:TACCCGTTCTTACCAT"	-1.63366566124614	13.4120454558167	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCGTTCTTACCAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2138.92929786624	41.0664618637655	0.0191995415204854	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2135.48124038679	2135.48124038679
"healthy-2"	"2019-08-01-count-4:GAACGTTGTGGGTCAA"	2.10014047202412	-9.84244825756224	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACGTTGTGGGTCAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2286.60505231964	40.6141164422097	0.0177617540033898	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2282.80495323851	2282.80495323851
"healthy-2"	"2019-08-01-count-4:CACGTGGAGCATTTCG"	6.94311346587483	-1.19710483467253	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGAGCATTTCG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2414.95074188298	38.1742620915705	0.0158074702847998	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2405.04891442539	2405.04891442539
"healthy-2"	"2019-08-01-count-4:GAGGGATTCGAAGAAT"	2.74118246611897	-11.054979347345	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATTCGAAGAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.4827214258	38.7784081137846	0.0161881393536846	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2391.13273339231	2391.13273339231
"healthy-2"	"2019-08-01-count-2:GGGTCTGGTCCGTACG"	2.26918568190877	-10.5237980118957	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGGTCCGTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.99227231664	37.4850869315305	0.0172742951252596	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2169.99227231664	2169.99227231664
"healthy-2"	"2019-08-01-count-4:TCAAGACTCACTGTCC"	3.15609039840047	-9.66902162944945	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACTCACTGTCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.34880038105	42.1510409733735	0.0168244202032717	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2502.48654116713	2502.48654116713
"healthy-2"	"2019-08-01-count-3:TAACACGGTGTACAGG"	2.06711043891255	-10.5674505463806	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACACGGTGTACAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.4744574462	36.5690546670026	0.0174514437706724	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2093.5339932673	2093.5339932673
"healthy-2"	"2019-08-01-count-4:TCAGGTAGTGTCTAAC"	2.51877250251119	-10.6215105286804	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTAGTGTCTAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.27983421089	37.1403743668446	0.0164608900916025	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2254.52124255163	2254.52124255163
"healthy-2"	"2019-08-01-count-4:TGGCGTGGTCCAGTTA"	2.17287506636922	-10.3436727753845	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGGTCCAGTTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.62495271486	32.7151266887783	0.0129430304340206	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2522.70201082349	2522.70201082349
"healthy-2"	"2019-08-01-count-2:TGAGTCAAGATTGACA"	-0.0922101241653741	11.6316251524719	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGTCAAGATTGACA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.07298570635	42.299711893368	0.0227164628981083	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1854.32246234058	1854.32246234058
"healthy-2"	"2019-08-01-count-3:GAGTTTGAGGGCAACT"	1.25380351123158	9.46503541553346	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTTGAGGGCAACT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1593.56094276532	35.1861065889765	0.022080176317523	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1584.48842785	1584.48842785
"healthy-2"	"2019-08-01-count-2:GGAATCTTCAACCCGG"	1.62912978705708	-8.8904600373474	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTTCAACCCGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.8946633698	44.9223363939512	0.0199221440911202	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2253.81592134124	2253.81592134124
"healthy-2"	"2019-08-01-count-4:AGAGAATTCTCCTGCA"	0.347705145447892	11.8027019270691	"2019-08-01-count-4"	"Control2"	"MAIT"	"MAIT"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAATTCTCCTGCA"	"MAIT"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2207.34434390417	35.1274498685286	0.0159138966992336	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2199.17213685741	2199.17213685741
"healthy-2"	"2019-08-01-count-2:TGTACAGAGTGCGACA"	1.84163429316823	-9.27644159710082	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTACAGAGTGCGACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.61335111982	40.9010694849766	0.0183116157791907	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2231.63221771309	2231.63221771309
"healthy-2"	"2019-08-01-count-2:ATGTCTTGTCGCTTGG"	1.64197005805318	-9.79885675823363	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCTTGTCGCTTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.26360065498	43.7866198070505	0.019253097923407	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2271.28648439178	2271.28648439178
"healthy-2"	"2019-08-01-count-3:ACTTCCGAGAGAGTGA"	-1.95866618576701	13.6070728071961	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCCGAGAGAGTGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1787.01501550834	38.1752959912607	0.0213626050480618	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1776.49299233106	1776.49299233106
"healthy-2"	"2019-08-01-count-4:TGTGGCGTCTAGGCCG"	2.2633031803066	-10.5564155808655	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGGCGTCTAGGCCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.78284069354	41.8011408190172	0.0183275409097284	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2272.74489216154	2272.74489216154
"healthy-2"	"2019-08-01-count-2:CGGGACTAGTGACACG"	1.31654109534566	9.40259931171266	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGACTAGTGACACG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1585.56271141059	39.8548124530761	0.0251360682023227	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1571.70339730792	1571.70339730792
"healthy-2"	"2019-08-01-count-4:TCCATCGCATCCTAAG"	11.1200701194698	3.94691441142885	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATCGCATCCTAAG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1577.46678280112	38.0270665081228	0.0241064134742653	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1560.67180119594	1560.67180119594
"healthy-2"	"2019-08-01-count-3:AAACGAACAACCGATT"	3.22770156440083	-10.7915935746399	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGAACAACCGATT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.65152643084	41.0498503874677	0.0171137199110157	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.65116904943	2392.65116904943
"healthy-2"	"2019-08-01-count-4:GGATCTAGTACGAGCA"	4.63723005828206	-10.5362682572571	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATCTAGTACGAGCA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.62383666165	45.1270561762692	0.0194544716531345	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2309.49404296593	2309.49404296593
"healthy-2"	"2019-08-01-count-4:TGTTACTTCGCCAGAC"	1.76221563395802	-9.62164213573607	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTTCGCCAGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.76728064482	41.8149552550735	0.0199902520906548	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2090.69197652818	2090.69197652818
"healthy-2"	"2019-08-01-count-4:TCTGTCGGTGCCCTTT"	4.46504511412923	-10.8411703339783	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTGCCCTTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.28788751855	42.103665105974	0.0178610619979451	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.8906837887	2353.8906837887
"healthy-2"	"2019-08-01-count-4:ATTACCTTCAACGTGT"	3.20066299018208	-10.2629766694275	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTTCAACGTGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.91557214121	39.5734296687373	0.0165170384669986	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2393.40316078875	2393.40316078875
"healthy-2"	"2019-08-01-count-3:CATGCCTTCTGAATGC"	1.47207846221272	-9.30482103740843	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTTCTGAATGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.59281960837	40.5140097950309	0.0165121162204483	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2451.59761130162	2451.59761130162
"healthy-2"	"2019-08-01-count-3:GTGCTGGGTGGATCAG"	-7.80779347840007	3.03471491420595	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	47	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGGTGGATCAG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2182.04699619294	41.6812942719498	0.0191019232604394	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2177.09585034231	2177.09585034231
"healthy-2"	"2019-08-01-count-4:CCTTTGGCAATTGGTC"	3.49601091918294	-10.4771232835022	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGCAATTGGTC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.66550536117	45.6492457935281	0.0208857419772404	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2181.48650471535	2181.48650471535
"healthy-2"	"2019-08-01-count-2:CGGGTCATCTTAGCAG"	1.96378089961354	-10.052462600824	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCATCTTAGCAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.8472706766	37.559444975441	0.0168288598726805	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.0790565011	2230.0790565011
"healthy-2"	"2019-08-01-count-4:ACCATTTCACTTTAGG"	2.21539463576619	-10.4753246537414	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCATTTCACTTTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.41065476408	39.6616023797584	0.0169247341686049	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2337.88370917203	2337.88370917203
"healthy-2"	"2019-08-01-count-4:ACCACAATCCGAGATT"	2.8107451396877	-10.8694048157898	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCACAATCCGAGATT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.96786272645	43.3895748038344	0.0187673780000843	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.80152832742	2302.80152832742
"healthy-2"	"2019-08-01-count-2:CACTAAGAGTGAACAT"	2.15149297293965	-9.48603441631468	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGAGTGAACAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.55332642654	38.8134359138835	0.0164774176319604	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2355.55332642654	2355.55332642654
"healthy-2"	"2019-08-01-count-2:GAGTGAGTCGCAGTTA"	10.9815136390621	4.0394031771454	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGTCGCAGTTA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1604.02528571909	38.2837221632593	0.0238672809612828	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1590.95058733731	1590.95058733731
"healthy-2"	"2019-08-01-count-2:ACGTAGTAGGCACTAG"	11.101410527795	3.96391055667726	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAGTAGGCACTAG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1687.98529512922	26.8896753193241	0.0159300412135792	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1687.98529512922	1687.98529512922
"healthy-2"	"2019-08-01-count-4:TGGGCGTGTGTCTAAC"	1.7201734977657	-4.73425581371459	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTGTGTCTAAC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2336.14138995516	42.0412127852195	0.017996005278613	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2329.36757075311	2329.36757075311
"healthy-2"	"2019-08-01-count-2:CGGGTGTTCTACGGGC"	1.84238590773885	-4.8711409798828	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTTCTACGGGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2251.10115890831	44.6331694164192	0.0198272606452143	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2247.55460485634	2247.55460485634
"healthy-2"	"2019-08-01-count-2:ATCTCTATCCCTCGAT"	2.01379420337026	-10.4110670319763	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTATCCCTCGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.16132334498	44.6646970336451	0.0197704770226471	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.69410175076	2256.69410175076
"healthy-2"	"2019-08-01-count-3:ACCTGTCTCCCTGGTT"	1.2112076478893	10.8631372221741	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGTCTCCCTGGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.24059130852	28.9078032994634	0.0145760445939594	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1981.01049520393	1981.01049520393
"healthy-2"	"2019-08-01-count-4:TCGGGCACACATGGTT"	2.14618744429891	-10.6717987290588	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCACACATGGTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.0230608854	41.3992638999316	0.0173362077519395	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2379.62451852431	2379.62451852431
"healthy-2"	"2019-08-01-count-4:GTGATGTGTGCTAGCC"	-4.78417001190837	3.6377804049286	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGATGTGTGCTAGCC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2900.80333893181	41.3471844171546	0.0142537013323972	3708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2892.24524777302	2892.24524777302
"healthy-2"	"2019-08-01-count-4:TGGTAGTAGATGAAGG"	2.31505908545796	-10.8753805390564	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTAGATGAAGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.80747810489	39.4158310697323	0.0158245193240393	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2486.93399584918	2486.93399584918
"healthy-2"	"2019-08-01-count-4:ATGAGGGTCATTGCTT"	2.23026909407918	-10.5234623185364	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGGGTCATTGCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.94830738622	39.7287300457399	0.0168631586360299	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2348.83574672369	2348.83574672369
"healthy-2"	"2019-08-01-count-2:ATGCCTCTCCTTTAGT"	1.74697186526601	-4.931019329187	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCTCCTTTAGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2575.60496197117	39.0482530561788	0.0151608082888202	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2569.51121495449	2569.51121495449
"healthy-2"	"2019-08-01-count-3:TGCTGAATCCACAGCG"	4.35812630233113	-10.7687807313171	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCCACAGCG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.07908737292	39.11424779536	0.0158931291546232	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2459.22702759135	2459.22702759135
"healthy-2"	"2019-08-01-count-3:TCCTTCTCAGGACATG"	7.0337721305782	-1.14671924030455	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTCAGGACATG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2424.14804869345	29.9861502845602	0.0123697685464062	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2408.9821699658	2408.9821699658
"healthy-2"	"2019-08-01-count-4:TCAAGACCAACTTGGT"	2.38564242896382	-10.6829138032165	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACCAACTTGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.68723809727	40.1295802393067	0.0169202665489322	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2364.65237448874	2364.65237448874
"healthy-2"	"2019-08-01-count-3:TATTCCAGTTCCTAAG"	6.80035461959187	-0.892842434999071	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCAGTTCCTAAG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1651.14744192115	46.7631421465601	0.0283216028800856	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1646.74812042272	1646.74812042272
"healthy-2"	"2019-08-01-count-4:TCACGCTCATACGCAT"	1.87912787970845	-5.14119341289672	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGCTCATACGCAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2667.34306589964	41.156498597197	0.0154297732164107	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2662.06547917072	2662.06547917072
"healthy-2"	"2019-08-01-count-3:GCCAGCAAGTGCCCGT"	2.00759722766225	-10.536988281366	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGCAAGTGCCCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.40884409224	38.7091305519079	0.0163232631304138	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2368.61734796226	2368.61734796226
"healthy-2"	"2019-08-01-count-4:AGTTCCCAGTTCCATG"	0.924623628228348	-8.3252687684265	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCCCAGTTCCATG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2341.42417102271	38.9019719085368	0.0166146623025356	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2339.48380303736	2339.48380303736
"healthy-2"	"2019-08-01-count-3:CACAACAAGAGCAGAA"	2.41308607634847	-10.6343307725159	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAACAAGAGCAGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.32135312271	38.6117728445169	0.01756420770315	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2196.21709965854	2196.21709965854
"healthy-2"	"2019-08-01-count-2:AAGAACATCTGGCTGG"	2.53989090499226	-10.5336551896301	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGAACATCTGGCTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.36645997373	39.2220347034244	0.0161715911185847	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2418.62372236086	2418.62372236086
"healthy-2"	"2019-08-01-count-3:AAGCGTTCATTGAGCT"	-2.61659298363383	13.2372627028259	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGTTCATTGAGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1809.30620238033	36.8186887214507	0.0203496172582683	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1803.15288402605	1803.15288402605
"healthy-2"	"2019-08-01-count-2:CACTTCGAGCGGCTCT"	2.66301335868184	-10.9767980805603	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTTCGAGCGGCTCT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.96706319138	37.8893417104942	0.0155413673476359	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2435.33519829098	2435.33519829098
"healthy-2"	"2019-08-01-count-3:GTGTGATTCGGTCATA"	1.78262033042256	-4.66596987163695	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATTCGGTCATA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2402.65788044361	41.3309507703029	0.017202178931389	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2398.80758362767	2398.80758362767
"healthy-2"	"2019-08-01-count-3:CTGTGAAAGAAATGGG"	-5.01793179932292	3.03065464580385	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAAAGAAATGGG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2640.18236576206	44.1316875285508	0.0167153936413073	3040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2631.95852408405	2631.95852408405
"healthy-2"	"2019-08-01-count-4:TTACAGGCAGGACTAG"	2.18659629401509	-10.2415113679138	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGCAGGACTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.70712589077	39.5769817116716	0.0171276494836683	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2306.43185689306	2306.43185689306
"healthy-2"	"2019-08-01-count-4:CTCAACCCATCCTAAG"	1.67061056670491	-9.79628183757933	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCCATCCTAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.96554794679	43.8494334005769	0.0173732297717961	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2520.78637670227	2520.78637670227
"healthy-2"	"2019-08-01-count-4:TATGTTCTCGCACGAC"	2.04746534404103	-9.90006544506224	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCTCGCACGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.09558780604	41.7351441377861	0.0184334726689823	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.99600815255	2261.99600815255
"healthy-2"	"2019-08-01-count-4:GACCAATGTGTAGTGG"	2.53022112426106	-10.9739151231018	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATGTGTAGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.93338832583	45.7410146349304	0.0209539213974875	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2178.38875187997	2178.38875187997
"healthy-2"	"2019-08-01-count-2:ACCCTCACAAGCCTGC"	2.34602989730183	-10.9989195100036	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTCACAAGCCTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.45902340226	44.5485476748054	0.0184813544815738	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2408.59651799347	2408.59651799347
"healthy-2"	"2019-08-01-count-4:CAGCACGCAAGAGGTC"	1.95984282073323	-10.3883295289245	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGCAAGAGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.91818770634	40.8971764312184	0.0185229582594742	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2203.95818066522	2203.95818066522
"healthy-2"	"2019-08-01-count-4:AGCCACGAGTATGACA"	1.60967328128163	-9.8101845017639	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGAGTATGACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.94332289163	45.0523330784566	0.018174006909486	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2472.72438878458	2472.72438878458
"healthy-2"	"2019-08-01-count-3:AGTACTGCACGTTCGG"	2.84041513976399	-10.9181795350281	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGCACGTTCGG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.28648671388	41.8613696352475	0.0181904208263194	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2291.38173984057	2291.38173984057
"healthy-2"	"2019-08-01-count-3:ATTCTTGAGTTGCTCA"	1.63212563571278	-8.55697634136351	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	51	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTTGAGTTGCTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.99846194324	41.0071693748094	0.0207631399036441	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1971.94984264253	1971.94984264253
"healthy-2"	"2019-08-01-count-4:TTGTTTGCACAAATCC"	2.59104384955708	-10.9861755601135	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTTGCACAAATCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.77534544489	38.3347893679386	0.0150937717529593	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2534.78417311539	2534.78417311539
"healthy-2"	"2019-08-01-count-4:CATGAGTTCTATCGCC"	-5.20658622208293	-5.5404901734558	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGAGTTCTATCGCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2740.72641879594	40.1681402522958	0.0146560196511487	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2736.07190249093	2736.07190249093
"healthy-2"	"2019-08-01-count-2:TGCACGGAGCTGCCAC"	2.17683329161946	-10.6112680665222	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCACGGAGCTGCCAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.4551222851	39.5417030407174	0.017129075917047	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2306.42055767345	2306.42055767345
"healthy-2"	"2019-08-01-count-3:TCAAGACTCTTCACGC"	3.35989656028096	-10.7086277238098	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGACTCTTCACGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.0013543033	44.6049878543664	0.019226276644895	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2319.04490690569	2319.04490690569
"healthy-2"	"2019-08-01-count-3:TGGATGTGTCGCAACC"	2.60019840773885	-10.9152670136658	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATGTGTCGCAACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.23315771429	40.3776369406997	0.0169922874822348	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2371.73587468435	2371.73587468435
"healthy-2"	"2019-08-01-count-4:CTGCAGGCACCGTCTT"	2.11798801001851	-10.6260919800964	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGCACCGTCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.442346908	40.8308970004026	0.0184969256649422	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2205.35171720182	2205.35171720182
"healthy-2"	"2019-08-01-count-4:AAGCATCAGACATCCT"	2.38525881347005	-10.9601249924866	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCATCAGACATCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.2247010866	38.3289467625163	0.0161778436401315	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2366.81830317671	2366.81830317671
"healthy-2"	"2019-08-01-count-2:GTCTCACGTGCGGCTT"	-2.15124855461772	13.1624469527039	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACGTGCGGCTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1786.65714448513	40.005255967089	0.0223911208093692	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1782.56006191071	1782.56006191071
"healthy-2"	"2019-08-01-count-4:AGGGTGATCAACGCTA"	-5.14153466644939	-5.50189354335936	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTGATCAACGCTA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2710.37125886678	40.7016575002996	0.0150170045402994	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2706.66904603634	2706.66904603634
"healthy-2"	"2019-08-01-count-3:ACGTCCTCAGATAAAC"	2.19080009040181	-10.7062216035095	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTCAGATAAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.26958206423	40.3668571556856	0.0163476914180995	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2465.74732225471	2465.74732225471
"healthy-2"	"2019-08-01-count-4:AGGTAGGGTGTGTGGA"	2.10285582122151	-10.3550033799377	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTAGGGTGTGTGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.95995662175	41.3298112672758	0.0172354051005511	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2393.45757381938	2393.45757381938
"healthy-2"	"2019-08-01-count-2:CTTCAATAGTAGGATT"	2.26395167884175	-10.5768308869568	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATAGTAGGATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.21487798593	41.7091377763292	0.0176867418510868	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.29902544275	2353.29902544275
"healthy-2"	"2019-08-01-count-3:ATCACGATCCATAAGC"	2.09088816222493	-10.5284681550232	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGATCCATAAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.50091274864	38.7660016205894	0.0163328361966781	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2364.13914759328	2364.13914759328
"healthy-2"	"2019-08-01-count-3:GATTCTTGTCTGTTAG"	2.24213900145833	-10.5984163514343	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTGTCTGTTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.11092093553	37.9022280656886	0.0149686286458909	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2530.2743619253	2530.2743619253
"healthy-2"	"2019-08-01-count-4:GATCAGTCAGACCTAT"	6.97375454482381	-1.11482372200163	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCAGTCAGACCTAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2216.92384228116	42.3301188399858	0.0190940789361664	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2206.5534428283	2206.5534428283
"healthy-2"	"2019-08-01-count-3:AGGGAGTCAGTGCGCT"	3.11004533347432	-10.8574514619079	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTCAGTGCGCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2269.02221062711	41.1352441390771	0.0181290619132847	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2265.91312751418	2265.91312751418
"healthy-2"	"2019-08-01-count-2:ACATCCCAGAGCCCAA"	3.07624759253804	-10.918932937738	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGAGCCCAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.25029223688	39.3043055464384	0.0160803112804248	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2436.95292254242	2436.95292254242
"healthy-2"	"2019-08-01-count-2:CCAATGATCGCCACTT"	-2.85110888901408	3.27756497943727	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGATCGCCACTT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3204.33244073412	44.4286916223325	0.0138651942156644	5739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3198.88507248011	3198.88507248011
"healthy-2"	"2019-08-01-count-2:TATGTTCGTAGGACCA"	2.49625029143636	-10.9446554414001	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATGTTCGTAGGACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.20647570917	43.1589160932485	0.0186414976573649	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2314.24208893151	2314.24208893151
"healthy-2"	"2019-08-01-count-4:TTTGGTTCATGTGACT"	6.77596821364705	-0.893626951333605	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTCATGTGACT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1968.55387838404	45.6147165225018	0.0231716881226265	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1952.42004229899	1952.42004229899
"healthy-2"	"2019-08-01-count-4:AACGGGAAGGTCTTTG"	3.11779489096944	-10.9485483399597	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGGGAAGGTCTTTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.96526814477	39.6925090100197	0.0179363452203187	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2207.91939438137	2207.91939438137
"healthy-2"	"2019-08-01-count-4:GTTAGTGAGTGACACG"	1.58967532691304	-9.58385183727416	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGAGTGACACG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2400.66847451743	41.7213543969602	0.0173790570584082	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2398.00990409576	2398.00990409576
"healthy-2"	"2019-08-01-count-3:CAAGAGGCAAACAGGC"	2.90101685103719	-10.4909525147644	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGCAAACAGGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.11944932531	46.7078649252482	0.0216830431292367	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2151.48162470384	2151.48162470384
"healthy-2"	"2019-08-01-count-2:TTCCTCTAGGTTCACT"	7.68522276458089	6.33352325046388	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTCTAGGTTCACT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1480.46305194696	49.0329770804985	0.0331200275589554	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1477.91316948465	1477.91316948465
"healthy-2"	"2019-08-01-count-4:TTTACTGCAGCTGCCA"	8.27110828933064	8.21616742694703	"2019-08-01-count-4"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACTGCAGCTGCCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2006.51136152545	38.0795596832619	0.018977993553105	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2006.51136152545	2006.51136152545
"healthy-2"	"2019-08-01-count-4:TGTGTGAAGATGATTG"	2.71065916594807	-10.9903822175232	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGTGAAGATGATTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.55797034491	43.0220644162837	0.0195683102272415	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2194.45684058331	2194.45684058331
"healthy-2"	"2019-08-01-count-2:TCCGTGTTCCCAGCGA"	1.95862903174703	-5.25697233593138	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGTGTTCCCAGCGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2152.47462442015	41.9087212024722	0.0194700187063817	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2148.07282051626	2148.07282051626
"healthy-2"	"2019-08-01-count-3:CAAAGAATCATCGGGC"	2.32156481322591	-10.8511314622131	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAAGAATCATCGGGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.03823513963	41.6370053875481	0.0170083149804942	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2443.37734454552	2443.37734454552
"healthy-2"	"2019-08-01-count-4:ATTTCACAGGTCGTGA"	1.79047634181325	-4.96289493953856	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACAGGTCGTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2505.34116718688	39.5193702490005	0.0157740473699136	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2500.72875954748	2500.72875954748
"healthy-2"	"2019-08-01-count-4:TGTCCCAAGCGATGCA"	-2.55640898171123	13.1192426451477	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCAAGCGATGCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1740.49847924172	44.1241315547913	0.0253514335582843	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1736.49763930199	1736.49763930199
"healthy-2"	"2019-08-01-count-2:TTGATGGTCAACTACG"	-4.35026917877849	3.58645055377809	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGTCAACTACG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2851.65404676847	38.8973119688074	0.0136402632755843	3970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2845.61653324072	2845.61653324072
"healthy-2"	"2019-08-01-count-4:CAGTGCGAGATTGAGT"	-7.46182046356853	3.21780178630678	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_MEP"	47	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTGCGAGATTGAGT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2108.17047055072	44.259456403487	0.0209942492894918	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2103.4727394897	2103.4727394897
"healthy-2"	"2019-08-01-count-4:TACTTGTAGGCATCAG"	1.83114435252492	-5.27292969143065	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTAGGCATCAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2348.35756022346	36.1930485349669	0.0154120689063734	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2342.89028330817	2342.89028330817
"healthy-2"	"2019-08-01-count-3:CACGGGTTCCGCACTT"	4.36551966246907	-10.0122385255066	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	81	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGGGTTCCGCACTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1885.23177536546	48.1126472460429	0.0255208128118443	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1885.23177536546	1885.23177536546
"healthy-2"	"2019-08-01-count-4:CTGCTCATCTGTCGCT"	3.11278118666951	-10.8854332200256	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCATCTGTCGCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.91722377478	37.7954833367614	0.0156249593682998	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2410.27377657351	2410.27377657351
"healthy-2"	"2019-08-01-count-2:TGCCGAGAGTACCATC"	1.52685584601704	10.6571702727112	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGAGTACCATC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.65612582225	38.2078615489021	0.021887392931357	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1738.22364534463	1738.22364534463
"healthy-2"	"2019-08-01-count-2:GGGACCTGTTGGGACA"	2.36400618132893	-10.8329677811828	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTGTTGGGACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.81405048999	35.7786782733522	0.016002528593785	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2229.8363693394	2229.8363693394
"healthy-2"	"2019-08-01-count-2:TTCCACGTCTTTCCAA"	1.79941787299458	-10.1019687882629	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCACGTCTTTCCAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.05904552713	42.6348986232917	0.0166864631554907	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2553.2902903115	2553.2902903115
"healthy-2"	"2019-08-01-count-2:TGCCGAGGTCCTATAG"	2.32015790519063	-10.8450584641662	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGGTCCTATAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.35591644586	39.304625058204	0.0162660743769966	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2411.13574320663	2411.13574320663
"healthy-2"	"2019-08-01-count-2:TAGGTTGGTACGTGAG"	2.20448197898213	-10.6321993104187	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGGTACGTGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.00708699507	37.0829389666929	0.0148927041856112	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2484.54555000256	2484.54555000256
"healthy-2"	"2019-08-01-count-4:TTTCACAAGCGATTCT"	3.45445599135701	-10.5011530152527	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCACAAGCGATTCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.39635965229	37.6206756669848	0.0155496124134003	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2410.34659294748	2410.34659294748
"healthy-2"	"2019-08-01-count-3:ACTCTCGGTGCAATAA"	3.08571519431416	-10.8093862763611	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCTCGGTGCAATAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.15290110279	41.5582425233587	0.0182420778268401	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2273.40713395825	2273.40713395825
"healthy-2"	"2019-08-01-count-3:CAACCAATCTGTCGTC"	4.36651100692098	-10.7353840104309	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAATCTGTCGTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.69985936477	38.4211767128984	0.0158522832620736	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2417.63232308956	2417.63232308956
"healthy-2"	"2019-08-01-count-2:TAGGTTGTCGCCTTTG"	1.54818882521932	-9.36160185253295	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGTCGCCTTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.82117246882	42.7192109829942	0.0179054538856275	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.09416624476	2380.09416624476
"healthy-2"	"2019-08-01-count-2:CTAACTTGTTCGAACT"	2.74182714995686	-11.0871401063171	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTGTTCGAACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.85764400922	38.8467676693938	0.016106575678662	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2405.18526693249	2405.18526693249
"healthy-2"	"2019-08-01-count-4:AACACACCATGCGGTC"	1.7673223215038	-10.2307234040466	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACCATGCGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.39714549963	40.2777609721489	0.015823762921775	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2535.45078572055	2535.45078572055
"healthy-2"	"2019-08-01-count-2:TTCCGGTGTACCCACG"	-2.77461491051372	3.47089169109193	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTGTACCCACG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3091.73901102779	43.1904052816786	0.0139696155230518	5542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3088.13054231673	3088.13054231673
"healthy-2"	"2019-08-01-count-2:AGGCATTTCACGTAGT"	1.8499342399532	-4.89258911525878	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTTCACGTAGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2399.05120779358	41.3819592408414	0.0172493021851337	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2393.95879642626	2393.95879642626
"healthy-2"	"2019-08-01-count-2:TCGTCCATCTGGCCTT"	2.405116935342	-10.4361820450989	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCATCTGGCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.61208618063	38.726868427848	0.0167749569794195	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2303.19351703023	2303.19351703023
"healthy-2"	"2019-08-01-count-4:GTACAGTAGCAGCACA"	9.82351173934285	5.0509199866089	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAGTAGCAGCACA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1719.49974381683	34.0640961542768	0.0198104688743155	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1717.54106673029	1717.54106673029
"healthy-2"	"2019-08-01-count-2:CCTTTGGAGAGTGTTA"	2.82482900199239	-10.9893656007019	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGAGAGTGTTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.22104666126	43.2709283239545	0.0186816920545333	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.22753750261	2308.22753750261
"healthy-2"	"2019-08-01-count-2:TGGTTAGAGTACGTCT"	2.50006093558614	-10.8909216157165	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGAGTACGTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.45945816588	42.7728350591205	0.0185528463350852	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.48247738575	2301.48247738575
"healthy-2"	"2019-08-01-count-4:CACGTGGCAAAGGGCT"	3.00730385360066	-10.8688698044983	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGCAAAGGGCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.45710865452	41.5909957317016	0.017508628373113	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2373.84299001938	2373.84299001938
"healthy-2"	"2019-08-01-count-3:CTGCATCTCCCTGGTT"	4.38691439208333	-10.7156887284485	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCATCTCCCTGGTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.66900739912	40.448287770481	0.0160148806720061	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2521.72684209012	2521.72684209012
"healthy-2"	"2019-08-01-count-2:CTAGACAAGAACCCGA"	2.87052835997884	-11.0894861451355	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACAAGAACCCGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.53156700573	40.0020451725553	0.0158516127539547	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2518.1206740878	2518.1206740878
"healthy-2"	"2019-08-01-count-2:ATTCATCAGTATTAGG"	6.97595562514607	-1.10852112686308	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCAGTATTAGG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1944.59292478263	45.3767504522204	0.0233348326397375	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1936.11114699175	1936.11114699175
"healthy-2"	"2019-08-01-count-2:ATACTTCAGTCACACT"	2.48572744902913	-10.8167467347351	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACTTCAGTCACACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.80470903477	40.7460163138986	0.0167554640232897	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2428.02878505107	2428.02878505107
"healthy-2"	"2019-08-01-count-4:GTCATTTCAGGAATCG"	-2.12157617035564	12.8143062361511	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATTTCAGGAATCG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1785.17018633019	41.9609005848001	0.0235052662799954	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1781.1985276898	1781.1985276898
"healthy-2"	"2019-08-01-count-2:CCGATCTGTAGAATAC"	2.4032687145168	-10.837483429071	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATCTGTAGAATAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.2108203002	42.8145338849074	0.0188925644081232	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2262.72311361728	2262.72311361728
"healthy-2"	"2019-08-01-count-3:TGGGAGAGTACCCACG"	2.90854491767232	-10.8688860169617	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAGAGTACCCACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.14176131133	40.4486239288906	0.0172404858887481	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.78493139149	2341.78493139149
"healthy-2"	"2019-08-01-count-2:AACTTCTCATGCGGTC"	1.6114967065746	-4.73811914837035	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTCATGCGGTC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2339.75592851196	40.0134751332848	0.0171015594599786	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2336.10098594547	2336.10098594547
"healthy-2"	"2019-08-01-count-3:CAATTTCTCCGAAATC"	4.61901249465291	-10.7689657441345	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATTTCTCCGAAATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.23952214174	43.0120588843365	0.0183011384495569	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.52153752083	2341.52153752083
"healthy-2"	"2019-08-01-count-4:TTCCTCTTCGCGCTGA"	3.09931339797322	-10.8595962754455	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTTCGCGCTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.18821515044	39.1012937249647	0.0166375158691116	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.57666994578	2342.57666994578
"healthy-2"	"2019-08-01-count-2:CTGTATTGTGTATTGC"	-1.24992821636851	12.4238528975281	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTATTGTGTATTGC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1871.69546878721	34.7727340655423	0.0185782006984682	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1868.22351756083	1868.22351756083
"healthy-2"	"2019-08-01-count-3:TTACGCCGTAAGATTG"	2.71759428557698	-10.7283983460632	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGCCGTAAGATTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.53442043339	38.8723523949264	0.0173109581582027	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2242.78600209035	2242.78600209035
"healthy-2"	"2019-08-01-count-2:AGCGTATGTTCCATTT"	2.82281436499898	-10.9615469208923	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATGTTCCATTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.06088004068	38.2057859642266	0.016596340390247	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2295.11928142088	2295.11928142088
"healthy-2"	"2019-08-01-count-3:CCATCACCAATGGGTG"	2.29032339629475	-10.458561920282	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACCAATGGGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.33819335672	38.0158853252507	0.0167667467679223	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2259.41585094885	2259.41585094885
"healthy-2"	"2019-08-01-count-3:CACACAAAGGGCCTCT"	1.36579241332356	-9.28402140056761	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACACAAAGGGCCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.55382355745	45.8537355826831	0.0189827008346902	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2413.81081633345	2413.81081633345
"healthy-2"	"2019-08-01-count-2:CCTAACCTCGATCCCT"	2.40018000182454	-10.949998878595	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCTCGATCCCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.12836889474	41.6396873767196	0.0177633989372147	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2340.26999891711	2340.26999891711
"healthy-2"	"2019-08-01-count-3:CAAGACTGTCTTGTCC"	2.79458918151204	-11.1454134217468	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTGTCTTGTCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.30154692161	38.8032177401743	0.0153901534655985	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2516.49127549702	2516.49127549702
"healthy-2"	"2019-08-01-count-4:ATGTCTTTCGGTAGGA"	3.110776801675	-10.9548750153747	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCTTTCGGTAGGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.99748715895	42.9621050631522	0.0193001588326071	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2221.27252471784	2221.27252471784
"healthy-2"	"2019-08-01-count-3:GACTATGAGTGCACAG"	3.15667452391927	-10.7572508088318	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGAGTGCACAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2547.83178455647	39.5955341350865	0.0155408745487408	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2542.4594823192	2542.4594823192
"healthy-2"	"2019-08-01-count-2:CGTCCATAGATTCGAA"	1.69705988940541	-9.51337816631468	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCCATAGATTCGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.81281664866	43.8813722478595	0.0189978044677783	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2305.80116045019	2305.80116045019
"healthy-2"	"2019-08-01-count-2:ACATGCAGTTTCCCAC"	4.1923471885616	-10.7347536317078	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCAGTTTCCCAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.14565162989	38.2899448339886	0.0156021484741783	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2448.12791887049	2448.12791887049
"healthy-2"	"2019-08-01-count-4:CCAATGACATGTGCCG"	1.70677794989888	-9.64145758068236	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGACATGTGCCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.21339627438	43.6155866040698	0.0197069052073742	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2209.06215161155	2209.06215161155
"healthy-2"	"2019-08-01-count-3:GGTCACGTCAAGAAAC"	3.19897450980489	-10.8505258790222	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCACGTCAAGAAAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.90548549143	46.8945693706552	0.0198882311692326	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2355.10387270575	2355.10387270575
"healthy-2"	"2019-08-01-count-2:GAAATGACAGTTTCGA"	2.56346621093099	-10.5503702393738	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGACAGTTTCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.55725523643	37.6020638009641	0.0156053829886165	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2404.88357522188	2404.88357522188
"healthy-2"	"2019-08-01-count-4:GATTGGTTCATACGAC"	2.58978714522664	-11.0151415101257	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTTCATACGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.6927253924	39.5107634621551	0.0159144798943696	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2477.95895868074	2477.95895868074
"healthy-2"	"2019-08-01-count-4:AACCCAACAATCGCGC"	2.19564523276631	-10.388529800531	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAACAATCGCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.6811857215	39.2202373836245	0.0173565357942748	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.56358875647	2256.56358875647
"healthy-2"	"2019-08-01-count-2:TCGAAGTGTGTGGTCC"	1.61993302878682	-9.24082090770873	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTGTGTGGTCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2239.97824046792	40.3356385581894	0.0180071564220925	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2234.92691109555	2234.92691109555
"healthy-2"	"2019-08-01-count-4:CCAATTTGTCATCGCG"	3.01538481292073	-11.0048246613708	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTGTCATCGCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.56309212635	36.4826596963588	0.0155406514179408	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2341.96259774564	2341.96259774564
"healthy-2"	"2019-08-01-count-3:CGTTGGGCAGACCCGT"	-4.66109691086467	-5.36991646206053	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTGGGCAGACCCGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2757.39306144109	44.4670836197682	0.0161264943477186	2750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2753.09140759984	2753.09140759984
"healthy-2"	"2019-08-01-count-3:AAGACTCAGTGCAGGT"	1.65734698352162	-9.73264982616576	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCAGTGCAGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.28637495398	42.7296489557339	0.0187798992804139	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2270.34365861712	2270.34365861712
"healthy-2"	"2019-08-01-count-4:CAAGAGGCAAGTACCT"	3.11907186087911	-10.5072298279968	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGAGGCAAGTACCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.08127151048	42.8312630678261	0.0187274775065333	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2284.06902391313	2284.06902391313
"healthy-2"	"2019-08-01-count-3:AGCCACGCAATAGTAG"	3.60057725486104	-10.7663040391174	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGCAATAGTAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.83514290112	42.5391607966497	0.0179275669124825	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2362.6634186033	2362.6634186033
"healthy-2"	"2019-08-01-count-3:GAAATGACAGGACTAG"	1.95846023139302	-10.4551172486511	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAATGACAGGACTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.85980770867	44.4255085276326	0.0207125465114161	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2143.70934900756	2143.70934900756
"healthy-2"	"2019-08-01-count-4:TTTGGAGCACGACGCT"	1.42693390425984	-9.09450151836547	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGAGCACGACGCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2465.79158510174	44.8182492214772	0.018176008666859	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2461.52568160171	2461.52568160171
"healthy-2"	"2019-08-01-count-3:TTAGTCTGTTCAGGTT"	2.3089095550472	-10.8669471970764	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGTCTGTTCAGGTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.56952234733	37.8029656749563	0.0163185111909145	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2310.40549721728	2310.40549721728
"healthy-2"	"2019-08-01-count-4:GTATTGGAGCCTAGGA"	1.94109608706776	-10.5198469392029	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTGGAGCCTAGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.0935778535	43.2697884499621	0.0188203685429629	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.87650379235	2292.87650379235
"healthy-2"	"2019-08-01-count-4:GAATCACTCCTGGGTG"	3.0132905441219	-11.0157566300598	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACTCCTGGGTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.71654991998	38.9054785559237	0.0169028104513026	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.95512821221	2294.95512821221
"healthy-2"	"2019-08-01-count-3:AAGACTCTCGGAATGG"	2.86832108077351	-10.8447818986145	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCTCGGAATGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.54621814673	43.3728157290489	0.0188861061825483	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2290.76141590353	2290.76141590353
"healthy-2"	"2019-08-01-count-4:AACCTTTAGTGTTGTC"	1.70376720008199	-9.78160383617552	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTAGTGTTGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.16032141268	48.9351851172915	0.0221711058515092	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2202.15803199117	2202.15803199117
"healthy-2"	"2019-08-01-count-4:GGTCTGGAGTCGAAAT"	2.33542336997334	-10.9158115617004	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCTGGAGTCGAAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.94207813631	42.5789930794052	0.0165680749934578	2439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2564.90305153954	2564.90305153954
"healthy-2"	"2019-08-01-count-2:CATCCACGTCGTTGGC"	0.96891220387761	9.38941571796266	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACGTCGTTGGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1605.74008825467	37.0391097108084	0.0230666905445871	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1595.95551588228	1595.95551588228
"healthy-2"	"2019-08-01-count-3:GATTCTTGTCTACATG"	1.6770416694576	-9.85162260448607	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTGTCTACATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.8832485094	40.0338702959521	0.016085073624859	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2484.77724947471	2484.77724947471
"healthy-2"	"2019-08-01-count-2:TGTTCCGTCAGGACGA"	2.45910110053365	-10.7268867722717	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCCGTCAGGACGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.95761059845	40.3872862588757	0.0163580314564762	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2463.10852926526	2463.10852926526
"healthy-2"	"2019-08-01-count-2:ACCACAACAGAACTAA"	1.82161655005757	-9.53515245830687	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAACAGAACTAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.06850009713	48.0817326344917	0.020329953501354	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.8687800957	2361.8687800957
"healthy-2"	"2019-08-01-count-2:GCACGTGAGCATTGAA"	-7.25671945038493	-1.31235029613646	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGTGAGCATTGAA"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3304.53452449574	44.6360406527911	0.0135075122750011	5186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3294.66530135134	3294.66530135134
"healthy-2"	"2019-08-01-count-4:ATCGGATAGTATTCCG"	2.05531706389729	-10.5770387879578	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATAGTATTCCG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.25245540315	42.9185394071487	0.0172901589093919	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2475.28092521266	2475.28092521266
"healthy-2"	"2019-08-01-count-2:CGTTCTGTCTCCCTAG"	-4.51986203613933	-5.35280897533568	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTCTGTCTCCCTAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2722.45537482826	40.5429807282147	0.0148920643853611	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2718.69181225778	2718.69181225778
"healthy-2"	"2019-08-01-count-4:TCCACGTAGAATCGTA"	-3.79628930512126	-5.54184152996215	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTAGAATCGTA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2431.01627200344	39.6417444687694	0.0163066553380574	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2427.04064588514	2427.04064588514
"healthy-2"	"2019-08-01-count-4:TTCCACGCAGCGGTTC"	4.43947996672933	-10.790704750177	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGCAGCGGTTC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.96605364144	42.6963752429377	0.017413118415538	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2446.5012003296	2446.5012003296
"healthy-2"	"2019-08-01-count-3:GCGTTTCGTACAGAAT"	-2.81020651283916	13.2456807860169	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTTTCGTACAGAAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1829.69277373818	41.1713943982231	0.0225018074013088	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1823.55555484825	1823.55555484825
"healthy-2"	"2019-08-01-count-4:GAGTCATCACCGGTCA"	2.63532723960225	-10.3885011903015	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCATCACCGGTCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.96281326885	41.1594633060206	0.0172145978505407	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2383.22476110941	2383.22476110941
"healthy-2"	"2019-08-01-count-3:ACTATCTCAGTAACGG"	-0.141969854862052	9.40004060352174	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATCTCAGTAACGG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2112.60907230624	35.8073730140968	0.0169493606192875	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2103.12373051091	2103.12373051091
"healthy-2"	"2019-08-01-count-3:CATACCCCATGGAACG"	-7.34693513336833	3.94614503467409	"2019-08-01-count-3"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCCATGGAACG"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2371.17028772527	39.4251974009834	0.0166268941564737	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2361.97136917623	2361.97136917623
"healthy-2"	"2019-08-01-count-2:TCGCAGGCACACCTTC"	-1.85185692730601	13.2374582060608	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCAGGCACACCTTC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2258.04300690487	46.126573777226	0.0204276772568882	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2246.01109850703	2246.01109850703
"healthy-2"	"2019-08-01-count-2:GAAGCCCTCCAAAGGG"	2.84193219718282	-10.9640932313171	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCCCTCCAAAGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.26201838552	47.8316550825699	0.0228175937278148	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2083.04368364675	2083.04368364675
"healthy-2"	"2019-08-01-count-4:GTTGCGGCATCAGCAT"	3.39544643935506	-10.5705776444641	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGCATCAGCAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.83422805296	44.9948727067513	0.0169546659060776	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2647.51105466431	2647.51105466431
"healthy-2"	"2019-08-01-count-4:CCTAACCTCACATCAG"	3.02339996871297	-11.0500707856384	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCTCACATCAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.14105769157	34.4362626005746	0.0146093346803348	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.36443224808	2353.36443224808
"healthy-2"	"2019-08-01-count-3:AGGACTTTCTCCGATC"	4.30023636397664	-10.3718147507873	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACTTTCTCCGATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.18276399848	41.5166643114652	0.0174353119546987	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.26369597426	2377.26369597426
"healthy-2"	"2019-08-01-count-4:CCTAAGACAGTATGAA"	4.45945038375203	-10.7727623215881	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAAGACAGTATGAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.97052146175	41.8928390589253	0.0164481051923924	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2537.39754275306	2537.39754275306
"healthy-2"	"2019-08-01-count-4:ACCTGTCCAAACTGCT"	-6.19004283371623	3.62796542728273	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGTCCAAACTGCT"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2599.63481631974	38.7787012175176	0.0149169802520248	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2590.52324792243	2590.52324792243
"healthy-2"	"2019-08-01-count-2:ATAGAGATCTCATTGT"	2.05213346061055	-10.046937965509	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGATCTCATTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.50366366761	40.551575399268	0.0173630964618514	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2331.61591840826	2331.61591840826
"healthy-2"	"2019-08-01-count-2:CGATCGGGTATCCTCC"	2.45648135718648	-10.7127981415954	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGGTATCCTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.64392412531	37.1740080073356	0.0147771342560975	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2509.65698963067	2509.65698963067
"healthy-2"	"2019-08-01-count-4:TCGTAGACACGGTCTG"	3.2601453262264	-10.9424152604309	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGACACGGTCTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.99165491234	39.6902483310588	0.0167399359035391	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2365.11861643843	2365.11861643843
"healthy-2"	"2019-08-01-count-2:TCAGTCCCAGACAAAT"	2.64804400977437	-10.405902885553	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTCCCAGACAAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.77926621488	47.503948455693	0.0238500065049719	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1983.58952348235	1983.58952348235
"healthy-2"	"2019-08-01-count-4:GCAGCCATCGGCACTG"	-4.95237145844157	-5.07858803188475	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCATCGGCACTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2395.0603893241	46.0952188459243	0.0192459526496251	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2393.72471400293	2393.72471400293
"healthy-2"	"2019-08-01-count-2:AGACCCGAGTAGATCA"	3.33815803107564	-10.6307478181091	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGAGTAGATCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.11236911069	38.8412076558215	0.0170797222614864	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.84567513174	2265.84567513174
"healthy-2"	"2019-08-01-count-4:TGCGACGCATGACAAA"	1.18966784056966	-8.99394705211791	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGACGCATGACAAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2269.02179657866	32.0651872730039	0.014131722895458	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2265.44327118695	2265.44327118695
"healthy-2"	"2019-08-01-count-4:TACGGTAAGCCTTTGA"	2.71210946616475	-10.8872165909973	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGTAAGCCTTTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.11526845752	38.7070613282801	0.0159806850781837	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2419.57647203571	2419.57647203571
"healthy-2"	"2019-08-01-count-3:AGTAGCTAGAATCCCT"	2.90789045867268	-10.8879995576111	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGCTAGAATCCCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.13680013333	40.2491495966021	0.0171628152329168	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2337.582068674	2337.582068674
"healthy-2"	"2019-08-01-count-2:ATTCTTGGTCTCAGAT"	3.03802694854085	-10.5795727006164	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGGTCTCAGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.5878513819	37.208476753075	0.0157025099244055	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2365.86616541714	2365.86616541714
"healthy-2"	"2019-08-01-count-3:CGGGTGTAGCTTTCCC"	2.50862803038899	-10.8072843781677	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTAGCTTTCCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.53160484972	36.9839385259493	0.0163318270527753	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2260.33707340978	2260.33707340978
"healthy-2"	"2019-08-01-count-4:ATACCTTTCTGGCCTT"	1.78800215300862	-4.75204470073851	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTTCTGGCCTT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2515.9789935793	37.7477742009748	0.0150032151688491	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2511.13045880698	2511.13045880698
"healthy-2"	"2019-08-01-count-2:ATTCTTGGTCATACCA"	8.42298092421834	7.37088248813478	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGGTCATACCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1770.82175783982	36.8217811246987	0.0207936123224602	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1768.99679209519	1768.99679209519
"healthy-2"	"2019-08-01-count-4:CACACAACAATACCCA"	-1.80782924118693	13.1834935911926	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAACAATACCCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1801.76958895684	40.765531162372	0.0226252742926879	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1795.55841996412	1795.55841996412
"healthy-2"	"2019-08-01-count-2:ATTGGGTCACAAACGG"	7.97206081923787	6.76934526050416	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTCACAAACGG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1679.23696560849	37.5800080601509	0.0223792167691672	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1665.44299763288	1665.44299763288
"healthy-2"	"2019-08-01-count-4:CCCAACTCAGACCATT"	1.20682837542836	11.1534280546936	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTCAGACCATT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2046.19283012581	38.4131934537923	0.0187730075524849	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2039.61664072162	2039.61664072162
"healthy-2"	"2019-08-01-count-2:CCAATGACAACACGAG"	11.2282864051754	4.13454196536867	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGACAACACGAG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.29091758996	38.2259756377735	0.0203190135456259	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1867.33313446116	1867.33313446116
"healthy-2"	"2019-08-01-count-2:CCAATGAGTGCTGCAC"	2.12877668914143	-10.3484812012878	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGAGTGCTGCAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.59720071914	44.7647804163837	0.0177878209526704	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2510.42592010228	2510.42592010228
"healthy-2"	"2019-08-01-count-3:CGAGTTAAGAGACAAG"	3.03008212622945	-10.923143409845	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTTAAGAGACAAG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.01078494181	43.9721767727557	0.0196918783685595	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2228.06342825859	2228.06342825859
"healthy-2"	"2019-08-01-count-3:TAGGTTGTCTAGACAC"	8.1729961830074	7.12557981098024	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGTCTAGACAC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.66174729005	38.3882144331535	0.0206204024383236	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1854.52954908228	1854.52954908228
"healthy-2"	"2019-08-01-count-3:CTGTACCCAGCACAAG"	4.47454609450643	-10.7214670411316	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCCAGCACAAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.04771754207	42.3887725004863	0.0177652660459582	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2381.31444392087	2381.31444392087
"healthy-2"	"2019-08-01-count-3:TCCTTCTCACTGTTCC"	7.96634020385091	8.02375028217164	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTCACTGTTCC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.13596726738	43.2640885966371	0.0212690249289271	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2025.73534280123	2025.73534280123
"healthy-2"	"2019-08-01-count-1:TATTGCTAGTATGCAA"	7.55832590636556	6.79675290668336	"2019-08-01-count-1"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TATTGCTAGTATGCAA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1804.24099446033	42.0394695701773	0.023300362700578	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1797.14152938285	1797.14152938285
"healthy-2"	"2019-08-01-count-3:CTCTCGATCCCTTCCC"	3.56968583640401	-10.8557768098083	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCGATCCCTTCCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.56806549987	41.3202078861749	0.0177068792194514	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2326.30005734392	2326.30005734392
"healthy-2"	"2019-08-01-count-4:ACACAGTCAAGTAGTA"	-7.24137340012248	1.8773531683716	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTCAAGTAGTA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2420.49818862197	41.210717996261	0.017025717346115	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2412.94107368424	2412.94107368424
"healthy-2"	"2019-08-01-count-4:GCACATATCACGGAGA"	3.30069365081136	-10.8124609223572	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACATATCACGGAGA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.99336852967	38.2497269883672	0.0175056490052902	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2180.56283961522	2180.56283961522
"healthy-2"	"2019-08-01-count-3:CATGGTAGTCCTCATC"	-1.98457394066508	13.5439271696839	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTAGTCCTCATC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1924.27181480139	42.5314811584561	0.0221026368682981	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1918.4803861554	1918.4803861554
"healthy-2"	"2019-08-01-count-3:ACGGGTCAGTGCACTT"	-8.34737620773967	0.345124132278837	"2019-08-01-count-3"	"Control2"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGGTCAGTGCACTT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2786.08720177595	40.3472790522463	0.0144817000079996	3321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2775.97478887627	2775.97478887627
"healthy-2"	"2019-08-01-count-4:AATAGAGTCCCACAGG"	4.46940388259236	-10.7885847321716	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGTCCCACAGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.78015778244	42.4781894118015	0.0180698264238679	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.70103822689	2344.70103822689
"healthy-2"	"2019-08-01-count-3:CCTACGTGTTCTCTCG"	3.24078621444051	-10.9491434327331	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTGTTCTCTCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.59694378517	42.7580020194474	0.0180749312057492	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2362.52073306742	2362.52073306742
"healthy-2"	"2019-08-01-count-2:TCACACCGTATCAAGA"	4.46395029601399	-10.6009750596252	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTATCAAGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.42579534173	45.8423072269714	0.0188308500980767	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2429.45163904455	2429.45163904455
"healthy-2"	"2019-08-01-count-2:GCACTAACACCCATAA"	3.52534761008565	-10.4461307755676	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAACACCCATAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.69606973806	48.480000939775	0.0202025587953173	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2396.3857627305	2396.3857627305
"healthy-2"	"2019-08-01-count-3:GGAGATGAGAGAGCCT"	1.1927122074062	9.07847783649293	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGAGAGAGCCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1649.86761728463	32.6052767464762	0.0197623593583456	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1640.52163993424	1640.52163993424
"healthy-2"	"2019-08-01-count-3:TTCCTTCCAGGAATAT"	-2.39879904213603	12.2798175581726	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCCAGGAATAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1903.22565251489	41.6170758753437	0.0218666009573546	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1892.70348567153	1892.70348567153
"healthy-2"	"2019-08-01-count-2:TCGGGTGAGAAACACT"	-2.62246547165568	13.3293676146301	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGAGAAACACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1673.67809007411	43.9895059508867	0.0262831342608655	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1669.41143443231	1669.41143443231
"healthy-2"	"2019-08-01-count-2:CTGAGCGTCTTCGCTG"	-2.88446460190471	3.39892361247865	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGCGTCTTCGCTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2998.29380187245	39.5571858162376	0.0131932320280067	4411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2996.09790635274	2996.09790635274
"healthy-2"	"2019-08-01-count-2:GTGTGATGTATCAGCT"	-5.09571633759196	-5.59361269390257	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGATGTATCAGCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1809.44509273751	39.4426006361535	0.0217981749180799	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	1807.65741383497	1807.65741383497
"healthy-2"	"2019-08-01-count-4:ACACGCGCAGCCGTTG"	2.27519955214803	-10.7464723817078	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACGCGCAGCCGTTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.06502459821	40.7037301925663	0.0172834846458265	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2352.10609782888	2352.10609782888
"healthy-2"	"2019-08-01-count-4:TTTAGTCCACTGTGAT"	-7.66542706909831	2.18282840335695	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTAGTCCACTGTGAT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2489.03500636344	42.9048682806328	0.0172375511677991	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2483.71637787703	2483.71637787703
"healthy-2"	"2019-08-01-count-3:AATCGTGCAATCCTTT"	2.80962051925008	-10.7938127747742	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGTGCAATCCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.24713474383	48.50493450722	0.0225998831737564	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2139.04527621674	2139.04527621674
"healthy-2"	"2019-08-01-count-2:CTCAGAATCCGTAGTA"	1.82359840449635	-9.57308390056761	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAATCCGTAGTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.01504261719	37.7699764334362	0.0175346855459025	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2150.07724846172	2150.07724846172
"healthy-2"	"2019-08-01-count-3:GACCAATGTATGATCC"	-0.26553306999858	10.214551902655	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATGTATGATCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1782.43318239724	44.463824148816	0.024945576971932	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1776.72389971839	1776.72389971839
"healthy-2"	"2019-08-01-count-2:CTCAGGGGTTCAGCGC"	4.56490196761434	-10.4788274995056	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGGGGTTCAGCGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.566010721	43.3051430110808	0.0180470730197036	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2395.71311000956	2395.71311000956
"healthy-2"	"2019-08-01-count-3:TTCGGTCGTTTCCCAC"	-3.92190227928813	-5.29105379497679	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGGTCGTTTCCCAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2560.3672459892	42.9752581623444	0.0167848023480479	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2552.31725895293	2552.31725895293
"healthy-2"	"2019-08-01-count-3:CCGTGAGGTATGCGTT"	-2.20032248917277	13.5499162443909	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTGAGGTATGCGTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1760.78582467129	41.5051215282882	0.0235719307520189	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1760.78582467129	1760.78582467129
"healthy-2"	"2019-08-01-count-3:CACGTTCCATTCTTCA"	-3.47246227684672	3.68335840785829	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTTCCATTCTTCA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3280.82513624955	47.6112114007613	0.0145119625165966	5480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3277.62335313677	3277.62335313677
"healthy-2"	"2019-08-01-count-2:CTCAGTCCAAACGTGG"	2.27811946448628	-10.5023298493591	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCCAAACGTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.07063561959	39.1843619072163	0.0157047104590231	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2493.14927641608	2493.14927641608
"healthy-2"	"2019-08-01-count-3:TCATTGTCAGTTAGGG"	4.37699045714681	-10.8901443711487	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTCAGTTAGGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.61383085302	42.4220614724172	0.0174245545370757	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2432.5579557362	2432.5579557362
"healthy-2"	"2019-08-01-count-4:AAGTCGTTCCGCGAGT"	1.30876793441121	-9.00253012096556	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	51	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTCGTTCCGCGAGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2352.3942618427	41.5125372259401	0.0176469301508252	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2351.43177018219	2351.43177018219
"healthy-2"	"2019-08-01-count-3:GCGATCGGTCCACTTC"	3.21235837516133	-10.9037256470886	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGATCGGTCCACTTC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.04082490013	39.6963784697822	0.0179293796317296	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2207.70824959974	2207.70824959974
"healthy-2"	"2019-08-01-count-2:CCTTTGGCAATATCCG"	-0.373992989689666	10.9423465498718	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGCAATATCCG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1832.48483139165	47.1001370677625	0.0257028796423887	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1830.70794322241	1830.70794322241
"healthy-2"	"2019-08-01-count-3:GTAGATCGTTTCGTGA"	2.49482907828633	-10.7554121247497	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGATCGTTTCGTGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.28390685843	41.6326600608636	0.0180283853090636	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2306.54972389035	2306.54972389035
"healthy-2"	"2019-08-01-count-2:AAGTCGTAGAAACTAC"	2.79214968261067	-10.7717046967712	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTAGAAACTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.44228637071	39.9005908764117	0.0177616808223789	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2243.31141462324	2243.31141462324
"healthy-2"	"2019-08-01-count-3:ACCACAATCCAATGCA"	1.25617327269856	10.0203237303528	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAATCCAATGCA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.06813979422	35.2606638367802	0.019352000656113	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1814.28134673173	1814.28134673173
"healthy-2"	"2019-08-01-count-4:GATGAGGGTAGACTGG"	1.88796224173848	-9.54477407848509	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGGTAGACTGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.79072265034	43.7961722188001	0.0200734982343304	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2179.34776576991	2179.34776576991
"healthy-2"	"2019-08-01-count-2:TGCGACGTCACCGGGT"	2.11221303519551	-9.49692060863646	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGTCACCGGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.92588430227	44.0299077451669	0.02011484630929	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2184.80297358739	2184.80297358739
"healthy-2"	"2019-08-01-count-4:GAAATGATCAACGAGG"	-2.84304080429729	3.95176956737367	"2019-08-01-count-4"	"Control2"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAATGATCAACGAGG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3145.10850067337	43.6700522869256	0.0138850701899714	5774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3140.99209093322	3140.99209093322
"healthy-2"	"2019-08-01-count-3:TTGCCTGCACCGAATT"	3.28607525405232	-11.0026417008606	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGCACCGAATT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.14085541859	39.7682972841797	0.0165278342681486	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2402.69501225766	2402.69501225766
"healthy-2"	"2019-08-01-count-3:ACACCAACACCTGTCT"	1.78756382045094	-5.00390293514403	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAACACCTGTCT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2446.28220036941	41.2701585292034	0.0168705632256864	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2441.19119967769	2441.19119967769
"healthy-2"	"2019-08-01-count-3:CAGCACGTCCGCACTT"	2.3424343067104	-10.6319160691467	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCACGTCCGCACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.6919470404	44.6890121780973	0.0184688849474239	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2415.82547415579	2415.82547415579
"healthy-2"	"2019-08-01-count-2:TCCGATCGTAACCAGG"	2.45729388770406	-10.57972814953	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCGTAACCAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.96400418164	37.2719784206219	0.0163547903135951	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2272.35664384866	2272.35664384866
"healthy-2"	"2019-08-01-count-2:ACCACAACATTGCAAC"	10.5532127815181	4.4517464407715	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAACATTGCAAC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1983.92563544326	35.9530148662476	0.0181221585244624	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1980.55971466714	1980.55971466714
"healthy-2"	"2019-08-01-count-3:AGAACCTCAACTACGT"	1.91366543349568	-9.87913610851439	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTCAACTACGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.82825314273	41.0088363029121	0.0178779018205599	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.85882543292	2292.85882543292
"healthy-2"	"2019-08-01-count-4:ATCGGATCAAACTCTG"	2.45327844199483	-10.2502384415832	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATCAAACTCTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.23701392424	39.4715037880789	0.0171522983287884	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2294.49591071558	2294.49591071558
"healthy-2"	"2019-08-01-count-3:AGGAAATGTCAGACTT"	2.66475190696065	-10.6259145966736	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATGTCAGACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.69010957129	43.9043635851506	0.0184884602029512	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2374.69010957129	2374.69010957129
"healthy-2"	"2019-08-01-count-2:TCAGCAAGTACCGGAA"	-4.95591340485271	-5.3975515595642	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAAGTACCGGAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2789.00283788605	41.1845464664102	0.0147667639153879	2943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2786.27695049056	2786.27695049056
"healthy-2"	"2019-08-01-count-2:ATGTCTTCAGTAACGG"	4.17884935912434	-10.8459339371887	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCTTCAGTAACGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.542449362	48.3117481291027	0.0235260528186853	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2045.662415698	2045.662415698
"healthy-2"	"2019-08-01-count-2:TTCTAGTTCTGGAAGG"	3.68228163298909	-10.6299858323303	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTTCTGGAAGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.08280533097	41.7166468768977	0.017579094493957	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2370.47565500243	2370.47565500243
"healthy-2"	"2019-08-01-count-4:GCACGTGAGTCTCCTC"	-4.96008286896403	3.0631999739441	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGAGTCTCCTC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2741.45699002932	42.6108227628896	0.0155431301376842	3453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2732.68441313866	2732.68441313866
"healthy-2"	"2019-08-01-count-2:CTAGGTAGTTGTTGCA"	3.03441872176473	-10.9730282059875	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGGTAGTTGTTGCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.03031874079	40.7420989835806	0.0169756601262256	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2394.94677219505	2394.94677219505
"healthy-2"	"2019-08-01-count-4:CCAAGCGCAACTCATG"	-1.25967405262645	13.3723830946716	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAAGCGCAACTCATG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2153.6874830241	31.2413004208655	0.0145059581146834	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2150.29304645816	2150.29304645816
"healthy-2"	"2019-08-01-count-2:TTAGTCTCACTAGTAC"	-2.41566191139873	12.6824846037659	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTCACTAGTAC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.92658641249	46.9274528167597	0.0250022846692452	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1873.00852282704	1873.00852282704
"healthy-2"	"2019-08-01-count-3:TTGGATGAGAGCAGCT"	2.49669732627217	-10.8564958802429	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGAGAGCAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.71276112199	46.0738191593654	0.0212938704190448	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2153.3188729532	2153.3188729532
"healthy-2"	"2019-08-01-count-4:GAGTCATGTCTGCGCA"	-2.5346921485966	4.13475368106691	"2019-08-01-count-4"	"Control2"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCATGTCTGCGCA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3321.92886221664	41.9846334060164	0.0126386310927806	5793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3317.93833739654	3317.93833739654
"healthy-2"	"2019-08-01-count-4:GTGACGCAGTATGACA"	1.76990415629689	-4.71876575863036	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGACGCAGTATGACA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2293.67668005127	41.5234679331079	0.018103452981952	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2291.09315879153	2291.09315879153
"healthy-2"	"2019-08-01-count-4:TTTAGTCTCGACGCGT"	2.49571432647054	-10.472550415155	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTAGTCTCGACGCGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.19495097796	40.7495383891857	0.018837663415756	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2162.27877707865	2162.27877707865
"healthy-2"	"2019-08-01-count-2:CAATTTCAGAATGTTG"	-5.67740521851237	-5.30679800426634	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCAGAATGTTG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2897.45543779935	42.8536858744309	0.0147901104242621	3423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2893.0517162433	2893.0517162433
"healthy-2"	"2019-08-01-count-3:CCCTCTCCACAAGGTG"	3.28977622565572	-10.5284538499084	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCTCCACAAGGTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.08507304045	41.9900214433985	0.0156732691566769	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2672.96546273214	2672.96546273214
"healthy-2"	"2019-08-01-count-3:GAGACTTGTATACGGG"	2.1640166240627	-10.2254028550354	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACTTGTATACGGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.85038256975	47.4617020576755	0.0240452379150871	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1971.68531444372	1971.68531444372
"healthy-2"	"2019-08-01-count-3:GTTGTAGCAGCAGTAG"	4.490251203149	-10.654320739862	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTAGCAGCAGTAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.3860763001	40.4730389926825	0.0179769429236213	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.88716121144	2248.88716121144
"healthy-2"	"2019-08-01-count-2:TTGGGTAAGTATTGCC"	2.44212235984151	-10.8223190537659	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGTAAGTATTGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.05501542342	35.8573354278833	0.0144816392222818	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2470.34835093569	2470.34835093569
"healthy-2"	"2019-08-01-count-2:AGAAATGCATCTGTTT"	2.72034229811971	-11.0340805283752	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGCATCTGTTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.50768405563	38.9194907545105	0.0166215515838494	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.16141231826	2333.16141231826
"healthy-2"	"2019-08-01-count-4:AATGACCAGTTCAACC"	9.90512241896931	6.29019210422365	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGACCAGTTCAACC"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2234.57872546323	34.2046502022234	0.0153069792585324	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2225.82032891311	2225.82032891311
"healthy-2"	"2019-08-01-count-2:CATGGTAAGACGCATG"	2.20882143554036	-10.6914253464905	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGTAAGACGCATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.31860791801	46.6792134699986	0.018988268371581	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.17432546801	2455.17432546801
"healthy-2"	"2019-08-01-count-3:GACTCTCCAATGGCAG"	2.3856860595638	-11.0116033784119	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCCAATGGCAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.43345182114	37.482977305721	0.0163080541992729	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2292.03216857923	2292.03216857923
"healthy-2"	"2019-08-01-count-3:TCCATGCTCAGTGCGC"	2.28107490119283	-10.4344225159851	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCTCAGTGCGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.78450407071	40.0862847897255	0.0167389945615507	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2390.59377857053	2390.59377857053
"healthy-2"	"2019-08-01-count-4:AATGCCAGTCTACGTA"	1.06579210337941	10.7612437971863	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGCCAGTCTACGTA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1587.28280819529	39.6464541803387	0.024977561639073	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1574.65577510629	1574.65577510629
"healthy-2"	"2019-08-01-count-3:CCTCAGTCATTCAGCA"	0.134039734571618	10.467053390387	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAGTCATTCAGCA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2230.30929153116	43.5551681209445	0.0195287569694169	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2226.29059357978	2226.29059357978
"healthy-2"	"2019-08-01-count-2:GTGGGAAAGCTTCTAG"	-7.60843024674113	0.897576070669569	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGGAAAGCTTCTAG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2803.01357970103	39.2141566784893	0.0139899988221505	2976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2791.0687351814	2791.0687351814
"healthy-2"	"2019-08-01-count-3:CAGATTGCAGTATGAA"	12.2466188865596	-2.77748086368712	"2019-08-01-count-3"	"Control2"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGCAGTATGAA"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1697.52299424607	31.5132335918463	0.0185642454910264	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	1694.91971610267	1694.91971610267
"healthy-2"	"2019-08-01-count-2:CTCCCAAAGTAACGAT"	1.705503364175	-4.97624590313109	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAAGTAACGAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2433.9936910357	37.6060487992653	0.0154503476889718	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2428.47660663203	2428.47660663203
"healthy-2"	"2019-08-01-count-2:CGAGGAACACTTCAAG"	2.61660470542256	-10.7532196274963	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACACTTCAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.78083549927	38.7867774014747	0.0165629408241379	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2331.91431684341	2331.91431684341
"healthy-2"	"2019-08-01-count-3:CAGATTGTCGTGGTAT"	1.92306150969807	-10.1104402772156	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGTCGTGGTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.26240679568	39.8614391925572	0.0176983992061869	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2248.28730967633	2248.28730967633
"healthy-2"	"2019-08-01-count-4:ACTGCAACAGAGTCTT"	2.06014837798421	-10.0245542756286	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAACAGAGTCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.3349676093	37.8883735225413	0.0158905414034719	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.17687762501	2380.17687762501
"healthy-2"	"2019-08-01-count-4:AACCTTTAGCTACAAA"	1.75611939009969	-4.81841566478881	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTAGCTACAAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2524.75722158271	37.9005570934654	0.0150115649811694	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2514.92280112166	2514.92280112166
"healthy-2"	"2019-08-01-count-3:CATGGATAGCACCGTC"	2.46601905402486	-10.912323021051	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGATAGCACCGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.59608883106	45.9419572969398	0.0189092983431018	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.76950523214	2425.76950523214
"healthy-2"	"2019-08-01-count-2:GATCATGGTGTTACAC"	4.25772776183431	-10.8583212128845	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGGTGTTACAC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.7563875898	41.6454944485779	0.0188291507519777	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2209.53609772763	2209.53609772763
"healthy-2"	"2019-08-01-count-4:CATGCTCAGCATCTTG"	1.83558835563008	-5.31376173412474	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCAGCATCTTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2399.05638919262	40.8612975464088	0.0170322372289716	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2395.12228284127	2395.12228284127
"healthy-2"	"2019-08-01-count-4:CTCACTGGTCTTACTT"	2.53579988059346	-10.9463930360046	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGGTCTTACTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.63130070884	41.9226114760576	0.017669248257634	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2368.12563106631	2368.12563106631
"healthy-2"	"2019-08-01-count-1:ACTGTCCGTCGATGCC"	2.28050722655599	-10.5622663727966	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTGTCCGTCGATGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.08025106532	40.4077649736304	0.0158768136905374	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2535.40937609332	2535.40937609332
"healthy-2"	"2019-08-01-count-3:GTCGTTCCACGACAGA"	-4.84297738495524	3.06882236087648	"2019-08-01-count-3"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTTCCACGACAGA"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2778.92126199006	39.36044957722	0.0141639312043814	2647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2774.11616157158	2774.11616157158
"healthy-2"	"2019-08-01-count-2:TGTTCCGGTACCTTCC"	2.88101138648335	-10.9827547303406	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCCGGTACCTTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.64757263323	41.2448852569539	0.0177347959950157	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2324.65811362673	2324.65811362673
"healthy-2"	"2019-08-01-count-3:AGCTTCCTCAAGTGGG"	4.47570957717244	-10.7976007691589	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCTCAAGTGGG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.86380909375	45.0783016013414	0.0202885079710299	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2215.56933386894	2215.56933386894
"healthy-2"	"2019-08-01-count-3:ACGCACGAGGTGTGAC"	10.7700277763302	4.19266507709352	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGCACGAGGTGTGAC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.23114948289	42.9145583692414	0.0238914453641426	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1785.1327377058	1785.1327377058
"healthy-2"	"2019-08-01-count-4:ATGAGGGCAATTGCTG"	-2.55056558075603	4.10313317859498	"2019-08-01-count-4"	"Control2"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGGGCAATTGCTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3172.73408567083	43.0985423746561	0.0135840386275371	5862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3167.47174803203	3167.47174803203
"healthy-2"	"2019-08-01-count-4:TCCTAATAGAGGTTTA"	-1.73284910145457	13.4522199400696	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATAGAGGTTTA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1799.83245434189	44.0650430175865	0.0244828583412221	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1793.84521148061	1793.84521148061
"healthy-2"	"2019-08-01-count-3:TGAGCGCAGCCTAGGA"	2.23606981810872	-10.749857925531	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCGCAGCCTAGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.00905059429	42.0430153270009	0.0178677660914149	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.74355963449	2342.74355963449
"healthy-2"	"2019-08-01-count-2:CCATAAGTCCCTCATG"	4.55256952819173	-10.4801264039245	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGTCCCTCATG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.24067568598	42.8993440884248	0.0179702635454206	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2380.73434070506	2380.73434070506
"healthy-2"	"2019-08-01-count-3:TCGCTCATCTGAGTCA"	1.8705162006313	-5.21323206340941	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCATCTGAGTCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2127.61220915625	43.9681581385481	0.0206654943740827	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2123.82543108182	2123.82543108182
"healthy-2"	"2019-08-01-count-4:GGAGGATGTATTGCCA"	2.34503020819966	-10.7884845963684	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGATGTATTGCCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2456.25615165279	39.1385441064845	0.0159342274135979	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2453.0125677862	2453.0125677862
"healthy-2"	"2019-08-01-count-4:GTGCACGGTGCATTTG"	6.78372873839681	-0.920093857404314	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGGTGCATTTG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1544.78447793309	48.8343489156193	0.0316124026446454	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1532.37596832722	1532.37596832722
"healthy-2"	"2019-08-01-count-3:AAGCCATGTCAAACGG"	-2.7456878227299	13.0513334044251	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCCATGTCAAACGG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1971.83279726475	41.1913220102533	0.0208898655440727	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1971.83279726475	1971.83279726475
"healthy-2"	"2019-08-01-count-4:CATTCCGAGAACAAGG"	1.6197016435558	-9.39969828045043	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGAGAACAAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.08913446499	40.0256875071156	0.0172295100146183	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2321.11730363515	2321.11730363515
"healthy-2"	"2019-08-01-count-4:GGAACCCTCCATTGTT"	3.23469700393025	-11.0094995728699	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCTCCATTGTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.37964819489	40.6179732906586	0.0158269542541097	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2559.18170070527	2559.18170070527
"healthy-2"	"2019-08-01-count-2:ATAGAGATCGTCTCAC"	-2.46217546883281	13.7163314589295	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGATCGTCTCAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1795.34156805336	41.5362038106606	0.0231355439821388	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1791.31904763936	1791.31904763936
"healthy-2"	"2019-08-01-count-3:CGGCAGTCACGGATCC"	1.00827379998509	-8.92575933849486	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTCACGGATCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2453.07300408526	45.4801791976462	0.0185400838547834	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2451.6177335705	2451.6177335705
"healthy-2"	"2019-08-01-count-4:ATTTCACAGAACAAGG"	2.53076638755147	-11.0172548524109	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACAGAACAAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.93439498411	40.7419412869356	0.0173596421672501	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.04944463487	2345.04944463487
"healthy-2"	"2019-08-01-count-2:GTATTGGCACGCAAAG"	-1.68883417072948	13.0833110579285	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTGGCACGCAAAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1849.52099111386	44.6433022783695	0.0241377645849174	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1845.60656026692	1845.60656026692
"healthy-2"	"2019-08-01-count-2:AGCTACAAGGGTCTTT"	4.47441162642781	-10.7497110596863	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTACAAGGGTCTTT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.59160152183	39.7708795562441	0.0158601901251016	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2505.74188774742	2505.74188774742
"healthy-2"	"2019-08-01-count-2:CTCCTCCTCCTGGGAC"	2.98703660544698	-10.8964462510315	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTCCTCCTGGGAC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.75156915956	39.3065708425997	0.0164755506611472	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2378.4402756677	2378.4402756677
"healthy-2"	"2019-08-01-count-2:ATAGGCTGTAGATGTA"	3.00833119925801	-10.3007498017517	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGGCTGTAGATGTA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2326.93655581706	47.6691477270236	0.0204857960599985	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2318.38787812688	2318.38787812688
"healthy-2"	"2019-08-01-count-1:GTGTGATGTAAGATCA"	0.822614093392533	8.43348977649537	"2019-08-01-count-1"	"Control2"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGTGATGTAAGATCA"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.92382092378	39.4451175704236	0.0216146652907717	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1799.42596744179	1799.42596744179
"healthy-2"	"2019-08-01-count-2:AATTTCCGTCACAGAG"	4.36116756972615	-10.8350858918396	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCGTCACAGAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.81232004703	43.5073507410964	0.0186982638721016	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2322.85299713617	2322.85299713617
"healthy-2"	"2019-08-01-count-2:CCCTCTCTCTGGAGAG"	-3.72073469582255	3.3205458887848	"2019-08-01-count-2"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCTCTGGAGAG"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2945.6273187648	39.9409561367883	0.0135594057952779	4089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2941.74586887826	2941.74586887826
"healthy-2"	"2019-08-01-count-4:GAGTTGTAGTCAAGCG"	2.27006139334981	-10.6692743531433	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTGTAGTCAAGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.21203323342	37.9814980244317	0.0155393629963381	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2440.03398714928	2440.03398714928
"healthy-2"	"2019-08-01-count-4:CATGAGTGTACGACTT"	-4.89368567887004	-5.37334253704222	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGAGTGTACGACTT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2924.33560344686	38.4591898134157	0.0131514282314535	2640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2920.15586737841	2920.15586737841
"healthy-2"	"2019-08-01-count-2:CCCTTAGAGGATATAC"	2.818531413644	-11.029040359613	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTTAGAGGATATAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.50881982663	39.81531523257	0.0157777594909715	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2515.93410207877	2515.93410207877
"healthy-2"	"2019-08-01-count-3:CCTGTTGCATGTAACC"	2.21023430404012	-10.6758642426697	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGTTGCATGTAACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2141.44864472205	46.2875711670342	0.0216150741140197	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2140.0365614546	2140.0365614546
"healthy-2"	"2019-08-01-count-3:TCAAGACTCCGACAGC"	7.98277439650838	6.7616133459839	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGACTCCGACAGC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1547.03851278831	39.7642303216276	0.025703452107316	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1532.42848310449	1532.42848310449
"healthy-2"	"2019-08-01-count-4:CTTCTCTTCACTTATC"	2.79184283789937	-10.9743767014709	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTTCACTTATC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.34968143373	39.1929327450762	0.0164929147638869	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2368.33585674154	2368.33585674154
"healthy-2"	"2019-08-01-count-4:AAAGGTACAGCCTTCT"	6.89303507384602	-1.10046806251677	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTACAGCCTTCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2354.9172178125	37.368673009132	0.0158683595017595	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2343.41264613246	2343.41264613246
"healthy-2"	"2019-08-01-count-2:TAAGTCGCAAGCACCC"	1.94962646540944	-9.8983478776184	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGCAAGCACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.72704183041	40.8323159424574	0.0170295931230297	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2392.46912811051	2392.46912811051
"healthy-2"	"2019-08-01-count-3:TCCTGCAGTAGGACCA"	2.45441832122151	-10.4759922257629	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAGTAGGACCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2148.95445486899	38.940579849163	0.0181207097064963	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2147.89443868552	2147.89443868552
"healthy-2"	"2019-08-01-count-3:CAGTTCCAGCTTAAGA"	3.62367143210713	-10.8199358216492	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTCCAGCTTAAGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.81293113994	44.1701536941488	0.0203192064328121	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2165.31600804668	2165.31600804668
"healthy-2"	"2019-08-01-count-2:GTGATGTGTGTATTCG"	9.14948048171346	7.74121472919313	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGATGTGTGTATTCG"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.50821333316	41.4393793449149	0.0203682536513452	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2031.07486730511	2031.07486730511
"healthy-2"	"2019-08-01-count-3:TCGGTCTAGTGCACCC"	2.27303280410115	-10.3613710633484	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTAGTGCACCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.34222227385	34.4044845867782	0.0145822357867272	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2358.36737236612	2358.36737236612
"healthy-2"	"2019-08-01-count-2:GAGTGTTCACGGTGTC"	2.65306391295735	-10.834442161676	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGTTCACGGTGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.83527152047	41.1487832691949	0.0174002746680695	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2361.55313590552	2361.55313590552
"healthy-2"	"2019-08-01-count-3:CTTACCGGTCTTGTCC"	0.436824997037095	11.6708335646423	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGGTCTTGTCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1856.04035409181	37.1953518921613	0.020040163356449	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1850.61888540242	1850.61888540242
"healthy-2"	"2019-08-01-count-4:CCACACTAGATACAGT"	3.34919490393941	-10.916756652948	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTAGATACAGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.53426296702	41.5052271472427	0.0174572572070725	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2367.89741370862	2367.89741370862
"healthy-2"	"2019-08-01-count-2:AGGTCTAAGTATTGCC"	10.1002174812252	5.06651828372804	"2019-08-01-count-2"	"Control2"	"B"	"Activated NFkB"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTAAGTATTGCC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.56435197961	35.3262991820856	0.0209209078355056	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1684.64538677234	1684.64538677234
"healthy-2"	"2019-08-01-count-3:GACTGATGTGCCGTAC"	2.20717658576314	-10.7950878373352	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATGTGCCGTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.56599024652	40.6449514102988	0.0172915593856763	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.04930269769	2344.04930269769
"healthy-2"	"2019-08-01-count-3:GCATGATCAGCTGTGC"	1.67045630988423	-4.82065012371215	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATGATCAGCTGTGC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2456.59155116551	43.1231636601402	0.0175540633279801	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2449.12088614595	2449.12088614595
"healthy-2"	"2019-08-01-count-4:CGGGTGTAGCAGCAGT"	1.46859302100484	10.6801004179749	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTAGCAGCAGT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2077.34714495782	36.7823651006129	0.0177064123297312	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2071.75822283006	2071.75822283006
"healthy-2"	"2019-08-01-count-2:ATACTTCAGAACCGCA"	-2.0864876312321	13.0771083601746	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACTTCAGAACCGCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1927.536899934	46.3074115176446	0.0240241374986026	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1919.8647071567	1919.8647071567
"healthy-2"	"2019-08-01-count-2:TGTTCCGAGGCACAAC"	1.5814092355663	-9.25929071819457	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCCGAGGCACAAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2344.83852046097	41.9749753038167	0.0179010089341098	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2342.00736469918	2342.00736469918
"healthy-2"	"2019-08-01-count-2:GTGTCCTCATCCCACT"	-4.07247291031535	-5.4343471757141	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTCATCCCACT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2556.36774159473	41.8729515655715	0.016379862288299	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2554.92593367611	2554.92593367611
"healthy-2"	"2019-08-01-count-2:CCTCAGTCATGGATCT"	4.51328005370442	-10.8050356141296	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTCATGGATCT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.38770451919	44.7457814218509	0.0177605778346808	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2511.51816543976	2511.51816543976
"healthy-2"	"2019-08-01-count-4:CGAAGTTTCAGACAAA"	10.8808065849239	4.50023315036622	"2019-08-01-count-4"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTTCAGACAAA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1701.04539376665	42.9632286576293	0.0252569559960391	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1695.36529712404	1695.36529712404
"healthy-2"	"2019-08-01-count-4:GTTAGACCAGTACTAC"	1.80096056041066	-10.2457714310852	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACCAGTACTAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2464.56889439346	40.863509670579	0.0165803884661279	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2459.36450851114	2459.36450851114
"healthy-2"	"2019-08-01-count-2:TTCTGTACAGTAGAAT"	1.52263512191121	-9.39437868511351	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTGTACAGTAGAAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2580.87711804853	42.8557996964832	0.0166051298594517	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2576.30981930766	2576.30981930766
"healthy-2"	"2019-08-01-count-2:GATAGAACAACAAGAT"	0.739115198224229	-7.54983427440795	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGAACAACAAGAT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2315.49458893649	47.4703432126934	0.0205011678453097	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2312.16372197565	2312.16372197565
"healthy-2"	"2019-08-01-count-2:TGTTGGAGTGCAATAA"	2.14927305754964	-10.3437433472839	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGAGTGCAATAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.485012348	40.1164613204755	0.017132913987883	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2338.54275061074	2338.54275061074
"healthy-2"	"2019-08-01-count-2:TAGGGTTAGATAGCTA"	10.5427271324093	4.88969419086305	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTAGATAGCTA"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1574.97454848107	29.1800537238661	0.0185273176331692	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1572.85620647592	1572.85620647592
"healthy-2"	"2019-08-01-count-3:AGTAACCCAACTCCCT"	-3.41485891762431	3.59052178943483	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCCAACTCCCT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3185.67254055652	43.098431289425	0.0135288328416504	5247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3178.61420328711	3178.61420328711
"healthy-2"	"2019-08-01-count-4:TCAGTGACAATTGCTG"	1.8395058113033	-5.1759882203308	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTGACAATTGCTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2248.45174015472	43.1686639252084	0.019199284180428	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2242.57695433116	2242.57695433116
"healthy-2"	"2019-08-01-count-3:TAGGAGGCAGTTTCGA"	1.71252586421315	-4.98155548488768	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGCAGTTTCGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2357.65822629352	41.3956176361452	0.017557938285747	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2353.8087651978	2353.8087651978
"healthy-2"	"2019-08-01-count-3:CTCAAGAGTGGGTTGA"	2.05554666098897	-8.96925451671752	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGAGTGGGTTGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2379.99994907601	42.9697052279509	0.0180544983812429	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2377.56733989225	2377.56733989225
"healthy-2"	"2019-08-01-count-4:CAGTTAGGTACGCTTA"	4.38529123839681	-10.7512531510559	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTAGGTACGCTTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.76415492328	40.2723348024629	0.0161298113492423	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2488.54439057082	2488.54439057082
"healthy-2"	"2019-08-01-count-3:CATAGACAGTGATAAC"	-7.17966161194499	3.53031013095704	"2019-08-01-count-3"	"Control2"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAGACAGTGATAAC"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2431.54162803353	39.4024893278125	0.0162047356596887	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2419.43494139787	2419.43494139787
"healthy-2"	"2019-08-01-count-4:TTCTTGATCCTTCAGC"	-7.28399787369426	3.68914935672609	"2019-08-01-count-4"	"Control2"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGATCCTTCAGC"	"HSC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2441.83725722781	38.3438927093458	0.0157028862574065	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2430.82524602599	2430.82524602599
"healthy-2"	"2019-08-01-count-2:GTCAAGTTCTAACGGT"	-2.20345316353496	12.7921113737854	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAGTTCTAACGGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1692.30347172324	40.0274588248285	0.023652648294853	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1686.05488072921	1686.05488072921
"healthy-2"	"2019-08-01-count-4:ACAGAAACATTCAGCA"	-5.03775439682658	-5.51170685207518	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAACATTCAGCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2762.8783609776	43.6174845482164	0.0157869724430369	2874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2758.14593278364	2758.14593278364
"healthy-2"	"2019-08-01-count-2:AGATAGACACCGTGCA"	7.71583809432332	6.92667815769044	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGACACCGTGCA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1652.67566776698	30.5387516734884	0.0184783695126043	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1649.10479471375	1649.10479471375
"healthy-2"	"2019-08-01-count-2:ACAGAAAGTCGTCAGC"	1.0921297269756	-8.96169855510863	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAAGTCGTCAGC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2538.20679896568	42.8671053198648	0.0168887363068026	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2534.56557918489	2534.56557918489
"healthy-2"	"2019-08-01-count-3:TAGGTTGAGTTGGCTT"	-2.49724731865581	13.3047446974548	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGAGTTGGCTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1741.08699827826	27.0056311250746	0.0155107878881297	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1736.71406743363	1736.71406743363
"healthy-2"	"2019-08-01-count-4:GGAATGGCAAGTGGTG"	-2.48138652268108	12.4189929732117	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATGGCAAGTGGTG"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1546.506306955	44.6426071636558	0.0288667475605419	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1546.506306955	1546.506306955
"healthy-2"	"2019-08-01-count-3:ACCACAATCGGCACTG"	-3.11791596832927	-5.31226780330809	"2019-08-01-count-3"	"Control2"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAATCGGCACTG"	"DC precursor"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2599.61203402424	42.1483430575965	0.0162133204901157	2571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2592.31455339304	2592.31455339304
"healthy-2"	"2019-08-01-count-3:CATCCACAGAGATGCC"	4.53784288939778	-10.7701816788879	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACAGAGATGCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.13817606839	42.56563157401	0.0179591350427587	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2365.87315930708	2365.87315930708
"healthy-2"	"2019-08-01-count-4:GTCGTAATCTGGGTCG"	-7.59468303147014	0.962672985437788	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTAATCTGGGTCG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2580.76291647984	43.1268896027177	0.0167109072000859	2773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2579.10731431585	2579.10731431585
"healthy-2"	"2019-08-01-count-4:TGTCCTGTCGAAGCAG"	2.39194860038106	-10.6400070420471	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGTCGAAGCAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.81310250713	35.1902586411274	0.0145245452918809	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2418.98636168818	2418.98636168818
"healthy-2"	"2019-08-01-count-3:GCGGAAAAGGATTTGA"	2.25778760489766	-10.6849241486755	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGAAAAGGATTTGA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.66146119002	43.7739548696585	0.0172225748936537	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2532.15523444344	2532.15523444344
"healthy-2"	"2019-08-01-count-1:CGTGCTTTCCGCTTAC"	2.52999581870381	-11.001265548822	"2019-08-01-count-1"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGTGCTTTCCGCTTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.92006776973	19.0603127004193	0.00850937181852094	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2235.66943000625	2235.66943000625
"healthy-2"	"2019-08-01-count-2:TATCTGTTCCGTTGAA"	-4.99880490723308	-5.08370973980101	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTGTTCCGTTGAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2093.66804095794	52.0617224691602	0.0248662736645394	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2090.54044557499	2090.54044557499
"healthy-2"	"2019-08-01-count-2:GAGACTTAGTAATACG"	-2.05315266075786	13.4814347990784	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACTTAGTAATACG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2022.00652785315	33.9253604066546	0.0167780667071706	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2020.11449067057	2020.11449067057
"healthy-2"	"2019-08-01-count-2:TCATACTCAACGACAG"	3.69879974898641	-10.9623670808044	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTCAACGACAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.03649027076	43.6981450978185	0.0188757910648344	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2300.77296533665	2300.77296533665
"healthy-2"	"2019-08-01-count-2:GAACGTTCAGTAGAAT"	1.77081408080403	-9.49560167705687	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTCAGTAGAAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.69940893312	47.6826371889555	0.0213756443373788	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.69940893312	2230.69940893312
"healthy-2"	"2019-08-01-count-2:CGCAGGTAGCCAGACA"	1.69536485251729	-4.78783180629881	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCAGGTAGCCAGACA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2517.83671456638	38.0530673173122	0.0151133975833956	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2511.50848134465	2511.50848134465
"healthy-2"	"2019-08-01-count-4:ATTCTTGCAGTTGGTT"	1.42734958705251	9.87674520099489	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGCAGTTGGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1852.40674560921	35.6893417859172	0.0192664715082215	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1845.26054352887	1845.26054352887
"healthy-2"	"2019-08-01-count-3:TCCTGCAGTAACACCT"	0.972166081040543	11.0859908827576	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAGTAACACCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.92082798728	33.444080819262	0.0185191290232451	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1796.68878159651	1796.68878159651
"healthy-2"	"2019-08-01-count-2:TAGACTGGTTGCTCCT"	1.41874506053273	9.66174600208131	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACTGGTTGCTCCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.56554264961	32.5057881089784	0.0179732430716093	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1805.49332147593	1805.49332147593
"healthy-2"	"2019-08-01-count-2:ATACCTTGTTCCTTGC"	4.47216763076131	-10.8640279999939	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTGTTCCTTGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.04299743177	42.3493519368781	0.0178010031691715	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2375.51236198184	2375.51236198184
"healthy-2"	"2019-08-01-count-4:GTTCCGTCAGTTGCGC"	-1.39177308502849	10.3915824660095	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCCGTCAGTTGCGC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1767.88682333769	39.4618203391511	0.02232146301348	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1761.65148600328	1761.65148600328
"healthy-2"	"2019-08-01-count-2:TGCTTCGTCCTACGAA"	2.53265633162801	-10.9400024644104	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGTCCTACGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.92445771263	43.0009726275448	0.0173256573115747	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2475.72413751398	2475.72413751398
"healthy-2"	"2019-08-01-count-2:GCGTTTCTCATATGGC"	2.88053931769673	-10.944850944635	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCTCATATGGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.24053289251	34.4423700024211	0.01468607143675	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2339.73453516239	2339.73453516239
"healthy-2"	"2019-08-01-count-4:TGTGGCGAGGTCGCCT"	3.13208331641499	-10.9128837815491	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGGCGAGGTCGCCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.37638911558	40.1766747217662	0.016483574265009	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2430.50663138783	2430.50663138783
"healthy-2"	"2019-08-01-count-3:AACGTCATCGTGCAGC"	3.0637318092281	-10.83927061474	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCATCGTGCAGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.32403786296	37.6359115278381	0.017112490419742	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2193.34905970764	2193.34905970764
"healthy-2"	"2019-08-01-count-4:CGTAAGTCAACTTGCA"	1.82724906977956	-5.09515716945799	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAAGTCAACTTGCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2467.35443965148	41.7580951836886	0.0169242385741657	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2462.99220323057	2462.99220323057
"healthy-2"	"2019-08-01-count-3:AACGTCAAGGACTTCT"	8.81996120986287	8.01126716220704	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCAAGGACTTCT"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2216.50960480511	40.4946473718431	0.0182695564612289	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2213.24299395	2213.24299395
"healthy-2"	"2019-08-01-count-2:CACTGTCCAGGCTTGC"	4.27704157409017	-10.8528967133728	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCCAGGCTTGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.3689270723	41.3659535265122	0.0177355962199499	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.96679965084	2328.96679965084
"healthy-2"	"2019-08-01-count-2:TGTTGGAGTCTTAGTG"	-0.67254219475444	8.31025502765504	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGAGTCTTAGTG"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2585.03732563872	42.2859874721375	0.0163579794584549	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2577.36956980755	2577.36956980755
"healthy-2"	"2019-08-01-count-3:TGAGGAGTCACCGCTT"	-1.44133315506633	12.9873904951843	"2019-08-01-count-3"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGTCACCGCTT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1650.16016836036	47.0883078787211	0.0285355984113404	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1645.9320346111	1645.9320346111
"healthy-2"	"2019-08-01-count-1:ATGAAAGAGGTAACTA"	2.54883851584737	-10.9367752305237	"2019-08-01-count-1"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATGAAAGAGGTAACTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.45459225056	45.2084743414022	0.0199379844235516	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2258.07961941788	2258.07961941788
"healthy-2"	"2019-08-01-count-4:ACACGCGTCCCGAATA"	1.81073584136311	-10.2703666917053	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACGCGTCCCGAATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.13490538549	32.5743201659959	0.0138783331504526	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2342.93167675256	2342.93167675256
"healthy-2"	"2019-08-01-count-3:TCGAACAGTGGACCAA"	3.40794028815572	-10.4529981843201	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAACAGTGGACCAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.13302796043	44.3434527916757	0.0192035072274907	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2305.19090205973	2305.19090205973
"healthy-2"	"2019-08-01-count-2:CTAGGTACAGAAATCA"	11.1682697730953	3.72132155979005	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGGTACAGAAATCA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1735.18153182153	24.9071447857391	0.0143542011766299	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1731.44845815634	1731.44845815634
"healthy-2"	"2019-08-01-count-3:ACCTGTCGTAAGAACT"	2.35597981986348	-10.9269790879455	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGTCGTAAGAACT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.19802749555	37.8212301277243	0.0160791012005029	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2347.17064421558	2347.17064421558
"healthy-2"	"2019-08-01-count-3:GTTGTAGCATCTGCGG"	2.90029778060262	-10.9924450150696	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTAGCATCTGCGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.00220090171	41.1144619768311	0.0177600098871684	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2315.00220090171	2315.00220090171
"healthy-2"	"2019-08-01-count-4:GGATGTTTCCGTAGTA"	-6.28003821793254	3.55765769565431	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTTCCGTAGTA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2514.42655996353	40.7836313013527	0.0162198538429153	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2511.18489832793	2511.18489832793
"healthy-2"	"2019-08-01-count-3:GGCTTGGTCCTATTGT"	2.53807248648946	-10.9315386048523	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTGGTCCTATTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.24428285272	40.8410117197061	0.0175641811145969	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2323.08389699993	2323.08389699993
"healthy-2"	"2019-08-01-count-2:GAGTCATGTCTTCCGT"	-7.4648998779362	2.17410752857057	"2019-08-01-count-2"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATGTCTTCCGT"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2535.39012287749	43.4179370297779	0.0171247559253333	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2529.35755281404	2529.35755281404
"healthy-2"	"2019-08-01-count-4:TCGGATAAGGTACCTT"	1.86831774291341	-9.83308603679808	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGATAAGGTACCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.138721154	38.6789023453143	0.0163745261863444	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2357.72744129885	2357.72744129885
"healthy-2"	"2019-08-01-count-3:TTAGGCACAGCTCATA"	-2.57482490959819	13.4078311690125	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCACAGCTCATA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1989.37462318323	44.5486707181518	0.0223933040056924	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1983.95136664142	1983.95136664142
"healthy-2"	"2019-08-01-count-4:CCAATTTGTAGCACGA"	2.11462392386739	-4.63967611705931	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTGTAGCACGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2540.49801809201	44.65035150967	0.0175754325300374	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2536.57728805261	2536.57728805261
"healthy-2"	"2019-08-01-count-2:TCACTATGTCACAATC"	4.48442091521565	-10.7218485108581	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTATGTCACAATC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.18195310379	43.4606220337055	0.0176440972941289	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.43076483163	2455.43076483163
"healthy-2"	"2019-08-01-count-4:TCTTAGTTCTAATTCC"	3.15133132514302	-10.8990020981994	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTAGTTCTAATTCC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.16421229645	41.1010131630145	0.0164524865742241	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2489.08056010213	2489.08056010213
"healthy-2"	"2019-08-01-count-4:CGGGCATCAACCACGC"	2.45647038993184	-10.8648672333923	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATCAACCACGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.18824237039	38.6363052955717	0.0159378321453258	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2419.25316524432	2419.25316524432
"healthy-2"	"2019-08-01-count-4:TGTTGAGCATAAGCGG"	3.06394590911214	-10.3322954407898	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGAGCATAAGCGG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2331.33696337833	37.2818887410234	0.0159916345541909	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2327.49472713138	2327.49472713138
"healthy-2"	"2019-08-01-count-2:GAAGGGTGTTCGGCCA"	1.81902362880055	-10.0387172929016	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTGTTCGGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.29106063	42.8084067641874	0.0173574025578523	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2462.37247510957	2462.37247510957
"healthy-2"	"2019-08-01-count-2:TGTGAGTCACTCGATA"	10.8984314399654	4.87048814380494	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTCACTCGATA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.95307466691	42.2797958724454	0.0218958173697404	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1914.2335387691	1914.2335387691
"healthy-2"	"2019-08-01-count-2:GTTTGGAGTGCAGATG"	4.47201408919637	-10.8725042573181	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAGTGCAGATG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.73414292293	41.1428182099916	0.018602063155574	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2207.35166184742	2207.35166184742
"healthy-2"	"2019-08-01-count-4:GTGGGAAAGGCACAAC"	-2.12293849411662	13.2430429228577	"2019-08-01-count-4"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAAAGGCACAAC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1748.0228615748	46.5195565456569	0.0266126705595529	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1739.58634367911	1739.58634367911
"healthy-2"	"2019-08-01-count-4:CACGGGTAGTAAACGT"	2.54755105552022	-10.9212904206482	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTAGTAAACGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.34412141136	35.3799858981557	0.0146177502550855	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2414.91065473395	2414.91065473395
"healthy-2"	"2019-08-01-count-3:CCCTAACTCAAGATAG"	1.88395204123799	-4.68659355556639	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACTCAAGATAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2403.62695465444	41.3715260970952	0.017212124376032	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2400.41630176479	2400.41630176479
"healthy-2"	"2019-08-01-count-3:CCGATGGCATGCAGGA"	-2.62067280235942	13.2938890227112	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATGGCATGCAGGA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2104.85899060161	44.5282336821629	0.0211549723192791	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2097.54810432548	2097.54810432548
"healthy-2"	"2019-08-01-count-3:CTAACTTGTCGTGGTC"	-7.16581187668498	-0.0332422337499485	"2019-08-01-count-3"	"Control2"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACTTGTCGTGGTC"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2391.73257898595	38.287590564483	0.0160083074926028	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2389.40682317719	2389.40682317719
"healthy-2"	"2019-08-01-count-2:AATGCCACAACCGTGC"	-2.27861247482951	13.3419675596985	"2019-08-01-count-2"	"Control2"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGCCACAACCGTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1907.95771442173	40.9425435017709	0.0214588317090559	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1894.99530333955	1894.99530333955
"healthy-2"	"2019-08-01-count-2:GTAATGCAGTGCACCC"	9.3464466529781	7.13292024219362	"2019-08-01-count-2"	"Control2"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAATGCAGTGCACCC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2126.26472158275	41.9486861964268	0.0197288163466311	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	2122.20343956679	2122.20343956679
"healthy-2"	"2019-08-01-count-4:TGTTGGACAACTGATC"	2.90834583815877	-10.9951944581238	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGGACAACTGATC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.28548289947	38.504020152558	0.0170803655724359	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2249.94051892575	2249.94051892575
"healthy-2"	"2019-08-01-count-4:AACCTGATCGCTAAAC"	2.73407258567159	-10.5708170167175	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTGATCGCTAAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.30241996191	40.8272070926039	0.016520522443074	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2466.98500259804	2466.98500259804
"healthy-2"	"2019-08-01-count-3:GCCAGCATCCCTCTTT"	2.95109881934468	-10.8859834901062	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGCATCCCTCTTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.50260764679	41.2573225276	0.0175078620298238	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2351.48186750661	2351.48186750661
"healthy-2"	"2019-08-01-count-2:ATGAGTCCAGCCCACA"	2.243336101144	-10.651827835199	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGTCCAGCCCACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.19444961983	41.8409461930997	0.0167955360527898	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2481.32800852095	2481.32800852095
"healthy-2"	"2019-08-01-count-4:GCACGGTCATGCAGCC"	1.55661465701405	-9.82060720836791	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTCATGCAGCC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2298.64931934484	45.9966595373255	0.0200102987220493	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2298.64931934484	2298.64931934484
"healthy-2"	"2019-08-01-count-4:CCGAACGGTTGGTGTT"	0.96924932774846	9.46571633899537	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGAACGGTTGGTGTT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1521.92663500743	32.8275351495369	0.0215697224783616	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1519.30215390079	1519.30215390079
"healthy-2"	"2019-08-01-count-4:CCGAACGCAATCGCAT"	2.17458667334859	-10.2743139497009	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGAACGCAATCGCAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.38307496409	40.5294628359686	0.0175879884192433	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.32364251989	2302.32364251989
"healthy-2"	"2019-08-01-count-2:GCTACAACAGGCATGA"	3.10918893393819	-10.9482355347839	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAACAGGCATGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.39627816815	40.9026992554883	0.0167675500784989	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2435.68165761217	2435.68165761217
"healthy-2"	"2019-08-01-count-4:CCTATCGAGAGCATAT"	3.25856890258138	-10.3914060822693	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTATCGAGAGCATAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2246.01687962991	38.0824518811879	0.0169555501681995	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2241.25109146899	2241.25109146899
"healthy-2"	"2019-08-01-count-1:AGTTCCCAGCAGGCAT"	-2.71589408341106	13.3561515578064	"2019-08-01-count-1"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGTTCCCAGCAGGCAT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2229.40339618044	38.3180684858869	0.0171875886398738	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2218.83265643641	2218.83265643641
"healthy-2"	"2019-08-01-count-4:AAATGGAGTTGACTAC"	-0.707845131785232	11.0970191725525	"2019-08-01-count-4"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAGTTGACTAC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1844.87901545079	37.3885202013017	0.0202661095324811	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1841.41703306297	1841.41703306297
"healthy-2"	"2019-08-01-count-3:ACCAACACAATGTCTG"	2.75915565070454	-10.9785003892151	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACACAATGTCTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.54056192821	45.3229750272937	0.0192737372942144	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.91396427573	2345.91396427573
"healthy-2"	"2019-08-01-count-4:GTTGCGGAGGCACCAA"	1.76789357241933	-5.07465078746947	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGAGGCACCAA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2321.36841163635	41.5235271701739	0.0178875214128134	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2315.40443539796	2315.40443539796
"healthy-2"	"2019-08-01-count-4:CAATGACTCCACGGGT"	2.37828578528706	-10.6043853989807	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATGACTCCACGGGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.59573990282	42.2739811097954	0.0168114422684217	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2512.71105787794	2512.71105787794
"healthy-2"	"2019-08-01-count-3:CTGTGGGTCATTTACC"	1.65962411937062	-4.80717136776122	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGTCATTTACC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2316.04362377926	41.1444657492307	0.0177649787451293	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2311.19489029378	2311.19489029378
"healthy-2"	"2019-08-01-count-2:GGGTGAAGTACCCGCA"	2.68495955046956	-10.2625007859436	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAAGTACCCGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.73380959512	41.5359969612624	0.0173882903128092	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2385.13126771648	2385.13126771648
"healthy-2"	"2019-08-01-count-4:GATGAGGGTCGGTACC"	2.40851487693135	-10.5464763871399	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGGTCGGTACC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.55295164858	42.6824650891627	0.0184249900520459	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2312.59374038926	2312.59374038926
"healthy-2"	"2019-08-01-count-2:GGGACCTAGTTCCGTA"	2.93850388106648	-10.546898864862	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTAGTTCCGTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.58734793553	37.7035131722876	0.014899115497059	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2522.61245953632	2522.61245953632
"healthy-2"	"2019-08-01-count-4:ACGTAACTCCGCCTAT"	0.358405818312806	11.3067321547302	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACTCCGCCTAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2618.73171245976	37.7144071578971	0.0144017834963598	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2602.00509507085	2602.00509507085
"healthy-2"	"2019-08-01-count-4:CAGCACGAGCGAATGC"	2.32946648177449	-10.8237533799377	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGAGCGAATGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.84167094518	41.7259775156222	0.0186957605724564	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2228.07853404009	2228.07853404009
"healthy-2"	"2019-08-01-count-2:ATACCTTCACGATAGG"	2.40169920501057	-10.6609029999939	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTCACGATAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.00049290269	42.6476221785768	0.0192366317982811	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2213.02194202154	2213.02194202154
"healthy-2"	"2019-08-01-count-3:AGTAGTCAGGGCTAAC"	2.56478395041768	-10.7525625458923	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGTCAGGGCTAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.68479868037	44.2801146533689	0.0211392734034567	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2086.86532583698	2086.86532583698
"healthy-2"	"2019-08-01-count-2:TTTACGTTCGTCGCTT"	2.15221490439717	-9.95615961467894	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACGTTCGTCGCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.64939036986	41.5101588816496	0.0186090019618757	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2227.03211982459	2227.03211982459
"healthy-2"	"2019-08-01-count-3:AGCTCAAAGCCTCATA"	1.33131887492482	9.50082967365114	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTCAAAGCCTCATA"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1832.79905881756	36.5344443592976	0.0199336878658526	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1820.81964492139	1820.81964492139
"healthy-2"	"2019-08-01-count-4:CAGCAGCCATGTGCTA"	2.60006060180013	-10.8545685044494	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCCATGTGCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.1859274016	42.5018620853963	0.017864035591289	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2376.0069382219	2376.0069382219
"healthy-2"	"2019-08-01-count-4:AGGGCTCCACACACTA"	2.13959517058675	-10.6461563340393	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCTCCACACACTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.78317445044	40.1177174261852	0.0168718989423656	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2373.9910059626	2373.9910059626
"healthy-2"	"2019-08-01-count-3:GGGATCCTCCGTATGA"	1.64162733134572	-9.15419962322386	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATCCTCCGTATGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.19752741544	40.0646807484124	0.0172010661512549	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2327.07974805925	2327.07974805925
"healthy-2"	"2019-08-01-count-2:CACACAACATACCATG"	1.61121644553487	-9.54954149639281	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAACATACCATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.35535328054	43.9823486627567	0.0187369792994015	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.36854738533	2344.36854738533
"healthy-2"	"2019-08-01-count-4:GATTTCTCATAACCCA"	2.83158435401265	-10.9180593720642	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTTCTCATAACCCA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.13577131807	43.0783971602429	0.0172373176578249	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2494.89454796574	2494.89454796574
"healthy-2"	"2019-08-01-count-4:TGATTTCTCCGAGGCT"	-2.84268794480022	13.5181588896546	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCTCCGAGGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1951.47307718687	39.2493447602459	0.0201126755060467	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1939.63663587056	1939.63663587056
"healthy-2"	"2019-08-01-count-2:TCCGAAAAGTATTGCC"	2.50003661689107	-10.846971534845	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGAAAAGTATTGCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.77139503649	39.7969031699115	0.0164806089933453	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2412.90296888039	2412.90296888039
"healthy-2"	"2019-08-01-count-3:GGGCGTTCAGTCGCAC"	2.46115126189534	-10.7485609284607	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCGTTCAGTCGCAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.01352419162	36.0043492741008	0.0163729549081952	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2195.11590723894	2195.11590723894
"healthy-2"	"2019-08-01-count-3:TTATTGCCAAAGACGC"	-1.54440842095073	12.9321069487366	"2019-08-01-count-3"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTATTGCCAAAGACGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1979.75005481604	43.7042158869167	0.0220756230215019	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1973.1398882221	1973.1398882221
"healthy-2"	"2019-08-01-count-3:GTTGCGGAGTTGCGCC"	2.89227451857869	-10.8802671662536	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGAGTTGCGCC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.54246310708	41.1670786259047	0.0181309441663427	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2263.52943287732	2263.52943287732
"healthy-2"	"2019-08-01-count-3:GTTATGGCAGGACATG"	2.34572662886922	-10.9227438203064	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTATGGCAGGACATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.99655318226	42.5724668281854	0.0182323467545018	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2328.30583828049	2328.30583828049
"healthy-2"	"2019-08-01-count-4:AATGGAACACTTCAGA"	2.67598261412923	-11.0002222291199	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAACACTTCAGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.01497549055	33.5591923933556	0.0143844736300071	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2325.45966433441	2325.45966433441
"healthy-2"	"2019-08-01-count-4:ATGACCACAGAGATGC"	1.42757644233052	9.50044343555299	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCACAGAGATGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1732.90678479411	35.8910258292911	0.0207114578488741	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1722.02219483286	1722.02219483286
"healthy-2"	"2019-08-01-count-2:AAAGTCCGTATCGTAC"	1.85411359843556	-10.4415674439636	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTCCGTATCGTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.72826099451	40.0426710235023	0.0176110187441608	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2264.61212230423	2264.61212230423
"healthy-2"	"2019-08-01-count-4:TGCGGGTCACACGCCA"	1.59638108786885	-9.54553892528685	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGGTCACACGCCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.39849258481	39.9341715983276	0.0160545934707991	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2483.21913472417	2483.21913472417
"healthy-2"	"2019-08-01-count-4:GATAGCTTCCAGTACA"	10.9692789512569	3.86772677982179	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATAGCTTCCAGTACA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1606.44669134752	16.3094759561326	0.0101525161363754	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1602.31867906592	1602.31867906592
"healthy-2"	"2019-08-01-count-4:GATCGTAGTGCTGTCG"	2.47845973548238	-10.8114986649719	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCGTAGTGCTGTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.941777487	40.4946966111709	0.0166443344373814	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2429.08170807388	2429.08170807388
"healthy-2"	"2019-08-01-count-3:CGTAAGTCATGAAGCG"	1.76732482489888	-4.86170723354491	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTCATGAAGCG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2451.73789360847	40.3337575533125	0.0164510886985351	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2443.70594798543	2443.70594798543
"healthy-2"	"2019-08-01-count-4:ATGCATGGTCCATACA"	2.13295402106587	-9.67071535503539	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCATGGTCCATACA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.34929611204	34.9991421440411	0.0147778632997661	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2366.37291197073	2366.37291197073
"healthy-2"	"2019-08-01-count-2:CAGGCCACACGACAAG"	1.72094692763631	-5.00443985378417	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCACACGACAAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2481.82472209666	37.8956430885534	0.0152692665002301	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2478.748322756	2478.748322756
"healthy-2"	"2019-08-01-count-4:AGCCAATAGGAAAGAC"	-5.00326428833659	-5.43527796184691	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATAGGAAAGAC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2768.63469115475	39.6157031194171	0.0143087505354107	2733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2762.27630957513	2762.27630957513
"healthy-2"	"2019-08-01-count-3:AGTGATCAGGAACGAA"	2.39440812644307	-9.96922972118529	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCAGGAACGAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.84852405939	39.5956104383904	0.0166939878481881	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2370.78593119606	2370.78593119606
"healthy-2"	"2019-08-01-count-4:CATTGAGAGCCTAACT"	1.82893290099446	-4.88839676296385	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGAGAGCCTAACT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2464.37720785553	41.3758186864577	0.0167895639330565	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2459.1463735279	2459.1463735279
"healthy-2"	"2019-08-01-count-4:ACTTTCAAGCACTAAA"	2.26149072226827	-10.8680687180725	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTCAAGCACTAAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.88849526719	39.488785151167	0.0155230015877797	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2535.01599219267	2535.01599219267
"healthy-2"	"2019-08-01-count-4:CATTGAGAGGACACTG"	11.0934807258541	3.82878491962282	"2019-08-01-count-4"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGAGAGGACACTG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.16655129734	23.7536046838884	0.0130717818170987	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1811.55827706571	1811.55827706571
"healthy-2"	"2019-08-01-count-3:AGAAGCGTCAGCAGAG"	3.01556601104085	-10.8800182572571	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGCGTCAGCAGAG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.46477412008	38.1385425931316	0.0166655580738821	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2287.55187480072	2287.55187480072
"healthy-2"	"2019-08-01-count-4:CTTCCTTTCTCGGTCT"	-2.18344269219096	13.5001077421936	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTTCTCGGTCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1846.68860845293	24.6445076390528	0.0133452426826301	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1840.21782381424	1840.21782381424
"healthy-2"	"2019-08-01-count-3:AAGCGAGGTAATTAGG"	2.35613717612569	-10.9836311570373	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGAGGTAATTAGG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.89500001144	41.811632100694	0.017961133169876	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2326.7923253108	2326.7923253108
"healthy-2"	"2019-08-01-count-3:GAGGGATTCGGACGTC"	7.88814892348592	6.99641082370607	"2019-08-01-count-3"	"Control2"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATTCGGACGTC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1516.01775211576	42.110029094878	0.0277767387856171	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1509.85078401417	1509.85078401417
"healthy-2"	"2019-08-01-count-3:AGTGACTCACCTGCAG"	4.43364967879598	-10.8519830933777	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTCACCTGCAG"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.0726342934	46.2390040775359	0.0205135377512051	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2249.14449328387	2249.14449328387
"healthy-2"	"2019-08-01-count-3:GTCCTCACATCTATCT"	3.72822870787923	-8.53831674968871	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCTCACATCTATCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.98658083707	36.9193318062177	0.014575415474178	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2527.63472795341	2527.63472795341
"healthy-2"	"2019-08-01-count-2:TTTACTGAGAGAGCGG"	-2.97494755211528	3.17069909656373	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGAGAGAGCGG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3080.34319855501	41.8295461733671	0.0135795083460146	5326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3075.55448609866	3075.55448609866
"healthy-2"	"2019-08-01-count-3:ACAAGCTGTTACGATC"	0.486065854399842	9.78756997669069	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTGTTACGATC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2190.98823058329	37.9575419836269	0.0173243933736338	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2173.43039579111	2173.43039579111
"healthy-2"	"2019-08-01-count-2:GACCCAGCACGAGAAC"	-0.979614357382613	11.4994554289612	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGCACGAGAAC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.20623571198	42.4751516180612	0.0231951763759404	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1821.1975844208	1821.1975844208
"healthy-2"	"2019-08-01-count-4:AGTGCCGAGCCACCGT"	1.83255734023396	-5.11874105846556	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGAGCCACCGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2467.32450402685	40.2016995791637	0.0162936409513834	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2462.22027788048	2462.22027788048
"healthy-2"	"2019-08-01-count-3:ATCACGATCTTCCGTG"	-3.00548873367961	3.11556003177492	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGATCTTCCGTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3254.89762713127	44.7231951911431	0.0137402770576721	5539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3250.22476229024	3250.22476229024
"healthy-2"	"2019-08-01-count-2:AGGTAGGAGCGATGCA"	1.76920845088307	-9.02236940776976	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTAGGAGCGATGCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2113.30979138543	46.5666803340138	0.0220349522459203	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2107.93242755208	2107.93242755208
"healthy-2"	"2019-08-01-count-3:AACCCAATCCAACTGA"	4.19666018065755	-10.8236112824646	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAATCCAACTGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.20863149323	40.2085137113707	0.0163435381847945	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2455.41351883217	2455.41351883217
"healthy-2"	"2019-08-01-count-3:TTACAGGAGACCTGGA"	2.395364900201	-10.773144744989	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACAGGAGACCTGGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.17192216546	36.272257724891	0.0159007119859947	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2275.1438344217	2275.1438344217
"healthy-2"	"2019-08-01-count-2:GATGCTATCCTACCAC"	2.39611663398091	-10.8334131470886	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTATCCTACCAC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.18396293551	42.9361605998515	0.0181841657718494	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2353.56315915313	2353.56315915313
"healthy-2"	"2019-08-01-count-3:TCTGGCTGTGCTTCAA"	6.80380978164021	-0.927659057733141	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTGTGCTTCAA"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1975.6011427211	48.9545241048952	0.0247795585081853	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1962.36074650509	1962.36074650509
"healthy-2"	"2019-08-01-count-3:ACATCGATCAAGGCTT"	1.84111036834065	-9.59464647686156	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCGATCAAGGCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.65256898834	42.5030954036752	0.0186937511840636	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2267.03504818686	2267.03504818686
"healthy-2"	"2019-08-01-count-4:TCATCCGCACACGGTC"	1.18606199797932	10.793056465033	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCCGCACACGGTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1976.00680821552	29.1549101846875	0.0147544583669813	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1966.69526879001	1966.69526879001
"healthy-2"	"2019-08-01-count-3:TAACTTCGTGTTGATC"	1.07338418540303	-8.92977049266966	"2019-08-01-count-3"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACTTCGTGTTGATC"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2264.3648849596	39.0140222028411	0.0172295651032131	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2258.54542294167	2258.54542294167
"healthy-2"	"2019-08-01-count-4:TCATTGTAGGATCATA"	4.36537804183309	-10.6625185242859	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTAGGATCATA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.76309842999	40.9639788536431	0.0170345174043911	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2399.95532800186	2399.95532800186
"healthy-2"	"2019-08-01-count-2:GACTATGGTGTGGTCC"	2.41068234023396	-10.6686496964661	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTATGGTGTGGTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.17768493647	39.4920833699275	0.0164196115809925	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2402.38382131003	2402.38382131003
"healthy-2"	"2019-08-01-count-4:CGAGGCTCAAGGTCGA"	2.79403652724568	-10.9638233414856	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTCAAGGTCGA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.69908808818	42.0880816734199	0.0182539351691023	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.89622456184	2301.89622456184
"healthy-2"	"2019-08-01-count-3:CTCCATGGTGTCATCA"	2.35646571692769	-10.388397239801	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGGTGTCATCA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.41608732007	44.400089435476	0.0192673925858204	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2300.0236563723	2300.0236563723
"healthy-2"	"2019-08-01-count-3:ATCCGTCGTCGTCTCT"	1.8048263984615	-9.4513845673767	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCGTCGTCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.88705637964	40.182409930926	0.0171361813873309	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2339.85202377072	2339.85202377072
"healthy-2"	"2019-08-01-count-3:GCATCGGGTGAATTAG"	3.04740681227986	-10.6356020203796	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCGGGTGAATTAG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2306.84564633355	41.5446908114074	0.0180093067247207	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2302.62547035043	2302.62547035043
"healthy-2"	"2019-08-01-count-2:TGGGAAGTCTTTGCGC"	10.6518436866695	4.3426565893921	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAAGTCTTTGCGC"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1619.295158161	25.6918035452015	0.0158660411078974	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1613.15748480481	1613.15748480481
"healthy-2"	"2019-08-01-count-4:AATGCCATCTACGCAA"	4.46559395369832	-10.7179165116516	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGCCATCTACGCAA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.75680182231	44.9177532375103	0.018275914526696	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2450.01090250696	2450.01090250696
"healthy-2"	"2019-08-01-count-2:AGGGTTTCAATAGGAT"	2.05018117007558	-10.2000446549621	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTTTCAATAGGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.19234005323	38.7207405344806	0.0159397590285635	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2425.26960504973	2425.26960504973
"healthy-2"	"2019-08-01-count-2:AAACCCAGTCTCCTGT"	4.34407295760457	-10.8506384125915	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACCCAGTCTCCTGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.76052448757	43.2885409822477	0.0193532300433301	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2234.31805350496	2234.31805350496
"healthy-2"	"2019-08-01-count-4:CTTCCTTAGTCCTACA"	3.58751859244649	-10.4213934174744	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTAGTCCTACA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.87397588541	37.6246295027965	0.0154650959629356	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2427.43201816963	2427.43201816963
"healthy-2"	"2019-08-01-count-2:GTTCCGTAGGTACAAT"	2.53075422820393	-10.8814668885437	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCCGTAGGTACAAT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.75176348664	32.8513607275884	0.0136326742137357	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2404.43247086923	2404.43247086923
"healthy-2"	"2019-08-01-count-3:AGAGCCCAGAGAGCAA"	3.07603349265401	-11.1096172562805	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCCCAGAGAGCAA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.31684584112	44.770795727105	0.0186287529272637	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2396.88179658148	2396.88179658148
"healthy-2"	"2019-08-01-count-2:GTTCGCTCATCGCTGG"	-5.04707274857219	-5.51756241237792	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCGCTCATCGCTGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.96511621345	45.490017363223	0.016470163615096	3307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2754.82400720557	2754.82400720557
"healthy-2"	"2019-08-01-count-2:TATCGCCTCGCTCCTA"	3.07712544974629	-10.9428119889465	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCTCGCTCCTA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.68115161054	38.0401265815572	0.0149606357672736	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2538.00533003857	2538.00533003857
"healthy-2"	"2019-08-01-count-3:GCCATGGAGGCAGCTA"	2.79420461234395	-11.0133352509704	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGGCAGCTA"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.86973901359	44.6385671276248	0.0199915679574504	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2222.70082025651	2222.70082025651
"healthy-2"	"2019-08-01-count-2:GTTACCCAGGTCGTAG"	6.95345034179036	-1.24631979381713	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCAGGTCGTAG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2406.56348628285	36.3218835167501	0.0150928424385149	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2402.9615686458	2402.9615686458
"healthy-2"	"2019-08-01-count-2:AATGAAGAGGATCATA"	1.99979295310323	-9.11109163677367	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGAAGAGGATCATA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.65075034742	39.2188395864567	0.0185990209995634	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2107.49983494626	2107.49983494626
"healthy-2"	"2019-08-01-count-2:CAGTTCCGTACCCAGC"	3.8232373195583	-10.6126203767029	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCGTACCCAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.7912435288	35.7784659604503	0.0144047798113736	2043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2478.09395649619	2478.09395649619
"healthy-2"	"2019-08-01-count-2:ACGTACACAAATGGCG"	2.56870903548543	-10.9101228944031	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACACAAATGGCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.26467764037	41.5405214588628	0.0186844696794946	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2219.28863054328	2219.28863054328
"healthy-2"	"2019-08-01-count-4:GGTAACTCAATCAAGA"	3.27817358550374	-10.5203829041687	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTCAATCAAGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2597.48626126889	40.9868691911649	0.0157794363736664	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2592.11732395883	2592.11732395883
"healthy-2"	"2019-08-01-count-2:TCACTATTCATGCCGG"	10.2133327918941	4.66276404941408	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTATTCATGCCGG"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.84606741031	32.2927233198935	0.0172702576338908	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1859.49758315019	1859.49758315019
"healthy-2"	"2019-08-01-count-4:CTACTATGTCCTTTGC"	1.233899016946	10.9520997771057	"2019-08-01-count-4"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATGTCCTTTGC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.05994888843	35.1227044110022	0.0187215256270529	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1867.32371351588	1867.32371351588
"healthy-2"	"2019-08-01-count-4:GCTGGGTTCCACGGAC"	3.01457037505452	-10.9585552445618	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTTCCACGGAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.52759664013	37.3984784726456	0.0154186983996597	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2420.56774961526	2420.56774961526
"healthy-2"	"2019-08-01-count-4:AACCTGATCCGTGCGA"	2.10927071151082	-9.7036924592224	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTGATCCGTGCGA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.92184830344	40.3333718671073	0.0179425151713116	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.97555092529	2245.97555092529
"healthy-2"	"2019-08-01-count-3:CCCATTGGTCCGTACG"	2.53125848349873	-10.8160524598328	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCATTGGTCCGTACG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.91540389117	39.9310685680381	0.0163389733148947	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2441.59510941563	2441.59510941563
"healthy-2"	"2019-08-01-count-3:CAGATCACAGACTGCC"	14.3017622428829	1.92914960468141	"2019-08-01-count-3"	"Control2"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCACAGACTGCC"	"Plasmablast"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1380.42566700367	28.917903814734	0.0209485410956626	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1360.03028914009	1360.03028914009
"healthy-2"	"2019-08-01-count-4:GACCGTGCAATAGAGT"	1.21976913985555	-8.9077129594055	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCGTGCAATAGAGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2358.63077325371	35.1399661445877	0.0148984599637494	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2355.89460462911	2355.89460462911
"healthy-2"	"2019-08-01-count-3:CCGTTCACAGCAGATG"	-7.3049467605656	-1.27070238506468	"2019-08-01-count-3"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTTCACAGCAGATG"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3122.28850933278	39.9018797972348	0.0127796901785228	4635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3115.49578913707	3115.49578913707
"healthy-2"	"2019-08-01-count-4:TTCAGGAAGACATAAC"	3.23746313628499	-10.8171482316223	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAGGAAGACATAAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.74001723274	41.2463724999168	0.0182124094536534	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2256.97306101352	2256.97306101352
"healthy-2"	"2019-08-01-count-4:GTGTGGCCAACAGTGG"	-5.17120776596721	-5.21257784282836	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGGCCAACAGTGG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2827.98769170594	40.9268679905185	0.0144720813709871	3398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2824.99042909495	2824.99042909495
"healthy-2"	"2019-08-01-count-3:CCGATCTTCCGTAATG"	2.24900736388509	-10.669309639093	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATCTTCCGTAATG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.61681486597	41.2045072009579	0.0174846020536866	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2350.97157604765	2350.97157604765
"healthy-2"	"2019-08-01-count-2:CGATGGCGTGGCTGAA"	11.0301491218502	3.87248871410219	"2019-08-01-count-2"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGGCGTGGCTGAA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1632.68895295939	31.0632752781158	0.0190258378497698	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1630.63560813346	1630.63560813346
"healthy-2"	"2019-08-01-count-4:CATGCGGGTTGCATCA"	-5.17833934250529	-5.57116892254027	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCGGGTTGCATCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2791.09799540854	40.1364812485142	0.0143801763014198	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2786.33744030016	2786.33744030016
"healthy-2"	"2019-08-01-count-3:GGAATGGAGCCTGTGC"	3.02286448058431	-10.3068962327209	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGAGCCTGTGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.50276449592	41.9466830692569	0.0176505930041088	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2369.08686254174	2369.08686254174
"healthy-2"	"2019-08-01-count-2:AATCGTGAGGAAGTGA"	2.91747297820393	-10.7592659226623	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGAGGAAGTGA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.92328455051	41.1530974327657	0.0178466897439684	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.35510533958	2301.35510533958
"healthy-2"	"2019-08-01-count-3:ATCGTAGGTCAACATC"	2.10813989219014	-10.4865637055603	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGGTCAACATC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.99910194263	43.475950373069	0.019788788413535	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2189.63822127506	2189.63822127506
"healthy-2"	"2019-08-01-count-4:ACAACCAAGGAAGTCC"	1.9192884164745	-9.73432733928832	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCAAGGAAGTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.74525016004	38.199036025631	0.0182880301093225	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2082.66880722097	2082.66880722097
"healthy-2"	"2019-08-01-count-2:GCAACCGCAGCAGATG"	-2.7518666786259	13.4092321165833	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGCAGCAGATG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1824.43424948831	43.6186310894661	0.0239080312714474	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1822.54706170406	1822.54706170406
"healthy-2"	"2019-08-01-count-3:TTTAGTCAGATTGTGA"	10.7481867271358	4.19737336719362	"2019-08-01-count-3"	"Control2"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCAGATTGTGA"	"Pro-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1578.673364611	34.1324349523656	0.0216209608127367	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1570.33451556745	1570.33451556745
"healthy-2"	"2019-08-01-count-4:TGTTCTATCCAGCTCT"	2.56652845916097	-10.8619690171448	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCTATCCAGCTCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.11288449136	42.6289556391207	0.0189200265697048	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2249.01849626726	2249.01849626726
"healthy-2"	"2019-08-01-count-3:TAATCTCCACAATGCT"	1.8122065263683	-9.74986650859984	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCACAATGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.25049060984	36.8089082065223	0.0152275936438991	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2414.83889925279	2414.83889925279
"healthy-2"	"2019-08-01-count-2:TGTGGCGTCATCCTAT"	3.4443859058315	-10.5771150819031	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGTCATCCTAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.4261743963	41.7491019296891	0.0180933641097367	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.04560683358	2302.04560683358
"healthy-2"	"2019-08-01-count-2:TTTACCATCTTGGATG"	3.03513612326924	-10.6404323807922	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACCATCTTGGATG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.16293157059	40.9862725459319	0.018494250563466	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2211.91518908517	2211.91518908517
"healthy-2"	"2019-08-01-count-4:ACGATGTCAAAGCACG"	2.88083161887471	-10.7949257127014	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATGTCAAAGCACG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.17232784426	42.0503059413216	0.0192787637200962	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2178.36969570422	2178.36969570422
"healthy-2"	"2019-08-01-count-4:TCGTCCAGTCATAAAG"	2.81862916526143	-10.9168968430725	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCAGTCATAAAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.29390091857	36.71481042665	0.016439757620593	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2230.33980399936	2230.33980399936
"healthy-2"	"2019-08-01-count-3:TGTTCCGCAGAGGGTT"	2.83103694495503	-10.9265737763611	"2019-08-01-count-3"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGCAGAGGGTT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.98873899462	42.0052416387585	0.0180126262774614	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2329.79765407014	2329.79765407014
"healthy-2"	"2019-08-01-count-2:CGAGGAAGTAACAGGC"	2.38222398337666	-10.8126621476379	"2019-08-01-count-2"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAAGTAACAGGC"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.50757374136	38.948973266871	0.0175484750435952	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2214.60489849926	2214.60489849926
"healthy-2"	"2019-08-01-count-3:GAGTCTACAGAGTAAT"	6.80181278762166	-0.983043216821276	"2019-08-01-count-3"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTACAGAGTAAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2338.20322806251	41.6458415605272	0.0178110444210771	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2332.3234316244	2332.3234316244
"healthy-2"	"2019-08-01-count-3:CTCCTCCGTCGGCACT"	-2.32573662224467	12.4168748625549	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCGTCGGCACT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2068.97737375977	39.9059111136254	0.0192877465069171	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2063.15314673417	2063.15314673417
"healthy-2"	"2019-08-01-count-2:TTCCACGGTCGCATGC"	4.00761498984639	-10.7659073106018	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCACGGTCGCATGC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.6453024139	50.9149847026683	0.0242262500928147	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2093.01218936653	2093.01218936653
"healthy-2"	"2019-08-01-count-4:TTGAACGTCATGAAAG"	0.911198397248429	-8.66381170665892	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAACGTCATGAAAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2266.22380367914	42.710536565194	0.018846566034588	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2263.11861954458	2263.11861954458
"healthy-2"	"2019-08-01-count-4:GTAGGTTAGAGCCATG"	-7.87130818787273	2.86006090724794	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGTTAGAGCCATG"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2347.38590030371	46.2615882757487	0.0197077047577747	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2337.75629764493	2337.75629764493
"healthy-2"	"2019-08-01-count-3:GCACTAAAGGTCTTTG"	3.15726317939107	-10.7640590897766	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAAAGGTCTTTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.73074070275	38.6660072282573	0.0159137004691614	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2427.86267554163	2427.86267554163
"healthy-2"	"2019-08-01-count-3:TCATCCGAGTATTCCG"	2.97023214873616	-11.0363226166931	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCCGAGTATTCCG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2614.20776420803	38.9389692358539	0.0148951318135383	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2606.9856514785	2606.9856514785
"healthy-2"	"2019-08-01-count-2:TGGTAGTGTCGTGTTA"	2.79864277419392	-10.8626632920471	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTGTCGTGTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.52506083687	41.9929031144585	0.0184866563166984	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2265.03847161657	2265.03847161657
"healthy-2"	"2019-08-01-count-2:TGCTTGCAGGCCACTC"	1.87792267379109	-5.4215970269409	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCAGGCCACTC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2459.08642540621	44.5769213950002	0.0181274317707791	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2450.80902608193	2450.80902608193
"healthy-2"	"2019-08-01-count-3:AGAACAAAGCAAGTGC"	1.75826015052144	-9.60681440746459	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAAAGCAAGTGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.12887411211	42.103125522203	0.0181156587275254	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2318.6266168963	2318.6266168963
"healthy-2"	"2019-08-01-count-2:TACAGGTAGTGAGTTA"	3.58040966567342	-10.3265228501526	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAGGTAGTGAGTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.82168742335	39.1718466565582	0.016459992302604	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2377.02303654027	2377.02303654027
"healthy-2"	"2019-08-01-count-4:CCTACGTCAACTTCTT"	2.00983311709706	-10.5155449143616	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTACGTCAACTTCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.03850339105	38.9336908836299	0.0155794681957877	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2491.39679559438	2491.39679559438
"healthy-2"	"2019-08-01-count-2:TAGGTACAGCAGGTCA"	-4.83712087097819	-5.19049217617186	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTACAGCAGGTCA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2829.462190126	43.9853206557134	0.015545470375681	3258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2823.83860076767	2823.83860076767
"healthy-2"	"2019-08-01-count-4:CTCAGTCGTACTCAAC"	-5.24113736572917	3.20984861934511	"2019-08-01-count-4"	"Control2"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTACTCAAC"	"MEP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2551.8717410906	40.9797740260725	0.016058712264496	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2544.91822559648	2544.91822559648
"healthy-2"	"2019-08-01-count-2:GGAGAACTCTTACCAT"	-2.89685283127483	3.23457572543947	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACTCTTACCAT"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3131.55824729868	42.7249644466835	0.0136433561417989	5332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3124.73859910503	3124.73859910503
"healthy-2"	"2019-08-01-count-4:CAGTTCCGTGCCCAGT"	2.14818992194478	-10.6607380143371	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCGTGCCCAGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.35125924189	40.6545152527417	0.0173119396396713	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2344.49042834937	2344.49042834937
"healthy-2"	"2019-08-01-count-3:ACAACCATCATGGAGG"	2.75082673606221	-10.7206297150818	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAACCATCATGGAGG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.93062599811	37.2514657754533	0.0152862233245544	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2433.42860686072	2433.42860686072
"healthy-2"	"2019-08-01-count-3:GCATCTCGTCCCTGTT"	3.32286967810933	-10.1630029908386	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCGTCCCTGTT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.95354787946	38.9552121810577	0.0151934157361298	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2555.27178719672	2555.27178719672
"healthy-2"	"2019-08-01-count-4:AGACACTCATGGATCT"	2.43440618094746	-10.9120140305725	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTCATGGATCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.52772639095	47.9593405734786	0.0197890620566154	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2417.81529340367	2417.81529340367
"healthy-2"	"2019-08-01-count-4:GTGTTAGTCGCAATGT"	-2.33086333695109	13.4324378737244	"2019-08-01-count-4"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTAGTCGCAATGT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1971.90186290479	44.4836092901463	0.0225587338431832	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1966.020513543	1966.020513543
"healthy-2"	"2019-08-01-count-2:CCTTGTGCACATGAAA"	8.58319630202596	7.40220687473146	"2019-08-01-count-2"	"Control2"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGCACATGAAA"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1414.62093455491	29.7076508957941	0.0210004321087905	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1409.6640251812	1409.6640251812
"healthy-2"	"2019-08-01-count-4:ACAGAAAGTCCAGTTA"	2.90842117842976	-10.9760198823181	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAAGTCCAGTTA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.20720966329	39.6034599103448	0.0171949183487206	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2298.23131663055	2298.23131663055
"healthy-2"	"2019-08-01-count-4:AGACAAAAGAGGTTAT"	1.82651783999745	-9.92401506817015	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAAAGAGGTTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.39052307387	37.3761445280566	0.0150808132052168	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2471.56287917394	2471.56287917394
"healthy-2"	"2019-08-01-count-3:AGTCTCCTCCGCACTT"	-1.97173152390178	12.2957563170227	"2019-08-01-count-3"	"Control2"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCTCCGCACTT"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.06523378855	42.351228190725	0.0203899364843138	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	2065.8254127393	2065.8254127393
"healthy-2"	"2019-08-01-count-4:TTCACGCGTGTCTTGA"	-4.96852717819865	-5.13718845760497	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACGCGTGTCTTGA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2637.17375567369	46.4313760652576	0.0176064910267531	3070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2632.93646743715	2632.93646743715
"healthy-2"	"2019-08-01-count-2:AACAAGAAGGACGGAG"	2.17516007003133	-10.2200927964416	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAGAAGGACGGAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.54801322876	45.7670107961546	0.0213809783818493	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2134.68289296039	2134.68289296039
"healthy-2"	"2019-08-01-count-2:GAGTCATTCGTGGCTG"	-2.52263365212138	3.3094444044861	"2019-08-01-count-2"	"Control2"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATTCGTGGCTG"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2917.77545411022	50.1907505136718	0.0172017179879174	4112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	2915.40925198373	2915.40925198373
"healthy-2"	"2019-08-01-count-2:TCCTCCCGTGAGTGAC"	-8.29824099960979	-0.681765162107073	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCGTGAGTGAC"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2971.01663017072	43.5495446144558	0.0146581288614171	4555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2963.52937151309	2963.52937151309
"healthy-2"	"2019-08-01-count-4:CTACTATTCAGGGTAG"	1.32012953337972	-9.10113527691039	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATTCAGGGTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.25228991044	43.417395220509	0.0191921101877757	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2261.27440185077	2261.27440185077
"healthy-2"	"2019-08-01-count-3:CGAGGAAGTGGCCTCA"	3.17105736312215	-10.8201017609802	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGAAGTGGCCTCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.80554471602	41.5072773207491	0.0175892786647995	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2355.76436864949	2355.76436864949
"healthy-2"	"2019-08-01-count-3:CAGCAATTCAAGTGTC"	1.38656391677205	10.8789844282898	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCAATTCAAGTGTC"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1711.38553150117	35.1574589162975	0.0205432722604932	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1703.59740302658	1703.59740302658
"healthy-2"	"2019-08-01-count-3:ACAAGCTTCAAGGAGC"	-2.55651412430461	3.54489967906801	"2019-08-01-count-3"	"Control2"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTTCAAGGAGC"	"Ery"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3132.88248315025	41.0889452785422	0.01311538032452	5650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	54	TRUE	"Ery_healthy-2"	3129.0043537403	3129.0043537403
"healthy-2"	"2019-08-01-count-2:GACCAATTCAACCTTT"	1.46513273295705	-9.52695181286009	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCAATTCAACCTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.36938163615	43.3317059600042	0.0175904215920812	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2461.00596720303	2461.00596720303
"healthy-2"	"2019-08-01-count-2:TGAATGCGTATGGGAC"	2.47129811820332	-11.000852607843	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCGTATGGGAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.58294154135	43.9348138653615	0.0196613037039729	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2226.96736290667	2226.96736290667
"healthy-2"	"2019-08-01-count-4:TACGTCCCAAGTTCGT"	1.24036254462544	-9.03540899669798	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCCAAGTTCGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2441.24903221118	39.8437533349613	0.0163210523831207	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2437.45720144102	2437.45720144102
"healthy-2"	"2019-08-01-count-3:ATCCGTCAGATCGGTG"	2.34953417357747	-10.8937988511291	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCAGATCGGTG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.76221470931	36.8403249086141	0.0154094475318171	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2386.74498537771	2386.74498537771
"healthy-2"	"2019-08-01-count-3:AAGACAAAGGTCGTGA"	4.48029675063435	-10.792133354303	"2019-08-01-count-3"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAAAGGTCGTGA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.2167280841	47.0692319408567	0.0203743793249614	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2302.22920108998	2302.22920108998
"healthy-2"	"2019-08-01-count-3:CCCAACTTCCTTTGAT"	2.47998752173726	-10.8495683900085	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTTCCTTTGAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.77075019881	37.6230308129161	0.0154778194569928	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2428.33831302283	2428.33831302283
"healthy-2"	"2019-08-01-count-4:TTTATGCCAGGCTTGC"	2.80739965018575	-10.7467966309753	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCCAGGCTTGC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.42115008306	37.5386770431908	0.0145587841776669	2427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2575.11432048684	2575.11432048684
"healthy-2"	"2019-08-01-count-2:TGCTGAAGTACATTGC"	-2.62462768974956	13.5766706236633	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAAGTACATTGC"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2188.52090099031	44.259286969743	0.0202233786982412	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	2183.38989476114	2183.38989476114
"healthy-2"	"2019-08-01-count-4:ACACTGAGTGGATCGA"	1.85244836386983	-4.68153860485228	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACTGAGTGGATCGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2248.70486615095	39.2332231499092	0.0174470308400513	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2244.0853393302	2244.0853393302
"healthy-2"	"2019-08-01-count-3:AGCGTATAGCTTTGTG"	1.79272737082784	-5.05830624019774	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGTATAGCTTTGTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2152.41902423242	39.2227346911855	0.0182226296318733	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2147.76121883474	2147.76121883474
"healthy-2"	"2019-08-01-count-2:GATCACACACGTCGGT"	5.826339383691	-1.53136315261992	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACACACGTCGGT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2321.91075417557	39.8894982716968	0.0171796001202726	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2318.1718318647	2318.1718318647
"healthy-2"	"2019-08-01-count-2:ACAGAAATCAACCTCC"	0.360795457928818	12.0627603300842	"2019-08-01-count-2"	"Control2"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAATCAACCTCC"	"CD8+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1899.27114654398	42.7108167184461	0.0224880037777466	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1889.9661970958	1889.9661970958
"healthy-2"	"2019-08-01-count-3:ATTGGGTAGGTAGGCT"	-2.4414316219395	12.9916696318421	"2019-08-01-count-3"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGGGTAGGTAGGCT"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1772.26294766393	36.6821135389195	0.0206978956408648	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1772.26294766393	1772.26294766393
"healthy-2"	"2019-08-01-count-2:CTTACCGTCATTGCCC"	1.57444037970845	-4.91273739254149	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTACCGTCATTGCCC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2218.31999162943	37.8464208867368	0.0170608483129331	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2205.0624459196	2205.0624459196
"healthy-2"	"2019-08-01-count-4:GTAGGAGAGGTACAAT"	6.90794529494588	-1.05467011844786	"2019-08-01-count-4"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGAGGTACAAT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1740.31144975376	50.8765428333155	0.0292341596905049	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	1728.7844535999	1728.7844535999
"healthy-2"	"2019-08-01-count-2:TCTATACGTTGATGTC"	10.6370836692745	4.80970046604005	"2019-08-01-count-2"	"Control2"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACGTTGATGTC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1521.48044439413	37.4866506245352	0.0246382730469222	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1519.38739211215	1519.38739211215
"healthy-2"	"2019-08-01-count-2:GTTCCGTGTGGGCTCT"	6.84623922881429	-1.18968071853789	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCCGTGTGGGCTCT"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2416.33403796782	31.3746945011994	0.0129844193758848	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2403.20352318087	2403.20352318087
"healthy-2"	"2019-08-01-count-2:TACCCACAGCAATAAC"	8.19490971144978	7.21195027911989	"2019-08-01-count-2"	"Control2"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACAGCAATAAC"	"B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1797.78211914497	39.6980985384561	0.0220817072968423	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1792.42080162037	1792.42080162037
"healthy-2"	"2019-08-01-count-2:CGGGTCACATAACTCG"	2.07499136504475	-10.687300705072	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCACATAACTCG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.59594464687	43.9803877361086	0.0189767279484991	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2308.39938015856	2308.39938015856
"healthy-2"	"2019-08-01-count-4:TACTTGTGTTTCGCTC"	1.94406427916829	-5.04830410396727	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTGTTTCGCTC"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2371.30006356575	40.4863467887683	0.0170734810877914	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2368.16086381213	2368.16086381213
"healthy-2"	"2019-08-01-count-2:TGTCCTGAGAAACTAC"	2.55827846106831	-10.6486912003723	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGAGAAACTAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.48918966615	49.2830451056903	0.0261936371340168	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1873.16327487825	1873.16327487825
"healthy-2"	"2019-08-01-count-4:GAAGGGTTCCACGAAT"	2.80204691466634	-10.9638605347839	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGGTTCCACGAAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.096160503	40.4090136997906	0.017447036262525	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2307.7306886426	2307.7306886426
"healthy-2"	"2019-08-01-count-4:TTCTTGACACTACTTT"	1.94304956969563	-8.71648027813109	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGACACTACTTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.50072073256	41.5299613905447	0.017676079442783	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2345.28142598079	2345.28142598079
"healthy-2"	"2019-08-01-count-2:TGTGGCGTCGCTCTCA"	1.82874347743337	-5.10477449810179	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGTCGCTCTCA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2328.06801870476	42.4781373308127	0.0182460894568045	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2323.03990982363	2323.03990982363
"healthy-2"	"2019-08-01-count-2:CAGCCAGGTTCGTTCC"	1.2681950527126	-8.83376219188841	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGGTTCGTTCC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.4795371442	42.4614305173367	0.0181732516130811	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2333.53015879486	2333.53015879486
"healthy-2"	"2019-08-01-count-2:TGTCCACGTTTGGGAG"	-2.03876672211345	13.1976423033508	"2019-08-01-count-2"	"Control2"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCACGTTTGGGAG"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1862.91763656504	44.5241427977878	0.0239002207740564	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1857.05091304719	1857.05091304719
"healthy-2"	"2019-08-01-count-2:CTTAGGACAAATACAG"	10.6600958305294	4.60660216892091	"2019-08-01-count-2"	"Control2"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTAGGACAAATACAG"	"Pre-B"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.14780235456	32.0238494687149	0.0159947479556975	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	134	TRUE	"B_healthy-2"	1990.95878086732	1990.95878086732
"healthy-2"	"2019-08-01-count-4:GATGAGGCAGAAGCGT"	2.91594519194905	-10.8256378403869	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGCAGAAGCGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.23268599929	43.718928681805	0.0193769591909098	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2252.33625208111	2252.33625208111
"healthy-2"	"2019-08-01-count-4:ACGTACAAGCGCATCC"	4.52089323577229	-10.8292255631653	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTACAAGCGCATCC"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.91867797962	42.5773962491697	0.0177411829158368	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2395.92589296434	2395.92589296434
"healthy-2"	"2019-08-01-count-4:CACGGGTAGGATGTTA"	4.61755289611165	-10.8180752030578	"2019-08-01-count-4"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTAGGATGTTA"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.23507997249	41.7338162166391	0.0180882375527754	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2304.99813353341	2304.99813353341
"healthy-2"	"2019-08-01-count-4:TAGACCACAAGTACCT"	2.9123076396877	-11.0297899476257	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCACAAGTACCT"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.21107091984	46.4562697842901	0.0182380919722974	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2541.38614810466	2541.38614810466
"healthy-2"	"2019-08-01-count-4:CAACAACGTGAGACGT"	2.41808428344075	-10.8096647492615	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACGTGAGACGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.7833249214	40.3393576550857	0.017946283882365	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2245.09720370913	2245.09720370913
"healthy-2"	"2019-08-01-count-3:AGGCCACTCATTGGTG"	3.26146091994588	-10.7917900315491	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCCACTCATTGGTG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.55442334449	41.2974590858436	0.018741292998411	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2200.64502485072	2200.64502485072
"healthy-2"	"2019-08-01-count-4:GTAATGCGTGAATTAG"	1.64901485022847	-9.58684542095336	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATGCGTGAATTAG"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.12332499213	40.4287449629473	0.0168094270022847	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2401.84202663923	2401.84202663923
"healthy-2"	"2019-08-01-count-4:CAACAACTCTGCGAGC"	2.30253924903218	-10.6211624375549	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACTCTGCGAGC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.41880014261	39.9054984858805	0.0160364881038487	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2482.87196719291	2482.87196719291
"healthy-2"	"2019-08-01-count-4:ATCACGACACCAGGTC"	2.20347370681111	-10.6894455186096	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACGACACCAGGTC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.95204730803	41.1154846843993	0.0166395316045054	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2468.2664290408	2468.2664290408
"healthy-2"	"2019-08-01-count-2:TTCCACGCATTGCCGG"	-8.14243255081828	-0.847922348138414	"2019-08-01-count-2"	"Control2"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCACGCATTGCCGG"	"GMP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3147.96443808747	42.3430206320654	0.0134509208934364	5440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	3139.96532795053	3139.96532795053
"healthy-2"	"2019-08-01-count-4:GAGCCTGCAATTCGTG"	2.78912581977193	-10.6519623032776	"2019-08-01-count-4"	"Control2"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGCAATTCGTG"	"CD11c+"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.57040087422	38.7860210632842	0.0175457072292044	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2203.44965267212	2203.44965267212
"healthy-2"	"2019-08-01-count-2:CTAACTTAGGCGAACT"	1.46898748454396	9.68113896930543	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTAGGCGAACT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1589.54190637405	37.7414163470176	0.0237435805848684	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1583.77639091636	1583.77639091636
"healthy-2"	"2019-08-01-count-2:CATCGTCTCGTTCATT"	3.04010905799214	-10.8802156678406	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGTCTCGTTCATT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1917.43710234033	44.6973507245472	0.0233109866654775	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	1907.95861459452	1907.95861459452
"healthy-2"	"2019-08-01-count-4:ACGTACAGTGGTAATA"	-7.68196044388469	0.952823019865431	"2019-08-01-count-4"	"Control2"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTACAGTGGTAATA"	"MPP"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2805.23317436189	41.3858029350133	0.014753070551587	4022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	91	TRUE	"HSPC_healthy-2"	2799.94790753031	2799.94790753031
"healthy-2"	"2019-08-01-count-2:ACGTAACTCTGAGTCA"	-2.03217420998271	12.4977321394714	"2019-08-01-count-2"	"Control2"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCTGAGTCA"	"NK"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1711.54054359567	48.6176111752858	0.0284057607383043	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	184	TRUE	"NK_healthy-2"	1707.37267687668	1707.37267687668
"healthy-2"	"2019-08-01-count-4:TATACCTTCAGCTGAT"	1.7809462743694	-5.0202036133972	"2019-08-01-count-4"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTTCAGCTGAT"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2469.91859115211	40.4025167874802	0.0163578333845547	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2462.51027189847	2462.51027189847
"healthy-2"	"2019-08-01-count-4:ATCGATGCAGCTCGGT"	3.08269705352132	-10.9833021393982	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGCAGCTCGGT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.74837428671	40.1772713999824	0.0175696075054671	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2280.20400599872	2280.20400599872
"healthy-2"	"2019-08-01-count-2:TACATTCTCGAGGCAA"	-4.1554459137028	-5.27701523220214	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACATTCTCGAGGCAA"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2562.57349622359	42.7027081252862	0.0166639935159777	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2558.94001735715	2558.94001735715
"healthy-2"	"2019-08-01-count-2:AGGATAACAGCTGAAG"	1.01455958661382	-8.92684652721556	"2019-08-01-count-2"	"Control2"	"Granulocyte"	"Granulocytes"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAACAGCTGAAG"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2421.77325702929	41.0107364013656	0.0169341767576013	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2417.88731097596	2417.88731097596
"healthy-2"	"2019-08-01-count-2:AGCCAGCTCCAAGCAT"	1.09586383876149	10.6264285811218	"2019-08-01-count-2"	"Control2"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCTCCAAGCAT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.91071367747	36.321937351935	0.0214426516454816	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1692.6662718661	1692.6662718661
"healthy-2"	"2019-08-01-count-3:ACAACCAAGAAAGTCT"	1.3251961666042	10.6774825819763	"2019-08-01-count-3"	"Control2"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAACCAAGAAAGTCT"	"CD4+ T"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.01530592956	34.2021472652804	0.0180009851281421	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	171	TRUE	"T_healthy-2"	1895.70534953126	1895.70534953126
"healthy-2"	"2019-08-01-count-2:TTCCGGTAGTTCACTG"	1.87341763552968	-5.13851358806761	"2019-08-01-count-2"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTAGTTCACTG"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2515.61053046857	41.9599039449542	0.0166798093094079	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2509.38115616797	2509.38115616797
"healthy-2"	"2019-08-01-count-3:AGTTCCCGTTTGTTCT"	2.88905372199361	-11.0491180649963	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTTTGTTCT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.0351226914	41.7121036301402	0.0180179139492479	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2311.86109683558	2311.86109683558
"healthy-2"	"2019-08-01-count-3:ACTTTCACAGCCTATA"	3.19857611235921	-11.0340290299621	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTCACAGCCTATA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.34306075172	42.1058658039607	0.0171906771569346	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2445.29166797262	2445.29166797262
"healthy-2"	"2019-08-01-count-4:TAGACCAAGCCAAGCA"	2.86695518073384	-11.0283518067566	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCAAGCCAAGCA"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.14608685964	38.8188505302202	0.0154401730007296	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2504.54528145544	2504.54528145544
"healthy-2"	"2019-08-01-count-4:TTCACGCGTACTAGCT"	-5.1070159477299	-5.26483156597289	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACGCGTACTAGCT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2789.14166135787	47.5433593408184	0.0170458747217853	3049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2784.49071634131	2784.49071634131
"healthy-2"	"2019-08-01-count-4:CACGGGTGTCGCTTAA"	1.78998591479604	-10.1781978837219	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTGTCGCTTAA"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.52245968511	40.3317935133531	0.0183199555089354	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2193.48532598355	2193.48532598355
"healthy-2"	"2019-08-01-count-2:CACCGTTTCGTGGTAT"	2.06853355941121	-10.0707855454651	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCGTTTCGTGGTAT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.96145345793	40.442807346809	0.0183334152477657	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2204.00031552157	2204.00031552157
"healthy-2"	"2019-08-01-count-3:TTTACTGAGCTCCCTT"	2.68312086638753	-10.6895532838074	"2019-08-01-count-3"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACTGAGCTCCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.24263010435	46.3173880878234	0.0211278566759825	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2188.8167676604	2188.8167676604
"healthy-2"	"2019-08-01-count-2:CCGGTAGTCAAGCCCG"	6.95014872130696	-1.13057210361632	"2019-08-01-count-2"	"Control2"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGTCAAGCCCG"	"pDC"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2093.19893713038	38.2140652611925	0.0182562988081683	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2087.60051639273	2087.60051639273
"healthy-2"	"2019-08-01-count-3:AGCCAATTCTCCGCAT"	2.97112764891927	-11.0154276124206	"2019-08-01-count-3"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATTCTCCGCAT"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.766656321	37.1777317433666	0.0146671219816845	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2528.93902039796	2528.93902039796
"healthy-2"	"2019-08-01-count-4:GCCATGGCAAATGAGT"	-5.13975272598918	-5.29366114055785	"2019-08-01-count-4"	"Control2"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGCAAATGAGT"	"Granulocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2728.75351276781	40.1496341803056	0.0147135437453203	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	175	TRUE	"Gran_healthy-2"	2726.30659969352	2726.30659969352
"healthy-2"	"2019-08-01-count-2:TGCTTCGAGTAAAGCT"	2.25091065940205	-10.3035907975403	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+ IFN+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGAGTAAAGCT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.22543323443	39.8281884636971	0.0172474232660393	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2305.45554114218	2305.45554114218
"healthy-2"	"2019-08-01-count-4:CTGCTCATCGCCGAAC"	2.22774138030354	-10.9055280915466	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCATCGCCGAAC"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.84684546497	44.8219329632233	0.0200111597156629	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2233.4653174334	2233.4653174334
"healthy-2"	"2019-08-01-count-3:CGACAGCTCGAACGGA"	1.82949974116628	-5.04037763988646	"2019-08-01-count-3"	"Control2"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCTCGAACGGA"	"cDC2"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2356.31008881025	39.9429747451597	0.0169514933262997	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	218	TRUE	"DC_healthy-2"	2349.82587573936	2349.82587573936
"healthy-2"	"2019-08-01-count-2:ATCGTCCTCAGACTGT"	2.40926351126973	-10.4121027222839	"2019-08-01-count-2"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCTCAGACTGT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.31247784109	41.3559077285075	0.0179393935208459	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2301.41471254267	2301.41471254267
"healthy-2"	"2019-08-01-count-4:TACAGGTCACAGGATG"	3.99003257331197	-10.5621309510437	"2019-08-01-count-4"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAGGTCACAGGATG"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.25804514518	41.0651844724786	0.0169883329398588	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2415.44164029378	2415.44164029378
"healthy-2"	"2019-08-01-count-2:AACACACAGTCCGCGT"	4.60243429717366	-10.5722360841003	"2019-08-01-count-2"	"Control2"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACACACAGTCCGCGT"	"CD16+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.22631713694	39.4684716269297	0.0172938465088085	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2278.61169234807	2278.61169234807
"healthy-2"	"2019-08-01-count-2:TAGGGTTTCTCCCAAC"	3.66475643691365	-10.4502096406189	"2019-08-01-count-2"	"Control2"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTTCTCCCAAC"	"HLA-II+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.82051131958	39.2217173387138	0.0165365453041354	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2369.35018513307	2369.35018513307
"healthy-2"	"2019-08-01-count-4:CACTGGGGTGTCCCTT"	2.0016139942104	-10.3006792298523	"2019-08-01-count-4"	"Control2"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGGTGTCCCTT"	"CD14+ monocyte"	"2"	"M"	39	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.75550183272	32.3053584542306	0.0132520912905101	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1372	TRUE	"Mono_healthy-2"	2434.67486908428	2434.67486908428
"healthy-3"	"2019-08-01-count-4:AATCGACAGTAGCAAT"	2.92272319373433	-6.55141594326171	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCGACAGTAGCAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.49595295494	44.8830545215059	0.019872984258742	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2247.92615260341	2247.92615260341
"healthy-3"	"2019-08-01-count-4:CATCAAGCACACAGAG"	10.7773939567501	7.42297027194826	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCAAGCACACAGAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2187.67008577106	44.732300432757	0.0204474617647801	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2175.76491663547	2175.76491663547
"healthy-3"	"2019-08-01-count-2:GATTTCTTCCGTAGGC"	11.1960731941158	6.33625362003175	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTTCCGTAGGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.05318039106	41.6259870100228	0.0210758816133655	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1965.05573437057	1965.05573437057
"healthy-3"	"2019-08-01-count-2:CAGTGCGGTATGTGTC"	-3.78932772103007	10.2968892821106	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTGCGGTATGTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.11908839126	46.1782042934004	0.0225356371696553	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.49050422745	2040.49050422745
"healthy-3"	"2019-08-01-count-2:CTCCACAGTAGGCAAC"	-2.92862067642863	10.0672492750916	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCACAGTAGGCAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.5917314728	50.4355910798274	0.0243816072125156	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2063.54632482948	2063.54632482948
"healthy-3"	"2019-08-01-count-4:GGGTGTCTCGCAAGAG"	1.72865047034566	-6.82430746471556	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGTCTCGCAAGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.24537340807	48.6624707880241	0.0262721513502753	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1850.42920730179	1850.42920730179
"healthy-3"	"2019-08-01-count-3:ACTTCGCCAGCCATTA"	-0.69460097971614	8.42780969226686	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCCAGCCATTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2017.06308476943	41.1328083702634	0.0203924253439824	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2011.17743606668	2011.17743606668
"healthy-3"	"2019-08-01-count-2:ATTTACCTCACCTTAT"	-4.07510648194011	13.0908221968445	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCTCACCTTAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2437.06391576464	42.9271405086002	0.017614285875277	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2432.51063812069	2432.51063812069
"healthy-3"	"2019-08-01-count-3:TACCTGCTCTATACTC"	-3.63223920288737	9.89043424213258	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCTCTATACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2211.90182487396	40.9230145634485	0.0185012798051199	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2210.29294402647	2210.29294402647
"healthy-3"	"2019-08-01-count-4:CAACGGCAGCCGTTAT"	-3.14308414879497	9.53087518298952	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCAGCCGTTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.05235313667	43.9582015036418	0.0224499622970876	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1952.88334742856	1952.88334742856
"healthy-3"	"2019-08-01-count-3:AGACTCATCCGTCAAA"	-2.90872655335124	9.30031106555787	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCATCCGTCAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2185.60898709522	36.7625946688764	0.0168202980889714	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2178.1599087097	2178.1599087097
"healthy-3"	"2019-08-01-count-2:TCGCTTGGTACTTCCC"	10.5736652809078	7.27730987155763	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTTGGTACTTCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.37877497925	44.7232966049397	0.022346243082049	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1993.02983552567	1993.02983552567
"healthy-3"	"2019-08-01-count-3:TGTTGAGTCAGAACCT"	2.69454254683797	-6.97596838390502	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGTCAGAACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.36646188512	40.5110715590331	0.0187954448932092	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2152.89447344253	2152.89447344253
"healthy-3"	"2019-08-01-count-4:TCACTATGTGTTCCAA"	10.4830118614132	7.39520595157472	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTATGTGTTCCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.55736293532	37.8798863488412	0.0194599383866705	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.79696503121	1938.79696503121
"healthy-3"	"2019-08-01-count-4:CACTGAACATATGGCT"	4.12041821059529	-7.26390793239745	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAACATATGGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.46090042565	47.1235503351823	0.0186225166835242	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2522.66252517837	2522.66252517837
"healthy-3"	"2019-08-01-count-4:TACAACGGTACTGGGA"	-4.86036477509196	3.27811715686647	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAACGGTACTGGGA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3048.97493794266	45.0076927043515	0.0147615817185828	3791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3031.34669763215	3031.34669763215
"healthy-3"	"2019-08-01-count-4:TCTATCAAGCTAGCCC"	3.7973128753597	-6.70700743114623	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATCAAGCTAGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.18686753762	40.2577885412679	0.0146916215890941	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2733.22243792078	2733.22243792078
"healthy-3"	"2019-08-01-count-3:CGTTAGAGTGTTAGCT"	3.89932360228841	-6.70452501690062	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGAGTGTTAGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.95014265072	49.0954007312745	0.0200639154331484	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2445.83793896954	2445.83793896954
"healthy-3"	"2019-08-01-count-3:ATCATTCCAGATCACT"	-1.75742361965831	11.7679261931214	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCATTCCAGATCACT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2091.94274662128	40.7871875137698	0.0194972771504601	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.81448625263	2085.81448625263
"healthy-3"	"2019-08-01-count-3:GGCAGTCGTGCCTATA"	-2.84616790238078	9.98572156513063	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCAGTCGTGCCTATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.05606511288	44.3187771113355	0.0246344613549077	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1789.62512132469	1789.62512132469
"healthy-3"	"2019-08-01-count-4:CAGGTATAGCAGTAAT"	5.54643787917439	-9.96824648296507	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGTATAGCAGTAAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.15389834767	46.8902147673321	0.0194795250937295	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2396.78823862831	2396.78823862831
"healthy-3"	"2019-08-01-count-2:AGGACTTAGTTAGTAG"	-3.08546505394633	9.69996640765993	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTAGTTAGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.90672215084	45.0207758239519	0.0219089145695282	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.31073744257	2053.31073744257
"healthy-3"	"2019-08-01-count-2:TCGGGCAAGGTCATCT"	0.476168622344178	8.26607701862184	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAAGGTCATCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.33141369278	39.2846094169243	0.0226381019250535	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1729.70262059856	1729.70262059856
"healthy-3"	"2019-08-01-count-3:GCCGATGGTTCCGCGA"	2.81312813338582	-6.40632202541503	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGGTTCCGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.00536518527	46.131787777534	0.0184896547403249	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2489.41960730891	2489.41960730891
"healthy-3"	"2019-08-01-count-3:ATGCCTCGTGAGTAAT"	-4.03059277954753	13.1958608397278	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCCTCGTGAGTAAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2073.96711552424	43.3899441335419	0.0209212305290454	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2066.71994038616	2066.71994038616
"healthy-3"	"2019-08-01-count-3:GCCATGGAGAACCCGA"	10.9544664817745	6.4050984152588	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGAACCCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.36919593542	49.765180856593	0.0249904341988259	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1981.74710123689	1981.74710123689
"healthy-3"	"2019-08-01-count-4:CCGCAAGAGCACCTGC"	-3.77221451225932	10.3758277663025	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGAGCACCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.16960711211	47.4416858074219	0.0246428603652162	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1918.08661754541	1918.08661754541
"healthy-3"	"2019-08-01-count-4:CACTGAACAACAAGAT"	-2.95111761513408	9.42825601184694	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAACAACAAGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2206.24612447104	44.8805254480059	0.0203424835290152	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2199.93746093868	2199.93746093868
"healthy-3"	"2019-08-01-count-3:AGGACTTCACCAGTAT"	10.2483765083248	7.84041497791139	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACTTCACCAGTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2214.2819633663	45.0795832218245	0.0203585559416704	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2204.37102326621	2204.37102326621
"healthy-3"	"2019-08-01-count-4:ACTATTCAGATAGGGA"	-3.64498005333598	11.3880738981995	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCAGATAGGGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1830.85124106973	47.7888965615676	0.0261020095404614	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1827.28224753227	1827.28224753227
"healthy-3"	"2019-08-01-count-4:CCTCATGGTGGATCAG"	-0.836730698973495	8.42466256702272	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGGTGGATCAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2069.74081242206	42.5115717229602	0.0205395629577465	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2066.87633817319	2066.87633817319
"healthy-3"	"2019-08-01-count-3:TTGCTGCCAAGACGGT"	-4.22132382813151	10.6212806471619	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCTGCCAAGACGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.29102690968	45.1597968981823	0.0222759319203528	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2025.73217642152	2025.73217642152
"healthy-3"	"2019-08-01-count-1:GTCCACTAGAGTGTTA"	10.5978638130123	6.4458904036316	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTCCACTAGAGTGTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.9540650844	36.7377845018159	0.018080027070046	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2023.3750863792	2023.3750863792
"healthy-3"	"2019-08-01-count-3:TACACCCTCCCTCTTT"	-3.19056640091594	12.1674318083557	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCTCCCTCTTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2368.80220280082	46.4706979719181	0.0196178042712778	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2363.79826139702	2363.79826139702
"healthy-3"	"2019-08-01-count-3:CCCAACTCATGACTAC"	-2.40947328034099	9.77170369708864	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTCATGACTAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.4902371691	45.4411369480176	0.0240112926637821	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1885.6846438138	1885.6846438138
"healthy-3"	"2019-08-01-count-3:CACAGGCGTTCTTGTT"	5.27043690261189	-9.0790062180725	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCGTTCTTGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.02702556116	43.0296146736211	0.0174207060199454	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2466.27886303508	2466.27886303508
"healthy-3"	"2019-08-01-count-4:AACCACAAGTGGGAAA"	4.41759504851643	-8.13354113018187	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACAAGTGGGAAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.89177937444	49.94159012075	0.0190044318083138	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2623.29434927766	2623.29434927766
"healthy-3"	"2019-08-01-count-4:GGTAACTAGGATTCCT"	-1.45165834847148	8.78520677173463	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTAGGATTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2197.73298899151	48.9368987951898	0.0222669901395282	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2194.69704830645	2194.69704830645
"healthy-3"	"2019-08-01-count-4:CAACGATGTATCGATC"	-3.40302715721782	9.9625205763611	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGATGTATCGATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2131.63298953739	45.7027119814977	0.0214402348836871	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2128.61435507586	2128.61435507586
"healthy-3"	"2019-08-01-count-3:TTACCGCCAATTTCCT"	-2.45434842529948	8.96585271442262	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCCAATTTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.01809818914	48.3285718882627	0.0228826504515751	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.80471627007	2108.80471627007
"healthy-3"	"2019-08-01-count-4:CCAATGACATCCGGTG"	10.4017044502193	7.29632947528688	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGACATCCGGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.5852721258	43.9783607292871	0.0221042854234128	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1986.5355139045	1986.5355139045
"healthy-3"	"2019-08-01-count-4:CCTCATGGTTTGTTCT"	-1.49717615070995	8.79211709583131	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGGTTTGTTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2211.01508814811	47.513762111483	0.0214895693684656	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2205.11256552391	2205.11256552391
"healthy-3"	"2019-08-01-count-3:GTCTGTCGTTCCACGG"	-1.74787185612376	10.1502055891785	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTGTCGTTCCACGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1739.45644630718	43.6953770826614	0.0251201328871588	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1733.66761896572	1733.66761896572
"healthy-3"	"2019-08-01-count-3:CTGAATGTCAAGTCTG"	-1.71038017693217	8.69311997974244	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAATGTCAAGTCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1901.99901587471	48.9959312431715	0.0257602295449341	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.53780551584	1893.53780551584
"healthy-3"	"2019-08-01-count-2:CTCCAACAGTTGGCGA"	-2.95169411125835	9.30105779254762	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACAGTTGGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2169.28199316241	46.3137067913318	0.0213497862137393	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2162.90108820336	2162.90108820336
"healthy-3"	"2019-08-01-count-3:GGAGAACCATATGCGT"	-4.06521592560466	9.97678849780885	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACCATATGCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2667.674204523	46.8820304392423	0.0175741214424739	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2659.06709937351	2659.06709937351
"healthy-3"	"2019-08-01-count-3:TACACCCTCATCCTGC"	-2.64827809754069	9.56702039325563	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCTCATCCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2186.86596908386	46.0915169178592	0.0210765166084542	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2178.54687191613	2178.54687191613
"healthy-3"	"2019-08-01-count-4:AGTCTCCAGGTGCAGT"	10.9654375511104	6.1602482565674	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCTCCAGGTGCAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.48532251149	45.6826701775272	0.025831523505466	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1763.16354702111	1763.16354702111
"healthy-3"	"2019-08-01-count-4:ACCAAACCACATACTG"	-0.650147358805496	8.54820630634157	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACCACATACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2233.58391693439	48.0855377575791	0.0215284222782087	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2224.89749793984	2224.89749793984
"healthy-3"	"2019-08-01-count-2:CCCTGATCACCTCGTT"	0.875797172158402	8.49441049182741	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTGATCACCTCGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.16805216126	47.7730043908228	0.0251414627966645	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.80468539541	1893.80468539541
"healthy-3"	"2019-08-01-count-4:TGATGCATCATGCCGG"	4.86917509612386	-7.97013380443724	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCATCATGCCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.7344090035	43.164919382934	0.016439179543416	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2620.5864264496	2620.5864264496
"healthy-3"	"2019-08-01-count-2:AACCATGAGACACACG"	-0.28683982315715	8.32671067798463	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGAGACACACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2094.23803772341	42.2106328866557	0.0201556041511603	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2090.44062136496	2090.44062136496
"healthy-3"	"2019-08-01-count-2:CATGCTCAGTTAACAG"	0.801477511494797	8.94190595233766	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCAGTTAACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1767.20707741549	50.1791991512035	0.0283946345578186	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1756.34903915581	1756.34903915581
"healthy-3"	"2019-08-01-count-4:ACTATTCAGGGTGAAA"	4.27902807769124	-8.19988920604857	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCAGGGTGAAA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.1780694495	38.1743759057733	0.0136670040207272	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2788.67312004575	2788.67312004575
"healthy-3"	"2019-08-01-count-3:CAGCGTGCAACAGCCC"	-0.53589109602626	8.32117555225221	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCGTGCAACAGCCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.79890434646	44.4136634457118	0.0246496228511257	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1801.79890434646	1801.79890434646
"healthy-3"	"2019-08-01-count-2:CCATAAGGTCCAGGTC"	-2.6901744407719	9.51472280109254	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGGTCCAGGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2131.15747987681	46.8886389025364	0.0220014894935154	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2129.51385947182	2129.51385947182
"healthy-3"	"2019-08-01-count-4:TTCCAATGTCTGCCTT"	-3.87666807594951	10.2918195494446	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCAATGTCTGCCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.60800683853	53.9795813358425	0.0259316745316639	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.36998211913	2078.36998211913
"healthy-3"	"2019-08-01-count-2:GGGTAGAAGTCGCTAT"	0.398037572472733	7.95383260333864	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTAGAAGTCGCTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.68805237628	43.7178451101763	0.0251441568546047	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1729.81006509805	1729.81006509805
"healthy-3"	"2019-08-01-count-3:AATGAAGCACGAAAGC"	-1.65585706654246	8.99000260913698	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGCACGAAAGC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2204.22518883283	46.097885576096	0.0209134192865773	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2194.45665939676	2194.45665939676
"healthy-3"	"2019-08-01-count-3:AATCGACCACGCTATA"	5.03235306319539	-8.43590643322142	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACCACGCTATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2852.22171801953	46.3878099011316	0.0162637461204599	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2846.14543310175	2846.14543310175
"healthy-3"	"2019-08-01-count-3:TAGACTGAGAGTAACT"	-1.19694493237193	8.47561357105104	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGAGAGTAACT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1944.61815616987	45.0050093611367	0.0231433658162376	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.00516829325	1940.00516829325
"healthy-3"	"2019-08-01-count-4:GTAAGTCAGTGAGGTC"	2.96004452285115	-6.90760710155638	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAAGTCAGTGAGGTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.26635109745	47.9233120338696	0.021221284199085	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2251.59487942358	2251.59487942358
"healthy-3"	"2019-08-01-count-2:ATAGAGAGTTGTGCAT"	4.88962616500203	-8.16201498424681	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGAGTTGTGCAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.98021520433	48.0937527973359	0.0213942064400974	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2240.39065299355	2240.39065299355
"healthy-3"	"2019-08-01-count-3:TGGGCGTTCGCCGTGA"	-4.17811141434367	13.1660184630188	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTTCGCCGTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.01001289193	46.7526516570581	0.0238411080768074	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1953.58126257937	1953.58126257937
"healthy-3"	"2019-08-01-count-2:CTCGAGGGTTACGTAC"	-3.80008612099345	10.6442050703797	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCGAGGGTTACGTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1898.86274004648	49.7850731859503	0.0262183633055709	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1895.22002510709	1895.22002510709
"healthy-3"	"2019-08-01-count-3:AGAGAATAGAAATCCA"	-4.36131082001384	12.3922481306824	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATAGAAATCCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2261.40424166101	42.3039043753333	0.0187069182926185	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2258.18340369487	2258.18340369487
"healthy-3"	"2019-08-01-count-3:TACCTGCTCACACCGG"	-2.59754190865214	10.7449550398621	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCTCACACCGG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2241.46183203051	40.8099737967746	0.0182068564423448	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2238.54028122131	2238.54028122131
"healthy-3"	"2019-08-01-count-4:CTACCTGAGTAGACAT"	1.93005706843678	-6.48311474239501	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCTGAGTAGACAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2587.73751849431	53.3248573374737	0.0206067489288871	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2586.69177300416	2586.69177300416
"healthy-3"	"2019-08-01-count-3:ATCTTCAAGCTTAGTC"	4.83415379103963	-8.36250688945922	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTTCAAGCTTAGTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.14015584338	45.2832332660261	0.017449243796742	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2591.64194211537	2591.64194211537
"healthy-3"	"2019-08-01-count-4:AAGCGAGCATGCACTA"	2.5239597755367	-6.50624468242797	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGCATGCACTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.13647637053	54.8956268627204	0.0248268831206787	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2208.24475265868	2208.24475265868
"healthy-3"	"2019-08-01-count-3:ATCTCTATCCTCACCA"	-1.97458730164226	9.66748616779176	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTATCCTCACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.07819148976	48.653704606537	0.0249624180389341	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1941.86645793319	1941.86645793319
"healthy-3"	"2019-08-01-count-4:GTAGAGGTCCGAGTGC"	-4.0519302887028	11.8295049437317	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGTCCGAGTGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2013.51203271059	43.4501295454157	0.0215792748389604	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.40041300385	2005.40041300385
"healthy-3"	"2019-08-01-count-4:CCTCCTCCACTGAATC"	-0.0765792978113473	8.28884694660035	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCCACTGAATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2332.79533219145	38.6893814156226	0.0165849874962145	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2325.35890897701	2325.35890897701
"healthy-3"	"2019-08-01-count-4:ATAGGCTCACAGTCAT"	10.3617416816646	7.53160617435304	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTCACAGTCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.9457588847	40.6744063897134	0.0200273228429546	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2022.41515094188	2022.41515094188
"healthy-3"	"2019-08-01-count-2:CTATCTAAGACGATAT"	4.56053509291951	-8.12875463878783	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTAAGACGATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.85587254555	47.8859101221789	0.0206062306565186	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2318.59065425409	2318.59065425409
"healthy-3"	"2019-08-01-count-2:ATCCCTGGTCGTCAGC"	2.01010956343953	-6.10650637066039	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGGTCGTCAGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2803.98044579821	44.0071018386216	0.0156945109601483	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2800.18209372586	2800.18209372586
"healthy-3"	"2019-08-01-count-3:TCATCCGAGGATTTCC"	-4.58480582657512	3.63955972278444	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCCGAGGATTTCC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2921.489194482	47.4391276368705	0.0162379952410818	3500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2908.7555776639	2908.7555776639
"healthy-3"	"2019-08-01-count-3:AGATGAATCCTAACAG"	-4.10327611389812	12.030958152655	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGAATCCTAACAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2095.67144425354	44.5442776055614	0.0212553727005751	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2092.18184219715	2092.18184219715
"healthy-3"	"2019-08-01-count-3:GTAATGCAGGTACAGC"	0.377154906361741	8.04090688312379	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCAGGTACAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.41929181206	40.4539872164799	0.0224567303127895	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1793.81071447255	1793.81071447255
"healthy-3"	"2019-08-01-count-4:ACGTTCCTCTCCCTAG"	-2.52835283699687	8.72098634326784	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTTCCTCTCCCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2122.1500954865	43.6888402053312	0.0205870641752678	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2118.24013866921	2118.24013866921
"healthy-3"	"2019-08-01-count-4:TTGCCTGGTCGCTCGA"	-3.95212636414226	11.0971603163513	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCCTGGTCGCTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.92868976734	47.268625716153	0.0235879779343051	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.23052303308	1998.23052303308
"healthy-3"	"2019-08-01-count-2:TATCCTATCCCGAAAT"	-1.14713964882548	8.35342881763307	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTATCCCGAAAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2084.12007320311	42.1369774512013	0.0202181141062763	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2077.06048494227	2077.06048494227
"healthy-3"	"2019-08-01-count-4:CCTTCAGCACAAACGG"	11.1901260810787	5.55701110446779	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTCAGCACAAACGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.4351425885	38.1772123825917	0.0188675246263407	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2017.32320357079	2017.32320357079
"healthy-3"	"2019-08-01-count-4:AGTACCACATTGACAC"	2.91372265395467	-6.33082678234252	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCACATTGACAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.73019314622	46.5397657548716	0.0186851895411778	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2487.02719063545	2487.02719063545
"healthy-3"	"2019-08-01-count-4:CGCAGGTTCACTGAAC"	-7.12576518479045	3.54321858966676	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCAGGTTCACTGAAC"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2387.88813388568	45.024475699198	0.018855353841862	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2379.23571018124	2379.23571018124
"healthy-3"	"2019-08-01-count-4:CACTAAGCAAGTTCGT"	4.4742280441219	-7.9467401734558	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTAAGCAAGTTCGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.03991319068	47.4515725900975	0.0189348830161617	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2499.47162405796	2499.47162405796
"healthy-3"	"2019-08-01-count-3:AAGGTAAGTCGTACTA"	10.6243511634762	6.52237413013307	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAAGTCGTACTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.83475367795	41.1257944665063	0.0222201330425537	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1844.17605554311	1844.17605554311
"healthy-3"	"2019-08-01-count-4:GTTACGATCTGGGATT"	3.41059174117391	-6.19468738948973	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGATCTGGGATT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2776.58270105663	47.3187989614779	0.0170420996080796	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2772.62627818449	2772.62627818449
"healthy-3"	"2019-08-01-count-4:GTAGCTACACATGGTT"	-0.716884712607223	8.37129781329957	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGCTACACATGGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.43878543404	46.9785267033614	0.0239999978813869	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1944.55948671093	1944.55948671093
"healthy-3"	"2019-08-01-count-3:TTGTTGTGTCCCGGTA"	4.1514479118282	-7.24935867702635	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTGTGTCCCGGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.26899779821	47.2121890914347	0.0198765651954362	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2375.26899779821	2375.26899779821
"healthy-3"	"2019-08-01-count-2:TTACGCCTCCAACCAA"	-4.20712790909465	10.4789342650208	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCTCCAACCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2226.3171125763	45.7780306715447	0.0205622237788803	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2214.56400389863	2214.56400389863
"healthy-3"	"2019-08-01-count-3:GATGATCAGTGTCATC"	14.4567762809688	1.97173640811769	"2019-08-01-count-3"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGATCAGTGTCATC"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	2239.92147477103	35.9033058684311	0.0160288234533316	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2209.53578017797	2209.53578017797
"healthy-3"	"2019-08-01-count-4:GTCTTTAGTTCGTACA"	4.72891392287557	-8.27641584789427	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTTTAGTTCGTACA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.09231863942	43.1665255997505	0.015875343879957	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2709.15666455862	2709.15666455862
"healthy-3"	"2019-08-01-count-1:CTGATCCTCATCGCCT"	0.316788663237733	8.25062081897584	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGATCCTCATCGCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2224.65802282952	35.9344066817041	0.0161527777810989	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2211.13871119661	2211.13871119661
"healthy-3"	"2019-08-01-count-4:TTGCATTCAGTCAGTT"	-3.96232543411906	10.3912820585999	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTCAGTCAGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2141.30471610719	49.6181403969474	0.0231719194487887	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2138.13642826503	2138.13642826503
"healthy-3"	"2019-08-01-count-1:GTAATCGTCGACCTAA"	11.0575853782589	6.41634175861207	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTAATCGTCGACCTAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2249.80351359347	45.1701205748837	0.0200773624460814	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2239.24906676017	2239.24906676017
"healthy-3"	"2019-08-01-count-2:AAGTGAATCGTGCAGC"	-2.6809974712437	9.44675824725953	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAATCGTGCAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1943.57712436497	45.5346506327083	0.0234282705131065	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1938.88245553243	1938.88245553243
"healthy-3"	"2019-08-01-count-4:ACATGCAAGAGAGCGG"	-0.0929783237284005	7.86534974658815	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATGCAAGAGAGCGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.21412928724	37.5653974388121	0.0197586357370988	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1896.02263968002	1896.02263968002
"healthy-3"	"2019-08-01-count-4:ATACCGATCGTTCATT"	4.93834461745564	-8.13575651561888	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGATCGTTCATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2687.73671895171	40.9585960031131	0.0152390655358118	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2681.41133428024	2681.41133428024
"healthy-3"	"2019-08-01-count-4:GTCCACTTCTGTACAG"	4.27131046828572	-7.72571470653685	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTTCTGTACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.76064653172	42.979492175411	0.0172279020976069	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2490.34621717474	2490.34621717474
"healthy-3"	"2019-08-01-count-4:CCTAACCCACGTATAC"	3.96704949912373	-6.50962212001952	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCCACGTATAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2751.6082628638	45.8294915533082	0.01665552912158	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2748.78915186926	2748.78915186926
"healthy-3"	"2019-08-01-count-3:TGCGGGTAGTCATCCA"	-1.53662000122722	8.65603540027467	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGGTAGTCATCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.47044970316	34.7972885018986	0.0180066342060981	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1924.23418458716	1924.23418458716
"healthy-3"	"2019-08-01-count-2:GGAGAACGTGTACGCC"	-4.2845119041508	13.1000270613464	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACGTGTACGCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1990.15753389532	37.0107176951361	0.0185968784203205	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1986.41974911308	1986.41974911308
"healthy-3"	"2019-08-01-count-4:ATACCGAGTACTGGGA"	-1.88555226746257	10.3996352919373	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGAGTACTGGGA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2099.97162427675	43.8546194763724	0.0208834343137739	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2089.65499485055	2089.65499485055
"healthy-3"	"2019-08-01-count-3:TGAGTCACAACTCCCT"	-8.01080069962199	-0.622930072900377	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGTCACAACTCCCT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3219.81814082431	42.2587727762021	0.0131245837273851	4810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3205.56169272084	3205.56169272084
"healthy-3"	"2019-08-01-count-2:CACAACATCTCGCGTT"	-3.01347289505656	9.98324487293092	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAACATCTCGCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1963.08115286992	47.1112515960316	0.0239986266116189	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.63663044553	1959.63663044553
"healthy-3"	"2019-08-01-count-2:ACCTGTCCAAGAAACT"	2.86871327933614	-6.42478516018065	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCCAAGAAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.10764557959	50.2122091436654	0.0205947465997667	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2430.60344307023	2430.60344307023
"healthy-3"	"2019-08-01-count-3:CAACAACCAATGGCCC"	4.47383083876912	-8.06291773235472	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACCAATGGCCC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2806.70310746703	48.0693345353662	0.0171266189172205	2774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2801.1122502755	2801.1122502755
"healthy-3"	"2019-08-01-count-4:TTTACGTTCTGCTTTA"	-0.608138720423538	8.14885900104371	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTTCTGCTTTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2090.44548024395	34.3205812223076	0.0164178312932143	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.92229381931	2084.92229381931
"healthy-3"	"2019-08-01-count-3:ACTCCCACATCTGCGG"	-3.78726563873943	10.7881059416565	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCACATCTGCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.35168457514	47.2047030561192	0.0236573349054356	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1993.7734998608	1993.7734998608
"healthy-3"	"2019-08-01-count-3:TACGCTCCAAGTGCTT"	-2.86289034310039	10.6095266112122	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCCAAGTGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.85851370148	45.4758436506941	0.0224034548929069	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2024.95604367532	2024.95604367532
"healthy-3"	"2019-08-01-count-4:CTATCTAAGACTCATC"	10.641132970422	7.54543445194093	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCTAAGACTCATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.67801125412	43.977102435195	0.0234334830863216	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1862.3614983628	1862.3614983628
"healthy-3"	"2019-08-01-count-3:CATGCCTGTTTCACAG"	10.7678972679073	6.75217816913453	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTGTTTCACAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1835.81184200717	44.799497935001	0.0244030988960284	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1829.09750927585	1829.09750927585
"healthy-3"	"2019-08-01-count-3:CGCCAGATCGCGAAGA"	-3.26144085350688	10.2042588957581	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGATCGCGAAGA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1969.32546279459	43.5292706185553	0.022103644847401	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1962.38213098239	1962.38213098239
"healthy-3"	"2019-08-01-count-3:CTTCTCTTCCTGCCAT"	10.9350162940914	6.82199905002443	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTTCCTGCCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2151.39675655782	38.7822467742295	0.0180265432937996	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2148.47367772775	2148.47367772775
"healthy-3"	"2019-08-01-count-4:TGTGCGGTCGAACACT"	11.0633112388546	6.4946660765442	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGTCGAACACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2120.66900244755	46.2018768846518	0.0217864630601609	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2114.55358278231	2114.55358278231
"healthy-3"	"2019-08-01-count-2:CTCATGCTCGGTCAGC"	-2.14568362656291	9.10395619953004	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATGCTCGGTCAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.47060571319	42.6478076336623	0.0215341785485901	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.12961232692	1977.12961232692
"healthy-3"	"2019-08-01-count-2:GGGATCCTCAGCGGAA"	4.82201637801473	-8.40634920513304	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCTCAGCGGAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2482.36888985574	43.5249278275915	0.0175336260478678	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2475.87400901701	2475.87400901701
"healthy-3"	"2019-08-01-count-1:CTGCCATGTGCTGTCG"	0.335427929728669	8.30696294391481	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGCCATGTGCTGTCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.67601365497	42.465220807748	0.0217027348990828	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1944.54255115934	1944.54255115934
"healthy-3"	"2019-08-01-count-4:GGGACCTAGCCTCTGG"	4.99289478835408	-8.29130937969359	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTAGCCTCTGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2728.45718895074	41.6640608738519	0.01527019043677	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2722.19366937304	2722.19366937304
"healthy-3"	"2019-08-01-count-4:AAGACAAAGAAGTCCG"	5.24736084517781	-10.1722517243591	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGACAAAGAAGTCCG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.33753612228	44.8102862905863	0.0197459767783842	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2256.53442589588	2256.53442589588
"healthy-3"	"2019-08-01-count-3:AGGGTTTCACATAGCT"	-3.77954779091533	10.1248416670593	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTTTCACATAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2076.97334845697	45.6301360426293	0.0219695337335594	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.30632950801	2075.30632950801
"healthy-3"	"2019-08-01-count-3:TACCTCGAGCTTAAGA"	10.4041439491207	7.67842290485231	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTCGAGCTTAAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.5573656771	42.6752854194641	0.0214820302483027	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1975.52260018718	1975.52260018718
"healthy-3"	"2019-08-01-count-2:TGGAGGAAGACCTTTG"	-0.0648286071723283	7.65582559192506	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGAAGACCTTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1910.82185755089	42.9199670504067	0.0224615219261818	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.22173877095	1908.22173877095
"healthy-3"	"2019-08-01-count-2:ATCGTCCGTTGTGTAC"	11.2065588432247	5.98016021335451	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCGTTGTGTAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1983.48716403758	48.4820680890344	0.0244428443844045	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1975.06905419052	1975.06905419052
"healthy-3"	"2019-08-01-count-3:AAAGTGAGTACTGCGC"	-2.55158815804179	9.0428781279358	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTGAGTACTGCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1906.1852549723	48.706781138457	0.0255519661645713	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1901.26364974148	1901.26364974148
"healthy-3"	"2019-08-01-count-2:TTGTTGTTCTCTCTAA"	-3.15971861305888	10.3204116591248	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTGTTCTCTCTAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2102.33638989609	41.1848196902973	0.01959002369375	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2095.4973189453	2095.4973189453
"healthy-3"	"2019-08-01-count-4:GACTATGTCTCTGACC"	3.15432228621785	-6.77959682857665	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGTCTCTGACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.54129913368	49.217017696744	0.0201499224247305	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2438.0792804546	2438.0792804546
"healthy-3"	"2019-08-01-count-2:TTTCATGAGATGCCGA"	-4.1274655860966	13.1524619826111	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCATGAGATGCCGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2240.1162338388	41.9629591768876	0.0187324918872524	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2231.44294140976	2231.44294140976
"healthy-3"	"2019-08-01-count-3:ATGAAAGCACCGTGCA"	3.58023919638936	-7.07928850567015	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGCACCGTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.42299231856	42.0155970421744	0.0166568403357101	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2521.51881224782	2521.51881224782
"healthy-3"	"2019-08-01-count-4:TCTATACCACCGTCGA"	3.78368629988973	-7.26565601741942	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACCACCGTCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.42235036448	43.9693297988532	0.0167922985353118	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2612.43584127947	2612.43584127947
"healthy-3"	"2019-08-01-count-4:CTGCGAGCATGGAGAC"	5.28800262984578	-9.31755831157836	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCGAGCATGGAGAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2751.42655450709	45.2768443690731	0.0164557706600983	2228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2744.33193359617	2744.33193359617
"healthy-3"	"2019-08-01-count-4:CACATGAGTACCGTCG"	4.31877579268758	-8.08459379589232	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGAGTACCGTCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.70290756036	47.9068641936716	0.0176797478646114	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2704.93861328813	2704.93861328813
"healthy-3"	"2019-08-01-count-3:CTATCTACAACTTGCA"	4.083268781274	-7.0850458375183	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATCTACAACTTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.44238541522	44.4920152633362	0.0174379854774168	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2548.17635820663	2548.17635820663
"healthy-3"	"2019-08-01-count-2:TGCGGGTGTCATCTAG"	3.45872892913167	-6.32825138485106	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTGTCATCTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.50749453354	45.0748248298615	0.0194329291610787	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2315.90828362446	2315.90828362446
"healthy-3"	"2019-08-01-count-3:GCACGGTAGTGTACAA"	-3.69753752175029	10.3344907530579	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTAGTGTACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2041.81957856913	46.1899237468392	0.0226219418364125	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.16211618726	2037.16211618726
"healthy-3"	"2019-08-01-count-4:CACTGGGCAAATTGGA"	-3.8478447002476	-5.71345760738524	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGCAAATTGGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2813.51857390303	44.9669147970051	0.0159824481750711	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2810.78346217807	2810.78346217807
"healthy-3"	"2019-08-01-count-2:TAACCAGTCTCTCGCA"	-1.8775169653004	8.78989980304567	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACCAGTCTCTCGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.60639044008	50.7540588614686	0.0246905531611053	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.53679473696	2052.53679473696
"healthy-3"	"2019-08-01-count-4:AATCGTGTCTATCACT"	-7.17407880249675	3.53394291484681	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCGTGTCTATCACT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2147.83878651251	45.7222580450156	0.0212875651245947	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2137.09476161638	2137.09476161638
"healthy-3"	"2019-08-01-count-3:TTCATGTGTGTCCATA"	-3.8480855030125	9.83735082233278	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATGTGTGTCCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.47959649945	43.8902891527802	0.0210962362844743	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.75922852881	2078.75922852881
"healthy-3"	"2019-08-01-count-3:GAAGGGTCAGAGGGTT"	-4.59771905365642	3.19897935474244	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGGTCAGAGGGTT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2891.95033081063	43.3422286343935	0.0149871967622087	3441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2885.43095517748	2885.43095517748
"healthy-3"	"2019-08-01-count-2:GAAGGACAGCGTCTCG"	-3.02847872200664	9.60780904376832	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGACAGCGTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.76540278874	39.2059249172471	0.0205077070963082	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1906.31603704293	1906.31603704293
"healthy-3"	"2019-08-01-count-4:CACGAATTCCCGTTGT"	-2.26325402680095	8.90594003284303	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATTCCCGTTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2071.60228855022	41.8932476607467	0.0202226305175908	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2068.26454668787	2068.26454668787
"healthy-3"	"2019-08-01-count-2:GCTTTCGAGCAACTTC"	4.77937235411946	-8.44855215465697	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTTCGAGCAACTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.44279970315	42.5580718095133	0.0178557135144229	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2382.17604576444	2382.17604576444
"healthy-3"	"2019-08-01-count-4:ATGGAGGAGTCGGGAT"	-3.8973310989445	9.75099561298219	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGAGTCGGGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2256.23976405774	41.0597040790841	0.0181982893543371	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2249.03851217152	2249.03851217152
"healthy-3"	"2019-08-01-count-2:GAAACCTGTAACGTTC"	-1.98846207085307	9.63250825488893	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTGTAACGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2158.47789287035	43.3149848072366	0.0200673747691881	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2149.68719785345	2149.68719785345
"healthy-3"	"2019-08-01-count-4:CTCCACACACGGATCC"	-0.143050069839317	8.45167539203493	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACACACGGATCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.22696200918	44.2450944640549	0.0226407143715618	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1946.30757789292	1946.30757789292
"healthy-3"	"2019-08-01-count-2:AGGGCCTCATCGGATT"	2.87261070784871	-6.82019951259764	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTCATCGGATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2065.69532907374	46.8175996511022	0.0226643295321267	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2057.17891541688	2057.17891541688
"healthy-3"	"2019-08-01-count-4:GGGTCACTCCTGGCTT"	0.275084559887093	7.78329465473024	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCACTCCTGGCTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.66299701155	40.7276662862691	0.0219123457839066	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.0832765495	1856.0832765495
"healthy-3"	"2019-08-01-count-3:TACTTCATCAAACCTG"	-2.37750373306926	9.15760991657106	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTCATCAAACCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2118.4803720654	46.1530726771861	0.0217859335803944	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.79484214281	2111.79484214281
"healthy-3"	"2019-08-01-count-3:TTCATTGGTCGGCTAC"	-2.41980252686198	9.46591088855592	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATTGGTCGGCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.80104257561	44.0086563919217	0.0223190146681516	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.85159532202	1964.85159532202
"healthy-3"	"2019-08-01-count-4:ACACGCGCACCCTCTA"	4.40183414992635	-7.91346647655638	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACGCGCACCCTCTA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2826.40157528865	46.0434705130252	0.0162904913850832	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2819.82158184535	2819.82158184535
"healthy-3"	"2019-08-01-count-3:AGACTCACAGGGAGAG"	-7.10568795624431	3.40339729869691	"2019-08-01-count-3"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCACAGGGAGAG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2325.68009516563	43.9425940776713	0.0188945135528375	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2315.20491176275	2315.20491176275
"healthy-3"	"2019-08-01-count-4:CGCGTGATCCTATTGT"	-1.99775181236919	8.78727338397828	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCGTGATCCTATTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.55727650811	48.7219522635037	0.0246623840487288	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.53699968135	1970.53699968135
"healthy-3"	"2019-08-01-count-4:CGCCATTTCTTCACGC"	2.99634756621663	-4.97003223812255	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTTCTTCACGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2928.98177076498	43.0663884851115	0.0147035358550093	2863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2925.36038965396	2925.36038965396
"healthy-3"	"2019-08-01-count-2:CAACCTCGTCACTCGG"	3.031670709222	-6.91935636913451	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCGTCACTCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.74191454253	47.582119526385	0.0224154049064601	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2119.71895609152	2119.71895609152
"healthy-3"	"2019-08-01-count-2:CAACCTCAGGATAATC"	4.51073088225667	-8.73730566417845	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCAGGATAATC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.61402939104	51.4188081394517	0.0211633648462012	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2422.58395870203	2422.58395870203
"healthy-3"	"2019-08-01-count-3:GTGAGTTTCATTGTTC"	0.21143196996991	8.29182050311891	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGTTTCATTGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1838.19116668688	35.1395763510772	0.0191163884300522	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1833.43774692353	1833.43774692353
"healthy-3"	"2019-08-01-count-2:AACCTTTGTTTCGTTT"	2.04060961779897	-6.70504763042601	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTTTGTTTCGTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.00449288984	48.8614266437735	0.0228430687294914	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2136.06782519355	2136.06782519355
"healthy-3"	"2019-08-01-count-3:AAGACAAGTGTATCCA"	-3.69608316841777	10.3115195997986	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAAGTGTATCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1813.98292363116	42.4259846867372	0.0233883043407104	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1812.10133372266	1812.10133372266
"healthy-3"	"2019-08-01-count-3:TCTACCGGTACTTCCC"	-7.65929112854655	0.208554274681486	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGGTACTTCCC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3334.43902708238	42.8372398645107	0.0128469105347514	5306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3324.67193787952	3324.67193787952
"healthy-3"	"2019-08-01-count-4:CAACGATTCCCTCTCC"	10.0412889915401	6.95186374271242	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGATTCCCTCTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1993.72046082327	47.8430443678987	0.0239968668165961	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1976.87922117735	1976.87922117735
"healthy-3"	"2019-08-01-count-3:TCCATCGAGCTCTATG"	0.502368112176102	8.43842790210573	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATCGAGCTCTATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1768.37616187142	28.693477040706	0.0162258899771305	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1761.29120594956	1761.29120594956
"healthy-3"	"2019-08-01-count-2:TTTGGTTAGGCATCGA"	-1.98538861694987	9.64227006519166	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGTTAGGCATCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.87589407592	44.9229394321048	0.0244961720568017	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1830.47308696515	1830.47308696515
"healthy-3"	"2019-08-01-count-4:CGTCCATTCATGAGAA"	-0.377253602177459	8.95179364765016	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCCATTCATGAGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2336.46484018009	39.613743963415	0.0169545645550402	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2336.46484018009	2336.46484018009
"healthy-3"	"2019-08-01-count-4:GTTGTAGAGTCGGCAA"	-1.95898042145427	8.97428414905397	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTAGAGTCGGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.33627484428	41.765042287563	0.0211111947036661	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.56452030315	1976.56452030315
"healthy-3"	"2019-08-01-count-2:CTGAATGCAGTTAAAG"	-0.348187873989898	8.7863445051941	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGCAGTTAAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2084.0356357674	43.6135176897395	0.0209274337449991	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2079.86343334157	2079.86343334157
"healthy-3"	"2019-08-01-count-2:CGTTGGGCAAAGCGTG"	-3.69878731194194	10.1121740111145	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGCAAAGCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2335.63396313582	46.9774438213169	0.0201133587551728	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2329.85501305774	2329.85501305774
"healthy-3"	"2019-08-01-count-3:CGTGCTTGTCCGTTTC"	2.405609746545	-4.30950453197631	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTGTCCGTTTC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2686.75184070036	39.0919763452063	0.0145499021357388	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2682.18776445888	2682.18776445888
"healthy-3"	"2019-08-01-count-3:AACCATGCAGCTACCG"	10.3356796699459	7.18971583927003	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGCAGCTACCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2065.69877812437	43.4942119696368	0.0210554474012562	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2061.85620744485	2061.85620744485
"healthy-3"	"2019-08-01-count-2:CACGTTCAGCAGTCTT"	4.97801603850667	-8.37515261089476	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCAGCAGTCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2817.50822350241	41.4958668108287	0.0147278600519028	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2809.61363171675	2809.61363171675
"healthy-3"	"2019-08-01-count-4:ACGTCCTAGCAACTTC"	-0.222944031388122	8.47925565326539	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTCCTAGCAACTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2184.57620334476	35.0569136270499	0.0160474665856814	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2174.51049755888	2174.51049755888
"healthy-3"	"2019-08-01-count-3:CCATAAGAGGCTCTCG"	-2.6430872482365	8.88036058032838	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATAAGAGGCTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.40208345332	49.0171961474041	0.0249908963393689	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1954.7536707194	1954.7536707194
"healthy-3"	"2019-08-01-count-4:AACAGGGCAATGACCT"	0.339869965880555	8.34737107837526	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGCAATGACCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1663.18240324333	48.3000050718106	0.0290407143423488	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1649.24245608401	1649.24245608401
"healthy-3"	"2019-08-01-count-3:GTTGAACGTGCCCTTT"	-1.84372709217723	9.00332925403444	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGAACGTGCCCTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2028.98824255278	50.9953722633638	0.0251333995899374	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2023.8214073561	2023.8214073561
"healthy-3"	"2019-08-01-count-4:CATACTTCAGGTTCAT"	-5.16279588165935	-2.78996350681456	"2019-08-01-count-4"	"Control3"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACTTCAGGTTCAT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3087.02773289869	41.828732881949	0.0135498403322319	2764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3077.92185603626	3077.92185603626
"healthy-3"	"2019-08-01-count-4:CCAATGAAGGCATTTC"	0.04905365019795	8.34685800159303	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGAAGGCATTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2101.9770027714	34.004000328639	0.0161771514549425	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2096.44653027268	2096.44653027268
"healthy-3"	"2019-08-01-count-4:AGGTCTAGTGCTAGCC"	4.80087580260579	-8.15362741863402	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTAGTGCTAGCC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2803.43342934263	38.6235740834647	0.0137772396088326	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2797.33637365017	2797.33637365017
"healthy-3"	"2019-08-01-count-4:AGTAGTCTCGCTCTAC"	-0.167950059205848	7.72376773441163	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCTCGCTCTAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2132.0481041026	33.0542041312622	0.0155034982877063	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2129.03599855018	2129.03599855018
"healthy-3"	"2019-08-01-count-4:CGCAGGTGTACGATGG"	-3.76709828797038	9.84989926898805	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCAGGTGTACGATGG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2120.0117323892	45.959810498734	0.0216790359206826	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2118.47311549446	2118.47311549446
"healthy-3"	"2019-08-01-count-2:CCGGTAGGTCAGATTC"	5.29520763930623	-9.83530905162963	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGGTCAGATTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.38498515625	49.0600297343323	0.0200540920713666	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2443.96966102771	2443.96966102771
"healthy-3"	"2019-08-01-count-3:GCTACCTTCGGAGTGA"	10.5244204002315	6.48900458896486	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTTCGGAGTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.54960081189	44.5194948192726	0.023449213441795	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1887.61436525753	1887.61436525753
"healthy-3"	"2019-08-01-count-2:CTACCTGCAATCAGCT"	9.71460308608357	7.34624097431032	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGCAATCAGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.43985038854	47.0766531470073	0.0243864905386885	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1921.18541415253	1921.18541415253
"healthy-3"	"2019-08-01-count-4:CGGGACTAGTAGGATT"	4.50999273833577	-7.88633348858031	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTAGTAGGATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.02184586901	46.9872746426579	0.0180026365361756	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2604.44166476812	2604.44166476812
"healthy-3"	"2019-08-01-count-4:AAACCCAAGGAGTACC"	4.91640772399251	-7.93934729015502	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCAAGGAGTACC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2861.90621693868	43.4406352379341	0.0151789164092182	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2857.67326456784	2857.67326456784
"healthy-3"	"2019-08-01-count-2:GCGTTTCAGGAACTCG"	4.8554822402889	-8.25811579143675	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCAGGAACTCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.51339696518	45.9689419371267	0.0175285823097502	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2617.16536529411	2617.16536529411
"healthy-3"	"2019-08-01-count-3:GCCAGCACACTGAGTT"	9.69585194167439	7.70709750736085	"2019-08-01-count-3"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGCACACTGAGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.41279167283	47.1309095583554	0.0246963915584754	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1901.51996597877	1901.51996597877
"healthy-3"	"2019-08-01-count-2:CGTCAAAAGGATTCAA"	3.56081761893575	-8.00311090862425	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCAAAAGGATTCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.90575585779	44.3648289949998	0.019323453883857	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2293.14318427151	2293.14318427151
"healthy-3"	"2019-08-01-count-4:ACAAAGAAGTGCACTT"	3.48071660575215	-7.46562626278075	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGAAGTGCACTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1931.40893242188	43.4932703691615	0.0225189340481217	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1924.57310684947	1924.57310684947
"healthy-3"	"2019-08-01-count-3:CTATCCGGTTCCTTGC"	10.262395520776	7.60864255512086	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATCCGGTTCCTTGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2008.378060407	44.2112230840644	0.0220133967581308	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1997.74529364685	1997.74529364685
"healthy-3"	"2019-08-01-count-2:CACCAAACATCACCAA"	3.64146627959554	-7.54645302211913	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAACATCACCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.51943790971	47.0572579798908	0.0202787605271169	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2315.59862396401	2315.59862396401
"healthy-3"	"2019-08-01-count-2:TCCTCCCCAGTCGAGA"	5.26739801940267	-9.73447420513304	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCCAGTCGAGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.3568725355	44.4327151218161	0.017266441198277	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2565.84809031923	2565.84809031923
"healthy-3"	"2019-08-01-count-4:TTTCCTCCATTGGGAG"	11.4243256050045	5.92544982517091	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCCATTGGGAG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.99944473054	46.5351101523864	0.0224590360150595	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2066.60776065267	2066.60776065267
"healthy-3"	"2019-08-01-count-2:CTCATGCTCATAGACC"	5.1159197288448	-8.57792284404906	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATGCTCATAGACC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2947.69514580169	41.7767564549968	0.0141726855690956	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2939.72449906079	2939.72449906079
"healthy-3"	"2019-08-01-count-3:ACTGTGAGTACCTGTA"	11.0375124412471	6.38484094226686	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTGAGTACCTGTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.4706151556	38.051707567041	0.0200962757290607	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1887.84497043603	1887.84497043603
"healthy-3"	"2019-08-01-count-3:TGGTTAGAGTAAGAGG"	3.92913355407063	-7.24264147197875	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGAGTAAGAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.57052584364	47.9177465028096	0.0215402235829935	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2220.23847538976	2220.23847538976
"healthy-3"	"2019-08-01-count-3:ATGGTTGAGCGCTGAA"	-0.610907356173354	7.94265267932741	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGTTGAGCGCTGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.64913737177	45.2896535602077	0.0230875403237946	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.44548759692	1957.44548759692
"healthy-3"	"2019-08-01-count-2:GGGTTTAGTTCGGCTG"	0.115417745977086	7.61515042865602	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTTAGTTCGGCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.38381111427	36.4526005817969	0.0198394044626368	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1830.85517625162	1830.85517625162
"healthy-3"	"2019-08-01-count-3:GTGTTAGCAGAGTTCT"	-7.72309861603435	-0.480617605802141	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGCAGAGTTCT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3184.70230031426	51.7380375302044	0.0162458002825253	4328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3176.68640932502	3176.68640932502
"healthy-3"	"2019-08-01-count-2:AGCTTCCGTATACCTG"	-2.84579286995586	9.14648721301881	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCGTATACCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2076.81224503409	45.3282280516976	0.0218258670999668	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.09256982948	2072.09256982948
"healthy-3"	"2019-08-01-count-4:CGTCCATTCAGAGTTC"	-0.752826253802139	8.8184547194275	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCCATTCAGAGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2047.10815192631	41.1253384687474	0.0200894800941752	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.56184632632	2040.56184632632
"healthy-3"	"2019-08-01-count-3:GTGTTAGTCTCCACTG"	-3.95022569122966	-4.56195642864379	"2019-08-01-count-3"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGTCTCCACTG"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3094.56602855859	45.5656454296195	0.0147244056223429	3667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3085.82383599086	3085.82383599086
"healthy-3"	"2019-08-01-count-3:ACTTCCGGTTGCCGCA"	10.2727390724117	6.7378301390442	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCCGGTTGCCGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1911.45830375201	47.3632996999578	0.0247786203899861	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1901.87418404421	1901.87418404421
"healthy-3"	"2019-08-01-count-3:TGCTTGCCATCACAGT"	10.1166683631832	7.37093780124513	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCCATCACAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2043.64537078609	34.0187011606632	0.0166460882337809	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2031.25242777069	2031.25242777069
"healthy-3"	"2019-08-01-count-3:GCAGCCATCTTCCACG"	-2.18807039681132	9.4224586256775	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCATCTTCCACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.60269732372	42.3410472546158	0.0208002511051313	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.87342626501	2027.87342626501
"healthy-3"	"2019-08-01-count-4:TGGAACTAGCCGATTT"	-1.28145764294322	8.50281522357789	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTAGCCGATTT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2240.94741957686	42.7123279566223	0.0190599420510666	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2232.72106463826	2232.72106463826
"healthy-3"	"2019-08-01-count-3:GGTAACTGTAGAGGAA"	-2.62529979172404	9.33076760852662	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAACTGTAGAGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.96891242674	42.6290323151584	0.0221683419007339	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.2400124846	1921.2400124846
"healthy-3"	"2019-08-01-count-3:GAAGAATCACGCAAAG"	2.53064121779744	-4.41346552288207	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGAATCACGCAAAG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2739.01644157364	41.0704383624117	0.0149945935844093	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2736.28484779176	2736.28484779176
"healthy-3"	"2019-08-01-count-3:GAAGCCCAGCTAATGA"	-3.64198718491252	10.4337215193543	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCCCAGCTAATGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2132.27186656675	47.2635838301203	0.0221658338090917	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2124.18975574294	2124.18975574294
"healthy-3"	"2019-08-01-count-2:CGAGTTACAGGACTTT"	0.015284494578284	7.7029123076233	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTTACAGGACTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.02185043676	43.952415633444	0.0236427644049034	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.37462148983	1845.37462148983
"healthy-3"	"2019-08-01-count-4:CTCGAGGGTGAGACGT"	3.48636807975118	-8.37837221538695	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGGTGAGACGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.61380001808	50.8623291291789	0.0245638897648295	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2063.41529301157	2063.41529301157
"healthy-3"	"2019-08-01-count-2:CACTGAATCACTCGAA"	0.0171223777229011	7.55531976306764	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAATCACTCGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.39511986692	47.4246023148645	0.0236603062164775	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.58865831799	1991.58865831799
"healthy-3"	"2019-08-01-count-4:ACCCTCAGTGATTAGA"	5.59013475951497	-9.93706896221312	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTCAGTGATTAGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.47118017048	48.082288200123	0.0188007155556364	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2552.18350876338	2552.18350876338
"healthy-3"	"2019-08-01-count-3:TGATCTTTCTTGGATG"	-2.27802429619487	9.5062045820984	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCTTTCTTGGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.47961391248	49.055879215822	0.0260039275558786	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1882.97830226652	1882.97830226652
"healthy-3"	"2019-08-01-count-3:CCATAAGCAGGTGTGA"	-1.01920590820964	9.46116540515748	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATAAGCAGGTGTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.80353781885	46.7630297689303	0.0246535968731393	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1891.66955385107	1891.66955385107
"healthy-3"	"2019-08-01-count-4:TAAGTCGCATCCTTGC"	5.20862736281697	-9.23324015056761	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGCATCCTTGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.72186797998	45.1278208422762	0.0170762657202253	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2637.67116114588	2637.67116114588
"healthy-3"	"2019-08-01-count-4:TTTCGATCAATCTCTT"	3.77187051352803	-6.62781670009764	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATCAATCTCTT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2930.72940180839	40.2882181501826	0.0137468229326539	2758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2924.20193678393	2924.20193678393
"healthy-3"	"2019-08-01-count-3:GTGCTGGCATGGGATG"	-4.81207404556926	2.45857522571412	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGCATGGGATG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3343.69044197997	43.9396311585944	0.0131410583369002	5094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3334.54643508718	3334.54643508718
"healthy-3"	"2019-08-01-count-2:CCCTAACGTCATCCGG"	4.7861291366512	-8.36181547557982	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACGTCATCCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2776.70878440877	42.7898097951542	0.0154102619746871	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2768.54341820979	2768.54341820979
"healthy-3"	"2019-08-01-count-3:TTTGACTAGTCATAGA"	-2.47948489609416	9.32233712756959	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGTCATAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.36177651854	43.9832576553405	0.0241088462943323	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1820.4941154327	1820.4941154327
"healthy-3"	"2019-08-01-count-2:TCGCTCATCGCTATTT"	-4.04652295532878	10.8355712660584	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCATCGCTATTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2072.22262845564	50.4238742229142	0.0243332321201866	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2068.72328648051	2068.72328648051
"healthy-3"	"2019-08-01-count-3:TAAGCGTTCCCGATCT"	-4.34461865845378	13.2432632216248	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCGTTCCCGATCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1905.65397572908	43.5018662471256	0.0228277886757916	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1899.70389074154	1899.70389074154
"healthy-3"	"2019-08-01-count-4:TCATACTGTCCCTCAT"	3.42135467109029	-7.1895323029724	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTGTCCCTCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.99364573788	47.3405592011255	0.0187934412939967	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2512.845206537	2512.845206537
"healthy-3"	"2019-08-01-count-4:AGAAATGCAGACTCTA"	-2.96747217598613	9.28768441760866	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAATGCAGACTCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.90778750512	43.5559529233033	0.0226510876945457	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1913.19008310531	1913.19008310531
"healthy-3"	"2019-08-01-count-2:AAGCGAGGTTGCATCA"	4.98052563247029	-8.206494354364	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGAGGTTGCATCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.0454131458	40.7132969912824	0.0168581910591279	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2408.955626223	2408.955626223
"healthy-3"	"2019-08-01-count-3:GCCCGAACAGTAGTTC"	3.20756401595418	-7.39984466945799	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAACAGTAGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.74257048955	48.3771089784241	0.0208007152606925	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2324.57177394661	2324.57177394661
"healthy-3"	"2019-08-01-count-2:TCGGGCACATCGGTTA"	-3.09493265572246	9.9435825117859	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCACATCGGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1880.22277376283	43.2033026231682	0.0229777573306948	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1873.14581117979	1873.14581117979
"healthy-3"	"2019-08-01-count-3:GACAGCCCACAGCCTG"	0.125208613544148	8.02039191806642	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACAGCCCACAGCCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.99108912982	39.4962211833385	0.0213378775377608	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1847.56442837258	1847.56442837258
"healthy-3"	"2019-08-01-count-2:CATCCGTTCGCTCTAC"	10.3658653694088	7.42310140216676	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTTCGCTCTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2128.98278851832	45.8319052515093	0.0215276072210083	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2114.7104133529	2114.7104133529
"healthy-3"	"2019-08-01-count-3:TACCTCGAGCAAGCCA"	4.13327612456624	-7.46894314205321	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTCGAGCAAGCCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.21511548223	43.7605317947192	0.0167779611179151	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2604.82572697871	2604.82572697871
"healthy-3"	"2019-08-01-count-2:GGTAGAGTCTAAGGAA"	-3.83693991127666	10.2160501250061	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAGAGTCTAAGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.53495169045	47.2543479624773	0.0231578233557481	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.4650159111	2037.4650159111
"healthy-3"	"2019-08-01-count-2:GTGGAAGAGGCTGTAG"	4.11817898330037	-7.95670130169066	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAAGAGGCTGTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.89824160311	49.0003320708858	0.0194530812168499	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2514.54854600776	2514.54854600776
"healthy-3"	"2019-08-01-count-2:TACTTACTCTGAGAGG"	2.54745521125142	-4.0145530930725	"2019-08-01-count-2"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACTCTGAGAGG"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2524.29717635638	40.4980047049981	0.0160432793271408	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2517.57855120338	2517.57855120338
"healthy-3"	"2019-08-01-count-3:CAACGGCGTTCTCTAT"	-4.31755576553996	11.5345248945984	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGGCGTTCTCTAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2257.2106914132	38.8674346731083	0.0172192320464219	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2250.54743951949	2250.54743951949
"healthy-3"	"2019-08-01-count-3:TACGTCCCACAGCGCT"	-4.13235936585124	12.8940782316956	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCCACAGCGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2606.29937072306	44.5878308637898	0.017107716544251	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2593.12123016359	2593.12123016359
"healthy-3"	"2019-08-01-count-2:GACATCAGTTCCTAGA"	-5.33750424805339	-5.41532661831053	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACATCAGTTCCTAGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2722.02126394316	51.9957953807793	0.0191019063919646	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2714.28782457436	2714.28782457436
"healthy-3"	"2019-08-01-count-2:CTTCTAATCCTTGACC"	5.36209406432454	-9.75703623211058	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTAATCCTTGACC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.55177301083	45.7443173270279	0.0176241205444978	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2589.14524718403	2589.14524718403
"healthy-3"	"2019-08-01-count-1:TCCTTTCGTGACTGAG"	11.1243015724117	6.10522935474244	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCTTTCGTGACTGAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.80796736851	40.163148786613	0.0194890302359896	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2049.27930523059	2049.27930523059
"healthy-3"	"2019-08-01-count-4:GAAACCTTCTCCTGCA"	10.8825327354366	6.72389028156129	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAACCTTCTCCTGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.6538186106	42.7051389836601	0.0200998104300995	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2119.15454657499	2119.15454657499
"healthy-3"	"2019-08-01-count-3:CATAGACGTAGCGATG"	3.22253336486165	-6.67131664669188	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAGACGTAGCGATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.70018436047	40.8051093550821	0.0184080416661554	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2211.77109562587	2211.77109562587
"healthy-3"	"2019-08-01-count-3:TCATCATGTCAATGGG"	-2.90397320213969	-5.74912168895873	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCATGTCAATGGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2520.80506510318	50.9966806701897	0.020230315059329	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2516.32189842055	2516.32189842055
"healthy-3"	"2019-08-01-count-4:CTAACTTGTCATACCA"	-1.58634934845622	8.79563615405885	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTGTCATACCA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2011.12198260527	48.1872737858312	0.0239603933538671	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.78858937907	2004.78858937907
"healthy-3"	"2019-08-01-count-2:TCCTAATTCGACGCGT"	-1.86881933632548	8.69075772846071	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTAATTCGACGCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1987.24159342025	39.7510410151261	0.0200031245052145	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.96915539927	1981.96915539927
"healthy-3"	"2019-08-01-count-4:CATCGGGAGTAAACAC"	-3.75134120407756	10.1541461714539	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGAGTAAACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.02216201665	41.9240470496497	0.0192133919533168	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.00256888221	2179.00256888221
"healthy-3"	"2019-08-01-count-4:TTTCGATTCCTATTTG"	6.71266474303548	-1.49580469047698	"2019-08-01-count-4"	"Control3"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATTCCTATTTG"	"pDC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2229.13152551861	47.2117946133636	0.0211794566955306	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2213.9632349151	2213.9632349151
"healthy-3"	"2019-08-01-count-3:TTCCTCTTCGCTTACC"	-3.17789946022685	9.54925057971803	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTTCGCTTACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2723.63638853949	49.6675853127885	0.0182357621310171	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2714.86711041731	2714.86711041731
"healthy-3"	"2019-08-01-count-4:ACGGGTCTCCACGGGT"	10.5054565864498	7.71723601901857	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCTCCACGGGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2095.17051801844	44.4522071288508	0.0212165104207808	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2090.46353408401	2090.46353408401
"healthy-3"	"2019-08-01-count-3:TTCCTCTCAGGCTATT"	2.58031453666036	-4.63932421123656	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTCAGGCTATT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2854.64465994808	47.9141518689155	0.016784629113799	2623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2844.70871753772	2844.70871753772
"healthy-3"	"2019-08-01-count-1:CATCGTCAGCTCCCTT"	9.79231609877889	7.33417651737062	"2019-08-01-count-1"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATCGTCAGCTCCCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2307.85533203155	36.2007820299048	0.0156858974336308	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2288.58763342081	2288.58763342081
"healthy-3"	"2019-08-01-count-2:CTTGATTTCATGGCCG"	10.5708376365596	6.30862472141115	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGATTTCATGGCCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.77140663589	46.8623191615662	0.0248636619786217	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1875.92116438582	1875.92116438582
"healthy-3"	"2019-08-01-count-2:CCTGCATTCTGTGCTC"	4.32681765136067	-7.30578806316527	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATTCTGTGCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.39404022956	43.4933656110737	0.0160409608362904	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2707.34612060217	2707.34612060217
"healthy-3"	"2019-08-01-count-3:CACTGAACACTTGGCG"	4.33377327498738	-7.58818485653075	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGAACACTTGGCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.62829867344	45.9886347194579	0.0175152875761938	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2621.26311343255	2621.26311343255
"healthy-3"	"2019-08-01-count-3:GTAATGCAGTAACGAT"	10.1648136573726	7.75953576648561	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCAGTAACGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.23941782526	44.1858681806081	0.0218715998662046	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2012.41777845167	2012.41777845167
"healthy-3"	"2019-08-01-count-2:ATTGTTCAGTCCCGAC"	10.0384870963985	6.9592566260132	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGTTCAGTCCCGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.57377607573	43.9303085938523	0.0222367340191746	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1975.57377607573	1975.57377607573
"healthy-3"	"2019-08-01-count-4:AGTAGTCGTCCAGCCA"	-4.31314120712932	13.096559501532	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCGTCCAGCCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2038.48963827086	41.9156631622828	0.0205621173516671	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2033.05187521981	2033.05187521981
"healthy-3"	"2019-08-01-count-2:CATGCTCGTTGTTGTG"	-0.872122148901779	8.57580278003541	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCGTTGTTGTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.3620816651	36.3571119740787	0.0200938841056183	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1806.18341398911	1806.18341398911
"healthy-3"	"2019-08-01-count-3:TAATTCCGTCGTACTA"	-2.19027409973796	9.16596410358278	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCGTCGTACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.56876110476	42.94686314336	0.0208321274330649	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.19140752912	2058.19140752912
"healthy-3"	"2019-08-01-count-2:ATTCGTTTCGGAACTT"	-3.94750962677653	12.7059726485047	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCGTTTCGGAACTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2040.70061255693	40.7813224828278	0.0199839811052589	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2037.17201783164	2037.17201783164
"healthy-3"	"2019-08-01-count-2:CTAACCCGTCATTGCA"	3.92314376410787	-7.2682152024475	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCGTCATTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.21612144663	44.464972349117	0.0177986892196376	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2492.85006611027	2492.85006611027
"healthy-3"	"2019-08-01-count-2:TGCATGAAGTATAGAC"	3.6105121570522	-7.29374124920043	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATGAAGTATAGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.72237579827	50.3775304242755	0.0233367342596088	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2157.2870116704	2157.2870116704
"healthy-3"	"2019-08-01-count-2:ACTTCGCGTGACTATC"	4.36974825438802	-8.21545507824095	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCGTGACTATC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.15940197653	47.7002912747457	0.0177445917975225	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2679.90273754092	2679.90273754092
"healthy-3"	"2019-08-01-count-2:CTCCAACAGCATTGAA"	-3.99066195908244	12.952383972052	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACAGCATTGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2130.16289154354	43.3581781405121	0.0203543955782153	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2128.35832414129	2128.35832414129
"healthy-3"	"2019-08-01-count-3:GGCAGTCCACATCCCT"	5.26972641524617	-10.2344818345276	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCAGTCCACATCCCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.59127714509	43.4686632516992	0.0173210130460563	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2496.79326117367	2496.79326117367
"healthy-3"	"2019-08-01-count-3:ACCCTTGTCTGGACCG"	-1.44758925858195	9.22959706867067	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGTCTGGACCG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2161.67071186161	48.9136461802764	0.0226277045397688	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2158.73923526977	2158.73923526977
"healthy-3"	"2019-08-01-count-3:GGCACGTTCGGTAGAG"	3.39151062545125	-6.92263128673705	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTTCGGTAGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.94728150608	47.5485134140492	0.0233659681733171	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2032.09539802193	2032.09539802193
"healthy-3"	"2019-08-01-count-4:CAACGGCAGAGAGAAC"	-1.62638924542125	8.95025918567506	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCAGAGAGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.69390986349	47.5895001208579	0.0234235579925795	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2022.17329088888	2022.17329088888
"healthy-3"	"2019-08-01-count-2:GGTTCTCCAGAAGCTG"	-3.58492193642314	-5.35523178493651	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTCTCCAGAAGCTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2511.615886828	48.476985166021	0.0193011142429283	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2507.2013153866	2507.2013153866
"healthy-3"	"2019-08-01-count-2:CATGCTCCAGAGGCTA"	-4.47621045532878	12.7684964903626	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCCAGAGGCTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2271.81098645126	39.8275781766115	0.0175312023817726	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2259.76273504968	2259.76273504968
"healthy-3"	"2019-08-01-count-3:GTGATGTGTCGCCTAG"	-7.16460166397746	3.16331074321596	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGATGTGTCGCCTAG"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2694.03451048695	44.2538531656935	0.0164266096048245	2771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2684.31915451082	2684.31915451082
"healthy-3"	"2019-08-01-count-2:ATTCTACTCCTACCAC"	4.55470861968343	-7.59143593227538	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTACTCCTACCAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2743.7018849254	48.738122629029	0.0177636363836788	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2737.83440820264	2737.83440820264
"healthy-3"	"2019-08-01-count-2:GACCCTTGTATGGAAT"	2.59340133246724	-4.44549562847289	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTGTATGGAAT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2798.8241696544	45.1771305202372	0.0161414679100101	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2793.26024733791	2793.26024733791
"healthy-3"	"2019-08-01-count-3:TAGTGCATCTCCTGAC"	9.77892365035359	6.9394206770691	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCATCTCCTGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.08359243284	43.1030591862125	0.0225189011371377	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1907.86956905739	1907.86956905739
"healthy-3"	"2019-08-01-count-3:ACGTCCTGTGGGAGAG"	14.3225027519161	1.98135457122651	"2019-08-01-count-3"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTGTGGGAGAG"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1594.45872004771	33.5676598245991	0.0210526992028961	2059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1576.51452665045	1576.51452665045
"healthy-3"	"2019-08-01-count-3:AGCCAATTCGCATTAG"	-4.02259860459025	12.8958987959656	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATTCGCATTAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1912.28476250456	45.4465129171474	0.0237655572058343	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1906.41164870855	1906.41164870855
"healthy-3"	"2019-08-01-count-2:AGGGCTCGTACTCCGG"	-2.33024535599406	8.76892659747926	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCTCGTACTCCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2326.21125237878	45.3180161011097	0.0194814705907589	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2322.39062517012	2322.39062517012
"healthy-3"	"2019-08-01-count-2:CAAGACTCAGCATTGT"	-1.44339523735698	8.65785405719606	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGACTCAGCATTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2081.58209982893	36.833017424469	0.0176947224072959	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.69408120692	2075.69408120692
"healthy-3"	"2019-08-01-count-3:ACAAAGAGTGAATAAC"	10.9375320869381	6.42938659274904	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAAGAGTGAATAAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.18047042289	43.3603158567417	0.0218750595638201	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1977.61957480275	1977.61957480275
"healthy-3"	"2019-08-01-count-2:TGTCCACGTGTCTTGA"	0.0120510580832183	8.24322793567506	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCACGTGTCTTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.92024232538	43.249810643873	0.0220221828319581	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.46559053958	1950.46559053958
"healthy-3"	"2019-08-01-count-2:TTGGTTTCATGACTCA"	-1.75259492817577	8.58390996539918	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTCATGACTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2185.38153556592	43.5599474367003	0.0199324222007852	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2182.47215178973	2182.47215178973
"healthy-3"	"2019-08-01-count-3:TCATTGTAGATGAAGG"	11.1185022788936	6.13580796802369	"2019-08-01-count-3"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTAGATGAAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.70862983331	42.1396923190387	0.0207921808289259	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2018.56420558001	2018.56420558001
"healthy-3"	"2019-08-01-count-4:GCTGGGTGTGCGGATA"	4.32427563247029	-8.04350283062132	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGGGTGTGCGGATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.76330655101	45.7239409800396	0.0178138517343383	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2564.53333321507	2564.53333321507
"healthy-3"	"2019-08-01-count-3:CACTTCGTCGATGGAG"	-0.0376807329362214	8.4414663084778	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTTCGTCGATGGAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.46319484107	37.6546354815004	0.0190226499687577	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.25632427535	1975.25632427535
"healthy-3"	"2019-08-01-count-1:TCACGCTGTGTACAGG"	-0.509120802313644	8.15018746936647	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCACGCTGTGTACAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2220.0062794037	39.026058929787	0.0175792561002438	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2213.38616151541	2213.38616151541
"healthy-3"	"2019-08-01-count-3:AACCCAAAGTATGATG"	-4.84281716767009	-4.18800117885741	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAAAGTATGATG"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3214.53153207968	41.3194267141555	0.012853949728539	3979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3211.89922408777	3211.89922408777
"healthy-3"	"2019-08-01-count-4:TAAGTCGTCGAACACT"	-4.01044736328776	10.6491012343201	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGTCGAACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2100.60521129319	49.1557860492926	0.0234007731605269	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2093.99594743534	2093.99594743534
"healthy-3"	"2019-08-01-count-3:CCTACGTCAGTTGCGC"	-1.49591730061229	8.76335141742555	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTCAGTTGCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.60214954814	46.6540359005919	0.0242157084230047	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1923.37502930449	1923.37502930449
"healthy-3"	"2019-08-01-count-3:ACATCGACAAGCGCAA"	-3.40585790100749	9.92708108508912	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCGACAAGCGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.7994498711	54.4426933498176	0.0276808565069436	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.71695319842	1961.71695319842
"healthy-3"	"2019-08-01-count-3:ACGATGTGTGCGCTCA"	-3.97756753388103	13.1151208647522	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGATGTGTGCGCTCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1893.06963296521	46.9358361744268	0.0247935075166299	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1887.63774967018	1887.63774967018
"healthy-3"	"2019-08-01-count-2:AAACCCATCGAATCCA"	3.40935697135274	-6.23114445125731	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACCCATCGAATCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.46670237953	43.532898502526	0.0167082920164622	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2600.51406424192	2600.51406424192
"healthy-3"	"2019-08-01-count-3:CACTGAATCTTGTTAC"	10.100244184106	7.33284280383912	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGAATCTTGTTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2092.71720957497	44.4360274518328	0.0212336512781188	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2077.33815664874	2077.33815664874
"healthy-3"	"2019-08-01-count-4:AATGGAATCTCTCGAC"	-3.90090094032939	10.0961017378601	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAATCTCTCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.66792525366	49.8498738506995	0.0244042965742996	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.05065977496	2041.05065977496
"healthy-3"	"2019-08-01-count-2:AAACCCATCCTAGCGG"	0.203685169189614	8.53908059680787	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACCCATCCTAGCGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.26331468966	42.3085389615945	0.0203968988228115	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.12514153556	2067.12514153556
"healthy-3"	"2019-08-01-count-4:CTACCCACATGTGGTT"	5.47088064727132	-9.57040598308715	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCACATGTGGTT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2877.72533731173	39.3079970401535	0.0136593984597827	2324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2868.19437954036	2868.19437954036
"healthy-3"	"2019-08-01-count-3:TTCTCTCTCGAGTACT"	-1.33536467972453	8.41703698718873	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTCTCTCGAGTACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.02814761178	48.5510739774103	0.0261163737836793	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1850.30210602473	1850.30210602473
"healthy-3"	"2019-08-01-count-3:CCGGACAGTTCGTAAC"	-4.93806539002116	2.64740178668825	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACAGTTCGTAAC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3221.29187780117	43.3136626142221	0.0134460534025832	4124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3213.4713690395	3213.4713690395
"healthy-3"	"2019-08-01-count-2:ACTTTGTTCTTGATTC"	-2.11201153221782	8.58491513812868	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTGTTCTTGATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.92134122784	46.6108345912697	0.02387946358635	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.33089348831	1950.33089348831
"healthy-3"	"2019-08-01-count-4:CTGTATTAGTGGTTCT"	3.79965056952779	-7.29086830532225	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTAGTGGTTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.2307407322	47.657808565612	0.0177151379039855	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2683.99272966313	2683.99272966313
"healthy-3"	"2019-08-01-count-2:CTCAGAAGTTGGGTTT"	5.23202290114705	-9.21842672741088	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAGTTGGGTTT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.46007603946	46.4979720673525	0.0171803650380818	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2699.61702479871	2699.61702479871
"healthy-3"	"2019-08-01-count-4:ATCCTATTCCTACCGT"	4.43087734755818	-8.33793737804564	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATTCCTACCGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2978.21999895715	41.7902821492107	0.0140319661287091	2449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2972.24212741278	2972.24212741278
"healthy-3"	"2019-08-01-count-3:TTCACCGAGGAGCTGT"	3.96484722670857	-7.98350813305052	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGAGGAGCTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1510.91660515306	45.5283220777955	0.0301329152929544	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1506.0675303822	1506.0675303822
"healthy-3"	"2019-08-01-count-4:AATTCCTAGCTCATAC"	10.3134447532589	7.09638068759767	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTCCTAGCTCATAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2247.56081993897	44.1982158804991	0.0196649699035505	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2239.32636492434	2239.32636492434
"healthy-3"	"2019-08-01-count-4:TACCGGGGTGGCTTGC"	4.50219788131062	-8.26685717022093	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGGGGTGGCTTGC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.81276857409	48.5244326296411	0.0181412445759741	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2673.1278668642	2673.1278668642
"healthy-3"	"2019-08-01-count-3:TTGCGTCAGTCCTACA"	-2.18133674088176	3.62983367526857	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCGTCAGTCCTACA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3148.33055573065	50.6248106484644	0.0160798905173144	4318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3143.1318072247	3143.1318072247
"healthy-3"	"2019-08-01-count-3:TCAGTGATCGATTGGT"	-1.87923548641856	8.91762826526491	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGATCGATTGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1806.06115591542	43.1802236111993	0.0239085057943749	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1804.11542441243	1804.11542441243
"healthy-3"	"2019-08-01-count-4:GTGCGTGTCATGCATG"	4.1784049468929	-8.68920614635619	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGTCATGCATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.47757753894	49.5329474108116	0.0236267479993554	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2090.59454148829	2090.59454148829
"healthy-3"	"2019-08-01-count-2:GCGTGCACACTACCGG"	-0.27450660887416	8.72868344867555	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTGCACACTACCGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.09462819298	45.8464629537159	0.02388963122516	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.45433612054	1912.45433612054
"healthy-3"	"2019-08-01-count-2:CGAGTTATCCCAGCGA"	4.51406445082967	-7.86966230785521	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTTATCCCAGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.81095202907	45.9937925794846	0.0194164049014073	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2362.8676153594	2362.8676153594
"healthy-3"	"2019-08-01-count-3:ACGTAACTCGGTCATA"	-1.57318387451823	8.77922818744508	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACTCGGTCATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2038.79830121907	41.1140108138456	0.020165805901085	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.29887581389	2030.29887581389
"healthy-3"	"2019-08-01-count-1:GTAGGTTCATCCTTCG"	10.5798908668453	6.73635861957399	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTAGGTTCATCCTTCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2211.40160934637	43.1577747334802	0.019516027550616	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2193.29704142591	2193.29704142591
"healthy-3"	"2019-08-01-count-4:GTCACTCCAGTTTCAG"	10.5310856300289	6.83210418308107	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCCAGTTTCAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1862.8470605416	45.5474951903949	0.0244504748431428	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1847.31422828037	1847.31422828037
"healthy-3"	"2019-08-01-count-4:CGGTCAGCAGTCACGC"	2.91946925696675	-6.50068809902342	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGTCAGCAGTCACGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.77942198738	46.1818631554536	0.0192843911766739	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2389.91555225383	2389.91555225383
"healthy-3"	"2019-08-01-count-3:TTACCGCCAGGTTCGC"	1.92083909091298	-6.42471744930419	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCCAGGTTCGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2218.93569099445	44.520649952844	0.0200639658614402	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2216.06448306533	2216.06448306533
"healthy-3"	"2019-08-01-count-2:CTATCCGTCGTCACCT"	4.43023075637166	-7.87955906307372	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGTCGTCACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.98035152505	42.5349840545173	0.0163975737246854	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2589.45643612528	2589.45643612528
"healthy-3"	"2019-08-01-count-4:TCATACTTCCGTGGCA"	-0.164999435574371	7.6380028494629	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTTCCGTGGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.86301976628	40.5973698030523	0.0210363996756459	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.34244004958	1917.34244004958
"healthy-3"	"2019-08-01-count-4:ACTTATCTCTCTCGCA"	-1.69412479820903	8.66890714252321	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCTCTCTCGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.04185147201	46.80638731549	0.0219743979599009	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2124.12518117906	2124.12518117906
"healthy-3"	"2019-08-01-count-4:GCAGCCATCACTGGTA"	10.0173832374508	6.92311332309572	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCATCACTGGTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.0232266362	40.7301589481035	0.0209084565272024	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1946.46147786055	1946.46147786055
"healthy-3"	"2019-08-01-count-2:AAAGGATTCATTCTTG"	3.26922120627705	-8.02007963573607	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATTCATTCTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.19480771447	52.0897085279667	0.0225185135096483	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2308.02781016311	2308.02781016311
"healthy-3"	"2019-08-01-count-3:AGACACTGTTTCCATT"	-3.56152806702312	10.3574599989685	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTGTTTCCATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2088.11147311145	50.1624749213449	0.0240228912906641	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2081.525947421	2081.525947421
"healthy-3"	"2019-08-01-count-3:CCCTTAGCATCGATGT"	11.1581751304561	5.77671191776124	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTTAGCATCGATGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.89746893559	49.1620635319425	0.0253687639929399	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1930.61671885468	1930.61671885468
"healthy-3"	"2019-08-01-count-3:GAGATGGAGCTCCATA"	-3.86733923378642	10.7895746001038	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGATGGAGCTCCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1936.34521060354	45.57162842982	0.0235348677396298	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1932.6633714005	1932.6633714005
"healthy-3"	"2019-08-01-count-3:TTCCAATGTCAGTCTA"	4.18098129805867	-6.54713013088378	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCAATGTCAGTCTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.69298294653	44.0685393769991	0.0163842266222974	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2686.16687785509	2686.16687785509
"healthy-3"	"2019-08-01-count-2:TGTGGCGAGGGTACGT"	4.83965506133382	-7.94310381328734	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGAGGGTACGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.60098975565	47.0298433479755	0.0191598730483105	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2448.91262486847	2448.91262486847
"healthy-3"	"2019-08-01-count-3:AACGGGATCTTCACAT"	4.77494015273396	1.64382073963014	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGGGATCTTCACAT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2554.8481496587	48.5494665755142	0.0190028775612358	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2544.12661750619	2544.12661750619
"healthy-3"	"2019-08-01-count-1:AAGCGTTTCTAGATCG"	10.9120680290157	6.74172017658082	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAGCGTTTCTAGATCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2155.22430104827	46.5753642611534	0.0216104487307886	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2150.47189776618	2150.47189776618
"healthy-3"	"2019-08-01-count-4:GTTCTATGTTCACCGG"	-4.00941119614299	10.8591117628845	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATGTTCACCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2066.98910374758	44.3868167150298	0.0214741416074975	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2060.15190516475	2060.15190516475
"healthy-3"	"2019-08-01-count-4:GCAGGCTTCCTACGGG"	4.21613182601277	-7.48193313991698	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGGCTTCCTACGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.41280963101	45.2218785723789	0.017786992891584	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2535.67162228015	2535.67162228015
"healthy-3"	"2019-08-01-count-3:TTTGGAGCAATCGTCA"	-5.7011903328007	-5.49362614071044	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGCAATCGTCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2581.50821463839	51.3809195001451	0.0199034499324041	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2574.19089027318	2574.19089027318
"healthy-3"	"2019-08-01-count-3:GAATAGAGTAGTCCTA"	-7.55688367310222	2.88623545253602	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATAGAGTAGTCCTA"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2513.38398315585	43.6186841034657	0.0173545643625441	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2499.59010732398	2499.59010732398
"healthy-3"	"2019-08-01-count-2:GTCTGTCAGTTGGAGC"	5.62106766280476	-9.62348463451537	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCAGTTGGAGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.56030788602	47.2479816615295	0.0170905953929646	2268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2756.92257432737	2756.92257432737
"healthy-3"	"2019-08-01-count-4:GGTAGAGTCAACCGAT"	2.47931470450703	-6.08046200191649	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAGAGTCAACCGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.02096680922	49.8214675664641	0.0207069964284375	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2402.6365321919	2402.6365321919
"healthy-3"	"2019-08-01-count-2:CGTGTCTGTCTCAAGT"	-2.4927593273228	9.76783177936403	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGTCTGTCTCAAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1755.53806393502	47.0265511592845	0.0267875428766693	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1751.79915433261	1751.79915433261
"healthy-3"	"2019-08-01-count-3:AATCACGAGCTTTCTT"	-2.11048899117168	10.0363740690979	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCACGAGCTTTCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1882.20059014098	46.7793773766325	0.0248535557908462	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1880.32751168301	1880.32751168301
"healthy-3"	"2019-08-01-count-3:TAGCACAAGAGTAACT"	-8.62457976761516	1.66363236987916	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACAAGAGTAACT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2957.28041459315	41.7719032330534	0.014125107320538	3839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2944.80972258702	2944.80972258702
"healthy-3"	"2019-08-01-count-3:ACTACGATCCTGGGTG"	-3.16287408295329	9.51792428577272	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTACGATCCTGGGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1981.64840748539	44.9069459745684	0.022661409463424	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.36474827355	1978.36474827355
"healthy-3"	"2019-08-01-count-2:CTACAGAAGGGATCAC"	-2.42325554314311	8.8815879591736	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGAAGGGATCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.43456973031	47.3523912574176	0.0244029827112381	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1938.66645100875	1938.66645100875
"healthy-3"	"2019-08-01-count-2:ACTTCGCGTAATGTGA"	3.07572187957112	-5.20599605953368	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCGTAATGTGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2713.52992583396	44.6320599765713	0.0164479704283543	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2710.05360127744	2710.05360127744
"healthy-3"	"2019-08-01-count-3:CGGAGAAAGTAGTCCT"	-3.54826078835185	10.3525962599548	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAAAGTAGTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.34836073534	47.5771640584844	0.0241588359921855	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.69794366375	1967.69794366375
"healthy-3"	"2019-08-01-count-3:AGCCAATAGTCACTGT"	4.6687728362972	-8.45222475444945	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATAGTCACTGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.10632395947	44.3276843186752	0.0167901133058139	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2630.68643714145	2630.68643714145
"healthy-3"	"2019-08-01-count-2:GAATAGAAGGGCCTCT"	-3.41914449158366	9.97132585132448	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATAGAAGGGCCTCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2043.3755620462	48.7465670393527	0.0238559019422444	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2038.41103849606	2038.41103849606
"healthy-3"	"2019-08-01-count-3:GGGCTCATCATTGTGG"	10.7633234458858	6.23532531345216	"2019-08-01-count-3"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTCATCATTGTGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2272.71712965994	51.1666439453797	0.0225134238122435	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2257.15114946729	2257.15114946729
"healthy-3"	"2019-08-01-count-3:GCCCAGACAACACTAC"	4.81948008117024	-8.86021521007689	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCAGACAACACTAC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.44329628671	44.7075881704972	0.0174336427072626	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2562.37787254762	2562.37787254762
"healthy-3"	"2019-08-01-count-3:ACCAAACAGCTTAAGA"	4.19264425811116	-7.99672892009886	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAAACAGCTTAAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.44025411531	47.0052770626702	0.0181456711800224	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2587.52490376894	2587.52490376894
"healthy-3"	"2019-08-01-count-4:ACACCAAGTATGCTAC"	10.4231974082882	7.48760745609132	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAAGTATGCTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.96897868185	46.4053215752146	0.0236765592108625	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1954.89941283644	1954.89941283644
"healthy-3"	"2019-08-01-count-4:CAGGGCTGTTTACCAG"	3.29756416854207	-7.13247396862181	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGGCTGTTTACCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.23965367073	47.1531734616303	0.0187693771144536	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2509.65495906832	2509.65495906832
"healthy-3"	"2019-08-01-count-4:ACACCAACATCACGGC"	0.051709555636537	8.01989266956178	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAACATCACGGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2100.70310120893	38.7610082814689	0.0184514452609521	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2089.82898259337	2089.82898259337
"healthy-3"	"2019-08-01-count-2:CCACAAACACAGTACT"	-2.98588023605998	9.44962308490602	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAACACAGTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.42143358686	46.2309159015314	0.0222112231360387	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.07322828404	2072.07322828404
"healthy-3"	"2019-08-01-count-4:ACACCAATCTCCCATG"	10.3951927619869	7.57126662814943	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAATCTCCCATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2194.52203292195	43.5095684653188	0.0198264441243212	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2189.93365352776	2189.93365352776
"healthy-3"	"2019-08-01-count-2:TACAACGTCGATACAC"	-2.54516063156779	9.6872987517151	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAACGTCGATACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.41288533517	50.9114904028189	0.0269456669836289	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1889.41288533517	1889.41288533517
"healthy-3"	"2019-08-01-count-3:AATCGACCACGGTCTG"	3.79776944693868	-7.06398870861205	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACCACGGTCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.71261352789	44.5724452040169	0.0183977434860141	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2419.80845313246	2419.80845313246
"healthy-3"	"2019-08-01-count-4:CACCGTTAGGTTACAA"	-2.16325674477275	9.00609490955202	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCGTTAGGTTACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.38325812223	53.9497458368557	0.0294584683995484	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1827.49710995011	1827.49710995011
"healthy-3"	"2019-08-01-count-4:CTGCATCCAAGTCATC"	-2.7873719734257	9.015917755011	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCATCCAAGTCATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.71534720105	39.6509283564321	0.0200691503523545	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1965.58744816719	1965.58744816719
"healthy-3"	"2019-08-01-count-3:AAGGTAACACTTCAGA"	10.8081718879635	6.60741422260133	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAACACTTCAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2091.97480975645	44.286110527909	0.0211695238018019	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2084.89574561284	2084.89574561284
"healthy-3"	"2019-08-01-count-2:CACCAAAAGTCCCAAT"	-0.0829852176016152	7.71940944278566	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAAAGTCCCAAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2008.06222136611	38.0918063854453	0.0189694352994356	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1999.21457210626	1999.21457210626
"healthy-3"	"2019-08-01-count-1:TCCGGGAGTACTGGGA"	10.2493969398433	7.54847476566163	"2019-08-01-count-1"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCGGGAGTACTGGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2277.77497194312	43.2219255365386	0.018975502878437	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2260.86740127015	2260.86740127015
"healthy-3"	"2019-08-01-count-3:TGGGTTATCCATCTAT"	5.43043150481526	-9.5559120408264	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGTTATCCATCTAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2746.35748561513	40.6519970299365	0.0148021505732096	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2739.44868116871	2739.44868116871
"healthy-3"	"2019-08-01-count-4:GTCGAATTCGGAGCAA"	-3.71466956558879	10.8564281233582	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATTCGGAGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.8726655392	44.9995594299168	0.0229839050424272	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.8726655392	1957.8726655392
"healthy-3"	"2019-08-01-count-4:GGAATCTAGGGCAATC"	-3.57863531532939	13.3583268889221	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTAGGGCAATC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.32406796582	46.5700245851926	0.0249795759146131	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1860.43229354696	1860.43229354696
"healthy-3"	"2019-08-01-count-2:CATCGGGCACTCATAG"	-3.93043480339702	11.5246457823547	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGCACTCATAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1885.58820826218	44.2773436350889	0.0234819794911088	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1878.917526985	1878.917526985
"healthy-3"	"2019-08-01-count-2:CGCGTGACAATGAGCG"	4.91481270369832	-8.26303388988646	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGACAATGAGCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.41539374037	47.6333053968731	0.0175676901100585	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2707.66645699957	2707.66645699957
"healthy-3"	"2019-08-01-count-3:AATGAAGTCATCTCTA"	10.9083191352779	6.73934171283571	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGTCATCTCTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1952.86938008267	39.305617467278	0.0201271103270687	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1945.1184608825	1945.1184608825
"healthy-3"	"2019-08-01-count-4:TTCGGTCCACAGTGTT"	4.76945414122884	-7.90011122142943	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCCACAGTGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2712.55351727112	46.6645888160783	0.0172031956305967	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2708.13209713924	2708.13209713924
"healthy-3"	"2019-08-01-count-2:CGTGCTTAGCACCGAA"	4.35164084014241	-7.76402094280394	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTAGCACCGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.72556156099	46.340504235855	0.0181107755095018	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2554.08544178026	2554.08544178026
"healthy-3"	"2019-08-01-count-4:TTCTAACGTACCAATC"	-1.65996931019481	8.95715806567994	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAACGTACCAATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.56812453507	40.9732915310194	0.0190434553588087	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2148.08556698154	2148.08556698154
"healthy-3"	"2019-08-01-count-2:CTTCGGTCAAACACCT"	4.00101604041402	-7.98804857647093	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCGGTCAAACACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.8350058766	53.2189016396746	0.022437859930314	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2369.48291719716	2369.48291719716
"healthy-3"	"2019-08-01-count-3:CCTACGTCAATTTCGG"	4.17793812331502	-7.49682810222777	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTCAATTTCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.85003741898	53.0110824282308	0.0229997967623064	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2302.09196060069	2302.09196060069
"healthy-3"	"2019-08-01-count-3:TTGCATTTCTTCCCGA"	-2.71450338783916	9.37957761371461	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCATTTCTTCCCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2261.18832491812	44.9645407619406	0.0198853586260087	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2252.88626101958	2252.88626101958
"healthy-3"	"2019-08-01-count-3:GTAACCACATCGTGGC"	3.06667007979695	-6.4892239800659	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCACATCGTGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.93292461226	45.2288656531425	0.0173961663491329	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2593.20874220161	2593.20874220161
"healthy-3"	"2019-08-01-count-2:GAGTGAGGTCAAAGCG"	-2.79153428497966	9.75719544971315	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGGTCAAAGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.16913141938	45.5412928909431	0.0250892834737289	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1813.31062455658	1813.31062455658
"healthy-3"	"2019-08-01-count-3:GTTTACTTCAAACCCA"	-2.42680678787883	8.74754808032838	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTTACTTCAAACCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.49769696018	46.506381572602	0.0233876969753077	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1983.1984414174	1983.1984414174
"healthy-3"	"2019-08-01-count-4:TACGGTAGTGTTGCCG"	4.55011858519856	-8.23890592968138	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGTAGTGTTGCCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.83479172686	44.7861805621331	0.0167748883567306	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2664.01061670462	2664.01061670462
"healthy-3"	"2019-08-01-count-2:GAGGCCTCAACGGGTA"	3.51780499991719	-7.43437578594359	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTCAACGGGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.62078872425	39.8907894166747	0.0158383467631427	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2508.02914934995	2508.02914934995
"healthy-3"	"2019-08-01-count-4:GGAGATGCACACCTAA"	5.0116831260616	-8.59410574352416	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGATGCACACCTAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.21468974327	47.4932419123132	0.0178063063670681	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2665.65851135763	2665.65851135763
"healthy-3"	"2019-08-01-count-3:TAGTGCATCGAGAATA"	-4.88955674591716	-5.11033060466918	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCATCGAGAATA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2791.55866087202	50.8117428879852	0.0182019255408062	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2788.31625045805	2788.31625045805
"healthy-3"	"2019-08-01-count-2:ACAGGGAGTTGTGCCG"	-2.10939703407939	8.64303205097047	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGGGAGTTGTGCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1915.6710362013	45.3387220274812	0.0236672795958674	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1914.0103982988	1914.0103982988
"healthy-3"	"2019-08-01-count-4:TGAGACTTCATTCACT"	10.9807526069576	6.34355018222658	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGACTTCATTCACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.64888313728	45.7157540009793	0.0231279082445946	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1969.89914505662	1969.89914505662
"healthy-3"	"2019-08-01-count-2:ACTCTCGGTATGTCAC"	-4.10998187485393	10.0740937956604	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCTCGGTATGTCAC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2542.44087009741	41.1345725861259	0.0161791658834331	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2535.966187383	2535.966187383
"healthy-3"	"2019-08-01-count-2:CCTGCATTCCTCATAT"	11.0183588462764	6.30584428394166	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATTCCTCATAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2096.99329492138	47.0572452703985	0.0224403413136153	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2090.06345783775	2090.06345783775
"healthy-3"	"2019-08-01-count-2:CTCATGCTCCCTCTAG"	-4.40717397156413	13.1774806746277	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATGCTCCCTCTAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2080.08510989585	47.2761638572793	0.0227279949423062	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2076.46745914425	2076.46745914425
"healthy-3"	"2019-08-01-count-2:ACATCCCAGTGAGTTA"	10.5265337425167	7.04707286441652	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGTGAGTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2072.16469885893	45.3225289163156	0.0218720688279619	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2067.1603457753	2067.1603457753
"healthy-3"	"2019-08-01-count-4:ACATCGACAACCGTGC"	-3.25348816338237	9.57831380451051	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCGACAACCGTGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2195.25476969062	42.0576950343245	0.0191584574214371	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2190.96937420784	2190.96937420784
"healthy-3"	"2019-08-01-count-3:GTGCACGCAAAGGATT"	3.29091062125508	-6.50784971630248	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCACGCAAAGGATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.46677393923	48.554635354118	0.0203458250013559	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2382.64077394789	2382.64077394789
"healthy-3"	"2019-08-01-count-3:TCGCAGGTCTCCAATT"	0.109443583607119	7.88663337314454	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCAGGTCTCCAATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.69520514997	38.9114275802144	0.0219628226498026	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1767.26107651434	1767.26107651434
"healthy-3"	"2019-08-01-count-3:CGATGGCCAATTGCAC"	5.01192106780354	-8.0110016099182	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGGCCAATTGCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.11393057131	47.2117229402101	0.0190131118669	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2483.11393057131	2483.11393057131
"healthy-3"	"2019-08-01-count-3:GTGCACGTCATGGATC"	-3.09495292130168	8.9776286848816	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCACGTCATGGATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2357.6314201277	46.2258376460284	0.0196068975207009	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2350.34466739962	2350.34466739962
"healthy-3"	"2019-08-01-count-3:ACCCTTGAGAGTTCGG"	-4.89929614487346	2.25178072536317	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGAGAGTTCGG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3285.4660197484	46.278398928377	0.014085794420093	4667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3276.87295632491	3276.87295632491
"healthy-3"	"2019-08-01-count-3:GCAGGCTTCATTACTC"	10.2413851219112	7.27643582904664	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGGCTTCATTACTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.74042736991	41.9256215784886	0.0208612122279669	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2004.99337005195	2004.99337005195
"healthy-3"	"2019-08-01-count-3:CCTATCGGTAACCAGG"	-1.99372301521953	8.79442021930543	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGGTAACCAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1712.10729420621	30.5421685619995	0.0178389337311712	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1708.01901163182	1708.01901163182
"healthy-3"	"2019-08-01-count-2:GAGGGTACACCGTCGA"	-2.84785590592082	9.28077218616334	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTACACCGTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1963.70718225959	48.7602957530439	0.0248307365749595	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.61106638627	1960.61106638627
"healthy-3"	"2019-08-01-count-4:TAGGTTGAGCTTACGT"	-3.38652930679973	10.905451751593	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTTGAGCTTACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.2487427308	48.376902084963	0.0256471487503422	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1884.46811633286	1884.46811633286
"healthy-3"	"2019-08-01-count-4:TTGCCTGGTCTCTCAC"	-0.0109713328188241	8.1448707350525	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCCTGGTCTCTCAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1987.53252807546	38.7413049766148	0.0194921614762844	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.4303489058	1978.4303489058
"healthy-3"	"2019-08-01-count-4:GAGACTTAGTCCCAAT"	4.24150147017781	-7.82962276851805	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACTTAGTCCCAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.81432491508	36.6377769453369	0.0144595350121263	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2526.98432514256	2526.98432514256
"healthy-3"	"2019-08-01-count-2:TGCCGAGAGGACTGGT"	10.4910665946895	5.25059459293214	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGAGGACTGGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1622.59292759452	46.4550758380205	0.0286301481092303	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1618.29401227456	1618.29401227456
"healthy-3"	"2019-08-01-count-4:TATACCTAGGCTAAAT"	-4.2307370704716	13.1877183684143	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTAGGCTAAAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2359.0254852666	45.5598472418313	0.0193129949321775	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2354.20339966338	2354.20339966338
"healthy-3"	"2019-08-01-count-2:CCATCACTCGTTAGTG"	0.770711978047532	8.32223794544069	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACTCGTTAGTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1796.86605878785	35.7816091787259	0.0199133424574027	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1791.64962251291	1791.64962251291
"healthy-3"	"2019-08-01-count-3:TGTCAGAAGATTTGCC"	-3.90707693520244	2.66617462718812	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCAGAAGATTTGCC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3146.09480981365	44.1047957935942	0.0140189023089888	4964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3137.6734769758	3137.6734769758
"healthy-3"	"2019-08-01-count-3:ATCGTAGAGCCTCACG"	0.669990857213181	8.00557277286378	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGAGCCTCACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.17710872133	39.9898429732122	0.0233971323212546	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1707.86354764306	1707.86354764306
"healthy-3"	"2019-08-01-count-2:CGGGCATGTCAACATC"	-3.87358603897746	10.3253469237122	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGCATGTCAACATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.15444157265	41.8412544868329	0.0203295018302231	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.03407888169	2055.03407888169
"healthy-3"	"2019-08-01-count-3:TGTAGACGTTCGTGCG"	-4.33731208267863	10.5716562041077	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACGTTCGTGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.58756635684	47.0092975726627	0.0234860059898483	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.04152188217	1998.04152188217
"healthy-3"	"2019-08-01-count-3:ATTACTCTCTCATTGT"	-1.71233127537425	11.7934903868469	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCTCTCATTGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2180.67963725092	44.4056427005952	0.0203632124325126	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2177.30659720176	2177.30659720176
"healthy-3"	"2019-08-01-count-2:ACCAAACAGACATCCT"	-3.4676915210789	-5.28073265468749	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACAGACATCCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3098.16212441711	45.3615086245617	0.0146414250781328	3634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3094.23094201971	3094.23094201971
"healthy-3"	"2019-08-01-count-3:GGAGCAACAGTCAACT"	10.9838110404903	6.3193354376587	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAACAGTCAACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1885.0091791397	43.905613772103	0.0232919893748959	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1883.43878339436	1883.43878339436
"healthy-3"	"2019-08-01-count-2:AATTTCCGTTTGTTCT"	-3.57576094093974	10.3530378111633	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCGTTTGTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1882.7065809677	35.3993411180044	0.0188023675467312	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1880.69638697892	1880.69638697892
"healthy-3"	"2019-08-01-count-4:CAGCAGCTCTCCATAT"	3.22515978392903	-6.50712921535643	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCTCTCCATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.16605578546	47.7145663562425	0.0179434323976991	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2650.51840612299	2650.51840612299
"healthy-3"	"2019-08-01-count-2:CAACCTCCACGTACAT"	-2.65637336197551	9.09941003406373	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCCACGTACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2330.29014280323	41.8859290396283	0.0179745553011873	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2324.42363084729	2324.42363084729
"healthy-3"	"2019-08-01-count-3:CACTGGGAGGGATCTG"	-3.27187953415568	11.3212880858215	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGAGGGATCTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1680.32717895685	44.6893108674371	0.0265956008014941	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1668.54168449046	1668.54168449046
"healthy-3"	"2019-08-01-count-4:GTCATCCTCGTGTCAA"	-3.55712185326274	11.0212383040222	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCTCGTGTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.36563884044	45.3639519909574	0.0227346562995439	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.96574018782	1991.96574018782
"healthy-3"	"2019-08-01-count-2:TTAGGCATCCTCCACA"	-4.06531892243083	10.7628879317078	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCATCCTCCACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2346.03866771443	47.6633243994697	0.0203165127051825	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2344.52224599415	2344.52224599415
"healthy-3"	"2019-08-01-count-4:GCAGGCTCAATGGCAG"	4.35637058791463	-8.08569052135619	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGGCTCAATGGCAG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.29402513121	45.5411456056757	0.0170611199728876	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2661.9842959643	2661.9842959643
"healthy-3"	"2019-08-01-count-2:AGACCCGTCCGTGTGG"	-2.93129644814189	8.98145768726198	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGTCCGTGTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2116.09627544651	44.7866331894118	0.0211647426958216	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.84811215721	2112.84811215721
"healthy-3"	"2019-08-01-count-4:GTTACGATCAGACAAA"	-1.81074045124705	8.78359220111696	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGATCAGACAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.88833559936	42.8321840553792	0.0206830002946453	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2062.52471017513	2062.52471017513
"healthy-3"	"2019-08-01-count-4:CAGAGCCAGCGCTGAA"	10.5998379188472	7.06070897662965	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCAGCGCTGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.27272676879	34.5867257420961	0.0182778757273302	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1887.17700379207	1887.17700379207
"healthy-3"	"2019-08-01-count-3:AAAGGGCGTAAGATTG"	-0.28300846639331	8.62305924976198	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGGCGTAAGATTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2244.15334330282	43.7303585482436	0.0194863504665344	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2241.64351414996	2241.64351414996
"healthy-3"	"2019-08-01-count-2:GTAACCATCTTGTTAC"	-2.77089343491252	8.80954835498659	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACCATCTTGTTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1987.70234246819	42.9802070102231	0.0216230599984368	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1987.70234246819	1987.70234246819
"healthy-3"	"2019-08-01-count-2:CGTAAGTAGGTTCTTG"	-0.28545636954959	8.46348760211793	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAAGTAGGTTCTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.11368490509	34.2486256027024	0.0165124148458958	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.02137671538	2067.02137671538
"healthy-3"	"2019-08-01-count-2:GTCACTCCACGGTGCT"	2.79651917990987	-6.37290337001952	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCCACGGTGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.86242427268	42.009287292765	0.0165726103675305	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2527.06758688491	2527.06758688491
"healthy-3"	"2019-08-01-count-2:AAGTGAAAGTGCAACG"	3.70275988158528	-6.45388414776	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAAAGTGCAACG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2639.68402591795	41.5041901214414	0.0157231659978729	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2635.2339232273	2635.2339232273
"healthy-3"	"2019-08-01-count-2:TCCTGCATCACCTCTG"	-2.49350176277812	9.1474628218445	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCATCACCTCTG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2325.04901912727	47.0381430522859	0.0202310328364355	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2319.50526420009	2319.50526420009
"healthy-3"	"2019-08-01-count-4:CTATCTAGTCTGTCCT"	-1.45115683499034	8.85204503619996	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCTAGTCTGTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.60910333958	45.696256678221	0.0230369262781096	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.12985925531	1975.12985925531
"healthy-3"	"2019-08-01-count-4:GAGGGTAGTCTGTGCG"	5.498551984399	-9.50143816387328	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGTAGTCTGTGCG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2735.31676430373	44.5541980639297	0.0162884966909018	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2729.67157478154	2729.67157478154
"healthy-3"	"2019-08-01-count-3:TATGTTCTCAAAGGAT"	-3.97580800476726	10.5678319700989	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCTCAAAGGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.28389135435	45.1206774774559	0.0238571679713007	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1882.37072458227	1882.37072458227
"healthy-3"	"2019-08-01-count-3:TTGCCTGTCCACCTGT"	10.9271112876827	6.70453164661256	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGTCCACCTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.07227732598	45.56303561258	0.0225999018611637	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2010.11400108144	2010.11400108144
"healthy-3"	"2019-08-01-count-4:TATCTTGAGAGTATAC"	4.93473066863362	-7.64878179943236	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGAGAGTATAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.14350738363	46.964150730899	0.0187470899740783	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2502.99096783462	2502.99096783462
"healthy-3"	"2019-08-01-count-4:CATCGCTTCCTCCACA"	4.02169336852376	-7.64289762890013	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTTCCTCCACA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1761.57102816773	29.001843027813	0.0164636239834046	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1759.42754395012	1759.42754395012
"healthy-3"	"2019-08-01-count-4:CGAATTGCATGACACT"	-3.76980815354045	10.484496093634	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAATTGCATGACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.12129983365	40.5553657741431	0.0205643363709747	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.37015377911	1967.37015377911
"healthy-3"	"2019-08-01-count-2:AGACACTAGAGTATAC"	-1.82160661640819	8.98227593982545	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTAGAGTATAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.61715360449	46.8415308832166	0.0241125899646789	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.95560958282	1940.95560958282
"healthy-3"	"2019-08-01-count-3:ATCTTCAAGTGCAAAT"	9.97753014144246	6.90857980335084	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTTCAAGTGCAAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.71661793956	43.5905793495138	0.0227186125048128	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1909.26335083313	1909.26335083313
"healthy-3"	"2019-08-01-count-3:ACGTAACCAAGCACCC"	-3.75360808792766	11.0479440459046	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACCAAGCACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2218.58617475362	44.0540059427118	0.0198567927827298	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2218.58617475362	2218.58617475362
"healthy-3"	"2019-08-01-count-3:TATTCCATCCGGCTTT"	-2.86868963661845	9.54036710346071	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCATCCGGCTTT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2255.22335627066	44.5274235782801	0.019744130200883	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2247.3390674793	2247.3390674793
"healthy-3"	"2019-08-01-count-2:TTGTTTGGTCTCAAGT"	-2.72444711151775	9.52036950671998	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGGTCTCAAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.10625613373	43.9674235022711	0.0229942365186196	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.6415377862	1908.6415377862
"healthy-3"	"2019-08-01-count-4:TCCGAAAAGACCATTC"	-3.48991356316264	9.80908868396608	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAAAGACCATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2092.05853132482	49.2627401750223	0.0235474961323506	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.26708076035	2085.26708076035
"healthy-3"	"2019-08-01-count-2:ACCCAAACATTCACAG"	-1.28803000870402	8.38167188251344	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCAAACATTCACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.11459377062	49.8893262091565	0.0246353102005285	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2018.74907760137	2018.74907760137
"healthy-3"	"2019-08-01-count-3:AATTTCCCACGCGTGT"	2.72313537177388	-7.01995804226073	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTTCCCACGCGTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.63905513748	52.3354114474227	0.0246442121700548	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2122.32642047401	2122.32642047401
"healthy-3"	"2019-08-01-count-4:TGACAGTCATTCGGGC"	2.71058549460713	-6.44427683269652	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTCATTCGGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.74423393311	41.1235963115642	0.0173829426367005	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2360.76781424524	2360.76781424524
"healthy-3"	"2019-08-01-count-2:AGACAGGGTTCTCCTG"	-3.02469644966777	9.51284024799196	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAGGGTTCTCCTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1977.75104093236	47.8514270504224	0.0241948688485403	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.69850600654	1970.69850600654
"healthy-3"	"2019-08-01-count-3:TCATATCGTATCTCGA"	-5.26137433472331	-5.25264027034911	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATATCGTATCTCGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3085.62416869547	45.2546136215364	0.0146662753295289	3470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3080.564825083	3080.564825083
"healthy-3"	"2019-08-01-count-3:ATATCCTCATGCACTA"	-0.228909115225631	7.77854964816896	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTCATGCACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2159.77680409781	39.4353879041665	0.0182590107595121	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2143.97752929487	2143.97752929487
"healthy-3"	"2019-08-01-count-3:CACAGGCCATTCACCC"	-1.48432407799419	8.69087407672731	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCCATTCACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2137.92575940888	48.3797899627966	0.0226293124304621	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2132.91397971741	2132.91397971741
"healthy-3"	"2019-08-01-count-4:CGTCCATCAATATCCG"	-7.34897599640544	3.51254103267518	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCCATCAATATCCG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2375.30556412333	47.0911543667336	0.0198253037748067	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2363.45772655756	2363.45772655756
"healthy-3"	"2019-08-01-count-2:ATGACCATCTCTAGGA"	-0.113176892430145	7.68446109378663	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCATCTCTAGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1987.54403711349	46.0925245807469	0.0231906934991423	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.28843708246	1979.28843708246
"healthy-3"	"2019-08-01-count-2:GGATGTTAGGATTACA"	-3.31972513619121	9.49885461414186	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTAGGATTACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.92073184788	42.895339546605	0.0212466685144907	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2015.84840609623	2015.84840609623
"healthy-3"	"2019-08-01-count-3:CATTGAGTCATTCATC"	-4.24853167954143	13.0363635786804	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGAGTCATTCATC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2296.42989896789	43.2940900231774	0.0188527810244221	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2289.33819620524	2289.33819620524
"healthy-3"	"2019-08-01-count-3:AAGGTAAGTCGCATTA"	-4.04652915421184	10.8476896055969	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAAGTCGCATTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2011.28645647256	38.7243327829848	0.0192535144152964	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.03686928371	2006.03686928371
"healthy-3"	"2019-08-01-count-1:TACCGGGCATTGTCGA"	-1.60781059685405	8.84068677509157	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACCGGGCATTGTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.96983849304	50.2927795465719	0.0235566698132236	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2125.35544144184	2125.35544144184
"healthy-3"	"2019-08-01-count-2:CTTCAATAGAGTTGTA"	4.40609087523763	-7.74007275020751	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATAGAGTTGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.72551472698	45.1024521416688	0.0198189332807475	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2266.65733572271	2266.65733572271
"healthy-3"	"2019-08-01-count-4:ATACTTCCACCTAAAC"	9.99873508986775	6.51037404620973	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACTTCCACCTAAAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1984.06101467057	49.3736059199984	0.0248851247793891	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1976.0624306902	1976.0624306902
"healthy-3"	"2019-08-01-count-3:TTGGGTATCCAAACCA"	-5.26592956009563	-5.3015814057556	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGTATCCAAACCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2605.75363604517	50.669597070951	0.019445275397506	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2601.74145347106	2601.74145347106
"healthy-3"	"2019-08-01-count-2:CAAGCTATCACAATGC"	2.99381007727925	-6.37846567546996	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTATCACAATGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.59147502572	42.9979751430053	0.0161914871121466	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2648.14765976541	2648.14765976541
"healthy-3"	"2019-08-01-count-4:TGCACGGGTGGCTACC"	2.52778067168538	-4.38732197200926	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCACGGGTGGCTACC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2653.57961616406	40.2620833247858	0.0151727436702983	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2651.1123526524	2651.1123526524
"healthy-3"	"2019-08-01-count-3:CTCCCAACACATAACC"	10.8973766761715	6.68396804416505	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAACACATAACC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2330.42121051533	45.1459649547311	0.0193724485303444	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2323.44850751783	2323.44850751783
"healthy-3"	"2019-08-01-count-4:CGAGTGCAGTACCATC"	-2.50283036652263	9.62213132465211	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCAGTACCATC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2094.70460430282	46.1877243148173	0.0220497554738464	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.3185503824	2084.3185503824
"healthy-3"	"2019-08-01-count-2:AAGCCATAGCAGTAAT"	4.46143545684163	-7.99995424663695	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATAGCAGTAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2753.07211687449	41.8902697178028	0.015215827242971	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2751.3594982504	2751.3594982504
"healthy-3"	"2019-08-01-count-3:ATCACTTCATCCGCGA"	10.6266018348629	6.56881139362184	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTCATCCGCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.35696561224	44.0789137954446	0.0228345920369523	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1926.10958697154	1926.10958697154
"healthy-3"	"2019-08-01-count-4:AAAGTCCAGGGTCTTT"	10.3174683051998	7.21626231754152	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCAGGGTCTTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2033.86760118068	46.2750821717234	0.0227522588711577	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2025.95930563616	2025.95930563616
"healthy-3"	"2019-08-01-count-2:CACAGATAGACTTGTC"	-0.810069124132949	8.72522447192994	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATAGACTTGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2080.09774343537	38.9428888148316	0.0187216629303755	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2076.88670473004	2076.88670473004
"healthy-3"	"2019-08-01-count-4:ACTTTGTGTGAGTAAT"	-2.89115391197856	10.6515006789002	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTGTGTGAGTAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.6842508611	40.3952042581135	0.0210755653884907	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1916.6842508611	1916.6842508611
"healthy-3"	"2019-08-01-count-3:TTCCTAATCCTACCGT"	-0.409995387226897	7.90537974918214	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAATCCTACCGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2189.53756531534	38.7618650921195	0.0177032199429458	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.38975451481	2180.38975451481
"healthy-3"	"2019-08-01-count-2:CCTGCATGTCGTCGGT"	-3.96315465393718	11.0345935591492	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATGTCGTCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1845.19595165963	49.9993406311956	0.027097035730121	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1839.69777773923	1839.69777773923
"healthy-3"	"2019-08-01-count-3:TTCCTAATCAATCAGC"	10.785977979272	6.06329915607301	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAATCAATCAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1855.90303634447	47.5744330112344	0.0256341156189607	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1850.75850764164	1850.75850764164
"healthy-3"	"2019-08-01-count-3:GTCTACCTCGGAGATG"	4.42233957824056	-6.80539371883544	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCTCGGAGATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.44208187896	49.4117428611325	0.0214419547575888	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2298.88246309949	2298.88246309949
"healthy-3"	"2019-08-01-count-2:TGGGATTTCGACGCTG"	-2.43737469139751	8.91010377490846	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGATTTCGACGCTG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2083.30741195049	46.712056059948	0.022422065890033	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2080.1362025103	2080.1362025103
"healthy-3"	"2019-08-01-count-3:TTGTTGTAGGAGTATT"	10.5971180396969	6.67273089969484	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTGTAGGAGTATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.5029626888	47.0354999944645	0.0272590085392669	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1723.49713420824	1723.49713420824
"healthy-3"	"2019-08-01-count-4:GGGATGACACTGTGTA"	3.80883063849751	-7.23488285457762	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATGACACTGTGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.02157937858	45.9064298983749	0.0177517582468922	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2575.57582692305	2575.57582692305
"healthy-3"	"2019-08-01-count-3:ACTATGGAGGTGCTAG"	-1.80634472790416	8.90244863117067	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATGGAGGTGCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.91044628921	43.937988411052	0.0228259909419445	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1915.5684908112	1915.5684908112
"healthy-3"	"2019-08-01-count-2:ACCTGAATCGTCCTCA"	-4.04484830322917	13.2219085463318	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGAATCGTCCTCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2127.78889239764	44.5318246005057	0.0209286855287257	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2122.57363282719	2122.57363282719
"healthy-3"	"2019-08-01-count-4:TTTACTGCATAATGAG"	-2.02365551415141	10.062135673407	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACTGCATAATGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2074.21764460801	49.3275705767363	0.0237812896370662	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.6402696119	2072.6402696119
"healthy-3"	"2019-08-01-count-4:CATGGATTCGCCCAGA"	4.58413519439046	-8.21578981792601	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGATTCGCCCAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.36676848211	46.0675670627553	0.0164858699231451	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2788.14356231055	2788.14356231055
"healthy-3"	"2019-08-01-count-3:CTTCAATGTGGCACTC"	-2.41519413414653	8.92680833423463	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCAATGTGGCACTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2025.3990341488	51.1346855853878	0.0252467216204029	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2023.78486441963	2023.78486441963
"healthy-3"	"2019-08-01-count-2:ACCTGTCCAGCCTATA"	-5.46298919144328	-5.52064421093138	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCCAGCCTATA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3363.89950172548	41.558588097273	0.0123542894417493	3755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3355.90006720543	3355.90006720543
"healthy-3"	"2019-08-01-count-4:ATTTACCTCAGCATTG"	-5.24194274368938	-4.35628464138182	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTACCTCAGCATTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3351.35423403468	42.6934929333603	0.0127391764498621	4448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3347.26241109552	3347.26241109552
"healthy-3"	"2019-08-01-count-2:AACAACCGTACTTGTG"	10.6643120246822	6.71705100620119	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCGTACTTGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.93929140734	43.775269191743	0.0221205720568678	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1971.29636032662	1971.29636032662
"healthy-3"	"2019-08-01-count-4:ATGGAGGAGAAAGCGA"	-3.38055406037028	9.95408818805543	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGAGAAAGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1763.95829335766	38.4267404580471	0.0217843815257687	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1758.22227565761	1758.22227565761
"healthy-3"	"2019-08-01-count-2:GTGAGTTAGGATTCCT"	-3.48309574547465	10.0908794173035	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTAGGATTCCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2183.29293460916	42.5227468583363	0.019476427640228	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.20816348849	2180.20816348849
"healthy-3"	"2019-08-01-count-4:AGGTTGTGTTCTCTCG"	-2.88109789314922	9.85403821552125	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTGTGTTCTCTCG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2002.17247885579	43.3154634133466	0.021634231751153	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1992.35097901255	1992.35097901255
"healthy-3"	"2019-08-01-count-4:ATTTCTGCACATATCG"	10.5061499076778	6.81219575488893	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCTGCACATATCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.67911299969	42.7693309334675	0.0218804870062958	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1950.0346739902	1950.0346739902
"healthy-3"	"2019-08-01-count-4:CTGCTCACATCTGCGG"	5.44114841994588	-9.57752611553343	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACATCTGCGG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.75254303604	46.8925289802812	0.0189177935942109	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2472.46504576792	2472.46504576792
"healthy-3"	"2019-08-01-count-4:TTTATGCCACGTCGTG"	-2.81794724884685	9.49652764880983	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCCACGTCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1633.04877558951	46.9505252641729	0.0287502283863043	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1630.93668417079	1630.93668417079
"healthy-3"	"2019-08-01-count-3:CTTCCTTTCAGACCTA"	0.0548987103043168	8.30166814411012	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTTCAGACCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1854.85778670993	44.9755873555404	0.02424745858027	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1844.53504698979	1844.53504698979
"healthy-3"	"2019-08-01-count-3:TGGTACATCGATTGGT"	-3.77923498573955	10.9791087874207	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTACATCGATTGGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2059.33569168503	46.5575160927794	0.0226080265984631	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.19238781194	2056.19238781194
"healthy-3"	"2019-08-01-count-3:CCACGTTCATCTTAGG"	0.730393369763535	8.33509252155153	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGTTCATCTTAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.58301130497	41.9144237896985	0.0238206572354965	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1753.86555885482	1753.86555885482
"healthy-3"	"2019-08-01-count-4:TTGAACGAGATGCGAC"	4.4451981979305	-7.5220051041809	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAACGAGATGCGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.30737624993	46.736700193193	0.0192386935676042	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2424.53447418888	2424.53447418888
"healthy-3"	"2019-08-01-count-2:ATGGATCCAGAGGCAT"	11.1510626274044	5.84367368305055	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCCAGAGGCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2032.8054	42.6325300140769	0.0209722632643916	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2027.97632717947	2027.97632717947
"healthy-3"	"2019-08-01-count-4:CGAGGCTAGGTCCGAA"	-4.12722621384318	10.7197103270325	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTAGGTCCGAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2216.57743662616	46.057288610885	0.0207785606087323	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2213.60273484584	2213.60273484584
"healthy-3"	"2019-08-01-count-2:ATCACGATCTGGCTGG"	-1.53069565716441	8.53779027545778	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACGATCTGGCTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1849.79083949183	48.9460375864376	0.0264603092098153	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1846.23022512888	1846.23022512888
"healthy-3"	"2019-08-01-count-4:ATGACCAAGAGCAAGA"	4.16652216491048	-7.50751497661742	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCAAGAGCAAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.19292379842	47.3124952573045	0.0180362240337228	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2617.2325186184	2617.2325186184
"healthy-3"	"2019-08-01-count-2:CCCGAAGGTTTGATCG"	3.86028232154195	-6.78324272548827	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGGTTTGATCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.43961450993	47.1901875478083	0.020301748108762	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2318.93052420427	2318.93052420427
"healthy-3"	"2019-08-01-count-2:TTTGATCGTAAGCAAT"	-1.58721540394481	9.18008229816285	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCGTAAGCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1854.10267345998	48.2609940325744	0.0260292996301621	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1846.91620426401	1846.91620426401
"healthy-3"	"2019-08-01-count-2:AGACCCGCAACACAAA"	-2.88458071175273	8.98190209949342	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGCAACACAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.99507864631	41.9461501498036	0.0221118919189481	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1895.30049257381	1895.30049257381
"healthy-3"	"2019-08-01-count-2:CATTTCATCAACACCA"	4.39825453337972	-8.19399835979613	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCATCAACACCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2906.06291277569	44.0715174312663	0.0151653693516126	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2900.92437953925	2900.92437953925
"healthy-3"	"2019-08-01-count-3:GGGCCATCAGCTGTTA"	3.69322647628133	-6.70616724407347	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCCATCAGCTGTTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.41131150721	45.5985294363467	0.0167002419174626	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2725.1761922813	2725.1761922813
"healthy-3"	"2019-08-01-count-1:TGAGACTGTGAACCGA"	9.93953003463094	7.57741401279298	"2019-08-01-count-1"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGAGACTGTGAACCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2175.02860699579	38.5032163822199	0.0177023953884458	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2161.26231554001	2161.26231554001
"healthy-3"	"2019-08-01-count-3:ACTGTCCAGTTGCCCG"	-2.72033248367961	9.03682515704957	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTCCAGTTGCCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2268.80050094159	48.6897115823288	0.021460552200214	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2261.52302652523	2261.52302652523
"healthy-3"	"2019-08-01-count-2:AACCAACCACCAGACC"	10.8760792213375	6.44284579837648	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCAACCACCAGACC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2017.0902895728	46.9748139913502	0.0232884042098577	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2015.70010417667	2015.70010417667
"healthy-3"	"2019-08-01-count-4:CGCCATTCACCGTGAC"	9.01087822493855	7.07524440372316	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTCACCGTGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1440.61231792723	46.4128853076222	0.0322174708143559	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1433.78470453925	1433.78470453925
"healthy-3"	"2019-08-01-count-2:CAGGGCTAGTGGTGGT"	2.46391763266866	-7.01441814815673	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGGCTAGTGGTGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.68258161053	44.6412336798331	0.0212104352788785	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2101.96716418028	2101.96716418028
"healthy-3"	"2019-08-01-count-4:GTTACGAAGTCGCTAT"	5.44665255126302	-9.98899366771849	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGAAGTCGCTAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.08392493965	52.3639804474192	0.0224537289963843	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2318.50609643292	2318.50609643292
"healthy-3"	"2019-08-01-count-3:AACGAAATCAATCCAG"	-0.213943730027038	8.46896932208864	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGAAATCAATCCAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2101.12735551982	35.5689674771569	0.0169285157245298	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2094.16701757725	2094.16701757725
"healthy-3"	"2019-08-01-count-2:TCGTGCTTCTGGCCTT"	-3.9526985687321	11.126700378302	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTTCTGGCCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.52144192977	42.3893878469341	0.0232331541152508	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1816.91182786302	1816.91182786302
"healthy-3"	"2019-08-01-count-2:GTGCTGGCAAATTAGG"	3.90149249610249	-7.24756100093993	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGCAAATTAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.04964458506	43.6719349403519	0.0173023280401964	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2520.96511191277	2520.96511191277
"healthy-3"	"2019-08-01-count-4:ACGTTCCGTCTCTCTG"	-3.5507701438969	10.5165834196839	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTTCCGTCTCTCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2202.29929815471	47.6586210148268	0.021640392409315	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2199.11272699238	2199.11272699238
"healthy-3"	"2019-08-01-count-2:TTCCTAAAGACCGTTT"	-1.45756671848949	9.58337686145631	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAAGACCGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1840.38360069275	46.2097940511577	0.0251087838610187	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1840.38360069275	1840.38360069275
"healthy-3"	"2019-08-01-count-2:GTGCTGGCAGGCCCTA"	-3.21375093880351	10.1277103194031	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGCAGGCCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.07043320312	46.3649155274933	0.0235346486836559	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.07043320312	1970.07043320312
"healthy-3"	"2019-08-01-count-3:CTTGAGATCCTCACTG"	4.79818501052205	-8.39201261913451	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGAGATCCTCACTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.70552328516	47.3095519873047	0.0204918087257772	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2298.8593487579	2298.8593487579
"healthy-3"	"2019-08-01-count-2:GTGCTGGGTCACTGAT"	-0.21502254429515	8.38402555072633	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGGTCACTGAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.83810054232	36.7412822845011	0.0208895192076931	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1754.24230918876	1754.24230918876
"healthy-3"	"2019-08-01-count-3:TCTTTGACAACCCTCT"	-4.12564168396648	13.0755347975525	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTTGACAACCCTCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2429.7260039539	42.7008158413328	0.0175743338021842	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2421.74829385817	2421.74829385817
"healthy-3"	"2019-08-01-count-2:TATCAGGCAAGGACAC"	0.408649613230866	8.21270749652711	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCAGGCAAGGACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.11742026569	40.4385498961462	0.0222419902286822	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1811.7807270525	1811.7807270525
"healthy-3"	"2019-08-01-count-3:GGCACGTTCTGCGATA"	-3.79033050957378	10.3348188170227	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTTCTGCGATA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2170.94194608952	44.3424842193686	0.0204254583128037	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2164.63748666719	2164.63748666719
"healthy-3"	"2019-08-01-count-2:TGACGCGTCCGGCAGT"	-4.56415257874187	12.9059657820496	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGTCCGGCAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2099.1779985763	43.2012024389565	0.0205800567975923	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2099.1779985763	2099.1779985763
"healthy-3"	"2019-08-01-count-4:CTGTGAAAGTATAGGT"	0.246965055435342	7.89650819385377	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAAAGTATAGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1785.74687474601	44.1829707025535	0.0247420120552291	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1781.68732693839	1781.68732693839
"healthy-3"	"2019-08-01-count-4:AACCACAAGCCTGAGA"	-2.03498039665874	8.87967298114625	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACAAGCCTGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.14761460821	38.4761734984065	0.0194113562556297	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.53467421559	1973.53467421559
"healthy-3"	"2019-08-01-count-4:CCAAGCGTCTGGTGCG"	11.2956692176754	6.23072145068971	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAAGCGTCTGGTGCG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.39795802163	38.4684661131862	0.0181079378126547	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2119.9886063665	2119.9886063665
"healthy-3"	"2019-08-01-count-4:ACTATCTTCCCTCGAT"	-2.93976674500163	9.23950097644655	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATCTTCCCTCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2160.24779685369	49.4334499738882	0.0228832312875801	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2154.0465167944	2154.0465167944
"healthy-3"	"2019-08-01-count-4:AGTCACAAGATCGGTG"	4.27335085448567	-7.21654322063597	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACAAGATCGGTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.59410990798	44.7791349722233	0.016538348494836	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2696.44154903019	2696.44154903019
"healthy-3"	"2019-08-01-count-3:AAGAACACAAGGCCTC"	-0.126078526408035	7.90127370441285	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGAACACAAGGCCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.6369865635	44.1978263758685	0.0217869567934573	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2021.28187711896	2021.28187711896
"healthy-3"	"2019-08-01-count-4:CCAATGACACAAGCCC"	10.8708826499874	7.18817851627199	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGACACAAGCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2369.48264086539	44.1175668111162	0.0186190715433996	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2365.00644756612	2365.00644756612
"healthy-3"	"2019-08-01-count-2:CAGTTAGTCTGTTCAT"	4.91350378569905	-8.24539568340453	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTAGTCTGTTCAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.63449640941	41.1679202463331	0.0161465968178219	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2546.57597042677	2546.57597042677
"healthy-3"	"2019-08-01-count-2:AGCCACGCAAGAGCTG"	4.46465267714803	-7.78711512005004	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCACGCAAGAGCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.44656569992	41.510810630286	0.0172212117127901	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2408.08893411501	2408.08893411501
"healthy-3"	"2019-08-01-count-4:TTTGACTAGATTGACA"	11.0287939506466	6.41610000217286	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGACTAGATTGACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.85624240844	41.6485988741669	0.0214257607972924	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.74490411716	1938.74490411716
"healthy-3"	"2019-08-01-count-2:TATCGCCCACATGTTG"	4.3364106613094	-8.10591699993285	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCCACATGTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.03305552769	42.9957895397066	0.0162984271366934	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2634.24258611772	2634.24258611772
"healthy-3"	"2019-08-01-count-4:TTTCGATTCGGCTATA"	0.0195827792281329	7.89386079395143	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATTCGGCTATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.629604268	45.8286015716504	0.022714080659159	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.82612570696	2003.82612570696
"healthy-3"	"2019-08-01-count-3:TGACAGTGTGAGAACC"	-3.61585936966594	9.68138597095338	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTGTGAGAACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2461.95934430263	47.7582078723004	0.0193984551299844	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2455.55956952996	2455.55956952996
"healthy-3"	"2019-08-01-count-2:AACCTTTCATGGAAGC"	14.188662191003	1.75300512397615	"2019-08-01-count-2"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTTTCATGGAAGC"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1338.62874155279	25.9189130708552	0.0193622863952477	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1317.18555693901	1317.18555693901
"healthy-3"	"2019-08-01-count-3:GTGACGCGTTGGACCC"	-3.97534594956096	10.4110193022522	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCGTTGGACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2166.90643457404	48.9410893923472	0.022585695723391	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2162.21467059751	2162.21467059751
"healthy-3"	"2019-08-01-count-1:CACGAATGTTGTTGCA"	-1.40451894226726	8.64822003925172	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CACGAATGTTGTTGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2303.10488525928	42.7769504741015	0.0185736006848362	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2295.72701560803	2295.72701560803
"healthy-3"	"2019-08-01-count-1:CAGATCACACAAATCC"	-3.99071822586711	9.81716630542604	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAGATCACACAAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2580.82904920374	39.2806280285021	0.0152201588247859	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2576.79230226304	2576.79230226304
"healthy-3"	"2019-08-01-count-2:AGGTTGTCACTGCTTC"	-4.265852312476	11.9547233351502	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTCACTGCTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2146.64390940799	39.6292725272835	0.0184610369487004	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2139.76575076192	2139.76575076192
"healthy-3"	"2019-08-01-count-4:CACTGTCGTCGAAGCA"	4.79325928267781	-8.38545992290648	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGTCGTCGAAGCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.28022482958	41.5965309908149	0.0165309612897475	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2515.40509405201	2515.40509405201
"healthy-3"	"2019-08-01-count-3:TCCCATGAGTGTCATC"	3.59924258765523	-7.38362314617308	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGAGTGTCATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.04982719188	47.4255238422901	0.0203189851775137	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2327.31447200099	2327.31447200099
"healthy-3"	"2019-08-01-count-2:AGCGCCAAGTTGGGAC"	-2.8014226955479	12.1611280211243	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCCAAGTTGGGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1755.80518924239	44.8319889426738	0.0255335781084109	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1751.5310777678	1751.5310777678
"healthy-3"	"2019-08-01-count-2:TACGTCCGTCGTATTG"	3.94994988021199	-7.29205849086913	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCGTCGTATTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.32859423463	47.9862099820255	0.0204690631253815	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2338.16701251866	2338.16701251866
"healthy-3"	"2019-08-01-count-4:TGGGCTGGTGTTTCTT"	4.37320389327351	-7.45986034786376	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCTGGTGTTTCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.08964717335	41.9430711817609	0.0163260442187796	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2564.1237255919	2564.1237255919
"healthy-3"	"2019-08-01-count-4:AGGATCTTCTACACTT"	4.11896099623982	-7.8004188767639	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTTCTACACTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.59678643329	41.4535863620689	0.0149619701304259	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2764.7078082312	2764.7078082312
"healthy-3"	"2019-08-01-count-4:GTTCCGTTCCACACAA"	-0.769341806799728	8.23309133136598	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCCGTTCCACACAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2042.72522405542	32.9042952056165	0.0161080378399066	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2036.45891216407	2036.45891216407
"healthy-3"	"2019-08-01-count-2:CGGTCAGCAAGCACCC"	-7.07461200180705	2.5561198958191	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGTCAGCAAGCACCC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2832.9843095929	41.7561071891244	0.0147392652503341	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2817.11979612371	2817.11979612371
"healthy-3"	"2019-08-01-count-3:TATCTTGGTGTCTTAG"	-0.103871206671554	8.19730470264284	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGGTGTCTTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.73561323743	42.0606728595664	0.0209806582882233	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1997.79622616982	1997.79622616982
"healthy-3"	"2019-08-01-count-3:TTTGGAGTCCATCTGC"	-1.30400345745738	8.90308568561403	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGTCCATCTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2098.40773958408	49.3591386742129	0.0235221867243	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2092.21579458592	2092.21579458592
"healthy-3"	"2019-08-01-count-4:GAGGGATCACGGCTAC"	2.82903875884358	-4.80041077053221	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATCACGGCTAC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2897.46040010054	45.6937199758629	0.0157702655657614	2977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2891.38873552463	2891.38873552463
"healthy-3"	"2019-08-01-count-2:CGTAATGGTCAGATTC"	-3.78724966469463	10.1588344343933	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAATGGTCAGATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.97791180711	45.5685908465024	0.0218242686327384	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2086.35929112071	2086.35929112071
"healthy-3"	"2019-08-01-count-3:GTGGCGTCAATTGGTC"	-2.92871437493022	9.44755742633668	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGCGTCAATTGGTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2062.16193864482	41.4597308122126	0.0201049830448614	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2060.58017371282	2060.58017371282
"healthy-3"	"2019-08-01-count-4:TTAATCCGTAAGATCA"	2.69502510604207	-4.41850092327269	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCGTAAGATCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2704.29289379292	42.9652143065561	0.0158877813883152	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2700.52385993645	2700.52385993645
"healthy-3"	"2019-08-01-count-2:CTAGACATCGGAAGGT"	5.51988520201985	-10.1812916032043	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACATCGGAAGGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.58837705796	42.4658021285271	0.01949234769437	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2174.76398563384	2174.76398563384
"healthy-3"	"2019-08-01-count-2:AGCGTATCAAGTGGGT"	10.9172197776729	6.05763909900514	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATCAAGTGGGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.14147804689	41.8976330221448	0.0226334040477287	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1846.67668807343	1846.67668807343
"healthy-3"	"2019-08-01-count-2:CATACCCAGTAGGAAG"	-7.54975257340129	0.0631815235125794	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCAGTAGGAAG"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2815.24715187361	44.5792168695251	0.0158349212216969	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2808.26999741167	2808.26999741167
"healthy-3"	"2019-08-01-count-2:GAACTGTTCGCCTTTG"	2.62505068358724	-6.09399320995482	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTTCGCCTTTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2751.06178253798	48.9135374930156	0.017779876047673	2348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2745.79396121821	2745.79396121821
"healthy-3"	"2019-08-01-count-3:AGAAGTAAGGGCAACT"	-3.64698610726054	-5.21971752559813	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGTAAGGGCAACT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2783.71289866135	47.7853387997289	0.017166044250723	3138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2776.79701826076	2776.79701826076
"healthy-3"	"2019-08-01-count-3:AGACAAAAGTTTGAGA"	-5.5787242454594	3.86569497669069	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAAAGTTTGAGA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2440.17479466404	41.1101579725357	0.0168472185117361	2527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2430.53276891489	2430.53276891489
"healthy-3"	"2019-08-01-count-2:CGTAGTATCTTCTGTA"	-7.59319243851359	0.57069799983827	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTATCTTCTGTA"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3032.20612278054	47.0252067058303	0.0155085785074228	4220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3026.57339710185	3026.57339710185
"healthy-3"	"2019-08-01-count-4:TTAATCCTCTGCATAG"	-3.81101952019389	10.8343658217224	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCTCTGCATAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2307.19244448729	47.6553428599271	0.0206551226248131	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2297.87687367764	2297.87687367764
"healthy-3"	"2019-08-01-count-3:GGTTAACTCAGGAACG"	-4.17449889603313	11.4929771193298	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTAACTCAGGAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2249.10296415786	46.9899629402989	0.0208927575522953	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2247.64088775607	2247.64088775607
"healthy-3"	"2019-08-01-count-3:ACGTAACAGGTTCACT"	3.14437546309773	-6.92008497631224	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACAGGTTCACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.60765811706	51.9251618256657	0.0209408781488827	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2474.3023352858	2474.3023352858
"healthy-3"	"2019-08-01-count-2:AAAGAACCACTGCGTG"	-3.24732098999675	10.9790401228699	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACCACTGCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.64259776676	47.3262683729279	0.0227023416021661	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2079.6670715713	2079.6670715713
"healthy-3"	"2019-08-01-count-2:TCTGCCACAGAGATGC"	-5.35446439209636	-4.27392914211424	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCACAGAGATGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3432.39860383441	43.5988495442813	0.0127021522196099	5051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3428.56984536203	3428.56984536203
"healthy-3"	"2019-08-01-count-4:CTGAGGCAGATCCGAG"	-3.76898131790813	10.3508262404236	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAGGCAGATCCGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2160.35931330203	51.8918649271143	0.0240200158406981	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2153.2416229981	2153.2416229981
"healthy-3"	"2019-08-01-count-4:TACGCTCCACTGGCCA"	-2.02421055260356	9.19830987537233	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGCTCCACTGGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.60418770087	50.488603800834	0.0250613019217701	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.97691215741	2005.97691215741
"healthy-3"	"2019-08-01-count-4:CAGCAATGTCGTGTTA"	2.66568531569783	-4.37827970897826	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAATGTCGTGTTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2787.07578973732	41.9473986226519	0.0150506845838611	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2781.24684608729	2781.24684608729
"healthy-3"	"2019-08-01-count-2:TCTGGCTAGAACTGAT"	-4.35112653198894	13.0607709654602	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTAGAACTGAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1981.24708525937	31.7474325011357	0.0160239642684343	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1977.51116297324	1977.51116297324
"healthy-3"	"2019-08-01-count-3:AAGGTAACATGAGTAA"	4.02483048018758	-8.12504675304564	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAACATGAGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.16130150344	46.6303186367897	0.0185840259089161	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2505.01631950334	2505.01631950334
"healthy-3"	"2019-08-01-count-3:GGTTGTAAGCTAATCC"	-1.76158640804942	9.44322106921998	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTAAGCTAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.72549711135	45.990522074963	0.0247297368059956	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1857.85585377375	1857.85585377375
"healthy-3"	"2019-08-01-count-3:TGTTCATAGCTTAAGA"	2.743589301675	-4.53017570888671	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCATAGCTTAAGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2777.32050702332	42.064560218846	0.0151457349313745	2695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2771.06954716627	2771.06954716627
"healthy-3"	"2019-08-01-count-3:TGAGGTTAGACACACG"	4.93885912474934	-8.32388403331908	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTAGACACACG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2757.59941456974	42.0023378156054	0.0152314863405057	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2754.38422284435	2754.38422284435
"healthy-3"	"2019-08-01-count-3:CTACGGGCATGGCCAC"	-3.97000108185466	-5.76779844677123	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGCATGGCCAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2293.91652606421	51.7762354333676	0.022571107032479	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2290.48099624443	2290.48099624443
"healthy-3"	"2019-08-01-count-4:TCATACTCAATAACGA"	2.64615525779073	-4.58964970028075	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTCAATAACGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2876.38321169527	41.329422314687	0.0143685382902539	2811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2873.78317108607	2873.78317108607
"healthy-3"	"2019-08-01-count-3:CCGAACGAGGTGGCTA"	-2.22491703453715	9.08412931049196	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGAACGAGGTGGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.92153096893	44.3534668985105	0.0227462829627154	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1948.17625324314	1948.17625324314
"healthy-3"	"2019-08-01-count-2:AGCTTCCAGTCAGAGC"	4.57492842253987	-8.43661692058715	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCAGTCAGAGC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.72831209009	44.4039407476213	0.0176716044205695	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2507.7966739653	2507.7966739653
"healthy-3"	"2019-08-01-count-3:AGTACTGGTCATTGCA"	-1.44275985184367	8.67289350116578	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGGTCATTGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2079.80960718307	43.4339685391069	0.0208836272267896	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2073.95203258126	2073.95203258126
"healthy-3"	"2019-08-01-count-2:CTGGCAGTCCTGGTCT"	1.73090340670888	-6.33448746120604	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGTCCTGGTCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2549.78298257141	45.7183065357602	0.0179302736147584	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2541.82811212398	2541.82811212398
"healthy-3"	"2019-08-01-count-2:TGGCGTGTCTCGGGAC"	-0.680724541575271	8.47912595355836	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGCGTGTCTCGGGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.70455588542	41.8970225243269	0.0216891461981995	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.16131049201	1926.16131049201
"healthy-3"	"2019-08-01-count-2:GTTACAGGTCTAACTG"	-2.30702219429668	8.91468999469606	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGGTCTAACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2013.32528441334	47.2267623376625	0.0234570949380511	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2011.71566711017	2011.71566711017
"healthy-3"	"2019-08-01-count-3:ATCACGAGTGGGTATG"	-3.75382671776469	2.8979716070923	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGAGTGGGTATG"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3148.8701199369	47.0103174624883	0.0149292653148331	4742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3140.27189218553	3140.27189218553
"healthy-3"	"2019-08-01-count-3:TTCCGTGCAAGATGTA"	2.34617723998372	-6.57009031688841	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGTGCAAGATGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.506823818	52.40470831806	0.0225057138686556	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2324.77907575508	2324.77907575508
"healthy-3"	"2019-08-01-count-3:TAATCTCCACTGTGTA"	-3.44302378121074	9.91437432849733	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCACTGTGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2034.05919868418	44.0114989944632	0.0216372753668791	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2032.47909423254	2032.47909423254
"healthy-3"	"2019-08-01-count-3:CTAGACACACTACACA"	3.86507691916768	-6.8690805665222	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACACACTACACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.18889884072	47.5215475859322	0.0180129435033307	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2633.65427129042	2633.65427129042
"healthy-3"	"2019-08-01-count-3:GTTACAGGTCAGCTTA"	-1.99026689949687	9.95727250659791	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGGTCAGCTTA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2146.03078032796	50.4464513888808	0.0235068629263423	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2135.85251480733	2135.85251480733
"healthy-3"	"2019-08-01-count-3:GATTCTTGTCACTACA"	-2.16422663155254	8.85823152149049	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTGTCACTACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2236.56726135699	42.9980410205304	0.0192250158371907	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2230.76394874591	2230.76394874591
"healthy-3"	"2019-08-01-count-2:ATTGGGTCAAACGAGC"	5.5979811149532	-9.81456282055052	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTCAAACGAGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.91889972503	48.4358537209301	0.018216371219874	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2654.85794787913	2654.85794787913
"healthy-3"	"2019-08-01-count-4:CGTTCTGAGGATTTCC"	-4.2992733520573	12.3239698179993	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTCTGAGGATTTCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2281.48525528674	43.3089613028749	0.0189827925481955	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2275.07416326764	2275.07416326764
"healthy-3"	"2019-08-01-count-2:TTGAGTGAGTCGGGAT"	10.760138173669	6.41000506961671	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAGTGAGTCGGGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.87819046435	39.8921416171364	0.022017010761034	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1803.76316851383	1803.76316851383
"healthy-3"	"2019-08-01-count-2:ACCTACCTCCGCGAGT"	-0.332908819348174	8.2674464949402	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCTCCGCGAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.66118382558	41.0059357584283	0.0220858474963844	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.2924123244	1855.2924123244
"healthy-3"	"2019-08-01-count-4:GCATCTCGTCTTACTT"	10.7894436317379	7.16630170429078	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATCTCGTCTTACTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.72575973601	45.5573755736299	0.0211921801500972	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2140.94289883122	2140.94289883122
"healthy-3"	"2019-08-01-count-4:GTGGGAAGTGGAACCA"	-4.39539561691936	12.745578742865	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAAGTGGAACCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2228.72493194914	45.9309895530747	0.0206086398974796	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2227.21249719021	2227.21249719021
"healthy-3"	"2019-08-01-count-2:TTGACCCCATCGTGGC"	2.528572221368	-7.10566284572753	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCCATCGTGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.16124108735	48.3016288830168	0.0219237829634194	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2201.94051460022	2201.94051460022
"healthy-3"	"2019-08-01-count-3:GGGCTCAAGTACCATC"	3.47610201415364	-6.00658705150756	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTCAAGTACCATC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2754.91813273672	43.6771783916069	0.0158542563833715	2635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2747.08658769368	2747.08658769368
"healthy-3"	"2019-08-01-count-4:CCCAACTTCGGTCGAC"	10.7240368324215	4.79866883838502	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTTCGGTCGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.39673787987	43.104186560374	0.0296575500941689	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1445.66555952913	1445.66555952913
"healthy-3"	"2019-08-01-count-2:TTGAGTGAGCCTCAGC"	-2.60407386246379	9.29619977557985	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAGTGAGCCTCAGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2439.06054857207	50.1833461774078	0.0205748669120934	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2428.75709628144	2428.75709628144
"healthy-3"	"2019-08-01-count-3:TTCCTCTCACAATCTG"	-4.09966359558757	9.90108678424684	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTCACAATCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2271.50407318834	48.3663424681272	0.0212926505565271	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2268.45934548467	2268.45934548467
"healthy-3"	"2019-08-01-count-2:AGTAGCTGTGCAGTGA"	10.5385281043941	7.61542794788209	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTGTGCAGTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2050.74702308065	44.6844000103093	0.0217893282337594	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2041.81332645615	2041.81332645615
"healthy-3"	"2019-08-01-count-2:TCAAGCATCGTTCCCA"	-3.97251973572429	11.3482465513977	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCATCGTTCCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2138.1238017884	48.4967738589989	0.0226819297453377	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2133.34388258779	2133.34388258779
"healthy-3"	"2019-08-01-count-2:CTCACTGGTTCTTGTT"	3.77633847770039	-7.50677778637084	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGGTTCTTGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.96358146303	46.8550040901326	0.0189163072242093	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2472.0293260922	2472.0293260922
"healthy-3"	"2019-08-01-count-3:GTAATGCTCCTAACAG"	-2.35783300820048	9.08434293353883	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCTCCTAACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2608.7881324653	50.3922113492912	0.0193163295716432	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2592.31722509576	2592.31722509576
"healthy-3"	"2019-08-01-count-2:CCTGTTGTCCACACCT"	-1.9598949951237	9.34074971759645	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGTTGTCCACACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2330.0685454362	50.8998520658727	0.021844787427206	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2318.1444861348	2318.1444861348
"healthy-3"	"2019-08-01-count-2:GTTAGTGGTACGACTT"	10.1284614997799	7.28122422778932	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGGTACGACTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.15376452235	37.113846165124	0.0184356738264004	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2003.50756311102	2003.50756311102
"healthy-3"	"2019-08-01-count-3:GTTAGTGAGAACCGCA"	3.83585919913594	-7.07454683696898	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGTGAGAACCGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.97885886832	40.215003446654	0.0148396004326941	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2706.0102984288	2706.0102984288
"healthy-3"	"2019-08-01-count-3:ACTCCCAGTGCGGCTT"	5.08691992339436	-8.56744673168334	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCAGTGCGGCTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.87842001044	47.5438620327907	0.0188450864915615	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2520.00511882047	2520.00511882047
"healthy-3"	"2019-08-01-count-4:TCATTACAGCAGCCCT"	-3.77336345139201	13.2773780592713	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTACAGCAGCCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2267.82138879246	44.2960399812408	0.0195324200574839	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2261.11921566144	2261.11921566144
"healthy-3"	"2019-08-01-count-3:AGAGAATTCGATACGT"	11.1097952323848	6.34103391254274	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATTCGATACGT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1988.74779824634	45.0331594017157	0.0226439769997109	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1978.98976755649	1978.98976755649
"healthy-3"	"2019-08-01-count-3:GTACAGTTCCTACGAA"	-2.62111697617229	9.5667686232361	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAGTTCCTACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.16331579433	41.1342020813245	0.0195303952798223	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2102.99416641332	2102.99416641332
"healthy-3"	"2019-08-01-count-2:CATCGGGGTAATGTGA"	-0.778216580778915	8.53570363605348	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGGTAATGTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.27940153135	36.3846230564809	0.0202217749091744	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1797.55395892415	1797.55395892415
"healthy-3"	"2019-08-01-count-3:TCATTCAAGTGCACCC"	-2.24020085755046	9.16346261585084	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTCAAGTGCACCC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2083.82540728435	44.2564498268093	0.0212380795781181	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2082.15258847854	2082.15258847854
"healthy-3"	"2019-08-01-count-2:AACAAGAGTCTGGTTA"	-4.02667460861857	10.8390712507996	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAGAGTCTGGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2074.10025449078	44.7451815395991	0.0215732973575979	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.06870237891	2069.06870237891
"healthy-3"	"2019-08-01-count-2:AGTCATGCACAAGCCC"	2.59344353255574	-4.33738901531371	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCATGCACAAGCCC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2763.51247870169	43.2442119034657	0.0156482781376048	2694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2759.55914401745	2759.55914401745
"healthy-3"	"2019-08-01-count-3:TTCGGTCGTGGTCTTA"	10.2972561317379	7.79318425739137	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGGTCGTGGTCTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2223.33789373908	48.8366482157887	0.0219654638880184	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2216.83510264939	2216.83510264939
"healthy-3"	"2019-08-01-count-2:CATCGGGGTTCCGCAG"	-1.66408524933513	8.7356385954651	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGGTTCCGCAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2017.83475987013	42.9400681375132	0.0212802698176717	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.29969977647	2016.29969977647
"healthy-3"	"2019-08-01-count-3:CTACTATGTACTGACT"	-1.18197570267375	8.75903699481813	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACTATGTACTGACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2177.41346655602	47.197456804286	0.0216759276679488	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2177.41346655602	2177.41346655602
"healthy-3"	"2019-08-01-count-2:GCAGTTAGTGACTGTT"	4.1798526245052	-7.96020224010619	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTAGTGACTGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.33291640853	45.7459795562125	0.0193320133608431	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2362.4165785957	2362.4165785957
"healthy-3"	"2019-08-01-count-3:CCGAACGTCGAAGGAC"	3.5198606449062	-5.76940061962279	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGAACGTCGAAGGAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2772.44667870526	45.1448441467978	0.0162833949137952	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2767.97759485202	2767.97759485202
"healthy-3"	"2019-08-01-count-2:GGGACTCGTGGTAATA"	-0.585646550089675	8.25036618793336	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCGTGGTAATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1843.29367559447	39.2669319329312	0.0213025913628589	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1839.66462488368	1839.66462488368
"healthy-3"	"2019-08-01-count-3:AACCTGACAGGGTTGA"	3.85758175429646	-7.00865557109984	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTGACAGGGTTGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.72562502392	44.310580981152	0.0177332719276562	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2496.65905373912	2496.65905373912
"healthy-3"	"2019-08-01-count-3:ATGGTTGAGACTTCCA"	4.4685169654781	-7.96847059642943	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGTTGAGACTTCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.42228164845	44.2868561629654	0.0169006562312947	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2617.25483994319	2617.25483994319
"healthy-3"	"2019-08-01-count-4:CTCATCGGTCACTCAA"	-3.7641912502354	10.9998121031555	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATCGGTCACTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1955.68485171868	48.8480824305054	0.0249774816160063	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.75119195083	1950.75119195083
"healthy-3"	"2019-08-01-count-4:CGCCATTGTGTTACTG"	2.79225959357564	-6.46689321911009	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTGTGTTACTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.48776222443	38.118022978975	0.0168032746809254	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2263.11024402661	2263.11024402661
"healthy-3"	"2019-08-01-count-2:ACGGGTCGTGCCTGAC"	10.7037846046383	6.42110822284547	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGGTCGTGCCTGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.65453463382	44.6304134721639	0.0232613076854306	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1916.04849898001	1916.04849898001
"healthy-3"	"2019-08-01-count-2:GCCATGGAGTATGAAC"	-2.9959765476292	10.1347703703674	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATGGAGTATGAAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2076.3931903313	41.7364270094213	0.020100444946442	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2064.1921987113	2064.1921987113
"healthy-3"	"2019-08-01-count-3:TTCTCTCAGCAACTCT"	4.52150597152059	-8.09598162090453	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTCTCAGCAACTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.19168908334	42.718230286885	0.0160282018219776	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2659.38845570599	2659.38845570599
"healthy-3"	"2019-08-01-count-2:AGTCTCCTCCGACAGC"	-0.607276122004348	8.55431840503541	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCTCCGACAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.87428432981	47.5200199541598	0.0237140724474403	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.87533885055	1996.87533885055
"healthy-3"	"2019-08-01-count-3:CTCATCGAGACGCAGT"	-1.93367813053783	8.60099599445192	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATCGAGACGCAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.95561384761	37.9571453438113	0.0184710292952469	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.49496298764	2051.49496298764
"healthy-3"	"2019-08-01-count-3:CTCATGCAGTCACTGT"	10.2100569206173	7.56405589664308	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCAGTCACTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.42000028672	44.0717566635702	0.0219216664464564	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1996.08072277876	1996.08072277876
"healthy-3"	"2019-08-01-count-4:GAACGTTGTTGAAGTA"	-3.82892260971721	9.91627404773561	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACGTTGTTGAAGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2149.86978504239	43.1126373204743	0.0200536039998461	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2142.48774133134	2142.48774133134
"healthy-3"	"2019-08-01-count-3:GCACTAATCCGGTAGC"	2.8584848838741	-6.96065905010375	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAATCCGGTAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.32760233884	46.0366901723322	0.0216711820350339	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2121.18542828885	2121.18542828885
"healthy-3"	"2019-08-01-count-3:TGCATGATCCCGAGGT"	4.08101524886434	-7.10884525692137	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATGATCCCGAGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.61454046747	46.450092384006	0.0184867561800243	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2505.02779490791	2505.02779490791
"healthy-3"	"2019-08-01-count-4:CACGTGGTCCAACTAG"	-2.15503797951396	8.83259866321412	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGTCCAACTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1898.85067567259	46.106165602045	0.024281090763345	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1890.71484813842	1890.71484813842
"healthy-3"	"2019-08-01-count-2:GTTGAACAGTAAACTG"	-4.48401389542277	12.9866647490296	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACAGTAAACTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2107.70748832298	36.9310950614398	0.0175219261999322	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2102.34576340724	2102.34576340724
"healthy-3"	"2019-08-01-count-3:TTCTGTACAGACCTAT"	9.45654072341267	7.20799920642702	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTACAGACCTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2017.57644685833	42.7930198719169	0.0212101107437847	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2007.03521955465	2007.03521955465
"healthy-3"	"2019-08-01-count-3:ATCGATGGTTTGGGTT"	-3.17412290993388	9.50140378558961	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGGTTTGGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.6451860437	47.9044947605366	0.0232022892283646	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2059.01575491148	2059.01575491148
"healthy-3"	"2019-08-01-count-2:GCCATTCTCGAGCACC"	-0.0323547971552193	8.28671262348024	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATTCTCGAGCACC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.35488635626	45.8346426751044	0.0238802334059845	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1904.9785079518	1904.9785079518
"healthy-3"	"2019-08-01-count-2:CATGCCTGTAGGGTAC"	-1.82222102108653	9.18331143939821	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTGTAGGGTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.68905683777	40.6313254336796	0.0197653070626265	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.09072276452	2052.09072276452
"healthy-3"	"2019-08-01-count-3:AATTCCTCACGGCCAT"	-3.93814192238505	10.4906072386536	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTCACGGCCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.84333662818	45.5962746128624	0.0221680833930742	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.36045584455	2053.36045584455
"healthy-3"	"2019-08-01-count-3:ATCGCCTTCAAGTGTC"	-0.512289027602035	8.33827684009401	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGCCTTCAAGTGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1971.31240812477	36.3907002434702	0.0184601385825432	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.10935687284	1964.10935687284
"healthy-3"	"2019-08-01-count-3:AACGTCATCTCTGCCA"	-0.136371756822425	7.96670434558717	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCATCTCTGCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.33232539656	38.5747093661172	0.0205805069055487	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1863.56481049103	1863.56481049103
"healthy-3"	"2019-08-01-count-4:GCCGATGGTCGCCTAG"	-3.67784200134929	9.81169793689577	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGATGGTCGCCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2140.94333594013	38.6132503336504	0.0180356246171712	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2137.78663874233	2137.78663874233
"healthy-3"	"2019-08-01-count-4:AATCACGGTCAGTTTG"	-0.0952715975349725	7.80650136554567	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCACGGTCAGTTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.49789373604	40.4865625334723	0.0209829524379937	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.14236514001	1921.14236514001
"healthy-3"	"2019-08-01-count-2:AGTGTTGAGGCTCAAG"	3.71076669272725	-7.10552933132323	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGTTGAGGCTCAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.57357409876	41.7221302385332	0.0166783542449134	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2492.78393151587	2492.78393151587
"healthy-3"	"2019-08-01-count-3:TCCAGAAAGCGTATAA"	3.60511889037434	-6.5947041741577	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCAGAAAGCGTATAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.87452384382	44.4380334065071	0.0193556019481882	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2292.50024839289	2292.50024839289
"healthy-3"	"2019-08-01-count-4:CCGATGGGTTCCGCAG"	-5.02241073074992	-5.03133251583251	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATGGGTTCCGCAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2822.69976792707	51.987912148529	0.018417797294364	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2818.01766127564	2818.01766127564
"healthy-3"	"2019-08-01-count-4:TTCCGGTAGCGAACTG"	-1.6153007549351	8.4681243666443	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTAGCGAACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.03163813863	46.2037379544268	0.0242662658691929	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.61049833199	1893.61049833199
"healthy-3"	"2019-08-01-count-2:CGACAGCTCCTTCTTC"	3.45009221610371	-7.70230200206908	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCTCCTTCTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.86048369131	53.9001131982108	0.0301309765013021	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1783.10383860127	1783.10383860127
"healthy-3"	"2019-08-01-count-3:CCTATCGTCTAGACAC"	-0.240278939635116	8.2699575194153	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGTCTAGACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.27497476484	39.9812518086106	0.0213886412370338	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1862.40746200971	1862.40746200971
"healthy-3"	"2019-08-01-count-2:TCTACCGTCACTGGTA"	-1.41351340237315	8.80015752399293	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACCGTCACTGGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.92714168748	48.2515408699975	0.0232098277531898	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.76261015149	2067.76261015149
"healthy-3"	"2019-08-01-count-4:ATCCTATGTTTCGTGA"	-4.30156026306804	13.0965814360413	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATGTTTCGTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1972.37414302183	44.5162740735267	0.0225698933597478	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1966.90215449889	1966.90215449889
"healthy-3"	"2019-08-01-count-4:TACACCCCACGACCTG"	0.461158086627167	8.08259389484254	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCCACGACCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.42523048158	39.4160450504054	0.0204289051618587	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1920.32511246524	1920.32511246524
"healthy-3"	"2019-08-01-count-4:AATGAAGGTTGTTGCA"	-4.09612212601359	9.8539361723694	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGAAGGTTGTTGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.42822810899	45.3148942745325	0.0226073917933611	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2001.22199474576	2001.22199474576
"healthy-3"	"2019-08-01-count-2:GACGTTAAGACGCCCT"	5.46066727217976	-9.89484121715697	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTAAGACGCCCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.03558224976	46.5802715095932	0.0195877100650973	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2374.23408667219	2374.23408667219
"healthy-3"	"2019-08-01-count-3:CCTCAACTCTAACGGT"	-0.526784817606765	8.26976106250612	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACTCTAACGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2164.29298765635	43.5841930916875	0.0201378433235528	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.1166267883	2151.1166267883
"healthy-3"	"2019-08-01-count-3:AGAGCAGCACTTACAG"	2.9799071746761	-6.84667732631835	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCAGCACTTACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.25842801674	47.7126146767819	0.0216653114229422	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2198.90688344962	2198.90688344962
"healthy-3"	"2019-08-01-count-2:AGCGATTGTCTCACAA"	-3.76729116860088	11.5158099898132	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTGTCTCACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.23459096149	46.387496686143	0.022658613180406	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.77521826123	2031.77521826123
"healthy-3"	"2019-08-01-count-4:AGGATCTCAATAGTCC"	-3.25305138054546	10.5125922926697	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTCAATAGTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.39591400049	43.0549391214761	0.0220410715579419	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1944.28912980222	1944.28912980222
"healthy-3"	"2019-08-01-count-3:CAGATTGAGACCACGA"	10.9428821998531	6.3861775168213	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGAGACCACGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.0262941504	41.078315714564	0.0201559301921021	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2031.717651865	2031.717651865
"healthy-3"	"2019-08-01-count-4:ACCATTTAGTTTCGGT"	11.2885738807613	5.23625896060792	"2019-08-01-count-4"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCATTTAGTTTCGGT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.86354775546	38.0236233089419	0.0197744782011841	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1907.18215893237	1907.18215893237
"healthy-3"	"2019-08-01-count-2:AGCGATTGTACCAATC"	-0.288486937910873	8.09950921619264	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTGTACCAATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.43454448426	40.4952219561053	0.0204167170873969	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.2589416564	1975.2589416564
"healthy-3"	"2019-08-01-count-3:GTTGTGACAGAGTTGG"	-3.30786238136943	11.0940923460755	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGACAGAGTTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1695.70266318173	44.8277453685001	0.0264360883200994	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1693.69921692534	1693.69921692534
"healthy-3"	"2019-08-01-count-3:CCTCAGTTCGATGCTA"	-3.18252907219585	11.7318668135437	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAGTTCGATGCTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2229.21880507268	40.0385563845261	0.0179608014670506	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2222.41347975051	2222.41347975051
"healthy-3"	"2019-08-01-count-4:GAATCACGTATGGGAC"	-3.65188298645671	10.2955960997376	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACGTATGGGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.08681652506	51.6957612706005	0.0252040824669641	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2049.33120457203	2049.33120457203
"healthy-3"	"2019-08-01-count-3:TTATTGCTCACCCATC"	0.083577866747421	7.98060081088869	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTATTGCTCACCCATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1887.94909461678	44.4005871032672	0.0235178942217612	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1882.84488508821	1882.84488508821
"healthy-3"	"2019-08-01-count-2:GCCTGTTGTTGTGTTG"	-2.16654692116435	9.49061677539674	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCTGTTGTTGTGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.2482944149	36.8224203686868	0.017743621554966	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.2482944149	2075.2482944149
"healthy-3"	"2019-08-01-count-4:TCCCACAGTTCCACAA"	5.49483360823934	-9.45032503521117	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACAGTTCCACAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2836.42282941303	44.1048172296094	0.015549450798468	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2827.46251198727	2827.46251198727
"healthy-3"	"2019-08-01-count-4:TCCCAGTAGCTATCTG"	4.8389650779659	-8.43234445964965	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTAGCTATCTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2904.94637808567	42.3737394870864	0.0145867544429547	2521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2899.57790867802	2899.57790867802
"healthy-3"	"2019-08-01-count-4:CAAGGGATCTATCCAT"	3.16736735877339	-8.31760504161986	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGGGATCTATCCAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.31560116255	49.5026544779998	0.021242897079393	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2329.21250229014	2329.21250229014
"healthy-3"	"2019-08-01-count-3:AGAACCTAGCATTGTC"	-2.4164608520573	8.9310149916443	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTAGCATTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1917.94918350687	46.9261438816085	0.024466833785349	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1911.10948660795	1911.10948660795
"healthy-3"	"2019-08-01-count-2:ACGTTCCGTCGCACAC"	-7.69211087647136	-0.941010200139605	"2019-08-01-count-2"	"Control3"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCGTCGCACAC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3233.98719767377	43.7835171078592	0.0135385561016917	4527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3224.99321644482	3224.99321644482
"healthy-3"	"2019-08-01-count-4:CAGATACCACTTCATT"	-4.30651221695598	13.2192334898743	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATACCACTTCATT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2301.73998720132	39.4292003797998	0.0171301713482163	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2301.73998720132	2301.73998720132
"healthy-3"	"2019-08-01-count-3:ATTCATCTCATTCGGA"	4.41265739974324	-7.78324749385985	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCATCTCATTCGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.40733513749	42.3769158443523	0.0161533877247207	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2619.57876282588	2619.57876282588
"healthy-3"	"2019-08-01-count-4:ATCGGCGCATTCGATG"	-2.58648930016215	8.8384217985901	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGCGCATTCGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.81574996577	45.9680309896261	0.0239814551766111	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1915.03112303412	1915.03112303412
"healthy-3"	"2019-08-01-count-3:AGCGATTTCAAACCCA"	2.79087366637532	-7.06735041057738	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTTCAAACCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2118.58381229007	49.7975803504489	0.023505126425289	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2115.97304467418	2115.97304467418
"healthy-3"	"2019-08-01-count-4:AGATGAATCGAGGCAA"	-4.75598226013835	-5.14873125469359	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGAATCGAGGCAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2986.24270758042	51.4586029938743	0.0172318890434623	2494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2974.96863507437	2974.96863507437
"healthy-3"	"2019-08-01-count-2:ATAGACCGTACCCGAC"	-3.64202843132671	10.0279264220032	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCGTACCCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.1562672685	45.6023091244352	0.0211792844846726	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.56701372871	2151.56701372871
"healthy-3"	"2019-08-01-count-4:TCCCAGTTCTGCTTAT"	0.367250521748704	8.92397782886354	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTTCTGCTTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.00439495146	42.4853367543471	0.0227437027820542	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.76364444012	1852.76364444012
"healthy-3"	"2019-08-01-count-4:CAATCGATCTGAATCG"	4.77743067321126	-8.18461134349974	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATCGATCTGAATCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2604.15140089563	44.5188566609413	0.0170953411716501	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2595.84149378886	2595.84149378886
"healthy-3"	"2019-08-01-count-2:CATTGCCAGTCCGCGT"	3.78809346732442	-7.92976810848387	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCAGTCCGCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.26786533692	44.8989597925852	0.0184749016489014	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2428.50761475543	2428.50761475543
"healthy-3"	"2019-08-01-count-4:CAGATTGAGAGGGCGA"	2.7290309863979	-4.59405138408812	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATTGAGAGGGCGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2682.79962304397	43.5790033458126	0.0162438532387919	2636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2679.02960580775	2679.02960580775
"healthy-3"	"2019-08-01-count-3:GCTTGGGCACTTCCTG"	10.172042508691	6.00872848117677	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGCACTTCCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1883.02279069678	42.8217493031695	0.0227409617741928	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1875.30131854174	1875.30131854174
"healthy-3"	"2019-08-01-count-2:CATTGCCGTCGGTGTC"	-2.10260830345805	9.35294149005739	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCGTCGGTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.89729788678	48.7258119246325	0.026071958036286	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1863.4534137752	1863.4534137752
"healthy-3"	"2019-08-01-count-3:TCGTGCTTCTAGACCA"	-4.10744414749797	12.7455959090027	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTGCTTCTAGACCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1505.64416322837	31.6380079630523	0.0210129383394379	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1503.29035491082	1503.29035491082
"healthy-3"	"2019-08-01-count-2:CATTGCCCATCGTCCT"	-1.67015657845195	9.28719804370729	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCCATCGTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.00542810016	46.1971610832901	0.0225571477738441	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2038.43240597413	2038.43240597413
"healthy-3"	"2019-08-01-count-4:TTGTTCAAGCGTCTCG"	-4.09205851975139	10.7251081236633	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCAAGCGTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1964.30504035294	43.7476301675854	0.0222713016913732	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.73202041362	1960.73202041362
"healthy-3"	"2019-08-01-count-3:CTCCTCCAGAAGTATC"	0.427023937075776	8.92628953540651	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCAGAAGTATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.45471847823	39.287752196133	0.0221657297004823	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1763.78103478101	1763.78103478101
"healthy-3"	"2019-08-01-count-4:TTCGCTGAGGGAGGCA"	-1.42598996582683	9.02295491779176	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGAGGGAGGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.5492088058	44.0471271651574	0.0231273242830917	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1902.79187674798	1902.79187674798
"healthy-3"	"2019-08-01-count-3:GAGAGGTAGGTTGTTC"	-1.74557755413707	8.78280732715455	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTAGGTTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.76638279105	44.6437890189417	0.0240179666644854	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.32323526496	1855.32323526496
"healthy-3"	"2019-08-01-count-3:CCCTGATGTCACGACC"	-1.17685006085094	8.86080358112184	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATGTCACGACC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1982.35196146412	44.4641744696545	0.0224300100759172	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.47465439634	1974.47465439634
"healthy-3"	"2019-08-01-count-4:CTCAAGAAGCCTGAAG"	10.8143288093502	6.48493335330812	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAAGAAGCCTGAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.71190631734	39.6850366726399	0.0211912128815798	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1867.1918950383	1867.1918950383
"healthy-3"	"2019-08-01-count-1:GTGTCCTGTTCAAACC"	10.0705992179805	7.75871226871339	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGTCCTGTTCAAACC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2264.34926514428	46.388884570575	0.0204866295516559	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2256.28471715804	2256.28471715804
"healthy-3"	"2019-08-01-count-2:CTCTCAGGTTAACCTG"	1.15859295901601	-6.09824087536009	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGGTTAACCTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2851.21075727811	49.1870375297932	0.0172512808477018	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2844.88364904963	2844.88364904963
"healthy-3"	"2019-08-01-count-3:TGGATCATCGAGAAGC"	3.2212995487148	-6.88802101528319	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCATCGAGAAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.48606821138	45.9304957740838	0.0196832097691886	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2326.9273174834	2326.9273174834
"healthy-3"	"2019-08-01-count-4:TCCGATCGTGTATTCG"	-7.2948354286259	3.36311338031618	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCGTGTATTCG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2303.20672070115	44.3050000542094	0.0192362238508587	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2283.61265973065	2283.61265973065
"healthy-3"	"2019-08-01-count-4:GCTCAAAGTTCAGCTA"	-1.86918209019359	9.203173614386	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAAGTTCAGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2251.84817399974	40.3204868717793	0.0179055086116938	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2247.14298245069	2247.14298245069
"healthy-3"	"2019-08-01-count-3:TTGGGTACACATTCGA"	4.903656621545	-8.70781805431517	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGTACACATTCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1837.68226230516	34.0487607234522	0.0185280999995842	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1827.48226510162	1827.48226510162
"healthy-3"	"2019-08-01-count-2:TCTGTCGTCCTTCACG"	0.0576562737928748	7.56570003116456	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGTCGTCCTTCACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2002.78352770004	39.3638345412456	0.0196545627606845	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.98383593214	1991.98383593214
"healthy-3"	"2019-08-01-count-2:AGACCCGGTGCCTGAC"	-2.90045915070232	9.38762471759645	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGGTGCCTGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.08726238741	39.3820167440511	0.0198089980702149	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1986.30494300099	1986.30494300099
"healthy-3"	"2019-08-01-count-3:GGAAGTGTCTAAGCGT"	-7.2999418777531	3.23553965175477	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGTCTAAGCGT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2400.94153646573	42.9523367880031	0.0178897887081542	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2388.11700679735	2388.11700679735
"healthy-3"	"2019-08-01-count-4:AGCCAGCTCCTAACAG"	-3.31061349335368	9.93125627124635	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCTCCTAACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2030.39313651816	47.4962552807162	0.0233926397929839	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2023.55099083512	2023.55099083512
"healthy-3"	"2019-08-01-count-4:GCTGAATGTTCTCACC"	-3.95869861069377	11.6398715742859	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGAATGTTCTCACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2179.53515075276	50.8908089287831	0.0233493866392596	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.30953751425	2176.30953751425
"healthy-3"	"2019-08-01-count-3:CTCGAGGTCGGCTCTT"	-3.95218072357829	-5.34428265010985	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGTCGGCTCTT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2979.34687015761	46.4118658814577	0.0155778658558822	3141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2973.28106198169	2973.28106198169
"healthy-3"	"2019-08-01-count-2:TCAGTTTGTTCTCCCA"	4.33801569518392	-7.84961130535277	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTTTGTTCTCCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.61661232613	45.5596344559741	0.0180033728673329	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2525.71170665488	2525.71170665488
"healthy-3"	"2019-08-01-count-3:GAATCACGTTAGGAGC"	3.77105249938313	-6.83418753063353	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCACGTTAGGAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.91064839059	44.5715067485984	0.0178149874286158	1980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2499.28478347683	2499.28478347683
"healthy-3"	"2019-08-01-count-4:ATGAGGGAGTCCCGAC"	-1.54702446880992	8.73099324786989	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGGGAGTCCCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.40317842565	51.2631183585274	0.0249771189683355	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.43455679518	2041.43455679518
"healthy-3"	"2019-08-01-count-2:TGTTCATTCGCAGTCG"	3.07352056083028	-5.30053331768187	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATTCGCAGTCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2687.36836594173	41.7780626990102	0.0155460871045752	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2683.37213838526	2683.37213838526
"healthy-3"	"2019-08-01-count-4:AGGTAGGTCATCGGGC"	5.53713097152059	-9.87950518047484	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTAGGTCATCGGGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.64165664961	42.9791794897771	0.0168701824205131	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2545.0798944097	2545.0798944097
"healthy-3"	"2019-08-01-count-4:CCCATTGAGGTCATTC"	-3.31082377854045	9.37592599475709	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGAGGTCATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2213.87660153167	42.2570909866691	0.019087374137038	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2209.10793099228	2209.10793099228
"healthy-3"	"2019-08-01-count-3:ATTTACCTCCATGATG"	3.75479569014851	-6.82835485851439	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTACCTCCATGATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.54878070839	47.4605776577477	0.017973755305901	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2632.44011611528	2632.44011611528
"healthy-3"	"2019-08-01-count-2:ATTGGGTGTTTCGCTC"	-1.09964583340343	8.3638238676819	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTGTTTCGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2093.72422082079	38.1956235823555	0.0182429105048906	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.26628127439	2085.26628127439
"healthy-3"	"2019-08-01-count-2:TCAAGCAAGCCGATTT"	-3.07191310349162	9.6240663298401	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCAAGCCGATTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.78411582865	43.3949591758176	0.0221314314133346	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.45939816063	1957.45939816063
"healthy-3"	"2019-08-01-count-2:GTAGGTTTCTCACCCA"	-1.02263746681865	8.76344106281129	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGTTTCTCACCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.63676049719	46.5691738172244	0.0249749306695033	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1859.40737396274	1859.40737396274
"healthy-3"	"2019-08-01-count-2:AGTAGCTCAAGAGAGA"	-1.27790174904521	9.08719823444215	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTCAAGAGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1865.46186055448	44.9989938653253	0.0241221730751172	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1859.99426098637	1859.99426098637
"healthy-3"	"2019-08-01-count-2:GCTGCAGAGTATGTAG"	-2.11212287369426	9.2043304213318	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGCAGAGTATGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1797.59425290219	46.0344123784686	0.0256089005091926	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1795.78777225325	1795.78777225325
"healthy-3"	"2019-08-01-count-2:GTAGTACAGGCGTTGA"	-1.47494242611583	8.82229898059694	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACAGGCGTTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.47353420039	47.499062965302	0.022974447885096	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2059.46159769084	2059.46159769084
"healthy-3"	"2019-08-01-count-2:TTTCAGTCAACGACAG"	-2.38782248917277	9.95755002582399	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCAGTCAACGACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2083.41897913711	43.2928486606355	0.0207797131033942	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2081.63755237931	2081.63755237931
"healthy-3"	"2019-08-01-count-4:TCCTCCCAGTGAGCCA"	4.37289871749226	-8.13102152263793	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCCCAGTGAGCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.16515028421	46.6769472922449	0.0199545326188591	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2330.46905069976	2330.46905069976
"healthy-3"	"2019-08-01-count-3:GTCTAGACACATGGTT"	11.0492865043575	7.23826692188112	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTAGACACATGGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2803.36101750908	41.7263628185626	0.0148844057393787	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2796.21376156783	2796.21376156783
"healthy-3"	"2019-08-01-count-3:GTCTGTCAGTTCATGC"	-3.69824753227885	10.5001497038635	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTGTCAGTTCATGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2153.51661972125	38.9746953126233	0.0180981632348248	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2146.83186598559	2146.83186598559
"healthy-3"	"2019-08-01-count-2:CGCCAGAGTTTACGAC"	-1.8201027912205	8.86370656574098	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGAGTTTACGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.6059115463	50.6755567056351	0.0249804836006851	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.48877692807	2010.48877692807
"healthy-3"	"2019-08-01-count-3:TGGGCGTCAGGTCCCA"	4.78601946410481	-8.02632334148558	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTCAGGTCCCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.67554023316	45.546248241472	0.017015976556316	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2669.5929618031	2669.5929618031
"healthy-3"	"2019-08-01-count-4:AGCGCTGTCCGCTGTT"	-2.5004132789677	9.62993333423463	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGTCCGCTGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.27585696302	44.8364476632765	0.0241150055788458	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1857.43555837414	1857.43555837414
"healthy-3"	"2019-08-01-count-3:GTACAACAGTGCAACG"	-3.53204117241557	10.4511689909729	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAACAGTGCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.47654879246	43.8648989488295	0.0227105521815698	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1929.75274838727	1929.75274838727
"healthy-3"	"2019-08-01-count-3:GCCGATGGTCTCTCAC"	-1.72498748722728	8.87065122211305	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGGTCTCTCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2011.00783357325	43.3215499609944	0.0215422084577457	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.89387846625	2005.89387846625
"healthy-3"	"2019-08-01-count-3:TTTACCAGTGTGAGCA"	2.72543015059773	-4.80444862758788	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCAGTGTGAGCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2802.07552885219	40.6338572301067	0.0145013425982673	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2798.14867604159	2798.14867604159
"healthy-3"	"2019-08-01-count-4:ATGCCTCGTGTTAGCT"	-3.39486871185954	11.3652200468811	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCCTCGTGTTAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1684.45307916142	45.1493888986866	0.0268035895194918	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1678.71117984239	1678.71117984239
"healthy-3"	"2019-08-01-count-2:ACACTGACAATGTGGG"	3.40958871421162	-6.50598766719969	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACTGACAATGTGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.24085054645	46.9069104760666	0.0176791000584835	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2647.28254622192	2647.28254622192
"healthy-3"	"2019-08-01-count-4:ATGCGATCATGAGGGT"	-1.26748547974284	8.89721677387086	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCGATCATGAGGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1713.6462315814	42.1147864940115	0.0245761264593958	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1709.24611716085	1709.24611716085
"healthy-3"	"2019-08-01-count-2:GCTTCACAGCGTCAAG"	-2.62333045426067	8.92591569507448	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTCACAGCGTCAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.06396070075	49.5887134090783	0.0250566502113048	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.43630405708	1977.43630405708
"healthy-3"	"2019-08-01-count-3:GAGTCATGTGACACAG"	-1.87558362904246	9.00918862903444	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATGTGACACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.44053414549	47.1637015489171	0.023935612738179	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.13872081024	1967.13872081024
"healthy-3"	"2019-08-01-count-3:TGGTACAAGAAGTCCG"	-4.85467324677165	2.59061811054078	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTACAAGAAGTCCG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3137.19439827174	44.6846491438939	0.0142435066084876	4307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3127.36500342982	3127.36500342982
"healthy-3"	"2019-08-01-count-2:TGAATGCAGGATACAT"	-2.06629667702373	9.01703450763551	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCAGGATACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.32484365916	38.9943536641943	0.0190464907339766	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.02958719314	2041.02958719314
"healthy-3"	"2019-08-01-count-3:CTGAGGCAGGGCAGAG"	-4.00328956070598	10.6499137648377	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCAGGGCAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.63103403477	41.1676347131809	0.0199009074290475	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2063.65027839269	2063.65027839269
"healthy-3"	"2019-08-01-count-4:CTCAGTCGTCACTAGT"	4.72975935515706	-8.37002661144408	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTCACTAGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.6374670247	45.3563767434673	0.0170152082961577	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2661.76556722503	2661.76556722503
"healthy-3"	"2019-08-01-count-3:CAACCTCGTCTAGTGT"	-4.01219687882121	12.8251666792664	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCTCGTCTAGTGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1727.96938788075	44.5390848252413	0.0257753899679124	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1725.83762487395	1725.83762487395
"healthy-3"	"2019-08-01-count-3:TTACAGGGTAGTTAGA"	-0.676218013197738	8.48622987354127	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACAGGGTAGTTAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.91942249079	35.8288851115669	0.019170909500109	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.30145806813	1867.30145806813
"healthy-3"	"2019-08-01-count-3:TCACATTCACACGGTC"	5.3786469894344	-9.63102342998656	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTCACACGGTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2984.25464643312	40.5960274092674	0.0136034059485471	2492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2971.70741712046	2971.70741712046
"healthy-3"	"2019-08-01-count-2:CGGAATTAGATAGCTA"	0.580306668847245	7.95292470538942	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTAGATAGCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.86207490153	43.8086280235962	0.0239671409703909	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1821.21159792184	1821.21159792184
"healthy-3"	"2019-08-01-count-4:CCTCTAGAGCGTACAG"	3.78439893302266	-7.79154922878417	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGAGCGTACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1889.66213811439	39.9702274379969	0.0211520496875074	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1887.78347720661	1887.78347720661
"healthy-3"	"2019-08-01-count-2:CTGCATCCACGATTCA"	-1.91015718403514	8.7629184492859	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCCACGATTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.58688310289	44.2877385570345	0.0234750590888208	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1883.05070422844	1883.05070422844
"healthy-3"	"2019-08-01-count-4:GAGAAATAGAGTCCGA"	10.6742445426876	6.62255904758302	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATAGAGTCCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.19788644314	43.7629323120375	0.0223371679884198	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1954.7683171774	1954.7683171774
"healthy-3"	"2019-08-01-count-4:AGTAGCTCACGACCTG"	5.16735186156575	-8.91808416759642	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGCTCACGACCTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.32770539423	42.1093474278619	0.0155137301012613	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2709.51771777028	2709.51771777028
"healthy-3"	"2019-08-01-count-2:AGATGAACAATTCACG"	-0.313013504177886	8.22757718646852	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATGAACAATTCACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2124.59315037401	37.3462174121569	0.0175780560177286	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.2646750178	2119.2646750178
"healthy-3"	"2019-08-01-count-3:TTTAGTCTCCTTCTTC"	10.528035779565	6.85855243289796	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCTCCTTCTTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.57530334619	52.5878653029519	0.0271691136025754	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1932.28404211865	1932.28404211865
"healthy-3"	"2019-08-01-count-2:TTACAGGCAAGACCGA"	-4.27276740494426	12.7550420531067	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACAGGCAAGACCGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1819.8465024478	43.9020518564148	0.0241240411196021	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1815.64501522821	1815.64501522821
"healthy-3"	"2019-08-01-count-3:CGAGTGCTCTTGGATG"	-3.63958297196086	10.3929481276306	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTGCTCTTGGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.92475813496	41.3471301857696	0.0196617259014248	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2093.05737040739	2093.05737040739
"healthy-3"	"2019-08-01-count-2:ATCGATGGTAAGACCG"	2.68967546996419	-6.79165079509886	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGATGGTAAGACCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.14143153098	46.0495272383885	0.0202225152117268	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2273.78897484198	2273.78897484198
"healthy-3"	"2019-08-01-count-2:GGAAGTGTCCGTGCGA"	2.96667255935017	-6.98542406475218	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAAGTGTCCGTGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.00994822869	48.4053348539867	0.0219226072295636	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2203.05947583658	2203.05947583658
"healthy-3"	"2019-08-01-count-3:TGCCGAGAGTATAACG"	-2.4285925430363	9.15272042835084	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCCGAGAGTATAACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1999.69431774876	47.7541461539339	0.023880723033556	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1998.04583722956	1998.04583722956
"healthy-3"	"2019-08-01-count-3:CTGCCTAAGACAGCGT"	-2.75714407387431	9.1673316725525	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTAAGACAGCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1981.21532183109	40.6624257069937	0.0205239810428139	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.09129738556	1974.09129738556
"healthy-3"	"2019-08-01-count-3:CTGCCATTCCATAGGT"	-1.48077092590984	9.62158105457155	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATTCCATAGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.69432199159	50.0915691238021	0.0243909566226123	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.80059534001	2043.80059534001
"healthy-3"	"2019-08-01-count-2:TTACCATTCAAGCCTA"	2.70053472098653	-4.5359359017578	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATTCAAGCCTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3004.65092058599	39.0563517373824	0.0129986320440064	3272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2999.80399414155	2999.80399414155
"healthy-3"	"2019-08-01-count-3:ATGTCCCTCCACTGAA"	10.5351053672725	7.58976838672487	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCTCCACTGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2272.74533834773	48.8937852470486	0.0215130945038454	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2260.91849683863	2260.91849683863
"healthy-3"	"2019-08-01-count-4:TCGACCTAGTGCAGGT"	2.88728560981099	-6.42222263729247	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACCTAGTGCAGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.31368993204	44.1454639460546	0.0184376275054033	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2392.02160821631	2392.02160821631
"healthy-3"	"2019-08-01-count-2:TTACCATTCGCCTATC"	10.0557056861812	7.51602599704591	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATTCGCCTATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.74936316125	48.5211861261872	0.0236026759855458	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2043.1492452384	2043.1492452384
"healthy-3"	"2019-08-01-count-2:TTTGGTTAGGCAGGTT"	4.45490183409993	-8.25971987163695	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGTTAGGCAGGTT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.09211615375	42.9013164912768	0.0165828329897501	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2579.66539071956	2579.66539071956
"healthy-3"	"2019-08-01-count-4:TTGCATTCACGCGGTT"	10.4913193183834	7.07776544177858	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTCACGCGGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.31789417565	44.2783246578617	0.0212537533429973	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2074.76136402831	2074.76136402831
"healthy-3"	"2019-08-01-count-2:TTACCGCAGTAGTGCG"	10.5449606376583	7.25302550876466	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCAGTAGTGCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1998.9052957248	38.6770690396824	0.0193491253049375	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1990.24565598154	1990.24565598154
"healthy-3"	"2019-08-01-count-4:AGGACGACATGGGTTT"	-0.733360628516036	8.24627206409303	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGACATGGGTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2132.67336520127	37.5804312974307	0.0176212784904753	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2126.84501029125	2126.84501029125
"healthy-3"	"2019-08-01-count-2:GAGGGTACACTCCCTA"	-1.93487165394481	8.82745072925416	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTACACTCCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.61493819717	46.2859361861595	0.0233930995327132	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.71874931299	1970.71874931299
"healthy-3"	"2019-08-01-count-3:GTGCAGCAGCGCCATC"	10.4687181907589	6.00403878772584	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCAGCGCCATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.72629941218	45.0716260623454	0.0246869566795729	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1819.90253919063	1819.90253919063
"healthy-3"	"2019-08-01-count-2:ATCGGCGGTCACTCAA"	-0.248911986977416	7.78401229465333	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGGTCACTCAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1967.64614542111	38.2971865129392	0.0194634521059898	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.27445841909	1963.27445841909
"healthy-3"	"2019-08-01-count-2:ATCGGCGCATGGGTTT"	-3.92182741585429	13.3010654219422	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGCATGGGTTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1901.91183982627	41.394871160126	0.0217648737934705	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1893.54093627652	1893.54093627652
"healthy-3"	"2019-08-01-count-4:AGGACTTGTAGTGGCA"	5.20648636397664	-9.54297735607298	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACTTGTAGTGGCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.16948742789	45.0965139391283	0.017929811157675	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2508.40391062372	2508.40391062372
"healthy-3"	"2019-08-01-count-3:AGGGTTTGTACCCGCA"	4.61018576201741	-8.05131151592406	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTTTGTACCCGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.83916870139	51.6003991117837	0.0249417160562429	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2065.70533534497	2065.70533534497
"healthy-3"	"2019-08-01-count-4:TCGCAGGGTTAGGCCC"	3.595391412347	-6.8001108399597	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCAGGGTTAGGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.67617656642	45.1389769986968	0.0172967732180805	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2601.99206721597	2601.99206721597
"healthy-3"	"2019-08-01-count-4:CCTGTTGCAGTCTCTC"	-1.44745002213176	8.74670217120973	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGTTGCAGTCTCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.36443382191	44.5522006808716	0.0213437576874383	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.02535333189	2084.02535333189
"healthy-3"	"2019-08-01-count-3:CTGCGAGCATCTGTTT"	-4.03306851807292	10.7915076979431	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGCATCTGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.85833121398	47.4640795671317	0.0238649876777096	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1983.8488866062	1983.8488866062
"healthy-3"	"2019-08-01-count-2:GGACGTCTCTCCTACG"	-0.445412675768691	8.19008443439332	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGACGTCTCTCCTACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1845.37612209511	40.3682083190469	0.0218753281977095	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1841.49704350268	1841.49704350268
"healthy-3"	"2019-08-01-count-3:TTTGACTAGGCCTGCT"	9.2803541618282	6.93717286670534	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGGCCTGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.73174793191	46.7257027102786	0.0252471503568747	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1846.93990760012	1846.93990760012
"healthy-3"	"2019-08-01-count-3:ACCTACCCACCTGAAT"	-2.48414717140849	9.3264531859192	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTACCCACCTGAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2107.4279606143	49.5565996590909	0.0235152045931124	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2099.30104017312	2099.30104017312
"healthy-3"	"2019-08-01-count-3:CATGCCTGTGCTTATG"	0.166210954158944	8.63959310138551	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTGTGCTTATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2000.15082963554	43.7921965128134	0.0218944470906692	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.00967843134	1991.00967843134
"healthy-3"	"2019-08-01-count-2:ATCGTCCGTCGTTCAA"	-3.40751848641093	-5.26097252285155	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCGTCGTTCAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2689.79320402609	48.5029803990804	0.0180322339748948	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2683.32712727402	2683.32712727402
"healthy-3"	"2019-08-01-count-2:CACTAAGAGCCAACCC"	-1.36095402661021	9.17647836292116	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGAGCCAACCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.15181743235	46.0485464354528	0.0236978634517094	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.54823786092	1936.54823786092
"healthy-3"	"2019-08-01-count-3:TATCTGTCATCTGTTT"	-3.50118265572246	10.0411710509094	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTCATCTGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2140.1812225144	43.1718165257905	0.020172037802981	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2137.159197423	2137.159197423
"healthy-3"	"2019-08-01-count-4:TACATTCCAGGAACCA"	-1.62142358246501	8.66662881458131	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACATTCCAGGAACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1943.01518476459	44.9290725983501	0.0231233769816335	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.19069608019	1936.19069608019
"healthy-3"	"2019-08-01-count-2:GGAGCAAAGTTGCGCC"	-3.10500727120097	10.09472081745	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGCAAAGTTGCGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.26412272078	46.9906726074483	0.0228635687685929	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.61876819219	2053.61876819219
"healthy-3"	"2019-08-01-count-2:GAAATGATCCATTCAT"	11.2931496101314	4.39758012378541	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGATCCATTCAT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.08940851972	39.0665743984886	0.0205603874340438	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1894.47061427645	1894.47061427645
"healthy-3"	"2019-08-01-count-3:GTCACTCGTTCACGAT"	-1.47753665867503	8.50662515247194	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACTCGTTCACGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.85400164565	44.0731755872512	0.0223511353023444	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1965.25455737969	1965.25455737969
"healthy-3"	"2019-08-01-count-4:TACATTCAGCCTTTCC"	-3.8723603290623	10.8430566557678	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACATTCAGCCTTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2185.48226521481	41.4366798119074	0.0189599707448711	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.22153521735	2179.22153521735
"healthy-3"	"2019-08-01-count-2:TCCACCACAGTGGTGA"	-2.64731131020244	9.74608132922975	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCACAGTGGTGA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2014.10695039606	40.505156729207	0.0201107278445378	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2007.79656044826	2007.79656044826
"healthy-3"	"2019-08-01-count-3:GTGCTTCCATTGTACG"	-1.49699972096141	8.56519696796266	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCCATTGTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1993.45249545362	49.0727347783474	0.0246169572087951	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1990.08395078576	1990.08395078576
"healthy-3"	"2019-08-01-count-4:CTAGGTACAAAGCTAA"	3.05311073836629	-6.5662241212097	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGGTACAAAGCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.19341225644	45.6263660205653	0.0174466507168195	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2612.71273716855	2612.71273716855
"healthy-3"	"2019-08-01-count-3:ATTCAGGAGCTCGGCT"	-3.81216202202495	13.3642730482849	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCAGGAGCTCGGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2299.23172358009	43.9221809287464	0.0191029814343184	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2293.50004200002	2293.50004200002
"healthy-3"	"2019-08-01-count-4:ATTCACTCAGTTCTAG"	11.1873012977535	5.19170520389406	"2019-08-01-count-4"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTCAGTTCTAG"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1852.58563349181	44.3278747360839	0.0239275712467518	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1846.7198249796	1846.7198249796
"healthy-3"	"2019-08-01-count-3:ACGATCATCCAGCTCT"	-1.90612290325816	9.21097371661989	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGATCATCCAGCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.16611559447	47.4070636388115	0.0230001178847919	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2057.7325747768	2057.7325747768
"healthy-3"	"2019-08-01-count-4:GGCGTCAGTCGATTAC"	3.8731333213741	-7.11376955425414	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCGTCAGTCGATTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.40067035692	46.105472881606	0.0187848192181684	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2451.56071861619	2451.56071861619
"healthy-3"	"2019-08-01-count-4:GGCTGTGAGACGGTCA"	3.79285111007039	-6.41649010097655	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTGTGAGACGGTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.19879299635	44.1861257795666	0.0182723297635991	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2414.42064291628	2414.42064291628
"healthy-3"	"2019-08-01-count-4:GAGGGATAGATGATTG"	2.75106133994405	-4.5449896088806	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATAGATGATTG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2919.30270221759	39.0331660655342	0.0133707155602204	3053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2910.62746351271	2910.62746351271
"healthy-3"	"2019-08-01-count-2:TGTGATGAGTACAACA"	4.70661844786946	-8.35809233104857	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGAGTACAACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.72940622403	47.5353949492779	0.0179600509358811	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2640.11068951244	2640.11068951244
"healthy-3"	"2019-08-01-count-4:ATTCAGGGTGAGTTTC"	-3.46609244766887	12.0701465376648	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCAGGGTGAGTTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2127.85316514697	43.9727864648089	0.0206653293493453	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2117.77020860572	2117.77020860572
"healthy-3"	"2019-08-01-count-3:GTGGAGAGTGTCACAT"	-2.71413050118144	8.95203015888063	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAGAGTGTCACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.20162059742	43.5656958438008	0.0203939999968809	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2130.28377276606	2130.28377276606
"healthy-3"	"2019-08-01-count-3:CTGTAGACAGAGATGC"	5.55656542357747	-9.82488729869994	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGACAGAGATGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.27976567578	42.3891499956679	0.0167726385386278	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2523.33868721256	2523.33868721256
"healthy-3"	"2019-08-01-count-3:CGGACACGTACTAGCT"	-2.38304171982463	4.07670447910158	"2019-08-01-count-3"	"Control3"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGACACGTACTAGCT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2912.51228647274	30.8656233831757	0.0105975942235616	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	2906.41093392728	2906.41093392728
"healthy-3"	"2019-08-01-count-4:GAGGGTAGTCATCACA"	-2.93970809403117	10.1823377379212	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGTAGTCATCACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.41551721734	44.6018853239698	0.0215424802186158	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.02023032666	2067.02023032666
"healthy-3"	"2019-08-01-count-2:TTAGGGTTCAGGACAG"	0.893424709408921	8.39652249896852	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTTCAGGACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.02868864144	37.7121577858259	0.0216982366472353	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1732.99337474365	1732.99337474365
"healthy-3"	"2019-08-01-count-4:GCGTGCAGTCCTCATC"	3.23013128814046	-6.95238878643187	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCAGTCCTCATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2058.33069885123	50.0110518180074	0.0242968983778549	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2056.94137458238	2056.94137458238
"healthy-3"	"2019-08-01-count-2:TTAGGGTTCGGTGTTA"	4.75357498702351	-8.24381925975951	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTTCGGTGTTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.78609916159	41.8527528524114	0.0160000670031185	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2611.79693084576	2611.79693084576
"healthy-3"	"2019-08-01-count-4:TGGTGATGTTGCTCGG"	-2.92390857163127	9.38770101154176	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTGATGTTGCTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.76140270675	42.0134657088849	0.020347855037298	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.30292080226	2056.30292080226
"healthy-3"	"2019-08-01-count-3:GTGTGATAGAATTGTG"	10.2921587425167	6.04693553531495	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATAGAATTGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1787.39198486909	39.915674387127	0.0223317966764019	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1777.09520130477	1777.09520130477
"healthy-3"	"2019-08-01-count-4:TTCGATTCATGGGAAC"	-5.67751632157024	-5.4427209130493	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTCATGGGAAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2868.92457482382	51.2695886689959	0.0178706645406125	2624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2861.42925842787	2861.42925842787
"healthy-3"	"2019-08-01-count-2:ATAGAGACACGCACCA"	3.10962643203084	-7.78589966213378	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGACACGCACCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.2821106668	48.2745036226833	0.0226398295897099	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2130.65262819216	2130.65262819216
"healthy-3"	"2019-08-01-count-3:CGGCAGTGTAGCGCTC"	-1.81798968735393	8.91566369617311	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTGTAGCGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.46831021833	41.0671204230335	0.021251122311234	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1927.42581008308	1927.42581008308
"healthy-3"	"2019-08-01-count-4:CCACGTTTCCTTATAC"	11.0587755638057	6.38752076709596	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGTTTCCTTATAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.8444268939	45.4585958282726	0.0232068433838594	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1948.03975241531	1948.03975241531
"healthy-3"	"2019-08-01-count-3:GGTTCTCTCCAAGCTA"	2.53711452063863	-6.22322847759398	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTCTCTCCAAGCTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.46499753801	46.3351368444427	0.0169945834207603	2313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2719.14674771852	2719.14674771852
"healthy-3"	"2019-08-01-count-2:AAAGAACGTGAATTAG"	4.42540039595906	-7.65569403087767	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACGTGAATTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.82547508533	43.8733537836487	0.018505518117933	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2369.51535098212	2369.51535098212
"healthy-3"	"2019-08-01-count-4:GTGCTGGCACCGTCTT"	3.09088720855061	-6.49560501491698	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGCACCGTCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.33064209931	46.2777279971469	0.0179070461199015	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2578.032739505	2578.032739505
"healthy-3"	"2019-08-01-count-3:TGTTCATCAAGAATGT"	10.6469904380733	7.84512612903444	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCATCAAGAATGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.91791053046	41.4851435828707	0.0205278716996385	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2018.70374428527	2018.70374428527
"healthy-3"	"2019-08-01-count-3:GTGTTAGGTACTAGCT"	-3.31314502182658	10.0185594328674	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGGTACTAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.78729824701	42.3779574265793	0.0212977324078378	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1986.43413245744	1986.43413245744
"healthy-3"	"2019-08-01-count-2:AGCTCAAGTAGACACG"	4.78197969970052	-8.29760458385619	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTCAAGTAGACACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.4067786354	46.8852935835464	0.0187211175051576	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2495.79997580324	2495.79997580324
"healthy-3"	"2019-08-01-count-3:TCTACATTCAGCATTG"	-0.298548797995406	8.86346242511598	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACATTCAGCATTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2018.34850348181	36.4185554964927	0.0180437399357285	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2014.12907565018	2014.12907565018
"healthy-3"	"2019-08-01-count-2:TAGACCACAAATAAGC"	-1.98316560211833	8.94953439319459	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCACAAATAAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.33894754591	46.7684933977453	0.0238939165116921	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1949.26938178056	1949.26938178056
"healthy-3"	"2019-08-01-count-3:CTGTGGGCAACTTGCA"	-1.39003501358684	8.86399171436159	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGCAACTTGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2235.7708402791	46.9833350503339	0.0210143786670323	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2231.0092676085	2231.0092676085
"healthy-3"	"2019-08-01-count-3:CTGTGGGAGATGGCAC"	5.16320147094075	-8.48417189037474	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGAGATGGCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.11520531134	45.857397076011	0.0182037713000678	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2515.94475371093	2515.94475371093
"healthy-3"	"2019-08-01-count-4:TCGTCCACATTCAGCA"	-2.23423157158549	9.02441213214723	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCACATTCAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.38325985342	43.0167418988807	0.0227435352802131	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1889.57286444095	1889.57286444095
"healthy-3"	"2019-08-01-count-2:AAAGGATTCCTCGATC"	-7.88995871964152	0.214388123992361	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATTCCTCGATC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3109.06731618278	42.3656860415748	0.0136264936500604	4597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3100.30866061626	3100.30866061626
"healthy-3"	"2019-08-01-count-3:AACACACAGTGAGGCT"	10.4312187629635	6.93749234760133	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACACACAGTGAGGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1816.54534156107	41.3230355877004	0.0227481443167221	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1807.25461726164	1807.25461726164
"healthy-3"	"2019-08-01-count-3:CGGGTCATCGACCAAT"	-2.22911701622661	9.14785764301149	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTCATCGACCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1766.15902839367	41.780810357502	0.0236563127588244	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1760.61140540366	1760.61140540366
"healthy-3"	"2019-08-01-count-4:ACGCACGCACGGATCC"	3.23531164702718	-6.42915537273558	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGCACGGATCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.93814100741	50.599398710595	0.0194692585838082	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2594.10484928055	2594.10484928055
"healthy-3"	"2019-08-01-count-2:CAGATCATCCGAACGC"	-0.46193633499797	8.07522389972535	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCATCCGAACGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1964.74698851451	38.625078301408	0.0196590596790335	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.1094351829	1957.1094351829
"healthy-3"	"2019-08-01-count-3:GGGCCATGTACAGTCT"	-2.79620109024699	8.85776803577272	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCCATGTACAGTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2207.78514567418	40.9288122602548	0.0185384036759413	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2201.56699513384	2201.56699513384
"healthy-3"	"2019-08-01-count-3:GTTACAGCATCTTTCA"	10.7948547798092	7.00171134555665	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGCATCTTTCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.80158334015	46.5904287755213	0.0238338403102338	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1946.72670117632	1946.72670117632
"healthy-3"	"2019-08-01-count-4:CATGCCTTCTCGGGAC"	-2.31640515747722	9.17521855914918	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTTCTCGGGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.1824125843	41.144367892025	0.0211846053313178	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1938.49900256714	1938.49900256714
"healthy-3"	"2019-08-01-count-3:CATTTCACACGCCACA"	-1.34048662605937	8.79408357227174	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCACACGCCACA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2177.4503125019	47.3654887017363	0.0217527299841405	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.00037815802	2176.00037815802
"healthy-3"	"2019-08-01-count-3:ATTGTTCTCATAGGCT"	-2.72119985047038	9.92924020374147	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGTTCTCATAGGCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2238.99340665067	45.9149311385125	0.0205069523662408	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2233.56903267043	2233.56903267043
"healthy-3"	"2019-08-01-count-2:ATGCATGAGATCCTAC"	-1.45133648338969	8.5372743376526	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGAGATCCTAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2312.72811639118	45.7808863594961	0.0197951873525598	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2307.64158916074	2307.64158916074
"healthy-3"	"2019-08-01-count-2:GAGACTTCACCATATG"	-1.88178441944774	9.21703527057496	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACTTCACCATATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.5543732081	42.4789843271255	0.0222106021780032	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1907.11739845369	1907.11739845369
"healthy-3"	"2019-08-01-count-3:TCAATCTGTCGGTGTC"	-4.19609294357951	12.7598991164002	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTGTCGGTGTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2350.3128727233	41.7487185891117	0.0177630472409138	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2343.861997965	2343.861997965
"healthy-3"	"2019-08-01-count-3:GTAATCGGTCACTACA"	-3.17353568497356	9.34132955158082	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATCGGTCACTACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.20672969412	45.7652886963086	0.0215142647197667	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2122.55117555445	2122.55117555445
"healthy-3"	"2019-08-01-count-4:AAAGTGAAGCCTATCA"	4.82662071761434	-8.20707514202269	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGAAGCCTATCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.22158768224	40.3679709942798	0.0146887613339522	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2743.54005400382	2743.54005400382
"healthy-3"	"2019-08-01-count-3:GGGCTACTCTCATTGT"	-3.03943977776225	10.2544889220032	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTACTCTCATTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.38167175676	44.135622899482	0.0228636769325084	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1923.33736231196	1923.33736231196
"healthy-3"	"2019-08-01-count-3:GTTACCCTCCAATCTT"	-0.0325035181945145	7.7201733359131	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACCCTCCAATCTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1875.67909141487	39.4281707832105	0.0210207444139439	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1871.26721970432	1871.26721970432
"healthy-3"	"2019-08-01-count-2:TTTCACAGTCCATACA"	-4.38154349747356	-5.28215124523314	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACAGTCCATACA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3116.00429369568	45.9606288059599	0.0147498605502398	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3111.81013997547	3111.81013997547
"healthy-3"	"2019-08-01-count-2:AAATGGAGTACCTAAC"	-2.81988344612773	9.50726411426393	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAATGGAGTACCTAAC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1929.01605608985	50.7111296026606	0.0262885990205043	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1927.22335525886	1927.22335525886
"healthy-3"	"2019-08-01-count-2:CCGATGGTCCGCCTAT"	-0.0252119553392709	7.80767295444337	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATGGTCCGCCTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1978.26432901348	42.26797649273	0.0213661925116995	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.23867089429	1973.23867089429
"healthy-3"	"2019-08-01-count-4:TTTACGTTCGTTCGCT"	-3.93613372269328	10.6164521940979	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTTCGTTCGCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2139.53469565665	44.3104375860619	0.020710315040001	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2135.46622673749	2135.46622673749
"healthy-3"	"2019-08-01-count-3:CGTAAGTAGCAGTAAT"	4.88435329970662	-8.3797703019348	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTAGCAGTAAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.22612786659	46.1101914515161	0.0190993672544928	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2410.02605432782	2410.02605432782
"healthy-3"	"2019-08-01-count-4:AGGTCTATCTACCCAC"	3.16023077544515	-6.61692764675292	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTATCTACCCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.1102540777	43.1167817545293	0.0166338533195883	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2584.81371407568	2584.81371407568
"healthy-3"	"2019-08-01-count-2:CGTTGGGAGCGGCTCT"	-0.153553987771827	8.01103446567384	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGAGCGGCTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1890.78212878096	36.2182993596815	0.0191551944607349	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1886.80542363575	1886.80542363575
"healthy-3"	"2019-08-01-count-4:ACGGTCGTCCGTGTCT"	-5.32333312454875	-5.55471374904784	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTCGTCCGTGTCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3092.75813480447	44.0259998737015	0.0142351900648981	3151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3082.75498571919	3082.75498571919
"healthy-3"	"2019-08-01-count-2:CCGGACATCATCGTAG"	-7.87286124649699	0.0684890982690229	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGACATCATCGTAG"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3020.47035500059	48.5232022547124	0.0160647834779702	4636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3014.65349682644	3014.65349682644
"healthy-3"	"2019-08-01-count-4:CGATGGCAGGTCACTT"	-3.62916074219401	10.3912753828797	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGGCAGGTCACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2152.50013936039	40.5487734954614	0.0188379887898685	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2146.14277005035	2146.14277005035
"healthy-3"	"2019-08-01-count-2:GTGAGGAAGCGTACAG"	-0.383797029883224	8.30638597095338	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGAAGCGTACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1961.13935238973	42.5650123715463	0.0217042263313308	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1953.75528600721	1953.75528600721
"healthy-3"	"2019-08-01-count-2:GCTGGGTCAGCCGGTT"	-5.00030789795573	-5.61164381420287	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTCAGCCGGTT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2634.33363872528	43.5545424130888	0.0165334192195049	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2627.04529586138	2627.04529586138
"healthy-3"	"2019-08-01-count-4:AGGTTGTTCGACGATT"	-0.701333979994613	8.29132649982301	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTGTTCGACGATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1941.82804610097	45.8116081218194	0.0235920004419574	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.17350998535	1940.17350998535
"healthy-3"	"2019-08-01-count-2:ACGATGTAGCTGACCC"	-3.13335357132609	9.81136605823366	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTAGCTGACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.83096060379	44.8145602249208	0.0216617795645526	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2062.4808722896	2062.4808722896
"healthy-3"	"2019-08-01-count-2:TCCTCCCCACTTGAGT"	10.5982853370601	6.64042422855226	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCCACTTGAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.61244658663	40.7265731645562	0.0197355725547793	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2055.24915982853	2055.24915982853
"healthy-3"	"2019-08-01-count-4:CATTCCGCACAGTGTT"	11.3089395957882	4.469371295813	"2019-08-01-count-4"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGCACAGTGTT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.68386074377	33.1082123851823	0.0170074931286134	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1941.28674858923	1941.28674858923
"healthy-3"	"2019-08-01-count-3:CTTCCTTGTGCCTGCA"	4.8717757659847	-8.65104486858519	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTGTGCCTGCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.68729258479	48.6647558117628	0.0195465333966657	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2482.32316282303	2482.32316282303
"healthy-3"	"2019-08-01-count-2:CTTCCTTTCTAGCCAA"	4.73622479018514	-8.20558931743773	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTTCTAGCCAA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.85408031551	42.9966038132162	0.0160264414411087	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2680.89114454417	2680.89114454417
"healthy-3"	"2019-08-01-count-3:CAACAGTCAGGATTCT"	1.73474862155263	-6.50436022197875	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAGTCAGGATTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.16231085937	53.9824034826237	0.0226706105822502	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2373.93755037714	2373.93755037714
"healthy-3"	"2019-08-01-count-3:TGTTTGTCAGCGAACA"	2.60720314559285	-4.42928030407103	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTTGTCAGCGAACA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2541.49529948636	39.4716840471532	0.0155308900453723	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2540.02287066775	2540.02287066775
"healthy-3"	"2019-08-01-count-2:CAGCCAGTCATTGCCC"	4.63320984420125	-8.29357054149779	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGTCATTGCCC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.36242519241	46.7576209154148	0.0172133219344259	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2711.69613135818	2711.69613135818
"healthy-3"	"2019-08-01-count-2:ACGATGTTCTGCATAG"	11.1037203269893	6.44030854785768	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTTCTGCATAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2146.38481405905	37.8159850240791	0.0176184553563649	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2136.88167144983	2136.88167144983
"healthy-3"	"2019-08-01-count-3:ATGGGAGCACTGTCGG"	-3.79790816727336	10.2190713652405	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGAGCACTGTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.54184065902	39.8314424412792	0.0204207064985705	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1948.93056996936	1948.93056996936
"healthy-3"	"2019-08-01-count-3:GTAGAGGGTACGTAGG"	4.4081789451534	-7.88147213375243	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAGGGTACGTAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.57679063433	47.9356220004042	0.0184468752946504	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2597.49531549529	2597.49531549529
"healthy-3"	"2019-08-01-count-2:TCATGCCCAATACGAA"	4.71748365935628	-8.2744293442932	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGCCCAATACGAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2717.46160574934	44.716130515788	0.0164551103210371	2304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2712.8538446493	2712.8538446493
"healthy-3"	"2019-08-01-count-2:AACAGGGGTGCTCTTC"	-3.46461043778117	10.0205783613953	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGGTGCTCTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1970.54143064549	45.1933387803297	0.0229344778432422	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.54143064549	1970.54143064549
"healthy-3"	"2019-08-01-count-2:AGGCATTGTCCTGGGT"	-3.99346385422404	12.3580388792786	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTGTCCTGGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.58558265864	49.4669245472481	0.0261096278785316	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1889.4458805193	1889.4458805193
"healthy-3"	"2019-08-01-count-4:TCTCCGACAAATTAGG"	-0.713319103152114	8.95694825733034	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGACAAATTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2110.96569954051	45.8813433958093	0.0217347649967957	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2104.60103887487	2104.60103887487
"healthy-3"	"2019-08-01-count-2:CCACGTTTCCGGGACT"	4.1122485595638	-7.01521065151366	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTTCCGGGACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.27558491678	42.9670371656474	0.0165750267508795	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2584.97613685231	2584.97613685231
"healthy-3"	"2019-08-01-count-2:TTTGATCCATGACAGG"	5.54795040664021	-10.0290298691955	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCCATGACAGG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.941693407	44.0691326689117	0.0171545865684736	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2563.42462713671	2563.42462713671
"healthy-3"	"2019-08-01-count-4:CATTGCCCAGGATCTT"	-3.38948545876201	9.76507375324098	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCCAGGATCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.4534385785	46.9220124131198	0.0228058684261347	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.91078862498	2050.91078862498
"healthy-3"	"2019-08-01-count-3:GTTCTATAGCATGGGT"	3.83182324942891	-7.9216313592163	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATAGCATGGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.18310878531	47.8657516955611	0.0194403704276792	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2451.06753125803	2451.06753125803
"healthy-3"	"2019-08-01-count-2:CTAAGTGAGCTTACGT"	-4.10497889939006	13.200958228949	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAAGTGAGCTTACGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2099.8361126256	45.9191983715956	0.0218679915520545	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2095.00390027024	2095.00390027024
"healthy-3"	"2019-08-01-count-3:TCACGCTAGGGAACAA"	-7.17533288422282	3.40783283794252	"2019-08-01-count-3"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTAGGGAACAA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2540.07820839897	52.953197202594	0.0208470735379328	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2526.06286918396	2526.06286918396
"healthy-3"	"2019-08-01-count-4:TCACACCTCATGCCAA"	-2.15799508515056	8.7753057249817	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACACCTCATGCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1865.00047799546	40.7638474847678	0.0218572852745763	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1858.79772824552	1858.79772824552
"healthy-3"	"2019-08-01-count-4:AACACACTCCATTTAC"	-3.98236499252971	11.0806636580261	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACTCCATTTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.11954397701	43.4134037652825	0.020409479988188	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2115.54107255532	2115.54107255532
"healthy-3"	"2019-08-01-count-2:CTTGATTTCTTGCAAG"	10.0482012229854	7.00039050662843	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGATTTCTTGCAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.65042836852	39.1682368754936	0.0195484383507889	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2000.454979082	2000.454979082
"healthy-3"	"2019-08-01-count-2:TATATCCCAGGCACAA"	0.239468162029427	8.38602826679078	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCCAGGCACAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2041.30945594912	41.5754351315216	0.0203670418565669	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.12217490968	2037.12217490968
"healthy-3"	"2019-08-01-count-2:GGGATCCAGTTGTCAC"	3.39877595481221	-6.98912908947142	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCAGTTGTCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.62097267118	49.27463121232	0.0216532681866085	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2268.44587827617	2268.44587827617
"healthy-3"	"2019-08-01-count-4:GGGTCACGTAGAGACC"	-2.69839797440227	8.95680234515993	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCACGTAGAGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.46174476244	43.0518826670031	0.0226058007126699	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1902.63560399249	1902.63560399249
"healthy-3"	"2019-08-01-count-2:GGGATCCTCCGTGGTG"	-1.69320140305217	8.9462795027527	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCTCCGTGGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.75332872635	50.0240947892305	0.0250276480195318	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1995.49462821237	1995.49462821237
"healthy-3"	"2019-08-01-count-2:TCCTGCATCTGCAGCG"	2.72993506964986	-6.67143871700438	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCATCTGCAGCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.32259902491	44.9649754312876	0.0188270108274509	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2384.64144416438	2384.64144416438
"healthy-3"	"2019-08-01-count-3:ACTTATCCAACCGATT"	-3.75494656983073	3.55587408626405	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTATCCAACCGATT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2984.71272094396	48.9805850586053	0.0164104855770221	4438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2974.36541461397	2974.36541461397
"healthy-3"	"2019-08-01-count-2:GATTGGTCACCTGATA"	-4.28171287003215	13.0369434126648	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTCACCTGATA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2396.03956481237	43.3849971182427	0.0181069619030436	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2387.67069088343	2387.67069088343
"healthy-3"	"2019-08-01-count-4:TCTGGCTAGCATCAAA"	-1.65310595455821	8.79761788928834	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTAGCATCAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.97367788235	47.3443826072865	0.024839998136747	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1897.83939614911	1897.83939614911
"healthy-3"	"2019-08-01-count-3:CTTGAGATCGTCGATA"	-1.77175996723827	8.63911531055299	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGAGATCGTCGATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2291.93786378061	34.6395811552934	0.0151136650354711	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2283.82313509619	2283.82313509619
"healthy-3"	"2019-08-01-count-3:CCCAACTCATTCAGCA"	3.78989781913106	-7.23485567485961	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTCATTCAGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2594.58970094235	49.6805967037729	0.0191477660940877	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2592.57960448664	2592.57960448664
"healthy-3"	"2019-08-01-count-3:GTTGCGGTCGGAATTC"	-1.54971013489421	8.83149907672731	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGTCGGAATTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2064.64106271195	47.9567755837376	0.0232276575574571	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2060.15298390233	2060.15298390233
"healthy-3"	"2019-08-01-count-3:AACTTCTGTTACTCAG"	10.9881159263546	6.18210170352785	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACTTCTGTTACTCAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.36680311865	41.6094423490692	0.0213451066687405	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1944.37114280754	1944.37114280754
"healthy-3"	"2019-08-01-count-2:AACCCAAAGGAACGTC"	-1.82048628750499	8.6940297850403	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCCAAAGGAACGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1883.03784919833	45.2770018855878	0.024044658425142	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1877.91504192373	1877.91504192373
"healthy-3"	"2019-08-01-count-3:TCACTCGCACCATTCC"	-2.68847833100017	9.52652165973512	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTCGCACCATTCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2132.60537801447	45.2700606867853	0.0212275844155158	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2125.88367673428	2125.88367673428
"healthy-3"	"2019-08-01-count-4:CGGACACTCGAGCTGC"	4.94183601912801	-8.24791338359984	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACTCGAGCTGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.48111269506	49.5509462007939	0.0198801691809876	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2487.8417519665	2487.8417519665
"healthy-3"	"2019-08-01-count-3:CCCAACTCACAGAGAC"	4.38951410826985	-7.91965153133544	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTCACAGAGAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.43840406348	44.6933435158993	0.0171013571417671	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2609.37514684546	2609.37514684546
"healthy-3"	"2019-08-01-count-2:TGCTCCAGTCCTTTGC"	-4.33611712876018	10.9461059340271	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCAGTCCTTTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2242.64938488248	40.013088631619	0.0178418833105808	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2232.96067422971	2232.96067422971
"healthy-3"	"2019-08-01-count-3:GTTGTAGAGTCATGGG"	4.24463381347005	-7.5932564965454	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTAGAGTCATGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.78028718661	45.5182311330784	0.0182161798564241	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2498.78028718661	2498.78028718661
"healthy-3"	"2019-08-01-count-3:AGTTCCCGTAAGAACT"	4.47544111785237	-8.00505354320677	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTAAGAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.84197472798	47.97796178023	0.0205839616329328	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2318.87794841525	2318.87794841525
"healthy-3"	"2019-08-01-count-4:ACTCCCACAATCAGCT"	3.02404107627217	-6.5164365998474	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCCCACAATCAGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2796.37063901359	43.708216638787	0.0156303374198654	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2790.51104332569	2790.51104332569
"healthy-3"	"2019-08-01-count-2:GGGCTCACACGAGGTA"	-4.37905965271648	12.9227399596008	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTCACACGAGGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1896.51635242963	42.6331673145292	0.0224797256611639	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1892.67130390712	1892.67130390712
"healthy-3"	"2019-08-01-count-2:GAAATGAAGTTGCGCC"	0.16048658367936	8.40338704669801	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGAAGTTGCGCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2022.18977871578	40.8659466564817	0.0202087593788721	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2019.23866230068	2019.23866230068
"healthy-3"	"2019-08-01-count-3:GTTGTCCCAGGTAGTG"	2.26729764518086	-6.15795757686766	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTCCCAGGTAGTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2660.85807308951	49.7492421506028	0.0186966913619858	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2658.94841421608	2658.94841421608
"healthy-3"	"2019-08-01-count-3:TTACTGTTCAAGCTTG"	-0.442185322672683	8.68379113757936	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTTCAAGCTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1930.90615966216	47.8331757895861	0.0247723979491345	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1919.65549208513	1919.65549208513
"healthy-3"	"2019-08-01-count-3:GGTGAAGAGTCTGCAT"	-3.00942407074626	9.30036733234254	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGAGTCTGCAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2024.95594089952	45.1743557404696	0.0223088092081659	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.38858525244	2016.38858525244
"healthy-3"	"2019-08-01-count-2:AACGAAAAGTCTGTAC"	-2.96739302101787	9.48674962604371	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGAAAAGTCTGTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2010.45333951584	42.1011142174573	0.0209411048692113	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.5290930913	2005.5290930913
"healthy-3"	"2019-08-01-count-4:CCTTTGGCATGGTACT"	-3.400462726981	10.5126132735047	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGCATGGTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.35520906752	49.2510531642629	0.0226404648578632	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2167.52274814381	2167.52274814381
"healthy-3"	"2019-08-01-count-4:CACTGTCGTGTTAGCT"	-3.5966821712559	9.92432496631471	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGTCGTGTTAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.6076549993	44.4947739787202	0.022579215028339	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.40201861944	1960.40201861944
"healthy-3"	"2019-08-01-count-2:CATGGTAGTCATCCCT"	3.1905697780544	-7.09001734172972	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGTAGTCATCCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.92349123051	46.788913056424	0.020888621079964	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2235.66194307091	2235.66194307091
"healthy-3"	"2019-08-01-count-3:AAAGAACGTGATCGTT"	-4.24275336685832	11.5592250593933	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGAACGTGATCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2523.40839418945	46.2598445990341	0.0183322860879573	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2517.54722272882	2517.54722272882
"healthy-3"	"2019-08-01-count-2:TCCACCAAGTTCATCG"	11.213226934045	6.05704686725465	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCAAGTTCATCG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2346.16638396498	46.9435667809595	0.0200086264562472	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2342.8004796954	2342.8004796954
"healthy-3"	"2019-08-01-count-3:TCAGCCTCATTACGGT"	-1.74073372307475	8.95718858325807	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCATTACGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2184.60946488689	46.0214493690811	0.0210662134851933	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.49251842574	2179.49251842574
"healthy-3"	"2019-08-01-count-4:CGGGCATTCACCTGGG"	11.0369736152584	6.38003728473512	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATTCACCTGGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1803.30517337947	42.2484412055031	0.0234283369388486	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1792.76944969684	1792.76944969684
"healthy-3"	"2019-08-01-count-4:TTGGGATAGTGGATTA"	0.474673052399796	8.45851514423219	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGATAGTGGATTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.60094725519	36.3981972132465	0.0199267372919858	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1820.52322088057	1820.52322088057
"healthy-3"	"2019-08-01-count-4:TTTGGAGCACAACGCC"	-4.86101708832439	3.71323177898256	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGAGCACAACGCC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2514.32559310596	45.5575058089044	0.0181191751513084	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2499.29878179333	2499.29878179333
"healthy-3"	"2019-08-01-count-3:GAACACTAGTAGTGCG"	-3.7139769596165	12.3967456587586	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTAGTAGTGCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1989.98594447536	38.434107621392	0.0193137583348734	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1988.1840096987	1988.1840096987
"healthy-3"	"2019-08-01-count-3:CAATCGAAGGAACTAT"	4.62429346618001	-7.56850149547728	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATCGAAGGAACTAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.00524453516	48.480597755596	0.0183638263052512	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2633.51112096265	2633.51112096265
"healthy-3"	"2019-08-01-count-3:CTGTACCCAGATTTCG"	11.0033756690914	5.4264197119507	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCCAGATTTCG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.58001662076	45.322454200915	0.0238717640574261	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1892.00469644133	1892.00469644133
"healthy-3"	"2019-08-01-count-4:ACTGTCCAGTAGACAT"	4.25378956374471	-7.83856823360594	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTCCAGTAGACAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.59919430301	46.5000429419827	0.0179426058798758	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2587.59813191645	2587.59813191645
"healthy-3"	"2019-08-01-count-2:TATCTTGTCAATCTCT"	4.74592794951741	-8.28212835704955	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTTGTCAATCTCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2879.48233828453	40.1889243509041	0.0139569963033171	2338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2873.92348765879	2873.92348765879
"healthy-3"	"2019-08-01-count-3:GAACACTTCCACCTCA"	-2.20722160759624	8.63540647113649	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTTCCACCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2184.60558684027	48.1942357133788	0.0220608406403854	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2171.46549555086	2171.46549555086
"healthy-3"	"2019-08-01-count-2:TCCAGAAGTCCAATCA"	-0.251664529473144	8.22956941211549	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCAGAAGTCCAATCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.66670482191	40.354221125335	0.0214574017936668	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1875.57634865817	1875.57634865817
"healthy-3"	"2019-08-01-count-4:AACGAAAAGAGTCACG"	-3.55588136139568	10.0889587172302	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGAAAAGAGTCACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.41728488989	44.2130897723883	0.0223590084451246	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.41728488989	1977.41728488989
"healthy-3"	"2019-08-01-count-2:CATACCCAGAGGGTCT"	-3.21210298958476	10.5984143980774	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCAGAGGGTCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1987.28965619439	48.136193124827	0.0242220317379434	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1985.73099335137	1985.73099335137
"healthy-3"	"2019-08-01-count-3:AGAACCTGTCTAGTGT"	11.3137842613155	5.34132144534913	"2019-08-01-count-3"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTGTCTAGTGT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.96868491354	38.0745195888547	0.0185190172730942	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2050.68978725834	2050.68978725834
"healthy-3"	"2019-08-01-count-3:TTCACCGAGACCAGCA"	-2.75144730034526	9.55302331531373	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGAGACCAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2335.13858433962	40.6863899916265	0.0174235440519401	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2333.59883563209	2333.59883563209
"healthy-3"	"2019-08-01-count-3:GAACTGTGTAGGAAAG"	-4.06758819046672	10.7103709944519	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACTGTGTAGGAAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.31009061107	48.8690651555262	0.0238698892657438	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.59823681204	2037.59823681204
"healthy-3"	"2019-08-01-count-4:AGTTAGCGTACTAACC"	4.41188158568684	-8.21057894146117	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCGTACTAACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.53197715569	44.133739536541	0.0173445411308505	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2539.07021840443	2539.07021840443
"healthy-3"	"2019-08-01-count-2:AAGAACAAGAGCAGCT"	10.37824501571	7.15349338138429	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGAACAAGAGCAGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.20826991478	37.2432799673527	0.0187226649570225	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1981.99140682803	1981.99140682803
"healthy-3"	"2019-08-01-count-3:TAACTTCAGCAATTCC"	-2.76574097099956	8.81901738727418	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACTTCAGCAATTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.78720138668	41.9595921922178	0.0197198254434808	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2117.49707199148	2117.49707199148
"healthy-3"	"2019-08-01-count-4:CAATCGATCAAATAGG"	4.34045185622518	-7.43679430401	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATCGATCAAATAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.19129081611	41.1280432469378	0.0166632316546821	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2464.90604924262	2464.90604924262
"healthy-3"	"2019-08-01-count-3:GAAGCGAAGCTTGTTG"	-3.08172402802165	9.33162686908571	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGAAGCTTGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.05310942186	45.6367901129644	0.0219718936920526	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2074.22206864451	2074.22206864451
"healthy-3"	"2019-08-01-count-3:TGTGATGTCACCGCTT"	-4.04287515106853	-4.51730062877806	"2019-08-01-count-3"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGATGTCACCGCTT"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3170.7038488334	43.0211829833269	0.0135683384618704	3723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3164.80426602255	3164.80426602255
"healthy-3"	"2019-08-01-count-3:TGTGTGATCAGCTAGT"	2.8655342060024	-6.36466410076293	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGTGATCAGCTAGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.68069073405	43.5177996067065	0.0172437819754641	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2517.82575477304	2517.82575477304
"healthy-3"	"2019-08-01-count-4:GACCAATCACTTTAGG"	-2.15233359757121	9.10318563068239	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATCACTTTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.79698147812	46.0121756466007	0.0234421471404294	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1954.35009524635	1954.35009524635
"healthy-3"	"2019-08-01-count-4:AGCATCATCTGAGAGG"	-5.16226945343669	2.7260761030945	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCATCTGAGAGG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2950.60079742572	44.2464438409806	0.0149957404876945	3515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2946.48249528291	2946.48249528291
"healthy-3"	"2019-08-01-count-3:CCTCTCCTCACCATAG"	10.7095715003902	7.68108413303224	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCTCACCATAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2506.19104873026	45.2608730690718	0.0180596260177383	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2499.03262244226	2499.03262244226
"healthy-3"	"2019-08-01-count-3:AAGGAATAGCCTAACT"	-0.33689052882846	8.4794244536194	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATAGCCTAACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.90547515548	37.7317365317317	0.0185970894128718	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2020.05261707649	2020.05261707649
"healthy-3"	"2019-08-01-count-1:ATTCCATCAACACGTT"	10.5671106773311	6.98495433414308	"2019-08-01-count-1"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATTCCATCAACACGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2300.19878566373	43.1176549920447	0.0187451863990108	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2291.53472433393	2291.53472433393
"healthy-3"	"2019-08-01-count-4:TGACAGTCAAGTGGCA"	2.58576931533162	-6.16284038936766	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTCAAGTGGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.54660668526	43.7580784918392	0.0186003024839088	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2348.07993693549	2348.07993693549
"healthy-3"	"2019-08-01-count-3:AAGGAATCACCGCTGA"	4.68892731246297	-8.23374178325804	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATCACCGCTGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.77660309663	43.532827359486	0.0160060305357143	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2713.98381286083	2713.98381286083
"healthy-3"	"2019-08-01-count-4:ACTTATCTCACCTACC"	-2.19579539719279	8.90137002551881	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCTCACCTACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.24146982456	50.2580171396099	0.0253285791592964	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1982.61942442722	1982.61942442722
"healthy-3"	"2019-08-01-count-3:CACAGGCCAATAAGGT"	-2.51033935967143	9.56202218616334	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCCAATAAGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2338.97860763669	43.7430710539624	0.0187017832959834	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2338.97860763669	2338.97860763669
"healthy-3"	"2019-08-01-count-4:GGTGTCGAGCAAATCA"	-3.76389465752299	10.2411021956238	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGAGCAAATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.65150844204	46.3524771536427	0.0239467057739906	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.9722898911	1926.9722898911
"healthy-3"	"2019-08-01-count-3:GAAGGACTCCAATGCA"	3.6633583503658	-7.02759220516356	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGACTCCAATGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.3649168099	45.4108989822637	0.0178336179086047	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2542.82829884997	2542.82829884997
"healthy-3"	"2019-08-01-count-2:CTATCCGTCGCTTACC"	-3.83878932419475	10.8507632979187	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGTCGCTTACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.2067935998	41.0910704034094	0.0198775809612419	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2063.93173262592	2063.93173262592
"healthy-3"	"2019-08-01-count-2:CATAGACCAGCATCTA"	-0.443659017712432	8.35117051685182	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAGACCAGCATCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2217.14895402151	44.2791340338528	0.0199712039885902	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2213.0351953214	2213.0351953214
"healthy-3"	"2019-08-01-count-2:TCGCTCATCGGCTATA"	-3.90381322327312	11.9344100722107	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCATCGGCTATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1756.60876246457	50.5238842448984	0.0287621725022093	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1752.4442429604	1752.4442429604
"healthy-3"	"2019-08-01-count-3:ATCACAGTCGGCTATA"	10.6512657600338	7.48879287326661	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGTCGGCTATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2000.86294367135	42.0001011087025	0.0209909935318394	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1995.73189810084	1995.73189810084
"healthy-3"	"2019-08-01-count-2:CTATCTAAGCTGCGAA"	-0.0474712428754151	8.26208970630494	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTAAGCTGCGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1996.6795350246	46.0014551161271	0.0230389776171869	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1988.43688847459	1988.43688847459
"healthy-3"	"2019-08-01-count-3:GAAGTAAAGTGCACTT"	-3.22272477570232	10.3670720824036	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAAAGTGCACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.78263187776	45.4154268077645	0.0216080512413359	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2090.43409151369	2090.43409151369
"healthy-3"	"2019-08-01-count-2:CCTCTAGTCATAGAGA"	-2.39802036705669	9.51697728717653	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTAGTCATAGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.3972341317	40.7118844781168	0.0203620790221796	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1990.6075832825	1990.6075832825
"healthy-3"	"2019-08-01-count-3:TGATCAGCAGCTACCG"	-3.02063403549846	9.55533597553102	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGCAGCTACCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2128.47225404247	43.0609650249933	0.0202309261693266	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2125.38002415784	2125.38002415784
"healthy-3"	"2019-08-01-count-2:GCAGTTATCGGTAGGA"	-2.44928584519084	10.5007505186829	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTATCGGTAGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.32687399101	49.9755437260646	0.0244340131455605	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.31429011245	2037.31429011245
"healthy-3"	"2019-08-01-count-3:TTCCGGTGTCTAGGCC"	-1.8589303297108	8.6418361433777	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGGTGTCTAGGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.55601673587	49.5912862196728	0.0267980465174706	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1836.98882991029	1836.98882991029
"healthy-3"	"2019-08-01-count-2:TCAAGACAGTTGCGAG"	-5.0003322166508	8.82674787128297	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACAGTTGCGAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	3245.34524273276	40.8444641009637	0.0125855528598771	2748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	3237.02176365681	3237.02176365681
"healthy-3"	"2019-08-01-count-3:TTCCTAAAGTCACTCA"	-3.85258160057719	10.9843568571839	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAAAGTCACTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.2363870573	43.611059340677	0.0219566309553359	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.31202744553	1979.31202744553
"healthy-3"	"2019-08-01-count-4:ATACTTCGTCTACACA"	-2.20269380036052	9.08751866901246	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACTTCGTCTACACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2249.47417632722	49.239637786825	0.0218893990004455	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2243.85682717663	2243.85682717663
"healthy-3"	"2019-08-01-count-2:CCTCTCCTCCGCATAA"	-4.26734385910686	13.2647142180237	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCTCCGCATAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2575.46540126876	33.0073003257067	0.0128160527062201	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2566.19276894826	2566.19276894826
"healthy-3"	"2019-08-01-count-3:GTAATCGGTCATCGCG"	-3.76360521736797	12.6791467436585	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATCGGTCATCGCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1580.6712777073	41.4813122119155	0.0262428455536197	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1576.34409161483	1576.34409161483
"healthy-3"	"2019-08-01-count-4:CATGCTCTCTATACGG"	-2.26076350632365	8.90233800494996	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCTCTATACGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2137.64970585736	38.7250496878033	0.0181157135248554	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2126.43615795272	2126.43615795272
"healthy-3"	"2019-08-01-count-4:CCCAACTTCCTTGGAA"	10.3335262733394	7.36959359729616	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTTCCTTGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.27788025123	43.2485325257647	0.021104279191489	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2040.63519275285	2040.63519275285
"healthy-3"	"2019-08-01-count-4:GCATGATCAGCAGTTT"	-2.77635798874553	9.5702390440735	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATGATCAGCAGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1981.12351389187	47.0096619624279	0.0237287890597383	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.85777301845	1977.85777301845
"healthy-3"	"2019-08-01-count-3:AAGTCGTTCGTGCATA"	-1.95889101448711	9.2559489973816	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTCGTTCGTGCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.93315039389	41.9968649591555	0.0230887347069688	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1812.57068380722	1812.57068380722
"healthy-3"	"2019-08-01-count-4:ATAGAGACAATAGGAT"	10.735295911401	7.56477258289186	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGACAATAGGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2208.71484531961	42.7054518706051	0.0193349775146847	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2189.50279299989	2189.50279299989
"healthy-3"	"2019-08-01-count-3:GACACGCAGGGTCAAC"	-4.08876262131389	11.0226878889832	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACACGCAGGGTCAAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2540.12948561236	50.9599222939993	0.020061938803767	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2530.89110234178	2530.89110234178
"healthy-3"	"2019-08-01-count-2:CTCAATTAGAAATCCA"	0.330327292054337	7.88919017398683	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAATTAGAAATCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1937.75681024888	41.8951008651616	0.0216204121402524	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1929.20032770912	1929.20032770912
"healthy-3"	"2019-08-01-count-3:AATAGAGAGGATCACG"	-4.19398198548015	13.2613010176453	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATAGAGAGGATCACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2046.01181740569	39.4543165206003	0.0192835232841557	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2038.67032956856	2038.67032956856
"healthy-3"	"2019-08-01-count-4:AGAAATGCAAAGCTAA"	3.98794641074483	-7.40517570888671	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAATGCAAAGCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2727.77219537055	42.7606775261265	0.0156760442087862	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2723.16886635131	2723.16886635131
"healthy-3"	"2019-08-01-count-4:CTAACCCCACACGGTC"	3.26374568518941	-5.37342741405638	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACCCCACACGGTC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2876.3739352854	43.7727854979395	0.0152180441356962	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2866.13263133725	2866.13263133725
"healthy-3"	"2019-08-01-count-3:AATCACGGTGCTAGCC"	-2.47925816002544	8.8818731077942	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCACGGTGCTAGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.95304307532	42.7343282145221	0.0228165507792731	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1862.32334415338	1862.32334415338
"healthy-3"	"2019-08-01-count-2:GGTCACGTCCCACAGG"	11.128657956689	5.72032449329225	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCACGTCCCACAGG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.55794959706	45.7628035109782	0.0243865655845079	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1872.11339100692	1872.11339100692
"healthy-3"	"2019-08-01-count-3:GACAGCCAGCGCCTAC"	-4.19161305847819	12.2870416411194	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACAGCCAGCGCCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2137.33354570683	45.4178974058465	0.0212497939299533	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2126.15587552322	2126.15587552322
"healthy-3"	"2019-08-01-count-4:CTAACCCGTGCCGTAC"	4.17110027846639	-8.29382994091185	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACCCGTGCCGTAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.27498220594	43.4602226294563	0.0165798029296729	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2616.69935109189	2616.69935109189
"healthy-3"	"2019-08-01-count-2:GGTCTGGCACTTGTGA"	4.51379551467244	-8.16323378002318	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCTGGCACTTGTGA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.98407191616	49.3240494707038	0.0184183505749574	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2674.62855381934	2674.62855381934
"healthy-3"	"2019-08-01-count-4:GGGCGTTAGGCGATAC"	-3.98507533493693	10.2170629271301	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCGTTAGGCGATAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.33460990303	49.2513065899907	0.0263893228623937	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1859.37792333619	1859.37792333619
"healthy-3"	"2019-08-01-count-4:TGAGCGCCAGACAAGC"	2.59379138526265	-4.7218318215576	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCGCCAGACAAGC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2612.33128303081	41.9847413486722	0.0160717523161771	2441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2608.89808499979	2608.89808499979
"healthy-3"	"2019-08-01-count-3:TGCACGGTCTGGGCCA"	10.6701160865719	6.82139251315919	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCACGGTCTGGGCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.93926432329	40.3792054468629	0.0213879790573329	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1881.10857472964	1881.10857472964
"healthy-3"	"2019-08-01-count-3:GTACAACAGTTTCAGC"	-3.03249392929729	10.2405442961487	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAACAGTTTCAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.36649102221	48.8020183971922	0.0230049916427577	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2118.44008650798	2118.44008650798
"healthy-3"	"2019-08-01-count-2:CTCAGAAGTCTTCTAT"	10.7318273979122	6.7437124022278	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAGTCTTCTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.65638477214	50.8853871161314	0.0255108536510885	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1989.88196880821	1989.88196880821
"healthy-3"	"2019-08-01-count-3:AGAGAATTCTTCGACC"	3.95989813384358	-7.83540537273558	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATTCTTCGACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.03078694795	43.0791252199509	0.0185523488586358	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2315.07003671097	2315.07003671097
"healthy-3"	"2019-08-01-count-2:GACAGCCAGCCATTGT"	11.2849136787349	4.52788732135621	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACAGCCAGCCATTGT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2108.99638257813	46.0324906348752	0.021826728113494	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2098.42598649628	2098.42598649628
"healthy-3"	"2019-08-01-count-3:TCATTCAAGGTGAGAA"	-2.83094606819804	10.833900428656	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTCAAGGTGAGAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2477.1414866307	50.9467433937413	0.0205667474662647	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2466.65057952698	2466.65057952698
"healthy-3"	"2019-08-01-count-2:GGTGATTGTACTAACC"	3.71003403243367	-7.06215908443602	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGATTGTACTAACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.96436945469	45.4675333576831	0.0175960372732532	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2578.30817810349	2578.30817810349
"healthy-3"	"2019-08-01-count-4:TTCACCGGTTAGGCCC"	-3.68329797211345	10.2474336394104	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACCGGTTAGGCCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2239.43649832269	43.2011354321026	0.0192910741003193	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2232.74946543044	2232.74946543044
"healthy-3"	"2019-08-01-count-2:CAAAGAACACGGGCTT"	-2.3232184452122	9.38801381671754	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAAGAACACGGGCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2051.77105252411	45.5823231072176	0.0222160864640047	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.42627442785	2043.42627442785
"healthy-3"	"2019-08-01-count-2:CAACAACCAGCACAAG"	0.377645780413789	7.93921039188234	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAACCAGCACAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1992.8516023372	38.2913820604159	0.0192143669982793	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1985.36761530729	1985.36761530729
"healthy-3"	"2019-08-01-count-3:CAACCTCGTTGCGTAT"	-1.85579345646556	8.60823342883912	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCTCGTTGCGTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2079.17832453569	45.8626146786842	0.022058047709268	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2077.45024148407	2077.45024148407
"healthy-3"	"2019-08-01-count-2:AACAGGGGTGGACCAA"	-0.454525272280532	8.40638635242311	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGGTGGACCAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.99002412001	41.6351273425149	0.0218329025406033	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1905.21029427387	1905.21029427387
"healthy-3"	"2019-08-01-count-4:CATAAGCAGTTCGGTT"	-1.97387228432353	8.86944291675416	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCAGTTCGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.537591168	45.841688923856	0.0235020791864901	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1949.04667926867	1949.04667926867
"healthy-3"	"2019-08-01-count-4:GGACGTCCAAAGGGTC"	-3.42586503449138	12.4645957716736	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGACGTCCAAAGGGTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1812.69963404964	51.9272607905607	0.0286463680000603	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1799.44782006118	1799.44782006118
"healthy-3"	"2019-08-01-count-4:CATAAGCAGTCAACAA"	-3.2309595150059	9.84508226001588	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCAGTCAACAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1977.01075267244	47.0509330896186	0.0237990274084332	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1971.74081004905	1971.74081004905
"healthy-3"	"2019-08-01-count-3:AATGCCAGTGGCGTAA"	5.10335983809773	-8.7936697236267	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCAGTGGCGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2678.26671007306	43.663254379932	0.0163028029343429	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2675.58682810844	2675.58682810844
"healthy-3"	"2019-08-01-count-4:AAGTGAAAGTAGCATA"	-3.15234957161601	10.0841407545838	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAAAGTAGCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.77918875125	48.8319754962519	0.0241171856010473	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2018.43474424373	2018.43474424373
"healthy-3"	"2019-08-01-count-4:GCCATTCCAGGGAATC"	-2.92020521584209	9.32495400989381	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATTCCAGGGAATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.81977714488	36.4357887206323	0.0203118446930187	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1789.45217969177	1789.45217969177
"healthy-3"	"2019-08-01-count-3:CCTAACCGTAGCACGA"	4.66270317611043	-8.14682199871215	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAACCGTAGCACGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2781.10169061267	43.6828844168418	0.0157070432067583	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2777.6230432666	2777.6230432666
"healthy-3"	"2019-08-01-count-4:ATCAGGTTCTGTTGGA"	-1.67662523213084	9.10691926563112	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCAGGTTCTGTTGGA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2165.71845248775	45.4734723750725	0.0209969455276318	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2161.149181674	2161.149181674
"healthy-3"	"2019-08-01-count-2:CTCATCGCAAGACGGT"	4.75979771193807	-8.30551531231078	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGCAAGACGGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.46315161382	45.5258414865987	0.0175676206154997	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2586.83345942407	2586.83345942407
"healthy-3"	"2019-08-01-count-2:AAGTCGTAGGAAAGAC"	-1.49782679501231	8.84555909717409	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTAGGAAAGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.91058703919	47.7683070923407	0.0256417604927895	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1857.54101850441	1857.54101850441
"healthy-3"	"2019-08-01-count-3:GACCTTCGTCGACTGC"	-3.63763366165813	10.1718835600647	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCGTCGACTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2167.84030253703	46.4101329592464	0.0214084648693598	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2160.41248713917	2160.41248713917
"healthy-3"	"2019-08-01-count-4:ATCATTCTCTTCGGAA"	11.0030237632686	6.43115518176881	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCATTCTCTTCGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.05173539647	43.6716981209791	0.0225105842922556	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1933.4530502992	1933.4530502992
"healthy-3"	"2019-08-01-count-2:TCGTGCTTCAAGTGTC"	-3.53633127632793	10.2965230711731	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTTCAAGTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1592.63841351623	42.1388823680148	0.0264585369851657	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1592.63841351623	1592.63841351623
"healthy-3"	"2019-08-01-count-4:GTAGAAAGTGACCGTC"	-1.99269638481792	9.01554486835328	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAAAGTGACCGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.95159617822	44.3337321612433	0.0208046640950241	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2120.45405665734	2120.45405665734
"healthy-3"	"2019-08-01-count-3:GACCTTCCAGCTGTCG"	2.08065332946126	-5.92907144939574	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCCAGCTGTCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2528.93287006976	47.1862046372847	0.0186585437659257	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2523.94886947713	2523.94886947713
"healthy-3"	"2019-08-01-count-4:TAAGTCGAGCACAAAT"	-1.67633853378947	8.63119695270387	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGAGCACAAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.06018292935	44.8338739457561	0.0230857284134882	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1933.78052301602	1933.78052301602
"healthy-3"	"2019-08-01-count-4:TGATCTTTCTCGTGGG"	4.45408834990804	-8.33191778576048	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTTCTCGTGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.23363305372	47.4752755042132	0.0200721293832266	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2365.23363305372	2365.23363305372
"healthy-3"	"2019-08-01-count-4:TGATGCACACCTGATA"	4.23504795607869	-7.78626634990843	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCACACCTGATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.46939007169	50.0307781204856	0.0204585583134283	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2438.18822620265	2438.18822620265
"healthy-3"	"2019-08-01-count-2:TCTAACTAGCAAGGAA"	2.8371852832729	-5.9573636285034	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTAACTAGCAAGGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.17509069083	45.5780985370009	0.0174617015921863	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2607.4784626212	2607.4784626212
"healthy-3"	"2019-08-01-count-2:GTTGAACGTCGAACAG"	-7.21018872681316	3.37163279140321	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACGTCGAACAG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2732.39282162863	44.455457959643	0.0162697902028397	2855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2719.58689193671	2719.58689193671
"healthy-3"	"2019-08-01-count-2:AAGTTCGTCTAAACGC"	3.59015669402425	-7.1349234811035	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTTCGTCTAAACGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.03069675417	46.8251671694313	0.0191746840986353	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2441.12402847802	2441.12402847802
"healthy-3"	"2019-08-01-count-2:AATCACGAGAAGCGAA"	5.67991079863851	-10.0790376893249	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGAGAAGCGAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.4583220905	41.9180552122558	0.0161629955088182	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2584.02642273787	2584.02642273787
"healthy-3"	"2019-08-01-count-3:TACCTGCAGCTTCGTA"	3.27904691275899	-6.97761061107787	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCAGCTTCGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.67627299511	47.8885818869523	0.0221739630544438	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2156.80210331614	2156.80210331614
"healthy-3"	"2019-08-01-count-3:CTCATTATCTAGACAC"	10.6711250739986	7.25760028446046	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTATCTAGACAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2319.5596396041	45.4905982154469	0.0196117389864618	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2307.15195536929	2307.15195536929
"healthy-3"	"2019-08-01-count-3:TACCTGCGTGGTCTGC"	-1.6112245124882	9.66389176929323	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCGTGGTCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1987.08935330083	40.8174459114193	0.0205413238431457	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1980.04358192681	1980.04358192681
"healthy-3"	"2019-08-01-count-2:GGTTAACTCGCCTATC"	-0.980487088591415	8.54012582385866	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACTCGCCTATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.72827432473	43.7651145549831	0.0239581962846452	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1824.87223077985	1824.87223077985
"healthy-3"	"2019-08-01-count-3:GACGTTAGTACAAGTA"	1.09354939040486	10.2123346098694	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGTTAGTACAAGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2062.11769151523	36.8705972033581	0.0178799674504833	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2057.22472659172	2057.22472659172
"healthy-3"	"2019-08-01-count-2:AATAGAGCAGGAGGTT"	-4.12373576584514	10.9850167998108	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATAGAGCAGGAGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.03541096141	40.4606264589515	0.0197848048215117	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2039.67329418847	2039.67329418847
"healthy-3"	"2019-08-01-count-2:AATCACGCAGGTGTTT"	4.2243091064388	-7.63768675243529	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGCAGGTGTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2710.10184523244	41.2631859078389	0.0152256956617436	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2704.69256695639	2704.69256695639
"healthy-3"	"2019-08-01-count-3:TACCTGCTCACCTCGT"	-1.57785151425059	8.45729730213014	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCTCACCTCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2231.42870752643	43.3357930991223	0.0194206487318883	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2220.67607646661	2220.67607646661
"healthy-3"	"2019-08-01-count-4:ATCCTATGTCTAGGCC"	-4.1732362312382	9.84340474689332	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATGTCTAGGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2242.08281300732	47.0966759751619	0.0210057700375442	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2228.91289318904	2228.91289318904
"healthy-3"	"2019-08-01-count-2:GACGCTGCAGACAAAT"	11.1378113227779	5.48220679843751	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGCTGCAGACAAAT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1847.66834503212	35.0361122146467	0.0189623382945589	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1843.28140798242	1843.28140798242
"healthy-3"	"2019-08-01-count-4:AGAGCAGCATTGACCA"	-2.21904716911967	9.35160348499147	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGCATTGACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2020.48270939686	43.4073357735536	0.0214836462453624	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2013.8967583937	2013.8967583937
"healthy-3"	"2019-08-01-count-2:TCTATACAGGAACTAT"	-2.40412841263469	8.95156858051149	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACAGGAACTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.89881494774	46.3515768506838	0.0231538060288495	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.81017870851	1996.81017870851
"healthy-3"	"2019-08-01-count-3:GACTCAACAGGGTCTC"	-3.83630381050761	10.4490060576233	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCAACAGGGTCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2233.1003169283	45.5815180630594	0.020411764629436	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2233.1003169283	2233.1003169283
"healthy-3"	"2019-08-01-count-4:CCGGACACATGAATCC"	-3.14673934403117	9.8693227537903	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGACACATGAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.40923456971	42.3912940725841	0.0211384755499442	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.4536329032	1998.4536329032
"healthy-3"	"2019-08-01-count-4:GCGAGAAAGTACTCGT"	-2.45052133026775	8.80926129901735	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAAAGTACTCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2090.6668557066	46.5736769473291	0.0222769480561685	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2089.01442256275	2089.01442256275
"healthy-3"	"2019-08-01-count-3:TTTGACTAGTTACTCG"	-3.1123198074406	9.2543210753235	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGTTACTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.63869316948	46.4722466494687	0.0230672858647212	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2009.70430807067	2009.70430807067
"healthy-3"	"2019-08-01-count-4:CAAGACTTCGGTAGGA"	-3.79966531220134	13.3131456145081	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTTCGGTAGGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1860.70166228218	41.8475534205005	0.0224902004812388	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1854.63028785961	1854.63028785961
"healthy-3"	"2019-08-01-count-3:TATCTGTGTGACCTGC"	10.591063161462	6.61360499942628	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTGTGACCTGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2006.77634125048	40.9222312286556	0.020392023957765	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2003.62166510064	2003.62166510064
"healthy-3"	"2019-08-01-count-2:ATTATCCTCTGGCCAG"	10.7412182289058	6.33268306339113	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCTCTGGCCAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.17877677162	41.5948096191924	0.0197021730593553	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2103.64286984372	2103.64286984372
"healthy-3"	"2019-08-01-count-2:CAAGCTAAGCAGCCCT"	-3.91220102730449	13.0497865446839	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTAAGCAGCCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1906.37925037466	51.3794764098904	0.0269513405581774	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1904.58146842912	1904.58146842912
"healthy-3"	"2019-08-01-count-2:ATACCGATCCATTTAC"	-2.58288298073466	8.70938298786012	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGATCCATTTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.22220061036	46.1717556288622	0.0241329813202735	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.18912945364	1909.18912945364
"healthy-3"	"2019-08-01-count-2:AATCGTGCAGCCCAGT"	2.02235176142995	-6.14304640209349	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGCAGCCCAGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2595.42839921422	45.1005650119334	0.0173769251448384	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2592.04553801095	2592.04553801095
"healthy-3"	"2019-08-01-count-3:TTGCATTAGACGCAGT"	-3.45985494080241	9.91797826373903	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCATTAGACGCAGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2025.70423303028	51.9254610752652	0.0256332885268197	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2024.20617963287	2024.20617963287
"healthy-3"	"2019-08-01-count-3:GACTGATAGCAGTAAT"	4.77439798888509	-8.08612825786742	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATAGCAGTAAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2883.01083068276	42.7830934756329	0.014839726934186	2523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2875.63378486591	2875.63378486591
"healthy-3"	"2019-08-01-count-3:GCTGAATGTACTTCCC"	3.07901658591573	-5.08786060726317	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATGTACTTCCC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3018.12196629009	42.9761086935354	0.0142393545302485	3259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3011.84859902081	3011.84859902081
"healthy-3"	"2019-08-01-count-3:TTGCATTTCCGCTAGG"	-3.22678742829021	10.0649156340393	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCATTTCCGCTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2113.04060159079	40.7195967674119	0.0192706172975363	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2105.02490112903	2105.02490112903
"healthy-3"	"2019-08-01-count-2:AATGACCCATCCCACT"	2.56796516951863	-4.57454492962035	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGACCCATCCCACT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2975.06631571237	41.0141399771023	0.0137859582357853	2935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2970.6162430971	2970.6162430971
"healthy-3"	"2019-08-01-count-4:ATCGGATAGAGGCGGA"	-7.23345408859904	3.31286904895631	"2019-08-01-count-4"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATAGAGGCGGA"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2526.08951383012	41.8555059406992	0.0165692885036512	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2517.01020117162	2517.01020117162
"healthy-3"	"2019-08-01-count-2:CTCCCAATCTTCGATT"	6.74524511870686	-1.13339891349944	"2019-08-01-count-2"	"Control3"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAATCTTCGATT"	"pDC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1823.15869708265	31.6545907290382	0.017362498821244	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	1805.12573338525	1805.12573338525
"healthy-3"	"2019-08-01-count-4:AATGGCTAGTGCCGAA"	-3.59723148766215	3.50258324230043	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGCTAGTGCCGAA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3248.13327780724	43.0031515335074	0.0132393432952167	5541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3235.3990643684	3235.3990643684
"healthy-3"	"2019-08-01-count-2:CAAGGGAGTACATTGC"	-1.96989403191264	9.22128579700319	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGAGTACATTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.88849385362	45.9694819257183	0.0229401396668114	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.35342000999	2002.35342000999
"healthy-3"	"2019-08-01-count-2:CAATACGAGCTACGTT"	10.9861332374508	6.40818927371827	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGAGCTACGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1857.85873665367	45.2867948416965	0.0243758009951101	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1853.38067919285	1853.38067919285
"healthy-3"	"2019-08-01-count-2:AGACAAACATCGATCA"	-1.71963022175487	9.27221486652223	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAAACATCGATCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.71051148856	47.0186820370604	0.0236665995197414	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.88409229488	1976.88409229488
"healthy-3"	"2019-08-01-count-3:TACTTACGTGGAGGTT"	-2.33855615082439	8.77298448169557	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTACGTGGAGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.21856416833	45.5545406314693	0.0227520318943759	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.83653910746	1998.83653910746
"healthy-3"	"2019-08-01-count-2:ATAGACCAGTCCCTAA"	-3.45541511002238	12.3196954497131	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCAGTCCCTAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2136.78354001362	43.9627015917503	0.0205742419709346	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2133.26917979368	2133.26917979368
"healthy-3"	"2019-08-01-count-3:GAGAAATCACAATGCT"	10.4383474784786	7.82119081104127	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATCACAATGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2328.68900775516	46.000378014732	0.0197537661154144	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2321.01089524242	2321.01089524242
"healthy-3"	"2019-08-01-count-2:CAATACGCAAGAATAC"	-3.8089009327	9.92512128436891	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGCAAGAATAC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2079.14120199161	43.0730292633581	0.0207167407495453	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.66221926441	2072.66221926441
"healthy-3"	"2019-08-01-count-2:CTCCGATGTATCAAGA"	-3.52891908112224	10.886466003302	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATGTATCAAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.16000217346	43.3087102568611	0.0220046694420347	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.36134112051	1963.36134112051
"healthy-3"	"2019-08-01-count-2:TCTCCGATCGCATAGT"	5.45749773558919	-9.45073797619017	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCCGATCGCATAGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.90387896318	44.7476012926311	0.0177435792323012	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2512.63009714325	2512.63009714325
"healthy-3"	"2019-08-01-count-2:GCGGATCTCACATTGG"	4.84232773360555	-7.98130323803099	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCTCACATTGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.67067296684	45.45878634609	0.0173264071647701	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2622.72696480795	2622.72696480795
"healthy-3"	"2019-08-01-count-3:ATCTTCAAGTCCTACA"	-0.682396928698379	9.61523244464723	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTTCAAGTCCTACA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.14495046945	40.0333488239023	0.0202275981930512	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.24730752396	1974.24730752396
"healthy-3"	"2019-08-01-count-4:AGCATCAAGATACCAA"	10.7009407478267	7.27449557864992	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCAAGATACCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2091.94026608254	38.864050155502	0.0185779923000768	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2084.38827091978	2084.38827091978
"healthy-3"	"2019-08-01-count-3:ATCTTCAGTTGAATCC"	-4.30237517777141	12.6763953932556	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTTCAGTTGAATCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1978.17325437986	42.4190657323356	0.0214435543693738	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1972.64131152085	1972.64131152085
"healthy-3"	"2019-08-01-count-3:ATTCCCGTCTTGGTGA"	2.56417383727376	-4.31396629726561	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCCGTCTTGGTGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2724.63482261299	43.7517013767539	0.0160578221395537	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2720.04116762412	2720.04116762412
"healthy-3"	"2019-08-01-count-3:AAATGGAAGTCATTGC"	5.14941086348836	-8.1008510819641	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAATGGAAGTCATTGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.36148313678	47.2471079076891	0.0184532958407909	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2554.54115097487	2554.54115097487
"healthy-3"	"2019-08-01-count-2:CAATCGATCATTACCT"	3.86246933516805	-7.39671471035155	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATCGATCATTACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.05930123404	46.0427813180983	0.0182777679332689	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2515.99249824111	2515.99249824111
"healthy-3"	"2019-08-01-count-2:GTAGAGGGTCGACGCT"	-2.65035853806193	8.82658383930055	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGGTCGACGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2251.33367299183	45.1610634293563	0.0200596934924094	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2242.652248481	2242.652248481
"healthy-3"	"2019-08-01-count-4:CTCAACCTCACCGACG"	10.9802061515743	5.9162068136963	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCTCACCGACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1921.41206460593	41.7644474266626	0.021736330377018	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1915.30263823429	1915.30263823429
"healthy-3"	"2019-08-01-count-3:CAGGTATCAGTTGTTG"	-1.54682205143626	8.76250264728395	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATCAGTTGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.70047092342	44.3254618713978	0.0225839156448276	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1952.25803476041	1952.25803476041
"healthy-3"	"2019-08-01-count-3:GCTTTCGAGGTCCCTG"	4.39101423796956	-8.06101324474486	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTTCGAGGTCCCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.69011922357	51.3229015778556	0.0213605995909454	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2401.61937616	2401.61937616
"healthy-3"	"2019-08-01-count-3:CCTGCATAGTCAGAGC"	-3.97518382492717	10.7088918455872	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGCATAGTCAGAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.78646433423	44.8329090519776	0.0229349393757169	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1945.7428718117	1945.7428718117
"healthy-3"	"2019-08-01-count-3:TAGACCACATACACCA"	-2.41915522041972	8.88601110065309	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACCACATACACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.83569270164	50.6232434461733	0.0242816465697463	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.44699020145	2078.44699020145
"healthy-3"	"2019-08-01-count-3:TTGGGCGAGCACTAGG"	4.52270807799642	-8.23974134838256	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGAGCACTAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.44323547593	51.1654945344948	0.0210432609686155	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2427.35372614865	2427.35372614865
"healthy-3"	"2019-08-01-count-3:TAGACCATCAGGTAAA"	10.4053560691768	7.54991481387941	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACCATCAGGTAAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.39587466745	39.5712218855231	0.0202992231592127	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1944.05440314113	1944.05440314113
"healthy-3"	"2019-08-01-count-2:CAATTTCGTTCTGAGT"	9.98506512221639	7.46638391101686	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCGTTCTGAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.88764721804	42.6445699772634	0.0219830102214524	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1935.38764757538	1935.38764757538
"healthy-3"	"2019-08-01-count-4:CTCAAGATCGATCCAA"	-2.82981048050578	9.46472261035768	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAAGATCGATCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.52909490199	45.0700605688982	0.0247837995527519	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1814.67325712386	1814.67325712386
"healthy-3"	"2019-08-01-count-2:AATTTCCTCATGCCCT"	4.95027317580525	-8.47866632854613	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCTCATGCCCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2803.17743393495	41.8156386998973	0.0149172286397864	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2795.82521586845	2795.82521586845
"healthy-3"	"2019-08-01-count-4:TGCGACGAGTAAGACT"	10.6390816169674	6.68641088092653	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGACGAGTAAGACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1980.65233333357	42.4859773789884	0.0214504972245592	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1977.75467089966	1977.75467089966
"healthy-3"	"2019-08-01-count-4:ATGAAAGGTAGCGCCT"	4.34179224547688	-8.04394247448119	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGGTAGCGCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.67513612622	44.7324328606935	0.0181567903189659	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2462.61817704955	2462.61817704955
"healthy-3"	"2019-08-01-count-4:CCTCAACTCGCACGAC"	-3.01747808876689	9.62722108447877	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAACTCGCACGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.52209221386	49.6544392234106	0.0244902087203364	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2017.62912811082	2017.62912811082
"healthy-3"	"2019-08-01-count-3:GTCGAATGTGAACCGA"	-2.1833954853123	9.6249904402527	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGAATGTGAACCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1767.03013661487	42.9521027298255	0.0243075100077861	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1755.33499601227	1755.33499601227
"healthy-3"	"2019-08-01-count-3:TTGGTTTCACGTATAC"	-3.66535768929179	9.64211270892946	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGTTTCACGTATAC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2579.04298188397	47.1687847476591	0.0182892588758651	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2568.50232111578	2568.50232111578
"healthy-3"	"2019-08-01-count-3:CAGTTAGCATTGACAC"	-1.11431191387828	8.5007753142151	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTAGCATTGACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1970.89363186863	46.4723985331967	0.0235793539447055	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.7110262692	1967.7110262692
"healthy-3"	"2019-08-01-count-4:GTCATCCTCACAAGAA"	-3.40477238121684	9.72664258563844	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCTCACAAGAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2161.09072400917	41.0579230531464	0.0189987040326458	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2149.63634877159	2149.63634877159
"healthy-3"	"2019-08-01-count-2:ACAACCACATTCACAG"	-2.28444824639018	9.25572393024293	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCACATTCACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2044.21654509963	41.4420914889097	0.020272848093444	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.88312848407	2040.88312848407
"healthy-3"	"2019-08-01-count-4:TGCGGGTCACTTCCTG"	10.2173716026241	7.64824578845827	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGGTCACTTCCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.1805233183	39.270181612603	0.0194582105807041	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2009.00525295809	2009.00525295809
"healthy-3"	"2019-08-01-count-2:CTCTCGACAAATGATG"	4.63210119780843	-8.27910044109496	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGACAAATGATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.80733936907	36.1285448897761	0.0162243694149187	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2225.07908686779	2225.07908686779
"healthy-3"	"2019-08-01-count-3:GAGGCAACAAAGCAAT"	-4.00434623184856	13.0810870894226	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAACAAAGCAAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2035.94285521971	39.3880363531585	0.0193463368837569	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2030.53291671458	2030.53291671458
"healthy-3"	"2019-08-01-count-3:GTAATGCAGTCACACT"	-0.326332400471526	8.33323285663453	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCAGTCACACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.6016500655	41.5040038723147	0.0218948975228422	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1878.29008153267	1878.29008153267
"healthy-3"	"2019-08-01-count-2:CGCAGGTGTTGGTAGG"	10.8239790397579	6.30282495105592	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCAGGTGTTGGTAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.28974938279	42.0961256267343	0.0228374978165152	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1838.95786287724	1838.95786287724
"healthy-3"	"2019-08-01-count-2:TCTTCCTCAGGATCTT"	-2.61798582497295	11.6394805678162	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTCAGGATCTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2013.92413931917	43.5817811305886	0.0216402297781295	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2009.86346488104	2009.86346488104
"healthy-3"	"2019-08-01-count-2:ACACAGTAGCCGTTGC"	-4.23350177231486	10.2882537611756	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTAGCCGTTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2296.85928778728	45.1878399763822	0.0196737519867465	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2290.79930187012	2290.79930187012
"healthy-3"	"2019-08-01-count-4:CAGCGTGTCAGATGCT"	-3.1952317756718	9.41735932910768	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCGTGTCAGATGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.39671578914	43.570884864202	0.0221690025805846	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.9983554572	1961.9983554572
"healthy-3"	"2019-08-01-count-3:CATACAGAGGTTGACG"	3.01123919066731	-6.7069301835266	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGAGGTTGACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.41360888657	47.8304125987129	0.0200260174455339	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2384.30711909717	2384.30711909717
"healthy-3"	"2019-08-01-count-3:ATGCATGAGCTTCGTA"	-3.30309210243877	3.03318450534669	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCATGAGCTTCGTA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3182.90682765654	48.296870090828	0.0151738246533554	5124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3178.56393166267	3178.56393166267
"healthy-3"	"2019-08-01-count-2:CGCATAATCCGACGGT"	-4.30462441864665	13.1658286818298	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAATCCGACGGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2611.58961306958	45.9579411577454	0.0175976887516136	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2602.50656378853	2602.50656378853
"healthy-3"	"2019-08-01-count-3:CATACAGCAGCGTTGC"	4.36309971389119	-7.36290552532347	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGCAGCGTTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.7550916142	44.707232564659	0.0185295360975691	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2409.31823500958	2409.31823500958
"healthy-3"	"2019-08-01-count-2:CACAGGCCAAGTGACG"	-4.34536443176921	12.3727273710999	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCCAAGTGACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.25196467931	51.2983916455141	0.0246360154850014	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.97533741156	2075.97533741156
"healthy-3"	"2019-08-01-count-2:TCTTTGACAATTGAGA"	-0.617210606962997	8.3388347395691	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTTGACAATTGAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1857.87029979961	43.2518336791271	0.0232803300013958	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1854.20831745998	1854.20831745998
"healthy-3"	"2019-08-01-count-3:ACCAAACGTTCCCAAA"	10.636229177087	7.26403663242189	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAAACGTTCCCAAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.62452763551	45.802706736777	0.0222924948674138	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2048.09225408486	2048.09225408486
"healthy-3"	"2019-08-01-count-4:ATGATCGGTGAGGCAT"	-3.4894519847935	10.1973199614319	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGATCGGTGAGGCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.05384953817	39.4671410907128	0.0197330392378316	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.26979393202	1991.26979393202
"healthy-3"	"2019-08-01-count-4:ATGATCGTCGCCGTGA"	2.85291828688924	-4.98763515865477	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGATCGTCGCCGTGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2786.38961550626	40.2632363780166	0.0144499664203282	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2784.82106934451	2784.82106934451
"healthy-3"	"2019-08-01-count-4:AGCGCTGGTACTCGAT"	5.05841126021687	-7.63959791576537	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGGTACTCGAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.86955840205	43.5263037647543	0.0186738479671055	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2328.31132718133	2328.31132718133
"healthy-3"	"2019-08-01-count-4:TGAGCGCCAACGAGGT"	-3.94326982918437	13.2799291380676	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCGCCAACGAGGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2013.12879294283	42.7357799088255	0.0212285374182909	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2005.28222488196	2005.28222488196
"healthy-3"	"2019-08-01-count-3:TAGGGTTCAAGGCAAC"	-3.30714688721355	10.9693031080994	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTCAAGGCAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2046.96190554215	49.6347661474124	0.02424801654248	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.53282663528	2040.53282663528
"healthy-3"	"2019-08-01-count-4:ATGCCTCGTAAGATAC"	-2.32757816734965	8.70711228931276	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCCTCGTAAGATAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.9011100756	44.4400570539337	0.0222768220587383	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1983.35657852104	1983.35657852104
"healthy-3"	"2019-08-01-count-3:TGGGCTGGTCAGATTC"	-2.52651772919353	9.96542546832887	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCTGGTCAGATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1807.08866720977	48.637605791589	0.0269148972455721	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1803.01105571471	1803.01105571471
"healthy-3"	"2019-08-01-count-3:ATGGATCCACAAGTTC"	-1.09840915623363	9.12580964649049	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGATCCACAAGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2127.63703091889	41.3892483855621	0.0194531528564752	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2120.45979408787	2120.45979408787
"healthy-3"	"2019-08-01-count-3:TAGGGTTTCGAGCCTG"	-1.96461735191997	9.24369618976442	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTTCGAGCCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.71700243081	45.7832750118149	0.0234820104429178	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.93511217696	1947.93511217696
"healthy-3"	"2019-08-01-count-2:TCATGAGAGGACGGAG"	2.45211495932881	-6.11739971553954	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGAGGACGGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.50561009679	48.7219416004155	0.0199884428567452	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2434.32852178547	2434.32852178547
"healthy-3"	"2019-08-01-count-2:TGAATCGTCTTGGAAC"	-2.4904228252476	10.5235080488953	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGTCTTGGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.93073614335	45.715346688708	0.0233966055413717	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1952.34114350098	1952.34114350098
"healthy-3"	"2019-08-01-count-2:CCACCATGTCGACTTA"	-3.27342806282695	10.0882692106995	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATGTCGACTTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2038.21465379311	49.2595254261174	0.0241679772709149	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2038.21465379311	2038.21465379311
"healthy-3"	"2019-08-01-count-2:TGAATCGTCGAGCCAC"	1.34986164149587	-6.07882788097533	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGTCGAGCCAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2424.45921780048	48.6198492595863	0.0200538944530877	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2421.7470604567	2421.7470604567
"healthy-3"	"2019-08-01-count-2:GAGCTGCAGGGCAGGA"	-0.278048674494582	8.14629647815553	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCAGGGCAGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2020.08621733965	41.9154699282322	0.0207493470171945	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.19773595497	2016.19773595497
"healthy-3"	"2019-08-01-count-3:ACCACAACATTGAGGG"	-5.2036865753239	-4.28966715252074	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAACATTGAGGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3273.7591827827	44.9960143509831	0.0137444484577929	4270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3269.70649383827	3269.70649383827
"healthy-3"	"2019-08-01-count-2:CTCAGGGTCCGAGAAG"	-4.30825887146648	10.7889680632385	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGGGTCCGAGAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.52623420171	45.5149602525478	0.0230394106970388	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.42830721368	1970.42830721368
"healthy-3"	"2019-08-01-count-4:CTCAGTCGTTTACACG"	-1.83413098278697	8.89411161029664	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTTTACACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.77126620267	40.2136026111741	0.0224184673758903	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1788.01358644189	1788.01358644189
"healthy-3"	"2019-08-01-count-4:TCTCCGAAGCACCCAC"	4.17098631438558	-7.24089434063109	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGAAGCACCCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2600.04588400822	45.4060667071962	0.0174635636188076	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2595.5343892419	2595.5343892419
"healthy-3"	"2019-08-01-count-2:TCCTCGATCAACTCTT"	-2.74818621102031	10.0458955534729	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCGATCAACTCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.10218299424	49.3994400181292	0.0238748189548775	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2062.95724106756	2062.95724106756
"healthy-3"	"2019-08-01-count-2:AGGCATTGTGTACGCC"	-3.98049960556682	9.94854161823121	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTGTGTACGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2430.83241342963	39.6800562813194	0.0163236494881749	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2415.57219976525	2415.57219976525
"healthy-3"	"2019-08-01-count-2:GGAACCCTCGAATGCT"	4.6695782142574	-8.00926973735961	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAACCCTCGAATGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2762.84920660461	46.4175482628807	0.0168006086441197	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2756.55506130696	2756.55506130696
"healthy-3"	"2019-08-01-count-1:TCTTCCTCAGAGGGTT"	-2.32395325127299	8.53937814319459	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCTTCCTCAGAGGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2208.35338486937	54.1820135579668	0.0245350286458668	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2200.11612893088	2200.11612893088
"healthy-3"	"2019-08-01-count-4:ATGGGAGGTTCGGCCA"	0.332742829888505	7.68627259815065	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGGAGGTTCGGCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.48116784347	44.3571469219155	0.0235506187580856	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1872.20328188552	1872.20328188552
"healthy-3"	"2019-08-01-count-2:GAGGCCTCAAGCCTGC"	-0.542496840388137	8.2156715163025	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTCAAGCCTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2096.82600166332	39.4332738277731	0.0188061736150221	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2090.36533158877	2090.36533158877
"healthy-3"	"2019-08-01-count-2:CACGAATTCGCAACAT"	-1.4427492422169	8.73227593982545	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCGCAACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.23828258329	43.4840186116309	0.0224232467985859	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.14751613343	1936.14751613343
"healthy-3"	"2019-08-01-count-1:TGAACGTGTTTCGGCG"	9.94438995894734	6.97975490177003	"2019-08-01-count-1"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGAACGTGTTTCGGCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2175.65829889671	44.8051073015281	0.0205938162827541	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2163.06532488726	2163.06532488726
"healthy-3"	"2019-08-01-count-2:ACAGGGAAGAGGGTGG"	-3.44524727287944	9.66958615863649	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGGGAAGAGGGTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.60638526757	44.7802994437222	0.0218482435289038	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2046.16488275196	2046.16488275196
"healthy-3"	"2019-08-01-count-3:TAGTGCATCCTATTTG"	3.26275863227193	-6.55128195202025	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCATCCTATTTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2783.25546546938	41.1492901691648	0.0147845897294322	2581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2776.84134669196	2776.84134669196
"healthy-3"	"2019-08-01-count-3:TATACCTAGGCCACTC"	-2.81986842575725	9.10823247516481	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTAGGCCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2655.17321513221	46.6853707625474	0.0175827966689634	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2648.49520103646	2648.49520103646
"healthy-3"	"2019-08-01-count-3:ACCCTCAAGATGCTGG"	2.83284678038899	-7.18021776592406	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCAAGATGCTGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.51409285449	46.3833248765387	0.0227089374995284	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2035.05248144314	2035.05248144314
"healthy-3"	"2019-08-01-count-3:TTTCACAGTCAAATCC"	-4.11069570007976	11.2778911360535	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCACAGTCAAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.17042816083	51.6263241412487	0.0252430425505785	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.15025204392	2040.15025204392
"healthy-3"	"2019-08-01-count-2:ATCGCCTGTTAGAAGT"	-2.87930832329448	9.21205327594606	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTGTTAGAAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.85371253466	44.4557418400763	0.0226600696861545	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1956.59197958107	1956.59197958107
"healthy-3"	"2019-08-01-count-3:GAGTGTTTCAGCTCTC"	-3.44849024239238	12.8077134856018	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTTCAGCTCTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2032.87156526636	45.3273980185438	0.022297226638912	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2027.93806819376	2027.93806819376
"healthy-3"	"2019-08-01-count-3:TATACCTCACGGCTAC"	-3.97205863419231	11.225860572699	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTCACGGCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.84887440888	38.1512736464368	0.0193479703954867	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1956.60067160324	1956.60067160324
"healthy-3"	"2019-08-01-count-2:GGAATCTGTAATCAAG"	-3.39441237869914	9.99104116046754	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTGTAATCAAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1962.23009890213	50.000553286661	0.0254814933858351	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.6703708042	1958.6703708042
"healthy-3"	"2019-08-01-count-3:TTTCACAGTGCCTGAC"	-1.7276693386143	9.09409902179567	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCACAGTGCCTGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.00393522044	53.6667646242797	0.0261151639198797	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.70644304009	2051.70644304009
"healthy-3"	"2019-08-01-count-2:TGACGCGCAGAGCTAG"	-1.45434747162517	9.01638028705446	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGCAGAGCTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2036.31270628116	48.7033977632524	0.0239174452985649	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.66072619455	2031.66072619455
"healthy-3"	"2019-08-01-count-2:ACATCCCCATGCGTGC"	-0.545170466334182	8.2455262907776	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCCATGCGTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2113.65833652714	42.521237028557	0.0201173653725047	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2113.65833652714	2113.65833652714
"healthy-3"	"2019-08-01-count-2:GTCATCCCATGCCATA"	10.2454019981319	7.56294868076173	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCCATGCCATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.42218593534	42.4841707679507	0.0216598808112754	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1950.79011975361	1950.79011975361
"healthy-3"	"2019-08-01-count-4:ATGTCTTTCGGTAGAG"	4.63140358504598	-7.95692541515502	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCTTTCGGTAGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.05218067957	47.4026726231454	0.0184370713979893	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2563.06742254919	2563.06742254919
"healthy-3"	"2019-08-01-count-3:TATATCCTCGAGGCAA"	5.54195751723592	-9.48379614269408	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCTCGAGGCAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2848.65772939612	46.3717250804672	0.0162784474252361	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2837.35839088501	2837.35839088501
"healthy-3"	"2019-08-01-count-4:GTCTTTAGTGGTAATA"	-3.01467857781108	10.1174211272034	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTTTAGTGGTAATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.02462230996	46.0380657056458	0.0250748629110017	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1825.59384919724	1825.59384919724
"healthy-3"	"2019-08-01-count-4:CTCCACACACCACTGG"	-2.62431106987651	9.93222711170045	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACACACCACTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.87466234976	46.0173371271815	0.0225257760425945	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2028.51800213997	2028.51800213997
"healthy-3"	"2019-08-01-count-4:TGGGAAGGTGACGCCT"	4.38498606261556	-7.7218637696472	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAAGGTGACGCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.44126932194	43.9307569381025	0.01709739680086	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2563.7918398086	2563.7918398086
"healthy-3"	"2019-08-01-count-4:TTGCCTGTCTGAATCG"	-2.06679258766826	9.18108747089235	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCCTGTCTGAATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.5480156214	43.7521172497706	0.0251948790682384	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1728.35303198337	1728.35303198337
"healthy-3"	"2019-08-01-count-2:GAGGGTATCGCGGTAC"	-2.38472805443462	8.82511994922487	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTATCGCGGTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.76093572281	42.8923755914066	0.0217643727424885	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.13306663377	1964.13306663377
"healthy-3"	"2019-08-01-count-3:AGGGTTTGTAACGTTC"	-2.80844698372539	3.87512538516847	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTTTGTAACGTTC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3509.9593064614	35.5227607316917	0.0101205619866586	4530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3501.9169045535	3501.9169045535
"healthy-3"	"2019-08-01-count-4:GAGAGGTTCATCGTAG"	5.61929955062215	-10.1427240601745	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAGGTTCATCGTAG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.69016860652	44.4742256441768	0.017906511128612	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2477.30978699618	2477.30978699618
"healthy-3"	"2019-08-01-count-4:ACCAAACTCCGTCACT"	0.465159555047196	8.26124379718629	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACTCCGTCACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1914.89113401998	39.0742231020789	0.0204054540792872	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.33217206943	1908.33217206943
"healthy-3"	"2019-08-01-count-3:GTGCTGGCATGGCTAT"	-0.0793497067993462	8.06700608814088	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGCATGGCTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.80816642578	39.7134801321668	0.020981249360921	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1883.73350491328	1883.73350491328
"healthy-3"	"2019-08-01-count-2:TTACGTTGTCAAATCC"	2.28198923644368	-6.82532980358275	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTGTCAAATCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1927.59924363982	50.654840658292	0.0262787199286519	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1922.26057241753	1922.26057241753
"healthy-3"	"2019-08-01-count-4:CATCCACCAACCAACT"	4.28936161574666	-7.96700670635375	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACCAACCAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.40283954698	43.2977939192525	0.0163857657398959	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2633.27177283526	2633.27177283526
"healthy-3"	"2019-08-01-count-2:CTGGACGCAGATCACT"	-3.92707453194316	10.7776107558045	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGACGCAGATCACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2095.0400098974	46.4808730695074	0.0221861505507877	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2091.60961512327	2091.60961512327
"healthy-3"	"2019-08-01-count-2:TCATTTGCACGAGAAC"	1.70706393298451	-6.11544992839965	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTTGCACGAGAAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2615.71297832473	46.5683890293002	0.0178033252941711	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2614.53707093389	2614.53707093389
"healthy-3"	"2019-08-01-count-3:GATCACATCGTTATCT"	4.78919949111287	-8.3194675675598	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCACATCGTTATCT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.03060031253	44.7064290004362	0.0166007876016143	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2687.25847715878	2687.25847715878
"healthy-3"	"2019-08-01-count-2:TGAGCATGTGATGAAT"	4.56282009658162	-8.49347498333129	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCATGTGATGAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.59711311117	49.3775336073137	0.0209974460897289	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2349.0126604555	2349.0126604555
"healthy-3"	"2019-08-01-count-2:TTGGTTTTCTGTAAGC"	4.03762616690938	-7.40573980724486	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTTCTGTAAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.02206353935	46.9533292240792	0.0172241192953211	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2719.29084237695	2719.29084237695
"healthy-3"	"2019-08-01-count-3:ACAAGCTAGGGTTTCT"	-4.00685153427775	10.7587737807068	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTAGGGTTTCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1970.95914775113	52.3981180731011	0.0265850858110822	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1967.68515647189	1967.68515647189
"healthy-3"	"2019-08-01-count-2:ACCAAACGTACTCGCG"	2.57342638549153	-4.72623016750487	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACGTACTCGCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2631.99826537036	49.5128456138386	0.018811883831873	2503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2629.30350920828	2629.30350920828
"healthy-3"	"2019-08-01-count-3:CATGCGGTCGCAGAGA"	5.42721142348592	-9.53898146068724	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCGGTCGCAGAGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.75139824989	45.1166639075423	0.0175568204528534	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2560.31818276275	2560.31818276275
"healthy-3"	"2019-08-01-count-2:CACTAAGCACGGGCTT"	9.70251621779744	7.65284345233766	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGCACGGGCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2075.55306457824	44.3201425238229	0.0213534133529026	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2067.05994005397	2067.05994005397
"healthy-3"	"2019-08-01-count-4:CTCCTCCGTCTCGCGA"	1.39790274676625	-6.01380875026854	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTCCGTCTCGCGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2906.82303266358	45.2135308036238	0.0155542770562795	2867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2902.98499553019	2902.98499553019
"healthy-3"	"2019-08-01-count-3:TATCTGTTCTCTTAAC"	-1.30094609680827	8.5069541701111	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTTCTCTTAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2012.10034629467	43.8694908800441	0.021802834516097	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.81275012921	2004.81275012921
"healthy-3"	"2019-08-01-count-2:CCCGAAGCATAGAAAC"	5.43447126921956	-9.62821485912474	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGCATAGAAAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2828.38741062078	43.6294496132317	0.0154255564316968	2704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2822.03992183564	2822.03992183564
"healthy-3"	"2019-08-01-count-2:ACCAACAAGTATGCAA"	-4.4188645881718	12.9004859694275	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAACAAGTATGCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2252.09030210996	37.7605823260959	0.0167669041915053	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2248.73104285293	2248.73104285293
"healthy-3"	"2019-08-01-count-4:AGGCATTAGTTAACGA"	-3.3460262817448	9.92634103381959	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTAGTTAACGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2091.34102175908	40.7579191743695	0.0194888919359919	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2088.10384726447	2088.10384726447
"healthy-3"	"2019-08-01-count-4:CTCCTTTCAGGCAATG"	5.37025847014729	-9.46720793163451	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTTTCAGGCAATG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2816.6756974472	43.8376462333717	0.015563611484667	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2808.4615159282	2808.4615159282
"healthy-3"	"2019-08-01-count-2:TGAGGAGTCAGGGATG"	5.56338753279988	-9.86110308086547	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGAGTCAGGGATG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.19461984357	48.2374562116977	0.019316658713096	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2490.79041569836	2490.79041569836
"healthy-3"	"2019-08-01-count-2:TGAGGGAAGGGTACGT"	11.2995315986568	6.09390256488649	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGGAAGGGTACGT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.67431877906	40.8485653170317	0.0196891458805308	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2069.97357460007	2069.97357460007
"healthy-3"	"2019-08-01-count-2:ACCAACATCCGTCAAA"	2.90778030928914	-6.53637840664061	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAACATCCGTCAAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.52294436165	51.2875567493719	0.0227285775566889	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2256.52294436165	2256.52294436165
"healthy-3"	"2019-08-01-count-3:ACGCACGGTCCCGCAA"	-2.7056761783665	8.87862012470094	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGCACGGTCCCGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.11275759728	46.7415439086868	0.0236293627495035	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.12479850964	1973.12479850964
"healthy-3"	"2019-08-01-count-3:AAAGGTAGTCGTATGT"	-3.09763441506084	3.83800432765809	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGTAGTCGTATGT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3242.19187072091	48.0041186180965	0.0148060696381373	4787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3235.68020370472	3235.68020370472
"healthy-3"	"2019-08-01-count-3:TTTGGTTGTACTCGAT"	-3.75616202774699	11.6130075224671	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTGTACTCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1927.98720855116	43.0598548505572	0.0223340977883954	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1922.28021956297	1922.28021956297
"healthy-3"	"2019-08-01-count-2:ACCACAAGTACGTTCA"	-1.38911650601085	8.67580792987672	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAAGTACGTTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.06573273859	49.1477858889953	0.0238805715032222	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.38565794273	2052.38565794273
"healthy-3"	"2019-08-01-count-2:ATGAAAGAGCCGATAG"	-2.89854560318645	10.6153507002625	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGAGCCGATAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1933.66401565019	45.4304640456492	0.0234944973262966	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1928.37091812013	1928.37091812013
"healthy-3"	"2019-08-01-count-3:CTGTAGATCCTTGAAG"	0.023979657411021	7.96789548480836	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGATCCTTGAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.4183888239	37.9837808650779	0.0204939052585859	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1843.41820666168	1843.41820666168
"healthy-3"	"2019-08-01-count-4:AGGCCACCAGTGTATC"	11.2168041664058	6.44670627200929	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACCAGTGTATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.86777027831	42.620745403223	0.0233427338479864	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1821.20862215792	1821.20862215792
"healthy-3"	"2019-08-01-count-4:GGCTTTCGTTTGACAC"	3.8755587535793	-7.06329777156981	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTTCGTTTGACAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.45641054296	48.322993590598	0.0185468439982566	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2597.54433913238	2597.54433913238
"healthy-3"	"2019-08-01-count-3:TGTGATGCAAGTACCT"	-2.62079534950908	8.90047929370729	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGATGCAAGTACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2264.92412311811	38.0630833215188	0.0168054562768829	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2253.77039748177	2253.77039748177
"healthy-3"	"2019-08-01-count-2:CGTAGTAGTGAGAACC"	-0.534850339323837	8.57349107349244	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTAGTGAGAACC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.12423828956	35.8813314975	0.0189535006587411	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1885.22338456971	1885.22338456971
"healthy-3"	"2019-08-01-count-2:GTCGTAAAGGGACCAT"	-2.47948370400127	9.59065911853639	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTAAAGGGACCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.99578494943	47.4163672925683	0.0271883497091956	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1742.09117663741	1742.09117663741
"healthy-3"	"2019-08-01-count-4:GTGCGTGAGGCGATAC"	9.90440525588338	7.27136132800905	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGAGGCGATAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.4246965947	47.0349097562215	0.0246201328113379	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1908.74578355045	1908.74578355045
"healthy-3"	"2019-08-01-count-3:CTCCGATCATCGATCA"	0.507568021386307	8.04805514896242	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCGATCATCGATCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1878.76250404463	39.0649049317043	0.0207928915164129	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1871.29112105217	1871.29112105217
"healthy-3"	"2019-08-01-count-2:TGTGCGGTCGTGCACG"	-2.54161320152934	3.89219758594362	"2019-08-01-count-2"	"Control3"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGTCGTGCACG"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3530.79228003393	36.1811421788056	0.0102473154207922	5430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3526.67383426225	3526.67383426225
"healthy-3"	"2019-08-01-count-2:ACCATTTTCGTTCAGA"	-2.20783458176311	9.46219155872194	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCATTTTCGTTCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.83734580953	41.6191612606955	0.0205848216954522	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2014.47909013405	2014.47909013405
"healthy-3"	"2019-08-01-count-3:CATTCCGTCACCTCTG"	5.06975473937337	-8.60910131847533	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGTCACCTCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2918.28682026788	44.0180353529838	0.0150835192234268	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2915.1500575201	2915.1500575201
"healthy-3"	"2019-08-01-count-4:GTGCGTGTCTGTGCAA"	5.08703913268392	-8.6080999604431	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGTCTGTGCAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.92626916595	43.1288340718134	0.0161899503642481	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2659.40370427727	2659.40370427727
"healthy-3"	"2019-08-01-count-3:GATGCTACAAAGCAAT"	-3.0607319873875	9.52358148181764	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGCTACAAAGCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2193.69040634233	44.8970669075472	0.0204664554203921	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2184.9538730082	2184.9538730082
"healthy-3"	"2019-08-01-count-3:GTGTGATTCCATAAGC"	4.62448134002034	-8.15611936962279	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATTCCATAAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.46867212075	43.271523400088	0.0159822803660341	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2701.94954595359	2701.94954595359
"healthy-3"	"2019-08-01-count-4:GAGTGTTAGACCATTC"	10.6695314842159	6.48774240100709	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGTTAGACCATTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.4477735347	44.5974166069241	0.0229122081842125	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1940.28996380189	1940.28996380189
"healthy-3"	"2019-08-01-count-2:AGCTCAACAGCATACT"	0.66248514231984	7.98104474628297	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTCAACAGCATACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1900.61535824402	43.8025017390357	0.0230464841552711	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1894.3015997844	1894.3015997844
"healthy-3"	"2019-08-01-count-4:GAGTGTTCATTATGCG"	1.81776215609853	-5.97963430797728	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGTTCATTATGCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2771.34430009023	37.3698415247578	0.0134843734585923	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2768.58135658465	2768.58135658465
"healthy-3"	"2019-08-01-count-3:TGTTACTTCCTCTCGA"	9.61950840529744	6.53602788532106	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTTCCTCTCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1541.5871164466	40.6220416516688	0.0263507921273393	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1541.5871164466	1541.5871164466
"healthy-3"	"2019-08-01-count-2:ACCCTTGCACGCGCAT"	-3.51104078713115	10.6283826597962	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGCACGCGCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.09964838243	48.5828304532931	0.0250801916637908	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1933.27560594153	1933.27560594153
"healthy-3"	"2019-08-01-count-4:ATTCCTAAGCGGTAAC"	3.1666075187618	-6.81860783016356	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCTAAGCGGTAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.40705470218	45.2032566692316	0.0179420219471344	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2510.13225301014	2510.13225301014
"healthy-3"	"2019-08-01-count-4:AAAGGATTCGTCCTCA"	4.58220161971394	-8.14316370403441	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGATTCGTCCTCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.63833790487	43.3913077432498	0.0159313764751263	2480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2717.2455470826	2717.2455470826
"healthy-3"	"2019-08-01-count-2:ACCCTTGCACAGCCAC"	-0.964476446539718	8.7161245116028	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGCACAGCCAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2033.87724542526	43.0269821680725	0.0211551519467814	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2026.3418259343	2026.3418259343
"healthy-3"	"2019-08-01-count-4:CTGATCCCAGACCAGA"	2.57878460463826	-4.41122772609862	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCCAGACCAGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2730.7707270697	39.4285676628876	0.0144386225002482	2483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2723.55421458127	2723.55421458127
"healthy-3"	"2019-08-01-count-3:GTGTTAGTCTAGACAC"	-2.45344863358195	9.78350637042848	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGTCTAGACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1619.90235772399	43.3476887877824	0.0267594454573714	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1617.65942642598	1617.65942642598
"healthy-3"	"2019-08-01-count-2:AGGAAATAGGCACGAT"	2.88473548468892	-6.45050814067992	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATAGGCACGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.62270213134	45.8267879422116	0.0187153324611108	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2442.46225358628	2442.46225358628
"healthy-3"	"2019-08-01-count-2:TTCAATCGTTTACCAG"	-3.23856578293498	9.84969232166139	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCGTTTACCAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1914.42922698612	47.2944431677839	0.0247042003439529	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1914.42922698612	1914.42922698612
"healthy-3"	"2019-08-01-count-2:CTTACCGTCCAGGACC"	-2.08208928528484	8.87489411914674	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTACCGTCCAGGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2196.76810159296	40.2950134839434	0.0183428617043027	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2191.40247420836	2191.40247420836
"healthy-3"	"2019-08-01-count-3:GGGCCATCACGAGGAT"	3.71097626265828	-6.91515495693358	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCCATCACGAGGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.91842741345	44.1174555589325	0.018398230337852	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2396.81618853095	2396.81618853095
"healthy-3"	"2019-08-01-count-2:CGTGCTTGTAGCACAG"	-2.21542940560039	9.54071710193483	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTGTAGCACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.79717211078	41.2026775828118	0.0229311790013612	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1789.80113651965	1789.80113651965
"healthy-3"	"2019-08-01-count-3:ATTGGGTGTGACTCGC"	-3.71281848374065	9.73786065662233	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGGGTGTGACTCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2108.68543854443	45.1498891532014	0.0214113913473824	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.68543854443	2108.68543854443
"healthy-3"	"2019-08-01-count-4:ATTCTACTCACATTGG"	-1.31106410446818	8.78656957233278	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTACTCACATTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2143.69114572897	43.8544526731528	0.0204574491808334	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2140.82938399212	2140.82938399212
"healthy-3"	"2019-08-01-count-4:CTGCAGGCAGTACTAC"	-1.43487654152568	8.64939496600953	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGCAGTACTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1828.73816356049	39.4925688730974	0.0215955294530556	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1823.67980008932	1823.67980008932
"healthy-3"	"2019-08-01-count-3:CTTAGGACAACCCTAA"	0.0590039185131013	8.65212247455446	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGACAACCCTAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2223.38784534461	35.9766622392306	0.016181010575622	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2218.16592225868	2218.16592225868
"healthy-3"	"2019-08-01-count-3:ACATGCAGTGAGATTA"	10.6932245689327	6.5020451315674	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATGCAGTGAGATTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.98340093008	44.2961481148397	0.0230951676085201	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1908.37740815366	1908.37740815366
"healthy-3"	"2019-08-01-count-2:AGGAATACAGGCGAAT"	0.00815650176946518	7.83997581088869	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAATACAGGCGAAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.14143905711	39.546900971179	0.0211013428053089	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.60397461606	1867.60397461606
"healthy-3"	"2019-08-01-count-3:GGGCTACAGGACTGGT"	5.44568457183186	-10.0827236405578	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTACAGGACTGGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.29977999717	41.3987661104413	0.0169160993061868	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2434.85161052756	2434.85161052756
"healthy-3"	"2019-08-01-count-4:GGGAGTACACCAGTTA"	2.69121255454366	-6.65041639721068	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGTACACCAGTTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.42203923223	43.9318819040503	0.0182864963718407	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2392.06578667401	2392.06578667401
"healthy-3"	"2019-08-01-count-4:GTGGGAACATAACGGG"	-3.91143784943278	13.1971711882385	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAACATAACGGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2052.44834131284	39.1843281177217	0.0190915051692154	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2048.88853109559	2048.88853109559
"healthy-3"	"2019-08-01-count-2:GTCTTTAGTCGTGATT"	0.0325227334046781	8.67021844470827	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTTTAGTCGTGATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1936.63374417853	39.0711896929785	0.0201747954720016	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1929.56528984891	1929.56528984891
"healthy-3"	"2019-08-01-count-3:ACTATCTCAGTTCTAG"	-3.95442424240764	10.0887126692566	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATCTCAGTTCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2271.90309442112	41.1549180397557	0.0181147330362882	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2265.46498752073	2265.46498752073
"healthy-3"	"2019-08-01-count-4:AAAGTGATCCATAGAC"	4.62744249877278	-8.23594858562621	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGATCCATAGAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.10471000138	43.61115280824	0.0153392707116365	2958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2836.37327269541	2836.37327269541
"healthy-3"	"2019-08-01-count-2:ATGCCTCTCCGTAATG"	-3.31713614884074	9.80864904010621	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCTCCGTAATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2046.20247429846	47.8883582064107	0.0234035286380098	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2038.68434068663	2038.68434068663
"healthy-3"	"2019-08-01-count-3:CTTCAATAGCAGTACG"	-2.35242805901225	8.84040544116823	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCAATAGCAGTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.33802250797	42.3301887373724	0.0210040143462857	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2013.76113858403	2013.76113858403
"healthy-3"	"2019-08-01-count-2:TGCAGTACAGCTACCG"	-2.81314812126811	9.41087625110475	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTACAGCTACCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.55830347069	46.9307749544238	0.0248106415056378	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1883.24603492796	1883.24603492796
"healthy-3"	"2019-08-01-count-4:CTGCCTACAGCGTAGA"	1.53193404254262	-6.53509809887084	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCCTACAGCGTAGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2193.09198003341	46.8150975730728	0.0213466183813957	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2186.96954042548	2186.96954042548
"healthy-3"	"2019-08-01-count-3:GTTACGAGTCGTTCAA"	-1.93728301945384	9.21295449817506	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGAGTCGTTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.48013655458	47.118117594484	0.0245217822958981	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1916.18876119889	1916.18876119889
"healthy-3"	"2019-08-01-count-2:GGCTTTCAGCATGGGT"	-4.01748547974284	12.7262773283753	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCAGCATGGGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.0457044985	44.2861180607355	0.0223436411986982	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1974.71001024876	1974.71001024876
"healthy-3"	"2019-08-01-count-4:AAATGGAGTCGCTGCA"	4.49952425536458	-8.11956598674925	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAGTCGCTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.95954540326	46.9140092751891	0.0198119977878253	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2363.42129786898	2363.42129786898
"healthy-3"	"2019-08-01-count-2:AACAACCCATAGAAAC"	-2.98614035072978	9.89263913715211	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCCATAGAAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.49302823658	46.1008865065917	0.0234551259375124	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1955.85644695251	1955.85644695251
"healthy-3"	"2019-08-01-count-4:ATTTACCTCCATATGG"	10.4326282936031	7.81961772525636	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTACCTCCATATGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2138.79996612434	45.7284335850781	0.0213804162658285	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2128.77886805407	2128.77886805407
"healthy-3"	"2019-08-01-count-4:GGGCGTTCACTCCCTA"	-1.78600202027019	8.59617993915407	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCGTTCACTCCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2117.46199141673	38.5085057988479	0.0181861615249505	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.26852043689	2111.26852043689
"healthy-3"	"2019-08-01-count-4:GGGCGTTCAGCGGTCT"	3.88008846816365	-7.71118309414061	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCGTTCAGCGGTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.09677285498	47.5802767809431	0.0222848338238648	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2130.35830583551	2130.35830583551
"healthy-3"	"2019-08-01-count-3:CCACGAGAGCGGTAGT"	-3.93914733353313	13.0017356642517	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGAGAGCGGTAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2146.69266341145	42.8386512902016	0.0199556517895412	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2141.81327524074	2141.81327524074
"healthy-3"	"2019-08-01-count-2:CAGCCAGAGGTTGACG"	-3.50916777077373	10.4961261519226	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGAGGTTGACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1972.66374974789	44.7702201669796	0.0226953124538844	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1967.5987305694	1967.5987305694
"healthy-3"	"2019-08-01-count-4:AACAAAGTCTCCAAGA"	-1.40681443634685	8.55627343738405	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAAGTCTCCAAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.07203255967	48.3739366133206	0.0245419425643725	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.72738776534	1960.72738776534
"healthy-3"	"2019-08-01-count-3:AGTCTCCTCAGTCATG"	10.2723356681759	7.59957025134889	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCTCAGTCATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2093.63761149577	36.4721327454689	0.0174204611844988	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2086.59332804514	2086.59332804514
"healthy-3"	"2019-08-01-count-4:ACGTAACAGTGAGGTC"	-4.39797006073649	12.4546689757141	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACAGTGAGGTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2222.40668022597	45.6644049359142	0.0205472766718246	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2219.19027415566	2219.19027415566
"healthy-3"	"2019-08-01-count-2:TGCATGAGTAGGGAGG"	-2.73347459259685	8.80296418750612	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATGAGTAGGGAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1963.78269647335	44.5379467470983	0.0226796716495576	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.78269647335	1963.78269647335
"healthy-3"	"2019-08-01-count-4:CTGGACGGTGACTCGC"	-4.22235904160197	3.49731180751649	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGACGGTGACTCGC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2899.34509522999	45.3489507679209	0.0156411014482302	3726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2891.77486845793	2891.77486845793
"healthy-3"	"2019-08-01-count-4:CGCATAAGTTCGAAGG"	10.7799898582393	6.89813325488893	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATAAGTTCGAAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.6217754665	45.4256024108858	0.0220125620648759	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2054.73881469593	2054.73881469593
"healthy-3"	"2019-08-01-count-3:TCACACCTCAGATTGC"	-3.51986179772075	10.425362563971	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCTCAGATTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.77941431969	49.9791383332397	0.0232268874777024	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2144.75580960763	2144.75580960763
"healthy-3"	"2019-08-01-count-4:AGTACTGCAAGGGCAT"	-3.01741800728496	-5.64154245769652	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGCAAGGGCAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2561.5594686983	46.2540417695994	0.018056985338351	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2554.06109220855	2554.06109220855
"healthy-3"	"2019-08-01-count-3:TCACATTAGTTCATCG"	-2.72527919235881	9.37674901569215	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTAGTTCATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.98031176574	43.4879900075133	0.02260313670653	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.12264510522	1917.12264510522
"healthy-3"	"2019-08-01-count-3:ACTGATGAGATACTGA"	-7.0868161720341	3.27977583492128	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGAGATACTGA"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2581.65227582751	42.8338609405888	0.0165916461103806	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2577.05603200897	2577.05603200897
"healthy-3"	"2019-08-01-count-2:TTAATCCCATCGTCCT"	-0.970076302916366	8.33204743945924	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCCATCGTCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.68612890086	41.0240591755233	0.0220359697258656	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1858.19292410491	1858.19292410491
"healthy-3"	"2019-08-01-count-3:CGAGGCTGTCGTAATC"	-1.07551513138469	9.48543641651002	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGCTGTCGTAATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.20626387011	44.2458409050505	0.0233585126123754	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1890.61941402179	1890.61941402179
"healthy-3"	"2019-08-01-count-4:AGCTTCCCAGCTCCTT"	5.08944620665852	-9.1719370118347	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCCAGCTCCTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2847.42523429361	41.8730657022633	0.0147055891750749	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2841.31786690408	2841.31786690408
"healthy-3"	"2019-08-01-count-3:CCGTTCAGTAACGTTC"	0.0504968090331226	8.35781762683717	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTTCAGTAACGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.65970917185	38.7263786012159	0.0204289717262251	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1895.65970917185	1895.65970917185
"healthy-3"	"2019-08-01-count-3:TTACCATCAGCCCACA"	10.9278551536495	6.62182710254518	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATCAGCCCACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2120.03981384077	49.0863413977482	0.0231534997962236	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2113.11424934246	2113.11424934246
"healthy-3"	"2019-08-01-count-3:ACTGATGTCACCGACG"	3.50927795943562	-10.0551157227722	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGTCACCGACG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.32486067711	50.0749578827441	0.021873242519165	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2281.48897359585	2281.48897359585
"healthy-3"	"2019-08-01-count-4:AACACACGTCAATCTG"	10.7117172676021	6.75299642169801	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACGTCAATCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.23637449251	44.8891496376839	0.022657139862568	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1973.26951280066	1973.26951280066
"healthy-3"	"2019-08-01-count-2:TCCTCTTTCGCCAACG"	-3.93751702728923	10.9334354170593	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCTTTCGCCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2219.82471842613	52.3776476716041	0.0235953979775214	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2219.82471842613	2219.82471842613
"healthy-3"	"2019-08-01-count-3:TTACCATTCTCGGTAA"	-3.6078613800114	12.4994869002136	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATTCTCGGTAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.35774532596	39.297532435456	0.0200358820460492	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1954.11848624069	1954.11848624069
"healthy-3"	"2019-08-01-count-3:ACTGTCCAGAACTTCC"	3.78800906714742	-7.33132555401	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGTCCAGAACTTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.02879783871	43.0381140117261	0.0177914847686719	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2413.04129705338	2413.04129705338
"healthy-3"	"2019-08-01-count-2:CAGGGCTCACGAAGAC"	4.66900362548177	-8.3809442750183	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGGCTCACGAAGAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.01155998624	43.0729695697505	0.0154938095185344	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2774.59902813397	2774.59902813397
"healthy-3"	"2019-08-01-count-2:ATGTCCCAGACTGGGT"	-1.86090264740642	9.09691712940065	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCAGACTGGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2187.8583340533	42.3174676939801	0.019341959685105	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.8696639376	2179.8696639376
"healthy-3"	"2019-08-01-count-2:TTCCGTGTCCGCGAGT"	-0.228256712586242	8.09836099231569	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGTGTCCGCGAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2129.60513861428	38.1533716985528	0.0179157023087289	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2121.19611098563	2121.19611098563
"healthy-3"	"2019-08-01-count-2:CTTTCAACATCTGTTT"	-0.0560937699979127	7.51322791660158	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAACATCTGTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2016.84237957205	40.3419630739372	0.0200025363818948	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.12259207325	2010.12259207325
"healthy-3"	"2019-08-01-count-2:CAGGTATAGGACTTCT"	-2.22491488876994	8.73555085742799	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATAGGACTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.21432954365	43.2076948083308	0.0217866995839392	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.15096343367	1978.15096343367
"healthy-3"	"2019-08-01-count-2:ATGTCCCCACAAATCC"	-2.907866815955	9.39258191669313	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCCACAAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.67762060052	46.538368550792	0.0219347030382588	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2115.92134778083	2115.92134778083
"healthy-3"	"2019-08-01-count-2:GGGATGAGTAGCGATG"	4.45376839217488	-8.00775625621947	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATGAGTAGCGATG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.92482945753	44.5529284470836	0.0179726823168064	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2474.21765874047	2474.21765874047
"healthy-3"	"2019-08-01-count-4:TGTGGCGAGGACAGTC"	-4.13621077957805	13.0328893431458	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGGCGAGGACAGTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2483.58314878673	41.2167120101913	0.0165956642242182	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2475.97889874385	2475.97889874385
"healthy-3"	"2019-08-01-count-4:CTGTATTCAGTTACCA"	2.59162058409993	-4.45218613063964	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTCAGTTACCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2728.18716149657	42.1231084734962	0.0154399628691124	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2723.266713696	2723.266713696
"healthy-3"	"2019-08-01-count-3:CCATCACTCCGCGAGT"	-4.48213706436809	2.86922309482423	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACTCCGCGAGT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2916.88737580105	41.9184954494711	0.0143709681070423	4547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2910.21495633219	2910.21495633219
"healthy-3"	"2019-08-01-count-4:TGTGGCGAGTGAGGCT"	-3.15598712387736	10.2549915083679	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGGCGAGTGAGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1936.77229487526	47.3657236778715	0.0244560105507509	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1933.50757559936	1933.50757559936
"healthy-3"	"2019-08-01-count-3:TTACGTTCATCCGATA"	-0.953744749457198	8.2938022383484	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGTTCATCCGATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.85954299164	32.4500697821128	0.0165573445802035	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1956.23014304233	1956.23014304233
"healthy-3"	"2019-08-01-count-2:ATGTCTTGTGAGGCAT"	3.95435156401936	-7.3484039536682	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCTTGTGAGGCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.31599670632	45.2477471906047	0.0180319048099147	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2506.1230106226	2506.1230106226
"healthy-3"	"2019-08-01-count-2:AGGGCCTCATGTGTCA"	-3.19402776184734	9.59336183154909	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTCATGTGTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.28283057529	44.4840821106845	0.0205537286912082	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2154.37558691447	2154.37558691447
"healthy-3"	"2019-08-01-count-4:GTTAGACTCAGACCGC"	4.6646372276241	-8.07928373729857	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACTCAGACCGC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.86407887042	45.9790515196253	0.0181243653937101	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2530.91054753	2530.91054753
"healthy-3"	"2019-08-01-count-2:GATTTCTAGATTGACA"	4.09183134612386	-7.3781686059204	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTAGATTGACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.03540512228	48.0695124957602	0.0199621286271409	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2404.01990179033	2404.01990179033
"healthy-3"	"2019-08-01-count-2:AGGGCCTAGCACGGAT"	-0.377175967127639	7.93215797031251	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTAGCACGGAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2062.320919131	43.4692242532234	0.0210778176422417	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2062.320919131	2062.320919131
"healthy-3"	"2019-08-01-count-2:TTCCTTCAGAAGTATC"	3.46445884284322	-6.67112400447997	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCAGAAGTATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.71896838632	45.7288889601894	0.0188283986560093	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2424.87071733342	2424.87071733342
"healthy-3"	"2019-08-01-count-4:TGTTACTCAGGGTTGA"	3.7324706512386	-6.72907402431639	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTCAGGGTTGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.51420191406	45.0522116536791	0.0210081199804918	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2144.51420191406	2144.51420191406
"healthy-3"	"2019-08-01-count-2:GATTTCTTCACGATCA"	-3.77615151825603	10.3246564635071	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTTCACGATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.84809897477	46.3042495050135	0.0223924811150157	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.17885520702	2056.17885520702
"healthy-3"	"2019-08-01-count-4:GTTAGTGTCAGCAGAG"	-1.75730297985728	8.82290074909059	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGTCAGCAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1888.17012689187	40.052551959442	0.0212123639649849	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1886.40326007474	1886.40326007474
"healthy-3"	"2019-08-01-count-4:TCACTCGTCGGTCTGG"	2.88210024413411	-5.94795753872069	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTCGTCGGTCTGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.07947703194	41.9355456229951	0.0159506572507034	2381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2626.88647421159	2626.88647421159
"healthy-3"	"2019-08-01-count-2:TGCTGAACAAATGGCG"	-3.86779938164409	10.2530622252258	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAACAAATGGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.61706258093	48.1948444490875	0.0248092356323982	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1939.32024568193	1939.32024568193
"healthy-3"	"2019-08-01-count-4:CAAGACTAGGGACCAT"	4.31291212615315	-7.97872545635375	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTAGGGACCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.7091959758	48.1795689081936	0.0212552933537875	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2258.65426358587	2258.65426358587
"healthy-3"	"2019-08-01-count-3:CTTTCAATCGTCGGGT"	4.95440973815267	-8.1057863465515	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAATCGTCGGGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.33206916605	46.6703765110298	0.0182425014616039	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2557.25524530534	2557.25524530534
"healthy-3"	"2019-08-01-count-4:ACTCCCAGTTAAGTCC"	-0.106441075832206	8.63072488391725	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCCCAGTTAAGTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2376.74287956415	47.0478286988107	0.0197950855783939	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2368.87149024377	2368.87149024377
"healthy-3"	"2019-08-01-count-3:TCAGCCTCAGGTGGAT"	-2.8703695339268	10.2910117872986	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCAGGTGGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.91793799181	51.1134550384294	0.0278711789549319	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1830.69045659513	1830.69045659513
"healthy-3"	"2019-08-01-count-3:ACCTGTCCACAAGTTC"	-2.52990732613261	9.24945828998414	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGTCCACAAGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2076.50589066751	44.9942429963418	0.0216682472217201	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.83716587715	2069.83716587715
"healthy-3"	"2019-08-01-count-4:TTGGATGAGTACAGAT"	2.44274105605428	-6.25877525722655	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGATGAGTACAGAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2534.57371534205	45.8581586223652	0.0180930459212059	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2533.7528621512	2533.7528621512
"healthy-3"	"2019-08-01-count-4:CTTACCGGTAGGCAAC"	5.4654389816219	-9.94066240703734	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGGTAGGCAAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.11212886983	46.9779354246234	0.0200408226407125	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2340.38648175312	2340.38648175312
"healthy-3"	"2019-08-01-count-3:GTTGTGACAATGAAAC"	5.00424732741658	-8.52984526073607	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGACAATGAAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2789.0234687654	47.0123789588613	0.0168562149029431	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2778.40612633573	2778.40612633573
"healthy-3"	"2019-08-01-count-2:CTACGGGGTCTCAAGT"	-3.53518329086955	12.4480504759583	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACGGGGTCTCAAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1986.31789877453	41.9800604210258	0.0211346131688818	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1981.2617804478	1981.2617804478
"healthy-3"	"2019-08-01-count-2:CCTCAACTCCACGGAC"	0.839450080960435	8.15786359393922	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACTCCACGGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1712.39608813549	37.9903651189917	0.0221855009960673	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1706.13719342711	1706.13719342711
"healthy-3"	"2019-08-01-count-3:AAGACTCGTTGCTCGG"	-2.29926667633708	10.2527351149353	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCGTTGCTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1642.309960918	48.634480750046	0.0296134602525706	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1638.20540791064	1638.20540791064
"healthy-3"	"2019-08-01-count-2:ATTCACTGTTGGTGTT"	-2.11366186562236	8.87186048114625	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTGTTGGTGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.76765051777	50.7716863054253	0.0271685387380065	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1864.38919887006	1864.38919887006
"healthy-3"	"2019-08-01-count-3:AGAACAAGTAAGACCG"	4.95026554641072	-8.29807379161986	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAAGTAAGACCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.29145721673	46.843061785026	0.0191642701391942	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2440.43555217023	2440.43555217023
"healthy-3"	"2019-08-01-count-2:TCGACCTGTCTAACTG"	4.15472044524495	-7.28080513393553	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTGTCTAACTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.08253133008	46.3920910112151	0.0219235735489272	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2109.34535565103	2109.34535565103
"healthy-3"	"2019-08-01-count-4:GGTAGAGAGACATAAC"	2.42542590674703	-6.20809891140135	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAGAGAGACATAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.74979775779	45.6138689390544	0.0187885378391061	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2424.57746934046	2424.57746934046
"healthy-3"	"2019-08-01-count-3:GTTTGGATCGACATAC"	3.41379227217976	-6.47882702266844	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTTGGATCGACATAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.3075720927	47.0645353295949	0.0191295331784727	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2449.72303514212	2449.72303514212
"healthy-3"	"2019-08-01-count-2:AACGTCACAGTTGCGC"	-3.22724638405498	9.62223336780397	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCACAGTTGCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2148.32295403856	44.5990772703475	0.0207599500747815	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2145.28575889536	2145.28575889536
"healthy-3"	"2019-08-01-count-2:TGGAACTAGTGGTTGG"	-1.87509117546733	9.02369210803834	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTAGTGGTTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2139.26650366689	49.4836231709011	0.0231311167103686	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2134.3933135862	2134.3933135862
"healthy-3"	"2019-08-01-count-2:CATACCCAGACTTAAG"	10.3526569801265	7.52378699863283	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCAGACTTAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.68464730571	39.3176998020667	0.0205455480125329	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1910.84764592134	1910.84764592134
"healthy-3"	"2019-08-01-count-4:TGTTTGTTCTTGCAGA"	2.32904495772664	-6.64621164714965	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTTGTTCTTGCAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.46106009294	49.7783255279081	0.0234752368080394	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2114.41779314677	2114.41779314677
"healthy-3"	"2019-08-01-count-4:ACTGTCCTCCCGAACG"	3.73386468467061	-8.06618978893431	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTCCTCCCGAACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.77157788865	47.0545998348097	0.0213809558009434	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2196.11817839276	2196.11817839276
"healthy-3"	"2019-08-01-count-2:CCTCAGTAGCAACCAG"	-1.85705147209819	8.86971948230592	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTAGCAACCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2104.05212062416	45.5509008363766	0.0216491314021556	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2101.1534259452	2101.1534259452
"healthy-3"	"2019-08-01-count-3:TCAGTCCAGTCGAATA"	-2.81356368485149	10.0460242995056	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTCCAGTCGAATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1895.49831663448	45.139722617415	0.0238141718308472	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1885.54492290285	1885.54492290285
"healthy-3"	"2019-08-01-count-2:CATACCCAGAGCATCG"	-3.98328338089641	11.2648057707581	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCAGAGCATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.94141723835	49.9432680218133	0.0260944601396824	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1913.94141723835	1913.94141723835
"healthy-3"	"2019-08-01-count-2:GTGTCCTAGGTTATAG"	-3.62467108193095	-5.13541605388793	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTAGGTTATAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2225.60093738271	53.713624381797	0.0241344364479662	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2221.5353335241	2221.5353335241
"healthy-3"	"2019-08-01-count-2:TCGATTTCATAATGCC"	-3.84505210343059	9.91238019550172	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGATTTCATAATGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.08209771973	48.3918201442149	0.0251375357973228	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1919.84569269876	1919.84569269876
"healthy-3"	"2019-08-01-count-4:CTTCCTTAGGGAACAA"	0.281051506369752	7.89718005740968	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTAGGGAACAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.98073113781	44.9848937435963	0.0235033158964217	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1903.74387063117	1903.74387063117
"healthy-3"	"2019-08-01-count-3:GGTTAACTCACGTAGT"	-3.22214756432231	10.5747985609802	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTAACTCACGTAGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2189.55491854075	45.2453423652365	0.0206641733359174	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2186.64325062184	2186.64325062184
"healthy-3"	"2019-08-01-count-2:GAAGAATAGAATACAC"	-1.62652907791789	8.56008336627809	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGAATAGAATACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1936.22581959837	49.0223766581535	0.0253185223345085	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1925.14138176934	1925.14138176934
"healthy-3"	"2019-08-01-count-2:CCTCAGTGTTGGCCGT"	4.1673718887264	-7.76551010524901	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTGTTGGCCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.79712120548	46.6668776700569	0.0180056059512681	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2587.01297657923	2587.01297657923
"healthy-3"	"2019-08-01-count-2:GGATCTAAGACGCAGT"	-2.99880037728007	10.4647893675598	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTAAGACGCAGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2012.79483959468	42.118228960367	0.0209252468914559	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.67300956211	2002.67300956211
"healthy-3"	"2019-08-01-count-4:AAACCCACAATTCGTG"	-7.45227370682414	3.64786622608034	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCACAATTCGTG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2334.13363720716	47.2179091986516	0.0202293084020454	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2321.49734563027	2321.49734563027
"healthy-3"	"2019-08-01-count-3:TGAGGGATCCCTCGTA"	10.4038359123165	6.76541659915773	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGGATCCCTCGTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2093.64929855663	46.168081061345	0.0220514873685738	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2080.72827968921	2080.72827968921
"healthy-3"	"2019-08-01-count-4:ACTTATCCACAAATCC"	-3.21828113022502	10.4888973006043	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCCACAAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.11073092909	41.6885997198399	0.0204645722428778	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.71658659291	2033.71658659291
"healthy-3"	"2019-08-01-count-2:TATTGCTCATCACAGT"	10.4342543083126	7.0762638815674	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTCATCACAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.69040403033	39.4922951921044	0.0208326713624449	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1894.04900754947	1894.04900754947
"healthy-3"	"2019-08-01-count-3:TGAGGGAGTCAATGGG"	-2.98587594452556	9.41445348346559	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGGAGTCAATGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.56080845298	46.1755116091333	0.0232673704995356	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.05143809851	1981.05143809851
"healthy-3"	"2019-08-01-count-3:CTACGGGAGGCGACAT"	4.00250353392903	-7.4566312066284	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGAGGCGACAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.91876442083	46.3751588777748	0.0205207194204876	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2257.32942479415	2257.32942479415
"healthy-3"	"2019-08-01-count-3:AGACACTAGTAAGACT"	-2.39145217362102	9.22145650470582	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTAGTAAGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.77302048037	47.2589801920404	0.0244513865266469	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1924.20487486235	1924.20487486235
"healthy-3"	"2019-08-01-count-2:CTATCCGGTGTTACAC"	10.5832802253658	6.53996751392213	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGGTGTTACAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.45087894313	41.066412301301	0.020788374309399	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1969.10239678802	1969.10239678802
"healthy-3"	"2019-08-01-count-4:TTACCATGTCGAGCAA"	-4.02911315384563	11.698758102301	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATGTCGAGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.02346084859	40.9716329832903	0.020506082028631	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.02346084859	1998.02346084859
"healthy-3"	"2019-08-01-count-4:CACAACAAGCCGATTT"	-7.18761907044108	3.36174318874208	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACAAGCCGATTT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2536.81435609244	46.2405230359757	0.0182277914522692	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2530.79810930235	2530.79810930235
"healthy-3"	"2019-08-01-count-4:AACTTCTCAGGCGTTC"	-4.36891446533855	12.9417361983093	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTCAGGCGTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2329.85331867835	40.5713372442754	0.0174136873420384	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2324.75248933516	2324.75248933516
"healthy-3"	"2019-08-01-count-4:CACAACAAGGTTGCCC"	-3.02844701233562	9.32673833453981	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACAAGGTTGCCC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1937.35800746079	47.6614009917782	0.0246012357077182	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1935.5800824466	1935.5800824466
"healthy-3"	"2019-08-01-count-3:TGAGGTTTCCACGGAC"	-0.514629880816299	8.39310166919557	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTTCCACGGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2072.3524537955	43.6426419340659	0.0210594688437937	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2065.15565794758	2065.15565794758
"healthy-3"	"2019-08-01-count-2:ACTATGGAGGAGAATG"	10.8522116142208	6.73410365665285	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATGGAGGAGAATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.29743946466	40.9178566763073	0.0217382523178401	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1876.94963466755	1876.94963466755
"healthy-3"	"2019-08-01-count-2:TCGCTTGGTACCCGCA"	-2.32598076286967	8.65761659229127	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTTGGTACCCGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.82772252033	46.5546141561245	0.0241863797011229	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.54674391639	1912.54674391639
"healthy-3"	"2019-08-01-count-4:CACAACAGTCTGTCCT"	10.9770647483761	6.4288701781067	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACAGTCTGTCCT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.84042340365	44.3154025459238	0.0206133450945923	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2145.74684891441	2145.74684891441
"healthy-3"	"2019-08-01-count-3:AGACAGGAGCATCCTA"	-2.83452806893047	9.21560380542604	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAGGAGCATCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2076.36442072906	47.3964723898065	0.022826663718869	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.51523814842	2067.51523814842
"healthy-3"	"2019-08-01-count-3:GCCAGTGTCTCCCTAG"	4.6989880996639	-8.10873510753783	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGTCTCCCTAG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.10024908455	41.8434658520149	0.0155315177548546	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2693.15932842073	2693.15932842073
"healthy-3"	"2019-08-01-count-2:GCAGTTATCGAACTCA"	-3.03966246071513	9.33533380115358	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTATCGAACTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2271.09295141153	45.8500662864503	0.0201885467778646	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2268.20096647104	2268.20096647104
"healthy-3"	"2019-08-01-count-3:TTCCGGTGTGTGTTTG"	-1.55006597462352	8.98466489398805	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCGGTGTGTGTTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.68118240125	41.954284629175	0.021969261160348	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1904.44138806434	1904.44138806434
"healthy-3"	"2019-08-01-count-4:CTTCTCTTCCGTGGTG"	-3.99707017365153	3.53380510890809	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTTCCGTGGTG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3271.45625136085	45.4072666967819	0.0138798330798077	4401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3262.6229382411	3262.6229382411
"healthy-3"	"2019-08-01-count-4:CGTGCTTCATCGGATT"	10.4291359382564	7.82556483829347	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGCTTCATCGGATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2441.92355894103	48.5126492942198	0.0198665716281708	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2426.56385355933	2426.56385355933
"healthy-3"	"2019-08-01-count-4:CACACAAAGGCACTAG"	-3.28557763519939	10.4551887282166	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAAAGGCACTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1832.24648296804	46.0788895726732	0.0251488486953078	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1826.54240231046	1826.54240231046
"healthy-3"	"2019-08-01-count-2:AAGCATCAGCAGTACG"	0.00887516614739296	8.11823651874391	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCATCAGCAGTACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.19177594171	41.0295975746462	0.0206574199287443	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.88998627777	1981.88998627777
"healthy-3"	"2019-08-01-count-3:TAATCTCGTAGGAGTC"	4.66489042815511	-7.7254848710266	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCGTAGGAGTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.49380213313	44.6740326322777	0.0171329391447569	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2601.12202126457	2601.12202126457
"healthy-3"	"2019-08-01-count-3:ATCACTTCACTCAGAT"	0.105841615318698	8.69413087451784	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTCACTCAGAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2169.37946845247	41.7785860776311	0.0192583117362284	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2159.68773554303	2159.68773554303
"healthy-3"	"2019-08-01-count-3:CTATCCGAGGCCTTCG"	-5.51118073883708	3.7103061445984	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATCCGAGGCCTTCG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2834.22775628756	44.7859214411506	0.0158018075088693	3238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2824.6165493624	2824.6165493624
"healthy-3"	"2019-08-01-count-2:GCATCTCAGGGTCTTT"	3.83387364920918	-8.36495687877806	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCAGGGTCTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1927.43579505438	49.9467889574676	0.0259135941573911	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1927.43579505438	1927.43579505438
"healthy-3"	"2019-08-01-count-2:ATTGGGTTCCGATCTC"	11.159308095544	5.60778901660768	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTTCCGATCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.60258592761	43.6777187974876	0.0222436653478199	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1955.03222462662	1955.03222462662
"healthy-3"	"2019-08-01-count-4:CTTGATTGTGCCTGCA"	-3.13926253739055	-5.55927326595458	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTGTGCCTGCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2637.62435157857	54.6608073510197	0.0207234996591938	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2634.62271049966	2634.62271049966
"healthy-3"	"2019-08-01-count-3:GCCATTCTCATGACAC"	-0.0338606936043084	8.77909276569215	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATTCTCATGACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2184.81308113702	40.221328352552	0.0184095054628747	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2173.85593320185	2173.85593320185
"healthy-3"	"2019-08-01-count-4:TTAGGCATCCATCCGT"	-3.55589185181316	9.71173570239869	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGCATCCATCCGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1988.39215948727	48.4504489828817	0.0243666465650192	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.82627635262	1981.82627635262
"healthy-3"	"2019-08-01-count-2:ACTCCCATCAAGAGTA"	-3.64223514023479	12.6591243513855	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCATCAAGAGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1687.39189212345	47.6545419082566	0.0282415378020378	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1687.39189212345	1687.39189212345
"healthy-3"	"2019-08-01-count-3:CCGGACAAGGTACTGG"	10.9810844856197	6.51440522754518	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACAAGGTACTGG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.10009808514	42.4599133906489	0.020904884712811	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2024.9083919888	2024.9083919888
"healthy-3"	"2019-08-01-count-3:TACAACGGTTCTCCCA"	-2.63660273972209	9.09604451740114	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAACGGTTCTCCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2066.91091337022	41.2940210053615	0.0199786167551988	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.40912086864	2053.40912086864
"healthy-3"	"2019-08-01-count-3:AGACCCGTCTCAACCC"	2.06199922141377	-5.97032358562621	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGTCTCAACCC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2967.27248318147	45.8747719063445	0.0154602491568817	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2958.13794591238	2958.13794591238
"healthy-3"	"2019-08-01-count-3:TCATGTTAGGATTCCT"	10.062046666711	6.17534444415895	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGTTAGGATTCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1874.69008430271	40.6121412874481	0.0216633893930013	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1871.21235844459	1871.21235844459
"healthy-3"	"2019-08-01-count-2:GAATCACCAAGACGAC"	-3.65343962135966	10.5620174177918	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCACCAAGACGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.95491354744	42.2780001717048	0.0215379374635254	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.437092285	1959.437092285
"healthy-3"	"2019-08-01-count-4:GTTTGGATCGCTGACG"	-7.14121470871623	3.63445184314577	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGATCGCTGACG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2438.29016038972	44.2397927356959	0.018143776919735	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2429.28860232444	2429.28860232444
"healthy-3"	"2019-08-01-count-2:TGGGCTGGTCGACTGC"	0.317504872649354	8.21517179096071	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGGTCGACTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1716.40259376569	39.7067727451297	0.023133717514383	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1707.68891652455	1707.68891652455
"healthy-3"	"2019-08-01-count-2:CATCCGTCACGCCAGT"	4.63991322097127	-7.98356344616088	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCACGCCAGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.68127963795	47.6040658375771	0.0205395220886512	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2312.4710195506	2312.4710195506
"healthy-3"	"2019-08-01-count-2:CATCCGTCACTGATTG"	-0.359865914017516	7.86708257282106	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCACTGATTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2005.49304177537	41.0446070818274	0.02046609298903	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2001.02151995943	2001.02151995943
"healthy-3"	"2019-08-01-count-3:TCATGTTTCTGACAGT"	-3.93758044663127	3.51976869190065	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGTTTCTGACAGT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3182.66683821	47.9695953880524	0.0150721385010036	4280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3169.03981730615	3169.03981730615
"healthy-3"	"2019-08-01-count-3:TACAGGTCACAAGCTT"	-2.15939269486125	8.65615365588991	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAGGTCACAAGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2184.06047800206	39.1789056825185	0.0179385626346569	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2182.53798309982	2182.53798309982
"healthy-3"	"2019-08-01-count-4:AGAACAATCATATGGC"	-2.28378282013591	8.6077260741028	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACAATCATATGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2651.87800156423	41.3958090198947	0.015609997517034	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2645.76074429342	2645.76074429342
"healthy-3"	"2019-08-01-count-3:CCGGTAGTCATTGTTC"	-1.97497139397319	8.65220353687135	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTAGTCATTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.91442010932	44.0927608608321	0.0223944527047468	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.04770331242	1964.04770331242
"healthy-3"	"2019-08-01-count-4:GCCAGGTAGACATACA"	-3.76668916168864	10.5169915922913	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTAGACATACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.75452917509	44.4854273227427	0.023028509394379	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.72627109986	1926.72627109986
"healthy-3"	"2019-08-01-count-4:AAGGTAAAGTACCCTA"	-1.85765622082408	8.78663156116334	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGTAAAGTACCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.37094759992	50.4160177516217	0.0237657717565434	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.93920998619	2111.93920998619
"healthy-3"	"2019-08-01-count-2:GTTCATTAGCGCCTTG"	0.0365589699590623	8.18642137134401	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCATTAGCGCCTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.18080038514	42.9622320745082	0.0237074755815631	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1806.97931538225	1806.97931538225
"healthy-3"	"2019-08-01-count-4:CACGAATCAATAACGA"	-2.52304277840312	9.63354394519655	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATCAATAACGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2066.51857468435	46.064555590658	0.0222908984003176	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.68090897771	2055.68090897771
"healthy-3"	"2019-08-01-count-4:CACGAATAGCCTCACG"	5.50017704543416	-9.74096777355345	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATAGCCTCACG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2838.237669579	43.4534886931134	0.0153100246532768	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2825.43286624655	2825.43286624655
"healthy-3"	"2019-08-01-count-4:GAAACCTGTATTGACC"	-4.29651580277141	13.1302909621033	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAACCTGTATTGACC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2411.61800485642	45.8797096967131	0.019024451469645	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2401.87068116623	2401.87068116623
"healthy-3"	"2019-08-01-count-4:CCCTCAAAGACTCCGC"	3.27925338324849	-7.09805681621703	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAAAGACTCCGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.40547454133	48.1158056377315	0.0210259091638362	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2287.10969040516	2287.10969040516
"healthy-3"	"2019-08-01-count-4:AAGTACCAGCTAGTTC"	-3.81627688828166	10.1462974318298	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCAGCTAGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.08989752734	46.1669130657308	0.02115720031427	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.2783891805	2176.2783891805
"healthy-3"	"2019-08-01-count-2:CATCGGGTCTGAGGTT"	-4.49711404267009	13.0148010023865	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGTCTGAGGTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1964.35109048107	40.6130443274025	0.020675043541965	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1960.65129498224	1960.65129498224
"healthy-3"	"2019-08-01-count-3:TTCTAACCAGGGCTTC"	-2.40845117989238	9.32423303211061	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAACCAGGGCTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1973.58211342235	42.0677186788722	0.0213154134265655	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1965.99995040076	1965.99995040076
"healthy-3"	"2019-08-01-count-2:CTTCTCTAGCCGCACT"	-1.27684829655345	8.63642499530641	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTCTAGCCGCACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.18154973316	40.8323740449224	0.0196575855635574	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.24414261367	2072.24414261367
"healthy-3"	"2019-08-01-count-4:GGGCTCACACGGTGCT"	-4.19510922852214	13.2053336867127	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTCACACGGTGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2634.84892499662	38.3988363062619	0.0145734489526041	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2632.02153624987	2632.02153624987
"healthy-3"	"2019-08-01-count-2:ACAGAAAGTTGGACTT"	10.8576113182003	6.78977487171022	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAAGTTGGACTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2104.6967427779	43.4504457789946	0.0206445160938702	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2088.64675037289	2088.64675037289
"healthy-3"	"2019-08-01-count-3:TACCCGTCATGTACGT"	-3.37197957459148	9.55072114551393	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTCATGTACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.46674873459	45.0804322143981	0.0241787268370403	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.94642201397	1856.94642201397
"healthy-3"	"2019-08-01-count-2:GGTGTCGCACTAACCA"	-4.22923360291179	12.6589021452698	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGCACTAACCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2141.27882938112	47.1358613560499	0.022012948855275	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2136.14981665482	2136.14981665482
"healthy-3"	"2019-08-01-count-4:CTACATTTCGGAGTAG"	2.67541827735249	-4.50690605556639	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTTCGGAGTAG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2729.67684989575	37.894439430861	0.0138823903028332	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2726.45061649986	2726.45061649986
"healthy-3"	"2019-08-01-count-4:GAACACTTCTCTATGT"	-3.60279760780986	9.6429929503235	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACACTTCTCTATGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.50127140903	46.3748000392163	0.022528429145673	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.06122869663	2055.06122869663
"healthy-3"	"2019-08-01-count-2:ACTTATCTCCCGAGGT"	-2.12920294228252	8.80389211261598	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCTCCCGAGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.89841416041	45.5778835244223	0.0228243375833343	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.43897676628	1991.43897676628
"healthy-3"	"2019-08-01-count-3:CCTAACCTCGAACGCC"	3.95174231108968	-7.27147152340087	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAACCTCGAACGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.6509210634	48.8000792730448	0.0198968711176747	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2447.64330501289	2447.64330501289
"healthy-3"	"2019-08-01-count-3:TCCACCAAGACTTGTC"	-2.83700714531596	9.90721986377565	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCAAGACTTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.93118715717	43.0663657228937	0.0218065145777995	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.20116016381	1966.20116016381
"healthy-3"	"2019-08-01-count-2:CATGCAAAGGTAGCAC"	-2.03661427918132	9.04271695697633	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCAAAGGTAGCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2216.39887511841	50.4635121513073	0.022768244794661	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2210.57325500975	2210.57325500975
"healthy-3"	"2019-08-01-count-4:CACGTGGGTATTGCCA"	10.7303949790889	6.48942086780397	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGGTATTGCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.30182984992	43.0250459884413	0.0226411643206381	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1894.72159038275	1894.72159038275
"healthy-3"	"2019-08-01-count-4:AAGTTCGTCGAGTCTA"	4.76173748549764	-8.33082392131957	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTTCGTCGAGTCTA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.94628115243	43.515017145051	0.0164957935102609	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2634.15481789094	2634.15481789094
"healthy-3"	"2019-08-01-count-3:AGATGAAAGAGGGCGA"	3.05419339713399	-5.24136450206908	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGAAAGAGGGCGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2960.27381840201	43.7537881744353	0.0147803179227705	2883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2952.46271032439	2952.46271032439
"healthy-3"	"2019-08-01-count-2:CATGCCTCAACCCGCA"	11.082461019128	6.38023421848146	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTCAACCCGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2090.10847504079	45.9318605064413	0.0219758261616277	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2080.04436666713	2080.04436666713
"healthy-3"	"2019-08-01-count-2:CATGCAATCATTACTC"	-1.36381612244304	8.81234357440797	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCAATCATTACTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2123.67440336423	47.0387718067147	0.0221497098294343	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2114.73806018949	2114.73806018949
"healthy-3"	"2019-08-01-count-3:AGATGAAGTGTCCCTT"	5.10041727599446	-8.04936125194701	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGAAGTGTCCCTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2754.5471403964	40.7433389371207	0.0147913021126432	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2749.4025987075	2749.4025987075
"healthy-3"	"2019-08-01-count-4:TAAGTCGGTATAGGGC"	-3.9334422153538	13.3024282225403	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGGTATAGGGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2333.15629637113	44.650854764311	0.0191375326349798	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2328.13754401624	2328.13754401624
"healthy-3"	"2019-08-01-count-2:TCGTGGGTCTTCCACG"	5.48433270034139	-9.75818636333617	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGGGTCTTCCACG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.49622640641	39.6871368833334	0.0157958991007511	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2505.54646584109	2505.54646584109
"healthy-3"	"2019-08-01-count-2:ACTTTCACACACGTGC"	4.16249718245809	-7.51105501567992	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTCACACACGTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.36250596226	46.3893051279545	0.0179917699783033	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2577.28448939368	2577.28448939368
"healthy-3"	"2019-08-01-count-4:TCCACGTTCAACTGAC"	-4.35837159577067	10.8226766356262	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTTCAACTGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2365.46031825059	44.2378080480509	0.018701564218489	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2360.70771009881	2360.70771009881
"healthy-3"	"2019-08-01-count-4:CCGATCTCACGCGTCA"	0.309645672410172	-3.46063640033873	"2019-08-01-count-4"	"Control3"	"cDC1"	"cDC1"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATCTCACGCGTCA"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2489.43282682321	40.1195659365628	0.0161159463731182	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2486.97776290586	2486.97776290586
"healthy-3"	"2019-08-01-count-3:TTCTTCCGTTTGTGGT"	10.5037418800289	6.99144408786622	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTCCGTTTGTGGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.59619251033	44.3648675139296	0.023973283687431	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1843.99392477642	1843.99392477642
"healthy-3"	"2019-08-01-count-2:GACCGTGAGTGCTCGC"	-1.53845749321635	8.85216996753541	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCGTGAGTGCTCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.76890139959	48.3090146350415	0.0247260638658109	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.3391909456	1943.3391909456
"healthy-3"	"2019-08-01-count-2:TGTAGACAGGTATCTC"	-1.89453480663951	8.63856885516969	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACAGGTATCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.39505600212	40.3018520209872	0.0207165387290587	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1939.66722524201	1939.66722524201
"healthy-3"	"2019-08-01-count-2:CATGCTCAGAATCTAG"	10.6591097312862	6.97208163822023	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCAGAATCTAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.98099374059	38.8735016343532	0.019378798580671	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1995.45672028368	1995.45672028368
"healthy-3"	"2019-08-01-count-4:GAAGAATCAGATGCGA"	4.98588671263997	-8.03990747844847	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATCAGATGCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.35089372541	44.9462187395505	0.0169906453038649	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2638.52570912369	2638.52570912369
"healthy-3"	"2019-08-01-count-3:CCTATCGTCGCATAGT"	-0.570045034319717	8.04788968646852	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGTCGCATAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2158.4104128133	42.1910174671702	0.0195472636791897	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.08585626889	2151.08585626889
"healthy-3"	"2019-08-01-count-4:AGAGAGCGTGCGGTAA"	-2.98807917061504	9.09924695575563	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAGCGTGCGGTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.23261002899	46.5342956147325	0.0248417069858785	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1866.13863830023	1866.13863830023
"healthy-3"	"2019-08-01-count-2:CATGCTCCATGAGAAT"	4.19573702391927	-7.71198370372923	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCCATGAGAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.56669957606	47.5470404053228	0.0197080729057886	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2411.26623026902	2411.26623026902
"healthy-3"	"2019-08-01-count-2:AATCACGGTGGGTCAA"	-3.4465151828831	11.4118690260681	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGGTGGGTCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.34911649273	44.1704946863584	0.0229893122010996	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1917.84374909937	1917.84374909937
"healthy-3"	"2019-08-01-count-3:GACTATGGTGTTAGCT"	10.1210237937862	7.27139184558717	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGGTGTTAGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2198.48521005028	43.4794517842666	0.0197770044508383	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2189.04247423533	2189.04247423533
"healthy-3"	"2019-08-01-count-4:GAAGCGACATCCGGTG"	-3.57003865662273	9.59516809070436	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGCGACATCCGGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2013.72767467725	47.3000664525152	0.0234888098561272	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2012.05060924758	2012.05060924758
"healthy-3"	"2019-08-01-count-4:TACACCCAGGTAGCCA"	10.930852552026	6.75203559482423	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCAGGTAGCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1941.42212929086	46.2443491094708	0.0238198320765831	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1937.02133679357	1937.02133679357
"healthy-3"	"2019-08-01-count-2:AGAAATGCAGTGTACT"	-1.72653685036357	9.63603875720827	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGCAGTGTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1499.51086631017	44.9892436568054	0.0300026126302839	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1499.51086631017	1499.51086631017
"healthy-3"	"2019-08-01-count-2:CATGGATAGGACATCG"	4.63716139373128	-7.47726395046385	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATAGGACATCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.33155394692	45.5138224740231	0.0182103980570918	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2497.12115739733	2497.12115739733
"healthy-3"	"2019-08-01-count-2:AGAAATGTCTCAAAGC"	-3.67433414879497	10.3844632872376	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAATGTCTCAAAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.31515743014	46.805742527908	0.0230307501062453	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2025.90354206438	2025.90354206438
"healthy-3"	"2019-08-01-count-3:GTTGTGAAGGCTAGCA"	-3.93438611450847	9.97998426044313	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGAAGGCTAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2010.94737798736	47.9237573160068	0.0238314328065466	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.35275108999	2004.35275108999
"healthy-3"	"2019-08-01-count-4:GTAGGTTCAATGCAGG"	-4.29005179825481	13.1619558104309	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGTTCAATGCAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2467.27777276216	40.6863173551938	0.0164903675639426	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2461.17309206068	2461.17309206068
"healthy-3"	"2019-08-01-count-2:GTTTACTGTACCCGAC"	-1.60147509995158	8.89344213092653	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTGTACCCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.35873705372	47.9828873379849	0.0255723419996585	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.7371213923	1867.7371213923
"healthy-3"	"2019-08-01-count-2:GACTATGCAACTGAAA"	-7.20183358612712	3.46146199786989	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTATGCAACTGAAA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2485.30844974968	47.2713793102855	0.0190203269598374	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2467.25041092631	2467.25041092631
"healthy-3"	"2019-08-01-count-3:TACGGTAAGGATCACG"	-2.10342274132426	8.99526879871217	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGTAAGGATCACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2193.3241778108	43.0729362182846	0.0196381987916062	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2187.35454869161	2187.35454869161
"healthy-3"	"2019-08-01-count-3:GCTGAATAGATGTAGT"	0.536930670111817	4.48884961688844	"2019-08-01-count-3"	"Control3"	"Ery"	"Erythrocytes"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATAGATGTAGT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1333.02742290918	38.8986687643888	0.0291806965827431	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	1302.85213253703	1302.85213253703
"healthy-3"	"2019-08-01-count-2:TGTCCTGCAAGATGGC"	-2.48218689385112	9.3045034178528	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGCAAGATGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1857.94637776875	40.3204491530482	0.0217016215513549	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.13141183776	1856.13141183776
"healthy-3"	"2019-08-01-count-4:AATGCCAGTGGGTATG"	-4.32068572464641	13.1602487334046	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGCCAGTGGGTATG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2598.34870517141	40.315854587799	0.0155159523075404	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2591.66682247687	2591.66682247687
"healthy-3"	"2019-08-01-count-3:CTCCCAAAGGTCCAGA"	-0.476022402674514	8.18394181812135	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAAAGGTCCAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2061.20485309758	40.6281179115872	0.0197108588457529	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2054.98684012737	2054.98684012737
"healthy-3"	"2019-08-01-count-2:TGTCCTGTCCATAGGT"	-2.68717346611674	9.17089650714723	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGTCCATAGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1870.45939001277	43.9916031662781	0.0235191436933457	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1868.70969561297	1868.70969561297
"healthy-3"	"2019-08-01-count-4:CACTTCGGTTGGGAAC"	3.9090105491573	-7.00833179866942	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTTCGGTTGGGAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.79753679865	49.6019771291717	0.0213636100232771	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2316.58157474712	2316.58157474712
"healthy-3"	"2019-08-01-count-2:CATTCCGAGATAGTCA"	0.199522097676438	8.12480352008668	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCCGAGATAGTCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1953.66604717132	38.9329952973244	0.0199281731663888	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1944.19286945807	1944.19286945807
"healthy-3"	"2019-08-01-count-4:AATGGAATCTCTGCTG"	-2.67682395401652	9.2059812315735	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAATCTCTGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2115.75073295753	42.6480941112963	0.0201574284942726	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2107.54882118329	2107.54882118329
"healthy-3"	"2019-08-01-count-4:GAATCGTGTACGTAGG"	-3.85970530930217	13.1997546919617	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCGTGTACGTAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2268.01089332232	34.0348644648152	0.0150064819199166	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2259.06696171918	2259.06696171918
"healthy-3"	"2019-08-01-count-3:GCTGCAGGTCATAGTC"	-3.29404268685039	10.0549316176209	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGCAGGTCATAGTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2091.61474847569	40.1156966158909	0.0191792951570675	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2088.37544148406	2088.37544148406
"healthy-3"	"2019-08-01-count-4:TGCAGTACAACTCCAA"	-3.03446612778361	9.63214109027711	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTACAACTCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2118.68960749532	46.6397029844339	0.0220134666349596	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2115.6025687827	2115.6025687827
"healthy-3"	"2019-08-01-count-4:AATTCCTAGGAACGCT"	-5.20985112610515	-4.34246542369994	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTCCTAGGAACGCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3477.69985321832	42.6237024008381	0.0122562912844228	4913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3471.70570081382	3471.70570081382
"healthy-3"	"2019-08-01-count-4:ATCGGCGCAACTCGAT"	11.1328598457271	5.6831483610901	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGCGCAACTCGAT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.4887893724	37.9554576627918	0.0190684106664871	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1987.0471770562	1987.0471770562
"healthy-3"	"2019-08-01-count-4:TACCGGGAGCCAAGCA"	-3.15189037743266	9.95910451495973	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGGGAGCCAAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.16986304645	35.7981633107458	0.0174355585258929	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.10471693845	2043.10471693845
"healthy-3"	"2019-08-01-count-2:GACTGATAGCAGTAAT"	-0.0489345890587151	7.98585794055787	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATAGCAGTAAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1976.08711738365	35.484012561545	0.0179567045649921	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.09115994551	1966.09115994551
"healthy-3"	"2019-08-01-count-3:CCTCTAGCACCAACAT"	-4.05800233307536	12.9652890929016	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGCACCAACAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2208.34549848391	43.072269263166	0.01950431637293	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2203.24075198038	2203.24075198038
"healthy-3"	"2019-08-01-count-2:TGTGATGGTTCACCGG"	2.34707512435262	-4.35584738170775	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGGTTCACCGG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2909.81347795907	42.4113000188981	0.0145752641329592	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2902.15765205702	2902.15765205702
"healthy-3"	"2019-08-01-count-4:TTCCTTCAGTACAGAT"	-5.25474343720134	-3.80762412464293	"2019-08-01-count-4"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTTCAGTACAGAT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3360.69790252617	43.0895001410943	0.0128215928330555	5512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3352.74919005628	3352.74919005628
"healthy-3"	"2019-08-01-count-4:ATCGTAGCACAATGTC"	-1.61150894585307	8.98415467822877	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTAGCACAATGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1988.67819468242	43.953684505738	0.0221019592929951	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1982.20205970424	1982.20205970424
"healthy-3"	"2019-08-01-count-2:TGTGCGGCAGTGTATC"	-2.27501974526103	10.2590923079285	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGCGGCAGTGTATC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1998.99027123587	41.582890197983	0.0208019472612413	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.99027123587	1998.99027123587
"healthy-3"	"2019-08-01-count-4:CAGATTGTCCTTGACC"	-1.95770583573039	9.37195775592653	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATTGTCCTTGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2181.34856437331	49.0789653940112	0.0224993685995853	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2174.59303462989	2174.59303462989
"healthy-3"	"2019-08-01-count-4:TCCCATGTCCATTTGT"	4.63078941878621	-7.89685203945311	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGTCCATTTGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.44209121173	43.6672605971087	0.0181309157303172	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2404.7791773322	2404.7791773322
"healthy-3"	"2019-08-01-count-2:TAACTTCTCCGTGTCT"	10.393797536462	7.38170001590577	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCTCCGTGTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2095.21090738538	44.3274752712763	0.021156569543919	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2089.94972629481	2089.94972629481
"healthy-3"	"2019-08-01-count-3:AGCGCTGAGAAACTAC"	-1.26861248436626	8.52518174732057	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGAGAAACTAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2158.88215962962	45.8348359491222	0.0212308188034616	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2152.99529037778	2152.99529037778
"healthy-3"	"2019-08-01-count-4:TTCGATTTCACCTTGC"	0.823958654969376	8.32867620075075	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTTCACCTTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.0171604495	40.3047388290891	0.0201220137425305	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1997.11430839919	1997.11430839919
"healthy-3"	"2019-08-01-count-3:TCCTAATAGTCGGCAA"	-1.61148057404216	8.53193280780641	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATAGTCGGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.22557611949	42.7486084569774	0.0216863097632547	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.1693942782	1966.1693942782
"healthy-3"	"2019-08-01-count-2:GTAGAGGTCCAAATGC"	-0.736390034586746	8.34982678974	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGTCCAAATGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1630.95612792712	42.0306763396759	0.0257705744624138	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1624.44818079583	1624.44818079583
"healthy-3"	"2019-08-01-count-2:TAAGCACTCAACTACG"	4.61543764647786	-8.35600569164427	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCACTCAACTACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.81160370978	45.2656462496954	0.01737103564404	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2600.56748844525	2600.56748844525
"healthy-3"	"2019-08-01-count-2:TAAGCACTCGTAACTG"	10.1738249259884	6.54067037189332	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCACTCGTAACTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.35749229972	41.2529402325218	0.0227244167650208	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1805.7217876271	1805.7217876271
"healthy-3"	"2019-08-01-count-4:ATGAAAGAGTTTAGGA"	9.78368534621541	7.08648870075075	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGAGTTTAGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.27308815431	37.6593021336835	0.0193097583935403	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1942.68146475262	1942.68146475262
"healthy-3"	"2019-08-01-count-2:CATTTCAAGAGCAGCT"	-0.388550679117996	8.57228658283082	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCAAGAGCAGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1973.92515458621	41.8602430938895	0.0212066009679403	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.52775730001	1966.52775730001
"healthy-3"	"2019-08-01-count-4:ACAACCACAGTATTCG"	-7.46066842499431	1.54469547355501	"2019-08-01-count-4"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCACAGTATTCG"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2607.9572787551	44.855538232616	0.0171994911872282	2949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2596.40567728941	2596.40567728941
"healthy-3"	"2019-08-01-count-2:AGACCATGTACAGTTC"	-4.09337697449382	10.9322681196961	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATGTACAGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.57318817437	45.1026724452012	0.0220058852767174	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.32260122925	2044.32260122925
"healthy-3"	"2019-08-01-count-4:CAGCAGCAGGTGCTGA"	-1.93619606915172	9.15810868823854	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCAGGTGCTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1788.36379411461	42.7037215965849	0.023878654744141	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1780.64787375443	1780.64787375443
"healthy-3"	"2019-08-01-count-4:CAGCAGCCACAGCTGC"	4.71884598311726	-8.37685015117797	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAGCCACAGCTGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.86594222879	45.5259340205507	0.018073980539142	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2511.01653492665	2511.01653492665
"healthy-3"	"2019-08-01-count-3:ACATCCCAGGATATAC"	11.1334759193355	6.04565332019655	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCCCAGGATATAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.0956691091	49.0049641116998	0.0251811690913087	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.01255788197	1938.01255788197
"healthy-3"	"2019-08-01-count-4:TGCGATACAATAAGGT"	2.53119601783101	-4.67606975948485	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGATACAATAAGGT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2605.33153269617	42.3128906432865	0.0162408853200723	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2600.11778640871	2600.11778640871
"healthy-3"	"2019-08-01-count-2:TAAGCGTAGCTTGTGT"	3.17289342459981	-5.34138395702513	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCGTAGCTTGTGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.18671596923	43.4998334015256	0.0157312463387408	2555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2761.7518584462	2761.7518584462
"healthy-3"	"2019-08-01-count-2:TGTTCATAGCCTCTCT"	4.5807281928951	-8.10071375286254	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATAGCCTCTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.72283455527	46.9044812182789	0.0175427612062418	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2666.58906307793	2666.58906307793
"healthy-3"	"2019-08-01-count-3:TCCTGCAAGTAGCATA"	5.38026632842366	-9.60592272197875	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAAGTAGCATA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2699.39068998844	40.1964964316879	0.0148909517176486	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2692.95612378761	2692.95612378761
"healthy-3"	"2019-08-01-count-2:TGTTCATAGTCATCGT"	10.0113731819088	7.61504886234132	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCATAGTCATCGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1880.93360911344	40.7772834160209	0.021679278427717	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1879.36477942318	1879.36477942318
"healthy-3"	"2019-08-01-count-4:GACCTTCGTAGCGTAG"	-1.95631776276286	8.75643537128297	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCGTAGCGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.55388077736	46.8469333891863	0.0247010822439617	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1891.12209058997	1891.12209058997
"healthy-3"	"2019-08-01-count-2:AGACTCAGTATCTTCT"	-1.34951327267345	10.0294151076111	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACTCAGTATCTTCT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2175.12717729467	47.494251978603	0.0218351609388074	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2164.7553618475	2164.7553618475
"healthy-3"	"2019-08-01-count-3:CCTTTGGCAAGAGGTC"	10.1604410606319	7.84575030887452	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTTGGCAAGAGGTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2436.1148476931	46.5617661033566	0.0191131243863353	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2423.16464267564	2423.16464267564
"healthy-3"	"2019-08-01-count-3:TCCTGCAGTCGAAACG"	4.63710941848103	-7.67098381435546	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAGTCGAAACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.50641312993	44.5606001647978	0.0177002926119251	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2514.26516084973	2514.26516084973
"healthy-3"	"2019-08-01-count-3:ACATGCAGTTATTCCT"	10.4129282432491	7.75983855808107	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATGCAGTTATTCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2320.55555113679	47.1655931288599	0.0203251299481948	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2309.69452297669	2309.69452297669
"healthy-3"	"2019-08-01-count-2:CACAGATAGAAGCGCT"	4.82895435866658	-8.2154636613098	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATAGAAGCGCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.02137940277	43.2683035562901	0.0167122233522348	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2584.70845146345	2584.70845146345
"healthy-3"	"2019-08-01-count-4:GACGCTGGTCGAAGCA"	-3.49359927597697	9.65859601581422	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGCTGGTCGAAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.03352513307	43.9160886012429	0.0207050421791366	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.33817240236	2119.33817240236
"healthy-3"	"2019-08-01-count-3:TTGTTCAAGAGTGACC"	-0.103822539479095	7.61236093128053	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTCAAGAGTGACC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.76107750729	39.7739231892382	0.0211028992819831	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1882.20543416057	1882.20543416057
"healthy-3"	"2019-08-01-count-3:GAGGCAACACGCGTCA"	-4.11295781555827	-5.31997396862181	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAACACGCGTCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2742.74707083516	49.096866391546	0.0179006175646361	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2738.09669876532	2738.09669876532
"healthy-3"	"2019-08-01-count-2:TTTCACAAGGGTCACA"	-2.02613673630412	8.66861245715944	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACAAGGGTCACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2129.92979487828	44.8279641494067	0.021046686260365	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2128.53108542838	2128.53108542838
"healthy-3"	"2019-08-01-count-2:GTAGGTTTCTACTCAT"	-2.05979881706889	9.19032380664674	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGTTTCTACTCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1944.74452131125	39.2079676390577	0.0201609862937789	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.5064024332	1937.5064024332
"healthy-3"	"2019-08-01-count-4:TGCTCGTGTGTCCGTG"	2.64651336249654	-6.18795349514159	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCGTGTGTCCGTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.47780006112	47.5298163955869	0.0195718554208693	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2425.23436986758	2425.23436986758
"healthy-3"	"2019-08-01-count-4:ATGAGTCTCATAAGGA"	3.29936232146565	-6.61957218563231	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGTCTCATAAGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.43797476667	48.2612125064158	0.0198488355480452	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2429.42249725822	2429.42249725822
"healthy-3"	"2019-08-01-count-4:TACTTACGTGTCCCTT"	3.56468166884724	-6.93561890041503	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACGTGTCCCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1998.17511537542	47.1592272475454	0.0236011483101095	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1991.86230489023	1991.86230489023
"healthy-3"	"2019-08-01-count-4:ACACCAACACTGCGTG"	-4.20112500611003	10.9660691984924	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAACACTGCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2088.96127500835	40.7755614837259	0.0195195391946952	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.53544999961	2085.53544999961
"healthy-3"	"2019-08-01-count-2:AGAGAGCAGTATTAGG"	3.93880118903462	-7.63863756572875	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCAGTATTAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.52938492511	48.4712413124846	0.0213198217862846	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2269.88400456549	2269.88400456549
"healthy-3"	"2019-08-01-count-3:TCCTTTCTCTTGGAAC"	10.6797787147457	7.07180402362672	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCTCTTGGAAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.60334567691	41.9803898467347	0.0216326483927046	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1936.50898904687	1936.50898904687
"healthy-3"	"2019-08-01-count-2:TGTTGAGGTTATTCCT"	-3.34263215485271	10.6802587279114	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGAGGTTATTCCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1958.51238738267	46.6637068822609	0.0238260973904901	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.97791730808	1947.97791730808
"healthy-3"	"2019-08-01-count-4:TTCTTCCCAACCCGCA"	10.7487284141475	6.65831325137941	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCCAACCCGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2216.02727012618	42.4444225979132	0.0191533846041057	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2207.08226457372	2207.08226457372
"healthy-3"	"2019-08-01-count-2:TCATCATGTAGTCCTA"	2.07082166251485	-5.858997844812	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCATGTAGTCCTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2750.62272618613	45.6803932251829	0.0166072914290652	2119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2745.02642439947	2745.02642439947
"healthy-3"	"2019-08-01-count-2:TACACCCAGCGTGCTC"	0.00881138545219299	8.4277305372986	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACACCCAGCGTGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1847.9505148137	41.0784732293144	0.0222292063018017	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.99688736262	1845.99688736262
"healthy-3"	"2019-08-01-count-4:AGCGTATAGCTGTCCG"	-3.99522862854655	10.8704681166443	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGTATAGCTGTCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.18159439138	47.9855694987812	0.0235202442913402	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2036.93340119445	2036.93340119445
"healthy-3"	"2019-08-01-count-4:TGCTTGCCACGGTGAA"	-3.23578153076823	12.8056421049866	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCCACGGTGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1951.81600027549	39.7241158703653	0.0203523876557823	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1942.91842426379	1942.91842426379
"healthy-3"	"2019-08-01-count-3:TTTACCAAGACTACCT"	2.16423787650411	-6.96776010906371	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCAAGACTACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.15079063387	49.6080096917356	0.0262177887392985	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1890.36559863134	1890.36559863134
"healthy-3"	"2019-08-01-count-2:ACACTGACATCTTTCA"	-3.21757564964946	9.8446359404358	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACTGACATCTTTCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2166.40554510853	43.5116081066905	0.0200847012254627	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2159.94079940574	2159.94079940574
"healthy-3"	"2019-08-01-count-3:ATGGATCAGCGTATGG"	5.04370083388631	-8.20897676860961	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGATCAGCGTATGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2768.85386959979	40.9333236533961	0.0147834900580407	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2757.14940514821	2757.14940514821
"healthy-3"	"2019-08-01-count-4:GTCGAATCATCCGCGA"	4.66881765899007	-8.13635828411254	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATCATCCGCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2585.5233583029	46.6663205997227	0.0180490810302924	2209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2583.18132948363	2583.18132948363
"healthy-3"	"2019-08-01-count-3:ATGGATCAGTCTTCCC"	-2.17499218407329	9.08611486041871	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGATCAGTCTTCCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.09429005996	48.0995851035769	0.0234621331012878	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.76562552638	2043.76562552638
"healthy-3"	"2019-08-01-count-4:AGCTACAGTTCTTCAT"	10.1312929588253	6.98486898029176	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTACAGTTCTTCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2032.96694230609	42.9487185463832	0.0211261273622406	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2026.94999717089	2026.94999717089
"healthy-3"	"2019-08-01-count-4:CAGTTCCAGCTTTCCC"	5.35413422164266	-9.60019876873168	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCAGCTTTCCC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.32124477676	42.5787395243917	0.0155605777668351	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2731.02159102837	2731.02159102837
"healthy-3"	"2019-08-01-count-4:TCCTTCTGTAGACAGC"	-0.413960854441482	8.49315736377565	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTCTGTAGACAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1997.1564498854	43.5724414998788	0.0218172399575301	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1993.91129331866	1993.91129331866
"healthy-3"	"2019-08-01-count-3:AGGCCACAGTCAGCCC"	4.88814701613728	-8.11491777813109	"2019-08-01-count-3"	"Control3"	"cDC1"	"cDC1"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCCACAGTCAGCCC"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3090.05557411121	43.7729292378927	0.0141657417441377	3998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3085.00667930708	3085.00667930708
"healthy-3"	"2019-08-01-count-3:ATGGGAGAGATCCTAC"	-1.3895814222401	8.76866242969362	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGAGAGATCCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.86878696131	44.4944230388871	0.0211488583863407	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2099.86706291861	2099.86706291861
"healthy-3"	"2019-08-01-count-2:CCACGAGAGGGAGGCA"	-1.82815502110179	8.89794442737428	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGAGAGGGAGGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.24398251763	43.2876627453826	0.020798937130388	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2074.2393573306	2074.2393573306
"healthy-3"	"2019-08-01-count-3:TAGGTTGAGCTTACGT"	3.36214842376057	-5.76256849682006	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGAGCTTACGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.28126938024	43.0357540652825	0.0157048674331944	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2737.34238737036	2737.34238737036
"healthy-3"	"2019-08-01-count-3:ATGGGTTAGGTCCGAA"	-3.53781710091289	13.3272599943909	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTAGGTCCGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1906.66724536966	43.7065244029531	0.0229229953517554	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1900.56450926858	1900.56450926858
"healthy-3"	"2019-08-01-count-2:AAGTACCGTATTGGCT"	0.0359774912590205	8.29862783038942	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCGTATTGGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.17051147135	38.4541966977329	0.0199848175972348	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1910.18409266773	1910.18409266773
"healthy-3"	"2019-08-01-count-4:TTGACCCAGCCATTGT"	-3.84181247177776	13.3331432112488	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGACCCAGCCATTGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2394.03039759139	41.626253215972	0.0173875207507188	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2384.13511014599	2384.13511014599
"healthy-3"	"2019-08-01-count-3:TCGATTTGTAACGATA"	-4.42836556854899	12.8621930846008	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGATTTGTAACGATA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2568.35891155275	44.9985245408749	0.0175203412336441	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2565.45528422165	2565.45528422165
"healthy-3"	"2019-08-01-count-2:CCACGTTCAGCGTGAA"	4.1791430908138	-7.58486177837523	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTCAGCGTGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.96454593782	47.2173544213955	0.0190241856994594	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2477.31611950929	2477.31611950929
"healthy-3"	"2019-08-01-count-2:GGAACCCTCGCGTTTC"	5.53916801986043	-10.0448742142883	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAACCCTCGCGTTTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.0235681569	49.0107772169633	0.0202941196364255	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2405.00471198761	2405.00471198761
"healthy-3"	"2019-08-01-count-4:TTGAGTGTCCCGAGTG"	-4.25695453110393	10.4295749434265	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAGTGTCCCGAGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2262.27588326818	41.6623587896677	0.0184161264759099	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2254.37037568381	2254.37037568381
"healthy-3"	"2019-08-01-count-3:TCGCACTAGTTACGTC"	10.3718601661617	7.70322415912477	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTAGTTACGTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.52893185515	44.328860108452	0.0221474990458244	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1990.44939270287	1990.44939270287
"healthy-3"	"2019-08-01-count-3:AGGGAGTCAGTCCCGA"	-0.537533263594467	8.25819203937379	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTCAGTCCCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1902.11946677385	44.3488004941202	0.0233154653368537	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1895.6702245757	1895.6702245757
"healthy-3"	"2019-08-01-count-2:AGATCGTGTCTTCGAA"	-3.90839872780498	10.6425208815369	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCGTGTCTTCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2044.88213770739	49.0131060903839	0.0239686704610441	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.27230627923	2043.27230627923
"healthy-3"	"2019-08-01-count-4:ATGGTTGAGTCTCTGA"	-2.22499857369121	9.57662293994752	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGAGTCTCTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.48851910264	39.6898021969731	0.0198599100358078	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1993.14816530681	1993.14816530681
"healthy-3"	"2019-08-01-count-2:TACCGAACAATAGGGC"	4.77570309218709	-8.37795832073363	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGAACAATAGGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.80016150709	43.012176672989	0.0162875545449991	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2635.38408536932	2635.38408536932
"healthy-3"	"2019-08-01-count-4:ATGGTTGTCGCTATTT"	-2.65692267838176	9.47964189136354	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGTCGCTATTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1825.01693028825	39.8592323609485	0.0218404726550416	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1823.17372243187	1823.17372243187
"healthy-3"	"2019-08-01-count-3:TTTCACACATATTCGG"	4.51209129866902	-8.12266542827757	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCACACATATTCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.45002611042	45.0112073504382	0.0174229061508908	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2580.41664887162	2580.41664887162
"healthy-3"	"2019-08-01-count-3:CGATCGGAGCATGTTC"	-4.30636201325114	10.8858814009461	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATCGGAGCATGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2085.93046405989	39.5349986076991	0.0189531718764734	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2082.49726730441	2082.49726730441
"healthy-3"	"2019-08-01-count-2:TTACCATCATTGACTG"	-1.61048338833507	8.91866300189821	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATCATTGACTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2247.59415748023	43.9218994585509	0.0195417394694564	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2243.10573046627	2243.10573046627
"healthy-3"	"2019-08-01-count-4:CATACCCGTTGTCCCT"	0.0920503000611484	8.36231229389039	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACCCGTTGTCCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2012.59740684053	40.2646107553861	0.0200062916798623	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.36763069644	2004.36763069644
"healthy-3"	"2019-08-01-count-3:CGATGCGGTGTCTAAC"	-2.49095068398173	9.15079019153444	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGCGGTGTCTAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.74860394373	45.2836309302996	0.0233090533887786	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.4782019324	1937.4782019324
"healthy-3"	"2019-08-01-count-4:GAGACCCAGCGGCTCT"	-2.68784676018413	9.08527181232301	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCAGCGGCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.71567785956	46.743881074396	0.0251484837789849	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.0751630581	1855.0751630581
"healthy-3"	"2019-08-01-count-2:CCATAAGGTATTTCCT"	4.13359417495076	-8.37726786052855	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGGTATTTCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.29266584834	47.1999523435381	0.0195178825996151	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2418.29266584834	2418.29266584834
"healthy-3"	"2019-08-01-count-2:AGCATCAGTCTACGTA"	-3.40156541290935	-5.27955009853514	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCATCAGTCTACGTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3064.69805624115	47.0370719932821	0.0153480281352653	3258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3060.64060090393	3060.64060090393
"healthy-3"	"2019-08-01-count-4:GTCTGTCTCTTCCACG"	-4.14989219132121	13.0638799437317	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCTCTTCCACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1742.15424720409	45.8606276730778	0.0263240914211113	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1738.10906957279	1738.10906957279
"healthy-3"	"2019-08-01-count-3:TCGCTTGCACTTGTGA"	-3.56953773918803	12.0341148146423	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGCACTTGTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2178.37058987992	49.7971916779223	0.0228598347357725	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2171.09787451904	2171.09787451904
"healthy-3"	"2019-08-01-count-2:AGCCAATCAAGCGAGT"	-4.46634040299113	13.0426826247009	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATCAAGCGAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2454.90008333666	45.3182552670727	0.0184603257683208	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2450.2443921347	2450.2443921347
"healthy-3"	"2019-08-01-count-4:CATACTTGTTCCGCAG"	3.83246149596516	-6.81938841259154	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACTTGTTCCGCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.8621741626	47.745491561955	0.0230893007080078	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2067.8621741626	2067.8621741626
"healthy-3"	"2019-08-01-count-4:CATACTTTCTCGGTCT"	4.32694878157918	-7.66237928783568	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACTTTCTCGGTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.72887255665	42.7793955171573	0.0164743404555125	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2595.51188416996	2595.51188416996
"healthy-3"	"2019-08-01-count-3:CGCATAACAGGCGATA"	-4.07961163941081	13.3543662794861	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCATAACAGGCGATA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2124.34237287016	42.2786500491749	0.0199019944191261	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2122.64569660357	2122.64569660357
"healthy-3"	"2019-08-01-count-3:TTTCCTCAGGTACAGC"	-0.0392694276874841	8.0314731367859	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCCTCAGGTACAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1783.90926585174	36.495460038997	0.0204581369342078	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1776.13683160239	1776.13683160239
"healthy-3"	"2019-08-01-count-4:GTGAGCCAGGGTTAAT"	5.64997543868367	-9.97226526653441	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGCCAGGGTTAAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.73629085926	42.9794840852508	0.0168300400629031	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2548.32310625773	2548.32310625773
"healthy-3"	"2019-08-01-count-3:TGTAGACAGTCATCCA"	-3.27645764771159	3.61293337428895	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACAGTCATCCA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3246.9650400702	47.2884766179781	0.0145639007609874	5620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3239.40426729116	3239.40426729116
"healthy-3"	"2019-08-01-count-3:AAACGAAGTAACAGGC"	3.09360923346822	-6.43014528667601	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGAAGTAACAGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.04878982824	44.1288797747809	0.0173186949759135	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2547.43075882035	2547.43075882035
"healthy-3"	"2019-08-01-count-4:TTGCGTCTCGGTGAAG"	-4.3053482574528	13.09370229328	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCGTCTCGGTGAAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2155.9703755965	44.6116430294632	0.0206921410119655	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2150.19581101232	2150.19581101232
"healthy-3"	"2019-08-01-count-4:AGGAGGTCAGCACAGA"	3.83303274688069	-7.21761610424193	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTCAGCACAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.49264567663	43.257580511364	0.0172238531479792	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2502.6831112294	2502.6831112294
"healthy-3"	"2019-08-01-count-4:AGGAGGTCATACGCAT"	-4.20996890488322	11.8322639235291	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTCATACGCAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2141.63677742968	39.4835138575323	0.018436139252763	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2137.08731436763	2137.08731436763
"healthy-3"	"2019-08-01-count-2:AGCCAGCAGAAATTCG"	-3.75762162628825	10.7193012007507	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCAGAAATTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2120.06536223983	49.1896744314342	0.0232019612732438	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2116.77878399854	2116.77878399854
"healthy-3"	"2019-08-01-count-3:GATCACAGTATCCTCC"	-0.818235973746139	8.37595937335817	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCACAGTATCCTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2061.86856101022	42.2511643387934	0.0204916865884469	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.55155801319	2050.55155801319
"healthy-3"	"2019-08-01-count-2:GTCCCATAGTGGATTA"	3.99566592749898	-8.00573732769164	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATAGTGGATTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.18801992185	45.8124486582617	0.018330933204335	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2498.16720094337	2498.16720094337
"healthy-3"	"2019-08-01-count-4:CATCCACTCACCATAG"	-0.0382193801110566	8.39787480914918	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACTCACCATAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.37060227198	44.6742082475902	0.0229761796415708	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1941.49180281149	1941.49180281149
"healthy-3"	"2019-08-01-count-4:TGGGCGTAGCTAATCC"	-3.7692006630009	-5.47232630169066	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTAGCTAATCC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2625.84685027599	51.7415266269327	0.0197047008364157	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2616.43033289347	2616.43033289347
"healthy-3"	"2019-08-01-count-1:TTGGGTACATGAGATA"	10.7334314781124	6.52410314166871	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTGGGTACATGAGATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.82965090265	45.3651648997558	0.0217075898411918	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2078.36596305099	2078.36596305099
"healthy-3"	"2019-08-01-count-3:GGCTTTCCATCCTAAG"	-2.35730967941936	9.52204034412233	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCCATCCTAAG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2231.62938528442	43.3104990717968	0.0194075680116916	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2225.60515111408	2225.60515111408
"healthy-3"	"2019-08-01-count-3:TCGGGACCACATTACG"	-4.04498324814494	12.2370633848938	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACCACATTACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1963.3101763688	42.5563189649605	0.0216758001242929	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1963.3101763688	1963.3101763688
"healthy-3"	"2019-08-01-count-3:TCGGGACGTACAGAAT"	4.04774679717366	-7.8061938515869	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACGTACAGAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.28470150413	46.3423304472213	0.0201990321501247	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2292.88338708204	2292.88338708204
"healthy-3"	"2019-08-01-count-3:CGGAACCGTTGCATCA"	-3.39256606522258	10.082529044989	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAACCGTTGCATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2099.18460223846	43.5434687305978	0.0207430393135341	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2088.76969244098	2088.76969244098
"healthy-3"	"2019-08-01-count-3:GGGAAGTAGGCTAACG"	-3.46964559975322	-5.54853823101195	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTAGGCTAACG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2521.91111095977	49.7619212871771	0.0197318299883452	2114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2517.84927144526	2517.84927144526
"healthy-3"	"2019-08-01-count-3:TGTCCCAAGATTTGCC"	-0.567528585821945	8.1077089079651	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCCAAGATTTGCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.85252714137	41.7287702311911	0.0216789440452164	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1913.64669044807	1913.64669044807
"healthy-3"	"2019-08-01-count-2:GGAGCAAGTTGCATGT"	4.80922331389729	-9.10375883495482	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGCAAGTTGCATGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.7784902079	46.9013093935945	0.0198332780798726	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2361.6196436116	2361.6196436116
"healthy-3"	"2019-08-01-count-3:CGGAATTAGACCTCCG"	4.09779085692708	-7.23628904735716	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAATTAGACCTCCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.22291398054	46.9832819129498	0.0195827080673384	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2394.25431748721	2394.25431748721
"healthy-3"	"2019-08-01-count-2:TACGTCCTCTTACTGT"	0.168461938470048	8.03467128360597	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCTCTTACTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2093.32582321792	37.8405119360813	0.0180767425292217	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.13424101185	2084.13424101185
"healthy-3"	"2019-08-01-count-3:CGGAATTAGACGATAT"	11.1955295997554	6.41588018024293	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAATTAGACGATAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2233.14841610905	47.5400163623899	0.0212883371384791	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2225.26135776611	2225.26135776611
"healthy-3"	"2019-08-01-count-4:TATCGCCAGTATAGAC"	-2.66280851784404	8.94404504382936	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCGCCAGTATAGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2076.62693849609	36.9281836806148	0.0177827721465264	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2062.45992063556	2062.45992063556
"healthy-3"	"2019-08-01-count-3:AGGTCTATCGTTCATT"	4.02379717406575	-7.2997617951599	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTATCGTTCATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.32728447262	47.8389692924826	0.0192253525454638	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2486.45312877521	2486.45312877521
"healthy-3"	"2019-08-01-count-2:GGAGGATCATAGACTC"	10.3747402625972	6.25428149783937	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATCATAGACTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.43635456936	39.4711365918458	0.0211819075521727	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1857.58509618415	1857.58509618415
"healthy-3"	"2019-08-01-count-2:AGCGCTGAGCCGAATG"	-2.78691087189372	-5.66042663967284	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGAGCCGAATG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2740.01430838238	46.9187923295501	0.0171235574157456	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2736.10710165854	2736.10710165854
"healthy-3"	"2019-08-01-count-4:GAGGGATTCTCTTCAA"	-3.62356481972392	10.3803014525208	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGATTCTCTTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.61621499991	48.5074518495252	0.0251253726518233	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1927.14488347175	1927.14488347175
"healthy-3"	"2019-08-01-count-2:GAGTTGTGTAGAGACC"	-3.11119757118877	9.29471108997194	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTGTGTAGAGACC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2010.88747840803	40.1253334115179	0.0199540421044763	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.56447380443	2002.56447380443
"healthy-3"	"2019-08-01-count-3:CGGAGAAAGGCACGAT"	-3.37800393524821	-5.58163740551146	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAAAGGCACGAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2694.75484311128	44.0449570518326	0.0163446990973694	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2688.49176259646	2688.49176259646
"healthy-3"	"2019-08-01-count-4:CATCGCTTCATGCCAA"	10.829588552087	7.07103154743043	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTTCATGCCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2189.77641157691	41.7463901284394	0.0190642249627563	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2180.20360466847	2180.20360466847
"healthy-3"	"2019-08-01-count-2:CCCTAACCATGGATCT"	-2.93091831627544	9.11254212940065	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACCATGGATCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.61006628842	43.561042040081	0.0212637059423431	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2046.84559503625	2046.84559503625
"healthy-3"	"2019-08-01-count-4:ACCTACCTCCTCACGT"	3.55580606040303	-6.69515707409056	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTACCTCCTCACGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2809.77918245053	41.7897380138262	0.0148729616458257	2274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2807.13856206319	2807.13856206319
"healthy-3"	"2019-08-01-count-4:CTCTGGTTCCCAAGCG"	-3.84453545036967	-4.81438162243041	"2019-08-01-count-4"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTGGTTCCCAAGCG"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3313.62721929805	46.4255945382416	0.0140105061510438	3922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3308.20155811597	3308.20155811597
"healthy-3"	"2019-08-01-count-3:CGGAGAACACGCGGTT"	-0.103237415582496	9.79644582355348	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAACACGCGGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.71240243488	42.7956492761629	0.0222463863215705	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1920.44321381925	1920.44321381925
"healthy-3"	"2019-08-01-count-3:TCGTAGAAGCGCATCC"	-4.35502992096599	12.9707250365051	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTAGAAGCGCATCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2525.97808301641	43.116951742824	0.017069408492783	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2523.41811797443	2523.41811797443
"healthy-3"	"2019-08-01-count-4:ACCTGAACAGAAGCTG"	-2.47307739678081	8.77789590442506	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAACAGAAGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2028.03285354668	41.3522736155536	0.0203903371403652	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2026.39066806873	2026.39066806873
"healthy-3"	"2019-08-01-count-2:ACCATTTGTCTGTGAT"	3.57716836509053	-5.85893633281859	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCATTTGTCTGTGAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2728.68123733429	44.1561002843418	0.0161822127407886	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2724.66921064816	2724.66921064816
"healthy-3"	"2019-08-01-count-4:CATCGGGGTGTTGACT"	-3.86508331719096	12.2924995192322	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGGTGTTGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.93519154066	45.4903264210768	0.0225653714523984	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2009.10680315216	2009.10680315216
"healthy-3"	"2019-08-01-count-2:CCCTCAACATAGGTAA"	-1.33264909210857	8.69398686969606	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAACATAGGTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.50182106148	48.6932884940891	0.0253412658579682	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.99661777288	1917.99661777288
"healthy-3"	"2019-08-01-count-3:TCGTGCTTCCCTCTAG"	3.2244984107906	-6.63903524791869	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTGCTTCCCTCTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.45951446551	45.5838592497868	0.0202553562758107	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2246.5589903712	2246.5589903712
"healthy-3"	"2019-08-01-count-2:AGCGTCGGTATCTTCT"	-5.6991437477177	-5.3926367989746	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTCGGTATCTTCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2723.92959136005	45.9904433576895	0.0168838590775493	2263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2718.98259665948	2718.98259665948
"healthy-3"	"2019-08-01-count-2:TTAGTCTGTTCTAACG"	-2.58497963371928	9.26533506000368	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTGTTCTAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.63905992955	47.4573212609641	0.0272486546454026	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1737.79301700504	1737.79301700504
"healthy-3"	"2019-08-01-count-4:ATTCCCGAGAGGGTAA"	5.35338081893269	-9.55669977581175	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCCGAGAGGGTAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.96736727463	48.3945155580407	0.0200560174225235	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2411.82476651394	2411.82476651394
"healthy-3"	"2019-08-01-count-3:TATTGGGAGCTGTTCA"	-3.17449269715007	10.2740773924622	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGAGCTGTTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.61692145624	43.0140219358873	0.0229210455496206	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1871.60199278543	1871.60199278543
"healthy-3"	"2019-08-01-count-2:CCCTCTCAGCCTAACT"	-0.0720337507432282	7.66042563999025	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCAGCCTAACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2081.26792324761	46.0328100905785	0.0221176762378334	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.78274448162	2072.78274448162
"healthy-3"	"2019-08-01-count-3:GGGAGATGTGTTGACT"	-2.74642286720927	10.0024776228699	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGATGTGTTGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.35389055991	47.0859034904629	0.0260236008754992	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1803.79591552683	1803.79591552683
"healthy-3"	"2019-08-01-count-4:TTGTTCAGTGGATCGA"	-2.64692197266276	10.3530416258606	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCAGTGGATCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.34668633699	43.4239581235639	0.0240663052463155	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1799.12052125909	1799.12052125909
"healthy-3"	"2019-08-01-count-4:TCGTCCACATGGATCT"	-3.69622598114665	12.6833314665589	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCACATGGATCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2016.68399883031	41.6351267129956	0.0206453399427695	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2013.12151507165	2013.12151507165
"healthy-3"	"2019-08-01-count-3:CGGGACTTCTGGCCAG"	-4.13371072235759	9.88857457721559	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGACTTCTGGCCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1929.22322532981	49.6235545367369	0.0257220387382873	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1929.22322532981	1929.22322532981
"healthy-3"	"2019-08-01-count-4:GAGTTACGTAATCAGA"	-4.11211238327678	11.3945741423401	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTACGTAATCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2140.52640787447	42.9763942754268	0.0200774884707459	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2137.34995971139	2137.34995971139
"healthy-3"	"2019-08-01-count-3:CGGGCATGTAACGCGA"	4.48127665099446	-8.20332529461058	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATGTAACGCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2903.77590568941	41.2051483613504	0.014190195696788	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2896.66751117373	2896.66751117373
"healthy-3"	"2019-08-01-count-2:GATCACATCAACCGAT"	-2.42736373367961	9.57411573016969	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACATCAACCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.8712708351	37.3533506479496	0.0189623307883028	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1962.72469354307	1962.72469354307
"healthy-3"	"2019-08-01-count-2:TAGACCAGTCCATCTC"	3.63003911551778	-7.37412502681883	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAGTCCATCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.39643931312	44.5336173114109	0.0190363704770306	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2336.82292003116	2336.82292003116
"healthy-3"	"2019-08-01-count-3:TCAAGACAGCATGTTC"	3.84234489974324	-6.69945528423461	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGACAGCATGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.57543462803	44.8618688374555	0.016976570753512	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2635.57068261451	2635.57068261451
"healthy-3"	"2019-08-01-count-4:GTGGAGACAACCGCTG"	5.49244417723958	-10.0696315995422	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGAGACAACCGCTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.10652304004	41.383741148315	0.0163049662307897	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2535.73271109252	2535.73271109252
"healthy-3"	"2019-08-01-count-3:CGGGTCACAGTGTATC"	-2.16940770569499	8.96445748889772	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTCACAGTGTATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.29611059031	31.3309666245004	0.0191241170762538	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1636.17384809286	1636.17384809286
"healthy-3"	"2019-08-01-count-4:ATTCGTTTCGAGATGG"	3.23300995406453	-6.51095011150511	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCGTTTCGAGATGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2789.0232850399	48.3031925547612	0.0173190352385567	2569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2778.8079987509	2778.8079987509
"healthy-3"	"2019-08-01-count-4:ATTCTACCACATGTTG"	4.09388794478719	-8.17588713085326	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTACCACATGTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.77079975746	48.0418840141433	0.0204279617805859	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2350.34034759818	2350.34034759818
"healthy-3"	"2019-08-01-count-4:CGAGGCTGTCTAGGTT"	-1.0835693878239	8.8630332716736	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTGTCTAGGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1800.73373204809	42.466228671147	0.0235827362565411	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1795.16101807575	1795.16101807575
"healthy-3"	"2019-08-01-count-4:TTTACCACACAAGCTT"	10.55038513717	6.93345401370851	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCACACAAGCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2262.58949772411	43.170112960945	0.0190799581649119	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2256.37143806319	2256.37143806319
"healthy-3"	"2019-08-01-count-2:TAGAGTCAGACCTGGA"	-1.29269478741344	9.1319312819275	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCAGACCTGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2112.37964650995	47.9472532803015	0.0226982177940975	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.10211836545	2108.10211836545
"healthy-3"	"2019-08-01-count-2:AAAGTCCAGCTCGCAC"	3.2670325237209	-6.68256094371947	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTCCAGCTCGCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.35060857572	45.3025107639229	0.017812137505215	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2538.70061850294	2538.70061850294
"healthy-3"	"2019-08-01-count-3:GTTACAGTCTACTGCC"	-3.42382464829143	10.1593045958313	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGTCTACTGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.08159197801	45.6314722800956	0.0238523398434436	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.8296422796	1909.8296422796
"healthy-3"	"2019-08-01-count-3:AACCAACCACTAGTAC"	4.12270845946614	-8.57384684002074	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACCACTAGTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.87762518639	46.4158114275116	0.0198793336861954	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2330.33580123184	2330.33580123184
"healthy-3"	"2019-08-01-count-3:ACGTTCCGTGGCACTC"	-3.0883461040562	9.79868409717409	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTTCCGTGGCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2484.871147238	44.4290042457112	0.0178798020553683	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2478.35663500096	2478.35663500096
"healthy-3"	"2019-08-01-count-3:TCAATCTAGCGACCCT"	-5.06250701370891	-4.34687855159911	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTAGCGACCCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3365.49319708348	40.9700472181311	0.0121735641164378	4187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3359.32816063416	3359.32816063416
"healthy-3"	"2019-08-01-count-2:TTCAGGACAGCTTTGA"	-3.20445189896281	9.91300771320192	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGACAGCTTTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1927.2415495281	47.021592232609	0.0243983906657277	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1923.81591933817	1923.81591933817
"healthy-3"	"2019-08-01-count-4:CATGCTCCAGGTCAAG"	-2.57328639450725	8.92493913257448	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCCAGGTCAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.96597836923	46.9951924923553	0.0238195655716272	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1969.53313093782	1969.53313093782
"healthy-3"	"2019-08-01-count-2:CCGATGGTCCTCTAAT"	0.165346753864926	8.0254769095215	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATGGTCCTCTAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1791.77979646548	39.9273007642198	0.0222835980420037	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1781.86766822605	1781.86766822605
"healthy-3"	"2019-08-01-count-3:TCTCACGAGTGAACAT"	4.3100434738094	-7.75537683880004	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGAGTGAACAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.37592734882	47.7174359843486	0.0197475216684115	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2413.11812516286	2413.11812516286
"healthy-3"	"2019-08-01-count-2:AGGACGAGTGCGACAA"	-3.84069261971172	13.2325172194275	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGAGTGCGACAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1996.09533371448	43.5476888732698	0.0218164373904091	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1992.47158081456	1992.47158081456
"healthy-3"	"2019-08-01-count-2:GATCGTAGTCCGGATC"	-1.87876794758495	9.35408017719118	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCGTAGTCCGGATC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2044.69397401653	43.0952613480533	0.0210766314645112	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.48974722691	2033.48974722691
"healthy-3"	"2019-08-01-count-3:CGGTCAGTCCACAAGT"	-1.33277891102489	9.16042993152467	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGTCCACAAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2049.83260948305	41.81696194211	0.0204001837753259	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2049.83260948305	2049.83260948305
"healthy-3"	"2019-08-01-count-4:TCAAGCAAGATGGCGT"	3.13036026534383	-7.02848436748656	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCAAGATGGCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.8391138348	48.9915257152611	0.0223415960642847	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2185.34319687385	2185.34319687385
"healthy-3"	"2019-08-01-count-2:GATGACTTCCACATAG"	3.87911214408223	-7.26327898418578	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGACTTCCACATAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.43184295546	51.7702097019971	0.0224557537279567	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2303.06321567804	2303.06321567804
"healthy-3"	"2019-08-01-count-2:AGGACTTAGGTTTGAA"	-3.09797416153606	-5.630002998468	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTAGGTTTGAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2652.73865060008	41.5429940274829	0.0156604172137671	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2649.18905186049	2649.18905186049
"healthy-3"	"2019-08-01-count-3:TCTCCGAAGATAGCAT"	4.47709002074544	-7.88914635097655	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCCGAAGATAGCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.15003867173	42.9003123217307	0.01641708730339	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2608.16919315631	2608.16919315631
"healthy-3"	"2019-08-01-count-2:CTTCCGATCCTTGACC"	-5.62213836136516	-5.46149637615355	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGATCCTTGACC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2869.68289162749	49.6248769938131	0.0172928086021621	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2864.15379182273	2864.15379182273
"healthy-3"	"2019-08-01-count-4:TTTACTGGTTCTCCTG"	10.775238652795	6.3250465163025	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACTGGTTCTCCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2004.28856629958	44.0695403366958	0.0219876224799601	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1988.24019776767	1988.24019776767
"healthy-3"	"2019-08-01-count-4:GGGCCATTCTGGCCAG"	-2.58981213989909	9.25769422138063	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCCATTCTGGCCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.74719673488	46.3031894695531	0.0217616028542335	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2118.45253816431	2118.45253816431
"healthy-3"	"2019-08-01-count-4:TCTATACGTGGGCTCT"	-2.79552469673808	9.29779908740846	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACGTGGGCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2294.89072446135	44.966434258472	0.0195941505097269	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2278.3960232616	2278.3960232616
"healthy-3"	"2019-08-01-count-3:TCTCTGGCATGCAGCC"	4.2536264854366	-7.58996155178221	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGCATGCAGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.4323504723	42.9556712310939	0.0163240644295431	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2627.28236372462	2627.28236372462
"healthy-3"	"2019-08-01-count-4:CATTCCGAGCACGGAT"	3.79521622237508	-6.71749880230101	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGAGCACGGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.0341036662	44.6294638142608	0.017198025933921	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2591.71053246312	2591.71053246312
"healthy-3"	"2019-08-01-count-3:AGTCTCCTCAGAACCT"	5.00592197951619	-7.7673230401245	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCTCAGAACCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.60814617589	45.3563834513307	0.0174945000918212	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2588.00066109262	2588.00066109262
"healthy-3"	"2019-08-01-count-4:ATTTCACGTCTACGAT"	3.77746524390523	-6.96517803585204	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACGTCTACGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.33067343264	51.6482711241005	0.0200705924261204	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2570.44921900951	2570.44921900951
"healthy-3"	"2019-08-01-count-3:CTTCCTTTCAAATGCC"	-2.28397260132487	8.69678876483766	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTTCAAATGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2157.86225322308	43.4128264595265	0.0201184419416407	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.00672856155	2151.00672856155
"healthy-3"	"2019-08-01-count-2:CCGGTAGGTTAAACAG"	0.288660799234551	8.69988725269166	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGGTTAAACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1978.06247999109	38.2886634030055	0.0193566501515048	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1971.61598562786	1971.61598562786
"healthy-3"	"2019-08-01-count-4:AGTACCAGTCTTAGTG"	-4.19895873490031	13.1686153181824	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCAGTCTTAGTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2014.25474281431	45.4747625966492	0.0225764704086594	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2008.8542718757	2008.8542718757
"healthy-3"	"2019-08-01-count-2:ACGATGTTCAGTGGGA"	5.42789902266805	-10.2103357545105	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTTCAGTGGGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.56332089883	47.0913197008405	0.0192873636730029	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2430.18648272377	2430.18648272377
"healthy-3"	"2019-08-01-count-2:AACACACAGAAGCCTG"	-2.12132511559184	9.49085900867311	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACACACAGAAGCCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.49870117165	47.1131407701407	0.0229652306107888	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.6635540635	2044.6635540635
"healthy-3"	"2019-08-01-count-4:TGTCCTGCAAGTTGGG"	-1.01655350151713	8.54123017871705	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGCAAGTTGGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.09422944646	47.2667714073163	0.0247198964775913	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.49171953273	1908.49171953273
"healthy-3"	"2019-08-01-count-3:CGTCAAATCGCAATGT"	-3.58292994919475	10.6140222319397	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAATCGCAATGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1791.58511551074	50.2736018335845	0.0280609619930073	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1783.88959207796	1783.88959207796
"healthy-3"	"2019-08-01-count-2:CCGGTGATCCGTATAG"	-5.43450150910075	3.2257132300171	"2019-08-01-count-2"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTGATCCGTATAG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2873.70136614882	45.3143639956101	0.0157686405864566	3350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2864.35380579207	2864.35380579207
"healthy-3"	"2019-08-01-count-4:ACGTACATCTAAACGC"	-3.84726653519328	10.598419166449	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTACATCTAAACGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2113.2045152726	41.1643464697077	0.0194795847596405	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.08970660404	2108.08970660404
"healthy-3"	"2019-08-01-count-2:TTTGATCAGAAGCGAA"	-4.30059180679973	12.6607303389343	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCAGAAGCGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1758.4420726356	44.7524192386525	0.0254500389492936	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1754.54486252037	1754.54486252037
"healthy-3"	"2019-08-01-count-4:TCACAAGCAGCGTTTA"	-2.00329051438029	8.91370008075563	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACAAGCAGCGTTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.8229122916	43.5387329403543	0.021957953315173	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.69244396976	1975.69244396976
"healthy-3"	"2019-08-01-count-4:CGCATGGTCATCTGTT"	10.0892111259395	7.51838347995607	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGTCATCTGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2157.09334831173	39.2864000649781	0.0182126564414683	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2149.86044478717	2149.86044478717
"healthy-3"	"2019-08-01-count-3:TTACCATTCGCATAGT"	10.8211723762447	6.78334519946901	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATTCGCATAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.06828637443	43.1903262600532	0.0221708481998007	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1946.77154522053	1946.77154522053
"healthy-3"	"2019-08-01-count-4:TTTCAGTAGACCAACG"	-1.65330312672313	8.76891324603883	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTAGACCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.99308353678	46.9639673853258	0.0228202746457318	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.89565793684	2051.89565793684
"healthy-3"	"2019-08-01-count-3:AGTGATCCAGATCCTA"	-4.82563624802287	-5.05931379711302	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCCAGATCCTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3134.05724694091	47.3959710391091	0.0151228798023301	3177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3130.90768982002	3130.90768982002
"healthy-3"	"2019-08-01-count-2:TTCCGGTGTCAAATCC"	9.00195469435994	6.1476635702881	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTGTCAAATCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.81654122782	43.7342374324725	0.0237065510066195	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1834.94919465278	1834.94919465278
"healthy-3"	"2019-08-01-count-2:CAGGCCATCTCCAATT"	-1.42555962029155	8.66408441150514	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCATCTCCAATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2050.08941031934	40.956744481412	0.0199780284095182	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2039.52262012084	2039.52262012084
"healthy-3"	"2019-08-01-count-4:TTTCAGTCATCACCAA"	2.99674429473225	-6.15195562755736	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTCATCACCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2800.14542969891	40.0708561407462	0.0143102767862506	2519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2797.23955675658	2797.23955675658
"healthy-3"	"2019-08-01-count-3:GGGTTATGTATGGAGC"	-2.30333028259929	8.85960004413453	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTTATGTATGGAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2007.49071206519	42.4936481695706	0.0211675440958108	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.03890778958	1998.03890778958
"healthy-3"	"2019-08-01-count-3:CCATAAGAGCTCCCTT"	5.32485498961751	-9.33853914653929	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATAAGAGCTCCCTT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2739.4145159987	44.2078074871936	0.0161376846143625	2380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2733.99474227479	2733.99474227479
"healthy-3"	"2019-08-01-count-2:TCCTGCAGTGAATAAC"	10.9006859260494	6.06435439670411	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCAGTGAATAAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2118.77179997562	34.8321150097015	0.0164397671377834	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2111.51601831772	2111.51601831772
"healthy-3"	"2019-08-01-count-2:TATACCTCAATCACGT"	-1.87053833428081	8.77069184863893	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATACCTCAATCACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2184.22245071652	49.9005547999579	0.0228459124131741	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.80506334095	2179.80506334095
"healthy-3"	"2019-08-01-count-4:TTTCATGGTACCGCGT"	-2.55573330345805	9.43466374957887	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCATGGTACCGCGT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2111.64323780759	45.5832640639759	0.0215866313247605	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2106.97921525899	2106.97921525899
"healthy-3"	"2019-08-01-count-3:TCTTCCTTCGTGACTA"	-3.97405467453654	11.3488664397034	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTCCTTCGTGACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.84823712564	48.6227720861732	0.0237433473851657	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.48642796961	2037.48642796961
"healthy-3"	"2019-08-01-count-4:TGTGCGGGTAGCGTAG"	-5.11748538437541	3.73193500125734	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGGTAGCGTAG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2647.26051981683	46.6924570999874	0.0176380287283619	2517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2632.83829508892	2632.83829508892
"healthy-3"	"2019-08-01-count-2:TATATCCGTGGTCCCA"	11.1690899330074	6.28265187824098	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCGTGGTCCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2160.0513770676	47.5070124852801	0.0219934641322161	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2149.20570076844	2149.20570076844
"healthy-3"	"2019-08-01-count-2:AGGCTGCTCGCACTCT"	10.9463030296261	6.39308116519777	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCTCGCACTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.27213700262	42.6872102715403	0.0215671253454743	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1973.53014319175	1973.53014319175
"healthy-3"	"2019-08-01-count-3:AGTGTTGCAAGAGTGC"	10.7646118598873	6.73009727084962	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGTTGCAAGAGTGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.17538057668	47.1730677854661	0.0245159917654326	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1915.97798467505	1915.97798467505
"healthy-3"	"2019-08-01-count-3:AGTGTTGGTGCCTACG"	-0.314506183296996	8.5093841322693	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGTTGGTGCCTACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2049.73632928879	37.3588247614337	0.0182261612030833	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.0552462622	2041.0552462622
"healthy-3"	"2019-08-01-count-4:ACTACGATCCTCAGAA"	3.7604669528896	-6.99587490474852	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTACGATCCTCAGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.21492067347	39.8851481709908	0.0143926578460027	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2766.34045564868	2766.34045564868
"healthy-3"	"2019-08-01-count-4:CGGACACGTAAGGCTG"	-0.451094488531905	8.17739293659059	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACGTAAGGCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.87883646035	40.2543575388114	0.021643537605612	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.38144684548	1856.38144684548
"healthy-3"	"2019-08-01-count-3:CCCAACTCACGGCGTT"	-0.263533185154754	7.98188493335573	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTCACGGCGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2098.97430917675	39.5002928272502	0.0188188548352184	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2092.53872395109	2092.53872395109
"healthy-3"	"2019-08-01-count-2:AACCATGTCCCTTGGT"	4.89511074599568	-8.27836801921996	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGTCCCTTGGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.76531228544	50.9959383299505	0.0210747455842258	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2413.4557780558	2413.4557780558
"healthy-3"	"2019-08-01-count-3:GGTAATCTCTAACGCA"	4.3008619743282	-6.73342039501341	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCTCTAACGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.48731335197	42.9491223495852	0.0167869201951664	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2551.97237117799	2551.97237117799
"healthy-3"	"2019-08-01-count-2:GGGCGTTTCCTTCACG"	5.03814091262166	-8.64311888134154	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTTCCTTCACG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.3917339962	39.5997396214176	0.0144927021732356	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2728.74412620623	2728.74412620623
"healthy-3"	"2019-08-01-count-3:CTTGATTAGTGGTGAC"	-8.36330352249797	-0.523149930593096	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTAGTGGTGAC"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2953.49109562812	44.0395505985768	0.0149110151927547	3736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2946.98348408615	2946.98348408615
"healthy-3"	"2019-08-01-count-2:TCCTTTCCACATGTTG"	-3.68794594231303	10.8083219298157	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCCACATGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2116.67923063456	43.2497549557355	0.0204328338133547	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.62240232626	2111.62240232626
"healthy-3"	"2019-08-01-count-4:GATTCTTTCTTTGCAT"	-2.67415843430217	8.79438493335573	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCTTTCTTTGCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.80302013876	48.3490358714456	0.0234954635590851	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2048.77223427691	2048.77223427691
"healthy-3"	"2019-08-01-count-4:CAACGGCAGGGTACGT"	-0.445846836001235	8.69845197284547	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCAGGGTACGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.5869934994	37.0883432465438	0.0202603554915709	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1828.85771165334	1828.85771165334
"healthy-3"	"2019-08-01-count-2:GATTTCTGTCGAATGG"	2.53751387175862	-4.44507601177367	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTGTCGAATGG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2620.53000760949	43.2718695554115	0.0165126403551033	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2616.27629665739	2616.27629665739
"healthy-3"	"2019-08-01-count-3:CTTTCAAGTTCCACAA"	10.1799150901729	5.83693502033082	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAAGTTCCACAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1654.60225525845	45.8759263556749	0.0277262563917569	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1641.04209573696	1641.04209573696
"healthy-3"	"2019-08-01-count-2:CCTACGTTCATTGCCC"	4.43291344222371	-7.58730223095091	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTTCATTGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2756.88860027597	41.4833251910748	0.0150471532244438	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2751.1107757727	2751.1107757727
"healthy-3"	"2019-08-01-count-3:AGTTCCCGTGCACGCT"	-4.36930785599406	10.5977821120056	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTGCACGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2147.28042893841	39.9762254365431	0.018617142361935	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2140.41079522356	2140.41079522356
"healthy-3"	"2019-08-01-count-2:GATTTCTTCGCCTAGG"	10.788723607629	6.87518451297609	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTTCGCCTAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.47222827116	38.2693190757415	0.0191014971586429	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1995.73895632339	1995.73895632339
"healthy-3"	"2019-08-01-count-2:CTACCTGAGTCATCCA"	-3.23994193497356	-5.52839758312377	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGAGTCATCCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2786.02176158473	49.021402332753	0.0175954843600608	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2782.9669863075	2782.9669863075
"healthy-3"	"2019-08-01-count-2:ATTATCCAGTGCAAAT"	-3.54133496704753	9.7562742003235	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCAGTGCAAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2141.83893134828	45.9543469301612	0.0214555568383627	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2135.83157410607	2135.83157410607
"healthy-3"	"2019-08-01-count-4:TCAGCAACATATAGCC"	4.93799366530721	-8.4846983185974	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAACATATAGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2837.96696663525	43.0750747194677	0.01517814520954	2599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2834.55631178903	2834.55631178903
"healthy-3"	"2019-08-01-count-4:CTTACCGCAAAGGGCT"	-4.00381551209148	13.2221650847229	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGCAAAGGGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2242.63396330398	42.3834636179597	0.0188989662653275	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2237.36954643152	2237.36954643152
"healthy-3"	"2019-08-01-count-3:TGACCCTCAGACAATA"	3.6454037624294	-6.84667637264403	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTCAGACAATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.57805319827	46.4898629491312	0.0189323499159721	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2449.49876776405	2449.49876776405
"healthy-3"	"2019-08-01-count-2:GTGGGAAAGCTGCGAA"	-3.95577273789104	10.8158283003601	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGGAAAGCTGCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2095.91191512486	43.0626149965686	0.0205460041931215	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2087.81919892572	2087.81919892572
"healthy-3"	"2019-08-01-count-2:GTGGGAAAGAACTGAT"	-0.886308113962966	8.35980031574098	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGGAAAGAACTGAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2159.72993717116	45.6064652690895	0.0211167444985392	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2159.72993717116	2159.72993717116
"healthy-3"	"2019-08-01-count-2:TCGACCTCATTGCCGG"	10.7896267372066	6.38155982578126	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTCATTGCCGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.80155240445	43.7485126947426	0.0241464152830004	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1808.34424271246	1808.34424271246
"healthy-3"	"2019-08-01-count-4:AGTGACTCAGAGGACT"	3.28977622565572	-6.72054006969603	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTCAGAGGACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.9715087386	47.7820141221211	0.0194317070988074	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2455.38685479307	2455.38685479307
"healthy-3"	"2019-08-01-count-2:CCTCAACTCGACGATT"	3.42896642264668	-6.6995420685974	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACTCGACGATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.92813566733	46.2675775815599	0.0188775741353846	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2448.68465992022	2448.68465992022
"healthy-3"	"2019-08-01-count-3:CTAACTTAGTGCACTT"	-0.261447022587615	7.75803182208864	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACTTAGTGCACTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1958.07184560656	41.2963421715738	0.0210903099721457	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.13987039937	1950.13987039937
"healthy-3"	"2019-08-01-count-4:TGTTGGAAGTTGTAAG"	9.8716570335323	6.07752606952516	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGGAAGTTGTAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.86461360529	39.804598113956	0.0208524993497452	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1900.92370818718	1900.92370818718
"healthy-3"	"2019-08-01-count-2:TTCTAACGTAAGATCA"	10.6442734199459	7.47614476764528	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACGTAAGATCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2192.02335038405	44.122532297848	0.0201286780499476	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2185.08116180816	2185.08116180816
"healthy-3"	"2019-08-01-count-2:GAACGTTTCACTCTTA"	10.678429265588	7.37426326358644	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTTCACTCTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.41173061859	41.7833592760175	0.019997666646414	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2080.29570078074	2080.29570078074
"healthy-3"	"2019-08-01-count-4:CTTCAATCAGCACGAA"	11.2203585105831	4.92945811832277	"2019-08-01-count-4"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATCAGCACGAA"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2100.44553108987	49.4463630135355	0.0235408927685352	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2092.08373536591	2092.08373536591
"healthy-3"	"2019-08-01-count-3:GGTGGCTCATCGATCA"	-5.22424445572551	-5.45512630855712	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTCATCGATCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3082.92478974654	44.0923131861381	0.0143021047197727	2894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3077.39392637869	3077.39392637869
"healthy-3"	"2019-08-01-count-3:TCAGGTACACCTCGTT"	10.5510326820308	6.48990676486818	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGTACACCTCGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.53793100724	44.2229407691038	0.0217682082594333	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2022.59252779666	2022.59252779666
"healthy-3"	"2019-08-01-count-3:GCATTAGGTATCATGC"	4.69172682341878	-7.72113754665526	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATTAGGTATCATGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.2044246631	49.5958983739879	0.0192142466129784	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2573.31113341169	2573.31113341169
"healthy-3"	"2019-08-01-count-4:CTTCAATGTGACATCT"	2.6488741832668	-4.46550896083983	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATGTGACATCT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2941.59359136419	42.5103504851993	0.0144514696421693	2768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2935.45491096096	2935.45491096096
"healthy-3"	"2019-08-01-count-2:CATACCCAGGTCATCT"	10.4047075706417	7.75007817828981	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCAGGTCATCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.94379618514	46.0526908066526	0.0221732965962972	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2065.39051896753	2065.39051896753
"healthy-3"	"2019-08-01-count-4:CCACACTTCAAGCGTT"	-0.63505200567897	8.41079232776491	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTTCAAGCGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2271.04026985407	46.2215721562131	0.0203525991017249	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2263.76084540243	2263.76084540243
"healthy-3"	"2019-08-01-count-2:CCTCACATCTTCTAAC"	-0.201794723898727	7.51549480045167	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACATCTTCTAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2163.0548968941	38.0542056811342	0.0175928062370381	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2148.25809022433	2148.25809022433
"healthy-3"	"2019-08-01-count-2:TTCTAGTCATACAGCT"	4.8126880126888	-7.95441629802855	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTCATACAGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.53237783512	45.1657153230185	0.0163909216550389	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2753.62386562446	2753.62386562446
"healthy-3"	"2019-08-01-count-4:GTTCTATGTCCCGTGA"	10.7613827186519	6.95366904819337	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATGTCCCGTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.28529035306	39.9759055860735	0.0202175709196398	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1971.02894123576	1971.02894123576
"healthy-3"	"2019-08-01-count-2:AGGTGTTAGAAATTGC"	3.63369693335835	-7.06581642543944	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTAGAAATTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.53951285136	46.2569450227608	0.0179600991527985	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2574.57889699862	2574.57889699862
"healthy-3"	"2019-08-01-count-2:CATACCCCAGAGATTA"	-2.12277970734294	9.05547807300416	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCCAGAGATTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.30843722855	47.2703781469998	0.0240279446031309	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.70988953944	1958.70988953944
"healthy-3"	"2019-08-01-count-3:GGTTAACCATATGAAG"	4.68235363539998	-8.15284349834593	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTAACCATATGAAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.10954721899	41.8567260078943	0.015914442062747	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2622.28279233518	2622.28279233518
"healthy-3"	"2019-08-01-count-3:TAACTTCCACATAGCT"	-3.87257323685344	10.5304555662903	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACTTCCACATAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.26302517241	45.8624255106986	0.0223581398133201	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.26302517241	2051.26302517241
"healthy-3"	"2019-08-01-count-3:CTACCCAGTTGTCCCT"	4.36141504821126	-7.77323343670043	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCCAGTTGTCCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.26399225606	49.8481700658466	0.0223307683315122	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2225.84021634316	2225.84021634316
"healthy-3"	"2019-08-01-count-2:AGGTGTTGTCGGATTT"	0.0117818946832835	7.70348498905031	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTGTCGGATTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.46913466327	40.8749617668255	0.0214288981268582	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1898.8558344829	1898.8558344829
"healthy-3"	"2019-08-01-count-3:AAGGAATAGGTAGTCG"	4.44061913070027	-8.42858316814574	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATAGGTAGTCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.97580263957	43.6428512355116	0.0176836625338199	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2462.47872415706	2462.47872415706
"healthy-3"	"2019-08-01-count-4:AGTTCGAGTCCAAAGG"	-3.8411103290623	12.6478585966858	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCGAGTCCAAAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1703.15066320369	44.8201841623324	0.0263160418691462	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1694.66301425484	1694.66301425484
"healthy-3"	"2019-08-01-count-4:CGTAGTAAGGTTCCAT"	3.7929924922878	-7.67354252254637	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAGTAAGGTTCCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.26193390208	50.3400641710079	0.0228169028334612	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2204.81187717232	2204.81187717232
"healthy-3"	"2019-08-01-count-3:GAAGCGAGTAATACCC"	-2.80301676216777	9.87187669360963	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGAGTAATACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1917.37137270274	47.0965095503971	0.0245630607721078	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.45709066385	1912.45709066385
"healthy-3"	"2019-08-01-count-3:TAAGCCATCTATTTCG"	-0.284218977124053	8.45285317981569	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCATCTATTTCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2241.85861507733	45.2779217439731	0.0201966000172635	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2229.11030098858	2229.11030098858
"healthy-3"	"2019-08-01-count-2:CCTCCAAAGGTGATAT"	-2.70840297165568	9.57055471027223	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCAAAGGTGATAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2227.1259750561	45.7406812463657	0.020537985618534	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2219.61264783359	2219.61264783359
"healthy-3"	"2019-08-01-count-3:GGTTGTAAGAAACTAC"	3.98908628997151	-7.31942703640135	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTAAGAAACTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.50112960896	46.7876890958106	0.0194018939163414	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2408.64737404512	2408.64737404512
"healthy-3"	"2019-08-01-count-2:CCTCCAAGTATCTTCT"	1.49889018115346	-10.1477775803772	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	68	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCAAGTATCTTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.82964658018	49.0927678825919	0.0213834541058913	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2293.45064319011	2293.45064319011
"healthy-3"	"2019-08-01-count-2:AGGTGTTTCTGTCGTC"	-1.99332342568095	9.19380662525026	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTTCTGTCGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.81416829222	38.6797662150745	0.0222962014733552	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1729.1372401154	1729.1372401154
"healthy-3"	"2019-08-01-count-4:CCACTTGAGGATTTCC"	-2.33040271225627	9.03882405841676	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACTTGAGGATTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1920.90725438057	46.3718155494465	0.0241405801574736	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.32774289092	1917.32774289092
"healthy-3"	"2019-08-01-count-2:GGGTTTACAAGGTACG"	5.39601912078206	-9.97434523021849	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTTACAAGGTACG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.16532951077	47.9475096253383	0.0195770816480225	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2439.08491768493	2439.08491768493
"healthy-3"	"2019-08-01-count-3:CACAGGCCAGACAAAT"	10.3623100715572	6.95728204334108	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCCAGACAAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2094.04448514764	39.5629065337607	0.0188930592517815	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2088.16158402676	2088.16158402676
"healthy-3"	"2019-08-01-count-2:AGGTTACTCGCATAGT"	4.57711567458455	-8.076611541864	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTACTCGCATAGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.99514723831	43.7478524213821	0.0177620538434415	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2456.61459202796	2456.61459202796
"healthy-3"	"2019-08-01-count-4:GCAGCTGAGCAGGCTA"	-4.17985377731975	13.0906562575134	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCTGAGCAGGCTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2219.98663833456	41.9155671400516	0.0188809997394835	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2207.9865245232	2207.9865245232
"healthy-3"	"2019-08-01-count-2:CCTCCTCTCAACTACG"	-2.21357045593913	9.2721490629944	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCTCAACTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2194.47444194731	50.4720100917368	0.0229995889343552	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2189.91498558289	2189.91498558289
"healthy-3"	"2019-08-01-count-2:GCAGTTAGTCTTGAGT"	5.49645771560018	-9.70122148906859	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTAGTCTTGAGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.59967545714	46.3687872361057	0.0176535418280045	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2618.62307370914	2618.62307370914
"healthy-3"	"2019-08-01-count-4:ACTTCGCCAGCAGATG"	1.95119370993916	-5.93251659786376	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCCAGCAGATG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2760.41779211677	46.477634315242	0.0168371738683808	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2752.56554357437	2752.56554357437
"healthy-3"	"2019-08-01-count-1:CACATGAGTTAGCGGA"	9.8824631172115	7.57777783954469	"2019-08-01-count-1"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CACATGAGTTAGCGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2169.96295436056	40.7214281517387	0.0187659554601652	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2153.65443360648	2153.65443360648
"healthy-3"	"2019-08-01-count-4:TCATCATAGACGGAAA"	-2.89047823372539	9.43285939777223	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCATAGACGGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1933.6979275616	44.4117834479652	0.0229672808844392	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.09552202928	1926.09552202928
"healthy-3"	"2019-08-01-count-2:AGGTTGTCATGTTACG"	-3.4271904033726	9.80444905841676	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTCATGTTACG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2016.14289563954	45.4266641758057	0.0225314704994637	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2012.9502172122	2012.9502172122
"healthy-3"	"2019-08-01-count-2:AAGATAGAGGCACTCC"	-3.65226636353191	11.2986249693665	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGATAGAGGCACTCC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2224.82598639668	45.3236668238862	0.0203717805801487	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2217.11681826488	2217.11681826488
"healthy-3"	"2019-08-01-count-2:TTGAACGCAAACTCTG"	2.64238705214803	-6.43545105373534	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAACGCAAACTCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.56754295133	47.7999250860719	0.0189865512128569	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2512.20218212674	2512.20218212674
"healthy-3"	"2019-08-01-count-3:ATCACGATCATGACAC"	-4.80494485321696	3.13173029506532	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGATCATGACAC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2930.23330864425	43.9630935952507	0.0150032741302744	3154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2922.12723443577	2922.12723443577
"healthy-3"	"2019-08-01-count-2:GGTAATCGTAGGCAAC"	-0.609477083117324	8.65072915637819	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCGTAGGCAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2017.94010423041	42.4768926083245	0.0210496300258248	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.46851110072	2006.46851110072
"healthy-3"	"2019-08-01-count-3:CACCAAAGTTCGTAAC"	10.6773163276607	6.81781766498414	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAAGTTCGTAAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.13731733044	42.6161460303482	0.0215435731670337	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1974.93353528163	1974.93353528163
"healthy-3"	"2019-08-01-count-3:TGATCTTGTCTAACGT"	-3.27341590347942	10.1485376127991	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCTTGTCTAACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.78109359409	44.2817839828555	0.0240821401400762	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1835.01419386506	1835.01419386506
"healthy-3"	"2019-08-01-count-2:TCGGATAGTGGACCTC"	2.59161462363545	-6.74293472683104	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATAGTGGACCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.2529960601	46.5859666226984	0.0213868484087755	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2174.47826707876	2174.47826707876
"healthy-3"	"2019-08-01-count-3:TCATGCCTCTACGCGG"	9.99975838240926	6.77726504886476	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCTCTACGCGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.54248292661	43.0225382323576	0.0212610007426852	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2017.09090015181	2017.09090015181
"healthy-3"	"2019-08-01-count-2:AGTAGCTAGGCTAGCA"	-8.2183030647343	0.676724291685499	"2019-08-01-count-2"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTAGGCTAGCA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3015.39996181315	44.6017994630644	0.0147913378085491	3649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3001.41464231967	3001.41464231967
"healthy-3"	"2019-08-01-count-4:CCCAACTGTTGGGCCT"	-2.4901319545811	8.79718396747438	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTGTTGGGCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2135.38814642101	51.2504831504524	0.0240005468028612	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2133.83277525327	2133.83277525327
"healthy-3"	"2019-08-01-count-3:CTATAGGGTTGGGTAG"	-0.601637880236465	9.32130239093629	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATAGGGTTGGGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1746.26979976566	46.5807883116225	0.0266744510601245	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1733.16716663677	1733.16716663677
"healthy-3"	"2019-08-01-count-2:TTGACCCGTACCTAGT"	-1.67804429951366	8.86551282489625	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCGTACCTAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.37069707498	46.0105352985628	0.0233157081772632	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1969.97407867812	1969.97407867812
"healthy-3"	"2019-08-01-count-4:ACTTTGTCACTCAGAT"	-2.31180558624919	9.28320977771608	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTGTCACTCAGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2043.65812872848	48.6177871903767	0.0237895891230231	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2039.09720530385	2039.09720530385
"healthy-3"	"2019-08-01-count-3:GACACGCTCTTCGACC"	2.7679840522701	-6.2890081635681	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACACGCTCTTCGACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2733.09209053859	43.5607585555472	0.0159382695908219	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2730.6352736925	2730.6352736925
"healthy-3"	"2019-08-01-count-3:TGATGGTGTTCAAACC"	-2.04066930237468	9.60465333545534	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGGTGTTCAAACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.72926601631	46.3380300117778	0.0240625880436639	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1919.10332190827	1919.10332190827
"healthy-3"	"2019-08-01-count-1:CATGGATTCTTCGGAA"	-3.36912141266521	9.27867887103883	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATGGATTCTTCGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2397.87582512273	45.3548040557404	0.0189145758010297	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2380.25768103485	2380.25768103485
"healthy-3"	"2019-08-01-count-2:GCATGATGTCGCACAC"	4.89520611342732	-8.11523725902709	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATGATGTCGCACAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.30770809054	46.4167040075192	0.0182433531368555	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2541.00773953263	2541.00773953263
"healthy-3"	"2019-08-01-count-3:GTAATGCCATTCTCTA"	3.60721888121907	-6.67600443279418	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCCATTCTCTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2643.42391800707	45.4104506174698	0.0171786486110429	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2639.97355976601	2639.97355976601
"healthy-3"	"2019-08-01-count-4:TCATGTTGTCAATGGG"	4.70886816558186	-7.60883524334105	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTGTCAATGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.70995967722	44.32629219406	0.0174053162299166	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2540.7208553694	2540.7208553694
"healthy-3"	"2019-08-01-count-4:CCCATTGGTATTTCGG"	-1.16073117676433	8.5228643187317	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGGTATTTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1771.05323243432	50.5823456795317	0.0285606015410423	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1767.28200716748	1767.28200716748
"healthy-3"	"2019-08-01-count-3:ATCCACCGTCTAGGCC"	-1.89455233040507	8.94735715473024	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCACCGTCTAGGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.8147185735	47.9143561133801	0.0247515196850493	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1934.11837491592	1934.11837491592
"healthy-3"	"2019-08-01-count-4:AGAACAACACTGCATA"	4.30784430083577	-8.35259821331175	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACAACACTGCATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.88503197679	45.1209070563457	0.0173951067607492	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2591.63471823554	2591.63471823554
"healthy-3"	"2019-08-01-count-3:TCATTACAGACTGTTC"	-1.39760826054271	8.93961904132692	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACAGACTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.45826124724	49.2889093987404	0.0268099148279287	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1833.15374793742	1833.15374793742
"healthy-3"	"2019-08-01-count-2:TCGGGCAGTTCCACAA"	-2.73353467407878	9.27941606128541	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAGTTCCACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1956.99830853432	42.877560600459	0.0219098608381383	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1953.71430688597	1953.71430688597
"healthy-3"	"2019-08-01-count-2:GCCAACGCATCTCATT"	-3.28629146042522	9.95172212207643	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGCATCTCATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2104.89282566973	48.1357810166178	0.0228685187338705	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2094.76738525728	2094.76738525728
"healthy-3"	"2019-08-01-count-3:TCATTACTCCGGCTTT"	-1.39524720135387	9.265016532782	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACTCCGGCTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.59715428084	45.1446725381772	0.0226221371589629	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1986.80627575039	1986.80627575039
"healthy-3"	"2019-08-01-count-2:TTGCATTAGTAATCCC"	4.56455912169759	-7.25040342723998	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTAGTAATCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.30740178883	47.5195473398687	0.018148956576834	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2611.60882605249	2611.60882605249
"healthy-3"	"2019-08-01-count-2:AAGGTAAAGCTATCCA"	2.65785135802571	-4.4353761903015	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAAAGCTATCCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2908.84785677433	43.1141887822116	0.0148217407389679	3056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2903.68089211832	2903.68089211832
"healthy-3"	"2019-08-01-count-4:AGAAGCGGTTCTCTAT"	-0.773395041853744	8.14840600574342	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAGCGGTTCTCTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.51127952373	49.6411512457054	0.0235655758068995	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2103.09994511917	2103.09994511917
"healthy-3"	"2019-08-01-count-3:CTCACTGAGATGTTGA"	-3.85827169838603	12.1929883726868	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCACTGAGATGTTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2026.02076129627	48.557720083343	0.0239670397317524	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2021.05862934431	2021.05862934431
"healthy-3"	"2019-08-01-count-4:GCCAGGTTCCCAACTC"	10.7032648521358	7.20687577808229	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTTCCCAACTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2120.7775545534	45.0836218892791	0.0212580625405445	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2114.58469099668	2114.58469099668
"healthy-3"	"2019-08-01-count-2:CTCAGGGCACGACCTG"	0.501848657696885	8.02029035175172	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGGGCACGACCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1770.3354880479	43.5299332995095	0.0245885221153809	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1762.36574065481	1762.36574065481
"healthy-3"	"2019-08-01-count-2:TGGTAGTCAAACTCGT"	-3.7045923275059	-5.51598551189574	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTCAAACTCGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2460.9490589032	48.0684185763974	0.0195324719959139	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2457.70111427775	2457.70111427775
"healthy-3"	"2019-08-01-count-3:TGCAGGCGTGCACATT"	-1.42455873909648	9.59481999957887	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCGTGCACATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1870.97005585077	42.1740207530973	0.0225412590763886	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1864.5002362624	1864.5002362624
"healthy-3"	"2019-08-01-count-2:CCTTGTGGTTAGAGAT"	-4.24965653839763	13.2388086088928	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGGTTAGAGAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2440.97680176362	40.2354575222833	0.0164833428540627	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2436.29188619368	2436.29188619368
"healthy-3"	"2019-08-01-count-3:GTAGAGGCACGTCGTG"	-3.22559628906901	-5.53783037578734	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAGGCACGTCGTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2717.7764710883	46.737419589645	0.0171969328923249	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2713.5456107905	2713.5456107905
"healthy-3"	"2019-08-01-count-3:GGGTGAAGTCGAAACG"	10.3225380378658	7.71882579410402	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGAAGTCGAAACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.08727118658	42.441785478941	0.0207937142512616	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2038.28180089808	2038.28180089808
"healthy-3"	"2019-08-01-count-3:TGCAGGCTCTGCGGCA"	4.23389401015584	-8.03234388744506	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCTCTGCGGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.1975262654	47.4429676754631	0.0191518710851402	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2468.47206758394	2468.47206758394
"healthy-3"	"2019-08-01-count-2:AGTCTCCAGTTACGGG"	-1.85790310326274	9.4843129881653	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCAGTTACGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.6996466575	46.8787501629981	0.0238362529035233	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.11157455119	1960.11157455119
"healthy-3"	"2019-08-01-count-2:ACTTATCCAACAGCTT"	-0.176419670612174	8.00114438617555	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCCAACAGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.98989055438	44.5850992271944	0.0214558787941454	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.96387163715	2069.96387163715
"healthy-3"	"2019-08-01-count-3:GCGATCGTCATCACAG"	3.38146652755086	-6.63732530986937	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGATCGTCATCACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.76568403819	44.0533011041428	0.0179826590727344	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2440.50850652795	2440.50850652795
"healthy-3"	"2019-08-01-count-2:GACCCAGCAGACCTGC"	-3.21856079521831	10.1004276045593	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGCAGACCTGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2043.01838514824	44.9020054136436	0.0219782679099021	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.09621239186	2040.09621239186
"healthy-3"	"2019-08-01-count-3:ATCCTATCAGACTCTA"	2.69413747367207	-6.39518263256224	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATCAGACTCTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.82919275995	43.7986952755172	0.0160798244588669	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2715.00225511334	2715.00225511334
"healthy-3"	"2019-08-01-count-2:TTGCGTCAGCAAGCCA"	4.68548216399495	-7.66389706051024	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCGTCAGCAAGCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.36224024217	42.620740818585	0.0161787700140535	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2626.87478220672	2626.87478220672
"healthy-3"	"2019-08-01-count-2:CCTTTGGTCGTCTAAG"	-0.314852069050628	7.84306905353395	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGTCGTCTAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1911.95843125158	44.0490929272787	0.023038729402942	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1907.96369524142	1907.96369524142
"healthy-3"	"2019-08-01-count-3:GTAGGAGTCTCGTCAC"	-4.14245543900188	11.9148883589539	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGGAGTCTCGTCAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1657.5441770219	48.4332246619837	0.029219869571744	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1653.18784260003	1653.18784260003
"healthy-3"	"2019-08-01-count-2:CGAAGGAAGCGTATGG"	-2.96715579453166	9.09982583606569	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGGAAGCGTATGG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2024.2388576738	43.4305998575586	0.0214552742592185	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2019.26764979401	2019.26764979401
"healthy-3"	"2019-08-01-count-3:GTAGGAGGTATGTCCA"	5.20718063887898	-9.22109701549681	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGGAGGTATGTCCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2580.22456026918	43.9583971972342	0.0170366555973904	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2575.38144859484	2575.38144859484
"healthy-3"	"2019-08-01-count-4:TCCACCAAGCTGGCTC"	-2.96067271652873	10.9097156294617	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCAAGCTGGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.0469531934	44.9101160677242	0.0226128168800402	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1984.27926470536	1984.27926470536
"healthy-3"	"2019-08-01-count-3:TGCATGATCGCAGTCG"	3.91802706298177	-7.64631750499877	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATGATCGCAGTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.50345534376	45.8798537849442	0.0181235596135949	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2526.24447550751	2526.24447550751
"healthy-3"	"2019-08-01-count-2:GCCATGGTCAGACATC"	-1.53616748276408	8.43563363635866	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATGGTCAGACATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2234.86246847655	43.4954096738165	0.0194622310264427	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2229.14514062226	2229.14514062226
"healthy-3"	"2019-08-01-count-3:CTCATGCGTGGCTGAA"	4.23548426207845	-7.43298437511595	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCGTGGCTGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.77783803925	41.1033931579635	0.0154536941281774	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2655.04116882969	2655.04116882969
"healthy-3"	"2019-08-01-count-3:TGCGACGAGATTGATG"	-3.72437224808391	9.63104817951051	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGACGAGATTGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2371.01042878403	41.0886800890813	0.0173296074915004	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2364.92708474944	2364.92708474944
"healthy-3"	"2019-08-01-count-4:CCCTTAGCAGGAGGAG"	4.89937223967854	-8.8134165040222	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTTAGCAGGAGGAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.52033063781	42.6353236826469	0.016439170797694	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2590.06356012235	2590.06356012235
"healthy-3"	"2019-08-01-count-4:TTCATTGGTGGATCAG"	4.55193819579427	-8.42088224804076	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATTGGTGGATCAG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.79992785337	42.868047941213	0.016232978306713	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2635.1091643364	2635.1091643364
"healthy-3"	"2019-08-01-count-2:AAGTTCGTCCATTTGT"	3.66358055648152	-7.00595381176146	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTTCGTCCATTTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.16204827511	49.2565694047661	0.0211568474974753	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2323.19551497103	2323.19551497103
"healthy-3"	"2019-08-01-count-3:AATTCCTAGAATCGTA"	-3.19287643852885	10.1402177580628	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTAGAATCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.62761514232	44.0998768552461	0.0214323896757168	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.10594084481	2051.10594084481
"healthy-3"	"2019-08-01-count-4:TAATCTCTCACTGAAC"	-0.0804934901302636	7.71843478763429	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATCTCTCACTGAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2072.21453795777	38.8512350036186	0.018748654780652	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2065.53086133337	2065.53086133337
"healthy-3"	"2019-08-01-count-4:CACTAAGCAGGTCTCG"	-4.09365735474284	10.6987313994202	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTAAGCAGGTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2123.746240476	41.9957229839366	0.0197743601300144	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2115.56613057237	2115.56613057237
"healthy-3"	"2019-08-01-count-3:GTAGTACTCCCTCAAC"	-4.07181964340861	11.7748336561951	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACTCCCTCAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2063.26777134176	46.0724107578799	0.0223298262095756	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2061.59908061771	2061.59908061771
"healthy-3"	"2019-08-01-count-2:CGACAGCCAATAGTAG"	-5.07304320755656	-4.41178657924803	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCCAATAGTAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3415.05645585613	41.3328277971036	0.0121031169854385	4524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3410.99982563187	3410.99982563187
"healthy-3"	"2019-08-01-count-2:TCACATTAGAGGCTGT"	2.2867497402126	-6.39296200191649	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTAGAGGCTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.39989982133	44.8849099485092	0.0203799999955278	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2192.81254368916	2192.81254368916
"healthy-3"	"2019-08-01-count-1:GACATCAAGCAACAGC"	-0.231589089066345	7.69377610767213	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GACATCAAGCAACAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2390.96111867904	48.9719744106783	0.0204821291438375	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2376.75192340557	2376.75192340557
"healthy-3"	"2019-08-01-count-3:GTATTGGGTAAGGCCA"	0.0893007117206275	7.51570651614992	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTGGGTAAGGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.1909823687	44.1190446510901	0.0222577163570628	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.91196597132	1974.91196597132
"healthy-3"	"2019-08-01-count-4:CTACGGGAGGGCATGT"	-4.14489160004314	12.8990173109802	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGAGGGCATGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2218.84482636267	40.9294352876919	0.0184462810564302	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2217.29994323723	2217.29994323723
"healthy-3"	"2019-08-01-count-2:TCACGCTGTATTGAGA"	-1.83851132813151	9.04566953265993	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGCTGTATTGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.24287747554	41.9183488548271	0.0209356963265508	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.11285684886	1996.11285684886
"healthy-3"	"2019-08-01-count-2:TGTCAGAAGAAGCGGG"	2.88264407691304	-6.38202526485594	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCAGAAGAAGCGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.2593644823	41.7633085403937	0.0177470062037047	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2350.91576861331	2350.91576861331
"healthy-3"	"2019-08-01-count-3:TCCATGCAGACCACGA"	10.7439056831295	5.80903766239015	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCAGACCACGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.88470294077	44.523162653177	0.0224650619620366	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1972.02611458973	1972.02611458973
"healthy-3"	"2019-08-01-count-4:GCCTGTTAGAAGTCAT"	-3.3184646171635	9.99495313251344	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCTGTTAGAAGTCAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2025.50346118935	48.585900385403	0.0239870734937545	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2020.3416850562	2020.3416850562
"healthy-3"	"2019-08-01-count-2:AGTTCCCAGCAAGCCA"	-0.270588139921981	8.38272950733034	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCCCAGCAAGCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.81516443817	44.8847864091389	0.0228908809066661	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.27888722631	1959.27888722631
"healthy-3"	"2019-08-01-count-3:TGCGGGTAGCCTGGAA"	10.3791405158931	7.64735839450685	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGGTAGCCTGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2032.17875365445	39.1618486764368	0.0192708680798933	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2028.32066287425	2028.32066287425
"healthy-3"	"2019-08-01-count-3:TGCGGCATCCGCTAGG"	11.0068642097408	5.99575231159059	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCATCCGCTAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1921.13579442548	40.4960329140134	0.0210792141979343	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1914.11096397378	1914.11096397378
"healthy-3"	"2019-08-01-count-4:CCGGACAAGGTTTGAA"	-3.70975933495219	10.1689357527527	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGACAAGGTTTGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2044.72444650257	44.7092664592447	0.0218656682741375	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.43698405478	2041.43698405478
"healthy-3"	"2019-08-01-count-2:CATGGATCACAAGCTT"	-0.527660767466384	8.9286489256653	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATCACAAGCTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2050.85823035982	41.775701940055	0.0203698633682376	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.98747300918	2037.98747300918
"healthy-3"	"2019-08-01-count-2:GCCGATGAGGGCCAAT"	-0.641314069659072	8.75461480701295	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGAGGGCCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.09185399747	47.4121264366146	0.0230034029510423	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.72747120683	2053.72747120683
"healthy-3"	"2019-08-01-count-3:TGCTCCAAGCATCTTG"	4.93065847930257	-8.52129557048949	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCCAAGCATCTTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.74239681243	42.8312481646253	0.0162378434741711	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2629.42030662581	2629.42030662581
"healthy-3"	"2019-08-01-count-4:GCGAGAAGTATGGAAT"	-2.91369138184245	10.2081250914368	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAAGTATGGAAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2068.84567087751	44.8323560401917	0.0216702273501028	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2063.72890442944	2063.72890442944
"healthy-3"	"2019-08-01-count-3:GCTGAATAGAGGTGCT"	5.10580935057942	-9.32603742992552	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATAGAGGTGCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.25142775788	43.8400027516247	0.0183796149292462	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2381.64517750547	2381.64517750547
"healthy-3"	"2019-08-01-count-4:GCGAGAATCCTAGCGG"	2.49736632880513	-4.32179596340331	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAATCCTAGCGG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2593.26514469023	38.5657123995183	0.0148714883545489	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2586.76316998341	2586.76316998341
"healthy-3"	"2019-08-01-count-3:GTCACGGTCGCTGACG"	10.5307795005733	5.62587974155275	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACGGTCGCTGACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1823.73026701834	46.2557879456967	0.0253632835854182	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1815.09455234338	1815.09455234338
"healthy-3"	"2019-08-01-count-4:CCGGGTATCGTGGGAA"	-4.27345405045207	10.9777345427307	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTATCGTGGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2110.74543565952	45.5334967135363	0.0215722350712127	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2100.77298956334	2100.77298956334
"healthy-3"	"2019-08-01-count-3:ACACAGTAGGGACACT"	-3.20784984055217	10.8626050719055	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACAGTAGGGACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2173.8294893815	46.8772122173028	0.0215643464431244	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2166.4733792806	2166.4733792806
"healthy-3"	"2019-08-01-count-3:ATCGTCCCAGCCATTA"	2.55654897269551	-4.74202062999877	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCCAGCCATTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2732.35994197879	44.1314789372384	0.0161514148481031	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2727.17586788875	2727.17586788875
"healthy-3"	"2019-08-01-count-3:GTCACTCGTTGGGCCT"	10.9996191459591	6.50182340228883	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACTCGTTGGGCCT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2415.49142999296	46.6298495459878	0.0193044980276017	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2400.09898794886	2400.09898794886
"healthy-3"	"2019-08-01-count-3:GTCACTCTCAACTGAC"	-3.05305276337321	-4.87082674419554	"2019-08-01-count-3"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACTCTCAACTGAC"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3058.26512073659	40.5176044476412	0.0132485585284648	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3054.85912887425	3054.85912887425
"healthy-3"	"2019-08-01-count-3:CTCCCAAGTTAGGAGC"	2.34734525260274	-4.39044144069823	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAAGTTAGGAGC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2841.11638810449	39.319775616369	0.0138395511641119	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2835.05095314476	2835.05095314476
"healthy-3"	"2019-08-01-count-1:GGCACGTTCTCACGAA"	11.3159624534542	4.77729127490846	"2019-08-01-count-1"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGCACGTTCTCACGAA"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2201.43308162793	49.7989178089275	0.0226211363064018	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2192.47972663923	2192.47972663923
"healthy-3"	"2019-08-01-count-4:CAGAGCCTCACGGACC"	-3.46170340004619	10.9222583540711	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCTCACGGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.50804383653	47.2374376639761	0.0233212787318796	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2020.57105788829	2020.57105788829
"healthy-3"	"2019-08-01-count-3:TTGCCTGAGGTATTGA"	2.69297136840169	-4.67418625270995	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGAGGTATTGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2810.36601099556	40.0427836892212	0.0142482450800194	2627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2804.6360081974	2804.6360081974
"healthy-3"	"2019-08-01-count-3:GCTGCAGCAAGCGGAT"	-4.26066670838054	3.48801229083864	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGCAGCAAGCGGAT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2644.05870487661	46.5213972280418	0.0175946915029683	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2636.93981994166	2636.93981994166
"healthy-3"	"2019-08-01-count-3:GAGAAATAGACCAAAT"	-3.97338328781779	11.0963973768982	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATAGACCAAAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2184.93087265328	41.1981620370047	0.0188555906059286	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.35621981002	2180.35621981002
"healthy-3"	"2019-08-01-count-2:AGAAGTATCTCTTAAC"	-0.176728020340759	8.46741101825563	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGTATCTCTTAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1845.92580799457	36.16197452584	0.0195901559906824	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1835.77633840329	1835.77633840329
"healthy-3"	"2019-08-01-count-3:TGCTTCGCAAGTAGTA"	3.60131682929341	-6.74336054241332	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTCGCAAGTAGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.64378232487	43.6981867234428	0.0171726145038339	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2540.80726914056	2540.80726914056
"healthy-3"	"2019-08-01-count-2:TCAGGGCAGCCACCGT"	1.7414034801418	-6.38953401958617	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCAGCCACCGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2572.95470284704	50.866353235918	0.0197696264064164	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2566.07195658049	2566.07195658049
"healthy-3"	"2019-08-01-count-3:ATCTCTACAAACGGCA"	10.9908997016842	4.48437068546144	"2019-08-01-count-3"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTACAAACGGCA"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1530.90492384428	47.6455987416932	0.0311225066949614	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1523.66940924653	1523.66940924653
"healthy-3"	"2019-08-01-count-3:GTCATGATCTACTATC"	10.4617735343868	6.1414847143921	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATGATCTACTATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1956.07041510445	42.6693788019875	0.0218138255517294	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.1100354984	1938.1100354984
"healthy-3"	"2019-08-01-count-4:AGATGCTTCAACTGGT"	-2.44617948952373	8.81331441486207	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGCTTCAACTGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2088.29256111063	44.1736910648196	0.021153018445522	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2082.98256713183	2082.98256713183
"healthy-3"	"2019-08-01-count-2:CGAGTGCGTGATACAA"	4.35693039473836	-7.86230757152709	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCGTGATACAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.2767055386	45.5430826765925	0.0199813750414435	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2276.94976940841	2276.94976940841
"healthy-3"	"2019-08-01-count-4:TTCCTTCAGTGAATAC"	-0.157714600593406	8.16146752918092	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTTCAGTGAATAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2154.25901462245	41.4093148636105	0.0192220687403589	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2143.39055593317	2143.39055593317
"healthy-3"	"2019-08-01-count-3:GTCATTTAGTTCACTG"	2.66599335250203	-4.5665116540161	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATTTAGTTCACTG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2832.73513849284	39.9502707218713	0.014103073096741	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2825.9804749544	2825.9804749544
"healthy-3"	"2019-08-01-count-3:CTCCCTCTCGCTGTCT"	-0.202262709767181	8.65328691089479	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCTCGCTGTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2196.40878027675	38.3252411362751	0.0174490474999131	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2186.52311911966	2186.52311911966
"healthy-3"	"2019-08-01-count-3:ACAGAAAGTCGTTGGC"	-4.01732430878337	11.5494069823059	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAAGTCGTTGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.63463377212	40.208595160996	0.020414240525407	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.40113617151	1964.40113617151
"healthy-3"	"2019-08-01-count-4:CTCAACCAGCTACGTT"	-3.73471532288249	10.5229167708191	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCAGCTACGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2267.71656481274	43.6521516854146	0.0192493860841111	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2264.9423916398	2264.9423916398
"healthy-3"	"2019-08-01-count-4:TCCCATGTCGCAATGT"	-4.98372064057048	-4.41620733654173	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGTCGCAATGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3224.81212465107	42.4920184182238	0.0131765872788082	4270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3219.2622268743	3219.2622268743
"healthy-3"	"2019-08-01-count-2:TCTGCCACAAACCGGA"	-1.34707901898082	9.46245954120485	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCACAAACCGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.2527885929	44.3436975031372	0.0211034568253122	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2090.30227832181	2090.30227832181
"healthy-3"	"2019-08-01-count-3:GTCCACTCATATTCGG"	-2.11703787270244	9.49613759601442	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCACTCATATTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1852.71143875707	43.287423553656	0.0233643635204716	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.24806201719	1845.24806201719
"healthy-3"	"2019-08-01-count-2:AGACAGGGTCTTCATT"	10.4226051765377	6.75255534732667	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAGGGTCTTCATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.58722972493	44.347274392823	0.0230664563392361	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1916.66286133785	1916.66286133785
"healthy-3"	"2019-08-01-count-3:GAGACTTGTCGAACGA"	0.482599635689896	7.90274331653444	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACTTGTCGAACGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.78378704346	37.05483338218	0.0208081596720398	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1775.15828179538	1775.15828179538
"healthy-3"	"2019-08-01-count-3:GTCCCATAGATCACCT"	10.7271019416744	7.61076543414918	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATAGATCACCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2221.36090978922	45.3264668696996	0.0204048188072241	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2214.12166469974	2214.12166469974
"healthy-3"	"2019-08-01-count-2:GCGTTTCTCGCTGTCT"	10.9833876090938	5.85409638965455	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCTCGCTGTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.0924716252	40.6440040716452	0.0223676035789711	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1809.99849245547	1809.99849245547
"healthy-3"	"2019-08-01-count-3:CTCCTCCGTATGATCC"	9.9854322868282	7.28590200031129	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCGTATGATCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.81132322168	44.4772330461048	0.0228110445951329	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1939.81236945202	1939.81236945202
"healthy-3"	"2019-08-01-count-3:ATGACCAAGGAGACCT"	4.86536802825276	-8.39492609417113	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCAAGGAGACCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2796.54383237919	45.4120350437423	0.0162386280229005	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2790.478334361	2790.478334361
"healthy-3"	"2019-08-01-count-3:TGGATCAGTAGTCGTT"	-2.69704375687297	9.33642861926881	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCAGTAGTCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.64959028789	48.5128423231375	0.0257820810917909	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1872.82623923746	1872.82623923746
"healthy-3"	"2019-08-01-count-2:GCTACAAGTACATACC"	-2.25372443619426	9.26412866199342	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAAGTACATACC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2260.48882024083	49.885676300515	0.022068534846901	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2246.99570793281	2246.99570793281
"healthy-3"	"2019-08-01-count-4:TCCGATCGTGGTACAG"	-4.24863801422771	13.2179240950379	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCGTGGTACAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2509.76774248438	40.9246669737887	0.0163061570523167	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2502.55896587291	2502.55896587291
"healthy-3"	"2019-08-01-count-1:TAAGTCGGTTAGAGAT"	11.2761751609737	5.93535659396974	"2019-08-01-count-1"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAAGTCGGTTAGAGAT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2228.02631938707	44.055497411063	0.0197733289897503	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2220.15658615226	2220.15658615226
"healthy-3"	"2019-08-01-count-3:CTCGAGGCATAGCACT"	-3.21658573570903	9.84703824603883	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGCATAGCACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.06346197895	46.4395817773242	0.0227414978241273	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.2497007355	2037.2497007355
"healthy-3"	"2019-08-01-count-3:GGAAGTGGTACAGCGA"	-1.9571045440739	8.78160760486452	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGGTACAGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.82316660477	50.6997544138734	0.026785256704574	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.83957332969	1887.83957332969
"healthy-3"	"2019-08-01-count-2:CGATGCGGTAACATGA"	-3.21858344498332	-4.88841249859007	"2019-08-01-count-2"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGGTAACATGA"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3054.19615003608	44.370582001501	0.0145277447229369	3200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3049.77558138984	3049.77558138984
"healthy-3"	"2019-08-01-count-1:TACCGAAGTGCGAGTA"	0.30081926760022	8.18461606586305	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACCGAAGTGCGAGTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.64342691813	37.7830076944022	0.0189802991251411	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.39968532086	1976.39968532086
"healthy-3"	"2019-08-01-count-4:AGCCAGCGTTCGTGCG"	-1.61287067356761	8.864719367865	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCGTTCGTGCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2015.74921620916	42.6433626812427	0.021155093271691	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.13694353269	2005.13694353269
"healthy-3"	"2019-08-01-count-4:CCTCAACTCTGTTCAT"	10.803221364587	6.85752818668214	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAACTCTGTTCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2039.60333629425	42.936043411925	0.0210511733570388	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2030.50063987394	2030.50063987394
"healthy-3"	"2019-08-01-count-2:TTTACTGTCTTCTGTA"	-4.15123830261882	10.9598865278992	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACTGTCTTCTGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2225.46016543636	46.3272354940447	0.0208169241640688	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2220.01943048635	2220.01943048635
"healthy-3"	"2019-08-01-count-3:CTCTCAGAGAAACTAC"	-2.46345267716106	9.0011358031067	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGAGAAACTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.74917763639	41.2078961266803	0.0205346520561261	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2001.58112787033	2001.58112787033
"healthy-3"	"2019-08-01-count-3:TGGCGTGTCGCCAATA"	2.8567234474117	-6.37321760570677	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGCGTGTCGCCAATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.1010928971	49.3256421368487	0.0228454528132646	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2153.12131652554	2153.12131652554
"healthy-3"	"2019-08-01-count-3:ATGAGTCAGAGGGTAA"	-7.74374661865886	-0.628553651925646	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCAGAGGGTAA"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3100.77793858658	44.0000822017696	0.0141900139491531	4091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3095.48381494295	3095.48381494295
"healthy-3"	"2019-08-01-count-4:GACGCTGGTAATGTGA"	2.7188683944637	-6.10851147091063	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGCTGGTAATGTGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.46893236824	49.3823987558923	0.0195614998951744	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2517.6900923973	2517.6900923973
"healthy-3"	"2019-08-01-count-3:ATGAGTCGTTGCTCAA"	-2.68418870392497	9.46621606433717	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCGTTGCTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.6664505409	46.687977800379	0.023812300040886	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.30994916856	1957.30994916856
"healthy-3"	"2019-08-01-count-4:GCTTCACAGACCCTTA"	4.59214939650838	-8.18294527446898	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTCACAGACCCTTA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2585.27705967887	49.4524486643536	0.0191284908823259	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2581.35229810695	2581.35229810695
"healthy-3"	"2019-08-01-count-4:TGCTCGTCAGATTTCG"	3.06573214110677	-6.6523156396118	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCGTCAGATTTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.77197312642	46.4155544462055	0.0206679729739385	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2236.41263174554	2236.41263174554
"healthy-3"	"2019-08-01-count-4:CAGCGTGGTAGTCTGT"	3.3321541744167	-6.43979456340941	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCGTGGTAGTCTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.71741233553	46.2448085276823	0.0191037616749593	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2417.38766562256	2417.38766562256
"healthy-3"	"2019-08-01-count-4:ATGAGTCGTTCTCTCG"	-5.03917727890666	-5.14759781276854	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGTCGTTCTCTCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2478.99702310124	43.6548606445741	0.0176098882885957	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2477.2627344851	2477.2627344851
"healthy-3"	"2019-08-01-count-4:TTCTCTCCAAATGAAC"	2.41359319266621	-4.50783445751341	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTCTCCAAATGAAC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2858.69508317284	42.6362804286918	0.0149145953619405	2719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2848.19367137248	2848.19367137248
"healthy-3"	"2019-08-01-count-4:CCTCAGTGTCGAGCAA"	10.575043340295	6.28538224780885	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTGTCGAGCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.25929064416	51.7734249840072	0.0276824851201115	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1854.33852740685	1854.33852740685
"healthy-3"	"2019-08-01-count-4:GCTTGGGTCGTGGTAT"	-2.06217751923259	9.33497617328493	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTGGGTCGTGGTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1997.18742878565	41.9793611930612	0.0210192396507251	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1995.36578941602	1995.36578941602
"healthy-3"	"2019-08-01-count-2:GCTGAATTCCATTTAC"	-1.62571678581889	8.92659089649049	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGAATTCCATTTAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2063.94333046932	44.5899221997606	0.0216042376462058	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.80876648719	2058.80876648719
"healthy-3"	"2019-08-01-count-2:CGCATGGAGCTGAGTG"	0.0911471555823505	8.08707711780397	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATGGAGCTGAGTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1778.4670821508	34.6747283781286	0.0194969750782198	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1770.41628682303	1770.41628682303
"healthy-3"	"2019-08-01-count-4:CTCAGAAAGGCATGGT"	-2.86086926880534	9.4262370833191	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAAAGGCATGGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2055.56848347493	41.1130175760768	0.0200008016792394	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.31846300581	2052.31846300581
"healthy-3"	"2019-08-01-count-4:AGCGCTGCACGTACAT"	4.03408994254414	-6.80378487026366	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGCACGTACAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.8949680974	46.8422226901849	0.0177708987866068	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2630.12808193836	2630.12808193836
"healthy-3"	"2019-08-01-count-4:CCTCATGGTCAGACGA"	10.9386059242183	6.17229077899782	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGGTCAGACGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1814.97239186188	38.0891243582244	0.0209860626690584	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1810.23585622381	1810.23585622381
"healthy-3"	"2019-08-01-count-4:GGAACCCCAAATAGCA"	-2.81247029724773	9.96965215289918	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCCAAATAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.76020035131	43.7691277794311	0.0208051886199397	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2100.6027542416	2100.6027542416
"healthy-3"	"2019-08-01-count-3:CTGAATGGTGGTCTCG"	-3.88066373291667	9.97897431934205	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAATGGTGGTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.65824817899	45.8239678117245	0.0226329395852062	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2021.31557070924	2021.31557070924
"healthy-3"	"2019-08-01-count-3:ACCAACAGTCTTGAGT"	-5.736648897559	-5.18385794078978	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACAGTCTTGAGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3055.98114002462	49.0975558337196	0.0160660532850422	4030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3047.06671515956	3047.06671515956
"healthy-3"	"2019-08-01-count-2:CTGAATGTCTCCCATG"	-7.15352616730388	3.61598322475282	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGTCTCCCATG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2469.67812933571	39.9923080061436	0.0161933280013702	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2458.73878990881	2458.73878990881
"healthy-3"	"2019-08-01-count-3:ATGCGATCATCTGGGC"	4.69886316832845	-8.00556375896605	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCGATCATCTGGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.62412535839	44.3822237949267	0.0166000236809568	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2666.73266170045	2666.73266170045
"healthy-3"	"2019-08-01-count-2:TCATCCGAGCAATAAC"	-1.00814483586009	8.40620610797731	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCCGAGCAATAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2085.70359642203	48.4303447678536	0.0232201473166823	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2076.03052611638	2076.03052611638
"healthy-3"	"2019-08-01-count-3:GGAGATGCATCATCCC"	4.37022318419759	-7.48824932491454	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGCATCATCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.18804098872	44.7915778443777	0.0182213797714034	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2452.34312282025	2452.34312282025
"healthy-3"	"2019-08-01-count-2:CTGAGGCCAAACGTGG"	-1.68671606007274	8.78165433490602	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGGCCAAACGTGG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2132.00752414848	40.738292873891	0.0191079498606187	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2129.15289903326	2129.15289903326
"healthy-3"	"2019-08-01-count-3:CTGAGGCAGATCACTC"	-3.24167237702068	10.0899057158264	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCAGATCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.81126056115	45.9723203977784	0.023314767146981	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.00797263459	1961.00797263459
"healthy-3"	"2019-08-01-count-4:GTCGAATGTAAGGTCG"	2.48403920707051	-7.07414343273314	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATGTAAGGTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.04450828576	44.1878298606215	0.0214291348625429	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2059.11955669552	2059.11955669552
"healthy-3"	"2019-08-01-count-4:TGGAACTAGAACGTGC"	-3.68363175812419	3.37363145435182	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTAGAACGTGC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3035.59716109322	44.2818238601873	0.014587516561071	4501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3028.71078121984	3028.71078121984
"healthy-3"	"2019-08-01-count-2:GCTTGGGAGACATAGT"	-1.74199567261394	10.2996444472107	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTGGGAGACATAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2043.55738224021	42.7463216291443	0.020917602804128	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2028.27975820715	2028.27975820715
"healthy-3"	"2019-08-01-count-3:TAGGTACAGTGCACAG"	-1.82054517689403	8.48699472034303	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACAGTGCACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1855.9830521302	46.4614160275577	0.0250333191212236	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1847.22849915175	1847.22849915175
"healthy-3"	"2019-08-01-count-3:TTTACCATCGTGGTAT"	0.204804604023141	8.01039550388185	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCATCGTGGTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1781.49953575304	39.4750492829887	0.0221583270109036	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1775.62001746805	1775.62001746805
"healthy-3"	"2019-08-01-count-2:TCATGAGGTATATGGA"	-2.86449490013774	10.6925983198914	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGGTATATGGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1801.55083747464	43.3874266660664	0.0240833762575835	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1793.99315745152	1793.99315745152
"healthy-3"	"2019-08-01-count-2:TCATGAGGTGTACAGG"	0.180116404860657	8.02900359714357	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGGTGTACAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1823.44165976443	43.9998221031502	0.0241300958917625	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1815.47408413136	1815.47408413136
"healthy-3"	"2019-08-01-count-3:GTGACGCGTAGACAGC"	4.95655741271321	-8.19043733989867	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCGTAGACAGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.59141514598	46.03967122424	0.018817883092054	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2444.34798366109	2444.34798366109
"healthy-3"	"2019-08-01-count-4:TGGAGAGAGTGCAGGT"	4.74611868438069	-8.19531538402709	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGAGAGTGCAGGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.25943502065	44.0726731682567	0.0163397975723159	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2693.98982507718	2693.98982507718
"healthy-3"	"2019-08-01-count-4:CAGTTCCGTCACTCTC"	-4.17662749710734	10.6930036314758	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCGTCACTCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2092.90676519505	52.8386107342718	0.0252465191536362	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2083.31196910905	2083.31196910905
"healthy-3"	"2019-08-01-count-4:AGCTTCCCAAGTCATC"	-0.312325219542342	7.68701455676881	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCCAAGTCATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.41777503306	40.1967162702806	0.021184958209628	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1894.08180384956	1894.08180384956
"healthy-3"	"2019-08-01-count-4:GGAATGGTCTAAGCCA"	-4.44959960404094	10.3624400862488	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATGGTCTAAGCCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2397.54733009568	37.9311247775197	0.0158208033273762	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2394.67432864131	2394.67432864131
"healthy-3"	"2019-08-01-count-3:CTGCAGGCATCCGTGG"	10.9442182975704	6.53171346271364	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCAGGCATCCGTGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2250.89247198348	44.879860175213	0.0199386957546066	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2242.66205972701	2242.66205972701
"healthy-3"	"2019-08-01-count-2:ATCCGTCTCATTACGG"	-0.86531106653865	8.70208833301393	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCGTCTCATTACGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.11032018556	45.7354517132032	0.0246404813419877	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1849.38112862288	1849.38112862288
"healthy-3"	"2019-08-01-count-4:AGCTTCCGTATCAAGA"	10.168265958398	7.71162078464357	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCGTATCAAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2282.40112797556	43.4949617644294	0.0190566685370544	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2277.6402772731	2277.6402772731
"healthy-3"	"2019-08-01-count-2:ATCGATGAGATCACTC"	-2.05652962151225	8.97262475574342	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGATGAGATCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.79093460801	43.0519100501798	0.0226137803618883	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1903.79093460801	1903.79093460801
"healthy-3"	"2019-08-01-count-4:AGGAAATGTCCTCCAT"	4.02937116202657	-7.70773174678954	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATGTCCTCCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.48932005088	43.9161114598177	0.0182414563977752	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2405.14551613921	2405.14551613921
"healthy-3"	"2019-08-01-count-2:TTTGATCGTCTGTGTA"	-4.13595328751262	12.8925447233948	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCGTCTGTGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.51333216236	42.8515451370496	0.0196340359096884	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2178.77764542229	2178.77764542229
"healthy-3"	"2019-08-01-count-3:GTGAGGATCGGTCTAA"	3.00517239150349	-6.56444981014403	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGATCGGTCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.02346346179	48.9628401151532	0.019007140583011	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2570.67099482324	2570.67099482324
"healthy-3"	"2019-08-01-count-4:CCTCTAGTCCACTAGA"	-0.59717826071437	8.28976819599	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGTCCACTAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2193.30771095992	40.7654711584831	0.0185862981991896	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.10338502125	2180.10338502125
"healthy-3"	"2019-08-01-count-2:CTGCCATGTGCAACAG"	-2.21528540077861	8.77990148151246	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATGTGCAACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.1517674899	47.4433288884411	0.0235433031168352	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.31433212605	2004.31433212605
"healthy-3"	"2019-08-01-count-4:TTGATGGGTATCCCAA"	5.07643093642537	-7.95638086712035	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGGTATCCCAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2847.65939394956	45.7154802740632	0.0160537037439222	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2843.36229672376	2843.36229672376
"healthy-3"	"2019-08-01-count-4:GGAGATGTCTCCGTGT"	3.89321484145467	-6.70774271404418	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGATGTCTCCGTGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2664.86347877329	44.6685706892892	0.0167620484295321	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2654.99700717343	2654.99700717343
"healthy-3"	"2019-08-01-count-4:TCGAAGTTCGAACACT"	0.0180685679310977	8.05929277026979	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTTCGAACACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2111.24551331211	42.507971929463	0.0201340733048033	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2103.73649266225	2103.73649266225
"healthy-3"	"2019-08-01-count-4:CTCATTACAGTCAACT"	10.4517904716427	7.00822589481202	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATTACAGTCAACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2177.01741672183	44.2409124147216	0.0203217999428502	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2166.69388504836	2166.69388504836
"healthy-3"	"2019-08-01-count-3:GTGATGTTCTCTCTAA"	0.418929954140824	8.41791150653688	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGATGTTCTCTCTAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1953.85944997099	38.4312567331018	0.0196694069953048	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.45661287902	1943.45661287902
"healthy-3"	"2019-08-01-count-4:AGGACGACATAGAAAC"	-3.82635221901591	11.010435081366	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGACATAGAAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.2245999556	44.2521742327124	0.0217645282442868	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.54283147199	2031.54283147199
"healthy-3"	"2019-08-01-count-4:TCGACCTTCTGGACCG"	4.11862864074056	-7.65114500438841	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGACCTTCTGGACCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2643.16472320804	47.6093373399415	0.0180122475613845	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2638.73349639389	2638.73349639389
"healthy-3"	"2019-08-01-count-3:TGTAAGCGTTAATCGC"	-4.07666097107585	12.0985555418762	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAAGCGTTAATCGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2079.70523226058	44.0554883407722	0.0211835252695331	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2072.6465254899	2072.6465254899
"healthy-3"	"2019-08-01-count-2:CACGTTCAGAATACAC"	-3.67476139488872	11.1455545195374	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCAGAATACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.82808453051	49.6154680602157	0.0239592404752731	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2065.99555892036	2065.99555892036
"healthy-3"	"2019-08-01-count-4:CCTGCATCAACCGACC"	-2.2493499321049	9.37616632068483	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATCAACCGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1844.69939774798	50.2950970608782	0.0272646573866065	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1835.06573543284	1835.06573543284
"healthy-3"	"2019-08-01-count-2:CGGAGAATCTGTGCTC"	-3.59333811226543	10.8082952269348	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAATCTGTGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.94294211357	46.7223985236192	0.0241341815955639	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1932.75774868227	1932.75774868227
"healthy-3"	"2019-08-01-count-3:ATTACCTAGCGTGAAC"	2.81519498404805	-6.6243558160034	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTAGCGTGAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.16778864235	44.874559799655	0.0198985459200223	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2249.06899360742	2249.06899360742
"healthy-3"	"2019-08-01-count-3:AAACCCAGTAGTTACC"	2.87768592414204	-6.95979788219603	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACCCAGTAGTTACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.15853455502	51.0631693855261	0.0233895837509272	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2179.22775957032	2179.22775957032
"healthy-3"	"2019-08-01-count-2:AGCCAATTCAACCTCC"	-2.93613038483318	9.21458051288453	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATTCAACCTCC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2154.83243203531	44.8248266048624	0.0208020010922724	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2150.2087254368	2150.2087254368
"healthy-3"	"2019-08-01-count-2:ACATGCAAGGCGTTGA"	-2.39998565140422	9.03900525653688	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCAAGGCGTTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1841.53835056398	43.7990198231334	0.0237839303263599	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1839.72006048871	1839.72006048871
"healthy-3"	"2019-08-01-count-2:TACCTGCCATACCGTA"	-1.46081374111827	8.93578240955202	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTGCCATACCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2114.26753463931	47.593587393871	0.0225106740817408	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2109.61174799185	2109.61174799185
"healthy-3"	"2019-08-01-count-2:CACGTTCCAGGCTATT"	-4.4535702270573	9.4389552840027	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCCAGGCTATT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	3161.44143378508	42.3791850170795	0.0134050198002057	3057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	3149.84696210031	3149.84696210031
"healthy-3"	"2019-08-01-count-2:ATCGTAGTCTCTAAGG"	3.25539960440938	-6.56662037288817	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTAGTCTCTAAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.79185083407	41.6848970073325	0.0163035942850546	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2550.38773901438	2550.38773901438
"healthy-3"	"2019-08-01-count-4:CTCCCAATCCTCAGGG"	-2.66261039200481	9.71203420245973	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCCAATCCTCAGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2210.26697275565	43.3262213060294	0.0196022570305217	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2205.85679559874	2205.85679559874
"healthy-3"	"2019-08-01-count-3:GTGCTGGCACACGCCA"	-2.14831386032756	9.51254365527955	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTGGCACACGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.04180121904	44.0738739213377	0.0217001313783323	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2026.41897666836	2026.41897666836
"healthy-3"	"2019-08-01-count-1:TTAGTCTCATAGGCGA"	0.128348429768723	7.93219850147096	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTAGTCTCATAGGCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2119.43973188568	40.2489979026095	0.0189903951016336	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.86982195826	2112.86982195826
"healthy-3"	"2019-08-01-count-2:GGAGAACGTCACTGAT"	-2.55684409561809	8.97098634326784	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACGTCACTGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.29520139032	45.824620461165	0.0250230658751112	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1824.52120608403	1824.52120608403
"healthy-3"	"2019-08-01-count-4:TGGGATTGTCCATACA"	4.67004980620686	-8.29164888775023	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGATTGTCCATACA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.46097994301	43.5189616390902	0.0160796560384944	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2697.34159170194	2697.34159170194
"healthy-3"	"2019-08-01-count-3:GTGCTTCAGAAGCGAA"	-2.38298449936565	9.32449815357057	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCAGAAGCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.44317781631	48.9172964618492	0.0254586224701388	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.44317781631	1921.44317781631
"healthy-3"	"2019-08-01-count-2:ACCAAACCAAGGAGTC"	4.72451128539388	-8.39361860668334	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACCAAGGAGTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.3535010061	47.0847910341234	0.0193100758420367	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2436.13144766234	2436.13144766234
"healthy-3"	"2019-08-01-count-3:AAAGAACCATGGGCAA"	4.91396917876546	-8.1683674088684	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGAACCATGGGCAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.65726653383	47.7092205006349	0.0173572824380532	2221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2745.14941006928	2745.14941006928
"healthy-3"	"2019-08-01-count-4:GGCAGTCAGATGCAGC"	4.78547634658162	-8.14279367839965	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCAGTCAGATGCAGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2758.8559373061	43.5816738294321	0.0157970096372584	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2755.18251467324	2755.18251467324
"healthy-3"	"2019-08-01-count-2:ACCAAACCAGCCGTTG"	-5.24953923645671	-5.24547340786131	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACCAGCCGTTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2855.35748109003	48.4476224439562	0.0169672703907678	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2849.23407370953	2849.23407370953
"healthy-3"	"2019-08-01-count-4:GTGAGGATCATGTCTT"	-2.62616835060771	9.37224195087282	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGATCATGTCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.93464448659	37.6982713616636	0.0189349617608291	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.15726368098	1989.15726368098
"healthy-3"	"2019-08-01-count-3:CTGGTCTCATCGCTAA"	2.60329069670979	-4.3997807732788	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGTCTCATCGCTAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3055.69958712115	43.319054254971	0.014176476783761	3235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3050.01835584884	3050.01835584884
"healthy-3"	"2019-08-01-count-2:ACCAAACTCTCTCAAT"	4.17755856093709	-7.62113001262816	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACTCTCTCAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3021.40549704785	45.48957254237	0.0150557654663755	3289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3017.09934052315	3017.09934052315
"healthy-3"	"2019-08-01-count-4:GTGAGTTGTCAATCTG"	-2.48451242867168	9.30972001636354	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGTTGTCAATCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2158.49701867875	37.9298308533892	0.0175723341404504	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2153.56874953557	2153.56874953557
"healthy-3"	"2019-08-01-count-2:TCCACGTCACACAGCC"	10.9565254646236	6.57273194873659	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACGTCACACAGCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.14700832018	43.5733509404598	0.0208970162614879	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2082.09404499489	2082.09404499489
"healthy-3"	"2019-08-01-count-4:GGCAGTCTCTGCGTCT"	5.25126232680623	2.37741253459779	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCAGTCTCTGCGTCT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1461.06808020537	48.0327341965713	0.0328750828570698	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	1447.79101841478	1447.79101841478
"healthy-3"	"2019-08-01-count-2:CGGTCAGAGCACTTTG"	-3.12986908379253	10.0304784544739	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGTCAGAGCACTTTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1866.02896899048	45.3647595530971	0.0243108549261373	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1859.39053180771	1859.39053180771
"healthy-3"	"2019-08-01-count-4:AGGCATTCAACTGCCG"	2.99956836280171	-6.76670029079589	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTCAACTGCCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.64096342472	53.1760896474708	0.023935501065617	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2215.60532418933	2215.60532418933
"healthy-3"	"2019-08-01-count-2:GGAGGATCAATCCTAG"	-1.02550468865092	8.23269555652467	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATCAATCCTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1969.28534151014	44.8975006508901	0.0227988802356395	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.01911452543	1966.01911452543
"healthy-3"	"2019-08-01-count-4:TGGGTTACAGGCACAA"	-2.87071023407634	9.64179132068483	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGTTACAGGCACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.20245406111	49.2997558861649	0.025849251494611	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1903.86886562613	1903.86886562613
"healthy-3"	"2019-08-01-count-3:CTGTACCCAGTGTATC"	-2.73062882843669	10.3857488402161	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCCAGTGTATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.09552316725	46.0136645880932	0.0228458203986943	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.52947103795	2010.52947103795
"healthy-3"	"2019-08-01-count-2:AAACGAAAGACATAAC"	3.06692447242085	-6.36280968105467	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGAAAGACATAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.30202151175	43.774430661235	0.0190050763001997	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2300.85596958573	2300.85596958573
"healthy-3"	"2019-08-01-count-2:GGAGGATGTAGAGATT"	-0.936736206442672	8.35544965350953	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATGTAGAGATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.85870196849	44.1305410878958	0.0224028967376167	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1964.83443692284	1964.83443692284
"healthy-3"	"2019-08-01-count-4:GGCTGTGGTGGTAACG"	4.84714855727498	-8.29021551525267	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTGTGGTGGTAACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.03156381461	41.304493493213	0.0150470012941543	2702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2740.85139936682	2740.85139936682
"healthy-3"	"2019-08-01-count-4:TCGGGCATCCTTTGAT"	-3.02333436432536	9.87667272174684	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCATCCTTTGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.94770808429	43.7499356843961	0.0219744273075322	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.47853775416	1978.47853775416
"healthy-3"	"2019-08-01-count-2:ATGAAAGAGCAGCAGT"	-4.03546653214152	10.6583757170471	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGAGCAGCAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.88656256503	49.9275978305197	0.0232017796379593	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2148.75472411911	2148.75472411911
"healthy-3"	"2019-08-01-count-3:AGGTTGTCATGCCGGT"	-3.75454054299052	10.4055108794006	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTCATGCCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.67083268274	52.1394357537832	0.0267152815324463	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1946.78356334497	1946.78356334497
"healthy-3"	"2019-08-01-count-2:AAACGCTTCATTGCCC"	0.137296167283696	8.21136090839235	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTTCATTGCCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.57558228859	41.2586286939231	0.0205924992591472	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1994.39359921347	1994.39359921347
"healthy-3"	"2019-08-01-count-4:CGAAGTTTCAGCCTCT"	-0.136213282973129	8.31941220844118	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTTCAGCCTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.97173910064	41.4802408261491	0.0207196934981627	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1992.65733244362	1992.65733244362
"healthy-3"	"2019-08-01-count-3:ATTCCATTCTTTCCAA"	10.7302919822628	6.50022552097169	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCATTCTTTCCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2077.20033375824	46.9022997318936	0.0225795745213627	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2070.4472231019	2070.4472231019
"healthy-3"	"2019-08-01-count-2:CGTAGTAGTAGGCTCC"	-3.97502360764201	11.0731754072937	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTAGTAGGCTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.83160425776	47.7141969794354	0.0234372022124253	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2032.18508989954	2032.18508989954
"healthy-3"	"2019-08-01-count-2:TCCATGCCATCAGTGT"	11.1816097694332	5.14028070056764	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCCATCAGTGT"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.82990057366	43.8017395057299	0.0221687805681109	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1969.4684280979	1969.4684280979
"healthy-3"	"2019-08-01-count-4:TGGTAGTTCTTTACAC"	0.163194452493828	8.52576348865358	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTTCTTTACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1836.57112444324	41.2669829953546	0.0224695806473952	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1829.03698021125	1829.03698021125
"healthy-3"	"2019-08-01-count-2:TCCCACAAGGTTACAA"	2.82792748984639	-6.95440199291381	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCACAAGGTTACAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.81542077351	47.5543739841738	0.0252704773588405	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1881.81542077351	1881.81542077351
"healthy-3"	"2019-08-01-count-2:GGATCTAAGTACTGGG"	-0.996342520148116	8.65131661975709	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTAAGTACTGGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.40017469173	38.0882615838185	0.0202661796549348	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1869.40604836359	1869.40604836359
"healthy-3"	"2019-08-01-count-3:ATTCCTAGTACTCCCT"	10.6446491676265	7.36815879428712	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTAGTACTCCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.27291717566	41.2614088418167	0.0205048770917861	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2009.31511887463	2009.31511887463
"healthy-3"	"2019-08-01-count-2:AAAGAACCATGTTCAG"	-0.17581849816497	8.69949243152467	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACCATGTTCAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2198.773217735	32.1088403673189	0.0146030705251153	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2194.95724227888	2194.95724227888
"healthy-3"	"2019-08-01-count-4:CATCGTCGTTGTGCAT"	-2.03661022606547	9.85258672321168	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCGTTGTGCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.11587763747	42.7244436789137	0.0207590078591481	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.03041240917	2055.03041240917
"healthy-3"	"2019-08-01-count-2:ATGACCACAAACTAGA"	4.69997705993001	-8.4004698029724	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCACAAACTAGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.14541799187	49.5348059621234	0.0194090844561277	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2549.0363217725	2549.0363217725
"healthy-3"	"2019-08-01-count-3:GTGTGGCTCTCCCTAG"	-2.64943919602092	9.08270261371461	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGGCTCTCCCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.67084151396	44.3622411244746	0.0230612432060158	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1918.25477643439	1918.25477643439
"healthy-3"	"2019-08-01-count-3:AACAACCCAGTAACAA"	-3.3697079223698	10.4272441633972	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAACCCAGTAACAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1984.81727434604	46.9044539326423	0.0236316231921633	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.81181645841	1974.81181645841
"healthy-3"	"2019-08-01-count-4:CGAGGAAAGTCAATCC"	-3.68969307366069	10.1223401793274	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAAAGTCAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2159.54531609351	44.8089968940291	0.0207492737291042	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2154.91346092601	2154.91346092601
"healthy-3"	"2019-08-01-count-4:TATTCCACAAGTGCTT"	-2.19190893593486	8.67893693530885	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTCCACAAGTGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.2781495872	40.349113076608	0.020111425270175	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.2781495872	2006.2781495872
"healthy-3"	"2019-08-01-count-3:ATTCGTTGTAAGATCA"	2.67657031592671	-4.48018219387206	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCGTTGTAAGATCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2804.84006278262	38.9465681704225	0.0138854862661169	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2801.03486537819	2801.03486537819
"healthy-3"	"2019-08-01-count-2:GGATGTTAGAGTCCGA"	3.17569961127583	-7.66654589092406	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTAGAGTCCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.53965013217	46.3470694147504	0.0218562616416352	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2112.39049080626	2112.39049080626
"healthy-3"	"2019-08-01-count-4:CGAGGAAGTCGTTCAA"	4.93710341033284	-8.34343244945677	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAAGTCGTTCAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.78386915328	45.737498972663	0.0165070612261937	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2763.62627051937	2763.62627051937
"healthy-3"	"2019-08-01-count-4:GGGACCTAGATCCGAG"	-3.26610813561137	13.0505256422791	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTAGATCCGAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1974.33521898374	47.1374963288694	0.0238751230670609	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1967.19531211649	1967.19531211649
"healthy-3"	"2019-08-01-count-2:AAAGGGCCAACCGCCA"	-0.219110141426879	7.94474408710328	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGGCCAACCGCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.9673412405	37.5218572928157	0.0192127418111264	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.13494136767	1937.13494136767
"healthy-3"	"2019-08-01-count-2:GGATGTTTCAAAGAAC"	-0.126979689032394	8.02808425510255	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTTCAAAGAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.61446166053	40.3561238940923	0.0203858502125919	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1971.54889719556	1971.54889719556
"healthy-3"	"2019-08-01-count-4:CATGCCTGTAGGAGTC"	4.0136739211971	-7.70240309154662	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTGTAGGAGTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.89820699894	47.0555993390757	0.0187554836652229	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2506.82229793327	2506.82229793327
"healthy-3"	"2019-08-01-count-3:AGTACTGGTTGCATCA"	-3.78156314316447	10.4991369017395	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGGTTGCATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2218.10288288708	37.1600905978808	0.0167530960284012	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2214.83232850597	2214.83232850597
"healthy-3"	"2019-08-01-count-2:CCCTTAGGTACTGCCG"	10.9340149360592	6.02255103671876	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTTAGGTACTGCCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.97468890553	38.8233114024543	0.0208282395858338	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1862.44899372671	1862.44899372671
"healthy-3"	"2019-08-01-count-4:GATAGAAGTCCCACGA"	2.76029266890828	-5.09349539196166	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATAGAAGTCCCACGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2623.09555028759	41.8733888549858	0.0159633486665764	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2616.14530222766	2616.14530222766
"healthy-3"	"2019-08-01-count-3:CATTGTTCATTAGGCT"	-4.92650304260905	-5.09492161190184	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGTTCATTAGGCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2951.91932993139	53.0311696999862	0.0179649793143971	2596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2947.25545914617	2947.25545914617
"healthy-3"	"2019-08-01-count-4:AGGGTGACAGTTACCA"	11.3860107856685	-2.35458447849425	"2019-08-01-count-4"	"Control3"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTGACAGTTACCA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1417.72321914914	43.3350305212024	0.0305666366579016	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	1410.05437051985	1410.05437051985
"healthy-3"	"2019-08-01-count-4:AGGGTGATCGAGTCTA"	-1.91937981072124	8.99965760791627	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTGATCGAGTCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.872666587	40.5483915397246	0.0191911193613119	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2107.60318027333	2107.60318027333
"healthy-3"	"2019-08-01-count-2:GTCTGTCAGGTTGCCC"	10.6023422676021	6.91844794833986	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCAGGTTGCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.36620294259	46.3842390014351	0.0237945230256981	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1933.81384438199	1933.81384438199
"healthy-3"	"2019-08-01-count-3:TGTTCCGGTGCCCACA"	4.86011137542073	-8.31034090435179	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGGTGCCCACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.23151230895	44.1876191303582	0.0166479897949516	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2653.22116224782	2653.22116224782
"healthy-3"	"2019-08-01-count-4:GATCACATCCCTCTTT"	-1.08816323700603	8.39710996234743	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCACATCCCTCTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2277.55481851309	38.1505039157833	0.0167506413482026	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2268.95856240318	2268.95856240318
"healthy-3"	"2019-08-01-count-2:GATCCCTAGGTACCTT"	-1.49046681347545	8.68540761554567	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTAGGTACCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.69907857459	38.7524274333909	0.0198659177415043	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.75622993029	1943.75622993029
"healthy-3"	"2019-08-01-count-3:CGGTCAGAGGCATCTT"	-3.02609000626262	10.1429767378601	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGAGGCATCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.34617196147	48.4529939032954	0.0253900443301089	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1897.46761634748	1897.46761634748
"healthy-3"	"2019-08-01-count-3:CTTACCGTCACGGAGA"	-7.34417424622233	0.242622784617819	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGTCACGGAGA"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2809.87272157117	46.5622491903822	0.0165709460193437	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2801.89445685324	2801.89445685324
"healthy-3"	"2019-08-01-count-4:CTGCAGGTCTGCACCT"	-3.24785981598552	9.38559148395387	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGTCTGCACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.70014392482	46.1557606411917	0.0231276030027337	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1992.16729682099	1992.16729682099
"healthy-3"	"2019-08-01-count-4:CGAGTTAGTGTCTTGA"	4.91663899001424	-8.69132521068724	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTTAGTGTCTTGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2691.10932371325	45.5009726582731	0.0169078871145561	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2690.36987734707	2690.36987734707
"healthy-3"	"2019-08-01-count-2:CGTTCTGTCTGCATGA"	-1.64893207970317	9.96216294849244	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTCTGTCTGCATGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1852.92104909697	48.8477809891259	0.0263625808627584	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1849.31010730993	1849.31010730993
"healthy-3"	"2019-08-01-count-3:ATTTCACGTGTTACAC"	-3.16757641258891	10.5615501173767	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACGTGTTACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.6122134524	43.5219332266688	0.0213592816824199	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2035.85322862774	2035.85322862774
"healthy-3"	"2019-08-01-count-2:CGTTCTGTCTCTATAC"	-2.32101688805278	8.91591260516969	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTCTGTCTCTATAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2172.56129000112	45.3823983043482	0.0208888920709458	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2166.36376881491	2166.36376881491
"healthy-3"	"2019-08-01-count-4:TCTACCGCACGCCACA"	-2.40760360184367	9.59542367542116	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGCACGCCACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.5592635909	45.2429095423576	0.0224802868471227	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.96905209789	2006.96905209789
"healthy-3"	"2019-08-01-count-3:ATTTCTGAGCACTTTG"	-4.36429295960124	10.9605827101502	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCTGAGCACTTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2218.57223910117	42.3298314269046	0.0190797625071041	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2212.16839622455	2212.16839622455
"healthy-3"	"2019-08-01-count-4:GTGGTTATCCTTCTAA"	-1.79683933678325	9.06629273975221	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGTTATCCTTCTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.20241194064	43.9959041322112	0.0220177414806955	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1988.56737524577	1988.56737524577
"healthy-3"	"2019-08-01-count-3:TGTTGAGCATTACGGT"	-3.14963088455852	9.86037442767946	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGCATTACGGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1990.71051245668	49.3818446854805	0.0248061405093701	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1984.0018321612	1984.0018321612
"healthy-3"	"2019-08-01-count-3:CTTCCGAGTCCGAAGA"	-3.51272545281108	10.6009588011536	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCGAGTCCGAAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1785.1116614173	42.8385542021172	0.0239976888437922	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1783.28626033354	1783.28626033354
"healthy-3"	"2019-08-01-count-4:GGGCCATGTCGTCAGC"	5.08451380309407	-7.89100315487059	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCCATGTCGTCAGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.47142553226	44.07792046965	0.0163708034379367	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2685.64187742431	2685.64187742431
"healthy-3"	"2019-08-01-count-2:TCCGTGTGTCTATGAC"	-1.25734446469005	8.49250886524049	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGTGTGTCTATGAC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1915.67894837417	44.0702770763343	0.0230050432582852	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.2712498229	1909.2712498229
"healthy-3"	"2019-08-01-count-4:GTGTAACTCTCTGGTC"	14.3386246162349	2.00771615588991	"2019-08-01-count-4"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACTCTCTGGTC"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1188.7573903546	27.7256859200313	0.0233232500971126	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1179.55114622769	1179.55114622769
"healthy-3"	"2019-08-01-count-4:AGGTTACGTGCTATTG"	-1.9955988925999	8.77079007709352	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTACGTGCTATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.97802677555	38.6975423391095	0.0188494673758826	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.24501115806	2051.24501115806
"healthy-3"	"2019-08-01-count-2:CTAACCCAGACTGTTC"	-2.2692223590916	9.70167729938356	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCAGACTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1680.28969748955	34.1425642370459	0.0203194510375544	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1680.28969748955	1680.28969748955
"healthy-3"	"2019-08-01-count-2:GGGAAGTCAAAGCACG"	-4.39199862900432	10.1933393248352	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAAGTCAAAGCACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2607.51530262386	38.1671598586777	0.0146373675430672	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2599.91728317314	2599.91728317314
"healthy-3"	"2019-08-01-count-3:CCACCATCAAATGGTA"	2.60351361808125	-5.00190832531127	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACCATCAAATGGTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2586.5742934424	43.025608835554	0.0166342056923068	2548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2579.1240497575	2579.1240497575
"healthy-3"	"2019-08-01-count-2:TTCCAATAGTCGGCCT"	4.87757839736287	-8.10074617778929	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATAGTCGGCCT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.79832926192	42.2219273474835	0.0155525096992978	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2712.37309921575	2712.37309921575
"healthy-3"	"2019-08-01-count-2:ACGATGTAGCTAAATG"	-0.684813777834731	8.07862947070924	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTAGCTAAATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2229.28949229627	37.9046440522793	0.0170030156169784	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2225.93773558936	2225.93773558936
"healthy-3"	"2019-08-01-count-3:GGGTCACAGGAACGAA"	-3.10606871071513	10.0038852461609	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACAGGAACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.24104599769	41.8607838022213	0.0203183913278215	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.90459738922	2056.90459738922
"healthy-3"	"2019-08-01-count-2:ATGGATCAGGGCCAAT"	-3.50961814346965	10.0889892348084	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCAGGGCCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.56817015043	43.2505985763382	0.0222875955823729	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1933.38058984302	1933.38058984302
"healthy-3"	"2019-08-01-count-2:TCCTCCCGTTCTCAGA"	-3.59587870064433	10.7380475767883	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCGTTCTCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.3092000268	47.0090275388205	0.0221603845107666	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.63910077387	2119.63910077387
"healthy-3"	"2019-08-01-count-4:GTGTGGCCACCGTACG"	-2.58156762543376	9.68390462482301	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGGCCACCGTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2330.19321189692	48.9126108083858	0.0209907961960664	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2319.74869825547	2319.74869825547
"healthy-3"	"2019-08-01-count-4:AGTACCATCCACTAGA"	0.396271248429459	8.37207505786744	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCATCCACTAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1857.89122310166	37.2169096937209	0.0200318023094964	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1854.01923962523	1854.01923962523
"healthy-3"	"2019-08-01-count-4:TCTCAGCCAGCAGTGA"	-3.96521697464641	13.2830343016419	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCAGCCAGCAGTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2131.3765399677	30.5048417250676	0.0143122724460174	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2125.95360422348	2125.95360422348
"healthy-3"	"2019-08-01-count-3:CTTCGGTTCAGCCTTC"	-3.54319796982463	10.4314212569031	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTTCAGCCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.87592130387	47.3237947543628	0.0240481598672173	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.23065826321	1966.23065826321
"healthy-3"	"2019-08-01-count-3:GTTCCGTAGTCACACT"	-4.03270945969279	11.0611533888611	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCCGTAGTCACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.16563560955	44.6991792341994	0.0225279474817976	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.10046319047	1979.10046319047
"healthy-3"	"2019-08-01-count-4:CGCATGGCAATACGAA"	-1.6690790456837	8.95239732349244	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGCAATACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.92468641984	49.9197059249537	0.0253924813446759	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.90198138435	1960.90198138435
"healthy-3"	"2019-08-01-count-2:CTAACTTCAAGAATGT"	3.44740929183308	-6.7606787911621	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTCAAGAATGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.15267128068	46.061830784868	0.0176607110818595	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2606.32623855797	2606.32623855797
"healthy-3"	"2019-08-01-count-2:TAGGTTGTCGAGTACT"	-0.625344614416915	8.54935453021852	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGTCGAGTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.09404221923	42.159776260582	0.0225925249782396	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.75265005686	1856.75265005686
"healthy-3"	"2019-08-01-count-4:CAACAGTAGGAATGTT"	10.3444982963497	7.61273620212404	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAGTAGGAATGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2208.28131448899	45.5983018892435	0.0206487740443501	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2201.47241262031	2201.47241262031
"healthy-3"	"2019-08-01-count-3:TCACATTCAGGATTCT"	3.60371627387349	-7.54890253460082	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTCAGGATTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.34667804158	48.9600541117298	0.0221503959528691	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2203.43426404121	2203.43426404121
"healthy-3"	"2019-08-01-count-2:ATGGGTTCAAGGCGTA"	-2.79308019104655	8.74870297992555	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGTTCAAGGCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.20964481033	45.6561990395637	0.0230678943785862	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.02398559773	1976.02398559773
"healthy-3"	"2019-08-01-count-4:GGGTAGAGTTCTTAGG"	4.48294128951375	-8.30595495617064	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTAGAGTTCTTAGG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.19508912499	48.7511970259084	0.0189017097742876	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2572.87782774389	2572.87782774389
"healthy-3"	"2019-08-01-count-2:GGGACTCGTTTAGAGA"	-2.78886948052104	10.8731336363587	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCGTTTAGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1594.15664468621	39.4821442052727	0.0247667908526294	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1594.15664468621	1594.15664468621
"healthy-3"	"2019-08-01-count-3:AACCTTTCACACTGGC"	-4.00353703919108	10.0302743681702	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTCACACTGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2166.90361044265	41.5842765667809	0.0191906443675573	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2163.5554404714	2163.5554404714
"healthy-3"	"2019-08-01-count-2:CTAAGTGTCTCCTGAC"	10.8204475837642	6.42950961673585	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAAGTGTCTCCTGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2070.66679522669	42.109728767609	0.0203363133386215	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2060.51179503028	2060.51179503028
"healthy-3"	"2019-08-01-count-2:TTCCGTGTCACTTTGT"	11.1635614829952	5.95436570728151	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGTGTCACTTTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1974.87880168678	39.7975235462629	0.0201518814786361	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1970.28437749928	1970.28437749928
"healthy-3"	"2019-08-01-count-2:GTGCAGCGTTCAATCG"	3.48667397078816	-6.50994732296141	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCAGCGTTCAATCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.37216118416	44.4954993309009	0.0213676979361836	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2078.06438741863	2078.06438741863
"healthy-3"	"2019-08-01-count-2:TCCTGCAGTATTCTCT"	-2.08015213432963	8.83772084796754	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCAGTATTCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.42578718951	45.8117437725606	0.0222449112065746	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.9170615285	2052.9170615285
"healthy-3"	"2019-08-01-count-3:CGTGATACACTGGATT"	4.0262619453365	-8.04636576091918	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGATACACTGGATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.24795521085	47.2874089201674	0.0211458701661323	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2231.53960271596	2231.53960271596
"healthy-3"	"2019-08-01-count-4:GTTACGATCCAAATGC"	4.27785601195638	-7.66455700313719	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACGATCCAAATGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.68597451234	47.3114264564418	0.0189421035867726	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2493.36209234839	2493.36209234839
"healthy-3"	"2019-08-01-count-3:AACGGGATCTATGTGG"	5.14562811431233	-8.61066248333129	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGGGATCTATGTGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.6810996607	45.0447549713691	0.0174613656615516	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2570.7081552349	2570.7081552349
"healthy-3"	"2019-08-01-count-4:TCTGCCAGTTCGTAAC"	4.58293880996053	-7.97090723430785	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCAGTTCGTAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.74002421956	48.3557023051688	0.0190471264658279	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2530.67688801696	2530.67688801696
"healthy-3"	"2019-08-01-count-4:TCTGCCATCTCATGCC"	-4.35557446900066	10.1604289778504	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCATCTCATGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2360.72590132863	43.0627468847544	0.0182413158853039	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2353.35068870658	2353.35068870658
"healthy-3"	"2019-08-01-count-3:GTTGCGGCAGTCAACT"	10.7585922676021	6.17732474887697	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGCAGTCAACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.337668697	41.623511981159	0.0213089178835754	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1945.81466676406	1945.81466676406
"healthy-3"	"2019-08-01-count-3:CTTGAGATCCCATTCG"	4.66786589202229	-8.15971376812132	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGAGATCCCATTCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.38526917342	46.9515248648514	0.0180140386074778	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2602.33963609608	2602.33963609608
"healthy-3"	"2019-08-01-count-2:TCCTTCTGTCACTCGG"	2.66354550895039	-6.88420774852904	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTGTCACTCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2031.74825494969	50.9017190759244	0.0250531624436832	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2025.22823049254	2025.22823049254
"healthy-3"	"2019-08-01-count-3:TCACTATGTGTCCATA"	2.63585295256917	-4.482777141687	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTATGTGTCCATA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2647.42009035596	43.25361697641	0.0163380255116951	2357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2642.31959671597	2642.31959671597
"healthy-3"	"2019-08-01-count-4:TTTCGATAGTCTACCA"	-1.36859951439555	8.68347165668336	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATAGTCTACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2083.95614032267	44.264848232258	0.0212407772773012	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2079.12027562158	2079.12027562158
"healthy-3"	"2019-08-01-count-3:GTTGCGGTCGAGATGG"	-0.361343185335952	8.26243684375612	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGTCGAGATGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1747.74957709682	39.5500971580715	0.0226291556160855	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1741.87751193134	1741.87751193134
"healthy-3"	"2019-08-01-count-3:CAAGAGGAGTGCCGAA"	-2.05432162705119	9.25567624652711	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGAGTGCCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.99893681605	42.0950856324382	0.021303192450228	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.99893681605	1975.99893681605
"healthy-3"	"2019-08-01-count-3:GCAGGCTCATTGACAC"	0.767032404511613	8.17335603320924	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGGCTCATTGACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.35882893231	34.5677214979416	0.0181805354002289	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1889.55300235936	1889.55300235936
"healthy-3"	"2019-08-01-count-2:TGCTCCACATCCTAAG"	-2.35254631462749	8.98920915210573	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCACATCCTAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2320.10512536718	43.6144963321786	0.0187985000573093	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2313.02892071502	2313.02892071502
"healthy-3"	"2019-08-01-count-3:AGTTAGCGTCCAACGC"	2.61709727820699	-4.91015627300414	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTAGCGTCCAACGC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2385.65305620822	39.2739428324317	0.0164625542386511	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2379.27998693128	2379.27998693128
"healthy-3"	"2019-08-01-count-2:GGGCTACAGGTAGGCT"	-2.02145109596904	8.79103276813356	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTACAGGTAGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.26631399777	48.6893811939858	0.0265878211278258	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1826.06196566843	1826.06196566843
"healthy-3"	"2019-08-01-count-3:CGTTAGACATGATCTG"	4.31648172911946	-7.6988620988098	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGACATGATCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.10960740558	43.7911330250721	0.0174737501088017	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2504.13305724476	2504.13305724476
"healthy-3"	"2019-08-01-count-4:GGGTTATAGACATCAA"	-1.78337428990062	9.55666921222535	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTATAGACATCAA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2085.54518754964	49.6301364774444	0.0237972002590632	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2079.21907945675	2079.21907945675
"healthy-3"	"2019-08-01-count-4:CAACGGCAGCCTATCA"	-0.232493053109008	8.12410924518434	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCAGCCTATCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1914.39345488299	36.1536178205978	0.0188851553625937	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.13534453528	1908.13534453528
"healthy-3"	"2019-08-01-count-3:AAGACAAAGTCGAATA"	-3.35259662094768	9.79174134815065	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAAAGTCGAATA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1965.16339033186	41.786658153033	0.0212637068035226	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.519003286	1961.519003286
"healthy-3"	"2019-08-01-count-3:AAGACAACAACTTGCA"	4.43293776091878	-7.4426479569641	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAACAACTTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2782.66691949644	44.9928530666543	0.0161689682481999	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2781.7742637742	2781.7742637742
"healthy-3"	"2019-08-01-count-2:CTACCTGCAAGATGTA"	-1.84083090248759	9.5423955687317	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGCAAGATGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.95326208432	47.0835342304417	0.0238644954927622	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.0376984555	1958.0376984555
"healthy-3"	"2019-08-01-count-2:TATCGCCCAGACAATA"	3.92752542075459	-8.3941049805847	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCCAGACAATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.49520664141	48.7243790580744	0.019964955852189	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2435.4114602305	2435.4114602305
"healthy-3"	"2019-08-01-count-3:GGTCTGGTCGCCGAGT"	-4.07956586304362	11.8307857283386	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCTGGTCGCCGAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1962.45946801435	50.749951134919	0.025860381812761	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1962.45946801435	1962.45946801435
"healthy-3"	"2019-08-01-count-4:CGGGACTGTAGAGGAA"	-3.40923414650615	10.0876531370911	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGACTGTAGAGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.61857740539	46.0431670770736	0.0217019060671036	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.86255761402	2112.86255761402
"healthy-3"	"2019-08-01-count-2:CTACCTGGTCAACATC"	4.49448980864827	-7.8843188515869	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGGTCAACATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2570.33789690594	48.6142781980263	0.0189135748480953	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2567.13109036073	2567.13109036073
"healthy-3"	"2019-08-01-count-2:CTACCTGGTCGCACAC"	10.0878159004146	6.87434909427492	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGGTCGCACAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2036.19616277146	36.6037189880838	0.017976518990323	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2033.12674240208	2033.12674240208
"healthy-3"	"2019-08-01-count-4:GGTAATCAGACGGATC"	-3.42549620094951	10.0191030272278	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAATCAGACGGATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.99179597157	43.3688978819056	0.02235519653844	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.56693521419	1936.56693521419
"healthy-3"	"2019-08-01-count-2:TCGACCTCAATTGGTC"	5.16084398803059	-10.1971254578796	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTCAATTGGTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.98909494854	52.9145666142987	0.0248543154776364	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2125.96212893749	2125.96212893749
"healthy-3"	"2019-08-01-count-4:CAAGAGGGTATATGGA"	-3.56484065476115	13.2390966185364	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGAGGGTATATGGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1620.04046865561	43.3187235232219	0.0267392848273538	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1620.04046865561	1620.04046865561
"healthy-3"	"2019-08-01-count-3:GGTGATTTCACAGAGG"	10.3794390159542	6.70586965167848	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGATTTCACAGAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1971.57643271311	46.2610555992926	0.0234639929914522	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1959.34738110927	1959.34738110927
"healthy-3"	"2019-08-01-count-2:TGCTTCGTCACTGCTC"	10.2687756019527	6.84315774524537	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGTCACTGCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1988.46490694913	49.2986992094834	0.0247923405825258	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1985.33287270606	1985.33287270606
"healthy-3"	"2019-08-01-count-4:CGGGCATCATCTGGGC"	2.57441057738606	-4.52522470867308	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATCATCTGGGC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2718.81276265735	39.3954712724988	0.0144899537818831	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2713.11832908943	2713.11832908943
"healthy-3"	"2019-08-01-count-4:CGGGCATTCCTCTTTC"	10.4020277458126	6.87358996951906	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATTCCTCTTTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.35220961817	42.4405906925029	0.0212803889342236	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1988.06371472204	1988.06371472204
"healthy-3"	"2019-08-01-count-2:CTACTATCACGACAAG"	-0.932916144759017	8.4867315062317	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCACGACAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2301.20474756229	50.8874879156787	0.0221134116682076	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2292.75539209875	2292.75539209875
"healthy-3"	"2019-08-01-count-2:ATTCAGGCAAACACGG"	-2.20611796799358	8.84462354266969	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCAGGCAAACACGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.7439556566	43.0888143598739	0.0223867773338064	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.14649377615	1921.14649377615
"healthy-3"	"2019-08-01-count-3:AAGACTCTCCTTCTTC"	-2.12260876122172	9.16626546466676	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCTCCTTCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2655.44728635281	50.1541824517081	0.0188872822704734	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2638.04072160558	2638.04072160558
"healthy-3"	"2019-08-01-count-4:TCTTCCTGTCGTTTCC"	-3.69854460182841	10.2445859679016	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTCCTGTCGTTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.05877908624	42.7237153267065	0.0206988850121896	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2064.05877908624	2064.05877908624
"healthy-3"	"2019-08-01-count-3:TTATTGCTCTCATAGG"	-2.09225020828899	9.12356565082399	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTATTGCTCTCATAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.28718572556	46.3351245721415	0.0256096019126781	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1809.28718572556	1809.28718572556
"healthy-3"	"2019-08-01-count-3:GAACACTCAATCTGCA"	3.71331300315205	-6.82720758831175	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTCAATCTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.87307302349	42.7785997126819	0.0158036962054152	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2698.11175638183	2698.11175638183
"healthy-3"	"2019-08-01-count-1:AGGCCACCAGCAGTAG"	-2.65889010849651	9.25413606250612	"2019-08-01-count-1"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGGCCACCAGCAGTAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2314.09228621566	42.7736289700512	0.0184839771623805	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2308.76117780662	2308.76117780662
"healthy-3"	"2019-08-01-count-3:GGTGTCGAGCGTATAA"	-2.25802979889568	9.38861272418825	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTCGAGCGTATAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.6635683552	38.418280164265	0.0211012516710994	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1820.6635683552	1820.6635683552
"healthy-3"	"2019-08-01-count-4:TCTTTGACAAGTGCTT"	-3.44280038300212	10.2372398146423	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTTGACAAGTGCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1994.62711785056	40.9749390739767	0.0205426561723135	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1994.62711785056	1994.62711785056
"healthy-3"	"2019-08-01-count-4:CGGGTGTTCGCTGTTC"	-3.85957775536235	10.2158593901428	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTTCGCTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.78349991423	46.044923032371	0.0229560782778101	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2000.46495536955	2000.46495536955
"healthy-3"	"2019-08-01-count-2:CTAGACATCGAGAACG"	-3.39828882637675	12.9257793196472	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACATCGAGAACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2343.64800920925	46.2213031066496	0.019721947547168	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2333.79685314643	2333.79685314643
"healthy-3"	"2019-08-01-count-3:CAATGACTCGCATAGT"	3.90016927298848	-6.73067095195922	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATGACTCGCATAGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.30832035974	47.606842193671	0.0186890773343636	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2544.52303462714	2544.52303462714
"healthy-3"	"2019-08-01-count-3:TTCACCGCACCAGTTA"	-3.80812821808513	3.52203295314638	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGCACCAGTTA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3397.11578505939	47.3041738834522	0.0139248047097768	5743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3383.49218074585	3383.49218074585
"healthy-3"	"2019-08-01-count-4:AGTTAGCTCTTCTCAA"	-2.50758037987407	9.12923905933229	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTAGCTCTTCTCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1923.70493016714	45.5301879855371	0.0236679686533741	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1913.88791096382	1913.88791096382
"healthy-3"	"2019-08-01-count-4:CCACCATGTGGATCAG"	-2.65165553513225	9.03083417499391	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACCATGTGGATCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.51823281683	44.9805074556674	0.0212923641353336	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.51823281683	2112.51823281683
"healthy-3"	"2019-08-01-count-2:TCGCACTCAATGGGTG"	5.45921291884725	-9.6115350953308	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCACTCAATGGGTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.910850203	44.9865296422626	0.0167803154061823	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2678.90646068722	2678.90646068722
"healthy-3"	"2019-08-01-count-2:AAGAACAAGGGAGGCA"	-4.45315347138103	12.9127101668152	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGAACAAGGGAGGCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2205.49750424548	42.9776077832117	0.0194865819165435	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2200.80970871504	2200.80970871504
"healthy-3"	"2019-08-01-count-4:TCAGTTTGTCTAACGT"	6.7274190383846	-1.1481904021469	"2019-08-01-count-4"	"Control3"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTTTGTCTAACGT"	"pDC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2234.23428956299	50.0386216042945	0.0223963179860076	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2229.84154726524	2229.84154726524
"healthy-3"	"2019-08-01-count-3:TGAGGGACAGTCTGGC"	4.07137407836263	-7.54090120708617	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGGACAGTCTGGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.16316097813	45.8237156398744	0.0172843815553653	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2646.41299785323	2646.41299785323
"healthy-3"	"2019-08-01-count-4:ACTTATCAGCGTGTTT"	-2.57256946983989	4.14105174625245	"2019-08-01-count-4"	"Control3"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCAGCGTGTTT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2663.44534484303	33.1862032451075	0.0124598776953928	2407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	2661.50798923538	2661.50798923538
"healthy-3"	"2019-08-01-count-2:AGGTGTTCACAGTCCG"	10.6817547279293	6.60599563205568	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTCACAGTCCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1836.18341076736	39.7782474352035	0.0216635479886946	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1832.92994337257	1832.92994337257
"healthy-3"	"2019-08-01-count-3:CTACGGGAGACAAGCC"	-1.27884111824687	8.34905431354371	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGAGACAAGCC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1969.45737990066	44.7016114881066	0.0226974251610164	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.77791492217	1963.77791492217
"healthy-3"	"2019-08-01-count-4:CGTCAAAGTCACTCAA"	4.10196222838704	-8.0208425751892	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCAAAGTCACTCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.1029420918	48.1242423264546	0.0188271925727185	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2550.48272362464	2550.48272362464
"healthy-3"	"2019-08-01-count-3:TAAGCCATCACTTTGT"	2.75431456145589	-6.40190699016722	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCATCACTTTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.73030190691	41.0767295775868	0.016458801476346	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2489.52919926682	2489.52919926682
"healthy-3"	"2019-08-01-count-2:CTATCCGCAGCAGTAG"	-3.3614743751591	9.60289952838746	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGCAGCAGTAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2086.43836021648	47.852144099888	0.0229348467763616	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.81553487207	2084.81553487207
"healthy-3"	"2019-08-01-count-4:AGTTCGATCAGAGCAG"	-2.46608481827434	8.85729882800905	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCGATCAGAGCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.29341744178	45.3567906270404	0.0238056722454543	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1898.15183214511	1898.15183214511
"healthy-3"	"2019-08-01-count-4:TGAATGCTCTCGTGAA"	-2.02040515366252	9.26568029010621	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATGCTCTCGTGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2010.84774191943	43.1925776146878	0.0214797852240463	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2000.51512700348	2000.51512700348
"healthy-3"	"2019-08-01-count-4:CTTCTAATCGGCTCTT"	3.98128022727315	-6.93927767192992	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAATCGGCTCTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2785.03213005224	39.9755298150406	0.0143537050735177	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2781.66844629027	2781.66844629027
"healthy-3"	"2019-08-01-count-2:CATAGACAGGCCCACT"	3.00922145423238	-6.49464132702025	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAGACAGGCCCACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.83579399598	47.6095405129336	0.0213224548983647	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2223.99160038212	2223.99160038212
"healthy-3"	"2019-08-01-count-4:GTTGCTCTCTTCGGAA"	10.7762199836666	6.48502013767091	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCTCTCTTCGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.69965975219	45.7891075447368	0.0237532373433231	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1919.98656765866	1919.98656765866
"healthy-3"	"2019-08-01-count-3:TTCATTGAGGTGCATG"	-4.08400664749797	11.7360811003479	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCATTGAGGTGCATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.9776844284	46.3654811064857	0.0239246723422211	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1934.35436185844	1934.35436185844
"healthy-3"	"2019-08-01-count-4:GGTGTCGCACTCCCTA"	-2.93609295311626	9.55110833728639	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGCACTCCCTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2132.40401457168	43.5820482006784	0.0204379882530996	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2124.02177280781	2124.02177280781
"healthy-3"	"2019-08-01-count-2:AAGACTCCACACCGAC"	5.51046957549397	-9.97481825267943	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCCACACCGAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.32090498077	45.7033039940916	0.0176438772146769	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2581.82802197385	2581.82802197385
"healthy-3"	"2019-08-01-count-2:GGTAACTAGTCTTGGT"	-0.021819899708587	7.54193828189699	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTAGTCTTGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.27339456321	47.0687678842488	0.0243971476603011	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1920.60689470754	1920.60689470754
"healthy-3"	"2019-08-01-count-4:ATACCTTCATAACAGA"	10.5928913551265	7.56525037372438	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTCATAACAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.39974924291	44.5163069078589	0.0224218356655048	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1975.3213725518	1975.3213725518
"healthy-3"	"2019-08-01-count-3:AAGGTAATCTAGCCAA"	5.54507031020467	-9.981152557489	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAATCTAGCCAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.2519733572	46.3787541892155	0.0185274014293556	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2492.76452362893	2492.76452362893
"healthy-3"	"2019-08-01-count-3:TAATCTCAGGATTTAG"	-3.96144614639934	10.4015912779602	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCAGGATTTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2088.52854085182	40.6669335422097	0.0194715718491562	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2088.52854085182	2088.52854085182
"healthy-3"	"2019-08-01-count-3:AGACCATAGGACTTCT"	-1.03890655461009	8.751438117865	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATAGGACTTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2096.61442400164	36.5887755872465	0.0174513611889651	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2095.00863053319	2095.00863053319
"healthy-3"	"2019-08-01-count-4:GGTGTTAAGGTTTACC"	-3.11684809151347	9.98810193622438	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTAAGGTTTACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1976.6842550125	47.6459750518732	0.0241039887534147	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.13035427689	1973.13035427689
"healthy-3"	"2019-08-01-count-3:AAGTACCAGAGTCAAT"	-3.48747978630717	3.01457140529481	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCAGAGTCAAT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3126.89189249062	48.0961839437773	0.0153814668358962	5001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3118.69367408904	3118.69367408904
"healthy-3"	"2019-08-01-count-4:GGTTAACAGCCTGACC"	-2.35367808762248	9.03034589374391	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACAGCCTGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.23966882435	49.8077658119421	0.0257106885706965	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1929.81390575509	1929.81390575509
"healthy-3"	"2019-08-01-count-3:TGATCTTTCGGTCTGG"	-3.05273709717448	9.45471856677858	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCTTTCGGTCTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.48970985459	40.2832255702152	0.0202582016746574	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1985.21027240369	1985.21027240369
"healthy-3"	"2019-08-01-count-2:TCGGATAGTCGCCTAG"	-1.78095744076427	8.78176496112672	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATAGTCGCCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.46039927443	46.6028073655708	0.0238932343270886	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.06091171202	1947.06091171202
"healthy-3"	"2019-08-01-count-4:TCATCCGGTTCCGTTC"	-1.85335920277293	8.93110368335573	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCCGGTTCCGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2072.57745611266	47.2367860917464	0.0227913248561258	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.57745611266	2072.57745611266
"healthy-3"	"2019-08-01-count-2:TTGACCCCAACAAGTA"	-7.225813249976	3.45425674999086	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCCAACAAGTA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2634.08072935767	42.307243326529	0.0160614831789327	2462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2618.4705182116	2618.4705182116
"healthy-3"	"2019-08-01-count-3:AAGTACCGTTACCCAA"	0.523048927157563	8.56792638385621	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCGTTACCCAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1632.51683908295	24.0587244709893	0.0147371983522718	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1624.59974657198	1624.59974657198
"healthy-3"	"2019-08-01-count-2:AAGCCATAGTCCGCGT"	-1.56181214276012	9.52672288501588	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATAGTCCGCGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2071.67601565166	47.3352656710384	0.0228487781455291	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2061.74377023017	2061.74377023017
"healthy-3"	"2019-08-01-count-4:CGTTCTGTCATTGCGA"	-3.31704364243205	9.5488652952942	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTCTGTCATTGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.51708672131	36.6416154535524	0.0181437511445076	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.08959877281	2016.08959877281
"healthy-3"	"2019-08-01-count-4:GTTTACTTCCCATACC"	4.18342890319173	-7.42190411007079	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTTCCCATACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.30594887892	42.6160239193109	0.016001174756978	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2657.69292272445	2657.69292272445
"healthy-3"	"2019-08-01-count-4:GTTTACTGTCCTGGTG"	10.7352453666622	6.67836663806764	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTGTCCTGGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.35541906342	37.4507577349695	0.0191235755115791	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1956.75726404407	1956.75726404407
"healthy-3"	"2019-08-01-count-4:GTCCACTAGAATCGAT"	10.6893354850704	6.3434266814026	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTAGAATCGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.51399117278	40.6701129751069	0.0212541497803109	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1903.92195001189	1903.92195001189
"healthy-3"	"2019-08-01-count-4:TGAGACTTCCCTTCCC"	0.232188795774621	7.78896663272706	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGACTTCCCTTCCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.11212293845	39.9113028245265	0.0210490204359196	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1886.0531426483	1886.0531426483
"healthy-3"	"2019-08-01-count-2:TCGGGACTCGGCATAT"	-4.48169694367107	-4.73314001476439	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACTCGGCATAT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3181.21299513715	43.2905150531654	0.0136081787416749	4242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3174.2181920749	3174.2181920749
"healthy-3"	"2019-08-01-count-2:GGTCTGGAGAATCGTA"	0.191881080239457	8.32646844470827	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCTGGAGAATCGTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.57639322877	38.053512412261	0.0204966046918663	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.61546619389	1852.61546619389
"healthy-3"	"2019-08-01-count-2:TCGGGCAAGAGTGGCT"	-4.12931476059611	11.7940244444641	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGCAAGAGTGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2198.04973833334	39.8169834600613	0.0181146872000505	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2191.60066735355	2191.60066735355
"healthy-3"	"2019-08-01-count-2:CATCCGTAGTTGGGAC"	-2.00091705742534	9.09074208820192	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTAGTTGGGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1784.26346282258	46.3653606528516	0.0259857143403614	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1782.33202931988	1782.33202931988
"healthy-3"	"2019-08-01-count-3:CACGAATCATCATCCC"	9.7506853538448	7.73457334125368	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATCATCATCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2147.75232057702	44.5003803781517	0.0207195121857423	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2137.92302990518	2137.92302990518
"healthy-3"	"2019-08-01-count-3:GACAGCCCAATATCCG"	-2.71252046051677	9.80564210498659	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACAGCCCAATATCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2117.62290448807	47.5402085076446	0.0224497989735984	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.55493945738	2111.55493945738
"healthy-3"	"2019-08-01-count-3:TCATGTTTCACTGGTA"	-2.56935272637065	8.9983978041443	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGTTTCACTGGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1963.13187676336	46.4402896860027	0.0236562251551686	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1956.36655361792	1956.36655361792
"healthy-3"	"2019-08-01-count-2:GGTCTGGGTTACTCAG"	-3.1718741458958	9.76987264240114	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCTGGGTTACTCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.53182877804	51.6665118904409	0.0263398794413788	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.87151908249	1959.87151908249
"healthy-3"	"2019-08-01-count-2:GAATCACTCGTTGTAG"	-0.720797876746017	8.40418527210084	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCACTCGTTGTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1885.86480948282	42.1733328281657	0.0223628611213819	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1877.72776129531	1877.72776129531
"healthy-3"	"2019-08-01-count-4:CTAAGTGAGGGCTTCC"	-1.31450448456462	9.08828637683717	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGAGGGCTTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.69620078785	46.5153476176219	0.0234134175115328	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.8783739737	1975.8783739737
"healthy-3"	"2019-08-01-count-2:AAGGAATGTATACAGA"	-3.93113789978679	10.7238197096619	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGAATGTATACAGA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1939.5772089872	46.5699035891976	0.0240103376000769	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1934.26474930542	1934.26474930542
"healthy-3"	"2019-08-01-count-3:TTCCTTCTCTGGACTA"	-4.23438678208049	12.6425370940003	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTTCTCTGGACTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2079.4712017215	41.1351241654895	0.0197815310601251	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2077.58455898672	2077.58455898672
"healthy-3"	"2019-08-01-count-2:ACTGCAATCTTAGTTC"	2.82161130484883	-6.52948000347289	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAATCTTAGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.05032289831	47.7561409855224	0.0192406014273543	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2475.05292476533	2475.05292476533
"healthy-3"	"2019-08-01-count-3:TTCGATTTCCTGTAGA"	4.06210388717	-7.46611692821654	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGATTTCCTGTAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.36068720936	42.5726213589464	0.0162903733752906	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2610.78907262213	2610.78907262213
"healthy-3"	"2019-08-01-count-2:CAAAGAACAATCCTAG"	3.98012103614156	-7.11889412319335	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAAGAACAATCCTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2641.35805824788	41.3295446483063	0.0156470814395084	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2635.77383211051	2635.77383211051
"healthy-3"	"2019-08-01-count-3:TACATTCTCGCGTTTC"	5.40990986403768	-10.1561146012512	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACATTCTCGCGTTTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.67936222646	40.0941819482031	0.0151832829542767	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2627.42861128554	2627.42861128554
"healthy-3"	"2019-08-01-count-2:TGGTACACAACAGATA"	-4.00697503510173	11.0721750029358	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTACACAACAGATA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2006.20679427316	48.7371357358831	0.0242931764935729	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1994.6728353462	1994.6728353462
"healthy-3"	"2019-08-01-count-2:CTCAGGGCAATTGCCA"	-2.25507150116618	9.41072080219118	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGGGCAATTGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.8736460302	49.0668542230621	0.0254117374919594	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1927.21338747923	1927.21338747923
"healthy-3"	"2019-08-01-count-4:CTACATTAGAGGTTTA"	5.36230864104573	-9.38941194927367	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTAGAGGTTTA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.05887032799	43.9419722508241	0.0164881807077741	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2659.2329872896	2659.2329872896
"healthy-3"	"2019-08-01-count-4:CTACAGATCCAACTGA"	-1.02964518490489	8.64870545947877	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACAGATCCAACTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.45966182851	48.6831176922886	0.0245074786202688	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.29028677322	1981.29028677322
"healthy-3"	"2019-08-01-count-4:ATCACGAAGTTGGCGA"	4.24206080016438	-7.56723501598509	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACGAAGTTGGCGA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2747.53832620354	45.4455556984584	0.016540462880914	2307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2741.38516933835	2741.38516933835
"healthy-3"	"2019-08-01-count-2:CAACAGTAGGTCACAG"	-0.112282927066642	8.107958770636	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAGTAGGTCACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.05883342722	35.3732198211902	0.018636524431289	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.56712912262	1893.56712912262
"healthy-3"	"2019-08-01-count-2:GGTGGCTTCCTGGGTG"	10.5365358787471	6.65168092334596	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGGCTTCCTGGGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.4627581114	44.5407795735624	0.0245071209161098	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1804.7560924174	1804.7560924174
"healthy-3"	"2019-08-01-count-4:TGAGGTTGTAGACAGC"	-3.78939185562785	13.2486028441223	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGTTGTAGACAGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1996.9514888971	43.2623297810085	0.021664186647269	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1996.9514888971	1996.9514888971
"healthy-3"	"2019-08-01-count-2:AAGTACCCACGGGTAA"	0.157131676643532	7.93705747211305	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCCACGGGTAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.01327573285	39.4729012389834	0.0221756218209845	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1773.61911677699	1773.61911677699
"healthy-3"	"2019-08-01-count-2:TCGTCCACACCATAAC"	-3.56136379662212	9.98838708484498	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCACACCATAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.16686985578	44.4413973028315	0.0225915747076859	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.79760886354	1963.79760886354
"healthy-3"	"2019-08-01-count-3:CTCAGTCGTACGATTC"	-7.74026618424113	-1.14223983204039	"2019-08-01-count-3"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGTCGTACGATTC"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3159.79816317024	48.0097549798228	0.0151939309097054	4609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3150.49601748236	3150.49601748236
"healthy-3"	"2019-08-01-count-3:TTCTAGTAGTTTCGAC"	0.71132524785344	8.21273324573366	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTAGTTTCGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1706.65375881845	37.062145110704	0.0217162648950909	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1696.40684826928	1696.40684826928
"healthy-3"	"2019-08-01-count-2:CTCATCGAGTGTTCCA"	2.62828292426412	-4.55546381389769	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGAGTGTTCCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2685.02786129821	39.9048610584219	0.0148619914279504	2878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2678.94880322637	2678.94880322637
"healthy-3"	"2019-08-01-count-2:CTCATCGCAACGTTAC"	3.44900574263875	-7.54799749767455	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGCAACGTTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.73796654082	49.0799158012306	0.0290286944355109	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1682.91728642105	1682.91728642105
"healthy-3"	"2019-08-01-count-3:CACTGAACACCACTGG"	2.59248604354207	-6.75724317943724	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGAACACCACTGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.55116822414	49.4520586108275	0.022411471495867	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2204.25879129972	2204.25879129972
"healthy-3"	"2019-08-01-count-2:AAGTCGTCACAGAGCA"	-3.6260224384373	9.9339561232361	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTCACAGAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.31289987126	44.5435821574106	0.0226648805695665	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.56323802619	1963.56323802619
"healthy-3"	"2019-08-01-count-4:CTACCCACAGACACCC"	-0.484292487532455	8.48038003528444	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCACAGACACCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2166.85723040312	41.1775680915608	0.0190033600339696	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2156.34074773619	2156.34074773619
"healthy-3"	"2019-08-01-count-4:CTACCCACACTCATAG"	-2.17931304398234	9.26561067188112	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCACACTCATAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.89850910227	49.51655141238	0.0245265183906635	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.7080157336	2003.7080157336
"healthy-3"	"2019-08-01-count-4:AAGTGAAGTTAGGGTG"	-3.85639319840129	3.44358131969301	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAAGTTAGGGTG"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2904.91007040518	43.5383067830077	0.0149878329200514	4469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2895.61768302383	2895.61768302383
"healthy-3"	"2019-08-01-count-3:CACTGGGAGACTTCCA"	10.764589925378	6.20496985996095	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGAGACTTCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.3223336782	39.4729688644077	0.0220726253433407	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1785.14963790822	1785.14963790822
"healthy-3"	"2019-08-01-count-4:CTACCCAGTTGCACGC"	4.54126514968221	-7.87537100231322	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCAGTTGCACGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2991.12325627488	40.1115013724965	0.0134101800346573	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2983.12261809517	2983.12261809517
"healthy-3"	"2019-08-01-count-2:GGTGTTATCACTCACC"	4.08243336257283	-7.38999559795531	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTATCACTCACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.07830062732	45.4947475109369	0.0171608463998108	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2650.0499372527	2650.0499372527
"healthy-3"	"2019-08-01-count-3:AATGGCTTCAAACCTG"	-1.0839344066685	9.17523572528688	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGCTTCAAACCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2065.88549820535	46.2437202883686	0.0223844546701842	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2059.15404764477	2059.15404764477
"healthy-3"	"2019-08-01-count-2:GGTTAACAGATGACAT"	-4.09849486771281	12.7170362242493	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACAGATGACAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2176.14302001785	37.5877806934304	0.0172726610097171	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2169.5396996655	2169.5396996655
"healthy-3"	"2019-08-01-count-2:GACCCTTGTGTTATCG"	-5.66399989548381	-4.53756668483885	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTGTGTTATCG"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3208.53166977422	44.6818274141087	0.0139259424599206	4119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3204.78121136456	3204.78121136456
"healthy-3"	"2019-08-01-count-4:CACGTTCTCTTCGACC"	-3.16416345062907	9.62975785816041	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCTCTTCGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2180.37571249622	42.0596676209343	0.0192901009582344	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2177.1417719488	2177.1417719488
"healthy-3"	"2019-08-01-count-2:CGAATTGAGTTGCGCC"	0.767173429101151	8.64119813526002	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAATTGAGTTGCGCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1835.75460557558	40.069602975092	0.0218273198680216	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1832.81846300481	1832.81846300481
"healthy-3"	"2019-08-01-count-1:CTTTCAACATTGCCGG"	-0.516516844660598	8.67487046802369	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTTTCAACATTGCCGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2206.26241912665	42.6844157760259	0.0193469350726296	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2193.12614933172	2193.12614933172
"healthy-3"	"2019-08-01-count-3:AATTCCTGTTCCATTT"	-1.71408341351207	8.6507301100525	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTGTTCCATTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2661.46079999935	33.1847507294805	0.0124686227689277	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2658.66509143561	2658.66509143561
"healthy-3"	"2019-08-01-count-2:AATAGAGAGGATTTAG"	-3.06248245659526	9.66379449451295	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATAGAGAGGATTTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1993.62438159852	45.822752776731	0.0229846470577319	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.80261290471	1981.80261290471
"healthy-3"	"2019-08-01-count-2:CTCCAACTCCATCTGC"	-3.9085353416508	9.85527608478395	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACTCCATCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2425.08887129432	43.4056069973338	0.0178985634345711	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2422.07941255842	2422.07941255842
"healthy-3"	"2019-08-01-count-2:AATAGAGAGGCATGCA"	4.87777485427205	-8.56167604839476	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATAGAGAGGCATGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.44776177434	44.5986488183331	0.017555428412818	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2534.97716945011	2534.97716945011
"healthy-3"	"2019-08-01-count-4:TGATGCAGTTTAGACC"	-1.35340533676799	8.64739987933961	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCAGTTTAGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.51160341719	42.3595476414405	0.0205577816553862	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.80097388675	2051.80097388675
"healthy-3"	"2019-08-01-count-3:AGCATCAGTCGCGTTG"	3.09688629683797	-6.71014883434447	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCATCAGTCGCGTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.9912877763	48.201603123132	0.0205639002902865	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2339.17756677421	2339.17756677421
"healthy-3"	"2019-08-01-count-3:TTCTTGAGTGGTATGG"	-1.44193540039714	9.11501977527467	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTGAGTGGTATGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.12903117545	46.4197690494242	0.0249685569269363	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.04862293504	1852.04862293504
"healthy-3"	"2019-08-01-count-4:GTAGCTACACGTCGGT"	3.63321580466573	-7.4813237420288	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGCTACACGTCGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2758.8856524365	37.081342125587	0.0134406955550473	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2753.03356464296	2753.03356464296
"healthy-3"	"2019-08-01-count-3:TACGCTCAGGCTTAAA"	-2.09153852883037	8.93717954242555	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCAGGCTTAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2304.5426422352	40.432990225139	0.0175449086877917	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2299.61849438315	2299.61849438315
"healthy-3"	"2019-08-01-count-2:GTTGTAGCATTCCTCG"	-2.13420329514201	9.13051984393922	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTAGCATTCCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1816.48473988129	46.579662162059	0.0256427489531803	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1814.56033847723	1814.56033847723
"healthy-3"	"2019-08-01-count-2:CTCCACAGTTTCGATG"	10.5580898719722	6.5517539747986	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCACAGTTTCGATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.20735659032	39.0036419653942	0.0215584144201699	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1802.52992587348	1802.52992587348
"healthy-3"	"2019-08-01-count-2:CTCCACATCTTCGACC"	0.423312773078126	8.36974237048952	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCACATCTTCGACC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.56344175786	41.101586438624	0.021546641930162	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1901.45353085305	1901.45353085305
"healthy-3"	"2019-08-01-count-2:TCTATACCAAATAAGC"	-3.64441476288493	13.1941184767517	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACCAAATAAGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2118.53077536567	43.9339916591536	0.0207379530049877	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2110.14367296885	2110.14367296885
"healthy-3"	"2019-08-01-count-3:TTGAGTGAGCTGGAGT"	-2.87225685539897	3.6925899752411	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAGTGAGCTGGAGT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3486.47323567859	45.8263764761872	0.0131440494099384	3854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3478.29741056316	3478.29741056316
"healthy-3"	"2019-08-01-count-4:GCGAGAACACAAGCCC"	-7.50865779343303	1.076065278891	"2019-08-01-count-4"	"Control3"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAACACAAGCCC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2836.632755651	42.8723927409592	0.0151138326438454	3440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2823.05118734173	2823.05118734173
"healthy-3"	"2019-08-01-count-4:GTAGGTTCAAGCGCTC"	-1.10627661171611	8.70051095569459	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGTTCAAGCGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.40530651884	32.4202074124946	0.0158968927406756	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2036.2019275103	2036.2019275103
"healthy-3"	"2019-08-01-count-2:CAAGAGGCACCGGCTA"	2.64666714248006	-6.99663164531859	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGAGGCACCGGCTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.11151049181	49.0066439916387	0.0215877694840733	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2269.09813989193	2269.09813989193
"healthy-3"	"2019-08-01-count-3:GACTCTCCAGAAGTTA"	-2.7819872898167	-5.66442205822142	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCCAGAAGTTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3063.09083265335	44.8082629259351	0.0146284473343942	3041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3058.61206469259	3058.61206469259
"healthy-3"	"2019-08-01-count-4:CTAGACACATAACTCG"	3.22035970267598	-5.28055574810179	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACACATAACTCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2916.52489502546	41.3537181631188	0.0141791068657269	2820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2910.96132534604	2910.96132534604
"healthy-3"	"2019-08-01-count-3:GACTCTCGTACAGTCT"	10.7727343040401	6.44888684833375	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCGTACAGTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.25402794124	44.7860721544241	0.0242841124248047	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1835.71872855821	1835.71872855821
"healthy-3"	"2019-08-01-count-3:TTGATGGAGGGCAGGA"	-1.85408268395122	8.70289990985719	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGATGGAGGGCAGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2470.35263180461	48.3138397701546	0.0195574668766463	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2459.71017176163	2459.71017176163
"healthy-3"	"2019-08-01-count-3:TTGATGGCAAGTGCAG"	4.71157087859456	-8.30517771160277	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGATGGCAAGTGCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.86057521744	45.0868067858037	0.0171181448289386	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2628.45657586798	2628.45657586798
"healthy-3"	"2019-08-01-count-2:CTCCCAAAGTCCGCGT"	-2.68413577500041	9.50801179492799	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAAGTCCGCGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2078.15597117671	47.1749905881748	0.0227004090368939	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2072.27165064419	2072.27165064419
"healthy-3"	"2019-08-01-count-2:AATCGTGGTCTGCATA"	-1.39688668671306	8.51824376666871	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGGTCTGCATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2043.96876201962	43.2989809718205	0.021183778233987	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2039.06588290379	2039.06588290379
"healthy-3"	"2019-08-01-count-2:TCTCACGCAGGATCTT"	5.31919350203816	-9.87965013897093	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGCAGGATCTT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.98635542325	49.6315781958915	0.0225599481894709	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2199.98635542325	2199.98635542325
"healthy-3"	"2019-08-01-count-3:GACTGATCAGACCCGT"	-2.70465932312663	9.07552049243776	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATCAGACCCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.17427774034	48.460682989483	0.0248239532412939	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1939.92947190145	1939.92947190145
"healthy-3"	"2019-08-01-count-4:GTATTGGTCTTCGTAT"	-3.20349345627483	10.6125755080017	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTGGTCTTCGTAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1989.19600550176	44.9695655902304	0.0226069052350058	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1985.64217895904	1985.64217895904
"healthy-3"	"2019-08-01-count-2:AGAAGCGAGGTCTGGA"	-4.01114163819011	10.4989385374817	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGCGAGGTCTGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.97135563145	51.6007766805685	0.0260613753496004	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.27059182679	1970.27059182679
"healthy-3"	"2019-08-01-count-3:CAGCACGGTACGCTTA"	0.413496186106843	8.38583848560182	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCACGGTACGCTTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1814.64638524986	38.1416435501761	0.0210187747101618	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1804.28098795065	1804.28098795065
"healthy-3"	"2019-08-01-count-2:GTTTGGATCTCCCTAG"	3.31782807883565	-6.67191269313964	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGATCTCCCTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.57454396137	45.7270448478877	0.0197817738421382	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2306.80880845365	2306.80880845365
"healthy-3"	"2019-08-01-count-2:AATGCCAGTCACCGAC"	-1.85473642769511	9.07997033679811	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGCCAGTCACCGAC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2170.54396126436	48.7851742047472	0.0224760129605159	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2163.01926023728	2163.01926023728
"healthy-3"	"2019-08-01-count-4:CAGAGCCTCCGCTGTT"	4.73739494857137	-7.0930705300537	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCTCCGCTGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.24761608438	47.5289922212271	0.0192250128636002	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2467.34599050381	2467.34599050381
"healthy-3"	"2019-08-01-count-3:ACACCAAGTGATTGGG"	-7.12686763230022	3.258837676886	"2019-08-01-count-3"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAAGTGATTGGG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2732.49752005015	41.4147924909938	0.0151563879517204	2790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2714.87845314561	2714.87845314561
"healthy-3"	"2019-08-01-count-2:CAAGGGATCCAAGCCG"	-0.859281639487106	8.77536485278932	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGATCCAAGCCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1867.28854626299	40.2886620013633	0.0215760237388019	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1860.0642764854	1860.0642764854
"healthy-3"	"2019-08-01-count-3:TACTTACGTTCAATCG"	-4.13471637192424	-5.30288841640624	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTACGTTCAATCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3004.24537072051	43.4564709680182	0.0144650205311279	3033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2994.35672178536	2994.35672178536
"healthy-3"	"2019-08-01-count-2:CTCCGATCACATTCTT"	-2.2996383709019	8.80304524982301	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATCACATTCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2122.02740690389	37.1220599184491	0.0174936759995063	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2110.33052799957	2110.33052799957
"healthy-3"	"2019-08-01-count-2:CAATACGCAAGTCATC"	-0.555719117552596	8.35591027820436	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGCAAGTCATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2107.83750607253	39.2097034198205	0.0186018624807938	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2102.37379569377	2102.37379569377
"healthy-3"	"2019-08-01-count-4:TACCGGGGTACCCAGC"	-1.93701801720317	8.87385175311891	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGGGGTACCCAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.13278356022	47.4843007816996	0.0233322863084302	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2029.86278276444	2029.86278276444
"healthy-3"	"2019-08-01-count-2:AATGGAACAAGAGTTA"	-3.18460426750835	9.90573594653932	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGAACAAGAGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.24707588899	42.8947058114958	0.0213592771160927	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.13667111326	2003.13667111326
"healthy-3"	"2019-08-01-count-2:CGAGTGCTCCCGAAAT"	4.69301714476888	-7.94798471843871	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCTCCCGAAAT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.39156817836	48.1220930949	0.0188463429168568	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2547.94100243325	2547.94100243325
"healthy-3"	"2019-08-01-count-3:ACACTGACAGACCTGC"	-4.02463469925578	10.740150428656	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACTGACAGACCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.84811353758	44.9219580729995	0.0219361766998425	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.20167690832	2041.20167690832
"healthy-3"	"2019-08-01-count-3:TACTTCATCATCGGGC"	-2.60658536377605	9.79561898792116	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTCATCATCGGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.05727320951	45.5915538324382	0.0230836616491384	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1968.09484672611	1968.09484672611
"healthy-3"	"2019-08-01-count-2:TAACGACTCCCTCTTT"	3.22002543982808	-6.91601326381835	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACGACTCCCTCTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.70851230683	46.5285470858169	0.0202764520357501	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2291.24068981841	2291.24068981841
"healthy-3"	"2019-08-01-count-2:CATTGCCCAGTGCGCT"	3.27983059462849	-6.38341429149779	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCCAGTGCGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.82337292043	46.7081211275312	0.0192624838778572	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2420.7268151382	2420.7268151382
"healthy-3"	"2019-08-01-count-4:TACCTGCCACTTTAGG"	-3.63689480248149	10.8568658598694	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTGCCACTTTAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2211.86106602266	40.9092638855775	0.01849540394467	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2207.16454488704	2207.16454488704
"healthy-3"	"2019-08-01-count-2:CATTGCCCACTGTGTA"	-1.65734730187114	8.73923776233522	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCCACTGTGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2114.85620540048	42.9319694804828	0.0203001837055645	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.03800731524	2108.03800731524
"healthy-3"	"2019-08-01-count-3:CAGGGCTGTGGATTTC"	2.51031436499898	-6.20200111782225	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGGCTGTGGATTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2541.06410330698	44.5720753903796	0.0175407127007827	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2538.07371136748	2538.07371136748
"healthy-3"	"2019-08-01-count-4:ATCGTGATCGGTAAGG"	10.2169538932735	7.66946551883546	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTGATCGGTAAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2073.79361134233	42.8476992932453	0.020661506072203	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2064.1870369718	2064.1870369718
"healthy-3"	"2019-08-01-count-4:TTCGATTTCGCGTTTC"	-0.339859555394012	8.41581151569215	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTTCGCGTTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2058.77091459991	37.8699628901866	0.0183944520595415	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2049.72476902892	2049.72476902892
"healthy-3"	"2019-08-01-count-4:TACGCTCAGCGTATGG"	3.86664213713948	-7.33289101040038	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGCTCAGCGTATGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.070845052	43.7378539169015	0.0167189103458825	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2615.06283725311	2615.06283725311
"healthy-3"	"2019-08-01-count-2:CAATTTCAGGGCATGT"	9.43619598922078	7.60272405231325	"2019-08-01-count-2"	"Control3"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCAGGGCATGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2098.01260076697	44.4936337658341	0.0212075150309243	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2087.37127564496	2087.37127564496
"healthy-3"	"2019-08-01-count-2:TAAGCACCACTACCGG"	10.2793108421261	7.40641925418702	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCACCACTACCGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.63678656249	43.5295406820792	0.0212584287251233	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2041.43237777043	2041.43237777043
"healthy-3"	"2019-08-01-count-3:GAGATGGAGAGGACTC"	4.4413181739742	-7.78866770183715	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGATGGAGAGGACTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2792.63062083364	52.9024296204915	0.0189435828805384	2472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2785.72478251942	2785.72478251942
"healthy-3"	"2019-08-01-count-3:CAGTGCGAGTACCATC"	11.3454357582027	5.89016101444093	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGAGTACCATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1826.34923882473	43.8136455517498	0.0239897411844102	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1824.96080477103	1824.96080477103
"healthy-3"	"2019-08-01-count-2:CAATTTCCACTAGGTT"	-0.679060379893142	8.44373033130494	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCCACTAGGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2124.78960443039	41.9047492442291	0.0197218346498183	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.7207323167	2119.7207323167
"healthy-3"	"2019-08-01-count-4:ATGAAAGAGGCTTTCA"	-0.436622331768829	8.56081292713014	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGAGGCTTTCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.8262495127	35.8546783785427	0.0186954779598272	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.44927760991	1909.44927760991
"healthy-3"	"2019-08-01-count-2:GTAGCTAAGCAGCAGT"	10.3052336173946	7.2844986685547	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTAAGCAGCAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2078.14077341493	44.7395504509737	0.0215286428250262	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2078.14077341493	2078.14077341493
"healthy-3"	"2019-08-01-count-2:CTCTCAGCATTCGATG"	-1.58537743511851	8.45037076557008	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGCATTCGATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2370.23607418989	48.3603306891191	0.0204031704756025	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2363.55834745335	2363.55834745335
"healthy-3"	"2019-08-01-count-2:ATCACGACACAAATAG"	0.763568242161912	8.28597543323366	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACGACACAAATAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.42397348879	41.9889732907529	0.0236234989046172	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1768.44702382051	1768.44702382051
"healthy-3"	"2019-08-01-count-3:CAGTTAGAGTAGGCCA"	-3.09245262566264	9.58879563892213	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTAGAGTAGGCCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2033.16616898828	43.7772602865096	0.0215315702937815	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.9169491586	2027.9169491586
"healthy-3"	"2019-08-01-count-2:CTCTCAGTCCTCTAAT"	10.3029352622921	6.73715875232545	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGTCCTCTAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.80854710153	38.7173292287102	0.0191498494178469	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2016.42330900654	2016.42330900654
"healthy-3"	"2019-08-01-count-4:GTCATCCGTAGCGAGT"	5.4050837951595	-10.1045589677063	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCGTAGCGAGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.36714563404	44.0781540238489	0.0166939488308412	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2630.43688149287	2630.43688149287
"healthy-3"	"2019-08-01-count-3:CAGTTAGCAGGGCTTC"	4.71468319472615	-8.44343759929808	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTAGCAGGGCTTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.42698104124	46.2596742758262	0.0177211140598058	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2607.91143241808	2607.91143241808
"healthy-3"	"2019-08-01-count-2:TCTGTCGTCTTGGCTC"	-0.990146974951583	9.26821229541627	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGTCGTCTTGGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1778.60126152197	46.5484649127209	0.0261713886747661	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1772.68344417902	1772.68344417902
"healthy-3"	"2019-08-01-count-4:CTCACTGAGACCGTTT"	5.47001423415486	-9.62966825878295	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGAGACCGTTT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2782.58413583371	43.0109984599225	0.0154572139997613	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2774.12944470824	2774.12944470824
"healthy-3"	"2019-08-01-count-2:CACACAAGTACGATTC"	3.86440577086751	-6.48612739956053	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAAGTACGATTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.99569184521	48.1958511036098	0.0183883747896126	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2618.90315858618	2618.90315858618
"healthy-3"	"2019-08-01-count-4:CTCACTGAGTGCTCGC"	-2.31660352173503	9.2118291624817	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGAGTGCTCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1948.99802454719	44.642283281525	0.0229052480912067	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.18950975048	1947.18950975048
"healthy-3"	"2019-08-01-count-3:TTGTGGAGTGGATGAC"	11.2686544853145	5.48822877490846	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGGAGTGGATGAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.76744333725	40.1878481819354	0.0206646035337636	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1936.73323039555	1936.73323039555
"healthy-3"	"2019-08-01-count-2:TCTTCCTCAAGTATCC"	0.0197836543316066	8.2041387327942	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTCAAGTATCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.65617418798	42.1173294982966	0.0225388330288201	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1863.92758078301	1863.92758078301
"healthy-3"	"2019-08-01-count-4:GTCATGATCCCTGTTG"	2.83824314650838	-7.06900122081908	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATGATCCCTGTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.20893977244	45.0714973066744	0.0200121296522464	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2250.92927269661	2250.92927269661
"healthy-3"	"2019-08-01-count-4:CTCACTGCATGGCGCT"	0.0617593434521973	8.31070802295534	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGCATGGCGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2098.21814050311	37.2454376056519	0.0177509844599481	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.94282616073	2085.94282616073
"healthy-3"	"2019-08-01-count-2:GTAGGTTGTGTGTGGA"	10.8059374290401	6.44691655719606	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGTTGTGTGTGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2065.56573570312	48.437786298076	0.0234501306159534	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2060.34961860691	2060.34961860691
"healthy-3"	"2019-08-01-count-3:GGAGAACAGAGGTTTA"	-0.614137033850509	8.86532685840455	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACAGAGGTTTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1946.3584145303	45.1966838272476	0.0232211516079656	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.06295253369	1937.06295253369
"healthy-3"	"2019-08-01-count-1:TCAAGTGAGAAACTAC"	2.65662493285481	-4.66945602810057	"2019-08-01-count-1"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAAGTGAGAAACTAC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3036.17691836775	40.3347736813814	0.0132847244300459	3344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3024.83046187871	3024.83046187871
"healthy-3"	"2019-08-01-count-3:GAGGCAAGTAGACGGT"	5.59657682952229	-9.91607954418334	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAAGTAGACGGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.56890931643	48.325966506491	0.0196003309110063	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2464.39232377388	2464.39232377388
"healthy-3"	"2019-08-01-count-4:AAAGTGACATCTCATT"	10.8967224555904	5.78238151157228	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGACATCTCATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1766.72817215704	41.7409356389148	0.0236261221713312	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1763.03877288954	1763.03877288954
"healthy-3"	"2019-08-01-count-3:TAGCACATCTGTCCCA"	-1.79499481144603	8.67967126453248	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACATCTGTCCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.67406878174	40.5558848497352	0.019700002766215	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.96031353678	2051.96031353678
"healthy-3"	"2019-08-01-count-4:TTCTGTACAGAGTGAC"	-4.18291554871257	13.2229079970154	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTGTACAGAGTGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2064.18787161954	47.2012521988609	0.0228667423386357	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2064.18787161954	2064.18787161954
"healthy-3"	"2019-08-01-count-3:TCCTTTCGTAGTTACC"	-2.86136804047282	9.42397782886354	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCGTAGTTACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2186.78214512361	44.8093740892823	0.0204910096733708	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.49076434936	2180.49076434936
"healthy-3"	"2019-08-01-count-3:TAGGAGGAGTTCGCAT"	-3.40105233612712	9.89401719653932	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGAGTTCGCAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1996.53925831267	44.1240686407049	0.0221002759935686	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.21241413143	1989.21241413143
"healthy-3"	"2019-08-01-count-3:GAGGGATGTGACCGAA"	-4.24183497849162	12.5887231596741	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATGTGACCGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2158.08679903392	42.0038691885379	0.019463475337202	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2158.08679903392	2158.08679903392
"healthy-3"	"2019-08-01-count-3:ACCAACAAGTGTGTTC"	-3.23012242737468	10.235195136908	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACAAGTGTGTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2013.2887286438	43.6546053013424	0.0216832313618272	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.30527610024	2010.30527610024
"healthy-3"	"2019-08-01-count-2:TGTTGGAGTAACGGTG"	3.72796024855916	-6.7265606156555	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGAGTAACGGTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.55314860247	46.7730200454054	0.0216988479619397	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2148.18335801959	2148.18335801959
"healthy-3"	"2019-08-01-count-4:TCCTCTTAGACTACCT"	3.80674471434895	-6.67090752041014	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCTTAGACTACCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2960.61712410991	42.3586649777241	0.0143073768751706	2738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2952.79229978393	2952.79229978393
"healthy-3"	"2019-08-01-count-4:GTCCTCAAGCGGGTAT"	10.6168934303219	6.21459720218507	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCTCAAGCGGGTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.68808580697	42.2629015053228	0.0217213138188048	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1940.85033195648	1940.85033195648
"healthy-3"	"2019-08-01-count-4:GTCCCATTCTGTCCCA"	-0.561790685087997	8.54445931995241	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCCATTCTGTCCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1863.38965003823	37.769778427802	0.0202693936971406	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1861.62739057567	1861.62739057567
"healthy-3"	"2019-08-01-count-3:GTCTTTAAGGACTTCT"	-1.63948963108714	8.8988580473694	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTTTAAGGACTTCT"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2167.16951351769	39.9775469922651	0.0184468943213282	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2162.53411984309	2162.53411984309
"healthy-3"	"2019-08-01-count-4:CCTCCTCAGAGCAAGA"	-3.49980841103252	10.8550386198792	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCAGAGCAAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1759.9814504696	47.8630029094728	0.0271951746404498	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1759.9814504696	1759.9814504696
"healthy-3"	"2019-08-01-count-4:CTCAGTCAGGTGCTTT"	-4.07659945908244	10.6361608275208	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCAGGTGCTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.55836091936	46.2965647311059	0.0237960297984733	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1942.19502408574	1942.19502408574
"healthy-3"	"2019-08-01-count-4:TCCTTCTCACGGCCAT"	4.3021899658138	-8.13234045421752	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTCTCACGGCCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.79344931576	46.3419439486983	0.0181676583657251	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2544.40677927158	2544.40677927158
"healthy-3"	"2019-08-01-count-2:ATCCATTTCGTGCATA"	-3.7779143852299	10.3734388121399	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTTCGTGCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2354.50004543575	47.3906964577981	0.0201277109973585	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2347.50800597036	2347.50800597036
"healthy-3"	"2019-08-01-count-4:GTCGAATGTGTGCCTG"	4.94754519042317	-8.33735086834105	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATGTGTGCCTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2681.48064926844	43.83362065289	0.016346797305753	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2675.44551410883	2675.44551410883
"healthy-3"	"2019-08-01-count-3:AGGATCTTCCCTCTTT"	10.464637418359	6.71144435489503	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGATCTTCCCTCTTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.41361406444	43.7294432977546	0.0210600831171383	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2069.85466836454	2069.85466836454
"healthy-3"	"2019-08-01-count-4:CAGTTAGGTAGTCTTG"	4.52338232573811	-8.05057146465453	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTAGGTAGTCTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.48004561486	47.2026525306994	0.018047414511856	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2610.19368256867	2610.19368256867
"healthy-3"	"2019-08-01-count-2:GTCAAGTCAGTTGAAA"	5.34221376952474	-10.0838384858337	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAGTCAGTTGAAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.37476276635	50.2639801294438	0.0211782736203267	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2367.35186974854	2367.35186974854
"healthy-3"	"2019-08-01-count-2:TTAATCCAGAACAGGA"	-3.60423384133037	11.3426856764588	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCAGAACAGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.21675111375	47.9036598678559	0.0267735364304168	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1783.62400210756	1783.62400210756
"healthy-3"	"2019-08-01-count-3:ACCACAAGTACTTCCC"	10.040279050439	6.95030686939088	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAAGTACTTCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.05395742611	9.87378756291394	0.00480463665065056	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2052.01796688552	2052.01796688552
"healthy-3"	"2019-08-01-count-3:TGGTAGTCAACACAAA"	2.9760385948116	-7.09125711834105	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTCAACACAAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.62054447155	47.9512577801531	0.0198587135730047	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2412.60603087688	2412.60603087688
"healthy-3"	"2019-08-01-count-2:TTTGACTTCTTTGCTA"	-0.232709656388122	8.33946893298952	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTTCTTTGCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1969.70117625052	40.4420419414926	0.0205320697520611	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.42802229011	1966.42802229011
"healthy-3"	"2019-08-01-count-2:TGACAGTAGCGCTTCG"	-0.337468038231689	8.19240949237672	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACAGTAGCGCTTCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.48411740868	38.4942426940866	0.0204812811864354	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1874.64312710679	1874.64312710679
"healthy-3"	"2019-08-01-count-3:ACCATTTCACGTGAGA"	11.19713463363	6.07018611514894	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTCACGTGAGA"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2097.77211387397	47.1654833729178	0.0224836068040856	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2090.75866683543	2090.75866683543
"healthy-3"	"2019-08-01-count-2:AGATAGATCCTGTTGC"	-4.2820066017216	12.7931270369324	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGATCCTGTTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2044.51661128861	45.8975796734816	0.022449110670005	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2038.89157079417	2038.89157079417
"healthy-3"	"2019-08-01-count-3:GAGTCTATCAGCGGAA"	-3.92832646790202	11.1162118681702	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTATCAGCGGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1916.10824125943	48.7555715086385	0.0254451029742413	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1910.74422423973	1910.74422423973
"healthy-3"	"2019-08-01-count-3:CATCCACGTCGCAACC"	-4.1484468978947	-5.34850742733153	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACGTCGCAACC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2634.67108964763	51.1521133114607	0.01941499017181	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2624.61142616398	2624.61142616398
"healthy-3"	"2019-08-01-count-3:TTTAGTCAGGTTGGAC"	-5.04322896423991	-5.06514313137206	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCAGGTTGGAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2494.17350163772	51.9739303930297	0.0208381375068345	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2491.12849972877	2491.12849972877
"healthy-3"	"2019-08-01-count-3:TTTATGCAGAGATGCC"	-3.55372271958049	10.1360416182312	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTATGCAGAGATGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.96960034523	45.1518552761323	0.0206836848616635	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.53166921851	2176.53166921851
"healthy-3"	"2019-08-01-count-2:GTCACTCAGCTTCGTA"	-3.32893858376201	10.1765126951965	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCAGCTTCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1773.24451478318	49.8974195071847	0.0281390519419066	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1771.38988186851	1771.38988186851
"healthy-3"	"2019-08-01-count-2:GTCACTCAGGGCCTCT"	-1.07464144650157	8.78601071918336	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCAGGGCCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1893.53328862508	47.9213322881238	0.0253078900571745	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1885.09864943401	1885.09864943401
"healthy-3"	"2019-08-01-count-3:TTTATGCCAGGATGAC"	10.5848957496578	6.72983310306398	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTATGCCAGGATGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1782.49874796697	37.8255856524723	0.0212205398155899	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1777.77798069703	1777.77798069703
"healthy-3"	"2019-08-01-count-3:TTTATGCTCAAATAGG"	-4.02876840058024	11.1770362623963	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTATGCTCAAATAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.88815510467	45.9828059574374	0.0224757183537655	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2038.60216178246	2038.60216178246
"healthy-3"	"2019-08-01-count-4:CCTCTCCAGGCGCTTC"	5.02863897857015	-8.83625032817992	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCAGGCGCTTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.96861751637	48.7782423728996	0.0198207494503229	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2454.39096716864	2454.39096716864
"healthy-3"	"2019-08-01-count-2:CACGTGGCAAGGTACG"	-3.12615714493449	-5.61434795772704	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGCAAGGTACG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2752.15438785495	47.4883141602705	0.0172549601031951	2475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2746.2643351992	2746.2643351992
"healthy-3"	"2019-08-01-count-2:ACATCCCAGGTCTACT"	5.03709854659383	-8.29066278850707	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGGTCTACT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3015.03230880514	42.3367036538388	0.0140418739561092	3525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3009.0721363055	3009.0721363055
"healthy-3"	"2019-08-01-count-2:ACATCCCAGTCTCGTA"	-1.54090092602428	8.95710561359254	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGTCTCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.03055659647	45.1706375497326	0.0214788308272784	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2096.04017069793	2096.04017069793
"healthy-3"	"2019-08-01-count-2:TACCGGGAGAAACACT"	-2.27633343163188	9.09307572925416	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGAGAAACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.70732993178	45.7325264757048	0.0237484303896403	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1925.70732993178	1925.70732993178
"healthy-3"	"2019-08-01-count-2:CACGTGGCATGATAGA"	3.05204071578328	-6.95947506343993	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGCATGATAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.82888122079	45.5292133769873	0.0186226585127107	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2441.31035418717	2441.31035418717
"healthy-3"	"2019-08-01-count-4:GTCTGTCAGCTCCATA"	-2.87156639519389	3.30089280689088	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCAGCTCCATA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3360.15658987725	46.0572458988496	0.0137068748633921	5503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3355.34469871421	3355.34469871421
"healthy-3"	"2019-08-01-count-2:CACGTGGGTGGTGATG"	3.04996265944783	-6.42292072689208	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGGTGGTGATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.64628183606	40.702235625449	0.0153904270317735	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2642.29075886287	2642.29075886287
"healthy-3"	"2019-08-01-count-3:TTTCAGTCATCCAACA"	-3.79361615601237	12.7033834227356	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCAGTCATCCAACA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1937.93080097304	44.0903779323386	0.0227512653755236	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1935.96072556046	1935.96072556046
"healthy-3"	"2019-08-01-count-4:ATGTCCCTCGTGCTCT"	0.528645415871781	8.11820027911989	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCTCGTGCTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1988.00189831923	38.9051760019696	0.0195699893621139	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1982.41442863353	1982.41442863353
"healthy-3"	"2019-08-01-count-4:TGGCGTGTCGTCGATA"	-2.54612408104594	9.08007524097291	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGTCGTCGATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.2768028747	47.2966670410582	0.0238117199841465	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.98647206605	1979.98647206605
"healthy-3"	"2019-08-01-count-2:GTCATCCGTGCTTCAA"	3.5271278816158	-7.26206734096678	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCGTGCTTCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.85439097846	45.0230733325104	0.0185367527587246	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2424.90442054261	2424.90442054261
"healthy-3"	"2019-08-01-count-3:TCGCTCATCGCCTCTA"	-1.42488358441051	8.58916471088258	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCATCGCCTCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.40197828232	41.5655019795615	0.0201734915893515	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.99001849265	2056.99001849265
"healthy-3"	"2019-08-01-count-2:TCATTCACACATGTTG"	-3.73505340042766	10.0339402922424	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCACACATGTTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2291.42764449479	48.8888866995222	0.0213355576891022	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2289.86402580799	2289.86402580799
"healthy-3"	"2019-08-01-count-3:ACCGTTCCAAGATGGC"	10.1343847709591	7.08177850330202	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCCAAGATGGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1756.17721228172	44.0413959362851	0.0250779907792245	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1751.39143566616	1751.39143566616
"healthy-3"	"2019-08-01-count-2:TACCTCGTCGTGTCAA"	9.76732983168904	5.99421308124391	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTCGTCGTGTCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1536.37819505787	42.0597668797266	0.0273759202096346	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1536.37819505787	1536.37819505787
"healthy-3"	"2019-08-01-count-3:CTGCTCAAGCACCCAC"	-4.31553969803508	13.0371122130188	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCAAGCACCCAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2347.9485645791	43.0731080617636	0.0183449964413871	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2344.72569619366	2344.72569619366
"healthy-3"	"2019-08-01-count-2:GAGGGTAGTCTAGATC"	-8.26160655441936	-0.144943543430887	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTAGTCTAGATC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3106.37192692531	46.7759274610284	0.0150580576187885	4541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3096.13638321454	3096.13638321454
"healthy-3"	"2019-08-01-count-2:CCATCACTCCAGCCTT"	-3.42121849480327	10.0229339369568	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACTCCAGCCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2235.09369288568	42.7921171558733	0.0191455585473132	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2228.77276760323	2228.77276760323
"healthy-3"	"2019-08-01-count-4:ACCAAACGTGTCTTAG"	-0.722653130919296	8.03752801502077	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACGTGTCTTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2118.33391359485	38.6038842281556	0.0182237011740251	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.80630162052	2111.80630162052
"healthy-3"	"2019-08-01-count-3:GGCTGTGCACTCGATA"	2.37743248519246	-6.79800846492919	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTGTGCACTCGATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1967.46758851933	52.4262860902212	0.0266465818273917	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1964.01471835944	1964.01471835944
"healthy-3"	"2019-08-01-count-2:CACGTTCTCAGGCGAA"	4.46042599257771	-8.05441286480101	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCTCAGGCGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.72026803767	49.0565709280137	0.0177437737535859	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2755.55332127529	2755.55332127529
"healthy-3"	"2019-08-01-count-4:CTCCCAACATGACCCG"	-2.38278518143352	8.85994336688844	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCCAACATGACCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.09669902335	46.8136476564152	0.0216319574247963	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2160.89970642939	2160.89970642939
"healthy-3"	"2019-08-01-count-2:ACATTTCTCGACACTA"	-2.72486911240276	9.81305310809938	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATTTCTCGACACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2163.24199914031	39.5835212823127	0.0182982400018322	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2161.54139945832	2161.54139945832
"healthy-3"	"2019-08-01-count-3:CTGCTCACAAACTAAG"	3.09400023993794	-6.72812464153441	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCACAAACTAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.30047195577	48.2479866851617	0.0204587953311772	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2355.11175828709	2355.11175828709
"healthy-3"	"2019-08-01-count-4:TGGGATTAGATGCTTC"	10.5256678062374	6.35860393131105	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGATTAGATGCTTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.74958071174	44.4037700434295	0.0229625234240962	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1925.69860975296	1925.69860975296
"healthy-3"	"2019-08-01-count-3:TATCTGTCAATAACGA"	4.7602559524471	-8.16377451336058	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTCAATAACGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2997.90043413827	41.263931896086	0.0137642769673727	3233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2994.64446707263	2994.64446707263
"healthy-3"	"2019-08-01-count-3:TTTGACTAGTGCTAGG"	-3.86726246300395	12.7906827696594	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGTGCTAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1691.88922203934	46.7982611787248	0.0276603577640362	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1683.58519871907	1683.58519871907
"healthy-3"	"2019-08-01-count-3:ACCTGAATCCGCGAGT"	-3.35767970505412	12.2292117842468	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGAATCCGCGAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1936.21441530883	46.6134310898497	0.0240745191861485	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1930.91857982238	1930.91857982238
"healthy-3"	"2019-08-01-count-4:ACCATTTAGACGCATG"	5.08177914199178	-8.55700590526732	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCATTTAGACGCATG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2920.81319722205	41.4481594384647	0.014190623172302	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2917.02533678032	2917.02533678032
"healthy-3"	"2019-08-01-count-4:TATATCCAGGACATCG"	-2.45025477829631	9.57511899555055	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATATCCAGGACATCG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2104.81546725887	42.9234535711917	0.0203929770751312	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2099.94791699598	2099.94791699598
"healthy-3"	"2019-08-01-count-2:ACCAAACTCTGCGTCT"	10.9123007255489	5.51362941348878	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACTCTGCGTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1877.01875271969	40.7584086654955	0.0217144387110885	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1870.40620931226	1870.40620931226
"healthy-3"	"2019-08-01-count-2:AGCGATTGTAGGTACG"	-1.33866105499919	8.42554280841676	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTGTAGGTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.54818324265	43.9911854508195	0.022178027144722	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.73290750218	1978.73290750218
"healthy-3"	"2019-08-01-count-4:GGCAGTCCAGGAATAT"	3.24581350859944	-6.58812239086302	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCAGTCCAGGAATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2643.36859974366	43.7529643138813	0.0165519724786488	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2640.03157252227	2640.03157252227
"healthy-3"	"2019-08-01-count-3:CTGTACCAGGCCTAGA"	-1.36043832722362	8.63350198352662	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCAGGCCTAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.49786047271	51.8201060350282	0.0254082669265549	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.15719191264	2033.15719191264
"healthy-3"	"2019-08-01-count-2:CACTGAATCGTAGTCA"	5.16074432906453	-9.197461151239	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAATCGTAGTCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.40884928012	42.1276987807861	0.0166617431325557	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2521.80317268766	2521.80317268766
"healthy-3"	"2019-08-01-count-4:TGGGTTAGTTGCTCCT"	-0.689924995333511	8.180637336615	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGTTAGTTGCTCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2274.66240209507	44.4811195794163	0.0195550423387871	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2271.12873228018	2271.12873228018
"healthy-3"	"2019-08-01-count-2:ACCAACACAGCGTGCT"	0.369361211627167	8.31217000568239	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAACACAGCGTGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.26743976262	40.1107051726587	0.0220719880271987	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1814.49945891814	1814.49945891814
"healthy-3"	"2019-08-01-count-2:CTGTACCAGTTTCGGT"	-3.68478570404704	10.4682197340759	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCAGTTTCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.47533612243	41.1275048976726	0.0198637985104888	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2061.77469845236	2061.77469845236
"healthy-3"	"2019-08-01-count-3:AGGTCTAGTGCCCAGT"	-0.338759670883971	8.03006932819215	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTAGTGCCCAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2052.64701875229	39.5002142789695	0.0192435493867718	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2039.53668511706	2039.53668511706
"healthy-3"	"2019-08-01-count-2:GTCCTCATCCGTGTCT"	11.1466480689937	6.04017922962037	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCATCCGTGTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.15583359307	39.0963029913839	0.01935311243878	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2012.1575688873	2012.1575688873
"healthy-3"	"2019-08-01-count-3:TATGTTCAGCTAAATG"	-3.92066750946696	-5.40334656154784	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCAGCTAAATG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3033.79228295966	47.635386684149	0.0157015979477928	3179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3027.35880270325	3027.35880270325
"healthy-3"	"2019-08-01-count-3:TTTGGTTGTAAGATTG"	-2.36195908013042	9.14186570728151	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTGTAAGATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1920.29113193669	43.0422134137384	0.0224144207604232	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.58530417296	1912.58530417296
"healthy-3"	"2019-08-01-count-2:TGAGGGATCTGGAAGG"	5.10115303572957	-8.77686598217162	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGGATCTGGAAGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.35339508149	44.4374004779711	0.0172347982098733	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2572.30550029016	2572.30550029016
"healthy-3"	"2019-08-01-count-4:GTGCACGGTCAGTCTA"	-3.26054416123088	9.89558026874391	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGGTCAGTCTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2039.48064782283	47.0497465927251	0.0230694743992551	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2034.55042850273	2034.55042850273
"healthy-3"	"2019-08-01-count-3:TATGTTCTCTGGAGAG"	-2.45186767998393	12.1280622252258	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCTCTGGAGAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2020.63848107135	43.5408203248371	0.0215480506447405	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2017.65777704665	2017.65777704665
"healthy-3"	"2019-08-01-count-4:TCGGGTGTCCTCAGGG"	-1.59831676903422	8.76862714374391	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGTGTCCTCAGGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.38242799232	44.968562721969	0.0233435282987062	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.38242799232	1926.38242799232
"healthy-3"	"2019-08-01-count-2:CACTGTCCAGACCCGT"	2.86868013915364	-6.30171635067137	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCCAGACCCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.28431744267	43.6144267167273	0.0163210278307757	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2666.98539124903	2666.98539124903
"healthy-3"	"2019-08-01-count-4:CTCTGGTCAAGAGATT"	-3.80564008179362	13.3251762160095	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTGGTCAAGAGATT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1930.38005520247	43.9154101146557	0.0227496186547833	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1920.69986287853	1920.69986287853
"healthy-3"	"2019-08-01-count-2:CACTGTCGTAAGTTAG"	-3.81713257256206	9.62191007221071	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCGTAAGTTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2317.19869180094	40.1339744120036	0.0173200401648817	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2303.49865947561	2303.49865947561
"healthy-3"	"2019-08-01-count-3:GATGAGGAGGCGACAT"	-2.90745172920879	9.06987378681032	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGAGGAGGCGACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1955.36056804734	44.8332281427937	0.0229283687496905	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1955.36056804734	1955.36056804734
"healthy-3"	"2019-08-01-count-3:GGGACCTTCGTTAGTG"	3.94315685805623	-7.37457134639891	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTTCGTTAGTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.33396581726	46.8335584074775	0.02056508141118	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2274.09086333209	2274.09086333209
"healthy-3"	"2019-08-01-count-3:CGGCAGTCACCCTATC"	5.04657330092732	-8.40806486522826	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTCACCCTATC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.87593045048	42.7302377715412	0.016070790397618	2211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2651.19052133496	2651.19052133496
"healthy-3"	"2019-08-01-count-4:TATCTTGTCAACCGAT"	3.3686007457668	-7.49873258983763	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGTCAACCGAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.33464756056	46.0242105068693	0.0192784914146402	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2384.66638452448	2384.66638452448
"healthy-3"	"2019-08-01-count-2:TGATCTTAGGTTCTAC"	2.97774924811665	-6.76134064113768	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCTTAGGTTCTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.39011351301	47.1234319244326	0.0228711211606845	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2058.83071100951	2058.83071100951
"healthy-3"	"2019-08-01-count-4:AAACCCAGTGGAGGTT"	-4.0176571411198	13.327760673407	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCAGTGGAGGTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2158.87898291532	36.4630201355996	0.0168897934641804	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2153.53288856443	2153.53288856443
"healthy-3"	"2019-08-01-count-2:CTGTCGTTCAACTTTC"	-0.388580004603225	8.03606937015382	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTCGTTCAACTTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2130.41796188354	44.5538790460497	0.0209132103855615	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2124.21829776694	2124.21829776694
"healthy-3"	"2019-08-01-count-2:GTCGTTCTCGGTATGT"	-2.99725184860881	10.5724773176941	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTTCTCGGTATGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.26358351451	43.2678222510662	0.0248627981766336	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1734.1595729294	1734.1595729294
"healthy-3"	"2019-08-01-count-2:CTGTGAATCCAACACA"	10.6454082923824	7.68377730930177	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAATCCAACACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2215.16513704135	42.9219982037989	0.0193764327029483	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2206.30548125429	2206.30548125429
"healthy-3"	"2019-08-01-count-2:CTGTGAATCTATCGTT"	11.1268898445064	5.74907014453737	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAATCTATCGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.91168970037	41.4523922160683	0.0222275362661962	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1857.65290494952	1857.65290494952
"healthy-3"	"2019-08-01-count-2:ACCCTCAAGCTGTCCG"	-0.120478595525581	8.26161573016969	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTCAAGCTGTCCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2038.08030593372	39.6281067768338	0.0194438397061488	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2032.94372317799	2032.94372317799
"healthy-3"	"2019-08-01-count-2:ATGAGGGCAAACCATC"	10.8008600669796	7.134485698584	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGGGCAAACCATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2158.83683375118	41.8784199664649	0.019398603596038	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2153.81310691397	2153.81310691397
"healthy-3"	"2019-08-01-count-2:CTGTGGGTCATGGCCG"	4.66462816771809	-7.93823101436766	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGGGTCATGGCCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2862.6275562101	44.262530692959	0.0154622038053596	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2855.77957555991	2855.77957555991
"healthy-3"	"2019-08-01-count-4:TGTAACGTCCAGCCTT"	-1.97932110253032	8.71697614276735	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGTCCAGCCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.11939163729	45.4291253607578	0.0230590722336901	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.95301871944	1961.95301871944
"healthy-3"	"2019-08-01-count-3:ACGTACAGTTGCTGAT"	4.63071789321248	-8.06662752544554	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACAGTTGCTGAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2975.9462002336	41.7010412820973	0.0140126999872591	2585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2971.88441163874	2971.88441163874
"healthy-3"	"2019-08-01-count-2:ACCCTTGCAACACGAG"	-2.8668945831364	9.75124547565309	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGCAACACGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.98619430224	41.2688934719481	0.0200238573096895	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.33191429637	2052.33191429637
"healthy-3"	"2019-08-01-count-4:GTGCTTCAGATGAACT"	2.9522131877834	-7.4058351746765	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTTCAGATGAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1933.44781580015	49.5604787419879	0.0256332125113382	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1931.76477689961	1931.76477689961
"healthy-3"	"2019-08-01-count-3:TCAAGACCATGAGTAA"	10.7276579338009	7.00775334918825	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGACCATGAGTAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.6262282466	40.7598730275809	0.0207468842884983	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1953.95411239517	1953.95411239517
"healthy-3"	"2019-08-01-count-4:AAAGGTAAGAAACCCG"	-0.812127391726333	8.55014607990114	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTAAGAAACCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.67673217534	40.3095471772467	0.0208030299935496	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1935.97306027702	1935.97306027702
"healthy-3"	"2019-08-01-count-3:ACGTAGTCATAGATCC"	3.08799447593037	-7.99208261882933	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAGTCATAGATCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.74983355529	46.4903015896322	0.0216864397430789	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2138.06990122486	2138.06990122486
"healthy-3"	"2019-08-01-count-4:TGTAAGCTCGTGGCTG"	-4.05683312836345	11.4773235091004	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCTCGTGGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.15930493982	48.3085886023821	0.0247335629409249	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.90114870142	1947.90114870142
"healthy-3"	"2019-08-01-count-3:GATTCGATCTCCGAGG"	-2.64809451523479	8.88716123187868	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCGATCTCCGAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.25499729261	45.3588452545295	0.0239454800538255	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1883.2377272317	1883.2377272317
"healthy-3"	"2019-08-01-count-3:AACAGGGAGTTTCGAC"	-3.27271972122844	10.2623510130676	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGAGTTTCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1914.63337526458	43.738996881439	0.0228445808197587	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1911.01091283018	1911.01091283018
"healthy-3"	"2019-08-01-count-2:CAGATTGAGTCCTACA"	0.0900450433487117	7.9227838286194	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGAGTCCTACA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.39466560585	37.6826358185176	0.018771911903604	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.37895805466	2002.37895805466
"healthy-3"	"2019-08-01-count-2:AGGAAATAGTTAACAG"	-5.7655762237614	-4.97925856029662	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATAGTTAACAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3131.24434299341	48.1534877278265	0.015378387137234	3910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3128.54595819449	3128.54595819449
"healthy-3"	"2019-08-01-count-3:TCTATACTCCTTCGAC"	-2.24994526329692	8.57730386340944	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATACTCCTTCGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.00096850523	37.6485985680863	0.0174865683382505	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2145.86803690282	2145.86803690282
"healthy-3"	"2019-08-01-count-3:AGTAGCTTCCATATGG"	3.2258743244106	-6.51601173793944	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGCTTCCATATGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.4468856635	44.2674071294606	0.0179042904363873	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2470.59168761706	2470.59168761706
"healthy-3"	"2019-08-01-count-4:AGGGTGATCGTCAAAC"	3.04604591903035	-7.18360760128173	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTGATCGTCAAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.11764614794	48.5056510651856	0.0232182477394816	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2086.45995170699	2086.45995170699
"healthy-3"	"2019-08-01-count-3:CTTAGGAAGTGCGCTC"	-3.76565251770671	13.3221378096375	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGAAGTGCGCTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2178.73771449385	44.8441966006723	0.0205826503586689	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2175.21731378416	2175.21731378416
"healthy-3"	"2019-08-01-count-4:TCTACATAGTTACTCG"	-3.27174911919292	9.44884011829225	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATAGTTACTCG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2135.38591470555	47.450160458497	0.0222208829475397	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2132.23312900697	2132.23312900697
"healthy-3"	"2019-08-01-count-2:CAGATTGCAGACAATA"	-3.93844852867778	13.1736631163391	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGCAGACAATA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1991.45930367244	43.8540971112177	0.0220210862608875	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1979.01651509046	1979.01651509046
"healthy-3"	"2019-08-01-count-3:AGTCAACCACAACATC"	-4.90893063965495	2.30394694888917	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACCACAACATC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2450.44555041021	18.3629579089409	0.00749372207265203	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2440.61327158688	2440.61327158688
"healthy-3"	"2019-08-01-count-2:GTCTTTACAGCGTATT"	10.9974466758663	6.31012818897096	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTTTACAGCGTATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.06748792884	43.4231792545251	0.0216891685801495	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1997.56506270481	1997.56506270481
"healthy-3"	"2019-08-01-count-3:CCAATGAAGATCGACG"	10.5447946983272	7.70077607715455	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCAATGAAGATCGACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2385.74760635918	46.1687419151679	0.0193518969869678	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2372.82523065374	2372.82523065374
"healthy-3"	"2019-08-01-count-2:GCATCTCGTGCTCTTC"	-3.96678433838542	13.0522327193054	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCGTGCTCTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1876.34241141762	44.1300841682685	0.0235192062492086	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1874.29016511066	1874.29016511066
"healthy-3"	"2019-08-01-count-2:ACCTGAATCACTGCTC"	-3.58125362816508	-4.67293550884398	"2019-08-01-count-2"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGAATCACTGCTC"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2925.95493942482	47.482548531657	0.0162280518718416	2869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2917.07490035393	2917.07490035393
"healthy-3"	"2019-08-01-count-3:TCAATCTTCCGCTAGG"	-4.23126349869426	13.2202262648377	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTTCCGCTAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1918.92810865473	42.1956108093806	0.021989156664635	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1917.00365612522	1917.00365612522
"healthy-3"	"2019-08-01-count-3:CCACAAACAGTTGCGC"	4.80060686644856	-8.59927847301634	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACAAACAGTTGCGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.07780066637	47.1603179681349	0.0184647147224061	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2545.31018192973	2545.31018192973
"healthy-3"	"2019-08-01-count-2:AGGACGAGTTGCGAAG"	5.32087673720662	-9.51760771190795	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGAGTTGCGAAG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.74884443694	45.0774302129351	0.0183334830293567	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2453.55458992652	2453.55458992652
"healthy-3"	"2019-08-01-count-4:AAATGGACATCACCAA"	11.1038748222286	6.38981483066408	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGACATCACCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1941.6881784146	42.2889084219627	0.0217794540297876	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1933.17491760867	1933.17491760867
"healthy-3"	"2019-08-01-count-3:GCAACCGCAGCAATTC"	-3.11925898018535	12.5262069472107	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACCGCAGCAATTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2110.12073808023	39.7751271130459	0.0188496925295531	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2103.58460236373	2103.58460236373
"healthy-3"	"2019-08-01-count-4:TGTCAGATCACCACAA"	-2.04482779923137	8.70621011340944	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCAGATCACCACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2157.88156028754	43.1254244875553	0.0199850748443343	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2154.62791053353	2154.62791053353
"healthy-3"	"2019-08-01-count-2:GTGAGCCTCAAGAGGC"	5.53317179259602	-9.83845426952513	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGCCTCAAGAGGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.48886366742	44.6526046859583	0.0186480736509118	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2386.04801174621	2386.04801174621
"healthy-3"	"2019-08-01-count-2:GATGAGGCAGACCTAT"	10.4995209175045	7.16571185672609	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGAGGCAGACCTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.83306615209	41.108952759967	0.0211266595655404	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1936.70018735993	1936.70018735993
"healthy-3"	"2019-08-01-count-3:TCAATTCCATTCGGGC"	-2.68023524704631	9.60585115039674	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCCATTCGGGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2143.4394617243	45.1918281618468	0.021083790314046	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2138.05209902444	2138.05209902444
"healthy-3"	"2019-08-01-count-3:CTTCCTTAGCATCTTG"	0.195717056363267	8.7468633421692	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTAGCATCTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.03523004971	44.9360656018119	0.0240552559603579	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.77477772978	1856.77477772978
"healthy-3"	"2019-08-01-count-4:ACGGTTATCCTACGAA"	-5.32354484024699	-5.10905792629393	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTATCCTACGAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3146.45466653572	46.4696030157309	0.0147688773367564	3760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3142.60120464315	3142.60120464315
"healthy-3"	"2019-08-01-count-4:GATGACTAGGTAAGAG"	-1.50415454331096	8.56905076587526	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTAGGTAAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.8936996692	39.2465441391394	0.0191363131816484	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.15127290339	2044.15127290339
"healthy-3"	"2019-08-01-count-2:CAGCAGCAGGCCTTGC"	5.4845196205074	-9.96228601848754	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAGCAGGCCTTGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.56482945207	49.5613295950098	0.0201422571767989	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2446.23903369039	2446.23903369039
"healthy-3"	"2019-08-01-count-4:TTTATGCAGCAGGCAT"	5.380050321191	-9.38157465374144	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCAGCAGGCAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.80900514628	45.5209708283699	0.0170311349373348	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2668.76517862667	2668.76517862667
"healthy-3"	"2019-08-01-count-3:GCACATAGTGTTGACT"	-2.47589097443278	8.83462712848512	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACATAGTGTTGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2215.99123999053	41.2054961628876	0.0185946114854965	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2209.64663672341	2209.64663672341
"healthy-3"	"2019-08-01-count-2:TTCCAATTCGCTTACC"	9.79906811293904	7.71107909763185	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATTCGCTTACC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.17280749037	44.8698724914707	0.021233413723868	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2105.92293482711	2105.92293482711
"healthy-3"	"2019-08-01-count-4:AACAACCTCCGAAGGA"	4.66571821746175	-8.04932215130004	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAACCTCCGAAGGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.85822096031	43.6294140629593	0.0157742771239413	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2763.47516002609	2763.47516002609
"healthy-3"	"2019-08-01-count-4:TCTCACGGTTGGCCTG"	-0.76317665997203	8.40437409961549	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCACGGTTGGCCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.49613852949	45.2324795252586	0.0229083656547161	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1971.06183184678	1971.06183184678
"healthy-3"	"2019-08-01-count-3:TCACACCAGGAACGAA"	-2.35038385811504	9.12685868823854	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCAGGAACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.70010078519	44.7630008709523	0.0227488939260053	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1957.61850232453	1957.61850232453
"healthy-3"	"2019-08-01-count-4:AACAACCTCGCTTAAG"	-3.18863902512248	9.48420331561891	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAACCTCGCTTAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2157.92040823852	45.1929974748253	0.0209428472441741	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2150.65693803382	2150.65693803382
"healthy-3"	"2019-08-01-count-3:GCACGGTGTCCAGGTC"	0.14011431959216	8.31007764423219	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTGTCCAGGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.44261157959	31.7924846620567	0.0169159113804154	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1873.48448091344	1873.48448091344
"healthy-3"	"2019-08-01-count-2:ACGCACGAGGCGTTGA"	-3.87920151177104	10.3209657439026	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGAGGCGTTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2038.65969151018	43.3765865594349	0.0212770119211524	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2036.99672427522	2036.99672427522
"healthy-3"	"2019-08-01-count-2:CAGCGTGAGTGAGGCT"	10.0871130424434	7.07327268207399	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCGTGAGTGAGGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.97112418571	45.9222235460652	0.0244661321393464	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1864.86393348831	1864.86393348831
"healthy-3"	"2019-08-01-count-4:AACAAGATCCCTCTAG"	-2.9661901992863	9.00773618305055	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAGATCCCTCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2066.48832718886	42.4834122209452	0.0205582638246679	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2057.79245731045	2057.79245731045
"healthy-3"	"2019-08-01-count-3:GTTCCGTTCTGCCTGT"	14.3929239707882	1.99636766994325	"2019-08-01-count-3"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCCGTTCTGCCTGT"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1392.12444005577	26.8030650861746	0.0192533543086859	2650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1380.83492643316	1380.83492643316
"healthy-3"	"2019-08-01-count-3:CTTCTAAAGGGATGTC"	-3.13657651367839	9.46103570545045	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAAAGGGATGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1900.54944438925	43.9791215598442	0.0231402143678388	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.90487896151	1887.90487896151
"healthy-3"	"2019-08-01-count-4:ACGTAGTAGTCGCTAT"	10.5122438865596	7.37940595233766	"2019-08-01-count-4"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTAGTCGCTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.50172899884	42.527019478068	0.0213649748997996	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1982.22754976325	1982.22754976325
"healthy-3"	"2019-08-01-count-4:AACACACCATTAGGAA"	10.0577141242916	6.75003240192262	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACCATTAGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2052.8639475286	52.5111821653604	0.0255794750687582	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2044.36282020826	2044.36282020826
"healthy-3"	"2019-08-01-count-2:TGCGATAAGCATATGA"	-1.83975682678874	9.0640249022278	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGATAAGCATATGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1978.95412033	49.6818800600741	0.0251051196941288	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.43197884222	1977.43197884222
"healthy-3"	"2019-08-01-count-4:AACACACCATTCCTAT"	-0.166762317449409	8.37445447528688	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACCATTCCTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.39435999717	35.6054995379956	0.0174588594714192	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2034.85978997994	2034.85978997994
"healthy-3"	"2019-08-01-count-4:CTGGTCTGTTTAGAGA"	0.680039783089799	8.22957894885866	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTGTTTAGAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.63937446481	41.8555482878847	0.0229390798388101	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1823.04381059347	1823.04381059347
"healthy-3"	"2019-08-01-count-4:TGTGATGAGTCCGCCA"	-3.474841217429	10.6805629500183	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGATGAGTCCGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.21125277847	47.9189120366813	0.0244707571610009	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.21125277847	1958.21125277847
"healthy-3"	"2019-08-01-count-4:TGTGATGTCAACCCGG"	4.17684855040852	-7.04152252590331	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGATGTCAACCCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.80319775946	45.6775038733486	0.0198356090167806	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2298.6917378065	2298.6917378065
"healthy-3"	"2019-08-01-count-2:CCGTGAGGTCCAGCCA"	-4.11633048477824	11.1777763136658	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGGTCCAGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2421.56216371917	48.3082377100343	0.0199492040443181	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2414.03639854399	2414.03639854399
"healthy-3"	"2019-08-01-count-2:AGGCTGCAGGGTTAGC"	-3.19123707237895	10.2958650358948	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCAGGGTTAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.83853652875	49.6601776244611	0.0258264938428535	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1916.57853944473	1916.57853944473
"healthy-3"	"2019-08-01-count-4:GATGCTATCAGTAGGG"	3.56586780127828	-6.70810367977294	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGCTATCAGTAGGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.82728346351	44.6977262724191	0.0186253929940783	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2399.82728346351	2399.82728346351
"healthy-3"	"2019-08-01-count-4:GATGGAGCAGCAGTAG"	4.49007763442342	-7.90533354198607	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGCAGCAGTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2727.53847773845	46.9971232053138	0.017230599527337	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2721.80141125898	2721.80141125898
"healthy-3"	"2019-08-01-count-2:TGCGGGTCATGAGAAT"	-3.41461120072063	10.068727470282	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTCATGAGAAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2032.01503009688	47.7267356652336	0.0234873930351579	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.31718035554	2030.31718035554
"healthy-3"	"2019-08-01-count-4:GATGGAGAGTCACAGG"	-2.71188054505046	9.14772698963014	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGAGTCACAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1910.36620106468	46.0895818813194	0.0241260454962158	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1906.87877690832	1906.87877690832
"healthy-3"	"2019-08-01-count-4:CATTTCACACAACATC"	-0.19744205001052	8.10590646350709	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTTCACACAACATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2045.79213699974	28.9255382496371	0.0141390406808669	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.446024549	2044.446024549
"healthy-3"	"2019-08-01-count-4:CATTGTTTCCACTAGA"	-0.883903424174148	8.81481359088746	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGTTTCCACTAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1949.21071526197	37.3817015858576	0.0191778658372671	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1944.03234987647	1944.03234987647
"healthy-3"	"2019-08-01-count-3:AGTGCCGTCTCCCAAC"	-1.76542888107951	8.76478860462037	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGTCTCCCAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.94099841325	46.6481518493862	0.0250804471158938	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1858.16682057249	1858.16682057249
"healthy-3"	"2019-08-01-count-4:CAACCTCTCCATACAG"	-1.80305824700053	12.8047427901062	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCTCCATACAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1743.67564248055	51.8208335059812	0.0297193080200747	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1735.60086385452	1735.60086385452
"healthy-3"	"2019-08-01-count-3:CCATCACTCCATTGTT"	2.85735668715779	-4.7519741288391	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACTCCATTGTT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2938.04809387145	43.0851346597438	0.0146645436981158	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2933.1330395395	2933.1330395395
"healthy-3"	"2019-08-01-count-3:CAAGAGGAGCACCAGA"	4.25765814360921	-7.49010612880858	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGAGCACCAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.38397550992	44.0400545324173	0.017329161967184	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2533.03335389456	2533.03335389456
"healthy-3"	"2019-08-01-count-4:GTTAGACGTAGTCTGT"	4.18553461608235	-8.01561262523802	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACGTAGTCTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.64005083733	43.8242598240895	0.016922915526395	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2586.13959742053	2586.13959742053
"healthy-3"	"2019-08-01-count-2:ACGTAACAGTGAGGCT"	-3.67112837258037	10.1328763731751	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACAGTGAGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.25239827394	44.353065224349	0.023576350129862	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1876.1935507937	1876.1935507937
"healthy-3"	"2019-08-01-count-3:TGAACGTTCGGAGCAA"	4.47705044326131	-8.33333780681761	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAACGTTCGGAGCAA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.75771304341	45.7879663308648	0.0188214247910383	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2430.66273379529	2430.66273379529
"healthy-3"	"2019-08-01-count-4:TCACTATAGTCCGCGT"	-2.85702071610149	8.81862351978151	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTATAGTCCGCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.0086976882	47.1280718027346	0.0216679923408245	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2168.38742995155	2168.38742995155
"healthy-3"	"2019-08-01-count-2:GATTGGTTCTCTCTAA"	3.11127223548238	-5.39580299770506	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTTCTCTCTAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2921.69309380452	40.398231364859	0.0138269934821436	2769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2916.98819268976	2916.98819268976
"healthy-3"	"2019-08-01-count-4:TCACTATGTGATTAGA"	-3.57224975052531	10.1748656996521	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTATGTGATTAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2073.97724705798	48.6355346637402	0.0234503704091893	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.16791554031	2069.16791554031
"healthy-3"	"2019-08-01-count-4:TTTCGATGTGCAGATG"	-3.3396147293156	10.2206859358582	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATGTGCAGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.18830336053	48.9312893389504	0.0248358439929264	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1965.0950145562	1965.0950145562
"healthy-3"	"2019-08-01-count-4:CTGTGAACAGCCCAGT"	-4.22845683518107	13.2378558882507	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAACAGCCCAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2182.01173843727	43.4194254881062	0.0198988047237558	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2173.37134215834	2173.37134215834
"healthy-3"	"2019-08-01-count-2:GATTTCTCAGCGATTT"	-3.54642496529277	10.1249027022156	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTCAGCGATTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2228.69291892289	44.0471678536636	0.0197636773912089	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2222.72668890674	2222.72668890674
"healthy-3"	"2019-08-01-count-2:TGCTGAAAGGACGCTA"	-1.27182267132457	8.9067983397278	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAAAGGACGCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1996.71915552669	48.0942640251758	0.0240866442794704	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1987.20516471365	1987.20516471365
"healthy-3"	"2019-08-01-count-2:GTGGAAGTCCCGATCT"	-4.20218024674113	13.2234248884949	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAAGTCCCGATCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2264.73052927742	45.8565884194586	0.0202481433559734	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2263.1926733623	2263.1926733623
"healthy-3"	"2019-08-01-count-4:AACCATGCATCTGCGG"	-1.57863650742229	8.73323438251344	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCATGCATCTGCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.08517353822	45.0694947757901	0.023448229764358	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.02533545917	1917.02533545917
"healthy-3"	"2019-08-01-count-3:AAGACAACACCGTCGA"	-3.60438571396526	10.6121082075867	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAACACCGTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1798.63403762965	49.7639671869616	0.027667644526812	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1795.01848389462	1795.01848389462
"healthy-3"	"2019-08-01-count-4:AGTCATGCATTCGGGC"	2.60554542121236	-4.42148735439452	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCATGCATTCGGGC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2604.71469527351	45.0213351284914	0.0172845552759335	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2600.83935242392	2600.83935242392
"healthy-3"	"2019-08-01-count-4:CTTACCGAGACCCGCT"	-1.78901467743571	8.96354863727418	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGAGACCCGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2236.11212257663	53.0472436981116	0.0237229802399113	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2233.20542249926	2233.20542249926
"healthy-3"	"2019-08-01-count-4:AACCCAAGTCATATGC"	-3.83709154549297	10.3717698820862	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAAGTCATATGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2316.81691383651	46.3987365155175	0.0200269327448425	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2309.76745801197	2309.76745801197
"healthy-3"	"2019-08-01-count-2:ACGTACACAGTAGTGG"	-3.90427504006084	10.4858102568421	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACACAGTAGTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2090.26627937909	47.7669094298223	0.0228520690885428	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2083.86395024494	2083.86395024494
"healthy-3"	"2019-08-01-count-4:AACCCAAGTGTCATCA"	10.1956707435543	7.11433980548707	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAAGTGTCATCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.81923737646	46.4444753611184	0.0243954228685707	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1894.30084744048	1894.30084744048
"healthy-3"	"2019-08-01-count-2:ACGTACACATGAGATA"	-3.94639335098918	10.9931354292664	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACACATGAGATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.6307165699	44.5366939344792	0.0214053813489315	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2070.40883952412	2070.40883952412
"healthy-3"	"2019-08-01-count-3:GAAATGACAACCGCTG"	-4.06713710251506	13.2004689940247	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAATGACAACCGCTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2180.44528520491	41.7451729795112	0.0191452513221804	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2175.20131107574	2175.20131107574
"healthy-3"	"2019-08-01-count-3:CAATACGCAACGACTT"	-4.38995681229289	11.5837220915589	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGCAACGACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2349.7996756146	49.3713614416252	0.021010881035513	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2342.58821867866	2342.58821867866
"healthy-3"	"2019-08-01-count-2:TTCGGTCAGAGTAACT"	2.59532632407491	-6.51661636745604	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGGTCAGAGTAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.11741093762	45.9360441932278	0.0193813369672076	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2364.7985418592	2364.7985418592
"healthy-3"	"2019-08-01-count-4:AACCTGATCAAGCGTT"	5.06401218947713	-8.51180460369261	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTGATCAAGCGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.30490761716	42.9644458974596	0.0157765829956414	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2717.00704057639	2717.00704057639
"healthy-3"	"2019-08-01-count-2:ACGTCCTTCCGTGACG"	-6.91646371308024	3.50522539699403	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTCCTTCCGTGACG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2585.97115854715	42.5362933807033	0.0164488661213844	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2575.09274865406	2575.09274865406
"healthy-3"	"2019-08-01-count-3:TCAGCCTTCCGCACGA"	-1.87474070015605	8.80070684039918	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTTCCGCACGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2131.65477930466	49.6789353332265	0.0233053380948634	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2131.65477930466	2131.65477930466
"healthy-3"	"2019-08-01-count-4:GGTAATCTCGAAGCAG"	-1.91843471947368	8.58569810474244	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAATCTCGAAGCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.90143271114	44.8420062639382	0.0225915531748542	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.50760757452	1979.50760757452
"healthy-3"	"2019-08-01-count-3:TCAGGGCTCTCGAACA"	11.0592924552852	5.96969935977785	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGGCTCTCGAACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1952.05210639786	46.1756199344421	0.0236549115585087	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1947.44718836714	1947.44718836714
"healthy-3"	"2019-08-01-count-4:AACCTTTAGGCCACTC"	-2.88553057137187	9.69385335529176	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTAGGCCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2226.13404678827	45.8252430156161	0.0205851229317165	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2226.13404678827	2226.13404678827
"healthy-3"	"2019-08-01-count-2:ACGTTCCCAACAGTGG"	-2.94785819473918	9.41374013507692	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCCAACAGTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1909.12312271139	48.5236034151412	0.0254166967221196	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1907.41228196173	1907.41228196173
"healthy-3"	"2019-08-01-count-4:GTTCGCTAGGCTCTCG"	-2.78122792664226	9.57972810352174	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCGCTAGGCTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2252.7206079295	45.5501832628684	0.020220076605387	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2249.92086813738	2249.92086813738
"healthy-3"	"2019-08-01-count-2:GTGTAACCAGCTATTG"	4.81057991561238	-8.07063295757445	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTAACCAGCTATTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.48502561285	47.4262749917735	0.0194172224166957	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2434.33086060286	2434.33086060286
"healthy-3"	"2019-08-01-count-2:ATTCATCCAGAAACCG"	-3.29211364212688	12.7232589491638	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCCAGAAACCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1973.09555015375	45.6709945151136	0.0231468742157747	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1969.31616468861	1969.31616468861
"healthy-3"	"2019-08-01-count-3:TCAGTCCCATTGGATC"	-3.8082836669987	10.2617378004822	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTCCCATTGGATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.36521578251	49.3092394601193	0.0247739656366199	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.92744531821	1978.92744531821
"healthy-3"	"2019-08-01-count-3:CCCTCAAAGGTCCCGT"	10.9511810737545	6.47011230075685	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAAGGTCCCGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.29672251527	46.352200075414	0.0238400854862573	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1937.978301534	1937.978301534
"healthy-3"	"2019-08-01-count-3:AGAACCTCACACCTGG"	10.2177740531856	7.00662372196046	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTCACACCTGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.01654926672	42.4878036939953	0.0206751637640855	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2055.01654926672	2055.01654926672
"healthy-3"	"2019-08-01-count-4:TTAATCCCATACCACA"	10.6099602180416	7.17924878681032	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCCATACCACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2057.15199406877	43.1563343330815	0.0209786804560435	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2047.81107971092	2047.81107971092
"healthy-3"	"2019-08-01-count-2:CCTCAGTCACCTCTGT"	0.191974465816659	9.01997277820436	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTCACCTCTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2113.48695483788	37.9045254204215	0.0179345916158394	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2101.78919068319	2101.78919068319
"healthy-3"	"2019-08-01-count-4:CTTCCGATCGCTGTTC"	-2.70642791214641	9.30864045703737	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCGATCGCTGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.26040319213	50.3046163514699	0.0249742368324119	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.56301829932	2006.56301829932
"healthy-3"	"2019-08-01-count-2:GAACTGTTCTCATGGA"	-0.200420777232009	8.3533897169861	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTTCTCATGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1954.9197225666	43.0858709395966	0.0220397136732702	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.99836648876	1940.99836648876
"healthy-3"	"2019-08-01-count-2:AACTTCTTCCACGGAC"	10.4192463355953	6.28084085071412	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTTCCACGGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.94830743108	44.1562618080472	0.0215612189271692	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2037.43727353087	2037.43727353087
"healthy-3"	"2019-08-01-count-4:TTTGTTGCATGAGTAA"	3.20921530303304	-6.92942287838133	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGTTGCATGAGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.16975524039	49.4409775830977	0.0199667157223224	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2469.76805743738	2469.76805743738
"healthy-3"	"2019-08-01-count-2:AGGTGTTAGACGCAGT"	10.4668060737545	6.1197209128174	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTAGACGCAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.44679889171	45.0167110064219	0.0244066193904165	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1838.02222668835	1838.02222668835
"healthy-3"	"2019-08-01-count-3:TAAGCCAAGACCTCAT"	-6.59712777558024	0.569370127561964	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	41	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCAAGACCTCAT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2601.4706412318	39.39463532654	0.0151432173410524	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2592.42228243206	2592.42228243206
"healthy-3"	"2019-08-01-count-3:TTCACGCTCTGTGCTC"	-1.54941628399547	8.76571748340455	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCTCTGTGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2294.88590443382	44.3685107002197	0.0193336455701339	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2289.09376419237	2289.09376419237
"healthy-3"	"2019-08-01-count-4:CGTAATGTCGTTCCTG"	-3.51684985581096	12.5935678252014	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAATGTCGTTCCTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2162.43519106913	44.2002450326257	0.0204400322447457	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2157.58511217197	2157.58511217197
"healthy-3"	"2019-08-01-count-3:AAGCGTTTCAGATTGC"	-4.02492318573649	13.1741838225159	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGTTTCAGATTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2362.38189803786	42.3123130410896	0.0179108691428059	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2354.71101641246	2354.71101641246
"healthy-3"	"2019-08-01-count-2:AGGTGTTCAATGGGTG"	-0.11140369895156	8.94899842822877	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTCAATGGGTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.70708444499	31.3120789840698	0.0169372851153811	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1840.1893298657	1840.1893298657
"healthy-3"	"2019-08-01-count-3:TCATACTTCTCAAAGC"	0.540416647761506	8.33433148944703	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATACTTCTCAAAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.98343743821	46.3012111021028	0.0237932195163265	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.51776090233	1940.51776090233
"healthy-3"	"2019-08-01-count-2:ACTATCTCAGCGGTTC"	-3.67623482170756	9.584596610907	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTCAGCGGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2178.45229220028	40.4509432155089	0.0185686615035543	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2175.10776181253	2175.10776181253
"healthy-3"	"2019-08-01-count-3:GCCAGGTTCACCTGTC"	10.8295694786007	6.51068065250245	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTTCACCTGTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.01735518348	40.6115066327951	0.0217055745208802	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1863.47951603641	1863.47951603641
"healthy-3"	"2019-08-01-count-4:CTTCTAACAACTCCCT"	11.0227533775264	6.66364047611085	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAACAACTCCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2125.43570056242	44.0867558538176	0.0207424556960964	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2119.03254677546	2119.03254677546
"healthy-3"	"2019-08-01-count-2:GAAGCGACATCACGGC"	-2.21443567696269	9.01077077472535	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCGACATCACGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.97102089271	46.3562831224408	0.0237362882636381	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1946.75371352626	1946.75371352626
"healthy-3"	"2019-08-01-count-2:AAGACAAGTAGTATAG"	3.85850801047627	-7.04905702984007	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAAGTAGTATAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.7235133717	44.7572310470684	0.0180492828356544	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2476.11260127649	2476.11260127649
"healthy-3"	"2019-08-01-count-4:TGAATGCTCGTAGTCA"	-3.88550553742107	12.4260873564514	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATGCTCGTAGTCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1863.41254051903	47.0603790625064	0.025254943840508	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1859.82803074932	1859.82803074932
"healthy-3"	"2019-08-01-count-4:TGACAGTAGACAAGCC"	-2.21534977379497	8.96881673419801	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTAGACAAGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.97438562664	42.8162201145317	0.0209066189572634	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.76706280405	2044.76706280405
"healthy-3"	"2019-08-01-count-3:GCCAGTGCATGTGCTA"	-1.04100141945537	8.29385945880739	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGCATGTGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.39829859707	41.2903743242075	0.0211593780490085	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1947.82362940406	1947.82362940406
"healthy-3"	"2019-08-01-count-2:CATAGACTCCCATTCG"	-3.32964334908183	9.57284448230592	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAGACTCCCATTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2105.98774242759	43.308362654466	0.02056439445585	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2101.37006520153	2101.37006520153
"healthy-3"	"2019-08-01-count-2:GAAGGACTCATTGCCC"	3.16099466857259	-6.63435604488524	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGACTCATTGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1859.03951469962	47.5649454006	0.0255857635216998	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1855.13032894207	1855.13032894207
"healthy-3"	"2019-08-01-count-4:GTTGTCCAGTAACGTA"	-1.90665946427043	8.6652040251526	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCAGTAACGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2148.72133923999	38.744992589951	0.0180316506763298	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2142.14237933371	2142.14237933371
"healthy-3"	"2019-08-01-count-2:GTTACAGGTCGTGGTC"	-3.45579443398173	-5.34983971035155	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGGTCGTGGTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2617.79433372897	48.6491119349842	0.0185840084181422	2394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2613.74674571709	2613.74674571709
"healthy-3"	"2019-08-01-count-3:CTAGACAAGGCTATCT"	-1.11432061615642	8.89729783618776	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAAGGCTATCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2082.16089749299	44.8352034185526	0.0215330157590299	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.75797365259	2075.75797365259
"healthy-3"	"2019-08-01-count-3:GCCATGGAGAAGAGCA"	-3.93018565598186	11.0450515517029	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGAAGAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1848.82034784427	40.7781308849805	0.0220562971045445	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.11721281468	1845.11721281468
"healthy-3"	"2019-08-01-count-2:AAGATAGAGAGGTTTA"	-0.406648318201858	8.21314809406129	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGATAGAGAGGTTTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2278.59987840866	43.7743611950014	0.019211078526684	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2275.33354990271	2275.33354990271
"healthy-3"	"2019-08-01-count-3:AGACAGGCATCTTAGG"	-1.00811992111858	8.32748601520387	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAGGCATCTTAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2025.21638708041	46.2133979186809	0.0228189926831982	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2015.75637196751	2015.75637196751
"healthy-3"	"2019-08-01-count-2:ACTATTCTCGCCACTT"	-2.55304012718852	9.63051412189332	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCTCGCCACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2111.60637853678	46.3864196109912	0.021967361001786	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2102.7131933767	2102.7131933767
"healthy-3"	"2019-08-01-count-2:GTTACCCAGTAGGCCA"	10.7607637840206	6.12291619861452	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCAGTAGGCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.09589387731	40.5202632270136	0.0206831443798387	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1944.96752892893	1944.96752892893
"healthy-3"	"2019-08-01-count-4:GGTTAACTCACTGAAC"	5.04167809066121	-8.81116773998412	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACTCACTGAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.9330986466	46.3135443888171	0.0172173592020259	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2685.81018492582	2685.81018492582
"healthy-3"	"2019-08-01-count-3:CTAGGTAGTCAGGAGT"	10.997991223901	5.53577849948732	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGGTAGTCAGGAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.33781014265	41.9549989192316	0.0223600455591959	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1870.20915058495	1870.20915058495
"healthy-3"	"2019-08-01-count-3:AAGTACCGTGATACCT"	4.13564981993977	-7.17628767406615	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCGTGATACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.28646768727	44.5740160891273	0.0167679505692654	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2655.88192957237	2655.88192957237
"healthy-3"	"2019-08-01-count-3:AGACCATTCTTCTGTA"	3.35364689406697	-5.51948168193968	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATTCTTCTGTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2973.08114462573	50.8919772475821	0.0171175877051242	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2967.44999466464	2967.44999466464
"healthy-3"	"2019-08-01-count-2:TGGGAGATCTCTGAGA"	-1.80012987080272	9.63744542682496	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGATCTCTGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.20226966478	39.5955530364554	0.0211831291236108	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1861.46730688833	1861.46730688833
"healthy-3"	"2019-08-01-count-3:AGACCCGCATCGATAC"	8.82266106185262	6.86076114261476	"2019-08-01-count-3"	"Control3"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGCATCGATAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.14672775881	39.6962604317778	0.0207817859512571	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1900.58944459064	1900.58944459064
"healthy-3"	"2019-08-01-count-2:GGTAGAGCACAACCGC"	10.0797983604366	7.76600740039674	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAGAGCACAACCGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.39391303062	40.538795254244	0.0194393946395147	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2084.10416566767	2084.10416566767
"healthy-3"	"2019-08-01-count-2:AGAGAATTCAGTAGGG"	-4.31352935257609	12.9552707442078	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAATTCAGTAGGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2707.37204017599	43.2678136005497	0.0159814805495801	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2694.24271401877	2694.24271401877
"healthy-3"	"2019-08-01-count-4:ACACAGTTCAAGATAG"	3.50035991248433	-6.51835110103758	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTTCAAGATAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.17329127886	50.1110383051445	0.0216072850155634	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2313.55849936864	2313.55849936864
"healthy-3"	"2019-08-01-count-2:TGGGCGTGTAACGTTC"	5.41308989104573	-9.4959345093933	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCGTGTAACGTTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.8637572994	49.7970845847472	0.0209155540429713	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2374.7305315557	2374.7305315557
"healthy-3"	"2019-08-01-count-4:GTTTGGACATGATGCT"	10.7617069679195	5.38242194736329	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGACATGATGCT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.60972974848	39.5546291536263	0.0211340155615359	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1868.5593475082	1868.5593475082
"healthy-3"	"2019-08-01-count-2:GAATAGATCGAGTACT"	-0.483912448317367	8.37538812244264	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATAGATCGAGTACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1834.34206466787	38.2722324694688	0.0208642832799009	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1820.09762041352	1820.09762041352
"healthy-3"	"2019-08-01-count-2:TGGGCTGAGAATCTAG"	-4.41188130798991	13.0277862318787	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGAGAATCTAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2226.63597784319	42.1072510286956	0.0189107027137334	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2221.95878033976	2221.95878033976
"healthy-3"	"2019-08-01-count-2:TCGGGACCAACATCGT"	4.58288921889607	-7.81954433834227	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACCAACATCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.72050808144	43.4562453055024	0.0191714175393789	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2261.18056734387	2261.18056734387
"healthy-3"	"2019-08-01-count-3:GCCCGAACAAGGTCTT"	-2.65638790550883	9.74737927997438	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAACAAGGTCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1956.18141128911	45.5076717132157	0.0232635232349062	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1954.40175790833	1954.40175790833
"healthy-3"	"2019-08-01-count-3:GCCCGAACATACCATG"	-3.25813947144206	9.92190930927125	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAACATACCATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.04576713571	47.1357072581622	0.02382943207953	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.69999105355	1974.69999105355
"healthy-3"	"2019-08-01-count-2:TTGATGGAGCTTGTTG"	3.33904423293416	-6.88822700893553	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGAGCTTGTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.5187000652	46.6688191027535	0.0202246764463641	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2307.5187000652	2307.5187000652
"healthy-3"	"2019-08-01-count-2:GTTAGTGCATGGGCAA"	-1.95214591446574	8.88671014392702	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGCATGGGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.04779395944	37.9873740306862	0.0193610849580922	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1954.46487072519	1954.46487072519
"healthy-3"	"2019-08-01-count-2:CCTTCAGAGTACGTCT"	4.82727970656697	-8.47812082683715	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGAGTACGTCT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.52818110253	46.4273079002893	0.0187620849319257	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2468.12309510258	2468.12309510258
"healthy-3"	"2019-08-01-count-2:GCCAACGCACATGACT"	-3.76052866402324	11.8216428526672	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGCACATGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1888.41206133295	47.5558130603838	0.0251829640543686	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1881.25429007657	1881.25429007657
"healthy-3"	"2019-08-01-count-2:CTCAGAAAGTGCACTT"	4.4967380958492	-8.14717295086058	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAAGTGCACTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.6889269256	41.3664776040919	0.0149300331777024	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2767.24186305337	2767.24186305337
"healthy-3"	"2019-08-01-count-4:CTTTCGGGTCCACTCT"	-4.01310668411906	13.1457834013733	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGGTCCACTCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2146.00053730878	37.7479365595861	0.0175899007960755	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2140.53541432722	2140.53541432722
"healthy-3"	"2019-08-01-count-4:CTTTCGGTCTCAGTCC"	2.90920724448506	-6.27641060268553	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGTCTCAGTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.54862399009	41.0554055780795	0.0162882815222536	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2517.58174184362	2517.58174184362
"healthy-3"	"2019-08-01-count-4:CACGAATCACCAAATC"	10.2283808189327	7.68975589359132	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATCACCAAATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2122.807251381	40.8759079751319	0.0192555908919851	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2116.23678526562	2116.23678526562
"healthy-3"	"2019-08-01-count-2:GTTATGGGTTTCGTTT"	-2.18481026116069	8.97646329486696	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTATGGGTTTCGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.95841125803	49.0028149610706	0.0245510200436415	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.61780914272	1989.61780914272
"healthy-3"	"2019-08-01-count-2:TGGTACAAGCCATCCG"	-7.77067599716838	0.487031556013502	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTACAAGCCATCCG"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3061.78439928598	46.4221126100094	0.0151617836385982	4417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3053.49280152398	3053.49280152398
"healthy-3"	"2019-08-01-count-4:AGAAGCGGTCAACATC"	-2.21973715248759	8.84260652149049	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAGCGGTCAACATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.63170432701	43.1727401977398	0.0224200401877098	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1925.63170432701	1925.63170432701
"healthy-3"	"2019-08-01-count-2:TCAATTCCAGTTGGTT"	-3.42706475678142	10.0392951735291	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCCAGTTGGTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2223.01331330325	47.2669362789418	0.0212625520486453	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2218.38210777441	2218.38210777441
"healthy-3"	"2019-08-01-count-4:TAACGACCACCCTTAC"	-1.26200137558635	9.3551921614441	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACGACCACCCTTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2155.36076629806	46.9844549514558	0.021798881971928	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2149.44183330416	2149.44183330416
"healthy-3"	"2019-08-01-count-4:AAGTACCAGAGCCGAT"	10.9792543846065	7.31636712634889	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCAGAGCCGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.87502883345	44.6154418080651	0.0205518241333495	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2160.82655718414	2160.82655718414
"healthy-3"	"2019-08-01-count-4:TTCACCGTCTTGGTCC"	11.2603374916012	6.20750806415407	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACCGTCTTGGTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.996178201	41.7968004327341	0.0205693302384744	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2029.38125599757	2029.38125599757
"healthy-3"	"2019-08-01-count-3:AATGACCTCAAACGTC"	10.9820991950924	6.77733132922975	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGACCTCAAACGTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2105.67921630539	48.2763060731656	0.0229267144298793	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2101.59903983778	2101.59903983778
"healthy-3"	"2019-08-01-count-4:AAGTACCTCGAGTTGT"	4.95920767363851	-8.50270941173705	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCTCGAGTTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2757.95725924016	41.468043281009	0.015035781697514	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2752.32059347181	2752.32059347181
"healthy-3"	"2019-08-01-count-2:ACTTAGGTCTGGCCTT"	4.08495678481404	-7.620228313562	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTAGGTCTGGCCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.93998779999	49.3882248646902	0.0187010023297926	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2634.25225030016	2634.25225030016
"healthy-3"	"2019-08-01-count-3:AGAGCCCGTGAACTAA"	-3.89036951485332	13.1217260130676	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCCCGTGAACTAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1852.04156187935	40.93053337045	0.0221002239976277	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1850.1861109371	1850.1861109371
"healthy-3"	"2019-08-01-count-4:GAAATGATCTACTGAG"	-2.91158447685893	9.22690103137819	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAATGATCTACTGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1795.11329081055	49.2450204809866	0.0274328203869243	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1788.96785552219	1788.96785552219
"healthy-3"	"2019-08-01-count-2:GGTGTCGCAAGGCGTA"	-2.65147648277934	9.86935041034547	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGCAAGGCGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2010.782826693	47.038601411467	0.0233931784114291	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.00415913012	2004.00415913012
"healthy-3"	"2019-08-01-count-3:AGATAGACACCATTCC"	-4.36983666840251	3.50910756671754	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATAGACACCATTCC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3048.3326108598	45.4853761888004	0.0149213953971942	4322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3038.96565975493	3038.96565975493
"healthy-3"	"2019-08-01-count-2:GTTCGCTTCTTACGTT"	-4.15998158875163	10.2412347563538	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCGCTTCTTACGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2287.04247882559	45.6346557786183	0.0199535671948043	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2283.91528764744	2283.91528764744
"healthy-3"	"2019-08-01-count-3:AGATAGACAGTTCACA"	-3.36334977570232	10.2444495924744	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATAGACAGTTCACA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2139.66102459779	50.1327156934318	0.0234302139998347	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2135.18042166261	2135.18042166261
"healthy-3"	"2019-08-01-count-3:AGATAGAGTGCGTGCT"	4.33994020995442	-7.65678884899291	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATAGAGTGCGTGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.0354645764	48.4419993258844	0.0222003721352386	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2182.0354645764	2182.0354645764
"healthy-3"	"2019-08-01-count-2:GTTCTATCAGAACATA"	-0.294560055167037	7.78969476306764	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATCAGAACATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2046.73347450725	38.7794252321093	0.01894698343244	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2042.57533456599	2042.57533456599
"healthy-3"	"2019-08-01-count-2:TGGTTAGTCGAACACT"	10.8343655067379	6.83601090991823	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGTCGAACACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.32105018955	47.1467118703349	0.0245898890358888	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1909.36445371633	1909.36445371633
"healthy-3"	"2019-08-01-count-3:AGATCCACAAGTGCTT"	-3.9659403366154	10.8245057829651	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCCACAAGTGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2013.36923603855	43.9609494902413	0.0218345193238066	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2011.69188603531	2011.69188603531
"healthy-3"	"2019-08-01-count-3:GTAGGTTTCGAACGGA"	-2.90526066246684	9.00680158222047	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGGTTTCGAACGGA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2124.06363964448	46.9344528167383	0.022096537947702	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2120.93812533572	2120.93812533572
"healthy-3"	"2019-08-01-count-2:ACTTCGCAGGCCCGTT"	-1.74753175202068	8.63683984363405	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCAGGCCCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.15361855403	47.3432424223491	0.0244143846930763	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.42531824674	1937.42531824674
"healthy-3"	"2019-08-01-count-2:ACTTCCGTCGCCCAGA"	-3.40480289879497	9.93650434100953	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCCGTCGCCCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.44603305549	49.6664038725508	0.0253342367171119	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.47409210711	1950.47409210711
"healthy-3"	"2019-08-01-count-2:GTTGAACAGAGTTGTA"	-2.35728726807292	9.47061536395875	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACAGAGTTGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.64593735378	43.5804537690544	0.0241624217184186	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1803.64593735378	1803.64593735378
"healthy-3"	"2019-08-01-count-2:AGTGATCCAACTGATC"	0.131665994494599	8.53358075702516	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGATCCAACTGATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.55348058307	42.9998944451262	0.0226487664871681	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1890.18622305372	1890.18622305372
"healthy-3"	"2019-08-01-count-2:CATGCCTCACAACGCC"	10.7078606086666	7.21970889652101	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTCACAACGCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2213.56390826371	44.5364345685001	0.0201197871008992	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2205.20466476166	2205.20466476166
"healthy-3"	"2019-08-01-count-3:GACCTTCGTTCCACGG"	-1.1434876722401	8.89256093585817	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCGTTCCACGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.31498582593	46.6354875108685	0.0229469781191008	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2023.01000318734	2023.01000318734
"healthy-3"	"2019-08-01-count-2:TCTAACTCATAGGTTC"	-3.82516107979472	10.7710647352966	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTAACTCATAGGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.22168173418	44.2676034786104	0.0228865201422626	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1928.31329842758	1928.31329842758
"healthy-3"	"2019-08-01-count-2:GGTTAACGTATAGCTC"	-2.06798587265666	9.24121472919313	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACGTATAGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2034.40664334324	40.5070417994511	0.0199109858061041	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2032.57335586661	2032.57335586661
"healthy-3"	"2019-08-01-count-2:TCTAACTGTTCGCGTG"	-3.91704402390178	10.6904229887756	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTAACTGTTCGCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.13430758522	43.5303337111632	0.0212848288494859	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.02736463372	2040.02736463372
"healthy-3"	"2019-08-01-count-3:TCCACGTCAGCTTTGA"	-0.368741939694244	8.71984574878541	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTCAGCTTTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2018.41801131208	44.471216673813	0.0220327089951522	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.81596276014	2016.81596276014
"healthy-3"	"2019-08-01-count-4:AATAGAGTCGCGTGAC"	0.482092847197694	9.25287435138551	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGTCGCGTGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.37510454414	41.4591239911453	0.0213225955702953	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.44719642967	1937.44719642967
"healthy-3"	"2019-08-01-count-2:ACTTTCACAGAGCTAG"	3.36593880233113	-7.09030582821044	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTCACAGAGCTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2148.31380654683	50.1691274612437	0.0233527929245518	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2144.0135394774	2144.0135394774
"healthy-3"	"2019-08-01-count-2:CGACAGCAGATTCGCT"	-1.48302874985393	8.81268403613893	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCAGATTCGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1846.92583599557	48.8682861036636	0.0264592574056021	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1837.72509142692	1837.72509142692
"healthy-3"	"2019-08-01-count-2:GTTGCGGTCCTTATGT"	-0.252618382603484	8.24351308429567	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCGGTCCTTATGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1977.69845524023	38.4760751766518	0.0194549755928176	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.1588956127	1976.1588956127
"healthy-3"	"2019-08-01-count-3:TGCGATAAGGTTGTTC"	2.80684747275655	-5.9790044060913	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGATAAGGTTGTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2490.05297075154	47.8398045594914	0.0192123642032614	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2488.0877236132	2488.0877236132
"healthy-3"	"2019-08-01-count-2:CGACAGCTCATGAGGG"	4.76561607894246	-8.36373426830443	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCTCATGAGGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.38289198822	45.1782532823939	0.0171559758437878	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2628.49441841347	2628.49441841347
"healthy-3"	"2019-08-01-count-2:GACCTTCGTGATATAG"	10.4655329185421	7.88156983936159	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCGTGATATAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.75165923251	42.6726324789839	0.0213817346870673	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1985.16160197228	1985.16160197228
"healthy-3"	"2019-08-01-count-3:TCCATCGAGGATCACG"	3.01119579848592	-6.28096821224364	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATCGAGGATCACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.05775252847	46.7864187522566	0.0183184654716358	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2551.74085548206	2551.74085548206
"healthy-3"	"2019-08-01-count-3:ATCGGCGCATCTGCGG"	-3.96352992478068	12.592822051886	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGCATCTGCGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1976.00769740944	48.0155440503631	0.0242992697413637	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1972.66857233713	1972.66857233713
"healthy-3"	"2019-08-01-count-3:ATCGGCGCATCCAATG"	2.65276350554768	-6.52103140270384	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGCATCCAATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.00834426282	50.1014591022943	0.0204829469285372	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2440.06014084343	2440.06014084343
"healthy-3"	"2019-08-01-count-3:TTGAACGTCTACTTCA"	2.60500158843343	-6.47648336803588	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAACGTCTACTTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2141.26398200516	44.999775679863	0.0210155198322271	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2141.26398200516	2141.26398200516
"healthy-3"	"2019-08-01-count-3:GCTACCTTCATCGCTC"	-2.00440202179607	9.29977986896364	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTTCATCGCTC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2558.3865089499	44.9962156807189	0.017587731768953	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2551.64386298464	2551.64386298464
"healthy-3"	"2019-08-01-count-3:CCTCAACGTCAGGCAA"	5.09671082076375	-8.62039186870726	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACGTCAGGCAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2792.31744495546	43.6925752490778	0.0156474240878349	2316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2789.81582162885	2789.81582162885
"healthy-3"	"2019-08-01-count-2:TCACGGGCAGACCTAT"	10.5973440605098	7.15308806979982	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGGGCAGACCTAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1969.5668214211	39.5998191769058	0.0201058520818976	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1961.37437297443	1961.37437297443
"healthy-3"	"2019-08-01-count-4:GAAGGGTTCCACCTGT"	-4.06798634949382	13.2307777174744	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGGTTCCACCTGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2333.52986805601	46.7107509062931	0.0200172072128677	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2324.44172301836	2324.44172301836
"healthy-3"	"2019-08-01-count-3:TCCCACAAGGCCTGAA"	2.98437799987141	-6.72691013729247	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCACAAGGCCTGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.48174185705	43.9124417653093	0.017373989706072	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2524.05564228013	2524.05564228013
"healthy-3"	"2019-08-01-count-3:AGCCACGCAAAGACTA"	-0.479673485190231	8.71104905689088	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGCAAAGACTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.89324028805	42.4547290724927	0.0217394009035694	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1948.03320014247	1948.03320014247
"healthy-3"	"2019-08-01-count-2:GTTTACTGTCCTTAAG"	2.98189463195149	-6.38706781780394	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTGTCCTTAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.11412704238	48.5637566667559	0.0214683052840711	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2258.85120003077	2258.85120003077
"healthy-3"	"2019-08-01-count-4:GAAGTAATCCGTGTAA"	4.48774399337117	-7.86588957225951	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGTAATCCGTGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2803.97364057744	43.5941251810557	0.0155472664044296	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2794.30152643504	2794.30152643504
"healthy-3"	"2019-08-01-count-3:CTCCATGCAATTTCTC"	4.30297913131062	-7.64597799694213	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGCAATTTCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2987.52005416835	41.9892391009877	0.0140548810852004	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2982.18940129897	2982.18940129897
"healthy-3"	"2019-08-01-count-4:TCCCACACACTAAACC"	3.35632028159444	-6.69537165081175	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACACACTAAACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.61475963136	43.6819407053111	0.0162228705569791	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2689.90045840295	2689.90045840295
"healthy-3"	"2019-08-01-count-3:AGCCACGTCACCGGTG"	4.91890539702718	-8.12404825603636	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGTCACCGGTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.14060099434	46.8418471732935	0.0188033735047298	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2484.74177625883	2484.74177625883
"healthy-3"	"2019-08-01-count-2:GACTCAAAGGCCCGTT"	-3.83101473274882	10.0345945128235	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCAAAGGCCCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.34443866127	44.4123094586648	0.0222468170314574	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.24887212021	1991.24887212021
"healthy-3"	"2019-08-01-count-4:GAATCACTCACAAGGG"	-2.38814411583598	9.10931680286256	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACTCACAAGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.54261261477	43.9794275922313	0.0211893638439088	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2070.39653930877	2070.39653930877
"healthy-3"	"2019-08-01-count-4:GAATCACTCCGAAGGA"	11.0237080055172	6.02258775317994	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACTCCGAAGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.23767260361	40.4345372776782	0.0213686355911319	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1886.96454411997	1886.96454411997
"healthy-3"	"2019-08-01-count-3:TGCTGAAAGAGGGCGA"	4.91306032714192	-8.05595877086791	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAAAGAGGGCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.09308719255	51.0491373266121	0.0215844093423018	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2361.22852104599	2361.22852104599
"healthy-3"	"2019-08-01-count-4:TACCCACCAATGCTCA"	-1.62115917626079	9.6042794951233	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCACCAATGCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1927.45334060538	48.605840280357	0.0252176482078112	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1923.90086569795	1923.90086569795
"healthy-3"	"2019-08-01-count-3:TTGCCTGCAGCTTTCC"	-0.222310255200225	8.12876794421998	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGCAGCTTTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.59523926133	44.5472372136811	0.0227328768314793	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1953.03185176461	1953.03185176461
"healthy-3"	"2019-08-01-count-4:TTCCTCTCACCAGCGT"	-3.86921344223674	-4.63946249401244	"2019-08-01-count-4"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTCACCAGCGT"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3298.68342130515	43.2471119774429	0.0131104160217751	4352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3291.35329855226	3291.35329855226
"healthy-3"	"2019-08-01-count-4:TGCAGGCTCGACCTAA"	-3.10773883286174	10.5210208662781	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGGCTCGACCTAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1956.93056585306	47.5786323719963	0.0243128873360184	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1951.52433627354	1951.52433627354
"healthy-3"	"2019-08-01-count-2:AGAAGTATCTCACTCG"	-7.25981507721599	3.29087398135988	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGTATCTCACTCG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2390.36538466252	45.7055994211329	0.0191207585728931	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2373.27425852499	2373.27425852499
"healthy-3"	"2019-08-01-count-2:CATTCTAGTAACGCGA"	4.74728359755818	-8.35376455700072	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCTAGTAACGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.57553458402	47.7526120831325	0.020025623592361	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2381.09967783458	2381.09967783458
"healthy-3"	"2019-08-01-count-4:AGATGAAAGAGTGTTA"	-2.01577315750774	10.4606532820496	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGAAAGAGTGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.48571477852	40.5036894980681	0.0214136904030549	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1884.50469343195	1884.50469343195
"healthy-3"	"2019-08-01-count-4:GACACGCAGAGTAACT"	-2.77247009697612	9.42115590656129	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCAGAGTAACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.63887709986	42.1611334344353	0.0197880240934228	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2125.85730405353	2125.85730405353
"healthy-3"	"2019-08-01-count-3:AGCGATTTCTCGAGTA"	5.48103680190389	-10.1046638718811	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTTCTCGAGTA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.07307404003	45.8253922218159	0.0174236193945076	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2620.29537331228	2620.29537331228
"healthy-3"	"2019-08-01-count-3:ATCTCTAGTCGTCAGC"	3.12305321273152	-6.89254715358885	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTAGTCGTCAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.52680778255	44.8674676716955	0.0198658114294188	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2255.98774159383	2255.98774159383
"healthy-3"	"2019-08-01-count-3:TCCGTGTCAATTTCGG"	-3.53968773308452	10.4150056608948	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGTGTCAATTTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.25025531342	48.1118457646268	0.0250419463219685	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.59980882436	1912.59980882436
"healthy-3"	"2019-08-01-count-4:GACATCAGTGAATGTA"	-2.54684029045756	9.7974586256775	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACATCAGTGAATGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1769.59137986388	48.0265714019862	0.0271399216499803	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1767.54354135089	1767.54354135089
"healthy-3"	"2019-08-01-count-2:TCAGGGCCAGCAGTGA"	1.05355169352834	-6.12406637584838	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCCAGCAGTGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2477.62071703408	51.8730325962355	0.0209366317611082	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2472.75089285328	2472.75089285328
"healthy-3"	"2019-08-01-count-2:ATAGACCTCTCAATCT"	2.57641663131062	-4.59015848552855	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCTCTCAATCT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2741.20960086178	42.3692965766293	0.0154564235304405	2827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2734.80277299065	2734.80277299065
"healthy-3"	"2019-08-01-count-3:GTCATTTAGTAGACAT"	-3.5166896385258	10.2965326079163	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATTTAGTAGACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.74644347682	49.103849236379	0.0247905780157235	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.15561194899	1974.15561194899
"healthy-3"	"2019-08-01-count-3:TACTTGTAGCATGATA"	10.664887090295	7.23850820148317	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTAGCATGATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2250.43119500151	46.7630684331101	0.0207796037208232	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2245.4646840904	2245.4646840904
"healthy-3"	"2019-08-01-count-2:AATGGCTTCTCGTCGT"	10.731742520898	6.49542806232301	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTTCTCGTCGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1926.10440167062	44.6420664336332	0.0231773866436901	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1919.64908423317	1919.64908423317
"healthy-3"	"2019-08-01-count-3:ACAGAAAGTCAACATC"	-3.73999534073527	9.75498006427614	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAAGTCAACATC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2034.72159392756	38.8213389470558	0.0190794352715941	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.20298426547	2031.20298426547
"healthy-3"	"2019-08-01-count-3:AGCGCTGTCCTCACTG"	2.73447408255879	-6.61572124874266	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGTCCTCACTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.19904264883	46.8698891495038	0.0197413478430235	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2369.59756577652	2369.59756577652
"healthy-3"	"2019-08-01-count-4:TACCTGCTCAGACCCG"	-4.05029616776164	10.9434308775696	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTGCTCAGACCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2179.17880371184	43.6210271100927	0.0200171858480782	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2169.570797741	2169.570797741
"healthy-3"	"2019-08-01-count-2:CGATCGGCACACGCCA"	4.18475737151448	-8.0277252427307	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGCACACGCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.96609788379	45.4109324101168	0.0179705348829754	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2525.7865962608	2525.7865962608
"healthy-3"	"2019-08-01-count-3:TGGAGAGAGTTGCCCG"	-3.93355236473735	10.9545783766541	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGAGAGTTGCCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.24220541778	50.8101232646477	0.0260132220795321	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1948.2399117481	1948.2399117481
"healthy-3"	"2019-08-01-count-2:CATTGCCTCTCACCCA"	-0.307470659643966	8.56868550861207	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCTCTCACCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2068.66426961953	39.9817251750753	0.0193273146166095	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2064.32940066679	2064.32940066679
"healthy-3"	"2019-08-01-count-2:ATAGGCTCAATGGCAG"	2.73805775222127	-6.51684763347777	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGGCTCAATGGCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.74181291242	44.5005004918139	0.0187865559045878	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2366.28031431319	2366.28031431319
"healthy-3"	"2019-08-01-count-4:CTCAAGACAAGGCTTT"	-0.178776319057304	8.15995404804078	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAAGACAAGGCTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2149.273189843	44.3240599963449	0.0206228134263298	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2140.43310587931	2140.43310587931
"healthy-3"	"2019-08-01-count-3:GGAACCCCAGAAGCTG"	0.303722669451874	7.73213241184083	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAACCCCAGAAGCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.53311003819	40.4236254420131	0.0221313400889667	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1825.31659303009	1825.31659303009
"healthy-3"	"2019-08-01-count-2:CATTGTTTCTGCACCT"	-0.878074983984786	8.20110700214235	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGTTTCTGCACCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2079.2790359591	46.0185586947725	0.0221319783919938	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2077.63877921547	2077.63877921547
"healthy-3"	"2019-08-01-count-4:TTCGCTGTCGAAGCAG"	-3.85958419266399	12.1524810560974	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGTCGAAGCAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2030.45680980867	47.0737063835178	0.0231838008846657	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2025.53159193993	2025.53159193993
"healthy-3"	"2019-08-01-count-2:CATTTCAAGGTGAGAA"	-0.55203471604045	8.30740830982057	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCAAGGTGAGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2202.89733490105	39.1100704883029	0.0177539233756709	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2198.10038677307	2198.10038677307
"healthy-3"	"2019-08-01-count-2:CATTTCAAGTTACGAA"	3.6558469730312	-6.40835430538329	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCAAGTTACGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.54600961179	45.0041646935414	0.016708147747596	2271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2691.10692763891	2691.10692763891
"healthy-3"	"2019-08-01-count-2:GTAGCTACACCGGCTA"	-4.02670607987102	9.75301835620729	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTACACCGGCTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2722.12464054634	40.620645100579	0.0149224045422205	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2713.48010109128	2713.48010109128
"healthy-3"	"2019-08-01-count-2:CATTTCACAGTCACGC"	-0.271757106215316	8.61319730365602	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCACAGTCACGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.42915669442	41.6892555533075	0.0205120337975823	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2032.42915669442	2032.42915669442
"healthy-3"	"2019-08-01-count-2:TGTTACTGTCCGCAGT"	11.1285253959591	6.24752376163331	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTACTGTCCGCAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.70607980843	45.853935551678	0.022101412820804	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2070.55510419993	2070.55510419993
"healthy-3"	"2019-08-01-count-4:CCTCAACTCCGATCGG"	3.91083445128743	-7.69161512767943	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAACTCCGATCGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.5444955686	47.4893212744026	0.0188708450647413	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2509.8440505913	2509.8440505913
"healthy-3"	"2019-08-01-count-4:TACGGTACACTCAGAT"	-2.5639856857365	8.88140676105348	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGTACACTCAGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1883.69622300476	45.1015774662488	0.0239431267714204	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1877.99755764083	1877.99755764083
"healthy-3"	"2019-08-01-count-3:TCCTGCAAGTGGAAAG"	3.26298441466634	-6.36369421398314	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAAGTGGAAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2704.46432925037	48.9915849583014	0.0181150789930666	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2699.59933435254	2699.59933435254
"healthy-3"	"2019-08-01-count-2:GAGACCCAGGACAGCT"	5.6629601913387	-10.152014755365	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACCCAGGACAGCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.1631192846	45.3128962526924	0.0172281695840285	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2621.95677180411	2621.95677180411
"healthy-3"	"2019-08-01-count-4:TTCTAACCATCGATGT"	-0.714905242354232	8.42908380115358	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAACCATCGATGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2012.11280977354	40.040511958039	0.0198997351259572	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.97729238466	2006.97729238466
"healthy-3"	"2019-08-01-count-2:TAAGTCGAGAAGGCTC"	4.19392218169515	-8.12691404735716	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGAGAAGGCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.93436325613	47.7295536933312	0.0208523033510814	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2286.59428833764	2286.59428833764
"healthy-3"	"2019-08-01-count-2:AGACTCACATGGAAGC"	5.52155127105061	-10.0536213151184	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACTCACATGGAAGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.73268627489	43.1329411040558	0.0169966448150101	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2531.92649236119	2531.92649236119
"healthy-3"	"2019-08-01-count-3:AGGAAATAGGTGATAT"	-7.31888709488566	3.20115349376527	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATAGGTGATAT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2504.26594874253	46.3034701039439	0.0184898373621996	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2494.12190281479	2494.12190281479
"healthy-3"	"2019-08-01-count-3:AGGAAATCAATAGGAT"	-1.91417560997661	8.90764901721803	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATCAATAGGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.83798917832	44.8583103793936	0.0224421942259732	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1997.15770223805	1997.15770223805
"healthy-3"	"2019-08-01-count-4:TACGTCCGTCGTGGTC"	-2.98342452469524	9.64694879138795	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCGTCGTGGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.08909837387	42.5538397928216	0.0210549054106816	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2015.98184629955	2015.98184629955
"healthy-3"	"2019-08-01-count-4:TTCTAGTTCCGGTAGC"	5.02943958815877	-8.78388502514037	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAGTTCCGGTAGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.44932164216	46.2853201664385	0.0183058128831221	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2520.12827018272	2520.12827018272
"healthy-3"	"2019-08-01-count-3:ACATGCAGTTCAGCGC"	10.7875639396602	7.12653729999391	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATGCAGTTCAGCGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1974.27563576824	43.0184791320934	0.0217895000843455	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1965.38015308018	1965.38015308018
"healthy-3"	"2019-08-01-count-3:TAGCACACATGACACT"	10.9427868324215	6.6643872031006	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACACATGACACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.07458682842	41.7949811748028	0.0197792266469563	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2103.17258053455	2103.17258053455
"healthy-3"	"2019-08-01-count-2:TTCATGTCACAAAGCG"	4.84529318389241	-8.31616117870482	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATGTCACAAAGCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.82606063519	46.8130181698791	0.0176998475879493	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2642.89559563877	2642.89559563877
"healthy-3"	"2019-08-01-count-2:AGGACGACAGAACCGA"	11.2430807548458	5.95421073520509	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGACAGAACCGA"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.34148482845	40.4378956568844	0.0207763622016456	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.95593239051	1938.95593239051
"healthy-3"	"2019-08-01-count-3:AGGAATACACACTGGC"	-0.101142967969734	8.02480790698854	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAATACACACTGGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2034.09268154467	38.1341595726295	0.0187475034538106	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2028.06440455722	2028.06440455722
"healthy-3"	"2019-08-01-count-2:AGAGAGCAGGCTGTAG"	0.0370330662349283	7.58160684192506	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCAGGCTGTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2041.19248459715	41.7668674208919	0.0204619935337138	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.55031439192	2030.55031439192
"healthy-3"	"2019-08-01-count-2:ATCATTCTCGTTCCCA"	4.41707005080525	-7.64075281536254	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCATTCTCGTTCCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.58778897984	44.4470088742315	0.0156306089956088	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2842.87708772354	2842.87708772354
"healthy-3"	"2019-08-01-count-2:GTAGTACGTGAGAACC"	2.24954380568807	-4.50138189708861	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACGTGAGAACC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.18321921268	43.0512136321611	0.0177298044445428	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2423.67451582947	2423.67451582947
"healthy-3"	"2019-08-01-count-4:TTCTGTATCCGCGGAT"	-3.09589491310771	10.3300103911194	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTGTATCCGCGGAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1927.85038445905	48.5130710658223	0.0251643340463035	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.98365060625	1921.98365060625
"healthy-3"	"2019-08-01-count-4:GACTATGTCGATCCCT"	-4.05344567719157	11.3481445082459	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGTCGATCCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2114.01133885114	45.1844920811052	0.0213738172784167	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2107.54419681113	2107.54419681113
"healthy-3"	"2019-08-01-count-2:AGAGAGCTCGAAGTGG"	-0.79339043322261	9.24446008289186	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCTCGAAGTGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2104.51746772773	41.3110592898136	0.0196297060600868	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2095.5317906044	2095.5317906044
"healthy-3"	"2019-08-01-count-2:GTAGTACTCTCACCCA"	10.4387394386226	7.58343789661256	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGTACTCTCACCCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1802.90458653902	37.4201387348672	0.0207554737029659	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1793.86763062771	1793.86763062771
"healthy-3"	"2019-08-01-count-2:TGTTGGAGTCCACACG"	4.25935091552083	-8.26686003124388	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGAGTCCACACG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.30402092425	42.7008636902879	0.0179091522371109	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2383.10615575269	2383.10615575269
"healthy-3"	"2019-08-01-count-2:CCACAAAGTCACTACA"	-0.482256452471572	8.21045205676881	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAAGTCACTACA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2063.1221525469	39.3630277238127	0.0190793490706401	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2054.61654181729	2054.61654181729
"healthy-3"	"2019-08-01-count-2:AGAGCCCAGTACTGGG"	4.97720350798909	-7.94884684002074	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCAGTACTGGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.16652881058	44.5026732517812	0.0160533910171967	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2768.78172454853	2768.78172454853
"healthy-3"	"2019-08-01-count-3:TCGAACATCAATGTCG"	-4.11471066895183	-5.34676601802977	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAACATCAATGTCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2267.59635828802	53.5819142921556	0.023629388050618	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2264.02816591073	2264.02816591073
"healthy-3"	"2019-08-01-count-2:CCACCATAGCGCTGAA"	2.55561222609822	-4.41768696224364	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATAGCGCTGAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2694.27307643606	39.2606594422372	0.0145718931705952	2760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2689.61426050052	2689.61426050052
"healthy-3"	"2019-08-01-count-2:CACATGATCCGCATAA"	5.54557241973226	-10.1694555512634	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGATCCGCATAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.76215367144	42.4771750658935	0.016731451193435	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2532.42279499766	2532.42279499766
"healthy-3"	"2019-08-01-count-4:TGCTTGCGTGTTTCTT"	2.64940418776814	-4.50991966640624	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTGCGTGTTTCTT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2796.39300228544	39.6136376481575	0.0141659765332634	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2791.41719203579	2791.41719203579
"healthy-3"	"2019-08-01-count-2:TGTTTGTTCAAAGAAC"	3.8858081298763	-6.91870739376219	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTTGTTCAAAGAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.27201090869	48.5170023870615	0.0197683884147374	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2447.06388077735	2447.06388077735
"healthy-3"	"2019-08-01-count-3:GTGACGCAGCAGGGAG"	4.08062376555745	-6.87664797222289	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCAGCAGGGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.66799948292	44.076839641238	0.0177181358808329	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2483.88824326718	2483.88824326718
"healthy-3"	"2019-08-01-count-2:TACATTCAGAGTAACT"	-0.960191587836105	8.78564355457155	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACATTCAGAGTAACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2080.29077407936	43.2630971688076	0.0207966586728501	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.22517927845	2075.22517927845
"healthy-3"	"2019-08-01-count-3:TTTACCATCGTCACCT"	-1.50445232811626	8.65928742969362	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCATCGTCACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.95572146681	46.0496980930608	0.0246921133638723	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1863.125705562	1863.125705562
"healthy-3"	"2019-08-01-count-2:CCACGAGAGCAGGCTA"	-4.2293737930363	10.7739066847595	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGAGAGCAGGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2172.33546540483	42.0231574490156	0.0193446905960191	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2167.65215252813	2167.65215252813
"healthy-3"	"2019-08-01-count-2:ACAGAAACAGATAAAC"	-1.21553168717082	8.77756974780885	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAACAGATAAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1984.19476491856	50.2618704670349	0.0253311173659395	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1984.19476491856	1984.19476491856
"healthy-3"	"2019-08-01-count-4:CTCAGTCTCGAGTACT"	-7.16880546036418	3.30684397304384	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCTCGAGTACT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2637.15128271344	44.7359626115032	0.016963745274967	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2620.21917798728	2620.21917798728
"healthy-3"	"2019-08-01-count-4:GACTTCCCATCGATGT"	-2.68537507477458	8.82998654926149	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCCATCGATGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2252.25868585561	39.2311151207706	0.0174185653571438	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2245.08417603127	2245.08417603127
"healthy-3"	"2019-08-01-count-4:ACAGCCGAGGTCGCCT"	-2.1164759201115	8.64805123889772	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGCCGAGGTCGCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.20446708079	52.1418222861145	0.0266955268457093	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1946.35126372385	1946.35126372385
"healthy-3"	"2019-08-01-count-3:CTGCAGGCAAGATGTA"	-3.94735107842143	10.178400970343	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCAGGCAAGATGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2141.9250094868	46.8019190994187	0.0218504004071703	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2139.14943020038	2139.14943020038
"healthy-3"	"2019-08-01-count-4:TTGACCCGTCGATTTG"	-2.47911129418071	9.92341992938844	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGACCCGTCGATTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1947.89499174247	50.814231806183	0.0260867408261714	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.91129486257	1937.91129486257
"healthy-3"	"2019-08-01-count-4:TTGAGTGTCTCTTGCG"	5.15011181411092	-8.76407339489134	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAGTGTCTCTTGCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.16695316486	45.7651657869664	0.0178898276089243	2117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2550.07837870694	2550.07837870694
"healthy-3"	"2019-08-01-count-4:ACAGGGATCAATGTCG"	-4.36636958542522	10.6444730528626	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGATCAATGTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2090.43220462768	41.5473680350283	0.0198750133790768	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.08314837034	2084.08314837034
"healthy-3"	"2019-08-01-count-2:AGATCCATCGCAATTG"	10.9605308967525	6.3412875899109	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCCATCGCAATTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.33641021197	48.0040463127772	0.0254348117553593	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1876.39041726425	1876.39041726425
"healthy-3"	"2019-08-01-count-4:TAGCACACATCTGGGC"	-3.72539864006694	3.37094996059266	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGCACACATCTGGGC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3053.54716644038	45.8245422677065	0.0150069868811379	5206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3044.74607695892	3044.74607695892
"healthy-3"	"2019-08-01-count-4:GACTTCCTCTAATTCC"	5.06682457503621	-8.589963935968	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCTCTAATTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2867.13585065066	43.3518661862754	0.0151202693016577	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2864.8369050482	2864.8369050482
"healthy-3"	"2019-08-01-count-4:ACATCCCCATCGAACT"	4.36330284652059	-7.79918386852416	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCCCCATCGAACT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.22494268641	43.0155913836316	0.0160732346139978	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2668.7223674475	2668.7223674475
"healthy-3"	"2019-08-01-count-3:AGGGAGTCATCGTGCG"	-0.109930078417617	8.00992057407228	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTCATCGTGCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1800.58354764256	38.4364083847198	0.0213466397796665	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1786.50291959468	1786.50291959468
"healthy-3"	"2019-08-01-count-4:ATGGTTGCAAGTGGGT"	5.3192101913387	-10.0122356644836	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGCAAGTGGGT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.86818431406	47.7382139808226	0.0188029509667987	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2535.45723862488	2535.45723862488
"healthy-3"	"2019-08-01-count-4:TTGATGGCAATGCTCA"	2.56080188330953	-6.30032160198363	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGATGGCAATGCTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.57003982326	50.4017114308975	0.0188307089599739	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2668.3133343231	2668.3133343231
"healthy-3"	"2019-08-01-count-2:TTACCATCATGTTTGG"	-4.37661300125774	12.4902429350647	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATCATGTTTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2306.83299227589	38.9693579148323	0.0168930122142851	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2298.33294472168	2298.33294472168
"healthy-3"	"2019-08-01-count-2:AGATGAAGTTTGTTCT"	-3.08952842178996	9.41932294452516	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATGAAGTTTGTTCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2093.63497135561	43.7774501519664	0.0209097816720271	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.45163368291	2085.45163368291
"healthy-3"	"2019-08-01-count-2:TCATTACAGTCATTGC"	-2.35143599930461	10.2832956084046	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACAGTCATTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.10249917477	46.4998328369764	0.0236147345587465	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.69979648177	1961.69979648177
"healthy-3"	"2019-08-01-count-4:GAGAAATTCTTCGATT"	-3.60339079323466	10.1559095152649	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATTCTTCGATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2007.34799360533	44.3883336299935	0.0221129240029125	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.86589675876	1996.86589675876
"healthy-3"	"2019-08-01-count-4:TTGCATTAGCCTGGAA"	-0.0651331273024857	8.85853765094606	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTAGCCTGGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2049.40205264489	42.0511854990037	0.0205187583591681	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2047.80928419916	2047.80928419916
"healthy-3"	"2019-08-01-count-2:GAGGGATCAACTCATG"	10.6180473762447	6.00555799091188	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGATCAACTCATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.4732998081	42.2707246876647	0.0219762471836141	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1915.91246728109	1915.91246728109
"healthy-3"	"2019-08-01-count-2:GAGGCCTTCTTCTGGC"	11.1389280754024	5.74483440006105	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCTTCTGGC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1847.21253429084	45.8620953882048	0.0248277307222861	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1847.21253429084	1847.21253429084
"healthy-3"	"2019-08-01-count-2:AGCATCAGTTAATCGC"	0.0920918035203635	7.9801945456299	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCATCAGTTAATCGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.42795274336	36.902235410487	0.0192456959635376	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.28456215507	1909.28456215507
"healthy-3"	"2019-08-01-count-4:ACATTTCCAGTAACAA"	-4.1208270591801	13.1518125304016	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATTTCCAGTAACAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2178.25325764803	44.829562112356	0.0205805096147364	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2173.01027425018	2173.01027425018
"healthy-3"	"2019-08-01-count-4:CATACTTGTGTGCTTA"	10.4230877357418	6.75211618030397	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACTTGTGTGCTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.60782696366	45.2087880031294	0.0229648523103042	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1959.82131195458	1959.82131195458
"healthy-3"	"2019-08-01-count-1:TGGGTTAGTCGAGATG"	-2.07698545876201	8.51990220630494	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGGTTAGTCGAGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2111.7960386357	47.4223784348133	0.0224559462974701	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2097.62314194105	2097.62314194105
"healthy-3"	"2019-08-01-count-4:TAGGTTGAGCCAAGTG"	5.47525515136067	-9.59575941478881	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTTGAGCCAAGTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.94710608607	43.2497590758043	0.0180587533502922	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2386.56601954425	2386.56601954425
"healthy-3"	"2019-08-01-count-4:TTGCCTGCATAGAGGC"	10.6483456092769	7.20733449542848	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCCTGCATAGAGGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2211.5378833085	45.2033907815452	0.0204397994367251	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2203.37992340677	2203.37992340677
"healthy-3"	"2019-08-01-count-2:TCATTCAGTGCACGCT"	-2.7029746574467	9.4406413801941	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCAGTGCACGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.41898490656	47.5055427122944	0.0233623975505852	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.22248584258	2030.22248584258
"healthy-3"	"2019-08-01-count-3:ACCGTTCGTACGAGCA"	-3.05283985558208	10.7802209624085	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCGTACGAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1646.23173567442	44.8081031412058	0.0272185878635422	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1642.06320277	1642.06320277
"healthy-3"	"2019-08-01-count-3:GTGCGTGCATCGCCTT"	2.92500938948933	-6.84864904796752	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCGTGCATCGCCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.8125479864	49.0381632738364	0.0207278312542446	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2360.63688071045	2360.63688071045
"healthy-3"	"2019-08-01-count-4:CCTGCATTCAACGCTA"	-1.50456450405772	8.72108552539674	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATTCAACGCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2199.46327323541	44.904074611732	0.0204159238111205	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2196.85745889474	2196.85745889474
"healthy-3"	"2019-08-01-count-2:GTCATTTGTTGATGTC"	-7.90612969818767	0.492527372482695	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATTTGTTGATGTC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3058.7454181231	43.3849621027815	0.0141839075085246	4045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3050.70566063949	3050.70566063949
"healthy-3"	"2019-08-01-count-2:TTACGTTCACCGGCTA"	5.04710926589314	-8.66590597545775	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTCACCGGCTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2788.58723874249	43.7320285371576	0.0156825032868179	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2786.19646324813	2786.19646324813
"healthy-3"	"2019-08-01-count-2:TACGCTCCACGCTATA"	10.8515593009884	6.58147761905519	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCCACGCTATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2146.35749769731	41.018074131739	0.0191105508638448	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2136.68595428771	2136.68595428771
"healthy-3"	"2019-08-01-count-4:TTGCTGCCACTGAGTT"	-2.49236045303996	9.01517770374147	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCCACTGAGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.84399361414	41.3266144383463	0.0201412069177604	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2045.18430698147	2045.18430698147
"healthy-3"	"2019-08-01-count-2:TACGCTCTCTGCGGGT"	4.85710253295247	-7.900426410791	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCTCTGCGGGT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2710.77080945106	42.2619009340363	0.0155903630018041	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2705.40227952002	2705.40227952002
"healthy-3"	"2019-08-01-count-3:GATAGCTTCCCGTTGT"	-2.14118943634685	8.91499040210573	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTTCCCGTTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.46385407901	45.5630729393348	0.0215686876020888	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2109.45668057017	2109.45668057017
"healthy-3"	"2019-08-01-count-4:GAGATGGGTAATCAAG"	-2.7724281353062	9.47733304584352	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGATGGGTAATCAAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2069.95459840177	40.6423118230661	0.019634397708262	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2066.56791966285	2066.56791966285
"healthy-3"	"2019-08-01-count-2:TTACTGTAGAAACTCA"	-2.82146773758586	9.89463136279909	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACTGTAGAAACTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.0178448775	47.8730483253103	0.0241903065448476	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1974.35088222534	1974.35088222534
"healthy-3"	"2019-08-01-count-3:CGCCATTCACACCTGG"	-4.20307288590129	13.2556171187195	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCATTCACACCTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2586.15797629354	43.8436056085824	0.0169531815188718	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2580.19801926191	2580.19801926191
"healthy-3"	"2019-08-01-count-4:TTGGATGAGACGCTCC"	-4.10508857193645	10.6463737257752	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGATGAGACGCTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.36514465315	46.5964990098748	0.0229159524704174	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.11735690069	2030.11735690069
"healthy-3"	"2019-08-01-count-2:GGAGATGTCAGCATTG"	-0.385555992752868	8.96997449481813	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGATGTCAGCATTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1992.24745385946	39.9279202543844	0.0200416470238346	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1984.70305473747	1984.70305473747
"healthy-3"	"2019-08-01-count-2:ATCGTCCTCCTGTAGA"	3.1402813392574	-6.89586450969847	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCTCCTGTAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.23902734142	50.2367877909622	0.0229262016439683	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2186.46103315781	2186.46103315781
"healthy-3"	"2019-08-01-count-2:TACGGTAGTGAGACGT"	-3.03947935524638	9.9307012327942	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGTAGTGAGACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.24365742017	46.0849129693203	0.0241504342436145	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1903.00931032644	1903.00931032644
"healthy-3"	"2019-08-01-count-4:TCGGATATCAGAACCT"	-1.8199294609135	9.34260938251344	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGATATCAGAACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2034.11453129586	50.2007381920231	0.0246794059133151	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.68005151346	2027.68005151346
"healthy-3"	"2019-08-01-count-3:GATCAGTTCGATACAC"	0.390468527644318	7.79232785785524	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCAGTTCGATACAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.34537555782	44.2065772834817	0.0227476689627506	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1934.91666901003	1934.91666901003
"healthy-3"	"2019-08-01-count-2:TGAGCGCTCTAGACAC"	4.48977961119954	-8.64152243053588	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCGCTCTAGACAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.47821038074	45.1413094481729	0.0202021703494174	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2229.53609051161	2229.53609051161
"healthy-3"	"2019-08-01-count-3:CTGTACCAGAGCTGAC"	-4.04946074906047	10.5457801588806	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCAGAGCTGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2245.44263493792	47.5965972430239	0.021196977603634	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2239.08597811604	2239.08597811604
"healthy-3"	"2019-08-01-count-3:CGGAACCTCGTTGTTT"	0.736085494130295	12.7443408736023	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAACCTCGTTGTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1932.2704867291	44.0477163740469	0.0227958335422334	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1924.96373853128	1924.96373853128
"healthy-3"	"2019-08-01-count-2:CCCGGAAAGGCTCAAG"	-3.59700999680217	13.294500327948	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGGAAAGGCTCAAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2248.79749604344	47.9568164105731	0.0213255379797197	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2245.69969004864	2245.69969004864
"healthy-3"	"2019-08-01-count-2:CCCGGAAAGAGCAGAA"	-4.36137280884441	10.9963006743225	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGGAAAGAGCAGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.7921053459	47.7752268188539	0.0233301157349583	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.30587807757	2043.30587807757
"healthy-3"	"2019-08-01-count-2:TCCACGTCACTGGAAG"	-2.44379220429118	9.41564843738405	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACGTCACTGGAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.17118458768	44.1533900362745	0.0237617450978135	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1850.49268786429	1850.49268786429
"healthy-3"	"2019-08-01-count-3:ATTCAGGTCGCCTCTA"	-4.82869944992717	3.53653690898744	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCAGGTCGCCTCTA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2807.51088771734	45.0625700178826	0.0160507195947229	3193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2793.09562515925	2793.09562515925
"healthy-3"	"2019-08-01-count-2:GAGTTACCAGATCACT"	4.46390738066976	-8.36627390300902	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTACCAGATCACT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.95888822831	48.4245946430845	0.0205279519218131	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2351.96288023107	2351.96288023107
"healthy-3"	"2019-08-01-count-2:GAGTTACTCCTTGAAG"	-2.4539934200352	8.71735379779664	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTACTCCTTGAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.24674122598	44.3334544597395	0.0214768194006736	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.88043514256	2058.88043514256
"healthy-3"	"2019-08-01-count-2:GAGTTGTAGCCTCTGG"	-1.80028579655345	8.93834016406862	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTGTAGCCTCTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.15995271144	53.1907939899633	0.0270669030867299	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.8092809895	1961.8092809895
"healthy-3"	"2019-08-01-count-2:TACTTACAGACAGTCG"	3.044370551675	-7.04665138637694	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACAGACAGTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2113.59886473726	49.516054733551	0.0234273662612448	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2112.201120318	2112.201120318
"healthy-3"	"2019-08-01-count-2:TACTTACCAACCCTAA"	11.1850239234859	4.51683280551759	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTACCAACCCTAA"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1690.98228234542	48.6110870322691	0.0287472479988641	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1672.14848414419	1672.14848414419
"healthy-3"	"2019-08-01-count-4:CTCTCGAAGGCTTAAA"	2.8015796142513	-6.09647848522338	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCGAAGGCTTAAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.95050981515	45.5806578435446	0.0173247872483725	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2626.3150064461	2626.3150064461
"healthy-3"	"2019-08-01-count-2:TCCATGCAGACGCCAA"	-3.57393393936809	13.1906528242859	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCAGACGCCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2195.74620824856	48.8292001933515	0.0222380892700255	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2190.28384080197	2190.28384080197
"healthy-3"	"2019-08-01-count-2:CCCTAACGTTGGGAAC"	-2.03513632240947	8.64944932544557	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACGTTGGGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2210.46105756814	40.8927215635456	0.0184996344647366	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2203.21251246743	2203.21251246743
"healthy-3"	"2019-08-01-count-2:CCCTAACGTTCCATTT"	4.09896578368489	-7.8898177376953	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACGTTCCATTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.77623948499	50.0309095734746	0.0197689976667616	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2524.92928820733	2524.92928820733
"healthy-3"	"2019-08-01-count-3:TCGTCCAAGGCAATGC"	0.506476868956727	8.94451997363893	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTCCAAGGCAATGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1779.45925847703	33.20643832032	0.0186609713946135	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1774.63273759033	1774.63273759033
"healthy-3"	"2019-08-01-count-4:TGGTGATCATGTCAGT"	-2.61966262283977	9.5738954314026	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTGATCATGTCAGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1991.12644218787	44.2847372200347	0.0222410472191682	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.39837374989	1989.39837374989
"healthy-3"	"2019-08-01-count-4:ACCTGAAGTACCTATG"	-0.117393578321296	8.53038117969362	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAAGTACCTATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.7668103692	41.6801582407164	0.0206361239459606	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.10420172724	2016.10420172724
"healthy-3"	"2019-08-01-count-3:GGGACCTGTAGTTACC"	-5.58132348480876	-5.45700504696044	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTGTAGTTACC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3087.16536742337	43.6232433391279	0.0141305172050233	3866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3084.61083693533	3084.61083693533
"healthy-3"	"2019-08-01-count-2:GATAGAAAGACCCTTA"	3.04049768027608	-5.24618675624999	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGAAAGACCCTTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3030.77120956629	43.4752490695097	0.0143446159618664	3019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3024.02645062264	3024.02645062264
"healthy-3"	"2019-08-01-count-3:GGGACTCAGGCTCCCA"	-4.26338849487956	12.2855224379334	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACTCAGGCTCCCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2014.7437996947	45.5341182594977	0.0226004508694344	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2008.0842791098	2008.0842791098
"healthy-3"	"2019-08-01-count-3:AGTAACCGTTGCATCA"	2.50219525870625	-3.99050714885863	"2019-08-01-count-3"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCGTTGCATCA"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2797.71266895098	40.3910680641631	0.0144371752369081	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2788.88705630366	2788.88705630366
"healthy-3"	"2019-08-01-count-2:GATAGCTAGGTGGCTA"	4.38925661620442	-7.96828176891478	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGCTAGGTGGCTA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.63977160839	42.3531669757897	0.0159604055640601	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2648.67849315361	2648.67849315361
"healthy-3"	"2019-08-01-count-2:TTAGTCTTCTCATTGT"	4.19454969939534	-7.28935625469359	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGTCTTCTCATTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.84114906905	45.475031163883	0.0173645626349076	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2612.54655522541	2612.54655522541
"healthy-3"	"2019-08-01-count-2:AGCTACATCAGCTCTC"	3.68092813071553	-7.54583790218505	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTACATCAGCTCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.73740885703	46.5042536067103	0.0197157400531689	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2356.13303497963	2356.13303497963
"healthy-3"	"2019-08-01-count-3:AGTACCATCGTGGAAG"	5.64416374739949	-9.75839903270873	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACCATCGTGGAAG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.09665941996	48.1385711789252	0.0180018067070795	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2666.4822417045	2666.4822417045
"healthy-3"	"2019-08-01-count-4:ACCTGTCTCATCTACT"	3.4624887901241	-6.65668299114379	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGTCTCATCTACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.25288414879	44.6117883733544	0.0176313556059288	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2526.73284832411	2526.73284832411
"healthy-3"	"2019-08-01-count-2:AAAGAACTCTAACGCA"	-2.67006025734599	8.92360971057741	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACTCTAACGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.98141384388	44.5036871256745	0.0214064862866621	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.68186028683	2069.68186028683
"healthy-3"	"2019-08-01-count-2:GATCACAAGTTTCTTC"	-3.82311950150188	10.499671913031	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACAAGTTTCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2234.33777262061	38.9597970135852	0.0174368430283887	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2224.70114374147	2224.70114374147
"healthy-3"	"2019-08-01-count-2:TAGACCACAGCGTTGC"	-2.88462124291118	9.22512528980104	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCACAGCGTTGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2073.67672359999	48.9775763138567	0.0236187134457629	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.81001041943	2069.81001041943
"healthy-3"	"2019-08-01-count-4:TATTGCTAGGTCGTCC"	10.1793676811153	7.93684337222902	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTAGGTCGTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2168.76900486073	46.2054634693397	0.0213049261427945	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2158.47501020962	2158.47501020962
"healthy-3"	"2019-08-01-count-2:CCCTCTCTCGCATTAG"	-1.92471847954448	9.30486295307008	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCTCGCATTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2167.38303395668	42.5404270708732	0.0196275537846272	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2160.77214902877	2160.77214902877
"healthy-3"	"2019-08-01-count-4:GGGACCTAGGGAGTTC"	-2.52982793274577	9.25656697833864	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTAGGGAGTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1915.89902223544	43.32898599246	0.0226154852054283	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1914.17127639648	1914.17127639648
"healthy-3"	"2019-08-01-count-4:CATGCCTCATCAGTCA"	10.5000359016353	6.75826737964479	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTCATCAGTCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2140.14703175671	41.6148352550207	0.0194448487125025	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2129.39770542258	2129.39770542258
"healthy-3"	"2019-08-01-count-4:TATTGCTGTTCTTAGG"	-1.70686695995982	8.82367799365846	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTGTTCTTAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2146.22096209484	48.3382339012889	0.0225224870854434	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2144.62674676457	2144.62674676457
"healthy-3"	"2019-08-01-count-3:AACACACCAAGGTTGG"	-3.04144297066386	9.5341644057068	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACACACCAAGGTTGG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2142.08020633399	42.2109020486995	0.0197055656104215	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2137.24539269031	2137.24539269031
"healthy-3"	"2019-08-01-count-2:TAGACCAGTGGTCTAT"	4.38318552550618	-7.7178206673828	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAGTGGTCTAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2820.00815672438	49.7082047301298	0.0176269719687155	2511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2810.85223717384	2810.85223717384
"healthy-3"	"2019-08-01-count-2:AAAGGGCTCTGGACCG"	-3.41789398613628	10.2859201201233	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGGCTCTGGACCG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1975.47030906392	42.0816581710169	0.0213020960011074	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1975.47030906392	1975.47030906392
"healthy-3"	"2019-08-01-count-3:ATTGGGTGTAATCAGA"	11.1259762245113	6.10970017993776	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGGGTGTAATCAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.08125402038	38.8967639668352	0.020100842735168	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1927.46736593135	1927.46736593135
"healthy-3"	"2019-08-01-count-4:CTGCAGGAGTATGTAG"	-2.79771409454997	9.40840051257936	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGAGTATGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2218.49502187767	45.9193984052475	0.0206984455463788	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2210.87017051567	2210.87017051567
"healthy-3"	"2019-08-01-count-4:GGGACTCCACGACAAG"	-1.39760325375255	8.73001573169557	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACTCCACGACAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.99512357066	47.7830687785764	0.0233202452406562	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.11571265597	2044.11571265597
"healthy-3"	"2019-08-01-count-2:ATGATCGTCCTACCAC"	2.87328137931172	-5.06268885051879	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGATCGTCCTACCAC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3135.66064338162	38.5001609673259	0.012278165702844	3175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3131.45722673122	3131.45722673122
"healthy-3"	"2019-08-01-count-2:ACCGTTCTCCGTGTGG"	-3.65307150307353	10.5325498350891	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCTCCGTGTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.77813797484	44.6864910342071	0.0221354145825231	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2018.77813797484	2018.77813797484
"healthy-3"	"2019-08-01-count-4:ACGGAAGTCGGTCTAA"	3.85961117324178	-7.48776247417601	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGAAGTCGGTCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.82404198449	44.0611629271179	0.0167991303350186	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2621.90901685768	2621.90901685768
"healthy-3"	"2019-08-01-count-3:GATTGGTCAGTCGCAC"	3.11552013930623	-6.76815178310546	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTCAGTCGCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.99827842535	41.2531957156838	0.0178199682047901	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2312.55437307688	2312.55437307688
"healthy-3"	"2019-08-01-count-2:GATCCCTAGCAACTTC"	4.21328653868977	-8.07175066387328	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTAGCAACTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.02355618743	50.449812825823	0.0214313118036641	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2343.64196263139	2343.64196263139
"healthy-3"	"2019-08-01-count-2:GTCTGTCCAGGCTTGC"	-2.94926867905315	9.4285211333069	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCCAGGCTTGC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2186.13134550139	46.1293742524818	0.0211009161674602	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2182.98453605372	2182.98453605372
"healthy-3"	"2019-08-01-count-3:AGTCAACCAAGGTTGG"	-3.98343596878703	12.0484599837097	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACCAAGGTTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2096.21246357852	47.7731051475035	0.0227902018414432	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2093.13391706272	2093.13391706272
"healthy-3"	"2019-08-01-count-2:CCTGCATAGTGTGTTC"	3.25708856162373	-5.39258816158446	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATAGTGTGTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2697.72488772694	42.1726224582882	0.0156326624149663	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2690.10866592787	2690.10866592787
"healthy-3"	"2019-08-01-count-2:CATCCACTCGCGTGCA"	-2.75864158096965	9.03204534137575	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACTCGCGTGCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2010.42884184278	42.2805724446068	0.0210306236981022	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2005.39484146308	2005.39484146308
"healthy-3"	"2019-08-01-count-3:CGGTCAGGTGACCGAA"	-2.01621566239055	8.68172547901002	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGGTGACCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2198.11722879721	44.4932274658907	0.0202415170960818	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2193.61223994472	2193.61223994472
"healthy-3"	"2019-08-01-count-2:TAGATCGGTCGAATGG"	-4.11625514450725	11.4708623656067	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGATCGGTCGAATGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2013.62706343979	45.2310990054626	0.0224625005427749	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.60866002424	2003.60866002424
"healthy-3"	"2019-08-01-count-2:TTCATGTTCCCAAGCG"	-1.10547349873241	8.357958770636	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATGTTCCCAAGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1888.20130029234	43.3915074310766	0.022980339767989	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1884.31695040881	1884.31695040881
"healthy-3"	"2019-08-01-count-2:TCCGGGAGTTCAGTAC"	3.84417428550069	-7.01420214092406	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGAGTTCAGTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.05611365666	45.4744819337631	0.0190664201455804	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2380.41773684839	2380.41773684839
"healthy-3"	"2019-08-01-count-2:TAGCACAAGACTCGAG"	5.06311096724812	-8.54601194774779	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGCACAAGACTCGAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2702.05002097085	46.9483421553758	0.0173750825451067	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2695.84096831504	2695.84096831504
"healthy-3"	"2019-08-01-count-2:GATGACTGTTGCTCAA"	2.66202797469441	-4.54209949886473	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGACTGTTGCTCAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2887.68555717589	39.7829331869482	0.0137767538740801	2833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2883.33903021065	2883.33903021065
"healthy-3"	"2019-08-01-count-2:TAGGAGGAGAACTTCC"	-4.04868779602702	10.7263297804627	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGAGGAGAACTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.69186214618	41.9130466516828	0.019895195593049	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2103.46314654414	2103.46314654414
"healthy-3"	"2019-08-01-count-4:GATCCCTTCCGCTGTT"	-3.36253271523173	10.8673906096253	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCCCTTCCGCTGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.20450155809	45.7137290257494	0.02199674237616	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2068.17165522565	2068.17165522565
"healthy-3"	"2019-08-01-count-4:TCAAGCAAGGATTACA"	-2.96849284592326	9.32455155933229	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCAAGGATTACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.90966765451	49.2224579957635	0.0234179702169076	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2101.90966765451	2101.90966765451
"healthy-3"	"2019-08-01-count-2:GATGATCGTACCCGCA"	-2.21952734413798	8.74100682819215	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGATCGTACCCGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2043.80860384342	40.4393272481082	0.0197862594237353	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.75139784433	2037.75139784433
"healthy-3"	"2019-08-01-count-2:AGGAGGTAGGCGTCCT"	-4.43500886383708	13.0825252302918	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAGGTAGGCGTCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2209.27483472415	44.2849308062192	0.0200450075790361	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2205.86872362873	2205.86872362873
"healthy-3"	"2019-08-01-count-4:CTGCTCACACACCGAC"	10.4603554206783	6.47377584064332	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCTCACACACCGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.06685938495	51.2754265020397	0.0253830343603832	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2017.04106233418	2017.04106233418
"healthy-3"	"2019-08-01-count-4:TCTATACGTCTGCATA"	-3.85380373421367	10.8354911574158	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACGTCTGCATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1878.2367698064	48.4975907486371	0.0258208078599356	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.66566568826	1867.66566568826
"healthy-3"	"2019-08-01-count-4:TCAAGTGCAACTTGGT"	-0.195365692407447	7.87176797473756	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGCAACTTGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2006.89365810783	37.119717655384	0.0184961059124487	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.89686602168	1996.89686602168
"healthy-3"	"2019-08-01-count-3:GCACATAGTGGTAATA"	-5.32243714752849	-5.22831108486327	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACATAGTGGTAATA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2747.16226110735	43.9928109069026	0.0160139106195968	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2740.87141449678	2740.87141449678
"healthy-3"	"2019-08-01-count-4:GATGACTCAAACTGCT"	11.1650635200435	6.24183366382448	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTCAAACTGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.96245429601	41.4081735664873	0.0206837912857105	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1990.24705239936	1990.24705239936
"healthy-3"	"2019-08-01-count-2:GATGCTAAGAACGTGC"	-3.73994241181071	10.3846292265686	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTAAGAACGTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2173.53165059544	43.1350886925969	0.019845622529021	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2170.62500957119	2170.62500957119
"healthy-3"	"2019-08-01-count-2:CCGGTAGTCATTTCCA"	0.33965908464734	8.4991359480652	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGTCATTTCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1854.8394989217	41.2607299514036	0.0222449058128158	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1846.21049820189	1846.21049820189
"healthy-3"	"2019-08-01-count-4:TGTCCTGAGACGCCCT"	4.25638689574544	-8.34334947979125	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGAGACGCCCT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.84508598136	42.4543676560449	0.0160033346388712	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2650.40858250893	2650.40858250893
"healthy-3"	"2019-08-01-count-3:GGGTCTGTCAACCGAT"	-3.54937992516215	10.3602571257385	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCTGTCAACCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.80643408897	41.064375631992	0.0206893603964159	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.20743386201	1981.20743386201
"healthy-3"	"2019-08-01-count-2:CCGGTGAAGGGAACAA"	-2.20706496658977	9.65660188281862	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTGAAGGGAACAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1936.88380728866	44.0524128180464	0.0227439625713599	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1928.30233833003	1928.30233833003
"healthy-3"	"2019-08-01-count-4:TTTATGCCAGTCCCGA"	-4.84483609619792	2.50175163829652	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCCAGTCCCGA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3356.66594577675	43.4820638210258	0.0129539443374559	4632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3342.40110231823	3342.40110231823
"healthy-3"	"2019-08-01-count-3:CGTCAAATCGCAAGAG"	-3.70705352249797	10.13120935047	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAATCGCAAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1857.34834462524	49.8418351128665	0.0268349420059506	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1853.77988228334	1853.77988228334
"healthy-3"	"2019-08-01-count-2:TAGGTTGCAGGAACCA"	-3.86654601517375	10.0185270079407	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGCAGGAACCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.0573327189	52.2087578922057	0.0274341487219489	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1898.21891645766	1898.21891645766
"healthy-3"	"2019-08-01-count-4:TCAATTCGTAACATCC"	-1.52753303471263	8.4751519926819	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCGTAACATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.55319336454	43.6169318743287	0.0220003841613488	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.31434056594	1977.31434056594
"healthy-3"	"2019-08-01-count-4:GATGAGGCAGGCATGA"	10.9666220146114	6.33449170673219	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGCAGGCATGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.53940059008	40.8703463225986	0.0214256891941292	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1902.80658359519	1902.80658359519
"healthy-3"	"2019-08-01-count-3:TCACATTCACTTGGCG"	4.02712764319722	-7.63538315212401	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTCACTTGGCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.57562485084	44.456198333628	0.0179579237601786	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2473.24478336972	2473.24478336972
"healthy-3"	"2019-08-01-count-3:AACCTGAAGGTACCTT"	10.8658701377803	6.35357806766359	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTGAAGGTACCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.67977015456	41.8121111231056	0.0203596060742999	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2049.15828287611	2049.15828287611
"healthy-3"	"2019-08-01-count-3:CGTCCATGTCACATTG"	11.1822849708492	5.79049298847047	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCCATGTCACATTG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.31747722243	41.4710302902678	0.0207945980336221	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1986.37354176339	1986.37354176339
"healthy-3"	"2019-08-01-count-4:TCACAAGCATTGACCA"	10.420032163232	7.42096421802369	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACAAGCATTGACCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2213.49230521331	39.5811008437025	0.0178817431397793	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2204.8562075997	2204.8562075997
"healthy-3"	"2019-08-01-count-3:CGTGAATAGAGGGCGA"	-3.74711642685588	10.193127609137	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATAGAGGGCGA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1957.43160684731	42.051715178156	0.0214831082889714	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1955.16430294765	1955.16430294765
"healthy-3"	"2019-08-01-count-2:TTCCGGTGTCGAGTTT"	0.102517769753379	8.10248277271119	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTGTCGAGTTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1902.06585800321	35.6606874458756	0.0187483978516455	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1899.16238762834	1899.16238762834
"healthy-3"	"2019-08-01-count-3:AGTGATCTCAGTGATC"	10.6621633964473	7.08282086932985	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCTCAGTGATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.56097001622	46.4357494415146	0.0240405299974169	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1926.90575823738	1926.90575823738
"healthy-3"	"2019-08-01-count-2:AGGCCACTCAAACTGC"	4.88351692733113	-8.36065676128539	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCCACTCAAACTGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2790.78170326594	41.8733863106918	0.0150041783137997	2465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2787.92605890212	2787.92605890212
"healthy-3"	"2019-08-01-count-4:CGCGTGACACTGCACG"	5.219978471368	-9.17515280162963	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCGTGACACTGCACG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2580.13823603605	44.3951222227178	0.0172064897929358	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2577.61574534718	2577.61574534718
"healthy-3"	"2019-08-01-count-2:GGGATCCAGAAGCTGC"	-3.08315382424052	9.66685865009157	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCAGAAGCTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.87832691314	45.4432971235839	0.0226550616325352	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2004.18555234341	2004.18555234341
"healthy-3"	"2019-08-01-count-4:TCTCCGATCTGAGGTT"	-1.28784487667735	8.93568227374879	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGATCTGAGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1861.78905979247	47.9201047335517	0.0257387401013589	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.73317022429	1852.73317022429
"healthy-3"	"2019-08-01-count-4:GCCCAGAAGTCTTGGT"	4.29220022734944	-7.71004297649535	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGAAGTCTTGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.48420925323	46.5402301869363	0.0235827730309264	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1969.80492721972	1969.80492721972
"healthy-3"	"2019-08-01-count-4:GATGGAGCACCTTCCA"	-0.0663135898416818	8.14155957782594	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGCACCTTCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2015.48246369563	43.1435259544507	0.0214060537521829	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.01306659728	2006.01306659728
"healthy-3"	"2019-08-01-count-3:TCTTCCTGTTTAGTCG"	-3.7501257461613	10.7603921660217	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTCCTGTTTAGTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.0859247316	47.0513088997727	0.0235481909548475	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.41651388659	1991.41651388659
"healthy-3"	"2019-08-01-count-2:GATTGGTAGCACCAGA"	3.01576342162434	-6.18862106716307	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTAGCACCAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.15496421904	47.4869056064612	0.0187980968226713	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2521.17417343212	2521.17417343212
"healthy-3"	"2019-08-01-count-2:CTACAGATCCTGTTAT"	-2.65161476555522	9.46046731555787	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGATCCTGTTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.91973189661	49.2969492564614	0.0248107401950279	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1980.60154410456	1980.60154410456
"healthy-3"	"2019-08-01-count-4:AGACCATGTACGTTCA"	2.85619463500325	-8.79954531109007	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATGTACGTTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.63426628253	44.2582580686688	0.0207140074307956	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2133.49026603493	2133.49026603493
"healthy-3"	"2019-08-01-count-3:CGTGCTTCAGAACCGA"	3.64824523505513	-7.3186507455078	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTCAGAACCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.00414935791	47.8934320782272	0.0201911249148496	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2365.16889658736	2365.16889658736
"healthy-3"	"2019-08-01-count-3:GGTAACTGTAGTCTTG"	5.20952381667439	-8.98506357586058	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAACTGTAGTCTTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2737.0684154559	43.0193685716992	0.0157173157706888	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2730.62779417533	2730.62779417533
"healthy-3"	"2019-08-01-count-2:CAGGTATTCTCATAGG"	5.32693399962727	-9.42299272930297	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATTCTCATAGG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.41480405294	47.7883494523022	0.0179088908440017	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2664.7847414183	2664.7847414183
"healthy-3"	"2019-08-01-count-2:AGGGAGTAGGTCTTTG"	-4.01799617233928	10.5279655226502	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGAGTAGGTCTTTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2616.8817536055	36.8180369474056	0.0140694308776765	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2606.97237458698	2606.97237458698
"healthy-3"	"2019-08-01-count-2:TTCCTCTCAGAGGACT"	-4.01257453385051	13.1078004606995	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTCTCAGAGGACT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2118.67783945682	43.808394876863	0.020677232782165	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2113.42848904561	2113.42848904561
"healthy-3"	"2019-08-01-count-2:TCCTTCTTCAGATGCT"	-0.946569721133071	8.19099137866823	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTTCAGATGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2223.71500484038	40.8685290757382	0.0183784922918536	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2216.35796097043	2216.35796097043
"healthy-3"	"2019-08-01-count-2:GGGCGTTTCCGCTAGG"	0.0648911810362756	8.77831742847291	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTTCCGCTAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.24944088009	38.0565380741433	0.0205350328103003	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.98366281667	1845.98366281667
"healthy-3"	"2019-08-01-count-4:AGTCAACCAATTCACG"	10.3217894035274	6.645640827063	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCAACCAATTCACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1772.29301392742	41.3899648394342	0.0233539062187655	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1764.61668768184	1764.61668768184
"healthy-3"	"2019-08-01-count-3:AGTTAGCCACGTACTA"	-2.35687551918681	8.95317075336305	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTAGCCACGTACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.16807165956	49.3545220297933	0.0242270251121633	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.33881085177	2031.33881085177
"healthy-3"	"2019-08-01-count-4:TCTGGCTTCGCTGTTC"	4.61075129088704	-8.33083345806273	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTTCGCTGTTC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.95648439598	46.5375260342477	0.0172555717170462	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2693.05259212774	2693.05259212774
"healthy-3"	"2019-08-01-count-4:GATTCTTTCTGCATAG"	-2.97044811669047	10.1444396742615	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCTTTCTGCATAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.42976969973	44.3136410162594	0.021590819657007	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2048.94096074899	2048.94096074899
"healthy-3"	"2019-08-01-count-4:CGGCAGTCAACACAAA"	-2.24261341515239	9.48793981159059	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGCAGTCAACACAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.41836693912	43.0958437193644	0.0212880126080483	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2024.41836693912	2024.41836693912
"healthy-3"	"2019-08-01-count-2:TCGAACAAGGGACTGT"	-1.42663906040843	8.47543904865114	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAACAAGGGACTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.28570798856	41.9743106454911	0.0218469905183624	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1916.73039999722	1916.73039999722
"healthy-3"	"2019-08-01-count-4:TTTCGATTCGACATTG"	-1.82656500759776	8.58292195880739	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATTCGACATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.6179191313	48.3620091081021	0.0243194072842451	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1980.1365342325	1980.1365342325
"healthy-3"	"2019-08-01-count-3:TGAATGCTCTCAAAGC"	-2.71530781212505	3.47469661319581	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAATGCTCTCAAAGC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3442.8573362314	43.4652573494077	0.0126247628363786	4568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3436.82805029454	3436.82805029454
"healthy-3"	"2019-08-01-count-3:CAAGCTATCTTCACGC"	-1.40005622330363	8.91544149005739	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTATCTTCACGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2050.37603273117	50.9275723681142	0.0248381621493483	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.11560766736	2044.11560766736
"healthy-3"	"2019-08-01-count-2:TTCGATTCACCGTCTT"	-2.58738217774089	8.84984204852907	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGATTCACCGTCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2233.71336816027	34.0451154149295	0.0152414879635921	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2227.51209003351	2227.51209003351
"healthy-3"	"2019-08-01-count-4:CCAATTTCAACACGTT"	3.18906082686726	-7.22075083171996	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTCAACACGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.62636045726	44.5525985932368	0.0182098089488867	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2438.26574589387	2438.26574589387
"healthy-3"	"2019-08-01-count-2:CCTATCGCAAGTAGTA"	4.00597681578938	-7.33002235805663	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGCAAGTAGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.28227309544	46.5524661660132	0.021322238878444	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2178.60959280487	2178.60959280487
"healthy-3"	"2019-08-01-count-2:TATCGCCTCCACATAG"	10.270150800317	6.96237418735353	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCTCCACATAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.55889128364	42.4945834777828	0.0222652723328868	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1896.97357847281	1896.97357847281
"healthy-3"	"2019-08-01-count-4:TTTGATCCAGGCGAAT"	10.4726492362911	7.5919356116089	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCCAGGCGAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.87626903861	46.9338281629244	0.0229182929029974	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2045.44359914105	2045.44359914105
"healthy-3"	"2019-08-01-count-3:GGTGAAGCACGCTGCA"	10.7664982276851	7.00303361499635	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGCACGCTGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.13562405121	41.2510066605098	0.0201309304158966	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2040.08853598472	2040.08853598472
"healthy-3"	"2019-08-01-count-3:GTTGTGACAAAGACTA"	5.13626684722249	-8.69734861766966	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGACAAAGACTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.64308968473	48.0265065014709	0.0180710896387401	2213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2653.66228023052	2653.66228023052
"healthy-3"	"2019-08-01-count-4:GTTCATTGTCACGACC"	4.01029886779134	-7.09871342098387	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTGTCACGACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.74348939096	47.0380597170392	0.0184264732874754	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2547.16391983809	2547.16391983809
"healthy-3"	"2019-08-01-count-2:CTACGGGCATGACAGG"	3.71249022063557	-7.10894968425902	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACGGGCATGACAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.19764769893	45.4238212995943	0.0175503680485835	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2583.03892367928	2583.03892367928
"healthy-3"	"2019-08-01-count-2:CCTCAACAGTATAGAC"	0.28915805098359	8.39082620227662	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACAGTATAGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2040.27133491989	38.7069011935347	0.0189714478319887	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.85126544255	2030.85126544255
"healthy-3"	"2019-08-01-count-4:TTTGGAGAGCGTCTCG"	-4.66973195496257	-4.96267273342284	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGAGAGCGTCTCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2836.73074535053	43.0973813955749	0.0151926232217184	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2831.32055755909	2831.32055755909
"healthy-3"	"2019-08-01-count-3:ATACCTTAGCCATCCG"	11.1238037544185	6.00495288455812	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTAGCCATCCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.20795609879	46.8436157093411	0.0235252252613122	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1981.84985444761	1981.84985444761
"healthy-3"	"2019-08-01-count-2:TTCTAACCAATTAGGA"	0.972973008721512	8.54193971240846	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACCAATTAGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1545.4216377279	32.047882060978	0.0207373064273224	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1533.35869086547	1533.35869086547
"healthy-3"	"2019-08-01-count-3:CTAAGTGTCCATCAGA"	-1.34200046482738	8.38014028156129	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAAGTGTCCATCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2124.733474455	42.797932667244	0.0201427299855676	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2117.05064009905	2117.05064009905
"healthy-3"	"2019-08-01-count-4:ACTGCAATCAGCTGAT"	-4.29399476471599	10.6441859968933	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAATCAGCTGAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2493.82910695983	37.8249727514144	0.0151674277302529	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2487.73769234087	2487.73769234087
"healthy-3"	"2019-08-01-count-3:ATACCTTTCGTAGTCA"	-3.2001522583073	10.7293052443298	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTTCGTAGTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1769.53366061376	51.9801658380901	0.0293750647388425	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1763.24339395548	1763.24339395548
"healthy-3"	"2019-08-01-count-4:TCAGGGCGTTTGAAAG"	-3.4035373729771	9.97705361926881	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGGCGTTTGAAAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1928.39878835696	49.1515148155374	0.0254882522807514	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.70747859907	1917.70747859907
"healthy-3"	"2019-08-01-count-2:CCTCACAGTACGGGAT"	10.4368454414303	5.45608470523683	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACAGTACGGGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1621.07758681846	50.021451110052	0.0308569136460794	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1613.27679253788	1613.27679253788
"healthy-3"	"2019-08-01-count-3:GCATTAGCACGCTTAA"	3.7684985595638	-7.10315134441527	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATTAGCACGCTTAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2689.14024366415	45.718980660467	0.0170013374230612	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2686.19828554856	2686.19828554856
"healthy-3"	"2019-08-01-count-3:ATACTTCGTGATAGAT"	-2.98508153381999	9.48068616474	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACTTCGTGATAGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.79433606597	41.6778848654873	0.0222069536680563	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1873.15937257906	1873.15937257906
"healthy-3"	"2019-08-01-count-3:GGTGTCGCAGCAAGAC"	4.80470528182332	-8.44344808971556	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTCGCAGCAAGAC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.39033959019	48.5918847837555	0.0190751625412746	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2543.07126172074	2543.07126172074
"healthy-3"	"2019-08-01-count-3:GGTGTTACAAGCCCAC"	-4.99874434891399	-5.10881426250609	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTTACAAGCCCAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2965.09349503126	50.8587845840875	0.0171525062091006	3421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2962.53300418765	2962.53300418765
"healthy-3"	"2019-08-01-count-1:AGGGTTTAGCAAGGAA"	-3.91115079346355	13.044837928656	"2019-08-01-count-1"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGGGTTTAGCAAGGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2339.06976932282	52.3480298602864	0.0223798496935992	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2332.97789466705	2332.97789466705
"healthy-3"	"2019-08-01-count-2:AACTTCTGTGGCTGAA"	-3.52967749062236	10.1534499892029	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTGTGGCTGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2191.63834111518	44.2402100601833	0.0201859080625832	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2184.18931408268	2184.18931408268
"healthy-3"	"2019-08-01-count-4:ACTGTGAGTGCACAAG"	3.20136394080464	-6.68942882930907	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGAGTGCACAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.67579278269	46.0651678379693	0.0189671951994833	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2426.05974579693	2426.05974579693
"healthy-3"	"2019-08-01-count-3:CTACCCAAGACTACCT"	2.65144600447957	-4.3969879380432	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCCAAGACTACCT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2914.58035855392	40.4029069316343	0.0138623410444173	3047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2908.69016110896	2908.69016110896
"healthy-3"	"2019-08-01-count-3:CCCTCAAGTCAAGCGA"	0.0924781794542491	8.11708448016969	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAGTCAAGCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.72609808576	43.0943493790763	0.0220688141677019	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1945.12281758379	1945.12281758379
"healthy-3"	"2019-08-01-count-2:GGGTGAACAATGAACA"	2.96851052817647	-5.13413669979247	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAACAATGAACA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2841.17387842447	43.5518306877719	0.0153288156766818	3031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2835.74290326743	2835.74290326743
"healthy-3"	"2019-08-01-count-4:AGTTCCCAGTAAACGT"	-2.61334715309795	9.20884893024293	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCCCAGTAAACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1587.51992661952	41.7996839255935	0.0263301790577219	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1585.20472745261	1585.20472745261
"healthy-3"	"2019-08-01-count-2:CCTCATGAGACCAGCA"	-0.370793293148834	8.14859006488649	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCATGAGACCAGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2044.90716127606	39.6545519339458	0.0193918592906685	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.46347550663	2033.46347550663
"healthy-3"	"2019-08-01-count-3:ATAGGCTTCTTCGGTC"	5.17163958129231	-8.44367220317992	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTTCTTCGGTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2819.09464886395	39.5241536528577	0.0140201584465372	2368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2811.20020947373	2811.20020947373
"healthy-3"	"2019-08-01-count-4:ACTTAGGCAATACCTG"	-1.39780400219615	9.15030953967897	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTAGGCAATACCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2123.29096843415	42.5467489951411	0.0200381151842405	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.93924144182	2119.93924144182
"healthy-3"	"2019-08-01-count-3:TGAGGAGTCAGACTGT"	-3.43141708794292	-4.54412844097289	"2019-08-01-count-3"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGTCAGACTGT"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2981.49171548819	39.104255907014	0.0131156681415132	3205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2974.06937204875	2974.06937204875
"healthy-3"	"2019-08-01-count-4:GGTGATTAGTGATGGC"	5.45827688750569	-9.63875391399535	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTAGTGATGGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.99108730679	49.7020586039519	0.0193695367259121	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2565.99108730679	2565.99108730679
"healthy-3"	"2019-08-01-count-1:ATTATCCCACCCAATA"	-1.80365143242534	8.68259141528932	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATTATCCCACCCAATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2086.4001403711	42.4163668439396	0.0203299290597226	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2064.07815077206	2064.07815077206
"healthy-3"	"2019-08-01-count-4:GCACTAATCCGTGACG"	-0.0510374632781327	8.16203782642213	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACTAATCCGTGACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.95355065135	37.4252530596802	0.0190270141596821	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1955.66584757771	1955.66584757771
"healthy-3"	"2019-08-01-count-4:GCAGCCACAGGTGGAT"	10.7476955848629	5.53315255725709	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCACAGGTGGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1980.66030073423	41.5885689212581	0.0209973254403298	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1973.5839494178	1973.5839494178
"healthy-3"	"2019-08-01-count-3:ATATCCTTCTGGACTA"	-2.37205658379253	9.73586747730104	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTTCTGGACTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2194.49935326355	46.8270773583046	0.0213383874042459	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2191.4067371405	2191.4067371405
"healthy-3"	"2019-08-01-count-1:ATTTCACCAAGAATGT"	10.8239399391109	6.69983003223268	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATTTCACCAAGAATGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2050.21890754848	48.3014269723419	0.0235591559489117	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2039.57337936261	2039.57337936261
"healthy-3"	"2019-08-01-count-2:ACTATCTGTATATGGA"	4.87206997451131	-7.52395679866942	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTGTATATGGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2812.76218763843	43.6352069781452	0.0155132940743849	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2808.64834852612	2808.64834852612
"healthy-3"	"2019-08-01-count-4:CTTCTAAGTAAGGCCA"	-2.93409333649333	9.98969838703004	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTAAGTAAGGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1871.32140531507	49.8484896750635	0.0266381229507022	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1860.60155361551	1860.60155361551
"healthy-3"	"2019-08-01-count-2:GGGTTATGTAGTGCGA"	2.17975415763203	-6.26450016414794	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTATGTAGTGCGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2402.438899457	49.4330921973214	0.0205762120354005	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2399.37807267071	2399.37807267071
"healthy-3"	"2019-08-01-count-4:TTACCATGTGTCCGGT"	-1.52313933792766	9.09497544849244	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATGTGTCCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.34554985675	45.7254059801843	0.0232540033380783	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.39630791058	1959.39630791058
"healthy-3"	"2019-08-01-count-4:GCAGCCATCGTTCTCG"	4.7854024368221	-8.27922155773314	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCATCGTTCTCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.07043129498	46.1857441085412	0.0182691682703171	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2524.85986194614	2524.85986194614
"healthy-3"	"2019-08-01-count-2:GGGTTTAGTTGGTACT"	11.2139240699703	5.65944240177003	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTTAGTTGGTACT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1955.49464277842	43.6621051763808	0.0223279083569079	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1941.8682956378	1941.8682956378
"healthy-3"	"2019-08-01-count-2:TATTGGGCAGTCAGAG"	-4.12227044525798	11.2146453627381	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGGGCAGTCAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.78386530883	45.2465497472698	0.0212346969976291	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2120.91297875528	2120.91297875528
"healthy-3"	"2019-08-01-count-3:GTAACCAAGCTGGAGT"	4.65411390837972	-7.96395018016966	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCAAGCTGGAGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2603.60495900429	45.1195310676132	0.0173296378590662	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2597.33973126093	2597.33973126093
"healthy-3"	"2019-08-01-count-2:TGGCGTGGTGTGGACA"	10.3936020332271	7.56826255405275	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGCGTGGTGTGGACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.29881067096	48.7832259652028	0.0246841346570668	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1969.5885898677	1969.5885898677
"healthy-3"	"2019-08-01-count-4:ATACCTTGTGATACCT"	10.6557671028072	7.16005704486696	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTGTGATACCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.41042087748	40.6126626521882	0.0200120499206996	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2022.18271480571	2022.18271480571
"healthy-3"	"2019-08-01-count-2:TCGCTTGGTATGCGTT"	-1.595979432494	8.84100148761598	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTTGGTATGCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1843.75382956267	46.2495133082512	0.0250844296926675	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1838.50137122801	1838.50137122801
"healthy-3"	"2019-08-01-count-4:ATACCTTTCACAGTGT"	-4.0284517807072	13.150122619513	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTTCACAGTGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2265.51925123157	45.1547287256631	0.0199312933232045	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2256.3443268782	2256.3443268782
"healthy-3"	"2019-08-01-count-2:TATTTCGTCTAGGCCG"	4.76936592635457	-8.01268484508666	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGTCTAGGCCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.35044370596	45.3022743826009	0.0185031822135841	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2445.90701778757	2445.90701778757
"healthy-3"	"2019-08-01-count-2:GGTAACTTCGGCTTCT"	-2.87032447281535	9.60682580554811	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTTCGGCTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.15081178373	34.0013769761882	0.0179317893729153	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.93827293117	1887.93827293117
"healthy-3"	"2019-08-01-count-2:ATTCTTGTCGGTAACT"	11.119196553796	6.41241500461427	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGTCGGTAACT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.95065923968	39.3850962404193	0.0191659571305676	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2052.44697748488	2052.44697748488
"healthy-3"	"2019-08-01-count-4:TGACTCCCAATCTAGC"	4.2370830970699	-8.36883737957152	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCCAATCTAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.07623372883	42.8796340340188	0.0168282382867601	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2541.827991132	2541.827991132
"healthy-3"	"2019-08-01-count-4:CTTGATTCACCCTGAG"	3.80765499648396	-7.58861591732176	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTCACCCTGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.29959518957	49.8824377189958	0.0209036777358348	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2380.92940875115	2380.92940875115
"healthy-3"	"2019-08-01-count-4:CCCAACTCAATTGCTG"	-3.51676974716838	-5.4680328599182	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTCAATTGCTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2767.69605943644	48.9595002855947	0.0176896231501532	2511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2766.27092709404	2766.27092709404
"healthy-3"	"2019-08-01-count-4:GCAGTTATCGCACGGT"	-3.3252891105717	11.0797490843567	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGTTATCGCACGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2169.61394092893	41.3773795138877	0.0190713097539241	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2161.59712324906	2161.59712324906
"healthy-3"	"2019-08-01-count-2:GCATCTCAGCGTGCCT"	10.5351072746212	6.35332152927247	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCAGCGTGCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.7817273826	46.0103759181292	0.0236462164643826	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1940.0668121448	1940.0668121448
"healthy-3"	"2019-08-01-count-4:ACTTTCAGTCTTTCAT"	5.45501961287801	-9.64965822612914	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTCAGTCTTTCAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2708.53597800818	41.6267794354316	0.0153687378618627	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2703.87289948991	2703.87289948991
"healthy-3"	"2019-08-01-count-2:TGTTCTAAGTCTGCGC"	-4.14374957504924	11.9264974364075	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCTAAGTCTGCGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2224.39433952812	41.6119286194676	0.0187070825887352	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2221.20575867166	2221.20575867166
"healthy-3"	"2019-08-01-count-3:GTCTACCCAACACAAA"	-2.70482025566753	9.31364057147828	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCCAACACAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2071.65552050348	47.2125699184729	0.0227897782479776	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2065.06480951715	2065.06480951715
"healthy-3"	"2019-08-01-count-2:GCTGAATCACGGCACT"	11.1058403449947	6.40702197635499	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGAATCACGGCACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.79781535018	42.2885715710345	0.0221894322841713	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1898.39870181264	1898.39870181264
"healthy-3"	"2019-08-01-count-3:AAGTGAAGTACGTACT"	4.89477600631062	-8.40798761760863	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTGAAGTACGTACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.68908879628	43.1397570434683	0.015897089029681	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2711.82108539599	2711.82108539599
"healthy-3"	"2019-08-01-count-2:AGTAGCTCACCATATG"	10.626409192651	6.3872089155945	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTCACCATATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1916.40619084684	42.3261319033592	0.0220862007780594	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1909.69589846935	1909.69589846935
"healthy-3"	"2019-08-01-count-4:GCATGATTCTGTTCAT"	-1.77795002880748	8.67645547473756	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATGATTCTGTTCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1895.02189554369	46.0394577368999	0.0242949476442282	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1889.46609164279	1889.46609164279
"healthy-3"	"2019-08-01-count-4:GTTTGGACACCCTGAG"	10.8548923927242	6.56157825076906	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGACACCCTGAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.27340866924	40.3705455671517	0.0200025157115707	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2011.02842427865	2011.02842427865
"healthy-3"	"2019-08-01-count-4:TCCTCCCGTTGGCCTG"	-2.89513335648234	12.7668800123963	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCCCGTTGGCCTG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1974.28245802558	43.9725849506183	0.0222726919199768	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1970.33417310305	1970.33417310305
"healthy-3"	"2019-08-01-count-2:AGTAGCTTCCGTGTCT"	-2.54682693901713	9.26693055713502	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTTCCGTGTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.44271971361	47.1102048312387	0.0237397655085945	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1977.68142999218	1977.68142999218
"healthy-3"	"2019-08-01-count-4:TCATGTTAGGTTCCAT"	4.47829641875569	-8.34090807354125	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTAGGTTCCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.98783763804	45.1263106088542	0.017857747448058	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2523.70658396498	2523.70658396498
"healthy-3"	"2019-08-01-count-2:TCAAGTGAGACCAACG"	-1.20202050629314	8.87885949695436	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGAGACCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.2015776135	44.9655722041034	0.0212181666336529	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2109.12239536699	2109.12239536699
"healthy-3"	"2019-08-01-count-3:ATCATTCTCGTAATGC"	4.61645426329915	-8.49363043224486	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCATTCTCGTAATGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.89140941264	43.4582245464225	0.0175951964449956	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2466.22005922704	2466.22005922704
"healthy-3"	"2019-08-01-count-3:AGACTCACATAGGTTC"	-3.96554503861125	11.5843057402405	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACTCACATAGGTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2174.45186291098	43.0682201021197	0.019806472075433	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2172.85524289333	2172.85524289333
"healthy-3"	"2019-08-01-count-2:AGTAGTCGTAGTACGG"	3.58310379561726	-6.16655065929564	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGTCGTAGTACGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2599.64921923731	48.2839159991305	0.0185732427443792	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2593.24209124723	2593.24209124723
"healthy-3"	"2019-08-01-count-4:TCATGTTTCCGCACTT"	-1.07955525341685	8.81438443744508	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTTCCGCACTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2061.38526581917	41.1335646151448	0.0199543313407738	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2052.10237375807	2052.10237375807
"healthy-3"	"2019-08-01-count-2:TCAAGTGGTGACGTCC"	-3.36062775078471	9.66019055927125	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGGTGACGTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2124.92334662219	48.2730477339231	0.0227175478167994	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2117.00928096528	2117.00928096528
"healthy-3"	"2019-08-01-count-3:ATCCATTTCGCCTTGT"	10.7932039695675	7.43059108341066	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCATTTCGCCTTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2069.06942533589	44.4770486150355	0.0214961605784761	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2061.40969860355	2061.40969860355
"healthy-3"	"2019-08-01-count-3:GTACAGTTCATCGCAA"	4.78191008147542	-8.19091131603392	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAGTTCATCGCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.57228685511	50.6163454729655	0.0228251163549433	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2217.57228685511	2217.57228685511
"healthy-3"	"2019-08-01-count-4:GCCAGGTAGTGATCGG"	10.5148655372554	6.76744506442872	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTAGTGATCGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1652.75963702641	41.6501420706573	0.0252003625557996	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1643.09503201917	1643.09503201917
"healthy-3"	"2019-08-01-count-3:TGCAGATGTAAGCTCT"	10.198635717004	7.72755906665651	"2019-08-01-count-3"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGATGTAAGCTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.14580950365	44.2475978679999	0.0203892280759329	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2164.85987019002	2164.85987019002
"healthy-3"	"2019-08-01-count-4:GTAATCGCAATTCGTG"	-4.18012843552287	11.8139362105164	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGCAATTCGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.39126313679	46.9638250390827	0.0227825866340476	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2056.39566351126	2056.39566351126
"healthy-3"	"2019-08-01-count-3:TTCGCTGCAGGTTCAT"	-0.0373067510431588	8.19497487628785	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGCTGCAGGTTCAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2170.60886150279	45.9673030432907	0.0211771470477946	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2165.49997389485	2165.49997389485
"healthy-3"	"2019-08-01-count-2:TTGCATTGTCTGATCA"	-2.07619772377666	9.7208213576111	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTGTCTGATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2199.20117959219	48.571763970994	0.0220860939970944	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2196.38538539773	2196.38538539773
"healthy-3"	"2019-08-01-count-2:TCAATTCCATATGAAG"	0.204840858548325	8.09412190997926	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCCATATGAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.61787464986	44.7215147982494	0.023224501281897	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1918.61227020235	1918.61227020235
"healthy-3"	"2019-08-01-count-3:CTCAGAAGTGATACTC"	4.84417023238484	-8.3432770005432	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGAAGTGATACTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.63236510243	42.2868314564625	0.0150560222768494	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2801.46844732605	2801.46844732605
"healthy-3"	"2019-08-01-count-3:CTCAGAATCAGTGTCA"	4.72568430480306	-8.45126917278441	"2019-08-01-count-3"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGAATCAGTGTCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.94657271424	46.9573474190076	0.0183789938781861	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2548.85458269076	2548.85458269076
"healthy-3"	"2019-08-01-count-3:CTCAGGGCACAAATCC"	-0.421003322035629	8.71195981586305	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGGGCACAAATCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2252.11895768274	37.3030891743849	0.0165635518706201	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2241.80165594202	2241.80165594202
"healthy-3"	"2019-08-01-count-4:AGACAAAGTATGGTTC"	-3.85609350624736	9.72699449146119	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAAGTATGGTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2237.54155501045	39.6774565101728	0.0177326121257165	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2232.90101545206	2232.90101545206
"healthy-3"	"2019-08-01-count-2:GCCAGGTTCAACCTTT"	-4.28099523010905	12.9620427855286	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGGTTCAACCTTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2311.06461747967	49.4312937337511	0.0213889708491398	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2304.59535410178	2304.59535410178
"healthy-3"	"2019-08-01-count-3:TGCAGTAAGCGCCTTG"	10.4895664649898	6.8806433447632	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGTAAGCGCCTTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1847.78407253365	38.6875923723103	0.0209372907513282	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1846.35810461474	1846.35810461474
"healthy-3"	"2019-08-01-count-3:AGATAGAAGAAATCCA"	-4.1622408432072	13.2878103026184	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATAGAAGAAATCCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2334.34767227809	33.6270158376612	0.0144053159848484	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2325.84088500389	2325.84088500389
"healthy-3"	"2019-08-01-count-2:AGTCTCCGTCCTGTCT"	4.73698439177815	-8.5386591187683	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCGTCCTGTCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.82252633587	45.587000050094	0.0169165129074671	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2689.25273008915	2689.25273008915
"healthy-3"	"2019-08-01-count-3:CTCAGTCAGTCTTCGA"	1.80427517470662	-6.01702024852904	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGTCAGTCTTCGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2690.1291816237	46.1390718661785	0.0171512476729203	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2684.55664847989	2684.55664847989
"healthy-3"	"2019-08-01-count-2:GCCAGTGTCCTCAGGG"	-4.25770936432536	13.1381196745667	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGTGTCCTCAGGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2286.16953709349	39.3867218810289	0.0172282594278213	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2281.29142617953	2281.29142617953
"healthy-3"	"2019-08-01-count-2:TTGCCTGTCGCCTTGT"	0.305135269730729	8.22688195789186	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCCTGTCGCCTTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2016.3357146021	37.1541154664879	0.0184265522836408	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2009.23894792423	2009.23894792423
"healthy-3"	"2019-08-01-count-4:TCATTTGCACGTTCGG"	-3.77422914925273	9.74047849262086	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTTGCACGTTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2139.06150463086	43.3739252138408	0.0202770818510549	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2137.40326390525	2137.40326390525
"healthy-3"	"2019-08-01-count-2:TCACAAGGTTCCAAAC"	-3.68017850342448	10.5523051985535	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGGTTCCAAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2226.09749212463	47.2227507774685	0.021213244677976	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2219.40104356107	2219.40104356107
"healthy-3"	"2019-08-01-count-3:GACCGTGTCGAGAGAC"	-0.0639675659244836	7.75435636127321	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGTCGAGAGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2044.3723813449	42.7245151468188	0.0208985973087312	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.55534984035	2037.55534984035
"healthy-3"	"2019-08-01-count-3:GACCTTCCACTCCTTG"	10.6394020515377	6.74159619891969	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCCACTCCTTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2086.61983100881	41.9392539157417	0.0200991351143564	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2075.07548279214	2075.07548279214
"healthy-3"	"2019-08-01-count-3:ATGTCCCCAAGGTCGA"	-1.26527426663097	8.88378427112428	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCCAAGGTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.23215540083	40.8221831203122	0.0207721937625156	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1961.60383872134	1961.60383872134
"healthy-3"	"2019-08-01-count-2:TCACACCCAACCAACT"	-0.357926051050979	8.63237378681032	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCCAACCAACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2030.11070350046	42.532196107499	0.020950678223686	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.21924483048	2027.21924483048
"healthy-3"	"2019-08-01-count-4:TGATCTTAGCACTTTG"	3.93911613997762	-8.77076055919798	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTAGCACTTTG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.4963694812	49.3632047441217	0.02055518607958	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2399.57333974134	2399.57333974134
"healthy-3"	"2019-08-01-count-4:AAGTGAACATCGTGCG"	2.50852598723714	-3.97436954891356	"2019-08-01-count-4"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAACATCGTGCG"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2847.05006753885	41.8687435927641	0.0147060088862286	2926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2838.22025738104	2838.22025738104
"healthy-3"	"2019-08-01-count-2:GCCATTCGTGATATAG"	-3.60926423493083	11.959313369635	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATTCGTGATATAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2092.27946595113	35.5276923623753	0.0169803761593697	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2085.82982189365	2085.82982189365
"healthy-3"	"2019-08-01-count-2:TACCGGGCAATACCTG"	-3.04965362969096	9.67405603015748	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGCAATACCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2072.51725048435	45.5035788857863	0.0219557057366601	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.88611688833	2067.88611688833
"healthy-3"	"2019-08-01-count-2:CGAAGTTCACTGATTG"	-2.7266574901646	9.39043996417848	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTCACTGATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2116.14676782422	44.5558464867911	0.0210551778185984	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2113.0900865767	2113.0900865767
"healthy-3"	"2019-08-01-count-3:TCCACGTCACCTGCTT"	3.18664922293965	-5.3193660012451	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTCACCTGCTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3037.28297606887	42.987060895488	0.0141531300291044	3376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3027.41027034121	3027.41027034121
"healthy-3"	"2019-08-01-count-4:AATAGAGGTACTTCCC"	-3.75189123573955	9.82783506000368	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGGTACTTCCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2297.75241142776	40.2913359084082	0.0175351076591286	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2290.23468350349	2290.23468350349
"healthy-3"	"2019-08-01-count-1:CTTCGGTCAAACTGCT"	-3.04922638359721	9.61984536731569	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTTCGGTCAAACTGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2337.98629177065	46.240923233158	0.0197780985268899	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2321.81309087145	2321.81309087145
"healthy-3"	"2019-08-01-count-2:GCCCAGAAGGTGCGAT"	-2.81732688370402	9.26012513721315	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGAAGGTGCGAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2046.53809789167	43.197342553546	0.0211075193753039	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.4501635749	2041.4501635749
"healthy-3"	"2019-08-01-count-4:CCGATCTAGCATCTTG"	4.03459562835042	-6.97691681301268	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATCTAGCATCTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.76086317223	44.7151121286493	0.0186253919807595	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2394.72539913728	2394.72539913728
"healthy-3"	"2019-08-01-count-3:AATTCCTTCGCCTATC"	-3.3558431667393	10.0151481398377	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTTCGCCTATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.03513954165	48.480707567467	0.0226965870879212	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2131.08342047751	2131.08342047751
"healthy-3"	"2019-08-01-count-4:CCGATGGGTATCGTTG"	-1.07418725910838	9.21268174732057	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATGGGTATCGTTG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1874.18354315922	34.0031935237713	0.0181429367725926	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1870.62247864884	1870.62247864884
"healthy-3"	"2019-08-01-count-2:GGTTAACGTGTAACGG"	10.4002195793087	7.56674716556398	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACGTGTAACGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2006.80596231574	42.0838877394024	0.0209705813764078	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2002.48759580165	2002.48759580165
"healthy-3"	"2019-08-01-count-4:ATCCGTCTCTCCAAGA"	4.40679564055745	-7.47992803966673	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCGTCTCTCCAAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.90087422301	39.9495198716155	0.014704077079382	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2713.35842965387	2713.35842965387
"healthy-3"	"2019-08-01-count-2:AGTTAGCCAGTTAGGG"	-4.1770843071049	11.7051343687805	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTAGCCAGTTAGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.13598850133	38.4516595788916	0.0190625023786621	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2008.54372715722	2008.54372715722
"healthy-3"	"2019-08-01-count-4:TCCATCGCACCAACAT"	3.84351195868794	-6.64542248165282	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATCGCACCAACAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.38185126767	46.5209308400161	0.0176390577715	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2631.51790867074	2631.51790867074
"healthy-3"	"2019-08-01-count-4:TGATGGTCAAATGCGG"	-2.34460316124614	8.66594503009645	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTCAAATGCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.910176323	37.8461379253268	0.0193892825522439	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1951.910176323	1951.910176323
"healthy-3"	"2019-08-01-count-3:GTATTTCAGAGTGTTA"	-4.20681891861613	12.3292808302673	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTTCAGAGTGTTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1922.14644923305	46.7090519577323	0.0243004647103604	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1918.31828470929	1918.31828470929
"healthy-3"	"2019-08-01-count-3:ATCGGCGAGTTAGTAG"	-1.92956624451335	8.82436463916627	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGAGTTAGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.45440093152	41.3464229262084	0.0212419170500071	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.13243489402	1943.13243489402
"healthy-3"	"2019-08-01-count-2:CGAGAAGAGTTCATCG"	-1.98272977295573	9.41488835895387	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGAAGAGTTCATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.19749161	37.1626295177768	0.0199885325176484	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.63102916192	1855.63102916192
"healthy-3"	"2019-08-01-count-3:GTCAAACCAAAGCTCT"	-4.17372355881389	13.0717468031677	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAACCAAAGCTCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2110.37143570325	44.1983194003476	0.0209433840188512	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2103.29592705041	2103.29592705041
"healthy-3"	"2019-08-01-count-2:GCCCGAATCCAATGCA"	11.0375791984493	6.48180339420167	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAATCCAATGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.8382768941	45.5981693605102	0.0232781694631829	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1955.64549851471	1955.64549851471
"healthy-3"	"2019-08-01-count-2:TTGGGTATCACTTGTT"	3.61852922019307	-6.57467796718749	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGTATCACTTGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.94573990736	46.9135614485952	0.0193302885504091	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2423.69354321134	2423.69354321134
"healthy-3"	"2019-08-01-count-2:AATCGACCATCACCAA"	11.0152193504268	6.31312511051027	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACCATCACCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1687.1364991275	47.6334831213694	0.0282333309403258	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1678.97309625026	1678.97309625026
"healthy-3"	"2019-08-01-count-4:AGAGCCCCAATTTCGG"	-2.81817756119426	9.1734294661316	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCCCCAATTTCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.89747383069	44.113099288334	0.0237180274230265	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1854.53006700731	1854.53006700731
"healthy-3"	"2019-08-01-count-2:TTGGTTTTCAGTCATG"	-1.40212736550029	8.75018308246461	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTTCAGTCATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1801.46129302159	44.0508297514601	0.0244528316662156	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1796.0166744654	1796.0166744654
"healthy-3"	"2019-08-01-count-2:ATACCGACACACAGAG"	-2.15474114838298	9.14411542499391	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGACACACAGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1863.21589085391	45.6005297586299	0.0244740987786075	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.42483665529	1856.42483665529
"healthy-3"	"2019-08-01-count-4:AGATAGAGTCTTCATT"	-3.08800683441814	9.34182546222535	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATAGAGTCTTCATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.13330912268	42.6673044198431	0.0228885478367015	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.72171136709	1856.72171136709
"healthy-3"	"2019-08-01-count-2:CAAGCTAAGGTTGGTG"	-0.256838421255904	8.68507001483766	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTAAGGTTGGTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.16144467131	44.02363707614	0.0222999173623663	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.2381854647	1967.2381854647
"healthy-3"	"2019-08-01-count-2:TCTATCATCTGTGCAA"	-3.39468608322795	13.5098848112854	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATCATCTGTGCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2703.57214741142	50.2575947936127	0.0185893299876361	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2691.66441980018	2691.66441980018
"healthy-3"	"2019-08-01-count-2:TTGTGTTCAAATGATG"	-2.47603760185893	8.99799535358278	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTCAAATGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.50045217226	42.4021661907386	0.021206379895875	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1997.74888866861	1997.74888866861
"healthy-3"	"2019-08-01-count-2:ATACCTTAGTTTGGCT"	3.93719138678853	-7.97723104869994	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTAGTTTGGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.68177387294	52.8425064838901	0.0218205823134971	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2419.64228352985	2419.64228352985
"healthy-3"	"2019-08-01-count-3:ATCGTCCGTTTGACAC"	10.3100382286007	6.71853778446046	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCGTTTGACAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1973.21730217569	42.5607380409646	0.0215692098351442	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1963.43157553562	1963.43157553562
"healthy-3"	"2019-08-01-count-2:GTTTGGAAGTGGTTCT"	0.0177218141848266	8.11068151080934	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAAGTGGTTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.97930599079	32.923480433824	0.01720158641777	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1906.18722029563	1906.18722029563
"healthy-3"	"2019-08-01-count-4:TGCAGATAGAATAGTC"	-5.48507771912273	-5.50012829219969	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATAGAATAGTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2913.52779725522	42.9028416347196	0.0147253929326288	2789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2905.30877222047	2905.30877222047
"healthy-3"	"2019-08-01-count-4:AGATCCATCACGAACT"	10.7173448997432	6.60667560184327	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCATCACGAACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.29500957526	40.8632959243544	0.0200872025601076	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2027.45790613329	2027.45790613329
"healthy-3"	"2019-08-01-count-3:GCTGAATTCGCCAGAC"	-3.73489175263103	12.9397840269837	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATTCGCCAGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2163.85550623703	46.1787057853531	0.0213409378085778	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2155.17743251174	2155.17743251174
"healthy-3"	"2019-08-01-count-4:TGCAGATGTATCGGTT"	4.89491905745809	-7.97351171886595	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATGTATCGGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.48412006532	43.4624797633461	0.0162204655134462	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2671.23379051979	2671.23379051979
"healthy-3"	"2019-08-01-count-2:GACTCTCCATCCAACA"	-1.39614973488505	8.54804895007936	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCTCCATCCAACA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2266.61789857988	47.2644347171845	0.0208524051393035	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2263.45824689475	2263.45824689475
"healthy-3"	"2019-08-01-count-3:TGCTGAATCGGCTGAC"	4.96032204207723	-8.5319862595764	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCGGCTGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.26113254955	45.7013461399794	0.0183963535641186	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2480.20897002345	2480.20897002345
"healthy-3"	"2019-08-01-count-2:CGAGTGCCAGCAAGAC"	-0.120529974729377	7.56213662708131	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCCAGCAAGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.7486639958	39.9076647303886	0.0209077630193833	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1901.40751959802	1901.40751959802
"healthy-3"	"2019-08-01-count-4:TTCCTCTCATAGGTTC"	4.69491209563558	-8.42384626781615	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTCATAGGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.91227358168	48.7643809179198	0.0187633809011627	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2590.3257433177	2590.3257433177
"healthy-3"	"2019-08-01-count-1:GGTGGCTAGTAAGCAT"	11.2567163902218	5.95631930911867	"2019-08-01-count-1"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTGGCTAGTAAGCAT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2136.15604351329	41.1046500372372	0.0192423442856887	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2124.89895716847	2124.89895716847
"healthy-3"	"2019-08-01-count-2:TCAGCCTTCGGTCGAC"	3.35050119933431	-6.30520632183226	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTTCGGTCGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.61065181011	47.5133767134005	0.0177248332134011	2644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2674.44066745884	2674.44066745884
"healthy-3"	"2019-08-01-count-2:TCTCCGATCACTTCTA"	11.0961615043575	6.15666864002077	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCCGATCACTTCTA"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.33752703922	44.3763364564298	0.0218458704502499	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2024.87885361579	2024.87885361579
"healthy-3"	"2019-08-01-count-4:GCGTGCAGTCATCACA"	-4.0507415336674	11.5191402205261	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCAGTCATCACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.88232876136	43.7662471793506	0.0223082936921006	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.39109924179	1958.39109924179
"healthy-3"	"2019-08-01-count-2:AATGGAATCCGTCAAA"	-2.88002405586894	10.0341758497986	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGAATCCGTCAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1857.42851161049	38.7845022523839	0.0208807510006163	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1850.87985840995	1850.87985840995
"healthy-3"	"2019-08-01-count-4:GTCAAGTAGTCCGTCG"	4.40229763564412	-8.5202322236267	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAGTAGTCCGTCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.93258646769	45.7640794342645	0.0183501669943224	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2488.0016154814	2488.0016154814
"healthy-3"	"2019-08-01-count-4:GTCACGGAGAGGTTTA"	2.67978920516316	-4.61826612865599	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACGGAGAGGTTTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2822.63684631236	44.1542391672485	0.015642904692091	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2815.1495589024	2815.1495589024
"healthy-3"	"2019-08-01-count-3:GAGACCCAGCCTCTTC"	4.95213522490804	-7.96410753643187	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACCCAGCCTCTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.6795056143	42.7461053931525	0.015886732442106	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2681.94787842603	2681.94787842603
"healthy-3"	"2019-08-01-count-4:AATTTCCGTTTGGGTT"	4.49693264540975	-8.30004599010619	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTTCCGTTTGGGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.65872918426	47.5732746317503	0.0201696303255382	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2350.87881551238	2350.87881551238
"healthy-3"	"2019-08-01-count-2:GACTGATTCGCCTTGT"	-2.07274899902995	8.9609746702942	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATTCGCCTTGT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2215.22233001553	48.9207591611158	0.0220839048515608	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2205.4079952413	2205.4079952413
"healthy-3"	"2019-08-01-count-4:TGCATGAAGGATTTCC"	3.8987304168636	-7.21833946621092	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGAAGGATTTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.463789183	43.2767011804477	0.0173213241543914	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2496.24115287144	2496.24115287144
"healthy-3"	"2019-08-01-count-3:TGGAACTGTCGGTGTC"	5.57673229750935	-10.1061077347961	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAACTGTCGGTGTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.73993090795	42.4420038532431	0.0171570193466802	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2466.59474957619	2466.59474957619
"healthy-3"	"2019-08-01-count-3:ACAGAAATCGGACAAG"	9.71824802932088	5.73913047397462	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAATCGGACAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1648.63618067006	51.5597778640314	0.0312742001349721	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1638.82239203853	1638.82239203853
"healthy-3"	"2019-08-01-count-4:TACGCTCAGATTAGAC"	-2.06110558930095	8.81828305805055	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGCTCAGATTAGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.35388058901	42.3343221072179	0.0208815651340152	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2019.35737555314	2019.35737555314
"healthy-3"	"2019-08-01-count-3:ATGAAAGGTATGTGTC"	-7.71318374100383	3.39786026561586	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGGTATGTGTC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2285.99374537078	42.651113709465	0.0186575811048631	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2278.76295425013	2278.76295425013
"healthy-3"	"2019-08-01-count-2:CTCCTTTGTTACTCAG"	-0.00437961417492035	8.26055142963258	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTGTTACTCAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1793.70526287936	42.9419494835373	0.023940359864142	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1772.53349277691	1772.53349277691
"healthy-3"	"2019-08-01-count-4:GCTACCTTCCGCACGA"	-3.26582394066508	9.86914155567018	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACCTTCCGCACGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2243.86823552487	49.9930488205803	0.0222798504961617	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2236.62560882841	2236.62560882841
"healthy-3"	"2019-08-01-count-4:GCTCAAACAAATTAGG"	10.8638283210689	6.11628530109254	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAACAAATTAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1821.0520821695	41.8228226567549	0.0229662968271229	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1815.41233057005	1815.41233057005
"healthy-3"	"2019-08-01-count-4:AGCCACGAGAATTGTG"	5.55273165282552	-9.68508627330931	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGAGAATTGTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.96785995926	40.3193011205878	0.0151067016300463	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2663.77908553262	2663.77908553262
"healthy-3"	"2019-08-01-count-4:GCTCAAAGTACAAACA"	-0.276970009238082	7.74987552249757	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAAGTACAAACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2205.67434581631	45.3568748673065	0.0205637223615257	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2198.62937393856	2198.62937393856
"healthy-3"	"2019-08-01-count-2:TCAGTCCCACGGCTAC"	2.62225570258443	-4.52926208889159	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTCCCACGGCTAC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2823.39664160575	44.8617313257466	0.0158892770022679	2835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2816.69113339735	2816.69113339735
"healthy-3"	"2019-08-01-count-2:CGATGCGAGATGTTAG"	4.36494268950765	-7.49558260357054	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGAGATGTTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.28048458848	49.7927416001514	0.024880441289263	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1999.04518631795	1999.04518631795
"healthy-3"	"2019-08-01-count-2:GCTACCTAGACCAGCA"	10.2924200492794	7.70370576465455	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTAGACCAGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2086.57064647598	47.5951792117584	0.0228102409530884	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2080.68710447504	2080.68710447504
"healthy-3"	"2019-08-01-count-2:CGATGCGAGCTAGCCC"	1.48122920569722	-10.0195427170959	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	68	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGAGCTAGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.9653695548	49.5833031416903	0.0242110066306781	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2043.57329156832	2043.57329156832
"healthy-3"	"2019-08-01-count-2:CACAACAAGCAGATAT"	-3.14862213555034	10.5080671080383	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAACAAGCAGATAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2067.2935316961	42.5466860765188	0.0205808635417205	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2064.23555025952	2064.23555025952
"healthy-3"	"2019-08-01-count-2:GTAGCTAGTGCCTGAC"	5.59990038451497	-10.0412082902161	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTAGTGCCTGAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.53052508385	46.5384637097155	0.0176113249281156	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2637.05381345691	2637.05381345691
"healthy-3"	"2019-08-01-count-2:CGATGGCCATCGAAGG"	-3.37131438675578	10.3967695006165	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGGCCATCGAAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2177.80372161384	46.8880679104164	0.0215299787786525	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.28341241599	2176.28341241599
"healthy-3"	"2019-08-01-count-3:CTCGAGGGTGTGGTCC"	2.55969037589375	-6.45717384731444	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGGTGTGGTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.24137507184	49.4483081487856	0.021572033681329	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2290.27922820087	2290.27922820087
"healthy-3"	"2019-08-01-count-2:GTAGCTATCAAGATAG"	4.51722921904866	-8.01417829906615	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTATCAAGATAG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2859.53093047891	46.4529948555563	0.0162449702363515	2515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2853.02853904629	2853.02853904629
"healthy-3"	"2019-08-01-count-2:TTTAGTCAGATCCCAT"	3.87593879279439	-7.42250158703002	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTAGTCAGATCCCAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.04538732871	45.3367923231037	0.0185726953535742	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2438.41253196726	2438.41253196726
"healthy-3"	"2019-08-01-count-2:GCTACCTTCGTGCAGC"	10.5124184089595	7.39429709995119	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTTCGTGCAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2042.62007528497	45.9758024623562	0.02250824958525	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2035.85097442138	2035.85097442138
"healthy-3"	"2019-08-01-count-2:GCTCAAAAGACAGCTG"	-0.534711877734023	8.53619096362916	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGACAGCTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.60792701541	41.1306929128238	0.0214489585349389	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1915.975544811	1915.975544811
"healthy-3"	"2019-08-01-count-2:GCTCAAAAGAGGGCGA"	4.58725513991658	-7.95991423046263	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGAGGGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.28173944079	47.1948966201707	0.0197197412416635	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2389.5057114234	2389.5057114234
"healthy-3"	"2019-08-01-count-4:AGCGCCAAGCACACCC"	2.46426643904988	-4.66081287777098	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCCAAGCACACCC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2711.14004836285	53.3331001682495	0.0196718351751895	2421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2706.49243810133	2706.49243810133
"healthy-3"	"2019-08-01-count-4:TCCGTGTTCAGAGTGG"	-4.05344567719157	13.0046920546326	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGTGTTCAGAGTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2079.41641885581	41.6744158320862	0.0200413998149622	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2069.70701381322	2069.70701381322
"healthy-3"	"2019-08-01-count-2:GCTCAAACACATACTG"	-1.26979933205302	8.97468659961549	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAACACATACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.09357653588	50.155684326991	0.0234800969760552	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2131.52578409973	2131.52578409973
"healthy-3"	"2019-08-01-count-3:TCCTTCTAGTGACACG"	4.78047289428059	-8.37396814739379	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTAGTGACACG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.27573596117	43.5791427520949	0.0166442144169728	1922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2614.30771330842	2614.30771330842
"healthy-3"	"2019-08-01-count-2:ACCTACCCATATGAAG"	10.6773697334224	6.3232645758423	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCCATATGAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.93455328896	48.1025727224882	0.0255194922489779	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1882.98049271652	1882.98049271652
"healthy-3"	"2019-08-01-count-4:AGGTCTAAGAATGTTG"	-0.402966151863891	7.86287973010866	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTAAGAATGTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.65849489322	43.1806677757164	0.0228148225853881	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1888.53920478866	1888.53920478866
"healthy-3"	"2019-08-01-count-4:CGAGTTACAGTCGGAA"	-2.11511359635051	8.80921170795289	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTTACAGTCGGAA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2162.20257867242	40.2747273957943	0.0186267132381845	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2155.8262141472	2155.8262141472
"healthy-3"	"2019-08-01-count-3:GTCTACCGTCCACTTC"	5.13957037505452	-8.30555536663207	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCGTCCACTTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.76405801285	44.5391298558153	0.0163460501193991	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2719.04958624535	2719.04958624535
"healthy-3"	"2019-08-01-count-3:CGAAGGAGTAGGCTCC"	2.79864086684529	-5.33702471172484	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGAGTAGGCTCC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.05132800787	40.7412519552532	0.0165948676878835	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2450.18952881609	2450.18952881609
"healthy-3"	"2019-08-01-count-3:GAGGCCTAGACAAGCC"	4.26557745513265	-8.25460626995238	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCCTAGACAAGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.85390963712	46.5181298009465	0.0188267422932254	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2463.22162249722	2463.22162249722
"healthy-3"	"2019-08-01-count-4:TACTTACGTGATACAA"	3.26163615760152	-6.584095501062	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACGTGATACAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.74976761736	45.0320681671975	0.0174763062883042	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2575.76158265163	2575.76158265163
"healthy-3"	"2019-08-01-count-2:GTGACGCTCCATAGGT"	2.06421365317647	-6.45696165477904	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGACGCTCCATAGGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2513.9796899702	51.1651553087248	0.0203522548383561	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2512.97222526879	2512.97222526879
"healthy-3"	"2019-08-01-count-3:TGGGCGTAGTACAGCG"	-3.56845007363017	-5.47157194530638	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTAGTACAGCG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2986.61130118578	46.2796234221042	0.0154956968801831	3179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2983.20082566308	2983.20082566308
"healthy-3"	"2019-08-01-count-2:TGTTGAGCAGAAGTGC"	-3.59184656563457	-5.72109367763671	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGAGCAGAAGTGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2814.87515937626	41.9831801249282	0.0149147574041014	2529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2809.7988577271	2809.7988577271
"healthy-3"	"2019-08-01-count-3:AGGACTTCAAAGACGC"	3.33891954001729	-6.6591367951599	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACTTCAAAGACGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.80972887631	47.6560622283612	0.0188452542254088	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2523.50073956493	2523.50073956493
"healthy-3"	"2019-08-01-count-3:ACCAACAGTCGCATGC"	-2.12504206124004	9.01242444599	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACAGTCGCATGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.8721222011	46.832320307606	0.0235946284819961	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1967.54790071024	1967.54790071024
"healthy-3"	"2019-08-01-count-2:TCATCATGTGGCTACC"	2.67030539092366	-4.56385567104491	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCATGTGGCTACC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2968.7470700382	41.4750967684385	0.0139705726995142	3138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2964.33064873022	2964.33064873022
"healthy-3"	"2019-08-01-count-3:CATACCCCACCCTTAC"	14.2599760490352	1.93859837138978	"2019-08-01-count-3"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCCACCCTTAC"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1152.33266774859	31.6651934319413	0.0274792117920326	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1136.79512235954	1136.79512235954
"healthy-3"	"2019-08-01-count-4:CAGTGCGCAGTGAGCA"	5.50064053115193	-9.86558630382689	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTGCGCAGTGAGCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.1879380012	45.8156608335013	0.0173729221847671	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2630.52226027359	2630.52226027359
"healthy-3"	"2019-08-01-count-4:AGCGTATCAATATCCG"	10.6808277564937	7.06146571719972	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGTATCAATATCCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2084.32863727926	46.4763254031066	0.0222979834234652	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2072.866745379	2072.866745379
"healthy-3"	"2019-08-01-count-2:TTTCGATCAACGTTAC"	-3.50447974625285	11.6373090513977	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCGATCAACGTTAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2099.99821495405	44.1773954957437	0.0210368728797754	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2091.05905196845	2091.05905196845
"healthy-3"	"2019-08-01-count-2:CGCCATTAGTCATGCT"	10.4868608909542	6.10468194568483	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCATTAGTCATGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2022.69181237766	45.0977089565884	0.0222958874311042	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2018.83444473207	2018.83444473207
"healthy-3"	"2019-08-01-count-4:TCCTTCTAGTGCGTCC"	10.4330431419307	7.82925460422365	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTCTAGTGCGTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2121.19871880543	44.2505121685223	0.0208610875427279	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2115.58801164897	2115.58801164897
"healthy-3"	"2019-08-01-count-2:TGAATCGGTGTGTTTG"	-7.11635432663615	3.29916045749513	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGGTGTGTTTG"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2638.26665620016	42.8369963085065	0.0162367955520477	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2624.40618330583	2624.40618330583
"healthy-3"	"2019-08-01-count-2:GTCAAGTAGCGGATCA"	-3.37075386467631	10.7214860686096	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAGTAGCGGATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1722.79129356482	48.1434922976756	0.0279450520080448	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1720.85845087694	1720.85845087694
"healthy-3"	"2019-08-01-count-2:TACAGGTTCCCAGCGA"	2.71879448470418	-7.25281526958617	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAGGTTCCCAGCGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1633.98841086265	47.2621704088089	0.0289244220427837	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1629.47686736102	1629.47686736102
"healthy-3"	"2019-08-01-count-3:AACCCAAAGTTCTCTT"	2.43305863913838	-6.84925367748412	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAAAGTTCTCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.37721373701	48.1501630715665	0.021226700206639	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2264.85459243924	2264.85459243924
"healthy-3"	"2019-08-01-count-3:TCGACCTGTTAAGCAA"	-2.57234106484111	10.7411136397156	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACCTGTTAAGCAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1910.15617334213	43.2344075101045	0.0226339647582107	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1906.55721924359	1906.55721924359
"healthy-3"	"2019-08-01-count-4:TCCTTTCTCAGTGCGC"	-1.22104511681255	8.34791562640993	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCTCAGTGCGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.4322345669	46.448986312957	0.0227754497186424	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2031.54386869005	2031.54386869005
"healthy-3"	"2019-08-01-count-4:CCTCCTCGTGTTTGCA"	5.25390495833699	-9.0914516679016	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCGTGTTTGCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.49252314204	42.2050468104177	0.0158934911104475	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2649.97648312907	2649.97648312907
"healthy-3"	"2019-08-01-count-2:GCTTTCGTCAACTCTT"	2.5836841064388	-4.34941961681517	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTTCGTCAACTCTT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2964.34064547589	45.763153381951	0.0154378861457079	2856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2957.87997764469	2957.87997764469
"healthy-3"	"2019-08-01-count-4:CCTCCTCTCGGAACTT"	-3.12613115730937	10.500708557013	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCTCGGAACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1828.12989584545	39.2374377485632	0.0214631563313597	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1823.89737981394	1823.89737981394
"healthy-3"	"2019-08-01-count-2:CTGCAGGGTAATCAAG"	4.92156519469563	-8.23401358043822	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGGTAATCAAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.31702182947	47.3298193396216	0.0179462002284388	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2634.58395503148	2634.58395503148
"healthy-3"	"2019-08-01-count-2:TCATGCCTCGTGTTCC"	4.34744085845296	-7.76614096080931	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGCCTCGTGTTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.41643420569	43.3830081205586	0.0197697243988523	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2190.34758387049	2190.34758387049
"healthy-3"	"2019-08-01-count-4:CCTCCTCTCTACTGCC"	-2.88428817215617	9.57982060993043	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCTCTACTGCC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2318.78510895671	45.4286383487216	0.0195915689527441	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2312.34609430296	2312.34609430296
"healthy-3"	"2019-08-01-count-3:GAGTCTATCCTTCTTC"	-3.47923145714458	10.7223605879578	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTATCCTTCTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2098.19513377979	40.6858305956869	0.0193908707253521	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2096.46434252339	2096.46434252339
"healthy-3"	"2019-08-01-count-3:ATGGGTTGTATAGCTC"	-0.234479735524017	7.76063582980958	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTGTATAGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2009.73181008525	40.9377266821387	0.0203697460908488	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2000.22246279494	2000.22246279494
"healthy-3"	"2019-08-01-count-4:TCGAACATCGCAGTTA"	-4.0934399169987	11.197464919928	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACATCGCAGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2143.88669722068	44.7441508590417	0.0208705762842075	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2135.4934090705	2135.4934090705
"healthy-3"	"2019-08-01-count-4:GGAGAACTCTTAGCCC"	2.94657983359639	-6.48789646541747	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGAACTCTTAGCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.94756870067	45.8856464650307	0.0189535895193541	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2415.32593524136	2415.32593524136
"healthy-3"	"2019-08-01-count-4:TCGAACATCGGCACTG"	3.67149414595906	-7.45798303997191	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACATCGGCACTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.11144237525	43.8409825571412	0.018662793840386	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2343.08769902545	2343.08769902545
"healthy-3"	"2019-08-01-count-4:GGAGATGAGTGCCAGA"	-2.4601141017979	9.30591580951539	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGATGAGTGCCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.88997389404	42.2097511526126	0.0214165943871618	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.88997389404	1970.88997389404
"healthy-3"	"2019-08-01-count-2:CGGAATTCAATTTCCT"	-2.41360459747966	8.71067426288453	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTCAATTTCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.99097691356	41.9771032404637	0.0212543265924506	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.11182146702	1973.11182146702
"healthy-3"	"2019-08-01-count-3:GCGGAAATCGCACTCT"	-0.565732519060928	8.38403890216676	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGAAATCGCACTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.37864559048	42.5037931713996	0.0218485965535509	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.89779667027	1936.89779667027
"healthy-3"	"2019-08-01-count-3:GAGTGTTGTGCCTAAT"	-3.00290522995647	9.45091912830202	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTGTGCCTAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1770.41109670368	43.72423972459	0.0246972241678782	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1766.55613487965	1766.55613487965
"healthy-3"	"2019-08-01-count-4:GTCTCACAGGACTTCT"	-2.21266518059428	10.7778539427551	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTCACAGGACTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2063.32492880571	49.0814777730364	0.0237875659271202	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2060.05087929675	2060.05087929675
"healthy-3"	"2019-08-01-count-2:GTCAGCGCATCCGAGC"	-2.16746674004253	8.76943109119264	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAGCGCATCCGAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1861.00368116032	49.2190107537525	0.0264475622762147	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.67320099713	1855.67320099713
"healthy-3"	"2019-08-01-count-3:AGTGTTGCATCGGTTA"	-4.26989779892619	13.1125364073547	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGTTGCATCGGTTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2269.83987137317	39.2093479836274	0.0172740590550589	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2265.09203132344	2265.09203132344
"healthy-3"	"2019-08-01-count-2:TTTGGAGTCGCAGTGC"	4.73956741866414	-8.33406832134398	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGAGTCGCAGTGC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.62340850401	41.8739652254141	0.0157206777398507	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2659.24264734795	2659.24264734795
"healthy-3"	"2019-08-01-count-2:ATCGGATGTGCGCTCA"	-3.2007454437321	10.1044482954773	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGATGTGCGCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.85050851629	40.9175902489428	0.0203686586311312	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.67894516757	1996.67894516757
"healthy-3"	"2019-08-01-count-3:GAGTTGTAGCTGACCC"	3.57569994506184	-6.81565096294554	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTGTAGCTGACCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.07676160348	48.6394976817232	0.0214452608064888	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2265.66731654324	2265.66731654324
"healthy-3"	"2019-08-01-count-2:CGGAGAATCCAAGGGA"	4.38935293731038	-7.55640222942504	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAATCCAAGGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.63269904296	44.6185528670931	0.016941828252401	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2628.16289553372	2628.16289553372
"healthy-3"	"2019-08-01-count-2:TTTGGTTGTATTAAGG"	-5.4152549308842	-5.49969866192015	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGTTGTATTAAGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2749.6839642007	49.6780075213752	0.0180668062832508	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2745.16222270852	2745.16222270852
"healthy-3"	"2019-08-01-count-3:TCGCTCAGTGGGCTTC"	-2.21181497994121	8.88865277850953	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCAGTGGGCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.02389131223	47.9273264501926	0.0256018775575546	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1866.8252956443	1866.8252956443
"healthy-3"	"2019-08-01-count-4:AGGACGATCTTAATCC"	-1.47133121910747	8.78743074024049	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGATCTTAATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1839.87845616978	44.7950803336845	0.0243467606153387	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1825.82267302427	1825.82267302427
"healthy-3"	"2019-08-01-count-4:GGAGGTAAGGATCATA"	2.19126429137532	-6.50073339855345	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGTAAGGATCATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.94730698117	49.7936704723804	0.0189838622910383	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2614.44583659362	2614.44583659362
"healthy-3"	"2019-08-01-count-4:TCGATTTTCCTGTTAT"	4.42244114455525	-8.03027822887572	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGATTTTCCTGTTAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.84051976416	50.5052772000266	0.0190525521333588	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2640.45520566279	2640.45520566279
"healthy-3"	"2019-08-01-count-2:TGACGCGTCGGCTATA"	1.86861683902089	-6.04035141384276	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGTCGGCTATA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2117.23192126869	50.3801547900328	0.0237952934130352	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2115.54998846197	2115.54998846197
"healthy-3"	"2019-08-01-count-3:CATGAGTTCAAAGAAC"	4.33954968032185	-7.64785292064818	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGAGTTCAAAGAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.06484790232	45.4995484571071	0.017941003557043	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2532.85081913043	2532.85081913043
"healthy-3"	"2019-08-01-count-2:GTCATTTAGGCATCGA"	0.120648798614186	7.69313809955446	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATTTAGGCATCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.63369195499	34.9256937862768	0.0183951722411048	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1888.99774187876	1888.99774187876
"healthy-3"	"2019-08-01-count-4:ATCCTATAGATGATTG"	-1.711009601981	8.82032964313356	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATAGATGATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2318.9373379844	49.3147706861588	0.0212661074874161	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2310.697953707	2310.697953707
"healthy-3"	"2019-08-01-count-4:TTGCGTCCACGATTCA"	-0.727331141859847	8.34807012164918	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCGTCCACGATTCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.35482663917	40.2282421634797	0.0198721299418969	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2021.17077539668	2021.17077539668
"healthy-3"	"2019-08-01-count-3:TATCGCCGTCGTAATC"	-1.47044752064403	8.53792474353639	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCGCCGTCGTAATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.77380640693	44.2109230583521	0.0218998893873306	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2018.77380640693	2018.77380640693
"healthy-3"	"2019-08-01-count-2:ATCGTCCCAGAGGAAA"	11.2236734825069	5.24922988498536	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCCAGAGGAAA"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1700.91558642645	38.8410462137088	0.0228353755610601	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1694.37496013407	1694.37496013407
"healthy-3"	"2019-08-01-count-2:ATCGTCCCATTCAGCA"	3.39578117904012	-6.73743965541991	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCCATTCAGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.66379776712	46.2455700717688	0.0188015817908734	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2456.46127419964	2456.46127419964
"healthy-3"	"2019-08-01-count-2:TTACGTTTCAAGCCCG"	-1.15716371956523	8.44282147968141	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTTCAAGCCCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2058.93108748018	47.0071179296298	0.022830835968949	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2054.14939356798	2054.14939356798
"healthy-3"	"2019-08-01-count-3:CATGCCTGTCGAACAG"	-2.90596971932109	9.40408036792604	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTGTCGAACAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2098.55362938402	46.6257645218503	0.0222180476443369	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2096.94056177203	2096.94056177203
"healthy-3"	"2019-08-01-count-4:CCTTGTGAGTCCCGAC"	-0.682536165148574	8.25499341571657	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTGTGAGTCCCGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2106.67840712926	39.769437566246	0.0188777923728943	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2098.69503311993	2098.69503311993
"healthy-3"	"2019-08-01-count-4:CCTTGTGGTAATCAAG"	4.09295668181722	-7.44849398052367	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTGTGGTAATCAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.48299784074	47.4687114230192	0.0182117863275315	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2598.75037347107	2598.75037347107
"healthy-3"	"2019-08-01-count-3:TGTCAGATCCATCGTC"	-1.60212371769603	8.71048925006715	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCAGATCCATCGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.60980126504	43.8172691102663	0.0222579756953913	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.63840537862	1963.63840537862
"healthy-3"	"2019-08-01-count-2:GTCCCATCAACTCCAA"	-3.30124221268352	10.0952701338562	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATCAACTCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.86768995182	41.1741780040526	0.0202045393854918	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2034.77417325418	2034.77417325418
"healthy-3"	"2019-08-01-count-2:TGAGCATTCCACCTCA"	-3.06247482720073	9.740358329657	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCATTCCACCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2269.60087159935	49.5930879802118	0.0218510173311946	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2268.11579837693	2268.11579837693
"healthy-3"	"2019-08-01-count-3:AGGTCATTCCGCAACG"	-2.5539644760197	9.3728570708069	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCATTCCGCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.26604538153	49.4538124452246	0.0253185235888155	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.07873677327	1950.07873677327
"healthy-3"	"2019-08-01-count-4:GTGAGGATCGTACCTC"	1.84612872180287	-6.01201870357665	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGATCGTACCTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2840.23517561397	41.0443613572152	0.0144510432479743	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2834.1409887977	2834.1409887977
"healthy-3"	"2019-08-01-count-2:TACGTCCCAAGAGTAT"	-4.0034044784611	10.3326682814392	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCCAAGAGTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1991.95645213013	41.10548142097	0.0206357329634457	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1988.52610070246	1988.52610070246
"healthy-3"	"2019-08-01-count-4:GAGGCAACAAAGACGC"	-4.15903125229533	13.2882709273132	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCAACAAAGACGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2259.80836041443	39.448598214869	0.0174566122092028	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2251.48924671459	2251.48924671459
"healthy-3"	"2019-08-01-count-3:ATTCACTTCACTAGCA"	2.11269368705098	-6.29110147869261	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTTCACTAGCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2608.37498216548	47.9009977605944	0.0183643065464563	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2606.50465078002	2606.50465078002
"healthy-3"	"2019-08-01-count-3:CATGCTCTCCAATCCC"	-1.08521113815959	8.62369916522828	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCTCCAATCCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2258.68176017476	40.6553933396329	0.0179996111256007	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2250.07432127898	2250.07432127898
"healthy-3"	"2019-08-01-count-3:ATTCAGGCATTACGGT"	4.9070483642513	-8.38033583080443	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCAGGCATTACGGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3006.4728922348	43.8793549820736	0.0145949611238493	2647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3001.17927240961	3001.17927240961
"healthy-3"	"2019-08-01-count-3:AAAGGATTCCCATAGA"	-2.46584902229961	9.04130551898805	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATTCCCATAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2157.13752560097	44.8910834579817	0.0208104874748193	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2144.58559098729	2144.58559098729
"healthy-3"	"2019-08-01-count-3:GATCATGTCTTACACT"	4.89160790023152	-8.21366312420043	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCATGTCTTACACT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3016.68732924521	39.5021701454523	0.0130945523463766	3077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3010.23505036988	3010.23505036988
"healthy-3"	"2019-08-01-count-2:GTCCTCAGTAGGACTG"	-0.801446895033675	8.38642594898073	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCAGTAGGACTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.31975093159	37.6573061437843	0.0202423836681446	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.65454494952	1855.65454494952
"healthy-3"	"2019-08-01-count-4:TTTGGTTAGATGATTG"	4.80956377562825	-8.28531649028929	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTAGATGATTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.07373299025	41.8122042396025	0.0162752060023344	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2560.17969045223	2560.17969045223
"healthy-3"	"2019-08-01-count-2:ACCACAACACGCACCA"	-2.92885218086894	9.66968343341676	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAACACGCACCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2235.82078269652	48.0122990159945	0.0214741268117604	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2228.29299577952	2228.29299577952
"healthy-3"	"2019-08-01-count-2:ATCTTCACAGTCTACA"	3.14767756041829	-6.86930754100951	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTTCACAGTCTACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.45052791361	46.3686049521776	0.0184261937351186	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2509.16614417438	2509.16614417438
"healthy-3"	"2019-08-01-count-4:GTGCACGCATACTGTG"	10.360196729272	7.24872539127199	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGCATACTGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.01018509136	40.1134760046965	0.020719661659633	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1925.31106726133	1925.31106726133
"healthy-3"	"2019-08-01-count-4:CTCGAGGTCGTAACCA"	-4.34890208664592	13.0077895888123	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGTCGTAACCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2108.5465833543	42.5105176895494	0.0201610521793278	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2108.5465833543	2108.5465833543
"healthy-3"	"2019-08-01-count-2:ATGAAAGAGTGGTTCT"	-3.14249382439311	10.0436553725037	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGAGTGGTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.00490853381	47.3307074104951	0.0229983452489504	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2051.98311400778	2051.98311400778
"healthy-3"	"2019-08-01-count-2:CCCTAACCAGTGTACT"	-1.28272245350536	8.37923810565797	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACCAGTGTACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1890.06850642848	48.9400868967335	0.0258932873228029	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1884.99048484201	1884.99048484201
"healthy-3"	"2019-08-01-count-4:ATTCATCGTGCATTAC"	10.4042650657589	7.4544262656006	"2019-08-01-count-4"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCATCGTGCATTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.56692840297	43.271482896099	0.0210611211043557	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2048.1827268094	2048.1827268094
"healthy-3"	"2019-08-01-count-2:AAACGCTCATTGGATC"	-0.139334673911887	8.46865079486696	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTCATTGGATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1843.68828479555	38.4803165321199	0.020871378773439	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1836.61440519014	1836.61440519014
"healthy-3"	"2019-08-01-count-2:GGAGGTAGTGGAACCA"	4.27719559249226	-8.33881666576537	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTAGTGGAACCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.28363056809	46.1901640180905	0.0195780462423539	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2349.6975082897	2349.6975082897
"healthy-3"	"2019-08-01-count-3:GTGGGAAAGGTAGTAT"	2.55065764960591	-4.3716554871765	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGGAAAGGTAGTAT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2706.04856134317	42.488447618302	0.0157012879315117	2787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2700.22753073558	2700.22753073558
"healthy-3"	"2019-08-01-count-2:TGAGTCATCAACGCTA"	-2.50610766831096	3.9050447710785	"2019-08-01-count-2"	"Control3"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGTCATCAACGCTA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3523.55137308913	43.5307539164099	0.0123542271155383	4462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3519.07794378353	3519.07794378353
"healthy-3"	"2019-08-01-count-4:TGGTAGTCAGATTCGT"	-3.28246269646342	10.2350663908753	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTCAGATTCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.39465340152	41.9818594722497	0.0207893288226422	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2008.07674428053	2008.07674428053
"healthy-3"	"2019-08-01-count-3:CGGAGAACATAGAAAC"	-3.31174431267436	9.54655454242555	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAGAACATAGAAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2173.04359328541	45.3669488825185	0.0208771462398177	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2167.31350895659	2167.31350895659
"healthy-3"	"2019-08-01-count-2:GGATCTAAGCAAATGT"	-4.39353738251384	-4.58987667476805	"2019-08-01-count-2"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTAAGCAAATGT"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2951.63999364688	43.5293770463175	0.0147475224417647	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2945.29985535755	2945.29985535755
"healthy-3"	"2019-08-01-count-2:CGTCAAATCTGAATGC"	0.132138018577737	7.82070825183717	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCAAATCTGAATGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1834.03506785632	43.0464654092453	0.0234709063985126	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1826.0423617508	1826.0423617508
"healthy-3"	"2019-08-01-count-2:ATGACCAAGGTCACTT"	-2.71225963059123	9.02740762317506	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCAAGGTCACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2126.79367944048	49.7081751590345	0.0233723541872251	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2114.40394278692	2114.40394278692
"healthy-3"	"2019-08-01-count-4:GGGACAAAGGAATGTT"	-1.90952942791637	9.11221788013307	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAAAGGAATGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.26122896199	43.2986907588348	0.0225365973695456	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.27532068482	1917.27532068482
"healthy-3"	"2019-08-01-count-4:ATTCCATGTGGTCTAT"	3.00610174712483	-6.47636988079222	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATGTGGTCTAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.20875408859	48.0570383020808	0.0215869415722226	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2218.25493114745	2218.25493114745
"healthy-3"	"2019-08-01-count-3:ATTCCTATCGCACTCT"	10.6020523506099	7.68239924991456	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTATCGCACTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2061.30727958778	44.9110067028046	0.0217876330945602	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2053.45849155169	2053.45849155169
"healthy-3"	"2019-08-01-count-4:CGAGAAGTCACCACAA"	-4.34355769577678	12.3846101530823	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGAAGTCACCACAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2055.29845299011	43.9395413125757	0.0213786670488907	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2055.29845299011	2055.29845299011
"healthy-3"	"2019-08-01-count-2:ATGACCACACAGTCGC"	3.124368806451	-6.93035890972289	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCACACAGTCGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.64977228594	52.5309410313703	0.0246433263636161	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2130.24685115383	2130.24685115383
"healthy-3"	"2019-08-01-count-4:ATTCCCGTCTAGTCAG"	-3.17655406418498	10.3305244215759	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCCGTCTAGTCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.18553386638	43.3022233655643	0.0205888746704908	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2094.52983100024	2094.52983100024
"healthy-3"	"2019-08-01-count-4:AGGGCCTGTTGAGTCT"	-4.08363185349162	10.0846595534119	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTGTTGAGTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.77312817222	42.4884974278174	0.020799420572873	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2035.73093512138	2035.73093512138
"healthy-3"	"2019-08-01-count-2:ACCCTTGAGCGACCCT"	5.58847202834432	-10.0502557984558	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGAGCGACCCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.92948915228	42.8801204195786	0.0173398071427738	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2463.88411991702	2463.88411991702
"healthy-3"	"2019-08-01-count-2:ATGACCATCCTGTAAG"	-3.51042685928996	10.0975017317566	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCATCCTGTAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2110.94148626357	50.6069388770325	0.023973634137348	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2101.40302918546	2101.40302918546
"healthy-3"	"2019-08-01-count-2:TCCCAGTTCTCTATGT"	4.52376284179036	-8.2721567383972	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTTCTCTATGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.06634355736	46.3060724612451	0.0175730195842931	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2625.89429984267	2625.89429984267
"healthy-3"	"2019-08-01-count-2:GTCTCACAGTAGGCCA"	2.64353766021077	-4.47710468685301	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACAGTAGGCCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2777.05228859241	40.6074051539355	0.0146224848990935	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2769.91975127675	2769.91975127675
"healthy-3"	"2019-08-01-count-2:TCCCATGTCAGTGTCA"	-0.992958883673507	8.30281446063844	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCATGTCAGTGTCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2057.1761751359	48.7716034014764	0.0237080343389911	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2057.1761751359	2057.1761751359
"healthy-3"	"2019-08-01-count-2:TCCCATGCATGACTCA"	4.52547802504842	-7.72331573879393	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCATGCATGACTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.00943906961	48.1934011337214	0.0183104970743408	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2626.32881963114	2626.32881963114
"healthy-3"	"2019-08-01-count-3:CATTGCCCAATAGTAG"	3.88827242430989	-7.07268145000609	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGCCCAATAGTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.97272144587	46.8190915620321	0.0200426533804097	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2330.39023026251	2330.39023026251
"healthy-3"	"2019-08-01-count-4:CGAGGCTCAAGGCCTC"	10.6644484001095	6.8495096930298	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTCAAGGCCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2042.22027334791	37.139721468426	0.0181859527853678	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2028.67573140029	2028.67573140029
"healthy-3"	"2019-08-01-count-2:TCTGTCGCAGTTTGGT"	5.21981443938558	-9.34020903026732	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGTCGCAGTTTGGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2684.70788293983	39.8743811217444	0.0148524095955202	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2682.05095914846	2682.05095914846
"healthy-3"	"2019-08-01-count-2:TGATTTCTCGTGCACG"	-3.17087898674663	3.07613465869752	"2019-08-01-count-2"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCTCGTGCACG"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3309.90863417498	45.9440851823112	0.0138807714230949	5668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3299.10029721029	3299.10029721029
"healthy-3"	"2019-08-01-count-2:TCCGAAAGTGAGACGT"	10.4864107566768	7.27842757785646	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGAAAGTGAGACGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.10659977627	42.7460574676912	0.021908622251902	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1945.17334066601	1945.17334066601
"healthy-3"	"2019-08-01-count-4:AAAGGTAAGGCCACTC"	3.96528567847554	-7.23049738323363	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTAAGGCCACTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.26035661021	48.2569932674232	0.018515799139188	2180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2600.91427431482	2600.91427431482
"healthy-3"	"2019-08-01-count-4:ACGCACGTCGCCTTTG"	-3.01507912102397	9.95221231067506	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGTCGCCTTTG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2174.11725733411	46.2625213329199	0.0212787609209481	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2169.61467163124	2169.61467163124
"healthy-3"	"2019-08-01-count-4:TCTAACTCAACTAGAA"	10.3558632331783	7.42651412570802	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTAACTCAACTAGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2000.49544754235	40.194056549384	0.0200920509960486	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1986.36140675698	1986.36140675698
"healthy-3"	"2019-08-01-count-4:TCTACATAGATGAACT"	4.33205999907796	-8.15129473125609	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATAGATGAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.15176695762	46.1712217335729	0.0193011256105604	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2389.57759498345	2389.57759498345
"healthy-3"	"2019-08-01-count-4:TTTACCATCGCTGATA"	-3.08840165558513	-5.7893014184204	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCATCGCTGATA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2542.92851134201	48.3236475113341	0.0190031482583172	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2538.05023689066	2538.05023689066
"healthy-3"	"2019-08-01-count-3:CATTTCATCTACCCAC"	-2.94303093376811	11.5247182616028	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCATCTACCCAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2085.67448986129	43.5604417002314	0.0208855417813201	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2082.16014507159	2082.16014507159
"healthy-3"	"2019-08-01-count-2:CAGATTGCAAATTGGA"	-2.83886108818706	9.7465495833191	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGCAAATTGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.11197359147	43.7125323688815	0.022718289251789	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1920.68593342194	1920.68593342194
"healthy-3"	"2019-08-01-count-2:GGTAATCTCTTCCCAG"	-2.1791652244633	9.66862485492555	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCTCTTCCCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.50289279004	48.1306194450685	0.0258141833038649	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1856.93165796886	1856.93165796886
"healthy-3"	"2019-08-01-count-2:CTCAAGAAGAATCTAG"	-0.300557057291824	8.6762714155945	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAAGAAGAATCTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2102.13242132055	40.9799854739617	0.0194944833438315	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2096.0961768958	2096.0961768958
"healthy-3"	"2019-08-01-count-2:TCCGGGACAGCTGAAG"	9.9802996116573	5.60152003848878	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGACAGCTGAAG"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1538.90906341471	32.6525259351291	0.0212179697367405	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1526.60203112806	1526.60203112806
"healthy-3"	"2019-08-01-count-3:TGTTCTACATGGCACC"	-2.51759849014934	9.45181081378785	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCTACATGGCACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1861.6737225039	44.5535055116588	0.0239319623912054	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1854.51813280767	1854.51813280767
"healthy-3"	"2019-08-01-count-3:ATTTCACGTCACTCTC"	-2.92322383347209	9.96114537799684	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACGTCACTCTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2016.33359925535	47.5771991039485	0.0235958965924682	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2013.08596008664	2013.08596008664
"healthy-3"	"2019-08-01-count-4:ATTGTTCGTATGTCAC"	3.8841949897701	-7.31140949642333	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGTTCGTATGTCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.64861833613	47.1251944161783	0.0194921602993783	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2407.49080032505	2407.49080032505
"healthy-3"	"2019-08-01-count-3:CACGAATAGCATCAGG"	4.42367281493489	-8.1732969514099	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATAGCATCAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.80499070977	46.4034172517495	0.0189416779816034	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2444.64185814994	2444.64185814994
"healthy-3"	"2019-08-01-count-4:TGTCAGACAAGATCCT"	4.49223436888997	-7.89026214992674	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCAGACAAGATCCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.08767605486	44.9721484910992	0.0171840435085815	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2615.42181364464	2615.42181364464
"healthy-3"	"2019-08-01-count-2:CGTTGGGAGTCCTGTA"	10.129411359399	5.67371890628663	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGAGTCCTGTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.77045153498	43.0350997137826	0.0229793777868023	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1863.31897642855	1863.31897642855
"healthy-3"	"2019-08-01-count-2:TCCGTGTCAGTGTGGA"	1.9145128923351	-6.33027079021605	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGTGTCAGTGTGGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2342.36067056883	49.2834709252212	0.0210400864155787	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2336.6597291789	2336.6597291789
"healthy-3"	"2019-08-01-count-4:TCTATACCACACCGCA"	3.18903054770772	-6.37125446712645	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACCACACCGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.67918108941	48.972056093767	0.0181466757652897	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2696.78241767764	2696.78241767764
"healthy-3"	"2019-08-01-count-2:AGGACTTCACACACTA"	-0.948455910116988	8.7013425596985	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTCACACACTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.19039204909	48.3873056167276	0.0241792614080973	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1994.7217897059	1994.7217897059
"healthy-3"	"2019-08-01-count-4:TCTATACGTCCACAGC"	11.0314165550167	6.59021613681642	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACGTCCACAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2234.68016990187	38.2564179615386	0.0171194153314649	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2218.81794389461	2218.81794389461
"healthy-3"	"2019-08-01-count-2:GATGATCAGATCCGAG"	0.585201819508713	8.31520459735719	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGATCAGATCCGAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.26972930362	38.0028050419668	0.0204506398843445	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.76374008517	1855.76374008517
"healthy-3"	"2019-08-01-count-3:ACTCCCAAGACGACTG"	-2.22576222840007	9.18362805927125	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCAAGACGACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.73998179914	43.3235926047766	0.0209217926854995	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2064.36718473071	2064.36718473071
"healthy-3"	"2019-08-01-count-2:GTGAGGAAGGAGGTTC"	2.08750452575032	-6.08410646831664	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGAAGGAGGTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2910.49761949536	40.8708875615799	0.0140425772169731	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2905.1912745847	2905.1912745847
"healthy-3"	"2019-08-01-count-2:GATGATCGTTGCCGAC"	10.8366724449093	6.54706714237062	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGATCGTTGCCGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.10273391654	39.4464208372262	0.0204586717000805	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1915.58516288541	1915.58516288541
"healthy-3"	"2019-08-01-count-3:CACGGGTCACAATGCT"	3.14673652228658	-6.76075222408446	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGGGTCACAATGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.52351962369	47.4383088526013	0.019413894923306	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2441.49738826351	2441.49738826351
"healthy-3"	"2019-08-01-count-2:TGCATCCTCACTCACC"	-2.21519623223003	8.84519193256227	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATCCTCACTCACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2301.87289237962	45.8597447610583	0.0199227963076838	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2292.71632955003	2292.71632955003
"healthy-3"	"2019-08-01-count-2:AACAACCGTGTCACAT"	-2.30165920677837	9.04141805255739	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCGTGTCACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.52210874775	46.9923443635321	0.0237272505850715	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.77470412936	1978.77470412936
"healthy-3"	"2019-08-01-count-4:GGGCTACAGGGTTAAT"	-7.43312726441081	1.43750581825105	"2019-08-01-count-4"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACAGGGTTAAT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2735.0538275773	44.0244071958893	0.0160963585988675	3165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2724.75421688792	2724.75421688792
"healthy-3"	"2019-08-01-count-4:CGCATAAGTCGCCACA"	-3.57872853699382	-5.48903372203978	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATAAGTCGCCACA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2533.10259050544	49.4952886690701	0.0195393936489536	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2528.56770017645	2528.56770017645
"healthy-3"	"2019-08-01-count-4:GTAATCGGTATAATGG"	2.67948259887044	-4.70177795803221	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGGTATAATGG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2808.19498081797	43.5316436082641	0.0155016456854375	2762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2801.96391480355	2801.96391480355
"healthy-3"	"2019-08-01-count-3:CAACCAATCCTCGATC"	3.82808794555013	-7.36618235027465	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAATCCTCGATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.41584685693	45.0892894096388	0.0174601195483358	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2575.66801334069	2575.66801334069
"healthy-3"	"2019-08-01-count-2:TCCTCCCTCGCGTGAC"	-3.81316576424297	13.3844432600769	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCTCGCGTGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2154.72855969882	42.4914281766117	0.0197200839917168	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2152.92544018727	2152.92544018727
"healthy-3"	"2019-08-01-count-3:CTTCGGTGTTAAGGAT"	2.06550921973531	-6.02789547359618	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTGTTAAGGAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2712.12641474135	44.3670991501078	0.0163587873002369	2068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2707.54325451771	2707.54325451771
"healthy-3"	"2019-08-01-count-3:CAACCTCCACGTGTGC"	10.7734447914058	6.99452207172243	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCTCCACGTGTGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.12181520747	44.4713093152081	0.0216497916462255	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2049.03360614228	2049.03360614228
"healthy-3"	"2019-08-01-count-2:GGGACTCAGGCTTAGG"	-3.93346987190898	10.9828824766907	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCAGGCTTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.85971988497	46.3483885293187	0.0236247210030064	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.10645759863	1960.10645759863
"healthy-3"	"2019-08-01-count-3:AGTGACTTCTGTGCTC"	-4.11141810837443	11.6595372923645	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTTCTGTGCTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2671.31202703759	39.4314275061613	0.0147610713788047	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2663.24922196365	2663.24922196365
"healthy-3"	"2019-08-01-count-2:GATGGAGGTGAGCCAA"	5.44295992430989	-9.54428865825804	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGGAGGTGAGCCAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.88877824888	40.4835622125651	0.016168274950646	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2498.84101383204	2498.84101383204
"healthy-3"	"2019-08-01-count-3:ACTGATGAGTATGACA"	-4.03912053528483	13.3005018004212	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGAGTATGACA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2198.20484240788	43.5384913842092	0.0198063849848124	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2190.41355519539	2190.41355519539
"healthy-3"	"2019-08-01-count-3:ACTGATGAGTCTGCGC"	-3.70360265198405	-5.47651483928832	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGAGTCTGCGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2751.48816807695	49.088732116567	0.0178407934608259	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2748.18445574211	2748.18445574211
"healthy-3"	"2019-08-01-count-2:TCCTCTTCATGGCTAT"	-0.75320796194728	9.27636716449586	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCTTCATGGCTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.89072331835	46.8457359353143	0.0243368287704957	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1924.89072331835	1924.89072331835
"healthy-3"	"2019-08-01-count-3:ACTGATGTCTCCATAT"	4.66243614730184	-8.01065637981566	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGTCTCCATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2814.14134773561	48.2895937159514	0.0171596191338461	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2809.44639940299	2809.44639940299
"healthy-3"	"2019-08-01-count-3:CAACGATGTAGATGTA"	-4.78688464585002	2.54322431171266	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATGTAGATGTA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3249.04514675065	35.2532346726894	0.0108503369699082	4220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3239.27469357621	3239.27469357621
"healthy-3"	"2019-08-01-count-2:AACCAACAGGTTCTAC"	-2.64511952820476	10.4385604628357	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCAACAGGTTCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2071.52886199109	51.6754655779158	0.0249455687179019	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.77455934309	2067.77455934309
"healthy-3"	"2019-08-01-count-4:CTGGTCTTCCGAGTGC"	3.0676244693691	-6.96760132229003	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTTCCGAGTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.37366760566	50.5168679315552	0.0215849582614887	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2330.28741577628	2330.28741577628
"healthy-3"	"2019-08-01-count-4:AACACACGTGACACAG"	4.77355255660359	-8.25137140667113	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACGTGACACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.13985406031	41.3606533787465	0.0148079421510604	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2781.8455956994	2781.8455956994
"healthy-3"	"2019-08-01-count-3:CATCCCAAGTATTAGG"	0.477422435849351	8.05581472003785	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCAAGTATTAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.916844088	38.81861871179	0.0195076587381625	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1980.74873553542	1980.74873553542
"healthy-3"	"2019-08-01-count-4:TTCATGTGTGCATACT"	4.47351660308186	-7.56063845073851	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTGTGCATACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.1882776435	44.764460702784	0.0166895296187458	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2678.43265182419	2678.43265182419
"healthy-3"	"2019-08-01-count-2:TAGTGCATCGTTCCCA"	4.74054588851277	-8.46068384563597	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCATCGTTCCCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.86074661465	47.6409662926954	0.0192889280733722	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2467.05492982296	2467.05492982296
"healthy-3"	"2019-08-01-count-2:TGTAACGTCAAGATAG"	0.440173585980576	10.9838247069153	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGTCAAGATAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.84290255103	40.2620808373832	0.0215900657274167	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1859.18808397952	1859.18808397952
"healthy-3"	"2019-08-01-count-1:TGCATCCTCCACGTGG"	-3.5303193134373	12.1224365004334	"2019-08-01-count-1"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCATCCTCCACGTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2390.83805236793	32.4317030980039	0.0135649936915982	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2381.67346044203	2381.67346044203
"healthy-3"	"2019-08-01-count-3:TTCTGTAAGCCGGAAT"	4.99714006957356	-8.65705206310423	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTAAGCCGGAAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.48842274238	46.5373349177543	0.0190923306480348	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2431.90478354714	2431.90478354714
"healthy-3"	"2019-08-01-count-4:TGATCTTTCGCTAAAC"	-1.90214703503307	8.92036626422731	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTTCGCTAAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2111.55474905204	49.4613899611433	0.0234241570024876	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.75827882108	2108.75827882108
"healthy-3"	"2019-08-01-count-2:CTACATTAGGGTTGCA"	10.7629324394161	6.89375207507936	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACATTAGGGTTGCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2173.27352865484	42.9625997961258	0.0197686113734233	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2169.46817003421	2169.46817003421
"healthy-3"	"2019-08-01-count-4:GGGTGAACACATGACT"	-7.20012317124065	3.51477549159852	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAACACATGACT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2452.45634749336	44.6351832153903	0.0182001947806376	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2437.50465178035	2437.50465178035
"healthy-3"	"2019-08-01-count-3:GCAGCTGTCAGCCTCT"	-1.64081404629405	8.80262849414674	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCTGTCAGCCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.06898717291	44.1319952130493	0.0217177642548679	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2025.55970447006	2025.55970447006
"healthy-3"	"2019-08-01-count-2:CTACATTTCTGGACCG"	4.40522684630696	-7.65492393886717	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACATTTCTGGACCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.30888028795	48.3364759338937	0.0188570625669052	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2558.03188553066	2558.03188553066
"healthy-3"	"2019-08-01-count-2:GGGCGTTCAGAGTAAT"	-4.17580781403239	12.381812072638	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTCAGAGTAAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2000.26470773633	49.8663722949745	0.0249298865805653	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1996.73048278132	1996.73048278132
"healthy-3"	"2019-08-01-count-2:ACGTAACAGGAACTCG"	3.36452545699422	-6.76413061535033	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACAGGAACTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.42020533275	47.9944243595447	0.0198125924865922	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2417.93259633752	2417.93259633752
"healthy-3"	"2019-08-01-count-3:CCCAACTCAATAGGGC"	-0.777996878058273	8.55870339954225	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTCAATAGGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.60728233607	49.5861412920249	0.0259123916122914	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1911.94813577495	1911.94813577495
"healthy-3"	"2019-08-01-count-4:CAACGATCACATAGCT"	-4.10538659516032	10.686180091742	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGATCACATAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2126.56066512756	43.6348812318777	0.0205189919795965	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2119.9090103299	2119.9090103299
"healthy-3"	"2019-08-01-count-4:CTGTCGTCACATTCGA"	-2.55038962784465	3.57985947215883	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTCGTCACATTCGA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3281.05226062817	46.9228042109064	0.0143011450241036	5280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3275.35937765503	3275.35937765503
"healthy-3"	"2019-08-01-count-4:TTTCGATCAATAGTAG"	2.66291560706441	-6.06941893016966	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATCAATAGTAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2510.67057527415	45.1188942739976	0.0179708539695897	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2508.35005045714	2508.35005045714
"healthy-3"	"2019-08-01-count-3:CAAGCTAGTACAAGCG"	2.61679925498311	-6.69408466732176	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTAGTACAAGCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.32178432551	50.9296980805365	0.0227738684287321	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2229.63850100386	2229.63850100386
"healthy-3"	"2019-08-01-count-2:ATCGTCCAGGTTACCT"	4.65244259414021	-8.2219219437805	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCAGGTTACCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.27244045198	43.5940462736308	0.0157705317448749	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2756.45113088712	2756.45113088712
"healthy-3"	"2019-08-01-count-4:AACCACACATGACTAC"	10.8178736167843	6.27636048877565	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACACATGACTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2219.6743140484	42.8706121109876	0.0193139199925222	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2211.15152057533	2211.15152057533
"healthy-3"	"2019-08-01-count-3:TTACTGTGTATGTGTC"	-1.55454562130626	8.92710206592409	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTGTATGTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.73888428113	51.4023558547484	0.0262158088804335	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.9216122661	1950.9216122661
"healthy-3"	"2019-08-01-count-3:CTTTCAACAGCTGCCA"	4.00430287894551	-7.77760507976683	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAACAGCTGCCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.98396144835	43.3378985030764	0.0198072286025298	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2181.73133433571	2181.73133433571
"healthy-3"	"2019-08-01-count-2:CTACCCATCCCGAGTG"	2.3880635696346	-4.60135033046874	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCATCCCGAGTG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2378.59894662648	36.1060561042433	0.0151795476725708	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2367.79221996756	2367.79221996756
"healthy-3"	"2019-08-01-count-4:GGGTTTATCCTATTGT"	10.0962873893673	7.5455922850403	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTTATCCTATTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2035.06341141599	44.6574240230764	0.0219439963258952	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2025.31422345136	2025.31422345136
"healthy-3"	"2019-08-01-count-4:CTTACCGAGTCACTCA"	-7.198562960059	3.50297138774721	"2019-08-01-count-4"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGAGTCACTCA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2407.77305159683	41.8805715761624	0.017393903278545	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2389.07090857206	2389.07090857206
"healthy-3"	"2019-08-01-count-2:CAGTTCCGTAATACCC"	-4.21287141266521	11.0127601393494	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCGTAATACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.76361200004	45.2904021709385	0.0209216387045116	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2158.15186146397	2158.15186146397
"healthy-3"	"2019-08-01-count-4:TCTGTCGGTTTCGTAG"	-1.73630819740947	8.62090871417848	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTTTCGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.40545849387	50.9490366828975	0.0253552793277898	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.28532439304	2006.28532439304
"healthy-3"	"2019-08-01-count-3:CTTTCGGGTATTCTCT"	4.475433965295	-7.47571661388548	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCGGGTATTCTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.02547765753	45.9761265492225	0.017349314916724	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2638.90600828886	2638.90600828886
"healthy-3"	"2019-08-01-count-4:CAAGACTGTGCTCTTC"	-2.6192287010258	9.41850755298463	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTGTGCTCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.37394087143	44.6236198142293	0.0217742691679072	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2046.02027161419	2046.02027161419
"healthy-3"	"2019-08-01-count-2:CATAAGCCACACGGAA"	4.43300785598103	-7.85332062160643	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAAGCCACACGGAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2927.24029763621	45.645425629404	0.0155933305735998	2948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2921.08239169908	2921.08239169908
"healthy-3"	"2019-08-01-count-3:GGTGAAGGTTGCGGCT"	0.531990070908707	8.0535473593506	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGGTTGCGGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.43750995278	34.9353765136391	0.0206909502470222	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1679.57351602061	1679.57351602061
"healthy-3"	"2019-08-01-count-2:CATAAGCCACAGAAGC"	5.5097242790157	-9.88455297863158	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATAAGCCACAGAAGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2735.11788379021	43.9524039489495	0.0160696561597711	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2728.36837740024	2728.36837740024
"healthy-3"	"2019-08-01-count-2:TTCGCTGGTCTTTCAT"	-2.4533785385197	9.6540841826233	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGGTCTTTCAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2113.92865586558	43.3542254279991	0.0205088404037207	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2110.7341389618	2110.7341389618
"healthy-3"	"2019-08-01-count-2:AACGGGATCATTTGTC"	-2.24481425705608	8.67692182147828	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGGGATCATTTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.06497506176	41.5418157783513	0.019585357481631	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2121.06497506176	2121.06497506176
"healthy-3"	"2019-08-01-count-2:GGGTCACAGCTCCACG"	10.6311937766964	6.95852849567262	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACAGCTCCACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2109.97700514203	44.8329181237187	0.0212480600567971	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2103.465640473	2103.465640473
"healthy-3"	"2019-08-01-count-2:GGGTCACAGGATAATC"	10.9271408515865	6.12911698901979	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACAGGATAATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.95680690631	40.3812846554101	0.0206875912994258	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1940.01354972548	1940.01354972548
"healthy-3"	"2019-08-01-count-3:GCATCTCTCAGGAACG"	10.865401883691	6.98334834659425	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCTCAGGAACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2329.78175066894	42.2498379128318	0.0181346763063539	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2320.32564596664	2320.32564596664
"healthy-3"	"2019-08-01-count-2:CATACAGGTATAGCTC"	2.93824829634969	-6.96983864223631	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGGTATAGCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2005.16466424497	49.2725975008523	0.0245728435072964	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1995.01714394321	1995.01714394321
"healthy-3"	"2019-08-01-count-2:CTACTATCACTAACGT"	10.7926699119503	6.09720418536989	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCACTAACGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.83201811453	52.7667668492973	0.0260727008847585	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2013.312734439	2013.312734439
"healthy-3"	"2019-08-01-count-2:GGGTCACTCACCCTCA"	2.85399260100667	-6.94108917629393	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACTCACCCTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.66479186994	46.6089824710781	0.0197691302986762	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2353.70011093572	2353.70011093572
"healthy-3"	"2019-08-01-count-2:CATTCTAAGGAGTCTG"	-2.8723124069279	9.11463258350221	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCTAAGGAGTCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.75253084182	43.1976300707186	0.0213664280923303	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.64844951938	2010.64844951938
"healthy-3"	"2019-08-01-count-3:CTACAGACACCCTCTA"	-2.48219571533855	8.87276837909547	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACAGACACCCTCTA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2277.76683855952	44.5353267133705	0.019552188555671	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2262.93581586398	2262.93581586398
"healthy-3"	"2019-08-01-count-4:TCTTGCGGTCCCTGAG"	-3.03833232346233	9.56645295703737	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGGTCCCTGAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2064.61182389608	46.1184785295982	0.0223376026407565	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2061.51560239937	2061.51560239937
"healthy-3"	"2019-08-01-count-2:GGGTCTGCAACGTTAC"	3.25745167311971	-6.50688364421996	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGCAACGTTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.7090151893	44.6859273280637	0.0184293979393544	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2416.17058556103	2416.17058556103
"healthy-3"	"2019-08-01-count-2:TGGAACTTCGAAGTGG"	-3.56848178330119	12.0890340575012	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTTCGAAGTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1930.97830641374	41.2855820532157	0.0213806555547961	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1919.47337895215	1919.47337895215
"healthy-3"	"2019-08-01-count-2:GTGTAACGTCATATGC"	-3.84295258942302	10.5309867628845	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTAACGTCATATGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2142.98240508913	49.1359067703991	0.0229287495098941	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2136.63720175799	2136.63720175799
"healthy-3"	"2019-08-01-count-4:CTTCCGAGTGGACCAA"	-2.30963359299358	8.70110795581666	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCGAGTGGACCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.15533696261	47.6999727924746	0.0233006122843846	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.70445630613	2043.70445630613
"healthy-3"	"2019-08-01-count-3:CTACATTCAGGTCCCA"	-0.830787043005782	8.64283845508424	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACATTCAGGTCCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2479.05562170118	43.5531105461987	0.0175684281405157	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2467.91138330148	2467.91138330148
"healthy-3"	"2019-08-01-count-4:TGAACGTCAATGCTCA"	-3.78488979759868	10.0539951094422	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAACGTCAATGCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2159.16007276238	44.7182337963194	0.0207109395734184	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2153.24073044929	2153.24073044929
"healthy-3"	"2019-08-01-count-2:AGGTCTAGTGCAAGAC"	-4.0220607322758	11.279607749823	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCTAGTGCAAGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.54778025954	47.7344140031973	0.0233929410842445	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.11820694609	2037.11820694609
"healthy-3"	"2019-08-01-count-4:TTTGGTTTCTGTCGCT"	-3.69187579575236	10.4022111662659	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTTCTGTCGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.95063659207	41.4311746566549	0.0200931942411246	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.58958189105	2058.58958189105
"healthy-3"	"2019-08-01-count-1:AGTGATCCAGAACATA"	10.2187715965206	7.79698894107667	"2019-08-01-count-1"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGTGATCCAGAACATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2172.1165822262	44.0718750297166	0.0202898294641936	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2158.38659003987	2158.38659003987
"healthy-3"	"2019-08-01-count-4:TGAATCGCAAATCAAG"	2.61595477637593	-4.40546419536742	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCAAATCAAG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2752.10317711328	42.3834972261591	0.015400402709689	2971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2748.39687620779	2748.39687620779
"healthy-3"	"2019-08-01-count-3:GAAGCGACATCTCATT"	0.594679315655869	9.00129411304323	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGACATCTCATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1999.80300584014	41.1178007589159	0.0205609255705873	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1993.35009906212	1993.35009906212
"healthy-3"	"2019-08-01-count-4:GGTGAAGTCGGCATTA"	10.4323631721431	7.12870118701784	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGTCGGCATTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1854.59190112159	40.8642035519773	0.0220340677252306	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1846.71285774326	1846.71285774326
"healthy-3"	"2019-08-01-count-2:CATACCCTCTCTTGCG"	-2.573957781226	8.89242742145387	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCTCTCTTGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.70952315587	45.1567037294043	0.0221605205335982	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2035.99104456755	2035.99104456755
"healthy-3"	"2019-08-01-count-2:CATACCCTCCGTCCTA"	10.4874893623287	7.5316066511902	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCTCCGTCCTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2220.06655885644	52.8370605543667	0.0237997641753512	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2206.79613206579	2206.79613206579
"healthy-3"	"2019-08-01-count-3:AGACAAATCGATACTG"	-1.43966565552409	8.71774957263795	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAATCGATACTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.37920918053	43.6140927557178	0.0210759306763253	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2057.69809097338	2057.69809097338
"healthy-3"	"2019-08-01-count-2:GGGTTATAGAGGTCGT"	-1.54393253746684	8.57161805713502	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTATAGAGGTCGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.40402615518	47.5812555606859	0.0242464115067624	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1960.72813140405	1960.72813140405
"healthy-3"	"2019-08-01-count-2:CTATCCGAGGACATCG"	-1.86643455448802	9.4677409895691	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCCGAGGACATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2044.44119486524	49.1899628034262	0.0240603461361327	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2044.44119486524	2044.44119486524
"healthy-3"	"2019-08-01-count-3:CACAGATAGTCATCGT"	-0.540742139250594	9.1192588576111	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGATAGTCATCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.9046971576	51.178064616998	0.0259931649768935	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.81040275303	1963.81040275303
"healthy-3"	"2019-08-01-count-3:GCCAGGTGTATCTTCT"	-2.07994041863139	8.88684651935426	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTGTATCTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2178.603239302	45.5204011435359	0.0208943052697012	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2174.06092092307	2174.06092092307
"healthy-3"	"2019-08-01-count-2:GTGTGGCTCCACTGAA"	3.27081479605977	-7.16622736370238	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGGCTCCACTGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2045.1227153746	51.282943126265	0.0250757290703075	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2035.88158499352	2035.88158499352
"healthy-3"	"2019-08-01-count-4:TTACCATGTGTCATCA"	-1.00679383698161	9.06315038287965	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATGTGTCATCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1947.26540447682	43.4149278440106	0.0222953315681562	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.87902132478	1943.87902132478
"healthy-3"	"2019-08-01-count-4:ACAACCAAGCTCGTGC"	-3.73925910416301	12.9314603575501	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCAAGCTCGTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1680.01309187917	44.13986302271	0.0262735232457846	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1675.87840432805	1675.87840432805
"healthy-3"	"2019-08-01-count-3:GAGAGGTTCACCCTCA"	-2.01691875878032	9.25474927509157	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTTCACCCTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.79359846531	47.3702495033334	0.0234182318647207	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2013.27098555503	2013.27098555503
"healthy-3"	"2019-08-01-count-2:TGGATGTGTTACAGCT"	-2.95413384857829	-5.75426247036131	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATGTGTTACAGCT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2508.9064044264	46.3151560219998	0.0184602964623499	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2503.72134478672	2503.72134478672
"healthy-3"	"2019-08-01-count-2:TCGCTTGAGATGCGAC"	5.14878906783406	-8.9829311600891	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTTGAGATGCGAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2700.16497154998	44.9609227430628	0.0166511762121163	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2694.87508594408	2694.87508594408
"healthy-3"	"2019-08-01-count-4:GGTGTCGGTCAAAGTA"	4.63650240477864	-7.52748157894286	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGGTCAAAGTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.70755342317	49.1297455834837	0.0207850355735983	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2356.05738367783	2356.05738367783
"healthy-3"	"2019-08-01-count-2:TGGCGTGGTACCAGAG"	4.66874327239339	-8.16958715831908	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGCGTGGTACCAGAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.58786415339	47.9733170372635	0.0194966892815143	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2456.84706338491	2456.84706338491
"healthy-3"	"2019-08-01-count-2:AGGTTGTCAAGGCCTC"	-8.2457164329594	-0.0810608497825489	"2019-08-01-count-2"	"Control3"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTCAAGGCCTC"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3077.25010574237	47.2225840098867	0.015345708794279	4058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3065.4372066372	3065.4372066372
"healthy-3"	"2019-08-01-count-2:TGATTTCGTGTTTACG"	10.8224426704342	6.65746448123781	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCGTGTTTACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.65608471933	39.2636395759631	0.020922128404702	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1869.90159308323	1869.90159308323
"healthy-3"	"2019-08-01-count-3:AGACAGGAGGCCCAAA"	-4.5089934867924	12.874822593573	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAGGAGGCCCAAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2211.89183258799	37.0680934786388	0.0167585471099949	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2208.51810565927	2208.51810565927
"healthy-3"	"2019-08-01-count-3:AAGTACCAGACAAGCC"	-3.42228279534038	10.0803460844788	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCAGACAAGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.99402671577	44.6399865610422	0.0225455157736445	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1979.99402671577	1979.99402671577
"healthy-3"	"2019-08-01-count-3:CACCAAAAGGCACGAT"	10.0874859291012	7.6501893767151	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAAAGGCACGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.60010396493	39.8558772146698	0.0205909666635315	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1925.71696047916	1925.71696047916
"healthy-3"	"2019-08-01-count-2:TCGGATACATAACGGG"	-3.22429070892985	9.51008889758912	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATACATAACGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.41023776944	48.3785084445332	0.0242570497926445	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.65407994142	1989.65407994142
"healthy-3"	"2019-08-01-count-2:CTATCTATCGGTAACT"	11.2382198768551	5.89284131610719	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTATCGGTAACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.77667820176	41.8540302651922	0.0208045111163152	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2002.26919699964	2002.26919699964
"healthy-3"	"2019-08-01-count-3:GTAAGTCGTTTGGAGG"	-3.01177893105205	-5.68698742305907	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAAGTCGTTTGGAGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2287.14051557068	51.3699539517301	0.0224603401505099	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2284.69433275201	2284.69433275201
"healthy-3"	"2019-08-01-count-4:CGTGCTTTCGGTGAAG"	2.55880369719807	-4.38650181209715	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGCTTTCGGTGAAG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2613.49748186379	43.3783710108733	0.0165978239167609	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2607.88130049212	2607.88130049212
"healthy-3"	"2019-08-01-count-2:GGTAATCGTGTCTAAC"	-3.86526165428813	10.4925689467224	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCGTGTCTAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.3016043641	47.5919354225531	0.0237330560744477	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.27170408092	1998.27170408092
"healthy-3"	"2019-08-01-count-4:GGTTAACTCATTTGGG"	10.6837698417598	6.22168967807619	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACTCATTTGGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.58996172778	40.7604181747224	0.0217901405485326	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1864.12504198648	1864.12504198648
"healthy-3"	"2019-08-01-count-4:GTCATTTCACGGCACT"	-3.63097248497661	13.3867177733215	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATTTCACGGCACT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2333.64920412484	41.197865392538	0.0176538381688725	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2323.8926384205	2323.8926384205
"healthy-3"	"2019-08-01-count-4:TGCTCCAGTAATTGGA"	5.21253599700276	-8.95084097301634	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCCAGTAATTGGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2757.49546581997	43.5308513883864	0.0157863727893537	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2753.4055642449	2753.4055642449
"healthy-3"	"2019-08-01-count-2:TCTTCCTGTCACTTCC"	-4.05817447128947	10.7705392607483	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTGTCACTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2226.923996676	44.7024778904769	0.0200736432663179	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2225.34097546279	2225.34097546279
"healthy-3"	"2019-08-01-count-3:TTGTGTTTCCGGCTTT"	-2.61811242523845	9.00771901691285	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTTCCGGCTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1895.44499027101	44.723673048099	0.0235953421374178	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.58037771381	1893.58037771381
"healthy-3"	"2019-08-01-count-3:GAGGCAACATGGTGGA"	11.0837265449459	6.29554030979005	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAACATGGTGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1803.17061274705	42.1938078471781	0.023399786769427	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1799.83643903529	1799.83643903529
"healthy-3"	"2019-08-01-count-4:CGTTGGGTCTGATTCT"	5.08333029326741	-8.25684454357298	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTGGGTCTGATTCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2814.92289390856	39.3738143313975	0.0139875285453117	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2810.65368941957	2810.65368941957
"healthy-3"	"2019-08-01-count-2:CTCAATTGTCCCGCAA"	-3.54205761376079	10.8709258803162	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAATTGTCCCGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2023.61349810066	47.2026991497836	0.0233259459842937	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.93325163004	2016.93325163004
"healthy-3"	"2019-08-01-count-2:TCATATCAGATTGGGC"	0.297263716428918	8.40987489307252	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCAGATTGGGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.09316541695	37.6581969664634	0.0204987954205993	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1830.6039694871	1830.6039694871
"healthy-3"	"2019-08-01-count-3:ACATTTCTCGTTCTGC"	-3.97341094437297	13.3010549315247	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATTTCTCGTTCTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2502.39673228295	52.0596438632963	0.0208039129813769	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2493.48752213815	2493.48752213815
"healthy-3"	"2019-08-01-count-3:TTGTTGTCACTGTCCT"	-0.141219834715682	8.31696603381959	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTGTCACTGTCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2017.33084343957	41.5954540890458	0.0206190542440352	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2015.89774585142	2015.89774585142
"healthy-3"	"2019-08-01-count-4:ATAGGCTAGAGAGCAA"	-3.35681448403056	-4.63998796856078	"2019-08-01-count-4"	"Control3"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTAGAGAGCAA"	"DC precursor"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3046.04148129811	42.343410973865	0.0139011274908245	3378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3041.30519625141	3041.30519625141
"healthy-3"	"2019-08-01-count-3:TCCTTTCTCTCTATAC"	-2.60998044434245	12.9355859526428	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCTCTCTATAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1987.56226995386	46.5200872930764	0.0234055999131823	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1975.23160211304	1975.23160211304
"healthy-3"	"2019-08-01-count-4:TTAGGGTTCTCGTGAA"	-3.60884175720866	3.55442402446596	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTTCTCGTGAA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2825.90692681616	51.0529298777925	0.0180660337371096	3472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	2824.56836470029	2824.56836470029
"healthy-3"	"2019-08-01-count-3:TAGGAGGCAGAAACCG"	-3.79617486420329	12.4808053740296	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGCAGAAACCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.94252653811	40.0938678186854	0.0198686866902342	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2016.20533706518	2016.20533706518
"healthy-3"	"2019-08-01-count-2:CTGAATGTCTCGGCTT"	-1.88721177998241	8.71292493427125	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGTCTCGGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.54858475235	48.0939510728241	0.0243939974113624	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1963.44792000094	1963.44792000094
"healthy-3"	"2019-08-01-count-2:GCCAACGAGCATTTCG"	2.91088475760762	-6.56294014370116	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGAGCATTTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.1549115529	47.0535617731949	0.0196699476049607	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2385.06606070615	2385.06606070615
"healthy-3"	"2019-08-01-count-3:TACAGGTTCCTAGAGT"	-2.75284848633464	3.47047088229982	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAGGTTCCTAGAGT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3203.09624378397	46.3380667623398	0.0144666482789161	5844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3194.12972332812	3194.12972332812
"healthy-3"	"2019-08-01-count-2:ACTGCAAGTAACGCGA"	-2.04837212982829	8.89531705463258	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAAGTAACGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1863.57433314883	43.9784816471086	0.0235989951486397	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.96216097444	1852.96216097444
"healthy-3"	"2019-08-01-count-2:CACCAAAAGAGTCACG"	-4.19793973389323	13.2183913954529	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAAAGAGTCACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2092.67293895496	47.2021188967087	0.0225558987350793	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2083.63000335125	2083.63000335125
"healthy-3"	"2019-08-01-count-4:TGAGGAGGTATCGAGG"	-3.95924125137981	13.1328925856384	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGGTATCGAGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2211.76201598484	38.3851381758091	0.0173550037926287	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2211.76201598484	2211.76201598484
"healthy-3"	"2019-08-01-count-3:TTCGATTGTATGCTAC"	-3.68717918816264	10.474621749762	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGATTGTATGCTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.77500102606	42.414983416442	0.0211043442150429	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2006.48357541998	2006.48357541998
"healthy-3"	"2019-08-01-count-4:AGAAGCGGTACCACGC"	4.46643461760823	-8.23312475597533	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAGCGGTACCACGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.11429748687	48.8309059152947	0.0191110456245825	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2551.737940507	2551.737940507
"healthy-3"	"2019-08-01-count-2:AGTCACAGTTGTGCAT"	2.66351928290669	-4.44141294872435	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCACAGTTGTGCAT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2798.94263842175	41.2159300666735	0.0147255358151656	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2792.6569577752	2792.6569577752
"healthy-3"	"2019-08-01-count-2:GTGAGTTGTGAGTGAC"	-0.937231282622176	8.42654988849489	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTGTGAGTGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1941.85971510841	38.3923066793495	0.0197708961057499	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1935.23191579329	1935.23191579329
"healthy-3"	"2019-08-01-count-1:CGATGCGAGGTAGCAC"	-2.30050621452983	8.64595220172731	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGATGCGAGGTAGCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2294.88643757939	46.5178159641371	0.0202702038769306	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2293.53163111614	2293.53163111614
"healthy-3"	"2019-08-01-count-3:CACGTGGTCCCTCTCC"	-4.15400443497356	13.0537013777527	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGTCCCTCTCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2176.55282781902	41.5769094331795	0.01910218254378	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2171.28896499506	2171.28896499506
"healthy-3"	"2019-08-01-count-3:GACCCAGAGCGCCCAT"	9.72427811202351	7.07756612384645	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCAGAGCGCCCAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2037.17350916123	40.4352823280473	0.0198487179153905	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2031.31455139597	2031.31455139597
"healthy-3"	"2019-08-01-count-4:GTAATGCTCCTTATGT"	3.32682504233662	-7.05093099987181	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATGCTCCTTATGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.32062865534	47.3827464236791	0.0200662061088507	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2357.58140194426	2357.58140194426
"healthy-3"	"2019-08-01-count-2:GGTGGCTGTGGAAATT"	-0.864145736128646	8.37515828693239	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGGCTGTGGAAATT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.72922683403	42.298893548429	0.0217617212132607	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.72922683403	1943.72922683403
"healthy-3"	"2019-08-01-count-4:ATCACTTAGCCGTTGC"	-3.89828167381938	11.061629272345	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACTTAGCCGTTGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2059.54210064246	45.7654223672034	0.0222211637979758	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2054.16508550504	2054.16508550504
"healthy-3"	"2019-08-01-count-2:TCGTCCAAGTCGAATA"	10.3805729347164	6.87227914417116	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCAAGTCGAATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1778.37623180594	40.3340604452754	0.0226802741309223	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1774.94666476659	1774.94666476659
"healthy-3"	"2019-08-01-count-3:GCGATCGAGATGCTTC"	2.68421592292134	-4.61299946224364	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGATCGAGATGCTTC"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2670.05228401486	44.557960975534	0.0166880481113777	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2662.09886186129	2662.09886186129
"healthy-3"	"2019-08-01-count-4:CACGGGTGTTACACTG"	3.21372189101521	-6.62260343944701	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTGTTACACTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.37962725981	52.236772012705	0.0220001769780133	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2368.30944425705	2368.30944425705
"healthy-3"	"2019-08-01-count-2:GACCCAGAGATCCTAC"	3.43043603476827	-6.69897653972777	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGAGATCCTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2744.97938379773	41.0395436735973	0.0149507657200756	2544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2740.11952903173	2740.11952903173
"healthy-3"	"2019-08-01-count-2:TCGTCCAGTTAAGAAC"	-3.63510213318523	10.6224555739197	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTCCAGTTAAGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1821.43048977493	46.9741614462232	0.0257897085339928	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1821.43048977493	1821.43048977493
"healthy-3"	"2019-08-01-count-2:ACTTATCTCAACTCTT"	4.45614685592	-8.1070184937683	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCTCAACTCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.65366616572	47.3563948614323	0.0185155619339292	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2551.98216047152	2551.98216047152
"healthy-3"	"2019-08-01-count-4:TGATCAGAGTAGTCAA"	-2.40216813507732	9.16072366321412	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCAGAGTAGTCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.90710890381	44.173255602883	0.0236865715144643	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1860.91590296719	1860.91590296719
"healthy-3"	"2019-08-01-count-4:CTACCCAAGATGGCAC"	-1.7406589788502	8.46643827045289	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCAAGATGGCAC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2252.45869950308	48.240829706634	0.0214169652554679	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2242.65602613024	2242.65602613024
"healthy-3"	"2019-08-01-count-2:GACCCAGTCGTGCATA"	3.75355329093282	-7.39187624370726	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGTCGTGCATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.91090019558	43.6972602061729	0.0168851486358632	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2580.67585175408	2580.67585175408
"healthy-3"	"2019-08-01-count-2:TTCCGTGCATACAGCT"	10.1416889625484	7.32166240299074	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGTGCATACAGCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2048.97579916472	45.7498232858025	0.0223281423355282	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2044.68671483546	2044.68671483546
"healthy-3"	"2019-08-01-count-3:CATCCCAAGTGAGTTA"	-3.77659974518474	12.9415578612122	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCAAGTGAGTTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1763.46625376131	41.0424155353986	0.0232737175706418	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1757.26021270836	1757.26021270836
"healthy-3"	"2019-08-01-count-4:ATGGTTGCATCACGGC"	-0.15222510221656	7.86424157703248	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGCATCACGGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.35570311128	39.6902198069597	0.0199412696659782	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.53107574419	1981.53107574419
"healthy-3"	"2019-08-01-count-2:CGAAGGACAGACCGCT"	-7.25359235230144	3.32994721019594	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGGACAGACCGCT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2530.17572269975	41.6116831874751	0.0164461633293495	2710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2511.99939428079	2511.99939428079
"healthy-3"	"2019-08-01-count-3:ATGTCCCCACGGCCAT"	-0.394414464861709	8.05843827808229	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCCCCACGGCCAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2120.44152262083	38.9395133687811	0.0183638704266895	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.97074803989	2111.97074803989
"healthy-3"	"2019-08-01-count-3:ACCCTCAGTAGGTCAG"	4.92064442214314	-8.37062933361205	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCAGTAGGTCAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.59236227682	43.2646771747496	0.0166236855997304	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2595.37985330452	2595.37985330452
"healthy-3"	"2019-08-01-count-3:TTCTGTAAGCAGATAT"	-4.0556415123051	3.64540336215822	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTAAGCAGATAT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3035.29080995265	43.2423842587973	0.0142465374708106	4212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3022.42312932516	3022.42312932516
"healthy-3"	"2019-08-01-count-2:GCCCAGAAGGCACCAA"	10.3082014518673	7.09099242770997	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGAAGGCACCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2218.95209972574	41.6002291970805	0.0187476914000182	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2213.61169500841	2213.61169500841
"healthy-3"	"2019-08-01-count-4:AGACCCGCATCACCAA"	-2.61784229698833	9.19793126666871	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCCGCATCACCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.56942233709	49.4315455685463	0.0240476166999726	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.70016382581	2050.70016382581
"healthy-3"	"2019-08-01-count-4:TTCCAATTCATAGCAC"	-3.24718318405803	3.04363296115724	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCAATTCATAGCAC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3373.34685797773	45.5274431623236	0.0134962235071245	5910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3367.19004590208	3367.19004590208
"healthy-3"	"2019-08-01-count-4:ATCCCTGCATTCTGTT"	10.4492441612178	6.96300647342531	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCCTGCATTCTGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2004.08903989912	41.9435854909116	0.020929002981336	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2001.1648199129	2001.1648199129
"healthy-3"	"2019-08-01-count-4:TGATGCAGTTAGGCCC"	-1.77659461918529	8.94253442371217	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCAGTTAGGCCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2163.74814014464	48.8014964430302	0.0225541483029388	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2155.0146660001	2155.0146660001
"healthy-3"	"2019-08-01-count-2:GTTGCGGCACACTTAG"	-3.1287559074467	9.53107354724733	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCGGCACACTTAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2116.26676385098	49.952560754221	0.0236040945345294	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.80148574764	2108.80148574764
"healthy-3"	"2019-08-01-count-4:CCGATCTAGAGGTTAT"	-3.49174008789714	10.6220454939636	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATCTAGAGGTTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.87378846882	50.2881184913876	0.0263858597540129	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1902.33979075994	1902.33979075994
"healthy-3"	"2019-08-01-count-3:AGGGCTCTCTGGAAGG"	10.5250441032345	6.69467113101808	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCTCTCTGGAAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2173.90908122407	44.855195435241	0.0206334275074577	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2170.51397724218	2170.51397724218
"healthy-3"	"2019-08-01-count-2:TTGGGATGTAAGGCCA"	-3.63136444512065	10.4913730391297	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATGTAAGGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2225.76036563488	44.5441115531015	0.0200129862319637	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2211.88852451357	2211.88852451357
"healthy-3"	"2019-08-01-count-2:CAACGGCCACGTCGGT"	-3.38314185562785	10.0115642317566	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCCACGTCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1777.84716913863	43.267525646833	0.0243370332376749	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1774.18725214371	1774.18725214371
"healthy-3"	"2019-08-01-count-4:GATTCTTCACCGTACG"	-3.80807671967204	13.3469400175842	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCTTCACCGTACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2245.8614377611	45.5290802282879	0.0202724350945159	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2238.82072868931	2238.82072868931
"healthy-3"	"2019-08-01-count-2:GTTGCTCTCTCAGAAC"	-1.38799188557323	8.70127961719362	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCTCTCTCAGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.74109279871	44.4875569818184	0.0220372771627403	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2017.22958102664	2017.22958102664
"healthy-3"	"2019-08-01-count-2:TGTAGACGTTAGAGTA"	-4.145828585059	12.6201104887756	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACGTTAGAGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1903.44492229841	36.413729724144	0.0191304351901995	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1901.52203255389	1901.52203255389
"healthy-3"	"2019-08-01-count-3:CGCCAGAAGACCAAAT"	-3.45056353035625	11.2190408476624	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGAAGACCAAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.94829267461	47.169556166267	0.024190157422876	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1941.517337424	1941.517337424
"healthy-3"	"2019-08-01-count-2:AATCACGTCTGTCGCT"	-2.73742495003398	9.88595101917116	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGTCTGTCGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.48234405795	45.0536809179673	0.0231938689459837	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1942.48234405795	1942.48234405795
"healthy-3"	"2019-08-01-count-4:CTACTATAGAGCTTTC"	3.59879698333089	-6.74284746563109	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATAGAGCTTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.96656414074	44.6822073117714	0.0163254487275036	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2731.20232691165	2731.20232691165
"healthy-3"	"2019-08-01-count-3:GACTCAACAATTTCTC"	-3.01109347763713	13.0270147093567	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCAACAATTTCTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2132.43195549057	45.2574506901331	0.0212233973391764	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2128.91164170224	2128.91164170224
"healthy-3"	"2019-08-01-count-2:CAAGACTTCTAATTCC"	4.25289883193318	-8.17148115551146	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGACTTCTAATTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.40825444983	47.3118509747924	0.0183634914587305	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2570.9175652776	2570.9175652776
"healthy-3"	"2019-08-01-count-4:TACACCCTCCGCAACG"	-1.55126057091411	9.49149606311647	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCTCCGCAACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2114.02707250057	49.8117586806806	0.023562498006121	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2104.11164584007	2104.11164584007
"healthy-3"	"2019-08-01-count-4:TGATTCTTCGATCCCT"	-3.35566530647929	10.0034217604431	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTCTTCGATCCCT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1912.02448918668	50.46190287308	0.0263918705845368	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1910.10488096946	1910.10488096946
"healthy-3"	"2019-08-01-count-3:CCTCAGTCAACGGGTA"	-2.73083792153056	8.87436101520387	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAGTCAACGGGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.75645714729	40.2129418253967	0.0203531876005904	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1971.48037854976	1971.48037854976
"healthy-3"	"2019-08-01-count-4:TGATTTCGTCACTTCC"	10.2846294837887	7.14138600910035	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCGTCACTTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2105.93916471194	43.4163259989138	0.0206161349417957	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2099.34056326867	2099.34056326867
"healthy-3"	"2019-08-01-count-2:GTAACACGTGAGACCA"	-3.54086766663249	9.80088613117067	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACGTGAGACCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1962.04573977574	40.4605768915164	0.020621627758862	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.81285671071	1958.81285671071
"healthy-3"	"2019-08-01-count-4:TACAGGTTCGTTCCTG"	10.5411764579708	6.71446034992067	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAGGTTCGTTCCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.78609624691	43.9008813593064	0.0227726932177664	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1920.33543628631	1920.33543628631
"healthy-3"	"2019-08-01-count-2:ATACCGACATGCCGCA"	-4.19245419922526	12.2637042769226	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGACATGCCGCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2282.6698305802	50.192298781206	0.0219884181710363	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2278.00334301313	2278.00334301313
"healthy-3"	"2019-08-01-count-4:GTAGTACTCTTAGTTC"	-3.47157369080241	-5.32723953640135	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGTACTCTTAGTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3042.44108066495	41.2961831737679	0.0135733715391268	3080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3038.78244653821	3038.78244653821
"healthy-3"	"2019-08-01-count-3:AGCCACGGTGCAGATG"	-3.86214790764506	10.156036353949	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGGTGCAGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.72026026013	47.4877197079927	0.0240113430914373	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1976.09700204658	1976.09700204658
"healthy-3"	"2019-08-01-count-2:GTAACCACACCATTCC"	10.7949968772823	6.33664176547853	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACCACACCATTCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.08226256721	42.5391888178363	0.0217360249139632	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1951.4957725619	1951.4957725619
"healthy-3"	"2019-08-01-count-3:CTCCCAAAGCCAAGGT"	-0.855696479708511	9.29592225635377	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAAAGCCAAGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2034.04202318008	39.6318381804999	0.0194842769858503	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.02450955073	2027.02450955073
"healthy-3"	"2019-08-01-count-2:AGAACCTGTAGGAAAG"	-3.37414012375529	9.69477746570436	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTGTAGGAAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.72066922408	48.020673275159	0.0229355682355446	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2087.0502484335	2087.0502484335
"healthy-3"	"2019-08-01-count-2:CGAGGAAGTAGCTTGT"	2.40004291114156	-6.03481438076171	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAAGTAGCTTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.65747774632	50.0983139462772	0.0218993946574692	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2284.80251091723	2284.80251091723
"healthy-3"	"2019-08-01-count-2:CAAGGGAAGACCTGGA"	-4.34312663498576	12.8734216460022	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGAAGACCTGGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2057.06439799807	40.1811416556053	0.0195332444111664	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2039.8052379973	2039.8052379973
"healthy-3"	"2019-08-01-count-2:TATCTTGCACAGAAGC"	-0.816916744143325	8.44289395892946	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTTGCACAGAAGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2168.6415856303	39.1719185988544	0.0180628827088868	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2168.6415856303	2168.6415856303
"healthy-3"	"2019-08-01-count-4:CCGGTGATCGGATACT"	-0.677548865706283	8.65883920276491	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTGATCGGATACT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2349.39151348787	52.6543681290286	0.0224119172248387	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2342.71744926235	2342.71744926235
"healthy-3"	"2019-08-01-count-3:GACTTCCGTCAATGGG"	14.1313196617061	1.90877029979555	"2019-08-01-count-3"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTTCCGTCAATGGG"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1364.57193691184	46.3191011836695	0.0339440522926877	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1345.44886614193	1345.44886614193
"healthy-3"	"2019-08-01-count-3:CAGCAGCAGACTCTTG"	-2.71613631668742	9.92145631397096	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCAGCAGACTCTTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2081.71833769315	46.8566627308426	0.0225086467666738	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.41894991406	2075.41894991406
"healthy-3"	"2019-08-01-count-3:TGCTGAATCTTCGTGC"	10.2817589240963	6.92498920047609	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCTTCGTGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.4199767896	44.0016996603024	0.022699776202873	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1929.41362900035	1929.41362900035
"healthy-3"	"2019-08-01-count-2:AATGCCAGTCGAGCAA"	-2.69085369530376	9.15689084613649	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGCCAGTCGAGCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1947.04641376904	49.3219760100692	0.0253316899182661	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.04339109842	1937.04339109842
"healthy-3"	"2019-08-01-count-4:TGCAGTACACTACCGG"	-2.15339503708537	9.99902341449586	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTACACTACCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1798.85354961945	47.7195525168806	0.0265277584864959	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1793.31596256704	1793.31596256704
"healthy-3"	"2019-08-01-count-2:TAACCAGGTTCAAACC"	-3.98002658310588	13.0325116881165	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACCAGGTTCAAACC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2051.70848562403	54.5117446364206	0.0265689521773561	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2046.3524151497	2046.3524151497
"healthy-3"	"2019-08-01-count-2:CATTGAGCAGCGATTT"	2.66948737677876	-4.57039120113524	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGAGCAGCGATTT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2759.50171040665	42.9523877853656	0.0155652694917286	2412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2747.92035788149	2747.92035788149
"healthy-3"	"2019-08-01-count-4:CCGTGAGGTGAGATAT"	-4.98841557923015	-2.74601533329161	"2019-08-01-count-4"	"Control3"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTGAGGTGAGATAT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2852.23236096302	40.5192439533457	0.0142061511214552	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2845.30284291882	2845.30284291882
"healthy-3"	"2019-08-01-count-3:CCTCTAGGTATGGAAT"	10.0087582069332	7.66349742496339	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGGTATGGAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.41527977159	38.9619885849204	0.0188822817039686	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2051.0033843646	2051.0033843646
"healthy-3"	"2019-08-01-count-4:ATCGTAGAGCCTTGAT"	-0.424034397036392	8.02676436984865	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTAGAGCCTTGAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2144.43492731965	34.7498237651191	0.0162046529472234	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2141.57086878709	2141.57086878709
"healthy-3"	"2019-08-01-count-2:CAATCGACATGAGTAA"	4.81789793547933	-8.58574964916381	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATCGACATGAGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.38175695424	49.1825499528957	0.0212784191987846	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2302.01442160973	2302.01442160973
"healthy-3"	"2019-08-01-count-2:GCACTAACACTCCCTA"	-3.33070621910747	10.2069072493347	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAACACTCCCTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2206.44369649956	42.4799364027329	0.0192526718312032	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2204.95316181764	2204.95316181764
"healthy-3"	"2019-08-01-count-4:TGCAGTATCCCATGGG"	-3.85857973519023	10.4457273253235	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTATCCCATGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2331.69795765504	40.954529640898	0.0175642516246339	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2326.00349990954	2326.00349990954
"healthy-3"	"2019-08-01-count-4:TATCTTGGTCACTGAT"	10.2599617439205	7.73948953235475	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGGTCACTGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2117.44150186279	43.8324855079996	0.0207006830977094	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2110.56489536454	2110.56489536454
"healthy-3"	"2019-08-01-count-2:GACTGATTCTTCGGAA"	9.87337555465047	6.17672154987184	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATTCTTCGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.50812356052	46.1961714812461	0.0233726190803747	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1967.67749031383	1967.67749031383
"healthy-3"	"2019-08-01-count-2:AGACACTTCACTGATG"	-0.637333909899551	8.44033429706422	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTTCACTGATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2184.283658487	40.2056432963438	0.0184067866552612	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2179.79845655628	2179.79845655628
"healthy-3"	"2019-08-01-count-2:TGTGGCGAGAGTTGCG"	-3.98548350754436	11.1030444868836	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGAGAGTTGCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.58192999441	39.5539485968035	0.0220162231047969	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1794.78902471758	1794.78902471758
"healthy-3"	"2019-08-01-count-3:CTCCGATTCTGAATCG"	-2.31488547745402	10.4605169066223	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCGATTCTGAATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.69231368929	44.2451268814711	0.0264514438904092	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1668.5008259358	1668.5008259358
"healthy-3"	"2019-08-01-count-3:TCCTAATCAATCGCCG"	-2.26832280579265	9.66879937732545	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATCAATCGCCG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1960.22078542104	42.6248379669917	0.0217449168399856	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1951.2974787998	1951.2974787998
"healthy-3"	"2019-08-01-count-2:GACTTCCTCCATGATG"	2.20618261870686	-6.0439081422058	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCTCCATGATG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2785.91337075002	41.8421888779642	0.015019199562081	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2779.76296372531	2779.76296372531
"healthy-3"	"2019-08-01-count-4:GACCAATTCTCTCTTC"	-5.85472188416179	-4.661084198114	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATTCTCTCTTC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3432.0895137474	40.441104945225	0.0117832314056018	5048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3427.90270704119	3427.90270704119
"healthy-3"	"2019-08-01-count-2:AATTTCCCAGAGTTCT"	-3.33656583252605	10.4534005888733	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCCAGAGTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.78689930689	30.2667548746778	0.0152878852189971	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.62974841769	1973.62974841769
"healthy-3"	"2019-08-01-count-2:CAATTTCAGTGCTAGG"	-3.085925201804	9.71598813617555	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCAGTGCTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.04837216805	42.882369051659	0.0218114516706273	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.91315488738	1958.91315488738
"healthy-3"	"2019-08-01-count-3:CGGGACTGTATGGTAA"	-4.10633979263957	13.2189512022766	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGACTGTATGGTAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2114.18834141109	48.4987506940404	0.022939654781026	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2107.20472035231	2107.20472035231
"healthy-3"	"2019-08-01-count-3:CATTGAGAGCCACTCG"	-3.94878564301189	10.7462091215881	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGAGAGCCACTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1943.75633710463	48.2867403883786	0.0248419719419695	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1942.0612773561	1942.0612773561
"healthy-3"	"2019-08-01-count-2:TCTGGCTGTACCGTCG"	5.62626852568929	-1.82118620788725	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTGTACCGTCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2441.72532888533	41.1281815084863	0.0168439017369991	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2437.85299490116	2437.85299490116
"healthy-3"	"2019-08-01-count-4:GTCATCCAGAACGTGC"	-3.99463687363322	12.3008575209412	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCAGAACGTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2306.06706344783	45.6201260709301	0.0197826536764819	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2301.4557614897	2301.4557614897
"healthy-3"	"2019-08-01-count-2:TGTGTGATCAGCTTGA"	10.5514027076656	7.78461406314699	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGTGATCAGCTTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.53267363069	43.6535111418739	0.0222095067294089	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1960.01704829292	1960.01704829292
"healthy-3"	"2019-08-01-count-2:AGACCATGTTCTAACG"	-3.61184583130534	9.43294522846071	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATGTTCTAACG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2014.3847103853	39.4719587951249	0.0195950448748069	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2007.12517431664	2007.12517431664
"healthy-3"	"2019-08-01-count-4:TACGGGCTCTTCTAAC"	-3.77619800987895	10.751627899054	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCTCTTCTAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2295.47652692261	46.8471090853608	0.0204084461487243	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2286.20628333295	2286.20628333295
"healthy-3"	"2019-08-01-count-2:GAGAAATGTCCTGTCT"	-3.00179157677348	9.23870275104371	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATGTCCTGTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2079.35739807243	47.5078931616175	0.0228473917978975	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.75775680791	2067.75775680791
"healthy-3"	"2019-08-01-count-2:CTCTCAGTCGGCAGTC"	0.175844487815541	7.66541526401369	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGTCGGCAGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.11352371306	38.5830642033182	0.0204780994975726	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1880.13015194072	1880.13015194072
"healthy-3"	"2019-08-01-count-4:GACCTTCCAGCTGAAG"	-4.31049285355266	12.9996528395447	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCCAGCTGAAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2575.48841861068	41.8868652881214	0.016263658957052	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2560.22115719613	2560.22115719613
"healthy-3"	"2019-08-01-count-3:GTTACAGAGTGAGGCT"	4.94993891295735	-8.53925611889037	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGAGTGAGGCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.1115697548	46.937556565386	0.0191027371907537	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2448.89465306776	2448.89465306776
"healthy-3"	"2019-08-01-count-3:AGCTTCCCAATGTCTG"	-3.69147596779521	11.1354551085266	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCCAATGTCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.13377011028	47.5126885867553	0.0261039542076495	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1812.45319014289	1812.45319014289
"healthy-3"	"2019-08-01-count-3:TTGTGGAAGTCACTAC"	-2.46677027168925	9.22326943958131	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGGAAGTCACTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.35266073771	43.1185094275863	0.0231278718536678	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.65549132903	1855.65549132903
"healthy-3"	"2019-08-01-count-3:GAGCTGCGTGGAGAAA"	-1.65834663334544	9.00286099994508	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCGTGGAGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.98956809477	41.1204959614926	0.0202964993547139	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2020.85605300418	2020.85605300418
"healthy-3"	"2019-08-01-count-4:CTCACTGCAGCCGGTT"	10.1458717781002	6.70732591235963	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGCAGCCGGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.08256435414	36.5071511232636	0.0183353276136521	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1986.19422706054	1986.19422706054
"healthy-3"	"2019-08-01-count-2:TCTTCCTAGCGGGTTA"	-7.27770839157756	3.26810572231141	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTAGCGGGTTA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2515.40372246306	44.513653775581	0.0176964251813994	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2507.57304081158	2507.57304081158
"healthy-3"	"2019-08-01-count-2:GTAGGAGTCTCCGAGG"	4.13111033019368	-7.56050827419432	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGAGTCTCCGAGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2681.3543929564	47.0857385972082	0.0175604309228563	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2672.47338805916	2672.47338805916
"healthy-3"	"2019-08-01-count-4:ACGGAAGTCATCCCGT"	3.83811416205708	-7.10841324245604	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGAAGTCATCCCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.93880670746	40.3942867020282	0.0174569381804464	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2309.1679302655	2309.1679302655
"healthy-3"	"2019-08-01-count-2:TAGAGTCAGGACGCTA"	-2.49213157120402	8.88114163959352	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCAGGACGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.15903982133	49.1308996391498	0.0245144714880162	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.46574328834	2002.46574328834
"healthy-3"	"2019-08-01-count-2:CAGATTGTCAAACGAA"	-2.16922173920329	8.64650628650514	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGTCAAACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2446.33277498258	49.2503361690155	0.0201323126079469	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2433.28868292004	2433.28868292004
"healthy-3"	"2019-08-01-count-2:TGCAGGCTCTCTGAGA"	-2.28972874108012	10.7998027571472	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGGCTCTCTGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1811.9812058551	46.9983962088995	0.0259375737767215	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1806.8538821438	1806.8538821438
"healthy-3"	"2019-08-01-count-4:ACGGGTCAGTCTTCGA"	-1.69426212731059	8.44015977466432	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCAGTCTTCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2090.83474123782	44.0730489858451	0.0210791642766338	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.53013924056	2085.53013924056
"healthy-3"	"2019-08-01-count-3:GATTTCTCAACACAGG"	-2.73941932144817	10.9658393629822	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTTCTCAACACAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.6517874415	48.1389997558136	0.0228509524178543	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2099.96348080177	2099.96348080177
"healthy-3"	"2019-08-01-count-4:TACTTACAGCACGATG"	-2.66595230522807	9.52901647174684	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACAGCACGATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.52828417974	44.7941129130963	0.0234828040478352	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1905.5996309704	1905.5996309704
"healthy-3"	"2019-08-01-count-4:GTGGTTAAGGGTTTCT"	11.1796165901119	5.81309745395509	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGTTAAGGGTTTCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1845.58737976859	40.2513002670412	0.0218094795772217	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1827.28964745649	1827.28964745649
"healthy-3"	"2019-08-01-count-3:AGTCACAAGATGTTGA"	10.9138885932857	6.40157268131105	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACAAGATGTTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.93700306437	43.1278988267451	0.0223236569092766	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1924.61420201885	1924.61420201885
"healthy-3"	"2019-08-01-count-4:GATCCCTCAGTGTATC"	4.90119661864583	-8.46472074901732	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCCCTCAGTGTATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.36458506842	43.8854490350042	0.0167286885264785	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2617.96459671377	2617.96459671377
"healthy-3"	"2019-08-01-count-4:AGCGCTGCACAGAGAC"	-4.81291757050212	-4.04534485256346	"2019-08-01-count-4"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGCACAGAGAC"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3339.16631331987	41.8191354499915	0.0125238252683539	5252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3331.44019054169	3331.44019054169
"healthy-3"	"2019-08-01-count-2:CAGCAATGTAATGCTC"	2.76708187636678	-6.00859358226927	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATGTAATGCTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2841.76167579531	45.5808067387125	0.0160396303204969	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2836.91549482715	2836.91549482715
"healthy-3"	"2019-08-01-count-2:GAGATGGCAAGTATCC"	-2.76418266716655	9.40400407398073	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGCAAGTATCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1992.33782820413	43.987684632	0.022078426665045	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1987.05824485148	1987.05824485148
"healthy-3"	"2019-08-01-count-4:TCAAGCAAGGACAGCT"	5.07001175460164	-8.45388128673705	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCAAGGACAGCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.86803607835	46.5742286306989	0.017123708949443	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2718.36767913036	2718.36767913036
"healthy-3"	"2019-08-01-count-4:TGTCCACCATATGCGT"	-3.09745750847514	10.1803807982239	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCACCATATGCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1867.98064110628	44.1266347859336	0.023622640307343	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1866.26151101099	1866.26151101099
"healthy-3"	"2019-08-01-count-2:CACATGACACAGCCAC"	-0.147428016096908	8.62572572315065	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGACACAGCCAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2165.28128672531	35.512303194427	0.0164007805416055	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.30412332161	2151.30412332161
"healthy-3"	"2019-08-01-count-1:TCATTCACATGCAGGA"	10.3282391029293	6.65652177417604	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCATTCACATGCAGGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.46058950936	47.7300645383543	0.02414926196439	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1965.04478728746	1965.04478728746
"healthy-3"	"2019-08-01-count-3:CATACCCCATGTACGT"	10.3792768913204	6.90626809680787	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACCCCATGTACGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.36078230469	43.0111596821193	0.022996183457782	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1862.34403718446	1862.34403718446
"healthy-3"	"2019-08-01-count-2:ACCTGTCTCCATACAG"	2.98510112342183	-6.80142786419066	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCTCCATACAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.9018421283	47.4810470643308	0.0207349704650225	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2286.2596728128	2286.2596728128
"healthy-3"	"2019-08-01-count-4:GTCGAATCAATTTCTC"	10.9110418754512	6.48891160571901	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGAATCAATTTCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1904.14869694849	42.9959287758717	0.0225801319218269	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1902.31290737529	1902.31290737529
"healthy-3"	"2019-08-01-count-2:CCACCATCAGCGTTGC"	3.49074186858479	-6.58944895183715	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATCAGCGTTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.75310905321	44.7238874814202	0.0168087325837363	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2657.32289164343	2657.32289164343
"healthy-3"	"2019-08-01-count-3:GGAGATGGTCGTTATG"	3.93111147460286	-7.77681782161864	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGGTCGTTATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.80620070539	47.70937823916	0.0205483895359852	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2317.98147244641	2317.98147244641
"healthy-3"	"2019-08-01-count-3:TCGAAGTTCTTTCGAT"	-1.64136491242107	8.73261067951051	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAAGTTCTTTCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2010.64298134155	43.9776861338767	0.0218724490334598	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.95041431727	2003.95041431727
"healthy-3"	"2019-08-01-count-3:AATCGTGTCCGCACTT"	-4.01690993729289	10.9925994643006	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGTGTCCGCACTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.71115488406	46.551356816416	0.0223620633953939	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.01498311974	2075.01498311974
"healthy-3"	"2019-08-01-count-2:TAGGTACAGTCAGCGA"	-7.22205720368083	3.55528042400209	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTACAGTCAGCGA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2366.88549706351	52.3713517812512	0.0221266942766036	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2355.76566404747	2355.76566404747
"healthy-3"	"2019-08-01-count-4:GATGAGGAGACGGTTG"	-3.51299033585246	10.0965661772522	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGAGACGGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2389.51878887091	47.0775927547213	0.0197017043657423	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2382.50494148501	2382.50494148501
"healthy-3"	"2019-08-01-count-4:GTCGTAACACAACGCC"	-3.85017285767253	11.5657691725525	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTAACACAACGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.9413486792	48.154567888682	0.0269028747362116	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1786.14751847913	1786.14751847913
"healthy-3"	"2019-08-01-count-3:GAGTCTACATGATGCT"	4.98173632201497	-8.65016081249388	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTACATGATGCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.67206806721	45.179099473851	0.0170058999817467	2115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2648.76266789156	2648.76266789156
"healthy-3"	"2019-08-01-count-3:CATCAAGCAACCGACC"	10.9500462013179	5.32324073398439	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCAAGCAACCGACC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2065.26535617199	53.6643457514892	0.025984237614365	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2060.58606201794	2060.58606201794
"healthy-3"	"2019-08-01-count-3:GGAGCAAGTTCAAGTC"	-1.78677366200145	9.087695098761	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAAGTTCAAGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.44255755184	45.6756344612503	0.0243805897742271	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.33905558034	1867.33905558034
"healthy-3"	"2019-08-01-count-2:GAGGCAAAGGATTTCC"	2.54890098151509	-6.62541153347167	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCAAAGGATTTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1598.79343949359	49.6739940995457	0.0310696759646948	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1598.79343949359	1598.79343949359
"healthy-3"	"2019-08-01-count-3:TAGGTTGCAGCTACCG"	-3.83165607872661	11.8502235182556	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGCAGCTACCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2188.73580022107	39.9149203974129	0.0182365182647359	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2187.12916751646	2187.12916751646
"healthy-3"	"2019-08-01-count-3:GGAGGATTCTTTGCTA"	5.05152191695516	-8.41820242321166	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGATTCTTTGCTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2916.5677093317	44.0816400794392	0.0151142179687438	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2912.7719633394	2912.7719633394
"healthy-3"	"2019-08-01-count-3:CATCCACCAAAGGAGA"	-0.228176037699539	8.35935113513795	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACCAAAGGAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1964.34881993877	39.8860293263921	0.0203049626021286	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1955.50571116619	1955.50571116619
"healthy-3"	"2019-08-01-count-3:CATCCACTCTTCGGAA"	-1.69259784641917	8.81076047504274	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCACTCTTCGGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.34225994762	47.9228401088745	0.0267077475566303	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1790.49566344855	1790.49566344855
"healthy-3"	"2019-08-01-count-2:TGACAGTTCTCTCAAT"	3.59034385260884	-6.21952154552611	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACAGTTCTCTCAAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2751.14104811013	46.3055845590404	0.0168314105853822	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2744.16098102581	2744.16098102581
"healthy-3"	"2019-08-01-count-3:TAGTGCAAGCGTCTGC"	-3.73240576210673	13.2248353728089	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCAAGCGTCTGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2010.07972976283	41.705539250681	0.020748201493282	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2002.67325375676	2002.67325375676
"healthy-3"	"2019-08-01-count-2:TACCCGTTCGGATAAA"	2.61687936362569	-4.45328762447508	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCGTTCGGATAAA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2523.21367796812	43.4516525850766	0.0172207581801265	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2518.76549056222	2518.76549056222
"healthy-3"	"2019-08-01-count-4:CCCTGATGTACTAGCT"	4.148858209222	-7.54386379635008	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATGTACTAGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.74669978037	43.4668062368893	0.0170675812559757	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2542.66315828594	2542.66315828594
"healthy-3"	"2019-08-01-count-4:ATCATTCCATCGGAGA"	-3.64689312401469	10.2021064528259	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCATTCCATCGGAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.2470013788	38.3485276035082	0.0200646633197295	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1905.61856109858	1905.61856109858
"healthy-3"	"2019-08-01-count-2:TTGCTGCAGATGAATC"	-1.47116587582286	8.91060254657594	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCAGATGAATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1977.26738671729	51.5138614466532	0.0260530577668495	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1965.70529618614	1965.70529618614
"healthy-3"	"2019-08-01-count-2:GAGGCCTTCCGGTAGC"	3.72095908698384	-7.30922987377318	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCCGGTAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.97574953995	39.033677700638	0.0160106915370277	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2434.29115751353	2434.29115751353
"healthy-3"	"2019-08-01-count-3:TCGCACTTCAAGAGGC"	-4.27625213089641	12.1478910216126	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTTCAAGAGGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1976.83820223156	48.9135776601155	0.0247433389363375	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1970.21193145589	1970.21193145589
"healthy-3"	"2019-08-01-count-4:TCCACCACATGCCGAC"	14.2584721046383	1.85905084693757	"2019-08-01-count-4"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCACATGCCGAC"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1885.85245783432	52.2206942263051	0.0276907634048289	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1858.16085792417	1858.16085792417
"healthy-3"	"2019-08-01-count-3:GAGTTACCAAGGCGTA"	-3.6658767265385	13.1675519713196	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTACCAAGGCGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2160.41235068495	40.6994098972471	0.0188387230263442	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2155.22167604637	2155.22167604637
"healthy-3"	"2019-08-01-count-3:CGTGATAGTTGTTTGG"	-4.00925193253215	13.3503560789856	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGATAGTTGTTTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1913.14004776414	48.5483388408694	0.02537625977649	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1909.24411511858	1909.24411511858
"healthy-3"	"2019-08-01-count-3:TGTAAGCAGCCATTGT"	10.8971477943355	6.49309346759645	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAAGCAGCCATTGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.03018976947	46.5491478165707	0.0238343206676519	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1943.19488407207	1943.19488407207
"healthy-3"	"2019-08-01-count-3:CGATGGCCAGACCATT"	4.93066515502278	-8.34146406566771	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGGCCAGACCATT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2960.6412210754	45.1764778670955	0.0152590180618664	3234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2955.99931548899	2955.99931548899
"healthy-3"	"2019-08-01-count-4:TAGGTACGTTCCAGGC"	-2.8191376728123	9.88332555377809	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTACGTTCCAGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.79653649395	44.1606395138963	0.0231474576398239	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1904.3092989257	1904.3092989257
"healthy-3"	"2019-08-01-count-3:CTGCCTACAGCTCATA"	3.25073804435078	-7.52587845241698	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTACAGCTCATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.90503282719	46.6435790919878	0.0185838023677923	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2503.7102129068	2503.7102129068
"healthy-3"	"2019-08-01-count-3:TCGCTCAGTAACAGGC"	-3.73752007904704	13.3410205611023	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCAGTAACAGGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1988.69844072942	47.7514807439094	0.0240114236356493	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1985.00253572828	1985.00253572828
"healthy-3"	"2019-08-01-count-3:ATGTCTTGTCACGTGC"	-1.94703529301341	8.95353696430055	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCTTGTCACGTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.29813146045	44.2383490714948	0.0226017428619758	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1951.07616333899	1951.07616333899
"healthy-3"	"2019-08-01-count-3:TCTTTGAGTGTGTGGA"	-2.76491008225139	3.90806291187135	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTTGAGTGTGTGGA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3441.85830323259	48.1985550326751	0.0140036430283626	5550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3431.70939795766	3431.70939795766
"healthy-3"	"2019-08-01-count-3:CTGCGAGAGGACAGCT"	-3.76693211022075	10.6961049803528	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGAGGACAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.28902543306	45.0381323677206	0.0231524116873554	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.50643394987	1943.50643394987
"healthy-3"	"2019-08-01-count-2:ATCGTAGCACAGCTGC"	-1.49689851227458	8.45436666095582	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTAGCACAGCTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2144.58828122971	39.0034251681021	0.0181869058548326	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2141.35346783401	2141.35346783401
"healthy-3"	"2019-08-01-count-3:GTGCAGCAGGACATCG"	-2.27572331848796	8.89064500415651	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCAGGACATCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2086.98451163718	43.6236735066242	0.020902729878145	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2075.12248662698	2075.12248662698
"healthy-3"	"2019-08-01-count-2:TTGGGATTCGGATACT"	4.12626232680623	-7.57792856609496	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATTCGGATACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.21887286838	45.896424139736	0.0176713732597545	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2589.28427315415	2589.28427315415
"healthy-3"	"2019-08-01-count-4:TGGGAGAAGGTGGTTG"	-1.48715327206309	9.03689096057741	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGAAGGTGGTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2027.67094944436	41.4742079506678	0.0204541116309	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2022.95796042131	2022.95796042131
"healthy-3"	"2019-08-01-count-2:GGGCTACCAATCTAGC"	-3.81252727928813	10.1684312590393	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTACCAATCTAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2402.16774303412	40.8787168873747	0.0170174281150499	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2399.33650766768	2399.33650766768
"healthy-3"	"2019-08-01-count-2:CACGTTCGTGAGCGAT"	4.94587149199788	-8.5921087495056	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCGTGAGCGAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.24562530194	45.1512752183416	0.0185331375249758	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2433.56548703985	2433.56548703985
"healthy-3"	"2019-08-01-count-2:GTCCACTGTCACTTAG"	-0.44830302420314	8.17690465534059	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCACTGTCACTTAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2263.35429098378	37.8724349109666	0.0167328796299518	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2255.34896415853	2255.34896415853
"healthy-3"	"2019-08-01-count-4:TGGGAGATCAAGTGGG"	-2.98790297928508	9.43284795368043	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGATCAAGTGGG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1989.72383386483	42.8845135575496	0.0215529978721976	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1982.924413493	1982.924413493
"healthy-3"	"2019-08-01-count-3:ATTACTCGTATCTCGA"	-2.72762451592143	9.39257810199586	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCGTATCTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.86139888047	49.619914867584	0.0300934419965648	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1644.57801778593	1644.57801778593
"healthy-3"	"2019-08-01-count-4:GTGAGGACAAGGTCGA"	-3.88801966133769	11.5937919386658	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGACAAGGTCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.92409913841	42.4316278614402	0.0215397272818778	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1966.55888769793	1966.55888769793
"healthy-3"	"2019-08-01-count-4:AGGATAAGTAGACGGT"	2.81384052810017	-6.65026714718016	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATAAGTAGACGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.78730154026	44.2134635514225	0.0188721628815191	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2339.32338160813	2339.32338160813
"healthy-3"	"2019-08-01-count-4:CTCCGATCAACTTGCA"	-0.622885684401351	8.51140592182008	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATCAACTTGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2557.59298920797	44.9697851983584	0.0175828544213693	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2550.63196165637	2550.63196165637
"healthy-3"	"2019-08-01-count-2:TACGGGCTCGCTTGAA"	-3.81117616120036	12.6459054716858	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGGCTCGCTTGAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2155.33357480012	42.8874650140048	0.0198982957976619	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2147.39743080929	2147.39743080929
"healthy-3"	"2019-08-01-count-2:GAGTGAGAGAGAACCC"	-2.88022957268413	10.9216518172058	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGAGAGAACCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2080.21438063772	48.6511625224298	0.0233875714807408	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2074.05844600739	2074.05844600739
"healthy-3"	"2019-08-01-count-2:CGGGTCATCACCTTGC"	-3.22969685021098	9.52789399707643	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCATCACCTTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.52507166094	44.6001279157548	0.0229126912183557	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.09468379045	1943.09468379045
"healthy-3"	"2019-08-01-count-2:GAGTGAGCAAGCTACT"	5.14983667907063	-8.73595907604369	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGCAAGCTACT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.01875029973	45.8740712845362	0.0182473067390873	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2507.01005377804	2507.01005377804
"healthy-3"	"2019-08-01-count-4:ATTATCCCATCATCCC"	-2.84802065315898	9.39882848346559	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCCATCATCCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2107.66349508863	46.7542417369055	0.0221829726831889	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2102.65450831902	2102.65450831902
"healthy-3"	"2019-08-01-count-4:AACCTGAAGACGGAAA"	0.310062070458573	7.96582791889039	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTGAAGACGGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1857.64472138441	41.1766671742993	0.0221660615188098	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1852.84533393486	1852.84533393486
"healthy-3"	"2019-08-01-count-2:CTGGTCTAGGCCACCT"	2.97114600714986	-6.87568809902342	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGTCTAGGCCACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.31860718034	52.8423631647757	0.0233369822591256	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2261.73351339633	2261.73351339633
"healthy-3"	"2019-08-01-count-4:CCTTTGGGTAATGTGA"	-3.31324134293254	10.2826347121033	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGGTAATGTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2128.61173404655	47.0278377722702	0.0220931967159971	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2124.9538815526	2124.9538815526
"healthy-3"	"2019-08-01-count-2:CTGGTCTTCCTTTAGT"	-3.73773990097697	13.2148647078308	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGTCTTCCTTTAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2604.21385588531	41.1994654285454	0.0158203080501388	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2593.50203232955	2593.50203232955
"healthy-3"	"2019-08-01-count-2:ACCAACATCCAGCCTT"	-4.2521222633427	13.0637817152771	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAACATCCAGCCTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2377.34131759777	36.2802918429942	0.0152608679176343	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2365.87217634544	2365.87217634544
"healthy-3"	"2019-08-01-count-4:GAGGCCTTCTTCCGTG"	5.29129757460896	-9.1539983979431	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCCTTCTTCCGTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.05839928207	49.3955582855267	0.01940841840779	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2538.95803296599	2538.95803296599
"healthy-3"	"2019-08-01-count-3:AGCCACGTCGCCTTGT"	-4.05568108978923	10.3625888594422	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGTCGCCTTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.66727975534	46.1082937688684	0.0226724864130259	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2026.70992541141	2026.70992541141
"healthy-3"	"2019-08-01-count-1:ACTGTCCTCGTTCAGA"	10.9498106437618	6.49896285617677	"2019-08-01-count-1"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTGTCCTCGTTCAGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2237.85936011659	43.7677902889674	0.0195578824429284	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2223.96255161746	2223.96255161746
"healthy-3"	"2019-08-01-count-3:ATACCTTGTACGTGAG"	4.05639233168904	-7.43059303676756	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTGTACGTGAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.23914200766	46.457894518692	0.0194854172554066	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2375.30456357513	2375.30456357513
"healthy-3"	"2019-08-01-count-3:GATCGTAGTGCCTGCA"	-3.6242826980656	2.85673878276674	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAGTGCCTGCA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3085.34076502262	50.2127322164894	0.0162746147154093	4912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3078.22019144944	3078.22019144944
"healthy-3"	"2019-08-01-count-2:CTGTACCCATCCTAAG"	3.986753364175	-7.96682741558226	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCCATCCTAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.34075456343	45.3905921239693	0.0186689554060964	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2425.27700723297	2425.27700723297
"healthy-3"	"2019-08-01-count-3:CGGACACCATAGGTTC"	-1.00993512097057	8.33698937976686	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGACACCATAGGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2185.76845626032	41.9976377126057	0.0192141292881774	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2176.76724527272	2176.76724527272
"healthy-3"	"2019-08-01-count-2:GTCGAATAGCAACAAT"	-3.26255832138713	10.3010139235291	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGAATAGCAACAAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1831.26268585921	43.5511103769621	0.023782011566805	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1831.26268585921	1831.26268585921
"healthy-3"	"2019-08-01-count-2:AGCGCTGGTGTGGTCC"	-3.93009982529338	12.9407901533875	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGGTGTGGTCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1683.44102377794	45.1603976852498	0.0268262428248907	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1683.44102377794	1683.44102377794
"healthy-3"	"2019-08-01-count-2:CTGTAGATCCGCACTT"	2.64833321151082	-6.21450569545897	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTAGATCCGCACTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.55469363663	47.7690513089259	0.0191954998743142	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2486.76868513508	2486.76868513508
"healthy-3"	"2019-08-01-count-3:CATTCATCAACCAACT"	-3.95923314514812	10.4501199492249	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATCAACCAACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.47312607286	48.6059431790036	0.0247929658063557	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1951.53173441031	1951.53173441031
"healthy-3"	"2019-08-01-count-3:TATTCCAGTGAGATTA"	3.76914109763448	-6.99587538158568	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCAGTGAGATTA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.56172841704	47.3035022196615	0.0190236589259239	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2483.53665043211	2483.53665043211
"healthy-3"	"2019-08-01-count-3:ACGGTTAAGTGCAACG"	4.35907187041585	-7.74584867870482	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGTTAAGTGCAACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.1358492675	49.7600890159195	0.0219097809723572	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2269.72530702065	2269.72530702065
"healthy-3"	"2019-08-01-count-3:CAGCGTGAGGTATTGA"	-4.18337426605876	-5.73991157924803	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCGTGAGGTATTGA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2351.34344031628	50.7116827743207	0.0215671100634705	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2348.69870612469	2348.69870612469
"healthy-3"	"2019-08-01-count-2:ACTACGATCGCCTCTA"	-1.40714667263682	8.48002431476442	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGATCGCCTCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.71855698098	46.3830645382314	0.023148492774413	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1989.95947970823	1989.95947970823
"healthy-3"	"2019-08-01-count-3:AGACAAACAAAGCTCT"	-1.17973373356517	8.50336930835573	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAACAAAGCTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2251.92668163102	39.9450013580718	0.017738144711328	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2243.86123595163	2243.86123595163
"healthy-3"	"2019-08-01-count-2:GTCGTAATCATCGCTC"	9.89535297927205	6.35015246951906	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTAATCATCGCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1635.84858143974	48.0275207568636	0.0293593926123612	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1627.58864448038	1627.58864448038
"healthy-3"	"2019-08-01-count-4:TGGTTAGTCCACGAAT"	2.99812211570088	-6.56898739254149	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTTAGTCCACGAAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.337780277	43.3169487335955	0.0201255347234674	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2149.66343699749	2149.66343699749
"healthy-3"	"2019-08-01-count-3:CATTCCGGTTCTTAGG"	-3.318262676627	10.0415382155213	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGGTTCTTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2558.36135510062	39.5646139713402	0.0154648263008117	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2553.05675986062	2553.05675986062
"healthy-3"	"2019-08-01-count-4:TATGTTCAGCACGGAT"	5.30326857146565	-9.40958979046019	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCAGCACGGAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.92164744075	43.2699487028528	0.0162796178527371	1905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2652.69135868308	2652.69135868308
"healthy-3"	"2019-08-01-count-3:CATTCCGTCTACTGAG"	4.69327797469441	-7.48959686672362	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGTCTACTGAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.01907993413	41.4249536533066	0.01576880578056	1756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2624.73243683345	2624.73243683345
"healthy-3"	"2019-08-01-count-4:ATTCCCGAGTCAGCGA"	-4.27738128128703	13.1142921217713	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCCGAGTCAGCGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2033.78941522943	40.9553619534221	0.020137464403512	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2029.89974337363	2029.89974337363
"healthy-3"	"2019-08-01-count-3:GATGCTATCGCTGTCT"	0.162198458879632	8.13796708667604	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGCTATCGCTGTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1785.49514330161	43.499175442193	0.0243625280110018	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1777.79398049821	1777.79398049821
"healthy-3"	"2019-08-01-count-2:TCCCAGTCATGATAGA"	-0.842648844153243	8.68995091998903	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTCATGATAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2150.42251617617	34.2251839004795	0.0159155624734333	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2139.81736546279	2139.81736546279
"healthy-3"	"2019-08-01-count-2:CTGTGAATCTCCTGCA"	-3.29985104027446	12.6439752348694	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAATCTCCTGCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1621.65442946161	49.6057733321658	0.0305896080144737	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1617.48961028453	1617.48961028453
"healthy-3"	"2019-08-01-count-2:CATACTTAGTGGATAT"	4.35138477858846	-7.87365486538085	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTAGTGGATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.1398650354	47.5447048541828	0.0186439596925884	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2545.77141261535	2545.77141261535
"healthy-3"	"2019-08-01-count-2:GCTACAAAGTTCTACG"	-1.15545974198039	8.68408296192018	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAAAGTTCTACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2128.26037350075	40.0638488575825	0.0188246933300186	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2122.3977206016	2122.3977206016
"healthy-3"	"2019-08-01-count-2:CAGATCAAGAACGTGC"	-7.36874804917033	3.25928757274476	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCAAGAACGTGC"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2345.4706997401	49.3215587407598	0.0210284267231414	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2333.18438096355	2333.18438096355
"healthy-3"	"2019-08-01-count-3:AGTACTGAGGTTGACG"	-1.25067506256755	9.18995854938356	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGAGGTTGACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1823.87908550169	47.7016507107327	0.0261539545520977	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1816.52123405231	1816.52123405231
"healthy-3"	"2019-08-01-count-2:CTTACCGAGTTCTACG"	-2.03602705422099	9.05875108325807	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTACCGAGTTCTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.67061469821	45.0410394392772	0.0219640536692949	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2040.47605904356	2040.47605904356
"healthy-3"	"2019-08-01-count-4:TGTAAGCCAGCGTTTA"	-2.81648431244548	8.99465844714967	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCCAGCGTTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1843.47975295738	41.9621037426926	0.0227624435122628	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1837.8882001004	1837.8882001004
"healthy-3"	"2019-08-01-count-3:TCTACCGTCCATAGGT"	1.16348208960835	8.63509080493776	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGTCCATAGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.66386057708	42.0774178313981	0.0216596492503333	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.42507053727	1936.42507053727
"healthy-3"	"2019-08-01-count-4:TACGGGCCAGTTACCA"	-1.37534449520763	8.60635087573854	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCCAGTTACCA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2189.85967693933	45.9554203342283	0.0209855548363072	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2188.45602521168	2188.45602521168
"healthy-3"	"2019-08-01-count-2:TAAGCCAGTCTATGAC"	10.323144574731	7.02312896335451	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCCAGTCTATGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.81437694353	41.4409212106739	0.0206913439846165	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1998.27675020138	1998.27675020138
"healthy-3"	"2019-08-01-count-3:GTTACAGCAGGACAGT"	-3.94518337670024	10.8153028258118	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGCAGGACAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.734434787	46.5625705454596	0.0223672000459673	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2067.64250269196	2067.64250269196
"healthy-3"	"2019-08-01-count-3:TCATGAGAGCCATATC"	-3.94121966782268	10.9293327101502	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGAGCCATATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.9573542574	42.1183768291313	0.0206669569120982	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2029.58399177696	2029.58399177696
"healthy-3"	"2019-08-01-count-3:TGTTCCGCACCGTGCA"	2.59074582633321	-6.50300600444945	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGCACCGTGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.82679474881	45.3300329851526	0.0184807313268913	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2450.12215470347	2450.12215470347
"healthy-3"	"2019-08-01-count-4:TCGTGGGGTATGTCAC"	4.80224146422688	-8.16484739696654	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTGGGGTATGTCAC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.35803838587	43.8794952023338	0.0182045548850155	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2406.95619477572	2406.95619477572
"healthy-3"	"2019-08-01-count-4:GGGACTCCATCTGCGG"	-3.16041098061259	9.57064721668092	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACTCCATCTGCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.44371900334	44.3013419193115	0.0217542677491687	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.86260320625	2030.86260320625
"healthy-3"	"2019-08-01-count-3:GGGCGTTCATTGTCGA"	4.95485987243001	-8.4731540909973	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCGTTCATTGTCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.36800591662	46.2003674478905	0.0187549596068977	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2459.03342527705	2459.03342527705
"healthy-3"	"2019-08-01-count-3:GTTACCCAGATTGACA"	10.4551626640255	7.02974174106447	"2019-08-01-count-3"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACCCAGATTGACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1996.12839603108	42.3190287509939	0.0212005544508746	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1989.81799467361	1989.81799467361
"healthy-3"	"2019-08-01-count-2:AGGAATAAGCCTCAAT"	10.7059999900753	6.10245273197023	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAATAAGCCTCAAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.13656884148	44.5957750153096	0.0227050276048848	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1953.28215680017	1953.28215680017
"healthy-3"	"2019-08-01-count-2:GTTACCCTCAATCAGC"	3.25374092635457	-6.57973577892455	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCTCAATCAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.64114681131	48.0698627966969	0.0198092177163741	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2420.6147368392	2420.6147368392
"healthy-3"	"2019-08-01-count-4:CACAGATAGGTAAACT"	2.76328672942464	-7.02911903774413	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAGATAGGTAAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.51818384752	47.8323827107065	0.0217963027432495	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2190.67010840681	2190.67010840681
"healthy-3"	"2019-08-01-count-4:TTACTGTGTATGCAAA"	4.72635569152181	-8.28921415722045	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTGTATGCAAA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.5613532307	49.558576544132	0.0207918191310494	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2377.79788832338	2377.79788832338
"healthy-3"	"2019-08-01-count-3:GGACGTCTCCGTAGGC"	5.42304148253743	-9.47909738933715	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGACGTCTCCGTAGGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.18603126447	42.9587692891448	0.0162465003525496	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2642.46914066979	2642.46914066979
"healthy-3"	"2019-08-01-count-2:GAGAGGTAGAGGTTTA"	-3.59936652603801	-5.14246799862059	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTAGAGGTTTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2869.09119565768	43.5255179651953	0.015170489537269	3459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2860.95464055738	2860.95464055738
"healthy-3"	"2019-08-01-count-2:TAATTCCAGATAGTGT"	2.90455641326253	-5.18271877681883	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATTCCAGATAGTGT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2986.88501646055	42.3531021588572	0.014179689517826	2901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2981.09336165671	2981.09336165671
"healthy-3"	"2019-08-01-count-4:AAAGTGATCTATTTCG"	4.70165981826131	-8.22916414653929	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGATCTATTTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.40724689932	50.0043250415241	0.0190318136255945	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2624.9247379878	2624.9247379878
"healthy-3"	"2019-08-01-count-4:CTTGATTTCTTTCTAG"	10.048748632043	7.63262698734132	"2019-08-01-count-4"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTTCTTTCTAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2118.4134312118	44.1737155098766	0.0208522637078485	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2114.13015745547	2114.13015745547
"healthy-3"	"2019-08-01-count-4:CTTGATTTCAACGAGG"	10.0828510719234	5.85799405658571	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTTCAACGAGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.12258589595	43.1173057917334	0.023130080670639	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1856.87726802886	1856.87726802886
"healthy-3"	"2019-08-01-count-3:AGGACGAAGCCGAACA"	-7.28685269776042	2.79007861697999	"2019-08-01-count-3"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACGAAGCCGAACA"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2789.99175585806	40.9828161333334	0.0146892248148343	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2772.58997994286	2772.58997994286
"healthy-3"	"2019-08-01-count-3:ACTATGGAGTTAGAAC"	-0.572287480265457	8.55998323047487	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATGGAGTTAGAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.42650434583	44.1122133239195	0.0244466666930897	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1802.62840656554	1802.62840656554
"healthy-3"	"2019-08-01-count-4:TCAAGACTCATGAAAG"	-3.49292192879375	10.9588527449402	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACTCATGAAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.7828790224	45.4557203537876	0.0243237033387026	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1868.7828790224	1868.7828790224
"healthy-3"	"2019-08-01-count-3:CGTAAGTAGGTTTGAA"	9.54828228530232	6.8601240881714	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAAGTAGGTTTGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.55611258813	43.5010193479754	0.0232308228605503	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1870.94292867291	1870.94292867291
"healthy-3"	"2019-08-01-count-3:AGGACGAGTCGCAACC"	14.3008142906124	1.74141070926515	"2019-08-01-count-3"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACGAGTCGCAACC"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1256.12719155649	33.7772634327518	0.0268900025887488	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1245.19252698787	1245.19252698787
"healthy-3"	"2019-08-01-count-2:GAGATGGGTCGCTTGG"	5.00135149535481	-8.34043028270873	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGATGGGTCGCTTGG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.18399995028	50.256523960638	0.0199574470974441	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2516.11602250204	2516.11602250204
"healthy-3"	"2019-08-01-count-4:ACGGTTACAGTGCGCT"	4.29585661467854	-7.00052740490111	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTACAGTGCGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.91160139789	45.0555968544504	0.0182122905398041	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2468.50342898995	2468.50342898995
"healthy-3"	"2019-08-01-count-3:AGTCATGGTCCTCAGG"	-0.207146833569366	7.64368341052858	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCATGGTCCTCAGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1793.37732338763	42.1796091920297	0.0235196512423575	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1789.13444926394	1789.13444926394
"healthy-3"	"2019-08-01-count-4:CCCGAAGAGATACTGA"	2.82339753684346	-6.43017198955687	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGAAGAGATACTGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.70723393104	44.7212573663989	0.0184287814949785	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2425.60307187914	2425.60307187914
"healthy-3"	"2019-08-01-count-3:TCATTACCACTTGTCC"	4.19419588622395	-7.39723303234252	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACCACTTGTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.63631687567	52.4083860260299	0.0239019967071911	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2191.16062770699	2191.16062770699
"healthy-3"	"2019-08-01-count-3:TCTCTGGCATATCTGG"	-3.9698408645695	9.97296998584596	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGCATATCTGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2165.95546402352	36.8434279813307	0.0170102426357787	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2157.48854115314	2157.48854115314
"healthy-3"	"2019-08-01-count-3:CGTAATGTCACCGACG"	3.04497899588887	-6.64909984981688	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGTCACCGACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.66393649987	51.2941765263462	0.0219237368778194	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2332.82847788118	2332.82847788118
"healthy-3"	"2019-08-01-count-2:ACGATGTCAGAGAGGG"	-3.6704412502354	-4.53335716640624	"2019-08-01-count-2"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTCAGAGAGGG"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2947.0584504359	44.9358560019789	0.0152476975797112	3201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2941.78360591697	2941.78360591697
"healthy-3"	"2019-08-01-count-2:AGAGCCCTCCGGTAGC"	-2.0575991672581	8.59589383685914	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCTCCGGTAGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.46948463269	48.9400045719557	0.0249889033022816	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1956.82618190329	1956.82618190329
"healthy-3"	"2019-08-01-count-3:CTCAATTTCTTGGTCC"	-1.52348075333293	8.59587762439577	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAATTTCTTGGTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2558.10277364197	44.4858108451275	0.0173901577776694	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2545.84914140437	2545.84914140437
"healthy-3"	"2019-08-01-count-3:GACCAATTCATTCGTT"	-4.38971457901652	2.57963559711305	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATTCATTCGTT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3307.7732703288	44.5721578172767	0.0134749736981961	4965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3295.66096919057	3295.66096919057
"healthy-3"	"2019-08-01-count-2:CAGCCAGTCACTTATC"	11.0485292869503	5.76592109287111	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGTCACTTATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.66976200417	43.7938038839915	0.0211088071393521	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2063.01578068351	2063.01578068351
"healthy-3"	"2019-08-01-count-4:TGTCCTGGTGCATACT"	-3.8838394683903	10.7488965758118	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGGTGCATACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1900.14910374278	40.1132980562094	0.0211106054662748	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1898.36480155886	1898.36480155886
"healthy-3"	"2019-08-01-count-2:TGCGACGCATTCTTCA"	-4.26104722443278	11.1036166914734	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGCATTCTTCA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2090.62710676363	40.7274513110146	0.0194809735218933	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2088.59861480556	2088.59861480556
"healthy-3"	"2019-08-01-count-2:CTTCTCTAGCCTGCCA"	2.54482974585835	-4.49063351070555	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTCTAGCCTGCCA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2971.83146520088	43.8057562786615	0.0147403231951784	3108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2967.2157243876	2967.2157243876
"healthy-3"	"2019-08-01-count-3:TTACAGGGTATTGACC"	-2.6398323577946	9.17861840808717	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACAGGGTATTGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2109.88134664467	42.6329701088813	0.0202063353831154	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2100.27786574918	2100.27786574918
"healthy-3"	"2019-08-01-count-3:GGGTGTCAGAAACCCG"	-2.87912259522136	9.63684938037721	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCAGAAACCCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2030.66709733613	47.2117692340347	0.023249388979596	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2027.38931228671	2027.38931228671
"healthy-3"	"2019-08-01-count-4:CATTGCCCAAATTGCC"	-2.76324139061626	8.9973687895569	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCCAAATTGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.12911263657	49.8973604004122	0.0242912483414281	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2047.89135475816	2047.89135475816
"healthy-3"	"2019-08-01-count-4:CTGGTCTAGACTTCAC"	10.9954334693844	5.1220378645691	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTAGACTTCAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1626.1802353267	32.4925605480645	0.0199809097676905	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1626.1802353267	1626.1802353267
"healthy-3"	"2019-08-01-count-2:GATTCGAGTATCCTCC"	2.12554754790608	-6.11307146465453	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGAGTATCCTCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.87051328438	47.9960203087573	0.0215048409050072	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2227.74600097158	2227.74600097158
"healthy-3"	"2019-08-01-count-4:GTGTTCCGTTTGGCTA"	-3.63341222229655	10.530961013678	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCGTTTGGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.57770970932	37.2259088161302	0.0181009006566505	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2053.07943104798	2053.07943104798
"healthy-3"	"2019-08-01-count-2:CAGGCCATCATTGCTT"	-7.17866979065593	3.54969141567079	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCATCATTGCTT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2655.75330682541	44.0612725630161	0.0165908755341758	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2639.41112951442	2639.41112951442
"healthy-3"	"2019-08-01-count-3:CAACGATCAAGGTCGA"	10.5418631034786	7.7889718779358	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATCAAGGTCGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2434.61953628661	49.1180776410683	0.0201748474079796	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2426.78149533772	2426.78149533772
"healthy-3"	"2019-08-01-count-2:TCATGTTCATACCATG"	-0.50620267811473	8.84945104205934	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTCATACCATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1991.28186532881	41.1428797228991	0.0206615047519178	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1988.52390998212	1988.52390998212
"healthy-3"	"2019-08-01-count-4:TAGGGTTCAAGATTGA"	-2.75782547417338	9.30854604328004	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTCAAGATTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.6674186496	42.9833133571834	0.0209402229346345	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2047.5247463904	2047.5247463904
"healthy-3"	"2019-08-01-count-2:TCACAAGTCCCGTTGT"	-2.73969421806987	9.21098802173463	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGTCCCGTTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.23255544964	39.0154627209851	0.0202758562682504	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.05483230137	1917.05483230137
"healthy-3"	"2019-08-01-count-2:GTCACTCCAAGTGGTG"	-2.31815634194072	8.6181430586609	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCCAAGTGGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.63325591915	49.3112121555103	0.0268633246845481	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1827.97501225758	1827.97501225758
"healthy-3"	"2019-08-01-count-2:TGACCCTAGTGTTGTC"	-1.75864611092265	9.92900846088258	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTAGTGTTGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1767.46937830133	44.5465282533596	0.0252035643730202	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1763.66865646601	1763.66865646601
"healthy-3"	"2019-08-01-count-2:ACTTCCGGTGAATAAC"	3.74466814574544	-7.51379015361937	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCCGGTGAATAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.12552988265	45.5796689932475	0.0202565005320501	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2247.49312103433	2247.49312103433
"healthy-3"	"2019-08-01-count-2:TGACCCTGTGTGTGGA"	0.276548956602257	7.72206637943117	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTGTGTGTGGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1851.09773976901	37.3214632596703	0.0201618004591845	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.06041575621	1845.06041575621
"healthy-3"	"2019-08-01-count-3:CGATGCGGTCTGCCTT"	-2.09987268868144	9.23846719348756	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGCGGTCTGCCTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.72050014923	41.7060932265311	0.0212599568712049	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1948.45793320496	1948.45793320496
"healthy-3"	"2019-08-01-count-4:CTGTATTCAGAACTCT"	-2.33316765251811	8.88663861835328	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTCAGAACTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2079.38271253174	45.3668578120077	0.0218174641630888	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2071.96988363413	2071.96988363413
"healthy-3"	"2019-08-01-count-2:GATTGGTCACTGCGAC"	3.0597833591396	-6.6760406724182	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTCACTGCGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.2462764051	47.586171064338	0.018949225136317	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2505.35814368086	2505.35814368086
"healthy-3"	"2019-08-01-count-2:GTGCTGGTCTAGGCAT"	-3.11322770538982	9.46510026538698	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGTCTAGGCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.26548582869	48.5131015000089	0.0238596985185319	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2023.27183039054	2023.27183039054
"healthy-3"	"2019-08-01-count-2:TGCTCCAAGTTACGAA"	-4.05182633820232	10.5468911894592	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCAAGTTACGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2176.82910037835	45.2305708326513	0.0207781910048841	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2175.32813006601	2175.32813006601
"healthy-3"	"2019-08-01-count-4:TTTCCTCTCTGTTCAT"	1.95966162261311	-6.27558424389037	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCTCTGTTCAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2530.82622319759	49.9453601988187	0.0197348042868446	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2529.72033055435	2529.72033055435
"healthy-3"	"2019-08-01-count-4:TTTCGATAGATCGCCC"	5.35180534896199	-10.1944999924866	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATAGATCGCCC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.34746570911	47.8946501075387	0.0192475732459213	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2482.14568473051	2482.14568473051
"healthy-3"	"2019-08-01-count-2:CAACGATGTTGCTCCT"	4.82715286788289	-8.23930551921996	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGATGTTGCTCCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2819.4632312482	43.0945708385337	0.015284672047117	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2813.08826865902	2813.08826865902
"healthy-3"	"2019-08-01-count-2:TATCCTAAGTGTACCT"	3.99361695823018	-7.38510420238646	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTAAGTGTACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.6062205898	46.680503033128	0.0182802276469809	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2546.70267618882	2546.70267618882
"healthy-3"	"2019-08-01-count-3:AGTTAGCCAAATGATG"	4.90880884703938	-8.203640007135	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTAGCCAAATGATG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.99593415368	48.4789420074045	0.0195086604936096	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2481.92078367414	2481.92078367414
"healthy-3"	"2019-08-01-count-3:ATAGGCTTCCACAGCG"	14.1805225807125	1.81559453094331	"2019-08-01-count-3"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTTCCACAGCG"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1419.35683118482	32.7154663752182	0.023049500771352	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1405.69286528247	1405.69286528247
"healthy-3"	"2019-08-01-count-3:CATGAGTCATTCGGGC"	-2.57325468483623	9.61737058246461	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGAGTCATTCGGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.19688703048	43.5704083514411	0.0230385364158749	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.59973376114	1887.59973376114
"healthy-3"	"2019-08-01-count-2:AACCTGACAGAGTTCT"	-1.70164392414745	8.64174840534059	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTGACAGAGTTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2367.95558090721	34.4077962324912	0.0145305919206934	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2360.02568589623	2360.02568589623
"healthy-3"	"2019-08-01-count-3:CTCCAACGTGACCGAA"	-0.767966727644759	8.27477929675905	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACGTGACCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.66900930496	43.237034409126	0.0207603964988922	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2077.47480236382	2077.47480236382
"healthy-3"	"2019-08-01-count-4:TGGGAGACAAATGAAC"	-2.09211788597758	8.80965707385866	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGACAAATGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2189.63616785255	46.9708245774261	0.0214514289026802	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2180.41913763436	2180.41913763436
"healthy-3"	"2019-08-01-count-3:TATCCTATCTGAATCG"	-0.480837861925918	8.33151242816774	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCCTATCTGAATCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2116.24425160584	44.4714748753338	0.0210143393616252	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2108.25759238567	2108.25759238567
"healthy-3"	"2019-08-01-count-4:CTGTGGGCAATAGTAG"	2.73607530173604	-6.32407286083373	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGGGCAATAGTAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.95110205015	45.4333975904417	0.0174948991355958	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2592.83537770005	2592.83537770005
"healthy-3"	"2019-08-01-count-1:AATTTCCTCAGGGATG"	10.8041902976925	6.29338023746339	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATTTCCTCAGGGATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2140.65215332409	42.6397002368267	0.0199190233549221	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2131.82085447802	2131.82085447802
"healthy-3"	"2019-08-01-count-2:GCAACATAGACATCCT"	10.7838818031246	6.84340999210206	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACATAGACATCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2052.25198479919	45.250719205562	0.0220492997647117	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2050.171177125	2050.171177125
"healthy-3"	"2019-08-01-count-4:TGTTCATGTGAGATTA"	-0.448613087565261	8.02822921359865	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATGTGAGATTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.13004433992	47.2900301140214	0.0230893688829521	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.24246262168	2041.24246262168
"healthy-3"	"2019-08-01-count-4:GTTATGGGTCAACACT"	4.60403360900227	-8.16348936473998	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGGTCAACACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.44824873577	48.7190634860743	0.0208875217327891	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2329.82181374085	2329.82181374085
"healthy-3"	"2019-08-01-count-2:GCAACATGTTTGGCTA"	4.70495047149007	-8.33799745952757	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACATGTTTGGCTA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.28131382594	41.207995288347	0.0157989075296105	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2606.45982226683	2606.45982226683
"healthy-3"	"2019-08-01-count-1:ACATTTCTCCACTTTA"	-2.67653236809428	8.74208448016969	"2019-08-01-count-1"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACATTTCTCCACTTTA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2571.99303196509	45.4856605957501	0.0176849859352059	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2558.59275725545	2558.59275725545
"healthy-3"	"2019-08-01-count-3:TTAGGCATCATACAGC"	14.1116301017696	1.8355070122513	"2019-08-01-count-3"	"Control3"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCATCATACAGC"	"Plasmablast"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1521.57562205181	48.0427634054952	0.0315743514217918	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1485.21989427945	1485.21989427945
"healthy-3"	"2019-08-01-count-3:GGTGAAGCATTGTACG"	11.1759439903194	6.12281558597413	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGCATTGTACG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1840.93938696937	42.9273441038773	0.0233181735410344	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1837.26132640147	1837.26132640147
"healthy-3"	"2019-08-01-count-2:GGGTATTGTCCCTCAT"	-3.87401876869853	13.2562970885071	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTATTGTCCCTCAT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2228.55482329637	49.010874413793	0.0219922228977515	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2217.55422694565	2217.55422694565
"healthy-3"	"2019-08-01-count-4:GCGATCGCACTAACGT"	9.49348797377889	7.68375537479249	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGATCGCACTAACGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2077.73270354062	45.0655945239828	0.0216897940948744	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2072.23181397325	2072.23181397325
"healthy-3"	"2019-08-01-count-4:CTTAGGAAGTGCTCGC"	5.62570347365682	-9.83808519756468	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTAGGAAGTGCTCGC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.1883172258	41.4719964065736	0.0161546374016651	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2562.22215948438	2562.22215948438
"healthy-3"	"2019-08-01-count-2:ACGTCCTCAGAACATA"	4.5309964614803	-8.34264185344847	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTCCTCAGAACATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.84770261136	48.8585363498706	0.0187351954260773	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2602.81426944785	2602.81426944785
"healthy-3"	"2019-08-01-count-2:TATCTGTCAGAGGTAC"	-3.10311112824138	10.0650338896546	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTGTCAGAGGTAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.5832587134	49.3987800288451	0.0252862425025992	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1950.2136845484	1950.2136845484
"healthy-3"	"2019-08-01-count-2:TTCTAACCACTCAAGT"	-3.78260598602946	12.154797531012	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACCACTCAAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2165.47017189412	44.112787680849	0.0203709976029196	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2158.33902734657	2158.33902734657
"healthy-3"	"2019-08-01-count-3:TCAGGGCGTTACCTGA"	-0.328564981848556	7.75066325748292	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGGCGTTACCTGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2051.37612944178	42.4323459135182	0.0206848199628144	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.74387802854	2043.74387802854
"healthy-3"	"2019-08-01-count-2:TACGTCCTCCTCACCA"	4.62996162947957	-8.3258095017639	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCTCCTCACCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.67416046492	42.5618633800724	0.0156669003590731	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2711.17343510404	2711.17343510404
"healthy-3"	"2019-08-01-count-3:TACGTCCTCACTCTTA"	-2.38690863075908	8.95081899249879	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCTCACTCTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2085.0112247503	45.8933150118456	0.0220110637617031	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.18872212933	2078.18872212933
"healthy-3"	"2019-08-01-count-4:ATCGGATAGTCCTGCG"	2.77318610724751	-4.76561596309813	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATAGTCCTGCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2783.71046446479	44.0978839058287	0.0158414046535214	2877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2779.02086382752	2779.02086382752
"healthy-3"	"2019-08-01-count-3:AGAACCTCAATAGTAG"	4.8336202102596	-8.37343695079955	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTCAATAGTAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2811.14561889533	42.772646133748	0.0152153790419992	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2803.93008169717	2803.93008169717
"healthy-3"	"2019-08-01-count-4:CAAGGGACAAATTAGG"	-2.29201779785808	8.82107160175172	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGGGACAAATTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.02058897339	51.2801827104998	0.0247967466977475	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.70038752225	2058.70038752225
"healthy-3"	"2019-08-01-count-2:AGGTCATTCGGTCACG"	-4.21820102158244	13.2822046049866	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCATTCGGTCACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1918.63984162286	45.7803941075601	0.0238608586741518	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1916.66358098444	1916.66358098444
"healthy-3"	"2019-08-01-count-3:TGAGCATGTCCTGTTC"	3.94082965430562	-7.6465726128784	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCATGTCCTGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.93119528768	49.2227853535682	0.0192808899215247	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2546.94162270833	2546.94162270833
"healthy-3"	"2019-08-01-count-3:ATGAGTCTCTAGCATG"	-2.69275198403056	9.86821744525758	"2019-08-01-count-3"	"Control3"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCTCTAGCATG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2108.96604677226	46.4972233502126	0.022047402527592	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2104.51344267349	2104.51344267349
"healthy-3"	"2019-08-01-count-2:TCGACGGTCTTACGTT"	3.22402658042256	-6.54842092907103	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACGGTCTTACGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.61192230313	48.1625932899086	0.0206209742423372	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2334.52336006217	2334.52336006217
"healthy-3"	"2019-08-01-count-2:ACTACGAAGGAGTATT"	2.16083159026448	-6.31191828167113	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGAAGGAGTATT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2437.27556701392	49.8863388023472	0.0204680748773379	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2431.12790326202	2431.12790326202
"healthy-3"	"2019-08-01-count-2:TCGATTTAGCAAATCA"	-3.61863408508952	11.0924291380676	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGATTTAGCAAATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1757.61022981741	47.0374387050027	0.0267621557425103	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1753.80724552683	1753.80724552683
"healthy-3"	"2019-08-01-count-2:GGGTGAAAGGACGCTA"	2.59814943847005	-6.07089664852294	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAAAGGACGCTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2694.86766420438	44.2378555620337	0.0164155947802707	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2691.5186004779	2691.5186004779
"healthy-3"	"2019-08-01-count-2:TATTCCAAGCCTGTCG"	-3.88560066643413	11.7474689253601	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCAAGCCTGTCG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2041.45051291234	46.1396815788567	0.02260142055221	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.96010210378	2030.96010210378
"healthy-3"	"2019-08-01-count-4:TGGTAGTGTTAAGGAT"	4.59213127669637	-8.12013151561888	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTGTTAAGGAT"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.41901455797	51.6059373144645	0.0209915140620336	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2449.72302242034	2449.72302242034
"healthy-3"	"2019-08-01-count-3:TTCACCGTCTCTGAGA"	-4.36575017395671	12.738405204657	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGTCTCTGAGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2154.19896791541	40.9177446387594	0.0189944128876614	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2152.54490965891	2152.54490965891
"healthy-3"	"2019-08-01-count-3:CAATTTCTCTGCACCT"	4.35061039504353	-7.81802275097045	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATTTCTCTGCACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2781.64822033705	44.2065931989248	0.0158922299648546	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2776.55266608404	2776.55266608404
"healthy-3"	"2019-08-01-count-3:AGACAAAGTCGAGTTT"	2.82492198523824	-6.36581709301146	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAAGTCGAGTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.0082197197	44.17843091987	0.0175939013552101	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2506.28507096994	2506.28507096994
"healthy-3"	"2019-08-01-count-3:TAGGAGGTCAGTGGGA"	4.73709406432454	-7.55970861828002	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGTCAGTGGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.53255672208	46.49831988607	0.0187075883437198	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2480.78188346824	2480.78188346824
"healthy-3"	"2019-08-01-count-3:CTACCTGTCATCGCTC"	10.378754277795	7.71328590000001	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCTGTCATCGCTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2463.70652326712	46.4057372437139	0.0188357407042845	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2451.52582056174	2451.52582056174
"healthy-3"	"2019-08-01-count-3:AGACAAATCTGAACGT"	3.88631286200826	-8.47289659893187	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAATCTGAACGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.36734717746	51.0508349487929	0.0227259513066453	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2243.47091275133	2243.47091275133
"healthy-3"	"2019-08-01-count-3:TCATATCAGACAACTA"	4.78343452987019	-8.33018686687621	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATATCAGACAACTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3034.28396805558	38.0082287460024	0.0125262596204398	2976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3028.67622169706	3028.67622169706
"healthy-3"	"2019-08-01-count-4:AACTTCTAGCCACTCG"	4.67488016661946	-7.81126787578734	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTAGCCACTCG"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2914.83862146598	43.8025725490789	0.0150274434496991	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2910.5573233604	2910.5573233604
"healthy-3"	"2019-08-01-count-2:ACTATCTCAGCAGTCC"	-7.58616767349895	-1.11798264896544	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTCAGCAGTCC"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3135.19754392202	48.7269918064137	0.0155419207637736	4253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3126.62652668756	3126.62652668756
"healthy-3"	"2019-08-01-count-4:TTACAGGTCCACGGAC"	-3.33859262886699	10.2696475752625	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGTCCACGGAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2109.10747698162	41.6719535714841	0.0197580986394878	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2104.48046290392	2104.48046290392
"healthy-3"	"2019-08-01-count-2:CATTGTTGTGGAAGTC"	-4.07709584656413	13.2280425795349	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGTTGTGGAAGTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1931.17684861251	48.0582326578024	0.0248854643697343	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1925.4144714751	1925.4144714751
"healthy-3"	"2019-08-01-count-2:TGATTCTAGCTGACCC"	4.54457296904866	-7.61010267650756	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTCTAGCTGACCC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2756.34373563204	43.6661380951171	0.0158420510223861	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2749.71480161596	2749.71480161596
"healthy-3"	"2019-08-01-count-4:ACAACCACACTGTGTA"	-3.77047620239909	13.2889137038025	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCACACTGTGTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2263.87031846738	35.2516388218641	0.0155714037744569	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2258.60109746432	2258.60109746432
"healthy-3"	"2019-08-01-count-2:TATTGGGAGTGGACGT"	-7.79640040817912	-0.42963700806769	"2019-08-01-count-2"	"Control3"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGGGAGTGGACGT"	"GMP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2743.62811874403	52.9131776081329	0.0192858417096102	3490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2735.95587783988	2735.95587783988
"healthy-3"	"2019-08-01-count-4:GTTGTAGTCCCAAGCG"	11.3370520072872	5.95189044559327	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTAGTCCCAAGCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.31426089368	41.9975600837675	0.0211541119262713	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1977.82831625803	1977.82831625803
"healthy-3"	"2019-08-01-count-4:TTACCGCCACTGAGTT"	-7.13438163223918	3.23618910396425	"2019-08-01-count-4"	"Control3"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCCACTGAGTT"	"MPP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2952.92243214647	43.1004305891239	0.0145958559967301	3328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2936.27021549869	2936.27021549869
"healthy-3"	"2019-08-01-count-2:TCAGTCCGTACAGCGA"	5.05610813674275	-8.9846983185974	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTCCGTACAGCGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.74630933583	44.7390414352633	0.0190075885654336	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2348.26926006346	2348.26926006346
"healthy-3"	"2019-08-01-count-2:GGATGTTCATGCCGGT"	3.29479350623433	-6.66085054790648	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTCATGCCGGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.38409345571	47.7654360200088	0.019095602368695	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2493.30369015377	2493.30369015377
"healthy-3"	"2019-08-01-count-2:ATGAGGGGTGTTCCAA"	-4.0794337791508	11.4156160124573	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGGGGTGTTCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.74820795062	49.6226419401789	0.0266968068767586	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1855.12644026507	1855.12644026507
"healthy-3"	"2019-08-01-count-4:ATACCTTCATGAGGGT"	2.63641967353169	-4.61432793056639	"2019-08-01-count-4"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTCATGAGGGT"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3047.93077153628	43.5694515405865	0.0142947641552323	3096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	3042.44945713217	3042.44945713217
"healthy-3"	"2019-08-01-count-3:CAGTTAGCACTTTAGG"	-2.83894143524821	9.73559949481813	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTAGCACTTTAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.19818467459	42.5739576888218	0.0206649816534745	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2058.52813281996	2058.52813281996
"healthy-3"	"2019-08-01-count-2:GTTACAGGTTCTTGTT"	10.8481594520504	6.72781322086183	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGGTTCTTGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.23622561992	44.5546554133158	0.0219888751617223	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2021.93179896524	2021.93179896524
"healthy-3"	"2019-08-01-count-2:CATCAAGTCGCCTTTG"	2.58241405066792	-4.4837332001892	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGTCGCCTTTG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2728.13137893005	42.3304681083792	0.0155162865085261	2838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2722.10981798013	2722.10981798013
"healthy-3"	"2019-08-01-count-2:GAAGGGTTCCATCTAT"	2.51000465926473	-6.19838478481444	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTTCCATCTAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2697.36931004818	46.9654695221043	0.0174115829623884	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2691.66198318489	2691.66198318489
"healthy-3"	"2019-08-01-count-4:ATACTTCGTAGGCAAC"	5.07471098479573	-8.59649946605834	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACTTCGTAGGCAAC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2685.91707258844	41.454006346894	0.01543383701975	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2682.03819362325	2682.03819362325
"healthy-3"	"2019-08-01-count-3:CCGCAAGAGTGACACG"	2.85087122496907	-6.20058014309081	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGCAAGAGTGACACG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.35214000732	48.2291555345181	0.0190602544096406	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2522.44984881576	2522.44984881576
"healthy-3"	"2019-08-01-count-2:GAAGTAAAGTACGAGC"	10.5656343894893	7.49382970416871	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAAAGTACGAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.8868792743	41.5963117054903	0.0201543563861002	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2054.38189145507	2054.38189145507
"healthy-3"	"2019-08-01-count-4:CCTCACACATCTCGTC"	-1.19609723511394	8.72129724109498	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACACATCTCGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2238.36693607553	42.0210669520184	0.0187730913438584	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2233.48599451689	2233.48599451689
"healthy-3"	"2019-08-01-count-3:CTCTCAGCATTCATCT"	10.6345497566158	7.58020970905153	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGCATTCATCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2324.61582809092	42.1650282795304	0.0181384931522893	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2314.39416501647	2314.39416501647
"healthy-3"	"2019-08-01-count-3:CGAAGGAAGATTCGAA"	-3.6057497066563	10.2451162108215	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGAAGATTCGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.10715029608	47.3989887484671	0.0245576981263429	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1925.46165126061	1925.46165126061
"healthy-3"	"2019-08-01-count-2:AGGAATACACATGTTG"	-3.95806870880778	10.6250610121521	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAATACACATGTTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2020.09356352597	48.754206398788	0.0241346278603501	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2010.42274412499	2010.42274412499
"healthy-3"	"2019-08-01-count-4:TTTACGTCATCCAATG"	-4.4353269142216	10.7729139097962	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTCATCCAATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2143.4620674823	49.1311468882394	0.0229213978794356	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2143.4620674823	2143.4620674823
"healthy-3"	"2019-08-01-count-3:TGCTGAATCTCTCTAA"	-3.84000168266948	10.9386167296204	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCTCTCTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.44859514074	48.0099809057946	0.0224929197241356	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2130.72342989876	2130.72342989876
"healthy-3"	"2019-08-01-count-2:TGGGCGTCACCAATTG"	-2.7358115715092	8.92867944324342	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCGTCACCAATTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2105.13538039281	45.5731959892424	0.0216485820407135	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2103.74396865577	2103.74396865577
"healthy-3"	"2019-08-01-count-3:TCCTTCTTCCCATAGA"	-0.33754343810733	7.98039958560792	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTTCCCATAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.43939997588	42.6347149774963	0.0199746664056043	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2120.402634599	2120.402634599
"healthy-3"	"2019-08-01-count-3:ACATTTCGTACTCCGG"	-1.96695194664653	8.97361943805543	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATTTCGTACTCCGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.83911492007	47.2304423950235	0.024074574737464	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1958.63844949093	1958.63844949093
"healthy-3"	"2019-08-01-count-3:AGTCAACGTGCATTAC"	-3.36510286751445	3.27719781482545	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACGTGCATTAC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2869.38044449759	53.3436686717075	0.01859065735741	3979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	2860.18976319936	2860.18976319936
"healthy-3"	"2019-08-01-count-4:TACTTACTCGCCAGTG"	-1.62471089783366	8.90311429584352	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACTCGCCAGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2178.37645674213	45.3163113081377	0.0208027915321443	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2175.35932002723	2175.35932002723
"healthy-3"	"2019-08-01-count-4:TACTTACGTATGGTTC"	0.499892135232133	9.11005971515504	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACGTATGGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.47913219961	36.0495779399848	0.0188103159248123	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.52348374165	1909.52348374165
"healthy-3"	"2019-08-01-count-2:TTCATTGAGGCTCTAT"	-3.89882526817973	10.9345063933167	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGAGGCTCTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.60888971604	48.2213294399577	0.023322268384414	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2065.97628307223	2065.97628307223
"healthy-3"	"2019-08-01-count-3:GAGGGATGTTAAACAG"	-2.85814867439922	9.58237168872682	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATGTTAAACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.62358809298	47.5479975858295	0.0247050892860264	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1916.24058738634	1916.24058738634
"healthy-3"	"2019-08-01-count-2:TTACCGCTCACTGAAC"	10.2928568321163	7.29758308017579	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCTCACTGAAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2350.00963913391	44.8503640988987	0.0190851830358569	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2342.91018226131	2342.91018226131
"healthy-3"	"2019-08-01-count-4:CATTCATTCTCTAGGA"	5.10223927077596	-8.61594583904418	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCATTCTCTAGGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2910.27228935743	44.1324500566742	0.0151643714638187	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2904.40091016696	2904.40091016696
"healthy-3"	"2019-08-01-count-4:GAGACCCCATTGACAC"	-2.55297909203227	3.80677197063295	"2019-08-01-count-4"	"Control3"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCCATTGACAC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3257.717964627	51.6421066498107	0.0158522337447722	5299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3248.75612816712	3248.75612816712
"healthy-3"	"2019-08-01-count-3:CACGAATTCTCGCTCA"	3.98824348029439	-7.94101383602294	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATTCTCGCTCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.39375917889	51.1648172211817	0.0212355564657137	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2403.07889654125	2403.07889654125
"healthy-3"	"2019-08-01-count-4:GACTCAAGTCGTTGGC"	-4.4054196876591	13.0588817366394	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAAGTCGTTGGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1958.34563228942	43.896263830901	0.0224149726724101	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1952.86498125715	1952.86498125715
"healthy-3"	"2019-08-01-count-2:CCACCATAGCCATATC"	-2.11049018326457	8.90564916217653	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATAGCCATATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.70916167167	47.9174868541864	0.02224881971389	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2150.60386554526	2150.60386554526
"healthy-3"	"2019-08-01-count-3:AGAGAATGTCTGATAC"	3.52561773833577	-6.99420072948607	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAATGTCTGATAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.2741137287	47.5031082390159	0.0214047953541007	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2216.41487611285	2216.41487611285
"healthy-3"	"2019-08-01-count-2:TGGTACAAGTAGACCG"	-1.72969291630443	8.94411370838014	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTACAAGTAGACCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2113.43283849479	41.2473019872427	0.0195167318478024	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2110.1585172558	2110.1585172558
"healthy-3"	"2019-08-01-count-2:TCGGGTGGTCGTTCAA"	4.45745863494222	-7.95835974132689	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGGTCGTTCAA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.83015274817	43.7240824094103	0.0172018112076202	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2538.70132895971	2538.70132895971
"healthy-3"	"2019-08-01-count-2:TTCCAATTCTTGATTC"	-0.202942292124587	7.85756299579469	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATTCTTGATTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.15325109284	41.8005245654846	0.0214125220661258	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1946.8375383308	1946.8375383308
"healthy-3"	"2019-08-01-count-2:TAGGGTTTCACGGTCG"	-2.12650380554851	9.23329351032106	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTTCACGGTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2158.73123327261	47.1742751864752	0.0218527783632239	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2149.5920910495	2149.5920910495
"healthy-3"	"2019-08-01-count-4:TCTCACGCAGTTCACA"	-3.94842324677165	12.3710107573303	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCACGCAGTTCACA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1944.8173950807	55.5049979922013	0.0285399534848865	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1942.92402340411	1942.92402340411
"healthy-3"	"2019-08-01-count-2:TTGCATTGTCGTGTTA"	4.9112569290096	-8.38706018840941	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTGTCGTGTTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.47094554617	43.7970868242412	0.0173627715718875	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2519.35528765227	2519.35528765227
"healthy-3"	"2019-08-01-count-3:ATCCCTGTCCCAGGAC"	10.9676519828731	5.92592809284059	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCCTGTCCCAGGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.93813054785	44.6252601203977	0.0224706195192934	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1983.07379065926	1983.07379065926
"healthy-3"	"2019-08-01-count-2:CCTTGTGGTATGTCCA"	5.42731632766072	-10.2328777543274	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGGTATGTCCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.33840035502	48.2781662051449	0.0191099364195868	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2515.84929255205	2515.84929255205
"healthy-3"	"2019-08-01-count-2:TGGTAGTGTGTCCCTT"	4.97080530700032	-8.58507254039916	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTGTGTCCCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.68086761541	47.3772087906975	0.0196693590370072	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2405.43844059367	2405.43844059367
"healthy-3"	"2019-08-01-count-2:ACTTAGGGTAGGACCA"	-0.891332368285018	8.4816741713318	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTAGGGTAGGACCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1936.59403313292	47.1446745036292	0.0243441184352722	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1933.2768621801	1933.2768621801
"healthy-3"	"2019-08-01-count-4:AGACAAACAGTAGGAC"	10.0275989967281	7.91177938068239	"2019-08-01-count-4"	"Control3"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAACAGTAGGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2106.02790977061	46.1804337179127	0.0219277406076459	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2101.78592133962	2101.78592133962
"healthy-3"	"2019-08-01-count-3:CTCAGGGGTCCTATAG"	-3.31146345558818	10.4253263243469	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGGGGTCCTATAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.32521405114	43.5267055793382	0.0212602791586833	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.76510340103	2041.76510340103
"healthy-3"	"2019-08-01-count-2:TTGCCTGAGTAAACAC"	4.76632370528523	-8.32499887859496	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCCTGAGTAAACAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2735.58835251708	39.8920341215312	0.014582615869389	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2731.92872800614	2731.92872800614
"healthy-3"	"2019-08-01-count-4:CCCTCTCCAACTTGCA"	-3.90039811554607	13.011863685492	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCTCCAACTTGCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2250.50768021653	34.6626507093623	0.0154021472639575	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2245.30630850268	2245.30630850268
"healthy-3"	"2019-08-01-count-4:GAACACTCATCGAGCC"	3.44560041007344	-6.87319614803465	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACACTCATCGAGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.24007338333	40.8999815777783	0.0158758424730445	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2572.52127386003	2572.52127386003
"healthy-3"	"2019-08-01-count-4:TCATTGTTCTTACGTT"	-3.8716484111851	10.5785331496033	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTTCTTACGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.13562244913	48.8767987839501	0.023395704069538	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2085.77913242275	2085.77913242275
"healthy-3"	"2019-08-01-count-2:GACCCAGCATACCACA"	-3.94466171684917	12.9386129149231	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGCATACCACA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2118.33634244708	43.6945719127185	0.0206268339154504	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2104.38791953906	2104.38791953906
"healthy-3"	"2019-08-01-count-4:TTCATGTGTCGCACAC"	3.0536650615627	-7.33476831829222	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTGTCGCACAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.04593048992	50.4850586477099	0.0231577958710092	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2177.53180354954	2177.53180354954
"healthy-3"	"2019-08-01-count-2:GATTCGATCTTAGCCC"	10.0888239341671	7.2576637038025	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGATCTTAGCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.0724408705	47.7731144781226	0.0243482928983638	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1958.31984561781	1958.31984561781
"healthy-3"	"2019-08-01-count-4:GTACAGTTCCATTGCC"	-3.86382494393047	10.9099330672058	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAGTTCCATTGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.15694172377	45.0739017203918	0.0209338673122019	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2147.58411839869	2147.58411839869
"healthy-3"	"2019-08-01-count-3:GGATCTATCTACGGGC"	10.9207788902218	6.29221150958864	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATCTATCTACGGGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1959.92230211552	40.6853055168124	0.0207586318462201	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1952.02264825011	1952.02264825011
"healthy-3"	"2019-08-01-count-2:TCGTGCTCATACATCG"	2.66322316703145	-4.48943092739256	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTCATACATCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2321.83372826673	47.7685642220253	0.020573636966539	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2319.42842573751	2319.42842573751
"healthy-3"	"2019-08-01-count-3:TCGATTTGTGAGTTTC"	-3.23481426659282	11.4402112730774	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGATTTGTGAGTTTC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1871.79100174308	47.4174351440173	0.0253326547140469	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1868.22166366121	1868.22166366121
"healthy-3"	"2019-08-01-count-3:GACTTCCGTTTGGGTT"	-4.14527736130412	13.1689615019592	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTTCCGTTTGGGTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2350.77778658347	46.4616855814203	0.0197643885553921	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2347.4581168651	2347.4581168651
"healthy-3"	"2019-08-01-count-3:GTCTACCGTATGAAAC"	3.02468576011006	-6.3778400651184	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTACCGTATGAAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.07729552915	49.2024527271445	0.0182767607783243	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2687.40581065796	2687.40581065796
"healthy-3"	"2019-08-01-count-4:TCCCAGTGTATGTCTG"	3.07110657271687	-7.53539898311766	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTGTATGTCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.4717403815	43.4985451489898	0.018068143612808	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2402.80109285157	2402.80109285157
"healthy-3"	"2019-08-01-count-4:CCGTGAGCATCATTGG"	0.195033942430657	7.68853471362916	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTGAGCATCATTGG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.66644649693	38.0184563555764	0.0199711753209376	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1897.9708395791	1897.9708395791
"healthy-3"	"2019-08-01-count-3:AGGGCCTCACGAGGTA"	-3.49116812172588	10.426149345282	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCCTCACGAGGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.54371129328	50.9234553096742	0.0284561114592012	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1789.54371129328	1789.54371129328
"healthy-3"	"2019-08-01-count-2:CGAAGTTTCACGGGAA"	10.6008783775264	6.60544393146364	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTTCACGGGAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2108.03873816518	45.8579313978916	0.0217538371414397	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2097.72137449962	2097.72137449962
"healthy-3"	"2019-08-01-count-4:AGACCATTCGGCCCAA"	-3.72111378136333	10.2896070250305	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATTCGGCCCAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2160.17814683817	50.212177108026	0.023244461194796	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2157.07972947945	2157.07972947945
"healthy-3"	"2019-08-01-count-3:GCTACAAAGGTCTACT"	-1.6141314310139	8.50965306842653	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAAAGGTCTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2043.43292956758	41.5984909619769	0.0203571599341798	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.07323040948	2033.07323040948
"healthy-3"	"2019-08-01-count-4:CACTAAGCACTTCAGA"	-2.75071225586589	8.92172334277955	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTAAGCACTTCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2199.43480972634	38.1712123671224	0.0173550096589913	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2193.56400295443	2193.56400295443
"healthy-3"	"2019-08-01-count-2:CTCCAACAGGGTAGCT"	-7.15626321259196	3.41137096965639	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACAGGGTAGCT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2528.86604572991	43.3668421018206	0.0171487304260529	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2517.48905301917	2517.48905301917
"healthy-3"	"2019-08-01-count-4:GCACGGTTCGCATGAT"	11.0703102546627	6.35635278308717	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTTCGCATGAT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2094.10784471214	46.3513026873751	0.0221341526437701	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2091.25462072601	2091.25462072601
"healthy-3"	"2019-08-01-count-3:ATGTCTTGTAACAGTA"	-3.28861723366435	10.9674587019714	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCTTGTAACAGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.45426518826	49.0334733277779	0.026772971763364	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1829.65788140234	1829.65788140234
"healthy-3"	"2019-08-01-count-3:TTGGATGCAGCGGTTC"	4.89823736724202	-8.09484388744506	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGCAGCGGTTC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.64992225041	45.3109124555992	0.0169218956066961	2064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2673.07878097289	2673.07878097289
"healthy-3"	"2019-08-01-count-2:AGACACTCATAATCGC"	-2.7029963535374	9.61894319141237	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTCATAATCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2171.05728781049	46.8632461531787	0.0215854489037644	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2165.12086193924	2165.12086193924
"healthy-3"	"2019-08-01-count-2:TATCCTAGTATCGCGC"	4.89556564864461	-8.36149504100951	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTAGTATCGCGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.50560990084	49.1692108680379	0.0197031057245316	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2489.62066783802	2489.62066783802
"healthy-3"	"2019-08-01-count-1:GAGACCCGTCTGCCTT"	0.247064878314179	8.46780965411989	"2019-08-01-count-1"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAGACCCGTCTGCCTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2094.71025820391	40.0905327023927	0.0191389394048073	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2081.36029906715	2081.36029906715
"healthy-3"	"2019-08-01-count-2:GGTTCTCGTAACATAG"	-1.71872780743297	8.8862094649109	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTCTCGTAACATAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.39620391358	41.3628476698319	0.0214049518344436	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.05216216027	1926.05216216027
"healthy-3"	"2019-08-01-count-2:TGCTCGTCACAGAGCA"	4.39392199096028	-7.98924925243529	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCGTCACAGAGCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1542.60912946424	42.7169959077461	0.027691393167485	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1537.7711700618	1537.7711700618
"healthy-3"	"2019-08-01-count-2:TGACTCCAGGACCCAA"	-0.506330708891708	8.48094842517702	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACTCCAGGACCCAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2056.92361139219	37.4982612704869	0.0182302643923208	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.25221056909	2050.25221056909
"healthy-3"	"2019-08-01-count-3:ATCGGCGGTCTTGCTC"	11.2456327873165	5.42078874194948	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGGTCTTGCTC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2152.66997405144	38.6103680548368	0.0179360368845439	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2148.00980671004	2148.00980671004
"healthy-3"	"2019-08-01-count-2:TCACGCTGTTTCCATT"	3.03638329085652	-6.45218660747679	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGCTGTTTCCATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.94566625712	50.291445653774	0.0190429686972885	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2634.25820793316	2634.25820793316
"healthy-3"	"2019-08-01-count-2:ACATTTCTCAGACATC"	-3.46224914017375	-5.60316946422728	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATTTCTCAGACATC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2611.36948750578	52.5405047445837	0.0201199045159891	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2605.1063737587	2605.1063737587
"healthy-3"	"2019-08-01-count-2:AATCGACCACTAGTAC"	11.2061249214107	5.68202254855958	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACCACTAGTAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.01658294526	40.7715836003068	0.0211249913397575	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1926.90750753511	1926.90750753511
"healthy-3"	"2019-08-01-count-3:GACTCAACATGCCGCA"	-0.724626581103164	8.37103269183961	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCAACATGCCGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2052.67705521191	48.1196169832123	0.023442370957006	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2046.3204385018	2046.3204385018
"healthy-3"	"2019-08-01-count-2:GGTTGTATCTGGGCAC"	3.98669566687886	-7.95527079021605	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTATCTGGGCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.88933243426	36.3607328533033	0.0172416505191065	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2107.28316934765	2107.28316934765
"healthy-3"	"2019-08-01-count-2:AGAACAAAGTGCAGCA"	-2.66657839241679	9.13244340503541	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACAAAGTGCAGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2116.69166157619	46.0493621839358	0.0217553472807868	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.48868603774	2112.48868603774
"healthy-3"	"2019-08-01-count-4:GAAGTAACACCGGCTA"	-5.85771022263225	-5.06198694622191	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGTAACACCGGCTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3207.45777976063	47.8326212911629	0.0149129387120827	4516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3200.06865188897	3200.06865188897
"healthy-3"	"2019-08-01-count-2:TTGGTTTTCGGTTAGT"	-4.32670865479167	10.8791332014832	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTTCGGTTAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.96149020769	45.7955409602603	0.0224822811724295	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2028.70417380508	2028.70417380508
"healthy-3"	"2019-08-01-count-2:CTCCCAAAGACCGTTT"	10.4430262046749	7.38844153964845	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAAGACCGTTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2080.63894428094	41.8563985365725	0.0201170888642757	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2076.78779819082	2076.78779819082
"healthy-3"	"2019-08-01-count-2:TATCGCCTCTCGTTTA"	14.1825005012447	1.9307960041794	"2019-08-01-count-2"	"Control3"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCTCTCGTTTA"	"Plasma cell"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1159.18555897925	26.3278990508461	0.0227124111812002	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1146.57585583058	1146.57585583058
"healthy-3"	"2019-08-01-count-3:ATCGTCCAGCTAGATA"	-2.90551147881206	3.34292028034059	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCAGCTAGATA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3673.20358664866	42.488420756153	0.0115671292793543	3984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3657.69914705376	3657.69914705376
"healthy-3"	"2019-08-01-count-4:AATGGAAAGCAGAAAG"	-1.83078406277354	8.86316773975221	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAAAGCAGAAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.16491032941	47.2202688885032	0.0229317567775324	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2059.16491032941	2059.16491032941
"healthy-3"	"2019-08-01-count-3:CCCGGAACATACACCA"	4.82127489623372	-8.20884897625121	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGGAACATACACCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.38304461792	45.1989270038988	0.0169386951753663	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2662.76163071236	2662.76163071236
"healthy-3"	"2019-08-01-count-2:TACGTCCGTTTGACAC"	-4.30659089508708	13.1212701567444	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCGTTTGACAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1957.95521609073	39.2787752448861	0.0200611203576507	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1956.01473969337	1956.01473969337
"healthy-3"	"2019-08-01-count-4:CTAGGTACACCTGCAG"	3.41392745551412	-5.77629425441893	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGGTACACCTGCAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2868.96658027207	39.520961702585	0.0137753301046947	2806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2861.40337739972	2861.40337739972
"healthy-3"	"2019-08-01-count-3:GGTGGCTCATGGGAAC"	0.00641652297918197	8.87152383411256	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTCATGGGAAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1667.44296981143	32.2752977415196	0.0193561628948362	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1662.94792864105	1662.94792864105
"healthy-3"	"2019-08-01-count-2:TGCTTGCGTGGGCTTC"	5.4254261451656	-9.60405352031859	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCGTGGGCTTC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.43453657769	50.3559914505313	0.0222869884634074	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2256.77821024349	2256.77821024349
"healthy-3"	"2019-08-01-count-3:TGACTCCCACATACGT"	3.35743083533589	-6.7549619904724	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACTCCCACATACGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.71754239474	44.1457348438781	0.0166920414510145	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2640.1210634037	2640.1210634037
"healthy-3"	"2019-08-01-count-3:GTCATCCCACAATCTG"	4.76734032210652	-7.9002313843933	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCCACAATCTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2879.30276041193	44.8798435464088	0.0155870525890747	2529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2871.66110316712	2871.66110316712
"healthy-3"	"2019-08-01-count-4:TCCCAGTCACCTCGTT"	-3.62060199204143	10.0941991575989	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTCACCTCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.77171254771	46.2991283699205	0.0212111638169804	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2178.28818193153	2178.28818193153
"healthy-3"	"2019-08-01-count-3:TGGGAAGTCGTGGGTC"	-0.81478045406993	8.74022100055543	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAAGTCGTGGGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2194.93709595727	40.7747732640812	0.018576738868363	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2185.88982676698	2185.88982676698
"healthy-3"	"2019-08-01-count-3:AGGTTACAGACGATAT"	-4.7349628013676	3.16974852168886	"2019-08-01-count-3"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTACAGACGATAT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2969.3457167362	39.9247987554426	0.0134456552264741	3578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2960.8104894532	2960.8104894532
"healthy-3"	"2019-08-01-count-2:TAAGTCGTCCATACTT"	4.19955124434773	-7.40884878551634	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGTCCATACTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.41621948475	45.882080099206	0.0176917533539301	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2589.48566950882	2589.48566950882
"healthy-3"	"2019-08-01-count-3:AGTCAACGTTGAATCC"	10.0489374595577	7.08605334842531	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACGTTGAATCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1679.24059776953	40.576645347052	0.0241636876817703	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1675.58491211226	1675.58491211226
"healthy-3"	"2019-08-01-count-3:CTCCCTCCATCGATCA"	4.35373129424397	-7.84859945690306	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCCATCGATCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.30359355478	42.6069932764362	0.0159977981404544	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2656.22940895693	2656.22940895693
"healthy-3"	"2019-08-01-count-2:GAGTTGTTCGCCAGAC"	-3.7901853126591	10.7426967390808	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTGTTCGCCAGAC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2024.42873504281	44.1861782061969	0.0218264923043894	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2022.76998451901	2022.76998451901
"healthy-3"	"2019-08-01-count-3:AGGTTGTTCCCTCTAG"	-3.54143510285075	9.56629083240358	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTTCCCTCTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2099.25536450218	44.7120494922988	0.0212990045176813	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2093.81220612865	2093.81220612865
"healthy-3"	"2019-08-01-count-2:TCATTACGTTTAAGGA"	4.44201769408528	-7.58210041439208	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACGTTTAAGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.92952783699	41.289301876625	0.0156997750090223	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2624.58506421227	2624.58506421227
"healthy-3"	"2019-08-01-count-2:CCTAACCTCGCCATAA"	-1.41344843331035	8.81742379749147	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCTCGCCATAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2213.59952345573	49.0938897711804	0.022178306984155	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2208.16352787761	2208.16352787761
"healthy-3"	"2019-08-01-count-4:GTGTAACAGCCGTCGT"	3.31185116347615	-6.79973843013915	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTAACAGCCGTCGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.47755092957	50.8243919425637	0.0220546266211456	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2298.33959803792	2298.33959803792
"healthy-3"	"2019-08-01-count-3:TCGTCCACAGCAGTAG"	-3.1746395629948	10.1172818907532	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTCCACAGCAGTAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.80716320559	39.8445270966961	0.0198349188645432	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2007.09795719651	2007.09795719651
"healthy-3"	"2019-08-01-count-3:CCATCACTCGCTGATA"	-3.8249114555424	10.6518440016541	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCATCACTCGCTGATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2247.29769020513	37.8007022169647	0.0168205139807331	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2238.73676672978	2238.73676672978
"healthy-3"	"2019-08-01-count-3:AGTCATGCACCGAATT"	10.7548519569332	6.58412740314332	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCATGCACCGAATT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.16568710215	43.785238754872	0.0224520608912644	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1938.57477984546	1938.57477984546
"healthy-3"	"2019-08-01-count-3:AGCGCCATCTTCACGC"	-0.0317217064207375	8.29595754230348	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCCATCTTCACGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1904.41721710739	44.290808595264	0.0232568831017697	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1898.99554719763	1898.99554719763
"healthy-3"	"2019-08-01-count-2:GTAGAGGCATCGAGCC"	4.12147631224934	-8.26164343273314	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGCATCGAGCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.28207940286	44.0195680661659	0.0175357058186214	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2502.98288900528	2502.98288900528
"healthy-3"	"2019-08-01-count-2:TCAGGTAAGAGCCGTA"	10.753754277795	6.5944237479004	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTAAGAGCCGTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1899.61963559082	47.5841506374302	0.0250493044743826	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1893.69098831267	1893.69098831267
"healthy-3"	"2019-08-01-count-4:TCCGAAAGTGGCGTAA"	4.25181021270101	-7.90798427974852	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAAGTGGCGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.09743347773	45.7179689386496	0.0179843495912369	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2537.28153558177	2537.28153558177
"healthy-3"	"2019-08-01-count-4:TCCGAAATCGGAAACG"	-3.95076642456706	13.1484203108582	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAATCGGAAACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1952.69224186786	44.4150851965065	0.0227455634043084	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1947.76573401668	1947.76573401668
"healthy-3"	"2019-08-01-count-4:TACGGGCCACCCATAA"	-2.69593892517741	9.45044229114381	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCCACCCATAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2310.87563761786	44.0214344851287	0.0190496770005796	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2309.45177663797	2309.45177663797
"healthy-3"	"2019-08-01-count-4:GTGCTGGGTACATACC"	-1.57091460648234	8.82584188068239	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTACATACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.53964751616	45.0191552005275	0.021933391277	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2047.98885942881	2047.98885942881
"healthy-3"	"2019-08-01-count-3:TCCTCCCCACCGTCGA"	-1.50794015350993	9.01534078204957	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ Activated"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCCCCACCGTCGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2179.83036915951	44.0056118435816	0.0201876313249774	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2173.70608513198	2173.70608513198
"healthy-3"	"2019-08-01-count-2:TAGACCAAGTTCCAGT"	-4.03994355621989	10.3427276381287	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAAGTTCCAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2091.15596632421	49.7541860972092	0.0237926710864451	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2083.63884366664	2083.63884366664
"healthy-3"	"2019-08-01-count-2:AGACCATCACCATAAC"	11.2756782966549	4.25853345477907	"2019-08-01-count-2"	"Control3"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATCACCATAAC"	"Pro-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.47214087939	41.2352843571754	0.0225888324635352	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1821.35021500435	1821.35021500435
"healthy-3"	"2019-08-01-count-2:TGTGTGAGTGTCCCTT"	-3.19656739655193	9.65674970233766	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGTGAGTGTCCCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2163.92024097874	44.6618374156886	0.0206393177391271	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2162.3408108827	2162.3408108827
"healthy-3"	"2019-08-01-count-2:GCTACAATCGAATGCT"	-4.38283334198649	12.8457460173401	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAATCGAATGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2465.13424392172	41.6193005272614	0.0168831781189532	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2461.15134068045	2461.15134068045
"healthy-3"	"2019-08-01-count-2:GATCACATCCCATGGG"	11.0443445640499	6.70776031101076	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACATCCCATGGG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2033.31846308385	41.9163454816791	0.0206147468990697	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2021.08594042841	2021.08594042841
"healthy-3"	"2019-08-01-count-3:AGCTACAAGACTTCAC"	-2.10507069054301	8.80862615192262	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTACAAGACTTCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.22678687458	52.1585588192999	0.0239784463551235	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2166.98009944763	2166.98009944763
"healthy-3"	"2019-08-01-count-3:ACGTAGTAGGTCCAGA"	-1.78100190582927	9.14230058276979	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAGTAGGTCCAGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1898.11374200538	42.5822166944373	0.0224339647051123	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.4218309387	1893.4218309387
"healthy-3"	"2019-08-01-count-2:GCTACCTCAATGAGCG"	11.1231876808101	5.6932916411194	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTCAATGAGCG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1955.71199259418	43.6879948792839	0.0223386649183111	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1946.53063288971	1946.53063288971
"healthy-3"	"2019-08-01-count-4:GGGACCTGTCAAGCGA"	-2.87916455689128	9.16551015460817	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTGTCAAGCGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.35961485296	43.6311592623864	0.0209930749955769	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2070.41369583841	2070.41369583841
"healthy-3"	"2019-08-01-count-4:AGCCAGCAGGTCGTCC"	4.93479790267293	-8.49097444927367	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCAGGTCGTCC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.74312205098	45.3463583204116	0.0161447153940155	3342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2799.55909599212	2799.55909599212
"healthy-3"	"2019-08-01-count-4:GGTGTCGTCCTAGCCT"	-3.99725947800334	13.1491603621277	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGTCCTAGCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1934.08524260276	44.0959240955476	0.0227993695025595	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1930.27061408853	1930.27061408853
"healthy-3"	"2019-08-01-count-4:CCTCAACTCTTTCAGT"	10.2042442756588	8.0330223807129	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAACTCTTTCAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2626.97148468797	47.6870224071498	0.0181528511767664	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2617.97669966242	2617.97669966242
"healthy-3"	"2019-08-01-count-2:GAGACCCTCGTTCTCG"	-2.37163839760478	9.28715703571168	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACCCTCGTTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.76346764509	45.8422618991144	0.0233559787793054	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1959.26386705111	1959.26386705111
"healthy-3"	"2019-08-01-count-4:GACCTTCTCCTACCGT"	9.9016338783199	7.25938460910646	"2019-08-01-count-4"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCTCCTACCGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.31356300532	39.0845910395246	0.01876078173424	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2078.94094227605	2078.94094227605
"healthy-3"	"2019-08-01-count-3:AGGAAATAGGTATTGA"	-4.06399569931682	9.93660924518434	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATAGGTATTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2219.00056685735	42.8993113343935	0.019332717609509	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2219.00056685735	2219.00056685735
"healthy-3"	"2019-08-01-count-2:CGTTAGACACTTGACA"	2.73552050170247	-4.67569353496703	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTAGACACTTGACA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2904.6440202142	40.8761867519425	0.0140727009807309	2794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2900.8283635942	2900.8283635942
"healthy-3"	"2019-08-01-count-4:GCAGTTAGTCGTTCAA"	-4.65422330322917	-5.07459595119628	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGTTAGTCGTTCAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3037.04230725781	52.5635525010117	0.0173074811553982	2736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3032.41445438992	3032.41445438992
"healthy-3"	"2019-08-01-count-3:GATTGGTCAGCTGCCA"	-2.01052771034892	9.11323163593141	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTCAGCTGCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.45823656562	41.5872131578121	0.0207888434747875	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1997.36087481596	1997.36087481596
"healthy-3"	"2019-08-01-count-2:TTAGGGTCAAGGCGTA"	4.55457081374471	-7.94654943859252	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTCAAGGCGTA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.00205552375	43.6399740434174	0.0168950597426329	2004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2580.30683219021	2580.30683219021
"healthy-3"	"2019-08-01-count-4:TTACTGTCACCTTCCA"	0.316667248576325	8.48850724780885	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTCACCTTCCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1998.71710657026	41.7919352365486	0.0209093798713027	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1983.66988164739	1983.66988164739
"healthy-3"	"2019-08-01-count-2:CACTGGGCATGGTACT"	10.2089811759884	6.60252759540407	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGGGCATGGTACT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.76045728737	42.5520916864351	0.021374792497344	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1984.77770479286	1984.77770479286
"healthy-3"	"2019-08-01-count-3:GGGACAAGTGCGGCTT"	-2.69707546654399	3.91755912387697	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACAAGTGCGGCTT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3501.04562501818	48.1409935022225	0.0137504616215827	5733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3494.55046172806	3494.55046172806
"healthy-3"	"2019-08-01-count-3:TCTCACGCATATCTGG"	3.96578158912007	-7.37258293544921	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGCATATCTGG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.59642066996	45.0475867681843	0.0169313866688736	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2653.54633705434	2653.54633705434
"healthy-3"	"2019-08-01-count-2:TAGATCGCAAGAGGCT"	-2.44739184799846	8.75047586047975	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGATCGCAAGAGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.51720854931	44.1017174832306	0.0226567313607766	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1940.8930538073	1940.8930538073
"healthy-3"	"2019-08-01-count-2:GAGAGGTTCCGACAGC"	10.4671627479488	7.62768361652223	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTTCCGACAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2270.9648901483	37.7509935246008	0.0166233276825938	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2267.23447436423	2267.23447436423
"healthy-3"	"2019-08-01-count-2:TCCTTCTGTATGTCAC"	-0.910347382456619	8.84898469531862	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTGTATGTCAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2156.04687602228	44.2418034406791	0.0205198708491448	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2148.5922439711	2148.5922439711
"healthy-3"	"2019-08-01-count-2:TATGTTCTCTCGGTAA"	2.85217346724812	-8.93614962017211	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATGTTCTCTCGGTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2021.69438438068	45.9042241177733	0.0227058176905584	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2017.15762450698	2017.15762450698
"healthy-3"	"2019-08-01-count-2:TTCCTAAGTTGGCTAT"	4.63354172286336	-7.87169744884642	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAGTTGGCTAT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.85638935259	47.5051287381542	0.0189123585804992	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2502.13000602819	2502.13000602819
"healthy-3"	"2019-08-01-count-4:AGTCAACAGGAGAGGC"	-3.1741717857426	10.4239454039368	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCAACAGGAGAGGC"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1892.64172776572	47.2718012605793	0.0249766242427636	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.22591170251	1887.22591170251
"healthy-3"	"2019-08-01-count-4:TCTGGCTCAAGTGCAG"	4.48501314696614	-7.98325922405394	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTCAAGTGCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2779.06271721204	41.8747061587412	0.0150679241239831	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2773.23141771148	2773.23141771148
"healthy-3"	"2019-08-01-count-2:TTCTCTCTCGTGTTCC"	-0.785253564745742	8.38397882068483	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCTCGTGTTCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.98409849999	40.9092102752564	0.0230087604887861	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1770.56999547532	1770.56999547532
"healthy-3"	"2019-08-01-count-3:CGTGCTTGTGACGCCT"	-2.67856846275981	9.98699472034303	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGCTTGTGACGCCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1915.40764768731	47.6382264972097	0.0248710641594904	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1915.40764768731	1915.40764768731
"healthy-3"	"2019-08-01-count-2:CACAGGCTCTTCGTGC"	-2.68036065521892	9.0270957716736	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCTCTTCGTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2343.46119635419	47.9872276937958	0.0204770737268666	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2330.68147285304	2330.68147285304
"healthy-3"	"2019-08-01-count-2:TTGATGGCAGACCATT"	-3.4806264442509	-5.28613712703856	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGCAGACCATT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3119.4742423925	48.1572316124963	0.0154376115558376	3574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3112.37125369957	3112.37125369957
"healthy-3"	"2019-08-01-count-2:TAGGAGGAGTAGGTTA"	10.5631290870601	7.04751393878785	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGAGGAGTAGGTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.36542542326	43.5996915961409	0.0228585938567413	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1905.68516539212	1905.68516539212
"healthy-3"	"2019-08-01-count-4:GGAAGTGAGTGCTCAT"	-3.4509941143101	10.1610240706238	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAAGTGAGTGCTCAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.33093903815	41.1278351896297	0.0199908699223947	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.37707097999	2050.37707097999
"healthy-3"	"2019-08-01-count-4:AGCGTATCAAGTGACG"	0.353688825934571	7.81883952701417	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGTATCAAGTGACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.40282037359	39.7375516983597	0.0218050319359216	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1811.11543041729	1811.11543041729
"healthy-3"	"2019-08-01-count-2:ATCCATTGTGCTAGCC"	10.4544550376827	7.44298169696657	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTGTGCTAGCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2286.91748266549	47.313290539404	0.0206886741205277	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2274.42190968948	2274.42190968948
"healthy-3"	"2019-08-01-count-4:TAACCAGCACCAGTTA"	-5.68264375153239	-5.29972460186156	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACCAGCACCAGTTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3235.73163451251	45.4518966709947	0.0140468684690047	4064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3230.95411754886	3230.95411754886
"healthy-3"	"2019-08-01-count-2:CCTTGTGCAAAGGCAC"	10.9794632392818	6.16243884647218	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGCAAAGGCAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2028.95553747599	44.4572055382319	0.0219113749498604	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2021.44085168929	2021.44085168929
"healthy-3"	"2019-08-01-count-4:ATCACAGCACGCGTCA"	-5.21381602707561	-4.31691934978636	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACAGCACGCGTCA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3321.67145555154	43.2192506974663	0.0130112960525441	4820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3317.39913590138	3317.39913590138
"healthy-3"	"2019-08-01-count-3:CGTCAAAAGCTCTATG"	5.50595154342	-9.51122667705687	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAAAGCTCTATG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.43245870625	44.0517857440212	0.0170450520367142	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2577.36859163452	2577.36859163452
"healthy-3"	"2019-08-01-count-3:AGGCCACCAGGAAGTC"	-1.95023928108867	9.22270867908327	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCCACCAGGAAGTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1909.91981494225	43.5796534448585	0.0228175304030636	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1902.99379452246	1902.99379452246
"healthy-3"	"2019-08-01-count-4:GACTGATAGTTTCAGC"	10.3198677497799	5.43212030017702	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTGATAGTTTCAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1671.48340182158	35.4455825694769	0.0212060631477694	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1662.42866974033	1662.42866974033
"healthy-3"	"2019-08-01-count-2:CCACGTTAGAAGCTGC"	4.3969165283138	-7.9720611802307	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTAGAAGCTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.83340151093	47.7328779979029	0.0206026371886618	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2312.84408700626	2312.84408700626
"healthy-3"	"2019-08-01-count-2:GAGCTGCCACCGGAAA"	-2.69451008263286	9.3231105574402	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCCACCGGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.40222954907	44.4090059048132	0.0217116248644178	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2043.85825385858	2043.85825385858
"healthy-3"	"2019-08-01-count-2:CGCGTGATCAAAGACA"	-3.31720791283305	-5.5247521630493	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGATCAAAGACA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2836.35768871888	45.8742292368021	0.0161736403766207	2763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2831.15384083094	2831.15384083094
"healthy-3"	"2019-08-01-count-4:TCCTTTCTCCAACTGA"	-4.02747283402141	13.1849298247131	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCTCCAACTGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2422.6007525122	48.8387402511455	0.0201596322466673	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2411.15903512009	2411.15903512009
"healthy-3"	"2019-08-01-count-2:TACCCACTCATACAGC"	4.31722988662068	-8.44429972088011	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACTCATACAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.92487023222	47.4082802709895	0.0186799384123028	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2532.31212025888	2532.31212025888
"healthy-3"	"2019-08-01-count-2:TACCCACCAACTGTGT"	0.373891432850999	8.28565785968629	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACCAACTGTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1834.58571897221	44.3918702761882	0.0241972178334942	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1823.29578394947	1823.29578394947
"healthy-3"	"2019-08-01-count-2:TTAATCCGTGACTGTT"	0.139273245900315	8.0190129050049	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCGTGACTGTT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1839.10329062094	39.674120800651	0.0215725353779645	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1833.00287298715	1833.00287298715
"healthy-3"	"2019-08-01-count-4:ACAGGGACAAACCGGA"	2.82526244696919	-6.41113855755004	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGACAAACCGGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.66856638584	49.2648028597012	0.0205042025142097	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2394.2563874569	2394.2563874569
"healthy-3"	"2019-08-01-count-2:GAGGCAATCGACCTAA"	-3.72944770279582	10.5447187193665	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCAATCGACCTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.0400703762	47.7278204111496	0.0232814085445614	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2046.58717616591	2046.58717616591
"healthy-3"	"2019-08-01-count-2:TACCCGTTCACCCTTG"	-1.38646839085277	9.48933122241823	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCGTTCACCCTTG"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2067.35422938673	48.7005987383568	0.0235569686346416	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2064.09102993445	2064.09102993445
"healthy-3"	"2019-08-01-count-4:AGGAAATGTAACTAAG"	-2.30847559395488	8.90400788867799	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATGTAACTAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.68741597246	39.9742204554732	0.0200202696404556	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1991.10586983453	1991.10586983453
"healthy-3"	"2019-08-01-count-2:TACCCGTCATTGTGCA"	-2.54327211800273	8.79544255817262	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCGTCATTGTGCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1920.78395495319	47.727142617277	0.0248477412018157	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1917.52270341382	1917.52270341382
"healthy-3"	"2019-08-01-count-2:GGTGTCGCATGAAGCG"	4.70741715010945	-7.95727255260619	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGCATGAAGCG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.48915888016	42.575259933662	0.0152354357140263	2466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2789.34672569427	2789.34672569427
"healthy-3"	"2019-08-01-count-2:TTTGATCTCAGTCATG"	-0.562056641012985	8.65347287738649	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCAGTCATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2393.1934409882	39.7556549813574	0.0166119688866193	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2383.00306377749	2383.00306377749
"healthy-3"	"2019-08-01-count-3:CTATAGGCATGTTACG"	-2.45227060738261	9.20268914783327	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATAGGCATGTTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.87047858164	40.9115237215167	0.0204366487039177	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.465517319	1998.465517319
"healthy-3"	"2019-08-01-count-4:GGTCACGCACTCCTTG"	3.12342943724934	-7.10928633129271	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGCACTCCTTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.58364511396	43.1249566736398	0.0186077239389214	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2313.83615407935	2313.83615407935
"healthy-3"	"2019-08-01-count-4:AAGCATCTCTAGAGCT"	-5.26981339874919	3.62624499881593	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCATCTCTAGAGCT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2766.15093916554	41.4289057584274	0.0149770951294961	2915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2751.96766618551	2751.96766618551
"healthy-3"	"2019-08-01-count-2:AGGTCATTCTCATTTG"	-3.16581187668498	9.49626729572145	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCATTCTCATTTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2373.60879050449	48.3579171569055	0.020373162313166	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2371.08831042664	2371.08831042664
"healthy-3"	"2019-08-01-count-2:TTCTAGTAGGTTTGAA"	-4.15918479386027	10.6749791868958	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTAGGTTTGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2132.18158014557	47.4399011741312	0.0222494658128002	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2127.46676450354	2127.46676450354
"healthy-3"	"2019-08-01-count-2:CTACAGATCGCCTTGT"	3.45050134238545	-6.67980053341063	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGATCGCCTTGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.04372639233	43.3940473714521	0.0170169816785235	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2546.06501161807	2546.06501161807
"healthy-3"	"2019-08-01-count-3:ATAGACCTCCCGAAAT"	11.1783195930416	5.86376140201417	"2019-08-01-count-3"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGACCTCCCGAAAT"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2150.46268363294	44.8499238187833	0.020855941449314	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2139.62931064397	2139.62931064397
"healthy-3"	"2019-08-01-count-3:AGTGCCGGTGTTGATC"	-3.96665511551555	12.2083348997864	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGGTGTTGATC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2187.32256007183	44.7696091363141	0.0204677672847867	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2182.57763890163	2182.57763890163
"healthy-3"	"2019-08-01-count-3:GATGACTAGAGTGACC"	4.52750219878499	-7.28807547008666	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGACTAGAGTGACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.15770974371	44.522602072683	0.0168063237265668	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2644.96115223003	2644.96115223003
"healthy-3"	"2019-08-01-count-2:TTGGATGGTGGGCTTC"	-3.43851314011272	10.8821391829285	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGATGGTGGGCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.34993047399	44.1699247781234	0.0219494254499363	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2012.34993047399	2012.34993047399
"healthy-3"	"2019-08-01-count-2:AGTGCCGTCCGGTAGC"	10.6734053092891	7.44377563083497	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGTCCGGTAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.40115214951	42.4920602299784	0.0223008473475742	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1900.32476229397	1900.32476229397
"healthy-3"	"2019-08-01-count-2:CATGCGGAGCTAATGA"	-1.37616370144542	8.60680291736452	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCGGAGCTAATGA"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2082.78196419638	52.488834861651	0.0252013104414909	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.41094242834	2078.41094242834
"healthy-3"	"2019-08-01-count-2:AGCGTATGTCTCAAGT"	-3.94588694992717	11.0583925017151	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATGTCTCAAGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1969.39829415307	44.6564354535596	0.0226751671239585	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1966.03964323648	1966.03964323648
"healthy-3"	"2019-08-01-count-2:GATAGAAGTGCGGCTT"	10.4647318321163	7.19893834674684	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGAAGTGCGGCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2399.33214316246	50.4142914872405	0.021011801817814	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2392.15529355512	2392.15529355512
"healthy-3"	"2019-08-01-count-3:CGGCAGTCAGAGTGTG"	3.82807673987691	-7.80911400234374	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGCAGTCAGAGTGTG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.69754632706	44.5574450832525	0.0188030093343831	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2368.34699336102	2368.34699336102
"healthy-3"	"2019-08-01-count-2:TCCCAGTAGTCTACCA"	4.14146484908406	-7.68856575405272	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTAGTCTACCA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.68781309367	46.0296073587935	0.0178777431285876	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2569.34324662268	2569.34324662268
"healthy-3"	"2019-08-01-count-3:TCTAACTAGACCATAA"	-1.76363048973735	8.78521726215211	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTAACTAGACCATAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2174.19940106626	49.7036746099481	0.0228606790092816	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2163.66764031014	2163.66764031014
"healthy-3"	"2019-08-01-count-2:TCTACATTCGACACTA"	-2.70866260948833	9.09386632526246	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACATTCGACACTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2157.80800231389	47.4992881805999	0.0220127500359924	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2151.88414031486	2151.88414031486
"healthy-3"	"2019-08-01-count-2:TCCTTTCCATAGCTGT"	-1.49686382237132	8.77306554401246	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTTCCATAGCTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2110.77328861153	48.908861316602	0.0231710632214672	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2103.82675232876	2103.82675232876
"healthy-3"	"2019-08-01-count-2:CTGCTCAGTTGACTGT"	-3.88545427742656	10.554847694281	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCTCAGTTGACTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2073.97406150083	42.6853237360069	0.0205814163872029	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2070.59653664557	2070.59653664557
"healthy-3"	"2019-08-01-count-4:CGGCAGTGTCAACGCC"	-4.30037150803264	9.99112222278444	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGCAGTGTCAACGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.72150828455	45.7053437562168	0.0222657304323823	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2042.70205486898	2042.70205486898
"healthy-3"	"2019-08-01-count-2:CACGTTCTCGGTGAAG"	-3.43128452721294	12.473099685553	"2019-08-01-count-2"	"Control3"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCTCGGTGAAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1936.45657027063	43.010550569094	0.022210955427254	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1932.83091289382	1932.83091289382
"healthy-3"	"2019-08-01-count-4:TGGGATTAGATGCTAA"	3.3982638317043	-6.86882545864256	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGATTAGATGCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.3085867554	45.3235338454351	0.0188902478387436	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2394.81172577316	2394.81172577316
"healthy-3"	"2019-08-01-count-4:CATCCCAAGTTAACAG"	-1.2892167371815	9.15652368152467	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCAAGTTAACAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2187.76602137139	44.8009688279525	0.0204779525736803	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2184.65013737676	2184.65013737676
"healthy-3"	"2019-08-01-count-3:GTGCTTCAGGTAAGTT"	-3.65089760246928	9.62447736347047	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCAGGTAAGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.68578468096	47.8756668679527	0.0245178549685477	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1945.66625337597	1945.66625337597
"healthy-3"	"2019-08-01-count-4:CCTTGTGCATTCACCC"	-3.4257894558018	12.6741056212219	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTGTGCATTCACCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2458.35291266816	39.5962927162805	0.016106838246143	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2450.97738447858	2450.97738447858
"healthy-3"	"2019-08-01-count-4:TATATCCAGAAGCCAC"	-2.08117423477824	9.00513074481813	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATATCCAGAAGCCAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.23341214024	45.2219585058317	0.021718006368628	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2078.87408353845	2078.87408353845
"healthy-3"	"2019-08-01-count-2:TACGGTAAGACTCTTG"	-3.97141442719157	2.61362001979677	"2019-08-01-count-2"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGTAAGACTCTTG"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3210.99683807663	45.2257850810078	0.014084655750735	4440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3198.41429725212	3198.41429725212
"healthy-3"	"2019-08-01-count-2:GACTATGAGACCAGAC"	-3.98761115494426	-5.26706221019896	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTATGAGACCAGAC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2806.11697782272	48.177334700044	0.0171686836581649	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2802.80802809041	2802.80802809041
"healthy-3"	"2019-08-01-count-4:CCACAAAAGCGTGCCT"	-4.0540374321049	13.1828002699646	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAAAGCGTGCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2204.26325362218	47.6455604574594	0.0216151861077234	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2193.69607438411	2193.69607438411
"healthy-3"	"2019-08-01-count-2:GTTTGGAAGCTTGTTG"	-3.52944741669353	-4.53710367595824	"2019-08-01-count-2"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAAGCTTGTTG"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2907.58921346667	45.7665409178047	0.0157403737453125	3123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2899.73978903964	2899.73978903964
"healthy-3"	"2019-08-01-count-2:GTGGTTAAGTGGATAT"	-5.56952033463176	-5.45921709453734	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGTTAAGTGGATAT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2737.8108592668	45.774578186531	0.0167194085126792	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2735.06815112972	2735.06815112972
"healthy-3"	"2019-08-01-count-2:TACGTCCTCGGCCCAA"	4.09623875197713	-8.11170675670775	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCTCGGCCCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.66822144498	41.4256495531635	0.0176154311120085	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2348.84204636056	2348.84204636056
"healthy-3"	"2019-08-01-count-4:TCGGGCAAGGAATCGC"	-1.88356695595439	8.9268178709778	"2019-08-01-count-4"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCAAGGAATCGC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2055.9710295688	44.4172170317923	0.0216040091971082	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2054.42481720951	2054.42481720951
"healthy-3"	"2019-08-01-count-4:GCGGAAATCATTTGCT"	-4.15499196472819	10.2170219191345	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGAAATCATTTGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2260.75957264468	46.5077372142621	0.0205717307479346	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2250.2056766493	2250.2056766493
"healthy-3"	"2019-08-01-count-2:AGAAGCGCAACTAGAA"	-2.22187004509624	9.15184304797975	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGCGCAACTAGAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.39857089147	49.6488901659462	0.0246470042638951	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2008.08167176858	2008.08167176858
"healthy-3"	"2019-08-01-count-4:TCAGGGCCAGCACAAG"	9.78435291823689	6.95549628818361	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGGCCAGCACAAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.26818429303	39.7704123266356	0.0206678116134042	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1915.52296037036	1915.52296037036
"healthy-3"	"2019-08-01-count-2:GTCACGGTCGCCTTTG"	0.0709075230056464	8.15433213794557	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGTCGCCTTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2093.86287028982	41.5707309227754	0.0198536071834645	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2089.79485950895	2089.79485950895
"healthy-3"	"2019-08-01-count-4:CGTGTCTGTCTTCTAT"	-3.42040477219279	10.0038757094177	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGTCTGTCTTCTAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1784.46571218239	43.4144313666334	0.0243290924954438	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1780.48774480762	1780.48774480762
"healthy-3"	"2019-08-01-count-3:TGAGCATAGCTCATAC"	3.54618968543355	-6.34474375164183	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCATAGCTCATAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.89778782763	49.2377780960912	0.0195551139264362	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2514.14828771348	2514.14828771348
"healthy-3"	"2019-08-01-count-2:GCGAGAACAGCGACCT"	-7.17117724838908	3.30547235095827	"2019-08-01-count-2"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGAGAACAGCGACCT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2637.55380277493	43.7109857934931	0.0165725475429185	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2625.01994108146	2625.01994108146
"healthy-3"	"2019-08-01-count-3:CTCTCGATCGATTTCT"	-7.23934970322307	3.42002675617067	"2019-08-01-count-3"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCGATCGATTTCT"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2422.06718224418	46.573743228349	0.019228922950517	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2409.95572679285	2409.95572679285
"healthy-3"	"2019-08-01-count-2:ATGCCTCGTATCGGTT"	10.8610369163448	6.62517354572145	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCGTATCGGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1987.22342353136	39.1847713118087	0.0197183521730919	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1981.28729275834	1981.28729275834
"healthy-3"	"2019-08-01-count-3:CTGTAGAGTTGGGTTT"	-3.58448968353923	9.77150914752809	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGAGTTGGGTTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.77927409781	44.1710775892514	0.0229605746272354	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1921.51701211383	1921.51701211383
"healthy-3"	"2019-08-01-count-2:TATTCCAAGACATACA"	-3.5449243587559	11.2139444121155	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCAAGACATACA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1678.3077252561	25.7328131505562	0.0153325953061615	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1675.93007119349	1675.93007119349
"healthy-3"	"2019-08-01-count-4:CTCTCGAAGCTCCCTT"	2.1783205467159	-6.21145059978636	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCGAAGCTCCCTT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2611.28575534314	49.9654646497586	0.0191344300590315	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2602.05633425036	2602.05633425036
"healthy-3"	"2019-08-01-count-3:ATAGACCAGTTCCATG"	-4.390701631934	-5.26889231121215	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGACCAGTTCCATG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2978.31295493817	44.1452777648891	0.0148222428041668	2691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2974.55534190903	2974.55534190903
"healthy-3"	"2019-08-01-count-4:CCGAACGGTTGGGATG"	-2.98481665077861	9.39842031085817	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGAACGGTTGGGATG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1882.03846845423	44.5365606820666	0.0236640012563855	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1876.66726638383	1876.66726638383
"healthy-3"	"2019-08-01-count-3:AACGTCAAGGTGAGCT"	3.73921551284139	-7.4000659218994	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCAAGGTGAGCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.53478449783	42.1765963183271	0.0158586368428683	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2652.89950329199	2652.89950329199
"healthy-3"	"2019-08-01-count-3:TTACGCCCAGGCACTC"	-3.86739073219951	10.8838853606018	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGCCCAGGCACTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.10194951006	44.3681599228013	0.0221276329284117	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2003.44505457619	2003.44505457619
"healthy-3"	"2019-08-01-count-2:CTACATTTCAACTACG"	-2.0635019344395	8.74309156024782	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACATTTCAACTACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.73993989263	47.0462670561312	0.0230988090991191	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2035.17055800308	2035.17055800308
"healthy-3"	"2019-08-01-count-2:GCAGCCATCTCACCCA"	-4.04175887528117	10.5739192732605	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCCATCTCACCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2214.74982539386	47.5106097602878	0.0214519081187144	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2209.9080815888	2209.9080815888
"healthy-3"	"2019-08-01-count-4:AAATGGATCCTACCGT"	-4.20101485672649	13.2455377348694	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGATCCTACCGT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2043.85756809261	44.2381669768127	0.0216444470825319	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2032.79595253987	2032.79595253987
"healthy-3"	"2019-08-01-count-2:TAGGAGGAGCATTGAA"	5.64346327361409	-9.76249887859496	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGAGGAGCATTGAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2761.9160412428	45.0281908223768	0.0163032438893816	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2755.87083327062	2755.87083327062
"healthy-3"	"2019-08-01-count-4:TACTTGTCATTGGATC"	10.1609798866207	6.93649385059205	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTCATTGGATC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2079.87943097204	45.4633778613793	0.0218586602590381	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2068.07444176929	2068.07444176929
"healthy-3"	"2019-08-01-count-3:AACAAAGCACCGTGAC"	-3.28150759163554	9.83083531940309	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAAGCACCGTGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1956.63696893362	49.7377826045099	0.0254200362122451	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1954.92077225771	1954.92077225771
"healthy-3"	"2019-08-01-count-2:TCCCAGTGTATCGCTA"	2.54777850684468	-4.40034248745116	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTGTATCGCTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2628.68273583402	43.5068160669009	0.0165508052660061	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2623.88672005595	2623.88672005595
"healthy-3"	"2019-08-01-count-2:GTCTACCAGAGCCATG"	5.08082451400105	-8.57953836834105	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTACCAGAGCCATG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2834.9226657778	41.1571057926565	0.0145178936587903	2410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2829.72703840968	2829.72703840968
"healthy-3"	"2019-08-01-count-2:TCAGGTATCATTCCTA"	0.158039716153783	7.88935945117799	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTATCATTCCTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.94264764223	41.0801426609014	0.0216445648196663	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1895.45090570528	1895.45090570528
"healthy-3"	"2019-08-01-count-2:TTTACCATCTGACCCT"	9.83620228347127	7.37371871555177	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACCATCTGACCCT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2199.93554526502	47.6663739132902	0.0216671683931303	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2186.4359194508	2186.4359194508
"healthy-3"	"2019-08-01-count-2:GCGTTTCTCAAGTTGC"	4.38960375365559	-7.96093275463256	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCTCAAGTTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.18572430646	48.1374044544439	0.0190931608053928	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2514.68962471502	2514.68962471502
"healthy-3"	"2019-08-01-count-4:GAGTTACCAAATGGTA"	-4.96011243286784	-4.37879803096923	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTACCAAATGGTA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3370.34483071587	42.5846298404947	0.0126350958075259	4350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3361.67313473151	3361.67313473151
"healthy-3"	"2019-08-01-count-4:AAAGAACGTCTTTATC"	4.75392689284627	-8.22867586528929	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGAACGTCTTTATC"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2747.71028785184	43.3281146005578	0.0157688075020572	2139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2745.86514624046	2745.86514624046
"healthy-3"	"2019-08-01-count-4:TCGTCCAGTACATTGC"	3.86094488677327	-7.13343145763548	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCAGTACATTGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.08534439185	46.4841684682797	0.0203780926402264	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2278.53283663257	2278.53283663257
"healthy-3"	"2019-08-01-count-2:CATCAAGAGGCAATGC"	-4.78617797318156	2.65527484500734	"2019-08-01-count-2"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGAGGCAATGC"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2914.67653284246	48.5837497508893	0.0166686591817135	3138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2904.813320974	2904.813320974
"healthy-3"	"2019-08-01-count-2:TTCCGGTAGGTAAACT"	4.830742974847	-7.5998687974182	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTAGGTAAACT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.00913458361	43.2422414972846	0.0158978295136881	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2710.08660126597	2710.08660126597
"healthy-3"	"2019-08-01-count-4:AGCCAATTCCGTAATG"	9.54039444503133	8.11768434131471	"2019-08-01-count-4"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATTCCGTAATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2056.94290480896	41.3598648515493	0.0201074442828983	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2051.65890707346	2051.65890707346
"healthy-3"	"2019-08-01-count-4:ATTCGTTAGATGGTAT"	-3.66208849373515	10.4695110091004	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCGTTAGATGGTAT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2133.94189820943	38.9110700053582	0.0182343624435174	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2128.88272498611	2128.88272498611
"healthy-3"	"2019-08-01-count-3:TCTGGCTTCAAAGAAC"	-2.5319164794987	8.7334413298401	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTTCAAAGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.85155660097	47.5589691305829	0.0231672713877711	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2041.03687620695	2041.03687620695
"healthy-3"	"2019-08-01-count-3:CCACTTGAGATGATTG"	4.89577688750569	-8.37371351635131	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGAGATGATTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.48138575149	46.0902371326941	0.0176086207846943	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2613.1679807693	2613.1679807693
"healthy-3"	"2019-08-01-count-3:AGTGATCCATCGAGCC"	-3.11290131035503	9.68711659992067	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCCATCGAGCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.06641714448	52.5986893433112	0.027408477827243	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1912.47422364314	1912.47422364314
"healthy-3"	"2019-08-01-count-2:ATTCTTGCACATCCCT"	0.227416803210419	8.2717303999695	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGCACATCCCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.43126893688	45.4238319071123	0.0237518768098596	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1901.34758476907	1901.34758476907
"healthy-3"	"2019-08-01-count-2:GCATCGGCAACCTAAC"	-3.92338858071025	9.98209664905397	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCGGCAACCTAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.37536201752	46.6044008788781	0.0225427862472916	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.07899011132	2055.07899011132
"healthy-3"	"2019-08-01-count-4:GGGAGATAGCCTCTGG"	-3.52231727066692	13.0813541182312	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGATAGCCTCTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1660.4503571066	44.8043941293989	0.0269832783242447	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1654.05053326273	1654.05053326273
"healthy-3"	"2019-08-01-count-3:AGTAGTCCAAGAGCTG"	-3.98815570297893	10.5647887953552	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGTCCAAGAGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.58633201751	48.8133955616599	0.0243873545601494	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.40170301202	1996.40170301202
"healthy-3"	"2019-08-01-count-2:GCATCGGTCCTTACCG"	-1.41228006306346	8.69089791858522	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCGGTCCTTACCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.62972483896	49.3607498495516	0.0261080999632311	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1887.29007772712	1887.29007772712
"healthy-3"	"2019-08-01-count-2:GTCTGTCCACTTCATT"	3.25474967536275	-6.64143373882445	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCCACTTCATT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2164.61849720146	45.8973191395109	0.0212034218495543	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2161.81690760494	2161.81690760494
"healthy-3"	"2019-08-01-count-4:AATGGAATCTTGCAAG"	0.0782185486400544	8.75266263568727	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAATCTTGCAAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2026.00496676392	36.1981163768417	0.0178667461189199	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2018.54993864157	2018.54993864157
"healthy-3"	"2019-08-01-count-2:TGCTTGCGTAGCGCTC"	-1.15517661991771	9.11342427814332	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCGTAGCGCTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.55068428505	48.9000857589838	0.0258109145163553	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1892.92042080371	1892.92042080371
"healthy-3"	"2019-08-01-count-4:TTACTGTAGACTCAAA"	-4.04453597489055	12.9692973860535	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTAGACTCAAA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1862.25665933174	43.4358233819831	0.0233242948356914	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1853.24196028581	1853.24196028581
"healthy-3"	"2019-08-01-count-4:CTATAGGTCGAGTCTA"	-4.36640582504924	12.5787772902283	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATAGGTCGAGTCTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2018.40932754664	43.1342577661816	0.0213704213399622	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2014.75685213852	2014.75685213852
"healthy-3"	"2019-08-01-count-4:GCGGATCTCGCTTGCT"	-2.57350645485576	4.084605670813	"2019-08-01-count-4"	"Control3"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCTCGCTTGCT"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2728.8867315224	31.5905127108758	0.0115763370996538	2925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	2727.3910642678	2727.3910642678
"healthy-3"	"2019-08-01-count-2:TCTCCGACACCTCGTT"	-3.47393165054973	9.87914273822633	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCCGACACCTCGTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2356.14352066966	41.3152708737851	0.0175351248815448	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2343.23046687931	2343.23046687931
"healthy-3"	"2019-08-01-count-4:GTTTACTTCTCCATAT"	3.73261870917622	-6.92803051387938	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTTCTCCATAT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.60519893868	47.8970280547586	0.0203591440146295	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2344.46561851338	2344.46561851338
"healthy-3"	"2019-08-01-count-4:TCAAGACGTGCATGTT"	10.9143196540767	6.68012235248414	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACGTGCATGTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2028.04959444331	39.8599170856936	0.0196543108190779	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2017.69358415747	2017.69358415747
"healthy-3"	"2019-08-01-count-2:GCGGATCAGCAGCACA"	10.8890615898067	6.20512435520021	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCAGCAGCACA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.06465802206	41.1739728726863	0.0199576744783954	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2058.75594033849	2058.75594033849
"healthy-3"	"2019-08-01-count-4:GCGTGCAAGAATTGTG"	-3.78887162628825	10.685089088324	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCAAGAATTGTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1981.53070134686	48.6572714667162	0.0245553962063992	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1978.18789662276	1978.18789662276
"healthy-3"	"2019-08-01-count-4:GCACGGTAGCGAGGAG"	-1.38569674912151	9.15007493579713	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGGTAGCGAGGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.20706413696	37.9245635516183	0.0200743286808232	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1884.45926823054	1884.45926823054
"healthy-3"	"2019-08-01-count-4:CAACCTCGTAGTTACC"	3.56675042685811	-7.10690119182738	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCGTAGTTACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.96898418193	52.4168069182336	0.0215090168395514	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2435.80230014467	2435.80230014467
"healthy-3"	"2019-08-01-count-4:AGACCATTCCTGTACC"	-2.58851800385173	11.9345531233582	"2019-08-01-count-4"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATTCCTGTACC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1702.91623648815	30.3710025785541	0.0178347013950533	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1696.76663193689	1696.76663193689
"healthy-3"	"2019-08-01-count-4:CTGTATTGTGCGGCTT"	-3.02867279473003	9.59457871997682	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTGTGCGGCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1972.30089468692	47.4632966425322	0.024064936932489	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1968.76739077309	1968.76739077309
"healthy-3"	"2019-08-01-count-2:ATGTCTTAGTTCTACG"	-0.437988649041015	8.56826016986696	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCTTAGTTCTACG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1886.32343115997	39.6532535692181	0.0210214499349318	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1872.63720947938	1872.63720947938
"healthy-3"	"2019-08-01-count-2:ATTCCCGAGCCAAGCA"	0.0166706527465999	8.05319306934205	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCCGAGCCAAGCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.41188532625	34.1692035999073	0.0183074292810423	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1858.30364676487	1858.30364676487
"healthy-3"	"2019-08-01-count-2:CTATAGGCACCACTGG"	1.98257889327351	-6.39445593273314	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGCACCACTGG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2169.22442932476	50.9119963530682	0.0234701378358145	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2166.86763301479	2166.86763301479
"healthy-3"	"2019-08-01-count-3:AGACAAACATTCTTCA"	-2.03454051438029	8.82917497241823	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAACATTCTTCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2023.81589988455	50.5926136570336	0.0249986244598235	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2022.33659100807	2022.33659100807
"healthy-3"	"2019-08-01-count-2:TCAATCTAGATTGGGC"	-1.20625827732738	8.57662866199342	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATCTAGATTGGGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.5084999676	40.9409165816072	0.0220170634241901	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1854.39519057725	1854.39519057725
"healthy-3"	"2019-08-01-count-3:ATCCATTGTTGTCATG"	-3.49504790726359	10.1515168913635	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCATTGTTGTCATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.30784441027	51.6897710721117	0.0277557608035959	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1860.55932270531	1860.55932270531
"healthy-3"	"2019-08-01-count-4:TCAAGTGGTACCAATC"	0.129096833139104	8.05259893024293	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGGTACCAATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.80444260406	37.7727242307573	0.019442370730905	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1932.21805881403	1932.21805881403
"healthy-3"	"2019-08-01-count-3:AGGATAATCACTGGTA"	-2.635969499976	9.00382993305055	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGATAATCACTGGTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2572.33345233317	45.9042875797963	0.0178453876336134	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2560.35761605035	2560.35761605035
"healthy-3"	"2019-08-01-count-2:GATGATCTCGAAATCC"	-1.04073701325114	8.74462792957155	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGATCTCGAAATCC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2059.87523103018	42.8577226317406	0.0208059798895231	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2050.70200338274	2050.70200338274
"healthy-3"	"2019-08-01-count-4:TTCAATCTCCAATCCC"	11.0562426048214	6.3913101919922	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAATCTCCAATCCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2102.9904862956	47.3168391281294	0.0224997875342164	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2097.17215185689	2097.17215185689
"healthy-3"	"2019-08-01-count-4:CTAAGTGCATTCTTCA"	-0.5735299390858	8.73633477771608	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGCATTCTTCA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2223.90647611594	47.0192808114963	0.0211426520478575	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2214.49418978948	2214.49418978948
"healthy-3"	"2019-08-01-count-3:TCTGGCTAGAATTGCA"	-7.19841227951701	3.39457151973573	"2019-08-01-count-3"	"Control3"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTAGAATTGCA"	"HSC"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2666.98140964251	45.5936065223974	0.0170955846777008	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2653.92129050429	2653.92129050429
"healthy-3"	"2019-08-01-count-3:CGTCAAAGTGTTAAAG"	3.86079659041707	-7.54880239879759	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAAGTGTTAAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.67664559113	42.8760147542329	0.0172700761617	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2474.79759727357	2474.79759727357
"healthy-3"	"2019-08-01-count-4:TCAATTCCAAATGGCG"	-0.472134689719039	8.05153558338014	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCCAAATGGCG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2002.45530187163	36.1036925520282	0.0180297120831028	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1998.68807843713	1998.68807843713
"healthy-3"	"2019-08-01-count-2:GAAATGAGTACAGGTG"	-2.05752025070842	9.33523080432741	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGAGTACAGGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1871.22347137631	45.2738419447055	0.0241947809212793	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1867.66453500265	1867.66453500265
"healthy-3"	"2019-08-01-count-2:TTCCGGTAGATGCTAA"	-3.58890686455424	9.85575482929078	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTAGATGCTAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.32257892291	46.2000123449929	0.0224128007995398	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.10597684292	2055.10597684292
"healthy-3"	"2019-08-01-count-2:CATCGTCAGCAGGCTA"	-2.31332550469096	9.04862496936647	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGTCAGCAGGCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.12699239403	43.8976123320996	0.0213392816750767	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2049.98659809859	2049.98659809859
"healthy-3"	"2019-08-01-count-2:TCATTTGTCGGCTGTG"	-3.28469286385234	11.0450286635193	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTTGTCGGCTGTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1843.6547715816	44.4339068126461	0.0241009908674648	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1838.16305533086	1838.16305533086
"healthy-3"	"2019-08-01-count-2:TCTATCATCTCTCAAT"	-3.57669196549113	9.89668176257936	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATCATCTCTCAAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2336.72115309611	40.5203401554773	0.017340682734775	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2330.44067339985	2330.44067339985
"healthy-3"	"2019-08-01-count-3:GACTGATAGCCGATTT"	-2.04516802254375	8.90918443286744	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATAGCCGATTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2079.01122955163	42.0812241711005	0.020240979737361	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.93134091253	2069.93134091253
"healthy-3"	"2019-08-01-count-3:AACCTTTAGAAATCCA"	5.15237011489217	-8.86446192180785	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTAGAAATCCA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.65355076536	47.032429135117	0.0185557624318775	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2530.47703112038	2530.47703112038
"healthy-3"	"2019-08-01-count-4:ACGTAGTGTGTTACAC"	-4.2036751312321	13.1776313551697	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTGTGTTACAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2072.63185395774	42.4442515112802	0.020478432496457	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2062.67660514998	2062.67660514998
"healthy-3"	"2019-08-01-count-3:CGTGAATAGCACCCAC"	-4.00037036362346	2.67896435344545	"2019-08-01-count-3"	"Control3"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATAGCACCCAC"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3051.20891349707	47.0817133974123	0.0154305112275812	4293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	3045.63354804359	3045.63354804359
"healthy-3"	"2019-08-01-count-3:TCACATTGTACTCGAT"	-2.82598457756694	10.1010188826355	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTGTACTCGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.83741148007	47.1840096450222	0.0223320589595056	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2112.83741148007	2112.83741148007
"healthy-3"	"2019-08-01-count-4:CTCATGCAGCAACCAG"	3.82327975806538	-7.40858414089354	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCAGCAACCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.2924637955	46.6339355898715	0.0194284389478651	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2397.75573949504	2397.75573949504
"healthy-3"	"2019-08-01-count-4:CCTCTAGTCACGGGCT"	0.446610351174515	8.69304654682008	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGTCACGGGCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1828.74900241122	46.4566458416668	0.025403511242064	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1813.35656447684	1813.35656447684
"healthy-3"	"2019-08-01-count-3:TCATGAGTCGGCTGGT"	-3.87313399735149	10.867275215033	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGTCGGCTGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.07919974745	45.0564841668808	0.0224823870097343	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2002.384803039	2002.384803039
"healthy-3"	"2019-08-01-count-3:CATAAGCCAAGGACAC"	-1.87744567814525	8.78502271259157	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCCAAGGACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.71212530298	42.315966966413	0.0196479215904772	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2147.98710400138	2147.98710400138
"healthy-3"	"2019-08-01-count-2:GACTCAATCCACGTGG"	-3.81018219414409	12.970995880011	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCAATCCACGTGG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1652.14053557656	28.112639282998	0.0170158885867341	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1647.31849012005	1647.31849012005
"healthy-3"	"2019-08-01-count-2:TGGGAGAAGATGTAGT"	10.8438354926998	6.36058805072633	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGAAGATGTAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1837.81744858362	40.8073386525246	0.0222042394275744	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1834.8657464663	1834.8657464663
"healthy-3"	"2019-08-01-count-2:TTGTTCAGTACCCACG"	-2.05075059357341	8.6236419447693	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCAGTACCCACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.19595145441	46.4570948546235	0.0232146656207554	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1996.15095514202	1996.15095514202
"healthy-3"	"2019-08-01-count-4:CCTCACAGTCGAACGA"	-1.58833346787151	8.95752713764039	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACAGTCGAACGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.04018233258	45.8481133778491	0.0233200286493907	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1953.55894626052	1953.55894626052
"healthy-3"	"2019-08-01-count-4:CTATCCGGTTCGTACA"	4.94972624358479	-8.48633005535277	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCCGGTTCGTACA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.08181601338	43.3423370466798	0.0168445234725697	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2562.59365772755	2562.59365772755
"healthy-3"	"2019-08-01-count-2:CGAGGCTTCCGTCCTA"	-2.74073014679607	8.8686370619568	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGCTTCCGTCCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2104.23737026048	42.9686404455819	0.0204200538650556	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2100.89839502037	2100.89839502037
"healthy-3"	"2019-08-01-count-4:TTGCGTCGTAATACCC"	3.56896915015523	-6.72714092647704	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCGTCGTAATACCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.85817888184	43.9242886140467	0.0203743868888577	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2150.06146387699	2150.06146387699
"healthy-3"	"2019-08-01-count-2:TCGAACAAGTAATCCC"	3.61296476897542	-6.93194487011107	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAACAAGTAATCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.86106938711	42.6306329024203	0.0177416137143933	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2396.86412665779	2396.86412665779
"healthy-3"	"2019-08-01-count-2:TCAGCCTCAGACGATG"	5.56853308257405	-9.82919790661009	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTCAGACGATG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.32252984944	46.8132746975048	0.0174006180218565	2297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2685.62154707065	2685.62154707065
"healthy-3"	"2019-08-01-count-3:ACGGGTCAGGAGGCAG"	-2.68719587746318	9.2943658598694	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGGTCAGGAGGCAG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1990.55831441595	44.136476802796	0.0221729132390407	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1980.80176175092	1980.80176175092
"healthy-3"	"2019-08-01-count-3:TGAGCATCACATTACG"	-4.16696677628215	12.4965276488098	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCATCACATTACG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1705.7343969021	41.7297353018001	0.0244643804906487	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1697.42210211575	1697.42210211575
"healthy-3"	"2019-08-01-count-3:TGACAGTTCCAGTACA"	3.85508002814595	-8.17154409801634	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTTCCAGTACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.36837588424	44.2229415953354	0.0170391771766382	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2591.36126710369	2591.36126710369
"healthy-3"	"2019-08-01-count-2:GTTGCGGAGGAGCTGT"	-0.283340523869354	8.19286248767702	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGCGGAGGAGCTGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2118.25808502918	37.3321302185818	0.0176239762673053	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2111.50575279643	2111.50575279643
"healthy-3"	"2019-08-01-count-2:GGGTGTCAGAGAGCAA"	10.8584839301998	6.77444121921388	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCAGAGAGCAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1880.35692803004	43.1681068675958	0.0229574003871813	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1874.72664928046	1874.72664928046
"healthy-3"	"2019-08-01-count-2:TCTTTGAGTTAAACCC"	-1.75801275196727	8.8955096968445	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTTGAGTTAAACCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.10546441272	42.08249429882	0.0197560613790652	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2122.20580417705	2122.20580417705
"healthy-3"	"2019-08-01-count-4:TCGGTCTTCTTCGATT"	-1.81187723103221	8.7943601378235	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTTCTTCGATT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1933.25124505938	40.5191494069888	0.0209590706384075	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1924.08969331891	1924.08969331891
"healthy-3"	"2019-08-01-count-2:TATTGCTCATATGGCT"	-2.88880024376567	8.91773316943971	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTCATATGGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2265.58065798226	45.0570537802699	0.0198876405576299	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2257.15167790795	2257.15167790795
"healthy-3"	"2019-08-01-count-3:GAAGCGATCAACACGT"	-2.57869992676433	9.28739354694215	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGATCAACACGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.95269209584	45.8528111737404	0.0231235023187957	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1981.32587146326	1981.32587146326
"healthy-3"	"2019-08-01-count-2:AGGTGTTGTGTCCGGT"	-3.58355722847636	10.5679111250672	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTGTGTCCGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.71701816423	40.8608560516588	0.0208716865984924	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1954.26946029925	1954.26946029925
"healthy-3"	"2019-08-01-count-2:CATACAGAGGCACTCC"	5.44051994857137	-9.51786329662474	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGAGGCACTCC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2891.04077439849	44.5282844708595	0.0154021641151443	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2883.55705099787	2883.55705099787
"healthy-3"	"2019-08-01-count-2:AGGGTGAGTCTGCATA"	3.34709324416463	-6.72395899212035	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTGAGTCTGCATA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.86151995742	48.9043675425123	0.0212548070009086	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2297.28789763553	2297.28789763553
"healthy-3"	"2019-08-01-count-3:TTTCCTCGTCAGACGA"	5.30904974517171	-9.59443094646605	"2019-08-01-count-3"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCCTCGTCAGACGA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2800.86338176156	41.7140154178465	0.0148932702999641	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2795.71089874583	2795.71089874583
"healthy-3"	"2019-08-01-count-3:CCCATTGCATGTCAGT"	-0.135355408222038	7.94792554462282	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCATTGCATGTCAGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2042.05045933223	45.7928006740614	0.0224249114240967	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2037.40197676319	2037.40197676319
"healthy-3"	"2019-08-01-count-4:GATTGGTGTCGTTATG"	-2.98830376091655	9.54711053455202	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTGTCGTTATG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2245.29113099177	45.2624295897806	0.0201588243791743	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2235.59631131657	2235.59631131657
"healthy-3"	"2019-08-01-count-3:CTAAGTGAGCAAGTCG"	-2.09761367264445	8.99162385547487	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAAGTGAGCAAGTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.27129863911	46.4852101860628	0.0240822159138127	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1925.2336303109	1925.2336303109
"healthy-3"	"2019-08-01-count-2:TGCTGAAGTGCCGTTG"	-2.81695399704631	-5.61265327846678	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAAGTGCCGTTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2697.28446293514	49.8158590099163	0.0184688933238089	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2689.87743209406	2689.87743209406
"healthy-3"	"2019-08-01-count-2:GAGAAATAGTCTTCCC"	3.953221698373	-8.24838449871215	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATAGTCTTCCC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2315.47292897012	44.8327340186844	0.0193622363093768	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2309.08612396558	2309.08612396558
"healthy-3"	"2019-08-01-count-2:AACGAAAGTGCAGATG"	10.87291588363	7.40243194187013	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGAAAGTGCAGATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2605.7547043366	49.7405289300903	0.0190887226826494	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2595.84461925582	2595.84461925582
"healthy-3"	"2019-08-01-count-4:TCTTAGTCAAACACCT"	-2.48816309395488	9.42423913562623	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTAGTCAAACACCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2263.75121819327	40.1975803146745	0.017757066232197	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2252.07494191417	2252.07494191417
"healthy-3"	"2019-08-01-count-4:ATTCCTACAGATAAAC"	2.84285940703694	-6.38054945385131	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCTACAGATAAAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.34623524449	43.6062152526935	0.0163973440820821	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2653.62260269977	2653.62260269977
"healthy-3"	"2019-08-01-count-2:TCGTAGATCCATGCAA"	-3.68311868134196	9.89183518970338	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTAGATCCATGCAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1888.59824515553	50.818930477479	0.0269082800472972	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1882.64823798431	1882.64823798431
"healthy-3"	"2019-08-01-count-2:AGATAGATCCAGCACG"	5.37864985045735	-9.45824530040892	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGATCCAGCACG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.86008518622	40.1679076784918	0.0155276692034932	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2580.78773584843	2580.78773584843
"healthy-3"	"2019-08-01-count-4:CCGGTGACACCAAATC"	-3.71092377129253	-5.76857521450194	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTGACACCAAATC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2588.01801158448	46.9744548636512	0.0181507449536225	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2582.90209488436	2582.90209488436
"healthy-3"	"2019-08-01-count-2:CGATCGGCACCAGTTA"	10.6557518440181	6.50960538471071	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGCACCAGTTA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1677.15853259854	36.7326542192778	0.0219017185944642	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1675.25690028613	1675.25690028613
"healthy-3"	"2019-08-01-count-2:GCACATACAAGTGACG"	-2.30062208595927	8.8991603621277	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACATACAAGTGACG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.21649074902	38.5819758018865	0.0199884189088628	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1926.77061471736	1926.77061471736
"healthy-3"	"2019-08-01-count-2:GTGGGAACAAACACGG"	-2.08391414108928	8.61910150134889	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGGAACAAACACGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.14137393473	45.6979003967434	0.0219264877940927	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2069.64498122493	2069.64498122493
"healthy-3"	"2019-08-01-count-2:ACGTCCTTCAAACCCA"	-1.15767810764964	8.26422879779664	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTCCTTCAAACCCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2190.36517314606	44.1414132808969	0.020152536125972	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2182.38429495612	2182.38429495612
"healthy-3"	"2019-08-01-count-4:TCCGATCCAAATCCCA"	2.49733485755269	-3.98070909893187	"2019-08-01-count-4"	"Control3"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCCAAATCCCA"	"cDC1"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2820.93361370422	40.1905837806065	0.0142472632412755	3210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2811.92473314388	2811.92473314388
"healthy-3"	"2019-08-01-count-4:TCGAACACAGCCGTTG"	5.51636805114095	-10.2068367234436	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACACAGCCGTTG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.13539277738	43.6733566431276	0.0169202114562978	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2577.08519049668	2577.08519049668
"healthy-3"	"2019-08-01-count-2:TACCCGTCATGTTCAG"	-2.96871695938762	9.21149346912233	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCGTCATGTTCAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.27607627131	40.8743773336026	0.0211206958194591	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1927.93397504917	1927.93397504917
"healthy-3"	"2019-08-01-count-3:TCTATCACAGAGATTA"	-0.674723545939285	8.23931405628053	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATCACAGAGATTA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2232.18694561329	38.202326363868	0.0171143041755277	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2228.45840823841	2228.45840823841
"healthy-3"	"2019-08-01-count-2:GAGACCCGTATCGTAC"	4.54783119735066	-7.51330425655516	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACCCGTATCGTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.22775671238	46.4865408580354	0.0167807649552989	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2763.18706720651	2763.18706720651
"healthy-3"	"2019-08-01-count-3:ATACCTTCAGGCAATG"	0.151118171482724	7.77414605701295	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTCAGGCAATG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.87768287996	40.9145560522	0.022782484821899	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1790.92076728321	1790.92076728321
"healthy-3"	"2019-08-01-count-1:AGACTCACATCGGTTA"	-2.90276227417644	9.13302896106569	"2019-08-01-count-1"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGACTCACATCGGTTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2398.16098935237	38.3025615807703	0.0159716389978948	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2389.27676273878	2389.27676273878
"healthy-3"	"2019-08-01-count-2:TCTTGCGAGCAACAAT"	-5.22436175766643	3.45181582057802	"2019-08-01-count-2"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTGCGAGCAACAAT"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2999.23590670319	43.4003396619775	0.0144704654825515	3856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	2989.67247904626	2989.67247904626
"healthy-3"	"2019-08-01-count-2:TGTTGGATCGTGGCTG"	-3.86439524117168	10.9802398451599	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGATCGTGGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1914.95790947772	46.8207884273945	0.0244500352700516	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1911.36980433269	1911.36980433269
"healthy-3"	"2019-08-01-count-2:TCAATTCTCTCGCTTG"	-2.20472822609599	8.68029115283815	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCTCTCGCTTG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2663.85560830165	34.0850022003123	0.0127953640182635	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2654.49106496906	2654.49106496906
"healthy-3"	"2019-08-01-count-4:GAGTCTACAGGACAGT"	-3.34871302071269	10.027449584845	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCTACAGGACAGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.460610189	44.2268284563179	0.0214853897312406	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2055.0701980137	2055.0701980137
"healthy-3"	"2019-08-01-count-4:TCAGTGAGTGTCATGT"	2.64471163329427	-6.01267340099486	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTGAGTGTCATGT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2416.32623752213	47.2724341239716	0.0195637631168745	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2407.80569761268	2407.80569761268
"healthy-3"	"2019-08-01-count-4:TAGTGCAGTTTAGACC"	-2.41522179070171	9.20478723132936	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGTGCAGTTTAGACC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.06959323439	45.8744085246877	0.0218338358102972	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2091.60516174249	2091.60516174249
"healthy-3"	"2019-08-01-count-2:TCAAGACCATTAGGAA"	3.32409586486165	-6.3714866868225	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACCATTAGGAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.56259161645	49.2242300288881	0.0182409072821997	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2695.45211090031	2695.45211090031
"healthy-3"	"2019-08-01-count-2:CGATGCGAGCCAACCC"	11.3299185234005	5.97594497287599	"2019-08-01-count-2"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGAGCCAACCC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.07573008571	41.1077476521322	0.0201698823283684	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2029.14673061833	2029.14673061833
"healthy-3"	"2019-08-01-count-4:TTCGCTGTCATCTGTT"	3.86959566649739	-7.71414806759032	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGTCATCTGTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.39536994056	48.7007628761268	0.0201459651498068	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2410.68859460688	2410.68859460688
"healthy-3"	"2019-08-01-count-2:CAGGTATTCCAGCTCT"	-2.29867062988933	9.4973106154236	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATTCCAGCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1917.47724825781	47.5614732432113	0.0248041916984543	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.99368170325	1908.99368170325
"healthy-3"	"2019-08-01-count-2:TGGAGGAGTTAGGCTT"	-2.96930513802226	9.93907449329225	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGAGTTAGGCTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.72301916719	42.1812617312478	0.0198994214573469	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2113.23117419851	2113.23117419851
"healthy-3"	"2019-08-01-count-3:ATCCGTCCACGAAGAC"	3.51887168464009	-6.80063726818236	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCCACGAAGAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.58363720799	46.7328893450979	0.0174794940748144	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2670.55497087916	2670.55497087916
"healthy-3"	"2019-08-01-count-4:GGGAAGTCAGAGTTCT"	-0.315595696598846	8.98245427692262	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAAGTCAGAGTTCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2107.15228058519	39.6799425155219	0.0188310749446652	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2098.21781117031	2098.21781117031
"healthy-3"	"2019-08-01-count-2:GCTGGGTTCCAGTTCC"	-4.16879067841228	12.9951905974182	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTTCCAGTTCC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1889.45355231776	40.0349380318651	0.0211886330747612	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1873.48061179176	1873.48061179176
"healthy-3"	"2019-08-01-count-2:CTACCTGGTTCGGTTA"	-4.2440107864445	12.5749969252381	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGGTTCGGTTA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2050.82170241897	40.4666978764411	0.0197319434589121	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2049.01852821246	2049.01852821246
"healthy-3"	"2019-08-01-count-3:GCATGATTCTCATAGG"	-2.78050957146342	8.95600984180299	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATGATTCTCATAGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2097.07844530692	43.4281394811252	0.0207088769513194	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2091.93941873469	2091.93941873469
"healthy-3"	"2019-08-01-count-2:TCACAAGAGCATTTGC"	-2.62371597710307	9.46970365131227	"2019-08-01-count-2"	"Control3"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGAGCATTTGC"	"MAIT"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1993.18348255758	45.1870152957253	0.0226707755162325	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1984.88399512491	1984.88399512491
"healthy-3"	"2019-08-01-count-2:ATTCTTGCACACACGC"	10.5620809989864	6.3025707968506	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGCACACACGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1972.58935737772	45.2646779386194	0.0229468326843214	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1959.35790870354	1959.35790870354
"healthy-3"	"2019-08-01-count-3:TGATCTTAGTTGAATG"	10.6304108100826	7.1958060034546	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCTTAGTTGAATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.19897906367	46.0158359284138	0.0246443129223909	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1867.19897906367	1867.19897906367
"healthy-3"	"2019-08-01-count-2:CCTTCAGTCCGGTAGC"	-4.19316802445109	12.8945703276428	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGTCCGGTAGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1868.07448398386	50.7560285902327	0.0271702381384656	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1864.3847186449	1864.3847186449
"healthy-3"	"2019-08-01-count-3:GTCGTTCTCCAGCAAT"	-0.93142662468608	8.24463365161744	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTTCTCCAGCAAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.35684892657	38.3596283261475	0.0195079689361002	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1962.10396037977	1962.10396037977
"healthy-3"	"2019-08-01-count-4:TGGAACTCAATGCAAA"	10.8224665122921	7.32872817600099	"2019-08-01-count-4"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTCAATGCAAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2156.65496021875	48.8073266948997	0.0226310316648655	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2139.65454055179	2139.65454055179
"healthy-3"	"2019-08-01-count-2:TTGCATTTCAAGTGGG"	-4.06798253479655	10.4891547926697	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTTCAAGTGGG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2150.8364744675	44.7277042013818	0.0207954926989303	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2143.07734463842	2143.07734463842
"healthy-3"	"2019-08-01-count-3:TGCGGGTTCTCGTCAC"	3.11430587348287	-6.39595653927001	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGGTTCTCGTCAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.58775230778	47.5909156159947	0.0198743669218758	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2392.3539902588	2392.3539902588
"healthy-3"	"2019-08-01-count-2:GTCACGGAGGATACAT"	-2.89754949036296	9.29988000476686	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGAGGATACAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1899.65781002313	42.0108727965198	0.0221149685879523	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1892.45041218541	1892.45041218541
"healthy-3"	"2019-08-01-count-2:TTCGCTGCATACACCA"	4.44931044158284	-8.31154158031615	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGCATACACCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.73321345339	42.2367813353235	0.0161781300048863	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2607.27970588759	2607.27970588759
"healthy-3"	"2019-08-01-count-3:ATCGTGAGTTAATCGC"	-3.39148531380351	10.1813096770081	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTGAGTTAATCGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1906.93511578457	48.6674388992562	0.025521287272133	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1903.36537584547	1903.36537584547
"healthy-3"	"2019-08-01-count-2:GACTTCCGTTGATGTC"	10.3217636543209	7.59881637180177	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCGTTGATGTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2110.69898839099	40.60845886182	0.0192393416044494	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2104.09459059092	2104.09459059092
"healthy-3"	"2019-08-01-count-4:TCATTACGTAGCGAGT"	3.71627153930013	-6.60390188610228	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTACGTAGCGAGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.30141799148	46.2027571911496	0.0179407182663627	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2570.86540212467	2570.86540212467
"healthy-3"	"2019-08-01-count-2:ACTGTCCCAATGTCTG"	-3.86439190331157	-5.43923523342284	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTCCCAATGTCTG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2536.7228044723	52.9327548658727	0.0208665900635856	2129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2531.73274987798	2531.73274987798
"healthy-3"	"2019-08-01-count-2:AGTCAACTCTCGTGAA"	-1.00021503391917	8.34859082782594	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCAACTCTCGTGAA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2033.87312802068	36.0549061422472	0.0177272149602246	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2029.6110871463	2029.6110871463
"healthy-3"	"2019-08-01-count-2:CATGAGTCAGGGTTGA"	4.23766293105428	-8.10357382213744	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGAGTCAGGGTTGA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.92689823359	44.023574686349	0.0190666818945323	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2305.03080643425	2305.03080643425
"healthy-3"	"2019-08-01-count-4:CAAAGAACACATGGTT"	-2.21413455429729	9.25449178302614	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAAGAACACATGGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.77948177586	41.2684274288631	0.0219305332152509	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1878.26383039986	1878.26383039986
"healthy-3"	"2019-08-01-count-4:CCCGGAAAGAAACACT"	-3.68660412254985	9.8814077147278	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGGAAAGAAACACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.26700716684	45.7074278702838	0.0226020736669779	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2017.39577396482	2017.39577396482
"healthy-3"	"2019-08-01-count-2:ACTATTCTCTGTGTGA"	10.9671198326046	6.16120622241823	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCTCTGTGTGA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1997.46460024037	40.8007874071912	0.0204262881065733	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1988.39550541538	1988.39550541538
"healthy-3"	"2019-08-01-count-3:GTAACCATCCATTGCC"	4.67881598052327	-8.16648294841918	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCATCCATTGCC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2710.72814467865	42.4451495586541	0.0156582096371327	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2708.96899727989	2708.96899727989
"healthy-3"	"2019-08-01-count-4:CTGGCAGTCAAATGAG"	-3.17747984352763	9.60757348621217	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGCAGTCAAATGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.55580550888	47.7643434633895	0.0234534911020788	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.25063278899	2033.25063278899
"healthy-3"	"2019-08-01-count-4:TTACGTTCACTAGGTT"	4.94776787337605	-8.57883360302123	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACGTTCACTAGGTT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2844.61282392343	43.401420011179	0.0152574085464881	2538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2836.70565938879	2836.70565938879
"healthy-3"	"2019-08-01-count-4:TCTTGCGGTATACCCA"	4.70614256438558	-8.17625429546507	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGGTATACCCA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2832.68441525539	43.5242633023537	0.0153650237449517	2446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2824.79562954623	2824.79562954623
"healthy-3"	"2019-08-01-count-2:GACTTCCGTTAACAGA"	-2.18298492851909	9.14503285968629	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCGTTAACAGA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2119.98560014005	43.722548552368	0.0206239837428516	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2110.79075116992	2110.79075116992
"healthy-3"	"2019-08-01-count-4:GTCGTAATCCAGCCTT"	4.00495066222493	-7.15704395687255	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTAATCCAGCCTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.15354060499	48.0093178336598	0.0190577180230666	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2518.12801887839	2518.12801887839
"healthy-3"	"2019-08-01-count-2:GCAACCGCATGTGACT"	-2.17963657799419	9.07285115802614	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGCATGTGACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2155.77221801491	41.6638709203336	0.019326657321291	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2148.60439256363	2148.60439256363
"healthy-3"	"2019-08-01-count-3:GGTGAAGCATTCTCTA"	-4.49244485321696	11.7570762404236	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGCATTCTCTA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2997.88192219487	41.1245456813368	0.0137178670636993	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2994.62871891175	2994.62871891175
"healthy-3"	"2019-08-01-count-2:TTGCCTGTCCATCTAT"	-2.23638377609904	9.04044721210328	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCCTGTCCATCTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2263.75008841868	49.4564139996902	0.0218471174237424	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2256.40856300141	2256.40856300141
"healthy-3"	"2019-08-01-count-2:GTCCACTAGCGTCAAG"	-1.07696721974071	8.41771791065065	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCACTAGCGTCAAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1900.16618334234	49.7880449833031	0.0262019424510162	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1893.52213090083	1893.52213090083
"healthy-3"	"2019-08-01-count-2:TTGCCTGGTATGGTAA"	11.1270338493282	6.61673257434694	"2019-08-01-count-2"	"Control3"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCCTGGTATGGTAA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.49853406533	41.6141671062035	0.0222595344943711	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1866.44534984164	1866.44534984164
"healthy-3"	"2019-08-01-count-3:CGTCCATTCAAATGAG"	-3.31615815582927	9.43840501392213	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCCATTCAAATGAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2173.59433913724	41.7752352066147	0.0192194258396884	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2173.59433913724	2173.59433913724
"healthy-3"	"2019-08-01-count-2:AAGGTAACAGCAGAAC"	-1.84017036381419	8.60780904376832	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAACAGCAGAAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2171.25100749783	40.2499306810804	0.0185376681655359	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2163.31050224057	2163.31050224057
"healthy-3"	"2019-08-01-count-3:ATTATCCAGTTTCTTC"	-2.10815201225932	8.96352861011354	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTATCCAGTTTCTTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.83637438642	49.9351410304716	0.0238942826541301	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2084.50387980539	2084.50387980539
"healthy-3"	"2019-08-01-count-4:TTCGCTGCATCGCCTT"	-3.98120341721233	10.5901965864929	"2019-08-01-count-4"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGCATCGCCTT"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2207.61839359375	43.5840347021828	0.0197425582377184	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2205.93721263254	2205.93721263254
"healthy-3"	"2019-08-01-count-2:TCTATACTCTCATTGT"	-3.92534647408183	11.3224334486756	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACTCTCATTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2203.98440745592	42.5069714457579	0.0192864211298229	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2197.60546964008	2197.60546964008
"healthy-3"	"2019-08-01-count-4:CAATTTCAGGGCATGT"	-3.46653066101726	9.961305595282	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCAGGGCATGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.47693561391	45.2960721286506	0.0233427521334183	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1932.06666521381	1932.06666521381
"healthy-3"	"2019-08-01-count-2:CTAACTTAGGGCAGAG"	-4.27811608734782	13.0265779265198	"2019-08-01-count-2"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTAGGGCAGAG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2413.33060127182	46.2189037466293	0.0191515011338571	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2407.64542465904	2407.64542465904
"healthy-3"	"2019-08-01-count-4:GCTTCACCAACGAGGT"	0.0338272425228774	8.28567311847535	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTCACCAACGAGGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2005.0379256183	41.7653741284874	0.0208302165235145	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1994.29963389847	1994.29963389847
"healthy-3"	"2019-08-01-count-4:TGCAGATAGCGATTCT"	4.9289456802303	-7.77745630657347	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATAGCGATTCT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.03432548061	42.6549283629217	0.0157570696320405	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2701.1823479046	2701.1823479046
"healthy-3"	"2019-08-01-count-2:TGATCTTGTTATGTCG"	4.26087822493855	-6.99969532406005	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCTTGTTATGTCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.41502008075	46.9216095245394	0.0197447033148886	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2373.8096318734	2373.8096318734
"healthy-3"	"2019-08-01-count-2:CTGTGAATCCACGGAC"	0.441160072653931	8.15420053088991	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAATCCACGGAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1704.95179811083	38.8795423271533	0.0228038953184681	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1690.10691417706	1690.10691417706
"healthy-3"	"2019-08-01-count-2:CGAGGAACACCCAAGC"	4.57600798186604	-8.47005274212035	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACACCCAAGC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.79391530789	44.2282022861465	0.0168373323953594	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2625.90468301101	2625.90468301101
"healthy-3"	"2019-08-01-count-4:ACCTGAATCTGTCTCG"	-1.87236164036449	8.73539064014284	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAATCTGTCTCG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2126.63858424385	44.5802792330684	0.0209627905575311	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2124.96029890684	2124.96029890684
"healthy-3"	"2019-08-01-count-4:TTACAGGGTAACTGCT"	-2.78512416306193	8.94436071002809	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGGTAACTGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2534.06954791485	48.5249859884035	0.0191490348117447	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2527.56460401537	2527.56460401537
"healthy-3"	"2019-08-01-count-4:GCCATGGTCGGACGTC"	1.11951591548268	8.74495313251344	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGTCGGACGTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.24489713901	38.1772728185939	0.0215417592005623	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1767.72561777072	1767.72561777072
"healthy-3"	"2019-08-01-count-2:AGATCCAGTCAGATTC"	10.373476644128	6.63931272113649	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCCAGTCAGATTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.05614065852	49.2504676982918	0.0250631351844163	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1955.13138329914	1955.13138329914
"healthy-3"	"2019-08-01-count-2:TCTTAGTAGTTGCTGT"	-2.97794042053874	10.1588439711365	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTAGTAGTTGCTGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1778.36587822207	45.50662537651	0.0255890117628694	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1778.36587822207	1778.36587822207
"healthy-3"	"2019-08-01-count-3:CATTGAGAGTCGAATA"	10.4625431495601	6.7739047774109	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGAGAGTCGAATA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1781.31244085478	39.3687827290261	0.0221009980203892	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1773.99925932445	1773.99925932445
"healthy-3"	"2019-08-01-count-3:GACTCTCCATAATCCG"	4.18720688399617	-7.92314579403075	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCCATAATCCG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.76556831281	41.0510069431492	0.0186361215799246	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2199.71879832203	2199.71879832203
"healthy-3"	"2019-08-01-count-2:TCAGCCTCACAAGTTC"	10.2956053214962	7.07343385303346	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTCACAAGTTC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.09375488704	38.7828897596297	0.0200418660138219	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1926.91229723836	1926.91229723836
"healthy-3"	"2019-08-01-count-3:TCATACTAGGGTGAAA"	-3.50894771042522	9.96631810748903	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATACTAGGGTGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2041.77721836899	42.1747687772718	0.0206559111336161	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2033.45675495693	2033.45675495693
"healthy-3"	"2019-08-01-count-2:CCCTCAAGTATGCTAC"	5.59912981566731	-10.0643511048523	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAAGTATGCTAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2819.59670177251	42.0348935944712	0.0149081226999757	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2805.63094163647	2805.63094163647
"healthy-3"	"2019-08-01-count-2:TCGTAGAGTATACCTG"	9.28602947768514	6.54062411868898	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTAGAGTATACCTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1804.5474400695	47.3193123620331	0.0262222601142648	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1797.19687837352	1797.19687837352
"healthy-3"	"2019-08-01-count-2:GATTCGACATCACAGT"	3.24634780463521	-6.29948713695677	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGACATCACAGT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.80637876898	47.1280695346696	0.0183677419795334	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2561.01914576118	2561.01914576118
"healthy-3"	"2019-08-01-count-4:GACTCAAGTCACTTCC"	-4.10072837296184	9.86447045886842	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAAGTCACTTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2166.60503834831	44.8474435635027	0.0206994088768905	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2164.96469160984	2164.96469160984
"healthy-3"	"2019-08-01-count-2:ACCAAACTCTTGCAGA"	3.14947166022603	-6.66667463695677	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACTCTTGCAGA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.25453228994	41.9209748858499	0.0165941215938564	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2523.59895540441	2523.59895540441
"healthy-3"	"2019-08-01-count-2:TTCGGTCAGAGTCGAC"	10.224644322961	7.44395206058351	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGGTCAGAGTCGAC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.73886975973	47.1049876486369	0.0235202843265774	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1995.70330874753	1995.70330874753
"healthy-3"	"2019-08-01-count-4:TCGCTCATCAGGAAGC"	11.0705696540767	6.07054660404054	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTCATCAGGAAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.97573266111	41.679229159588	0.0212218656607912	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1955.82282450116	1955.82282450116
"healthy-3"	"2019-08-01-count-4:TGGGAGATCCGGCTTT"	4.85907330092732	-8.33931734478148	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGATCCGGCTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2769.63448007266	45.9296834602177	0.0165833014394783	2353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2762.12087629641	2762.12087629641
"healthy-3"	"2019-08-01-count-4:TGTAAGCAGCTGCGAA"	-4.65158830109294	-5.11973812496337	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCAGCTGCGAA"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3065.11597497932	47.549936595537	0.0155132585467203	3046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	3061.98091245677	3061.98091245677
"healthy-3"	"2019-08-01-count-2:ACAACCACATGAAGGC"	-2.91922293129619	9.32856080615846	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCACATGAAGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.0105820405	46.3278767643038	0.0217093003915688	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2131.08231136845	2131.08231136845
"healthy-3"	"2019-08-01-count-4:TCCTTTCCATACTTTC"	-3.52254662934001	13.3457135924133	"2019-08-01-count-4"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCCATACTTTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2100.44958867524	42.377174508974	0.0201752875848363	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2097.96682352387	2097.96682352387
"healthy-3"	"2019-08-01-count-4:AGCTCAATCTGTGCAA"	2.73982777175252	-7.41396191036376	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTCAATCTGTGCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.09583655087	47.1864995684835	0.0223093907864863	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2112.05270871654	2112.05270871654
"healthy-3"	"2019-08-01-count-3:CTGCTCAGTGGTTCTA"	-2.33896742287334	9.4795293577942	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCAGTGGTTCTA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2460.16609973351	41.0665972229989	0.0166926116197794	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2452.53727734326	2452.53727734326
"healthy-3"	"2019-08-01-count-2:GCCGATGCAGGACGAT"	-2.52016983452495	10.0625686415466	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGCAGGACGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.10105279212	44.6958241969998	0.0226525773394885	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1973.10105279212	1973.10105279212
"healthy-3"	"2019-08-01-count-3:CTACCCATCAGAACCT"	0.372742493718308	8.92990586841432	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCCATCAGAACCT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2171.83490730413	37.1060633445125	0.017085121534662	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2158.73586695414	2158.73586695414
"healthy-3"	"2019-08-01-count-2:TACACCCGTAACAGGC"	-1.27426038208659	8.45793149555055	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACACCCGTAACAGGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.15189930046	44.4532959948393	0.0235059362557195	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1886.01817991692	1886.01817991692
"healthy-3"	"2019-08-01-count-2:TCACTCGAGCGAGAAA"	-3.40681991997417	10.4817819365296	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTCGAGCGAGAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1897.16469628932	46.8882478555315	0.024714906379631	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1897.16469628932	1897.16469628932
"healthy-3"	"2019-08-01-count-3:CCCTGATCAATCGCCG"	2.58716668662373	-4.45142462169798	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATCAATCGCCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2665.51939486015	43.4997705074828	0.016319435000684	2759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2663.73176468039	2663.73176468039
"healthy-3"	"2019-08-01-count-2:CCTTCAGTCTGATGGT"	-3.21927104416545	10.022714591864	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGTCTGATGGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2221.78340218035	43.7407864769323	0.0196872415348891	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2213.70505378705	2213.70505378705
"healthy-3"	"2019-08-01-count-3:TCGGGTGAGGACGGAG"	10.3870655494625	7.44327781284181	"2019-08-01-count-3"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGAGGACGGAG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.06681068236	39.045065561668	0.0207789661015242	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1868.62026973348	1868.62026973348
"healthy-3"	"2019-08-01-count-3:TGACCCTGTCTATGAC"	-3.71744714203532	13.180598235968	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTGTCTATGAC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2099.99946868393	43.3554045628477	0.0206454359676664	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2093.12182690422	2093.12182690422
"healthy-3"	"2019-08-01-count-2:CATCCACAGCCGAACA"	3.8131078678066	-8.10136320507201	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACAGCCGAACA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.94387152841	46.1302990482055	0.0198928053475486	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2311.72928354327	2311.72928354327
"healthy-3"	"2019-08-01-count-4:TCTCACGTCACCTTAT"	-3.62600861015971	9.59168336475221	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCACGTCACCTTAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2409.33760284264	41.2995579327135	0.0171414574213205	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2404.99941803812	2404.99941803812
"healthy-3"	"2019-08-01-count-2:CTAACTTAGCATCCTA"	2.61002220687215	-4.56451418316039	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTAGCATCCTA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2799.11247924319	41.9003364175201	0.0149691506605154	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2790.58427518222	2790.58427518222
"healthy-3"	"2019-08-01-count-4:ACCACAAGTTAGGAGC"	3.49931873854939	-7.08433487331542	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCACAAGTTAGGAGC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.32415524673	47.0308576421965	0.0201648032227413	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2326.22202466011	2326.22202466011
"healthy-3"	"2019-08-01-count-3:GTCGTAACAGGCACTC"	-3.5940080684727	12.600613571051	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTAACAGGCACTC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1574.94689309693	44.2636756273196	0.0281048686919728	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1570.39511839522	1570.39511839522
"healthy-3"	"2019-08-01-count-3:GTCATCCCACAACCGC"	-3.01320491257365	12.8297757872376	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCCACAACCGC"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2227.63694696207	41.9309182405658	0.0188230484764355	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2219.04717146762	2219.04717146762
"healthy-3"	"2019-08-01-count-2:GGTGGCTGTCTTGCTC"	-0.919766644865829	8.2474212416443	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGGCTGTCTTGCTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.95656362803	45.0200001242982	0.02388383954994	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1879.77706811297	1879.77706811297
"healthy-3"	"2019-08-01-count-3:AGGTCATAGAATTGCA"	-4.11555133286174	11.8490237959656	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCATAGAATTGCA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1945.0464519639	46.9722312871083	0.024149670687649	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1943.1846164423	1943.1846164423
"healthy-3"	"2019-08-01-count-2:GATAGAACAACCCTAA"	4.34881748732869	-7.63043453609618	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGAACAACCCTAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.56789606473	48.6039338694202	0.0187185299267863	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2592.41025130683	2592.41025130683
"healthy-3"	"2019-08-01-count-4:TTGAGTGGTATGCTAC"	11.0670315223629	6.23494765842286	"2019-08-01-count-4"	"Control3"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAGTGGTATGCTAC"	"Pre-B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.57503597046	38.6920588883317	0.020695643739299	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1860.98902087018	1860.98902087018
"healthy-3"	"2019-08-01-count-2:TGACAGTCAAACTCGT"	-1.41043661060985	9.75716397846071	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACAGTCAAACTCGT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.49380228328	48.5084198694843	0.024946554117336	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1937.27571045212	1937.27571045212
"healthy-3"	"2019-08-01-count-4:TTCTTGAAGCACCAGA"	-3.86389432373698	3.40158889377443	"2019-08-01-count-4"	"Control3"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGAAGCACCAGA"	"MEP"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3229.89484637632	41.0379961958635	0.0127056756172433	4655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	107	TRUE	"HSPC_healthy-3"	3222.90455109113	3222.90455109113
"healthy-3"	"2019-08-01-count-2:TCAATCTTCGCTGCGA"	4.65351929244344	-8.17058947002562	"2019-08-01-count-2"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATCTTCGCTGCGA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2746.06927197543	45.4066324732472	0.0165351373094034	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2741.21656665615	2741.21656665615
"healthy-3"	"2019-08-01-count-3:ATAGGCTCATCCGTTC"	4.72474159774129	-7.63144066249999	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTCATCCGTTC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.32260685165	45.1023036315359	0.0170305171714536	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2643.26097826242	2643.26097826242
"healthy-3"	"2019-08-01-count-3:TCGATTTGTTGTAAAG"	3.76740421828572	-7.03808882152709	"2019-08-01-count-3"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGATTTGTTGTAAAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.25408035336	46.9241779449063	0.0178063201930852	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2630.3429077698	2630.3429077698
"healthy-3"	"2019-08-01-count-1:CGTGCTTCATACCATG"	10.9064632850582	6.98620841586915	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGTGCTTCATACCATG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2162.86855293988	43.5279295624818	0.0201250924395366	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2149.81041548209	2149.81041548209
"healthy-3"	"2019-08-01-count-4:TGTTCATCATGTAACC"	4.66083445128743	-7.66062309658202	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATCATGTAACC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.28997613424	46.5323752092872	0.0179295476178729	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2591.54799928168	2591.54799928168
"healthy-3"	"2019-08-01-count-2:GCAACATGTTAAACAG"	-2.35343466225322	8.56985948169557	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACATGTTAAACAG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.5535581649	49.2457290452664	0.0233773923546317	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2098.68064414106	2098.68064414106
"healthy-3"	"2019-08-01-count-3:TGAGGAGGTTAAGTCC"	-3.90957889977153	10.6920375593933	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGGTTAAGTCC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.27819999827	44.1816253950178	0.0226656335637761	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1945.82258620523	1945.82258620523
"healthy-3"	"2019-08-01-count-4:GCGGATCCACACAGAG"	0.270693455904168	7.77151677692262	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCCACACAGAG"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1930.75242380056	41.1460417432868	0.021310884417948	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1923.14347819202	1923.14347819202
"healthy-3"	"2019-08-01-count-4:TTTGATCCAGATCCTA"	5.32690777358357	-9.47953131115111	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCCAGATCCTA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2662.88675879248	46.9003127936429	0.01761258252488	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2659.39372577201	2659.39372577201
"healthy-3"	"2019-08-01-count-2:GCCAGGTGTACCGTGC"	0.140210767357987	7.64377305591432	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGGTGTACCGTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.58715986489	43.9290291240609	0.0226136721335666	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1936.82020078604	1936.82020078604
"healthy-3"	"2019-08-01-count-4:AACGTCATCTCATGGA"	-1.60327146473582	9.03481862628785	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCATCTCATGGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2167.83017542983	49.6595710174349	0.0229075005875811	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2160.41323195186	2160.41323195186
"healthy-3"	"2019-08-01-count-3:AGGACTTTCTCAGGCG"	-2.98513255539592	9.9476051100525	"2019-08-01-count-3"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACTTTCTCAGGCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2023.40324355783	44.2165991965536	0.0218525888684481	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2023.40324355783	2023.40324355783
"healthy-3"	"2019-08-01-count-3:CTCTCAGAGAGCATCG"	-3.32520614090617	12.4877033003601	"2019-08-01-count-3"	"Control3"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGAGAGCATCG"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1957.93161073962	37.3216297809321	0.0190617637389457	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1953.10128910009	1953.10128910009
"healthy-3"	"2019-08-01-count-2:ATCACTTCAGGGATAC"	5.36575760421101	-9.54568197643431	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTCAGGGATAC"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.66067042428	42.9959060216209	0.0162330745126115	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2644.34287755514	2644.34287755514
"healthy-3"	"2019-08-01-count-2:TGACAGTGTCAAGTTC"	0.679505606263322	8.15067861163942	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACAGTGTCAAGTTC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.33311371448	37.6570164833055	0.0203735009690048	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1845.50116867695	1845.50116867695
"healthy-3"	"2019-08-01-count-4:TGAGGAGGTACCATAC"	-1.89267895641978	8.81277940357057	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGGTACCATAC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2087.76196603813	47.7566111151746	0.0228745479092142	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2086.17729740026	2086.17729740026
"healthy-3"	"2019-08-01-count-3:TCAGCCTCAAGAAACT"	-1.74923298779185	8.75563523853151	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCAAGAAACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2278.55490459607	45.7784667403802	0.0200910088442637	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2269.18061424549	2269.18061424549
"healthy-3"	"2019-08-01-count-3:AGCGTCGGTACTCGCG"	2.83887090262715	-4.7214975587097	"2019-08-01-count-3"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGTCGGTACTCGCG"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2364.03336118592	41.4693756112475	0.0175417895077608	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2358.02767810328	2358.02767810328
"healthy-3"	"2019-08-01-count-4:TCCGATCCAAATACGA"	-2.31986890259441	9.71415231311647	"2019-08-01-count-4"	"Control3"	"NK"	"Activated NK"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCCAAATACGA"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1922.26646293073	51.7320257647565	0.0269119951694339	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1918.59429108991	1918.59429108991
"healthy-3"	"2019-08-01-count-2:GGGACCTTCACGGAGA"	2.9710177379543	-5.07216217434081	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTTCACGGAGA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2786.65538726355	45.9982076513676	0.0165066006588411	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2783.71834454021	2783.71834454021
"healthy-3"	"2019-08-01-count-4:TACACCCTCGTAACAC"	-2.0889404815739	8.78858468616334	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCTCGTAACAC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2190.8956119115	33.3568773964324	0.0152252244310852	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2185.7242424812	2185.7242424812
"healthy-3"	"2019-08-01-count-4:GCGGATCCACTCTAGA"	4.70040144500081	-8.78253557598265	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCCACTCTAGA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.64473194872	50.2618690803308	0.0229334017268574	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2188.56062291485	2188.56062291485
"healthy-3"	"2019-08-01-count-3:GACCCAGAGGCGTCCT"	-3.57842002335246	13.1655597456726	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCAGAGGCGTCCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1976.95207425709	45.1838048575143	0.0228552858948256	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1973.07960026378	1973.07960026378
"healthy-3"	"2019-08-01-count-4:TCAATTCCACCATTCC"	4.90376772460286	-8.24387075817259	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCCACCATTCC"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2899.9759123731	38.7263253780973	0.0133540162222958	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2896.13331252997	2896.13331252997
"healthy-3"	"2019-08-01-count-2:TCTATCACAGTGGTGA"	-2.33712015572246	8.96238229358522	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATCACAGTGGTGA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2165.18598219274	52.0447833644766	0.0240370960243191	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2160.00847946179	2160.00847946179
"healthy-3"	"2019-08-01-count-2:GATAGAATCCGCAGTG"	10.9460102516109	6.72177217090455	"2019-08-01-count-2"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGAATCCGCAGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.95372301589	45.712038531674	0.0224634290277259	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2028.40941254423	2028.40941254423
"healthy-3"	"2019-08-01-count-3:TGAGGGAAGCTAATCC"	10.9355732398922	5.96498630130617	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGGAAGCTAATCC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.8820941352	40.460567853249	0.0215229284748637	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1867.68379942594	1867.68379942594
"healthy-3"	"2019-08-01-count-4:GACTCAAAGTGGAATT"	10.6014505821163	6.7403878935608	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAAAGTGGAATT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.0331720851	42.9680234960083	0.0220798001351486	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1941.1466638823	1941.1466638823
"healthy-3"	"2019-08-01-count-4:AGACAAATCAATCAGC"	10.7839018302852	7.31187770450441	"2019-08-01-count-4"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAATCAATCAGC"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2068.9177496234	42.822475823988	0.0206980078506179	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2059.39691035477	2059.39691035477
"healthy-3"	"2019-08-01-count-4:TGTCCTGTCATCCTGC"	-0.623266558081466	8.44304082477418	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGTCATCCTGC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2052.66827079338	42.1334409818466	0.0205261812545879	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2042.45945785199	2042.45945785199
"healthy-3"	"2019-08-01-count-2:GAGCTGCGTACGACAG"	5.29494156417195	-9.29799845134886	"2019-08-01-count-2"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCTGCGTACGACAG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.3658349278	43.0320760674813	0.0171076809066688	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2513.74984661393	2513.74984661393
"healthy-3"	"2019-08-01-count-3:ATCCATTTCTAGACCA"	9.9995514350826	7.46213624561159	"2019-08-01-count-3"	"Control3"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCATTTCTAGACCA"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.56370646307	46.1602332183046	0.0230851525605829	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1989.28060610497	1989.28060610497
"healthy-3"	"2019-08-01-count-4:CGCATGGAGTAGGCCA"	4.79589857634847	-8.71452047741088	"2019-08-01-count-4"	"Control3"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGAGTAGGCCA"	"CD11c+"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.42737924171	46.681718209912	0.0213898151452497	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2176.30997371309	2176.30997371309
"healthy-3"	"2019-08-01-count-4:ACTCCCACAGTCCGTG"	4.81508459624593	-8.30432894146117	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCCCACAGTCCGTG"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3069.34997025248	45.5486246640256	0.0148398276851691	3961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	3062.28042787056	3062.28042787056
"healthy-3"	"2019-08-01-count-3:CGAGGAAAGAATTGTG"	-3.06864915314372	9.38688180530397	"2019-08-01-count-3"	"Control3"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGAAAGAATTGTG"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2111.25753460709	41.9612319058131	0.019874994508248	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2102.86185879173	2102.86185879173
"healthy-3"	"2019-08-01-count-4:CTGTGGGCACGCTATA"	0.196313460438889	7.93977830493776	"2019-08-01-count-4"	"Control3"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGGGCACGCTATA"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2076.38115241617	37.2643049877599	0.0179467555580523	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2068.08170783527	2068.08170783527
"healthy-3"	"2019-08-01-count-2:TGGATCAAGTGCACAG"	-2.95565877381023	-5.63671972667845	"2019-08-01-count-2"	"Control3"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCAAGTGCACAG"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2896.65611616738	48.4779004207573	0.0167358148418734	2786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2890.81382244557	2890.81382244557
"healthy-3"	"2019-08-01-count-4:AACGTCAGTACGTACT"	-3.47075186196025	9.60849759662477	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCAGTACGTACT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2117.57723050761	39.9882287456212	0.0188839529295635	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2114.30589092898	2114.30589092898
"healthy-3"	"2019-08-01-count-4:TCAGCCTTCCAACCAA"	5.42639174041097	-9.47790625011595	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCCTTCCAACCAA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2760.29726949857	44.0377628929601	0.0159539928469226	2330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2754.19554206803	2754.19554206803
"healthy-3"	"2019-08-01-count-2:TCATGGATCTTTGATC"	4.94581284102742	-8.44681646740111	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGGATCTTTGATC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2683.71977427296	42.1929012658073	0.0157217984046929	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2679.95143459957	2679.95143459957
"healthy-3"	"2019-08-01-count-4:CAAGAGGTCTGAGCAT"	5.43758310851399	-9.51579382335814	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGAGGTCTGAGCAT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2746.49113891482	44.468178690243	0.0161909055740893	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2740.17389897464	2740.17389897464
"healthy-3"	"2019-08-01-count-2:GAAGCCCAGCCAAGTG"	10.4244133430416	7.41071174228517	"2019-08-01-count-2"	"Control3"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCCCAGCCAAGTG"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2172.71898150367	48.2397413752686	0.0222024761535812	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2161.04640746827	2161.04640746827
"healthy-3"	"2019-08-01-count-4:GATTGGTTCGAGAATA"	-3.43149552765544	11.1001796492371	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTTCGAGAATA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1867.17398971388	46.9919228585608	0.02516740438622	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1861.83755327064	1861.83755327064
"healthy-3"	"2019-08-01-count-2:TGGTGATGTTGGACTT"	4.41205563124959	-7.96856405651244	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTGATGTTGGACTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.49776926648	46.5977448579174	0.0187027038244695	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2486.80293627629	2486.80293627629
"healthy-3"	"2019-08-01-count-2:GGTGATTAGTGCGACA"	2.61577310141866	-4.54423477565917	"2019-08-01-count-2"	"Control3"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGATTAGTGCGACA"	"cDC2"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2831.42464447934	49.2662638505374	0.0173998145938992	2854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"DC_healthy-3"	2823.93572112709	2823.93572112709
"healthy-3"	"2019-08-01-count-2:GCCAGCACAAGAGTAT"	-1.27349660816844	8.73791596973268	"2019-08-01-count-2"	"Control3"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGCACAAGAGTAT"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2110.32888655294	43.146179699343	0.0204452395900332	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2107.25824023875	2107.25824023875
"healthy-3"	"2019-08-01-count-3:GAAACCTCACCTCGTT"	-1.75332115116771	9.05329892719118	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAACCTCACCTCGTT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2121.80470514603	47.3110325970431	0.0222975434460576	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2114.68677460757	2114.68677460757
"healthy-3"	"2019-08-01-count-2:CGATGCGAGATACCAA"	3.04883970794026	-6.91931774532469	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGAGATACCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.70429065462	51.4566141187948	0.0247422743464159	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2075.3471259756	2075.3471259756
"healthy-3"	"2019-08-01-count-3:ATGGAGGCACAATGCT"	-3.13684640350993	12.8495473631653	"2019-08-01-count-3"	"Control3"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGAGGCACAATGCT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1930.71964506904	46.9774065929616	0.0243315525964318	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	1928.68093886452	1928.68093886452
"healthy-3"	"2019-08-01-count-4:GTCGTAAGTTACTCAG"	2.98560061034505	-6.48951532756957	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTAAGTTACTCAG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.96992093245	44.1280120795306	0.0174077063854465	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2528.50412653055	2528.50412653055
"healthy-3"	"2019-08-01-count-2:TGCGACGTCCGGTTCT"	5.54663338240926	-9.60702803051146	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGTCCGGTTCT"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.52016339654	44.5671676899874	0.016632518127236	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2674.00586791203	2674.00586791203
"healthy-3"	"2019-08-01-count-2:GGGTTATCAGCAGGAT"	-3.74708376351054	10.3808994063172	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTTATCAGCAGGAT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1655.98868972246	45.2855291623273	0.0273465208086155	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1654.06400283081	1654.06400283081
"healthy-3"	"2019-08-01-count-2:TCCTCCCGTTGATCGT"	9.87179245528523	6.85300777042238	"2019-08-01-count-2"	"Control3"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCGTTGATCGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.38058498637	44.8203006791123	0.0235477345059885	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1900.27093084896	1900.27093084896
"healthy-3"	"2019-08-01-count-3:GGTTCTCCAATCGTCA"	12.5436893897945	-2.4865761033264	"2019-08-01-count-3"	"Control3"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTCTCCAATCGTCA"	"Ery"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1256.88930997379	37.7355496257487	0.0300229696651137	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	34	TRUE	"Ery_healthy-3"	1244.832425677	1244.832425677
"healthy-3"	"2019-08-01-count-3:GATAGCTCAGACCCGT"	-4.09420953217204	10.8644170531067	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTCAGACCCGT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1874.30856625056	43.7041286726274	0.0233174672834446	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1868.9691105519	1868.9691105519
"healthy-3"	"2019-08-01-count-1:ACGCACGAGCGACAGT"	10.9162079292232	6.49432466113893	"2019-08-01-count-1"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACGCACGAGCGACAGT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.46133012468	51.5306760609078	0.0253913071887613	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	2025.37604842607	2025.37604842607
"healthy-3"	"2019-08-01-count-3:AGTTCGAGTTGTACGT"	5.10407509383504	-8.52761557018431	"2019-08-01-count-3"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCGAGTTGTACGT"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.65612360701	43.5107266231372	0.0165084990539627	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2631.35113223192	2631.35113223192
"healthy-3"	"2019-08-01-count-4:TGTGAGTCAAGGCTTT"	4.66793169555013	-7.69768145000609	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGAGTCAAGGCTTT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.56073937388	43.1203430392286	0.0168599487689137	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2551.8711846581	2551.8711846581
"healthy-3"	"2019-08-01-count-2:TCATTTGCACTAGTAC"	3.40174259719197	-6.55096247112425	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTTGCACTAGTAC"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.17893801912	47.3974977601072	0.0236729579260286	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	1995.67069040644	1995.67069040644
"healthy-3"	"2019-08-01-count-2:GACGTTAGTACAGTAA"	-3.81926212731059	11.4755353697571	"2019-08-01-count-2"	"Control3"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTAGTACAGTAA"	"gd T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2034.13052258327	52.335135280554	0.0257285039969266	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2030.65224016644	2030.65224016644
"healthy-3"	"2019-08-01-count-2:GGGTAGATCGGAATTC"	-1.22659907761272	8.60827443683473	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTAGATCGGAATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.60537499248	39.9578626689098	0.0205374960320842	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1943.96406490077	1943.96406490077
"healthy-3"	"2019-08-01-count-4:GAGTCTACAGTAACCT"	3.63833632048909	-6.87935640728148	"2019-08-01-count-4"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCTACAGTAACCT"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.46832459675	42.875069866676	0.017425572781435	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2450.94163677707	2450.94163677707
"healthy-3"	"2019-08-01-count-3:AGTTCGAAGGCCGCTT"	-4.50853429260905	-5.72768976604613	"2019-08-01-count-3"	"Control3"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCGAAGGCCGCTT"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2469.39055342373	46.7656134216924	0.0189381195116558	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2466.81911257401	2466.81911257401
"healthy-3"	"2019-08-01-count-2:ACTACGAGTGTGGACA"	5.31848825988118	-9.6275034180847	"2019-08-01-count-2"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGAGTGTGGACA"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.40265805518	44.6583187488152	0.0183220932336425	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2430.74333549611	2430.74333549611
"healthy-3"	"2019-08-01-count-4:GTGTTCCGTTCCTTGC"	-2.93323908272441	9.35659692371217	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCGTTCCTTGC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.10484949744	43.3530571842033	0.021960868590764	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1970.56856196839	1970.56856196839
"healthy-3"	"2019-08-01-count-2:ACTACGAGTGCTCTCT"	-2.85996542397197	8.82541654193727	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGAGTGCTCTCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2142.60817315083	46.5573959074628	0.0217293093953792	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2133.84752805211	2133.84752805211
"healthy-3"	"2019-08-01-count-4:ATAGGCTTCGGTCTAA"	4.94567455825154	-8.18175222789916	"2019-08-01-count-4"	"Control3"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTTCGGTCTAA"	"HLA-II+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.0338327118	45.3220535162866	0.0176005662296706	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2572.08240844415	2572.08240844415
"healthy-3"	"2019-08-01-count-2:AGACACTTCACGATCA"	-4.05690513077434	10.6981372603211	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTTCACGATCA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2096.7058802382	43.602865806322	0.0207958904571625	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2091.67987993613	2091.67987993613
"healthy-3"	"2019-08-01-count-2:GATGCTAGTATCCCAA"	4.59341444548909	-8.19101526653441	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTAGTATCCCAA"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.17038589985	47.4845189809712	0.0187895993265462	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2520.12973318539	2520.12973318539
"healthy-3"	"2019-08-01-count-4:CTTCCTTAGTGGTTGG"	5.41941990432088	-9.41152861034545	"2019-08-01-count-4"	"Control3"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTAGTGGTTGG"	"CD16+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.16113057574	41.1508352557413	0.0157716726550579	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2602.43114180933	2602.43114180933
"healthy-3"	"2019-08-01-count-3:GCACGGTTCTTTGATC"	-0.0321764898603738	7.94691655719606	"2019-08-01-count-3"	"Control3"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTTCTTTGATC"	"CD4+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.33423034904	42.7532025969089	0.0223448689302494	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1908.57185737609	1908.57185737609
"healthy-3"	"2019-08-01-count-2:CATCGTCAGGAGAATG"	3.0067740875179	-6.63949348842772	"2019-08-01-count-2"	"Control3"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGTCAGGAGAATG"	"CD14+ monocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.98619604399	44.1896821626446	0.0172954680659589	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	976	TRUE	"Mono_healthy-3"	2547.11574315057	2547.11574315057
"healthy-3"	"2019-08-01-count-2:TCCTCCCTCGGATAAA"	-4.04652200165446	10.844549156073	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCTCGGATAAA"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2170.17034215709	44.2600332157643	0.0203947277114529	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2161.98001729665	2161.98001729665
"healthy-3"	"2019-08-01-count-2:CAGTTCCAGGTGAGCT"	-1.6339934867924	8.68622491443483	"2019-08-01-count-2"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCAGGTGAGCT"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1860.24150275272	46.6405173488689	0.0250722915706653	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1851.03390993157	1851.03390993157
"healthy-3"	"2019-08-01-count-3:ATAGGCTTCATTGCTT"	10.679387708276	6.5450663336548	"2019-08-01-count-3"	"Control3"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTTCATTGCTT"	"B"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1797.98864636054	39.3490698417029	0.0218850491193883	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	517	TRUE	"B_healthy-3"	1791.17656217355	1791.17656217355
"healthy-3"	"2019-08-01-count-2:CCACCATTCCATTGTT"	-4.26782308045085	13.0887975462708	"2019-08-01-count-2"	"Control3"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATTCCATTGTT"	"NK"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2692.39163487565	44.7730826929107	0.0166294836579295	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"NK_healthy-3"	2685.32928365092	2685.32928365092
"healthy-3"	"2019-08-01-count-4:TGTCCTGAGGTACAGC"	2.08702721175496	-6.00809194957884	"2019-08-01-count-4"	"Control3"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGAGGTACAGC"	"Granulocyte"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2657.62195582259	45.6075080946758	0.0171610217152045	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	148	TRUE	"Gran_healthy-3"	2653.94726369327	2653.94726369327
"healthy-3"	"2019-08-01-count-4:GTTATGGAGTTGCATC"	-2.47336659851726	9.40327355945436	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGAGTTGCATC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2086.02932225456	39.9429682403008	0.0191478460126011	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2081.07813190643	2081.07813190643
"healthy-3"	"2019-08-01-count-4:TAGACTGCAACGATTC"	-4.18262801590617	11.0376596220764	"2019-08-01-count-4"	"Control3"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACTGCAACGATTC"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2255.43879130024	48.2690296168043	0.0214011702747107	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	2252.48476959549	2252.48476959549
"healthy-3"	"2019-08-01-count-3:CTACCTGAGTTTGCTG"	-1.36356840553935	9.03105828845827	"2019-08-01-count-3"	"Control3"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"female"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCTGAGTTTGCTG"	"CD8+ T"	"3"	"F"	50	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.26671995967	44.5894480471505	0.0233054009574213	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1795	TRUE	"T_healthy-3"	1909.79680053331	1909.79680053331
"healthy-4"	"2019-08-01-count-4:ATAGAGATCGCCTTGT"	3.14764060553853	-6.10887529766234	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGATCGCCTTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.06707291143	44.3156088171004	0.0178615118071346	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2477.04260464928	2477.04260464928
"healthy-4"	"2019-08-01-count-4:CACCAAATCCCTAGGG"	3.77145876464192	-6.3910532227722	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACCAAATCCCTAGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.9650486072	41.0566835875234	0.014811400168322	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2767.42998637492	2767.42998637492
"healthy-4"	"2019-08-01-count-4:AAGCGAGTCGAGGCAA"	-2.02280531349834	3.50246117198793	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGTCGAGGCAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2974.03827791732	43.6902646227166	0.0146905522188881	4739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2968.03027932495	2968.03027932495
"healthy-4"	"2019-08-01-count-3:CCCAACTGTATTAAGG"	10.840294499963	5.9206914671692	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCAACTGTATTAAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.70149198689	45.8869188557275	0.0236933358318692	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.46300181065	1930.46300181065
"healthy-4"	"2019-08-01-count-2:TCAGGGCTCTGCTCTG"	4.89410128173177	-7.07462313091429	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCTCTGCTCTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.0832718807	42.3212912349878	0.0172452547637288	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2451.44140050517	2451.44140050517
"healthy-4"	"2019-08-01-count-3:GGTAGAGCACCTTCGT"	-0.287828455597717	7.699192024115	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAGAGCACCTTCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1988.15309168131	41.9537854432838	0.0211018887925804	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1977.7320026328	1977.7320026328
"healthy-4"	"2019-08-01-count-4:ACACCAATCGTTGTAG"	-0.408791909844238	8.17573258960573	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACCAATCGTTGTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.75582585003	41.9627030422828	0.0210893731266529	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1981.75644087947	1981.75644087947
"healthy-4"	"2019-08-01-count-3:CGTTCTGAGTACGAGC"	3.33929743346516	-6.32099392330321	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTCTGAGTACGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.83149827709	53.2313651876099	0.0237551842825032	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2235.41332101972	2235.41332101972
"healthy-4"	"2019-08-01-count-4:TCACTCGCACTACCCT"	11.3918692069942	3.82764957034913	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTCGCACTACCCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1821.36400081781	46.4810507074576	0.0255199129260199	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1799.87115679129	1799.87115679129
"healthy-4"	"2019-08-01-count-3:CACGAATCACGCGGTT"	11.2762352424556	6.12620589816896	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATCACGCGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.91085984316	43.4271176720666	0.0227616072564504	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1898.13673802155	1898.13673802155
"healthy-4"	"2019-08-01-count-3:GGTAACTAGGTAGGCT"	3.81021537360494	-6.68822672283324	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAACTAGGTAGGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.81624014191	45.1372971838944	0.0178916309740242	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2519.77494001011	2519.77494001011
"healthy-4"	"2019-08-01-count-3:CACGAATGTCGTTTCC"	-2.81065736237224	9.21355626666871	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATGTCGTTTCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.85524858343	44.1620750986778	0.023630548771582	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1867.0272615507	1867.0272615507
"healthy-4"	"2019-08-01-count-3:TGTTGAGGTATGCAAA"	-4.42435393753703	12.678738571051	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGGTATGCAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2160.55549106168	46.8173873216944	0.0216691436602207	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2160.55549106168	2160.55549106168
"healthy-4"	"2019-08-01-count-3:GCCCGAAGTAGAGCTG"	-5.71854672852214	-5.54909279262694	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAAGTAGAGCTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2453.77216295443	51.9082388511245	0.0211544656161658	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2452.36437467639	2452.36437467639
"healthy-4"	"2019-08-01-count-2:ATGGAGGCATGAGAAT"	10.3400541740352	7.31889674747316	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGCATGAGAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1877.57134680529	41.8102537910447	0.0222682636599591	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.88110266505	1874.88110266505
"healthy-4"	"2019-08-01-count-2:CCTACGTCATGATGCT"	-1.55588076534923	8.80069158161012	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTCATGATGCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1857.44247595318	45.4785594757704	0.0244845049386697	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1852.07850204967	1852.07850204967
"healthy-4"	"2019-08-01-count-2:CCTATCGCAAATCGTC"	11.4358631568844	3.5352585085663	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGCAAATCGTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.60320338984	51.7335729445576	0.0355898864448796	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1432.20783601105	1432.20783601105
"healthy-4"	"2019-08-01-count-3:CACTGGGCACAAGCTT"	4.99222006377522	-7.21180202877196	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGCACAAGCTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.14194347229	44.9373950286062	0.0160884752504709	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2788.28567374662	2788.28567374662
"healthy-4"	"2019-08-01-count-4:CACGTTCGTCATTCCC"	2.3079375225002	-5.92318823253783	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCGTCATTCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2809.9037737371	42.8263379739179	0.0152412115938618	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2804.25636072982	2804.25636072982
"healthy-4"	"2019-08-01-count-3:CCTATCGTCCCGAGAC"	11.2407452064449	6.25106332385866	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGTCCCGAGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.16900074888	41.4003158706987	0.0201837663574203	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.45499636439	2043.45499636439
"healthy-4"	"2019-08-01-count-4:AAGCGTTTCGCATAGT"	-2.74861703339275	8.75320718372194	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGTTTCGCATAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.75041843967	42.6772561687698	0.020441742361458	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2084.42028423196	2084.42028423196
"healthy-4"	"2019-08-01-count-4:CTAACTTCAAGCAGGT"	-3.962789396674	12.7845697172913	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTCAAGCAGGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1788.06727452097	50.4513988488544	0.0282156043946224	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1786.04465201082	1786.04465201082
"healthy-4"	"2019-08-01-count-4:TGAGCGCAGTTCGCAT"	4.7694202857906	-7.7015009156433	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCGCAGTTCGCAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.51000091509	46.1890283323354	0.0166656545771384	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2762.60346972458	2762.60346972458
"healthy-4"	"2019-08-01-count-3:GGTCTGGTCCGCTAGG"	0.0695377859169662	7.68629214847413	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTCTGGTCCGCTAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1786.6934914649	40.4188232575052	0.0226221360578003	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1779.3484389232	1779.3484389232
"healthy-4"	"2019-08-01-count-4:ATGTCCCGTATATGGA"	2.25645269927327	-6.40857031261595	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCGTATATGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.5793923915	47.2141200847716	0.0221394430862549	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2131.21065899904	2131.21065899904
"healthy-4"	"2019-08-01-count-4:TGTTACTCACCCTGAG"	3.41501249846761	-6.26002552425536	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTCACCCTGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.6502822769	37.6426054529001	0.0145695436070112	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2577.48720187818	2577.48720187818
"healthy-4"	"2019-08-01-count-2:CGATCGGAGGCCTTCG"	10.9560476737911	6.59188840473024	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGAGGCCTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1735.50942387305	46.5289305748977	0.0268099555870238	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1731.91492629839	1731.91492629839
"healthy-4"	"2019-08-01-count-1:TCAGTTTGTCGACGCT"	10.2806688743526	7.49996087634889	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGTTTGTCGACGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2290.97574785441	45.1642501432502	0.0197139800303641	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2275.67838831577	2275.67838831577
"healthy-4"	"2019-08-01-count-4:TCACTCGGTTCAGGTT"	10.8433233695919	6.50738093936769	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTCGGTTCAGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1829.4396387114	46.007508489372	0.0251484156764955	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1820.54754694491	1820.54754694491
"healthy-4"	"2019-08-01-count-4:ACCTACCGTGGTCCCA"	11.1352926689083	5.6306786307129	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTACCGTGGTCCCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2130.49022577363	46.8299830012381	0.0219808485552817	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2121.08561848786	2121.08561848786
"healthy-4"	"2019-08-01-count-4:GTGTGATGTAGGAAAG"	-7.17222152176555	3.3809821375641	"2019-08-01-count-4"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGATGTAGGAAAG"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2494.10731548769	44.5312139960492	0.0178545701379901	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2478.64648981843	2478.64648981843
"healthy-4"	"2019-08-01-count-2:CTCATTATCAGTGTCA"	11.3190523582393	6.10034034335939	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATTATCAGTGTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.39100051728	40.8540646088292	0.0211307824428161	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1924.18026424386	1924.18026424386
"healthy-4"	"2019-08-01-count-2:TTGGGCGAGACATACA"	2.0004332261974	-6.63526680385741	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGCGAGACATACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1676.71476843358	51.1751815944525	0.0305211014764672	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1672.9454902404	1672.9454902404
"healthy-4"	"2019-08-01-count-2:ATGGAGGTCGAAGAAT"	-4.90165315094646	-5.13897755062255	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGTCGAAGAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2768.52085011122	46.4816508793148	0.0167893447063791	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2764.00936099437	2764.00936099437
"healthy-4"	"2019-08-01-count-3:GCTTGGGAGGTAAGAG"	-0.312016199261504	7.87528846347658	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGAGGTAAGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1836.97919552285	45.3097669336576	0.0246653674925051	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1830.1666919141	1830.1666919141
"healthy-4"	"2019-08-01-count-4:TAAGTCGTCACTTCTA"	0.0842921445960223	7.86656091296998	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGTCACTTCTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.42298143273	46.2819829143777	0.0256919021192725	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1791.39347758817	1791.39347758817
"healthy-4"	"2019-08-01-count-4:AAATGGAAGACGCCCT"	11.5756184059078	3.79791352832643	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAAGACGCCCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2202.37481200998	34.6549502096877	0.0157352645066169	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2182.46567233226	2182.46567233226
"healthy-4"	"2019-08-01-count-3:GTGTGATAGTGAACAT"	0.705278416245621	8.02427432620851	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATAGTGAACAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.20847558128	43.3445720729527	0.0225728469716454	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1911.48255097773	1911.48255097773
"healthy-4"	"2019-08-01-count-4:TGAGACTCATGATAGA"	11.4852243858272	3.75554845416871	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGACTCATGATAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2062.85964739495	39.8592674128897	0.0193223360897216	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.74616464619	2051.74616464619
"healthy-4"	"2019-08-01-count-2:GCGTTTCAGAAGTCTA"	10.7267013984615	7.08456370914308	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCAGAAGTCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.69822623686	45.9418348767125	0.0237094890497653	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.8520391951	1931.8520391951
"healthy-4"	"2019-08-01-count-4:AACAGGGGTCTGTCCT"	2.62312330779378	-5.66397097026976	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGGTCTGTCCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2527.74482903554	40.6993942160724	0.0161010691223929	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2520.38304543657	2520.38304543657
"healthy-4"	"2019-08-01-count-4:AGGACGAAGAGAACCC"	10.4727007347042	7.73436782443849	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACGAAGAGAACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.91090323712	42.8644024552868	0.021892928010369	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.01597345158	1954.01597345158
"healthy-4"	"2019-08-01-count-4:AATGAAGAGGTCCCGT"	11.0573641258175	6.03480479801027	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGAAGAGGTCCCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1770.24084708563	41.7672066341171	0.0235940813945621	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1765.00606335693	1765.00606335693
"healthy-4"	"2019-08-01-count-3:TTACCGCTCTACTATC"	-3.01667437973674	9.77186963641969	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCTCTACTATC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2336.98262739202	46.556292110197	0.0199215396659375	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2317.84276707728	2317.84276707728
"healthy-4"	"2019-08-01-count-2:CAATGACTCAAGAAAC"	10.8219248252803	7.5242504843506	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATGACTCAAGAAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2201.98881781431	46.7400129730899	0.0212262717208	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2188.82405572566	2188.82405572566
"healthy-4"	"2019-08-01-count-2:CTCACTGTCTATCGCC"	-3.48705683174785	-5.42618992244872	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGTCTATCGCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2714.94894476183	43.9646168059744	0.0161935335435309	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2707.92722972241	2707.92722972241
"healthy-4"	"2019-08-01-count-2:ACATCCCGTGAATGTA"	-8.02340064469035	3.10695860469667	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCGTGAATGTA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2597.74465450091	45.2392680617451	0.0174148248109615	2586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2582.92523765042	2582.92523765042
"healthy-4"	"2019-08-01-count-2:ACGTAACGTGACCGTC"	-2.67770991745647	-5.81174137508544	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACGTGACCGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2299.21345789089	49.0319032123204	0.0213255115761624	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2295.19401028416	2295.19401028416
"healthy-4"	"2019-08-01-count-4:CACATGACACGAGGAT"	4.89769234237019	-7.2204571000305	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGACACGAGGAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2854.62960451244	47.7172480944207	0.0167157406407444	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2853.75551020027	2853.75551020027
"healthy-4"	"2019-08-01-count-3:TGTAGACCACTTGTCC"	-2.07350216332133	3.44511339748231	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACCACTTGTCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2913.08545615848	43.9541575109289	0.0150885232075861	4598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2904.81684701912	2904.81684701912
"healthy-4"	"2019-08-01-count-3:CAAAGAACATACATCG"	-2.0629075569218	9.4299745329651	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAAGAACATACATCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.48184330351	45.9204580405138	0.0235552119647849	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1944.32683849254	1944.32683849254
"healthy-4"	"2019-08-01-count-3:ACTTCGCCAACGATCT"	-6.92723403397258	3.22482273662416	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCCAACGATCT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2695.64303493456	42.8570224199126	0.0158986267337704	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2687.30989939421	2687.30989939421
"healthy-4"	"2019-08-01-count-3:GGGATGATCGAGTGGA"	4.2542482810909	-6.50509645855101	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATGATCGAGTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.67342728463	43.2713071635678	0.0173038617083856	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2492.05771543013	2492.05771543013
"healthy-4"	"2019-08-01-count-3:GGCACGTAGTCAGAGC"	3.41483988341634	-6.0887398949829	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTAGTCAGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.17784696252	46.136801189628	0.0179229268265472	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2572.16506105858	2572.16506105858
"healthy-4"	"2019-08-01-count-2:GACACGCCACGCGTGT"	4.33791079100911	-6.56635095989379	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACACGCCACGCGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2754.53835904077	43.4006440545895	0.0157560499791708	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2753.54219477604	2753.54219477604
"healthy-4"	"2019-08-01-count-2:TGGGTTACAAGCGAGT"	0.111888640641612	7.6140737303528	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGTTACAAGCGAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2045.04011276117	44.6142569906053	0.0218158346685768	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2040.87690100253	2040.87690100253
"healthy-4"	"2019-08-01-count-4:TCACTCGAGTGCACTT"	-0.0278307450121224	7.79217193210451	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTCGAGTGCACTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.79977988231	36.8926863590742	0.018786378701644	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1950.21570100215	1950.21570100215
"healthy-4"	"2019-08-01-count-4:CAACGGCTCCCTCGTA"	5.10172667083089	-8.28572657024535	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGGCTCCCTCGTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2939.45913974799	42.1185750419739	0.0143286819239763	2664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2934.99111090899	2934.99111090899
"healthy-4"	"2019-08-01-count-1:GCACGGTCATGGCGCT"	10.3409773307735	7.08839795673219	"2019-08-01-count-1"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCACGGTCATGGCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2249.99464789861	46.6372132906153	0.0207276996566068	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2244.65835673235	2244.65835673235
"healthy-4"	"2019-08-01-count-2:ACTGATGCATGACCCG"	10.8840986686641	6.67810962283937	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGATGCATGACCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1983.30109747169	42.696237611091	0.0215278646623652	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1976.73562292087	1976.73562292087
"healthy-4"	"2019-08-01-count-4:GTAACCATCGGCACTG"	11.2736603218013	4.14990041339723	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAACCATCGGCACTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.74033320677	38.0792750513644	0.0195806475554368	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1924.51041606494	1924.51041606494
"healthy-4"	"2019-08-01-count-2:CAGTTAGCACCGTGAC"	4.74717678603475	-7.05873443996581	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTAGCACCGTGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2852.37940460478	46.1556968208367	0.0161814717727679	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2848.48530218894	2848.48530218894
"healthy-4"	"2019-08-01-count-3:TTACTGTCATGACGAG"	10.7950760322506	7.04835794055787	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTCATGACGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.34554689895	45.8231067078412	0.0233630972269477	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1959.8127902134	1959.8127902134
"healthy-4"	"2019-08-01-count-4:TTTCCTCCATGACACT"	10.8567577796871	6.67666051471559	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCCATGACACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2015.4508448685	48.3330895422287	0.02398127925833	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2013.92186746324	2013.92186746324
"healthy-4"	"2019-08-01-count-2:ACATCGAAGAGGGTGG"	11.5064751106197	3.52327654445497	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCGAAGAGGGTGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.59806389025	36.5396053604208	0.0194815755379021	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.08854424179	1863.08854424179
"healthy-4"	"2019-08-01-count-4:TAACACGTCCGCTGTT"	11.2963320213253	6.21776769244996	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGTCCGCTGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2410.27130186736	45.68848475097	0.0189557435777345	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2400.32816291424	2400.32816291424
"healthy-4"	"2019-08-01-count-4:AATAGAGAGGATTTAG"	4.11717905577962	-6.56916572963866	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATAGAGAGGATTTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.39725029116	45.9869159968608	0.0196324154628958	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2336.95689280015	2336.95689280015
"healthy-4"	"2019-08-01-count-4:CATGCTCTCCTTCTGG"	2.69432177123372	-6.0024075738159	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCTCCTTCTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2912.92197988437	41.0271637504884	0.0140845391788067	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2906.14117007276	2906.14117007276
"healthy-4"	"2019-08-01-count-2:AACCACAGTGGTTTGT"	10.9313551383907	6.1257376440796	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCACAGTGGTTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.23256160494	48.7979710362751	0.0260223569254315	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1871.86824873597	1871.86824873597
"healthy-4"	"2019-08-01-count-3:TGCCGAGAGTGTTCAC"	4.58986963805501	-6.68698313152465	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCCGAGAGTGTTCAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.79411078958	43.628232239113	0.0161180460919455	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2703.64931957881	2703.64931957881
"healthy-4"	"2019-08-01-count-2:ATCGGATAGGCCATAG"	10.561992307275	7.26250169360963	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGATAGGCCATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.42793670286	42.4809335128667	0.0219377817824704	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.0440406102	1931.0440406102
"healthy-4"	"2019-08-01-count-2:ACGGTCGGTGTCTTGA"	4.14832033690755	-6.83299257671507	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGGTGTCTTGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2787.98454698346	43.4527690483719	0.0155857280828141	2127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2784.23255095342	2784.23255095342
"healthy-4"	"2019-08-01-count-3:TGATTCTAGAGATCGC"	5.531426568597	-10.07022764599	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTCTAGAGATCGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.10958449003	45.1242562190755	0.0180633613910446	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2491.96443786032	2491.96443786032
"healthy-4"	"2019-08-01-count-3:TTGGGATCAGCTGTCG"	1.50794257697408	-6.40653040325316	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGATCAGCTGTCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2281.41638733529	45.9602673377911	0.0201454971538418	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2275.99494687255	2275.99494687255
"healthy-4"	"2019-08-01-count-2:CCTTCAGAGCCGCTTG"	3.42738952216451	-6.33545687114867	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGAGCCGCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.51555767929	46.5513911017303	0.0186839656522516	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2483.26436602883	2483.26436602883
"healthy-4"	"2019-08-01-count-4:GAAGAATGTAGGTTTC"	0.171303589909714	7.56012389743654	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATGTAGGTTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1915.11132435553	45.8436116443705	0.0239378312170953	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1911.12232247755	1911.12232247755
"healthy-4"	"2019-08-01-count-3:GGTAATCTCGTGGACC"	1.94561268863026	-6.97241356289061	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCTCGTGGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.99738267824	43.8699716277455	0.0239989247487163	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1826.293664773	1826.293664773
"healthy-4"	"2019-08-01-count-4:TGCATGACAATGTTGC"	3.65270127829854	-5.83988287365111	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGACAATGTTGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2954.17268319401	45.3817372907567	0.0153619108148041	2910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2948.86772317643	2948.86772317643
"healthy-4"	"2019-08-01-count-3:TGGTAGTAGATGAACT"	2.82414331015889	-4.7794809571472	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTAGATGAACT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3015.58897436018	38.9452227802354	0.0129146323027986	2917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3008.85718408505	3008.85718408505
"healthy-4"	"2019-08-01-count-4:TACAACGAGTAGGCCA"	-1.96899447861369	3.45018646800844	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAACGAGTAGGCCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2909.45741328699	43.4368036270478	0.0149295203389744	5072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2903.74101188056	2903.74101188056
"healthy-4"	"2019-08-01-count-3:AATTCCTTCAAGAAAC"	2.6248582797939	-5.91848041927489	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATTCCTTCAAGAAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.53721245779	47.315895961708	0.0196287764060131	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2406.67022487144	2406.67022487144
"healthy-4"	"2019-08-01-count-4:CTACGGGAGAGCAGAA"	0.616966207593125	7.94806525791017	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGAGAGCAGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.51422224882	38.6363855498988	0.0197173284639691	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.15995277961	1958.15995277961
"healthy-4"	"2019-08-01-count-4:GCCAACGGTGTCATGT"	2.63183297690694	-5.95913793956908	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGGTGTCATGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.76964277443	40.0566665118439	0.0154493734618787	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.37365549925	2586.37365549925
"healthy-4"	"2019-08-01-count-4:ACATCGACACCGAATT"	10.6637007194454	7.47969577396242	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCGACACCGAATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2229.39501630999	45.6832095939361	0.0204913033624473	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2223.67980158999	2223.67980158999
"healthy-4"	"2019-08-01-count-4:CCACGAGAGAGCTTTC"	-3.36865435066875	12.5871848830017	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGAGAGCTTTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1819.24254775534	48.3448310216931	0.0265741536670539	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1815.38840711902	1815.38840711902
"healthy-4"	"2019-08-01-count-3:ATGAAAGCAGTGTGGA"	-0.0282930386370004	7.71466062152711	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGCAGTGTGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1863.98154249569	41.6613084977875	0.0223507087103486	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1857.66265370828	1857.66265370828
"healthy-4"	"2019-08-01-count-2:CATCCGTCAACAGATA"	2.96112837371175	-6.91417457973631	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCGTCAACAGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.39424418661	54.2228605623954	0.0318509421349124	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1698.24119706628	1698.24119706628
"healthy-4"	"2019-08-01-count-2:CACGTTCCAAAGGCGT"	-2.62346516075786	10.2466830977234	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCCAAAGGCGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1966.28425277645	47.5065141088877	0.0241605525965064	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1954.36314979362	1954.36314979362
"healthy-4"	"2019-08-01-count-4:CTGTGAAAGTAGGCCA"	-0.238998065621215	7.61680409992067	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAAAGTAGGCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.68623990665	46.7535622191975	0.0226773411560987	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2053.22596043191	2053.22596043191
"healthy-4"	"2019-08-01-count-4:GTTGTCCGTAGACAGC"	4.22871985015218	-7.57972290432128	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCGTAGACAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.47404316686	43.2198503573632	0.0207242331780512	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2078.59172980371	2078.59172980371
"healthy-4"	"2019-08-01-count-2:CTGCCTACAATCGTCA"	6.7336389022762	-1.75141909038695	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTACAATCGTCA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3132.45927764849	34.6882205603552	0.0110737977690153	2898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3121.14569067904	3121.14569067904
"healthy-4"	"2019-08-01-count-3:TGCGGGTCAATGTCTG"	2.64691223677937	-6.38831140911254	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGGTCAATGTCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.03841023222	47.2461734526597	0.0207946191577944	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2269.25550559019	2269.25550559019
"healthy-4"	"2019-08-01-count-2:TATTTCGTCCACTAGA"	9.76740994033162	6.06053874576417	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGTCCACTAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1659.13376802523	27.2147823985931	0.0164030067515202	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1650.83053556147	1650.83053556147
"healthy-4"	"2019-08-01-count-2:ACTTCGCAGGTACTGG"	-8.14722762528117	0.0193596475752964	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCAGGTACTGG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3180.49488135962	46.5227558032021	0.0146275210426731	4346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3162.7265083067	3162.7265083067
"healthy-4"	"2019-08-01-count-1:CTGGTCTTCCAGTGCG"	0.388257165520829	7.99598405444948	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTGGTCTTCCAGTGCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1914.6699149863	46.5535065144636	0.0243141160521116	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.44211834249	1902.44211834249
"healthy-4"	"2019-08-01-count-2:AGCGTATGTATGAAAC"	10.3079296546871	7.2608284720215	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATGTATGAAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1836.68279709641	41.9085113100407	0.0228175008642175	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1832.53149087448	1832.53149087448
"healthy-4"	"2019-08-01-count-4:TTCCGGTTCGACGACC"	6.81195368346517	-1.75097420131835	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTTCGACGACC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2895.16529557818	33.5297976992246	0.0115813068602456	2657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2878.46863735511	2878.46863735511
"healthy-4"	"2019-08-01-count-2:AATGGAACAGGCGTTC"	4.78668798980061	-7.18144085323485	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGAACAGGCGTTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2828.80952471465	38.0754492552626	0.0134598844222654	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2820.74850927336	2820.74850927336
"healthy-4"	"2019-08-01-count-4:CCGTTCATCCAAACCA"	2.80857886847798	-7.16508104717406	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTTCATCCAAACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1720.12435205966	48.0696345975553	0.0279454415839164	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1715.88095500558	1715.88095500558
"healthy-4"	"2019-08-01-count-4:CAGGGCTAGCTACAAA"	3.61906923827474	-6.35613825237425	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGGCTAGCTACAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.66879857006	41.8701001173808	0.0168107859790186	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2484.69031322967	2484.69031322967
"healthy-4"	"2019-08-01-count-4:AGGCTGCCACGGCTAC"	10.4590841728145	7.14177653873292	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCTGCCACGGCTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2227.49881374752	45.6161116602258	0.0204786244458114	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2219.60653944551	2219.60653944551
"healthy-4"	"2019-08-01-count-2:CGCCAGAGTCACTTCC"	11.0735556083614	6.2172846564087	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGAGTCACTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2134.20155422218	46.3377371473636	0.0217119779786927	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2124.65494889499	2124.65494889499
"healthy-4"	"2019-08-01-count-2:GTGCTTCCATCCTTCG"	-0.287456731230575	7.93967816913453	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCCATCCTTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.83635436304	47.3254675844033	0.0229530668058395	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.14336191939	2054.14336191939
"healthy-4"	"2019-08-01-count-2:ATCCACCGTTCAGCGC"	1.62125124511067	-5.96296789562377	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCGTTCAGCGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2561.1072462054	44.2755503914187	0.0172876596468259	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2554.0103120223	2554.0103120223
"healthy-4"	"2019-08-01-count-2:CTTTCAATCAAACTGC"	4.60315527495686	-6.75347378170165	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCAAACTGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2966.85157688521	42.6403983284102	0.01437227216239	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2955.30712296667	2955.30712296667
"healthy-4"	"2019-08-01-count-4:CGAAGTTCAACTCGTA"	-3.00762854042705	3.12710068309633	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTCAACTCGTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3294.87767623693	47.0753320175979	0.0142874293504463	5362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3283.75060617945	3283.75060617945
"healthy-4"	"2019-08-01-count-4:GCTACAAAGTGCAGGT"	-0.26067421856578	7.57049415195314	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAAAGTGCAGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2104.8860952534	44.3296984282403	0.0210603787673858	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2099.62932570112	2099.62932570112
"healthy-4"	"2019-08-01-count-4:GGCTTTCTCTGGTTGA"	4.43231024321858	-6.8052230111328	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTTCTCTGGTTGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.30874533796	45.3727002631138	0.0171456563195989	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2640.38914754216	2640.38914754216
"healthy-4"	"2019-08-01-count-3:TGTAGACAGCATCAGG"	0.472537388175172	7.67332313144533	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACAGCATCAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.43240356338	38.8691128276691	0.0207143687957296	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1863.18917709084	1863.18917709084
"healthy-4"	"2019-08-01-count-4:AACCTTTGTCAACGCC"	-2.76789174500163	9.23073480213014	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTGTCAACGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.00107151573	40.3154556075687	0.0214901026548964	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1874.16598843097	1874.16598843097
"healthy-4"	"2019-08-01-count-3:ATCAGGTCACTAAACC"	10.2770887809688	7.76426169956056	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTCACTAAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.21258830496	44.6206899035316	0.0215121102605956	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2063.85190320318	2063.85190320318
"healthy-4"	"2019-08-01-count-3:TACACCCCAAATGGTA"	11.383245130151	4.37595794284669	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCCAAATGGTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2143.44792395084	36.5796861431779	0.0170658151916999	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2134.39996619813	2134.39996619813
"healthy-4"	"2019-08-01-count-2:TCTTTGACACATACTG"	3.54485191878621	-6.25103762066039	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTTGACACATACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.10532778843	42.130991479457	0.0154546455157094	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2722.00151016157	2722.00151016157
"healthy-4"	"2019-08-01-count-3:TGGAACTGTAGGACCA"	5.61964335021321	-9.94112303173216	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAACTGTAGGACCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.68197797199	44.4140818572123	0.0170059303666446	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2606.81937361474	2606.81937361474
"healthy-4"	"2019-08-01-count-4:AAGACAACAATCGCCG"	5.09813799437825	-7.55550959026488	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGACAACAATCGCCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2883.68079925124	45.1681522527293	0.0156633675490218	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2882.77612881629	2882.77612881629
"healthy-4"	"2019-08-01-count-3:GAAGTAAAGAGGTTTA"	-0.694296042353469	8.24767587268678	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAAAGAGGTTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1921.39711957593	42.2548553891784	0.0219917345345581	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1913.35178419621	1913.35178419621
"healthy-4"	"2019-08-01-count-4:ACCACAAGTTACCCAA"	10.6540380912716	6.39027259433595	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCACAAGTTACCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2052.13684907339	46.9101467468492	0.0228591708043402	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2037.96339767004	2037.96339767004
"healthy-4"	"2019-08-01-count-2:CATTGCCCAGGTCTCG"	4.71763720092122	-6.73423864757689	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCCAGGTCTCG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2681.40742996332	44.5832509436694	0.0166268096543162	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2678.2301547582	2678.2301547582
"healthy-4"	"2019-08-01-count-1:GTCATCCTCATAGGCT"	10.648246427148	6.77807185733644	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTCATCCTCATAGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.35186829355	42.040469249847	0.020880835541916	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.23132405474	1998.23132405474
"healthy-4"	"2019-08-01-count-4:ACTTCCGTCCCTTGGT"	3.20045032080953	-6.24897291576537	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGTCCCTTGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2641.87960949891	43.9124022499775	0.0166216515287411	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2635.36735560047	2635.36735560047
"healthy-4"	"2019-08-01-count-3:TCATCCGAGCGATGCA"	11.5786415534908	3.49482295596925	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCCGAGCGATGCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1743.89029246853	39.3743816645315	0.0225784740213193	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1731.00283134066	1731.00283134066
"healthy-4"	"2019-08-01-count-4:AAAGGTATCGAGCACC"	3.57823266562764	-7.1102710000244	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTATCGAGCACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1983.99740272133	45.8040747082954	0.0230867614269398	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1980.70971835554	1980.70971835554
"healthy-4"	"2019-08-01-count-1:TTACTGTTCTGCATGA"	0.0476533454725563	7.79813048923341	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTACTGTTCTGCATGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2206.26781970392	47.583062193992	0.021567219432307	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2184.82808796823	2184.82808796823
"healthy-4"	"2019-08-01-count-2:TGGAGGAAGGATGGCT"	11.5427156883175	4.09364411914674	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGAAGGATGGCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2127.13165771763	36.5612406433544	0.0171880478158009	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.20897697012	2117.20897697012
"healthy-4"	"2019-08-01-count-2:GAATCACTCACGACTA"	10.8437267738277	6.52059552753297	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCACTCACGACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.34192763794	48.82475940395	0.0240002719015088	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2023.80004459185	2023.80004459185
"healthy-4"	"2019-08-01-count-3:AAAGGATTCTTACCAT"	4.48353876647298	-7.02656748211058	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATTCTTACCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.27600393244	41.6552322384992	0.016896782417893	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2463.83513129541	2463.83513129541
"healthy-4"	"2019-08-01-count-3:GAGTTTGCAGCGGATA"	1.9063968854839	-5.87836506282958	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTTGCAGCGGATA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2726.78956942702	44.2160274524896	0.0162154160879311	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2721.94583824132	2721.94583824132
"healthy-4"	"2019-08-01-count-2:ATCCACCCAGTAGAAT"	11.5523535209591	3.59962103450624	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCCAGTAGAAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.74524172297	39.7720859510191	0.020018714586943	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.30007070959	1968.30007070959
"healthy-4"	"2019-08-01-count-3:TATTCCAGTTGGTAGG"	-1.05858359757121	8.56268022144166	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCAGTTGGTAGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1958.98606440319	40.0576057385925	0.0204481320548833	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.12576336855	1952.12576336855
"healthy-4"	"2019-08-01-count-2:ACCATTTCAGGTGACA"	-2.14056168022807	9.32076451862184	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCATTTCAGGTGACA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.1302096706	40.0583569534135	0.0201487592505576	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1980.92448657663	1980.92448657663
"healthy-4"	"2019-08-01-count-3:GGTTGTATCAGGGATG"	0.0152001130277335	7.56350276553956	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTATCAGGGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.89689183924	43.281741805953	0.0229137662267045	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1880.96987607	1880.96987607
"healthy-4"	"2019-08-01-count-2:GTTACAGAGCAGAAAG"	2.3316511112148	-6.35082056438597	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGAGCAGAAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.5457508745	47.8356717649915	0.0222538514221111	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2146.58781088764	2146.58781088764
"healthy-4"	"2019-08-01-count-4:CTACCCAGTGCACGCT"	-2.60877213898357	3.43189666354982	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCAGTGCACGCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3419.08664924509	44.7506696699682	0.0130884865640503	5956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3411.22235107948	3411.22235107948
"healthy-4"	"2019-08-01-count-3:TCAATCTGTGTATCCA"	10.1672436195308	6.67717645252077	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTGTGTATCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1773.08238485717	35.3201490255732	0.0199201962228159	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1756.37021619957	1756.37021619957
"healthy-4"	"2019-08-01-count-4:GGAGCAACATACATCG"	-1.80903528156932	8.83328435504762	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGCAACATACATCG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1898.66927630387	41.752855982177	0.0219905891474987	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.47935739466	1895.47935739466
"healthy-4"	"2019-08-01-count-1:AATGACCGTGAGTGAC"	10.5957075553829	6.64348456943361	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATGACCGTGAGTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1877.23292878129	45.1995926070909	0.0240777752798289	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.68393321733	1862.68393321733
"healthy-4"	"2019-08-01-count-2:CCATAAGAGGTCCTGC"	-1.88351414623912	9.33214566791383	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGAGGTCCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1849.99730599236	42.3372753139178	0.0228850470088699	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1845.04108042619	1845.04108042619
"healthy-4"	"2019-08-01-count-4:CATACCCAGCGTTCCG"	2.66171445426289	-5.99001934444579	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACCCAGCGTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.78503664111	42.6304557551489	0.0170673036829767	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.12506767258	2494.12506767258
"healthy-4"	"2019-08-01-count-4:TGGCGTGGTGACGTCC"	11.0716482597286	5.87018249118654	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGGTGACGTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2104.54952389924	41.9740410135294	0.0199444301675359	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2096.5572244704	2096.5572244704
"healthy-4"	"2019-08-01-count-2:AGTAACCCATGGGCAA"	10.8090883689815	6.44147012317506	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAACCCATGGGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1983.93605183293	46.860173415928	0.0236198003320896	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1976.54677752194	1976.54677752194
"healthy-4"	"2019-08-01-count-4:ATACCGAGTGCGGTAA"	11.5277973609859	4.08028695667116	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGAGTGCGGTAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2181.19131159991	36.5328927758715	0.0167490547856045	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2152.41921579663	2152.41921579663
"healthy-4"	"2019-08-01-count-4:AGTCATGGTCTTTCAT"	-0.226407448679763	8.56640908801881	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCATGGTCTTTCAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1816.87574363459	42.3298667579678	0.0232981627424276	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1811.49783900693	1811.49783900693
"healthy-4"	"2019-08-01-count-3:GTTAGACAGATCCGAG"	10.351317067712	6.93428609454957	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTAGACAGATCCGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1808.09558504546	46.2481240613992	0.0255783623630917	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1796.69871042494	1796.69871042494
"healthy-4"	"2019-08-01-count-2:CTTCCTTCAGCAGACA"	2.74644698676412	-6.1701665154663	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTCAGCAGACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.23943656086	47.1325248404444	0.0179058653197694	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2625.07917748463	2625.07917748463
"healthy-4"	"2019-08-01-count-4:GGGCCATTCCTTGGAA"	4.63280643996541	-7.24823715603026	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCCATTCCTTGGAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.71210355568	42.4965055091181	0.0160502742923026	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2641.29222029685	2641.29222029685
"healthy-4"	"2019-08-01-count-4:CCTCCAAAGCTACAAA"	3.45629586753194	-6.48556234752806	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCAAAGCTACAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.21384197919	45.7174948265797	0.0184552072380047	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.21377486189	2470.21377486189
"healthy-4"	"2019-08-01-count-4:ATAGGCTGTGTGCCTG"	11.2071453529293	5.99525878513185	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTGTGTGCCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.92139621585	42.9893676853547	0.0211778484455088	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2024.95379653571	2024.95379653571
"healthy-4"	"2019-08-01-count-4:ACTTTGTCAGCGATTT"	-4.25409207764323	12.8173541792664	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTGTCAGCGATTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2007.84266672445	45.848967511843	0.0228349403425318	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1997.9354463218	1997.9354463218
"healthy-4"	"2019-08-01-count-2:ACTCTCGAGGTCGTCC"	3.40437116202657	-6.62762310421141	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCTCGAGGTCGTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.17101181507	49.4675473144546	0.0206789343529922	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2386.65555793326	2386.65555793326
"healthy-4"	"2019-08-01-count-4:CCCATTGAGGGCAAGG"	3.37945236739461	-6.31680061733397	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCATTGAGGGCAAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.31743077195	40.9796279087947	0.0154446759492595	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2652.25194969924	2652.25194969924
"healthy-4"	"2019-08-01-count-4:TTCCTAATCAGACCTA"	-4.28354201737102	12.4354572066101	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTAATCAGACCTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2302.82356512973	48.9092273800727	0.0212388079228803	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2299.46236506749	2299.46236506749
"healthy-4"	"2019-08-01-count-1:GTATTGGGTCATCACA"	3.18661322173421	-6.1342754594055	"2019-08-01-count-1"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTATTGGGTCATCACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2900.03165156005	43.7707996109665	0.0150932144438563	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2893.7670529062	2893.7670529062
"healthy-4"	"2019-08-01-count-4:ACAAGCTGTGCAGTGA"	11.5580011802608	3.74854109371034	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTGTGCAGTGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1996.45765363986	33.6531495749158	0.0168564304449738	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.96761536461	1977.96761536461
"healthy-4"	"2019-08-01-count-4:ATTGTTCTCTGGCCAG"	2.69242300566975	-6.06441833889159	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGTTCTCTGGCCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.82107812231	47.0408628111719	0.018455929768843	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2541.58076453018	2541.58076453018
"healthy-4"	"2019-08-01-count-4:CGTCCATCACGACAGA"	6.79071821746175	-1.6010940304962	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCCATCACGACAGA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2648.68822848508	41.6636394605647	0.0157299145337291	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2638.00344693949	2638.00344693949
"healthy-4"	"2019-08-01-count-4:CATGGTAGTGGATCGA"	4.60515036162679	-6.91551878368529	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGTAGTGGATCGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.64650032169	44.2420168321453	0.0177490136794109	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2490.3940780555	2490.3940780555
"healthy-4"	"2019-08-01-count-3:GCCTGTTCATTCACAG"	-0.0706106153434098	7.59900376880494	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCTGTTCATTCACAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.30268588951	39.1939513129764	0.0208444904148158	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1872.25607481246	1872.25607481246
"healthy-4"	"2019-08-01-count-2:CACGAATCAAGAGAGA"	3.65624990042989	-6.54925396358641	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATCAAGAGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.12856858895	43.2153464269231	0.017340737139975	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2488.71491570458	2488.71491570458
"healthy-4"	"2019-08-01-count-1:CACAGGCCACGAAAGC"	0.579918583005112	8.24455068195192	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CACAGGCCACGAAAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.20946494619	30.5524922347563	0.0158040257865211	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1924.49427433834	1924.49427433834
"healthy-4"	"2019-08-01-count-4:AGCCAGCCAACTTGCA"	10.9795366722042	6.73147056186525	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCCAACTTGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.01907321246	46.9259657113671	0.0237477291325324	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1972.65992904045	1972.65992904045
"healthy-4"	"2019-08-01-count-3:TGAATCGGTCATCCCT"	10.5697094398433	7.27173898303834	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAATCGGTCATCCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2171.38101384323	45.0524665170838	0.0207483008416581	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2162.83293272539	2162.83293272539
"healthy-4"	"2019-08-01-count-4:ACTATTCCACAAAGCG"	10.8165508705074	5.41542575443117	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATTCCACAAAGCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1758.33219879256	49.1959478541554	0.0279787561690208	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1750.40844340492	1750.40844340492
"healthy-4"	"2019-08-01-count-3:ATGCATGAGGCCTTGC"	-2.04723773422893	3.45251891696779	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCATGAGGCCTTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3102.68569762968	44.7557914291681	0.0144248550419914	4851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3095.62912595493	3095.62912595493
"healthy-4"	"2019-08-01-count-3:TACTTCAAGGGAGGCA"	-3.80075679245647	11.9272670515808	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTCAAGGGAGGCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2162.19824899515	46.5891671758524	0.0215471301937757	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2156.03929689954	2156.03929689954
"healthy-4"	"2019-08-01-count-2:AGGACGATCATTTGGG"	0.36934926089589	7.83225534046022	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGATCATTTGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1890.23659102828	45.9506415729026	0.0243094656991619	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1885.88306582668	1885.88306582668
"healthy-4"	"2019-08-01-count-3:ATGGATCCACCGCTAG"	4.79005684432332	-6.9103951684204	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGATCCACCGCTAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2784.99355055774	40.5913621678454	0.0145750291449387	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2779.71524424724	2779.71524424724
"healthy-4"	"2019-08-01-count-2:ATCTCTATCGTAGCTA"	-3.26609430733379	-5.49145986950072	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTATCGTAGCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2388.72033523632	50.4836638529145	0.0211341876686958	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2385.01433170655	2385.01433170655
"healthy-4"	"2019-08-01-count-2:GTCAAGTGTCCCGGTA"	0.289975320070428	8.00939271533815	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAGTGTCCCGGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.3465901593	38.0381038389685	0.0194037646352513	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1955.87693012362	1955.87693012362
"healthy-4"	"2019-08-01-count-2:ACGTTCCGTCGCTGCA"	4.80573620375935	-6.85285999691161	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCGTCGCTGCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.27952231616	43.4729135871579	0.0171946626958923	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2524.47773118163	2524.47773118163
"healthy-4"	"2019-08-01-count-2:TACTGCCGTTCTCCTG"	11.2583233314449	6.20708749378053	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTGCCGTTCTCCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2086.08933209666	43.2367395707662	0.0207262167087113	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2079.77159468583	2079.77159468583
"healthy-4"	"2019-08-01-count-2:AACCACAAGGAGAATG"	5.10034098204915	-7.72151853954466	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCACAAGGAGAATG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2798.73742460135	41.3840337659805	0.0147866796656979	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2792.78149702694	2792.78149702694
"healthy-4"	"2019-08-01-count-3:TCACGCTCATGGAAGC"	11.486384053796	4.27819297397462	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTCATGGAAGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2553.0312688972	42.3578501471316	0.0165911991220649	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2537.7626827878	2537.7626827878
"healthy-4"	"2019-08-01-count-3:AACCAACAGGGATCGT"	3.88871111449544	-7.34358360683592	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACAGGGATCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.81579321818	50.0275918198235	0.0222659961581308	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2242.10274374292	2242.10274374292
"healthy-4"	"2019-08-01-count-2:CTACAGATCCATCAGA"	11.3513494926387	3.73701284015504	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGATCCATCAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.40517741595	41.3797474247038	0.0218662197284871	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.05141827892	1877.05141827892
"healthy-4"	"2019-08-01-count-3:TTGGTTTCATTAAGCC"	5.61559786376302	-10.057101272699	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGTTTCATTAAGCC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.43917955009	46.3272732910996	0.0172064326068977	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2685.58708239081	2685.58708239081
"healthy-4"	"2019-08-01-count-4:CAACCTCCAAGTGCAG"	2.265388627618	-6.22175934230956	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCCAAGTGCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2058.20349981201	48.3242775895068	0.0234788628014288	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2056.57450321925	2056.57450321925
"healthy-4"	"2019-08-01-count-2:AAGCATCGTCGTATTG"	4.38847460326497	-6.54393579876097	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCATCGTCGTATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.00462005725	45.4767994298936	0.0172521698497273	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2633.87012193059	2633.87012193059
"healthy-4"	"2019-08-01-count-4:GTATTGGGTTAAACCC"	-4.28119121018107	12.0687236555847	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTATTGGGTTAAACCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2556.60281011119	47.0494545034052	0.0184031146008789	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2546.09727224268	2546.09727224268
"healthy-4"	"2019-08-01-count-2:AGCGCCATCCAAGAGG"	0.0467249872976958	7.70958421314088	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCCATCCAAGAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.17613176515	37.1727891857971	0.020580932574648	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1794.52885336322	1794.52885336322
"healthy-4"	"2019-08-01-count-2:ATCGGCGAGCCTCAAT"	1.91632666167561	-6.11583902752074	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGAGCCTCAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2546.31452767623	45.5580616300334	0.0178917651903788	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2543.29163877955	2543.29163877955
"healthy-4"	"2019-08-01-count-4:CCTCTCCGTGTTCATG"	10.919767041772	6.40972707355348	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCGTGTTCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1845.29347096775	47.7468711230707	0.0258749471963559	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1833.94355612375	1833.94355612375
"healthy-4"	"2019-08-01-count-4:TTCCACGTCACAAGAA"	3.11723293837849	-5.96229364788207	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGTCACAAGAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2758.98684632796	37.9869371685072	0.0137684372142134	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2753.41164626753	2753.41164626753
"healthy-4"	"2019-08-01-count-2:CCTACGTAGATGCGAC"	10.6320024925167	5.74180314624635	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTAGATGCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.21381699898	43.1627360676688	0.0227986589153929	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1884.87483149873	1884.87483149873
"healthy-4"	"2019-08-01-count-2:CTGCGAGTCGCTGATA"	-3.60704813423808	9.96422002399293	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCGAGTCGCTGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.77520290363	46.1064101504628	0.0233476752607941	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1972.5256936427	1972.5256936427
"healthy-4"	"2019-08-01-count-3:CGCATGGCACCCTTAC"	-0.331610808998901	8.34791562640993	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCATGGCACCCTTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2228.43772338401	46.1359331984081	0.0207032634182606	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2218.54557459861	2218.54557459861
"healthy-4"	"2019-08-01-count-4:ACATTTCGTTAACCTG"	11.2319418388302	5.60144708240358	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATTTCGTTAACCTG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.52996945525	35.6809886722549	0.0180432100769041	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.98905288451	1969.98905288451
"healthy-4"	"2019-08-01-count-4:ACTATGGAGTATCTGC"	10.6098276573116	7.50204608524171	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATGGAGTATCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2139.82012694469	43.9679393377853	0.0205474931206317	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2133.6004806633	2133.6004806633
"healthy-4"	"2019-08-01-count-4:AACAGGGCACGGTAGA"	2.30595745620076	-6.04649355327757	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGCACGGTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.88912190017	44.6700812868717	0.0183911570454584	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2424.20927305366	2424.20927305366
"healthy-4"	"2019-08-01-count-4:AACCATGAGGAACATT"	2.81439175185506	-6.20675852214965	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCATGAGGAACATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.61328629035	42.9861202881665	0.0194805861793902	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2201.55786010174	2201.55786010174
"healthy-4"	"2019-08-01-count-3:TGGGATTGTAACATCC"	10.7064110237056	6.65722081744996	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGATTGTAACATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.02172303644	50.7490063347848	0.0277769036322359	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1819.95388139359	1819.95388139359
"healthy-4"	"2019-08-01-count-3:TTACCGCTCTGGTGCG"	3.06482114371602	-5.99374868786009	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCTCTGGTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.34312552547	47.6588676629347	0.0178074579482694	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2670.64503354306	2670.64503354306
"healthy-4"	"2019-08-01-count-4:CACTGAATCTTACACT"	1.8590108352596	-6.10220148479613	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAATCTTACACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2626.54463954817	54.4867195360734	0.0207446386844757	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2619.7725737295	2619.7725737295
"healthy-4"	"2019-08-01-count-2:GACATCATCGACATTG"	-6.77347026291545	3.20813200557557	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACATCATCGACATTG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3005.62627569788	37.62658903012	0.0125187184229628	3180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2994.24650687384	2994.24650687384
"healthy-4"	"2019-08-01-count-4:CCGGACAGTACTGTTG"	10.4847332435543	7.61369655216066	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGACAGTACTGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2103.74410250134	48.1548614781963	0.0228900755661967	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.34668650514	2093.34668650514
"healthy-4"	"2019-08-01-count-4:GGCACGTCAGCTGGTC"	11.3185354667598	4.91319463336793	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCACGTCAGCTGGTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2244.38387936483	38.8909336179325	0.0173281112805617	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2239.39129987493	2239.39129987493
"healthy-4"	"2019-08-01-count-3:TGATCAGAGTGTTGTC"	2.69855989989583	-6.59616091167601	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGAGTGTTGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1895.91035189029	51.3527676343108	0.0270860737603497	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1888.3985053419	1888.3985053419
"healthy-4"	"2019-08-01-count-2:CATCAAGCAAAGGAGA"	-2.68601522865947	9.40563390338746	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGCAAAGGAGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1944.95340887933	41.8975328194071	0.0215416639946909	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1939.24080471003	1939.24080471003
"healthy-4"	"2019-08-01-count-4:ACGGAAGGTCTTTATC"	-4.05694518509563	10.9447479018006	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGAAGGTCTTTATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.91122543475	38.4041930783261	0.0181159440157454	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2113.05430023874	2113.05430023874
"healthy-4"	"2019-08-01-count-3:ACCAACAGTGACTAAA"	4.60821785506551	-6.78243544017943	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACAGTGACTAAA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.1739106493	45.3309117390697	0.0165551616582018	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2734.37175075259	2734.37175075259
"healthy-4"	"2019-08-01-count-4:ATTCTTGAGAGAGTTT"	2.44985951957051	-6.01604559337767	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGAGAGAGTTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2513.56094172494	45.1123100326792	0.0179475696347035	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2506.6815729584	2506.6815729584
"healthy-4"	"2019-08-01-count-4:GAAGGACCAATTGAAG"	3.44563569602315	-6.26611664211424	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGACCAATTGAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.87805482723	44.9161067144548	0.0181195305783548	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2478.87805482723	2478.87805482723
"healthy-4"	"2019-08-01-count-4:AGGATCTGTTCTCTAT"	11.580224652856	3.79028818691102	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTGTTCTCTAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1992.57179765657	40.5992563429804	0.020375304112368	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.57058687058	1977.57058687058
"healthy-4"	"2019-08-01-count-2:CTCCCAATCGTTATCT"	10.7088304954464	6.19276521289674	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAATCGTTATCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1996.26703941617	44.4035536288391	0.0222432934833335	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.44323139131	1990.44323139131
"healthy-4"	"2019-08-01-count-3:ATGAGGGTCCTCGATC"	-3.00763187828715	9.55758950794069	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGGGTCCTCGATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.58408449337	48.8266796147842	0.0254095982626009	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1921.58408449337	1921.58408449337
"healthy-4"	"2019-08-01-count-2:ATGCATGAGCTCGAAG"	4.91872849044148	-7.1241870156494	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGAGCTCGAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2678.68601497163	44.304658531359	0.0165396983012315	2055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2674.94872300686	2674.94872300686
"healthy-4"	"2019-08-01-count-3:CCTACGTGTCTAGGTT"	4.45619740065877	-6.59709789669188	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTGTCTAGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.2316393939	40.8532318753836	0.0155736273007224	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2617.95692344011	2617.95692344011
"healthy-4"	"2019-08-01-count-3:GCAGCCATCAGTCAGT"	4.09053244170491	-6.53102066433104	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCATCAGTCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.82081641675	44.1832705056021	0.018972378722372	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2326.07594157947	2326.07594157947
"healthy-4"	"2019-08-01-count-3:AACGAAAGTGTATTCG"	-3.88417993012126	3.73499033534852	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGAAAGTGTATTCG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3136.96190695294	42.4383856772806	0.0135284988903492	4501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3121.50871440691	3121.50871440691
"healthy-4"	"2019-08-01-count-2:AACTTCTAGGCTAGCA"	11.3716103034908	4.22169730747072	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACTTCTAGGCTAGCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1633.67157896693	45.2828846387534	0.0277184748891748	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1620.39426755284	1620.39426755284
"healthy-4"	"2019-08-01-count-3:TCATGCCGTACGATTC"	2.35173048552815	-6.08327248012694	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCGTACGATTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2670.40409741305	42.3578010379815	0.0158619442948787	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2669.13201356695	2669.13201356695
"healthy-4"	"2019-08-01-count-3:ATCGATGAGAGTAACT"	4.36586918410603	-6.59310104763182	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGAGAGTAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.39991885039	46.418999014057	0.0190210623494545	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2440.39991885039	2440.39991885039
"healthy-4"	"2019-08-01-count-4:TCAGGTAAGTCTGCAT"	-2.09489951553996	8.59440991962282	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTAAGTCTGCAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2141.35838097555	46.3163722998031	0.021629435180627	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2132.84492331735	2132.84492331735
"healthy-4"	"2019-08-01-count-3:GTGGAGATCCAAATGC"	10.9415499168331	7.22959992969362	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAGATCCAAATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.12631216231	43.83203838192	0.0245128311595145	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1786.37598288409	1786.37598288409
"healthy-4"	"2019-08-01-count-4:ACCTACCGTGCGAGTA"	4.56239332732503	-6.89245130932006	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTACCGTGCGAGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.39811769167	44.2133261153408	0.0161811435270246	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2720.08304998522	2720.08304998522
"healthy-4"	"2019-08-01-count-2:GTGTCCTCAAGAGGCT"	0.27409784969632	8.27218244159547	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTCAAGAGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.38506114174	41.2023637916656	0.0219583733877069	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1875.03270771012	1875.03270771012
"healthy-4"	"2019-08-01-count-2:CATTGCCAGATACGAT"	3.27845563468282	-6.02914764797362	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCAGATACGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.26859553095	44.1461246574417	0.0160224396013683	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2752.91891860824	2752.91891860824
"healthy-4"	"2019-08-01-count-4:TGAACGTCAGCATCTA"	3.8675774532253	-5.91171839153441	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAACGTCAGCATCTA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2897.09821615191	41.3230617816017	0.0142636040266834	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2893.56592865689	2893.56592865689
"healthy-4"	"2019-08-01-count-2:CATACCCGTCTGATAC"	0.84339733895604	8.25447175586549	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCGTCTGATAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.4010043254	42.1919986168429	0.0233698765624694	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1793.42858175531	1793.42858175531
"healthy-4"	"2019-08-01-count-3:GCCAGCACATAACGGG"	0.228337590664071	7.75831697070924	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGCACATAACGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1825.92566160197	43.6703463272699	0.0239168259944142	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1818.86150313836	1818.86150313836
"healthy-4"	"2019-08-01-count-4:CATCGGGGTGACGTCC"	11.4671274619991	4.44805047595827	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGGTGACGTCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2261.00259275067	39.5444603661667	0.0174897899245918	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2254.47402731775	2254.47402731775
"healthy-4"	"2019-08-01-count-2:ATGAAAGTCGAGAGAC"	3.33428635176961	-6.19318773662718	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGTCGAGAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.76758472792	42.0472624647983	0.0164647960590658	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2550.17716206778	2550.17716206778
"healthy-4"	"2019-08-01-count-2:ATTCCCGGTTTCGCTC"	2.80316032943074	-4.59438326275023	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCCGGTTTCGCTC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3065.29304738444	42.5680104373861	0.0138870932662404	3363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3058.03927792142	3058.03927792142
"healthy-4"	"2019-08-01-count-2:AATTCCTAGCCTCATA"	10.3034225898678	7.69032332980958	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTCCTAGCCTCATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2177.53252766648	49.3072332003492	0.02264362647808	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2172.44790669901	2172.44790669901
"healthy-4"	"2019-08-01-count-3:CGTTAGACAATCGAAA"	3.53553547438924	-6.19205381786498	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGACAATCGAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.78061620788	45.2762898653608	0.0166043023763043	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.43833092502	2721.43833092502
"healthy-4"	"2019-08-01-count-2:GGAGAACAGGCGCTTC"	10.4362169700557	5.94747779453126	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACAGGCGCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.51687890194	41.7940824652094	0.0224275309434472	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1858.54526040973	1858.54526040973
"healthy-4"	"2019-08-01-count-4:CACTGAAGTTCTTGTT"	11.4409185844356	5.86180875385133	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAGTTCTTGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2244.84282396318	44.0170051922813	0.0196080566186683	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2233.31318379701	2233.31318379701
"healthy-4"	"2019-08-01-count-4:TACACCCCATGATAGA"	10.6293064552242	7.32174441898195	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACACCCCATGATAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2066.0187957443	45.4212149805315	0.0219848992052214	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2061.4306559625	2061.4306559625
"healthy-4"	"2019-08-01-count-4:CATCCACGTCTTCTAT"	10.4100786643917	6.76695392215577	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACGTCTTCTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2014.07898204191	51.87047754097	0.0257539441121534	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.29092102516	2006.29092102516
"healthy-4"	"2019-08-01-count-3:TTACTGTGTCCTCAGG"	-3.49101005020793	12.5381431349548	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTGTCCTCAGG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1579.95082792679	48.2985029854374	0.0305696241501481	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1571.21389922336	1571.21389922336
"healthy-4"	"2019-08-01-count-3:CAAGGGACACACCGAC"	-1.48874102059062	8.73471162402955	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGGGACACACCGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2069.65287452408	45.0393939825266	0.0217618106576851	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2064.91179513504	2064.91179513504
"healthy-4"	"2019-08-01-count-3:AACAAAGTCGATTGGT"	-1.51725969734843	8.70524594867555	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAAGTCGATTGGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1960.24012845439	50.4028579076159	0.0257125936644086	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1954.86983807533	1954.86983807533
"healthy-4"	"2019-08-01-count-2:CGTGATAAGGGTGAAA"	-3.24615416947063	-5.08168461239012	"2019-08-01-count-2"	"Control4"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGATAAGGGTGAAA"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2907.77240900765	50.3577551429421	0.0173183275922643	2919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2898.54174197758	2898.54174197758
"healthy-4"	"2019-08-01-count-4:ACGATGTGTTTCGATG"	5.59898914870564	-10.0928993455139	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATGTGTTTCGATG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.54294350023	43.804614335945	0.0170277485344303	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2560.00274320459	2560.00274320459
"healthy-4"	"2019-08-01-count-4:TGACAGTCATAACTCG"	-0.775767783552963	8.13329503619996	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTCATAACTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2142.36973237314	48.8181018755593	0.0227869639576557	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2138.11239691396	2138.11239691396
"healthy-4"	"2019-08-01-count-3:CGGGCATCAACACACT"	4.84310259398763	-6.74844505703124	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATCAACACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2847.52744241996	46.3919473572044	0.0162920106286239	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2837.68626747029	2837.68626747029
"healthy-4"	"2019-08-01-count-2:CATCAAGGTGTCCGTG"	0.393522401421708	7.93243501270143	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGGTGTCCGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.03781808992	42.9593415133563	0.0244220681736135	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1749.63552825431	1749.63552825431
"healthy-4"	"2019-08-01-count-2:GCTACCTGTGCCTGCA"	2.12591805037801	-6.26564981853636	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTGTGCCTGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.41288495955	45.964976265526	0.0210326280136198	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2185.41288495955	2185.41288495955
"healthy-4"	"2019-08-01-count-4:CATGCCTTCCGCTTAC"	2.98917712745015	-6.24796106731566	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTTCCGCTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.60458467991	42.1111777129904	0.015923430654601	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2640.37545047668	2640.37545047668
"healthy-4"	"2019-08-01-count-2:TGCACGGGTACCGTCG"	0.382580419152421	7.82354829395143	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCACGGGTACCGTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.4021606875	48.4789455465157	0.024945400662396	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.85459853743	1937.85459853743
"healthy-4"	"2019-08-01-count-3:TGGCGTGGTCCAGCAC"	4.95749105986897	-7.62715771114501	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGCGTGGTCCAGCAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.82432140586	42.4544366326882	0.0158600010815769	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2670.82866749815	2670.82866749815
"healthy-4"	"2019-08-01-count-2:AACGTCACAACAAGTA"	11.1537577110225	6.33312890613405	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCACAACAAGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.04505513579	45.3628376136847	0.0228063399049489	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1984.34416861928	1984.34416861928
"healthy-4"	"2019-08-01-count-2:CTTTCAATCACTTGGA"	-8.27484927597697	-0.284221403953157	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCACTTGGA"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3323.9505024917	45.298738436124	0.0136279822464766	4584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3304.75728841076	3304.75728841076
"healthy-4"	"2019-08-01-count-2:ACCACAACAGTGGGTA"	4.37302650985066	-6.48937323009642	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAACAGTGGGTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2814.73660469886	41.4602778100924	0.0147297184897796	2426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2809.36496842828	2809.36496842828
"healthy-4"	"2019-08-01-count-2:CCCGGAACAGCATGCC"	-0.129340345889884	7.58219382846681	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGGAACAGCATGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1938.09897760485	40.3949444020584	0.0208425600904963	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1932.45077008574	1932.45077008574
"healthy-4"	"2019-08-01-count-2:CCTCACACATGAGAAT"	-5.39205108109172	-5.26419212734374	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACACATGAGAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3097.29657432837	51.003942529224	0.0164672453235396	2978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3088.05704606452	3088.05704606452
"healthy-4"	"2019-08-01-count-4:TCTGCCAGTGTCATTG"	2.89668359336202	-6.08350946819457	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCAGTGTCATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.36909963657	42.7514689697328	0.0163088322722885	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2616.75829374591	2616.75829374591
"healthy-4"	"2019-08-01-count-4:CACGTGGTCCACTGGG"	-3.14063249054607	3.53351829135744	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGTCCACTGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3296.45744794976	48.7029528919543	0.014774330826641	5389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3284.17604759667	3284.17604759667
"healthy-4"	"2019-08-01-count-4:ATTGGGTAGTAGGAAG"	2.82773484763448	-6.26714422619017	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGGGTAGTAGGAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.18414470641	41.9518230726299	0.0188109233814649	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2227.28940853709	2227.28940853709
"healthy-4"	"2019-08-01-count-2:GCATCTCCACAATTCG"	4.74265780028645	-7.37426617061766	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCTCCACAATTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2826.74087156748	44.0967207316601	0.0155998454528334	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2819.6129882329	2819.6129882329
"healthy-4"	"2019-08-01-count-2:AAAGTCCTCTGCGTCT"	2.37490024146382	-6.20204355632933	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTCCTCTGCGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.7399618614	46.2907749288674	0.0202431302644428	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2283.09153324556	2283.09153324556
"healthy-4"	"2019-08-01-count-3:GGACGTCTCGACCCAG"	2.51334394988362	-6.01089765941771	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGACGTCTCGACCCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.13266344686	44.7663819495294	0.018152463009415	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2460.80077346391	2460.80077346391
"healthy-4"	"2019-08-01-count-4:TCATGCCTCTCGTGGG"	5.09962334212605	-7.51639273082884	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGCCTCTCGTGGG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2869.59464003037	44.2529678236	0.0154213306668051	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2861.27134437768	2861.27134437768
"healthy-4"	"2019-08-01-count-2:GGCTTGGAGTAAGAGG"	10.8153025108272	7.6310825117859	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTGGAGTAAGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2285.61382495918	49.8410625572868	0.0218064232955787	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2280.73493619982	2280.73493619982
"healthy-4"	"2019-08-01-count-2:TCCGGGAGTGGCTTGC"	-1.73771629753764	8.89283940875856	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGAGTGGCTTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.20256591257	47.252305631714	0.0244298639989757	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1930.762350096	1930.762350096
"healthy-4"	"2019-08-01-count-4:AGAAATGCACTGGCCA"	-3.17945800247844	10.1272840269837	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAATGCACTGGCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2063.34678457567	51.9612372690527	0.0251829879773401	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2055.58520603789	2055.58520603789
"healthy-4"	"2019-08-01-count-3:TGATGGTTCATGTCTT"	10.7170921760494	7.28393600070802	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGGTTCATGTCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.78191514763	48.182007857533	0.0236791999667627	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2031.84369703053	2031.84369703053
"healthy-4"	"2019-08-01-count-2:AGTAGCTTCCATCACC"	-3.14591846886333	10.7665786513123	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAGCTTCCATCACC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1946.81463859351	52.9104651268191	0.0271779675773574	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1940.34045786498	1940.34045786498
"healthy-4"	"2019-08-01-count-4:GTAACACCATAGATGA"	2.94869532164876	-6.08048345958861	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAACACCATAGATGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.76529705992	43.7539791538881	0.018700157322988	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2335.69683630071	2335.69683630071
"healthy-4"	"2019-08-01-count-2:CTCACTGCATGACCCG"	5.68160261687581	-9.8905821076599	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGCATGACCCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.47712501982	48.0725357917905	0.0189824165900074	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.74056871526	2526.74056871526
"healthy-4"	"2019-08-01-count-2:AAGCGTTCAAAGTGTA"	-3.34250364723857	10.0922965773377	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGTTCAAAGTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.57028966927	44.529536658866	0.0226432469222113	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1961.31047759631	1961.31047759631
"healthy-4"	"2019-08-01-count-4:ATTTACCTCTAGCAAC"	4.73222794112508	-7.53278353130492	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTACCTCTAGCAAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2719.17247814316	43.9629423614876	0.0161677652722892	2113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2714.46582120566	2714.46582120566
"healthy-4"	"2019-08-01-count-1:CCGATCTGTGATTGGG"	0.246443097561043	7.74289176547853	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCGATCTGTGATTGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.95568241913	35.7455955323537	0.0180994418510541	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1964.3377988338	1964.3377988338
"healthy-4"	"2019-08-01-count-2:CATCGCTCACATATCG"	5.15338244017903	-7.67750074779662	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGCTCACATATCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.45152601865	44.6977359164585	0.0158196789096723	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2819.78370950193	2819.78370950193
"healthy-4"	"2019-08-01-count-4:ATCCTATAGGGCCAAT"	10.4784256416256	7.69459531390993	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATAGGGCCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2122.50055971488	43.1924314347649	0.0203497856512071	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2113.08600636436	2113.08600636436
"healthy-4"	"2019-08-01-count-4:AGTCACATCCATTGCC"	10.2219692665035	7.7167382010254	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACATCCATTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.0829989385	39.836428233136	0.0191237834754716	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2079.22326421909	2079.22326421909
"healthy-4"	"2019-08-01-count-3:CTTCCTTTCGCCTAGG"	5.03586973723714	-7.75274374401244	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTTCGCCTAGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.09955095838	49.6302487802267	0.0177625198655515	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2788.84544029071	2788.84544029071
"healthy-4"	"2019-08-01-count-4:ATGGAGGAGAGCACTG"	2.56223382529561	-6.0823226205078	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGAGAGCACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.51482002867	50.8131301485229	0.0203617825631423	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.22010692204	2494.22010692204
"healthy-4"	"2019-08-01-count-3:ATCACAGAGTCGCCCA"	2.41001500663106	-6.16429617321166	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGAGTCGCCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.24803883395	43.0235571851693	0.0197968922168007	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2164.85874435927	2164.85874435927
"healthy-4"	"2019-08-01-count-2:AGGATAATCCTGTAGA"	0.370498080819291	7.86189029300538	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAATCCTGTAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.89421997255	43.3884481435146	0.0230190361261474	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1876.14993608498	1876.14993608498
"healthy-4"	"2019-08-01-count-3:GTGACGCCACTACGGC"	-1.8840094608372	9.61208055103151	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCCACTACGGC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1890.27073346714	50.2545127325818	0.0265858809761101	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1882.06761498722	1882.06761498722
"healthy-4"	"2019-08-01-count-3:TCACACCAGGAGAATG"	4.56286587294881	-6.74543430721434	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCAGGAGAATG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2810.7635119079	42.0662029284067	0.0149661124993945	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2804.24779545064	2804.24779545064
"healthy-4"	"2019-08-01-count-2:ATCCCTGGTCACTTCC"	10.6067511039669	7.38681361759035	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGGTCACTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2269.72769993665	48.9503847409714	0.0215666331879095	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2261.46333998954	2261.46333998954
"healthy-4"	"2019-08-01-count-2:TCGGTCTGTAGACGGT"	3.14309777793233	-6.42405512249144	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGTCTGTAGACGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.72801324751	40.574152486759	0.0160643395781123	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2521.93204217117	2521.93204217117
"healthy-4"	"2019-08-01-count-4:ATGGAGGTCCGCAGTG"	11.0021673637325	6.18057534778444	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGTCCGCAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.25581696382	44.0740790977912	0.0238980290545321	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1836.90046180068	1836.90046180068
"healthy-4"	"2019-08-01-count-2:CACTGAAAGTTACGGG"	-2.85382113876994	9.71913716876832	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAAGTTACGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1901.29835210243	38.7741815671406	0.0203935282036428	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1891.65584770002	1891.65584770002
"healthy-4"	"2019-08-01-count-3:GGGAAGTCAACTGCCG"	10.8919025855953	6.41014239871827	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTCAACTGCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.07670827039	44.6806324908454	0.0239693100035046	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1852.29280906589	1852.29280906589
"healthy-4"	"2019-08-01-count-2:ATTCAGGAGTTCTCTT"	9.95839848098103	7.49617574298707	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCAGGAGTTCTCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.53894460005	42.5753853388622	0.0213996239955087	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1980.67512940942	1980.67512940942
"healthy-4"	"2019-08-01-count-4:AGTGACTCATATTCGG"	2.56961669501607	-5.93199875270995	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTCATATTCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.96326732521	47.2674623277604	0.019564644449289	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2410.30661747595	2410.30661747595
"healthy-4"	"2019-08-01-count-2:ACCGTTCGTCGTACAT"	2.00293840941731	-6.21071579372557	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCGTCGTACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.79513931318	49.589678558101	0.0214321820093464	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2309.95852991816	2309.95852991816
"healthy-4"	"2019-08-01-count-4:TCTTCCTCACCGTCGA"	5.45981659468953	-10.1324920884338	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTCCTCACCGTCGA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.17642182797	45.7672707064431	0.0183276080561985	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.84733277221	2494.84733277221
"healthy-4"	"2019-08-01-count-2:CTGTACCCAGCTCCTT"	2.86835803565328	-6.14022924816283	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCCAGCTCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.50401346668	46.2580183285579	0.0218765337090654	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2110.38918215629	2110.38918215629
"healthy-4"	"2019-08-01-count-4:GGTTAACAGTATGAAC"	3.60927929457967	-6.44600536739501	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACAGTATGAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.16426634078	46.828523935756	0.0194618981716371	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2400.97302391912	2400.97302391912
"healthy-4"	"2019-08-01-count-4:AGTAGTCAGCGTGCCT"	-4.30780873718913	-5.47676184093627	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCAGCGTGCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2879.72610628002	52.9886684500623	0.0184005931447807	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2871.01818659522	2871.01818659522
"healthy-4"	"2019-08-01-count-4:CCACAAATCCTCTAAT"	10.9210277992183	6.78119037235109	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAATCCTCTAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.55911211797	45.7543324508407	0.0225439762644279	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.53998647784	2018.53998647784
"healthy-4"	"2019-08-01-count-3:TGTCCTGCACTGATTG"	2.35473026809041	-6.10033752834471	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGCACTGATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.97081818924	46.8862617391089	0.0217673616295899	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2150.18361011663	2150.18361011663
"healthy-4"	"2019-08-01-count-3:CGTGATAGTAGCGTCC"	4.88599886473958	-7.27117588436278	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGATAGTAGCGTCC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.96082897902	38.6755392975693	0.0147957608502785	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.87273767999	2612.87273767999
"healthy-4"	"2019-08-01-count-1:TGCGACGAGCACTCCG"	11.1811377006466	5.30344722354738	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCGACGAGCACTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2118.16212352034	44.0279180836349	0.0207859056654556	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2110.0260124362	2110.0260124362
"healthy-4"	"2019-08-01-count-3:AATGCCATCGGAAACG"	10.8015600639278	7.08101842487184	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCATCGGAAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.78104607198	47.8225769253276	0.0237476547008965	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.82314805685	1998.82314805685
"healthy-4"	"2019-08-01-count-2:TCGTGCTTCGGTGCAC"	6.8668872314388	-1.5661751261917	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTTCGGTGCAC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2503.66090414769	35.7777801686912	0.0142901860668991	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2498.34962039252	2498.34962039252
"healthy-4"	"2019-08-01-count-3:CACTGGGAGCCTCTTC"	11.0652862983638	6.29902312839357	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGAGCCTCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.8858458939	44.9529327931972	0.0221673882108398	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.75569693486	2018.75569693486
"healthy-4"	"2019-08-01-count-4:CTACCCATCCTAGCTC"	2.17634977874104	-6.02916624462279	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCATCCTAGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.45987383813	45.2772972423367	0.0177526012884099	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2544.73091444979	2544.73091444979
"healthy-4"	"2019-08-01-count-3:TGCGACGCATACTTTC"	10.8330475288326	6.69856498325197	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGACGCATACTTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.91194654935	48.5271814271034	0.0242283149345166	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.75735273801	1998.75735273801
"healthy-4"	"2019-08-01-count-4:CACGTTCTCTGGCTGG"	5.00526775893514	-8.10099508678588	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCTCTGGCTGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2994.36759342195	43.9418776756699	0.0146748441214104	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2985.00076509481	2985.00076509481
"healthy-4"	"2019-08-01-count-4:GTAGAGGTCGTTCGCT"	5.03140892562215	-7.39901926433715	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGTCGTTCGCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.36285640466	45.2702104723104	0.0166229080953521	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2718.73709361293	2718.73709361293
"healthy-4"	"2019-08-01-count-3:TACCTCGGTAATTAGG"	1.95399214801137	-6.25043346798094	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTCGGTAATTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2084.49532003727	49.5946759887516	0.0237921743033057	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2080.97637790417	2080.97637790417
"healthy-4"	"2019-08-01-count-3:TTTCATGCAAACACGG"	0.00891124185864326	8.62285897815553	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGCAAACACGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.190428942	28.8587501360054	0.0146999240168249	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.81448822809	1958.81448822809
"healthy-4"	"2019-08-01-count-4:CTACGGGCAGTAGAAT"	0.126460959284943	7.55459306323854	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGCAGTAGAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.36132242804	36.5510520573989	0.0192236223732179	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.7735087996	1895.7735087996
"healthy-4"	"2019-08-01-count-2:CAGTGCGCATGGAAGC"	10.5407406288082	7.4324946173462	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTGCGCATGGAAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.57502520018	45.0528687178084	0.0237298332274534	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1892.09250609193	1892.09250609193
"healthy-4"	"2019-08-01-count-2:TATCCTAGTGCAGATG"	10.681922574609	5.90047977054445	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTAGTGCAGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.59214623224	45.4006079794116	0.0240393925549178	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.94950737487	1886.94950737487
"healthy-4"	"2019-08-01-count-4:GGGTGTCCAAACTAAG"	11.2300707298214	6.04139325702516	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGTCCAAACTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.06148305886	44.21159772002	0.0231466882674464	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1901.72465365161	1901.72465365161
"healthy-4"	"2019-08-01-count-4:TACAACGAGGCCACCT"	-4.00636659088786	12.6375417479309	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACAACGAGGCCACCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2178.25264522489	48.239918340292	0.0221461539119635	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2169.75595039481	2169.75595039481
"healthy-4"	"2019-08-01-count-2:AACAACCGTCTTGCTC"	-0.988017062575179	9.26199243152467	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCGTCTTGCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1814.47250966523	42.6861553040565	0.0235253800080621	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1808.89160990892	1808.89160990892
"healthy-4"	"2019-08-01-count-2:CTTCCTTTCCATTGCC"	-2.54013214531596	9.25199506366578	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTTCCATTGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2097.5565703237	44.9127193177806	0.0214119227834935	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.08242389437	2090.08242389437
"healthy-4"	"2019-08-01-count-4:ACCAACACAACGCATT"	10.368443151086	7.06695220554201	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAACACAACGCATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.35672762157	42.8950315353871	0.0211268448306795	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2015.69898346025	2015.69898346025
"healthy-4"	"2019-08-01-count-3:GAGTCATCAACAGTGG"	3.26037182387654	-6.22899200832518	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATCAACAGTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.78939936663	45.8355277257899	0.0190839079137734	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2392.47450264396	2392.47450264396
"healthy-4"	"2019-08-01-count-4:ATCCTATTCAATCCGA"	2.80599608001057	-6.36522295391234	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCTATTCAATCCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.98112514309	49.1208960598583	0.0219585652769941	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2234.18197345175	2234.18197345175
"healthy-4"	"2019-08-01-count-2:CAACGGCGTAGCGTTT"	-3.93471394005473	-4.54380419170531	"2019-08-01-count-2"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCGTAGCGTTT"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2984.17880944892	38.2893780982724	0.0128307921686982	3185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2972.68357607495	2972.68357607495
"healthy-4"	"2019-08-01-count-3:AAGACAACAGGTTCCG"	4.8501693206722	-7.48591139232787	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAACAGGTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.65413563774	46.3073340199485	0.0195748538733304	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2364.27242393198	2364.27242393198
"healthy-4"	"2019-08-01-count-4:TCAGCAAAGGTATTGA"	11.3108307319576	5.93536946857301	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAAAGGTATTGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2123.95235052543	37.7766192438442	0.0177860012888231	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.90665245277	2117.90665245277
"healthy-4"	"2019-08-01-count-4:GCTGAATCACTCATAG"	3.54495253142659	-6.52376701748046	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGAATCACTCATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.65763562649	45.3956787076338	0.0184411016587531	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2458.92088787669	2458.92088787669
"healthy-4"	"2019-08-01-count-4:ACAAGCTAGTTAGTAG"	5.66029133376424	-10.0966930619446	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTAGTTAGTAG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.55846169161	49.5984935589384	0.0214289223538078	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2307.34868982487	2307.34868982487
"healthy-4"	"2019-08-01-count-4:CCATAAGGTACTAACC"	-0.167712340981323	7.58888528430787	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGGTACTAACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2147.88162872468	41.9678230826694	0.01953916944091	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2139.76784676615	2139.76784676615
"healthy-4"	"2019-08-01-count-2:CTTAGGAAGACGAAGA"	-0.434089223772842	7.83304879749147	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTAGGAAGACGAAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2037.18847499466	48.4749655372772	0.0237950322870369	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2027.52918585199	2027.52918585199
"healthy-4"	"2019-08-01-count-2:TATTTCGTCGCTGACG"	1.64757170256917	-6.78768303310546	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGTCGCTGACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2257.16451007962	44.0508386419269	0.0195160071165451	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2251.89205738556	2251.89205738556
"healthy-4"	"2019-08-01-count-4:AAAGGTATCAGTGGGA"	11.0512205558712	5.90556380832521	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGTATCAGTGGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.98555149954	48.151925115752	0.0248720477683604	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.35495186963	1927.35495186963
"healthy-4"	"2019-08-01-count-3:ATCGTCCAGGGCTAAC"	3.52610721167867	-6.19657232677611	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCAGGGCTAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2570.78606642678	45.0472352261199	0.0175227475418569	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.4062556228	2568.4062556228
"healthy-4"	"2019-08-01-count-4:ACGGAAGCAGAGTGAC"	-2.16595039787944	8.99525163257448	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGAAGCAGAGTGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.30624482584	42.3723009130598	0.020466682655746	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2065.52120124379	2065.52120124379
"healthy-4"	"2019-08-01-count-3:CACCAAACAGACATCT"	11.1137100654537	5.99706790531007	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAACAGACATCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.23480554527	42.7697492499776	0.0221463227191071	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.13154228245	1919.13154228245
"healthy-4"	"2019-08-01-count-2:CATTCCGCACTGGCCA"	-3.59374819222148	-5.45752479946288	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCCGCACTGGCCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3053.76732494591	46.0035574940285	0.0150645260751303	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3041.80182814865	3041.80182814865
"healthy-4"	"2019-08-01-count-2:AGAACCTGTAGGAGTC"	10.750372548669	5.99134204471437	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTGTAGGAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.21592516305	45.3006855398366	0.0242351271086485	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1858.10329235462	1858.10329235462
"healthy-4"	"2019-08-01-count-4:AACACACTCTTTGCAT"	10.4066606956417	5.60653207385866	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACTCTTTGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.04620288318	39.6439345700932	0.0204979252879243	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1922.08967328113	1922.08967328113
"healthy-4"	"2019-08-01-count-4:GGTTAACTCTGCTTAT"	2.29041852530782	-6.01984121715697	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTAACTCTGCTTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2274.84631020884	44.8963786702515	0.0197360052275927	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2270.73628394112	2270.73628394112
"healthy-4"	"2019-08-01-count-2:CTACTATTCCCATTTA"	-2.0258301300114	3.45208737933961	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATTCCCATTTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2897.14928893144	45.8151673622314	0.0158138786762795	4326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2883.64768759833	2883.64768759833
"healthy-4"	"2019-08-01-count-3:TGTCCTGGTCTGTGGC"	6.76482929763143	-1.76535906707915	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGGTCTGTGGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2879.0252303611	33.0430306437548	0.0114771591076367	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2863.58888188636	2863.58888188636
"healthy-4"	"2019-08-01-count-2:AAACGCTAGCTCGTGC"	11.1898132759029	6.47781894290773	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTAGCTCGTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.0282156331	44.0970976893616	0.0217224062945397	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2022.26774614789	2022.26774614789
"healthy-4"	"2019-08-01-count-2:GGGTCTGGTAGTGCGA"	3.70023335990254	-6.43012335216673	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCTGGTAGTGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.60328049538	46.7242282007108	0.0202304129870689	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2305.72614731783	2305.72614731783
"healthy-4"	"2019-08-01-count-4:AGTGTTGCATCCGGTG"	4.71960606154744	-7.61063053524169	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGTTGCATCCGGTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2737.1344684317	38.7488019748036	0.014156703816238	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2729.86288430911	2729.86288430911
"healthy-4"	"2019-08-01-count-4:TATCTGTCACCAACAT"	10.641844411462	6.80740926349489	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTGTCACCAACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2064.96693739769	42.9823641338211	0.0208150374494558	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2056.48793572081	2056.48793572081
"healthy-4"	"2019-08-01-count-2:AGCGTATCACAAAGCG"	4.71278156813924	-6.83467152034911	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATCACAAAGCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2692.06011894461	43.4084176779207	0.0161246093177661	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2688.53227105289	2688.53227105289
"healthy-4"	"2019-08-01-count-4:TTAATCCCATTGAAAG"	11.5678869682247	3.45425555789796	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCCATTGAAAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.14688178137	37.1265921967333	0.0214710459752762	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1722.91223782698	1722.91223782698
"healthy-4"	"2019-08-01-count-4:GACACGCTCTAGACAC"	2.97014607962911	-6.22134687816771	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCTCTAGACAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2779.55582258167	47.2425252589497	0.0169964297443289	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2777.4340776545	2777.4340776545
"healthy-4"	"2019-08-01-count-1:GTAGATCTCCAACCGG"	0.260942553251427	7.68945882404176	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTAGATCTCCAACCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2057.14002266324	50.0248119649441	0.0243176504340139	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2043.80846233824	2043.80846233824
"healthy-4"	"2019-08-01-count-3:ACACTGACACAATTCG"	-3.62554321709331	3.75280759418336	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACTGACACAATTCG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3286.23567130334	42.1656587643189	0.0128309905258852	4532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3269.86264855572	3269.86264855572
"healthy-4"	"2019-08-01-count-3:TGCTTGCTCGTAACAC"	3.75267424163167	-6.29535057460936	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCTCGTAACAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.13297387369	49.7287166598541	0.0206075326963962	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2411.69725099447	2411.69725099447
"healthy-4"	"2019-08-01-count-3:TTGGATGCAGATCACT"	-3.67122230950053	10.463653541449	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGCAGATCACT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2233.62946858984	46.0850635095189	0.0206323672558877	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2222.13278384101	2222.13278384101
"healthy-4"	"2019-08-01-count-4:GCTACAAAGTCGAATA"	-1.76514754715617	4.11568496311036	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAAAGTCGAATA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2886.09241764256	46.7932299863297	0.0162133512081196	4636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2881.2720819275	2881.2720819275
"healthy-4"	"2019-08-01-count-2:CGAGTTATCGTGCGAC"	11.4822632270748	3.53141877734987	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTTATCGTGCGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1997.72697456485	35.940887595166	0.0179908906736341	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.62369877067	1990.62369877067
"healthy-4"	"2019-08-01-count-2:CAACGGCCACCTGCAG"	0.194622878997964	7.81999108875123	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCCACCTGCAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.63177912836	43.7923398312007	0.0218129341677455	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.10315327262	1996.10315327262
"healthy-4"	"2019-08-01-count-3:GTTGCTCCAACTTGGT"	2.25415100631062	-6.61341669475707	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCTCCAACTTGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1877.11680005167	45.5857169911991	0.0242849656398282	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1873.70331372337	1873.70331372337
"healthy-4"	"2019-08-01-count-4:ACCAACAGTCCAAAGG"	11.0727430778438	6.26412675464479	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAACAGTCCAAAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2044.16397834734	46.1511552158701	0.0225770318353728	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2036.37184987508	2036.37184987508
"healthy-4"	"2019-08-01-count-4:GGAATCTCAAGACCGA"	11.1023136573726	5.70974299991456	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTCAAGACCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.90050952642	46.2917357683466	0.024378178601833	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.12140844462	1897.12140844462
"healthy-4"	"2019-08-01-count-4:TGATGGTGTACTGCCG"	11.3002392249996	5.88701579654542	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTGTACTGCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2214.14023974821	36.424358117174	0.0164507909044262	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2211.11516092008	2211.11516092008
"healthy-4"	"2019-08-01-count-2:TTATTGCTCCGATCTC"	5.03668942031209	-7.46601250087889	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTATTGCTCCGATCTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3098.35821104637	40.4626640913109	0.013059388661728	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3093.59912088102	3093.59912088102
"healthy-4"	"2019-08-01-count-4:ATACCGACACAGTGAG"	-2.10344896736797	8.95673177326051	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCGACACAGTGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.06498073104	45.7326481758829	0.0233084268997265	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.0980026664	1952.0980026664
"healthy-4"	"2019-08-01-count-1:CAAGACTGTTAGAAGT"	11.0811335044796	6.19914720142213	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAAGACTGTTAGAAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2283.72928855436	53.3453997951726	0.0233588981244537	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2273.68322590441	2273.68322590441
"healthy-4"	"2019-08-01-count-4:ACTTCCGAGAGTTGCG"	3.40837134894673	-6.33154919063719	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGAGAGTTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.40977589933	47.0948927091675	0.0191566488104854	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2451.58196372304	2451.58196372304
"healthy-4"	"2019-08-01-count-2:ATTCGTTCAGGTGTGA"	-5.06035361710246	-5.60462047969969	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCGTTCAGGTGTGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2684.65185597289	47.1048300979059	0.0175459734166669	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2677.02473207384	2677.02473207384
"healthy-4"	"2019-08-01-count-3:AAGGAATGTAGCACAG"	-3.04553757134135	3.61108038509218	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATGTAGCACAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3175.80651343836	49.9408734586382	0.0157254143938916	4551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3163.13891609381	3163.13891609381
"healthy-4"	"2019-08-01-count-3:GTAACACCATCGCTCT"	-2.6655458015507	8.98105619037477	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACACCATCGCTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2073.38325797025	46.3866119091077	0.0223724252285698	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2066.43392491974	2066.43392491974
"healthy-4"	"2019-08-01-count-2:AGGTTGTTCGTCGCTT"	4.1784893470699	-6.39150764858397	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTTCGTCGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.73012836795	44.7262677512787	0.0167719512655191	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2661.98422506	2661.98422506
"healthy-4"	"2019-08-01-count-2:TACGTCCGTCGGATTT"	2.27146305617635	-6.2380204430786	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGTCCGTCGGATTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.34695374373	43.2182196358879	0.0169859773142562	1951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2541.47394488226	2541.47394488226
"healthy-4"	"2019-08-01-count-4:TGAGTCACACTATCCC"	10.970327993005	6.54979274356691	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGTCACACTATCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2118.75200619507	48.1009309724531	0.0227024827973305	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.83635464836	2104.83635464836
"healthy-4"	"2019-08-01-count-2:ATCACTTAGAGAGTGA"	4.62176479873006	-6.76859571849974	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTAGAGAGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.540070065	45.2885919598673	0.0171123772022674	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2642.4805185187	2642.4805185187
"healthy-4"	"2019-08-01-count-2:CAAGCTATCAAGCGTT"	0.192685251205605	7.71731231296388	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTATCAAGCGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2090.80770203602	41.9860548581142	0.0200812608530323	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2082.04601528347	2082.04601528347
"healthy-4"	"2019-08-01-count-2:GTGCGTGAGTGGTTGG"	10.0620247322017	7.19139192188112	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCGTGAGTGGTTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2169.84047542183	45.5152114069732	0.0209762938439632	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2153.72365916646	2153.72365916646
"healthy-4"	"2019-08-01-count-2:CTCTCGAAGTGCTCGC"	-0.456095258623916	8.07363698566285	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGAAGTGCTCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1968.43612572757	44.9737776966413	0.0228474661223859	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1960.81414085231	1960.81414085231
"healthy-4"	"2019-08-01-count-4:CTCACTGAGTGCGACA"	11.3591734367305	5.96819636905519	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGAGTGCGACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2082.68749606631	42.8359269044994	0.0205676209154787	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2073.41931705581	2073.41931705581
"healthy-4"	"2019-08-01-count-2:CGGTCAGCACCAGTAT"	4.7134219604427	-6.91369917308959	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGTCAGCACCAGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.814567895	43.1034275404119	0.0165158965968903	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2607.6329879547	2607.6329879547
"healthy-4"	"2019-08-01-count-3:TCACGCTAGGTAGTCG"	6.80853809890096	-1.68272104179534	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTAGGTAGTCG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2827.8685284775	38.8169135960329	0.0137265623225177	2291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2809.02383602124	2809.02383602124
"healthy-4"	"2019-08-01-count-2:ATGCCTCCACATTCGA"	-0.560238341719467	8.19116971576539	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCCTCCACATTCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2222.35963569889	38.41265574105	0.0172846262702075	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2222.35963569889	2222.35963569889
"healthy-4"	"2019-08-01-count-3:TTGTGTTGTTCGGTCG"	-5.97494492951091	-2.6198666325775	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTGTTCGGTCG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3141.93122230722	40.0056043179171	0.0127328071454536	3657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3129.40002609502	3129.40002609502
"healthy-4"	"2019-08-01-count-3:TGGGAAGGTGGCAGAT"	-0.243705551058608	7.57573411548463	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAAGGTGGCAGAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.28857511312	41.6707740427184	0.0219749117247266	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1892.42173785847	1892.42173785847
"healthy-4"	"2019-08-01-count-4:TGACTCCTCTCCAAGA"	-0.255905757576782	7.65292069995729	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCTCTCCAAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.40433604616	46.8050720271518	0.0239240279551535	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1948.86753574182	1948.86753574182
"healthy-4"	"2019-08-01-count-1:TCAAGTGAGTAGATCA"	11.197282453149	6.06563708865968	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAAGTGAGTAGATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.87580318689	43.6351929922156	0.0204296490119456	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2125.67935786944	2125.67935786944
"healthy-4"	"2019-08-01-count-3:GTAATGCAGGCACTAG"	11.1529976325924	5.81238839710084	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCAGGCACTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1826.9327248776	44.191507472561	0.0241889079279161	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1819.00312515291	1819.00312515291
"healthy-4"	"2019-08-01-count-2:ACACAGTCAGCAGTCC"	-3.82477603378947	10.9798936613831	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTCAGCAGTCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2189.90803068237	45.9061143444901	0.0209625763736689	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2188.47157712349	2188.47157712349
"healthy-4"	"2019-08-01-count-3:GTCTAGAAGAAGGATG"	2.71729936179463	-6.46674158489379	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTAGAAGAAGGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.27965131854	50.1680287840413	0.0230204640114397	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2172.77907772727	2172.77907772727
"healthy-4"	"2019-08-01-count-1:TCAGCAAGTAACTTCG"	0.481074621050996	7.87125012958375	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGCAAGTAACTTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2112.63821991049	37.2125578691006	0.0176142595160838	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2099.09687955519	2099.09687955519
"healthy-4"	"2019-08-01-count-2:CGCCAGAAGACCGTTT"	4.95799603041951	-7.79105856334838	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGAAGACCGTTT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.17526233144	43.0916324731593	0.0186691336556625	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2303.9415872966	2303.9415872966
"healthy-4"	"2019-08-01-count-3:ATGCATGTCGGCATCG"	3.38606872138326	-6.17148878490599	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCATGTCGGCATCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.53137070128	40.3826308890753	0.0155465421301814	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2591.77564842562	2591.77564842562
"healthy-4"	"2019-08-01-count-3:AATCGACAGTATGCAA"	2.26450409468953	-5.92916633999022	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACAGTATGCAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2562.0349224863	40.7391733052726	0.0159010999216739	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2555.18348106464	2555.18348106464
"healthy-4"	"2019-08-01-count-2:CACATGAGTGCCTTCT"	4.69586147841756	-6.9965710869995	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACATGAGTGCCTTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.27899235839	42.6056286262938	0.0156737512028995	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.53263442114	2712.53263442114
"healthy-4"	"2019-08-01-count-3:CTGAATGGTGTTGATC"	0.336928655474824	7.76605269992677	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAATGGTGTTGATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1679.35535797772	40.2860028442979	0.0239889685365998	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1677.8216108361	1677.8216108361
"healthy-4"	"2019-08-01-count-2:CTCAGAAAGGTACTGG"	0.594804008572739	7.98445079410402	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGAAAGGTACTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.39418532268	43.7827141813821	0.0242108244633455	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1801.0812976113	1801.0812976113
"healthy-4"	"2019-08-01-count-4:AGAGCAGAGATACGAT"	5.66734804686849	-9.73059561168822	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGAGATACGAT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.85398589067	42.8504132143455	0.015924466150534	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2683.15440890096	2683.15440890096
"healthy-4"	"2019-08-01-count-4:TTTCGATGTTCATCTT"	11.9809729057247	-3.29824497615965	"2019-08-01-count-4"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCGATGTTCATCTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2585.5975856136	36.7123261687937	0.0141987780206259	3821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2578.67082508328	2578.67082508328
"healthy-4"	"2019-08-01-count-2:GCTTGGGAGTCACGCC"	-3.2569149536198	-6.35538484966429	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	56	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTGGGAGTCACGCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2238.06062034018	51.7455109014248	0.0231206922775664	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2231.25644163637	2231.25644163637
"healthy-4"	"2019-08-01-count-3:GTTATGGAGCGTATAA"	-3.77421031418498	10.7341317900452	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTATGGAGCGTATAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.28721508664	46.56619950159	0.0229697100416035	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2018.95847809989	2018.95847809989
"healthy-4"	"2019-08-01-count-4:TTCTTGAGTATTTCCT"	-3.46615443649943	10.6543407210144	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGAGTATTTCCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2176.9000918552	44.880001257023	0.0206164726736611	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2168.98772672512	2168.98772672512
"healthy-4"	"2019-08-01-count-4:CGCATAAAGTATAACG"	0.136600655584973	7.88408324802247	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATAAAGTATAACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1964.55213815178	42.914395796308	0.021844365930996	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1957.70020225523	1957.70020225523
"healthy-4"	"2019-08-01-count-3:AGAGAGCTCCCTTCCC"	-1.62206874314006	3.72645018184511	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAGCTCCCTTCCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2918.51611294441	43.5811642281642	0.0149326447213602	4612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2913.57609687299	2913.57609687299
"healthy-4"	"2019-08-01-count-2:CGCCATTTCAACCTTT"	0.217061643570107	7.65613267505494	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCATTTCAACCTTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.64676651938	48.5813519914043	0.0242464653965914	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1993.41401761391	1993.41401761391
"healthy-4"	"2019-08-01-count-4:CTCAGTCGTCACAATC"	-3.82304559174235	12.2094526060852	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTCACAATC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2027.40691190139	38.9117012165565	0.0191928423387209	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2016.20567994316	2016.20567994316
"healthy-4"	"2019-08-01-count-3:GAGTCTAAGATTAGTG"	-2.47562466087993	3.39487383449403	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTAAGATTAGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3008.56285511738	49.3031609714183	0.0163876120745015	4136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2999.51183206163	2999.51183206163
"healthy-4"	"2019-08-01-count-2:AAAGGGCCACCTAAAC"	-1.38079045239146	8.65725419605104	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGGCCACCTAAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2263.29048275182	45.3166857011502	0.0200224787964697	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2253.74818224654	2253.74818224654
"healthy-4"	"2019-08-01-count-4:AGCTCAAGTGGAGAAA"	-1.65441427651103	8.56222245776979	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTCAAGTGGAGAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2104.79288157306	43.7016702307974	0.0207629314092587	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2101.65472616709	2101.65472616709
"healthy-4"	"2019-08-01-count-4:TTCCTAAAGAATTGCA"	11.2582870918209	4.96800134265748	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTAAAGAATTGCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2157.22277010746	41.3084526204594	0.0191489044121307	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2151.53520000031	2151.53520000031
"healthy-4"	"2019-08-01-count-2:CACAACAAGAACTGAT"	-3.01784787598308	9.34015176380006	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAACAAGAACTGAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1852.85983242827	38.5903972742841	0.0208274779337784	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1846.76427120423	1846.76427120423
"healthy-4"	"2019-08-01-count-3:AAAGAACTCTCTATAC"	2.763843913644	-6.18249084865721	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGAACTCTCTATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.01123088559	44.2865127272766	0.0187019859321843	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2360.08922496888	2360.08922496888
"healthy-4"	"2019-08-01-count-3:GTGAGCCGTATCGATC"	10.3910032707149	6.29805371845094	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGCCGTATCGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1799.89687625056	44.1659634399062	0.0245380521643608	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1794.75824743852	1794.75824743852
"healthy-4"	"2019-08-01-count-4:CAGCCAGCAGTCCCGA"	11.1290413337642	5.91032073581544	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGCAGTCCCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.35729251874	45.4252846682093	0.0223290593226955	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2024.15529439317	2024.15529439317
"healthy-4"	"2019-08-01-count-4:CAGAGCCGTCACCACG"	1.18748893317525	-6.08442165767821	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCGTCACCACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2879.34399798259	43.5732603519715	0.0151330512722693	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2875.02588171608	2875.02588171608
"healthy-4"	"2019-08-01-count-2:GTGCGTGAGTTGAATG"	-2.50364480438884	9.4736232527527	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCGTGAGTTGAATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2069.96943409778	45.195407958933	0.021833852816591	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2065.08399123349	2065.08399123349
"healthy-4"	"2019-08-01-count-2:CTTTCAACACCGCTAG"	10.7904592948848	5.79633853519288	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAACACCGCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2069.89650158298	44.6259099693051	0.0215594885711323	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2055.69591125988	2055.69591125988
"healthy-4"	"2019-08-01-count-4:CAACCAAAGCGAGTCA"	2.0549131828243	-6.06603195583495	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCAAAGCGAGTCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2418.10704346053	43.1613735147964	0.0178492402276074	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2416.85551969956	2416.85551969956
"healthy-4"	"2019-08-01-count-3:TGTCCTGAGCCGATCC"	-2.66493425789531	3.54699108684389	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGAGCCGATCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2984.93311846347	45.5680885928798	0.0152660333697314	4995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2979.1051119767	2979.1051119767
"healthy-4"	"2019-08-01-count-4:CGCCATTTCTGAGAGG"	2.98239936408345	-6.25791599666747	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTTCTGAGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.70638809033	48.5258620275046	0.0195219605420836	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2477.74945236753	2477.74945236753
"healthy-4"	"2019-08-01-count-2:AGGCTGCGTCGATTTG"	11.196022649377	5.80527064884035	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCGTCGATTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1857.83444365844	47.567267404773	0.0256036093889528	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1854.11132307019	1854.11132307019
"healthy-4"	"2019-08-01-count-2:AACCACACAGCGTGAA"	5.60942425307576	-10.0753402940002	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCACACAGCGTGAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2734.24416878226	47.1830773318109	0.0172563510861668	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2724.42014825538	2724.42014825538
"healthy-4"	"2019-08-01-count-4:ATGGTTGTCCATGCAA"	-4.45619426193889	12.4792880781922	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGTTGTCCATGCAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2440.64691544484	46.4290689564718	0.0190232633252523	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2431.71902108881	2431.71902108881
"healthy-4"	"2019-08-01-count-2:CGGAATTTCTGCGGAC"	11.0771948295528	6.0464730032715	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTTCTGCGGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1894.76861661573	46.7320146540671	0.0246637052378119	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.82805765891	1886.82805765891
"healthy-4"	"2019-08-01-count-2:ACATCCCAGGTTCATC"	3.53237523612325	-6.215931438562	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGGTTCATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.05128280845	51.3360797494622	0.0192338304176175	2155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2664.58439642787	2664.58439642787
"healthy-4"	"2019-08-01-count-2:TCATTACCAAGCAATA"	-2.31216559830363	8.95448396289674	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACCAAGCAATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2267.73133948181	51.2445040788836	0.0225972553215203	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2260.17720991635	2260.17720991635
"healthy-4"	"2019-08-01-count-2:TCATTACCATCCGTTC"	11.4884239631588	4.51466701114503	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACCATCCGTTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2380.98968930158	41.0754085019276	0.0172514012498628	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2362.4522904231	2362.4522904231
"healthy-4"	"2019-08-01-count-3:TGTAAGCCAACCAACT"	9.9684587913448	8.07539270007936	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAAGCCAACCAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2334.21066241944	50.8154095577485	0.0217698472446689	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2330.15132156154	2330.15132156154
"healthy-4"	"2019-08-01-count-2:CTGCCTAAGCAGGCAT"	4.12510265883748	-6.39318849956664	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTAAGCAGGCAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2828.39783813076	43.8568094750989	0.015505884244376	2164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2824.06463097897	2824.06463097897
"healthy-4"	"2019-08-01-count-2:CACGTGGTCCTTCAGC"	10.5332905250484	7.55284736240236	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGTCCTTCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1947.58995067992	45.5214427169092	0.023373217088647	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.21968632428	1940.21968632428
"healthy-4"	"2019-08-01-count-3:TTCTTCCCAACGGTAG"	10.1377197700435	7.65961740100709	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTCCCAACGGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.92549022857	43.1110665400487	0.0228109873976221	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1885.96277302539	1885.96277302539
"healthy-4"	"2019-08-01-count-3:ATCGGATGTACAGTAA"	-1.89356503906901	8.98027989948121	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGATGTACAGTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1830.2396870465	36.6102721578617	0.0200029932784053	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1824.99061961531	1824.99061961531
"healthy-4"	"2019-08-01-count-4:AATCGACAGCACTGGA"	-1.07592390003856	8.76521298969118	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCGACAGCACTGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.28243140313	44.1929880273651	0.0218314338660405	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2012.6494435317	2012.6494435317
"healthy-4"	"2019-08-01-count-3:GCTACAAGTACTGGGA"	4.33536209639851	-6.69499256527098	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAAGTACTGGGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.67793518865	44.6640070889668	0.0174900704875563	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2551.28561814554	2551.28561814554
"healthy-4"	"2019-08-01-count-3:GCTACAATCACGTAGT"	0.14546781507079	7.86945245349733	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAATCACGTAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.35593619807	45.3133027410168	0.0230443033770527	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1955.77764077345	1955.77764077345
"healthy-4"	"2019-08-01-count-3:TATATCCGTCACTGAT"	1.97577335414235	-6.27310659801634	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCGTCACTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.5475904711	44.4048744392089	0.0174647171229472	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2537.97255774894	2537.97255774894
"healthy-4"	"2019-08-01-count-3:GGCAGTCCATACTTTC"	2.57574548301045	-6.32103111660155	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCAGTCCATACTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.40355368176	49.9657161908924	0.0243806136185959	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2046.50977696672	2046.50977696672
"healthy-4"	"2019-08-01-count-2:ATTTCACGTATCGTGT"	4.50336279448811	-6.64163639461669	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCACGTATCGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2684.16471081285	40.7899148961605	0.0151965021862641	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2677.19188617522	2677.19188617522
"healthy-4"	"2019-08-01-count-2:CTAACCCGTCGCGTTG"	11.2745233970577	5.8938908346924	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACCCGTCGCGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1799.99553220147	40.6045611021328	0.02255814549299	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1793.19058184352	1793.19058184352
"healthy-4"	"2019-08-01-count-4:AGGAGGTAGTTAGTGA"	4.51694454726521	-6.73707678234252	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTAGTTAGTGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2905.75737397624	46.0836063218897	0.0158594130172778	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2899.02199256581	2899.02199256581
"healthy-4"	"2019-08-01-count-3:CTGCGAGTCCATTTAC"	3.1726299720699	-6.13996174251708	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCGAGTCCATTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.96106642972	44.7183369736895	0.017407168040829	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2564.92834548961	2564.92834548961
"healthy-4"	"2019-08-01-count-4:CCTGTTGCATTCTCTA"	-5.42915282669719	-5.55050184642943	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGTTGCATTCTCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3219.17907675284	51.3490693200382	0.0159509825628693	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3214.63661194242	3214.63661194242
"healthy-4"	"2019-08-01-count-3:GGCTTGGAGAGCCGAT"	4.25091375884358	-7.07583334362181	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTGGAGAGCCGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.78201680263	40.1501226513824	0.0168148190952311	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2386.42268609058	2386.42268609058
"healthy-4"	"2019-08-01-count-2:AGTTCGAAGGGAGGAC"	11.4622189002926	3.59911797130433	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCGAAGGGAGGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.83934054599	40.9528554047216	0.0203559273244987	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1999.12306330987	1999.12306330987
"healthy-4"	"2019-08-01-count-1:GCACATATCTTGCGCT"	0.579633136361283	8.24935147846071	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCACATATCTTGCGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2065.39842638703	50.8335632941293	0.0246119889725353	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2050.50534318426	2050.50534318426
"healthy-4"	"2019-08-01-count-4:GTGAGGACAATTGCGT"	-0.557149390608627	7.94269797885744	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGACAATTGCGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.55090252386	44.6166619026088	0.0233405565311918	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.23413322824	1902.23413322824
"healthy-4"	"2019-08-01-count-2:CTGGACGCAGCGTGAA"	4.18145479735677	-6.61304857647093	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGACGCAGCGTGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.04757906063	47.4480416914832	0.019777866060523	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2390.01943200879	2390.01943200879
"healthy-4"	"2019-08-01-count-4:CACTGGGGTGTGCTTA"	-2.06850657883342	9.36547849262086	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGGTGTGCTTA"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1913.30427777969	48.4194648235931	0.0253067248037421	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.37194005378	1906.37194005378
"healthy-4"	"2019-08-01-count-4:CATCCGTAGTTCTCTT"	-0.351838449866134	7.85229013049928	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTAGTTCTCTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2044.88408184207	44.7196298882433	0.0218690292938067	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2041.06029909964	2041.06029909964
"healthy-4"	"2019-08-01-count-4:TGCGGCACAAAGGAGA"	3.24049725112264	-6.16004898464354	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGCACAAAGGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2683.96258356649	44.2169852754988	0.0164745162791139	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2677.9261629494	2677.9261629494
"healthy-4"	"2019-08-01-count-3:ATTCACTCACAGCCAC"	-2.99079356613811	3.65624425494996	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTCACAGCCAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3419.32248503878	46.5241482688927	0.0136062475746171	5291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3409.51733632077	3409.51733632077
"healthy-4"	"2019-08-01-count-2:AGACCCGCACCTGAAT"	3.15877236899678	-6.30789616024169	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGCACCTGAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.98777354649	40.7038073196633	0.0153022535383289	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2653.08961299102	2653.08961299102
"healthy-4"	"2019-08-01-count-3:AAGACTCAGGCTTAAA"	0.0688326611066281	7.89223096454469	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCAGGCTTAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.31168295577	45.0804575462704	0.0223246653435312	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2010.62408652671	2010.62408652671
"healthy-4"	"2019-08-01-count-4:CTCCGATTCGCATAGT"	-2.44159708443339	9.09931848132936	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATTCGCATAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2126.63187317607	47.1802946137073	0.022185454477951	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2123.11056639491	2123.11056639491
"healthy-4"	"2019-08-01-count-3:CTAGACAGTCGACTGC"	-0.287147859961349	7.55092332446901	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAGTCGACTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.09980656889	44.2762049368149	0.0219286856413772	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2009.33544054145	2009.33544054145
"healthy-4"	"2019-08-01-count-2:TGAGGAGCATTCCTAT"	10.5921226936275	6.78529164874879	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGAGCATTCCTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1984.70554956865	46.2915157151295	0.023324122676631	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1980.09015832196	1980.09015832196
"healthy-4"	"2019-08-01-count-2:TGAGGAGCACGACCTG"	10.4531752067501	7.63960454547731	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGAGCACGACCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1842.95699712051	42.1427970905201	0.0228669454340851	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1835.57970196575	1835.57970196575
"healthy-4"	"2019-08-01-count-2:AAACCCAAGTATGAGT"	3.91858496245686	-7.00002529537352	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACCCAAGTATGAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.44685547137	46.1987283048855	0.0206942119099766	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2226.36232925947	2226.36232925947
"healthy-4"	"2019-08-01-count-2:ATTCAGGCACATGGTT"	3.89363970336263	-6.51646091854247	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCAGGCACATGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.70407495198	44.391468577355	0.0171481433536116	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.76947387691	2584.76947387691
"healthy-4"	"2019-08-01-count-4:ATTCACTTCAGTCTTT"	11.5816265541012	3.86237285220949	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTTCAGTCTTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2158.86077859207	34.9373868942019	0.016183251481824	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2144.4303516375	2144.4303516375
"healthy-4"	"2019-08-01-count-4:AGTGCCGTCCATTCAT"	-3.2263597053593	10.7561597594055	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGTCCATTCAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1850.07282931277	44.4364157214266	0.0240187386233509	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1844.4700320055	1844.4700320055
"healthy-4"	"2019-08-01-count-4:ATTCACTTCTGAGAGG"	10.2055221992428	6.97162196719972	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCACTTCTGAGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.41666270938	43.2010764771866	0.0222065932225647	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.36343162089	1937.36343162089
"healthy-4"	"2019-08-01-count-4:AGGCATTTCCTTCGAC"	4.72214331206624	-7.10422708904418	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTTCCTTCGAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.92374412105	47.0960683548276	0.0178670071392872	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2632.67128238561	2632.67128238561
"healthy-4"	"2019-08-01-count-4:ATTCAGGGTACTCAAC"	2.42121924933736	-5.97671034252318	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCAGGGTACTCAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.18240560739	46.4182379792404	0.0179001052447632	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.17709710117	2589.17709710117
"healthy-4"	"2019-08-01-count-2:CATACCCCAAGAAACT"	4.41494383391683	-6.68371107494506	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCCAAGAAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2684.26270462624	46.7334753443355	0.0174101719864422	2032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2678.53591950776	2678.53591950776
"healthy-4"	"2019-08-01-count-4:CGGTCAGAGTCATAGA"	-0.0185461220448792	7.83333537662355	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGTCAGAGTCATAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2231.79453062982	41.975140228325	0.0188077977843594	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2222.57533583712	2222.57533583712
"healthy-4"	"2019-08-01-count-4:TATCTGTTCATGCCGG"	-0.303284476429778	7.8637485274109	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTGTTCATGCCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2120.71906603087	39.6516130515443	0.0186972492899572	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2118.1524497144	2118.1524497144
"healthy-4"	"2019-08-01-count-2:TCCATCGGTCGTTATG"	3.78290905532185	-6.84439852153929	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATCGGTCGTTATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.95539119987	49.4046155092931	0.0206804261357427	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2388.95539119987	2388.95539119987
"healthy-4"	"2019-08-01-count-4:TATCTTGAGGTTTGAA"	10.2938314872677	6.22629401767579	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGAGGTTTGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.80666567803	44.0429733121393	0.0237197410620327	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.76991804822	1851.76991804822
"healthy-4"	"2019-08-01-count-2:GGAGGTATCGTCTCAC"	3.69304909285848	-6.54219868099364	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTATCGTCTCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.71401014532	44.1715527198031	0.0198996593786022	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2212.0607711959	2212.0607711959
"healthy-4"	"2019-08-01-count-3:CATTCATTCGCGCCAA"	-0.162574808031875	7.94845674121705	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATTCGCGCCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1995.52224257656	43.3970505261831	0.021747214638986	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.07670287262	1992.07670287262
"healthy-4"	"2019-08-01-count-3:GTGTAACAGTGGACGT"	4.55703367766683	-6.65840246593627	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTAACAGTGGACGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.68437504873	40.8304914762917	0.0158154466405371	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2576.65785174278	2576.65785174278
"healthy-4"	"2019-08-01-count-3:TGTGCGGGTTCGTAAC"	3.81453194197957	-7.22144367611083	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGCGGGTTCGTAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1711.5420050975	49.3120285245467	0.0288114626329241	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1707.16891615832	1707.16891615832
"healthy-4"	"2019-08-01-count-3:TGTGATGTCTCTCGCA"	10.6786467033321	6.30251977527467	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGATGTCTCTCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1920.17020700468	44.2491557585719	0.0230443924174812	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1913.81261051817	1913.81261051817
"healthy-4"	"2019-08-01-count-3:TATTCCATCACCCTCA"	5.24987139281575	-8.58247854625853	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCATCACCCTCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3021.88708590745	45.3296417260412	0.0150004419216839	2556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3011.26007776295	3011.26007776295
"healthy-4"	"2019-08-01-count-2:ATAGAGATCCCAACTC"	10.8653999763424	6.70317075336305	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGATCCCAACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.78017179663	45.2490561933321	0.0220750775209574	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2041.60355608975	2041.60355608975
"healthy-4"	"2019-08-01-count-3:AAACGAAGTCAACCAT"	10.9329220252926	6.29131219470827	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGAAGTCAACCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1823.78871896989	43.8984183446571	0.0240699034312766	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1820.11977958131	1820.11977958131
"healthy-4"	"2019-08-01-count-4:TGCATGAGTAGCTTGT"	-4.23601899567302	-5.71598150646361	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGAGTAGCTTGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2537.03423241535	42.4148171258217	0.0167182675676556	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2534.68685896993	2534.68685896993
"healthy-4"	"2019-08-01-count-4:CGAGGAAAGTCTAACC"	10.4180637794429	7.55688378894655	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAAAGTCTAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.38165096826	45.4206355914815	0.0224812156503767	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2013.5978455933	2013.5978455933
"healthy-4"	"2019-08-01-count-2:AAAGGATGTGCCTACG"	0.488783975213212	7.78352735126344	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATGTGCCTACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.00664410558	34.1478555555393	0.0189815060813835	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1791.58528794976	1791.58528794976
"healthy-4"	"2019-08-01-count-2:CAGATACAGAACCGCA"	9.95777287062947	6.2158837088379	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATACAGAACCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.55709762611	44.0303938240415	0.0236524541096214	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.95828585716	1851.95828585716
"healthy-4"	"2019-08-01-count-2:GTCTAGAAGCAGTAAT"	10.3295656639034	7.57936952197877	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTAGAAGCAGTAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.93005883354	42.0058894687979	0.02067290125769	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2029.15225791453	2029.15225791453
"healthy-4"	"2019-08-01-count-4:CTCAATTAGGGATCTG"	2.23252286490743	-6.08348276531371	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAATTAGGGATCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.10427799947	48.6451116922124	0.0202848191959329	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2392.44025741148	2392.44025741148
"healthy-4"	"2019-08-01-count-4:CGAGGAACAAGTGACG"	-3.90371451798137	12.9727086790833	"2019-08-01-count-4"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAACAAGTGACG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2170.65904190659	45.7694991385479	0.0210855312856258	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2167.1088020462	2167.1088020462
"healthy-4"	"2019-08-01-count-3:TAAGTCGAGTACTGGG"	10.5339685874874	6.3593768843445	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGAGTACTGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.79677963286	43.0683093388894	0.0226223249244045	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.66049228934	1893.66049228934
"healthy-4"	"2019-08-01-count-2:AAGACTCCAATTCGTG"	-0.776150385767776	8.33456037128297	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCCAATTCGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1864.31415625789	45.9210438445364	0.0246316017557419	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1857.93113510188	1857.93113510188
"healthy-4"	"2019-08-01-count-4:AAAGGGCCATACACCA"	10.2499004798824	7.42812345111696	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGGCCATACACCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.70086610932	44.7107560327173	0.0220826477536081	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2020.18239191536	2020.18239191536
"healthy-4"	"2019-08-01-count-4:AAAGGGCTCTGAGAGG"	10.8368565040523	5.73488090122072	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGGGCTCTGAGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.28420592586	44.1517507456373	0.0229683782499642	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.02514413165	1917.02514413165
"healthy-4"	"2019-08-01-count-4:CCTTTGGGTAACTAAG"	0.512413610785645	7.82334182346193	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGGTAACTAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.82840828808	37.6984031206877	0.0217303353695298	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1727.78440058073	1727.78440058073
"healthy-4"	"2019-08-01-count-4:CATGCCTCATCTGTTT"	11.2442051368648	6.01346776569215	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTCATCTGTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2065.32698607197	45.917874361529	0.022232738288507	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2052.96135988228	2052.96135988228
"healthy-4"	"2019-08-01-count-3:GGGATGACACTGCTTC"	4.84581484374349	-7.23288919841918	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATGACACTGCTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2828.78649611211	40.9759335329876	0.0144853397700056	2550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2822.12480481614	2822.12480481614
"healthy-4"	"2019-08-01-count-3:TATCTGTTCTTAGCCC"	4.22650494155232	-6.39711239254149	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTTCTTAGCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2865.2077518024	42.8849476263508	0.014967482759103	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2856.48562505789	2856.48562505789
"healthy-4"	"2019-08-01-count-4:CTCACTGAGCAAATGT"	11.3471895652706	4.94578120792238	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGAGCAAATGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2058.57842143541	40.7787850841115	0.0198091968027514	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2046.67211008811	2046.67211008811
"healthy-4"	"2019-08-01-count-3:ACGTCCTAGTACTCGT"	-0.0362259027665437	7.80934617603151	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTAGTACTCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.28318041636	40.6313420994378	0.0208228833760398	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.87001778529	1945.87001778529
"healthy-4"	"2019-08-01-count-3:TCAAGCAAGGGCAATC"	5.06046309050862	-7.52921774303588	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGCAAGGGCAATC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2800.24346394697	43.0812466710815	0.0153848217934443	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2795.48388349568	2795.48388349568
"healthy-4"	"2019-08-01-count-3:ACACAGTCAGAAATCA"	2.63014878806416	-5.87856342708739	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACAGTCAGAAATCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.46955982562	42.938417314903	0.0158183454883397	2315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.02202931726	2712.02202931726
"healthy-4"	"2019-08-01-count-3:TGTTCTACAATCCTTT"	3.50717701491658	-6.80891420757445	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCTACAATCCTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.77301032838	47.1340880046003	0.0215050042967444	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2185.68848788082	2185.68848788082
"healthy-4"	"2019-08-01-count-3:TGTTCCGTCCTTCTAA"	10.5559708076412	6.44795224750368	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGTCCTTCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.42312822328	45.4815684655171	0.0235238566258967	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1926.58491538866	1926.58491538866
"healthy-4"	"2019-08-01-count-3:ACGTTCCAGGTACAAT"	11.3002602058345	5.09434173190919	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTTCCAGGTACAAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2257.88953659547	42.3023063412832	0.0187353303408581	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2241.84403777963	2241.84403777963
"healthy-4"	"2019-08-01-count-2:CCGATCTCACACGGTC"	6.67361082610433	-1.66739215767058	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATCTCACACGGTC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3162.38335027997	42.0935688258933	0.0133107103609582	2659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3154.06656767105	3154.06656767105
"healthy-4"	"2019-08-01-count-2:CAGATTGTCGAACCTA"	-3.30789552155193	-5.25952246105345	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGTCGAACCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2882.79030780092	45.230931067406	0.0156899830504528	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2871.18785967857	2871.18785967857
"healthy-4"	"2019-08-01-count-2:GTCTTTAAGCATGCAG"	6.78963388976399	-1.71882738983306	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTTTAAGCATGCAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2918.54425050661	36.3613324111585	0.0124587223252986	2376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2900.11664817238	2900.11664817238
"healthy-4"	"2019-08-01-count-3:TCAATCTAGTGCCGAA"	10.9663702445919	5.27113006198732	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTAGTGCCGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.76998828197	42.8950606958642	0.0228193135134946	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1870.1801095902	1870.1801095902
"healthy-4"	"2019-08-01-count-4:CCTCAGTGTCGCTTAA"	11.0299040275509	6.19408080661622	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTGTCGCTTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1818.84946009768	41.4897217884793	0.0228109707255547	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1816.94335111889	1816.94335111889
"healthy-4"	"2019-08-01-count-3:GAGGCAAGTCACAATC"	10.8988825279171	6.45925281131593	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAAGTCACAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1813.86226000062	42.3504234618901	0.0233482025597002	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1808.34791705562	1808.34791705562
"healthy-4"	"2019-08-01-count-4:AAAGTGAGTGACATCT"	3.3784290748531	-6.07160189067992	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGAGTGACATCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.86623954688	42.4276648453893	0.0162193556398123	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2607.80765606941	2607.80765606941
"healthy-4"	"2019-08-01-count-3:GTTACGAAGTGTAGAT"	-0.132338802248794	7.61146495426027	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGAAGTGTAGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.78391563963	40.9627037968483	0.0217333687203857	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1879.27797125164	1879.27797125164
"healthy-4"	"2019-08-01-count-2:TCCGGGATCGAACTCA"	-0.166327978402931	7.80827949130861	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGATCGAACTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.30952583592	38.1400573045387	0.0203814798022265	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.88712490135	1866.88712490135
"healthy-4"	"2019-08-01-count-4:CGATGCGGTGGTATGG"	10.8106056648189	7.4944071539673	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGCGGTGGTATGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.73510616862	44.593079305769	0.0229892623812174	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.03479434647	1923.03479434647
"healthy-4"	"2019-08-01-count-2:AACAAAGGTCTGTAGT"	10.3604027229244	6.13369462573854	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGGTCTGTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.55595849573	39.5941672606521	0.0208548855689371	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.72343220819	1889.72343220819
"healthy-4"	"2019-08-01-count-2:CGTTGGGCAACCAACT"	10.3613039451534	7.11933229053346	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGCAACCAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1883.73513652005	44.5005805063045	0.0236235868002724	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1872.98187673554	1872.98187673554
"healthy-4"	"2019-08-01-count-3:TCAATTCCAGGGTTGA"	0.188044284551781	7.86034343326417	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCCAGGGTTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1471.04015841005	42.7661614674776	0.0290720557307563	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1464.27520521466	1464.27520521466
"healthy-4"	"2019-08-01-count-2:CGTTGGGGTGGTTTGT"	10.2212816673214	6.48722217166749	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGGTGGTTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.28402240711	51.6728595403399	0.0271493160936582	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1887.70975104494	1887.70975104494
"healthy-4"	"2019-08-01-count-2:ATGGAGGGTTAGCGGA"	-3.10459933701213	10.3145417937073	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGGTTAGCGGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2031.31501786082	47.1926691682579	0.023232570405528	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2023.72123735941	2023.72123735941
"healthy-4"	"2019-08-01-count-2:GGGAAGTGTCGTTGCG"	-3.05085096779521	9.41230294788209	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAAGTGTCGTTGCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.95003035514	45.2174738646623	0.0236995063525042	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.26649842036	1906.26649842036
"healthy-4"	"2019-08-01-count-4:AGCGTATAGGTACAGC"	4.28343929824178	-7.01812651073607	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGTATAGGTACAGC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.1841792386	43.8935493911847	0.0169069474123587	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2591.23204555369	2591.23204555369
"healthy-4"	"2019-08-01-count-3:CTTCCTTAGTCCTACA"	-0.179490516812164	7.81581494891969	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTAGTCCTACA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2318.37760860046	42.341135918158	0.0182632612397072	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2312.12198474627	2312.12198474627
"healthy-4"	"2019-08-01-count-4:GTGTGGCAGAAACTGT"	5.09337915953938	-7.49471189891966	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTGGCAGAAACTGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.88734640063	46.4308396014559	0.017254843337668	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2686.02287318731	2686.02287318731
"healthy-4"	"2019-08-01-count-3:TTTACCATCGCCGAAC"	4.54003634032552	-7.48497679149779	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCATCGCCGAAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.75464609892	50.741414601608	0.0219303350453169	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2310.72014725254	2310.72014725254
"healthy-4"	"2019-08-01-count-4:AGCTACAAGAAACTCA"	0.174368192523164	7.67005107486574	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTACAAGAAACTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.54364504874	41.117661765615	0.0221235922412447	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1850.54717485452	1850.54717485452
"healthy-4"	"2019-08-01-count-4:CACGAATTCCTAACAG"	10.2573887306148	7.69077203357545	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGAATTCCTAACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.02081681184	43.2955062743522	0.0210886835242062	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.69767192425	2043.69767192425
"healthy-4"	"2019-08-01-count-1:TCCCAGTAGTAAGAGG"	-0.0921047431534112	7.53250501239625	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCCAGTAGTAAGAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2221.17639518769	34.8626651003279	0.0156955859858136	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2203.45201208288	2203.45201208288
"healthy-4"	"2019-08-01-count-4:GGGCTACAGCTGCCTG"	3.12860955771748	-6.06359436428221	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACAGCTGCCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2678.55542901527	46.5792961902375	0.0173897077826617	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2673.07109069105	2673.07109069105
"healthy-4"	"2019-08-01-count-2:GTGAGTTTCGACCAAT"	4.39696278151814	-6.81169607555541	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTTCGACCAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.59457082756	46.0615232968527	0.0187196720024303	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2453.28148797924	2453.28148797924
"healthy-4"	"2019-08-01-count-3:TTAATCCTCACTTGGA"	3.86183371123616	-7.02950289165648	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAATCCTCACTTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.26008884224	49.0475242760273	0.021378362686324	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2288.57772682855	2288.57772682855
"healthy-4"	"2019-08-01-count-3:GGAGCAACATCCGGCA"	-6.71527371826823	1.43304941737977	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAACATCCGGCA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2730.95727421959	48.9364358605916	0.0179191510327	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2716.77196420449	2716.77196420449
"healthy-4"	"2019-08-01-count-4:ACGTAGTAGCGACATG"	3.97084917601888	-6.89173986828002	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTAGCGACATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.75373906354	46.8544703567298	0.0217245341960431	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2153.16377183709	2153.16377183709
"healthy-4"	"2019-08-01-count-3:TACCCGTAGCTAGCCC"	-4.25418792191203	12.5424394377503	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTAGCTAGCCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2349.66080461178	45.2178818512604	0.019244429562986	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2346.17471947536	2346.17471947536
"healthy-4"	"2019-08-01-count-4:ACGCACGCACCAGACC"	10.5899979072506	7.10198495471803	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGCACCAGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.47831648237	42.4412773686124	0.0211626707802331	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1994.04808133281	1994.04808133281
"healthy-4"	"2019-08-01-count-4:GTACAACCAGCAGGAT"	10.2641426521236	7.27545545184938	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAACCAGCAGGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2077.55024314889	44.7777626623573	0.0215531551210472	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2067.96297164966	2067.96297164966
"healthy-4"	"2019-08-01-count-4:GGGCTCAGTTAGTTCG"	10.578892369836	6.64812371814577	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTCAGTTAGTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1855.85647803008	39.5190629457645	0.0212942452251009	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1844.89503624666	1844.89503624666
"healthy-4"	"2019-08-01-count-4:CATGCCTTCCAGCTCT"	11.7463165718013	3.78533003414003	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCCTTCCAGCTCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2666.74131868964	33.2946897256325	0.0124851591312173	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2651.8160650734	2651.8160650734
"healthy-4"	"2019-08-01-count-2:GTGCTGGAGTTGCTCA"	2.36554469641988	-6.31294157421263	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGAGTTGCTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.46214013143	48.3995713261346	0.0202808879773257	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2380.09273654274	2380.09273654274
"healthy-4"	"2019-08-01-count-3:TACCCGTCAGGACATG"	10.7919804054195	7.25542161548463	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTCAGGACATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.53337433712	48.0685558361745	0.0241001511705212	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1985.67470568587	1985.67470568587
"healthy-4"	"2019-08-01-count-4:AGTAGTCAGTGTGTTC"	11.3489729362423	4.77053449237672	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGTCAGTGTGTTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.34578767173	42.4466512833037	0.0193789727275999	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2182.14475074586	2182.14475074586
"healthy-4"	"2019-08-01-count-2:GTGCAGCGTTTCGTTT"	10.5214115577633	7.34265229785768	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCAGCGTTTCGTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.75256641439	45.8818746962116	0.0230475024723193	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1985.02892502947	1985.02892502947
"healthy-4"	"2019-08-01-count-2:AGGCCACTCCGTGGCA"	4.13632072982137	-6.65252211010131	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCCACTCCGTGGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.61822340139	42.4479378406329	0.01601435373298	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2645.4464683997	2645.4464683997
"healthy-4"	"2019-08-01-count-3:TGCATGACACGTAGAG"	-0.85055915537532	8.29689977252809	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATGACACGTAGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.4172305924	46.6047830183982	0.0230213329120699	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.03647570356	2015.03647570356
"healthy-4"	"2019-08-01-count-4:TGGATCAGTTGCCATA"	-3.32069192352946	10.0391435393128	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATCAGTTGCCATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.4140568548	43.4840657282669	0.02121780397808	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2039.51274165345	2039.51274165345
"healthy-4"	"2019-08-01-count-4:AAGTTCGTCGTTCTAT"	4.58623566207234	-7.4594822159973	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTTCGTCGTTCTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.77683906432	48.0037511214924	0.0198709377229087	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2410.50099443645	2410.50099443645
"healthy-4"	"2019-08-01-count-2:CCGTTCAAGCCAGACA"	11.1110550361568	6.16897628391115	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTTCAAGCCAGACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.44501457748	42.8350595001043	0.0214234746081058	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.05997154237	1987.05997154237
"healthy-4"	"2019-08-01-count-3:GTTCTATTCGTCGATA"	5.57908596572225	-9.7944431534973	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATTCGTCGATA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2830.42438115404	43.8675435512615	0.0154985746460308	2534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2828.29983840246	2828.29983840246
"healthy-4"	"2019-08-01-count-4:TCTGCCATCTAGACAC"	-3.69347606125529	9.75590417468873	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCATCTAGACAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.43401167965	45.0026394312834	0.0214050187455494	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2086.08669952087	2086.08669952087
"healthy-4"	"2019-08-01-count-3:GTTGAACGTACGTACT"	-0.110662366182166	7.59370944583742	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGAACGTACGTACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.04983515062	42.2757095001871	0.0216238526200689	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.73777887401	1945.73777887401
"healthy-4"	"2019-08-01-count-2:TGCGGGTAGGACACTG"	-1.56705687466319	9.05625436389772	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTAGGACACTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1726.79855354391	44.3381527743171	0.025676505625582	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1714.61974120649	1714.61974120649
"healthy-4"	"2019-08-01-count-2:CAGGTATCACTACCCT"	10.5905968147213	7.63543126666871	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATCACTACCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2335.79001569304	43.6839012152525	0.0187019813090053	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2326.90298548196	2326.90298548196
"healthy-4"	"2019-08-01-count-3:ACTTATCAGGTAACTA"	10.6370378929073	6.25694320285646	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTATCAGGTAACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.59317678967	45.2796816106652	0.0240262366267278	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.2217401934	1875.2217401934
"healthy-4"	"2019-08-01-count-2:GTCATCCCACACGCCA"	4.65262379226033	-6.77725126659545	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCCACACGCCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2701.10822578312	35.6365147977035	0.0131932939441446	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2695.16047776349	2695.16047776349
"healthy-4"	"2019-08-01-count-4:ATGTCTTTCACTACTT"	3.51584281501119	-6.22861101543578	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCTTTCACTACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.19626541793	43.1678099418933	0.0175679128889409	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2453.4296659099	2453.4296659099
"healthy-4"	"2019-08-01-count-4:TAATTCCCAAGGCAAC"	-0.232605109841186	8.04400966251222	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATTCCCAAGGCAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2013.51726863299	43.3750107717274	0.0215419114836673	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2007.47369399617	2007.47369399617
"healthy-4"	"2019-08-01-count-4:CATCAAGAGCATTTCG"	2.98111166533772	-6.14432098781737	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCAAGAGCATTTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.56920913239	45.297473303402	0.017044701281059	2150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2651.62455282076	2651.62455282076
"healthy-4"	"2019-08-01-count-3:CGCAGGTGTCCGTACG"	10.7851034599239	7.00422999942628	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCAGGTGTCCGTACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.40670505787	44.8668943644906	0.0225983392975309	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1980.07824009948	1980.07824009948
"healthy-4"	"2019-08-01-count-4:AACCAACGTGTCTTCC"	5.56246199187581	-10.0784845582214	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCAACGTGTCTTCC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.5609226876	52.265965477228	0.0202302043734495	1897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2575.32895833433	2575.32895833433
"healthy-4"	"2019-08-01-count-2:GTGCTTCGTACGTGAG"	3.70351590689961	-6.39201166546019	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCGTACGTGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.60609984166	46.8315287249606	0.0211371185195362	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2214.1250514372	2214.1250514372
"healthy-4"	"2019-08-01-count-4:GTTAGACTCGTGTGAT"	2.88114513930623	-6.00062658703002	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACTCGTGTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.33972010804	43.5398909442196	0.0169130323415095	1870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2569.30457367891	2569.30457367891
"healthy-4"	"2019-08-01-count-3:GCAGGCTTCATCGGGC"	10.3884073692257	6.27219626987306	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGGCTTCATCGGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1860.55515420349	43.3987042308819	0.0233256746691075	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1855.28965944199	1855.28965944199
"healthy-4"	"2019-08-01-count-3:TCACTCGGTTGCCAAT"	2.20854939994161	-6.29855730449828	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTCGGTTGCCAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.51206926682	48.1098513121828	0.0217739708152611	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2206.90191483444	2206.90191483444
"healthy-4"	"2019-08-01-count-4:TGTTACTCATCGTGCG"	4.94456305083577	-7.63162567531737	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTCATCGTGCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.35844141552	43.6146649343285	0.0170013921759264	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2562.80298447444	2562.80298447444
"healthy-4"	"2019-08-01-count-3:TCAGCAAGTATAGGGC"	2.28353585776631	-6.00289299404296	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAAGTATAGGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.84609513883	42.7887740218175	0.0175879494010392	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2427.44039707733	2427.44039707733
"healthy-4"	"2019-08-01-count-4:CTGTGAATCGAGGCAA"	-0.0712749314611733	7.53966138446657	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAATCGAGGCAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1807.37847688328	37.3874518222381	0.0206860114250728	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1800.26955946213	1800.26955946213
"healthy-4"	"2019-08-01-count-2:TATCGCCCACCAGTTA"	-1.60503826561626	8.44261930072633	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCCACCAGTTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2411.08414723523	45.7775080025416	0.0189862755536899	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2399.73746946237	2399.73746946237
"healthy-4"	"2019-08-01-count-2:AGGGCCTTCCAACTGA"	0.0435430846059739	7.54963204944459	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTTCCAACTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2138.63308918478	43.4953035428311	0.0203378988956965	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2128.18800700646	2128.18800700646
"healthy-4"	"2019-08-01-count-3:TTACTGTTCCATGAGT"	-3.97678647461589	10.7119550474915	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTTCCATGAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2098.23023371853	44.1793399036327	0.0210555253630757	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2085.83398657836	2085.83398657836
"healthy-4"	"2019-08-01-count-3:GTTGTCCCAATACCCA"	-2.81066546860393	3.73803160274354	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTCCCAATACCCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3063.39815035998	47.3379854650302	0.0154527694872009	4311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3055.05626540147	3055.05626540147
"healthy-4"	"2019-08-01-count-1:GCAGTTAAGTTTCGGT"	0.530968715518159	8.16931150043336	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCAGTTAAGTTTCGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2111.77246784316	36.343618766044	0.0172100069110018	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2104.47458345098	2104.47458345098
"healthy-4"	"2019-08-01-count-2:GTAACACGTACAGAGC"	-3.99911294403728	11.0601730116638	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACGTACAGAGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2092.36872784107	45.2976874454274	0.0216489984975861	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.75950029827	2090.75950029827
"healthy-4"	"2019-08-01-count-1:TTTGTTGCAACAGCCC"	11.0643621879512	6.19717452609865	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTTGTTGCAACAGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.6472624298	43.0891851318544	0.0207994796765333	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2062.99861260662	2062.99861260662
"healthy-4"	"2019-08-01-count-4:GGCACGTTCGGCTATA"	10.7421776252681	7.56946656787721	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCACGTTCGGCTATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.78388731428	44.4092155965571	0.0213118144673797	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2083.78388731428	2083.78388731428
"healthy-4"	"2019-08-01-count-3:TGCTCGTAGTCATGAA"	0.653124471276444	7.9379033812317	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTAGTCATGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.60997034787	40.2734173524018	0.0223789698968031	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1794.14385626488	1794.14385626488
"healthy-4"	"2019-08-01-count-3:AGAAATGAGGCTCAAG"	-2.10137162628825	8.97745606983034	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAATGAGGCTCAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1936.70189160028	47.835181175818	0.0246993000746709	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1931.80291604584	1931.80291604584
"healthy-4"	"2019-08-01-count-3:GCATCTCTCAAGGACG"	-2.99124250832255	9.5289907225403	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCTCAAGGACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.15304012299	41.9351920038986	0.0210713403233085	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1984.778731386	1984.778731386
"healthy-4"	"2019-08-01-count-4:AGTGACTGTGTTCATG"	11.1992641883785	5.71620748126832	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTGTGTTCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.89692693314	45.9662418688975	0.0223148261778971	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.71783265405	2051.71783265405
"healthy-4"	"2019-08-01-count-4:ACTGCAAAGGTATAGT"	10.3044573265011	7.48801992023317	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAAAGGTATAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.66660295952	52.9436838698265	0.0253359477511122	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2075.82534192328	2075.82534192328
"healthy-4"	"2019-08-01-count-3:GAACACTAGTATAACG"	-0.290575305849868	7.62582824313966	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACACTAGTATAACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2196.73892475332	43.5181746404069	0.0198103534971929	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2186.53591583932	2186.53591583932
"healthy-4"	"2019-08-01-count-4:CGAAGGATCCTTCTTC"	-0.0300249186461747	7.59588716113893	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGGATCCTTCTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2059.1598869678	44.4912271740492	0.0216064946950595	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.23557121013	2054.23557121013
"healthy-4"	"2019-08-01-count-2:CACTGAAGTTGCGTAT"	3.24655999717061	-6.11498405849608	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAGTTGCGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.62545443816	43.9690542004828	0.0169789241626149	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.37911451076	2586.37911451076
"healthy-4"	"2019-08-01-count-4:CTTCAATAGCGACTAG"	0.463960130780381	7.6576618918213	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATAGCGACTAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2402.72415197862	43.9758050799048	0.0183024776455054	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2395.64938330297	2395.64938330297
"healthy-4"	"2019-08-01-count-2:CTGTACCGTCTCTCTG"	3.43722810324971	-6.60369875347289	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTACCGTCTCTCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.02609908307	46.423619536423	0.0181553170509562	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2553.55793238797	2553.55793238797
"healthy-4"	"2019-08-01-count-3:TCAGGTAAGATGCTGG"	-3.50487099114116	-4.64583637630614	"2019-08-01-count-3"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGTAAGATGCTGG"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3154.09940677777	49.2773750973046	0.0156232790226629	3294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3148.84578778982	3148.84578778982
"healthy-4"	"2019-08-01-count-4:AGTGCCGGTGGTCAAG"	3.11939372596089	-6.64560081874999	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGGTGGTCAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1872.08130606552	49.6407465427886	0.026516341134305	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1867.00073452892	1867.00073452892
"healthy-4"	"2019-08-01-count-3:GCATTAGTCCTTCACG"	0.191859890788239	7.93209264362184	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATTAGTCCTTCACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.56798314628	46.3032305591611	0.0236655362645272	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1949.11567434375	1949.11567434375
"healthy-4"	"2019-08-01-count-2:AAACGCTAGAAGATCT"	-4.76607308808024	-5.12004616176756	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTAGAAGATCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2421.75229346594	55.1248717974047	0.0227623906648651	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2416.32328731357	2416.32328731357
"healthy-4"	"2019-08-01-count-3:AAAGGTAGTGCCGGTT"	-1.53282664242442	8.64031789386598	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGTAGTGCCGGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.79665095466	46.0475473567687	0.0227081681662163	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2019.03194214346	2019.03194214346
"healthy-4"	"2019-08-01-count-4:CAAGGGATCTTGTTAC"	10.444617887109	6.67810819232789	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGGGATCTTGTTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.37014728354	45.4922935279614	0.0233488968158272	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1941.88448816192	1941.88448816192
"healthy-4"	"2019-08-01-count-2:TGGAGAGTCGTTCTCG"	-2.15935597840007	9.18933580005494	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGAGTCGTTCTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1593.95923596724	52.1269090872615	0.0327027868160191	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1589.5991539184	1589.5991539184
"healthy-4"	"2019-08-01-count-2:ATTCATCGTGGAGGTT"	2.13479866561238	-6.42486574566039	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCGTGGAGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1967.48266625538	50.8207676582521	0.0258303508995975	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1964.17974035261	1964.17974035261
"healthy-4"	"2019-08-01-count-4:GTTGAACCACTCTAGA"	10.7301393943721	6.64323327625123	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACCACTCTAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.6736674545	42.4386822075667	0.0216228927464074	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1949.72957289534	1949.72957289534
"healthy-4"	"2019-08-01-count-2:ACTACGACAGAAACCG"	2.8864504295284	-4.76447393810423	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGACAGAAACCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2793.80730693166	42.2000836428456	0.0151048655138612	2683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2786.1133610734	2786.1133610734
"healthy-4"	"2019-08-01-count-4:ACTGTGATCCCTTCCC"	-5.94049964371379	-4.45350506221923	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGATCCCTTCCC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3476.72553530782	42.2712081612516	0.0121583391418066	4151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3468.53466468556	3468.53466468556
"healthy-4"	"2019-08-01-count-4:CTTCCTTAGTCCCAGC"	10.9287954765255	6.21388671481935	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTAGTCCCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.40511383287	45.699753452209	0.0232166402795117	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1960.8421358717	1960.8421358717
"healthy-4"	"2019-08-01-count-3:TTCACGCTCGTAGGAG"	3.82208241996114	-6.75015594875487	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCTCGTAGGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.81753301081	47.1049839420192	0.0193942045056086	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2422.98706147484	2422.98706147484
"healthy-4"	"2019-08-01-count-2:ATTCCATTCCCATAAG"	-0.098895083100158	7.55977342212526	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCATTCCCATAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.06242167829	43.2651269569635	0.0210427108149993	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2042.84275308973	2042.84275308973
"healthy-4"	"2019-08-01-count-4:ATTCCATCACTTCCTG"	11.8306271034176	-3.39351417934569	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATCACTTCCTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2558.88660073918	41.3965969878131	0.0161775816778497	3642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2551.86646592965	2551.86646592965
"healthy-4"	"2019-08-01-count-2:TCTGCCATCACTTATC"	10.9667841392452	6.39346311176149	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCATCACTTATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2200.19476416992	44.5961411292574	0.020269178827031	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2197.00933205016	2197.00933205016
"healthy-4"	"2019-08-01-count-2:AGACAGGAGCCATTTG"	9.91245617446248	5.944459892157	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAGGAGCCATTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1625.71238292853	43.9982427165307	0.0270639771084681	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1621.56756171593	1621.56756171593
"healthy-4"	"2019-08-01-count-2:CCCTCTCCATGGTGGA"	11.4852615791256	3.65136954868165	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCCATGGTGGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2109.1946905538	35.7857084836065	0.0169665269137437	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.40092714194	2093.40092714194
"healthy-4"	"2019-08-01-count-4:AGGGCCTAGTTCCAGT"	-7.2802303833073	3.31915471637575	"2019-08-01-count-4"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTAGTTCCAGT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2565.21359204395	41.6648518081513	0.0162422544217664	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2554.12806255217	2554.12806255217
"healthy-4"	"2019-08-01-count-2:ATAGGCTCACGCAGTC"	10.4817282157833	6.563440776709	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGGCTCACGCAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1734.75746446732	43.3364016209376	0.0249812452222216	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1723.84189380409	1723.84189380409
"healthy-4"	"2019-08-01-count-2:AGCTCAAAGACTCTAC"	4.89092125472371	-7.01525499736937	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTCAAAGACTCTAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2855.30681847938	43.0999228476201	0.0150946730378255	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2844.62985552362	2844.62985552362
"healthy-4"	"2019-08-01-count-2:CCTCCTCCAGACCCGT"	11.2121797996456	6.25006101215211	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCCAGACCCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.42479995938	47.748740005311	0.0241347257708715	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1965.48359563168	1965.48359563168
"healthy-4"	"2019-08-01-count-2:ACTATGGAGGAAAGAC"	3.87306561049764	-6.53337290203246	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATGGAGGAAAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.50728166247	49.4955276244906	0.0218667410639553	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2259.42112397855	2259.42112397855
"healthy-4"	"2019-08-01-count-3:TATTGGGGTCATAAAG"	-3.11871586266215	3.67280767047731	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGGTCATAAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3125.8517942664	44.0207853038677	0.0140828126863253	4301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3117.25343571594	3117.25343571594
"healthy-4"	"2019-08-01-count-3:TCATCATCAACACGAG"	2.85933246192281	-5.9307170144287	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCATCAACACGAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2864.84068447463	44.6251017789472	0.0155768179434141	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2854.79800723894	2854.79800723894
"healthy-4"	"2019-08-01-count-3:TCATATCTCTCAACCC"	2.88295402106587	-6.06748011028441	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATATCTCTCAACCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1826.31652293551	49.9493410533824	0.0273497723018444	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1822.66239078178	1822.66239078178
"healthy-4"	"2019-08-01-count-4:AGCCACGTCTTTCCAA"	-4.07703195038493	12.3558950194153	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCACGTCTTTCCAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1992.46254642494	47.2219646272921	0.0237003022777126	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1983.43980887509	1983.43980887509
"healthy-4"	"2019-08-01-count-2:GTTACAGCAGGACGAT"	10.1388842063839	6.9085073241028	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGCAGGACGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.95673805476	39.4245764020903	0.0215911886521968	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1819.90101035852	1819.90101035852
"healthy-4"	"2019-08-01-count-4:TGACAGTTCGACCTAA"	10.6961447196895	6.0018534430298	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACAGTTCGACCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.07944647505	44.2698122303673	0.0223012798349095	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1972.5590913411	1972.5590913411
"healthy-4"	"2019-08-01-count-3:AGACACTTCTTACGTT"	-1.79892168465312	8.7880706557068	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTTCTTACGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2200.66405255159	41.7974613709371	0.0189931131571283	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2189.7851340646	2189.7851340646
"healthy-4"	"2019-08-01-count-2:ACTATTCAGTAGTCCT"	10.7911564308101	5.59564492786256	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATTCAGTAGTCCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1752.21452123646	51.1243762047387	0.0291770074868816	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1737.61372667688	1737.61372667688
"healthy-4"	"2019-08-01-count-3:GTAACACTCTGAGATC"	10.4329115348751	7.57976005161134	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACACTCTGAGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2061.19930021777	42.7060951387279	0.0207190518326957	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2056.53351651294	2056.53351651294
"healthy-4"	"2019-08-01-count-4:CCATAAGGTCTACATG"	2.71149792250935	-5.89454939281615	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGGTCTACATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.97599836704	45.0862935225253	0.0169435175477695	2267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.21806278481	2656.21806278481
"healthy-4"	"2019-08-01-count-2:CCGAACGCACCCTAGG"	4.79377665099446	-7.12715103542479	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGAACGCACCCTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2882.03600544511	42.7984425301271	0.0148500721189002	2285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2878.42576022082	2878.42576022082
"healthy-4"	"2019-08-01-count-2:GGTAATCAGCGTATGG"	-4.12459884110149	12.9435186156067	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCAGCGTATGG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2162.18192566192	43.3163707703581	0.0200336383614424	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2154.34286044508	2154.34286044508
"healthy-4"	"2019-08-01-count-2:AAGCATCCAACCAATC"	10.4333712058956	7.35821864688722	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCATCCAACCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.09571535304	49.4954150136768	0.0244531000378329	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2016.99460876126	2016.99460876126
"healthy-4"	"2019-08-01-count-2:ATTGGGTAGTTTGAGA"	10.5906635719234	7.79829070651857	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTAGTTTGAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2380.54862783645	46.1278997739779	0.0193770037858462	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2363.83818191552	2363.83818191552
"healthy-4"	"2019-08-01-count-3:GTTACAGGTCGCGTCA"	-4.43039880219157	3.61867115581361	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGGTCGCGTCA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2950.11140453616	27.7729142221889	0.00941419167407867	2909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2933.91174588704	2933.91174588704
"healthy-4"	"2019-08-01-count-2:ATGCATGTCTATGCCC"	10.9416090446407	6.06574342334596	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGTCTATGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1902.21394266764	50.2373223620794	0.026409922267538	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1894.57829025125	1894.57829025125
"healthy-4"	"2019-08-01-count-4:ACTTTCATCGAACACT"	4.7460695701534	-6.96618606960448	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTCATCGAACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.42195467857	42.0604553877753	0.0174349496804258	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2411.07183502812	2411.07183502812
"healthy-4"	"2019-08-01-count-2:AAGCCATGTTGGGAAC"	-2.44448671761211	8.75727937305299	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCCATGTTGGGAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2185.17282712539	46.8077267131519	0.0214206062477574	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2175.92544958523	2175.92544958523
"healthy-4"	"2019-08-01-count-4:CACAGGCCAATTGAGA"	-6.33365283432658	2.84217784488527	"2019-08-01-count-4"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAGGCCAATTGAGA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2597.58673325277	44.4280040418594	0.0171035690447284	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2586.61736599756	2586.61736599756
"healthy-4"	"2019-08-01-count-3:TAATTCCAGCAATAAC"	10.5756889778072	7.55410764301149	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATTCCAGCAATAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.27140056642	48.0507785537506	0.0246506353808854	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.61246526693	1931.61246526693
"healthy-4"	"2019-08-01-count-4:ATTGTTCCACTGAGGA"	4.93022789534871	-7.70780851757201	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGTTCCACTGAGGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2842.80993047213	40.2954663637001	0.0141745200520697	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2838.30634372457	2838.30634372457
"healthy-4"	"2019-08-01-count-3:TCATGGAAGCCGGAAT"	0.176588093012017	7.95006225192872	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGGAAGCCGGAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.14474509662	40.5468711541011	0.0239053130762088	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1691.97301355321	1691.97301355321
"healthy-4"	"2019-08-01-count-3:CTATCTATCATATGGC"	11.0070959525997	6.14920327747194	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATCTATCATATGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.33340486836	47.7986252017473	0.0245204976646749	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1944.30372834422	1944.30372834422
"healthy-4"	"2019-08-01-count-2:CTCACTGAGGTCCCTG"	-2.62411413613017	9.64320752704469	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGAGGTCCCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.15349525485	47.8237181353824	0.0267597149670475	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1781.57382360642	1781.57382360642
"healthy-4"	"2019-08-01-count-2:CTCACTGAGCGGGTAT"	2.26161636885945	-5.93016102230223	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGAGCGGGTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2571.01241892089	45.7593218101837	0.0177981722194052	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2567.05726534273	2567.05726534273
"healthy-4"	"2019-08-01-count-4:AAGCGTTAGCAATAGT"	10.83190025863	6.39121959293214	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGTTAGCAATAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.67344572815	40.4690021612463	0.0204732866972565	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1971.58001087163	1971.58001087163
"healthy-4"	"2019-08-01-count-4:AAGCGAGTCAGCGTCG"	-5.69388757172282	-4.66179230129393	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGTCAGCGTCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3315.33293775626	42.387637332525	0.0127853335180303	3439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3311.77124434276	3311.77124434276
"healthy-4"	"2019-08-01-count-3:TCATGTTAGTACAGCG"	10.4377018409664	7.8233980902466	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGTTAGTACAGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2397.999970055	50.8870550826713	0.0212206237356642	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2386.08659731991	2386.08659731991
"healthy-4"	"2019-08-01-count-2:GGTCTGGAGTCCCAAT"	10.7045389610225	6.61382243717042	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCTGGAGTCCCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.34602669239	45.0492071812853	0.0224869825686895	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.61047024527	1992.61047024527
"healthy-4"	"2019-08-01-count-4:AAGGAATAGATGCCGA"	-4.03311429444011	11.4038848646912	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGAATAGATGCCGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2076.8126627376	45.7969051428432	0.0220515340475991	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2069.91399928055	2069.91399928055
"healthy-4"	"2019-08-01-count-3:TCATTACAGCTTTGTG"	-2.87286053124126	3.52641532504884	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACAGCTTTGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3303.99668418001	48.7097824986599	0.0147426850432051	5197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3293.43799332046	3293.43799332046
"healthy-4"	"2019-08-01-count-2:CAGCCAGGTGTATTCG"	2.15054239806477	-6.18790533458861	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGGTGTATTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.17794144725	47.5806335442651	0.0235994217405785	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2016.17794144725	2016.17794144725
"healthy-4"	"2019-08-01-count-4:CGCAGGTCATGATCTG"	-2.55725870552714	9.6500148543152	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCAGGTCATGATCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.7198780849	49.8442571688291	0.0245330361269155	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2026.22356643717	2026.22356643717
"healthy-4"	"2019-08-01-count-2:CAGCCAGAGTCAAGCG"	2.7648889022762	-6.2251506081787	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCCAGAGTCAAGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.98370703963	51.4452242459397	0.0225539639266901	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2272.62599076417	2272.62599076417
"healthy-4"	"2019-08-01-count-3:TGGGTTACATACTGAC"	0.966196735470933	8.35528657520143	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGTTACATACTGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1918.16089310514	41.5681756931617	0.0216708493237346	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1907.04237180581	1907.04237180581
"healthy-4"	"2019-08-01-count-4:TGTCCCAGTACCCGCA"	0.324652751057786	7.69165847385255	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCAGTACCCGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.76775686076	41.0858896059434	0.0219855514175615	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1856.98454531852	1856.98454531852
"healthy-4"	"2019-08-01-count-2:GACAGCCTCGAAGCCC"	-1.75481591644939	8.57409379566041	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACAGCCTCGAAGCCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.55069915335	47.7138649710839	0.0235095703650016	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.44965025909	2024.44965025909
"healthy-4"	"2019-08-01-count-2:ACTGTGATCGATAACC"	11.2468868690426	5.61484668338624	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTGATCGATAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.06217567312	45.7478670690244	0.022816183769297	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1997.04758243798	1997.04758243798
"healthy-4"	"2019-08-01-count-4:AAGGTAATCTCGAGTA"	4.9821363883907	-7.57150032436522	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGTAATCTCGAGTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2938.83752083916	42.5515562273203	0.014479043474023	2736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2933.30146023575	2933.30146023575
"healthy-4"	"2019-08-01-count-2:GCCAGGTAGGGCGAAG"	4.25784220275227	-7.20072462474974	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGGTAGGGCGAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.40166663223	40.8943275558736	0.016368195755728	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2490.54622885559	2490.54622885559
"healthy-4"	"2019-08-01-count-3:CCGTGAGCACTGTGTA"	-0.0511665445869744	7.95439956271974	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTGAGCACTGTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1795.3423835954	43.272257097286	0.0241025096341946	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1789.78036317302	1789.78036317302
"healthy-4"	"2019-08-01-count-4:GGGCTCACACCAATTG"	11.0003830390865	5.84799096668092	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTCACACCAATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.5065291563	46.9871285601354	0.0239424062351199	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1952.44580110586	1952.44580110586
"healthy-4"	"2019-08-01-count-2:GTTCCGTTCTCGACCT"	10.5141359764034	7.06833503330079	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCCGTTCTCGACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.02637287324	44.8626395386077	0.0223750870041269	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1995.80999816429	1995.80999816429
"healthy-4"	"2019-08-01-count-2:CAACAACTCGGAACTT"	4.73672165450398	-6.75609209453734	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAACTCGGAACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2628.12812271224	42.4085700224864	0.0161364165072442	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2620.95280393023	2620.95280393023
"healthy-4"	"2019-08-01-count-1:TCGCTCAGTGGTCTTA"	11.1655193763668	6.05302045429078	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGCTCAGTGGTCTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2236.01014532426	45.6197166884163	0.0204022851970561	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2221.16347236317	2221.16347236317
"healthy-4"	"2019-08-01-count-3:CACTAAGTCTAGAACC"	-0.0215644863551438	7.58942267978517	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTAAGTCTAGAACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2100.63159457965	44.7964604577216	0.0213252340740337	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2099.33841743952	2099.33841743952
"healthy-4"	"2019-08-01-count-3:TTACCGCAGGCTCTCG"	11.4550053077633	4.42014691913453	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCAGGCTCTCG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2259.70069275184	42.1726849949626	0.0186629517485367	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2253.17597044317	2253.17597044317
"healthy-4"	"2019-08-01-count-4:ACGTAGTTCGTTATCT"	-2.21409950676616	4.22079751575319	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTTCGTTATCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3342.31518824196	47.129003657083	0.0141007059486429	5906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3335.67869220973	3335.67869220973
"healthy-4"	"2019-08-01-count-2:CCGTGAGTCAGGACGA"	-0.890179376036483	8.2466249235901	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGTCAGGACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1965.67603204102	49.3250126602511	0.0250931546481927	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1959.06902364456	1959.06902364456
"healthy-4"	"2019-08-01-count-3:TTACCGCAGCCGTCGT"	10.4116655784542	7.23595378482667	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCGCAGCCGTCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.61286947217	40.8405022311408	0.022068636236594	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.41058253309	1846.41058253309
"healthy-4"	"2019-08-01-count-3:TCACATTTCATCGTAG"	-2.44944177094157	8.97116372669069	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTTCATCGTAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2258.48439985686	46.108354829687	0.0204156180280055	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2252.06707167996	2252.06707167996
"healthy-4"	"2019-08-01-count-4:ATCCACCCAGGTCAAG"	11.4780603843624	4.20114324176637	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCACCCAGGTCAAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2410.92908392476	38.1964211073531	0.015843029710842	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2392.35647315882	2392.35647315882
"healthy-4"	"2019-08-01-count-3:TCCACCAGTACTAACC"	11.1564823585445	5.88951919162599	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCAGTACTAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2007.69183244754	45.7671278649331	0.0227958928383642	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1997.29251359349	1997.29251359349
"healthy-4"	"2019-08-01-count-2:GACCCTTCACACGGAA"	-1.90370676937755	4.20155046069948	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTCACACGGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3138.02833935374	43.6357792008057	0.0139054764590788	5782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3131.68813289353	3131.68813289353
"healthy-4"	"2019-08-01-count-2:TGTAACGTCCCTAGGG"	3.11676921424214	-6.03450729763182	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGTCCCTAGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.04376094532	44.1325394990291	0.0171585492319963	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2572.04376094532	2572.04376094532
"healthy-4"	"2019-08-01-count-2:ACTTCGCGTATAATGG"	-0.393635908991653	7.92416474902955	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCGCGTATAATGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2152.5792552403	41.1372801135574	0.019110692446474	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2143.0004623621	2143.0004623621
"healthy-4"	"2019-08-01-count-2:GGTTAACCATTCTTCA"	11.3032547431881	5.20338246906129	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACCATTCTTCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2112.19312963881	39.6012775727398	0.0187488904385896	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2107.17243790729	2107.17243790729
"healthy-4"	"2019-08-01-count-4:ATCCATTTCCGTGGTG"	-2.1835335296696	9.70172879779664	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCATTTCCGTGGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.02821279113	45.0600473680749	0.0228495956983794	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1963.81466779849	1963.81466779849
"healthy-4"	"2019-08-01-count-2:GGTTAACAGGCTTCCG"	11.2137400108272	5.93894097888795	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACAGGCTTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1894.36021709464	41.9076836145728	0.022122341483103	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1888.2955519703	1888.2955519703
"healthy-4"	"2019-08-01-count-3:AATGGCTTCAGGAGAC"	-0.0997693044250787	8.11815164172975	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGCTTCAGGAGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.47413186636	43.1345213705695	0.0221035578520922	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1944.86796563766	1944.86796563766
"healthy-4"	"2019-08-01-count-4:TAATCTCGTTGCCGCA"	3.26632823523824	-6.04530622875365	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATCTCGTTGCCGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2705.81735518282	39.837588479834	0.014722940705339	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2703.57910880357	2703.57910880357
"healthy-4"	"2019-08-01-count-2:AGCCAATTCGCGGTAC"	3.55393638190572	-6.44041254436644	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATTCGCGGTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.89776403283	46.1571705992752	0.0185750783261059	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2477.47762407928	2477.47762407928
"healthy-4"	"2019-08-01-count-1:GAATCACAGCACCGTC"	10.7827450233394	6.87667367542116	"2019-08-01-count-1"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAATCACAGCACCGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2218.54418887231	42.2508728953244	0.0190444134974839	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2206.23831832089	2206.23831832089
"healthy-4"	"2019-08-01-count-4:GGGTGTCAGTCTGCAT"	3.11589016494099	-6.33904030239256	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGTCAGTCTGCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.01375842551	43.5486188864065	0.0166215229772598	2054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.73848187397	2612.73848187397
"healthy-4"	"2019-08-01-count-2:CTCCAACGTGACTCGC"	10.5160633521969	7.57095906818239	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACGTGACTCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.32903773348	50.6342634700721	0.0248899084321608	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2024.14423210736	2024.14423210736
"healthy-4"	"2019-08-01-count-3:CACTTCGAGCCGATAG"	10.7333160835201	6.7863788374695	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTTCGAGCCGATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.59936865003	45.8999504178529	0.025156180149187	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1819.35268788338	1819.35268788338
"healthy-4"	"2019-08-01-count-2:GACCTTCGTATCGCGC"	4.647233625024	-6.64635088359984	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCGTATCGCGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2866.08654397311	44.0008770199439	0.0153522499564677	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.56082571809	2859.56082571809
"healthy-4"	"2019-08-01-count-2:ACTTTGTAGCTGTGCC"	3.67210712012593	-6.88101198589476	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTGTAGCTGTGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.19037496316	52.0108011101184	0.0242227245970264	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2142.26241294668	2142.26241294668
"healthy-4"	"2019-08-01-count-2:AATCACGGTACCTTCC"	-3.40149007263835	-5.15073683178099	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGGTACCTTCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2315.00000172754	42.7006458938169	0.0184452033960916	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2309.0478960793	2309.0478960793
"healthy-4"	"2019-08-01-count-4:GTAGCTACATACCACA"	10.5218903022701	7.47245595538942	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGCTACATACCACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2210.9141706269	46.8357990525937	0.0211839064920885	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2203.79820144075	2203.79820144075
"healthy-4"	"2019-08-01-count-3:AGCCAATGTTCCATTT"	-3.04646406593974	-5.77291109478148	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATGTTCCATTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2501.85960638808	54.8117186271105	0.0219083910572591	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2499.33017939351	2499.33017939351
"healthy-4"	"2019-08-01-count-4:GAAGGACAGCGACTTT"	0.352097918360871	8.07503411853639	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGACAGCGACTTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.83558605288	37.4382023207532	0.0206176168196668	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1811.69218678074	1811.69218678074
"healthy-4"	"2019-08-01-count-3:GCTACCTCATCGCTAA"	-0.14353227141555	7.83598277652589	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTCATCGCTAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2121.17083514767	42.5663478459935	0.020067383136083	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2114.40921944955	2114.40921944955
"healthy-4"	"2019-08-01-count-2:GACGCTGCAAAGAGTT"	11.5172373252803	3.59847519481508	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGCTGCAAAGAGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2086.48582433687	48.3824985305471	0.0231885105406475	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2076.25666927236	2076.25666927236
"healthy-4"	"2019-08-01-count-2:CTCCATGAGCAAATGT"	9.91495575484578	7.53461120212404	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGAGCAAATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.67253338957	47.769364928251	0.0236052840269761	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2014.86069208087	2014.86069208087
"healthy-4"	"2019-08-01-count-3:GCTACCTGTAAGATAC"	11.4387575584346	3.48014280879823	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTGTAAGATAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.61135199015	46.189846887293	0.024785128529061	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1840.50526636589	1840.50526636589
"healthy-4"	"2019-08-01-count-2:AATCGACTCGACGCTG"	-1.71493111077006	9.46570966327516	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGACTCGACGCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1757.84237729727	39.7297639931455	0.0226014371403602	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1753.88223411293	1753.88223411293
"healthy-4"	"2019-08-01-count-3:GCTCAAAAGTTGAAAC"	0.039618942967993	7.86941049182741	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTCAAAAGTTGAAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1950.557999126	45.222207860561	0.0231842415764227	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1946.84436080827	1946.84436080827
"healthy-4"	"2019-08-01-count-4:CTCCGATTCGGTAACT"	10.9697452979976	6.57228038394777	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATTCGGTAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.83598999594	41.9301754404053	0.0236648175548694	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1764.2977508166	1764.2977508166
"healthy-4"	"2019-08-01-count-4:AATGACCGTAGCTGCC"	10.7127300697262	7.49531076038209	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGACCGTAGCTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.76405600925	47.3918298902626	0.0221896373604188	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2127.85756551106	2127.85756551106
"healthy-4"	"2019-08-01-count-4:CTCCGATGTCTGTGCG"	-0.0664560970967591	7.63315293872682	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATGTCTGTGCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.54527014398	45.2584851487931	0.0226117719263664	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.35107673609	1992.35107673609
"healthy-4"	"2019-08-01-count-2:CACTAAGCAAGCACAG"	10.51119007644	7.74894330585328	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGCAAGCACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2048.44057135517	43.7650672534742	0.0213650656335716	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2042.05464255401	2042.05464255401
"healthy-4"	"2019-08-01-count-3:TACGGTAGTACGTACT"	4.96085228499715	-7.52333214199217	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGTAGTACGTACT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.35069474534	40.9202159482604	0.0157910760713466	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.49024856398	2586.49024856398
"healthy-4"	"2019-08-01-count-3:GCTCAAATCACTACGA"	2.93479098853413	-6.19578936016234	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTCAAATCACTACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.28917120296	43.2279230396652	0.018874438906315	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2281.63001799031	2281.63001799031
"healthy-4"	"2019-08-01-count-2:TCTCACGCAGCGATTT"	-3.93935356560405	12.3179158934387	"2019-08-01-count-2"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGCAGCGATTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2127.40033424439	48.2116087782579	0.0226622173561807	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2125.5222211746	2125.5222211746
"healthy-4"	"2019-08-01-count-2:AATGAAGTCTACTATC"	14.3721014457637	2.11541435802308	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGAAGTCTACTATC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1670.88778976194	44.7773602689682	0.0267985441891032	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1643.69439478012	1643.69439478012
"healthy-4"	"2019-08-01-count-4:CTAGGTATCGACGCTG"	3.0732704597408	-6.42220547115477	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGGTATCGACGCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.59461520664	45.9390353191302	0.0189158927683867	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2427.22509471477	2427.22509471477
"healthy-4"	"2019-08-01-count-3:GTTTGGACAGAGGCTA"	2.55078258094136	-6.31907417690428	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTTGGACAGAGGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1814.90800306997	45.0890649772545	0.024843719296507	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1813.12207141906	1813.12207141906
"healthy-4"	"2019-08-01-count-2:CTCCCTCAGTGTTGTC"	10.8242527442867	6.5054983862671	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCTCAGTGTTGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1966.32199597995	49.9374141039018	0.0253963563475344	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.18965694429	1958.18965694429
"healthy-4"	"2019-08-01-count-2:ACGTTCCCATCGGAGA"	0.534782935946625	7.79499576175538	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCCATCGGAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.71335030595	39.2215137307871	0.0207223739001192	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1887.09916105167	1887.09916105167
"healthy-4"	"2019-08-01-count-4:TACCCGTCACGCCAGT"	-2.61771688881572	10.0435008772644	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCGTCACGCCAGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2107.15396559106	42.5448461787823	0.0201906680164439	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2100.23072495977	2100.23072495977
"healthy-4"	"2019-08-01-count-3:GCTGCAGCATTGCCGG"	-4.06556830826457	-4.59189464962157	"2019-08-01-count-3"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGCAGCATTGCCGG"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3244.76370633629	42.2671771345285	0.0130262727766556	3871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3237.84878964256	3237.84878964256
"healthy-4"	"2019-08-01-count-4:TACCGAACAGGTTACT"	10.6468197303707	7.3194894560608	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCGAACAGGTTACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.50772242911	43.3667082838851	0.0208844435373226	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2068.71602027774	2068.71602027774
"healthy-4"	"2019-08-01-count-4:TTAATCCCACATTGTG"	-0.653483728796798	8.1773414381775	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCCACATTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2102.85087181884	40.2018461549799	0.0191177827651695	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2092.2179302666	2092.2179302666
"healthy-4"	"2019-08-01-count-3:TTCACCGAGCGACTAG"	3.63702144202535	-6.73417379772338	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGAGCGACTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.43443339721	45.3116947209932	0.0192289223408048	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2351.52421268744	2351.52421268744
"healthy-4"	"2019-08-01-count-3:CCTCTAGCACTAGGTT"	4.38111986693684	-7.1801386109558	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGCACTAGGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.69591821651	20.4725475518599	0.0114455158886217	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1784.33392710419	1784.33392710419
"healthy-4"	"2019-08-01-count-3:GCTGGGTAGATACAGT"	-0.410944382578689	7.66056916797487	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGGGTAGATACAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2040.63295814733	42.7783465622273	0.0209632733762496	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2031.75903742588	2031.75903742588
"healthy-4"	"2019-08-01-count-3:TCCGATCTCTACCTTA"	-1.12712774697002	8.32199094379274	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGATCTCTACCTTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.99689907562	42.5143732733089	0.0209018869658209	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.30526881498	2032.30526881498
"healthy-4"	"2019-08-01-count-3:ACACGCGGTACACGTT"	-6.21357236328776	2.83530256831972	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACGCGGTACACGTT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2812.62894437118	41.2092071468341	0.014651490815845	3100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2797.98711711186	2797.98711711186
"healthy-4"	"2019-08-01-count-4:CAGATCATCCTTCTTC"	-1.74263415756877	9.09790132129518	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGATCATCCTTCTTC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2205.09549230653	48.0532206291414	0.0217919000772514	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2198.76794549543	2198.76794549543
"healthy-4"	"2019-08-01-count-2:ATAGAGAAGGAAAGGT"	3.99401082572286	-6.37762358104857	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGAAGGAAAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.09751923264	39.6899771703571	0.0159519379218697	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2485.7949376327	2485.7949376327
"healthy-4"	"2019-08-01-count-2:GACTGATTCAAGCCCG"	10.3334261375362	7.55246350849	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATTCAAGCCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.66643570616	47.8822733230472	0.0235332300581392	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2027.26957044768	2027.26957044768
"healthy-4"	"2019-08-01-count-3:CCTCTAGGTTACGTAC"	10.512712140649	7.47443959796754	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGGTTACGTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2241.02348682634	51.4100466937354	0.0229404319035231	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2228.12940145547	2228.12940145547
"healthy-4"	"2019-08-01-count-3:GCTTCACTCCGCACTT"	10.1667057472164	7.31907603824464	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTCACTCCGCACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.11387141847	46.3298001780675	0.0222193141646264	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2072.42355861295	2072.42355861295
"healthy-4"	"2019-08-01-count-4:TTCGATTCAAGTGGAC"	4.81702389296834	-7.25956013118895	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTCAAGTGGAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2759.39833109298	47.4956442792429	0.0172123189842005	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2752.16182386724	2752.16182386724
"healthy-4"	"2019-08-01-count-2:CTCCTCCCATCCCGTT"	11.3358131843502	5.89040372455446	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTCCCATCCCGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2408.15129555162	47.6628012957815	0.0197922785764438	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2399.42794100126	2399.42794100126
"healthy-4"	"2019-08-01-count-3:CAGGTATCAGCTCTGG"	10.480524678796	7.05175445163576	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATCAGCTCTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.90901324918	41.795918067084	0.0216121429605741	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.18675996463	1931.18675996463
"healthy-4"	"2019-08-01-count-2:CATTGCCTCATTCATC"	0.134821084409398	8.15976712787477	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGCCTCATTCATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2113.06852835009	46.8109844816544	0.022153083941014	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2103.05015146592	2103.05015146592
"healthy-4"	"2019-08-01-count-3:GCTTGGGTCCGGCTTT"	-2.92613254013713	-5.77012779628905	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGTCCGGCTTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2164.31963001754	46.4591226055326	0.0214659248852056	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2159.09090519779	2159.09090519779
"healthy-4"	"2019-08-01-count-3:AGTACCAGTGCTGTCG"	10.6567207771236	6.17793366992799	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACCAGTGCTGTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.04474375907	47.7920490602457	0.0254342262040215	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.53403821609	1868.53403821609
"healthy-4"	"2019-08-01-count-3:CAGGTATCATACCACA"	-2.96631370011027	3.41025111759035	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATCATACCACA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3405.73374811896	45.4545689683903	0.0133464834100715	5580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3397.42936870134	3397.42936870134
"healthy-4"	"2019-08-01-count-4:GTCAGCGCAACTCGAT"	-4.00062213364299	12.5275354155335	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGCAACTCGAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2008.99547539516	52.0130396804769	0.025890073082542	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1995.4838641595	1995.4838641595
"healthy-4"	"2019-08-01-count-1:GTTAGTGAGATTACCC"	0.209340308874291	7.78135392749635	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTTAGTGAGATTACCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2099.31381409652	38.0096587223082	0.0181057536358214	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.61832735697	2087.61832735697
"healthy-4"	"2019-08-01-count-2:TCGCTCATCCGTAATG"	11.530606885522	3.61999223316041	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCATCCGTAATG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.89102079877	35.4139636890754	0.0166662493946456	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2102.49002164974	2102.49002164974
"healthy-4"	"2019-08-01-count-4:CTCAATTAGGTGATAT"	-3.13886962357219	10.534490562323	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAATTAGGTGATAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.00560262557	46.1534132529348	0.0230420789599571	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1998.81550858155	1998.81550858155
"healthy-4"	"2019-08-01-count-3:TTGGGCGTCAACGAGG"	-4.01520286026652	12.2754792937073	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGTCAACGAGG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1761.12945758752	45.0776475556008	0.0255958739213586	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1759.14720820258	1759.14720820258
"healthy-4"	"2019-08-01-count-3:TCATCATCAGACCAGA"	3.65102090415303	-6.34855415737303	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCATCAGACCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.97902769631	44.0228299376576	0.0174556685262645	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2514.78626767391	2514.78626767391
"healthy-4"	"2019-08-01-count-4:GTCAGCGTCAAGGACG"	0.538029004901093	8.23704240405885	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGTCAAGGACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.77433560043	36.9822716684089	0.0219248484446763	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1676.39880284039	1676.39880284039
"healthy-4"	"2019-08-01-count-2:TGTGTGAGTTCTTCAT"	3.12545361098592	-6.12361242687377	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGTGAGTTCTTCAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.33774169785	42.2417708621898	0.0154712621142328	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2729.41295199011	2729.41295199011
"healthy-4"	"2019-08-01-count-3:GGAAGTGAGTTCCGTA"	2.31345929679219	-5.97404863750609	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGAGTTCCGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.45162505727	44.6760751670365	0.0176484017015437	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2530.44936230031	2530.44936230031
"healthy-4"	"2019-08-01-count-2:TGTTACTCAAACTGCT"	-5.61391148987468	-5.39349510585936	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTACTCAAACTGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3050.57846530866	46.9583449753597	0.0153932591832574	2913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3043.57138239051	3043.57138239051
"healthy-4"	"2019-08-01-count-4:ATGAAAGTCCTACCGT"	11.0712410407955	6.30670211398927	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGTCCTACCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2119.98402102676	45.0917927529881	0.0212698738791196	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2118.36892351045	2118.36892351045
"healthy-4"	"2019-08-01-count-4:ACAAGCTAGGTAGTAT"	0.447084267705125	7.76808259570924	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTAGGTAGTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1835.18810545468	40.096454789324	0.0218486893360666	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1826.03440418332	1826.03440418332
"healthy-4"	"2019-08-01-count-1:TACCTCGGTCATTGCA"	-0.27474538508113	8.08172891223756	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACCTCGGTCATTGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.45982535082	42.2265777094392	0.0202967522827885	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2069.53885471994	2069.53885471994
"healthy-4"	"2019-08-01-count-4:ACAAGCTCAGAACTCT"	2.85552658614461	-5.45892622387084	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTCAGAACTCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2996.28642062061	40.60580728586	0.0135520446264444	2687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2991.10138298695	2991.10138298695
"healthy-4"	"2019-08-01-count-3:GGAATCTTCTTCGATT"	-1.73804746094401	9.95459649646608	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATCTTCTTCGATT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.8214014016	38.9199660855631	0.0212003008875748	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1828.58745859278	1828.58745859278
"healthy-4"	"2019-08-01-count-3:GGAATGGAGCAGGGAG"	-2.85879145088847	3.59527442539064	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGAGCAGGGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2854.25956884103	44.6861995810654	0.0156559690887575	4120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2847.26608550334	2847.26608550334
"healthy-4"	"2019-08-01-count-2:AGACCCGTCTTGGGCG"	3.66702785071675	-6.38128378307494	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGTCTTGGGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.54715521159	42.0987131857242	0.0162760277155203	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2582.55876651656	2582.55876651656
"healthy-4"	"2019-08-01-count-1:CATCCGTTCATGCGGC"	11.2194248634273	6.24298522556154	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATCCGTTCATGCGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.1828247402	43.9818213312401	0.0200813470156115	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2180.4024376949	2180.4024376949
"healthy-4"	"2019-08-01-count-2:CACAGATCAGAGTAAT"	-2.98709712448772	10.5749988325867	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATCAGAGTAAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2076.20257970542	43.587774787668	0.0209939893215297	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2058.48376995212	2058.48376995212
"healthy-4"	"2019-08-01-count-2:CTCTGGTAGACTGTTC"	-0.760547141463119	8.31391809070436	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTAGACTGTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2144.80721030064	41.0640617332375	0.01914580552323	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2144.80721030064	2144.80721030064
"healthy-4"	"2019-08-01-count-2:CTCTCGATCCATTTGT"	2.43213357505147	-6.16974499141844	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGATCCATTTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.60178593371	42.7277816774258	0.0177765642909221	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2398.67642339706	2398.67642339706
"healthy-4"	"2019-08-01-count-2:CCAATTTCAGTCTTCC"	10.6336313682491	6.30657384479371	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTCAGTCTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.74431751893	35.8353005555607	0.0176812142734555	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.79495077038	2018.79495077038
"healthy-4"	"2019-08-01-count-4:GTCCACTCAGCTGAGA"	11.1317297416622	3.88798759067384	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTCAGCTGAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1574.03996734957	49.1330955173465	0.0312146429166463	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1547.50085226502	1547.50085226502
"healthy-4"	"2019-08-01-count-4:AAGCGAGAGAGCAACC"	-3.89426122131999	11.1791829832825	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGAGAGCAACC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1809.0540303093	49.2121343331035	0.0272032418648598	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1803.18714975389	1803.18714975389
"healthy-4"	"2019-08-01-count-4:CAGGCCACAACTGCCG"	-4.16930756989177	12.0637063750061	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGCCACAACTGCCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2254.84239726556	48.9570591555598	0.0217119649758803	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2250.30366428724	2250.30366428724
"healthy-4"	"2019-08-01-count-4:TTCTCTCGTCTAGTGT"	11.6122480827266	3.8172786005768	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTCTCGTCTAGTGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.12673601828	36.0245335121455	0.0175804321318582	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2037.93529962369	2037.93529962369
"healthy-4"	"2019-08-01-count-2:CTGAATGGTGTTGAGG"	-3.93702135506328	-5.35758068477782	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGGTGTTGAGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2604.76737508942	49.631916512403	0.0190542606556945	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2601.17089436709	2601.17089436709
"healthy-4"	"2019-08-01-count-2:CGCATGGGTACAAGTA"	11.2690674262935	4.84137628162233	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATGGGTACAAGTA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2125.03541697343	47.0131842805972	0.022123482698258	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2122.87056289081	2122.87056289081
"healthy-4"	"2019-08-01-count-2:ATCCACCCACTTGTCC"	-4.47610173645671	13.0230102309021	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCCACTTGTCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2582.31578445497	44.286837759374	0.0171500472660904	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2579.39002113551	2579.39002113551
"healthy-4"	"2019-08-01-count-2:CCACAAACAGCTACTA"	5.60734762725179	-9.63862039959105	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAACAGCTACTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3063.9742463687	42.9789890881181	0.0140272031134254	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3056.56943907874	3056.56943907874
"healthy-4"	"2019-08-01-count-4:TACTTCACAATCCAGT"	-0.142571384937125	8.38599202716676	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTCACAATCCAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2034.93299176424	43.0140561878186	0.0211378243715663	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.65142833418	2024.65142833418
"healthy-4"	"2019-08-01-count-2:ATCCATTCACGGCGTT"	2.42026581343953	-5.92936375057372	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTCACGGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.68197825585	48.758575773739	0.0195137181114076	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.0573047695	2495.0573047695
"healthy-4"	"2019-08-01-count-3:TGGGCGTTCTTAATCC"	-2.8891159099644	9.37130735004274	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGCGTTCTTAATCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1995.22396981944	50.0166337845531	0.0250681800846044	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1991.73102050696	1991.73102050696
"healthy-4"	"2019-08-01-count-2:CTGAGCGAGCCATTCA"	-1.81489894810374	8.55312535846559	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGCGAGCCATTCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.03249850606	44.0909803084811	0.0212483324189981	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.69921890339	2070.69921890339
"healthy-4"	"2019-08-01-count-2:ACTGCAACAAGGATGC"	0.267453198402566	7.51790950382081	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAACAAGGATGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.72322989644	48.0644382255485	0.0242783625002282	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1973.70463024394	1973.70463024394
"healthy-4"	"2019-08-01-count-3:TAGGGTTAGGGAGATA"	-1.97205362740214	3.81962225520936	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTAGGGAGATA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2822.64392140945	41.1193219733034	0.0145676617802967	3580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2818.0783152434	2818.0783152434
"healthy-4"	"2019-08-01-count-3:TAGGGTTAGGTGTGAC"	-0.143811191350776	7.56570623004762	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTAGGTGTGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.22024851382	44.3592365905873	0.0223672769697814	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1974.22581086517	1974.22581086517
"healthy-4"	"2019-08-01-count-3:TAGGGTTTCTGGACCG"	4.57421221312825	-6.70111229335936	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTTCTGGACCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.60236097474	43.9169787364512	0.0166693006075508	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2632.41780801688	2632.41780801688
"healthy-4"	"2019-08-01-count-1:TCCTCGAAGCACGTCC"	10.4524103599483	7.73385188663331	"2019-08-01-count-1"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCTCGAAGCACGTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2334.26007704072	45.4751409877816	0.0194816085127212	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2323.54985716294	2323.54985716294
"healthy-4"	"2019-08-01-count-3:CAACAGTTCGAACTCA"	11.1454369026119	6.30798003757326	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAGTTCGAACTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2022.35552492602	48.8615279528915	0.0241607013953093	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2015.60286994237	2015.60286994237
"healthy-4"	"2019-08-01-count-4:TTCACCGCAATGAGCG"	5.64877237853352	-9.72878458416136	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACCGCAATGAGCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.3705951847	45.6222609853299	0.0177769574943429	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2565.24615175536	2565.24615175536
"healthy-4"	"2019-08-01-count-4:CTCAGTCAGTCATGAA"	6.83283819732015	-1.6718937388626	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCAGTCATGAA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2796.84159346269	36.7293051642345	0.0131324223903439	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2786.3002508024	2786.3002508024
"healthy-4"	"2019-08-01-count-2:CCACCATGTCGCATTA"	11.4691883521969	4.43915364826051	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACCATGTCGCATTA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2238.85489407337	34.5733129513303	0.0154424089934778	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2225.49928519071	2225.49928519071
"healthy-4"	"2019-08-01-count-3:GGAGCAACACTAGGTT"	2.45387043532674	-6.39522793209227	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAACACTAGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.63083205911	47.2656671383406	0.0206704407531223	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2284.35471840836	2284.35471840836
"healthy-4"	"2019-08-01-count-4:AGCTCAAAGGTTTGAA"	11.2054287391597	6.00650880420534	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTCAAAGGTTTGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.28304763252	50.3951522343468	0.0244721833126748	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2053.58897545536	2053.58897545536
"healthy-4"	"2019-08-01-count-3:TAGGTACTCAAGCTTG"	-3.23944101753886	10.1772508391174	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACTCAAGCTTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2035.50810568144	47.4101910142393	0.0232915756424205	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2030.69224385691	2030.69224385691
"healthy-4"	"2019-08-01-count-3:TACCCGTAGCCTGAGA"	2.68778409537618	-5.97112610256346	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTAGCCTGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.38675438169	41.5025012492905	0.015100677218417	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2743.75078722115	2743.75078722115
"healthy-4"	"2019-08-01-count-4:TTCACGCTCTCAACGA"	0.443939824669999	7.95571611011354	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACGCTCTCAACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2063.16290018545	36.6072935765171	0.0177432880230769	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2055.58610121175	2055.58610121175
"healthy-4"	"2019-08-01-count-3:TGGTAGTTCATCTACT"	6.77909912642781	-1.72813012516173	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTTCATCTACT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2916.61563758403	36.3921590769012	0.0124775299864491	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2903.08359277568	2903.08359277568
"healthy-4"	"2019-08-01-count-2:CGGAACCGTTATGTCG"	3.27733339843099	-6.1610465279785	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAACCGTTATGTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.01207129914	47.4646869421553	0.0178773902594462	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2651.05600723684	2651.05600723684
"healthy-4"	"2019-08-01-count-2:CTAACTTCATTGTCGA"	2.38599910315816	-6.1317987672058	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTCATTGTCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.21550852253	44.5118691811384	0.0204350161896196	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2173.982456402	2173.982456402
"healthy-4"	"2019-08-01-count-4:ATGGGTTTCCATTCGC"	-0.444423387677032	8.0409536131653	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGGTTTCCATTCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.92293979053	43.3297104421906	0.0203337763337654	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2116.68182081295	2116.68182081295
"healthy-4"	"2019-08-01-count-3:ATCCTATCAGTCAACT"	0.0104843537205875	7.48848817432252	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATCAGTCAACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1894.78799789	39.7577388693697	0.0209826845608286	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1889.61487564642	1889.61487564642
"healthy-4"	"2019-08-01-count-4:CACGGGTTCTGTTGGA"	-1.47556922856029	8.36246774280397	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTTCTGTTGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2095.55125123619	48.5221794064638	0.0231548521554126	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.18973736866	2089.18973736866
"healthy-4"	"2019-08-01-count-3:GAGTGTTCAGCGATTT"	-2.59134231033977	3.4081353911194	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTCAGCGATTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3166.1944811968	45.2323299516211	0.0142860238751106	4851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3159.94799006701	3159.94799006701
"healthy-4"	"2019-08-01-count-2:GGTGTTAAGGACTATA"	-3.0265785259312	10.738646484259	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTAAGGACTATA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2020.26868427049	46.0653671744233	0.022801604327722	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2020.26868427049	2020.26868427049
"healthy-4"	"2019-08-01-count-3:GGAGGTATCGCTTAAG"	2.99525012549703	-5.96372511303099	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGTATCGCTTAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.15809476963	41.5785789720792	0.0160587254428658	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.03186484629	2580.03186484629
"healthy-4"	"2019-08-01-count-3:CGAGTTAGTGTCGCTG"	-4.6126106781071	3.56773231113283	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTTAGTGTCGCTG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3073.16321485681	43.42988721197	0.0141319819923699	3777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3060.17496769285	3060.17496769285
"healthy-4"	"2019-08-01-count-4:ACATCCCTCTAGTGTG"	0.605958898633164	8.05772206867067	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCCCTCTAGTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1949.54388154734	37.2601422230062	0.0191122357263552	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1938.30221855464	1938.30221855464
"healthy-4"	"2019-08-01-count-4:CATACAGCAAGAGTGC"	4.86580719527547	-7.2552004090515	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACAGCAAGAGTGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.73316443123	47.9399147103431	0.0181197088787482	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2642.20528619191	2642.20528619191
"healthy-4"	"2019-08-01-count-4:ACATCGAAGTTCCATG"	-4.07326684418376	10.9608726271423	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATCGAAGTTCCATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2294.21942986054	46.8492752855095	0.0204205729738577	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2280.91809928657	2280.91809928657
"healthy-4"	"2019-08-01-count-3:GGATGTTTCGTCTCAC"	5.66640963134114	-9.83530428325804	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGATGTTTCGTCTCAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.36362991079	42.5534880217221	0.0155397506587203	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2727.29464605381	2727.29464605381
"healthy-4"	"2019-08-01-count-4:CTCCAACTCCATTTGT"	10.7280718284542	6.83839366519777	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCAACTCCATTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2112.24036484031	49.2515908935927	0.0233172283388856	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2097.88442684658	2097.88442684658
"healthy-4"	"2019-08-01-count-4:TTGCATTAGGATTACA"	10.3884073692257	7.64800975406495	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCATTAGGATTACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2040.45871577322	48.7729102332171	0.0239029145045628	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2031.70726430957	2031.70726430957
"healthy-4"	"2019-08-01-count-2:GTCATCCAGTTCCGGC"	-1.31812737408336	8.6044301756653	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCAGTTCCGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.70894961253	38.0992403263252	0.0190333566394356	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2001.70894961253	2001.70894961253
"healthy-4"	"2019-08-01-count-2:AGCCAATAGATGGCAC"	-0.467163900763351	7.72255847537843	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATAGATGGCAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1894.93721075851	46.1208932641907	0.0243390087029476	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1885.48654227352	1885.48654227352
"healthy-4"	"2019-08-01-count-3:GCTACAAAGCACACCC"	0.0727274353498637	7.64151475513307	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAAAGCACACCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2109.22522455644	42.9958902091869	0.0203846842473775	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2094.40299586589	2094.40299586589
"healthy-4"	"2019-08-01-count-4:TGGGAAGAGTCTGCAT"	11.1318193870479	5.82422444904176	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAAGAGTCTGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.84748944193	45.232501629548	0.0238839198413369	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1888.31120419822	1888.31120419822
"healthy-4"	"2019-08-01-count-3:GCTACAAAGGTTGACG"	4.86088718947713	-7.1820368996826	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAAAGGTTGACG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2750.37519648988	41.4513937195323	0.0150711778423664	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2748.27716050687	2748.27716050687
"healthy-4"	"2019-08-01-count-2:ATCGTAGAGAGAGGGC"	2.65713705596272	-6.10020830547484	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTAGAGAGAGGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.72790291835	46.8530568590168	0.0189173210362792	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2471.55440318822	2471.55440318822
"healthy-4"	"2019-08-01-count-2:TTACCGCGTCAGTCTA"	-2.95512447777446	9.74467465961305	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCGTCAGTCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1783.36297457894	48.1292103805417	0.0269878936966857	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1773.77079044209	1773.77079044209
"healthy-4"	"2019-08-01-count-3:ACCGTTCAGCAAGCCA"	-5.17279658737834	-5.14995863353881	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCGTTCAGCAAGCCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2951.6747366335	46.7424363251141	0.0158359035109762	2772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2950.26528940878	2950.26528940878
"healthy-4"	"2019-08-01-count-2:CTGCGAGGTACCTATG"	4.68853582915608	-6.88686993038329	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCGAGGTACCTATG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2685.25631072322	46.6354996097166	0.0173672432771068	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2676.12456673968	2676.12456673968
"healthy-4"	"2019-08-01-count-4:AGGAGGTAGTCACTCA"	4.32385601577107	-6.50717880642089	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTAGTCACTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.33396725645	38.454744186426	0.0146252795062588	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2623.36052272948	2623.36052272948
"healthy-4"	"2019-08-01-count-3:TATCAGGGTTCTCCAC"	10.9323851066524	6.66458175266115	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCAGGGTTCTCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2115.52860098089	45.2732615498921	0.0214004488187495	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2106.82708285941	2106.82708285941
"healthy-4"	"2019-08-01-count-3:GTGCAGCTCCTGATAG"	10.7631269889766	6.5487341650757	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCTCCTGATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.92957334219	38.5722023117563	0.0196503241051492	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.13511940641	1954.13511940641
"healthy-4"	"2019-08-01-count-4:CATCCACAGACTCATC"	-1.66182647171672	8.84325883472291	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACAGACTCATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2181.40074667572	49.3209743940795	0.022609772399336	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2167.90050128796	2167.90050128796
"healthy-4"	"2019-08-01-count-2:CGGGCATAGGGAGGAC"	11.4425302940303	3.55298779094545	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGCATAGGGAGGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.89623469155	36.2395262879876	0.0184528722280886	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1955.16760058558	1955.16760058558
"healthy-4"	"2019-08-01-count-4:ACCACAAAGAGTATAC"	2.85873641547505	-6.16504099285277	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCACAAAGAGTATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.03334761659	48.4079353592963	0.0212685527696631	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2269.90232762832	2269.90232762832
"healthy-4"	"2019-08-01-count-4:ACCACAACACTATGTG"	2.31840099868123	-6.0746002427307	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCACAACACTATGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.96398128438	45.0612036815251	0.0177269245407471	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2539.52385062574	2539.52385062574
"healthy-4"	"2019-08-01-count-3:TTTGACTAGAGCATAT"	4.04231109198872	-6.46010782634886	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTAGAGCATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2734.75020869981	44.780146377671	0.0163744923522507	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2726.90192149376	2726.90192149376
"healthy-4"	"2019-08-01-count-4:TATACCTTCCTGGGAC"	0.0204493376309096	7.75499579990236	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTTCCTGGGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1973.35861996605	36.3100333609393	0.0184001189614303	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1964.43647437987	1964.43647437987
"healthy-4"	"2019-08-01-count-2:CCCATTGCACTCTCGT"	-4.06716189804729	13.1410312422547	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCATTGCACTCTCGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1906.74513453408	46.5495719647787	0.0244131064617365	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1904.86333136174	1904.86333136174
"healthy-4"	"2019-08-01-count-3:TTGAGTGTCTTAGCAG"	3.9849280315334	-7.37472727214965	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAGTGTCTTAGCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.53753893412	46.2608067950627	0.0218982176375448	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2112.53753893412	2112.53753893412
"healthy-4"	"2019-08-01-count-2:GGAGATGTCGTCAAAC"	2.47056402739827	-6.55938532268675	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGATGTCGTCAAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.00582291414	49.6948535263221	0.0230923415713754	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2147.95888943335	2147.95888943335
"healthy-4"	"2019-08-01-count-2:CTGGCAGGTATTGCCA"	0.0576220537418544	7.75260541522828	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGGTATTGCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2045.1072834912	35.6209504647393	0.0174176439310953	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2031.99476099292	2031.99476099292
"healthy-4"	"2019-08-01-count-2:CATGGTATCAGTAGGG"	4.75211300429646	-7.33564093029173	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGTATCAGTAGGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.94146046051	48.1063679143547	0.018243244545123	1854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2631.47823338385	2631.47823338385
"healthy-4"	"2019-08-01-count-4:ACCCAAAGTACTCCCT"	10.5056263404781	7.78647468173829	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCAAAGTACTCCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2032.44062159622	43.0318370120727	0.0211724940718203	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2029.92181702352	2029.92181702352
"healthy-4"	"2019-08-01-count-4:ACCCAAACAAATGGTA"	6.78515972670857	-1.74503257190856	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCAAACAAATGGTA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3075.83197417959	28.6694609760316	0.00932088007950386	2661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3064.10366175404	3064.10366175404
"healthy-4"	"2019-08-01-count-4:CATCCCATCCTAGCTC"	-0.497123400599319	8.57370755756227	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCATCCTAGCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2062.28610268642	39.2973765520677	0.0190552496575898	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2050.44135670207	2050.44135670207
"healthy-4"	"2019-08-01-count-4:CATCCCATCGAATCCA"	3.10065116462056	-6.04911281978758	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCATCGAATCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.71239788985	43.9869741304639	0.0160202409270064	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2742.96501358768	2742.96501358768
"healthy-4"	"2019-08-01-count-4:TTGGGATCAACAAAGT"	0.156692733138245	7.90091083133546	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGATCAACAAAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1947.81338451219	44.5558922156123	0.0228748259817358	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1934.81821497668	1934.81821497668
"healthy-4"	"2019-08-01-count-2:TTAGGCAGTGTTATCG"	0.0764886840129315	7.96416280353395	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCAGTGTTATCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1775.42032562768	43.4485071864309	0.024472237114369	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1768.37681209278	1768.37681209278
"healthy-4"	"2019-08-01-count-3:GCTGAATCAGAGTAAT"	4.27215399321858	-6.83937933361205	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATCAGAGTAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.94056601625	49.7786052525298	0.0196835805164628	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2528.94056601625	2528.94056601625
"healthy-4"	"2019-08-01-count-4:TATCCTACATCATCTT"	10.295894284814	7.55542991245119	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCCTACATCATCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2157.88943308741	43.0164564382145	0.0199345044183605	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2148.82566630808	2148.82566630808
"healthy-4"	"2019-08-01-count-2:AGCGCCATCGGCACTG"	4.60372747954671	-7.62888004696044	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCCATCGGCACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2902.32797895922	41.5539980659262	0.0143174714805415	2612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2893.51093974875	2893.51093974875
"healthy-4"	"2019-08-01-count-3:AGGTGTTTCCACTAGA"	4.42703165587727	-6.58507683193358	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTGTTTCCACTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.54503873414	45.360263799076	0.0176187493777071	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2569.70264517329	2569.70264517329
"healthy-4"	"2019-08-01-count-2:CCCTAACAGCGACAGT"	4.99680532988851	-7.46129610454711	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACAGCGACAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.51280643963	42.7219990503199	0.0160337000246607	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2657.35621025256	2657.35621025256
"healthy-4"	"2019-08-01-count-2:TTAGGGTCACAGCGCT"	11.3236948448116	4.99224231326906	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTCACAGCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1783.9053849525	44.3189767621831	0.0248437933625966	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1777.83580842923	1777.83580842923
"healthy-4"	"2019-08-01-count-4:GGCTTGGGTAGTCTTG"	-2.70883617821391	3.61038849437562	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTGGGTAGTCTTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3309.88892401959	45.8967320179036	0.0138665475100493	5465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3304.01422667959	3304.01422667959
"healthy-4"	"2019-08-01-count-4:TTGGGCGTCGTAACCA"	2.10074986991231	-6.38007786190184	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGTCGTAACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.96381029637	42.9830428251031	0.0202945124067481	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2113.68963709622	2113.68963709622
"healthy-4"	"2019-08-01-count-2:AAACGCTTCATTGGTG"	9.97192921218221	7.36936900699464	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACGCTTCATTGGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.15440151739	33.2840684983654	0.0172980237303813	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.8328362205	1917.8328362205
"healthy-4"	"2019-08-01-count-3:GGGACCTCAACAAGAT"	10.6487318473751	6.40005061710206	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTCAACAAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1932.41465908979	42.2764672244056	0.0218775339058537	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.34510230049	1927.34510230049
"healthy-4"	"2019-08-01-count-2:TCCATGCCATCTATCT"	-4.34688268128093	12.475748992804	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCCATCTATCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2237.6964088147	49.845101338453	0.0222751849366625	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2221.77110957435	2221.77110957435
"healthy-4"	"2019-08-01-count-4:ATTCCATAGTCATGCT"	10.5644794898922	6.14062974536744	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATAGTCATGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.93768453063	43.6894595684439	0.0225210633912783	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1936.84790299889	1936.84790299889
"healthy-4"	"2019-08-01-count-2:CTGTCGTAGGAACTAT"	0.186803449958008	7.91563794696657	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTCGTAGGAACTAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1948.97888748288	42.9651513552549	0.0220449547356281	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1941.62849137447	1941.62849137447
"healthy-4"	"2019-08-01-count-4:AAACCCACATCAGCGC"	10.5507084327633	6.21736190402833	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCACATCAGCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1942.8269992078	45.3891355975585	0.0233624175575418	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.59906422942	1934.59906422942
"healthy-4"	"2019-08-01-count-3:GGGACCTTCCCAGGAC"	4.66210474547688	-7.69347669994506	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTTCCCAGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2832.83535194154	44.136683827034	0.0155803914960267	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2828.05278211683	2828.05278211683
"healthy-4"	"2019-08-01-count-4:CTGAATGGTCAAGCGA"	-1.58425126496013	8.64343545520631	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGGTCAAGCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2309.48758066253	43.7697654623975	0.018952154507729	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2302.73428859125	2302.73428859125
"healthy-4"	"2019-08-01-count-3:GAGACTTAGTAACCTC"	-3.56127582016643	-5.1976151696411	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACTTAGTAACCTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2908.48362633032	44.5097521618272	0.0153034219477405	2883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2903.86430973737	2903.86430973737
"healthy-4"	"2019-08-01-count-4:AGGCTGCGTCTTACTT"	-0.00237238305862549	8.03786227786867	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCTGCGTCTTACTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2038.19210404312	42.0290759432004	0.0206207628122139	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.24731608603	2032.24731608603
"healthy-4"	"2019-08-01-count-4:TCGTAGAAGCCTGCCA"	9.68316521224324	6.73383472049562	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGAAGCCTGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.2620770739	41.8100857186205	0.0227319892253401	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1834.24058005213	1834.24058005213
"healthy-4"	"2019-08-01-count-3:TACTTGTCATTGGGAG"	11.4015537696773	4.27859351718751	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTCATTGGGAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.20208527919	38.8871307075722	0.0202621344598608	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1907.37575816337	1907.37575816337
"healthy-4"	"2019-08-01-count-2:TTATTGCTCAGGAACG"	3.04913749274556	-6.5316953889099	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTATTGCTCAGGAACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.41283348082	42.7651554117172	0.0178529374202168	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2391.831828955	2391.831828955
"healthy-4"	"2019-08-01-count-2:GATCACAAGCTGAAGC"	11.5237566429073	3.76603553378908	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCACAAGCTGAAGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2331.73498154053	41.9103083227598	0.0179738729549233	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2322.75849485124	2322.75849485124
"healthy-4"	"2019-08-01-count-3:TCTACATGTTCCATTT"	10.4879623847896	7.3087062605652	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACATGTTCCATTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2181.06997967806	42.8852584386088	0.0196624862284056	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2169.40000778934	2169.40000778934
"healthy-4"	"2019-08-01-count-2:AGCTTCCAGCGACTGA"	11.2767559486324	5.85663983905641	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCAGCGACTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1942.2568388969	46.6682914874785	0.0240278682782158	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.36471261384	1937.36471261384
"healthy-4"	"2019-08-01-count-3:GGGAGTACATCCCGTT"	3.3894382911617	-6.31153919613036	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGTACATCCCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.76680141438	46.9184646601045	0.0182934622493673	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2560.44301306754	2560.44301306754
"healthy-4"	"2019-08-01-count-2:CCCTGATGTACCGGCT"	10.5454718070919	7.2051324614319	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTGATGTACCGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2000.70260668366	39.5471180599031	0.0197666149520623	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1995.13804151423	1995.13804151423
"healthy-4"	"2019-08-01-count-4:ACGATGTGTGTCATGT"	4.95530666884725	-7.17712643062743	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATGTGTGTCATGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.56199769203	44.2676534840665	0.0166072496240551	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.58832672156	2656.58832672156
"healthy-4"	"2019-08-01-count-4:CATGCAACAAATAAGC"	-4.13028035584148	-4.39325001156005	"2019-08-01-count-4"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCAACAAATAAGC"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3260.30349840728	44.2443118548992	0.0135706114098008	4174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3250.03213577113	3250.03213577113
"healthy-4"	"2019-08-01-count-4:CTGATCCCAGCCGTCA"	-2.38996396485026	8.55251691425172	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCCAGCCGTCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.78441302524	47.8636686346044	0.0236974145982808	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2014.66829007577	2014.66829007577
"healthy-4"	"2019-08-01-count-4:ACGCACGAGTAAGACT"	2.26748241957967	-6.22934343731078	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGAGTAAGACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.81612093976	48.6957873574361	0.0183839817994462	2375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2641.82631221582	2641.82631221582
"healthy-4"	"2019-08-01-count-4:GAGTTTGAGAGTACCG"	11.4836222129757	4.40543696964113	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTTGAGAGTACCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2258.1220178691	40.05636788035	0.0177387969132641	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2241.54220531837	2241.54220531837
"healthy-4"	"2019-08-01-count-2:CAGATCAGTTGGAGGT"	3.21237649497334	-5.94705440914305	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCAGTTGGAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.14649213257	44.6506703754246	0.0172253653529783	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.31211056762	2586.31211056762
"healthy-4"	"2019-08-01-count-3:GATTCTTAGTCACTGT"	-0.00485961410458687	7.62986037814943	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCTTAGTCACTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1968.12938218995	42.7991618502911	0.0217461119363343	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1957.06947559363	1957.06947559363
"healthy-4"	"2019-08-01-count-4:TTTACCAAGTTTCGAC"	3.0447527366573	-5.96019794857176	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCAAGTTTCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.82178277544	39.9576877633785	0.0151078942345399	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2640.19018273857	2640.19018273857
"healthy-4"	"2019-08-01-count-2:CCCTTAGTCGAACACT"	10.6070028739864	6.82582376087037	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTTAGTCGAACACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.00537774128	40.7362762843839	0.020911788411805	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.40354601905	1930.40354601905
"healthy-4"	"2019-08-01-count-3:CGGGTGTAGGCTCACC"	-4.73859391632732	-5.07058098232421	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTAGGCTCACC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3105.78458987612	46.2078756859731	0.0148780040433571	3156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3102.07050697075	3102.07050697075
"healthy-4"	"2019-08-01-count-4:GTTGTGAGTTCGCGTG"	2.6697584587032	-6.18114807521971	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTGAGTTCGCGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.78611523137	43.219736738758	0.0213137551411958	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2024.86426934366	2024.86426934366
"healthy-4"	"2019-08-01-count-2:ACAAGCTCACCACTGG"	10.2136351066524	6.54253528201906	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTCACCACTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.3916626046	46.6745629605193	0.0229427616218023	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2026.97908497633	2026.97908497633
"healthy-4"	"2019-08-01-count-3:AACCAACAGGTGCTTT"	10.4325033622677	6.6045932539734	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACAGGTGCTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.03693036497	40.4315635579839	0.0201649969363029	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.53102247149	1992.53102247149
"healthy-4"	"2019-08-01-count-3:ATTTACCTCGTCCTTG"	2.86318077620808	-6.35842182552489	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTACCTCGTCCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.71838364972	44.9599272524733	0.0185960149687091	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2411.99810099513	2411.99810099513
"healthy-4"	"2019-08-01-count-3:TCTATCATCGTAACCA"	0.393434573977631	7.83192441547243	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATCATCGTAACCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.00677487835	40.1788548357653	0.0208612219644466	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1919.78782153413	1919.78782153413
"healthy-4"	"2019-08-01-count-4:CATGCTCCAGATCCTA"	-3.34257278862651	10.1339244612488	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCCAGATCCTA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2288.41144400137	47.7454948123238	0.0208640342790976	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2282.11840993773	2282.11840993773
"healthy-4"	"2019-08-01-count-4:TTTACGTCAGCTGTGC"	-2.80695090714152	9.92390534961549	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTCAGCTGTGC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2116.70010918641	51.7858438165347	0.0244653664408037	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2105.72840321216	2105.72840321216
"healthy-4"	"2019-08-01-count-3:GGACGTCGTAGTGGCA"	-1.52663038197215	10.4847688444885	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGACGTCGTAGTGGCA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2127.46550238249	44.9894485518024	0.0211469697165101	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2117.38563607486	2117.38563607486
"healthy-4"	"2019-08-01-count-4:AGGTCTAGTAGACGGT"	-0.0447645587032616	7.54324815357057	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTAGTAGACGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.04625382114	43.8537099598776	0.0216663576126718	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.9248770328	2015.9248770328
"healthy-4"	"2019-08-01-count-4:CTGCCATGTAGAGATT"	10.8273474174434	7.00926063144533	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCCATGTAGAGATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2042.64700672687	43.0642338876722	0.0210825628441197	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.26920491051	2034.26920491051
"healthy-4"	"2019-08-01-count-2:CTTCCGATCAAGCGTT"	3.56576551970784	-6.21240951931151	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGATCAAGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.88978223364	42.6323001233334	0.0172538250916212	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2467.50473217623	2467.50473217623
"healthy-4"	"2019-08-01-count-2:CTTCCGACAGGTTTAC"	6.75400127944295	-1.79553570663603	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGACAGGTTTAC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3076.15730650086	38.9296517489405	0.0126552864077108	2730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3070.84917590883	3070.84917590883
"healthy-4"	"2019-08-01-count-2:CCGCAAGTCCTTGAAG"	10.310976644128	6.38622520053712	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGCAAGTCCTTGAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.9706148261	48.1195934491278	0.0260110042091945	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1844.91852975322	1844.91852975322
"healthy-4"	"2019-08-01-count-2:AACAAAGCATTGCCGG"	0.0759762666070878	7.67666242206422	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGCATTGCCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1841.7292383125	46.8819678242679	0.0254554072602028	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1835.92351624709	1835.92351624709
"healthy-4"	"2019-08-01-count-3:ACTATTCAGGTACATA"	4.19613089141194	-6.34961702739867	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATTCAGGTACATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.73143669354	47.7890274730664	0.018283832379321	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2606.15325191903	2606.15325191903
"healthy-4"	"2019-08-01-count-2:AACAACCGTCCTCATC"	-0.136579732329208	8.15476892078248	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAACCGTCCTCATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2057.16899730671	45.2547276908863	0.021998546424788	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.67584457449	2054.67584457449
"healthy-4"	"2019-08-01-count-2:AGGAGGTAGAGGTCAC"	0.10838177528922	7.56771562183229	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAGGTAGAGGTCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.61100822191	47.1220081188186	0.0248978833548524	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.07170964319	1888.07170964319
"healthy-4"	"2019-08-01-count-2:CCGGTAGAGTCCCAAT"	-0.852056483656722	8.34666535938112	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGAGTCCCAAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1816.35056676149	46.1214592895477	0.0253923775143149	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1805.13063346582	1805.13063346582
"healthy-4"	"2019-08-01-count-3:TCAATTCTCGGAGATG"	-4.07075820389445	10.8132390745911	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCTCGGAGATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2233.09477521512	44.7527879990093	0.0200407024796778	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2225.17694599524	2225.17694599524
"healthy-4"	"2019-08-01-count-2:CTGAGGCCAGAGTCTT"	-1.98345885697063	9.27107045734254	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGGCCAGAGTCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.2965380236	45.673251067089	0.0236490099618928	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1926.29521712438	1926.29521712438
"healthy-4"	"2019-08-01-count-3:TAGGGTTTCTATCGTT"	0.471147735684556	7.97612187946168	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTTCTATCGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1864.72852111443	45.8680117410767	0.0245976887368379	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1856.38061383036	1856.38061383036
"healthy-4"	"2019-08-01-count-4:CATTCCGGTCCGTTTC"	-1.49822423878368	8.54153153980104	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGGTCCGTTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2264.41933913552	41.8155723594037	0.0184663554301597	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2254.3683779289	2254.3683779289
"healthy-4"	"2019-08-01-count-4:CATTCCGTCAAGTAAG"	2.25148334082906	-6.68544437801512	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGTCAAGTAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.28009152204	52.4146427812856	0.0238326364083128	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2195.25937242299	2195.25937242299
"healthy-4"	"2019-08-01-count-3:CCACGAGCAAGCTGTT"	4.74872364577596	-7.35873796856078	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGAGCAAGCTGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2776.12962684994	43.2692389746224	0.0155861738429411	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2771.95419819177	2771.95419819177
"healthy-4"	"2019-08-01-count-4:TTTATGCTCAGCTCTC"	-0.0171798718279183	8.10975644672243	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCTCAGCTCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2261.88312413647	46.4702419786465	0.0205449350953479	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2248.96117333978	2248.96117333978
"healthy-4"	"2019-08-01-count-4:AACAAGACAAGTATAG"	2.57714404639546	-6.29445555126341	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAGACAAGTATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.21852330244	45.8312023275575	0.0184415180789235	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2483.02781009014	2483.02781009014
"healthy-4"	"2019-08-01-count-4:ATGGAGGGTTCTTGCC"	-0.215725402266341	7.56174275958864	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGGTTCTTGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.68954251542	47.9478498893	0.023189095317941	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.82587410422	2058.82587410422
"healthy-4"	"2019-08-01-count-4:CTGGCAGGTGACTGAG"	-3.06937227669414	10.6844100722107	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGCAGGTGACTGAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1770.12797747884	49.8602465191789	0.028167594181633	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1766.29704134761	1766.29704134761
"healthy-4"	"2019-08-01-count-2:ACGCACGGTTAAACCC"	2.4196273284847	-4.03081085598143	"2019-08-01-count-2"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGGTTAAACCC"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3089.32048603858	42.2541289912858	0.0136774831818981	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3083.5954536289	3083.5954536289
"healthy-4"	"2019-08-01-count-4:CTGGCAGGTCGCTTGG"	9.92446007308308	7.18921372974244	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGCAGGTCGCTTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.94944327822	43.6389811785725	0.0231144861076355	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1881.52452063632	1881.52452063632
"healthy-4"	"2019-08-01-count-2:CTCAGTCTCTACACAG"	10.3913389640743	7.29653594577638	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCTCTACACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2037.68608847644	45.9538087798971	0.0225519568690074	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2029.76594844887	2029.76594844887
"healthy-4"	"2019-08-01-count-2:AGGCATTGTCTAGTGT"	10.9521347480709	6.95607516849367	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTGTCTAGTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.40774273629	46.4238732694484	0.0244799007213841	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1887.46657706664	1887.46657706664
"healthy-4"	"2019-08-01-count-3:TCATTTGCAATCGCCG"	2.15089716491048	-6.33350040828856	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTTGCAATCGCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.21149144885	40.811827125835	0.0199255923014893	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2048.21149144885	2048.21149144885
"healthy-4"	"2019-08-01-count-2:CACGAATTCTCACTCG"	0.601152260869187	7.90851304614869	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCTCACTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.60671707289	40.2393657357661	0.0198751517499373	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2021.82614854055	2021.82614854055
"healthy-4"	"2019-08-01-count-3:CAACGATCAAGGCTTT"	2.64498343047444	-6.14415600216063	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATCAAGGCTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.02943386436	43.9251191661148	0.0177115313900412	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2476.82060982244	2476.82060982244
"healthy-4"	"2019-08-01-count-3:GTTCTATGTGCCCAGT"	-0.787142733961898	8.21534059131471	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATGTGCCCAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.56315332715	44.8770980646929	0.0216008346089617	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2066.34449216797	2066.34449216797
"healthy-4"	"2019-08-01-count-2:CTGCATCGTCTAACGT"	-4.75418839874919	-5.10747768795165	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCGTCTAACGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2752.15573486314	50.8826813054924	0.0184883001571939	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2745.80519609163	2745.80519609163
"healthy-4"	"2019-08-01-count-4:CATTGCCTCGGCAGTC"	-4.49265084686931	-3.5934310189453	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCTCGGCAGTC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2994.30053860573	47.2101605286095	0.0157666740261792	3895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2985.05551749753	2985.05551749753
"healthy-4"	"2019-08-01-count-3:CCACTTGGTGGATACG"	11.1485582786495	5.8218374022278	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGGTGGATACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.98184468673	43.9445179760955	0.0233501285361286	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1871.76372066495	1871.76372066495
"healthy-4"	"2019-08-01-count-4:ACGTCCTGTGACAGGT"	-0.6834753555363	8.20201776111452	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTCCTGTGACAGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.26828569183	43.7576720216222	0.0222881774949075	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1956.5922789719	1956.5922789719
"healthy-4"	"2019-08-01-count-2:ATGGTTGTCTTCCACG"	2.8141299682552	-6.10700800335082	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGTTGTCTTCCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.49156242774	46.2720713825544	0.0179384464971867	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2572.46385351035	2572.46385351035
"healthy-4"	"2019-08-01-count-3:GCAGCCACAAGGCGTA"	3.27236690100972	-6.58166029369506	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCACAAGGCGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.576501804	47.8558008478075	0.0208288171515648	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2296.20942775253	2296.20942775253
"healthy-4"	"2019-08-01-count-2:CAGGTATAGAGAACCC"	4.55393900451009	-6.74238827144774	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATAGAGAACCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2851.70615254839	41.205761622032	0.0144495117721751	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2842.6603939279	2842.6603939279
"healthy-4"	"2019-08-01-count-2:ACGGTCGCAAAGCGTG"	-1.73432074013408	8.87059781635133	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGCAAAGCGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.78087005992	41.0191151642662	0.0227280307791075	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1792.43807166619	1792.43807166619
"healthy-4"	"2019-08-01-count-2:TTCCTAAGTGACGTCC"	3.48074974593465	-6.39906170284423	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAGTGACGTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.40629025053	44.2779787820426	0.0182108514564549	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2427.90803653714	2427.90803653714
"healthy-4"	"2019-08-01-count-2:TTCCTAACAAAGGATT"	2.76859583434407	-6.04380228435668	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAACAAAGGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.23777061175	44.5458901368298	0.0168783163960648	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2632.78909835875	2632.78909835875
"healthy-4"	"2019-08-01-count-2:CTTTCAATCCCGTGTT"	4.21342052993123	-7.43616487896117	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCCCGTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1920.95188086862	50.7984244104591	0.0264444023384328	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1919.00567696402	1919.00567696402
"healthy-4"	"2019-08-01-count-3:GGCACGTCACGACAGA"	3.03769793090169	-6.13831665432128	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTCACGACAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.93299940587	43.8152682397808	0.0168395067243413	2081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2601.04785949639	2601.04785949639
"healthy-4"	"2019-08-01-count-4:AACCAACGTCTTCAAG"	11.3238417106563	5.77315900409547	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCAACGTCTTCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.7811256784	41.3730127608459	0.0205653648067178	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2010.20266757163	2010.20266757163
"healthy-4"	"2019-08-01-count-2:CCATCACAGTAAGCAT"	-7.52414069595988	0.730037368181623	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATCACAGTAAGCAT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3070.76681202385	44.4961982138946	0.0144902563228396	4060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3057.75884528119	3057.75884528119
"healthy-4"	"2019-08-01-count-2:ACGTAACAGGGCAGAG"	0.3880897956783	4.42610452258912	"2019-08-01-count-2"	"Control4"	"Ery"	"Erythrocytes"	54	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACAGGGCAGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1706.07184808114	42.3504317247894	0.024823357687088	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	1665.36511035175	1665.36511035175
"healthy-4"	"2019-08-01-count-3:TGAACGTAGTGTAGTA"	2.28525580939595	-6.56249143993529	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAACGTAGTGTAGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1915.97400055861	45.9284041723369	0.0239713086706533	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1910.8844526033	1910.8844526033
"healthy-4"	"2019-08-01-count-1:AACCTTTCATTGAGCT"	-0.234580616385299	7.60843942249147	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AACCTTTCATTGAGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2149.06626614979	40.0569006549939	0.0186392114966091	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2133.13532039027	2133.13532039027
"healthy-4"	"2019-08-01-count-3:CGTTAGAAGGTGCTAG"	2.4494170146877	-5.9493732682434	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGAAGGTGCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.92417730174	45.6141079679871	0.0177976814031267	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2556.28124227428	2556.28124227428
"healthy-4"	"2019-08-01-count-2:TATCCTAGTCGAATGG"	-1.73001072827037	8.94530675494996	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTAGTCGAATGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.57837625058	47.2235792199254	0.0257128036737172	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1836.57837625058	1836.57837625058
"healthy-4"	"2019-08-01-count-2:AGGGCCTTCAAGGAGC"	-0.75824354115184	8.40326688373414	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTTCAAGGAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1984.54225450325	44.2584124789653	0.0223015722535188	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.17643462693	1979.17643462693
"healthy-4"	"2019-08-01-count-3:CGTTAGAGTCCATAGT"	10.9035936790401	6.94828460300294	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTAGAGTCCATAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.83373298449	44.7802175940554	0.0217291753707879	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2053.78376378562	2053.78376378562
"healthy-4"	"2019-08-01-count-3:AGTTCCCGTCAAGGCA"	4.4861909347469	-7.63084461605223	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTCAAGGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.24238614948	43.7734728778698	0.0166804229323107	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2624.24238614948	2624.24238614948
"healthy-4"	"2019-08-01-count-4:GATTCTTTCCGTGTAA"	11.6570164161617	3.44321105563966	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCTTTCCGTGTAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.81168628903	37.7389093998145	0.0184109153305379	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2033.67893735877	2033.67893735877
"healthy-4"	"2019-08-01-count-2:CCTACGTGTTCTGAGT"	-1.81298373165782	4.08948991382448	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTGTTCTGAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3226.47190777337	43.8561870865824	0.0135926139573452	5901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3218.22801798471	3218.22801798471
"healthy-4"	"2019-08-01-count-3:TCAGCAAGTTAGTTCG"	5.24701656874959	-7.63887503063353	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAAGTTAGTTCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.98159733678	44.5478906306438	0.0170944762910721	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2600.47125344013	2600.47125344013
"healthy-4"	"2019-08-01-count-4:CCAATGAGTGTACGCC"	-2.40851531449016	8.8619289168152	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGAGTGTACGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1827.78015994769	47.7016303233836	0.0260981223938599	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1822.21990877451	1822.21990877451
"healthy-4"	"2019-08-01-count-2:CCTACGTTCCGCATAA"	11.0160118537838	6.52825782382814	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTACGTTCCGCATAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1980.25937135986	45.8010902318329	0.0231288339771274	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.17803408203	1968.17803408203
"healthy-4"	"2019-08-01-count-3:CTTTCGGAGCCTCATA"	4.5443021255428	-6.62605955516966	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCGGAGCCTCATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2768.35445922619	42.5120135405067	0.015356419911773	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2763.06822674728	2763.06822674728
"healthy-4"	"2019-08-01-count-3:GCTCAAACACGGCGTT"	3.15634049948995	-6.42889978801879	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTCAAACACGGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2013.79497591157	46.5953433328162	0.0231380770585765	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2012.21397567263	2012.21397567263
"healthy-4"	"2019-08-01-count-4:TCAGCAACACTGCTTC"	-3.16561565819438	-5.70652391826781	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAACACTGCTTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2283.20298183703	49.8449576947177	0.0218311547817852	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2280.31183370573	2280.31183370573
"healthy-4"	"2019-08-01-count-3:CCCGAAGTCCGCATAA"	4.41195358809773	-6.47588255321654	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGAAGTCCGCATAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.94078607451	45.6620382650698	0.0189867619732967	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2402.35095136617	2402.35095136617
"healthy-4"	"2019-08-01-count-3:GGCTTTCGTCTGTGCG"	-3.98257193985637	13.2530250319275	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCGTCTGTGCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2135.22302574259	36.1819101200665	0.0169452603703929	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2131.53839495799	2131.53839495799
"healthy-4"	"2019-08-01-count-2:ATTCACTAGCACACAG"	6.80433907088582	-1.76311602508696	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTAGCACACAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3135.21067484907	39.9373913891305	0.012738343776867	2881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3123.46428239555	3123.46428239555
"healthy-4"	"2019-08-01-count-4:ACTGATGGTCGCTTGG"	1.81553759154622	-6.05376818096312	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGATGGTCGCTTGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2440.32418340392	51.0719105697351	0.0209283303083514	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2434.84659191544	2434.84659191544
"healthy-4"	"2019-08-01-count-4:ACTGATGGTAAGATTG"	-4.92696891251262	-2.99919893657836	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGATGGTAAGATTG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2938.67141735624	39.6405101173623	0.0134892624889055	3024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2923.86656873764	2923.86656873764
"healthy-4"	"2019-08-01-count-4:CCACAAACATCATCCC"	3.98823370513265	-6.45373108303221	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAACATCATCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2840.80171507488	42.6889881815438	0.015027091808278	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2836.11698659938	2836.11698659938
"healthy-4"	"2019-08-01-count-3:GGTGATTTCTCGACCT"	5.01417030867879	-7.81239225780638	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGATTTCTCGACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.22330677209	45.7745573097405	0.0167658657063694	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2720.59517334411	2720.59517334411
"healthy-4"	"2019-08-01-count-3:AAGACTCGTCGATTAC"	0.442394842475098	8.079150176886	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCGTCGATTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1833.90546660738	39.5734738850299	0.0215787970566653	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1832.4854192074	1832.4854192074
"healthy-4"	"2019-08-01-count-3:TATCTTGAGGTAGCCA"	3.67731275138203	-6.27241327678832	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGAGGTAGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.12646807392	42.5000467691714	0.0158990033867699	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2671.4080168059	2671.4080168059
"healthy-4"	"2019-08-01-count-4:TGTTGGATCTTAGCAG"	0.736247976391953	8.22624108875123	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGGATCTTAGCAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.3237685966	44.6492984748937	0.0246229047719644	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1801.64406106091	1801.64406106091
"healthy-4"	"2019-08-01-count-2:AGGTAGGGTAGCGCCT"	1.88413610038106	-6.48610975658568	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTAGGGTAGCGCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1959.37756435382	52.5479733974657	0.0268187073045289	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1956.06678032595	1956.06678032595
"healthy-4"	"2019-08-01-count-4:TCAGGGCTCCTGTAGA"	-0.0619230148499787	7.65315387332765	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGGCTCCTGTAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.42188162557	43.7668627868142	0.0222911149134074	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.38207983696	1952.38207983696
"healthy-4"	"2019-08-01-count-4:CCACAAATCATCACTT"	5.69065060195271	-9.87019541179808	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAATCATCACTT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2904.72161898467	46.1329635087802	0.0158820601627586	2424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2896.83300213648	2896.83300213648
"healthy-4"	"2019-08-01-count-3:GGTGGCTGTCACAGTT"	9.9195953803951	7.00019643390504	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTGTCACAGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.7714807309	45.462680454587	0.0233169276009435	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1946.89456523568	1946.89456523568
"healthy-4"	"2019-08-01-count-2:TTCTAACTCGGCTTGG"	4.655609746545	-6.79814245617064	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACTCGGCTTGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.39047401197	45.7588148849632	0.0172065047732277	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2652.95975690595	2652.95975690595
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTACCCACG"	4.38554205474202	-6.68920805370482	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTACCCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2762.85585571333	47.5086682440842	0.0171954928976264	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2755.40662066921	2755.40662066921
"healthy-4"	"2019-08-01-count-2:ACGTTCCGTTGCAAGG"	-0.217774937779266	8.41425321185914	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCGTTGCAAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.09742228293	42.4890828486049	0.0229907159310458	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1833.87671105583	1833.87671105583
"healthy-4"	"2019-08-01-count-4:CCACACTCATCAGCAT"	11.5252043205196	3.75094173038331	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTCATCAGCAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2275.34536104441	41.1427365177151	0.0180819743772128	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2249.43559460889	2249.43559460889
"healthy-4"	"2019-08-01-count-3:GGTGTTAAGTATTGCC"	2.38088860091512	-5.96777012264403	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTTAAGTATTGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.69818226378	42.552163461918	0.0165142210891512	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.497648441	2568.497648441
"healthy-4"	"2019-08-01-count-3:AGAAGCGGTGGTCTCG"	-3.08111105385478	3.74721906268922	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGCGGTGGTCTCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3256.66441776944	45.7451546720735	0.01404662833004	4836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3247.77928560742	3247.77928560742
"healthy-4"	"2019-08-01-count-2:TATTCCACACGGGCTT"	3.96073259887044	-7.27391102230223	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCACACGGGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.13264984397	41.9019397227272	0.0156810851905776	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2661.80885400359	2661.80885400359
"healthy-4"	"2019-08-01-count-3:CTACATTGTCCTACAA"	-3.40309677544292	3.6888389357361	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACATTGTCCTACAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3351.04336959301	47.3074383836211	0.0141172265369298	5143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3339.11717242042	3339.11717242042
"healthy-4"	"2019-08-01-count-3:TCAGTGACACCTCTGT"	0.32192083176915	7.78602216327516	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGACACCTCTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.88188578967	41.5987383955212	0.0210639120723352	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1968.29495048583	1968.29495048583
"healthy-4"	"2019-08-01-count-3:TCAGTGATCGGCTTGG"	-1.85540578785594	8.83517739856569	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGATCGGCTTGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2100.13459285683	49.1196419989917	0.0233888066822297	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.00769117481	2089.00769117481
"healthy-4"	"2019-08-01-count-3:TCAGTGATCTAGACAC"	2.43847884711568	-5.99563076412352	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGATCTAGACAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.08768166717	47.6540271179783	0.0186214905645332	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2552.79836185205	2552.79836185205
"healthy-4"	"2019-08-01-count-4:TGAATCGTCCTGGGAC"	-2.73978672447856	9.41328332507936	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGTCCTGGGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2123.09219226223	46.8700921505891	0.0220763339064647	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2116.46778781635	2116.46778781635
"healthy-4"	"2019-08-01-count-3:TATTCCATCGGACTTA"	3.78368391570393	-6.99794485485228	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCATCGGACTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2006.8436348598	45.5102204874784	0.0226775119381225	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1999.91923693774	1999.91923693774
"healthy-4"	"2019-08-01-count-3:TTCAGGAAGAAGTATC"	0.287789602845353	7.72075793826906	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAGGAAGAAGTATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1887.00546681609	41.6066752089029	0.0220490485801851	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1875.91221546259	1875.91221546259
"healthy-4"	"2019-08-01-count-1:CAACAACGTGAGCCAA"	9.44297184523885	6.90192792499391	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAACAACGTGAGCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2152.2107548507	43.576141746863	0.0202471536064255	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2143.94057354004	2143.94057354004
"healthy-4"	"2019-08-01-count-4:ACTTATCGTACTGAGG"	4.58527864989583	-6.86301424419554	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCGTACTGAGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.44139149681	48.16618551933	0.0190196644554373	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2528.78791917792	2528.78791917792
"healthy-4"	"2019-08-01-count-4:CCACGTTGTAAGACCG"	-3.40921388092693	-5.5784597626892	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGTTGTAAGACCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2785.11869340675	51.1208427720841	0.0183549961059481	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2774.28976337799	2774.28976337799
"healthy-4"	"2019-08-01-count-3:ATATCCTTCGGCTGAC"	0.252752085297745	8.04979703510133	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTTCGGCTGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.17486066472	43.2334216980986	0.0225623572178067	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.98442980924	1906.98442980924
"healthy-4"	"2019-08-01-count-3:TGAGGTTAGCTTTGTG"	11.2331901985103	5.91639134967653	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTAGCTTTGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.51963296407	47.1578673562306	0.0255664762323239	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1842.82573759374	1842.82573759374
"healthy-4"	"2019-08-01-count-2:GCAGGCTGTACCAATC"	0.464256753295106	8.02369783008424	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTGTACCAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.92995248878	42.4286964169038	0.0238640990088003	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1767.10931760921	1767.10931760921
"healthy-4"	"2019-08-01-count-3:TCATATCCACACGCCA"	-0.885941485792953	8.34441850269166	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATATCCACACGCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2273.34798077735	47.7572870782163	0.0210074689321808	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2259.13893662549	2259.13893662549
"healthy-4"	"2019-08-01-count-4:CCACTTGCACGAAAGC"	5.11944260176961	-7.93497755443724	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACTTGCACGAAAGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2798.65889420391	40.9741001686933	0.0146406195673048	2468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2793.22420330691	2793.22420330691
"healthy-4"	"2019-08-01-count-3:TGAGGTTAGTTTCGAC"	-2.0663620037144	9.15846822345582	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTAGTTTCGAC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2026.67518582345	51.4917696645298	0.0254070163905463	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2017.5643973009	2017.5643973009
"healthy-4"	"2019-08-01-count-1:CAACGATAGTGTTGAA"	-0.169858972460586	7.61586902225343	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAACGATAGTGTTGAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2144.8764484889	37.3946491206526	0.0174344070713247	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2132.19565688917	2132.19565688917
"healthy-4"	"2019-08-01-count-4:CCATAAGCAAAGGCAC"	5.29574217376058	-10.2648744813171	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGCAAAGGCAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.71009374548	49.9739870168097	0.0219308226851571	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2268.45526867491	2268.45526867491
"healthy-4"	"2019-08-01-count-3:TGAGGTTTCTTAATCC"	2.58123483237569	-5.48442938244017	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTTCTTAATCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2958.57858372344	40.8798460649876	0.013817394031677	2713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2955.69523935053	2955.69523935053
"healthy-4"	"2019-08-01-count-1:CAAGCTAAGGGACCAT"	10.8711191612178	6.5278634794983	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAAGCTAAGGGACCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2196.01309066425	41.0348037475214	0.0186860469648244	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2186.06334713487	2186.06334713487
"healthy-4"	"2019-08-01-count-4:CTTCTCTCAGTTTCAG"	3.15666379508321	-5.9866981736389	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTCAGTTTCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2866.84864734078	46.9657824464104	0.016382372501588	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2854.26473049498	2854.26473049498
"healthy-4"	"2019-08-01-count-3:ATCACGACACCATTCC"	4.61344160613362	-6.96609785473021	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGACACCATTCC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2844.10007152569	43.0567398727365	0.0151389679652303	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2841.36080504183	2841.36080504183
"healthy-4"	"2019-08-01-count-4:GCAGCTGTCTCCCTAG"	3.08265127715413	-6.14743187343749	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCTGTCTCCCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.62399784034	47.5166709652314	0.0179604777564839	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2640.48340718512	2640.48340718512
"healthy-4"	"2019-08-01-count-3:TGATCAGCAAGCTGCC"	4.13279356536214	-7.23406317150267	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGCAAGCTGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.89189332923	49.8862658014501	0.0221235731739651	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2254.89189332923	2254.89189332923
"healthy-4"	"2019-08-01-count-2:GCATCGGGTGTTCATG"	10.2277389961178	7.5895843275818	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCGGGTGTTCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2298.16027547543	46.8759170218868	0.0203971487637822	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2288.79563258941	2288.79563258941
"healthy-4"	"2019-08-01-count-3:TCAAGTGAGCTGTTCA"	9.82933201369588	6.70068500125734	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGTGAGCTGTTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1739.60273231878	40.9847481740334	0.0235598320309622	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1732.2932961028	1732.2932961028
"healthy-4"	"2019-08-01-count-4:AGGTAGGTCTCACTCG"	11.420803685754	4.63848397815553	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTAGGTCTCACTCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2200.83433408602	36.0297831838498	0.0163709656041932	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2192.07693912081	2192.07693912081
"healthy-4"	"2019-08-01-count-3:TGATCTTGTCATCCGG"	2.88086428222005	-6.17949201976927	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCTTGTCATCCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.46947622927	50.5266360565778	0.0223325161233944	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2257.99370911593	2257.99370911593
"healthy-4"	"2019-08-01-count-2:CATCCACTCCTAACAG"	9.97783722457234	7.83150813663331	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACTCCTAACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2233.66472728829	45.2623318669806	0.0202637089237336	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2225.88192134994	2225.88192134994
"healthy-4"	"2019-08-01-count-3:TGATGCACACGTAGAG"	-4.06161199036296	12.5555763014588	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGCACACGTAGAG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.62333763204	50.4220834692815	0.0257042636585615	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1954.46843900035	1954.46843900035
"healthy-4"	"2019-08-01-count-3:ATCACTTCATGATAGA"	10.3890091377193	6.89557311618654	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTCATGATAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1620.90013003544	35.2015201829625	0.0217172665549683	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1607.37550382072	1607.37550382072
"healthy-4"	"2019-08-01-count-2:CCTGCATGTCCTTGTC"	4.02553953704183	-6.30031301891478	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATGTCCTTGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2920.16329423906	41.4755985080802	0.0142031778119751	2747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2917.30971868182	2917.30971868182
"healthy-4"	"2019-08-01-count-2:AGTACTGTCTTCACAT"	-3.09351382675822	9.48015592182008	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACTGTCTTCACAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.21092439083	47.8582165964701	0.0245904572812168	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.9450980573	1937.9450980573
"healthy-4"	"2019-08-01-count-2:TCAAGCAAGAGGTCAC"	10.555961270898	7.44012830341188	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCAAGAGGTCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.3690777682	42.2363161763959	0.0220167832487859	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1916.29213444856	1916.29213444856
"healthy-4"	"2019-08-01-count-3:CTATCCGAGTCACGAG"	2.95566215094869	-6.06779673015746	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTATCCGAGTCACGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.03857945212	44.4815329132067	0.0179213704740341	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2478.73512796442	2478.73512796442
"healthy-4"	"2019-08-01-count-4:TTAGGGTCACCATTCC"	-3.39937887612041	3.74378893459169	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTCACCATTCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3369.53907616057	47.2334097180438	0.0140177658280384	5122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3358.71397916223	3358.71397916223
"healthy-4"	"2019-08-01-count-1:CATGCTCGTTCAGGTT"	0.427171667187852	7.99765775287477	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATGCTCGTTCAGGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.69901312125	40.685386683544	0.0217371417083225	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1861.71015916438	1861.71015916438
"healthy-4"	"2019-08-01-count-2:GCATGATTCGTCCTCA"	-2.37624822083171	8.93174932086793	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATGATTCGTCCTCA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2091.9955826091	48.5572941891645	0.0232109926965547	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2077.53849487119	2077.53849487119
"healthy-4"	"2019-08-01-count-3:ATCAGGTCATTCTCTA"	10.3629681068355	7.68965671146242	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTCATTCTCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2081.35052437608	45.6650146375327	0.0219400884679055	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2073.53296233499	2073.53296233499
"healthy-4"	"2019-08-01-count-3:TGATTTCCATAGACTC"	3.14656605300252	-5.94473698055419	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTTCCATAGACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.80061433003	44.1605020897822	0.0169275113809811	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2597.9228043642	2597.9228043642
"healthy-4"	"2019-08-01-count-3:TGATTCTTCCGGTAGC"	10.6293112235958	6.79459664905397	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTCTTCCGGTAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.197052376	48.243057424703	0.0239277492087644	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2011.39704294086	2011.39704294086
"healthy-4"	"2019-08-01-count-3:GCCCGAATCTTCACGC"	6.78585400161092	-1.41927971756133	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAATCTTCACGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2435.0529081541	45.6511098261056	0.0187474816966961	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2414.65818906932	2414.65818906932
"healthy-4"	"2019-08-01-count-1:CCGAACGAGGCTGGAT"	0.383413543074769	8.05620858753053	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCGAACGAGGCTGGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2142.81647147538	35.7838504029973	0.0166994471432074	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2128.84727437833	2128.84727437833
"healthy-4"	"2019-08-01-count-1:CCCGGAAGTCTTGCGG"	0.788909931748551	8.16383550250856	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCCGGAAGTCTTGCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.52675628767	45.6857492781847	0.023267189577065	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1943.82574729961	1943.82574729961
"healthy-4"	"2019-08-01-count-4:AGAACAATCAGGAAAT"	4.78090824660603	-6.8749890557495	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACAATCAGGAAAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2832.76546112664	43.8839147642013	0.0154915454055091	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2825.84124711113	2825.84124711113
"healthy-4"	"2019-08-01-count-2:ACTGCAACACTCTGCT"	5.60505308684651	-10.1506386033264	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAACACTCTGCT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.63747861667	42.5088546026775	0.0156131159350218	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.25291827851	2716.25291827851
"healthy-4"	"2019-08-01-count-3:TACAGGTTCTATCGTT"	0.218183641403359	7.91355559909669	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAGGTTCTATCGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.39421470178	44.2713118432184	0.0232591396470934	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1891.69556216331	1891.69556216331
"healthy-4"	"2019-08-01-count-3:AACCATGGTTGCTTGA"	10.3531242805416	6.74446961963502	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGGTTGCTTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.51067367966	43.1481079830326	0.0224086568684537	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.6447057229	1919.6447057229
"healthy-4"	"2019-08-01-count-3:AACCCAAAGCCAGAGT"	11.2021624046261	5.1468467482361	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAAAGCCAGAGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2178.12069579965	46.7352265822644	0.0214566744039438	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2173.98789611176	2173.98789611176
"healthy-4"	"2019-08-01-count-4:ATCACAGCAAGAGCTG"	0.502849658101243	7.85881135547487	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACAGCAAGAGCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.35746067775	47.3092355561663	0.025026608215784	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1879.12048822694	1879.12048822694
"healthy-4"	"2019-08-01-count-4:TCATTCAAGATTCGCT"	10.9461494880611	6.42295644367067	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTCAAGATTCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2017.35018486808	42.8819964621419	0.0212565953019932	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2013.78188158674	2013.78188158674
"healthy-4"	"2019-08-01-count-2:ACTGTGAGTTGTCTAG"	4.54058708724324	-7.76748993312987	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTGAGTTGTCTAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.45698060591	44.4370586893632	0.0171013255255053	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2597.41110548894	2597.41110548894
"healthy-4"	"2019-08-01-count-3:ATCCCTGAGGCTCAAG"	10.8504320579464	7.08228728854982	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCCTGAGGCTCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.22634917354	43.8382278344819	0.0230094591403789	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1899.24918493905	1899.24918493905
"healthy-4"	"2019-08-01-count-3:TCATTCAAGGTTCATC"	-1.92309544506724	3.97524187648622	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTCAAGGTTCATC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2641.99007545708	33.6596122622618	0.0127402493199898	3181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2640.19079278693	2640.19079278693
"healthy-4"	"2019-08-01-count-3:GTAGAAATCGTCTAAG"	11.0993505912716	4.42294881427614	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAAATCGTCTAAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1808.20223664439	42.3592603041853	0.0234261740449975	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1802.09712411762	1802.09712411762
"healthy-4"	"2019-08-01-count-4:AACACACAGGTAAACT"	-1.31733928147014	8.41244504535524	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACAGGTAAACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2312.50498718825	40.2452797641559	0.0174033266899414	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2304.07972456554	2304.07972456554
"healthy-4"	"2019-08-01-count-2:ACTTATCCAAATACAG"	4.68909754332845	-6.76382591640624	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCCAAATACAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.66029651203	48.2910441817861	0.0185973668741549	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2594.65999530653	2594.65999530653
"healthy-4"	"2019-08-01-count-4:AGACAAACAAGTATAG"	11.5413843589718	4.06083581531373	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAACAAGTATAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2206.16905796388	40.8153619380469	0.0185005595064035	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2191.56215152067	2191.56215152067
"healthy-4"	"2019-08-01-count-1:CGTCAAATCTTCGTGC"	10.9692417579586	6.02781245792238	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGTCAAATCTTCGTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2239.30414098956	39.4970538826654	0.0176380926376581	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2227.58889006857	2227.58889006857
"healthy-4"	"2019-08-01-count-4:AAGTACCTCGTTACCC"	0.55508311566655	8.06353185260621	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTACCTCGTTACCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.56709171027	41.9054970728573	0.0221071030701679	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1885.81507195203	1885.81507195203
"healthy-4"	"2019-08-01-count-3:TTCTAGTCAGAGTCTT"	10.4278742271358	6.97576949680177	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTCAGAGTCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.47460398165	44.8132115668743	0.0229991253030961	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.86952410036	1942.86952410036
"healthy-4"	"2019-08-01-count-1:CTAGACATCAGCGTCG"	10.4667478996212	7.25406739795534	"2019-08-01-count-1"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTAGACATCAGCGTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.09655128373	48.2939541193031	0.0244514396462867	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1972.00557027565	1972.00557027565
"healthy-4"	"2019-08-01-count-2:ACTTATCTCCGAACGC"	3.20242800292317	-7.01991369640502	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTATCTCCGAACGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1741.54854918327	51.4696032034444	0.0295539295919037	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1739.42812827845	1739.42812827845
"healthy-4"	"2019-08-01-count-4:AGACACTAGTAATACG"	11.3677326637203	3.61495969379274	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACACTAGTAATACG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1447.6825581353	48.1277406691046	0.0332446781227342	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1427.85174077458	1427.85174077458
"healthy-4"	"2019-08-01-count-3:TCACGCTAGAGCTGCA"	11.2130524116451	5.99370906436769	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGCTAGAGCTGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1988.7898870896	46.4343084705668	0.0233480212122955	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.34596622411	1987.34596622411
"healthy-4"	"2019-08-01-count-4:TCATTTGCATCATGAC"	11.2960878807003	4.90775392139284	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTTGCATCATGAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.21062441676	43.4980615182055	0.0213412985866721	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2030.25315307785	2030.25315307785
"healthy-4"	"2019-08-01-count-2:GGTGTTATCACCTTAT"	4.00207199630086	-7.61031725322875	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTTATCACCTTAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.60884606221	48.77064128887	0.022499742689955	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2159.84146110714	2159.84146110714
"healthy-4"	"2019-08-01-count-3:TGCCGAGAGTGGAAAG"	-3.5041061443394	-5.4279618493286	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCCGAGAGTGGAAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2773.463090381	49.4490026762729	0.0178293350460561	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2766.05055210701	2766.05055210701
"healthy-4"	"2019-08-01-count-4:GCCCAGAAGGTCACAG"	6.78835548934285	-1.71493592178496	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGAAGGTCACAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2941.01939457716	43.7569660425045	0.0148781630353021	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2915.04327216906	2915.04327216906
"healthy-4"	"2019-08-01-count-3:ATCCTATTCAGGTGTT"	11.5582472282345	3.5268447169098	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATTCAGGTGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.14747693098	44.7607429217828	0.02227847554036	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.14419348124	1992.14419348124
"healthy-4"	"2019-08-01-count-3:CTCATGCCAAGTGCAG"	4.19190992888753	-6.37563040172728	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCCAAGTGCAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2793.26952905197	40.5473944806128	0.014516105251889	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2788.22891854559	2788.22891854559
"healthy-4"	"2019-08-01-count-4:GCCCAGACAGTAACCT"	4.88356604155843	-7.46103813564452	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGACAGTAACCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2860.5346470088	49.5573348826357	0.017324500835694	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2855.2077941739	2855.2077941739
"healthy-4"	"2019-08-01-count-3:TCCACCAGTTATGGTC"	0.30719213661496	7.88836143100587	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCAGTTATGGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1932.46037977472	40.7116354998025	0.0210672549491279	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1925.35341489186	1925.35341489186
"healthy-4"	"2019-08-01-count-3:AGATGAAAGGTTACCT"	-0.228148172528106	7.62954375827638	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGAAAGGTTACCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.74305425655	41.5076059546781	0.0212017638701012	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1950.89171104538	1950.89171104538
"healthy-4"	"2019-08-01-count-4:GAACTGTTCGTGACTA"	3.11481346663777	-6.27145912563475	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACTGTTCGTGACTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.28386846417	44.5987059955947	0.0209257465209142	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2123.17116081604	2123.17116081604
"healthy-4"	"2019-08-01-count-2:GTTGAACGTCAGCGTC"	11.6307217079097	3.51556608760682	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACGTCAGCGTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2233.64484336301	36.4705573614967	0.0163278228720489	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2222.01040664176	2222.01040664176
"healthy-4"	"2019-08-01-count-4:AGAGAATCATTGTAGC"	0.249547843902749	7.68136928165285	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAATCATTGTAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1833.02368764593	37.8221625000266	0.0206337554473177	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1830.23584417633	1830.23584417633
"healthy-4"	"2019-08-01-count-2:GCCCAGAAGGCAGTCA"	10.5934435325557	7.55193564975587	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGAAGGCAGTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.54473460225	47.7656441374234	0.023757563467929	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2005.05176831119	2005.05176831119
"healthy-4"	"2019-08-01-count-3:ATCGATGTCTTCCTAA"	3.81838359412495	-7.07808401500853	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGTCTTCCTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.82597658147	50.3871016094773	0.020865727840483	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2410.77259239265	2410.77259239265
"healthy-4"	"2019-08-01-count-4:AGAGAATGTTGAGTCT"	11.5299564796383	3.6170923479828	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAATGTTGAGTCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2094.99870548691	39.4272843106529	0.0188197177436868	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2072.37390623818	2072.37390623818
"healthy-4"	"2019-08-01-count-4:CACTAAGCATTCAGGT"	10.1209818321163	7.37069127643434	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTAAGCATTCAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.72389109504	42.74984971242	0.0213778761671994	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1997.05972969955	1997.05972969955
"healthy-4"	"2019-08-01-count-2:TGTAGACAGGAAAGGT"	11.0767303901607	5.53779981220094	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAGACAGGAAAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1766.66363812479	44.7195023280783	0.0253129692393202	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1764.8634995105	1764.8634995105
"healthy-4"	"2019-08-01-count-4:GCCGTGACACGACAGA"	-4.67150912705119	3.5085296400818	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCGTGACACGACAGA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2762.43831154855	42.4422491872338	0.0153640532024919	2656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2755.97685511707	2755.97685511707
"healthy-4"	"2019-08-01-count-4:TCCAGAATCCCAGGCA"	10.9494759040767	5.83032653415529	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCAGAATCCCAGGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1998.3519569848	48.1248863791401	0.0240822875124325	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.91605237808	1991.91605237808
"healthy-4"	"2019-08-01-count-3:GCTACAATCCGTGTGG"	0.219978828995866	7.82175014102785	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACAATCCGTGTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.46221763272	42.6784149214605	0.0218699673177546	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1940.55673335933	1940.55673335933
"healthy-4"	"2019-08-01-count-2:CATGCTCTCGGACTTA"	11.0130983787471	4.47047946536867	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCTCTCGGACTTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.48548793271	48.0714403664305	0.0267586021091372	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1775.30167130898	1775.30167130898
"healthy-4"	"2019-08-01-count-2:AGTTAGCCATAGATCC"	5.06231321868245	-7.76035597240599	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTAGCCATAGATCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.23444066956	46.2547204378531	0.0176866439652771	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2609.21126524461	2609.21126524461
"healthy-4"	"2019-08-01-count-3:TGCGGCACACATACTG"	13.9901606040889	1.74444410884706	"2019-08-01-count-3"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCACACATACTG"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1253.77810980329	55.7109820221044	0.0444344829332244	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1245.61302064368	1245.61302064368
"healthy-4"	"2019-08-01-count-3:GTATTTCGTAGCTGAG"	2.12525238570516	-6.10194160854491	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTTCGTAGCTGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.18591467593	45.7111379758469	0.0176342050610832	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2587.13327449383	2587.13327449383
"healthy-4"	"2019-08-01-count-2:GCCCGAATCCAAGGGA"	10.1584841209346	6.0928482779297	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAATCCAAGGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1673.08449918735	40.4181366760174	0.0241578573560686	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1666.89745304018	1666.89745304018
"healthy-4"	"2019-08-01-count-3:AGCCAATTCATGTCAG"	0.406869967549485	8.12737748706666	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATTCATGTCAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1838.51447772701	43.4771462216186	0.0236479759873146	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1832.42470500559	1832.42470500559
"healthy-4"	"2019-08-01-count-4:AGAGCAGGTCTCTCAC"	-4.72146687927898	-5.15451671993407	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGGTCTCTCAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2854.4270645417	51.7367345969646	0.0181250854995208	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2848.70081727562	2848.70081727562
"healthy-4"	"2019-08-01-count-3:GCTACCTTCTAGTTCT"	2.8229726749355	-4.6775636903015	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTTCTAGTTCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3098.98098611535	39.4538218146134	0.0127312242286681	3179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3090.76370115522	3090.76370115522
"healthy-4"	"2019-08-01-count-2:GCCGATGAGAGAGCAA"	3.01192535933797	-6.27939274227294	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGAGAGAGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.85820454937	47.5584066330151	0.0226483895579135	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2098.26668114936	2098.26668114936
"healthy-4"	"2019-08-01-count-4:GCGAGAACACTGAGTT"	11.2575737434322	5.18478391254274	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAACACTGAGTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.88116821862	43.6061942896969	0.0209054067672212	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.95234252319	2077.95234252319
"healthy-4"	"2019-08-01-count-4:CTTACCGTCAGAGTTC"	-2.98966226998027	-5.86623384868773	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGTCAGAGTTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2342.66478373905	51.3097815263706	0.0219023147837979	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2337.65741048125	2337.65741048125
"healthy-4"	"2019-08-01-count-2:CATTCATCAGAATGTA"	1.99807800826375	-6.70935823833617	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCATCAGAATGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.67749809621	50.3823537096234	0.0260956859751586	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1927.28529772772	1927.28529772772
"healthy-4"	"2019-08-01-count-2:ATACCTTAGCGGACAT"	3.08320059356038	-6.25309231197508	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTAGCGGACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.3361772761	46.309355143127	0.0205788608878793	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2241.91299083274	2241.91299083274
"healthy-4"	"2019-08-01-count-2:AGAACCTCAAACACGG"	5.61781992492024	-9.88567449962767	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCAAACACGG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2897.05215685527	42.8646738402009	0.014795962074335	2520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2887.19621791117	2887.19621791117
"healthy-4"	"2019-08-01-count-1:GCTACAATCCCTCGTA"	-3.1222017807072	9.0469646223816	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCTACAATCCCTCGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2693.16257686195	36.6442599954082	0.0136064047192078	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2681.55142441522	2681.55142441522
"healthy-4"	"2019-08-01-count-1:GGAGAACGTTGCCTAA"	0.428073992102784	8.09265801990358	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGAGAACGTTGCCTAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2010.60591846709	38.6964210910533	0.0192461490019665	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1995.78220722847	1995.78220722847
"healthy-4"	"2019-08-01-count-2:GACTCAACAACAGCTT"	10.5324312644893	6.5264854201111	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCAACAACAGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2107.21840687367	45.4557823695626	0.0215714622752381	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.17927129531	2104.17927129531
"healthy-4"	"2019-08-01-count-3:TGCTCGTCATATTCGG"	4.82348217543904	-7.68779995357665	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTCATATTCGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.00411363142	49.917199303532	0.0195370328514206	1929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2544.5169019611	2544.5169019611
"healthy-4"	"2019-08-01-count-4:AGATCCATCGTCGGGT"	-1.49911079827006	8.65142438495485	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCATCGTCGGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1947.74593000665	46.9360671917234	0.0240976333045467	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1942.32371430678	1942.32371430678
"healthy-4"	"2019-08-01-count-2:AATGACCGTCTGTCAA"	2.32093562659566	-6.28866913234862	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGACCGTCTGTCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.82561290053	45.3099036155591	0.0202021518547588	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2242.15373119457	2242.15373119457
"healthy-4"	"2019-08-01-count-2:AGAAGTAGTCATAGTC"	10.9707809883053	6.73647019946901	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAAGTAGTCATAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1826.64814893737	45.7078718793597	0.0250228112655137	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1817.99564226513	1817.99564226513
"healthy-4"	"2019-08-01-count-2:TAACACGGTGGCCCAT"	10.8882996040279	6.2671532400879	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACACGGTGGCCCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2056.95485045063	46.6378984561811	0.0226732727973898	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2044.39990204874	2044.39990204874
"healthy-4"	"2019-08-01-count-3:GCTGCAGAGTAACGTA"	-2.96004424515422	9.71808526599733	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGCAGAGTAACGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.00840773148	44.3229797560621	0.0213090387477819	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2076.81479685693	2076.81479685693
"healthy-4"	"2019-08-01-count-4:AGATGAACAGCAGACA"	4.86125244674031	-7.22900631343993	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGAACAGCAGACA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2761.90154154979	41.1374248806762	0.0148946022375557	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2760.02057575619	2760.02057575619
"healthy-4"	"2019-08-01-count-4:CCGTAGGTCGTGGGTC"	10.2434240775997	5.84294078433839	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTAGGTCGTGGGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1952.64268706524	44.4285238396173	0.0227530229334441	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1944.17727265237	1944.17727265237
"healthy-4"	"2019-08-01-count-2:TGTGATGCAGAACTCT"	-3.22867117348369	9.80293557727662	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGCAGAACTCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1987.31823407831	43.4164125632796	0.021846733864149	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1983.68386265422	1983.68386265422
"healthy-4"	"2019-08-01-count-3:TGCTTGCCAGGAATAT"	3.62342276152913	-6.23324873363646	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTTGCCAGGAATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2773.85049811398	43.1954475875042	0.0155723776810877	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2765.45517718777	2765.45517718777
"healthy-4"	"2019-08-01-count-2:TAACCAGTCCATGATG"	9.80547775801961	8.04734942996827	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACCAGTCCATGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2338.70419563384	47.1161153429311	0.0201462482646984	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2335.40126424022	2335.40126424022
"healthy-4"	"2019-08-01-count-2:ATAGACCTCACTGTCC"	11.0884939628536	6.77012822711793	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCTCACTGTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2144.46309520055	45.9459174320595	0.0214253710100629	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2137.35891476021	2137.35891476021
"healthy-4"	"2019-08-01-count-1:GTAGGTTGTCGCTTGG"	0.622993786900681	8.18076226795045	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTAGGTTGTCGCTTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1973.0329917411	36.2194099588816	0.0183572246944132	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.86525530724	1967.86525530724
"healthy-4"	"2019-08-01-count-3:GTCATGATCTTAATCC"	0.0544614452751398	8.36442563617555	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATGATCTTAATCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.55259668712	42.4767782140158	0.0222094693173894	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1909.38339793586	1909.38339793586
"healthy-4"	"2019-08-01-count-2:GCGGATCTCTCCGAGG"	-0.244325498968917	7.54835364902345	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCTCTCCGAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2009.07268484279	42.8245142652975	0.021315562442505	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1999.71136522166	1999.71136522166
"healthy-4"	"2019-08-01-count-3:TGGAACTCACGTCGTG"	14.1517015891964	2.21535012805787	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAACTCACGTCGTG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1144.91760800588	39.3331309093964	0.0343545514841923	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1135.58257940901	1135.58257940901
"healthy-4"	"2019-08-01-count-4:GCTACAAAGGACAAGA"	4.81896366652791	-7.38613941585692	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAAAGGACAAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.87936503732	46.9491450475105	0.0193774175161161	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2417.84783476705	2417.84783476705
"healthy-4"	"2019-08-01-count-4:GCTACAAAGTACTGGG"	11.6012455421383	4.07968041980592	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAAAGTACTGGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2449.56519650599	35.5900449219593	0.014529127443811	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2433.39298153315	2433.39298153315
"healthy-4"	"2019-08-01-count-4:CAGCAATAGAAACCAT"	-0.31236026707347	7.72307822788087	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAATAGAAACCAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2057.16343577146	48.3580005933408	0.0235071262460029	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2044.34362577562	2044.34362577562
"healthy-4"	"2019-08-01-count-2:AATTCCTAGTTGGGAC"	3.60400118407552	-6.52006342327269	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTCCTAGTTGGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.20318252247	49.3059891671054	0.0199280275425229	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2467.61411737181	2467.61411737181
"healthy-4"	"2019-08-01-count-3:ATGAAAGCATAGTCAC"	4.65979494628255	-6.78083565151366	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGCATAGTCAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.87093182019	39.9574109685783	0.0150619506170859	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.58658660196	2649.58658660196
"healthy-4"	"2019-08-01-count-4:TTCGATTTCTAACGCA"	10.4735237556392	7.7433929213318	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGATTTCTAACGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.12701826392	50.6662150279413	0.0239996052296306	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2105.77245967743	2105.77245967743
"healthy-4"	"2019-08-01-count-4:TACGCTCCACCTCTAC"	4.61235489425008	-6.7421274415222	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGCTCCACCTCTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2763.66565577582	42.3391339988492	0.0153199190033585	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2759.10763909241	2759.10763909241
"healthy-4"	"2019-08-01-count-3:TAGACCAAGGCTGAAC"	-5.20795236054118	3.05252502048341	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACCAAGGCTGAAC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2617.87090257412	51.9664067753482	0.0198506376782179	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2606.40013725621	2606.40013725621
"healthy-4"	"2019-08-01-count-2:CTCCTTTTCGATTGAC"	0.368819763034028	7.80028054797975	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTTCGATTGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2015.23312948488	38.5665469115846	0.0191375113614982	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2011.09462635955	2011.09462635955
"healthy-4"	"2019-08-01-count-2:TAAGCACTCACGAACT"	3.86398353156392	-6.76608040249022	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCACTCACGAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.95774684973	45.651349581107	0.018919249473269	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2408.85085930832	2408.85085930832
"healthy-4"	"2019-08-01-count-2:CTCGAGGCAGTCACGC"	-2.34718738022502	3.47150919521181	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCGAGGCAGTCACGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3111.85000492287	46.1336695965387	0.0148251585145673	4842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3103.21340390057	3103.21340390057
"healthy-4"	"2019-08-01-count-2:TCTGGCTGTTGTTGCA"	2.91048373755757	-4.80586483394774	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTGTTGTTGCA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2938.13205460962	42.4504431084796	0.0144481059120128	3094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2932.01623225418	2932.01623225418
"healthy-4"	"2019-08-01-count-3:ATGACCAAGGTGCGAT"	-0.405861328274566	8.09950921619264	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCAAGGTGCGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.81335923324	42.9658118043747	0.021177804064053	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2017.13549880685	2017.13549880685
"healthy-4"	"2019-08-01-count-2:ATCACAGCAAATGCTC"	-0.318569610745269	7.80325315082399	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACAGCAAATGCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2453.93864725697	42.3343135749319	0.0172515778347814	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2444.74776613107	2444.74776613107
"healthy-4"	"2019-08-01-count-3:ATGACCACAGCACAAG"	10.8377577262813	6.6825847395691	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCACAGCACAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2182.30029285813	44.5666967940929	0.0204218901220622	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2177.20311742798	2177.20311742798
"healthy-4"	"2019-08-01-count-2:ATCACAGGTTTCCCAC"	4.91030134734456	-7.4483943215576	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACAGGTTTCCCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.63602166188	44.4219356862814	0.0168351888330181	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2635.26447409096	2635.26447409096
"healthy-4"	"2019-08-01-count-1:TAACACGAGACTCTAC"	-0.610861460596877	8.39216802203981	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAACACGAGACTCTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2411.9737073618	45.9549095055283	0.0190528235715279	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2403.80212793871	2403.80212793871
"healthy-4"	"2019-08-01-count-2:AGACCCGCAATACAGA"	4.24861492690389	-6.49936487590941	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCCGCAATACAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.34294688406	44.5271323974788	0.0170253512834822	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2610.98150749018	2610.98150749018
"healthy-4"	"2019-08-01-count-2:ATCACGAGTTCAGCGC"	5.02527536925618	-7.40622618114623	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACGAGTTCAGCGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2803.15045026026	44.7601170357095	0.0159677897529738	2246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2798.75659424683	2798.75659424683
"healthy-4"	"2019-08-01-count-3:ATGACCAGTCACTCGG"	3.13795985755269	-6.17445804989012	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCAGTCACTCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.27242706433	46.187579453889	0.018842287354084	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2442.34564121273	2442.34564121273
"healthy-4"	"2019-08-01-count-2:GCTACCTCATGGCCCA"	0.14437541839425	7.66562173450319	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTCATGGCCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.56896241826	45.9840732111837	0.0216950115926964	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2108.24945220948	2108.24945220948
"healthy-4"	"2019-08-01-count-3:TGGATGTGTTTCGTAG"	2.71726765212361	-6.02396252071532	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATGTGTTTCGTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.45996131995	45.0220227431031	0.0185929247075229	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.09678940174	2413.09678940174
"healthy-4"	"2019-08-01-count-3:ATGAGGGGTCCCTGAG"	-2.86753449860271	9.01618669116823	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGGGGTCCCTGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.00840373894	43.1896218579661	0.0217798481219407	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.68528881258	1975.68528881258
"healthy-4"	"2019-08-01-count-2:AGTACCAGTAGTCCTA"	-2.72646723213847	9.2327260741028	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACCAGTAGTCCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.42399292326	42.3657550673464	0.0209480085360884	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2011.27819517885	2011.27819517885
"healthy-4"	"2019-08-01-count-4:CAGCCAGTCGGTATGT"	-4.36496816101726	12.3340730437073	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGTCGGTATGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2165.49608183081	44.2013560345925	0.0204116536646986	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2158.30792304338	2158.30792304338
"healthy-4"	"2019-08-01-count-4:ATGAGGGAGACCAGAC"	2.66958012160603	-6.28309299862059	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGGGAGACCAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2032.59591045636	50.39730628012	0.0247945526313712	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2029.69182678042	2029.69182678042
"healthy-4"	"2019-08-01-count-2:CCAATGAGTGATACCT"	10.5211979347164	6.51404187763063	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGAGTGATACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.94050078296	44.5264167882889	0.022230523957593	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.47361614653	1992.47361614653
"healthy-4"	"2019-08-01-count-3:GGAATGGTCGTGGGTC"	0.280504693358582	7.77611634815065	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGTCGTGGGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.35857157402	36.2812425878066	0.0205053080651316	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1766.51072622238	1766.51072622238
"healthy-4"	"2019-08-01-count-1:TCACATTAGTCACAGG"	11.0154167610103	6.2762355574402	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCACATTAGTCACAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2562.18077530514	44.6894409483589	0.0174419546735677	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2545.66400351846	2545.66400351846
"healthy-4"	"2019-08-01-count-4:ACACAGTGTTGTTGCA"	11.5421091514522	4.35875270450441	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTGTTGTTGCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2180.34132124375	38.3055107524619	0.0175685845052054	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2165.51123748217	2165.51123748217
"healthy-4"	"2019-08-01-count-4:CCTCAGTCAAGAGAGA"	10.7933203178341	7.1050700911316	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTCAAGAGAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1973.75538187397	48.1482792702785	0.0243942485033604	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1960.41336559367	1960.41336559367
"healthy-4"	"2019-08-01-count-4:GCTTGGGTCCGCAACG"	2.15170445021932	-5.96548511898192	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTGGGTCCGCAACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.78275334284	47.5376057923945	0.0183345888625281	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2587.70124837153	2587.70124837153
"healthy-4"	"2019-08-01-count-4:CCTCAGTGTTCGGCCA"	11.5258881050045	4.44974324786989	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTGTTCGGCCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2256.99568486653	36.3335825968604	0.0160982064965751	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2249.31676170222	2249.31676170222
"healthy-4"	"2019-08-01-count-2:ATCATTCTCTCCACTG"	-3.1213530105656	-5.69818308269652	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCATTCTCTCCACTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2567.71328791594	52.958758863547	0.0206248723768262	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2562.32896966062	2562.32896966062
"healthy-4"	"2019-08-01-count-4:CTCAGAAAGGTACATA"	-2.92313085022624	9.18087956989137	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAAAGGTACATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.82358225851	51.836183816941	0.0267496919180468	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1928.24907786337	1928.24907786337
"healthy-4"	"2019-08-01-count-2:CTCTGGTTCGAAGAAT"	4.22443260726277	-7.89179470455321	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTTCGAAGAAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.55399829117	47.5182401636377	0.0189954884827982	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2499.2062960253	2499.2062960253
"healthy-4"	"2019-08-01-count-4:CCTCATGCAACCGGAA"	-3.35862527313884	10.5518970259461	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGCAACCGGAA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1983.37816768925	45.9815407443785	0.0231834460484909	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.24416771019	1975.24416771019
"healthy-4"	"2019-08-01-count-4:GCTTTCGTCGAGTCCG"	-2.51699052277263	3.40135238254396	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTTCGTCGAGTCCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3117.53425011003	44.7740658856778	0.0143620125052668	4935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3111.02153826947	3111.02153826947
"healthy-4"	"2019-08-01-count-3:ATGCCTCGTACGTGTT"	14.2356602149898	2.15224025333253	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCCTCGTACGTGTT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1336.41575211941	39.0042173342678	0.029185691108782	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1320.03015669686	1320.03015669686
"healthy-4"	"2019-08-01-count-2:ACACCAAGTCTTGCTC"	-2.83832393112834	9.36261174762575	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACCAAGTCTTGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.70416678896	49.8355817175272	0.0245048333633565	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.8464146304	2015.8464146304
"healthy-4"	"2019-08-01-count-2:TCATATCTCTATTTCG"	5.04872049865071	-7.28067638790282	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCTCTATTTCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2997.95410724409	42.0596225405674	0.0140294417579431	2510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2989.76208653123	2989.76208653123
"healthy-4"	"2019-08-01-count-2:GCTGGGTCAGAGTGTG"	11.1429783302242	5.298548198584	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTCAGAGTGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1800.30484804964	45.8787053051458	0.0254838536678099	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1793.74753983982	1793.74753983982
"healthy-4"	"2019-08-01-count-4:GGAACCCGTCCACTTC"	0.103869569569272	7.7521648176941	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAACCCGTCCACTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.67261119434	44.4125414124377	0.0248437779570644	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1783.99535317544	1783.99535317544
"healthy-4"	"2019-08-01-count-1:TCATACTCACGTAGAG"	0.75913049754445	7.934863067511	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCATACTCACGTAGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2017.46190464309	25.5216910864051	0.0126503955428691	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2005.72272236368	2005.72272236368
"healthy-4"	"2019-08-01-count-3:ACCACAAAGTTGAATG"	3.10251917418782	-7.14898159420165	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAAAGTTGAATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1643.66568307013	46.4517844444038	0.0282610903925662	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1638.07184866254	1638.07184866254
"healthy-4"	"2019-08-01-count-2:CACCAAAAGTGCAGGT"	9.96097435530965	7.5421309241089	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAAAGTGCAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2008.36449966193	44.7986241034967	0.0223060226921147	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2000.82854044141	2000.82854044141
"healthy-4"	"2019-08-01-count-2:GCTTCACAGAAGTCCG"	2.73367585715596	-6.23818256771239	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTCACAGAAGTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.6076197798	47.6127508601384	0.0220673816794351	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2150.01593458309	2150.01593458309
"healthy-4"	"2019-08-01-count-3:ATGGAGGTCCGTGTCT"	-2.00463376465495	3.49414465511171	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGAGGTCCGTGTCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2794.04059869674	49.1804824076396	0.0176019211856047	4133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2789.4834432777	2789.4834432777
"healthy-4"	"2019-08-01-count-3:GGAGATGCATGACGAG"	0.617449124425095	7.97408435428468	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGCATGACGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1733.28973166172	37.4641357919341	0.0216144682031993	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1722.10781314002	1722.10781314002
"healthy-4"	"2019-08-01-count-4:AGCTACAGTTCACCGG"	-2.70755920830424	9.48807714069215	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTACAGTTCACCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.28217262107	42.7355174753227	0.0209870311933803	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.77820314758	2032.77820314758
"healthy-4"	"2019-08-01-count-4:GGAATCTAGCATCGAG"	5.17204203185384	-8.46942999279173	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTAGCATCGAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.92163891874	45.7560895949112	0.01786006601444	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2554.38197359253	2554.38197359253
"healthy-4"	"2019-08-01-count-2:TTTCGATTCGGACTGC"	6.69081177291219	-1.77403356945189	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCGATTCGGACTGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2918.73401367318	38.492714574245	0.0131881543141379	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2907.65194885674	2907.65194885674
"healthy-4"	"2019-08-01-count-2:ATCCCTGGTACTGTTG"	10.8631922202999	5.36226842487184	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGGTACTGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.25655684183	45.2706460535883	0.0240257335919614	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.21951824593	1877.21951824593
"healthy-4"	"2019-08-01-count-4:CAGTTCCCAACGTTAC"	11.0012127357418	6.11173675144044	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCCAACGTTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.15157389408	43.9862076525581	0.0226365293595752	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1936.23831310452	1936.23831310452
"healthy-4"	"2019-08-01-count-4:AGCTCAAAGTTGGACG"	3.22791828688924	-6.25269987499388	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTCAAAGTTGGACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.38153990651	50.2298900236445	0.0200088668695019	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2504.97771686171	2504.97771686171
"healthy-4"	"2019-08-01-count-2:GCTTTCGTCCTTATGT"	-4.18275056305583	10.6922702559265	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTTCGTCCTTATGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.04489753062	43.747168832464	0.0208018235292226	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.84340607333	2090.84340607333
"healthy-4"	"2019-08-01-count-4:GTCGTTCTCGTGCTCT"	0.239966650574845	8.06779477680055	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTTCTCGTGCTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.20012521058	41.7187481302135	0.0220012368818826	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.38291766583	1888.38291766583
"healthy-4"	"2019-08-01-count-2:CACGAATCATGGACAG"	4.00433673438374	-6.30676128780516	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATCATGGACAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.00857782321	41.9214223765153	0.0155957174848244	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2680.0364645039	2680.0364645039
"healthy-4"	"2019-08-01-count-3:TGGTAGTTCTGCCTGT"	-4.99483190003093	-5.81895258342894	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTAGTTCTGCCTGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2910.39778304008	50.5697452325732	0.0173755441703746	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2905.67671172194	2905.67671172194
"healthy-4"	"2019-08-01-count-2:CCACGTTGTGAGTTTC"	0.144541253417176	7.84414479816285	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTGTGAGTTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1839.79114967605	37.7435500949871	0.0205151275467506	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1837.29481247811	1837.29481247811
"healthy-4"	"2019-08-01-count-2:TTTGATCAGGAATGTT"	2.92871131476704	-5.97775318538817	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCAGGAATGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.84496419151	43.2213956104465	0.0164788221189312	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2614.68006678523	2614.68006678523
"healthy-4"	"2019-08-01-count-2:ATCCTATCATACAGGG"	4.65335955199544	-6.90572550213011	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCTATCATACAGGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.43778890801	39.1950139583863	0.0142608335966589	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2746.59501783559	2746.59501783559
"healthy-4"	"2019-08-01-count-2:AGATCGTCAGGTCTCG"	10.6751743751461	5.68459317767946	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATCGTCAGGTCTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1627.67898386725	43.8254394743274	0.0269251123278629	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1611.42573487753	1611.42573487753
"healthy-4"	"2019-08-01-count-3:TGGTTAGAGCAGCCCT"	9.03635658797566	5.74182937229005	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGAGCAGCCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1710.17563697578	39.4679671819306	0.0230783121502798	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1710.17563697578	1710.17563697578
"healthy-4"	"2019-08-01-count-2:GAGGCCTAGCGAGTCA"	-7.1731518310612	3.28938815677492	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTAGCGAGTCA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2400.17405954284	41.7547148985014	0.0173965361939019	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2382.04597237903	2382.04597237903
"healthy-4"	"2019-08-01-count-2:GGAAGTGTCAACGAGG"	3.49565615233724	-6.18278696453246	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAAGTGTCAACGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.83062897115	40.1811174293961	0.0158954943297566	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2522.83761808283	2522.83761808283
"healthy-4"	"2019-08-01-count-4:AGGAAATTCCAATCCC"	10.9072729545528	5.56633470142213	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATTCCAATCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.33068596141	49.6184307348615	0.0307362247192318	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1605.73950204226	1605.73950204226
"healthy-4"	"2019-08-01-count-4:AGGAATAAGGTGCGAT"	11.5305687385494	3.47027728641359	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAATAAGGTGCGAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.66083622301	35.751889116946	0.0183940986259827	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1925.87543291111	1925.87543291111
"healthy-4"	"2019-08-01-count-2:TTTGATCTCGCGGTAC"	-3.90568910065349	10.816602683905	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCGCGGTAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1901.00506940122	41.9889184179963	0.0220877466840328	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.59550583257	1897.59550583257
"healthy-4"	"2019-08-01-count-3:TGGTTAGAGTGGCCTC"	11.259239812463	5.17142913425294	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGAGTGGCCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1912.24592875579	42.0148104600244	0.0219714472015435	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1901.60435510818	1901.60435510818
"healthy-4"	"2019-08-01-count-3:TGGTTAGGTTTCGCTC"	4.33590855178182	-6.7746563187805	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTTAGGTTTCGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.25421595335	34.4551879816531	0.0149853755807367	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2296.07755601784	2296.07755601784
"healthy-4"	"2019-08-01-count-4:AGGAATAGTGTGGTCC"	-0.167326788336593	7.68385121906129	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAATAGTGTGGTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1922.3037615796	43.0336572584359	0.0223865021327712	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.21834145819	1916.21834145819
"healthy-4"	"2019-08-01-count-2:ATCGGATAGTAACAGT"	0.050807569373776	7.79966209018556	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGATAGTAACAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.47723823147	39.1872393257909	0.0209952945169166	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1855.20906980304	1855.20906980304
"healthy-4"	"2019-08-01-count-4:GGAGCAAGTGGCTACC"	4.81031574782674	-7.30019619381102	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGCAAGTGGCTACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2883.50091898529	41.8438836498569	0.0145114861501698	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2880.63999902348	2880.63999902348
"healthy-4"	"2019-08-01-count-4:CCTCTCCGTCACTAGT"	-0.11521221223529	7.59611413562623	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTCCGTCACTAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2204.27879377638	44.7332953532458	0.0202938464406349	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2191.53478575939	2191.53478575939
"healthy-4"	"2019-08-01-count-3:ATGTCTTCACTTTATC"	4.95069183883016	-7.7467193833557	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGTCTTCACTTTATC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.49320920763	43.1935111934589	0.0155793027914407	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2768.99386083733	2768.99386083733
"healthy-4"	"2019-08-01-count-4:GGAGGATGTGGACCTC"	5.65188898619954	-10.0012693635193	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGATGTGGACCTC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.0282254413	46.1692936257544	0.0178464591811242	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2579.11136492774	2579.11136492774
"healthy-4"	"2019-08-01-count-2:ATCGGCGAGTATGAGT"	11.3074785667354	4.63810060108034	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGAGTATGAGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.45007410494	44.6257882126517	0.0234816945841996	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.73208849456	1886.73208849456
"healthy-4"	"2019-08-01-count-2:CACGTTCAGAATTCAG"	10.9596115547115	6.38664767825929	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCAGAATTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1862.37342683051	45.4398970969812	0.0243989183062569	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1847.7894545029	1847.7894545029
"healthy-4"	"2019-08-01-count-3:TGTACAGGTTCTCGTC"	10.7411819892818	5.80506751621095	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGGTTCTCGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.25912943453	40.3927742858193	0.0222517951464054	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1811.43634964365	1811.43634964365
"healthy-4"	"2019-08-01-count-3:AGGGCTCCATACGCAT"	11.4943481880123	4.0704946287903	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCTCCATACGCAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2304.73597951186	36.7894055270713	0.015962524928718	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2286.4267400894	2286.4267400894
"healthy-4"	"2019-08-01-count-4:ACCAAACGTAAGCGGT"	11.3070694404537	5.88883206928102	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACGTAAGCGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2090.75161854257	42.3931695444701	0.0202765212129893	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2084.76858831246	2084.76858831246
"healthy-4"	"2019-08-01-count-3:TGTACAGTCTTTCGAT"	-1.87119422379192	3.53697726810304	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGTCTTTCGAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2882.2906669621	41.5930019225971	0.0144305369334716	4134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2876.53174007293	2876.53174007293
"healthy-4"	"2019-08-01-count-3:TCGCTTGTCCACGGAC"	-4.02047238770183	-5.3317647210327	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGTCCACGGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2820.18574661995	48.1842008658824	0.0170854706728563	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2818.21606202877	2818.21606202877
"healthy-4"	"2019-08-01-count-2:GAGGGTATCGCGTTTC"	10.0632406669552	7.16442916477052	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGTATCGCGTTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.10528763458	42.6016242557968	0.0218907088565479	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.70380603396	1939.70380603396
"healthy-4"	"2019-08-01-count-4:TCGCACTTCAGACATC"	10.6737534004146	6.02116344058839	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCACTTCAGACATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.36082803204	46.183768920986	0.0243410574513063	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.04888748687	1889.04888748687
"healthy-4"	"2019-08-01-count-3:CGCCAGACACAGCCAC"	-0.0490102720564187	7.65984962070314	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGACACAGCCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2026.54754220435	45.6990314166218	0.0225501896525523	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.58583708648	2022.58583708648
"healthy-4"	"2019-08-01-count-3:AAACGCTGTAAGCAAT"	11.2518497901851	5.84143064105836	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTGTAAGCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1993.06323579409	47.2659183795471	0.0237152126087535	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1979.96942020801	1979.96942020801
"healthy-4"	"2019-08-01-count-4:TTGCTGCCAGGGCTTC"	4.71164526519124	-6.81910374080809	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCCAGGGCTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2837.18212379683	44.5976257731748	0.0157189858906528	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2830.71491096404	2830.71491096404
"healthy-4"	"2019-08-01-count-2:CCCAACTTCAGCCCAG"	-1.54376039925273	8.40653607929078	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCAACTTCAGCCCAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2276.17156636623	44.0990099919717	0.0193742030010388	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2261.87477898748	2261.87477898748
"healthy-4"	"2019-08-01-count-2:CGGGTCAAGACCTCAT"	2.88484730300252	-6.21155598079833	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCAAGACCTCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.8959611425	45.989904529506	0.019012766678805	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2416.54849550144	2416.54849550144
"healthy-4"	"2019-08-01-count-3:ATTACTCGTTAAGACA"	2.61752643164937	-6.18683674251708	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCGTTAAGACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.62983783241	42.5701740189124	0.0176447183697102	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2406.5943805335	2406.5943805335
"healthy-4"	"2019-08-01-count-4:CATCCACTCCAGTGCG"	11.0799538093502	6.02796838367311	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACTCCAGTGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2058.9973876259	46.4731232103689	0.0225707538482864	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2052.95228608624	2052.95228608624
"healthy-4"	"2019-08-01-count-3:TTTGACTGTTAGTTCG"	11.164190908044	6.49617478931276	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTGTTAGTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2105.42998180066	47.0364317178866	0.0223405347717424	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2098.25616926602	2098.25616926602
"healthy-4"	"2019-08-01-count-3:TGTCCACAGAGTCACG"	-4.61707530441936	-5.15246250545653	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCACAGAGTCACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2663.35305267041	50.7612676488633	0.0190591583785588	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2659.26851816734	2659.26851816734
"healthy-4"	"2019-08-01-count-2:CGGGTGTCACAAACGG"	4.13152613219563	-6.86296751415404	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTCACAAACGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.73646702521	44.8104894161095	0.0187747956404926	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2385.40884597548	2385.40884597548
"healthy-4"	"2019-08-01-count-3:AAAGAACAGCTCGACC"	-1.62925134125407	9.22200200641481	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGAACAGCTCGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.07855885793	46.943853146267	0.025637268766637	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1823.53588638901	1823.53588638901
"healthy-4"	"2019-08-01-count-2:CGGGTGTCACCTTCCA"	11.5885778861934	3.67621586406556	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTCACCTTCCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2143.96331918339	39.9032837355328	0.0186119246437162	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.41876032635	2117.41876032635
"healthy-4"	"2019-08-01-count-3:ATTCACTCACCCTAGG"	-1.7202721637791	3.36011359775392	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTCACCCTAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2918.224056655	41.3097653713473	0.0141557894696744	4333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2908.20337037909	2908.20337037909
"healthy-4"	"2019-08-01-count-3:TGTCCACTCTGCGGAC"	-2.16393146935161	9.86701772296754	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCACTCTGCGGAC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2044.74835638315	48.501454154356	0.0237200113172595	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2036.34700225026	2036.34700225026
"healthy-4"	"2019-08-01-count-2:GGAGCAACATGTGTCA"	4.42562593993489	-7.36249830639037	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGCAACATGTGTCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.39988679081	42.8143608679043	0.0162582071498757	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2627.18732175372	2627.18732175372
"healthy-4"	"2019-08-01-count-3:CTGTACCAGGCTCTCG"	5.6146408515865	-9.52322103893431	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCAGGCTCTCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3018.37032013861	44.4710067483893	0.0147334495213123	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3011.45595972716	3011.45595972716
"healthy-4"	"2019-08-01-count-4:ACCCTCAAGAACAAGG"	0.366555084555787	7.83742091739503	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTCAAGAACAAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.55902163894	41.6977761007488	0.0216661456634566	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1918.34377785436	1918.34377785436
"healthy-4"	"2019-08-01-count-3:TGTCCCACATGCCGGT"	-0.392879704863387	7.6807331808838	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCCACATGCCGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1844.7536280766	41.3042953391486	0.0223901418110849	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1843.2187344094	1843.2187344094
"healthy-4"	"2019-08-01-count-2:AAACCCAAGCTTTGTG"	0.238041822879952	7.59865806186525	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAACCCAAGCTTTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1841.70985765304	39.4626718991084	0.0214271926357593	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1833.79721373336	1833.79721373336
"healthy-4"	"2019-08-01-count-3:ATTCATCCAGGGATAC"	2.36380376395528	-6.33650257503661	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCATCCAGGGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.87130963307	46.3413546297314	0.0221002378242471	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2096.87130963307	2096.87130963307
"healthy-4"	"2019-08-01-count-3:AAAGGTAGTCGCATTA"	11.1741720634395	5.46761844241945	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGTAGTCGCATTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.87331402491	46.7937859365404	0.0250117341381445	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1860.41812508585	1860.41812508585
"healthy-4"	"2019-08-01-count-2:CGTAAGTCATTGTCGA"	2.4196912246639	-6.09392931377562	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAAGTCATTGTCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.59135393421	45.7883066019281	0.0181369180919414	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2518.42353946422	2518.42353946422
"healthy-4"	"2019-08-01-count-4:CATCGCTGTACGGTTT"	-1.00112472000774	8.24698827350465	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTGTACGGTTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2296.02634184996	43.1573080216015	0.0187965212920113	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2287.41018892706	2287.41018892706
"healthy-4"	"2019-08-01-count-4:AGGCCACAGTCCTGCG"	-5.42785344544108	-5.14128639614256	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCCACAGTCCTGCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2660.98749807868	45.9568589188535	0.0172706030945414	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2656.97074677727	2656.97074677727
"healthy-4"	"2019-08-01-count-2:TTAGGGTTCATTCACT"	-1.82665429535564	3.55250332439271	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTTCATTCACT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2751.09927629357	50.2859247189549	0.0182784842234784	3236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2740.17143033643	2740.17143033643
"healthy-4"	"2019-08-01-count-4:TCGGGTGTCGTCGGGT"	10.5348659950191	5.61692330921022	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGTGTCGTCGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1720.55393161456	44.6083142302939	0.0259267166292391	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1709.22048566038	1709.22048566038
"healthy-4"	"2019-08-01-count-4:CATCGGGCACTTGTGA"	11.0304829078609	6.59408328616945	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGCACTTGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1901.58093161431	43.3083357087921	0.0227749105961146	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.53218563865	1896.53218563865
"healthy-4"	"2019-08-01-count-4:ATTCCATAGAAGTCAT"	3.33908071097676	-6.12756063854369	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATAGAAGTCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.93766586137	41.0695650323022	0.0165473797336682	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2475.65793784248	2475.65793784248
"healthy-4"	"2019-08-01-count-3:AAAGTCCTCGCCATAA"	-2.63636980477031	9.09954354846803	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTCCTCGCCATAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.24106572773	46.767674876045	0.0219130236162419	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2129.29028384603	2129.29028384603
"healthy-4"	"2019-08-01-count-4:CATCGGGGTCTACAGT"	11.5899254280025	-3.25509693538817	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGGTCTACAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2630.44035508721	40.6473198058563	0.01545266735558	3677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2621.86640529218	2621.86640529218
"healthy-4"	"2019-08-01-count-2:TCCATGCTCACCCTGT"	3.23034205016438	-5.22238638317259	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATGCTCACCCTGT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2940.14800574049	43.8866844307013	0.0149266922430486	2532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2936.17063505573	2936.17063505573
"healthy-4"	"2019-08-01-count-4:AGGCTGCAGGTCCTGC"	0.0538962465593636	7.55227944934694	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCTGCAGGTCCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.06791238392	45.272917768602	0.0224671920436876	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2011.25034139796	2011.25034139796
"healthy-4"	"2019-08-01-count-4:CGACAGCCAAGGTTGG"	3.14697231826131	-5.96580889141234	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCCAAGGTTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.098274224	44.3834775169059	0.0167226202390274	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.90121653812	2649.90121653812
"healthy-4"	"2019-08-01-count-3:ACGTAACTCGTTCCCA"	-7.09167132797893	3.31539795482484	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACTCGTTCCCA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2646.45469726359	44.0377677329573	0.0166402877700842	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2626.34148064448	2626.34148064448
"healthy-4"	"2019-08-01-count-2:CCCTCAATCTAGAACC"	-3.77166734162028	11.4677066572937	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAATCTAGAACC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2085.65530127546	47.1416115268483	0.0226027817242952	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2078.93123788495	2078.93123788495
"healthy-4"	"2019-08-01-count-3:AACAAAGTCACGGACC"	0.128026125102681	7.72979209506837	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAAGTCACGGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1833.71435105824	38.7060331588049	0.021107994893789	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1823.66370398783	1823.66370398783
"healthy-4"	"2019-08-01-count-2:AGCTACACAGAGAGGG"	2.91740908202474	-6.37477781688841	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTACACAGAGAGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.27670771406	47.5299792398913	0.0207529418082112	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2286.74467590043	2286.74467590043
"healthy-4"	"2019-08-01-count-3:TGTTACTAGCAGCCCT"	2.39790405806844	-6.09567263042601	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTAGCAGCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.51182972406	43.9112626471153	0.0180815518827861	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2426.26384759889	2426.26384759889
"healthy-4"	"2019-08-01-count-2:ATGACCAGTTCGGGTC"	3.98027505454366	-6.67292835628661	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCAGTTCGGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.74797325764	46.4013468055756	0.0208008019560426	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2223.38832475722	2223.38832475722
"healthy-4"	"2019-08-01-count-3:TGTTACTCACTATCCC"	1.87798728522603	-6.82690050518187	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTCACTATCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1995.08480525847	44.1909198887569	0.0221498954692464	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1993.25591345175	1993.25591345175
"healthy-4"	"2019-08-01-count-4:GGGACCTAGAGGCGTT"	3.62951983985249	-6.43548777019652	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTAGAGGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.48145301284	43.4583635563745	0.0190232945419891	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2277.47910320673	2277.47910320673
"healthy-4"	"2019-08-01-count-4:ACGATGTAGAAGGCTC"	0.359761734574479	7.86839196765748	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATGTAGAAGGCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1938.54972734981	40.9108322323026	0.0211038343020645	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1932.60285212361	1932.60285212361
"healthy-4"	"2019-08-01-count-4:TATTGCTCATGTGACT"	0.182794679968995	7.84137818897096	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTCATGTGACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1797.85575174785	38.3567991470737	0.0213347478571535	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1792.95672456034	1792.95672456034
"healthy-4"	"2019-08-01-count-4:CGAGGAATCCAGCCTT"	11.3521143394405	4.53086087787477	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAATCCAGCCTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2096.38978937531	40.5930655593817	0.0193633196293509	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2076.68858184994	2076.68858184994
"healthy-4"	"2019-08-01-count-4:GGGACCTCACATATGC"	-0.997263769537765	8.11428258502809	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTCACATATGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2147.05945902978	48.1864634428027	0.0224430037277949	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.59428374414	2142.59428374414
"healthy-4"	"2019-08-01-count-2:CGTGATATCTCCAAGA"	-2.1508449119633	9.38337323749391	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGATATCTCCAAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.75058765113	37.1654186028737	0.0205362102692341	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1804.11625143109	1804.11625143109
"healthy-4"	"2019-08-01-count-3:TGTTCCGAGTAAGAGG"	4.47453417357747	-7.12813045894774	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGAGTAAGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.67992375579	45.8820197385725	0.0186840391106016	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2446.65621770582	2446.65621770582
"healthy-4"	"2019-08-01-count-2:TTCAATCTCTTCTGGC"	4.7113000350887	-6.7401218644348	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCTCTTCTGGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2900.94401157215	42.9545365786446	0.0148070891431529	2564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2896.34139010927	2896.34139010927
"healthy-4"	"2019-08-01-count-4:TTTACCAAGCTTCGTA"	10.1522165733272	6.58776042545167	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCAAGCTTCGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.90952579221	47.9464587368917	0.0296898730059637	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1610.50019496387	1610.50019496387
"healthy-4"	"2019-08-01-count-4:CGAGGCTTCGAACCTA"	-4.00614438477214	-4.77717354213866	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTTCGAACCTA"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3182.45417994379	47.2746333196785	0.0148547726523791	3335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3180.10946740432	3180.10946740432
"healthy-4"	"2019-08-01-count-4:CGAGTGCAGGTGAGCT"	4.62743439254109	-6.66520359432372	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCAGGTGAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.787201515	41.8050487484095	0.0163826547619605	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2549.50039165609	2549.50039165609
"healthy-4"	"2019-08-01-count-3:AACAGGGCATGATCTG"	-1.29631827297862	8.37325570667116	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGCATGATCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.8243552219	46.9187032983275	0.0230465379677676	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2028.26032197713	2028.26032197713
"healthy-4"	"2019-08-01-count-4:CGAGTGCCACTTCAGA"	11.2390400367672	6.0857567557129	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCCACTTCAGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2456.65543508108	46.0781269036717	0.0187564467713605	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2443.45516097238	2443.45516097238
"healthy-4"	"2019-08-01-count-2:ATGCATGTCGCATAGT"	-3.88842282715495	-4.62648203289183	"2019-08-01-count-2"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGTCGCATAGT"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3122.03581992528	45.0187601576177	0.0144196808602584	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3118.09789114078	3118.09789114078
"healthy-4"	"2019-08-01-count-4:CGAGTGCTCCGGACGT"	-4.4683989090031	11.2721042403015	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCTCCGGACGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2693.05710097952	46.9944664436401	0.0174502302333461	1834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2688.28212985753	2688.28212985753
"healthy-4"	"2019-08-01-count-3:TCAAGTGTCTCCAATT"	4.4819766479427	-6.79110529338988	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGTGTCTCCAATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.06940235192	46.8608647970244	0.0182404043869443	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2561.55584430917	2561.55584430917
"healthy-4"	"2019-08-01-count-2:AAAGTGAGTATCAAGA"	5.08307852324788	-7.579625629541	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTGAGTATCAAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.53219931746	47.4545770708445	0.0174816777206682	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2708.93060749039	2708.93060749039
"healthy-4"	"2019-08-01-count-3:TGTTCCGTCACCGCTT"	3.29912128028218	-6.22640039837035	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGTCACCGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.90870346892	46.9542273586542	0.0194919082201157	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2402.68304534062	2402.68304534062
"healthy-4"	"2019-08-01-count-2:GGCGTCACATGACACT"	4.66657127913777	-7.28764440929564	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCACATGACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.70661712791	45.9069379247926	0.0183282695110348	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2500.60726197879	2500.60726197879
"healthy-4"	"2019-08-01-count-3:TGTTCTAAGTTGCTGT"	-1.66245136681255	8.65124509418336	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCTAAGTTGCTGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.27889897189	46.0976457455705	0.0224179928941637	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2048.90787713361	2048.90787713361
"healthy-4"	"2019-08-01-count-2:ACCTGAATCCATCTGC"	5.69911207732503	-9.87695982372435	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGAATCCATCTGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2821.52446509323	40.7607567733395	0.0144463595044506	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2816.29141851624	2816.29141851624
"healthy-4"	"2019-08-01-count-3:AACCAACGTAGTGATA"	-3.86989937248881	9.87196443164674	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACGTAGTGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2258.98688803183	42.6591454061925	0.0188841934551288	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2254.37862865859	2254.37862865859
"healthy-4"	"2019-08-01-count-2:AAATGGACAACTCCCT"	2.26269306716267	-6.07690193569335	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAATGGACAACTCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.68632435563	46.8080357065558	0.0191546825138855	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2440.5418266994	2440.5418266994
"healthy-4"	"2019-08-01-count-4:CGATCGGTCACGGACC"	0.646166999905747	7.96088836276857	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATCGGTCACGGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1877.65162735204	42.4517160483684	0.0226089416321791	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1870.54306426625	1870.54306426625
"healthy-4"	"2019-08-01-count-4:CATGGATTCTCACCCA"	-0.0708667663043321	7.61370036685792	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGATTCTCACCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2022.37756583721	40.4936553059285	0.0200227969247499	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2008.85333052797	2008.85333052797
"healthy-4"	"2019-08-01-count-2:AAATGGATCCCGTGAG"	4.8152662712032	-7.18937876140746	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAATGGATCCCGTGAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.09006106862	39.8381877425296	0.0146566842332175	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.07582855827	2712.07582855827
"healthy-4"	"2019-08-01-count-4:GGGATGACATTAAAGG"	10.479020734399	7.87331054294435	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATGACATTAAAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2384.67245263057	48.9545701937785	0.0205288445965717	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2372.843307973	2372.843307973
"healthy-4"	"2019-08-01-count-2:ACCTGTCAGCCTCCAG"	-7.0883072418278	1.67338345134584	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCAGCCTCCAG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2981.30350158871	45.3710274973284	0.0152185201785563	2931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2970.48675842404	2970.48675842404
"healthy-4"	"2019-08-01-count-2:ATGGAGGAGAAATTGC"	10.7277103858883	6.10762116992799	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGAGAAATTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.72133095145	40.5461052637449	0.0207532694767678	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.78634826827	1940.78634826827
"healthy-4"	"2019-08-01-count-2:GGCTTTCCAAGGTCTT"	2.48773016509358	-5.90287735378417	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCCAAGGTCTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2715.34422706562	43.6081808704844	0.016059908882201	2342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2708.07595230576	2708.07595230576
"healthy-4"	"2019-08-01-count-2:ATGGAGGAGGTTCCGC"	0.0902311551267325	7.54994056308595	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGAGGTTCCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1968.2016502678	39.0833602260902	0.0198573963296761	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1961.92568068443	1961.92568068443
"healthy-4"	"2019-08-01-count-3:AACCATGCAGTAGATA"	-3.6026180786198	10.9268989332947	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGCAGTAGATA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2037.33673132284	48.2689834331341	0.0236921971174559	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.44039133832	2032.44039133832
"healthy-4"	"2019-08-01-count-3:CAACAACCAAGTGGCA"	10.4805695014888	6.60328719699708	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACCAAGTGGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1854.17009409815	44.8642837840931	0.0241964229316916	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1838.33656117772	1838.33656117772
"healthy-4"	"2019-08-01-count-4:GTGTCCTTCAGCATTG"	9.97107853469197	7.22729489887086	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTCCTTCAGCATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.19007528565	43.5786177369387	0.0225074068363404	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.76784008887	1934.76784008887
"healthy-4"	"2019-08-01-count-3:CAACAACCAGGCCTGT"	11.1548420387203	5.92656705463258	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACCAGGCCTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2132.00296124649	45.1638697877523	0.0211837744171551	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2124.12318803985	2124.12318803985
"healthy-4"	"2019-08-01-count-4:ATTTCACTCTAGTTCT"	11.07675232467	6.06850621784059	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACTCTAGTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.73817389134	50.7321440154341	0.0255869104067668	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.58694337349	1977.58694337349
"healthy-4"	"2019-08-01-count-3:TCACAAGCAATCTCTT"	-0.302087466151077	7.74662635410158	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACAAGCAATCTCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2257.82858702564	47.3314326031573	0.020963253311231	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2249.7545027513	2249.7545027513
"healthy-4"	"2019-08-01-count-3:TTAATCCAGCAGCACA"	0.0424723216215193	7.5749940642151	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAATCCAGCAGCACA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2099.63358350535	41.7168615948372	0.0198686389485116	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.85219588828	2089.85219588828
"healthy-4"	"2019-08-01-count-4:GGGCTACAGACAAGCC"	10.5347439247066	6.09462449634401	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACAGACAAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.86975704495	40.4649824950452	0.0207420215259981	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1943.21610392177	1943.21610392177
"healthy-4"	"2019-08-01-count-3:CTTCCTTTCGAGTACT"	14.2915245490963	2.18682262981264	"2019-08-01-count-3"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCTTTCGAGTACT"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1160.45075087072	25.8981640817829	0.0223173314872266	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1140.43373986486	1140.43373986486
"healthy-4"	"2019-08-01-count-3:CGTCAAAAGGTTAAAC"	10.4863134818966	7.83062312686769	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAAAGGTTAAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2187.44812173398	47.1637362711815	0.0215610764902598	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2181.06022980316	2181.06022980316
"healthy-4"	"2019-08-01-count-3:TTAATCCCAATCGTCA"	4.84515394744222	-7.24213030254515	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAATCCCAATCGTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.92087062184	51.2440901835135	0.0199710329224201	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2555.92579870516	2555.92579870516
"healthy-4"	"2019-08-01-count-2:ATGGATCGTGTCCATA"	6.58834280547444	-1.41541125690611	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCGTGTCCATA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2967.73451733032	42.7586962014837	0.014407857559964	3213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2957.32745204413	2957.32745204413
"healthy-4"	"2019-08-01-count-4:CATTGAGCACAAACGG"	-3.27153120461162	10.3530349501404	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGAGCACAAACGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2006.39988721633	50.4566155685721	0.0251478361268129	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2003.02800995122	2003.02800995122
"healthy-4"	"2019-08-01-count-4:TCTCAGCTCTGTAAGC"	2.42939438399617	-6.13289787685546	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCAGCTCTGTAAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.13184676038	47.3199056844627	0.0232515184506541	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2032.08957828223	2032.08957828223
"healthy-4"	"2019-08-01-count-3:TTACAGGCACAAGCTT"	0.00632849064413902	7.81300208652345	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACAGGCACAAGCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.79934888771	48.0111361365849	0.0235256524178882	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2029.66952779693	2029.66952779693
"healthy-4"	"2019-08-01-count-4:AGTACTGCAGCAAGAC"	4.65651764449422	-7.04974701320799	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGCAGCAAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.30284730047	43.1920010645009	0.0170833969160847	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2527.03307084375	2527.03307084375
"healthy-4"	"2019-08-01-count-2:ATGGGTTCAAAGTATG"	2.18889321860616	-6.41001369869383	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGTTCAAAGTATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.19853287727	50.4821504568815	0.0209974965738233	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2399.75778146403	2399.75778146403
"healthy-4"	"2019-08-01-count-3:CAACCTCCAGACGATG"	2.82671441611592	-6.16696169292601	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCTCCAGACGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.93293659007	49.6640865791088	0.0216031036785153	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2292.4086151176	2292.4086151176
"healthy-4"	"2019-08-01-count-3:CTTCGGTTCTTAATCC"	10.6382442909176	6.53797433460084	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTTCTTAATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.97684998746	44.6936814779347	0.0238242180217913	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.01129774304	1874.01129774304
"healthy-4"	"2019-08-01-count-3:CTTCTAATCTCACTCG"	5.65734448012654	-9.94242193615111	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAATCTCACTCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.76130621288	44.4684162320635	0.0174402271003601	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2544.43142327963	2544.43142327963
"healthy-4"	"2019-08-01-count-2:GTGCAGCCAGTAGATA"	6.82917608794515	-1.60949780857237	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCAGCCAGTAGATA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2599.44690371738	21.0265503979111	0.00808885550531604	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2593.20906437601	2593.20906437601
"healthy-4"	"2019-08-01-count-3:GGGTGTCTCCTTATAC"	-0.286917398602325	7.69638726795045	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCTCCTTATAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.08364328995	44.7958708171794	0.0235633350354102	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1879.55139184309	1879.55139184309
"healthy-4"	"2019-08-01-count-2:TAGTGCATCACGGACC"	-0.954318742186385	8.21885297382203	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCATCACGGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.1935709242	44.2172758617908	0.0226384504434286	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1948.95814064561	1948.95814064561
"healthy-4"	"2019-08-01-count-2:CTAAGTGTCCCTAGGG"	-0.0925024253433526	7.52164790714113	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAAGTGTCCCTAGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2162.4008759161	45.8843200215832	0.0212191553067811	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2151.80493791904	2151.80493791904
"healthy-4"	"2019-08-01-count-3:CAACGATTCCGCGAGT"	2.10873117026631	-6.03766348278197	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATTCCGCGAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.1597100362	46.2926555364973	0.0174810663273267	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2639.34306126504	2639.34306126504
"healthy-4"	"2019-08-01-count-2:AACCACAAGCTAGATA"	-3.31637893143352	10.3161296614441	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCACAAGCTAGATA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2129.93584993127	49.2149093514623	0.0231062871461835	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2123.90817189427	2123.90817189427
"healthy-4"	"2019-08-01-count-4:GTTACAGTCATTGAGC"	2.37900962409322	-6.14069750225218	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTACAGTCATTGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.15629001626	46.3667544764831	0.019637308496916	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2356.06758728372	2356.06758728372
"healthy-4"	"2019-08-01-count-4:GGGTCACTCAGATGCT"	10.321438451379	7.56083200061647	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCACTCAGATGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.13487901452	44.3293105906336	0.0220638798587665	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2001.69999896486	2001.69999896486
"healthy-4"	"2019-08-01-count-3:GTTCTATTCCATTCAT"	4.41289915618245	-6.5591726533142	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCTATTCCATTCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2903.17686005289	43.1145569803871	0.0148508200012319	2254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2893.02691120375	2893.02691120375
"healthy-4"	"2019-08-01-count-3:GGTAACTCACAATGCT"	10.0395761924678	6.95294711673585	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAACTCACAATGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2039.83457027222	49.0956538751157	0.0240684487804145	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.03306439983	2034.03306439983
"healthy-4"	"2019-08-01-count-2:GGGATCCTCGAGTCCG"	10.7326275306637	6.43278501117555	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATCCTCGAGTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.58539643503	45.3192670125236	0.0244759259280071	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1842.98846853256	1842.98846853256
"healthy-4"	"2019-08-01-count-4:GGGTCTGCAAGTCATC"	4.59278072890584	-6.8212576142517	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCTGCAAGTCATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.9177685904	46.3007087912038	0.018506087359254	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2496.0473214691	2496.0473214691
"healthy-4"	"2019-08-01-count-4:GGGTGAAAGCAGTACG"	2.40868939933125	-6.03764774715575	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAAAGCAGTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.6180571905	47.4805298627224	0.0195102636267979	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2426.80624369631	2426.80624369631
"healthy-4"	"2019-08-01-count-4:TCTGGCTAGGGCAACT"	3.16795124587361	-5.95109512722167	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTAGGGCAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2671.45805718797	44.3994049725211	0.0166199146765781	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2668.50619294576	2668.50619294576
"healthy-4"	"2019-08-01-count-4:ACTACGATCGCCGAAC"	6.76909317550008	-1.74971201336058	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTACGATCGCCGAAC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3037.99365260619	35.3102991967112	0.0116229009123899	2442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3022.29462242598	3022.29462242598
"healthy-4"	"2019-08-01-count-4:CGGACACAGGGCAGGA"	-3.78227768364604	3.67499468410341	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACAGGGCAGGA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3030.1853185322	44.3571759555261	0.0146384366937044	4448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3019.79951130639	3019.79951130639
"healthy-4"	"2019-08-01-count-2:ACGTAACCATACCATG"	2.44163908538167	-7.30780317699584	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACCATACCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1821.63495202985	42.61638547162	0.0233945804696668	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1816.39684349093	1816.39684349093
"healthy-4"	"2019-08-01-count-3:TTACGTTGTAACGCGA"	10.737906118005	6.68979547107545	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGTTGTAACGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.0641711387	45.2328843819774	0.0241878781915995	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.72180864917	1866.72180864917
"healthy-4"	"2019-08-01-count-2:CTACCCAAGGTGAGCT"	-0.202967862517196	7.68568894946901	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAAGGTGAGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.63809921054	43.7878370648223	0.0230263776703888	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.42753155545	1897.42753155545
"healthy-4"	"2019-08-01-count-4:GGGTGAATCTCGGGAC"	9.66132130202596	6.97775361621705	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAATCTCGGGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.8859416443	38.117579333141	0.0203089481824063	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1869.56756459719	1869.56756459719
"healthy-4"	"2019-08-01-count-2:GGGCGTTGTGAGTTGG"	10.6820370155269	6.73190925205079	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTGTGAGTTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2200.51178350941	46.9924019965322	0.0213552148862334	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2186.24418390555	2186.24418390555
"healthy-4"	"2019-08-01-count-3:CAAGAGGGTAAGCAAT"	4.85561193999593	-7.13851311123046	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGAGGGTAAGCAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2757.40403661198	43.8911349353631	0.0159175566411704	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2751.60051422239	2751.60051422239
"healthy-4"	"2019-08-01-count-2:AACCCAAGTACCACGC"	10.8599316078121	6.3607778319153	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCCAAGTACCACGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.83257342116	43.9015915425632	0.0234287695524524	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.5960199184	1862.5960199184
"healthy-4"	"2019-08-01-count-2:GGGCTACAGCATCTTG"	0.257973198860329	8.13681314075319	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTACAGCATCTTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2010.80444642945	46.8970471042606	0.0233225300389279	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.91970335267	1996.91970335267
"healthy-4"	"2019-08-01-count-4:GGGTTATCAGGAGACT"	-2.35963473740276	4.10987756336061	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTATCAGGAGACT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3593.66426719442	45.4192274529739	0.0126386952358332	5735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3585.04846586484	3585.04846586484
"healthy-4"	"2019-08-01-count-4:AGTCACATCTTCACAT"	2.56743301925008	-6.2353406182495	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACATCTTCACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.55279327041	50.3007292873447	0.021472612882769	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2337.94993036307	2337.94993036307
"healthy-4"	"2019-08-01-count-4:GGGTTATGTGACACAG"	-3.495748381049	3.69033882701723	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTATGTGACACAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3244.95149324711	48.8153307912156	0.0150434701081981	5329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3233.44996495533	3233.44996495533
"healthy-4"	"2019-08-01-count-2:TTCGATTAGAATTCAG"	3.18014897879903	-6.31573393261107	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGATTAGAATTCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.28479302709	45.4602315418632	0.0189632169169437	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2391.07523278337	2391.07523278337
"healthy-4"	"2019-08-01-count-4:TCTGTCGGTGTTTGCA"	4.45177139815633	-6.60271551525267	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTGTTTGCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.02488065379	40.8598648071233	0.0153376438425363	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2662.08069845365	2662.08069845365
"healthy-4"	"2019-08-01-count-2:AACCTTTCACAACGTT"	10.6050621467525	6.29014775836793	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTTTCACAACGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2128.62732625485	40.7101798532079	0.0191250856131939	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2123.91689210016	2123.91689210016
"healthy-4"	"2019-08-01-count-2:AGGGCTCGTTGCTCAA"	11.6272331672603	3.39872429454652	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCTCGTTGCTCAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.84729704045	43.3381128484565	0.0197814393120874	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2168.2079039044	2168.2079039044
"healthy-4"	"2019-08-01-count-4:TCTTAGTAGCCGAACA"	10.3443170982296	7.61980960452882	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTAGTAGCCGAACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.88948470149	45.8314375621808	0.0222386682558183	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2056.82871974035	2056.82871974035
"healthy-4"	"2019-08-01-count-3:TTAGGCACACGCTGTG"	4.74058022078816	-7.06248762523802	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCACACGCTGTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2786.36688841357	44.2844369764076	0.0158932541010854	2100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2782.46703712386	2782.46703712386
"healthy-4"	"2019-08-01-count-2:AACGAAACAGGTCTCG"	11.5313545661861	3.42870733821718	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGAAACAGGTCTCG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.13281528211	51.6791872252777	0.0263248552634739	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1938.15984418273	1938.15984418273
"healthy-4"	"2019-08-01-count-4:CTTACCGCAAGCGCTC"	4.06039537963216	-6.29276659404906	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGCAAGCGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2901.64338572185	40.6422178216416	0.014006620531534	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2897.01078825226	2897.01078825226
"healthy-4"	"2019-08-01-count-3:TCAGCCTCATATCGGT"	4.96287788924519	-7.71840145504149	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCATATCGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.94260987543	43.256320277336	0.0167924239117376	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2575.94260987543	2575.94260987543
"healthy-4"	"2019-08-01-count-2:ATTCACTAGGGTATAT"	3.08369149741475	-6.84844067012938	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTAGGGTATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.20135722386	47.7923758311845	0.0242084606295634	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1970.47507868814	1970.47507868814
"healthy-4"	"2019-08-01-count-3:TTAGGGTCATCTCATT"	5.1207763153011	-7.57998659526976	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGGTCATCTCATT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.79756334005	43.7216561290292	0.0162304906367272	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2690.67227315355	2690.67227315355
"healthy-4"	"2019-08-01-count-2:AACGGGATCAGCAGAG"	2.17713012275044	-6.43035795604857	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGGGATCAGCAGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2100.51130982712	46.2876256095923	0.0220363610483973	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2097.75162676483	2097.75162676483
"healthy-4"	"2019-08-01-count-2:ATTCACTAGGACAAGA"	3.56483974036519	-6.08903124248656	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCACTAGGACAAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.70457886722	45.3607263580594	0.0173350582730651	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2609.77005950984	2609.77005950984
"healthy-4"	"2019-08-01-count-4:ACTGCAAAGAACTTCC"	-0.102684999734718	7.58334062183229	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAAAGAACTTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2117.29170792323	41.6368496356471	0.0196651455630018	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2110.55510651735	2110.55510651735
"healthy-4"	"2019-08-01-count-3:GTTGTGATCCGACATA"	4.84119667586629	-7.09061386501464	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTGATCCGACATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.96318733242	47.9006793007236	0.0189258696216794	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2527.52132630074	2527.52132630074
"healthy-4"	"2019-08-01-count-2:AGGTCATCATGACACT"	5.19126667556111	-8.33892252361449	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTCATCATGACACT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2916.23887558939	43.0053803076082	0.0147468647604928	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2910.67410754114	2910.67410754114
"healthy-4"	"2019-08-01-count-4:AGTGCCGAGCGATGCA"	-3.37166319313701	9.72456643665162	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGAGCGATGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2011.52533535572	48.977333234946	0.0243483551383084	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2009.8477888532	2009.8477888532
"healthy-4"	"2019-08-01-count-4:CGGGTCAGTCGCAACC"	0.496252407401246	8.16050431812135	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTCAGTCGCAACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1790.60513191838	40.4860369140371	0.0226102540377856	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1781.16131493306	1781.16131493306
"healthy-4"	"2019-08-01-count-4:CGGGCATTCTACAGGT"	6.73718084868733	-1.59845056450041	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGCATTCTACAGGT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2855.37013905366	40.339183867802	0.0141274797673591	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2847.28138743601	2847.28138743601
"healthy-4"	"2019-08-01-count-2:CTACTATTCGCTCTCA"	3.20930709418599	-6.15655519878539	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATTCGCTCTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2837.62073432682	46.6673040914995	0.0164459272259196	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2832.04324133994	2832.04324133994
"healthy-4"	"2019-08-01-count-2:ATTCATCAGTCCCTAA"	10.7766205268795	6.10447547519533	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCAGTCCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2042.90741766123	46.7401273484525	0.0228792195595245	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2042.90741766123	2042.90741766123
"healthy-4"	"2019-08-01-count-3:CAATGACCACGAAAGC"	-3.39685736122783	-6.34168198024901	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATGACCACGAAAGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2837.80125062706	49.9261162251017	0.0175932392073158	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2835.79654549693	2835.79654549693
"healthy-4"	"2019-08-01-count-4:TCTTGCGGTGAGCGAT"	11.5712534385616	3.68753979289857	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGGTGAGCGAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2253.70798067494	31.6427539336102	0.0140403078859107	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2240.93495092859	2240.93495092859
"healthy-4"	"2019-08-01-count-3:TTCACCGAGCAACAGC"	5.67839684066121	-9.85007479107054	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACCGAGCAACAGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2867.49965241406	45.1902361648847	0.0157594565449522	2475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.67459997305	2859.67459997305
"healthy-4"	"2019-08-01-count-2:ATTCATCGTGTCTTGA"	-2.50533066216167	8.97421834552614	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCATCGTGTCTTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2094.348774864	42.9364832155152	0.0205011141080374	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.48828588952	2089.48828588952
"healthy-4"	"2019-08-01-count-3:AAGCCATCAAGTGGAC"	2.08312763747517	-6.22937490856322	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCCATCAAGTGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.62004510871	42.8616980937261	0.0187363710968397	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2286.31130065547	2286.31130065547
"healthy-4"	"2019-08-01-count-3:GAACTGTGTGCGACAA"	4.47202028807942	-6.97919990932616	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAACTGTGTGCGACAA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.84048384297	41.9746683200884	0.0157217888387362	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2664.13527046025	2664.13527046025
"healthy-4"	"2019-08-01-count-3:CAATTTCCACAAATGA"	-0.214574287564117	7.72598455036012	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATTTCCACAAATGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.99501838186	41.4132327591942	0.0206241710662047	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2001.6409846124	2001.6409846124
"healthy-4"	"2019-08-01-count-2:TTCTCTCCACAGGATG"	10.0566717582637	7.53163001621095	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCCACAGGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2298.35211340272	44.9181027489573	0.019543612350353	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2293.65980631142	2293.65980631142
"healthy-4"	"2019-08-01-count-4:TGAATCGCAAATCCCA"	-7.53498588028606	0.873622752073683	"2019-08-01-count-4"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCAAATCCCA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2720.53759307242	38.1982853821955	0.0140407122031556	3275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2710.09794334977	2710.09794334977
"healthy-4"	"2019-08-01-count-3:TAAGCACCATGCAGCC"	10.288949628442	7.59767386997072	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCACCATGCAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1992.79241267429	44.9656200515308	0.0225641264817883	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1986.35020423512	1986.35020423512
"healthy-4"	"2019-08-01-count-4:TGAATCGCAGAGTGAC"	4.46366324004476	-6.85573294078978	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCAGAGTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.03454390988	44.0366159667252	0.0175722302287262	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2493.42660751893	2493.42660751893
"healthy-4"	"2019-08-01-count-2:AGGTGTTGTCCAATCA"	3.2879134612972	-6.39603950893553	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTGTCCAATCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.48748581952	45.0304252554519	0.0180302906465518	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.00380817476	2494.00380817476
"healthy-4"	"2019-08-01-count-3:TAAGCACTCTCCCTAG"	-1.11836598339732	8.52828309619752	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCACTCTCCCTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2178.30692403554	48.1261238629728	0.0220933622034374	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2169.15074328978	2169.15074328978
"healthy-4"	"2019-08-01-count-4:TCAGTTTTCTACTATC"	11.1957518058712	5.45199868762819	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTTTTCTACTATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2121.95744167914	38.3449268952324	0.0180705447442383	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.92121528824	2117.92121528824
"healthy-4"	"2019-08-01-count-2:ATTCCTATCAAATGAG"	10.5541883903438	6.63154409015504	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCTATCAAATGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.49368451176	40.8976715465719	0.020978611970633	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1936.93358602781	1936.93358602781
"healthy-4"	"2019-08-01-count-3:TAAGCCATCGTAGAGG"	3.17423905906026	-6.12503149425658	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCCATCGTAGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.27333493153	44.8677829317788	0.019530885702426	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2292.85859028903	2292.85859028903
"healthy-4"	"2019-08-01-count-3:AAGGAATCACCCTCTA"	3.9242602783138	-6.50911714946898	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGAATCACCCTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.51158595998	43.5405166540593	0.0167753119999868	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2583.34310571363	2583.34310571363
"healthy-4"	"2019-08-01-count-4:CCACGTTTCGATACTG"	0.252819378941697	7.74404714191285	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGTTTCGATACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1891.81501167046	44.1260756435589	0.0233247306799811	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1880.08503720352	1880.08503720352
"healthy-4"	"2019-08-01-count-4:GGTGGCTAGTTTGGCT"	-4.14391265335734	12.4919252165589	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGGCTAGTTTGGCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1853.49805392091	48.8738614504813	0.026368444977373	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1845.71003141838	1845.71003141838
"healthy-4"	"2019-08-01-count-2:TCGCTCATCCTTCTAA"	0.771637459366959	8.13881585681764	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCATCCTTCTAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.38859828469	38.7429549319118	0.0214715139348265	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1799.57819832119	1799.57819832119
"healthy-4"	"2019-08-01-count-2:AAGACTCAGCCAACCC"	-1.64785871926005	3.37444636905519	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCAGCCAACCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2733.2023654918	40.9821360819963	0.0149941828674739	5528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2725.57324488355	2725.57324488355
"healthy-4"	"2019-08-01-count-2:AAGACTCCAACTACGT"	10.6903158622677	6.34514043414918	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCCAACTACGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.40760994013	46.5505004667215	0.0241518712630628	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1925.70359668498	1925.70359668498
"healthy-4"	"2019-08-01-count-3:AAGGTAAAGAGTGGCT"	-0.893009583384353	8.26427171314088	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAAAGAGTGGCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1938.16010345435	43.9962095848967	0.022699987223183	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1931.90653411107	1931.90653411107
"healthy-4"	"2019-08-01-count-2:AAGACTCCAGCGTACC"	2.59563126143758	-4.55257131969603	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCCAGCGTACC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3051.4205624869	36.9337675369889	0.0121037945378752	3005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3046.28424111433	3046.28424111433
"healthy-4"	"2019-08-01-count-3:TAAGTCGTCTAGACAC"	-4.03457627716716	12.5466985472473	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGTCTAGACAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1769.91327513017	44.6723490088884	0.0252398519388487	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1763.71906278116	1763.71906278116
"healthy-4"	"2019-08-01-count-3:TGATCAGAGCAAGGAA"	3.07867850837056	-6.11668159877928	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGAGCAAGGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.84251136448	43.4774162714948	0.0167941526302346	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.49526916849	2580.49526916849
"healthy-4"	"2019-08-01-count-3:TAAGTCGTCTATTTCG"	4.51673521575276	-6.79322912609252	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGTCGTCTATTTCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.8420226753	45.8154152602788	0.0172573037751264	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.4359582158	2649.4359582158
"healthy-4"	"2019-08-01-count-3:AAGGTAAGTGTTACTG"	0.397492428391618	7.74430177295534	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGGTAAGTGTTACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.36727520446	34.5858080541533	0.0185808617755753	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1859.98341207242	1859.98341207242
"healthy-4"	"2019-08-01-count-2:AAGATAGTCTACTGCC"	10.1465240913326	7.66962764346925	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGATAGTCTACTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2017.17216481172	43.3361284160106	0.0214836042118673	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.99326341064	2007.99326341064
"healthy-4"	"2019-08-01-count-4:ATACTTCCACGTAACT"	10.9716488319332	6.57255647266237	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACTTCCACGTAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2271.68743108295	45.8597559887443	0.0201875290417407	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2263.14596350135	2263.14596350135
"healthy-4"	"2019-08-01-count-3:TAATCTCCAGAGGCTA"	2.94642581519429	-6.01389315044554	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCCAGAGGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.27175862241	30.4710648750111	0.0119014963049885	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2557.77298332543	2557.77298332543
"healthy-4"	"2019-08-01-count-2:GGTAATCCAACAGCTT"	10.8981157737667	6.42993066394655	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCCAACAGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.24706586013	48.82886028703	0.024374856760898	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1995.79700228757	1995.79700228757
"healthy-4"	"2019-08-01-count-3:CACCAAACAGCACAAG"	3.02704491195027	-6.27188541805419	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAACAGCACAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2176.12568343327	44.7937520286507	0.0205841750638132	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2176.12568343327	2176.12568343327
"healthy-4"	"2019-08-01-count-2:TTGACCCCAAATGGAT"	10.6494270759517	6.7320608862671	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCCAAATGGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1916.10700431413	43.079333778612	0.0224827390545615	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1914.37891811244	1914.37891811244
"healthy-4"	"2019-08-01-count-4:ATAGAGACACCCTTGT"	-0.247006515890914	8.01582048023073	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGACACCCTTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2286.95614736358	44.3224715037592	0.0193805515487713	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2277.86522551725	2277.86522551725
"healthy-4"	"2019-08-01-count-4:TGAGACTAGCCTGCCA"	11.3240944343502	5.23219201648561	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGACTAGCCTGCCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2544.69292679564	44.4464177771134	0.0174663187487544	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2526.10918102711	2526.10918102711
"healthy-4"	"2019-08-01-count-3:GAATCGTAGAGATGCC"	11.5748049217159	3.43066999996034	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCGTAGAGATGCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.04224041627	37.7833693696489	0.0196989245458165	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1902.61113308058	1902.61113308058
"healthy-4"	"2019-08-01-count-4:TGACTCCGTTTACGAC"	11.3113371330196	4.69248578632203	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCGTTTACGAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.28715025274	38.8157798479098	0.0202240607106646	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1908.83072299956	1908.83072299956
"healthy-4"	"2019-08-01-count-3:GAATCACTCCGCACGA"	2.73340143737141	-5.86414577877196	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATCACTCCGCACGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2854.1489024926	46.6014110877311	0.0163276033170635	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2849.20921620685	2849.20921620685
"healthy-4"	"2019-08-01-count-4:ACTTTGTTCCACTAGA"	3.72423138198201	-5.96982958233031	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTTGTTCCACTAGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2668.85599302094	48.1621134249765	0.018045976834614	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2662.78997957483	2662.78997957483
"healthy-4"	"2019-08-01-count-2:CTCACTGCACAACGAG"	0.018576336174649	7.68967769229738	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGCACAACGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.31871033587	39.4505043842279	0.0207818129639822	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1893.38983158901	1893.38983158901
"healthy-4"	"2019-08-01-count-2:TCAAGCACATGACACT"	11.362435956567	4.77358148181764	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCACATGACACT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2340.59500262965	46.1979754592883	0.0197377057574613	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2329.85880922936	2329.85880922936
"healthy-4"	"2019-08-01-count-2:AAGCGAGGTAGGCTGA"	5.62096561965291	-9.53625490581664	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGAGGTAGGCTGA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.69335855025	45.0932959539638	0.0166108248697545	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2702.28398928617	2702.28398928617
"healthy-4"	"2019-08-01-count-4:ATAGAGATCGAACACT"	-7.73379168930705	-0.396055572387301	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGATCGAACACT"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3100.6956195649	45.1328529443097	0.0145557186134391	4260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3090.07383578124	3090.07383578124
"healthy-4"	"2019-08-01-count-3:GACAGCCAGTGCAACG"	10.4544531303341	7.54210231387941	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACAGCCAGTGCAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2114.5531072565	44.6393279266005	0.0211105258001854	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2107.72562036715	2107.72562036715
"healthy-4"	"2019-08-01-count-2:CTCACTGCACGTTCGG"	2.78052439269368	-6.11552860653075	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCACTGCACGTTCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.73035354978	52.3228231076759	0.023423965665563	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2228.33139995961	2228.33139995961
"healthy-4"	"2019-08-01-count-2:AAGCGTTAGTACCGGA"	11.2879854637081	6.06418655002443	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGTTAGTACCGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1983.36546855143	43.7530268494891	0.0220599922420978	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.29946362944	1975.29946362944
"healthy-4"	"2019-08-01-count-3:CCGGGTATCGAGAACG"	9.10719837722127	5.89832589710084	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGGTATCGAGAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1571.04788862332	34.5878764421258	0.0220158002137252	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1571.04788862332	1571.04788862332
"healthy-4"	"2019-08-01-count-3:TACAGGTAGGTGCTTT"	10.0843149619991	7.4741639860901	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAGGTAGGTGCTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.79168323296	45.6023856844903	0.0226113515161808	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2008.93964742625	2008.93964742625
"healthy-4"	"2019-08-01-count-2:AAGCGTTTCTCCAATT"	-4.37982688370402	12.979351020697	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGTTTCTCCAATT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2006.83748963888	43.7550371382381	0.0218029797450672	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2002.97788279227	2002.97788279227
"healthy-4"	"2019-08-01-count-2:AAGCGTTTCCTAAACG"	-0.40348125520404	8.43666646564332	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGTTTCCTAAACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2071.41243875594	41.2820341044681	0.0199294130575277	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2063.94206291263	2063.94206291263
"healthy-4"	"2019-08-01-count-3:TACATTCAGACGATAT"	11.0390602546627	6.02712104404298	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACATTCAGACGATAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1838.23451845237	47.3054631033647	0.0257341827870753	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1821.44241161308	1821.44241161308
"healthy-4"	"2019-08-01-count-4:ATATCCTAGTACAGAT"	10.0486275154049	7.6657094725403	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATATCCTAGTACAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.22668917228	41.2929063354472	0.0210117777063363	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.07267291036	1954.07267291036
"healthy-4"	"2019-08-01-count-3:CCGGTGATCTCCATAT"	9.92228283461873	6.67424390399782	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTGATCTCCATAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1814.60626680439	45.710451053131	0.0251902861184478	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1802.94415352616	1802.94415352616
"healthy-4"	"2019-08-01-count-2:CATCGCTGTCGTCGGT"	10.7256332832271	7.67356536472169	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGCTGTCGTCGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.63964182177	47.301646852372	0.0231684602333467	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2033.67473748992	2033.67473748992
"healthy-4"	"2019-08-01-count-2:AAGGAATGTGGTTCTA"	2.67727102813069	-6.34433653270873	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGAATGTGGTTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.51250306536	48.2888771191332	0.0231544414373717	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2080.43278864528	2080.43278864528
"healthy-4"	"2019-08-01-count-3:AGAGAGCAGGCTAAAT"	10.4213301139766	5.59534308994142	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAGCAGGCTAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.47021738268	40.0114328993042	0.0218346975136397	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1828.86466044406	1828.86466044406
"healthy-4"	"2019-08-01-count-4:TGAGGGAAGGAAACGA"	-0.0603548688000024	7.52579305255739	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGAAGGAAACGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.1280043893	46.0368049389443	0.0223357330747562	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2057.38061058532	2057.38061058532
"healthy-4"	"2019-08-01-count-3:TTCGGTCCAAGACCTT"	-2.65846381607707	4.04804132068483	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGGTCCAAGACCTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3531.18096076797	45.939958125786	0.0130098000176674	5356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3522.01005811376	3522.01005811376
"healthy-4"	"2019-08-01-count-2:AAGGTAACACCTCTAC"	6.77084650573079	-1.74845364010008	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAACACCTCTAC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3106.50397270048	32.6990418457965	0.0105259938931838	2584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3094.70263229868	3094.70263229868
"healthy-4"	"2019-08-01-count-4:GAAATGAAGCTTAAGA"	0.0803896813536107	7.56733987415162	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAATGAAGCTTAAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.91992539853	42.9790752617191	0.0231080245309539	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1855.57031165784	1855.57031165784
"healthy-4"	"2019-08-01-count-2:CATCGTCCAAATCAAG"	4.77376427230184	-7.02906372463378	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGTCCAAATCAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.32009787539	42.8978427931478	0.015625807287954	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2741.45079958293	2741.45079958293
"healthy-4"	"2019-08-01-count-3:TACCCACCATTCTCCG"	10.6668573814327	7.55247399890748	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACCATTCTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2339.35861184988	43.061472709205	0.0184073841826045	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2333.38454317522	2333.38454317522
"healthy-4"	"2019-08-01-count-2:AAGTACCCAAACGAGC"	10.4843203025753	7.49395034396974	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCCAAACGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.31324339139	43.1373144797696	0.0229293631091478	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.42152060836	1866.42152060836
"healthy-4"	"2019-08-01-count-3:AATGACCTCTCTCTAA"	-3.97953830185588	-5.33251335537108	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGACCTCTCTCTAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3202.80758622794	43.3183340410486	0.0135251128501497	3584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3194.0981943575	3194.0981943575
"healthy-4"	"2019-08-01-count-3:TACCCACGTCCCTGTT"	-8.23725257340129	1.30344412410585	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACGTCCCTGTT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2925.27108596111	48.8740456199187	0.0167075269893699	2751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2907.03835579691	2907.03835579691
"healthy-4"	"2019-08-01-count-2:AGTCTCCCAGCCTTCT"	0.556196292012376	8.19486615741578	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCCAGCCTTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.12911076048	37.8505923079604	0.0193993273429289	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1933.46461040316	1933.46461040316
"healthy-4"	"2019-08-01-count-2:AAGTACCTCCATGCAA"	11.0174404579097	5.702769733313	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTACCTCCATGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2082.82539243597	53.6133370099476	0.0257406776413669	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2075.60002832849	2075.60002832849
"healthy-4"	"2019-08-01-count-4:GTACAACTCACTGTTT"	4.07595076140706	-6.89232208645018	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAACTCACTGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.00515284696	39.7366331829154	0.0156197141104241	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2534.05937038932	2534.05937038932
"healthy-4"	"2019-08-01-count-2:CAACCAACACTCCTGT"	0.0497323687536686	7.5664810904297	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCAACACTCCTGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.55156964741	44.7083887043602	0.0219422120992485	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2031.29694231038	2031.29694231038
"healthy-4"	"2019-08-01-count-3:TTCTAGTCATACCAGT"	3.27533616599385	-6.37675096904906	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTCATACCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.56498698369	48.1237968256558	0.0193847077832698	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2478.86056183328	2478.86056183328
"healthy-4"	"2019-08-01-count-3:TTCTAGTTCTGGGCCA"	4.72188200530354	-7.6855564347473	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTTCTGGGCCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.84865084283	42.4980991032169	0.0157818372339327	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2686.12487332333	2686.12487332333
"healthy-4"	"2019-08-01-count-2:AGTGACTGTGATTCTG"	10.4239870506221	7.00037763202516	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGACTGTGATTCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.43687269591	39.7161504571606	0.0218769107615306	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1809.35074553565	1809.35074553565
"healthy-4"	"2019-08-01-count-2:AAGTCGTTCGAGATAA"	4.64037241515462	-7.15786650097045	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTCGTTCGAGATAA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.47708438228	45.4320735244021	0.0194446903965307	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2333.49693446189	2333.49693446189
"healthy-4"	"2019-08-01-count-2:CAACCTCAGATCGCTT"	10.7789875465328	5.87854287708131	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCAGATCGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1748.10964342602	40.9716711555985	0.0234377010101612	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1734.49303739946	1734.49303739946
"healthy-4"	"2019-08-01-count-4:TGATCAGTCAGACAAA"	10.8194366889888	6.12291953647462	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCAGTCAGACAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1993.62456756776	45.5043545325807	0.0228249366870998	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.53849549413	1990.53849549413
"healthy-4"	"2019-08-01-count-3:AATGCCATCCTGGTCT"	3.81075443801228	-6.5434460869995	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCATCCTGGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2802.31152258903	46.5093543744735	0.0165967823347148	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2798.32902303541	2798.32902303541
"healthy-4"	"2019-08-01-count-4:GTAGAGGAGATAGTGT"	-1.937243561179	8.82333657825319	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGAGATAGTGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.47276528253	43.8245812926058	0.0222180919625161	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1969.13261788179	1969.13261788179
"healthy-4"	"2019-08-01-count-2:AGTGATCCAAGTTTGC"	-3.83106599274333	10.798970199469	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGATCCAAGTTTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2094.44709901661	45.5674729674095	0.02175632556621	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.46336523419	2089.46336523419
"healthy-4"	"2019-08-01-count-2:CTCCAACAGAATCGTA"	-2.0553482574528	3.88428757274476	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACAGAATCGTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3277.53201342358	41.5910202397038	0.0126897372990903	5201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3268.12089552445	3268.12089552445
"healthy-4"	"2019-08-01-count-3:GACCTTCTCATTATCC"	-4.30049357834514	12.5960016020569	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCTCATTATCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2171.62918144073	41.195679907537	0.0189699421335859	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2164.63723294467	2164.63723294467
"healthy-4"	"2019-08-01-count-3:CACTGGGCATAACGGG"	-2.8435300392216	10.9275073775086	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGCATAACGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1699.82142542034	50.1079291809913	0.0294783489792762	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1695.74082246471	1695.74082246471
"healthy-4"	"2019-08-01-count-4:ATCCCTGCATCTTCGC"	-3.34772429886516	-5.41375448619994	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCCTGCATCTTCGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2625.12335545224	46.9186824803918	0.017872943906786	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2621.4539428129	2621.4539428129
"healthy-4"	"2019-08-01-count-4:CTACCTGCACCTGTCT"	5.0397068458492	-7.54138138210448	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCTGCACCTGTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2958.57739477695	42.5831080803046	0.0143931026294869	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2948.92022556241	2948.92022556241
"healthy-4"	"2019-08-01-count-3:CACTGTCCAATGCTCA"	2.46036233481709	-6.46601202404173	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGTCCAATGCTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.47760042694	51.9987221737828	0.0221697799050895	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2338.56686096349	2338.56686096349
"healthy-4"	"2019-08-01-count-2:GCCCAGATCACTGAAC"	10.2485453086788	7.47328279102174	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCAGATCACTGAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.35791622071	46.186575428242	0.0229059409823481	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.11605244662	2007.11605244662
"healthy-4"	"2019-08-01-count-4:ATCCGTCCATCATCTT"	10.1054779487545	7.57024190509645	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCGTCCATCATCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2147.65207051968	46.7230489804492	0.0217554089052904	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2143.64344903985	2143.64344903985
"healthy-4"	"2019-08-01-count-4:ATCCGTCCATGCGGTC"	4.09601082381551	-6.32893373882445	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCGTCCATGCGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2829.51580921225	45.7111187917386	0.0161551028069587	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2825.23132435466	2825.23132435466
"healthy-4"	"2019-08-01-count-2:CAACGGCAGTCGAGGT"	0.176943865686101	8.10302827442018	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCAGTCGAGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.88192908196	39.0516939158887	0.0209181380501618	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1861.61188715128	1861.61188715128
"healthy-4"	"2019-08-01-count-2:CTCCAACTCTAGTACG"	10.9634663062984	6.24844548786012	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACTCTAGTACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2061.81119687648	46.838579378057	0.0227172009973632	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2060.25226816919	2060.25226816919
"healthy-4"	"2019-08-01-count-3:GTATTGGGTTTGGGTT"	11.5382811027462	3.77158877933351	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTGGGTTTGGGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2145.16988579162	38.1464791414843	0.0177824979709742	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2127.72977553348	2127.72977553348
"healthy-4"	"2019-08-01-count-4:TGATGGTAGCCTCTCT"	6.74689259108846	-1.68758513843688	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTAGCCTCTCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2769.95758306686	27.8491474741053	0.0100539978100571	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2767.3586076096	2767.3586076096
"healthy-4"	"2019-08-01-count-2:GGTTCTCTCGACCAAT"	-3.13296685639079	10.0538291701111	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTCTCTCGACCAAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1948.37100737795	44.4604538382958	0.0228192955396771	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1946.43710389608	1946.43710389608
"healthy-4"	"2019-08-01-count-3:GACTATGTCACTTGGA"	4.21170773085896	-6.42810490047606	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGTCACTTGGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2661.01862086169	39.3942496897296	0.0148041991818054	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2654.55426910506	2654.55426910506
"healthy-4"	"2019-08-01-count-4:GTAGGAGAGAGTCACG"	4.15079893645589	-6.64305593883666	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGAGAGTCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2705.41943213865	47.8392807453162	0.0176827593448233	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2701.04753594124	2701.04753594124
"healthy-4"	"2019-08-01-count-3:TGCGGCACAGGCTCTG"	-3.81867204132732	3.76044032657472	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCACAGGCTCTG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2993.9302046997	44.2756921969933	0.0147884850914333	4650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2979.16510522904	2979.16510522904
"healthy-4"	"2019-08-01-count-2:GGTTGTATCACCGGTG"	-2.35902891579326	9.40387818897096	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTATCACCGGTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2044.38342410275	46.914069551286	0.0229477841574048	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.80307641986	2032.80307641986
"healthy-4"	"2019-08-01-count-3:TTGACCCGTAGAATGT"	-2.29769025269206	9.18716428363649	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGACCCGTAGAATGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1871.25960129941	49.2719857732183	0.0263309194186651	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1861.98557662541	1861.98557662541
"healthy-4"	"2019-08-01-count-2:GTAACACCACTGTGTA"	-0.924303810030776	8.40774152362672	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACCACTGTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.71030539725	44.9296993312631	0.02185604616239	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2046.58814886327	2046.58814886327
"healthy-4"	"2019-08-01-count-2:GTAACACAGGTCGTAG"	4.80887093123738	-6.75753166591796	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACAGGTCGTAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2847.80220969905	43.5742655581693	0.0153010154320985	2763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2841.64590582387	2841.64590582387
"healthy-4"	"2019-08-01-count-3:TACGGGCGTCCTGTCT"	4.27985205230061	-6.84726240551146	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGGCGTCCTGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.46740681442	41.6964012670678	0.016994886971499	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2450.73101571641	2450.73101571641
"healthy-4"	"2019-08-01-count-2:CATGGTATCAAGCTGT"	5.09824337539021	-7.4730262986389	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGTATCAAGCTGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2833.04513982262	41.4105819621205	0.014616986288017	2222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2826.63869000453	2826.63869000453
"healthy-4"	"2019-08-01-count-3:TGCTCGTAGCGACTAG"	4.31979193267171	-6.57114365017089	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTAGCGACTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.26820134883	38.8448229219745	0.0139716099702644	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2774.06801755261	2774.06801755261
"healthy-4"	"2019-08-01-count-4:GTAGTACAGTCTAGAA"	2.80452169951741	-5.97130443966063	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGTACAGTCTAGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.54191807456	40.2719507957294	0.0170821780461151	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2355.42328512478	2355.42328512478
"healthy-4"	"2019-08-01-count-3:TACGGTATCCAAAGGG"	11.0991836982662	6.40709540927736	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGTATCCAAAGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1807.62626230744	41.6459992560541	0.0230390541034145	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1804.08480308702	1804.08480308702
"healthy-4"	"2019-08-01-count-4:ATCGGATAGAAACACT"	10.4784609275753	7.21926782214967	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATAGAAACACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.98106710548	39.0955635258225	0.0207736221204138	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.81673021355	1874.81673021355
"healthy-4"	"2019-08-01-count-2:CAAGCTATCGTCTAAG"	11.466741223901	4.507457233313	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTATCGTCTAAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.9624823956	39.7647413980803	0.0190265336019336	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2072.64947731214	2072.64947731214
"healthy-4"	"2019-08-01-count-2:TCTCACGTCTCGGCTT"	-1.8876898092335	8.94224450671998	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGTCTCGGCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2144.80515430163	43.4508705398509	0.0202586563412092	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2139.1982722633	2139.1982722633
"healthy-4"	"2019-08-01-count-4:CTATAGGAGAGGACTC"	5.01212324675862	-7.3613376847473	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATAGGAGAGGACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.37492338539	38.8991709750698	0.0147380240034924	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2634.79034786314	2634.79034786314
"healthy-4"	"2019-08-01-count-2:AATGACCTCAAGCCGC"	10.8188358741695	6.29801843250123	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGACCTCAAGCCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1819.32774140871	47.4294189670148	0.0260697497693792	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1812.53796142486	1812.53796142486
"healthy-4"	"2019-08-01-count-3:TACGTCCGTCACATTG"	10.9917894798214	5.61469409549562	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCGTCACATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.81253617077	42.8071136603013	0.0232418407517736	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1836.77291311661	1836.77291311661
"healthy-4"	"2019-08-01-count-3:TTGCCTGGTCACAGTT"	0.256036211817902	7.82898948276369	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGGTCACAGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2013.64378503698	41.9064168272639	0.0208112363957632	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2001.44678288082	2001.44678288082
"healthy-4"	"2019-08-01-count-2:TCTCCGAGTGGCAGAT"	11.1028229194576	5.94236896121827	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCCGAGTGGCAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1750.12333866299	44.9505026170918	0.0256841912933016	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1736.16592975709	1736.16592975709
"healthy-4"	"2019-08-01-count-4:GTCAAACGTGTATTGC"	-2.33986769142802	8.96875093067018	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACGTGTATTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.71491231139	43.1710078397387	0.0217517425661209	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.45180720152	1979.45180720152
"healthy-4"	"2019-08-01-count-2:CTCCGATCAGACCTAT"	2.15791906890218	-5.85747625744017	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATCAGACCTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2809.67249095185	44.2217667536961	0.015739117956312	2303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2797.75537571661	2797.75537571661
"healthy-4"	"2019-08-01-count-3:GAGAAATAGCGTATGG"	-0.129274333745796	8.16733071887819	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATAGCGTATGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.36570600544	44.3254988270389	0.0219502087686338	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2009.47931002285	2009.47931002285
"healthy-4"	"2019-08-01-count-2:AATGGAAAGGCACTAG"	2.99585451659505	-6.37995817577513	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGAAAGGCACTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.99711054618	49.3777214622514	0.021375663734305	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2305.86279126733	2305.86279126733
"healthy-4"	"2019-08-01-count-2:AATGGCTCAAGTTGGG"	11.5217949348385	3.54857490146486	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTCAAGTTGGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2080.85479133782	26.8358191701071	0.0128965362128194	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2073.87546909881	2073.87546909881
"healthy-4"	"2019-08-01-count-4:CTATCTATCCGGACGT"	2.95526995238606	-4.88292553341063	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCTATCCGGACGT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2983.79508986121	41.0360313903234	0.0137529656542977	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2977.98385630876	2977.98385630876
"healthy-4"	"2019-08-01-count-4:CTATCTATCTTCCTAA"	11.2543159919674	5.03360889041749	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCTATCTTCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2014.20822335459	47.6324383353428	0.0236482195748426	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2002.16538893572	2002.16538893572
"healthy-4"	"2019-08-01-count-2:AATGGCTGTCAACGCC"	10.7450291114742	6.68587443912355	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTGTCAACGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.63005472829	50.6038647201519	0.0257705694605261	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1948.5084285839	1948.5084285839
"healthy-4"	"2019-08-01-count-2:AATGGCTTCCACTTCG"	-4.25240979614909	10.6817865141663	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTTCCACTTCG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2394.14245709898	45.0686656861204	0.0188245547179055	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2379.39758403987	2379.39758403987
"healthy-4"	"2019-08-01-count-3:TTGGATGCAGGCTCTG"	11.303146024316	5.37681672656862	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGCAGGCTCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.45069754883	42.2790452487605	0.0194793852246945	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2161.50449975307	2161.50449975307
"healthy-4"	"2019-08-01-count-4:AGCATCAAGTAGGAAG"	4.62187304076497	-6.90513946926268	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCAAGTAGGAAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.26730231128	44.5797636416182	0.0168845645297328	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2638.21637994712	2638.21637994712
"healthy-4"	"2019-08-01-count-2:TCAGGGCTCTGAATCG"	10.1944118934566	7.4828514822754	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCTCTGAATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.2082454309	42.1614940678921	0.0225076385237636	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.76837935065	1868.76837935065
"healthy-4"	"2019-08-01-count-3:TTGGATGTCAGGGTAG"	11.0228125053341	6.38425347888795	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGATGTCAGGGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.66058967544	43.7434164423804	0.0235602655033612	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.44802014709	1851.44802014709
"healthy-4"	"2019-08-01-count-2:AATTTCCCAACCGTAT"	10.5309759574825	7.61583087528077	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTTCCCAACCGTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.87785657732	41.8890610480146	0.0192959087592603	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2164.56679705677	2164.56679705677
"healthy-4"	"2019-08-01-count-3:TGGAGAGAGTAGAATC"	-4.22399459305461	3.70800445163576	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGAGAGTAGAATC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2759.96568518654	44.3501141667183	0.0160690817298045	3272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2747.160680352	2747.160680352
"healthy-4"	"2019-08-01-count-1:GTGGAAGCACCCATAA"	11.1741968589718	6.20812652194826	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGGAAGCACCCATAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2175.89978715607	48.0562894827864	0.0220857089864404	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2164.32588920524	2164.32588920524
"healthy-4"	"2019-08-01-count-4:TCCGAAATCTGGTTGA"	11.6237589317257	3.75085113132326	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAATCTGGTTGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2315.02013938674	31.3363585185198	0.0135361062244672	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2305.90456123229	2305.90456123229
"healthy-4"	"2019-08-01-count-3:TGGAGGATCTTGTGCC"	-4.09209905090983	-4.05795099651488	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGGATCTTGTGCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3151.32292672753	38.7854523280688	0.0123076730725103	3360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3146.13315946687	3146.13315946687
"healthy-4"	"2019-08-01-count-4:CTCAACCTCGTAACTG"	5.59818853911702	-9.97567942058715	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCTCGTAACTG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2766.66039885409	45.182780015417	0.0163311623046078	2260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2757.47533826824	2757.47533826824
"healthy-4"	"2019-08-01-count-4:GTCAGCGGTTGTTGTG"	0.0117020542616069	7.582896686438	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGGTTGTTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.68996261176	41.6146201720736	0.0216327064032575	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.25225948387	1916.25225948387
"healthy-4"	"2019-08-01-count-3:TTGGGCGGTGTACATC"	4.69997896727864	-7.01920750057372	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGCGGTGTACATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.82250972601	46.9287925877631	0.0206024799506472	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2273.43604559681	2273.43604559681
"healthy-4"	"2019-08-01-count-2:CAATTTCGTACGACAG"	4.53388657149617	-6.813916229364	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATTTCGTACGACAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2749.11719884987	44.1719161583383	0.0160676729885572	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2749.11719884987	2749.11719884987
"healthy-4"	"2019-08-01-count-3:TAGACCAGTTGTTGCA"	-2.46764193001445	3.40852353656618	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACCAGTTGTTGCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3037.44769467078	46.3849682210538	0.0152710343958964	4699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3024.80921355503	3024.80921355503
"healthy-4"	"2019-08-01-count-3:CAGTGCGGTCTGTGCG"	-7.78867469254191	1.16186986053316	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGGTCTGTGCG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2783.55736924613	48.5503095872034	0.0174418210752927	2846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2768.56422529853	2768.56422529853
"healthy-4"	"2019-08-01-count-3:TTGGGTAAGCGTATGG"	4.66494431075398	-7.25137712871703	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGTAAGCGTATGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.80920248134	44.9897164881526	0.0174798180241096	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.42187119124	2568.42187119124
"healthy-4"	"2019-08-01-count-2:CTCTCAGTCTGCATGA"	11.4118305641109	3.4669241675171	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCAGTCTGCATGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1434.63168391985	44.8562922325965	0.0312667653554364	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1413.68833024282	1413.68833024282
"healthy-4"	"2019-08-01-count-2:ACAAAGACAGACTCTA"	3.94567551192586	-6.86314203655394	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGACAGACTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.97309272565	42.9437562838333	0.0170684481515304	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2507.27163681621	2507.27163681621
"healthy-4"	"2019-08-01-count-3:ACATCCCCAGCAGTGA"	-3.15787349167522	10.0849561461243	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCCCCAGCAGTGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2053.30299747167	43.6299920348117	0.0212486866714437	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2050.20238567667	2050.20238567667
"healthy-4"	"2019-08-01-count-4:GTCATCCGTTGGGATG"	10.552546163171	7.30360171878663	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATCCGTTGGGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2067.10783722293	39.5603351339246	0.0191380122611659	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2058.52502417228	2058.52502417228
"healthy-4"	"2019-08-01-count-2:CACACAATCATTCTTG"	9.78300251540486	6.90551612460939	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAATCATTCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1971.15987454973	44.1312150196942	0.0223884503684791	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1966.55604573088	1966.55604573088
"healthy-4"	"2019-08-01-count-3:CAGTTCCAGATTGCGG"	3.03247704085652	-6.30984785473021	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTCCAGATTGCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.01046531074	43.177642046137	0.0184125583594849	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2340.24122886099	2340.24122886099
"healthy-4"	"2019-08-01-count-3:TAGATCGCACCCAACG"	-4.32364879074748	12.7937087782654	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGATCGCACCCAACG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1953.36360106277	49.0513119284204	0.0251112040286472	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1949.44826978874	1949.44826978874
"healthy-4"	"2019-08-01-count-2:CACAGATCATAAGCAA"	3.81430091437642	-6.67199804699095	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATCATAAGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.67946324665	44.6058944596433	0.018705195036533	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2380.48102969041	2380.48102969041
"healthy-4"	"2019-08-01-count-3:TCCTGCATCCATAGGT"	10.7018429237301	7.18054006183473	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCATCCATAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.17826514943	45.7279594571613	0.0232809619516294	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.02723826054	1958.02723826054
"healthy-4"	"2019-08-01-count-2:ACAACCAGTACAGTTC"	-3.25809894028361	9.67840001666871	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCAGTACAGTTC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2121.61637993884	46.8037226595761	0.0220604078579584	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2119.82352512112	2119.82352512112
"healthy-4"	"2019-08-01-count-3:TGGGAAGGTGCACAAG"	10.2290121513302	7.32052133167116	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAAGGTGCACAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1880.7868730048	42.3571148916967	0.0225209541281122	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1872.16608127482	1872.16608127482
"healthy-4"	"2019-08-01-count-2:ACAAGCTCAATTGAGA"	5.10037912902181	-7.63034822857054	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTCAATTGAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2717.66211048844	48.2403811041479	0.0177506912717261	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2715.47904712821	2715.47904712821
"healthy-4"	"2019-08-01-count-2:ACAAGCTCAGAGTGTG"	1.70340361174886	-6.94432547008666	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTCAGAGTGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1923.38586507584	54.4869797730224	0.0283286784843218	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1917.6988736842	1917.6988736842
"healthy-4"	"2019-08-01-count-2:CACAGATGTAGTGATA"	2.85207547721211	-6.197292350885	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATGTAGTGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.24732940264	45.3662294087411	0.0216107119791599	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2095.13948971889	2095.13948971889
"healthy-4"	"2019-08-01-count-2:ACACAGTCAGTAGAGC"	10.9597259956295	7.35587165439454	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACAGTCAGTAGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2687.67407474494	38.5597697523821	0.0143468920263486	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2677.31745250822	2677.31745250822
"healthy-4"	"2019-08-01-count-2:CTCTGGTAGCGTATGG"	11.5162283378536	4.22407672489015	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTAGCGTATGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2068.98510715707	41.3161541278948	0.0199692854167839	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2059.92022245018	2059.92022245018
"healthy-4"	"2019-08-01-count-2:GTAGGTTTCCAACTAG"	3.80316462096516	-6.99889471447142	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGTTTCCAACTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.82396468122	45.1734892092391	0.0184094253945831	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2451.23328395817	2451.23328395817
"healthy-4"	"2019-08-01-count-4:GCTTTCGCAGGCGATA"	-0.106544996530372	7.70790050113527	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTTCGCAGGCGATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1878.58330412222	41.8831144386819	0.0222950530576827	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1870.33650249435	1870.33650249435
"healthy-4"	"2019-08-01-count-3:TGGGATTTCCGGCTTT"	5.06594194945638	-7.70143797313841	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGATTTCCGGCTTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2809.19155273274	45.5922175815357	0.016229657795028	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2805.35910696159	2805.35910696159
"healthy-4"	"2019-08-01-count-3:GAGGGATCAATTGAAG"	-2.839747051627	9.47904489124147	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATCAATTGAAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2052.69419465401	39.330056518687	0.0191602122815553	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2045.76856853833	2045.76856853833
"healthy-4"	"2019-08-01-count-3:CATACAGTCATCCTAT"	-0.149938131601173	7.62662217700807	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACAGTCATCCTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2084.57842431479	43.9277630683382	0.0210727322877178	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2076.24152727316	2076.24152727316
"healthy-4"	"2019-08-01-count-3:CTCTGGTTCTATCCAT"	5.64796986159627	-1.89817430889281	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTTCTATCCAT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3045.57031701658	37.8286698153019	0.0124208820935576	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3037.85185453331	3037.85185453331
"healthy-4"	"2019-08-01-count-4:CTCAGAATCACCTGGG"	4.58947815474812	-6.95307447826537	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAATCACCTGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2686.23186560411	44.9209186377125	0.0167226512397917	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2682.63286272923	2682.63286272923
"healthy-4"	"2019-08-01-count-2:ACACCAACACGGATCC"	1.78554203090016	-6.23852112209471	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACCAACACGGATCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2561.93579027032	49.5378662651412	0.0193361076625243	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2555.58089807654	2555.58089807654
"healthy-4"	"2019-08-01-count-4:ATGCCTCAGTCACGAG"	3.7424873310024	-7.20356323635253	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCCTCAGTCACGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.53330381878	44.0085489320366	0.0237687050193854	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1847.83051338125	1847.83051338125
"healthy-4"	"2019-08-01-count-2:GTATTTCCATGCTGCG"	2.45725621756856	-6.50908806240233	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTTCCATGCTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.15666230043	47.6907642865865	0.0223883835074757	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2130.15666230043	2130.15666230043
"healthy-4"	"2019-08-01-count-1:TCCAGAAAGCACTCGC"	-2.2655762237614	9.09539792621461	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCCAGAAAGCACTCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2287.00350520322	45.9920678583002	0.0201101868683902	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2271.501637755	2271.501637755
"healthy-4"	"2019-08-01-count-4:CTCAGGGCATGGAATA"	11.0644213157589	6.39075896823732	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGGGCATGGAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.08076639716	42.8750152055541	0.0226243735706664	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.55577224612	1889.55577224612
"healthy-4"	"2019-08-01-count-4:CTCAGGGTCTGGGATT"	3.25918640670125	-6.07503893291625	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGGGTCTGGGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.91169218366	45.4736506553295	0.0169873555366463	2027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2673.04057794914	2673.04057794914
"healthy-4"	"2019-08-01-count-3:TTTACCACACTTGACA"	11.1201254325802	5.91725490177003	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCACACTTGACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.94289606191	45.2240842934392	0.0226126877834812	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.17467882225	1991.17467882225
"healthy-4"	"2019-08-01-count-2:TCATCCGTCGTGGAAG"	10.7082849937374	5.46570966327516	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCCGTCGTGGAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1771.86279135483	47.3077034332352	0.0266994169436009	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1763.74966629973	1763.74966629973
"healthy-4"	"2019-08-01-count-2:ACACTGACACTAACCA"	-3.21806774559672	9.29379556262819	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACTGACACTAACCA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2428.47827704383	39.3958136511186	0.0162224278567872	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2423.72732614889	2423.72732614889
"healthy-4"	"2019-08-01-count-4:TGGAACTAGTTCCAGT"	10.8876120048458	6.1104149588379	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTAGTTCCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.88822944261	47.5822481346567	0.0245409959233884	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.27347171356	1934.27347171356
"healthy-4"	"2019-08-01-count-2:ACAGAAACAATGCAGG"	10.757512708276	7.41798684680787	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGAAACAATGCAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.47569692832	43.5076291280728	0.022929215482709	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.1024527199	1893.1024527199
"healthy-4"	"2019-08-01-count-3:CATAGACCAATCTCGA"	2.15853275832478	-6.13417293941649	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAGACCAATCTCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.20647801248	47.3123976863103	0.0199444686307199	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2366.0067363509	2366.0067363509
"healthy-4"	"2019-08-01-count-3:CTGAGGCAGCTCTATG"	2.70447291907613	-6.15820267116698	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCAGCTCTATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.76235149729	45.7918994733687	0.0197910988757059	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2308.4880500844	2308.4880500844
"healthy-4"	"2019-08-01-count-3:TAGGTACTCTTGGAAC"	11.0026194053585	5.97905967319337	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACTCTTGGAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1988.99418138085	46.9546999933378	0.0236072585997913	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1984.2285621793	1984.2285621793
"healthy-4"	"2019-08-01-count-4:TTGACCCAGCCTGTCG"	-5.50172982636149	-5.42054083263548	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGACCCAGCCTGTCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2871.34435249481	40.2333010668552	0.0140120083583489	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2867.40770124157	2867.40770124157
"healthy-4"	"2019-08-01-count-4:CTCATCGCATGGGAAC"	0.202245910733384	7.81844136798707	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATCGCATGGGAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.31642707626	36.6252732841661	0.0176565507586465	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2062.4157786523	2062.4157786523
"healthy-4"	"2019-08-01-count-1:TCGCACTTCAAGAGTA"	-0.123727659613448	7.58874270999757	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGCACTTCAAGAGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2223.2865551684	47.4202243136224	0.0213288854751477	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2204.40339425085	2204.40339425085
"healthy-4"	"2019-08-01-count-2:GGAACCCTCAGTGTTG"	10.3152195411617	6.60101649844972	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAACCCTCAGTGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1727.33110375665	49.7713465738491	0.0288140162969363	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1720.84148322214	1720.84148322214
"healthy-4"	"2019-08-01-count-3:ACCATTTGTCCTTTGC"	-3.51507864418681	11.1321782835755	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTGTCCTTTGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1902.49740344508	48.592857444775	0.0255416156451946	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.08439078456	1897.08439078456
"healthy-4"	"2019-08-01-count-2:CACGAATTCGATCCCT"	2.77300109443013	-6.41835167324217	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCGATCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.78753249432	52.1774795074057	0.0206824708126796	1777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2515.01608587487	2515.01608587487
"healthy-4"	"2019-08-01-count-3:TGGTGATTCCAACCGG"	10.5055166679317	6.32668159091798	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTGATTCCAACCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.57648034284	40.4851693920863	0.0212233531967274	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.21104866406	1889.21104866406
"healthy-4"	"2019-08-01-count-3:GGAGGTACAGGCGTTC"	11.3482481437618	4.77750060642091	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGTACAGGCGTTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2148.78043322758	39.3543286336776	0.0183147277521349	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2135.50597763922	2135.50597763922
"healthy-4"	"2019-08-01-count-2:GGAAGTGAGCAAATCA"	2.65788139876668	-6.13851978695067	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAAGTGAGCAAATCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2195.74421748115	48.1516050126378	0.0219295146626299	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2189.28717973059	2189.28717973059
"healthy-4"	"2019-08-01-count-4:CTCATGCGTTGGTAGG"	-2.85650883141215	3.42054531658021	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCGTTGGTAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3206.36181293649	46.2417587755509	0.0144218779642966	4921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3197.97926923229	3197.97926923229
"healthy-4"	"2019-08-01-count-3:TAGTGCATCTATTTCG"	4.05496897277181	-6.27723553096923	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGTGCATCTATTTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2874.7512726566	46.523982007058	0.0161836547215664	2539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2865.51288834728	2865.51288834728
"healthy-4"	"2019-08-01-count-2:CACGTGGAGGATACAT"	10.4401861625606	7.58970544421998	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGAGGATACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2195.11475310975	52.260936656501	0.0238078381016139	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2183.202402728	2183.202402728
"healthy-4"	"2019-08-01-count-2:GTCAGCGCAGGTTCGC"	4.18428864058797	-6.39166786586913	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAGCGCAGGTTCGC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.99717159215	46.3408943023536	0.0172015378453297	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2688.06807201854	2688.06807201854
"healthy-4"	"2019-08-01-count-3:CATCCCACATGCTGCG"	-2.7497128051823	9.32317540729371	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCCCACATGCTGCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2072.24427504261	45.339366981032	0.0218793544405375	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2064.26926593518	2064.26926593518
"healthy-4"	"2019-08-01-count-2:GGAATCTCATCACCAA"	3.09904398497884	-6.0675087205139	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTCATCACCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.7351487033	47.896384021278	0.0189483396018955	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2525.25471549631	2525.25471549631
"healthy-4"	"2019-08-01-count-2:CTGCCTAAGTCTCCTC"	9.89838566359822	6.92864177310792	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTAAGTCTCCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2046.9727893011	46.5586366212993	0.0227451175045642	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2040.21866903878	2040.21866903878
"healthy-4"	"2019-08-01-count-2:CACGTGGGTTACAGCT"	10.5282570320064	7.76269576633302	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGGTTACAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2126.04462062275	42.8286366341015	0.0201447496532582	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2116.27675877292	2116.27675877292
"healthy-4"	"2019-08-01-count-3:GAGTTACTCCTCAGGG"	-1.96661577645	4.18905065143434	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTACTCCTCAGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3107.79051086655	49.2632874095044	0.0158515470194187	5107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3100.28874099328	3100.28874099328
"healthy-4"	"2019-08-01-count-3:GAGTTGTTCGTGGACC"	10.713938375085	6.48390290820924	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTGTTCGTGGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1773.50025643089	45.183267817086	0.0254768882345785	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1763.2372786617	1763.2372786617
"healthy-4"	"2019-08-01-count-2:ACATGCAAGCAATTAG"	5.66558470305745	-9.91081526195677	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCAAGCAATTAG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2890.09606456625	42.9255677468358	0.0148526439218131	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2886.42038787218	2886.42038787218
"healthy-4"	"2019-08-01-count-4:GAGACTTAGCAAGTCG"	-1.98069749298747	4.03786680782167	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACTTAGCAAGTCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2969.56128813198	50.78664860693	0.0171024079583411	4461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2962.33995944545	2962.33995944545
"healthy-4"	"2019-08-01-count-2:GTCATCCTCAACGTGT"	3.10407175597493	-6.18181707775267	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCTCAACGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.50845364123	45.5737038511981	0.0206355125225169	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2205.82886970331	2205.82886970331
"healthy-4"	"2019-08-01-count-2:TGACGCGGTTTCGACA"	10.7417427497799	6.02278754794923	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGGTTTCGACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.99182484066	47.2910524961947	0.0250616096337291	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1879.10374835742	1879.10374835742
"healthy-4"	"2019-08-01-count-2:ACATGCAAGGCGACAT"	3.46071376380269	-6.26497509395751	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCAAGGCGACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.07121785815	49.0860502082766	0.0225158012298801	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2175.91298662149	2175.91298662149
"healthy-4"	"2019-08-01-count-3:TTTCCTCAGCTTTCTT"	-1.93627212467845	9.24457261646119	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCCTCAGCTTTCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.83380738729	47.7235894518084	0.0243384162757769	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1955.48776046591	1955.48776046591
"healthy-4"	"2019-08-01-count-3:TGTAGACAGAAGTCAT"	4.73982729491536	-6.96307947551879	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACAGAAGTCAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.33285632198	41.7719352208301	0.0163341800100702	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2553.07842559647	2553.07842559647
"healthy-4"	"2019-08-01-count-2:CGGGCATCATTGAAAG"	11.6548658805782	3.46288464153139	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGCATCATTGAAAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2194.83920795708	37.74981454234	0.0171993531031719	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2183.12295127983	2183.12295127983
"healthy-4"	"2019-08-01-count-2:ACATGCAGTCTATGAC"	0.037411398335737	7.64771936023561	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATGCAGTCTATGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2006.88863422396	41.3077265286093	0.0205829689919902	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1998.21976196124	1998.21976196124
"healthy-4"	"2019-08-01-count-3:TGTAGACCACTTCAAG"	2.11431374129598	-6.05847170269164	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAGACCACTTCAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2494.25924257041	43.8851295782517	0.0175944540283738	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2487.84809022478	2487.84809022478
"healthy-4"	"2019-08-01-count-1:TTAGTCTCAAGTATAG"	3.83910073813741	-6.3605265847412	"2019-08-01-count-1"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTAGTCTCAAGTATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2888.08677476529	39.4579397584842	0.0136623110161539	2455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2881.25233107546	2881.25233107546
"healthy-4"	"2019-08-01-count-2:CGGGTCACACATTGTG"	9.92224659499471	7.04726264560548	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCACACATTGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1868.24767067632	43.9354188615648	0.0235169134966243	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1859.67545297656	1859.67545297656
"healthy-4"	"2019-08-01-count-4:ATTACTCCAGGACGAT"	3.1028856235439	-6.24311687862548	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACTCCAGGACGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.0262676248	48.9510961567698	0.0216021750745543	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2261.94396443881	2261.94396443881
"healthy-4"	"2019-08-01-count-4:GTGAGGACAAGTTGGG"	3.0619031387264	-6.01292517101439	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGACAAGTTGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.8773359921	42.8186758310418	0.0165522637023762	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2581.19938187029	2581.19938187029
"healthy-4"	"2019-08-01-count-4:ATTACTCTCTCTAGGA"	0.187396665185136	7.89095923984376	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACTCTCTCTAGGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.72166584529	42.2600558932441	0.0210802609725002	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.88371503946	1996.88371503946
"healthy-4"	"2019-08-01-count-4:ATTATCCAGCATCAAA"	4.62199892577474	-6.82710363781127	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCAGCATCAAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2931.06828670422	37.3888539374472	0.0127560501087773	2697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2924.71721797018	2924.71721797018
"healthy-4"	"2019-08-01-count-3:TATCTGTCATAACGGG"	-7.22945628586467	0.176188386324324	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTCATAACGGG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2823.47819595003	45.5605794679548	0.0161363312574209	3528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2814.36246755339	2814.36246755339
"healthy-4"	"2019-08-01-count-2:GTCCCATCAAGAATGT"	10.4144798713619	6.71060464465944	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATCAAGAATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2040.13224908308	41.5161251171511	0.0203497224926522	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2031.53709774887	2031.53709774887
"healthy-4"	"2019-08-01-count-3:TATCTGTGTCTATGAC"	-3.56397710266765	-5.47789623653563	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTGTCTATGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2719.03660882814	50.1522469333493	0.0184448590248897	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2715.08200245885	2715.08200245885
"healthy-4"	"2019-08-01-count-2:ACCAAACGTTGCCGAC"	4.27041115340535	-6.59328081524047	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACGTTGCCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.81794509762	44.4059297088309	0.0171928222014705	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.28510943453	2580.28510943453
"healthy-4"	"2019-08-01-count-2:CACTGAAGTATACGGG"	1.22193171557729	-6.12292816555174	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAGTATACGGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2549.40129717722	42.3474680890135	0.0166107501929578	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2541.57586672018	2541.57586672018
"healthy-4"	"2019-08-01-count-3:GATCATGAGCGTGCCT"	4.29542412337605	-7.00336744701537	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCATGAGCGTGCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.08774205817	44.7280292211752	0.0166393486794924	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2682.41504970456	2682.41504970456
"healthy-4"	"2019-08-01-count-2:ATCTCTATCCAGCCTT"	10.6029974418575	7.40722320163576	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTCTATCCAGCCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.85329074217	48.2571414622409	0.0229593291191134	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2091.57010191025	2091.57010191025
"healthy-4"	"2019-08-01-count-3:TTTGGAGCATGGGAAC"	11.4025007682735	4.60680530155031	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGCATGGGAAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1992.42129113009	40.7944820682845	0.0204748274122016	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1988.96204954377	1988.96204954377
"healthy-4"	"2019-08-01-count-2:CACTGAAGTGGGCTTC"	10.5602594810421	7.40492103183595	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAGTGGGCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2097.47867084368	48.4193043591371	0.0230845276436881	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2090.30990529223	2090.30990529223
"healthy-4"	"2019-08-01-count-3:TTTGGAGGTGATAGTA"	2.40226258811299	-6.71502735531005	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGGTGATAGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2026.3432481702	44.4801774902342	0.0219509589653185	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2021.9229679517	2021.9229679517
"healthy-4"	"2019-08-01-count-3:TTTGGAGTCATCTACT"	4.4274717765743	-6.76622917568358	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGAGTCATCTACT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.1821546243	41.5289627099388	0.0152110593205652	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2726.07561755271	2726.07561755271
"healthy-4"	"2019-08-01-count-4:CTCGAGGGTCACGCTG"	-2.85420785370525	3.4604556330475	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGGTCACGCTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3350.14104763242	44.4014623189525	0.0132536098294522	5156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3343.55468410544	3343.55468410544
"healthy-4"	"2019-08-01-count-3:TTTGGTTAGCACTCGC"	10.2089840370113	7.30843970859376	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTAGCACTCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.09368466013	45.8660071102891	0.0233047885208827	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.32958005612	1958.32958005612
"healthy-4"	"2019-08-01-count-4:CTCGAGGTCAAGCTGT"	-4.33721051636394	13.1152114638123	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCGAGGTCAAGCTGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2105.21847991309	45.1168857438466	0.0214309755373747	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2096.50900445152	2096.50900445152
"healthy-4"	"2019-08-01-count-3:TTTGGTTGTAATGCGG"	0.675608296960038	7.87848613345949	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTGTAATGCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.04211075862	42.1161872191779	0.0231529479004825	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1810.62452739424	1810.62452739424
"healthy-4"	"2019-08-01-count-2:GGAGGATGTTGCTCGG"	3.58508481559102	-6.76262667095336	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATGTTGCTCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.34454537166	41.9994855376403	0.0169397535393147	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2473.88767550857	2473.88767550857
"healthy-4"	"2019-08-01-count-3:TTTGGTTTCCAATCTT"	14.4775225120479	1.9722667702469	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTTCCAATCTT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1782.7292049055	36.6042877910636	0.0205327245945937	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1769.28970972273	1769.28970972273
"healthy-4"	"2019-08-01-count-3:TGTGAGTCACATTCTT"	2.39700951155965	-6.0015907517639	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGAGTCACATTCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.20550794282	44.0031904530535	0.0173774167677259	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2524.50988291606	2524.50988291606
"healthy-4"	"2019-08-01-count-3:TGTGAGTTCGGATAAA"	-2.52945766869243	9.03882215106813	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGAGTTCGGATAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1834.9756534141	46.6328761565746	0.025413348711091	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1829.29570060932	1829.29570060932
"healthy-4"	"2019-08-01-count-3:ATTCCATTCTTGAGCA"	4.46301521834676	-6.74179460918578	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCATTCTTGAGCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.34962222882	41.5521108998857	0.0155430889227437	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2665.28518763934	2665.28518763934
"healthy-4"	"2019-08-01-count-2:CTGTATTCATTGACTG"	4.82248272475545	-7.21573736583861	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTATTCATTGACTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.14810516629	50.94062342329	0.0189500806616229	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2684.26222008778	2684.26222008778
"healthy-4"	"2019-08-01-count-4:GGCTTTCGTTGCTGAT"	11.2275215583736	6.06895825946657	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTTCGTTGCTGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.99013776851	40.6353193367063	0.0196877487896523	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2058.92125186581	2058.92125186581
"healthy-4"	"2019-08-01-count-2:GTCGTAAAGTTTCGGT"	3.02497353133504	-6.53106739437255	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTAAAGTTTCGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2017.15356462628	45.1711402968295	0.0223935059228862	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2011.13273787036	2011.13273787036
"healthy-4"	"2019-08-01-count-2:ACCATTTCAGTAACCT"	11.0023905235225	6.38477704608766	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCATTTCAGTAACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.85804530026	50.5661214161505	0.0239439016882222	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.43245163819	2104.43245163819
"healthy-4"	"2019-08-01-count-3:CATTCCGCAACCAATC"	10.5089327293331	7.87815568530885	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGCAACCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2581.0307567051	44.6543241818483	0.017300965540935	1729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2568.42629620082	2568.42629620082
"healthy-4"	"2019-08-01-count-4:AAACCCACATCGCTCT"	3.02717437323872	-6.90735676204833	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACCCACATCGCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1780.21956976074	51.3464584845392	0.0288427671264394	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1778.2364371485	1778.2364371485
"healthy-4"	"2019-08-01-count-3:TGTGTGAGTCGAATGG"	4.37188734587972	-6.49596836483153	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGTGAGTCGAATGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2737.65001200909	43.7510891340919	0.0159812572615826	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2733.33514505532	2733.33514505532
"healthy-4"	"2019-08-01-count-4:CATCGTCCACTTGTGA"	11.0564094978267	6.15671632373659	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCCACTTGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1997.56012440379	44.4735763277061	0.022263948796525	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.25671488268	1987.25671488268
"healthy-4"	"2019-08-01-count-4:CTGAATGGTGAGCCAA"	2.88591947135274	-6.20160725032958	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGGTGAGCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.57988358222	40.9278950923472	0.0176293287953526	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2319.04319731347	2319.04319731347
"healthy-4"	"2019-08-01-count-2:TGATGCAAGGGAGGGT"	11.3428789573604	5.89839933002321	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATGCAAGGGAGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.10332000682	48.8963736968696	0.024289053229868	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.96107067116	2007.96107067116
"healthy-4"	"2019-08-01-count-3:ACGTACAAGCACAAAT"	10.2338005500728	7.65102002704469	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACAAGCACAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.76596357504	43.187768131994	0.0230118027341704	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.00136196119	1875.00136196119
"healthy-4"	"2019-08-01-count-4:GTGCTGGGTAGCGATG"	0.1290516006643	7.82063863361207	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCTGGGTAGCGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1791.48084301483	37.7605949157397	0.0210778669852777	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1786.37543306554	1786.37543306554
"healthy-4"	"2019-08-01-count-4:AAACGCTAGTTACTCG"	2.02505673941914	-6.42957355892333	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGCTAGTTACTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.80538311513	51.9339777301938	0.0221768974077213	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2338.19726151775	2338.19726151775
"healthy-4"	"2019-08-01-count-3:CATTCTACAACAGAGC"	-0.735384504229385	8.59755609119264	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCTACAACAGAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.97903209039	46.5575365666593	0.0248045054157096	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1871.75825406177	1871.75825406177
"healthy-4"	"2019-08-01-count-2:AAAGGATAGTGGTTCT"	10.7132688957149	5.90359017932741	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATAGTGGTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.82954609331	47.9223105703661	0.0253580068474599	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1884.7067853938	1884.7067853938
"healthy-4"	"2019-08-01-count-3:ATTCTACGTAACTTCG"	5.6101299720699	-9.78147795116576	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTACGTAACTTCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2797.51872537842	47.2981226523364	0.0169071692794258	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2789.51067154265	2789.51067154265
"healthy-4"	"2019-08-01-count-3:CATTGAGCAACAGAGC"	11.0121599632198	6.23709008777467	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGAGCAACAGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.57961498237	50.8141412194588	0.026252674302897	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.70729786104	1923.70729786104
"healthy-4"	"2019-08-01-count-3:TATTGGGGTCTGTAGT"	9.72882999953572	7.14126632297365	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGGTCTGTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.43766404439	44.104943995672	0.0230501075757275	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1905.82151166191	1905.82151166191
"healthy-4"	"2019-08-01-count-2:CAGATCAGTTAGGAGC"	5.05007280883138	-7.6094804040161	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCAGTTAGGAGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2820.11136255812	41.6408950071196	0.014765691724084	2277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2815.74030563812	2815.74030563812
"healthy-4"	"2019-08-01-count-3:GATTCGAAGAGTGGCT"	-5.29563937607463	3.73932716930238	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCGAAGAGTGGCT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2878.81944676686	42.4438335154773	0.01474348575877	2902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2863.5649326969	2863.5649326969
"healthy-4"	"2019-08-01-count-2:GTCTCACCATGTGCTA"	-0.605617026717025	7.91097209537355	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACCATGTGCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2128.11136816895	45.7963285906803	0.0215197048780788	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2125.43126555517	2125.43126555517
"healthy-4"	"2019-08-01-count-2:CAGATTGAGGTGGGTT"	3.3735531764919	-6.22246029293212	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGAGGTGGGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.65701524592	45.5565424641552	0.0177424563302867	2038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2563.17347800864	2563.17347800864
"healthy-4"	"2019-08-01-count-3:ACGTCCTAGAACAGGA"	2.73226680335347	-5.95109321987303	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTCCTAGAACAGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.43678654842	47.2714589790588	0.0183689994742248	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2569.15099717214	2569.15099717214
"healthy-4"	"2019-08-01-count-2:ACCGTTCCAGAACTCT"	11.0469862419063	6.40942428195802	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCCAGAACTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.93038270863	46.1565723512835	0.0238667186595608	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.23909161861	1927.23909161861
"healthy-4"	"2019-08-01-count-3:CATTTCACAACGGTAG"	-2.19420633736308	9.34545610034791	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCACAACGGTAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1664.54656158019	47.4684697374251	0.0285173577195476	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1662.40793252237	1662.40793252237
"healthy-4"	"2019-08-01-count-4:AAAGTCCAGGCTCCCA"	0.107341897755307	7.64605233753053	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCAGGCTCCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2079.11023444237	41.4922457559139	0.0199567320041798	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2063.55902700545	2063.55902700545
"healthy-4"	"2019-08-01-count-2:AAAGTCCCATTACGGT"	4.23543276366536	-6.43550636684569	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGTCCCATTACGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2842.21501006393	42.5901135072559	0.0149848316740464	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2833.96870018035	2833.96870018035
"healthy-4"	"2019-08-01-count-3:CATTTCATCCTCAGAA"	-8.23453650894817	-0.48020919477614	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCATCCTCAGAA"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3411.41083806501	43.8149909447871	0.0128436570746312	5517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3399.07133313882	3399.07133313882
"healthy-4"	"2019-08-01-count-4:CGAGTTACAATGACCT"	11.4787527519161	3.56812951648561	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTTACAATGACCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1868.53195794713	38.1736227089306	0.0204297403352256	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1857.76246104741	1857.76246104741
"healthy-4"	"2019-08-01-count-4:TGTACAGTCCGATCTC"	5.06066145476643	-7.93784525310668	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGTCCGATCTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.22592734153	39.8494455749888	0.0148181843592377	2049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2687.33036477608	2687.33036477608
"healthy-4"	"2019-08-01-count-2:ACCTACCCATGTTACG"	-0.254260222346145	7.67195222461549	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCCATGTTACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2257.03617676639	45.2555975818416	0.0200508959704307	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2245.0193912703	2245.0193912703
"healthy-4"	"2019-08-01-count-2:TGCAGGCAGTGTACAA"	2.54939069327657	-7.60359337246092	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGGCAGTGTACAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1457.82657144021	49.8450550353356	0.0341913475936255	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1455.5938822306	1455.5938822306
"healthy-4"	"2019-08-01-count-4:GTGGGAAGTAACGATA"	11.4388548332149	3.71782968128053	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAAGTAACGATA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.97113241221	42.2861807134751	0.0231328492904994	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1812.18750132113	1812.18750132113
"healthy-4"	"2019-08-01-count-3:TCAATCTCATTGAGCT"	-0.0608615380829156	7.6647853621277	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTCATTGAGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1910.69384083371	41.5132478972525	0.0217267921265391	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.78199242422	1906.78199242422
"healthy-4"	"2019-08-01-count-2:CAGATTGTCTTGAACG"	-5.6876724762028	-4.57938816463622	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGTCTTGAACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3168.73876792217	41.5843795895635	0.0131233221275705	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3162.98119813979	3162.98119813979
"healthy-4"	"2019-08-01-count-2:CTTCCGAAGGGCGAAG"	-1.2797431749409	8.7051906355652	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGAAGGGCGAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1878.04776769689	39.9180839948752	0.021255095147994	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1872.32162284149	1872.32162284149
"healthy-4"	"2019-08-01-count-3:TGTTGAGCAGTCCGTG"	4.07286133345906	-6.22961571132811	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGCAGTCCGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2815.67014466252	44.3097441455479	0.0157368377221114	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2809.07032822531	2809.07032822531
"healthy-4"	"2019-08-01-count-3:CCACAAAGTGTATTCG"	-3.50845895233806	3.70131704891054	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACAAAGTGTATTCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3252.17851293399	46.317320084353	0.0142419365665654	5029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3240.36829587502	3240.36829587502
"healthy-4"	"2019-08-01-count-4:AGGTTACCATAGTCAC"	-1.95086441460307	9.0251426466736	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTACCATAGTCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.77276382098	33.6738733049897	0.0175405516421473	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1914.21279201953	1914.21279201953
"healthy-4"	"2019-08-01-count-2:TGCAGTAGTGCTCTCT"	-0.263906906277496	7.78799007022706	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTAGTGCTCTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.44700684136	44.2620596880668	0.0218962255939764	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.51662824301	2016.51662824301
"healthy-4"	"2019-08-01-count-2:GTGAGCCTCTACAGGT"	10.8959137397701	5.99946925723878	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGCCTCTACAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.7785248654	48.8638118925253	0.0250355310656444	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1941.70954719158	1941.70954719158
"healthy-4"	"2019-08-01-count-4:AAATGGAGTTACGTAC"	11.5711027580196	3.71575782382814	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAGTTACGTAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2173.61296332734	36.2228170902006	0.0166647962177917	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2164.87860162852	2164.87860162852
"healthy-4"	"2019-08-01-count-4:GGGCCATTCGTGACTA"	5.01507772979085	-7.97246935283812	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCCATTCGTGACTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2942.29103524495	42.8756396317373	0.0145721953124762	2637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2937.18624883021	2937.18624883021
"healthy-4"	"2019-08-01-count-2:ACCTGTCGTTACGATC"	10.4065824943477	7.18050811374513	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCGTTACGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.2643275629	40.6109278348491	0.0217488907357071	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.09609892507	1862.09609892507
"healthy-4"	"2019-08-01-count-2:ATGGAGGGTACCATAC"	10.1245666938717	5.43868348682252	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGGTACCATAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1751.18641760616	40.7286382535665	0.0232577399208257	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1745.87810420612	1745.87810420612
"healthy-4"	"2019-08-01-count-4:AACAAAGAGCGTGCTC"	1.99303843554799	-6.25231316005858	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAAGAGCGTGCTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2410.06182663919	45.1295994929911	0.0187254945056426	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2402.84997776933	2402.84997776933
"healthy-4"	"2019-08-01-count-2:GGGAAGTTCGCTAAAC"	-0.143778051168281	7.56903407657472	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAAGTTCGCTAAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.68582042707	42.9219736634909	0.0237704550691655	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1797.53608549482	1797.53608549482
"healthy-4"	"2019-08-01-count-3:CCACCATCATCGATCA"	10.7181211906368	6.70195005023805	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACCATCATCGATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.23474766458	49.0316051012047	0.0238105952499162	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.4964084171	2043.4964084171
"healthy-4"	"2019-08-01-count-2:ACGATGTCAGGACTTT"	10.9790216880733	6.07159373843995	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTCAGGACTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2117.68545453797	48.1217486435357	0.0227237470703763	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2105.34076008496	2105.34076008496
"healthy-4"	"2019-08-01-count-4:AACAAGAAGATCCGAG"	11.018457074731	6.37704465473024	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAGAAGATCCGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2052.14465829826	44.8736223591396	0.021866695497164	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2047.55125907676	2047.55125907676
"healthy-4"	"2019-08-01-count-3:GCACGGTGTCACCGAC"	2.46467246589009	-6.10052063381346	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTGTCACCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.59649834933	39.4082659290588	0.0151652116648704	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2592.64808838022	2592.64808838022
"healthy-4"	"2019-08-01-count-3:ACTCCCATCTGTTCAT"	10.4894358116085	7.7882623442444	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCATCTGTTCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2374.39995276389	46.8882906448969	0.0197474273827866	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2361.03716859533	2361.03716859533
"healthy-4"	"2019-08-01-count-4:CAAAGAACAGTTAAAG"	5.03760685500447	-7.41988565838011	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAAGAACAGTTAAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.2877246285	47.1650948008789	0.0186623368369393	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2523.07115980607	2523.07115980607
"healthy-4"	"2019-08-01-count-4:AACAAGACAGTCAGTT"	0.0817223871940791	7.97466657245485	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAAGACAGTCAGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1897.39993637736	38.3450422142426	0.020209256614319	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1891.30092249408	1891.30092249408
"healthy-4"	"2019-08-01-count-3:GCACGGTGTGCCTGAC"	4.95602240142171	-7.26231481945189	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTGTGCCTGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2663.66184547675	41.9943392618704	0.0157656420739676	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2663.66184547675	2663.66184547675
"healthy-4"	"2019-08-01-count-2:CTTCTAATCTGTAAGC"	3.05530395087544	-5.17059519207152	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCTAATCTGTAAGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2935.84661939452	41.0495992680444	0.0139822015894381	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2933.08999604307	2933.08999604307
"healthy-4"	"2019-08-01-count-2:AACAGGGCACAGTCAT"	-3.50108728829082	9.70478532398073	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGCACAGTCAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2090.94145951443	44.2866040919412	0.0211802218997684	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.3695035736	2087.3695035736
"healthy-4"	"2019-08-01-count-2:ACGCACGCAGCCTATA"	11.1341129737789	5.96727273547975	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGCAGCCTATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.78557728338	46.6793075962817	0.0250185810012786	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1858.60497681464	1858.60497681464
"healthy-4"	"2019-08-01-count-2:CAGGCCAGTCGAATTC"	10.3454281288082	7.82527682864992	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCAGTCGAATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2235.15717887137	50.7034004779741	0.0226844899129539	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2225.06241629033	2225.06241629033
"healthy-4"	"2019-08-01-count-2:ATGGGTTGTGGTAATA"	5.05840124663655	-7.55358126079711	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGGTTGTGGTAATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2766.90233339388	44.0949714664172	0.0159365840037911	2335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2762.03307025895	2762.03307025895
"healthy-4"	"2019-08-01-count-2:CCGTGAGCAGTGGCTC"	3.89471687850301	-6.65878155147704	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGCAGTGGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.86456989907	49.1014317743251	0.0197920645770369	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2474.2071526247	2474.2071526247
"healthy-4"	"2019-08-01-count-4:TCTCCGATCACTCTTA"	5.13658203658406	-7.65378000652465	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGATCACTCTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.87999885899	43.7260985039665	0.016000006777547	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2729.37490827959	2729.37490827959
"healthy-4"	"2019-08-01-count-3:TTACCATGTCATTGCA"	-1.66268990460094	8.98974416339723	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATGTCATTGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.29222985199	42.3777686915479	0.0222304681453998	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.91424076931	1902.91424076931
"healthy-4"	"2019-08-01-count-3:CCACTTGCACTCCACT"	-2.1391466659611	3.92855570400087	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGCACTCCACT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3315.53516565793	44.8656888041055	0.0135319598684463	5275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3307.2002333049	3307.2002333049
"healthy-4"	"2019-08-01-count-3:GCACTAAGTTCACCGG"	4.6477595764095	-7.12955381786498	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAAGTTCACCGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.8511461757	49.4318982967392	0.0206236830249598	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2391.77979189194	2391.77979189194
"healthy-4"	"2019-08-01-count-4:CAACAGTTCAATCTTC"	11.1463400321895	6.34655091846315	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAGTTCAATCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2043.59034445989	45.982066994787	0.0225006284255761	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2035.03766035757	2035.03766035757
"healthy-4"	"2019-08-01-count-4:CATTGCCTCGACGCTG"	-1.8258960050648	8.54968164050905	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCTCGACGCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.23651799502	40.2357461592256	0.0193605231218067	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2074.04747224684	2074.04747224684
"healthy-4"	"2019-08-01-count-3:CGTGAATGTGCACATT"	10.1915298896724	7.47735116565553	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATGTGCACATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.96167956148	44.5974230521701	0.0222657395332366	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.81112911567	1998.81112911567
"healthy-4"	"2019-08-01-count-4:TGTGCGGCAAGCGAGT"	-1.46099970760997	8.52686498248903	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGCAAGCGAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.49883501569	47.644508806535	0.0247697102484319	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1914.87155425752	1914.87155425752
"healthy-4"	"2019-08-01-count-2:ATGTCCCAGGTAATCA"	10.8927351432735	6.34583280170289	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCAGGTAATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.68489745118	44.6650833491742	0.0231223443368578	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1924.0242535365	1924.0242535365
"healthy-4"	"2019-08-01-count-4:CTGTAGAGTCATTCCC"	4.21932854232137	-6.63375856792601	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTAGAGTCATTCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.30997332925	37.6778545454118	0.0138556673990655	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2717.17277088446	2717.17277088446
"healthy-4"	"2019-08-01-count-3:GCAGCCACACGTCGGT"	2.04343750056569	-6.54066755687865	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCCACACGTCGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.99652170578	45.0520038127295	0.0198118173808528	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2271.53716076656	2271.53716076656
"healthy-4"	"2019-08-01-count-2:ACGGTCGCACACGTGC"	10.9386574226314	5.67265126788942	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGCACACGTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.76639096312	39.0529311808296	0.020279163331591	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1920.3785612112	1920.3785612112
"healthy-4"	"2019-08-01-count-2:ACGGTCGCAACTCGAT"	-2.75192223015483	9.24956700885621	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGCAACTCGAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.95845526538	44.2148665426414	0.0220417658334763	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2000.7472182096	2000.7472182096
"healthy-4"	"2019-08-01-count-2:ACGGTCGCACCTTCCA"	10.4393354850704	7.22920129382936	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGCACCTTCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2137.97719735715	45.2978250828669	0.0211872348960791	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2125.44415363524	2125.44415363524
"healthy-4"	"2019-08-01-count-2:CCTAACCTCCTAAACG"	-3.54547677460368	10.9699239500794	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAACCTCCTAAACG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2018.06615715878	44.3654498351545	0.0219841404493975	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2005.01875815448	2005.01875815448
"healthy-4"	"2019-08-01-count-4:CTGTCGTAGCTTCTAG"	-0.196034098893958	8.19968888843385	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTCGTAGCTTCTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.01199920067	36.3068833099526	0.019456939894012	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1860.18638763429	1860.18638763429
"healthy-4"	"2019-08-01-count-4:AACCAACCATAGACTC"	1.66262211379353	-6.00188877498778	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCAACCATAGACTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2559.26549736652	45.409320339198	0.0177431065225253	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2554.37844190099	2554.37844190099
"healthy-4"	"2019-08-01-count-2:ACGGTTAGTCTTCAAG"	4.79411425170247	-7.86957933818968	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTTAGTCTTCAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.20200735759	44.9604922162085	0.0179396920456593	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2501.08329407219	2501.08329407219
"healthy-4"	"2019-08-01-count-4:CAACGATGTACTTGTG"	3.09264864501302	-5.13676121151122	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACGATGTACTTGTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2787.27455895688	44.200263778284	0.0158578793883964	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2779.55879604182	2779.55879604182
"healthy-4"	"2019-08-01-count-4:TGTTACTAGTCCTGTA"	0.169493091374081	7.64693734729616	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTAGTCCTGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.8858225596	42.4375199862992	0.0243071565379245	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1743.10322697214	1743.10322697214
"healthy-4"	"2019-08-01-count-3:ACTTCCGCATCTTCGC"	-0.227083156735259	7.67942521655885	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCCGCATCTTCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2169.67790272766	40.3212303820532	0.0185839706121183	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2164.26805835046	2164.26805835046
"healthy-4"	"2019-08-01-count-2:GAAACCTCAAGATCCT"	3.97477879103963	-6.08556511318358	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTCAAGATCCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2863.83836861765	42.7525545567023	0.0149284104246912	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2857.88625777722	2857.88625777722
"healthy-4"	"2019-08-01-count-2:ACGTAACGTACTCCCT"	11.0796982246334	5.72305677020875	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACGTACTCCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.88070828802	45.1938376826525	0.0233092409911889	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.19468219831	1931.19468219831
"healthy-4"	"2019-08-01-count-3:GCAGTTACAGACAAAT"	-2.931144575507	3.35709498012391	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGTTACAGACAAAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3525.89535229499	43.933534036949	0.0124602489998329	5841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3519.57188478155	3519.57188478155
"healthy-4"	"2019-08-01-count-2:GTGGAAGCAGTAACAA"	-0.0331043032115281	7.65302274310914	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAAGCAGTAACAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2044.72278571834	45.2595925268306	0.0221348306200492	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2030.45355022328	2030.45355022328
"healthy-4"	"2019-08-01-count-3:GCAGTTATCCTCATAT"	1.74037005481068	-6.3364205590454	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGTTATCCTCATAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2378.07487391909	43.9815225590278	0.01849459116758	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2374.00468109265	2374.00468109265
"healthy-4"	"2019-08-01-count-2:ACGTAACTCGTCAAAC"	11.3969284492428	3.53503463352052	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCGTCAAAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1679.30674279692	46.5945192670438	0.0277462824864502	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1650.56306669542	1650.56306669542
"healthy-4"	"2019-08-01-count-2:GAAATGACACAAGTTC"	0.725982268422288	7.99208734119264	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGACACAAGTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.90664738629	45.2987422897345	0.0255938596290541	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1758.3552511327	1758.3552511327
"healthy-4"	"2019-08-01-count-4:GGGTTTATCTCTCGAC"	10.7083965736324	7.54759547794191	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTTTATCTCTCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2057.85689235347	44.3676780471656	0.0215601377394249	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2049.45927247025	2049.45927247025
"healthy-4"	"2019-08-01-count-2:ACGTACACAGAGTCTT"	-0.15574255111869	8.04753635013429	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACACAGAGTCTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2018.10554412887	42.9689421591083	0.0212917219736672	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2002.62057195253	2002.62057195253
"healthy-4"	"2019-08-01-count-2:GTGGCGTGTCGTGGAA"	11.1390787559444	4.31899640643922	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGCGTGTCGTGGAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1635.90917051112	44.4508623247236	0.0271719623106186	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1622.93127161605	1622.93127161605
"healthy-4"	"2019-08-01-count-3:AAGACAATCAGAGCAG"	11.547979970544	3.57221911037294	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAATCAGAGCAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.93419896354	38.2765700858937	0.0197920746767948	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1899.11463110626	1899.11463110626
"healthy-4"	"2019-08-01-count-2:ACGTACAGTATGCAAA"	-3.96085772934611	10.5413493880066	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACAGTATGCAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2133.65598291574	53.9286836437421	0.0252752477791879	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2132.12880316096	2132.12880316096
"healthy-4"	"2019-08-01-count-4:GTTCATTCAACAGAGC"	-4.04061446610149	-4.59273483669432	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTCAACAGAGC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3073.53683331239	41.6499671840778	0.013551152773787	3375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3067.47597342925	3067.47597342925
"healthy-4"	"2019-08-01-count-4:AACCCAATCGACATAC"	10.121240277856	7.27937648380128	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAATCGACATAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.2814306261	45.9106889174312	0.0230096307281448	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.38909545416	1991.38909545416
"healthy-4"	"2019-08-01-count-4:AACCCAATCTCGGTAA"	5.05366529998128	-7.82580711757811	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAATCTCGGTAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2874.43454216144	41.1383648693559	0.014311811337482	2319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2871.88542669472	2871.88542669472
"healthy-4"	"2019-08-01-count-2:CATACAGCAGAGTCAG"	10.5163694816524	7.67799708927003	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGCAGAGTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2134.73472047592	43.6680825761427	0.0204559761722559	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2130.79372845898	2130.79372845898
"healthy-4"	"2019-08-01-count-3:CCCTAACAGGTTGCCC"	0.182893578975838	8.00063798511354	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACAGGTTGCCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.48094751264	39.3780896733025	0.0205900559294551	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1908.2227187742	1908.2227187742
"healthy-4"	"2019-08-01-count-2:AACGTCACAGCAGTGA"	-5.92545876923259	-4.62103702938231	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCACAGCAGTGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3473.14718640757	43.5238598835618	0.0125315333752327	5242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3466.49710562259	3466.49710562259
"healthy-4"	"2019-08-01-count-4:GGTAGAGGTGAACGGT"	-5.57418570938762	-5.40791895305785	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAGAGGTGAACGGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2607.84237023662	50.8771509961648	0.0195092892027629	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2606.57526912673	2606.57526912673
"healthy-4"	"2019-08-01-count-2:ACGTTCCCAGTATGAA"	3.50212158736531	-5.58933403408202	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCCAGTATGAA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2717.54599386595	46.2647121592386	0.0170244449454278	2415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2709.85732398125	2709.85732398125
"healthy-4"	"2019-08-01-count-2:GTGGTTAGTTCGGCGT"	-0.0381980639999688	8.29434964740602	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGTTAGTTCGGCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.05620185185	42.3737117166467	0.0234231040877949	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1800.16710345307	1800.16710345307
"healthy-4"	"2019-08-01-count-3:CCCTAACTCGAGAAAT"	5.11604561385457	-7.80407335674437	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACTCGAGAAAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2949.65278606347	43.3227930978456	0.0146874212797308	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2941.4142448395	2941.4142448395
"healthy-4"	"2019-08-01-count-4:AACCTTTCAAGCACCC"	-4.30871043625529	11.8330907591614	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTCAAGCACCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2301.98728848565	46.2497478038083	0.0200912264090882	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2290.73411951059	2290.73411951059
"healthy-4"	"2019-08-01-count-3:GCATTAGCAACGAGGT"	-1.95510492745097	3.76832459056703	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATTAGCAACGAGGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2994.23662108937	46.5248494473924	0.0155381338668103	4957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2988.91524370811	2988.91524370811
"healthy-4"	"2019-08-01-count-3:TCAGGTAGTCACTCAA"	0.425506551831406	7.81670043552247	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGTAGTCACTCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1810.75640449743	44.394172864629	0.02451692163251	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1803.45983768236	1803.45983768236
"healthy-4"	"2019-08-01-count-4:TGTTTGTTCGGTCGGT"	-2.16809521141704	10.0775766142639	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTTGTTCGGTCGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1722.75054327959	48.8077482789067	0.028331291764385	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1714.23867559384	1714.23867559384
"healthy-4"	"2019-08-01-count-2:GAACTGTTCCGGACTG"	0.162726764648598	8.02347657764284	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTTCCGGACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.89063444762	35.5673773179599	0.0206320381393317	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1711.45660213024	1711.45660213024
"healthy-4"	"2019-08-01-count-2:GAACTGTTCCTTATGT"	10.1779648261959	7.09669587695924	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACTGTTCCTTATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.10952040448	45.2025688949096	0.0227250276725426	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1981.83412157918	1981.83412157918
"healthy-4"	"2019-08-01-count-2:ACGTTCCTCGCAGATT"	5.70575680312459	-9.83790686046752	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTTCCTCGCAGATT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.33921162716	39.6741267490899	0.0150832738886735	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2622.36954219599	2622.36954219599
"healthy-4"	"2019-08-01-count-4:GTTCTATTCTTCCACG"	1.95453002032582	-6.67679550563964	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATTCTTCCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1725.85858636033	43.3863487382365	0.0251389940526553	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1721.81418886186	1721.81418886186
"healthy-4"	"2019-08-01-count-2:CATACCCGTCCGGTGT"	10.8075682121212	6.92002532565919	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCGTCCGGTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.16304988331	41.0250708962955	0.0210475316052967	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1944.63779741026	1944.63779741026
"healthy-4"	"2019-08-01-count-3:CCCTCAACACGGATCC"	14.2405220466549	2.01992187583772	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAACACGGATCC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1281.8062968575	34.5594112863371	0.0269614928332492	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1259.48852948267	1259.48852948267
"healthy-4"	"2019-08-01-count-4:AACGGGACACATGAAA"	-0.229607234627563	7.9541387327942	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGGGACACATGAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2161.77580748473	40.4975407533424	0.0187334600623837	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2158.26436016044	2158.26436016044
"healthy-4"	"2019-08-01-count-4:TTAATCCGTTAGCGGA"	10.3129612403804	7.56403062427369	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCGTTAGCGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.475522586	45.5521658270472	0.0235110922930512	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1928.98000356721	1928.98000356721
"healthy-4"	"2019-08-01-count-4:GGTGAAGTCCGCACGA"	-0.0158014101093591	7.80437705600587	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGTCCGCACGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.02129142823	42.6830493967969	0.023247578661571	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1826.52817626308	1826.52817626308
"healthy-4"	"2019-08-01-count-3:GGTTAACTCCGCCTAT"	-0.0783838582342446	7.68186090076295	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTAACTCCGCCTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2137.73944179648	45.5911781640674	0.0213268171380859	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2128.25164714228	2128.25164714228
"healthy-4"	"2019-08-01-count-3:TTCACGCGTGTAACGG"	2.9111758666927	-5.97267868435057	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCGTGTAACGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.64324636313	44.1903360686059	0.0168302895413593	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2621.49564509925	2621.49564509925
"healthy-4"	"2019-08-01-count-3:GAAGCGACATGGCCCA"	4.13673748549764	-6.96834900295409	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGACATGGCCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.72079944839	48.1138465479562	0.0192785373101793	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2486.77998168251	2486.77998168251
"healthy-4"	"2019-08-01-count-4:GGTGATTAGTGGCCTC"	4.71238007125203	-6.8932881585327	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTAGTGGCCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2725.92763406028	42.7011985943767	0.0156648320596733	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2722.72511851175	2722.72511851175
"healthy-4"	"2019-08-01-count-2:GCAGGCTCATTGACAC"	11.1800533729488	5.81702802265016	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTCATTGACAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.50093458737	50.9013876310058	0.0270823954882368	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.03910232986	1876.03910232986
"healthy-4"	"2019-08-01-count-2:AGGTGTTGTTTGGCTA"	-0.616266469389755	7.9108905562195	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTGTTTGGCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2094.77217042323	43.6198198491156	0.0208231809000511	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.26846870248	2089.26846870248
"healthy-4"	"2019-08-01-count-4:CAATTTCTCCCGTTGT"	0.646662672131699	8.13870236957399	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCTCCCGTTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.26832460103	38.5920204445532	0.0202447997202232	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1894.37823606484	1894.37823606484
"healthy-4"	"2019-08-01-count-2:CATACTTGTGGCAGAT"	11.3539749580318	3.46023390376893	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTGTGGCAGAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1689.54463701606	40.0850339344484	0.0237253476802148	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1677.40220007836	1677.40220007836
"healthy-4"	"2019-08-01-count-4:AACTTCTCACACACGC"	-2.85223756256755	9.04446981036989	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTCACACACGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2182.64031693004	46.9049842846248	0.0214900201012497	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2172.03921268215	2172.03921268215
"healthy-4"	"2019-08-01-count-2:ACTATGGTCGCACGGT"	11.0645758109981	6.33615539157716	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATGGTCGCACGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.68403909211	45.9991952259705	0.0236538143478801	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.08158343036	1939.08158343036
"healthy-4"	"2019-08-01-count-2:ACTATGGAGGACAACC"	3.07675852355306	-6.08599140560301	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATGGAGGACAACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.11807433621	45.3129598021955	0.0194884553616193	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2320.28034658415	2320.28034658415
"healthy-4"	"2019-08-01-count-4:CACAACACAACATACC"	4.41780342635457	-6.53605940258177	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACACAACATACC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2949.96360713022	44.8826780774704	0.0152146548414993	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2944.35793979802	2944.35793979802
"healthy-4"	"2019-08-01-count-2:CATCAAGGTCCTGTTC"	-1.20413086834605	8.38594720447389	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGGTCCTGTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2945.96273292235	25.9376872290595	0.008804485861004	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2930.69480573854	2930.69480573854
"healthy-4"	"2019-08-01-count-4:TTACCGCGTAAGCAAT"	2.14584197577779	-5.90534164821776	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCGTAAGCAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2869.1450042673	42.4293078840317	0.0147881364730351	2359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2864.83244590442	2864.83244590442
"healthy-4"	"2019-08-01-count-4:CACAACAGTGTGACCC"	2.83166923102681	-4.72485783016356	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACAGTGTGACCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2908.40361657176	39.4639648921223	0.0135689436869288	2867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2907.12492811192	2907.12492811192
"healthy-4"	"2019-08-01-count-4:AAGATAGAGGATACGC"	9.8162599998409	7.7788982161316	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGATAGAGGATACGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2082.44722426519	44.8686045139523	0.0215460944177274	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2070.24734050199	2070.24734050199
"healthy-4"	"2019-08-01-count-2:GAAGGGTTCAAGCCCG"	10.0129896598751	7.58883426273195	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTTCAAGCCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.74871549661	46.8423991583292	0.0228082427050977	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2049.40312658293	2049.40312658293
"healthy-4"	"2019-08-01-count-3:TCATCCGTCCGCGATG"	11.1507307487423	6.16789624774782	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCCGTCCGCGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.11415335281	45.0567490570501	0.0234290559291537	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1914.04647479847	1914.04647479847
"healthy-4"	"2019-08-01-count-4:GTTGTCCTCCGTTGGG"	10.8350092369014	6.26204726779786	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTCCTCCGTTGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1842.00306632743	46.163612849589	0.0250616373520103	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1834.39934450049	1834.39934450049
"healthy-4"	"2019-08-01-count-4:GGTGTTACAGATACTC"	3.94876541671101	-6.95894291317137	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTACAGATACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.27262255601	48.4629315449272	0.0219460817699369	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2202.23080846036	2202.23080846036
"healthy-4"	"2019-08-01-count-2:ACTCCCAAGGCTTAGG"	2.39137448844258	-6.10356047069701	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCAAGGCTTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.77478506512	49.2775257958219	0.0203729285174003	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2414.57013140251	2414.57013140251
"healthy-4"	"2019-08-01-count-4:TTACGTTTCCCATTTA"	10.5245930152828	7.55110786044923	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACGTTTCCCATTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2302.42157841425	45.809802051349	0.0198963571575365	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2292.69068720639	2292.69068720639
"healthy-4"	"2019-08-01-count-4:ATAGACCAGCGGCTCT"	-0.127536307007629	7.80964706027833	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGACCAGCGGCTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1976.1572138892	43.8744763615374	0.0222019159473601	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1968.28436980213	1968.28436980213
"healthy-4"	"2019-08-01-count-3:TCATGCCAGCGACTTT"	0.264382888644379	7.81891868198244	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCAGCGACTTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.31078175352	42.1954513317296	0.0227676068941908	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1841.8191484615	1841.8191484615
"healthy-4"	"2019-08-01-count-4:CTTGATTGTCGTGGTC"	-3.86968145790752	-5.3556528321472	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTGTCGTGGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2779.93470349356	50.2531725858408	0.0180771053804564	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2776.53224529195	2776.53224529195
"healthy-4"	"2019-08-01-count-3:TCATGCCCACTAAACC"	0.330383022397202	8.15154645526735	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCCACTAAACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1765.86939562216	40.1448854240165	0.0227337794762973	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1758.76236869353	1758.76236869353
"healthy-4"	"2019-08-01-count-2:GAAGTAATCTTCCACG"	9.86439957198445	6.67282435977785	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAATCTTCCACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.64769274708	46.5641460397928	0.0225968496233907	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2049.76729729018	2049.76729729018
"healthy-4"	"2019-08-01-count-2:TGGGATTTCACTACGA"	2.85560025748555	-6.06088068401488	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGATTTCACTACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.28759561753	40.3087476152863	0.015874037932865	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2534.24994279675	2534.24994279675
"healthy-4"	"2019-08-01-count-4:AAGCCATTCCTATGGA"	-4.35516105118449	12.5300864943298	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATTCCTATGGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2060.45097107042	43.4552433720684	0.0210901613201178	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2055.10824774471	2055.10824774471
"healthy-4"	"2019-08-01-count-2:ACTCCCATCACTTGGA"	11.4794470268184	4.1753301390442	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCATCACTTGGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2271.33567143157	39.3634402256143	0.0173305252590888	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2250.33216167639	2250.33216167639
"healthy-4"	"2019-08-01-count-3:TACAACGCATAGGAGC"	10.7006565528804	6.23659989917604	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAACGCATAGGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.05027453868	39.0326526058998	0.0203395675057459	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1913.38649027049	1913.38649027049
"healthy-4"	"2019-08-01-count-2:GTTAGACTCAGCTGAT"	2.94589318808858	-6.35979893123778	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACTCAGCTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.34435255102	42.9943859308024	0.0198099374784775	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2167.18542275895	2167.18542275895
"healthy-4"	"2019-08-01-count-4:AAGCGAGCAGCCGGTT"	10.9190260368282	6.04786489093629	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGCAGCCGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.41467028453	44.7748869253921	0.0234372608323425	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.8962462618	1896.8962462618
"healthy-4"	"2019-08-01-count-2:GAATAGATCTTTACAC"	-3.1867278617924	10.0144815214905	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATAGATCTTTACAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2074.83045323369	48.1290025935958	0.023196595422332	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2068.78549307178	2068.78549307178
"healthy-4"	"2019-08-01-count-4:CACATGATCATGTCAG"	10.5463768440181	6.25414416873781	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGATCATGTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.98806506476	44.7348273520222	0.0234337910072291	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1905.88968593495	1905.88968593495
"healthy-4"	"2019-08-01-count-4:TAACACGAGTGCCGAA"	11.9760204749996	-3.10304572498473	"2019-08-01-count-4"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGAGTGCCGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2134.37303393183	30.5184065803211	0.0142985345556497	3003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2129.54597014158	2129.54597014158
"healthy-4"	"2019-08-01-count-3:TGATTTCTCCTTCAGC"	-1.03323314610179	8.19297406757203	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATTTCTCCTTCAGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2151.10145309824	48.2461623920492	0.0224285852824654	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2140.07630018099	2140.07630018099
"healthy-4"	"2019-08-01-count-4:TTAGTCTTCCAAGCTA"	2.90121235427205	-5.88453152095946	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGTCTTCCAAGCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2842.49118929758	39.3510766449751	0.0138438693471199	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2836.89372262594	2836.89372262594
"healthy-4"	"2019-08-01-count-2:ACTGCAAAGCCTTGAT"	4.22121300277059	-6.564488910791	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGCAAAGCCTTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.4178534499	37.0455359668818	0.0150260678590622	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2462.6118523001	2462.6118523001
"healthy-4"	"2019-08-01-count-2:TGGGTTAAGTCAAGCG"	14.2008463340694	2.23318026149598	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGTTAAGTCAAGCG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1179.0951217397	38.448896868275	0.0326088168455362	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1165.79484993262	1165.79484993262
"healthy-4"	"2019-08-01-count-3:GCCGATGAGGTTCTTG"	11.0268322425777	5.60909650409547	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGAGGTTCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1860.05527943917	45.8290657087608	0.0246385503782333	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1848.92400067074	1848.92400067074
"healthy-4"	"2019-08-01-count-3:CCGGTGAAGCCTCAGC"	10.0870853858883	6.80522487247316	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTGAAGCCTCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.60733074516	45.9848150885918	0.0235988104750724	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1947.39930344105	1947.39930344105
"healthy-4"	"2019-08-01-count-4:TAACCAGTCGGTCAGC"	10.434213300317	7.439417339209	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACCAGTCGGTCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.92616749865	45.761164733196	0.023516393117843	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1936.99794691037	1936.99794691037
"healthy-4"	"2019-08-01-count-2:ATTTCTGGTGAATAAC"	2.72761549529378	-6.04745056545409	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCTGGTGAATAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.65051710581	51.7399878399151	0.0201350290615354	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2567.50013511467	2567.50013511467
"healthy-4"	"2019-08-01-count-2:GACACGCGTTGCGAAG"	0.542940666049164	8.41033933246461	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACACGCGTTGCGAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.95581197011	42.2196242772982	0.0231472845998914	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1814.15921662538	1814.15921662538
"healthy-4"	"2019-08-01-count-2:ACTGTCCGTACAGCGA"	0.567621310322922	8.00896117770997	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTCCGTACAGCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1793.20668933571	44.8253647501442	0.0249973218462338	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1791.81610711571	1791.81610711571
"healthy-4"	"2019-08-01-count-4:TAACGACAGGAAACGA"	2.39223064956014	-5.97184088146361	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACGACAGGAAACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.40563716067	42.8552483698971	0.0163544329786791	2088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2617.22274119986	2617.22274119986
"healthy-4"	"2019-08-01-count-2:TGGTAGTAGAGCTGAC"	-2.23708234253581	9.05940911853639	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTAGAGCTGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1920.83604871819	41.6694257581172	0.0216933797061566	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1915.39255730716	1915.39255730716
"healthy-4"	"2019-08-01-count-2:ACTGTGAAGCCAGAGT"	10.3160921531612	7.59927413547365	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTGAAGCCAGAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1912.03555160193	45.0992850694707	0.0235870536150261	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1903.30954702144	1903.30954702144
"healthy-4"	"2019-08-01-count-2:ACTGTGAGTCCTTTGC"	11.42893566665	3.91869423473207	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTGAGTCCTTTGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.19079810403	34.104492482552	0.0167986637090473	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2017.69682001193	2017.69682001193
"healthy-4"	"2019-08-01-count-4:TAACGACTCGCCGATG"	11.2827059226925	6.21336076343385	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACGACTCGCCGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.46884821849	40.0849558552783	0.0210367941164483	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.61110165119	1897.61110165119
"healthy-4"	"2019-08-01-count-4:TAACTTCCAGTGACCC"	14.3939262824947	1.92552516544191	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACTTCCAGTGACCC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1378.56390491161	48.7794707593466	0.0353842651657662	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1358.26181559858	1358.26181559858
"healthy-4"	"2019-08-01-count-2:GACCAATGTCGACTTA"	-0.899075428873855	9.17289350116578	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCAATGTCGACTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2013.39169654233	50.5763757154138	0.025119988227959	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2005.29056630064	2005.29056630064
"healthy-4"	"2019-08-01-count-4:AAGTCGTCAAGTATCC"	10.7086435752803	6.93168971622316	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTCGTCAAGTATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2095.7839664816	44.5159255786521	0.0212407033790727	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2086.99444621407	2086.99444621407
"healthy-4"	"2019-08-01-count-3:TTCTAGTAGCACGTCC"	3.38956751403157	-6.40030481731566	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTAGCACGTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.87558741822	44.3087374164493	0.0178457340516699	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2480.44659890423	2480.44659890423
"healthy-4"	"2019-08-01-count-2:GTTCGCTGTACTGCCG"	4.81950153884236	-7.19243814861449	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCGCTGTACTGCCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2729.04813170519	45.9652100372946	0.0168429458987131	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.87510029077	2721.87510029077
"healthy-4"	"2019-08-01-count-2:CATGAGTCACCTTCCA"	0.138170612126034	7.59182975375978	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGAGTCACCTTCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2114.33012025752	39.205131820027	0.0185425783061974	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2101.13957986689	2101.13957986689
"healthy-4"	"2019-08-01-count-2:GACCCAGGTACGTAGG"	10.2686726051265	7.19890830600587	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCAGGTACGTAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.54460767519	43.5198622484786	0.0241034544721188	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1802.25619527755	1802.25619527755
"healthy-4"	"2019-08-01-count-2:GTTCTATCAATTGCAC"	0.249272008507889	7.58119294727174	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATCAATTGCAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1957.30823153185	41.6027305865071	0.0212550736344411	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.45231417614	1952.45231417614
"healthy-4"	"2019-08-01-count-2:GTTCTATCACGACGAA"	5.06088175353352	-8.24821569835814	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATCACGACGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2853.78257991983	43.4421305757742	0.0152226490137853	2506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2849.23651163256	2849.23651163256
"healthy-4"	"2019-08-01-count-2:GGTGTCGGTGAGTTTC"	5.42206682738606	-9.41156866466673	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGGTGAGTTTC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.96425220127	42.4965301602765	0.0163954923854315	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.49631402306	2586.49631402306
"healthy-4"	"2019-08-01-count-2:AAGTGAAAGCTGGCTC"	4.27161278304402	-6.44511797344359	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAAAGCTGGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.250875148	42.5882639557696	0.0155417390217855	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2734.44004288642	2734.44004288642
"healthy-4"	"2019-08-01-count-3:AGATCGTGTATCCCTC"	-0.00843831422980431	7.81876466358034	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCGTGTATCCCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1941.58830864184	45.613224144774	0.0234927373335292	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1929.45817463984	1929.45817463984
"healthy-4"	"2019-08-01-count-3:TCCACCACACAATGAA"	3.57654609259908	-6.12461235439452	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCACACAATGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.5300321774	44.2587608671001	0.015969071362481	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2766.89492369505	2766.89492369505
"healthy-4"	"2019-08-01-count-2:ACTTCCGGTGGGCTTC"	2.38195600089375	-6.02233269130858	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTCCGGTGGGCTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.48190181635	42.1946491493505	0.0188328453423986	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2236.62483550499	2236.62483550499
"healthy-4"	"2019-08-01-count-3:AGATCGTGTCGTTGGC"	10.9429069953853	5.88352201068727	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCGTGTCGTTGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.89135899308	47.2730619067137	0.0251466988667018	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.48525567042	1868.48525567042
"healthy-4"	"2019-08-01-count-4:AAGTTCGGTGAGTGAC"	3.76517238196675	-6.45448162471923	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTTCGGTGAGTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2708.56672917357	47.1045046811217	0.0173909338004363	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2703.12142199567	2703.12142199567
"healthy-4"	"2019-08-01-count-4:ATCCCTGAGGGACTGT"	11.3753162818844	3.78410909259645	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCCTGAGGGACTGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1604.43482445085	43.2765321843898	0.0269730695973905	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1604.43482445085	1604.43482445085
"healthy-4"	"2019-08-01-count-2:GTTGAACAGTACCATC"	11.0468813377315	6.21750352466432	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACAGTACCATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.89380796393	46.1213550004601	0.0237262729123915	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.19023514132	1937.19023514132
"healthy-4"	"2019-08-01-count-2:GTTGAACCAGTTCTAG"	10.6285911994869	6.61727140033571	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACCAGTTCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.07942394601	46.5446257178013	0.0234945783370419	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.24693756538	1975.24693756538
"healthy-4"	"2019-08-01-count-3:GCGTGCATCCATATGG"	-3.82881293717082	10.1950893172058	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTGCATCCATATGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2062.54050420077	42.7721552170993	0.0207376073972779	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2057.39450120642	2057.39450120642
"healthy-4"	"2019-08-01-count-2:GACCCTTGTGTTTCTT"	3.43415655669515	-6.51864674007567	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTGTGTTTCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.88110649423	44.3413006554951	0.0220726356139994	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2007.04754082607	2007.04754082607
"healthy-4"	"2019-08-01-count-4:TAATCTCAGAAGTATC"	4.28484215316121	-6.46660139476927	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAATCTCAGAAGTATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.779885326	43.662423960484	0.0163727138489146	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2657.29303535597	2657.29303535597
"healthy-4"	"2019-08-01-count-2:CATGCGGCAGCGTACC"	-2.9419313472813	9.11847016895143	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCGGCAGCGTACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2402.36078993065	40.5002297133352	0.0168585126276991	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2397.29924903139	2397.29924903139
"healthy-4"	"2019-08-01-count-2:ACTTTCATCCACAGGC"	-1.43175373497661	8.38170907581178	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTTTCATCCACAGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.36500293885	43.5763755377405	0.0226799048963043	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1913.21055587186	1913.21055587186
"healthy-4"	"2019-08-01-count-3:CCTATCGAGAAGAGCA"	-3.02108774605449	-5.70673086559447	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGAGAAGAGCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2313.8062304868	52.5551223449147	0.0227137094076618	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2313.8062304868	2313.8062304868
"healthy-4"	"2019-08-01-count-3:CCTATCGCAGCAGATG"	0.71000232276265	8.06308076465455	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTATCGCAGCAGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1665.38632554942	38.4781876303821	0.0231046616872442	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1657.57833351476	1657.57833351476
"healthy-4"	"2019-08-01-count-4:AATCACGGTCTACGTA"	3.65167250212972	-5.78955747997435	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATCACGGTCTACGTA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2787.20267410696	42.9242046931121	0.0154004605018059	2575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2774.21882343993	2774.21882343993
"healthy-4"	"2019-08-01-count-3:TCCACGTTCTTCACAT"	11.1358715492183	5.68016908252565	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTTCTTCACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2036.09621974772	45.1254191601649	0.02216271447415	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2027.47357045507	2027.47357045507
"healthy-4"	"2019-08-01-count-2:AATCACGAGATGAACT"	10.6997505622799	6.33475539768068	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCACGAGATGAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1956.26548616434	46.2037242557418	0.0236183302228235	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1947.80574638841	1947.80574638841
"healthy-4"	"2019-08-01-count-4:GAAGCCCCAGAGGACT"	0.477627118199509	7.89596221530763	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGCCCCAGAGGACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.28705769135	40.7181213189673	0.022505064160976	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1803.32140947586	1803.32140947586
"healthy-4"	"2019-08-01-count-3:GCTACCTAGAGTGTTA"	4.97872700270955	-7.46154882824095	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTAGAGTGTTA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.44514064405	49.7920011596431	0.0199291953021661	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2496.0753999694	2496.0753999694
"healthy-4"	"2019-08-01-count-4:CACTGAAGTGTTCCAA"	11.1387735801632	5.84573791110841	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAGTGTTCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.74703627631	45.6118181199444	0.0242262063044621	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1878.15220195633	1878.15220195633
"healthy-4"	"2019-08-01-count-4:GAAGCGATCTATCCAT"	4.17273582991902	-6.72382023250731	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGCGATCTATCCAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.57809702003	48.3801468045675	0.0185607892815021	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2598.44166298529	2598.44166298529
"healthy-4"	"2019-08-01-count-2:TGTCAGACATTCTTCA"	11.4441076713497	4.34044358814088	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCAGACATTCTTCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.7587340009	43.3099735572023	0.0225132043804314	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.57272924192	1910.57272924192
"healthy-4"	"2019-08-01-count-2:CATGGATAGCACTCCG"	-2.82990251007732	9.2701205977234	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGGATAGCACTCCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.00698710907	46.5796505404467	0.0228107204502718	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2033.3104555453	2033.3104555453
"healthy-4"	"2019-08-01-count-2:TGTCAGATCGTCAAAC"	-1.51089320603068	8.58427999103395	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCAGATCGTCAAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1915.63652692146	40.8044336778285	0.0213007181186943	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1915.63652692146	1915.63652692146
"healthy-4"	"2019-08-01-count-2:GTTGTCCGTTGCCATA"	10.1944261985714	6.81049535358278	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTCCGTTGCCATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1589.79128346308	35.8762738718905	0.0225666565448393	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1589.79128346308	1589.79128346308
"healthy-4"	"2019-08-01-count-4:CACTGGGCACACCGAC"	5.07666315612142	-7.81608297741088	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGCACACCGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3060.56355791005	41.7696188107234	0.0136476887411044	2892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3053.58419742051	3053.58419742051
"healthy-4"	"2019-08-01-count-4:CACTGGGGTGGCACTC"	3.11094989356343	-6.02373411571654	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGGGGTGGCACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.24639638875	41.0117827046439	0.0155333164210501	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2635.81881904869	2635.81881904869
"healthy-4"	"2019-08-01-count-3:CAGATCATCAAGGAGC"	3.02343644675557	-6.01883556759032	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCATCAAGGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.20859530113	42.0886674398188	0.0166608044632996	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2525.17895130351	2525.17895130351
"healthy-4"	"2019-08-01-count-4:AATGCCACATCTCATT"	11.6343275505001	3.59141848171083	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGCCACATCTCATT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2411.23334784224	36.1366437665154	0.0149867883167978	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2397.60265270452	2397.60265270452
"healthy-4"	"2019-08-01-count-3:CAGATTGAGTTTCGGT"	4.75857271727864	-6.93810751354369	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGAGTTTCGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.76969426214	45.4729648731582	0.0177506061434831	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2556.50396725852	2556.50396725852
"healthy-4"	"2019-08-01-count-2:TGTCCTGCAAGCTGCC"	-1.78546212139781	3.59693667972413	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGCAAGCTGCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3746.50667408762	42.97042680045	0.0114694649011708	4948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3735.83096902033	3735.83096902033
"healthy-4"	"2019-08-01-count-3:TCCCAGTCAGCTCTGG"	4.76430811461751	-7.00436928188475	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCAGTCAGCTCTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.65115471917	40.9387449538053	0.0150142950567587	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2720.54613350347	2720.54613350347
"healthy-4"	"2019-08-01-count-4:CACTTCGAGTGTAGAT"	3.67665280875508	-6.90640070354613	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTTCGAGTGTAGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.03515706232	45.1964852701821	0.0192814877942466	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2344.03515706232	2344.03515706232
"healthy-4"	"2019-08-01-count-3:CCTCATGTCATCGCAA"	2.49314751204793	-5.9910927048889	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCATGTCATCGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.96517485535	45.0953545261467	0.0179522212240636	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2507.21663178133	2507.21663178133
"healthy-4"	"2019-08-01-count-3:CCTCATGTCGCCTAGG"	-1.93426905098613	3.47539970958558	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCATGTCGCCTAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2802.09612817677	46.3411392310703	0.01653802621726	4814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2796.16224208596	2796.16224208596
"healthy-4"	"2019-08-01-count-4:AATGGAAGTCAGACTT"	-2.29770479622539	4.21069667423097	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGGAAGTCAGACTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2613.3992812916	49.0933880468599	0.0187852611724133	2621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2607.85025456272	2607.85025456272
"healthy-4"	"2019-08-01-count-2:TGTGAGTGTGCCGGTT"	-4.12025580826457	12.0964441069397	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTGTGCCGGTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1782.4520733154	47.6946108205354	0.0267578643681692	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1778.26449401932	1778.26449401932
"healthy-4"	"2019-08-01-count-4:CAGAGCCGTCCAGTTA"	-4.1984752220219	11.9651899107727	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGAGCCGTCCAGTTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2274.80241135258	41.8951165615675	0.0184170354104104	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2271.42999190963	2271.42999190963
"healthy-4"	"2019-08-01-count-2:AATGCCACACAGCCAC"	11.1702906089718	5.31949470126954	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGCCACACAGCCAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.62913934626	40.7383488275814	0.0192741233876921	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2099.12914309944	2099.12914309944
"healthy-4"	"2019-08-01-count-3:AGCCAGCGTGGCTCTG"	-2.67980943146403	3.29596064174501	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAGCGTGGCTCTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3226.64498251886	50.8057345219625	0.0157456846963998	4030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3221.47649895908	3221.47649895908
"healthy-4"	"2019-08-01-count-4:TTCCTCTCATTGCCTC"	10.3617121177608	6.59363458240358	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTCATTGCCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2185.89979526499	40.1149407368881	0.0183516832856582	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2176.90749215968	2176.90749215968
"healthy-4"	"2019-08-01-count-2:AGACAAACAGGACGAT"	3.39616503295247	-5.96736099636229	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAAACAGGACGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.99517478174	40.3622246149489	0.0153410485134383	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2628.23931088191	2628.23931088191
"healthy-4"	"2019-08-01-count-2:AGACAAAAGTCTGTAC"	11.2458893257076	-2.76767470752867	"2019-08-01-count-2"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACAAAAGTCTGTAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1957.7553645572	30.0071192470287	0.0153273078905932	2495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	1952.41337396988	1952.41337396988
"healthy-4"	"2019-08-01-count-4:GACACGCAGTCCGCGT"	10.8931805091793	6.33540961826173	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCAGTCCGCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.1734311474	47.8373090053549	0.0233674921125481	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2042.51093728758	2042.51093728758
"healthy-4"	"2019-08-01-count-3:GCTGGGTTCGTTGTTT"	5.51109137114827	-9.47039129650267	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGGGTTCGTTGTTT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.81928330793	48.5918069397564	0.0190420251377545	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2549.68544667985	2549.68544667985
"healthy-4"	"2019-08-01-count-2:AGACACTCAGAACATA"	5.21779217299764	-8.83009817516478	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTCAGAACATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2922.10823583697	44.3065217757964	0.0151625190444412	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2915.2476411473	2915.2476411473
"healthy-4"	"2019-08-01-count-2:AGACACTCAAGAATAC"	-1.87820158425029	8.62329194629518	"2019-08-01-count-2"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTCAAGAATAC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2285.18491097077	44.4881684067437	0.019468082514095	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2274.86381137685	2274.86381137685
"healthy-4"	"2019-08-01-count-4:AATTTCCGTACTCGCG"	2.15075554427449	-5.91765644466551	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATTTCCGTACTCGCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2724.35128904545	36.2482090090648	0.0133052624875573	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2721.3174730888	2721.3174730888
"healthy-4"	"2019-08-01-count-2:AGACACTGTTTAGAGA"	-2.26541457596477	9.2475375899109	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTGTTTAGAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.99914279936	45.399365250415	0.0222436963830111	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2033.44451263003	2033.44451263003
"healthy-4"	"2019-08-01-count-2:GTAGAGGCAGCTCATA"	10.4145075279171	7.06200692737428	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGCAGCTCATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1899.8675437862	40.5264811451975	0.0213312139984419	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.22312573127	1893.22312573127
"healthy-4"	"2019-08-01-count-3:CAGGGCTGTAGACGTG"	3.29834236678426	-6.99249269878539	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGGCTGTAGACGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.07532836664	48.2196768140537	0.0207211499457126	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2320.06819221174	2320.06819221174
"healthy-4"	"2019-08-01-count-4:ACAAAGAAGGGCAGAG"	-1.63646624508556	8.79937837207643	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGAAGGGCAGAG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2033.70281210137	46.1870050292999	0.0227107937081407	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.98919959948	2022.98919959948
"healthy-4"	"2019-08-01-count-2:AGACACTTCCACGAAT"	-3.63790259781535	-5.7387585869995	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACACTTCCACGAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2735.24229260504	45.6459744851565	0.0166880918039927	2151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2735.24229260504	2735.24229260504
"healthy-4"	"2019-08-01-count-2:AATTCCTTCTGTCGCT"	9.98860420760457	6.49376390064088	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATTCCTTCTGTCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.09742301954	42.2693118728989	0.0205780462986817	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.79102208992	2043.79102208992
"healthy-4"	"2019-08-01-count-2:GTAGAGGTCTACTATC"	11.2886225181514	5.79775855625001	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGTCTACTATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.21361268718	47.2398298630342	0.0251782790315521	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.09117860716	1862.09117860716
"healthy-4"	"2019-08-01-count-3:TTGGGATGTCTAGGCC"	0.266679604619187	7.80389020526735	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGATGTCTAGGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1905.95242566012	44.6423998702069	0.0234226202444403	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1901.8081506775	1901.8081506775
"healthy-4"	"2019-08-01-count-2:GTAGATCCACCCTAGG"	2.68994583663289	-6.05574228679808	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGATCCACCCTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.17780110051	44.919252773216	0.0178663787237139	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2512.08519581662	2512.08519581662
"healthy-4"	"2019-08-01-count-4:TTCGCTGCACGCCAGT"	2.1621319251949	-6.11913063442381	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGCACGCCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.27157173253	43.986361289179	0.0175435169389267	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2502.79688269825	2502.79688269825
"healthy-4"	"2019-08-01-count-4:CAGCACGAGCTAGAAT"	3.19722141799275	-6.19051124965819	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGAGCTAGAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.08495701187	37.3184770729325	0.0166668428350906	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2237.51009210036	2237.51009210036
"healthy-4"	"2019-08-01-count-2:TAAGCCAAGACTTGTC"	4.51021589812581	-6.70342256939086	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCCAAGACTTGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.48407021998	44.6202443569617	0.0184955602019345	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2407.68005571308	2407.68005571308
"healthy-4"	"2019-08-01-count-2:CATTTCACACAGTCAT"	9.97216381606404	7.52391097629396	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCACACAGTCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2057.11006276434	41.7821477907681	0.0203110900807229	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2046.21088491132	2046.21088491132
"healthy-4"	"2019-08-01-count-4:TACGGGCTCCGATAGT"	-4.44434628906901	12.6801652678284	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCTCCGATAGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2366.55570911768	45.2798493630643	0.0191332277489237	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2365.08741378123	2365.08741378123
"healthy-4"	"2019-08-01-count-4:ACAACCATCGACCATA"	3.54605736312215	-6.32509663021239	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCATCGACCATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.38798575324	44.2244480189306	0.0169028631302933	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2613.59963256029	2613.59963256029
"healthy-4"	"2019-08-01-count-4:GACCGTGGTCGTATTG"	2.99123658713643	-6.15982820903929	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCGTGGTCGTATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.70875772433	42.7924149384193	0.0173128872099874	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.70561853924	2470.70561853924
"healthy-4"	"2019-08-01-count-2:AGACCATGTGTGAGCA"	4.61825813826863	-7.54917385494383	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATGTGTGAGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.96045480801	43.043015753004	0.0162859098684966	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2632.89875034786	2632.89875034786
"healthy-4"	"2019-08-01-count-4:TTCGGTCGTCTGTGAT"	-4.288557390601	12.6414537199768	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGGTCGTCTGTGAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2024.61014209799	42.5750866767824	0.0210287826735197	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2021.08737792113	2021.08737792113
"healthy-4"	"2019-08-01-count-2:TAAGCGTAGTTTGAGA"	4.24384512481038	-6.73674061214598	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCGTAGTTTGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.86016969239	46.7392590319267	0.0181029397256224	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2575.45331730899	2575.45331730899
"healthy-4"	"2019-08-01-count-3:GGAATCTAGACCAGCA"	-4.18644080582316	12.4979715117249	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATCTAGACCAGCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2039.24203546888	39.7875280794815	0.0195109395488374	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2035.69777140048	2035.69777140048
"healthy-4"	"2019-08-01-count-2:CCAAGCGTCAGATTGC"	11.3454433875972	4.81581113422243	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAAGCGTCAGATTGC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.87358670105	38.2161197234997	0.018400792406534	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2069.17761803087	2069.17761803087
"healthy-4"	"2019-08-01-count-3:GGAATCTTCATTCCTA"	-0.289750466973144	7.66315028751222	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATCTTCATTCCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.98303579589	44.6556602856632	0.0212344367622361	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2089.03582507127	2089.03582507127
"healthy-4"	"2019-08-01-count-2:CCAATGAAGAATTTGG"	14.4239670234615	1.98405478084413	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATGAAGAATTTGG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1708.73505022457	30.2374131055604	0.0176957879465201	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1690.60032129567	1690.60032129567
"healthy-4"	"2019-08-01-count-4:AGCGATTGTTCCAGGC"	3.00137462195699	-6.0374155274597	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGATTGTTCCAGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.89354904457	46.0639039446796	0.0181504476269389	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2535.79228056064	2535.79228056064
"healthy-4"	"2019-08-01-count-2:ACAACCAGTATTTCGG"	4.0702620941097	-6.17114880001219	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCAGTATTTCGG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2807.31532717005	38.8589705463911	0.013842039820145	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2802.99926079397	2802.99926079397
"healthy-4"	"2019-08-01-count-4:TACGTCCCAGTTTGGT"	10.8967415290767	6.0605373152527	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCCAGTTTGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.21625216294	40.2434682193518	0.0215180828274856	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.23769900964	1863.23769900964
"healthy-4"	"2019-08-01-count-3:ACATGCACAGGTACGA"	-0.947261552244979	8.27242276752321	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATGCACAGGTACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2030.0429298057	42.2645395856131	0.0208195299543041	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2021.63591911172	2021.63591911172
"healthy-4"	"2019-08-01-count-2:AGAGAATCAGTGAGCA"	-2.23087225380595	9.01417443836061	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAATCAGTGAGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1825.03378282118	44.805817691772	0.0245506785208711	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1825.03378282118	1825.03378282118
"healthy-4"	"2019-08-01-count-2:TAATCTCGTCTCGGAC"	4.7466479736263	-7.73340036785277	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATCTCGTCTCGGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.04452693271	47.9127063491836	0.0211905187087054	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2258.10859765914	2258.10859765914
"healthy-4"	"2019-08-01-count-4:CAGCGTGCAACCCGCA"	0.650328834622544	7.9579753645691	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCGTGCAACCCGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.20702424346	38.3128170232653	0.0208538376555805	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1828.6011174755	1828.6011174755
"healthy-4"	"2019-08-01-count-4:ACACAGTGTTGGTAGG"	4.74926104125325	-7.28319885646971	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTGTTGGTAGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2741.8331741385	43.5578279331205	0.0158863888379374	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2739.18584326948	2739.18584326948
"healthy-4"	"2019-08-01-count-2:TGTTCTACAATTGCTG"	10.595605512231	6.65631053531495	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCTACAATTGCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1857.74638172854	46.0951534590394	0.024812403841772	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1850.97968031857	1850.97968031857
"healthy-4"	"2019-08-01-count-4:CAGGCCAAGGGCCTCT"	3.94174613532369	-6.4208121529785	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGCCAAGGGCCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2671.15912501883	39.7383162730668	0.0148768060655266	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2665.72156296335	2665.72156296335
"healthy-4"	"2019-08-01-count-4:ATGATCGGTATCTTCT"	-5.00448689881023	-5.06249525463256	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGATCGGTATCTTCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.40503759395	48.5959486212153	0.0175982689825023	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2758.13316388108	2758.13316388108
"healthy-4"	"2019-08-01-count-4:GTCCACTTCCAACACA"	0.0420966633478224	7.90707347476808	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTTCCAACACA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.36206509161	43.1920718923027	0.023154792681056	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1853.07134310089	1853.07134310089
"healthy-4"	"2019-08-01-count-2:AGAGAGCTCCCATTCG"	11.2440697151119	5.50709722125856	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAGCTCCCATTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.24432180686	49.3687734920366	0.0255235457772568	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.60088535414	1932.60088535414
"healthy-4"	"2019-08-01-count-4:TACTTACTCTTACGGA"	2.64397158202474	-6.17184212124022	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTACTCTTACGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.64900725873	46.2331436628038	0.0207263193413025	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2228.08934076255	2228.08934076255
"healthy-4"	"2019-08-01-count-3:GGAGAACCACTGCGTG"	2.02863206443135	-6.74933197414549	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACCACTGCGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1508.67360278215	52.39985839471	0.0347324022227732	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1506.52172396072	1506.52172396072
"healthy-4"	"2019-08-01-count-2:TCATATCTCCGTTTCG"	10.63974060592	6.60867498004762	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATATCTCCGTTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.7634089134	46.2175582866018	0.0232627388239846	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.26224145988	1969.26224145988
"healthy-4"	"2019-08-01-count-3:CGAAGTTTCACCTCGT"	11.4129902320797	4.59721038425294	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTTCACCTCGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2280.20550944418	43.8462944021529	0.0192290976495539	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2270.14330117365	2270.14330117365
"healthy-4"	"2019-08-01-count-3:GGAGAACGTAGCTGTT"	5.55953898009602	-10.1308183900085	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACGTAGCTGTT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.44800435596	43.4207264290054	0.0165258175830766	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2624.54021664573	2624.54021664573
"healthy-4"	"2019-08-01-count-4:CAGGTATTCCTAGCCT"	-1.93373392048534	8.75640866840211	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGTATTCCTAGCCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2353.16891282772	49.7463103228401	0.0211401357767649	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2345.2341738551	2345.2341738551
"healthy-4"	"2019-08-01-count-2:CCACAAATCAGTCATG"	-4.33640847626384	13.0614871748718	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAATCAGTCATG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2201.96074845251	49.0158805796861	0.0222601064138557	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2198.5003625113	2198.5003625113
"healthy-4"	"2019-08-01-count-3:TTTACCACACTGTGTA"	0.0723742554778277	7.67235276782838	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTACCACACTGTGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.10676047828	41.7133587029884	0.0217358197897195	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1914.01457317447	1914.01457317447
"healthy-4"	"2019-08-01-count-4:CAGTGCGAGTGTGTTC"	10.0765215354854	7.23094937885133	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTGCGAGTGTGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1971.10866531576	46.4763666974858	0.0235787947743817	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1956.86214405469	1956.86214405469
"healthy-4"	"2019-08-01-count-4:CAGTGCGGTTAGAAAC"	4.22758593138997	-7.15538837825926	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTGCGGTTAGAAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2993.00819801818	45.6028460350527	0.0152364587792471	2994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2982.13427428642	2982.13427428642
"healthy-4"	"2019-08-01-count-2:CACCAAAAGCAGGTCA"	10.9213730293209	5.29944799030153	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCAAAAGCAGGTCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1680.49299569693	44.4373330404868	0.0264430337729899	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1669.91474786581	1669.91474786581
"healthy-4"	"2019-08-01-count-4:ACAGAAAAGGCCATAG"	-3.68076882782634	10.1217202910217	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAAAGGCCATAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2091.89528818734	45.4603090440653	0.0217316369996021	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.99072860954	2087.99072860954
"healthy-4"	"2019-08-01-count-2:AGAGCCCTCTCCGAGG"	3.97237743911092	-6.08189537441405	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCTCTCCGAGG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2862.93885240669	43.6133012853835	0.0152337522852507	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2856.42353665834	2856.42353665834
"healthy-4"	"2019-08-01-count-2:TGTTTGTTCCGTGTGG"	-2.20044789734538	8.66690538013307	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTTGTTCCGTGTGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.67068373385	46.2650649180053	0.0226714997607322	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2037.42131067049	2037.42131067049
"healthy-4"	"2019-08-01-count-3:TCGACCTGTGTCCGTG"	4.20599140700643	-6.56848623668822	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACCTGTGTCCGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2685.77341380411	48.1979729733925	0.0179456586790489	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2680.68329509352	2680.68329509352
"healthy-4"	"2019-08-01-count-3:TCGACCTTCCCTCGTA"	0.70964135703389	9.04877278888551	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACCTTCCCTCGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1915.51718062305	42.9804690385818	0.0224380493546928	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.5760189088	1910.5760189088
"healthy-4"	"2019-08-01-count-4:ACAGAAAGTCTTTATC"	1.67479779300038	-6.13723041927489	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAAGTCTTTATC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2358.30287310157	50.5238024696025	0.0214237971915605	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2354.09392585821	2354.09392585821
"healthy-4"	"2019-08-01-count-4:TTGAACGGTATCATGC"	11.1641441780025	6.04331824863283	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAACGGTATCATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.86556416791	43.1117634497903	0.0204140662082231	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2101.24698460838	2101.24698460838
"healthy-4"	"2019-08-01-count-2:CCACGAGTCGTAACTG"	10.5075041252071	5.58123061740724	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGAGTCGTAACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1791.82286016315	44.5333805403284	0.0248536736138491	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1790.03440539165	1790.03440539165
"healthy-4"	"2019-08-01-count-4:CAGTTCCCATCGCTGG"	-4.07160411301311	3.22151062572328	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCCATCGCTGG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3205.64046801898	45.4887979824262	0.0141902370013869	5190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3194.71169543494	3194.71169543494
"healthy-4"	"2019-08-01-count-3:TAGGTTGAGGTTAAAC"	5.57549538192098	-9.548215889093	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGAGGTTAAAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2671.70202449104	41.5751765033989	0.0155613074071458	1957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2657.40836516603	2657.40836516603
"healthy-4"	"2019-08-01-count-2:GTCACGGAGTAGTCCT"	3.96640004691426	-6.36323549663695	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGAGTAGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.35639038482	39.6998173458369	0.0149508433179034	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2652.4655509671	2652.4655509671
"healthy-4"	"2019-08-01-count-2:CCACGTTGTGCCGGTT"	-3.03507624092754	9.15504739368287	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTGTGCCGGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.06082165464	45.6496613735814	0.0218517627157569	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.36772774643	2087.36772774643
"healthy-4"	"2019-08-01-count-2:TTAATCCTCCATAAGC"	-1.27542028847392	8.48606965625612	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCTCCATAAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2154.30385885121	48.501737946651	0.0225138797144961	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.89378852932	2141.89378852932
"healthy-4"	"2019-08-01-count-2:ACAGCCGTCATTGGTG"	11.4110676246578	3.78461787784425	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGCCGTCATTGGTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1622.36905032219	37.9579053577915	0.0233965911456788	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1617.86135250072	1617.86135250072
"healthy-4"	"2019-08-01-count-2:CGGAATTAGGTCTTTG"	-1.88492606106456	10.0918512114319	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTAGGTCTTTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1747.75968072291	46.1074426987277	0.0263808824561376	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1736.50414513277	1736.50414513277
"healthy-4"	"2019-08-01-count-3:TCGCACTCAAGAGGTC"	11.1471840339595	6.4788198241028	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTCAAGAGGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2359.03211000586	43.646146362822	0.0185017177925202	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2353.77607423402	2353.77607423402
"healthy-4"	"2019-08-01-count-4:CATAAGCCACTGGACC"	10.7929693656856	6.7874078520569	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCCACTGGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.20079257696	41.9380572371193	0.0208005360336741	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2012.78073253843	2012.78073253843
"healthy-4"	"2019-08-01-count-4:GACTTCCTCGCCAATA"	10.8759533363277	7.44670436466066	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCTCGCCAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2588.96247678708	49.9725091132299	0.0193021372697708	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2576.44649662494	2576.44649662494
"healthy-4"	"2019-08-01-count-4:CATAAGCGTCGAGATG"	4.61990179595296	-6.78374674236449	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCGTCGAGATG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.8056101398	40.768916592009	0.0158337842792705	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2570.30369425229	2570.30369425229
"healthy-4"	"2019-08-01-count-2:TTACCATCATCCGATA"	4.50561394271199	-6.73497774517211	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATCATCCGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.41688502118	37.1985001095785	0.014794086188005	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2507.41054624992	2507.41054624992
"healthy-4"	"2019-08-01-count-2:GAGGCCTTCCAGTACA"	0.148203154175919	8.03430221164552	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCCAGTACA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2078.64605452059	39.5384609876756	0.0190212570830365	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.33544875874	2070.33544875874
"healthy-4"	"2019-08-01-count-4:CATAAGCTCAGGTGTT"	-4.18454442444499	13.1567268141541	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCTCAGGTGTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2344.62689795087	38.479586723729	0.0164118166337505	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2331.36445294579	2331.36445294579
"healthy-4"	"2019-08-01-count-2:AGATGAATCGCGAAGA"	4.10528292235677	-6.45451786434325	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATGAATCGCGAAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.30032341302	46.1227686321966	0.0189860299229685	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2424.6379758025	2424.6379758025
"healthy-4"	"2019-08-01-count-3:TCGCAGGTCATGCCCT"	-1.53854439678844	8.79923627460328	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCAGGTCATGCCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.37777019041	48.5553894629784	0.0239262448698365	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.98909506287	2022.98909506287
"healthy-4"	"2019-08-01-count-2:TTACCGCAGCTAAACA"	9.6968637901241	7.29954860294191	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCAGCTAAACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1929.7432013539	42.4804455329809	0.0220135225781217	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.5460885351	1923.5460885351
"healthy-4"	"2019-08-01-count-3:GGCACGTAGTGAGGCT"	-7.08401952210124	3.48736450755922	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTAGTGAGGCT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2490.94093469809	40.0969076767465	0.0160970929170612	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2472.1790920395	2472.1790920395
"healthy-4"	"2019-08-01-count-3:CGATGGCTCCACAGCG"	3.14265169677083	-6.05143215572508	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGATGGCTCCACAGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.15599546884	45.3184516419922	0.0169531638702753	2322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2665.4116612679	2665.4116612679
"healthy-4"	"2019-08-01-count-4:GTCTGTCTCCCTCTTT"	11.1474348503048	5.8509220846924	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCTCCCTCTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.22971460274	45.7094315893318	0.0274493249721023	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1658.72474442134	1658.72474442134
"healthy-4"	"2019-08-01-count-3:TGTACAGGTGCATACT"	-1.85007999363597	8.72798249805299	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGGTGCATACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.74965264715	42.7577856972837	0.0220315823006655	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1930.6000806909	1930.6000806909
"healthy-4"	"2019-08-01-count-4:GAGACCCTCGAACGCC"	-2.68015537682231	8.78504846179811	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCTCGAACGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.87512203553	41.5802580866205	0.020443859918502	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2021.72433884993	2021.72433884993
"healthy-4"	"2019-08-01-count-4:GAGACCCTCATCACAG"	-3.32473597946818	9.51891515338746	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCTCATCACAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2141.99851949099	48.9565060410008	0.0228555274877755	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2133.1384931027	2133.1384931027
"healthy-4"	"2019-08-01-count-3:CTGCCTATCTTACGGA"	-0.935954312712509	8.34698293292848	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTATCTTACGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1972.6203697746	47.9750063556842	0.0243204455813086	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1966.75692746337	1966.75692746337
"healthy-4"	"2019-08-01-count-4:ACCAAACAGCTCCGAC"	3.77687849578206	-6.45492699062499	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCAAACAGCTCCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.50349549203	44.5225450132664	0.0175181915319959	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2538.97954588822	2538.97954588822
"healthy-4"	"2019-08-01-count-4:CATAGACTCCTTGAAG"	10.7038666206295	6.71698711002199	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAGACTCCTTGAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1992.7740460467	43.8826602031806	0.0220208910740461	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1988.09715131971	1988.09715131971
"healthy-4"	"2019-08-01-count-2:GTCATTTCAGCGAGTA"	-3.94259629669841	-5.47081043636473	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATTTCAGCGAGTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2690.71439874579	51.6382999391211	0.0191912972863976	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2685.93115631728	2685.93115631728
"healthy-4"	"2019-08-01-count-2:AGCCAATTCTTAGGAC"	11.5632721382076	3.51411006534425	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAATTCTTAGGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2474.93141714238	49.6945030100745	0.0200791434727727	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2464.13118913121	2464.13118913121
"healthy-4"	"2019-08-01-count-4:GAGATGGAGATGCTTC"	2.87984861907307	-6.00223734295043	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGATGGAGATGCTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.23040158665	41.2770844467663	0.0166156425830724	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2483.25084747435	2483.25084747435
"healthy-4"	"2019-08-01-count-2:GGAGAACAGGATTACA"	-2.70913658562358	9.71181199634401	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGAACAGGATTACA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1981.69311857503	40.1057247733219	0.0202381107333917	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.2575786912	1975.2575786912
"healthy-4"	"2019-08-01-count-3:TCGCTTGTCTACGCAA"	9.58016933974568	7.08546540820924	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGTCTACGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.15268499544	45.9602338067635	0.0244709784108289	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1872.94862813891	1872.94862813891
"healthy-4"	"2019-08-01-count-4:CTCCCTCCATCGATCA"	-4.52113280716594	12.9636773833069	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCCTCCATCGATCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2681.40776490247	39.3340708345769	0.0146691865927402	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2675.45753931629	2675.45753931629
"healthy-4"	"2019-08-01-count-2:TTACGTTCATTCAGCA"	10.802434583276	6.21169898593751	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTCATTCAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1823.3598091359	40.8218757038597	0.0223882721881455	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1816.26818652416	1816.26818652416
"healthy-4"	"2019-08-01-count-4:CATCCACGTGCTCTTC"	1.59960653361623	-6.38150837337645	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCACGTGCTCTTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2498.22471220789	48.4262242015521	0.0193842547329354	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2489.69322922567	2489.69322922567
"healthy-4"	"2019-08-01-count-3:TCGGGACAGTAACCGG"	-3.2957526248997	-5.61704256450804	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACAGTAACCGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2580.84219941644	50.6079027038334	0.0196090651010265	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2577.86715779357	2577.86715779357
"healthy-4"	"2019-08-01-count-3:CGCCATTAGTCGTTAC"	3.05682220038716	-6.27311947261962	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCATTAGTCGTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.21850479416	45.9334818080497	0.0188776641791714	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2429.59848432165	2429.59848432165
"healthy-4"	"2019-08-01-count-2:TTACTGTTCTGGCTGG"	-4.09604821625407	10.737241721991	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACTGTTCTGGCTGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2219.01723612961	41.0230186532217	0.0184870211845554	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2213.97286314439	2213.97286314439
"healthy-4"	"2019-08-01-count-3:GGCTTTCTCAATCCGA"	4.74575914916341	-8.20487978374632	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCTCAATCCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2987.40391986224	43.0686282781126	0.0144167409006073	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2976.44782083107	2976.44782083107
"healthy-4"	"2019-08-01-count-4:CATCCCAGTAATTGGA"	4.42035164412801	-6.60779907619628	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCAGTAATTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.11636338623	41.7601621807494	0.0163054528789685	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2557.64230827195	2557.64230827195
"healthy-4"	"2019-08-01-count-4:CATCCCATCAAAGGAT"	3.26316823539082	-6.36521055614623	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCCATCAAAGGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.2911146479	40.902708712408	0.0164778049081523	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2475.97415660087	2475.97415660087
"healthy-4"	"2019-08-01-count-2:TTAGGCACACTGAATC"	11.5821100669796	4.09420440280763	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCACACTGAATC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2379.22658883142	35.8950948663688	0.0150868753042976	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2362.3127111348	2362.3127111348
"healthy-4"	"2019-08-01-count-4:TATCAGGAGTCGAGGT"	11.1485773521358	6.18827865207521	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCAGGAGTCGAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.0232494732	43.4764512738086	0.0243153724576109	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1782.99603994463	1782.99603994463
"healthy-4"	"2019-08-01-count-3:CGCGTGATCCTACAAG"	9.62984432753865	6.51085803592531	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCGTGATCCTACAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1880.96534244661	45.778993565407	0.0243380313992715	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.34228050155	1876.34228050155
"healthy-4"	"2019-08-01-count-3:GGGAAGTAGCCTGGAA"	10.6085020500118	6.78948829257814	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTAGCCTGGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1742.66946795954	47.5218270293139	0.0272695585152796	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1739.13376064711	1739.13376064711
"healthy-4"	"2019-08-01-count-3:TCGGGTGAGAGGATCC"	10.4058939414913	7.00466296756593	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGAGAGGATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1835.46008343826	49.892381332305	0.0271824932519614	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1828.08681889982	1828.08681889982
"healthy-4"	"2019-08-01-count-2:CCCGAAGTCAAGTTGC"	-3.30401144447978	9.63540265643922	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGTCAAGTTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2005.75858888184	47.6979964483327	0.0237805270847292	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1993.25556410129	1993.25556410129
"healthy-4"	"2019-08-01-count-4:CATCCGTTCCGTCAAA"	0.31189270791356	7.88439033115236	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTTCCGTCAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1846.41779253195	40.134251940472	0.0217362788112201	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1841.81841127429	1841.81841127429
"healthy-4"	"2019-08-01-count-4:CATCCGTGTGAGTAAT"	3.20363940772359	-6.11980202114256	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTGTGAGTAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2763.76008052279	42.6180272624516	0.0154203064017011	2318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2759.67241112507	2759.67241112507
"healthy-4"	"2019-08-01-count-2:TACTGCCCACACCTAA"	-2.56525979462321	9.05644795978395	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTGCCCACACCTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2079.19525303083	45.6292096109529	0.02194561070897	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2072.6290892662	2072.6290892662
"healthy-4"	"2019-08-01-count-4:TTGGGCGAGGTGCTGA"	-2.22982583466228	3.55570194804994	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGAGGTGCTGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2910.21742474206	42.8439343605572	0.0147219015308983	3989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2904.40830385285	2904.40830385285
"healthy-4"	"2019-08-01-count-4:CATCCGTTCTCCCTAG"	10.5739838081295	6.87255904758302	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTTCTCCCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2159.83886784687	44.1443741037219	0.0204387349264295	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2147.49967136663	2147.49967136663
"healthy-4"	"2019-08-01-count-3:CGGAATTTCTGGTTGA"	10.2990185218746	7.44274184787599	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGAATTTCTGGTTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.88667977981	43.4867169648155	0.0202274461132385	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2137.12365435945	2137.12365435945
"healthy-4"	"2019-08-01-count-4:ACCCTCATCGCTATTT"	10.7512003379757	7.18856475437013	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCCTCATCGCTATTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2229.79733982032	46.9190613946208	0.0210418501075087	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2220.22604574794	2220.22604574794
"healthy-4"	"2019-08-01-count-3:TCGGTCTCACCTTCGT"	4.16330637511556	-6.75946953212889	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTCACCTTCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.19831228756	45.1550302465367	0.0181476814060785	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2483.69592101469	2483.69592101469
"healthy-4"	"2019-08-01-count-2:AGCGCTGGTTCGTAAC"	5.60769571837727	-10.0310564271179	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGGTTCGTAAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.05503564037	44.1560519898297	0.0166372028450328	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2645.06361158854	2645.06361158854
"healthy-4"	"2019-08-01-count-3:TCGGTCTCAGGTCCCA"	10.9995800453121	6.54305741870729	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTCAGGTCCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.64805999957	42.683128161979	0.0215392072000859	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1971.90004012712	1971.90004012712
"healthy-4"	"2019-08-01-count-3:AGGTTGTCATACAGGG"	4.86563219603841	-7.13854315197142	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTCATACAGGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2863.37172691802	43.0360606387888	0.0150298545711739	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.31545366996	2859.31545366996
"healthy-4"	"2019-08-01-count-3:TCGGTCTGTACGGCAA"	-2.59001598778422	3.37039778316347	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTGTACGGCAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3317.16227399966	48.2590176443434	0.01454828364069	5556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3308.97224314054	3308.97224314054
"healthy-4"	"2019-08-01-count-2:CCCTAACGTGCAGATG"	4.33614124831502	-6.69405414974364	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACGTGCAGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2863.08346126526	41.5394568213266	0.0145086433501905	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2861.27454163721	2861.27454163721
"healthy-4"	"2019-08-01-count-4:TATCTTGCAACTCCAA"	3.68205918845479	-6.58271315014037	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGCAACTCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.66249076486	39.1260076632116	0.015640002521383	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.14781222751	2494.14781222751
"healthy-4"	"2019-08-01-count-4:GTGCAGCGTTAGGGAC"	3.33140029486958	-6.61815216457518	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCAGCGTTAGGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.71026236246	45.4713042571922	0.0193189896752848	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2348.28484149658	2348.28484149658
"healthy-4"	"2019-08-01-count-4:TATCTTGCAACTGAAA"	5.10363258895223	-7.71314146434935	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGCAACTGAAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.15515391569	42.3044064433687	0.0153546367010383	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2748.88538798678	2748.88538798678
"healthy-4"	"2019-08-01-count-2:CCCTAACTCTTGGGCG"	-0.40992913666423	7.76422975147096	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACTCTTGGGCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2033.80395078249	47.1268662645793	0.0231717842058708	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2030.22584116522	2030.22584116522
"healthy-4"	"2019-08-01-count-2:CCCTCAAGTCCTTGTC"	-7.63691268387492	0.543602681997694	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAAGTCCTTGTC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3431.881062422	43.5887284720071	0.0127011186224633	5207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3418.04024096049	3418.04024096049
"healthy-4"	"2019-08-01-count-4:CATCGGGTCACCACAA"	10.9709803062374	6.0070795782837	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGGGTCACCACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.16091653816	47.4465260563212	0.0242301465909156	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1953.76748459779	1953.76748459779
"healthy-4"	"2019-08-01-count-4:CGACAGCGTAATTAGG"	2.61067428168599	-6.0562749139038	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCGTAATTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.97607714838	42.9229141320783	0.0168194813879451	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2549.92853115665	2549.92853115665
"healthy-4"	"2019-08-01-count-4:ACCTGTCAGGATGGCT"	4.68404449996297	-6.78306009685668	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGTCAGGATGGCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.29897863781	40.3894746883592	0.0152281002306545	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.05324176858	2649.05324176858
"healthy-4"	"2019-08-01-count-4:CATCGTCCAAGAGTTA"	0.052765926573104	7.60713098132936	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCCAAGAGTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1999.09270390545	43.5298429666904	0.0217747995786539	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.30010971074	1992.30010971074
"healthy-4"	"2019-08-01-count-4:TATGTTCTCTTTCTAG"	-3.68893919411357	-5.43734743511351	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCTCTTTCTAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2806.5238641782	50.4834565586136	0.0179878949910144	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2803.66215982398	2803.66215982398
"healthy-4"	"2019-08-01-count-2:AGCTCAAGTTGGTACT"	0.51945718106572	7.92834518039552	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTCAAGTTGGTACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1928.20130438567	42.1971890211685	0.0218842238749613	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1924.84643329183	1924.84643329183
"healthy-4"	"2019-08-01-count-2:TAGACCAAGGTTTGAA"	-1.9719480079716	3.53540060603944	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAAGGTTTGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3052.58822812826	46.7140103284232	0.0153030827734885	5100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3046.31463672804	3046.31463672804
"healthy-4"	"2019-08-01-count-2:CCCTCTCGTTTAGAGA"	5.32845511016194	-9.19224550640257	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCGTTTAGAGA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2859.9564637026	43.0845665650842	0.0150647630870945	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2856.93842790751	2856.93842790751
"healthy-4"	"2019-08-01-count-4:CATGCAAAGCCTGAGA"	0.0802701367879331	7.85783336246339	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCAAAGCCTGAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.83011078541	40.9984361590065	0.0214895634193174	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.88657121726	1897.88657121726
"healthy-4"	"2019-08-01-count-2:AGCTTCCAGCTGGCCT"	10.2752253013546	7.57763383472291	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCAGCTGGCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2123.91941337596	49.5940890993938	0.0233502687470445	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.00652467754	2117.00652467754
"healthy-4"	"2019-08-01-count-2:CCCTGATTCAGCTTCC"	11.0864941078121	5.54419849002687	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTGATTCAGCTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2088.23598436737	47.8282700191357	0.0229036710300849	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2080.25355891359	2080.25355891359
"healthy-4"	"2019-08-01-count-3:GGGATCCCAATAGTCC"	-2.20428619805034	9.5158071287903	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATCCCAATAGTCC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2147.03480195541	46.2834380008273	0.0215569109353396	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2135.32343569583	2135.32343569583
"healthy-4"	"2019-08-01-count-4:ACGCACGAGCTAGCCC"	4.09445728835408	-6.32622196590575	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGCACGAGCTAGCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.66151597719	41.8623898857479	0.0159678851105019	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2609.90073747451	2609.90073747451
"healthy-4"	"2019-08-01-count-2:AGCTTCCGTCTGTGTA"	-2.61170397225078	9.00888822162477	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTTCCGTCTGTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.18544961519	46.6942366449426	0.0238944756518054	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.12155225077	1945.12155225077
"healthy-4"	"2019-08-01-count-2:GATCATGCAGCACCCA"	4.56082691726033	-6.91375687038573	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGCAGCACCCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2816.34675719417	50.757109077303	0.0180223223392671	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2810.58943902409	2810.58943902409
"healthy-4"	"2019-08-01-count-4:TATTGGGCAGATTCGT"	3.01223792609517	-6.13388969814452	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGGGCAGATTCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.9276621028	42.0324150839794	0.0162605769206658	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.38384225389	2580.38384225389
"healthy-4"	"2019-08-01-count-2:TAGACTGGTCACGCTG"	11.5738026100094	3.58744404399721	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACTGGTCACGCTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2152.74928333973	44.3967713791645	0.0206232893550373	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2137.15443595618	2137.15443595618
"healthy-4"	"2019-08-01-count-2:TTCACCGGTTGGGTTT"	3.01957954940144	-6.22440197384032	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCACCGGTTGGGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.00477498253	46.5084244732698	0.0184264407636042	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2519.04912789201	2519.04912789201
"healthy-4"	"2019-08-01-count-3:TCAAGCAAGTAGTCCT"	1.96858145770375	-6.31061222469481	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGCAAGTAGTCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2430.78644450486	49.7281038076864	0.0204576193520018	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2426.79364193648	2426.79364193648
"healthy-4"	"2019-08-01-count-4:CATGCTCCAAGCTGCC"	-0.240223268896896	7.69247338855592	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGCTCCAAGCTGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2154.49554834787	45.3055416737695	0.0210283756253343	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2149.4721758491	2149.4721758491
"healthy-4"	"2019-08-01-count-2:CCGATCTCACTGCACG"	11.3753820854122	4.87492892825929	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATCTCACTGCACG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2389.66050276873	32.5035136722752	0.0136017286282364	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2378.48058252896	2378.48058252896
"healthy-4"	"2019-08-01-count-2:CCGAACGTCAGGGATG"	2.83297528800313	-6.27373030101927	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGAACGTCAGGGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.41481170596	43.9623941312298	0.0186090918129164	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2353.22084970117	2353.22084970117
"healthy-4"	"2019-08-01-count-2:AGGAATACAGGCTACC"	10.2652555900509	6.72065255725709	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAATACAGGCTACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.43027017635	48.8915592633746	0.0267835808697592	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1814.79358837546	1814.79358837546
"healthy-4"	"2019-08-01-count-3:CGGTCAGAGTAATACG"	-4.11303363266643	12.9540967711243	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGAGTAATACG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1795.75953332709	47.562204055372	0.0264858424375179	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1791.66893299548	1791.66893299548
"healthy-4"	"2019-08-01-count-4:GATCATGCAACGATCT"	11.4788366752559	4.32546136463014	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGCAACGATCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2034.84219402208	41.0260020908405	0.0201617610502504	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.52480056196	2018.52480056196
"healthy-4"	"2019-08-01-count-4:TTTACGTGTCGTACTA"	2.15160288390462	-6.13800909435423	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTGTCGTACTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.28488696306	41.1677036578528	0.018149265065629	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2266.98876963282	2266.98876963282
"healthy-4"	"2019-08-01-count-3:GGGCTACAGTGGACGT"	-1.59903154793437	9.1018085249695	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTACAGTGGACGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2438.42528122474	51.4217507799116	0.0210880977882924	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2423.03417425917	2423.03417425917
"healthy-4"	"2019-08-01-count-4:CATGGATAGCAACTCT"	-1.75898013535197	8.97346494281618	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGATAGCAACTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2297.12880300383	45.7934692174978	0.0199350899077214	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2291.59122124308	2291.59122124308
"healthy-4"	"2019-08-01-count-3:TCTCACGGTCCGGTCA"	0.448858429759186	7.74664065921632	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGGTCCGGTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2107.58488949639	44.6669045260598	0.0211934070834666	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2093.90659775504	2093.90659775504
"healthy-4"	"2019-08-01-count-3:GGGCTCAGTCTAGGTT"	10.7680736976558	6.65122459018556	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTCAGTCTAGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.98701591396	46.9277723718458	0.0244672002377887	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1914.70010124513	1914.70010124513
"healthy-4"	"2019-08-01-count-2:AGGACGATCAACGAGG"	10.9370428520137	6.59794042194215	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGATCAACGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1831.77296375028	44.0144120297129	0.0240283118600026	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1826.78766799443	1826.78766799443
"healthy-4"	"2019-08-01-count-3:GGGTAGAAGCGCCTCA"	2.08113636550252	-5.92464258587035	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTAGAAGCGCCTCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2595.30439375636	41.0662205890451	0.0158232771030019	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2591.55192306065	2591.55192306065
"healthy-4"	"2019-08-01-count-4:TTTACGTTCTGTCCCA"	3.08194937285725	-6.25125124370726	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTTCTGTCCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.9383499705	47.3158354929804	0.0178017054058103	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2654.72741533998	2654.72741533998
"healthy-4"	"2019-08-01-count-2:TTCATTGAGCTAGATA"	10.4348274665767	7.64850041950075	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGAGCTAGATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.83867341306	41.0006388771835	0.0219508458951993	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1864.98071886844	1864.98071886844
"healthy-4"	"2019-08-01-count-2:CCGGTAGAGTAGCATA"	-1.41672406616862	3.69167635524598	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGAGTAGCATA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2741.54833909984	40.8155406955788	0.0148877698465022	4727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2734.30280822906	2734.30280822906
"healthy-4"	"2019-08-01-count-3:CCACACTGTCGATTAC"	-1.01381657543834	8.26172635639039	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACACTGTCGATTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2794.16281989464	37.8494944510756	0.0135459158577247	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2783.0227624922	2783.0227624922
"healthy-4"	"2019-08-01-count-4:ACGGTTATCCTAGCCT"	3.15176190909688	-6.14582970058592	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTATCCTAGCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2715.73142004461	43.4218225784642	0.0159889973868443	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2713.66190813993	2713.66190813993
"healthy-4"	"2019-08-01-count-3:CGTAATGAGCCTTGAT"	2.52310170707051	-6.01972248470458	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGAGCCTTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.83744189221	45.5896569192603	0.0181716264904257	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2499.4658780128	2499.4658780128
"healthy-4"	"2019-08-01-count-3:GGGTATTGTACCCGAC"	5.59047617492024	-9.59470941936644	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTATTGTACCCGAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.37383092774	42.8631643140735	0.0164392093706111	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2594.40827246036	2594.40827246036
"healthy-4"	"2019-08-01-count-4:ATTTCACCAGAGATTA"	11.4724356132442	4.08865020358888	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACCAGAGATTA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2104.00502435298	38.4118018279776	0.0182565162076027	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2089.87270544814	2089.87270544814
"healthy-4"	"2019-08-01-count-2:GTGAGTTAGCCAACCC"	10.2833372550899	7.47329948032228	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTAGCCAACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.25491380005	44.2842225908224	0.0215573161311823	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.5154476575	2051.5154476575
"healthy-4"	"2019-08-01-count-3:GGGTATTGTTATGTCG"	-1.91045628014262	3.45652601802675	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTATTGTTATGTCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3148.94457118466	47.1943908878102	0.0149873679326325	4567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3137.90637109046	3137.90637109046
"healthy-4"	"2019-08-01-count-4:TTTATGCAGTCAATCC"	-2.71541819992717	9.38999650562135	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCAGTCAATCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.64698569368	44.7289545029343	0.0243535937234234	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1834.71831519342	1834.71831519342
"healthy-4"	"2019-08-01-count-2:TTCCAATTCTTCTCAA"	0.012028300284785	7.67303083026735	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATTCTTCTCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2034.93871683568	41.406281922433	0.0203476800455296	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2027.54520761999	2027.54520761999
"healthy-4"	"2019-08-01-count-4:CATTCCGGTGACAGGT"	1.86239852485005	-6.70287706768187	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGGTGACAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1964.00610973855	49.6656574864519	0.0252879343094628	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1962.27770222205	1962.27770222205
"healthy-4"	"2019-08-01-count-2:CCGGTGATCCACAGGC"	10.9309297996456	5.61867663944093	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTGATCCACAGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.91171759409	40.8318131258835	0.0210482841850782	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.42933551648	1934.42933551648
"healthy-4"	"2019-08-01-count-2:CCGGTGACACCTGTCT"	3.01705898818318	-6.15846445476683	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTGACACCTGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.93618530579	41.3106761806671	0.0161122091951521	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2557.55233840165	2557.55233840165
"healthy-4"	"2019-08-01-count-2:TTCCGGTAGACACACG"	5.46398796614949	-9.40942480480345	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTAGACACACG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.25545111597	45.348866280571	0.0163995215206138	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2761.44835312433	2761.44835312433
"healthy-4"	"2019-08-01-count-3:ACTCTCGGTATGCAAA"	10.5032621818477	7.15268848026124	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCTCGGTATGCAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2058.22450422734	42.4856574106408	0.0206418966071877	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2048.96666180275	2048.96666180275
"healthy-4"	"2019-08-01-count-2:AGGCATTAGACTTCGT"	3.62582101401631	-5.68628790294798	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCATTAGACTTCGT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2775.69511694846	40.725632551567	0.0146722283376497	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2770.2718342861	2770.2718342861
"healthy-4"	"2019-08-01-count-2:CCGTAGGAGTCTAGCT"	-2.28951058808025	3.4348459013733	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTAGGAGTCTAGCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2917.5811400068	45.2341210527993	0.0155039804831937	4080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2914.246459203	2914.246459203
"healthy-4"	"2019-08-01-count-4:CATTGCCAGCCATTCA"	3.52075352248494	-6.34566357052001	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCAGCCATTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.96798368407	42.5321218048624	0.0160743146051387	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2643.20249123789	2643.20249123789
"healthy-4"	"2019-08-01-count-4:TTTCACATCCGAGAAG"	0.456141014664811	7.88035295093385	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCACATCCGAGAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.37671705556	42.3077230786302	0.0232795560114666	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1806.64397844932	1806.64397844932
"healthy-4"	"2019-08-01-count-4:CGCCAGAGTCTTGTCC"	11.3520819145137	-2.74217727100524	"2019-08-01-count-4"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCAGAGTCTTGTCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2652.6878348475	46.1421466687916	0.0173944879840881	3129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2642.36966937086	2642.36966937086
"healthy-4"	"2019-08-01-count-2:ACGGAAGCACCCATAA"	0.747798462479752	8.59340856159059	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGAAGCACCCATAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.95430661556	39.3710524336698	0.0221689557479096	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1768.28739224593	1768.28739224593
"healthy-4"	"2019-08-01-count-2:AGGCCACAGCAACAAT"	0.465246875851792	7.95299670780031	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCCACAGCAACAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1941.11729022337	43.4757428470409	0.0223972776225377	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1935.40984023755	1935.40984023755
"healthy-4"	"2019-08-01-count-2:AGGCCACCAGGGAATC"	5.02907671508138	-7.66774227535399	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCCACCAGGGAATC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.08833930474	46.5326694432575	0.0175854557658056	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2642.23006370254	2642.23006370254
"healthy-4"	"2019-08-01-count-4:TCACACCGTCCAGTTA"	1.95457925376241	-6.23620273983153	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACACCGTCCAGTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.4001098143	45.3207842611084	0.0174216892242476	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2597.07089510291	2597.07089510291
"healthy-4"	"2019-08-01-count-3:GGGTTATCACAATCTG"	2.79908766326253	-5.96807577526244	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTTATCACAATCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.14932008992	42.818373101626	0.0161569662422543	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2644.26376448693	2644.26376448693
"healthy-4"	"2019-08-01-count-2:ATGGTTGTCCGAAATC"	-0.0220465091174424	7.65012643421022	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGTTGTCCGAAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2083.22880479088	46.28286667614	0.0222168907081649	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2072.73723825372	2072.73723825372
"healthy-4"	"2019-08-01-count-4:TCTGCCAAGACTGGGT"	11.4820133644039	4.42962739551393	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGCCAAGACTGGGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2175.7554509113	32.487181456724	0.0149314489563232	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2168.04106940129	2168.04106940129
"healthy-4"	"2019-08-01-count-4:TCACATTGTTGTCCCT"	2.832855840295	-4.70794346248778	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACATTGTTGTCCCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3068.06994271829	41.1371921570379	0.0134081663472739	3255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3061.58765468171	3061.58765468171
"healthy-4"	"2019-08-01-count-4:CAACCAATCCATTCGC"	-1.70212374153789	8.50217816913453	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCAATCCATTCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2491.46811425055	45.1359805322254	0.0181162184151823	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2480.21063063997	2480.21063063997
"healthy-4"	"2019-08-01-count-4:TCACGCTAGGTAGACC"	2.61130299147908	-6.3387661210266	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGCTAGGTAGACC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.8915214255	49.9906284940664	0.0204386122835616	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2435.58713562372	2435.58713562372
"healthy-4"	"2019-08-01-count-4:CATTTCACACCGCTAG"	4.30210175093953	-6.53670360958251	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTTCACACCGCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2789.10885667292	44.0357333865428	0.0157884599165743	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2780.94328377532	2780.94328377532
"healthy-4"	"2019-08-01-count-3:AGTGCCGTCTCTATAC"	2.85126533088033	-4.76082518016966	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGTCTCTATAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2836.14449274415	43.6616012921558	0.0153947027042724	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2834.1584584813	2834.1584584813
"healthy-4"	"2019-08-01-count-2:TTCCTAAGTAGCACGA"	2.93943323668782	-5.90621521389159	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAGTAGCACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.42193556946	49.9260044692327	0.0198558578267913	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2508.7510601467	2508.7510601467
"healthy-4"	"2019-08-01-count-4:TCACGGGAGACTCATC"	3.96303667601888	-7.00268986141356	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGGGAGACTCATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.11015432492	45.4516182578095	0.0198990482887823	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2277.15839952418	2277.15839952418
"healthy-4"	"2019-08-01-count-2:AACCATGCATCGTCCT"	4.66885199126546	-6.9512624970642	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGCATCGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2661.75445129533	42.9726724514453	0.0161444916267663	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2658.05835544362	2658.05835544362
"healthy-4"	"2019-08-01-count-3:GGTAATCGTTCCGTTC"	0.173502621322316	7.64080951297609	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCGTTCCGTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.83890018437	45.6838539904392	0.0244974801769325	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1857.23777623381	1857.23777623381
"healthy-4"	"2019-08-01-count-4:CATTTCATCGACACTA"	-2.28220591965373	4.14839217746583	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTTCATCGACACTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3438.26580302608	46.4668461123274	0.0135146171862079	5954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3431.5346377433	3431.5346377433
"healthy-4"	"2019-08-01-count-4:ACTATCTGTCGAATTC"	11.5717960792476	3.56214783275453	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATCTGTCGAATTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2037.82605804135	42.5566369385714	0.0208833510449241	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2022.68938110262	2022.68938110262
"healthy-4"	"2019-08-01-count-2:AGGGCCTCAAATCCCA"	0.00447562065665123	7.74601886356202	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCCTCAAATCCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.208971124	42.3641529411708	0.0225316194060308	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1871.8034507905	1871.8034507905
"healthy-4"	"2019-08-01-count-2:CCTAAGACAAGCAATA"	10.7484203773433	6.22347209537355	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTAAGACAAGCAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.2606318501	45.9951415790569	0.0240401860642375	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1904.33330749325	1904.33330749325
"healthy-4"	"2019-08-01-count-4:CCAATGAAGCGATTCT"	10.758148809045	7.5519284971985	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGAAGCGATTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2238.65246018973	50.0227033291699	0.022345006301215	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2226.44843338741	2226.44843338741
"healthy-4"	"2019-08-01-count-4:CCAATGACAAGCACCC"	11.3423868614132	3.76856134021608	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATGACAAGCACCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1371.28962026841	45.5078891638796	0.0331861982262886	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1356.39902727265	1356.39902727265
"healthy-4"	"2019-08-01-count-2:TATCCTATCCCACAGG"	10.3478561836178	6.21825740421144	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTATCCCACAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1813.17092012679	46.124477728468	0.0254385712987514	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1808.0116821475	1808.0116821475
"healthy-4"	"2019-08-01-count-3:CAAGCTAAGCGAATGC"	10.4625021415645	7.38650415027467	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTAAGCGAATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2033.90260900098	40.9158376977261	0.0201169109654779	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2029.94175690931	2029.94175690931
"healthy-4"	"2019-08-01-count-3:TGAATCGGTGGACTGA"	4.56211151656453	-7.82212593471678	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAATCGGTGGACTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.16975113453	46.859475222872	0.0190860429105639	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2452.57538027537	2452.57538027537
"healthy-4"	"2019-08-01-count-2:AGGGCTCAGAGAATCT"	4.57270254668538	-6.61464073574217	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCTCAGAGAATCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.83044894679	43.9107302169707	0.0172142880900222	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2546.44685474593	2546.44685474593
"healthy-4"	"2019-08-01-count-3:CGTTCTGAGCTGAGCA"	0.269527097314042	7.65571353519288	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTCTGAGCTGAGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1892.62388820933	45.2803123589192	0.023924622657997	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1883.78301729815	1883.78301729815
"healthy-4"	"2019-08-01-count-4:TTTGACTAGAGTCAAT"	-2.75211725655254	-5.78581621563109	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGACTAGAGTCAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2497.64813941899	50.8686908413971	0.0203666361320335	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2496.4452682541	2496.4452682541
"healthy-4"	"2019-08-01-count-3:CTTTCAATCGTTCTGC"	3.31859697875325	-5.73682501232298	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAATCGTTCTGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2962.5533015027	42.117725230068	0.014216697876357	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2958.41152763868	2958.41152763868
"healthy-4"	"2019-08-01-count-4:TTTGACTCACGCACCA"	3.36543073233907	-6.57317974483641	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGACTCACGCACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.45822627684	47.6519725315389	0.02026486033179	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2347.33296267455	2347.33296267455
"healthy-4"	"2019-08-01-count-4:TTTGACTTCTGCATAG"	9.41462864455525	6.80881402576295	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGACTTCTGCATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2146.11519356566	45.0497392051816	0.0209912959659606	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2139.41328439472	2139.41328439472
"healthy-4"	"2019-08-01-count-3:TCAGCCTCAGACGGAT"	3.67448510703389	-6.49378111278685	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTCAGACGGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.00782570871	43.3442922278004	0.0176410883898174	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2447.2577497657	2447.2577497657
"healthy-4"	"2019-08-01-count-4:ACTGATGAGGGATGTC"	5.11982836303059	-7.62899877941283	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGATGAGGGATGTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.00734446575	44.8953877044109	0.0160684572978442	2258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2784.44624332683	2784.44624332683
"healthy-4"	"2019-08-01-count-2:AGGGTCCTCATATGGC"	3.4140063720638	-6.33280279552611	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTCCTCATATGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.55161378898	42.5893748858948	0.0179055920582067	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2378.55161378898	2378.55161378898
"healthy-4"	"2019-08-01-count-2:TATCGCCTCTCTCGCA"	3.17431344565694	-6.00295355236205	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCTCTCTCGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2727.74571788105	47.7151852446548	0.0174925341947638	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.3499862229	2721.3499862229
"healthy-4"	"2019-08-01-count-4:GATTTCTGTTCCTAGA"	-0.132696862251121	7.69904229724733	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTTCTGTTCCTAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2069.39392367016	39.234037639721	0.0189591924432336	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2059.63226992336	2059.63226992336
"healthy-4"	"2019-08-01-count-2:TATCTGTAGTCTAGCT"	0.335796942084473	7.82064387882081	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTGTAGTCTAGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.21017046982	41.1406861840748	0.023559985435777	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1735.88955333054	1735.88955333054
"healthy-4"	"2019-08-01-count-3:GGTGATTGTGGGTTGA"	4.25775541838948	-6.72587444698485	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGATTGTGGGTTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.63777295338	46.5267806120297	0.0196179961133316	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2364.94715526922	2364.94715526922
"healthy-4"	"2019-08-01-count-2:TTCGGTCTCGAGTACT"	11.3314529853756	3.65252897823182	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGGTCTCGAGTACT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1653.13915368873	35.3817175578901	0.0214027460900319	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1631.72604004064	1631.72604004064
"healthy-4"	"2019-08-01-count-3:CCCTAACGTAACCCTA"	-2.80501876297649	-5.66043331539305	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACGTAACCCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2573.94960385533	47.3137209078407	0.0183817588491139	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2569.18372211956	2569.18372211956
"healthy-4"	"2019-08-01-count-4:CCACAAAGTCCCGCAA"	14.3067957359249	1.96737454021303	"2019-08-01-count-4"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAAGTCCCGCAA"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1236.77633171957	30.3716097857211	0.0245570755251223	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1221.54138553977	1221.54138553977
"healthy-4"	"2019-08-01-count-1:ACTGTGACACAATGAA"	0.383208652108353	7.88238809192506	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTGTGACACAATGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2134.64828915281	38.7929531295516	0.0181729952080057	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2112.94566940557	2112.94566940557
"healthy-4"	"2019-08-01-count-2:TATCTTGAGCAGCAGT"	2.9209734397823	-6.27269508754881	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCTTGAGCAGCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2072.77198867868	49.7069255753926	0.023980894110345	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2069.8132221167	2069.8132221167
"healthy-4"	"2019-08-01-count-4:GCAACCGTCATTATCC"	-3.20157037201579	9.71557710254518	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACCGTCATTATCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1974.60126434016	41.5349300060738	0.0210345910114432	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.4063630168	1967.4063630168
"healthy-4"	"2019-08-01-count-4:TTTGGTTCAGGTCCGT"	-4.9035533470219	-5.12297298824462	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTCAGGTCCGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2164.06887980584	54.8722077816238	0.0253560357037004	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2162.8336113356	2162.8336113356
"healthy-4"	"2019-08-01-count-3:TGAGACTTCCTCTAGC"	0.143524837761563	7.71853110874025	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGACTTCCTCTAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.1165925351	45.4094490742712	0.0216017747234032	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2091.1001391217	2091.1001391217
"healthy-4"	"2019-08-01-count-4:ACTGTCCTCACGGGCT"	10.4585682350094	6.7197603949341	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTCCTCACGGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.48182413162	41.4081483462783	0.0217538974217255	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1894.73820484677	1894.73820484677
"healthy-4"	"2019-08-01-count-2:TATGTTCCAGCAAGAC"	0.0331836520576894	7.57060811603395	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATGTTCCAGCAAGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2023.38277786198	43.906288248974	0.021699447444822	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2014.18972315885	2014.18972315885
"healthy-4"	"2019-08-01-count-3:CTACAGACAGCGATTT"	0.246917714446229	8.39889237964479	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACAGACAGCGATTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1831.2586962447	41.0851493390117	0.0224354698892426	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1818.19589787977	1818.19589787977
"healthy-4"	"2019-08-01-count-4:ACTGTCCTCTACAGGT"	-0.0894707840984643	7.79303691470949	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTCCTCTACAGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.63184365618	44.0686088175095	0.0215007436354516	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2041.59667626941	2041.59667626941
"healthy-4"	"2019-08-01-count-4:CCACACTTCCAAGAGG"	11.2313038307125	6.09500167453615	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTTCCAAGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1862.81978640026	44.2622682789253	0.0237608965730702	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1854.85921322281	1854.85921322281
"healthy-4"	"2019-08-01-count-4:ACTGTGAGTACGCTAT"	4.66182484206502	-6.86779549038085	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGAGTACGCTAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2981.92398554993	43.847711338389	0.0147045033846839	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2973.91578772647	2973.91578772647
"healthy-4"	"2019-08-01-count-4:ACTGTGAGTGCCCACA"	11.496845861047	3.43777582729188	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGAGTGCCCACA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1777.79048007338	41.2100589739437	0.0231804925472673	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1754.58330606329	1754.58330606329
"healthy-4"	"2019-08-01-count-2:CCTCAGTCAGAGATTA"	5.10893024977986	-8.11143972789916	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAGTCAGAGATTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2686.61378978997	45.1448990886046	0.0168036430320466	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2679.36505265257	2679.36505265257
"healthy-4"	"2019-08-01-count-3:GGTGTTATCGCCGTGA"	3.46043481406514	-6.32157041942748	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTTATCGCCGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.11433757964	44.5079185972482	0.0201019061399973	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2208.31070419169	2208.31070419169
"healthy-4"	"2019-08-01-count-4:TCAGTCCCAGTAGGAC"	3.86655535277669	-6.32312014019164	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTCCCAGTAGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2670.16889372029	40.2417501265258	0.0150708632031354	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2666.89424984655	2666.89424984655
"healthy-4"	"2019-08-01-count-4:AACGGGATCCCTTCCC"	5.08258642730061	-8.88619425213011	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGGGATCCCTTCCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.13054524633	46.3487895953928	0.01692716575397	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2735.16662768734	2735.16662768734
"healthy-4"	"2019-08-01-count-3:TTCACGCCAACTCATG"	2.99517383155171	-6.57151892101439	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCACGCCAACTCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.72931767948	40.6442310475793	0.0167072558184767	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2421.37766745213	2421.37766745213
"healthy-4"	"2019-08-01-count-1:ATGCGATCACATAACC"	11.0787521797115	6.26419971072999	"2019-08-01-count-1"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATGCGATCACATAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2426.27347662714	32.87231480837	0.0135484788194887	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2405.66889881464	2405.66889881464
"healthy-4"	"2019-08-01-count-4:CAATGACTCCCGTTCA"	10.8973986106807	6.17333314502565	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATGACTCCCGTTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2222.35007441298	48.5377656551427	0.0218407379710254	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2215.16258315272	2215.16258315272
"healthy-4"	"2019-08-01-count-2:GAAGCCCTCACCTTGC"	3.42666234549825	-6.22031071102294	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGCCCTCACCTTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.37833994864	41.8578181213784	0.0152967948584785	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2729.41104681844	2729.41104681844
"healthy-4"	"2019-08-01-count-4:ACTTATCAGGGAGGCA"	-0.638186971575576	8.19232652271119	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCAGGGAGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.0633905219	42.3524156124473	0.0217855116345139	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1936.86587923621	1936.86587923621
"healthy-4"	"2019-08-01-count-4:CGTAGTAGTTCTCTCG"	0.104726211249274	7.6540431746277	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAGTAGTTCTCTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.89365764327	43.3048091344083	0.0226383777066629	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.39225905384	1910.39225905384
"healthy-4"	"2019-08-01-count-4:AGTTCGAGTCTAGTGT"	3.73870887336079	-6.33294060146483	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTTCGAGTCTAGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.64663010662	49.6201310534277	0.0198508582996434	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.86201972967	2495.86201972967
"healthy-4"	"2019-08-01-count-4:ACTTATCGTACCTTCC"	-2.71418199959453	-5.68266155635985	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTATCGTACCTTCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2784.37047376031	50.7916145630548	0.0182416869600188	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2775.18195815362	2775.18195815362
"healthy-4"	"2019-08-01-count-4:TCATACTAGCGACTAG"	11.005390782922	6.24748847568361	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTAGCGACTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2014.41626073819	42.6552443611638	0.0211749900914385	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2012.87220276565	2012.87220276565
"healthy-4"	"2019-08-01-count-4:GCAGCCAGTTCGGTTA"	4.85548700866048	-7.42029240047606	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCAGTTCGGTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.51225918879	41.4289735303955	0.0161421296087984	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2563.01789666882	2563.01789666882
"healthy-4"	"2019-08-01-count-3:ATCACAGAGAAGTCCG"	5.02253450927083	-8.16630651867064	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACAGAGAAGTCCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.26475617364	45.0844754936306	0.0172521652798944	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2610.952013249	2610.952013249
"healthy-4"	"2019-08-01-count-2:CCTCCAATCGCACGAC"	3.17340340194051	-6.02565243160399	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCAATCGCACGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2831.63279361033	43.1370639200093	0.0152339893849759	2276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2822.4550979462	2822.4550979462
"healthy-4"	"2019-08-01-count-2:AGGTTACAGGTACTGG"	3.93250360068623	-6.25382711803588	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTACAGGTACTGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.07972876827	43.363563347148	0.0162710191665408	2158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2663.33849209368	2663.33849209368
"healthy-4"	"2019-08-01-count-3:TGAGGTTTCTCCGCAT"	-0.107384498149711	7.60458562457887	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGTTTCTCCGCAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1940.81699022757	40.246832702697	0.0207370570771735	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1935.32069868148	1935.32069868148
"healthy-4"	"2019-08-01-count-4:ACTTCCGAGTAGTCTC"	11.489986081689	3.69109413707582	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGAGTAGTCTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1743.26063769972	40.845202525583	0.0234303475006923	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1732.86166721676	1732.86166721676
"healthy-4"	"2019-08-01-count-3:CTACTATTCAGCGCAC"	9.35323776778523	6.5138835676941	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACTATTCAGCGCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.37730567163	46.2869846131315	0.023001146197921	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2004.11665010058	2004.11665010058
"healthy-4"	"2019-08-01-count-4:ACTTCCGTCACATCAG"	-4.51219067993816	12.8445062407288	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGTCACATCAG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2001.20771405223	50.3368828944142	0.025153252478968	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1993.63123030325	1993.63123030325
"healthy-4"	"2019-08-01-count-4:TCATATCGTGAATTGA"	-4.66023431244548	-5.64171650325926	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATATCGTGAATTGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2489.79650497924	47.1992517296516	0.0189570720479605	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2483.25505031982	2483.25505031982
"healthy-4"	"2019-08-01-count-2:TATTTCGGTCCAGGTC"	-3.94861159744914	12.6755637892517	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGGTCCAGGTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1789.8852580849	40.5239212028924	0.0226405134183021	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1787.80245743427	1787.80245743427
"healthy-4"	"2019-08-01-count-2:TTCTTGAGTTGCCAAT"	10.2706648307735	6.91210458362428	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGAGTTGCCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.77389622089	43.6450251851968	0.0218687223376561	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1993.03499975923	1993.03499975923
"healthy-4"	"2019-08-01-count-2:AGTAACCGTTGCCGCA"	10.3735262351925	7.47152087772218	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTAACCGTTGCCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.62232571015	43.4829813639187	0.0214770828177383	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2020.37305149068	2020.37305149068
"healthy-4"	"2019-08-01-count-4:TCATCATTCCGCAGTG"	10.997967382043	6.6890020140442	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATCATTCCGCAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1779.15519935381	40.8823192405553	0.0229785008387147	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1769.87025284122	1769.87025284122
"healthy-4"	"2019-08-01-count-4:ACTTCGCGTGATAGTA"	-1.36099574986156	8.66004655444948	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCGTGATAGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.02526873219	44.8465338779546	0.0222892498294582	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2002.84112254836	2002.84112254836
"healthy-4"	"2019-08-01-count-1:CAGGCCACAAGGATGC"	10.9485479789669	6.0043005713257	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAGGCCACAAGGATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2350.22805420305	44.6296254184529	0.0189894871430197	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2335.01324917161	2335.01324917161
"healthy-4"	"2019-08-01-count-4:ACTTCGCTCGACCATA"	5.58911575850789	-9.82333948528441	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCTCGACCATA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2873.17473757577	44.9051013837488	0.0156290881986654	2280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2866.78937222699	2866.78937222699
"healthy-4"	"2019-08-01-count-2:AGTACCACAAAGCAAT"	5.01297201690022	-7.45794727718505	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTACCACAAAGCAAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.23271576038	49.0828481485732	0.0185552098520996	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2636.35922068152	2636.35922068152
"healthy-4"	"2019-08-01-count-2:GCATCGGGTTAACAGA"	5.10986055907552	-7.36069776928099	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATCGGGTTAACAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2790.31940131848	45.3535909185322	0.0162539065947439	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2785.23356966188	2785.23356966188
"healthy-4"	"2019-08-01-count-2:TCAAGCAAGCAGCACA"	10.0282751518184	6.83623359287111	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCAAGCAGCACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1845.97395111387	44.8440180933541	0.0242928769749405	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1837.39087580953	1837.39087580953
"healthy-4"	"2019-08-01-count-4:TCATGAGTCGACATCA"	0.428653617470902	7.98102185809938	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGAGTCGACATCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.93814762303	46.2871071724238	0.0243752579463228	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.49161512995	1888.49161512995
"healthy-4"	"2019-08-01-count-3:GTAATCGCACACCTAA"	11.5272261100704	4.26926276767579	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATCGCACACCTAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2440.35522641669	43.7903543357717	0.0179442541240488	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2424.61383698804	2424.61383698804
"healthy-4"	"2019-08-01-count-4:CCCAACTGTCCAGTTA"	10.6568142372066	6.70972535693971	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTGTCCAGTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2099.82344924749	50.4033313592596	0.0240036043874653	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2078.81530870353	2078.81530870353
"healthy-4"	"2019-08-01-count-2:CCTGCATGTACTGGGA"	-3.44845543327983	11.1481446989807	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGCATGTACTGGGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2029.38487451705	45.328811201263	0.0223362319146339	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2025.27012301393	2025.27012301393
"healthy-4"	"2019-08-01-count-3:TGATGCATCCAGTACA"	-1.98685298386272	3.98649284923402	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGCATCCAGTACA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3393.07630749877	42.5547198093062	0.0125416335952302	5019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3385.64161456803	3385.64161456803
"healthy-4"	"2019-08-01-count-2:TCAAGCAAGTAATTGG"	-2.35296354714091	8.69621942127077	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCAAGTAATTGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.58917424007	47.5822717302083	0.0237485170822284	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2000.49152759294	2000.49152759294
"healthy-4"	"2019-08-01-count-1:CATGGATAGCATGATA"	10.8072878318721	5.94865892017213	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CATGGATAGCATGATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2199.8817732835	42.7666560593985	0.019440433835481	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2194.29125429472	2194.29125429472
"healthy-4"	"2019-08-01-count-4:TCATGGACAATGTGGG"	6.77604546126668	-1.73451294815215	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGGACAATGTGGG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2935.88183424655	34.3228423707719	0.011690811929282	2487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2924.30837894096	2924.30837894096
"healthy-4"	"2019-08-01-count-2:TCAAGCAGTGCCCAGT"	10.4832426505977	7.64643619144288	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGCAGTGCCCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.66687914463	40.6920586951519	0.0205966193616454	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1970.87481485005	1970.87481485005
"healthy-4"	"2019-08-01-count-4:GCATTAGTCTCGCTCA"	3.32040085372273	-5.98749020015868	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATTAGTCTCGCTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.31647475778	42.794214914586	0.0160439210418299	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2663.86673363888	2663.86673363888
"healthy-4"	"2019-08-01-count-2:TCAAGTGAGACTACGG"	10.9906231361324	6.48771855914918	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGAGACTACGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1757.83393561303	45.1513054798348	0.0256857627817321	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1748.91889564952	1748.91889564952
"healthy-4"	"2019-08-01-count-2:ATTTACCCACGGGCTT"	11.4085241752559	4.68152663791505	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCCACGGGCTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2267.6544150991	36.1303069699864	0.0159328982094511	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2260.7330750454	2260.7330750454
"healthy-4"	"2019-08-01-count-4:TCATGTTGTGCTATTG"	2.79240455207173	-6.19399502193602	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTGTGCTATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.93158282594	45.2008445273352	0.0174457885445336	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2583.241537634	2583.241537634
"healthy-4"	"2019-08-01-count-3:CTCAAGAAGGACTAAT"	3.17684354361836	-6.2014165154663	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGAAGGACTAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.68506533896	46.2312251701932	0.0206695282615423	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2233.84707445505	2233.84707445505
"healthy-4"	"2019-08-01-count-1:CCGATCTGTCAACACT"	-0.481370787054855	8.39489839160768	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCGATCTGTCAACACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2975.52300047667	34.7429387338195	0.0116762460677514	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2949.32228133034	2949.32228133034
"healthy-4"	"2019-08-01-count-3:CTCAAGACACCGTACG"	11.2597652870113	6.3101801642212	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGACACCGTACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2438.08583789278	44.4549105773639	0.018233529716815	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2428.8778416424	2428.8778416424
"healthy-4"	"2019-08-01-count-2:GCCAACGCAGCACAAG"	9.62478508529012	6.31155107105104	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGCAGCACAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1689.90777453906	41.5422392333405	0.0245825481480324	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1685.91799222608	1685.91799222608
"healthy-4"	"2019-08-01-count-2:TCGGGTGCAATCCTTT"	10.6932655769283	7.58155200565187	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGCAATCCTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.78051916519	47.5317982217035	0.0235215045725695	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.84867136259	2007.84867136259
"healthy-4"	"2019-08-01-count-2:CATCGGGAGGATGCGT"	-0.160899530083495	7.57010839069215	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGAGGATGCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.66253399922	42.9398842503708	0.0226039538506729	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.30915843224	1895.30915843224
"healthy-4"	"2019-08-01-count-4:GCCAGGTAGCCTTCTC"	-2.72692547264751	4.04849383914796	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTAGCCTTCTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2525.81807019969	0	0	2026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2522.27393915456	2522.27393915456
"healthy-4"	"2019-08-01-count-1:CCTCCAAAGTGGAAAG"	11.2464863258297	5.69868562305299	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCTCCAAAGTGGAAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2098.39416126727	42.5235176249758	0.0202647902905405	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2070.96025990933	2070.96025990933
"healthy-4"	"2019-08-01-count-2:TCAATTCCAATGGCAG"	-2.43733606758769	9.27265546405641	"2019-08-01-count-2"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCCAATGGCAG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2020.9602688394	46.5868179515057	0.0230518227744575	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.72670817435	2016.72670817435
"healthy-4"	"2019-08-01-count-2:TCAATTCAGAGTTGTA"	-0.300888310105163	7.67512319171754	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCAGAGTTGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.97156708921	42.2095084668161	0.0221691905469712	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.0871528114	1888.0871528114
"healthy-4"	"2019-08-01-count-3:TGCAGGCGTTCCGCGA"	-2.92093716087993	3.95692203128663	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCGTTCCGCGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3277.79223334529	42.9206459745981	0.0130943766166636	4205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3271.51814876343	3271.51814876343
"healthy-4"	"2019-08-01-count-1:CGGGACTGTTTCGGCG"	3.97435369071309	-6.43641569530638	"2019-08-01-count-1"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGGGACTGTTTCGGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.75551858902	30.0041046178043	0.0113705511580883	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2630.25441178442	2630.25441178442
"healthy-4"	"2019-08-01-count-3:ATCCCTGTCCCGTGTT"	4.35994305190389	-6.82528068935546	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCCTGTCCCGTGTT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2614.63911296192	50.6579530715492	0.0193747400245087	1867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2610.34124929489	2610.34124929489
"healthy-4"	"2019-08-01-count-2:CCTTGTGTCCACTGAA"	10.3605619865352	6.53671262348024	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGTCCACTGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.00167552167	43.7630736668012	0.0233030003312668	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1871.14901381625	1871.14901381625
"healthy-4"	"2019-08-01-count-2:TTGCATTTCGCAGATT"	4.57956375655476	-6.97489311611327	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTTCGCAGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.62302814788	47.4642433348358	0.0183357108465483	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2582.21099283358	2582.21099283358
"healthy-4"	"2019-08-01-count-1:CGGTCAGCAATGTCAC"	10.8166405158931	5.82564303958742	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGGTCAGCAATGTCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.27626111836	50.6065391897298	0.0263675116578795	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1912.82965104721	1912.82965104721
"healthy-4"	"2019-08-01-count-4:GCCATGGGTACCTGTA"	9.38837017592732	7.14551255786744	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGGTACCTGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.01932044308	41.8671781885472	0.0217489651890406	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.68859553708	1919.68859553708
"healthy-4"	"2019-08-01-count-2:GTTCGCTAGGTTGAGC"	-0.14843156459983	7.5052485235962	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCGCTAGGTTGAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2107.5235222187	46.3395972443007	0.0219877010888669	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2103.71575950247	2103.71575950247
"healthy-4"	"2019-08-01-count-3:TGCATCCCAACCCTCT"	-0.350072692066985	8.36462972247926	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATCCCAACCCTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1985.7941862287	41.3351670745077	0.02081543362407	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1977.81129374769	1977.81129374769
"healthy-4"	"2019-08-01-count-1:CGTGAATCAGTAACGG"	-0.381833265454131	8.16333959186403	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CGTGAATCAGTAACGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2153.06291738182	46.2971732268635	0.0215029355868346	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2139.78251708272	2139.78251708272
"healthy-4"	"2019-08-01-count-3:TGCATCCGTAACTTCG"	-0.193895365030128	7.56293294513551	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATCCGTAACTTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.44248865609	41.1074252156835	0.0200480752047946	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2043.72395948372	2043.72395948372
"healthy-4"	"2019-08-01-count-2:CCTTTGGGTCAACGCC"	11.4110647636348	6.02437350833742	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGGTCAACGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2242.09446256735	50.3253173768816	0.0224456722127826	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2229.71709938231	2229.71709938231
"healthy-4"	"2019-08-01-count-4:GCCATTCAGGAGACCT"	3.79076804694478	-6.89383556759032	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATTCAGGAGACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.25615109953	41.542737479816	0.0182665164870419	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2266.23336270645	2266.23336270645
"healthy-4"	"2019-08-01-count-2:AGTCTCCTCGCAATGT"	11.4907137351925	3.9330262907776	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCTCGCAATGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2150.71319554814	47.4767443356394	0.0220748840123889	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2131.92327374154	2131.92327374154
"healthy-4"	"2019-08-01-count-2:CATGAGTTCTGCCCTA"	10.2993256050045	7.38299701297609	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGAGTTCTGCCCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2160.06075166803	46.0933049478807	0.0213388928585859	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2152.57148537837	2152.57148537837
"healthy-4"	"2019-08-01-count-2:CGAAGGAAGATCCGAG"	11.014852185815	5.61083076083986	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGGAAGATCCGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1798.8406050205	46.6071426921724	0.025909545605149	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1793.60902035913	1793.60902035913
"healthy-4"	"2019-08-01-count-4:AGACAGGAGCAGCGAT"	0.588123400777024	7.87171886051027	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAGGAGCAGCGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1751.11945542546	36.6285753999607	0.0209172339936462	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1745.24917280352	1745.24917280352
"healthy-4"	"2019-08-01-count-2:CGAAGTTCAACAGATA"	-1.04721544209178	8.31128308856813	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTCAACAGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.94149740573	41.111030964516	0.0205561167753377	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1989.89055098763	1989.89055098763
"healthy-4"	"2019-08-01-count-4:AGACCATAGTACTCGT"	-2.97870359841045	3.65341494167177	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATAGTACTCGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3253.69383047308	42.8358091478907	0.0131652857889405	5220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3244.89265826281	3244.89265826281
"healthy-4"	"2019-08-01-count-3:CCTACGTAGAGCATCG"	10.1657759147579	6.32770154559938	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTAGAGCATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.4968435292	43.8984385583764	0.0231227345507573	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1885.23977940332	1885.23977940332
"healthy-4"	"2019-08-01-count-3:GTAGTACCAAACTGCT"	10.2666984992916	6.72994277561036	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACCAAACTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.82388175756	42.1362089291045	0.0224987567381732	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.66011566543	1862.66011566543
"healthy-4"	"2019-08-01-count-3:TGCGACGCAGCATTGT"	-1.65986988964732	3.33810637080995	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGACGCAGCATTGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2644.37358037959	43.1130413832146	0.0163036878386244	3589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2639.46520845338	2639.46520845338
"healthy-4"	"2019-08-01-count-3:ATCGATGTCCATCGTC"	10.283611913293	7.84365222537843	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGTCCATCGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2226.49971484234	48.3783193836435	0.0217284193036913	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2216.7146553087	2216.7146553087
"healthy-4"	"2019-08-01-count-3:GTAGTACGTCTCTCTG"	-2.24856553497966	3.93621680820314	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACGTCTCTCTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3222.28220695719	50.1404608563839	0.0155605430052421	4305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3214.31746743004	3214.31746743004
"healthy-4"	"2019-08-01-count-2:AGTGCCGTCTTCCAGC"	0.171080310910386	7.8417176970276	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGTCTTCCAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.74735850288	32.9981307778573	0.0176578875832062	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1861.43281108194	1861.43281108194
"healthy-4"	"2019-08-01-count-4:AGACCCGTCCCGTTCA"	0.140046184032601	8.08351132953493	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCCGTCCCGTTCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1910.88843030858	42.2818708305868	0.0221268129315948	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1900.19909734795	1900.19909734795
"healthy-4"	"2019-08-01-count-3:ATCGCCTGTTTCACAG"	2.39425315436665	-6.11546471035155	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGCCTGTTTCACAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.68518823305	42.6192734626751	0.0170090295711606	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2502.6259335182	2502.6259335182
"healthy-4"	"2019-08-01-count-3:CTCATTATCCGACAGC"	0.216125224798363	7.89327142322389	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTATCCGACAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.27063786334	35.930798178136	0.0190284154493835	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1877.3352859196	1877.3352859196
"healthy-4"	"2019-08-01-count-3:ATCGCCTTCTACCACC"	2.78525723990743	-6.14142420208129	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGCCTTCTACCACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.38926121114	42.8970764972721	0.0175996001869461	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2432.36463733513	2432.36463733513
"healthy-4"	"2019-08-01-count-4:CCGATCTCAGACTGCC"	-2.56936154785808	3.93580434406129	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGATCTCAGACTGCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3581.53507090848	48.0899457289793	0.0134271882801307	5728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3570.95078829292	3570.95078829292
"healthy-4"	"2019-08-01-count-3:GTATTGGCATGTGACT"	10.9805962043697	6.48521707141725	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTGGCATGTGACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.5738663935	43.2233342524497	0.0225406358576123	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.55835206033	1910.55835206033
"healthy-4"	"2019-08-01-count-3:AGCATCATCATGGATC"	4.2430325942928	-6.90466644680174	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCATCATCATGGATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.06456499915	45.4969778917411	0.0208504269862238	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2180.50375104734	2180.50375104734
"healthy-4"	"2019-08-01-count-3:TGCGGCAAGCTCTATG"	-7.36961160126384	0.875691808107771	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAAGCTCTATG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2846.38225461258	42.8434397581349	0.0150518925167928	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2832.15205255609	2832.15205255609
"healthy-4"	"2019-08-01-count-4:AGAGAGCTCCCAATAG"	5.01534332808797	-7.90333750164183	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGAGCTCCCAATAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.34344224785	41.4680435506941	0.0162406838283327	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2547.22583184149	2547.22583184149
"healthy-4"	"2019-08-01-count-4:AGAGCAGCATGGTGGA"	4.30587067183797	-6.90352537548216	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAGCAGCATGGTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2603.71716348307	47.433900312778	0.0182177622738885	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2596.73318672097	2596.73318672097
"healthy-4"	"2019-08-01-count-2:AGTTAGCTCGAAACAA"	4.16960825499837	-7.70358374035033	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTAGCTCGAAACAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.88162582758	46.3246995803405	0.0205898386157541	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2242.86231415886	2242.86231415886
"healthy-4"	"2019-08-01-count-4:CCGCAAGGTGTTAACC"	-3.79294357720073	11.0110606917175	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGGTGTTAACC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2119.61035093954	46.3423139829126	0.0218636005256206	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2112.27822108038	2112.27822108038
"healthy-4"	"2019-08-01-count-1:GATGGAGGTCGAATTC"	11.2380081611568	5.70576808536378	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GATGGAGGTCGAATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.63402719319	30.4354591181854	0.0147699488198989	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2050.85140893347	2050.85140893347
"healthy-4"	"2019-08-01-count-3:ATCGTAGAGGAACGAA"	-2.01733408394511	8.91633603656618	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGAGGAACGAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.36970811962	40.4377431495033	0.0206170937493836	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1953.40780379661	1953.40780379661
"healthy-4"	"2019-08-01-count-4:TCCATGCGTCTTCCGT"	-2.91346702995952	3.4419591196808	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCGTCTTCCGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3287.39282419055	45.4429037319136	0.0138233871527365	5545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3278.07682126447	3278.07682126447
"healthy-4"	"2019-08-01-count-4:TCCATGCCAAACTCTG"	-1.07322774353679	8.43518159473268	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCCAAACTCTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2114.16483743048	41.2400060579051	0.0195065234875572	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2107.12393897866	2107.12393897866
"healthy-4"	"2019-08-01-count-2:ATACCGAAGCATCCTA"	-4.40366778793986	12.5301732786926	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCGAAGCATCCTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2229.89303658417	41.4907782080103	0.0186066226170056	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2226.77023623301	2226.77023623301
"healthy-4"	"2019-08-01-count-4:TCCATGCTCTCAACCC"	11.6543795066768	3.81932995403139	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCTCTCAACCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2442.47635825346	36.3040594112084	0.0148636277639012	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2436.73237421229	2436.73237421229
"healthy-4"	"2019-08-01-count-3:ATCGTAGGTGATTAGA"	2.90490331229512	-5.89345552837523	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGGTGATTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.90362826657	42.812961789694	0.0161564221932478	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2646.21526155127	2646.21526155127
"healthy-4"	"2019-08-01-count-4:TACATTCAGATCACTC"	10.7246576744014	7.51997420871583	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACATTCAGATCACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2290.05172501116	46.2521692748096	0.0201969976353195	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2283.89115203073	2283.89115203073
"healthy-4"	"2019-08-01-count-3:CTCCATGAGTAGGGTC"	2.65562142905537	-6.13733103191527	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGAGTAGGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.88881738343	47.3615836986204	0.0184150976428308	1832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.71482767806	2568.71482767806
"healthy-4"	"2019-08-01-count-1:GCTACCTAGAGACAAG"	0.157760855823201	7.73942372882692	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCTACCTAGAGACAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.51493402594	42.6731157749242	0.0197148631797857	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2157.29861818338	2157.29861818338
"healthy-4"	"2019-08-01-count-4:TCCCACACAGGCGATA"	4.26842989501302	-7.73501255428465	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACACAGGCGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.8584473478	40.2834976540137	0.014854572403442	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2707.28047865875	2707.28047865875
"healthy-4"	"2019-08-01-count-2:TCACTCGTCAGCAATC"	11.0147081809932	6.55443141544191	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTCGTCAGCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.54714015344	45.3006078222516	0.0228843288969316	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.12148202819	1973.12148202819
"healthy-4"	"2019-08-01-count-4:TCCCACAGTTTCGCTC"	11.4622026878292	3.63343570316163	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACAGTTTCGCTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2069.69575548878	49.0447045879712	0.0236965768799139	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2054.5311503884	2054.5311503884
"healthy-4"	"2019-08-01-count-2:CGAGGAAGTCGACTTA"	4.6647969680721	-6.98027899181517	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAAGTCGACTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.91135565904	48.1567966522396	0.0190575726150394	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2523.56753989033	2523.56753989033
"healthy-4"	"2019-08-01-count-3:TGCTCGTGTGATCGTT"	2.95119227942769	-5.99615719234618	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTCGTGTGATCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.17874037229	42.40950292731	0.0159904392120106	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2650.36760726653	2650.36760726653
"healthy-4"	"2019-08-01-count-3:ATCGTCCTCACTCTTA"	1.63941802558247	-6.20148613369139	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCTCACTCTTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2644.03674348066	48.3444306657075	0.018284326337336	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2640.04055564221	2640.04055564221
"healthy-4"	"2019-08-01-count-4:AGATCCATCGAAACAA"	11.3774200874263	6.03597304904786	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCATCGAAACAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2156.87596940193	43.8093257419537	0.0203114719452789	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2144.47513637563	2144.47513637563
"healthy-4"	"2019-08-01-count-3:AGCCACGTCTTCGACC"	-0.0269238379901231	7.54999063098756	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGTCTTCGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2183.94298843595	43.6637278310053	0.019993071276222	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2173.1675918248	2173.1675918248
"healthy-4"	"2019-08-01-count-3:CAGCACGTCGCAATTG"	10.2317367988521	7.33917710864869	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCACGTCGCAATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.92714217713	49.4250435690051	0.0257030245633988	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1911.99681333789	1911.99681333789
"healthy-4"	"2019-08-01-count-4:ATCGGATGTGATACTC"	2.00236692008321	-6.15327646648558	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATGTGATACTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2610.31574152501	46.8258416914105	0.0179387653939725	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2602.55130547072	2602.55130547072
"healthy-4"	"2019-08-01-count-1:GGTAATCTCCAACACA"	-1.32648537579234	8.4581088789734	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGTAATCTCCAACACA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2218.82831712357	43.7950334327073	0.0197379099116068	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2201.88718057813	2201.88718057813
"healthy-4"	"2019-08-01-count-4:GCGGATCTCGTGCACG"	0.0519360859702851	7.72144029224244	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCTCGTGCACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1854.73302705144	34.7285030276569	0.0187242597835585	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1842.97314534455	1842.97314534455
"healthy-4"	"2019-08-01-count-4:TCCCAGTTCGATGCTA"	2.31571378287618	-6.34736587917479	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTTCGATGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.75583331801	46.5634976560071	0.0219250711054008	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2122.31052074681	2122.31052074681
"healthy-4"	"2019-08-01-count-4:GCGTGCACATAGACTC"	-0.222861896187621	7.66789958560792	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCACATAGACTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.70955110404	44.4794399786136	0.0223659809718924	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1977.4898783269	1977.4898783269
"healthy-4"	"2019-08-01-count-2:ATAGACCAGTGTTGAA"	-5.25962338867839	-5.19522907650145	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGACCAGTGTTGAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2041.55183732683	48.9368548773072	0.023970419943578	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2041.55183732683	2041.55183732683
"healthy-4"	"2019-08-01-count-4:AGATGCTAGTATCCTG"	-0.138788218528587	7.60874459827272	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGCTAGTATCCTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.35279147238	44.3525241570699	0.0232534454849498	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1903.25381891179	1903.25381891179
"healthy-4"	"2019-08-01-count-4:TCCCATGAGCCTCTGG"	11.18150963363	5.45237014377443	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGAGCCTCTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.9611392971	45.0832121323539	0.0232392346522409	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.27996141283	1931.27996141283
"healthy-4"	"2019-08-01-count-3:ATCTCTATCTCGGTCT"	10.53986610946	6.1926960715088	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTATCTCGGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1909.10969970712	44.0743993446689	0.0230863629006916	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1902.1006209685	1902.1006209685
"healthy-4"	"2019-08-01-count-4:AGATGCTTCACTTTGT"	4.95965780791585	-7.23109629070433	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATGCTTCACTTTGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2884.51648100039	39.4812533603052	0.0136873037891649	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2877.76005906709	2877.76005906709
"healthy-4"	"2019-08-01-count-2:CGAGTTAGTACCTAGT"	3.53351559218709	-6.2560286751953	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTTAGTACCTAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.78041975234	44.6397435583267	0.0183191489871146	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2434.33300465131	2434.33300465131
"healthy-4"	"2019-08-01-count-4:AGCATCACAATTGCCA"	-2.00243196907695	9.14685914600221	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCACAATTGCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2708.32079951273	41.7058035673701	0.0153991371978067	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2701.4593171798	2701.4593171798
"healthy-4"	"2019-08-01-count-2:ATAGAGACAGTCCCGA"	0.174385321407956	8.2759742506775	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGACAGTCCCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.4277231475	45.0759568511687	0.0258103763778615	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1732.49797832612	1732.49797832612
"healthy-4"	"2019-08-01-count-3:TCCGTGTTCGGAGTAG"	11.1856857734615	4.31188390338746	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGTGTTCGGAGTAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1734.04923602673	39.2026855945252	0.022607596589559	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1729.78292474354	1729.78292474354
"healthy-4"	"2019-08-01-count-2:GCGTGCATCGAGTGAG"	2.51316370543782	-4.04159166729125	"2019-08-01-count-2"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTGCATCGAGTGAG"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2696.63478848476	39.8424371087525	0.0147748732156422	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2677.19946017009	2677.19946017009
"healthy-4"	"2019-08-01-count-2:ATAGAGATCTACAGGT"	5.17561831054036	-7.62814047252806	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGAGATCTACAGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.4069993734	45.5420707336905	0.0171506931873107	1948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2650.40087563707	2650.40087563707
"healthy-4"	"2019-08-01-count-2:TAACTTCTCTATGCCC"	10.8426166969234	7.32602975452272	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCTCTATGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2383.98348692439	39.9575970066257	0.0167608530955789	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2367.79339044813	2367.79339044813
"healthy-4"	"2019-08-01-count-3:GCTTGGGCATTGTACG"	1.66287841376607	-6.27543737804564	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTGGGCATTGTACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2491.94608766425	45.4913987727666	0.0182553703701538	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2484.51959973392	2484.51959973392
"healthy-4"	"2019-08-01-count-3:CTCCTCCAGCATCAAA"	-4.27208934250529	12.2156018980774	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCAGCATCAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1919.59230104234	44.8188537620315	0.0233481108137884	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1909.93838007512	1909.93838007512
"healthy-4"	"2019-08-01-count-2:CGATCGGCACGGCTAC"	-4.31498036804851	12.4513253935608	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATCGGCACGGCTAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1904.22799509571	45.6399743373659	0.0239677047364656	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1902.24817567615	1902.24817567615
"healthy-4"	"2019-08-01-count-2:ATAGGCTAGTCTCTGA"	4.38337482985799	-6.99580337917479	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGGCTAGTCTCTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.38799560865	46.7807028520319	0.0182852260612264	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2555.13495501189	2555.13495501189
"healthy-4"	"2019-08-01-count-3:TGGATCAAGATGCTGG"	4.31062140044515	-7.10600044643553	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCAAGATGCTGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.25536072375	42.7342334356255	0.016352873155033	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2604.22118700564	2604.22118700564
"healthy-4"	"2019-08-01-count-2:AGACCATCAGTTCCAA"	10.4641748863155	6.0615229376587	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATCAGTTCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.47338564851	46.0236352572141	0.0243837267360466	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1880.44514360982	1880.44514360982
"healthy-4"	"2019-08-01-count-2:ATCACAGAGATTCGCT"	0.138683964579743	7.98513314807741	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACAGAGATTCGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1673.20916615058	45.4048122860344	0.0271363635847714	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1669.41114900963	1669.41114900963
"healthy-4"	"2019-08-01-count-2:GCTACAATCACGGACC"	-0.23117102208789	7.7126049765381	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAATCACGGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2152.76336228451	46.3334584098289	0.0215227828666964	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.30902739294	2141.30902739294
"healthy-4"	"2019-08-01-count-4:TCCGATCTCGCACTCT"	11.0372330146724	6.30445811832277	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCTCGCACTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.4202326548	50.5403202013702	0.0256886248105582	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.73658356558	1950.73658356558
"healthy-4"	"2019-08-01-count-4:AGCCAGCAGAGTCAGC"	10.2107397514278	6.47828528964845	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAGCAGAGTCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.37839338523	46.454022197364	0.0238791704253112	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.30127955733	1932.30127955733
"healthy-4"	"2019-08-01-count-1:TACCCACGTTGATCGT"	0.374178995459718	7.98902938449708	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TACCCACGTTGATCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.80347233079	29.7892347106161	0.0150465615031707	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1961.67707188825	1961.67707188825
"healthy-4"	"2019-08-01-count-3:GTCGAATCATGCCGCA"	9.96902527388875	6.95197770679323	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGAATCATGCCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1812.04256058634	43.4514229159602	0.0239792507422674	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1812.04256058634	1812.04256058634
"healthy-4"	"2019-08-01-count-2:ATCACGAGTGAACGGT"	11.5714413124019	3.96323607051698	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACGAGTGAACGGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2601.30196392137	38.0792424300172	0.0146385321497294	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2589.83131425111	2589.83131425111
"healthy-4"	"2019-08-01-count-2:TCAGTTTGTACGTAGG"	0.272193108766717	7.99346587741701	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTTTGTACGTAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.89622050416	43.8566131377016	0.0231568196096969	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1886.04337398447	1886.04337398447
"healthy-4"	"2019-08-01-count-3:GTCGCGAAGCTCAGAG"	11.3470379310543	4.57797000491945	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGCGAAGCTCAGAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.62723241253	41.2316176526263	0.0221481599187788	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1847.17726995742	1847.17726995742
"healthy-4"	"2019-08-01-count-3:CTCGAGGTCTAGGCAT"	11.1341082054073	5.77977511966554	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGTCTAGGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1885.24335426074	46.7886458511985	0.0248183587256541	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.26901452459	1874.26901452459
"healthy-4"	"2019-08-01-count-2:ATCACTTAGCTCATAC"	-1.47790942612346	8.54838464343873	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTAGCTCATAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2108.8121471235	46.788050528863	0.0221869219563647	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2097.3594857167	2097.3594857167
"healthy-4"	"2019-08-01-count-2:TCATACTCAATTTCCT"	-6.99540648880656	3.34408018672792	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTCAATTTCCT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2879.97820643169	43.297578029908	0.0150339950258005	2999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2859.34636865137	2859.34636865137
"healthy-4"	"2019-08-01-count-3:TCCTGCAGTGATACAA"	3.02092256125752	-5.02257015621337	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCAGTGATACAA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2759.50950223399	44.7534282169742	0.0162178924119463	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2754.61182382806	2754.61182382806
"healthy-4"	"2019-08-01-count-2:TTTATGCAGCGTGCCT"	-1.71614609184917	8.90594098651735	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCAGCGTGCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.38535799485	49.5490230865282	0.0265481203408931	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1864.5861153438	1864.5861153438
"healthy-4"	"2019-08-01-count-4:GCTTCACCACTGGACC"	0.146343437104863	7.85996005618898	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTCACCACTGGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.80496887768	43.7288290220461	0.0221433659076207	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1968.58138186559	1968.58138186559
"healthy-4"	"2019-08-01-count-3:TGGGAGACATCTGTTT"	3.57602777060811	-6.32929518139037	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGAGACATCTGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.59293386184	44.0985121083467	0.0167956393923885	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2621.50447523062	2621.50447523062
"healthy-4"	"2019-08-01-count-4:GCTTCACGTCCTCATC"	0.124484037130517	8.32118890369264	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTCACGTCCTCATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.22403369642	44.7865875709027	0.0219625636177501	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2033.14259186157	2033.14259186157
"healthy-4"	"2019-08-01-count-4:AGCGCCAGTTCGGACC"	3.4431742626125	-6.0909519425598	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCCAGTTCGGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.21721637476	38.6220205175541	0.0141981384005156	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.22922010886	2716.22922010886
"healthy-4"	"2019-08-01-count-4:AGCGCCATCCGAAGGA"	-0.409264962107497	7.73009965503541	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCCATCCGAAGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1937.34464232201	41.1720155700553	0.0212517766176639	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1931.4510212451	1931.4510212451
"healthy-4"	"2019-08-01-count-4:CCTCAGTGTCGTACAT"	3.73287214812581	-6.10892155086669	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTGTCGTACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.28865314194	44.1931512968558	0.0166371795642701	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2653.25011227679	2653.25011227679
"healthy-4"	"2019-08-01-count-3:CTCTGGTCAGAGCGTA"	2.16566838797871	-4.4325218430725	"2019-08-01-count-3"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTCAGAGCGTA"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2810.52646426906	45.8232032541902	0.0163041351279742	2655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2805.63470906959	2805.63470906959
"healthy-4"	"2019-08-01-count-3:CTCTGGTCAATTGTGC"	3.52818622168843	-7.26183750545653	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTCAATTGTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2026.45481365936	42.0454965449114	0.020748302040343	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2026.45481365936	2026.45481365936
"healthy-4"	"2019-08-01-count-2:ATCCACCAGAGGCGTT"	9.8764120536739	7.246959186438	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCAGAGGCGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1853.19109321391	44.7431892349613	0.0241438615795228	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.85630465063	1846.85630465063
"healthy-4"	"2019-08-01-count-3:CTCTGGTTCGAGCCAC"	10.9079557853634	6.30309817874757	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTTCGAGCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.9264021055	43.3714867441227	0.0219277556020051	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.14103250224	1968.14103250224
"healthy-4"	"2019-08-01-count-3:AGGACGAGTTATGACC"	10.4887510734493	6.41936490619508	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACGAGTTATGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.87318032427	46.6786783806756	0.0257626631309381	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1800.28032134355	1800.28032134355
"healthy-4"	"2019-08-01-count-3:GTCTCACTCGTTATCT"	6.79368843612019	-1.66778066074523	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTCACTCGTTATCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2878.4445319727	37.9061244447185	0.0131689612301614	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2862.4559452229	2862.4559452229
"healthy-4"	"2019-08-01-count-4:ATGCATGAGTGCACCC"	10.9757276969845	6.16753718936769	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCATGAGTGCACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.52897787611	48.7049920687837	0.0256270715341645	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1895.55478654876	1895.55478654876
"healthy-4"	"2019-08-01-count-4:TCCTCGAGTAGTCACT"	10.5127703147823	7.86201713168947	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCGAGTAGTCACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2399.0138667982	51.5230872715116	0.0214767775979036	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2392.58057422482	2392.58057422482
"healthy-4"	"2019-08-01-count-4:CTCAGGGCAAGCGAAC"	11.3572689491207	4.83178756320802	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGGGCAAGCGAAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.5002306237	47.5685429416123	0.0243379571904336	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.26321200283	1951.26321200283
"healthy-4"	"2019-08-01-count-2:ATCCACCTCTGTGCGG"	11.0846649604732	6.1075081595215	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCACCTCTGTGCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.26008443984	46.6299576515186	0.0256594848754916	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1812.9662082423	1812.9662082423
"healthy-4"	"2019-08-01-count-3:CTGAGCGCACGCCAGT"	-4.42229638519939	12.561104751471	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGCGCACGCCAGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2154.28206770928	43.902904803447	0.0203793669647589	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2150.73572189377	2150.73572189377
"healthy-4"	"2019-08-01-count-4:GGAAGTGAGTGCGACA"	5.48055567321126	-9.97621824657591	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAAGTGAGTGCGACA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.93389477019	47.3887644750249	0.0185189482900967	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2550.08875557294	2550.08875557294
"healthy-4"	"2019-08-01-count-4:TCCTGCACAACACTAC"	-7.09063945236857	2.6079907187256	"2019-08-01-count-4"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTGCACAACACTAC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3052.88702113911	39.129434817158	0.0128171905957259	3142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3034.77498108437	3034.77498108437
"healthy-4"	"2019-08-01-count-2:TCATCCGTCCTGTAAG"	3.71700563010518	-6.24887182628783	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATCCGTCCTGTAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.88357924072	46.6325951621474	0.0198446406341607	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2347.56694102748	2347.56694102748
"healthy-4"	"2019-08-01-count-2:TTTCGATAGCCATATC"	10.536149640649	6.31106278980104	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCGATAGCCATATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.79438090228	42.5151549579332	0.0229713010784086	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1840.73378681804	1840.73378681804
"healthy-4"	"2019-08-01-count-4:GGAAGTGGTGGAACCA"	2.87652744826619	-6.51504757320555	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAAGTGGTGGAACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.25334704278	49.3296516373031	0.0223691539584119	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2200.44579389804	2200.44579389804
"healthy-4"	"2019-08-01-count-3:GTGACGCAGACTACCT"	3.12559999999349	-6.11991932308348	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCAGACTACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.44982091664	43.3570740423834	0.0175930033853386	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2460.72943102973	2460.72943102973
"healthy-4"	"2019-08-01-count-4:CCTCCTCAGCCTGTCG"	-2.64796910706218	9.26338765704957	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCAGCCTGTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.25968596294	42.5210278281296	0.0206486962853576	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2052.02981811183	2052.02981811183
"healthy-4"	"2019-08-01-count-2:TTTCGATGTATACAGA"	10.588021894067	6.72079989993898	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCGATGTATACAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2110.88476704107	46.3287238041527	0.0219475380785915	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2101.39661674565	2101.39661674565
"healthy-4"	"2019-08-01-count-3:GTGACGCCATCTCATT"	2.0846229988033	-6.09727528011473	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGACGCCATCTCATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.854761967	41.2574364404429	0.0179939161977485	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2291.63082843528	2291.63082843528
"healthy-4"	"2019-08-01-count-2:CGCGTGACATCGTGGC"	10.2312790351803	7.23654410922853	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCGTGACATCGTGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1593.11155807841	51.4556220666977	0.0322988191290023	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1588.66066779372	1588.66066779372
"healthy-4"	"2019-08-01-count-3:ATGGGAGTCGTTCTGC"	0.0433343519339382	7.66338775241701	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGAGTCGTTCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1929.79547661831	42.4508718582428	0.0219976014933105	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1920.81444826467	1920.81444826467
"healthy-4"	"2019-08-01-count-4:CAGTTCCGTGTTACAC"	10.6711479621822	7.22116420352785	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGTTCCGTGTTACAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.64111209891	43.0321189485846	0.0217703247621369	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.07746176114	1968.07746176114
"healthy-4"	"2019-08-01-count-4:AGCTTCCCACATTCGA"	-0.11838104847129	7.63684079730836	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCTTCCCACATTCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2215.2053998984	41.9952850386023	0.0189577386550829	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2205.12199620708	2205.12199620708
"healthy-4"	"2019-08-01-count-4:TCGAACAAGACCCTTA"	2.62093820151631	-6.2193117371765	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACAAGACCCTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.55980918251	45.9724567838089	0.0203728066930623	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2252.59543149209	2252.59543149209
"healthy-4"	"2019-08-01-count-3:ATGGGTTCAGTTCCAA"	-0.0355201614206612	7.87897918308107	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTCAGTTCCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.17892353037	40.8927431207874	0.0197151473563263	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2065.80785924214	2065.80785924214
"healthy-4"	"2019-08-01-count-2:ACAGCCGTCATATGGC"	-0.0465061691706956	7.69792077625123	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGCCGTCATATGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1942.49090261099	41.0926585742987	0.0211546208628644	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1939.82053339768	1939.82053339768
"healthy-4"	"2019-08-01-count-4:GGAGAACCATGCACTA"	-2.13509951058086	3.91562197292177	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGAACCATGCACTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3124.49528913967	41.9357720548971	0.0134216147486797	5575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3118.41137809408	3118.41137809408
"healthy-4"	"2019-08-01-count-2:ATCGATGCATGGCTGC"	-3.62403331223186	9.86396882617799	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGATGCATGGCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2188.98200655138	45.5928213047504	0.020828321643712	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2184.11678972405	2184.11678972405
"healthy-4"	"2019-08-01-count-3:CTGCATCGTGTCACAT"	-3.54589901390727	-5.20719101345214	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCATCGTGTCACAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2799.29914301266	42.2392585844937	0.0150892264193797	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2795.16531625948	2795.16531625948
"healthy-4"	"2019-08-01-count-2:TCATGTTCATCGCTGG"	3.98355712470357	-6.55261328136595	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTCATCGCTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.00707896042	49.325612350422	0.0211515705914627	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2324.72268460661	2324.72268460661
"healthy-4"	"2019-08-01-count-4:AGGAAATGTTCATCGA"	-1.61956594410594	9.86791226947633	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATGTTCATCGA"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1896.04113963233	45.7503824060822	0.0241294249632969	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1890.6876320458	1890.6876320458
"healthy-4"	"2019-08-01-count-2:ATCGCCTCAACCAATC"	0.358210851519746	7.71857116306154	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTCAACCAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.21827316278	41.62090981935	0.0213198034213255	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.07085772074	1945.07085772074
"healthy-4"	"2019-08-01-count-3:CTGCCATCACAAATAG"	0.155631651251954	8.0996055372986	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATCACAAATAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.5033964347	39.2701374688028	0.0206738969472291	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1891.472691985	1891.472691985
"healthy-4"	"2019-08-01-count-4:AGGAATACAGAGCGTA"	-3.02203784409221	9.42798707568971	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAATACAGAGCGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.54604259714	44.1152831766171	0.0223873394597134	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.00866974249	1967.00866974249
"healthy-4"	"2019-08-01-count-1:TGCAGATCATCGTCCT"	-0.0874400389498055	7.60575912082521	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGCAGATCATCGTCCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2158.82071582154	38.1735721108285	0.0176826041324611	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.6861038081	2141.6861038081
"healthy-4"	"2019-08-01-count-3:CTGCCATGTCGAATTC"	10.5596929984981	6.65274427020875	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATGTCGAATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.49305331746	42.6261246664851	0.0217314685842969	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.16849963231	1958.16849963231
"healthy-4"	"2019-08-01-count-2:TCATTACCAATCGCAT"	0.363999863236588	8.05416867816774	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACCAATCGCAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2096.23122340914	47.9491052858952	0.022873958154251	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2083.79011432625	2083.79011432625
"healthy-4"	"2019-08-01-count-3:GTGATGTGTGGTAACG"	10.6055876213009	6.52799604022828	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGATGTGTGGTAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1860.42064067467	48.7868448576927	0.02622355600183	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1855.4114280613	1855.4114280613
"healthy-4"	"2019-08-01-count-3:CTGCCTAAGATAGCTA"	11.4917122322017	4.31948659503785	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCTAAGATAGCTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2238.65465736074	36.6755218326729	0.0163828403421149	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2220.24200906002	2220.24200906002
"healthy-4"	"2019-08-01-count-2:GGAATCTGTCCTCAGG"	3.15070929107015	-6.99062063610228	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTGTCCTCAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1808.04295784529	47.4871589689338	0.0262643975149385	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1808.04295784529	1808.04295784529
"healthy-4"	"2019-08-01-count-3:GTGCACGCACAACGCC"	2.5952328639919	-6.38682558452757	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCACGCACAACGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.91416903943	40.9786756755656	0.0181408732731935	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2251.87360591285	2251.87360591285
"healthy-4"	"2019-08-01-count-4:TGGGAAGCACGTTCGG"	-0.9288326901501	8.20386121356813	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAAGCACGTTCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2072.79497578342	42.7436136873978	0.0206212453169627	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2065.07054641533	2065.07054641533
"healthy-4"	"2019-08-01-count-2:ATCGGCGAGGTAGACC"	11.3345123725826	4.05935905063478	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGGCGAGGTAGACC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1621.15534671901	43.3712579705346	0.026753301624247	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1608.92645821991	1608.92645821991
"healthy-4"	"2019-08-01-count-2:CTGCCTATCCGATAAC"	14.3136793571407	2.01411805236665	"2019-08-01-count-2"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTATCCGATAAC"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1348.8966577698	34.4966800704665	0.0255739977349352	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1327.51863181752	1327.51863181752
"healthy-4"	"2019-08-01-count-4:AGGACTTGTCTTAGTG"	0.0104051354223907	7.76632402026979	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGACTTGTCTTAGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.92019027453	44.4699816608799	0.0225630555109822	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1965.51274416786	1965.51274416786
"healthy-4"	"2019-08-01-count-4:TCGCACTCAATCCAGT"	10.220418592065	7.23814771259157	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCACTCAATCCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.29206523378	46.245576561039	0.0232355729939601	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1983.59367503345	1983.59367503345
"healthy-4"	"2019-08-01-count-2:TTACGCCTCCCTGTTG"	4.3582579093868	-6.53330566799315	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGCCTCCCTGTTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2872.78055569198	44.2893206789147	0.0154168826404655	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2867.17977120677	2867.17977120677
"healthy-4"	"2019-08-01-count-3:ATTACCTTCGGCACTG"	10.8429113822872	6.20960424030153	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTTCGGCACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1820.29070845603	41.099391741462	0.0225784769160979	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1815.41641678913	1815.41641678913
"healthy-4"	"2019-08-01-count-3:GTGCAGCTCATCCTAT"	10.1080728965694	7.36757180774537	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCTCATCCTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2075.49912962188	40.7807734967792	0.0196486584430459	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2066.71112095121	2066.71112095121
"healthy-4"	"2019-08-01-count-3:GGCAGTCGTGCTCTCT"	10.4313503700191	7.69099996173707	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCAGTCGTGCTCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.35026924692	48.8999130048429	0.0236992786603751	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2059.230652908	2059.230652908
"healthy-4"	"2019-08-01-count-4:GTGAGCCCAGAAACCG"	-3.8210953277653	12.7750215300354	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGCCCAGAAACCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1763.20818543197	47.4045483190614	0.026885394878908	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1761.14860258432	1761.14860258432
"healthy-4"	"2019-08-01-count-3:CGCCAGACATAGAAAC"	-0.322257469326812	7.48621318424074	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGACATAGAAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1978.1282916059	39.5550820543141	0.0199962167378953	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1972.4219442572	1972.4219442572
"healthy-4"	"2019-08-01-count-4:AGGAGGTGTACTCCGG"	5.27913488921468	-8.83121302044066	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTGTACTCCGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2916.85153575695	44.4954101466929	0.0152546023001976	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2911.11310314006	2911.11310314006
"healthy-4"	"2019-08-01-count-3:CTGCTCACACAAATCC"	10.8068710761959	7.5760812529358	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCTCACACAAATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2290.5193918705	51.344134937691	0.022415935494771	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2283.78641993797	2283.78641993797
"healthy-4"	"2019-08-01-count-3:ATTATCCAGCAGCCCT"	2.67539181289021	-6.23337461864623	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTATCCAGCAGCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.48451541316	44.9561396640803	0.0168470678410963	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2666.52128124211	2666.52128124211
"healthy-4"	"2019-08-01-count-3:TGTCCACGTAGACACG"	2.8165680366451	-6.19143965160521	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCACGTAGACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.26301495544	46.4907868604364	0.018616696191797	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2497.26301495544	2497.26301495544
"healthy-4"	"2019-08-01-count-3:ATTCACTAGACCAGCA"	1.87934197959248	-6.62617733394774	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTAGACCAGCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2132.5984472225	47.6659100434258	0.0223510947902574	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2130.93122634971	2130.93122634971
"healthy-4"	"2019-08-01-count-1:TTCGGTCGTCGAGATG"	10.258844991296	5.9011602171692	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCGGTCGTCGAGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1641.92815217159	44.077838633212	0.0268451689405017	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1639.8700259779	1639.8700259779
"healthy-4"	"2019-08-01-count-4:GGCACGTGTGTAAATG"	2.76106991347615	-4.92115929042967	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCACGTGTGTAAATG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2771.56164239496	37.8338774445979	0.0136507436334358	2356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2762.20732175674	2762.20732175674
"healthy-4"	"2019-08-01-count-2:GGAGATGTCAGAATAG"	0.994200189679307	8.83948991382448	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGATGTCAGAATAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.20510577216	44.2332195624865	0.0253310561378338	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1741.33491518246	1741.33491518246
"healthy-4"	"2019-08-01-count-4:AGGATCTGTCGTGATT"	2.22017015990559	-7.24253847515257	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTGTCGTGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1570.32751428027	38.9448589595373	0.0248004690775522	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1562.98806921809	1562.98806921809
"healthy-4"	"2019-08-01-count-2:ATCGTGACACACACGC"	4.29162420806233	-6.89006569301756	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTGACACACACGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.02183240321	43.2814464536338	0.0159532245324008	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2710.73836281722	2710.73836281722
"healthy-4"	"2019-08-01-count-3:CTGGTCTTCGCGTAGC"	-7.05425391617473	3.15395281398622	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGTCTTCGCGTAGC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2886.77961047404	47.8220145643163	0.0165658695907386	2721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2870.98844174295	2870.98844174295
"healthy-4"	"2019-08-01-count-4:CCTTTGGGTTAGAAAC"	-1.57789085331615	8.90429780567018	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGGTTAGAAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.07779423002	41.5069629350422	0.0222667546727508	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1850.14876991191	1850.14876991191
"healthy-4"	"2019-08-01-count-4:TCGGGACTCGAACTCA"	10.1149279075557	7.36095426166383	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACTCGAACTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.91246847489	46.0935818244149	0.0238097447973602	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1929.54902349553	1929.54902349553
"healthy-4"	"2019-08-01-count-4:TCGGGACTCGATACAC"	-1.60966346684154	8.72713944995729	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGACTCGATACAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1852.20702745138	45.185816036367	0.0243956616980027	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1848.41284575158	1848.41284575158
"healthy-4"	"2019-08-01-count-4:AGGCATTCACACGCCA"	3.44681467589681	-6.48558952724608	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTCACACGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.36807433195	49.3459730885996	0.0232833426558782	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2117.73492611181	2117.73492611181
"healthy-4"	"2019-08-01-count-3:GTGGAAGGTGTTAGCT"	3.69815339621846	-6.27118351375731	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGGTGTTAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.35657256311	39.5131517468801	0.0157150151963533	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2511.36343823379	2511.36343823379
"healthy-4"	"2019-08-01-count-3:TGTCCTGCAAACCGGA"	0.0751597947323739	7.71423814380494	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGCAAACCGGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.67680023095	44.707835730882	0.0228371893284978	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.43298149001	1952.43298149001
"healthy-4"	"2019-08-01-count-4:AGGCATTGTCCCGCAA"	-5.60214791718181	-5.55948831951293	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGCATTGTCCCGCAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2879.83192128023	53.1286349007248	0.0184485193417491	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2872.46175158938	2872.46175158938
"healthy-4"	"2019-08-01-count-2:ATCTTCAAGCGGTATG"	10.3614355522091	7.05613277042238	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCTTCAAGCGGTATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.53218364929	46.7910520041685	0.0257726370402956	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1804.30873951219	1804.30873951219
"healthy-4"	"2019-08-01-count-3:CTGTAGAAGATTTGCC"	0.523318697779816	7.7815747031006	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGAAGATTTGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.65006020631	46.7964786356184	0.0239779044357325	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1938.42117773144	1938.42117773144
"healthy-4"	"2019-08-01-count-3:AAAGGTAGTCAGACGA"	0.478162010281724	8.26499841296998	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGTAGTCAGACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1851.59915183862	39.7523878483077	0.0214692190849375	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1843.92212857238	1843.92212857238
"healthy-4"	"2019-08-01-count-3:ATTCATCTCAAGAATG"	0.179665465920609	7.67614123905031	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCATCTCAAGAATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2011.38151875345	43.5620908823688	0.0216577961347514	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2006.30764767136	2006.30764767136
"healthy-4"	"2019-08-01-count-4:TCGGGTGGTTGCAACT"	11.5732075172359	3.47497890079347	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGTGGTTGCAACT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2087.21831314621	48.7845996901498	0.0233730220662033	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2066.91658672902	2066.91658672902
"healthy-4"	"2019-08-01-count-2:CGTAGTAAGTCTCTGA"	-3.38388190689738	10.0471572645935	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTAAGTCTCTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.70431359183	46.5626971249327	0.0234725996237933	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1969.39888010987	1969.39888010987
"healthy-4"	"2019-08-01-count-3:AAAGTCCAGGTTGAGC"	10.1039139228756	6.97540853107301	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTCCAGGTTGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.35719619358	42.7814632186188	0.0219802733549037	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1933.0281408478	1933.0281408478
"healthy-4"	"2019-08-01-count-3:AAAGTCCCAGCTGAGA"	-4.10069308701213	11.3961276778015	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTCCCAGCTGAGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2154.3075568739	45.5290855808781	0.0211339766393175	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.78211510043	2141.78211510043
"healthy-4"	"2019-08-01-count-3:AAAGTCCGTCCTTGTC"	0.126617160707158	7.75047204578248	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGTCCGTCCTTGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.28458452951	41.2470128080182	0.0214796354354551	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1905.46912357304	1905.46912357304
"healthy-4"	"2019-08-01-count-2:GGAGGTATCAAGGCTT"	0.0528125685755208	7.94175527179567	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTATCAAGGCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.02792149109	43.7409985951166	0.0227933101469049	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1911.80838775875	1911.80838775875
"healthy-4"	"2019-08-01-count-3:CTGTATTGTATCTTCT"	2.49083485183064	-5.81121160900267	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTATTGTATCTTCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2709.99205014742	44.2803992464645	0.0163396786511074	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2706.45894774158	2706.45894774158
"healthy-4"	"2019-08-01-count-3:ATTCCCGAGGCGTTGA"	14.3394133048946	1.93746206844179	"2019-08-01-count-3"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCCGAGGCGTTGA"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1604.70852181424	32.0282647882637	0.0199589298323495	3008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1587.43573067326	1587.43573067326
"healthy-4"	"2019-08-01-count-2:ATGAAAGGTCATAAAG"	0.375818003981751	7.78081891620485	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGGTCATAAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.40086552716	39.3447239936481	0.0217086212779998	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1806.37763832322	1806.37763832322
"healthy-4"	"2019-08-01-count-3:TGTGCGGTCCACGGAC"	5.66671957549397	-9.64857962047728	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTGCGGTCCACGGAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2818.44832009266	44.5771445457957	0.0158162007896352	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2811.59931175727	2811.59931175727
"healthy-4"	"2019-08-01-count-4:GTGCGTGTCTCCAAGA"	11.3740955787594	4.31424090946046	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCGTGTCTCCAAGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.27706643065	41.6333919119687	0.0209289055881347	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1982.19842985865	1982.19842985865
"healthy-4"	"2019-08-01-count-2:GGATCTACACTATGTG"	-4.31021295014079	12.3315429457459	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTACACTATGTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2284.25212884081	47.6286608130997	0.0208508772791512	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2275.00224810239	2275.00224810239
"healthy-4"	"2019-08-01-count-3:AAATGGAGTAGGAGTC"	10.6612526374752	5.53827998721925	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAATGGAGTAGGAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.59868941045	45.5916797679889	0.023445289774319	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1938.53406710893	1938.53406710893
"healthy-4"	"2019-08-01-count-4:AGGGAGTTCGAGCACC"	-1.92567453804668	4.172740436438	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGAGTTCGAGCACC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3078.34995620867	41.6680150477298	0.0135358278429944	5912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3074.64649011641	3074.64649011641
"healthy-4"	"2019-08-01-count-3:CTGTGAACAGCTCGGT"	6.82904686507527	-1.71157672321471	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAACAGCTCGGT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2876.23301432698	38.3640034048859	0.0133382807351798	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2864.4858060981	2864.4858060981
"healthy-4"	"2019-08-01-count-4:AGGGAGTTCGTACACA"	2.00934495505635	-6.42409136211547	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGAGTTCGTACACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.66081157162	42.3242839215995	0.0181988206152031	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2325.66081157162	2325.66081157162
"healthy-4"	"2019-08-01-count-3:CTGTGAAGTGCCTTTC"	4.29359449920003	-6.41402199184569	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAAGTGCCTTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.77337315645	43.2771878385394	0.0165700394541648	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2608.56544243982	2608.56544243982
"healthy-4"	"2019-08-01-count-3:TGTTACTCAGTAGATA"	-1.6287581724232	9.88237760150758	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTCAGTAGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1716.88308183325	43.3003648034566	0.0252203340236898	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1716.88308183325	1716.88308183325
"healthy-4"	"2019-08-01-count-4:TCGTCCACACACTTAG"	11.5701958137447	3.6947667368683	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCACACACTTAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2115.42572073225	39.8418879820131	0.0188339810713003	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2099.87516692075	2099.87516692075
"healthy-4"	"2019-08-01-count-4:AGGGCCTGTATCGCTA"	2.97909059104268	-6.96128466045531	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTGTATCGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.28717781385	44.7471671199705	0.0236972255310107	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1884.62954817256	1884.62954817256
"healthy-4"	"2019-08-01-count-3:AACAACCTCACCGCTT"	11.1515480476314	6.16360137546388	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAACCTCACCGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2082.7375083753	49.865849204312	0.023942455063966	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2079.67705565788	2079.67705565788
"healthy-4"	"2019-08-01-count-3:TGTTCATGTCATTGCA"	4.62707008895223	-7.1559629670349	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCATGTCATTGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.18694802398	40.7670884705187	0.0163974348360731	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2478.2449822737	2478.2449822737
"healthy-4"	"2019-08-01-count-4:AGGGCCTTCTTGGATG"	10.7893825965816	6.83982560718385	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCCTTCTTGGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.23561484054	46.6272757506825	0.0233810264964157	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1985.81164811385	1985.81164811385
"healthy-4"	"2019-08-01-count-2:GGATGTTTCTGTCAGA"	4.51620497283284	-6.78871872341307	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTTCTGTCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.93532683947	44.000591325673	0.0175866221854968	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2497.01059353753	2497.01059353753
"healthy-4"	"2019-08-01-count-4:AGGGCTCGTTCATCGA"	-4.10511479798015	3.7061569460663	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCTCGTTCATCGA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2786.23950449047	42.5829785931611	0.0152833159261908	3307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2774.89840025107	2774.89840025107
"healthy-4"	"2019-08-01-count-4:AGGGTCCAGTTGGACG"	11.6115843254024	3.67994520747987	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTCCAGTTGGACG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2239.40167291311	42.6986755731637	0.0190670017306987	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2215.45874172767	2215.45874172767
"healthy-4"	"2019-08-01-count-4:AGGGTCCAGGATTCCT"	10.1751743751461	6.61238143527833	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTCCAGGATTCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.1168999935	45.430214208382	0.0233440314960184	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1938.66564610818	1938.66564610818
"healthy-4"	"2019-08-01-count-4:TCTAACTAGAAGAGCA"	-4.11105094376262	3.66773793781129	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTAACTAGAAGAGCA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2861.72217054696	48.1737692466699	0.0168338386383128	3567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2850.95467961688	2850.95467961688
"healthy-4"	"2019-08-01-count-2:ATGATCGAGCATGGGT"	10.217338224023	7.5321531065735	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGATCGAGCATGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.64989090781	42.9204078524935	0.0221851033896131	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1929.7056060568	1929.7056060568
"healthy-4"	"2019-08-01-count-3:CTTACCGCAATGCAAA"	0.12323242154662	7.65918586337892	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGCAATGCAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.27932130626	45.110925103805	0.0207379919727807	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2166.07029021842	2166.07029021842
"healthy-4"	"2019-08-01-count-4:AGGGTGACATAATGCC"	10.8138014274532	7.5218148001465	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTGACATAATGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2367.46310049466	45.2902465662153	0.0191302861517683	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2359.55134917837	2359.55134917837
"healthy-4"	"2019-08-01-count-2:TCCGATCAGTTAGTGA"	4.85511269149129	-7.2168760529724	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCAGTTAGTGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.21222111136	44.1507252027424	0.0166404801136672	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.02585337638	2649.02585337638
"healthy-4"	"2019-08-01-count-4:TCTAACTGTGTCCTAA"	11.5722080665523	3.79761788928834	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTAACTGTGTCCTAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2242.86430220066	39.4363676342945	0.0175830377235039	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2233.83361700992	2233.83361700992
"healthy-4"	"2019-08-01-count-2:ATGCATGGTAATACCC"	-3.44896922531779	13.4729261168274	"2019-08-01-count-2"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCATGGTAATACCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2072.71475560315	47.3832665376728	0.0228604859446203	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2069.06121557014	2069.06121557014
"healthy-4"	"2019-08-01-count-2:TCCGATCTCCATACAG"	0.0315738945150792	8.00295827472535	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCTCCATACAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.26093389086	46.1759247883913	0.0260548116281137	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1766.54008645491	1766.54008645491
"healthy-4"	"2019-08-01-count-4:TCTACATAGCTAAATG"	10.9077803092891	6.35821483218995	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATAGCTAAATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.37269516044	47.0124395536498	0.0237752041730481	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1960.90173005664	1960.90173005664
"healthy-4"	"2019-08-01-count-3:AACAGGGGTGCCTGAC"	11.168697019189	6.08436677539674	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGGTGCCTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.76291411921	51.6998147459762	0.0270997063436707	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1900.36101948992	1900.36101948992
"healthy-4"	"2019-08-01-count-4:TCTACATGTAGGTCAG"	-0.271450619131881	7.97573897922365	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATGTAGGTCAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.04768191528	44.4310803070106	0.0250309221322266	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1770.73177971221	1770.73177971221
"healthy-4"	"2019-08-01-count-3:GTTACCCTCAAGCTTG"	9.72722496566121	6.82630727374879	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACCCTCAAGCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.88734934703	46.9930587047873	0.0226812807750371	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2063.42658748885	2063.42658748885
"healthy-4"	"2019-08-01-count-4:AGGTCTAAGCCTATTG"	-2.6361235183781	3.52205560291139	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTCTAAGCCTATTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3174.15962534982	45.0403211466177	0.014189683715624	5247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3165.95293660833	3165.95293660833
"healthy-4"	"2019-08-01-count-3:CTTAGGAGTGGTCTTA"	5.06351723250691	-7.87580301677855	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGAGTGGTCTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.12553197437	45.5760524647105	0.0167305257888311	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.46635352483	2716.46635352483
"healthy-4"	"2019-08-01-count-3:ATTTCACGTAGGAAAG"	11.4107233482296	4.5990419157776	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACGTAGGAAAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2180.44342765976	41.7325636013482	0.0191394846901115	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2174.02544234895	2174.02544234895
"healthy-4"	"2019-08-01-count-4:CGATGCGAGGTCCCGT"	0.457736332982224	7.97067496860353	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGCGAGGTCCCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.22815569805	40.9861112292438	0.0213000267706691	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1915.70548331194	1915.70548331194
"healthy-4"	"2019-08-01-count-3:CTTCAATCATCGATGT"	-1.71517751637157	3.78572294795839	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCAATCATCGATGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3200.5099042265	43.3288525412202	0.0135381091881645	5165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3192.55737031688	3192.55737031688
"healthy-4"	"2019-08-01-count-3:AACCATGAGAGCATAT"	0.021995565935415	7.72096440875856	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGAGAGCATAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.47829098824	39.7434841819183	0.0209343895953796	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1887.60711466871	1887.60711466871
"healthy-4"	"2019-08-01-count-3:AACCACAGTTTACGTG"	4.95303740081136	-7.66167356884154	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCACAGTTTACGTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.20517334588	44.2922512419115	0.0175400603916967	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2518.74355125084	2518.74355125084
"healthy-4"	"2019-08-01-count-4:AGGTGTTTCCATACTT"	11.4742428260738	4.44792935932008	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTGTTTCCATACTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2327.19447795306	38.5847138981515	0.0165799267159184	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2320.85933583915	2320.85933583915
"healthy-4"	"2019-08-01-count-2:GGCTTTCAGGACACTG"	11.3725973564083	4.54764506900636	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCAGGACACTG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2057.83233013196	45.41515623894	0.0220694152647645	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2044.66975173815	2044.66975173815
"healthy-4"	"2019-08-01-count-4:AGGTTACCATCGTGGC"	2.91265716132466	-6.09189274227294	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTACCATCGTGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2594.42471619062	43.3766942020187	0.01671919556244	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2592.17883562687	2592.17883562687
"healthy-4"	"2019-08-01-count-2:ATGGAGGGTCGTCTCT"	2.21461715277974	-6.04569485103758	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGGTCGTCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.78785505559	48.9975662817514	0.0205977032283976	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2372.21482217614	2372.21482217614
"healthy-4"	"2019-08-01-count-4:CGATGGCCATCGCTCT"	3.16223396834676	-6.06028654491576	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGGCCATCGCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.4426607841	40.2047726269516	0.0148278159108573	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2702.91857841272	2702.91857841272
"healthy-4"	"2019-08-01-count-2:CGTTGGGTCTTTCTAG"	4.30482019957845	-6.59444239055785	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGTCTTTCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.69505885931	50.8593617980745	0.0203462264798344	1863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2493.90358586918	2493.90358586918
"healthy-4"	"2019-08-01-count-4:TCTATACTCGCGAAGA"	3.17294349250142	-5.98757460033568	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACTCGCGAAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.03615740203	43.5513195535823	0.0160941380751521	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2700.81849886108	2700.81849886108
"healthy-4"	"2019-08-01-count-3:AACCATGGTTCTCGTC"	2.6137932735378	-6.08031036770018	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCATGGTTCTCGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.37221833126	41.9513773590218	0.0163274814990675	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2559.26103880081	2559.26103880081
"healthy-4"	"2019-08-01-count-4:AGGTTGTTCTTACTGT"	2.9452723461086	-6.22533514415892	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTGTTCTTACTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.1351415873	46.8656719739391	0.0193809151390834	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2409.73136279769	2409.73136279769
"healthy-4"	"2019-08-01-count-3:CAACAACTCTTCGGTC"	10.5960422950679	7.50757739627687	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACAACTCTTCGGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2269.13405751075	46.4909780114901	0.0204884228226211	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2259.38961863306	2259.38961863306
"healthy-4"	"2019-08-01-count-2:GGGACCTAGGAAAGAC"	3.20124830779378	-5.23501064693602	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTAGGAAAGAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2925.9500968161	42.1080808021316	0.0143912505028544	3121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2918.81573910524	2918.81573910524
"healthy-4"	"2019-08-01-count-2:ATGGATCCAATAGGGC"	4.19755901870076	-6.53996565258177	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCCAATAGGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.96486394961	48.763370274795	0.017934534911187	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2705.7048206658	2705.7048206658
"healthy-4"	"2019-08-01-count-2:AGGATCTTCATGAGAA"	3.64454998549764	-6.67498400127562	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATCTTCATGAGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.95840366637	46.2091512379687	0.0189540359542133	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2434.70898987686	2434.70898987686
"healthy-4"	"2019-08-01-count-2:AACAGGGGTACCATAC"	10.8394342857296	7.6537465819153	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGGTACCATAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2766.73148952188	44.4166386838799	0.0160538306127985	2528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2754.19067861192	2754.19067861192
"healthy-4"	"2019-08-01-count-3:CTTCGGTGTGGCTGCT"	4.60642017897908	-6.60821773922118	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTGTGGCTGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2791.99220984813	36.9749336589094	0.0132432080320599	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2781.642758408	2781.642758408
"healthy-4"	"2019-08-01-count-2:TCCTCGAAGGACAGCT"	10.6654097038204	7.59379384601442	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCGAAGGACAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2183.05253938563	42.7468032081254	0.0195812067904493	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2179.27154557366	2179.27154557366
"healthy-4"	"2019-08-01-count-2:TCCTCGAGTGTAAATG"	11.3381144004757	4.65331790531007	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCGAGTGTAAATG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.76427499696	41.8481251864594	0.0204960610286521	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2036.41190378512	2036.41190378512
"healthy-4"	"2019-08-01-count-4:AGTACTGTCACTTGTT"	4.69854940947835	-7.08316185390624	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGTCACTTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2747.42717105976	44.9422784023257	0.0163579507678051	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2738.76796923816	2738.76796923816
"healthy-4"	"2019-08-01-count-2:CTAACTTGTATAATGG"	11.3726946311886	3.84009382808534	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTGTATAATGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1730.65241850627	46.6739424312283	0.0269689869162248	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1722.34365512867	1722.34365512867
"healthy-4"	"2019-08-01-count-3:CTTCTAACACACTTAG"	11.5013042884762	4.13932750308839	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAACACACTTAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2287.19328063487	38.9563487050171	0.0170323815808884	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2273.86049021465	2273.86049021465
"healthy-4"	"2019-08-01-count-3:GGGTGTCGTCCCACGA"	4.60025419768636	-6.87806560909423	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCGTCCCACGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.38543094347	41.5572985342547	0.015877408822924	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.99160624966	2612.99160624966
"healthy-4"	"2019-08-01-count-2:CTAACTTTCACCGGGT"	9.75264324721639	6.61415097797243	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAACTTTCACCGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.15133324645	49.0553834495854	0.0251031650491926	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1947.77932252625	1947.77932252625
"healthy-4"	"2019-08-01-count-4:AGTAGCTCACTCTAGA"	2.92775454100911	-5.94282390987548	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGCTCACTCTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.16959994092	43.281580888394	0.0164871560638855	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2619.634580953	2619.634580953
"healthy-4"	"2019-08-01-count-4:GGGTATTAGACAAGCC"	6.78333010253255	-1.72178831016692	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTATTAGACAAGCC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2793.22528988988	29.753370001124	0.0106519764477347	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2783.4240130466	2783.4240130466
"healthy-4"	"2019-08-01-count-2:CTAAGTGTCATCTCTA"	2.79289450225179	-6.72097256099852	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAAGTGTCATCTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.67328055284	46.3172833200459	0.0194555396149488	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2375.62666455505	2375.62666455505
"healthy-4"	"2019-08-01-count-2:CTTGATTTCGAACGCC"	-0.193772937089759	7.58057353580324	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGATTTCGAACGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.47365239872	43.3060031760696	0.0216912470264952	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1983.59770391672	1983.59770391672
"healthy-4"	"2019-08-01-count-4:TGTGATGTCCCATTCG"	-2.95545897904094	9.27088735187379	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGATGTCCCATTCG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2265.98215990029	45.6192620923886	0.020132224736666	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2262.88873336974	2262.88873336974
"healthy-4"	"2019-08-01-count-2:CTACAGAGTGGTCCGT"	10.2290016609127	6.38718173587648	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGAGTGGTCCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1969.69217872914	42.7945560588344	0.0217265197684066	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.93974495776	1958.93974495776
"healthy-4"	"2019-08-01-count-4:GGGTATTTCGGCTTCT"	11.1050211387569	6.21085784519044	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTATTTCGGCTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2257.38177087075	48.4408602016753	0.0214588692204199	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2249.79679355924	2249.79679355924
"healthy-4"	"2019-08-01-count-4:GGGTCACTCCGTAATG"	-4.134513716132	-4.55967285549315	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTCACTCCGTAATG"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3330.293238574	42.3063713246439	0.0127034973481072	3621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3321.92363083623	3321.92363083623
"healthy-4"	"2019-08-01-count-3:CTTCTCTGTGCCCAGT"	-2.55657968941386	3.88488528812257	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTGTGCCCAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3585.88877397881	43.1893225990018	0.0120442449058675	5489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3579.61037844971	3579.61037844971
"healthy-4"	"2019-08-01-count-4:CGCGTGAGTGTTACAC"	3.95421280440633	-6.97999193584593	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCGTGAGTGTTACAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.92582527652	43.329531833936	0.0170191650533377	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2535.88881030638	2535.88881030638
"healthy-4"	"2019-08-01-count-3:CTTGAGAGTCGCGTTG"	2.41514434394185	-6.28783180629881	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGAGAGTCGCGTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.77069291062	47.0892283475241	0.0213772720415592	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2198.14628510799	2198.14628510799
"healthy-4"	"2019-08-01-count-3:CAAGACTCAGTATACC"	3.85328902777974	-6.7137398949829	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTCAGTATACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.67642639965	45.8164009615311	0.0177261650601857	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2579.16651435499	2579.16651435499
"healthy-4"	"2019-08-01-count-4:GATGTTGTCATAAGGA"	10.7989918189937	6.15459487521974	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGTTGTCATAAGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1730.66174431762	46.2536649632754	0.0267259995288755	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1724.92663913418	1724.92663913418
"healthy-4"	"2019-08-01-count-2:TCCTTCTGTCCACTCT"	3.96759118613545	-6.94767715847167	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTGTCCACTCT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2924.4728435305	43.9591535745782	0.0150314794927312	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2916.15438935117	2916.15438935117
"healthy-4"	"2019-08-01-count-4:GGGTGAATCCCAATAG"	-2.62749205055888	3.41310808742372	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAATCCCAATAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3235.32222755075	46.8237286535484	0.0144726631105909	5308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3226.34822293049	3226.34822293049
"healthy-4"	"2019-08-01-count-3:CTTGATTAGTAATACG"	1.87215985831563	-5.94470503246459	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTAGTAATACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2691.26099539842	44.2874705661691	0.0164560295868342	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2685.97033244825	2685.97033244825
"healthy-4"	"2019-08-01-count-4:TCTGGCTTCCCTCTCC"	11.4696337181026	4.35524556720582	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTTCCCTCTCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2577.11594523796	39.1545811892213	0.0151931779637512	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2558.25236359317	2558.25236359317
"healthy-4"	"2019-08-01-count-3:AACTTCTGTAACGTTC"	10.7662931877071	7.16023585880128	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACTTCTGTAACGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.0672545133	49.9143338040325	0.0255046594279897	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.50510579343	1951.50510579343
"healthy-4"	"2019-08-01-count-4:AGTCACAGTACTCCCT"	2.39979734000508	-6.43665316021117	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACAGTACTCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.56850732754	46.2716978714738	0.0214661226095018	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2151.51963348803	2151.51963348803
"healthy-4"	"2019-08-01-count-2:ATTACTCAGAAACCCG"	11.616697927087	3.94607398593751	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCAGAAACCCG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2194.80048974738	41.724185010052	0.0190104682429948	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2181.19684039575	2181.19684039575
"healthy-4"	"2019-08-01-count-2:ATTACCTTCCGTGGGT"	2.76864256438557	-6.02472832119139	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACCTTCCGTGGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.00427729953	41.772430038456	0.0158830274152054	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2626.05320366177	2626.05320366177
"healthy-4"	"2019-08-01-count-4:GTTAGTGGTCTGTCAA"	10.4294744926387	6.78323743427125	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGGTCTGTCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1911.73335942412	44.7487688181533	0.0234074321073903	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.08095828828	1896.08095828828
"healthy-4"	"2019-08-01-count-4:TCTGTCGGTCGCATTA"	11.1524044471676	6.07386586749879	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTCGCATTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1931.64181654232	39.4611630028216	0.0204288200146018	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1928.55879843954	1928.55879843954
"healthy-4"	"2019-08-01-count-2:ATTACTCCAACCAACT"	11.6374012428219	4.09567210758058	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTACTCCAACCAACT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2301.26473088481	36.8600327815227	0.0160172935720222	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2288.77907579528	2288.77907579528
"healthy-4"	"2019-08-01-count-3:GTTGTCCAGTAGAATC"	2.2164281803066	-5.97334816372069	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTCCAGTAGAATC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2481.77478456046	44.6631519355607	0.0179964564929169	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2475.95893885473	2475.95893885473
"healthy-4"	"2019-08-01-count-2:TCGAACAGTTTAGAGA"	-7.28954492035564	3.35779426181642	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAACAGTTTAGAGA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2661.78170167899	44.9082101402907	0.0168714850327371	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2643.42784947581	2643.42784947581
"healthy-4"	"2019-08-01-count-4:TCAGCAAAGAGTCTTC"	11.5439135032589	3.5900714167389	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAAAGAGTCTTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2068.14162411611	42.4528928819456	0.0205270724146318	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2047.60893108303	2047.60893108303
"healthy-4"	"2019-08-01-count-2:TCGAAGTAGAGTGACC"	10.4761816459591	6.34213683688966	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTAGAGTGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.88661452101	47.9460092563141	0.0265498447525905	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1804.07174198908	1804.07174198908
"healthy-4"	"2019-08-01-count-2:CTACCTGAGGAGAGGC"	-0.308881441981155	7.63696763599244	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGAGGAGAGGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2105.6372179173	41.7180571797204	0.0198125568947647	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2096.06164756625	2096.06164756625
"healthy-4"	"2019-08-01-count-4:TCTGTCGTCACGATCA"	2.54833640631978	-6.03085663234862	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGTCACGATCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.22462268798	43.3303806831328	0.0161727315866711	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2668.73698549257	2668.73698549257
"healthy-4"	"2019-08-01-count-4:AGTCTCCGTGTCTCCT"	-3.0399788421696	9.61639115894166	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCTCCGTGTCTCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.49174629389	45.8570717633775	0.0226511527386195	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.88606083352	2022.88606083352
"healthy-4"	"2019-08-01-count-4:AGTGACTAGCTCACTA"	5.5453859764034	-9.47619535839232	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGACTAGCTCACTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.24274635119	44.1678747705622	0.0165655864722021	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2661.95502791623	2661.95502791623
"healthy-4"	"2019-08-01-count-2:AACGAAATCTGGTGCG"	4.69088043746297	-6.95559503948363	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGAAATCTGGTGCG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2934.55026292456	43.7928021986126	0.0149231733229776	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2924.1335854588	2924.1335854588
"healthy-4"	"2019-08-01-count-2:TCGACCTCATCTGGGC"	10.1622206169063	6.15027568424074	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTCATCTGGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1828.60591865597	47.1506253803009	0.0257850119040175	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1815.5981627984	1815.5981627984
"healthy-4"	"2019-08-01-count-4:TCTTAGTTCTTGCGCT"	4.45479311522786	-7.15662672435912	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTAGTTCTTGCGCT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.20290180804	46.2450171084147	0.0185187263217306	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2492.25475640717	2492.25475640717
"healthy-4"	"2019-08-01-count-3:CAATACGCAACGCCCA"	-0.449499706656295	7.88465879047243	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGCAACGCCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2246.94872035831	42.2662264907809	0.0188104989258682	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2238.10039829457	2238.10039829457
"healthy-4"	"2019-08-01-count-2:TCGACCTGTACCCGCA"	1.83136739310567	-7.10232593929442	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTGTACCCGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.83303868301	53.0746649397455	0.0294886602251628	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1794.20149171557	1794.20149171557
"healthy-4"	"2019-08-01-count-2:TCGACCTGTACGTTCA"	0.453029324381989	8.02908370578615	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTGTACGTTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.13272336989	37.8938738810728	0.0207850330342541	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1814.61951112511	1814.61951112511
"healthy-4"	"2019-08-01-count-4:TCTTCCTCACATTCGA"	10.4541431861812	7.41312358463136	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTCCTCACATTCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2279.57929881053	41.9169067038456	0.0183880011218376	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2271.38435768251	2271.38435768251
"healthy-4"	"2019-08-01-count-3:CAATACGTCTGACCCT"	14.2989870506221	1.90599570358125	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGTCTGACCCT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1252.89152801798	29.2757166971258	0.0233665213966597	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1238.83433567741	1238.83433567741
"healthy-4"	"2019-08-01-count-2:TCGACCTTCGCACTCT"	2.71794523772542	-6.60143282329711	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACCTTCGCACTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.7372460039	41.5946900862712	0.0194300772614274	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2135.25020272445	2135.25020272445
"healthy-4"	"2019-08-01-count-3:CAATACGGTGGGAGAG"	11.4598528343136	4.31928441608278	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGGTGGGAGAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2199.22098652094	43.6628011155285	0.0198537579366232	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2192.41395025274	2192.41395025274
"healthy-4"	"2019-08-01-count-4:GGTCACGAGTTGTAAG"	3.04412998732869	-6.12540104305419	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGAGTTGTAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.24123716663	45.6596016826807	0.0186119493635348	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2449.80531692345	2449.80531692345
"healthy-4"	"2019-08-01-count-4:AGTGCCGGTGGGCTTC"	5.0347134071285	-8.25698282634886	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTGCCGGTGGGCTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2852.26453239933	43.8370111623584	0.0153691954811367	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2848.62750628331	2848.62750628331
"healthy-4"	"2019-08-01-count-2:ATTCAGGCATGTGCTA"	4.67568649825398	-6.96915581142577	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCAGGCATGTGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.83983719863	44.1087763633731	0.01780848955226	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2466.80067388945	2466.80067388945
"healthy-4"	"2019-08-01-count-2:ATTCAGGGTCCGAAAG"	4.06545557555501	-6.36905004894408	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCAGGGTCCGAAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.85264704641	44.0828556619591	0.0171805874015032	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2562.36601934252	2562.36601934252
"healthy-4"	"2019-08-01-count-4:CGGGTGTTCATGCATG"	2.92650117453877	-6.41314365780028	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTTCATGCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.29160544167	48.8706083327773	0.0203518007650672	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2395.21755270338	2395.21755270338
"healthy-4"	"2019-08-01-count-4:TCTTGCGTCAAATAGG"	-3.84399710121806	10.9434499510559	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGTCAAATAGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2102.84314962559	44.342126111785	0.0210867492041335	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2096.58240340112	2096.58240340112
"healthy-4"	"2019-08-01-count-3:CAATGACTCAAACCTG"	10.6389500099117	6.81975743854371	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATGACTCAAACCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.58749680164	44.8201920454287	0.0228956264374682	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.22284964587	1951.22284964587
"healthy-4"	"2019-08-01-count-4:CGGGTGTTCGCTTACC"	-0.181753302842933	7.67476651752321	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTGTTCGCTTACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1800.95434874632	41.3343606599578	0.0229513650297308	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1793.98505744204	1793.98505744204
"healthy-4"	"2019-08-01-count-4:TGAACGTCACAACCGC"	0.543727357953232	7.97360513294069	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAACGTCACAACCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1704.6860515321	34.7691615599444	0.0203962257617438	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1701.0619245918	1701.0619245918
"healthy-4"	"2019-08-01-count-2:TCGCACTCAAGGCGTA"	-4.44592509689982	12.9148759611878	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCACTCAAGGCGTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2061.31930234365	37.2511959092906	0.018071531114533	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2051.47192326274	2051.47192326274
"healthy-4"	"2019-08-01-count-2:TCGCACTCAAAGTGTA"	-6.25749240341838	-3.57152297413024	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCACTCAAAGTGTA"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3383.47940291929	44.8938255187801	0.0132685381445045	4003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3372.35371723896	3372.35371723896
"healthy-4"	"2019-08-01-count-3:GAAGCCCAGGGCAGAG"	-4.11527429047282	12.9682979353699	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCCCAGGGCAGAG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2487.10453181393	42.1133274695846	0.0169326728856345	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2477.96163300682	2477.96163300682
"healthy-4"	"2019-08-01-count-3:TAAGCACCACTAACCA"	4.30115141448323	-6.4136796227661	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCACCACTAACCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2784.55281634675	43.8997107359495	0.0157654437287868	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2776.26831916213	2776.26831916213
"healthy-4"	"2019-08-01-count-2:AGGTGTTAGTTGAAGT"	4.11827911910359	-6.45737411892089	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTAGTTGAAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.21375481227	47.1749472381527	0.0228205463166709	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2065.6238762065	2065.6238762065
"healthy-4"	"2019-08-01-count-3:TGAGGAGTCGGACGTC"	10.5631653266842	7.7093181380066	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGTCGGACGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.35758734053	45.2193569115435	0.0231970558943141	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.38173611803	1942.38173611803
"healthy-4"	"2019-08-01-count-2:TCGCACTTCGCTATTT"	0.255992789834183	7.64063689792482	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCACTTCGCTATTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2031.64635973599	40.9240322062113	0.0201432852770348	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.43173023268	2024.43173023268
"healthy-4"	"2019-08-01-count-4:TCAGTTTAGGTAGTCG"	4.69932856139485	-6.84496214306029	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTTTAGGTAGTCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.96266784748	44.5431298548415	0.0174818612599499	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2541.65902162036	2541.65902162036
"healthy-4"	"2019-08-01-count-2:CCTCATGGTGCCTTCT"	10.6573196845943	6.56299827182619	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCATGGTGCCTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.10506475462	45.5763356891517	0.0225502060649604	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.86219498501	2006.86219498501
"healthy-4"	"2019-08-01-count-3:CACAGATAGGGAGTGG"	3.33202518996541	-6.16176226055297	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGATAGGGAGTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.42281447712	48.3591608848929	0.019340393394629	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2497.2940446648	2497.2940446648
"healthy-4"	"2019-08-01-count-2:ATTCCTAGTCCAACGC"	3.88993968543355	-6.39740564739379	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCCTAGTCCAACGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.89673425594	45.4087484131284	0.0177732226137714	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2553.68441798347	2553.68441798347
"healthy-4"	"2019-08-01-count-3:TTCAGGATCACTCTTA"	0.531463463872117	7.85459945285646	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAGGATCACTCTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.56906289872	41.6717872745993	0.0228517735480544	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1822.02153956931	1822.02153956931
"healthy-4"	"2019-08-01-count-4:TGAATGCCAGCCGTCA"	5.64440693435018	-10.1482763520447	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATGCCAGCCGTCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.69817190499	46.9274397411706	0.0180789277617476	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2591.44131998889	2591.44131998889
"healthy-4"	"2019-08-01-count-4:CGTCAAATCTTAATCC"	-2.95834289017375	9.08823106372682	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTCAAATCTTAATCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2202.0759165342	48.2715291924106	0.021920919633136	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2195.41120931876	2195.41120931876
"healthy-4"	"2019-08-01-count-2:ATTCGTTAGCAACAAT"	3.2550069290096	-6.08475735103758	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCGTTAGCAACAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.22567749683	45.7794318353549	0.0180858752510076	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.96083249471	2526.96083249471
"healthy-4"	"2019-08-01-count-3:GAAGGGTAGTCAATCC"	0.127456945448559	7.93796584689943	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGGTAGTCAATCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1765.34395184646	38.3022933401883	0.0216967879262997	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1759.64222836529	1759.64222836529
"healthy-4"	"2019-08-01-count-2:AAGACTCAGGATTCCT"	-3.68353209915813	12.5282687910828	"2019-08-01-count-2"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCAGGATTCCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2221.37869786278	48.1640512791247	0.0216820532786526	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2214.86316029399	2214.86316029399
"healthy-4"	"2019-08-01-count-3:CACAGGCGTCATATGC"	11.6145559745723	4.00203654849855	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGGCGTCATATGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2147.98027859964	38.9678312386705	0.0181416149984744	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2126.5690323303	2126.5690323303
"healthy-4"	"2019-08-01-count-4:CACAACACATCCGTGG"	10.9476887184078	5.85158870303956	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACACATCCGTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.49611841004	46.9692001087085	0.0244313627782788	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1911.68201318252	1911.68201318252
"healthy-4"	"2019-08-01-count-4:ATACCTTAGTCTGGAG"	-0.0918652665918649	7.48758456790773	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATACCTTAGTCTGGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2060.76937986487	47.4027255173165	0.023002440729406	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2051.0440268186	2051.0440268186
"healthy-4"	"2019-08-01-count-3:GAAGTAAAGGCCTGCT"	9.74802555617635	7.40480372989503	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAAAGGCCTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.72320481752	43.1340010481843	0.022237193915635	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.30891534964	1932.30891534964
"healthy-4"	"2019-08-01-count-2:ATTCTTGCACAAAGCG"	-4.10581384125407	12.005079246405	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTCTTGCACAAAGCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1872.7685045956	45.7642150682283	0.0244366641984459	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1870.82180409288	1870.82180409288
"healthy-4"	"2019-08-01-count-4:GGTGTTAAGGCCCAAA"	-4.21385989609416	12.7929439314636	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTAAGGCCCAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2001.81808612371	43.7027742628041	0.0218315413202353	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1998.11052494617	1998.11052494617
"healthy-4"	"2019-08-01-count-4:TGACGCGAGGCCCAAA"	4.0953651863033	-6.24964239513548	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACGCGAGGCCCAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2717.15232179029	42.0300161653349	0.0154684063268275	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.27243114932	2712.27243114932
"healthy-4"	"2019-08-01-count-4:TGACGCGCATTAAGCC"	-3.35470138016399	3.64470670307008	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACGCGCATTAAGCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3231.52794229028	45.3991348524849	0.0140488139552676	5752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3221.30179233254	3221.30179233254
"healthy-4"	"2019-08-01-count-3:GAATAGACAGCAGAAC"	-0.855200628668624	8.18849561298219	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATAGACAGCAGAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.2356554831	50.2049814880656	0.0253658432986402	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1974.60561806818	1974.60561806818
"healthy-4"	"2019-08-01-count-2:TCGGATACATAGGCGA"	11.3569647270137	4.00250170314638	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATACATAGGCGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.63127360508	44.3305551615486	0.0236728691795294	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1857.32512331768	1857.32512331768
"healthy-4"	"2019-08-01-count-2:ATTGGGTAGTATGATG"	4.35506166991536	-6.71944191372069	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTAGTATGATG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.00599027002	46.8542837389477	0.0192894887565671	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2427.84199397997	2427.84199397997
"healthy-4"	"2019-08-01-count-2:GGTAATCGTCAGGTAG"	11.5617224174434	3.49440238559572	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAATCGTCAGGTAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2045.41194706109	44.067805876728	0.021544709338403	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2029.34777426968	2029.34777426968
"healthy-4"	"2019-08-01-count-3:TTCCTAACAGGATCTT"	-1.87050316754039	8.79528329456178	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAACAGGATCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.95442062405	47.057637723462	0.0220208897622252	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2124.49855526269	2124.49855526269
"healthy-4"	"2019-08-01-count-3:TAATCTCGTGATAGAT"	3.11730684813802	-5.93467047130736	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAATCTCGTGATAGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.08714580868	44.1137333491121	0.0176307741411039	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2496.79125589044	2496.79125589044
"healthy-4"	"2019-08-01-count-4:CGTTCTGGTACTGAGG"	10.4684711891109	7.74292275989381	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTCTGGTACTGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2404.76373070777	48.8635903228921	0.0203194973788591	2145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2395.94237190544	2395.94237190544
"healthy-4"	"2019-08-01-count-3:AAGTACCGTGATACTC"	10.1899343925411	7.05635163867799	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTACCGTGATACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.64365343982	45.0256428079241	0.0229999176452817	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.57310692939	1942.57310692939
"healthy-4"	"2019-08-01-count-4:AAGCCATGTGATAGAT"	-3.31898127022441	3.00945708835451	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATGTGATAGAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3237.27092822888	45.4125698819918	0.0140280411769049	4993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3228.59334592026	3228.59334592026
"healthy-4"	"2019-08-01-count-2:TCGGGACAGCCGGAAT"	11.473761220544	4.06280706012575	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACAGCCGGAAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.499247269	31.5051895354984	0.016168951350459	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.81431677358	1931.81431677358
"healthy-4"	"2019-08-01-count-4:CGTTGGGGTCGACGCT"	10.9987560707027	5.12712047183839	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTGGGGTCGACGCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1656.78898482438	48.674844818178	0.029379024887311	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1652.40718262205	1652.40718262205
"healthy-4"	"2019-08-01-count-4:ATAGAGATCAACTACG"	9.83789124068562	6.91780755603639	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGATCAACTACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1929.08630872517	40.3391566347898	0.0209110170199941	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1929.08630872517	1929.08630872517
"healthy-4"	"2019-08-01-count-3:TTCCTCTAGGACGCTA"	10.0684687095577	7.12095687473146	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTAGGACGCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2144.16208399262	46.0747805171303	0.0214884783483043	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2139.75572014764	2139.75572014764
"healthy-4"	"2019-08-01-count-4:TGAGCATAGGCTCTCG"	10.3029924827511	7.66245744312135	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCATAGGCTCTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2105.99948232012	40.9741624734944	0.0194559223862459	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2098.13264685502	2098.13264685502
"healthy-4"	"2019-08-01-count-3:TTCCTCTAGTCGCCCA"	10.2606369453365	5.94740340793458	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTAGTCGCCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.81459855756	43.8850697777879	0.0226116754327817	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.75818615068	1930.75818615068
"healthy-4"	"2019-08-01-count-2:AAGCGAGAGGTACAGC"	-1.86330173435863	3.62320015514223	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGCGAGAGGTACAGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2946.03164533119	45.6759464523808	0.0155042280434316	4710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2940.31215815835	2940.31215815835
"healthy-4"	"2019-08-01-count-4:TGAGCATTCAGTCACA"	11.3855415779049	4.25530765140382	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCATTCAGTCACA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1723.62943974619	38.7310812121696	0.0224706542595797	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1711.19932945778	1711.19932945778
"healthy-4"	"2019-08-01-count-3:CCGGGTACACAGTCAT"	0.272860904305619	7.75883386218873	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGGTACACAGTCAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2098.36286179457	47.1008306702052	0.0224464660177618	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2092.6086942092	2092.6086942092
"healthy-4"	"2019-08-01-count-2:GCATTAGGTGGAGAAA"	3.25998749312703	-6.22475483333739	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATTAGGTGGAGAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.94133607645	46.6598905648183	0.0209618689444275	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2214.43627570764	2214.43627570764
"healthy-4"	"2019-08-01-count-3:CCGGTAGAGGATTCAA"	5.48118986663167	-9.31493379985961	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTAGAGGATTCAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.42293284613	46.8220908277243	0.0185109774327221	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.24227383686	2526.24227383686
"healthy-4"	"2019-08-01-count-4:ATAGGCTGTACAACGG"	3.08972444114034	-6.15157797252806	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGGCTGTACAACGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.52968888643	45.3761777307736	0.0180169318356683	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2513.42673488828	2513.42673488828
"healthy-4"	"2019-08-01-count-3:GACATCAGTAGGCAGT"	-2.6036847633427	3.43261811817018	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACATCAGTAGGCAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3354.49954002677	45.6954005695798	0.0136221215785932	5730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3348.03241305685	3348.03241305685
"healthy-4"	"2019-08-01-count-2:ATTTACCTCGCTATTT"	-7.79835448685344	1.1702910431656	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTACCTCGCTATTT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3318.37913046981	45.6716284931593	0.0137632340059628	4284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3296.23069618364	3296.23069618364
"healthy-4"	"2019-08-01-count-4:CTAAGTGAGGACTAAT"	-5.62266335907634	-5.43050625240477	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGAGGACTAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2992.63679983879	49.346461144331	0.0164892916998779	2536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2985.05793074662	2985.05793074662
"healthy-4"	"2019-08-01-count-3:AATCGTGAGGCTGGAT"	10.5377270179683	6.04348037326661	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGTGAGGCTGGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1772.74011882986	44.6804020739554	0.0252041467327133	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1770.91859852763	1770.91859852763
"healthy-4"	"2019-08-01-count-3:TTCGATTAGGCTAAAT"	-3.85724482956584	10.8404893645081	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCGATTAGGCTAAAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2096.66292724045	46.1009361870315	0.0219877671265489	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2088.29153387914	2088.29153387914
"healthy-4"	"2019-08-01-count-4:ATATCCTCAGTTCTAG"	11.2038999992305	6.09660146320192	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATATCCTCAGTTCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.36738988204	42.0186562835627	0.0204036717731893	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.08626040011	2051.08626040011
"healthy-4"	"2019-08-01-count-4:GTAATCGCAGAGAGGG"	11.5003897148067	3.71330258930055	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGCAGAGAGGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1492.07375140152	43.4650458220923	0.0291306282824594	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1478.26928880878	1478.26928880878
"healthy-4"	"2019-08-01-count-2:CAAAGAAGTAGACACG"	1.98635878142659	-6.80977251445922	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAAGAAGTAGACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.33307867211	52.5351000796417	0.0299459097695442	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1750.55930196026	1750.55930196026
"healthy-4"	"2019-08-01-count-4:TGAGGAGTCTATGTGG"	11.5073963600094	3.96015522563783	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGAGTCTATGTGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2105.19809207238	37.582663293834	0.0178523168130165	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2096.16706566415	2096.16706566415
"healthy-4"	"2019-08-01-count-3:GACCAATTCATGTCTT"	-7.57941613617595	-0.482633613702379	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATTCATGTCTT"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3001.2904265368	38.9027585824269	0.0129620106866222	3847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2991.04655038563	2991.04655038563
"healthy-4"	"2019-08-01-count-3:TACCCACCATGTAACC"	1.45596851882283	-5.9564419022766	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACCATGTAACC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2861.7167734852	41.1907370084517	0.0143937154753043	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2854.61215163249	2854.61215163249
"healthy-4"	"2019-08-01-count-3:TTCTAACCACTCCCTA"	-2.79619131508525	-5.74788572704466	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAACCACTCCCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2491.35089693137	46.6381056917496	0.0187200067839478	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2483.0802461864	2483.0802461864
"healthy-4"	"2019-08-01-count-2:AAGGTAATCAGGAACG"	2.58462132987325	-6.01165439998778	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAATCAGGAACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.90899690064	47.0086804298427	0.0195388439423106	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2403.91168496976	2403.91168496976
"healthy-4"	"2019-08-01-count-4:CTACATTCACACGTGC"	10.914588590234	6.3587436445984	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTCACACGTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.46443952161	48.4690953642352	0.0243996793498643	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1974.97373990318	1974.97373990318
"healthy-4"	"2019-08-01-count-4:ATCACGATCTGTACAG"	4.8853517967159	-7.28713323986205	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACGATCTGTACAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2941.70596067487	42.7859800912521	0.0145446148130442	2429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2934.88743306108	2934.88743306108
"healthy-4"	"2019-08-01-count-2:CAACAGTCAGGTCCCA"	0.537468333810013	7.91345832431642	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAGTCAGGTCCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.73334988193	41.3520803731798	0.0221521088567873	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1858.32539407758	1858.32539407758
"healthy-4"	"2019-08-01-count-4:TGAGTCAAGTATCCTG"	-2.62153683129008	3.59677336299745	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGTCAAGTATCCTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3352.74591416141	48.0249990791722	0.0143240795183205	5512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3343.08963924057	3343.08963924057
"healthy-4"	"2019-08-01-count-4:CTACATTTCAACGTGT"	-0.0466814142769158	8.33306024158327	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACATTTCAACGTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2091.3198424937	42.684303968365	0.0204102228176958	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.18431235719	2087.18431235719
"healthy-4"	"2019-08-01-count-3:CACTAAGTCCATTCGC"	3.69294752654378	-5.83050205623778	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTAAGTCCATTCGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2885.46303039371	40.2412311681547	0.0139461953746342	2676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2878.25391024574	2878.25391024574
"healthy-4"	"2019-08-01-count-4:ATCAGGTGTCTTACTT"	10.4563127952511	7.77218959415285	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCAGGTGTCTTACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2140.3661883579	45.0795396499215	0.0210616014657318	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2130.7756582686	2130.7756582686
"healthy-4"	"2019-08-01-count-3:AATGCCAGTTGAGTCT"	3.62600960311238	-5.66797020351561	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCAGTTGAGTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2731.75153613316	42.4088364493566	0.015524412044218	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2723.11400483713	2723.11400483713
"healthy-4"	"2019-08-01-count-3:TGCATGACAAGAAACT"	11.0301958518917	6.39938066089479	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATGACAAGAAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2008.95342756814	48.0556893216944	0.023920758272563	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1999.57606574693	1999.57606574693
"healthy-4"	"2019-08-01-count-3:AATGCCAGTTGGTACT"	2.20317401465718	-6.1818886033264	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCAGTTGGTACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2611.91340767119	50.2817147851103	0.0192509118554363	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2609.00781400501	2609.00781400501
"healthy-4"	"2019-08-01-count-4:CTACCCAAGGATGGCT"	4.95692743834798	-7.24816133892211	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCAAGGATGGCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2851.40960745107	42.8544284891	0.0150292081422172	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2842.95699062537	2842.95699062537
"healthy-4"	"2019-08-01-count-3:TACCGAACACGCAGTC"	4.13594116744344	-6.36707355892333	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCGAACACGCAGTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2923.33166329767	44.2755559304985	0.0151455808064397	2362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2916.28459408608	2916.28459408608
"healthy-4"	"2019-08-01-count-2:TCGTGCTGTTAAACAG"	2.79037060317342	-4.61749222194823	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTGTTAAACAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2507.44543217941	42.6275067652317	0.0170003726574344	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2500.45504074665	2500.45504074665
"healthy-4"	"2019-08-01-count-3:AATGCCATCATCGGGC"	4.3979135948116	-7.37889435207518	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCATCATCGGGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.17628552739	46.9975351820163	0.0211970223066124	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2212.82274413614	2212.82274413614
"healthy-4"	"2019-08-01-count-3:GCGGATCTCGCTTTAT"	-2.59055481377299	3.41947529399721	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGATCTCGCTTTAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3301.53215501606	46.7369516076792	0.0141561400626285	5691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3294.41669303405	3294.41669303405
"healthy-4"	"2019-08-01-count-3:TTCTGTACAACAGATA"	3.23758234557454	-6.03590681469115	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTGTACAACAGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2750.12308245934	41.8043857462721	0.0152009144655765	2146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2741.83298397567	2741.83298397567
"healthy-4"	"2019-08-01-count-3:AATGGAATCGTTCAGA"	1.8512325483257	-6.07970955288085	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGAATCGTTCAGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2437.94644241002	49.247562487432	0.0202004283731305	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2432.1835534316	2432.1835534316
"healthy-4"	"2019-08-01-count-3:TACCGGGTCGATCCAA"	5.57897152480428	-9.8441486588684	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCGGGTCGATCCAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.63254022198	44.4878791508424	0.016352035231929	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.90350539208	2712.90350539208
"healthy-4"	"2019-08-01-count-2:CAACGATAGAGGATCC"	2.07997073706929	-5.96707012569579	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGATAGAGGATCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2645.70289815361	44.0970399541464	0.0166674194539836	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2638.04840116453	2638.04840116453
"healthy-4"	"2019-08-01-count-3:CACTGGGGTTTCCAAG"	10.2014929252559	7.50726077640382	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGGGGTTTCCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2036.25824803528	40.971136638978	0.0201207959150122	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2027.81228780183	2027.81228780183
"healthy-4"	"2019-08-01-count-3:GACGCTGCAATACGAA"	10.110500951379	6.5852799185547	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGCTGCAATACGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.47793411575	41.9678842712288	0.0227656016351285	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1834.19321722108	1834.19321722108
"healthy-4"	"2019-08-01-count-4:TGATGCAGTCGCCACA"	11.1859108406002	4.16786620700685	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCAGTCGCCACA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1751.57142576473	38.9914782024782	0.0222608553833051	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1739.88884758917	1739.88884758917
"healthy-4"	"2019-08-01-count-4:GTAGCTAAGATCGCTT"	5.16234554824178	-7.7927079430786	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGCTAAGATCGCTT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2750.22301197794	41.8562457108882	0.0152192187792021	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2745.71879179937	2745.71879179937
"healthy-4"	"2019-08-01-count-3:TACCTGCAGAGCTGCA"	5.07161202010457	-7.82976677333983	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCAGAGCTGCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.7596187704	44.2604349361448	0.0182988150590364	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.38893098376	2413.38893098376
"healthy-4"	"2019-08-01-count-2:CTCCAACGTAGTGCGA"	-0.113855312496978	7.61270711505739	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCAACGTAGTGCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1838.40821490756	44.483093119339	0.0241965265160522	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1829.54086232319	1829.54086232319
"healthy-4"	"2019-08-01-count-3:CACTGTCTCGCTCCTA"	-1.55660424652751	8.40312192523805	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACTGTCTCGCTCCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2261.06789423661	47.2822703582559	0.0209114774831738	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2256.26889708617	2256.26889708617
"healthy-4"	"2019-08-01-count-2:TCTACATCAGTAGAAT"	-1.42492947998698	8.73293683612672	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACATCAGTAGAAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1902.16963980329	47.8602174142669	0.0251608565360218	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1898.67663367986	1898.67663367986
"healthy-4"	"2019-08-01-count-4:TGATGCATCTGCTTTA"	-5.62765489044841	-5.45056106960448	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGCATCTGCTTTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3031.20747242604	49.1683080865313	0.0162207003426194	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3025.28875747885	3025.28875747885
"healthy-4"	"2019-08-01-count-4:TGATGGTAGCAATTCC"	-3.93565855446513	11.1053180464539	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATGGTAGCAATTCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2055.16149964036	52.9734435172726	0.0257758057099369	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2052.12967489788	2052.12967489788
"healthy-4"	"2019-08-01-count-3:TTGAACGAGATCACTC"	10.8917404609615	6.79240558231202	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGAACGAGATCACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2265.64324421853	50.1035818356457	0.0221145063166939	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2254.27521033065	2254.27521033065
"healthy-4"	"2019-08-01-count-2:CAACGGCGTAGCGATG"	-0.323100308806258	7.67064569080202	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCGTAGCGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2078.29074328891	44.6232060857058	0.0214711085202108	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2068.628378653	2068.628378653
"healthy-4"	"2019-08-01-count-4:TGATTCTCAGAAACCG"	10.83017029342	6.4855074652466	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTCTCAGAAACCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1718.74194883839	44.5569083480985	0.0259241408392995	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1716.66281093201	1716.66281093201
"healthy-4"	"2019-08-01-count-2:CAAGACTCAATAGTCC"	14.3056160407955	1.96127519691316	"2019-08-01-count-2"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGACTCAATAGTCC"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1341.77803890845	32.768748238652	0.0244218844610915	1930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1331.66548524914	1331.66548524914
"healthy-4"	"2019-08-01-count-2:CTCCATGAGATGTAGT"	11.3046175437862	5.25319812381593	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGAGATGTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2339.92516810373	45.5340166692022	0.0194596037898523	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2334.7937101321	2334.7937101321
"healthy-4"	"2019-08-01-count-4:GTAGGAGTCTTGCAAG"	2.73824252662007	-5.50102093135985	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGTCTTGCAAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2945.73020557768	45.4447595419531	0.0154273325696645	2667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2937.17791648935	2937.17791648935
"healthy-4"	"2019-08-01-count-3:CAGATCAAGCACTAGG"	4.3777309852535	-6.99107363140257	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCAAGCACTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.15433250254	44.7887684651255	0.0187310236969315	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2386.88413788218	2386.88413788218
"healthy-4"	"2019-08-01-count-3:GACTCAATCGTTCTCG"	3.91639318045918	-6.35679819500121	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCAATCGTTCTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.65559312912	41.4522869870766	0.0155039740696605	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2665.18566411949	2665.18566411949
"healthy-4"	"2019-08-01-count-3:CAGATCAGTCCCGGTA"	3.23056139525716	-5.91443731701048	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCAGTCCCGGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.43902810432	44.2941457498065	0.017936926259649	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2467.06033176453	2467.06033176453
"healthy-4"	"2019-08-01-count-4:ATCGATGGTGCCCAGT"	4.5964204269344	-6.97058107769164	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGGTGCCCAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.24597545936	44.0599496512274	0.0159392290130423	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2754.076781761	2754.076781761
"healthy-4"	"2019-08-01-count-1:GCGTGCAGTCGTACAT"	10.5569836097652	6.54153726184694	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GCGTGCAGTCGTACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2189.02406224813	39.902618644598	0.0182284970424756	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2174.02603615648	2174.02603615648
"healthy-4"	"2019-08-01-count-2:CAAGCTACACTCGATA"	1.97712196883504	-6.07696773922118	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGCTACACTCGATA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2711.17176353172	42.2994387325698	0.0156019029489553	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2707.03282512356	2707.03282512356
"healthy-4"	"2019-08-01-count-3:GACTCTCCATAGGCGA"	4.75510325011556	-7.50019981777342	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCTCCATAGGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.30650678955	50.2156693563852	0.0216231876410687	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2319.38898320819	2319.38898320819
"healthy-4"	"2019-08-01-count-4:ATCGCCTCACTTCAGA"	10.9605175453121	6.6008262404236	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGCCTCACTTCAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.42213811972	44.095520706137	0.0234622758835079	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.86222661207	1875.86222661207
"healthy-4"	"2019-08-01-count-4:TGCACGGGTCTACATG"	11.2802483039791	3.6223299273285	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCACGGGTCTACATG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1523.16859561393	51.5606224071569	0.0338508964507469	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1499.96809494942	1499.96809494942
"healthy-4"	"2019-08-01-count-3:ACAAGCTTCTTACACT"	0.619575758546036	7.9272455939087	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTTCTTACACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.85206060478	42.8379243878793	0.0229466090494613	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1859.82670922197	1859.82670922197
"healthy-4"	"2019-08-01-count-2:GTAACCAGTCTCAAGT"	5.11195816573445	-8.10023214733275	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACCAGTCTCAAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.2803173961	46.6161267332974	0.0189090572801615	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2456.48676152911	2456.48676152911
"healthy-4"	"2019-08-01-count-2:CTCCCAATCCTTCTGG"	0.100748927413863	7.9651627310547	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAATCCTTCTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2043.27239466703	44.9437757991024	0.0219959785667374	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2040.67872103406	2040.67872103406
"healthy-4"	"2019-08-01-count-4:TGCAGATAGACCGTTT"	4.9335843521053	-8.14003755962523	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATAGACCGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2888.05463738693	42.7052927175254	0.014786871468666	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2882.030202808	2882.030202808
"healthy-4"	"2019-08-01-count-2:GTAAGTCAGCATTGAA"	4.30513014373128	-6.38086512005004	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAAGTCAGCATTGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3115.66767083947	42.652613875255	0.0136897186675121	3212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3108.86679851607	3108.86679851607
"healthy-4"	"2019-08-01-count-2:CAAGGGAAGCTGCCAC"	11.1439606147701	5.45077846134035	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGAAGCTGCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.95345387163	41.3194551919021	0.0228290153559013	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1808.14341488613	1808.14341488613
"healthy-4"	"2019-08-01-count-4:TACCCGTGTAACGATA"	3.44779839095418	-6.41030409252318	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCGTGTAACGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.77271086288	47.089803533563	0.0224368285759741	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2094.06841174302	2094.06841174302
"healthy-4"	"2019-08-01-count-3:TTGCCTGGTACAAACA"	-0.191104303032714	7.65989205921022	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGGTACAAACA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.17365644178	46.2656790073286	0.0223811283890709	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2061.06774661437	2061.06774661437
"healthy-4"	"2019-08-01-count-3:ACACCAATCGAACGCC"	10.6373821693355	7.19592282855836	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAATCGAACGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.44891221652	43.551827303798	0.0216304605692	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2003.24780426329	2003.24780426329
"healthy-4"	"2019-08-01-count-3:GACTTCCTCCTCACTG"	4.77008213576619	-6.89460756694945	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTTCCTCCTCACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2841.19637117156	44.9703484947667	0.0158279621046479	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2841.19637117156	2841.19637117156
"healthy-4"	"2019-08-01-count-3:TTGCCTGTCGATACGT"	1.74225058135335	-6.2632251015869	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGTCGATACGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2329.25914932041	54.0465533307437	0.0232033234028564	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2329.25914932041	2329.25914932041
"healthy-4"	"2019-08-01-count-2:CAATACGCAACGGTAG"	-1.81078992310222	3.44964430415956	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGCAACGGTAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2741.4419275739	52.0217906971539	0.0189760688249164	3170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2734.99907130032	2734.99907130032
"healthy-4"	"2019-08-01-count-3:CAGCCAGAGAAAGTCT"	0.307695497840089	7.76721665942994	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCCAGAGAAAGTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.19315723695	37.2441847590529	0.0203832772750599	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1824.45643273551	1824.45643273551
"healthy-4"	"2019-08-01-count-4:ATCGTAGAGAGTCACG"	4.48662628707234	-7.03173973476561	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTAGAGAGTCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.73394406243	45.9365506047175	0.0173953724902896	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2634.59042791485	2634.59042791485
"healthy-4"	"2019-08-01-count-4:GTCAAACTCTAAACGC"	-0.0614227232640565	7.90548942172853	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACTCTAAACGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1991.63564016877	46.4645074127679	0.0233298232245083	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1977.47463565414	1977.47463565414
"healthy-4"	"2019-08-01-count-2:TCTCTGGGTGGACCTC"	11.5647598701412	3.77862475002138	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGGTGGACCTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2046.80452842424	36.9362970411184	0.018045835119172	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.24331626771	2043.24331626771
"healthy-4"	"2019-08-01-count-4:ATCGTAGGTAGGACTG"	9.73129143294637	6.695361114386	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTAGGTAGGACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.08521925386	42.7228510267349	0.0229558811089065	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1856.05930341727	1856.05930341727
"healthy-4"	"2019-08-01-count-2:AATGGCTCACCTCAGG"	-1.91193721714671	8.90265081012575	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATGGCTCACCTCAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.17538629823	44.9855546630067	0.0217303108522836	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2064.9115708278	2064.9115708278
"healthy-4"	"2019-08-01-count-4:GTCACGGGTCGTGCCA"	-1.98992381516154	8.70718286121217	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACGGGTCGTGCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.38598642103	43.6949372377225	0.0231633067422343	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1882.7303815204	1882.7303815204
"healthy-4"	"2019-08-01-count-4:CTCAACCAGCTAAATG"	0.100982067256612	7.71470401370851	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCAGCTAAATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.19137242741	42.2527769797677	0.0202924560822234	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2075.64403071405	2075.64403071405
"healthy-4"	"2019-08-01-count-4:ATCGTGACAGACCAGA"	-4.1191762489384	10.6279020079407	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTGACAGACCAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.8947971345	40.7677383838859	0.0212122632542997	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.56931086646	1910.56931086646
"healthy-4"	"2019-08-01-count-3:GAGACCCAGGACAGCT"	-4.08111463013347	3.66287586772767	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGACCCAGGACAGCT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3041.06055410562	44.3891452618845	0.0145966002557747	3857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3028.38176926525	3028.38176926525
"healthy-4"	"2019-08-01-count-2:CTCCTTTAGGCCCGTT"	10.4645840125972	6.43327281558839	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTAGGCCCGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.75825053355	42.7274562852763	0.0210816737881927	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2021.76350328607	2021.76350328607
"healthy-4"	"2019-08-01-count-3:GTCCACTGTACGTAGG"	3.28387775000874	-6.14378311550292	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCACTGTACGTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.00884478481	45.32417559487	0.0175606432680198	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2575.01554920009	2575.01554920009
"healthy-4"	"2019-08-01-count-2:TCTGCCAGTTGTATGC"	2.56924237784688	-6.05199482357176	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGCCAGTTGTATGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.34004281684	43.1454912938179	0.0170715022762549	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2520.43561155024	2520.43561155024
"healthy-4"	"2019-08-01-count-3:TACTTGTTCATGTCTT"	2.89100446280782	-6.07000114833983	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTTCATGTCTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2638.58519604445	47.0858923506812	0.0178451286777735	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2636.67496013056	2636.67496013056
"healthy-4"	"2019-08-01-count-4:CTCAACCTCGGACAAG"	0.507041473954362	7.74187848651735	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCTCGGACAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1774.91174729269	34.1525309987655	0.0192418192345953	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1772.19306619821	1772.19306619821
"healthy-4"	"2019-08-01-count-3:ACAGAAATCGTTCATT"	11.5536037879879	3.63927218997804	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAATCGTTCATT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2283.6916415244	40.605298855877	0.0177805523817446	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2265.09228639482	2265.09228639482
"healthy-4"	"2019-08-01-count-4:ATCTCTAGTATCGCGC"	2.22394551810567	-6.48343803798827	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCTCTAGTATCGCGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.41799333071	47.0825720009895	0.0204403074636526	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2297.73979561279	2297.73979561279
"healthy-4"	"2019-08-01-count-2:GTAGATCCAGGTGACA"	-1.47273097458537	8.4956598051819	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGATCCAGGTGACA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2023.28328994164	46.4643268456023	0.0229648151974519	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2018.26179279518	2018.26179279518
"healthy-4"	"2019-08-01-count-3:ACAGCCGGTCATATGC"	14.2985788780147	2.01238951766816	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGCCGGTCATATGC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1181.19118807401	34.0942422821937	0.0288642877007795	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1163.43278595885	1163.43278595885
"healthy-4"	"2019-08-01-count-4:TGCGACGAGAGCAAGA"	11.2316452461178	5.73911283099977	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGACGAGAGCAAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.06367459495	39.9088402051744	0.0204864146514474	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.60338633252	1939.60338633252
"healthy-4"	"2019-08-01-count-3:CAGTGCGGTAGACTGG"	0.0551087498547554	8.17464253986207	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGGTAGACTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.45077569844	41.2788025792152	0.0226625957340992	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1811.63890503004	1811.63890503004
"healthy-4"	"2019-08-01-count-4:GTCAGCGTCATTATCC"	-4.16553197327312	12.5582446821961	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAGCGTCATTATCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1971.94726866495	50.150102568825	0.0254317665414946	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1971.94726866495	1971.94726866495
"healthy-4"	"2019-08-01-count-4:ATGAAAGCATGGCTAT"	1.56599332866017	-6.3529262772766	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAAAGCATGGCTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2468.22758936306	49.6009749497831	0.0200957866136578	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2468.22758936306	2468.22758936306
"healthy-4"	"2019-08-01-count-3:GAGATGGCATACCGTA"	2.12512673911397	-6.22687008297118	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGATGGCATACCGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.8920557046	51.2391068800142	0.0216940934096705	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2360.74374257081	2360.74374257081
"healthy-4"	"2019-08-01-count-4:TGCGGCACAGTCTACA"	-4.33686194840129	12.8299360045227	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGGCACAGTCTACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2142.35170924709	49.5906676707093	0.0231477714217791	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2135.08907018713	2135.08907018713
"healthy-4"	"2019-08-01-count-2:ACAAAGAGTGTCCGTG"	11.0171772437984	6.58057448947755	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAAGAGTGTCCGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.37517033871	48.6274420743653	0.0247925245561091	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1957.03596860328	1957.03596860328
"healthy-4"	"2019-08-01-count-2:TCTTAGTAGTAGCCAG"	0.0470583849469244	7.91789147937623	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTAGTAGTAGCCAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1887.79980317635	36.9003328121673	0.0195467404700859	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1880.81153943185	1880.81153943185
"healthy-4"	"2019-08-01-count-3:TAGACTGTCGTTACCC"	6.79797758635823	-1.66822411930235	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGTCGTTACCC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2735.37088374607	42.2658217159162	0.0154515871931902	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2729.81091360402	2729.81091360402
"healthy-4"	"2019-08-01-count-2:CACACAAGTAGACTGG"	10.3245645957882	5.66524074161378	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAAGTAGACTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1765.11208714741	45.895420898619	0.0260014200983635	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1752.42484891162	1752.42484891162
"healthy-4"	"2019-08-01-count-3:GAGCTGCGTGAGCAGT"	5.72268786010091	-9.79996397411498	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCGTGAGCAGT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.01039162025	46.8482198661602	0.0169309880468963	2086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2756.11637076929	2756.11637076929
"healthy-4"	"2019-08-01-count-4:ATGACCATCTATCGTT"	-2.09225902977641	3.44772503459779	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCATCTATCGTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3190.57275410103	43.780480251633	0.0137218247712294	5259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3181.51664827354	3181.51664827354
"healthy-4"	"2019-08-01-count-4:ATGACCATCGTTGTAG"	10.6634746986324	6.79802463138429	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCATCGTTGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.61205283449	45.4177990891664	0.0239215794618816	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1892.86313786049	1892.86313786049
"healthy-4"	"2019-08-01-count-2:GTAGGAGTCCTACGGG"	-4.2029746574467	12.3711175688538	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGAGTCCTACGGG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2093.42000094048	40.0774155842716	0.0191444696077551	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2088.01226031262	2088.01226031262
"healthy-4"	"2019-08-01-count-2:CTCTCGATCCAACCAA"	10.6370207267696	6.76607225025026	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGATCCAACCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.59112828092	47.5789407375078	0.0241813149356275	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1962.44705612292	1962.44705612292
"healthy-4"	"2019-08-01-count-4:GTCATTTGTGACACGA"	-0.474780778319198	7.83653113925783	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATTTGTGACACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2115.73814291852	38.1107373615459	0.0180129745682869	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2110.17434665226	2110.17434665226
"healthy-4"	"2019-08-01-count-3:TTGTGTTTCCGATTAG"	2.42622675475423	-5.96345713054808	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTGTTTCCGATTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.94364236486	46.2355435618843	0.0184503525060331	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2504.94465491991	2504.94465491991
"healthy-4"	"2019-08-01-count-3:CATAAGCTCGCTGTCT"	4.95706476744954	-7.29471208965453	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCTCGCTGTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.41183063512	41.5656089881353	0.0154037306374958	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2696.56628761863	2696.56628761863
"healthy-4"	"2019-08-01-count-2:ACAAGCTCACCGGTCA"	10.6051289039547	6.03339622104494	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAAGCTCACCGGTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.52517897802	47.6171694272263	0.0248067438493191	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1908.48573959599	1908.48573959599
"healthy-4"	"2019-08-01-count-4:ACACAGTTCTCGTTTA"	14.3014217811519	1.9403790005478	"2019-08-01-count-4"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACAGTTCTCGTTTA"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1365.94888605398	38.0198611721289	0.0278340291941396	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1351.91688519759	1351.91688519759
"healthy-4"	"2019-08-01-count-4:GTCCACTGTCGATTCA"	10.5326439338619	7.08219192111818	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCACTGTCGATTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.87745550734	45.1200755982092	0.0228239112508012	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.38148119012	1975.38148119012
"healthy-4"	"2019-08-01-count-3:GAGGCCTCATGTTCAG"	-4.27219758454021	12.7784156569275	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCCTCATGTTCAG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2006.6370814083	43.1721525306611	0.0215146789275726	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2000.95215532242	2000.95215532242
"healthy-4"	"2019-08-01-count-2:CTCTGGTTCAGTCATG"	10.1963526206905	6.71577451312868	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTTCAGTCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2035.36153792084	48.0357842115336	0.0236006150831577	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2028.26723417798	2028.26723417798
"healthy-4"	"2019-08-01-count-3:ATGCATGTCCACATAG"	-2.32308063927348	9.20681283557741	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCATGTCCACATAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1830.10110385095	40.9986876435137	0.0224024167611522	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1816.55768043312	1816.55768043312
"healthy-4"	"2019-08-01-count-4:CTCAGAAGTAGGCTGA"	10.8089500862056	6.52466867053834	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGAAGTAGGCTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.65623237172	44.8880864849035	0.0231303647375222	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1935.79368316946	1935.79368316946
"healthy-4"	"2019-08-01-count-4:GACTATGCAGCACAAG"	-2.5817588371342	3.60833809459535	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGCAGCACAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3348.59469896327	46.7562442331645	0.0139629451864211	5922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3340.84917600228	3340.84917600228
"healthy-4"	"2019-08-01-count-4:TGCTTCGGTGCCTGAC"	3.34554256972615	-6.26990511333617	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGGTGCCTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.24037938181	47.9091759095827	0.0217251490393138	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2199.83635565384	2199.83635565384
"healthy-4"	"2019-08-01-count-4:TACTTGTAGGAGGTTC"	10.4776569801265	7.71803710544435	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTAGGAGGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2284.66380917398	44.2506820699597	0.0193685748827783	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2280.97048550751	2280.97048550751
"healthy-4"	"2019-08-01-count-4:ATGCATGGTGCCCACA"	-4.32662377777751	13.1017141112122	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCATGGTGCCCACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2281.85217705671	43.3169353493437	0.0189832346656289	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2273.23930146015	2273.23930146015
"healthy-4"	"2019-08-01-count-3:GAGGGTACAAGCGCTC"	-2.64148984375651	9.49087045276491	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGTACAAGCGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.54481366958	44.8594804591953	0.0228578120340176	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1959.10435355983	1959.10435355983
"healthy-4"	"2019-08-01-count-3:GAGTCATAGCGAGTAC"	-4.06919799271281	-5.34855987941893	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATAGCGAGTAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2921.97000116789	48.1584725010661	0.0164815081885911	2772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2915.55299220352	2915.55299220352
"healthy-4"	"2019-08-01-count-2:ACACGCGCACGTACAT"	5.06778444823567	-7.68529512798461	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACGCGCACGTACAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2859.22882441776	41.4380460473206	0.0144927351366356	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2852.24210771582	2852.24210771582
"healthy-4"	"2019-08-01-count-3:GAGTCATAGGGTTAGC"	11.1398140388424	5.813449836615	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCATAGGGTTAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.06949098915	42.6715123291814	0.0225528251115519	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1881.02446354955	1881.02446354955
"healthy-4"	"2019-08-01-count-4:CTCAGTCAGAGGATGA"	-0.17508995059188	7.56641957843629	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCAGAGGATGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.80551469273	41.0339896920623	0.0209271084687318	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1953.15140831724	1953.15140831724
"healthy-4"	"2019-08-01-count-2:CTGAGGCAGCGTGTTT"	9.63705601271931	6.7245769270691	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAGGCAGCGTGTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.0856353958	41.6738026039215	0.0226108878521925	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1837.87141189222	1837.87141189222
"healthy-4"	"2019-08-01-count-3:CATACTTTCGGTCACG"	-1.2232577604359	8.3283595808777	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACTTTCGGTCACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2118.15563508036	44.3793497339393	0.0209518833266733	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2108.25617215202	2108.25617215202
"healthy-4"	"2019-08-01-count-2:GTCAAACGTACGATTC"	10.4729525047237	5.89767882907716	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAACGTACGATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.68065726468	38.9629286450062	0.0208952286243808	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1859.71166563394	1859.71166563394
"healthy-4"	"2019-08-01-count-2:CTGATCCCAGAATCGG"	3.93604340133016	-6.27278664028319	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGATCCCAGAATCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.40190268956	47.1177450792791	0.018409670255291	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2553.26679006299	2553.26679006299
"healthy-4"	"2019-08-01-count-3:ACCACAACATGTGACT"	-0.70016179505046	8.1587867506775	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAACATGTGACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.1520020155	46.1913714800269	0.0217151249352468	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2115.9319937444	2115.9319937444
"healthy-4"	"2019-08-01-count-4:ATGGAGGAGTGATCGG"	11.0820309120113	6.41853616321412	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGAGTGATCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2280.06981756702	45.3845381686556	0.019904889674424	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2272.70140291257	2272.70140291257
"healthy-4"	"2019-08-01-count-2:CACCGTTAGATGCTAA"	3.33302654799764	-6.53711225902709	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCGTTAGATGCTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.52750020459	45.2047816750152	0.0193801709394853	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2329.84243858244	2329.84243858244
"healthy-4"	"2019-08-01-count-4:TGGAGAGAGCCTCAGC"	3.12976326522176	-5.96353628551634	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGAGAGCCTCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.25927389546	46.3003187138199	0.0177378236625218	2015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2603.72180716992	2603.72180716992
"healthy-4"	"2019-08-01-count-4:ATGGAGGTCGCTAAAC"	4.24055256423299	-6.86747124111327	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGAGGTCGCTAAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.83161313891	47.317943512241	0.0214318624802045	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2203.47245081488	2203.47245081488
"healthy-4"	"2019-08-01-count-2:ACAGCCGCACCCTATC"	-3.02447162094768	9.38029382312623	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAGCCGCACCCTATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.24301712323	43.0915344320778	0.0204881385941875	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2103.24301712323	2103.24301712323
"healthy-4"	"2019-08-01-count-4:ATGGATCAGGTGATAT"	3.69944228705708	-6.39529468929442	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGATCAGGTGATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.79682286284	47.5025616202561	0.0194539370251791	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2439.17666280348	2439.17666280348
"healthy-4"	"2019-08-01-count-3:TAGGTTGCACCCATAA"	0.223190714686555	8.12294480884401	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTTGCACCCATAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1872.48942531828	47.1444133534536	0.0251773989834096	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1867.71978186805	1867.71978186805
"healthy-4"	"2019-08-01-count-3:TGGTGATAGTCACTAC"	5.43188585814778	-10.1723852387634	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGTGATAGTCACTAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.94580319462	47.4412271864139	0.0184456558639327	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2561.78954961889	2561.78954961889
"healthy-4"	"2019-08-01-count-2:TGACAGTCACATCATG"	10.2606245475704	7.65307376468507	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACAGTCACATCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2171.88907538286	46.9886584397371	0.0216349255458426	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2163.0054741817	2163.0054741817
"healthy-4"	"2019-08-01-count-4:GTCTACCTCCACCTGT"	-1.55454943600352	8.71264932239381	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCTCCACCTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.32702939279	41.9706117765576	0.0207331182991451	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2019.45290967178	2019.45290967178
"healthy-4"	"2019-08-01-count-4:CTCATGCGTAGAGACC"	-2.56086383286174	8.90282628619996	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCGTAGAGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2026.09238647736	40.5489171114053	0.0200133603887161	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2018.93972406563	2018.93972406563
"healthy-4"	"2019-08-01-count-4:ATGGGTTTCTTTGCTA"	2.7253974872524	-6.02779772197875	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGGGTTTCTTTGCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2812.81619389052	46.6093893356085	0.0165703644044871	2289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2808.41036593828	2808.41036593828
"healthy-4"	"2019-08-01-count-3:ACCCAAAGTGTCCATA"	5.07029881057088	-7.77588179027709	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCAAAGTGTCCATA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3061.45534931933	45.0821116970234	0.0147257126278346	2983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3053.65355618984	3053.65355618984
"healthy-4"	"2019-08-01-count-4:TGGATCATCACCCTCA"	3.12499680098836	-5.14804079448851	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATCATCACCCTCA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2954.35628897358	40.2770098501503	0.0136330915808884	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2944.58209110421	2944.58209110421
"healthy-4"	"2019-08-01-count-2:CTGCCATGTACTAGCT"	10.4949528175289	7.4914831885132	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATGTACTAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2138.24757387609	45.6618821552837	0.0213548153699108	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2127.93690394261	2127.93690394261
"healthy-4"	"2019-08-01-count-2:CACGGGTTCGCTCCTA"	-2.20426998558696	9.15796372974244	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGGGTTCGCTCCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.99718486227	51.4275823137219	0.0258430427464556	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1976.5634355874	1976.5634355874
"healthy-4"	"2019-08-01-count-2:TGACCCTTCACAGTGT"	10.4797417121822	6.31195161426393	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTTCACAGTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1909.23487623449	51.5390891228184	0.026994630029212	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1905.85908687152	1905.85908687152
"healthy-4"	"2019-08-01-count-4:CTCATTAAGACGACTG"	14.290321012109	2.04149041259614	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATTAAGACGACTG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1409.84839139031	49.0124538593076	0.0347643435695766	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1394.66179379639	1394.66179379639
"healthy-4"	"2019-08-01-count-4:CTCCAACAGAGCATCG"	-2.60785327377971	9.90924737537233	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCAACAGAGCATCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.5489677453	40.9574379924087	0.0251342173835247	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1618.53829714707	1618.53829714707
"healthy-4"	"2019-08-01-count-4:GTCTGTCAGATCCTAC"	-4.03509889069255	10.6167325743469	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCAGATCCTAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.63207902136	46.8616436361849	0.0222977390305188	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2093.18614743949	2093.18614743949
"healthy-4"	"2019-08-01-count-3:ACCCTCAGTCTGTGTA"	3.17575110968892	-6.20918419277342	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCAGTCTGTGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.44661642569	47.4679146702687	0.0210926641511099	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2249.256542382	2249.256542382
"healthy-4"	"2019-08-01-count-2:TGACGCGAGCGCGTTC"	3.6516384082729	-6.54188682949217	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGAGCGCGTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.18608097634	50.1986047950945	0.0217104519433392	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2312.18608097634	2312.18608097634
"healthy-4"	"2019-08-01-count-4:GTCTGTCTCCCGTTCA"	10.4398247199947	6.20070312106935	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTGTCTCCCGTTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1687.45949699501	44.4451582760968	0.0263385037420121	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1683.28385970477	1683.28385970477
"healthy-4"	"2019-08-01-count-4:ATGTCCCTCATGCATG"	4.46411051329915	-7.28100445186766	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCTCATGCATG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.97331047141	39.0646110806207	0.0152836537535737	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2551.99470010029	2551.99470010029
"healthy-4"	"2019-08-01-count-3:CATCGTCCATAATCGC"	-3.14122806015666	9.14501473987428	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCGTCCATAATCGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2060.79256311423	42.768441386431	0.0207533946656912	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.96164587732	2058.96164587732
"healthy-4"	"2019-08-01-count-2:TGACGCGGTCAGCTTA"	11.0447193580562	6.16742608630983	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACGCGGTCAGCTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2022.75998656641	45.1599036801313	0.0223258834365164	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2014.38108083271	2014.38108083271
"healthy-4"	"2019-08-01-count-2:TACCGGGTCTTGGCTC"	2.28283872184102	-6.34037401592406	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGTCTTGGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.80105830021	43.2913639284856	0.0202598944624836	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2136.80105830021	2136.80105830021
"healthy-4"	"2019-08-01-count-3:GAGTTTGTCTTGGTGA"	14.4088140922481	2.08551452243654	"2019-08-01-count-3"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTTGTCTTGGTGA"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1187.80647421698	24.1234516350714	0.0203092441055887	2391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1169.48441036403	1169.48441036403
"healthy-4"	"2019-08-01-count-2:TGACTCCAGCTGACAG"	6.77295078810994	-1.73628606712493	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACTCCAGCTGACAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2899.23070315358	32.2766802370584	0.0111328429993343	2397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2886.7774218392	2886.7774218392
"healthy-4"	"2019-08-01-count-2:TCATTCATCAAGAATG"	11.3004147010738	5.41322038257448	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCATCAAGAATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.44795199097	39.5262620023433	0.0199683259984618	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.33320125696	1975.33320125696
"healthy-4"	"2019-08-01-count-4:ATTACCTCATAGGAGC"	3.91902651366536	-6.59071304714354	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTCATAGGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.60419033302	49.3418633655329	0.0210988518576573	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2335.9801841066	2335.9801841066
"healthy-4"	"2019-08-01-count-2:CACGTTCCACCCTTGT"	11.3432795005733	5.8891973265442	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCCACCCTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.32616063659	44.612647826287	0.0220056588291044	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2020.43737111261	2020.43737111261
"healthy-4"	"2019-08-01-count-2:TCATTGTAGATTGCGG"	10.4612137275631	6.34570643985597	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTGTAGATTGCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.53130333522	43.224138859183	0.0238869251830653	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1805.39539320775	1805.39539320775
"healthy-4"	"2019-08-01-count-2:AGCCACGAGATGGTAT"	4.49319185790364	-6.74747755443724	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCACGAGATGGTAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2824.03162966105	43.5807223739567	0.0154320942854268	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2814.62143707828	2814.62143707828
"healthy-4"	"2019-08-01-count-4:AGGAGGTCAACCGCCA"	-7.15391288223918	3.13784406268922	"2019-08-01-count-4"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAGGTCAACCGCCA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2742.7888621627	46.4345160981345	0.0169296721080895	2812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2722.2653240471	2722.2653240471
"healthy-4"	"2019-08-01-count-4:ATTACCTTCTCTCGAC"	10.9691902595455	6.28520295703737	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTTCTCTCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2074.19254162708	44.0503711125523	0.0212373587449107	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2067.82397587553	2067.82397587553
"healthy-4"	"2019-08-01-count-2:CTGGACGAGCGATCGA"	10.7490316825802	6.47577474201051	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGACGAGCGATCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1774.7721976332	43.756046716107	0.024654458061975	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1767.65714823511	1767.65714823511
"healthy-4"	"2019-08-01-count-4:GTGAGGAAGTATTAGG"	2.67735471305196	-5.94712593471678	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGGAAGTATTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.29505751971	46.7481431029019	0.0193470341949415	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.32328525406	2413.32328525406
"healthy-4"	"2019-08-01-count-2:GTCCCATAGGCGATAC"	10.2690531211788	7.29619834506837	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATAGGCGATAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1980.13126246848	48.0797661627612	0.0242811004876635	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.39241725644	1973.39241725644
"healthy-4"	"2019-08-01-count-4:ATTACTCTCTACTGAG"	-2.02420912209209	9.3813848265442	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACTCTCTACTGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.96622723722	45.2293886100614	0.0232426380154992	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1940.64006122338	1940.64006122338
"healthy-4"	"2019-08-01-count-2:ACCAAACAGTTCACTG"	10.8604504066402	6.23542592609254	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCAAACAGTTCACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.07568306871	37.4917465965306	0.0189632328785401	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.03499486037	1969.03499486037
"healthy-4"	"2019-08-01-count-4:TGGGCGTCACTTTATC"	10.9337536292965	6.55423781955568	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTCACTTTATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.85080885983	47.7344997278811	0.0247604739477286	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1922.87240121661	1922.87240121661
"healthy-4"	"2019-08-01-count-3:GATCAGTAGTATCTGC"	3.28375758704488	-6.06169512188109	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCAGTAGTATCTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2782.16259540363	39.4961160824996	0.0141961926120891	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2775.08473952757	2775.08473952757
"healthy-4"	"2019-08-01-count-3:TTTGACTTCACCTGTC"	-1.9538816017216	3.46862123096315	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGACTTCACCTGTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2854.86256312345	48.200336684295	0.0168835926839014	4149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2847.71093409009	2847.71093409009
"healthy-4"	"2019-08-01-count-3:GATCAGTTCCTCGATC"	-2.2012086910313	3.59679863536683	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCAGTTCCTCGATC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3123.44256375301	46.2703134679717	0.0148138832469437	4160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3114.11175422898	3114.11175422898
"healthy-4"	"2019-08-01-count-3:TTTGATCTCGGTGTTA"	4.08822550353352	-6.91016342556151	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGATCTCGGTGTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.69537108256	43.5743267806205	0.0184504434035651	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2353.14653774457	2353.14653774457
"healthy-4"	"2019-08-01-count-2:CTGGTCTGTCTCTCCA"	10.8422800498897	6.7232889899048	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGTCTGTCTCTCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.80824093635	42.806999662191	0.0221018264779253	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1928.68501507763	1928.68501507763
"healthy-4"	"2019-08-01-count-2:CACTGAAAGGCCTAAG"	10.9121662574703	6.53940866077272	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAAAGGCCTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.01960716586	41.7625754893712	0.0208915286972001	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.14855574456	1991.14855574456
"healthy-4"	"2019-08-01-count-3:TATCTTGAGGATTACA"	4.22938217696492	-6.54792215740355	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTTGAGGATTACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.17728111202	41.5631842654431	0.0154155976895928	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2690.84529655528	2690.84529655528
"healthy-4"	"2019-08-01-count-2:TGAGGAGGTTATTCTC"	0.53500317510907	8.13138578021852	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGAGGTTATTCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1754.60895574413	41.2115558497274	0.0234876014480671	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1744.72045063792	1744.72045063792
"healthy-4"	"2019-08-01-count-2:CTGGTCTTCTGCTTAT"	4.78811707076375	-6.99484875118407	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGTCTTCTGCTTAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.06867813193	43.5398487217465	0.0154119611529363	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2820.20746074181	2820.20746074181
"healthy-4"	"2019-08-01-count-4:TGGTACACACGCGGTT"	11.2616430717403	5.4203219183716	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTACACACGCGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.59401691965	41.887575772544	0.0208230763365892	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2001.22932275097	2001.22932275097
"healthy-4"	"2019-08-01-count-2:ACCACAAAGACCCGCT"	0.126078021794003	7.73624847019044	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAAAGACCCGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2096.74793741952	47.3509334799916	0.0225830356787028	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.70601811445	2087.70601811445
"healthy-4"	"2019-08-01-count-3:GATCCCTCACGTTGGC"	4.65709414061849	-6.75036957180174	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCCCTCACGTTGGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2855.50871385939	44.3526456188735	0.0155323096734411	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2849.92837632003	2849.92837632003
"healthy-4"	"2019-08-01-count-3:CATGGTACAAGAATAC"	-4.39292273941691	12.6914348372254	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTACAAGAATAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2501.35426231992	39.0028131533058	0.015592678630468	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2497.99483070993	2497.99483070993
"healthy-4"	"2019-08-01-count-2:GTCGAATAGATCGCTT"	-3.79149375382121	10.802502609137	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGAATAGATCGCTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2137.875977075	42.2350722988638	0.0197556232221895	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2127.2539642835	2127.2539642835
"healthy-4"	"2019-08-01-count-3:GATCGTAGTTGGTAGG"	-1.9172844690388	8.66148564899293	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCGTAGTTGGTAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1956.11758863848	43.47352446626	0.0222243921933747	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1949.25709427463	1949.25709427463
"healthy-4"	"2019-08-01-count-2:ACCACAAGTTCGGACC"	-2.25915251198466	9.12095544421998	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAAGTTCGGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1813.19354399005	48.4546167068319	0.0267233560738389	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1811.28776037213	1811.28776037213
"healthy-4"	"2019-08-01-count-3:TATTCCAAGAAGGCTC"	-2.85227213326152	9.67445275867311	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCAAGAAGGCTC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1937.31050414498	41.6693632090591	0.0215088717683124	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1933.56275775747	1933.56275775747
"healthy-4"	"2019-08-01-count-2:CACTGTCAGACCTTTG"	4.45673002776448	-6.69125082409056	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCAGACCTTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.04648551821	47.872660973387	0.0175354746621833	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2722.56399123336	2722.56399123336
"healthy-4"	"2019-08-01-count-4:CTCTCGACACCGGCTA"	0.751037855714005	8.192995048407	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCGACACCGGCTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.26505655489	43.7818353458232	0.0220090506298074	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1983.07615611431	1983.07615611431
"healthy-4"	"2019-08-01-count-3:TTTGTTGCAGTAGTGG"	4.596208234399	-6.63032534038695	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGTTGCAGTAGTGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.67727302645	46.1914115335131	0.0171163154613562	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2690.93630092832	2690.93630092832
"healthy-4"	"2019-08-01-count-2:TGATCAGAGAATAGTC"	10.1221519905025	6.71894452655641	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCAGAGAATAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.05327078456	43.3745650125689	0.0229124904628768	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1879.51337513097	1879.51337513097
"healthy-4"	"2019-08-01-count-2:TGATCAGAGACTACGG"	10.6717173057491	7.35100171649782	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATCAGAGACTACGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.14904085737	36.9057475873328	0.0176654450523008	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2082.52477022156	2082.52477022156
"healthy-4"	"2019-08-01-count-2:CACTGTCGTCCCGTGA"	9.92918648299519	5.9209675558838	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGTCGTCCCGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1891.72691888545	42.5271323739791	0.022480587419581	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1888.65194188773	1888.65194188773
"healthy-4"	"2019-08-01-count-3:GATGAGGCATAATGCC"	-2.60131297531779	3.87388203227846	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGAGGCATAATGCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3555.2305638529	46.4392114811017	0.0130622221673224	5612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3546.28357892178	3546.28357892178
"healthy-4"	"2019-08-01-count-4:ATTCCATCAAGTGACG"	11.1402031379635	4.65850923145143	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCATCAAGTGACG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.79082079243	41.6835156369838	0.0208857136743586	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.01455322636	1987.01455322636
"healthy-4"	"2019-08-01-count-4:GGGAAGTAGGCTTCCG"	2.09663524207417	-6.55782272731932	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAAGTAGGCTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1643.21972223195	40.1597405144086	0.0244396655974043	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1641.21535866332	1641.21535866332
"healthy-4"	"2019-08-01-count-2:CACTTCGTCGGCTGTG"	0.624243636696976	7.87083385074464	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTTCGTCGGCTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.13685677464	40.7912112326887	0.0219527485739098	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1849.60965553234	1849.60965553234
"healthy-4"	"2019-08-01-count-2:CAGAGCCAGCAGTACG"	0.458087672560853	8.17068193042604	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGAGCCAGCAGTACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1810.65937209286	43.6402367872289	0.0241018479012908	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1806.39824286619	1806.39824286619
"healthy-4"	"2019-08-01-count-2:GTCGTTCCATCATCCC"	4.67304052886311	-6.95664169704589	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTTCCATCATCCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.59835845536	47.4972259058228	0.0200190755997762	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2370.43746709765	2370.43746709765
"healthy-4"	"2019-08-01-count-4:TGTAACGAGTTAACGA"	0.0658470802823126	7.61466548526613	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGAGTTAACGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1790.10149163731	48.2786690272476	0.0269697943121034	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1787.61782910949	1787.61782910949
"healthy-4"	"2019-08-01-count-3:ACGTAACTCTTTGCAT"	4.24032940444295	-6.79932453548583	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACTCTTTGCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.07050329497	46.1256309620978	0.01798922100731	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2554.89096097558	2554.89096097558
"healthy-4"	"2019-08-01-count-4:TGTAACGGTCTTGCGG"	2.25857557830159	-6.37564470684203	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGGTCTTGCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.07194902858	39.9250236547576	0.0177754874112671	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2244.33542216641	2244.33542216641
"healthy-4"	"2019-08-01-count-3:GATGGAGCAATGACCT"	0.0516635888720907	7.63212726199952	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGGAGCAATGACCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2000.38026831728	46.7627202551121	0.0233769153774191	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.89132419345	1996.89132419345
"healthy-4"	"2019-08-01-count-3:ACGTACACATTGTAGC"	-1.65118680420573	8.47050950610963	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACACATTGTAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.47693891816	45.7789892569563	0.022668735836855	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2010.41023994516	2010.41023994516
"healthy-4"	"2019-08-01-count-2:CAGATACCACCAGCGT"	-3.55151544037517	10.1076459654602	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATACCACCAGCGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2160.640676294	50.0425195912195	0.0231609633847374	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2157.81236504491	2157.81236504491
"healthy-4"	"2019-08-01-count-3:GATGTTGCACAACGTT"	0.126888332038563	7.64150331104127	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGTTGCACAACGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.52721277728	40.9460376513828	0.0204778596608895	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.41806492536	1996.41806492536
"healthy-4"	"2019-08-01-count-2:ACCCTTGAGCTTGTGT"	-2.57694421234782	3.4243764647278	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGAGCTTGTGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3235.50277821759	48.1131558922335	0.0148703800275327	5463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3228.38683536592	3228.38683536592
"healthy-4"	"2019-08-01-count-4:CTGATCCCAAGAATAC"	3.88703813132588	-6.66430761730345	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCCAAGAATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.36372407266	40.657798692653	0.015334674123926	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2644.00378510616	2644.00378510616
"healthy-4"	"2019-08-01-count-3:TATTGGGTCAAGCCGC"	-0.0248311040108979	7.8659572371277	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGTCAAGCCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.91707396786	43.6566558169868	0.0232845795812169	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1869.58963467344	1869.58963467344
"healthy-4"	"2019-08-01-count-2:ACCCTTGTCCTCAGAA"	-1.78842900219615	9.01741216266481	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCCTTGTCCTCAGAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.03409147869	37.8923333847764	0.0202412624627182	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1865.07237781642	1865.07237781642
"healthy-4"	"2019-08-01-count-4:CTGATCCGTGTTGAGG"	3.72897996482198	-6.28881075298461	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCGTGTTGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.35570420408	44.3998182107142	0.0178502086113661	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2481.82001486172	2481.82001486172
"healthy-4"	"2019-08-01-count-2:GTCTCACCATGGATCT"	-0.264254490763503	7.65236995303956	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACCATGGATCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.93633808625	41.9781921924724	0.0222940050300041	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1874.86524043913	1874.86524043913
"healthy-4"	"2019-08-01-count-4:TGTACAGCAAATGGTA"	-1.8741332096165	8.81365392291871	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGCAAATGGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.23302565911	39.2267869025041	0.0208516363297208	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1875.6300841077	1875.6300841077
"healthy-4"	"2019-08-01-count-4:TGTACAGCAGAGAAAG"	2.92377461966817	-6.24379255687865	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGCAGAGAAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.86727393009	40.0168923178557	0.0173920907004354	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2298.49116590666	2298.49116590666
"healthy-4"	"2019-08-01-count-3:TCAAGCAAGGAACGAA"	11.3499800163204	4.74374482715455	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGCAAGGAACGAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2205.15171832044	37.2716798937182	0.0169020932138431	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2192.27252986431	2192.27252986431
"healthy-4"	"2019-08-01-count-4:AAAGTCCAGGGCTAAC"	-0.535927216440994	7.82273814761964	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTCCAGGGCTAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2184.02833741597	39.8333699742439	0.0182384858711919	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2177.14097966071	2177.14097966071
"healthy-4"	"2019-08-01-count-4:GTGGCGTTCTACTCAT"	-0.047862502664882	8.03596112811891	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGCGTTCTACTCAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.42355810049	46.0389826451733	0.0242511648408107	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.59877328634	1895.59877328634
"healthy-4"	"2019-08-01-count-3:CATTTCATCGAGAAAT"	10.9935766654903	5.95361898029176	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTTCATCGAGAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1859.41407231463	47.7320193114383	0.0256704625516901	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1850.36781071696	1850.36781071696
"healthy-4"	"2019-08-01-count-4:ATTCTTGTCCGTCAAA"	10.9697929817135	6.56175611102907	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGTCCGTCAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2044.55512497541	41.9400456622858	0.0205130422505924	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2037.51844054658	2037.51844054658
"healthy-4"	"2019-08-01-count-3:GATTGGTCAACGTTAC"	-3.61517010155376	3.66131351077882	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTCAACGTTAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3311.83816113521	46.1859125685076	0.0139457033590906	5274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3303.20667999634	3303.20667999634
"healthy-4"	"2019-08-01-count-2:CTTCAATGTCTGCATA"	-4.17875705185588	12.4306955107483	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATGTCTGCATA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1970.33385701635	44.5677256220726	0.022619377656922	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1960.79736600252	1960.79736600252
"healthy-4"	"2019-08-01-count-3:CCAAGCGAGGATGAGA"	2.11481465873067	-6.15396120464476	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCAAGCGAGGATGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.12386323967	45.1905550500195	0.0199154201240915	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2265.70766484601	2265.70766484601
"healthy-4"	"2019-08-01-count-2:GTCTTTAGTAACACCT"	11.3055426078731	5.68363235080568	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTTTAGTAACACCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2469.22485236659	44.7125255228074	0.0181079197708355	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2455.16866623614	2455.16866623614
"healthy-4"	"2019-08-01-count-4:ATTGGGTTCCGTCACT"	11.1200128990108	5.33779809558717	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTGGGTTCCGTCACT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.88473967962	46.0165154551299	0.0237702764590962	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.9659799915	1932.9659799915
"healthy-4"	"2019-08-01-count-2:CTTCAATTCGCAAGAG"	0.295172859996003	7.68063447559205	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCAATTCGCAAGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2111.47859372919	42.6046868449445	0.0201776551140394	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2104.54937983039	2104.54937983039
"healthy-4"	"2019-08-01-count-4:TGTAGACTCATCACTT"	3.51484622535054	-6.10041477596434	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAGACTCATCACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.83624965167	42.3167153405169	0.0175018946575118	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2414.37715608463	2414.37715608463
"healthy-4"	"2019-08-01-count-3:TCAATCTTCACCTGTC"	-4.00577769699748	12.9935312041077	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATCTTCACCTGTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2063.77115875244	41.5557560555051	0.0201358352544406	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2054.50638721939	2054.50638721939
"healthy-4"	"2019-08-01-count-4:TGTCAGAAGTGGTCAG"	2.88756646689717	-5.85843613063964	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCAGAAGTGGTCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.8591172071	40.5814838540203	0.0159904399652728	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2533.43709109676	2533.43709109676
"healthy-4"	"2019-08-01-count-3:GCAACATAGTGAGTGC"	-2.26645884934123	8.82877156818239	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACATAGTGAGTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.6543486591	46.9279101204119	0.0226852350422053	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2061.7849173987	2061.7849173987
"healthy-4"	"2019-08-01-count-2:CAGCAATTCCAGTTCC"	-1.85126088085826	8.62583253467409	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATTCCAGTTCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.07725690423	45.7598618592117	0.0212729978490257	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.9086218819	2142.9086218819
"healthy-4"	"2019-08-01-count-4:AAATGGAGTACAGAGC"	11.0778776603634	6.51376674259035	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAATGGAGTACAGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.61284346544	40.2195158444765	0.0208974578866769	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1912.38845147497	1912.38845147497
"healthy-4"	"2019-08-01-count-2:TGCAGTAGTGCAGTGA"	10.6946999031002	6.28468988025514	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTAGTGCAGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1842.5683050262	46.069741253237	0.025003003214354	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1833.9201204023	1833.9201204023
"healthy-4"	"2019-08-01-count-3:GCAACCGCATGCCGCA"	-1.55925951424297	3.62349436366884	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACCGCATGCCGCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2615.31713169894	40.6945224041753	0.0155600718210949	4558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2609.59506155072	2609.59506155072
"healthy-4"	"2019-08-01-count-2:CAGCACGCATGGCTGC"	6.78836836394612	-1.76543595707091	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCACGCATGGCTGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2792.96446416802	33.5170705971506	0.0120005359993489	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2778.45009180615	2778.45009180615
"healthy-4"	"2019-08-01-count-2:CAGCACGTCTTCCCAG"	3.97855915602986	-6.38943006908568	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCACGTCTTCCCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.53627549089	41.5557503819519	0.0152860753621719	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2711.05484099689	2711.05484099689
"healthy-4"	"2019-08-01-count-4:ATTTCACCAGAACGCA"	6.7972170310909	-1.73780777370604	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTTCACCAGAACGCA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3041.12882273711	36.3646972034983	0.0119576313017773	2253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3030.62895694829	3030.62895694829
"healthy-4"	"2019-08-01-count-4:TGTCCACTCGCCGAAC"	-1.93244073811229	10.0047492750916	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCACTCGCCGAAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1871.62970776125	44.6452454472855	0.0238536742936656	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.43402807648	1866.43402807648
"healthy-4"	"2019-08-01-count-2:GTGAGGATCAGGAACG"	10.4260345893795	5.74997184360353	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGATCAGGAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1821.9170464362	47.8227434559464	0.0262485844509173	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1816.66398285331	1816.66398285331
"healthy-4"	"2019-08-01-count-2:CTTCCTTGTAATCAGA"	4.7901689010555	-7.44429924404296	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCTTGTAATCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.41035405542	45.579338788087	0.0171067263414256	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2658.66206392787	2658.66206392787
"healthy-4"	"2019-08-01-count-2:GTGAGGAAGTCTTGGT"	4.77365221556966	-6.81810858165892	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGGAAGTCTTGGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2766.77759492512	41.8529088871642	0.0151269509207866	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2761.79537718853	2761.79537718853
"healthy-4"	"2019-08-01-count-4:TTTATGCAGGAAACGA"	-2.64058385315593	8.88614270770875	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCAGGAAACGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.29603220696	43.7936867514716	0.0210112604326654	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2082.65800888679	2082.65800888679
"healthy-4"	"2019-08-01-count-3:GCACGGTCACCCAATA"	-0.0534739595955193	7.69633720004884	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTCACCCAATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2096.82442969158	42.5850378761715	0.0203093007088034	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2086.8088226102	2086.8088226102
"healthy-4"	"2019-08-01-count-4:CAAAGAACAAATGAGT"	10.4847265678341	6.34129951083986	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAAGAACAAATGAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1800.55606928666	43.3989526974227	0.0241030831739755	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1789.62707015788	1789.62707015788
"healthy-4"	"2019-08-01-count-2:CTTCGGTTCCATACTT"	10.8512751060421	6.13423535907594	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCGGTTCCATACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.34273193478	44.9180362574875	0.0229837047123353	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.89643976874	1950.89643976874
"healthy-4"	"2019-08-01-count-3:CCACGAGGTGGCTACC"	-3.82651005211528	2.88668058002321	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACGAGGTGGCTACC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3295.0816396981	45.8184403513881	0.0139051001952067	4761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3282.51304088844	3282.51304088844
"healthy-4"	"2019-08-01-count-3:ACTCCCATCATGGATC"	4.78366102752034	-7.33029510891112	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCCCATCATGGATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.16485755194	41.7588075261286	0.016234887668076	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.22489811228	2568.22489811228
"healthy-4"	"2019-08-01-count-2:GTGATGTAGGGCAACT"	3.51219095763509	-6.52599480068358	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGATGTAGGGCAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.03438515311	46.1493738847035	0.0196210455833533	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2344.90172773131	2344.90172773131
"healthy-4"	"2019-08-01-count-3:TCACACCGTTTCCAAG"	10.7375618415767	6.18128392780153	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACACCGTTTCCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1748.5922528104	41.2370094833389	0.0235829762010332	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1739.81683201417	1739.81683201417
"healthy-4"	"2019-08-01-count-2:ACGATGTTCTTCCGTG"	-2.55939135971721	9.56595323169557	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGATGTTCTTCCGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.23461577021	47.4331064321336	0.0243217436756452	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.68240847104	1937.68240847104
"healthy-4"	"2019-08-01-count-4:CAACAACCATCTCAAG"	11.1666037040645	4.63950393283693	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACCATCTCAAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.33143496176	48.113321876456	0.0257107431519416	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1867.41016766306	1867.41016766306
"healthy-4"	"2019-08-01-count-2:GTGATGTGTCCAAAGG"	4.82883276519124	-7.43601753627928	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGATGTGTCCAAAGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.01006287604	45.9768239578152	0.0175953489850745	1829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2608.81365521887	2608.81365521887
"healthy-4"	"2019-08-01-count-2:CAGGCCAGTCTATGAC"	-5.82558665695842	-4.94058802044066	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGCCAGTCTATGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3278.349224755	43.6395342271338	0.0133114354924757	3675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3274.24258871551	3274.24258871551
"healthy-4"	"2019-08-01-count-3:CCACTTGAGGTAATCA"	11.122331281274	6.31652305209962	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACTTGAGGTAATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2165.38028821052	48.4861433682501	0.0223915141521489	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2154.83168244887	2154.83168244887
"healthy-4"	"2019-08-01-count-3:TTACCATCAGAGATTA"	0.569234390824479	7.87229201877443	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACCATCAGAGATTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.36361414383	36.2739298161601	0.020283307896267	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1783.57048524224	1783.57048524224
"healthy-4"	"2019-08-01-count-3:TCACATTCATTCAGGT"	5.61075272139851	-9.54344084179076	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTCATTCAGGT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2988.28250156414	41.9552363001853	0.0140399163326175	2435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2978.54005184243	2978.54005184243
"healthy-4"	"2019-08-01-count-2:CAGGGCTAGAGAGCCT"	-4.15047250214274	13.0735254057678	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGGCTAGAGAGCCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1844.97294959204	40.9849931370201	0.0222144141170648	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1840.93105385994	1840.93105385994
"healthy-4"	"2019-08-01-count-4:CAACAGTAGGTAAAGG"	2.76153268393819	-5.96896412288817	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAGTAGGTAAAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.90874427776	44.7916662643145	0.017867290289906	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2501.48245557188	2501.48245557188
"healthy-4"	"2019-08-01-count-4:CTGGTCTTCTGCTAGA"	11.4994551139766	4.24804017627565	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGTCTTCTGCTAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.86905814398	38.6296737366807	0.0176321234685774	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2176.73076279366	2176.73076279366
"healthy-4"	"2019-08-01-count-2:TAGTGCAGTCTCTCAC"	-1.76951620999034	8.47936437213746	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCAGTCTCTCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2310.33769806969	43.9876779919156	0.0190395014671092	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2301.41519478037	2301.41519478037
"healthy-4"	"2019-08-01-count-4:TTTCAGTTCAAATGCC"	4.0464514690334	-6.43825008785399	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCAGTTCAAATGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.26564117365	47.1243174160605	0.0176676506039064	2255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2664.82203827244	2664.82203827244
"healthy-4"	"2019-08-01-count-3:GGGTGTCTCTTAATCC"	-2.89548955383952	3.46931622112123	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCTCTTAATCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3307.72426709365	47.4382647567893	0.014341662401767	5457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3297.93144894686	3297.93144894686
"healthy-4"	"2019-08-01-count-2:TTCCGTGTCGAGTACT"	10.7673784690792	5.65895173633424	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGTGTCGAGTACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.23006024117	40.4537298517264	0.0223596383570666	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1799.94846373468	1799.94846373468
"healthy-4"	"2019-08-01-count-2:TGCGGCACAGTAGAAT"	-3.1692672771519	9.67692945087282	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGCACAGTAGAAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1969.5153497526	50.2398279455909	0.0255087262721266	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1957.26667995008	1957.26667995008
"healthy-4"	"2019-08-01-count-4:TGTGCGGCATTCGGGC"	11.1540752845699	5.61625812137452	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGCATTCGGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.59993957013	41.2194209051691	0.0219415640536011	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1871.05626983222	1871.05626983222
"healthy-4"	"2019-08-01-count-4:CTGTAGAAGTAGTCCT"	4.2520829635555	-6.4375095597473	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTAGAAGTAGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.02366046392	41.8441352314556	0.0179048830096778	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2337.02366046392	2337.02366046392
"healthy-4"	"2019-08-01-count-3:GGGTTTAAGCAAATGT"	-2.01244507256206	3.93385598743287	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTTTAAGCAAATGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3264.36134063598	45.6183844036704	0.013974673647735	4582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3257.42832750138	3257.42832750138
"healthy-4"	"2019-08-01-count-3:TCACGGGGTCGACGCT"	4.59533180770223	-6.67705252086791	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGGGGTCGACGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.97723917844	43.6912944193007	0.0170404377042366	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2558.53502361894	2558.53502361894
"healthy-4"	"2019-08-01-count-4:CAACCTCGTCAACACT"	10.7733351188595	6.79718492114869	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCGTCAACACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2099.45896336176	47.7669811910409	0.0227520432762134	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.57155527297	2093.57155527297
"healthy-4"	"2019-08-01-count-2:TGCTCCAAGGCGTTAG"	10.0763231712276	6.00027988040773	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCAAGGCGTTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1643.72068968028	28.3743373247443	0.0172622620758417	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1637.46466638021	1637.46466638021
"healthy-4"	"2019-08-01-count-4:CAACCTCTCGCTCCTA"	-0.710340420634109	8.01595351779786	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACCTCTCGCTCCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2310.08992248419	43.6679555776402	0.0189031410217492	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2306.22469446305	2306.22469446305
"healthy-4"	"2019-08-01-count-2:CAGGTATTCTCGTGGG"	4.32635321196858	-7.32782223140868	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATTCTCGTGGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.90220484804	46.5144805346898	0.0182846968118683	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2538.14811209445	2538.14811209445
"healthy-4"	"2019-08-01-count-2:CAGTGCGAGCAGGCTA"	3.73131074485127	-6.54605963146361	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTGCGAGCAGGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.52676080521	41.9903893830378	0.0217057681670736	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1930.83049062171	1930.83049062171
"healthy-4"	"2019-08-01-count-2:GTGCTTCCAAGAGTAT"	-4.37551293793376	12.9917173155579	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCCAAGAGTAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1920.80445926628	43.0283289300361	0.0224012021226108	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1914.9084751832	1914.9084751832
"healthy-4"	"2019-08-01-count-3:TCACTCGCACAATGTC"	0.368950625031632	8.00528714740602	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTCGCACAATGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2037.04998291943	41.744342697875	0.0204925470891237	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2029.16345044985	2029.16345044985
"healthy-4"	"2019-08-01-count-2:TGCTCCACAGACTCTA"	3.07924403724019	-7.29867746746215	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCCACAGACTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.27823230401	47.1065778440407	0.0219072011874326	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2143.21645961452	2143.21645961452
"healthy-4"	"2019-08-01-count-3:CGTGTCTTCTTCCACG"	11.3998905616695	3.91075990283815	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGTCTTCTTCCACG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.25092647265	41.9273442175684	0.0221223182808841	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1878.33352520644	1878.33352520644
"healthy-4"	"2019-08-01-count-2:TGCTCGTCACAATTCG"	-0.0822325897520364	7.56214330280153	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTCGTCACAATTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.84108065594	40.0781176183155	0.0195613598324983	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2041.67945846343	2041.67945846343
"healthy-4"	"2019-08-01-count-3:TCAGCAAAGACGAGCT"	-0.406668911606628	8.15183351123659	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAAAGACGAGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2168.99301212697	44.815949130669	0.0206620993613628	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2158.88651097511	2158.88651097511
"healthy-4"	"2019-08-01-count-4:AACCACATCTAACACG"	2.78193177756612	-6.1143427125183	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCACATCTAACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2727.19857977342	46.9459833472035	0.0172139952313644	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2726.20714266499	2726.20714266499
"healthy-4"	"2019-08-01-count-2:CAGTTCCAGCACGGAT"	2.49194874343221	-6.24346735393675	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCAGCACGGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.01483023161	44.2069511105338	0.0185586380695352	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2376.96196392085	2376.96196392085
"healthy-4"	"2019-08-01-count-2:TGCTGAACAGTAGATA"	-2.00656710091289	3.59971067989198	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAACAGTAGATA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2985.5760493843	42.4280771166582	0.0142110187162735	3883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2973.58013570966	2973.58013570966
"healthy-4"	"2019-08-01-count-4:TCTGTCGGTTCAAGTC"	2.72712912139241	-5.94288732921752	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGGTTCAAGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.17364952871	46.2580565359973	0.0175540828378693	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2626.93469950398	2626.93469950398
"healthy-4"	"2019-08-01-count-3:ACTTTCATCGATCCAA"	0.771089096635026	8.24872682178346	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTCATCGATCCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1710.12741249288	37.4842986852028	0.0219190093155465	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1704.29665394669	1704.29665394669
"healthy-4"	"2019-08-01-count-2:CAGTTCCCACACCAGC"	11.2745663124019	6.41671083057252	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGTTCCCACACCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2091.62979663849	48.1581521094386	0.0230242235919735	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.025476371	2077.025476371
"healthy-4"	"2019-08-01-count-4:TGTTCATTCATCAGTG"	-2.70258627358134	3.74843332851259	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCATTCATCAGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3138.09104000583	44.7594147425641	0.0142632620188358	4532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3130.31158610671	3130.31158610671
"healthy-4"	"2019-08-01-count-2:TGCTTCGCAGGAGGAG"	11.0111690956051	5.91354367816774	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGCAGGAGGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1972.82443771745	40.4321007712412	0.0204945255128839	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1966.25405454638	1966.25405454638
"healthy-4"	"2019-08-01-count-4:TGTTCCGAGCGAGAAA"	-3.85655150833781	3.67964456165162	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCCGAGCGAGAAA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2777.63524701857	42.937745517739	0.0154583815725363	3895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2765.59987486224	2765.59987486224
"healthy-4"	"2019-08-01-count-2:TGCTTCGGTACGGGAT"	0.4592687683994	7.83965299213258	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGGTACGGGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.87292432884	46.1999498809725	0.0259423057366004	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1778.04394192255	1778.04394192255
"healthy-4"	"2019-08-01-count-4:CAAGAGGCAACCACGC"	3.72281302985494	-6.86383440410765	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGAGGCAACCACGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.92685337884	43.709878932285	0.0161295419755651	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2703.69766379808	2703.69766379808
"healthy-4"	"2019-08-01-count-3:GCATCTCTCAAGCCGC"	10.253473897546	7.35871884906618	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCTCAAGCCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2050.76277351987	41.1817946687627	0.020081208416944	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2030.96485804044	2030.96485804044
"healthy-4"	"2019-08-01-count-4:TGTTGAGCACCATTCC"	-4.39187035980876	13.1988496550354	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGAGCACCATTCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2171.27498110964	37.9274130850991	0.0174678073551587	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2165.90993004799	2165.90993004799
"healthy-4"	"2019-08-01-count-4:TGTTGAGGTGGCACTC"	10.4257427650387	7.23301980579225	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGAGGTGGCACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2070.47448260744	45.7113095940106	0.0220776976379078	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2067.50004663151	2067.50004663151
"healthy-4"	"2019-08-01-count-2:ACGTAGTCAATACAGA"	-0.569001058966476	8.3004054793152	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAGTCAATACAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2005.45604461841	41.5664725171894	0.0207266933766671	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.80993690132	1992.80993690132
"healthy-4"	"2019-08-01-count-4:CAAGCTAAGGAGATAG"	-2.79230032387431	3.49410650813905	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGCTAAGGAGATAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3017.1348447527	50.4498644483003	0.0167211169020307	3980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3009.19017329423	3009.19017329423
"healthy-4"	"2019-08-01-count-3:GCATGATCAATTTCCT"	-2.53125796738322	9.51594541156618	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATGATCAATTTCCT"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2114.58714993373	45.0371567615273	0.021298321406587	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2106.13630327015	2106.13630327015
"healthy-4"	"2019-08-01-count-4:CAAGCTATCGACCACG"	-3.18959412995036	10.12108800495	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGCTATCGACCACG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2092.22889868788	51.3228269972874	0.0245302160913053	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.63455799025	2090.63455799025
"healthy-4"	"2019-08-01-count-2:CATACAGTCCCTCTAG"	4.37406506118123	-6.4863867989746	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGTCCCTCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2868.78936121627	46.4943561530487	0.0162069606021324	2172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2862.97293873623	2862.97293873623
"healthy-4"	"2019-08-01-count-2:GTGTAACCACCTATCC"	-0.912849108607131	8.70581624591676	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTAACCACCTATCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.84078642118	41.2786292532489	0.0225832739699777	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1818.74079936305	1818.74079936305
"healthy-4"	"2019-08-01-count-4:GTTCGCTCAGACATCT"	-3.99658809128459	12.46381948078	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCGCTCAGACATCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1775.13818594155	46.1934594107287	0.0260224582945509	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1771.01551539285	1771.01551539285
"healthy-4"	"2019-08-01-count-2:CATACAGTCTGGGCAC"	-4.46652589264567	13.0061616667542	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGTCTGGGCAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2323.69507454138	44.1897546510106	0.0190170195457905	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2322.11643991055	2322.11643991055
"healthy-4"	"2019-08-01-count-2:CATACAGTCGTGGACC"	5.13797487792317	-7.51619102871092	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGTCGTGGACC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2801.71762257881	42.6907591577125	0.0152373525489047	2373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2790.94404096478	2790.94404096478
"healthy-4"	"2019-08-01-count-4:AACCTTTGTACCGGCT"	-2.243555645377	4.08196876132814	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTTTGTACCGGCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3227.97474498811	52.1420372200159	0.0161531738440562	5271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3217.76459244435	3217.76459244435
"healthy-4"	"2019-08-01-count-3:CCCTCAAAGCGCTGCT"	-4.47455153885539	12.7141151198181	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAAGCGCTGCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2300.59600268744	44.1873082722174	0.0192068960480675	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2298.98994945434	2298.98994945434
"healthy-4"	"2019-08-01-count-2:ACTACGAAGACGATAT"	3.59182014045064	-6.48230602657469	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGAAGACGATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.88332701947	48.3054659889687	0.017753596969512	2202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2715.73906894665	2715.73906894665
"healthy-4"	"2019-08-01-count-3:CCCTCAAAGTGGCCTC"	-4.36907277527507	12.3632020720276	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCAAAGTGGCCTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2404.63193119816	45.4407919804495	0.0188971922858097	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2392.37720065954	2392.37720065954
"healthy-4"	"2019-08-01-count-2:ACTACGACATCCAATG"	2.855325837701	-6.45572616970214	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGACATCCAATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1855.8840606844	52.9205385246164	0.0285150024431486	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1855.8840606844	1855.8840606844
"healthy-4"	"2019-08-01-count-4:CAATCGACACGTATAC"	4.36644997176473	-6.66918184673461	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATCGACACGTATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.36179689269	38.9380607436627	0.0145325878680587	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2674.66193705441	2674.66193705441
"healthy-4"	"2019-08-01-count-2:CATACCCCAGTGACCC"	11.3570677238399	5.79471967304078	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCCAGTGACCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2266.08463865298	36.8574451766532	0.0162648140091371	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2258.93968564338	2258.93968564338
"healthy-4"	"2019-08-01-count-3:AGAAGTACACAGTATC"	3.71397914466206	-6.21192457592162	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAGTACACAGTATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.59948366521	44.5750793269195	0.0167600721840607	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2652.50012368002	2652.50012368002
"healthy-4"	"2019-08-01-count-4:AACGGGAGTGGTAACG"	0.376007159321946	7.78684899890748	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGGGAGTGGTAACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.14450787153	39.7858341020174	0.0228241743139231	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1737.58312436281	1737.58312436281
"healthy-4"	"2019-08-01-count-4:AACGTCAAGAGTCACG"	-2.28836546364482	3.61685345256654	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCAAGAGTCACG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3162.66914208653	44.6612892632215	0.0141213915388433	5196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3155.85656775798	3155.85656775798
"healthy-4"	"2019-08-01-count-4:TGAATCGCACCAGCCA"	10.6425577598507	5.75332162463991	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGCACCAGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.83816908979	45.6975195601062	0.0236917333410458	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.33770946925	1917.33770946925
"healthy-4"	"2019-08-01-count-2:AAGAACATCTCTATAC"	-4.16671452942546	12.664391494635	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGAACATCTCTATAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2199.40240741395	46.6241207042404	0.0211985403612706	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2181.70782977078	2181.70782977078
"healthy-4"	"2019-08-01-count-2:TGGATCAAGTTGGGAC"	10.8243996101314	6.38643977725831	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCAAGTTGGGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1847.56510380242	42.1349546023527	0.0228056670455812	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1840.60013514465	1840.60013514465
"healthy-4"	"2019-08-01-count-2:AAGACAACACTTGGCG"	4.50556244429891	-6.94224312221678	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACAACACTTGGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2759.26039292435	42.636211033762	0.0154520432877938	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2750.32495607731	2750.32495607731
"healthy-4"	"2019-08-01-count-3:TTCAGGACACTGTGTA"	-0.136882956058341	7.69118259036867	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCAGGACACTGTGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.85759342064	43.7526683666556	0.0229810614606136	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1899.84956155578	1899.84956155578
"healthy-4"	"2019-08-01-count-2:GTGTTAGCATACCATG"	9.87526764449422	6.79225537860719	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTTAGCATACCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1543.8505051043	48.0137382510557	0.031099991930768	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1537.02352316215	1537.02352316215
"healthy-4"	"2019-08-01-count-3:AGACACTAGGAACGTC"	-4.33320079270061	3.42982671344606	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTAGGAACGTC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2983.18970891895	44.0820041069616	0.0147768021507878	3451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2973.91536619971	2973.91536619971
"healthy-4"	"2019-08-01-count-2:CATACTTCAATGTGGG"	0.211742346256417	8.0180191763672	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTCAATGTGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.15159742215	43.4368123894032	0.0239037912142408	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1811.02553804511	1811.02553804511
"healthy-4"	"2019-08-01-count-4:CAATTTCTCTACTTCA"	4.24283995208089	-7.12494137203368	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATTTCTCTACTTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.5041029137	42.4339673866127	0.0166505391684863	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2542.05967490922	2542.05967490922
"healthy-4"	"2019-08-01-count-3:AGACACTGTACAACGG"	2.90452422675435	-5.84317877208861	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTGTACAACGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2614.96331772553	46.2063697855307	0.0176699877479431	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2609.18857952854	2609.18857952854
"healthy-4"	"2019-08-01-count-4:CACAACAAGCCTCAGC"	11.4923960166866	4.38915155017702	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACAACAAGCCTCAGC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2499.18029515594	39.3021868965925	0.0157260310401656	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2486.05345375492	2486.05345375492
"healthy-4"	"2019-08-01-count-2:TGGCGTGAGGTACAGC"	-0.264930914074737	8.34792039478151	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGCGTGAGGTACAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.00902107009	37.578931268046	0.0222622810654314	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1682.2813520267	1682.2813520267
"healthy-4"	"2019-08-01-count-2:GTGTTCCTCATTCGGA"	3.4864350753719	-6.60002329265746	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTTCCTCATTCGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.55978451359	46.6008597806464	0.0193802042605787	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2397.18165914951	2397.18165914951
"healthy-4"	"2019-08-01-count-3:AGACACTTCAAAGCCT"	-7.01979813996013	3.33706019008485	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACACTTCAAAGCCT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2783.34842991885	44.9845865925651	0.016162039257829	2921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2762.23354656386	2762.23354656386
"healthy-4"	"2019-08-01-count-4:CCATAAGCAGGACATG"	11.2750174003536	5.85089681232301	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGCAGGACATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.51227519845	45.7601086216973	0.0242822024690067	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.17776396335	1876.17776396335
"healthy-4"	"2019-08-01-count-4:CTTCTCTCACACGGAA"	10.4291378456051	7.44493529880372	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTCACACGGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.02226289185	43.6224776301238	0.021909588076009	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1980.62275511153	1980.62275511153
"healthy-4"	"2019-08-01-count-3:TCATCATTCGTCAGAT"	10.4446073966915	6.05584333026735	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCATTCGTCAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.45765018739	41.854250825757	0.0224364518924097	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1857.83524524486	1857.83524524486
"healthy-4"	"2019-08-01-count-4:TTACCGCTCTATTGTC"	10.9451376396114	6.27461860263673	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCTCTATTGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.60295209681	43.09948374217	0.0215324841008156	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1995.2397138002	1995.2397138002
"healthy-4"	"2019-08-01-count-2:CATCAAGTCACAGAGG"	0.501856078475159	7.93876788699952	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGTCACAGAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1793.76460940722	42.8423317840579	0.0238840322522674	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1788.58581966363	1788.58581966363
"healthy-4"	"2019-08-01-count-4:AAGATAGGTCGCAACC"	10.8404537635738	6.38733718479005	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGATAGGTCGCAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1906.6176555667	45.4794555467699	0.0238534744572331	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1903.12641956086	1903.12641956086
"healthy-4"	"2019-08-01-count-4:CACACAAAGAATCGAT"	10.3888641792232	6.55113980853883	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAAAGAATCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1977.42168855702	44.7706953332531	0.0226409448183627	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1967.45704303824	1967.45704303824
"healthy-4"	"2019-08-01-count-3:TCATGAGAGAGCACTG"	2.52373923835103	-6.23655130779418	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGAGAGAGCACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.49201995842	45.5875042635274	0.0191424131936933	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2379.06065267857	2379.06065267857
"healthy-4"	"2019-08-01-count-4:AAGCATCCAGACTGCC"	0.332797517150086	7.73360250079957	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCATCCAGACTGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1981.89540842512	45.5300253904992	0.0229729708222488	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1969.94788689731	1969.94788689731
"healthy-4"	"2019-08-01-count-4:AAGCCATAGATGTTCC"	1.66512133654897	-5.98972322857054	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATAGATGTTCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2715.88228673087	44.0101059045811	0.016204717752166	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2711.5823932604	2711.5823932604
"healthy-4"	"2019-08-01-count-2:ACTCCCACATGGGATG"	1.99290468272511	-6.3231730691162	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCACATGGGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.83915672987	43.2106774135893	0.0189700301208377	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2276.47283271947	2276.47283271947
"healthy-4"	"2019-08-01-count-4:CACACAATCTAGTTCT"	4.5571834045345	-6.76444294368895	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAATCTAGTTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3081.09510271328	47.5225244624674	0.0154239070454586	2554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3075.09104971888	3075.09104971888
"healthy-4"	"2019-08-01-count-4:AAGCCATCAGCACGAA"	10.8654619651729	6.5939526327881	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCCATCAGCACGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.97555554403	49.5712783223713	0.0246258719763609	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2005.34614016484	2005.34614016484
"healthy-4"	"2019-08-01-count-3:GCCATGGGTCCAACGC"	14.1180025535518	1.9301992424759	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGGTCCAACGC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1227.49774255277	32.8994683179331	0.0268020601402604	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1215.34086918857	1215.34086918857
"healthy-4"	"2019-08-01-count-3:GTAAGTCTCCAGTTCC"	11.0708080726558	5.75821397388307	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAAGTCTCCAGTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1858.30442344061	47.1692550335886	0.0253829536423617	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1854.92338697824	1854.92338697824
"healthy-4"	"2019-08-01-count-3:TCATGCCCAGCCGGTT"	-4.43415008011516	-4.74943067943724	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCCAGCCGGTT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3005.08756453959	40.2625811122397	0.0133981390716674	2598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2999.60787108453	2999.60787108453
"healthy-4"	"2019-08-01-count-4:CACATGACAATGTCAC"	2.27403678473775	-6.05108501827391	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGACAATGTCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2923.27336007678	47.8819505193313	0.016379566541144	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2910.21024391149	2910.21024391149
"healthy-4"	"2019-08-01-count-4:TTAGGGTAGTATGAGT"	-3.03192601624187	9.36629674518434	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTAGTATGAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1959.37945194615	45.0072589146914	0.0229701596951974	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1953.43030943086	1953.43030943086
"healthy-4"	"2019-08-01-count-4:AAGCGAGAGCACCGAA"	11.7088772254879	3.67534277522889	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGAGCACCGAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2302.81092498177	36.4405793602397	0.0158243905154862	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2272.0926591024	2272.0926591024
"healthy-4"	"2019-08-01-count-3:GCCCGAAAGTTAACAG"	11.2278992134029	6.14267156207887	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAAAGTTAACAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.69600095836	43.8726905344101	0.0219396800880653	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.11965625357	1998.11965625357
"healthy-4"	"2019-08-01-count-2:ACTGATGAGGTCATTC"	3.5081738429958	-6.10827352916869	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGATGAGGTCATTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.93410040329	45.9415302229778	0.0173042073684613	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2650.42985069466	2650.42985069466
"healthy-4"	"2019-08-01-count-3:CCGGGTAAGGTCACTT"	4.1305419403011	-6.49733021175536	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGGTAAGGTCACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.92960099368	42.2233753137856	0.0160916570695325	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2622.85705337516	2622.85705337516
"healthy-4"	"2019-08-01-count-3:GTAATGCGTAGTGTGG"	0.151855190365952	7.66082570636598	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCGTAGTGTGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.29396437093	39.9036054256015	0.0220061425282716	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1808.84177247253	1808.84177247253
"healthy-4"	"2019-08-01-count-4:GTAACCACACAACCGC"	3.1028696494991	-5.08754208004149	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAACCACACAACCGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2916.1389507233	41.5719196628725	0.014255808919037	2922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2909.89066577908	2909.89066577908
"healthy-4"	"2019-08-01-count-1:CCCGGAAAGCGGCTCT"	11.0517069297725	6.43867824161378	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCCGGAAAGCGGCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2072.55651811918	41.9044182618912	0.0202187095481087	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2066.5829409303	2066.5829409303
"healthy-4"	"2019-08-01-count-4:TTAGTCTGTAGATGTA"	10.6784588294918	6.24968431079713	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGTCTGTAGATGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.67549068075	42.4997362022475	0.0214463651602453	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1976.90300713824	1976.90300713824
"healthy-4"	"2019-08-01-count-2:GAATCACTCTGCGATA"	2.07612742957417	-6.43565847789916	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCACTCTGCGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.18156012274	47.1863733557879	0.0235439614327647	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2004.18156012274	2004.18156012274
"healthy-4"	"2019-08-01-count-2:TGGGCTGTCTTCACAT"	11.2244469123775	6.14041850650636	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGTCTTCACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.83477131138	44.5570902362262	0.0234038640892848	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1895.31384203034	1895.31384203034
"healthy-4"	"2019-08-01-count-4:TAACACGTCCTTTAGT"	3.09541167792622	-6.35346939479979	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACACGTCCTTTAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.69665585237	47.6807892645235	0.0203703410885425	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2333.35804091132	2333.35804091132
"healthy-4"	"2019-08-01-count-2:GTTAGTGTCTTAAGGC"	10.6035849052364	7.6120452650818	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGTCTTAAGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.28782349957	49.7430738509252	0.0229200354498211	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2159.69771346684	2159.69771346684
"healthy-4"	"2019-08-01-count-4:AAGGTAAAGAATAGTC"	-3.95392165604289	-4.6468224755493	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGTAAAGAATAGTC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3292.34540077364	43.9341477874143	0.0133443313016583	3925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3288.54717595531	3288.54717595531
"healthy-4"	"2019-08-01-count-4:AAGGAATGTGCCCAGT"	3.27026977118794	-6.13445331966551	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGGAATGTGCCCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.86937391741	44.9174910830236	0.0176363544762151	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2540.77836225711	2540.77836225711
"healthy-4"	"2019-08-01-count-3:GCCGATGTCATTTGGG"	-1.92717061463054	3.4916052588257	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGTCATTTGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3005.67290875818	43.9249907220196	0.014614028889846	4182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2997.49790128792	2997.49790128792
"healthy-4"	"2019-08-01-count-4:TTCACCGAGTAAATGC"	10.3267513709957	7.5087566145691	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACCGAGTAAATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2115.7597748095	39.8966310227851	0.0188568813424848	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2111.73794270992	2111.73794270992
"healthy-4"	"2019-08-01-count-3:TCATTACTCTAGAGCT"	3.91163816031758	-7.00885488903197	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACTCTAGAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.55125283264	43.0020866413182	0.0164032980834739	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2614.03289920927	2614.03289920927
"healthy-4"	"2019-08-01-count-3:GCCGTGACATACTTTC"	3.21100439605061	-6.18999483501586	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGTGACATACTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.42653182328	45.7250094636611	0.0189304078849981	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.3510652681	2413.3510652681
"healthy-4"	"2019-08-01-count-3:GCCTGTTAGATGCAGC"	10.3346172767574	6.87216470325319	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCTGTTAGATGCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.5057606669	49.8902427564107	0.0262096620810496	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.88422352191	1893.88422352191
"healthy-4"	"2019-08-01-count-2:CATCGGGTCTTCCAGC"	3.17094077643697	-6.26208259975585	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGGGTCTTCCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.80913537129	40.5299855913052	0.0146274909642501	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2767.98122452503	2767.98122452503
"healthy-4"	"2019-08-01-count-3:GCCTGTTTCGACCAAT"	14.2212568717891	2.0102523335251	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCTGTTTCGACCAAT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1401.17220721478	36.2627726140721	0.0258803110904936	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1383.44183998655	1383.44183998655
"healthy-4"	"2019-08-01-count-3:GCGAGAACAAAGGCAC"	2.69957747039143	-5.89604141628417	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGAGAACAAAGGCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.76442710234	43.2460695951721	0.016679521341437	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.73032873655	2586.73032873655
"healthy-4"	"2019-08-01-count-3:CCGTGAGTCAAAGGAT"	-1.75062582913097	3.59401509845582	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTGAGTCAAAGGAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2798.86871593701	41.2172536854646	0.0147263976515832	4251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2792.59254151369	2792.59254151369
"healthy-4"	"2019-08-01-count-2:CATGAGTAGCATACTC"	-6.49214110794719	3.43952605808107	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGAGTAGCATACTC"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2846.70603457445	45.0237234580015	0.0158160775686598	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2826.39876329192	2826.39876329192
"healthy-4"	"2019-08-01-count-4:CACGGGTGTCGGTACC"	3.00002684172932	-6.42864992534789	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTGTCGGTACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.73998173822	42.039211841722	0.0183678408981149	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2282.12220781362	2282.12220781362
"healthy-4"	"2019-08-01-count-3:GCGATCGGTCCTCATC"	10.2898537116939	7.12464997852174	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGATCGGTCCTCATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.55880162824	43.8997866239429	0.0221765509505624	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.8638191152	1973.8638191152
"healthy-4"	"2019-08-01-count-2:GTTCGCTGTCGACTGC"	3.40099491652791	-6.36564400112303	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCGCTGTCGACTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.44526999885	45.2928456004151	0.0166613049378898	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2712.51399744337	2712.51399744337
"healthy-4"	"2019-08-01-count-4:TTCAGGACAGCATGCC"	10.1833197074825	6.85284564578859	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAGGACAGCATGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.60676860753	45.1468306342115	0.0227255999262785	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1982.58527732611	1982.58527732611
"healthy-4"	"2019-08-01-count-3:CCTAACCCAGGTCAAG"	2.0540620284969	-6.12523605739745	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAACCCAGGTCAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.67166897634	47.7628889549582	0.0200375284803673	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2375.22481972931	2375.22481972931
"healthy-4"	"2019-08-01-count-4:GAACGTTCAGTTAGAA"	0.667908509343308	8.06556127155153	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACGTTCAGTTAGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.99794634519	43.3471759389102	0.0220821300499149	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.09334630156	1952.09334630156
"healthy-4"	"2019-08-01-count-4:TTCATGTTCCGCTGTT"	0.397843052714509	7.69124553287355	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTTCCGCTGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1959.60723830814	47.0826191844125	0.0240265591308297	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1953.19118258145	1953.19118258145
"healthy-4"	"2019-08-01-count-4:CACGTGGCATGGGTTT"	10.9323555427486	6.12024495685426	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTGGCATGGGTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.39239151679	48.6305962317414	0.0251010566804531	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.81692690319	1927.81692690319
"healthy-4"	"2019-08-01-count-2:CATGCAACAAGGGTCA"	14.3723894554073	1.97297082031099	"2019-08-01-count-2"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCAACAAGGGTCA"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1569.93965859747	34.390288817685	0.0219054844747397	2458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1551.88537754426	1551.88537754426
"healthy-4"	"2019-08-01-count-2:TGTAACGGTTCCTAGA"	11.4743238883907	3.48907587612001	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGGTTCCTAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1760.81715216781	43.1148061963445	0.0244856804940049	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1741.19080346214	1741.19080346214
"healthy-4"	"2019-08-01-count-4:CCCTGATTCAGGAACG"	2.09059943732564	-5.96969654476317	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATTCAGGAACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2566.45402005298	45.1750996300445	0.0176021464935935	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2562.32601907847	2562.32601907847
"healthy-4"	"2019-08-01-count-3:GCGTGCAAGTAAGGGA"	3.51784410056416	-6.5743184319702	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTGCAAGTAAGGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.67607647434	42.8225537489742	0.0194588173183485	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2190.83921189893	2190.83921189893
"healthy-4"	"2019-08-01-count-4:CACGTTCGTCATGACT"	10.1013618904049	6.84765670383302	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGTTCGTCATGACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2070.25263269468	48.9125908952291	0.0236263874866148	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2063.14337264243	2063.14337264243
"healthy-4"	"2019-08-01-count-2:CATGCCTCACGCTATA"	0.132246394723099	7.55468127811281	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTCACGCTATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.84934102268	44.5412079627312	0.0211411452615357	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2099.41555270189	2099.41555270189
"healthy-4"	"2019-08-01-count-3:GCGTGCACAAGCACCC"	10.3627420860225	6.65706632221071	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTGCACAAGCACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.35878038414	48.0785506697018	0.0237148703697093	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2021.00107039447	2021.00107039447
"healthy-4"	"2019-08-01-count-2:CATGCCTCACATTCGA"	11.3356977897579	5.69027373874513	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTCACATTCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1966.93430090759	44.2431452808828	0.022493453523317	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1955.95774420446	1955.95774420446
"healthy-4"	"2019-08-01-count-2:CATGCCTTCATGCTAG"	2.46161617812459	-6.35547068035277	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCCTTCATGCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.54648038646	45.816451312755	0.0204670538289852	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2234.15106245865	2234.15106245865
"healthy-4"	"2019-08-01-count-2:CATGCGGGTACTCGAT"	10.6065250831539	6.70289275729982	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGCGGGTACTCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.44687848906	46.5970162046793	0.0235166618447079	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.49161506704	1969.49161506704
"healthy-4"	"2019-08-01-count-3:TCCACGTCACTGCTTC"	-2.06417642059978	9.23444268787233	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTCACTGCTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2223.0287340063	44.4581858991532	0.0199989254385532	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2211.02252046961	2211.02252046961
"healthy-4"	"2019-08-01-count-4:TTCCACGGTAGGGAGG"	10.9854914146358	5.84430787647096	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGGTAGGGAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.55754455219	44.5876829153846	0.0231918586997458	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1918.97095472842	1918.97095472842
"healthy-4"	"2019-08-01-count-4:TTCCACGGTTGCCATA"	2.89726318892781	-5.92482616817626	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGGTTGCCATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.99803457234	47.5605414955263	0.0174855058316262	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.38659182712	2716.38659182712
"healthy-4"	"2019-08-01-count-4:TTCCACGGTGGTCTCG"	-1.72779498520549	3.37299916828004	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCACGGTGGTCTCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2796.83742064618	43.1732118125314	0.0154364395634254	3876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2789.85364028151	2789.85364028151
"healthy-4"	"2019-08-01-count-3:AGCATCACACAATGCT"	0.106896997510833	8.19130704486696	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCATCACACAATGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.48729081011	41.3776504001093	0.0227164090624571	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1817.86155569523	1817.86155569523
"healthy-4"	"2019-08-01-count-2:GACCTTCAGTAGCTCT"	3.10252656516377	-6.18769314205321	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCAGTAGCTCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2627.48280800723	47.2137498582468	0.017969194589728	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2621.39283814402	2621.39283814402
"healthy-4"	"2019-08-01-count-3:TGCGGCAAGACTTGTC"	-4.13282237473186	13.1516303786072	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCGGCAAGACTTGTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1765.29964472968	46.2183207880993	0.0261815725880218	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1765.29964472968	1765.29964472968
"healthy-4"	"2019-08-01-count-4:CACTGAAAGTTGCTGT"	4.38494839248006	-7.48304273998412	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGAAAGTTGCTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2701.73549623897	43.5943782892057	0.016135694389733	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2693.96674269096	2693.96674269096
"healthy-4"	"2019-08-01-count-1:GACTTCCAGTCCGTCG"	-3.3052581352299	10.8014745482239	"2019-08-01-count-1"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GACTTCCAGTCCGTCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2630.19437322919	46.1013425447218	0.0175277321759766	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2614.24865057512	2614.24865057512
"healthy-4"	"2019-08-01-count-2:GTTGTCCAGGCACTCC"	3.47654690322224	-7.24077036296996	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGTCCAGGCACTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.41617472383	43.6252713665776	0.0166545781413208	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.76055107602	2612.76055107602
"healthy-4"	"2019-08-01-count-4:TTCCGGTAGTAAACGT"	3.40265883979146	-6.03734352504881	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGGTAGTAAACGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.73186071141	42.9437313087598	0.0162990898425483	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2631.79020459265	2631.79020459265
"healthy-4"	"2019-08-01-count-4:CCGCAAGTCCCTCTAG"	11.4761063056881	3.68896529758302	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGTCCCTCTAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2231.68075352807	38.4478014843083	0.0172281816848248	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2219.32433660315	2219.32433660315
"healthy-4"	"2019-08-01-count-2:AGTTCCCTCGGCCAAC"	-5.47748170319255	-5.58724691784056	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTTCCCTCGGCCAAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2242.44482457678	51.9087938567152	0.0231483037120041	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2237.54289805583	2237.54289805583
"healthy-4"	"2019-08-01-count-2:TGTCCACAGACTGGGT"	-4.09802327576335	10.5620803602966	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCACAGACTGGGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2064.18130493968	47.2860717443602	0.0229079062150222	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2059.20220581428	2059.20220581428
"healthy-4"	"2019-08-01-count-3:TCCATGCGTCACTTAG"	2.367927690118	-4.41314651882323	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCGTCACTTAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2998.07520032897	42.239478573503	0.0140888656057954	3312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2989.84481728094	2989.84481728094
"healthy-4"	"2019-08-01-count-2:GACGTTAGTAGCTGCC"	11.4405170875484	4.625123954657	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTAGTAGCTGCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2381.98872814758	38.3274762327741	0.0160905363572314	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2368.88025724495	2368.88025724495
"healthy-4"	"2019-08-01-count-4:AATGAAGTCTCCCAAC"	-4.17055497589763	-4.06140282070311	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGAAGTCTCCCAAC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3270.46182114216	35.4729010749632	0.0108464501391351	3172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3256.93476108148	3256.93476108148
"healthy-4"	"2019-08-01-count-4:TTCCGTGGTGCTCTTC"	5.60092558440511	-9.93482687389525	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGGTGCTCTTC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2670.15719250252	44.1920268802844	0.0165503465505216	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2665.81398917517	2665.81398917517
"healthy-4"	"2019-08-01-count-3:GCTCAAAGTGTGCTTA"	4.74433960494344	-6.80007364666136	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTCAAAGTGTGCTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2872.66751202319	41.7379691795661	0.0145293421549403	2339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2868.33879568135	2868.33879568135
"healthy-4"	"2019-08-01-count-3:TCCCACAAGGTACTGG"	2.95830835875813	-6.75063230907591	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCACAAGGTACTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2121.47081061996	46.7273128883028	0.0220259042238001	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2121.47081061996	2121.47081061996
"healthy-4"	"2019-08-01-count-2:GACGTTATCACACGAT"	-2.99456248703654	-5.6583872071472	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTATCACACGAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2734.82012725759	48.0504650940827	0.0175698813297336	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2732.72049928801	2732.72049928801
"healthy-4"	"2019-08-01-count-2:GTTTACTTCTTCTAAC"	10.9997297721798	6.30496070468751	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTTCTTCTAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.21295076168	45.8692236253743	0.0230938095574214	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.6772466405	1977.6772466405
"healthy-4"	"2019-08-01-count-2:AGAACCTCACGTTGGC"	6.79902042922322	-1.64273478901061	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCACGTTGGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3088.4633271668	39.6623507691415	0.0128420986644921	2281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3075.19970015328	3075.19970015328
"healthy-4"	"2019-08-01-count-2:CATTCATTCCCGAATA"	10.0993572669918	7.56529948795167	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCATTCCCGAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.45578578333	45.4035982662874	0.0226852866742281	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1993.97584024859	1993.97584024859
"healthy-4"	"2019-08-01-count-4:TTCCTAAAGCAATAGT"	10.7253757911617	7.48591039264528	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTAAAGCAATAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2114.59030899437	47.1872081288369	0.0223150592945248	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2109.73356814996	2109.73356814996
"healthy-4"	"2019-08-01-count-3:GCTGAATAGTTAACAG"	5.15520062026326	-7.99987032329711	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGAATAGTTAACAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2792.52784861854	44.4206353800833	0.0159069623610229	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2789.96364671213	2789.96364671213
"healthy-4"	"2019-08-01-count-4:TTCCTAACAGTTGTCA"	0.55085795101468	7.89429853046266	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTAACAGTTGTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1947.89818712209	36.8547582686819	0.0189202692996664	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.82314338446	1937.82314338446
"healthy-4"	"2019-08-01-count-2:GACTCTCCACATGAAA"	-2.15030394020732	8.79555032337037	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCTCCACATGAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2095.59220077449	41.9588036965625	0.0200224087878621	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.32124998455	2087.32124998455
"healthy-4"	"2019-08-01-count-2:GTAATCGTCCGTCACT"	0.0902931588584601	7.7150144346985	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAATCGTCCGTCACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2051.51230841435	44.5568325017022	0.0217190178771781	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2044.19819438511	2044.19819438511
"healthy-4"	"2019-08-01-count-4:ATCGGATCATCGGCCA"	2.04577853259389	-5.95827677166136	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATCATCGGCCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2702.81419299144	45.9285304604548	0.0169928552911814	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2697.79519754537	2697.79519754537
"healthy-4"	"2019-08-01-count-2:TGTGAGTTCATGGCCG"	3.26360501822774	-6.25454475795897	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTTCATGGCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.88775580449	43.9083652379229	0.017452434090758	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2512.08009309674	2512.08009309674
"healthy-4"	"2019-08-01-count-3:CTCCCTCAGAATTGCA"	14.2836815315181	2.11184952342836	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCAGAATTGCA"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1366.09361911625	45.3023176015772	0.0331619421741272	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1349.01100276156	1349.01100276156
"healthy-4"	"2019-08-01-count-4:GAATCGTTCCCTCTCC"	0.190426086157006	7.82912728870241	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCGTTCCCTCTCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2223.3819371105	47.2318140002599	0.0212432300595381	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2214.05268371346	2214.05268371346
"healthy-4"	"2019-08-01-count-2:TAACCAGAGAGTAACT"	-2.67630181732829	10.1591968306336	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACCAGAGAGTAACT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2111.48697755442	49.0495240160887	0.0232298491714588	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2101.95968746532	2101.95968746532
"healthy-4"	"2019-08-01-count-3:TCCGATCGTATCGTAC"	11.2218166786129	4.80281159961549	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGATCGTATCGTAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1786.46396617886	46.9894126002835	0.0263030284908523	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1776.2302464096	1776.2302464096
"healthy-4"	"2019-08-01-count-3:AGCGATTCACTTCAAG"	-3.01627455177959	3.53752849185792	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTCACTTCAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3306.27562724145	45.2197390176875	0.0136769417059811	5341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3298.9422013473	3298.9422013473
"healthy-4"	"2019-08-01-count-4:GACACGCTCACGATCA"	-5.25819001618083	3.48205039584962	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACACGCTCACGATCA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2865.16007743001	45.0762711451218	0.0157325489421011	3094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2850.70840425922	2850.70840425922
"healthy-4"	"2019-08-01-count-3:GCTGGGTCAGATACCT"	6.71119465407674	-1.63332500373992	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTGGGTCAGATACCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2943.66881472755	40.8487366933781	0.0138768113073749	2286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2935.43685195507	2935.43685195507
"healthy-4"	"2019-08-01-count-3:AGCGCCACACCTGCGA"	10.8312345939571	6.92547938907472	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCCACACCTGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2235.35391973248	41.9513546361621	0.0187672091948566	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2226.24207479086	2226.24207479086
"healthy-4"	"2019-08-01-count-2:TTGTTTGCAAGCCCAC"	-2.16892371597942	8.64711759174196	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGCAAGCCCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.1255037425	42.9881867249015	0.0225882037944241	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1894.59429208202	1894.59429208202
"healthy-4"	"2019-08-01-count-2:TTGTTTGGTACGTTCA"	0.121484507888001	7.96233222568361	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGGTACGTTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1997.61623794682	40.3790202611319	0.0202136023396737	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1989.33454951436	1989.33454951436
"healthy-4"	"2019-08-01-count-3:AGCGCTGCAGCAGGAT"	-3.75159702721294	3.56230018222658	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGCAGCAGGAT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3173.65295333516	47.3259235459298	0.014912129411061	4204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3162.20639269009	3162.20639269009
"healthy-4"	"2019-08-01-count-2:GACTTCCGTCGAGTTT"	-1.79357872429546	8.71659371936647	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCGTCGAGTTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.05816335631	37.9664798416436	0.0209405746649411	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1805.7069044508	1805.7069044508
"healthy-4"	"2019-08-01-count-4:GACCAATGTAGCGTAG"	0.304316927760285	7.77534864032594	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATGTAGCGTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.65269222995	40.7637495797246	0.0230088830381399	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1766.23203544969	1766.23203544969
"healthy-4"	"2019-08-01-count-4:ATCGTGATCGATGCAT"	-4.48557792130168	12.4832982786926	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTGATCGATGCAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2223.48181308779	43.1384001742287	0.0194012831228521	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2215.06471618099	2215.06471618099
"healthy-4"	"2019-08-01-count-3:CCTCTCCGTTTGCAGT"	10.9667164283687	6.24472854221193	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCGTTTGCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.30376184426	40.3026582165147	0.0193269963608902	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2071.76225757745	2071.76225757745
"healthy-4"	"2019-08-01-count-4:ACAAAGATCGACCTAA"	5.58145393904988	-9.88001062786254	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGATCGACCTAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.24345185339	46.5654229157345	0.017225759997239	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2697.06579134875	2697.06579134875
"healthy-4"	"2019-08-01-count-4:TACGGGCAGATGTTCC"	3.44229402121846	-6.12092831051024	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCAGATGTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2787.24846042479	40.2600001655461	0.0144443528222131	2282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2779.45488180445	2779.45488180445
"healthy-4"	"2019-08-01-count-3:CCTCTCCTCGTTCTGC"	-3.00566087189372	10.7148265608582	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTCCTCGTTCTGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2208.91086329796	47.0870883703905	0.0213168802565841	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2196.04498519524	2196.04498519524
"healthy-4"	"2019-08-01-count-3:GCTTTCGCATGTCTAG"	1.65952457961385	-5.95429851925048	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTTCGCATGTCTAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2739.1064993503	39.0326065510108	0.0142501237393541	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2734.20752378602	2734.20752378602
"healthy-4"	"2019-08-01-count-3:GCTTTCGTCGTGAGAG"	3.17816938933675	-6.40677359020384	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTTTCGTCGTGAGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.7189131287	43.5105986618564	0.0188707298249185	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2303.13004149564	2303.13004149564
"healthy-4"	"2019-08-01-count-2:AGACCATAGGTTAAAC"	11.3321262794429	6.08473203265993	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACCATAGGTTAAAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2075.79057301805	45.2369095165767	0.0217926172825833	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2071.99910138911	2071.99910138911
"healthy-4"	"2019-08-01-count-4:CAGCACGCAGCGTTGC"	-1.91847632351573	3.42949292743532	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGCAGCGTTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2703.19311109088	41.5703500831072	0.0153782391322873	4162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2695.37947280238	2695.37947280238
"healthy-4"	"2019-08-01-count-4:CAGCACGGTGTTAAAG"	2.87212457236592	-4.74876358425292	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGGTGTTAAAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2939.044362759	42.0010443667332	0.0142907146618587	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2925.86222768593	2925.86222768593
"healthy-4"	"2019-08-01-count-2:CATTTCACATGGTGGA"	-1.12525878372844	8.69914624774782	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTTCACATGGTGGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.35069097639	50.622882805073	0.0250813117023702	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2007.31726539636	2007.31726539636
"healthy-4"	"2019-08-01-count-4:TACGGGCTCCTTGACC"	-4.28606162491496	3.53817126834718	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCTCCTTGACC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3170.98489834538	43.7598245636804	0.0138000734681878	4776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3160.35596298642	3160.35596298642
"healthy-4"	"2019-08-01-count-3:TCCTCTTGTTCGGACC"	11.3426529365474	4.47911403262941	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCTTGTTCGGACC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2169.26524585955	36.8317895580882	0.0169789239137024	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2159.52364795738	2159.52364795738
"healthy-4"	"2019-08-01-count-3:CCTGTTGGTTGGGTTT"	3.0282322364742	-6.47804739391478	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGTTGGTTGGGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.59269066696	47.465928098088	0.0190199018756552	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2488.0406348087	2488.0406348087
"healthy-4"	"2019-08-01-count-4:TACGGTAAGTTACGTC"	2.46791662749593	-6.21911384975585	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGTAAGTTACGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.17801653172	43.2424192121443	0.0183683727009952	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2351.37695585684	2351.37695585684
"healthy-4"	"2019-08-01-count-3:TCCTCTTTCATTGCTT"	11.0244289833004	5.99636838519899	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCTTTCATTGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.45931498855	46.4728615049082	0.0231040524452132	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.32400207906	2006.32400207906
"healthy-4"	"2019-08-01-count-4:TACGGTACAGCGAACA"	11.0600429969722	4.01569864833681	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGTACAGCGAACA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1397.4362426943	45.2145389517446	0.0323553501550594	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1382.61945632941	1382.61945632941
"healthy-4"	"2019-08-01-count-4:CAGCCAGAGATCCAAA"	-3.01138625565227	9.39867971027223	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGAGATCCAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.68373584386	44.1198248303968	0.022008371715464	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1996.0241512592	1996.0241512592
"healthy-4"	"2019-08-01-count-4:ACAAGCTGTCGAAGCA"	11.1111322837764	6.07893655383912	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTGTCGAAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.27480687598	43.4860567586116	0.0218602561135851	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1981.24690035519	1981.24690035519
"healthy-4"	"2019-08-01-count-3:CCTTTGGAGCAGTAAT"	6.77583612975423	-1.74332144176634	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTTGGAGCAGTAAT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2831.64869599062	30.7575460758158	0.010862062839704	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2816.58313240932	2816.58313240932
"healthy-4"	"2019-08-01-count-3:CCTTGTGTCCTCTCTT"	-3.27874718132671	10.7039384611878	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTGTGTCCTCTCTT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2076.4686480923	42.732446731942	0.0205793845099474	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2069.68871357436	2069.68871357436
"healthy-4"	"2019-08-01-count-4:CAGCCAGGTGTTCATG"	5.03158726271932	-7.34788229381713	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGGTGTTCATG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.17995310961	45.8042103994822	0.0179682137950317	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2545.65865863305	2545.65865863305
"healthy-4"	"2019-08-01-count-4:CAGCCAGTCCTCTCGA"	10.5481344657833	7.59844062412111	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCCAGTCCTCTCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.11741064911	43.5022603878062	0.0216416514564482	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2005.94730730352	2005.94730730352
"healthy-4"	"2019-08-01-count-2:TGTTCCGGTCCTGGGT"	3.79005612906758	-6.67306663906249	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCCGGTCCTGGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.73735563309	46.4125966647957	0.0215098452754822	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2155.00199165775	2155.00199165775
"healthy-4"	"2019-08-01-count-3:GGAATGGGTTCCGCAG"	2.1160475212032	-6.00732376491698	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGGTTCCGCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.71665895112	45.2196070561952	0.0175425048750684	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2572.39515608684	2572.39515608684
"healthy-4"	"2019-08-01-count-2:AGAGAATGTAAGATAC"	3.22457804259602	-6.3640666238037	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGAATGTAAGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.56357520825	49.2103857893091	0.0208645576937497	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2356.01153326505	2356.01153326505
"healthy-4"	"2019-08-01-count-3:GGACGTCAGTTACTCG"	10.8913618522579	6.37029597843019	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGACGTCAGTTACTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1813.86356011304	41.889712580394	0.0230941915927698	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1805.2505428975	1805.2505428975
"healthy-4"	"2019-08-01-count-2:CCAATTTCACAATCTG"	-6.95816359940227	3.1919169195923	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAATTTCACAATCTG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2728.96343205059	41.3955366009294	0.0151689598016431	2977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2717.94597236972	2717.94597236972
"healthy-4"	"2019-08-01-count-2:CGCATAAGTTAGGGAC"	10.7199083763057	6.21050784671632	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAAGTTAGGGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1770.42957388744	43.5945886518559	0.0246237349933849	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1766.62374894279	1766.62374894279
"healthy-4"	"2019-08-01-count-2:TGTTCTACATTCATCT"	-2.76889429512675	9.03747556293336	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCTACATTCATCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.95334913135	44.341791218762	0.0230952440791459	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.37635472223	1916.37635472223
"healthy-4"	"2019-08-01-count-2:TGTTCTATCCTCCACA"	-4.20739684525188	12.4242706068787	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTCTATCCTCCACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1822.07729113144	41.310507490886	0.0226722036940781	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1817.88085606267	1817.88085606267
"healthy-4"	"2019-08-01-count-2:CCACAAAAGAATGTTG"	10.7586409049923	6.46531865680543	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAAAGAATGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1907.76718527514	41.8442730827472	0.0219336370840828	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.98576839282	1897.98576839282
"healthy-4"	"2019-08-01-count-3:CGAAGTTAGCGACTGA"	1.28638972815816	-6.08235504543456	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGTTAGCGACTGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2600.28260816916	46.0894197345062	0.0177247732956832	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2595.16196786274	2595.16196786274
"healthy-4"	"2019-08-01-count-3:GGAGAACCACCATTCC"	11.1594644981319	5.4522609480652	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGAACCACCATTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.05260254327	46.4036157044306	0.024243647036018	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1905.9816593937	1905.9816593937
"healthy-4"	"2019-08-01-count-4:TCCTCCCTCGTTCATT"	2.92771234092061	-4.82886459743651	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTCCCTCGTTCATT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3230.46950873205	37.9889701644632	0.0117595817146015	3385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3225.7311736497	3225.7311736497
"healthy-4"	"2019-08-01-count-3:TAGGAGGCAAGTTGGG"	4.87566246566121	-7.15645983135375	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGAGGCAAGTTGGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2683.0162571265	43.9637905496183	0.0163859575702696	1903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2678.8055818925	2678.8055818925
"healthy-4"	"2019-08-01-count-3:GTCTGTCGTGGGTCAA"	-2.18378935280498	3.40790889346925	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTGTCGTGGGTCAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2890.93565873297	44.2081982558934	0.0152920035153148	3824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2884.96999113436	2884.96999113436
"healthy-4"	"2019-08-01-count-2:AGAGCAGTCTGGTGGC"	-4.09225545349773	11.3278188475403	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCAGTCTGGTGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1854.70454147858	44.4913282103422	0.023988364300264	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1848.80857783555	1848.80857783555
"healthy-4"	"2019-08-01-count-2:AGAGCCCAGGCGTTGA"	4.10369839248006	-6.2734847298828	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCAGGCGTTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.76809951289	44.7393348096938	0.0162939232987777	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2744.00543886731	2744.00543886731
"healthy-4"	"2019-08-01-count-3:GGAGATGAGATGCTGG"	11.18870129165	5.41392943942872	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGAGATGCTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1748.77041012714	40.3237279973695	0.023058331593361	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1741.37354152548	1741.37354152548
"healthy-4"	"2019-08-01-count-4:ACACGCGTCGGTTGTA"	-2.6792918247288	9.7733525999817	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACGCGTCGGTTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1587.20488112086	42.5947876403171	0.0268363512152491	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1587.20488112086	1587.20488112086
"healthy-4"	"2019-08-01-count-3:GGAGATGAGGTCACCC"	10.2274166541988	6.9874171980652	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGAGGTCACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1885.32938401787	44.9972117684433	0.0238670293636164	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.56434657049	1874.56434657049
"healthy-4"	"2019-08-01-count-4:TTCTTGAAGGTTAAAC"	5.08114161071126	-7.92810585415038	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTGAAGGTTAAAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2810.60195584205	43.5226247648283	0.0154851613457264	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2807.44443984225	2807.44443984225
"healthy-4"	"2019-08-01-count-2:AGAGCCCCATTCGGGC"	10.7318130927974	6.80852267825929	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCCATTCGGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.18312282532	44.7465199906869	0.0221059643695825	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2016.76865990266	2016.76865990266
"healthy-4"	"2019-08-01-count-2:TGTTTGTCACTCGATA"	11.1977125602657	6.5297436484131	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTTGTCACTCGATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2260.72260566498	40.7565375806202	0.0180281019345281	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2255.89864709529	2255.89864709529
"healthy-4"	"2019-08-01-count-3:CGAGAAGGTTAGCTAC"	10.9986549812252	5.90047595584718	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGAAGGTTAGCTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.88882853906	47.9259088113368	0.0259074535031308	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1839.42570999111	1839.42570999111
"healthy-4"	"2019-08-01-count-4:TTGAACGCAAGCGAAC"	4.3976055580074	-6.53988935863646	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAACGCAAGCGAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.91189430089	46.0373147679251	0.0185640928912531	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2473.40079221872	2473.40079221872
"healthy-4"	"2019-08-01-count-4:TAGACCAGTTGATGTC"	-2.94272003594096	3.41097328746644	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCAGTTGATGTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3239.48567956606	46.2256146793534	0.0142694301663174	5114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3229.80664712877	3229.80664712877
"healthy-4"	"2019-08-01-count-2:AGATAGACATCTCAAG"	3.95193614539449	-6.3115706673828	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGACATCTCAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.48425805187	42.1141215628179	0.0154463101844239	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.28664740212	2721.28664740212
"healthy-4"	"2019-08-01-count-4:ACAGCCGAGCCTGTCG"	10.4026857810909	6.94261596286622	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGCCGAGCCTGTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1727.08099932251	47.0844252456344	0.0272624302300265	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1719.02569132401	1719.02569132401
"healthy-4"	"2019-08-01-count-2:TTAATCCCAGCGTGAA"	4.76080669936482	-6.97076704418334	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCCAGCGTGAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.21175326941	50.6099139962594	0.0190677755585699	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.89301742177	2649.89301742177
"healthy-4"	"2019-08-01-count-3:GGAGGATAGATACAGT"	-0.454649905592757	8.23757836902467	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGATAGATACAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2124.9771738401	42.6914599273337	0.0200903145939139	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2115.79413175574	2115.79413175574
"healthy-4"	"2019-08-01-count-4:ACAGCCGCATACAGCT"	2.49400605735127	-5.9592609635559	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGCCGCATACAGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2788.18686077293	46.1974652947063	0.0165689989952465	2361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2783.21436971682	2783.21436971682
"healthy-4"	"2019-08-01-count-3:GAGTGAGAGCGGTAGT"	-3.96908841553386	-5.38454916393431	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGAGAGCGGTAGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2257.32243491083	45.9195759577353	0.0203424974862084	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2254.07574612175	2254.07574612175
"healthy-4"	"2019-08-01-count-3:GGAGGTAAGGGACACT"	-3.79348550263103	11.238685584906	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGTAAGGGACACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.99705837918	41.288624016055	0.0209374673459153	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1966.78665311336	1966.78665311336
"healthy-4"	"2019-08-01-count-4:ACAGGGATCATCGCTC"	14.2246338325435	1.79996655071107	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGGGATCATCGCTC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1326.52974547597	43.4808408538406	0.0327778860610769	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1301.30159450163	1301.30159450163
"healthy-4"	"2019-08-01-count-4:GACTTCCTCTCGGGAC"	4.61126246032063	-7.30223419582518	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCTCTCGGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.02616935512	46.6156709840933	0.0191516720612925	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2426.45567035049	2426.45567035049
"healthy-4"	"2019-08-01-count-4:GACTTCCTCCCTGTTG"	-3.59915767136272	-5.4609093896118	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCTCCCTGTTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3021.32130418457	47.8939146639815	0.0158519766162069	2709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3018.32272092089	3018.32272092089
"healthy-4"	"2019-08-01-count-2:CCACGTTTCGAGAGAC"	5.01621260222737	-7.57837631618651	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACGTTTCGAGAGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.04504293078	46.5901957465735	0.0168071568192541	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2767.53958102816	2767.53958102816
"healthy-4"	"2019-08-01-count-4:TAGGGTTCAACCGATT"	-1.90512214127238	3.47228524768678	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTCAACCGATT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2758.53315664763	48.2327508421596	0.017484926989522	3980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2746.93414171439	2746.93414171439
"healthy-4"	"2019-08-01-count-3:CGAGTTATCACGGGCT"	-4.28922734680827	11.2967824705872	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTTATCACGGGCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2383.77510807272	46.1907860937609	0.0193771576594346	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2371.87550608187	2371.87550608187
"healthy-4"	"2019-08-01-count-4:CATAAGCGTTAGAGAT"	11.3337990241939	4.9434513815674	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCGTTAGAGAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.12632425117	43.5350064358147	0.0204954883985831	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2109.34599843432	2109.34599843432
"healthy-4"	"2019-08-01-count-2:GAGGCCTCAAGGTTGG"	11.0218845802242	6.30723044956056	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTCAAGGTTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1904.4402539554	47.6058545537629	0.0249972948507513	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.08945020492	1896.08945020492
"healthy-4"	"2019-08-01-count-4:GAGAAATTCTCACGAA"	2.0083815055782	-6.25921871578368	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATTCTCACGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.58231569116	45.5510882816519	0.0188337969669784	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2417.23795720855	2417.23795720855
"healthy-4"	"2019-08-01-count-4:TAGGGTTGTGCATTTG"	4.36727585372273	-6.60442211544188	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTGTGCATTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.64193602812	48.2403694019552	0.0186066454960837	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2588.28662408873	2588.28662408873
"healthy-4"	"2019-08-01-count-4:TAGGGTTTCATGCAGT"	-1.78477595272716	9.25088975513307	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTTCATGCAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1937.98182757223	47.3186704668218	0.02441646758169	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1934.44550280719	1934.44550280719
"healthy-4"	"2019-08-01-count-3:GGCACGTAGACTCATC"	-2.90066037598308	9.29979894244996	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTAGACTCATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.10072527316	40.6126770853764	0.0203562038602416	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1988.40292156759	1988.40292156759
"healthy-4"	"2019-08-01-count-4:GAGACCCAGTTGCCCG"	11.0688969093258	6.11484906757203	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCAGTTGCCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1970.75617402307	46.7036961392476	0.0236983634783736	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1961.45754033342	1961.45754033342
"healthy-4"	"2019-08-01-count-2:CCATAAGCATGACTAC"	-4.52817283096965	12.8669252165589	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCATAAGCATGACTAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2209.71315150098	40.1906403453188	0.0181881708573887	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2204.65596713393	2204.65596713393
"healthy-4"	"2019-08-01-count-2:AGCATCATCGAAGAAT"	-1.69405935230907	8.45779130542604	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCATCATCGAAGAAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.98170478734	45.1831274663341	0.0208699811949553	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2160.43924166618	2160.43924166618
"healthy-4"	"2019-08-01-count-4:ACATTTCAGATACTGA"	11.3337122398311	6.05827186191408	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATTTCAGATACTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1901.36631629929	48.2947714571928	0.0254000352500149	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.95372432635	1897.95372432635
"healthy-4"	"2019-08-01-count-3:CGCAGGTTCCAGTTCC"	10.7355019050533	6.15863750064699	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCAGGTTCCAGTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1860.35803254203	48.8773288047707	0.0262730764453892	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1845.75502600271	1845.75502600271
"healthy-4"	"2019-08-01-count-2:TTTGTTGAGATGTTCC"	4.8269907432491	-7.3604421845642	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGTTGAGATGTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.76133600278	44.4101376951971	0.018924011152681	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2338.9070750561	2338.9070750561
"healthy-4"	"2019-08-01-count-2:GGAATGGGTGGCTAGA"	-0.0999789190595925	7.55315158450929	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATGGGTGGCTAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2020.63075377354	41.9235975211323	0.0207477776149055	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.68453793137	2015.68453793137
"healthy-4"	"2019-08-01-count-4:TAGGTTGAGGGCAATC"	14.3341013389522	2.19889781558839	"2019-08-01-count-4"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTTGAGGGCAATC"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1290.66665676287	28.9524055493994	0.0224321325709421	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1273.46200323394	1273.46200323394
"healthy-4"	"2019-08-01-count-3:CGCATAAGTGATACCT"	10.4970909553463	6.10328385913698	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCATAAGTGATACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.27419254009	45.2180249076872	0.0256443524773355	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1759.68777115865	1759.68777115865
"healthy-4"	"2019-08-01-count-4:GAGACTTGTGAACCGA"	-2.93898020210918	-5.73626234447631	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACTTGTGAACCGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2630.26729952125	50.0547729762096	0.0190302989301963	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2623.54394102055	2623.54394102055
"healthy-4"	"2019-08-01-count-3:AGGGTTTAGTCACTCA"	10.4161516624386	7.82325694644777	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTTTAGTCACTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.4535258865	46.2790299052595	0.0230306545083409	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2000.76899325018	2000.76899325018
"healthy-4"	"2019-08-01-count-4:TAGTGCAGTGCAGATG"	11.0147940116817	5.78163955295411	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGTGCAGTGCAGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.56002132926	40.1619050748065	0.02083561841416	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1918.8231683032	1918.8231683032
"healthy-4"	"2019-08-01-count-2:CGGGACTTCACCTCAC"	10.2726007896358	7.50876567447511	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGACTTCACCTCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.71458591338	45.1203739360164	0.0226199649085916	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.6528538943	1990.6528538943
"healthy-4"	"2019-08-01-count-4:TATACCTAGCGTGAGT"	-0.829594294459182	8.55399034107057	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTAGCGTGAGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1857.87622709481	47.10383083482	0.0253535893015204	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1852.36278852366	1852.36278852366
"healthy-4"	"2019-08-01-count-2:TTACGTTCATGGACAG"	3.99169721183125	-6.53835775768431	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACGTTCATGGACAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.78853520471	40.2590287058692	0.0165553164360486	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2420.36490225206	2420.36490225206
"healthy-4"	"2019-08-01-count-2:GAGTCATCAGCGTATT"	3.08308782157246	-6.3680196038452	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATCAGCGTATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.14817377686	46.5723128511597	0.0221440949486333	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2101.79848047874	2101.79848047874
"healthy-4"	"2019-08-01-count-3:CGCCAGATCCATCTGC"	10.2014128166134	7.48359582507936	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCAGATCCATCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1662.88020742258	34.8552442390271	0.0209607667969371	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1648.6779605043	1648.6779605043
"healthy-4"	"2019-08-01-count-2:TACGCTCTCTGGAGAG"	10.8559843498165	5.99625489795534	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGCTCTCTGGAGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1770.81265804509	44.1510962410905	0.0249326748600451	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1768.26345341576	1768.26345341576
"healthy-4"	"2019-08-01-count-2:CCCGAAGAGCTCGCAC"	11.4824148612911	3.52971694553224	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGAGCTCGCAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1680.68492801162	39.1123239948769	0.0232716574909431	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1667.05243903356	1667.05243903356
"healthy-4"	"2019-08-01-count-3:GGCTTTCAGCATCCCG"	-4.31636987152751	12.6030063399109	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCAGCATCCCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2079.73194290748	44.2085720414728	0.0212568606219842	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2076.11273801034	2076.11273801034
"healthy-4"	"2019-08-01-count-2:AGCGATTAGAAGCCAC"	10.97248329696	6.10478446567384	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGATTAGAAGCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1993.47574457561	41.7101035308753	0.0209233062626277	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.0834368669	1990.0834368669
"healthy-4"	"2019-08-01-count-2:CCCGAAGCAACCCTAA"	10.8883091407711	6.53082749927369	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGCAACCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.329387466	47.3532738959873	0.0233344444664633	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2017.992282118	2017.992282118
"healthy-4"	"2019-08-01-count-4:ACCATTTCATGAGTAA"	10.6044107871944	7.57524583423463	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCATTTCATGAGTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2154.56909052901	43.5079663296726	0.0201933493434597	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2152.29729474703	2152.29729474703
"healthy-4"	"2019-08-01-count-4:GAGCCTGGTGGGCTTC"	-4.13682017746623	12.6460180052551	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGGTGGGCTTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1930.85349347155	44.1593794105241	0.0228703936160005	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1922.72609893028	1922.72609893028
"healthy-4"	"2019-08-01-count-2:TTAGGCACAGGCGATA"	11.4436918693477	3.57891104305116	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCACAGGCGATA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1916.19674486035	42.3665373077912	0.0221097011157269	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1899.20643972892	1899.20643972892
"healthy-4"	"2019-08-01-count-3:TCGGGCAAGCGCGTTC"	-3.03988371315654	9.60701749408571	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGCAAGCGCGTTC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2073.25861763549	48.1170258282309	0.0232084050773692	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2068.39729920031	2068.39729920031
"healthy-4"	"2019-08-01-count-3:AGGTCTACACGACGAA"	-3.87331591072734	11.1805133589539	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTACACGACGAA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2000.26603915701	50.752782332504	0.0253730160583505	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1998.62185687895	1998.62185687895
"healthy-4"	"2019-08-01-count-4:TATCCTAAGACTTCGT"	2.72421731528584	-6.12168075954589	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCCTAAGACTTCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.3970216904	46.678478129416	0.0200388674385538	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2328.12564862181	2328.12564862181
"healthy-4"	"2019-08-01-count-2:TTAGGCATCCTTACCG"	4.10053362426106	-6.66719629680785	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGCATCCTTACCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2742.49774649786	46.0067131353984	0.0167754789203194	1972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2737.41030979506	2737.41030979506
"healthy-4"	"2019-08-01-count-4:CATCCGTGTCCAGTTA"	3.13002504882161	-6.18583300029906	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCCGTGTCCAGTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.34742046424	43.5890833156385	0.019552395878504	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2223.97029767665	2223.97029767665
"healthy-4"	"2019-08-01-count-3:GGGAAGTTCGATTGGT"	-0.791109184653121	8.71675679767457	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAAGTTCGATTGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1964.43515580583	44.3357821464532	0.0225692265867979	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.45270085632	1958.45270085632
"healthy-4"	"2019-08-01-count-3:TCGGGTGGTCTTCGAA"	-2.21885667267497	3.48274133289186	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGTGGTCTTCGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3046.6673065081	47.2245581345547	0.0155003987582354	4144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3038.66148362657	3038.66148362657
"healthy-4"	"2019-08-01-count-3:TCGGTCTAGAGGCGGA"	2.36257495459859	-5.95662834560546	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTAGAGGCGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.13687879758	44.1235141850323	0.016782509324966	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2624.85936923697	2624.85936923697
"healthy-4"	"2019-08-01-count-2:CCCGGAATCGTGGACC"	3.15371455725972	-5.86111833965453	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGGAATCGTGGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.31599292387	43.3014279495596	0.0161553443936749	2186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2673.25346648416	2673.25346648416
"healthy-4"	"2019-08-01-count-2:TTAGGGTCAAGTATAG"	4.4824444251949	-6.94877531444701	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTCAAGTATAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.97143551134	44.8894976552566	0.0173454378357106	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2586.87146191766	2586.87146191766
"healthy-4"	"2019-08-01-count-4:CATCGCTCAGCTAACT"	-1.22094617310222	8.39616963947145	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGCTCAGCTAACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.92762325851	42.0230773720557	0.020640752103357	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2026.74512923439	2026.74512923439
"healthy-4"	"2019-08-01-count-2:TTAGGGTGTAACACCT"	4.59408201751058	-7.4024753800598	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTGTAACACCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2700.51290881424	43.6458777867093	0.016162069673599	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2694.05043370108	2694.05043370108
"healthy-4"	"2019-08-01-count-4:TATCTGTAGTAAACGT"	-3.61048970642741	10.4002361067566	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTGTAGTAAACGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.23693004324	44.4301751907115	0.0224481336803578	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.40443149997	1975.40443149997
"healthy-4"	"2019-08-01-count-4:TTGGGCGTCGGATAAA"	-3.00190601769145	3.70143601978151	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGTCGGATAAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2999.86579691174	44.8822748715921	0.0149614275804594	4513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2993.8092704013	2993.8092704013
"healthy-4"	"2019-08-01-count-4:GGCTTGGTCGACGACC"	4.33032335814778	-7.18005802547606	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTGGTCGACGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.75875850535	42.6784536002024	0.0158729203448237	1887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2686.62878658992	2686.62878658992
"healthy-4"	"2019-08-01-count-4:GAGGGTACAACCACAT"	14.2652136283809	2.07910583103029	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGTACAACCACAT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1529.3118754638	43.4757013130208	0.0284282768024905	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1515.51159457812	1515.51159457812
"healthy-4"	"2019-08-01-count-4:TTGGTTTAGTGAGCCA"	-7.20465598526652	3.39558670604555	"2019-08-01-count-4"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTAGTGAGCCA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2603.88817170266	46.6369315695688	0.0179104971082815	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2587.58678969823	2587.58678969823
"healthy-4"	"2019-08-01-count-2:TTAGGGTTCCATTCAT"	0.23979010161702	8.21508023822633	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTTCCATTCAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2008.90469151025	43.3399679977385	0.0215739294058577	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1997.3228042708	1997.3228042708
"healthy-4"	"2019-08-01-count-2:CCCTAACTCGCCACTT"	10.9531790214473	6.94741199100343	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTAACTCGCCACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.07969617749	39.7895928829631	0.0190830081727371	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2080.7760612827	2080.7760612827
"healthy-4"	"2019-08-01-count-2:AGCGTATGTCATCCGG"	3.7185124355251	-6.98136284267577	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATGTCATCCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.59969608033	48.7288172318883	0.0219045328998951	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2219.16654140908	2219.16654140908
"healthy-4"	"2019-08-01-count-2:CCCTCAACACCAGTTA"	3.18739904937093	-6.03323223507079	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAACACCAGTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2776.21407776587	44.9849754335176	0.0162037127445585	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2767.04330812284	2767.04330812284
"healthy-4"	"2019-08-01-count-4:TTGGTTTGTTGCTCGG"	11.0618521171505	6.32140586459962	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTGTTGCTCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2131.6599529013	44.8506358976929	0.0210402394794014	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2123.74508994437	2123.74508994437
"healthy-4"	"2019-08-01-count-3:GATGATCGTTGCTCGG"	0.267181490629357	7.87595794284669	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGATCGTTGCTCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.07159054868	39.4657801348245	0.021888082725997	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1791.42135479353	1791.42135479353
"healthy-4"	"2019-08-01-count-4:TTGTGTTTCGAGAATA"	4.26904787597005	-6.53307440197142	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTGTTTCGAGAATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.85410796806	41.0208398540999	0.0155744540785314	1968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2633.85410796806	2633.85410796806
"healthy-4"	"2019-08-01-count-4:TATGTTCCAGTCAGCC"	10.8745914894039	6.51448438251344	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCCAGTCAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.19441631393	40.4606197665067	0.0203299835608244	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1981.22222482688	1981.22222482688
"healthy-4"	"2019-08-01-count-4:GAGTGAGAGGCTCTCG"	10.912258763879	6.75717399204103	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGAGAGGCTCTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.32309034835	46.4597894923606	0.025259178083586	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1834.32490918679	1834.32490918679
"healthy-4"	"2019-08-01-count-2:GATAGCTGTATCCCAA"	3.12661304053609	-6.99507810985716	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATAGCTGTATCCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.48698824805	45.6446520681396	0.0213244239833007	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2132.51164513196	2132.51164513196
"healthy-4"	"2019-08-01-count-3:AGTACCAGTAACTAAG"	10.688192029565	7.13070914829103	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACCAGTAACTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.50961080386	43.7471024740522	0.0232140511373627	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.16070971162	1877.16070971162
"healthy-4"	"2019-08-01-count-4:TATGTTCTCTGGGCCA"	0.247435649007004	7.9099402197632	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATGTTCTCTGGGCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.24033736421	43.7109355721495	0.0239743135758727	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1819.07404337626	1819.07404337626
"healthy-4"	"2019-08-01-count-2:TTATTGCTCATCCTGC"	11.3184458213741	6.03009460056154	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTATTGCTCATCCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2129.96400197445	49.2337282185733	0.0231148170452338	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2118.61812371789	2118.61812371789
"healthy-4"	"2019-08-01-count-4:CATCGTCTCGCTGACG"	11.629037519067	3.54493115032045	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATCGTCTCGCTGACG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2281.4586908827	34.1354615495772	0.0149621212454959	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2262.55247103391	2262.55247103391
"healthy-4"	"2019-08-01-count-2:CCCTCTCGTCGCGTTG"	0.195033197372597	7.68312833392946	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCTCGTCGCGTTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.21066478183	30.8631608115073	0.0170872431512496	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1801.77248222987	1801.77248222987
"healthy-4"	"2019-08-01-count-4:ACGATCATCCGTGTAA"	-1.29228232327159	8.4260101088318	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGATCATCCGTGTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.45390598254	42.2582125740388	0.0204199825141674	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2064.38998861305	2064.38998861305
"healthy-4"	"2019-08-01-count-2:AGCTCAATCACTCGAA"	4.72467150267903	-6.82789280330809	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCTCAATCACTCGAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2800.4964091251	41.2415493013245	0.0147265139019438	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2799.38146797944	2799.38146797944
"healthy-4"	"2019-08-01-count-4:TTGTTGTTCTGGAGAG"	11.3071114021236	4.86436603153077	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTGTTCTGGAGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.98009399677	34.8835708429138	0.018486454072246	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1878.03354308881	1878.03354308881
"healthy-4"	"2019-08-01-count-2:TTCAATCGTACTGAGG"	0.12872059372012	7.89600179279176	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCGTACTGAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1984.17100590074	43.623742338846	0.0219858783386679	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1974.5530684178	1974.5530684178
"healthy-4"	"2019-08-01-count-4:TATTGCTGTACATTGC"	0.233804945915383	8.28093717182008	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTGTACATTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2175.95500299035	44.3153019231571	0.0203659091581655	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2164.32064809293	2164.32064809293
"healthy-4"	"2019-08-01-count-3:GGGATCCAGTAAAGCT"	2.50800385054891	-5.95352651989134	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGATCCAGTAAAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.5980652692	41.0710923742981	0.0163525736630539	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2506.60490026136	2506.60490026136
"healthy-4"	"2019-08-01-count-2:GATCAGTCAGCTGTCG"	-8.13678012314494	-0.559548818227373	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCAGTCAGCTGTCG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3187.7984950191	42.0709075039848	0.0131974801951002	4258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3179.15304767139	3179.15304767139
"healthy-4"	"2019-08-01-count-2:TAGACCATCACACCCT"	3.47885288771932	-6.29145958339842	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCATCACACCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2777.07470850616	43.2957957299332	0.0155904324782184	2105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2773.67287955249	2773.67287955249
"healthy-4"	"2019-08-01-count-3:AGTAGCTCAGGGATAC"	10.6306129890377	6.48082730853883	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGCTCAGGGATAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.86595226877	43.0266234249899	0.0235650505293262	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1822.337273673	1822.337273673
"healthy-4"	"2019-08-01-count-3:TCTATACCACGGCGTT"	3.0007435279781	-6.19829704677733	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATACCACGGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2535.09850833407	44.3558852921272	0.0174967107377912	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2529.73059371179	2529.73059371179
"healthy-4"	"2019-08-01-count-3:CGGGTGTAGCGGTAAC"	10.8228451209957	5.79147431934205	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTAGCGGTAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.70037986585	43.090935408668	0.0246699067025894	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1740.86610671736	1740.86610671736
"healthy-4"	"2019-08-01-count-2:CCGAACGAGCTTCATG"	4.24440922316853	-7.01472952282103	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGAACGAGCTTCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.97190761611	45.1699372579728	0.0182802309968594	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2464.86081509381	2464.86081509381
"healthy-4"	"2019-08-01-count-4:TTTACCAGTTTCAGAC"	-2.51235495033916	9.31255052173463	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACCAGTTTCAGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.68225103612	37.722109186145	0.018314528450769	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2057.81935568641	2057.81935568641
"healthy-4"	"2019-08-01-count-2:TTCACGCCAACGCATT"	10.2450167137081	7.00353715503541	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCACGCCAACGCATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.27552138636	49.6308386528201	0.0251133195324932	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.55703498764	1969.55703498764
"healthy-4"	"2019-08-01-count-3:TCTATCAGTGGGACAT"	3.26878203925435	-6.57511141216429	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATCAGTGGGACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.80456531987	48.1963745201926	0.0193419561032089	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2486.75395553105	2486.75395553105
"healthy-4"	"2019-08-01-count-3:TCTATCAGTTTCAGAC"	-2.13953671875651	4.19017169559327	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTATCAGTTTCAGAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3501.78466861841	43.8426143339463	0.012520077184313	5250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3497.15379920365	3497.15379920365
"healthy-4"	"2019-08-01-count-2:TTCAGGACACACCTGG"	9.95264114913289	6.7371992834839	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGACACACCTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2103.81461822963	47.6736548201113	0.022660577793793	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2092.12463267745	2092.12463267745
"healthy-4"	"2019-08-01-count-4:TTTACGTAGAGAGGGC"	-2.20222411575969	3.46473190868226	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACGTAGAGAGGGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2917.6281312541	40.7990090206312	0.0139836220331117	4293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2911.93788462767	2911.93788462767
"healthy-4"	"2019-08-01-count-3:TCTCACGAGTACAGCG"	11.352384229272	5.8816027411255	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGAGTACAGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.09381057973	47.6652014374251	0.0243426546674559	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.78922539282	1951.78922539282
"healthy-4"	"2019-08-01-count-2:AGGACGAGTACGTTCA"	2.67290272292439	-5.60557558452757	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACGAGTACGTTCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2881.22574692653	43.0224007454744	0.0149319784440242	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2877.27214378347	2877.27214378347
"healthy-4"	"2019-08-01-count-2:TTCATGTGTCCCGGTA"	-0.242928753525573	7.72525308215944	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATGTGTCCCGGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2150.81430361736	46.2273905264874	0.0214929714986271	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.69448049976	2142.69448049976
"healthy-4"	"2019-08-01-count-4:GATCATGGTTCATCGA"	5.10408033904378	-8.00861647045287	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGGTTCATCGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2733.0226759243	42.7287835804753	0.0156342587117484	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2729.09682634268	2729.09682634268
"healthy-4"	"2019-08-01-count-4:CATGGATAGCTGACCC"	10.4572597938472	7.55575082385866	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATGGATAGCTGACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2229.71896937526	48.8230147677139	0.0218964880499687	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2219.48042724754	2219.48042724754
"healthy-4"	"2019-08-01-count-2:CCGCAAGCAACCTATG"	-7.25276551666911	2.97320029819337	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGCAAGCAACCTATG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2677.32523497889	45.7530429051411	0.0170890866404215	2805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2663.06688032992	2663.06688032992
"healthy-4"	"2019-08-01-count-3:TCTCAGCCAGGAATCG"	10.5146213966304	7.6803407439026	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCAGCCAGGAATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.10987565075	45.3026975726538	0.0233145321015272	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.0468928414	1940.0468928414
"healthy-4"	"2019-08-01-count-4:ACGGTCGGTGACTAAA"	-5.47151647034343	-5.24597027218016	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTCGGTGACTAAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2765.31789047735	49.918308836046	0.0180515625375096	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2764.13286804201	2764.13286804201
"healthy-4"	"2019-08-01-count-4:TCAAGCACAATCGCAT"	4.47160543975179	-6.81208565151366	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGCACAATCGCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2813.18661683763	45.351475099415	0.0161210332894288	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2805.0597922284	2805.0597922284
"healthy-4"	"2019-08-01-count-4:CATTCATCACCACATA"	0.391145934432191	7.75102708423463	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCATCACCACATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.21335220182	41.7742531752762	0.0217890476963874	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.67437767517	1910.67437767517
"healthy-4"	"2019-08-01-count-4:TTTACTGTCAAAGCCT"	-5.66995130005534	-5.30559446727904	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACTGTCAAAGCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3172.05164290291	46.1407615060946	0.0145460309920644	2918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3169.04464952307	3169.04464952307
"healthy-4"	"2019-08-01-count-3:GGGTAGAGTCATCGCG"	-3.81892762604411	3.60424492442933	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTAGAGTCATCGCG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2948.41611645685	46.2866561598448	0.0156988207673577	4074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2937.68417419308	2937.68417419308
"healthy-4"	"2019-08-01-count-2:TTCCAATAGACGCAGT"	-0.437572847039062	7.97679088199464	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATAGACGCAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.62018172304	43.2585355583845	0.0224764013020256	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1918.60090077456	1918.60090077456
"healthy-4"	"2019-08-01-count-2:TAGGAGGTCCTCTTTC"	-4.09941707077678	12.2726888426575	"2019-08-01-count-2"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGAGGTCCTCTTTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2374.21221098779	49.6653697153125	0.0209186733542446	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2367.71714336879	2367.71714336879
"healthy-4"	"2019-08-01-count-2:AGGATAAAGACGACTG"	2.92516054686849	-6.65059902584227	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAAAGACGACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.60249269306	48.0780587798942	0.0280403527842655	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1714.60249269306	1714.60249269306
"healthy-4"	"2019-08-01-count-3:GGGTCACAGACAGTCG"	2.43293370780293	-6.03432133114012	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACAGACAGTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.77137309158	46.1186129076388	0.0210609260283311	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2185.95345638612	2185.95345638612
"healthy-4"	"2019-08-01-count-4:GATGACTCATCCAACA"	2.52701439437215	-5.89557793056639	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTCATCCAACA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2838.92425976142	36.8994364405599	0.0129976825953296	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2833.24562885287	2833.24562885287
"healthy-4"	"2019-08-01-count-2:CCGGTAGCATCAGCTA"	-3.40128121796306	-5.5376129380432	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGGTAGCATCAGCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2447.3239569128	46.1800628552159	0.0188696158204859	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2442.93874205138	2442.93874205138
"healthy-4"	"2019-08-01-count-4:ACGTAACTCAATCTTC"	-1.36211536350902	8.50796315753785	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACTCAATCTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2156.63810386051	51.249492330415	0.0237636032854448	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2146.94179884233	2146.94179884233
"healthy-4"	"2019-08-01-count-4:TCAATCTCAGAATGTA"	2.38673152503316	-6.1462726823059	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATCTCAGAATGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.66975582761	44.3683012967288	0.0175808665909136	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2517.33249074008	2517.33249074008
"healthy-4"	"2019-08-01-count-2:AGGATAATCATCACAG"	10.4964338737423	7.06789538944093	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAATCATCACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2115.17809653539	44.2241727933826	0.020908013781828	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2110.01792433329	2110.01792433329
"healthy-4"	"2019-08-01-count-4:TTTATGCGTAGGTCAG"	6.65484728392903	-1.6767126551834	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCGTAGGTCAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3020.95496989932	42.2793344604693	0.0139953540790045	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3011.4909290949	3011.4909290949
"healthy-4"	"2019-08-01-count-4:TCAATTCAGCATCTTG"	10.678034444421	7.50653455341188	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCAGCATCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2303.99581753842	48.5259662519841	0.0210616555301862	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2293.34467813548	2293.34467813548
"healthy-4"	"2019-08-01-count-3:TCTGGCTGTACGTGTT"	10.7316280799801	7.60646102512208	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTGTACGTGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2546.47262929565	45.5927099243535	0.0179042607408525	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2538.80678356987	2538.80678356987
"healthy-4"	"2019-08-01-count-4:TCAATTCCACTAGGTT"	10.6857572990352	6.4956016310486	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCCACTAGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.87324393523	47.0660499358532	0.0239050685872399	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1965.530843009	1965.530843009
"healthy-4"	"2019-08-01-count-3:CGTCCATAGGACTGGT"	0.0728510926360309	7.66069505298463	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCCATAGGACTGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.45853316859	47.050391748281	0.0248620463400609	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.67692071594	1888.67692071594
"healthy-4"	"2019-08-01-count-3:CGTCAAATCGTGGCGT"	4.52683939513509	-7.22114899074706	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTCAAATCGTGGCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.53634609018	45.1600185051402	0.0184738584792857	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2443.15916639073	2443.15916639073
"healthy-4"	"2019-08-01-count-4:TTTCACACACTTGAAC"	3.09365977820699	-5.9618187180725	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCACACACTTGAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.38415759119	43.1411221757501	0.0156969039632221	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2740.97889116672	2740.97889116672
"healthy-4"	"2019-08-01-count-3:GGGTGAAGTGGTGATG"	-1.20901403847392	8.34277246082155	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGAAGTGGTGATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.97016265509	47.4539340121335	0.0228037551252477	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2075.47028590541	2075.47028590541
"healthy-4"	"2019-08-01-count-3:GGGTGTCAGTAGTCCT"	2.650491853326	-6.11660053646239	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCAGTAGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.89082048049	48.1191632912361	0.0203904192828033	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2358.55151106091	2358.55151106091
"healthy-4"	"2019-08-01-count-3:GGGTGTCAGGCTAACG"	2.27175750312154	-6.00033857738646	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGTCAGGCTAACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.64688829824	48.2243506285975	0.019566433981906	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2462.33218494775	2462.33218494775
"healthy-4"	"2019-08-01-count-2:CCGTGAGAGGTGCCTC"	4.28158773955647	-6.40700390255126	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGAGGTGCCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.21457997114	41.5170063095551	0.0157129578438737	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2639.25466994576	2639.25466994576
"healthy-4"	"2019-08-01-count-4:CATTGCCCATACCAGT"	-4.44337687912639	13.0001640089783	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCCATACCAGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2268.16901625948	38.6911255751801	0.0170583079558097	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2264.73524895181	2264.73524895181
"healthy-4"	"2019-08-01-count-2:CCGTGAGCAATTCACG"	2.49951519545857	-6.09910871898802	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGCAATTCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.94501940325	48.3850204422791	0.0183349861730808	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2635.42091142824	2635.42091142824
"healthy-4"	"2019-08-01-count-4:AGTAGCTGTATGACAA"	8.89540924605672	6.37677619541017	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGCTGTATGACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.7309414567	42.7532174995248	0.0229642299794796	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1850.94989951771	1850.94989951771
"healthy-4"	"2019-08-01-count-2:GGGAGTACAGGTGAGT"	-0.286242137581664	7.62629983508912	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAGTACAGGTGAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.08034015647	44.8589764409419	0.0224735325219552	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1990.84799943984	1990.84799943984
"healthy-4"	"2019-08-01-count-3:AACCTTTGTTAGAGAT"	2.34122552451436	-6.09100773250731	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTGTTAGAGAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2814.6190475989	45.1491067335537	0.0160409298629843	2588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2810.93286710482	2810.93286710482
"healthy-4"	"2019-08-01-count-2:AACCAACGTCTGGTTA"	10.7026297050411	6.5465779074463	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCAACGTCTGGTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2092.91607538532	44.5940466933016	0.0213071356361442	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2081.74317418058	2081.74317418058
"healthy-4"	"2019-08-01-count-2:AGGCTGCAGTGTTGAA"	-4.41588149491008	12.7530631789002	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCAGTGTTGAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2315.6169397653	42.9175316168765	0.0185339513111467	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2310.90741503321	2310.90741503321
"healthy-4"	"2019-08-01-count-4:TCACATTCAGAAGTGC"	-2.04441771927531	3.53262970531312	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACATTCAGAAGTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3060.06920211019	45.9937156429409	0.0150302861161519	5099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3053.88302702568	3053.88302702568
"healthy-4"	"2019-08-01-count-4:TCACGCTCAGTCAGAG"	-2.88565645638164	9.49612901294557	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGCTCAGTCAGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.49075505445	44.8031004138928	0.0217967900384481	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2051.89988860334	2051.89988860334
"healthy-4"	"2019-08-01-count-4:CATTGTTGTAGTTACC"	-1.99334154549297	3.48189542377321	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGTTGTAGTTACC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3061.62501423573	47.5512732070206	0.0155313838193508	4525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3052.50726919158	3052.50726919158
"healthy-4"	"2019-08-01-count-2:TTCCTAAAGACGGATC"	-7.81413541260417	-0.799738430139147	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAAGACGGATC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2642.06185405795	51.0664775608646	0.0193282672328172	2731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2635.59286822803	2635.59286822803
"healthy-4"	"2019-08-01-count-2:AGGCTGCTCTAAGCGT"	10.4116226631099	6.14100406253663	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCTCTAAGCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1786.4218952931	41.6871614372544	0.0233355634226677	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1777.87487533773	1777.87487533773
"healthy-4"	"2019-08-01-count-4:TCACGCTTCGCTTTAT"	-1.98541579666789	4.13417623126832	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGCTTCGCTTTAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3380.1751621129	43.0560266071936	0.0127378092975158	5908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3371.59917387597	3371.59917387597
"healthy-4"	"2019-08-01-count-2:TATATCCTCATTATCC"	3.16506399688069	-6.07644560253295	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCTCATTATCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.23862946099	42.7387406288238	0.0164554539363576	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2593.6128962638	2593.6128962638
"healthy-4"	"2019-08-01-count-2:TTCCTAATCTCGCTCA"	10.1576782661373	6.99260280216066	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAATCTCGCTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1929.3586723351	45.3516251866399	0.0235060623184961	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.89094336653	1917.89094336653
"healthy-4"	"2019-08-01-count-4:ACTATCTCAGGGTTGA"	4.81309761580769	-6.85014822399291	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATCTCAGGGTTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.55049610715	43.2428102726726	0.0156929841546228	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2752.74495981215	2752.74495981215
"healthy-4"	"2019-08-01-count-1:AAAGAACCACTAGGTT"	0.0186807821387469	7.69430873477785	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAAGAACCACTAGGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2042.52285306372	40.9455792658209	0.0200465709377028	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2033.6257138457	2033.6257138457
"healthy-4"	"2019-08-01-count-3:TGAACGTAGACCAACG"	-3.0178955596989	-5.96127321636351	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAACGTAGACCAACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2807.00020881872	46.8892742052197	0.0167044070954851	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2797.98493658816	2797.98493658816
"healthy-4"	"2019-08-01-count-4:GATTCGAGTCTGTCCT"	10.6884991126949	7.30613038623659	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCGAGTCTGTCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2189.19841671822	49.1072369650332	0.022431606285669	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2183.18752410499	2183.18752410499
"healthy-4"	"2019-08-01-count-2:AGGGAGTGTGGCAGAT"	10.211328168481	7.51442620838014	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGAGTGTGGCAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.29748364775	44.7838517907661	0.0219712049639686	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2027.01014821759	2027.01014821759
"healthy-4"	"2019-08-01-count-3:AACTTCTCAATGCTCA"	11.1712748008663	6.28985068881837	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACTTCTCAATGCTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.68769688272	50.4986264532673	0.0245892433060386	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.30743248648	2043.30743248648
"healthy-4"	"2019-08-01-count-2:TTCCTTCAGATACATG"	3.21337689933125	-5.96186211025389	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTTCAGATACATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.88440929627	43.733195596131	0.0160790640391392	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.39360830397	2716.39360830397
"healthy-4"	"2019-08-01-count-3:GTTGCTCCAGTTTCGA"	-3.97681699219401	13.2044248350891	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCTCCAGTTTCGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1900.6337415016	48.2432372124909	0.0253827111236993	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1894.94943911749	1894.94943911749
"healthy-4"	"2019-08-01-count-4:CGGAGAATCTATCGCC"	10.0088488059932	7.00625655734865	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGAGAATCTATCGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2015.41051644338	41.6972309482514	0.0206891998469051	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2010.2119179158	2010.2119179158
"healthy-4"	"2019-08-01-count-3:AGTTCCCAGGTATAGT"	-4.2174747985905	12.359890914801	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCAGGTATAGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1825.18908598844	49.553071302891	0.0271495549054608	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1823.2566076653	1823.2566076653
"healthy-4"	"2019-08-01-count-1:AATGACCAGGAATGTT"	-2.17068658295329	8.94155595386354	"2019-08-01-count-1"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATGACCAGGAATGTT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2325.30720593532	42.6258954112965	0.0183312963132331	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2318.12926249955	2318.12926249955
"healthy-4"	"2019-08-01-count-1:AATGACCTCTCTAGGA"	0.831746538251084	8.32537362659303	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATGACCTCTCTAGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1948.60433223179	42.3901281132063	0.0217540972336111	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1943.06397770523	1943.06397770523
"healthy-4"	"2019-08-01-count-4:GATTGGTCACTAACCA"	10.7924286323482	6.47191379154054	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTCACTAACCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2006.13016039728	45.3499931447367	0.0226057082635934	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2002.11694941675	2002.11694941675
"healthy-4"	"2019-08-01-count-4:GATTGGTGTATGTCCA"	-2.69385872307475	4.0070340403351	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTGTATGTCCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3541.81318386563	44.3093067661332	0.012510345539392	5388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3532.50523694495	3532.50523694495
"healthy-4"	"2019-08-01-count-4:TCAGCAACAACAGTGG"	4.04357590255086	-7.01295187389525	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAACAACAGTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2071.22375090691	47.0051253711197	0.0226943734835688	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2064.10421775654	2064.10421775654
"healthy-4"	"2019-08-01-count-2:AGGGCTCGTCCACACG"	3.39160384711568	-6.42260172283324	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGCTCGTCCACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.65604546246	38.4012178012937	0.0151684182652383	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2529.48232666296	2529.48232666296
"healthy-4"	"2019-08-01-count-2:TTCGCTGAGAGCCCAA"	10.6365391212398	6.02613494479982	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGAGAGCCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1449.64718210501	35.8639751810269	0.0247397957404708	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1444.94663380167	1444.94663380167
"healthy-4"	"2019-08-01-count-2:CCTATCGCAGCAGTAG"	2.4193238216335	-6.05853273784789	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGCAGCAGTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.87769078249	49.1777023168884	0.022364910300849	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2193.79050968777	2193.79050968777
"healthy-4"	"2019-08-01-count-2:CCTCAACAGCCTCACG"	10.4126106697017	7.25745437229005	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCAACAGCCTCACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.93136497934	44.1275846646685	0.0215473943215444	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2043.46354404202	2043.46354404202
"healthy-4"	"2019-08-01-count-2:CCTATCGGTGTTGACT"	-1.66039095345195	8.69840333545534	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGGTGTTGACT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2046.68324802362	48.104972664273	0.0235038678851384	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2043.14001801172	2043.14001801172
"healthy-4"	"2019-08-01-count-2:CCTATCGGTGAGCCAA"	4.71471323546712	-6.77718927776488	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTATCGGTGAGCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.2407511841	43.4968447517426	0.0162772926550382	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2663.13866679265	2663.13866679265
"healthy-4"	"2019-08-01-count-4:CCAATTTGTGGCGTAA"	5.60438837584798	-10.1438961259094	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTGTGGCGTAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.89203308551	46.1711297115462	0.0182646763023302	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2516.18783152595	2516.18783152595
"healthy-4"	"2019-08-01-count-2:GCACATAAGTGAGGTC"	-5.7717436355656	-5.27061130916747	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACATAAGTGAGGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3030.48432651812	48.0320586888071	0.0158496311195226	3091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3024.39968769308	3024.39968769308
"healthy-4"	"2019-08-01-count-3:TGACCCTTCCTGTAAG"	-4.87306056442912	-4.43148329174193	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTTCCTGTAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3468.58389758679	42.9736820142085	0.0123894025005729	4320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3459.60047912585	3459.60047912585
"healthy-4"	"2019-08-01-count-4:ACTGCAAAGGCTTTCA"	4.0841232734615	-6.33591654216918	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAAAGGCTTTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.98088566578	40.1980161100182	0.0149825950400102	2109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2679.26844543648	2679.26844543648
"healthy-4"	"2019-08-01-count-3:CTAACTTCACGGAAGT"	4.10119404372518	-6.85083200847777	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACTTCACGGAAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.84101845786	45.1199386063594	0.0180274888710911	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2500.30336215085	2500.30336215085
"healthy-4"	"2019-08-01-count-4:TTTGGAGCATGAAAGT"	11.4158007102901	3.69145200336305	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGAGCATGAAAGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.47557810673	35.1667035732397	0.0185823817121176	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1870.26453927329	1870.26453927329
"healthy-4"	"2019-08-01-count-4:CCACAAAGTGCTCTTC"	-4.18453250351604	12.9703006514343	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACAAAGTGCTCTTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1927.1035349074	41.5353055415394	0.0215532299065266	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1927.1035349074	1927.1035349074
"healthy-4"	"2019-08-01-count-4:TCAGGGCCAGAGCGTA"	11.5641466575557	3.40514133060304	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGGCCAGAGCGTA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.48863259331	34.0878773376696	0.0185311704207775	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1816.48071038746	1816.48071038746
"healthy-4"	"2019-08-01-count-2:CCTCACACAAATGCGG"	3.55241908606831	-6.68811705028685	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACACAAATGCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1938.20855008343	45.5519244440706	0.0235020758948307	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1934.54501257277	1934.54501257277
"healthy-4"	"2019-08-01-count-2:TTCTAACGTCTTACAG"	10.928332944482	6.38406322086183	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACGTCTTACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.4629399607	43.9023883753302	0.0218044183997681	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2002.26518682399	2002.26518682399
"healthy-4"	"2019-08-01-count-2:GCACGGTTCACCTCAC"	4.45414080199544	-7.04745247280272	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGGTTCACCTCAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2769.00098619181	42.8496103161686	0.0154747544438759	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2763.58526443064	2763.58526443064
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTAACGGTG"	-2.30555472794231	8.7198972471985	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTAACGGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2691.6534531342	48.5493933074553	0.0180370148508248	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2681.19270786858	2681.19270786858
"healthy-4"	"2019-08-01-count-2:CCTCACATCCATTTCA"	-4.2713717025822	12.8601331480774	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACATCCATTTCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2213.76068146138	42.8135301320506	0.019339728314168	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2206.60943049857	2206.60943049857
"healthy-4"	"2019-08-01-count-4:CCACACTCAGTATACC"	2.55148686942403	-6.51801683818968	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTCAGTATACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.99402362906	48.0916074920244	0.0219797709557993	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2178.47798643361	2178.47798643361
"healthy-4"	"2019-08-01-count-2:CCTCACATCTGCGAGC"	5.01650490340535	-7.49764635479125	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCACATCTGCGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.03928020052	46.1526638634218	0.0174289951846662	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2642.6716966037	2642.6716966037
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTTCCAAAC"	10.3969732719356	7.42510554874269	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTTCCAAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2203.73858870552	47.2973281305417	0.0214623133492091	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2195.28490985433	2195.28490985433
"healthy-4"	"2019-08-01-count-4:CCACACTTCTTCTTCC"	2.26005162772481	-6.09191801464232	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACACTTCTTCTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.55912177782	41.3052692099471	0.0165118101148823	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2500.39073924604	2500.39073924604
"healthy-4"	"2019-08-01-count-4:GCACGTGCACTGTGTA"	0.0678190841222226	7.82335994327394	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACGTGCACTGTGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1902.57582328106	42.3566249200899	0.0222627789136121	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1900.17636586569	1900.17636586569
"healthy-4"	"2019-08-01-count-3:GGTTAACAGACTAGAT"	3.74813069876973	-6.3385277024475	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTAACAGACTAGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.63696524612	46.6043763052563	0.0199024771973387	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2337.53169591413	2337.53169591413
"healthy-4"	"2019-08-01-count-4:TCAGTCCCAGAGTTCT"	4.06274952468221	-6.86055662548216	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTCCCAGAGTTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.44612882968	43.9082225176183	0.0168073217024721	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2606.41078613055	2606.41078613055
"healthy-4"	"2019-08-01-count-2:GCAGCCAGTACTGCCG"	0.402962555258912	7.73547742450563	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCCAGTACTGCCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.30291127769	38.4419274581608	0.0199874534753463	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.29108384956	1916.29108384956
"healthy-4"	"2019-08-01-count-1:ATCCGTCAGTATGCAA"	0.403332789509934	7.91311023319093	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATCCGTCAGTATGCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.59011844691	46.4097319088838	0.0256465436210026	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1798.35623686126	1798.35623686126
"healthy-4"	"2019-08-01-count-4:AACGTCACACCATATG"	-4.00348840180095	11.1719922789368	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCACACCATATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2081.34469076515	48.1035274053002	0.0231117544435257	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2072.48791099094	2072.48791099094
"healthy-4"	"2019-08-01-count-3:CTACCTGTCAATCGGT"	10.8136707740719	7.29079053485719	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCTGTCAATCGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2094.97273026936	44.1505242409181	0.0210745102325229	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2090.50287315228	2090.50287315228
"healthy-4"	"2019-08-01-count-1:ATGTCTTCAATTGCAC"	10.4627634483272	7.12391421878663	"2019-08-01-count-1"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATGTCTTCAATTGCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2183.34525227882	40.7162131351086	0.0186485454339445	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2169.39294219931	2169.39294219931
"healthy-4"	"2019-08-01-count-3:GGTTCTCCATTCCTAT"	5.72685017165486	-9.99142172252806	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTCTCCATTCCTAT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.32569548117	49.486732524393	0.0186578641562402	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2643.0415573466	2643.0415573466
"healthy-4"	"2019-08-01-count-2:GCAGGCTAGCTCGACC"	0.512611408799332	7.87793538654176	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTAGCTCGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.47740948184	34.871736494107	0.0193037213258645	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1799.24285496494	1799.24285496494
"healthy-4"	"2019-08-01-count-2:TTCTTCCGTGCACAAG"	2.52785529670064	-6.26675846492919	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCGTGCACAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.82983963904	45.8548737380009	0.0202912949168444	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2249.22610039183	2249.22610039183
"healthy-4"	"2019-08-01-count-2:TTCTTCCGTGTTCCTC"	-2.12814913216289	9.15274903858034	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCGTGTTCCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.03236204962	46.9317196696316	0.0252452408186635	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1857.27100782147	1857.27100782147
"healthy-4"	"2019-08-01-count-2:AGGTGTTTCGACATAC"	2.22649802741353	-6.05010940944823	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTTCGACATAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2648.52455597782	44.5012998435169	0.0168022983751749	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2641.42191149515	2641.42191149515
"healthy-4"	"2019-08-01-count-3:GGTTGTACAACTCGAT"	3.30349435386006	-5.97151615535887	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTACAACTCGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.09054969876	45.3549015158756	0.018090651540817	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2501.62211950115	2501.62211950115
"healthy-4"	"2019-08-01-count-3:CTACGGGCAGGTTTAC"	10.2302004295284	7.0373325117859	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACGGGCAGGTTTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.36900891834	42.768616458289	0.0203527397029157	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2091.86924833186	2091.86924833186
"healthy-4"	"2019-08-01-count-2:CCTCCTCCAATGTGGG"	2.97724427756612	-5.95508387005004	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCCAATGTGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.39509712734	42.0189207549929	0.0151561805885934	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2765.01438628881	2765.01438628881
"healthy-4"	"2019-08-01-count-2:GCAGTTAAGTGTCATC"	4.5095702606136	-6.70888998424681	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTAAGTGTCATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.87321473963	48.3015843361283	0.0209927187759427	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2296.89138075791	2296.89138075791
"healthy-4"	"2019-08-01-count-2:CCTCCTCCAGCAGTTT"	4.63740458068196	-7.67693331157836	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCCAGCAGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.47893446478	47.3771858374955	0.0180314236647329	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2624.94888491669	2624.94888491669
"healthy-4"	"2019-08-01-count-4:GGTGTCGAGCGTTAGG"	2.87721123275105	-6.46209766781005	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGAGCGTTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.96937955272	48.0346033297939	0.0235467276181988	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2034.87206571026	2034.87206571026
"healthy-4"	"2019-08-01-count-2:AGGTTGTAGCCGATAG"	5.11475290831868	-8.14687445079955	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTAGCCGATAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.17376919834	49.5313230808166	0.0190859370068761	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2590.13905909663	2590.13905909663
"healthy-4"	"2019-08-01-count-4:CCATAAGCAGTACTAC"	5.49212517318074	-9.40647604381713	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGCAGTACTAC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2775.89040213545	44.2860920079011	0.0159538330381605	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2771.70874542018	2771.70874542018
"healthy-4"	"2019-08-01-count-2:TTCTTGAGTTCCTAAG"	10.1898027854854	7.55212972247926	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGAGTTCCTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.09964596416	45.4051926983407	0.0212660766368292	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2130.22288715828	2130.22288715828
"healthy-4"	"2019-08-01-count-4:CCATAAGGTCGGAACA"	4.37727894362752	-6.89758398449095	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGGTCGGAACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.28627583255	40.0174474440064	0.0155874503831985	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2566.14222404702	2566.14222404702
"healthy-4"	"2019-08-01-count-4:CGTGATATCCGAGGCT"	4.60580839690511	-6.75023701107176	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGATATCCGAGGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.43028873575	45.0402830098767	0.0175977768209208	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2557.16240084535	2557.16240084535
"healthy-4"	"2019-08-01-count-2:TTCTTGATCTTTACAC"	-2.14824638786967	8.96160600269166	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGATCTTTACAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1991.29203683965	39.2757814156272	0.0197237676287609	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1987.94317492995	1987.94317492995
"healthy-4"	"2019-08-01-count-4:CCATAAGTCGGTATGT"	4.73958220061604	-6.79630424892577	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATAAGTCGGTATGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.72554624917	48.3973034643857	0.0183690113504554	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2628.73884669364	2628.73884669364
"healthy-4"	"2019-08-01-count-4:CCATCACGTACACGTT"	11.1164423423702	6.30104158008424	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCATCACGTACACGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2044.49592690302	42.9117902179875	0.0209889340708982	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2038.03705238534	2038.03705238534
"healthy-4"	"2019-08-01-count-4:ACTTCGCTCCGGTAGC"	6.74767603453938	-1.78531267559203	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCGCTCCGGTAGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2942.04236434462	35.5550469187173	0.0120851580349821	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2933.57820086299	2933.57820086299
"healthy-4"	"2019-08-01-count-2:CCTCTCCGTCGCTTAA"	-3.1105571788853	9.37978074634401	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCGTCGCTTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.12225444136	38.9783981838335	0.0183936524200719	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2112.18165260117	2112.18165260117
"healthy-4"	"2019-08-01-count-2:CCTCTCCGTTCGAGCC"	4.45680870589559	-6.98837330257567	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCGTTCGAGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.45232696772	46.138770288031	0.0179287449021432	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.44410546865	2568.44410546865
"healthy-4"	"2019-08-01-count-3:CTAGGTACATCGATGT"	-3.21352301064189	10.2256717451843	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGGTACATCGATGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2057.09836761148	47.3135139450369	0.0230001222547141	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2053.52823503442	2053.52823503442
"healthy-4"	"2019-08-01-count-3:ATCACTTCACATTACG"	11.4174572425777	4.56889245593873	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTCACATTACG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2494.72270273758	40.7961935095242	0.0163529972548679	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2479.89638327274	2479.89638327274
"healthy-4"	"2019-08-01-count-4:TCATGAGAGTACGTCT"	11.3396603065426	3.64282319629518	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGAGAGTACGTCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1760.33323237702	42.803628545368	0.0243156396516864	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1755.68392349188	1755.68392349188
"healthy-4"	"2019-08-01-count-3:TCATGCCAGTACGAGC"	0.446789582341355	7.87909362399904	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGCCAGTACGAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1765.27843887095	39.0213055182274	0.0221049012206737	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1752.24549436416	1752.24549436416
"healthy-4"	"2019-08-01-count-2:CATCCCAAGACGACGT"	-0.364813397557098	7.74204681003419	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCCAAGACGACGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.63418649296	42.6080958905	0.0226562380905967	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1868.64924782161	1868.64924782161
"healthy-4"	"2019-08-01-count-3:GTAAGTCTCTTGTTAC"	2.44957913932149	-6.16370298778685	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAAGTCTCTTGTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.32573336506	47.4900101328111	0.019637557289162	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.52425706886	2413.52425706886
"healthy-4"	"2019-08-01-count-2:TTGACCCCAGTATGAA"	2.3000463443691	-6.03781225597533	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGACCCCAGTATGAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2649.15264973015	49.1066769088297	0.0185367486897487	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2644.68397369381	2644.68397369381
"healthy-4"	"2019-08-01-count-3:ATCACTTTCGCGCCAA"	10.8294941383297	6.72822854602662	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACTTTCGCGCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2134.64373316655	49.5575452817644	0.0232158390235219	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2127.21914387568	2127.21914387568
"healthy-4"	"2019-08-01-count-3:GTAATCGGTCGTACAT"	-3.69473753395732	10.4902143248352	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATCGGTCGTACAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2015.87315833549	44.9301936275287	0.0222882047125563	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2012.32089388037	2012.32089388037
"healthy-4"	"2019-08-01-count-3:TGATGGTTCACCACAA"	4.27245773848836	-6.55988075649413	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATGGTTCACCACAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.90411279337	41.4035085456699	0.0169138604446492	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2441.32493684597	2441.32493684597
"healthy-4"	"2019-08-01-count-3:ATCAGGTCAACGTTAC"	2.62810530242268	-6.10146429454955	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTCAACGTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.69335234193	46.0117228839281	0.0189919714104347	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2418.07013870145	2418.07013870145
"healthy-4"	"2019-08-01-count-2:CCTGTTGAGAAACACT"	4.7711841064388	-7.63693621074828	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTGTTGAGAAACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.51634659165	42.952946006787	0.0179081314446008	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2397.04801163682	2397.04801163682
"healthy-4"	"2019-08-01-count-3:TACACCCAGCTCCCTT"	2.77564563330953	-6.0784368745056	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACACCCAGCTCCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.87649932791	43.0508626773585	0.0164890459921948	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2604.38417504579	2604.38417504579
"healthy-4"	"2019-08-01-count-2:TGGGCTGAGTCACTAC"	-0.424335996538955	7.71290538394777	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGCTGAGTCACTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.95121947261	38.4527408997893	0.0206740588125169	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1853.73531990904	1853.73531990904
"healthy-4"	"2019-08-01-count-3:GTAATGCCAACTGAAA"	-2.73924861374553	-5.76741936123046	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAATGCCAACTGAAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2349.40075787477	53.9654721179668	0.0229698879329481	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2344.77849963846	2344.77849963846
"healthy-4"	"2019-08-01-count-2:CCTTCAGGTACTGACT"	0.176279691129369	8.01804111087648	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGGTACTGACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2095.57622671636	45.867256940668	0.0218876585618359	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2079.17317038234	2079.17317038234
"healthy-4"	"2019-08-01-count-3:ATCATTCTCGAACGGA"	-0.278138528496581	7.61883208835451	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCATTCTCGAACGGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.95802333998	47.2774530463326	0.0232898673286579	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2021.30796273427	2021.30796273427
"healthy-4"	"2019-08-01-count-4:GCCAACGGTCTCGGAC"	2.52577628669087	-6.14164545452269	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGGTCTCGGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.23645850778	43.6482312023355	0.0183300700971494	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2380.08642672811	2380.08642672811
"healthy-4"	"2019-08-01-count-2:TCAAGTGCAGGCCTGT"	6.77318062362019	-1.71143247997435	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGTGCAGGCCTGT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2894.6268234948	38.8066033920955	0.0134064270658705	2283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2878.85940331438	2878.85940331438
"healthy-4"	"2019-08-01-count-3:TGCAGATCAAGATCCT"	4.11563362654988	-6.44807484066161	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGATCAAGATCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2763.03031583576	39.8100665135422	0.0144081178861407	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2760.56509685063	2760.56509685063
"healthy-4"	"2019-08-01-count-1:CCTAACCTCGCCTTGT"	10.2804905372554	7.90969131076661	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCTAACCTCGCCTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2369.67902293183	44.8591064226621	0.0189304568207559	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2347.49490037322	2347.49490037322
"healthy-4"	"2019-08-01-count-4:AGAACCTGTCTTGCTC"	4.13968481597249	-6.58726694500121	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACCTGTCTTGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.56767926226	46.7148619857221	0.0193470915671311	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2412.06171612935	2412.06171612935
"healthy-4"	"2019-08-01-count-4:TCATTACCAAAGCAAT"	2.60737528380696	-6.19719841396483	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTACCAAAGCAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.18998120846	43.285192809449	0.0178555282981044	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2418.21477629644	2418.21477629644
"healthy-4"	"2019-08-01-count-3:ATCCATTTCTGCCTCA"	10.8234344917232	5.98237798297731	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCATTTCTGCCTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.92398678782	49.9012912575142	0.0268009282933206	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1856.77884256532	1856.77884256532
"healthy-4"	"2019-08-01-count-3:AATGAAGAGGCATCAG"	4.8762546974117	-7.21964504635008	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGAGGCATCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.56726601058	48.1969196319453	0.0206981006456037	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2325.83799394484	2325.83799394484
"healthy-4"	"2019-08-01-count-3:GTAGAAAAGGAAACGA"	-1.43192730370219	8.75971505725709	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAAAAGGAAACGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1759.79013172741	44.4476076848419	0.0252573343170257	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1752.64736477652	1752.64736477652
"healthy-4"	"2019-08-01-count-3:CTCAGAAAGTCGAATA"	10.6104732948238	7.00030562961427	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGAAAGTCGAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.89356971	49.1813710488793	0.0264858319567341	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1853.40179899701	1853.40179899701
"healthy-4"	"2019-08-01-count-4:AGAAGTAAGTCCCTAA"	11.2081419425899	5.77932069385377	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAAGTAAGTCCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.7371613632	46.4419294628548	0.0245888789678577	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1881.31587388985	1881.31587388985
"healthy-4"	"2019-08-01-count-4:TCATTCATCGGATTAC"	2.40494598922078	-6.58453180706175	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTCATCGGATTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1908.16095598157	50.7136834096916	0.0265772566254004	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1904.73591313865	1904.73591313865
"healthy-4"	"2019-08-01-count-4:AGACAAAAGATAGTGT"	3.38040699538533	-6.23956015026244	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAAAGATAGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.83824117478	42.2675007927944	0.0164860247865821	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2562.02699714289	2562.02699714289
"healthy-4"	"2019-08-01-count-4:TCATTGTAGGCATGGT"	-3.18319592896159	10.4946126707825	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTAGGCATGGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1933.86204546711	46.1510748226099	0.0238647192703254	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1928.43365975737	1928.43365975737
"healthy-4"	"2019-08-01-count-3:GTAGAGGGTGCAAGAC"	-2.87168488922771	10.253334022406	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGAGGGTGCAAGAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1945.9351068776	50.938706799416	0.0261769812463844	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1942.5166035503	1942.5166035503
"healthy-4"	"2019-08-01-count-4:TCATTGTAGTCACTCA"	10.4931875663692	5.85903213107911	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTAGTCACTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1874.93466194399	44.6040921924024	0.023789678167321	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.76648851822	1863.76648851822
"healthy-4"	"2019-08-01-count-3:CTCAGTCAGACGGTCA"	3.59426273879353	-6.08605720913085	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGTCAGACGGTCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2894.81849164856	41.1109542069469	0.0142015654264855	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2890.08457264742	2890.08457264742
"healthy-4"	"2019-08-01-count-4:AGACAAATCAAATGAG"	4.22154583510701	-6.43648197567137	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACAAATCAAATGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.8138720449	47.2763658035479	0.0184542547448269	1881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2555.79124631497	2555.79124631497
"healthy-4"	"2019-08-01-count-3:CTCAGTCAGGAACGTC"	0.136239235370797	7.59661624515382	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGTCAGGAACGTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1814.82520164695	43.0465074009194	0.0237193683236572	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1806.81866634873	1806.81866634873
"healthy-4"	"2019-08-01-count-2:GCCAGTGTCCGACGGT"	10.54474892196	6.76138541782228	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGTGTCCGACGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.30829573081	40.9284264574596	0.02167465267721	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.51948860284	1875.51948860284
"healthy-4"	"2019-08-01-count-3:TGCATCCCAAGCGATG"	1.49775447425191	-6.03362896358641	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCATCCCAAGCGATG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2478.75603908938	48.5458390169723	0.0195847587464907	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2470.63687178492	2470.63687178492
"healthy-4"	"2019-08-01-count-4:CCCTGATAGAAGCTGC"	-1.81881282749828	8.97646424854127	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATAGAAGCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.73327205247	49.3659765319911	0.0255420534461885	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1926.3077077414	1926.3077077414
"healthy-4"	"2019-08-01-count-2:TCACAAGCAAGATTGA"	10.9542566734249	6.79084251010744	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGCAAGATTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.59922752277	43.4901730873951	0.0225501350756305	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1924.03173113417	1924.03173113417
"healthy-4"	"2019-08-01-count-1:CTCCGATCACGCAGTC"	10.8334251838619	6.49544332111207	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTCCGATCACGCAGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2230.00355080091	43.6667053074115	0.0195814510213352	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2219.55704382635	2219.55704382635
"healthy-4"	"2019-08-01-count-2:TTGCTGCAGTATGATG"	-4.2972596687382	12.5711354979309	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCAGTATGATG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2114.42602240595	39.6244563933718	0.018740053316353	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2109.04954673996	2109.04954673996
"healthy-4"	"2019-08-01-count-4:CCCTGATGTTCTCAGA"	5.1328989463741	-7.77264025127562	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATGTTCTCAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2604.13152237224	39.1312275585155	0.0150265941725051	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2600.50535617193	2600.50535617193
"healthy-4"	"2019-08-01-count-3:GTAGGTTAGCGATGAC"	-2.79317055168803	8.73109719837037	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGGTTAGCGATGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.07573409026	42.112124611198	0.0215840543118814	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1951.07573409026	1951.07573409026
"healthy-4"	"2019-08-01-count-2:GACCCTTCAAGACCTT"	11.4201685386593	4.1204509505066	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTCAAGACCTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2247.68546823896	36.2505069079532	0.0161279268919931	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2235.31935870325	2235.31935870325
"healthy-4"	"2019-08-01-count-4:GCCCAGATCGAAGCAG"	5.00606264647786	-7.90520670330199	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGATCGAAGCAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.25125820977	43.459458222383	0.0167393113763381	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2593.23581999023	2593.23581999023
"healthy-4"	"2019-08-01-count-3:ATCGATGAGGCGTCCT"	-2.97431216660197	9.66183564746705	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGATGAGGCGTCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.49955517208	46.9033231343936	0.0247968988446981	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1889.70747758126	1889.70747758126
"healthy-4"	"2019-08-01-count-2:CGAAGTTGTCACTCGG"	3.00285591658894	-6.10365154659423	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAAGTTGTCACTCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.64793144835	39.3920064784334	0.0146457854270991	2296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2683.2696140353	2683.2696140353
"healthy-4"	"2019-08-01-count-2:AGTGATCTCGCAATTG"	11.122237821191	5.64784858310548	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGATCTCGCAATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.71647704793	46.6058612359323	0.0252645118183771	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1834.83271273468	1834.83271273468
"healthy-4"	"2019-08-01-count-4:GCCCGAACAGACCAGA"	-2.42226443710979	9.08038709247438	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCGAACAGACCAGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2551.8909995389	44.7421591171124	0.0175329428745964	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2537.3208256034	2537.3208256034
"healthy-4"	"2019-08-01-count-2:TCACACCGTCAAGGCA"	2.74242319640462	-6.26517155086669	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTCAAGGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.32096041497	49.2346398423796	0.0228857714624241	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2148.22789438231	2148.22789438231
"healthy-4"	"2019-08-01-count-2:CGAATTGAGATGCTAA"	4.25371422347371	-6.66211416637572	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAATTGAGATGCTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.75351108773	42.9958382269069	0.0163249286791267	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2630.20434981109	2630.20434981109
"healthy-4"	"2019-08-01-count-4:TCCACGTTCCCGAAAT"	2.03833105143849	-6.38936474239501	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTTCCCGAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.71208389738	43.4796984321033	0.0173176760134956	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2509.54459517513	2509.54459517513
"healthy-4"	"2019-08-01-count-2:TCACACCGTTCGGCTG"	-0.182379166514236	7.58148048007814	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTTCGGCTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1894.65762714824	43.4327784371279	0.0229238136826342	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1889.49319248486	1889.49319248486
"healthy-4"	"2019-08-01-count-2:TCACACCTCTTGGCTC"	-7.21528420868571	3.01207921588746	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCTCTTGGCTC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2680.30690340959	37.3386304474012	0.0139307294996342	2560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2662.56856365089	2662.56856365089
"healthy-4"	"2019-08-01-count-1:GAATAGAAGCCTCAAT"	11.0293871360714	6.18551013553468	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GAATAGAAGCCTCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.7800958633	44.3113813574925	0.0209630989733561	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2087.41109482699	2087.41109482699
"healthy-4"	"2019-08-01-count-4:TCCAGAAAGCCGTTAT"	-3.09556160393413	-5.82279827510985	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCAGAAAGCCGTTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2339.69653086175	50.9851985079604	0.0217913724431526	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2333.80833641329	2333.80833641329
"healthy-4"	"2019-08-01-count-4:TCCAGAAAGGTTCACT"	0.0533179073477208	7.60637137973634	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCAGAAAGGTTCACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1847.44013209211	40.4897073859254	0.0219166546631599	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1842.11363250341	1842.11363250341
"healthy-4"	"2019-08-01-count-2:TTGGGATGTACCGCGT"	3.01331533965413	-5.99395754253539	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGATGTACCGCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.22836686439	42.5360061961709	0.0160136856931408	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2655.32103863686	2655.32103863686
"healthy-4"	"2019-08-01-count-3:CTCCAACAGTGGATAT"	10.5779501396114	6.83167264545289	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACAGTGGATAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2065.57575166923	47.9670516614999	0.0232221217850456	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2054.97038107817	2054.97038107817
"healthy-4"	"2019-08-01-count-2:GGTTCTCGTCTACTGA"	4.2387601333553	-6.45547964489134	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTCTCGTCTACTGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2779.31574461434	45.16010053442	0.0162486398394748	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2774.59098717549	2774.59098717549
"healthy-4"	"2019-08-01-count-2:CGACAGCTCGTGCAGC"	10.6336533027584	5.92096326434938	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCTCGTGCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1723.30540893545	47.1967992056102	0.0273873678808711	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1719.3341621121	1719.3341621121
"healthy-4"	"2019-08-01-count-3:TACCTGCTCTCTAGGA"	3.68948068198506	-5.74132969295653	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCTGCTCTCTAGGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2852.71642319505	41.1527682148273	0.0144258181010281	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2845.51458780925	2845.51458780925
"healthy-4"	"2019-08-01-count-4:CTACGGGGTCAAATCC"	-3.14188681069072	-5.64762737667235	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGGTCAAATCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2416.64229623838	44.6495558622081	0.0184758646042516	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2413.17876720175	2413.17876720175
"healthy-4"	"2019-08-01-count-3:ACAAAGAAGTCCTGTA"	0.052386140064757	7.81389663303224	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAAGAAGTCCTGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.359482313	44.4192585831591	0.0231427510023448	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.73512533993	1916.73512533993
"healthy-4"	"2019-08-01-count-4:TCCATGCAGGATCACG"	-3.97643456879314	10.9141664274964	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCAGGATCACG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2299.45740779414	44.7791063196876	0.0194737707112584	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2296.34860189286	2296.34860189286
"healthy-4"	"2019-08-01-count-3:GTCAAACCAACACTAC"	2.94385804709737	-6.0464716187683	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAACCAACACTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.82196384873	41.7753649834548	0.0162371767539493	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2570.67156143352	2570.67156143352
"healthy-4"	"2019-08-01-count-2:CGAGAAGTCATGAGAA"	-7.03751645508464	0.857750273588575	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGAAGTCATGAGAA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2741.01112098482	42.6657435213946	0.015565695153424	3873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2727.60321444889	2727.60321444889
"healthy-4"	"2019-08-01-count-3:ATCGTAGCAATCAAGA"	10.9586149650509	5.95669410312501	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGCAATCAAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.33595656744	41.9885042793252	0.0224617218386076	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.32954468693	1862.32954468693
"healthy-4"	"2019-08-01-count-3:GTCAAACTCTTCGACC"	-1.8150831264561	8.63215539539186	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAACTCTTCGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.34862155123	44.2279982965518	0.0207026127900592	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2132.87738615651	2132.87738615651
"healthy-4"	"2019-08-01-count-4:CCGGGTACAACTCGAT"	10.4580198722774	7.8840555914673	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTACAACTCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2015.71760417805	41.5210949582358	0.0205986666347377	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.55244325391	2006.55244325391
"healthy-4"	"2019-08-01-count-3:GTCAAGTGTTGGGTTT"	-2.21323953095134	9.33218286121217	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAGTGTTGGGTTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.86781989745	43.6853660969967	0.0229335419710899	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1899.46472771118	1899.46472771118
"healthy-4"	"2019-08-01-count-2:ATACCTTAGAAATTCG"	5.70975126799886	-9.67667295848998	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACCTTAGAAATTCG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.557458993	45.9161596527468	0.016147435145906	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2835.89410000576	2835.89410000576
"healthy-4"	"2019-08-01-count-3:GTCACGGTCGCCTCTA"	2.17754115638081	-6.26585628902587	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCACGGTCGCCTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.96493472684	50.3165781046193	0.0222544707933289	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2257.23478015703	2257.23478015703
"healthy-4"	"2019-08-01-count-2:CGAGGAACATAACTCG"	-4.07699761810954	11.2996530302796	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACATAACTCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2284.20828993242	44.2825406594357	0.0193863847069506	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2276.11723807668	2276.11723807668
"healthy-4"	"2019-08-01-count-2:TTGTGTTAGAGTCTGG"	-3.59094224396403	-5.48431923305663	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTAGAGTCTGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2312.12599606787	48.9633957208339	0.0211767852634778	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2309.96412418587	2309.96412418587
"healthy-4"	"2019-08-01-count-4:GCGGAAAAGCAAATGT"	10.4415184455806	7.52232978427736	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGAAAAGCAAATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.37235372429	43.8847901334242	0.0232394792514695	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.78567586724	1877.78567586724
"healthy-4"	"2019-08-01-count-4:AGATCCACATCAGTCA"	-0.749845246702987	8.19533250415651	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCCACATCAGTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2150.36196250367	48.7915599419415	0.0226899288551093	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.00013690677	2141.00013690677
"healthy-4"	"2019-08-01-count-4:TCCCACATCCCGAACG"	10.8599497276241	6.80043933475343	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCACATCCCGAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2254.88941398799	45.0296909198617	0.0199698001332236	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2249.40679942483	2249.40679942483
"healthy-4"	"2019-08-01-count-3:CTCCCAAGTCCTTGTC"	-0.155335838825065	7.58325097644655	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAAGTCCTTGTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2030.49542938032	41.0957277760877	0.0202392614046069	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2017.80962772369	2017.80962772369
"healthy-4"	"2019-08-01-count-3:CCTCCAAGTATCCCTC"	3.78460087355916	-6.73092129146727	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCAAGTATCCCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2746.05308383347	43.0560208491745	0.015679238359467	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2742.90542345361	2742.90542345361
"healthy-4"	"2019-08-01-count-3:CCTCCAATCTCATTTG"	4.66382422026936	-6.77079441463622	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCAATCTCATTTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2897.13852045307	45.712920685833	0.0157786451573203	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2891.7476050894	2891.7476050894
"healthy-4"	"2019-08-01-count-2:TCAGCCTCACGCCACA"	1.34571518477742	-6.11954882061156	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTCACGCCACA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2385.38197785926	34.0732010889318	0.0142841697494128	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2382.23974058578	2382.23974058578
"healthy-4"	"2019-08-01-count-4:CTATCCGAGACTCTTG"	10.3815866905147	7.59278581226198	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCCGAGACTCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2048.55141603735	46.6641338514314	0.0227790884261509	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2040.76155433875	2040.76155433875
"healthy-4"	"2019-08-01-count-4:AGATCGTGTTAATCGC"	11.2756868797237	5.9611606367859	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGATCGTGTTAATCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.81476729159	44.3918230749781	0.0235024756496544	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1882.22874229549	1882.22874229549
"healthy-4"	"2019-08-01-count-3:GTCATCCTCAAACCTG"	-4.38934169235881	12.2867440947327	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATCCTCAAACCTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2551.43417355257	45.4453497013499	0.0178116880977856	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2539.72131173832	2539.72131173832
"healthy-4"	"2019-08-01-count-3:CTCCCTCCAACGTTAC"	1.63334395465199	-5.97683718120726	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCCAACGTTAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2916.40033157495	47.1992988845999	0.0161840946092304	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2907.86414194295	2907.86414194295
"healthy-4"	"2019-08-01-count-2:GCGGATCCAGTTTGGT"	4.20459332045857	-6.44845344936522	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGATCCAGTTTGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2783.3116315843	43.4132261534541	0.0155976878984056	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2780.91566942321	2780.91566942321
"healthy-4"	"2019-08-01-count-2:TCAGGGCAGTCATAGA"	0.68753602084462	7.89761254871217	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCAGTCATAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.01929583009	36.3979977739937	0.0203679937082529	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1778.33710166374	1778.33710166374
"healthy-4"	"2019-08-01-count-4:CCGTGAGGTTTCAGAC"	11.3852993446285	4.11315438831178	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTGAGGTTTCAGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.09474822895	52.2990102220934	0.0276993568628641	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1880.67846921172	1880.67846921172
"healthy-4"	"2019-08-01-count-4:CCGTTCACAAATGCGG"	11.2720705467159	5.62637946689454	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGTTCACAAATGCGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2180.28107091148	43.3286323321044	0.0198729571660183	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2168.67939613824	2168.67939613824
"healthy-4"	"2019-08-01-count-4:GCGTTTCGTCCTTAAG"	-1.83779285374339	3.58073899829713	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTTTCGTCCTTAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2962.01504051116	44.7938521638167	0.0151227632375852	4564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2957.20058180323	2957.20058180323
"healthy-4"	"2019-08-01-count-2:CTCCTCCCAACCCTCT"	10.4678856330806	7.62895534122316	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTCCCAACCCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2261.9896885051	45.1076240506646	0.0199415692652761	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2251.38820647949	2251.38820647949
"healthy-4"	"2019-08-01-count-4:ATCGTCCAGAGGCGTT"	11.3586069541866	4.86707017505494	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTCCAGAGGCGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2185.54689925675	48.9188425683058	0.0223828839293917	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2169.87215852112	2169.87215852112
"healthy-4"	"2019-08-01-count-2:GTAGAGGAGAAGGATG"	10.1722446876461	5.73987577045289	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGAGAAGGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.20527850656	40.9161752179465	0.0218428677771865	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.17069231547	1866.17069231547
"healthy-4"	"2019-08-01-count-4:TCCGAAAAGAACGCGT"	-2.88194618645366	3.53390286052553	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAAAGAACGCGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3294.65340087961	46.9879052300024	0.0142618659727477	5292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3286.37888838115	3286.37888838115
"healthy-4"	"2019-08-01-count-3:GTCATTTTCAGATTGC"	4.50362171706502	-6.67693951046141	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCATTTTCAGATTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.39353542958	47.1979601337936	0.0179501316550102	1714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2627.01771332628	2627.01771332628
"healthy-4"	"2019-08-01-count-4:CAGCAATAGGACGCTA"	6.77391447600667	-1.72955336486968	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAATAGGACGCTA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2942.76109521229	36.173956449683	0.012292522321481	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2936.06414380971	2936.06414380971
"healthy-4"	"2019-08-01-count-3:TGGAGAGAGAAGTATC"	4.60829844054524	-6.9521374932495	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGAGAGAGAAGTATC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2869.79471657755	40.6639718907877	0.0141696448376219	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2863.73391796121	2863.73391796121
"healthy-4"	"2019-08-01-count-3:GTCCACTGTGAATGTA"	3.1773017841274	-6.08048775112303	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCACTGTGAATGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.59903342323	38.872775916931	0.0150576349826817	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2581.59903342323	2581.59903342323
"healthy-4"	"2019-08-01-count-4:AGCCAATCACTAACCA"	2.99304594573323	-6.0011310807434	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCCAATCACTAACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.62229045909	38.542933340611	0.0149008741951923	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.49247679911	2584.49247679911
"healthy-4"	"2019-08-01-count-2:TTTACCAGTTCGCGTG"	2.9927610355312	-5.84909489071044	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACCAGTTCGCGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.70446582795	43.1972832724015	0.0160542652755101	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2688.91242810112	2688.91242810112
"healthy-4"	"2019-08-01-count-4:GCTCAAAAGGCGCTCT"	3.81750287589375	-6.23706581508788	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAAAGGCGCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2844.28903804986	45.1629139422223	0.0158784544531337	2728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2835.75751148319	2835.75751148319
"healthy-4"	"2019-08-01-count-3:TGGATCAAGATGAAGG"	2.98913564261739	-6.59132673656615	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCAAGATGAAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.59873535711	43.0879087152767	0.0188519130889984	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2283.13799186547	2283.13799186547
"healthy-4"	"2019-08-01-count-4:GCTCAAACAGTTTCAG"	3.98895325240437	-6.48395349895629	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTCAAACAGTTTCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.36698254985	46.3103387318288	0.0196282897380295	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2352.61518513656	2352.61518513656
"healthy-4"	"2019-08-01-count-2:ATAGGCTTCATGAGGG"	10.5002132850582	6.85575244510499	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATAGGCTTCATGAGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.15192618098	42.470920664774	0.0229677832651039	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1844.63547229398	1844.63547229398
"healthy-4"	"2019-08-01-count-3:CTCCTCCTCATTGCGA"	0.0881956490570724	7.67047736728517	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCTCATTGCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2146.90129689066	42.665093913087	0.0198728716475594	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2130.81024914729	2130.81024914729
"healthy-4"	"2019-08-01-count-2:ATCACAGGTGACGTCC"	3.09506978568379	-5.10783007061156	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACAGGTGACGTCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2894.90120035742	44.0540590271612	0.0152178108951428	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2884.6090016641	2884.6090016641
"healthy-4"	"2019-08-01-count-2:CGATGCGTCCCATACC"	-4.11542163315471	11.8394193419251	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGCGTCCCATACC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1986.92973969041	44.4860297041078	0.0223893320510867	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1985.11772830113	1985.11772830113
"healthy-4"	"2019-08-01-count-3:CTCGAGGCACTGTCCT"	2.6450637775356	-6.12240316784056	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCGAGGCACTGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.10205605056	49.9858555302079	0.0189404784159852	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2634.04615723019	2634.04615723019
"healthy-4"	"2019-08-01-count-2:TCAGTGAAGTACGAGC"	3.15788998183553	-6.15187027370604	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTGAAGTACGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.89021733679	43.8714288259505	0.0201255221373253	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2169.03245219628	2169.03245219628
"healthy-4"	"2019-08-01-count-1:TAATTCCGTGAGATCG"	11.1766210990841	6.27607772434083	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TAATTCCGTGAGATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2131.90191724782	43.9401357918789	0.0206107679890843	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2119.67607066594	2119.67607066594
"healthy-4"	"2019-08-01-count-2:CGATGGCTCTGATTCT"	10.8170105415279	6.32819697940675	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGGCTCTGATTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1906.9835047439	43.6164502686038	0.0228719599095124	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.31803719535	1897.31803719535
"healthy-4"	"2019-08-01-count-2:TCAGTGATCTGTCGCT"	10.4398476081783	5.77714965427247	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTGATCTGTCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1713.77733328855	47.5518147549045	0.0277467870716074	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1701.27971644105	1701.27971644105
"healthy-4"	"2019-08-01-count-2:CGATGGCGTGCCCACA"	1.50243570384328	-6.35327865993651	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGGCGTGCCCACA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2437.75533419804	43.7570973968146	0.0179497494202837	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2432.95554324878	2432.95554324878
"healthy-4"	"2019-08-01-count-4:TCCGGGAGTTGTGTAC"	0.0636004266211807	7.59854362094728	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGAGTTGTGTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2072.11685261351	42.1795526684353	0.0203557789780221	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2067.28662982466	2067.28662982466
"healthy-4"	"2019-08-01-count-2:ATCACTTTCAAGCTGT"	4.09178556975667	-6.69581940090331	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCACTTTCAAGCTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.07447287972	44.9082182197433	0.0174260459650439	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2573.66110270081	2573.66110270081
"healthy-4"	"2019-08-01-count-2:ATCAGGTAGCAGTCTT"	4.8144346671993	-8.14936354076537	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCAGGTAGCAGTCTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2744.27538560117	41.2805487390186	0.0150424221109922	2124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2737.6905121045	2737.6905121045
"healthy-4"	"2019-08-01-count-2:GCTCAAAAGCGGATCA"	0.277392928569955	7.57159755313722	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAAAGCGGATCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1887.58260971727	41.3996738785751	0.0219326421346804	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1882.49766808257	1882.49766808257
"healthy-4"	"2019-08-01-count-4:AGCGCCAAGCGTTCCG"	4.83139338073079	-7.61768200313719	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCCAAGCGTTCCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.93635904819	44.155383247904	0.0165690197808981	2143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2659.64025041363	2659.64025041363
"healthy-4"	"2019-08-01-count-2:ATCAGGTCATCGGAAG"	-2.85930571976359	-5.69899275219115	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCAGGTCATCGGAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2830.24934936508	49.5545479220009	0.0175088982647828	2479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2827.13749422976	2827.13749422976
"healthy-4"	"2019-08-01-count-4:AGCGCCAGTGGTATGG"	-0.229659656912643	8.13043305957643	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCCAGTGGTATGG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2098.46159746536	40.7486573355604	0.0194183478910355	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2085.4516788138	2085.4516788138
"healthy-4"	"2019-08-01-count-3:CTCTCGAGTACGACAG"	-0.717964391142684	8.38522241199342	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCGAGTACGACAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.98491002636	37.9912276675898	0.0202405610533418	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1869.84191553892	1869.84191553892
"healthy-4"	"2019-08-01-count-3:TAGCACACAGCAGTTT"	0.103165534406346	7.80827519977418	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGCACACAGCAGTTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.90032075578	46.2257709299347	0.0236703176494155	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.23055682608	1945.23055682608
"healthy-4"	"2019-08-01-count-2:GCTGAATCAGAAACCG"	11.1707712608272	5.38899037921754	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGAATCAGAAACCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.59934119348	43.7148395446431	0.0224224734903133	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1948.04856670849	1948.04856670849
"healthy-4"	"2019-08-01-count-4:AGCGCTGAGCAACAGC"	-0.51479552212413	7.81948087299196	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGCTGAGCAACAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.86302864974	49.3069181379127	0.023139412282711	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2125.06189023559	2125.06189023559
"healthy-4"	"2019-08-01-count-4:CCTCATGCAAACTAAG"	11.1324364143306	6.07244727695314	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCATGCAAACTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.33312517506	46.9802811001205	0.0235450815241684	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1989.21479426615	1989.21479426615
"healthy-4"	"2019-08-01-count-2:CGCATGGGTCTCACAA"	0.542233099311036	8.15068147266237	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATGGGTCTCACAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.49668212305	40.65384368593	0.0231976722698728	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1747.31397651124	1747.31397651124
"healthy-4"	"2019-08-01-count-3:TGGGATTTCGGTTAGT"	2.89223422583882	-6.36827852642211	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGGATTTCGGTTAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.11367173874	47.090482224388	0.0201231601665739	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2334.9743114744	2334.9743114744
"healthy-4"	"2019-08-01-count-1:TCAGCAAAGCGGGTTA"	11.0941673713619	5.49662683093873	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCAGCAAAGCGGGTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2164.71939678152	41.903245553526	0.0193573567159916	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2140.6757162843	2140.6757162843
"healthy-4"	"2019-08-01-count-3:GAGGGATCAGGGTCTC"	-3.32865128937419	-5.38539602672728	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATCAGGGTCTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2388.88609070173	47.6384140690239	0.0199416850616892	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2386.70646071038	2386.70646071038
"healthy-4"	"2019-08-01-count-3:TTGTTTGAGCGATGAC"	10.2925735908443	5.64606854999391	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGTTTGAGCGATGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1808.26092865324	38.6619576247209	0.0213807404739511	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1797.41886111007	1797.41886111007
"healthy-4"	"2019-08-01-count-2:TGAACGTCACGCCACA"	10.4824062782222	6.23124883258668	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAACGTCACGCCACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.34048061118	45.0394258348161	0.0239783076070218	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.69169785511	1876.69169785511
"healthy-4"	"2019-08-01-count-1:TCATCATCAAAGCTAA"	2.93267025527303	-4.81034185802611	"2019-08-01-count-1"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCATCATCAAAGCTAA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3110.38847342094	40.6695277140498	0.0130753852972326	3574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3095.30985540667	3095.30985540667
"healthy-4"	"2019-08-01-count-3:ATGCGATCAATGCAAA"	10.8137175041134	5.94283721530763	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGCGATCAATGCAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1818.98779175883	50.5157407479503	0.0277713467769376	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1801.55124733703	1801.55124733703
"healthy-4"	"2019-08-01-count-3:GTCTTTAAGAAGCGCT"	-1.81200931492503	3.43700192058412	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCTTTAAGAAGCGCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2675.07688977033	41.6767177071956	0.0155796335673827	3898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2668.00390115872	2668.00390115872
"healthy-4"	"2019-08-01-count-4:CCTCCAATCCACGAAT"	10.7092510658199	6.9521593817505	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCAATCCACGAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2043.55491058737	43.4923917456399	0.021282712551697	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2032.58911659781	2032.58911659781
"healthy-4"	"2019-08-01-count-4:CCTCCAATCTCACCCA"	5.08593287047688	-7.4580812684265	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCAATCTCACCCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2917.5001026636	45.8979355220655	0.0157319396424911	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2909.23606831782	2909.23606831782
"healthy-4"	"2019-08-01-count-2:CGCCATTAGGTGATCG"	10.5343452888424	7.82602593982545	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCATTAGGTGATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1958.84401773138	44.2645841515168	0.0225972990962197	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1955.53887294187	1955.53887294187
"healthy-4"	"2019-08-01-count-4:ATGCCTCTCTGGGAGA"	0.174403821199578	7.68041226947633	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGCCTCTCTGGGAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1977.70636423863	43.6080300305507	0.0220498001215356	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1972.54965049513	1972.54965049513
"healthy-4"	"2019-08-01-count-2:TGAATCGGTAGTGATA"	11.4552742439205	4.51339910114137	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGGTAGTGATA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.67118093667	43.10489633578	0.0222457229894616	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1924.24734077519	1924.24734077519
"healthy-4"	"2019-08-01-count-2:TACAGGTGTTGTCCCT"	3.84854688224141	-6.64410021221312	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAGGTGTTGTCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.98461998431	47.7965495035434	0.0188845673443245	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2523.69783407794	2523.69783407794
"healthy-4"	"2019-08-01-count-2:ACACTGATCCGCATAA"	1.17362417754475	8.79581449115602	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACTGATCCGCATAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1766.87270789781	35.40464530758	0.0200380282910723	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1762.15968832367	1762.15968832367
"healthy-4"	"2019-08-01-count-4:TCCTTCTTCTCATTTG"	10.4808174568111	6.81235883319703	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTCTTCTCATTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2081.59702260803	40.8140462438	0.0196070833117661	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2076.88095506789	2076.88095506789
"healthy-4"	"2019-08-01-count-2:ATCCCTGGTCCGGACT"	10.8942953544552	6.8429178961548	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGGTCCGGACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1947.47127302579	38.1951602222136	0.0196126950632087	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.67809292919	1937.67809292919
"healthy-4"	"2019-08-01-count-4:GGAATCTTCCTTATGT"	3.57456483420674	-6.22349169170531	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAATCTTCCTTATGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.87989269092	42.2620199204497	0.0168114714005733	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2511.2436067084	2511.2436067084
"healthy-4"	"2019-08-01-count-1:TCGAACAAGAAGTGTT"	-3.21599016609843	9.32349107349244	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TCGAACAAGAAGTGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2308.4409451566	44.3255888206706	0.019201525996873	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2296.53428323721	2296.53428323721
"healthy-4"	"2019-08-01-count-3:CTGATCCAGACTCAAA"	3.79742707785909	-6.35167410289916	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGATCCAGACTCAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.02288242334	41.1964314721833	0.0160859286947103	1720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2555.3035803236	2555.3035803236
"healthy-4"	"2019-08-01-count-3:GTGAGCCGTATATGGA"	-4.01379142227824	10.9009256132874	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGCCGTATATGGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2147.90617401382	42.4755024195224	0.0197753062649603	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.10090458272	2141.10090458272
"healthy-4"	"2019-08-01-count-2:CGGAACCGTCCGTTTC"	4.40493788298909	-6.59742071544798	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAACCGTCCGTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.46183431158	42.7908625935027	0.0157350480354637	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.25906367341	2716.25906367341
"healthy-4"	"2019-08-01-count-2:TCATGGAGTATTCCTT"	4.55416121062581	-6.73121025478514	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGGAGTATTCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2895.15177661208	42.3366163717401	0.0146232804489727	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2891.34065688075	2891.34065688075
"healthy-4"	"2019-08-01-count-4:TCGAACAAGGCACCAA"	-0.186242560774642	7.66524407947389	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAACAAGGCACCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.34538537095	45.5182469194406	0.0228695216689525	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1986.57422432151	1986.57422432151
"healthy-4"	"2019-08-01-count-3:GTGAGGACAATCGCAT"	-4.29132543030437	12.4320592650208	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGGACAATCGCAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1970.12412631582	40.2372041528916	0.0204236898657427	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1963.90075675055	1963.90075675055
"healthy-4"	"2019-08-01-count-4:CCTCTAGCACTCTGCT"	10.768101354211	6.71218297565309	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGCACTCTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.251657673	40.5531952964921	0.0204581467441416	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.59001620582	1975.59001620582
"healthy-4"	"2019-08-01-count-2:GGAAGTGAGAGGACTC"	-0.207132975489456	7.87199399555055	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAAGTGAGAGGACTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.87316158154	45.1312314310378	0.0242788116821483	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1849.82320798936	1849.82320798936
"healthy-4"	"2019-08-01-count-3:CTGCATCGTATGTCTG"	11.141111989587	5.4289512404236	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCATCGTATGTCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.91332060695	47.2350923208188	0.0245388152365868	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.23689944742	1923.23689944742
"healthy-4"	"2019-08-01-count-4:AGGAAATGTCGAATGG"	4.22993864592854	-6.7464056245056	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATGTCGAATGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.84795581835	49.7502627176922	0.0203573477634916	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2441.28625567229	2441.28625567229
"healthy-4"	"2019-08-01-count-3:CTGCCATAGACTGAGC"	11.2978235679561	4.47765967929689	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCCATAGACTGAGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2143.48891520515	45.2996272871426	0.0211335953108052	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2127.2956276608	2127.2956276608
"healthy-4"	"2019-08-01-count-3:GTGAGTTTCCGGACTG"	10.7066198783809	-2.77545049106749	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGTTTCCGGACTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2536.47051960431	35.678215161991	0.0140660870631987	4108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2529.18395160328	2529.18395160328
"healthy-4"	"2019-08-01-count-4:AGGAATACACTTACAG"	-4.02336678925212	11.4851112135681	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAATACACTTACAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1967.93272558471	41.4387433967221	0.021056991866635	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1957.21204033412	1957.21204033412
"healthy-4"	"2019-08-01-count-2:TTTGATCTCTGTCGCT"	11.5766865211422	3.46315000140993	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCTGTCGCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2119.36769184146	36.9051019006654	0.0174132605883973	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2105.00497931197	2105.00497931197
"healthy-4"	"2019-08-01-count-4:TCGAAGTTCCGTGTGG"	10.9184595542843	6.68331763828126	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTTCCGTGTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2139.23658535237	43.2196011542772	0.020203282540233	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2132.52245784014	2132.52245784014
"healthy-4"	"2019-08-01-count-2:CGGACACAGTGCTAGG"	10.7934872108394	5.71371600711671	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGACACAGTGCTAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.81394903778	41.0533839748163	0.0217465200931168	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1884.34943677138	1884.34943677138
"healthy-4"	"2019-08-01-count-2:GGAATCTGTAGAATAC"	0.262356643646401	8.39059445941774	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTGTAGAATAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.17740953322	43.2241778021767	0.0237864380084275	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1808.58732130196	1808.58732130196
"healthy-4"	"2019-08-01-count-2:TCATTACGTAAGCTCT"	10.3405195671016	7.76515863025514	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTACGTAAGCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2157.33691291459	45.5680473292704	0.0211223601916251	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2148.03943808214	2148.03943808214
"healthy-4"	"2019-08-01-count-2:GGAATCTGTTTGGAGG"	2.77977170523946	-6.40048172390135	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTGTTTGGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.0495544792	46.126178540261	0.0194950179521553	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2360.30785305563	2360.30785305563
"healthy-4"	"2019-08-01-count-2:CGGAGAATCCTGTTGC"	2.26368584212605	-5.93420936977538	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAATCCTGTTGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2806.65999085297	48.2851100974363	0.017203761857439	2518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2802.04871163194	2802.04871163194
"healthy-4"	"2019-08-01-count-4:CCTGCATCAAACAGGC"	4.04722704467122	-6.75393345272215	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATCAAACAGGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.54213876037	45.1864042200057	0.0172168712983013	1959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2617.65486134003	2617.65486134003
"healthy-4"	"2019-08-01-count-3:TATATCCCAGTTCCAA"	11.0601316886837	6.05334470355836	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCCAGTTCCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.6903272953	39.9273616541257	0.0205737933005373	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.83813596412	1923.83813596412
"healthy-4"	"2019-08-01-count-3:CATCGTCAGCCATTTG"	5.69983400878255	-10.0677757493225	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCGTCAGCCATTTG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2774.99176243305	40.6487168853917	0.0146482297481675	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2768.12345297745	2768.12345297745
"healthy-4"	"2019-08-01-count-4:CCTGCATGTCGTTGGC"	2.98257507857625	-6.18069269573363	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGCATGTCGTTGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.47044045194	44.2803505261038	0.0178300292223513	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2482.59788886422	2482.59788886422
"healthy-4"	"2019-08-01-count-3:GTGCAGCCAGCTGAGA"	4.27023424681966	-6.75533916866454	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCAGCCAGCTGAGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2695.69686428997	39.8800950364826	0.0147939835390159	2377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2694.1509456795	2694.1509456795
"healthy-4"	"2019-08-01-count-1:TGTCAGAAGACTCTTG"	10.9425445991451	5.56010816181032	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGTCAGAAGACTCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1736.12052539534	46.5186091425207	0.0267945735690946	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1725.33734768336	1725.33734768336
"healthy-4"	"2019-08-01-count-3:ATTACCTTCCTAGCTC"	11.2433048683101	4.36418674075929	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTTCCTAGCTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1727.86563465001	46.6774392278027	0.0270145075472015	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1713.71960109166	1713.71960109166
"healthy-4"	"2019-08-01-count-2:CTGCTCAAGTGGTTCT"	0.579305608838242	7.74518392169801	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCTCAAGTGGTTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.07170336813	39.8382791984009	0.0210220431910814	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1888.37225086407	1888.37225086407
"healthy-4"	"2019-08-01-count-3:ATTACTCAGCACCCAC"	3.4895039993221	-6.42561485683592	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACTCAGCACCCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2701.22431707032	42.4884316364638	0.015729323687766	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2694.51414110369	2694.51414110369
"healthy-4"	"2019-08-01-count-2:TCATTGTGTGGATACG"	3.66083421286885	-6.07927420055541	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTGTGTGGATACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.82308565249	43.5215172865909	0.0161860843574354	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2683.41389476966	2683.41389476966
"healthy-4"	"2019-08-01-count-4:GGATGTTGTTAGCTAC"	4.64608540114705	-6.84202816402587	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATGTTGTTAGCTAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.1457561484	46.0114587118629	0.0168038748881596	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2734.01551429533	2734.01551429533
"healthy-4"	"2019-08-01-count-3:AAACGCTGTTGGAGGT"	11.5816389518673	3.95198605144349	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTGTTGGAGGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2186.81001716073	32.9887272364046	0.0150853192447124	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2179.47358364848	2179.47358364848
"healthy-4"	"2019-08-01-count-2:CGGGTCAGTATTGACC"	10.507868428796	6.90213773334352	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTCAGTATTGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2126.15992592858	42.9180083224413	0.0201856914896453	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2115.93179342354	2115.93179342354
"healthy-4"	"2019-08-01-count-4:CCTTGTGGTTCGGCCA"	6.74944653090779	-1.75065829670104	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTGTGGTTCGGCCA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2952.32240768074	33.9558903739386	0.0115014167441873	2248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2936.31578348019	2936.31578348019
"healthy-4"	"2019-08-01-count-4:AGGATCTCAAACCGGA"	0.906494637101334	8.33743283832399	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTCAAACCGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.21332517932	38.7612953420729	0.0221466119497757	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1741.73577649907	1741.73577649907
"healthy-4"	"2019-08-01-count-2:ATCGTCCTCTTACTGT"	11.2627006965572	5.82335755908815	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCTCTTACTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.66422028346	52.0241793441185	0.0271147910062306	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.10913741362	1910.10913741362
"healthy-4"	"2019-08-01-count-3:GTGCTTCCAGCACACC"	10.6190191703731	7.30567596042482	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCCAGCACACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.80828005489	42.8574870151486	0.0224289833064349	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1902.95061813225	1902.95061813225
"healthy-4"	"2019-08-01-count-3:CTGGCAGTCCGATAAC"	-3.46679864350017	-5.11031868374022	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGGCAGTCCGATAAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2880.74358922779	41.8165037423002	0.0145158714918843	2949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2873.82549143881	2873.82549143881
"healthy-4"	"2019-08-01-count-3:TGTCCACTCTCTATGT"	-1.43221519413646	8.70966241443483	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCACTCTCTATGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1886.69744546903	48.758317206515	0.0258432094258727	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1881.37830406262	1881.37830406262
"healthy-4"	"2019-08-01-count-3:ATTCACTGTTGTGTTG"	4.18219866332356	-6.4185157052246	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCACTGTTGTGTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.23586650709	45.718035414515	0.0181403796454487	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2514.37219894912	2514.37219894912
"healthy-4"	"2019-08-01-count-3:GTGCTTCGTCGTGGAA"	10.2995687919552	7.51369521701661	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCTTCGTCGTGGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.58627419187	44.8533315761364	0.0241590343522602	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.05550352069	1846.05550352069
"healthy-4"	"2019-08-01-count-3:AAAGGATTCCACGAAT"	-0.0667277899688065	7.61603782260744	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATTCCACGAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2073.1214032194	38.5206804536438	0.0185810056245737	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.27911462919	2070.27911462919
"healthy-4"	"2019-08-01-count-3:GTGGAAGGTCAGATTC"	-1.8793355030125	4.16115806186525	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGGTCAGATTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3179.94000485154	45.6010069293932	0.0143402098340916	5360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3174.0327319377	3174.0327319377
"healthy-4"	"2019-08-01-count-4:GGCGTCACACAATGCT"	1.38767160949056	-5.97217895900878	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCGTCACACAATGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2704.92652554529	43.5052567385268	0.0160837110833376	1927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2704.92652554529	2704.92652554529
"healthy-4"	"2019-08-01-count-2:GGAGGATCACCGAATT"	4.9649793106014	-7.48203947460326	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATCACCGAATT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2854.02533398697	37.3394450303578	0.0130830811435706	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2845.6457761149	2845.6457761149
"healthy-4"	"2019-08-01-count-3:TGTCCTGAGGACAGCT"	6.78710856017415	-1.74282636558684	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGAGGACAGCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2842.24266024403	34.4808591867134	0.0121315676768264	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2833.57558721268	2833.57558721268
"healthy-4"	"2019-08-01-count-4:CGAAGTTCAAACTAAG"	-7.21425090256389	3.29654762828676	"2019-08-01-count-4"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTCAAACTAAG"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2545.98517274258	43.767236774338	0.0171906880067142	2449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2528.13294704118	2528.13294704118
"healthy-4"	"2019-08-01-count-3:AAAGGGCGTGGCCCAT"	4.06339087065999	-7.60342647945555	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGGCGTGGCCCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.28984289962	49.8146321168781	0.0210963648815372	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2356.73585098546	2356.73585098546
"healthy-4"	"2019-08-01-count-3:TGTCCTGTCACAGAGG"	11.4624573188717	4.36720893466798	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCTGTCACAGAGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2130.52675805905	42.9373057617176	0.0201533754970692	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2112.68568636682	2112.68568636682
"healthy-4"	"2019-08-01-count-2:TCCATCGAGATTTGCC"	-2.36965046349223	9.25794503772584	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCATCGAGATTTGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1992.89504368052	43.5323646998344	0.0218437819080718	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.89504368052	1992.89504368052
"healthy-4"	"2019-08-01-count-3:CTGTAGAAGCCTGTCG"	11.2608019309932	5.41170547092286	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGAAGCCTGTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.20261733338	41.3131356945497	0.0208000610481601	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1971.50586939305	1971.50586939305
"healthy-4"	"2019-08-01-count-3:CATGGTAGTGGAATGC"	10.2917658286983	7.15715501392213	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTAGTGGAATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.93531568057	42.8710269831285	0.0234532516634304	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1827.93531568057	1827.93531568057
"healthy-4"	"2019-08-01-count-3:ATTCCATCAACATCGT"	10.9166275459224	7.30669734561769	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCATCAACATCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2109.2273546097	47.80170586823	0.0226631357514683	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2100.81625499153	2100.81625499153
"healthy-4"	"2019-08-01-count-3:ATTCCATCATCGTCCT"	4.50716127929036	-6.69931652462157	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCATCATCGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2806.5845570962	44.0602236724875	0.0156988762590762	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2796.76693899575	2796.76693899575
"healthy-4"	"2019-08-01-count-4:TCGGTCTAGGTCATAA"	3.86525525626485	-6.6123953095642	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTAGGTCATAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.62856287312	45.1118376138137	0.0172734508479203	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2605.3809003782	2605.3809003782
"healthy-4"	"2019-08-01-count-2:CTGTATTCAAGGGTCA"	2.26597466048543	-5.95108034526976	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTATTCAAGGGTCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2683.56069692561	47.5961653932682	0.0177361985692353	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2678.65303929217	2678.65303929217
"healthy-4"	"2019-08-01-count-3:CATTCATTCGCGATCG"	0.118860614567441	7.61639497363893	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATTCGCGATCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.66995889084	42.8231612140639	0.0227701628409696	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1873.47556639926	1873.47556639926
"healthy-4"	"2019-08-01-count-2:GGAGGTATCTGAACGT"	0.31433125314061	7.96564099872438	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTATCTGAACGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.30417180125	39.6729084005773	0.0212574718526655	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1858.86798926367	1858.86798926367
"healthy-4"	"2019-08-01-count-4:GGCTTTCTCTTAAGGC"	-4.01372037354167	-4.6639123192993	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTTTCTCTTAAGGC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3351.56185763577	40.6113909418101	0.0121171539320649	4086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3339.7158744104	3339.7158744104
"healthy-4"	"2019-08-01-count-2:ATGAAAGGTCAACGCC"	4.87427296218221	-6.90157654201659	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAAAGGTCAACGCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.74100782774	41.2320208883652	0.0148973551975248	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2760.26867812907	2760.26867812907
"healthy-4"	"2019-08-01-count-4:TCGTAGAAGAGATTCA"	-0.0171364125912965	7.67310235584108	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGAAGAGATTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.61673611141	44.1350568354089	0.0235435094466083	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.67221670347	1866.67221670347
"healthy-4"	"2019-08-01-count-3:CTGTCGTGTTTGTTCT"	11.196851392358	5.9220194586548	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTCGTGTTTGTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1803.36268396557	44.1093275153162	0.0244594877711012	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1791.77709991071	1791.77709991071
"healthy-4"	"2019-08-01-count-4:CGAGAAGGTGCATTAC"	-3.88465819779094	11.0633430250916	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGAAGGTGCATTAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2067.40939665396	45.7107330130949	0.0221101505522208	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2061.02324249642	2061.02324249642
"healthy-4"	"2019-08-01-count-4:GGGACAAAGGTAAACT"	-2.75516162338908	9.11769864642946	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAAAGGTAAACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.21611209171	39.8231666367401	0.0203989539836711	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1945.24360553841	1945.24360553841
"healthy-4"	"2019-08-01-count-2:GGATCTATCCACGAAT"	10.8845058875972	6.02962014758912	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTATCCACGAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.13395288811	41.1470696867082	0.0205413470364188	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1993.34046344221	1993.34046344221
"healthy-4"	"2019-08-01-count-3:GTGTGGCGTGACGTCC"	10.4711786704952	6.55200860584108	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGGCGTGACGTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.2930668712	46.4216915675638	0.0238635979113565	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.81797274919	1939.81797274919
"healthy-4"	"2019-08-01-count-4:GGGACAAGTTCCATTT"	11.2837797599727	5.65839145267335	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAAGTTCCATTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2279.52220960354	39.7428996555364	0.0174347499173735	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2270.16592156259	2270.16592156259
"healthy-4"	"2019-08-01-count-3:GTGTTAGAGCTAAACA"	3.03235282477681	-6.00021126186522	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTTAGAGCTAAACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.64201821074	41.5121826107971	0.0193923982887597	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2134.57023440125	2134.57023440125
"healthy-4"	"2019-08-01-count-2:CGTGAATTCCTACGGG"	-3.90860591355022	-5.44776394283446	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATTCCTACGGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2773.39186442245	43.4178068431224	0.0156551287973739	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2772.25258807049	2772.25258807049
"healthy-4"	"2019-08-01-count-2:TCCCAGTTCCTACTGC"	3.58735408362691	-6.43539955532225	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTTCCTACTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.01866293634	43.8987296331615	0.0161391280991328	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2714.76814651749	2714.76814651749
"healthy-4"	"2019-08-01-count-4:CGAGGAAGTCTCGCGA"	3.94247140464131	-6.5149455300537	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGAAGTCTCGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.44208829665	46.7888897595029	0.01875725637369	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2486.11508311086	2486.11508311086
"healthy-4"	"2019-08-01-count-3:AACAAGAAGGACATCG"	2.68231787261311	-6.36925842678221	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAAGAAGGACATCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1673.13673219802	42.3088666253381	0.0252871542481507	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1671.02110822824	1671.02110822824
"healthy-4"	"2019-08-01-count-4:CGAGGCTAGGACGCTA"	3.6360420185024	-6.70587160503539	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGGCTAGGACGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.34507351259	42.0364666881962	0.0168730005068821	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2489.50156957508	2489.50156957508
"healthy-4"	"2019-08-01-count-2:ATGAGGGCATCGGTTA"	10.9592024284298	6.82183263385621	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGGGCATCGGTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1973.96769474829	42.6109103906779	0.0215864274294071	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.5950864522	1968.5950864522
"healthy-4"	"2019-08-01-count-3:GTTACAGAGGAGCAAA"	-2.29189405861552	3.86238262737123	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGAGGAGCAAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3143.39783792179	45.6088482732189	0.0145094100794358	4409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3139.04564361193	3139.04564361193
"healthy-4"	"2019-08-01-count-2:CGTGCTTAGTGCGACA"	-4.27362189713176	13.0925473936829	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTAGTGCGACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2002.07084741704	35.5927042084091	0.017777944399085	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2000.11471659945	2000.11471659945
"healthy-4"	"2019-08-01-count-2:CGTGCTTCAAGCAGGT"	-7.18265710297282	2.86817166889039	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTCAAGCAGGT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2468.80496884318	44.8100794776213	0.0181505141326001	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2456.05830193833	2456.05830193833
"healthy-4"	"2019-08-01-count-3:GTTACAGCAAGCCATT"	-1.46551285210307	8.85144040668336	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGCAAGCCATT"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2088.49458116714	38.9515591968344	0.0186505435772147	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2083.52199549578	2083.52199549578
"healthy-4"	"2019-08-01-count-2:CGTGCTTGTGTTACTG"	5.05320133742635	-7.4466648331848	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGCTTGTGTTACTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.37558554873	44.0411015813095	0.0164493550396977	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2674.44114980869	2674.44114980869
"healthy-4"	"2019-08-01-count-3:ATTGGGTTCAGTCATG"	4.13071455535237	-6.78587152874144	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGGGTTCAGTCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.29641362045	46.5723132750573	0.0181902036917673	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2559.18659882184	2559.18659882184
"healthy-4"	"2019-08-01-count-4:GGGAGATCAGTGACCC"	4.0695501762325	-6.32551004802855	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGATCAGTGACCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2870.0178235585	42.7652225322527	0.0149006818637902	2844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2865.55735450334	2865.55735450334
"healthy-4"	"2019-08-01-count-3:AACAGGGGTATCAGGG"	0.0127600665086925	7.97322461688844	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACAGGGGTATCAGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.10526169692	38.1504808541908	0.0210183297130241	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1808.40740873767	1808.40740873767
"healthy-4"	"2019-08-01-count-4:CGAGTGCTCGTAACAC"	-3.31422672691997	10.6475429304871	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTGCTCGTAACAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1981.87794256217	43.0415581511666	0.0217175625334033	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1978.0613244209	1978.0613244209
"healthy-4"	"2019-08-01-count-2:CGTTAGAGTGTACAGG"	4.84971155700032	1.505912519339	"2019-08-01-count-2"	"Control4"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTAGAGTGTACAGG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2557.99144054958	47.9099501898497	0.0187295193527138	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2544.36717719695	2544.36717719695
"healthy-4"	"2019-08-01-count-4:GTGGGAACAGCTCCTT"	10.6987329917843	6.4902682074341	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAACAGCTCCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.15248377621	46.5351817636741	0.0246458811793665	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.45376333129	1886.45376333129
"healthy-4"	"2019-08-01-count-4:GGGAGTAGTGCGAACA"	2.76655830916707	-5.95507051860961	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGTAGTGCGAACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.39870475037	40.5496712965807	0.0151282237320575	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2675.63853667871	2675.63853667871
"healthy-4"	"2019-08-01-count-4:TCTACATTCGCAGATT"	10.4192148643428	7.76461360538331	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACATTCGCAGATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.0023327479	45.0240064229647	0.023364790824493	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1915.91192081289	1915.91192081289
"healthy-4"	"2019-08-01-count-4:CGAGTTAGTGAATTGA"	0.192011256783646	7.98380944812623	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAGTTAGTGAATTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.17154018604	42.5681233375807	0.0227737917159513	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1858.0086856883	1858.0086856883
"healthy-4"	"2019-08-01-count-3:TGTTCTACATAGACTC"	4.36051859435384	-6.72127582943114	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCTACATAGACTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.71032976368	44.4241246139059	0.0181344398454618	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2444.53928647737	2444.53928647737
"healthy-4"	"2019-08-01-count-4:TCTACCGCACGAAAGC"	0.0597221698494672	7.76517627322999	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGCACGAAAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2051.1941134987	40.5354413333245	0.0197618748350363	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2044.87705442248	2044.87705442248
"healthy-4"	"2019-08-01-count-3:GTTACCCTCCGAGTGC"	-2.55346427384074	3.46851894939271	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACCCTCCGAGTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3342.67835936249	46.6238231334026	0.0139480434911765	5729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3333.90337114722	3333.90337114722
"healthy-4"	"2019-08-01-count-3:GTTACGACATGATCTG"	-4.45984301987346	13.0154676207337	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGACATGATCTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2375.49512907898	40.9801391348791	0.0172511989745766	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2370.62856704442	2370.62856704442
"healthy-4"	"2019-08-01-count-4:CGATGCGCACAACATC"	10.4730307060177	7.70194814288942	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGCGCACAACATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.78645320058	46.7228896822856	0.0237922456416463	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1957.54239406113	1957.54239406113
"healthy-4"	"2019-08-01-count-2:AACAAAGCAAAGGGCT"	11.537406583398	3.74061629855958	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAAAGCAAAGGGCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2324.50853443792	32.4306139048972	0.0139516002735344	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2311.65837584515	2311.65837584515
"healthy-4"	"2019-08-01-count-3:ATTTCTGCATCTTAGG"	1.99948789653127	-5.92670729076537	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCTGCATCTTAGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2703.7042023274	42.2582614411912	0.0156297650478238	2076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2700.04230298384	2700.04230298384
"healthy-4"	"2019-08-01-count-3:TGTTGAGGTCAGTCCG"	5.28798927840535	-8.93877031719359	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGGTCAGTCCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.54048704882	42.5277165656852	0.0156955457093042	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2699.59877942414	2699.59877942414
"healthy-4"	"2019-08-01-count-3:ACTATGGTCTGGACCG"	6.79509367522542	-1.73809757148894	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATGGTCTGGACCG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2825.10850043409	37.7522838797333	0.0133631270706709	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2802.81464439216	2802.81464439216
"healthy-4"	"2019-08-01-count-3:CTTCCGAGTGAATTGA"	0.257614825933617	7.7626275786194	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCCGAGTGAATTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1895.23351180115	38.547030607457	0.0203389346840028	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1887.49187366572	1887.49187366572
"healthy-4"	"2019-08-01-count-4:CGATGGCCAATGTGGG"	-2.0894447368687	3.77261493289796	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGATGGCCAATGTGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3342.30005168045	42.364327895552	0.0126752018790928	4768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3334.5300101789	3334.5300101789
"healthy-4"	"2019-08-01-count-2:GGGAAGTAGTTGTCAC"	2.19969667968099	-6.18737461483153	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAAGTAGTTGTCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.16961173234	46.75148162179	0.0187518255484053	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2486.29048673903	2486.29048673903
"healthy-4"	"2019-08-01-count-2:GGCTTTCGTTACAGCT"	11.3519274192745	4.30907962406007	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCTTTCGTTACAGCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.83427826102	37.1683531638513	0.0197721435307769	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.64572107113	1868.64572107113
"healthy-4"	"2019-08-01-count-4:CGCAGGTAGGGATCAC"	-3.67753324928935	9.79232881152955	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCAGGTAGGGATCAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2076.73024870457	41.5353683852193	0.0200003676024503	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2073.26978280635	2073.26978280635
"healthy-4"	"2019-08-01-count-2:GGGAAGTTCGCCGTGA"	3.69034757193868	-6.18368389522704	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAAGTTCGCCGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.69195936038	39.9185205944706	0.0159311364852128	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2504.53105895117	2504.53105895117
"healthy-4"	"2019-08-01-count-3:TCTCTGGCACATCCCT"	14.4081026512081	2.01048812949983	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGCACATCCCT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1661.70389209867	41.5849747955857	0.0250255024335686	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1644.62576576313	1644.62576576313
"healthy-4"	"2019-08-01-count-4:GGGCGTTGTTCAGTAC"	11.3667046028072	4.22431466663209	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCGTTGTTCAGTAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1574.38613153602	39.557317972201	0.0251255503207511	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1567.16957998721	1567.16957998721
"healthy-4"	"2019-08-01-count-4:TCTATCACATTACTCT"	-1.93507895889934	9.14520833576051	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATCACATTACTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2071.03230590887	43.2681589847933	0.02089207341737	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2059.75985794384	2059.75985794384
"healthy-4"	"2019-08-01-count-4:AGTACCATCTGCATGA"	0.0327276690745771	7.77737662875978	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACCATCTGCATGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2145.784003777	44.3174507624562	0.0206532673766086	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2136.62184796053	2136.62184796053
"healthy-4"	"2019-08-01-count-3:CTTCGGTGTGCCTATA"	-2.23680458489116	9.33230207050172	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTGTGCCTATA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1852.53268887988	50.3141530704367	0.0271596573558217	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1850.73148391495	1850.73148391495
"healthy-4"	"2019-08-01-count-2:ATGGATCGTAGTCGGA"	3.35384120520894	-6.35838034069213	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCGTAGTCGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.78260913687	46.1277153093971	0.0208554471487585	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2203.51220019554	2203.51220019554
"healthy-4"	"2019-08-01-count-3:GTTCATTTCGTTCATT"	1.63244678553883	-6.10568954860839	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCATTTCGTTCATT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2711.33977480831	45.3243365770368	0.0167165830701692	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2707.09067936002	2707.09067936002
"healthy-4"	"2019-08-01-count-3:CAACCAATCTTGATTC"	10.6375347572262	6.46027228916017	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAATCTTGATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.69674926149	45.8113858434104	0.0242298961276071	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1872.97363761846	1872.97363761846
"healthy-4"	"2019-08-01-count-3:GTTCCGTAGGCCTTGC"	3.11844410476033	-6.00542881405028	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCCGTAGGCCTTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.11184899246	43.2337263457109	0.015935106531552	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2709.49048682059	2709.49048682059
"healthy-4"	"2019-08-01-count-4:CGCATGGTCACTACTT"	-2.86402998390849	3.52119920337526	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGTCACTACTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3332.39799763746	47.3482241538665	0.0142084541484644	5360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3323.61907670082	3323.61907670082
"healthy-4"	"2019-08-01-count-3:AACCCAATCGCAATTG"	-0.1909166527098	7.83473727786867	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAATCGCAATTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2072.85370060618	47.0019248046818	0.0226749841491161	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.51484984232	2070.51484984232
"healthy-4"	"2019-08-01-count-4:CAACAACTCCACCTGT"	2.18926205214803	-6.2488322488037	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACTCCACCTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.06157684096	49.0242912687379	0.0191272389675326	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2557.30167039926	2557.30167039926
"healthy-4"	"2019-08-01-count-4:AGTACTGTCTCGTGAA"	-0.164713705808479	7.75888869846193	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTACTGTCTCGTGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.60356222969	39.7986958503495	0.0208741327451453	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1898.7662251284	1898.7662251284
"healthy-4"	"2019-08-01-count-2:GGGACTCGTTTCTATC"	-4.1991642517155	13.0678310164246	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCGTTTCTATC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2089.51439975331	43.8842980588598	0.0210021515353236	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2083.6231644721	2083.6231644721
"healthy-4"	"2019-08-01-count-2:AACAGGGGTTGTGCCG"	11.4340673881466	4.43351266467897	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACAGGGGTTGTGCCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1894.70496146311	48.8485535619189	0.0257816148452989	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.33267352267	1889.33267352267
"healthy-4"	"2019-08-01-count-4:CGCCATTAGCCAACCC"	-3.94951568070109	12.6178626784119	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCCATTAGCCAACCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1971.00534974263	51.3011345120621	0.0260279022168869	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1957.51493697417	1957.51493697417
"healthy-4"	"2019-08-01-count-3:GCACTAAGTGGATACG"	2.57812156256978	-5.97436430370482	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAAGTGGATACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.09108135781	46.9414323291792	0.020267524324501	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2312.28168361755	2312.28168361755
"healthy-4"	"2019-08-01-count-2:CTTGATTAGGCGAAGG"	11.5320078330928	3.68578527057496	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGATTAGGCGAAGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.43137095722	39.2704536038921	0.0199805773858013	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1959.90217408309	1959.90217408309
"healthy-4"	"2019-08-01-count-2:TGCGATACACACCTAA"	11.2924305396969	5.96226308429567	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGATACACACCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2343.32645602322	45.1003052649036	0.0192462749477262	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2335.72209269589	2335.72209269589
"healthy-4"	"2019-08-01-count-2:ATGGTTGAGACCCTTA"	2.25851668891255	-6.06945326244506	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGTTGAGACCCTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.95364929525	43.9688079955796	0.0173792938885769	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2524.68061850036	2524.68061850036
"healthy-4"	"2019-08-01-count-3:CTTCTCTCACCGTGCA"	10.8614193397457	6.02817437732545	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTCACCGTGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1966.31155568537	46.424942472449	0.0236101661195127	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1955.57326380419	1955.57326380419
"healthy-4"	"2019-08-01-count-2:CTACAGACAGCTGGTC"	2.91084708747212	-6.58943130886229	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACAGACAGCTGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.985941014	46.5855490734819	0.0186417811756792	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.04518451867	2495.04518451867
"healthy-4"	"2019-08-01-count-3:CAACGGCCAAGAGCTG"	2.38008131560628	-4.37404730236205	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGGCCAAGAGCTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2997.67480436569	41.629084399234	0.0138871248938034	3368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2987.49112956777	2987.49112956777
"healthy-4"	"2019-08-01-count-3:TCTTCCTAGGTTATAG"	-3.48615680161174	3.6399035223755	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTCCTAGGTTATAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3449.0362348681	48.6609868952191	0.014108575144349	5499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3438.09865071432	3438.09865071432
"healthy-4"	"2019-08-01-count-4:GATGGAGCATAAGCAA"	4.24923672255818	-6.69410755550536	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGGAGCATAAGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.48941892661	42.1019878299425	0.016973258385501	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2477.89056047356	2477.89056047356
"healthy-4"	"2019-08-01-count-2:ATGTCCCCATGTCAGT"	-3.81343946877177	10.1397533186707	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCCCCATGTCAGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2270.23760342005	40.8751700680148	0.018004798267123	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2263.15260187858	2263.15260187858
"healthy-4"	"2019-08-01-count-2:GGGATGAAGGATAATC"	-0.0786062580650628	7.83936736667482	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATGAAGGATAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.57716977004	42.3850064279587	0.0221149490333563	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1912.37958841694	1912.37958841694
"healthy-4"	"2019-08-01-count-2:AACCATGAGGAAAGGT"	4.25739874419515	-6.31595709240111	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCATGAGGAAAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.97101495056	44.8136203097939	0.0166657134125404	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2684.77091557037	2684.77091557037
"healthy-4"	"2019-08-01-count-2:CTACATTTCCTACGGG"	-5.40265021744426	-5.25792028820189	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACATTTCCTACGGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3128.09403059732	46.2865401553709	0.0147970424490508	3008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3123.96440778253	3123.96440778253
"healthy-4"	"2019-08-01-count-4:CGGACACAGCATACTC"	3.40621223029439	-5.92317202007445	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGACACAGCATACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2785.15460876308	39.2040433356721	0.0140760743451449	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2777.76521118499	2777.76521118499
"healthy-4"	"2019-08-01-count-2:CTACCCAAGGAGATAG"	-0.156284774572212	7.61028812015382	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAAGGAGATAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.89079774628	46.011187553312	0.0232980920290982	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.60467572641	1967.60467572641
"healthy-4"	"2019-08-01-count-2:GGGCGTTCAGCGACAA"	11.1577688651973	6.15649459445802	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCGTTCAGCGACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.60314340259	43.1550919958302	0.0221126370603144	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1941.67365734965	1941.67365734965
"healthy-4"	"2019-08-01-count-2:CTACCCAAGGCCACCT"	11.1639601188595	6.35076758945314	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCAAGGCCACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1818.00836909067	42.9637046105925	0.0236322919855876	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1809.98826733179	1809.98826733179
"healthy-4"	"2019-08-01-count-4:TCTGGCTGTTCTTAGG"	-3.03408394280131	9.98085210407106	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTGTTCTTAGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2000.96793306686	41.6435136331306	0.0208116846576867	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1997.37279132649	1997.37279132649
"healthy-4"	"2019-08-01-count-2:TATCCTACAATGCAAA"	0.846689184277695	8.17910001361696	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTACAATGCAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1728.15427543487	40.658206240792	0.0235269540565531	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1716.38330641295	1716.38330641295
"healthy-4"	"2019-08-01-count-4:GGGTGTCCATATGGCT"	9.84285225447957	6.40830037677614	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGTCCATATGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.35494537313	37.1925654239672	0.0203532244888378	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1825.541104313	1825.541104313
"healthy-4"	"2019-08-01-count-2:GAAACCTTCACTGCTC"	10.3207365470821	6.94074962222902	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTTCACTGCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1972.9465501622	42.9261518402245	0.0217573820419491	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.35506046112	1969.35506046112
"healthy-4"	"2019-08-01-count-4:CGGCAGTAGCATTGTC"	4.973556180566	-6.97545959865721	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGCAGTAGCATTGTC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2827.16373846018	43.5651375917828	0.0154094851313814	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2824.77122218856	2824.77122218856
"healthy-4"	"2019-08-01-count-3:CAAGCTAGTTGACGGA"	-3.68906507912334	-5.48180582439574	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTAGTTGACGGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2599.12013668039	47.763389007712	0.0183767530918042	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2594.43329688632	2594.43329688632
"healthy-4"	"2019-08-01-count-3:CTTTCAAGTTGTCTAG"	-7.13239131394084	2.76343653285829	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTTCAAGTTGTCTAG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2566.29533627616	45.1126017802012	0.0175788815661654	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2554.49498395041	2554.49498395041
"healthy-4"	"2019-08-01-count-4:CGGCAGTTCAGCTGAT"	11.2436100440914	5.32065103137819	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGCAGTTCAGCTGAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.283041015	43.3659834480941	0.0214017403148039	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2017.97931078684	2017.97931078684
"healthy-4"	"2019-08-01-count-2:GGGCTCACATCCTAAG"	-0.372481982142288	8.12500856006471	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTCACATCCTAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2012.209366251	42.2764228187355	0.0210099523080452	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1998.86887335787	1998.86887335787
"healthy-4"	"2019-08-01-count-3:AAGACAACAAGCGCTC"	10.1180864768917	7.09255263889161	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAACAAGCGCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.72058381576	48.5652954316186	0.0259191769846054	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1870.60981202049	1870.60981202049
"healthy-4"	"2019-08-01-count-4:AACCCAAAGCTTAAGA"	-5.44975886765178	-4.17911913311156	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCCAAAGCTTAAGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3352.39686904847	43.5343309003294	0.0129860313682628	4230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3346.13325405126	3346.13325405126
"healthy-4"	"2019-08-01-count-3:GTTGTCCGTTCAACGT"	-3.58939538422282	10.6631507643494	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTCCGTTCAACGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1998.35361478883	41.6407727488328	0.020837539683002	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1991.73645482445	1991.73645482445
"healthy-4"	"2019-08-01-count-3:AAGACAATCAAGCTTG"	11.0185591178829	6.55588576877443	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACAATCAAGCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.53690923283	48.2426339318694	0.0240547225582219	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1994.02340333126	1994.02340333126
"healthy-4"	"2019-08-01-count-4:TCTTAGTCAGTCGCTG"	2.02020933207814	-6.32683136379393	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTAGTCAGTCGCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.41172691777	47.8899425598651	0.0217838824154237	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2195.82940322821	2195.82940322821
"healthy-4"	"2019-08-01-count-2:CTACGGGCATGCCATA"	-3.56215773049052	11.0821237334046	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACGGGCATGCCATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.62332090569	42.0224686210531	0.0222032922012943	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1880.83852868781	1880.83852868781
"healthy-4"	"2019-08-01-count-3:TTAGGCATCGTCGACG"	4.95506157454793	-7.3803110352722	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCATCGTCGACG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1980.00027095341	48.9562076474068	0.0247253540141353	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1978.22716991051	1978.22716991051
"healthy-4"	"2019-08-01-count-3:GAAACCTGTACCGCGT"	3.21060432967488	-6.14696600353392	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAACCTGTACCGCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.52289071441	47.7269067816528	0.0230062087987937	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2071.02764862855	2071.02764862855
"healthy-4"	"2019-08-01-count-4:GGTAATCCAACGACTT"	10.0041052299434	7.41349837863771	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAATCCAACGACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2025.51767265991	43.5177703226121	0.021484764566613	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2022.56224923855	2022.56224923855
"healthy-4"	"2019-08-01-count-2:CTACTATCAATGTTGC"	4.0578896003658	-6.83271267330321	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCAATGTTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.63904933158	42.713757853723	0.0167725998959036	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2546.63904933158	2546.63904933158
"healthy-4"	"2019-08-01-count-2:AACGTCAAGAGAGCAA"	-3.69355283203776	10.9880971678528	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCAAGAGAGCAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2133.10829439722	43.1787289717536	0.0202421644907415	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2128.05878827552	2128.05878827552
"healthy-4"	"2019-08-01-count-4:CTTCAATAGCACTCGC"	3.05106629905049	-6.35189106380614	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCAATAGCACTCGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.23244330502	45.5838425575794	0.0191429621605153	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2375.87905425799	2375.87905425799
"healthy-4"	"2019-08-01-count-3:AGAACAATCCGCCTAT"	-0.246438632637817	7.78082749927369	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAATCCGCCTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2040.08615014803	49.4066082378974	0.0242179028735196	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.94486452767	2032.94486452767
"healthy-4"	"2019-08-01-count-4:CGGGTCATCTACGGGC"	-1.4997401041096	8.79178426349489	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGGGTCATCTACGGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.64895444311	48.0296239862264	0.0251641999826207	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.57260708047	1895.57260708047
"healthy-4"	"2019-08-01-count-3:CAATCGAAGTCTCCTC"	0.512142618268174	7.94845483386842	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATCGAAGTCTCCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.09108896592	39.3517768294551	0.021270183432671	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1845.69746496617	1845.69746496617
"healthy-4"	"2019-08-01-count-3:AAGATAGCAAGCAATA"	-1.40626810017284	8.49720571124879	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGCAAGCAATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.18646123554	40.9778626623637	0.0216792700099957	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1885.4325668557	1885.4325668557
"healthy-4"	"2019-08-01-count-2:CTAGACACACCAATTG"	5.26064552840535	-9.01607897197875	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACACACCAATTG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2708.05329686356	43.64454665443	0.016116575956972	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2706.23298541853	2706.23298541853
"healthy-4"	"2019-08-01-count-4:GGTCACGTCCTCTAGC"	11.6720863777095	3.98171351039735	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGTCCTCTAGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2138.84606926714	32.2452921505788	0.0150760228208603	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2120.59627482399	2120.59627482399
"healthy-4"	"2019-08-01-count-3:TAACCAGGTGATGGCA"	0.393895556300324	7.87760303104249	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACCAGGTGATGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.65163978671	41.0488105772419	0.0217921454849741	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1875.85927531311	1875.85927531311
"healthy-4"	"2019-08-01-count-3:AAGATAGTCGGCATAT"	5.60113682326619	-9.88084604656371	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGTCGGCATAT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2817.21283303	45.0160324727132	0.0159789249661684	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2812.67407915808	2812.67407915808
"healthy-4"	"2019-08-01-count-3:AAGATAGGTAATTAGG"	10.5011183219845	6.54598519885866	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGGTAATTAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1838.01132124482	36.0657581847885	0.019622163241281	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1829.17061239997	1829.17061239997
"healthy-4"	"2019-08-01-count-3:AAGCATCTCACTAGCA"	10.052148480981	7.5956034430298	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCATCTCACTAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2165.40664523417	42.6772184092734	0.0197086392540641	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2152.96917280073	2152.96917280073
"healthy-4"	"2019-08-01-count-2:TCGATTTAGCTCCATA"	10.74130310592	5.79816863620607	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGATTTAGCTCCATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1776.59404282591	41.2812359432539	0.0232361670410594	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1767.56187184242	1767.56187184242
"healthy-4"	"2019-08-01-count-3:TAACGACTCGAAGCAG"	-2.61032615128215	10.5272559889588	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACGACTCGAAGCAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1624.82366344174	45.4665905540902	0.0279824768540002	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1613.66692357163	1613.66692357163
"healthy-4"	"2019-08-01-count-2:TCGATTTCATGTGTCA"	4.57466330107991	-6.61276533519896	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGATTTCATGTGTCA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2737.36252726408	40.7204545915302	0.0148757989436749	2257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2734.83606010471	2734.83606010471
"healthy-4"	"2019-08-01-count-3:TAACTTCGTAACCAGG"	4.86272968825643	-7.60217239772948	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACTTCGTAACCAGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.88245379553	43.1357926760701	0.0167006410271139	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2579.62521796659	2579.62521796659
"healthy-4"	"2019-08-01-count-3:TAAGCACAGGTCGTAG"	3.06450404700581	-6.08330871975096	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAAGCACAGGTCGTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.6275236794	41.026827451944	0.01654556059737	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2477.19520323623	2477.19520323623
"healthy-4"	"2019-08-01-count-4:CGTAATGAGGGCAACT"	6.78531183776204	-1.70954623138579	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAATGAGGGCAACT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2809.33567438806	39.1182992929887	0.0139243948843919	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2793.16817045888	2793.16817045888
"healthy-4"	"2019-08-01-count-4:CCACGAGAGTGGGAAA"	-3.92579541626628	10.974829650763	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGAGTGGGAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2130.91432018757	41.2575761031309	0.0193614429788521	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2127.57166747754	2127.57166747754
"healthy-4"	"2019-08-01-count-4:CGTAGTAAGAGAGCGG"	11.0849968391353	5.92391107166139	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAGTAAGAGAGCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1812.31565721463	41.6935594872178	0.0230056829897376	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1807.16324328785	1807.16324328785
"healthy-4"	"2019-08-01-count-2:CTATAGGTCTAGGCCG"	3.33472313460652	-5.56600429927977	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGTCTAGGCCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2633.26652449805	49.6662164723407	0.0188610670474414	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2621.87722828345	2621.87722828345
"healthy-4"	"2019-08-01-count-3:AAGCGTTTCGCCAACG"	4.71263851699178	-7.1958308449951	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGTTTCGCCAACG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.23649768649	40.3981779623894	0.0156628436355587	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2573.98724759463	2573.98724759463
"healthy-4"	"2019-08-01-count-4:TGAATCGTCGAGTGGA"	2.71935309943501	-7.08779003536376	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGTCGAGTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1689.17935662848	53.705385495152	0.0317937732807399	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1687.61096853483	1687.61096853483
"healthy-4"	"2019-08-01-count-4:TGAATCGTCGCTTGCT"	4.64345707473103	-6.91508772289427	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATCGTCGCTTGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.7102892594	43.0131354457544	0.0158912963889916	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2701.08854961749	2701.08854961749
"healthy-4"	"2019-08-01-count-4:TGAATGCAGATTGAGT"	2.14008035239522	-6.05769255077513	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAATGCAGATTGAGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2755.37203545625	42.1385479092648	0.015293233496974	2070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2751.67384055342	2751.67384055342
"healthy-4"	"2019-08-01-count-3:GAAGCGATCATGGGAG"	0.633823116391343	8.17950055682985	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGCGATCATGGGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.17033879709	34.7673128713431	0.0192385366918347	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1800.1343358675	1800.1343358675
"healthy-4"	"2019-08-01-count-3:GAAGGACCAACTCGAT"	2.94901146468465	-5.91355564510497	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGACCAACTCGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2708.43076105981	41.175339201091	0.0152026552766588	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2704.88164167553	2704.88164167553
"healthy-4"	"2019-08-01-count-3:GAAGGACCAATAACGA"	3.96104397353474	-6.50558187877806	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGGACCAATAACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.08555222917	47.6659721331788	0.019623010844322	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2424.48500679431	2424.48500679431
"healthy-4"	"2019-08-01-count-3:CCCTTAGCACTTGAGT"	4.01176371154134	-6.6774153939453	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTTAGCACTTGAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.37668631819	46.5452557449645	0.0192783735896422	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2410.32660574557	2410.32660574557
"healthy-4"	"2019-08-01-count-2:TATTGGGAGCATGTTC"	-0.0566441592877686	7.58981511676637	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGGGAGCATGTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2254.59596212572	36.1587192122949	0.0160377822987863	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2247.76009608706	2247.76009608706
"healthy-4"	"2019-08-01-count-3:CCCTGATTCCGGTTCT"	4.76149048384969	-7.01357319271239	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATTCCGGTTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2870.64176016008	42.8871190297327	0.0149399063390414	1991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2866.1888476713	2866.1888476713
"healthy-4"	"2019-08-01-count-3:TCATCATTCCAGTACA"	-3.71702728691753	10.9329070814881	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATCATTCCAGTACA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2203.81172773711	48.8767224026101	0.0221782658597598	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2200.45110028661	2200.45110028661
"healthy-4"	"2019-08-01-count-4:CGTGAATTCAGTGCGC"	-0.0998124581878961	7.63129184329835	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTGAATTCAGTGCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.19246128802	45.3042121365549	0.0232187306149433	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1941.93945481305	1941.93945481305
"healthy-4"	"2019-08-01-count-3:TTCCAATGTTCCAAAC"	-4.29853806915935	12.6211843260559	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCAATGTTCCAAAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2483.88690150295	42.8766597595884	0.0172619211179239	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2480.88384460893	2480.88384460893
"healthy-4"	"2019-08-01-count-3:TTCCAATTCTCGTCAC"	-2.73566470566447	9.1305942305359	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCAATTCTCGTCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2145.19481959076	45.5033115341961	0.021211738495097	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.02395479932	2142.02395479932
"healthy-4"	"2019-08-01-count-4:CTTCTCTGTACGATTC"	-0.234723518521148	7.58765838229982	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTGTACGATTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1955.38459235873	42.745974789922	0.0218606482617103	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.75708255471	1952.75708255471
"healthy-4"	"2019-08-01-count-2:AAGACTCTCAGCAGAG"	2.08380331572835	-6.15738680278929	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGACTCTCAGCAGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.56396738398	47.9443108929699	0.019036368150208	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2511.51983098304	2511.51983098304
"healthy-4"	"2019-08-01-count-2:AAGATAGGTTCGTACA"	2.87948336180989	-6.41169407283934	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGATAGGTTCGTACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2080.85389482455	49.3747482926939	0.0237281187379362	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2077.82396500671	2077.82396500671
"healthy-4"	"2019-08-01-count-2:CTATCTATCCGGACGT"	0.117261399596375	7.86280629718629	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATCTATCCGGACGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1904.36290768264	45.5940037015994	0.0239418671292445	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.66146784533	1902.66146784533
"healthy-4"	"2019-08-01-count-2:CTCAACCCACAACGCC"	-0.724715988070327	8.40360448444215	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAACCCACAACGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2393.33342963947	43.2090661805776	0.0180539266470225	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2382.57404771019	2382.57404771019
"healthy-4"	"2019-08-01-count-2:TCGGATAAGGGACAGG"	0.150921714573544	7.90110967243043	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATAAGGGACAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1935.14578063651	48.3948519349447	0.0250083752961632	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1928.16757185641	1928.16757185641
"healthy-4"	"2019-08-01-count-3:GAATAGATCAGACATC"	0.252663333981675	7.78853223407594	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATAGATCAGACATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1834.77873873779	43.5897407774291	0.0237574917656916	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1827.90288003346	1827.90288003346
"healthy-4"	"2019-08-01-count-2:TCGGATACATCATCCC"	5.5673939186031	-9.80960466777953	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATACATCATCCC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.95560895461	46.417079743156	0.0176897351406218	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2622.81327173449	2622.81327173449
"healthy-4"	"2019-08-01-count-3:CACCAAAGTCGGTGTC"	2.63795413550679	-6.04993727123412	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACCAAAGTCGGTGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.84560955087	46.0879125572676	0.0190300787034127	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2415.4389947177	2415.4389947177
"healthy-4"	"2019-08-01-count-3:TTCCTAAGTCCAGCCA"	10.6323877769405	6.48419187152711	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTAAGTCCAGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1840.85661498246	42.9309214976101	0.0233211653467205	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1835.58500714224	1835.58500714224
"healthy-4"	"2019-08-01-count-2:TGGGAGATCGGCATTA"	2.67797150191609	-6.4817800751892	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGATCGGCATTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.55659509745	38.1835909396388	0.018758304746526	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2033.73204795683	2033.73204795683
"healthy-4"	"2019-08-01-count-2:TCAAGACTCGTTACCC"	-0.247510860592681	7.79780623996583	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAAGACTCGTTACCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.4773098763	40.0330493810972	0.019205317895004	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2075.27341046902	2075.27341046902
"healthy-4"	"2019-08-01-count-2:ACTCCCAGTTCAGGTT"	11.2810532051021	3.85541627490846	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTCCCAGTTCAGGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1478.09334365187	47.0556570591637	0.0318353757976511	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1461.53281032259	1461.53281032259
"healthy-4"	"2019-08-01-count-4:CGTTGGGGTGTCATGT"	-2.66101036492046	3.68834874713746	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTTGGGGTGTCATGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3292.09249214757	49.1178502281541	0.0149199484356263	5943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3286.87283460962	3286.87283460962
"healthy-4"	"2019-08-01-count-4:ATAGAGAGTGCGAACA"	4.2950722175533	-6.44216921245726	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATAGAGAGTGCGAACA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2700.57917607061	37.4920837348445	0.013882978905805	2233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2691.50149253148	2691.50149253148
"healthy-4"	"2019-08-01-count-3:AAGTTCGTCAGTCTTT"	2.84735073623006	-6.08377458965453	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTTCGTCAGTCTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.37800181338	47.3931216824712	0.0202935548958974	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2333.15932343163	2333.15932343163
"healthy-4"	"2019-08-01-count-3:TACAACGAGTTCTACG"	2.66419877585713	-6.24541284954222	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACAACGAGTTCTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.71796135051	48.1888726282296	0.0209542532771848	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2295.246112232	2295.246112232
"healthy-4"	"2019-08-01-count-4:TGAGCATCAAGACAAT"	10.7880026298458	5.9501914747986	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCATCAAGACAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.59575000122	44.6725603736411	0.0226121970416333	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1970.82057808882	1970.82057808882
"healthy-4"	"2019-08-01-count-4:CACATGATCAATGTCG"	-2.1107910675114	8.68827626788942	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACATGATCAATGTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2196.72245582157	45.2637894901488	0.0206051471683164	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2192.41648149914	2192.41648149914
"healthy-4"	"2019-08-01-count-2:ATTGTTCCAGAACTAA"	5.57062925872151	-9.95965387737425	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGTTCCAGAACTAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.65117581324	46.3373534250785	0.0172216130584349	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2685.48273607328	2685.48273607328
"healthy-4"	"2019-08-01-count-4:TGAGCATGTCTTCAAG"	10.2415663200313	6.29660413349	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGCATGTCTTCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.60656845385	46.3661016229385	0.0239666826211567	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1926.14929036104	1926.14929036104
"healthy-4"	"2019-08-01-count-4:TTAGTCTCATGTGGCC"	-5.04527888718303	-2.79082205211791	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGTCTCATGTGGCC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3308.65324475887	42.3423772397829	0.0127974659498864	3975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3295.89547843345	3295.89547843345
"healthy-4"	"2019-08-01-count-2:GGTCTGGCAGCGCGTT"	10.9042850929195	5.86687228763429	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCTGGCAGCGCGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.8216094917	44.2339241652068	0.0237201906820802	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1854.89468421383	1854.89468421383
"healthy-4"	"2019-08-01-count-4:CTAACTTCATGGAATA"	-0.224702636629897	7.66413066470949	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACTTCATGGAATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2093.21114221415	44.4951608378157	0.0212568908795076	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2084.1831619981	2084.1831619981
"healthy-4"	"2019-08-01-count-3:AATCGACCACTGTGAT"	10.7612463432247	6.96498630130617	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACCACTGTGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.61711207361	47.692990408106	0.0244627471275012	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.20794250052	1932.20794250052
"healthy-4"	"2019-08-01-count-3:CACGGGTCAATGCAGG"	-1.87304101410564	3.76052925670473	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGGGTCAATGCAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3109.00828173969	45.014462555855	0.0144787206969634	5151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3103.96821015408	3103.96821015408
"healthy-4"	"2019-08-01-count-4:GTAAGTCTCCGTTTCG"	10.6638266044552	7.76823899829713	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAAGTCTCCGTTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2183.04535455431	48.5328916103051	0.0222317376544903	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2177.46458304664	2177.46458304664
"healthy-4"	"2019-08-01-count-2:ATTTCTGCAGACCCGT"	-0.134228150278884	7.56929013812868	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCTGCAGACCCGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.12905230911	43.9393085717402	0.0218698288799519	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2000.71338298992	2000.71338298992
"healthy-4"	"2019-08-01-count-3:TCATTACTCTACGCAA"	0.0348408381337344	7.66570184314577	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTACTCTACGCAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2115.20361411006	41.2822314357131	0.0195169066279617	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2105.0041112723	2105.0041112723
"healthy-4"	"2019-08-01-count-3:TACATTCGTAGCTTGT"	-8.07852969589885	-0.0727575949397908	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACATTCGTAGCTTGT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3156.39240887186	45.0821288520677	0.0142828023300755	4368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3146.13378427644	3146.13378427644
"healthy-4"	"2019-08-01-count-3:TACATTCTCAGCATTG"	2.53396572646443	-6.2611704102722	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACATTCTCAGCATTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.49413027904	50.6579339140655	0.0211383509243843	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2390.07389983155	2390.07389983155
"healthy-4"	"2019-08-01-count-2:AAGGTAACAAGTTCGT"	9.88112701949422	7.1347708472046	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAACAAGTTCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.35960885229	42.8399998406232	0.0211309328910205	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2012.51787061304	2012.51787061304
"healthy-4"	"2019-08-01-count-3:CACGTGGGTTGTGCCG"	-7.35737452927287	0.871412492636122	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGGTTGTGCCG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2791.55294171598	41.2567469286795	0.0147791382753854	3309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2780.69689670722	2780.69689670722
"healthy-4"	"2019-08-01-count-3:TACCCACCAACAAGAT"	3.36386646804158	-6.2215261689392	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCACCAACAAGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.50790705972	44.9417385849194	0.0164470662532422	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2728.09006097127	2728.09006097127
"healthy-4"	"2019-08-01-count-3:AATGAAGTCATTACTC"	10.2272354560787	7.11914489353029	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGTCATTACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.64718129519	46.7675726069749	0.0264425675745724	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1759.7243799658	1759.7243799658
"healthy-4"	"2019-08-01-count-3:CACGTTCCAATCGCGC"	11.1586100059444	6.14860770786134	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTTCCAATCGCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1976.70167026873	52.0634228226131	0.0263385333283677	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1967.98235235482	1967.98235235482
"healthy-4"	"2019-08-01-count-3:AATGAAGTCCGTATGA"	9.74112000045125	6.93120620334474	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGAAGTCCGTATGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.67141691497	43.3718718864864	0.0231480672090835	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1860.2931633087	1860.2931633087
"healthy-4"	"2019-08-01-count-4:TGAGGGATCGCTAAAC"	4.53103031691853	-6.76519730007323	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGATCGCTAAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.78183224775	42.1561445200932	0.0163918043091736	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.74388132091	2568.74388132091
"healthy-4"	"2019-08-01-count-4:GTACAACGTCAAGGCA"	-0.532401899725753	8.1456146010193	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAACGTCAAGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2056.89539754314	44.6072709302913	0.0216866987906009	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2053.89793910593	2053.89793910593
"healthy-4"	"2019-08-01-count-4:GTACAACGTTGTAAAG"	-5.12516389313396	-2.82937481319579	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAACGTTGTAAAG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3153.8918520789	41.6431875952087	0.0132037462120838	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3134.87524556483	3134.87524556483
"healthy-4"	"2019-08-01-count-3:AATGCCAAGATTAGCA"	-4.6443923515385	3.51277515971986	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGCCAAGATTAGCA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3010.49415473261	41.5842496921072	0.0138130976360593	3404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3003.08681274477	3003.08681274477
"healthy-4"	"2019-08-01-count-4:GTACAACTCCCGATCT"	3.4368392425472	-6.36095526134642	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTACAACTCCCGATCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.91435079893	41.6940093825752	0.0166051101541193	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2506.79057507836	2506.79057507836
"healthy-4"	"2019-08-01-count-2:GGTGTCGCATACTGAC"	10.7974640327388	5.33021257007448	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGCATACTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.30943431199	42.4371325164483	0.0228610229157063	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.05517346339	1851.05517346339
"healthy-4"	"2019-08-01-count-3:TACCCGTGTCGATGCC"	-2.23953805390056	9.65477368915407	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACCCGTGTCGATGCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.93285885705	48.6564061577509	0.0264590443981693	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1829.59879113378	1829.59879113378
"healthy-4"	"2019-08-01-count-2:CAACCAACAGGCACTC"	-3.00834999504741	9.075656867865	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCAACAGGCACTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2274.28175238184	40.1748995985641	0.0176648735612856	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2269.40097942492	2269.40097942492
"healthy-4"	"2019-08-01-count-2:CAACCTCAGCCTTGAT"	0.754392583935898	8.14172170245973	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCAGCCTTGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1968.59319692821	40.7730309868205	0.020711760586414	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1955.01376366621	1955.01376366621
"healthy-4"	"2019-08-01-count-4:TGATCAGCACCAGTTA"	-3.4949086708134	-4.64539863979491	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCAGCACCAGTTA"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3049.97952813711	50.2801477030997	0.0164854049803443	2873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3043.41205242952	3043.41205242952
"healthy-4"	"2019-08-01-count-2:CTCATCGTCGGCTATA"	4.71324886855428	-6.87545635616454	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCATCGTCGGCTATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.47895320378	47.0201660288365	0.0174830020412783	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2687.55037110822	2687.55037110822
"healthy-4"	"2019-08-01-count-4:GCCCAGAAGATACCAA"	1.97511007365529	-5.90383150493773	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCCAGAAGATACCAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2819.99573949768	41.8984636531386	0.0148576336716743	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2816.58539038739	2816.58539038739
"healthy-4"	"2019-08-01-count-2:GACCCTTCAATTAGGA"	-3.49565611305888	-5.12197115337523	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTCAATTAGGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2680.13971309515	39.2873069254343	0.0146586787000232	2345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2671.24677758233	2671.24677758233
"healthy-4"	"2019-08-01-count-2:AAGTGAACATCCGTTC"	10.0425278144771	6.7995280989441	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGTGAACATCCGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1760.77859321055	40.3957833939294	0.0229420005159609	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1752.64745455341	1752.64745455341
"healthy-4"	"2019-08-01-count-4:ATCCATTTCAACGAGG"	2.90486969527547	-6.29014971172484	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCATTTCAACGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.20699523615	41.5809930940611	0.016121619230586	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2573.34297059569	2573.34297059569
"healthy-4"	"2019-08-01-count-4:CTACCCATCGTTGTGA"	11.5316530662471	3.59000609004823	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCCATCGTTGTGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2108.11669151398	32.5286237629438	0.01543018177973	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2094.69195687492	2094.69195687492
"healthy-4"	"2019-08-01-count-2:CAACCTCTCGATACTG"	3.02719010886495	-6.16826536571654	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACCTCTCGATACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.89157195689	43.5265333381996	0.0157028268271947	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2766.45759270065	2766.45759270065
"healthy-4"	"2019-08-01-count-4:GTAGAGGTCCTTATCA"	11.4267946678096	4.42157981479494	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGTCCTTATCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2320.26761933767	37.1873824991744	0.0160271953929994	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2307.68994067697	2307.68994067697
"healthy-4"	"2019-08-01-count-4:ATCCCTGGTCCAGCAC"	-2.77327762070354	9.75689790332643	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCCTGGTCCAGCAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1963.38302752446	46.3926949073247	0.0236289579042655	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1957.69966250283	1957.69966250283
"healthy-4"	"2019-08-01-count-3:TTCTTCCCATATAGCC"	5.07546963271443	-7.7203579179016	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTTCCCATATAGCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.30418357152	49.7866787480252	0.0179069178984834	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2779.5462885085	2779.5462885085
"healthy-4"	"2019-08-01-count-2:GGTTAACTCCGTTGGG"	3.35985364493672	-6.30377247249755	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACTCCGTTGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.9967325464	44.0815084295516	0.0176679623882962	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2484.56574499712	2484.56574499712
"healthy-4"	"2019-08-01-count-3:GACGTTAAGGTGAGAA"	10.5989920097286	6.74696204746095	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGTTAAGGTGAGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1760.91625928437	44.1352147350723	0.0250637783042611	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1753.34475899124	1753.34475899124
"healthy-4"	"2019-08-01-count-3:GACGTTACACTGCGTG"	11.4696413474971	4.42775390231935	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACGTTACACTGCGTG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2243.47264169901	38.1243853426589	0.0169934701382349	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2236.78672056235	2236.78672056235
"healthy-4"	"2019-08-01-count-2:CTGCGAGAGGTAGGCT"	-0.493131617934066	8.05887410724489	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCGAGAGGTAGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.18153381696	31.6411744104708	0.0188994883597433	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1668.29780133131	1668.29780133131
"healthy-4"	"2019-08-01-count-2:TCACATTGTACCGTGC"	11.3531080680782	4.70189521396486	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACATTGTACCGTGC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.86065301242	46.6551933849796	0.0217014964758788	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2146.3765941785	2146.3765941785
"healthy-4"	"2019-08-01-count-3:AGCATCATCTGAGGCC"	-6.68270049515422	1.78930971706239	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCATCATCTGAGGCC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2792.12316751701	41.8518663248687	0.0149892622258806	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2783.13363838185	2783.13363838185
"healthy-4"	"2019-08-01-count-3:GACTATGGTAGAGACC"	10.5446096855098	5.85981652820436	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTATGGTAGAGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1778.12037479766	41.3565321664216	0.023258567165976	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1769.59999342537	1769.59999342537
"healthy-4"	"2019-08-01-count-3:GCTACCTAGCCGATCC"	-7.1930869621342	-2.07546737110289	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCTACCTAGCCGATCC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3215.97213920217	53.2834679658742	0.0165683860616693	4367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3208.70694216457	3208.70694216457
"healthy-4"	"2019-08-01-count-3:AGCCAATCAATTGCTG"	11.032038350671	6.39281985843507	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAATCAATTGCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.78830157282	44.83035277718	0.023303163212152	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1906.02524435576	1906.02524435576
"healthy-4"	"2019-08-01-count-3:GTATTTCAGGTGGCTA"	-2.81819448891338	9.38580796802369	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTTCAGGTGGCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.03578051035	37.6703171298237	0.0189389841545023	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1985.213864288	1985.213864288
"healthy-4"	"2019-08-01-count-3:ATCGGCGTCGGCTTGG"	11.4800020652706	3.48739121044008	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGGCGTCGGCTTGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1679.70189850617	44.1873410881646	0.0263066566320263	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1662.23569673481	1662.23569673481
"healthy-4"	"2019-08-01-count-2:GGTTGTATCCCGTGTT"	11.5844856697017	3.4216475256714	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTATCCCGTGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.46257456517	36.6007416418475	0.0181150307373174	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1997.51619186875	1997.51619186875
"healthy-4"	"2019-08-01-count-4:ATCGATGAGGTAGTAT"	11.1642185645992	5.05453155124513	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGAGGTAGTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.24690149326	44.8370706313198	0.022304260535367	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2001.66153344558	2001.66153344558
"healthy-4"	"2019-08-01-count-3:ACAACCAGTAGTCTGT"	-4.14527926865275	12.4972266920838	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAACCAGTAGTCTGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2124.87497911534	42.0376956732885	0.0197836089588623	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2121.38291965811	2121.38291965811
"healthy-4"	"2019-08-01-count-3:TACGGGCAGCGTTCCG"	3.09898700293843	-6.14303924953612	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGGCAGCGTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.05477059246	40.460318004401	0.0155793087086765	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2597.05477059246	2597.05477059246
"healthy-4"	"2019-08-01-count-4:CTAGACACAGGACATG"	0.677231212227982	7.99338433826295	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACACAGGACATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1948.75429520494	41.9906037531717	0.0215474079295131	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1944.97389965239	1944.97389965239
"healthy-4"	"2019-08-01-count-2:TCTATACTCCTAACAG"	1.22972895678822	-5.99564602291258	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTATACTCCTAACAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2826.82531272406	44.3683931445884	0.015695484593575	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2817.5176446243	2817.5176446243
"healthy-4"	"2019-08-01-count-3:CAGATTGAGTCGCCCA"	5.54820980605428	-10.0598926774231	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGAGTCGCCCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.05638669433	43.1271077362138	0.0169988763207611	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2533.60893787839	2533.60893787839
"healthy-4"	"2019-08-01-count-3:TACGGTAAGAGTCACG"	11.2578884559566	5.38635871494142	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGTAAGAGTCACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2056.74100791607	44.8033343010814	0.0217836539110372	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2045.38229876534	2045.38229876534
"healthy-4"	"2019-08-01-count-2:CTCCCAAAGGAACGTC"	-3.56848750534709	-5.35103371059569	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAAGGAACGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2824.72766458431	48.421005406366	0.0171418314103182	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2819.71166360982	2819.71166360982
"healthy-4"	"2019-08-01-count-4:CTAGACATCTGCGTCT"	4.70845570144002	-6.96104051983031	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACATCTGCGTCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2956.01876476161	40.4219486557032	0.0136744560412028	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2950.18788995919	2950.18788995919
"healthy-4"	"2019-08-01-count-2:TCTCACGAGTGAGGTC"	4.11572565612142	-6.59331753170165	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCACGAGTGAGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.97040063105	42.8516098309483	0.0169845868267936	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2518.47272708155	2518.47272708155
"healthy-4"	"2019-08-01-count-2:GTAACCATCACTAGCA"	5.00410952147786	-7.54494764721068	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACCATCACTAGCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2756.6733838953	39.9739954590148	0.0145008094511835	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2755.80580585398	2755.80580585398
"healthy-4"	"2019-08-01-count-2:CTCCCAAGTGATGTAA"	3.96234716948811	-6.08346989071044	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCAAGTGATGTAA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2921.41677865138	42.8414868509898	0.0146646268221841	2604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2916.79309556195	2916.79309556195
"healthy-4"	"2019-08-01-count-3:ACACAGTTCCTACCAC"	-4.27987800064738	13.0343532332214	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACAGTTCCTACCAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2360.92729307187	43.689393907506	0.0185051839739886	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2353.03096019392	2353.03096019392
"healthy-4"	"2019-08-01-count-3:CAGCACGCAATGGGTG"	4.56710733947102	-7.34134867107543	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCACGCAATGGGTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.04658363349	41.0693156576629	0.0150324360879098	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2725.56087858877	2725.56087858877
"healthy-4"	"2019-08-01-count-2:TCTCAGCAGTGGCCTC"	-2.80787835541423	10.226161933783	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCAGCAGTGGCCTC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2213.30967002483	50.9468073934962	0.0230183819659201	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2193.94929178159	2193.94929178159
"healthy-4"	"2019-08-01-count-3:TACGTCCCATGTTTGG"	0.168707807629746	7.98026654804078	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGTCCCATGTTTGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.59467958643	43.2528362585148	0.0228537238982233	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1890.08470641718	1890.08470641718
"healthy-4"	"2019-08-01-count-3:TCCGAAAAGTCCCTAA"	-0.0135258165305436	7.66319129550783	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGAAAAGTCCCTAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.84172366742	40.9098077777941	0.0205490006018319	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1981.48979681173	1981.48979681173
"healthy-4"	"2019-08-01-count-4:TGCAGGCGTCTGCGCA"	2.64885272559468	-5.97980215465697	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGGCGTCTGCGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.84283257863	47.2499642120662	0.0185160165856767	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2547.14404119218	2547.14404119218
"healthy-4"	"2019-08-01-count-4:CTATCCGAGTTAACAG"	4.08545889434163	-6.90196516430052	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTATCCGAGTTAACAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.31743970759	44.7625550863512	0.0190696640893731	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2342.82149944688	2342.82149944688
"healthy-4"	"2019-08-01-count-3:CAGCAGCTCTAACACG"	10.8486954170162	5.68936917865602	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCAGCTCTAACACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.30228156108	47.2834116414251	0.0239010044532293	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1968.92543143781	1968.92543143781
"healthy-4"	"2019-08-01-count-2:CTCCCTCTCAGTGCGC"	10.1695085960323	6.89353177631227	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCTCTCAGTGCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2001.26775237967	43.1368815579916	0.0215547777186228	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1990.93549721351	1990.93549721351
"healthy-4"	"2019-08-01-count-3:CAGCAGCCACCAAATC"	3.85701670226399	-6.45526745235594	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCAGCCACCAAATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.1953777525	39.8027735868968	0.0146646678102649	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2710.04485807954	2710.04485807954
"healthy-4"	"2019-08-01-count-3:ACACGCGCAGTCGGAA"	3.94693316993062	-6.5351019135681	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACGCGCAGTCGGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.01457239601	47.4551778527265	0.0223211912415279	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2121.62446785204	2121.62446785204
"healthy-4"	"2019-08-01-count-3:ACACGCGGTTTGGAGG"	4.30266823348348	-6.82853557979735	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACGCGGTTTGGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.03367292444	49.8816348025948	0.0211091510773363	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2358.18639003453	2358.18639003453
"healthy-4"	"2019-08-01-count-4:TGCAGTAGTTCTATCT"	-2.68642125549968	3.26213643634645	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTAGTTCTATCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3191.84619590108	51.1251134334177	0.0160174113336262	3862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3175.87504533949	3175.87504533949
"healthy-4"	"2019-08-01-count-2:GTACAGTTCAAGCCGC"	10.7162195640499	5.83874414050905	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAGTTCAAGCCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.90661076296	50.466897732484	0.0260958297839284	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.90725343867	1927.90725343867
"healthy-4"	"2019-08-01-count-2:TAACGACGTTTGGCTA"	-4.32191691818889	13.120391822699	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACGACGTTTGGCTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2228.58349354208	46.3163450335351	0.0207828628219446	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2218.40369788211	2218.40369788211
"healthy-4"	"2019-08-01-count-2:TCAGGGCCATTCTGTT"	3.21257295188252	-6.14756824886473	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCCATTCTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.74211733196	46.2868799053581	0.0172922447798201	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2671.83066859556	2671.83066859556
"healthy-4"	"2019-08-01-count-3:CCTCTAGTCAATCTTC"	2.20119370993916	-5.9973149529663	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCTAGTCAATCTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.59186202485	41.9660511578433	0.0159107448586175	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2630.12431246499	2630.12431246499
"healthy-4"	"2019-08-01-count-3:ACAGAAACACCTAAAC"	11.3317457633907	5.63131377780763	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAACACCTAAAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2565.93418889231	44.3762544741664	0.0172943852832497	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2547.40258495978	2547.40258495978
"healthy-4"	"2019-08-01-count-3:TCCGTGTGTTAGAAAC"	-1.56322000446971	8.66208741748659	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGTGTGTTAGAAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.45490268867	40.3929690442107	0.0216531469005187	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1854.18647417922	1854.18647417922
"healthy-4"	"2019-08-01-count-4:GTCACTCCACTCCGAG"	10.2391277748043	7.40793988788453	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCCACTCCGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.26637155918	43.4011807075385	0.0213876213176446	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2020.87304305818	2020.87304305818
"healthy-4"	"2019-08-01-count-3:TACTTGTCAGGCATGA"	2.56754364547078	-6.34900810634764	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTCAGGCATGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.85699937185	47.3786415273056	0.02000908059054	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2358.89689702491	2358.89689702491
"healthy-4"	"2019-08-01-count-2:CTCCTTTTCAACTGAC"	4.47234358367268	-7.25291731273802	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTTTTCAACTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.95617802568	44.4520407186802	0.0195827748345975	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2265.37006052092	2265.37006052092
"healthy-4"	"2019-08-01-count-4:GTCACTCTCCTAAGTG"	10.5620256858761	6.84593532169191	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCTCCTAAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.04863570985	36.450277615686	0.0193982619305201	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1873.37117376737	1873.37117376737
"healthy-4"	"2019-08-01-count-2:CTCCTCCTCTAGTGTG"	5.02294220504109	-7.71774914180907	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCTCCTCTAGTGTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2699.87794596302	45.3467841723639	0.0167958645094192	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2690.13518116998	2690.13518116998
"healthy-4"	"2019-08-01-count-4:CAGCACGAGAGCAACC"	10.6528316932613	6.95083186710206	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCACGAGAGCAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1728.52971456314	40.4772042155607	0.0234171295260554	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1726.48274089292	1726.48274089292
"healthy-4"	"2019-08-01-count-4:ATCTCTAGTAGTATAG"	1.80399002608601	-6.898464225885	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCTCTAGTAGTATAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1930.72237790832	47.1058034373866	0.0243980201277925	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	1927.09605123438	1927.09605123438
"healthy-4"	"2019-08-01-count-2:TCTGGCTAGGATTTCC"	0.00179040905777809	7.68100164020387	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTAGGATTTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.8640157236	39.1576196351913	0.0206216028693711	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1886.50513753019	1886.50513753019
"healthy-4"	"2019-08-01-count-2:TCTGGCTCATTCGATG"	-3.23144112053569	-5.78355743801268	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTGGCTCATTCGATG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2111.34567731278	50.0775906965528	0.0237183286633997	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2107.71410992198	2107.71410992198
"healthy-4"	"2019-08-01-count-3:GAGAGGTGTAAGGCCA"	0.0937746810609519	7.99360368335573	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAGGTGTAAGGCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.71132755517	40.8810504873064	0.0223306918310824	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1825.63521615074	1825.63521615074
"healthy-4"	"2019-08-01-count-3:ACAGCCGTCCCTTGTG"	4.9095684486324	-7.07331135189208	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGCCGTCCCTTGTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.02709093211	46.0140746509549	0.0177590094723407	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.92815859699	2589.92815859699
"healthy-4"	"2019-08-01-count-3:TAGACTGAGCCGCTTG"	2.98553599891011	-6.16788866436156	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGAGCCGCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.6503237843	44.6342509034174	0.019691723260118	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2259.75631867201	2259.75631867201
"healthy-4"	"2019-08-01-count-3:CAGTGCGGTGCGCTCA"	0.720315356820267	7.97537229144899	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTGCGGTGCGCTCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.00290075434	43.181746411586	0.0237131672847409	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1812.8427529167	1812.8427529167
"healthy-4"	"2019-08-01-count-3:TAGACTGCACTTGGGC"	3.39827837523763	-6.14401295101317	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGCACTTGGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.07808972194	41.8670808811375	0.0169291382488633	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.65577074601	2470.65577074601
"healthy-4"	"2019-08-01-count-3:ACATCCCCAAGAAATC"	-0.00290098685081604	7.73823020541994	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATCCCCAAGAAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2027.25244989324	40.1034503425778	0.0197821688880878	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.0817158822	2016.0817158822
"healthy-4"	"2019-08-01-count-3:TAGACTGTCTTACCGC"	-0.671760956675369	8.19255063617555	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGACTGTCTTACCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.7820863134	42.7749963251441	0.0215623462981439	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.16912937988	1979.16912937988
"healthy-4"	"2019-08-01-count-2:CTCTCGAAGTATGCAA"	4.17525353011434	-6.61926605617674	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGAAGTATGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2802.13120247655	44.5323270353039	0.0158923061832172	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2796.57548165092	2796.57548165092
"healthy-4"	"2019-08-01-count-4:CTCACTGCACCTGTCT"	-4.27153907242473	13.0489949950012	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCACTGCACCTGTCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2599.98850565152	37.022343458606	0.0142394258198186	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2598.41510682296	2598.41510682296
"healthy-4"	"2019-08-01-count-3:TAGATCGAGTATAGAC"	2.19542231139485	-6.06714298641356	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGATCGAGTATAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.09761363753	49.6994845459379	0.0220387287208252	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2253.96441093464	2253.96441093464
"healthy-4"	"2019-08-01-count-2:CTCTCGAGTCTGTAAC"	1.73911656913106	-6.1865911713806	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTCGAGTCTGTAAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2443.50588672027	46.2661534617348	0.0189343327197113	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2433.43217900877	2433.43217900877
"healthy-4"	"2019-08-01-count-3:GAGCTGCGTTCTAACG"	4.67649569091145	1.48803601348726	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCGTTCTAACG"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2412.81987349691	46.05719581516	0.0190885346730874	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2403.79886697459	2403.79886697459
"healthy-4"	"2019-08-01-count-3:TAGATCGCATGACAGG"	11.151067395776	4.02584788883058	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGATCGCATGACAGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.67200644926	45.4900545779311	0.0263607767918373	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1717.08898972125	1717.08898972125
"healthy-4"	"2019-08-01-count-3:ACATGCAAGGATGGCT"	5.21046175536458	-8.12744905864867	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATGCAAGGATGGCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2705.35107155767	43.6514898391075	0.0161352403752812	2176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2700.84745786919	2700.84745786919
"healthy-4"	"2019-08-01-count-2:CACAGATGTCAACCTA"	10.8826090293819	6.9756755598816	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGATGTCAACCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2281.1725297201	45.9865414455791	0.02015916851814	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2273.39831283922	2273.39831283922
"healthy-4"	"2019-08-01-count-4:TGCTCGTAGGGAGAAT"	2.66175260123555	-6.10694363033446	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCGTAGGGAGAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.96213163234	47.5357143794406	0.0206590598454212	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2293.97474505422	2293.97474505422
"healthy-4"	"2019-08-01-count-2:GAGAGGTTCCGCGGAT"	-1.53957674923595	8.6793174513611	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTTCCGCGGAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.80742176589	46.8988685454683	0.022980545859093	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2035.58462960759	2035.58462960759
"healthy-4"	"2019-08-01-count-4:TTCTCTCAGTCTGCGC"	-3.36655531349834	-5.61843349849852	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTCTCAGTCTGCGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2667.10681284387	51.8016247030089	0.0194224035023832	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2660.04537949954	2660.04537949954
"healthy-4"	"2019-08-01-count-4:GACGTTACAGATCCTA"	-4.25747428360637	12.9774846800598	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTACAGATCCTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2350.003129937	45.5947261513427	0.0194019852869579	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2343.47227634266	2343.47227634266
"healthy-4"	"2019-08-01-count-2:CTCTGGTCACGTGAGA"	11.5580660301143	3.67792699420778	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCTGGTCACGTGAGA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2075.15215154492	41.9181327392903	0.0202000285656562	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2069.5312950473	2069.5312950473
"healthy-4"	"2019-08-01-count-3:ACATTTCCATCCTTGC"	10.4181353050167	6.90423963153688	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACATTTCCATCCTTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.77247433587	46.193600777807	0.0224265550459408	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2054.77463501609	2054.77463501609
"healthy-4"	"2019-08-01-count-4:TGCTTCGCAAACACCT"	3.54291739043538	-6.33167841350707	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGCAAACACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.37675191362	42.8735308335364	0.0159122256392267	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2689.4990061054	2689.4990061054
"healthy-4"	"2019-08-01-count-4:TTCTGTACAGGTCAAG"	0.664218683808488	8.27244279468385	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTGTACAGGTCAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.59284753219	42.2040994403112	0.024260906510499	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1729.90630126665	1729.90630126665
"healthy-4"	"2019-08-01-count-2:CACAGGCTCGCCAGTG"	2.96361865577046	-6.26810648357543	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACAGGCTCGCCAGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.70908095298	42.8483692240408	0.0170662421819803	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2508.71370026956	2508.71370026956
"healthy-4"	"2019-08-01-count-3:ACCAAACGTCAAAGCG"	10.7839542823726	7.37465999210206	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAAACGTCAAAGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.47744607783	44.5029824436866	0.022146544879391	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2004.97771367382	2004.97771367382
"healthy-4"	"2019-08-01-count-2:CTGAATGTCCACGGGT"	5.16162600097005	-7.7538953057495	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGTCCACGGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2751.07180749539	45.5527679081906	0.0165581893515395	2251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2745.99224082415	2745.99224082415
"healthy-4"	"2019-08-01-count-3:GAGGGTAAGCTGTTAC"	11.3513361411983	5.91185996616212	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGTAAGCTGTTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2349.35373024955	42.8552795419532	0.0182413056791584	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2341.02904514608	2341.02904514608
"healthy-4"	"2019-08-01-count-4:GTCCTCATCAGCTGAT"	11.4613443809444	4.02150509441224	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCTCATCAGCTGAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.08634748064	39.4015534133422	0.018549883087416	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2110.5710730609	2110.5710730609
"healthy-4"	"2019-08-01-count-3:GAGGGTATCACGATAC"	2.83276667174641	-6.30839445507201	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGTATCACGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.93107092965	45.3935397302726	0.0186733142182073	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2425.15139611998	2425.15139611998
"healthy-4"	"2019-08-01-count-3:ACCAACATCCGCGATG"	4.21856083449666	-6.89557506954344	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCAACATCCGCGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.42704901733	46.6575091982636	0.0182154354995835	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2558.17131248516	2558.17131248516
"healthy-4"	"2019-08-01-count-3:CATACTTGTCCACAGC"	11.1033731895382	5.92385289752809	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATACTTGTCCACAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.47841769376	48.532938806467	0.0247430399277757	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.48836494635	1950.48836494635
"healthy-4"	"2019-08-01-count-2:GAGCCTGGTTGGAGGT"	3.85679950293843	-7.56130649959715	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGGTTGGAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.02395307364	49.6245987035631	0.0237549208713232	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2087.27312282742	2087.27312282742
"healthy-4"	"2019-08-01-count-4:ACACTGAGTTCCGGTG"	-2.81018171730693	10.4442434080872	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACTGAGTTCCGGTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2068.45790459159	43.153140357762	0.0208624696987888	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.07333737434	2058.07333737434
"healthy-4"	"2019-08-01-count-3:CGACAGCAGTTAACAG"	11.5308853584224	3.93491051280824	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCAGTTAACAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.38514094796	40.5541093684889	0.0199736042933976	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2014.8968945599	2014.8968945599
"healthy-4"	"2019-08-01-count-4:ACAGAAACAATGGCAG"	11.2570864158565	4.25415895068971	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAACAATGGCAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.09052164845	45.215874844906	0.0267852193143954	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1668.35268954267	1668.35268954267
"healthy-4"	"2019-08-01-count-3:AGGCATTGTGTCCTAA"	10.977781911462	6.34371469104616	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCATTGTGTCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1720.78215903304	41.9358763375913	0.0243702412402721	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1715.13432660422	1715.13432660422
"healthy-4"	"2019-08-01-count-3:TAGGTACTCAAACGAA"	10.8748833137447	7.17365787113038	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGTACTCAAACGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2091.92037848899	48.3626267864971	0.0231187703336155	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2091.92037848899	2091.92037848899
"healthy-4"	"2019-08-01-count-2:CTGCAGGCACCCGTAG"	3.351161857217	-5.41815760051879	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGCACCCGTAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2928.42364159847	42.4091410143384	0.0144819009148517	3219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2923.01331853132	2923.01331853132
"healthy-4"	"2019-08-01-count-2:CTGCAGGCACGTCATA"	-0.177531669766265	7.49804780567018	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGCACGTCATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.32239510442	45.0820185929909	0.0225486488339147	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1991.8094198304	1991.8094198304
"healthy-4"	"2019-08-01-count-2:GTCACGGAGGTCTGGA"	5.0143162208492	-7.35926678096923	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGAGGTCTGGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.12109440356	46.6152272019815	0.0182652881574476	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2547.7909553431	2547.7909553431
"healthy-4"	"2019-08-01-count-4:TGGAGAGAGGATTTGA"	-4.28204570236857	12.4991187819275	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGAGAGGATTTGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1922.60939491867	43.4540982606527	0.0226016258817309	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1915.14066179443	1915.14066179443
"healthy-4"	"2019-08-01-count-4:CTCAGTCTCTCAAAGC"	11.026160855859	6.56559608066408	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCTCTCAAAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.75932126231	47.4778235919651	0.0239574115194388	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1970.50803327292	1970.50803327292
"healthy-4"	"2019-08-01-count-3:TTTAGTCAGCGACTAG"	-4.38408790054973	12.6532563933167	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCAGCGACTAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2662.21195195401	41.403416274158	0.0155522614357466	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2660.76045660559	2660.76045660559
"healthy-4"	"2019-08-01-count-2:GTCACGGGTAGGAAAG"	4.98830904540364	-7.49507048046263	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGGTAGGAAAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.03122019437	47.7301505507734	0.0189177803939725	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2514.82637982552	2514.82637982552
"healthy-4"	"2019-08-01-count-2:CTGCATCCAAGAGATT"	10.6443211036617	7.43366525256959	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCCAAGAGATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2160.13804814097	47.0930390449467	0.0218009395674852	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2151.17937387009	2151.17937387009
"healthy-4"	"2019-08-01-count-2:CACGAATTCGGTCAGC"	3.27342834052388	-6.27200462734374	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATTCGGTCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.14807979654	42.2456864306527	0.0161665872505556	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2606.48706614669	2606.48706614669
"healthy-4"	"2019-08-01-count-4:GTCTACCTCAAGCGTT"	11.4941517311031	3.3466324576172	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCTCAAGCGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1972.54025642068	39.8532476575197	0.0202040224668653	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.25490832507	1950.25490832507
"healthy-4"	"2019-08-01-count-3:ACCATTTTCGTGCACG"	3.25945653495137	-6.40562393581542	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTTCGTGCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.91217021343	47.16147647718	0.0193212509047617	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2438.85835059774	2438.85835059774
"healthy-4"	"2019-08-01-count-3:GAGTGTTCACGACAGA"	4.8774901824886	-7.25865890895995	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTCACGACAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.33304934788	45.5640994273128	0.0177062582081474	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2571.06975111957	2571.06975111957
"healthy-4"	"2019-08-01-count-2:CTGCCATCATCGTGGC"	6.87887253341023	-1.65529134189757	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATCATCGTGGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2796.85034679722	35.7405760204236	0.0127788660774616	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2781.86984799023	2781.86984799023
"healthy-4"	"2019-08-01-count-2:ACATCCCAGAAATCCA"	4.18441881713216	-6.17724897777709	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACATCCCAGAAATCCA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3030.30307409291	44.4504080240504	0.0146686344359652	2979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3020.71598082946	3020.71598082946
"healthy-4"	"2019-08-01-count-4:GTCTAGAGTTCGGCTG"	2.55012073096578	-6.17468216335448	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTAGAGTTCGGCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.2507075836	43.8783611784422	0.0186935128133855	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2343.71487015636	2343.71487015636
"healthy-4"	"2019-08-01-count-2:GTCAGCGCAGTGTATC"	11.5129944282467	3.5286917456421	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAGCGCAGTGTATC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.68019879118	40.3467146329542	0.020308610644785	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1971.95947410742	1971.95947410742
"healthy-4"	"2019-08-01-count-3:ACCCTCAGTATTGCCA"	2.34464349326436	-6.41768648540648	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTCAGTATTGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1863.18928703867	48.0951366500935	0.0258133389799248	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1861.60993125416	1861.60993125416
"healthy-4"	"2019-08-01-count-4:ATGTCCCAGCTCGACC"	10.9887844520504	6.74863383853761	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCAGCTCGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1998.65935344302	42.4711777116553	0.0212498331136278	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1988.68852076833	1988.68852076833
"healthy-4"	"2019-08-01-count-4:TGGCGTGAGCTGCCAC"	4.14732803878133	-6.45673611080321	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGAGCTGCCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.81380444634	47.1250126812718	0.0194746441212464	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2414.44668425473	2414.44668425473
"healthy-4"	"2019-08-01-count-2:TGACCCTTCCAACACA"	10.0148178535396	6.25381753528444	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTTCCAACACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1904.42161779726	47.8087660646007	0.0251040870455453	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1891.55740136184	1891.55740136184
"healthy-4"	"2019-08-01-count-2:TGACCCTTCTCTCGCA"	0.217655454843682	7.72144506061403	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTTCTCTCGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2066.51130946989	45.4920287138898	0.0220139268076687	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.54437979576	2058.54437979576
"healthy-4"	"2019-08-01-count-4:CTCCACAAGACGGTTG"	10.8456961112911	7.44462392413942	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACAAGACGGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.00100009718	46.0450839544385	0.0221051665132615	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2071.82243079533	2071.82243079533
"healthy-4"	"2019-08-01-count-2:CACGTGGTCATTGGTG"	-2.93438373032268	9.57965085590211	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTGGTCATTGGTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1920.66533751114	44.5478498725913	0.0231939677374081	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1916.93873957477	1916.93873957477
"healthy-4"	"2019-08-01-count-3:GGCACGTGTCTTACAG"	-3.75837955895122	3.7157673605713	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCACGTGTCTTACAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3023.90309881951	48.2183822241695	0.0159457431830383	4189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3014.77409685867	3014.77409685867
"healthy-4"	"2019-08-01-count-2:GAGGGATCATAGTCGT"	-7.3062838119572	2.49761364543764	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGGATCATAGTCGT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2806.99582739436	41.6320283620898	0.0148315248479494	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2791.3265381515	2791.3265381515
"healthy-4"	"2019-08-01-count-4:CTCCACACAGGTGTGA"	-4.26410470429118	11.9755134352478	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACACAGGTGTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2297.63134152607	44.5054891114442	0.0193701610467604	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2295.98478711247	2295.98478711247
"healthy-4"	"2019-08-01-count-2:TCCTTCTTCTCACCCA"	9.87210812148396	7.00944898212282	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTTCTCACCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2310.8490337391	40.0504960992607	0.0173315069545917	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2299.73373048554	2299.73373048554
"healthy-4"	"2019-08-01-count-3:TATCAGGCAAATTAGG"	-3.13135562363322	3.48766658389894	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCAGGCAAATTAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3552.3489570714	46.0582051653193	0.0129655632714896	5825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3541.52428437758	3541.52428437758
"healthy-4"	"2019-08-01-count-4:GGATCTACAACGGCTC"	-1.14769313755687	8.30175778949586	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGATCTACAACGGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2052.83220023884	47.4366696110221	0.0231079138399636	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2042.68086028628	2042.68086028628
"healthy-4"	"2019-08-01-count-4:CCTGTTGCACCATAAC"	3.61776651915852	-6.26438000118407	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTGTTGCACCATAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.03647239979	42.0937618193093	0.0175096186362306	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2397.95701063912	2397.95701063912
"healthy-4"	"2019-08-01-count-3:TTTCGATCACGTTCGG"	0.375957180827302	8.14373014057008	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCGATCACGTTCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.65635341201	41.0164767347346	0.0219732339376564	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.65635341201	1866.65635341201
"healthy-4"	"2019-08-01-count-3:TATCCTATCTAGTACG"	11.046608586877	5.94686315143434	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCCTATCTAGTACG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.86057892316	44.8667772252658	0.0231288669468049	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.95069805654	1934.95069805654
"healthy-4"	"2019-08-01-count-3:CATGCCTAGGTAGCCA"	4.62837137755696	-7.35718824779662	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCCTAGGTAGCCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.96780848753	48.5883081580953	0.0189282888540483	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2564.67433245646	2564.67433245646
"healthy-4"	"2019-08-01-count-2:TGAGACTTCCATGCAA"	5.53801550444905	-9.44279005443724	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGACTTCCATGCAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2814.54172480073	46.4540535853061	0.0165050150708265	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2807.59767989315	2807.59767989315
"healthy-4"	"2019-08-01-count-4:CTCCATGTCCTTCACG"	-1.43866692009624	8.51541516864625	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCATGTCCTTCACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2141.06415957968	45.8613267537183	0.0214198750413539	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2136.8640111361	2136.8640111361
"healthy-4"	"2019-08-01-count-2:TGAGCATGTACAGTCT"	11.5551897483761	3.75025651538698	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCATGTACAGTCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2092.55745807982	39.3804598165107	0.0188192967722125	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2082.91672328942	2082.91672328942
"healthy-4"	"2019-08-01-count-4:CTCCGATCACGGTCTG"	3.8208142715389	-6.37635328685912	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATCACGGTCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.52493595668	43.1631510529987	0.0170975340501605	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2514.84753708575	2514.84753708575
"healthy-4"	"2019-08-01-count-2:CTGGCAGAGTCGGCCT"	4.89062466201131	-7.05040838634642	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGAGTCGGCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.49230967751	46.8772138774759	0.0176197516929331	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.40923425911	2656.40923425911
"healthy-4"	"2019-08-01-count-2:CACTAAGAGGATGGCT"	3.59021939811055	-6.20468094265135	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGAGGATGGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.11110348064	45.2926746571704	0.0181162647508402	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.49285558173	2495.49285558173
"healthy-4"	"2019-08-01-count-2:CTGGCAGTCAAGTCTG"	5.53285278853719	-9.61839582836302	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGTCAAGTCTG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.80073640793	45.5605253125237	0.0167268202491962	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2717.06058525479	2717.06058525479
"healthy-4"	"2019-08-01-count-4:GTGAGTTCATAGCACT"	5.02629723128621	-7.50646068966063	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGTTCATAGCACT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2896.17071079353	38.850850012707	0.0134145580120386	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2893.44427856326	2893.44427856326
"healthy-4"	"2019-08-01-count-4:TGGGCTGAGGTCGTGA"	11.2274776893551	5.28412482822267	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCTGAGGTCGTGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1880.40842727894	40.6559363153607	0.021620800952372	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1864.28451506055	1864.28451506055
"healthy-4"	"2019-08-01-count-3:ACCTGTCCAGCTTCCT"	0.186157231300515	7.81931684100953	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCTGTCCAGCTTCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2160.41308410064	46.9879412691543	0.0217495170784502	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2151.48580576597	2151.48580576597
"healthy-4"	"2019-08-01-count-3:CATGCTCGTCCGTTTC"	10.4711309867794	7.41979835117189	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCGTCCGTTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2143.53900077885	45.8838578860162	0.0214056557260421	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2138.4844291775	2138.4844291775
"healthy-4"	"2019-08-01-count-4:CTCCTCCTCTATTTCG"	-3.46582088890727	10.0677385100159	"2019-08-01-count-4"	"Control4"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTCCTCTATTTCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2526.16748443429	39.0674662285552	0.0154651132473522	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2521.90147008894	2521.90147008894
"healthy-4"	"2019-08-01-count-4:CTCCTCCGTTCATCGA"	0.307274569838685	8.20911405170289	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCTCCGTTCATCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.3411065825	36.5621919847646	0.0189114025767519	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1931.93215528203	1931.93215528203
"healthy-4"	"2019-08-01-count-3:GATCATGTCACCGGGT"	10.5840994316036	6.29435203159181	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCATGTCACCGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1830.92085868674	48.9707570899357	0.0267465176649201	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1824.0846573153	1824.0846573153
"healthy-4"	"2019-08-01-count-3:ACGATCAAGTCGGCAA"	2.08781208571736	-6.06240370189818	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGATCAAGTCGGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.99047370226	42.014697076592	0.0173114388094406	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2424.57424352308	2424.57424352308
"healthy-4"	"2019-08-01-count-3:ACGATCACACAACGAG"	-3.47818551483806	3.7397410639557	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGATCACACAACGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3092.97329323814	46.1940847640228	0.0149351709130539	4391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3084.02104927082	3084.02104927082
"healthy-4"	"2019-08-01-count-3:CATGGTAAGAGCATCG"	11.5541416603023	3.79300472820131	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTAAGAGCATCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.71728721778	42.6745813021283	0.0220231204952511	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1931.96347965872	1931.96347965872
"healthy-4"	"2019-08-01-count-4:ATTCAGGAGATGGTAT"	10.8598858314449	4.39181754672853	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCAGGAGATGGTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1384.66109823677	50.677116574337	0.03659893142002	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1374.75692240381	1374.75692240381
"healthy-4"	"2019-08-01-count-4:GTGCACGCAAGAGATT"	9.72694744643514	6.19890449130861	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGCAAGAGATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1691.91076911845	47.9075031615135	0.0283156204428411	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1673.33252029546	1673.33252029546
"healthy-4"	"2019-08-01-count-3:ACGGAAGGTCTTGTCC"	5.13594545897786	-7.84860565578612	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGAAGGTCTTGTCC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.31325797512	43.7023636060052	0.0165959608009607	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2629.12068155995	2629.12068155995
"healthy-4"	"2019-08-01-count-4:ATTCAGGTCCGAGAAG"	-5.44455514374431	-2.84127499973448	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCAGGTCCGAGAAG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3226.35867939559	39.9723062048242	0.0123892939926668	3597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3217.08786140404	3217.08786140404
"healthy-4"	"2019-08-01-count-2:TACTGCCTCAGTCACA"	4.99411024627034	-7.40009930050048	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTGCCTCAGTCACA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3071.78629503232	42.1518831749637	0.013722270733199	3157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3065.73811070378	3065.73811070378
"healthy-4"	"2019-08-01-count-3:TTTGGTTTCCTAAGTG"	2.05786146697347	-6.08806898510131	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTTCCTAAGTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2393.54045596525	44.9966236880136	0.0187991907869666	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2389.22130009724	2389.22130009724
"healthy-4"	"2019-08-01-count-3:TATTCCACAATTCTCT"	-0.945118407637435	8.35269734943239	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTCCACAATTCTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2038.68198269778	42.9813632782454	0.0210829171214671	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2030.71172661396	2030.71172661396
"healthy-4"	"2019-08-01-count-3:ACGGGTCTCGAGCTGC"	11.6047254997188	4.02659843051759	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGGTCTCGAGCTGC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2346.78934690852	38.8211662636236	0.0165422458197041	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2332.79391006159	2332.79391006159
"healthy-4"	"2019-08-01-count-4:GTGCAGCCACGTGAGA"	-2.7333336872166	8.87835309589235	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCAGCCACGTGAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1985.88869202383	44.7728346192473	0.0225454904895093	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1976.52611827329	1976.52611827329
"healthy-4"	"2019-08-01-count-3:TCGTAGAAGCCATGCC"	6.76123060759847	-1.74815561687621	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTAGAAGCCATGCC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2772.03812022078	32.8778122705176	0.0118605195327902	2396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2760.94974694203	2760.94974694203
"healthy-4"	"2019-08-01-count-4:TTGGTTTCATTCTTCA"	4.03885259208028	-6.64598181163939	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTCATTCTTCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2870.76377263941	44.972330612465	0.0156656326240027	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2862.54380586275	2862.54380586275
"healthy-4"	"2019-08-01-count-3:ACGGTTACAATCTCTT"	-1.75023577633556	8.92710015857545	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGGTTACAATCTCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.66922421432	46.6064382268616	0.0228388009550178	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2035.20131266719	2035.20131266719
"healthy-4"	"2019-08-01-count-2:TACTTCACAAGTGGAC"	1.67469992217366	-6.00198080455931	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCACAAGTGGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2675.10374542406	45.4812158420969	0.0170016642980279	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2671.24658674323	2671.24658674323
"healthy-4"	"2019-08-01-count-3:ACGTAACCAGGAGACT"	0.399051209061784	7.90072391116945	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAACCAGGAGACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.22807658416	38.5702088450516	0.0222277459462147	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1727.13942907886	1727.13942907886
"healthy-4"	"2019-08-01-count-2:CTGTGAAAGCTACGTT"	-7.12709699097331	3.31186363780824	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGAAAGCTACGTT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2484.17415792976	38.9038749655683	0.015660687412508	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2468.92028044994	2468.92028044994
"healthy-4"	"2019-08-01-count-3:TATTGCTAGCATTTCG"	10.7253939109737	6.20497319782106	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGCTAGCATTTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2014.13712385702	43.6858816871727	0.0216896263763389	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1999.73583142124	1999.73583142124
"healthy-4"	"2019-08-01-count-4:TGTAACGAGCCTCAGC"	-2.72501621666606	9.07808110797731	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAACGAGCCTCAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1753.79835506632	32.6765613552315	0.018631880490044	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1749.81538227723	1749.81538227723
"healthy-4"	"2019-08-01-count-4:CTGAATGGTGCAGATG"	-4.71553216400798	-5.15054991161498	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGAATGGTGCAGATG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2930.20053780137	47.4206763907608	0.0161834235503698	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2928.23704263436	2928.23704263436
"healthy-4"	"2019-08-01-count-4:AAACGAAGTGTTAAAG"	0.0145260627264201	7.63883731448976	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAACGAAGTGTTAAAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.29428949894	46.360406695216	0.0231652121022258	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1993.0180758365	1993.0180758365
"healthy-4"	"2019-08-01-count-3:CATTCCGTCTCGGTAA"	3.28058471259419	-6.42597391521605	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCCGTCTCGGTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.5200216472	50.2556468932072	0.0193923436722145	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2581.70241122416	2581.70241122416
"healthy-4"	"2019-08-01-count-3:ACGTACAAGGCATCTT"	1.60604705390279	-6.49211456691893	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTACAAGGCATCTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1971.78427795783	49.7837227200837	0.0252480574455358	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	1969.99800625935	1969.99800625935
"healthy-4"	"2019-08-01-count-3:TATTGGGCAGCGTGCT"	-3.67350278320964	-5.35431864177855	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGCAGCGTGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.88221984884	37.1650442598599	0.0134564189568858	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2758.64753610356	2758.64753610356
"healthy-4"	"2019-08-01-count-4:ATTCCCGTCTATTTCG"	2.69857039031331	-6.55893661892089	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCCCGTCTATTTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.10710703035	47.537387750862	0.0178168963403317	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2660.25761820642	2660.25761820642
"healthy-4"	"2019-08-01-count-4:AAAGAACAGGCTCCCA"	-3.58665929260905	-5.47552111065062	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGAACAGGCTCCCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2440.14456095549	44.5644398785437	0.0182630326873313	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2437.78717926687	2437.78717926687
"healthy-4"	"2019-08-01-count-2:GTCTAGAAGCCTGTGC"	0.503935267298859	7.96883151614992	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTAGAAGCCTGTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.68004955383	49.911957197951	0.0248977173235497	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1994.38741531254	1994.38741531254
"healthy-4"	"2019-08-01-count-4:CTGATCCAGTTGGCTT"	-0.570349494845229	7.76426456058351	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCAGTTGGCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2182.57005973406	43.6619814617318	0.0200048476185236	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2176.75011246722	2176.75011246722
"healthy-4"	"2019-08-01-count-3:TATTGGGGTTAATGAG"	-1.56379995766338	8.85163114154664	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTGGGGTTAATGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.74002326925	44.2075109967263	0.0223864966911134	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1973.10168194473	1973.10168194473
"healthy-4"	"2019-08-01-count-3:ACGTAGTCACATAGCT"	10.5295473533565	6.66864774310914	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAGTCACATAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2045.93776544925	47.0700182911745	0.0230065738489552	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2031.51668099001	2031.51668099001
"healthy-4"	"2019-08-01-count-3:CATTGCCCAAAGGATT"	-0.0655086961692155	7.65382239902345	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGCCCAAAGGATT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1993.53273410161	41.8951105032584	0.0210155117027152	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1983.50965752037	1983.50965752037
"healthy-4"	"2019-08-01-count-3:GATTCGACACCTGTCT"	0.263224874704522	7.87933871829835	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTCGACACCTGTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.34975308515	39.8298622882962	0.0203281023337365	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1954.90522581904	1954.90522581904
"healthy-4"	"2019-08-01-count-3:ACGTAGTTCGTCCATC"	10.6803060966427	6.33067081058351	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACGTAGTTCGTCCATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2022.92700874602	49.4263216451238	0.0244330721926356	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2016.99723352025	2016.99723352025
"healthy-4"	"2019-08-01-count-4:CTGCAGGAGGAAACGA"	-2.69125924530681	3.32321760738222	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGAGGAAACGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3291.46662041364	47.3790820924976	0.0143945199986696	5496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3283.945912799	3283.945912799
"healthy-4"	"2019-08-01-count-2:GTCTCACGTGTGTCCG"	-0.711621562868911	8.32880113208619	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTCACGTGTGTCCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2230.91650141019	48.60275314551	0.021786002799651	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2220.43150593573	2220.43150593573
"healthy-4"	"2019-08-01-count-4:CTGCAGGCACTATCGA"	6.80819954451863	-1.67374315178069	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGCACTATCGA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2897.27495988812	37.1854595046153	0.0128346325493564	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2886.22927180829	2886.22927180829
"healthy-4"	"2019-08-01-count-2:AGGAAATCATGAAGGC"	10.365775724023	7.38169953906862	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAAATCATGAAGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2121.48478929657	50.4849647140786	0.0237969958440372	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2112.67590344122	2112.67590344122
"healthy-4"	"2019-08-01-count-4:GTGGCGTTCTCAATCT"	1.79567279395406	-5.90768625652465	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGCGTTCTCAATCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2911.5631020137	45.5831356357947	0.015655898237022	2308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2899.3918774832	2899.3918774832
"healthy-4"	"2019-08-01-count-3:TCAAGTGGTCTTGCTC"	2.18732966956441	-6.2250375977722	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGTGGTCTTGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.06005004293	50.4485200887351	0.0237621729482947	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2116.11489174666	2116.11489174666
"healthy-4"	"2019-08-01-count-4:GATCAGTTCGCGGACT"	2.16199078139607	-6.22694017803343	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCAGTTCGCGGACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2761.44512654082	45.8766123259559	0.0166132623404414	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2759.53138330797	2759.53138330797
"healthy-4"	"2019-08-01-count-3:TCAAGTGTCTCAAAGC"	-0.131817425519782	7.5385064848694	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAAGTGTCTCAAAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.83269180896	42.8730119374073	0.0225074948166141	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1894.58336789883	1894.58336789883
"healthy-4"	"2019-08-01-count-2:GTCTGTCGTCATCCGG"	-3.5726035636967	11.2477245100769	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCGTCATCCGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1487.79620433784	50.235648499261	0.0337651409196995	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1483.30243093584	1483.30243093584
"healthy-4"	"2019-08-01-count-4:CTGCAGGTCTGGGATT"	4.24037804183309	-6.7810211411682	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCAGGTCTGGGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2642.08831446488	44.8532091738209	0.0169764231302409	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2641.03352094867	2641.03352094867
"healthy-4"	"2019-08-01-count-2:ACCTACCTCGGAATGG"	-4.25361762467082	12.7340097197327	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTACCTCGGAATGG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2085.54049486268	47.3740541000713	0.0227154803355619	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2083.62344345806	2083.62344345806
"healthy-4"	"2019-08-01-count-3:CCAATTTGTAGTATAG"	-4.20567021790202	-5.28411676799925	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCAATTTGTAGTATAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2579.29133660026	47.6303393726798	0.0184664441340159	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2575.52439008072	2575.52439008072
"healthy-4"	"2019-08-01-count-4:CTGCATCTCCCATACC"	2.24377884444539	-6.25362732326659	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCATCTCCCATACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.87823651778	48.7785794908149	0.0199106138271378	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2445.08758203115	2445.08758203115
"healthy-4"	"2019-08-01-count-2:CTTCCGAAGCTGGCCT"	5.18135275420491	-7.47136833583983	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCCGAAGCTGGCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2804.28127608104	42.9580986804453	0.0153187553070564	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2794.8322861564	2794.8322861564
"healthy-4"	"2019-08-01-count-4:AAAGTGATCTTGCGCT"	6.72922243651692	-1.54479410564574	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAAGTGATCTTGCGCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2686.72760861455	40.5869500178559	0.0151064625560554	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2670.53235109074	2670.53235109074
"healthy-4"	"2019-08-01-count-3:CCACAAAGTCCTCAGG"	11.1905228095943	4.19246432864992	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACAAAGTCCTCAGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1561.21447997008	34.7823949692098	0.0222790624961898	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1558.61259162621	1558.61259162621
"healthy-4"	"2019-08-01-count-4:CTGCGAGCAATGCAGG"	4.01039113578145	-6.6472845307556	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGCGAGCAATGCAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.70528037131	44.5249345311353	0.0173403602319565	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2563.34795227406	2563.34795227406
"healthy-4"	"2019-08-01-count-2:CCGCAAGTCGGTCACG"	-3.66137061539348	9.56137559497682	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGCAAGTCGGTCACG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2523.33958820179	47.3558700697146	0.0187671410899799	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2513.6087963965	2513.6087963965
"healthy-4"	"2019-08-01-count-3:TCAATTCAGTGAGGTC"	11.500821729272	4.34918735111085	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAATTCAGTGAGGTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.686567527	45.3857093388091	0.0211127101152336	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2128.00444703829	2128.00444703829
"healthy-4"	"2019-08-01-count-3:CCACACTCAACTGGTT"	5.46102442321126	-10.1828298798767	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACACTCAACTGGTT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.96720862835	50.6624581772011	0.0211802477870309	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2379.31820405479	2379.31820405479
"healthy-4"	"2019-08-01-count-2:CAGCACGGTTGGCTAT"	11.4727589088375	3.78075263583986	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCACGGTTGGCTAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1544.7672782943	42.8439860658252	0.0277349129981136	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1529.69380319482	1529.69380319482
"healthy-4"	"2019-08-01-count-3:ACTATTCTCAAGTTGC"	10.5106922584469	6.93065211856691	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTATTCTCAAGTTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2134.49068437419	44.3226695415268	0.0207649861702356	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2118.94474462017	2118.94474462017
"healthy-4"	"2019-08-01-count-2:TGCATCCCAAACCACT"	4.81709875640218	-7.54963734066161	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCATCCCAAACCACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2901.55814915707	44.9935918380202	0.0155067000298068	2409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2894.7993459206	2894.7993459206
"healthy-4"	"2019-08-01-count-3:CCACACTTCTAACACG"	3.52338518676106	-6.29303266918334	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACACTTCTAACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.52615025924	41.2855158140066	0.0152259331189041	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2710.56940239061	2710.56940239061
"healthy-4"	"2019-08-01-count-4:TTTAGTCGTCGATGCC"	3.97858347472493	-6.35932924663695	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTAGTCGTCGATGCC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.33563352109	50.2303628098569	0.0184376558423296	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2713.12142413733	2713.12142413733
"healthy-4"	"2019-08-01-count-3:CGTAATGCAATGTGGG"	-0.339015494019347	7.6615304716858	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGCAATGTGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.41342500616	45.5115284708156	0.0226830262913915	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1999.13577961852	1999.13577961852
"healthy-4"	"2019-08-01-count-4:TGTCCCAGTACCAGAG"	0.170115803449792	7.63461921298829	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCAGTACCAGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1937.67141812166	39.3569831927306	0.0203114846122272	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1931.02578643132	1931.02578643132
"healthy-4"	"2019-08-01-count-2:CTTCGGTGTGTATTCG"	10.5178553062374	7.34769961917726	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTCGGTGTGTATTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.94004557247	42.733336201976	0.0221537918195346	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1920.50771154541	1920.50771154541
"healthy-4"	"2019-08-01-count-2:AGGATAAGTTCTGAGT"	0.292603095143479	8.02455566013185	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATAAGTTCTGAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2063.43603155241	36.8603699203445	0.0178635874127936	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2059.89231247508	2059.89231247508
"healthy-4"	"2019-08-01-count-2:TTCCACGAGTGATCGG"	0.364987392991227	7.59205815875856	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCACGAGTGATCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.70884683465	42.3057606278184	0.0225786203119484	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1869.48879353595	1869.48879353595
"healthy-4"	"2019-08-01-count-2:GTGAGTTTCCCGATCT"	2.09768428382222	-6.25450613414916	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTTCCCGATCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2546.45728117818	46.1380922927716	0.0181185416436378	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2541.39455413958	2541.39455413958
"healthy-4"	"2019-08-01-count-3:ACTCTCGAGTCACTCA"	-2.53292236748393	9.75921247089235	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTCTCGAGTCACTCA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2125.42640167058	47.2746000169421	0.022242407443412	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2118.04586081828	2118.04586081828
"healthy-4"	"2019-08-01-count-2:GTGAGTTTCTTCCACG"	1.83809949931447	-5.89700128948363	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGTTTCTTCCACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2874.93288998521	41.3653469556428	0.0143882826273053	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2867.12529864209	2867.12529864209
"healthy-4"	"2019-08-01-count-4:CTGGACGTCAAGAGTA"	10.8926760154659	5.93894622409669	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGGACGTCAAGAGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.03944468907	39.5399628622732	0.0210875365711732	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1865.62660914586	1865.62660914586
"healthy-4"	"2019-08-01-count-3:TCACATTAGGATGTTA"	-2.32129512253459	9.59772012317506	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACATTAGGATGTTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.43991137596	46.7756800935803	0.0243061265862731	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1912.65134796284	1912.65134796284
"healthy-4"	"2019-08-01-count-4:CAACAACCACCCTAGG"	10.2889038520748	7.3030853041443	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAACAACCACCCTAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2230.5091118783	46.0884176755697	0.0206627345434867	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2224.638637595	2224.638637595
"healthy-4"	"2019-08-01-count-4:GTGTTCCAGCTATCCA"	11.2543655830318	5.21055696094362	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCAGCTATCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2200.36529663553	39.8496897566093	0.0181104882073633	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2195.16039407735	2195.16039407735
"healthy-4"	"2019-08-01-count-3:AGTGACTTCCCATTTA"	2.88863863524739	-6.25958301937255	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTTCCCATTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.60697210839	44.0780863358505	0.0183002402825673	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2403.69249178772	2403.69249178772
"healthy-4"	"2019-08-01-count-2:ACGCACGTCCAACCGG"	-2.3116766017979	9.15207288349	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGCACGTCCAACCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1778.54890122207	47.0316018326709	0.0264438058466398	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1769.49114517655	1769.49114517655
"healthy-4"	"2019-08-01-count-2:GTGCACGGTTACGGAG"	-2.36081848564799	4.17262265765993	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCACGGTTACGGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3229.94825144469	49.6094913495876	0.0153592217235673	5655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3223.1357800285	3223.1357800285
"healthy-4"	"2019-08-01-count-2:GTGCAGCAGTTTGGCT"	2.06831779059712	-6.06148292934569	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCAGCAGTTTGGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2597.27744090242	39.8347487459135	0.015337117290047	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2594.3576689042	2594.3576689042
"healthy-4"	"2019-08-01-count-4:GATGCTAGTTCCGCTT"	5.12686218795125	-7.62352850353392	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGCTAGTTCCGCTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2853.97387183147	40.8327757386057	0.0143073404215864	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2849.59095099291	2849.59095099291
"healthy-4"	"2019-08-01-count-4:CATTGCCGTTCCATTT"	5.20883907851521	-8.18744280254515	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTGCCGTTCCATTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2795.52654557466	40.4358841630218	0.0144644965818808	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2792.58628981381	2792.58628981381
"healthy-4"	"2019-08-01-count-3:TCTTAGTCAATCCTAG"	11.3198667961055	5.94580361926881	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTCAATCCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.19418132893	43.2129430609627	0.0213166274148608	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2021.86004502994	2021.86004502994
"healthy-4"	"2019-08-01-count-3:AACCTTTCAAGACGAC"	11.2945343452388	5.51060292804567	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCTTTCAAGACGAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2144.45927705661	41.4547056428313	0.0193310761768021	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2137.1286862363	2137.1286862363
"healthy-4"	"2019-08-01-count-2:AGGCTGCCAAAGGCAC"	-0.419715355069	7.8295311697754	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGCTGCCAAAGGCAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2118.23206723325	41.1218209633552	0.0194132746829137	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2101.9127220209	2101.9127220209
"healthy-4"	"2019-08-01-count-3:CGTGAATGTTAGGGTG"	5.15302624282185	-7.70394661342772	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATGTTAGGGTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.39977927319	40.6920711699308	0.0153358236809219	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2650.42618000565	2650.42618000565
"healthy-4"	"2019-08-01-count-4:TGTGCGGCAGTGGGTA"	-4.21949801865275	12.1747331389221	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGCGGCAGTGGGTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2035.34728779024	44.0102799163339	0.0216229830556905	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2033.62974854967	2033.62974854967
"healthy-4"	"2019-08-01-count-2:TCCTGCACAGCTACCG"	-2.50954828682597	9.15364453876344	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCACAGCTACCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2092.57747809964	46.6827525550148	0.0223087331501864	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.83240525151	2090.83240525151
"healthy-4"	"2019-08-01-count-2:TAGTGCATCGGAAACG"	10.4016004997188	6.72648570621339	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCATCGGAAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.27748197134	42.3342633949337	0.0224909790402403	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.48439237806	1875.48439237806
"healthy-4"	"2019-08-01-count-4:AACAGGGGTACCGTCG"	0.36222149905507	7.7743201025757	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGGTACCGTCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.37114332344	46.3467225145349	0.0237143915437278	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1949.74973089904	1949.74973089904
"healthy-4"	"2019-08-01-count-3:TCACGGGCAAACGGCA"	-2.29867635193523	8.96165845477907	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGGGCAAACGGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2061.55735399012	43.8751229403144	0.0212825138507035	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2056.85604257657	2056.85604257657
"healthy-4"	"2019-08-01-count-2:GTGCTGGTCGAGCACC"	-6.23071036759074	-3.47735598003539	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTGGTCGAGCACC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3422.22795073617	40.8800711567436	0.0119454553423157	4458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3414.51368644751	3414.51368644751
"healthy-4"	"2019-08-01-count-3:TCACTATAGGTAGGCT"	-3.31670461121257	-5.58967592632445	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTATAGGTAGGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2387.617966051	51.2475554400382	0.0214638841593235	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2378.75972991209	2378.75972991209
"healthy-4"	"2019-08-01-count-2:CTTTCAATCGCTTGCT"	4.03713430938069	-6.73639395153197	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCGCTTGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.83142623876	45.8918254586784	0.018365314673409	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.24587871443	2495.24587871443
"healthy-4"	"2019-08-01-count-2:CTTTCAATCGCACGGT"	10.4181667762691	7.74867341602174	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTTCAATCGCACGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.87937088059	48.2671075063239	0.0237783132331577	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2016.33463307532	2016.33463307532
"healthy-4"	"2019-08-01-count-2:GAAACCTAGCGGCTCT"	10.8018595176632	6.14604852283327	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTAGCGGCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1756.29640601693	50.9217578071183	0.0289938290784314	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1747.27324733082	1747.27324733082
"healthy-4"	"2019-08-01-count-3:GCAGGCTCACAGCATT"	-1.74869082394298	3.734756685141	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGGCTCACAGCATT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3025.04808397683	42.9173153779531	0.014187316758791	5143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3017.42141560011	3017.42141560011
"healthy-4"	"2019-08-01-count-4:TGTTACTAGGAGTACC"	-2.63626418533977	-5.81674721157225	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTACTAGGAGTACC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2340.39709481708	52.1766619020018	0.0222939355110077	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2338.25205633161	2338.25205633161
"healthy-4"	"2019-08-01-count-4:GAAGAATCAAACACGG"	-0.0671556619113267	7.53121898258058	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATCAAACACGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.14041802453	42.7763808660001	0.021312101775172	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1997.60634374206	1997.60634374206
"healthy-4"	"2019-08-01-count-2:TTCCTCTTCCACTGGG"	10.9201456504757	6.60691783511964	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTCTTCCACTGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2209.4695121147	43.697009891576	0.0197771499683439	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2204.3462422192	2204.3462422192
"healthy-4"	"2019-08-01-count-2:GATTTCTCAACTGTGT"	10.677528043359	5.87830636585084	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTCAACTGTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2176.72567165321	43.1877518376215	0.0198406957753297	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2172.37061536727	2172.37061536727
"healthy-4"	"2019-08-01-count-3:AGTTCCCAGGTCTTTG"	4.77310146865193	-7.18979790126952	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCAGGTCTTTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2628.36700183252	43.9460204322037	0.0167198950533028	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2621.54703023704	2621.54703023704
"healthy-4"	"2019-08-01-count-2:AACCTGAGTGTTCCTC"	9.66949715194051	6.57681844318239	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTGAGTGTTCCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.38468410667	45.0579593722672	0.0237599257945351	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1888.83554505459	1888.83554505459
"healthy-4"	"2019-08-01-count-3:TCAGCAACATAGGCGA"	9.51596893843953	7.23529670322267	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAACATAGGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1617.49463786762	50.3369279853524	0.0311203059391361	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1611.07844328821	1611.07844328821
"healthy-4"	"2019-08-01-count-3:TCAGCAAGTGTTAAAG"	4.77487148818318	-7.34245397960814	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAAGTGTTAAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.20285587588	43.9980726104902	0.016979787016952	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.36792940371	2584.36792940371
"healthy-4"	"2019-08-01-count-3:ACTTCGCTCCGCGGAT"	11.4719034629757	3.98862955653993	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCTCCGCGGAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2057.60390188006	35.7888189245636	0.0173934443319547	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2047.8381470629	2047.8381470629
"healthy-4"	"2019-08-01-count-2:ACGTAACTCCTCAGAA"	-0.466235141188461	7.76867101276246	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCCTCAGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2076.6998989723	41.279675073673	0.0198775350709562	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2071.25367413611	2071.25367413611
"healthy-4"	"2019-08-01-count-4:CAAGACTGTCGAAGCA"	10.274822850793	7.28502843463746	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTGTCGAAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1698.87233238341	39.6555362990549	0.0233422697769294	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1684.32352326164	1684.32352326164
"healthy-4"	"2019-08-01-count-4:CCAATTTAGTTCGCAT"	4.90663113173787	-7.66049911892089	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTAGTTCGCAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2797.73727583083	42.4315951016461	0.0151663973126446	2220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2795.01337922864	2795.01337922864
"healthy-4"	"2019-08-01-count-2:GTGGCGTCACACCAGC"	3.67494406279866	-6.4622578850952	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGCGTCACACCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.55203395131	43.193603994193	0.0173778715569787	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2483.18435736874	2483.18435736874
"healthy-4"	"2019-08-01-count-3:CCCATTGTCCTTCTAA"	0.153258410363835	7.6121730574402	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCATTGTCCTTCTAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1931.29757066625	43.0938933687936	0.0223134404678649	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1924.78094021628	1924.78094021628
"healthy-4"	"2019-08-01-count-3:ACTTTGTAGCAACTTC"	0.631082554429215	7.93453357303468	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTGTAGCAACTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1939.40109094089	43.9763643436774	0.022675229249429	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1935.2414988779	1935.2414988779
"healthy-4"	"2019-08-01-count-4:GTTCATTAGACCACGA"	3.13222565230672	-6.52759554302367	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTAGACCACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.39473366377	42.8146363494459	0.0205307108809209	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2082.45090714415	2082.45090714415
"healthy-4"	"2019-08-01-count-3:ACTTTGTCATGGGAAC"	-3.41771064224895	3.4286420115265	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTGTCATGGGAAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3341.24733902298	43.8149965534348	0.0131133651920085	5740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3332.80784902791	3332.80784902791
"healthy-4"	"2019-08-01-count-4:CTTACCGGTCACAGTT"	6.72236933287923	-1.64753451263579	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTACCGGTCACAGTT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2955.58117332524	43.6535552421173	0.0147698718736268	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2946.64183399978	2946.64183399978
"healthy-4"	"2019-08-01-count-3:AGAAATGTCCGTGGCA"	-2.63911304894145	3.44464323604432	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAAATGTCCGTGGCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3129.14015164927	46.4439419218623	0.0148423974865374	4735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3120.4544794966	3120.4544794966
"healthy-4"	"2019-08-01-count-2:GAACGTTAGGCTGGAT"	11.4230591255123	4.50529859149782	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTAGGCTGGAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2295.56572926093	38.3668663884036	0.0167134688845333	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2291.25237949198	2291.25237949198
"healthy-4"	"2019-08-01-count-3:TCAGCCTGTACCGGCT"	-1.26788793030437	8.60053823078004	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCCTGTACCGGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2020.78901267681	48.4181537365349	0.0239600242443908	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.85409219776	2015.85409219776
"healthy-4"	"2019-08-01-count-2:GTGGTTAGTCCCTGTT"	10.2249580818111	7.02110574329225	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGTTAGTCCCTGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.77420993451	51.4864141376011	0.0264606313901827	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.90598538539	1937.90598538539
"healthy-4"	"2019-08-01-count-4:TCAGCCTTCGATGGAG"	-1.86059210720714	3.40186474407045	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCCTTCGATGGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2810.44472992747	45.2479273410874	0.0160999171623116	4043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2804.48247407006	2804.48247407006
"healthy-4"	"2019-08-01-count-3:TCAGGGCCATCGGAGA"	-2.52082453194316	9.32637975299684	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGGCCATCGGAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.54023753475	36.8916295748472	0.0184408335721897	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1990.93701911357	1990.93701911357
"healthy-4"	"2019-08-01-count-4:GCAACCGGTCTGTGCG"	4.96066155013387	-7.70897581493529	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACCGGTCTGTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.06572224067	45.749871375067	0.0204417014748181	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2236.48760062468	2236.48760062468
"healthy-4"	"2019-08-01-count-3:AGAACCTAGATCCTAC"	-0.282036553055602	7.76784226978151	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACCTAGATCCTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.75219745772	40.985138946549	0.0219670859840848	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1855.7593907042	1855.7593907042
"healthy-4"	"2019-08-01-count-3:CCCTAACTCCCGAAAT"	4.41719784316365	-6.64002182399901	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTAACTCCCGAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.59920162431	45.2883101636591	0.0179530343680827	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2515.00896510742	2515.00896510742
"healthy-4"	"2019-08-01-count-3:ATACTTCAGTAGGGTC"	4.14795794066731	-6.49450447475585	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACTTCAGTAGGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.33939499876	46.1219067302778	0.018365461403635	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2510.10419213694	2510.10419213694
"healthy-4"	"2019-08-01-count-2:GTGTCCTAGCCGGAAT"	-5.39742074433024	-4.96029426967772	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTAGCCGGAAT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2905.2677059203	38.797649652487	0.0133542425620283	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2901.79757259121	2901.79757259121
"healthy-4"	"2019-08-01-count-2:TGGAACTGTTATGGTC"	4.72262873229329	-6.97966005718382	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAACTGTTATGGTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.77870591654	47.0551948364986	0.0177047075935058	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2654.69107476348	2654.69107476348
"healthy-4"	"2019-08-01-count-2:GCACTAAAGTTGGCTT"	9.96799816664998	7.35553691470949	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAAAGTTGGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.06644834917	53.0685491309611	0.0262967303055717	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2012.20254967491	2012.20254967491
"healthy-4"	"2019-08-01-count-4:GTTCTATCACAAATCC"	4.95868887481038	-7.55987932598265	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCTATCACAAATCC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2741.28015507959	45.8306821560887	0.0167187151853723	1862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2733.19348061833	2733.19348061833
"healthy-4"	"2019-08-01-count-2:TGGAGGAAGTCAGGGT"	4.98874344405476	-7.46003296291503	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGAAGTCAGGGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.0339043153	45.2093064159458	0.0178197486202484	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2532.36378328978	2532.36378328978
"healthy-4"	"2019-08-01-count-3:TCAGTGAAGCATTGTC"	4.57124056395833	-7.82078363811644	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGAAGCATTGTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2492.84276778718	38.2792558298353	0.0153556639530116	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2490.05826829687	2490.05826829687
"healthy-4"	"2019-08-01-count-4:CAATCGACAAGCACCC"	-0.0436075356906236	7.89633796298829	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAATCGACAAGCACCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2092.18442414613	44.4369674306625	0.0212395078167157	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2076.36226997002	2076.36226997002
"healthy-4"	"2019-08-01-count-2:GTGTCCTTCCATACTT"	2.15846457061116	-6.10290148174437	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTTCCATACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.63807350183	43.8415417629989	0.0169361419086645	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.33337401447	2584.33337401447
"healthy-4"	"2019-08-01-count-2:TGGAGGAAGTCCTGTA"	10.862360616296	6.42675111377565	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGAAGTCCTGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1860.17992059716	47.6733540083228	0.025628356418888	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1860.17992059716	1860.17992059716
"healthy-4"	"2019-08-01-count-2:GAAGAATCATTGTCGA"	-2.12936792793925	9.05111215198366	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGAATCATTGTCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1823.95515840227	42.4149589909923	0.0232543869270046	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1820.10281952643	1820.10281952643
"healthy-4"	"2019-08-01-count-4:CGTAATGCATGACTAC"	4.09220900115315	-6.47093775188597	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAATGCATGACTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.87043178302	47.2731805417029	0.0176532740272376	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2675.56473549558	2675.56473549558
"healthy-4"	"2019-08-01-count-2:CATACCCTCATCTGTT"	10.5933567481929	7.2249488600525	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACCCTCATCTGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.9891705223	49.7732672916656	0.0247629529659266	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.77648566473	2006.77648566473
"healthy-4"	"2019-08-01-count-4:CTTCCTTTCCGAGGCT"	-3.28162608566936	9.8550987013611	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTTCCGAGGCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2122.99714639889	46.1821328687731	0.0217532712877683	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2117.59769587621	2117.59769587621
"healthy-4"	"2019-08-01-count-2:ACTATCTAGTCGAAAT"	11.3926121192867	3.87328550899354	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTAGTCGAAAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1701.20682626043	29.1960255684658	0.0171619494571651	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1673.90356701157	1673.90356701157
"healthy-4"	"2019-08-01-count-3:TCATACTGTGAGTGAC"	2.6758095222408	-6.2370290986267	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATACTGTGAGTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.65787710972	46.1893083536518	0.019144574451221	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2407.89363103778	2407.89363103778
"healthy-4"	"2019-08-01-count-4:TTACCATCAGCGCTTG"	-0.476786772639114	7.84446761691896	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCATCAGCGCTTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2084.49724316177	46.3544098293297	0.0222376930367244	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2079.65885230857	2079.65885230857
"healthy-4"	"2019-08-01-count-3:CCCTGATCAAGACCGA"	0.102006753056687	7.90986631000368	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATCAAGACCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.61900407191	43.4763699840777	0.0233917601664616	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1845.05015887033	1845.05015887033
"healthy-4"	"2019-08-01-count-2:TGGATCAGTTTGGAAA"	0.343941618769807	8.07203672015993	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCAGTTTGGAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1705.21354209459	37.9651718108706	0.0222641744706275	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1700.16113918967	1700.16113918967
"healthy-4"	"2019-08-01-count-4:AACTTCTCAACCGACC"	4.53610434111897	-7.32649853145751	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACTTCTCAACCGACC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2906.44285877025	41.0540248145633	0.0141251787182679	2386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2898.00123080028	2898.00123080028
"healthy-4"	"2019-08-01-count-2:GTGTTAGTCTACCTTA"	-4.15232263031657	-5.69483234798583	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTTAGTCTACCTTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2277.69321384131	50.8980061564512	0.0223462957377881	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2274.80238499949	2274.80238499949
"healthy-4"	"2019-08-01-count-4:GTTGCTCTCCCTTTGG"	-5.72450051727946	-5.42600157177123	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCTCTCCCTTTGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2998.33543108536	50.4800653603472	0.0168360300308608	2533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2988.92899047882	2988.92899047882
"healthy-4"	"2019-08-01-count-4:GCAGCCATCCTGTAAG"	-3.02294598046001	9.5859336622986	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGCCATCCTGTAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.84381929599	47.6155532484492	0.024184525345172	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1965.50952047283	1965.50952047283
"healthy-4"	"2019-08-01-count-3:GCCAGTGAGACTCAAA"	3.33960237082784	-6.63669683849486	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGAGACTCAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.78878545167	44.8796308274317	0.0191728664740556	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2338.04855933702	2338.04855933702
"healthy-4"	"2019-08-01-count-3:CTACTATGTGCCCAGT"	10.2736069160396	7.74096009815065	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACTATGTGCCCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2565.57358328028	50.5862269765384	0.0197173167459341	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2552.34261936528	2552.34261936528
"healthy-4"	"2019-08-01-count-3:CCGAACGTCACACCCT"	4.11586823043172	-7.00171759044798	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGAACGTCACACCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2792.12469663465	46.5426568847488	0.0166692615630121	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2786.30987657919	2786.30987657919
"healthy-4"	"2019-08-01-count-1:CAATGACCAAGTTGGG"	9.84368958052937	6.90686509692994	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CAATGACCAAGTTGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1707.87714951088	29.1027718871242	0.0170403192615224	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1697.45338197038	1697.45338197038
"healthy-4"	"2019-08-01-count-3:CTAGACAAGACGGAAA"	4.70280041274373	-7.05839588558348	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGACAAGACGGAAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2712.00461290788	42.2860389867294	0.0155921707453843	2121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2705.71598006385	2705.71598006385
"healthy-4"	"2019-08-01-count-2:GAAGGGTTCAGCTTGA"	-7.64843831482585	1.11964068496553	"2019-08-01-count-2"	"Control4"	"MEP"	"MEP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTTCAGCTTGA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2963.74474449357	41.9316294968334	0.0141481919368189	3791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2956.6420873217	2956.6420873217
"healthy-4"	"2019-08-01-count-4:AAGATAGAGTCGGCCT"	11.3728729682857	4.82409331882326	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGATAGAGTCGGCCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2039.75954704788	40.0537092818031	0.0196364857513584	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2033.21880537456	2033.21880537456
"healthy-4"	"2019-08-01-count-3:CCGATCTTCGCAGTCG"	4.74530472335164	-7.55791618740233	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATCTTCGCAGTCG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.13334921178	45.9026654057114	0.0168010340413854	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2728.09389596198	2728.09389596198
"healthy-4"	"2019-08-01-count-4:GTTGTGAAGTGGATTA"	-0.349053571850616	8.04001996600953	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTGAAGTGGATTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2272.27705955104	44.5887265886976	0.0196229268791313	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2260.86306973722	2260.86306973722
"healthy-4"	"2019-08-01-count-4:TTACGTTCAGGATCTT"	2.92180933532063	-5.89604093944701	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACGTTCAGGATCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.88058490944	44.3985880830745	0.0168439300085363	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2630.36661913761	2630.36661913761
"healthy-4"	"2019-08-01-count-4:GTTGTGACACCTAAAC"	14.3050857978756	2.04730043495027	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTGACACCTAAAC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1270.20373139243	44.611919633532	0.0351218615809191	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1254.43972944085	1254.43972944085
"healthy-4"	"2019-08-01-count-4:CTTGAGAAGTCCTGCG"	3.17155088958089	-6.58607151424559	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGAGAAGTCCTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.03094577111	42.2514509576527	0.0189295990889839	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2224.81490134487	2224.81490134487
"healthy-4"	"2019-08-01-count-2:GAAGTAACACCTGCTT"	-0.233805010945159	7.73915145480958	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGTAACACCTGCTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.79719861362	44.2024717408525	0.0225891941035943	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1949.84851835534	1949.84851835534
"healthy-4"	"2019-08-01-count-4:GTTTACTAGAGCCGAT"	0.0989412079447925	7.71409938419191	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTAGAGCCGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1999.58482623209	39.2153674555778	0.0196117548708714	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1994.96018862867	1994.96018862867
"healthy-4"	"2019-08-01-count-4:CACACAATCGTAACCA"	5.62701763686482	-9.77512934124144	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACACAATCGTAACCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2921.37982040377	43.4855705624566	0.0148852847749344	2388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2909.47480107675	2909.47480107675
"healthy-4"	"2019-08-01-count-2:GTTACCCTCACCTTAT"	0.0256960886413276	8.44116304004518	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCTCACCTTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.85681175291	43.4336857581539	0.0226233985223602	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1909.98011184609	1909.98011184609
"healthy-4"	"2019-08-01-count-2:GTTACGAAGTCTAGAA"	2.68594827231709	-5.94880726253661	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACGAAGTCTAGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.13991569683	48.128699820672	0.0194291406455066	1743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2474.9871232049	2474.9871232049
"healthy-4"	"2019-08-01-count-2:TCGGATATCAGCTTCC"	10.0764795738155	7.25189254367677	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATATCAGCTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.8052978027	46.9270080668978	0.0268644754661136	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1740.73853011827	1740.73853011827
"healthy-4"	"2019-08-01-count-4:CTTGATTGTTCGGTTA"	4.89836611327474	-7.26562693035277	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTGATTGTTCGGTTA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.40342239201	45.3919115268463	0.0184190263308382	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2460.5963198214	2460.5963198214
"healthy-4"	"2019-08-01-count-3:CCGGACAAGACGCCCT"	-4.00912032547649	11.8239164122376	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACAAGACGCCCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1819.33533873757	45.4705743320079	0.0249929594417485	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1817.45393782274	1817.45393782274
"healthy-4"	"2019-08-01-count-3:TCATGGACAAGTGGTG"	-3.69749556008037	-5.44053175365599	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATGGACAAGTGGTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2760.52429043002	49.1870724446869	0.0178180183435462	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2756.53747655081	2756.53747655081
"healthy-4"	"2019-08-01-count-4:CTTTCAAGTAGTCTTG"	-1.95017800751384	10.526545501593	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAAGTAGTCTTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1828.78298119376	46.0216923397051	0.0251652015646295	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1822.09332388521	1822.09332388521
"healthy-4"	"2019-08-01-count-3:CCGGACATCTTTGCTA"	-3.05146084252055	-5.67917063152465	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACATCTTTGCTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2586.0031015006	49.7419180629128	0.0192350573880011	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2582.8099211726	2582.8099211726
"healthy-4"	"2019-08-01-count-4:GGTTGTACATCTGTTT"	2.96492471274678	-6.05738022243651	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTGTACATCTGTTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2752.35552524233	43.5997949842012	0.0158409023050765	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2751.48265290966	2751.48265290966
"healthy-4"	"2019-08-01-count-3:GCCCGAAAGTACGTCT"	2.1963025527889	-6.01662495052489	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCCGAAAGTACGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.05872849224	49.7139655948855	0.0202661130846394	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2448.47288175782	2448.47288175782
"healthy-4"	"2019-08-01-count-2:GAATCGTTCATTACGG"	-1.30459962311443	8.4069032439026	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCGTTCATTACGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.33807514816	42.2723379337915	0.0206273130072672	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2044.38813074732	2044.38813074732
"healthy-4"	"2019-08-01-count-4:TCATGTTGTTCCCACT"	3.30424584922139	-6.19110586559447	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGTTGTTCCCACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.52684637796	40.0648367820022	0.0155138123106808	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2577.11972751077	2577.11972751077
"healthy-4"	"2019-08-01-count-2:TTGATGGCACTCTAGA"	-3.77534900131877	9.69552133167116	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGCACTCTAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2131.70453242667	41.0797685018017	0.0192708547910426	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2126.68004486075	2126.68004486075
"healthy-4"	"2019-08-01-count-3:GCCGATGAGAGTGGCT"	0.310545106499833	7.86450812900392	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGATGAGAGTGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1905.96885887326	40.8805815785693	0.0214487143314275	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1899.71683505555	1899.71683505555
"healthy-4"	"2019-08-01-count-4:CTTTCGGGTTTCGCTC"	-4.2701452774113	12.1055812605652	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGGTTTCGCTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1937.58086719032	45.3954256475326	0.0234289192344061	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1933.74905263994	1933.74905263994
"healthy-4"	"2019-08-01-count-4:CTTTCGGTCAGGTAAA"	5.15208210524861	-7.55706932460936	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCGGTCAGGTAAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2801.44782451195	40.3481564885427	0.0144026085852846	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2797.63733098119	2797.63733098119
"healthy-4"	"2019-08-01-count-2:TGGGTTAGTTAGCGGA"	11.2429377036983	5.64042041385499	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGTTAGTTAGCGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2096.84886433555	42.2727379871749	0.0201601263239209	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2092.21452862812	2092.21452862812
"healthy-4"	"2019-08-01-count-2:GCCAACGGTTAAGCAA"	10.4649273353512	7.60747191989747	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGGTTAAGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2125.99061197016	46.6449747566876	0.0219403484164314	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2116.34839680061	2116.34839680061
"healthy-4"	"2019-08-01-count-2:GCCAACGTCTTCGGAA"	-3.81948361817058	-5.78003218090209	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGTCTTCGGAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2230.37904762777	51.0992444000194	0.0229105651141982	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2228.9489774547	2228.9489774547
"healthy-4"	"2019-08-01-count-3:GCCGTGACAAGCTGTT"	3.31812157210652	-6.4998555413452	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCGTGACAAGCTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.17224609819	50.6966347421955	0.0211573415996063	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2389.57556227123	2389.57556227123
"healthy-4"	"2019-08-01-count-4:TAACGACCACATGTTG"	0.640105743973893	8.01946113193361	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACGACCACATGTTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1918.38244661373	42.7121240444996	0.022264655371453	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1903.03960252313	1903.03960252313
"healthy-4"	"2019-08-01-count-3:AGAGAGCTCACCTTGC"	11.2487694221431	-2.65067341243895	"2019-08-01-count-3"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGAGCTCACCTTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1678.58120736053	28.8059180726284	0.0171608724953641	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	1675.7015825091	1675.7015825091
"healthy-4"	"2019-08-01-count-4:TAACGACGTAAGCTCT"	3.00887813147847	-6.36754324352416	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACGACGTAAGCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.80253820908	50.3222265250702	0.0199469541364873	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2517.04377516751	2517.04377516751
"healthy-4"	"2019-08-01-count-3:AGAGCAGCATCCGGCA"	-0.621368507773238	8.3059453734192	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCAGCATCCGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2140.39005818712	43.2579858117401	0.0202103283213616	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2131.80338336087	2131.80338336087
"healthy-4"	"2019-08-01-count-4:CACGGGTAGGTAGCCA"	10.2379375892574	6.56000278079835	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACGGGTAGGTAGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.5523341338	47.9115464126572	0.0260169344767457	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1841.5523341338	1841.5523341338
"healthy-4"	"2019-08-01-count-3:TCATTGTCACTGCACG"	10.8621565299923	6.08886811817018	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTCACTGCACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.62635827005	47.8007184331692	0.0232989395171717	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2045.17442977519	2045.17442977519
"healthy-4"	"2019-08-01-count-3:AGAGCCCCATGTCGTA"	3.06105794486348	-6.14164497768553	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCCCCATGTCGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.95078811414	44.0998606712286	0.0174311140273607	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.90082991274	2526.90082991274
"healthy-4"	"2019-08-01-count-3:TCATTGTTCCCATAGA"	11.2183042961055	5.62675855243532	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTTCCCATAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2263.10945004081	40.8872947406261	0.0180668658070818	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2254.22247040042	2254.22247040042
"healthy-4"	"2019-08-01-count-3:CCGTTCACATCCTATT"	-0.910742263228256	8.3846921690735	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGTTCACATCCTATT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2114.74167302536	44.5933391805092	0.021086896687818	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2107.49989561607	2107.49989561607
"healthy-4"	"2019-08-01-count-4:TTCAGGAAGGCGACAT"	10.2310749488765	7.10679528796998	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAGGAAGGCGACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.51625746395	43.2837018817703	0.0210778471923202	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2050.71644576395	2050.71644576395
"healthy-4"	"2019-08-01-count-3:TCATTGTTCTTTCCAA"	4.18242992934529	-6.52117350017699	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTTCTTTCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.0345060112	43.5338473669811	0.0177324788146104	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2447.07117924446	2447.07117924446
"healthy-4"	"2019-08-01-count-4:TTCAGGAGTCTGTCCT"	3.10578550872151	-6.33359434520873	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCAGGAGTCTGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.98300567631	44.1668126463294	0.018049497092491	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2444.52930521468	2444.52930521468
"healthy-4"	"2019-08-01-count-3:CCTAACCCACTCTAGA"	3.14124145087544	-6.20371534740599	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAACCCACTCTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.69933856971	45.6938640915234	0.0175361229959114	1739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2603.38803808316	2603.38803808316
"healthy-4"	"2019-08-01-count-2:CATGAGTCAGTCTTCC"	4.62682451781575	-6.86371233379515	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATGAGTCAGTCTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2784.66183260382	43.203487474465	0.0155148057723286	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2780.90985485092	2780.90985485092
"healthy-4"	"2019-08-01-count-3:AGATCCAAGTGGATAT"	2.63161053237264	-5.98836805736693	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCCAAGTGGATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.34193842775	43.3450268397267	0.0173217841151481	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2501.3945937472	2501.3945937472
"healthy-4"	"2019-08-01-count-2:GACCCTTAGACAGTCG"	-1.18126116219218	8.76897714221803	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTAGACAGTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2039.52285658675	41.4539563482502	0.020325320804507	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2033.19560503841	2033.19560503841
"healthy-4"	"2019-08-01-count-3:TCCACCAAGGAGGGTG"	5.65420450743977	-9.79735090648802	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACCAAGGAGGGTG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.21974273891	44.837737949299	0.0172637444616123	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.02459690735	2589.02459690735
"healthy-4"	"2019-08-01-count-2:TCGTGCTCAGAGTGTG"	11.3406235176021	4.2302036055359	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTCAGAGTGTG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1764.24147634557	39.7385682477281	0.0225244496178846	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1755.545689772	1755.545689772
"healthy-4"	"2019-08-01-count-4:CCCTGATGTCGACTTA"	-0.283659527928191	7.82696626270143	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATGTCGACTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2076.32055512924	36.9192017793085	0.0177810703111835	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2071.74305055968	2071.74305055968
"healthy-4"	"2019-08-01-count-2:TGTAACGTCCACACAA"	-8.18944487991985	0.445780820492186	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGTCCACACAA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2810.18386608221	43.0896828867097	0.0153334034141982	3625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2796.06899806865	2796.06899806865
"healthy-4"	"2019-08-01-count-2:GACCCTTCATCTAGAC"	4.11323847350423	-6.45246841823729	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTCATCTAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.02237960978	43.819093236921	0.0178414877652227	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2451.01760417966	2451.01760417966
"healthy-4"	"2019-08-01-count-4:TTCATTGCAGTCAGTT"	11.4531837898189	4.24333665454713	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATTGCAGTCAGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2133.13541875414	41.2953988368009	0.0193590141881004	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2112.05187732044	2112.05187732044
"healthy-4"	"2019-08-01-count-4:CCCTTAGCACGAAAGC"	4.6606875854427	-7.48356153881224	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTTAGCACGAAAGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.39921622253	44.3865325939301	0.0168169075451403	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2634.49197567274	2634.49197567274
"healthy-4"	"2019-08-01-count-2:AGTGCCGCAGAGGCAT"	9.7414137321407	6.89486072147218	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTGCCGCAGAGGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2079.82020732166	46.7576117070521	0.022481564292168	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.1057278016	2077.1057278016
"healthy-4"	"2019-08-01-count-4:GAAGAATAGCACCTGC"	10.638125081628	6.56220672214357	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATAGCACCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1956.38813069339	39.6980588089211	0.0202915046284047	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1948.51861082452	1948.51861082452
"healthy-4"	"2019-08-01-count-3:AGATGCTCAGAGGTAC"	10.743931432336	7.82479283893434	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGCTCAGAGGTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2957.18637727327	35.3822938978888	0.0119648508358522	2763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2946.57106081215	2946.57106081215
"healthy-4"	"2019-08-01-count-2:GTTGAACGTGTGCCTG"	3.02319349822347	-6.64060690319213	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTGAACGTGTGCCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.95181093821	47.5995529260624	0.0222121434010328	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2138.43928744232	2138.43928744232
"healthy-4"	"2019-08-01-count-3:CCTACGTTCTCGCTTG"	4.62818207320516	-6.74792435085448	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTACGTTCTCGCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.98719128175	46.3183147338873	0.0184169187399644	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2511.25706062458	2511.25706062458
"healthy-4"	"2019-08-01-count-3:TCCACGTTCTCCTACG"	2.69356646117513	-6.21516611492308	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCACGTTCTCCTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.88360376688	45.7105273529973	0.0172305061888476	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2647.75193925275	2647.75193925275
"healthy-4"	"2019-08-01-count-1:TGGTAGTTCGCCGATG"	0.378304888575715	7.81316707218019	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGGTAGTTCGCCGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2120.26534800791	42.9761996062428	0.0202692552828923	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2109.53152992043	2109.53152992043
"healthy-4"	"2019-08-01-count-1:TGTAAGCTCGCCAGTG"	11.1298891502315	5.88074920261232	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TGTAAGCTCGCCAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2087.66054076336	44.7170850644483	0.0214197108156757	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2076.4586036996	2076.4586036996
"healthy-4"	"2019-08-01-count-3:TCGCTTGGTCCATACA"	-3.9020987552708	12.8006229170593	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGGTCCATACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2046.86349876933	46.2387551110102	0.0225900530928473	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2044.93852051845	2044.93852051845
"healthy-4"	"2019-08-01-count-3:CTCCAACAGCGATGCA"	3.05711926993672	-6.40910580074462	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACAGCGATGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.83598615483	43.5943550764178	0.0192824049791254	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2256.2105459288	2256.2105459288
"healthy-4"	"2019-08-01-count-3:CTCCAACTCACTCACC"	0.14465588805024	7.75831077182619	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCAACTCACTCACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.65410180006	42.549702093289	0.0210157883539017	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2013.29478279292	2013.29478279292
"healthy-4"	"2019-08-01-count-2:GCCCGAACAATACGCT"	6.79507269439046	-1.72693874752196	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCCGAACAATACGCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3007.09583060271	34.9092982972506	0.0116089743273176	2682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2995.0440159437	2995.0440159437
"healthy-4"	"2019-08-01-count-3:CAGAGCCAGGATGTTA"	5.52283873137776	-9.99925806438597	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGAGCCAGGATGTTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.96659081042	48.6751842946536	0.0192546786304835	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2523.42118706043	2523.42118706043
"healthy-4"	"2019-08-01-count-3:CAGAGCCAGTTGCTCA"	10.3726946311886	6.29523894870607	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGAGCCAGTTGCTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.23432294642	48.5107666976788	0.0274345803993019	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1762.91401664283	1762.91401664283
"healthy-4"	"2019-08-01-count-2:TCTACCGGTTAGGGAC"	-3.35869322243388	-5.50157167827757	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACCGGTTAGGGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2269.05678726891	50.5488497976917	0.0222774723318112	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2267.78727586059	2267.78727586059
"healthy-4"	"2019-08-01-count-3:GTATTTCGTGGACCAA"	11.2754045921261	4.74451396549074	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTATTTCGTGGACCAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1754.07788801226	50.39644645042	0.0287310197539345	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1740.19359877038	1740.19359877038
"healthy-4"	"2019-08-01-count-3:CCTCAACGTTGCGAAG"	11.3105045753414	4.95638988101808	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAACGTTGCGAAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2151.63758484756	44.0629921724861	0.0204788169173053	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2138.01947993315	2138.01947993315
"healthy-4"	"2019-08-01-count-2:TTGGGTAAGGACTTCT"	10.072038312524	6.20389316165773	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGTAAGGACTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1837.62114391868	46.7653565686242	0.0254488563779247	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1830.60150380426	1830.60150380426
"healthy-4"	"2019-08-01-count-2:TGTCCCAGTCTGCATA"	4.40602507170979	-6.63317253505858	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCCAGTCTGCATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.28821486329	43.1143498725005	0.0163666031792721	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2627.07965217883	2627.07965217883
"healthy-4"	"2019-08-01-count-4:TTCCGTGCAGCCGGTT"	2.45009173926656	-6.1826644173828	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGCAGCCGGTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2657.6665898088	47.5582529230367	0.017894740109766	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2647.60911185332	2647.60911185332
"healthy-4"	"2019-08-01-count-2:GACGTTACAGCAAGAC"	10.6444851356441	6.26478288257448	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACGTTACAGCAAGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1942.76439881595	47.2314331664574	0.0243114570121027	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1934.58790438997	1934.58790438997
"healthy-4"	"2019-08-01-count-3:AGCCACGAGAGTCAAT"	2.86677946624104	-6.34546902095946	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGAGAGTCAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.10371409545	44.8240912634658	0.0176257425188847	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2539.74195192799	2539.74195192799
"healthy-4"	"2019-08-01-count-3:CCTCAGTGTAGAGACC"	-2.30458722534831	3.95785281741945	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCAGTGTAGAGACC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3293.27223143874	48.6624257952864	0.014776314369258	4524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3287.16362389849	3287.16362389849
"healthy-4"	"2019-08-01-count-4:TTCCGTGGTTTCACTT"	-3.36013112488444	9.51998517597047	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCGTGGTTTCACTT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2073.86687114286	42.9850663256846	0.0207270133506673	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2066.66079075024	2066.66079075024
"healthy-4"	"2019-08-01-count-4:GAATAGATCAGCGGAA"	3.41642918166463	-6.20756819164427	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATAGATCAGCGGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.27259469937	49.0826250698961	0.0207689223748392	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2363.27259469937	2363.27259469937
"healthy-4"	"2019-08-01-count-2:AGAACCTCATAGTCAC"	0.0795798945123374	7.92240378940431	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCATAGTCAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2190.96082583871	46.3104059718366	0.0211370305784033	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2185.3836222984	2185.3836222984
"healthy-4"	"2019-08-01-count-2:AGAACCTCAGCTTTCC"	3.79245080527608	-6.25314857875975	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAACCTCAGCTTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.39851838548	47.4692034782833	0.0191841383372863	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.02611012441	2470.02611012441
"healthy-4"	"2019-08-01-count-3:TCCCATGCAGGTTCCG"	2.61552252349202	-4.2088456383911	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGCAGGTTCCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3028.03756802692	37.2696818617894	0.0123081966536084	3437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3022.1023451822	3022.1023451822
"healthy-4"	"2019-08-01-count-4:TACCCACCAAGTGTCT"	2.40359558638875	-6.11624481594237	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCACCAAGTGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.11349420663	46.551307967133	0.0185528905227351	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2508.08749750136	2508.08749750136
"healthy-4"	"2019-08-01-count-2:GTTTGGAGTGTGAATA"	1.05450202998464	-6.73578312313231	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTGGAGTGTGAATA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1961.77108819798	45.3019198106255	0.0230923577593542	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	1956.30259945765	1956.30259945765
"healthy-4"	"2019-08-01-count-3:TCCCATGGTGCTGATT"	3.33638538894002	-6.38720419323119	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCCATGGTGCTGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.15804226224	41.0094738793868	0.0161508158203693	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2536.91669405296	2536.91669405296
"healthy-4"	"2019-08-01-count-3:CCTCCAAGTCACGACC"	-0.00594935837443474	7.69864699924318	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCCAAGTCACGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.93010371905	45.4363348999934	0.0235186225487799	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1919.67052966499	1919.67052966499
"healthy-4"	"2019-08-01-count-3:TGCTGAATCCTCACCA"	3.32782210883443	-6.26169159328612	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCTGAATCCTCACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.58424389009	34.8640512705879	0.0152672498787244	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2282.13592381404	2282.13592381404
"healthy-4"	"2019-08-01-count-1:GGGTCTGCACACCGCA"	11.171198506921	6.34574983203737	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGGTCTGCACACCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2230.53358758277	47.246831079286	0.0211818514378379	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2223.79207572797	2223.79207572797
"healthy-4"	"2019-08-01-count-3:AGCCAGCCACAAACGG"	11.1132656532222	6.40442226016847	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAGCCACAAACGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1993.20775397514	37.8204018540274	0.0189746411424501	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.17377687832	1987.17377687832
"healthy-4"	"2019-08-01-count-4:TCCCAGTGTATGCTTG"	4.95141615447347	-7.95305445110472	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTGTATGCTTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2743.63710989581	44.1340573878807	0.0160859675022972	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2738.99894289864	2738.99894289864
"healthy-4"	"2019-08-01-count-3:TCCGATCTCACCTTAT"	2.4863084751064	-5.92211773311766	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGATCTCACCTTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.49197941528	48.676165822169	0.0186320823970773	1817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2609.16953126277	2609.16953126277
"healthy-4"	"2019-08-01-count-3:TCCGAAAGTAGGTAGC"	4.65141834792439	-6.81007578289183	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGAAAGTAGGTAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.34969004836	45.3585164978236	0.0183166847073758	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.31266577795	2470.31266577795
"healthy-4"	"2019-08-01-count-2:GACTCTCTCGCCATAA"	0.0860440852934539	7.83454845035402	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCTCTCGCCATAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2178.90442729106	43.0120499497934	0.0197402187131578	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2168.10262651158	2168.10262651158
"healthy-4"	"2019-08-01-count-2:GACTGATGTGACAACG"	11.3347145515377	3.5255350836548	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATGTGACAACG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.54440865878	43.2254476071706	0.0239403957055147	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1795.60313801474	1795.60313801474
"healthy-4"	"2019-08-01-count-2:TGTGATGGTTATGGTC"	10.6632839637691	6.65713164890138	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGATGGTTATGGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1785.16845202428	41.9276070425198	0.023486639031166	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1781.61626070147	1781.61626070147
"healthy-4"	"2019-08-01-count-2:GACTGATCACCATTCC"	0.178829019039315	7.79485128009645	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATCACCATTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2234.06822177665	40.2794723388633	0.0180296518907694	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2225.18146307221	2225.18146307221
"healthy-4"	"2019-08-01-count-2:TCTCTGGGTTTAGTCG"	2.27482833442037	-5.89949610149535	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGGTTTAGTCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2563.63477219077	42.2161576784453	0.0164673057708487	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2558.97593360674	2558.97593360674
"healthy-4"	"2019-08-01-count-4:AGCATCAAGCACAAAT"	10.7802092033321	7.3684887656006	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCATCAAGCACAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2444.77393141026	44.4866718015684	0.018196640282362	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2438.36179432546	2438.36179432546
"healthy-4"	"2019-08-01-count-4:GACATCATCGCCATAA"	11.2211195426876	-3.11803295528563	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACATCATCGCCATAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2645.22888823135	38.2690972632061	0.0144672158365825	5022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2641.55495725336	2641.55495725336
"healthy-4"	"2019-08-01-count-2:GTAGAGGAGCCGTCGT"	11.6531931358272	4.07092044437257	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGAGGAGCCGTCGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2331.03225296364	34.1077958554657	0.0146320565972872	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2315.10274625153	2315.10274625153
"healthy-4"	"2019-08-01-count-4:ACAAAGAAGGATACCG"	11.4423433738643	4.27347514713136	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAAGAAGGATACCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.07635133916	41.8648736077852	0.0201653824440419	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2061.56484527351	2061.56484527351
"healthy-4"	"2019-08-01-count-2:TAACTTCTCGCCAGTG"	10.5457340675289	7.49255845630494	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCTCGCCAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2147.79647167231	36.7780231701417	0.0171236072203367	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2135.51267168794	2135.51267168794
"healthy-4"	"2019-08-01-count-2:TAACTTCTCCTGTACC"	2.81168999251668	-6.17648460781249	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAACTTCTCCTGTACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.31732942839	46.072427218722	0.0198560889212821	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2316.91245708493	2316.91245708493
"healthy-4"	"2019-08-01-count-4:CAGCAATTCGCCAGAC"	0.121651952236336	7.80978820407716	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGCAATTCGCCAGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.84691197274	45.7375989578017	0.0231249439382455	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.21773088606	1967.21773088606
"healthy-4"	"2019-08-01-count-4:TCCGAAATCCTACTGC"	6.77494015273396	-1.65186860477599	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGAAATCCTACTGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2806.37048246526	41.5027416962271	0.0147887607696647	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2786.55577493792	2786.55577493792
"healthy-4"	"2019-08-01-count-4:TTCGCTGCAACGTTAC"	-3.78236875954326	-5.42563440715941	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCGCTGCAACGTTAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2648.04502384554	45.7845708356799	0.0172899518034594	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2641.82852091977	2641.82852091977
"healthy-4"	"2019-08-01-count-4:GACCCTTCACGGTGCT"	-3.29921732369121	10.5242557295593	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCCTTCACGGTGCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2000.84370790799	49.9967918014516	0.0249878546754292	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1997.36051411008	1997.36051411008
"healthy-4"	"2019-08-01-count-2:CATTGTTGTTTCACTT"	4.73693623122518	-7.01396419918212	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTGTTGTTTCACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2766.71257930217	43.7045404806352	0.0157965597176916	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2761.25056092883	2761.25056092883
"healthy-4"	"2019-08-01-count-4:TACGGGCCAGGTTACT"	-4.77405486527141	3.56167671764223	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGGGCCAGGTTACT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2912.51816148964	39.5491290906718	0.0135790154422399	3252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2902.29726535507	2902.29726535507
"healthy-4"	"2019-08-01-count-3:TCCTCGATCCGATAGT"	1.89969029006307	-6.5721268883911	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCGATCCGATAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.10076692194	48.2687316355999	0.0198792127135602	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2425.88211796355	2425.88211796355
"healthy-4"	"2019-08-01-count-2:GAGAAATCACATACTG"	11.0528322654659	6.38520953739015	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATCACATACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1809.71061580169	49.0052843633592	0.027079072165165	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1801.49431203763	1801.49431203763
"healthy-4"	"2019-08-01-count-3:GGAAGTGAGATACAGT"	0.117918972938698	7.60046098316041	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAAGTGAGATACAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1877.19449404658	43.1719707420624	0.0229981341192828	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.48566086669	1866.48566086669
"healthy-4"	"2019-08-01-count-4:GACCGTGGTCGGAACA"	4.14881815490071	-7.37199118053588	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCGTGGTCGGAACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.6346986657	44.233523836695	0.0177243584008287	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2492.61044402816	2492.61044402816
"healthy-4"	"2019-08-01-count-2:GAGAAATGTGACCTGC"	3.10492744025533	-5.96945764934691	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATGTGACCTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.50051838614	47.2343483579016	0.0182477646894006	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.76070491115	2584.76070491115
"healthy-4"	"2019-08-01-count-3:CCTGTTGGTGGGTTGA"	2.80376734313313	-6.1545243493286	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGTTGGTGGGTTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.23784705062	45.9493244196845	0.0199498825006389	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2300.59140454148	2300.59140454148
"healthy-4"	"2019-08-01-count-3:AGCTCAAGTGTTGAGG"	-2.59155569496806	3.78653595531312	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTCAAGTGTTGAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3049.83588715178	45.6215280477567	0.0149586829376456	4007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3042.8162174275	3042.8162174275
"healthy-4"	"2019-08-01-count-3:AGCTTCCAGCGAGTCA"	4.57369436797444	-7.00523664867552	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCAGCGAGTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.72544907824	49.8687100487179	0.0197521318870234	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2519.96247667083	2519.96247667083
"healthy-4"	"2019-08-01-count-3:TCCTGCACACCAACAT"	-7.16287980499919	3.17002270305482	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTGCACACCAACAT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3131.64308146044	41.1943175296291	0.0131542185549504	3126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3109.80858651354	3109.80858651354
"healthy-4"	"2019-08-01-count-2:CCAAGCGCAGCTACTA"	-1.66708932343181	3.6734888323578	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCAAGCGCAGCTACTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2914.02362312448	43.0903422871037	0.0147872316288573	5176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2908.43696379009	2908.43696379009
"healthy-4"	"2019-08-01-count-4:ACAAGCTGTCCCAAAT"	-0.00286103683765534	7.58544108951417	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTGTCCCAAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2047.36646031096	47.6480938905247	0.023272870203846	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2038.78400796983	2038.78400796983
"healthy-4"	"2019-08-01-count-4:TACGTCCCACTCAGAT"	10.5035129981929	7.7351035841736	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCCACTCAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2102.5239019355	42.8714901151797	0.0203904888195154	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2089.3507165514	2089.3507165514
"healthy-4"	"2019-08-01-count-4:GACGCTGCAAGTGCAG"	-0.505041341215926	8.14600179279176	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGCTGCAAGTGCAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1953.12500206155	43.1200921823978	0.0220774871740845	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1947.38062421764	1947.38062421764
"healthy-4"	"2019-08-01-count-4:ACAAGCTGTTACCTGA"	-4.25113616409953	12.5864848860535	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAAGCTGTTACCTGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2160.78555787153	46.5943185138581	0.0215636014152907	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2157.33523331772	2157.33523331772
"healthy-4"	"2019-08-01-count-3:TCCTTCTAGGCTTCCG"	4.14890780028645	-6.54729940807494	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTAGGCTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.560092142	42.7795581076628	0.0160912511378275	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.37651235741	2656.37651235741
"healthy-4"	"2019-08-01-count-4:TACGTCCTCCGGACTG"	0.0449241917463064	7.96690175617067	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCTCCGGACTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.52282487528	49.754291886123	0.0251344875951394	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1970.43276632597	1970.43276632597
"healthy-4"	"2019-08-01-count-2:GAGAGGTAGTATAGGT"	10.8643747764522	6.0190014609131	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTAGTATAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.56905079139	41.9875428391531	0.0216478721507859	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.43747125107	1930.43747125107
"healthy-4"	"2019-08-01-count-4:CCTCAGTCAACCACGC"	-1.8574734729832	3.88871977413026	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCAGTCAACCACGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3006.57825703489	45.0868253931908	0.0149960591538555	5034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2997.88518070853	2997.88518070853
"healthy-4"	"2019-08-01-count-4:GCTTGGGCACCGCTGA"	0.353655715554398	8.03416488254396	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTGGGCACCGCTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1904.81849088321	46.6549699340935	0.0244931315804588	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1896.80734112609	1896.80734112609
"healthy-4"	"2019-08-01-count-4:TCCTAATGTGTAGGAC"	10.1759859519893	6.11176774585573	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATGTGTAGGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1835.20023841389	45.2795605570486	0.024672817499295	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1824.94432019382	1824.94432019382
"healthy-4"	"2019-08-01-count-2:TAATTCCAGCCTAACT"	2.61514796790425	-6.04960014736327	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAATTCCAGCCTAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2687.96662224255	47.6522836808806	0.0177280042417806	2093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2682.889862626	2682.889862626
"healthy-4"	"2019-08-01-count-4:GACGTTATCTTCTAAC"	-0.17928127470668	7.8217940100464	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTATCTTCTAAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2105.05743769739	44.7983420238774	0.0212812920073477	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2096.13315375961	2096.13315375961
"healthy-4"	"2019-08-01-count-3:TCCTTTCTCAGCTAGT"	10.2602068382198	6.52028224552003	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTTCTCAGCTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1836.17428618505	42.3393764251614	0.0230584736665322	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1827.60296271928	1827.60296271928
"healthy-4"	"2019-08-01-count-2:CCACAAAAGGAATTAC"	10.4604898887569	6.26604507053224	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACAAAAGGAATTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1761.99752762619	39.8134322711689	0.0225956232326879	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1751.01630734196	1751.01630734196
"healthy-4"	"2019-08-01-count-2:TACAACGCATACAGAA"	11.1400219398433	6.12207267368165	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAACGCATACAGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.21056935015	41.5239588647474	0.0213687386841633	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.30053695835	1937.30053695835
"healthy-4"	"2019-08-01-count-4:GATCCCTTCCATACTT"	0.419849325984162	7.85705611789552	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCCCTTCCATACTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2267.98044008712	43.0310662211564	0.0189732968858865	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2256.46945841899	2256.46945841899
"healthy-4"	"2019-08-01-count-2:GAGAGGTTCGCAGATT"	10.9991089301998	6.2414250143799	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAGGTTCGCAGATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1830.47526196071	41.3594217102264	0.0225949088576725	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1826.17686443384	1826.17686443384
"healthy-4"	"2019-08-01-count-3:AGTCACAGTAGCTGTT"	1.51888598975484	-6.85073759472045	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACAGTAGCTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.07319723357	51.7723015101583	0.0239900581576775	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2154.70886500332	2154.70886500332
"healthy-4"	"2019-08-01-count-4:CAGGTATGTTTCGTGA"	2.80378379401509	-5.93393614208373	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAGGTATGTTTCGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.72445363698	39.7628221110019	0.0162448114010218	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2443.62646035678	2443.62646035678
"healthy-4"	"2019-08-01-count-4:TTCTTCCGTGCATACT"	6.68227018889729	-1.73220887100371	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCGTGCATACT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3162.69458652738	39.3139091700792	0.0124305107858187	2717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3149.97561567644	3149.97561567644
"healthy-4"	"2019-08-01-count-2:CCACACTCATCCTTCG"	-0.573081056505996	8.09798238361207	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACACTCATCCTTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2356.70009496575	43.7447974634842	0.0185618855606318	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2342.33132643015	2342.33132643015
"healthy-4"	"2019-08-01-count-4:TTCTTCCTCCTAAGTG"	2.85782517966573	-6.33630993282469	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCTCCTAAGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.82051551279	37.6365641750247	0.0152016529224169	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2469.6172040055	2469.6172040055
"healthy-4"	"2019-08-01-count-3:TCGAAGTCATAGCACT"	11.0537163215572	5.72846314990846	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAAGTCATAGCACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2076.99826455714	36.8055763426923	0.0177205619141622	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2068.77018124486	2068.77018124486
"healthy-4"	"2019-08-01-count-3:GGAGATGCAACCAGAG"	0.287933935492676	8.0725412138733	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGATGCAACCAGAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1719.9528593605	38.5966677661834	0.0224405381555248	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1715.1692655475	1715.1692655475
"healthy-4"	"2019-08-01-count-2:TGAATCGAGTGCGCTC"	10.8007484870845	7.27075812900392	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATCGAGTGCGCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.03804809952	44.8992128510737	0.0221939537386619	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2021.76929733928	2021.76929733928
"healthy-4"	"2019-08-01-count-3:TAGGGTTGTTAAGACA"	10.3107000785762	6.38278863513795	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAGGGTTGTTAAGACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1784.5221307322	43.8473425939676	0.0245709155626872	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1771.92050841649	1771.92050841649
"healthy-4"	"2019-08-01-count-2:GTCAAACAGAGTCAAT"	5.08066668090169	-7.41688063060912	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAACAGAGTCAAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2725.26941772143	41.7487050124592	0.0153191111091559	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.40699987642	2721.40699987642
"healthy-4"	"2019-08-01-count-2:TGTTTGTAGCATTTGC"	0.532517750828904	8.0172548064026	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTTGTAGCATTTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.86585104903	40.0250551547099	0.0223870572455004	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1783.893053763	1783.893053763
"healthy-4"	"2019-08-01-count-3:AGGATAATCTAGTTCT"	4.80671801146809	-7.09316494381102	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGATAATCTAGTTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.50766029907	43.7086189321017	0.0175008948428481	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2492.63983367716	2492.63983367716
"healthy-4"	"2019-08-01-count-4:GACTGATAGGAGCTGT"	-7.85603127899821	-1.03542389785918	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTGATAGGAGCTGT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2975.46466754107	41.5546257452431	0.0139657601041466	4145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2962.89182303642	2962.89182303642
"healthy-4"	"2019-08-01-count-2:AGATAGAAGTTCATGC"	10.7472912269527	6.69257733905641	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGAAGTTCATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.83724749654	45.8794923112113	0.0225914175878781	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2025.47692949247	2025.47692949247
"healthy-4"	"2019-08-01-count-2:TACATTCCAAGTATCC"	2.85027970847432	-4.68130066311034	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACATTCCAAGTATCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2869.2448927232	41.7909689609907	0.0145651453687269	2937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2859.41695093223	2859.41695093223
"healthy-4"	"2019-08-01-count-2:TTAATCCAGTTCATGC"	4.73064961013143	-6.96620943462523	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCAGTTCATGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2895.65037831788	44.3251910691721	0.0153075079094739	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2893.85678122012	2893.85678122012
"healthy-4"	"2019-08-01-count-3:GGAGCAAGTTAGAAAC"	-3.74953470650371	10.2606162794861	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGCAAGTTAGAAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1917.07714614753	35.4174703638742	0.0184747235837887	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.18098937384	1910.18098937384
"healthy-4"	"2019-08-01-count-2:AGATAGATCATTGCCC"	0.0846210840040862	8.44467828357545	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGATCATTGCCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.26758872221	41.3589550909415	0.0212613191782571	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1930.03046405586	1930.03046405586
"healthy-4"	"2019-08-01-count-4:TAGACTGCAGGCGATA"	-0.322745571762878	7.81282613361207	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACTGCAGGCGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2273.63378675262	46.5921071861243	0.020492353455334	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2267.1284699942	2267.1284699942
"healthy-4"	"2019-08-01-count-4:TAGAGTCGTGGTATGG"	-7.21461854401286	2.88095829570619	"2019-08-01-count-4"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGAGTCGTGGTATGG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2756.71131241749	45.8395708172961	0.0166283537238062	2704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2742.28920463526	2742.28920463526
"healthy-4"	"2019-08-01-count-2:TACCCACTCTGTGCGG"	11.2931219535762	5.90002343738405	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACTCTGTGCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.09159662731	47.3497250377605	0.0239370740558692	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.03617299832	1975.03617299832
"healthy-4"	"2019-08-01-count-4:TAGATCGTCTTACTGT"	-4.51223073425944	12.932930923346	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGATCGTCTTACTGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2107.52449398348	42.3933530193765	0.0201152362121532	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2107.52449398348	2107.52449398348
"healthy-4"	"2019-08-01-count-3:AGGGAGTAGTTTGGCT"	9.4711672264034	6.56685826862184	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTAGTTTGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1692.54386862549	39.3948226157305	0.0232755105176227	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1690.50221334545	1690.50221334545
"healthy-4"	"2019-08-01-count-2:ATCGATGAGGCTCTAT"	10.5094744163448	7.5794958838257	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGATGAGGCTCTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2046.17090194145	45.6867502029368	0.0223279248862293	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2039.98360322592	2039.98360322592
"healthy-4"	"2019-08-01-count-3:AGGGAGTAGAAGTCTA"	-7.30294547501262	3.08274672115175	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTAGAAGTCTA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2499.15967416012	43.3162298295732	0.0173323178496509	2118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2483.49938612356	2483.49938612356
"healthy-4"	"2019-08-01-count-4:CATAAGCCATGGCTAT"	3.32776035842244	-6.41537620937499	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATAAGCCATGGCTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.04114959192	46.072754629637	0.0202336065107537	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2271.52097591008	2271.52097591008
"healthy-4"	"2019-08-01-count-2:CCACTTGAGATCCTAC"	-5.12448392334636	-4.41681911861571	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGAGATCCTAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3338.05100471305	43.4078691804277	0.0130039562364803	4537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3334.46221560308	3334.46221560308
"healthy-4"	"2019-08-01-count-4:GAGAAATCATCTGCGG"	5.11225380477254	-7.63843824779662	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATCATCTGCGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2781.97056439546	44.2292817321681	0.0158985441105052	2214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2776.74769361438	2776.74769361438
"healthy-4"	"2019-08-01-count-4:GAGAAATCACACGGAA"	10.9992205100948	5.81413171375123	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGAAATCACACGGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1911.24982393786	43.3099469070768	0.0226605367674241	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1904.51104909084	1904.51104909084
"healthy-4"	"2019-08-01-count-4:TAGGGTTCACCAACAT"	10.2614408927852	7.75824258411256	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTCACCAACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2140.65721928417	49.5090817683697	0.0231279820619415	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2132.01768850365	2132.01768850365
"healthy-4"	"2019-08-01-count-4:CATACAGGTATAGGAT"	2.40113772925679	-6.26233675396117	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACAGGTATAGGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.6958348317	39.6575471575274	0.0184222715145579	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2146.78154472604	2146.78154472604
"healthy-4"	"2019-08-01-count-2:CCACTTGTCGCTGCGA"	9.98466171798055	7.26044747913209	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGTCGCTGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.50073776431	36.4832229063589	0.0206879544335268	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1759.12595999466	1759.12595999466
"healthy-4"	"2019-08-01-count-2:GAGGCCTTCGCAGAGA"	11.552696843713	3.72343347156373	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCGCAGAGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2139.17734963441	45.7208609659845	0.0213731044664428	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2125.51468540345	2125.51468540345
"healthy-4"	"2019-08-01-count-4:GAGACCCAGATTAGCA"	-0.105181465775329	7.56970975482789	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGACCCAGATTAGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1870.35840456978	36.5498810167131	0.0195416455623757	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1861.86951965788	1861.86951965788
"healthy-4"	"2019-08-01-count-3:AGGGCTCAGAATCGCG"	-3.27872453156169	-5.60851290142211	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGCTCAGAATCGCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2451.5564514197	45.2523515527642	0.0184586210635935	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2447.83698326644	2447.83698326644
"healthy-4"	"2019-08-01-count-4:TAGGTACCAAGAATGT"	-3.41642938080485	2.9632951983246	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGTACCAAGAATGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3316.6319762892	44.7990009861278	0.0135073777574354	5369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3309.76113667509	3309.76113667509
"healthy-4"	"2019-08-01-count-4:CATACTTCAGTCTACA"	-4.13888917389567	11.8563270338806	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATACTTCAGTCTACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2374.60052993378	43.170444613555	0.0181800871638645	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2368.3527400369	2368.3527400369
"healthy-4"	"2019-08-01-count-3:TGTAAGCTCGTCAACA"	10.257564206689	5.78620717609254	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTAAGCTCGTCAACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1718.55003562682	46.2596039624544	0.0269178103654001	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1713.06024443161	1713.06024443161
"healthy-4"	"2019-08-01-count-3:TGTACAGAGCAGGGAG"	4.67838635024373	-6.94062664425048	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGAGCAGGGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.09432762285	41.1127833682191	0.0162302615105538	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2527.87117339956	2527.87117339956
"healthy-4"	"2019-08-01-count-3:GTGCACGTCCGTAATG"	10.9608513313228	5.89599320972291	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGCACGTCCGTAATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.7932092178	41.4826022352779	0.0222809934153246	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1850.27620993892	1850.27620993892
"healthy-4"	"2019-08-01-count-3:TCACTATTCCTATTGT"	10.2283617454464	6.6272516020569	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTATTCCTATTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2004.16992053505	42.6907291331102	0.0213009529260439	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.91519113412	1998.91519113412
"healthy-4"	"2019-08-01-count-2:GATTGGTTCGTTCATT"	0.430224766104859	7.84248015964357	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTTCGTTCATT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1886.19592697733	39.4345454512255	0.0209069189935216	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1878.66406694051	1878.66406694051
"healthy-4"	"2019-08-01-count-4:TAGTGCAGTGAATGAT"	2.64551915702168	-6.49915077602538	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGTGCAGTGAATGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.94295522896	49.8127146795907	0.0219251608254269	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2267.99367857355	2267.99367857355
"healthy-4"	"2019-08-01-count-2:CACGTTCCACAGTCGC"	11.5313545661861	3.64664504611818	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCCACAGTCGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2222.29937052632	35.6982005705344	0.0160636325798354	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2207.52124540556	2207.52124540556
"healthy-4"	"2019-08-01-count-3:CATGCAACAAAGGAGA"	11.2941614585811	5.04113481128541	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCAACAAAGGAGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.86836543755	42.8753020018941	0.0208044835472988	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2048.01636434935	2048.01636434935
"healthy-4"	"2019-08-01-count-2:TACCTGCCATGGATCT"	10.8693214851314	5.9332270392212	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCTGCCATGGATCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.07930699103	48.3243597484525	0.0262478425372296	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1832.08114292561	1832.08114292561
"healthy-4"	"2019-08-01-count-3:TCGGATACAAGAGGCT"	0.501866956322831	7.87669704044191	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGATACAAGAGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.94279744018	40.4905924869401	0.0242612224631333	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1653.24099217291	1653.24099217291
"healthy-4"	"2019-08-01-count-2:AGCCACGCAGCGACCT"	0.420954932540101	7.78356072986452	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCACGCAGCGACCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2105.4041070141	44.0495553953865	0.0209221380582647	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2099.54875170148	2099.54875170148
"healthy-4"	"2019-08-01-count-3:AGGGTTTGTAGCTGTT"	4.9697753387386	-7.5825143090454	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTTTGTAGCTGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.71175761252	44.2078428048299	0.0167981324994858	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2628.51279019779	2628.51279019779
"healthy-4"	"2019-08-01-count-3:GATAGCTAGAACTTCC"	3.87784208831136	-5.99761965191039	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTAGAACTTCC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3000.07646415618	42.5230580245331	0.0141739914074135	2669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2990.14721676778	2990.14721676778
"healthy-4"	"2019-08-01-count-4:GAGCCTGCAAAGGTTA"	4.58977665480916	-6.79179336940917	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCCTGCAAAGGTTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2861.88580586133	46.8968957911215	0.0163867110613126	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.30947742008	2859.30947742008
"healthy-4"	"2019-08-01-count-2:CCCATTGAGCAGTAAT"	11.4684635597164	3.52573869312135	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCATTGAGCAGTAAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2063.50628084237	40.5928777162481	0.0196717975094688	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2047.92017879762	2047.92017879762
"healthy-4"	"2019-08-01-count-3:GGCTTTCAGATGTAGT"	10.3388306098873	6.67709539020387	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTTCAGATGTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.69424644831	45.4105191464212	0.0240306172449699	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.73616883042	1877.73616883042
"healthy-4"	"2019-08-01-count-2:TTACTGTTCGAGGCAA"	10.1758638816768	6.7570819624695	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACTGTTCGAGGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2044.79688596006	44.0531284656348	0.0215440119104794	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2033.37479618076	2033.37479618076
"healthy-4"	"2019-08-01-count-3:CGCCATTCACCGAATT"	2.10681190070454	-6.75441744243773	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGCCATTCACCGAATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1790.63275046836	49.9405091128373	0.0278898669198219	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1786.613832001	1786.613832001
"healthy-4"	"2019-08-01-count-2:GAGTGAGAGCCTGAGA"	-7.25894580307658	0.944829858187117	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGAGCCTGAGA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2787.81000526924	43.8501902642542	0.0157292606674676	3686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2778.66486847171	2778.66486847171
"healthy-4"	"2019-08-01-count-3:TCGGGACGTACTCGCG"	4.84750475463216	-7.50358393108519	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACGTACTCGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.97577341264	46.1552034993458	0.0171010069649444	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2695.28794479178	2695.28794479178
"healthy-4"	"2019-08-01-count-2:TCCACCATCTGGTGCG"	10.2687775093013	7.15193460071412	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCATCTGGTGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1916.46457243108	43.3130274136131	0.0226004842649763	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1912.06044741153	1912.06044741153
"healthy-4"	"2019-08-01-count-3:TCGGGCAAGGACAGCT"	10.5711723762447	7.45748565280763	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGCAAGGACAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.12057404634	41.7282883557443	0.0207384631388314	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2008.20345654479	2008.20345654479
"healthy-4"	"2019-08-01-count-2:GAGTGAGTCGTGCGAC"	4.93214096602742	-7.7164926758972	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGTCGTGCGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.66631200431	42.5107656181736	0.0208932370715359	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2031.15251704578	2031.15251704578
"healthy-4"	"2019-08-01-count-3:AGGTCTAGTAAGGCCA"	11.5134817558223	3.72881171787111	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTAGTAAGGCCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2120.94509168586	38.7922492680354	0.0182900771076544	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2108.08509109491	2108.08509109491
"healthy-4"	"2019-08-01-count-2:CCCGAAGTCCTAGCGG"	11.2442347007686	5.96006391132203	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCGAAGTCCTAGCGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.7726764966	43.9084287021774	0.0221449635768433	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.1781440792	1977.1781440792
"healthy-4"	"2019-08-01-count-2:TTAGGGTAGCACTGGA"	1.16209163245503	-5.99735691463622	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTAGCACTGGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2545.52162693677	48.2512494014685	0.0189553484405211	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2538.64249258101	2538.64249258101
"healthy-4"	"2019-08-01-count-4:TTGGGCGAGTGAATAC"	-3.92648301544841	10.8572978743347	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGAGTGAATAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1883.94814253203	49.4353898683718	0.0262403134950045	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1872.75861413872	1872.75861413872
"healthy-4"	"2019-08-01-count-2:TTAGGGTAGTCAGAGC"	4.57744803008382	-6.59384014522704	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTAGTCAGAGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.83568920174	42.3998651459897	0.0159467790048806	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2653.09216017365	2653.09216017365
"healthy-4"	"2019-08-01-count-3:TCGGTCTAGATGTTCC"	2.95482148703877	-6.00555088436278	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGTCTAGATGTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.8252483339	43.9801178744347	0.0168130947976922	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.1634123395	2612.1634123395
"healthy-4"	"2019-08-01-count-3:AGGTTGTCAGGTTCCG"	4.29305471953694	-6.85899975216063	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTCAGGTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.85885156117	46.8651276689276	0.0192081306830272	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2435.47451472024	2435.47451472024
"healthy-4"	"2019-08-01-count-4:TATCGCCTCAAGTCTG"	-1.37752018395122	8.6689243086609	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCGCCTCAAGTCTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.1588092401	43.6641280224625	0.0231866414070951	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1879.83857987965	1879.83857987965
"healthy-4"	"2019-08-01-count-3:CTGTAGAGTCGTCATA"	4.4338489967281	-7.04067327892455	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGAGTCGTCATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.75154443864	43.3538821837096	0.0169037356767432	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2562.31840926618	2562.31840926618
"healthy-4"	"2019-08-01-count-4:CGAAGTTGTACCTAAC"	2.56473030623738	-6.36656382000121	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGTTGTACCTAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.49257964119	48.3759616180128	0.0230527198844251	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2097.03258791399	2097.03258791399
"healthy-4"	"2019-08-01-count-4:TTGGTTTAGCGTCAAG"	1.10262050208394	-6.02538063442381	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTAGCGTCAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2617.27249797067	45.6200914642436	0.0174303942366015	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2612.94721420697	2612.94721420697
"healthy-4"	"2019-08-01-count-3:AGGTTGTTCGGAAGGT"	9.645280500024	7.21930120075075	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTGTTCGGAAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1872.80847494645	47.1372284863787	0.025169273375766	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.54559749433	1868.54559749433
"healthy-4"	"2019-08-01-count-4:CTCTCGACAAAGGGCT"	-0.180776233703452	7.61622426593629	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCTCGACAAAGGGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.18890717326	40.8796713044544	0.0201656940602826	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2010.85238634675	2010.85238634675
"healthy-4"	"2019-08-01-count-3:CATTCATGTCCTGGGT"	0.848757346242112	8.18283746326295	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATGTCCTGGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.84967338972	41.068695934841	0.0211383806463975	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.53173862398	1937.53173862398
"healthy-4"	"2019-08-01-count-4:TATCTTGCACCAGACC"	-2.06190596047099	9.46613595569459	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGCACCAGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.79413545667	47.5554095983124	0.0236618312091486	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2006.40694817761	2006.40694817761
"healthy-4"	"2019-08-01-count-2:GTCGTAAGTCCGATCG"	4.88218416747395	-7.12690737163695	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGTAAGTCCGATCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.93197664935	40.4654791282839	0.0154216951843228	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2619.94023119924	2619.94023119924
"healthy-4"	"2019-08-01-count-2:CCCTCAAAGCATATGA"	0.32795744118039	7.79867980563966	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCCTCAAAGCATATGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1870.51071300089	39.4993653059792	0.0211168880410258	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1857.63524521054	1857.63524521054
"healthy-4"	"2019-08-01-count-4:TTGTGTTGTTTCGTAG"	10.5575891929561	6.88792607868043	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTGTTGTTTCGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.30620626146	42.6102383648293	0.0221316683165788	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1915.626781196	1915.626781196
"healthy-4"	"2019-08-01-count-2:AGCGTATTCTCTCGAC"	-4.99094138565715	-2.84173109447631	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGTATTCTCTCGAC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3278.4189801473	41.9449195690217	0.0127942522975319	3046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3268.15336039122	3268.15336039122
"healthy-4"	"2019-08-01-count-3:AAATGGAAGGCGATAC"	-2.93896255913432	3.6424464949402	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAATGGAAGGCGATAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3074.80085166761	46.1616729803875	0.0150128984631157	4748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3068.81070125287	3068.81070125287
"healthy-4"	"2019-08-01-count-2:TACTTGTCACGGATCC"	11.0786882835323	6.49502370441285	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTGTCACGGATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.47236666857	47.9774800457051	0.0233640738606777	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2048.74606745556	2048.74606745556
"healthy-4"	"2019-08-01-count-2:TACTTGTCATATCGGT"	2.25611176070516	-6.0171485177246	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTGTCATATCGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.07505229511	47.9616590436474	0.0197366986663023	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2426.41557023039	2426.41557023039
"healthy-4"	"2019-08-01-count-2:ATGACCACAACTGCCG"	-2.60779390755351	9.11596963489381	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCACAACTGCCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.24203508623	50.6678576760002	0.0251423187854615	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2008.90100117908	2008.90100117908
"healthy-4"	"2019-08-01-count-3:AGTACCATCCCAATAG"	2.86165465888326	-6.20453169262084	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACCATCCCAATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.28394796005	44.7251301539981	0.0186332663650103	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2396.69301163544	2396.69301163544
"healthy-4"	"2019-08-01-count-4:GAGTGTTAGCTTGTGT"	-4.04516539993938	11.8158807524475	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTGTTAGCTTGTGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2149.68932833517	46.8829020943434	0.0218091523627983	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2144.63717047437	2144.63717047437
"healthy-4"	"2019-08-01-count-3:GGGAGATTCACCGCTT"	-2.23730454865153	9.23888967120973	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGATTCACCGCTT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1957.01196361385	50.3239897379539	0.0257147072545355	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1953.58001353314	1953.58001353314
"healthy-4"	"2019-08-01-count-3:GGGAGATTCGACGATT"	2.93077458915059	-6.27911617672118	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGATTCGACGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1920.20028372884	42.8749629941102	0.0223283807201878	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1916.8911038954	1916.8911038954
"healthy-4"	"2019-08-01-count-3:GGGAGTAAGGTCTGGA"	2.15371574935262	-6.03072311794432	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGTAAGGTCTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.97603670583	49.9928406270585	0.0196746604080022	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2532.76844470005	2532.76844470005
"healthy-4"	"2019-08-01-count-2:TAGACCACATCTCATT"	10.3152471977169	6.97383449161378	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCACATCTCATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1902.72902524389	45.206719133345	0.0237588844935765	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1889.64549069641	1889.64549069641
"healthy-4"	"2019-08-01-count-2:TAGACCAGTCAATGGG"	3.39728178557698	-6.12600042736205	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAGTCAATGGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.30136741661	47.3129697243105	0.0187281574298844	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2522.16343737217	2522.16343737217
"healthy-4"	"2019-08-01-count-4:TTGTTTGCAATCAAGA"	2.94620766219441	-4.85555889522704	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTTGCAATCAAGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2905.14693802716	37.3361868475766	0.0128517378446032	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2900.55722109548	2900.55722109548
"healthy-4"	"2019-08-01-count-3:TCTACCGGTTCAATCG"	3.29458941993062	-6.30954458629759	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGGTTCAATCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.52989432886	37.5330993743046	0.0157600790414944	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2377.80616007728	2377.80616007728
"healthy-4"	"2019-08-01-count-3:CGGGCATGTCGTAATC"	0.0494687169207304	7.74960658634035	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGCATGTCGTAATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.44173964442	42.2595450115468	0.0214903620888298	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1960.21859053707	1960.21859053707
"healthy-4"	"2019-08-01-count-2:GATCAGTAGGCTTTCA"	-5.06239734116252	-2.86309935962828	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCAGTAGGCTTTCA"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3531.39702464864	40.7236296180067	0.0115318751569879	3852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3515.6018825658	3515.6018825658
"healthy-4"	"2019-08-01-count-4:GATAGAAGTACGTACT"	2.1811167198116	-5.9968242875305	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATAGAAGTACGTACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.8720534547	41.7697491357733	0.0157332437476298	2229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2653.04491824983	2653.04491824983
"healthy-4"	"2019-08-01-count-2:TAGACTGCAGACCGCT"	10.9583507972652	7.44688222492067	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACTGCAGACCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2394.6530911735	42.403722461658	0.0177076682288364	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2393.38735976357	2393.38735976357
"healthy-4"	"2019-08-01-count-2:TAGACTGAGAGCAAGA"	2.80204739150349	-6.2722172967163	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACTGAGAGCAAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.10866497639	43.6369417710144	0.0179567862128661	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2425.78656413201	2425.78656413201
"healthy-4"	"2019-08-01-count-3:CTTACCGCATCGAACT"	2.18220343169515	-6.43986513530882	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGCATCGAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.54349361528	43.2382141544607	0.0180947592165577	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2387.34357350087	2387.34357350087
"healthy-4"	"2019-08-01-count-4:TATTTCGTCGTCACCT"	11.1471697288448	4.82183787906495	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTTCGTCGTCACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1789.12896578803	40.0560853477425	0.0223885958551342	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1781.16596543826	1781.16596543826
"healthy-4"	"2019-08-01-count-4:TATTTCGTCAGCGCGT"	2.22240461882893	-6.76658012783202	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTTCGTCAGCGCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.41979607181	48.9076905932016	0.0289837127115938	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1683.96434585071	1683.96434585071
"healthy-4"	"2019-08-01-count-2:TAGAGTCAGCATACTC"	9.83928169783894	6.33210418308107	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCAGCATACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.19310795148	43.9444126832391	0.0220361872217985	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1986.44635902473	1986.44635902473
"healthy-4"	"2019-08-01-count-4:GGGAGATGTGTAGCAG"	4.85829939421956	-7.16776754772338	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGATGTGTAGCAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.69192498464	44.4266879556881	0.0163833832104434	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2706.61090606203	2706.61090606203
"healthy-4"	"2019-08-01-count-2:TAGAGTCAGCTTTCCC"	-4.29662118378337	12.1886195906433	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCAGCTTTCCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2267.11667901826	46.6193606270815	0.0205632824541123	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2260.65965994081	2260.65965994081
"healthy-4"	"2019-08-01-count-4:GATCATGAGACTCCGC"	-0.635274986655074	8.11041448200075	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGAGACTCCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2079.78189058228	45.0333704165223	0.0216529293867033	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2071.38499812095	2071.38499812095
"healthy-4"	"2019-08-01-count-4:ACGGGTCAGGTAAGAG"	6.78263725814168	-1.68090798771056	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCAGGTAAGAG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2796.81234314333	37.1034123407051	0.0132663217221806	2287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2782.54222579138	2782.54222579138
"healthy-4"	"2019-08-01-count-2:AGGAATAGTTCGTGCG"	-0.25272704187091	7.60857913577882	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGAATAGTTCGTGCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.94869529023	44.4777098231343	0.0237220943350929	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1865.20480561673	1865.20480561673
"healthy-4"	"2019-08-01-count-3:CGGTCAGGTACTAGCT"	3.08735503730122	-6.20787002956542	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGGTACTAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.79731054747	44.9023601150786	0.0189078705435821	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2370.94100222272	2370.94100222272
"healthy-4"	"2019-08-01-count-2:GATCCCTGTCTGCGCA"	10.8810373741085	5.78890178287355	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCCCTGTCTGCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.87706221366	46.2151548853981	0.0246365584484844	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.43418616529	1863.43418616529
"healthy-4"	"2019-08-01-count-3:GGGCTCAGTATAGCTC"	10.509915013879	6.93818662250368	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGCTCAGTATAGCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.32249582165	50.8258161034322	0.0247288764691468	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2048.78016775887	2048.78016775887
"healthy-4"	"2019-08-01-count-2:TAGATCGGTGAGTTGG"	11.6445709663326	3.89608094776002	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGATCGGTGAGTTGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2547.86435197489	38.1801989790644	0.0149851772718866	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2530.55943546067	2530.55943546067
"healthy-4"	"2019-08-01-count-3:TCTCACGTCTAAACGC"	10.7261148887569	6.52000854099122	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCACGTCTAAACGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.09652497859	40.5284178838281	0.0202127016724348	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1998.83687996604	1998.83687996604
"healthy-4"	"2019-08-01-count-4:TTTACTGCAGTAGTTC"	11.1281448799068	6.36102006519166	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTACTGCAGTAGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.64291827786	44.8820760468711	0.0224002369072068	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.45368758321	1992.45368758321
"healthy-4"	"2019-08-01-count-3:AAGTGAATCAGCACCG"	-1.87810740891154	8.53290364826051	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTGAATCAGCACCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.90465930741	41.0951195183597	0.019504973486493	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2103.74715917318	2103.74715917318
"healthy-4"	"2019-08-01-count-3:CTTCAATGTGATAGTA"	2.57391299781148	-6.07339908992919	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCAATGTGATAGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.75862083857	46.8645362110833	0.0181451475306149	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2579.45894021418	2579.45894021418
"healthy-4"	"2019-08-01-count-4:CTAACCCGTAGGACTG"	3.02123226699178	-6.11340286647948	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAACCCGTAGGACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.05058331477	41.2111052655353	0.0155159338923822	2106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2651.73246025587	2651.73246025587
"healthy-4"	"2019-08-01-count-3:TCTCAGCTCCAGTTCC"	10.5284582572872	7.08720634067384	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCAGCTCCAGTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.71682767317	43.7893299413494	0.0223675504661187	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1952.86552055851	1952.86552055851
"healthy-4"	"2019-08-01-count-4:GATCGTATCGTACACA"	4.06158842620198	-6.54174950039061	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCGTATCGTACACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.11924842389	44.3454363574981	0.0196469178083807	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2251.19573788841	2251.19573788841
"healthy-4"	"2019-08-01-count-4:CATTCCGAGATACATG"	-2.58553586426433	3.51408073985902	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGAGATACATG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3316.30752661542	48.0322807590641	0.0144836630419753	5849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3308.94548561956	3308.94548561956
"healthy-4"	"2019-08-01-count-3:GGGTATTCACAAGCTT"	11.1971270042354	4.48402688587037	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTATTCACAAGCTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1607.59573912305	45.9721955293634	0.0285968632601885	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1585.73042154928	1585.73042154928
"healthy-4"	"2019-08-01-count-2:TTCCAATAGCCTCCAG"	10.6013447242672	7.26725432956544	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCAATAGCCTCCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.84594494692	41.1378977347284	0.0203769375457769	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2014.22218682226	2014.22218682226
"healthy-4"	"2019-08-01-count-2:GATGAGGTCTAGTACG"	2.69656624373738	-4.40339996730956	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGAGGTCTAGTACG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2819.16901914847	39.4154120697163	0.0139812163804289	2755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2815.33016029821	2815.33016029821
"healthy-4"	"2019-08-01-count-3:TCTCTGGCAGGGAGAG"	10.9918114143306	6.22386643970338	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGCAGGGAGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1759.60525074304	48.1956740081011	0.0273900489827189	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1748.73639673931	1748.73639673931
"healthy-4"	"2019-08-01-count-2:GATGCTAAGTGCAGCA"	11.0862232643062	6.57879207218019	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTAAGTGCAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.3170105265	42.6340900265967	0.0226257523486901	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1882.6693751107	1882.6693751107
"healthy-4"	"2019-08-01-count-4:ACGTAACCACCAGTAT"	2.9000424343044	-6.11419012462767	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAACCACCAGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.33390144981	47.3206971620409	0.0185838538830661	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2538.59530327645	2538.59530327645
"healthy-4"	"2019-08-01-count-2:GATGCTAAGCGGATCA"	5.0197602706844	-7.55504467403563	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTAAGCGGATCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.72732315328	43.0978503736626	0.0167583281421993	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.23238511733	2568.23238511733
"healthy-4"	"2019-08-01-count-4:TGTCCCAGTTCCACAA"	3.80782379683797	-6.7682938805786	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCCAGTTCCACAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.03962379939	43.3938156251901	0.0192259875137429	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2252.56618270747	2252.56618270747
"healthy-4"	"2019-08-01-count-4:CATTCCGTCGACCACG"	4.37533535537068	-7.69306948101195	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CATTCCGTCGACCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.65757463239	41.5286816072696	0.0158769565290312	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.0623633218	2612.0623633218
"healthy-4"	"2019-08-01-count-3:GGGTCACCACTACTTT"	-1.61121104183849	8.65059182727662	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTCACCACTACTTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.88759996584	47.7240549550872	0.0241776963166055	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1967.58941778135	1967.58941778135
"healthy-4"	"2019-08-01-count-2:AGGATCTGTTTCACTT"	10.2436491447384	7.74003503406373	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGATCTGTTTCACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.57976801605	47.6819782535941	0.0235515433903201	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2016.50045447903	2016.50045447903
"healthy-4"	"2019-08-01-count-4:TCAATTCCAACGCATT"	4.53058733519856	-6.71829225933226	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATTCCAACGCATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2835.2425447983	45.5150521428282	0.016053318692728	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2825.11103208286	2825.11103208286
"healthy-4"	"2019-08-01-count-2:TAGGTTGTCAACCGAT"	0.0618330939555585	7.88110015476076	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGTCAACCGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.51554422786	42.6527139774449	0.022657297098144	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1878.6602123897	1878.6602123897
"healthy-4"	"2019-08-01-count-3:GGGTGAACATTAGGAA"	-3.35867510262187	3.71993253314821	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGTGAACATTAGGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3112.25476141151	49.3328665380404	0.0158511658973787	4831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3104.29958313122	3104.29958313122
"healthy-4"	"2019-08-01-count-2:CAGCGTGCACCGTACG"	-0.18991100314315	7.56803367221681	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCGTGCACCGTACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.44887396744	39.876360673915	0.018814495203779	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2109.08989215713	2109.08989215713
"healthy-4"	"2019-08-01-count-2:TTCCGGTCATAGGCGA"	9.7854114967281	5.98056552493898	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTCATAGGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1780.13233584774	46.4394245663205	0.0260876248530169	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1774.40786436476	1774.40786436476
"healthy-4"	"2019-08-01-count-4:GATGATCAGTACAACA"	-2.51218495789226	-5.89163448726805	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGATCAGTACAACA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2214.01402621703	52.6273302978764	0.0237700979644641	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2210.31270186546	2210.31270186546
"healthy-4"	"2019-08-01-count-3:TCTTAGTAGTTGTAGA"	4.8790246444637	-7.40388920223387	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTAGTTGTAGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.95706824806	47.0212088089712	0.0195355411316897	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2402.77515195024	2402.77515195024
"healthy-4"	"2019-08-01-count-4:GATGATCGTGTTGAGG"	2.48193683203999	-6.01729156887206	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGATCGTGTTGAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.93512284266	47.0129995006118	0.0188282823492384	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2494.83224243817	2494.83224243817
"healthy-4"	"2019-08-01-count-4:GGGTAGATCCGCTGTT"	11.4681650596553	4.31518218601076	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTAGATCCGCTGTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2127.41836089578	41.0320839831618	0.0192872660767507	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2113.56726702963	2113.56726702963
"healthy-4"	"2019-08-01-count-2:GTGCACGTCTGTGCGG"	-3.48122344437297	9.63916013324586	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCACGTCTGTGCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.5432386753	46.2187017770556	0.0229084070621467	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2017.5432386753	2017.5432386753
"healthy-4"	"2019-08-01-count-4:AGTAGCTGTGCGGTAA"	-2.77589235726054	9.21338460529176	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTAGCTGTGCGGTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1829.50507424724	47.9887538936659	0.0262304568427673	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1827.58404258936	1827.58404258936
"healthy-4"	"2019-08-01-count-3:AGTGATCTCGACCAAT"	11.527454038232	4.20569417560426	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGATCTCGACCAAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2157.00839549218	40.687239912375	0.0188628101760777	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2143.69261779239	2143.69261779239
"healthy-4"	"2019-08-01-count-3:CTTCTCTCAGAGATTA"	10.6774536567623	6.24467990482179	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTCAGAGATTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1808.94574451063	45.8665767630552	0.0253554187029879	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1796.81430228722	1796.81430228722
"healthy-4"	"2019-08-01-count-3:CTTCTCTAGGCGATAC"	1.98708905753438	-6.15902235424193	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTCTAGGCGATAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2477.8556831889	44.9308628490165	0.0181329619613651	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2470.46518775069	2470.46518775069
"healthy-4"	"2019-08-01-count-4:TCACATTCACTGCTTC"	10.6020113426143	6.6135854491028	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACATTCACTGCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.41125261416	47.0392485450454	0.0240805659750834	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.74229360769	1942.74229360769
"healthy-4"	"2019-08-01-count-2:TTCCGTGGTGAGTGAC"	3.92847623404805	-6.40362694179686	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGTGGTGAGTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2176.29309170816	48.0889669349731	0.022096732796789	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2176.29309170816	2176.29309170816
"healthy-4"	"2019-08-01-count-3:CTCATGCCAGAGGTAC"	10.5785452323848	7.42079446399537	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCCAGAGGTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1960.7037038854	46.2534501197178	0.0235902293794113	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1949.74479701801	1949.74479701801
"healthy-4"	"2019-08-01-count-4:TTTCATGTCCTCAGAA"	5.1499306159908	-7.51539852535399	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCATGTCCTCAGAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2867.94966360631	38.0996600103947	0.0132846334417481	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2862.32515252599	2862.32515252599
"healthy-4"	"2019-08-01-count-2:TATATCCGTTAGGGAC"	14.3505627113277	1.95429227435914	"2019-08-01-count-2"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATATCCGTTAGGGAC"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1373.91966769971	30.3323206242497	0.0220772155296631	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1358.29643133851	1358.29643133851
"healthy-4"	"2019-08-01-count-2:TTCCTAAGTCTGATAC"	4.34076942977254	-6.4051666489807	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTAAGTCTGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.31550531074	43.0862968934934	0.016750004734854	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2565.14923852027	2565.14923852027
"healthy-4"	"2019-08-01-count-2:CTACATTAGGGCCCTT"	3.51284040984456	-7.03709366237792	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACATTAGGGCCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.48248214242	47.7077945126092	0.0218294106232512	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2177.74422660605	2177.74422660605
"healthy-4"	"2019-08-01-count-3:TTACGCCAGCTAGATA"	-0.242519984871703	7.62871120059816	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACGCCAGCTAGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1963.47574140145	40.5692516977845	0.0206619571825357	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1951.11283408031	1951.11283408031
"healthy-4"	"2019-08-01-count-3:GGTAATCAGCACTCCG"	-1.94365177574809	9.35058877551881	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTAATCAGCACTCCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1974.17978356107	47.0302595830767	0.0238226832098556	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1968.73341138317	1968.73341138317
"healthy-4"	"2019-08-01-count-2:TATCCTACAAGATCCT"	4.15760101851766	-6.51269247448119	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCCTACAAGATCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.37368976633	45.473360279213	0.0178370713017678	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2545.19615805803	2545.19615805803
"healthy-4"	"2019-08-01-count-4:ACTATCTCATGGCCCA"	-4.15524659577067	12.2311887511047	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTATCTCATGGCCCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2059.83242779391	46.3525475184597	0.0225030671878992	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2052.52360887941	2052.52360887941
"healthy-4"	"2019-08-01-count-3:GTAGTACTCAGCAATC"	10.2801891761715	7.66448924625245	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACTCAGCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1887.73617045636	42.1653798057053	0.0223364792525598	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1885.03434038586	1885.03434038586
"healthy-4"	"2019-08-01-count-4:GTGACGCAGCTCATAC"	0.545685161917847	7.98410222614137	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGACGCAGCTCATAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1970.25228010897	40.9914150356436	0.0208051605621674	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1963.20038971564	1963.20038971564
"healthy-4"	"2019-08-01-count-3:CTTGATTTCCAAAGGG"	10.3325792747432	7.49171540820924	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTTCCAAAGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2014.65995407755	45.7632045355183	0.0227151010982753	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.50885326195	2007.50885326195
"healthy-4"	"2019-08-01-count-4:AGTCACAGTATAGGGC"	-4.15636954727824	12.9543285139832	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGTCACAGTATAGGGC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1776.0034826844	39.412291070849	0.0221915618156772	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1771.91420669631	1771.91420669631
"healthy-4"	"2019-08-01-count-3:TCACTCGCATAACGGG"	-0.35450835052188	7.68698117816774	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACTCGCATAACGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.35501144679	43.9503820606924	0.0220927797239814	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1985.40854239625	1985.40854239625
"healthy-4"	"2019-08-01-count-4:TCTGTCGAGACATACA"	0.328297664492768	7.95694348895875	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGTCGAGACATACA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.03415667458	41.2956415809908	0.0230826456984758	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1778.79894177175	1778.79894177175
"healthy-4"	"2019-08-01-count-1:AAGGAATAGGACTTCT"	10.4479319053585	7.47178456867067	"2019-08-01-count-1"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AAGGAATAGGACTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2312.84327884139	40.7111322034013	0.0176022009687554	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2302.86327921255	2302.86327921255
"healthy-4"	"2019-08-01-count-4:GATTGGTCACATGACT"	-0.4441796046799	7.66924760425416	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTGGTCACATGACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2192.5205439428	43.3622539966779	0.0197773535652714	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2185.16810806078	2185.16810806078
"healthy-4"	"2019-08-01-count-3:TGACAGTAGACTCTTG"	-3.06748972359355	3.38095328891603	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTAGACTCTTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3397.58227501689	43.0592439825483	0.0126734955910182	5897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3386.49467027578	3386.49467027578
"healthy-4"	"2019-08-01-count-2:GATTTCTTCTACTATC"	3.48082484778706	-6.72323181545409	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTTCTTCTACTATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.83867907436	45.5578981691156	0.021370237164895	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2130.25090963477	2130.25090963477
"healthy-4"	"2019-08-01-count-4:AACCATGGTCACAGAG"	-3.62342033806499	10.1193122633728	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCATGGTCACAGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2170.40424201373	45.5626971779194	0.0209927239801401	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2162.8324596599	2162.8324596599
"healthy-4"	"2019-08-01-count-3:CGTTCTGGTATCCCAA"	-4.3112042945927	12.486111617926	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTTCTGGTATCCCAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.02596408199	45.859674040353	0.02460248672713	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1858.27835323627	1858.27835323627
"healthy-4"	"2019-08-01-count-3:TGACAGTGTGCCTACG"	3.1297468143398	-6.06394483959349	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTGTGCCTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.47354357565	45.6694442668203	0.0177807727009882	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2567.25031104392	2567.25031104392
"healthy-4"	"2019-08-01-count-3:TGACAGTTCGCATTGA"	10.4885088401729	6.86622331226198	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACAGTTCGCATTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1781.43759829659	42.3633187306555	0.0237804112651285	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1774.71054528477	1774.71054528477
"healthy-4"	"2019-08-01-count-4:CCAATTTGTACCAGAG"	10.3222080665523	7.74824092471925	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCAATTTGTACCAGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.04805156156	44.3103074135214	0.0221324894669537	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.10734204986	1991.10734204986
"healthy-4"	"2019-08-01-count-2:AGGGTCCGTACCCAGC"	10.9076687293941	6.28675363147584	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTCCGTACCCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.69128183152	45.8545051661804	0.0240240554366549	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1901.61168226342	1901.61168226342
"healthy-4"	"2019-08-01-count-4:TCAGCAAGTCCAACGC"	6.78639330443684	-1.72542180931243	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCAAGTCCAACGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2879.55944802278	32.0528238834845	0.0111311554639003	2279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2871.51991013353	2871.51991013353
"healthy-4"	"2019-08-01-count-3:AGTTCGATCCACTGGG"	-1.85187612000163	4.12541768634645	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCGATCCACTGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3156.21911359097	44.1158689281817	0.0139774417873001	5238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3150.79094124902	3150.79094124902
"healthy-4"	"2019-08-01-count-4:TTTGATCTCCTCAGAA"	3.06264247474019	-5.01051094448241	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCTCCTCAGAA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2949.26154532882	39.2899710498149	0.0133219690576593	2558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2940.39389983309	2940.39389983309
"healthy-4"	"2019-08-01-count-2:AGGGTTTAGCACAAAT"	4.14876093444173	-6.31701376354369	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTTTAGCACAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.14868762285	41.4226357718182	0.0175806543913873	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2354.73500525647	2354.73500525647
"healthy-4"	"2019-08-01-count-3:CTAACCCCATATAGCC"	10.3960596519405	7.65818498218385	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAACCCCATATAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2073.50275406263	39.8638999890526	0.0192253904225335	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2067.38666177231	2067.38666177231
"healthy-4"	"2019-08-01-count-3:AAGACTCCATGTTTGG"	-5.27730689469035	-4.2543950310913	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGACTCCATGTTTGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3493.16689909774	42.1258115481361	0.0120594900744699	4820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3484.36288870771	3484.36288870771
"healthy-4"	"2019-08-01-count-3:TGACTCCCAGTAACGG"	-7.12101827088054	3.27234027469484	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACTCCCAGTAACGG"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2568.26102991552	44.392020329546	0.017284855321348	2387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2552.22981484489	2552.22981484489
"healthy-4"	"2019-08-01-count-2:GGGTCACAGTTCAACC"	-0.0500855771010697	7.51577994907228	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACAGTTCAACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1848.27186892963	40.0153433785929	0.0216501392740272	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1836.61070556589	1836.61070556589
"healthy-4"	"2019-08-01-count-4:GCAACCGCACGATTCA"	-2.60336432877238	3.56641433322755	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACCGCACGATTCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3247.36881404254	49.3490409123615	0.015196623401371	5781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3242.04100914895	3242.04100914895
"healthy-4"	"2019-08-01-count-3:GGTGGCTCAGGATCTT"	11.5095020729	4.18312594974367	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGGCTCAGGATCTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2133.73484721703	35.8254413871808	0.0167900156075657	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2120.49341456066	2120.49341456066
"healthy-4"	"2019-08-01-count-4:TTTGGTTCAGGTCAGA"	0.107242197811049	7.68998096072999	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTCAGGTCAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2060.51347143102	44.8307426252096	0.0217570732959464	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.9071725844	2054.9071725844
"healthy-4"	"2019-08-01-count-4:GCACATACAAGAGATT"	3.24098290976827	-6.95378639614256	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACATACAAGAGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.59717580754	48.3519420805545	0.0213606654917763	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2262.09865981043	2262.09865981043
"healthy-4"	"2019-08-01-count-2:AACGTCATCGAACTCA"	-3.3446515602177	10.1736907728943	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACGTCATCGAACTCA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2078.18900533155	47.7661628645596	0.022984513315207	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.77564937662	2070.77564937662
"healthy-4"	"2019-08-01-count-1:AGGGCTCGTTCGTACA"	10.4727150398189	7.77181289279786	"2019-08-01-count-1"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGGGCTCGTTCGTACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.52491272088	41.2991242765544	0.0207478560115593	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1986.19682819166	1986.19682819166
"healthy-4"	"2019-08-01-count-1:AGGGTCCCAGTTGGTT"	5.25239338454549	-7.85667612468871	"2019-08-01-count-1"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGGGTCCCAGTTGGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.52396662825	47.8323329583156	0.0178978125381089	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2662.72826412071	2662.72826412071
"healthy-4"	"2019-08-01-count-3:CAATGACCAGTAACAA"	11.2325188117916	5.83708140933839	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATGACCAGTAACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.92431094653	46.6657992954022	0.0248232330544767	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.63400135662	1876.63400135662
"healthy-4"	"2019-08-01-count-1:AGGTCTAGTCAAAGTA"	11.329962392419	5.04582307422487	"2019-08-01-count-1"	"Control4"	"B"	"Activated AP-1"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGGTCTAGTCAAAGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2622.73873012416	40.2063940207536	0.0153299272851514	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2603.31494755021	2603.31494755021
"healthy-4"	"2019-08-01-count-3:ATAGACCGTCACCGAC"	-1.99611506882365	9.24298474872438	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGACCGTCACCGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1938.35560507356	41.4080477290805	0.0213624618829985	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1934.53038214588	1934.53038214588
"healthy-4"	"2019-08-01-count-3:GGTGTTAGTATAGCTC"	5.17423595961873	-7.82407762920531	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGTTAGTATAGCTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.95722167282	44.3837541297047	0.0166420945071873	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2663.8459511441	2663.8459511441
"healthy-4"	"2019-08-01-count-3:TGAGGAGAGTCTTCCC"	1.91414370116536	-6.01944925701293	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGGAGAGTCTTCCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2489.09837636925	44.5368544588778	0.0178927658632127	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2484.20613877471	2484.20613877471
"healthy-4"	"2019-08-01-count-4:TTTGTTGTCCTTGAAG"	9.7652756172115	6.05041835391847	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGTTGTCCTTGAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1870.21789709326	41.5516406956013	0.0222175398707188	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1864.57391871741	1864.57391871741
"healthy-4"	"2019-08-01-count-2:GCAGCCAAGCACTCGC"	10.831372876733	6.62255141818849	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCCAAGCACTCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.61416814838	46.5032988807568	0.0236825032305648	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1952.40528331225	1952.40528331225
"healthy-4"	"2019-08-01-count-4:TCAGTCCGTTCTTCAT"	11.0665747123653	6.05485866153566	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTCCGTTCTTCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.93736634994	46.2142471376008	0.0230387288819957	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1995.57719079615	1995.57719079615
"healthy-4"	"2019-08-01-count-1:ATCTCTAAGCGCATCC"	11.4410244422847	4.76496503436891	"2019-08-01-count-1"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATCTCTAAGCGCATCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2483.53788302938	38.6629137410091	0.015567676259421	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2462.08647587741	2462.08647587741
"healthy-4"	"2019-08-01-count-4:CCACGAGCAGGCTATT"	10.4944731193477	7.61648986423341	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGCAGGCTATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1926.18406648554	43.8876275878424	0.0227847526887285	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1920.80307228371	1920.80307228371
"healthy-4"	"2019-08-01-count-2:GCAGCTGGTTTCGATG"	3.79807438430135	-6.43600990688475	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCTGGTTTCGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.8085879093	45.47460894527	0.0170648688058108	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2660.94669223297	2660.94669223297
"healthy-4"	"2019-08-01-count-4:GCACTAATCCCTTGTG"	4.65709080275838	-6.95496990596923	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACTAATCCCTTGTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2968.6806779575	43.6497158401375	0.0147034055108174	2573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2961.87308357488	2961.87308357488
"healthy-4"	"2019-08-01-count-4:CCACGAGGTTTCGCTC"	-0.0934263271396935	7.76490066135255	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCACGAGGTTTCGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2208.22369189636	44.8749850592256	0.0203217569052926	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2195.77091713567	2195.77091713567
"healthy-4"	"2019-08-01-count-2:GCAGGCTCAGGTCTCG"	10.7481943565303	6.09097526157228	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGGCTCAGGTCTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1745.0929742899	46.9153503273216	0.02688415518171	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1743.08408180546	1743.08408180546
"healthy-4"	"2019-08-01-count-1:ATTGTTCCATAGACTC"	11.4038502174312	4.83728978717653	"2019-08-01-count-1"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ATTGTTCCATAGACTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2756.51590425517	41.9283523690033	0.0152106332142976	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2736.057076923	2736.057076923
"healthy-4"	"2019-08-01-count-3:ATATCCTGTGCCGAAA"	-0.0277069014614404	7.79198405826417	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTGTGCCGAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.56620917691	45.6744396162509	0.0229454511011403	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1981.81885470317	1981.81885470317
"healthy-4"	"2019-08-01-count-2:TATTGCTGTAGATGTA"	-3.04591784897502	10.0009765394959	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTGTAGATGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2185.584825149	45.2138160846472	0.0206872849611613	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2184.12733145985	2184.12733145985
"healthy-4"	"2019-08-01-count-2:TTCTTCCTCATGGATC"	3.25354685363118	-6.42696096813353	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCTCATGGATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.24460973671	42.7976208277029	0.0187360060499983	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2276.37138096862	2276.37138096862
"healthy-4"	"2019-08-01-count-2:CATACTTCAGCTACTA"	11.2358280616695	6.32288167560426	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACTTCAGCTACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2290.99788983514	41.7135801138336	0.018207603027009	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2280.28649198169	2280.28649198169
"healthy-4"	"2019-08-01-count-2:TTCTTCCTCGTCACCT"	10.8805767494137	6.89880082691041	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCTCGTCACCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2315.08108903212	41.9576838790427	0.01812363466568	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2303.80811359475	2303.80811359475
"healthy-4"	"2019-08-01-count-2:TTCTTGAAGACTTCCA"	4.15725912627522	-6.52656176006468	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGAAGACTTCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.87836929721	44.9150946303847	0.0172958022067626	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.07762070074	2589.07762070074
"healthy-4"	"2019-08-01-count-4:ACTTCCGAGCATTTGC"	3.41382374343221	-6.16056444561156	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTTCCGAGCATTTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.02886960465	42.3037647744529	0.0157730460152313	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2678.03565099713	2678.03565099713
"healthy-4"	"2019-08-01-count-2:CCTCCTCTCGGTGTAT"	11.5574556785518	3.635227180365	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCCTCTCGGTGTAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1682.58799537709	39.6679286614358	0.0235755447979086	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1666.83133708481	1666.83133708481
"healthy-4"	"2019-08-01-count-2:TATTTCGCAGGTCCGT"	11.6407209831173	3.61490891063539	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTTCGCAGGTCCGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2087.15330353202	52.9606588749086	0.0253745897751186	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2069.86341703435	2069.86341703435
"healthy-4"	"2019-08-01-count-3:GCCAGTGTCAAGTAAG"	-2.93581948700603	-5.75952818309935	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGTCAAGTAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2477.04827244716	45.4039276761846	0.0183298517760934	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2468.83635897979	2468.83635897979
"healthy-4"	"2019-08-01-count-4:TGACCCTAGCTCGGCT"	3.63253941115682	-6.44542171871337	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACCCTAGCTCGGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.09078384574	43.3080011878977	0.0170162893452694	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2540.27721113284	2540.27721113284
"healthy-4"	"2019-08-01-count-3:CACATGAAGCCGAACA"	-3.57889090004619	10.2562007674011	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACATGAAGCCGAACA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2056.93016007432	47.2894927490379	0.0229903249351594	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2051.94496631155	2051.94496631155
"healthy-4"	"2019-08-01-count-3:ATCACGACAGCGACCT"	5.5278078514034	-10.0216036072937	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCACGACAGCGACCT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.18720959673	49.3579584123391	0.0192941150777311	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2548.2610520958	2548.2610520958
"healthy-4"	"2019-08-01-count-4:GCAGGCTAGTATGAGT"	4.65726198729817	-6.98785927211913	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGGCTAGTATGAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2779.1143167886	42.2804080012914	0.0152136267824162	2116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2775.3192569505	2775.3192569505
"healthy-4"	"2019-08-01-count-3:GTAACCAAGGCTAACG"	-2.15924439850505	8.66700742328493	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCAAGGCTAACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1985.28049961619	46.8765718453203	0.0236120648212597	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1976.48242659119	1976.48242659119
"healthy-4"	"2019-08-01-count-3:TGATCAGGTATTCTCT"	-2.79326830330547	8.85862538898317	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGATCAGGTATTCTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.87186286584	38.6645277217766	0.0185809267796657	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2071.65083542855	2071.65083542855
"healthy-4"	"2019-08-01-count-4:GCAGGCTTCGTGGCTG"	10.8369738059932	6.19606301868287	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGGCTTCGTGGCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1733.00858988906	35.5341003261887	0.0205042840142318	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1733.00858988906	1733.00858988906
"healthy-4"	"2019-08-01-count-4:GCAGGCTTCTCGCAGG"	2.23630084571187	-6.54907562648924	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAGGCTTCTCGCAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.19801577415	53.2008439980991	0.0233726783124381	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2271.51445165385	2271.51445165385
"healthy-4"	"2019-08-01-count-2:TTGAACGGTGAGGAAA"	11.0459305244381	6.13307759845582	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAACGGTGAGGAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1793.28473275679	49.9578332559792	0.0278582828166834	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1785.25239889965	1785.25239889965
"healthy-4"	"2019-08-01-count-4:TCATGAGAGGACACTG"	2.88947286185567	-6.20663549816283	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATGAGAGGACACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.00189446202	46.8942075481557	0.0189701341464228	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2463.18740860647	2463.18740860647
"healthy-4"	"2019-08-01-count-2:CCTCTCCAGTAGCATA"	10.8217064338619	6.6754464873108	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCAGTAGCATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.85723742646	44.9835449212501	0.0230701735787704	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.19191615123	1930.19191615123
"healthy-4"	"2019-08-01-count-3:AGACCATAGGCGCTTC"	-4.8063829940861	2.79072711551515	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATAGGCGCTTC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2926.93831168497	42.2979939178148	0.0144512761847259	3553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2911.62209327698	2911.62209327698
"healthy-4"	"2019-08-01-count-4:GTTTACTGTAGATGTA"	11.3068252998287	5.01228568637697	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTACTGTAGATGTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1960.0114449482	37.6324517409957	0.0192001183656304	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1949.90473382491	1949.90473382491
"healthy-4"	"2019-08-01-count-3:AGACCCGAGTCTCCTC"	10.8317867713863	6.61426017368165	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGAGTCTCCTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.38324585715	38.50655079106	0.0213287405205636	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1796.45375947991	1796.45375947991
"healthy-4"	"2019-08-01-count-2:GGTAGAGTCTACCAGA"	3.08145656165425	-5.96743872081908	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAGAGTCTACCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.25124379357	49.1854517781989	0.0184890250095549	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.78213489141	2656.78213489141
"healthy-4"	"2019-08-01-count-4:GCATGATGTAACGATA"	0.0480780774610161	7.58398292148439	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATGATGTAACGATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1977.88421735887	40.9202354799365	0.0206888932733275	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1962.96782560419	1962.96782560419
"healthy-4"	"2019-08-01-count-4:GCATGATTCGTGTCAA"	-0.378328750759918	8.46000096881715	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCATGATTCGTGTCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.43658131257	51.9865825041288	0.025628892213376	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2019.64259589901	2019.64259589901
"healthy-4"	"2019-08-01-count-2:GCATGATCATTCGATG"	0.468679060309571	8.14328477466432	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATGATCATTCGATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2077.34782258819	44.9631376789047	0.0216444916879084	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2071.25664769534	2071.25664769534
"healthy-4"	"2019-08-01-count-4:TTAGGGTGTAGAGATT"	-3.32623515549358	-5.63224890148314	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTGTAGAGATT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2649.17716159903	48.393140733118	0.0182672346095223	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2643.23030880455	2643.23030880455
"healthy-4"	"2019-08-01-count-2:TTTCACAGTCGAGCTC"	-5.21661553803142	2.95147583568422	"2019-08-01-count-2"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTCACAGTCGAGCTC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2710.73246194191	44.2475943948159	0.0163231137768269	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2698.97354031294	2698.97354031294
"healthy-4"	"2019-08-01-count-2:GGTCACGTCAAATAGG"	-2.00363216820415	8.9480581053528	"2019-08-01-count-2"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTCACGTCAAATAGG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2070.26076556569	46.5396421094168	0.0224800869936305	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.71112508631	2058.71112508631
"healthy-4"	"2019-08-01-count-4:GCCAACGCAGGTCAAG"	-2.46601496163066	9.02559373462526	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAACGCAGGTCAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1887.48751665151	43.0227787505261	0.0227936759162522	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1885.78104837036	1885.78104837036
"healthy-4"	"2019-08-01-count-4:CTTTCAATCTGAGGTT"	11.5370441871578	3.96098539913026	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTTCAATCTGAGGTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2122.46120650784	38.8249883890957	0.0182924372280875	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2107.3952622439	2107.3952622439
"healthy-4"	"2019-08-01-count-3:GTACAACAGTGGTTGG"	2.99487247046773	-6.04381515895995	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAACAGTGGTTGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.65740897459	38.1578252206133	0.0164639627379163	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2313.7831361715	2313.7831361715
"healthy-4"	"2019-08-01-count-2:CCTTCAGTCCTTATAC"	2.23711218413655	-6.1722884408203	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTCAGTCCTTATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.42800793931	41.638427161761	0.01805320912616	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2304.9963761164	2304.9963761164
"healthy-4"	"2019-08-01-count-3:TGCAGATAGGTTCAGG"	3.5111035304958	-6.4582500687805	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGATAGGTTCAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.72629197074	46.6134537354437	0.0199396541398128	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2332.26194448504	2332.26194448504
"healthy-4"	"2019-08-01-count-1:CCGGTAGCAGAAGTGC"	0.671546657651108	8.06596276843873	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CCGGTAGCAGAAGTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1697.9534148204	32.5357124666207	0.0191617226848725	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1694.39748822551	1694.39748822551
"healthy-4"	"2019-08-01-count-2:GGTGAAGTCACTGATG"	11.268628736108	4.78729913318483	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGAAGTCACTGATG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.70657808951	44.537663116984	0.0213537530086231	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.50944396682	2077.50944396682
"healthy-4"	"2019-08-01-count-4:GTAATCGCAATCAGCT"	4.27263893660848	-6.77247955715331	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGCAATCAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.97593125661	48.6439636953195	0.019280391498262	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2517.46055795157	2517.46055795157
"healthy-4"	"2019-08-01-count-2:GGTGATTCATACTGTG"	10.1546074348385	7.21779487216798	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGATTCATACTGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1555.14836186548	40.1535230803299	0.0258197378880068	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1546.38271676372	1546.38271676372
"healthy-4"	"2019-08-01-count-4:GCCAGGTGTAAGGCTG"	2.91138662871663	-6.43935396587523	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGGTGTAAGGCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.48076064408	46.5260017731137	0.0182563676726973	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2543.60211459462	2543.60211459462
"healthy-4"	"2019-08-01-count-3:TGCAGGCGTCCAGCCA"	3.64609756049458	-6.13744070446166	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCGTCCAGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.17490346804	42.2617880156707	0.0167361824947765	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2524.06945282435	2524.06945282435
"healthy-4"	"2019-08-01-count-4:CCCTAACGTGGCAGAT"	10.6388641792232	6.30388829791871	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTAACGTGGCAGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.19204154495	46.6405136985641	0.0256945340388707	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1807.72039238212	1807.72039238212
"healthy-4"	"2019-08-01-count-4:GTAATCGTCCTTCGAC"	11.2296911674434	6.14496705615846	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATCGTCCTTCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1997.45284823476	43.9269345611932	0.0219914750928982	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1984.2627779764	1984.2627779764
"healthy-4"	"2019-08-01-count-3:TGCAGGCTCCGTTGAA"	2.77565683898274	-6.00075771724852	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGGCTCCGTTGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.69355836588	39.0857075062277	0.0161531642596196	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2417.53467184676	2417.53467184676
"healthy-4"	"2019-08-01-count-4:CCCTCAAAGGGCAGTT"	-4.13649592819865	13.1378669508728	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAAAGGGCAGTT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2501.86402669389	37.7713523664777	0.015097284250252	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2492.72967743042	2492.72967743042
"healthy-4"	"2019-08-01-count-2:AGTCTCCAGCACTCCG"	0.235145886510056	7.68828008258668	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCAGCACTCCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2026.19215169059	46.0680465347668	0.022736267385267	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2019.95566604802	2019.95566604802
"healthy-4"	"2019-08-01-count-2:GCCAGGTTCCCATACC"	4.44927563247029	-6.94008495723876	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGGTTCCCATACC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2685.41454102541	45.2791984488275	0.0168611578425199	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2680.12662761929	2680.12662761929
"healthy-4"	"2019-08-01-count-3:TGCAGTAAGCGTATAA"	10.7169586616451	7.25985667789308	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGCAGTAAGCGTATAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1839.28895777697	42.4388326235635	0.0230734993781817	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1827.74432945096	1827.74432945096
"healthy-4"	"2019-08-01-count-2:GCCAGTGGTTCAGCTA"	10.2882057624752	6.79531858051149	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGTGGTTCAGCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.89629924653	43.2478439138531	0.023005441274174	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1876.6397132198	1876.6397132198
"healthy-4"	"2019-08-01-count-2:AGTCTCCCACTCTGCT"	0.482906122773331	8.04934117877809	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCCACTCTGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.78617675798	38.9761166127342	0.0214179649843102	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1817.10149300738	1817.10149300738
"healthy-4"	"2019-08-01-count-2:TCACAAGCAACCCTCT"	11.0203730064327	6.61799142444459	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGCAACCCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.04179384037	46.2192534045482	0.0223169100411262	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2064.74740851629	2064.74740851629
"healthy-4"	"2019-08-01-count-4:GCCATTCAGCATAGGC"	10.3505407768184	6.40550658786622	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATTCAGCATAGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1575.26816066738	50.8207750009042	0.0322616658355956	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1570.67757677458	1570.67757677458
"healthy-4"	"2019-08-01-count-3:GTAGATCTCGTTCTGC"	11.1808296638424	6.11020133579103	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGATCTCGTTCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.60594538259	43.8078907925822	0.0210250363748785	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2074.47975860898	2074.47975860898
"healthy-4"	"2019-08-01-count-4:GCCATTCTCACCGCTT"	4.75525202330892	-7.01020767604979	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATTCTCACCGCTT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2887.86483000182	42.8160705659059	0.014826203124569	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2883.04223635063	2883.04223635063
"healthy-4"	"2019-08-01-count-1:CTCAGAAGTGGTCTAT"	0.582796116440934	8.18195436084596	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.CTCAGAAGTGGTCTAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1726.74866171703	37.0161607129591	0.0214369129298477	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1720.93395574811	1720.93395574811
"healthy-4"	"2019-08-01-count-4:AAGTGAACATAGGAGC"	0.241653268306893	7.60043428027955	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAACATAGGAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.16694448755	43.5654464863847	0.0221125659469007	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1968.95748450898	1968.95748450898
"healthy-4"	"2019-08-01-count-2:GTTCTATTCCACGTAA"	3.42636122283284	-6.59858562862548	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATTCCACGTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.82472458952	48.1574067701039	0.0204853242635997	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2345.23300460321	2345.23300460321
"healthy-4"	"2019-08-01-count-2:TTGCTGCTCTTCGTAT"	10.55256142196	6.52159497821657	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCTCTTCGTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1951.67020275472	42.8768810498986	0.0219693270868097	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1946.96606874437	1946.96606874437
"healthy-4"	"2019-08-01-count-2:ATCGCCTCAATAGTGA"	-2.40544901314433	8.90402410114137	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTCAATAGTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.35766940297	43.1038793487601	0.0235108948287198	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1831.26609471024	1831.26609471024
"healthy-4"	"2019-08-01-count-4:TCCACCATCATGGAGG"	-3.52777586403545	3.66271064365236	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCATCATGGAGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3238.57891975568	43.9959121526925	0.0135849436567109	4984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3232.68037017415	3232.68037017415
"healthy-4"	"2019-08-01-count-4:GTAGAGGCACTAACGT"	11.3204370933468	4.21824405277101	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGAGGCACTAACGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1953.72879550632	40.7391410417685	0.0208519939591773	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1948.32588047012	1948.32588047012
"healthy-4"	"2019-08-01-count-2:TCGTGGGGTCTACATG"	0.0935691828722179	7.5249452360901	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGGGGTCTACATG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1679.01303588331	41.7860907225255	0.0248872938026609	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1674.44877311359	1674.44877311359
"healthy-4"	"2019-08-01-count-3:GTAGTACCACTAGGTT"	10.5012356239254	6.34464023197023	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACCACTAGGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.53179148449	48.5299671876037	0.024715651357452	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.52892375333	1954.52892375333
"healthy-4"	"2019-08-01-count-3:CTCATTACAGTAGTTC"	4.66148104247395	-6.67556526577147	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTACAGTAGTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.35063477906	47.1315368427391	0.0179524731738187	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2618.93723154239	2618.93723154239
"healthy-4"	"2019-08-01-count-3:CTCATTAGTGAAGCGT"	0.11069674518649	7.77632424915162	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTAGTGAAGCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.02436106506	39.3601098418228	0.0224015732018444	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1749.85289808413	1749.85289808413
"healthy-4"	"2019-08-01-count-2:TTGGATGTCTGGGATT"	4.64117540892903	-7.48408892070922	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGATGTCTGGGATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.82644461311	40.9399903215931	0.0156748509863785	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2608.48754301961	2608.48754301961
"healthy-4"	"2019-08-01-count-2:CGACAGCCACCAGTAT"	4.3867675262386	-6.60921099102172	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGACAGCCACCAGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.94939522322	48.0206991377139	0.0176096774006263	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.21507836364	2721.21507836364
"healthy-4"	"2019-08-01-count-4:CTCCACACACCAATTG"	10.7251564460689	6.43420264804689	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCACACACCAATTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2121.05994782475	47.1777397564508	0.0222425301108693	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2109.81713977702	2109.81713977702
"healthy-4"	"2019-08-01-count-2:CTGCCTAGTGGCTTAT"	-1.35933611813243	8.58861825549928	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCTAGTGGCTTAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2034.85529197056	47.6346302073331	0.0234093453206707	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2034.85529197056	2034.85529197056
"healthy-4"	"2019-08-01-count-4:GATTCGACATCTGGGC"	-3.74824343147929	3.44650623882142	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCGACATCTGGGC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3320.07304164389	46.2213225348202	0.0139217788148222	5290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3312.1308752918	3312.1308752918
"healthy-4"	"2019-08-01-count-3:TGTACAGTCGACTCCT"	11.4572998481685	4.21843669498292	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTACAGTCGACTCCT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2177.42398721168	37.2695502474111	0.0171163496251995	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2159.02913514569	2159.02913514569
"healthy-4"	"2019-08-01-count-2:TCTACATTCCCATTTA"	0.414272983639878	8.22238729083864	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACATTCCCATTTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.37517823812	40.73902018577	0.0225404335946914	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1801.22880062446	1801.22880062446
"healthy-4"	"2019-08-01-count-2:GGTTCTCTCAGCCTCT"	11.184135099023	5.68925998294679	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTCTCTCAGCCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.12202190629	42.3401337976988	0.02152389802269	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.86206088366	1954.86206088366
"healthy-4"	"2019-08-01-count-2:GACCTTCTCTCGCTTG"	11.1715742546016	5.37300298297731	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCTTCTCTCGCTTG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2102.71033266379	39.4405415879598	0.0187570018443744	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2089.85907128249	2089.85907128249
"healthy-4"	"2019-08-01-count-2:CAACGGCCATCTGGGC"	-0.430877487093765	8.32962892139284	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGGCCATCTGGGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2150.90177160633	41.211644312095	0.0191601703323334	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.63440026672	2141.63440026672
"healthy-4"	"2019-08-01-count-4:TCGCTCAAGCTGGCCT"	-2.0302439731663	3.45622155750123	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTCAAGCTGGCCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3098.97124614084	43.2313098124274	0.0139502132736028	4917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3092.31803807609	3092.31803807609
"healthy-4"	"2019-08-01-count-4:CCGCAAGTCGGATTAC"	-0.281307826668578	7.82721803272096	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGTCGGATTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1913.80712723908	43.8711014096758	0.0229234705970427	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1907.12165549105	1907.12165549105
"healthy-4"	"2019-08-01-count-4:GTAGGAGTCAAGTGGG"	-2.53539762917216	3.53736660564271	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGAGTCAAGTGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3256.00721611895	46.7086469039223	0.0143453757327963	5207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3249.54667570162	3249.54667570162
"healthy-4"	"2019-08-01-count-2:TTGGTTTAGCAGAAAG"	-3.96263156357463	11.0850238570007	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGTTTAGCAGAAAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2048.45607565666	41.0052788487394	0.0200176510182649	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2044.98986785247	2044.98986785247
"healthy-4"	"2019-08-01-count-3:CTCCACATCAGCTCTC"	-0.269624481827575	8.20725629413453	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACATCAGCTCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2363.54399139984	42.0971261395748	0.0178110186621245	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2350.71280815042	2350.71280815042
"healthy-4"	"2019-08-01-count-2:GCCGATGCATGACTGT"	4.65735687789266	-6.9169755212036	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGCATGACTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2783.96661433273	45.7453989717432	0.0164317340359729	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2778.26575652526	2778.26575652526
"healthy-4"	"2019-08-01-count-2:GCCGATGTCAAGCTTG"	-4.02466283264812	10.6830358275208	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGTCAAGCTTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2029.67021839907	49.7992733923271	0.0245356476834976	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.51014945171	2024.51014945171
"healthy-4"	"2019-08-01-count-2:CGAGGAACACATCATG"	10.2717367607052	7.62881419742433	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACACATCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2035.69974807737	40.6820419011351	0.0199843036477052	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2026.54332787036	2026.54332787036
"healthy-4"	"2019-08-01-count-2:GCCGATGTCTCTCGCA"	10.5845791297847	6.80258462512819	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCGATGTCTCTCGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1974.0785339466	40.6699755025516	0.020602004835767	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1963.23504533877	1963.23504533877
"healthy-4"	"2019-08-01-count-4:GCGATCGCATCGTCCT"	10.9708944755489	5.70656106555787	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGATCGCATCGTCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.22461927683	48.2261997735268	0.025883191577967	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1848.47907767349	1848.47907767349
"healthy-4"	"2019-08-01-count-4:CCGGGTAGTTAAGTCC"	6.83293833312337	-1.73933222210082	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTAGTTAAGTCC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2771.15584245564	34.0749858279959	0.0122963080264012	2148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2759.70392694905	2759.70392694905
"healthy-4"	"2019-08-01-count-4:TGCACGGCATATCGGT"	4.81920494612996	-7.29805185711058	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCACGGCATATCGGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2594.70910728143	49.2540135150891	0.0189824799153283	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2591.28848665196	2591.28848665196
"healthy-4"	"2019-08-01-count-2:TCAGCAACAAATGCGG"	0.580195029347581	8.07511327350465	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAACAAATGCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.30042092501	40.5625391747764	0.0225937334509602	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1786.45752360385	1786.45752360385
"healthy-4"	"2019-08-01-count-3:ATCGTCCGTGATACTC"	-2.06935272637065	9.40128705585328	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTCCGTGATACTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2019.48635207283	48.5045885138971	0.0240182799275229	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2013.12679208584	2013.12679208584
"healthy-4"	"2019-08-01-count-2:TTGTGTTCAACTCCAA"	3.96909489211385	-6.38145973598631	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTCAACTCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.16221592616	47.6794761680667	0.0184363826346414	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2582.83527317688	2582.83527317688
"healthy-4"	"2019-08-01-count-2:TGTGAGTCAACGCATT"	4.65327944335286	-6.85755207454833	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGAGTCAACGCATT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.80972806312	47.4223730675661	0.0175846195503105	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2690.45466361805	2690.45466361805
"healthy-4"	"2019-08-01-count-4:TCCCAGTAGCCGCACT"	2.81618895110432	-5.88236334240111	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTAGCCGCACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2866.93353243164	44.8772321480664	0.0156533912071561	2562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2862.20108663944	2862.20108663944
"healthy-4"	"2019-08-01-count-3:CTCCCAATCCTGTAAG"	10.6401707130367	6.77862689578859	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAATCCTGTAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.37274930358	46.9699248065661	0.0243572850858472	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1916.50779031996	1916.50779031996
"healthy-4"	"2019-08-01-count-3:CAGCACGGTCCACTCT"	-0.323601226240951	7.64616439426271	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCACGGTCCACTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2109.39473934901	42.9385457799262	0.0203558608443186	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2091.5218358684	2091.5218358684
"healthy-4"	"2019-08-01-count-2:TCTCAGCGTCCTCAGG"	2.20122828063313	-5.87417080318602	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCAGCGTCCTCAGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2605.02667074847	44.2830226608225	0.0169990669032571	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2598.38998762647	2598.38998762647
"healthy-4"	"2019-08-01-count-3:ATCTCTAAGCGACCCT"	10.3428484397823	5.75112578952638	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCTCTAAGCGACCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1816.10721730144	46.262134990928	0.0254732399883687	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1807.31443748788	1807.31443748788
"healthy-4"	"2019-08-01-count-4:GTCAAACCACCCGTAG"	10.818976064294	6.68870732868043	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACCACCCGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.89470229697	40.0407870856442	0.0210309882355031	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.79059219326	1893.79059219326
"healthy-4"	"2019-08-01-count-2:GCGGAAATCAGCTTCC"	-5.40910849991496	-5.57230808651122	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGGAAATCAGCTTCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2675.04492026514	45.1582114757685	0.0168812909023198	1789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2668.01933069882	2668.01933069882
"healthy-4"	"2019-08-01-count-4:GCGTGCACAGGTACGA"	6.84229483184163	-1.60050167953642	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGTGCACAGGTACGA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2635.44954462453	36.1620685699417	0.0137214042453215	1844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2625.62234182725	2625.62234182725
"healthy-4"	"2019-08-01-count-2:TTGTTGTCAGCTCATA"	0.74096586283986	8.1784047850403	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTGTCAGCTCATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.60715177992	44.1396409212988	0.0237232458657773	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1851.02711413189	1851.02711413189
"healthy-4"	"2019-08-01-count-3:CAGCCAGGTTCCGTTC"	-3.56916675987895	10.5962419279846	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGCCAGGTTCCGTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.15101297373	42.6631533179887	0.0197135750057321	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2157.9755894478	2157.9755894478
"healthy-4"	"2019-08-01-count-2:TCAGGGCAGTGACACG"	2.4835168319637	-6.67523004924925	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGGCAGTGACACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.02320077256	43.2039226357349	0.0205632772735915	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2098.31626675499	2098.31626675499
"healthy-4"	"2019-08-01-count-3:GAGAAATGTCTCACAA"	11.4303137260372	3.38379452312318	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATGTCTCACAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1793.42981936225	40.5224704152994	0.0225949574261619	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1765.4506102503	1765.4506102503
"healthy-4"	"2019-08-01-count-4:TACCTCGAGTTCAACC"	2.73102964934651	-6.19246675884398	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTCGAGTTCAACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2796.1173234062	39.6320292326612	0.014173950749814	2203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2788.83831768928	2788.83831768928
"healthy-4"	"2019-08-01-count-4:GTCACGGCAAGAATGT"	0.0514629679032646	7.82761237705079	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACGGCAAGAATGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.96728395719	41.2541638245737	0.0218395332597558	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1883.80904400217	1883.80904400217
"healthy-4"	"2019-08-01-count-4:TGCATCCTCGTGACTA"	2.44957818564717	-6.19531967556151	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATCCTCGTGACTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.37151541738	50.4370231646194	0.023037215387816	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2183.63269855526	2183.63269855526
"healthy-4"	"2019-08-01-count-2:CTCCGATTCGCTGCGA"	10.9169784980709	6.63479755008546	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCGATTCGCTGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.89892868784	43.6890252903566	0.0219996217628374	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.11905244421	1975.11905244421
"healthy-4"	"2019-08-01-count-4:GACCAATCAATAGAGT"	0.536027123301667	8.19507119739381	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATCAATAGAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.14681506381	46.7209404204929	0.0240315906486514	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1936.1925177889	1936.1925177889
"healthy-4"	"2019-08-01-count-4:GCTACAATCAGTGTGT"	-1.7286835712498	9.0135869749817	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAATCAGTGTGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.620320223	43.5007807900682	0.0217436463832475	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1998.96510430767	1998.96510430767
"healthy-4"	"2019-08-01-count-3:TACTTGTCAATGGCCC"	11.4645754295284	4.59585092151491	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTCAATGGCCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2252.89808486433	29.2159564526527	0.0129681660475166	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2240.96412095321	2240.96412095321
"healthy-4"	"2019-08-01-count-2:GCGTTTCGTCTTGCTC"	11.3315874534542	3.60219857776491	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCGTCTTGCTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1518.67955962616	43.0670629597412	0.0283582291516077	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1502.36786086285	1502.36786086285
"healthy-4"	"2019-08-01-count-1:GTGCGTGCACCCTTAC"	0.060217862564516	7.86505267703859	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GTGCGTGCACCCTTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.8329880829	43.037553882028	0.0219262434161873	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1952.10144049333	1952.10144049333
"healthy-4"	"2019-08-01-count-3:TCCTAATTCACTGTCC"	-2.78790960732158	10.0055532225403	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATTCACTGTCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2318.57867199215	47.4067392731177	0.0204464656928743	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2309.58336944746	2309.58336944746
"healthy-4"	"2019-08-01-count-3:ATGAAAGTCGCGTTTC"	1.79506351527516	-6.74689628994139	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGTCGCGTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2025.6551687077	46.717781614748	0.0230630476185897	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2024.04455401702	2024.04455401702
"healthy-4"	"2019-08-01-count-3:ATGAAAGTCGGTGCAC"	4.06305088576619	-6.88318684017333	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGTCGGTGCAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.04780556717	39.1018769234042	0.0157348590380457	1763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2480.85888000105	2480.85888000105
"healthy-4"	"2019-08-01-count-4:CCTACGTTCATCGCTC"	3.34860601004903	-7.0555892220703	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTACGTTCATCGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.93439308919	47.416468966591	0.0219527357489664	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2155.42570794273	2155.42570794273
"healthy-4"	"2019-08-01-count-3:GTCCCATCAACGTATC"	-2.85539040985759	9.62865541065065	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATCAACGTATC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.78123529747	48.2944618165054	0.0232656799258447	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2070.8096784	2070.8096784
"healthy-4"	"2019-08-01-count-3:GTCCCATCATCGGTTA"	4.26111282882039	-7.04131224071654	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATCATCGGTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.99914135053	38.5151592920723	0.0171483410580971	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2245.99914135053	2245.99914135053
"healthy-4"	"2019-08-01-count-4:CCTATCGCAGCGATTT"	-3.79903278771098	10.7008809813294	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTATCGCAGCGATTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.68057431569	49.868612180955	0.0244732235314666	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.35300594101	2032.35300594101
"healthy-4"	"2019-08-01-count-4:GCTGAATAGTTGTCAC"	-1.97959289971049	9.75086972797243	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGAATAGTTGTCAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1712.14462709553	26.0866783275584	0.0152362586166635	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1707.75092295949	1707.75092295949
"healthy-4"	"2019-08-01-count-3:TGGATCATCGTCAGAT"	0.357157279818696	8.18010137164918	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGGATCATCGTCAGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.2037343345	35.1207120685947	0.020251779749553	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1727.11553651762	1727.11553651762
"healthy-4"	"2019-08-01-count-2:GCTACCTAGTGGTGGT"	10.56587757644	7.15938994968263	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACCTAGTGGTGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2061.18312975174	42.1703230468026	0.0204592801280505	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2059.78286319002	2059.78286319002
"healthy-4"	"2019-08-01-count-3:ATGACCAGTGTTCATG"	10.5551992851192	7.61578891361085	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCAGTGTTCATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2155.49504787588	40.5003281259433	0.0187893394447155	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2147.07318108444	2147.07318108444
"healthy-4"	"2019-08-01-count-4:GACCTTCCAGAGGGTT"	-0.188252965838271	8.65839955890504	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCCAGAGGGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.20463358914	40.7855258639712	0.0213737694301987	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1895.82251227221	1895.82251227221
"healthy-4"	"2019-08-01-count-2:CGATGGCGTCTACACA"	-4.36526475372966	12.9480523833069	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGATGGCGTCTACACA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2011.906450309	42.1894648676606	0.0209698939337766	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2006.51672608099	2006.51672608099
"healthy-4"	"2019-08-01-count-3:GTCGTAACAGCGATTT"	10.864690442651	6.09048125827638	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTAACAGCGATTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1701.30456093241	43.3131508771576	0.0254587872575969	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1697.39023024795	1697.39023024795
"healthy-4"	"2019-08-01-count-4:CCTCACAAGCCAAGCA"	5.34903969344441	-9.36069586193236	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACAAGCCAAGCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3071.96437920921	40.651938595577	0.0132332063713713	2666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3065.54353987683	3065.54353987683
"healthy-4"	"2019-08-01-count-3:CTCTCAGGTAATTAGG"	-0.0837710005348504	7.80538318240968	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTCAGGTAATTAGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.21642210256	44.0171609425373	0.0237133776096424	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1853.46066416927	1853.46066416927
"healthy-4"	"2019-08-01-count-3:GTCGTTCGTGCCTTTC"	3.5862475830013	-6.98819115078124	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTTCGTGCCTTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.88927439134	40.5984389444492	0.0170948765410775	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2371.94104436697	2371.94104436697
"healthy-4"	"2019-08-01-count-1:TATACCTTCGACGTCG"	4.07235064086263	-6.5874700776306	"2019-08-01-count-1"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TATACCTTCGACGTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.88543063189	46.7533886590318	0.017616958184928	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2647.02360358906	2647.02360358906
"healthy-4"	"2019-08-01-count-3:ATGAGTCTCGGTCGAC"	10.410227437585	6.35620114887086	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCTCGGTCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1850.63546695522	47.3120056903189	0.0255652755689156	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1836.41225220456	1836.41225220456
"healthy-4"	"2019-08-01-count-3:CATAAGCGTTACTCAG"	4.66690887984578	-6.75281002437743	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCGTTACTCAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.98226382255	42.3692591956497	0.0176613474116054	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2396.41281489501	2396.41281489501
"healthy-4"	"2019-08-01-count-3:GAGGCAACACCTTCGT"	11.0082832771236	6.59158752048341	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGCAACACCTTCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1987.90669059381	47.2170937512681	0.0237521680341867	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1984.67430806789	1984.67430806789
"healthy-4"	"2019-08-01-count-4:GACGTTACAACGGGTA"	-3.99656091156657	13.2191304930481	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTACAACGGGTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1927.15871803872	48.143644361202	0.0249816706380043	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1921.30210503224	1921.30210503224
"healthy-4"	"2019-08-01-count-2:CGCATAAGTTTACGTG"	-2.1951941055363	3.44459698283998	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAAGTTTACGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3157.36218549859	43.8266836424335	0.0138807906941195	4898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3151.62731319742	3151.62731319742
"healthy-4"	"2019-08-01-count-4:GCTTGGGTCTCCTGTG"	2.65459003028218	-6.0371942750183	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTGGGTCTCCTGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.30373913412	43.6967266952029	0.0166507885667306	1993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2618.52557628611	2618.52557628611
"healthy-4"	"2019-08-01-count-2:CGCATGGAGCATTTCG"	-3.75111661377605	10.9100465544495	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATGGAGCATTTCG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2100.05258565217	43.2125931714541	0.0205769100577233	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2098.3317970318	2098.3317970318
"healthy-4"	"2019-08-01-count-3:CTCTGGTGTTTCGTAG"	3.53818049010579	-6.18691446697386	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCTGGTGTTTCGTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.75786676629	40.3620351602381	0.0152323484596331	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2639.11675999256	2639.11675999256
"healthy-4"	"2019-08-01-count-3:AACCAACTCGCCTTGT"	-3.69946942749675	9.99159619891969	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACTCGCCTTGT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2347.81479725163	47.7526037953978	0.0203391697894133	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2338.70902940527	2338.70902940527
"healthy-4"	"2019-08-01-count-2:ATGCGATGTCATCAGT"	11.1878782707149	6.23059985721437	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGCGATGTCATCAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.56040599104	49.813777837899	0.0264045496129931	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1878.45145640717	1878.45145640717
"healthy-4"	"2019-08-01-count-2:GGTAGAGTCTTGAACG"	2.42435540732686	-6.04593183910521	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAGAGTCTTGAACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2545.93597729622	40.7515422361688	0.0160065070762097	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2544.90360760613	2544.90360760613
"healthy-4"	"2019-08-01-count-3:CCACACTCAACTCGAT"	11.0218731361324	6.04149005496827	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACACTCAACTCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2110.13647229117	47.2866519156524	0.0224092860990687	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2102.42790591885	2102.42790591885
"healthy-4"	"2019-08-01-count-4:GTCCCATTCCGTATGA"	-2.91716895523723	9.17342660510866	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCCATTCCGTATGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2139.51442063027	39.9805787108567	0.0186867535574165	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2134.57154537368	2134.57154537368
"healthy-4"	"2019-08-01-count-2:GTATTTCCAGATCCTA"	4.77243580397908	-6.83502724086913	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTATTTCCAGATCCTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.42525590813	43.8992247194489	0.016414451898579	2167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2664.650375072	2664.650375072
"healthy-4"	"2019-08-01-count-2:GCTGGGTAGCGACAGT"	11.1194702583248	6.57321975314943	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTGGGTAGCGACAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.24075219273	42.5231185311646	0.0213550865129386	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1986.18759606385	1986.18759606385
"healthy-4"	"2019-08-01-count-2:ATCCATTGTCAAGCCC"	10.3056713539058	7.74160001361696	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCATTGTCAAGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2097.82713043219	50.0637950730358	0.0238645951073775	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2083.97597594292	2083.97597594292
"healthy-4"	"2019-08-01-count-4:CCTCCAAGTTGAGTCT"	11.114012380212	6.17168710315553	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCAAGTTGAGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.92362206256	47.0171271102139	0.0250501014306306	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.59472453594	1868.59472453594
"healthy-4"	"2019-08-01-count-4:ACACTGACAGTTAGAA"	4.39683928069417	-6.68967678463133	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACACTGACAGTTAGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.05023691517	40.0977037248077	0.0190483357696815	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2103.33341554237	2103.33341554237
"healthy-4"	"2019-08-01-count-2:AGAGCCCAGTAGAGTT"	10.8607975440914	6.51426265323488	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGAGCCCAGTAGAGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.05085059134	50.1093971484413	0.0261934475672468	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1897.36892179517	1897.36892179517
"healthy-4"	"2019-08-01-count-2:GAGCCTGTCAACGTGT"	-7.178046087653	2.56846759403077	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGTCAACGTGT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2758.59927273896	42.9650293306221	0.0155749440504865	3601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2744.1312182629	2744.1312182629
"healthy-4"	"2019-08-01-count-3:AGGATAACACAACCGC"	4.98443426665608	-7.78623011028441	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGATAACACAACCGC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2691.25525918389	42.6834049606161	0.0158600358754374	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2688.18213534065	2688.18213534065
"healthy-4"	"2019-08-01-count-2:GAGCCTGTCTCCTGAC"	10.5348431068355	6.5159644850525	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGTCTCCTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.21732956506	44.0421675146873	0.0223880538529136	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1963.92559211234	1963.92559211234
"healthy-4"	"2019-08-01-count-2:AGATAGAAGTGAGCCA"	4.52730669555013	-6.81151392376097	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGAAGTGAGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2863.9097901996	38.6345892698633	0.0134901558010215	2284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.46383643139	2859.46383643139
"healthy-4"	"2019-08-01-count-2:AGATAGACAAGAATAC"	-1.015852312476	8.31334302509157	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGACAAGAATAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1918.82826551798	43.3140274996024	0.022573165237333	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1915.69983569205	1915.69983569205
"healthy-4"	"2019-08-01-count-2:TTTGACTGTATGGTAA"	3.12070288237874	-5.93249037182006	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTGTATGGTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.41694123015	40.5728788042518	0.0142690571389431	2703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2834.75045432622	2834.75045432622
"healthy-4"	"2019-08-01-count-2:TCATGAGTCAAGTCGT"	10.5499817329342	6.22095677936403	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGAGTCAAGTCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.15304722707	17.5763433447542	0.00942353946282586	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1854.82342343283	1854.82342343283
"healthy-4"	"2019-08-01-count-3:ATGGGAGGTGGCCCAT"	3.02541198310201	-6.30431988155516	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGAGGTGGCCCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.53589684237	48.5061667630161	0.0210938941329956	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2298.08108517251	2298.08108517251
"healthy-4"	"2019-08-01-count-2:GCTTTCGGTGTCCATA"	-0.125587115914184	8.35131261432496	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTTTCGGTGTCCATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2056.10746985267	46.5311448808265	0.0226306968692452	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.59759476331	2054.59759476331
"healthy-4"	"2019-08-01-count-2:GGAACCCGTTGTCCCT"	-0.815579513937789	8.10344598377077	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAACCCGTTGTCCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.39502461932	51.4362993401164	0.0240762119118311	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2128.95339952575	2128.95339952575
"healthy-4"	"2019-08-01-count-3:ATGGGTTAGTGATTCC"	2.32327069815938	-5.96240713512572	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGGGTTAGTGATTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.92806629023	47.2884450702796	0.0196631432486983	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2402.62778174134	2402.62778174134
"healthy-4"	"2019-08-01-count-2:CGGAACCCAAGACGAC"	-1.79408786717113	8.74566075885621	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAACCCAAGACGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2167.72573720325	43.6765170926803	0.0201485438600875	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2163.77653121046	2163.77653121046
"healthy-4"	"2019-08-01-count-2:TCATGGACAAACGAGC"	2.5282265144283	-5.88749697124632	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGGACAAACGAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.42941354376	45.0789353478794	0.017235768288925	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2611.67286663107	2611.67286663107
"healthy-4"	"2019-08-01-count-4:TGGAGGAGTAATACCC"	10.2205845313961	6.81482789600221	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAGGAGTAATACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1980.74966410031	45.7158843367031	0.0230800919294706	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.77175458657	1975.77175458657
"healthy-4"	"2019-08-01-count-4:AGGAAATCATTGAGCT"	-3.5527015728062	-4.67237999355467	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGAAATCATTGAGCT"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3071.25058917368	41.297299338577	0.0134464115315605	3230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3065.97989471663	3065.97989471663
"healthy-4"	"2019-08-01-count-4:TGGATCAAGTTCCGGC"	10.6713196235592	7.27237079227296	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATCAAGTTCCGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1926.03186812635	41.7896697181964	0.0216972888194469	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1920.57328709195	1920.57328709195
"healthy-4"	"2019-08-01-count-4:CTCATGCCAGCATACT"	10.5983158546383	7.22911546314088	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCCAGCATACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2352.96723916606	44.218830923505	0.0187927949813602	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2343.99870424795	2343.99870424795
"healthy-4"	"2019-08-01-count-3:CTGCATCGTCTACTGA"	-0.77446417036708	8.02641389453737	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGCATCGTCTACTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1930.11199842692	42.3657110015559	0.0219498718396056	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1925.33493931423	1925.33493931423
"healthy-4"	"2019-08-01-count-4:CCTCTAGTCAGCAGAG"	-3.66180596771892	10.7727651366028	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCTAGTCAGCAGAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1897.25659312119	48.7277886255011	0.0256832885979533	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1890.35291538268	1890.35291538268
"healthy-4"	"2019-08-01-count-4:GGAGATGCACCCTAGG"	-4.74744544449504	-4.07097198879393	"2019-08-01-count-4"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGATGCACCCTAGG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3358.76544738329	45.3897725049853	0.0135138262007391	4464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3349.30899990698	3349.30899990698
"healthy-4"	"2019-08-01-count-2:GGAATCTCAAATTGGA"	-7.33092914047893	3.10321877086488	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTCAAATTGGA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2539.94060848874	43.4710969495098	0.0171150052895824	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2530.46505596827	2530.46505596827
"healthy-4"	"2019-08-01-count-2:CGGAATTCATGCAGCC"	10.2570473152095	7.66925904834596	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAATTCATGCAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.00618444239	46.0730944431173	0.0220973418625322	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2082.32077540733	2082.32077540733
"healthy-4"	"2019-08-01-count-4:TAAGTCGAGATTAGTG"	2.95875062522237	-4.90054943477782	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGTCGAGATTAGTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2996.92512208984	40.964539749602	0.0136688566049446	3145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2990.95114171992	2990.95114171992
"healthy-4"	"2019-08-01-count-2:TACCGAAGTCCCGTGA"	10.1396013694698	7.69556329334108	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGAAGTCCCGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1910.01001871141	43.3412221821667	0.0226916203357963	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1903.51507460256	1903.51507460256
"healthy-4"	"2019-08-01-count-3:TATACCTCACCACTGG"	-3.3294292491978	3.61853835666505	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATACCTCACCACTGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3711.96824178677	32.2196103307917	0.00867992618258034	4529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3702.13859603566	3702.13859603566
"healthy-4"	"2019-08-01-count-2:TTTGGAGTCAGATTGC"	11.397646566003	4.3907465704712	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGGAGTCAGATTGC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2167.92033562342	50.4125449654602	0.0232538733721335	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2159.56604542331	2159.56604542331
"healthy-4"	"2019-08-01-count-3:GAGTGTTTCTTGCAGA"	3.69216861304585	-6.41911985790404	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTTCTTGCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2177.89496014587	45.8244974491296	0.0210407289091942	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2176.30675993528	2176.30675993528
"healthy-4"	"2019-08-01-count-4:TGGCGTGGTACTGACT"	-0.566745261580306	8.13993928516237	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGGTACTGACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2064.82616673339	43.9356119513542	0.0212781166081702	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2062.16314177695	2062.16314177695
"healthy-4"	"2019-08-01-count-2:CGGAGAACATCAGTCA"	-1.49897728386577	8.67394731128541	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGAGAACATCAGTCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2148.23212419972	43.964636451835	0.0204654962359867	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.58200195648	2142.58200195648
"healthy-4"	"2019-08-01-count-2:TACCGGGTCAAAGGTA"	9.79858269271199	7.24995610797731	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGTCAAAGGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2085.51267265695	45.0837030828641	0.0216175637165644	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2078.52808291245	2078.52808291245
"healthy-4"	"2019-08-01-count-2:GTCATCCGTACGATCT"	-0.503811637789565	8.06380078876344	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATCCGTACGATCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.97577179027	40.730401951701	0.0205607774369152	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1978.27918178093	1978.27918178093
"healthy-4"	"2019-08-01-count-3:CTTGATTAGGATTCAA"	-1.70643470707591	8.57849023425905	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTAGGATTCAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.51339251845	44.1198386348463	0.0222096859759462	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.49402784825	1979.49402784825
"healthy-4"	"2019-08-01-count-2:ATGTCTTTCTACGGGC"	5.06977285918538	-7.39510013973387	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGTCTTTCTACGGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.19413706299	41.4415273360756	0.014992263669334	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2758.75232859827	2758.75232859827
"healthy-4"	"2019-08-01-count-4:CTACCTGCAGTTAGAA"	-3.02439771118816	3.7854797610077	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACCTGCAGTTAGAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3212.30225840978	44.2310087294323	0.0137692549365913	5107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3202.24939636543	3202.24939636543
"healthy-4"	"2019-08-01-count-3:GCAGCTGTCTTCGACC"	0.295724322169465	7.98081157291261	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCTGTCTTCGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.20739808707	42.0694170562734	0.0216272141971312	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1937.27214601049	1937.27214601049
"healthy-4"	"2019-08-01-count-4:ATGTCTTTCTTTGCGC"	10.1332146125728	7.4348139532837	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCTTTCTTTGCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2178.42685148305	41.4494847345968	0.0190272557035269	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2173.64997896824	2173.64997896824
"healthy-4"	"2019-08-01-count-3:AGGGTGAGTATGAGGC"	4.18516172942464	-7.12168362056883	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGTGAGTATGAGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.85574049057	39.2436427845778	0.0197317693715171	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1983.72681616347	1983.72681616347
"healthy-4"	"2019-08-01-count-2:GTCATGAGTCGCTTAA"	9.88754238662068	7.08950183475343	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATGAGTCGCTTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.72099197756	38.5061591856809	0.0200060992456458	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.63752033909	1917.63752033909
"healthy-4"	"2019-08-01-count-2:GTCATTTTCCAGTGCG"	10.5131832557613	6.64963576877443	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATTTTCCAGTGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1920.65751045848	43.8554681887986	0.0228335702487269	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1912.3807205381	1912.3807205381
"healthy-4"	"2019-08-01-count-3:CATGCAACAAGAGTGC"	-1.83856199207957	9.09842488849489	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCAACAAGAGTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1617.66599987989	40.505262424119	0.0250393235854166	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1617.66599987989	1617.66599987989
"healthy-4"	"2019-08-01-count-2:GGGCTCACAACTGAAA"	-4.29408202591594	12.2635621794495	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTCACAACTGAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2052.14297982012	46.4201030932196	0.0226203064551031	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2046.63425236975	2046.63425236975
"healthy-4"	"2019-08-01-count-3:GATAGCTGTATCGATC"	10.7990395027095	5.70887515628663	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGCTGTATCGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1969.6840754938	47.4529355402617	0.0240916480620707	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1964.3082964438	1964.3082964438
"healthy-4"	"2019-08-01-count-2:AACCTTTAGCCTCAAT"	0.0386801958898127	8.2736024626526	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AACCTTTAGCCTCAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2140.54371096577	37.4164317006662	0.0174798727580222	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2136.86316655835	2136.86316655835
"healthy-4"	"2019-08-01-count-3:TCGGATATCTGCACCT"	-2.59532413902934	9.69318196857301	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGATATCTGCACCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1536.52172309712	49.3298175946542	0.0321048618142682	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1527.19553887569	1527.19553887569
"healthy-4"	"2019-08-01-count-4:TCGCTTGCACCCAAGC"	-0.198070715100127	7.5579361685547	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTTGCACCCAAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1921.54568143463	41.1123443865283	0.0213954551191486	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1907.25310450003	1907.25310450003
"healthy-4"	"2019-08-01-count-3:TGTCAGAAGGTCTTTG"	-2.21518955650981	9.41780755603639	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCAGAAGGTCTTTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2158.98474131627	47.2813236284473	0.0218997951785529	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2152.30740015282	2152.30740015282
"healthy-4"	"2019-08-01-count-3:TGTCAGAGTCGTGATT"	4.56017508086507	-6.92580749904784	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCAGAGTCGTGATT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2594.21920588261	48.4848296445362	0.0186895654517524	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2590.11062517502	2590.11062517502
"healthy-4"	"2019-08-01-count-1:TTCCAATTCATTGTTC"	11.046704907983	6.34485290134279	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.TTCCAATTCATTGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2310.72135955119	44.9994484314684	0.0194741993643961	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2300.31601184151	2300.31601184151
"healthy-4"	"2019-08-01-count-3:ATTATCCCATGGGATG"	10.4213520484859	7.85417172992555	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTATCCCATGGGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2227.92200790317	45.4351311385249	0.0203935016474327	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2224.22148914432	2224.22148914432
"healthy-4"	"2019-08-01-count-2:ATCGTGACAACAGCCC"	4.24186291274373	-6.63313295757445	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTGACAACAGCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.49630314176	44.9658004517955	0.018615553413727	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2412.71911030187	2412.71911030187
"healthy-4"	"2019-08-01-count-2:TCCACCACATGTTTGG"	10.7428957420284	6.85664651477662	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCACCACATGTTTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2160.2827628322	46.0278677264756	0.0213064088268387	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2149.07554096704	2149.07554096704
"healthy-4"	"2019-08-01-count-2:ATCGTGACAACTAGAA"	0.171649676829022	7.67893884265748	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTGACAACTAGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1985.41353090668	44.7157084996988	0.0225221133046668	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1974.73383286712	1974.73383286712
"healthy-4"	"2019-08-01-count-2:GTCCTCAAGAATAGTC"	-5.23525987091716	-5.16631796276244	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCAAGAATAGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2584.44259156351	44.6982538126122	0.0172951235049764	1787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2579.8972548748	2579.8972548748
"healthy-4"	"2019-08-01-count-4:AGGATCTTCGACACTA"	1.96327020701711	-6.12450745021971	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATCTTCGACACTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2492.63808940879	49.2670579143265	0.0197650265089272	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2486.3851556561	2486.3851556561
"healthy-4"	"2019-08-01-count-3:TGTCCCACATCAACCA"	-2.25929413262065	8.67175195300905	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTCCCACATCAACCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1979.53691473236	38.3151108321173	0.0193555929909484	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1976.00703839869	1976.00703839869
"healthy-4"	"2019-08-01-count-3:GTGGAAGCACCACATA"	-1.83702013912852	4.09642980182496	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGGAAGCACCACATA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2845.15605225299	40.2990724809087	0.014164099170939	5112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2840.08532618635	2840.08532618635
"healthy-4"	"2019-08-01-count-4:CGAAGGAAGTCATCCA"	-0.353158096701461	7.72959659183351	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGAAGGAAGTCATCCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1903.1253225469	39.9893006476123	0.0210124368447242	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1894.55740912764	1894.55740912764
"healthy-4"	"2019-08-01-count-3:CTGTACCCACCTGCGA"	-2.59387026253398	9.01832959735719	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTACCCACCTGCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.96662307106	44.3551610435657	0.0237197608215706	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1863.91007584184	1863.91007584184
"healthy-4"	"2019-08-01-count-4:TCGGGCAAGTTGGACG"	0.466770221560639	8.04096171939699	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGGCAAGTTGGACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1920.55398470165	42.1833255323899	0.0219641446522229	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1910.30513997824	1910.30513997824
"healthy-4"	"2019-08-01-count-2:GGAGGATAGCCTGCCA"	4.48523058471028	-7.4746394387451	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGATAGCCTGCCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.52530824219	47.2789616488035	0.0210266531025903	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2245.31043610323	2245.31043610323
"healthy-4"	"2019-08-01-count-4:GGCTGTGCATGACCCG"	3.13888539847676	-6.36674168026122	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCTGTGCATGACCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.47638612622	44.0650111876783	0.0183874172275518	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2394.00610283978	2394.00610283978
"healthy-4"	"2019-08-01-count-2:CACTGAATCGTCAAAC"	11.3232847648555	5.92560861194459	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTGAATCGTCAAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.47179667206	47.6631489974792	0.0245247443668058	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.13318410537	1932.13318410537
"healthy-4"	"2019-08-01-count-2:GTCCTCATCGCTTACC"	10.8171822029049	6.08558175647584	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCATCGCTTACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.01934809966	45.2625342804878	0.0232590361060325	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.08186025127	1937.08186025127
"healthy-4"	"2019-08-01-count-3:ATTCATCGTTGTTGTG"	-2.26809869232829	4.1030702360901	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCATCGTTGTTGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3112.71406944148	47.8120674435728	0.0153602503721621	5230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3105.73345910925	3105.73345910925
"healthy-4"	"2019-08-01-count-2:TGAGGGAGTCAACACT"	4.71693338927571	-6.83753445064696	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGGAGTCAACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2782.82300004849	44.4526408366944	0.015973937557624	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2782.82300004849	2782.82300004849
"healthy-4"	"2019-08-01-count-4:TGGTAGTAGGGACTGT"	11.4588428932125	3.52984497630922	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTAGGGACTGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1412.96430912933	39.2410369771099	0.0277721360147379	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1400.17846275917	1400.17846275917
"healthy-4"	"2019-08-01-count-4:ATTCATCAGAACTCCT"	1.82965519007985	-5.99710132991942	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCATCAGAACTCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2857.81848315816	43.4173575807788	0.0151924826005039	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2852.38131668799	2852.38131668799
"healthy-4"	"2019-08-01-count-2:CGTAGTACAAGTGGCA"	11.4804951148922	4.01650497997133	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTAGTACAAGTGGCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.06246207855	35.3666397760312	0.0180990323811918	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1944.86666410736	1944.86666410736
"healthy-4"	"2019-08-01-count-2:ACCACAATCATGCAGT"	0.108278733759564	7.59560535037843	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAATCATGCAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2033.84361778722	45.6256346224892	0.0224332068716911	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2028.17709112122	2028.17709112122
"healthy-4"	"2019-08-01-count-2:GTCGCGACATGATAGA"	-0.510315279394943	8.18801019275514	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGCGACATGATAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2303.47968659143	42.0415300108157	0.0182513135477338	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2298.47084357719	2298.47084357719
"healthy-4"	"2019-08-01-count-3:GGGACCTCAAGCGCAA"	-0.291787813336211	7.64740512454835	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGACCTCAAGCGCAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2330.88775752143	42.3306591847059	0.0181607454276213	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2322.0827297991	2322.0827297991
"healthy-4"	"2019-08-01-count-3:CTGTCGTAGTGGTCAG"	11.1222692924434	6.13513085925905	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTCGTAGTGGTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1822.62735641625	46.8053238350072	0.0256801389874002	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1808.21950936635	1808.21950936635
"healthy-4"	"2019-08-01-count-3:CATTCATTCGTTCTAT"	-4.1667893928593	12.5649413832459	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATTCGTTCTAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2167.9484697329	40.5180711233705	0.0186895914220519	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2166.06661866397	2166.06661866397
"healthy-4"	"2019-08-01-count-3:ATTCCTAAGAGGTCGT"	0.10335268926565	7.91961238468019	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTAAGAGGTCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.53478970943	39.4315874747661	0.0218151195203855	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1800.57977443424	1800.57977443424
"healthy-4"	"2019-08-01-count-2:CACTTCGGTTGTACGT"	10.533632894128	6.42551086032716	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTTCGGTTGTACGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.87995275081	44.9846522966572	0.0245431525557054	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1819.47098635982	1819.47098635982
"healthy-4"	"2019-08-01-count-4:AGGGAGTCACAACGTT"	9.8729473548824	5.63789699161378	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGAGTCACAACGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1642.47118711208	46.338024057785	0.0282123816973984	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1640.39968641205	1640.39968641205
"healthy-4"	"2019-08-01-count-4:AGGGAGTCATTGTAGC"	3.10108270224873	-6.18483116542967	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGAGTCATTGTAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.11252376471	45.4819343678844	0.0187700463440388	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2421.99811082097	2421.99811082097
"healthy-4"	"2019-08-01-count-3:TCGTGGGAGGCCTGCT"	10.3514801460201	6.60295531833497	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTGGGAGGCCTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1682.94505843558	37.4772096755896	0.0222688254068302	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1670.55065777401	1670.55065777401
"healthy-4"	"2019-08-01-count-3:TGTTACTCAATTGGTC"	2.29640760001485	-5.92216493999632	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTACTCAATTGGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2884.30563289454	45.6607815104367	0.015830770841235	2953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2877.53684587131	2877.53684587131
"healthy-4"	"2019-08-01-count-2:TCCCAGTGTTACACAC"	-0.106858546764213	7.73028132999269	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTGTTACACAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2156.5731752829	42.6672693900038	0.0197847538303015	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2151.23666962726	2151.23666962726
"healthy-4"	"2019-08-01-count-2:AAAGGATAGTAGACAT"	10.6013838249141	6.74582669818727	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGATAGTAGACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2124.47915218749	42.8020620218239	0.0201470849821013	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2117.09156453515	2117.09156453515
"healthy-4"	"2019-08-01-count-4:GGGACAATCAAGATAG"	-1.71618352356609	9.01764104450075	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAATCAAGATAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.74171141604	40.6328271488921	0.0205450625399408	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1970.59065359494	1970.59065359494
"healthy-4"	"2019-08-01-count-2:GGATGTTAGAAGTATC"	-7.00927243652995	3.33606860721437	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATGTTAGAAGTATC"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2410.71108320893	44.2231478514963	0.0183444412561584	1982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2392.71353849285	2392.71353849285
"healthy-4"	"2019-08-01-count-2:CGTGAATTCTACGGTA"	4.95513119277303	-8.72544100200804	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATTCTACGGTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2448.75389199292	41.1824775368813	0.0168177282623387	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2445.89807605781	2445.89807605781
"healthy-4"	"2019-08-01-count-2:TCCCATGCACGGGTAA"	10.8076797920162	6.40605018222658	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCATGCACGGGTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2044.46089580686	47.0112183956266	0.0229944326604855	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2038.6711271954	2038.6711271954
"healthy-4"	"2019-08-01-count-3:ATTCTTGAGGCGTCCT"	-3.02642784538921	9.49045560443727	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTTGAGGCGTCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.99420795508	40.7794266361762	0.0225800428686594	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1800.07174774278	1800.07174774278
"healthy-4"	"2019-08-01-count-2:CGTGATAGTCTTAGTG"	-1.78690443459209	4.05513045871583	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGATAGTCTTAGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2828.48661730362	46.9466912838197	0.0165978127655324	4067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2821.57963756645	2821.57963756645
"healthy-4"	"2019-08-01-count-4:GGGACCTGTGGGAGAG"	2.82680978354756	-6.10541345989379	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTGTGGGAGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.61482968098	44.910493030181	0.0190733925838163	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2352.30153294449	2352.30153294449
"healthy-4"	"2019-08-01-count-3:TGTTCCGCAAGTGCTT"	4.17343725737874	-6.70581676876219	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGCAAGTGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.70987331302	47.866115657265	0.020284746103156	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2355.40463350925	2355.40463350925
"healthy-4"	"2019-08-01-count-4:GGGACCTTCCCGTTGT"	10.812031407922	6.33406636798707	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTTCCCGTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1774.21269060847	42.0909996005055	0.023723761995001	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1770.46799068869	1770.46799068869
"healthy-4"	"2019-08-01-count-4:GGGACCTTCTACTGAG"	10.609394689172	7.22024390781251	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACCTTCTACTGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.27186865938	43.8270894453141	0.0213450006861144	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2041.32476081672	2041.32476081672
"healthy-4"	"2019-08-01-count-3:TGTTCCGCAGTTAGGG"	10.4254957633907	6.37701413715211	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGCAGTTAGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1754.76889427079	45.6217833380165	0.0259987417642111	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1753.00691360224	1753.00691360224
"healthy-4"	"2019-08-01-count-3:TGTTCCGCATTGGATC"	10.5332762199337	6.91041228854982	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGCATTGGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1793.38164646803	40.1379824300283	0.0223811716313022	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1789.97244930854	1789.97244930854
"healthy-4"	"2019-08-01-count-2:ACCGTTCGTACTGCGC"	11.5606676536495	3.69412181461183	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCGTTCGTACTGCGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.50059904465	35.122694106852	0.0160340947280134	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2172.49002104789	2172.49002104789
"healthy-4"	"2019-08-01-count-2:TCCGATCAGACCTTTG"	10.8925043540889	6.26258466327516	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGATCAGACCTTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.95149668407	45.4703234167572	0.0228959888963445	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.92738369145	1973.92738369145
"healthy-4"	"2019-08-01-count-3:TGTTCCGGTGCTATTG"	2.75876655158345	-5.77844240581664	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGGTGCTATTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2878.05300361403	41.4790567612334	0.0144121934895387	2385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2873.05254120945	2873.05254120945
"healthy-4"	"2019-08-01-count-3:TGTTCCGGTTGAATCC"	-4.27449212494548	11.0569476851257	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTCCGGTTGAATCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2325.37297405768	40.1964786163768	0.0172860349994674	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2323.73088064358	2323.73088064358
"healthy-4"	"2019-08-01-count-2:CAGATTGCAAGTCCCG"	3.21457972106282	-6.40015699779662	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGCAAGTCCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.99843681427	45.2211072538625	0.0179448949623279	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2513.26457582107	2513.26457582107
"healthy-4"	"2019-08-01-count-2:TGCAGGCAGATAACAC"	0.686917026608628	8.22000978076784	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGGCAGATAACAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1801.26774850434	44.2891969688991	0.0245877921290014	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1793.02373859619	1793.02373859619
"healthy-4"	"2019-08-01-count-4:GGGATCCAGTGCAAAT"	-2.94501409950908	8.86042211139528	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATCCAGTGCAAAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2142.96939468968	43.1956082199688	0.0201568946000854	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.27192543478	2141.27192543478
"healthy-4"	"2019-08-01-count-2:GGCGTCATCATCGCTC"	2.56650795516316	-6.21676733410033	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCATCATCGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.74915282369	45.6582232413142	0.018331120654825	1931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2486.98426201778	2486.98426201778
"healthy-4"	"2019-08-01-count-4:TCTACCGCACAGCGCT"	-0.565896014601547	7.87754199588624	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTACCGCACAGCGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2254.93047774539	45.4508161119436	0.0201561939760502	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2247.28454101814	2247.28454101814
"healthy-4"	"2019-08-01-count-4:GGGATCCTCCGGTAAT"	11.2107931571895	6.45447251880494	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATCCTCCGGTAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2075.47757389828	44.184516335154	0.021288843055126	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2072.37981015915	2072.37981015915
"healthy-4"	"2019-08-01-count-2:GGCGTCATCGCGATCG"	0.086451985954684	7.73487851703493	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCATCGCGATCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.22438776821	43.9740833842635	0.0241851796071439	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1812.89887970674	1812.89887970674
"healthy-4"	"2019-08-01-count-3:TGTTGAGAGTCCTGCG"	14.4143282371456	1.99622438037721	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGTTGAGAGTCCTGCG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1775.38351682116	43.8618348297191	0.0247055548359793	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1754.55714486967	1754.55714486967
"healthy-4"	"2019-08-01-count-2:AAATGGAGTGAACGGT"	4.52915587004964	-7.03804638302001	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAATGGAGTGAACGGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2420.97971492393	46.8085003032824	0.0193345280899031	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2412.83294593954	2412.83294593954
"healthy-4"	"2019-08-01-count-3:ATCAGGTAGACCTCAT"	-0.065788353711921	7.77959439838258	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCAGGTAGACCTCAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1887.61508567881	46.0447203891176	0.0243930665411902	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1875.44656761574	1875.44656761574
"healthy-4"	"2019-08-01-count-2:GTTAGACTCAATCCAG"	2.04753555831258	-6.15220549022826	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACTCAATCCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.64952953879	45.8577010038618	0.0184415618120368	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2481.48870406371	2481.48870406371
"healthy-4"	"2019-08-01-count-2:ACCTGAATCTTGGTGA"	-7.16143355789836	2.5755154856476	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGAATCTTGGTGA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2836.74506736068	43.053856643087	0.0151772033160331	2611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2822.62802180491	2822.62802180491
"healthy-4"	"2019-08-01-count-4:TTAGGGTGTTCTCCCA"	1.79634739932362	-6.94270565426024	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTGTTCTCCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.1023068466	45.7456235196125	0.0226901300416463	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2011.44435112823	2011.44435112823
"healthy-4"	"2019-08-01-count-2:ACCTGTCAGCAGGGAG"	-3.43795190277751	10.5293254622254	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGTCAGCAGGGAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1946.3822799531	45.1980742642644	0.0232215812534799	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1939.27503365097	1939.27503365097
"healthy-4"	"2019-08-01-count-2:TCCTAATGTCACGTGC"	11.1731525855953	5.31112668598024	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTAATGTCACGTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2137.68942697208	41.4943793683673	0.0194108549374929	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2129.94768996438	2129.94768996438
"healthy-4"	"2019-08-01-count-4:AGGTTACGTGATGTAA"	5.67897333678548	-9.8041973344055	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGTTACGTGATGTAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.30240108195	41.3058648106835	0.0151731360903429	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2716.42655651596	2716.42655651596
"healthy-4"	"2019-08-01-count-4:GTGTCCTGTTATTCCT"	3.56365050849263	-6.72263529216918	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTCCTGTTATTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.13769568522	46.598318046641	0.0200756371038491	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2315.53402477634	2315.53402477634
"healthy-4"	"2019-08-01-count-3:GCAACCGGTGTTTGCA"	3.44706048545186	-6.41666891491088	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACCGGTGTTTGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.69533050174	43.0227020271962	0.0182477784430445	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2355.2868077751	2355.2868077751
"healthy-4"	"2019-08-01-count-2:TCGGGTGAGACGACTG"	-0.114323924214202	8.10157964313356	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGTGAGACGACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.21656513374	40.3432311916565	0.0223481392597723	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1801.76752807841	1801.76752807841
"healthy-4"	"2019-08-01-count-4:TCAAGTGAGGTGAGAA"	10.9353357749874	6.14528844440309	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGAGGTGAGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1778.9455261376	40.8537925165893	0.0229651734223082	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1772.27347904427	1772.27347904427
"healthy-4"	"2019-08-01-count-3:CGTAATGAGTTTCAGC"	-3.73211894455608	11.5411071547302	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAATGAGTTTCAGC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1948.56689932955	49.4120357589416	0.0253581418097285	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1946.74443042755	1946.74443042755
"healthy-4"	"2019-08-01-count-2:TAGGGTTCAACCACGC"	-0.279237131506759	7.6627421149048	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTCAACCACGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.45019658623	41.8458450354125	0.0206193012796283	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.62416386964	2024.62416386964
"healthy-4"	"2019-08-01-count-2:AGTCACAAGCCGTTAT"	0.0737901470506608	7.49723861301271	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCACAAGCCGTTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2140.31816028834	48.3412809943925	0.0225860257093179	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2127.90034932115	2127.90034932115
"healthy-4"	"2019-08-01-count-3:TCTCTGGTCCGCAAAT"	2.43010701712911	-6.32597258007201	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGTCCGCAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.95741289448	50.2600001430874	0.0225385470827669	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2226.02151613361	2226.02151613361
"healthy-4"	"2019-08-01-count-4:GGGCTACGTAAGATAC"	3.65704621848409	-6.29179909145506	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACGTAAGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.5015879514	46.2509295245296	0.017338669912489	2087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2664.74155480486	2664.74155480486
"healthy-4"	"2019-08-01-count-3:CAACCAACAACCGTAT"	0.481546630232972	8.32501695239869	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAACAACCGTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1852.9348655103	41.1574816721948	0.0222120498881432	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1842.31781769318	1842.31781769318
"healthy-4"	"2019-08-01-count-2:GGGACCTGTCCTGTCT"	9.80921711501424	7.1911959418091	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACCTGTCCTGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1988.39148684982	46.0358093851522	0.0231522865037438	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1978.9138318289	1978.9138318289
"healthy-4"	"2019-08-01-count-4:GGGCTACTCCCTCGTA"	10.8251520591671	6.10425708377687	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTACTCCCTCGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.99267341948	45.5529504884347	0.0221777570474964	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.9485408932	2034.9485408932
"healthy-4"	"2019-08-01-count-3:CAACCAATCGATTGAC"	10.5511166053707	6.24249312961427	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAATCGATTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.82084051007	47.9675179974958	0.0253686213785099	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1882.68150686651	1882.68150686651
"healthy-4"	"2019-08-01-count-3:GTTCCGTAGCCATTTG"	-1.64548383179362	8.53396127307741	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCCGTAGCCATTTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.58760311798	44.8361987700649	0.0219721999200407	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2035.72614603422	2035.72614603422
"healthy-4"	"2019-08-01-count-2:GGGACTCAGCACTTTG"	3.79956497725789	-6.52160360729369	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGACTCAGCACTTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.46480068905	43.9921583383169	0.0163147534234733	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2692.67041070858	2692.67041070858
"healthy-4"	"2019-08-01-count-4:GATGAGGCAGGATGAC"	4.62435020980184	-7.02989437496337	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGCAGGATGAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2779.48941937471	44.229265767263	0.0159127303953591	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2769.80893884022	2769.80893884022
"healthy-4"	"2019-08-01-count-4:AACACACCAATTGAAG"	4.93375172194783	-7.29459907924803	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACCAATTGAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.55437042361	48.0204917041331	0.0180084427442237	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2658.5466209032	2658.5466209032
"healthy-4"	"2019-08-01-count-3:CTTCTAAAGTTTCGAC"	4.03293885764424	-6.93576815044554	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCTAAAGTTTCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.46982453067	43.6502483857416	0.0174777881025828	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2491.65609286462	2491.65609286462
"healthy-4"	"2019-08-01-count-4:TCTCCGAGTGTGGACA"	2.89224876937215	-5.95018389141234	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGAGTGTGGACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.02228410844	45.7254690802784	0.0175326220787679	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2606.16647224534	2606.16647224534
"healthy-4"	"2019-08-01-count-4:TGTGATGAGATCGCTT"	3.68446483191792	-6.31134416973265	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGATGAGATCGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.20338414216	44.47719508562	0.0174269791200711	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2548.35655587585	2548.35655587585
"healthy-4"	"2019-08-01-count-3:CGTGAATAGCAAGTGC"	0.478761901229066	7.90369460666505	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGAATAGCAAGTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1798.44779403698	40.4934628686715	0.0225157844464173	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1794.50932881825	1794.50932881825
"healthy-4"	"2019-08-01-count-3:GCACTAAGTCTGATAC"	14.3745933967525	2.02286980235902	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACTAAGTCTGATAC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1860.88950198244	39.9646713534407	0.0214761119942186	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1845.58638903914	1845.58638903914
"healthy-4"	"2019-08-01-count-4:TGATCAGAGTCACTGT"	-4.37943301621135	12.7044372328552	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCAGAGTCACTGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2203.28561574828	42.0881102432335	0.0191024304531392	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2198.22672213873	2198.22672213873
"healthy-4"	"2019-08-01-count-2:GGGAGATTCTCGTCGT"	11.4155956703121	4.61074063861696	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGAGATTCTCGTCGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2032.82875421375	41.3220738683279	0.0203273757234462	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2020.53508702641	2020.53508702641
"healthy-4"	"2019-08-01-count-4:TCACATTAGCGGCTCT"	10.9477230506832	6.06683061206666	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACATTAGCGGCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2068.2999384382	43.7162136098691	0.0211363027177189	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2056.56091365284	2056.56091365284
"healthy-4"	"2019-08-01-count-3:CAACGATTCCTCGATC"	-1.05767438831981	8.55855462634889	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATTCCTCGATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2195.99679567299	41.5293183781199	0.0189113747615432	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2187.5431951514	2187.5431951514
"healthy-4"	"2019-08-01-count-2:GTCACTCCAGCGGATA"	2.1950019794399	-6.4571480981079	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACTCCAGCGGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.47688466818	47.030963676251	0.0212379564681246	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2206.12031789549	2206.12031789549
"healthy-4"	"2019-08-01-count-3:CCTAAGAGTGCGACAA"	-0.885258595377761	9.06595800006715	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAAGAGTGCGACAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.19450569766	50.5890486276224	0.0278084880254305	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1813.22802450172	1813.22802450172
"healthy-4"	"2019-08-01-count-3:TCTTCCTTCGGACGTC"	-0.259317259222823	7.65241906726686	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTCCTTCGGACGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1915.12305813541	43.7020066263895	0.0228194248096717	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1907.2804169928	1907.2804169928
"healthy-4"	"2019-08-01-count-3:CAAGACTAGGTCATTC"	0.0776681295478761	7.5673036345276	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTAGGTCATTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.53581895947	37.7924661068583	0.0211422147215251	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1780.26143372331	1780.26143372331
"healthy-4"	"2019-08-01-count-4:GTTAGACAGCCTCTCT"	3.73281325873677	-6.27664282238158	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACAGCCTCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.38167900424	44.6548586114588	0.0164270010191564	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2714.20133164234	2714.20133164234
"healthy-4"	"2019-08-01-count-3:ACTTATCAGCCACAAG"	4.51725639876668	-6.7693810692993	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTATCAGCCACAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.78013442486	47.2974390672067	0.0183909341370599	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.04673311294	2568.04673311294
"healthy-4"	"2019-08-01-count-2:CAGGTATTCGATTCCC"	11.3516107994014	4.7377457388672	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGGTATTCGATTCCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.75854455327	41.3099611340035	0.0197678153974647	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2078.58095783589	2078.58095783589
"healthy-4"	"2019-08-01-count-4:GGGTGAACAGGAGGTT"	3.68983854827229	-7.13710977947386	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAACAGGAGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2012.32212547712	41.9985407987043	0.0208706848008971	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2007.09153959177	2007.09153959177
"healthy-4"	"2019-08-01-count-2:TCTACATAGAGTGTGC"	0.244512264698189	7.64004466617433	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTACATAGAGTGTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.44299399877	44.4699039294791	0.0235484492096393	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1887.08024559635	1887.08024559635
"healthy-4"	"2019-08-01-count-4:ATCCGTCCACTGGACC"	11.0444389778072	5.24099729144899	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCCGTCCACTGGACC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.14456502947	39.9541692633121	0.0208731200314	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1907.90120402137	1907.90120402137
"healthy-4"	"2019-08-01-count-4:GGAGGTAAGCAGCGAT"	3.26860155638997	-6.46754553234252	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGTAAGCAGCGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.10435253646	42.2917016776039	0.0198822881572186	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2127.10435253646	2127.10435253646
"healthy-4"	"2019-08-01-count-2:TCATTCACACGGGTAA"	-7.51159701767619	3.67836639964906	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCACACGGGTAA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2581.37752340495	45.5452490070546	0.0176437768571636	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2560.84941458127	2560.84941458127
"healthy-4"	"2019-08-01-count-4:TCACTATCAATGCAAA"	-1.89901934090312	8.91355130756227	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACTATCAATGCAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1941.86262962653	43.1893601050358	0.0222412025681457	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1939.94700601452	1939.94700601452
"healthy-4"	"2019-08-01-count-2:GATTGGTCAGAGGCTA"	4.95419086989705	-7.61338140880736	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTCAGAGGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.36748404246	47.4225388757387	0.0195366128892699	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2426.15288116487	2426.15288116487
"healthy-4"	"2019-08-01-count-3:TGAATCGCACAGTCAT"	10.2640158134395	7.82804296100465	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAATCGCACAGTCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2436.87241730324	39.1816787226121	0.016078674634092	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2425.56288458275	2425.56288458275
"healthy-4"	"2019-08-01-count-2:GGGCTACTCTCTCTTC"	-0.0560516146128953	7.60586736286012	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGCTACTCTCTCTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.91559180449	35.9963191091052	0.0181166825896282	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1980.31943251612	1980.31943251612
"healthy-4"	"2019-08-01-count-2:TGACTCCGTAGCGAGT"	0.351020713418168	7.71796748721925	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACTCCGTAGCGAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2044.01704713197	45.9584643054096	0.0224843840563343	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2034.84612810012	2034.84612810012
"healthy-4"	"2019-08-01-count-3:TTACTGTGTTCCGCGA"	0.114670329808634	9.14265916431276	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTACTGTGTTCCGCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.71294410338	43.6620003884146	0.0249395542173111	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1746.98429831038	1746.98429831038
"healthy-4"	"2019-08-01-count-4:CTACGGGCATGTTCAG"	4.45979847487752	-6.90542938625487	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACGGGCATGTTCAG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2952.82262324752	45.9107894666749	0.0155481027221954	2452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2950.21613744212	2950.21613744212
"healthy-4"	"2019-08-01-count-3:CAAGCTAGTGAAAGTT"	4.7790981727535	-7.55527117168578	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGCTAGTGAAAGTT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.51990547699	46.0780524444397	0.0175100527830085	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2627.28859597928	2627.28859597928
"healthy-4"	"2019-08-01-count-4:CAAGACTCACTGTGTA"	11.4460665183956	4.09189269626466	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGACTCACTGTGTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2042.84227567436	42.6820103818587	0.0208934438503183	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.73568813689	2034.73568813689
"healthy-4"	"2019-08-01-count-3:GCATCGGCATCAGCGC"	4.10086836394612	-6.35058023845824	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCGGCATCAGCGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.2932289761	44.3346095913411	0.0160325165977992	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2761.48592200978	2761.48592200978
"healthy-4"	"2019-08-01-count-2:GGGTAGAGTCCTCATC"	2.6375912624294	-5.84561064159545	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTAGAGTCCTCATC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2588.60537997999	45.8338953426001	0.0177060187300369	1944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2585.63286384379	2585.63286384379
"healthy-4"	"2019-08-01-count-2:TCGAAGTTCACCTGGG"	5.61852898177449	-9.94021131908568	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAAGTTCACCTGGG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2743.59136262224	46.8354421071804	0.0170708520026891	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2728.89452634227	2728.89452634227
"healthy-4"	"2019-08-01-count-3:TTAGGCAGTGGGATTG"	-2.05476389351543	9.03932187640993	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTAGGCAGTGGGATTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1868.35786639455	49.2131312626545	0.0263403131422693	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1862.52872345449	1862.52872345449
"healthy-4"	"2019-08-01-count-4:GGTAACTCAGGATCTT"	0.1126367720658	7.67511270130006	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAACTCAGGATCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.43612200181	42.4478423749726	0.0208852036801848	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.95307348606	2024.95307348606
"healthy-4"	"2019-08-01-count-3:GAAACCTCAGGTGAGT"	4.79558577117268	-6.84037735378417	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAACCTCAGGTGAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2816.85453939445	42.5702989600356	0.015112707583824	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2810.1505332139	2810.1505332139
"healthy-4"	"2019-08-01-count-3:CAATACGAGTAACGAT"	4.72504486617391	-6.93760349666747	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGAGTAACGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.45479361204	45.3453090826645	0.0167483162376901	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2701.06191011413	2701.06191011413
"healthy-4"	"2019-08-01-count-3:GAAATGAAGAAGCGAA"	11.4472509818966	3.61193749988405	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAATGAAGAAGCGAA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1973.2298338617	41.6293503904278	0.0210970611106955	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1964.38640341014	1964.38640341014
"healthy-4"	"2019-08-01-count-4:GGTAATCCATGACAGG"	10.9661756950313	5.96923587406007	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTAATCCATGACAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1766.72727345924	43.3740226624437	0.024550491359947	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1759.1728039646	1759.1728039646
"healthy-4"	"2019-08-01-count-4:GTTCCGTCACGGTAGA"	-4.32801042023357	12.2617606886658	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCCGTCACGGTAGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2185.95676654248	47.2308495015622	0.0216064883919306	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2180.77116063202	2180.77116063202
"healthy-4"	"2019-08-01-count-4:GTTCCGTCAGAACTTC"	4.59405817565267	-6.79712774669798	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCCGTCAGAACTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.18775924456	43.8990137924164	0.0164158308034502	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2669.0338268574	2669.0338268574
"healthy-4"	"2019-08-01-count-2:CATACAGGTACCGGAA"	4.68265928801839	-6.92093899166258	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGGTACCGGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.80778951434	46.9467071874036	0.0183830229432934	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2550.17636924694	2550.17636924694
"healthy-4"	"2019-08-01-count-4:CAAGCTACATGAGATA"	10.8243595558101	6.05163810336915	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGCTACATGAGATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.41908007726	39.3703546888679	0.0192857777577831	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2036.08803772745	2036.08803772745
"healthy-4"	"2019-08-01-count-2:TCGACGGAGCTTTGTG"	11.4668327766353	4.0743837126526	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACGGAGCTTTGTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.47518392982	41.5399739675386	0.0200533292842701	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2057.60858706346	2057.60858706346
"healthy-4"	"2019-08-01-count-2:GGGTCACTCTGGGAGA"	4.16823257979695	-6.34628727352294	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTCACTCTGGGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.19851469217	43.4278159615616	0.0175168772101954	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2474.6301719022	2474.6301719022
"healthy-4"	"2019-08-01-count-4:TGTTTGTCAACCAGAG"	4.34236397322957	-6.90519668972167	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTTGTCAACCAGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.42783308922	50.1069553832343	0.0224249602700118	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2232.8297346512	2232.8297346512
"healthy-4"	"2019-08-01-count-2:TCGACGGCAGATCACT"	-3.93030081215556	-5.70133688366088	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGACGGCAGATCACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2724.85886275692	43.2205585598184	0.0158615769611235	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2717.43430956123	2717.43430956123
"healthy-4"	"2019-08-01-count-3:AAGATAGCATTGAGGG"	0.165663127868813	7.66430947864381	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGCATTGAGGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.57726325412	43.2162687387598	0.0237246421606938	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1810.89407908931	1810.89407908931
"healthy-4"	"2019-08-01-count-2:TATGTTCGTTGGTACT"	5.11271490630452	-7.40736725246581	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATGTTCGTTGGTACT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.72868574439	46.9021929729557	0.0179858407929302	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2604.75354511864	2604.75354511864
"healthy-4"	"2019-08-01-count-2:GGGTGAAAGGACCCAA"	5.04891027983968	-7.60124685680541	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAAAGGACCCAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.01083874553	37.6809809795861	0.0150843945090763	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2498.01083874553	2498.01083874553
"healthy-4"	"2019-08-01-count-4:ACTGTGACACCAGCGT"	-2.53065286102946	3.46939323032228	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGTGACACCAGCGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3319.64914505944	49.2222637528769	0.0148275500217044	5076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3310.7710238674	3310.7710238674
"healthy-4"	"2019-08-01-count-4:AACGAAAAGCAAACAT"	10.5597483116085	6.20133969867555	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGAAAAGCAAACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.94059991122	42.8177030499686	0.0237093640023784	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1797.02353360751	1797.02353360751
"healthy-4"	"2019-08-01-count-4:GGTGAAGCAAAGAACT"	-3.71249328079875	12.234007812384	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGCAAAGAACT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2076.57360155654	45.1249031848363	0.0217304617332187	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2065.8522949733	2065.8522949733
"healthy-4"	"2019-08-01-count-2:AAGAACAAGCCTGACC"	11.6368090110714	3.46493218028871	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGAACAAGCCTGACC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.08725475229	38.1002062721249	0.0180305882714679	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.8549969703	2093.8549969703
"healthy-4"	"2019-08-01-count-4:GGTGAAGGTGGATCGA"	-0.198313872248489	8.20392892444459	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGGTGGATCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2113.34576824626	44.695421720161	0.0211491287378171	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2109.37033917336	2109.37033917336
"healthy-4"	"2019-08-01-count-4:GGTGAAGTCGCGTGAC"	-5.71191916886027	-5.38115551387938	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGTCGCGTGAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3065.92022585629	44.8458997174085	0.0146272232849383	2600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3056.51532922517	3056.51532922517
"healthy-4"	"2019-08-01-count-2:ACTACGATCTGCTTTA"	9.76020206984822	6.9216589697632	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGATCTGCTTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1972.0549538403	43.281726259907	0.0219475254356488	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1961.60677924101	1961.60677924101
"healthy-4"	"2019-08-01-count-3:AAGCGTTAGGCGATAC"	-5.52723155441936	-5.27582552349242	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCGTTAGGCGATAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2681.21398207597	46.5196227779263	0.0173502089310708	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2673.80072855885	2673.80072855885
"healthy-4"	"2019-08-01-count-4:CTTCCTTTCACCATCC"	0.00212761488501426	7.74876687610475	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTTCACCATCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2170.13706479852	35.7406190750755	0.0164692911129066	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2160.14000084453	2160.14000084453
"healthy-4"	"2019-08-01-count-2:GGGTGTCTCGTACACA"	10.3138224082882	6.96317813480226	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCTCGTACACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1814.53165373227	43.8489129415967	0.0241654163769505	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1809.62048298014	1809.62048298014
"healthy-4"	"2019-08-01-count-2:CTATAGGTCCGTAGGC"	10.542385717004	6.27065322482911	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTATAGGTCCGTAGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.07184620281	49.6840851476715	0.0264971634277835	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.65458654979	1862.65458654979
"healthy-4"	"2019-08-01-count-4:GGTGATTCACTGAGTT"	10.2465998130733	6.15905616367189	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGATTCACTGAGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.56166410378	46.8398054368029	0.0249338663360561	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1874.67705155611	1874.67705155611
"healthy-4"	"2019-08-01-count-2:TCGCAGGTCGATGGAG"	2.02602829512898	-6.08241751110228	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCAGGTCGATGGAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2361.49828864351	46.2210499893291	0.019572764550204	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2358.97173279632	2358.97173279632
"healthy-4"	"2019-08-01-count-3:GCCAGGTGTCCGTTTC"	2.96716680106465	-6.51705362713011	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTGTCCGTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.85620943176	44.874411886569	0.020079328458442	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2230.09779440158	2230.09779440158
"healthy-4"	"2019-08-01-count-3:CACAGATCAACAGAGC"	5.55109562453572	-10.0941372147766	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGATCAACAGAGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.65554580842	44.5028917453066	0.0180052968225194	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2463.42574002085	2463.42574002085
"healthy-4"	"2019-08-01-count-2:TCGCTCAAGACCTCCG"	2.26599063453023	-4.44548370754393	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCTCAAGACCTCCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2979.71897128197	45.8330395223709	0.0153816651718172	3298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2973.5267297587	2973.5267297587
"healthy-4"	"2019-08-01-count-2:TCGCAGGTCTGAGAAA"	0.336296071379822	7.78014609897462	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGCAGGTCTGAGAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1810.31928093547	40.9759373063052	0.0226346466823969	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1798.81695316676	1798.81695316676
"healthy-4"	"2019-08-01-count-4:GACCCTTGTCTTACTT"	-5.11990724030192	-4.37231638347777	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCCTTGTCTTACTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3529.86997227742	42.6999776162197	0.012096756524057	4825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3522.87072503552	3522.87072503552
"healthy-4"	"2019-08-01-count-2:TTCTTCCTCCCGAGTG"	10.6876970725948	6.42462442005006	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCTCCCGAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1866.93576905148	45.13136018481	0.0241740294084887	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.36440291522	1863.36440291522
"healthy-4"	"2019-08-01-count-4:TTACCGCCAACAGCCC"	10.6715265708858	6.8323125609192	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCCAACAGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2195.48694950799	41.5409263022866	0.0189210536239334	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2190.1557783064	2190.1557783064
"healthy-4"	"2019-08-01-count-2:TGGCGTGGTGCAATGG"	2.67859115180318	-6.13147308742674	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGCGTGGTGCAATGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.82739649007	43.2104257911373	0.0176669972104929	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2440.38719683014	2440.38719683014
"healthy-4"	"2019-08-01-count-4:TCATATCAGCACCAGA"	4.55535616454427	-7.17656519329222	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATATCAGCACCAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2678.05156345403	43.1174422225506	0.0161003032245352	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2677.04594336154	2677.04594336154
"healthy-4"	"2019-08-01-count-2:AGGTTGTCACTGAATC"	2.96222438391988	-6.10036518489989	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTTGTCACTGAATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.19587112066	50.7872244325606	0.0231461671681214	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2188.99800227405	2188.99800227405
"healthy-4"	"2019-08-01-count-4:TTACCGCGTCGCACGT"	11.3476597267086	3.80411527240602	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACCGCGTCGCACGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.65860552761	41.4057432372312	0.0208839500263903	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1967.62175536176	1967.62175536176
"healthy-4"	"2019-08-01-count-3:GAAGTAAGTTCCACAA"	10.7209869819576	7.09403178775636	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAAGTTCCACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1965.17344866154	46.1104255102111	0.0234637942730278	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1963.76018992971	1963.76018992971
"healthy-4"	"2019-08-01-count-2:TCGGATACAAGGACAC"	4.7528187232906	-6.84607555782469	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGATACAAGGACAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2750.29683380543	44.4318974228174	0.0161553098111739	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2746.59489451772	2746.59489451772
"healthy-4"	"2019-08-01-count-3:GAATAGACAAGAAACT"	3.56952514228169	-6.1009092560974	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAATAGACAAGAAACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.97834740889	42.0257289655749	0.0156813688462099	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2671.75412479535	2671.75412479535
"healthy-4"	"2019-08-01-count-3:CCGATGGAGGCTGTAG"	9.80679001387898	7.24634788120119	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATGGAGGCTGTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1957.99025574822	44.327308445181	0.0226391874602266	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.14318378354	1951.14318378354
"healthy-4"	"2019-08-01-count-4:TGACTCCAGGGCAATC"	10.8929516273433	5.91392419421998	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGACTCCAGGGCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.13352388734	46.8112729308491	0.025071197282875	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.2946240779	1862.2946240779
"healthy-4"	"2019-08-01-count-2:CTCAACCGTTGTAAAG"	4.64153780516927	-6.9720816842285	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAACCGTTGTAAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2756.45304901302	45.8894237919374	0.0166479976172163	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2747.85116808869	2747.85116808869
"healthy-4"	"2019-08-01-count-3:CAGTTCCTCCATTTCA"	11.2516304450924	5.92753360355226	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTCCTCCATTTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2049.39667098498	47.2930006082762	0.0230765479801166	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2044.5776403551	2044.5776403551
"healthy-4"	"2019-08-01-count-2:GTAGGAGAGCACTCCG"	2.21777500685994	-6.09997274791869	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGAGAGCACTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.88295804339	47.0926450041287	0.0196556533974377	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2393.42907968474	2393.42907968474
"healthy-4"	"2019-08-01-count-2:CATCCACTCACGGTCG"	10.9980322318966	4.7894339331421	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACTCACGGTCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1631.6054688723	43.7822505584584	0.0268338464130786	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1624.94304201914	1624.94304201914
"healthy-4"	"2019-08-01-count-4:TTACTGTTCCTACCAC"	-3.98593125763591	3.64343807781068	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACTGTTCCTACCAC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3431.66860612726	45.5975195103346	0.0132872735522655	5061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3415.65221039524	3415.65221039524
"healthy-4"	"2019-08-01-count-3:GCCATGGGTAACGGTG"	11.126409192651	5.76946399295656	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGGTAACGGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1842.74954804607	40.8774406588954	0.022182852087653	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1837.88194557736	1837.88194557736
"healthy-4"	"2019-08-01-count-2:GTTAGACCAGTTGTCA"	6.81675972518269	-1.76247336780699	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGACCAGTTGTCA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2749.70983463402	30.6687480481375	0.0111534488700767	2178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2736.18695370551	2736.18695370551
"healthy-4"	"2019-08-01-count-3:TTCCTCTAGACACACG"	1.69737472113912	-5.94141104137572	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCCTCTAGACACACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3025.54727513697	40.5214723602208	0.013393105007221	2580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3017.19921677581	3017.19921677581
"healthy-4"	"2019-08-01-count-3:CACGAATAGGCCTAGA"	4.99077763137166	-7.47409346019896	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATAGGCCTAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3035.97473028098	43.2160557128788	0.0142346559349916	2675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3030.14612520959	3030.14612520959
"healthy-4"	"2019-08-01-count-4:GGTTGTACAACCAACT"	10.7234455543453	7.28843257510988	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTGTACAACCAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.72212782162	41.3734972904909	0.020464482591913	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2008.1971151756	2008.1971151756
"healthy-4"	"2019-08-01-count-4:GACGTTATCACTGATG"	-0.867770831019241	8.43083665454713	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACGTTATCACTGATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1847.66727559814	46.6829756196314	0.0252658994593705	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1841.8534626293	1841.8534626293
"healthy-4"	"2019-08-01-count-2:GTGACGCTCCATGCAA"	11.331053395837	4.64697501743165	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGACGCTCCATGCAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2092.79211728952	42.3658482698565	0.020243696409143	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2085.42552026346	2085.42552026346
"healthy-4"	"2019-08-01-count-3:CACGAATAGCAGGGAG"	10.29683460769	7.64234206760255	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATAGCAGGGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1877.04038930269	45.3331968976213	0.0241514232490556	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.93384108121	1866.93384108121
"healthy-4"	"2019-08-01-count-4:ACGGTCGGTCTGTGCG"	4.99770607528035	-7.43252661144408	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTCGGTCTGTGCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.33261624492	43.6253275142545	0.0163187054424722	1850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2666.86693155655	2666.86693155655
"healthy-4"	"2019-08-01-count-2:ACTGATGGTAATGATG"	-0.101069982082206	7.51799438083497	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGATGGTAATGATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.58038137602	36.0293783689343	0.0173587005794728	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2067.92134842344	2067.92134842344
"healthy-4"	"2019-08-01-count-2:GCATTAGTCCATCCGT"	10.6410061317379	7.53265235507814	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATTAGTCCATCCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.0663520908	45.0268368829833	0.0210891979253431	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2130.5168850566	2130.5168850566
"healthy-4"	"2019-08-01-count-3:GTACAACAGGTAGTAT"	3.3489805656368	-7.02630522167357	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAACAGGTAGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2080.20562652771	47.0943012226996	0.0226392528806441	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2073.68059301445	2073.68059301445
"healthy-4"	"2019-08-01-count-3:CACGAATGTTGCCAAT"	10.9004551368648	5.7430586584839	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATGTTGCCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1710.71058414602	46.7742361179763	0.0273419925915322	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1703.48510525355	1703.48510525355
"healthy-4"	"2019-08-01-count-3:CGAATTGTCGACACTA"	11.1258436637813	5.64143130863038	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAATTGTCGACACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1901.66003848014	44.4517424513893	0.0233752308782364	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.06209136276	1896.06209136276
"healthy-4"	"2019-08-01-count-3:CCGGTAGTCGGAGCAA"	5.26239361342732	-7.74081470882567	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGTAGTCGGAGCAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2814.7455236946	43.9291526633543	0.0156067936847425	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2802.59868523318	2802.59868523318
"healthy-4"	"2019-08-01-count-4:AGAACCTGTATCGCGC"	-0.329928676516372	7.66951463306276	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGAACCTGTATCGCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2381.76381767532	41.8492484019451	0.0175706961754047	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2367.52852616862	2367.52852616862
"healthy-4"	"2019-08-01-count-3:AGTCATGTCCGCGATG"	3.04863824424092	-6.31529905712279	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCATGTCCGCGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.23466091273	46.3218727828349	0.0184165213300717	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2506.47423918514	2506.47423918514
"healthy-4"	"2019-08-01-count-2:AAGGTAAAGTGTGTTC"	0.440631528466386	7.77174089038698	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAAAGTGTGTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.70452835777	42.9613761482816	0.0242486122604786	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1762.0417446105	1762.0417446105
"healthy-4"	"2019-08-01-count-4:CTAAGTGGTATGCGGA"	11.2261902290279	5.76002309406129	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGGTATGCGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2222.17508489125	41.7776998809831	0.0188003637359779	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2216.64783006362	2216.64783006362
"healthy-4"	"2019-08-01-count-2:CTCAGGGAGTGGCCTC"	3.10724176940266	-6.24157621776732	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGGGAGTGGCCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.55899958358	48.554127392692	0.022024417310611	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2201.64486991875	2201.64486991875
"healthy-4"	"2019-08-01-count-2:GTTCATTCAACGACTT"	-1.31925151768382	8.5595378645691	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCATTCAACGACTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.99507820825	44.6389912215292	0.0225108936033583	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.58131876777	1979.58131876777
"healthy-4"	"2019-08-01-count-2:AAGGTAACATGAATAG"	2.94476522979085	-6.03926803981932	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAGGTAACATGAATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.99290637293	49.7304501940344	0.021725908392104	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2282.21421513682	2282.21421513682
"healthy-4"	"2019-08-01-count-2:CAACAACGTACTCAAC"	10.4854456382686	7.40985534274904	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAACGTACTCAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2062.26211277632	46.2509424321483	0.0224272861076243	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2055.41356521608	2055.41356521608
"healthy-4"	"2019-08-01-count-2:CAACAACGTGTCATTG"	-0.00655124235208634	7.59993932330934	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACAACGTGTCATTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1965.56919822519	44.466477442277	0.0226226975282417	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.24472304989	1958.24472304989
"healthy-4"	"2019-08-01-count-3:CACGTTCAGCGATGCA"	9.73096432265584	6.41296622836915	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTTCAGCGATGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.69143717354	41.6293366272952	0.0222178186874211	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1864.45919431057	1864.45919431057
"healthy-4"	"2019-08-01-count-2:CTCAGTCGTATCGAAA"	-1.29056618633922	8.46648595416871	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAGTCGTATCGAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1900.91907619151	48.7523782748443	0.0256467405085542	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.45613625478	1897.45613625478
"healthy-4"	"2019-08-01-count-2:TGGTGATGTTCGGACC"	10.414284368127	6.04523465717164	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTGATGTTCGGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.07524643295	43.4176027702856	0.0235443769739167	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1842.47550008743	1842.47550008743
"healthy-4"	"2019-08-01-count-2:CATCGTCCAGAATGTA"	10.5479170280391	7.25411508167116	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCGTCCAGAATGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1923.95763980908	45.6040385522567	0.0237032446082244	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1916.02589144953	1916.02589144953
"healthy-4"	"2019-08-01-count-3:GACCGTGCAGCGTTTA"	11.4217297035152	4.69229075992433	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGCAGCGTTTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2238.34608551649	36.8273579749999	0.0164529329102842	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2227.9683867675	2227.9683867675
"healthy-4"	"2019-08-01-count-3:TTCTAGTTCCCTTGGT"	-1.79873357239421	3.38388655269472	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTCTAGTTCCCTTGGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2949.69762836043	43.0482354708788	0.0145941180739962	4165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2942.69194693718	2942.69194693718
"healthy-4"	"2019-08-01-count-3:GACCGTGCAACACACT"	11.4549490409786	4.05999848926393	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGCAACACACT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2135.3941770461	38.7048175415418	0.0181253737401693	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2124.89182029884	2124.89182029884
"healthy-4"	"2019-08-01-count-2:CTGCATCCAGTGTGGA"	2.34167947348897	-6.18936779415282	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCCAGTGTGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.81717573821	41.2111247734231	0.0195701342206862	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2102.46669705822	2102.46669705822
"healthy-4"	"2019-08-01-count-3:GACCGTGGTTCGTTCC"	10.943415303796	6.38302943790285	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGGTTCGTTCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.31299052936	47.3420549484943	0.0237981932324769	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1981.32965904543	1981.32965904543
"healthy-4"	"2019-08-01-count-2:GCCATGGAGTTCATCG"	-3.69328604164775	-5.15927793895873	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATGGAGTTCATCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2983.22440645283	47.7491862922466	0.0160058982451884	3656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2974.59897295211	2974.59897295211
"healthy-4"	"2019-08-01-count-4:GATGCTATCCTGGTCT"	10.4922367530758	6.58643767917482	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGCTATCCTGGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.12686123905	49.1711454531817	0.025502028129821	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1920.94601420637	1920.94601420637
"healthy-4"	"2019-08-01-count-2:TGACCCTGTGGGTATG"	-1.80508647385295	9.2405681380066	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTGTGGGTATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.42297343125	45.1302205934694	0.0237100325169	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1901.67498561865	1901.67498561865
"healthy-4"	"2019-08-01-count-4:TGATCTTTCCATACTT"	4.75598825988118	-7.0966778031555	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATCTTTCCATACTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2805.16038108471	41.558627670036	0.0148150629640527	2063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2803.49236379702	2803.49236379702
"healthy-4"	"2019-08-01-count-2:GACCCTTCATAGACTC"	2.91692843016927	-6.36051323330077	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTCATAGACTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.0608596266	40.8519188765876	0.0152771088696508	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2669.6654481859	2669.6654481859
"healthy-4"	"2019-08-01-count-2:TTGGATGAGCCACCGT"	3.04243149337117	-6.0047326317993	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGATGAGCCACCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.57911468119	41.9738437492178	0.0165474214883668	1780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2528.77561300727	2528.77561300727
"healthy-4"	"2019-08-01-count-3:GACCTTCGTCTAGGTT"	5.36841787871663	-10.1185255280701	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCTTCGTCTAGGTT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.79020803201	49.9081540408899	0.0211583691805001	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2350.36535582775	2350.36535582775
"healthy-4"	"2019-08-01-count-2:TCGTGGGGTATGGTTC"	11.0213381248409	6.67646358096925	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGGGGTATGGTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.19335130658	46.6923638210276	0.0235916131135967	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.9577327194	1973.9577327194
"healthy-4"	"2019-08-01-count-4:GAAGAATAGAGCACTG"	0.164740179746789	7.58780810916749	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGAATAGAGCACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.80355964194	39.6140406984863	0.0203587050204471	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1942.313149583	1942.313149583
"healthy-4"	"2019-08-01-count-2:GGTTAACGTATCATGC"	0.175194648175877	7.79211566531984	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTAACGTATCATGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2198.9474185603	44.3437026432927	0.0201658767594932	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2184.36362881867	2184.36362881867
"healthy-4"	"2019-08-01-count-4:ACATGCAGTAGGCTGA"	-2.0238860649174	3.51035711849061	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACATGCAGTAGGCTGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3062.91148268748	46.2038842252353	0.0150849557639501	5233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3056.64968089883	3056.64968089883
"healthy-4"	"2019-08-01-count-3:TATATCCCAGGCTATT"	10.5950314002926	6.83007905567018	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATATCCCAGGCTATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.86488237086	41.9964177695458	0.0205979406152265	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2028.75869159949	2028.75869159949
"healthy-4"	"2019-08-01-count-4:GTTAGACGTCGTCATA"	3.09444489058797	-5.94507267391356	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACGTCGTCATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.06331175537	44.1254927327863	0.0195153724813348	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2261.06331175537	2261.06331175537
"healthy-4"	"2019-08-01-count-3:AACGTCAGTGGTTTAC"	-0.19132892313655	7.68076846683351	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCAGTGGTTTAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1816.88482592034	42.9675113812316	0.0236490011740102	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1805.33556171954	1805.33556171954
"healthy-4"	"2019-08-01-count-3:TTTCATGGTGTATTCG"	9.86707748946492	7.03807685458986	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTCATGGTGTATTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1857.14159199694	43.6481356956483	0.0235028583085658	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1847.45617339818	1847.45617339818
"healthy-4"	"2019-08-01-count-2:GTCATGAGTGCCTTCT"	10.8695932823116	7.33537910068361	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCATGAGTGCCTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.9866010926	42.3792364591289	0.0211474649760748	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2000.51775587675	2000.51775587675
"healthy-4"	"2019-08-01-count-3:CTTGATTGTTATGTGC"	-4.54173074188884	2.94872686946718	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTGATTGTTATGTGC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2959.91620718192	41.9831117709104	0.0141838852292652	3542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2946.90219913221	2946.90219913221
"healthy-4"	"2019-08-01-count-2:TCACGCTAGACGAAGA"	9.85967316207234	6.04733846271364	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACGCTAGACGAAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1764.26787547326	46.3905685598586	0.0262945152517808	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1753.53206069974	1753.53206069974
"healthy-4"	"2019-08-01-count-2:GTGGAAGCAGCACAAG"	-4.92751059952434	-5.10185005581053	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAAGCAGCACAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2720.35524648955	50.0814900259155	0.0184099080774625	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2714.84141218553	2714.84141218553
"healthy-4"	"2019-08-01-count-2:GTCCACTGTAACCAGG"	0.0659180712768852	7.50795552814332	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCACTGTAACCAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.65644581803	47.2284458417653	0.0227206597496101	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2069.98306141584	2069.98306141584
"healthy-4"	"2019-08-01-count-3:TCGCTTGTCTGAATCG"	3.22984470900838	-6.18577148830565	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTTGTCTGAATCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.19173685382	44.9319183179054	0.0174547675196958	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2571.26351998412	2571.26351998412
"healthy-4"	"2019-08-01-count-2:TTGGGTAAGAAGCTGC"	1.04171021756474	-6.74112751400145	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGGTAAGAAGCTGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2275.24044086079	50.2654475386261	0.0220923673102476	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2273.80597834691	2273.80597834691
"healthy-4"	"2019-08-01-count-2:GGTTGTATCTCTCAAT"	11.3651682334835	5.88339421832887	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTTGTATCTCTCAAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2285.27436680618	39.4296456368382	0.0172537907087033	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2277.48958978046	2277.48958978046
"healthy-4"	"2019-08-01-count-3:CAGATCAAGTTATGGA"	3.74426736411397	-6.19836428081664	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCAAGTTATGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.87085064266	44.5474999748912	0.0176714725244787	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2513.57973694707	2513.57973694707
"healthy-4"	"2019-08-01-count-4:TGATTTCCACCAGCGT"	2.40153040465657	-6.09018900310668	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCCACCAGCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.90734059142	41.6453689099367	0.0157932621555812	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2631.4886066168	2631.4886066168
"healthy-4"	"2019-08-01-count-2:CTCCATGGTAACATAG"	9.36040272292439	6.48350045764772	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGGTAACATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.4336403299	45.7233699288932	0.0241483878573778	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1885.38773687148	1885.38773687148
"healthy-4"	"2019-08-01-count-2:AATCGTGCAAGGCGTA"	10.5732246833736	7.8184866675171	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AATCGTGCAAGGCGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.61288225783	44.2051252730814	0.021801560672596	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2021.02178906053	2021.02178906053
"healthy-4"	"2019-08-01-count-4:GTAGGTTGTCTTCATT"	11.4637409645015	3.66762659633485	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGGTTGTCTTCATT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2242.66101104152	35.4253278801956	0.0157961135034597	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2225.84293173252	2225.84293173252
"healthy-4"	"2019-08-01-count-2:GTAACACTCCGACAGC"	2.85235824164693	-6.05093529140624	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACTCCGACAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.92543101308	45.4845918385748	0.0172753057503317	2021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2629.10592663453	2629.10592663453
"healthy-4"	"2019-08-01-count-4:GTAGTACCATGAAGGC"	4.7368651824886	-6.98844530498656	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAGTACCATGAAGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.5270156227	47.2146394453764	0.0186065563655842	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2531.04319125922	2531.04319125922
"healthy-4"	"2019-08-01-count-4:CACTGTCTCACCGGGT"	10.4398333030636	6.48102471912233	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CACTGTCTCACCGGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1859.49191835496	43.5645724881517	0.0234282128672504	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.0976913575	1851.0976913575
"healthy-4"	"2019-08-01-count-2:TGTCCTGGTCGACGCT"	6.802910943597	-1.73839785968932	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTCCTGGTCGACGCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2698.76037673426	37.9057739767891	0.0140456241701082	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2686.3219645595	2686.3219645595
"healthy-4"	"2019-08-01-count-3:CAGATTGGTCCACAGC"	2.59025969085042	-6.10632803356322	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATTGGTCCACAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.97723946063	47.2933550420186	0.0206703782827698	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2284.28110317118	2284.28110317118
"healthy-4"	"2019-08-01-count-4:TACCCACCAAGCAGGT"	11.3873688178951	4.87171027744142	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCCACCAAGCAGGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2496.49257077588	42.7277419938133	0.0171151088106519	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2483.26804072095	2483.26804072095
"healthy-4"	"2019-08-01-count-2:GCCTGTTGTTGTGGCC"	3.13298501548116	-6.09150459682616	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCTGTTGTTGTGGCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2654.15598747831	46.9981976866067	0.0177073984755731	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2646.1038800406	2646.1038800406
"healthy-4"	"2019-08-01-count-4:ATCGGATAGCTCGCAC"	0.562803228467148	7.8437404402527	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGGATAGCTCGCAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1829.41540730754	38.1910623533472	0.0208761018414922	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1821.02651256901	1821.02651256901
"healthy-4"	"2019-08-01-count-3:TTGCCTGAGAGGGTGG"	-3.14498982849773	3.31124661052553	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGCCTGAGAGGGTGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3239.79039888905	48.152348192534	0.0148627973615348	4786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3233.73165819987	3233.73165819987
"healthy-4"	"2019-08-01-count-1:GGGAGATGTCGTCTCT"	0.419968922703904	7.90514085376588	"2019-08-01-count-1"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.GGGAGATGTCGTCTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2136.83440711726	33.2788469386234	0.0155739007326819	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2127.42450674371	2127.42450674371
"healthy-4"	"2019-08-01-count-2:TCAGCAATCCTTTGAT"	3.96920623359029	-6.33209135448607	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAATCCTTTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2864.0547546426	42.6168033324411	0.0148798842841114	2417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2859.9698461581	2859.9698461581
"healthy-4"	"2019-08-01-count-4:GTCAAACAGATTGGGC"	-2.68810520592387	-5.62177374279173	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCAAACAGATTGGGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2679.68606961187	46.0932050270443	0.0172009719906185	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2675.71304563527	2675.71304563527
"healthy-4"	"2019-08-01-count-4:TCCCAGTCATCTTAGG"	-1.81948075714763	9.39024064624635	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCAGTCATCTTAGG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2169.23918976221	41.0852867578039	0.0189399522891284	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2158.3396012055	2158.3396012055
"healthy-4"	"2019-08-01-count-2:TCTCCGAAGAGTCAGC"	4.789887090295	-7.31397249614867	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCCGAAGAGTCAGC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.14833863936	45.8224107101114	0.0188093680435339	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2433.56321383363	2433.56321383363
"healthy-4"	"2019-08-01-count-2:GTACAACCATTCCTCG"	3.59917606887166	-6.7620215645996	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAACCATTCCTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.48460610935	50.8015668139652	0.0229820948191901	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2208.96627391281	2208.96627391281
"healthy-4"	"2019-08-01-count-3:AGCCAGCTCTGGGCCA"	0.0152398954028308	7.62443492496339	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCAGCTCTGGGCCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.04919015587	42.0509354983784	0.0213994314793936	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1959.04629210376	1959.04629210376
"healthy-4"	"2019-08-01-count-3:CTCCCTCAGATGCAGC"	0.194757704704446	7.61105821216432	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCAGATGCAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2036.95724027071	40.9679034013756	0.0201123040736639	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2032.15265434185	2032.15265434185
"healthy-4"	"2019-08-01-count-2:CAATACGGTTCGGACC"	3.37091531333272	-6.46712543880614	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAATACGGTTCGGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2643.69014779826	38.3420824631074	0.0145032436933049	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2636.5290703806	2636.5290703806
"healthy-4"	"2019-08-01-count-4:TGCAGTAGTATCATGC"	10.1802584129268	6.9972090491089	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGTAGTATCATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1855.98252633763	37.6912164154733	0.0203079586583439	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.05585331085	1846.05585331085
"healthy-4"	"2019-08-01-count-2:GACTGATCATACTGAC"	10.3119760948116	5.3515791662964	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATCATACTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.07241300731	45.8325428312374	0.0245741358413721	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1851.1775755442	1851.1775755442
"healthy-4"	"2019-08-01-count-3:GAGAAATGTATATGGA"	10.5669084983761	5.67472503269044	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGAAATGTATATGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.20156431944	41.8277887610014	0.0221521841478175	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1881.60943361039	1881.60943361039
"healthy-4"	"2019-08-01-count-4:TCCCATGGTATCAAGA"	4.58418001708333	-6.74318268215331	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCCATGGTATCAAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.95317502181	38.3566849333749	0.0135730079579535	2237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2814.70906450786	2814.70906450786
"healthy-4"	"2019-08-01-count-2:TCTCTGGCATCCCGTT"	-0.230999420315582	8.07361695850221	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGCATCCCGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.25024696586	41.4966008720699	0.0204190408804349	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2017.34169929421	2017.34169929421
"healthy-4"	"2019-08-01-count-3:ACACTGAGTTAAGACA"	5.66100849685018	-9.91761877453002	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACTGAGTTAAGACA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.72553597572	45.6829428934267	0.016790720816697	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2713.66570854534	2713.66570854534
"healthy-4"	"2019-08-01-count-2:GACTTCCAGCGTTAGG"	11.1609789329464	5.54824159229127	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCAGCGTTAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.23274299641	44.3330864476071	0.0246811481532466	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1786.16579425056	1786.16579425056
"healthy-4"	"2019-08-01-count-4:GACCAATCATCCTAAG"	-1.9919105571812	3.42820594394533	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCAATCATCCTAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3127.29729091667	44.8411449467466	0.0143386255847786	5282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3119.3871544058	3119.3871544058
"healthy-4"	"2019-08-01-count-4:ATCGTGAGTCGGTGTC"	1.65136863765065	-7.20728733455809	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGTGAGTCGGTGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1571.18915458726	48.5781986002262	0.0309181096740623	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1571.18915458726	1571.18915458726
"healthy-4"	"2019-08-01-count-3:CAGGTATCAATGAAAC"	5.22713341292684	-8.64351560985716	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGGTATCAATGAAAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.55899021861	47.3508931880861	0.0183704401597692	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2576.45599396637	2576.45599396637
"healthy-4"	"2019-08-01-count-4:CCTAACCTCCTGGGAC"	3.11022104796712	-5.25200512325438	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAACCTCCTGGGAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3144.88929508984	40.8271626373861	0.0129820667141225	3072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3138.83642459528	3138.83642459528
"healthy-4"	"2019-08-01-count-3:TCCTAATGTCACTCGG"	11.3287378745968	4.75672242725221	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTAATGTCACTCGG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2045.02223905912	43.4812118364847	0.0212619750563151	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2035.82033244357	2035.82033244357
"healthy-4"	"2019-08-01-count-4:GACCCAGAGTACTGGG"	2.74230732497517	-5.80018379604491	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCCAGAGTACTGGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2785.03338451546	39.9190163722498	0.0143334067714218	2548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2781.46438425597	2781.46438425597
"healthy-4"	"2019-08-01-count-2:TGTGGCGTCCGGACGT"	10.386829038232	5.68960568988649	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGGCGTCCGGACGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1783.46277578407	40.6945536209644	0.0228177196482689	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1781.46778471944	1781.46778471944
"healthy-4"	"2019-08-01-count-2:TGTGTGAGTAGGCAGT"	4.77843918380086	-7.16985514080199	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTGTGAGTAGGCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.53805928359	46.9340158486781	0.0183225916470687	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2559.28910333012	2559.28910333012
"healthy-4"	"2019-08-01-count-4:CCTACGTTCGGTTGTA"	2.19035377082173	-6.30509617244872	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTACGTTCGGTTGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.5082611877	45.0027561122378	0.0219364245144126	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2045.11400082713	2045.11400082713
"healthy-4"	"2019-08-01-count-2:GTAGCTACAATTTCGG"	11.067604680627	6.10132072055665	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTACAATTTCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.4647844247	45.9356428949027	0.0242345008318605	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1883.14880511516	1883.14880511516
"healthy-4"	"2019-08-01-count-4:TGCGATAAGCTTCATG"	3.78864850577657	-6.21837999736937	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCGATAAGCTTCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.11019900943	44.8084086848247	0.0171475388607073	1995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2611.20636926121	2611.20636926121
"healthy-4"	"2019-08-01-count-3:TCCTCGATCTTCCTAA"	10.8214088874752	5.59952161395875	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCGATCTTCCTAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2187.99605958134	42.0639890113287	0.0192248924887814	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2177.28972065948	2177.28972065948
"healthy-4"	"2019-08-01-count-3:TTGGGTAGTTCATCTT"	11.5918270545894	3.94438669765321	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTGGGTAGTTCATCTT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2100.52796365039	38.7387328338805	0.0184423790133975	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2090.06979419444	2090.06979419444
"healthy-4"	"2019-08-01-count-2:CACACAACACCAAATC"	-4.24718604508098	13.166911102179	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACACAACACCAAATC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2433.13112915858	48.6553863688314	0.0199970259661498	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2422.57389795575	2422.57389795575
"healthy-4"	"2019-08-01-count-4:TCCGGGAGTAGGGTAC"	4.58904757079427	-6.77535726940306	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGGGAGTAGGGTAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2863.59233972631	41.935475933951	0.0146443595871468	2590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2858.41007881084	2858.41007881084
"healthy-4"	"2019-08-01-count-4:ATGACCAAGCTAGTTC"	4.53195347365682	-6.7319636574951	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCAAGCTAGTTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.10517115985	45.7874809910959	0.0174288724691144	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2622.70074209092	2622.70074209092
"healthy-4"	"2019-08-01-count-4:ATGACCACACCTCAGG"	2.82707013663594	-6.26638939296874	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCACACCTCAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.89347018844	42.0638529391038	0.0171556609006634	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2448.44041658262	2448.44041658262
"healthy-4"	"2019-08-01-count-2:ACAACCAAGTTCCGGC"	-3.01358066025432	9.47660253131715	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACAACCAAGTTCCGGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2017.39614783756	42.9221740158788	0.0212760265562552	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2012.09801621182	2012.09801621182
"healthy-4"	"2019-08-01-count-4:GTCATGATCACTGATG"	2.16585459288899	-6.25587704097899	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATGATCACTGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1877.93498172552	49.0129972686262	0.0260994111859992	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1877.93498172552	1877.93498172552
"healthy-4"	"2019-08-01-count-2:GTAGGAGTCAAGCCTA"	2.7602969604427	-4.4022574654785	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGGAGTCAAGCCTA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2720.3403182586	40.1868234966359	0.0147727191435964	2711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2713.31239707067	2713.31239707067
"healthy-4"	"2019-08-01-count-4:GGGAGATGTGCGAGTA"	-1.97909937325175	9.07875630939332	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGAGATGTGCGAGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1697.68881885799	33.5533739316614	0.0197641485052793	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1697.68881885799	1697.68881885799
"healthy-4"	"2019-08-01-count-4:TATTTCGTCTCCGATC"	3.04716744002644	-5.92971565639647	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTTCGTCTCCGATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2805.50316673323	39.6148515374217	0.0141204087762802	2134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2803.55235868374	2803.55235868374
"healthy-4"	"2019-08-01-count-3:CATAAGCGTTAATCGC"	5.51958336409871	-10.2461319199768	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAAGCGTTAATCGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.7100951136	47.2682447570568	0.017778638161389	1939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2646.9267752223	2646.9267752223
"healthy-4"	"2019-08-01-count-3:CGAAGGAAGAACAGGA"	-4.88219628754314	2.84343884075014	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAAGGAAGAACAGGA"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3204.4464713932	43.6386663212032	0.0136181604875523	3997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3191.00644794289	3191.00644794289
"healthy-4"	"2019-08-01-count-4:TACTGCCTCGAGTTGT"	2.94275703009908	-6.17839577114256	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTGCCTCGAGTTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.99285663549	43.6826772588331	0.0171439559357769	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2545.86982258306	2545.86982258306
"healthy-4"	"2019-08-01-count-4:TCCTAATGTCAAAGCG"	-2.78919372978862	9.83042142474977	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATGTCAAAGCG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.08154003518	49.0452736650517	0.0253978263725509	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1919.75615066604	1919.75615066604
"healthy-4"	"2019-08-01-count-3:AGGAAATGTCCAGGTC"	3.763684173196	-6.71824076091918	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGAAATGTCCAGGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.60098557673	45.4818004162105	0.02187044569206	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2071.04563355293	2071.04563355293
"healthy-4"	"2019-08-01-count-3:TCCTTCTTCCGTAGTA"	4.55036320266072	-7.26878025447997	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTTCTTCCGTAGTA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2851.62217621844	45.9448435267326	0.0161118271241881	2108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2848.56039150572	2848.56039150572
"healthy-4"	"2019-08-01-count-3:GATTTCTTCCGGACGT"	2.59084167060201	-6.03341724788817	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTTCTTCCGGACGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.26135404471	49.5006199709803	0.0189711237221398	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2603.68982370117	2603.68982370117
"healthy-4"	"2019-08-01-count-2:TCGGGACGTACTCCCT"	2.30104555663411	-6.13493206417235	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGGGACGTACTCCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.66818620353	43.3590581183978	0.0166594644481535	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2597.11281159585	2597.11281159585
"healthy-4"	"2019-08-01-count-2:GATCGTATCGGATACT"	3.19135775145833	-5.97468378460082	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCGTATCGGATACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2711.29735852914	41.8319242399613	0.0154287481999594	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2706.2954850641	2706.2954850641
"healthy-4"	"2019-08-01-count-4:GTTTGGAAGTCATTGC"	-2.11440883103068	3.79728195751039	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTTGGAAGTCATTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3141.99519013661	44.0111243948474	0.0140073812121061	5558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3138.20063042374	3138.20063042374
"healthy-4"	"2019-08-01-count-2:TAGCACACATAGGAGC"	9.67098774489705	7.03411338413087	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGCACACATAGGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.95373293598	42.5488272475095	0.0255402214397179	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1658.53116323981	1658.53116323981
"healthy-4"	"2019-08-01-count-3:GCAACATGTTGCCGAC"	-3.11843905869182	3.75931069934694	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACATGTTGCCGAC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3078.20231193672	48.7388696091569	0.0158335498028041	4162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3068.46225877809	3068.46225877809
"healthy-4"	"2019-08-01-count-3:TCGAACAAGATTCGCT"	-2.22918520394023	9.42603013599244	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAACAAGATTCGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1900.59818121853	42.0019593231659	0.022099336797343	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.21153586747	1897.21153586747
"healthy-4"	"2019-08-01-count-4:TACTTGTCATACGCAT"	11.0961414771969	5.94390246951906	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTCATACGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2020.38132238031	47.4918160745721	0.0235063626596091	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2010.57391933669	2010.57391933669
"healthy-4"	"2019-08-01-count-2:GAGCCTGCAATGTCAC"	11.030085225671	6.17654845798341	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGCCTGCAATGTCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.37962631326	50.7154472698697	0.026002859436004	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.32235745787	1942.32235745787
"healthy-4"	"2019-08-01-count-2:TAGGAGGCATATAGCC"	-3.86657939377483	11.5401220091614	"2019-08-01-count-2"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGAGGCATATAGCC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2163.96019713655	39.4755635991634	0.0182422780471652	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2158.57177269328	2158.57177269328
"healthy-4"	"2019-08-01-count-2:ACACGCGCATCAGTCA"	2.41568412360494	-6.01391174709471	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACACGCGCATCAGTCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2719.25134860043	42.7995421161769	0.0157394578982945	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2714.93514158116	2714.93514158116
"healthy-4"	"2019-08-01-count-4:TCCTGCAAGTCCTGCG"	-0.177347178489524	8.09693524921266	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTGCAAGTCCTGCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2155.04194649607	41.6389509165574	0.0193216428962132	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2152.08685035269	2152.08685035269
"healthy-4"	"2019-08-01-count-2:GTCAAACAGAGGTTAT"	-0.069768282503444	7.97194001758424	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCAAACAGAGGTTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1783.33287049208	42.6935572521751	0.0239403186912573	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1768.66356581388	1768.66356581388
"healthy-4"	"2019-08-01-count-2:ATTTCTGAGACGGTTG"	10.1748892265255	7.58627078616945	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTTCTGAGACGGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.10732704748	46.8564735727853	0.023556533594563	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1981.65665136624	1981.65665136624
"healthy-4"	"2019-08-01-count-4:TACTTGTGTCCCTAAA"	10.6036478477413	6.93575809085695	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTGTCCCTAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.68180348269	37.9909208711324	0.0205169812651818	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.53429245656	1846.53429245656
"healthy-4"	"2019-08-01-count-4:TACTTGTGTTGTGTTG"	3.65522040900533	-6.81870796596678	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTTGTGTTGTGTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.31597951035	48.3718791211817	0.0219342169424273	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2205.31597951035	2205.31597951035
"healthy-4"	"2019-08-01-count-3:CGACAGCGTTGGGCCT"	-3.84199366989787	10.3593778380188	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCGTTGGGCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2135.20538513322	46.8868533854403	0.0219589430187368	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2127.16645702575	2127.16645702575
"healthy-4"	"2019-08-01-count-4:GACTCTCGTGGGATTG"	5.17059053954427	-7.60373690044554	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCTCGTGGGATTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2862.58911805991	42.4379887369105	0.014825036701625	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2857.19177646337	2857.19177646337
"healthy-4"	"2019-08-01-count-3:CATAGACCATAATGAG"	2.8320447402889	-6.16187813198241	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAGACCATAATGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.89277979726	38.9604905644684	0.0151074487740166	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2574.03375318906	2574.03375318906
"healthy-4"	"2019-08-01-count-4:GTCGTAACACTCTAGA"	4.79486383971517	-7.02248670971068	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCGTAACACTCTAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.77715388791	42.7790310404617	0.0169168845007518	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2523.63011523062	2523.63011523062
"healthy-4"	"2019-08-01-count-3:CATAGACTCCATCTAT"	-6.84291634979899	3.38371274555055	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATAGACTCCATCTAT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2580.13164255614	40.8309150407103	0.0158251285970273	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2565.22229161903	2565.22229161903
"healthy-4"	"2019-08-01-count-2:CACCGTTGTCTACTGA"	-3.20111642304118	10.1920346983704	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACCGTTGTCTACTGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2044.19288649491	44.360613788661	0.0217007964765616	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2037.5340152174	2037.5340152174
"healthy-4"	"2019-08-01-count-2:GTCACGGAGGTTGACG"	-0.189510385424453	7.60464141452638	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGAGGTTGACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2187.81991579889	42.069960246363	0.0192291696142646	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2181.61740637857	2181.61740637857
"healthy-4"	"2019-08-01-count-3:CATCAAGTCCCGAGGT"	0.150058907538098	7.7451805838379	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCAAGTCCCGAGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1862.1809998365	43.3008615692031	0.0232527673588148	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1854.29794283078	1854.29794283078
"healthy-4"	"2019-08-01-count-2:CACGAATCATCCGCGA"	2.9252094226772	-5.92259313976439	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATCATCCGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2799.70866606524	45.4654759733102	0.0162393596606636	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2793.24246142001	2793.24246142001
"healthy-4"	"2019-08-01-count-3:TTTAGTCAGGGATCAC"	11.35591663894	4.29907462680665	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTAGTCAGGGATCAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.35633324471	34.360063469539	0.0176535318238765	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.34504683767	1937.34504683767
"healthy-4"	"2019-08-01-count-4:TTGAGTGAGTATGATG"	10.4408184486324	6.93029306018678	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGAGTGAGTATGATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.30535561069	45.6860205539539	0.0235094399457346	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.01344487932	1940.01344487932
"healthy-4"	"2019-08-01-count-4:GTCTACCGTGAATAAC"	4.74655308303182	-6.85733892833861	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCGTGAATAAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2806.37782870054	43.4179630308578	0.0154711751877551	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2800.23784967794	2800.23784967794
"healthy-4"	"2019-08-01-count-2:TACCCACTCGGATTAC"	-1.50821862641032	8.81954572284547	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACTCGGATTAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1959.13249162354	51.3897971547464	0.026230894222044	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1955.62993187998	1955.62993187998
"healthy-4"	"2019-08-01-count-2:CTGCATCCAGGTCAGA"	0.243421410291833	7.82903192127077	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCCAGGTCAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1767.43928779257	44.3054148130298	0.0250675738165608	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1761.36944808522	1761.36944808522
"healthy-4"	"2019-08-01-count-2:TTCCGGTTCCGCGATG"	-2.43172202530559	9.48323056781618	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCGGTTCCGCGATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1916.63435410293	49.4935144173973	0.0258231385195861	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.35397408916	1906.35397408916
"healthy-4"	"2019-08-01-count-3:ACCCAAACAGGATGAC"	4.99662317809407	-7.24716665661009	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCAAACAGGATGAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.77709036363	44.4036569588192	0.0165021685065776	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2688.4303182593	2688.4303182593
"healthy-4"	"2019-08-01-count-3:CGAGTTACAGTGACCC"	10.5349222618038	6.51105640018312	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTTACAGTGACCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1859.55293708775	44.5101104569694	0.0239359200640326	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1853.15033121511	1853.15033121511
"healthy-4"	"2019-08-01-count-2:CACGGGTTCACCTTAT"	11.0133415656978	6.54100368106691	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGGGTTCACCTTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.20295033246	44.461639795726	0.0226590423728559	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.2313757073	1951.2313757073
"healthy-4"	"2019-08-01-count-3:GCGGATCAGCTGGTGA"	-3.30195651474651	-5.61590387737425	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGATCAGCTGGTGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1943.6466142426	50.8682478209612	0.0261715516844524	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	1938.25312421801	1938.25312421801
"healthy-4"	"2019-08-01-count-4:TTCATGTTCGACATCA"	10.1054207282955	7.41840074146119	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTTCGACATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.38384391275	48.8265222987656	0.023125365119912	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2105.43264655647	2105.43264655647
"healthy-4"	"2019-08-01-count-2:GGAATCTCAACACAAA"	-3.35666070404704	9.3786000975403	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTCAACACAAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2380.37864900015	43.4849600574481	0.0182680852374951	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2371.45079010619	2371.45079010619
"healthy-4"	"2019-08-01-count-2:GAGGCCTTCCGTTGAA"	-2.78682790222819	8.82831094348756	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCCTTCCGTTGAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.16872701547	39.2385123027458	0.0194426322128045	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.44681043635	2016.44681043635
"healthy-4"	"2019-08-01-count-4:TGGATGTGTCGTGCCA"	10.3414331870968	7.60597655856935	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGATGTGTCGTGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.10250560492	44.2542560156635	0.0223381959744434	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1972.77633439412	1972.77633439412
"healthy-4"	"2019-08-01-count-2:CTGCCATGTGCGAACA"	10.148701329797	6.59003350818483	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATGTGCGAACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1782.74333948192	40.1485576884653	0.022520660601729	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1775.23542253617	1775.23542253617
"healthy-4"	"2019-08-01-count-4:TAGGGTTTCTGCGGAC"	0.229810257523698	7.76007697666017	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTTCTGCGGAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.24324974428	42.8502408477472	0.0229238441030129	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1864.47488955733	1864.47488955733
"healthy-4"	"2019-08-01-count-4:ATGTCCCTCATAGACC"	-2.8093412918156	9.36197373950807	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGTCCCTCATAGACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2014.7284960853	41.1428586952957	0.0204210437164303	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2002.36682313255	2002.36682313255
"healthy-4"	"2019-08-01-count-4:AACAGGGTCTTGGATG"	4.3605920272762	-6.75329544460448	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACAGGGTCTTGGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2990.71267021561	43.635709522926	0.0145904051423904	2927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2985.55695100117	2985.55695100117
"healthy-4"	"2019-08-01-count-2:ACGGTCGTCGTCACCT"	1.69812907752339	-6.13166143810423	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGGTCGTCGTCACCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2519.53429688261	49.4615809270048	0.0196312393874546	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2514.3014055341	2514.3014055341
"healthy-4"	"2019-08-01-count-2:GTGCTTCAGTGGATAT"	1.77021445807759	-6.82282593166503	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGCTTCAGTGGATAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1982.6326689214	46.3541404529033	0.0233800951530376	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	1979.46671377424	1979.46671377424
"healthy-4"	"2019-08-01-count-3:GCGTTTCTCACCATGA"	-4.14604697647746	12.717294669989	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGTTTCTCACCATGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1817.01489994606	46.476295862354	0.025578379056624	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1812.93418350643	1812.93418350643
"healthy-4"	"2019-08-01-count-3:GAGTTGTCAAACGGCA"	-0.0107606676524461	7.86203143680421	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTTGTCAAACGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.43715531775	41.468238863311	0.0221822053473965	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.27238101245	1866.27238101245
"healthy-4"	"2019-08-01-count-2:GAAACCTAGCAACCAG"	2.61536445197408	-6.12881710445555	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAACCTAGCAACCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.08656793234	40.5585118307923	0.0175952228410984	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2302.80082005178	2302.80082005178
"healthy-4"	"2019-08-01-count-3:AGTGTTGTCTTGATTC"	0.266590048640412	7.81878850543825	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGTTGTCTTGATTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1769.31583096402	39.552478721489	0.0223546740662681	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1763.23718759528	1763.23718759528
"healthy-4"	"2019-08-01-count-2:TCATTCACACTTCAAG"	10.7873588996822	6.62358424747316	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATTCACACTTCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2026.70822997715	46.2231932126951	0.0228070289196074	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2009.21100619593	2009.21100619593
"healthy-4"	"2019-08-01-count-4:GGAGGTAGTGGTCCGT"	2.0048392015392	-6.30878879940184	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGAGGTAGTGGTCCGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2403.34570173562	49.0762817203318	0.0204199843929612	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2398.25895285916	2398.25895285916
"healthy-4"	"2019-08-01-count-2:GGACGTCTCCGTGTGG"	-2.21602282944377	9.43791005695192	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGACGTCTCCGTGTGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2094.61863671419	50.0320976174438	0.0238860175978997	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2091.31854653982	2091.31854653982
"healthy-4"	"2019-08-01-count-3:GATAGAACAGGCATGA"	0.160415005951565	7.61628482425538	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGAACAGGCATGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.59661443557	39.0956438769113	0.0207889579172965	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1871.5000211856	1871.5000211856
"healthy-4"	"2019-08-01-count-2:TGCTGAAAGAGCGACT"	4.04803862151448	-6.73950626766356	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTGAAAGAGCGACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.00847082675	44.1725899493215	0.0180664363646908	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2440.52286288578	2440.52286288578
"healthy-4"	"2019-08-01-count-4:GTTAGTGTCGCAATGT"	-2.38272772255595	9.56252954089967	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGTGTCGCAATGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.72004687645	45.477410860307	0.0232892630631063	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1946.09807234523	1946.09807234523
"healthy-4"	"2019-08-01-count-1:AATCACGGTCTCGCGA"	10.8332554298336	6.98143241489259	"2019-08-01-count-1"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AATCACGGTCTCGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2317.96960995402	46.2332852829275	0.0199455959579404	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2302.75877093921	2302.75877093921
"healthy-4"	"2019-08-01-count-4:TGGGAGAGTGCCGTAC"	-2.21360693398173	9.52495381915895	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGAGAGTGCCGTAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2497.77899190439	46.1447086555961	0.0184742960867061	1889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2483.32809669231	2483.32809669231
"healthy-4"	"2019-08-01-count-3:GATCACACATCAGCTA"	-7.03763280335124	3.36262676799623	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCACACATCAGCTA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2477.43040594019	40.3010420233941	0.0162672751277951	2216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2464.33625426033	2464.33625426033
"healthy-4"	"2019-08-01-count-2:TGAGCATTCCACAGCG"	3.52425922927205	-6.2890629998413	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCATTCCACAGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.65024294488	47.1568150852625	0.0180563286422644	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2607.79101009998	2607.79101009998
"healthy-4"	"2019-08-01-count-2:CTGGCAGAGAAACACT"	4.88161148604695	-7.26416780864867	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGCAGAGAAACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.84691333292	43.9052352696069	0.0160305547038328	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2730.85529837127	2730.85529837127
"healthy-4"	"2019-08-01-count-2:AGCCAGCTCCTTCTAA"	2.30126680907552	-6.03262903606566	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCCAGCTCCTTCTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.42667712844	45.150522777953	0.0166642349686338	1801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2707.06633012829	2707.06633012829
"healthy-4"	"2019-08-01-count-4:ATTATCCAGCGTGTTT"	0.171602566807908	7.63625142658082	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTATCCAGCGTGTTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1764.85939610242	36.7675939204242	0.0208331575884306	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1757.79823652849	1757.79823652849
"healthy-4"	"2019-08-01-count-2:CACTAAGAGTTACGGG"	14.306974073022	2.12194249713746	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACTAAGAGTTACGGG"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1263.09964068389	34.5182456642104	0.027328204800629	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1246.02473770434	1246.02473770434
"healthy-4"	"2019-08-01-count-2:GTCCCATTCTTGGTGA"	3.36388053473775	-6.44880535518798	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATTCTTGGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2739.90054631536	42.7071546741654	0.0155871185658904	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2734.79418513901	2734.79418513901
"healthy-4"	"2019-08-01-count-4:GAGCTGCTCTGTGCAA"	2.22661175307576	-6.24918177044066	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGCTGCTCTGTGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.1019588354	46.0968035782129	0.0215093842773877	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2135.34515140173	2135.34515140173
"healthy-4"	"2019-08-01-count-3:GATCATGAGCGCACAA"	-0.482258955866653	8.2044992216858	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCATGAGCGCACAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2045.81889108039	38.2303809201579	0.0186870798225783	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2034.60272811027	2034.60272811027
"healthy-4"	"2019-08-01-count-4:GTGAGTTTCAATCCGA"	-3.7038885158604	9.99056336963502	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGAGTTTCAATCCGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2146.15534214543	41.4301305075684	0.0193043484290156	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2134.27454144829	2134.27454144829
"healthy-4"	"2019-08-01-count-3:AAAGGATCATAACTCG"	-3.24652777138408	10.6279697188172	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGATCATAACTCG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1915.5538771189	48.4991283366885	0.0253185926618957	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1907.96375606131	1907.96375606131
"healthy-4"	"2019-08-01-count-2:GGAGCAATCATTCTTG"	6.5256892639095	-1.66643848335417	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGCAATCATTCTTG"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2903.59713417628	41.6014891578141	0.0143275692995254	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2899.35950626214	2899.35950626214
"healthy-4"	"2019-08-01-count-3:CATGCTCTCTCCTGCA"	11.3653274970943	4.74837873065797	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCTCTCCTGCA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2364.13738234939	41.7187146367465	0.0176464849074414	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2350.57232535032	2350.57232535032
"healthy-4"	"2019-08-01-count-4:GTGATGTCACGCCAGT"	3.6591907936031	-6.35939552700194	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGATGTCACGCCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.5784705471	46.4117515461653	0.0184424018918335	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2512.00384637092	2512.00384637092
"healthy-4"	"2019-08-01-count-3:CATGCTCTCCGCTTAC"	9.56445660170857	7.06290814960328	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCTCCGCTTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2168.51045399775	46.5542060061901	0.0214682875613374	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2158.24336478252	2158.24336478252
"healthy-4"	"2019-08-01-count-3:CATGGTAAGGAGAATG"	4.45218481597249	-7.02179100429686	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGGTAAGGAGAATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1663.16801279448	48.4259701852348	0.0291167036719693	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1654.23685704478	1654.23685704478
"healthy-4"	"2019-08-01-count-3:CTGTAGAAGATTCGCT"	-4.2112229866093	10.5349559553894	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTAGAAGATTCGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2117.88631886732	44.5313227713364	0.0210263045634822	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2117.88631886732	2117.88631886732
"healthy-4"	"2019-08-01-count-2:TACTGCCTCAAGCCGC"	11.3149658637935	5.87822530353395	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTGCCTCAAGCCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2096.11831425611	38.3569772034027	0.0182990516053075	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2090.15464559332	2090.15464559332
"healthy-4"	"2019-08-01-count-3:TATGTTCGTAGGAGGG"	12.1705433326656	-2.47073628818663	"2019-08-01-count-3"	"Control4"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCGTAGGAGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1676.59374803972	40.251849097742	0.0240081111746985	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	1672.63635149122	1672.63635149122
"healthy-4"	"2019-08-01-count-3:AGGTTACCAGCACGAA"	2.61022677001302	-5.95176699077757	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTTACCAGCACGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2535.30718822452	44.6965641780917	0.0176296444019444	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2534.35019220001	2534.35019220001
"healthy-4"	"2019-08-01-count-4:TGGTAGTAGCTGAAAT"	4.22715200957601	-6.42726423656615	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTAGCTGAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.46878282397	44.6207550289749	0.0173454991278813	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2566.78126685876	2566.78126685876
"healthy-4"	"2019-08-01-count-3:TATGTTCGTCAACCTA"	5.67122091826741	-9.7003793946472	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATGTTCGTCAACCTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2744.77975481385	42.7432292245034	0.0155725533713732	1967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2736.43314211085	2736.43314211085
"healthy-4"	"2019-08-01-count-3:TTTGGTTTCTGGAAGG"	-2.30860481682475	9.71890733325807	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TTTGGTTTCTGGAAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.92474307457	45.1559637578591	0.0261028486578001	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1728.05002143962	1728.05002143962
"healthy-4"	"2019-08-01-count-2:ACCACAATCCCTCTAG"	11.0620209175045	6.64451882922975	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCACAATCCCTCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2108.15715611588	46.5205421961386	0.0220669232657442	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.92273229994	2093.92273229994
"healthy-4"	"2019-08-01-count-2:TGAGTCAAGTCTTCCC"	0.223333676427048	7.90334746921388	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGTCAAGTCTTCCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1856.28023144827	45.0588481866808	0.0242737316399291	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1847.03225876536	1847.03225876536
"healthy-4"	"2019-08-01-count-2:TACTTCAAGGCGTCCT"	3.05066480216328	-6.51570608532103	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCAAGGCGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.07842051853	45.0983632539224	0.0197619691104547	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2277.87216608119	2277.87216608119
"healthy-4"	"2019-08-01-count-4:GAGGGTATCTGTGCAA"	3.27206100997273	-6.16737892543944	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGGTATCTGTGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.18641788787	41.7172742825293	0.0165139334085284	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2515.6502764197	2515.6502764197
"healthy-4"	"2019-08-01-count-2:GAGTTTGGTGTCGCTG"	2.9869200187618	-6.43449404155882	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTTGGTGTCGCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.51720243093	48.5550493404892	0.0209422855649205	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2317.1765665985	2317.1765665985
"healthy-4"	"2019-08-01-count-3:TCGTCCACATAGAGGC"	11.4815432029659	3.75931856716005	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGTCCACATAGAGGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1942.08415459597	40.6344962457203	0.0209231387576889	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1922.38413597624	1922.38413597624
"healthy-4"	"2019-08-01-count-3:AGTAACCGTTACACAC"	11.1435686546261	4.21891019428102	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCGTTACACAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2087.56809407635	41.6460654730289	0.0199495602520479	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.03782218809	2077.03782218809
"healthy-4"	"2019-08-01-count-4:TATCTTGTCCGATCGG"	3.07840528067891	-6.09342958843382	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATCTTGTCCGATCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.15597411181	46.010113833009	0.0181631586460606	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2527.97386848187	2527.97386848187
"healthy-4"	"2019-08-01-count-3:GATGCTACAGGAATCG"	11.0062538581783	6.14001748645631	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGCTACAGGAATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.49956704987	42.5243188581965	0.0219254077601467	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1932.56552917471	1932.56552917471
"healthy-4"	"2019-08-01-count-3:GTGTGATGTTGGTACT"	1.73823203620259	-6.0586934319702	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATGTTGGTACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2539.44797926147	46.7648597982537	0.0184153643548366	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2537.20186195061	2537.20186195061
"healthy-4"	"2019-08-01-count-4:TATTCCAAGCACCCAC"	2.44480957564656	-6.10454370891722	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTCCAAGCACCCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.35746038718	43.9923374297096	0.0174409607363727	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2516.77513573577	2516.77513573577
"healthy-4"	"2019-08-01-count-3:AGTACTGAGATAGTGT"	10.6437908607418	6.98194596851198	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGAGATAGTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1862.79838220962	44.0079708835101	0.0236246559497806	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1859.48900970695	1859.48900970695
"healthy-4"	"2019-08-01-count-4:TCCGATCAGTAAATGC"	11.0464722114498	6.65572831714479	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCGATCAGTAAATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.66881151753	39.8285961338763	0.020922019572368	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1900.20339989129	1900.20339989129
"healthy-4"	"2019-08-01-count-2:TGATTCTTCTGTCCGT"	-5.61314521256145	-5.32956125652465	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTCTTCTGTCCGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2918.07395278573	50.9733643653363	0.0174681537171718	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2912.74462387232	2912.74462387232
"healthy-4"	"2019-08-01-count-4:TTGTTCATCGTGCACG"	3.24669899520223	-6.19442322170409	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCATCGTGCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.97897673761	42.6778584280419	0.0164273301709448	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2591.16156781921	2591.16156781921
"healthy-4"	"2019-08-01-count-2:TTCAATCAGCAATAAC"	11.0609318214351	5.89427087390748	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAATCAGCAATAAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1967.73895445453	44.8156184435746	0.0227751848598219	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1962.55939455749	1962.55939455749
"healthy-4"	"2019-08-01-count-4:TGTAAGCGTGAGCAGT"	-3.21514640274699	9.53083322131959	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAAGCGTGAGCAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.77566030833	45.556884300837	0.0222036381375101	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2046.8231754667	2046.8231754667
"healthy-4"	"2019-08-01-count-4:GTGGAGAAGGATATGT"	10.6566902595455	7.47629163349	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGAGAAGGATATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2414.82712058017	46.5943543410896	0.0192951097592009	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2400.00681380572	2400.00681380572
"healthy-4"	"2019-08-01-count-2:CTTACCGGTCATATGC"	10.6674705940181	6.14980790698854	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTACCGGTCATATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1569.8189794432	48.3722293564386	0.0308138900025249	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1556.35561149386	1556.35561149386
"healthy-4"	"2019-08-01-count-4:TATTGCTGTCTACTGA"	4.85346331176106	-7.54343607341918	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATTGCTGTCTACTGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2791.09914866834	38.0355455762184	0.0136274433655879	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2789.28094416771	2789.28094416771
"healthy-4"	"2019-08-01-count-2:TAGACCAGTGCGGTAA"	14.497460980981	2.05252180183259	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAGTGCGGTAA"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1649.48145659291	29.8892996765129	0.0181204217586361	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1637.15280562718	1637.15280562718
"healthy-4"	"2019-08-01-count-4:GTGGCGTAGAACTCCT"	5.09297527846639	-7.6232629052368	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGCGTAGAACTCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2712.86368142929	46.9489160343329	0.0173060358158496	1953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2706.60735799442	2706.60735799442
"healthy-4"	"2019-08-01-count-2:TGCACGGCAGACTGCC"	10.6955496269161	6.45764730060426	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCACGGCAGACTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1996.46904915157	42.0025553180806	0.0210384204733503	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1991.66327355009	1991.66327355009
"healthy-4"	"2019-08-01-count-2:GGCAGTCAGCCTGTGC"	3.65476479110066	-6.27929403698119	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCAGTCAGCCTGTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.96551577735	45.7874616651031	0.0199948258389211	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2284.08277540409	2284.08277540409
"healthy-4"	"2019-08-01-count-4:GATAGCTCAAATCGTC"	10.9200788932735	5.98680541599122	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATAGCTCAAATCGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.02135740407	42.6379092331195	0.0228741527363717	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1855.28143237639	1855.28143237639
"healthy-4"	"2019-08-01-count-4:ATTCTTGAGTCGAATA"	3.08407868918721	-6.1096778145996	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTCTTGAGTCGAATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.90549500902	47.2987080419284	0.019659420596548	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2401.72460097297	2401.72460097297
"healthy-4"	"2019-08-01-count-4:GTGGGAAAGCCAAGTG"	11.0492054420406	6.70828673923341	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGGAAAGCCAAGTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.75936603513	51.2092329739505	0.0254676088242852	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2004.45647318122	2004.45647318122
"healthy-4"	"2019-08-01-count-4:GTTGTGATCACCCTGT"	3.20858516272847	-6.0499100915161	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTGATCACCCTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.54483578725	45.5459369731946	0.0168218588188039	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2698.0219217822	2698.0219217822
"healthy-4"	"2019-08-01-count-3:GGAATGGCATCCAACA"	10.4849716621334	7.65985677326051	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGCATCCAACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2013.10978592872	41.323604934415	0.0205272485501087	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.75983950618	2007.75983950618
"healthy-4"	"2019-08-01-count-3:AGTCAACAGTTGGCTT"	9.85781349715535	7.45421168887941	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACAGTTGGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.91936619121	52.3192217955001	0.0263450886708673	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1972.40244206513	1972.40244206513
"healthy-4"	"2019-08-01-count-3:CGGGTGTTCAGCACCG"	-2.74318967285808	3.56699130618898	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTTCAGCACCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3205.67536345454	44.2688916936022	0.0138095367354655	5355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3195.77055982759	3195.77055982759
"healthy-4"	"2019-08-01-count-3:GATTGGTGTAACATAG"	3.53663076934163	-6.722044014093	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTGTAACATAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.90641573141	42.6854147750198	0.0181415692904857	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2351.48762671314	2351.48762671314
"healthy-4"	"2019-08-01-count-4:TGTAGACAGGGCGAGA"	2.76731767234151	-5.9675593606201	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTAGACAGGGCGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.53543433779	46.5327913653175	0.01800431549403	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.86474242672	2580.86474242672
"healthy-4"	"2019-08-01-count-3:GATTGGTTCACACCCT"	4.95448412474934	-7.38571932232054	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTGGTTCACACCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3032.57891859928	42.3823846512268	0.0139756905883929	2725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	3021.94160809364	3021.94160809364
"healthy-4"	"2019-08-01-count-4:GTGGTTAAGAATACAC"	10.569111486047	6.64727351749269	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGGTTAAGAATACAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2037.47020439767	41.4085244845497	0.0203234994039047	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2028.62539514989	2028.62539514989
"healthy-4"	"2019-08-01-count-2:ACCTGAATCGCTTACC"	2.30202664908711	-6.49652101909789	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACCTGAATCGCTTACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.29811821638	46.5361238863065	0.0219065881042061	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2122.59135393561	2122.59135393561
"healthy-4"	"2019-08-01-count-3:CCGGACATCTCCCTAG"	3.92857517775838	-6.4862909547058	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGGACATCTCCCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.28701435118	43.5031034201954	0.0169319749709556	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2568.10491064097	2568.10491064097
"healthy-4"	"2019-08-01-count-4:TCCTAATTCACTCGAA"	4.24406542357747	-6.94867327129515	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTAATTCACTCGAA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.43212589364	47.7464671216639	0.0176353330024494	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2704.12443589995	2704.12443589995
"healthy-4"	"2019-08-01-count-4:TTAGGGTCATTAAAGG"	-2.97678552094157	10.0298175581726	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAGGGTCATTAAAGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1860.00823068687	41.4057605697903	0.0222610630892208	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1856.24822574683	1856.24822574683
"healthy-4"	"2019-08-01-count-3:AGTCACAAGTAAATGC"	4.41392006453816	-7.04206135189208	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACAAGTAAATGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.92965370546	42.2360341958981	0.0155626856938724	1983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2707.86293659562	2707.86293659562
"healthy-4"	"2019-08-01-count-3:ATTTCACTCCCGAACG"	0.122097198932809	7.64732453906862	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACTCCCGAACG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2118.15034384644	45.5503918242686	0.021504796369436	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2107.49248276926	2107.49248276926
"healthy-4"	"2019-08-01-count-3:GCAACCGGTCGACTGC"	2.0495556789333	-6.25004579937132	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAACCGGTCGACTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.46577888585	47.0038089229932	0.0204500799423595	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2296.06582891912	2296.06582891912
"healthy-4"	"2019-08-01-count-2:TGCAGTATCACCGACG"	0.529362072318238	8.13905809009401	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTATCACCGACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.37671946245	42.5797439768449	0.0229741441821901	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1845.03292591608	1845.03292591608
"healthy-4"	"2019-08-01-count-2:AGGACTTGTCGCGGTT"	-5.68057523194011	-5.49511625682982	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGACTTGTCGCGGTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2873.95586232063	50.6098021945548	0.0176098049584133	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2869.00662010528	2869.00662010528
"healthy-4"	"2019-08-01-count-3:CACGAATGTTGACGGA"	11.4223085838253	4.64039990985719	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGAATGTTGACGGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2216.1553704166	40.8232526119561	0.0184207538681198	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2211.21469006221	2211.21469006221
"healthy-4"	"2019-08-01-count-2:GTTAGTGTCTCATTAC"	4.42667831954305	-6.75451757824095	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGTCTCATTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.8780083596	45.2275677730729	0.0179625730964379	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2508.94271785524	2508.94271785524
"healthy-4"	"2019-08-01-count-3:CTCAAGACAGCTGTGC"	2.94006170806233	-6.04542400753173	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAAGACAGCTGTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.42517171522	44.7023494926385	0.0186459832073326	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2391.32742702714	2391.32742702714
"healthy-4"	"2019-08-01-count-4:TCAAGTGCACTTGGCG"	10.6753012138302	6.74754569614259	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGTGCACTTGGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1927.65799960997	41.4592490130107	0.0215075750062508	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.99090378733	1919.99090378733
"healthy-4"	"2019-08-01-count-2:TGTTGGATCCCTATTA"	5.64164890822713	-9.63577368175658	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGATCCCTATTA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2731.22518000821	40.7866019192078	0.014933445333528	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2722.84536961714	2722.84536961714
"healthy-4"	"2019-08-01-count-3:CACGGGTTCATCGGGC"	-0.953150133520919	8.91848561847535	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGGGTTCATCGGGC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1564.78961724038	36.1398473724132	0.0230956589782008	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1562.60848603032	1562.60848603032
"healthy-4"	"2019-08-01-count-3:GACCAATCATGGATCT"	2.04900898513142	-6.31065275585326	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATCATGGATCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.19774895749	47.395954209137	0.0194948988536455	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2420.50125257989	2420.50125257989
"healthy-4"	"2019-08-01-count-3:CGTAGTATCTAGCCTC"	0.0103179710799873	8.04630801761476	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAGTATCTAGCCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1968.92969015642	50.4610595633363	0.0256286752216772	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.36803863335	1958.36803863335
"healthy-4"	"2019-08-01-count-4:CAAAGAACAGTAGAGC"	10.8121963935787	6.20994994724122	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAAGAACAGTAGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.75263272446	43.7769770379712	0.0234132452987552	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1868.00703212307	1868.00703212307
"healthy-4"	"2019-08-01-count-3:GCACGGTGTCAGCTTA"	3.21994819220845	-6.14298632061156	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGGTGTCAGCTTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.00141041032	34.450805420745	0.0141948023898843	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2421.84263615233	2421.84263615233
"healthy-4"	"2019-08-01-count-2:TGCCGAGCACTTGTCC"	2.45277180251424	-6.23696091091307	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCCGAGCACTTGTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.25405026602	44.1470637838451	0.0184773418209461	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2386.73306093598	2386.73306093598
"healthy-4"	"2019-08-01-count-4:GATGAGGCACACTGGC"	10.7167536216671	6.42672488773195	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGCACACTGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.78781438366	44.3499330378538	0.0224013567088555	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.65174869067	1973.65174869067
"healthy-4"	"2019-08-01-count-4:TTTATGCTCATTGCCC"	11.062516828149	6.19922111118165	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTATGCTCATTGCCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.44740796951	42.694180527882	0.0231474100825042	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1837.5328890512	1837.5328890512
"healthy-4"	"2019-08-01-count-2:GATGGAGAGCAATAGT"	10.8834167915279	6.66320703113405	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGGAGAGCAATAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.22995589074	42.6496711107594	0.0215268656644072	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.18413569037	1973.18413569037
"healthy-4"	"2019-08-01-count-4:CGCATGGAGTGGATAT"	10.3780886131221	6.49201772296754	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATGGAGTGGATAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1736.88119863125	43.2124492066087	0.0248793350061377	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1731.30555782803	1731.30555782803
"healthy-4"	"2019-08-01-count-3:AGTGACTGTTGTGTTG"	10.6776997047359	6.82614467227785	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTGTTGTGTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1795.90324618062	43.4778394322739	0.0242094553393893	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1787.81460550175	1787.81460550175
"healthy-4"	"2019-08-01-count-4:AACACACCAGAGACTG"	-0.20897019925769	7.61350486362306	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACACACCAGAGACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2071.33016131239	37.5070643970512	0.0181077189419608	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2063.52500659032	2063.52500659032
"healthy-4"	"2019-08-01-count-2:CTTGAGACATACCACA"	3.15430678901021	-6.19452955639037	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGAGACATACCACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.83991798811	45.8329709306438	0.0207968693898987	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2200.72530712581	2200.72530712581
"healthy-4"	"2019-08-01-count-4:GTGTTCCGTTCGGTCG"	11.0810104804928	6.21768996799318	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCGTTCGGTCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1814.46547639933	39.2137188729304	0.0216117194749537	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1804.09134437596	1804.09134437596
"healthy-4"	"2019-08-01-count-2:TAGTGCACACGCTGTG"	0.270246719091576	7.99333093250123	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGTGCACACGCTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1727.12335282083	39.821963598937	0.0230568149830744	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1723.0128020246	1723.0128020246
"healthy-4"	"2019-08-01-count-2:TCCTCTTGTTCTCCTG"	4.41276182708089	-6.67248394405516	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCTTGTTCTCCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2869.46734285383	44.3502854894334	0.0154559296867009	2179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2860.74258975573	2860.74258975573
"healthy-4"	"2019-08-01-count-3:TCATTTGGTTCCGGTG"	-2.51908073845561	3.43553397739259	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTTGGTTCCGGTG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3305.57938551567	46.9511057923842	0.0142035934753568	5375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3296.05584930377	3296.05584930377
"healthy-4"	"2019-08-01-count-3:GCGGAAAGTAACTGCT"	10.6416927772457	7.4669527777466	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGAAAGTAACTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1990.70556030003	46.8712519340107	0.0235450449673464	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1983.17662761017	1983.17662761017
"healthy-4"	"2019-08-01-count-2:TCCTGCACAAGACCTT"	-4.15174184265788	10.7117194899353	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTGCACAAGACCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2086.92430275067	38.1296638953258	0.018270746018468	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2077.33537233214	2077.33537233214
"healthy-4"	"2019-08-01-count-2:TACCGAAAGGCTTAGG"	2.92749490317647	-6.26635601436766	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGAAAGGCTTAGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.81765912477	44.6544483795904	0.0183625808505979	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2424.97696671757	2424.97696671757
"healthy-4"	"2019-08-01-count-2:ATCGCCTCAAACTGCT"	0.0656563100287735	7.72707984531251	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTCAAACTGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2005.82614277337	38.665228793252	0.0192764606905518	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1992.73940556619	1992.73940556619
"healthy-4"	"2019-08-01-count-2:TTGCTGCGTGGTAATA"	-0.110066111118156	7.73930356586305	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCTGCGTGGTAATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.18032522396	42.617195510323	0.0214352767551517	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.85760553165	1979.85760553165
"healthy-4"	"2019-08-01-count-3:AGTGCCGAGCCGTCGT"	10.8709312873775	7.50646398151246	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGCCGAGCCGTCGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2583.20870627965	46.5088706549251	0.0180043023786132	1958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2572.17849605585	2572.17849605585
"healthy-4"	"2019-08-01-count-2:TCCTTCTCAGCGTACC"	-0.0543852848118127	7.81350419605104	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTCAGCGTACC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.53324893883	42.367626439735	0.0206115014007228	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2054.22848327516	2054.22848327516
"healthy-4"	"2019-08-01-count-4:ACTACGAAGTAACCTC"	2.99063219603841	-6.26518442546996	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTACGAAGTAACCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.89336228341	50.8992613002259	0.0218461763633432	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2325.83357453246	2325.83357453246
"healthy-4"	"2019-08-01-count-3:CGTGATATCGAGAATA"	2.04707266864125	-6.22589924251708	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTGATATCGAGAATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.47495533429	52.2118175588354	0.023293509229082	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2238.98553894303	2238.98553894303
"healthy-4"	"2019-08-01-count-4:CCGAACGGTTCTATCT"	14.3509880500728	1.94958303058473	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGAACGGTTCTATCT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1632.31142512603	32.2671293920847	0.0197677531967243	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1605.86430575087	1605.86430575087
"healthy-4"	"2019-08-01-count-4:TTCCAATTCGGTCAGC"	-0.323565940291244	8.09266088092653	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCAATTCGGTCAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.56533924154	41.0560405087579	0.0228907414803855	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1787.98841669567	1787.98841669567
"healthy-4"	"2019-08-01-count-2:TTCCTCTAGATACAGT"	5.15208782729451	-8.02752878582152	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCCTCTAGATACAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.70543329238	43.8065642407124	0.016671033094385	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2625.25063809669	2625.25063809669
"healthy-4"	"2019-08-01-count-3:ACCCTTGAGCCTATCA"	-2.16969356957133	3.43144152248231	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCCTTGAGCCTATCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3233.49007697972	45.619178105947	0.0141083402205948	4966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3221.80105912626	3221.80105912626
"healthy-4"	"2019-08-01-count-4:TCGCACTAGGGCTGAT"	2.2730835872585	-6.30969431316527	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCACTAGGGCTGAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.14967241393	54.2271726697327	0.0227544133284776	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2377.28029443715	2377.28029443715
"healthy-4"	"2019-08-01-count-2:CGGCAGTGTGACAGGT"	10.2512041526729	5.886034942511	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGCAGTGTGACAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1657.78213035604	38.5223674316141	0.0232372919976769	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1655.8569958901	1655.8569958901
"healthy-4"	"2019-08-01-count-3:GATAGAAAGCGCTGCT"	10.1698624092037	7.17328212344972	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATAGAAAGCGCTGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.48008199098	44.1466403732925	0.0225068002365244	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.9496109238	1950.9496109238
"healthy-4"	"2019-08-01-count-2:GGAATGGTCTGTGCTC"	4.25025810775105	-7.16645433818968	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATGGTCTGTGCTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2778.85864456061	43.2377751952071	0.0155595446640806	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2775.85349611352	2775.85349611352
"healthy-4"	"2019-08-01-count-3:AACGTCACAATCTAGC"	10.9271494346553	6.20702788913576	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCACAATCTAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2087.5013869347	42.813837700357	0.020509609223889	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2075.72613814844	2075.72613814844
"healthy-4"	"2019-08-01-count-3:ATTACCTGTCTACTGA"	-2.31619439545329	9.13142774188844	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTACCTGTCTACTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1837.61518486577	41.9562419042809	0.0228318976953522	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1835.64978107941	1835.64978107941
"healthy-4"	"2019-08-01-count-2:CACGTTCGTAGCTGCC"	10.6111990409786	5.95270392978517	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCGTAGCTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1917.08526942431	45.7163786765331	0.0238468154785111	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.01536922035	1910.01536922035
"healthy-4"	"2019-08-01-count-4:ATTACCTTCTATCCAT"	10.2240406471187	7.65175387943117	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATTACCTTCTATCCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.81784215202	40.6193732774102	0.0196056682450511	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2064.29363697733	2064.29363697733
"healthy-4"	"2019-08-01-count-3:ACTTCGCCACAAATAG"	10.64000572738	7.02933785999147	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTCGCCACAAATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2089.34725300796	50.7594575737732	0.0242944094145655	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2081.3505730268	2081.3505730268
"healthy-4"	"2019-08-01-count-2:GTGGAGAGTAGGACTG"	4.1614428955013	-7.06514456188353	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAGAGTAGGACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.62257844969	46.5654539788412	0.018256505047934	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2544.84965533677	2544.84965533677
"healthy-4"	"2019-08-01-count-2:TTCGCTGAGAATCCCT"	-3.9217303794926	-4.87451364910277	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGAGAATCCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3078.58315281576	42.8629922780264	0.0139229607096442	3286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3071.84805127419	3071.84805127419
"healthy-4"	"2019-08-01-count-2:GTGGCGTCACAACCGC"	10.6844822364742	6.66314122760621	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGCGTCACAACCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1883.65233755796	47.0144995013401	0.0249592234001587	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.82505367869	1875.82505367869
"healthy-4"	"2019-08-01-count-2:GTGGCGTGTTAGGCCC"	11.3951593833858	4.28011748874513	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGCGTGTTAGGCCC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.6216625285	39.0438170998023	0.0196930245632485	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.71440706753	1969.71440706753
"healthy-4"	"2019-08-01-count-4:ACTCTCGCAATAGGAT"	-0.159267599613029	7.58254144275514	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTCTCGCAATAGGAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2111.73034475781	39.0177691484186	0.0184766815731359	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2102.39615163242	2102.39615163242
"healthy-4"	"2019-08-01-count-3:CCCGAAGTCCACAGCG"	-7.81989083710368	-0.499273978826128	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGAAGTCCACAGCG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3345.66103088072	45.084655701085	0.0134755599222246	5723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3335.30730140666	3335.30730140666
"healthy-4"	"2019-08-01-count-4:TGTTGAGAGGCGAAGG"	11.4135023551876	3.57489178264467	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGAGAGGCGAAGG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1840.22053038602	29.9159586702747	0.0162567247654819	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1826.40629091007	1826.40629091007
"healthy-4"	"2019-08-01-count-2:ACGTACATCCATCAGA"	-2.09700403633769	9.09864709461061	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACATCCATCAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.99851955844	39.0774053365463	0.018590596031797	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2097.05450004038	2097.05450004038
"healthy-4"	"2019-08-01-count-2:ACGTACATCTCTTGCG"	3.89613856849019	-6.30885841762694	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTACATCTCTTGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.54353519321	39.7752766415828	0.0152656350217665	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2603.18782196593	2603.18782196593
"healthy-4"	"2019-08-01-count-4:AACCTGAAGCTGAGCA"	9.69263042983357	7.04369256580202	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACCTGAAGCTGAGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1881.89270173552	43.5388191237643	0.0231356543779632	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.29550590645	1875.29550590645
"healthy-4"	"2019-08-01-count-2:AGGGTGACATCTCATT"	11.2204824882442	5.11936709964601	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGGTGACATCTCATT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2206.16780623985	40.4688971310213	0.0183435262796241	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2198.75421769441	2198.75421769441
"healthy-4"	"2019-08-01-count-1:ACTACGATCCTATTGT"	-0.0616401759093583	7.61433551395265	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTACGATCCTATTGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2165.42529793679	44.9056038939411	0.0207375446923646	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2157.95284051949	2157.95284051949
"healthy-4"	"2019-08-01-count-4:TCAGGGCCACAACGAG"	-3.84939108315166	10.5808210142883	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGGCCACAACGAG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2012.81239355614	43.7601823403744	0.02174081522971	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2007.88757372545	2007.88757372545
"healthy-4"	"2019-08-01-count-4:ACTGCAACACGCTGAC"	3.44998278197591	-6.22632982647093	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACTGCAACACGCTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2662.32995518447	43.517036512722	0.0163454707888402	1884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2657.05922270498	2657.05922270498
"healthy-4"	"2019-08-01-count-3:ATACCTTAGGAGCTGT"	-3.26628027382548	3.84675953471986	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTAGGAGCTGT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2901.77474146423	43.8593275048394	0.01511465617166	3104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2894.11412322761	2894.11412322761
"healthy-4"	"2019-08-01-count-3:TCAGGGCGTTGGGAAC"	11.5769630866939	3.50676796520082	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGGGCGTTGGGAAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1975.5053986865	38.5228034333581	0.0195002268578823	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1958.32397109121	1958.32397109121
"healthy-4"	"2019-08-01-count-4:CAAGGGAAGTAGGAAG"	-2.33875976029094	8.83011624896852	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGGGAAGTAGGAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.99054670967	49.3302971333219	0.0249018336888367	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.71821566769	1975.71821566769
"healthy-4"	"2019-08-01-count-4:TCTTGCGCAACCGCCA"	-4.52936110916789	12.7108325728211	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTTGCGCAACCGCCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2347.20090953988	45.9266824513217	0.0195665749210725	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2343.91207509619	2343.91207509619
"healthy-4"	"2019-08-01-count-4:TCAGGTAAGGCTTAGG"	-3.84252176705058	-5.38384678280028	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGGTAAGGCTTAGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2841.729053317	46.9910972028973	0.0165360934562171	2182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2834.90216659261	2834.90216659261
"healthy-4"	"2019-08-01-count-3:GCATTAGAGCCACTCG"	-2.00781975212749	9.22816560352174	"2019-08-01-count-3"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATTAGAGCCACTCG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1789.64009144883	46.5222057141864	0.0259952858323171	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1785.92119069474	1785.92119069474
"healthy-4"	"2019-08-01-count-3:CTACAGATCTCAAAGC"	3.51320662078206	-6.21066620266112	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACAGATCTCAAAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.23235181828	46.9633544389258	0.0184950992788417	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2530.50049355706	2530.50049355706
"healthy-4"	"2019-08-01-count-2:CTAGACAAGTATGGCG"	9.50874676284139	5.69818780505983	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGACAAGTATGGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.62776292005	42.859747869829	0.0218490728363411	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1951.38473089339	1951.38473089339
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTTGCATCA"	-1.52356741848643	8.79856584155885	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTTGCATCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.2917389379	47.6849890274631	0.0232236793842696	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2051.48139357595	2051.48139357595
"healthy-4"	"2019-08-01-count-4:TTAATCCGTCTGTAAC"	3.53859653052632	-6.32712271129759	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTAATCCGTCTGTAAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.96322667922	44.6448547559203	0.0193522177725324	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2303.29591570836	2303.29591570836
"healthy-4"	"2019-08-01-count-3:TCAGTGAGTTGCACGC"	-1.73573217812236	8.85014913165895	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTGAGTTGCACGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.43485941236	49.6933259287387	0.0249786142499872	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1979.1276587262	1979.1276587262
"healthy-4"	"2019-08-01-count-2:ACTACGAGTACCGGCT"	-0.0169616294210732	7.74753854358522	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTACGAGTACCGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2141.65879382959	40.6696849045354	0.0189898059493466	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2136.18379439019	2136.18379439019
"healthy-4"	"2019-08-01-count-4:GTTGAACGTGATCATC"	-1.7199926179951	3.35356543147889	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACGTGATCATC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2825.57109546086	39.5486023522477	0.0139966757218675	5508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2818.62731431313	2818.62731431313
"healthy-4"	"2019-08-01-count-2:AGGTGTTAGTTACGGG"	-2.97077045860942	9.28678414905397	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGGTGTTAGTTACGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.57388562078	43.5421129576957	0.0214538200684315	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.26512154126	2024.26512154126
"healthy-4"	"2019-08-01-count-4:AACGTCACACAAGCAG"	4.42252077636067	-6.83910324489745	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AACGTCACACAAGCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.60417078659	42.4323787618497	0.0159065498646817	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2659.96286165159	2659.96286165159
"healthy-4"	"2019-08-01-count-4:TCAGTGACAGACATCT"	3.29480828818623	-5.61060717022093	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGTGACAGACATCT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2862.56058493416	42.0697295011549	0.0146965376811833	2778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2852.51192341432	2852.51192341432
"healthy-4"	"2019-08-01-count-2:ACTATCTAGCGTGCTC"	1.85957409915273	-6.40565779125365	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTATCTAGCGTGCTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2266.80883396158	48.5426006485282	0.0214145100906867	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2265.39863809724	2265.39863809724
"healthy-4"	"2019-08-01-count-4:GTTGCGGGTCACTCAA"	5.33327498015706	-9.38322355663451	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGGTCACTCAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2795.09999405999	42.9699042528711	0.015373297679578	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2786.85254295762	2786.85254295762
"healthy-4"	"2019-08-01-count-3:CCCTGATAGCCTGAGA"	3.44317903098409	-6.13260939037474	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTGATAGCCTGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2662.50542520977	42.9377691905236	0.0161268288071716	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2651.71307508062	2651.71307508062
"healthy-4"	"2019-08-01-count-4:CTTCGGTCAAGCCATT"	-3.96075807038005	11.9696874388489	"2019-08-01-count-4"	"Control4"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCGGTCAAGCCATT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2170.21677413227	39.9818317104736	0.0184229668607459	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2164.94812889646	2164.94812889646
"healthy-4"	"2019-08-01-count-2:TATTGCTGTAGATCGG"	2.97666015204732	-6.17328121578368	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTGTAGATCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.6070514274	53.4845418937906	0.0211350639616777	2017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.19311216118	2526.19311216118
"healthy-4"	"2019-08-01-count-2:TGGATCATCCTACGAA"	0.556920190423173	7.873668170813	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGATCATCCTACGAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.7989850518	40.826555537443	0.0234797442881109	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1722.23745065201	1722.23745065201
"healthy-4"	"2019-08-01-count-2:TCAGGTATCCGGCTTT"	-6.76899609986003	1.20038328254548	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGGTATCCGGCTTT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2667.00917850508	39.1619040187581	0.0146838279876896	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2656.8119615271	2656.8119615271
"healthy-4"	"2019-08-01-count-4:TCGTCCAAGACGCTCC"	0.408132215111893	7.9898381003174	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTCCAAGACGCTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.09013758979	39.5717859845895	0.0208702029508424	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1891.51077532988	1891.51077532988
"healthy-4"	"2019-08-01-count-2:GAGAAATAGAATTGTG"	4.71824516829793	-8.08372976696166	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATAGAATTGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2681.61347028662	41.5560179964798	0.0154966472450029	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2674.43856901917	2674.43856901917
"healthy-4"	"2019-08-01-count-3:GGTTGTATCATAGACC"	2.87427725371663	-6.24126341259154	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTATCATAGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.24263053539	40.1840413545972	0.0180177890981084	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2226.8269344708	2226.8269344708
"healthy-4"	"2019-08-01-count-4:TCATACTTCTCCTGTG"	4.6801253753597	-6.93866398250731	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATACTTCTCCTGTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.64402957096	42.2042687547716	0.0159042691048487	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2646.24813567706	2646.24813567706
"healthy-4"	"2019-08-01-count-3:GCCAGTGGTAGGCAAC"	0.249141757457894	7.74844024265138	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGGTAGGCAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.49496623604	43.0833835995995	0.0230825072550188	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1859.71897068148	1859.71897068148
"healthy-4"	"2019-08-01-count-2:GCAGTTATCACTCGAA"	10.9392372566158	5.50750539386598	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGTTATCACTCGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.99052152053	44.1891828874828	0.0228133191136085	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1929.95625574163	1929.95625574163
"healthy-4"	"2019-08-01-count-2:GGTAACTCAGCCTACG"	3.00909962233846	-5.98158409511717	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTCAGCCTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.44584986087	45.2438695653737	0.0176496295280937	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2555.6162372624	2555.6162372624
"healthy-4"	"2019-08-01-count-2:TGGGAAGGTACCCAGC"	10.8911272483761	6.88324592197267	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAAGGTACCCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.04459146289	46.4177758273712	0.025212738486952	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1835.40100351953	1835.40100351953
"healthy-4"	"2019-08-01-count-4:TTACGCCTCCCTAGGG"	11.0552574592525	6.21843764865724	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACGCCTCCCTAGGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2029.61676118759	43.9576857652624	0.0216581211812329	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2024.50986214312	2024.50986214312
"healthy-4"	"2019-08-01-count-2:CATCAAGTCGAACACT"	2.72361530837361	-6.05723955547484	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCAAGTCGAACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.4554196184	41.2436896293277	0.0151494453617568	2195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2720.68850001153	2720.68850001153
"healthy-4"	"2019-08-01-count-2:CCTCTCCAGGCTCAAG"	10.5880886512691	7.24520061099855	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCTCCAGGCTCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2098.49018860273	47.2019282413027	0.022493280405915	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2094.5267352229	2094.5267352229
"healthy-4"	"2019-08-01-count-3:GCCATGGAGGTTGTTC"	2.58980621871297	-6.45517256176146	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGGTTGTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2024.9737623826	45.4071384621153	0.0224235687916711	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2020.29516642945	2020.29516642945
"healthy-4"	"2019-08-01-count-2:GTTACCCGTAGGCAGT"	3.3142692047054	-5.94534923946532	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCGTAGGCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.05912609622	40.569428830798	0.0156574693422459	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2582.21011837165	2582.21011837165
"healthy-4"	"2019-08-01-count-4:TTCTAGTCATCCGATA"	4.40301670607869	-6.54397823726805	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAGTCATCCGATA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2710.41982534556	42.2965333675471	0.015605159382331	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2708.6823163394	2708.6823163394
"healthy-4"	"2019-08-01-count-2:CAGATTGAGTGCGCTC"	-0.401743153960067	7.93146274173585	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATTGAGTGCGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.20025897034	42.1085684105642	0.0209266290583381	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2006.3738756421	2006.3738756421
"healthy-4"	"2019-08-01-count-2:AGACTCATCGTCTAAG"	-2.5171984237736	8.89611528003541	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGACTCATCGTCTAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.55685488086	46.3605820897247	0.0224554639801383	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2057.78154851675	2057.78154851675
"healthy-4"	"2019-08-01-count-3:CCGATGGGTAGACAGC"	-1.69314608994182	9.66023824298707	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGATGGGTAGACAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1725.64416348682	47.8242421107827	0.0277138491948129	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1723.6318837414	1723.6318837414
"healthy-4"	"2019-08-01-count-2:GTTACCCGTTTACGAC"	-3.27338967743571	-5.10752680217894	"2019-08-01-count-2"	"Control4"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCGTTTACGAC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3161.35315674576	41.1513964421983	0.0130170197386485	3490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3157.02090976636	3157.02090976636
"healthy-4"	"2019-08-01-count-3:AGACCATTCGATACTG"	4.23583759841268	-6.45727207576903	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCATTCGATACTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2775.84218399656	43.6786592524667	0.0157352818918472	2358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2771.84985403962	2771.84985403962
"healthy-4"	"2019-08-01-count-2:GTTACCCTCCGCCTAT"	14.3165079551632	2.02132580364076	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACCCTCCGCCTAT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1716.77571506958	47.0707005045567	0.0274180838483313	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1683.16730107192	1683.16730107192
"healthy-4"	"2019-08-01-count-3:CCGCAAGTCAGAGTGG"	4.90507187423055	-8.19135477459105	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCGCAAGTCAGAGTGG"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.57656604019	46.6932806112766	0.0194833252035118	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2394.16567795154	2394.16567795154
"healthy-4"	"2019-08-01-count-4:AAGCGAGAGAGGGTAA"	5.60227551039998	-9.59122373973998	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGCGAGAGAGGGTAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2845.26065556972	43.5872220144445	0.0153192368963176	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2834.73556043302	2834.73556043302
"healthy-4"	"2019-08-01-count-2:TCATACTTCTATTCGT"	-4.85940251770671	3.35116694057313	"2019-08-01-count-2"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTTCTATTCGT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3179.79276040264	44.2558403167281	0.0139178379383203	3867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3165.59264475957	3165.59264475957
"healthy-4"	"2019-08-01-count-4:TCAAGACTCATCGCCT"	10.562984128564	7.09863183582155	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAAGACTCATCGCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2039.55810343948	41.7776742358075	0.0204836891703915	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2022.57590421136	2022.57590421136
"healthy-4"	"2019-08-01-count-2:ATCATTCAGAAATTGC"	4.96426500853841	-7.37190344249877	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCATTCAGAAATTGC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2874.82098847533	43.6084233639179	0.0151690917586649	2647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2867.83513159253	2867.83513159253
"healthy-4"	"2019-08-01-count-3:AGACCCGTCCATGAGT"	-2.87768421593364	3.31054971301881	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACCCGTCCATGAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3398.2795944325	50.7265557119942	0.0149271283608038	5300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3386.88443055473	3386.88443055473
"healthy-4"	"2019-08-01-count-4:GGGATGACACTTTAGG"	4.94928278502767	-7.33820536052855	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGATGACACTTTAGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.69367014054	46.7247008691677	0.0187071382803075	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.36880904782	2495.36880904782
"healthy-4"	"2019-08-01-count-2:CAGCAATGTAGTCGTT"	10.6985365348751	7.54978892886964	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATGTAGTCGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1904.37455731035	43.6738229375376	0.0229334207232953	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1898.25357743225	1898.25357743225
"healthy-4"	"2019-08-01-count-2:GTTAGTGAGGACGCTA"	4.19485916671101	-6.57333471691283	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTAGTGAGGACGCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.49449156037	44.7919971766987	0.0188956343649694	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2369.22106249052	2369.22106249052
"healthy-4"	"2019-08-01-count-2:GCATTAGTCGGCTATA"	10.4298922019893	7.75149676883546	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCATTAGTCGGCTATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2055.51673590962	43.3823188854054	0.0211053104689062	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2044.26345101201	2044.26345101201
"healthy-4"	"2019-08-01-count-2:TGAACGTAGCGACCCT"	4.1192122894222	-6.32163622295531	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAACGTAGCGACCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.37213459601	44.1193676653152	0.0178594014429855	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.37213459601	2470.37213459601
"healthy-4"	"2019-08-01-count-2:TACACCCCACAAACGG"	5.17673506316487	-7.5550198785034	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACACCCCACAAACGG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2966.9241777414	42.871571534496	0.014449837261137	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2959.99565076211	2959.99565076211
"healthy-4"	"2019-08-01-count-3:CGACAGCAGGCAGCTA"	-1.74138496342357	9.09560678088991	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCAGGCAGCTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1944.94902931051	39.9039538557529	0.0205167093092917	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1939.2698958494	1939.2698958494
"healthy-4"	"2019-08-01-count-2:GAATCGTTCTTGGCTC"	6.77663149413411	-1.75779917156371	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATCGTTCTTGGCTC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3039.13224064952	40.7683207714623	0.0134144609524294	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3029.79909726477	3029.79909726477
"healthy-4"	"2019-08-01-count-4:CCCGAAGCAAATACGA"	3.55011167105977	-6.38035490429076	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCGAAGCAAATACGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.43773222145	41.9697921473229	0.0164882415374172	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2536.35963394248	2536.35963394248
"healthy-4"	"2019-08-01-count-4:GATGACTAGATGTTCC"	2.93784060057942	-6.13562204754027	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTAGATGTTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.8436257668	45.2775268095187	0.0188198128608994	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2404.6895136885	2404.6895136885
"healthy-4"	"2019-08-01-count-2:TTGCATTAGAGTCGAC"	-0.367011914879638	7.7920145758423	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTAGAGTCGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1899.72292142382	44.9467097866989	0.0236596133466726	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1889.46391954789	1889.46391954789
"healthy-4"	"2019-08-01-count-2:TGGTACATCCACGGAC"	2.80938901480977	-4.64994051372679	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTACATCCACGGAC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2679.47590680057	39.2644562268599	0.0146537821546392	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2676.7195513799	2676.7195513799
"healthy-4"	"2019-08-01-count-2:ACTGTCCGTGACACGA"	4.10538448867146	-6.70990230953368	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACTGTCCGTGACACGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.04086190423	49.0533444264475	0.019771276313764	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2475.6866001672	2475.6866001672
"healthy-4"	"2019-08-01-count-2:GCCAGCAGTCGAACGA"	11.342096944421	4.76786754215089	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGCAGTCGAACGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1955.31619146158	38.4499351873888	0.0196643056275455	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1941.16822170225	1941.16822170225
"healthy-4"	"2019-08-01-count-2:TGGTAGTCACAAATCC"	2.43502535399739	-6.04297735607298	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTCACAAATCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.41452877539	44.5599388208497	0.0171885855160282	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2581.80701066238	2581.80701066238
"healthy-4"	"2019-08-01-count-2:GTTCATTTCGATAACC"	5.49051441726033	-10.2203016511169	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCATTTCGATAACC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.26210331142	46.5006096976916	0.0190790352972349	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2427.44049986142	2427.44049986142
"healthy-4"	"2019-08-01-count-4:TAACTTCGTACGGCAA"	-0.649237672716934	8.58203504169313	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAACTTCGTACGGCAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.77568265767	43.7608178226203	0.0227237357999183	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1918.69917301439	1918.69917301439
"healthy-4"	"2019-08-01-count-3:GCGAGAAAGGCCTTGC"	10.6905170875484	6.99243972385255	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGAGAAAGGCCTTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.68535342647	45.3626040881651	0.0232666281297352	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1942.90491804313	1942.90491804313
"healthy-4"	"2019-08-01-count-3:GCGAGAACACATACTG"	-1.8041173023289	8.67095944965211	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGAGAACACATACTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.71010976701	46.0631304788191	0.0246365092846181	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1864.2394383568	1864.2394383568
"healthy-4"	"2019-08-01-count-4:TTCACGCTCTCGCAGG"	-3.06884012642558	9.24586484515993	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCACGCTCTCGCAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2295.16669961206	47.0668697908011	0.0205069504532096	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2285.85073544083	2285.85073544083
"healthy-4"	"2019-08-01-count-4:CCCTCAACATCAGCAT"	-4.2755893272465	12.988161064032	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAACATCAGCAT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1905.91051334777	44.4603512292713	0.0233276173870178	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1893.99052386471	1893.99052386471
"healthy-4"	"2019-08-01-count-4:TCATTGTGTTTGACAC"	2.21020831641499	-6.0644512406555	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTGTTTGACAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2555.58859259187	46.5150955975506	0.0182013238485993	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2549.93080945571	2549.93080945571
"healthy-4"	"2019-08-01-count-4:GAACACTCAGTGCGCT"	10.1300159889156	6.41225574100343	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACACTCAGTGCGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1831.2573229425	44.8411189062008	0.0244865199141698	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1818.29751950393	1818.29751950393
"healthy-4"	"2019-08-01-count-3:AGATAGACAAGCCTGC"	4.71110214766805	-6.85373833095702	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATAGACAAGCCTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2795.77287812646	44.6472274028815	0.0159695473663802	2165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2787.42662747292	2787.42662747292
"healthy-4"	"2019-08-01-count-3:GCGGAAAAGACCAACG"	10.8584267097408	7.37670991504518	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGAAAAGACCAACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2253.89425643004	46.5138862471411	0.0206371200043851	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2248.78666142275	2248.78666142275
"healthy-4"	"2019-08-01-count-2:GAGGCAAAGGTATCTC"	5.02755465087239	-7.23465301906737	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGGCAAAGGTATCTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2701.67357897771	40.0782297705306	0.0148345936690456	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2697.45901770427	2697.45901770427
"healthy-4"	"2019-08-01-count-3:AGGGAGTAGAAGCGGG"	-3.24586425247844	10.0481815108093	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTAGAAGCGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.74575500564	50.1887695007984	0.0244020289715686	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2047.3750260187	2047.3750260187
"healthy-4"	"2019-08-01-count-4:AAGTGAACAGCACAAG"	-3.34160838547404	3.6676773794922	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AAGTGAACAGCACAAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3256.12208448001	46.6757897685552	0.0143347787821074	5201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3246.54860172193	3246.54860172193
"healthy-4"	"2019-08-01-count-3:GACCGTGCATGCAGCC"	1.84667839583699	-6.00117447292479	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCGTGCATGCAGCC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2478.97896591308	42.1842714144446	0.0170167927983636	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2477.80599913889	2477.80599913889
"healthy-4"	"2019-08-01-count-3:TCATTTGTCTCTGAGA"	14.407448430627	2.04372963989107	"2019-08-01-count-3"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTTGTCTCTGAGA"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1297.5694076274	26.2024918116925	0.020193518479758	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1280.49380668486	1280.49380668486
"healthy-4"	"2019-08-01-count-2:CCGTGAGCATGAAAGT"	5.00691904601399	-7.54989435588988	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGTGAGCATGAAAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.31569722034	42.6454286298663	0.016728186578212	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2549.31569722034	2549.31569722034
"healthy-4"	"2019-08-01-count-4:TAGGGTTCAATCTCTT"	10.4703194099361	7.38527438724367	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTCAATCTCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.99892783899	40.3580322628197	0.0200586748354616	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2007.5797115138	2007.5797115138
"healthy-4"	"2019-08-01-count-3:GTAGTACAGCAATAGT"	-2.01955399933513	3.73283908450929	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACAGCAATAGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3030.90567332812	46.0077035523219	0.0151795233870814	5283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3024.93748245287	3024.93748245287
"healthy-4"	"2019-08-01-count-3:GTAGTACAGTCGGGAT"	3.94424881514851	-7.46478607570799	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACAGTCGGGAT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.78393929406	45.9470841147938	0.0200661221027514	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2285.2834078338	2285.2834078338
"healthy-4"	"2019-08-01-count-2:GCCATTCAGACTCGAG"	10.5779615837032	6.00735185230104	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCATTCAGACTCGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.77651244442	46.2543060294188	0.0237107150585178	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1947.55753778301	1947.55753778301
"healthy-4"	"2019-08-01-count-4:AGACCATTCCTTCTTC"	2.98625435408894	-6.21384622966918	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGACCATTCCTTCTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.95077842218	47.7970670018558	0.0200579329773247	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2376.50598993487	2376.50598993487
"healthy-4"	"2019-08-01-count-4:TTCCAATAGTTAACGA"	11.1580912071163	5.85908458316652	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCAATAGTTAACGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1795.87369996074	37.7842264896535	0.0210394675808658	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1787.61669006001	1787.61669006001
"healthy-4"	"2019-08-01-count-2:TTACCGCAGCTTACGT"	6.71814074096028	-1.78240337288054	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCGCAGCTTACGT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2812.16714862117	36.8377659025189	0.0130994226003176	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2797.43992853146	2797.43992853146
"healthy-4"	"2019-08-01-count-2:GGGATGATCAGATGCT"	-3.45393906059917	-5.59230186855467	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGATGATCAGATGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2496.80333380477	52.9087983870555	0.0211906150839802	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2492.12850699291	2492.12850699291
"healthy-4"	"2019-08-01-count-3:TCGCTCACAGCATACT"	0.0107374648446262	7.69808957660524	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCTCACAGCATACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.15034227297	40.7950109185413	0.0189642769809552	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2142.73677970578	2142.73677970578
"healthy-4"	"2019-08-01-count-4:TTTCCTCTCTGCGGGT"	-2.92127333107646	3.75033543193666	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCCTCTCTGCGGGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3178.44328968662	45.0126221888157	0.0141618453080073	4792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3169.95634831156	3169.95634831156
"healthy-4"	"2019-08-01-count-3:AGATGCTCACCCTCTA"	-7.03789554062541	3.10411284053651	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGCTCACCCTCTA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2672.31654322062	42.9663003107983	0.0160782974680897	2473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2656.07664154057	2656.07664154057
"healthy-4"	"2019-08-01-count-4:TGTGTGATCACTTGTT"	3.03525509414021	-6.01024057781371	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTGTGATCACTTGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.07064255355	42.087607068241	0.0184265785322593	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2280.1144579347	2280.1144579347
"healthy-4"	"2019-08-01-count-4:TCACGGGGTCTGTGCG"	4.96990503844563	-7.51807310497435	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACGGGGTCTGTGCG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.47491934005	43.5969776394448	0.016168137640277	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2686.11916641214	2686.11916641214
"healthy-4"	"2019-08-01-count-3:CAAGACTCATACCGTA"	-3.64858279648479	11.483223892096	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAAGACTCATACCGTA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2365.76766908216	41.1374139240495	0.0173886110887674	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2351.26941040291	2351.26941040291
"healthy-4"	"2019-08-01-count-3:ACTTATCCACTAACGT"	1.86798109587972	-6.41094210064086	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTATCCACTAACGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.72848101688	48.7347816935375	0.0192040961269463	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2532.41349472474	2532.41349472474
"healthy-4"	"2019-08-01-count-2:CGGCAGTTCTCGGTCT"	10.2536903816158	6.86695954883424	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGCAGTTCTCGGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.67796072027	47.2185727062583	0.0251741363363497	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.74704837265	1866.74704837265
"healthy-4"	"2019-08-01-count-2:TGCGGGTTCTTTGGAG"	11.5147806602413	3.74888537013856	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGGGTTCTTTGGAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2241.31396922625	38.4751218727481	0.017166324040728	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2227.8058071731	2227.8058071731
"healthy-4"	"2019-08-01-count-4:TCTGGCTTCTGTGCAA"	10.1843916374141	7.40705010974733	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTGGCTTCTGTGCAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1999.33204731096	45.291959524937	0.0226535455107886	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1993.08241166589	1993.08241166589
"healthy-4"	"2019-08-01-count-2:TCGAACAAGGACATCG"	9.89675201949422	7.05701015079347	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGAACAAGGACATCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.66195877409	45.312955674221	0.023803047313821	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1899.56391508887	1899.56391508887
"healthy-4"	"2019-08-01-count-2:CTACCCATCACTGGGC"	-0.0569754121011079	7.58415029132692	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCCATCACTGGGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2146.01495535813	45.0388820945092	0.0209872172521711	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2139.11735311169	2139.11735311169
"healthy-4"	"2019-08-01-count-4:CCGCAAGCACAGTGAG"	2.0891543823177	-5.95944836055907	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGCAAGCACAGTGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.20732935386	42.221140589838	0.0163825161091806	1805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2572.93778653653	2572.93778653653
"healthy-4"	"2019-08-01-count-2:GAAATGAAGGCTGTAG"	3.41719355162923	-6.02451755916747	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGAAGGCTGTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.5463198584	41.2961881349893	0.0152409972962364	2230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2707.85449934226	2707.85449934226
"healthy-4"	"2019-08-01-count-3:GGCTTGGAGGCATGCA"	10.9829145866329	5.67724320972291	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGCTTGGAGGCATGCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.26320872682	47.0858424296177	0.026213219867144	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1784.94350637474	1784.94350637474
"healthy-4"	"2019-08-01-count-4:AATGAAGTCCTCACTG"	3.04528870162312	-6.22163298046263	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AATGAAGTCCTCACTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2668.38837654631	45.6814839673567	0.0171195034309369	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2662.35416983218	2662.35416983218
"healthy-4"	"2019-08-01-count-2:GTTTACTAGGCATCTT"	2.78890075263326	-6.21649362957152	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTAGGCATCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.79589395477	43.6591512176366	0.0172647983658967	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2527.72100333648	2527.72100333648
"healthy-4"	"2019-08-01-count-3:CCTCACACAGACAATA"	10.6377960639888	6.11726949298707	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCACACAGACAATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.55245050814	42.4931920781909	0.0230496246887245	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1833.03567546152	1833.03567546152
"healthy-4"	"2019-08-01-count-2:TCACTATGTCGGATTT"	10.9858910041744	6.67369124973146	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTATGTCGGATTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.30264412367	42.1581269612078	0.0224687243783626	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1865.93087616439	1865.93087616439
"healthy-4"	"2019-08-01-count-3:AGCCACGCAACCCTCT"	10.806545873254	7.22161052310792	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGCAACCCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.38550876885	43.7321188171856	0.0212355183771929	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2049.57877391012	2049.57877391012
"healthy-4"	"2019-08-01-count-2:TCACTCGGTGGTGATG"	4.10653748092	-6.44834568416747	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACTCGGTGGTGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2710.70667458596	39.8184922285966	0.0146893400905056	2135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2700.66940758736	2700.66940758736
"healthy-4"	"2019-08-01-count-4:CCGGGTACATCGTGGC"	-1.95743380013164	8.93165967548219	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTACATCGTGGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2149.75726183295	42.1640512134067	0.0196134009927504	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2137.62893040219	2137.62893040219
"healthy-4"	"2019-08-01-count-2:GTAACACTCCTTGACC"	11.4501882987911	4.0971002348694	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAACACTCCTTGACC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2210.5982958101	34.8455204454464	0.0157629364464324	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2201.09463068817	2201.09463068817
"healthy-4"	"2019-08-01-count-2:TTGTGTTCAGCTCATA"	3.31054033812825	-6.70474150097045	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTCAGCTCATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1956.2614079902	46.6007275733625	0.0238213192690023	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1949.29403011371	1949.29403011371
"healthy-4"	"2019-08-01-count-2:CATTCATTCACGTAGT"	11.2266785102779	6.01446387851564	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATTCATTCACGTAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2066.58217393986	41.5836318181315	0.0201219348267453	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2061.85268408355	2061.85268408355
"healthy-4"	"2019-08-01-count-3:AGCCACGTCCCTCGAT"	11.1840816932613	6.15275428378908	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCCACGTCCCTCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2214.04681924102	48.6485152541839	0.0219726678006117	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2205.32211320265	2205.32211320265
"healthy-4"	"2019-08-01-count-2:GCGAGAAAGTCTGGAG"	2.97069539603536	-6.10083773052367	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGAGAAAGTCTGGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.87088432669	43.7479247605941	0.0165094552415184	2091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2647.20485381929	2647.20485381929
"healthy-4"	"2019-08-01-count-2:CAAGGGAAGATTGACA"	2.68084849891011	-6.33328154003295	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGGGAAGATTGACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.35673311835	45.5914246274458	0.0198624570941998	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2290.82814705458	2290.82814705458
"healthy-4"	"2019-08-01-count-3:CTCCCAATCCGAAGGA"	10.8623796897823	5.43418834293214	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCAATCCGAAGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1894.68505584968	44.6809000866825	0.0235822306977795	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.15590133768	1877.15590133768
"healthy-4"	"2019-08-01-count-3:GACTGATTCAGTCAGT"	11.3470941978389	5.0828237303528	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATTCAGTCAGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2771.96364332739	40.5921418121707	0.0146438218660924	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2753.59638798007	2753.59638798007
"healthy-4"	"2019-08-01-count-2:CGAGTGCCAATTGCGT"	0.0920066322082698	7.56268451297609	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCCAATTGCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.39946654251	45.873049893038	0.024408355280333	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1867.34527791893	1867.34527791893
"healthy-4"	"2019-08-01-count-2:GACTCTCTCATAGAGA"	2.47141398963277	-6.01659729396971	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCTCTCATAGAGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.39376488889	41.3139733335385	0.015808552805396	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2607.20264272246	2607.20264272246
"healthy-4"	"2019-08-01-count-3:CTCCCTCAGTAATACG"	10.6712929206783	6.69242189014284	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCCTCAGTAATACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2011.38899745347	49.8442012642888	0.0247809853426634	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2005.48417116788	2005.48417116788
"healthy-4"	"2019-08-01-count-2:ATACTTCCACAGTGAG"	11.0764910179073	5.56615159595338	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACTTCCACAGTGAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1791.46487433845	39.8999836966936	0.022272266829361	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1789.66870316761	1789.66870316761
"healthy-4"	"2019-08-01-count-2:GACTGATAGCCTCCAG"	-1.78891382637675	8.82523057544557	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTGATAGCCTCCAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1997.96111541319	48.7432507629066	0.0243964962014921	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1994.59546228292	1994.59546228292
"healthy-4"	"2019-08-01-count-3:TCCGATCTCTGCGATA"	10.752364774316	5.68735835635988	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCGATCTCTGCGATA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1822.81835901808	46.4948375187098	0.0255071150061028	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1810.30983758515	1810.30983758515
"healthy-4"	"2019-08-01-count-4:GTGCACGGTGACAGGT"	4.40565743026082	-6.56889154827269	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGGTGACAGGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2830.25884337799	49.9164165715282	0.0176366966181622	2481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2819.7805476501	2819.7805476501
"healthy-4"	"2019-08-01-count-3:CATTCATAGGATATGT"	9.99248947676961	7.60839126193849	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATAGGATATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.54722830841	45.1862478254842	0.0236138659955778	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1906.3359186799	1906.3359186799
"healthy-4"	"2019-08-01-count-2:GTACAGTGTCTTCAAG"	-2.83310542526897	9.01895425403444	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTACAGTGTCTTCAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.46162988376	42.8909377956085	0.0228573486995657	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1870.8299816728	1870.8299816728
"healthy-4"	"2019-08-01-count-2:TCTCTGGCATGACTCA"	10.1058069663936	7.44360063159791	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCTGGCATGACTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2186.64891215984	50.4838372037809	0.023087308128453	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2183.09086371705	2183.09086371705
"healthy-4"	"2019-08-01-count-2:GTCGCGATCAAATAGG"	9.65760864791219	6.09039399707643	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGCGATCAAATAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1602.6257703119	46.3159255244167	0.0289000254347606	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1596.67763567076	1596.67763567076
"healthy-4"	"2019-08-01-count-2:TACTTCAAGGCTTCCG"	4.60837378081624	-7.1715765229431	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTCAAGGCTTCCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2678.40322407456	43.2039707021387	0.016130495331623	1828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2675.02752325876	2675.02752325876
"healthy-4"	"2019-08-01-count-4:TGCATCCAGCGCCCAT"	10.6360689598018	7.59575316989747	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATCCAGCGCCCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2112.4347880097	51.7915030530792	0.0245174446790267	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2102.30764437556	2102.30764437556
"healthy-4"	"2019-08-01-count-2:TTTACCACAATAGTGA"	2.24759330329244	-6.54814054882201	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACCACAATAGTGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1829.94595877166	46.5366578708077	0.0254306186735946	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1829.94595877166	1829.94595877166
"healthy-4"	"2019-08-01-count-2:TTGTTTGTCTGTGTGA"	9.06048168715779	6.24301478946535	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTTGTCTGTGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1505.23844615137	43.8316523914122	0.0291194079605673	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1497.93906564575	1497.93906564575
"healthy-4"	"2019-08-01-count-4:CTCAACCGTGTATCCA"	-4.16532884064372	12.0650434263977	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCGTGTATCCA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2455.00250438409	36.1515943520735	0.0147256853251737	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2448.68005393553	2448.68005393553
"healthy-4"	"2019-08-01-count-4:CCTAAGACATTCACAG"	0.293772717087907	7.7466830977234	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTAAGACATTCACAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2026.8995441351	42.5517964509431	0.0209935398989398	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2018.4773661635	2018.4773661635
"healthy-4"	"2019-08-01-count-3:CTCCTCCAGCCAGAGT"	10.8187357383663	6.19760797107545	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCAGCCAGAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2046.78187058482	42.7272553542718	0.0208753340882698	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.38545210885	2034.38545210885
"healthy-4"	"2019-08-01-count-3:GTGTGGCAGTGCGTCC"	-3.81609068337138	11.203194595221	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGGCAGTGCGTCC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1854.4211621621	38.6972288885503	0.0208675513837604	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1850.78683669619	1850.78683669619
"healthy-4"	"2019-08-01-count-3:AGCGTATAGTAAAGCT"	3.51593007621114	-6.29756548320922	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGTATAGTAAAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.34603802282	45.0703374763487	0.0165435436054438	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2718.57963243651	2718.57963243651
"healthy-4"	"2019-08-01-count-2:GGATCTATCCCATAGA"	10.5948406654293	7.19173715198366	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGATCTATCCCATAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.54069531336	45.5905574251699	0.0244513608846214	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1862.93105881024	1862.93105881024
"healthy-4"	"2019-08-01-count-3:GGGAGTAAGCATCAGG"	-1.16555700722392	8.47710130298463	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGGAGTAAGCATCAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.44869823367	46.6282012535509	0.0226301199799458	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2052.7038883971	2052.7038883971
"healthy-4"	"2019-08-01-count-3:AGCTACAGTAGCTGTT"	-0.23491812768634	7.9369120367798	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTACAGTAGCTGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2156.95521415271	40.0679271787891	0.0185761516585445	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2154.17488182395	2154.17488182395
"healthy-4"	"2019-08-01-count-4:ACAACCAGTGTCCCTT"	2.77803625640218	-5.95075752651366	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAACCAGTGTCCCTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2744.38304596019	42.9129262982951	0.0156366387561912	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2740.85194412625	2740.85194412625
"healthy-4"	"2019-08-01-count-2:TAAGCCAGTCAGATTC"	3.30622186240498	-6.08844330227049	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGCCAGTCAGATTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2705.9848209666	42.9315532124164	0.0158654079948168	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2701.08457472817	2701.08457472817
"healthy-4"	"2019-08-01-count-3:AGCTCAATCTTGAACG"	2.80865349349324	-6.03125574505004	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTCAATCTTGAACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.64303035652	37.9315954810738	0.0144907441699213	1924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2615.62792354726	2615.62792354726
"healthy-4"	"2019-08-01-count-4:GCTGAATGTAACCCTA"	10.9250885444576	6.07643506610719	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTGAATGTAACCCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.30713715675	46.518689554266	0.0240617171789266	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.47619828636	1919.47619828636
"healthy-4"	"2019-08-01-count-3:ATGACCACATTGACCA"	0.152420659630936	8.01406762683717	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGACCACATTGACCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2104.69713218346	45.8459045628995	0.0217826612018699	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2091.74058732536	2091.74058732536
"healthy-4"	"2019-08-01-count-4:TTCTAACAGCTAGATA"	2.31577720221822	-6.02615644848021	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTAACAGCTAGATA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2788.56957348131	45.0056054583976	0.016139315972745	2269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2784.06753698403	2784.06753698403
"healthy-4"	"2019-08-01-count-4:GACCTTCGTTAAGAAC"	-3.86953912201579	12.7727641829285	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCTTCGTTAAGAAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1724.26558997124	48.0094475839746	0.0278434180112446	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1720.05782157086	1720.05782157086
"healthy-4"	"2019-08-01-count-2:GAGACTTAGAATACAC"	4.49408545073811	-6.6699519387451	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACTTAGAATACAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.73996083969	45.3447085327173	0.016709304939699	1973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2705.55638566284	2705.55638566284
"healthy-4"	"2019-08-01-count-3:AGTAGTCAGATGCAGC"	9.77288593825642	6.40097901904909	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGTCAGATGCAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1891.79748702188	43.6900726283361	0.0230944765113914	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1881.32860321729	1881.32860321729
"healthy-4"	"2019-08-01-count-2:TTGAACGCAAGGTACG"	-0.642634729773361	8.03783462131349	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGAACGCAAGGTACG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1931.51862243995	45.6665316145684	0.0236428119739695	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1920.96375254881	1920.96375254881
"healthy-4"	"2019-08-01-count-2:GGCAGTCTCCTGCCAT"	5.23822273787801	-8.96683790599974	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCAGTCTCCTGCCAT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.10448973852	42.4767656142415	0.0162989495553586	1759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2603.91690291347	2603.91690291347
"healthy-4"	"2019-08-01-count-4:TACGTCCTCAAGGAGC"	10.8739611106807	6.86274764621583	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACGTCCTCAAGGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.09130625999	43.3140761213371	0.0222684025073462	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.16877426118	1939.16877426118
"healthy-4"	"2019-08-01-count-2:TTTATGCTCAAAGCCT"	-2.56052408638652	9.34692189777223	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCTCAAAGCCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2191.02015478568	43.6833883327601	0.0199374653114649	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2189.39086735247	2189.39086735247
"healthy-4"	"2019-08-01-count-3:GTCGTTCTCGTTCGCT"	5.26035418090169	-9.17218592083129	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTTCTCGTTCGCT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.8318306013	45.1007184886544	0.0197219217806653	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2285.3400119675	2285.3400119675
"healthy-4"	"2019-08-01-count-4:TTCTCTCAGACCATGG"	-2.20561824265178	9.02670571887819	"2019-08-01-count-4"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTCTCAGACCATGG"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2281.91645363254	44.0007952581565	0.0192823866045194	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2273.29647978156	2273.29647978156
"healthy-4"	"2019-08-01-count-3:ATGATCGCACACAGCC"	10.6068817573482	7.30996558750001	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGATCGCACACAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1942.36827664082	48.0954970519975	0.0247612657344131	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1935.15019949572	1935.15019949572
"healthy-4"	"2019-08-01-count-4:ACGGGTCGTGTACATC"	2.83125629004781	-6.00603296672972	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGGTCGTGTACATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.78177544057	40.8666103927488	0.0165802144433026	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2460.49627732539	2460.49627732539
"healthy-4"	"2019-08-01-count-3:GACACGCGTATCAAGA"	10.6713139015133	6.43950460040895	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACACGCGTATCAAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1867.11822761706	42.191635586613	0.0225971954868979	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1863.93962809436	1863.93962809436
"healthy-4"	"2019-08-01-count-3:GTTACGAAGATTTGCC"	0.317779203026932	7.91494700992433	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACGAAGATTTGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1976.45861778557	40.5154320770176	0.0204990034764356	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1971.11612196605	1971.11612196605
"healthy-4"	"2019-08-01-count-4:GGTTCTCGTTGATGTC"	10.2377821403438	7.33721301639406	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTTCTCGTTGATGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.92697097584	44.9809348679545	0.0231154280396234	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1938.34040207702	1938.34040207702
"healthy-4"	"2019-08-01-count-2:TGCAGTAAGTTCACTG"	0.180363734334153	7.88140294635621	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTAAGTTCACTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.6489679099	46.2789471081366	0.0260631171726533	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1771.54839618876	1771.54839618876
"healthy-4"	"2019-08-01-count-2:GTGAGCCCAATCTCGA"	-4.54524980011638	-5.61452104961547	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGAGCCCAATCTCGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2728.78761985812	51.0784733528886	0.0187183762419533	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2720.89982665898	2720.89982665898
"healthy-4"	"2019-08-01-count-3:GAGGGATTCCTACTGC"	11.6221863227779	3.59508130634157	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGGGATTCCTACTGC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2350.13329224015	48.2972287519856	0.0205508465887688	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2342.25002482658	2342.25002482658
"healthy-4"	"2019-08-01-count-4:TGCTTCGGTGTAGTGG"	-3.80705342713054	-5.48335697567137	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTTCGGTGTAGTGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2098.77067119505	46.359114498577	0.0220886994157299	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2098.77067119505	2098.77067119505
"healthy-4"	"2019-08-01-count-4:TCTATACCATCTTTCA"	2.06076635894124	-6.09491779720458	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACCATCTTTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.31090341602	40.7953235505361	0.0174092663039572	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2339.16078990819	2339.16078990819
"healthy-4"	"2019-08-01-count-4:TGTCCACGTTAGCTAC"	4.60228361663167	-6.73999502575072	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCACGTTAGCTAC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.65053495906	41.3869487309428	0.0157745660786293	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2620.27634002425	2620.27634002425
"healthy-4"	"2019-08-01-count-4:GACTATGTCTCTGCTG"	4.19025959548299	-6.59896232998046	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTATGTCTCTGCTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.79163766601	42.621305186059	0.0170499431007992	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2496.29843637686	2496.29843637686
"healthy-4"	"2019-08-01-count-2:TGTTGGAGTGTTGACT"	-0.000107060105162891	7.71357343280641	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTTGGAGTGTTGACT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.33387562345	44.9125068891613	0.0228872912235143	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.62581500236	1958.62581500236
"healthy-4"	"2019-08-01-count-4:GACTCAACAATGGCCC"	4.15503420409505	-6.75574209606322	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAACAATGGCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.53205243348	43.929435553531	0.0165675672346537	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2648.44621949927	2648.44621949927
"healthy-4"	"2019-08-01-count-3:GTACAACTCTCTCCGA"	0.176582914858502	8.14717385852662	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTACAACTCTCTCCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1947.44418462437	39.466806780918	0.0202659501579146	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1940.88928284964	1940.88928284964
"healthy-4"	"2019-08-01-count-2:TTGATGGGTACTGCCG"	-0.323360214859802	7.837863899115	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGGTACTGCCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1906.96953400432	46.5190675458649	0.0243942374098566	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1903.15382978327	1903.15382978327
"healthy-4"	"2019-08-01-count-2:GCCAACGGTCGTCATA"	1.82522680339162	-6.18207361614379	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAACGGTCGTCATA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2478.02116959893	48.9984614024791	0.0197732214734911	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2469.69062219412	2469.69062219412
"healthy-4"	"2019-08-01-count-2:TACAGGTCACTACAGT"	0.527936865657014	8.17255876148073	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAGGTCACTACAGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.33049134609	44.1529846248536	0.0244705639219754	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1790.1239501191	1790.1239501191
"healthy-4"	"2019-08-01-count-3:TCGAAGTTCGATACTG"	2.25272502478902	-6.49198629772338	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGAAGTTCGATACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.15061324181	50.6935815632401	0.0221161651727343	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2292.15061324181	2292.15061324181
"healthy-4"	"2019-08-01-count-3:CGAGAAGCACATAGCT"	2.2789737182552	-5.96528866207274	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGAAGCACATAGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2749.88248555055	43.4819329335737	0.0158122876748561	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2747.73297105258	2747.73297105258
"healthy-4"	"2019-08-01-count-3:CTGAGGCCAGACGCTC"	-2.57942138138469	9.39201924884645	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGAGGCCAGACGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.04242325481	49.857461758865	0.0265052298355905	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1879.27713095212	1879.27713095212
"healthy-4"	"2019-08-01-count-2:AGATAGACACTCTGCT"	-1.6540096801823	3.33441875064699	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATAGACACTCTGCT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2891.47078240258	41.1687951724359	0.0142380118184102	5843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2886.81851063557	2886.81851063557
"healthy-4"	"2019-08-01-count-4:ACAGAAATCGAATGCT"	2.50442709502522	-5.93059065258177	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACAGAAATCGAATGCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2763.37515691082	44.060721669221	0.0159445312950111	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2755.19846959848	2755.19846959848
"healthy-4"	"2019-08-01-count-4:TTGACCCAGCAATTAG"	2.5946065383846	-5.94900276577147	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGACCCAGCAATTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.37776115352	46.7949193325371	0.0178308626239726	2002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2616.85305868307	2616.85305868307
"healthy-4"	"2019-08-01-count-4:GACTGATTCTAGCCTC"	-1.72705505314525	8.69344613635866	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTGATTCTAGCCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2097.66230511387	46.6292475250397	0.0222291488059649	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2090.86506338838	2090.86506338838
"healthy-4"	"2019-08-01-count-3:AGGCTGCCACAGTGTT"	-7.24367223206218	3.08313415134279	"2019-08-01-count-3"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCTGCCACAGTGTT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2549.65700203041	39.2874281394715	0.0154089072013158	2309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2529.75416267329	2529.75416267329
"healthy-4"	"2019-08-01-count-4:TAGATCGTCAGTCACA"	2.80702247199361	-6.05245735561522	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGATCGTCAGTCACA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.5907026589	47.8609871852433	0.0189429127301371	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2518.56999039406	2518.56999039406
"healthy-4"	"2019-08-01-count-2:CACGAATGTGCATTAC"	-2.1784328025883	8.80240342700807	"2019-08-01-count-2"	"Control4"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGAATGTGCATTAC"	"MAIT"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2423.77652296747	47.2653895524924	0.0195007209223334	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2418.12639923036	2418.12639923036
"healthy-4"	"2019-08-01-count-3:CGAGTGCAGCTACTAC"	10.7409779029781	6.72199533069459	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTGCAGCTACTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1861.02607123381	41.1476282568591	0.0221101836738801	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1852.16019072232	1852.16019072232
"healthy-4"	"2019-08-01-count-2:GTCACGGGTGCCTACG"	10.4471813636715	5.92895505512086	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGGTGCCTACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1794.00554145906	43.9397116981571	0.0244925172652594	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1792.11275385905	1792.11275385905
"healthy-4"	"2019-08-01-count-3:TCTTAGTAGGTATCTC"	-1.99759803238567	8.75840661609498	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTAGTAGGTATCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.11277886718	41.540956711555	0.0206762692211721	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1999.81578703955	1999.81578703955
"healthy-4"	"2019-08-01-count-2:GATTCGATCAAATGCC"	-8.00440345230754	0.180095902923025	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGATCAAATGCC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2937.25391607105	45.6445073437386	0.0155398575158915	3944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2919.2609818542	2919.2609818542
"healthy-4"	"2019-08-01-count-4:TAGGGTTAGACTTCGT"	2.35088433799092	-6.36343719875487	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTAGACTTCGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1954.54340263151	52.4491467076028	0.0268344753240003	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1952.97606936159	1952.97606936159
"healthy-4"	"2019-08-01-count-4:TCGAAGTAGTAAGGGA"	6.7460147338802	-1.73666157638701	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTAGTAAGGGA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2775.64373687722	38.9989218249246	0.0140504061478729	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2766.35767516051	2766.35767516051
"healthy-4"	"2019-08-01-count-2:TGACCCTAGGGAGGGT"	3.06211056289021	-5.95599081432494	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGACCCTAGGGAGGGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2653.48268489866	46.6264234706865	0.0175717835793857	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2646.05275999476	2646.05275999476
"healthy-4"	"2019-08-01-count-3:ATCCTATGTCGCACAC"	3.38433541831319	-6.46570923244628	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATGTCGCACAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.64243105621	40.3011285554103	0.015610654702062	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2579.19581777912	2579.19581777912
"healthy-4"	"2019-08-01-count-4:CCCTGATAGGATACCG"	3.55377497252766	-6.23599150097045	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATAGGATACCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.66991100604	41.092269886161	0.0158432920518486	1901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2593.66991100604	2593.66991100604
"healthy-4"	"2019-08-01-count-2:TCATGTTGTTCGGCCA"	11.0142275291378	6.81121203983156	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATGTTGTTCGGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.11509222253	40.805920324632	0.0219019858166433	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1859.9478830225	1859.9478830225
"healthy-4"	"2019-08-01-count-3:CGAGTTATCGGAGCAA"	5.11212839659993	-7.52460195934447	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGTTATCGGAGCAA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.25672928976	43.8851077894677	0.0166720469554309	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2626.86758007664	2626.86758007664
"healthy-4"	"2019-08-01-count-2:AGATGCTGTCAACACT"	10.50142445144	7.83367583835451	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGATGCTGTCAACACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2035.21509041238	40.0441108055469	0.019675616102784	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2032.41849432578	2032.41849432578
"healthy-4"	"2019-08-01-count-3:AGGGAGTTCTGGGAGA"	-2.04526887360271	8.97822473132936	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTTCTGGGAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2027.25647559844	46.1135207281066	0.0227467620812478	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.67985756918	2022.67985756918
"healthy-4"	"2019-08-01-count-3:AGGGAGTTCGGTGTAT"	3.31615151938741	-6.1034031144348	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGGAGTTCGGTGTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.70326392445	46.1740155228583	0.018368920542662	1783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2510.56539349165	2510.56539349165
"healthy-4"	"2019-08-01-count-4:TCCACGTCACTAGGCC"	0.561373491852921	8.14700219714967	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACGTCACTAGGCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.71037293777	43.9913310987184	0.0230597535783035	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1904.64111401514	1904.64111401514
"healthy-4"	"2019-08-01-count-3:CTCATGCTCAGTCAGT"	4.0277234512264	-7.01273538982543	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATGCTCAGTCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.28083386729	51.0668610027852	0.0217557525567358	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2343.16789951181	2343.16789951181
"healthy-4"	"2019-08-01-count-3:TCTTTGACACCGAATT"	5.01485743102376	-7.52873995220336	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTTGACACCGAATT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.46378064728	45.6982658471751	0.0172416111402265	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2647.11361398329	2647.11361398329
"healthy-4"	"2019-08-01-count-2:CAACGATAGGTTGTTC"	-8.17511210861858	-0.0154647163120137	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAACGATAGGTTGTTC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3048.41262213179	44.7989475424486	0.0146958279916582	4514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3035.14096006148	3035.14096006148
"healthy-4"	"2019-08-01-count-2:TCCTTCTGTGTGTCCG"	10.1793362098629	7.36746451938478	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTTCTGTGTGTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1873.40964682033	44.2345994832651	0.0236118136566356	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1870.71443662428	1870.71443662428
"healthy-4"	"2019-08-01-count-4:TGGCGTGTCGGAGCAA"	1.64555229720418	-6.69131376659545	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGCGTGTCGGAGCAA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2124.62122717314	49.5443269512018	0.0233191339319912	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2124.62122717314	2124.62122717314
"healthy-4"	"2019-08-01-count-4:GATTCGACAACACGAG"	2.80670585212056	-5.92392589962157	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTCGACAACACGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.73125747606	43.5957118462086	0.0170780655889772	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2546.04270578211	2546.04270578211
"healthy-4"	"2019-08-01-count-3:AACGTCAGTATCCTTT"	2.17927898940389	-6.5195784798828	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACGTCAGTATCCTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.9832882832	48.840148018083	0.0260205556026848	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1871.72999641698	1871.72999641698
"healthy-4"	"2019-08-01-count-3:GTTGCGGGTTCGGGTC"	1.77277817305867	-6.45026543056639	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGGTTCGGGTC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2234.9098620127	44.2980217239735	0.0198209433306093	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2234.9098620127	2234.9098620127
"healthy-4"	"2019-08-01-count-2:GATTGGTCAGAGTCAG"	10.7543274360592	7.10332439029542	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTGGTCAGAGTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2231.19523180476	52.4481736704545	0.0235067612743284	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2226.60479617046	2226.60479617046
"healthy-4"	"2019-08-01-count-3:AGTACCACATACTGAC"	3.93502130088155	-6.29510071193846	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACCACATACTGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.41448462297	44.4919846204546	0.0167741447946357	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2649.4029688521	2649.4029688521
"healthy-4"	"2019-08-01-count-2:TCCCAGTAGGGCGAGA"	10.5330368476803	6.48869512164918	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTAGGGCGAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.86393310442	42.517841416081	0.0224859339012698	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1884.68234811769	1884.68234811769
"healthy-4"	"2019-08-01-count-4:CTCCATGCAATGGCAG"	3.19871606406514	-6.02415850078734	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCATGCAATGGCAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.74021693652	43.6561585987793	0.0168443420036834	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2587.18319041115	2587.18319041115
"healthy-4"	"2019-08-01-count-2:CACGTTCCAACTTGCA"	-0.87577454271968	8.23503205859987	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CACGTTCCAACTTGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2183.7945415845	43.6140357192772	0.0199716753974631	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2178.72829814244	2178.72829814244
"healthy-4"	"2019-08-01-count-2:CTACCTGAGCCGGATA"	-0.0818928879803002	7.56267783725587	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACCTGAGCCGGATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1914.40405621232	40.3160367062728	0.0210593142944122	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.53067256571	1902.53067256571
"healthy-4"	"2019-08-01-count-3:ATTCCTATCCAATCTT"	11.1921574073726	6.50426194751588	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCTATCCAATCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.01466500107	42.9802740130322	0.0212666809189183	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2013.0939599483	2013.0939599483
"healthy-4"	"2019-08-01-count-2:TACGGGCGTGCGAACA"	-8.35189567032512	0.0724399846973791	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGGCGTGCGAACA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3037.16196534768	44.0668822615519	0.0145092302499275	4473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3021.91703874073	3021.91703874073
"healthy-4"	"2019-08-01-count-4:TATACCTTCTCCGATC"	10.3637377220089	6.10287187183229	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATACCTTCTCCGATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.33373689104	42.9218751524014	0.0218061979774812	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1961.76742526382	1961.76742526382
"healthy-4"	"2019-08-01-count-4:TATATCCAGACGCCCT"	-3.39928017082866	-5.11618235027465	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TATATCCAGACGCCCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2552.14010373132	54.4645564772615	0.0213407392476739	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2543.6361221919	2543.6361221919
"healthy-4"	"2019-08-01-count-4:TCGGATACAGTGCCTG"	9.62907852706258	5.79186532581178	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGATACAGTGCCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1448.98702127457	44.4190293352099	0.0306552292622591	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1441.54347101663	1441.54347101663
"healthy-4"	"2019-08-01-count-2:GAGTGAGTCGAGCCAC"	10.3297239738399	6.50833413684694	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGAGTCGAGCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.54102599573	46.0030765132559	0.0249131082741307	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1841.70180757851	1841.70180757851
"healthy-4"	"2019-08-01-count-4:TGGGCGTTCTCCCATG"	3.62031020697896	-6.12299396907958	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTTCTCCCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.8217931846	41.6771764319697	0.0150577528273657	2325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2762.62283585937	2762.62283585937
"healthy-4"	"2019-08-01-count-2:TGAGCGCGTTAGGCCC"	2.31508554992024	-6.09884359752806	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCGCGTTAGGCCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.34588614177	43.9592458034414	0.0194911326344903	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2249.39104526022	2249.39104526022
"healthy-4"	"2019-08-01-count-2:CGGGTGTCATAACTCG"	2.55032887038533	-3.97323706066283	"2019-08-01-count-2"	"Control4"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGGGTGTCATAACTCG"	"cDC1"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2369.07389428882	48.6776199917922	0.0205471091928118	1641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2360.43805433684	2360.43805433684
"healthy-4"	"2019-08-01-count-4:TGGGCTGAGTCATTGC"	3.75533523139302	-6.28705599224242	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCTGAGTCATTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.75033927983	46.8672586736787	0.0176209240324296	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.979484791	2656.979484791
"healthy-4"	"2019-08-01-count-4:CAAGCTAAGACAACAT"	14.2707745033199	2.1915826567444	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGCTAAGACAACAT"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1265.92954196345	45.2317484492049	0.0357300678670084	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1241.21121437152	1241.21121437152
"healthy-4"	"2019-08-01-count-4:GAGGCCTGTATCTCGA"	10.3877626853878	7.6375899084839	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCCTGTATCTCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2067.82905237006	50.8570494046128	0.024594416712698	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2061.19575955592	2061.19575955592
"healthy-4"	"2019-08-01-count-2:GAGTGTTTCCTCATAT"	11.1809584098751	6.09762666309205	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTGTTTCCTCATAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2030.33916772355	42.9135476944872	0.0211361472884368	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.01532913612	2018.01532913612
"healthy-4"	"2019-08-01-count-3:AGGTCTATCCGTAGGC"	5.52772297438924	-10.0467891923157	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTATCCGTAGGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2670.21176497226	47.2398370813534	0.0176914197222272	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2667.45254880399	2667.45254880399
"healthy-4"	"2019-08-01-count-2:GAGTTACAGGGAGGTG"	4.74641575393025	-7.25798656856688	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTTACAGGGAGGTG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.03433698148	45.7257740433126	0.0169540941382633	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2693.0061204743	2693.0061204743
"healthy-4"	"2019-08-01-count-2:GTCCTCAGTTGACTGT"	-3.46935902062114	-5.62321188366088	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCTCAGTTGACTGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2079.32136869302	40.8796148696189	0.0196600753905175	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2077.40111109922	2077.40111109922
"healthy-4"	"2019-08-01-count-4:GTGCACGAGGTAACTA"	-0.57787005129512	8.53782556140748	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGAGGTAACTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.78196099154	37.3032839660481	0.0193604075195159	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1921.64391203502	1921.64391203502
"healthy-4"	"2019-08-01-count-2:AGCGCTGCATCCAATG"	10.9454285102779	6.61963508212892	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGCGCTGCATCCAATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.55897561484	40.3960795214304	0.0186109108184852	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2159.85422991564	2159.85422991564
"healthy-4"	"2019-08-01-count-4:TGTTTGTCAGCTCCTT"	2.3691221671993	-6.10724689876708	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTTGTCAGCTCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.02847897978	41.8303744382014	0.0168873207527393	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2470.02284479331	2470.02284479331
"healthy-4"	"2019-08-01-count-2:TTCTAGTAGATGCCGA"	11.2279650169307	5.0059227713379	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTAGATGCCGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2298.16763896711	40.6050677230807	0.0176684533515276	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2284.28530827397	2284.28530827397
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTAGGTACG"	1.7830705839092	-6.41832926189574	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTAGGTACG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2340.47345652795	44.7680717278944	0.0191277844245698	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2335.90307332866	2335.90307332866
"healthy-4"	"2019-08-01-count-2:GGAGGTAAGAACTCCT"	-3.69374356690105	11.3249645003113	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGGTAAGAACTCCT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1814.79364519362	38.1296850151373	0.0210104796851816	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1812.77277696052	1812.77277696052
"healthy-4"	"2019-08-01-count-3:ATTCCATAGGTAGGCT"	10.4417530494625	7.34646890247194	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCCATAGGTAGGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.54827927215	48.5333211396493	0.0249458323171533	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1935.41712076139	1935.41712076139
"healthy-4"	"2019-08-01-count-3:TGAGCGCTCTTGATTC"	0.469350536435288	8.13491532886354	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGCGCTCTTGATTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.56496684288	33.3519211884546	0.018042060618197	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1842.79487335651	1842.79487335651
"healthy-4"	"2019-08-01-count-1:AGTCACATCCGTCAAA"	11.2932239967281	5.744104839209	"2019-08-01-count-1"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.AGTCACATCCGTCAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2158.93657974584	40.9960395593925	0.0189889966866089	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2148.00252099037	2148.00252099037
"healthy-4"	"2019-08-01-count-3:GATGACTTCGCAACAT"	4.60712017592732	-7.18989326870116	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATGACTTCGCAACAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.86937671401	45.293659225812	0.0178894139019906	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2529.52646878905	2529.52646878905
"healthy-4"	"2019-08-01-count-3:CATTCATGTCATATGC"	10.7322870689327	7.66794345462648	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTCATGTCATATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2358.92729997487	44.5526790215243	0.0188868385312252	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2350.50756846114	2350.50756846114
"healthy-4"	"2019-08-01-count-3:ATAGGCTAGGTAAGAG"	11.3509069877559	4.38499496066896	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTAGGTAAGAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1775.58869209846	39.8426604397967	0.0224391271565878	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1773.52928102028	1773.52928102028
"healthy-4"	"2019-08-01-count-2:CTAGGTATCAATCCAG"	9.89235844191853	6.04246995532838	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGGTATCAATCCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1911.28906531007	49.3657038775229	0.0258284865295948	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1903.31681309885	1903.31681309885
"healthy-4"	"2019-08-01-count-4:TGGTTAGGTCGCTTAA"	-0.970609168440658	8.31991765582887	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTTAGGTCGCTTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2059.21597983877	42.3231776768956	0.0205530542163962	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2052.86830770212	2052.86830770212
"healthy-4"	"2019-08-01-count-4:TCGGTCTTCCTGTAGA"	-4.53174720230754	12.9590368040833	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGGTCTTCCTGTAGA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2061.04785412995	42.8784876948295	0.0208042174318801	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2057.46264600177	2057.46264600177
"healthy-4"	"2019-08-01-count-4:GAGTCTACACGACTAT"	-5.45332751694377	-5.5682091942993	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTCTACACGACTAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2266.6635160775	50.052300599177	0.0220819280162912	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2260.70238960329	2260.70238960329
"healthy-4"	"2019-08-01-count-3:AGTCATGCATCGTCCT"	-0.0478266355698884	7.57569978320924	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCATGCATCGTCCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.18215022169	39.9504033477838	0.0208380843432973	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1913.13536591645	1913.13536591645
"healthy-4"	"2019-08-01-count-3:AATCGACCAGTGAGCA"	2.79716052588765	-4.69778110897215	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATCGACCAGTGAGCA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2928.8067766939	44.9533066918973	0.0153486761399267	2943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2922.06958747062	2922.06958747062
"healthy-4"	"2019-08-01-count-4:TCGTAGAAGTTTCTTC"	10.2991777854854	7.06749913776246	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGAAGTTTCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.95323821308	45.0192137688275	0.0237825281998646	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.10973068136	1886.10973068136
"healthy-4"	"2019-08-01-count-2:TACTTGTCATGGCACC"	-7.18525014343913	3.20673868739931	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTGTCATGGCACC"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2731.98581150863	43.5765448814871	0.015950501901554	2501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2708.65610128732	2708.65610128732
"healthy-4"	"2019-08-01-count-3:GCCAGGTGTAGAATAC"	11.4397045570308	4.57004687869874	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTGTAGAATAC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1987.33688615966	39.8714243121219	0.020062740539763	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1971.63278410429	1971.63278410429
"healthy-4"	"2019-08-01-count-4:GCCAGCAGTTTGACAC"	-5.18971000137981	-5.09644415294798	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCAGCAGTTTGACAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2667.92513094362	47.8289031367758	0.0179273783143455	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2662.89767911269	2662.89767911269
"healthy-4"	"2019-08-01-count-2:TAGGGTTTCCGATCGG"	-0.0941759896581948	7.81475446307985	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGGTTTCCGATCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2111.62329420448	47.5094597033432	0.0224990223558041	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2102.28167415453	2102.28167415453
"healthy-4"	"2019-08-01-count-3:GTCCCATAGATGGCAC"	10.219610829919	7.59336755359498	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCCCATAGATGGCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.14434371952	44.3534045353212	0.0216026723454668	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2039.9900769713	2039.9900769713
"healthy-4"	"2019-08-01-count-4:TTGTTCATCCGTATGA"	0.370859672396821	7.81652257526246	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCATCCGTATGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.64674355521	41.8974753648817	0.0206937212618687	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.49335121394	2016.49335121394
"healthy-4"	"2019-08-01-count-3:TCTACCGCATCAGTCA"	-3.56053076210673	3.73949835384218	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGCATCAGTCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3332.39164019051	47.1904332695687	0.0141611306127484	5202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3322.1416304197	3322.1416304197
"healthy-4"	"2019-08-01-count-4:GAGTTACTCTCTCAAT"	10.3631645637447	7.55129811847535	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTACTCTCTCAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2134.55324956809	45.391299284123	0.0212650114459818	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2128.4424852475	2128.4424852475
"healthy-4"	"2019-08-01-count-3:AGTACTGCAGTAGAGC"	9.90156139907185	6.92166278446046	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTACTGCAGTAGAGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2062.50093560078	48.0300920334797	0.0232873067858702	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.58439867812	2051.58439867812
"healthy-4"	"2019-08-01-count-4:GAGTTTGAGAGGTTTA"	-3.94077358666118	-4.62050774013671	"2019-08-01-count-4"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTTGAGAGGTTTA"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3162.40832022367	39.1045934112626	0.012365447295717	3465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3158.63918328522	3158.63918328522
"healthy-4"	"2019-08-01-count-4:AGGGCTCTCATCGTAG"	-4.25848422470744	-5.26308491146239	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGCTCTCATCGTAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2923.09665435354	49.7634954298471	0.0170242387831177	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2916.14046200028	2916.14046200028
"healthy-4"	"2019-08-01-count-4:AGGGTCCAGCCTATCA"	4.70327295836751	-7.29752781307372	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGGTCCAGCCTATCA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2834.46763540202	46.3050906829414	0.016336433023471	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2830.34634032656	2830.34634032656
"healthy-4"	"2019-08-01-count-3:CTTACCGCAACCGATT"	2.29068507727925	-5.92099001323851	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGCAACCGATT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2809.03970041939	45.8204080805522	0.0163117694896627	2363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2804.04852792011	2804.04852792011
"healthy-4"	"2019-08-01-count-3:AGTAGCTAGGGAGGCA"	0.0716172690385997	7.63726613605348	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGCTAGGGAGGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1846.74901347196	43.4035531573469	0.0235026811118997	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1844.42288209082	1844.42288209082
"healthy-4"	"2019-08-01-count-3:CATTGTTCAACTAGAA"	-4.4362567466801	12.7305593260559	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATTGTTCAACTAGAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2175.55894710181	40.5491912317161	0.0186385164537758	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2172.1325320418	2172.1325320418
"healthy-4"	"2019-08-01-count-2:GGCACGTTCGTAGGGA"	10.7869106727535	7.18363950336305	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCACGTTCGTAGGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2229.31411663105	47.3592191968168	0.0212438520186587	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2218.14283815318	2218.14283815318
"healthy-4"	"2019-08-01-count-3:CGGGTGTAGTTGGCTT"	11.3167025047237	5.77193210208742	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGGTGTAGTTGGCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1804.72502769702	41.1389657300683	0.0227951433590774	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1802.9990062458	1802.9990062458
"healthy-4"	"2019-08-01-count-3:CTAGGTAGTACCCACG"	10.5515133338863	7.60786721790162	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAGGTAGTACCCACG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2142.15849266089	49.3951318830319	0.0230585794899217	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2129.44276291898	2129.44276291898
"healthy-4"	"2019-08-01-count-4:AGCGATTCATGGAATA"	-0.520011286169845	8.10266015613405	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGCGATTCATGGAATA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1747.28792562769	38.9360931886763	0.0222837304702881	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1739.02770878466	1739.02770878466
"healthy-4"	"2019-08-01-count-3:GTCGTAACATCCGGTG"	11.4874683814937	3.88961479747621	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTAACATCCGGTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1987.54099346107	37.4255117238286	0.0188300577683464	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1970.25859950485	1970.25859950485
"healthy-4"	"2019-08-01-count-4:TGTACAGTCCCGAGGT"	-0.130189399153549	7.70196483218995	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTACAGTCCCGAGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.85732692626	35.6589548290139	0.0185737525017573	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1913.52669736482	1913.52669736482
"healthy-4"	"2019-08-01-count-2:TCATACTCAGAGCCCT"	10.1495958763057	5.94048497760621	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTCAGAGCCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1961.8078887782	40.6431738339533	0.0207172037927044	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1954.74811437469	1954.74811437469
"healthy-4"	"2019-08-01-count-2:GGCGTCAAGCTGACAG"	3.81183876571004	-6.3992319337097	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCAAGCTGACAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.15421643606	46.0083388827715	0.0178040221400656	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.65223684832	2580.65223684832
"healthy-4"	"2019-08-01-count-2:CCGATCTGTACGCTAT"	10.1832891899044	7.52255723560182	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCGATCTGTACGCTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1921.30967887947	43.850805150041	0.0228233926222738	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1911.38460684835	1911.38460684835
"healthy-4"	"2019-08-01-count-2:TAGAGTCTCAGGCGAA"	3.26687588271443	-6.68303778087767	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCTCAGGCGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.28525649122	50.3889026829489	0.0246125460646891	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2038.49359154402	2038.49359154402
"healthy-4"	"2019-08-01-count-3:CGGTCAGAGTTGAAAC"	-3.04014335098918	9.46736142719118	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGGTCAGAGTTGAAAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1890.7313872903	48.663019690199	0.0257376695692032	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1883.4071199108	1883.4071199108
"healthy-4"	"2019-08-01-count-2:ATTGGGTTCTGCATAG"	-2.00457773628886	3.40973613345949	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTGGGTTCTGCATAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3128.93149748521	47.7078488857578	0.0152473292956723	4435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3121.22055185239	3121.22055185239
"healthy-4"	"2019-08-01-count-2:TCATACTGTTTCGTGA"	0.564536114304703	7.80741069400636	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCATACTGTTTCGTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.32031458664	38.4563637563918	0.0213489868764493	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1797.7924344062	1797.7924344062
"healthy-4"	"2019-08-01-count-2:GAATAGACACCCTTGT"	10.5691381889278	7.56550881946412	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAATAGACACCCTTGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2107.88587335614	43.191357792599	0.0204903682588044	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2093.24717653921	2093.24717653921
"healthy-4"	"2019-08-01-count-2:CTCAATTGTCAACATC"	10.364009519189	7.610728717688	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCAATTGTCAACATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1994.30831973488	43.159060353591	0.0216411173370267	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1987.30191672547	1987.30191672547
"healthy-4"	"2019-08-01-count-3:GATTTCTCATGTCTAG"	-1.94903335991557	3.73386976802675	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATTTCTCATGTCTAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3230.49857126263	44.7609689285849	0.0138557463936875	5623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3224.77749682954	3224.77749682954
"healthy-4"	"2019-08-01-count-2:TCCGGGAAGCTCGTGC"	-7.05703912201579	2.7119478949341	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGAAGCTCGTGC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2704.11916868871	40.4748260378728	0.0149678411020251	2259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2685.1308159635	2685.1308159635
"healthy-4"	"2019-08-01-count-4:GATCATGTCGGTATGT"	10.5203567939693	5.5039376982483	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATCATGTCGGTATGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.7225246207	41.6273384706236	0.0220282808339701	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1875.67927171489	1875.67927171489
"healthy-4"	"2019-08-01-count-2:TGCAGTAGTATGTCCA"	3.88223399695699	-6.33092882549437	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGTAGTATGTCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.17565629733	45.1495349391342	0.0187251122999753	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2405.5419146138	2405.5419146138
"healthy-4"	"2019-08-01-count-4:ACGGTTACACTGTCCT"	3.77515687522237	-6.56722309505614	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGGTTACACTGTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2827.24972643723	45.3973392436429	0.0160570673397325	2440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2819.28401393439	2819.28401393439
"healthy-4"	"2019-08-01-count-3:ATCATTCGTGCGGCTT"	-1.63384662094768	3.92321822727052	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCATTCGTGCGGCTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3072.17527785934	47.857754989348	0.0155778074689458	4500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3063.84397975495	3063.84397975495
"healthy-4"	"2019-08-01-count-3:CTCAACCTCGCCAATA"	-7.87476096573527	-1.43571784412535	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAACCTCGCCAATA"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2694.67184748792	38.090342628292	0.0141354290184912	2808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2688.43066916688	2688.43066916688
"healthy-4"	"2019-08-01-count-4:CTGTATTGTCACTCGG"	10.1392427879268	5.46853921497194	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTATTGTCACTCGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1838.49507366124	42.6249243226002	0.0231846823705192	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1830.96339984963	1830.96339984963
"healthy-4"	"2019-08-01-count-3:GGTTCTCAGACCATTC"	10.4919678169185	6.87274692142335	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTCTCAGACCATTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.95881777928	42.8997653059773	0.0214933118478406	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1992.84286682851	1992.84286682851
"healthy-4"	"2019-08-01-count-4:TTCTTCCTCCGTAGTA"	10.9208599525387	6.04119966113893	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCTTCCTCCGTAGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1941.6966315082	47.4641666329388	0.0244446871167879	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1933.80726803908	1933.80726803908
"healthy-4"	"2019-08-01-count-3:AGGACTTTCGAGAAAT"	10.09650673446	6.59266135776369	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGACTTTCGAGAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.76052724788	39.7457163055014	0.0216862572685285	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1823.29557218916	1823.29557218916
"healthy-4"	"2019-08-01-count-4:CTCCATGGTTGACGGA"	3.3538404899532	-5.65052177822264	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCATGGTTGACGGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2661.87714146348	40.2609215819419	0.0151250112016089	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2659.55361603013	2659.55361603013
"healthy-4"	"2019-08-01-count-2:TTCTTCCGTCTAGTGT"	2.12570609626119	-6.24647953426512	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCGTCTAGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.630268739	47.7760935507731	0.0232415791289553	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2054.16451659651	2054.16451659651
"healthy-4"	"2019-08-01-count-3:TCTGCCAAGCTTAAGA"	-1.36283121529277	8.74901006305543	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGCCAAGCTTAAGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1906.76029709492	38.12016795468	0.0199921133310561	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1903.39354468195	1903.39354468195
"healthy-4"	"2019-08-01-count-4:GATGAGGAGTTCAACC"	11.2227179008419	5.43071601474611	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGAGGAGTTCAACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1902.89995231752	42.2008067391133	0.0221771022106115	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.54122787799	1896.54122787799
"healthy-4"	"2019-08-01-count-3:AGTCTCCTCGACCTAA"	-1.31836996498759	8.64630506122438	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCTCGACCTAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2068.58237645109	46.8826103475658	0.0226641253842637	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.43944285427	2058.43944285427
"healthy-4"	"2019-08-01-count-2:TCCTCCCTCTCTAGGA"	-0.174024815589744	7.84134671771852	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCTCCCTCTCTAGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1958.75310022528	43.496857220877	0.0222064012130341	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1948.88145423661	1948.88145423661
"healthy-4"	"2019-08-01-count-3:AACCCAACACCAGCTG"	10.8786331611568	6.54898593509523	"2019-08-01-count-3"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCCAACACCAGCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1956.17932045115	51.1324807487591	0.0261389537319956	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1950.06563916807	1950.06563916807
"healthy-4"	"2019-08-01-count-4:GGGCTCAAGATAGTGT"	3.42838015136067	-6.46347238933715	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGCTCAAGATAGTGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.8614627393	43.7839292032992	0.0169911847557204	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2571.0724736552	2571.0724736552
"healthy-4"	"2019-08-01-count-3:AGTGACTAGTGCAGCA"	-1.9339636367863	8.78187749469606	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTAGTGCAGCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.94600416939	46.6549619966288	0.023293170110183	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2001.19287506186	2001.19287506186
"healthy-4"	"2019-08-01-count-3:TCTGGCTGTTAATCGC"	-0.0685226199334443	7.68595883930055	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGGCTGTTAATCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.16158000167	42.1256492810723	0.0214144327081849	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1958.41908210009	1958.41908210009
"healthy-4"	"2019-08-01-count-3:TCTGTCGAGAGTTGTA"	2.0172037082607	-6.22471001064452	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTGTCGAGAGTTGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.12948821847	50.022225109837	0.0229235823904639	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2179.60286202938	2179.60286202938
"healthy-4"	"2019-08-01-count-4:GATGATCAGGTAACTA"	10.568545003503	6.50081918323366	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGATCAGGTAACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.5420772982	42.2233108783299	0.0219394064574601	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.02289713639	1923.02289713639
"healthy-4"	"2019-08-01-count-4:ACGTAGTCAGTATGAA"	4.04988207396809	-6.39994671260985	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACGTAGTCAGTATGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.13636900938	47.6041257543779	0.0190177915768997	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2495.16524684616	2495.16524684616
"healthy-4"	"2019-08-01-count-2:CTTGAGATCACTCACC"	10.7844168144161	5.67762754047243	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTTGAGATCACTCACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1781.82973734808	46.475249028896	0.0260828787704855	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1774.47122651268	1774.47122651268
"healthy-4"	"2019-08-01-count-2:TCACAAGAGCACAAAT"	10.391522069543	7.40933034503785	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACAAGAGCACAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2058.00959613463	44.585861822957	0.0216645548721923	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2036.53742280292	2036.53742280292
"healthy-4"	"2019-08-01-count-3:ATCCTATCACCTAAAC"	-2.87355742874797	9.97875497424928	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCTATCACCTAAAC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.79667274529	48.8154271432991	0.0240494172636891	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2028.07647655843	2028.07647655843
"healthy-4"	"2019-08-01-count-4:TGAGTCATCGACCCAG"	10.9627806144649	5.74198482120363	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGTCATCGACCCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1810.87024153886	42.5709359256199	0.0235085512750177	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1794.23900187647	1794.23900187647
"healthy-4"	"2019-08-01-count-4:CCCTGATCAATGTGGG"	-3.05040607872661	10.295497871283	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTGATCAATGTGGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2003.07648529625	45.9246585272167	0.0229270618792295	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2001.27489091756	2001.27489091756
"healthy-4"	"2019-08-01-count-3:TCATTTGTCGGCTGTG"	0.570580740540665	8.112277961615	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTTGTCGGCTGTG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1872.93004805616	40.9029852217474	0.0218390351867113	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1862.48024869261	1862.48024869261
"healthy-4"	"2019-08-01-count-2:ATCGCCTAGATGGTAT"	10.9321876960689	6.38883874500123	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGCCTAGATGGTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.54713604067	45.4799710375382	0.0254284441942178	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1781.49075672904	1781.49075672904
"healthy-4"	"2019-08-01-count-4:CTCATGCTCAAAGGTA"	-1.60805080357249	3.96695754611818	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCATGCTCAAAGGTA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3049.20779874933	42.8502563961914	0.0140529144697081	5020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3042.02247314282	3042.02247314282
"healthy-4"	"2019-08-01-count-3:CCTAAGAGTACGTACT"	10.7996231513912	6.21814105594484	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAAGAGTACGTACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1848.06463386234	43.2551272253723	0.023405635513392	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1842.61334463005	1842.61334463005
"healthy-4"	"2019-08-01-count-2:GTTCTATGTAAGATAC"	4.48319687423055	-6.57106211101683	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATGTAAGATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2833.85064477504	35.9183708722922	0.0126747579088253	2208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2829.34665723838	2829.34665723838
"healthy-4"	"2019-08-01-count-3:AATGGAATCACACCGG"	-0.366386423737365	8.36306283557741	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AATGGAATCACACCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2024.74602622987	42.9189448380467	0.021197199195379	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2008.98058238962	2008.98058238962
"healthy-4"	"2019-08-01-count-4:TAGGGTTCATGCCGAC"	10.2329002815181	6.3151907690796	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGGGTTCATGCCGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.00396380809	49.1370591762935	0.0256723915443366	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.28683802929	1910.28683802929
"healthy-4"	"2019-08-01-count-2:CCACTTGGTGTTTACG"	2.22779860076253	-6.2262902489868	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCACTTGGTGTTTACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.2270415427	45.7066867687341	0.0223261445072997	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2044.28630712867	2044.28630712867
"healthy-4"	"2019-08-01-count-4:TCCACCATCTGGACCG"	2.3164812522823	-6.08121540462645	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCACCATCTGGACCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.46630993211	44.1192225883772	0.0174559092696916	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2524.54363840079	2524.54363840079
"healthy-4"	"2019-08-01-count-2:TCACACCGTATTGAGA"	4.90724625167195	-7.43471434032591	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCACACCGTATTGAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2857.94084723639	42.143678421592	0.0147461688937141	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2851.47676074782	2851.47676074782
"healthy-4"	"2019-08-01-count-3:GTTGCGGCATGTCTAG"	-3.15028033676799	-4.74814417278441	"2019-08-01-count-3"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGCATGTCTAG"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2892.10455580371	43.8755980419452	0.0151708201399213	2894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2887.66785347375	2887.66785347375
"healthy-4"	"2019-08-01-count-2:GACCCTTTCTAGACAC"	-4.24424729767497	12.8695363768372	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCCTTTCTAGACAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1894.22632783036	46.1130723377176	0.0243440140495436	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1892.20138857903	1892.20138857903
"healthy-4"	"2019-08-01-count-3:GTTGCGGTCCGTCCTA"	-0.116445655853111	7.90745685184327	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGCGGTCCGTCCTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2075.04105187961	40.6195477169802	0.0195752983682834	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2064.26246158591	2064.26246158591
"healthy-4"	"2019-08-01-count-2:TACCGGGGTGGAACCA"	11.273285527795	6.13281533801881	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCGGGGTGGAACCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.74675542844	43.6707336310605	0.023647386141436	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1836.78276150633	1836.78276150633
"healthy-4"	"2019-08-01-count-3:TCTTTGAGTCTTACTT"	10.8939730125362	5.70865342700807	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTTTGAGTCTTACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.42703509232	47.5780710579352	0.023999910319887	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.53027724779	1977.53027724779
"healthy-4"	"2019-08-01-count-2:GGGTGTCAGTTTCAGC"	-1.01080964031871	9.20969483936159	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGTCAGTTTCAGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1705.16581763967	41.3000610269584	0.0242205541535702	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1705.16581763967	1705.16581763967
"healthy-4"	"2019-08-01-count-2:CCTCATGGTATCTTCT"	3.89837374266927	-6.24343063747557	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTCATGGTATCTTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.76942175027	42.0285197082483	0.0154700356135382	2160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2710.81307522595	2710.81307522595
"healthy-4"	"2019-08-01-count-2:CTGAATGTCACTTCTA"	11.2192789512569	5.76033732974855	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGAATGTCACTTCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.4002234092	45.1415029604616	0.0220052149967311	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2045.07384133422	2045.07384133422
"healthy-4"	"2019-08-01-count-2:TTCTTCCGTCTTCGAA"	5.51721252974812	-10.0240364304748	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCGTCTTCGAA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2879.47309550012	36.5142695406665	0.0126808858182176	2166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2870.05680450065	2870.05680450065
"healthy-4"	"2019-08-01-count-2:TATTGCTCATTCTGTT"	0.158235159784001	7.84589669788209	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTCATTCTGTT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2036.31361285929	41.7012514202986	0.0204787961721397	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2021.63391258821	2021.63391258821
"healthy-4"	"2019-08-01-count-4:CTGTGAACAGTTACCA"	3.25628771361653	-6.15966417705687	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGTGAACAGTTACCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.7774083509	41.9097872011405	0.015924518186134	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2626.44318861788	2626.44318861788
"healthy-4"	"2019-08-01-count-3:AGCGCTGTCTGCATGA"	10.5371242958004	7.65260312640993	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGCTGTCTGCATGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.6587019315	43.7570526188965	0.021327647029061	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2044.91980339409	2044.91980339409
"healthy-4"	"2019-08-01-count-2:GAAATGAAGCATGCGA"	10.6359449821407	7.05401275241701	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGAAGCATGCGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2109.25815930173	43.7455987225969	0.0207398030106846	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2092.96109453529	2092.96109453529
"healthy-4"	"2019-08-01-count-2:AAAGAACGTGCTCTCT"	-0.239234010607559	7.54005382144777	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGAACGTGCTCTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1911.14378534216	41.94587999238	0.0219480503320006	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1905.98608209921	1905.98608209921
"healthy-4"	"2019-08-01-count-3:TCAGCAATCACGGGAA"	11.082894940942	5.36859176242677	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGCAATCACGGGAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1997.90996200515	41.0771496184007	0.0205600604629723	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1989.42122747515	1989.42122747515
"healthy-4"	"2019-08-01-count-3:ACTTTCACACCGGCTA"	0.261270959942979	7.94102761829225	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTCACACCGGCTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1833.86488559771	38.7681542415576	0.0211401366294889	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1823.36337390307	1823.36337390307
"healthy-4"	"2019-08-01-count-3:AGTTCCCGTTAATCGC"	-7.85339675369914	3.62881658161012	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTTCCCGTTAATCGC"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2369.63228813677	45.0463233473887	0.0190098369155868	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2353.53007111216	2353.53007111216
"healthy-4"	"2019-08-01-count-3:GTTGTCCTCTCGACCT"	-5.48806891861613	-5.22536899959715	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTGTCCTCTCGACCT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3138.0326774983	48.4744947299884	0.0154474155344466	3257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3134.44340628268	3134.44340628268
"healthy-4"	"2019-08-01-count-3:GGTGAAGCACAGTCGC"	11.1538721519405	6.03406570041505	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTGAAGCACAGTCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1816.93946410864	46.0759027930314	0.0253590742582255	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1810.03986762022	1810.03986762022
"healthy-4"	"2019-08-01-count-1:ACACGCGCACCGAATT"	0.305860390036744	7.82273147189943	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACACGCGCACCGAATT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2260.61274589303	45.2290491207304	0.0200074290490047	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2248.23082891637	2248.23082891637
"healthy-4"	"2019-08-01-count-4:TTTGATCCATTAGGAA"	-4.1286862892216	12.9638757475647	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGATCCATTAGGAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1964.80772701872	46.1400675746687	0.023483248228405	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1960.98704158967	1960.98704158967
"healthy-4"	"2019-08-01-count-4:GATTTCTTCACCTTAT"	11.5559174018795	3.85629484737245	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATTTCTTCACCTTAT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2159.15516748195	35.1789643698239	0.0162929301699286	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2144.48810035789	2144.48810035789
"healthy-4"	"2019-08-01-count-4:GCAACATCATGCCGGT"	4.73964943465535	-7.19592621242674	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACATCATGCCGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.1595155907	45.3341553562481	0.0180890941195987	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2501.35478037966	2501.35478037966
"healthy-4"	"2019-08-01-count-2:GGGTATTTCACCTACC"	1.20607091960255	-6.46231796657714	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTATTTCACCTACC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2116.24714723141	45.6430548254447	0.0215679226715828	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2112.73300808596	2112.73300808596
"healthy-4"	"2019-08-01-count-2:TGCTTGCCAATTCTCT"	11.1672932105953	5.7253436812195	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCCAATTCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2059.43755836892	47.5482422735004	0.0230879747143967	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2051.38285789744	2051.38285789744
"healthy-4"	"2019-08-01-count-4:GAATCACCAGACCTGC"	-3.56898389282878	10.5786933668884	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAATCACCAGACCTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.11682355973	43.8727817103456	0.0218913294846846	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1995.56918641558	1995.56918641558
"healthy-4"	"2019-08-01-count-4:CAAGCTAAGAGTGGCT"	0.738352199166459	8.1550664671692	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CAAGCTAAGAGTGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1819.91305116372	41.516856935562	0.0228125497034128	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1813.34780266075	1813.34780266075
"healthy-4"	"2019-08-01-count-3:ATACCTTCAGAACGCA"	0.0327007128739774	7.54311559284059	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTCAGAACGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2046.82914972013	41.091062160054	0.0200754724280102	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2040.98036889578	2040.98036889578
"healthy-4"	"2019-08-01-count-3:TGAGACTCAGGCGAAT"	2.17913569983785	-5.88691475307616	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGAGACTCAGGCGAAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2668.85706469345	45.5720116529697	0.0170754785843895	2256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2664.79741317208	2664.79741317208
"healthy-4"	"2019-08-01-count-2:GAACGTTGTGGCGTAA"	4.46004786071126	-7.70895483410033	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTGTGGCGTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.81874823613	46.2767732717682	0.019275413150521	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2395.71323171918	2395.71323171918
"healthy-4"	"2019-08-01-count-3:AAGATAGAGCCTCAGC"	2.70967211303059	-5.99763586437377	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGATAGAGCCTCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.92362868709	41.7092510319243	0.0167243497564045	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2489.95340061947	2489.95340061947
"healthy-4"	"2019-08-01-count-2:GCACGGTGTATCAGGG"	-1.82857284966167	8.58924195850221	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACGGTGTATCAGGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.25926811677	47.179116021416	0.0251990292289334	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1866.98431008096	1866.98431008096
"healthy-4"	"2019-08-01-count-2:ATACTTCCACTGAATC"	2.57346190985982	-5.99074985897215	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATACTTCCACTGAATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.62395557511	43.5438403996989	0.0166730896715603	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2604.77590224701	2604.77590224701
"healthy-4"	"2019-08-01-count-2:TCAGCCTCAGAACTTC"	-0.281956623226959	8.27429196918336	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCCTCAGAACTTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2354.43943640931	43.6815438624818	0.0185528424248191	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2339.50328621641	2339.50328621641
"healthy-4"	"2019-08-01-count-4:TTTGGTTGTGTATTGC"	-2.10374985161479	8.81302354419557	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTGGTTGTGTATTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1853.58435119276	46.145942157944	0.0248955177724982	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1851.83809724763	1851.83809724763
"healthy-4"	"2019-08-01-count-2:GCACTAACACATATCG"	-5.67061601105388	-5.32783558284911	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAACACATATCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2957.58754063034	48.5069229970912	0.0164008409998756	2505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2954.20281135909	2954.20281135909
"healthy-4"	"2019-08-01-count-3:AGCGATTCAAATAAGC"	3.40565385398213	-6.32527878200682	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTCAAATAAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.29451921058	40.1748270654812	0.0151700752216399	1987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2643.52896093402	2643.52896093402
"healthy-4"	"2019-08-01-count-4:CTTCCGATCATTTCGT"	4.08210100707356	-6.32093527233275	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCGATCATTTCGT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2893.05464954104	38.8093346092916	0.0134146565864037	2617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2888.49000937976	2888.49000937976
"healthy-4"	"2019-08-01-count-2:GCACTAATCCAACTAG"	10.2408415275509	7.5338301428589	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAATCCAACTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2066.62464004538	48.4042601016176	0.0234218924732044	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2062.29388953692	2062.29388953692
"healthy-4"	"2019-08-01-count-3:ATAGAGACAGGACATG"	10.435958524316	7.26198003375856	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGAGACAGGACATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1982.88476702786	42.8517295053081	0.0216108017056071	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1973.06566773377	1973.06566773377
"healthy-4"	"2019-08-01-count-3:AGCGATTTCTGATGGT"	10.7413860755855	6.87872407520143	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGATTTCTGATGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.45128910098	46.5501640146167	0.0241386257862484	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1919.83331191293	1919.83331191293
"healthy-4"	"2019-08-01-count-3:CTACCTGGTCCAAAGG"	0.0651578652555167	7.8731274374756	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACCTGGTCCAAAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.99483177322	42.0937676115964	0.0212166720081496	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1974.54218626389	1974.54218626389
"healthy-4"	"2019-08-01-count-4:GTCCCATGTGGTATGG"	-0.0757454884355843	7.57559058750001	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCCCATGTGGTATGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.58939774012	40.7450617921759	0.0212591501550719	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1906.95806471238	1906.95806471238
"healthy-4"	"2019-08-01-count-4:GACTCAAAGAAGCCAC"	11.1457277732784	6.36907718265382	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCAAAGAAGCCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2081.30246661509	45.5185512824683	0.021870224060464	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2066.78590771015	2066.78590771015
"healthy-4"	"2019-08-01-count-4:ACCTGAAGTGTAACGG"	2.22858538207356	-5.99301006710204	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ACCTGAAGTGTAACGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.58217292804	46.8835181822516	0.019178540489026	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2439.29790197124	2439.29790197124
"healthy-4"	"2019-08-01-count-2:CGCCAGATCTCTGACC"	10.0257708030636	7.42343804920045	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCCAGATCTCTGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2005.16900263331	45.731863406064	0.0228069870150626	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2000.35716508944	2000.35716508944
"healthy-4"	"2019-08-01-count-2:GATGAGGAGGATATAC"	3.96381773528401	-6.57921602642211	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGAGGAGGATATAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.82964037695	47.793792938162	0.0204349184365815	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2331.99748592288	2331.99748592288
"healthy-4"	"2019-08-01-count-3:CACAGATAGGATCATA"	11.2404419380123	4.92192218387452	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACAGATAGGATCATA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2053.89695576169	44.5985458253457	0.0217141106812763	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2048.14094664898	2048.14094664898
"healthy-4"	"2019-08-01-count-2:GCGTTTCCACGTACAT"	1.86024500903432	-6.57356073772582	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGTTTCCACGTACAT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2387.21662541236	45.5384224160136	0.019075948923633	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2384.50502878607	2384.50502878607
"healthy-4"	"2019-08-01-count-4:TCGTAGATCTATTGTC"	4.53823151168172	-7.05311491405638	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTAGATCTATTGTC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.2680635299	39.6226709419727	0.0167873605351059	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2358.86878710013	2358.86878710013
"healthy-4"	"2019-08-01-count-3:CACGGGTTCGATGGAG"	2.41823639449422	-6.25613453304442	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGGGTTCGATGGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.25378803858	43.5289183819296	0.0197746023736391	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2196.22629327126	2196.22629327126
"healthy-4"	"2019-08-01-count-2:ATGACCACAATTGGTC"	-0.154712374240714	7.55692479694215	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGACCACAATTGGTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1967.44965764688	42.997701405067	0.0218545370337421	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1959.65090499933	1959.65090499933
"healthy-4"	"2019-08-01-count-3:AGCGTATTCTATGTGG"	10.4222237068111	7.4753789671692	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGTATTCTATGTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2080.99003868184	47.834459523746	0.0229863952419713	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2074.24580905452	2074.24580905452
"healthy-4"	"2019-08-01-count-3:GGTTGTACATTCTCCG"	11.3693644004757	4.44392964923707	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGTTGTACATTCTCCG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2266.33880115081	41.1181748765463	0.0181429955908037	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2258.1513351882	2258.1513351882
"healthy-4"	"2019-08-01-count-4:CTTCTCTAGCCTAACT"	-5.73829350891765	-5.57695915615233	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTAGCCTAACT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2669.19599498028	47.6734597644094	0.0178606066598574	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2662.32159191706	2662.32159191706
"healthy-4"	"2019-08-01-count-2:TTCTTGAAGTGTTCAC"	-4.15016541901286	12.564462638739	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGAAGTGTTCAC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2153.08281113883	41.5577268777976	0.0193014995349001	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2147.7343470064	2147.7343470064
"healthy-4"	"2019-08-01-count-3:ACAGGGAGTGCATTAC"	3.02442802962605	-6.00561525737914	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGGGAGTGCATTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.99236667241	47.1653136404769	0.0215662909296024	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2181.1420839295	2181.1420839295
"healthy-4"	"2019-08-01-count-4:GGTGTCGGTGCATACT"	4.01988162574117	-6.97687580501708	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTCGGTGCATACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.30789532667	46.6036056558529	0.0206182554828963	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2257.14705252285	2257.14705252285
"healthy-4"	"2019-08-01-count-3:AGCTCAATCTGGGCGT"	0.459033508866471	7.78788325870363	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTCAATCTGGGCGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.72271791764	43.8502522327235	0.024947195473853	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1752.32862083456	1752.32862083456
"healthy-4"	"2019-08-01-count-4:CTTCTCTCATCCTTGC"	-3.70834622803386	11.4520501860413	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCTCTCATCCTTGC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2376.34065547583	36.801293959131	0.0154865397241466	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2363.10682683989	2363.10682683989
"healthy-4"	"2019-08-01-count-2:TTCTTGATCTCCGAAA"	2.92696156081502	-6.33308412944945	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTGATCTCCGAAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.92566522376	45.5581842255092	0.0206620045945567	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2203.51488070797	2203.51488070797
"healthy-4"	"2019-08-01-count-4:GGTGTTAAGGTAGGCT"	5.72873796996419	-9.70786859905394	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGTTAAGGTAGGCT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.48479923655	41.9002743877016	0.0149992849072072	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2786.99074041667	2786.99074041667
"healthy-4"	"2019-08-01-count-3:GAAGTAATCTCCCATG"	-3.49249659004863	-5.09562017833861	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGTAATCTCCCATG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2860.34674885719	45.4382727251221	0.0158855819642413	3835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2852.25456793469	2852.25456793469
"healthy-4"	"2019-08-01-count-4:CCCAACTAGATGAATC"	10.8150955635006	6.64048907840577	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCAACTAGATGAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.9051236077	46.0659596440946	0.0236611219958846	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1941.98629708089	1941.98629708089
"healthy-4"	"2019-08-01-count-2:TCAGTTTTCCGATCTC"	0.213504512875718	7.81464717471925	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTTTTCCGATCTC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1987.29769451746	48.3660792602171	0.0243376115182184	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1983.45980803488	1983.45980803488
"healthy-4"	"2019-08-01-count-3:ATTGTTCCAAGCTCTA"	3.1607309776241	-6.11659910595091	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTGTTCCAAGCTCTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.8435497304	41.5574928487596	0.0160773725949851	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2580.64670668611	2580.64670668611
"healthy-4"	"2019-08-01-count-2:GATCATGGTCTACGTA"	4.39918818053548	-6.83461811458739	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGGTCTACGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2134.42916101522	42.4358080118472	0.0198815724536218	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2132.82733305718	2132.82733305718
"healthy-4"	"2019-08-01-count-2:TTTATGCAGATACATG"	11.5852371650631	3.47540876949159	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCAGATACATG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2131.46290716473	37.5106998277281	0.0175985703066374	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2120.80714003433	2120.80714003433
"healthy-4"	"2019-08-01-count-3:AGTAGTCTCAAACCCA"	-7.23492227020915	2.97676131809083	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAGTCTCAAACCCA"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2522.56493367018	46.7676963941294	0.0185397393620648	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2509.3410689806	2509.3410689806
"healthy-4"	"2019-08-01-count-2:TGGGAGAAGTCGAAAT"	1.34448601779286	-6.77305557644042	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGAAGTCGAAAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1800.29051217963	49.079075868344	0.0272617533316461	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1800.29051217963	1800.29051217963
"healthy-4"	"2019-08-01-count-2:CATCCACGTCTCGCGA"	4.66303219374959	-6.86525061046752	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACGTCTCGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.59871064811	44.6606490316908	0.0175167365927708	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2545.21035323619	2545.21035323619
"healthy-4"	"2019-08-01-count-3:GCCATGGCAATCGAAA"	9.69419922408406	6.75510785663453	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGCAATCGAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.90660562996	47.6657608392716	0.0254094530592394	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1866.52651535712	1866.52651535712
"healthy-4"	"2019-08-01-count-2:TGGGATTCAGATCCTA"	-2.87338099899943	9.45467469776002	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGATTCAGATCCTA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2087.80315260499	48.0614551888003	0.0230201085427202	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2081.31336713565	2081.31336713565
"healthy-4"	"2019-08-01-count-2:GCTCAAATCATGCTAG"	10.7603527503902	7.64126393878785	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTCAAATCATGCTAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2073.34946988794	45.8015486954592	0.0220906071844871	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2070.61229472684	2070.61229472684
"healthy-4"	"2019-08-01-count-2:TCCGGGACACAAAGCG"	11.1671835380489	6.1744985350403	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGACACAAAGCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1926.57780391963	39.7283424884868	0.0206211980682324	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1915.92217828686	1915.92217828686
"healthy-4"	"2019-08-01-count-2:CGCATAACAACTGTGT"	0.0850869315559089	7.74158141696779	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCATAACAACTGTGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2027.72223954398	45.1441093808352	0.0222634582293617	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.92984907472	2016.92984907472
"healthy-4"	"2019-08-01-count-2:CAGCAATAGAGCAAGA"	10.7924324470455	6.96871659839479	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCAATAGAGCAAGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2024.56514436404	44.5917791337584	0.0220253614747307	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2015.85078858887	2015.85078858887
"healthy-4"	"2019-08-01-count-3:AGTCAACTCAGGAGAC"	4.77812876281087	-7.3314213982788	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCAACTCAGGAGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2815.58347116267	44.4848133799392	0.0157995008265799	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2813.55102649147	2813.55102649147
"healthy-4"	"2019-08-01-count-3:ATTTCACCAGACCATT"	10.9138933616573	6.80237290942994	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTTCACCAGACCATT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1960.66901691202	45.6444771894935	0.023280052265722	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1935.532457913	1935.532457913
"healthy-4"	"2019-08-01-count-2:CGTTGGGAGATGAACT"	10.1888328987056	7.6101879843506	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTTGGGAGATGAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2038.44155698515	42.7041525280161	0.020949412251571	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2034.74082827433	2034.74082827433
"healthy-4"	"2019-08-01-count-4:TCTATACAGTAGCATA"	0.105382871895474	7.57939145648805	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACAGTAGCATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.61100019092	41.801460749055	0.0201879835204202	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2063.81966811914	2063.81966811914
"healthy-4"	"2019-08-01-count-3:CCACAAAGTTGCGAAG"	3.72830404815022	-6.40253593837889	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCACAAAGTTGCGAAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.9398763581	47.5222203834436	0.0183063640326345	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.66756876856	2589.66756876856
"healthy-4"	"2019-08-01-count-3:TCACGGGTCTAGCCAA"	-4.26635585251506	12.9499463804993	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCACGGGTCTAGCCAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2085.14560250019	43.5537812775692	0.020887645076366	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2075.93390231767	2075.93390231767
"healthy-4"	"2019-08-01-count-3:AGTAACCAGCGGACAT"	11.2707334953243	5.04227969730226	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTAACCAGCGGACAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2036.88823951281	44.8931698154294	0.0220400751227113	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2031.63055499149	2031.63055499149
"healthy-4"	"2019-08-01-count-3:TCTCCGAGTCGCATGC"	-3.52990374985393	9.72371003711549	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCCGAGTCGCATGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2017.70091008627	43.6966880129954	0.0216566725992739	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2015.95966882439	2015.95966882439
"healthy-4"	"2019-08-01-count-4:GTCACTCCAAGGGTCA"	4.34942211684529	-6.55633070385131	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCACTCCAAGGGTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.07099030153	42.7598632196256	0.0163138897717175	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2612.95167623951	2612.95167623951
"healthy-4"	"2019-08-01-count-3:TACTTGTCAGAGTCAG"	10.4183250862056	6.78334710681764	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACTTGTCAGAGTCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2116.68626269687	44.0598418422998	0.0208154806022897	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.92882265043	2104.92882265043
"healthy-4"	"2019-08-01-count-2:TACACCCAGGCTCAAG"	2.79644550856892	-4.66320946132811	"2019-08-01-count-2"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACACCCAGGCTCAAG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2939.50094221264	42.2896336112174	0.0143866712216071	3156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2928.5837115896	2928.5837115896
"healthy-4"	"2019-08-01-count-3:GCCAGGTCACAGCCAC"	-3.64719949188884	10.7391481169495	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTCACAGCCAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2062.02787280689	50.0326744134051	0.0242638206171768	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.53860908156	2058.53860908156
"healthy-4"	"2019-08-01-count-2:TACTTGTAGATTCGAA"	-4.04003606262858	10.7384128340515	"2019-08-01-count-2"	"Control4"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACTTGTAGATTCGAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1909.4833452522	47.8395723112152	0.0250536735133956	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1905.70486325107	1905.70486325107
"healthy-4"	"2019-08-01-count-3:ATGAAAGGTAGTGATA"	-4.18829379501994	10.7436332472595	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAAAGGTAGTGATA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2017.68855516445	45.4281589281813	0.0225149509878044	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2006.16661082761	2006.16661082761
"healthy-4"	"2019-08-01-count-2:TTGCATTCATCCCACT"	14.2089172798092	1.83481202209321	"2019-08-01-count-2"	"Control4"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTCATCCCACT"	"Plasma cell"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1526.70145429862	39.0846611460861	0.0256007230726337	1866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1507.98513642298	1507.98513642298
"healthy-4"	"2019-08-01-count-3:ATCCCTGAGCGAGAAA"	10.1098667579586	7.0659231909546	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCCTGAGCGAGAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.90145911316	45.803931253114	0.0271205469128824	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1678.01562233678	1678.01562233678
"healthy-4"	"2019-08-01-count-4:TCATTCAAGGGACACT"	11.30113853988	4.80180833423463	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTCAAGGGACACT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1874.43497857667	45.6333599760159	0.0243451282640207	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1855.05338307756	1855.05338307756
"healthy-4"	"2019-08-01-count-4:GCCATGGAGCTGAAGC"	2.41457404670064	-5.9816522828308	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCCATGGAGCTGAAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.50536314476	38.5836634078436	0.0149057691582175	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2585.48594544151	2585.48594544151
"healthy-4"	"2019-08-01-count-2:TTGCATTGTCTTTCAT"	3.98022927817647	-6.50295927440795	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGCATTGTCTTTCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.0760947693	38.5423269437005	0.0142428836418166	1898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2701.80050654744	2701.80050654744
"healthy-4"	"2019-08-01-count-2:AGTCTCCAGCAGGGAG"	4.7407566505367	-6.70526173031005	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AGTCTCCAGCAGGGAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.52776500568	47.4299114636215	0.0174212774147861	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2715.97455130964	2715.97455130964
"healthy-4"	"2019-08-01-count-3:CTCAGGGCATTCCTAT"	3.18590154227559	-5.27735044872435	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGGGCATTCCTAT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2991.87526132554	36.1309845859636	0.0120763673048174	3042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2983.19036589008	2983.19036589008
"healthy-4"	"2019-08-01-count-3:TCATTGTGTCATATGC"	10.5382429557735	7.68400189960328	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCATTGTGTCATATGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2180.08371988656	41.3604730927537	0.0189719654871355	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2169.51267286481	2169.51267286481
"healthy-4"	"2019-08-01-count-2:GACCAATTCCTTACCG"	10.990121503442	6.28866908634035	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCAATTCCTTACCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.16674962928	45.2236584357543	0.0220477727829431	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2035.07346031847	2035.07346031847
"healthy-4"	"2019-08-01-count-4:CCCTCTCGTCAACATC"	0.186298658221406	7.93352172458497	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCTCGTCAACATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2097.6525555162	50.4679629213721	0.0240592574726718	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2085.71528596769	2085.71528596769
"healthy-4"	"2019-08-01-count-3:ATCCGTCTCGAACGGA"	10.8656717735225	6.23483035648195	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCTCGAACGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1978.31136694846	44.9646393244102	0.0227287979413311	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1970.04866925105	1970.04866925105
"healthy-4"	"2019-08-01-count-4:TAGATCGTCAAGAGGC"	2.91727342185323	-5.98433973705443	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGATCGTCAAGAGGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.27916297793	42.7794321671504	0.0175665413713138	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2431.3360573822	2431.3360573822
"healthy-4"	"2019-08-01-count-2:GATTCGAGTGTTACAC"	11.2308527427608	3.70621011340944	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGAGTGTTACAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1351.36920098958	46.4546969196076	0.0343760216568423	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1331.26368909873	1331.26368909873
"healthy-4"	"2019-08-01-count-3:CAACGATAGTCACACT"	2.59378828582112	-6.05547335064086	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACGATAGTCACACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.12134534904	49.1450293983686	0.0208673024408791	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2352.68228987359	2352.68228987359
"healthy-4"	"2019-08-01-count-3:ACCATTTGTTCCACAA"	11.1211725669796	6.03601834857789	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCATTTGTTCCACAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.84097291223	41.839274399451	0.0221742452067247	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1879.5568303469	1879.5568303469
"healthy-4"	"2019-08-01-count-3:ATCCGTCCAGTCACGC"	-2.9167517227238	9.54614636981813	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCCGTCCAGTCACGC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1996.87539508288	45.8427633779038	0.0229572478537155	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1993.56161562367	1993.56161562367
"healthy-4"	"2019-08-01-count-3:GTAGCTAAGGACATCG"	0.234982182353181	7.90289352023927	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGCTAAGGACATCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1886.074317259	42.1355122475005	0.0223403244834676	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1883.32814084236	1883.32814084236
"healthy-4"	"2019-08-01-count-3:GCGGAAACATCCCACT"	11.0245310264522	6.38519952380983	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCGGAAACATCCCACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.82628636885	45.3373497878792	0.024482506875296	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1842.57087230942	1842.57087230942
"healthy-4"	"2019-08-01-count-2:GGAATCTCAAATCCCA"	4.0258649784023	-6.46598102962645	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAATCTCAAATCCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2930.97642460086	44.8757939308622	0.0153108682670395	2250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2925.38497662379	2925.38497662379
"healthy-4"	"2019-08-01-count-3:GAGTGTTGTACAAACA"	5.45128979262654	-10.2466879121033	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTGTACAAACA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.77125080848	47.6183469149361	0.0186171249285426	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2549.77717742107	2549.77717742107
"healthy-4"	"2019-08-01-count-2:CTGCCATCAGTTCTAG"	4.45635618743245	-7.79762604152831	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCCATCAGTTCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.77561890692	49.1100082799617	0.0200385575493302	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2443.71269960128	2443.71269960128
"healthy-4"	"2019-08-01-count-2:TGTAACGAGGGTTTCT"	0.151920002966565	7.69538829410402	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGTAACGAGGGTTTCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1825.10820174846	43.3360080991483	0.0237443500925765	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1819.72009750602	1819.72009750602
"healthy-4"	"2019-08-01-count-2:TGGTTAGTCAAGCTTG"	3.50198831137959	-6.30614235317381	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTTAGTCAAGCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.56076363316	36.8377301236159	0.0161034979744579	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2282.30603832205	2282.30603832205
"healthy-4"	"2019-08-01-count-2:GTAATGCTCTCTCTTC"	11.5243221717769	4.01535627925722	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAATGCTCTCTCTTC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2481.01185705556	38.5236033819863	0.0155273757650259	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2469.56518851329	2469.56518851329
"healthy-4"	"2019-08-01-count-4:TGGTAGTCACCGGTCA"	2.55316748198811	-6.00317099010619	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTAGTCACCGGTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2600.27208734897	43.5902748732349	0.016763736027977	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2595.31894971717	2595.31894971717
"healthy-4"	"2019-08-01-count-3:AAGTGAACATGAGGGT"	-0.35419855538066	7.61256167972413	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGTGAACATGAGGGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2413.86324455409	43.9807085420198	0.0182200498065682	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2407.73929664303	2407.73929664303
"healthy-4"	"2019-08-01-count-3:CTCATTAAGTCAAGCG"	-2.75089369240459	-5.85413792049559	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCATTAAGTCAAGCG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2406.95186470121	51.1897697195411	0.0212674671522339	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2404.17967196681	2404.17967196681
"healthy-4"	"2019-08-01-count-3:GCAGCTGTCAGACCGC"	-4.10112367096599	10.6533212431702	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCTGTCAGACCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2321.02821958634	41.1380184589096	0.017724049243245	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2316.49138229433	2316.49138229433
"healthy-4"	"2019-08-01-count-3:AGATGCTAGCACCTGC"	10.7764612632686	5.99404189670411	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATGCTAGCACCTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.0785349466	47.3373880270737	0.0250055067199887	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.35279164531	1886.35279164531
"healthy-4"	"2019-08-01-count-4:GTTAGACGTAGAGACC"	-1.64144263687785	8.87794206226198	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTAGACGTAGAGACC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1873.58501426092	46.0120845022199	0.0245583115535169	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1873.58501426092	1873.58501426092
"healthy-4"	"2019-08-01-count-4:TTACAGGAGCAATTCC"	11.40718617019	4.69588849628297	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGAGCAATTCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2228.11219811569	41.3953633645026	0.0185786709482182	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2212.28512488483	2212.28512488483
"healthy-4"	"2019-08-01-count-2:ATGGAGGAGGTTCCAT"	4.20197166976277	-6.61552383815917	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGAGGAGGTTCCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.80025205236	43.6937697635851	0.0183294593269577	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2382.48845412818	2382.48845412818
"healthy-4"	"2019-08-01-count-4:TTACAGGCAACTCGAT"	10.4778706031734	7.32257411563722	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGCAACTCGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.15637353488	44.5673593723006	0.0229119673763347	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.51751062294	1940.51751062294
"healthy-4"	"2019-08-01-count-4:TTACAGGCACGACGCT"	6.83354916152303	-1.64609255706938	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTACAGGCACGACGCT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2819.7223905097	31.7940632990058	0.0112756005364268	2092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2807.76368354327	2807.76368354327
"healthy-4"	"2019-08-01-count-4:TCTATACCAGTTGGTT"	2.4954842525417	-6.15004684841307	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTATACCAGTTGGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.62989605218	50.8447989974032	0.0238749461076111	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2121.14193683053	2121.14193683053
"healthy-4"	"2019-08-01-count-4:GCTACAATCGCAGTTA"	9.99249710616414	6.6391620405945	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTACAATCGCAGTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1921.56123491402	40.3977444107859	0.0210233968487575	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1916.49387345695	1916.49387345695
"healthy-4"	"2019-08-01-count-3:GCCAGGTAGCGCCATC"	0.582511623471421	8.34202096546022	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGGTAGCGCCATC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1972.95884493746	41.1883769918657	0.0208764501588838	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1963.77972294215	1963.77972294215
"healthy-4"	"2019-08-01-count-3:ATAGGCTTCCTTGACC"	10.680120130151	6.6144490011963	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGGCTTCCTTGACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1964.61758357165	48.8957507505305	0.024888177301986	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1947.61531220277	1947.61531220277
"healthy-4"	"2019-08-01-count-2:GTGTGGCGTACTTCCC"	-0.627677838236648	8.81181523883668	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGGCGTACTTCCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2108.66736263535	40.5757812464309	0.0192423812145129	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2103.36452155858	2103.36452155858
"healthy-4"	"2019-08-01-count-3:ACAGAAAGTTTACGAC"	11.4822021919185	3.73589966380922	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAGAAAGTTTACGAC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2127.56266330969	43.4098936466635	0.0204035793611521	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.19107278816	2104.19107278816
"healthy-4"	"2019-08-01-count-2:TCCCAGTCATGCCGAC"	3.33051671561543	-6.01700165187987	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCCAGTCATGCCGAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.6309200683	40.4552747080712	0.014476070674507	2290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2788.59045577116	2788.59045577116
"healthy-4"	"2019-08-01-count-3:GACTCAAGTCTGCGCA"	3.60759343680684	-6.44227173244628	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTCAAGTCTGCGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.75913857177	42.9781440882986	0.0166468449539696	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2577.78587066402	2577.78587066402
"healthy-4"	"2019-08-01-count-4:GCGAGAACAATCCTTT"	2.1350425678188	-5.96970465099486	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGAGAACAATCCTTT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2670.40936038775	42.3349890296364	0.0158533705197503	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2660.49459991629	2660.49459991629
"healthy-4"	"2019-08-01-count-4:TCCATGCTCCTATGGA"	0.626395125954789	7.96216724002687	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCATGCTCCTATGGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1894.21952211506	38.8050348943125	0.020486028383333	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1881.81943780864	1881.81943780864
"healthy-4"	"2019-08-01-count-3:ACAACCACATCGCCTT"	11.5318132835323	3.99313423717348	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAACCACATCGCCTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2431.31253503402	36.513305396469	0.015017939845384	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2414.61961996449	2414.61961996449
"healthy-4"	"2019-08-01-count-3:ATCGTAGGTCGTACAT"	-3.95922980728801	2.67664287174074	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTAGGTCGTACAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3213.35199733237	42.2924835736688	0.0131614848322807	4943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3205.1357637136	3205.1357637136
"healthy-4"	"2019-08-01-count-3:GTCAAGTGTATCCTCC"	3.64212908324544	-6.57434847271117	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCAAGTGTATCCTCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.92180808967	43.3848998319164	0.0196853171798875	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2197.71145832651	2197.71145832651
"healthy-4"	"2019-08-01-count-4:CTAGACACATATAGCC"	3.62163486060445	-6.46611215984496	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAGACACATATAGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2836.98949987204	41.0446930975541	0.014467692989137	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2834.133521211	2834.133521211
"healthy-4"	"2019-08-01-count-4:CCGGGTACATCTGTTT"	3.11485375937764	-6.32978918468627	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTACATCTGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.13002681486	46.2109567698962	0.0191339415504848	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2411.19111824125	2411.19111824125
"healthy-4"	"2019-08-01-count-2:CGAGGAACAAGCAGGT"	3.039558549493	-6.54751112377318	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAACAAGCAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.33729766023	49.6302160223705	0.0235399791472876	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2097.65187382161	2097.65187382161
"healthy-4"	"2019-08-01-count-2:TTGTGGATCAGATGCT"	3.0993980365688	-6.27416660701903	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGGATCAGATGCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.54752592586	44.7124413485205	0.0208396415405555	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2137.93555979859	2137.93555979859
"healthy-4"	"2019-08-01-count-2:TGAGCGCGTGAGCTCC"	-2.45216427269633	9.65734956348268	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCGCGTGAGCTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2312.27468088101	42.3365792437464	0.0183094939341789	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2303.03846813009	2303.03846813009
"healthy-4"	"2019-08-01-count-4:TCAGCCTTCCGTTTCG"	3.48157038268391	-6.68592407619628	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAGCCTTCCGTTTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.76834323491	47.8758436016994	0.020453046428138	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2336.23161928856	2336.23161928856
"healthy-4"	"2019-08-01-count-2:GACTCAAAGGTTCTTG"	11.2241054969722	6.3312835463318	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTCAAAGGTTCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.16351617614	44.7750686236313	0.0229832189402232	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1937.95073599518	1937.95073599518
"healthy-4"	"2019-08-01-count-4:TTCCTAAAGGATTCCT"	3.11477055129353	-6.59513904964598	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTAAAGGATTCCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.34127338677	47.5676559272788	0.024080728007937	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1973.50428401914	1973.50428401914
"healthy-4"	"2019-08-01-count-2:TCAGCAATCACTGCTC"	0.00975330647770759	7.52396390521852	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGCAATCACTGCTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.73859642602	50.6044298122321	0.0248947060390378	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2024.58262484048	2024.58262484048
"healthy-4"	"2019-08-01-count-3:ACACCAAAGAGCATAT"	0.583691139786881	8.06239698016969	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACACCAAAGAGCATAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.0186094073	42.0018904518826	0.0234776151746111	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1784.71737365489	1784.71737365489
"healthy-4"	"2019-08-01-count-3:ATCGTGAGTAGCTGCC"	11.513332982629	4.32475802982179	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTGAGTAGCTGCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.22478604919	41.3921178706523	0.0212788353137947	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1936.26059660615	1936.26059660615
"healthy-4"	"2019-08-01-count-4:TGGTACAGTCCTGTTC"	-6.09505162659343	3.05547902667848	"2019-08-01-count-4"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGTACAGTCCTGTTC"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2810.15422898697	41.8430966722878	0.0148899644868857	2864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2797.37210273356	2797.37210273356
"healthy-4"	"2019-08-01-count-3:CTAAGTGTCCTCTCTT"	11.0403562980587	6.30381343448488	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTAAGTGTCCTCTCTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1829.89420512487	43.295957167069	0.023660360826223	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1821.19845443088	1821.19845443088
"healthy-4"	"2019-08-01-count-3:ATACCTTTCTCTCTAA"	3.60616364058797	-6.32297136699828	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTTCTCTCTAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2790.48953658194	45.6366151430509	0.0163543401775127	2366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2786.37651342433	2786.37651342433
"healthy-4"	"2019-08-01-count-2:CGAGGCTTCGTGGCTG"	-7.23311887207683	-1.44706013118895	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGCTTCGTGGCTG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3176.49011343651	43.3842748055719	0.0136579284859276	3116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3166.395284509	3166.395284509
"healthy-4"	"2019-08-01-count-2:TTTATGCGTGCCTTTC"	11.1995464759762	4.28214070880739	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTATGCGTGCCTTTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.45286890651	44.1059266622575	0.023257064483595	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1883.83552565003	1883.83552565003
"healthy-4"	"2019-08-01-count-3:CCAATGAGTATCGTTG"	0.114984867244405	7.61208913410035	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCAATGAGTATCGTTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.43428921555	43.0619381614065	0.0225640140741271	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1898.34476194992	1898.34476194992
"healthy-4"	"2019-08-01-count-2:TATGTTCTCCTTCTTC"	5.69165291365926	-9.86805441295775	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATGTTCTCCTTCTTC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2839.2172972864	46.3463365655893	0.0163236313789315	2173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2833.34518870051	2833.34518870051
"healthy-4"	"2019-08-01-count-2:TGAGGTTGTTCACCGG"	-0.00634293901975754	8.04324576938478	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGTTGTTCACCGG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1845.41338016262	41.7256951523068	0.0226104869515089	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1828.91715141428	1828.91715141428
"healthy-4"	"2019-08-01-count-4:TTCCTCTTCTACCAGA"	11.5318075614864	4.09759519183961	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCCTCTTCTACCAGA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2274.6595555785	37.6686832834577	0.0165601411389572	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2252.94721051257	2252.94721051257
"healthy-4"	"2019-08-01-count-2:TGAGGTTGTCTGTAGT"	2.93789615210835	-6.09507181560668	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGGTTGTCTGTAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.99392528929	44.5040389039382	0.0167245924468241	2225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2647.70455612469	2647.70455612469
"healthy-4"	"2019-08-01-count-4:GTTGAACCATGTTTGG"	4.31219114836995	-7.31334831630858	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACCATGTTTGG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.60156960942	42.7430397236708	0.0166990988875636	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2556.33689941968	2556.33689941968
"healthy-4"	"2019-08-01-count-3:AGTCACAAGCTGAAAT"	11.063719411462	6.20525834644166	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCACAAGCTGAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.90120658343	45.8684573797762	0.0247683068711851	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1845.72568831339	1845.72568831339
"healthy-4"	"2019-08-01-count-4:GTGCACGTCCTTTAGT"	11.2802883583004	4.69662902438966	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGTCCTTTAGT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1992.34571442066	37.5797206229032	0.0188620480626931	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1975.76663197314	1975.76663197314
"healthy-4"	"2019-08-01-count-3:TCTCAGCCAGTCAGTT"	10.4288889366085	7.73584077442018	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCAGCCAGTCAGTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2213.68426372775	45.0755819493991	0.0203622452795024	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2203.16291004662	2203.16291004662
"healthy-4"	"2019-08-01-count-3:ATAGAGAGTTTCAGAC"	10.9883467155391	6.72776887500612	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGAGAGTTTCAGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.25191835875	43.1908448535661	0.0229463678226594	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1877.56090343997	1877.56090343997
"healthy-4"	"2019-08-01-count-3:GTGTGATCAGCATACT"	10.0822798210079	6.70823857868043	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGTGATCAGCATACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1790.20523421392	40.5775028165572	0.0226663971488022	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1781.20474955968	1781.20474955968
"healthy-4"	"2019-08-01-count-2:GGGTGAATCCCTCTAG"	4.54858793792073	-6.55122949993285	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTGAATCCCTCTAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2797.47661819852	43.1192815214449	0.0154136342877505	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2793.5496643741	2793.5496643741
"healthy-4"	"2019-08-01-count-4:TACCTGCCAGCGTTTA"	11.1968580680782	6.17783067310182	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACCTGCCAGCGTTTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1919.80779182264	43.1524044000955	0.0224774608082652	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1910.02444593845	1910.02444593845
"healthy-4"	"2019-08-01-count-2:TTCTTCCCAAACACCT"	3.09035338935201	-6.15240671550902	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTTCCCAAACACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.17750910698	42.9404099355796	0.0155346065128257	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2750.96902832307	2750.96902832307
"healthy-4"	"2019-08-01-count-4:CGACAGCTCCACAAGT"	-2.71814928475078	-5.65773775493773	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCTCCACAAGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2838.58294398355	46.5856816573367	0.016411597820693	2502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2833.84674213823	2833.84674213823
"healthy-4"	"2019-08-01-count-4:CTAAGTGAGTTCAACC"	5.19572844085042	-7.97961714183959	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTAAGTGAGTTCAACC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.58034156783	46.8481514758787	0.0177685279440492	1893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2632.36263260978	2632.36263260978
"healthy-4"	"2019-08-01-count-2:CGTGAATGTGTAAACA"	0.0609719102153599	7.7101464041504	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTGAATGTGTAAACA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.26355479305	42.9537565694901	0.0244296461997393	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1750.26051878406	1750.26051878406
"healthy-4"	"2019-08-01-count-4:GGGACAAGTCTCTCCA"	5.06831183013265	-7.47352793132933	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGACAAGTCTCTCCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2897.34401978945	43.6615114019186	0.0150694950629617	2677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2887.63310374097	2887.63310374097
"healthy-4"	"2019-08-01-count-2:TTTACGTTCGATGGAG"	-7.10235152664836	3.35738966548768	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTACGTTCGATGGAG"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2346.44939496843	43.7254797048325	0.0186347422614758	2090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2336.6397875605	2336.6397875605
"healthy-4"	"2019-08-01-count-3:CTCCTTTTCATCAGTG"	11.5098349052364	4.07548425281373	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTTTTCATCAGTG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2281.98315438813	40.1813211275176	0.017608070879161	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2271.44425925562	2271.44425925562
"healthy-4"	"2019-08-01-count-3:ATTCTACGTTGTCCCT"	5.11743416365926	-7.66455891048583	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATTCTACGTTGTCCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2830.03957866477	41.7634382136839	0.0147571922769321	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2826.67613818942	2826.67613818942
"healthy-4"	"2019-08-01-count-2:GCTACAATCTGAATCG"	-2.50686273995097	3.4266478785309	"2019-08-01-count-2"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCTACAATCTGAATCG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3245.04491703584	43.0944106568504	0.0132800659955779	5363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3237.79592064283	3237.79592064283
"healthy-4"	"2019-08-01-count-2:TGATTTCCACTCACTC"	11.2804895835811	6.10122344577638	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGATTTCCACTCACTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2145.94200452071	43.4527789602079	0.0202488132804469	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2138.34895022902	2138.34895022902
"healthy-4"	"2019-08-01-count-3:AGCTCAACAGCTGTAT"	-3.77431998673137	10.8616161116394	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTCAACAGCTGTAT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2097.57803646841	47.9123468810209	0.0228417470282482	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2094.14966440227	2094.14966440227
"healthy-4"	"2019-08-01-count-3:CAGTTAGCAAGCGATG"	3.28123726424519	-6.51794674312743	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTAGCAAGCGATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.45604440023	48.9095649407491	0.0212423446952229	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2297.29597870361	2297.29597870361
"healthy-4"	"2019-08-01-count-2:ATGAGTCTCACCCTTG"	3.13517846640889	-6.44177582180174	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGAGTCTCACCCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2134.70162071844	43.3522294762283	0.0203083321132431	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2129.80096722675	2129.80096722675
"healthy-4"	"2019-08-01-count-3:GTCGTAACACCGTGAC"	-4.37999902191814	10.2714881666931	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTCGTAACACCGTGAC"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2095.65063806762	46.9991509731283	0.0224269971909372	1104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2094.05499841176	2094.05499841176
"healthy-4"	"2019-08-01-count-4:TCTAACTAGACTCGAG"	0.390348007052582	7.90651366794435	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTAACTAGACTCGAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.76704892876	44.8864070211283	0.0231999025650044	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1926.41575942838	1926.41575942838
"healthy-4"	"2019-08-01-count-4:GTTGTGACAATCACGT"	4.18748631057088	-6.44993879711302	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGTGACAATCACGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.70179970375	47.1285398456235	0.018212508045177	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2584.35645996152	2584.35645996152
"healthy-4"	"2019-08-01-count-2:TGGGAGACAAGAGTGC"	3.24147166785542	-6.5974536172119	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGACAAGAGTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.34983219496	40.3849748726399	0.0201486657787749	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1996.98615768857	1996.98615768857
"healthy-4"	"2019-08-01-count-2:GTCTGTCCAACTTGGT"	2.83536519584004	-6.27199270641478	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCTGTCCAACTTGGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2810.64772388574	41.4052532582253	0.0147315698464631	2433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2805.79776341659	2805.79776341659
"healthy-4"	"2019-08-01-count-3:CAGTTCCGTGAGGAAA"	11.2137791114742	6.07429263675538	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGTTCCGTGAGGAAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1836.95791879248	40.275674843386	0.0219252027666813	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1824.76295871907	1824.76295871907
"healthy-4"	"2019-08-01-count-2:TCTTCCTCATCCGTTC"	-0.0841473442619622	7.64258477771608	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTCATCCGTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2290.90675700137	44.4389161933246	0.0193979593702416	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2285.90351394803	2285.90351394803
"healthy-4"	"2019-08-01-count-4:ATGAGGGCAGACACAG"	11.5363842445308	4.06571862781373	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGAGGGCAGACACAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2314.58846452769	46.149379870592	0.0199384817551181	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2298.17696883833	2298.17696883833
"healthy-4"	"2019-08-01-count-4:TACTGCCCAGGATTCT"	11.4646631675655	4.37737462604371	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TACTGCCCAGGATTCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2113.54543839236	39.0936419370692	0.0184967123142643	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2094.25235404238	2094.25235404238
"healthy-4"	"2019-08-01-count-3:CTTAGGACAATAAGGT"	4.17384447631184	-6.44598295604857	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTAGGACAATAAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.37606676897	49.339726812365	0.0229874566606764	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2140.9514223804	2140.9514223804
"healthy-4"	"2019-08-01-count-3:TAACACGGTGTCCGGT"	10.6181408363277	6.33016822421876	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACACGGTGTCCGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.67244110496	47.3653508425514	0.0253335021692671	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1860.31557042518	1860.31557042518
"healthy-4"	"2019-08-01-count-4:GTGCACGGTCGGAAAC"	-3.44364986839946	-5.48911192333373	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGCACGGTCGGAAAC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2764.39305326274	47.3549827446142	0.0171303363277963	2240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2760.79363238738	2760.79363238738
"healthy-4"	"2019-08-01-count-2:GGCGTCATCAATCTTC"	14.366830487817	2.07385680759279	"2019-08-01-count-2"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCGTCATCAATCTTC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1331.35991418733	37.9245934085397	0.0284856055859915	2048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1312.76977826152	1312.76977826152
"healthy-4"	"2019-08-01-count-2:GCGAGAATCATGCAGT"	10.7849708991939	4.90392158115236	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGAGAATCATGCAGT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1593.11456746534	46.5984708449074	0.0292499182397446	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1588.57144627259	1588.57144627259
"healthy-4"	"2019-08-01-count-3:AAGCCATCAGTAGATA"	-1.40714166584666	8.59026334369508	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAGCCATCAGTAGATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1993.20245399252	44.5710108821872	0.0223615071278426	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1984.46778802135	1984.46778802135
"healthy-4"	"2019-08-01-count-2:GTCGAATCACTATCGA"	3.55627145346944	-6.47830583965453	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGAATCACTATCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.9365491695	43.0508199652091	0.017702279272011	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2429.16363426405	2429.16363426405
"healthy-4"	"2019-08-01-count-2:TTCATTGAGACGCAGT"	3.37071575698201	-6.16680242931517	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCATTGAGACGCAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.62183488343	48.1063155685477	0.0178328611321559	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2694.31360235314	2694.31360235314
"healthy-4"	"2019-08-01-count-4:GGGTGAACACTCTCGT"	-3.99153552475627	11.1018171080383	"2019-08-01-count-4"	"Control4"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGGTGAACACTCTCGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2158.27944775668	47.4171093144811	0.0219698655629448	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2151.16731102782	2151.16731102782
"healthy-4"	"2019-08-01-count-3:GTAGTACCACGTAGAG"	-4.05281768265422	2.78787300670473	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGTACCACGTAGAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2970.29779776674	50.4816666049444	0.0169954900289459	3428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2955.27249149124	2955.27249149124
"healthy-4"	"2019-08-01-count-2:CTAGGTAGTTGACTAC"	11.1747213798458	5.98427817905275	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTAGGTAGTTGACTAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.20150728621	45.3071326370892	0.0235337093107488	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.4598929106	1917.4598929106
"healthy-4"	"2019-08-01-count-2:GTCACGGAGACCTCCG"	0.0717049307072579	7.71287486636964	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCACGGAGACCTCCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.54892593478	38.8102682721127	0.0192172953938954	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2016.73316961527	2016.73316961527
"healthy-4"	"2019-08-01-count-4:TTGGTTTCATACACCA"	-0.316363404423553	7.8684625395569	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGTTTCATACACCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2148.65732357909	45.1141486120043	0.0209964372247391	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2141.29924532946	2141.29924532946
"healthy-4"	"2019-08-01-count-2:TTCTCTCGTCAAGCGA"	0.483298678963822	7.69226214969484	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCGTCAAGCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.57957459832	42.3636252218196	0.0227568167377215	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1856.16736281102	1856.16736281102
"healthy-4"	"2019-08-01-count-4:GGTGAAGCAGGCGTTC"	-0.581105689436752	7.83838889682619	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTGAAGCAGGCGTTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.59505802663	46.3410454740689	0.0230255188639422	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2006.10706973089	2006.10706973089
"healthy-4"	"2019-08-01-count-3:CGAGGCTAGGGAGTTC"	-2.64172134819682	3.86652062023012	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGCTAGGGAGTTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3338.43003367523	44.7714035878789	0.0134109156508488	4473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3331.65180536562	3331.65180536562
"healthy-4"	"2019-08-01-count-3:TCAGTTTCATTGACAC"	2.72698273238484	-6.18596270000609	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCAGTTTCATTGACAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.84718734916	42.3958149218058	0.0163700063574793	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2583.99700269362	2583.99700269362
"healthy-4"	"2019-08-01-count-4:TGCATGACAGTCTACA"	10.7398630577022	6.22232816303102	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCATGACAGTCTACA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1897.88910151989	44.5488467837089	0.023472839771319	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1896.07534993625	1896.07534993625
"healthy-4"	"2019-08-01-count-2:TGGAGGATCAGGAAAT"	9.70208038863484	5.78178498828737	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGAGGATCAGGAAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1429.24808759624	41.8183400953371	0.0292589792200938	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1426.92061713742	1426.92061713742
"healthy-4"	"2019-08-01-count-2:TACAGGTAGGTAAGTT"	2.37488259848897	-6.28891470348509	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACAGGTAGGTAAGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.58708393208	46.3657527342416	0.0201014533798573	1341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2300.95018909881	2300.95018909881
"healthy-4"	"2019-08-01-count-3:AGGATCTTCTCTCTTC"	10.379712720483	7.07129237735597	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGATCTTCTCTCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2064.78204044899	51.622596993774	0.0250014752077893	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2057.3261685932	2057.3261685932
"healthy-4"	"2019-08-01-count-2:TGAATGCAGTCTAGAA"	11.2673756080562	4.76646850192872	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCAGTCTAGAA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1901.86741807699	44.2364713813931	0.0232594927285317	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1883.16590582239	1883.16590582239
"healthy-4"	"2019-08-01-count-4:CCTCCTCCAGTGTGGA"	10.2924477058345	7.12680146777955	"2019-08-01-count-4"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCCTCCAGTGTGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1971.29465285553	42.9961974885499	0.0218111470176554	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1969.64257055509	1969.64257055509
"healthy-4"	"2019-08-01-count-2:TTTGACTGTTGCCAAT"	-0.159021983773071	7.85988614642946	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGACTGTTGCCAAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.85567961833	41.572734492597	0.0213977471042851	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1936.02418024151	1936.02418024151
"healthy-4"	"2019-08-01-count-2:GTTCTATCATGGCACC"	11.1761433082515	6.39193103397218	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTCTATCATGGCACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1937.64479085058	45.7379229685326	0.0236049059066469	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1926.94472574481	1926.94472574481
"healthy-4"	"2019-08-01-count-2:ATCCCTGTCTCCGCAT"	5.46255697783772	-9.75954725658568	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCCCTGTCTCCGCAT"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.39704112799	44.6940960451832	0.0159999081359145	2120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2790.563860556	2790.563860556
"healthy-4"	"2019-08-01-count-4:TCCTTTCTCTAAGCGT"	1.29107882556264	-6.69341757213744	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCCTTTCTCTAAGCGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2188.37131618411	53.0190858476446	0.0242276461291289	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2181.97946106242	2181.97946106242
"healthy-4"	"2019-08-01-count-2:CTGCATCAGGTGATAT"	2.77154507216756	-5.88309671795043	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCATCAGGTGATAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.02279869877	47.1723984596223	0.0180804853384758	2078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2602.58554667521	2602.58554667521
"healthy-4"	"2019-08-01-count-2:TGGGAGATCAATCTCT"	4.71899904784505	-6.77534105693968	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAGATCAATCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2775.57840479235	47.5467313978134	0.0171303867027206	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2771.40511026957	2771.40511026957
"healthy-4"	"2019-08-01-count-4:GTCTACCAGTCGTCTA"	4.70474400100057	-7.01170637523802	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCTACCAGTCGTCTA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2763.33717306467	39.1184562211533	0.0141562371043448	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2753.74630841289	2753.74630841289
"healthy-4"	"2019-08-01-count-4:TTTCACATCCGTGGGT"	0.16715102371518	7.6567811735901	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTTCACATCCGTGGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.14677575184	42.6376992766617	0.0221018430596317	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1921.10564051236	1921.10564051236
"healthy-4"	"2019-08-01-count-2:GGTGTCGCAAGTGTCT"	4.68911613997762	-6.94498350536498	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGTCGCAAGTGTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2681.09477089355	41.2022029491402	0.0153676786797837	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2679.13865258814	2679.13865258814
"healthy-4"	"2019-08-01-count-2:TCGTGCTAGAGTCAAT"	-8.27206740799602	-0.893497609254442	"2019-08-01-count-2"	"Control4"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCGTGCTAGAGTCAAT"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3140.28591192894	45.9468953473672	0.0146314369570075	3793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3132.91177031097	3132.91177031097
"healthy-4"	"2019-08-01-count-4:TCACAAGGTCACTTCC"	11.5758167701656	3.73046705806581	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCACAAGGTCACTTCC"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2196.28315458885	34.7499876654189	0.0158221801195412	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2185.70858078455	2185.70858078455
"healthy-4"	"2019-08-01-count-2:CCTTTGGAGCTGGCCT"	10.9862371879512	6.21507737720338	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGAGCTGGCCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1903.40659239047	43.0836143212156	0.0226350032060713	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1895.0880019235	1895.0880019235
"healthy-4"	"2019-08-01-count-3:GGAGGTATCAACTGAC"	10.4665075736934	6.42014787280885	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAGGTATCAACTGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.16101198351	48.2490956882526	0.0254994661567802	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1883.82443946703	1883.82443946703
"healthy-4"	"2019-08-01-count-2:TTACAGGTCTTAGCCC"	-7.14753518524821	3.45817325198976	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACAGGTCTTAGCCC"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2491.29294765454	43.0271988668809	0.0172710314567339	2327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2472.28149440424	2472.28149440424
"healthy-4"	"2019-08-01-count-2:TTCTAGTTCCTCACTG"	11.007790227502	6.10357472980348	"2019-08-01-count-2"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAGTTCCTCACTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1970.51805389828	48.3584222078006	0.024540968864575	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1964.28816750335	1964.28816750335
"healthy-4"	"2019-08-01-count-4:TAAGCGTCATGACTCA"	11.3906322914058	4.10125348651735	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAAGCGTCATGACTCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1989.3026810267	38.0673137395347	0.0191360088651204	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1979.87539212383	1979.87539212383
"healthy-4"	"2019-08-01-count-3:CCTAAGAAGGCGAAGG"	-7.58488355103191	0.056146671575956	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTAAGAAGGCGAAGG"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3178.98425961087	43.4042524142795	0.0136534971140727	4262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3175.72734962533	3175.72734962533
"healthy-4"	"2019-08-01-count-3:TCGCACTCAGCACGAA"	4.27933563765828	-7.40846731578978	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGCACTCAGCACGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.41872722731	46.4991737447052	0.0205165855656299	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2260.31989744352	2260.31989744352
"healthy-4"	"2019-08-01-count-3:AGGTCATCAGAATGTA"	-1.73047862473186	9.19384000385133	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCATCAGAATGTA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1715.222653925	42.2444303606495	0.0246291233758954	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1713.21508563231	1713.21508563231
"healthy-4"	"2019-08-01-count-2:TTCAGGATCAGTCTTT"	-7.60941253128703	3.0786311396393	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCAGGATCAGTCTTT"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2596.43798132971	41.530352308043	0.0159951258634624	2513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2585.72647418477	2585.72647418477
"healthy-4"	"2019-08-01-count-2:GCACTAAAGGTTAGTA"	6.75868906554524	-1.63380255615386	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCACTAAAGGTTAGTA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2828.40533455928	35.2288790523064	0.012455385591965	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2812.49652354918	2812.49652354918
"healthy-4"	"2019-08-01-count-3:ATACCTTTCTCAATCT"	-1.95729861679729	9.0638799437317	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTTCTCAATCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.65217203451	46.7323254413159	0.0227557159277946	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2046.53826316924	2046.53826316924
"healthy-4"	"2019-08-01-count-2:CGAGGAATCATTTCGT"	-7.14721761170085	3.4124500521454	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAATCATTTCGT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2561.17501694896	45.7603281862804	0.0178669274389507	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2547.87758646603	2547.87758646603
"healthy-4"	"2019-08-01-count-2:TTGTGTTGTTCAGCGC"	-0.371337483555633	7.63342568958131	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTGTTGTTCAGCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.1440377948	43.828750737616	0.0233610798822951	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1872.51245581518	1872.51245581518
"healthy-4"	"2019-08-01-count-3:GCAGCTGTCGGAATTC"	11.0092588859493	5.55984542453615	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCAGCTGTCGGAATTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1600.82205183552	47.8236051438959	0.0298744042718932	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1587.98194296711	1587.98194296711
"healthy-4"	"2019-08-01-count-2:TTCTCTCAGCGTCTCG"	4.83319153365437	-7.51199152385863	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTCTCAGCGTCTCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.21768359967	48.8209084706676	0.0192722910418396	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2528.4517526826	2528.4517526826
"healthy-4"	"2019-08-01-count-3:GCCAACGTCACGACTA"	11.4672972160274	3.71585915172426	"2019-08-01-count-3"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAACGTCACGACTA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2170.67798691781	45.8359610628014	0.021115965306252	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2152.32828373595	2152.32828373595
"healthy-4"	"2019-08-01-count-4:TTGCTGCGTTTAGACC"	2.77718128737752	-6.00315906917723	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCGTTTAGACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.95044120016	38.3676223024694	0.0142686238149279	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2684.09510767136	2684.09510767136
"healthy-4"	"2019-08-01-count-2:GGAGATGAGTAGACAT"	-1.84113142910655	8.67151639545289	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGAGATGAGTAGACAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.98909539682	48.067391266692	0.0233905821565492	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2050.59882122526	2050.59882122526
"healthy-4"	"2019-08-01-count-4:TGGGCGTCATCATCTT"	-3.80335817757304	10.4936036833557	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTCATCATCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2212.83802732102	48.6706989791484	0.021994695670551	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2205.11508104789	2205.11508104789
"healthy-4"	"2019-08-01-count-3:ATAGAGATCCATTCGC"	6.7912126975948	-1.73519637500914	"2019-08-01-count-3"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATAGAGATCCATTCGC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2990.64298547319	37.1950236211234	0.0124371326841068	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2978.72506313633	2978.72506313633
"healthy-4"	"2019-08-01-count-2:GTAATGCGTACCAATC"	11.1944986778194	6.08888576114503	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAATGCGTACCAATC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2002.28716122115	50.152038983662	0.0250473757985221	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1994.52278401014	1994.52278401014
"healthy-4"	"2019-08-01-count-2:GTCCCATTCAAACTGC"	4.08844818648641	-6.33188059246215	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCCCATTCAAACTGC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2730.56137125208	40.5156714784163	0.0148378541881438	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2727.11896681405	2727.11896681405
"healthy-4"	"2019-08-01-count-2:TATTCCATCACCCTTG"	11.2947708564693	5.88734052265016	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTCCATCACCCTTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2098.80904908835	43.172850266699	0.0205701658688063	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2081.5532364093	2081.5532364093
"healthy-4"	"2019-08-01-count-4:CTCAACCCAACGCATT"	6.82292522963826	-1.73080708896788	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAACCCAACGCATT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3125.26156072717	33.9191124351163	0.0108532075719205	2595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3114.32919558148	3114.32919558148
"healthy-4"	"2019-08-01-count-3:ATATCCTCACTCAAGT"	-2.32054219666179	8.84389779651491	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATATCCTCACTCAAGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.40629113477	46.240695287151	0.0223449090133937	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2063.98169873886	2063.98169873886
"healthy-4"	"2019-08-01-count-3:CTCCGATTCTCGCGTT"	4.10135855254476	-6.56521179592284	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCGATTCTCGCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.79499384446	26.0752678165882	0.0105023845630574	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2478.32145239562	2478.32145239562
"healthy-4"	"2019-08-01-count-4:GAGATGGTCACGGACC"	4.71360315856282	-6.77210380947264	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGATGGTCACGGACC"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2853.60424257281	40.5699896272055	0.014217104468077	2321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2844.91508009407	2844.91508009407
"healthy-4"	"2019-08-01-count-4:AGGATAAGTCTGCCTT"	3.88695945319478	-7.34882738506468	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.AGGATAAGTCTGCCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2005.39182767421	45.9935153499807	0.0229349270877017	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1999.67280177586	1999.67280177586
"healthy-4"	"2019-08-01-count-2:ATCGTCCTCCACGTCT"	11.3755661445553	6.05612418735353	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCGTCCTCCACGTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2224.40078294047	37.1423977010674	0.016697709327349	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2214.04325946518	2214.04325946518
"healthy-4"	"2019-08-01-count-2:TTAGGGTAGCACTCGC"	0.205474500625771	7.83612773502199	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAGGGTAGCACTCGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.23298186489	38.7718886277454	0.0214537301038721	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1799.75107629469	1799.75107629469
"healthy-4"	"2019-08-01-count-3:AAAGGGCGTAGTCACT"	2.25022806701009	-6.19995548641356	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAAGGGCGTAGTCACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.00961773047	51.0841443537095	0.023219964104706	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2197.54182513841	2197.54182513841
"healthy-4"	"2019-08-01-count-3:TAACACGCAAGGTCAG"	11.3372074562008	5.29453513706056	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TAACACGCAAGGTCAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2289.68064876904	40.717310129882	0.0177829646906315	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2280.67958417534	2280.67958417534
"healthy-4"	"2019-08-01-count-4:TGGGCGTGTAACGCGA"	0.35319091853444	7.7708472975525	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGGCGTGTAACGCGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.5470617591	37.7213117215291	0.0201767115110952	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1858.58437076581	1858.58437076581
"healthy-4"	"2019-08-01-count-2:TATTGGGCAATTGCTG"	10.0702015357906	6.30413529956666	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGGGCAATTGCTG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1798.59994253986	50.1522470716023	0.0278840479672098	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1793.33192053535	1793.33192053535
"healthy-4"	"2019-08-01-count-4:GGTCACGGTGTCATTG"	-4.14857755127605	-3.93754031574401	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGTCACGGTGTCATTG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3070.81239506388	38.142214205061	0.0124208871458159	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3061.94651460392	3061.94651460392
"healthy-4"	"2019-08-01-count-3:CATGCTCGTCAGCGTC"	-4.19847665253337	12.7509040602478	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATGCTCGTCAGCGTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2094.71229322188	45.462233729677	0.0217033307518101	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2092.8964570096	2092.8964570096
"healthy-4"	"2019-08-01-count-2:GCAACCGCATTCTTCA"	5.49820961531941	-9.49479200756224	"2019-08-01-count-2"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGCATTCTTCA"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2744.63179574209	40.5895696405844	0.0147887121702639	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2738.15293337492	2738.15293337492
"healthy-4"	"2019-08-01-count-2:TGAGCGCAGAGTCTTC"	10.7407375770504	6.65983579242555	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCGCAGAGTCTTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.33180969369	41.4790213120093	0.0214546831040767	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1926.88155665399	1926.88155665399
"healthy-4"	"2019-08-01-count-4:CCTTTGGGTTTCGACA"	11.4352690177852	4.39755914295045	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTTTGGGTTTCGACA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2071.32733367505	35.1709527505233	0.016979910504112	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2054.40334970721	2054.40334970721
"healthy-4"	"2019-08-01-count-3:GATCATGCACTCATAG"	11.0315958457882	6.20497605884401	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GATCATGCACTCATAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.04858543674	48.8131720948447	0.0254493929223018	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1911.9651497285	1911.9651497285
"healthy-4"	"2019-08-01-count-4:GGCGTCACACACAGCC"	3.6403783756191	-6.86657907879027	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GGCGTCACACACAGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.00491393219	47.0763479794455	0.0243413797143517	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1930.57455806121	1930.57455806121
"healthy-4"	"2019-08-01-count-4:TTGGGCGAGGCATGCA"	3.39508785781209	-6.27126314556273	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGGGCGAGGCATGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.00125910911	44.4737082094487	0.0183927564313323	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2413.27918091359	2413.27918091359
"healthy-4"	"2019-08-01-count-3:CTCCTCCGTACGACTT"	10.9211355644161	7.11220834338991	"2019-08-01-count-3"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCTCCGTACGACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2060.81500615926	46.0827283868425	0.0223614095632616	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2060.81500615926	2060.81500615926
"healthy-4"	"2019-08-01-count-4:TCGTGCTAGGCTGTAG"	11.4856544929439	3.88012168491212	"2019-08-01-count-4"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTGCTAGGCTGTAG"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1905.70051583002	33.5492354693556	0.0176046735521522	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1899.45488370075	1899.45488370075
"healthy-4"	"2019-08-01-count-2:GTAGCTAAGTTTCAGC"	2.77874841269795	-6.10776665126952	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTAAGTTTCAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.49050153411	48.6490905239807	0.0213420895990747	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2274.16208628681	2274.16208628681
"healthy-4"	"2019-08-01-count-2:CGAGTGCAGTAGATCA"	-2.42430315437968	8.98448083484498	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGTGCAGTAGATCA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1995.66217626959	43.8445557333981	0.0219699287057466	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1990.19135703334	1990.19135703334
"healthy-4"	"2019-08-01-count-2:TCCGGGAAGACTTCCA"	11.549782415002	3.69291040981141	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGGGAAGACTTCCA"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2112.40134323117	42.5670663736704	0.0201510316730621	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2100.73328313892	2100.73328313892
"healthy-4"	"2019-08-01-count-3:TCTACCGGTGGTCTGC"	-4.84645162048991	-5.11705305492552	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTACCGGTGGTCTGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2859.00293824103	48.3171973110934	0.0169000166683354	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2857.06574216437	2857.06574216437
"healthy-4"	"2019-08-01-count-2:CTCCCTCCAAATCAAG"	0.122706641524476	7.99256894672243	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCCTCCAAATCAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2186.04845454802	42.3226919093531	0.0193603631343586	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2179.41948738941	2179.41948738941
"healthy-4"	"2019-08-01-count-2:TAAGTCGTCTTCCCGA"	2.86260976371114	-5.91495993053588	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGTCTTCCCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.50238655824	46.0120427202659	0.0175384032261655	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2619.55254162305	2619.55254162305
"healthy-4"	"2019-08-01-count-3:ATACCTTTCTACCAGA"	5.0474931198055	-7.52956297313841	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCTTTCTACCAGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.53936411552	42.8596169500762	0.015736734895328	1974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2721.51269003074	2721.51269003074
"healthy-4"	"2019-08-01-count-2:TTGTTCAAGCAGCCCT"	11.2263847785885	3.81706020915834	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCAAGCAGCCCT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1452.90505966915	44.4477348887826	0.0305923188807011	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1435.82263287284	1435.82263287284
"healthy-4"	"2019-08-01-count-4:GCGGATCTCCACACAA"	-1.87374697151836	8.6556768187317	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCGGATCTCCACACAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2124.56036508907	40.3406520120095	0.0189877645629139	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2119.85939776841	2119.85939776841
"healthy-4"	"2019-08-01-count-3:GAAGAATGTTAAGCAA"	2.63889398154561	-6.77340128338011	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAAGAATGTTAAGCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.16947309811	48.4236939368281	0.026243493967805	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1843.4746425816	1843.4746425816
"healthy-4"	"2019-08-01-count-3:AACCAACGTGTTCGAT"	-1.19993899288829	9.04766557300416	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACGTGTTCGAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1732.48173578752	46.6462671360279	0.0269245361566969	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1732.48173578752	1732.48173578752
"healthy-4"	"2019-08-01-count-4:TGCTCCAAGAAGGCTC"	2.31124319609944	-6.17153170025023	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCCAAGAAGGCTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.31988432392	45.9583132516422	0.0202074974450237	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2269.75347337198	2269.75347337198
"healthy-4"	"2019-08-01-count-2:TGCAGATCAGACCAAG"	-3.95773921433147	-5.35748865520629	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGATCAGACCAAG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2903.3577687141	48.6111474593778	0.0167430786461111	2275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2899.53621677955	2899.53621677955
"healthy-4"	"2019-08-01-count-3:GGAATGGGTACCACGC"	5.5838700729305	-9.9237327805725	"2019-08-01-count-3"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GGAATGGGTACCACGC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2650.0614397281	45.3446963189985	0.0171108094473655	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2641.35800617355	2641.35800617355
"healthy-4"	"2019-08-01-count-4:TCGTGGGCACCAGCGT"	-3.59062228623088	3.24668524349061	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTGGGCACCAGCGT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3175.68406794219	43.3088762677779	0.0136376526572562	4044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3167.83855861621	3167.83855861621
"healthy-4"	"2019-08-01-count-3:AGTGACTAGTTGCTCA"	11.0057684379512	6.00405833804933	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTAGTTGCTCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.20512153556	43.1709467050422	0.0223082019702319	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1923.44586349303	1923.44586349303
"healthy-4"	"2019-08-01-count-3:AACCAACCATCCGGCA"	0.31711839613263	8.13027284229127	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AACCAACCATCCGGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2051.55891585813	43.6592870901359	0.0212810301242916	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2043.51782373134	2043.51782373134
"healthy-4"	"2019-08-01-count-2:TAGACCAGTCTACTGA"	-8.17390666428264	-0.22451832210692	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGACCAGTCTACTGA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3222.37434522643	46.321358575944	0.0143749153926091	5040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3206.68001681976	3206.68001681976
"healthy-4"	"2019-08-01-count-2:GAAGGGTCACGTACAT"	10.5675169425899	7.51950166309205	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTCACGTACAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1918.88476908602	42.8248842906669	0.0223175903944794	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1917.36294311832	1917.36294311832
"healthy-4"	"2019-08-01-count-2:GTGTGATCAACCACGC"	2.23877586898152	-6.23098232662352	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGATCAACCACGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.3937944262	40.8803238121042	0.0186976032937529	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2182.83320680278	2182.83320680278
"healthy-4"	"2019-08-01-count-4:CGACAGCGTTCGGACC"	11.3618265586788	4.78036735141603	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGACAGCGTTCGGACC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1830.16872441939	43.504325239696	0.0237706636875775	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1823.51032388043	1823.51032388043
"healthy-4"	"2019-08-01-count-3:CCCTCTCGTCTGCATA"	-2.73094282570537	8.84164331043092	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCTCTCGTCTGCATA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2178.00868506123	41.8999008521239	0.0192377106388563	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2170.33025587088	2170.33025587088
"healthy-4"	"2019-08-01-count-3:CTGTGAAAGCACTAAA"	-4.3732684654301	12.6481885679993	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGAAAGCACTAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2175.19417445422	40.797801580907	0.0187559354746542	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2166.83499773508	2166.83499773508
"healthy-4"	"2019-08-01-count-2:GACTTCCTCTTTGCAT"	4.60525764998738	-7.2218342057434	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACTTCCTCTTTGCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2839.91234033382	43.9764491261742	0.0154851431509344	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2828.05116604134	2828.05116604134
"healthy-4"	"2019-08-01-count-2:TTGGATGTCTTCCGTG"	-4.34006581726726	12.7791709669861	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGGATGTCTTCCGTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2009.95378116344	46.3898151426418	0.0230800407339664	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2002.99979393297	2002.99979393297
"healthy-4"	"2019-08-01-count-3:GTTATGGTCTACACAG"	0.0411676532471597	7.92062852466432	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTATGGTCTACACAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.63512926537	44.7588319319465	0.0220201015359422	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2020.20393084648	2020.20393084648
"healthy-4"	"2019-08-01-count-2:GATGCTACAATACGCT"	-1.16310511055644	8.29988858783571	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTACAATACGCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2329.74474030528	39.7756792812006	0.0170729773923595	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2320.67324757536	2320.67324757536
"healthy-4"	"2019-08-01-count-2:TAAGTCGCATACTTTC"	2.04080512103383	-6.12569096004637	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGCATACTTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.7845311828	44.3195650139425	0.0176939630783387	1621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2490.34075346019	2490.34075346019
"healthy-4"	"2019-08-01-count-2:TTACCATAGCCGCACT"	-1.41324232044871	8.65833280170289	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACCATAGCCGCACT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.67207441804	49.6940896819478	0.0255671161488631	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1938.82425363783	1938.82425363783
"healthy-4"	"2019-08-01-count-2:TAGGTACCAACGGCCT"	5.01982369002644	-8.019895576593	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTACCAACGGCCT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.41555301383	50.5212545187626	0.020335267365991	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2482.12827126531	2482.12827126531
"healthy-4"	"2019-08-01-count-2:CATCCACGTGCTTATG"	10.971958776086	6.39429996097413	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATCCACGTGCTTATG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1902.68862644184	50.537716616693	0.0265612123362518	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1893.79715427421	1893.79715427421
"healthy-4"	"2019-08-01-count-2:ATCAGGTCACATTCTT"	11.4933849769527	4.44044015491334	"2019-08-01-count-2"	"Control4"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATCAGGTCACATTCTT"	"Pro-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2314.40539530326	41.7376014775665	0.0180338334685301	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2292.90867332494	2292.90867332494
"healthy-4"	"2019-08-01-count-2:GTTACAGTCTGGGATT"	-1.42219744148906	8.57099244678346	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTACAGTCTGGGATT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.41063968628	34.9800178253934	0.0194938756223096	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1788.70687886549	1788.70687886549
"healthy-4"	"2019-08-01-count-2:TCCGAAAGTCAATCTG"	-3.2126034301823	9.59577748859254	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGAAAGTCAATCTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2107.98030338932	46.6203125357098	0.0221161044345392	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2101.09889115724	2101.09889115724
"healthy-4"	"2019-08-01-count-2:TGGGAAGGTGCAATAA"	-1.89935324612315	4.14505574786989	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAAGGTGCAATAA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3291.27245865651	44.9960700788629	0.0136713294460071	5601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3285.84708475787	3285.84708475787
"healthy-4"	"2019-08-01-count-4:ATGACCATCCTACTGC"	9.9773289161617	6.70033166492311	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATGACCATCCTACTGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1899.65809692096	47.6761228808256	0.0250972124710761	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1890.39451696739	1890.39451696739
"healthy-4"	"2019-08-01-count-4:TGCTCCAAGATCACTC"	-2.617668013007	8.70663163745729	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCTCCAAGATCACTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2011.34512043653	42.8499613770124	0.0213041317184355	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2007.72731113961	2007.72731113961
"healthy-4"	"2019-08-01-count-2:ATGGATCCACGCAAAG"	2.45924295958821	-5.92969515239867	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATGGATCCACGCAAAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2691.62559159342	42.9303217357583	0.0159495889286533	2042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2689.67369663129	2689.67369663129
"healthy-4"	"2019-08-01-count-2:TGCTTGCTCACGTCCT"	-4.25708327713664	12.6072673567566	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTGCTCACGTCCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1969.85449508219	45.060002361394	0.0228747871854941	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1964.27179960035	1964.27179960035
"healthy-4"	"2019-08-01-count-2:CTACTATCACTCCTTG"	4.63277449187581	-8.01396658336791	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTACTATCACTCCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.28807611053	40.9347295432231	0.0155392001028461	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2630.7192702966	2630.7192702966
"healthy-4"	"2019-08-01-count-2:TAGGTTGAGCTAATGA"	-1.63234291496928	8.89727304065553	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGGTTGAGCTAATGA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1964.06999881966	46.4581477291533	0.0236540183176125	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1951.61635506912	1951.61635506912
"healthy-4"	"2019-08-01-count-3:GCATCGGAGTGCAGGT"	4.63843454894368	-7.47749330913695	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCGGAGTGCAGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.215539807	43.8554815405244	0.0169246752602413	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.96068713683	2589.96068713683
"healthy-4"	"2019-08-01-count-3:GAGTGTTTCACGTAGT"	-3.24762282791789	-5.70693161403807	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTGTTTCACGTAGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2962.03329704664	46.2007267917398	0.0155976392425451	2549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2956.13346718063	2956.13346718063
"healthy-4"	"2019-08-01-count-4:TGAGGGATCCGAAGGA"	10.902381558984	6.89642760837404	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGATCCGAAGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2168.2945284621	46.2629836621223	0.0213361160372134	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2161.85174254142	2161.85174254142
"healthy-4"	"2019-08-01-count-3:GCACGTGGTTTCTATC"	4.63933004912679	-6.75566580211791	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGTGGTTTCTATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.76076271659	43.0920911744667	0.0173146779795057	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2482.36762546745	2482.36762546745
"healthy-4"	"2019-08-01-count-2:GCGATCGCAGAGGTAC"	6.54361738738362	-1.65161945736083	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCGATCGCAGAGGTAC"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2946.59692517192	39.7754339298911	0.0134987699166117	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2937.39846770647	2937.39846770647
"healthy-4"	"2019-08-01-count-2:TAAGTCGGTCGTGGAA"	-2.76724610748943	9.86860654437868	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAAGTCGGTCGTGGAA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2098.7933935711	47.9167409334414	0.0228306135707389	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.45274414371	2087.45274414371
"healthy-4"	"2019-08-01-count-4:CCGGTGACACGACGTC"	3.2898220020229	-5.55147840892943	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGTGACACGACGTC"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2806.87949540338	42.807577498048	0.0152509495217557	3046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2800.52980845048	2800.52980845048
"healthy-4"	"2019-08-01-count-4:CTTCCTTCAACAAGTA"	-4.48592744293864	-4.80111458217772	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTCCTTCAACAAGTA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3257.08213435165	39.7796164478751	0.0122132678289962	3364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3251.84405161898	3251.84405161898
"healthy-4"	"2019-08-01-count-4:CGTAAGTCATGTACGT"	11.233903546899	5.90398738468019	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGTAAGTCATGTACGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1855.91631765736	43.0899630014301	0.0232176217168136	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1846.84391569461	1846.84391569461
"healthy-4"	"2019-08-01-count-3:GACCCTTTCCGAGGCT"	-0.183954696089584	7.65356586063234	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCCTTTCCGAGGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1982.67901998698	48.653739574307	0.0245393929546027	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1975.91834013981	1975.91834013981
"healthy-4"	"2019-08-01-count-2:GTCGAATAGTAACGTA"	0.383672078221482	7.69956157291261	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTCGAATAGTAACGTA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1831.30470480199	41.9786914634019	0.0229228327505121	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1828.32206671218	1828.32206671218
"healthy-4"	"2019-08-01-count-2:GTGGAGAGTCCAGCCA"	-7.30371032181438	2.83671376788942	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAGAGTCCAGCCA"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2632.1262098014	44.8038314778324	0.0170219160885955	2589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2624.92260837145	2624.92260837145
"healthy-4"	"2019-08-01-count-4:TTCATGTGTAAGATTG"	4.93413319167439	-7.2419586411682	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTCATGTGTAAGATTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2856.03906088863	46.4064664960097	0.0162485405509723	2451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2851.19516210161	2851.19516210161
"healthy-4"	"2019-08-01-count-2:TTCTAACGTAGGACTG"	-7.12828193131145	3.01539061153261	"2019-08-01-count-2"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCTAACGTAGGACTG"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2861.85755548682	45.7858988714404	0.015998664498049	2910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2840.73198253517	2840.73198253517
"healthy-4"	"2019-08-01-count-2:ATTATCCTCCCTTGGT"	10.7905489402706	6.99360606754152	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ATTATCCTCCCTTGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2067.84271203278	49.1241358398874	0.0237562245687421	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2060.74076839016	2060.74076839016
"healthy-4"	"2019-08-01-count-4:TCGAAGTGTAACCCTA"	10.9136997657711	6.00163838947145	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGAAGTGTAACCCTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1947.40071032202	42.6893095435242	0.0219211738586997	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.47872223419	1940.47872223419
"healthy-4"	"2019-08-01-count-3:AGATCCAAGACGTCGA"	-1.91745267334636	8.82392308795778	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGATCCAAGACGTCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.95090602907	45.890521369964	0.0243199339332769	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1886.95090602907	1886.95090602907
"healthy-4"	"2019-08-01-count-2:TGCGACGTCATTACTC"	-3.24081311646159	-4.8054089776245	"2019-08-01-count-2"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCGACGTCATTACTC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3139.78269548194	42.2306928854465	0.0134501960744657	3484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3132.19780462681	3132.19780462681
"healthy-4"	"2019-08-01-count-4:TCTCCGAGTATGGGAC"	0.339980532496613	7.91366145694581	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCTCCGAGTATGGGAC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1889.84749101414	37.9436128661223	0.0200776057573624	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1883.49237769377	1883.49237769377
"healthy-4"	"2019-08-01-count-4:GTTGCGGCAGTCTTCC"	-2.80240331116374	3.41591212833253	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGCGGCAGTCTTCC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3310.53292573067	46.5798349311584	0.0140701923152985	5390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3302.41246868955	3302.41246868955
"healthy-4"	"2019-08-01-count-3:CTTCGGTAGCATGGGT"	3.36480273780171	-6.22164442455443	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTCGGTAGCATGGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.51763316583	45.5550526126926	0.0204694188595981	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2222.76999810153	2222.76999810153
"healthy-4"	"2019-08-01-count-3:AGACAAACATAACCCA"	1.47799267348592	-6.03296472942504	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAAACATAACCCA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2722.14870595091	46.6010279403429	0.0171192072785987	2265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2719.5847234893	2719.5847234893
"healthy-4"	"2019-08-01-count-3:CACGTGGAGTGCCTCG"	3.19288386878316	-5.17661573803099	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CACGTGGAGTGCCTCG"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2748.77558585214	42.8225427876051	0.0155787700560247	2478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2742.83663576118	2742.83663576118
"healthy-4"	"2019-08-01-count-4:GATAGCTGTGAGTTTC"	5.51380600508992	-9.91219618236693	"2019-08-01-count-4"	"Control4"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATAGCTGTGAGTTTC"	"CD16+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.8159508872	43.8087616157476	0.0171811465845229	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2543.0389794145	2543.0389794145
"healthy-4"	"2019-08-01-count-4:GTTATGGCATTAAGCC"	10.4094635444576	7.69850776279298	"2019-08-01-count-4"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTATGGCATTAAGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2033.74520110423	40.7714429758185	0.020047468558835	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2024.06669505996	2024.06669505996
"healthy-4"	"2019-08-01-count-2:CCTTGTGCAATCCAGT"	4.89669146117513	-7.89593365108641	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTGTGCAATCCAGT"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.48958678263	42.9094006461323	0.0156575674846875	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2738.45832681279	2738.45832681279
"healthy-4"	"2019-08-01-count-2:CGAGGAATCGTGACTA"	10.3304077583248	7.60813186252443	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGGAATCGTGACTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2028.68416622941	42.7863321837801	0.0210906817808434	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2018.55355545999	2018.55355545999
"healthy-4"	"2019-08-01-count-3:CAATACGAGCCTCCAG"	-2.12521038475688	3.48460075939027	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAATACGAGCCTCCAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3211.93019749504	44.2143056746971	0.0137656496113083	5633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3202.52660486512	3202.52660486512
"healthy-4"	"2019-08-01-count-2:TTGTTCAAGGTTCAGG"	9.32886566695515	6.69110057437745	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGTTCAAGGTTCAGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1687.30882213547	40.6195913474288	0.0240735962584611	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1676.82015097879	1676.82015097879
"healthy-4"	"2019-08-01-count-2:TAGAGTCGTGAGGCAT"	10.693379064172	6.21357486331788	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TAGAGTCGTGAGGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1777.62877115366	43.4039056329471	0.0244167434378205	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1774.11939158551	1774.11939158551
"healthy-4"	"2019-08-01-count-3:CTCAGGGTCCAACTAG"	-2.32846532288249	3.77066347682802	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCAGGGTCCAACTAG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3264.66594817728	45.2965829399466	0.0138747987264169	4754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3258.91030706602	3258.91030706602
"healthy-4"	"2019-08-01-count-4:GTCATGAAGCATCAAA"	-3.0064528984135	10.3913240202698	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTCATGAAGCATCAAA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1983.33108447562	44.0707440530654	0.0222205684154431	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1976.61493466999	1976.61493466999
"healthy-4"	"2019-08-01-count-4:TGTCCTGTCAAACGTC"	-4.28835616532024	11.8390626677307	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGTCAAACGTC"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2236.76883783808	50.3287739025071	0.0225006594562323	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2233.27501528468	2233.27501528468
"healthy-4"	"2019-08-01-count-3:TGACGCGCATGGAGAC"	10.8549143272335	7.12471721256105	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACGCGCATGGAGAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.59432161717	43.719446273019	0.0216262213469445	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2017.59629115074	2017.59629115074
"healthy-4"	"2019-08-01-count-2:GTGTCCTCACACGGTC"	0.353720476000947	7.81996390903322	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTCCTCACACGGTC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.96845874558	43.198307131363	0.0221193060942264	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1947.48843428638	1947.48843428638
"healthy-4"	"2019-08-01-count-3:GTAACCAGTTATCTGG"	10.0596090751583	7.29339644992677	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAACCAGTTATCTGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1908.96012933391	41.54892426374	0.0217652132306386	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1903.64282007736	1903.64282007736
"healthy-4"	"2019-08-01-count-3:CTACTATAGCATATGA"	-2.41000400009807	3.95266792857973	"2019-08-01-count-3"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTACTATAGCATATGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3382.06539396353	42.8239289695931	0.0126620641475553	5008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3373.84035436927	3373.84035436927
"healthy-4"	"2019-08-01-count-3:GACTGATGTAACGCGA"	3.70834674414937	-6.55671169674071	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACTGATGTAACGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.64967930643	36.6159543149483	0.0176833168260567	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2067.50135107432	2067.50135107432
"healthy-4"	"2019-08-01-count-4:GCACATAGTCCTGTTC"	2.14899363097493	-6.1339526406494	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCACATAGTCCTGTTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.67034270525	46.973947412848	0.0197895834850059	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2369.67048525756	2369.67048525756
"healthy-4"	"2019-08-01-count-2:TGCTTCGGTTGCTCCT"	0.232733015983742	7.76740930164186	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGGTTGCTCCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.85341587975	33.9156291017143	0.0176841612716041	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1908.91350647963	1908.91350647963
"healthy-4"	"2019-08-01-count-4:GCAACCGAGAGAGTTT"	-2.08737550202068	3.8477618464264	"2019-08-01-count-4"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCAACCGAGAGAGTTT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3084.87186126551	41.4640355236764	0.0134410884433516	4380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3079.90087662701	3079.90087662701
"healthy-4"	"2019-08-01-count-4:GTTGAACGTAAGATCA"	10.6810738044674	6.8659629591736	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACGTAAGATCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1985.87755954241	41.7730281960989	0.0210350471988436	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1977.54297902115	1977.54297902115
"healthy-4"	"2019-08-01-count-2:TGAGCGCGTGGTATGG"	10.5784889656002	7.59404561603395	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAGCGCGTGGTATGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2201.505220124	46.8034074344391	0.0212597303911016	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2196.57567319305	2196.57567319305
"healthy-4"	"2019-08-01-count-3:GCCATGGAGACCTTTG"	2.34400310096089	-6.03962900554808	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCATGGAGACCTTTG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2526.71259228339	40.0303271068461	0.015842849411959	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2522.48367573954	2522.48367573954
"healthy-4"	"2019-08-01-count-4:GTTGAACTCTCCGAGG"	-1.88848946514781	8.71515748584596	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTGAACTCTCCGAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.55106822529	43.5957757509249	0.0211573381622	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2058.99582179659	2058.99582179659
"healthy-4"	"2019-08-01-count-2:TATTGCTAGCCTGACC"	0.230414782732171	7.59840438449708	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATTGCTAGCCTGACC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1969.65744728806	43.5366894672813	0.022103685860313	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1962.63648608915	1962.63648608915
"healthy-4"	"2019-08-01-count-2:CGTCCATGTCTCCTGT"	4.43847384032552	-6.97225954448851	"2019-08-01-count-2"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGTCCATGTCTCCTGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.74806634123	47.5022774037934	0.0183212083042169	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2582.78134839867	2582.78134839867
"healthy-4"	"2019-08-01-count-3:TCTCTGGTCTTACGGA"	10.8147179084713	6.12447354877321	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGTCTTACGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.99274020431	41.8383143552271	0.0225301442754289	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1847.15888860892	1847.15888860892
"healthy-4"	"2019-08-01-count-2:GAGACTTAGAATCGTA"	10.2982489067012	7.52988956058351	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGACTTAGAATCGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2112.81150156439	41.7019551697589	0.019737660051018	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2104.44453815491	2104.44453815491
"healthy-4"	"2019-08-01-count-2:TTATTGCTCTGTCGCT"	-0.193797360092956	7.76615808093873	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTATTGCTCTGTCGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.73468271025	43.3095235286729	0.0216036186245462	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1997.26986643316	1997.26986643316
"healthy-4"	"2019-08-01-count-4:GACCGTGAGGTCACCC"	-2.25709710541423	8.81852815234987	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCGTGAGGTCACCC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2047.61509956866	47.0653197932882	0.0229854330548758	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2041.11121763342	2041.11121763342
"healthy-4"	"2019-08-01-count-3:ATCGTGAGTACGACAG"	10.252551694482	7.20457313144533	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATCGTGAGTACGACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1979.40765257725	47.846873598372	0.0241723191966414	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1966.68781154171	1966.68781154171
"healthy-4"	"2019-08-01-count-3:CCTTTGGGTGCGCTCA"	-1.85312066498454	3.75388166988222	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTTGGGTGCGCTCA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3120.68772119375	43.5895087560248	0.0139679175394553	5003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3112.31706950028	3112.31706950028
"healthy-4"	"2019-08-01-count-4:CTTAGGAAGGCGAACT"	11.4700132804805	4.36895797336427	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTAGGAAGGCGAACT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2229.36709565734	34.343096014606	0.0154048635962664	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2221.43584768569	2221.43584768569
"healthy-4"	"2019-08-01-count-3:CTTACCGAGGTTGTTC"	-3.9563549560612	-4.59344675457152	"2019-08-01-count-3"	"Control4"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTTACCGAGGTTGTTC"	"DC precursor"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3328.3043806874	39.8392326481079	0.0119698285046513	4379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	3322.93197235401	3322.93197235401
"healthy-4"	"2019-08-01-count-2:CCTTTGGCACCAGCCA"	3.68881930884663	-6.76966955578002	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CCTTTGGCACCAGCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.76122831608	52.3089840786822	0.0231480137915552	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2255.66489469049	2255.66489469049
"healthy-4"	"2019-08-01-count-2:TCTTAGTCATGCAGGA"	2.57414712485616	-6.21862366115721	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTAGTCATGCAGGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.77423334033	45.0350995678586	0.022463925772241	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2004.77423334033	2004.77423334033
"healthy-4"	"2019-08-01-count-2:TCCGAAAAGGTTAGTA"	2.71389784392659	-6.26657583629759	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGAAAAGGTTAGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.34307365017	45.5432280737626	0.0189736328001254	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2395.2591621196	2395.2591621196
"healthy-4"	"2019-08-01-count-3:GTAGATCAGATCCAAA"	-4.33160338822063	12.7160453566345	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGATCAGATCCAAA"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2046.38060178222	42.3411647624594	0.0206907574893859	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2042.71509155901	2042.71509155901
"healthy-4"	"2019-08-01-count-3:CCTCATGGTGAGTTTC"	5.14470161971394	-7.69880440151366	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTCATGGTGAGTTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2856.22162598396	42.387614308649	0.0148404500277693	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2851.80807577372	2851.80807577372
"healthy-4"	"2019-08-01-count-3:GAGCTGCGTACAGTCT"	0.137178299098653	7.64930532062379	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCGTACAGTCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1847.73550255207	35.1228982751379	0.0190086179686576	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1843.04189003673	1843.04189003673
"healthy-4"	"2019-08-01-count-2:TGCAGATTCGATGGAG"	5.0003797012264	-8.23211958324584	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCAGATTCGATGGAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2839.34713578465	42.8271727570348	0.015083457819327	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2834.78559738569	2834.78559738569
"healthy-4"	"2019-08-01-count-4:CCTCACAAGGGTAATT"	2.31522192534749	-6.05606844341429	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACAAGGGTAATT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.75418961563	51.1556243936677	0.0209417814576411	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2439.29189092689	2439.29189092689
"healthy-4"	"2019-08-01-count-2:CAGATCACATCGATCA"	5.05964293059651	-7.39946844494017	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGATCACATCGATCA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2910.68875158886	46.536350055039	0.01598808874004	2457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2900.82690720695	2900.82690720695
"healthy-4"	"2019-08-01-count-3:CTGTGGGCATGGCTGC"	0.631400545209092	7.9926137694153	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGTGGGCATGGCTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.58445806127	32.0343250519088	0.0170071083963398	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1881.02706222932	1881.02706222932
"healthy-4"	"2019-08-01-count-3:ATGAGTCTCCGTATGA"	3.92612518843953	-6.04628803646239	"2019-08-01-count-3"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATGAGTCTCCGTATGA"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2876.39383607607	43.8284423368105	0.0152372883668116	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2871.57507934164	2871.57507934164
"healthy-4"	"2019-08-01-count-3:GTTACAGAGCACTCCG"	-4.26547799530681	12.3779840239319	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTACAGAGCACTCCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.62345871288	46.6387848790293	0.0235237733489279	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1971.57693699424	1971.57693699424
"healthy-4"	"2019-08-01-count-4:CCCTCAACAAATCAAG"	10.8810106712276	6.74674413287965	"2019-08-01-count-4"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAACAAATCAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.05359589447	35.8444195649281	0.0178414451651149	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2001.32719243747	2001.32719243747
"healthy-4"	"2019-08-01-count-3:ACAAGCTGTGATCGTT"	2.75802053984944	-6.16450264370116	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACAAGCTGTGATCGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.78724306316	44.3676290555318	0.0169809574711167	2046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2608.17859021217	2608.17859021217
"healthy-4"	"2019-08-01-count-4:GACTTCCGTATGGTTC"	5.06465830382649	-7.58927395260008	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTTCCGTATGGTTC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2902.52355514617	43.0297230230901	0.0148249349938258	2340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2898.19545506132	2898.19545506132
"healthy-4"	"2019-08-01-count-2:GCAGCTGCAGTCGCAC"	10.8139130073482	6.57962749088136	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAGCTGCAGTCGCAC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1856.35661652218	43.0602146103102	0.0231960897098436	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1849.08353969986	1849.08353969986
"healthy-4"	"2019-08-01-count-2:GTGTGATAGGTTGGTG"	4.35450424727742	-6.81153490459593	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGTGATAGGTTGGTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.40903108291	45.1107435132556	0.017046020846897	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2641.07724067118	2641.07724067118
"healthy-4"	"2019-08-01-count-2:GAACACTGTCCCGGTA"	9.98134102401082	7.16967675769655	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACACTGTCCCGGTA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.59667993505	45.0433823636385	0.0243926477573993	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1844.88747892436	1844.88747892436
"healthy-4"	"2019-08-01-count-2:TTGATGGTCAGGCGAA"	2.44721951064412	-6.21671774303588	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTGATGGTCAGGCGAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.3827544639	46.5441532339834	0.0185185297190882	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2509.98326506685	2509.98326506685
"healthy-4"	"2019-08-01-count-4:ATCACGAAGTCATCCA"	3.38320221480672	-6.17802622234496	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCACGAAGTCATCCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.27347099682	43.6416841942991	0.0163619083940385	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2656.78533673838	2656.78533673838
"healthy-4"	"2019-08-01-count-4:GTAATGCAGGTTCCAT"	2.86331595954244	-6.3854060403076	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTAATGCAGGTTCCAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.79175581472	42.8376201340122	0.0177323314523711	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2415.79175581472	2415.79175581472
"healthy-4"	"2019-08-01-count-3:CCTTTGGGTTTGGAAA"	-1.50439403477367	8.55608079517213	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTTTGGGTTTGGAAA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.15809168569	42.9644169580842	0.0224104715956456	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1912.61509375762	1912.61509375762
"healthy-4"	"2019-08-01-count-4:GCTTCACCAAACACCT"	2.1399356323177	-6.25942804729613	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GCTTCACCAAACACCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.49314695623	49.6560897200084	0.0201404290177449	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2461.60481875022	2461.60481875022
"healthy-4"	"2019-08-01-count-2:CTGTGGGTCTCAAAGC"	-0.00790453973467949	8.04006002033082	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGGGTCTCAAAGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1915.8753833521	41.6336698949147	0.021730886182206	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1903.72359801511	1903.72359801511
"healthy-4"	"2019-08-01-count-4:GAACGTTCACAACGTT"	0.0070587704772174	7.79010055148927	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAACGTTCACAACGTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.7163480632	39.1335391835663	0.0205455994659568	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1897.00921682422	1897.00921682422
"healthy-4"	"2019-08-01-count-4:CCGGGTACACACGGAA"	-3.36637793007548	10.0148925551209	"2019-08-01-count-4"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCGGGTACACACGGAA"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2153.06825175279	47.3487541173336	0.0219912926953373	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2147.16695830549	2147.16695830549
"healthy-4"	"2019-08-01-count-3:GCACGTGGTTGCACGC"	-3.4437612098759	3.37862989986268	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCACGTGGTTGCACGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3355.20837627935	48.8910934280103	0.0145717010525071	5405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3344.73428145962	3344.73428145962
"healthy-4"	"2019-08-01-count-4:TCATTGTTCCGTAGGC"	-0.345684776932555	7.69347379291383	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCATTGTTCCGTAGGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.57379881545	41.4454588190085	0.0204006661452191	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2022.57206508823	2022.57206508823
"healthy-4"	"2019-08-01-count-2:GGTAACTTCCGGTAAT"	10.7244383293087	6.97652957523195	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTAACTTCCGGTAAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.93391587213	40.9171584390971	0.0215474367470575	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1892.26132161134	1892.26132161134
"healthy-4"	"2019-08-01-count-4:GTGATGTCACCTGCAG"	11.1613718467647	5.91739795291749	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGATGTCACCTGCAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.62142072891	49.841850535431	0.0257364965614556	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.4988251135	1927.4988251135
"healthy-4"	"2019-08-01-count-2:TCTCAGCAGCTCCACG"	3.21676172789876	-6.35070993816527	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTCAGCAGCTCCACG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.83517255029	50.8656872321349	0.0218698589790267	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2321.8980652982	2321.8980652982
"healthy-4"	"2019-08-01-count-3:GACCAATTCGCCTTTG"	-3.01963386955913	10.5439691313538	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GACCAATTCGCCTTTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2017.94012409981	38.8085350266303	0.0192317574556096	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2012.45270901011	2012.45270901011
"healthy-4"	"2019-08-01-count-4:TGAGGGAGTACCCGCA"	-0.334056149155456	7.59015891635744	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGAGTACCCGCA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1999.35841863253	39.7466787521931	0.0198797166039784	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1991.35062365464	1991.35062365464
"healthy-4"	"2019-08-01-count-2:TTTGATCTCGAACTCA"	2.58479156073872	-6.08419229900511	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTTGATCTCGAACTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.73665322379	45.3368976008108	0.0179641950925814	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2520.42091499669	2520.42091499669
"healthy-4"	"2019-08-01-count-4:CCCTCAACAGGCAATG"	0.169385639100712	8.04364297473756	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCCTCAACAGGCAATG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2099.55865485097	48.95833289252	0.0233183925485498	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2096.96022907943	2096.96022907943
"healthy-4"	"2019-08-01-count-2:GTTTACTTCGATACTG"	3.96215428885762	-6.35555794155272	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTTTACTTCGATACTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.43785148514	42.3941281870332	0.0156468354362864	2138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2704.08634409707	2704.08634409707
"healthy-4"	"2019-08-01-count-3:GCCAGTGGTGCGGCTT"	-7.40326533737834	-0.729671739694201	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCCAGTGGTGCGGCTT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3368.54309766511	48.1130174917865	0.0142830345632614	4918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3353.34698995841	3353.34698995841
"healthy-4"	"2019-08-01-count-3:TATTTCGAGCCATATC"	-2.68379340592082	3.41951034152833	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATTTCGAGCCATATC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3325.24205751693	46.0879435806687	0.0138600266637684	5460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3316.16958020214	3316.16958020214
"healthy-4"	"2019-08-01-count-2:CTGGTCTGTATACCTG"	-4.29443583908732	10.0150975950989	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGGTCTGTATACCTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2184.75468805183	42.6902340621224	0.0195400583395428	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2176.99235635239	2176.99235635239
"healthy-4"	"2019-08-01-count-4:TGTTCTATCTATCGCC"	4.23894466933553	-7.20309164440306	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTCTATCTATCGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.70080407346	40.6557560297995	0.0170485773143334	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2379.41030578633	2379.41030578633
"healthy-4"	"2019-08-01-count-3:ACTTTGTTCGCCCAGA"	0.0832287232274234	7.74598071658937	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTTTGTTCGCCCAGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1961.62795504173	44.5628377795127	0.0227172730002028	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1950.18240074032	1950.18240074032
"healthy-4"	"2019-08-01-count-2:GGCACGTGTATCAGCT"	11.1774307685787	6.05373094165651	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGCACGTGTATCAGCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1799.20306799741	45.5450639241318	0.025314020820799	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1792.13335641206	1792.13335641206
"healthy-4"	"2019-08-01-count-3:CGAGGAATCTTACGGA"	5.06483997878377	-7.42729570781859	"2019-08-01-count-3"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGAATCTTACGGA"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2742.04528177409	44.3287434631302	0.0161663061357068	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2737.97931010073	2737.97931010073
"healthy-4"	"2019-08-01-count-4:TGATTTCCAAGTTTGC"	4.96879925307576	-7.49489071285399	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGATTTCCAAGTTTGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.14170917365	42.0774608827072	0.0152171083106196	2110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2757.54126808985	2757.54126808985
"healthy-4"	"2019-08-01-count-3:GTAGCTAGTTGAGAGC"	-5.07814202728923	-5.15234854137572	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTAGCTAGTTGAGAGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2562.64136964678	46.8878042644575	0.018296670310493	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2561.52868936046	2561.52868936046
"healthy-4"	"2019-08-01-count-3:ACCACAATCATGAGGG"	-2.48652778092082	3.39044807041017	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACCACAATCATGAGGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3161.45783046815	42.666824656398	0.0134959335042213	5094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3151.4475818049	3151.4475818049
"healthy-4"	"2019-08-01-count-3:AGGTCTAGTCTCTCTG"	-3.85949573937114	10.9806232222351	"2019-08-01-count-3"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTCTAGTCTCTCTG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2101.29564670484	47.9408737019005	0.0228149112558622	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2093.48053736203	2093.48053736203
"healthy-4"	"2019-08-01-count-3:GAGCTGCGTCTACTGA"	11.1078716712887	5.51194140994874	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGCTGCGTCTACTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.83100061512	44.1473468013826	0.0233604733899556	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1886.41313243843	1886.41313243843
"healthy-4"	"2019-08-01-count-3:GCATCTCTCACTCACC"	11.2488523918087	6.25198791110841	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCTCACTCACC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2155.08431327002	40.8215707497863	0.0189419831504623	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2147.80845617384	2147.80845617384
"healthy-4"	"2019-08-01-count-3:CCCGGAACAGCTACCG"	2.42884840545003	-6.73957207119139	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGGAACAGCTACCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1654.07859580028	37.8858304216875	0.0229044922761711	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1651.70003193526	1651.70003193526
"healthy-4"	"2019-08-01-count-2:TACCCACAGTTTCGGT"	4.20154728469197	-6.79793217098387	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACAGTTTCGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.26500414482	48.7998693794587	0.0213634886017651	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2282.69136519024	2282.69136519024
"healthy-4"	"2019-08-01-count-3:AGGCCACTCCGTGACG"	4.49358524855916	-6.64012863552245	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGCCACTCCGTGACG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2576.61839288739	41.7688545904996	0.0162107259289153	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2574.22618613546	2574.22618613546
"healthy-4"	"2019-08-01-count-4:GTGTTCCGTCAAGCGA"	2.14296617087666	-6.14832022106322	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCGTCAAGCGA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.71866890284	46.3206847280662	0.0199940913628512	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2312.40944976466	2312.40944976466
"healthy-4"	"2019-08-01-count-4:GTGTTCCGTAGATCGG"	-2.67909608307536	8.82571218097535	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTGTTCCGTAGATCGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.01141035386	36.7498425626942	0.0181479681422004	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2023.2707912894	2023.2707912894
"healthy-4"	"2019-08-01-count-3:AGCTTCCCACGACTAT"	-0.25507147136386	7.97452685916749	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCCACGACTAT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2179.88251070565	47.6351259841202	0.0218521529257557	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2173.15321015054	2173.15321015054
"healthy-4"	"2019-08-01-count-3:TACGCTCTCGTAGCCG"	4.50026716765706	-6.74391367351683	"2019-08-01-count-3"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCTCGTAGCCG"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2881.92569371683	40.9010907769727	0.0141922780542695	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2877.51077813019	2877.51077813019
"healthy-4"	"2019-08-01-count-2:CGAGAAGTCCAACCGG"	3.41618575629537	-6.22143413936766	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGAGAAGTCCAACCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.04508670577	45.3034780545496	0.0181938384555455	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2482.73711800772	2482.73711800772
"healthy-4"	"2019-08-01-count-2:TTACAGGGTCGCATCG"	-0.287741343409377	8.05534551227418	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTACAGGGTCGCATCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.4821628972	45.4830460408626	0.0239828493674729	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1892.59478590062	1892.59478590062
"healthy-4"	"2019-08-01-count-4:ATCGATGTCATTTGTC"	11.0539738136226	6.15749547565309	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.ATCGATGTCATTTGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2083.87021330285	46.5179827379389	0.0223228790550299	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2077.08569666935	2077.08569666935
"healthy-4"	"2019-08-01-count-3:TCCTCCCTCTATCACT"	-4.61555943909343	2.43218348110048	"2019-08-01-count-3"	"Control4"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCTCCCTCTATCACT"	"MEP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3504.35734531565	42.2651868839983	0.0120607525772151	5226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	3490.45045332003	3490.45045332003
"healthy-4"	"2019-08-01-count-2:TTAATCCAGCCTGGAA"	10.9680019813472	5.52706191623536	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTAATCCAGCCTGGAA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2041.71138680718	48.1316756589154	0.0235741819191122	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2032.9941174857	2032.9941174857
"healthy-4"	"2019-08-01-count-4:GAAATGACAAGCAGGT"	0.0491857408428609	7.7091436156067	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAATGACAAGCAGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1794.27048279699	44.6130344359819	0.0248641633821213	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1786.57396063697	1786.57396063697
"healthy-4"	"2019-08-01-count-3:GAGTCTAGTTGGACTT"	11.1130157905513	5.62313792789308	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTAGTTGGACTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1933.15463233335	45.7874524180409	0.0236853543178668	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1927.56018985211	1927.56018985211
"healthy-4"	"2019-08-01-count-2:TTCGCTGAGCCAGAGT"	2.31417240676228	-6.25722696697386	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGAGCCAGAGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.47962168135	50.0793181569439	0.0213878940876639	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2337.67806793536	2337.67806793536
"healthy-4"	"2019-08-01-count-4:CTGATCCCAAAGAACT"	10.8537775474483	5.91313264453737	"2019-08-01-count-4"	"Control4"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTGATCCCAAAGAACT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.04065553565	45.5861209147835	0.0241446712395344	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1882.93369108768	1882.93369108768
"healthy-4"	"2019-08-01-count-2:GATGGAGAGTAGACAT"	-2.22399554672893	9.19711968982545	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGGAGAGTAGACAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2064.69422487797	45.8596419488243	0.0222113480031334	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2057.11416226185	2057.11416226185
"healthy-4"	"2019-08-01-count-2:GCCAGTGCACTGTGAT"	11.3016249137813	5.09172294223634	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGTGCACTGTGAT"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2196.27037789143	39.693940544533	0.0180733396689719	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2187.40343224341	2187.40343224341
"healthy-4"	"2019-08-01-count-4:CTTAGGAGTACGCTAT"	3.93988456305806	-6.490589641687	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTTAGGAGTACGCTAT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2747.83137200558	44.0521226864056	0.0160315960925408	1906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2743.45151266292	2743.45151266292
"healthy-4"	"2019-08-01-count-4:CCTCACAAGCACGTCC"	14.3310028510982	1.9495137699875	"2019-08-01-count-4"	"Control4"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CCTCACAAGCACGTCC"	"Plasmablast"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1460.9038797917	39.6831006241732	0.0271633891682397	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1439.65830631569	1439.65830631569
"healthy-4"	"2019-08-01-count-3:AGCTTCCTCACCTACC"	3.36615242537801	-6.5054502717224	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCTTCCTCACCTACC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.37894417354	42.1900362628723	0.016779505873861	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2508.85815481717	2508.85815481717
"healthy-4"	"2019-08-01-count-2:CAAGAGGGTTCGGACC"	-3.90133557739909	-5.37102415477904	"2019-08-01-count-2"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAAGAGGGTTCGGACC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2846.11119287519	45.6769975505427	0.0160489153287082	2448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2840.0718774144	2840.0718774144
"healthy-4"	"2019-08-01-count-4:TGCAGATCAACGGTAG"	0.0898736352914989	8.24964044177858	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGCAGATCAACGGTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2055.4059551105	40.8313257303284	0.0198653339642257	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2052.95733257381	2052.95733257381
"healthy-4"	"2019-08-01-count-2:GTAGCTATCGGACGTC"	10.5212351280147	7.73298976505128	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTAGCTATCGGACGTC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.04190851718	46.4487084402019	0.0246799543782731	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1864.50379757339	1864.50379757339
"healthy-4"	"2019-08-01-count-4:TGTTGGAAGCAGCAGT"	4.0784555869991	-6.21100618755492	"2019-08-01-count-4"	"Control4"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTTGGAAGCAGCAGT"	"cDC2"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2781.89490789512	40.97286803002	0.0147284025409218	2413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2774.03543628951	2774.03543628951
"healthy-4"	"2019-08-01-count-3:TCGGGACAGTTGGCTT"	3.41691484031026	-6.1816992989746	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACAGTTGGCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.18917983596	43.7115745854	0.0166635235161093	1923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2618.15485184141	2618.15485184141
"healthy-4"	"2019-08-01-count-2:TGCTTCGCATTGGGAG"	2.42190112647359	-6.32795717632445	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGCTTCGCATTGGGAG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.49495970016	47.8024783931154	0.0220237684402267	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2167.83965159326	2167.83965159326
"healthy-4"	"2019-08-01-count-3:AGTGACTAGTAGATCA"	3.98033632811849	-6.84096386348876	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTGACTAGTAGATCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.0931099238	42.9458108207701	0.0195377578078387	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2194.99832938754	2194.99832938754
"healthy-4"	"2019-08-01-count-3:CTCCATGAGCATCTTG"	3.56736864623372	-6.38140013134154	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCATGAGCATCTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.45886322659	42.8822776467021	0.0156022992450249	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2742.30064440759	2742.30064440759
"healthy-4"	"2019-08-01-count-2:GGGTATTCACTTGTGA"	-0.0408297506278336	7.82237670505372	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGGTATTCACTTGTGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1846.73964432025	38.9064595502203	0.0210676473372298	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1834.70992303437	1834.70992303437
"healthy-4"	"2019-08-01-count-3:AGACAGGAGCTCGTGC"	1.93765224990193	-5.97544815456542	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGACAGGAGCTCGTGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3027.02121191155	44.3405015784307	0.0146482295545032	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	3023.48318898876	3023.48318898876
"healthy-4"	"2019-08-01-count-3:CGACAGCCATACCATG"	3.28376903113667	-6.08817579662474	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGACAGCCATACCATG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.5155191582	44.6835992417475	0.0169287124540181	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2636.59095285342	2636.59095285342
"healthy-4"	"2019-08-01-count-2:TCAGTCCAGCGTTAGG"	-3.7316566509312	10.9993314513001	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAGTCCAGCGTTAGG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1836.40108918488	41.8407203651934	0.0227840860101892	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1828.66868560179	1828.66868560179
"healthy-4"	"2019-08-01-count-2:CTGTGGGTCTCGTCAC"	2.90615810927693	-6.2311640015808	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGTGGGTCTCGTCAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.148263004	45.5596170975217	0.0190375238349558	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2392.04593694373	2392.04593694373
"healthy-4"	"2019-08-01-count-2:TGAATGCGTAACACGG"	11.1170250373775	5.84537742221681	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCGTAACACGG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.64114972293	45.4641913905115	0.0226117879845324	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2004.38175851501	2004.38175851501
"healthy-4"	"2019-08-01-count-4:TCGCTTGTCGTTCCTG"	4.53295673903768	-6.62026550686034	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGCTTGTCGTTCCTG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.44287464905	44.7716098520583	0.0177071866249985	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2526.48627473933	2526.48627473933
"healthy-4"	"2019-08-01-count-2:TACGGGCGTTGGTAGG"	-2.73336253586467	9.32915303790895	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACGGGCGTTGGTAGG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1938.89410121648	45.1331046196156	0.0232777564237772	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1935.56548633443	1935.56548633443
"healthy-4"	"2019-08-01-count-4:GACCGTGCATCGATAC"	-7.08573518219646	3.03506991947023	"2019-08-01-count-4"	"Control4"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACCGTGCATCGATAC"	"MPP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2464.1161057851	41.591692760118	0.016878950087811	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2450.67867837218	2450.67867837218
"healthy-4"	"2019-08-01-count-2:GAGAAATAGTATGGCG"	-3.10268173638042	9.7470025786194	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGAAATAGTATGGCG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2119.13542482985	47.1073892266391	0.0222295322303064	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2112.17866053018	2112.17866053018
"healthy-4"	"2019-08-01-count-4:GAAGGGTGTGCACGCT"	0.438345034688157	7.73794505679933	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAAGGGTGTGCACGCT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1828.59264919767	35.7098484246872	0.0195285967273004	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1821.33935929303	1821.33935929303
"healthy-4"	"2019-08-01-count-4:TGGAACTCAGCTACTA"	2.22159518775288	-6.13318111812743	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTCAGCTACTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2598.73526687813	45.4934638347763	0.0175060016364913	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2589.09609523034	2589.09609523034
"healthy-4"	"2019-08-01-count-3:TACGGGCTCACTCCGT"	2.67098702964131	-5.90840818798216	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGGGCTCACTCCGT"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2715.29284343794	44.1903370652241	0.0162746118423355	2461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2711.63228707821	2711.63228707821
"healthy-4"	"2019-08-01-count-2:TGGGAAGCATCGTTCC"	0.930886586278123	8.74842355335084	"2019-08-01-count-2"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAAGCATCGTTCC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1672.79822561339	40.0281546794691	0.0239288600780236	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1667.9998329081	1667.9998329081
"healthy-4"	"2019-08-01-count-3:AGAACAACATTCAGGT"	0.224389438598794	8.0597991713318	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAACAACATTCAGGT"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.91295882271	42.6994946493697	0.0247977079390608	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1718.82364472764	1718.82364472764
"healthy-4"	"2019-08-01-count-2:CATACAGCATTCTCCG"	10.6414791541988	6.80970141971437	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CATACAGCATTCTCCG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2118.76346118665	45.7094430218226	0.021573641352217	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2111.10469647958	2111.10469647958
"healthy-4"	"2019-08-01-count-3:CCTGCATCACCGCTAG"	0.411662151187104	7.73618838870851	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCTGCATCACCGCTAG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.86124261912	36.3610429512577	0.0201016208952596	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1799.3601391963	1799.3601391963
"healthy-4"	"2019-08-01-count-2:TCTTCCTAGAAACTCA"	3.2310422855312	-6.65682747280272	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCTTCCTAGAAACTCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.03550948866	48.9802924858607	0.0228555673804712	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2136.50861984642	2136.50861984642
"healthy-4"	"2019-08-01-count-2:GAACGTTCAAGAGTGC"	-1.85582528534587	3.90461752498475	"2019-08-01-count-2"	"Control4"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAACGTTCAAGAGTGC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2981.11010140232	46.1683068650852	0.0154869512680419	5253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2976.41438328528	2976.41438328528
"healthy-4"	"2019-08-01-count-2:GATCATGGTACGACAG"	10.994516034692	6.02808520877687	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATCATGGTACGACAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1921.71994791274	42.9230822360218	0.022335763482417	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1916.95262290637	1916.95262290637
"healthy-4"	"2019-08-01-count-2:CGCAGGTCAATCCTTT"	-2.9594923061436	10.6597156294617	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CGCAGGTCAATCCTTT"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1886.83599587454	45.498522891395	0.0241136606418761	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1884.8857086491	1884.8857086491
"healthy-4"	"2019-08-01-count-1:ACTGTCCAGTCATCGT"	-0.0731239867513955	7.69577167117921	"2019-08-01-count-1"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613747"	"2019-08-01-count-1_metadata.csv"	"2019.08.01.count.1.ACTGTCCAGTCATCGT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2207.03579414643	42.9852943999546	0.0194764826714463	1683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2193.56773035991	2193.56773035991
"healthy-4"	"2019-08-01-count-3:GTTCATTGTACCAATC"	3.14890684661214	-6.14475204860839	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTTCATTGTACCAATC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.23887022036	46.9379317000874	0.0197696753636802	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2370.62223244623	2370.62223244623
"healthy-4"	"2019-08-01-count-2:GAAGGGTCAAATAAGC"	2.4571062522823	-6.20414116298827	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTCAAATAAGC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.50236661799	50.6772143366632	0.0211022962296853	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2392.50614076061	2392.50614076061
"healthy-4"	"2019-08-01-count-2:TTCGCTGCACGAGGAT"	10.3058926063472	6.93780324542848	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TTCGCTGCACGAGGAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.59420061005	39.0449804267181	0.021624449399276	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1800.35285234557	1800.35285234557
"healthy-4"	"2019-08-01-count-3:AGCGTATCATTCAGGT"	11.1739098030025	5.99856135928956	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGCGTATCATTCAGGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1743.63764706501	43.5553997487945	0.0249796165058202	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1737.88458417362	1737.88458417362
"healthy-4"	"2019-08-01-count-2:CAGCGTGCAACGTTAC"	2.55802096900288	-5.94022371685179	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CAGCGTGCAACGTTAC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.17336661023	43.7369541126483	0.0166669453585474	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2619.45908478098	2619.45908478098
"healthy-4"	"2019-08-01-count-3:TATCTGTAGTATGGCG"	-4.16340384903606	13.0299072035584	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TATCTGTAGTATGGCG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2039.21203612304	45.2215010438372	0.0221759680909948	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2031.63536024311	2031.63536024311
"healthy-4"	"2019-08-01-count-2:TCCGAAAAGGACAGCT"	-7.05192933502849	3.31906840885011	"2019-08-01-count-2"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCCGAAAAGGACAGCT"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2338.71976073275	41.9005068256838	0.0179160015360523	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2319.50147162774	2319.50147162774
"healthy-4"	"2019-08-01-count-3:GCATGATAGGAACGTC"	3.26084365424458	-6.01252844249877	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATGATAGGAACGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.55451760845	46.7007730318787	0.0174090676350964	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2678.25791025623	2678.25791025623
"healthy-4"	"2019-08-01-count-4:TGGAACTTCGGTGTAT"	4.70778431472127	-7.44226362621459	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGGAACTTCGGTGTAT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.47556864396	48.3703502666009	0.0178522924607175	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2704.3957541714	2704.3957541714
"healthy-4"	"2019-08-01-count-2:TACACCCTCAGCGCGT"	-4.10985598984416	13.1739625700745	"2019-08-01-count-2"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACACCCTCAGCGCGT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2176.13087725689	38.1796608876336	0.0175447447975927	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2170.76395863892	2170.76395863892
"healthy-4"	"2019-08-01-count-4:TGTCCTGAGGGCGAGA"	2.32452168044392	-5.90459444439086	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGTCCTGAGGGCGAGA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2792.48554256301	41.9259356125947	0.015013841602243	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2790.68617884846	2790.68617884846
"healthy-4"	"2019-08-01-count-3:AGTCTCCTCCATTCGC"	-7.15826974335368	0.835489428881086	"2019-08-01-count-3"	"Control4"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGTCTCCTCCATTCGC"	"GMP"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2897.26864964372	42.1544416965753	0.0145497179565171	3596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2881.36579310836	2881.36579310836
"healthy-4"	"2019-08-01-count-2:ACGTAACTCGTCACCT"	-2.30973015251811	8.74453923786012	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.ACGTAACTCGTCACCT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2186.40368795205	44.9963014571211	0.020580051938747	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2174.89029954029	2174.89029954029
"healthy-4"	"2019-08-01-count-3:TCGACGGCAAATAGCA"	3.57121648368184	-6.74167396938475	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGACGGCAAATAGCA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.41377296593	41.4326581946379	0.0195860775438495	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2109.09840647634	2109.09840647634
"healthy-4"	"2019-08-01-count-2:CTGCAGGTCTAGCAAC"	4.25441374358479	-6.55262567913207	"2019-08-01-count-2"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTGCAGGTCTAGCAAC"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.20414755025	49.8913791611654	0.0206572099554278	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2406.39751758988	2406.39751758988
"healthy-4"	"2019-08-01-count-2:GCCAGCAAGTAAACTG"	-2.80342231217082	9.36760614002077	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCCAGCAAGTAAACTG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2120.53452615731	44.7516280877738	0.0211039374911144	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2115.36819880234	2115.36819880234
"healthy-4"	"2019-08-01-count-3:GCATCTCAGTTCCGTA"	4.40859045562093	-6.42273094570311	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCAGTTCCGTA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2788.95556659059	47.3706438708032	0.016985083749008	2341	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2779.83608277184	2779.83608277184
"healthy-4"	"2019-08-01-count-3:GCATCTCTCAATCCGA"	-2.09204612198527	8.89237878406373	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GCATCTCTCAATCCGA"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1983.93241642319	50.1493668388539	0.0252777596775538	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1978.22821225554	1978.22821225554
"healthy-4"	"2019-08-01-count-4:GATGACTTCCATATGG"	-3.19414768639262	3.59276816928712	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GATGACTTCCATATGG"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3342.18471120847	43.2205295373767	0.0129318195348183	5682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3329.99532523182	3329.99532523182
"healthy-4"	"2019-08-01-count-2:TACCCACAGTGGAAAG"	-0.479114035994369	8.48749921405641	"2019-08-01-count-2"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TACCCACAGTGGAAAG"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.19999568014	48.3792041030383	0.0244561744053612	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1973.59244345954	1973.59244345954
"healthy-4"	"2019-08-01-count-4:TAGACCACACGACCTG"	4.85390486296956	-8.0357876054016	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCACACGACCTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2784.34244151664	42.7947152406954	0.0153697744223534	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2778.62676622814	2778.62676622814
"healthy-4"	"2019-08-01-count-4:GTTCATTTCTTGGTGA"	5.00918068465535	-7.76870109951171	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GTTCATTTCTTGGTGA"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.31348207754	41.7978258846785	0.0155827520399684	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2677.1167138333	2677.1167138333
"healthy-4"	"2019-08-01-count-3:CGAGGAACATCTGTTT"	2.44256796416585	-6.44488718425902	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGAGGAACATCTGTTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1933.44635209238	51.2734868156027	0.0265192187826233	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	1930.09208010998	1930.09208010998
"healthy-4"	"2019-08-01-count-4:GAGGCCTGTAAGGCCA"	10.8845230537349	5.8763217695984	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGGCCTGTAAGGCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.9238129187	43.1856557551137	0.023651400704437	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1817.77942707273	1817.77942707273
"healthy-4"	"2019-08-01-count-4:TTGTTCATCGGTAGAG"	4.6995116668636	-7.48307421123656	"2019-08-01-count-4"	"Control4"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGTTCATCGGTAGAG"	"HLA-II+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.17442706312	42.7042625904766	0.0167719313086235	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2541.77279177672	2541.77279177672
"healthy-4"	"2019-08-01-count-4:CTCCGATAGACATAGT"	3.82705750045125	-6.21852924739989	"2019-08-01-count-4"	"Control4"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCCGATAGACATAGT"	"CD11c+"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.21705313919	40.6373527843689	0.0148299758728291	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2727.38975110744	2727.38975110744
"healthy-4"	"2019-08-01-count-3:AGAGCCCAGCAGTCTT"	-0.257808963686782	7.65706727588502	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGAGCCCAGCAGTCTT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.14912006668	44.0439450046859	0.0210419528080651	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2087.55849678538	2087.55849678538
"healthy-4"	"2019-08-01-count-4:GAGTTGTTCAAACGTC"	-2.67105780068095	3.45324871623842	"2019-08-01-count-4"	"Control4"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GAGTTGTTCAAACGTC"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3343.03150821187	44.522641422647	0.0133180442102568	4919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3334.31364966523	3334.31364966523
"healthy-4"	"2019-08-01-count-2:TGGGAAGCAGGTCCCA"	6.79539551314656	-1.70452465927275	"2019-08-01-count-2"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGGAAGCAGGTCCCA"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2625.90878542406	41.3882019529967	0.0157614773912693	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2612.01087535558	2612.01087535558
"healthy-4"	"2019-08-01-count-3:AGGTAGGCAGAGGACT"	4.8753248649532	-8.26690866863402	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTAGGCAGAGGACT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.25608431116	42.1186242353796	0.0154890245454941	2104	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2711.96512789402	2711.96512789402
"healthy-4"	"2019-08-01-count-2:GAAGGGTCACGACGTC"	3.64381470259969	-6.6204519501892	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAGGGTCACGACGTC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2031.01889941721	50.6220904877344	0.0249244802705972	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2027.68924109249	2027.68924109249
"healthy-4"	"2019-08-01-count-2:GCAACCGAGTATGAGT"	11.1195122199947	6.05707261646119	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GCAACCGAGTATGAGT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.25175403702	41.7147454196519	0.0206380750623151	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2006.59537370014	2006.59537370014
"healthy-4"	"2019-08-01-count-3:AGGTAGGCATGGACAG"	11.0616661506588	5.45003268802492	"2019-08-01-count-3"	"Control4"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTAGGCATGGACAG"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2048.29578907143	40.828011865046	0.0199326738271307	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2036.74069055081	2036.74069055081
"healthy-4"	"2019-08-01-count-3:TCCATGCCATGGCCCA"	11.0171362358028	6.43245742404786	"2019-08-01-count-3"	"Control4"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCCATGCCATGGCCCA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2086.53188960671	46.8899744296869	0.0224726852550168	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2081.90030356232	2081.90030356232
"healthy-4"	"2019-08-01-count-2:TGGTAGTGTGCCTTCT"	10.9090057807857	5.70277068698732	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGGTAGTGTGCCTTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1819.75159568473	43.3745623269086	0.0238354303025561	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1817.94477711965	1817.94477711965
"healthy-4"	"2019-08-01-count-2:TATCGCCTCAGGGATG"	-2.58759031716045	10.5586185225281	"2019-08-01-count-2"	"Control4"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TATCGCCTCAGGGATG"	"gd T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1962.02486732268	51.393168599125	0.0261939435402032	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1950.78623307022	1950.78623307022
"healthy-4"	"2019-08-01-count-3:GTGAGCCGTAGATCGG"	2.95129861411397	-6.01766588604125	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GTGAGCCGTAGATCGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.48944770721	44.459462912847	0.0188508212135814	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2357.36459764721	2357.36459764721
"healthy-4"	"2019-08-01-count-3:ACTGATGAGCCTCTCT"	10.4002624946529	7.68320558154909	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ACTGATGAGCCTCTCT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1914.41944278609	47.5698798661816	0.0248482013936049	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1901.0622165065	1901.0622165065
"healthy-4"	"2019-08-01-count-3:ATACCGATCTCGGTCT"	-4.0926755470341	12.1991452940735	"2019-08-01-count-3"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.ATACCGATCTCGGTCT"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.7847243611	41.3661443537657	0.0215248585491374	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	1921.7847243611	1921.7847243611
"healthy-4"	"2019-08-01-count-4:TAGACTGCACAGGATG"	-4.25302682343181	12.4665431746277	"2019-08-01-count-4"	"Control4"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACTGCACAGGATG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2119.64527038589	42.8939622640102	0.0202363871272674	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2112.35372580115	2112.35372580115
"healthy-4"	"2019-08-01-count-4:TGAGGGACATAGGTTC"	11.1796966987545	5.07903764331666	"2019-08-01-count-4"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TGAGGGACATAGGTTC"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1940.2416522866	41.5345888350796	0.021406915363419	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1940.2416522866	1940.2416522866
"healthy-4"	"2019-08-01-count-3:CAGATCAAGCAAACAT"	-1.45366189900096	3.5280666121277	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAGATCAAGCAAACAT"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2740.76734792464	39.8500153772835	0.0145397293234169	4317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	2737.4116690528	2737.4116690528
"healthy-4"	"2019-08-01-count-3:AAACGCTGTCCTTTGC"	-1.4269189638203	8.38446042621461	"2019-08-01-count-3"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AAACGCTGTCCTTTGC"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2220.12030671331	40.0006499330719	0.0180173343814369	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2207.18385764966	2207.18385764966
"healthy-4"	"2019-08-01-count-3:TGACCCTAGCACCTGC"	2.2908145385677	-5.90685989772948	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TGACCCTAGCACCTGC"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2717.99038342118	40.9974595318748	0.0150837397298922	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2715.53911446384	2715.53911446384
"healthy-4"	"2019-08-01-count-4:TAGACTGCAGAATGTA"	-3.87480650368388	-5.38074591076048	"2019-08-01-count-4"	"Control4"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACTGCAGAATGTA"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2901.09685732842	51.6114857849667	0.0177903352845982	2470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2894.68686034424	2894.68686034424
"healthy-4"	"2019-08-01-count-4:TCGTGGGCAGGATCTT"	6.77712740477864	-1.69035437023314	"2019-08-01-count-4"	"Control4"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCGTGGGCAGGATCTT"	"pDC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2450.01860604439	35.5930542331928	0.0145276669105214	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	178	TRUE	"DC_healthy-4"	2442.41649008005	2442.41649008005
"healthy-4"	"2019-08-01-count-2:AAAGGGCGTAAGCTCT"	2.95422305640523	-6.06751587307128	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.AAAGGGCGTAAGCTCT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.41133208101	44.4669083941173	0.0185401510572146	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2392.02869924061	2392.02869924061
"healthy-4"	"2019-08-01-count-3:CATCAAGCAGGTACGA"	10.4284731346065	7.86376664722291	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CATCAAGCAGGTACGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2461.80494642494	47.2303766696394	0.0191852635352886	1858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2450.56988835372	2450.56988835372
"healthy-4"	"2019-08-01-count-2:GAAATGACAAGACCTT"	3.17795028266255	-6.52471783077391	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAAATGACAAGACCTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.70906242984	51.5777034056425	0.0216921843890076	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2376.39415978401	2376.39415978401
"healthy-4"	"2019-08-01-count-3:TCTCTGGTCATCGGGC"	10.3314491706783	5.59788940036622	"2019-08-01-count-3"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCTCTGGTCATCGGGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.15986832424	46.208764583573	0.0261338159582635	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1762.48094098983	1762.48094098983
"healthy-4"	"2019-08-01-count-3:CTGATCCTCTACTGAG"	-3.89168272438701	12.3053674467835	"2019-08-01-count-3"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTGATCCTCTACTGAG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2436.69487126643	48.5563087186126	0.0199271190214212	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2430.94409257683	2430.94409257683
"healthy-4"	"2019-08-01-count-4:TCAATCTAGTCCGTCG"	-1.31012568894084	8.59842393482057	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TCAATCTAGTCCGTCG"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1959.90080949224	45.3755939805883	0.0231519849172081	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1954.01578719498	1954.01578719498
"healthy-4"	"2019-08-01-count-4:CTCAGTCGTGGCTTAT"	11.114651342004	5.92576739871827	"2019-08-01-count-4"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTCAGTCGTGGCTTAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1936.84105009577	44.8804347303507	0.0231719762074082	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1930.02757069496	1930.02757069496
"healthy-4"	"2019-08-01-count-3:CGTAGTACAAATGCGG"	2.11502899703328	-6.13606216823729	"2019-08-01-count-3"	"Control4"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CGTAGTACAAATGCGG"	"Granulocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2374.08606100454	45.9235385149764	0.0193436705051648	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	273	TRUE	"Gran_healthy-4"	2369.63660122287	2369.63660122287
"healthy-4"	"2019-08-01-count-2:GATTCGACATGGGTTT"	10.3671661811763	7.74328420245973	"2019-08-01-count-2"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATTCGACATGGGTTT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.21976008253	48.8363252603722	0.0232418932032383	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2089.3261836376	2089.3261836376
"healthy-4"	"2019-08-01-count-3:GAGTCTACACTTGTGA"	-2.59436164322551	3.47593758190004	"2019-08-01-count-3"	"Control4"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.GAGTCTACACTTGTGA"	"Ery"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3251.8607572592	46.5769050686044	0.0143231548167091	5581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	206	TRUE	"Ery_healthy-4"	3243.82015364564	3243.82015364564
"healthy-4"	"2019-08-01-count-4:CGCATAAGTGAATTGA"	-0.0993244302576363	7.86510131442872	"2019-08-01-count-4"	"Control4"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CGCATAAGTGAATTGA"	"CD4+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.5119622566	47.9860935974133	0.0246650210989987	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1932.16100664857	1932.16100664857
"healthy-4"	"2019-08-01-count-4:TAGACCATCTAGTGTG"	-4.05758700791057	12.9126357802185	"2019-08-01-count-4"	"Control4"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TAGACCATCTAGTGTG"	"NK"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2156.30880808845	42.5765625136926	0.0197451136655313	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	162	TRUE	"NK_healthy-4"	2152.77664899172	2152.77664899172
"healthy-4"	"2019-08-01-count-3:CTCCACATCTTACGTT"	2.24686636504475	-6.47213222896727	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CTCCACATCTTACGTT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.99614597787	47.5334017212352	0.0194729523844427	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2436.72555688837	2436.72555688837
"healthy-4"	"2019-08-01-count-2:TGAATGCGTCAAAGCG"	2.48297919806783	-6.2210993996826	"2019-08-01-count-2"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TGAATGCGTCAAAGCG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.0389722347	45.4642511553001	0.021106512807488	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2151.62371260007	2151.62371260007
"healthy-4"	"2019-08-01-count-4:CTACTATGTACTGCGC"	0.101792433380526	7.65775010669557	"2019-08-01-count-4"	"Control4"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATGTACTGCGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1910.81842979662	41.956009836108	0.0219570887436823	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1902.37454329294	1902.37454329294
"healthy-4"	"2019-08-01-count-4:TTGCTGCGTTCGAGCC"	3.14035811003987	-6.38203956997069	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.TTGCTGCGTTCGAGCC"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.0465134469	42.2111576725801	0.0166379124106916	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2532.29858486102	2532.29858486102
"healthy-4"	"2019-08-01-count-2:GAGTCATAGTATTGCC"	11.0489088493282	6.67744538867799	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GAGTCATAGTATTGCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1844.4621084964	44.1536265254043	0.0239384839200617	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1837.47387732807	1837.47387732807
"healthy-4"	"2019-08-01-count-3:CCCGAAGAGGTGCCAA"	2.34407391127889	-6.34750416195067	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CCCGAAGAGGTGCCAA"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.96488504688	44.7217923565765	0.0190714123873469	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2343.70511655472	2343.70511655472
"healthy-4"	"2019-08-01-count-2:CTCCATGAGTCTGCGC"	11.0858799415523	6.01585338199464	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.CTCCATGAGTCTGCGC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1949.02473800506	48.156700247599	0.0247081010869519	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1939.5531104945	1939.5531104945
"healthy-4"	"2019-08-01-count-4:GACTCTCAGGTCTTTG"	2.97851528701131	-5.89617588436278	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.GACTCTCAGGTCTTTG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.3897281524	48.1215914694846	0.0183712988381562	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2613.88636175968	2613.88636175968
"healthy-4"	"2019-08-01-count-2:GATGCTACAGTTAAAG"	11.1321226554805	5.27754495227662	"2019-08-01-count-2"	"Control4"	"B"	"Atypical memory"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GATGCTACAGTTAAAG"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1947.30288982967	40.7698148291716	0.0209365553977778	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1943.09950650656	1943.09950650656
"healthy-4"	"2019-08-01-count-2:TCAATTCTCTAGGCAT"	10.1486479240352	7.24773404682008	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.TCAATTCTCTAGGCAT"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1934.17352840856	45.4048876776857	0.0234750848415576	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1928.71151362907	1928.71151362907
"healthy-4"	"2019-08-01-count-2:GACCAATAGGTCGTGA"	11.07954945144	5.61964128101198	"2019-08-01-count-2"	"Control4"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GACCAATAGGTCGTGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1742.20832228043	44.2208881721104	0.0253820898491796	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1735.27708626722	1735.27708626722
"healthy-4"	"2019-08-01-count-3:TACGCTCCACGTGTGC"	-1.40614901009257	8.33188531482545	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TACGCTCCACGTGTGC"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.17349570785	46.8340134395028	0.0221001317420966	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	2112.57068239899	2112.57068239899
"healthy-4"	"2019-08-01-count-4:CTACTATCAGGTATGG"	2.59413590010945	-6.74207451259764	"2019-08-01-count-4"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613750"	"2019-08-01-count-4_metadata.csv"	"2019.08.01.count.4.CTACTATCAGGTATGG"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2033.54562512639	44.1744370225194	0.0217228649688024	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2031.9219886974	2031.9219886974
"healthy-4"	"2019-08-01-count-3:TCGGGACAGTACCGGA"	10.1890245872432	7.67178580844728	"2019-08-01-count-3"	"Control4"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.TCGGGACAGTACCGGA"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.18466644563	47.2589112841683	0.0243078304750584	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1938.77466259307	1938.77466259307
"healthy-4"	"2019-08-01-count-3:AGGTAGGCAGCTATTG"	-7.13225064697917	3.13692233646242	"2019-08-01-count-3"	"Control4"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTAGGCAGCTATTG"	"HSC"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2677.45604745519	41.2647052380909	0.015411907611821	2576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4"	2661.86629547273	2661.86629547273
"healthy-4"	"2019-08-01-count-2:GGTGATTTCCGTCCTA"	11.3194042640621	4.97530124271242	"2019-08-01-count-2"	"Control4"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GGTGATTTCCGTCCTA"	"Pre-B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2375.22144304157	36.8443649323363	0.015511970490278	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	2360.13030368322	2360.13030368322
"healthy-4"	"2019-08-01-count-3:CAACCAAAGGTGATAT"	-2.04075417938884	9.56022260272828	"2019-08-01-count-3"	"Control4"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.CAACCAAAGGTGATAT"	"CD8+ T"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.97023892767	45.1966575029578	0.0233819727757583	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1298	TRUE	"T_healthy-4"	1927.55995166385	1927.55995166385
"healthy-4"	"2019-08-01-count-2:GTGGAGACATAGATCC"	10.1720053153927	6.78568360889284	"2019-08-01-count-2"	"Control4"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613748"	"2019-08-01-count-2_metadata.csv"	"2019.08.01.count.2.GTGGAGACATAGATCC"	"B"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1780.00241655183	44.4591537160398	0.0249770187403256	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1631	TRUE	"B_healthy-4"	1771.28426765093	1771.28426765093
"healthy-4"	"2019-08-01-count-3:AGGTAGGGTAGACGGT"	2.96954240378682	-5.96889355098876	"2019-08-01-count-3"	"Control4"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_19to26yrs"	"control_19to26yrs"	"male"	"Control"	NA	"GSM5613749"	"2019-08-01-count-3_metadata.csv"	"2019.08.01.count.3.AGGTAGGGTAGACGGT"	"CD14+ monocyte"	"4"	"M"	20	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.85409544179	49.55561814331	0.0200560681566467	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1657	TRUE	"Mono_healthy-4"	2461.72011350614	2461.72011350614
"healthy-4003"	"2020-08-26-Control4003-c2:ACTACGATCATGAAAG"	-3.50515041771587	9.85627839649049	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTACGATCATGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.71789596929	42.8379646062651	0.0206874942693307	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2067.24619258381	2067.24619258381
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTCCTGTCGTTTCC"	-3.78061495247539	13.1422223814758	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTCCTGTCGTTTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1748.7185238096	3.14075270538846	0.00179603101506942	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1746.49082762118	1746.49082762118
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCGTCCATCTATCT"	3.85646619376485	-6.75419905101927	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCGTCCATCTATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.47959305714	8.57386126433487	0.00373023162364955	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2296.93495652098	2296.93495652098
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCTATAGCTGTGCC"	-3.47669206085857	10.0073690184387	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCTATAGCTGTGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1918.000950342	34.2472042117622	0.0178556763518056	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.18551196482	1912.18551196482
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCTATCACCTGCTT"	5.60203375396077	-10.1454267731872	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCTATCACCTGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.05833356886	36.0950455159131	0.0152489040950215	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2358.11551464881	2358.11551464881
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCTATGTGGAACCA"	-3.8147750896519	12.6811084517273	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCTATGTGGAACCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1758.91246289314	41.3960124788235	0.023535004357598	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1756.5724893625	1756.5724893625
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCTATTCATGGATC"	4.07004704055135	-6.85136415874632	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCTATTCATGGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.82905699	8.96128305132589	0.00352552545840267	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2537.90629728216	2537.90629728216
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCTATTCTCCTACG"	2.97150840339009	-4.90835096752318	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCTATTCTCCTACG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2900.39697216771	30.8053087871612	0.010621066386005	2747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2891.64480174294	2891.64480174294
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGATGAGAGTAACT"	-1.12155018273051	8.78052899921266	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGATGAGAGTAACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1767.63854588176	46.0073322595985	0.0260275678909505	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1759.55772590206	1759.55772590206
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGATGAGTCGGGAT"	-4.22250304642375	13.2022828825745	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGATGAGTCGGGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2309.36888832253	24.22406272732	0.010489473054656	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2302.67383341349	2302.67383341349
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGATGCAAACAGGC"	-3.75346169892009	10.531524635199	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGATGCAAACAGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.34996476942	37.781018193983	0.0205851847981098	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.31976814013	1827.31976814013
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGATGGTCGACGCT"	4.88026871260945	-8.17296316539916	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGATGGTCGACGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.98148080679	33.563932387242	0.0148186343560242	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2262.29567102474	2262.29567102474
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGATGGTGGAGAAA"	3.40206613120381	-6.66454937374266	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGATGGTGGAGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.37779778274	24.010774802581	0.0101209743342826	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2363.96812149369	2363.96812149369
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGCCTGTGAGATAT"	-3.47443352165874	10.3428258665833	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGCCTGTGAGATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1702.63899188678	32.3471435082803	0.0189982395930184	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1698.33991070371	1698.33991070371
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGGATAGGTTACAA"	3.98840465125386	-7.35677482998046	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGGATAGGTTACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.34852460312	34.4111066780647	0.0164618991871694	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2090.34852460312	2090.34852460312
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAACGTAAGCAAT"	4.33013500747029	-7.96829988872679	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAACGTAAGCAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1869.8934632866	5.30553007299214	0.00283734350494329	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1868.2241222136	1868.2241222136
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAACTCAGGGTAG"	5.50031437453572	-9.68636324321898	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAACTCAGGGTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.35495876871	21.044568142836	0.00801284231309774	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2619.78350058241	2619.78350058241
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAACTCATGCCAA"	4.48453535613362	-7.16923572933348	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAACTCATGCCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.24693285175	34.1027204265382	0.0147551176561045	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2303.72494316818	2303.72494316818
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAACTCTCTCCGA"	10.5029322105343	7.01527164066163	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAACTCTCTCCGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2111.56614346567	34.518513159477	0.0163473511195924	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2104.5938381603	2104.5938381603
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTACAAGCCAAGCA"	10.109464307397	7.10733983600465	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTACAAGCCAAGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1680.52474655414	44.6010085561146	0.0265399296544531	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1672.90817525334	1672.90817525334
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTACAAGTTGGACG"	-6.9766505760258	3.37099669063417	"2020-08-26-Control4003-c2"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTACAAGTTGGACG"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2389.27361897321	27.7520895340726	0.0116152831193939	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2375.10058430337	2375.10058430337
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTACACACGATTCA"	-0.492255250841934	8.59001920307008	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTACACACGATTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1712.79431933379	8.30463780966405	0.00484859023405347	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1701.86991526345	1701.86991526345
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAGTCACGGATCC"	4.21661152419393	-8.13413717662963	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAGTCACGGATCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.54849708662	35.9579554088783	0.01355089437723	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2645.03198530559	2645.03198530559
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAGTGTGAGATTA"	3.57273401793782	-7.20486261760863	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAGTGTGAGATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.83051164367	10.1944417998115	0.0041561949557534	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.09502972303	2449.09502972303
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAGTGTGTGACCC"	-4.09759936752971	12.5748824843201	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAGTGTGTGACCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2048.59064956723	24.7804854650222	0.0120963577912733	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2040.40449305246	2040.40449305246
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAGTTCCGAGATT"	-1.9313579601353	9.27953527057496	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAGTTCCGAGATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.33138226167	24.2446133998631	0.0159889940177201	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.3017423054	1505.3017423054
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTCCTAGGATCACG"	2.95434608039204	-6.49768211757811	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTCCTAGGATCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.98344098727	24.6444612794588	0.0105454154476369	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.7010890373	2332.7010890373
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTCCTCATACTGAC"	5.5799056487972	-9.62071897899779	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTCCTCATACTGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.99376848497	31.7241217617889	0.0122581909385201	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2578.36786687168	2578.36786687168
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTCCTGTCGCTGCA"	2.95401753959004	-4.92590954219969	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTCCTGTCGCTGCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2644.8007518617	36.9419172511969	0.0139677505858213	2130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2640.37621865917	2640.37621865917
"healthy-4003"	"2020-08-26-Control4003-c2:ATCATTCTCAAGCCAT"	-4.18325839462932	12.6384954222473	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCATTCTCAAGCCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2120.02370318593	44.1278320940815	0.0208147824138791	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2114.52841961606	2114.52841961606
"healthy-4003"	"2020-08-26-Control4003-c2:ATCATTCTCATAGCAC"	2.98772158202474	-4.95189287578734	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCATTCTCATAGCAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2663.95851312485	19.5456780752674	0.00733708050593482	2140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2662.17200678356	2662.17200678356
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCACCCATGAGATA"	3.67395772513692	-7.06038668071898	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCACCCATGAGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.46500219558	31.1921777670133	0.0129456861745615	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2402.63229286547	2402.63229286547
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCACCGTAGAGCTG"	-3.77342043343242	12.8770847090515	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCACCGTAGAGCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1781.3111514649	39.5678296738458	0.0222127558351086	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1779.20789058591	1779.20789058591
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCACCGTATAATGG"	4.72799505767171	-7.19831182872923	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCACCGTATAATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2073.94444586665	0.527507411168892	0.000254349827074784	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2073.94444586665	2073.94444586665
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCACCGTCCGGCAT"	3.92411746558492	-6.88031628048094	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCACCGTCCGGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.52325661468	36.7220312234429	0.0143865608778609	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2549.36436987606	2549.36436987606
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCACCTCGCTGTTC"	5.50657620009725	-9.8042145005432	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCACCTCGCTGTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.75037904211	4.74369817204498	0.0018107443403747	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2611.91078191164	2611.91078191164
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCATTAGTTTGCTG"	3.7309967475826	-6.54236366665038	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCATTAGTTTGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.26509976367	31.6477426647497	0.0125076786095282	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.00155103334	2529.00155103334
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCATTCATTGACTG"	4.05582680281941	-6.77940943157347	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCATTCATTGACTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.24041228015	2.97453246566098	0.00118354473815035	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2507.82731837258	2507.82731837258
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCATTTCGTGGGAA"	4.14724125441853	-7.45829870617064	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCATTTCGTGGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.76810299231	17.8596621753349	0.00785811018370991	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.14800408667	2256.14800408667
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCCTGCACTGGCCA"	3.85129847106282	-6.64052011882933	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCCTGCACTGGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2891.56749772786	31.2840892653128	0.010819076258775	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2887.05275961957	2887.05275961957
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCCTGCAGAAGTGC"	5.58357920226399	-9.70097734844359	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCCTGCAGAAGTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.64492673986	16.4546404922238	0.00617517190643323	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2658.72798459467	2658.72798459467
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCCTGGTAGCTAAA"	5.38848318633382	-9.38281252300414	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCCTGGTAGCTAAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.64018197399	27.4030769336943	0.0116975185282631	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2338.29867437143	2338.29867437143
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCCTGGTCACCACG"	3.27656449851338	-6.37251427089842	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCCTGGTCACCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.05509119919	32.1191197521169	0.0125218050334743	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2559.17971490371	2559.17971490371
"healthy-4003"	"2020-08-26-Control4003-c2:ATCCCTGTCGTGGACC"	6.76569523391072	-1.75867392933043	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCCCTGTCGTGGACC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2879.66512819301	33.5027726106774	0.0116342599292788	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2866.08002924754	2866.08002924754
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTGGAGAGCGACT"	4.06712498244588	-6.79585935985716	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTGGAGAGCGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.10000178564	17.7426267715046	0.00809758877141399	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2184.57943372355	2184.57943372355
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTGGCACAGGATG"	5.33517660674397	-10.1007976762024	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTGGCACAGGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1842.97690290655	8.16896187286494	0.00443248195893379	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1842.97690290655	1842.97690290655
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTGGTCCTCACCA"	3.09948386725728	-6.41815044796141	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTGGTCCTCACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.65030889798	14.7905319050157	0.00653392966523003	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2262.20603193183	2262.20603193183
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTGGTCTCCAAGA"	-4.4018157524174	12.8028125532898	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTGGTCTCCAAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2215.80482654392	7.74044200816434	0.00349328691563391	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2211.60592560616	2211.60592560616
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTGGTCTCGAGTA"	3.61795892295186	-6.57277538692626	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTGGTCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.89593418662	45.1850972886279	0.0178322624378543	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2532.76876806639	2532.76876806639
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTTCAGACATAAC"	4.58080877837483	-6.98836138164672	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTTCAGACATAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.71527154789	29.7722514589147	0.0122181905315521	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.82454124997	2433.82454124997
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTTCCACTATGTG"	4.61303820189778	-7.27620985424193	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTTCCACTATGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.40085708721	17.8862235147835	0.0077182259858422	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.90298746546	2311.90298746546
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTTCCAGGGACTA"	4.44722809371297	-7.31449940120848	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTTCCAGGGACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.68148893192	35.2128242875007	0.0150374098501167	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2340.22007022874	2340.22007022874
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCTTCTCATCGGGC"	-5.38856349411662	-4.51107838070067	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCTTCTCATCGGGC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3325.13530261994	28.2416540158961	0.00849338491388421	3404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3317.12160609503	3317.12160609503
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAAGAGAGTCAAT"	3.64992370185201	-6.6215391389099	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAAGAGAGTCAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.56057966066	31.7437796657443	0.0125739821501971	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2521.88953727287	2521.88953727287
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAAGAGGGTATAT"	-0.666673819453079	8.84824178302614	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAAGAGGGTATAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.92860994127	28.2280202842942	0.0156134595852273	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1798.59203852653	1798.59203852653
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAAGAGTATCCTG"	0.643046160309952	8.8862848051819	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAAGAGTATCCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1557.7401117977	37.5468158546081	0.0241033889865476	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1555.68402059326	1555.68402059326
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAAGCAGTTCACA"	4.23311247405354	-7.89300444042357	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAAGCAGTTCACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2036.13913337653	34.2677113535659	0.0168297493976945	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2034.45693584483	2034.45693584483
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAGACACCCTGTT"	3.62205137786214	-7.73932936107787	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAGACACCCTGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.28795002521	18.761958071798	0.00972985288403257	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1926.52714906056	1926.52714906056
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAGAGTTCGCGTG"	-3.75032291832622	10.7424945601257	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAGAGTTCGCGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.99948755039	43.037039774583	0.0223685297491306	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.60986368716	1916.60986368716
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGAGATCGAAATCC"	5.44936003264729	-10.0953760377136	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGAGATCGAAATCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.50306741729	36.1408333190976	0.0155277274711398	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2315.22379565025	2315.22379565025
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGCGTAGGGTGAGG"	-4.04654727402385	13.1831683882507	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGCGTAGGGTGAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1558.40597710438	33.1597354158241	0.0212779826970614	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1548.78632922856	1548.78632922856
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAAAGCGTCTGC"	0.160450902848881	8.7918662794861	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAAAGCGTCTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1477.75592483392	40.5641157379876	0.0274498075469036	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1475.73389665489	1475.73389665489
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAACAACTGAAA"	5.57830490645711	-9.86009695446166	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAACAACTGAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.90541302197	37.1751767603688	0.0151124415449371	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.73633174803	2449.73633174803
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAACATACCATG"	-0.839760105044204	8.46632669055787	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAACATACCATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1711.00739100488	44.8331298865766	0.026202768101572	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1701.19087358932	1701.19087358932
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAAGTAATGATG"	-3.05713615837749	9.84427640521852	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAAGTAATGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.90973240495	44.0499178130864	0.0223160750919534	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1972.45553276405	1972.45553276405
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAAGTTTCCCAC"	-1.82294414463695	8.81883428180543	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAAGTTTCCCAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2046.96094963159	12.4661431781135	0.00609007376538236	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2045.36791547239	2045.36791547239
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAATCATTTGGG"	-1.15206168118175	8.67377278888551	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAATCATTTGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1558.9379712719	37.0810417366336	0.0237860918265915	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1552.23836566682	1552.23836566682
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGGAATCGACATTG"	4.29097284850423	-7.08214380657347	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGGAATCGACATTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.06565403412	27.6174205750911	0.0133413259242626	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2066.78338663524	2066.78338663524
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGTTAAGGTTACCT"	5.17570843276326	-8.9032020798889	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGTTAAGGTTACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.07519908066	36.3652734052584	0.01502029900561	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.33252980931	2418.33252980931
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGTTAGTGTGAGCA"	4.24486889418904	-7.39420130169066	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGTTAGTGTGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.18658500892	7.46327937917146	0.00344058894276297	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.64778935541	2167.64778935541
"healthy-4003"	"2020-08-26-Control4003-c2:GTGGTTATCTCGTGGG"	-7.17146525803264	2.6119916209015	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGGTTATCTCGTGGG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2377.72806669237	34.596867528973	0.0145503886729572	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2372.92703808403	2372.92703808403
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTAACAGCGAGGAG"	-1.97149906578715	9.09675119006959	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTAACAGCGAGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.36899236214	29.6149579591723	0.0150914318736377	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1960.44066773656	1960.44066773656
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTAACCACCATTCC"	2.64885963973348	-4.70158626949462	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTAACCACCATTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2340.42615082863	28.5455186265115	0.0121967183696033	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2338.32550809469	2338.32550809469
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTCCTAGTTTCGAC"	-2.10541377487834	8.83752725208131	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTCCTAGTTTCGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.64022415473	29.1920366270314	0.0156976797166775	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.65411830732	1851.65411830732
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTCCTCAGCCGTCA"	5.62079968032185	-9.92166426098021	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTCCTCAGCCGTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.40676894656	35.8803748183417	0.0131699771221077	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2714.36300481452	2714.36300481452
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGATAGCGGATCA"	10.5316034751827	5.9643549689087	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGATAGCGGATCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1709.89858102663	33.0979878415593	0.0193566964782713	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1702.10276358618	1702.10276358618
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGATCAAATCAGA"	3.1542657810146	-6.80994083797606	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGATCAAATCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1874.69072405172	31.3098043880699	0.0167013171753476	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1870.66956004557	1870.66956004557
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGATCAAGGCTTT"	4.43973793563191	-7.07560541546019	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGATCAAGGCTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.93639716952	31.8932548425143	0.0140564781288276	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.40897032106	2267.40897032106
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGATCACCCTCTA"	5.372237821191	-10.0540485612121	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGATCACCCTCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.19501051662	29.6481555332395	0.0129967650273464	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.17406082192	2278.17406082192
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGGCCAGCGTTTA"	2.66481556472127	-4.37861969387206	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGGCCAGCGTTTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2486.85588847468	29.8910177118916	0.0120196018797958	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2485.82100588596	2485.82100588596
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTGGCGTGAGATTA"	4.08418240126912	-7.01988413250121	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTGGCGTGAGATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.47621472976	29.0296471375224	0.013174477193566	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.4961524642	2200.4961524642
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTAGAGGCCCGTT"	3.35258473929707	-6.73055508052977	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTAGAGGCCCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.8633296113	37.7704456889082	0.017683924418414	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2129.8520843826	2129.8520843826
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTAGAGTCGCGAA"	-0.530754546553451	8.40240094745485	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTAGAGTCGCGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.85625482391	25.3833740529764	0.014181794758414	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1789.85625482391	1789.85625482391
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTAGGTATGACAA"	-0.346398304135162	8.75661752307741	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTAGGTATGACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.8228571568	33.6253430381555	0.0171485878570961	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1948.67601443924	1948.67601443924
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTAGTCCACAGGC"	4.23745932158772	-7.43054726040038	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTAGTCCACAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.9736167836	25.6359769418435	0.01175976477168	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2175.62441351402	2175.62441351402
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTAGTCCTGCTAC"	4.61614861068074	-7.9397297135559	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTAGTCCTGCTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.59563476829	14.5232018752629	0.00644445775950222	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.15662773172	2252.15662773172
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTCCAGCGCAATG"	-2.17383132401164	9.6186485060486	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTCCAGCGCAATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1781.78025791532	7.34097124485194	0.00412002053128643	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.23830667639	1774.23830667639
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTCCGTCCGGACT"	-0.180566663772422	8.25140092456666	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTCCGTCCGGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1921.29915873349	28.3452364679002	0.0147531613382818	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.46129627492	1916.46129627492
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTCCGTTGTAAAG"	-4.04578957977946	11.1702623137268	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTCCGTTGTAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1826.53840335775	21.9088351398205	0.0119947300859074	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1824.36280548793	1824.36280548793
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTCCTCCGTGTAA"	5.60602011260335	-9.94159986889037	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTCCTCCGTGTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.91258556531	40.985475677946	0.0167704343927938	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.93107026021	2429.93107026021
"healthy-4003"	"2020-08-26-Control4003-c2:GTGTTCCTCGCTTGAA"	-4.47314200821574	13.2133712538513	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGTTCCTCGCTTGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2278.40727999157	36.8390502114264	0.0161687730437566	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2271.212474014	2271.212474014
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACAGAGACTAGAT"	5.67583908614461	-9.52789690410765	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACAGAGACTAGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.18207824603	34.3768232472142	0.0133960966911243	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2562.92614513471	2562.92614513471
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACCCCAGCGAGTA"	-3.37945685806926	-5.6198826066223	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACCCCAGCGAGTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2326.2806083763	34.6388817364361	0.0148902422225896	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2320.64043739561	2320.64043739561
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACCCCATCCTGTC"	3.92195977744405	-7.45534469997557	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACCCCATCCTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.24060281504	22.1202897572538	0.0120530734353436	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1833.23569190285	1833.23569190285
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACCCGTCGTCTCT"	-1.67133782330211	9.05994031513063	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACCCGTCGTCTCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2027.86527485168	34.9828383037483	0.0172510662999084	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2024.68005588551	2024.68005588551
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACGAAGAAGCTGC"	2.65787567672078	-4.39225962078246	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACGAAGAAGCTGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2984.7327718308	32.51713452406	0.0108944877179455	2846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2979.89743967883	2979.89743967883
"healthy-4003"	"2020-08-26-Control4003-c2:GTTACGAAGCCAGACA"	5.5689546066219	-10.0474128953186	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTACGAAGCCAGACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2823.46137816305	41.5077838117994	0.0147010276580459	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2812.31092093589	2812.31092093589
"healthy-4003"	"2020-08-26-Control4003-c2:GTTAGACCAGAGATGC"	10.2893721061641	5.7736515768799	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTAGACCAGAGATGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1544.65430877805	5.36171430832782	0.00347114191043133	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1540.65905691082	1540.65905691082
"healthy-4003"	"2020-08-26-Control4003-c2:GTTAGACTCGGTAAGG"	-4.30648932877238	12.6402311095032	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTAGACTCGGTAAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1877.44121556775	29.3703663028478	0.015643827385544	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1866.94338927217	1866.94338927217
"healthy-4003"	"2020-08-26-Control4003-c2:GTTAGTGCATGTTTGG"	-4.4075325531071	12.6422595747742	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTAGTGCATGTTTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2174.53568377295	33.7386231882774	0.0155153228526188	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2164.9139075214	2164.9139075214
"healthy-4003"	"2020-08-26-Control4003-c2:GTTAGTGTCAAGGACG"	4.3896504836971	-7.43495848095091	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTAGTGTCAAGGACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.15822785243	36.3473825435944	0.0150434611957932	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.86467737596	2408.86467737596
"healthy-4003"	"2020-08-26-Control4003-c2:GTTAGTGTCCCATAGA"	-0.670468787581283	8.44507310474244	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTAGTGTCCCATAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1561.19714490151	19.1640105694839	0.0122752021626923	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1552.25050482449	1552.25050482449
"healthy-4003"	"2020-08-26-Control4003-c2:GTTATGGCAAGAATGT"	2.59019984778706	-4.57933905040892	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTATGGCAAGAATGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2263.39836596731	35.3350153361648	0.0156114875169417	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2263.39836596731	2263.39836596731
"healthy-4003"	"2020-08-26-Control4003-c2:GTTATGGCACACACTA"	5.2270962196285	-9.00941946422728	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTATGGCACACACTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.22637507155	21.1620931662664	0.00944640836379335	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.80919611159	2238.80919611159
"healthy-4003"	"2020-08-26-Control4003-c2:GTTATGGCACGGATCC"	4.47819151458089	-8.22577478801879	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTATGGCACGGATCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.32578204474	22.6341542459081	0.0107509034653655	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2099.01020168561	2099.01020168561
"healthy-4003"	"2020-08-26-Control4003-c2:GTTATGGCACTAGGCC"	4.11286844786946	-7.49058296596678	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTATGGCACTAGGCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.96803498158	30.5480233266863	0.0129114268980071	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2363.19741517075	2363.19741517075
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCATTCAAATCAGA"	-4.15740380707439	13.0279807814392	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCATTCAAATCAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2245.03386574421	36.3101297045227	0.0161735331740692	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2237.68276745625	2237.68276745625
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCATTCATCATCCC"	5.6313907104427	-9.87438394939574	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCATTCATCATCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2942.92583730662	29.5487473164735	0.0100406020912565	2224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2938.21584741459	2938.21584741459
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCATTGTATATGGA"	10.7618671852047	6.62858245456544	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCATTGTATATGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1995.91636159325	32.6689609251363	0.016367900756652	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1985.77811787855	1985.77811787855
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCATTTCCATACTT"	-4.17028508606608	12.7074937590393	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCATTTCCATACTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2046.64060697697	29.6391475430682	0.0144818525744231	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2036.42185423172	2036.42185423172
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCATTTCTAGCAAC"	5.61664070662801	-9.85227968609007	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCATTTCTAGCAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.27659162226	11.7115732649596	0.00442400816825213	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2638.48979503288	2638.48979503288
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCCGTAGAAGAACG"	-3.91253242912944	10.8668498762879	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCCGTAGAAGAACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1826.9234498412	31.7841271342566	0.0173976239327484	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1820.66397179083	1820.66397179083
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCCGTAGCCTGCCA"	4.46365179595296	-6.9375620118347	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCCGTAGCCTGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.90752582118	17.1120066168516	0.0070948021156099	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2409.02955631633	2409.02955631633
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCCGTAGGGAGATA"	4.36293568190877	-6.65579559719237	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCCGTAGGGAGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.95669670985	23.4853019077033	0.0103370376476425	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.68623117317	2267.68623117317
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCCGTGTCTCACAA"	-3.61182246628459	10.7449626692566	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCCGTGTCTCACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.4408850759	36.8887350673192	0.0196903651250382	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1865.937972267	1865.937972267
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCCGTGTGTTCGTA"	-2.40794930878337	9.58805463397828	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCCGTGTGTTCGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.33880914725	39.3241720142136	0.0213911449938083	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1830.69294397791	1830.69294397791
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCGCTCAATTCTCT"	-3.60027251663859	10.4261054762634	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCGCTCAATTCTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.5641798032	33.7369680438682	0.0167133492119916	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2002.47086485356	2002.47086485356
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCGCTCACATAGCT"	3.69680990752522	-6.82718946849974	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCGCTCACATAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.03006274394	8.75306890347541	0.00426556562810339	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.08709834545	2047.08709834545
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCGCTGTGTACATC"	3.89524426039998	-7.4077472916809	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCGCTGTGTACATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2036.86971298703	32.8882018259521	0.0161464435433733	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2035.06800498623	2035.06800498623
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCTATAGCTGTTCA"	-2.9075804752415	9.57715127551881	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCTATAGCTGTTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.36561727947	28.1341896518097	0.0148908127651442	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.50768083058	1881.50768083058
"healthy-4003"	"2020-08-26-Control4003-c2:GTTCTATTCTATCGGA"	3.18681730803792	-6.39762833034667	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTCTATTCTATCGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.85802494691	10.3050563450359	0.00486579186312277	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2107.13442511377	2107.13442511377
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGAACGTGTAACGG"	-0.415792415768462	8.34479138934938	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGAACGTGTAACGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.79357639543	33.0271874733195	0.0184633866697308	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1784.5138885246	1784.5138885246
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCGGAGCATCAGG"	4.39811625060384	-6.74612667476805	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCGGAGCATCAGG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2847.95257871024	9.5782267553334	0.00336319741660556	2476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2839.86710537672	2839.86710537672
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCGGCAACTGATC"	-4.43877397003825	12.8914623030457	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCGGCAACTGATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2051.0401126854	41.4325921740825	0.0202007712661628	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2043.18387328355	2043.18387328355
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCGGCAGGCGTTC"	3.63391604003255	-6.52925064479979	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCGGCAGGCGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.70387410035	29.2872909942163	0.0124855022484238	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.95334946642	2342.95334946642
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCGGGTCCAAGAG"	-2.79403696480449	9.86147782886354	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCGGGTCCAAGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.28073398385	2.06470348442832	0.00104052992556301	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1982.50632445235	1982.50632445235
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCAGGGAGATA"	5.34888376769368	-9.76190378582152	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCAGGGAGATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.17137152675	4.64096415472282	0.00193763344447648	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.01291919765	2391.01291919765
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCCACACGGAA"	-3.12373910370525	9.77269647205202	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCCACACGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2281.52236347487	25.0646259386205	0.0109859216547174	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2279.83273833043	2279.83273833043
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCGTCACGTGC"	3.52102007445638	-7.28768684780272	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCGTCACGTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1946.05993251508	2.71575821626806	0.00139551622788833	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1941.73338752022	1941.73338752022
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCGTGGTCCCA"	3.34945835646932	-6.24312212383422	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCGTGGTCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.28993038614	29.0243623137905	0.013013717148768	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.74688456592	2224.74688456592
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCGTGTGCCTG"	4.65181603011434	-7.65323355114134	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCGTGTGCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.38394182137	31.4966199053481	0.0135621932868888	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.02944103186	2321.02944103186
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGCTCTCCATAGAC"	-4.07081399384196	-5.21665766155394	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGCTCTCCATAGAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2765.67499194763	30.0864415384164	0.010878516682551	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2756.6129340048	2756.6129340048
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTAGGTAGCACGA"	10.0671125846798	7.74353692615358	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTAGGTAGCACGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1924.44010646246	22.0941553361793	0.0114808225322186	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1916.11353875771	1916.11353875771
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTAGTCGTGGAAG"	-2.76504836502727	9.64651105487672	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTAGTCGTGGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.08471435016	34.3239590526532	0.0179981302321691	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1899.6543416278	1899.6543416278
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTCCAGAGCAGAA"	-4.18270574036296	13.1122407683167	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTCCAGAGCAGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1657.27718740222	37.3341254559645	0.0225273875364722	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1648.43479200061	1648.43479200061
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTCCGTGGCATCC"	-4.14723716202434	13.0926685103211	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTCCGTGGCATCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2302.95028106447	35.8202248276584	0.0155540591224147	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2296.14485758097	2296.14485758097
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTCCTCACACGAT"	-4.07343087616618	12.9669112929138	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTCCTCACACGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2317.18863041633	35.3078252514328	0.015237354778963	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2315.42161899665	2315.42161899665
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTCCTCGACGATT"	-4.32419667664226	12.8956670531067	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTCCTCGACGATT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1821.59882270384	31.0154595911362	0.0170265039725373	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1817.50461454134	1817.50461454134
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTGAGTTAAGCAA"	-3.21494040909465	10.5727357634339	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTGAGTTAAGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2012.51653628057	35.8096070107981	0.0177934473408002	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2006.91386216153	2006.91386216153
"healthy-4003"	"2020-08-26-Control4003-c2:GTTGTGATCTTAATCC"	10.5621878105098	7.2708906897339	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTGTGATCTTAATCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1962.20096113344	32.1568930106401	0.0163881751398517	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1955.53683965825	1955.53683965825
"healthy-4003"	"2020-08-26-Control4003-c2:GTTTACTCACCAGTTA"	-4.08675990524943	10.0843724974426	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTTACTCACCAGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2477.42256454959	35.8627132108033	0.0144758160048984	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2468.36354042789	2468.36354042789
"healthy-4003"	"2020-08-26-Control4003-c2:GTTTACTTCGGCACTG"	4.57163061675374	-7.83179047023924	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTTACTTCGGCACTG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.2032712755	39.0911445165386	0.0151328178278579	1926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2579.24036785178	2579.24036785178
"healthy-4003"	"2020-08-26-Control4003-c2:GTTTGGATCTCTAAGG"	-1.25129650059398	9.05738065326539	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTTTGGATCTCTAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1815.50197178994	42.3682179404033	0.0233369165105514	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.83368834139	1807.83368834139
"healthy-4003"	"2020-08-26-Control4003-c2:TAACACGAGATGCAGC"	4.7935024696285	-7.60433771526488	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACACGAGATGCAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.45175811838	35.3210836574127	0.0140528194119209	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.99383099559	2510.99383099559
"healthy-4003"	"2020-08-26-Control4003-c2:TAACACGCAGTAGAGC"	0.548033674328965	9.45997045123903	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACACGCAGTAGAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1598.97553751959	44.953861806263	0.0281141648208062	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1594.84126903658	1594.84126903658
"healthy-4003"	"2020-08-26-Control4003-c2:TAACACGGTCATGACT"	-0.743586401373702	8.14280603015748	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACACGGTCATGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1747.77673654631	6.27763847004016	0.00359178511692808	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.81276454565	1745.81276454565
"healthy-4003"	"2020-08-26-Control4003-c2:TAACACGGTGGTTTGT"	-1.89230726185496	8.97415158832399	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACACGGTGGTTTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1513.99664590325	15.884908907512	0.0104920370533813	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1513.99664590325	1513.99664590325
"healthy-4003"	"2020-08-26-Control4003-c2:TAACCAGTCGGAGATG"	0.496931900351685	8.0248870619568	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACCAGTCGGAGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1507.68232329561	44.7736975355848	0.0296970368649775	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.85457946072	1505.85457946072
"healthy-4003"	"2020-08-26-Control4003-c2:TAACGACAGTTTAGGA"	3.99711789664571	-8.21402838146361	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACGACAGTTTAGGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.12995565715	10.8887760797368	0.00464512475234515	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.17084618255	2341.17084618255
"healthy-4003"	"2020-08-26-Control4003-c2:TAACGACTCTACGCAA"	-4.18722854080852	13.1795930632385	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACGACTCTACGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2535.76044940626	19.1608329617248	0.00755624726547463	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2525.77244900242	2525.77244900242
"healthy-4003"	"2020-08-26-Control4003-c2:TAACTTCCATTATGCG"	-0.899433831602889	9.62239453876344	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACTTCCATTATGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1351.55322114342	6.69716120844257	0.00495515907451778	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1346.87282767167	1346.87282767167
"healthy-4003"	"2020-08-26-Control4003-c2:TAACTTCTCGTTACCC"	4.44580950316731	-7.31087305462035	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAACTTCTCGTTACCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.3354716414	8.19186762130827	0.00353656355981258	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2309.73688507487	2309.73688507487
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCAAGATACAGT"	5.16438927230184	-7.68212177669676	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCAAGATACAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2787.25924987728	35.8009027111669	0.0128444825190707	2249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2785.49291060246	2785.49291060246
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCAAGCGTACAG"	4.5657602744991	-7.25749161159667	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCAAGCGTACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2760.91521382428	36.2253533722409	0.0131207771940462	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2751.80002297915	2751.80002297915
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCAAGTAACAGT"	5.56493105468099	-10.083221458551	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCAAGTAACAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.90296955241	41.3444417727233	0.01582318297101	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2606.16670985134	2606.16670985134
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCACAACACACT"	4.27187122878377	-7.11983158504637	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCACAACACACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.02551355321	30.1509996975384	0.0137048409265228	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2194.75335911614	2194.75335911614
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCACACTCATAG"	3.56125678595845	-6.53698923504027	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCACACTCATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.52601735412	23.4253288477596	0.0102539120455674	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.15809933491	2281.15809933491
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCAGTACCGCGT"	-2.11863384667094	9.27835843646852	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCAGTACCGCGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1787.65784134624	41.6565869489983	0.0233023266452532	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.63276922598	1785.63276922598
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCCATCTGCATAG"	4.24780239638631	-7.60127451336058	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCCATCTGCATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.70154839126	37.2853823645059	0.0170978841153261	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2179.31992993972	2179.31992993972
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTAGAAATTCG"	5.32169212874715	-8.86680509960326	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTAGAAATTCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.11205070746	19.5868749061766	0.00785639574467522	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.39116134489	2489.39116134489
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTAGATCGCTT"	5.5195766883785	-10.1357097855774	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTAGATCGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.37216270188	5.03791598187871	0.00184988157361517	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2713.36050024258	2713.36050024258
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTAGTTAGTGA"	3.13392986831014	-6.93757631694945	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTAGTTAGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1944.82186105029	36.7735351361656	0.0189084336579322	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1941.33008760483	1941.33008760483
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTCAAACACGG"	2.85057582434956	-7.22500708019408	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTCAAACACGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1817.74624547214	21.0793709446476	0.0115964321187044	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1812.07055044605	1812.07055044605
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTGTTCCACGG"	-2.69534955444987	9.87511441791383	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTGTTCCACGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1454.4300723425	31.8378885088654	0.0218902848024776	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1454.4300723425	1454.4300723425
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTTCATTATCC"	-7.1374810737675	2.80302569949952	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTTCATTATCC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2566.6069773445	35.6078203479491	0.0138734993952172	2261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2556.88957599656	2556.88957599656
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGCGTTCTAACGCA"	4.52766956862752	-8.00951292431029	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGCGTTCTAACGCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.53237854322	32.3480491410145	0.0138741582311742	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.88152278545	2327.88152278545
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGTCGAGACTTGTC"	-0.180255125195342	8.64921948993532	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGTCGAGACTTGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1578.21563071541	3.61966095970309	0.00229351483362403	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1570.16532606089	1570.16532606089
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGTCGCAAATCGTC"	-3.08133707466777	10.5451440581116	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGTCGCAAATCGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1768.06049703925	41.5192784614765	0.0234829512513873	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1768.06049703925	1768.06049703925
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGTCGCAGAACTCT"	0.23479857024495	8.40292832935182	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGTCGCAGAACTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.99633141164	27.5598517559365	0.0156590393196056	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1753.5727990122	1753.5727990122
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGTCGTCCAGCACG"	4.14301695403401	-6.53801586544188	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGTCGTCCAGCACG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2610.81540607077	11.87816737058	0.00454960061249847	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2609.73967750479	2609.73967750479
"healthy-4003"	"2020-08-26-Control4003-c2:TAAGTCGTCCGAACGC"	3.48069085654561	-6.55151512539061	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAAGTCGTCCGAACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.85212964791	28.4328956630032	0.0116918686446284	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.85439459706	2425.85439459706
"healthy-4003"	"2020-08-26-Control4003-c2:TAATCTCAGCAAATCA"	2.54841556128804	-4.17331316387328	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATCTCAGCAAATCA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2760.42305160614	35.2954786719418	0.0127862570381758	2684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2753.26515563082	2753.26515563082
"healthy-4003"	"2020-08-26-Control4003-c2:TAATCTCAGTTCCATG"	-2.74928460541423	10.9815063246521	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATCTCAGTTCCATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1684.47071155986	32.1339188711835	0.0190765672864841	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1682.43002596519	1682.43002596519
"healthy-4003"	"2020-08-26-Control4003-c2:TAATCTCGTTCCACGG"	11.0895220237667	6.27323196018068	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATCTCGTTCCACGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.91293606389	33.0481567724905	0.016957225826227	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1942.40974820565	1942.40974820565
"healthy-4003"	"2020-08-26-Control4003-c2:TAATCTCTCTGTTCAT"	3.91397752341573	-6.89935734188231	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATCTCTCTGTTCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.94832121507	35.6637121805895	0.0158720660568214	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.65429292975	2238.65429292975
"healthy-4003"	"2020-08-26-Control4003-c2:TAATTCCAGTACGTCT"	5.61067165908162	-10.0351190797058	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATTCCAGTACGTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.50299646326	24.8595888582537	0.011016864988532	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2253.66778125137	2253.66778125137
"healthy-4003"	"2020-08-26-Control4003-c2:TAATTCCCACACCGCA"	-0.914967874914962	9.02478883350221	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATTCCCACACCGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.36986576627	35.5296111744317	0.0202751781279322	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.2866118927	1745.2866118927
"healthy-4003"	"2020-08-26-Control4003-c2:TAATTCCTCCACTGAA"	4.52792372283284	-7.55515673076781	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAATTCCTCCACTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.72685142269	35.0622304108518	0.0126090163774673	1913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2772.00247637316	2772.00247637316
"healthy-4003"	"2020-08-26-Control4003-c2:TACAACGAGACTGTTC"	-0.18068658831771	8.6622218855652	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACAACGAGACTGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.42792967871	30.2300475603086	0.0150816335737021	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1993.5039724526	1993.5039724526
"healthy-4003"	"2020-08-26-Control4003-c2:TACAACGAGCCTCTGG"	4.30661739882771	-7.26255562221678	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACAACGAGCCTCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.65562471466	7.388334533576	0.00285632709007835	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2583.99937901678	2583.99937901678
"healthy-4003"	"2020-08-26-Control4003-c2:TACAACGTCGTTCTGC"	5.28417172011678	-9.51068975841673	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACAACGTCGTTCTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.75555945818	32.4302324678148	0.0127589894894251	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2536.00803452453	2536.00803452453
"healthy-4003"	"2020-08-26-Control4003-c2:TACACCCAGTGTACAA"	4.52905621108357	-7.2623009911743	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACACCCAGTGTACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.67949438402	32.9381177853131	0.0124075685426409	1779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2643.67054308265	2643.67054308265
"healthy-4003"	"2020-08-26-Control4003-c2:TACACCCCATCGCTCT"	-3.6758705181187	10.3417939909729	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACACCCCATCGCTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2028.30992932851	37.6963882461924	0.0185851223726307	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2020.81488148872	2020.81488148872
"healthy-4003"	"2020-08-26-Control4003-c2:TACACCCTCAGACAAA"	-3.79910741272624	10.4559449919495	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACACCCTCAGACAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2602.45557023682	39.6560309835007	0.0152379281464129	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2593.30038306546	2593.30038306546
"healthy-4003"	"2020-08-26-Control4003-c2:TACAGGTCAGTGAGCA"	-0.847597937018234	8.47816178882448	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACAGGTCAGTGAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.35513312588	41.1459729434147	0.0218587726722357	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1875.41286645987	1875.41286645987
"healthy-4003"	"2020-08-26-Control4003-c2:TACATTCGTGCATCTA"	2.59809960898702	-3.97361471569213	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACATTCGTGCATCTA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2598.05310255187	24.9743888363673	0.00961273224624884	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2586.06028319314	2586.06028319314
"healthy-4003"	"2020-08-26-Control4003-c2:TACCCACAGTGGCGAT"	-8.04877887192424	0.211341641190924	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCCACAGTGGCGAT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2938.78576816888	31.0761913321174	0.0105745004173886	3238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2920.70832555416	2920.70832555416
"healthy-4003"	"2020-08-26-Control4003-c2:TACCCACGTATTAAGG"	5.47342981871907	-10.0976915589538	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCCACGTATTAAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.02291868826	35.6960083751247	0.014445842693387	1521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.9120054038	2457.9120054038
"healthy-4003"	"2020-08-26-Control4003-c2:TACCCACGTCGTGCCA"	5.3251015144283	-10.0697813264099	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCCACGTCGTGCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2083.28178567586	45.8984370204215	0.0220317948997625	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.411080421	2080.411080421
"healthy-4003"	"2020-08-26-Control4003-c2:TACCCGTCAAGTGGTG"	3.84441651877705	-6.60689213192137	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCCGTCAAGTGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.03689510381	24.2812853143619	0.00929947997283911	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2603.73001221825	2603.73001221825
"healthy-4003"	"2020-08-26-Control4003-c2:TACCCGTTCTATTCGT"	2.53572573241536	-4.15914060985716	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCCGTTCTATTCGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2166.71047502554	32.9382765859231	0.015201974128793	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2157.84339456729	2157.84339456729
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGAAGTTTACTTC"	-3.67165718498881	13.1572885283264	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGAAGTTTACTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1617.78306388862	42.9340027232884	0.0265387885938731	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1617.78306388862	1617.78306388862
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGAAGTTTGGGTT"	-4.39568744126018	13.0615319975647	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGAAGTTTGGGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1781.36393276864	35.6300354169997	0.020001547556665	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1779.17086276911	1779.17086276911
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGAATCGGTCTGG"	6.72763838347737	-1.49211075222167	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGAATCGGTCTGG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1983.76653623157	1.46398374833289	0.000737981875182713	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1980.12662709749	1980.12662709749
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGAATCTATCGGA"	5.6118709045345	-9.80797197734984	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGAATCTATCGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.84784744627	40.289395132654	0.0158754178952042	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2534.13252575172	2534.13252575172
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGGGAGCCGGAAT"	5.42946209487264	-10.0268554917541	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGGGAGCCGGAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.1980111229	37.4108181511537	0.0152498159469931	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.06429054229	2449.06429054229
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGGGAGGTTGTTC"	-4.02799497070964	12.2820777663025	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGGGAGGTTGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2017.00461517594	29.0960591025976	0.014425380528968	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2011.37815496988	2011.37815496988
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGGGGTATGCAAA"	5.51572432097737	-9.68549635326537	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGGGGTATGCAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.55490342151	17.7952597583884	0.00704607915443858	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2520.34618555727	2520.34618555727
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGGGTCACGATCA"	5.38471998748128	-9.964963935968	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGGGTCACGATCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.59146426766	34.0489075196015	0.0135891696651966	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.43588161883	2500.43588161883
"healthy-4003"	"2020-08-26-Control4003-c2:TACCGGGTCTCTATGT"	5.70573200759236	-10.1247787705627	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCGGGTCTCTATGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.63501487341	35.6181923245153	0.0137807435554918	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2578.58375270577	2578.58375270577
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTCGGTGGCTGCT"	-3.76696978035625	12.3631257780823	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTCGGTGGCTGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1925.44295075403	41.2984196366939	0.0214487890282705	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1913.55454602967	1913.55454602967
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTCGTCAGTCTTT"	-3.14572916451152	9.46574208820192	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTCGTCAGTCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2533.45580296722	40.9907352110515	0.0161797711896306	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2525.70696508489	2525.70696508489
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTCGTCCACAGCG"	5.1212965446407	-7.85825445568236	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTCGTCCACAGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.7214300985	24.774013227428	0.009207201068942	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2683.52595536037	2683.52595536037
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTCGTCCATTCAT"	5.63179029998128	-9.86099054729613	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTCGTCCATTCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.23494964216	25.9234578356455	0.0101731034806213	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2542.81200666901	2542.81200666901
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTCGTCCGACGGT"	4.93656458434407	-7.47815134441527	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTCGTCCGACGGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2793.62158457264	28.1688086883114	0.010083258535755	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2790.05361924781	2790.05361924781
"healthy-4003"	"2020-08-26-Control4003-c2:TACCTGCCAGCTGAGA"	-3.93095646324809	10.0311136015686	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACCTGCCAGCTGAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.66992405447	41.6559400503058	0.021278326615977	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1952.00066577574	1952.00066577574
"healthy-4003"	"2020-08-26-Control4003-c2:TACGCTCAGATTGAGT"	-3.41854653778728	-5.450710319635	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGCTCAGATTGAGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2812.92077683958	47.7522669532032	0.0169760440273951	2399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2804.45148995029	2804.45148995029
"healthy-4003"	"2020-08-26-Control4003-c2:TACGCTCTCGTCACCT"	4.63342680510823	-7.31659510051879	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGCTCTCGTCACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2804.18100654072	31.8681392523398	0.0113645086312216	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2801.05948932899	2801.05948932899
"healthy-4003"	"2020-08-26-Control4003-c2:TACGGGCCACTTGAGT"	5.10596432265584	-8.22458937084349	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGGGCCACTTGAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.69124299755	15.3993653024377	0.00677582815082567	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2269.9087300256	2269.9087300256
"healthy-4003"	"2020-08-26-Control4003-c2:TACGGGCGTTTCGATG"	-3.91793451729472	12.9450464018616	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGGGCGTTTCGATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2069.55458198805	33.6146938121629	0.0162424775382692	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2065.38017677934	2065.38017677934
"healthy-4003"	"2020-08-26-Control4003-c2:TACGTCCAGGTCACAG"	5.56291880187337	-9.68821527874144	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGTCCAGGTCACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.52151563624	45.7109292285992	0.0167837591758186	1911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2719.17481975525	2719.17481975525
"healthy-4003"	"2020-08-26-Control4003-c2:TACGTCCGTCAAACGG"	-7.40769706192668	0.492331183794416	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGTCCGTCAAACGG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2149.85936872337	2.18120808146469	0.00101458175041465	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2143.14378749447	2143.14378749447
"healthy-4003"	"2020-08-26-Control4003-c2:TACGTCCTCTGACAGT"	9.11482491072957	6.1794714697632	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACGTCCTCTGACAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1843.7174936367	37.8176786186961	0.0205116449506054	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1834.66696205608	1834.66696205608
"healthy-4003"	"2020-08-26-Control4003-c2:TACTGCCCAAGAGATT"	10.2266594367916	7.09558866107789	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTGCCCAAGAGATT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.36162757159	31.5787702821742	0.0168387631579439	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1863.92315610273	1863.92315610273
"healthy-4003"	"2020-08-26-Control4003-c2:TACTGCCGTTGGGCCT"	9.89576592025105	7.09783647144166	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTGCCGTTGGGCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1735.61600163714	34.5391655231615	0.0199002345510654	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1730.32273762108	1730.32273762108
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTACGTTTATGCG"	2.43774380263631	-4.33176710521849	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTACGTTTATGCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2406.82958130839	37.6386030365774	0.0156382501398859	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2404.88145947373	2404.88145947373
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTACTCGGCTTCT"	-0.53366450491603	8.04792211139528	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTACTCGGCTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.59755058747	26.0682498744676	0.0134123702031772	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1934.44434314331	1934.44434314331
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTCAAGAGAAGGT"	4.16804565963094	-6.51820232784423	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTCAAGAGAAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.37107733132	15.2308172562559	0.00650508473591288	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.048415808	2336.048415808
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTCAGTGTCTCCT"	9.09433426436726	6.99781844699708	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTCAGTGTCTCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1754.48416698982	25.5404932664413	0.0145572663162081	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1748.31398192353	1748.31398192353
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTCAGTTCAAAGA"	-3.11918602410014	10.4625034102234	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTCAGTTCAAAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1588.808096719	47.0576442131823	0.0296182051881279	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1586.6358281037	1586.6358281037
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTCATCCATAAGC"	-4.30844054642375	12.5417699583801	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTCATCCATAAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2508.21048457391	14.0125387897158	0.00558666781591745	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2500.30827913446	2500.30827913446
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTGTGTACCGGAA"	-3.74355588379558	10.2998904951843	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTGTGTACCGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2058.97344551319	35.4537444857036	0.0172191363433864	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2048.03870749036	2048.03870749036
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTGTGTGTTTGCA"	4.04457797583882	-6.88592674648436	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTGTGTGTTTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.58115055589	34.8457581756483	0.0149131384404767	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.03842697042	2331.03842697042
"healthy-4003"	"2020-08-26-Control4003-c2:TACTTGTGTTTACGTG"	5.10352625426595	-8.39319994365843	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TACTTGTGTTTACGTG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.56020892297	18.9711487154552	0.00745850192533409	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2540.83266612609	2540.83266612609
"healthy-4003"	"2020-08-26-Control4003-c2:TAGACCAAGTGGAAAG"	5.58969702300374	-9.66637899791869	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGACCAAGTGGAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.72387984743	18.4748164109752	0.0076287873133328	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2415.59885329307	2415.59885329307
"healthy-4003"	"2020-08-26-Control4003-c2:TAGACCAAGTTAACGA"	11.2043920951778	5.84442517841188	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGACCAAGTTAACGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1619.04473118791	32.443347640043	0.0200385739906266	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1619.04473118791	1619.04473118791
"healthy-4003"	"2020-08-26-Control4003-c2:TAGACCATCATGAGGG"	4.92962135848348	-8.47811415111693	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGACCATCATGAGGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.60992956777	12.5455338958825	0.00614492206086521	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2038.20266187482	2038.20266187482
"healthy-4003"	"2020-08-26-Control4003-c2:TAGACTGAGGGTAGCT"	4.1488958793575	-8.17864229595336	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGACTGAGGGTAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1832.31015176684	43.7449429946317	0.0238742021662925	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1832.31015176684	1832.31015176684
"healthy-4003"	"2020-08-26-Control4003-c2:TAGACTGGTTGTGGCC"	-2.10366568985637	9.15029332721559	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGACTGGTTGTGGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1628.79839075612	35.8691062582368	0.022021820786295	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1626.64721935491	1626.64721935491
"healthy-4003"	"2020-08-26-Control4003-c2:TAGAGTCGTCAGGAGT"	1.16129877147023	8.90717504108278	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGAGTCGTCAGGAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1428.46719791287	34.0925797188425	0.023866547141338	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1428.46719791287	1428.46719791287
"healthy-4003"	"2020-08-26-Control4003-c2:TAGAGTCGTCTCGGGT"	-3.50238738480266	10.3243283995422	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGAGTCGTCTCGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1722.58849615889	36.1047894602145	0.0209596137096717	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1718.44764512094	1718.44764512094
"healthy-4003"	"2020-08-26-Control4003-c2:TAGATCGAGACATAGT"	-3.65101919594463	12.6149415739807	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGATCGAGACATAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1589.67265322207	31.3431012007693	0.0197167015091068	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1587.3760893723	1587.3760893723
"healthy-4003"	"2020-08-26-Control4003-c2:TAGATCGAGAGCACTG"	-4.39657864990886	12.9947051771912	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGATCGAGAGCACTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2064.65939102699	35.2760890831585	0.0170856700318068	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2060.53401440794	2060.53401440794
"healthy-4003"	"2020-08-26-Control4003-c2:TAGCACAAGACAACTA"	4.31133856353108	-6.57096102153929	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGCACAAGACAACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.03734009986	13.9553810125272	0.00644579229838294	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2163.54118250755	2163.54118250755
"healthy-4003"	"2020-08-26-Control4003-c2:TAGCACAAGAGTCCGA"	3.9258836704189	-6.75204660808715	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGCACAAGAGTCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.37529086439	33.3950720977395	0.0137237655955144	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.37529086439	2433.37529086439
"healthy-4003"	"2020-08-26-Control4003-c2:TAGCACAAGTTAGAAC"	-3.34923301163371	12.5603189238342	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGCACAAGTTAGAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1791.92153081481	33.7197538518967	0.0188176509250178	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1785.50140206852	1785.50140206852
"healthy-4003"	"2020-08-26-Control4003-c2:TAGCACACAAACTAAG"	-0.885921756655532	8.53538129413453	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGCACACAAACTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.6911006399	34.9121465175078	0.0198512100873229	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1758.6911006399	1758.6911006399
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGAGGAGCGCTGCT"	3.17378272589986	-6.74994137203368	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGAGGAGCGCTGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.02330211162	25.0592771661635	0.0126945194311321	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1972.45336369613	1972.45336369613
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGAGGCACGGTAGA"	-4.38009963455852	12.8839406737122	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGAGGCACGGTAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1697.65888905435	25.8278855680416	0.0152138251886565	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1695.25759456	1695.25759456
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGAGGGTTTGTTCT"	-4.11196790161784	12.4896754988464	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGAGGGTTTGTTCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2347.66987949053	39.2403834168444	0.0167146087103865	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2342.33035677996	2342.33035677996
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGGTTAGCTGTTCA"	4.88263144072835	-7.52347853099974	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGGTTAGCTGTTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.62103414168	39.148646422137	0.0164033777722136	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2385.26994998734	2385.26994998734
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGGTTAGCTTTCCC"	-3.71937666359599	10.8161611326965	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGGTTAGCTTTCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1721.27230431714	36.8940739837275	0.0214341878918245	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1719.10695813828	1719.10695813828
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGGTTCATAAGATG"	-0.451698998839217	8.39306733692018	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGGTTCATAAGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1461.65335461563	26.3990381502968	0.0180610799865327	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1455.193454479	1455.193454479
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGGTTTCGTCAAAC"	2.52169789847676	-4.36494591152342	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGGTTTCGTCAAAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2372.95829605724	31.4231093516127	0.013242166709724	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2366.02026086524	2366.02026086524
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTACAGGGAGGGT"	4.12743916091268	-7.02897312557372	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTACAGGGAGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.96580590191	37.1839973754772	0.0144181816177564	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2575.86855449629	2575.86855449629
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTACGTCAAAGCG"	4.98391546782796	-7.8274717560974	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTACGTCAAAGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.98730389274	32.4097452162306	0.0134816623880459	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2398.65997219103	2398.65997219103
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTTGAGCACTCTA"	3.88780035552327	-7.93799736416014	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTTGAGCACTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.32176022158	24.5346657332903	0.0117428852752141	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2084.78891809419	2084.78891809419
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTTGAGCTGCGAA"	3.32206167754475	-5.73563291942748	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTTGAGCTGCGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.40901475525	12.3385220731321	0.00533117612075882	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2310.14833819212	2310.14833819212
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTTGCACAGCGCT"	3.50285877761189	-7.15980818187865	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTTGCACAGCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.59862539286	15.2370790589458	0.00741608549262625	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.757012315	2049.757012315
"healthy-4003"	"2020-08-26-Control4003-c2:TAGGTTGTCCACGGGT"	-3.94570336762126	10.794406867865	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGGTTGTCCACGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.15461784979	35.8517624122226	0.0187592160662327	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1905.47604686974	1905.47604686974
"healthy-4003"	"2020-08-26-Control4003-c2:TAGTGCAAGCCTGAGA"	4.73445667800252	-7.92118933117064	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGTGCAAGCCTGAGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.58312102736	30.2178979918297	0.0128227592407842	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2353.76605741615	2353.76605741615
"healthy-4003"	"2020-08-26-Control4003-c2:TAGTGCAAGTGGACTG"	4.51187195357625	-7.37936928188475	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGTGCAAGTGGACTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.5840584783	34.0641228008539	0.0146224055220849	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.1067364886	2328.1067364886
"healthy-4003"	"2020-08-26-Control4003-c2:TAGTGCACACGCCAGT"	4.60070337828938	-7.11616041576537	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGTGCACACGCCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.27785561837	30.1901158325794	0.0122461311059831	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.4870360225	2457.4870360225
"healthy-4003"	"2020-08-26-Control4003-c2:TAGTGCAGTCAGGAGT"	3.84221424636189	-8.04743387615355	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TAGTGCAGTCAGGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.41802868652	25.8996281628377	0.012336575093166	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2091.45605131127	2091.45605131127
"healthy-4003"	"2020-08-26-Control4003-c2:TATACCTAGGCCTAGA"	-1.39852045002635	8.62542913043825	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATACCTAGGCCTAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.49987719958	37.4779565920489	0.0209432574260351	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.30852425476	1785.30852425476
"healthy-4003"	"2020-08-26-Control4003-c2:TATACCTAGTCCTACA"	10.6896740394527	6.59969852054445	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATACCTAGTCCTACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.29272381246	18.1855528078402	0.0096922791295	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1867.69876617355	1867.69876617355
"healthy-4003"	"2020-08-26-Control4003-c2:TATACCTGTTCGAACT"	14.19185413894	2.07123110378114	"2020-08-26-Control4003-c2"	"Control4003"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATACCTGTTCGAACT"	"Plasma cell"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1230.33266893853	28.0489879195264	0.0227978892438301	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1221.01590011766	1221.01590011766
"healthy-4003"	"2020-08-26-Control4003-c2:TATATCCGTTCACGAT"	5.08547129210774	-8.41562654888304	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATATCCGTTCACGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.77750005382	31.9909242204708	0.0121602546090714	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2625.02448736828	2625.02448736828
"healthy-4003"	"2020-08-26-Control4003-c2:TATATCCGTTCTCGCT"	3.39222087439839	-6.47982885753783	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATATCCGTTCTCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.39955977098	13.4596044936441	0.00580305555243493	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2314.92761198827	2314.92761198827
"healthy-4003"	"2020-08-26-Control4003-c2:TATATCCTCCCGTTCA"	3.546718497842	-7.48839523708495	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATATCCTCCCGTTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.45212964694	39.7728100656876	0.0194255140277912	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.08537832906	2044.08537832906
"healthy-4003"	"2020-08-26-Control4003-c2:TATATCCTCCGCTGTT"	5.63763203200643	-9.94407179271849	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATATCCTCCGCTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.26094105981	30.1891587380503	0.0111925243414485	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2690.57859245211	2690.57859245211
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGAGTTACTCG"	14.3746887641842	2.05375418746797	"2020-08-26-Control4003-c2"	"Control4003"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGAGTTACTCG"	"Plasma cell"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1248.38205794488	16.8273398680398	0.0134793188999699	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1234.97137196974	1234.97137196974
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGCAACAACAA"	-4.13151727142985	12.7337770231995	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGCAACAACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2078.49156523554	29.545319334944	0.0142147891428156	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2070.73204558183	2070.73204558183
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGCAACCTATG"	-4.11002955856975	13.1246957548889	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGCAACCTATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2022.26270208263	38.4368212704162	0.0190068388398955	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2016.27595534086	2016.27595534086
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGCAGTAGAGC"	-4.17649541321452	11.5015830763611	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGCAGTAGAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2316.87721299772	40.5049993592184	0.0174825835102459	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2304.23333247709	2304.23333247709
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGGTATACCCA"	-2.25382266464885	9.73379323566285	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGGTATACCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.58638181225	36.8955629575244	0.0191507441897406	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1920.9615513129	1920.9615513129
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGGTTGTCCCT"	5.5249740081722	-9.98657324230345	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGGTTGTCCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.48900209821	30.1149428118866	0.0126348150905568	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.29382441948	2376.29382441948
"healthy-4003"	"2020-08-26-Control4003-c2:TATCAGGTCCGACGGT"	-3.75953422012981	11.1375550993714	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCAGGTCCGACGGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1965.2010251713	34.0554703679985	0.0173292553442618	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1960.1431210757	1960.1431210757
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTAAGAGGGTCT"	-0.400198201567489	8.57402036273805	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTAAGAGGGTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1839.40886807125	29.5097963405254	0.0160430869138238	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1828.97424460017	1828.97424460017
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTAGTAAGCTCT"	-0.493188242346603	8.5453948744568	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTAGTAAGCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1552.75310946544	28.9696395419868	0.0186569515561686	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1546.69087533903	1546.69087533903
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTAGTGGGACAT"	-3.98105321350749	11.0562991865906	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTAGTGGGACAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.40086419091	43.9589672171178	0.0221746106002931	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1975.64464418369	1975.64464418369
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTATCCAACACA"	5.32013382491414	-9.22144319927367	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTATCCAACACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.80187647863	4.4707268793771	0.00173431748970727	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2572.15089598624	2572.15089598624
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTATCGCAGAGA"	5.50692047652547	-9.79845335399779	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTATCGCAGAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.85695957968	0	0	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2480.90889488644	2480.90889488644
"healthy-4003"	"2020-08-26-Control4003-c2:TATCCTATCTCCTGCA"	4.70982803878133	-8.09507658397826	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCCTATCTCCTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.75939085306	3.43530089484979	0.00141210055863568	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2431.52181893929	2431.52181893929
"healthy-4003"	"2020-08-26-Control4003-c2:TATCGCCAGGATAATC"	4.51398291167561	-7.17066576397093	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCGCCAGGATAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.03136327406	5.80969977535313	0.00224483360510879	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.65366443867	2586.65366443867
"healthy-4003"	"2020-08-26-Control4003-c2:TATCGCCGTGATAGTA"	4.80143751677815	-7.84678127681883	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCGCCGTGATAGTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.16875031716	18.4747929796161	0.00823235461994784	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.73546374928	2242.73546374928
"healthy-4003"	"2020-08-26-Control4003-c2:TATCTGTCAACCACAT"	5.41342558440511	-9.3371792069641	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCTGTCAACCACAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2692.16839819774	4.87912412573561	0.00181233987034463	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2685.15530644253	2685.15530644253
"healthy-4003"	"2020-08-26-Control4003-c2:TATCTGTGTATAGGAT"	0.199888934462708	8.44938275897828	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCTGTGTATAGGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1842.23308194662	27.5363449459237	0.0149472643911199	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1833.81364979708	1833.81364979708
"healthy-4003"	"2020-08-26-Control4003-c2:TATCTTGCAGGTTCGC"	-6.98147139969524	3.24993918025819	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCTTGCAGGTTCGC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2597.93449541905	24.6452753884135	0.00948648837446465	2041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2584.37624423533	2584.37624423533
"healthy-4003"	"2020-08-26-Control4003-c2:TATCTTGGTAGATCGG"	4.35551657256429	-7.84137108242186	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCTTGGTAGATCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1844.57128206836	31.8737757257672	0.0172797744579577	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1844.57128206836	1844.57128206836
"healthy-4003"	"2020-08-26-Control4003-c2:TATCTTGTCCGAAGGA"	-0.500841419131118	8.61605546558229	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATCTTGTCCGAAGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1867.16560089835	35.2807689660601	0.0188953614768211	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1858.46968625749	1858.46968625749
"healthy-4003"	"2020-08-26-Control4003-c2:TATGTTCCACCCTAAA"	5.67703308638875	-9.84232523357543	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATGTTCCACCCTAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.2478316004	22.0453113214917	0.00855050125565602	1604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2574.56004965167	2574.56004965167
"healthy-4003"	"2020-08-26-Control4003-c2:TATGTTCCAGACTCTA"	11.1062466102535	5.3083286055359	"2020-08-26-Control4003-c2"	"Control4003"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATGTTCCAGACTCTA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1810.62932320368	27.4237277409912	0.0151459646596623	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1808.84996948649	1808.84996948649
"healthy-4003"	"2020-08-26-Control4003-c2:TATGTTCGTCGGTGAA"	5.0975829559261	-10.1550646058288	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATGTTCGTCGGTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1607.38108954738	4.23321586898189	0.00263361059583817	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1601.20718602242	1601.20718602242
"healthy-4003"	"2020-08-26-Control4003-c2:TATTCCAAGGTGCTTT"	-4.29300246658977	12.9577226408753	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTCCAAGGTGCTTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1912.25008003614	26.5068609443752	0.0138616079670261	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1910.12271020082	1910.12271020082
"healthy-4003"	"2020-08-26-Control4003-c2:TATTCCACATCCTCAC"	-3.04130135002788	9.83224961841432	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTCCACATCCTCAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2282.60316733815	34.1290033208042	0.0149517900479405	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2274.74026365881	2274.74026365881
"healthy-4003"	"2020-08-26-Control4003-c2:TATTCCATCTCGAGTA"	3.7650064426357	-6.7381801835266	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTCCATCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.65598848005	20.4866270232818	0.00812749820559022	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2514.79638311568	2514.79638311568
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGCTAGCGTGCCT"	-0.149505491287071	8.67335221851198	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGCTAGCGTGCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2125.73432050867	21.5374340517833	0.0101317619252765	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2117.69119452406	2117.69119452406
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGCTAGCTGACAG"	5.60668530043904	-9.96435167705687	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGCTAGCTGACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.3741829774	11.1475570700824	0.00428525705491683	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2591.94687707566	2591.94687707566
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGCTAGCTTCGTA"	-1.03753731671031	9.32905957782594	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGCTAGCTTCGTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2022.99068834489	36.4716243792396	0.0180285676001203	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2019.48484271254	2019.48484271254
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGCTAGGGTACGT"	5.41939320144002	-10.0633630982605	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGCTAGGGTACGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.81458363739	41.0116922028332	0.0180523941074318	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.60704418303	2267.60704418303
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGCTTCAGAACCT"	3.56236805495564	-5.70886328136595	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGCTTCAGAACCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2819.65378646559	23.8718910210376	0.00846624898972467	2295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2816.1646291085	2816.1646291085
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGGGCATACAGAA"	3.90706696090047	-7.43823339855345	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGGGCATACAGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.34766975608	14.8373988499557	0.00624115649499344	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2374.61057045392	2374.61057045392
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGGGTCCAAGCAT"	-1.1348788541859	8.82570550525514	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGGGTCCAAGCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1723.03182100816	31.3214257074755	0.0181780889508756	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1721.08322873455	1721.08322873455
"healthy-4003"	"2020-08-26-Control4003-c2:TATTGGGTCGGAAGGT"	2.80957974967305	-4.59346725856932	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTGGGTCGGAAGGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2453.11378051439	35.4935351628004	0.0144687684055804	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2451.9725420709	2451.9725420709
"healthy-4003"	"2020-08-26-Control4003-c2:TATTTCGCAAGTATAG"	-0.989065508276779	8.61740777576295	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTTCGCAAGTATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1753.18796560391	33.128057679926	0.0188958961217342	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1749.11557257613	1749.11557257613
"healthy-4003"	"2020-08-26-Control4003-c2:TATTTCGTCTGCTTTA"	-3.37482271614726	9.97779843890993	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TATTTCGTCTGCTTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.60595085146	33.5791377301077	0.0161313613253135	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2079.77292151877	2079.77292151877
"healthy-4003"	"2020-08-26-Control4003-c2:TCAAGACAGACTACGG"	-0.178700278431732	8.63172433460084	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAAGACAGACTACGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2287.03426383964	28.0377392652999	0.0122594312243613	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2273.23460617993	2273.23460617993
"healthy-4003"	"2020-08-26-Control4003-c2:TCAAGACAGGCATGCA"	-0.39435781064685	8.56284234607545	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAAGACAGGCATGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1694.95539544812	26.3893841296524	0.01556936790226	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.18368637525	1693.18368637525
"healthy-4003"	"2020-08-26-Control4003-c2:TCAAGCAAGCTATCTG"	3.41818203505818	-6.39093019878539	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAAGCAAGCTATCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.36158247445	34.1725059394445	0.0126876785359244	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2687.64221068727	2687.64221068727
"healthy-4003"	"2020-08-26-Control4003-c2:TCAAGTGGTACGCTAT"	5.58688749846761	-9.53988649761351	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAAGTGGTACGCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2826.87908411522	36.3452690774521	0.0128570299598887	2098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2821.89844507842	2821.89844507842
"healthy-4003"	"2020-08-26-Control4003-c2:TCAAGTGTCTCGCAGG"	-3.89104137840922	11.7561120756897	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAAGTGTCTCGCAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1840.67935860292	38.2038515594295	0.020755299602222	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1828.60409248326	1828.60409248326
"healthy-4003"	"2020-08-26-Control4003-c2:TCAATCTAGCTGCCAC"	10.6177021461422	6.24226996982423	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAATCTAGCTGCCAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2107.32688566212	32.7695870522299	0.0155503103363737	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2094.40505862623	2094.40505862623
"healthy-4003"	"2020-08-26-Control4003-c2:TCAATCTGTGGTCTCG"	3.91785540160481	-6.68206837093505	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAATCTGTGGTCTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.07250289907	27.6799556010846	0.010358983736801	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2668.30950102332	2668.30950102332
"healthy-4003"	"2020-08-26-Control4003-c2:TCAATTCAGGAGAATG"	3.60542048987691	-6.89017202770384	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAATTCAGGAGAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.11128722911	30.1329662542347	0.0147630197543719	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2041.11128722911	2041.11128722911
"healthy-4003"	"2020-08-26-Control4003-c2:TCAATTCCAAGACGAC"	4.34881891784017	-7.53864242946776	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAATTCCAAGACGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.08352589019	45.6107722908377	0.0190594151008044	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.81198459903	2391.81198459903
"healthy-4003"	"2020-08-26-Control4003-c2:TCACAAGCACCACATA"	-7.11096988144572	3.37515661800233	"2020-08-26-Control4003-c2"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACAAGCACCACATA"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2810.09417254109	32.3710926871748	0.0115195757506954	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2793.23543817592	2793.23543817592
"healthy-4003"	"2020-08-26-Control4003-c2:TCACAAGGTACGGTTT"	-0.432243983179885	8.62479016864625	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACAAGGTACGGTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.99634535826	42.7364258038113	0.0235592678635584	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.33633367502	1809.33633367502
"healthy-4003"	"2020-08-26-Control4003-c2:TCACAAGGTTCGGTCG"	4.88534082946126	-7.79419233715209	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACAAGGTTCGGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.00609878701	39.3324049801367	0.0159111278080732	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2465.39371117432	2465.39371117432
"healthy-4003"	"2020-08-26-Control4003-c2:TCACACCTCCATAGAC"	10.2395836311275	7.8221487768921	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACACCTCCATAGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2131.71082037551	9.9596047462864	0.0046721181180344	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2127.6303287664	2127.6303287664
"healthy-4003"	"2020-08-26-Control4003-c2:TCACATTAGTAACCTC"	-1.16799030724223	8.55161283099977	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACATTAGTAACCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2026.9676460161	33.0288725899218	0.0162947211588889	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2018.96815313949	2018.96815313949
"healthy-4003"	"2020-08-26-Control4003-c2:TCACATTGTGGATCAG"	-4.15557513657268	12.9791745909485	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACATTGTGGATCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1888.06623737714	40.470983808844	0.0214351504241003	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1882.1431604841	1882.1431604841
"healthy-4003"	"2020-08-26-Control4003-c2:TCACATTGTGGCCTCA"	4.01764001426045	-6.86769964611205	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACATTGTGGCCTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.76844164981	32.244323204786	0.0129924785341177	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2473.49723763215	2473.49723763215
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGCTAGGAGATAG"	4.82988514479939	-7.75738670742186	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGCTAGGAGATAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.51365556783	34.4969512433765	0.0136810487491125	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2518.2855398031	2518.2855398031
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGCTAGGTGCCAA"	-0.601166645914871	8.25190064990846	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGCTAGGTGCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2242.2340155596	19.8641645061479	0.00885909515612731	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2231.1979920913	2231.1979920913
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGGGCAGTTAAAG"	5.47980703887288	-10.1931886903015	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGGGCAGTTAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.03129300632	31.7109653396722	0.0151507363724717	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2086.77175104847	2086.77175104847
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGGGGTTCCTAGA"	-3.92184267464336	10.4359264143738	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGGGGTTCCTAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1897.17279408468	33.1739062191341	0.01748596981918	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1889.08487889889	1889.08487889889
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGGGTCAGATGCT"	4.23783793029134	-7.30242493068846	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGGGTCAGATGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.46907334452	28.0828254442567	0.0109850049574498	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2551.89381610377	2551.89381610377
"healthy-4003"	"2020-08-26-Control4003-c2:TCACGGGTCTTCGGTC"	3.08504023131673	-5.07958605205687	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACGGGTCTTCGGTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2602.59533174004	20.9843009980219	0.00806283663929893	1932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2597.13201556399	2597.13201556399
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTATCAGTGTACT"	4.01633419570271	-7.03019668972167	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTATCAGTGTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.76188762915	22.3355797146852	0.0122402708353938	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1824.76188762915	1824.76188762915
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTATTCTAGTCAG"	-3.27355537834819	10.3436107405457	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTATTCTAGTCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2202.1626190044	36.8504011068924	0.016733732917305	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2198.90940393054	2198.90940393054
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTCGAGTAAGGGA"	3.44514741477315	-7.05186417019042	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTCGAGTAAGGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.59085842239	40.4683582052111	0.017854284576696	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2266.59085842239	2266.59085842239
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTCGCACTAGGTT"	-0.87601343813594	8.42396352374879	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTCGCACTAGGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.50387354527	33.1029158322688	0.0176407394085084	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1874.77003870211	1874.77003870211
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTCGCATGTCGTA"	-2.77076158943828	9.97941491687623	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTCGCATGTCGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.21382936815	35.093581123821	0.0183140214238996	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.71517074084	1912.71517074084
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTCGTCAGCTTCC"	-5.24412904205974	-5.08327200328978	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTCGTCAGCTTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2777.74137983602	41.6161304012652	0.014982003257525	1962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2769.13762089709	2769.13762089709
"healthy-4003"	"2020-08-26-Control4003-c2:TCACTCGTCTACTGCC"	4.44980587539021	-6.70955469524535	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCACTCGTCTACTGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.4456896143	38.3482673849699	0.0170402989780848	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2247.90654731407	2247.90654731407
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGCAAGTCAGGTAG"	6.81633915480916	-1.6512329808441	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGCAAGTCAGGTAG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2245.65288827527	29.4603816500364	0.0131188492236941	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2229.19513133826	2229.19513133826
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGCAATCACTACGA"	-2.7502592605656	10.2401084669861	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGCAATCACTACGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.71491768967	46.1184487183533	0.0234018874594096	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1965.89078592911	1965.89078592911
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGCCTTCTCCTACG"	-2.39868889275249	9.85206029498903	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGCCTTCTCCTACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2532.77383318586	32.874016650239	0.0129794521008961	1596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2521.01307470383	2521.01307470383
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCAGGTCTGGA"	4.88408293303792	-7.75045587932738	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCAGGTCTGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.83959793184	30.0555674816455	0.0121788982990764	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.83959793184	2467.83959793184
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCAGTCAGGGT"	-2.72685275498088	9.94961736286012	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCAGTCAGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1985.20801921279	35.176531559961	0.0177193176833478	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1981.46442117928	1981.46442117928
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCCAGGGTCTC"	4.1054798561031	-6.56070568477782	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCCAGGGTCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.88916149793	25.6212787585742	0.00997756411870538	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2563.38722723229	2563.38722723229
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCCATCGCTGG"	5.33868088301961	-10.2646503678528	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCCATCGCTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.55313740941	31.491081573929	0.0146910664468004	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2133.94284931508	2133.94284931508
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCGTGTATTCG"	3.87096824225728	-7.23537638103636	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCGTGTATTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2012.17014515177	1.52989595782415	0.000760321368205548	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2010.2503374278	2010.2503374278
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGGCTCGGTATGT"	5.53911509093587	-10.0705871812073	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGGCTCGGTATGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.36904447867	31.3699776184305	0.0132008021613127	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.9304184531	2368.9304184531
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGTAAGTATGAAC"	3.98158683356587	-7.28597214138182	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGTAAGTATGAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1960.81520675911	29.7259848887391	0.0151600134404664	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1960.81520675911	1960.81520675911
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGTACATCTATCT"	-3.11747894707378	10.5800237425598	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGTACATCTATCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2034.10835057887	36.5813895757896	0.0179839926252597	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2023.68933796007	2023.68933796007
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGTACATGTCAGT"	5.24404348906819	-10.1199245682922	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGTACATGTCAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.50401053406	31.9044405099872	0.0160767830856644	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1980.91362863535	1980.91362863535
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGGTAGTGCCTACG"	6.78047384795491	-1.76580920135649	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGGTAGTGCCTACG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2565.69295771595	30.4456456386646	0.0118664415970366	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2553.0541207762	2553.0541207762
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTCCCAGGACATG"	3.98728408393208	-7.35330965435179	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTCCCAGGACATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.39004534895	33.962851668137	0.0170805782032452	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1988.39004534895	1988.39004534895
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTGAAGATTTGCC"	-4.12637362900432	13.2299365767273	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTGAAGATTTGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2244.40737396395	37.173959205067	0.0165629286538176	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2240.94993007231	2240.94993007231
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTGAGTTCTCCCA"	5.30494608458821	-9.87348749553832	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTGAGTTCTCCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.03708675221	38.3995461382876	0.0149354306618715	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2561.86882042184	2561.86882042184
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTTTAGAGATTCA"	4.52455153045003	-7.02003099834593	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTTTAGAGATTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.97600639195	0.0419418601460017	1.89612636053927e-05	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2210.54735251686	2210.54735251686
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTTTAGTGGTTCT"	-0.0110468668049157	7.90020272815553	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTTTAGTGGTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.11594439605	32.6818406431784	0.0174478471239088	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1866.38242071726	1866.38242071726
"healthy-4003"	"2020-08-26-Control4003-c2:TCAGTTTTCTTGAACG"	-0.359168122441131	8.90913484180299	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCAGTTTTCTTGAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1572.98769479967	40.8181188528917	0.0259494203214921	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1564.61904488989	1564.61904488989
"healthy-4003"	"2020-08-26-Control4003-c2:TCATACTCAACGTAAA"	-2.03766475144084	4.21363256061403	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATACTCAACGTAAA"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3283.31331331253	26.1849190306858	0.00797515087107782	5658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3279.09037723788	3279.09037723788
"healthy-4003"	"2020-08-26-Control4003-c2:TCATACTTCGAGAAAT"	-7.63881287995036	-0.567208432313524	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATACTTCGAGAAAT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3142.92981223048	27.3793504601078	0.00871141008417149	3892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3134.87825671237	3134.87825671237
"healthy-4003"	"2020-08-26-Control4003-c2:TCATACTTCTCGAACA"	5.56749119338338	-9.90546514904173	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATACTTCTCGAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.79854800674	34.83184081037	0.0134392546971515	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2585.63090396521	2585.63090396521
"healthy-4003"	"2020-08-26-Control4003-c2:TCATATCAGATTGGGC"	5.44764151152913	-10.2129488221374	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATATCAGATTGGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.69723708472	35.2784457707718	0.0129571680942922	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2715.30257365631	2715.30257365631
"healthy-4003"	"2020-08-26-Control4003-c2:TCATATCAGTCGTCTA"	10.502099652856	6.96243760669557	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATATCAGTCGTCTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1737.62833786264	24.2935652518153	0.0139808753819574	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1734.21203364561	1734.21203364561
"healthy-4003"	"2020-08-26-Control4003-c2:TCATATCCACATGACT"	4.3350736099178	-7.00741913234862	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATATCCACATGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2641.00347556409	3.95350845539695	0.00149697207594644	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2637.85708431858	2637.85708431858
"healthy-4003"	"2020-08-26-Control4003-c2:TCATCATAGGGTCACA"	-0.541644553572494	8.44135282123414	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATCATAGGGTCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1972.11362806298	33.2362397450706	0.0168531058617121	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1959.04728102184	1959.04728102184
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGAGCATACTGAC"	-4.03955111923869	10.5107640990051	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGAGCATACTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1947.41178221423	35.0482404713126	0.017997344368258	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1943.57486169539	1943.57486169539
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCCAGTGGGTA"	4.50774063643758	-7.8108759156433	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCCAGTGGGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.68659592904	6.40439175374336	0.00296955142477923	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2155.14636531056	2155.14636531056
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCCATGGAAGC"	-4.37812314453776	12.941810584906	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCCATGGAAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2383.40515669224	32.7425754715228	0.013737729558731	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2379.03294089791	2379.03294089791
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCGTCACTTCC"	3.56489409980122	-7.02757599270018	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCGTCACTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.53981839824	14.0078911070977	0.00624087440653831	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2237.07932142469	2237.07932142469
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCGTCCGAAAG"	3.33948840674703	-7.23314669048461	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCGTCCGAAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.46515294971	4.92542758171466	0.0022142075703831	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.51439335937	2221.51439335937
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCGTGCTTCAA"	-3.73605022850688	12.5095186003479	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCGTGCTTCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1686.26544221921	31.9375315476055	0.0189398007857969	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1674.67730989055	1674.67730989055
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCGTTGACTGT"	-3.20608697357829	13.2001809843811	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCGTTGACTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1895.72497479903	34.5258040731366	0.0182124540912359	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1891.6671296782	1891.6671296782
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCTCCGTATAG"	5.01394953307454	-8.20965006267699	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCTCCGTATAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.85281428303	13.341662963759	0.00528413493582104	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2523.66230384836	2523.66230384836
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGCCTCGCTGTTC"	-4.13651643219646	12.6619605788025	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGCCTCGCTGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1643.28060055777	38.0114946699779	0.0231314692433392	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1634.27983120224	1634.27983120224
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAAGCAGCCTC"	-1.88292203369792	8.86417577350465	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAAGCAGCCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.81969188837	40.2566804482007	0.0204160048780362	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1968.06776191263	1968.06776191263
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAAGGCGAAGG"	5.52111401137654	-9.52977373516234	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAAGGCGAAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2715.69748077924	13.8294299089198	0.00509240444003786	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2702.37686959017	2702.37686959017
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAAGTAACAGT"	4.44970573958699	-7.8678016892639	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAAGTAACAGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.57699239569	32.314023226372	0.0123214774323379	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2612.09395664487	2612.09395664487
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGACACTTGTCC"	-3.12001285973247	10.1300210722717	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGACACTTGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2105.76066570836	26.2314764086208	0.0124570075012759	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2086.91462443647	2086.91462443647
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGACATGATCTG"	-4.33094392243083	13.0914468535217	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGACATGATCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2168.7990630215	33.5090764352442	0.0154505214459843	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2166.96271411898	2166.96271411898
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAGTAGCGCTC"	3.76701511916463	-6.94058515941771	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAGTAGCGCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.20305203105	28.7428939535306	0.0133613114421686	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2149.55017512456	2149.55017512456
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAGTCTCAAGT"	3.96919288214986	-6.77359964763793	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAGTCTCAAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.66255013916	30.7589981372857	0.0120497705956507	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.21331521454	2545.21331521454
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGGAGTGAGTTGG"	-0.214810739189941	8.88461015308229	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGGAGTGAGTTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.50805242531	35.1831256885848	0.0187093725247327	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1873.06381154928	1873.06381154928
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGTTCAAAGCAAT"	3.58877815779988	-6.04799320614012	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGTTCAAAGCAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2364.28387100435	33.9910571565049	0.0143768933897372	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2361.40359631016	2361.40359631016
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGTTGTTGAGGAC"	-3.92394028130229	-5.16060354625853	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGTTGTTGAGGAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2832.69150992618	34.5056696631641	0.0121812310102427	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2829.3194030803	2829.3194030803
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGTTTCGACGATT"	3.5416976409847	-7.04870178615721	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGTTTCGACGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.83256655134	28.8169487996872	0.0126122803139062	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.8796022207	2281.8796022207
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGTTTCGTCGCTT"	5.46759285506551	-9.76847078716429	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGTTTCGTCGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.28853739423	9.02063348823572	0.00378177874366937	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2380.95166724385	2380.95166724385
"healthy-4003"	"2020-08-26-Control4003-c2:TCATGTTTCTCTAGGA"	-3.74235926094707	10.5350255736145	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATGTTTCTCTAGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.08352899063	42.4935919381372	0.0231184226766192	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1832.23549262115	1832.23549262115
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTACAGTGCAACG"	5.40797390517537	-9.53202249920043	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTACAGTGCAACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.42954158588	5.57714791477271	0.00205994203324895	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2703.62241044736	2703.62241044736
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTACCAAAGCAAT"	-3.70396194878276	10.839798904303	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTACCAAAGCAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.64038060799	37.7892501592015	0.0190793091614145	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1973.28248861472	1973.28248861472
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTCAAGCAACTTC"	4.13777842101399	-6.46682026302489	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTCAAGCAACTTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2773.18627281775	30.9939374192518	0.0111762912297124	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2766.81587694346	2766.81587694346
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTCAGTGGCAACA"	-7.25730786743816	-1.93432691013487	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTCAGTGGCAACA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3334.69480231195	32.5771566792257	0.00976915688255486	5174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3325.08883357738	3325.08883357738
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTTGCAACTCCAA"	-4.17976746979411	12.7957830199036	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTTGCAACTCCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2188.97743324527	35.499260789146	0.0162172803839812	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2178.26451475187	2178.26451475187
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTTGGTAACGGTG"	-3.30650196495708	9.7946624525818	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTTGGTAACGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.16983455355	35.5343321495797	0.0178191102552381	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1982.94931614638	1982.94931614638
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTTGGTGTTACAC"	-2.41487513008769	9.39204213703004	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTTGGTGTTACAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2219.64114085821	41.8373288786783	0.0188486904971054	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2211.28343175903	2211.28343175903
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTTGTCCAAACCA"	-0.0537247088855088	8.60380742633668	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTTGTCCAAACCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.57029667288	38.3264153305964	0.022236641815295	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1712.42142314781	1712.42142314781
"healthy-4003"	"2020-08-26-Control4003-c2:TCATTTGTCCGAGCTG"	3.79776444014851	-5.93347170269164	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCATTTGTCCGAGCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.09341164018	31.3177326843787	0.0115858862107824	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2696.9085633719	2696.9085633719
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACCACAAAGCTCT"	4.04957689818684	-6.95319559490355	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACCACAAAGCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.77689395905	25.1868877072311	0.0092948197186937	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2698.30514801542	2698.30514801542
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACCATCGGAGCAA"	4.0106438594753	-6.90524151241454	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACCATCGGAGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.44503103103	38.6584143283419	0.0186265662305387	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2073.87362629564	2073.87362629564
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACCATCGTTGTTT"	4.27675737914388	-7.42123272335204	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACCATCGTTGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.00396470305	29.9061141523173	0.0138710849524975	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.82329280413	2152.82329280413
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACGTCACACCGCA"	-4.21296344223674	12.4690103300842	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACGTCACACCGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2049.71976617757	15.9196561505811	0.00776674763705331	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2047.74647966887	2047.74647966887
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACGTGTATGCAAA"	3.34410466727559	-6.46808817302855	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACGTGTATGCAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1923.91503684958	39.7541671569668	0.0206631615198894	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1922.20052111568	1922.20052111568
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACGTGTCAGCTTA"	4.64531960067098	-6.80180122768553	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACGTGTCAGCTTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2576.04013743297	14.6865158529902	0.0057011983779202	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2566.17934788627	2566.17934788627
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACGTTCAATCCAG"	-0.247373829514343	8.23787973010866	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACGTTCAATCCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2313.55318864205	1.02221894339776	0.000441839395962949	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2300.92416503347	2300.92416503347
"healthy-4003"	"2020-08-26-Control4003-c2:TCCACGTTCGCATTAG"	-4.01489673081096	12.7445306547913	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCACGTTCGCATTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2234.92971652648	32.1679670408846	0.0143932790382688	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2221.95410183529	2221.95410183529
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAACACTGTCGG"	5.4355899291927	-10.1043958893982	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAACACTGTCGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.23381288907	34.8911997798477	0.0135962668735033	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2557.31135350473	2557.31135350473
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAACATGGTGGA"	4.15094961699788	-7.50426103984984	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAACATGGTGGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2414.35448553012	39.8663931076393	0.0165122368511208	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2403.85892581627	2403.85892581627
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAAGTAGCTTGT"	4.05091156539266	-6.5539498559204	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAAGTAGCTTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2770.67243310659	34.9918167345735	0.0126293589658808	2034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2760.25894542475	2760.25894542475
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAATCATCGTAG"	3.42962851104085	-6.59211685573729	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAATCATCGTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.83742645637	32.6685808851789	0.0127719535836325	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2552.8549028385	2552.8549028385
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAATCCTCCACA"	3.63467945632283	-6.9434910050598	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAATCCTCCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.26500999282	29.1505489928511	0.0125256680557154	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.17063117793	2318.17063117793
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAATCGACGAGA"	0.685395856469315	9.08850572192994	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAATCGACGAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.98203478585	34.0650208999642	0.0201094345751256	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1688.25144280333	1688.25144280333
"healthy-4003"	"2020-08-26-Control4003-c2:TCCAGAATCTAGAACC"	3.56064786490743	-6.73708298122557	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCAGAATCTAGAACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.26266298591	15.4783140845339	0.00657738480620536	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.7400423264	2351.7400423264
"healthy-4003"	"2020-08-26-Control4003-c2:TCCATCGTCCGTCAAA"	4.61622347411458	-7.52819588100585	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCATCGTCCGTCAAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.0334925186	36.2073927947441	0.0147542374238683	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.71360432761	2452.71360432761
"healthy-4003"	"2020-08-26-Control4003-c2:TCCATGCAGCTGCCTG"	-4.01772914353068	10.8941287764343	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCATGCAGCTGCCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2201.00009389618	29.0169282269473	0.0131835197587757	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2187.11027342615	2187.11027342615
"healthy-4003"	"2020-08-26-Control4003-c2:TCCATGCGTCAAAGAT"	4.27296127852742	-6.44116499340209	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCATGCGTCAAAGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2766.68137647389	31.700045942924	0.0114577870124406	2384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2760.30679166179	2760.30679166179
"healthy-4003"	"2020-08-26-Control4003-c2:TCCATGCTCGTGGGAA"	-3.83736811104472	12.8327922591004	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCATGCTCGTGGGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1770.72167896905	40.2049877780748	0.0227054247178376	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1760.09604270069	1760.09604270069
"healthy-4003"	"2020-08-26-Control4003-c2:TCCATGCTCTCGGTCT"	5.33988060530965	-9.17197992717894	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCATGCTCTCGGTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2721.66515414728	36.0930084131848	0.0132613699220811	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2714.31942665259	2714.31942665259
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCACAAGCTAAATG"	4.67762865599934	-7.8931980363098	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCACAAGCTAAATG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2662.37846211195	25.9970145345381	0.00976458264837216	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2657.69306426215	2657.69306426215
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCACACATGACGTT"	5.54822792586629	-9.68550493633422	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCACACATGACGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.78300889846	0	0	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2490.31630263108	2490.31630263108
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCACAGTAACGGTG"	6.74630703505818	-1.64638712322386	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCACAGTAACGGTG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2432.81802816688	12.4205737723385	0.00510542655822776	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2424.01832500147	2424.01832500147
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCACAGTGTGAGCA"	4.87047018584554	-7.14876415645751	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCACAGTGTGAGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.04705494796	0	0	2247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2735.99353943848	2735.99353943848
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCACATCCCTCTTT"	-2.60486731949504	9.02509019458619	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCACATCCCTCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2335.4791168307	39.4576338820747	0.0168948776282015	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2325.47166451621	2325.47166451621
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTCACAATGAA"	10.7706695991451	5.87061259830324	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTCACAATGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.77234976276	33.3652820348354	0.0167515539809605	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1983.89371176793	1983.89371176793
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTGTCATGGCC"	4.88781752166097	-7.38798763668212	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTGTCATGGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.8625017679	0	0	1528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2317.73523508599	2317.73523508599
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTGTCTGCATA"	4.73057713088338	-7.99397089397582	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTGTCTGCATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.24760794388	36.1654635221415	0.014961422819611	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2411.93983700947	2411.93983700947
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTTCCATACAG"	4.79725946959798	-6.97556784069213	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTTCCATACAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.45060595733	19.5879629121846	0.00734883732919496	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2662.83705951081	2662.83705951081
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTTCCATATGG"	0.377168466418427	9.09476659381715	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTTCCATATGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1549.14337072909	30.4111841631877	0.0196309681452369	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1543.20140542095	1543.20140542095
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCAGTTCGCTTGCT"	-4.27676186981853	12.9213933714661	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCAGTTCGCTTGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2073.94782698198	42.0592148615645	0.02027978443545	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2064.06518665771	2064.06518665771
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCATGAGCATGTTC"	2.28711189803426	-4.44934322750243	"2020-08-26-Control4003-c2"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCATGAGCATGTTC"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2862.83900755887	39.3129461909935	0.0137321540216526	2526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2857.34477139752	2857.34477139752
"healthy-4003"	"2020-08-26-Control4003-c2:TCCCATGGTACGCTTA"	0.32124968346898	8.31295201862184	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCCATGGTACGCTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1551.75906765203	0.957894385345258	0.00061729581950802	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1546.68565514991	1546.68565514991
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGAAAGTAGATGTA"	0.381643076508683	9.13222787463991	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGAAAGTAGATGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1572.96606418205	5.47516500928155	0.00348079029418137	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1568.70615941783	1568.70615941783
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGAAAGTCCATACA"	-3.93438277664836	10.5721750029358	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGAAAGTCCATACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2167.88830632059	31.4632534477431	0.0145133184933976	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2159.59937612411	2159.59937612411
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGATCGTACATTGC"	-3.2165621322697	-5.6353535882202	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGATCGTACATTGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2288.61105494712	27.4749551402701	0.0120050783993547	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2284.97454412718	2284.97454412718
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGATCTCAAGATAG"	-0.357167105109054	8.08272168720094	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGATCTCAAGATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1950.25759268459	27.1031578846801	0.0138972195192799	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1946.28511482868	1946.28511482868
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGAAGAGTCTTC"	10.2534243064815	6.91417739475099	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGAAGAGTCTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1888.14886337529	27.1645150408919	0.0143868502996803	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1878.6241488012	1878.6241488012
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGAAGATCGGTG"	2.37000932273213	-4.15409853374632	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGAAGATCGGTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2180.61337708568	26.6412194349227	0.0122173053301764	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2178.26938222184	2178.26938222184
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGACAACTTGCA"	4.06811489638631	-7.17738296901854	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGACAACTTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2838.11232280949	1.37876807620659	0.000485804619192001	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2838.11232280949	2838.11232280949
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGACAAGATGTA"	4.3321815925533	-6.94680120861205	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGACAAGATGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.51159998936	33.0648064188486	0.0136772069341856	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2415.01668453467	2415.01668453467
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGACAATCACGT"	5.58359636840169	-9.73551561748656	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGACAATCACGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.79929359716	36.7645184243744	0.0142785958174674	1707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2571.32840850154	2571.32840850154
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGACACATTACG"	4.10862030562703	-7.34235575115355	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGACACATTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.86970442633	32.6981726481936	0.0133741984650532	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2441.60427874872	2441.60427874872
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGACACGTACTA"	5.09219517287557	-7.41641046917113	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGACACGTACTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.44828745202	27.2687598774245	0.0101960318340662	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2670.42884359197	2670.42884359197
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGAGTCATCGGC"	4.28902306136434	-7.14608814632567	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGAGTCATCGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.10108013567	29.083277783944	0.0130646708019977	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.91287676237	2221.91287676237
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGGGAGTTTAAGGA"	4.90992607650105	-8.34575846111449	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGGGAGTTTAAGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2069.96313968158	27.0598324136088	0.0130726155914889	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2063.24200570258	2063.24200570258
"healthy-4003"	"2020-08-26-Control4003-c2:TCCGTGTCATGCACTA"	10.3412901359493	6.69841001117555	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCGTGTCATGCACTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1808.69609315471	45.1589074757165	0.0249676591034986	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1800.04114830721	1800.04114830721
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTAATAGGGTACGT"	-1.01328072968181	8.30851647937623	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTAATAGGGTACGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.10248685031	37.2353457706423	0.0198049553314626	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.45352578248	1876.45352578248
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTAATCATCCTGTC"	4.95327868041341	-7.98702719127806	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTAATCATCCTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.38016952886	47.6663457244754	0.0192717424970521	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2472.13914391191	2472.13914391191
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCCCCAAACGAGC"	0.192537804215592	8.27672860706178	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCCCCAAACGAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.0766036826	37.4002774426052	0.0199566428443281	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1867.82797801999	1867.82797801999
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCCCGTATTGGCT"	-0.835994820029098	9.19880864703981	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCCCGTATTGGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2348.41160883525	37.9251874938073	0.0161492931439805	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2335.65973519398	2335.65973519398
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCCCGTGGAACAC"	-0.56981203976329	8.74232671344606	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCCCGTGGAACAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2171.55283702331	34.2167526819297	0.0157568133266482	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2163.23060952775	2163.23060952775
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCCCGTTACGTAC"	-3.94514069977458	12.8746261366638	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCCCGTTACGTAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	3100.86180078203	30.1465589660837	0.00972199372396435	2050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	3084.23302565814	3084.23302565814
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCCCTCTCTTAAC"	5.3683463531429	-9.97782041942748	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCCCTCTCTTAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.93524412715	5.44156915701351	0.00210918827106241	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2574.28928402729	2574.28928402729
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCGAGTGCCTTCT"	4.0653940635616	-6.49977495586547	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCGAGTGCCTTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.14058674269	33.144130747404	0.0141693624296255	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.1611246816	2336.1611246816
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCGAGTGGTAACG"	3.50368609008138	-7.68497373973998	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCGAGTGGTAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1932.05726790231	0.843953187104897	0.000436815823798639	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1932.05726790231	1932.05726790231
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCGAGTGTGTCGC"	4.09182896193807	-7.46648313915404	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCGAGTGTGTCGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1670.68324071351	44.9238670490828	0.0268895179854064	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1666.63156693075	1666.63156693075
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCGATCTTGGATG"	3.32187356528584	-7.44428875362548	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCGATCTTGGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.48256060007	28.610591867802	0.0143664787399299	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1989.79810243054	1989.79810243054
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCTTAGCAGGTCA"	5.09241547164266	-8.2912168732849	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCTTAGCAGGTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.06756009868	37.3083651114952	0.0145391203612973	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2563.64050329547	2563.64050329547
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTCTTGTATCGCGC"	5.53224482116048	-9.75627138530882	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTCTTGTATCGCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.78125101196	31.236005267443	0.0136355251090188	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2282.88986105531	2282.88986105531
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTGCAAGCTGGAGT"	3.45905508574788	-6.31778051769408	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTGCAAGCTGGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.05276772458	14.6552169318222	0.00581544050169029	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.48352801809	2515.48352801809
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTGCATCCCGTTGT"	3.70572890815083	-6.91998770153197	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTGCATCCCGTTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.01877012789	22.37982387391	0.00843560706237714	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2646.08750422879	2646.08750422879
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTTCTAGAGTCTGG"	-1.45372353020366	8.95206639850465	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTTCTAGAGTCTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1711.92393260452	35.1204820455428	0.0205152117898782	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1708.16127252191	1708.16127252191
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTTCTAGCAGCACA"	5.14289869841878	-7.99573042308959	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTTCTAGCAGCACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.39219073367	13.9280703924434	0.00529505464679722	1822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2624.99046226276	2624.99046226276
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTTTCAGACTCCGC"	0.478577693074387	8.4516448744568	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTTTCAGACTCCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.3978266297	29.7060096778429	0.0164176220622389	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1802.02495254156	1802.02495254156
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTTTCAGATCCCAT"	3.88771857795064	-7.52189495479735	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTTTCAGATCCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.86960815058	26.3063333700661	0.0106768366649938	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.03601751496	2457.03601751496
"healthy-4003"	"2020-08-26-Control4003-c2:TCCTTTCGTGAGCGAT"	-4.05716786804851	12.7885217436585	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCCTTTCGTGAGCGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1814.91793713566	45.5432884362384	0.0250938554875466	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1806.4382989335	1806.4382989335
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAACAAGTGTACCT"	-0.233129630715209	8.55624387348024	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAACAAGTGTACCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.89314340194	31.4701082953445	0.0170118519589035	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.66062723935	1840.66062723935
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAACACAACAAGAT"	-3.57702956619914	12.7562284239563	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAACACAACAAGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1570.780445238	32.245553609426	0.0205283645509989	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1563.6678336382	1563.6678336382
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAACACAGTTTCGA"	-3.65274296227153	13.2460918196472	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAACACAGTTTCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1827.49480928981	32.6039152107045	0.0178407703512848	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1823.11229183636	1823.11229183636
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAACATCTCGGTCT"	5.49967159804646	-9.61067774212035	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAACATCTCGGTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.54511706886	0	0	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2520.53849744519	2520.53849744519
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAAGTAGATGTTAG"	3.9938653903896	-7.7042012444702	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAAGTAGATGTTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2081.47200654255	19.4802570860374	0.00935888497409833	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2072.70547840026	2072.70547840026
"healthy-4003"	"2020-08-26-Control4003-c2:TCGAAGTTCCGTGTCT"	4.60989298400227	-7.80935337459715	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGAAGTTCCGTGTCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.67151411685	34.8670093515712	0.0150115972661888	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2319.59831140604	2319.59831140604
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACCTCAGAACTAA"	4.29503788527791	-7.1124682656494	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACCTCAGAACTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.32063422664	35.5524536980983	0.0135835301312265	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2606.34066162583	2606.34066162583
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACCTGTGTAGGAC"	-1.75663850727733	8.93657968128053	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACCTGTGTAGGAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1998.61671475124	32.886807678096	0.0164547846695004	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1992.14496323824	1992.14496323824
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACCTTCCGTGGGT"	-0.861674706370193	8.91699788654176	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACCTTCCGTGGGT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2047.82142726149	29.0843650435088	0.014202588495425	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.39414214868	2041.39414214868
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGAGATGCCGA"	4.22494663771932	-7.70708944713744	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGAGATGCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.33379722643	39.7084704872373	0.01946175206293	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2033.47717439947	2033.47717439947
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGAGCCTCTTC"	4.0975190597469	-7.09961225902709	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGAGCCTCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.99368365658	33.4877000161456	0.0153472946631207	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2178.99693821501	2178.99693821501
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGAGGCAGTCA"	-3.09609041634257	-5.72031309520873	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGAGGCAGTCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2162.81756160935	31.7414979934666	0.0146759942016782	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2159.98496310649	2159.98496310649
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGCAACAAGTA"	-0.321940849453765	8.21665284717409	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGCAACAAGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1862.23571511796	22.5536657346532	0.0121110692655922	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1850.08341880965	1850.08341880965
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGCAAGCGCAA"	-4.10850034180339	12.470356918219	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGCAAGCGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1890.65616359432	41.6231767082274	0.0220152016584008	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1886.46163647786	1886.46163647786
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGCAGCTACTA"	4.07627739486043	-6.33490755474242	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGCAGCTACTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2688.84123654616	4.03775510260984	0.00150167107218141	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2686.8484967022	2686.8484967022
"healthy-4003"	"2020-08-26-Control4003-c2:TCGACGGCATTCTTCA"	4.95336355742757	-7.69565584575804	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGACGGCATTCTTCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.11078664408	22.1218304181973	0.00842379938070582	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2620.83046961019	2620.83046961019
"healthy-4003"	"2020-08-26-Control4003-c2:TCGATTTCATATTCGG"	-0.232661227614242	8.42462251270143	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGATTTCATATTCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1907.49903708002	30.618967924659	0.0160518916809155	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1904.13402297885	1904.13402297885
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCACTTCGCCAGAC"	10.2149225669796	6.16791246021119	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCACTTCGCCAGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1787.71697995409	40.0038591856968	0.0223770650691723	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1774.06058932367	1774.06058932367
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCAGGAGCACCGTC"	-5.11901793900188	4.08033702457277	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCAGGAGCACCGTC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2347.82962182218	33.1230623279918	0.0141079497507509	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2341.81100665561	2341.81100665561
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCAGGGTAACTGCT"	4.33252777633016	-7.17340519344481	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCAGGGTAACTGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2097.0771004556	10.7364802161064	0.00511973556612384	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2094.24080520334	2094.24080520334
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCAGGTCACAAGAA"	5.51156296309773	-9.9685678712097	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCAGGTCACAAGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.29844703164	16.3867001273879	0.00695737737527062	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2345.65461066438	2345.65461066438
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTCAAGCATAGGC"	5.5237246948177	-10.1428890458313	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTCAAGCATAGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.92293684396	17.626601814987	0.00680058869205807	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2587.61623741143	2587.61623741143
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTCATCGAAGGAC"	0.411005308001679	8.45397279346315	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTCATCGAAGGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1687.5804198159	31.626302448126	0.0187406194553834	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1671.81237070841	1671.81237070841
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTTGAGATCACCT"	4.9974123435909	-8.58621122753295	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTTGAGATCACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.81805412424	26.9937184390563	0.0107595361069255	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.36046935528	2501.36046935528
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTTGAGGGCCAAT"	-3.26596818390544	10.2032994993958	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTTGAGGGCCAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1675.34811349078	11.5302679978413	0.00688231174464195	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1671.00312767386	1671.00312767386
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTAGACAAGCC"	3.51459755477254	-6.73354008114012	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTAGACAAGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.91594727336	23.6129240383299	0.00912782808549238	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2584.56480876779	2584.56480876779
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTAGCTGGCTC"	0.54264317926709	8.39083192432252	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTAGCTGGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1443.98284326698	17.8490474142675	0.0123609830251754	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1443.98284326698	1443.98284326698
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTAGTGGAAAG"	-4.09064135971721	12.7377605208191	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTAGTGGAAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1670.51802727331	21.8387864529894	0.013073062425214	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1668.11888811466	1668.11888811466
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTCACGCTGAC"	-0.54259959879573	8.40251538837282	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTCACGCTGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.74013681289	36.350531891739	0.01887613556827	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1919.36555789949	1919.36555789949
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTGTCGACTTA"	4.2999288040096	-7.1561899415222	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTGTCGACTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.16995707892	30.6690076368782	0.0137395486126032	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2227.31947793324	2227.31947793324
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATCTGTTCTCAGA"	4.04022016105	-6.80834057247313	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATCTGTTCTCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.48617177387	22.7618828402393	0.00963879573478144	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2358.61985177246	2358.61985177246
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATGGAGGTGATAT"	-3.67134747925456	10.717406249884	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATGGAGGTGATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.86875557431	28.8579189613428	0.0151257359171208	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1903.78045509316	1903.78045509316
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATGGCAATATCCG"	-0.588350991637069	8.6941871413025	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATGGCAATATCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1798.33102127287	34.2860085413154	0.0190654602160216	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1794.65884196978	1794.65884196978
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATGGGTAACATGA"	-4.3231032890385	12.9498615034851	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATGGGTAACATGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2120.96669592443	28.3008205765361	0.0133433592478929	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2119.00030015182	2119.00030015182
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATGGGTTTCGCTC"	-1.95630441132243	9.20482156360475	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATGGGTTTCGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2065.28773279395	29.3937660908717	0.0142322861963197	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2057.47464356488	2057.47464356488
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATGGTCCATCTGC"	-1.32053742829021	8.70117471301881	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATGGTCCATCTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2091.49349164398	40.5985113316797	0.0194112539646337	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2083.20685343727	2083.20685343727
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATTCAGACACACG"	4.22431959685628	-7.44899322902831	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATTCAGACACACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.46730591563	30.280391783107	0.0117390097225359	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2572.16047215314	2572.16047215314
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATTCGTTATCCAG"	-3.74153480950053	12.863480544928	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATTCGTTATCCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1612.47233255904	28.6695363417746	0.0177798624899661	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1602.90732057373	1602.90732057373
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATTCTCACTTTGT"	-1.1813909811085	8.70948693836061	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATTCTCACTTTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1962.46962222629	29.5966512561192	0.0150813296271786	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1949.52687389846	1949.52687389846
"healthy-4003"	"2020-08-26-Control4003-c2:ACTATTCTCGCTGATA"	-7.12139592590983	3.43776724422304	"2020-08-26-Control4003-c2"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTATTCTCGCTGATA"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2290.3381914795	32.4332478010492	0.0141608989981075	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2276.77219894953	2276.77219894953
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCCCACAGTTGCGC"	-0.218032847077209	8.19491574848024	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCCCACAGTTGCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2080.16041949381	30.3582222100606	0.0145941735673675	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2069.26022769148	2069.26022769148
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCTCGAGCGCCTTG"	3.11027564582173	-5.33300878917845	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCTCGAGCGCCTTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2463.77843335285	33.889063189196	0.0137549151053643	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2459.48276413214	2459.48276413214
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCTCGCAGTATACC"	-0.127205218107063	8.46799848163453	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCTCGCAGTATACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.38671970342	28.7594903869877	0.0153516036408866	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1870.23723757967	1870.23723757967
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCTCGGTGGACTGA"	4.26119865950887	-7.22549250042113	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCTCGGTGGACTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.0508689578	28.5999977970254	0.0112862761152021	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.20382632586	2529.20382632586
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCTCGTCATTATCC"	-3.16495547714885	9.96356008136598	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCTCGTCATTATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.04850994346	41.023427705584	0.0214440080804833	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.20298892792	1911.20298892792
"healthy-4003"	"2020-08-26-Control4003-c2:ACTCTCGTCGACCACG"	-3.70883760872539	12.6962194212708	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTCTCGTCGACCACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1872.08254730888	32.0416166730513	0.017115493501668	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1870.11960926145	1870.11960926145
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGATGTCAACCGAT"	4.36142077025716	-7.07478716289672	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGATGTCAACCGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.25715135016	33.5829847500643	0.0141505882457612	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.90424168401	2371.90424168401
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGATGTCTTGCAGA"	5.41202940520589	-10.2275076142517	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGATGTCTTGCAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.85044598369	10.7212972524375	0.00476957765210475	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2241.9903863525	2241.9903863525
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGCAATCTGCTGAA"	-4.24362359467204	13.1011543043884	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGCAATCTGCTGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1718.1753356404	42.5388485317228	0.0247581534022357	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1715.95421432163	1715.95421432163
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGTCCAGCGTGAAC"	5.49262680587117	-10.1221294633118	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGTCCAGCGTGAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.61396412849	38.7804670314266	0.0164350896464329	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.38780790192	2355.38780790192
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGTCCCACGTATAC"	-2.22052703324016	8.5768890150818	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGTCCCACGTATAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2392.0684048331	29.3802968169074	0.0122823815395687	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2379.00541595845	2379.00541595845
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGTCCCAGTACTAC"	-1.58310757103618	8.77868936145631	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGTCCCAGTACTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1717.10674489786	18.3958334933843	0.0107132730961805	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.10674489786	1717.10674489786
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGTGACACGAGGTA"	2.73668684539143	-7.30622103130492	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGTGACACGAGGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1559.71400830307	2.51264219948277	0.00161096341130927	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1559.71400830307	1559.71400830307
"healthy-4003"	"2020-08-26-Control4003-c2:ACTGTGATCCCTTGGT"	-3.67574320259746	10.1796293028626	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTGTGATCCCTTGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2238.66627988289	35.1305746420395	0.0156926358152307	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2225.22743821777	2225.22743821777
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTAGGAGTCATGCT"	-3.95246444168742	12.7106294401917	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTAGGAGTCATGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1672.05180664064	24.3225920898225	0.0145465541158618	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1662.52896444295	1662.52896444295
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTAGGCAAATGGCG"	-3.94752655449565	10.2669448622498	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTAGGCAAATGGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.59484388478	40.616906533652	0.0197784420108969	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2051.7190318154	2051.7190318154
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTAGGCACCAGCGT"	-4.23544726792033	12.7446136244568	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTAGGCACCAGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2072.64691494933	37.6538871025772	0.0181670533610872	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2066.71733753324	2066.71733753324
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTAGGGTTTGTTGG"	-4.08056769791301	12.7137384184631	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTAGGGTTTGTTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1583.49095987293	41.4898233131417	0.0262014904818093	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1571.65498240111	1571.65498240111
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTAGGTCCCGAGGT"	3.98168625411336	-6.80689670955809	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTAGGTCCCGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.23557093697	32.7195348217865	0.014071492467579	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2319.93484189876	2319.93484189876
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTATCGTTGGGTAG"	-4.85772071304973	3.07345244968263	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTATCGTTGGGTAG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1711.38344286256	0.949114599066844	0.000554589097507744	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1710.09856880672	1710.09856880672
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTATCTCCACCTGT"	5.18532671508138	-8.15192606365355	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTATCTCCACCTGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3427.52058686539	1.98145172854775	0.00057810060605934	3706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3416.44220714012	3416.44220714012
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTCCGCAAGGCGTA"	4.92849220809285	-8.47478487407836	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTCCGCAAGGCGTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2902.16213423708	31.9931343051604	0.0110238962626293	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2896.99345243308	2896.99345243308
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTCCGGTTCCAAAC"	-3.02642593804057	10.3342485197815	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTCCGGTTCCAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.28015538894	26.3617475468683	0.015226736969642	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.13316020328	1729.13316020328
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTCCGTCGACGACC"	-0.752641360194045	8.20990560138551	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTCCGTCGACGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1701.05720797855	17.3913923647669	0.0102238727088044	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1699.20764728291	1699.20764728291
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTCGCCAGTTACCA"	4.6570106941158	-7.4182167283264	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTCGCCAGTTACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3432.89126932063	23.5847674897868	0.00687023434169364	3845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3425.50185591133	3425.50185591133
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTCGCGTACATTGC"	-0.664443830878097	8.40697476947633	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTCGCGTACATTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.47913680508	30.6353166187041	0.0177959267491099	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.62170822791	1717.62170822791
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTTCACAACCACAT"	-0.254416237503845	8.40892217243043	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTTCACAACCACAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1828.7153319004	25.7001617226849	0.014053669958559	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1824.37844554119	1824.37844554119
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTTCATCTGGCCTT"	-2.7770496410435	9.2047719725403	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTTCATCTGGCCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2600.54566774066	32.9510891001126	0.0126708365512921	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2592.09466662889	2592.09466662889
"healthy-4003"	"2020-08-26-Control4003-c2:ACTTTGTCAGAAGCTG"	3.97494186934773	-7.69891025936278	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACTTTGTCAGAAGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1913.08633231959	24.8607808715023	0.0129951170794048	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1911.23736438793	1911.23736438793
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAATGAGCGATCGA"	-3.37516007843669	10.703734374884	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAATGAGCGATCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.79843138536	35.4577093032107	0.019034646318035	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.09749541136	1855.09749541136
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAATGGTACCGGAA"	4.41304411467854	-7.11337568676146	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAATGGTACCGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.132077076	14.6592787096256	0.00680519029711675	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.89571267653	2150.89571267653
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAATGGTTCAGCGC"	10.4831434684688	7.63253734195558	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAATGGTTCAGCGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2358.77384717274	39.4338171638252	0.0167179304667512	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2352.24969909809	2352.24969909809
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACAAAGAAGTGTT"	5.43822540816609	-10.2348308793274	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACAAAGAAGTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.64591552214	35.1562898073456	0.015817314652697	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2218.30549739075	2218.30549739075
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACAACATGGAATA"	10.6398455100948	6.21440742099611	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACAACATGGAATA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.14346064288	28.9196124191123	0.0148447036901322	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1938.09411562524	1938.09411562524
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACAATCCACGAAT"	-4.81652770462688	-5.15667965328368	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACAATCCACGAAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2168.08845224662	45.6049469131051	0.0210346339264194	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2163.26526668268	2163.26526668268
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACCTCACCCAATA"	5.13987936553304	-7.62264540111693	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACCTCACCCAATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2921.92156304067	8.47178918506839	0.00289938966611147	2436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2913.42464871617	2913.42464871617
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACCTCAGTTAAAG"	-5.70537696304973	-5.39334871685179	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACCTCAGTTAAAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2822.79765579273	41.7469353794465	0.0147892057703026	2547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2819.07628150513	2819.07628150513
"healthy-4003"	"2020-08-26-Control4003-c2:AGAACCTTCGGACCAC"	-4.0911696952885	13.3581208952698	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAACCTTCGGACCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2090.15655958656	25.779434980761	0.0123337339791715	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2078.16091184839	2078.16091184839
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGCGCAATGCAAA"	2.49340500411336	-4.34509899532469	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGCGCAATGCAAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2240.39928769309	31.1062509801671	0.0138842442733486	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2239.2990194374	2239.2990194374
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGCGCATCACAGT"	5.35744967040364	-9.6015081635681	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGCGCATCACAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.13803023951	25.9201105174282	0.0113677813244953	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.3569766917	2272.3569766917
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGCGTCATCCCGT"	3.06056918677632	-6.49529364025267	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGCGTCATCCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1492.25638600241	33.1890283734626	0.0222408352108798	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1492.25638600241	1492.25638600241
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGCGTCTGGACCG"	5.45489706572835	-10.2198276749817	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGCGTCTGGACCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.13606597445	23.9909429764755	0.0124039582315469	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1930.52549933353	1930.52549933353
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGTAAGGGCCTCT"	4.23750891265218	-7.04282286083373	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGTAAGGGCCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.1843706995	34.65192276011	0.0142296916722393	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.85152096959	2433.85152096959
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGTAAGGTAAAGG"	2.4642616706783	-4.0770211449829	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGTAAGGTAAAGG"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2689.28312173592	26.1742332110316	0.00973279198440673	3088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2677.6099868712	2677.6099868712
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGTAGTACGATGG"	3.41006769713704	-7.81593706524047	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGTAGTACGATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.63753603105	39.6690471514534	0.0180425588580933	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2197.0375727177	2197.0375727177
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGTATCAGGCGAA"	0.0990737724000632	8.55719945514528	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGTATCAGGCGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1940.0812160592	33.3816830409656	0.017206332788878	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1931.92760987284	1931.92760987284
"healthy-4003"	"2020-08-26-Control4003-c2:AGAAGTATCATCGCAA"	-0.314860443503219	8.54009149158327	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAAGTATCATCGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1855.75275864083	31.2687593514092	0.0168496364646715	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1854.19148710144	1854.19148710144
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAAAAGACAAGCC"	0.615066726773423	8.70029256427614	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAAAAGACAAGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.49852885241	25.9524704039672	0.0150755112298979	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1714.36690480118	1714.36690480118
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAAACATACTGTG"	4.34471907195393	-7.35316898739012	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAAACATACTGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.29472921703	27.052819847173	0.0109512519001113	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2464.4304463182	2464.4304463182
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAAACATGTGCCG"	3.67462315139119	-6.82157518779906	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAAACATGTGCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.44338421279	23.775903547634	0.00990892458812249	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.72621355827	2396.72621355827
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAAAGTCCCGTGA"	-2.2756396335667	9.5705241926941	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAAAGTCCCGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1795.17006844444	36.4277067475712	0.020292064461133	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1795.17006844444	1795.17006844444
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAAAGTGGCTTAT"	4.57642807540242	-7.8351416817871	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAAAGTGGCTTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.65302647778	12.7306354096685	0.0049426826046821	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.73045512505	2568.73045512505
"healthy-4003"	"2020-08-26-Control4003-c2:AGACACTCATAGATCC"	5.28124775466268	-9.37679769909056	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACACTCATAGATCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2731.49625913856	3.55112435806799	0.00130006561282567	2008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2723.90058336908	2723.90058336908
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAGGAGCTAGTTC"	-3.16088734093364	9.89523599231569	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAGGAGCTAGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2127.69228427442	40.1647925899124	0.0188771623071469	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2122.1679004436	2122.1679004436
"healthy-4003"	"2020-08-26-Control4003-c2:AGACAGGTCCACGAAT"	-3.83896789971049	10.9200305708679	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACAGGTCCACGAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1867.43088665392	40.9639238177974	0.0219359785203066	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1863.34435102115	1863.34435102115
"healthy-4003"	"2020-08-26-Control4003-c2:AGACCATGTCCAACGC"	5.6095630126888	-9.9121942750183	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACCATGTCCAACGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.71265718822	27.3763380298842	0.0111028095467956	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2463.29531749794	2463.29531749794
"healthy-4003"	"2020-08-26-Control4003-c2:AGACCATTCACCATAG"	-4.19769130173381	12.9099101790222	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACCATTCACCATAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2205.69819494277	38.9159633535129	0.0176433763434814	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2205.69819494277	2205.69819494277
"healthy-4003"	"2020-08-26-Control4003-c2:AGACCATTCTCCTGTG"	-1.70380626145061	9.61016557300416	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACCATTCTCCTGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1666.77956690688	41.0171992321789	0.0246086525456371	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1662.45507986744	1662.45507986744
"healthy-4003"	"2020-08-26-Control4003-c2:AGACCCGGTACTAGCT"	-3.94476733627971	11.7708539732727	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACCCGGTACTAGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2575.13919129847	39.829645442479	0.0154669874067645	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2564.8930619548	2564.8930619548
"healthy-4003"	"2020-08-26-Control4003-c2:AGACCCGTCTGTGCTC"	0.378727396100205	7.99241778934327	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACCCGTCTGTGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1622.36217279942	37.6237434141834	0.0231907178588014	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1614.18361636866	1614.18361636866
"healthy-4003"	"2020-08-26-Control4003-c2:AGACTCAAGGACAAGA"	-2.55179415169414	9.85624311054078	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGACTCAAGGACAAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.97143789035	38.6651591412615	0.0207992217379846	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.11488627487	1855.11488627487
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGAATCAATCTGCA"	-7.14962945404704	2.41612002933351	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGAATCAATCTGCA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2770.09221916881	25.3113370487924	0.00913736260245781	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2757.14049531445	2757.14049531445
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGAATGTAATGATG"	-1.91388438168224	8.80560491168825	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGAATGTAATGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1742.80817977701	27.7558426922096	0.0159259309281879	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.40900467291	1733.40900467291
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGAATGTTAGAAGT"	4.19246449050252	-6.87715866481932	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGAATGTTAGAAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.74997095772	35.1851771019649	0.0146193736476762	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.8083970422	2397.8083970422
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGCAGAGCCACCGT"	5.5304614501888	-10.087429069635	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGCAGAGCCACCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.11044427397	35.8727134164717	0.0174638678832826	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2050.89449592337	2050.89449592337
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGCAGCAACGGCCT"	5.40088572081868	-10.0063734284607	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGCAGCAACGGCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.14315635342	43.7847500249653	0.0187182857560642	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.1740283809	2332.1740283809
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGCCCAGCGACAGT"	2.86841835555379	-4.7576532593933	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGCCCAGCGACAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2325.08420603214	3.97447117436755	0.00170938805745456	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2323.0505418932	2323.0505418932
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGCCCAGCTCAGAG"	-3.86245904389079	12.3171462782654	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGCCCAGCTCAGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.64101745478	23.0325559467884	0.0119361869583228	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1923.15665456072	1923.15665456072
"healthy-4003"	"2020-08-26-Control4003-c2:AGAGCCCGTCATTCCC"	3.60803117331807	-6.97625353252562	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGAGCCCGTCATTCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.09079518603	20.4962306666114	0.00955494784305105	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2137.78816424935	2137.78816424935
"healthy-4003"	"2020-08-26-Control4003-c2:AGATAGACACTGAGTT"	-0.496434966952163	9.20428559863893	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATAGACACTGAGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1705.15288544473	36.9999431196575	0.0216989006883141	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1698.71175348676	1698.71175348676
"healthy-4003"	"2020-08-26-Control4003-c2:AGATAGAGTAAGTAGT"	4.6434174972469	-7.81023981487425	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATAGAGTAAGTAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.51258033266	36.9155358441534	0.0173760024703516	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2123.04538090417	2123.04538090417
"healthy-4003"	"2020-08-26-Control4003-c2:AGATAGATCCTGATAG"	-3.75130973282512	10.3026122816834	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATAGATCCTGATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2132.32248404835	4.08716336205658	0.00191676605796363	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2123.42325921078	2123.42325921078
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCCACAAACTAGA"	-1.09899280491527	9.01696298206178	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCCACAAACTAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1697.54502663171	39.1890714484841	0.0230857331226398	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.61002478807	1693.61002478807
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCCAGTAACTTCG"	-8.14242492142375	0.203328780177511	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCCAGTAACTTCG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2711.97029604924	27.5109781528237	0.0101442770936324	2595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2700.77272383015	2700.77272383015
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCCATCCAAATGC"	-3.80245194855388	12.6129216917786	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCCATCCAAATGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1894.60640017207	33.5557278729158	0.0177111868036908	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1890.64645098111	1890.64645098111
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCCATCCTGTTGC"	5.40106834945027	-9.44788744365843	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCCATCCTGTTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.15254745636	4.50421783325578	0.00181610515767479	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2477.28277583117	2477.28277583117
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCGTAGAATTGCA"	-3.31345138970073	10.3233670958313	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCGTAGAATTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1690.26722776861	34.8267422330336	0.0206042817732494	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1688.19811483103	1688.19811483103
"healthy-4003"	"2020-08-26-Control4003-c2:AGATCGTAGCTAGTTC"	-3.63483105126079	12.6826219328674	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATCGTAGCTAGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1729.69898116283	47.9607686464514	0.0277278122776072	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1727.45683592267	1727.45683592267
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGAAAGAAGGGAT"	5.17949690398518	-8.44394209301146	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGAAAGAAGGGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.76276638564	7.94665457079774	0.0030543348046437	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2598.54678356766	2598.54678356766
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGAACATACAGCT"	-3.05245314064677	10.1091193922791	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGAACATACAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.08639313233	34.0178531351111	0.016585285363412	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2045.89508764409	2045.89508764409
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGAATCCCGAACG"	3.46924151953999	-7.80294516002806	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGAATCCCGAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1843.79041289332	8.69097126636516	0.0047136438098336	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1840.13914793036	1840.13914793036
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGCTGTGTATTCG"	3.670417924493	-6.95737459575804	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGCTGTGTATTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.15169235272	29.4496818408113	0.0153691808213012	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1908.4245984162	1908.4245984162
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGCTTCCCGTGTT"	6.72356810149495	-1.61198713695677	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGCTTCCCGTGTT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2645.83892609989	34.282544134058	0.0129571546460662	1998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2632.67748170293	2632.67748170293
"healthy-4003"	"2020-08-26-Control4003-c2:AGATGCTTCTTAGCTT"	0.321850885718507	8.06422135913698	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGATGCTTCTTAGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1670.62838819612	0.846426631874994	0.000506651651471655	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.82242279111	1660.82242279111
"healthy-4003"	"2020-08-26-Control4003-c2:AGCATCAAGGCAATGC"	-0.757212023169357	8.34376046741334	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCATCAAGGCAATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1943.52595878721	28.1272138129417	0.0144722604222346	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1938.10154353911	1938.10154353911
"healthy-4003"	"2020-08-26-Control4003-c2:AGCATCACAACCAACT"	4.20012535628621	-6.90518524562987	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCATCACAACCAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2687.68860826872	0	0	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2685.59886571422	2685.59886571422
"healthy-4003"	"2020-08-26-Control4003-c2:AGCATCACATGGAGAC"	-0.275464097887832	8.66001699054567	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCATCACATGGAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2055.82293623968	31.4333483281493	0.015289910319633	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2049.98724285798	2049.98724285798
"healthy-4003"	"2020-08-26-Control4003-c2:AGCATCAGTTGGACCC"	-0.947301487356979	8.94049546802369	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCATCAGTTGGACCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2106.24938666206	31.5143898926264	0.0149623259677572	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2101.50938068756	2101.50938068756
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCAATGTCGTATTG"	-2.09268103066142	9.18277261340944	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCAATGTCGTATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1570.30900695369	40.085071610554	0.0255268685545635	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1565.94396514015	1565.94396514015
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCAATGTGTGAATA"	2.88566364821736	-6.67392589962157	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCAATGTGTGAATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.69035347413	24.5777387454595	0.0106688551733502	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2298.05428126879	2298.05428126879
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCACGCAGCATGCC"	-2.38790855827983	9.60159108722535	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCACGCAGCATGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1991.04299152042	29.4761088247007	0.0148043557824896	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1983.5232934849	1983.5232934849
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCACGCATAACCCA"	3.65608920630757	-7.07497122203978	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCACGCATAACCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.55887307114	32.8490666679311	0.016090188287598	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.40040608723	2036.40040608723
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCACGGTGTATTCG"	-3.93016753616984	11.1048412092957	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCACGGTGTATTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1913.07684443802	25.7461395598923	0.0134579745893351	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1901.3152463799	1901.3152463799
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCACGTCACTACTT"	4.34082951125447	-6.54223062908324	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCACGTCACTACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.84598358501	32.5970083648373	0.0127889282344902	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2540.15238951159	2540.15238951159
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCAGCCAGACCATT"	5.6212383705074	-9.91889479076537	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCAGCCAGACCATT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.58644823742	33.6643135163478	0.0145318615422107	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2312.64277463495	2312.64277463495
"healthy-4003"	"2020-08-26-Control4003-c2:AGCCAGCTCTCGTGAA"	-3.8598133129185	10.5633277663025	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCCAGCTCTCGTGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1780.59773457063	37.7230246931197	0.0211855962527191	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1776.65261009318	1776.65261009318
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGATTAGTCAACAA"	3.58526148375813	-7.0342588654724	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGATTAGTCAACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.76223845951	2.72810584084278	0.00132964034024287	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.53595358081	2049.53595358081
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGATTCACTGGAAG"	5.53766073760335	-9.99431993877562	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGATTCACTGGAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.37152445079	34.9562548114328	0.0149489738674623	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.24479582355	2333.24479582355
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGATTTCTGCGGAC"	3.92130341109578	-7.4966702691284	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGATTTCTGCGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.57508862455	31.5550493200001	0.0129134764333197	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.92695433398	2439.92695433398
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCCAAGATGGTAT"	-2.81533894959148	10.2165021666321	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCCAAGATGGTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.42617848368	28.7848543735052	0.0165294714924805	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.68338345744	1733.68338345744
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCCACAGTGAGCA"	10.906640668481	6.07184455478517	"2020-08-26-Control4003-c2"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCCACAGTGAGCA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1673.52581392885	34.4849027792046	0.0206061373491731	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1671.71069130756	1671.71069130756
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCCAGTGCAATGG"	3.08147563514058	-6.35421326076659	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCCAGTGCAATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.9783285782	38.6502745157953	0.0175206954733351	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2203.16994611276	2203.16994611276
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCCATCAGGAAAT"	-2.39154754105266	9.09386346423952	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCCATCAGGAAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.10929459861	35.890144638282	0.0191300926559083	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1870.28059717358	1870.28059717358
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCTGAGACATGCG"	4.22691502150838	-7.95132448589476	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCTGAGACATGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2006.11560109919	8.11775251017631	0.00404650285642984	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2004.48168197274	2004.48168197274
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCTGAGGAGAATG"	3.45333137091939	-8.1438608399597	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCTGAGGAGAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1445.48538431436	10.9999104023992	0.00760983855095622	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1442.95025263378	1442.95025263378
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGCTGAGGCTATCT"	3.64099921759908	-6.86704590236815	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGCTGAGGCTATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.53240014781	13.8510067266186	0.00577960336599844	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.53240014781	2396.53240014781
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGTATAGGATGAGA"	-3.42576132240947	3.85613272273866	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGTATAGGATGAGA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2543.4407835099	5.46201778985524	0.00214749162837507	2207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2541.19611999743	2541.19611999743
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGTATAGTCATTGC"	3.48018350180928	-6.94024040615233	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGTATAGTCATTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.58313259812	2.90208687754526	0.00138090510555131	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2098.79617643706	2098.79617643706
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGTATCACTAAACC"	6.7729717689449	-1.66127839004668	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGTATCACTAAACC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2586.89920467737	11.7336910019721	0.00453581298442413	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2571.45892620344	2571.45892620344
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGTATGTACAGGTG"	-1.00480935993846	9.33515546405641	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGTATGTACAGGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1753.95303811317	38.7840240666804	0.0221123503445694	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1747.63950914437	1747.63950914437
"healthy-4003"	"2020-08-26-Control4003-c2:AGCGTATTCATTGCCC"	4.25067820128743	-7.04176857387694	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCGTATTCATTGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.6247273681	27.5328903665409	0.0113602118577325	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.2530999877	2418.2530999877
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTACAAGAAACCCG"	5.29398788985555	-10.0167350999084	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTACAAGAAACCCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.98079484969	0.598174069072436	0.000325628918249731	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1830.69589040011	1830.69589040011
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTACAAGAATAGTC"	-3.83439503136333	10.1511001356873	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTACAAGAATAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2132.73889793093	33.7042463557236	0.0158032689273036	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2119.71803743844	2119.71803743844
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTACAGTCATACCA"	4.93497767028157	-7.94840433513793	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTACAGTCATACCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2847.98383608365	0	0	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2846.93575143554	2846.93575143554
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTACAGTGAGATAT"	9.41174187239949	6.70520017230836	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTACAGTGAGATAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1535.53590232483	38.4436747318979	0.0250359986202169	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1525.80992846112	1525.80992846112
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTACAGTGATACTC"	3.30650128897969	-7.44651796734007	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTACAGTGATACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.3874613909	47.558000144455	0.0224077841626938	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2118.19654714707	2118.19654714707
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTCAAAGCGACATG"	4.53578772124593	-7.16556503688964	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTCAAAGCGACATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.84048623224	29.6827210554692	0.012631802553995	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.39437099768	2342.39437099768
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTCAATCATGCTAG"	3.84804763373677	-7.00262119686278	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTCAATCATGCTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.17237476821	23.7642803883322	0.0107961923658226	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2193.6682794959	2193.6682794959
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTCAATCGCACTCT"	-3.19078860703166	9.38842866504518	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTCAATCGCACTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2101.70769559323	41.4769151511382	0.0197348638148422	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2099.93653394692	2099.93653394692
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTTCCAGGTCGTCC"	-0.902737240225631	8.47738645160524	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTTCCAGGTCGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1967.95609037581	25.4585953170256	0.0129365667463464	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.51134970991	1964.51134970991
"healthy-4003"	"2020-08-26-Control4003-c2:AGCTTCCCAAGCCATT"	-0.923283199698287	8.57521054828493	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGCTTCCCAAGCCATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1910.10642582949	35.572196886385	0.0186231491635013	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1901.69238826373	1901.69238826373
"healthy-4003"	"2020-08-26-Control4003-c2:AGGAAATTCTCTAAGG"	0.357519974082154	8.27510259235231	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGAAATTCTCTAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1635.67105783145	3.22995329364929	0.00197469612131642	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1630.12461114898	1630.12461114898
"healthy-4003"	"2020-08-26-Control4003-c2:AGGAATAAGCAAACAT"	3.38895048674886	-6.68474819576415	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGAATAAGCAAACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.11202751779	34.7852195341865	0.0153096410356967	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2268.98768032487	2268.98768032487
"healthy-4003"	"2020-08-26-Control4003-c2:AGGAATAGTAGTCGTT"	4.52136339721028	-6.99020817196044	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGAATAGTAGTCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.24633324827	29.2703984152301	0.0120392565800288	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2428.6410291581	2428.6410291581
"healthy-4003"	"2020-08-26-Control4003-c2:AGGAATAGTCACTCTC"	4.49370922622029	-7.35252859508666	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGAATAGTCACTCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.31889010366	32.6556553335246	0.0118950317397523	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2738.67848800516	2738.67848800516
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGAAGGGTAATT"	3.75192846831624	-6.80932238018187	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGAAGGGTAATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.33229071084	26.2136430541497	0.0103597630834429	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2522.2126146588	2522.2126146588
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGACAATCTAGC"	-4.00000415268596	10.7713756331238	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGACAATCTAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2107.65833518293	39.235993025262	0.0186159171865286	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2100.5258565494	2100.5258565494
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGACAGTTGTCA"	-0.938235561281997	8.42489144885866	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGACAGTTGTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.51057606834	29.125093481703	0.017167646280874	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1692.92568221899	1692.92568221899
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGACATGTCTAG"	5.51374878463094	-10.0114994279114	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGACATGTCTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.11395841782	36.841470890218	0.014601588155503	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2508.70169428005	2508.70169428005
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGAGTATACCTG"	-4.4661525291508	13.127905822638	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGAGTATACCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2007.84125486832	33.9535294769574	0.0169104651050634	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2007.84125486832	2007.84125486832
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGAGTGCGAACA"	-7.49214635315593	0.25457396293012	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGAGTGCGAACA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2897.2216175404	21.9801076941787	0.00758661593614601	3191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2891.10719842104	2891.10719842104
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACGATCACCCTGT"	-2.97907553139384	-5.75805523311766	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACGATCACCCTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2186.84015564854	24.7634586259764	0.0113238539918033	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2184.24758996009	2184.24758996009
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACTTGTAGACGGT"	4.89791645583455	-7.53126385128173	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACTTGTAGACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.49119443327	21.7600819195591	0.00930916102331454	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.84155454628	2331.84155454628
"healthy-4003"	"2020-08-26-Control4003-c2:AGGACTTGTAGACTGG"	-1.16490576687511	8.45155809009401	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGACTTGTAGACTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2052.66855056834	32.6323408450202	0.0158975207351352	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2044.27384110486	2044.27384110486
"healthy-4003"	"2020-08-26-Control4003-c2:AGGAGGTAGGCCTAAG"	-3.19702563706096	10.1095094450745	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGAGGTAGGCCTAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1780.85901768846	37.5470065601775	0.0210836490633117	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1776.80962884674	1776.80962884674
"healthy-4003"	"2020-08-26-Control4003-c2:AGGATCTAGGGCAGTT"	4.93579544600789	-8.11660864269408	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGATCTAGGGCAGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.07623111852	0.393273076642686	0.000161835695360746	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.24722912186	2425.24722912186
"healthy-4003"	"2020-08-26-Control4003-c2:AGGATCTCATGAATCC"	9.19921745833699	6.47655627811281	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGATCTCATGAATCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1765.03602385349	29.0506040723846	0.0164589298347351	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1759.88712583492	1759.88712583492
"healthy-4003"	"2020-08-26-Control4003-c2:AGGATCTGTCGTCAGC"	3.90096320685689	-6.72713282024535	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGATCTGTCGTCAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.26050698948	36.1424506503539	0.0143692673382817	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.81578929342	2505.81578929342
"healthy-4003"	"2020-08-26-Control4003-c2:AGGATCTTCAGCCCAG"	4.24734463271443	-6.87509539043578	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGATCTTCAGCCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.88437311258	35.8620704998452	0.0165043621021003	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2172.88437311258	2172.88437311258
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCATTAGTGTTCCA"	4.67375578460042	-7.04945852672728	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCATTAGTGTTCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.95302092879	32.6189115355304	0.013981812425243	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2324.50883975026	2324.50883975026
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCCACAGATCGCTT"	3.6211482482845	-7.1607876054016	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCCACAGATCGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.28308134274	34.9532793464771	0.0170065523643788	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.02658988023	2047.02658988023
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCCACCAGTCCGTG"	3.49149169501607	-7.99941160595091	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCCACCAGTCCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1972.62546774336	28.8932734846479	0.0146471157131015	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1967.65279566775	1967.65279566775
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCTGCCAACTGAAA"	0.307530452578706	8.15904042804567	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCTGCCAACTGAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1664.68492607026	24.4855009575591	0.0147087899782698	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1657.28932668032	1657.28932668032
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCTGCCATACCAGT"	4.30889381942098	-7.08148910915526	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCTGCCATACCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.18385561242	2.77214619016743	0.00113140333686287	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2443.8404549967	2443.8404549967
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCTGCGTAGCTTAC"	5.55001034316365	-10.1246071091858	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCTGCGTAGCTTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.088266084	46.8182308469175	0.0220623390625092	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2112.79409368654	2112.79409368654
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCTGCTCCATAGAC"	5.57700123366658	-9.78573038494261	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCTGCTCCATAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2725.70829887751	37.6878158118432	0.0138267971768526	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2720.0055170944	2720.0055170944
"healthy-4003"	"2020-08-26-Control4003-c2:AGGCTGCTCCATGATG"	-0.330225448042709	8.49954984271852	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGCTGCTCCATGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2036.98409962591	17.9858686612368	0.00882965589399536	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2035.40963539833	2035.40963539833
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGAGTCACAGTATC"	-3.60685549202617	12.4583682783875	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGAGTCACAGTATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1554.11607962731	35.2151377312656	0.0226592712043173	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1554.11607962731	1554.11607962731
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGAGTTCTCGAGTA"	4.14525808867757	-7.24246456539305	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGAGTTCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.44353422138	28.0278211105201	0.010807183862183	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2587.42906980027	2587.42906980027
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCCTAGTCGAATA"	5.38613380965535	-10.1038208237854	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCCTAGTCGAATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1899.99987824224	8.32420073448691	0.00438115856206682	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1894.3159417728	1894.3159417728
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCCTGTGCTCCGA"	-4.02616105499919	12.6908788450989	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCCTGTGCTCCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1882.76259207671	35.6349034865421	0.0189269234668808	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1874.3228595058	1874.3228595058
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCCTGTGGATACG"	-6.55365786972697	3.29932878101198	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCCTGTGGATACG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2511.84985161789	0	0	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2499.49654171614	2499.49654171614
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCCTGTTCTCGTC"	-3.63947854462321	10.2142152556214	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCCTGTTCTCGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.95394922242	26.6743062372243	0.0141737295156693	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.87800372038	1872.87800372038
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCTCCATCGTGCG"	0.120602590113324	8.12298963153688	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCTCCATCGTGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1727.09506404542	34.7755279584015	0.0201352714638335	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1721.09070443996	1721.09070443996
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCTCTCGTCGACG"	5.06381716307942	-7.79308273708495	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCTCTCGTCGACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.4275078697	25.8540550225958	0.00956343565615666	2171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2697.4465716901	2697.4465716901
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGCTCTCGTGACTA"	-7.83468614044841	-0.415660463925921	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGCTCTCGTGACTA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3135.5203716845	30.5923485033408	0.00975670538759908	4346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3126.23363352119	3126.23363352119
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTCCAGATGTAGT"	-4.33173690262492	10.8017987974915	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTCCAGATGTAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2458.68902764351	35.5431269685499	0.0144561294937797	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2452.19941701684	2452.19941701684
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTCCAGCTAGCCC"	4.20888628539388	-6.87907745754393	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTCCAGCTAGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.77003995699	19.0731112287559	0.00860013025927873	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2211.7705984991	2211.7705984991
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTCCCAAGTTGGG"	-3.15104828301128	11.1873025664124	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTCCCAAGTTGGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1986.73808907118	27.4275297693956	0.0138053072623268	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1983.13035125214	1983.13035125214
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTCCCAGCGACAA"	-3.76430855217631	10.2041063078674	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTCCCAGCGACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.52414179894	40.9416871416127	0.0201531875990203	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2023.99161888721	2023.99161888721
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTCCGTACGGGAT"	4.7284013229305	-8.12498476421507	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTCCGTACGGGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.63065320025	0	0	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.92570015859	2318.92570015859
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTGAGTCGTGTTA"	-4.05458198013957	11.0869741209778	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTGAGTCGTGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2105.48887266451	37.8432863430226	0.0179736339784744	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2105.48887266451	2105.48887266451
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTGATCGAGAAAT"	4.38768734511678	-7.59326651012572	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTGATCGAGAAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.76607886349	32.1483816599659	0.0149265892779452	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2148.16116120847	2148.16116120847
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTTTAGCTCACTA"	-0.265279869467574	8.0296683081421	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTTTAGCTCACTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2015.63573556237	32.1712239678439	0.015960832307266	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2011.31633452157	2011.31633452157
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTTTGTCGCGGTT"	-2.75113687935527	9.55739781940309	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTTTGTCGCGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1699.91285569944	37.8491910028318	0.0222653713547326	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1697.9155016857	1697.9155016857
"healthy-4003"	"2020-08-26-Control4003-c2:AGGGTTTGTTGGGCCT"	4.67114653167073	-7.60434009945067	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGGTTTGTTGGGCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.00848262229	39.3292588328122	0.0161648671238594	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2426.81940340928	2426.81940340928
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTAGGAGCCTAACT"	4.47480835494344	-7.65066149151	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTAGGAGCCTAACT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.99968471023	0.0254356809524315	9.42760708853207e-06	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2692.40728783232	2692.40728783232
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTAGGAGGTATCTC"	4.24727215346639	-7.24287559902342	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTAGGAGGTATCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.17316709868	32.6663613292034	0.0155171849231879	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2098.53261536575	2098.53261536575
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTAGGGTTTAAGGA"	-3.92690453949626	12.7216501005921	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTAGGGTTTAAGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1778.9014520549	31.1202082546647	0.0174940597292313	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1774.43860384488	1774.43860384488
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTAGGTCAGACCCG"	4.44525827941243	-7.50745155727538	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTAGGTCAGACCCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2406.72842514655	20.7988525047102	0.0086419607162132	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2401.14606977498	2401.14606977498
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTCATAGGCGCTCT"	-5.44800601425822	-5.32826902782591	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTCATAGGCGCTCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2542.5128645395	15.7443002623543	0.00619241714838125	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2537.07279415838	2537.07279415838
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTCATCAACGTTAC"	-4.24703536453899	12.2003927000794	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTCATCAACGTTAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1898.16735726955	35.353764780734	0.0186252095450578	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1896.10862939963	1896.10862939963
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTCATCAAGTGATA"	-4.23570332947429	12.4140014418396	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTCATCAAGTGATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1734.80448678936	9.24690989212514	0.00533023171345297	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1726.0366423691	1726.0366423691
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTCTACATTGCCTC"	-3.76626048508342	13.1103400954041	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTCTACATTGCCTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2208.91277623365	31.9915776857748	0.0144829519888616	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2193.15410576862	2193.15410576862
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTCTATCTCGGTAA"	4.64216675338094	-7.54155018245848	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTCTATCTCGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2741.34529748628	33.2657906147519	0.0121348414755542	1912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2733.84910088136	2733.84910088136
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTGTTTCAACCCGG"	-4.09009967270549	12.4633254774841	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTGTTTCAACCCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1777.69318040634	41.981625707024	0.0236157882416065	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1769.50000897249	1769.50000897249
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTGTTTCTTGGTGA"	10.6929623084957	6.83768079364625	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTGTTTCTTGGTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1930.21542006976	37.439327476579	0.0193964503066844	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1921.56304800867	1921.56304800867
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTTACAGCATTGTC"	-3.28154979172404	10.4929466017517	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTTACAGCATTGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1609.91349681643	33.848478789266	0.0210250295163067	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1607.66357086395	1607.66357086395
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTTACCAACAGATA"	3.25030197676961	-6.15318539058837	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTTACCAACAGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.95074504936	28.2154925635353	0.010814881276343	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2605.11287812982	2605.11287812982
"healthy-4003"	"2020-08-26-Control4003-c2:AGGTTGTAGATGCAGC"	-4.01609168472941	3.64081809604494	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGGTTGTAGATGCAGC"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3150.17952043062	4.17459225954413	0.00132519186048593	3856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3139.56158689918	3139.56158689918
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAACCAGGAAGTCC"	4.08831991729085	-7.59746744548949	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAACCAGGAAGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.05375712114	37.7760871634003	0.0173998856727952	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2165.11908882169	2165.11908882169
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACCACACAACGCC"	5.41744198378865	-9.93175222789916	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACCACACAACGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.37555660608	18.1356349969885	0.00703101762383575	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2570.53372717215	2570.53372717215
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACCACACATTCTT"	5.53717007216756	-10.1414365998474	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACCACACATTCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.2936707405	18.8884734632746	0.00802298952676265	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.37594671091	2351.37594671091
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACCAGTCAAGTTC"	-4.42187486115153	13.1016816862854	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACCAGTCAAGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2131.15775606511	33.8929214780355	0.0159035253873529	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2122.81473864915	2122.81473864915
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACCATCTACTCAT"	-4.08454308930095	12.87082288349	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACCATCTACTCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1689.55715786566	32.5615089217524	0.0192722150713657	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1689.55715786566	1689.55715786566
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACTGAGAGATTCA"	0.655574877827805	9.16850183093873	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACTGAGAGATTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1478.69607820402	23.3578918532704	0.0157962763258562	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1471.98675029938	1471.98675029938
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACTGAGAGGCGTT"	4.24864496764485	-7.33373882686766	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACTGAGAGGCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.35259768591	27.1566900335069	0.0126465909989688	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.0143843994	2142.0143843994
"healthy-4003"	"2020-08-26-Control4003-c2:AGTACTGAGCTGAAAT"	-5.21494470062907	-5.13645841991576	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTACTGAGCTGAAAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2323.86655231413	48.2189550238775	0.0207494509423791	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2315.111368608	2315.111368608
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGCTCATGTCTAG"	4.17605080184285	-7.38924457943114	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGCTCATGTCTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.50818388675	35.2597987545214	0.0145791521357831	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2410.62875982333	2410.62875982333
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGCTTCCATTCGC"	3.43745603141133	-7.3725738755432	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGCTTCCATTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.8325157398	33.5845324731499	0.015170313126387	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.91602827971	2207.91602827971
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGTCAGGTTGTTC"	-3.982658247382	12.909282661322	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGTCAGGTTGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1994.13578372969	17.8586698342467	0.00895559368622589	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1992.09421071943	1992.09421071943
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGTCCAAGAGAGA"	3.92922319945638	-7.18071319973143	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGTCCAAGAGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.87431141145	5.16101745233595	0.0026346853508009	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1957.39961757263	1957.39961757263
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGTCTCCAAGCCG"	4.46198286589925	-7.72903015529784	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGTCTCCAAGCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.98510921317	35.1796658884737	0.0191507626882953	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1831.47598694803	1831.47598694803
"healthy-4003"	"2020-08-26-Control4003-c2:AGTAGTCTCTTTCAGT"	8.73244728621785	6.22766778552858	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTAGTCTCTTTCAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1426.48392303465	32.0957654930893	0.022499913931599	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1418.1171654296	1418.1171654296
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCAACCAACACGAG"	-2.44386396828349	9.61909005725709	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCAACCAACACGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1888.94199510253	39.5586316363966	0.0209422161924297	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.00792099166	1882.00792099166
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCAACCAATACCCA"	3.41610397872273	-6.16325619136962	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCAACCAATACCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.20665489642	31.5863550095343	0.0134226864197461	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.37215258767	2347.37215258767
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCAACTCGGAGCAA"	4.63337673720662	-7.33188965236815	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCAACTCGGAGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.6685174162	0.620962466122028	0.00030504105202265	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2032.10528909925	2032.10528909925
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCAACTCTTGCAAG"	-3.05238280716594	10.3111972578797	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCAACTCTTGCAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.48031771172	28.9855116510329	0.0148000015057079	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1948.46224489799	1948.46224489799
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCACACAGTACTAC"	-5.71496043625529	3.38976142490236	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCACACAGTACTAC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2729.03979892612	27.7922728031848	0.0101839016104203	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2717.86764955028	2717.86764955028
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCACACATCAGTCA"	-0.347039262682754	7.81352946842042	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCACACATCAGTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2062.86684259949	23.9552950532422	0.0116126230537766	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2054.65911885643	2054.65911885643
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCACAGTCGCGTCA"	2.49809803542439	-4.00272085582884	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCACAGTCGCGTCA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2635.08094583235	0	0	2144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2628.13346558384	2628.13346558384
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCACAGTTCGGTTA"	5.66200747069661	-9.91713335430297	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCACAGTTCGGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.73696467853	35.6657938918945	0.0142450242957027	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2498.13743017155	2498.13743017155
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCACATCGTTCAGA"	-0.133415262133437	8.83433339679567	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCACATCGTTCAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1704.19796179184	38.7697979008761	0.0227495858873769	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.67634947041	1685.67634947041
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCATGAGGTACTGG"	5.33577789840047	-9.19650270855101	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCATGAGGTACTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.18113195617	5.20777399279899	0.00215448231162737	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.53097600757	2408.53097600757
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCATGGTTCCTAAG"	3.73212804374043	-7.0860600701538	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCATGGTTCCTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.33289465867	8.03229572439769	0.00377044157959391	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2127.18837348031	2127.18837348031
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCATGTCACAGAGG"	-7.87791428986247	0.227512262109198	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCATGTCACAGAGG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3118.29193763673	38.5210314754176	0.0123532473051935	4201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3101.82415949501	3101.82415949501
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCATGTCCTCTCTT"	4.53907074508016	-7.53852703487548	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCATGTCCTCTCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.68403431294	2.16506830116337	0.000774709510835862	2147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2791.77988329623	2791.77988329623
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCATGTCTTAAGGC"	5.36574186858479	-9.89933683788451	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCATGTCTTAAGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.93116576993	17.1846804387769	0.00780436768683823	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.23896037044	2200.23896037044
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCTCCAGCCTGACC"	5.47225822982137	-9.55510713970336	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCTCCAGCCTGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.40292883907	35.9053314673605	0.0136657118987172	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2622.51521968524	2622.51521968524
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCTCCCAACTGTGT"	-1.95921884003337	9.40794656360475	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCTCCCAACTGTGT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2055.35467606629	35.123859304206	0.0170889529253554	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.93463538851	2046.93463538851
"healthy-4003"	"2020-08-26-Control4003-c2:AGTCTCCTCCATCGTC"	5.55359329757039	-9.82842352306517	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTCTCCTCCATCGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.04670637238	15.1349018171164	0.00578098999543351	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2613.83933640926	2613.83933640926
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGATCCATGCCGCA"	4.25205339965169	-6.8539610139099	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGATCCATGCCGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.04037862737	2.86728157100537	0.00123162879704687	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.21986954481	2325.21986954481
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGATCCATGTTCAG"	-3.53068862381633	-4.61219885265502	"2020-08-26-Control4003-c2"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGATCCATGTTCAG"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2895.76322113825	27.8601913006451	0.00962101842349319	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2888.1935477827	2888.1935477827
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGATCTCGACATTG"	-3.98886619034465	13.0030822523865	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGATCTCGACATTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1991.40808044733	39.7906475933066	0.0199811620651697	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1987.58148012168	1987.58148012168
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGAGAGCTTTC"	10.3559128242428	7.41767308795778	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGAGAGCTTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1789.21143519295	33.0840908335211	0.018490878262218	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1785.37160099265	1785.37160099265
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGAGATGGGCT"	-1.77624032917674	3.95678041065065	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGAGATGGGCT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2850.77039035628	0	0	4328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2846.99065999609	2846.99065999609
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGCACTTCCTG"	5.24324001845662	-10.148500465509	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGCACTTCCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1691.14104691466	7.6177146410572	0.00450448213941414	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1691.14104691466	1691.14104691466
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGTCACCGACG"	10.5071979957515	5.88610646808473	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGTCACCGACG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1896.24263639489	32.5175679933952	0.0171484214990636	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1892.57609244488	1892.57609244488
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGTCCGTGTGG"	-1.78930900517161	8.70211122119752	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGTCCGTGTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.51721828514	35.6360136901375	0.0191127297407921	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.51721828514	1864.51721828514
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGCCGTCCTTTAGT"	2.90487541732137	-4.80906488811644	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGCCGTCCTTTAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2665.13769350152	24.6579600827073	0.0092520398262467	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2663.3210116359	2663.3210116359
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGTTGTCAGTGTGT"	-0.00311897221263054	8.32994744861452	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGTTGTCAGTGTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.40987675405	40.3110792624819	0.0225401792880087	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1784.76032534414	1784.76032534414
"healthy-4003"	"2020-08-26-Control4003-c2:AGTGTTGTCCGTGGTG"	-7.95817981186565	2.31175086582033	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTGTTGTCCGTGGTG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3007.37743675362	30.0834081630545	0.0100032033875763	3556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2982.02753593726	2982.02753593726
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTAGCGTTAAAGTG"	4.22129740294759	-7.06608679210814	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTAGCGTTAAAGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.4935539293	27.2846029406151	0.0111707983411959	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.96720806494	2439.96720806494
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTAGCTCAGCAATC"	3.05102910575215	-7.47437097942504	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTAGCTCAGCAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1718.15330643378	2.12736140753289	0.00123816739726705	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1716.3345432961	1716.3345432961
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTAGCTCTCCGCAT"	10.7579132514888	6.41955134952394	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTAGCTCTCCGCAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1889.2885574199	35.8167108401844	0.0189577768306062	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1882.19545339119	1882.19545339119
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTAGCTCTCCTACG"	3.27836789664571	-6.85208942806395	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTAGCTCTCCTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.78953036252	18.7298885814154	0.00782436732379681	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2393.78953036252	2393.78953036252
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTCCCGTGAACGGT"	3.99010672149007	-6.6656327477661	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTCCCGTGAACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.43689114855	30.9205902046731	0.0130607875210022	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.67389319132	2361.67389319132
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTCCCTCGGCATCG"	-0.331090341240722	8.4889812239441	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTCCCTCGGCATCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1712.86742702783	29.4211333371137	0.0171765385183168	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1703.93264658019	1703.93264658019
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTCGAAGCGCAATG"	3.33966579016988	-7.00058414852294	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTCGAAGCGCAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.42186075214	29.9381284591101	0.0127644962128516	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2340.72844586838	2340.72844586838
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTCGAGTGAGACCA"	-4.21163163605388	13.0634183653626	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTCGAGTGAGACCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2108.18622789215	36.2598446466085	0.0171995453565136	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2102.58364338295	2102.58364338295
"healthy-4003"	"2020-08-26-Control4003-c2:AGTTCGATCAAATGCC"	-1.79845807972606	9.64911553943483	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AGTTCGATCAAATGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2030.36816930318	32.9693071336862	0.016238092988328	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2019.36529285098	2019.36529285098
"healthy-4003"	"2020-08-26-Control4003-c2:ATACCGAAGTGCGACA"	4.35790838774983	-7.08621551906737	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACCGAAGTGCGACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.20836452528	17.9902817664478	0.00734234770679734	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.38288844725	2445.38288844725
"healthy-4003"	"2020-08-26-Control4003-c2:ATACCGATCTAGCCTC"	4.04010762748067	-6.57454826748046	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACCGATCTAGCCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.18262231399	6.65810171440622	0.00311245129095338	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2132.13391876385	2132.13391876385
"healthy-4003"	"2020-08-26-Control4003-c2:ATACCTTAGGTATCTC"	-3.58135519447978	10.2810439833435	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACCTTAGGTATCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1792.92609606945	16.9379937388569	0.00944712321159768	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1786.74986672391	1786.74986672391
"healthy-4003"	"2020-08-26-Control4003-c2:ATACCTTCACCTGATA"	-7.07811818543132	3.29247925365297	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACCTTCACCTGATA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2433.86413814073	24.9214741818429	0.0102394680916252	2052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2416.11423529605	2416.11423529605
"healthy-4003"	"2020-08-26-Control4003-c2:ATACTTCAGGTGAGCT"	2.66780151900594	-4.33018734371337	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACTTCAGGTGAGCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2408.8782689513	23.985213634443	0.00995700527652021	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2400.28043187736	2400.28043187736
"healthy-4003"	"2020-08-26-Control4003-c2:ATACTTCGTCTGCCTT"	3.28049554404561	-6.83893349086913	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACTTCGTCTGCCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.04762534795	9.783139985674	0.00411220854994155	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2373.7987205815	2373.7987205815
"healthy-4003"	"2020-08-26-Control4003-c2:ATACTTCGTTTCTATC"	5.42322363433186	-9.35391046917113	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACTTCGTTTCTATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.64886476416	26.6553421910114	0.00998832875428408	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2662.47256622149	2662.47256622149
"healthy-4003"	"2020-08-26-Control4003-c2:ATACTTCTCTTTCCGG"	3.89877810057942	-6.60433008587035	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATACTTCTCTTTCCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.17156838146	32.5709992472862	0.0138589878651785	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.05039508662	2347.05039508662
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGACCAGGTAGGCT"	-4.90731034699138	3.44536779010621	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGACCAGGTAGGCT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3095.3355643544	34.1022267411399	0.0110172955507177	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3073.5047959078	3073.5047959078
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGACCCATCCTTCG"	-0.433709363371688	8.40614984119264	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGACCCATCCTTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2110.895264962	32.6175401088474	0.0154519935926023	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2106.88552523487	2106.88552523487
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGACCTCTTAGCTT"	3.92342104491536	-6.61109259044798	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGACCTCTTAGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.64861573382	35.4228534141178	0.0137583253876458	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.59383842374	2568.59383842374
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGAGACAGAGGGTT"	5.60204472121541	-9.65463926708373	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGAGACAGAGGGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2722.75628393591	36.9455988482964	0.0135691905538051	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2712.01660329249	2712.01660329249
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGAGAGTCAAAGCG"	5.38146080550496	-10.2070770493713	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGAGAGTCAAAGCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.21962486696	7.48384467927182	0.00360281820452719	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2070.38985496773	2070.38985496773
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGAGATCGGCCCAA"	-0.890502492815811	9.68888185108034	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGAGATCGGCCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1409.57430199913	38.5850459331732	0.0273735452458588	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1407.03389131383	1407.03389131383
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGGCTAGCAAACAT"	-4.09830460968669	12.7043018111023	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGGCTAGCAAACAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2032.69649237607	9.76198210403485	0.00480247894392921	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2028.76179561971	2028.76179561971
"healthy-4003"	"2020-08-26-Control4003-c2:ATAGGCTTCTCGGTCT"	-0.377788345248061	8.27748200977174	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATAGGCTTCTCGGTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2121.60092755337	28.2390342228479	0.0133102478680631	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2113.17962858988	2113.17962858988
"healthy-4003"	"2020-08-26-Control4003-c2:ATATCCTAGTTGCGCC"	4.38661684569661	-7.55481245433959	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATATCCTAGTTGCGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.34503594551	29.5691913384275	0.0149691273171799	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1971.85326454312	1971.85326454312
"healthy-4003"	"2020-08-26-Control4003-c2:ATATCCTCACAGACGA"	-4.30863032761272	13.2309560545715	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATATCCTCACAGACGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1855.34562076943	41.0649861692916	0.022133335002166	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1844.69758930618	1844.69758930618
"healthy-4003"	"2020-08-26-Control4003-c2:ATATCCTCACGAGGAT"	-4.3066819709843	12.829466796759	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATATCCTCACGAGGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2090.78258352225	34.8488938694525	0.0166678707504556	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2090.78258352225	2090.78258352225
"healthy-4003"	"2020-08-26-Control4003-c2:ATATCCTTCCCGAAAT"	4.19526829299275	-7.09682753002318	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATATCCTTCCCGAAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.19000164937	6.29527639575926	0.00250888788478401	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.75420601029	2505.75420601029
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACAGCAACCCTCT"	4.9558559852535	-7.76486256038817	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACAGCAACCCTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.09755700692	3.74865485077361	0.00149820491222487	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.53410586627	2495.53410586627
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACAGGTCGCGTTG"	-4.87478528443034	3.5205712088379	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACAGGTCGCGTTG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2980.62688483572	33.2687104795056	0.0111616487956825	3395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2970.17272965768	2970.17272965768
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACGAAGGTGATAT"	3.96860637244527	-7.19044401561888	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACGAAGGTGATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.918521145	31.0921285710777	0.0129393187065961	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2393.08564709452	2393.08564709452
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACTTTCAGGACGA"	-3.80098376694377	10.4691295393738	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACTTTCAGGACGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2301.28209399754	37.467663548767	0.0162812128276208	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2287.84125133829	2287.84125133829
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACTTTCCATTTAC"	4.71815790709798	-7.60971786892089	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACTTTCCATTTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.7658717423	6.53559270127979	0.00253733958236623	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.67851006071	2568.67851006071
"healthy-4003"	"2020-08-26-Control4003-c2:ATCACTTTCGTTCGCT"	-0.765041391283828	8.47349736774293	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCACTTTCGTTCGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2254.892033832	11.9631842143315	0.00530543548641709	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2242.27611629003	2242.27611629003
"healthy-4003"	"2020-08-26-Control4003-c2:ATCATTCCATCCGAGC"	4.69109262999837	-7.38964273845824	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCATTCCATCCGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.61961479966	35.7080402659492	0.0165958889853651	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.77160345254	2144.77160345254
"healthy-4003"	"2020-08-26-Control4003-c2:ATCATTCGTCATCACA"	3.94807924804036	-7.30028297817381	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCATTCGTCATCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.26534835816	12.6476604856861	0.0052824806967862	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.1371729525	2389.1371729525
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGTGATCAGCTTCC"	-1.57369003716167	8.83718583667604	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGTGATCAGCTTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2102.18966853686	42.8595780721391	0.0203880642710844	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2092.37178516076	2092.37178516076
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTACTAGTGTTGAA"	-0.27274046364482	8.14925096118776	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTACTAGTGTTGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1766.68952030011	27.143940185196	0.0153642956916306	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1759.25723599904	1759.25723599904
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTACTCAAGTCGTT"	4.15710796889607	-8.08020117199095	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTACTCAAGTCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1790.48370608495	3.88643129603477	0.00217060411263545	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1790.48370608495	1790.48370608495
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATAGAAACCCG"	4.85166277465169	-7.57273437893065	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATAGAAACCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.66879387725	12.58712320243	0.005138295933675	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.75003558858	2445.75003558858
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATAGAGTCTGG"	0.436024178832215	8.24981401050416	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATAGAGTCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1775.13588626381	34.6845544077763	0.019539098204351	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1771.15727858001	1771.15727858001
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATAGTGTCATC"	-3.8945201438969	12.1864194639954	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATAGTGTCATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1884.62479333425	17.6681014057466	0.00937486414709023	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1884.62479333425	1884.62479333425
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATGTGACAGGT"	5.58548512038533	-10.1186838380066	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATGTGACAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.79009707657	17.853781353941	0.00782103504689513	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2277.02166113655	2277.02166113655
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATTCATTTGGG"	4.250655789941	-6.92907669460448	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATTCATTTGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.27232652505	9.5097817544644	0.00393246932951077	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2411.38151034177	2411.38151034177
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATTCCTTGAAG"	-2.32663212242778	8.81165692890016	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATTCCTTGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2249.66909123748	7.40789295674065	0.00329288115554175	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2245.17572048095	2245.17572048095
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCATTCGACGCGT"	-3.96251950684245	11.6307039030823	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCATTCGACGCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1664.77577967546	33.0834080917792	0.0198725909492921	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.77577967546	1664.77577967546
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCCGCAACGAGGT"	-1.6195242208546	9.53164193713991	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCCGCAACGAGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.90588923527	28.4147943819813	0.0150589356597415	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1884.98073823027	1884.98073823027
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCCGGTATTGGCT"	5.46019663390462	-10.094714187738	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCCGGTATTGGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.39531114052	38.0691481610286	0.0152557584728446	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.16813927431	2489.16813927431
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCCGGTCACTTCC"	-0.23467923227008	8.37122724140016	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCCGGTCACTTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1500.20874810355	33.157845361426	0.0221021543857423	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1496.43935859291	1496.43935859291
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCTAAGGGACACT"	-3.19268451157268	-5.9701285592285	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCTAAGGGACACT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2640.33708907242	41.5115614808041	0.0157220688421219	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2637.72133150524	2637.72133150524
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTCTACACACTTAG"	5.48917116698567	-10.1853533021179	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTCTACACACTTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.2555009474	35.372709842899	0.014627366640556	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.01870743966	2408.01870743966
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGAGAGGTTGCCC"	9.06575264510457	6.20396707141725	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGAGAGGTTGCCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1416.87057589557	45.0262672245564	0.0317786733598419	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1414.35105259027	1414.35105259027
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGAAGGATCATA"	2.62221970137898	-4.46810152446898	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGAAGGATCATA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2359.46094931041	26.9764949722068	0.0114333297103692	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2356.1521098365	2356.1521098365
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGACACCGTGGT"	3.61367215689961	-7.08637859737548	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGACACCGTGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.18937721829	35.0460529390002	0.0172200451374709	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2031.67149811101	2031.67149811101
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGACACGGGCTT"	2.93708934363667	-4.73844053661498	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGACACGGGCTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2429.47080098764	19.7449501667653	0.00812726382994128	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2424.57010867518	2424.57010867518
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGAGTAGCGCTC"	5.14994968947713	-10.1316871873108	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGAGTAGCGCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.71353076525	47.9429982985662	0.0245645672599135	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1949.8505064839	1949.8505064839
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGAGTATAGGGC"	4.4318753677303	-7.345729850885	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGAGTATAGGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.6086475125	12.4578700102515	0.00540563363055068	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2299.75508117743	2299.75508117743
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGAGTGTGGTCC"	0.205394049256486	8.15424916828004	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGAGTGTGGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1593.51643838067	39.2629866165863	0.0246392102841972	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1579.96054265011	1579.96054265011
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGAGTTTATGCG"	-4.01406703415568	12.69370935047	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGAGTTTATGCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1716.59949013623	25.0673836424339	0.0146029308446576	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1714.3804598008	1714.3804598008
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTGGATCTAAGGAA"	-3.6240647834843	-5.42774107372435	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTGGATCTAAGGAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2852.28874092033	41.375431321456	0.0145060458739201	2344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2843.03010961225	2843.03010961225
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTTGTAGGGCCCTT"	-4.26750407639201	13.1191968687805	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTTGTAGGGCCCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2345.67982609495	31.7155643794641	0.0135208411764634	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2338.70163385945	2338.70163385945
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTTGTAGGTGGTTG"	-3.3168355030125	10.7668752440247	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTTGTAGGTGGTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1649.28373651457	25.8800209491687	0.0156916729221261	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1642.72244525406	1642.72244525406
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTTGTTCTCTCCGA"	3.60297741469685	-6.95258333599242	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTTGTTCTCTCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.06349585369	29.7434092635956	0.0118685776768252	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2503.33516892355	2503.33516892355
"healthy-4003"	"2020-08-26-Control4003-c2:TGTTTGTTCTCTCTAA"	-0.998234729201156	8.69256970966188	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTTTGTTCTCTCTAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1886.67062777221	31.0648500021204	0.0164654336293993	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1877.11729064116	1877.11729064116
"healthy-4003"	"2020-08-26-Control4003-c2:TTACAGGAGGAGAGTA"	4.41994347152059	-7.08640100872191	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACAGGAGGAGAGTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.92225748597	36.2079615813743	0.0150058550245624	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2410.41849627041	2410.41849627041
"healthy-4003"	"2020-08-26-Control4003-c2:TTACAGGCAATACGCT"	10.6712395149166	7.2127852209839	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACAGGCAATACGCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.92421210267	32.671010821058	0.0171869086695043	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1899.27931173776	1899.27931173776
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCATCAATTCTCT"	1.5150497156078	-3.86445619976195	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCATCAATTCTCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2682.21751660567	20.6232606205112	0.00768888447444404	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2677.60530598579	2677.60530598579
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCATCATCATTTC"	-2.03408728066142	4.19085166538087	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCATCATCATTTC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3174.4840551773	20.2490358598404	0.00637868564084171	4279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3169.79050328862	3169.79050328862
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCATGTTAGGCCC"	4.37442411956136	-7.96573164379271	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCATGTTAGGCCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.68667861012	9.33148204934445	0.00381860822462389	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.13466564675	2439.13466564675
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCATGTTGAGTCT"	-3.06946120682414	10.3378114470276	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCATGTTGAGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1892.09966827956	40.5680080698256	0.0214407352582611	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.56093467861	1882.56093467861
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCATTCTGGTGCG"	5.32282652434651	-10.1457615128723	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCATTCTGGTGCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.48925388834	11.591309717651	0.0049866049921553	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.49658944358	2321.49658944358
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCGCAGACTTAAG"	4.30655064162557	-7.40305616771849	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCGCAGACTTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.36048612394	0.112324714171626	4.67559780559224e-05	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.28798608004	2396.28798608004
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCGCCAGCAGTTT"	2.70544971999471	-6.61345245754393	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCGCCAGCAGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.13508231719	43.8933429415406	0.0227410730697901	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1928.42779831568	1928.42779831568
"healthy-4003"	"2020-08-26-Control4003-c2:TTACCGCTCTACTTCA"	11.1328035789425	6.41365001285402	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACCGCTCTACTTCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2285.68704280192	30.1956824040359	0.013210768507932	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2281.97612400871	2281.97612400871
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGCCAGGAAGTAG"	-0.233570168644744	8.18770310962526	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGCCAGGAAGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1401.47834768899	30.9206245949573	0.0220628628661618	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1401.47834768899	1401.47834768899
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGCCAGGCCACTC"	-3.2654791873997	11.860472656134	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGCCAGGCCACTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1946.24641237403	27.8541255463476	0.014311715808057	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1944.37480633065	1944.37480633065
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGCCCACTAACGT"	3.42841925200765	-6.97440769588622	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGCCCACTAACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.83100502429	28.5533069375471	0.0114679698661992	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2485.81533764589	2485.81533764589
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGCCTCCCTTTGG"	4.61035027083699	-7.26172687923583	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGCCTCCCTTTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.57851978969	42.9793751385715	0.0159562362198846	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2689.74142800632	2689.74142800632
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGTTAGCCATGCC"	-4.01351390305217	12.9216232069763	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGTTAGCCATGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2068.04474803469	31.0354058454805	0.0150071249062546	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2061.94570672299	2061.94570672299
"healthy-4003"	"2020-08-26-Control4003-c2:TTACGTTTCCCATTCG"	-0.416939268738586	8.6631459959778	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACGTTTCCCATTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.75115461314	30.9698171899688	0.0160486066381846	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1924.84306249945	1924.84306249945
"healthy-4003"	"2020-08-26-Control4003-c2:TTACTGTCACGCCACA"	3.74838604506795	-6.73132231151732	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTACTGTCACGCCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.48644281279	18.3874679282871	0.00807357953164268	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2276.12637062291	2276.12637062291
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGGCACAAAGCACG"	-4.04168878021892	10.9519605406555	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGGCACAAAGCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.37439589357	40.9929982832266	0.0209001393966657	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.48386686269	1957.48386686269
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGGCAGTCTAATCG"	3.68033256110494	-6.70582487499388	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGGCAGTCTAATCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.16827432277	8.07757963755247	0.00374974403524345	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.42748598235	2146.42748598235
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGGCATCGCCTTGT"	4.67011608657185	-7.75776913082274	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGGCATCGCCTTGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.90134445451	10.5307381115468	0.00433203023050279	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2428.26704392827	2428.26704392827
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGGGTAGTTGCGAG"	4.71255793151204	-6.94264318859252	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGGGTAGTTGCGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.62725239373	6.18407016964664	0.00237062238921717	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2606.01300661742	2606.01300661742
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGGGTTCACTTGTT"	3.06287159499471	-6.37445452129515	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGGGTTCACTTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.57392674574	27.6526475685644	0.013465620695908	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2051.85127314515	2051.85127314515
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGTCTAGACCATAA"	3.72062863883321	-6.85896112835082	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGTCTAGACCATAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1965.14186423007	17.5606995649546	0.00893609763478054	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1961.53370908809	1961.53370908809
"healthy-4003"	"2020-08-26-Control4003-c2:TTAGTCTGTCCTCCTA"	4.4629770713741	-7.0777740708557	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTAGTCTGTCCTCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2739.1040262043	2.1185298963221	0.00077343900635196	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2734.48979869953	2734.48979869953
"healthy-4003"	"2020-08-26-Control4003-c2:TTATTGCAGATGAACT"	4.85564150389974	-7.76023580944213	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTATTGCAGATGAACT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.96001282567	0	0	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2394.03411897908	2394.03411897908
"healthy-4003"	"2020-08-26-Control4003-c2:TTATTGCAGGCTCCCA"	-0.0778917175834954	8.68271157825319	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTATTGCAGGCTCCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.51125259009	39.5410439499605	0.0210379394619055	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1877.76223559507	1877.76223559507
"healthy-4003"	"2020-08-26-Control4003-c2:TTATTGCCAACTTCTT"	-4.22441039505656	13.13178823078	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTATTGCCAACTTCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2607.22091844353	34.4758973318635	0.0132232359321683	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2596.25919426799	2596.25919426799
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAATCCAATAGTCC"	3.7153500514919	-6.79442455684813	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAATCCAATAGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.39833942663	35.5356940166713	0.0143035412046171	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2480.4007119005	2480.4007119005
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAATCCATCATCCC"	-3.83853850784953	10.6723069914612	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAATCCATCATCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1817.71865850567	17.2208816840011	0.00947389828641484	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1811.57040752011	1811.57040752011
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAATCCATTGACCA"	2.64798655089681	-4.27636387264403	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAATCCATTGACCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2211.05370825313	19.412388643863	0.00877970018159349	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2208.78177657817	2208.78177657817
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAATCTCCGAGTGC"	5.41445793685262	-9.54264166271361	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAATCTCCGAGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.72015262825	19.6142273725492	0.00847369274867988	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.73178286921	2311.73178286921
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACCGAGCTATCTG"	5.01013197478597	-8.39296438610228	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACCGAGCTATCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2779.8651061192	38.6546947228231	0.0139052411707799	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2773.79350759391	2773.79350759391
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACCGAGTCACGAG"	5.08448757705037	-7.86028864299925	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACCGAGTCACGAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3007.24545482891	22.2439393433493	0.00739678209759397	2553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2998.46915704093	2998.46915704093
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACCGTCGACCAAT"	4.19554438170735	-7.02807905590209	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACCGTCGACCAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.35282911072	32.2679925434207	0.0129002163021091	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2496.39200331135	2496.39200331135
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACCGTCGCCATAA"	3.92044152793233	-6.39652635967406	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACCGTCGCCATAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.8676579825	32.0666557040374	0.012791523159162	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.30807248527	2501.30807248527
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACGCCACAACGCC"	0.687038798897904	8.29360387409059	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACGCCACAACGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.78280931338	32.9783882170683	0.0171424695435545	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.89872067423	1912.89872067423
"healthy-4003"	"2020-08-26-Control4003-c2:TTCACGCCATTCGGGC"	-4.13051209870036	13.0808877714905	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCACGCCATTCGGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2070.50138053012	32.143438015344	0.0155244706995144	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2064.83929940374	2064.83929940374
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAGGAAGCTTGTGT"	2.63641085204427	-4.43430521404418	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAGGAAGCTTGTGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2358.0114021444	1.80931818369402	0.000767306800148891	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2356.87076418982	2356.87076418982
"healthy-4003"	"2020-08-26-Control4003-c2:TTCAGGATCGAAGCCC"	-4.17510590973552	13.1023263701233	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCAGGATCGAAGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1959.76739968067	32.946313364974	0.0168113386161758	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1950.29709023798	1950.29709023798
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATGTCACCGTCGA"	5.12991060790364	-9.23674681102904	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATGTCACCGTCGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2109.54126061895	4.46563609574947	0.00211687544544127	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.23211786395	2100.23211786395
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATGTCAGAGTTCT"	-1.8352007669514	8.93068120563356	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATGTCAGAGTTCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2271.0736858837	21.4984049090013	0.00946618555030991	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2263.9776586309	2263.9776586309
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATGTCAGGGAATC"	-2.4678102535313	9.41015527332155	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATGTCAGGGAATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1918.98252965949	35.3425799043748	0.0184173536538898	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1913.44219893061	1913.44219893061
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATGTGTTAAGTCC"	5.40836538848226	-9.73056127941283	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATGTGTTAAGTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.63260053661	23.5225693026489	0.0107919881987716	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2178.07477921547	2178.07477921547
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGAGCATTTCG"	4.84314550933186	-7.82333853161009	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGAGCATTTCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.58037713672	37.0580743396615	0.0143715025012372	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2578.58037713672	2578.58037713672
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGAGCTGAGCA"	4.56349482116048	-8.11443903362425	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGAGCTGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.16923422911	31.4709685159973	0.012612759120413	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.4076696178	2489.4076696178
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGAGGACCCAA"	5.60429539260213	-9.67805960094603	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGAGGACCCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.21133699365	38.9116280334804	0.0185363080637736	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2097.65637139147	2097.65637139147
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGAGGAGTATT"	-3.33357940140422	9.44493005359498	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGAGGAGTATT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1979.8859085746	36.0362630522178	0.0182011816419067	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1978.03386774391	1978.03386774391
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGGTAAGACCG"	-3.84159765663798	10.7721280821594	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGGTAAGACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1679.30216182465	41.4347976058808	0.0246738190111419	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1670.63095022109	1670.63095022109
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGTCATTACTC"	-4.06364522400554	13.0410709151062	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGTCATTACTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1898.27882519488	35.4677123803019	0.0186841426610027	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1894.12979675925	1894.12979675925
"healthy-4003"	"2020-08-26-Control4003-c2:TTCATTGTCCTCTGCA"	5.48290171202962	-10.0816412202087	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCATTGTCCTCTGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.61053407397	43.4086414679502	0.0175842405550756	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2464.06075448302	2464.06075448302
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCAATGTACGCGTC"	4.77095188674275	-7.83646061336669	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCAATGTACGCGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.76447915311	26.8493729294065	0.011470343628557	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2340.76447915311	2340.76447915311
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCAATGTGATCGTT"	-4.26797042313274	12.6459665068421	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCAATGTGATCGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2093.84284149478	36.2447235353426	0.0173101451632673	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2080.31134163904	2080.31134163904
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCAATTCTCTATGT"	4.87599815902059	-7.32036163723143	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCAATTCTCTATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2754.50401733255	32.94985673249	0.0119621741428421	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2751.16162157449	2751.16162157449
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCACGAGAGTCCGA"	3.97514309462849	-7.00703432476195	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCACGAGAGTCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.04080614369	13.383326242936	0.00507898253861282	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2629.79755678394	2629.79755678394
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGGTAGCACCCAC"	-1.98327670517619	9.32171151721803	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGGTAGCACCCAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2386.296590418	27.2534245396461	0.0114208035367776	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2375.6780463691	2375.6780463691
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGGTCAGACACCC"	4.2449857192928	-7.57633640682372	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGGTCAGACACCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.17848025913	1.19823352193301	0.000494896816448148	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2417.09066217844	2417.09066217844
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGGTTCACGGACC"	4.18929590758626	-7.52921440517577	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGGTTCACGGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.79325422875	33.5901108043057	0.0151799589682016	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.47297172132	2205.47297172132
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGAGGTTGAGC"	4.57334961470906	-7.25609877025756	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGAGGTTGAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.87300053229	4.42911399139336	0.00187923320025859	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.60821112324	2349.60821112324
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGCACACTGGC"	4.36844076690022	-7.2620306245056	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGCACACTGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.15840857794	21.5824507675663	0.00909439955190313	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2370.23108108039	2370.23108108039
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGGTACTGCGC"	-3.93371758881267	12.8345222243103	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGGTACTGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1682.15147163917	38.5761125948605	0.0229326034220153	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1680.00138687739	1680.00138687739
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGGTCGGTAAG"	3.94729437407796	-6.74517300045165	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGGTCGGTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.59523070865	23.998907069697	0.0102885004452342	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2329.88718735011	2329.88718735011
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGGTGATTAGA"	5.53963007506673	-9.7195558778015	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGGTGATTAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.90433326001	2.6774280044293	0.00109421033263779	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.62447466901	2445.62447466901
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCGTGTCCATTGGA"	-4.01875482025798	13.0821666487488	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCGTGTCCATTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1910.3948891307	30.5294385385107	0.015980695254269	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1904.13094079237	1904.13094079237
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTAAAGATGTTGA"	-3.92525420609172	12.855236984137	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTAAAGATGTTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1521.37032271938	45.6453195327373	0.0300027671442601	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1521.37032271938	1521.37032271938
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTAAAGGGACTGT"	-2.87504659119304	9.58071420276491	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTAAAGGGACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.20564068812	33.7031149230208	0.0163829586388589	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2051.86408831856	2051.86408831856
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTAAAGGGCATGT"	3.83563437041585	-7.38386394893798	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTAAAGGGCATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.95401622936	15.7027513027593	0.00768629698858402	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2039.5616393194	2039.5616393194
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTCTAGGTTATAG"	-0.577985922724563	8.99829099262086	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTCTAGGTTATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2021.58134918278	36.9570736816048	0.0182812696093307	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2008.3512097454	2008.3512097454
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTTCAGATCCGAG"	-4.41373238983806	13.0488996275696	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTTCAGATCCGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2136.95005090165	47.4827295253678	0.0222198593295773	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2125.44636611101	2125.44636611101
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTTCAGTCCGCCA"	4.93059505996053	-7.7913127175537	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTTCAGTCCGCCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.75560503123	23.8699282942084	0.00937636285550495	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2541.09205434394	2541.09205434394
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTTCGTATGCGTT"	3.77670492705647	-7.75959350979003	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTTCGTATGCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.2533585143	34.4863214149313	0.0140116909523482	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.24687793233	2457.24687793233
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTTCTCCCGAGAC"	-3.76429257813151	13.0374650725159	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTTCTCCCGAGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1850.85466526569	27.6733443949515	0.0149516571529289	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1846.74430025161	1846.74430025161
"healthy-4003"	"2020-08-26-Control4003-c2:TTCCTTCTCGCTACGG"	-4.38097510758098	-4.81761314785155	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCCTTCTCGCTACGG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3305.96340589001	37.0555451365362	0.0112086979155658	3545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3296.39228855606	3296.39228855606
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGATTAGATCACCT"	10.1208063560421	5.87845704639284	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGATTAGATCACCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1603.20623733088	43.3926871566153	0.0270661915767357	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1596.91157559683	1596.91157559683
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGATTCAATCGCGC"	5.23258175429646	-10.1158333054748	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGATTCAATCGCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.9299649731	26.3891607909128	0.0119736839238605	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.08779974978	2200.08779974978
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGATTCAGACAAAT"	3.35010447081868	-6.62409832393798	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGATTCAGACAAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.56604827808	17.1054451901938	0.00775909853259075	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2204.56604827808	2204.56604827808
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGCTGCAGTGTACT"	-4.35926566544231	12.646403289679	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGCTGCAGTGTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1943.3638629571	36.2508906857024	0.0186536815758947	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1933.19447505365	1933.19447505365
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGCTGGTGAAGCTG"	-4.37371716919597	3.20567820155946	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGCTGGTGAAGCTG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2837.21086136731	25.187327187232	0.00887749568782268	2907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2827.31366518196	2827.31366518196
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGCTGTCATCGTAG"	5.2700683074886	-10.1731758347717	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGCTGTCATCGTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.0251328909	26.8451840462923	0.0135034429908113	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1979.1239270546	1979.1239270546
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGCTGTCTACGCAA"	-0.908550779253799	8.35890100086061	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGCTGTCTACGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1987.11546590543	22.5998296097664	0.0113731838926978	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1977.55402584513	1977.55402584513
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGCTGTCTGTACAG"	4.18826832351033	-7.80040647899779	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGCTGTCTGTACAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.27194318539	31.4946092516594	0.0139648831915037	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2247.94066279446	2247.94066279446
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGGTCCAATTGCGT"	4.74937834319417	-7.36661388790282	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGGTCCAATTGCGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.70565881659	33.4954559770791	0.0137574970739419	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2430.69457908366	2430.69457908366
"healthy-4003"	"2020-08-26-Control4003-c2:TTCGGTCGTCAAGCGA"	4.55922140654866	-6.97888948833617	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCGGTCGTCAAGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.07341604001	39.6637275265055	0.0165813169698476	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2384.26777176458	2384.26777176458
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAACAGTGGATTA"	4.94948114928548	-8.06495001232298	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAACAGTGGATTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2946.00000388618	22.3358094517825	0.0075817411481054	2300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2933.04719347469	2933.04719347469
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAACGTTCGAAGG"	0.262008731334847	8.18397042835084	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAACGTTCGAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1659.1367183166	23.1239380855263	0.0139373312821311	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1651.72216999672	1651.72216999672
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAACTCTTAGCTT"	3.74557580527608	-6.74566652691039	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAACTCTTAGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1756.56042350692	23.1344804030191	0.013170329977509	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1749.98928059801	1749.98928059801
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAGTAGCTGACTT"	5.009529252618	-7.44629909908446	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAGTAGCTGACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.14809940152	24.7603340604597	0.0100400839943346	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2459.19622387605	2459.19622387605
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAGTCAAGTACCT"	-0.383876035839874	8.69509122455446	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAGTCAAGTACCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1714.68169128953	28.0830580242124	0.016378000748986	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1712.88349247925	1712.88349247925
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTAGTTCTCTATGT"	-1.4963415664738	8.59986589038698	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTAGTTCTCTATGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.77331342389	18.8294255718718	0.00948694011780597	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1975.8838366173	1975.8838366173
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTCTCCAAAGGATT"	4.10676350173299	-6.99807407772215	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTCTCCAAAGGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.97714948586	31.6447975448353	0.0142225269828716	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.77568079127	2221.77568079127
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTCTCGTCCCTGTT"	5.61621775206868	-9.8012380830017	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTCTCGTCCCTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.92669643477	36.4284368211016	0.0158045966830306	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2295.6877147488	2295.6877147488
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTCTCGTTTGGAAA"	4.09771790084187	-7.02435257351073	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTCTCGTTTGGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.30320335628	25.5617975459342	0.0119991358533667	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2128.55997484493	2128.55997484493
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTAAGCCGTAAG"	-3.42999086800273	10.9190816649231	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTAAGCCGTAAG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1807.3580108974	31.1804431340446	0.0172519461811347	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.85619074461	1800.85619074461
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTAAGCTCTTCC"	4.3012191253597	-7.31484558498534	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTAAGCTCTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.03222906215	24.7997848469153	0.0112265382644255	1292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.65135251234	2207.65135251234
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTAAGGTACTGG"	3.54785980758016	-6.56334116375121	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTAAGGTACTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.3029303002	44.5774669222799	0.0201134358994156	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.26932916738	2214.26932916738
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTAAGTTCCTGA"	-2.14841399613078	9.24415586078493	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTAAGTTCCTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2112.82448391338	25.3142342250699	0.011981229116667	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2107.46249192728	2107.46249192728
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTAAGTTGTAAG"	14.1433426338131	1.91751597011415	"2020-08-26-Control4003-c2"	"Control4003"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTAAGTTGTAAG"	"Plasma cell"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1435.39712709271	35.5992393202201	0.0248009687690567	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1428.53851258259	1428.53851258259
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTACATCTGTTT"	5.20502008971517	-10.0457525483337	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTACATCTGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.36244833333	32.7844427040515	0.0152531010902668	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2147.13903500791	2147.13903500791
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTATCCGAGTGC"	5.30294479903523	-9.42792799389037	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTATCCGAGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.0897568793	30.5047648269306	0.0120902416347885	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2519.25734043397	2519.25734043397
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTGTATCTCGGTAA"	-3.59128389778789	10.5076617964539	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTGTATCTCGGTAA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1899.35174145681	19.2476970909261	0.010133824436417	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1897.42183881016	1897.42183881016
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTCCCAGCTACTA"	-3.50000844422038	10.3851394423279	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTCCCAGCTACTA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1812.85936456131	31.3824156515489	0.0173110039670083	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1812.85936456131	1812.85936456131
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTCCGTAACCCTA"	-3.65641866150554	10.5786304243836	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTCCGTAACCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.43167209435	29.165569858467	0.0163170264429149	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.3344177423	1783.3344177423
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTCCGTCAACCTA"	3.29034318503682	-5.39433338558348	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTCCGTCAACCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2730.98253500869	31.2115828711585	0.011428701015497	2252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2727.52095281292	2727.52095281292
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTCCGTTGAAGTA"	-1.90015647831615	9.09919545734254	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTCCGTTGAAGTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2112.77499415016	27.8409788070413	0.0131774461947567	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2103.88271763188	2103.88271763188
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTCCTCCATCTCG"	4.38906302031819	-8.03651335155638	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTCCTCCATCTCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2545.45004585648	39.8759822652912	0.0156655921534197	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2541.48118418993	2541.48118418993
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTGAAGAGGATCC"	3.10367335852925	-6.69052984630736	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTGAAGAGGATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.08758208262	30.9164411840192	0.0147777948919531	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2087.37231643516	2087.37231643516
"healthy-4003"	"2020-08-26-Control4003-c2:TTCTTGATCTTCCAGC"	4.25278534468953	-6.85953524028929	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTCTTGATCTTCCAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.36422022651	28.4991002537847	0.0103431336026574	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2745.93020270077	2745.93020270077
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGAGGAACTCG"	4.38814606246297	-6.72010757839354	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGAGGAACTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.00101940564	3.42232546648068	0.00123683563630049	1996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2764.91806132786	2764.91806132786
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGAGTGGATTA"	-2.99900947037395	9.9140939482483	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGAGTGGATTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2582.00622231453	39.8172366570649	0.0154210459730699	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2570.82532470022	2570.82532470022
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGCAACTGCCG"	3.98015417632405	-6.70359804546507	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGCAACTGCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.7228001864	8.99750395275293	0.00368037797662251	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2440.93464548117	2440.93464548117
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGCACCGTGAC"	3.93904389914815	-7.32319643413695	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGCACCGTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.41701366219	36.2010027714423	0.0162890234141021	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2216.19622372623	2216.19622372623
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGCACTGAGGA"	5.3256684738094	-10.2488327256409	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGCACTGAGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1781.87821997057	43.1644309694801	0.0242241195193424	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1776.11244885616	1776.11244885616
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAACGTCAAAGGAT"	-2.32570062103923	9.41504762256471	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAACGTCAAAGGAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2154.50236382612	34.8394534475679	0.0161705338701497	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2146.42916099365	2146.42916099365
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAGTGAGTTTGAGA"	4.2835074859554	-8.01883318340453	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAGTGAGTTTGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.09914160413	37.348501283391	0.017314225648255	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2155.59317772038	2155.59317772038
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAGTGCAAGCACAG"	-3.64465270462688	10.6420068510803	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAGTGCAAGCACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.22502675514	20.4688174251766	0.0102230354488921	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1992.25416950207	1992.25416950207
"healthy-4003"	"2020-08-26-Control4003-c2:TTGAGTGCAAGGATGC"	4.19011988219563	-7.49869396602782	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGAGTGCAAGGATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.35195288791	16.6258948023727	0.00733921048390639	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.33808834183	2259.33808834183
"healthy-4003"	"2020-08-26-Control4003-c2:TTGATGGAGTTGCTCA"	3.94343080100362	-7.21502354061278	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGATGGAGTTGCTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.06356812642	11.5526726216769	0.00474040676360297	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2431.7802356246	2431.7802356246
"healthy-4003"	"2020-08-26-Control4003-c2:TTGATGGGTGTGTCCG"	3.83508767661397	-7.50131847774657	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGATGGGTGTGTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1778.67350566019	5.77084273118639	0.00324446432289124	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1778.67350566019	1778.67350566019
"healthy-4003"	"2020-08-26-Control4003-c2:TTGATGGTCAAGAAAC"	-0.467513958842117	7.93613526904909	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGATGGTCAAGAAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.95721026808	35.6120945112156	0.020467224309343	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1739.95721026808	1739.95721026808
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCATTAGGACAACC"	-3.27049646797832	11.1086101301941	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCATTAGGACAACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.92119810257	31.7208738730723	0.0153246770467155	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.87121321821	2059.87121321821
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCATTCATTCACCC"	5.41519131240193	-9.94539644634398	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCATTCATTCACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.07031859754	27.8128262439315	0.0113657650262668	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2444.48118269091	2444.48118269091
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCCTGTCCATTCAT"	-1.6788458627766	9.18891427600709	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCCTGTCCATTCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2396.09605065407	36.2840202770755	0.0151429740336039	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2384.11559064624	2384.11559064624
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCCTGTCCTACGGG"	4.16274942931477	-7.06981470501097	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCCTGTCCTACGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.51382153976	24.5699399921888	0.010273802213014	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2387.14550315844	2387.14550315844
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCCTGTCCTGATAG"	3.29825439032857	-7.06430675899657	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCCTGTCCTGATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.58937437335	38.727673954344	0.01594657143896	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.94185623066	2418.94185623066
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCCTGTCGCAGTCG"	-3.07654772225078	10.0551242598328	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCCTGTCGCAGTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.89771908585	36.0337177561506	0.0178570585690907	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2012.01082955306	2012.01082955306
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCGTCCAATTGTGC"	5.41973080214803	-9.44126512920531	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCGTCCAATTGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.88970256311	33.1608947194715	0.0122868654795263	1843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2691.63261610656	2691.63261610656
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCTGCAGCTCGGCT"	-3.85747514191325	10.7067298659119	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCTGCAGCTCGGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2281.37480394671	32.6817649271608	0.014325469392676	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2269.68330084628	2269.68330084628
"healthy-4003"	"2020-08-26-Control4003-c2:TTGCTGCGTCTCTCCA"	4.6010238128597	-7.29816534435423	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGCTGCGTCTCTCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.93585006532	19.0346528794291	0.00834510662756428	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2273.56536031652	2273.56536031652
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGATGGTCGTTGCG"	10.1912075477535	5.83881852710573	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGATGGTCGTTGCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1431.26285154361	42.6137569473436	0.0297735366368133	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1430.07873531025	1430.07873531025
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGATGTCTGTGTGA"	-3.95825419846233	12.7045745619568	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGATGTCTGTGTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1873.67985190364	34.9061029156782	0.0186297050054811	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1863.13678620632	1863.13678620632
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATAGACAGCTG"	-1.0128415626591	8.70199773395387	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATAGACAGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2081.92810916811	37.5128139776129	0.0180183041923586	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2070.86499798682	2070.86499798682
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATAGACGGAAA"	4.58335222777669	-6.87521459972533	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATAGACGGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.27143294211	24.4662190205523	0.00929824977926957	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2626.70141600206	2626.70141600206
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATAGCTTAAGA"	-0.723605076701003	8.33825490558473	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATAGCTTAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1725.38619470291	35.353929031159	0.0204904439016023	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.94232386522	1717.94232386522
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATCACCGGCTA"	-0.777557591826278	8.57839105213014	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATCACCGGCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.03942925498	12.2517369354925	0.00728819129538342	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1673.83775383964	1673.83775383964
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATCAGTTGCGC"	-0.644673268229324	8.29345510089723	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATCAGTTGCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.09998076792	32.1810559884724	0.016485352341335	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1943.8410422082	1943.8410422082
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGATTCCGCAACG"	4.99910511550252	-8.09117033397826	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGATTCCGCAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.97382217109	3.34300199695191	0.00136897536189792	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2437.67639865455	2437.67639865455
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGCGAGAAGTGTT"	4.06554569777791	-6.26060154354247	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGCGAGAAGTGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.73394824256	29.6564697973245	0.011998245126022	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2470.61863843231	2470.61863843231
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGCGAGACTTCAC"	-3.51957784119304	10.3298730620178	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGCGAGACTTCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.54858501892	41.0128704524246	0.0217396311858108	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1886.54858501892	1886.54858501892
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGCGAGATCCCAT"	-2.10353169861491	8.90699098193971	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGCGAGATCCCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1730.27105606727	30.7292482867172	0.0177597886637263	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1721.66091380298	1721.66091380298
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGCGGTACCGTGC"	-2.25770006600078	9.2399282225403	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGCGGTACCGTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.54398356312	38.2718514851873	0.0202867528234901	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.64655476862	1882.64655476862
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGCGGTTGGACTT"	-4.42345509949382	12.9909724959168	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGCGGTTGGACTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2297.71477903281	46.7717873699125	0.0203557847112775	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2285.90407208809	2285.90407208809
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGTAAGCCATCCG"	-0.62833265486415	8.89462945545045	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGTAAGCCATCCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.84640760248	32.3222622644048	0.0165513591537837	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1949.82820573812	1949.82820573812
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGTACAACCTAAC"	4.29048075255696	-7.87565472042235	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGTACAACCTAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.96003023927	34.333320005531	0.0146413241858233	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2344.96003023927	2344.96003023927
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGGTAGTGACCTGC"	-3.89137206497844	13.0846338042053	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGGTAGTGACCTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1828.68112732771	36.1945510321053	0.0197927077013132	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1824.42658589717	1824.42658589717
"healthy-4003"	"2020-08-26-Control4003-c2:TTGGTTTCAAGTGCTT"	5.59504808959309	-9.95107176220091	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGGTTTCAAGTGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.32080184669	3.54780271957303	0.00135966521136924	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2608.13233961693	2608.13233961693
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTGGACAAATTAGG"	-1.93544683876689	8.87079522693483	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTGGACAAATTAGG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1990.08028908664	44.9435911870525	0.0225838080169518	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1988.49784371399	1988.49784371399
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTGGATCCACGAAT"	-0.463457445532638	8.62555883014528	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTGGATCCACGAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1581.11505164536	35.1642600361364	0.0222401652552377	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1579.23594591763	1579.23594591763
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTGTTCAATAGTGA"	-2.67275009575542	9.17675874317018	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTGTTCAATAGTGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2251.8679842256	36.1488646631076	0.0160528347648847	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2243.56752614337	2243.56752614337
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTGTTCAGCATGCC"	-3.88798890534099	10.8948526152405	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTGTTCAGCATGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.60120027766	34.1917928651112	0.0166740333812745	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2048.69723988837	2048.69723988837
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTGTTTCGTTCCCA"	4.1622277694637	-7.34656670009764	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTGTTTCGTTCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.31517864198	34.3964802180659	0.0153946410725152	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.68611754763	2232.68611754763
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTCAGTGGTAATA"	3.46337284621541	-6.49006559765013	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTCAGTGGTAATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2084.98956599562	33.7117484986659	0.0161687852296603	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2078.5096363892	2078.5096363892
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTGTCATTGCCGG"	10.9002500968868	6.85484263980714	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTGTCATTGCCGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.20779739444	31.4986020943273	0.0189157185929668	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1661.68809930818	1661.68809930818
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTTGCACTGTGAT"	-0.241439769894439	8.02078864658204	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTTGCACTGTGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.26677127762	21.5889371629449	0.0113133747796125	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1906.33363408258	1906.33363408258
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTTGCATCGAAGG"	4.66407646712605	-7.77769138729247	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTTGCATCGAAGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.40720097621	17.889223537873	0.00791415968332921	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.00409351798	2252.00409351798
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTTGCATGCCGGT"	-3.18507466736491	10.9644860991272	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTTGCATGCCGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1574.70592178125	2.22753411147876	0.00141457149596482	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1572.46877723303	1572.46877723303
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTTGGTGTTTACG"	-2.7022536796635	9.03551766956178	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTTGGTGTTTACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2376.32621366909	32.3747031317529	0.0136238463160181	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2372.04609901425	2372.04609901425
"healthy-4003"	"2020-08-26-Control4003-c2:TTGTTTGTCAGAGCGA"	4.1077696281368	-7.53345634853514	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTGTTTGTCAGAGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1810.76949932453	20.7328212193281	0.0114497296464636	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1810.76949932453	1810.76949932453
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACCAAGGATACGC"	-2.64772496643718	9.06529710376588	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACCAAGGATACGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.69960015482	30.7973711040005	0.014822821885178	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2070.98556358818	2070.98556358818
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACCATCTCGTGGG"	-2.21081767502483	9.19024465167848	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACCATCTCGTGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1773.97543166566	22.8910324458566	0.0129038046622569	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1773.97543166566	1773.97543166566
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACGTAGACCATGG"	3.04636110839192	-6.42090084468993	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACGTAGACCATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.92405081695	26.6405279510298	0.0123798644013092	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2148.6451464286	2148.6451464286
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACGTCAAGTGGAC"	5.3877669769222	-9.87929251110228	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACGTCAAGTGGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.78509326442	16.8173647507738	0.00708760553094879	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.3426081923	2371.3426081923
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACGTTCGAAGAAT"	-4.83943019333537	-5.10723020946654	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACGTTCGAAGAAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2971.27623269695	36.3831419044717	0.0122449543748572	2245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2969.25859719157	2969.25859719157
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACTGCACGACGAA"	10.3130241828853	7.03694722736207	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACTGCACGACGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2133.05635347735	0	0	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2119.25184870985	2119.25184870985
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACTGCATGACAGG"	5.57017387923543	-9.87878324901732	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACTGCATGACAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.10003719158	5.67850632093051	0.00246238507842267	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.55809875184	2301.55809875184
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACTGGTTGGGACA"	-2.54444561424907	9.80673883045045	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACTGGTTGGGACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1659.9565321257	0	0	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1655.6617124487	1655.6617124487
"healthy-4003"	"2020-08-26-Control4003-c2:TTTACTGTCCCAAGCG"	-7.56409774246867	-0.732664250489794	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTACTGTCCCAAGCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2739.35203607453	29.0192919137182	0.0105934876319521	2477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2733.17652407872	2733.17652407872
"healthy-4003"	"2020-08-26-Control4003-c2:TTTAGTCCACGCGCAT"	-0.0574197423761666	8.37402246082155	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTAGTCCACGCGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.86737905705	32.2383560451071	0.0185826054684534	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.15079512245	1730.15079512245
"healthy-4003"	"2020-08-26-Control4003-c2:TTTAGTCGTCGCGTCA"	4.29962982711141	-7.53334953701171	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTAGTCGTCGCGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2107.54922537395	7.78276806776242	0.00369280488164232	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2099.99778545694	2099.99778545694
"healthy-4003"	"2020-08-26-Control4003-c2:TTTAGTCTCCTTACCG"	-3.27962027016338	10.3806409605774	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTAGTCTCCTTACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.06365132698	36.123055914618	0.0185621142915785	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1944.14678131821	1944.14678131821
"healthy-4003"	"2020-08-26-Control4003-c2:TTTATGCAGTTGGAAT"	-2.45323501053508	9.63313481891481	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTATGCAGTTGGAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.07550713583	44.4541447968095	0.0233345841833029	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1901.27803989983	1901.27803989983
"healthy-4003"	"2020-08-26-Control4003-c2:TTTATGCGTTGGACCC"	5.40867437896077	-10.2122764817444	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTATGCGTTGGACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.00260673527	0	0	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2241.55857688664	2241.55857688664
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCACACAATTGCTG"	3.41469182547871	-6.41649105465087	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCACACAATTGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.41118137437	10.7341978527946	0.00445326421306849	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2406.51316980188	2406.51316980188
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCACACATAACCCA"	-2.13708577576335	10.1638345488342	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCACACATAACCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1450.113059793	33.7724209648325	0.0232895088674351	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1443.00207361593	1443.00207361593
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCACACATGTTTGG"	3.9122585254604	-6.75131227886351	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCACACATGTTTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2043.28155423911	0	0	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2039.81993497078	2039.81993497078
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCACAGTCTCCCTA"	4.12282099303548	-7.43693449413451	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCACAGTCTCCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.22293234008	1.49205579782069	0.000619309976587121	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2399.40223575704	2399.40223575704
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCACAGTGGCCCAT"	4.16265644606893	-7.52206280147704	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCACAGTGGCCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.42172684971	28.0202590760602	0.0111838493199676	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.22737428623	2500.22737428623
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCAGTCATCGAACT"	-3.76192269745525	9.98891828143922	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCAGTCATCGAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2211.13856273712	33.8624703962044	0.0153144949696354	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2206.37797333037	2206.37797333037
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCAGTTCAGCTTGA"	3.16687526282613	-6.56558897411498	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCAGTTCAGCTTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.23531315248	24.934875975934	0.0103540031323987	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.15758332101	2397.15758332101
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCATGCAGCTGTTA"	-3.08845196190532	12.6507873305115	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCATGCAGCTGTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1529.52770913602	34.8595950888452	0.0227910843854776	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1527.05544101908	1527.05544101908
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCATGTCCATACAG"	-1.94073210182841	8.87788293445436	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCATGTCCATACAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2182.92694039422	28.078052495625	0.0128625708795157	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2165.05842344716	2165.05842344716
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCATGTCGCACGGT"	4.14343895491902	-6.77754070675048	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCATGTCGCACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.23505405746	36.2270890578894	0.0157083246974993	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2304.62290325702	2304.62290325702
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCCTCAGAGGGTGG"	5.37875666198079	-9.40635588085326	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCCTCAGAGGGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2685.45875363526	35.945556851269	0.0133852574732753	1684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2681.67168026326	2681.67168026326
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCCTCAGTACCGGA"	4.91392101821248	-7.78704264080199	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCCTCAGTACCGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.03153402638	14.1740261747821	0.00560231205981258	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2526.75378485327	2526.75378485327
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCCTCTCCTACGGG"	4.14498104628865	-7.25311329281005	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCCTCTCCTACGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.38742239891	29.4710657301349	0.0134793428777591	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2184.67356941147	2184.67356941147
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCGATAGATGCTGG"	4.04295410689656	-7.45410110866698	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCGATAGATGCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.83110222831	30.3445431364723	0.0138950961480078	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2180.73992371801	2180.73992371801
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCGATCAATGCAAA"	-1.69100211086925	9.2935466536316	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCGATCAATGCAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1589.27943219247	2.705417354724	0.00170229180591092	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1589.27943219247	1589.27943219247
"healthy-4003"	"2020-08-26-Control4003-c2:TTTCGATCATTAGGAA"	3.60136284407918	-8.09494974529418	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTCGATCATTAGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.48096926974	40.2174942250688	0.0228057432577359	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1761.58761474	1761.58761474
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGACTAGCGAGTAC"	4.22041954573934	-6.9626674882141	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGACTAGCGAGTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.45214304328	21.0751315699472	0.00868557479296275	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.27122957179	2418.27122957179
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGATCAGCAGATAT"	11.1773258644039	5.46791455829469	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGATCAGCAGATAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1559.16549872703	20.5288472570943	0.0131665607492308	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1551.37428975883	1551.37428975883
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGATCCAATTTCGG"	10.2790256935054	7.01131532276002	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGATCCAATTTCGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1772.53898240611	40.6687748874893	0.0229437971695743	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1765.88439039239	1765.88439039239
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGATCCAGGTTCGC"	-4.21823201599773	12.4411849745545	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGATCCAGGTTCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2111.47520467124	31.8719634092594	0.0150946425223221	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2107.59820970972	2107.59820970972
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGATCTCCATCTAT"	-2.78067002716716	9.63984010303346	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGATCTCCATCTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1618.76175926158	11.4803724850858	0.0070920704788101	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1614.51538376754	1614.51538376754
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGAGAGCACCAGA"	4.60627808150594	-6.82510473644408	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGAGAGCACCAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.54047086817	25.9102017078872	0.0103000536099286	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.84223679428	2510.84223679428
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGAGGTGTGTCGC"	5.46762337264363	-9.79454328930052	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGAGGTGTGTCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.11462457783	33.7873183657359	0.0157508218808519	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.83074692524	2140.83074692524
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGAGTCGCCTATC"	-2.8378053707188	9.84024427020875	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGAGTCGCCTATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.87480285246	30.834607904407	0.0163156881386361	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1884.389156841	1884.389156841
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGAGTCGTAGCCG"	4.1941372352535	-7.62815048610839	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGAGTCGTAGCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.97540557031	41.2002341537138	0.0163235481862408	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2520.35203260793	2520.35203260793
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGTTAGGTTACAA"	-2.29609594765361	9.37838361347047	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGTTAGGTTACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1664.70999108782	31.6174143029838	0.0189927461673508	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.70999108782	1664.70999108782
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGTTCACAGAAGC"	-0.880951861769515	8.96864125812379	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGTTCACAGAAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1905.64500098732	36.0173731106842	0.0189003581947443	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1900.94870161341	1900.94870161341
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGGTTGTGCGTCGT"	5.10664095458333	-8.15386106884154	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGGTTGTGCGTCGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.19798261978	7.18876405734503	0.00393431041722035	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1823.21448940113	1823.21448940113
"healthy-4003"	"2020-08-26-Control4003-c2:TTTGTTGCACACCGAC"	5.60390295562093	-9.89097406780394	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TTTGTTGCACACCGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.24133713169	5.90116218384239	0.00266389132638851	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2210.18108645153	2210.18108645153
"healthy-4003"	"2020-08-26-Control4003-c3:AAACCCAAGATTGCGG"	4.84114279326741	-7.48279049312743	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACCCAAGATTGCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.31972780151	24.032446159618	0.0107368245300785	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.31972780151	2238.31972780151
"healthy-4003"	"2020-08-26-Control4003-c3:AAACCCAGTCGATGCC"	-2.4314206642216	3.59527084911195	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACCCAGTCGATGCC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3097.20142689815	26.2320004843056	0.00846958168638615	4537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3092.1763892533	3092.1763892533
"healthy-4003"	"2020-08-26-Control4003-c3:AAACCCATCAGGACGA"	4.13769545134847	-6.81847574627074	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACCCATCAGGACGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.97768901984	9.99203304161649	0.00438443653474903	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2274.62477016708	2274.62477016708
"healthy-4003"	"2020-08-26-Control4003-c3:AAACGAACACTTCAGA"	3.62724508818929	-6.73535730755004	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACGAACACTTCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.12449674295	33.4554640095551	0.0150353223195043	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2216.49812433294	2216.49812433294
"healthy-4003"	"2020-08-26-Control4003-c3:AAACGAAGTACAAAGT"	-3.61312613907512	10.394450164679	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACGAAGTACAAAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1966.27690626533	38.8769605816477	0.0197718645109295	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1952.00871655023	1952.00871655023
"healthy-4003"	"2020-08-26-Control4003-c3:AAACGAAGTTGTGCAT"	2.4514123397762	-4.31759788906249	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACGAAGTTGTGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2420.59679421045	30.1364075732661	0.0124499906987178	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2412.343709337	2412.343709337
"healthy-4003"	"2020-08-26-Control4003-c3:AAACGCTGTGAACTAA"	4.15029587325398	-8.29975225841673	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACGCTGTGAACTAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.78970525779	37.4794033007925	0.0174339858494662	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.74465026961	2146.74465026961
"healthy-4003"	"2020-08-26-Control4003-c3:AAACGCTGTGCGGATA"	-3.24173961105998	10.0432386168274	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAACGCTGTGCGGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1707.48608152569	36.0607864241566	0.0211192271575855	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1703.33447433199	1703.33447433199
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGAACAGTCGAATA"	4.47518887099568	-7.54919197475585	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGAACAGTCGAATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.55945169721	32.3350022005005	0.014247259386098	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2263.72432562625	2263.72432562625
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGAACGTATGAAGT"	9.78554882582967	7.29731271350709	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGAACGTATGAAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1628.06781390002	36.8957339313644	0.0226622832392841	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1621.35197264606	1621.35197264606
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGAACGTTCAAAGA"	3.01571526107137	-6.86127903377684	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGAACGTTCAAAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.74372724621	28.9824956151634	0.0138028728168525	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2095.0604994521	2095.0604994521
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGAACTCCGCTTAC"	-5.5987118286198	-5.25551321422728	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGAACTCCGCTTAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2960.90689438089	48.6126065837745	0.0164181476547033	2795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2950.78365992031	2950.78365992031
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGATAGTCATTGC"	-4.28006635132487	12.7713908919129	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGATAGTCATTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2118.39169941121	36.7195854914429	0.0173337091066061	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2109.2967030272	2109.2967030272
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGATTCATCTCTA"	4.22274651107137	-7.36429407512816	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGATTCATCTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.67472287579	3.91942044033242	0.00160193768451802	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2441.25394206456	2441.25394206456
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGTAAGTATAGGT"	-4.25439963761027	12.341489768866	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGTAAGTATAGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1916.76750412064	30.4984356892953	0.0159113902044615	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1912.68975130756	1912.68975130756
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGTACAGGCATTT"	-3.93575773659404	13.1406574019226	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGTACAGGCATTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1805.21912269231	38.6578381662938	0.0214144851892769	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1797.19072795575	1797.19072795575
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGTAGTCTCACGG"	-0.11666881564315	8.16426370227662	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGTAGTCTCACGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1577.95733100832	4.47156857061304	0.00283377026915911	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1576.08192027492	1576.08192027492
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGTAGTTCTCACC"	4.39829363402669	-6.82794144069823	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGTAGTTCTCACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.9569768936	19.9802919181037	0.00864215559276958	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.9569768936	2311.9569768936
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGGTATCCAACACA"	3.82727922972981	-6.7413859597412	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGGTATCCAACACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.97166945321	28.443130796789	0.0108479931832065	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2618.7258306663	2618.7258306663
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGTCCCAGGCGTTC"	5.65465225753133	-9.97543623363646	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGTCCCAGGCGTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.98353136213	2.52964663560644	0.000987763726173193	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2550.57512171299	2550.57512171299
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGTCCGTGGCTGAA"	3.92581309851949	-6.13248398220214	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGTCCGTGGCTGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.55196450711	31.1008892215682	0.0117470363711476	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2644.58335789724	2644.58335789724
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGTCCTCAACCTCC"	0.0427716570789039	8.22719380939332	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGTCCTCAACCTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1745.30756386667	25.121898129179	0.0143939662265155	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1741.95948676094	1741.95948676094
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGTCCTCGCCAGAC"	3.82769550856892	-7.31814863598021	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGTCCTCGCCAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.65909251555	1.29535228525496	0.000589691996208461	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2193.72262609424	2193.72262609424
"healthy-4003"	"2020-08-26-Control4003-c3:AAAGTGAGTTGCGGAA"	2.49011053618733	-4.0911584130493	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAAGTGAGTTGCGGAA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2289.8323767168	0.0453791379362281	1.98176680518831e-05	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2283.41343484534	2283.41343484534
"healthy-4003"	"2020-08-26-Control4003-c3:AAATGGAAGGCTGGAT"	9.93964542922322	6.15355060184327	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAATGGAAGGCTGGAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.54518040918	42.7396048456428	0.0247687544382395	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1723.83119426598	1723.83119426598
"healthy-4003"	"2020-08-26-Control4003-c3:AAATGGAGTGTTCCAA"	3.45603980597798	-6.57136585628661	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAATGGAGTGTTCCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1938.77558501938	24.9831007610231	0.0128860198952698	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1935.50728380417	1935.50728380417
"healthy-4003"	"2020-08-26-Control4003-c3:AAATGGAGTTTCGTTT"	-3.80220661583598	12.5364837416443	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAATGGAGTTTCGTTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1472.86299062079	32.3440602600409	0.0219599925220528	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1470.44187385657	1470.44187385657
"healthy-4003"	"2020-08-26-Control4003-c3:AACAAAGAGGGTAGCT"	-2.66988525810893	9.49379823291627	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAAAGAGGGTAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1841.29181378506	31.716897836275	0.0172253510273725	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.32932949507	1837.32932949507
"healthy-4003"	"2020-08-26-Control4003-c3:AACAAAGCACAAAGCG"	0.758546670048875	8.73099515521852	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAAAGCACAAAGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1683.38771892089	38.1492861966556	0.0226622101182433	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1674.43348408673	1674.43348408673
"healthy-4003"	"2020-08-26-Control4003-c3:AACAAAGCAGATTAAG"	5.348969121545	-10.1756162873474	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAAAGCAGATTAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.14262997846	31.7030012898884	0.0136996747215117	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2309.56848438531	2309.56848438531
"healthy-4003"	"2020-08-26-Control4003-c3:AACAACCAGACTACCT"	5.18353714522664	-8.81040861522826	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAACCAGACTACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.77730156044	14.6480816509781	0.00538378559780583	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2718.51812815189	2718.51812815189
"healthy-4003"	"2020-08-26-Control4003-c3:AACAACCAGTAAGCAT"	-3.68715582314189	10.6485605009827	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAACCAGTAAGCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.46391811683	37.9770686468587	0.0174569977146452	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2170.27499552152	2170.27499552152
"healthy-4003"	"2020-08-26-Control4003-c3:AACAACCAGTGCACTT"	3.48279513892476	-6.82854702388915	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAACCAGTGCACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.73255863985	25.4194731720092	0.0117046977404664	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2168.8074911436	2168.8074911436
"healthy-4003"	"2020-08-26-Control4003-c3:AACAACCTCGGTCTGG"	-3.70941029015239	10.3344421156677	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAACCTCGGTCTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.0312191839	6.11342168051163	0.00292643864025158	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2078.03213382757	2078.03213382757
"healthy-4003"	"2020-08-26-Control4003-c3:AACACACAGTAGCCAG"	-2.3108061355656	9.38014886463014	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACACACAGTAGCCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1653.39907473138	35.7795209407763	0.0216399788094651	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1653.39907473138	1653.39907473138
"healthy-4003"	"2020-08-26-Control4003-c3:AACACACCACCGCTAG"	5.22992100295369	-10.1015291444031	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACACACCACCGCTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.45042244778	31.5580867405594	0.0149390898859495	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2107.51364285052	2107.51364285052
"healthy-4003"	"2020-08-26-Control4003-c3:AACAGGGTCTACGCGG"	-4.1386230987614	12.9835138090881	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACAGGGTCTACGCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1662.3225167112	4.35864867798461	0.00262202348471338	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1662.3225167112	1662.3225167112
"healthy-4003"	"2020-08-26-Control4003-c3:AACCAACAGTCTTGGT"	-1.64413628998454	8.71421525562135	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCAACAGTCTTGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2359.54038285553	32.4151117840229	0.0137378923537617	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2346.42818856209	2346.42818856209
"healthy-4003"	"2020-08-26-Control4003-c3:AACCAACCAAACTGCT"	-2.79017363014873	9.86549184406129	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCAACCAAACTGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1429.26430370811	32.2980410114493	0.0225976685541328	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1429.26430370811	1429.26430370811
"healthy-4003"	"2020-08-26-Control4003-c3:AACCAACCACAGTATC"	5.30755056914632	-9.35004141246947	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCAACCACAGTATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.39185987307	33.5822503666394	0.0153526448473609	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.21060144986	2183.21060144986
"healthy-4003"	"2020-08-26-Control4003-c3:AACCACAAGGCACGAT"	-2.08432469788249	8.86925504291383	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCACAAGGCACGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1944.03511803073	20.5241200886495	0.0105574842235567	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.88490619441	1932.88490619441
"healthy-4003"	"2020-08-26-Control4003-c3:AACCACAAGTTCCGGC"	5.32937731322591	-10.1748333207336	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCACAAGTTCCGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.13854517442	5.17980948241202	0.00260535639982654	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1986.41465813325	1986.41465813325
"healthy-4003"	"2020-08-26-Control4003-c3:AACCACAGTCCGAAGA"	-3.68036613884624	10.3866843947205	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCACAGTCCGAAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2179.03533575017	32.1307064954463	0.0147453811181014	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2173.77929077311	2173.77929077311
"healthy-4003"	"2020-08-26-Control4003-c3:AACCACATCAGCATTG"	5.05260719832723	-7.73805048381957	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCACATCAGCATTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2726.88725366684	26.4013977994195	0.00968188096662876	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2721.16784394654	2721.16784394654
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGAGACGCATG"	3.35585226592366	-7.22525312816771	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGAGACGCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.98660378521	32.787312367905	0.0161118074718126	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2031.65126398898	2031.65126398898
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGAGCAGCACA"	-0.519005755812484	8.58505437457887	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGAGCAGCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1764.18231991208	34.1816319127771	0.0193753397973519	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1757.31386029858	1757.31386029858
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGAGTATGATG"	0.86214323815648	8.78849790180055	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGAGTATGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1428.7520380089	11.7648097189508	0.00823432576540449	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1415.70075856737	1415.70075856737
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGGTTGGGTTT"	-1.19011269035991	8.74126718128053	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGGTTGGGTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2298.03879389482	31.5599364351964	0.0137334219592121	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2292.33049259888	2292.33049259888
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGTCCGGACTG"	5.58659948882405	-10.1035709611145	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGTCCGGACTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.69267449438	27.0278346286917	0.0110874659925283	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.22751005819	2432.22751005819
"healthy-4003"	"2020-08-26-Control4003-c3:AACCATGTCTCGGCTT"	-3.06038532677348	10.1539773710999	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCATGTCTCGGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1687.49551220742	41.0040370455103	0.0242987532404592	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.23884664212	1685.23884664212
"healthy-4003"	"2020-08-26-Control4003-c3:AACCCAATCCATATGG"	3.66521849211995	-6.42795994197997	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCCAATCCATATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.66561818991	33.5725272029666	0.0141556747905254	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2367.48468365579	2367.48468365579
"healthy-4003"	"2020-08-26-Control4003-c3:AACCCAATCTTCTCAA"	-3.00217853012736	10.6038579710755	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCCAATCTTCTCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.1495057697	30.3694229760334	0.0174521918233689	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1738.02894613845	1738.02894613845
"healthy-4003"	"2020-08-26-Control4003-c3:AACCTGACAGCAGATG"	-2.92658505860026	9.05276391589967	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCTGACAGCAGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2152.77494528476	40.8160563463292	0.0189597414424248	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2143.37504970291	2143.37504970291
"healthy-4003"	"2020-08-26-Control4003-c3:AACCTTTCAGTATGAA"	3.32295002517049	-6.47003366863402	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCTTTCAGTATGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.49114056511	36.0462568897725	0.0151423612865097	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2377.78633513627	2377.78633513627
"healthy-4003"	"2020-08-26-Control4003-c3:AACCTTTTCCCAACTC"	-0.79049382630046	8.5140113600525	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACCTTTTCCCAACTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1619.26276155671	26.2315717859007	0.0161997005110415	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1617.41121765904	1617.41121765904
"healthy-4003"	"2020-08-26-Control4003-c3:AACGAAACAGACCGCT"	2.01774980601613	-6.52446224605712	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGAAACAGACCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.48451255367	34.4094910518564	0.0137227132927785	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2499.94673260366	2499.94673260366
"healthy-4003"	"2020-08-26-Control4003-c3:AACGAAACATGTCGTA"	-0.0175412249868691	8.43644139850465	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGAAACATGTCGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.74555063422	12.760687414395	0.00677770153810561	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1879.05492641543	1879.05492641543
"healthy-4003"	"2020-08-26-Control4003-c3:AACGAAATCATCTATC"	4.28540052947347	-7.4392709962097	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGAAATCATCTATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.00296282687	4.93612662859211	0.00200818579279303	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.28674924502	2452.28674924502
"healthy-4003"	"2020-08-26-Control4003-c3:AACGGGACACCAAATC"	5.38873543319051	-10.2497205964294	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGGGACACCAAATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1956.24012229883	32.5635802029432	0.0166460036432934	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1952.02947801162	1952.02947801162
"healthy-4003"	"2020-08-26-Control4003-c3:AACGGGAGTTTACGTG"	10.8979164558345	6.04203078830568	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGGGAGTTTACGTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1430.78026594332	41.425301405459	0.0289529443419792	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1428.66566603697	1428.66566603697
"healthy-4003"	"2020-08-26-Control4003-c3:AACGGGATCACGGACC"	5.4935437637264	-10.13281824505	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGGGATCACGGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.41521665265	31.9509598572852	0.0155978922620467	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2046.84840197847	2046.84840197847
"healthy-4003"	"2020-08-26-Control4003-c3:AACGTCACAGCACGAA"	5.16460909423177	-9.68165113842162	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGTCACAGCACGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.2070592692	13.5354903432631	0.00627745386746422	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2151.0828604257	2151.0828604257
"healthy-4003"	"2020-08-26-Control4003-c3:AACGTCAGTGGAACAC"	4.88670744475667	-8.34105970775756	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACGTCAGTGGAACAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.68657138396	0.0953341827127621	4.48697629084482e-05	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2123.2100585151	2123.2100585151
"healthy-4003"	"2020-08-26-Control4003-c3:AACTTCTAGGCTCACC"	10.2312351661617	7.59131524646608	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACTTCTAGGCTCACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2210.3382190382	17.053572309721	0.00771536779431956	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2206.28811271418	2206.28811271418
"healthy-4003"	"2020-08-26-Control4003-c3:AACTTCTCATATGGCT"	3.73352088507954	-6.65935566341551	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACTTCTCATATGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.95301293498	19.3816490146794	0.00803566608086399	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2410.62406898438	2410.62406898438
"healthy-4003"	"2020-08-26-Control4003-c3:AACTTCTGTGCGTTTA"	-0.664011816412765	8.75068280780641	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACTTCTGTGCGTTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1813.3270956984	38.3954875942013	0.0211740549651984	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.69299115698	1807.69299115698
"healthy-4003"	"2020-08-26-Control4003-c3:AACTTCTTCCGTGTGG"	-3.16179309311565	9.93039987171022	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AACTTCTTCCGTGTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.6559782502	30.7415053380247	0.0155208706992029	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1976.82547360314	1976.82547360314
"healthy-4003"	"2020-08-26-Control4003-c3:AAGAACAAGTAAATGC"	5.22359098967854	-9.20181753551634	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGAACAAGTAAATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.90178988858	38.3807049415885	0.0166085400554556	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.18715466491	2308.18715466491
"healthy-4003"	"2020-08-26-Control4003-c3:AAGACAAAGAAACTCA"	-3.53647265854533	12.2025127180847	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGACAAAGAAACTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1856.05902453364	35.0243757313389	0.0188702919833809	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1847.99350207763	1847.99350207763
"healthy-4003"	"2020-08-26-Control4003-c3:AAGACAAAGAGTCAAT"	-4.21241126480754	12.8080672987732	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGACAAAGAGTCAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2235.6073297668	1.88466170032232	0.000843020004107302	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2218.51268682339	2218.51268682339
"healthy-4003"	"2020-08-26-Control4003-c3:AAGACAAAGGTGGGTT"	5.56153263625447	-9.93450262462767	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGACAAAGGTGGGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.95984588128	33.2534543916675	0.0135564609618469	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.54908028387	2445.54908028387
"healthy-4003"	"2020-08-26-Control4003-c3:AAGACTCAGGCAATGC"	10.2870356040889	5.72458074176637	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGACTCAGGCAATGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1579.32882155459	33.2452778559007	0.0210502571739153	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1567.94720743416	1567.94720743416
"healthy-4003"	"2020-08-26-Control4003-c3:AAGACTCTCCTGTAGA"	5.24444546279256	-9.77125837719115	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGACTCTCCTGTAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.61935870668	2.76102683254081	0.00109581108868684	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2513.20141888029	2513.20141888029
"healthy-4003"	"2020-08-26-Control4003-c3:AAGATAGAGCTAGCCC"	-1.03732929650005	8.37307546222535	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGATAGAGCTAGCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.49310980715	1.93626067313725	0.00100507012627264	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.82169314135	1916.82169314135
"healthy-4003"	"2020-08-26-Control4003-c3:AAGATAGCATGACTTG"	4.43710865554158	-6.95621206676634	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGATAGCATGACTTG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2609.68250509546	0	0	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2605.29035841448	2605.29035841448
"healthy-4003"	"2020-08-26-Control4003-c3:AAGATAGGTGCGACAA"	5.26946558532063	-9.3348427048889	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGATAGGTGCGACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2745.73325071391	26.9583489575077	0.00981826947337232	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2741.24805884556	2741.24805884556
"healthy-4003"	"2020-08-26-Control4003-c3:AAGATAGTCGCCTAGG"	4.96096195754353	-7.49234678661498	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGATAGTCGCCTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.59250699962	31.0332058194674	0.0129380900377641	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2395.79373304849	2395.79373304849
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCAGCGCATCC"	-3.51108823242839	10.4893045195374	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCAGCGCATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.98155704799	28.4409712216208	0.0138602470007267	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.06774314735	2041.06774314735
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCGTTGGTACT"	-3.58699808540996	10.6671485670838	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCGTTGGTACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.73123098185	28.9890244684252	0.014845373499685	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.68790916048	1950.68790916048
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCGTTGTGGAG"	3.98956956443135	-7.44395782863768	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCGTTGTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.58794949979	35.7555136690766	0.0174622602549558	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.31071890565	2044.31071890565
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCTCGAGAATA"	-1.61973855915721	9.10833737933961	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCTCGAGAATA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1846.99876299814	36.0455840461834	0.01951575971154	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1841.26459538857	1841.26459538857
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCTCTCCGTGT"	-0.286834160715896	8.20134637439577	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCTCTCCGTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.21532692155	19.021165070529	0.0110381823869391	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.98057689543	1717.98057689543
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCATCTCTGAGGCC"	3.70678629454915	-6.54588272487792	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCATCTCTGAGGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.54220754003	26.0068205585868	0.0115763774530034	1368	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2240.11322308538	2240.11322308538
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCCATAGCTTTCCC"	5.73341860350911	-9.93887140667113	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCCATAGCTTTCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.53751353201	23.2393253659113	0.0103078015896502	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2250.0577906203	2250.0577906203
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCCATTCCGAACGC"	3.99003066596333	-7.11332228099974	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCCATTCCGAACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.91563520209	11.0029634140989	0.00480916483318101	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.91345904631	2283.91345904631
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGAGAGAAGGCTC"	10.4938894706661	7.55160043323366	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGAGAGAAGGCTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1866.92931737267	36.8649394933998	0.019746296311464	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1858.31385882197	1858.31385882197
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGAGAGTGCCGAA"	3.74268140372578	-6.82368853008422	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGAGAGTGCCGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2216.9366064466	31.0427014423136	0.0140025210247533	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2209.10706123673	2209.10706123673
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGAGCATGTTTGG"	3.87747492369954	-6.70206262981566	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGAGCATGTTTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.75340245512	28.1571436829476	0.0130131019787185	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2156.78877266467	2156.78877266467
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGAGGTCGTTGCG"	4.47635092315022	-7.18663027202757	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGAGGTCGTTGCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.40523628422	31.5342650813603	0.0142727393614739	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.45328725457	2199.45328725457
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGTTAGCTGTCCG"	-4.08566556397136	13.1073703535828	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGTTAGCTGTCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1825.53261820857	45.5002125824406	0.0249243492713326	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1823.66022309629	1823.66022309629
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGTTCAGGCACTC"	10.0127436119014	6.82262752139894	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGTTCAGGCACTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.57485475342	26.4722858504961	0.0140319297608554	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1885.06312334392	1885.06312334392
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGTTGTTAACCTG"	-3.93206797066386	12.7111406096253	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGTTGTTAACCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1663.65182540043	5.54305331021545	0.0033318590017363	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1663.65182540043	1663.65182540043
"healthy-4003"	"2020-08-26-Control4003-c3:AAGCGTTTCCTCGCAT"	-3.50018129769023	13.2231464155945	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"IFN+ NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGCGTTTCCTCGCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1714.86468356081	44.5139344185826	0.0259576949979238	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1714.86468356081	1714.86468356081
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGAATCACAGCTTA"	-3.78504143181499	10.1856126555237	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGAATCACAGCTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2175.18595696054	34.9143374802104	0.016051196619988	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2166.98880778822	2166.98880778822
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGAATTCGCTGTCT"	-2.14014349404033	8.77622697437135	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGAATTCGCTGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.14685428659	38.7337164406006	0.0215889331177421	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1791.97459498958	1791.97459498958
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGAATTCTCTATGT"	5.05213989791219	-7.77629473125609	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGAATTCTCTATGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2802.29339954931	14.7935708336223	0.00527909420048647	2053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2795.08708494648	2795.08708494648
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGTAAAGGCCACCT"	3.70745100554768	-7.12903644954833	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGTAAAGGCCACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.63830234952	28.1065141087768	0.0124385013652637	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2258.10158886377	2258.10158886377
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGTAAGTAACGTTC"	-1.06286690655406	8.59678361499635	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGTAAGTAACGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1700.37562899545	42.1064505602697	0.0247630287345069	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.40195415882	1685.40195415882
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGTAAGTGAGATAT"	4.57432045516316	-8.17680170452269	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGTAAGTGAGATAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.94973016705	36.2589585347983	0.0164667512786714	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2195.37881224998	2195.37881224998
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGTAAGTGCGGATA"	2.71156515654866	-4.38470699703368	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGTAAGTGCGGATA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2356.03144051185	30.4599658033948	0.0129285056555855	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2348.02079322269	2348.02079322269
"healthy-4003"	"2020-08-26-Control4003-c3:AAGGTAAGTTCCTAAG"	-1.95633278313335	9.53493115985719	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGGTAAGTTCCTAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1791.18593945163	40.5226513811422	0.022623363933701	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.26933224861	1785.26933224861
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTACCAGGCTAGCA"	9.46968235549275	7.22075555408327	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTACCAGGCTAGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.81336106116	35.1388292967132	0.0193942875419203	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1803.3236829582	1803.3236829582
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTACCCAAAGGGCT"	5.64061274108235	-9.783154510614	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTACCCAAAGGGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.92483889902	5.11740425490417	0.00232934880806789	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2192.43099604759	2192.43099604759
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTACCGTGTTACAC"	0.557651300995988	8.39129731738893	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTACCGTGTTACAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1904.31750134075	32.0639247023843	0.0168374888535181	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1895.57611865614	1895.57611865614
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTACCTCATCTATC"	-1.26477322998698	9.93550870502321	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTACCTCATCTATC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1898.80268189715	37.3200604345522	0.0196545227107351	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1883.16900654654	1883.16900654654
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTCGTCAGTGTGCC"	-3.96449695053752	13.0675954588684	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTCGTCAGTGTGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1717.43656849835	15.7070100991166	0.0091456129368726	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1710.66778239012	1710.66778239012
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTCGTCATTAGGCT"	3.82370175895039	-6.88169672405394	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTCGTCATTAGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.47518271427	27.2433993260703	0.0120520674300692	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.02419365534	2259.02419365534
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTGAAGTAATGCGG"	4.03848566588704	-7.53518917476805	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTGAAGTAATGCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.92026582755	31.8974244102231	0.0137434382731152	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2316.79524495238	2316.79524495238
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTGAATCAACCTCC"	-1.62048695507701	8.92004869067994	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTGAATCAACCTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.29246857235	23.7707591381002	0.0124305039782155	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1910.44486403535	1910.44486403535
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTGAATCCGTGTGG"	-0.599367181689102	8.4298000105652	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTGAATCCGTGTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.89748386831	35.0152204686081	0.0191246209998761	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1823.0951581187	1823.0951581187
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTGAATCTCAATCT"	2.12506355819051	-6.6160607567993	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTGAATCTCAATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1521.51444900974	37.4907613154616	0.0246404241115568	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1517.88809956825	1517.88809956825
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTTCGCAGCTACCG"	-2.04949102822002	9.21589372241823	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTTCGCAGCTACCG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1885.32711825874	0.760700904393272	0.00040348483667696	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.5729053728	1881.5729053728
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTTCGGTAGAATGT"	3.1957856613094	-6.45286705410155	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTTCGGTAGAATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.88151719624	29.2310471644156	0.0123761699948079	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.47667508644	2359.47667508644
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTTCGTCAGAATAG"	5.1663052040035	-8.4540643922058	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTTCGTCAGAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.73100651221	28.2471651334917	0.0112640331280101	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.01767778461	2505.01767778461
"healthy-4003"	"2020-08-26-Control4003-c3:AAGTTCGTCCATTCGC"	4.12363018569295	-7.03254368221434	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AAGTTCGTCCATTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.35982711152	44.6978906877198	0.0192550461870177	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.75574592835	2318.75574592835
"healthy-4003"	"2020-08-26-Control4003-c3:AATAGAGAGCTGGTGA"	5.67824282225911	-9.85963632976683	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATAGAGAGCTGGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.9280087046	23.7886948641606	0.0101751186416306	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2337.9280087046	2337.9280087046
"healthy-4003"	"2020-08-26-Control4003-c3:AATAGAGCAACTCCAA"	-4.25929103317912	13.0755367049011	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATAGAGCAACTCCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1640.10493072806	40.7543794803049	0.0248486415208895	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1629.12959741179	1629.12959741179
"healthy-4003"	"2020-08-26-Control4003-c3:AATAGAGGTTATCTTC"	3.34842433509175	-6.46538212215575	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATAGAGGTTATCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.07635843096	22.0746453310061	0.00903189675513145	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.40225453145	2439.40225453145
"healthy-4003"	"2020-08-26-Control4003-c3:AATCACGTCGCTACAA"	4.97925438460652	-8.20553686535033	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCACGTCGCTACAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.16794671244	25.85429799047	0.0107405459705378	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2399.64325191802	2399.64325191802
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGACCAAATACAG"	-3.43554435196574	10.3113546141419	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGACCAAATACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1883.71943378832	28.0172742307828	0.0148733796170684	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1879.81902596416	1879.81902596416
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGACCAACGATCT"	-1.58629880371745	8.86774919116823	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGACCAACGATCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1534.22446714465	32.5624178333726	0.0212240246005035	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1531.98639195921	1531.98639195921
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGACTCCTACACC"	-3.63520751419719	13.0414418944153	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGACTCCTACACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2044.97701302241	37.5472754630621	0.0183607322840116	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2035.76771428828	2035.76771428828
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGACTCTATCGCC"	4.21864094313924	-7.25369884884032	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGACTCTATCGCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2366.32311700497	17.05026617604	0.00720538376754751	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2362.60621907704	2362.60621907704
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGTGCAATTCGTG"	-7.04835877838786	4.08533713901369	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGTGCAATTCGTG"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1732.93018790794	43.633927569425	0.0251792760457947	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1718.32355573058	1718.32355573058
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGTGGTAGGCTCC"	3.22659291800801	-5.34997894680174	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGTGGTAGGCTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.44301330852	27.6682584182426	0.012138166322519	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.30156380982	2278.30156380982
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGTGGTCACGACC"	3.19500746306722	-6.38631727611693	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGTGGTCACGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.1826209326	19.4078016621293	0.00854147966951858	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.67085750377	2267.67085750377
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGTGGTGTGTGTT"	-3.9567473930424	12.8044938811096	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGTGGTGTGTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2037.10831569997	34.1464003764762	0.0167621918350194	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2030.84947479293	2030.84947479293
"healthy-4003"	"2020-08-26-Control4003-c3:AATCGTGTCTACGCAA"	4.99706043776814	-8.23375704204711	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATCGTGTCTACGCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1936.97007177055	4.39789651127887	0.00227050307868661	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1935.3089894441	1935.3089894441
"healthy-4003"	"2020-08-26-Control4003-c3:AATGCCAAGGCGAAGG"	-7.4021032852238	1.10689315879671	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGCCAAGGCGAAGG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1349.22920967502	0	0	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1347.12452889428	1347.12452889428
"healthy-4003"	"2020-08-26-Control4003-c3:AATGCCACAATTGGTC"	-3.80813608589824	10.7013358839783	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGCCACAATTGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.07853897416	36.1615601576422	0.0198681317225045	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1814.03355767631	1814.03355767631
"healthy-4003"	"2020-08-26-Control4003-c3:AATGCCATCCACGTAA"	10.5116335349971	6.93205068195192	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGCCATCCACGTAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1577.1238872622	3.46082081030885	0.00219438741512986	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1573.41406422355	1573.41406422355
"healthy-4003"	"2020-08-26-Control4003-c3:AATGCCATCCATACAG"	2.59231700476949	-4.47805502330931	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGCCATCCATACAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2536.94096227491	28.0113041604596	0.0110413701292211	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2534.01605785569	2534.01605785569
"healthy-4003"	"2020-08-26-Control4003-c3:AATGCCATCCATTTGT"	5.34669937667195	-9.31291487133177	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGCCATCCATTTGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.15418178029	26.1762499419948	0.00985494370829411	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2643.17493548664	2643.17493548664
"healthy-4003"	"2020-08-26-Control4003-c3:AATGGAAGTTACAGCT"	3.31606807288472	-7.31728985225829	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGGAAGTTACAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.66940661862	33.8638405620534	0.0169177989382667	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2001.66940661862	2001.66940661862
"healthy-4003"	"2020-08-26-Control4003-c3:AATGGCTGTGATACCT"	4.1557957130367	-7.17035629665526	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATGGCTGTGATACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.73985664247	7.75352462604896	0.00313180102717418	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2472.89616405186	2472.89616405186
"healthy-4003"	"2020-08-26-Control4003-c3:AATTCCTAGCGACTAG"	-4.333816866309	12.0220060118469	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTCCTAGCGACTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2434.41619495646	39.9022288607276	0.0163908821110358	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2424.54726320034	2424.54726320034
"healthy-4003"	"2020-08-26-Control4003-c3:AATTCCTGTACTCAAC"	-1.0527357858723	8.95763681018678	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTCCTGTACTCAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1645.68784842731	16.3952879360242	0.00996257458648204	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1638.59442009899	1638.59442009899
"healthy-4003"	"2020-08-26-Control4003-c3:AATTCCTGTCGCACAC"	-3.50535831871684	11.1738595732483	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTCCTGTCGCACAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2333.89550026158	45.6429043024064	0.019556532971288	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2319.84011868548	2319.84011868548
"healthy-4003"	"2020-08-26-Control4003-c3:AATTCCTGTCTGCGCA"	-3.09712539139445	9.53816888416139	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTCCTGTCTGCGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2544.45322811851	33.9861321186643	0.0133569490462968	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2536.03013026547	2536.03013026547
"healthy-4003"	"2020-08-26-Control4003-c3:AATTTCCCAACGACAG"	3.21043958243672	-7.36937143718871	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTTCCCAACGACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1669.90853904414	17.0467778934561	0.0102082105066747	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1669.90853904414	1669.90853904414
"healthy-4003"	"2020-08-26-Control4003-c3:AATTTCCCAGAAGTGC"	5.54683270034139	-10.1128807297912	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTTCCCAGAAGTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.71527745943	30.8731886647834	0.0138214520786632	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2229.32727340825	2229.32727340825
"healthy-4003"	"2020-08-26-Control4003-c3:AATTTCCCAGCATGCC"	4.46805061873738	-7.19430925762328	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTTCCCAGCATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2747.13738493234	31.3522217088927	0.0114126879423123	1874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2740.50225702092	2740.50225702092
"healthy-4003"	"2020-08-26-Control4003-c3:AATTTCCCATGAATAG"	-4.25121436539348	9.82888600910035	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTTCCCATGAATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.18135081214	27.6071556480654	0.0141272229604444	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1948.52582249866	1948.52582249866
"healthy-4003"	"2020-08-26-Control4003-c3:AATTTCCTCTGCGATA"	-2.2066846889561	9.20641419971315	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AATTTCCTCTGCGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1689.08205226738	36.4510938091728	0.0215804162741779	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1684.98276910467	1684.98276910467
"healthy-4003"	"2020-08-26-Control4003-c3:ACAAAGAAGCTGACCC"	4.49126066741292	-7.76447966015013	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAAAGAAGCTGACCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.40268420225	0.999265588787393	0.000464471665915917	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.01102753062	2150.01102753062
"healthy-4003"	"2020-08-26-Control4003-c3:ACAAAGACACCCTAAA"	5.30153383788411	-9.90415670787963	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAAAGACACCCTAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.71060989123	30.0143927585458	0.0141064262306236	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2126.11247427763	2126.11247427763
"healthy-4003"	"2020-08-26-Control4003-c3:ACAAAGATCCGTGGGT"	3.8171042400295	-7.24346640026244	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAAAGATCCGTGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1859.6399847357	41.4944298242019	0.0223131520965329	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1859.6399847357	1859.6399847357
"healthy-4003"	"2020-08-26-Control4003-c3:ACAACCAGTTTACACG"	5.47963633117024	-10.10112192547	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAACCAGTTTACACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.40885321435	31.4799199988406	0.0128102085892887	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.57802122715	2450.57802122715
"healthy-4003"	"2020-08-26-Control4003-c3:ACAAGCTCAACCGATT"	-0.8987874192303	8.6008672484192	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAAGCTCAACCGATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1841.59048677787	30.0976562809443	0.0163432948296798	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1834.34164296677	1834.34164296677
"healthy-4003"	"2020-08-26-Control4003-c3:ACAAGCTGTCTAGGTT"	6.79199089583699	-1.66581263458403	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAAGCTGTCTAGGTT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2760.23095167226	20.3785295032076	0.00738290739434736	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2745.50039997925	2745.50039997925
"healthy-4003"	"2020-08-26-Control4003-c3:ACACAGTAGGTGCCAA"	-0.472702602774459	8.26154515827028	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACAGTAGGTGCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1597.91508717626	10.6585044796447	0.00667025711515109	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1594.08933478482	1594.08933478482
"healthy-4003"	"2020-08-26-Control4003-c3:ACACAGTCACTTGAGT"	4.12520470198934	-7.41462566768798	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACAGTCACTTGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1954.73842946316	26.0906391199952	0.0133473812796327	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1950.77002878475	1950.77002878475
"healthy-4003"	"2020-08-26-Control4003-c3:ACACAGTGTAGTCTTG"	3.97633256491963	-7.11049082195433	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACAGTGTAGTCTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.6830059769	37.8154974044792	0.0171991584515283	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2197.01216891337	2197.01216891337
"healthy-4003"	"2020-08-26-Control4003-c3:ACACAGTTCTGAGAGG"	4.91202559050862	-7.67167856609496	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACAGTTCTGAGAGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.25041269807	0.582453206636381	0.00021960716976338	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2650.4210059675	2650.4210059675
"healthy-4003"	"2020-08-26-Control4003-c3:ACACCAAAGAGGGTCT"	4.68552794036214	-8.63612654125365	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACCAAAGAGGGTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.76206665338	37.6009926560256	0.0203715274765623	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1841.96337334704	1841.96337334704
"healthy-4003"	"2020-08-26-Control4003-c3:ACACCAAGTAGCTGCC"	2.29862393912618	-6.19725658809813	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACCAAGTAGCTGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2078.42207516398	29.7746957883316	0.0143256252635705	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2076.97303291873	2076.97303291873
"healthy-4003"	"2020-08-26-Control4003-c3:ACACCAAGTGCCCACA"	3.28201450881307	-7.66340782558592	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACCAAGTGCCCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.65731439899	21.8725203872443	0.0106817289364965	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2040.57748925581	2040.57748925581
"healthy-4003"	"2020-08-26-Control4003-c3:ACACCAAGTTTCACAG"	-3.62792478027995	11.9539670714172	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACCAAGTTTCACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1833.3603007416	34.2892969208423	0.0187029777545484	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1831.35169551574	1831.35169551574
"healthy-4003"	"2020-08-26-Control4003-c3:ACACGCGAGTCTCCTC"	4.76223196563069	-7.93080236828002	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACGCGAGTCTCCTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.03367268132	11.8700893166148	0.00506611981509893	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2338.93584831136	2338.93584831136
"healthy-4003"	"2020-08-26-Control4003-c3:ACACGCGAGTTGCCCG"	-4.23573718491252	13.0919255980286	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACGCGAGTTGCCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1986.01266096084	10.222990783361	0.00514749527246976	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1984.023522756	1984.023522756
"healthy-4003"	"2020-08-26-Control4003-c3:ACACGCGCACTACCCT"	4.57554974135701	-7.28076460277709	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACGCGCACTACCCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2437.32929577859	32.0923576722702	0.013167017574463	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2435.16388866326	2435.16388866326
"healthy-4003"	"2020-08-26-Control4003-c3:ACACGCGCAGAGATTA"	4.21161284026448	-6.82832147991332	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACGCGCAGAGATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1895.93514195958	15.7733396788433	0.00831955657646624	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1893.9602345049	1893.9602345049
"healthy-4003"	"2020-08-26-Control4003-c3:ACACTGAAGGAACTAT"	-3.26097617569621	10.1448821791443	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACTGAAGGAACTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.17442822101	36.1497149954332	0.0208816133176027	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1719.63639778553	1719.63639778553
"healthy-4003"	"2020-08-26-Control4003-c3:ACACTGACAATTGGTC"	-3.42133722725566	9.88825414264528	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACACTGACAATTGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2067.98811603035	36.3539236868974	0.0175793677947634	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2060.48228036563	2060.48228036563
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGAAAAGGTGCTTT"	0.714590032666367	8.23118112171022	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGAAAAGGTGCTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.16420357096	26.165500307003	0.015628992813962	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1666.34936875241	1666.34936875241
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGAAAAGTTGCTGT"	2.72302569922749	-4.45225622570189	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGAAAAGTTGCTGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2452.51317706627	29.5410094897415	0.0120451990904607	1875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2452.51317706627	2452.51317706627
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGAAACAAACTGCT"	0.273847420781296	8.57241532886354	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGAAACAAACTGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.34077952212	17.3481753139443	0.00951972073987917	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1814.98810710533	1814.98810710533
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGAAACAAATAAGC"	5.43970026549642	-10.2061872712341	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGAAACAAATAAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.20874270139	33.7044273341758	0.0141900906342416	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2362.35047842825	2362.35047842825
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGAAACATGTTTGG"	-2.16201529923137	3.64529106700746	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGAAACATGTTTGG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3272.73487872044	34.4495640463441	0.0105262312173032	5010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3266.07113928692	3266.07113928692
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGCCGAGATTCGAA"	5.0356260734493	-7.94452097332152	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGCCGAGATTCGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2080.67291672648	16.6984687193376	0.00802551356587527	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2077.28450767624	2077.28450767624
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGCCGAGCAGTAAT"	-3.85766873779948	12.5823707350525	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGCCGAGCAGTAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2190.14688598673	48.6428227357097	0.0222098449409683	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2179.3392892148	2179.3392892148
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGCCGTCGGTCATA"	11.2020498710567	5.17837236011354	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGCCGTCGGTCATA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1802.41329925378	0.619302546446913	0.000343596303191567	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1798.61631448304	1798.61631448304
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGGGACAAAGACTA"	3.8450411754543	-6.86256744777831	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGGGACAAAGACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.76499212215	31.4529420629133	0.0141503677511513	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2222.76499212215	2222.76499212215
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGGGAGTACTCGTA"	2.49204268035237	-4.14527418529662	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGGGAGTACTCGTA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2310.36475813867	31.5182033855446	0.0136420897499047	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2302.32861822158	2302.32861822158
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGGGAGTAGAAACT"	3.2071393924648	-6.23337271129759	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGGGAGTAGAAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.41692394804	9.9783477093227	0.00460592215608173	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2160.99480854565	2160.99480854565
"healthy-4003"	"2020-08-26-Control4003-c3:ACAGGGAGTTCGGACC"	-2.29669747772868	9.58873078906862	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACAGGGAGTTCGGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.65250786092	35.7412349653681	0.0218113570716859	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1630.0204239362	1630.0204239362
"healthy-4003"	"2020-08-26-Control4003-c3:ACATCCCAGGGTTTCT"	10.9819122749263	6.18275830829469	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATCCCAGGGTTTCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2197.5464170781	34.5766571158687	0.0157342101387067	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2182.45187081703	2182.45187081703
"healthy-4003"	"2020-08-26-Control4003-c3:ACATCCCGTACTGTTG"	1.96321179446523	-7.18001558696898	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATCCCGTACTGTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1467.91288419573	7.76406679572909	0.00528918771632896	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1465.92178784017	1465.92178784017
"healthy-4003"	"2020-08-26-Control4003-c3:ACATCCCTCTTTGATC"	4.98509087142293	-7.91962101375731	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATCCCTCTTTGATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.95549295651	34.4787759936912	0.0132511013685765	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2599.50205389791	2599.50205389791
"healthy-4003"	"2020-08-26-Control4003-c3:ACATCGACAATTGCAC"	2.58757962760274	-4.32982113277587	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATCGACAATTGCAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2378.31182987257	25.2910048958626	0.0106340155139445	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2374.20434377811	2374.20434377811
"healthy-4003"	"2020-08-26-Control4003-c3:ACATCGATCAATCTTC"	3.74369921263997	-7.06270077144774	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATCGATCAATCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.22259195096	27.9437521132433	0.0125352004838546	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2226.5552488354	2226.5552488354
"healthy-4003"	"2020-08-26-Control4003-c3:ACATGCAGTTTACCTT"	-1.42190788212474	9.38271806323854	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATGCAGTTTACCTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2082.13255553587	37.6185511464154	0.018067318070791	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2074.42072084316	2074.42072084316
"healthy-4003"	"2020-08-26-Control4003-c3:ACATTTCAGCGCCATC"	-1.78046045723613	9.0185861357483	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATTTCAGCGCCATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.44390861196	33.1564602349726	0.0189417439038446	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1748.54595124559	1748.54595124559
"healthy-4003"	"2020-08-26-Control4003-c3:ACATTTCAGCTTCATG"	5.43072142180745	-10.158772491571	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATTTCAGCTTCATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.74439060238	2.18403840793799	0.000955922429187875	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2280.09594610842	2280.09594610842
"healthy-4003"	"2020-08-26-Control4003-c3:ACATTTCCACCACTGG"	-4.13047442856486	12.9414129027161	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATTTCCACCACTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1963.20276047673	34.1954083440203	0.0174181745423568	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1961.16023453185	1961.16023453185
"healthy-4003"	"2020-08-26-Control4003-c3:ACATTTCGTCACGCTG"	4.52540649947469	-7.47016527568968	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACATTTCGTCACGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.65589713056	12.2069942299806	0.00519301623214256	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2345.74713307053	2345.74713307053
"healthy-4003"	"2020-08-26-Control4003-c3:ACCAAACGTGTAAACA"	2.98714389380757	-6.43570330059203	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCAAACGTGTAAACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2195.41577593435	22.9111559436547	0.0104359074917843	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2192.59470998827	2192.59470998827
"healthy-4003"	"2020-08-26-Control4003-c3:ACCAAACTCATTGGTG"	3.81706156310384	-6.54792025005492	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCAAACTCATTGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.17634882201	36.2889322037839	0.013770969149752	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2627.37978789911	2627.37978789911
"healthy-4003"	"2020-08-26-Control4003-c3:ACCAACAAGTGAGCCA"	3.50463308867757	-7.68650343334349	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCAACAAGTGAGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.9362947759	36.029329752361	0.0166191828787503	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2159.20660495085	2159.20660495085
"healthy-4003"	"2020-08-26-Control4003-c3:ACCACAAAGAAGCCAC"	4.02879728850667	-7.35961582576903	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCACAAAGAAGCCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.38342876502	41.9977033289221	0.0180295364044847	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.97023037992	2327.97023037992
"healthy-4003"	"2020-08-26-Control4003-c3:ACCACAAGTTGTCAGT"	3.96356954154317	-7.11571361934813	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCACAAGTTGTCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.81897254388	35.1284861815999	0.0170293596525725	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2051.78326184197	2051.78326184197
"healthy-4003"	"2020-08-26-Control4003-c3:ACCACAATCGTGTTCC"	4.33564867553059	-8.17220117962035	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCACAATCGTGTTCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1804.53089172929	29.634251234241	0.0164221357307119	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1804.53089172929	1804.53089172929
"healthy-4003"	"2020-08-26-Control4003-c3:ACCATTTGTCACCCTT"	-1.63631139221843	9.59338948810426	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCATTTGTCACCCTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1907.67266930179	15.9064380470589	0.00833813803752854	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1902.23901941624	1902.23901941624
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCAAACACGGATCC"	4.19097151336018	-6.8818192712036	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCAAACACGGATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.05097555439	31.0093540933733	0.0124833807351529	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2478.72005575843	2478.72005575843
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCAAACAGCACCCA"	4.02212466773335	-7.52389385616454	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCAAACAGCACCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2073.45954210151	33.2121784902787	0.0160177605667759	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2071.92057211464	2071.92057211464
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCAAGATTGAGT"	5.22094692763631	-8.87594320690306	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCAAGATTGAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2799.28284966731	36.7894019581374	0.0131424382364611	2096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2795.33814315789	2795.33814315789
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCAAGGACAGTC"	-0.880450109869796	8.74246976459352	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCAAGGACAGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.86931683582	41.0153421321321	0.0204885212971652	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1994.87657914694	1994.87657914694
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCACATCCAATG"	8.8396393257076	6.45521400058595	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCACATCCAATG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1681.89286979383	31.2689087405471	0.0185914984849065	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1671.57726220146	1671.57726220146
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCACATTACGGT"	5.01124300536458	-8.1531667939392	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCACATTACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.75467891132	32.9313701968584	0.012446872137975	1761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2644.67428425671	2644.67428425671
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCAGTATAATGG"	10.6674448448116	6.47692868793336	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCAGTATAATGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2051.75808086616	39.9445167870636	0.0194684340028045	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2041.49581804231	2041.49581804231
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCATCACGATCA"	5.11981644210164	-7.98172380840453	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCATCACGATCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2805.27700801262	31.532646727566	0.011240475232036	2215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2799.86906259239	2799.86906259239
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCATCGAACTCA"	3.75081338462178	-7.93844463741454	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCATCGAACTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.84531812162	36.4589498955542	0.0212607804973862	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1708.63112598812	1708.63112598812
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTCATCTCTCTAA"	5.45321526107137	-9.68932821666869	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTCATCTCTCTAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.3597924313	16.7903514980534	0.00666453102430835	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.14964513179	2515.14964513179
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTTGAGGCTTAAA"	4.05679812011067	-7.08428814327391	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTTGAGGCTTAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.32583070595	22.3260454189133	0.0101145218836011	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.66498311487	2202.66498311487
"healthy-4003"	"2020-08-26-Control4003-c3:ACCCTTGTCGACATTG"	-0.286622504622298	8.10887525165407	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCCTTGTCGACATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.97430497445	15.2359433552122	0.00875641859288028	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1731.25896485272	1731.25896485272
"healthy-4003"	"2020-08-26-Control4003-c3:ACCGTTCAGGTTGAGC"	-4.09331069412883	12.9990606077942	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCGTTCAGGTTGAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1897.28038178406	41.2046882248672	0.0217177643433605	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1895.27893564031	1895.27893564031
"healthy-4003"	"2020-08-26-Control4003-c3:ACCGTTCCAAGAAATC"	14.2342583137447	1.86293087089387	"2020-08-26-Control4003-c3"	"Control4003"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCGTTCCAAGAAATC"	"Plasma cell"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1398.82483883609	0	0	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1385.15968027339	1385.15968027339
"healthy-4003"	"2020-08-26-Control4003-c3:ACCGTTCGTAGGCAAC"	-2.31768689575847	10.6156816252503	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCGTTCGTAGGCAAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1857.28989522201	19.3384593016356	0.0104121921684843	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1845.62146589501	1845.62146589501
"healthy-4003"	"2020-08-26-Control4003-c3:ACCGTTCTCACTGTCC"	4.8029052215511	-7.30238583004149	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCGTTCTCACTGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.78049732477	2.02583450014518	0.000762227919944598	1753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2653.20393619819	2653.20393619819
"healthy-4003"	"2020-08-26-Control4003-c3:ACCGTTCTCAGAATAG"	-3.80267630043681	11.193091369513	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCGTTCTCAGAATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2186.75739881247	36.4839837894691	0.0166840564066604	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2177.94080007723	2177.94080007723
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTACCAGAGCATAT"	5.04270567473714	-8.88434889232787	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTACCAGAGCATAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.23927255225	24.7782301076116	0.0112513796372795	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.84392481653	2200.84392481653
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTACCAGTCACGCC"	5.44840158995931	-9.84212210094603	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTACCAGTCACGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.2716115642	6.53793736407947	0.00280084688160962	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.17298437678	2328.17298437678
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTACCAGTGAACAT"	4.12872519072835	-7.55295469677123	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTACCAGTGAACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.16730017363	13.7416436532157	0.00639393855104046	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.15862645406	2144.15862645406
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGAAAGAAGTCAT"	2.61586632308308	-4.53410723125609	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGAAAGAAGTCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2540.57925027308	34.0074055240729	0.0133856897085252	1942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2528.1800756814	2528.1800756814
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGAACAACCTAAC"	-3.52144775810893	11.5377092131409	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGAACAACCTAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2116.16987547559	40.5991862739157	0.0191852207823303	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2114.38360873992	2114.38360873992
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGAACAGTTAGGG"	-1.11339245262797	8.43160150134889	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGAACAGTTAGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.36486422836	35.5972028809618	0.0187712837083419	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1893.13033904621	1893.13033904621
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGAATCAGTGCGC"	4.76718153533284	-7.30365421688231	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGAATCAGTGCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.61769543099	25.7558534504769	0.0101296602697131	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2536.57052174912	2536.57052174912
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGAATCGTGTTCC"	5.45936789092366	-10.2321729890076	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGAATCGTGTTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.54990764533	26.5650585432757	0.0112824359581497	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.82085364975	2351.82085364975
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGTCAGAACGCGT"	-5.56823382797893	-5.27302505886229	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGTCAGAACGCGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2700.25003274833	3.61792416460526	0.00133984783658087	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2693.15400050355	2693.15400050355
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGTCCAACCGACC"	3.78425087508504	-6.94988825237425	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGTCCAACCGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2065.71064556414	3.41226322221705	0.00165185924250546	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2065.71064556414	2065.71064556414
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGTCGTGCGTTTA"	-0.162911544472534	8.25790975177614	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGTCGTGCGTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.94014624953	33.1659927728622	0.0179378401405462	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.85935661638	1840.85935661638
"healthy-4003"	"2020-08-26-Control4003-c3:ACCTGTCTCTACTCAT"	5.49996485289876	-10.1188917390076	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACCTGTCTCTACTCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.12566276908	31.9140429460139	0.0139051396896105	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2289.64279251079	2289.64279251079
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATCATCTCGAACA"	4.41811432418172	-7.00149109279784	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATCATCTCGAACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.85533906692	27.5372306841297	0.0120415271633952	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.22313632524	2281.22313632524
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATGTAGCGAAACC"	-4.00251994553264	13.016613937262	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATGTAGCGAAACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2314.59565899938	39.2372955666448	0.0169521166317263	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2308.19673306711	2308.19673306711
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATGTAGTCCCAAT"	5.24479355391805	-9.55670931255492	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATGTAGTCCCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.93673782294	38.9637137424755	0.017841045057613	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2182.29204196773	2182.29204196773
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATGTCAGCATTGT"	4.16596712645833	-6.79965879833373	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATGTCAGCATTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2477.39998023558	31.1788481774583	0.0125853105781059	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2472.12413168156	2472.12413168156
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATGTGTCTACAAC"	0.0265895753050267	8.18936917865602	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATGTGTCTACAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1842.19537385622	25.6834857037136	0.0139417816743025	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1838.39715845794	1838.39715845794
"healthy-4003"	"2020-08-26-Control4003-c3:ACGATGTGTTTGATCG"	3.87074293670003	-7.02072145855101	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGATGTGTTTGATCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.63613581157	25.1093809768739	0.0107275883648475	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2340.63613581157	2340.63613581157
"healthy-4003"	"2020-08-26-Control4003-c3:ACGCACGAGGTTCATC"	10.2463137107784	6.12297246539918	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGCACGAGGTTCATC"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1869.56510458307	38.7926858859218	0.0207495774235542	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1869.56510458307	1869.56510458307
"healthy-4003"	"2020-08-26-Control4003-c3:ACGCACGAGTGGTGGT"	-4.03889880600627	11.7599162825379	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGCACGAGTGGTGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.33776102935	28.2050181813941	0.0179268678855969	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1571.09974451828	1571.09974451828
"healthy-4003"	"2020-08-26-Control4003-c3:ACGCACGTCAGATGCT"	4.36203493651692	-7.71268370067748	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGCACGTCAGATGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.62137409976	0.356056058714242	0.000177794995758647	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2002.62137409976	2002.62137409976
"healthy-4003"	"2020-08-26-Control4003-c3:ACGCACGTCCCTATTA"	-3.1840537590092	10.1468953856262	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGCACGTCCCTATTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.92846662492	37.5214833875136	0.0207309206299639	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.92846662492	1809.92846662492
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGAAGTCCTTCACG"	-3.52843795242961	10.2407665022644	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGAAGTCCTTCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2115.31676542886	38.4778531638341	0.0181901140257984	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2109.89861143704	2109.89861143704
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGGTCCATCCAATG"	4.58992733535115	-7.00822689449462	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGGTCCATCCAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3032.50491654772	4.01906430522081	0.00132532820747945	2591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3019.18360976447	3019.18360976447
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGTCGGTAGTATAG"	4.49475540694539	-7.00086357509764	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGTCGGTAGTATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.95137478286	35.7634227796716	0.0144093970345412	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2479.27377718143	2479.27377718143
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGTCGGTCCGGATC"	5.3251539665157	-9.14239981090697	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGTCGGTCCGGATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2829.39668223491	34.8890807670424	0.012330925877627	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2822.14147100779	2822.14147100779
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGTCGGTGTACGCC"	-0.0605884892051995	7.98847148502199	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGTCGGTGTACGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1609.62500564654	13.3754734764015	0.00830968295688778	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1606.48986107977	1606.48986107977
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGTTAAGCTTGTGT"	4.56597723540608	-7.48605635082396	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGTTAAGCTTGTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.22134794482	7.06608948446986	0.00331551177979886	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2131.22134794482	2131.22134794482
"healthy-4003"	"2020-08-26-Control4003-c3:ACGGTTAGTCTCGCGA"	4.66919817504231	-8.08202364360961	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGGTTAGTCTCGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.53122883857	13.4212874678944	0.0061834113647266	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.03468435754	2169.03468435754
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTAACCAGCTGGTC"	-3.9481237930363	11.2671136626038	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTAACCAGCTGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2026.87898710578	30.4334407084616	0.0150149273351134	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2026.87898710578	2026.87898710578
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTACATCCATCACC"	3.5277918773586	-6.37646582042845	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTACATCCATCACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.58771193329	28.1234410018135	0.0113237156339131	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2480.036390256	2480.036390256
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTAGTAGAAGTGTT"	2.87339057502095	-4.84095909511717	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTAGTAGAAGTGTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2541.13547712489	31.1269714373552	0.0122492372868577	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2531.83373232222	2531.83373232222
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTAGTAGAGAGGTA"	9.71859898146931	5.49301669681398	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTAGTAGAGAGGTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1470.87699866932	36.4354964676649	0.0247712735331558	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1464.7014742794	1464.7014742794
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTCCTCACAATGCT"	5.35377516326253	-9.97599127208861	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTCCTCACAATGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.26559556327	18.9291462442295	0.00874218215216469	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2161.42331672909	2161.42331672909
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTTCCGTACAAAGT"	-0.936904172331649	8.24293038928834	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTTCCGTACAAAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.83145520356	26.9989884457319	0.0144392631595732	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1860.42484528908	1860.42484528908
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTTCCTCTCTCGCA"	4.14738049086873	-7.33883669292601	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTTCCTCTCTCGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.61950555734	43.8679069820392	0.0174382122912981	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.94549590974	2510.94549590974
"healthy-4003"	"2020-08-26-Control4003-c3:ACGTTCCTCTTACTGT"	-1.61720881882365	8.8276042708191	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACGTTCCTCTTACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1732.2765649415	43.4716665166424	0.0250951074421019	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1726.41740354738	1726.41740354738
"healthy-4003"	"2020-08-26-Control4003-c3:ACTACGACAGTACTAC"	-3.99046311798747	10.8739223250183	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTACGACAGTACTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2245.05002404414	39.3911812195897	0.0175457922085104	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2241.48244763909	2241.48244763909
"healthy-4003"	"2020-08-26-Control4003-c3:ACTACGAGTCACCGAC"	-3.8720727962559	12.8672294386658	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTACGAGTCACCGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1943.49944690233	0	0	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1937.44760734879	1937.44760734879
"healthy-4003"	"2020-08-26-Control4003-c3:ACTACGAGTCATCCCT"	3.94542827185933	-6.97084381496581	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTACGAGTCATCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.4672297426	29.7436333675124	0.0120935270077273	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.16569926884	2452.16569926884
"healthy-4003"	"2020-08-26-Control4003-c3:ACTATCTAGGATATGT"	4.00482525405232	-7.45882751857909	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTATCTAGGATATGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.35641673243	27.9583345035257	0.0116040675050654	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2402.76941922414	2402.76941922414
"healthy-4003"	"2020-08-26-Control4003-c3:ACTATGGAGGAATGTT"	5.14076818999593	-10.156671547052	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTATGGAGGAATGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.30476863677	44.6836435752516	0.0231725006866218	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1926.59782797581	1926.59782797581
"healthy-4003"	"2020-08-26-Control4003-c3:ACTATGGCATGGCTGC"	3.52050842818562	-6.58080580150756	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTATGGCATGGCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.42955153976	13.0327143942054	0.00608030918713571	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2139.25719172161	2139.25719172161
"healthy-4003"	"2020-08-26-Control4003-c3:ACTATTCCACTCAGAT"	-3.99040208283122	13.1391238936218	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTATTCCACTCAGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1926.99796398322	45.4099583772989	0.02356513043918	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1919.00665106816	1919.00665106816
"healthy-4003"	"2020-08-26-Control4003-c3:ACTATTCTCCACACAA"	-1.56076405468639	8.57038972461549	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTATTCTCCACACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.64665199825	31.3578095205144	0.0160591315834968	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.92831595053	1950.92831595053
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCCCAAGTTCCATG"	-4.01588235321696	12.6587552794251	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCCCAAGTTCCATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2434.11081954868	37.2373863819726	0.0152981475136276	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2419.72273205887	2419.72273205887
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCCCACATGGAAGC"	4.15260090407674	-6.95038988506468	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCCCACATGGAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.85169113857	33.0015317424063	0.0138612295193508	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.86927505333	2376.86927505333
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCCCACATTGTAGC"	4.6527906852657	-7.38910152828368	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCCCACATTGTAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.43568804693	26.619338987806	0.010400471913447	1813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2552.03265166013	2552.03265166013
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCCCATCCCAGCGA"	5.09469856795613	-8.72245600139769	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCCCATCCCAGCGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.76832835266	23.3989024282167	0.0102278286390412	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2282.72715126074	2282.72715126074
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCTCGGTCGCATCG"	4.12052025374715	-8.06062700664672	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCTCGGTCGCATCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1768.4981966816	8.83736507651721	0.0049971015481382	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1762.74244612722	1762.74244612722
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCTCGGTCTCACAA"	-3.44726572457011	-5.41801836406859	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCTCGGTCTCACAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1909.13015609721	17.6156008585414	0.00922702980846133	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1905.44954363278	1905.44954363278
"healthy-4003"	"2020-08-26-Control4003-c3:ACTCTCGTCTATTGTC"	5.52026333388631	-9.90166857158812	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTCTCGTCTATTGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2371.90340146615	40.4402348314238	0.017049697220564	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.51203341296	2361.51203341296
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGATGCAGTATTCG"	0.0392905809799254	8.14081952655641	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGATGCAGTATTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1568.42746830395	33.7314204509048	0.0215065223815424	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1560.85193847926	1560.85193847926
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGATGTCGGCTCTT"	5.29993977126424	-9.19033815776976	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGATGTCGGCTCTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.04828739458	22.7150423853196	0.010090873000157	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2246.54303316188	2246.54303316188
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGCAAAGTGCTAGG"	-2.4440909427708	8.82746026599733	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGCAAAGTGCTAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1721.98898654201	39.9074260855451	0.0231751924068253	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1719.90044733783	1719.90044733783
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGCAACACCATTCC"	6.78794493254964	-1.71906711971434	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGCAACACCATTCC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3098.93380653364	0	0	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3088.07246320086	3088.07246320086
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGCAACAGGCTTGC"	-0.613594154745895	8.12020299518434	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGCAACAGGCTTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.19458657728	42.2057936236237	0.0231493631751384	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.3582968621	1816.3582968621
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTCCTCTGTTCAT"	10.3598677116329	6.67636106098024	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTCCTCTGTTCAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1618.74288433798	28.6207964336771	0.0176808786068469	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1615.21332719307	1615.21332719307
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTGAAGCCTCAGC"	10.7623764472896	7.41552255237428	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTGAAGCCTCAGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2021.00812973552	31.5407549620536	0.0156064463561466	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2017.50043411216	2017.50043411216
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTGAAGGTTGGAC"	10.5451733070308	6.19064519489137	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTGAAGGTTGGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.80318552378	22.1999929041658	0.0131453997093691	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1681.93108045754	1681.93108045754
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTGACAAAGGAGA"	3.88391151007954	-7.17629434978636	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTGACAAAGGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.94076981556	39.0540177908468	0.0184222211992483	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2115.1254132855	2115.1254132855
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTGAGTTACGTAC"	4.83577646788899	-7.7892956963745	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTGAGTTACGTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.88715692383	3.02877005454945	0.00122976403772084	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2456.61140594416	2456.61140594416
"healthy-4003"	"2020-08-26-Control4003-c3:ACTGTGATCACCTCAC"	5.43766893920247	-10.0760412446228	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTGTGATCACCTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.24405473099	38.1989492559371	0.0184782000792393	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.40810816643	2062.40810816643
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTAGGGTCGCGGTT"	3.5858231979305	-6.91418650066527	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTAGGGTCGCGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.16435693866	26.2019168400066	0.0119470831071597	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2190.07869824379	2190.07869824379
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTAGGGTTTGACAC"	5.66445841368977	-10.0338306657043	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTAGGGTTTGACAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.90646465066	24.0610076096997	0.0106657824633814	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2247.90764571078	2247.90764571078
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTATCAGCATCAAA"	-3.60386476936992	11.8442563780579	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTATCAGCATCAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1970.09351037593	38.1524915090623	0.0193658277173768	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1961.96370772266	1961.96370772266
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTATCGTCAGGTGA"	6.71017994460408	-1.52539017116698	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTATCGTCAGGTGA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1989.73023855954	37.6288656270882	0.0189115413224707	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1985.5632510026	1985.5632510026
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTCCGCACCCAATA"	4.58358587798421	-7.63899233257445	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTCCGCACCCAATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2506.06069407322	6.12147281558723	0.00244266742224735	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.85006991038	2500.85006991038
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTCCGGTGGTAACG"	3.89566721495931	-6.51564075863036	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTCCGGTGGTAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.51959502558	30.0026355870361	0.0115817057105641	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.84879396867	2586.84879396867
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTCCGTCGTCGATA"	-0.83142981949504	8.63377473438112	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTCCGTCGTCGATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.68226783419	50.2230760750601	0.0265915961251929	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.20705104961	1882.20705104961
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTCGCAGGTTGCCC"	-7.81620297852214	-0.204737626668535	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTCGCAGGTTGCCC"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2818.72666826152	27.7486128510099	0.00984437872726558	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2809.69584377609	2809.69584377609
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTCGCAGTGGTTAA"	10.512356420129	6.52687881076661	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTCGCAGTGGTTAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1766.05350287543	32.7334667211729	0.0185348103372165	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1752.22824504397	1752.22824504397
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTTCAAGTAGAGTT"	-3.93304572525676	13.0757741698059	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTTCAAGTAGAGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2032.65965355714	41.0032890824875	0.0201722354309202	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2030.7873172123	2030.7873172123
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTTCACAATTGCCA"	4.35393156585042	-6.60948231136473	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTTCACAATTGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.9309727517	19.7426638385134	0.00877478646127875	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2249.9309727517	2249.9309727517
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTTGTGTTGGTACT"	5.34943022307698	-10.3071794739929	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTTGTGTTGGTACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.56099429974	20.3990940836058	0.00972051521924561	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2093.16024206462	2093.16024206462
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTTGTTCGCTACAA"	0.68348910388295	8.50901315296022	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTTGTTCGCTACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1627.56461566472	43.3630474780879	0.0266429037967121	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1623.99930502531	1623.99930502531
"healthy-4003"	"2020-08-26-Control4003-c3:ACTTTGTTCGGAGTGA"	5.25183357772176	-10.2847624055115	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ACTTTGTTCGGAGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.22142376229	38.9201216461034	0.0183652926540388	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.69499954635	2114.69499954635
"healthy-4003"	"2020-08-26-Control4003-c3:AGAAATGCAAGCGAAC"	2.90990795668904	-3.92314078724059	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAAATGCAAGCGAAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2487.14154375371	37.137417288597	0.0149317667029708	1979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2482.6513948198	2482.6513948198
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACAAAGTATGAGT"	-0.822749237448531	8.56128690326539	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACAAAGTATGAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2082.4143593077	25.7294345565076	0.0123555787259656	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2077.6775643429	2077.6775643429
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACAAGTCGATTCA"	-0.138717914850074	8.38710973346559	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACAAGTCGATTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.98987915213	28.8381665669092	0.0163854161370529	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1754.43072064977	1754.43072064977
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACAATCGTTCCCA"	4.87679161605184	-8.36882212078246	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACAATCGTTCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.24339064021	32.6451564163992	0.0152530112038491	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2135.76728741087	2135.76728741087
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACCTAGCTGAGTG"	5.62927784499471	-9.95179941570433	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACCTAGCTGAGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.06649215527	39.9133287412721	0.0153923275249674	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.98884579466	2586.98884579466
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACCTGTATTTCCT"	1.98857345160787	-6.58986713802489	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACCTGTATTTCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1772.83198697358	34.7095511567635	0.019578590307374	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1769.51243101146	1769.51243101146
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACCTTCCTGTTGC"	-2.33661804619487	9.04742715442506	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACCTTCCTGTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2118.9602969223	29.5523091779363	0.0139466082591825	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2115.46695276323	2115.46695276323
"healthy-4003"	"2020-08-26-Control4003-c3:AGAACCTTCGGACCAC"	4.10995115813558	-7.07894899761351	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAACCTTCGGACCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.38732204199	20.5620837991317	0.00955315225496882	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2149.57748081891	2149.57748081891
"healthy-4003"	"2020-08-26-Control4003-c3:AGAAGCGTCCAGGACC"	-0.0827547264402688	8.91337392413942	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAAGCGTCCAGGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.29261189123	27.1659696872392	0.0151825193412751	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1780.65201304903	1780.65201304903
"healthy-4003"	"2020-08-26-Control4003-c3:AGAAGTAGTTAATGAG"	-4.42850194397624	12.9448995360169	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAAGTAGTTAATGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1986.06428076937	3.47740082614135	0.00175090044154777	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1977.00055311601	1977.00055311601
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAAACAAGACAAT"	5.63553871688191	-9.66457083141478	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAAACAAGACAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.13260680493	49.8218069213119	0.018906755125967	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2630.40515974737	2630.40515974737
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAAACACTTTATC"	3.90833057936971	-7.15251209652098	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAAACACTTTATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.73662651937	36.5016962231249	0.017211800733141	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2116.14496800285	2116.14496800285
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAAAGTCGCTTGG"	3.62199630317037	-7.79466535961302	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAAAGTCGCTTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.52759105809	35.8545314956085	0.0185339985127831	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1934.52759105809	1934.52759105809
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAAATCGCCAGTG"	-0.196838493377525	8.47534272754518	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAAATCGCCAGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1967.88894871844	26.4494972217533	0.0134405436033259	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1960.21729636257	1960.21729636257
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAAATCTCTTCAA"	4.22454084929768	-7.53765346920165	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAAATCTCTTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.17458170956	41.4307646178595	0.0194677471359414	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2125.6453745868	2125.6453745868
"healthy-4003"	"2020-08-26-Control4003-c3:AGACACTAGAATAACC"	5.31370606002156	-10.2624893418518	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACACTAGAATAACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.648950327	43.8433205558901	0.0215166211769962	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2025.88194639893	2025.88194639893
"healthy-4003"	"2020-08-26-Control4003-c3:AGACACTCAGACCGCT"	3.93257059630696	-6.89621689235839	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACACTCAGACCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.90005774524	29.8204764751432	0.0121177113151298	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.5762647012	2449.5762647012
"healthy-4003"	"2020-08-26-Control4003-c3:AGACACTCATGACACT"	4.93276133117024	-8.04341032421263	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACACTCATGACACT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.4592171394	32.7731887938103	0.0139137152345231	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.89009076165	2349.89009076165
"healthy-4003"	"2020-08-26-Control4003-c3:AGACACTGTGCATTAC"	-2.98677144470866	-5.73144771968993	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACACTGTGCATTAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2081.38775598627	38.9402826202548	0.0187088073850049	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2077.61008038306	2077.61008038306
"healthy-4003"	"2020-08-26-Control4003-c3:AGACACTTCGCCAGAC"	-0.725762526423293	8.72185800159303	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACACTTCGCCAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.67833959633	26.6766132223011	0.0151858269217523	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1751.70474892369	1751.70474892369
"healthy-4003"	"2020-08-26-Control4003-c3:AGACAGGTCTCGCTCA"	5.43155922469441	-10.012836479303	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACAGGTCTCGCTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.06006139894	35.873852416667	0.0136867723654986	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2616.16658488542	2616.16658488542
"healthy-4003"	"2020-08-26-Control4003-c3:AGACCATGTATGTCTG"	-1.8312637609547	9.20228478992311	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACCATGTATGTCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.02631670914	35.7771498751883	0.0197770201266456	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1805.12181162963	1805.12181162963
"healthy-4003"	"2020-08-26-Control4003-c3:AGACCCGAGGGCTTCC"	-0.284564535052139	8.42162225330202	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACCCGAGGGCTTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1987.44070431058	21.8937665630099	0.0110160602605775	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1981.80557954278	1981.80557954278
"healthy-4003"	"2020-08-26-Control4003-c3:AGACCCGGTAGGTGCA"	-1.84316037121471	9.05572030628053	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACCCGGTAGGTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.84711193078	18.7890241854961	0.00922909391151516	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2028.637076511	2028.637076511
"healthy-4003"	"2020-08-26-Control4003-c3:AGACCCGTCAGTGATC"	-0.82350585880931	8.47090528095094	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACCCGTCAGTGATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1548.78754109993	9.48229946208492	0.00612240169193942	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1543.45047820069	1543.45047820069
"healthy-4003"	"2020-08-26-Control4003-c3:AGACTCACAGCTATTG"	-4.30681691590007	12.5665921934876	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACTCACAGCTATTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1991.41255009817	36.4722485702813	0.0183147628393139	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1985.36980466751	1985.36980466751
"healthy-4003"	"2020-08-26-Control4003-c3:AGACTCAGTCGCTTAA"	4.93370928344075	-8.48091699993285	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACTCAGTCGCTTAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.3995388494	37.914235161461	0.0171915494193137	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.03788720542	2199.03788720542
"healthy-4003"	"2020-08-26-Control4003-c3:AGACTCAGTTACGTAC"	3.17423214492146	-5.26958801662596	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGACTCAGTTACGTAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2462.69893289965	32.6489366673414	0.013257380441912	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2460.70952941607	2460.70952941607
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGAATGTACAATAG"	5.40903486785237	-9.98310663616332	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGAATGTACAATAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1965.60387485362	33.6870931558572	0.0171382919960747	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1958.63479803599	1958.63479803599
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGAATGTGCAACGA"	-5.57816014710124	-5.50190212642821	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGAATGTGCAACGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2518.72013649329	31.1728150628695	0.0123764504881714	1713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2517.59706439574	2517.59706439574
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGAATTCGTTGTTT"	5.37863745269124	-9.73618605053099	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGAATTCGTTGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.85063236284	36.6005491262796	0.015555831986463	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.94139925596	2347.94139925596
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGCAGAGTAAAGCT"	5.41046251830403	-10.1553983918396	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGCAGAGTAAAGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1817.89477006517	17.9205297533981	0.00985784768650587	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1815.73550558944	1815.73550558944
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGCAGAGTGGAAGA"	0.955872495740098	-6.8781194916931	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGCAGAGTGGAAGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1502.58645964373	31.3182092328904	0.0208428666662656	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1495.9989753835	1495.9989753835
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGCAGCACTGCACG"	-2.82109771195109	9.45606801593629	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGCAGCACTGCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1918.28188344383	32.6564206496159	0.0170237861971511	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1913.05858926309	1913.05858926309
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGCAGGTCATAACC"	5.58426298674886	-9.83036520397338	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGCAGGTCATAACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.86686005245	13.2769546451664	0.00602439053185382	1196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.38477947448	2202.38477947448
"healthy-4003"	"2020-08-26-Control4003-c3:AGAGCAGTCATAGAGA"	3.60219230231587	-7.05388357555541	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGAGCAGTCATAGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.02200804906	28.7370959393992	0.0132184015768946	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.44512594006	2169.44512594006
"healthy-4003"	"2020-08-26-Control4003-c3:AGATAGAAGCCTTTCC"	2.56331266936604	-4.41178991710814	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATAGAAGCCTTTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2525.67416911313	30.4594008791909	0.0120599090934547	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2519.91890458915	2519.91890458915
"healthy-4003"	"2020-08-26-Control4003-c3:AGATAGAAGCGGTAAC"	11.2181164222652	4.93365237796632	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATAGAAGCGGTAAC"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1606.59827641751	42.1568333562095	0.0262398098983483	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1600.22914148927	1600.22914148927
"healthy-4003"	"2020-08-26-Control4003-c3:AGATAGACAGTAACAA"	5.32153334197347	-10.3069467774597	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATAGACAGTAACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.37002686196	46.1304015436835	0.0205997226855475	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2227.08274553508	2227.08274553508
"healthy-4003"	"2020-08-26-Control4003-c3:AGATAGACATTGAAAG"	5.10411800917928	-10.2906952134338	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATAGACATTGAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1424.13188250348	44.155386755519	0.0310051248048027	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1424.13188250348	1424.13188250348
"healthy-4003"	"2020-08-26-Control4003-c3:AGATAGATCATGAGAA"	-4.80904899063762	8.69130990588991	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATAGATCATGAGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2551.14333001708	31.6392381283968	0.0124019837521967	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2548.32585087165	2548.32585087165
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCAAGGCAGGGA"	3.70626701888387	-5.80426838314208	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCAAGGCAGGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2525.30310460384	6.03314856994592	0.00238907898182479	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2518.75892483043	2518.75892483043
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCAAGGGCTGAT"	2.41615833815877	-3.98768141185912	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCAAGGGCTGAT"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2512.47638158443	12.5522641849823	0.0049959730077409	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2509.84642723086	2509.84642723086
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCAAGTCGAAGC"	-2.32895884934123	9.30025003040162	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCAAGTCGAAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2116.88386311086	34.8183045551568	0.0164479049426876	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2116.88386311086	2116.88386311086
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCAAGTGCACAG"	0.547781934111756	8.87719533527223	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCAAGTGCACAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1371.44028417651	42.7724450816772	0.0311879748430754	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1369.14145679285	1369.14145679285
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCACATCGGTTA"	3.74477018889729	-7.34342338955077	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCACATCGGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.57073404528	13.9118910879854	0.00607089752077035	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.39552569198	2285.39552569198
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCACATTCTGTT"	-0.763350884348708	8.21253583515016	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCACATTCTGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.14541271692	39.2249082770547	0.0208626992421678	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.96878659816	1872.96878659816
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCCATCGCTTTAT"	-0.430718610913116	8.5864162215027	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCCATCGCTTTAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1791.00797276354	36.9200741512608	0.0206141316581036	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.2560674292	1787.2560674292
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCGTCACCAGTTA"	3.81121387061421	-6.91288807308348	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCGTCACCAGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.45433829346	28.4872174088345	0.0143047303978087	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1991.45433829346	1991.45433829346
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCGTTCTCCGAGG"	-4.18616328659709	13.1506128081116	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCGTTCTCCGAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1853.52573852523	32.569703510802	0.0175717568058787	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1842.98466444731	1842.98466444731
"healthy-4003"	"2020-08-26-Control4003-c3:AGATCGTTCTGTGCGG"	-1.9682174724644	9.84492299640504	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATCGTTCTGTGCGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1780.04965262574	33.6299005380368	0.0188926755433083	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1768.34426579699	1768.34426579699
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGAAAGAGTCTTC"	10.127066274255	6.67889926517335	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGAAAGAGTCTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1600.3434878856	31.7696357972031	0.019851760598706	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1592.12384660052	1592.12384660052
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGAAAGCATTGAA"	0.0457925941677808	8.16281888568727	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGAAAGCATTGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.75577982647	30.1904616824464	0.0171853492836828	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1743.22381508558	1743.22381508558
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGAACACAAGGTG"	11.1514126258785	5.92496202075807	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGAACACAAGGTG"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1854.05190083013	26.8021628127619	0.0144559938159021	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1848.51721482951	1848.51721482951
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGAATCTGAGTCA"	5.50111307677571	-10.1314735642639	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGAATCTGAGTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.75547447817	42.7237126480653	0.0205130718279685	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.75547447817	2082.75547447817
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGCTAGACCTGGA"	-4.3188980621403	12.9279269942078	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGCTAGACCTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1790.74370691702	21.1550574933489	0.0118135595907076	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1784.82880120886	1784.82880120886
"healthy-4003"	"2020-08-26-Control4003-c3:AGATGCTAGCGGGTTA"	-3.48927197876628	13.3583040007385	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGATGCTAGCGGGTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2090.19988559845	37.8705245287148	0.0181181353944396	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2084.40035218349	2084.40035218349
"healthy-4003"	"2020-08-26-Control4003-c3:AGCATCAAGGCTAACG"	-3.84333119812663	9.83617684924928	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCATCAAGGCTAACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2431.70943707332	7.99867620785105	0.00328932235319934	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2422.83599046771	2422.83599046771
"healthy-4003"	"2020-08-26-Control4003-c3:AGCATCATCCGGTTCT"	5.51696648177449	-9.96679403698119	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCATCATCCGGTTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.4785560966	2.5276449157087	0.0013763541683172	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1830.67842674483	1830.67842674483
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCAATGTACAGTTC"	-0.990231971175033	8.65412042224733	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCAATGTACAGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.82292544751	38.9084195970141	0.0208980236870066	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.61467332323	1851.61467332323
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCACGTCACCTCAC"	-0.540986279875594	8.35591027820436	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCACGTCACCTCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2177.89438323929	29.9147127589727	0.0137356122451076	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2168.86459738972	2168.86459738972
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCACGTCCTAGCTC"	0.533991356461686	8.90438745105592	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCACGTCCTAGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.13150364839	35.6490839235407	0.0185177396224522	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1914.97107067666	1914.97107067666
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCACGTCTGTAACG"	4.15541138228719	-7.42856314098509	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCACGTCTGTAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.96789611409	38.5691323067251	0.0184455879874593	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2088.48025997679	2088.48025997679
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCAGCAGCTGGCTC"	5.3587814765865	-10.2686348191467	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCAGCAGCTGGCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.18958738036	29.1197458991251	0.014543950324517	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1996.51603188863	1996.51603188863
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCAGCAGGAACATT"	-1.88426087322887	8.68482873523561	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCAGCAGGAACATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2401.18294211	25.8143710236693	0.0107506889920621	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2395.93272240364	2395.93272240364
"healthy-4003"	"2020-08-26-Control4003-c3:AGCCAGCGTTATCCAG"	-0.00527087125237587	8.22942636096803	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCCAGCGTTATCCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.46537187538	33.9868004374362	0.019415865622651	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1742.19162582136	1742.19162582136
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGATTAGCAATTAG"	3.61970915374104	-7.4697566262451	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGATTAGCAATTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.40067156104	30.3846188997831	0.0128291717126377	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2364.69430007574	2364.69430007574
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGATTCACGTAGAG"	5.35390629348103	-10.1648121110168	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGATTCACGTAGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.43744087122	40.5630603204431	0.0166212252119695	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2431.89761315551	2431.89761315551
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGATTCAGTTCACA"	5.64137329634969	-10.001322769281	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGATTCAGTTCACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3141.32130958275	27.4216901027757	0.00872934902237618	3116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3127.1411386358	3127.1411386358
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGATTTCGCAGAGA"	0.216651980846566	8.53129670703737	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGATTTCGCAGAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1641.41303470404	39.1877451341	0.0238743962095841	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1633.97923141626	1633.97923141626
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCCAAGCACTCAT"	5.247087140649	-8.79691412365111	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCCAAGCACTCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.1542049632	23.103632417803	0.00934932849249167	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2463.26855580411	2463.26855580411
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCCAGTACTGCCG"	-2.65001998367961	9.87195966327516	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCCAGTACTGCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.62306240174	21.6856580273297	0.0115556812989264	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1869.27519862152	1869.27519862152
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCCAGTCATTGCA"	4.37913622435872	-7.09542658245238	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCCAGTCATTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.6057445573	35.8468928834116	0.0160202005963761	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.71878422446	2232.71878422446
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCCAGTCTCTCAC"	-1.84423635426219	9.2684640654358	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCCAGTCTCTCAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1964.33068972397	30.8303170416911	0.0156950747666745	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1955.80706432663	1955.80706432663
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCTGAGTAAGACT"	-4.57301888886149	3.47017572009889	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCTGAGTAAGACT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2547.11334706733	41.1759151501526	0.0161657176338703	2543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2538.35939552104	2538.35939552104
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGCTGCAGATTAAG"	2.67843546447102	-4.38247063076171	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGCTGCAGATTAAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2501.26306695355	30.4065825573852	0.0121564912380125	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2498.51356615845	2498.51356615845
"healthy-4003"	"2020-08-26-Control4003-c3:AGCGTATGTAGACACG"	0.523024966090363	8.44514367664186	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCGTATGTAGACACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1491.42414155235	31.7185127720237	0.0212672652187387	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1489.5783603888	1489.5783603888
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTACAAGAAGTCCG"	-0.0157240507310212	8.34905526721803	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTACAAGAAGTCCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1683.26707334789	38.5646588049181	0.0229106001154148	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1676.50102962647	1676.50102962647
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTACATCCACGTGG"	5.50180019912068	-10.1690511933533	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTACATCCACGTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.5928501544	32.8540843613068	0.0118709962556356	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2762.74909857016	2762.74909857016
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTCAAAGAGTGTTA"	4.20217527922933	-7.37901832973631	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTCAAAGAGTGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.84338083833	30.517095109757	0.0139804327592375	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2178.47439669435	2178.47439669435
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTCAATCTAGAGCT"	3.02812923964803	-6.4025712243286	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTCAATCTAGAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.51221892464	27.0053670826464	0.0116276533929929	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.21286639549	2318.21286639549
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTCAATCTCTCTTC"	0.040312709368211	8.62600228870241	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTCAATCTCTCTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2086.65939322744	16.7097424337812	0.00800789169905501	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2077.58365429182	2077.58365429182
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTTCCAGCGAAACC"	1.86762561377828	-6.1724252930847	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTTCCAGCGAAACC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2388.80842413083	10.4520386250073	0.00437541935947012	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2382.30415988983	2382.30415988983
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTTCCCAACGAGGT"	-7.17613015595134	3.40651938999025	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTTCCCAACGAGGT"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2517.00984994051	31.5073963895549	0.0125177882757588	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2500.45539747005	2500.45539747005
"healthy-4003"	"2020-08-26-Control4003-c3:AGCTTCCCACTGCATA"	4.10967983779256	-7.01017572796019	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGCTTCCCACTGCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2427.12651436047	35.2403955245169	0.0145193896222597	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.95127287696	2425.95127287696
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAAATAGCGCTGCT"	-7.34523139420207	-0.782862030622087	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAAATAGCGCTGCT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1938.21450185557	17.78642342339	0.00917670536793632	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1931.88902105678	1931.88902105678
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAAATCAAGGGTCA"	4.49529757079427	-6.98936750805052	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAAATCAAGGGTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2664.2343937417	33.7914428916443	0.0126833596064297	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2661.16839785495	2661.16839785495
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAAATGTTCAGTAC"	-3.69482932511027	-5.68697550213011	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAAATGTTCAGTAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1551.89308954449	43.7649239927036	0.0282009916066766	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1549.80741162913	1549.80741162913
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAATAAGGGTTAAT"	-4.66382680359538	3.61385724628297	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAATAAGGGTTAAT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2728.69207075608	27.7979043747298	0.0101872632213233	2892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2715.72392693341	2715.72392693341
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAATATCCTGCTAC"	4.33862461623494	-7.45052339946898	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAATATCCTGCTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1918.79754556824	24.2214391837817	0.0126232385692408	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1913.44089037591	1913.44089037591
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACGACAATGTTGC"	3.70112003859822	-6.82002832805785	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACGACAATGTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.33332793921	40.2769991515685	0.0157004934652777	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2559.10253593426	2559.10253593426
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACGAGTAGGCTCC"	4.22663178023641	-7.39719059383544	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACGAGTAGGCTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2084.37351269253	33.6458795869944	0.0161419627442548	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.83341351329	2080.83341351329
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACGATCCGCACTT"	5.07876314696614	-7.88343908703002	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACGATCCGCACTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.00902708614	10.5008439014292	0.00425306014932719	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2461.74123196691	2461.74123196691
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACTTAGTGGAAAG"	-3.16029367867168	10.8140983351502	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACTTAGTGGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.13130849649	23.6483725127574	0.0121890577246979	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1930.35351954385	1930.35351954385
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACTTGTCGTTATG"	5.41632093962972	-9.6765871278015	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACTTGTCGTTATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.62088850206	2.67227330921072	0.00123852773369559	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.77574670433	2154.77574670433
"healthy-4003"	"2020-08-26-Control4003-c3:AGGACTTTCACTGAAC"	-1.38022563877757	9.09924028003541	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGACTTTCACTGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2036.92544026758	40.278148650903	0.019773992633531	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2028.624257872	2028.624257872
"healthy-4003"	"2020-08-26-Control4003-c3:AGGAGGTTCCTTGGAA"	5.55405964431111	-9.98751261150511	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGAGGTTCCTTGGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.66559121564	40.1520569220582	0.0168023748049335	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2384.44771797381	2384.44771797381
"healthy-4003"	"2020-08-26-Control4003-c3:AGGATAATCATACGGT"	4.93256201323811	-8.06478693401488	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGATAATCATACGGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.77204338524	35.1065505151351	0.0143833794762922	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.5125143726	2433.5125143726
"healthy-4003"	"2020-08-26-Control4003-c3:AGGATAATCATCGACA"	-0.253424028784591	8.57284448230592	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGATAATCATCGACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.92207994067	38.9845626898189	0.0210736241880357	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1844.50451997166	1844.50451997166
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTAGAATTGCA"	4.193620343774	-6.91465666210326	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTAGAATTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.28430478361	43.7770399030202	0.0190394201412774	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2295.27821345421	2295.27821345421
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTAGCCTCTTC"	4.1971398788387	-6.95988848125609	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTAGCCTCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.25444904814	31.8237631618528	0.0140548528789382	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2258.97731912753	2258.97731912753
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTAGGGCCCTT"	3.74002732810323	-7.05282547390135	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTAGGGCCCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1850.86736583996	30.2384460318432	0.016337446210318	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1850.86736583996	1850.86736583996
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTAGTAGCCAG"	3.89421834525411	-7.33888485347899	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTAGTAGCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.23715114386	0	0	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2526.71572144774	2526.71572144774
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTCACTAGGCC"	4.94684567031209	-7.6168160668579	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTCACTAGGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2686.61199719963	0	0	1878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2682.28085727108	2682.28085727108
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCATTTCTAAGCGT"	-3.56512031975444	10.4323997267517	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCATTTCTAAGCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.79316343268	34.0386762618489	0.0188706094201355	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.78334321943	1801.78334321943
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCCACAGAGAAGGT"	-1.69511089745219	3.89867684924928	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCCACAGAGAAGGT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2423.60873726114	20.5010139203527	0.00845887935835732	2963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2419.22664756795	2419.22664756795
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCCACTCCACTTTA"	0.329674680798691	9.00596997821657	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCCACTCCACTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2037.56797955196	30.8333616964641	0.0151324333744408	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2027.3734665465	2027.3734665465
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCTGCAGCCTGGAA"	4.98220886763875	-8.54239370739134	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCTGCAGCCTGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.04261162844	23.605103167492	0.0104031114473215	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2257.40856160029	2257.40856160029
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCTGCCACTTGGGC"	10.9370523887569	6.24393174732057	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCTGCCACTTGGGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.4912255991	43.9560386096892	0.0232142816483248	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1886.70081930353	1886.70081930353
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCTGCTCGAAGGAC"	-2.30808005753215	10.2581653364929	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCTGCTCGAAGGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1463.12655108616	36.0045132627119	0.0246079282998342	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1458.36913958789	1458.36913958789
"healthy-4003"	"2020-08-26-Control4003-c3:AGGCTGCTCGGACTGC"	-3.44354949417766	10.3454656370911	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGCTGCTCGGACTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.53066776082	29.7404420055231	0.0171758101425849	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.43306785717	1729.43306785717
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGAGTAGGTTAGTA"	-4.05813441696818	10.8519401320252	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGAGTAGGTTAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2342.49635554334	25.3316923362675	0.0108139729977902	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2335.32057118863	2335.32057118863
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGAGTCAACCGTAT"	4.65561880645101	-8.05222895061644	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGAGTCAACCGTAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.84499645733	35.827990949868	0.0153580675116764	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.73271545936	2328.73271545936
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGAGTCAAGGTCTT"	-3.76407561722453	11.4275102385315	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGAGTCAAGGTCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1823.18695697299	46.9756525716366	0.0257656804706576	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1817.21011858432	1817.21011858432
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTAGACCATAA"	-3.05741701546367	10.4437265166077	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTAGACCATAA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2018.0524625769	24.2070319684032	0.0119952441362662	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2011.16503489789	2011.16503489789
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTAGATTCGAA"	-3.45421443405803	10.4572839506897	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTAGATTCGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1810.67097957146	28.3087225285854	0.0156343824184366	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1806.86003051137	1806.86003051137
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTAGCCTTGAT"	-2.19718680802043	9.48210332477418	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTAGCCTTGAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1839.0457065572	38.83035679499	0.0211144055074535	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1830.11403562555	1830.11403562555
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTCACCGGTCA"	-4.08978066864665	12.9181585081848	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTCACCGGTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1977.28682423877	35.958849162639	0.0181859549772111	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1970.87372013665	1970.87372013665
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTCACTCGATA"	4.3403455215389	-7.19424202358397	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTCACTCGATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2911.2457574203	14.5130895521797	0.00498518186422021	2152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2903.04765217005	2903.04765217005
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCCTTCTGCATGA"	10.0330130058223	5.84890983188478	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCCTTCTGCATGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1593.54659520778	41.119387390344	0.0258036931671787	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1583.53982681225	1583.53982681225
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCAGGAGGTTC"	3.95126714286153	-6.97399809276732	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCAGGAGGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.87283552171	35.393941390414	0.0157665685246659	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2237.87407041358	2237.87407041358
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCCACAAGGTG"	5.29566349562947	-9.95545198833617	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCCACAAGGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.092886505	37.0087229015201	0.017715211774731	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2077.58445848913	2077.58445848913
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCCACCGTGAC"	-5.65166554871257	3.52249000156251	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCCACCGTGAC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2617.36702000664	4.2998658428094	0.00164282112899798	2299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2606.54148448401	2606.54148448401
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCCATACTTTC"	-3.29738841477092	10.0578775175842	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCCATACTTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.10873967188	38.2413294464162	0.0189116088052819	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2015.74931420281	2015.74931420281
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCGTTTCCATT"	3.51086892661397	-7.02712442791136	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCGTTTCCATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.04690626489	0	0	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.27116065063	2425.27116065063
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGCTCTCACTGCTC"	5.33304895934407	-9.82470419323119	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGCTCTCACTGCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2686.47629748829	32.2316076393142	0.0119977264156207	1945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2680.19884104848	2680.19884104848
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGTCCAGACAGCTG"	-2.91765556755717	10.9208888777527	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGTCCAGACAGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1769.90730480109	40.4101873728056	0.0228318100406659	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1758.4656275915	1758.4656275915
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGTCCCAGTTAGGG"	4.29806484755818	-7.14476540004881	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGTCCCAGTTAGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.98279652597	7.31708907836628	0.00444002758632619	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1645.58966195052	1645.58966195052
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGTCCGTTACGATC"	-0.35980928960498	8.80756185138551	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGTCCGTTACGATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1863.3453355848	26.4916123942809	0.0142172317113546	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.22186800002	1855.22186800002
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGTGAAGTTGGGAC"	0.63293625888173	8.24688813770143	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGTGAAGTTGGGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1710.84353635042	36.1260577761139	0.0211159331689549	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1707.25345070793	1707.25345070793
"healthy-4003"	"2020-08-26-Control4003-c3:AGGGTTTTCGGCATAT"	-1.67329094830211	3.66715786540834	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGGTTTTCGGCATAT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2781.61974533485	26.1987417238992	0.00941852018696591	3936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2776.96061106134	2776.96061106134
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTAGGGTCATGGCC"	-1.18218920651134	8.57624242389528	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTAGGGTCATGGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1657.99137668963	31.0433869698678	0.018723491211305	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1652.34901028855	1652.34901028855
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTAGGGTGTTCATG"	-1.174548248679	8.30678269946901	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTAGGGTGTTCATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2850.76104226095	32.7149732640046	0.0114758735576301	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2835.6651970843	2835.6651970843
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTCATGTTGTTGAC"	10.2755619483883	7.28766486728517	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTCATGTTGTTGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1738.04924139998	31.021709150195	0.0178485789765124	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1732.32569736012	1732.32569736012
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTCTATCGGCATCG"	9.80344166335408	7.18808314884035	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTCTATCGGCATCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1647.55302088661	26.1134329101373	0.0158498285512442	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1644.10850395609	1644.10850395609
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTGTTAGCCAGACA"	5.38634790953938	-9.80651571666869	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTGTTAGCCAGACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.15621015888	35.0528096650381	0.0163862786170416	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2131.28649821902	2131.28649821902
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTGTTGTCATTCCC"	2.63491906699483	-4.370068573114	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTGTTGTCATTCCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2448.42572559379	27.4803223867933	0.0112236700094829	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2437.82527956879	2437.82527956879
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTTACCAAATTGCC"	5.61895336684529	-9.99025633251341	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTTACCAAATTGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.15594199708	33.8353722332707	0.0140444923649163	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2404.4022033241	2404.4022033241
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTTGTGTCCTATAG"	-1.10054789009746	8.52685926044313	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTTGTGTCCTATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1790.91550601627	34.1188771293342	0.0190510814243987	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.47790173999	1787.47790173999
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTTGTTCGTTTACT"	-0.417553643614608	8.86896512592164	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTTGTTCGTTTACT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1728.37666078887	27.3009975329843	0.0157957453096615	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.86036828478	1717.86036828478
"healthy-4003"	"2020-08-26-Control4003-c3:AGGTTGTTCTCCAATT"	-3.41332183304484	10.6980914839539	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGGTTGTTCTCCAATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1603.58158665525	36.2557742114456	0.0226092482684763	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1596.88307306696	1596.88307306696
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAACCCAAGATTGA"	4.23584999617879	-8.43962576305541	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAACCCAAGATTGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2919.27056162712	27.9037572188006	0.00955846901811245	2432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2914.35268207646	2914.35268207646
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAACCGTACTGACT"	5.56206097182576	-9.52363684093627	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAACCGTACTGACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.30414076036	5.64560828993329	0.00216613564074922	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2596.2968898652	2596.2968898652
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAACCTCTCTATAC"	-2.13458834114726	9.28444860065309	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAACCTCTCTATAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.56811110091	40.8938456326566	0.0205026067573521	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1977.64102087481	1977.64102087481
"healthy-4003"	"2020-08-26-Control4003-c3:AGTACCATCGTCAGAT"	-2.63768825951274	10.0616349943909	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTACCATCGTCAGAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1918.75355902985	34.8309959273279	0.0181529283755121	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1907.99977332562	1907.99977332562
"healthy-4003"	"2020-08-26-Control4003-c3:AGTACTGCAATTTCTC"	-3.50827894631084	-5.60801842128905	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTACTGCAATTTCTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2377.41130194484	41.2549309638648	0.0173528791295457	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2370.56670042425	2370.56670042425
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTAGACTTAAG"	-1.32613692703899	9.47614095294801	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTAGACTTAAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1955.42188025448	38.5446769111725	0.0197116935738472	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1943.25454639173	1943.25454639173
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTAGTCTCGTA"	9.05505432662312	6.1378602751526	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTAGTCTCGTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1751.70990574998	37.9637271428583	0.0216723825207829	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1747.77676986728	1747.77676986728
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTGTACGAGCA"	-4.12472091141399	12.8751287230286	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTGTACGAGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1968.52117552981	31.6473987139668	0.0160767377599833	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1964.34049088473	1964.34049088473
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTGTCTTTATC"	0.465144683688325	8.25288770282594	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTGTCTTTATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1317.64273400153	7.50199883389745	0.00569349994525052	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1315.60691508744	1315.60691508744
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTTCGATGCTA"	4.36120142516438	-7.82701876079711	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTTCGATGCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1906.67393951614	2.14870821843091	0.00112694057116876	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1906.67393951614	1906.67393951614
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGCTTCGCGGTAC"	-0.396311889321166	7.84381864154664	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGCTTCGCGGTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1863.38023038944	37.4574300915129	0.0201018715775923	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.44509558003	1855.44509558003
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCAGTTGGAAT"	-3.20247302475627	10.0927695997986	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCAGTTGGAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2234.81486900822	33.1122139703224	0.0148165355571565	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2230.75828955705	2230.75828955705
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCCAACAAGAT"	-4.43835292282756	12.9711942442688	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCCAACAAGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1983.25640819226	29.2229672769076	0.0147348407176178	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1975.29451074829	1975.29451074829
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCCAGCACAAG"	3.71955647048299	-7.66365530407103	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCCAGCACAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.40241421985	33.4103144687587	0.0150945504776341	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2210.11162432089	2210.11162432089
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCGTTGTGCCG"	4.1432019668514	-7.24737217342528	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCGTTGTGCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.53157022566	2.9877438845111	0.00136455848599761	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2186.68574525549	2186.68574525549
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCTCAATCCGA"	4.08622660216634	-7.28211691295775	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCTCAATCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2056.8428989511	11.2731810293416	0.00548081773045982	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2056.8428989511	2056.8428989511
"healthy-4003"	"2020-08-26-Control4003-c3:AGTAGTCTCTTCGATT"	3.75243463095967	-6.47268202221068	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTAGTCTCTTCGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.54516518299	6.49848166048523	0.00315376812422752	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2053.93753664056	2053.93753664056
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCAACAGTCGGCAA"	-2.80233369293864	10.0893773802551	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCAACAGTCGGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1545.92566217247	31.157525778825	0.0201546080391987	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1543.56660449157	1543.56660449157
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCACAAGTGATGGC"	4.18241324004476	-7.08217623150023	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCACAAGTGATGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.91712894605	0	0	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2294.69824732383	2294.69824732383
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCACAGTCAAATCC"	4.94152226027791	-7.774290107843	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCACAGTCAAATCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2870.69381226183	21.6160052465681	0.00752988882138451	2231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2861.59538215825	2861.59538215825
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCATGCACGGTAGA"	-3.82546625557597	12.9868840941223	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCATGCACGGTAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1745.44019840054	33.5180765133629	0.0192032225131962	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1741.00645148195	1741.00645148195
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCATGTCATGTCTT"	5.50010408934895	-9.49201013958129	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCATGTCATGTCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.77753628236	45.6041911039053	0.0185852997794571	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.41067968731	2449.41067968731
"healthy-4003"	"2020-08-26-Control4003-c3:AGTCATGTCGTCCTTG"	-2.89366779747661	9.92588040912477	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTCATGTCGTCCTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1757.83185347843	20.4109022044427	0.0116114076349529	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1744.24439179447	1744.24439179447
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTAGGCTTCCG"	-2.27520523491557	9.14496705615846	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTAGGCTTCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1724.35823796045	8.91033188644974	0.00516733222267594	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1722.21070171621	1722.21070171621
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTCACGGTGAA"	-3.13363514366801	-5.68953516399535	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTCACGGTGAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1887.9029747067	11.2025315351656	0.00593384918888958	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1884.59518430068	1884.59518430068
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTCAGGCGATA"	5.57141794738118	-9.67426588451537	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTCAGGCGATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.8916488323	28.7237703218916	0.010851887471315	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2639.52059328517	2639.52059328517
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTCAGTTGGTT"	3.82868160781209	-6.55445434963378	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTCAGTTGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.84033175774	31.3755450168964	0.0136543625696114	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2293.54899707999	2293.54899707999
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTTCAGATTGC"	0.802669842808884	8.65004537189332	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTTCAGATTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1513.47243474302	20.5618604004645	0.013585883646408	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1508.47044042728	1508.47044042728
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGACTTCTATGCCC"	-3.12445054474528	9.9192905195984	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGACTTCTATGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.47602626823	47.0966960405234	0.0235899131373771	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1989.80315258514	1989.80315258514
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCAGACGAGCT"	0.322844524949235	8.51315209949342	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCAGACGAGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1500.3507708203	20.5952598630497	0.0137269632299315	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1495.84538989651	1495.84538989651
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCAGTCGTCTA"	4.12765659865682	-7.8657436600891	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCAGTCGTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.35285611812	23.9627820356153	0.0116757612923049	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.06386677188	2049.06386677188
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCCACATTCGA"	-4.35231385651286	12.8337793120178	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCCACATTCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1802.8079090037	41.0155162335954	0.0227509076417698	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1799.38557679186	1799.38557679186
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCGTTAGGAGC"	6.74612917479817	-1.72264900123747	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCGTTAGGAGC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2673.71750794689	14.7707473687043	0.00552442332624979	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2661.37665807318	2661.37665807318
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCGTTCTTAGG"	4.18858971175496	-7.69476511394652	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCGTTCTTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2061.07254253158	18.1906447204249	0.00882581488280932	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2057.52721776616	2057.52721776616
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGATCTCACAGTGT"	10.1706520515377	7.51030490482179	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGATCTCACAGTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1802.19496618524	37.0006647574095	0.0205308889724234	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1796.44831296865	1796.44831296865
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGCCGGTATCGAGG"	3.99567617949788	-7.61801483547362	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGCCGGTATCGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.80700948226	13.2626767469572	0.00587934902729164	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2251.24964653977	2251.24964653977
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGTTGAGGTACATA"	10.4061562019283	6.57831428134767	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGTTGAGGTACATA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1759.73086765429	41.7042126714221	0.0236991993707615	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1751.59563767769	1751.59563767769
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGTTGCAAGCTGTT"	-0.644091467291671	8.42995736682741	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGTTGCAAGCTGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.80718016289	43.3631280554589	0.025676778595456	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.33313846121	1685.33313846121
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGTTGGTAGCTAAA"	-4.19250951233562	12.9038429030213	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGTTGGTAGCTAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1944.30047604466	39.1575727842819	0.0201396714482842	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1942.34378291609	1942.34378291609
"healthy-4003"	"2020-08-26-Control4003-c3:AGTGTTGGTGCAACGA"	-0.264322410256225	8.38837812030641	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTGTTGGTGCAACGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1678.38669976614	36.0763986149348	0.0214946880953963	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1670.36389785119	1670.36389785119
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTAGCGTTTGTTCT"	-0.321883181959945	8.20243070209352	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTAGCGTTTGTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.9161174945	29.9572668814603	0.0171486579014602	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.08744357558	1745.08744357558
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCCCCAAGTACCT"	-1.90696106377299	9.48572824085084	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCCCCAAGTACCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1558.17637531528	39.3627262692304	0.0252620479252651	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1550.91769831919	1550.91769831919
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCCCCACTGCACG"	4.25680508193318	-7.41550400173339	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCCCCACTGCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2023.03702682796	22.2396897874972	0.0109932193492119	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2017.62660819455	2017.62660819455
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCCCGTATGCTTG"	-1.87513075295146	9.2824611433777	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCCCGTATGCTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1764.75883086651	31.8409495052738	0.0180426633647384	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1757.30320338589	1757.30320338589
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCCCTCCCATAGA"	-3.98856387558635	12.5501260527405	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCCCTCCCATAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1913.28877398251	29.9522254252849	0.0156548378021052	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1904.92860440808	1904.92860440808
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCGAAGGACACTG"	-4.08985600891765	11.1170825728211	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCGAAGGACACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.596027075	37.9997302731789	0.0194511709414528	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1951.74820952631	1951.74820952631
"healthy-4003"	"2020-08-26-Control4003-c3:AGTTCGACAAAGGCTG"	-3.174796919257	9.83465955341188	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.AGTTCGACAAAGGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.89355135627	36.2430268870955	0.0172021158182219	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2098.67908921268	2098.67908921268
"healthy-4003"	"2020-08-26-Control4003-c3:ATACCGAAGCGAGTCA"	3.89642991599385	-7.29378273403319	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACCGAAGCGAGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1710.35809829205	23.2795039735716	0.0136108946990799	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1706.85309279752	1706.85309279752
"healthy-4003"	"2020-08-26-Control4003-c3:ATACCTTAGTTTGCTG"	-2.26011357727702	9.13931844318239	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACCTTAGTTTGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.30733848757	37.0022866252878	0.0180559967411214	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2037.3222582492	2037.3222582492
"healthy-4003"	"2020-08-26-Control4003-c3:ATACCTTTCTCGTTTA"	-0.195957909256774	8.37493989551393	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACCTTTCTCGTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1935.45698209654	24.8853493526151	0.0128576091242589	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1925.65018497108	1925.65018497108
"healthy-4003"	"2020-08-26-Control4003-c3:ATACTTCGTCATTGCA"	-2.67636738243755	10.469512916449	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACTTCGTCATTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.43454646543	40.2597639972178	0.0212965659522525	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1884.40638423547	1884.40638423547
"healthy-4003"	"2020-08-26-Control4003-c3:ATACTTCGTTACGCCG"	5.11368670043294	-7.87009432232054	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACTTCGTTACGCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.61197605912	35.7572766803537	0.012976165363997	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2749.41081866077	2749.41081866077
"healthy-4003"	"2020-08-26-Control4003-c3:ATACTTCTCTTAGCTT"	-4.14044223251994	11.4865712889465	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATACTTCTCTTAGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2165.47882192336	33.9814953174934	0.0156923701924323	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2154.31479977696	2154.31479977696
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGACCAGTGAGGTC"	4.17703880843465	-7.25842764293822	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGACCAGTGAGGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2018.49815929614	31.201678422957	0.0154578681576985	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2015.32123496932	2015.32123496932
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGACCGTAGACAGC"	5.01158871230428	-7.89517691051634	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGACCGTAGACAGC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.98721857717	2.42792695239171	0.00106162681307079	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.52014085268	2285.52014085268
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGACCGTATGGTAA"	3.83461632308308	-6.92694618618163	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGACCGTATGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.84031174952	40.3123032831225	0.0177756357333747	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.33481948305	2259.33481948305
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGAGAAGAAGAACG"	-0.0561332953279794	8.0261659392151	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGAGAAGAAGAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2277.73953691349	44.9512638318593	0.0197350325194652	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2266.15295799186	2266.15295799186
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGAGAAGGGTCTTT"	-1.25676677647288	9.08895871723024	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGAGAAGGGTCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2075.33027489159	31.8283401694026	0.0153365180253371	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2061.74179096558	2061.74179096558
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGAGAAGTATGAGT"	2.81557812270467	-4.69834806835326	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGAGAAGTATGAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2414.16774148213	0	0	1672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2413.07748844092	2413.07748844092
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGAGAGTCGATGCC"	6.796075006097	-1.71467580711516	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGAGAGTCGATGCC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2372.77142765331	17.7265931065191	0.00747083891011401	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2363.70380584999	2363.70380584999
"healthy-4003"	"2020-08-26-Control4003-c3:ATAGAGATCGGTAGGA"	-1.19640348377879	9.92099664295045	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATAGAGATCGGTAGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1417.46327043913	1.94350323500083	0.00137111364755062	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1415.31301146066	1415.31301146066
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTAGCCTTTCC"	5.14082350310628	-7.59906151210936	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTAGCCTTTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.47550757213	11.3475836282381	0.00412868282688899	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2741.27798373989	2741.27798373989
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTAGGGAGGAC"	3.49913515624349	-6.8466744652954	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTAGGGAGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.55010784255	24.9431817364666	0.0118576598881445	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.38227784699	2100.38227784699
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTCAAACGTGG"	4.7386871772701	-8.29575636303099	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTCAAACGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2782.85750838364	8.88763517320817	0.00319370831831428	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2777.932517247	2777.932517247
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTGTGCTCCGA"	3.91069020804707	-7.1273813477722	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTGTGCTCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2102.62036133781	0.569496846981588	0.000270851009270756	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2099.32928786834	2099.32928786834
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTTCAGTGTGT"	5.31877054747884	-10.0711403123108	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTTCAGTGTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.16800232591	20.4098376904694	0.00872898682650973	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2334.1506352409	2334.1506352409
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTTCCGACAGC"	-0.172900373966056	8.74221417987672	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTTCCGACAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1776.27472268079	25.6599639580286	0.0144459433163031	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.64274727123	1774.64274727123
"healthy-4003"	"2020-08-26-Control4003-c3:ATATCCTTCTTCGCTG"	4.34433235701863	-7.12665607845458	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATATCCTTCTTCGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.1342291536	22.7800787682351	0.008512307985179	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2672.40012334141	2672.40012334141
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACAGAGGACGCTA"	5.55426039275472	-9.54306318676146	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACAGAGGACGCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.01733617144	6.0850271087882	0.00250513943156094	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.35498284673	2423.35498284673
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACAGAGTGCTACT"	4.6585189300472	-7.65417911922606	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACAGAGTGCTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.56790916573	33.5977064470245	0.0134306593572466	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.8922411576	2495.8922411576
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACGAAGAAAGTCT"	0.365069021552247	8.90638730609743	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACGAAGAAAGTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1662.83647794529	35.28760507051	0.0212213320663459	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1655.14723145927	1655.14723145927
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACGACAAGTGTCT"	-2.27587876740153	8.9356651076111	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACGACAAGTGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2074.18834238159	36.5759484772161	0.0176338607877911	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2067.76038719869	2067.76038719869
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACGAGTAGGAGTC"	0.00117052820269462	8.59418866718141	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACGAGTAGGAGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1591.908701965	33.4183115073951	0.0209926055848207	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1590.13388353224	1590.13388353224
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACGATCTAGAGCT"	-2.70949659767802	10.2204208143982	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACGATCTAGAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.86894334277	38.4418008180045	0.0215014646130214	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.63347347135	1775.63347347135
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACTTCAGGCAATG"	5.41851963576619	-9.65715792095336	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACTTCAGGCAATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2544.58981594327	5.67254798836592	0.00222925830828381	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2537.94630303602	2537.94630303602
"healthy-4003"	"2020-08-26-Control4003-c3:ATCACTTCAGGCACAA"	-3.86402903023418	13.1457996138367	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCACTTCAGGCACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1783.9824307191	45.1706272971481	0.0253201077092113	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1775.63517258224	1775.63517258224
"healthy-4003"	"2020-08-26-Control4003-c3:ATCAGGTGTGAAGCGT"	5.31045450743977	-9.53146078502806	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCAGGTGTGAAGCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2676.70993355244	0	0	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2664.92069470838	2664.92069470838
"healthy-4003"	"2020-08-26-Control4003-c3:ATCATTCAGCTAGCCC"	-2.98931656304057	9.9662408598694	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCATTCAGCTAGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2293.72724197252	33.0905043019213	0.0144265210337149	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2286.65683797785	2286.65683797785
"healthy-4003"	"2020-08-26-Control4003-c3:ATCATTCAGGGCAACT"	5.57804884490315	-9.76775648510131	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCATTCAGGGCAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.23139347865	0.981577970613409	0.000385502265476502	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2539.46914284934	2539.46914284934
"healthy-4003"	"2020-08-26-Control4003-c3:ATCATTCCAAGTCCCG"	-4.18477282944377	12.8952197798523	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCATTCCAAGTCCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2038.52796248488	35.6962243919724	0.0175107847667001	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2030.40409576194	2030.40409576194
"healthy-4003"	"2020-08-26-Control4003-c3:ATCATTCGTGATTCAC"	5.26836313781087	-9.50231649791869	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCATTCGTGATTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.87312255039	37.1610771795956	0.0134404276552543	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2760.04055958936	2760.04055958936
"healthy-4003"	"2020-08-26-Control4003-c3:ATCATTCTCTAGAGCT"	3.59533514556233	-6.8145437470642	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCATTCTCTAGAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.01217413317	34.7066969364969	0.0161200653454132	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.6489091422	2146.6489091422
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCACCTCGCCTAGG"	3.59638180312459	-6.92653086101683	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCACCTCGCCTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.28215941484	31.5901845746401	0.0143053207399053	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.13302522828	2205.13302522828
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCACCTCGCGGACT"	-2.26132021370586	9.16186807239381	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCACCTCGCGGACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2103.15706313617	21.8691963060721	0.0103982706234319	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2094.47773542185	2094.47773542185
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCATTCAGCACCCA"	5.58801140364949	-9.82120802318724	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCATTCAGCACCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2512.91323663788	4.50219850165196	0.00179162512895814	1554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2504.9310703229	2504.9310703229
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCATTCATAGTCAC"	-1.61479912224467	9.73829457843629	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCATTCATAGTCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1529.3770646241	20.0097750954682	0.0130836113332106	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1529.3770646241	1529.3770646241
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCATTGTGACCGTC"	5.57145180281941	-9.74788858806761	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCATTGTGACCGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2579.99726888622	38.272436521901	0.0148342934248233	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2572.81150224969	2572.81150224969
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCATTTCGCAGATT"	4.06678070601766	-6.82769062435301	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCATTTCGCAGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.70410991245	31.9233107703761	0.013511345172866	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2357.47783069016	2357.47783069016
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCCTGTCCTCTTTC"	-1.21611843529399	8.84968183124391	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCCTGTCCTCTTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2608.58196130776	17.589757712279	0.00674303432791537	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2589.92545777797	2589.92545777797
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCCTGTCGCAGTGC"	-3.80811152878459	13.0772981413635	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCCTGTCGCAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1776.55837921167	24.9477090834982	0.0140427184242426	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1776.55837921167	1776.55837921167
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCGTCGTTGTACGT"	-0.0599559647148431	8.5218820341858	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCGTCGTTGTACGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.20437401987	27.0270425208543	0.0159809440751462	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1686.28006242593	1686.28006242593
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCTATCAGCTCATA"	-4.5081504386967	12.9620609053406	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCTATCAGCTCATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2155.04006927816	35.6207867597705	0.0165290600706565	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2142.25184651701	2142.25184651701
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCTATGTGGATGAC"	-3.75694809380229	10.532935119513	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCTATGTGGATGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1989.66315148591	38.7557588263646	0.0194785528381632	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1985.97617177391	1985.97617177391
"healthy-4003"	"2020-08-26-Control4003-c3:ATCCTATTCACAACCA"	4.35195412215535	-7.1157231560913	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCCTATTCACAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.43057051656	30.0439325495713	0.0113483363394528	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2640.56214384753	2640.56214384753
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGATGGTCCAATCA"	-3.71510944786723	11.0340633162293	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGATGGTCCAATCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1715.95349233051	36.240985726396	0.0211200279543566	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1709.63419111037	1709.63419111037
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGATGTCCTTATAC"	3.20374216613118	-6.52602388775023	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGATGTCCTTATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.40495376067	29.2120081202894	0.0122512780701182	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2379.52425809426	2379.52425809426
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGATGTCGTAGGAG"	-3.57933745804484	10.5330457457337	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGATGTCGTAGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.67019419414	36.7962172307863	0.020378149536443	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1799.13236496289	1799.13236496289
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGCCTCAATACGCT"	1.9000914293224	-6.7189979783264	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGCCTCAATACGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1838.90750474534	37.7098408314636	0.0205066544859666	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1836.91407717675	1836.91407717675
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGCCTCACGTGTGC"	5.19391693648641	-9.03776361858519	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGCCTCACGTGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.3864646573	1.2268358978183	0.000489093652475084	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2503.16835503314	2503.16835503314
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGATAGCAGCGAT"	-4.85246787491496	9.07990930164186	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGATAGCAGCGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2857.88326756484	37.7684226693256	0.0132155232153717	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2846.11118728791	2846.11118728791
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGATGTATGAGAT"	5.39300789412801	-10.0780496827331	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGATGTATGAGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.49612926932	47.5970083206007	0.020441094027301	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2322.90060624911	2322.90060624911
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGATTCACATCAG"	4.2237364250118	-7.56498386776122	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGATTCACATCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.66249437362	0	0	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2038.21230542126	2038.21230542126
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGAGAACAAGG"	-1.52203534069713	9.13814637744752	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGAGAACAAGG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1944.12268550416	40.6827556313051	0.0209260227940579	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1936.46207418677	1936.46207418677
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGAGCTCCGAC"	4.29665102538411	-7.51768019115599	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGAGCTCCGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.77010261188	1.60537402944735	0.000688478691638222	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2330.37259636962	2330.37259636962
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGCAAAGCTAA"	5.01657452163045	-8.56371405040892	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGCAAAGCTAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.59189210248	41.4558003946098	0.017957180104646	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2302.02095446916	2302.02095446916
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGCATAACCCA"	-1.38004146042522	8.96604440296022	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGCATAACCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.1000350165	43.4860368996854	0.0225071352991896	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.47444289057	1916.47444289057
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGCATCATTTC"	3.000016828149	-4.9761066666809	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGCATCATTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.72226636022	42.3768581138823	0.0187780564518603	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2255.45318523324	2255.45318523324
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGGTACGAGCA"	-2.23245106163676	9.8251800307068	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGGTACGAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1628.24845118363	26.9784547820538	0.0165690038043287	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1626.2438331413	1626.2438331413
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGGCGTCCGTCCTA"	5.57106365737264	-9.79908087169798	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGGCGTCCGTCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.83387123891	34.2410826913088	0.0157950676689723	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2161.81592210548	2161.81592210548
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTAGAGCTCCATA"	5.28156866607015	-9.24473001873168	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTAGAGCTCCATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.1698634335	39.0711738708365	0.0171577775106883	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.677242381	2272.677242381
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTAGGTGATCGTT"	0.597788353531998	8.45807836139528	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTAGGTGATCGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1447.91606986085	32.0023665327073	0.0221023629745216	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1447.91606986085	1447.91606986085
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTCCCAGAGCGTA"	5.4396149116451	-9.54141333019408	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTCCCAGAGCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.56117036213	26.3754510462842	0.0101931700585045	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2579.35236629465	2579.35236629465
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTCCTCCCTATTA"	0.339658488600892	8.64691445911256	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTCCTCCCTATTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1923.12109856403	33.6242563276414	0.0174842116561189	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1906.10059843796	1906.10059843796
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTGACAGAGACTG"	4.82436432418172	-7.403431438562	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTGACAGAGACTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.12633480833	36.3796056613202	0.0142770023465327	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2544.97039567544	2544.97039567544
"healthy-4003"	"2020-08-26-Control4003-c3:ATCGTGATCCGAACGC"	-3.72753034058269	12.662157989386	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCGTGATCCGAACGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2053.69123532634	37.2580795169249	0.0181420063912404	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2049.8710354518	2049.8710354518
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTCTAAGGAAAGTG"	3.40814461287801	-6.50606539165648	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTCTAAGGAAAGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.89758220287	12.9474512211928	0.00553570678755345	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2335.64905494502	2335.64905494502
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTCTACAAGCTGCC"	10.7447468238765	6.46260354602662	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTCTACAAGCTGCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.46533257783	38.0387669132252	0.0197248901863213	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1920.14299825023	1920.14299825023
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTCTAGTAATTAGG"	-4.00187621536906	12.2491788634094	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTCTAGTAATTAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1756.66999395998	26.8384668707748	0.0152780356942707	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1752.46185585021	1752.46185585021
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTCTATCCCATAGA"	5.3509108024532	-9.76129152691039	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTCTATCCCATAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.50201689842	36.8347616597806	0.0141102214904797	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2603.84451002589	2603.84451002589
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTTCAAGCACCGTC"	10.1401306587154	7.82488963687745	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTTCAAGCACCGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2416.47055730876	25.7243212597069	0.010645410589383	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2405.22445071481	2405.22445071481
"healthy-4003"	"2020-08-26-Control4003-c3:ATCTTCACACTAGGTT"	-2.98338566246684	10.1374215849671	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATCTTCACACTAGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2099.17397777212	30.7431109561489	0.0146453373001398	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2089.23335746769	2089.23335746769
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAAAGAGGAACATT"	-3.36790953102763	9.9994382628235	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAAAGAGGAACATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.23115788196	39.7177253942477	0.0218201546667642	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.42469064428	1816.42469064428
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAAAGCATAAGCGG"	10.2734772163326	6.90426776492921	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAAAGCATAAGCGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1477.88425345998	39.0421344577467	0.0264175860635516	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1472.45771893107	1472.45771893107
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAAAGTCCTTCAGC"	3.87637295302693	-6.96848442470702	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAAAGTCCTTCAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.87635634557	28.4039664182757	0.0116702585750592	1568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2430.23429568943	2430.23429568943
"healthy-4003"	"2020-08-26-Control4003-c3:ATGACCATCGTCTAAG"	-1.69215808335002	9.47062490070192	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGACCATCGTCTAAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1718.47169578641	32.3491929957322	0.018824396744532	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1713.01967810562	1713.01967810562
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGGGCACGCAGTC"	-1.26619241657909	8.69286630237428	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGGGCACGCAGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1599.24261784086	37.3274939089969	0.0233407323520385	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1597.06432810685	1597.06432810685
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGGGCACTGTCCT"	0.411690761416596	8.90357682788698	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGGGCACTGTCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1485.98258715805	41.222633251094	0.0277409934728324	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1479.92229351847	1479.92229351847
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGGGGTACCTATG"	3.58297600325887	-6.59956123745116	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGGGGTACCTATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.63224661153	35.358301332847	0.015449533836289	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.2003027528	2283.2003027528
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGGGGTCCTGAAT"	4.1799861389095	-6.93644239818724	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGGGGTCCTGAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.18634133263	37.5979986496419	0.0151410299033235	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2478.30355143159	2478.30355143159
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGGGGTTCACCGG"	-3.83028493347819	10.6887159117493	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGGGGTTCACCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1882.36045384769	36.3576745963475	0.0193149375413351	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.44092436188	1872.44092436188
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGTCCATCAGCTA"	5.60502209243123	-10.1418037644592	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGTCCATCAGCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.88473360585	28.3700766349378	0.0115377822503027	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.4662257773	2450.4662257773
"healthy-4003"	"2020-08-26-Control4003-c3:ATGAGTCTCGTAGCTA"	4.37486471709554	-6.74236776744994	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGAGTCTCGTAGCTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2288.75302742772	33.4289614038783	0.014605753003175	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2286.3392997156	2286.3392997156
"healthy-4003"	"2020-08-26-Control4003-c3:ATGATCGGTGGTCTCG"	-2.68644771996196	9.53382966602174	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGATCGGTGGTCTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1843.94873706462	37.9540383441019	0.0205830225001378	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.05975471744	1840.05975471744
"healthy-4003"	"2020-08-26-Control4003-c3:ATGATCGTCATCTATC"	3.83441962775533	-7.21827032482298	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGATCGTCATCTATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.39170941781	39.8185906215262	0.0215773108865262	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1845.39170941781	1845.39170941781
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCATGAGACCACGA"	5.60221304473226	-10.0942592850891	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCATGAGACCACGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.56195268323	39.9066544271626	0.0159335864638561	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.76628049001	2500.76628049001
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCCTCCAAATGCGG"	4.08649887618367	-7.72153713619383	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCCTCCAAATGCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2028.65660071867	38.9275535962465	0.0191888334292043	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2026.97448906082	2026.97448906082
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCCTCCATTGCAAC"	5.41022553023641	-10.0499468079773	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCCTCCATTGCAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.03967106049	38.3017176703074	0.0196415069081532	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1946.64035722217	1946.64035722217
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCCTCGTTCTCCAC"	4.29294886168782	-7.23134233867797	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCCTCGTTCTCCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.83295281478	3.12334584881342	0.00144744561655673	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.81591492787	2152.81591492787
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCCTCTCTACGCGG"	-1.91423259201701	3.83406875217286	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCCTCTCTACGCGG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2305.00532265562	0	0	2801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2302.82341753391	2302.82341753391
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCGATAGCCTGACC"	-3.29346309128459	10.8104619749817	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCGATAGCCTGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.36438177999	28.2490355548097	0.0157871900449413	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.18279410377	1783.18279410377
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCGATAGCGAGGAG"	-3.5091417831486	11.005214668158	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCGATAGCGAGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1609.245145768	27.582746146464	0.0171401766965097	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1604.6546705482	1604.6546705482
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCGATGTGAGCAGT"	4.27196850356404	-7.20986177837523	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCGATGTGAGCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.44942418744	34.0951376045817	0.0148533604118292	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2295.44942418744	2295.44942418744
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCGATGTTTACACG"	3.98751415786092	-6.89335396206053	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCGATGTTTACACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.37623217128	48.499112388969	0.0211382561015601	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.75803610761	2290.75803610761
"healthy-4003"	"2020-08-26-Control4003-c3:ATGCGATTCGCTAAAC"	-2.38066945496257	4.13838765704957	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGCGATTCGCTAAAC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3206.23458551976	15.884257630111	0.00495417824442689	4984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3203.53498479242	3203.53498479242
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTTGAGGTAGCAC"	4.52690329131429	-7.15197327053221	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTTGAGGTAGCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.27908292685	23.301474398891	0.0099994350760872	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2322.26306455485	2322.26306455485
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTTGCACCGAATT"	3.13090076026265	-7.39569284832152	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTTGCACCGAATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1651.90460354446	3.41246319935968	0.00206577498000649	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1649.90170477233	1649.90170477233
"healthy-4003"	"2020-08-26-Control4003-c2:TCGCTTGTCAGTCCGG"	4.28265823897664	-7.16772320186766	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGCTTGTCAGTCCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.43128168769	30.7190159968271	0.0133710271300306	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2293.06930848989	2293.06930848989
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGATAAGCCATCCG"	4.42175831374471	-7.250768207666	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGATAAGCCATCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.23304345799	34.1773988157553	0.0138975844142439	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2455.05508993407	2455.05508993407
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGATAAGTACAGAT"	4.70057358321492	-7.80306770717772	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGATAAGTACAGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.59993314777	2.84248184254592	0.00125740154233655	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2255.33319269903	2255.33319269903
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGATAGTAGGCAAC"	-3.86114798012431	12.3216514357361	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGATAGTAGGCAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2084.92568491887	35.8925691036841	0.0172152750399259	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2076.84102670834	2076.84102670834
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGGACTCAAACTGC"	4.99219002303426	-8.20973875438841	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGGACTCAAACTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.03379304232	31.7955929777296	0.0123764790731212	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2564.37039865528	2564.37039865528
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGGCAGTTGACTAC"	4.49081816253011	-7.0375957719055	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGGCAGTTGACTAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.57413500663	20.719711243951	0.00864194810138529	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2392.16408658078	2392.16408658078
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGGTGAGTCATCCA"	3.71230902251546	-7.16495611583861	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGGTGAGTCATCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.44558590349	2.67660230923178	0.00119627593452779	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.66023342279	2232.66023342279
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGGTGCAATACGCT"	-4.36025939408	12.8960037001404	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGGTGCAATACGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1789.24525979826	30.4085522688678	0.0169951839203399	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1785.10307530274	1785.10307530274
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGTCTAGACGGTTG"	3.61186279830281	-7.32205583965453	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGTCTAGACGGTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.71489480013	25.5252543985955	0.0127389652414305	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2003.71489480013	2003.71489480013
"healthy-4003"	"2020-08-26-Control4003-c2:TCGGTCTTCGACCTAA"	10.3303562599117	7.54091737354127	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGGTCTTCGACCTAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2023.15483325656	32.5254643919879	0.0160766066231488	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2009.05541133953	2009.05541133953
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTAGACACCTCGTT"	3.71363772925679	-7.42741348659667	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTAGACACCTCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1716.9314507086	16.5314213281653	0.00962846904653216	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1713.11147904219	1713.11147904219
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTAGATCAAGCCAT"	2.70013989981953	-4.41349270260008	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTAGATCAAGCCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2669.54044490529	31.6894871153716	0.0118707649385308	2011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2663.67965382988	2663.67965382988
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTAGATCGTCCTTG"	-3.94643507424052	12.7642974623474	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTAGATCGTCCTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1895.18907452446	29.0913331110948	0.0153500954084987	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1895.18907452446	1895.18907452446
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTCCAAGTAACAGT"	-0.206971834332305	8.63659188831178	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTCCAAGTAACAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1698.5887154147	38.1028688939727	0.0224320746677456	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1687.36316890587	1687.36316890587
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTCCACAATCTAGC"	5.54491200026814	-10.0539980164734	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTCCACAATCTAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.12851903774	4.83351507685656	0.00202482398342129	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2381.56426485216	2381.56426485216
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTCCATCGCTCCTA"	3.75183095511739	-7.75309612667235	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTCCATCGCTCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.86600543338	29.8238043819514	0.0155100793802996	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1919.13405300206	1919.13405300206
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTGGGAGGATTACA"	-2.99567137184795	-5.61678793346556	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTGGGAGGATTACA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2537.35374912671	0	0	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2533.63128919375	2533.63128919375
"healthy-4003"	"2020-08-26-Control4003-c2:TCGTGGGCACGCGTGT"	4.63398184356038	-8.4590635529724	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCGTGGGCACGCGTGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.81638554147	0	0	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1920.88034054526	1920.88034054526
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTAGGCCCGTT"	-3.50448308411296	-5.3360920182434	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTAGGCCCGTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2526.88907849307	36.7372722045134	0.0145385377289382	1681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2518.81369070759	2518.81369070759
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTCAACGATTC"	3.92570104178731	-7.44534113323363	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTCAACGATTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.64318260671	31.6771900023046	0.0123853046498924	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2552.64580047846	2552.64580047846
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTCAGACCGCT"	-3.6352428001469	10.423352218512	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTCAGACCGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2328.54487866098	39.7811169830088	0.0170841100584176	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2321.83518051055	2321.83518051055
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTGTATTTCCT"	-7.69314704361613	-0.446200155374132	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTGTATTTCCT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3495.19403901259	35.6462239001775	0.0101986394753202	4554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3485.696816292	3485.696816292
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTGTCCCACGA"	-0.185194398195106	8.2055339583191	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTGTCCCACGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1969.38040282013	26.0770840727114	0.0132412631076095	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1967.84202292221	1967.84202292221
"healthy-4003"	"2020-08-26-Control4003-c2:TCTAACTTCCGATAAC"	4.74232830581014	-7.81085064327391	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTAACTTCCGATAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.58724464257	37.3225559269485	0.0156122961044782	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2386.30296654765	2386.30296654765
"healthy-4003"	"2020-08-26-Control4003-c2:TCTACATAGCGAACTG"	4.82327713546101	-7.55211689388426	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTACATAGCGAACTG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.47244534434	6.27420494370801	0.00222058613738962	2040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2819.22602987319	2819.22602987319
"healthy-4003"	"2020-08-26-Control4003-c2:TCTACATGTCTGTGCG"	10.2573372322017	7.27810475910035	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTACATGTCTGTGCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1600.73906195943	43.6322082027097	0.0272575394951008	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1588.78209454174	1588.78209454174
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATACCAAATGAGT"	-4.12416873398479	12.7433194884094	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATACCAAATGAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1694.29565755346	18.8504452365613	0.0111258298706739	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1692.10299723232	1692.10299723232
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATACCATCCAACA"	4.61999191817586	-6.85726883327635	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATACCATCCAACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3019.5278818781	12.3062757256132	0.00407556287175559	2632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3007.18928811311	3007.18928811311
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATACTCGGCTGTG"	-0.278042475611526	9.01862619006959	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATACTCGGCTGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.71498397889	26.5984656874445	0.0141202177153476	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.16439889231	1876.16439889231
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATCAAGAGTACCG"	-2.83141503754314	9.74360749805299	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATCAAGAGTACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1965.70740653823	37.1463639330836	0.0188971989470709	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1963.93509592362	1963.93509592362
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATCAAGATACTGA"	5.27770247039143	-9.89323427593382	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATCAAGATACTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.13475547723	41.0930684711924	0.0183768300951176	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2230.42058205719	2230.42058205719
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATCAAGGTCTGGA"	-4.30318770828899	12.8963336714539	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATCAAGGTCTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1798.01661938513	36.105304064337	0.0200806286633123	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1791.65143249989	1791.65143249989
"healthy-4003"	"2020-08-26-Control4003-c2:TCTATCATCGCAGTCG"	3.0402373271877	-7.28854801571044	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTATCATCGCAGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2084.87281396383	12.4083358824403	0.00595160328214417	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2083.057592499	2083.057592499
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCACGAGTGTACCT"	5.35963501509969	-9.39040090953978	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCACGAGTGTACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.21391833332	21.8749349199718	0.0101215963558301	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2158.18492335164	2158.18492335164
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCACGGTGTCCATA"	4.71087803420369	-7.17423965847167	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCACGGTGTCCATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.93971382477	20.0318045309939	0.00849186794117536	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.08419020454	2355.08419020454
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCAGCGTCATGCAT"	5.40854801711385	-10.0708027116028	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCAGCGTCATGCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2069.3815921186	1.06842281288015	0.000516300530046908	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2063.83662439923	2063.83662439923
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCAGCGTCTACGTA"	3.41366376456563	-7.12919857418212	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCAGCGTCTACGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.78263467727	38.6206474852043	0.0166555704306366	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2317.39965345648	2317.39965345648
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCAGCGTTAACAGA"	3.54463376578633	-5.66725065624388	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCAGCGTTAACAGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2917.93994203517	32.1095637219335	0.011004189380107	3003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2912.97349679561	2912.97349679561
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCCGAGTAACGGTG"	4.92376102980916	-8.76466658031615	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCCGAGTAACGGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.00912792355	34.9206655181319	0.0149105591014895	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.00912792355	2342.00912792355
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCTGGCACCGAATT"	5.1643496948177	-8.39697458660277	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCTGGCACCGAATT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.6540328947	0.80422515294217	0.00030352081553212	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2644.61043126475	2644.61043126475
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCTGGCAGAATTCC"	2.95883073386495	-6.89086439525756	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCTGGCAGAATTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.37349895428	8.33205985589516	0.00401666327693421	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2074.37349895428	2074.37349895428
"healthy-4003"	"2020-08-26-Control4003-c2:TCTCTGGTCCTCATAT"	3.13753618773763	-6.59614756023558	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTCTGGTCCTCATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.96232454909	21.7950868875594	0.00918475892435459	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.94320412724	2368.94320412724
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGCCAAGTTGCCCG"	4.18641390380208	-6.50104334270629	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGCCAAGTTGCCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2837.73871812745	23.3765353195204	0.00823773350597477	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2830.91886701803	2830.91886701803
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGCCATCGTCTCAC"	4.34609045562093	-6.88971855556639	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGCCATCGTCTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2549.17326833585	29.4551398073775	0.0115547813768683	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.52760251571	2545.52760251571
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGGCTAGAGTGTGC"	-3.41015348854716	10.1703805693421	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGGCTAGAGTGTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1675.48817615229	38.4966798298474	0.0229763960007489	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1671.20435481999	1671.20435481999
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGTCGCACTTGGGC"	0.460432996123475	8.17882821643678	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGTCGCACTTGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1592.26556345075	1.19543517529497	0.000750776254121976	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1590.57459424594	1590.57459424594
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGTCGGTACGATGG"	-3.72239623490031	12.9265060194763	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGTCGGTACGATGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1744.88724308087	38.4204986658387	0.0220189005439694	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1742.63797105509	1742.63797105509
"healthy-4003"	"2020-08-26-Control4003-c2:TCTGTCGTCCGAAATC"	5.58715548095052	-10.0339718095032	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTGTCGTCCGAAATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.34796996113	38.6043727937988	0.0142591101041042	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2697.86127255246	2697.86127255246
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTAGGTAACTA"	2.49560465392415	-3.95370342647704	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTAGGTAACTA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2877.01117529392	29.9625174258681	0.0104144598683413	2651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2864.79935860202	2864.79935860202
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTCAAGGCAAC"	0.667995234101456	9.10465333545534	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTCAAGGCAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1496.87519545692	24.6260627092258	0.0164516472608852	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1489.12808052445	1489.12808052445
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTCAATAAGGT"	4.32659401473348	-7.36597254192504	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTCAATAAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2607.43589654093	30.1188528402353	0.0115511383732162	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2599.0255729444	2599.0255729444
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTGTCTTGTCC"	4.16362919387166	-7.58105614101561	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTGTCTTGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1952.09506823662	27.7184924703885	0.0141993558210397	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1948.33444109715	1948.33444109715
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTGTTTACGAC"	3.89206161078755	-7.31679251110228	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTGTTTACGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.01622188437	20.2911564676941	0.0102067358627792	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.23748966167	1984.23748966167
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTAGTTCTCTAAGG"	2.65649547156636	-6.55911495601805	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTAGTTCTCTAAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.22237641527	31.5970251553576	0.0123222640305985	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2562.08788114955	2562.08788114955
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTCCTAGTATGAGT"	4.19637741622273	-7.43160726940306	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTCCTAGTATGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.85399779338	0.124789176365374	5.70633322989515e-05	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.35774946851	2183.35774946851
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTCCTCACGCTGCA"	-0.551787416369277	8.52253720844118	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTCCTCACGCTGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.2759928484	30.1470329927089	0.0160932148320916	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.02143796351	1864.02143796351
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTCCTCAGGAACCA"	4.29003014144246	-7.16517021572264	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTCCTCAGGAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.46062310087	0.682513493703418	0.000285396082674546	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.44258389619	2388.44258389619
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTCCTTCATAAGGA"	5.50866856154744	-10.0400696030823	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTCCTTCATAAGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.76999512022	19.1815457342133	0.00754356303205725	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2538.92172678568	2538.92172678568
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGAGGATTCCT"	2.74446906623189	-4.52890446102294	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGAGGATTCCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2645.4391703759	37.4973934813143	0.0141743548297072	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2637.60855219943	2637.60855219943
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGCAACCCTAA"	-2.16070828858073	9.03996465289918	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGCAACCCTAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1804.48997569782	27.9668817361559	0.0154984965906174	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1802.53291417	1802.53291417
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGCACTGGACC"	-3.69570551338847	10.4245242842468	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGCACTGGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2077.33364405057	35.2359953220544	0.0169621261480886	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2066.40918896511	2066.40918896511
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGCAGGGTCTC"	0.678267021744889	9.20863626087037	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGCAGGGTCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1516.32239563596	30.4150936629166	0.0200584610175597	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1514.5390124281	1514.5390124281
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGCATCCAATG"	-7.43007979813274	-0.707091116067492	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGCATCCAATG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3612.56708135809	32.4008487948864	0.00896892654591367	4849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3598.79014232061	3598.79014232061
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTGCGTCAAACTGC"	-3.52542076531108	9.9742393263611	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTGCGTCAAACTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2153.43622611218	38.1762698476176	0.0177280707850546	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2142.00766032804	2142.00766032804
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTTGAAGAGAGTGA"	4.29241957244222	-7.09130527889403	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTTGAAGAGAGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.4593993487	9.61539951101189	0.00404951102286666	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2366.62870300093	2366.62870300093
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTTGAAGTGCCCGT"	-0.48536972227748	7.8671779402527	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTTGAAGTGCCCGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1927.98846600553	32.0288127579269	0.0166125541322792	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1915.74378907834	1915.74378907834
"healthy-4003"	"2020-08-26-Control4003-c2:TCTTTGAGTCAAGTTC"	-3.17699180069621	10.9291286238464	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TCTTTGAGTCAAGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.65312403106	20.7978498880526	0.0119758226903582	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.22304280948	1730.22304280948
"healthy-4003"	"2020-08-26-Control4003-c2:TGAACGTAGTACGTCT"	-1.48283086243327	9.11315248096315	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAACGTAGTACGTCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1941.41318137193	42.7905654933854	0.0220409369339641	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1930.79056136471	1930.79056136471
"healthy-4003"	"2020-08-26-Control4003-c2:TGAACGTGTAGAGGAA"	2.74653782424275	-7.11166384136351	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAACGTGTAGAGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1620.88133536714	27.6174795740815	0.0170385573400572	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1620.88133536714	1620.88133536714
"healthy-4003"	"2020-08-26-Control4003-c2:TGAACGTTCTTCCACG"	-0.314811448485214	8.73971555316774	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAACGTTCTTCCACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.76461998531	1.9141909356661	0.00107977726658487	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1763.84919671705	1763.84919671705
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATCGAGAGGTCGT"	5.50246920165364	-10.0266189805237	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATCGAGAGGTCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.90413772936	33.9716490021446	0.0147388554890666	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.65251480652	2300.65251480652
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATCGAGATAACAC"	4.88269295272176	-7.3550539246765	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATCGAGATAACAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.62737041282	31.7680773853202	0.0127142117153994	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.32905264397	2495.32905264397
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCAGCTTACGT"	10.520527501672	5.22230527484743	"2020-08-26-Control4003-c2"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCAGCTTACGT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1578.05774548124	34.7755939162539	0.0220369590503476	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1573.64565995844	1573.64565995844
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCAGTCACTGT"	4.85349525985066	-7.38821985637816	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCAGTCACTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.73852123958	27.7943114866733	0.0113411982738228	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.42341834142	2449.42341834142
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCGTCATACCA"	5.59124960479085	-10.1249428025452	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCGTCATACCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.74185989499	7.65468417191716	0.00320985860174158	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2381.94623679907	2381.94623679907
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCGTCGTCATA"	4.46966709670369	-7.52228071605834	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCGTCGTCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1961.71944385867	34.1686855383747	0.0174177228274628	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1960.15853137798	1960.15853137798
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCGTGGTCAAG"	4.12405504760091	-6.24392082607421	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCGTGGTCAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2848.22705060969	37.0765442061888	0.0130174117257443	2112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2838.13959026636	2838.13959026636
"healthy-4003"	"2020-08-26-Control4003-c2:TGAATGCTCGGAATGG"	2.51778139647786	-4.35481502926024	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAATGCTCGGAATGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2578.44102783911	15.8826707942424	0.00615979602510165	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2574.29501827471	2574.29501827471
"healthy-4003"	"2020-08-26-Control4003-c2:TGACAGTGTAAGACCG"	4.12843336638753	-6.59945633327635	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACAGTGTAAGACCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.09110884945	13.5513230714308	0.00531405447609472	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.08137691685	2545.08137691685
"healthy-4003"	"2020-08-26-Control4003-c2:TGACAGTGTGTCTTCC"	5.30150665816609	-9.8410330048767	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACAGTGTGTCTTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.5037158603	0	0	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2271.5037158603	2271.5037158603
"healthy-4003"	"2020-08-26-Control4003-c2:TGACCCTAGCCTTTCC"	5.57876457747762	-9.96355249797972	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACCCTAGCCTTTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.94479788611	13.2376619124044	0.00516703635586798	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.39532700578	2556.39532700578
"healthy-4003"	"2020-08-26-Control4003-c2:TGACCCTCAGTTGTCA"	3.31210674819295	-7.64023449337157	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACCCTCAGTTGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1994.39323517134	34.1524783914852	0.0171242450030428	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1989.56714206564	1989.56714206564
"healthy-4003"	"2020-08-26-Control4003-c2:TGACCCTGTCACCGAC"	-1.81959019127544	9.0934734114441	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACCCTGTCACCGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2355.06735340078	39.7558597621111	0.0168809863143415	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2344.96948565582	2344.96948565582
"healthy-4003"	"2020-08-26-Control4003-c2:TGACCCTGTCGTACTA"	9.44922031935994	7.00856587970582	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACCCTGTCGTACTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1815.11599257513	27.41558697821	0.0151040413341933	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1810.27154197167	1810.27154197167
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGCACTTCTCG"	-1.85830138149913	9.42861936176149	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGCACTTCTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.41191432913	36.172320729019	0.0181368354596831	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1991.02698993021	1991.02698993021
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGGTCATTGCA"	4.53794636306111	-6.78970005428465	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGGTCATTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.32760687953	30.4071827918803	0.0115999170466439	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2616.37831588533	2616.37831588533
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGGTGCCTGAC"	5.02716984328572	-7.58991005336913	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGGTGCCTGAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.9181139802	33.2690893850793	0.0149798811471966	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2220.9181139802	2220.9181139802
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGTCAGCTAGT"	3.24970449981038	-7.11381294643553	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGTCAGCTAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1809.10915870054	34.7066293120952	0.0191843754398019	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1809.10915870054	1809.10915870054
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGTCATGCAGT"	3.32411970671956	-6.98320248043212	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGTCATGCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1805.13201935565	22.1559466731592	0.0122738649780684	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1803.11650586929	1803.11650586929
"healthy-4003"	"2020-08-26-Control4003-c2:TGACGCGTCGCTGTTC"	3.97675194320027	-7.93871691143187	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACGCGTCGCTGTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.05319982803	26.1427576887973	0.0136583234421834	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1910.19587062175	1910.19587062175
"healthy-4003"	"2020-08-26-Control4003-c2:TGACTCCCACAGCTGC"	4.13755955275838	-6.99245693599852	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACTCCCACAGCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.39809814215	20.3589684840053	0.00777832325103938	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2606.368480673	2606.368480673
"healthy-4003"	"2020-08-26-Control4003-c2:TGACTCCCACCTCTAC"	5.60050072249715	-10.0699959031311	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGACTCCCACCTCTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.80883316876	1.03392286709094	0.00046619115751906	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2216.25507788384	2216.25507788384
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGACTCACTAGAGG"	3.42790188369099	-6.82226898586424	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGACTCACTAGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1844.32946495902	33.1574498483506	0.0179780513613859	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1837.54194887395	1837.54194887395
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGACTCATTGTCGA"	-3.09400139275249	10.4965114363464	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGACTCATTGTCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1674.19672000757	16.8119020718408	0.0100417721949454	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1667.66596340957	1667.66596340957
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGACTGTACAATAG"	3.72395743903462	-6.52298262035521	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGACTGTACAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2445.4362416542	30.828921109593	0.0126067163741464	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2438.38558846238	2438.38558846238
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGACTTCCGGTAAT"	4.51325430449788	-6.86161711132201	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGACTTCCGGTAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.20870093582	11.7348017720013	0.00513062134085097	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2284.58959776616	2284.58959776616
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGACTTCTTACTGT"	2.7259439426357	-4.47599651729735	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGACTTCTTACTGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2440.95436903112	1.76668410310062	0.000723767771128741	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2439.85606525422	2439.85606525422
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGCATGTGCAAGAC"	-3.14273891869243	9.85853097522584	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGCATGTGCAAGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.56762622304	35.4679835207294	0.0176935829236938	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1991.08367306633	1991.08367306633
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGCGCAGTCAACAA"	3.23181190070454	-6.7137809029785	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGCGCAGTCAACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1981.92420030478	34.5922423833077	0.0174538674980547	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1980.47002294614	1980.47002294614
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGCGCTCACCTCAC"	4.59775652465169	-7.092809223291	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGCGCTCACCTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.05350757032	16.2143577833954	0.00735660805316365	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2201.1620911655	2201.1620911655
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGCGCTCGAACGCC"	11.0068613487178	5.830370880011	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGCGCTCGAACGCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.38613507269	32.6310038411663	0.0182460617431705	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1777.58789968342	1777.58789968342
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGAGCACTATCGA"	4.1909610229427	-7.1530161133972	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGAGCACTATCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.93681931918	35.1489985617332	0.0133802222814185	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2620.51801793858	2620.51801793858
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGAGGTATCCTTT"	-0.91948233071025	8.82544515216676	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGAGGTATCCTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2067.86984616549	30.3746611758603	0.0146888650812259	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2049.41832378474	2049.41832378474
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGAGGTGTAACGG"	-4.2904728454655	12.9924936064514	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGAGGTGTAACGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1737.22815463028	29.5474568322418	0.0170083916459034	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1737.22815463028	1737.22815463028
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGAGTCCCACAGG"	-3.36227045479472	9.86661145770875	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGAGTCCCACAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1686.97411024201	38.0899019111049	0.0225788301550405	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1684.90256908652	1684.90256908652
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGAAGTGGAAGA"	-3.13201771202739	9.95324418628541	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGAAGTGGAAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.58099121024	38.6761225721039	0.0215516172084389	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1790.37712534637	1790.37712534637
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGACAACTTCTT"	4.06411852416341	-7.54827167904051	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGACAACTTCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.39813435144	6.25040260440565	0.00256227243777385	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.17643598601	2429.17643598601
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGACATTAGGAA"	3.49471702155415	-7.36948206340941	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGACATTAGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.83073859476	40.1634965446571	0.0198845852660901	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2014.30668887965	2014.30668887965
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGAGTACAGAAT"	-4.0272983116215	13.0793885954651	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGAGTACAGAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1770.68596072697	33.4242333789788	0.018876432140037	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1766.33700585518	1766.33700585518
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGAGTTCCGGTG"	-3.7511445087498	12.7769012221131	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGAGTTCCGGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1702.49135416582	24.95965809928	0.0146606665803068	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1702.49135416582	1702.49135416582
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGAGTTTATGCG"	5.36914887008016	-9.12730410015257	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGAGTTTATGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.55855337425	28.1383638952934	0.0126660464800962	1246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2218.75944855676	2218.75944855676
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGGATCTGTCGCT"	-0.614150862128097	8.263476348761	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGGATCTGTCGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2096.47186407612	27.1229789288532	0.0129374399883997	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2086.67532410245	2086.67532410245
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGTTCACATACTG"	-3.6213997406071	10.5424861677918	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGTTCACATACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2187.0592614319	38.4963177402971	0.0176018631132533	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2179.99699327989	2179.99699327989
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGTTCACATGAAA"	0.316989411681336	7.87988565051881	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGTTCACATGAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.68042832729	28.7092429804491	0.0146799254952939	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1947.81880103495	1947.81880103495
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGTTGTGTTAACC"	-4.01127658310588	13.0859393843445	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGTTGTGTTAACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1494.31404088058	32.9707769100491	0.0220641551963333	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1489.22779844784	1489.22779844784
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGTTTCACCGGTG"	-3.05341420593913	10.837185836676	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGTTTCACCGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1683.51500991716	34.1414178927326	0.020279841695271	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1683.51500991716	1683.51500991716
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGGTTTCCACAGGC"	4.59280409392659	-7.57733108913573	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGGTTTCCACAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2688.5030134802	29.9988857799331	0.0111582116997891	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2683.63652679901	2683.63652679901
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGTCAAGGTGCATG"	-4.19950566712077	10.224094367865	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGTCAAGGTGCATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2179.66331634938	36.1512477207282	0.016585702686081	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2175.9464474762	2175.9464474762
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGTCAGTGTCTAAC"	4.26267542418782	-7.40124514019164	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGTCAGTGTCTAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.49777830883	9.95215211051991	0.004283263019844	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2317.27414780035	2317.27414780035
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGTCATCACTGGTA"	3.46647419509236	-7.02961685573729	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGTCATCACTGGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.44109417226	30.1740382865392	0.0145948720723383	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.15308879684	2062.15308879684
"healthy-4003"	"2020-08-26-Control4003-c2:TGAGTCATCATCGCTC"	-3.72801194611247	11.4623718031677	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGAGTCATCATCGCTC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1680.79916647112	29.6774102917028	0.0176567259692372	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1674.296942206	1674.296942206
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCAGCATGGCCAC"	-4.21219716492351	12.205331779364	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCAGCATGGCCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2377.35531416856	37.7249843443682	0.0158684669975644	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2370.89286601276	2370.89286601276
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCAGGTAGCGATG"	4.35118641433064	-7.24754621898802	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCAGGTAGCGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.17572513478	1.73782774385298	0.00079346498269952	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2190.17572513478	2190.17572513478
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCTTAGCAATAAC"	-4.20201812210734	12.5431098707947	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCTTAGCAATAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1873.94897826559	45.2097147649065	0.0241253712290234	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1859.4871293119	1859.4871293119
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCTTAGTTAACGA"	-5.3619102043217	-4.31187250530394	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCTTAGTTAACGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3113.73948440326	31.6586921373398	0.0101674184034722	3247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3107.48521595615	3107.48521595615
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCTTGTGCCGAAA"	5.51605572280232	-9.93659498607787	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCTTGTGCCGAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.7698101081	21.8212384724763	0.00865657720311261	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2517.98845989736	2517.98845989736
"healthy-4003"	"2020-08-26-Control4003-c2:TGATCTTTCATGCAGT"	4.7904015975887	-7.47538759624632	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATCTTTCATGCAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.60273059045	29.2202809890404	0.0109908414118535	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2651.49342144062	2651.49342144062
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGCAGTTGCTTGA"	-3.20159969750102	10.0489959486756	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGCAGTTGCTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1701.94204817947	38.3343935742086	0.0225239123830416	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1699.8041378472	1699.8041378472
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTAGCAATTCC"	5.49429382857625	-9.63467981731566	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTAGCAATTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.72498491478	19.229598589884	0.00815253949183004	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.32112180831	2355.32112180831
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTAGTATGACA"	10.1141382652218	7.4890098341736	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTAGTATGACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.44165782878	31.3021453423016	0.0164883367435696	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1892.36476834924	1892.36476834924
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTAGTTGCTGT"	4.8670937019283	-7.76906635677489	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTAGTTGCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.32534665096	29.5776650777088	0.0124311141892978	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.5696631905	2376.5696631905
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTCATGCTGCG"	4.09527554091756	-6.80652286922606	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTCATGCTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.70863101132	28.8576927731761	0.011100356566478	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2596.44611681896	2596.44611681896
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTGTCCGGACT"	4.47722639617268	-7.41738941585692	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTGTCCGGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.54281020762	29.8902381701649	0.0117191674064596	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2547.77233158951	2547.77233158951
"healthy-4003"	"2020-08-26-Control4003-c2:TGATGGTGTTGCTCAA"	9.46468510207478	6.11155221546022	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATGGTGTTGCTCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1341.45276502361	44.8296421368	0.0334187258065781	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1336.85203050038	1336.85203050038
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTCTAGGAGAGTA"	10.5325437980587	5.99048755252687	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTCTAGGAGAGTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1628.97663284772	34.7619467769075	0.0213397455039843	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1619.50871054721	1619.50871054721
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTCTTCTCATGGA"	4.48164095458333	-7.22483923351439	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTCTTCTCATGGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.30533899594	35.6243971579391	0.0136058986808621	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2617.18607503508	2617.18607503508
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTCTTCTGGCCTT"	10.2324673133785	6.98156640613405	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTCTTCTGGCCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2241.26528780239	20.3161672584739	0.009064597292003	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2231.4264346307	2231.4264346307
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTTCAGACGGTCA"	-3.90806827965434	13.0872506865296	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTTCAGACGGTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2205.65261519676	41.1793161541191	0.0186699010852376	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2200.28644625185	2200.28644625185
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTTCAGCCATTGT"	10.3110119300777	7.71403930270997	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTTCAGCCATTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.87173183812	29.2570504958603	0.0154482745605293	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1889.16789046236	1889.16789046236
"healthy-4003"	"2020-08-26-Control4003-c2:TGATTTCTCACCGGTG"	3.52110709723775	-5.67966558849486	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGATTTCTCACCGGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.18488142205	1.83816597240787	0.00077915299766582	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.50369884421	2355.50369884421
"healthy-4003"	"2020-08-26-Control4003-c2:TGCACGGCAAATCGTC"	5.25402512130086	-9.44808199321898	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCACGGCAAATCGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2740.59492104137	13.3033818134311	0.00485419487254108	1773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2733.39960430876	2733.39960430876
"healthy-4003"	"2020-08-26-Control4003-c2:TGCACGGGTAGCTAAA"	-3.60853228989299	9.96956250751344	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCACGGGTAGCTAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1898.88487479249	40.6707578186192	0.0214182325419089	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1893.43639522062	1893.43639522062
"healthy-4003"	"2020-08-26-Control4003-c2:TGCACGGGTATGATCC"	10.4032274681026	7.64200685108034	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCACGGGTATGATCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2092.18538697285	43.3809971382864	0.0207347768550538	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2068.4692242244	2068.4692242244
"healthy-4003"	"2020-08-26-Control4003-c2:TGCACGGTCCACAGCG"	-1.47599957409557	9.00543973529664	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCACGGTCCACAGCG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2184.86440510909	34.8969148448401	0.0159721192597751	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2176.00774231196	2176.00774231196
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGATGTCTGATAC"	-0.474694411188918	8.69137666309205	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGATGTCTGATAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.37919009027	24.7306149320604	0.0136982940026155	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1797.72340074925	1797.72340074925
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGATGTGAATGTA"	5.56050266799275	-9.84661772167357	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGATGTGAATGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.81738209312	39.5705757308959	0.0161392834637279	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2448.1309425475	2448.1309425475
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGATGTTCACGAT"	-1.59819291058238	9.03259561145631	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGATGTTCACGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2036.12465069795	38.4099896523543	0.0188642623815728	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2027.8201524862	2027.8201524862
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGATTCCCGTTGT"	-2.02165589752849	9.06984708392946	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGATTCCCGTTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1778.15561397642	43.4543799771402	0.0244378948814074	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1776.11773412434	1776.11773412434
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGGCAGTTCGGTT"	0.297856842249078	8.44801805103151	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGGCAGTTCGGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1613.18318827481	32.1413278680881	0.0199241649068146	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1607.86624129159	1607.86624129159
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGGCCAAAGGGTC"	10.1574474769527	7.49786899173585	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGGCCAAAGGGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1898.47985949028	24.4747623534344	0.0128917682381975	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1893.39977475622	1893.39977475622
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGGCGTTGTTGTG"	3.55959000167195	-7.03735973751219	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGGCGTTGTTGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.04649295049	35.7585656600703	0.0157384832445194	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2270.6816179279	2270.6816179279
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGGCTCCAGCCTT"	5.55166592177693	-9.56443598186644	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGGCTCCAGCCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.91066957341	48.2960108631627	0.0215231432864234	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.17275084292	2235.17275084292
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGGCTCGATCCCT"	5.02723040160481	-7.76715853130492	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGGCTCGATCCCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.15220162746	10.4146917249949	0.00388296075020484	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2678.24838184072	2678.24838184072
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGTAAGGGAGTGG"	-2.90642700615581	9.795289970282	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGTAAGGGAGTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.40802815579	33.1084580587269	0.016186725388273	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.94066789924	2041.94066789924
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGTACACGTCGGT"	-2.65088019791301	4.11787793720094	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGTACACGTCGGT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2456.91750809758	0.0231754174687143	9.43272103859086e-06	1894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2456.91750809758	2456.91750809758
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGTAGTCTACGAT"	5.17666210707967	-10.2566852799621	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGTAGTCTACGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1968.97645330707	38.5257045449729	0.0195663612331501	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1962.63566430251	1962.63566430251
"healthy-4003"	"2020-08-26-Control4003-c2:TGCAGTATCTTAATCC"	-4.14301572266276	12.8635062941345	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCAGTATCTTAATCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2017.43856365906	10.9966039981822	0.00545077515433108	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2013.67769570582	2013.67769570582
"healthy-4003"	"2020-08-26-Control4003-c2:TGCATCCAGGTTCACT"	-1.35915551605876	8.73239705646364	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCATCCAGGTTCACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2398.54542653827	30.4026741602277	0.0126754631468901	1349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2389.53028017052	2389.53028017052
"healthy-4003"	"2020-08-26-Control4003-c2:TGCATCCAGTATGATG"	-4.33484588089641	13.1431922682556	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCATCCAGTATGATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2137.64379719709	27.5202403291704	0.0128741001495456	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2133.78195845805	2133.78195845805
"healthy-4003"	"2020-08-26-Control4003-c2:TGCATCCCATACTGTG"	-4.33045087280925	12.823893524054	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCATCCCATACTGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2343.60996144325	33.7833546713563	0.0144150926251191	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2340.32714036455	2340.32714036455
"healthy-4003"	"2020-08-26-Control4003-c2:TGCCGAGCATAGGAGC"	5.5589620071346	-10.1319885483948	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCCGAGCATAGGAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.16147818442	33.2863713247895	0.0143837721086363	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2307.06491431071	2307.06491431071
"healthy-4003"	"2020-08-26-Control4003-c2:TGCCGAGGTAACAAGT"	-3.94614491882976	12.2087220915589	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCCGAGGTAACAAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2121.89369131608	39.4357521540558	0.0185851686705361	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2114.48175319712	2114.48175319712
"healthy-4003"	"2020-08-26-Control4003-c2:TGCCGAGGTGAGAGGG"	9.16915478286092	6.02994821155397	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCCGAGGTGAGAGGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1438.77974718172	37.7086577429321	0.026208777136873	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1433.07610260229	1433.07610260229
"healthy-4003"	"2020-08-26-Control4003-c2:TGCCGAGTCACCTACC"	2.67130031165425	-4.40820648586424	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCCGAGTCACCTACC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2631.23061665081	0.630115331629692	0.000239475524358158	2141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2626.10099653238	2626.10099653238
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGACGAGGCTCAAG"	3.74167432364766	-6.86251356517943	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGACGAGGCTCAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.70688787474	5.28129082275102	0.00252125529033293	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2089.38855407233	2089.38855407233
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGACGGTTGTCAGT"	-3.596911529929	12.6474380263123	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGACGGTTGTCAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1862.79450716317	33.8154075874873	0.0181530530917146	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1858.86984828247	1858.86984828247
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGACGTCCACTTTA"	-0.0217591998284638	8.9407806166443	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGACGTCCACTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1942.40405645446	34.4192180111816	0.0177199063690221	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1937.93731329069	1937.93731329069
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGGCACATGTGACT"	3.89939941939656	-6.93463327800902	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGGCACATGTGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.82184799604	20.4307463039318	0.00997194867084963	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.19785564666	2047.19785564666
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGGCATCAAGGTGG"	-4.47013936463054	13.082435584906	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGGCATCAAGGTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1886.42512932405	33.9790558036305	0.018012406257441	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1878.24843506972	1878.24843506972
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGGGTGTCTAACGT"	-0.421137581497985	8.67644498432008	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGGGTGTCTAACGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.88624175472	32.1869061968145	0.0165410009620037	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.99038221941	1932.99038221941
"healthy-4003"	"2020-08-26-Control4003-c2:TGCGGGTGTGACTGTT"	4.35985340651814	-7.3409085503784	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCGGGTGTGACTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.14633378855	40.7126830713238	0.0185635962562492	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2190.07047668944	2190.07047668944
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTCCACACTTGGCG"	2.53794588622395	-4.00415565883788	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTCCACACTTGGCG"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2536.73185305676	23.4797202091884	0.00925589363373008	2278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2526.99351325825	2526.99351325825
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTCCAGTCTTTCAT"	-4.11887441101726	13.0349988707337	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTCCAGTCTTTCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2263.89086241443	41.1958915136433	0.0181969423515885	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2256.34739601566	2256.34739601566
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTCGTAGAGGCGGA"	-1.35391424122508	8.52614686572877	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTCGTAGAGGCGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.02507659493	18.634802064541	0.0100293598290351	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1854.50901246767	1854.50901246767
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTCGTAGGGATCTG"	5.5320483642513	-9.62133219158324	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTCGTAGGGATCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.96047689653	35.1738772833242	0.0140697733457728	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2498.75297417871	2498.75297417871
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTCGTGTCTTGTCC"	-3.80302010002788	10.4189071425232	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTCGTGTCTTGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1971.57258626126	35.756347798596	0.0181359530193111	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.03064995761	1964.03064995761
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAAAGAGCACTG"	-2.05434523049052	9.04482743823854	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAAAGAGCACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1845.6902798759	29.5779540473281	0.0160254157318945	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.54244502742	1837.54244502742
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAAAGGGAACAA"	-4.11179194870647	12.6133270033631	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAAAGGGAACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.00773273286	38.544233386646	0.0196053315279017	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1962.11114020737	1962.11114020737
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAACAGCCCACA"	4.95894398269002	-7.56483080303343	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAACAGCCCACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.40449765733	39.3567001379879	0.0148213577903891	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2644.58170529147	2644.58170529147
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAACAGTCGGTC"	3.87869062003438	-7.33729269420775	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAACAGTCGGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.39360940681	26.3936002500257	0.00964539610065355	1899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2730.88567547749	2730.88567547749
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAAGTCTGTAAC"	-0.179573173553306	8.65796659076539	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAAGTCTGTAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1650.42445241945	28.5486475720253	0.0172977609063985	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1648.6116604002	1648.6116604002
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAAGTTCGGCTG"	3.78286685523335	-7.75664236461791	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAAGTTCGGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.75114721571	36.4360133628391	0.0166774204051907	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.87468538542	2173.87468538542
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTGAATCAGAATAG"	3.9439181285793	-6.91023161327513	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTGAATCAGAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.30519686355	31.1799177425522	0.0130334197256399	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.70529191048	2389.70529191048
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGCAGAAGCGT"	4.02473845061604	-8.16543295299681	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGCAGAAGCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.99634437362	35.292874076934	0.0178607992759833	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1972.35661064705	1972.35661064705
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGGTAACTAAG"	5.53137840804402	-9.97229864513548	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGGTAACTAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.71100582215	3.02737531442312	0.00117444325899425	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2570.18195651136	2570.18195651136
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGGTATGTCCA"	5.5222279029781	-9.67329027568968	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGGTATGTCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.60411328188	34.7826793869256	0.0122318993788422	2082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2832.50158940595	2832.50158940595
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGGTTGGACTT"	3.15431155738179	-7.41387798702391	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGGTTGGACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.95391072039	7.37650932637546	0.00385608314190778	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1911.3568836131	1911.3568836131
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGTCAGTCTTT"	3.28136171874349	-7.36498453533324	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGTCAGTCTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1712.38956478672	21.127422119594	0.0123379764476815	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1703.89112246076	1703.89112246076
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTCGTCGACATAC"	-3.11772761765178	-5.61150553142699	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTCGTCGACATAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2630.95115949114	38.1945198163507	0.0145173807877673	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2627.33384459112	2627.33384459112
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTGCAGCTTTCTT"	-1.46754835072215	9.58343312824098	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTGCAGCTTTCTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1897.78631405985	28.1205959751758	0.0148175775991443	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1887.05869265895	1887.05869265895
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTGCGTATAGGGC"	-1.76495573940929	9.13222501361696	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTGCGTATAGGGC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1790.85229495355	41.0278396381127	0.0229096725362138	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1786.86310502408	1786.86310502408
"healthy-4003"	"2020-08-26-Control4003-c2:TGCTTGCTCTTGCAAG"	4.05516924437825	-6.38403990184935	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGCTTGCTCTTGCAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.25984729208	31.1523101508725	0.0116358933864345	1883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2675.11108119603	2675.11108119603
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAACTAGCACTAAA"	4.41417421874349	-7.49438478862914	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAACTAGCACTAAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.87316616281	30.3022552495448	0.01211182711393	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2499.14761968182	2499.14761968182
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAACTAGGCATGCA"	-3.85128245773967	12.7920913466248	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAACTAGGCATGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1891.75619219336	10.2522153906998	0.00541941685350746	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1889.57312459485	1889.57312459485
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAACTCATGCCGAC"	4.5546895461971	-7.06764843380126	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAACTCATGCCGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.48623521857	13.9852842752876	0.00601391832103155	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2320.95391465957	2320.95391465957
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAACTGTCTCGCGA"	-3.99918828430827	12.8136272200379	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAACTGTCTCGCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2184.79280611144	28.3675833129628	0.0129841068835503	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2181.14066521339	2181.14066521339
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGAGAGGCTAGCA"	-0.529718677431899	8.37358853900758	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGAGAGGCTAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1599.88332382761	27.6179990488823	0.017262508232668	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1595.7569273179	1595.7569273179
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGAGGTAGCGTCC"	-3.11554298821147	10.5648507841858	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGAGGTAGCGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1735.05737026824	35.2306060593643	0.0203051533990012	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1726.53684808288	1726.53684808288
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGAGTCCTGTTGC"	11.134462972253	5.20973250949708	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGAGTCCTGTTGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1799.78527653337	28.232692495697	0.0156867004435535	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1793.2414315975	1793.2414315975
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGAGTCTAGTGTG"	5.31882681426351	-10.0724096528259	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGAGTCTAGTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.90984440841	37.4000793951718	0.0169238032446449	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2204.14671022042	2204.14671022042
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGGACACTGTGAT"	4.10269131240193	-7.14678528225096	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGGACACTGTGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2177.45236775461	20.4243003377241	0.00937990683065347	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.18786747226	2167.18786747226
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGGACATAACGGG"	5.34795822676961	-10.0704460374084	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGGACATAACGGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.70933514706	39.9983171800463	0.0179872056783002	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2219.37673358278	2219.37673358278
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGGAGTCATGGCC"	-0.689003805548507	9.28518292987672	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGGAGTCATGGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1550.50908084666	14.5326024883576	0.0093727941795878	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1548.29320324834	1548.29320324834
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGGAGTGACTGTT"	-1.05229328098949	8.79418943012086	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGGAGTGACTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1622.22425549898	35.9558900795373	0.0221645619942216	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1615.93061227213	1615.93061227213
"healthy-4003"	"2020-08-26-Control4003-c2:TGGAGGAGTGCTTATG"	-0.219531307846862	8.7454795607361	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGAGGAGTGCTTATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1438.547076112	28.2508294167681	0.019638446239189	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1434.57478394013	1434.57478394013
"healthy-4003"	"2020-08-26-Control4003-c2:TGGATCAAGTCCCGGT"	-0.25224200907405	8.35299203479616	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGATCAAGTCCCGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1829.23775700244	35.089164462352	0.0191823967814071	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.68886158018	1827.68886158018
"healthy-4003"	"2020-08-26-Control4003-c2:TGGATCACATCGCTAA"	3.86006393012349	-7.62423565303954	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGATCACATCGCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.02886024018	39.8484497466859	0.0185166892893056	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.42991220443	2150.42991220443
"healthy-4003"	"2020-08-26-Control4003-c2:TGGATCAGTGATACCT"	0.257380773394746	8.2668475874695	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGATCAGTGATACCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1778.55338501641	27.7362665783345	0.0155948462452695	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1765.48780454929	1765.48780454929
"healthy-4003"	"2020-08-26-Control4003-c2:TGGATGTTCACAACCA"	2.62519301947896	-4.35135700618895	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGATGTTCACAACCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2362.90891838819	3.63353968107991	0.00153774005117322	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2355.57713570069	2355.57713570069
"healthy-4003"	"2020-08-26-Control4003-c2:TGGATGTTCATTGGTG"	-3.40532336655315	9.9670085676941	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGATGTTCATTGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1761.7990064447	28.3151549446777	0.0160717282965311	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1757.60743383405	1757.60743383405
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGAGTACTGTC"	10.0717312293941	7.5816325911316	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGAGTACTGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1704.87627427279	31.9909610619912	0.0187643886801327	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1698.14321804309	1698.14321804309
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGCAACTGCCG"	-1.7602404159611	8.55025861347047	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGCAACTGCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1918.71948499949	31.9084836111089	0.0166300930701797	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.20338296758	1911.20338296758
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGTCACATTGG"	-3.95633016052898	11.6633910902771	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGTCACATTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1646.3273053225	38.4192356146163	0.0233363289853777	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1642.05125267663	1642.05125267663
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGTCACCGACG"	-4.04753051224406	12.4899377592835	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGTCACCGACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1817.17159657858	39.465906699903	0.0217183158564719	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1813.00488882959	1813.00488882959
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGTCACTTATC"	-3.06067667427714	-5.66089584743651	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGTCACTTATC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2349.80948979581	34.8632520162946	0.0148366291683178	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2345.95332257675	2345.95332257675
"healthy-4003"	"2020-08-26-Control4003-c2:TGGCGTGTCGCTTGCT"	-3.58997855606731	12.4124278792175	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGCGTGTCGCTTGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1782.68664580151	44.3568558196095	0.024882026195729	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1778.17683033157	1778.17683033157
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAAGCACCTATCC"	-0.301731566817123	8.01813933933107	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAAGCACCTATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.46374448049	4.49825586293468	0.00233619348888252	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1919.08536389915	1919.08536389915
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAAGCAGCAGTCC"	3.8017906146938	-6.36306288158568	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAAGCAGCAGTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.97173696936	3.07679968594136	0.00126255041831864	1534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2435.76344618971	2435.76344618971
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAAGCAGCATGCC"	4.59233583983724	-7.63332369243773	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAAGCAGCATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.94559711958	33.9032302095711	0.0135887653216617	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2493.61558592803	2493.61558592803
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAAGGTGTGTTTG"	4.39470686492268	-7.39875414287718	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAAGGTGTGTTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.36382010916	33.5604072137367	0.0155418030538458	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.33152871022	2154.33152871022
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAAGTCACCGGGT"	4.07912029799764	-6.8510747185913	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAAGTCACCGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2460.18896782667	31.6353644325722	0.0128589164679162	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2453.78448168581	2453.78448168581
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGAGATCTCGAACA"	-3.39033399048503	10.1663160094055	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGAGATCTCGAACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.97626126255	42.6240729402954	0.0231781528876462	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.10827235548	1837.10827235548
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGATTAGTATGTAG"	0.775585849850815	8.60636804187623	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGATTAGTATGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1281.83140271305	43.1728041207575	0.0336805636290238	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1279.72277227346	1279.72277227346
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGATTCAACCGACC"	4.20954718169515	-7.66891863262328	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGATTCAACCGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1976.23734462011	19.3024068520149	0.00976725133980573	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1973.00516427171	1973.00516427171
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGATTGTACAAACA"	5.43168892440144	-10.2208671799866	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGATTGTACAAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.58821801693	32.4711802150853	0.013743901695379	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.85614938182	2359.85614938182
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGATTGTAGATTGA"	-1.43816922131236	9.26103589618532	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGATTGTAGATTGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1838.70797204605	35.3136891619517	0.019205708409833	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1836.88343331468	1836.88343331468
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGATTTCATGCCAA"	-3.7435134452885	13.0639343031677	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGATTTCATGCCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2589.00037433272	35.3631928646177	0.0136590141952885	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2569.0452096072	2569.0452096072
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGCGTAGAACTTCC"	5.14986624297444	-9.2900543442932	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGCGTAGAACTTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.33663744631	24.1056113983713	0.0107790620583391	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.91377586016	2231.91377586016
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGCTGAGGAGAGGC"	9.54836620864217	6.05982778156129	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGCTGAGGAGAGGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1707.87866373508	37.8726248590178	0.022175243278812	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1698.06082722108	1698.06082722108
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGCTGAGTTAGTGA"	-0.901211897761184	9.0132903822693	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGCTGAGTTAGTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.95814349293	31.1861419860715	0.017306807096873	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.41563288272	1800.41563288272
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGCTGGTACGTACT"	4.21531261977498	-7.19188644802245	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGCTGGTACGTACT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.41046184497	8.08219191900113	0.00321434866806542	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.87006187831	2511.87006187831
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGCTGTCTGGGTCG"	10.6186748939449	6.22345349872438	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGCTGTCTGGGTCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1752.1490689292	31.1824542344001	0.017796690240207	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1740.95695905664	1740.95695905664
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGTTACAAACTAAG"	4.77241673049275	-8.16652300274047	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGTTACAAACTAAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.45338643766	30.1627508723178	0.0118171603182202	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2546.42416082993	2546.42416082993
"healthy-4003"	"2020-08-26-Control4003-c2:TGGGTTATCTTGGTGA"	2.67824282225911	-4.2656665078369	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGGTTATCTTGGTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2485.29993596888	27.9881118803022	0.0112614624396999	1879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2482.38431109125	2482.38431109125
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTACACACGACTAT"	9.73028149184529	6.78383967960206	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTACACACGACTAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2245.433491432	33.4360844008099	0.0148907035226799	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2230.02747490406	2230.02747490406
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTACATCCAATCTT"	5.60897268828694	-9.71452429210814	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTACATCCAATCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.70833002656	42.3000747762026	0.0152119783004349	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2776.85377771474	2776.85377771474
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTGATAGCCTATTG"	-0.147645081312019	8.30823896015016	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTGATAGCCTATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1707.06445101005	35.8905301569336	0.0210247071431296	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1701.90676958376	1701.90676958376
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTGATAGGCAGTCA"	-2.1624735397404	9.51217076862184	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTGATAGGCAGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.6179375171	39.7903099430272	0.0221473409076706	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.62000550409	1792.62000550409
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTGATGTGTGTGTT"	-3.83435759964641	12.8667516478333	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTGATGTGTGTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1740.80579234761	41.5652363565793	0.0238770094511952	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1740.80579234761	1740.80579234761
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTGATTCCGCATAA"	-3.70904550972636	-4.63885404979857	"2020-08-26-Control4003-c2"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTGATTCCGCATAA"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2910.07829091392	28.3128049390417	0.0097292244773765	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2902.52209221578	2902.52209221578
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTTAGAGAATTGTG"	5.69470181044881	-10.0109462968078	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTTAGAGAATTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.49181170214	19.8178587250979	0.00802182732653689	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2463.92264623828	2463.92264623828
"healthy-4003"	"2020-08-26-Control4003-c2:TGGTTAGGTTCCTACC"	-3.46794782105144	10.8286447294983	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGGTTAGGTTCCTACC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2046.13596369563	28.5935883231384	0.0139744322129474	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2032.0509334498	2032.0509334498
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAACGAGGTGCATG"	-2.39846144142802	9.10560414874879	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAACGAGGTGCATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1844.01652948695	34.6450307816587	0.0187878092347132	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1836.18898727873	1836.18898727873
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAACGCAGACGGAT"	2.71596374091451	-6.40786220943602	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAACGCAGACGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.80464075797	38.9251370732563	0.0153744631187669	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2530.53623612121	2530.53623612121
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAACGGTATCTTCT"	10.3991819816524	7.02448937976686	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAACGGTATCTTCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2079.23578803303	35.8549478883809	0.0172442914337772	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2073.66871353953	2073.66871353953
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAAGCCATAGCACT"	6.75840248641316	-1.75151386177214	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAAGCCATAGCACT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2692.8072342815	22.5203937794559	0.00836316595289628	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2681.07210748737	2681.07210748737
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAAGCGTTGCATGT"	0.273610179393929	8.32992646777955	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAAGCGTTGCATGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1539.56585876516	3.90492086531653	0.00253637792958631	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1539.56585876516	1539.56585876516
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAAGCTCAAATGAG"	4.5024548965389	-7.01239635860594	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAAGCTCAAATGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.00508151835	30.8857869119834	0.0125449728531575	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2455.19463978488	2455.19463978488
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAAGCTCTTCACGC"	5.60202612456624	-9.63464357769164	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAAGCTCTTCACGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.73005873145	4.48826748695128	0.0018366461839411	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.23534160132	2439.23534160132
"healthy-4003"	"2020-08-26-Control4003-c2:TGTACAGAGGTGAGCT"	-2.56424079361613	9.56006429279176	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTACAGAGGTGAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1763.93801675262	37.6349316523034	0.0213357449609191	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1761.75364939884	1761.75364939884
"healthy-4003"	"2020-08-26-Control4003-c2:TGTACAGGTAAGACCG"	5.42215122756307	-9.66112139141234	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTACAGGTAAGACCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2842.17726700664	17.6142817750587	0.0061974606508657	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2833.50979792544	2833.50979792544
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAGACAGGATTACA"	5.56625332412068	-9.92135622417601	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAGACAGGATTACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.47451428075	30.0536183472552	0.0127428209061739	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.69004604787	2354.69004604787
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAGACAGTGAGTGC"	-3.33057866516765	12.4343280562195	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAGACAGTGAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2037.61466609995	28.9192527092526	0.0141926995277301	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2030.11357734095	2030.11357734095
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAGACAGTGGATAT"	10.3773046928341	7.07581851566163	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAGACAGTGGATAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1816.20325355605	38.7704751113379	0.02134699133229	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1800.34350797537	1800.34350797537
"healthy-4003"	"2020-08-26-Control4003-c2:TGTAGACGTTGCCTAA"	1.85016920146291	-5.99021055614623	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTAGACGTTGCCTAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2341.76180763113	38.0129318250266	0.0162326209698841	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2334.15490401933	2334.15490401933
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCAGACAACACAAA"	3.51014723357503	-7.28950884258422	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCAGACAACACAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2006.85917305704	22.7163401598269	0.011319349391728	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2005.31008757783	2005.31008757783
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCAGACATAATGAG"	2.8595777946407	-7.52476169979247	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCAGACATAATGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.53999132421	37.7142830384177	0.0165592187983886	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2274.44673380172	2274.44673380172
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCAGAGTAATACCC"	5.46936192092244	-10.0270748368469	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCAGAGTAATACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.02553730608	35.4767732579261	0.0143862148713518	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.80657240061	2462.80657240061
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCAGATCCAGCACG"	4.30544390258138	-7.13875200664672	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCAGATCCAGCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.6136666928	26.1297365539853	0.010576213070562	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.70536038935	2467.70536038935
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCACAGTGTAGTA"	-4.09057078781779	13.2415294417175	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCACAGTGTAGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1772.55993322017	32.7831995888263	0.0184948327977096	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1772.55993322017	1772.55993322017
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCACCATCTTCGC"	-0.0970054966514886	8.53330895984498	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCACCATCTTCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.01836548719	24.9440225130744	0.0136603349585803	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1822.33723664096	1822.33723664096
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCACTCAACTACG"	-0.46883867207225	8.51418683612672	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCACTCAACTACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2199.38864441417	33.0892568870659	0.0150447520819493	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2186.61883620074	2186.61883620074
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCACTCGGCCCAA"	-0.891466359526473	8.46430013263551	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCACTCGGCCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.1991107471	35.3039033986033	0.0180934396721233	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1943.76271332984	1943.76271332984
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCCACACACCAGC"	-0.270476172596771	9.34272096240846	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCCACACACCAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1898.5255256053	30.1367089366069	0.015873744403304	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1887.28848309876	1887.28848309876
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCCACACGTTGGC"	-4.43034539642985	13.0918168791565	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCCACACGTTGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2179.31378508653	43.0422572408527	0.0197503716699263	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2166.68151250338	2166.68151250338
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCTGAGCTGGTGA"	10.9177576499874	6.36036107623903	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCTGAGCTGGTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1865.37974947276	0.354740704191854	0.000190170770478301	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1856.21700979224	1856.21700979224
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCTGGTACTCGAT"	-2.38356194916423	9.66627690875856	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCTGGTACTCGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.12495036581	24.6952193641868	0.0147687643550706	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1672.12495036581	1672.12495036581
"healthy-4003"	"2020-08-26-Control4003-c2:TGTCCTGGTCTGTCCT"	10.3864036994869	7.02738378131715	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTCCTGGTCTGTCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1788.35741699204	22.7339394771251	0.0127121901143021	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1786.49049107765	1786.49049107765
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGAGTTCTCATGCC"	-3.59077201309856	10.4834928282532	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGAGTTCTCATGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.49410808549	35.92739480839	0.0178877272598206	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2004.56482532663	2004.56482532663
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGATGCATGGAAGC"	5.28684534606282	-9.49366476452025	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGATGCATGGAAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.47047240832	18.615067192627	0.0069447014560477	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2674.36993165795	2674.36993165795
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGATGTCTTGAGCA"	-1.82638810101207	9.24562070453493	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGATGTCTTGAGCA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1670.96872275774	40.6138200362751	0.0243055537085378	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1658.90240147244	1658.90240147244
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGCGGCATAGCTGT"	4.84862055358235	-7.87834265148314	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGCGGCATAGCTGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.41551995655	27.3880254979393	0.0121486146877072	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2251.87363432605	2251.87363432605
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGGCGAGATTGCGG"	9.13200821456258	5.73512694919435	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGGCGAGATTGCGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1446.91535570973	42.3626999003391	0.0292779392610425	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1434.55206268084	1434.55206268084
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGGCGTCTGTCGCT"	5.49591269072835	-9.86143209850463	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGGCGTCTGTCGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.21064301049	45.7359616346766	0.0174417573037414	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2620.08764196992	2620.08764196992
"healthy-4003"	"2020-08-26-Control4003-c2:TGTGGCGTCTGTGTGA"	5.55499996718709	-9.96446707164916	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.TGTGGCGTCTGTGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.481308063	44.965514615992	0.01826766446233	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.27999070697	2457.27999070697
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGAGTCAAGTCTG"	-4.19343648377116	12.7866391905579	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGAGTCAAGTCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1985.53234389437	37.7045656774688	0.0189896507067299	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1962.97202571242	1962.97202571242
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGTTCAACCACGC"	4.07201542434041	-6.7791695824829	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGTTCAACCACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.84063557156	0	0	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2517.79348828493	2517.79348828493
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGTTTCTCCTGTG"	-0.162224124104339	8.35062215411989	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGTTTCTCCTGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1524.21660092353	36.6962838271215	0.024075504626368	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1522.06139861836	1522.06139861836
"healthy-4003"	"2020-08-26-Control4003-c3:CCACTTGAGGAGGGTG"	-2.40126667442973	9.37566182697145	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACTTGAGGAGGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1474.24306816691	40.063771735254	0.0271758250727743	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1469.70029753787	1469.70029753787
"healthy-4003"	"2020-08-26-Control4003-c3:CCACTTGAGGTTGTTC"	4.25644650039021	-6.68467237865599	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACTTGAGGTTGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.79152848648	34.1008510847172	0.0144999463905132	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2348.12111997098	2348.12111997098
"healthy-4003"	"2020-08-26-Control4003-c3:CCACTTGCAGCGACAA"	-4.29517255249675	12.759157157782	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACTTGCAGCGACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2411.20451681874	36.5454833518598	0.0151565257517337	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2408.11242202401	2408.11242202401
"healthy-4003"	"2020-08-26-Control4003-c3:CCACTTGGTACCTATG"	4.19972099837605	-7.28984358226927	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACTTGGTACCTATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.62850448373	28.9402470667472	0.0131092015744357	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2204.03169237909	2204.03169237909
"healthy-4003"	"2020-08-26-Control4003-c3:CCATAAGCACAATGCT"	-2.54463754120525	8.95038793170778	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCATAAGCACAATGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.72773439609	32.4331834456973	0.0167550337112961	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1929.23597723921	1929.23597723921
"healthy-4003"	"2020-08-26-Control4003-c3:CCATAAGCACCCTATC"	-4.18650565567668	12.9318513640198	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCATAAGCACCCTATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2435.42828905324	35.2133312900667	0.0144587838813992	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2432.02217576639	2432.02217576639
"healthy-4003"	"2020-08-26-Control4003-c3:CCATAAGTCGGTTCAA"	4.93195261534993	-7.46000101482543	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCATAAGTCGGTTCAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.99909034887	8.87592147085125	0.00346715805654511	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.14283127296	2556.14283127296
"healthy-4003"	"2020-08-26-Control4003-c3:CCATCACAGAGAGCGG"	-3.51131878319438	12.646927810553	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCATCACAGAGAGCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1552.46031475124	11.1199787594596	0.00716281031714583	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1545.48960776863	1545.48960776863
"healthy-4003"	"2020-08-26-Control4003-c3:CCATCACAGCACTGGA"	-0.298315147787887	8.78887364948121	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCATCACAGCACTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2267.1345219449	39.1268437333284	0.0172582805980841	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2255.59716470361	2255.59716470361
"healthy-4003"	"2020-08-26-Control4003-c3:CCCAACTAGGATTTAG"	2.73218144950215	-4.45187857067259	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCAACTAGGATTTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2520.88663660134	12.3253866105739	0.00488930617966661	1891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2510.08129303905	2510.08129303905
"healthy-4003"	"2020-08-26-Control4003-c3:CCCAACTCATTGTAGC"	-3.57542238655742	10.6542968519959	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCAACTCATTGTAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.81463530813	33.1325594573644	0.0168286840534274	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.20467768579	1964.20467768579
"healthy-4003"	"2020-08-26-Control4003-c3:CCCAACTGTCCGAAAG"	-3.55242667618449	-4.7936091653076	"2020-08-26-Control4003-c3"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCAACTGTCCGAAAG"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3101.39935178342	31.1919256995611	0.010057371580227	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3098.32013626514	3098.32013626514
"healthy-4003"	"2020-08-26-Control4003-c3:CCCATTGGTGGATTTC"	-1.93898079815562	8.87361142719118	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCATTGGTGGATTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2738.96942014479	28.2795253402611	0.0103248780845338	2191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2717.7156431698	2717.7156431698
"healthy-4003"	"2020-08-26-Control4003-c3:CCCATTGTCTAGTGTG"	-1.61337480965312	8.68725106799928	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCATTGTCTAGTGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.97142189219	28.5998547703896	0.0153599858913654	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1858.31400318724	1858.31400318724
"healthy-4003"	"2020-08-26-Control4003-c3:CCCATTGTCTGCCCTA"	-1.43493853035625	9.54561231220094	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCATTGTCTGCCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1891.31028207028	34.6383518498085	0.0183144733987764	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.55433067994	1882.55433067994
"healthy-4003"	"2020-08-26-Control4003-c3:CCCGAAGCATCTCATT"	-0.641659955412704	8.47917268359987	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCGAAGCATCTCATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1783.02772837784	24.1427650844435	0.0135403194802855	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1779.46208435367	1779.46208435367
"healthy-4003"	"2020-08-26-Control4003-c3:CCCGGAACAGCCCACA"	-0.135701711208183	8.23612878406373	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCGGAACAGCCCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1576.75900870265	36.6111343723889	0.0232192327237834	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1574.67384103851	1574.67384103851
"healthy-4003"	"2020-08-26-Control4003-c3:CCCGGAAGTCGAGTTT"	-4.10882029953654	-4.81559421932372	"2020-08-26-Control4003-c3"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCGGAAGTCGAGTTT"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2489.56833355289	36.2592331724976	0.0145644659292206	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2488.37413005315	2488.37413005315
"healthy-4003"	"2020-08-26-Control4003-c3:CCCGGAAGTGCACGCT"	-2.16969428482707	9.56235215747682	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCGGAAGTGCACGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1709.19966698848	33.3202394168533	0.0194946442246632	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1700.46970951662	1700.46970951662
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTAACGTCTGATCA"	-2.43937216225322	10.5107784041199	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTAACGTCTGATCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1808.08595458317	27.2456858449201	0.015068800117526	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.61032355225	1801.61032355225
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTCAAAGACTCCGC"	5.49473919448201	-10.0939111939636	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTCAAAGACTCCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.7420146278	24.4904465067873	0.010321579993023	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.7420146278	2372.7420146278
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTCAACACCGGAAA"	0.022179619490546	8.83463380420534	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTCAACACCGGAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.36188200856	5.97160000860705	0.00352647598369459	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1690.21666610327	1690.21666610327
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTCAAGTTGTCAGT"	4.75744738158528	-8.04431154644164	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTCAAGTTGTCAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.45138354963	34.0880028061956	0.0128418260049698	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2647.04245057075	2647.04245057075
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTCAATCTCGTTTA"	4.40451349791829	-6.88002350246581	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTCAATCTCGTTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2086.80307784683	24.3221032978767	0.0116551981143196	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2086.80307784683	2086.80307784683
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTCTCAGTGGATTA"	-4.06737313690837	10.8011255034241	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTCTCAGTGGATTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2145.79518526569	33.8033807011559	0.0157533118413491	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2143.98736570299	2143.98736570299
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTGATAGATGCTTC"	4.74015249785726	-7.40962364589842	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTGATAGATGCTTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2760.62911381447	16.8841790933017	0.00611606209932783	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2752.96938465725	2752.96938465725
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGGATTCAACACGT"	2.9734636741573	-7.18709375774535	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGGATTCAACACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.80650953836	38.7403675097976	0.0185289108930273	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2084.98846807587	2084.98846807587
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGGATTCAAGATAG"	4.26364912566487	-7.11164095317992	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGGATTCAAGATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.25385646926	16.1284853086083	0.00676742230578086	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2378.17179414829	2378.17179414829
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGGCGCATCTAGAC"	3.66224112090413	-6.9997277489868	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGGCGCATCTAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.17670467018	35.2788619353659	0.0151530001415265	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2326.81411888872	2326.81411888872
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGGCGCATGCCGGT"	-1.08925710144694	9.2216062315735	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGGCGCATGCCGGT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1975.25893805306	29.5479764010149	0.0149590394614993	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1970.78674243139	1970.78674243139
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTAGAGGCTTAAA"	4.48711695250813	-7.86139871990355	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTAGAGGCTTAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1976.2878985121	35.0679105819081	0.0177443330034606	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1962.00952308863	1962.00952308863
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTAGCACTGGAAG"	-1.71058366718944	9.28810117328493	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTAGCACTGGAAG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1839.68953203882	30.8613117553278	0.0167752825777761	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1836.32911779172	1836.32911779172
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTCCAGGTCATCT"	-4.06700072708781	10.3062276610169	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTCCAGGTCATCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2227.57933888348	32.5961651595308	0.0146329985157201	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2220.76907023891	2220.76907023891
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTCCCAAGGCTTT"	5.55311550673787	-9.95241644298705	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTCCCAAGGCTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.96561925591	33.338749288125	0.0143765603988654	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2310.35799608422	2310.35799608422
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTGAGTCGCTTGG"	9.77483334121053	6.87203166568605	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTGAGTCGCTTGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1792.41241108913	14.0133908527155	0.00781817329874466	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1781.43801197566	1781.43801197566
"healthy-4003"	"2020-08-26-Control4003-c2:ATCGTGATCTCACGAA"	-1.95634541931804	9.46018693530885	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCGTGATCTCACGAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2029.39480873335	33.0155879178624	0.0162686864949995	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2022.48395943477	2022.48395943477
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTAAGGTCATAA"	2.26098026809041	-6.66141083156737	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTAAGGTCATAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.10466397697	31.197909258857	0.0159002268490725	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1955.2263644655	1955.2263644655
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTAGTATGCTAC"	5.29817690429036	-10.1785288087097	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTAGTATGCTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.72791878833	12.4128756557301	0.00512139814023989	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2422.40454936708	2422.40454936708
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTAGTGACAGCA"	-0.118609229952651	8.43430898273317	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTAGTGACAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1456.63982900478	43.2216054292124	0.0296721293545451	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1456.63982900478	1456.63982900478
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTATCAAGCCAT"	0.504083355038804	8.70792958820192	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTATCAAGCCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.46657917126	28.253072644407	0.0155111671921325	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.16778755751	1809.16778755751
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTATCACCGACG"	5.10919298705403	-9.92120172893675	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTATCACCGACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1976.79532579797	41.3845122108663	0.0209351528055444	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1973.33152240676	1973.33152240676
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTCTATCTATTGTC"	5.5781737762386	-9.96970178997191	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTCTATCTATTGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.73976749669	34.0453027794211	0.0132074242748264	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2567.42761017689	2567.42761017689
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTTCACATTGCTGA"	-1.94799910011943	10.5090255507263	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTTCACATTGCTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1389.89400373926	45.650796817395	0.0328448044919827	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1387.56369122725	1387.56369122725
"healthy-4003"	"2020-08-26-Control4003-c2:ATCTTCAGTAGAATGT"	4.68422474440877	-8.28873350536498	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATCTTCAGTAGAATGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.90897516615	30.173391105479	0.013886173535259	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.03023891412	2167.03023891412
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAAAGAGTCCTGCG"	3.56139864501302	-6.81770660793456	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAAAGAGTCCTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.5609507393	2.75696006090893	0.00115762733683263	1538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2379.18812465266	2379.18812465266
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAAAGGTCAGACGA"	-4.22996221008952	12.8696069487366	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAAAGGTCAGACGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1917.77497070113	36.0701687360737	0.0188083426299419	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1909.80959250657	1909.80959250657
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAAAGTCGAACCTA"	-4.21635804596599	12.9166040190491	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAAAGTCGAACCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1937.98795364996	11.9345486356297	0.00615821610921393	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1935.89211366801	1935.89211366801
"healthy-4003"	"2020-08-26-Control4003-c2:ATGACCACAACGGTAG"	-4.33759723129924	13.029664970282	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGACCACAACGGTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2319.91082687629	40.5597275859358	0.0174833132015461	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2304.18285501667	2304.18285501667
"healthy-4003"	"2020-08-26-Control4003-c2:ATGACCACAGAGGAAA"	5.51863016661946	-10.2000789872375	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGACCACAGAGGAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.98403562583	20.7622409480805	0.00837192524218854	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2474.58686197841	2474.58686197841
"healthy-4003"	"2020-08-26-Control4003-c2:ATGACCATCCAAATGC"	4.86635841903035	-7.75147869503173	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGACCATCCAAATGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.31924725176	28.4571977618322	0.0125510325889596	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.31924725176	2267.31924725176
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAGGGAGCAAGGAA"	0.14738985624854	8.57511804187623	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAGGGAGCAAGGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1678.67933842732	24.9708460950512	0.0148752924536769	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1667.63633313117	1667.63633313117
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAGGGTCAGATTGC"	4.5121828514034	-6.77365448391112	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAGGGTCAGATTGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2593.67161671054	25.1719688293224	0.00970514874247927	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2585.91328638622	2585.91328638622
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAGTCAGACTTAAG"	-0.663589040667373	8.83643434131471	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAGTCAGACTTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1512.32178288202	0	0	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1510.31874536515	1510.31874536515
"healthy-4003"	"2020-08-26-Control4003-c2:ATGAGTCCATTGTACG"	0.191528027027291	8.36636731708375	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGAGTCCATTGTACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.93417551883	26.2806851793527	0.0144563458530353	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1811.65183858055	1811.65183858055
"healthy-4003"	"2020-08-26-Control4003-c2:ATGCATGCAGGTGTTT"	5.65496649321858	-9.82419111644896	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGCATGCAGGTGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2737.52271254218	17.5379465806556	0.00640650267495647	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2731.31594101058	2731.31594101058
"healthy-4003"	"2020-08-26-Control4003-c2:ATGCCTCTCGCCCAGA"	-4.24622664871867	13.0655660399231	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGCCTCTCGCCCAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2104.22505752777	41.1109013880493	0.0195373119624144	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2100.40240568337	2100.40240568337
"healthy-4003"	"2020-08-26-Control4003-c2:ATGCCTCTCTATCACT"	-0.112811977893668	8.13456914508668	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGCCTCTCTATCACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1928.37874965807	33.2379873522349	0.0172362339909255	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1920.48520083074	1920.48520083074
"healthy-4003"	"2020-08-26-Control4003-c2:ATGCGATTCAACCTTT"	-3.88818703118022	11.7956428297791	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGCGATTCAACCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.33059330708	43.0846952819584	0.0206906124418663	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2075.27163541382	2075.27163541382
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGAGGAGTAGACAT"	4.33290590819661	-7.93218471920165	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGAGGAGTAGACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.46298937081	1.21162952444182	0.000533413720633609	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.0041693191	2267.0041693191
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGAGGCATGACACT"	-0.603897253901321	8.60758779132692	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGAGGCATGACACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2060.11540582288	34.5507263792703	0.016771257707997	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2058.39839265241	2058.39839265241
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGATCCAGTCGCTG"	-0.386955062777358	8.30826089465944	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGATCCAGTCGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1340.49126362705	19.0474427238173	0.0142093001578238	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1335.96323425198	1335.96323425198
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGATCGTCGTACTA"	2.85345711287801	-7.4781532517639	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGATCGTCGTACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1874.16286366625	27.060724553837	0.0144388329736193	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1872.40671219014	1872.40671219014
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGATCGTTCCTACC"	4.7955342727596	-7.4763598672119	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGATCGTTCCTACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.57287961712	21.5263745217952	0.00841671988835675	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2554.24197200425	2554.24197200425
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGATCGTTTCACTT"	-7.35540042343791	0.203441626671232	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGATCGTTTCACTT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2828.0699979198	18.7454352306529	0.00662834910184017	3376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2820.13387906175	2820.13387906175
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGAGAGCACCTGC"	3.16160955008809	-5.18928911602172	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGAGAGCACCTGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2751.09414381537	36.5358045632368	0.0132804632096548	2425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2747.27440840173	2747.27440840173
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGAGAGCTGTCCG"	-0.389607707888442	8.37226579273073	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGAGAGCTGTCCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1917.53269843632	37.2733751607638	0.0194381953388116	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1915.89158757499	1915.89158757499
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGAGCATACCGTA"	0.0901062647694766	8.15702912891237	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGAGCATACCGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1553.25109525009	28.059036334405	0.0180647136964595	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1553.25109525009	1553.25109525009
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGAGGTGCATTTG"	-3.20672545853313	10.7550878294739	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGAGGTGCATTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1667.84188320725	37.9487095005694	0.0227531817510148	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1651.65265768071	1651.65265768071
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGTTAGCACAAAT"	2.71042575415913	-4.49703075802001	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGTTAGCACAAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2868.60037827484	33.9864505944912	0.0118477466753074	2546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2862.41443663778	2862.41443663778
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGTTGTGTTACAC"	5.37779345092122	-10.2224340668884	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGTTGTGTTACAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.22668510732	1.74593936894531	0.000808969410392813	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2155.28385148911	2155.28385148911
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGGTTTCTTCCCGA"	6.75530495223348	-1.68995883381041	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGGTTTCTTCCCGA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2490.47988219112	6.21357948566457	0.00249493261523473	1545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2486.60502547053	2486.60502547053
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGTTGAGCTCCACG"	5.65443863448445	-10.0911054841247	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGTTGAGCTCCACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.5708757081	33.1479814678147	0.0142170164386479	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.19582109362	2327.19582109362
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGTTGCAGCATTGT"	5.45907892760579	-10.1935224763122	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGTTGCAGCATTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.66648626836	0	0	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2168.74209493084	2168.74209493084
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGTTGCAGGAAGTC"	-3.59044704857524	10.3578777083191	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGTTGCAGGAAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1846.65874622287	41.5918662477325	0.0225227678545394	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1841.03790865224	1841.03790865224
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGTTGTCCACTTCG"	-2.16233525696452	9.74062821948854	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGTTGTCCACTTCG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1719.30642544469	34.7451877210721	0.0202088395685984	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1715.56922744144	1715.56922744144
"healthy-4003"	"2020-08-26-Control4003-c2:ATGGTTGTCGAACGGA"	0.0618312834644735	8.29775426471559	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGGTTGTCGAACGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.65544102826	33.6369351743212	0.0184346778125768	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1824.65544102826	1824.65544102826
"healthy-4003"	"2020-08-26-Control4003-c2:ATGTCCCAGTGCACTT"	3.63487209853474	-6.95127108013304	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGTCCCAGTGCACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.6405237983	22.2989207537802	0.0104756629898178	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2122.24312192154	2122.24312192154
"healthy-4003"	"2020-08-26-Control4003-c2:ATGTCTTAGATACCAA"	-1.77024028721507	9.34206006610719	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGTCTTAGATACCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1945.78965483438	42.9528026700469	0.0220747409995367	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1938.80218539537	1938.80218539537
"healthy-4003"	"2020-08-26-Control4003-c2:ATGTCTTCACTCCCTA"	-2.89817462387736	10.0369262465271	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATGTCTTCACTCCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.58344322872	34.5098801594486	0.0187902598635977	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1836.58344322872	1836.58344322872
"healthy-4003"	"2020-08-26-Control4003-c2:ATTACCTAGTAGATCA"	4.44805779036824	-7.70265390789183	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTACCTAGTAGATCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1808.38854990439	24.7962006938807	0.0137117660334621	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1804.39495033579	1804.39495033579
"healthy-4003"	"2020-08-26-Control4003-c2:ATTACCTCACCAACAT"	5.54773439940755	-10.1298847428528	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTACCTCACCAACAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.91557401597	11.7712038434271	0.00478520643869489	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2458.56029079024	2458.56029079024
"healthy-4003"	"2020-08-26-Control4003-c2:ATTACCTCAGGAACCA"	9.73740353164021	7.47912452304689	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTACCTCAGGAACCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.37355383215	29.4926468498379	0.0140349376701986	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2087.24383165347	2087.24383165347
"healthy-4003"	"2020-08-26-Control4003-c2:ATTACTCCAGGCTTGC"	4.13315071639363	-6.82554056560668	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTACTCCAGGCTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2891.29126535121	50.1935445734233	0.0173602518621818	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2883.55347861824	2883.55347861824
"healthy-4003"	"2020-08-26-Control4003-c2:ATTACTCGTGATGAAT"	-3.2645197910374	11.0256156691345	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTACTCGTGATGAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1687.83674139029	33.1476843758718	0.0196391532208072	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1686.00389987269	1686.00389987269
"healthy-4003"	"2020-08-26-Control4003-c2:ATTATCCCAGTTAAAG"	-2.57121382179912	9.04237554157106	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTATCCCAGTTAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.46907139527	33.6429255933591	0.0178338071392159	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.45028201695	1882.45028201695
"healthy-4003"	"2020-08-26-Control4003-c2:ATTATCCCATCATCTT"	-4.27671323242839	12.0710162886414	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTATCCCATCATCTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2819.0247295291	38.6250450979151	0.0137015630594937	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2810.963797753	2810.963797753
"healthy-4003"	"2020-08-26-Control4003-c2:ATTATCCGTCCTCCTA"	5.54155935820882	-10.0479698411194	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTATCCGTCCTCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2138.85720445782	23.0456105968052	0.010774730799594	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2137.19309749746	2137.19309749746
"healthy-4003"	"2020-08-26-Control4003-c2:ATTATCCTCTGTGCAA"	4.19181074675862	-7.14431145107421	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTATCCTCTGTGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2780.90468000425	28.7138274494215	0.0103253547868378	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2773.64410736663	2773.64410736663
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTAGGAGAATG"	5.42676605758016	-9.9854889146057	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTAGGAGAATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1791.01169030401	28.6849775931302	0.0160160750197344	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1788.85475639833	1788.85475639833
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTAGTAGCCAG"	5.39518274840657	-10.2346782914368	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTAGTAGCCAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.54424866515	29.1569436230983	0.0142191243334928	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.46322997674	2047.46322997674
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTAGTTACGTC"	-3.76622496071513	10.4412355192932	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTAGTTACGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.84336922833	3.26073219959238	0.00198965457030085	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1636.74285485752	1636.74285485752
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTAGTTGCTGT"	3.63642801818196	-7.49289991771849	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTAGTTGCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.37093130614	29.0599544227022	0.0124274357133195	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2338.37093130614	2338.37093130614
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTCACGTTCGG"	-4.06752715531047	12.7355041273865	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTCACGTTCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1601.48011524274	31.1643816904925	0.0194597368983059	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1596.31782095332	1596.31782095332
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCACTCAGTAACCT"	2.80408539351766	-6.17506315624388	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCACTCAGTAACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.07209416643	37.0649175248542	0.0150177612770962	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2460.33548859498	2460.33548859498
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCAGGCATAGTCAC"	6.80123438414876	-1.71099593555602	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCAGGCATAGTCAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2929.83249303957	15.5017475156293	0.00529100129528121	2430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2912.46182289044	2912.46182289044
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCAGGTCCATCAGA"	5.46386684951131	-9.64715006267699	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCAGGTCCATCAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2827.79865396947	25.6957537218741	0.00908683992964073	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2825.92874598563	2825.92874598563
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCATCGTCGAATGG"	0.66506459292714	9.00541589343873	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCATCGTCGAATGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1335.68787753498	34.0483052241878	0.0254912137759491	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1327.02191793742	1327.02191793742
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCATCGTCGTCAGC"	5.42089285430257	-9.98459818279418	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCATCGTCGTCAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.5614730775	43.8227748614888	0.0214548132034732	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.03902172251	2036.03902172251
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCATCTCCTTACCG"	3.87564744529073	-7.15966417705687	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCATCTCCTTACCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1862.09161644001	20.5478377716557	0.0110348156826674	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1856.80521928504	1856.80521928504
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCATCAAGCGATG"	-3.96354518356975	13.0412349470886	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCATCAAGCGATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2139.95091916775	38.8803002540983	0.0181687813051429	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2127.82517704147	2127.82517704147
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCATTCTGAGATC"	4.48852982100789	-7.17657949840697	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCATTCTGAGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2629.57708576081	10.1609199660091	0.00386408902824359	1730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2622.81072271747	2622.81072271747
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCATTCTTCCACG"	4.94142450866048	-7.83051969921263	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCATTCTTCCACG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.72983742258	40.7142727584745	0.0169098177568203	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2403.48994991673	2403.48994991673
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCCGCATGACCCG"	4.14605345305745	-6.86093571102294	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCCGCATGACCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3128.71144040113	9.45206875138609	0.00302107398890524	2699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3118.36096526367	3118.36096526367
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCCGTCCGCCTAT"	-2.4769152206486	9.33746526325075	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCCGTCCGCCTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1759.53789602327	28.2661363180909	0.0160645226124286	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1753.42095562893	1753.42095562893
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCTACAATACGCT"	5.56548561629598	-9.90691187297972	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCTACAATACGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.23958314768	3.49529540131665	0.00132185276386941	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2639.42282816537	2639.42282816537
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCTACACTCCCTA"	3.64742340621297	-6.89423897182616	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCTACACTCCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.70605449721	25.0327746591019	0.0127802610308098	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1953.60756232966	1953.60756232966
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCTACATCCGATA"	3.57926477965657	-7.05224802410277	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCTACATCCGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.78002172711	2.36686926010058	0.00109487054016237	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2153.94901899022	2153.94901899022
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCTATCATTGTGG"	-4.06112084809001	10.4272060164246	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCTATCATTGTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2199.60941528579	36.4321966454239	0.0165630299598851	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2176.04239664119	2176.04239664119
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCCTATCGTGTTCC"	-1.39222155037578	9.27460286701051	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCCTATCGTGTTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1520.21301130318	34.9118668659925	0.0229651151558456	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1518.0130352585	1518.0130352585
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCGTTAGCGCTGCT"	0.55745961245839	9.39487454974977	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCGTTAGCGCTGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1533.32320263805	42.5474886984518	0.0277485455285942	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1529.33140894851	1529.33140894851
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCGTTGTTCGATTG"	5.37390436705892	-10.2417211762634	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCGTTGTTCGATTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1804.53551462557	30.4101199493218	0.016852048465021	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1802.52605398396	1802.52605398396
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCGTTGTTGTGTAC"	4.44885696944539	-7.82891561901244	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCGTTGTTGTGTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.30596096959	1.05405027414555	0.000387617388140362	2061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2717.85564521648	2717.85564521648
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCGTTGTTTACTTC"	5.5346790748531	-9.69973757183226	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCGTTGTTTACTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2741.02910406729	31.7069597642242	0.0115675385267437	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2737.64440286386	2737.64440286386
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCGTTTCATTGTGG"	4.10232510146443	-6.91153767025145	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCGTTTCATTGTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.22670050271	27.3282464756369	0.0107751592041122	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2533.61151080118	2533.61151080118
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTACAGTGGCAGT"	-2.19875917854961	9.02828500354616	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTACAGTGGCAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.26233064299	40.7031921274367	0.0221784054779657	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.61474731708	1827.61474731708
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTACCATCTGTTT"	3.8581084209377	-7.0536828271118	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTACCATCTGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.16508425025	44.6771526200118	0.0182791059850675	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2437.5119917265	2437.5119917265
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTACGTGACTCTA"	-0.20851511779483	8.48403356159059	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTACGTGACTCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.84439120572	34.2054838549393	0.0182736791667315	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1866.7998711154	1866.7998711154
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTACGTTGCCTAA"	3.88232245024983	-7.03676226055297	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTACGTTGCCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.25663668728	30.0139989654806	0.0138106095979679	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2170.4664290514	2170.4664290514
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTACTCCTCTAGC"	3.83433641967122	-6.39092495357665	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTACTCCTCTAGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2515.17015075978	22.0206801686589	0.00875514531770622	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2511.56336946045	2511.56336946045
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTTGCATCGCTAA"	3.59702767905537	-6.51884891903075	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTTGCATCGCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.94917088656	32.9205966590205	0.0130484581452952	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2518.55439364068	2518.55439364068
"healthy-4003"	"2020-08-26-Control4003-c2:ATTCTTGCATTACGGT"	4.73889793929402	-7.18565418636473	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTCTTGCATTACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.38287467963	37.3238811876888	0.0164903082042502	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.45913889652	2256.45913889652
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGGGTAGGACTATA"	5.00151886519734	-8.06988241588744	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGGGTAGGACTATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.50879038646	41.9924721162991	0.0167000697221047	1532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2506.86977574964	2506.86977574964
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGGGTCAAGTGGGT"	-3.4843193096226	10.4051027067932	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGGGTCAAGTGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1773.32723348088	40.3418067588391	0.0227492174017154	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1767.5847151045	1767.5847151045
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGGGTCATGATCTG"	-2.80489812317546	11.0725803145203	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGGGTCATGATCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1677.8846430306	41.1264835613389	0.0245109124349909	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1668.51043369255	1668.51043369255
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGGGTGTGATTCTG"	5.52949299392049	-9.87464525615843	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGGGTGTGATTCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.60327727954	25.3910184737447	0.010581340138246	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.94910113559	2396.94910113559
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGGGTTCATTGGTG"	-2.62655673447307	9.23565480792848	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGGGTTCATTGGTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2362.01245605017	7.81638149425379	0.0033092041806268	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2350.84551641303	2350.84551641303
"healthy-4003"	"2020-08-26-Control4003-c2:ATTGTTCGTGTCTTAG"	-1.90599320355113	8.95213792407838	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTGTTCGTGTCTTAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2046.63899784045	30.9036093572286	0.0150996875315271	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2040.40425063106	2040.40425063106
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTACCAGGAAGTGA"	5.21320166167561	-8.7893104783264	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTACCAGGAAGTGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.12231143548	2.17837073919627	0.00077107130207379	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2821.36601745597	2821.36601745597
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTACCGTTCAATCG"	-4.99756179276164	8.86318872058717	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTACCGTTCAATCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2532.08928835874	40.5744091550955	0.0160240830928182	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2528.7663229695	2528.7663229695
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTACCTCAGTCTTT"	-3.99859080734904	11.3734597929749	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTACCTCAGTCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.42186412026	36.2573316063909	0.0167515086626275	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2153.36836809523	2153.36836809523
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTACCTCCTTACCG"	-1.15783296051677	9.23068616474	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTACCTCCTTACCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2029.53625854691	43.1976855233792	0.0212845103611539	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2022.20979512677	2022.20979512677
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTCACAGGTGCGAT"	5.46756138381307	-9.5143089524475	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTCACAGGTGCGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2729.79687504707	16.2907125912318	0.00596773801748561	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2720.84484768596	2720.84484768596
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTCACCAAGGTCAG"	-3.16046271744426	-5.8264312974182	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTCACCAAGGTCAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2568.7931864218	39.6055087536345	0.0154179437110712	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2559.94991873968	2559.94991873968
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTCACGTAACACGG"	-3.88019404831584	10.3925199278626	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTCACGTAACACGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2045.27678254277	29.2377868541035	0.0142952714780021	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.57012394861	2041.57012394861
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTCACGTCGCACAC"	10.3926407295162	7.51774022662965	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTCACGTCGCACAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2291.88942018332	31.7692804535439	0.0138616113734679	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2281.24133010721	2281.24133010721
"healthy-4003"	"2020-08-26-Control4003-c2:ATTTCTGAGGCATGCA"	3.64579739150349	-6.89135935222777	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ATTTCTGAGGCATGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2032.50639106849	33.2363374571263	0.0163523901342588	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2030.76781109264	2030.76781109264
"healthy-4003"	"2020-08-26-Control4003-c2:CAAAGAAGTACCCACG"	3.37726845321004	-7.4466910592285	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAAGAAGTACCCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.13042197799	26.4171532643325	0.0126693049920938	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2081.97200231289	2081.97200231289
"healthy-4003"	"2020-08-26-Control4003-c2:CAAAGAAGTGGAAATT"	2.69658865508382	-4.34690477764281	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAAGAAGTGGAAATT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2501.46786253314	30.0840847763543	0.0120265725684316	1848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2495.52774626762	2495.52774626762
"healthy-4003"	"2020-08-26-Control4003-c2:CAAAGAATCCGTTGGG"	-0.589511613280135	8.22402951801149	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAAGAATCCGTTGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1620.24813291309	25.3884315840397	0.0156694712793114	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1616.24744951727	1616.24744951727
"healthy-4003"	"2020-08-26-Control4003-c2:CAAAGAATCGGACTGC"	3.96760906752889	-7.04806663906249	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAAGAATCGGACTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.128188379	8.03851812743119	0.0035582390449473	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2253.99021866095	2253.99021866095
"healthy-4003"	"2020-08-26-Control4003-c2:CAACAACGTTCCATTT"	-0.400154839188415	8.94141004169313	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACAACGTTCCATTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1881.56429063135	35.8486999396798	0.01905260432406	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.58482898506	1876.58482898506
"healthy-4003"	"2020-08-26-Control4003-c2:CAACAGTAGTTCCAGT"	2.86135949668233	-7.62844183361205	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACAGTAGTTCCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2086.09862970116	30.3569138169352	0.0145520031434391	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.47237204945	2082.47237204945
"healthy-4003"	"2020-08-26-Control4003-c2:CAACAGTCACGCGTCA"	-3.71639428559001	10.6607446440491	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACAGTCACGCGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.6858418119	45.8896269228575	0.0281585724963021	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1629.6858418119	1629.6858418119
"healthy-4003"	"2020-08-26-Control4003-c2:CAACAGTTCTACGCAA"	3.02817549285237	-6.70915224468382	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACAGTTCTACGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1798.91404906299	25.2385152395645	0.0140298616560978	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1789.42627231294	1789.42627231294
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCAACAACTAGAA"	-3.52696214142497	10.3028135069641	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCAACAACTAGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1996.57603339522	36.8077783325986	0.0184354503494696	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1988.20916774809	1988.20916774809
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCAAGTACGTGTT"	4.12335886534993	-7.15325739299925	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCAAGTACGTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.50279719776	33.9712018616435	0.0143066590200417	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.07627360064	2372.07627360064
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCTCAGATACTGA"	-0.935146371752578	8.32929895007936	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCTCAGATACTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.40947413124	50.163791225663	0.0265640433988718	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1886.71254304413	1886.71254304413
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCTCCATACGCAT"	2.80034031447713	-4.60389282619628	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCTCCATACGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2480.89729701487	18.1760871439346	0.00732641660168881	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2479.07516405183	2479.07516405183
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCTCGTGTTTCTT"	5.45148624953572	-9.44036486065062	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCTCGTGTTTCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.91253540582	15.5815113014071	0.00655535745186635	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.54952260289	2375.54952260289
"healthy-4003"	"2020-08-26-Control4003-c2:CAACCTCTCCACGAAT"	-4.15647826615031	13.1349143751892	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACCTCTCCACGAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2313.91730957334	29.2209788164604	0.0126283591447131	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2310.55260509472	2310.55260509472
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGATAGATGTTGA"	5.44234909591023	-10.0219497910705	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGATAGATGTTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.46865735894	9.01270528025202	0.00369453620691709	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2434.3739897449	2434.3739897449
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGATAGCGTTCAT"	4.19137301024739	-6.96696569835814	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGATAGCGTTCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.29862536105	35.1537204974002	0.0140205558850566	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.14121608807	2500.14121608807
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGATTCCGGCAGT"	3.4786397415096	-6.65317394649657	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGATTCCGGCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.33667082118	14.9562146155428	0.00607152680049902	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2460.4188144184	2460.4188144184
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGGCAGATAGCTA"	-3.68867860260661	10.7455882796082	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGGCAGATAGCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.3025879038	8.98010049973006	0.00516007995514541	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1738.12578816763	1738.12578816763
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGGCCAACTTGGT"	9.95239319381062	5.88488242709962	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGGCCAACTTGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1610.81533853915	24.5023811481045	0.0152111670170248	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1610.81533853915	1610.81533853915
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGGCTCCTAAGTG"	-3.68153415146526	12.0451659926209	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGGCTCCTAAGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.15245521612	28.3677020642795	0.0144280276888098	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1962.40670008023	1962.40670008023
"healthy-4003"	"2020-08-26-Control4003-c2:CAACGGCTCGTCGCTT"	4.04543580588643	-7.60506346141966	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAACGGCTCGTCGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.52852875251	29.9070647706756	0.0127343842770186	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.24066831326	2342.24066831326
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGACTCACCAAATC"	-1.82543728771861	8.8247384794983	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGACTCACCAAATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2145.12016166167	34.3818987768528	0.0160279593615957	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2138.44650543281	2138.44650543281
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGACTCAGATACCT"	8.59673370894734	6.29552028262941	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGACTCAGATACCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1430.47284686635	33.6423135874667	0.0235183168007453	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1425.51523367549	1425.51523367549
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGACTCATGAGAAT"	8.78415264663045	6.65657756412355	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGACTCATGAGAAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1651.85689231786	28.7080169057805	0.0173792397145844	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1646.38302641906	1646.38302641906
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGACTCATGGAATA"	-3.97855840149577	12.8906841048035	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGACTCATGGAATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1838.24732712737	23.8500657681582	0.0129743508483316	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1834.12767206205	1834.12767206205
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGACTGTGCATACT"	4.63009991225545	-7.82547047054442	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGACTGTGCATACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.22326073299	20.9018133987705	0.00923541824680657	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2258.40369895309	2258.40369895309
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGAGGTCTGTCCCA"	-2.56324944916423	9.38768479907838	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGAGGTCTGTCCCA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2040.59229808213	39.1926098492476	0.0192064871978999	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2033.85483486815	2033.85483486815
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGCTAAGCGTTAGG"	3.82391490516011	-7.2564530602661	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGCTAAGCGTTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1669.58638747082	0.243172185940834	0.000145648160386121	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1665.4346528352	1665.4346528352
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGCTACAATGGCAG"	5.13772692260091	-8.81233980571898	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGCTACAATGGCAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.30658004443	40.7600169372138	0.0170166179464417	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.2030337332	2389.2030337332
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGCTACAGGCACTC"	-4.22887645188029	12.9487237700256	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGCTACAGGCACTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2148.95008683339	34.8539002824569	0.0162190366802872	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2147.01949224792	2147.01949224792
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGGGACAGATGCGA"	4.42058529433553	-7.33466198360594	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGGGACAGATGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2535.99268920074	25.7652288005599	0.0101598198253009	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.89201174465	2529.89201174465
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGGGAGTGCCTTTC"	3.9693738418514	-6.84466841137084	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGGGAGTGCCTTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.74532030455	8.35097747987778	0.00406423968817704	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2051.33493110446	2051.33493110446
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGGGAGTGTGCCTG"	2.39990582045857	-7.20325615322264	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGGGAGTGTGCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1819.7023672895	23.2547374926464	0.012779418167865	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1818.07558139313	1818.07558139313
"healthy-4003"	"2020-08-26-Control4003-c2:CAAGGGATCAACCGAT"	0.325200428336304	8.32053182208864	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAAGGGATCAACCGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1440.07760621688	30.756793559425	0.0213577333795391	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1440.07760621688	1440.07760621688
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGAGCAATTAG"	3.29214467582051	-7.11536409771117	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGAGCAATTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.97453836855	16.9256849000252	0.00693967265084567	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.01114681797	2432.01114681797
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGCAAGTGCTT"	0.53229727324788	9.47184178912965	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGCAAGTGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.00908064775	36.2587157019251	0.0214420585417768	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1682.22380058695	1682.22380058695
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGCAGCATTGT"	3.73674406585042	-6.87260439312132	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGCAGCATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.67468946555	7.51446727490191	0.00267544949334513	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2803.70706258602	2803.70706258602
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGCATCAGCTA"	0.036808361380738	8.15233895862428	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGCATCAGCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1660.7321721612	33.410968003406	0.0201182156662423	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1654.77992715246	1654.77992715246
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGGTTCCGGTG"	2.86806048926656	-6.58156301891478	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGGTTCCGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.28755096997	25.3623615785763	0.0139946674383995	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1810.34144229842	1810.34144229842
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGTCAGCCCAG"	-1.68187723580058	9.34186265552369	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGTCAGCCCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2831.82217541911	35.2879558920819	0.0124612188570277	2192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2813.74029021826	2813.74029021826
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGTCCCGAATA"	4.02696098861043	-7.71344854747923	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGTCCCGAATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.8688768878	29.1961374876751	0.0121809489743906	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2395.42229601532	2395.42229601532
"healthy-4003"	"2020-08-26-Control4003-c2:CAATACGTCTGCAGCG"	3.36676873740498	-7.21129801189574	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATACGTCTGCAGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.06249924057	39.6495131705145	0.0171119739685527	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.72692397056	2308.72692397056
"healthy-4003"	"2020-08-26-Control4003-c2:CAATCGAAGTCCCAAT"	2.56142653998677	-4.3300729027954	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATCGAAGTCCCAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2327.5805310998	27.120498167615	0.0116517979959217	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2321.55154012692	2321.55154012692
"healthy-4003"	"2020-08-26-Control4003-c2:CAATCGATCCAGTGCG"	4.60246147689168	-7.24583008205565	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATCGATCCAGTGCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.00978425145	8.23535229740699	0.0039650040937939	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2073.75872816072	2073.75872816072
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACCAAGAGATT"	3.12609519538228	-6.71299316799315	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACCAAGAGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.37847339091	35.5029782562267	0.0178912333167771	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1980.57889155932	1980.57889155932
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACCACAAGCAG"	-3.94760022583659	12.6434659727844	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACCACAAGCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2082.29898540269	44.707344051868	0.0214701848126877	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2072.63925352096	2072.63925352096
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACCATTCACCC"	4.87784113463704	-7.87673571026	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACCATTCACCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.80539323658	13.9121140944331	0.00578272628931006	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2401.44871190096	2401.44871190096
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACGTGAACTAA"	4.33307089385335	-7.545521282312	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACGTGAACTAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1926.43381173706	2.7560572193464	0.00143065243277747	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1924.53829069262	1924.53829069262
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACGTTGGGTTT"	-0.896484593779403	8.47941205585328	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACGTTGGGTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.91840724976	40.4276710097541	0.0248034937392784	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1627.80048067784	1627.80048067784
"healthy-4003"	"2020-08-26-Control4003-c2:CAATGACTCCTCATAT"	5.2748872238094	-10.3451538315979	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATGACTCCTCATAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1939.41048557183	41.3490592156419	0.0213204267602226	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1932.10052201159	1932.10052201159
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCAGGACATCG"	5.51712622222249	-10.1390171281067	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCAGGACATCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2604.98030581841	42.0034000661816	0.0161242678005526	1750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2592.58311128033	2592.58311128033
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCCACGCTTAA"	-4.35185037079509	12.3180560835632	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCCACGCTTAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2638.51124280393	41.7669857087764	0.0158297546855972	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2626.21509578298	2626.21509578298
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCCACGTTGGC"	4.54501690444295	-6.84146883403929	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCCACGTTGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.41119053458	37.9312680984641	0.016945621188306	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.52658038713	2232.52658038713
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCCATATCTCT"	-0.844486872584182	8.21090600574342	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCCATATCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1817.01604949094	11.0201073369673	0.00606494771471869	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.45766129595	1815.45766129595
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCGTACGCTAT"	5.31256355819051	-10.3370199433533	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCGTACGCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.69710433616	40.657541422805	0.0188955691490548	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2147.11159067497	2147.11159067497
"healthy-4003"	"2020-08-26-Control4003-c2:CAATTTCTCCTTGGAA"	-3.21184645119365	10.5240201720032	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAATTTCTCCTTGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2113.5826610752	44.4142050989885	0.0210137062140709	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2105.54458104858	2105.54458104858
"healthy-4003"	"2020-08-26-Control4003-c2:CACAACACAATTGCAC"	-3.95917354050334	13.0259742506775	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACAACACAATTGCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1819.88661510343	37.3008536972576	0.0204962514629725	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1807.64801445667	1807.64801445667
"healthy-4003"	"2020-08-26-Control4003-c2:CACAACAGTTGTAGCT"	-0.507090846926528	8.62310597980348	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACAACAGTTGTAGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.67351891897	33.9943422720396	0.0173380942538473	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1948.00886430208	1948.00886430208
"healthy-4003"	"2020-08-26-Control4003-c2:CACAACATCATGGAGG"	-3.89680896225627	10.3299131163391	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACAACATCATGGAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1879.57204845466	31.0496818182745	0.0165195486088458	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1873.59595094641	1873.59595094641
"healthy-4003"	"2020-08-26-Control4003-c2:CACAACATCTCTCCGA"	-3.75434408608134	9.91377256000368	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACAACATCTCTCCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2378.9648638949	39.950155948285	0.0167930836451605	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2375.77441249804	2375.77441249804
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAAAGGAGGGTG"	3.71896113929097	-6.68098070537718	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAAAGGAGGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.94770036313	1.41211311992361	0.0006256738336012	1302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2254.15779445314	2254.15779445314
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAACAACCAACT"	3.95071138915364	-7.16388323223265	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAACAACCAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2684.02835862782	39.1386976786859	0.0145820730816328	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2676.95001907971	2676.95001907971
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAACAACCAATC"	-2.57252512398418	9.62392137134401	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAACAACCAATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1874.55791210247	40.1336598147854	0.0214096665436024	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.62847235156	1872.62847235156
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAACACTCACTC"	3.77488126334493	-6.91951897060546	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAACACTCACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.86858240416	34.9691438936919	0.0147619602680541	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.88679801265	2365.88679801265
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAATCAAGCCAT"	5.32531418380086	-10.1148939362732	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAATCAAGCCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.97426603151	34.663726511902	0.0143358541895459	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.5384722967	2408.5384722967
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAATCGAAGCAG"	5.40811075743977	-9.46419718181761	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAATCGAAGCAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.57762415743	9.56297964514036	0.00440573031745525	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2157.79486824109	2157.79486824109
"healthy-4003"	"2020-08-26-Control4003-c2:CACACAATCTCCGCAT"	-4.23015246811565	12.8540496596131	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACACAATCTCCGCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2381.38201197481	5.1352113487173	0.0021563996548621	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2367.73399120635	2367.73399120635
"healthy-4003"	"2020-08-26-Control4003-c2:CACAGATCATCATGAC"	0.487098594277543	8.26827523792116	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACAGATCATCATGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1612.15705976032	37.4460915411454	0.0232273222478166	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1606.66567902719	1606.66567902719
"healthy-4003"	"2020-08-26-Control4003-c2:CACATGACATATACCG"	-3.12199840965922	-5.63097431575926	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACATGACATATACCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2168.55332253442	29.7143900399613	0.0137024023025791	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2163.987908759	2163.987908759
"healthy-4003"	"2020-08-26-Control4003-c2:CACCAAAGTACTGCCG"	4.15187134322469	-7.01671507274779	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACCAAAGTACTGCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.25319215494	37.6411801120884	0.0151641179195788	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2479.53048431593	2479.53048431593
"healthy-4003"	"2020-08-26-Control4003-c2:CACCAAAGTCAGCGTC"	3.52011169967	-6.42476370250853	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACCAAAGTCAGCGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.76954834225	34.7374455273646	0.0145055483737094	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.28913284811	2388.28913284811
"healthy-4003"	"2020-08-26-Control4003-c2:CACCGTTAGATTGGGC"	-0.366119037300903	8.30323693836061	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACCGTTAGATTGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1619.2371793437	21.9188189296577	0.013536509171894	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1616.14711957587	1616.14711957587
"healthy-4003"	"2020-08-26-Control4003-c2:CACCGTTCAATATCCG"	2.66304721412007	-4.48394253170165	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACCGTTCAATATCCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2815.56376647704	30.2003724077749	0.0107262256914049	2570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2810.40052644905	2810.40052644905
"healthy-4003"	"2020-08-26-Control4003-c2:CACGAATGTACACGTT"	0.275776867836159	7.91722867572633	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACGAATGTACACGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1820.99665868005	26.7878183396395	0.0147105258057182	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.72678730711	1815.72678730711
"healthy-4003"	"2020-08-26-Control4003-c2:CACGGGTAGTCATGCT"	-3.15944753113444	9.54059121692506	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACGGGTAGTCATGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2523.01076859102	30.540699480883	0.0121048629126298	1674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2514.50949137049	2514.50949137049
"healthy-4003"	"2020-08-26-Control4003-c2:CACGGGTTCCATTGTT"	-4.21153483811076	13.0267019041809	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACGGGTTCCATTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1997.38025945337	31.1312990971557	0.0155860652721558	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1995.38238029198	1995.38238029198
"healthy-4003"	"2020-08-26-Control4003-c2:CACGTTCAGTGATTCC"	4.34139885482137	-7.5037150613037	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACGTTCAGTGATTCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2923.16800273596	27.65085241034	0.00945920740253723	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2915.99559381477	2915.99559381477
"healthy-4003"	"2020-08-26-Control4003-c2:CACGTTCCACAAACGG"	-3.8537269634312	12.7644033201965	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACGTTCCACAAACGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1791.89999848781	25.8205517229433	0.0144095941429396	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1783.28591885882	1783.28591885882
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGAAAGGATACGC"	4.45543398436849	-6.97435190593871	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGAAAGGATACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2509.40597742782	4.28164285072101	0.00170623760732002	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2506.61149540503	2506.61149540503
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGAAGTATGGAGC"	4.05804457244222	-6.95580913936766	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGAAGTATGGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2076.22796493634	27.9382621295181	0.0134562594288025	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2067.87863782474	2067.87863782474
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGAATCAGCTTCC"	3.61111583289449	-6.51935102855834	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGAATCAGCTTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2897.64966269445	3.38789852349441	0.00116918845197597	2159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2891.10777219644	2891.10777219644
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGAATCTTCTCAA"	2.85050477561299	-4.90636589443358	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGAATCTTCTCAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2648.53599766133	34.1818871953596	0.0129059552996608	2234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2644.49823131152	2644.49823131152
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGAGCAGCCCT"	2.91081847724263	-7.14469196712645	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGAGCAGCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1659.728463747	21.9045670049254	0.0131976811167495	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1655.45723442996	1655.45723442996
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGAGCCTCAAT"	-0.881098727614242	8.65401551807252	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGAGCCTCAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1770.61602251372	33.8146950488404	0.0190977008108365	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1765.07185669844	1765.07185669844
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGAGGTAAGAG"	-4.25249658051189	13.1436404951843	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGAGGTAAGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1654.09256282356	42.8673402726378	0.0259159258895782	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1649.26873772433	1649.26873772433
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGGTCTTCAAG"	2.88962378081624	-6.44966509258422	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGGTCTTCAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.74150112587	36.25145420566	0.0164798701061492	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2195.15101030612	2195.15101030612
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGGTGTATTGC"	5.268233914941	-9.33886911785277	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGGTGTATTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.77705802089	33.8190027888993	0.0150790746980185	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.31907708559	2238.31907708559
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGTCGATTGGT"	9.23795666274373	6.77243230426637	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGTCGATTGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1675.18065190273	34.6430310894773	0.0206801762246529	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1664.41937027152	1664.41937027152
"healthy-4003"	"2020-08-26-Control4003-c2:CACTGGGTCTCAAAGC"	-4.08786902847941	10.8777589567932	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTGGGTCTCAAAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1800.50561108489	35.6971765538588	0.0198261956719755	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1798.5258913372	1798.5258913372
"healthy-4003"	"2020-08-26-Control4003-c2:CACTTCGAGTGTAGTA"	4.38188995894734	-7.06620981609496	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTTCGAGTGTAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.14933609791	26.7529297281443	0.0104866184623531	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2544.55881415249	2544.55881415249
"healthy-4003"	"2020-08-26-Control4003-c2:CACTTCGCAAGACGAC"	2.74643697318379	-4.73719932949217	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTTCGCAAGACGAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1982.52216304503	19.0209343784542	0.00959431109170514	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1980.94181968029	1980.94181968029
"healthy-4003"	"2020-08-26-Control4003-c2:CACTTCGCAAGCGCTC"	4.85151114043538	-7.36498548900756	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTTCGCAAGCGCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2762.66722221173	34.381566324049	0.0124450625278436	1882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2761.53097455292	2761.53097455292
"healthy-4003"	"2020-08-26-Control4003-c2:CACTTCGTCTAGGAAA"	-3.86331305924113	10.1136350401672	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTTCGTCTAGGAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.15841865434	38.229485084824	0.0198888315935935	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1920.06962940248	1920.06962940248
"healthy-4003"	"2020-08-26-Control4003-c2:CACTTCGTCTAGGCAT"	-2.03418240967448	9.87603280628053	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CACTTCGTCTAGGCAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2015.57877690723	34.8984056400433	0.0173143347409088	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2005.19523681225	2005.19523681225
"healthy-4003"	"2020-08-26-Control4003-c2:CAGAGCCAGACATCCT"	-4.02383122864421	13.0303811796936	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGAGCCAGACATCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1950.72403582409	34.9496422237744	0.0179162411401825	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1942.81062344926	1942.81062344926
"healthy-4003"	"2020-08-26-Control4003-c2:CAGAGCCAGGACACTG"	-7.50434480133708	1.05501399123994	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGAGCCAGGACACTG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2799.56552490066	31.2716655323777	0.0111701852499014	2950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2790.15249047884	2790.15249047884
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATACTCACCTACC"	-3.66040692749675	13.0831546553406	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATACTCACCTACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2040.55235152477	46.2881096203445	0.0226841078523452	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2035.37575648482	2035.37575648482
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATACTCCACAGCG"	-3.61796079102214	11.0859451063904	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATACTCCACAGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1825.00275518846	35.7846274403107	0.0196079854337619	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1820.99868333206	1820.99868333206
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATCATCCAAGGGA"	5.46519865569417	-10.0929308167663	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATCATCCAAGGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2696.54783997887	36.4372264809785	0.0135125459080541	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2693.00780269014	2693.00780269014
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATCATCGCAATGT"	4.21774448928182	-7.61365082180174	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATCATCGCAATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2013.47339736646	34.5233741727426	0.0171461784485943	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2013.47339736646	2013.47339736646
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATCATCTACTTCA"	-3.31982574883159	10.2122773894104	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATCATCTACTTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2284.09355786132	50.1725281392627	0.0219660564982465	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2276.22898078624	2276.22898078624
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATTGAGGAGGTTC"	-2.61268530312236	9.47207067096559	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATTGAGGAGGTTC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2118.08128334009	31.8640141750791	0.0150438108422503	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2110.59010975876	2110.59010975876
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATTGCAACGGTAG"	-3.91294370117839	12.811011291388	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATTGCAACGGTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1857.15231903772	39.7238422292305	0.0213896522229331	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1852.93900345558	1852.93900345558
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATTGCATGCCGGT"	-6.25064740601237	3.97123739803163	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATTGCATGCCGGT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1611.55640418192	23.1924364153929	0.0143913277594316	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1596.53163442783	1596.53163442783
"healthy-4003"	"2020-08-26-Control4003-c2:CAGATTGTCCCTCAAC"	10.4607397514278	6.95304105365602	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGATTGTCCCTCAAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1821.79620951889	35.7817691849077	0.0196409285505963	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1816.6702539127	1816.6702539127
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAATGTGTGAGCA"	-0.552105466753799	8.48904416644899	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAATGTGTGAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2007.57737333769	25.5210249869789	0.0127123493848454	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1995.89422699647	1995.89422699647
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAATTCATTGAGC"	4.97837414321248	-8.66141035473021	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAATTCATTGAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.07464637991	9.88538204690052	0.00458915482038363	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.48893113056	2144.48893113056
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAATTCGTGGGAA"	-2.1407335800236	9.4079265364441	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAATTCGTGGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1524.0858573591	30.1155784664435	0.0197597650559051	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1521.8497548421	1521.8497548421
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCACGTCTCATAGG"	-2.05350385132487	9.42811677539674	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCACGTCTCATAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.43063744259	30.3297474211468	0.0161205769787898	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1875.28651868222	1875.28651868222
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCAGAAGCTGC"	3.54291476783101	-6.56744673168334	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCAGAAGCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.03095257454	15.1096244555698	0.00622043306593316	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2420.5662224188	2420.5662224188
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCCAAGCGATG"	2.70546927031819	-4.54054787075194	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCCAAGCGATG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2292.51797729823	0	0	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2289.68772707635	2289.68772707635
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCCAGAGTGTG"	5.33520187911336	-9.83726980602416	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCCAGAGTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.66310015045	23.5096082041854	0.0109978079345294	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2134.74572997986	2134.74572997986
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCGTAGTCCTA"	5.39391579207723	-10.2937717667786	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCGTAGTCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.53452058692	8.55021030160636	0.00368458655786074	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2316.17320766942	2316.17320766942
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCGTGTCTTAG"	-3.09062943878825	-5.3166280022827	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCGTGTCTTAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2469.2132300617	44.0119257299049	0.0178242709840029	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2464.42799204854	2464.42799204854
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCAGCTCTGAGCAT"	0.252801601856393	8.64465711200563	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCAGCTCTGAGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1564.31073490253	48.2820323080647	0.0308647324542416	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1556.50278636035	1556.50278636035
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCCAGCAATTCACG"	-3.86420998993571	10.6381044157776	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCCAGCAATTCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2062.96225476083	44.0145620611514	0.0213356119141667	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2055.71227433563	2055.71227433563
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCCAGTCCATGAGT"	-2.44870887222942	9.41008660877077	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCCAGTCCATGAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.63980628009	37.9390077165029	0.0197945422985536	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.24496817808	1911.24496817808
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCGTGAGACCATTC"	-0.295004288584548	8.78759572589723	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCGTGAGACCATTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1769.66870655638	34.1802998364922	0.0193145189887004	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1763.41410881965	1763.41410881965
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCGTGGTAGCTTGT"	4.24376120147054	-7.02361681377562	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCGTGGTAGCTTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.11516526852	0.902926724086605	0.000406702651381329	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.79283317994	2214.79283317994
"healthy-4003"	"2020-08-26-Control4003-c2:CAGCGTGGTGGTCTGC"	4.06569113311116	-7.67611458217772	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGCGTGGTGGTCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.29531546981	18.790069396653	0.00796427190502485	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2353.34374668913	2353.34374668913
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGCCATCACAAGGG"	-3.13290725174602	10.4097270735535	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGCCATCACAAGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1714.60172083777	29.4179131063652	0.0171572865866431	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1710.38451257881	1710.38451257881
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGCCATCAGTCACA"	3.70400347289388	-6.97499468242797	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGCCATCAGTCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.68454601764	1.32466149903665	0.000541410825189028	1418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2443.8962646588	2443.8962646588
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGGCTAGGGTTAGC"	5.09297241744344	-9.12476637279662	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGGCTAGGGTTAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2850.72788217399	35.7295958303768	0.0125334992700633	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2844.49895780515	2844.49895780515
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGGCTAGTAAACGT"	-0.121508876711685	8.45431516254274	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGGCTAGTAAACGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1922.70831764328	37.5538768566601	0.0195317597120977	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1915.0171115497	1915.0171115497
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGGCTCAGGATGAC"	5.42995132979695	-10.2038336030212	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGGCTCAGGATGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.81383994697	11.3177853767897	0.00529409304276489	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2128.34929823571	2128.34929823571
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGGCTGTTTGTGGT"	-4.09896932068523	13.0932998427185	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGGCTGTTTGTGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1809.56248740168	36.4219512467373	0.0201274902084398	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1803.14710495243	1803.14710495243
"healthy-4003"	"2020-08-26-Control4003-c2:CAGGGCTTCTAAGGAA"	-4.15650639954265	12.7377052077088	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGGGCTTCTAAGGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2198.38759195127	30.3282132587624	0.0137956624981873	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2192.70073881502	2192.70073881502
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTGCGAGCCGTTGC"	-3.82656703415568	12.592390991095	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTGCGAGCCGTTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1822.07991657957	48.1463141643192	0.026423821329802	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1807.66393972611	1807.66393972611
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTGCGTCACCTCAC"	4.94496502456014	-8.61314394390257	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTGCGTCACCTCAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2693.51047057088	36.0555888344025	0.0133860956652456	2174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2688.43200961281	2688.43200961281
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTAGAGTATCTGC"	4.15022625502889	-7.020534538385	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTAGAGTATCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.57619619319	25.1779734634888	0.00993380017586565	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.83355081276	2529.83355081276
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTAGAGTGGAAGA"	-1.07842598381694	8.77333638751832	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTAGAGTGGAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1881.18288442919	45.773645712435	0.0243323741095615	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1875.70592302266	1875.70592302266
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTAGCAAAGCGTG"	4.88683905181233	-7.95010664379271	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTAGCAAAGCGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.10180300011	42.7305048689519	0.0164976159699426	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.22876422861	2586.22876422861
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTAGTCACGTCCT"	4.40828909453694	-7.29141857540282	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTAGTCACGTCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2944.50643337201	23.101447561662	0.00784560947119637	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2938.24754645352	2938.24754645352
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCAGCCTGGAA"	3.52013315734212	-5.77461721813353	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCAGCCTGGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.57901159708	33.7843012969538	0.0122159956939519	2235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2762.10219590077	2762.10219590077
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCCAAGGAGTC"	-3.3046010536259	9.71769807422487	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCCAAGGAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2176.125296328	32.4296374086312	0.0149024679154978	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2167.18246236339	2167.18246236339
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCCAAGTTCGT"	-4.24049315872844	12.6643523939881	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCCAAGTTCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1855.35842355018	40.3990945699896	0.0217742804070639	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1853.32943975961	1853.32943975961
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCCACTTGTGA"	-3.25382218781169	9.92425630176393	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCCACTTGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.31150770951	44.9454859461847	0.0231760012599879	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1933.83563387994	1933.83563387994
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCCAGGGTCTC"	5.55621685561482	-10.0860948792663	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCCAGGGTCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.76846536258	20.3944956611172	0.00898923621889195	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2260.66159865083	2260.66159865083
"healthy-4003"	"2020-08-26-Control4003-c2:CAGTTCCGTCCGTTTC"	-1.04813406887706	8.54324624622194	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CAGTTCCGTCCGTTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1468.40892390205	19.2294964422481	0.0130954641648111	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1461.93559250206	1461.93559250206
"healthy-4003"	"2020-08-26-Control4003-c2:CATAAGCAGGGTTAGC"	5.14393581923787	-9.35319998180541	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAAGCAGGGTTAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.71823035468	19.8984224513878	0.007976220404081	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2490.43513800728	2490.43513800728
"healthy-4003"	"2020-08-26-Control4003-c2:CATAAGCTCAACACCA"	4.70915855941121	-8.27963640606078	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAAGCTCAACACCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.27940047066	34.0455190998054	0.0144857326720336	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.6687783576	2347.6687783576
"healthy-4003"	"2020-08-26-Control4003-c2:CATAAGCTCCCTCGAT"	4.55494560775105	-7.36631729519042	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAAGCTCCCTCGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2646.86013856449	23.3181177657879	0.00880972795881626	1619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2641.62542211859	2641.62542211859
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGCAACTCCCT"	4.06341757354085	-7.21540071880492	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGCAACTCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.29876224548	36.7982229625084	0.013657810885026	1831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2689.82077303443	2689.82077303443
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGGTGAATTAG"	-7.06755147400554	3.14941713893739	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGGTGAATTAG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2944.9528020566	31.682486687705	0.0107582324122749	2614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2917.4462232152	2917.4462232152
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGGTGCCTTCT"	-0.103106106550056	8.41678330982057	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGGTGCCTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2068.42015474821	25.301534403816	0.0122322992965111	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.64928551231	2059.64928551231
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGTCAATCTTC"	3.86718883094136	-7.41153242504271	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGTCAATCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.6900494102	18.0366912891606	0.00786704303697769	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2286.48085319926	2286.48085319926
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGTCACAGAGG"	-4.4432238143986	12.7986411818298	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGTCACAGAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1823.88136074291	28.0049873255149	0.015354610189178	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1817.37809087864	1817.37809087864
"healthy-4003"	"2020-08-26-Control4003-c2:CATACAGTCGCCGAGT"	5.44605364379231	-9.50087454235228	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACAGTCGCCGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.67327828838	31.0546520399513	0.0119364150368573	1728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2591.00628323885	2591.00628323885
"healthy-4003"	"2020-08-26-Control4003-c2:CATACCCAGACCCGCT"	3.53543867644612	-6.49064018642577	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACCCAGACCCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.83858075922	12.3552031455349	0.00477433300415133	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.56854039518	2586.56854039518
"healthy-4003"	"2020-08-26-Control4003-c2:CATACCCAGTCATCCA"	-2.35499391976054	9.87509248340455	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACCCAGTCATCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2030.22875272509	45.9968568859195	0.0226559971747912	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2016.41927922618	2016.41927922618
"healthy-4003"	"2020-08-26-Control4003-c2:CATACCCAGTTGTAGA"	3.16230239447896	-6.6458950272766	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACCCAGTTGTAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.79423329882	15.6348662223016	0.00711065455126505	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2192.2974078274	2192.2974078274
"healthy-4003"	"2020-08-26-Control4003-c2:CATACTTTCCAAGCTA"	-3.69626102867778	12.8517350920471	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACTTTCCAAGCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2369.99136505931	41.0258881848869	0.0173105644137485	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2358.1022945253	2358.1022945253
"healthy-4003"	"2020-08-26-Control4003-c2:CATACTTTCTAACGGT"	-2.45145521584209	9.12432954395143	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACTTTCTAACGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.17224220702	39.7815830609158	0.0205041501963056	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1938.30567883945	1938.30567883945
"healthy-4003"	"2020-08-26-Control4003-c2:CATACTTTCTGTCGTC"	2.56478275832478	-7.18283750927123	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATACTTTCTGTCGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.8344032322	36.0959896152252	0.0178002649317376	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2024.79363231182	2024.79363231182
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACAGCTGAGCA"	5.52424110946004	-10.1175356141296	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACAGCTGAGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.30558277424	37.7131188525819	0.0171555397703118	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2195.07320692703	2195.07320692703
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACAGGGAGGCA"	5.60989679869954	-10.1333294144836	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACAGGGAGGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.79629002005	30.0501340965183	0.0122764031545583	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2443.42089211109	2443.42089211109
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACCAGTCGCAC"	-0.173936183482963	8.70668027484743	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACCAGTCGCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1934.59147958073	31.6978795795805	0.0163847923006722	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1926.19222372243	1926.19222372243
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACGTCACGACC"	4.77882494506184	-7.45348455822142	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACGTCACGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.69858033075	35.3322589011424	0.014973208525722	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2357.1679365062	2357.1679365062
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACTCGGATACT"	2.68157829818074	-4.5162768593994	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACTCGGATACT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2650.5001238357	31.6924153961696	0.0119571454123555	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2643.17241711191	2643.17241711191
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACTCTACAGGT"	3.61370029029195	-7.89274122631224	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACTCTACAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.33642966474	17.8205692860196	0.00835729720606116	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2130.75402702602	2130.75402702602
"healthy-4003"	"2020-08-26-Control4003-c2:CATAGACTCTCAAAGC"	3.79432191428487	-6.93929769909056	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATAGACTCTCAAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.30796516118	33.1074761745806	0.0133750937824921	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2469.76744705539	2469.76744705539
"healthy-4003"	"2020-08-26-Control4003-c2:CATCAAGTCAAACCCA"	4.74314179000203	-7.38471510326537	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCAAGTCAAACCCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.93632058295	37.3934104434435	0.0154394688768873	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2419.36480287507	2419.36480287507
"healthy-4003"	"2020-08-26-Control4003-c2:CATCAAGTCCATTCGC"	-2.89254603806193	9.7486362227234	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCAAGTCCATTCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2286.52338945875	31.466916689118	0.0137619045727613	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2270.72369930305	2270.72369930305
"healthy-4003"	"2020-08-26-Control4003-c2:CATCAAGTCTACTGAG"	-0.707662979990798	8.54384133899537	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCAAGTCTACTGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1663.46745192008	36.0690303598085	0.021683039435593	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1663.46745192008	1663.46745192008
"healthy-4003"	"2020-08-26-Control4003-c2:CATCAAGTCTTAAGGC"	-1.63271961632426	9.12708089435426	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCAAGTCTTAAGGC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2131.93366963703	39.0013810010755	0.0182938998321255	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2123.6802636401	2123.6802636401
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCACCATTCGATG"	-0.19648433747943	8.15086743915407	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCACCATTCGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2208.86094527477	37.237809478013	0.0168583765119632	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2200.23592084957	2200.23592084957
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCACTCAGGACAG"	3.79723538932149	-7.02082207119139	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCACTCAGGACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.44862852503	36.2915679359506	0.0147320173498726	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.08021007809	2462.08021007809
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCACTCTTACCGC"	3.64288272437398	-6.70478918468627	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCACTCTTACCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.09979293587	1.09108781066349	0.00042769311247046	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2543.65790189337	2543.65790189337
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCCACACTTGACA"	-0.484807412058669	8.47575376117555	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCCACACTTGACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2034.94266360312	33.2791438199365	0.0163538483983679	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2029.02682645633	2029.02682645633
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCGTAGAAGTCTA"	5.21941389617268	-9.80016424572142	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCGTAGAAGTCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.13332567416	32.6588611887958	0.0147635139391261	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.43615107766	2205.43615107766
"healthy-4003"	"2020-08-26-Control4003-c2:CATCCGTCAGAATCGG"	4.03178085860555	-7.04766895687255	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCCGTCAGAATCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.02810717271	20.143209854917	0.00823170350837957	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2442.10999579644	2442.10999579644
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGCTGTGTTGCCG"	5.30933012542073	-10.3692884675232	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGCTGTGTTGCCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.629831649	1.29491041021395	0.000564568175886942	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2292.20734291298	2292.20734291298
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGGGCAGGACAGT"	4.11802877959554	-7.2153907052246	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGGGCAGGACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.42410048653	0	0	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.8788481374	2199.8788481374
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGGGCAGTTTCGA"	-3.13455853882487	9.91000554645387	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGGGCAGTTTCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.77532445891	22.9386610802036	0.0122484853258258	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.77532445891	1872.77532445891
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGGGGTGTATTCG"	-3.48299346390422	11.1135215529236	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGGGGTGTATTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1657.8216997714	50.7795422301448	0.0306302796236452	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1655.82067236578	1655.82067236578
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGTCCAACAACAA"	5.54270519789998	-9.83145143901976	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGTCCAACAACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.6511027438	36.389821858074	0.0140628780361805	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2581.59977908137	2581.59977908137
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGTCTCATTCCTA"	3.36467899855916	-7.08871986782225	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGTCTCATTCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.8077554932	27.0357274342729	0.0128753345936294	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2094.6662337837	2094.6662337837
"healthy-4003"	"2020-08-26-Control4003-c2:CATCGTCTCCAACACA"	5.12993635711018	-8.8792991868225	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATCGTCTCCAACACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2946.27753801476	24.8986822738939	0.00845089505405897	2243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2942.62431726999	2942.62431726999
"healthy-4003"	"2020-08-26-Control4003-c2:CATGAGTCACAACGAG"	4.79582466658894	-7.69394876873168	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGAGTCACAACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.76538928884	19.7193010799695	0.00732851000628531	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2687.02185502573	2687.02185502573
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCAAAGCGACTAG"	5.49340309676473	-10.2840872040954	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCAAAGCGACTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.3676981103	36.8089465141555	0.0152774300672434	1478	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.48882685986	2400.48882685986
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCAACACAGCCTG"	0.276774262159508	8.7868556746277	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCAACACAGCCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.82572106316	41.482622969962	0.0236122584457941	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1750.22253225502	1750.22253225502
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCCTCATAACTCG"	-3.45689735832866	10.8297567137512	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCCTCATAACTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.63439766979	32.4772221721639	0.015445967310416	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2091.27340151126	2091.27340151126
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCCTGTATGGGAC"	-3.66386709633525	13.0161094435486	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCCTGTATGGGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2010.36539963472	32.4405209865122	0.01613662918811	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1999.01074261805	1999.01074261805
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCGGAGTCTGGAG"	5.07803835448567	-7.76861717617186	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCGGAGTCTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.29042042029	9.3058454708005	0.00376710584062308	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2464.59533938442	2464.59533938442
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCGGCAAGTCATC"	-2.82143388214763	9.95650003040162	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCGGCAAGTCATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1685.48831327186	36.1307251662155	0.0214363546051998	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1683.22683380682	1683.22683380682
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCGGCATGGTGGA"	-4.24677262726482	12.3978996046814	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCGGCATGGTGGA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1750.05413785692	32.1686376375204	0.0183815100011211	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1750.05413785692	1750.05413785692
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCGGGTAATCAGA"	-3.19531999054607	10.1396312483582	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCGGGTAATCAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1951.29853055253	32.6669210903807	0.0167411190952574	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1935.37451630784	1935.37451630784
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCTCAGTATGATG"	-4.22431598129924	13.0184468992981	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCTCAGTATGATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2179.77756236745	43.13786345243	0.019790030045808	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2174.24167372359	2174.24167372359
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCTCCATGAGATA"	-1.29883394661601	8.91033074939577	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCTCCATGAGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.18779757562	36.1968341012199	0.0185416762394335	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1939.65120572641	1939.65120572641
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCTCGTCACGACC"	4.4161397415096	-7.1940751305786	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCTCGTCACGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.3851322124	33.0440379550973	0.0128406889203904	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2566.91996453847	2566.91996453847
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCTCGTTGCCGCA"	9.74593987044637	7.32259461963502	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCTCGTTGCCGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.9735682008	33.5736808340679	0.0177078844331822	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1890.62108284416	1890.62108284416
"healthy-4003"	"2020-08-26-Control4003-c2:CATGCTCTCCACAAGT"	-1.3281264108723	9.10864827716676	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGCTCTCCACAAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1902.51508257035	28.1034397043598	0.0147717303068059	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1894.84476333497	1894.84476333497
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGATAGGTTACAA"	4.18832172927205	-7.28985598003539	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGATAGGTTACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1963.08313418282	23.0635961508425	0.0117486599264393	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1959.78171649148	1959.78171649148
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGATCATAGATCC"	4.31018557128255	-7.07804968273314	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGATCATAGATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.05575526979	4.17650541282863	0.00217293665981213	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1918.94022407228	1918.94022407228
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGATGTGGATTTC"	5.50706352767293	-10.1780271760193	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGATGTGGATTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.77288210314	45.7346519915534	0.0192991709614656	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.84497772484	2365.84497772484
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGATTCCGTATGA"	-0.453003446490127	8.31909654224244	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGATTCCGTATGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2011.3467031162	34.3920996852195	0.01709904097187	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1999.51163832554	1999.51163832554
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGTAAGAGCTGAC"	-3.87831650200542	11.3608436354431	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGTAAGAGCTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1751.05297228482	25.0749225562036	0.0143199109067987	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1751.05297228482	1751.05297228482
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGTAGTGTAAATG"	4.18596520003621	-6.83612778103026	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGTAGTGTAAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.67806606325	32.2218179487773	0.013121352669991	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2446.60654160983	2446.60654160983
"healthy-4003"	"2020-08-26-Control4003-c2:CATGGTATCTTAGCCC"	-3.93999133530315	13.1650342711243	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATGGTATCTTAGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2704.5750410015	40.5931013723067	0.015009049760836	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2689.30243095228	2689.30243095228
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCATAGCATGCGA"	-2.84224234047588	9.81503865802614	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCATAGCATGCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1914.39714029676	41.7207066933695	0.021793130492716	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.57006012108	1912.57006012108
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCATCACCAATTG"	4.60053648528401	-7.50463154232176	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCATCACCAATTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.61204972127	26.4178597095435	0.0105603343701862	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2496.71979115875	2496.71979115875
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCATGTAGAATAC"	4.11822809752767	-6.83709909832152	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCATGTAGAATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.05263863682	27.7514854604015	0.0122304282359328	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2265.52496427357	2265.52496427357
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCATGTCAGACGA"	-0.956198434264022	8.94106767261354	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCATGTCAGACGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1624.60280027343	24.6383070765372	0.0151657420954773	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1624.60280027343	1624.60280027343
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCCGAGGAGGTTC"	4.41107954558675	-7.28193571483763	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCCGAGGAGGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.89633910328	28.5586506856556	0.0129230725352683	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.40726073248	2205.40726073248
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTAAGCAAGTCG"	4.36979593810384	-7.58855440532836	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTAAGCAAGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.63409014325	0.799231485253814	0.000329765738361345	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2422.25356716383	2422.25356716383
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTACAAACCACT"	3.85279621657674	-7.08153536235961	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTACAAACCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.89871474069	29.6581922499957	0.0141101909630572	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2101.89871474069	2101.89871474069
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTACAACAACAA"	-2.46578107300456	9.58296868884889	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTACAACAACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1772.19377602711	26.0334136333504	0.0146899362730592	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1772.19377602711	1772.19377602711
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTACACTACACA"	14.1913744407589	2.35425589168397	"2020-08-26-Control4003-c2"	"Control4003"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTACACTACACA"	"Plasmablast"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1144.45368505167	7.55884598205117	0.00660476354856588	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1136.6481400876	1136.6481400876
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTACATTGGATC"	2.50711764869038	-4.14686539089354	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTACATTGGATC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2322.91236287601	0	0	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2317.0736951504	2317.0736951504
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTATCATGGAGG"	3.89203419265096	-7.00724747097167	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTATCATGGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.11265424328	36.1444565546805	0.0151098471430955	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.69769557835	2389.69769557835
"healthy-4003"	"2020-08-26-Control4003-c2:CATTCTATCGCGTCGA"	-0.025544780225116	8.40474793994752	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTCTATCGCGTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.10188400772	1.75471647035097	0.000961961875997681	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1818.8653663577	1818.8653663577
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGAGGTAACTAAG"	9.67605843123738	6.66465900028077	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGAGGTAACTAAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1669.97678701599	24.7186019442523	0.0148017637948255	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1664.37734617292	1664.37734617292
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGAGGTACGGATG"	5.40740980681722	-9.92040254985961	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGAGGTACGGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.89268625563	6.94452065730498	0.00271919047134538	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2548.21672280137	2548.21672280137
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGCCAGTCAATCC"	3.84443344649617	-6.98316862499388	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGCCAGTCAATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.08347146203	0	0	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2576.52877968646	2576.52877968646
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGCCCAGCCGTTG"	5.58437170562093	-9.93466379558715	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGCCCAGCCGTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.2618264528	35.5883858385549	0.0139111585337223	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2557.02055932996	2557.02055932996
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGCCGTATGTCCA"	4.04566635665242	-6.88794996654662	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGCCGTATGTCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.92252318534	30.3166473489458	0.0111955372021812	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2698.51445412515	2698.51445412515
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGTTCATTCACAG"	3.09545602378194	-6.50596954738768	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGTTCATTCACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.55000932101	31.9234654489831	0.0146535380470484	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2177.03038108486	2177.03038108486
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGTTGTTTGACAC"	6.05816835581932e-05	8.5172719725403	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGTTGTTTGACAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1626.46298790016	20.7580275415579	0.0127626805503625	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1617.13972213917	1617.13972213917
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGTTTCAAGTGTC"	-1.15798650208171	8.40353677356569	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGTTTCAAGTGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1926.60428603643	7.65082551033373	0.00397114527658072	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.8528499155	1916.8528499155
"healthy-4003"	"2020-08-26-Control4003-c2:CATTGTTTCTGAGATC"	3.4640163379604	-6.68854811107787	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTGTTTCTGAGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.34723535809	25.6248030072132	0.0113617994628418	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.29978529902	2252.29978529902
"healthy-4003"	"2020-08-26-Control4003-c2:CATTTCACAGTTGAAA"	3.72844090041463	-6.73879673397215	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTTCACAGTTGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2565.28593652706	25.2114411948456	0.00982792632815715	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.52556117813	2556.52556117813
"healthy-4003"	"2020-08-26-Control4003-c2:CATTTCACATCCAACA"	5.55003799971883	-9.85648252880248	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTTCACATCCAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.88511320809	39.3246634096087	0.0160450864047783	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2440.62297498171	2440.62297498171
"healthy-4003"	"2020-08-26-Control4003-c2:CATTTCATCTACACTT"	-2.0306752723759	8.77686116779176	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CATTTCATCTACACTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.53777570556	33.040614390986	0.0171680778668389	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1915.70530854582	1915.70530854582
"healthy-4003"	"2020-08-26-Control4003-c2:CCAAGCGCATAATGAG"	-3.19523725929912	10.4434690245422	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAAGCGCATAATGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1953.59806311864	36.1879088847795	0.0185237227493002	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1944.91330688899	1944.91330688899
"healthy-4003"	"2020-08-26-Control4003-c2:CCAAGCGTCGCTATTT"	5.02703918990437	-8.16846754467162	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAAGCGTCGCTATTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.76405873597	34.7867144626427	0.0149957985303031	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.52850888794	2318.52850888794
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATGAAGGAACGTC"	5.51797117766683	-10.2154474488464	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATGAAGGAACGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.10907470491	37.0532086488234	0.0160604494408495	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2295.13915860391	2295.13915860391
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATGAAGGGTTGCA"	2.50309814986531	-4.31026461040648	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATGAAGGGTTGCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2165.79167610555	32.0483531685255	0.0147975234747202	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2162.24608578719	2162.24608578719
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATGACATGGCCAC"	4.54568352279012	-7.6343622437683	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATGACATGGCCAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2909.86200637996	10.0665479308108	0.0034594588708123	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2903.87463024769	2903.87463024769
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATGATCGTGCGAC"	-3.90439687195476	10.0996665724548	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATGATCGTGCGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.84709869014	28.3785835990939	0.0136511163408675	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2077.06691044376	2077.06691044376
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATTTCATATTCGG"	4.76057686385457	-7.36249830639037	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATTTCATATTCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.59824958226	5.51822174010036	0.00241117974336807	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2284.31216843727	2284.31216843727
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATTTGTGCGGATA"	-4.22550187531169	12.8982867964539	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATTTGTGCGGATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1864.48082822062	28.8356878652012	0.0154658001459424	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1860.36750826186	1860.36750826186
"healthy-4003"	"2020-08-26-Control4003-c2:CCAATTTTCCGTTTCG"	4.08968414840047	-7.60650637066039	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCAATTTTCCGTTTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.07835371854	25.7466511806391	0.0119082877530121	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2160.74739034382	2160.74739034382
"healthy-4003"	"2020-08-26-Control4003-c2:CCACAAACATGATCTG"	3.39350404319112	-7.14919950878295	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACAAACATGATCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.97164400794	12.1463951522309	0.0069888339053795	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1732.06260410726	1732.06260410726
"healthy-4003"	"2020-08-26-Control4003-c2:CCACAAAGTCTTGGTA"	-0.0422506732052148	8.34647176349489	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACAAAGTCTTGGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2154.84293273714	47.7874777017258	0.0221767800222102	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2146.23598179501	2146.23598179501
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTAGTCAGGGT"	-1.03046772900279	8.59765718067018	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTAGTCAGGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.80463282461	44.1128230565926	0.0237958317049724	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.78108415695	1848.78108415695
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTAGTTAACAG"	3.26801838454549	-6.96527674114379	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTAGTTAACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1923.43520692991	24.078649781342	0.0125185655823443	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1919.72659156232	1919.72659156232
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTCAAACCGGA"	3.29604734954182	-6.75385811245116	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTCAAACCGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.00650840737	28.202647702295	0.0114971760595147	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2451.9314189564	2451.9314189564
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTCAAATGAGT"	-3.53940306130107	10.6244497069153	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTCAAATGAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2062.63500507808	44.0471069982621	0.0213547752703802	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.05672140243	2059.05672140243
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTGTAACTGCT"	11.0925566154415	5.38608310306398	"2020-08-26-Control4003-c2"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTGTAACTGCT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2022.46150630862	29.909785228946	0.0147888032161052	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2012.18920367995	2012.18920367995
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTGTCAGATTC"	5.46732534941976	-9.55655577098998	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTGTCAGATTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.83402225069	27.6522608480518	0.0110000344506811	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2509.23053998825	2509.23053998825
"healthy-4003"	"2020-08-26-Control4003-c2:CCACACTTCTTCTTCC"	-4.15297589722331	-5.72307255184325	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACACTTCTTCTTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2226.58355433005	23.179541899214	0.0104103624829783	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2222.23614744231	2222.23614744231
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATAGAATCGTA"	4.15028061446492	-6.50081684505614	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATAGAATCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2691.76059934537	31.6971801774324	0.0117756312300362	1963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2686.78923746057	2686.78923746057
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATAGGTAAACT"	5.44159330901448	-10.0588417283264	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATAGGTAAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.39356704729	40.2090206767376	0.015350507530666	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2612.36884563083	2612.36884563083
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATCAAGGCAAC"	4.58297075805013	-7.21693136608275	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATCAAGGCAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.82955431183	33.3670194886051	0.0140858676082748	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.82955431183	2368.82955431183
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATCAGAGTCAG"	4.05133761939351	-6.96721889888915	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATCAGAGTCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.60019721104	17.8482658930179	0.00824933641438237	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2162.02278835638	2162.02278835638
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATGTCAACCAT"	-1.33199785175975	8.96946332538453	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATGTCAACCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1596.56884224003	35.9901497300291	0.022542184701246	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.71823201965	1592.71823201965
"healthy-4003"	"2020-08-26-Control4003-c2:CCACCATTCACTGATG"	-0.546256999403793	8.89159963214723	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACCATTCACTGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.90159585995	5.51362693768855	0.00330770991603982	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1666.90159585995	1666.90159585995
"healthy-4003"	"2020-08-26-Control4003-c2:CCACGAGAGAGCAGAA"	5.52918209609334	-10.0703582993713	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACGAGAGAGCAGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.28497510629	3.52630114500848	0.00159540565344472	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.58048124813	2205.58048124813
"healthy-4003"	"2020-08-26-Control4003-c2:CCACTTGGTACCGTGC"	5.10079207000081	-10.2098922959534	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCACTTGGTACCGTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.52204434926	40.7089474957544	0.0188334639483217	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2159.84073002351	2159.84073002351
"healthy-4003"	"2020-08-26-Control4003-c2:CCATAAGAGATCGACG"	-3.15472898903545	12.1679801710877	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATAAGAGATCGACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1663.76628459692	29.8521782606599	0.017942531073643	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1659.3113675955	1659.3113675955
"healthy-4003"	"2020-08-26-Control4003-c2:CCATAAGAGCAAATCA"	2.82283224639241	-4.79271700298461	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATAAGAGCAAATCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2530.9248075473	29.1907184616218	0.0115336174249721	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2524.04721792627	2524.04721792627
"healthy-4003"	"2020-08-26-Control4003-c2:CCATAAGTCGACACTA"	-1.91540990296062	9.27107331836549	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATAAGTCGACACTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1960.70518726351	33.6235901717938	0.0171487230156825	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1953.41960016739	1953.41960016739
"healthy-4003"	"2020-08-26-Control4003-c2:CCATCACAGCTTAAGA"	10.3976208167965	7.36864230716554	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATCACAGCTTAAGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2639.31490897405	30.7957170967766	0.0116680722683249	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2627.856970049	2627.856970049
"healthy-4003"	"2020-08-26-Control4003-c2:CCATCACCAACCGCCA"	2.82699217376057	-6.56237080013426	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATCACCAACCGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.19883724295	6.12753894176801	0.00257762995916432	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.91814150107	2372.91814150107
"healthy-4003"	"2020-08-26-Control4003-c2:CCATCACCACACGCCA"	5.60267605361287	-10.2370672455994	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCATCACCACACGCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.08999952667	41.7833456295168	0.0185944246284386	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.89142487798	2242.89142487798
"healthy-4003"	"2020-08-26-Control4003-c2:CCCAACTAGACGCATG"	4.77015652236287	-7.60100939190062	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCAACTAGACGCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.39817884664	3.11994050815379	0.00123006731915117	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2527.30275132288	2527.30275132288
"healthy-4003"	"2020-08-26-Control4003-c2:CCCAACTAGTAATTGG"	-0.717333416373092	8.75964353168336	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCAACTAGTAATTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1707.46198980701	39.1086526602227	0.0229045524255817	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1699.29124710617	1699.29124710617
"healthy-4003"	"2020-08-26-Control4003-c2:CCCAACTTCAAGGCTT"	4.25644316253011	-7.72411682521971	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCAACTTCAAGGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.24953012968	8.12922363660721	0.0034915603037422	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2322.38522328658	2322.38522328658
"healthy-4003"	"2020-08-26-Control4003-c2:CCCATTGCATGGCTGC"	5.32755722579305	-9.3942966691223	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCATTGCATGGCTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.89098654948	33.9895474741283	0.0145509990277144	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.71187968399	2331.71187968399
"healthy-4003"	"2020-08-26-Control4003-c2:CCCATTGTCGGACTGC"	-2.99064383927043	9.45439050281373	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCATTGTCGGACTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.7548000229	6.74374103505037	0.00337059845363019	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1998.90348273241	1998.90348273241
"healthy-4003"	"2020-08-26-Control4003-c2:CCCGAAGAGGCGACAT"	-0.991372684866744	8.81222817981569	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCGAAGAGGCGACAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.8196882784	40.1939228612128	0.0207847314332578	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.06453695928	1932.06453695928
"healthy-4003"	"2020-08-26-Control4003-c2:CCCGGAACACCATTCC"	-3.6187473339146	10.6431550749573	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCGGAACACCATTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1861.74738155947	35.6641387083022	0.0191562717163209	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.98434437398	1853.98434437398
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTAACCATCCGGTG"	10.307296414941	7.57312581622926	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTAACCATCCGGTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2771.02974072398	33.4881134756179	0.0120850790532723	1868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2756.80212287523	2756.80212287523
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCAAAGCTCGTGC"	4.60937227782552	-8.23593809520873	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCAAAGCTCGTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.70212964127	30.2139055702286	0.0139061425669137	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.46452867334	2167.46452867334
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCAAGTCCCGTGA"	3.51405276831929	-6.97554924404296	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCAAGTCCCGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2214.5730434933	13.8250908662406	0.00624277935056625	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2211.48930181105	2211.48930181105
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCAAGTGGAACCA"	-1.99253640595134	9.17629144275514	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCAAGTGGAACCA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2162.27895916786	32.8395092136974	0.0151874526061778	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2150.05914770938	2150.05914770938
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCAATCGTGCATA"	5.4928375678951	-9.53053762828978	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCAATCGTGCATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.10869137924	24.218569212816	0.00986456090431187	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2455.10869137924	2455.10869137924
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCAGCTGCGAA"	5.55943693694417	-9.61370184337767	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCAGCTGCGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.197389814	17.5156418349697	0.00697779461728607	1559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.23623586648	2505.23623586648
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCCACCTATCC"	3.75738753852193	-6.62934973156127	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCCACCTATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.96611501597	18.9511208007725	0.00707668431445387	1704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2673.07638384779	2673.07638384779
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCGTATGGTTC"	2.87899174269978	-6.8871379128662	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCGTATGGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.37685269186	9.47124811030172	0.0041624964669465	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2271.29074403825	2271.29074403825
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCGTTGAATCC"	5.41025032576863	-10.2491836777893	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCGTTGAATCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.43048557105	35.7005116230437	0.0158568127472027	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2248.53404110165	2248.53404110165
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCTCATGCCCT"	5.55591167983357	-9.98164942180785	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCTCATGCCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2856.04793012377	3.77155617492378	0.00132055072855879	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2852.59238839528	2852.59238839528
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCTCATTCGGA"	-3.66616378250774	12.634928680304	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCTCATTCGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2031.0678227745	37.9364808877392	0.0186780965472225	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2025.25122184759	2025.25122184759
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCTCCAACACA"	11.0350204902584	6.43054864490358	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCTCCAACACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2104.12653563589	29.5115434543116	0.0140255554761077	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2089.23305516654	2089.23305516654
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTCTCTCCACAGGC"	4.95056881484334	-7.90852978145751	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTCTCTCCACAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.13082971025	27.7287840180611	0.0118746169016585	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.72997842823	2333.72997842823
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTGATAGCTTCATG"	4.42944635924642	-7.92610123073729	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTGATAGCTTCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.80020623701	0	0	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.3922055732	2214.3922055732
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTGATAGGTCCGAA"	5.59963001784627	-9.63288690960082	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTGATAGGTCCGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2902.35858920645	13.1125181035857	0.00451788354214731	1970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2894.43861637688	2894.43861637688
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTGATCATGCACTA"	4.91162552413289	-8.71554090892943	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTGATCATGCACTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.97273036091	28.1033161124576	0.0121819021710157	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2304.4783757028	2304.4783757028
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTGATGTAGCTGAG"	4.42658199843709	-7.1751485100952	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTGATGTAGCTGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2856.84242094989	37.9778214538289	0.0132936353700605	2445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2848.27302280504	2848.27302280504
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTGATTCCACCTCA"	-1.59663389149364	8.77179429614869	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTGATTCCACCTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1979.54582228517	35.5556763805846	0.0179615323779368	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1969.37388070565	1969.37388070565
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTTAGCAACTGCTA"	-4.51114020767863	13.0339717634949	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTTAGCAACTGCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2334.88254319733	24.1292524312468	0.0103342467917914	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2329.98387386172	2329.98387386172
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTTAGCATTGTCGA"	-2.91117940369304	10.6413659819397	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTTAGCATTGTCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1449.31421280684	35.8028823188815	0.0247033265819861	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1449.31421280684	1449.31421280684
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTTAGGTAGGCTGA"	-2.74324880066569	10.7806033858093	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTTAGGTAGGCTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1518.65636595512	43.0040870912657	0.0283171941034992	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1516.36910694571	1516.36910694571
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTTAGGTGTCTTGA"	-4.07233367386516	10.4586610564026	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTTAGGTGTCTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2137.26589388913	37.351878692327	0.0174764772128369	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2129.92319289318	2129.92319289318
"healthy-4003"	"2020-08-26-Control4003-c2:CCCTTAGTCGCCGAGT"	-3.42919788780864	10.2844314345154	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCCTTAGTCGCCGAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.00111038757	44.7312088676731	0.0228921102602653	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1946.39428665045	1946.39428665045
"healthy-4003"	"2020-08-26-Control4003-c2:CCGAACGGTACAATAG"	5.31046213683431	-10.1359081498352	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGAACGGTACAATAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.41609971709	42.5313333967769	0.0174708561127736	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2427.15869882129	2427.15869882129
"healthy-4003"	"2020-08-26-Control4003-c2:CCGAACGGTGCGAACA"	-0.14764672043975	8.69061372363893	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGAACGGTGCGAACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.95051061647	30.1172077661235	0.0166766517626459	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1793.07245154938	1793.07245154938
"healthy-4003"	"2020-08-26-Control4003-c2:CCGAACGTCTGTCGCT"	4.87578405913655	-7.81475307857665	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGAACGTCTGTCGCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.55694051231	28.0039881120704	0.0114229401117717	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.16177827121	2449.16177827121
"healthy-4003"	"2020-08-26-Control4003-c2:CCGATCTAGGACTAAT"	2.80855598029439	-4.7672157517639	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGATCTAGGACTAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2629.75940913737	27.366247550074	0.0104063692879992	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2627.16369990893	2627.16369990893
"healthy-4003"	"2020-08-26-Control4003-c2:CCGATCTCAAATACGA"	5.13009752806966	-8.33979608928832	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGATCTCAAATACGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.93667397146	31.4122833044094	0.0122995544973957	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2550.44013246553	2550.44013246553
"healthy-4003"	"2020-08-26-Control4003-c2:CCGATGGCAATAGTAG"	-3.54675255242046	10.0062923201355	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGATGGCAATAGTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1941.14569102133	35.5075175003842	0.0182920414807721	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1935.5156586874	1935.5156586874
"healthy-4003"	"2020-08-26-Control4003-c2:CCGATGGTCCCGAAAT"	4.00048675116841	-7.35037472164305	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGATGGTCCCGAAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.05264051274	15.9242210971589	0.00662390699305258	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2402.57531522309	2402.57531522309
"healthy-4003"	"2020-08-26-Control4003-c2:CCGCAAGAGAGTACCG"	4.00878133353536	-7.20571806347045	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGCAAGAGAGTACCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2036.5436074076	24.7739367986656	0.0121646974356721	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2028.31746135281	2028.31746135281
"healthy-4003"	"2020-08-26-Control4003-c2:CCGCAAGCAGATACTC"	4.22097363051717	-7.1741309395996	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGCAAGCAGATACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.6252257595	29.5531447799123	0.0121937766886591	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2420.68677230441	2420.68677230441
"healthy-4003"	"2020-08-26-Control4003-c2:CCGCAAGCAGCATTGT"	4.1521860557491	-7.41917040264281	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGCAAGCAGCATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.29748930319	25.1264759669709	0.00984850887531483	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.67247447883	2545.67247447883
"healthy-4003"	"2020-08-26-Control4003-c2:CCGCAAGTCATAGAGA"	-0.5880363387173	8.35721204364625	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGCAAGTCATAGAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.42548565002	37.282394624968	0.0187402820029655	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1983.19967353597	1983.19967353597
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGACACAAATAAGC"	2.8752130466396	-7.11387159740599	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGACACAAATAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.06982568349	46.3495807370145	0.0239647918195687	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1929.78443551685	1929.78443551685
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGACACATCGAGCC"	5.34317745742146	-9.72134497081908	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGACACATCGAGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.76508008599	25.4817203430545	0.0111285304176696	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2282.43180701644	2282.43180701644
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGACATCAGTGTTG"	-4.11718306961711	12.9897594221863	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGACATCAGTGTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1800.04764161006	22.0542478054495	0.0122520356104147	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1791.47618656441	1791.47618656441
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGGTACACTGTGAT"	2.61361589011495	-6.7058692208496	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGGTACACTGTGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.51978532447	30.7950412166375	0.0119707694348222	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2569.91872742011	2569.91872742011
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTAGCAGCCCAGT"	3.93344583091084	-7.41258337413939	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTAGCAGCCCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.63501764502	34.8395434781294	0.0152762468385251	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2275.10445199135	2275.10445199135
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTAGTCGGTCTGG"	-3.06297884407695	10.6640138396057	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTAGTCGGTCTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1566.23051986406	40.2647149284201	0.025708038770637	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1561.81414030519	1561.81414030519
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTGAAGTTAACAG"	0.00762220200840828	8.40637300098268	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTGAAGTTAACAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.51143916631	12.1066096292318	0.00713617919085837	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1690.41320664731	1690.41320664731
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTGACAAGAGTGC"	5.10078205642049	-7.66473629390868	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTGACAAGAGTGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3064.38949115182	27.8788690018594	0.00909769110041576	2583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3060.25822103068	3060.25822103068
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTGAGTAAGATTG"	-3.24313865128215	9.89655110919801	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTGAGTAAGATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.5565944878	34.3290852801588	0.0166843941848922	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.88240755231	2046.88240755231
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTGAGTAGGGAGG"	-0.572340886027175	8.41672608936159	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTGAGTAGGGAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1560.57385799969	39.0393784561818	0.0250160402572819	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1560.57385799969	1560.57385799969
"healthy-4003"	"2020-08-26-Control4003-c2:CCGGTGAGTCCGTTTC"	5.35882010039632	-10.0156994096008	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGGTGAGTCCGTTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.03641194541	12.6219735718344	0.00533014336610859	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.88456038186	2360.88456038186
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTAGGGTCGTTTCC"	2.84347738799397	-6.94420816814574	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTAGGGTCGTTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1858.12358450866	4.86820740583869	0.00261995889101531	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1851.45898836081	1851.45898836081
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTGAGCAAGTGGCA"	5.43387522277181	-9.58409120952757	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTGAGCAAGTGGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.47179125553	4.72170700927256	0.00202520443394679	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.14687060451	2323.14687060451
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTGAGCAATCCAGT"	0.128018890588921	8.37753484332887	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTGAGCAATCCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.81366436522	47.5181825407529	0.027375163311743	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.22819421978	1729.22819421978
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTGAGCATAGTCAC"	10.4703928428585	7.30440709674684	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTGAGCATAGTCAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1886.1302036608	36.3679932550412	0.019281804185339	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1878.61791701844	1878.61791701844
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTGAGGTTGCTAGT"	5.51310839232747	-9.66509725963744	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTGAGGTTGCTAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.36429507896	2.25446214822167	0.00105232436584207	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2139.50515257327	2139.50515257327
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTTCAAGCGGTATG"	3.94491376456563	-7.50128891384276	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTTCAAGCGGTATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.01727512568	33.336842094236	0.0149290569605466	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.48563659532	2231.48563659532
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTTCACAAGTGGCA"	-3.78804216805156	10.5819282301697	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTTCACAAGTGGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.01353546499	35.9160495816479	0.0175199085080681	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.79842119329	2041.79842119329
"healthy-4003"	"2020-08-26-Control4003-c2:CCGTTCATCACAACCA"	2.8509427505428	-6.57744171535643	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCGTTCATCACAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.53212789833	34.9929149340507	0.0154389670913239	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.61800766767	2259.61800766767
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCAGATTCGCT"	3.1836322742397	-5.77855064785155	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCAGATTCGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.13716557875	7.36663392816312	0.00290123512350072	1708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2533.5257758607	2533.5257758607
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCGTGCCTATA"	4.37145008620564	-7.52768900310668	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCGTGCCTATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.74569526927	3.41994780105146	0.00143831521085528	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.21427993661	2376.21427993661
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCTCAAGTTGC"	-0.181277240545112	8.12019345844118	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCTCAAGTTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2041.44690691778	0	0	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2036.51898889696	2036.51898889696
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCTCAGGAAGC"	-3.58187590065654	10.1014051207337	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCTCAGGAAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2231.82632869251	36.4549084085185	0.0163341152220725	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2224.95738592509	2224.95738592509
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCTCCCGAGGT"	4.32671942290608	-7.19657614147338	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCTCCCGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.43490020396	35.2725964787159	0.0154878615742461	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2269.75108554441	2269.75108554441
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAACCTCTGCACCT"	5.44771494445149	-9.82429983532103	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAACCTCTGCACCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.17644527006	15.2335220208035	0.00702920246943952	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2165.35209772407	2165.35209772407
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAAGAAGAAACTGT"	4.52131571349446	-6.82263805782469	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAAGAAGAAACTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2303.85820546861	35.2136275536921	0.0152846331732163	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2302.43987359359	2302.43987359359
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAAGAAGCGAAACC"	-4.18928943100627	10.9340171583923	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAAGAAGCGAAACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1851.11335101736	1.86167432804564	0.00100570520277566	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1844.82300349813	1844.82300349813
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAAGAGTTATCTGG"	5.50260748442952	-10.063331627008	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAAGAGTTATCTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.6814832434	32.7887424705455	0.0161705587102852	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2026.27246879359	2026.27246879359
"healthy-4003"	"2020-08-26-Control4003-c2:CCTAAGATCGAGGCAA"	5.38434519347493	-9.93053820049437	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTAAGATCGAGGCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.75891407401	10.1518747515354	0.00465306899220075	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2172.10904749995	2172.10904749995
"healthy-4003"	"2020-08-26-Control4003-c2:CCTACGTAGCGTGAGT"	4.63874210891072	-7.59228184139403	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTACGTAGCGTGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.0758924036	24.2478820882331	0.00950496304733097	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2538.98314434338	2538.98314434338
"healthy-4003"	"2020-08-26-Control4003-c2:CCTACGTTCCTTTGAT"	2.59874715384786	-4.44306566631468	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTACGTTCCTTTGAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2600.74720845565	46.2855953866266	0.0177970374191467	1950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2591.77079899874	2591.77079899874
"healthy-4003"	"2020-08-26-Control4003-c2:CCTACGTTCGACGACC"	3.92853226241414	-7.36417391216429	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTACGTTCGACGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1994.51236529627	40.2239107196082	0.0201672907220273	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1992.79243484855	1992.79243484855
"healthy-4003"	"2020-08-26-Control4003-c2:CCTATCGAGCCTGAGA"	-1.07956788960155	8.69885823810426	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTATCGAGCCTGAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1731.87990113745	31.6226947782352	0.0182591730277984	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1727.9496291883	1727.9496291883
"healthy-4003"	"2020-08-26-Control4003-c2:CCTATCGCAGGATTCT"	4.66101135787312	-7.13542797481688	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTATCGCAGGATTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2925.81107505641	10.5149735083385	0.0035938661925175	2393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2920.11383728746	2920.11383728746
"healthy-4003"	"2020-08-26-Control4003-c2:CCTATCGGTCTTGTCC"	-1.72355912151988	9.72802636707155	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTATCGGTCTTGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2418.74204952399	27.0107365636993	0.0111672662940701	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2413.37144704901	2413.37144704901
"healthy-4003"	"2020-08-26-Control4003-c2:CCTATCGTCACGAACT"	-0.332802305847961	8.30517289722291	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTATCGTCACGAACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.16207787495	30.8939509018898	0.016697970016429	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.20099494082	1848.20099494082
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCAACTCTCTGCTG"	4.71295227584187	-6.9559273949829	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCAACTCTCTGCTG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2263.35257344836	44.0971897760747	0.0194831288299418	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2263.35257344836	2263.35257344836
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCAACTCTTGGTCC"	-3.60927043381389	11.1341905363831	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCAACTCTTGGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.75156051703	33.0256176748229	0.018098692660093	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1817.99491556079	1817.99491556079
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCACAGTCGTACTA"	3.44404663619344	-7.20833160793456	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCACAGTCGTACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1966.68138361357	30.4584310227612	0.0154872219143078	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1966.68138361357	1966.68138361357
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCACAGTTCGTACA"	-1.06171057644542	9.1440391310486	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCACAGTTCGTACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.13603210054	34.883726213774	0.0182911578548241	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1901.76132192064	1901.76132192064
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCAGTCACAAGTGG"	2.91069259223287	-6.92685367977294	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCAGTCACAAGTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.66159813798	8.43175826495131	0.00382451359976181	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.92611744953	2199.92611744953
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCAGTGTATGACAA"	-7.25945792618449	1.18709621513215	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCAGTGTATGACAA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2466.94031443947	25.5892632338749	0.0103728748863911	2175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2454.40989180334	2454.40989180334
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCAGTTCTAGTACG"	6.73288549956624	-0.930358671304308	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCAGTTCTAGTACG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1454.79034113517	31.0706646496674	0.0213574862102969	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1442.60676432151	1442.60676432151
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCATGAGTATTCCG"	3.91786326941792	-6.85558130657347	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCATGAGTATTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.96027625175	12.7816598937505	0.00584448653802577	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2185.4339896002	2185.4339896002
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCATGCAGCAGTTT"	4.26334156569783	-7.32436134731444	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCATGCAGCAGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2851.77486715274	34.3018129245526	0.0120282331258498	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2846.18379056843	2846.18379056843
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCATGGTCGCCACA"	4.00777282294576	-7.48772051250609	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCATGGTCGCCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.81972519971	9.96341488781785	0.00413279134216163	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2409.48396511252	2409.48396511252
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCATGTCGCATTAG"	3.25518383559529	-6.97617247020873	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCATGTCGCATTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.56340512158	33.5958417882683	0.0155136726584933	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2163.81854430238	2163.81854430238
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCATGTCGTTTACT"	-7.66081653061565	-0.240853243228518	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCATGTCGTTTACT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2025.59801480988	27.1618056283382	0.0134092773737673	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2024.51582953371	2024.51582953371
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCAACAATCACGT"	-1.65273092213328	9.00719354236452	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCAACAATCACGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2401.01876149774	33.5778248335703	0.0139848240138801	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2393.7941022504	2393.7941022504
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCAATCCGAGGCT"	4.90638079222981	-7.88464691555174	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCAATCCGAGGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2705.89665792443	35.4217203515534	0.0130905665771892	2075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2701.13456817385	2701.13456817385
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCTCGTGATGTAA"	3.95711936530415	-6.80149176036986	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCTCGTGATGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.82098969087	29.495196205419	0.0126381570547645	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2324.03955088392	2324.03955088392
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCTCGTTAAGAAC"	4.66061749038045	-7.23946907436522	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCTCGTTAAGAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.17962791688	27.124066382397	0.0111889672159752	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2421.68847992413	2421.68847992413
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCTCGTTCAGTAC"	-3.8532489341801	10.9271192320618	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCTCGTTCAGTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2429.40422313597	34.4543068057241	0.0141822042118825	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2417.39970947438	2417.39970947438
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCCTCTCTCAGAAC"	4.32616915282552	-7.33106901561888	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCCTCTCTCAGAAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2597.85716295248	6.53580247057175	0.00251584365906545	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2595.33425155989	2595.33425155989
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTAGAGAATTCAG"	-1.96128402176555	4.1587080725464	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTAGAGAATTCAG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3236.22145711601	34.2980075912421	0.0105981645711623	4841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3230.8919727355	3230.8919727355
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTAGGTATTTCTC"	4.44072546538655	-7.67198231136473	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTAGGTATTTCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.75308438566	29.0706484145005	0.0125371901865104	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2314.26574649232	2314.26574649232
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTAGGTGTGTCGC"	2.80355372008626	-4.67529394542845	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTAGGTGTGTCGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2724.09602356448	36.7751113594579	0.0134999321027376	2162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2718.59453546383	2718.59453546383
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCAGACAGTCG"	10.0339828926021	6.79118201816408	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCAGACAGTCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1954.43517287846	36.2151537770867	0.0185297288340086	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1952.69086333816	1952.69086333816
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCAGCGACTTT"	-3.19674501839336	10.1801709898743	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCAGCGACTTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2174.94797231216	33.8984784968617	0.0155858801812278	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2167.78045984528	2167.78045984528
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCCAAATACAG"	-4.34974036637004	13.0279664763245	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCCAAATACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2268.03441460433	40.326981978357	0.0177805864490783	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2262.25180673683	2262.25180673683
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCCAGGCTTGC"	5.13229479369466	-8.13274862682494	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCCAGGCTTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2743.45142294402	28.2888443241557	0.0103114070428113	1786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2742.24477863108	2742.24477863108
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCGTCAATGGG"	4.73450388488118	-7.64798738872679	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCGTCAATGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.81202099663	25.9611616676766	0.0099857841482418	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2592.68428481962	2592.68428481962
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCGTTAAGGAT"	4.43447937545125	-6.86016085064086	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCGTTAAGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.82073166204	24.8698247171552	0.00946404920910473	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2625.32481653319	2625.32481653319
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCTCTAAGAAG"	-2.89876876297649	9.71394250476686	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCTCTAAGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1875.75883323603	31.6462984112509	0.016871197858978	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1870.07373876448	1870.07373876448
"healthy-4003"	"2020-08-26-Control4003-c2:CCTCTCCTCTAGCAAC"	3.97663631018941	-7.0900073281494	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTCTCCTCTAGCAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.38533094289	29.1478173759605	0.0114692632483033	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.26961150707	2529.26961150707
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGCATAGTCATAGA"	5.66553320464436	-10.2242889634338	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGCATAGTCATAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.62308083731	25.6663962386565	0.0105034186491076	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2440.78404840731	2440.78404840731
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGCATCACAGCTGC"	5.40668501433675	-9.63436033641966	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGCATCACAGCTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.52646125473	28.4708486851067	0.0112155020322436	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2535.86609506005	2535.86609506005
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGCATCACTCCTTG"	0.856657703488511	9.22994515979616	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGCATCACTCCTTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1412.59712162335	38.2876450713816	0.0271044337308161	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1410.3810243184	1410.3810243184
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGTTGAGTTACTCG"	4.33723225173299	-7.03212644970091	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGTTGAGTTACTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.52219885156	14.5497581847119	0.00621115061016071	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.46533056111	2333.46533056111
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGTTGGTATATGGA"	3.26298322257344	-7.3568268052307	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGTTGGTATATGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.34123711132	37.8016233787528	0.0211496398079234	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1787.34123711132	1787.34123711132
"healthy-4003"	"2020-08-26-Control4003-c2:CCTGTTGGTTGTCAGT"	-3.95770726624187	10.4330739744934	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTGTTGGTTGTCAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.06763089995	28.4507392340993	0.0141964965630043	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1989.41949125482	1989.41949125482
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTCAGAGCCAGAGT"	4.32403769072835	-7.67024280941161	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTCAGAGCCAGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.44374288527	34.3088688674446	0.0157059979132851	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2181.61915664822	2181.61915664822
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTCAGCACGGGTAA"	4.19751419600789	-8.24855997478636	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTCAGCACGGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.91629478501	19.129463047119	0.00895190096767152	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2135.2948395904	2135.2948395904
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTCAGCATCCGGTG"	4.47906937178914	-7.14514114772948	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTCAGCATCCGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2683.30580838501	26.4031671798724	0.0098397905663103	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2677.16443869078	2677.16443869078
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTCAGTCATACAGC"	-0.258213321596938	7.89921805942384	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTCAGTCATACAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.78450787667	29.0388155294893	0.0152692460208917	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1891.21505228323	1891.21505228323
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTGTGGTGTGGACA"	2.98403372344319	-5.01002170955809	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTGTGGTGTGGACA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2204.60970222113	19.8419579634796	0.00900021348154685	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2197.66036500455	2197.66036500455
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTGTGGTTCCGGTG"	5.20478453215901	-10.2304115525452	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTGTGGTTCCGGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1943.41242295377	39.5842534991546	0.0203684267073846	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1938.65476210219	1938.65476210219
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTGTGTCGGAAGGT"	5.66902555999104	-9.87465670025023	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTGTGTCGGAAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2580.10126433747	32.9782195059079	0.012781753941885	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2576.06575247225	2576.06575247225
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTTGGCAAGAATGT"	-3.35654221001323	10.5163011320862	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTTGGCAAGAATGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1792.03993750884	34.8379421736137	0.0194403826859142	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1788.04578083319	1788.04578083319
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTTGGCACGGATCC"	-2.20600519600566	4.10969874942628	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTTGGCACGGATCC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3318.68782006021	32.7867157437738	0.00987942148266871	4953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3313.65863401183	3313.65863401183
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTTGGTCGGTTCAA"	-3.05465112152751	9.64103219592897	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTTGGTCGGTTCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.58156938941	31.9352604373856	0.0157737583509747	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2020.83724926757	2020.83724926757
"healthy-4003"	"2020-08-26-Control4003-c2:CCTTTGGTCTGACGCG"	3.1395558315212	-6.67964031612548	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CCTTTGGTCTGACGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.6732794658	37.8741824968207	0.0171401730965299	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2206.39389401781	2206.39389401781
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGGAAGAGCGACT"	-2.42268286171611	9.01302430713502	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGGAAGAGCGACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1608.45681933052	33.109243327838	0.0205844775749832	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1606.26072176427	1606.26072176427
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGGAAGGCACCAA"	4.81626858290975	-7.44111206447753	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGGAAGGCACCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.58578414013	31.1896709970026	0.0128163433564858	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.91817616183	2429.91817616183
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGGACATGGACAG"	4.94531931456868	-7.49138691341551	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGGACATGGACAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2737.85619666773	32.0262740113171	0.0116975734701832	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2734.65448961186	2734.65448961186
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGGATCCATTCGC"	3.13082017478291	-6.51974966442259	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGGATCCATTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.2815179257	31.2943806869548	0.0155594233865529	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2008.24687427362	2008.24687427362
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGGATCTCGTGGG"	5.27475370940511	-9.15685465252074	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGGATCTCGTGGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2619.73449529902	32.7107996433949	0.0124863033647466	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2614.54008490313	2614.54008490313
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGTTAGGTTAGTA"	-1.17111061039622	8.581422782782	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGTTAGGTTAGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.29252403855	35.6180610534439	0.0194603106255674	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.85015085474	1821.85015085474
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGTTCATATCTCT"	3.80542125281636	-6.85835697567137	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGTTCATATCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2500.41739508199	20.8236161554649	0.00832805602633481	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2497.05694985454	2497.05694985454
"healthy-4003"	"2020-08-26-Control4003-c2:CGAAGTTTCGCAGTGC"	4.7957521873409	-8.26384832775267	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAAGTTTCGCAGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.12570969112	27.8273618102176	0.010572200905056	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2622.2888815947	2622.2888815947
"healthy-4003"	"2020-08-26-Control4003-c2:CGAATTGAGAGAAGGT"	9.88573898848836	6.60560987079469	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAATTGAGAGAAGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1623.25026952232	41.1860663497012	0.0253725917210666	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1616.67156107985	1616.67156107985
"healthy-4003"	"2020-08-26-Control4003-c2:CGAATTGAGTCGAGGT"	9.66776241835896	7.78818891132203	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAATTGAGTCGAGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2190.57832021605	9.91747069192432	0.00452732988380264	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2183.40741415564	2183.40741415564
"healthy-4003"	"2020-08-26-Control4003-c2:CGAATTGGTGCGAGTA"	-2.8481150669163	10.0660199888977	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAATTGGTGCGAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.24806797326	41.848887369325	0.0230540872664581	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.35132098386	1813.35132098386
"healthy-4003"	"2020-08-26-Control4003-c2:CGACAGCTCCATTTCA"	-0.288798014551955	8.50587365711061	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGACAGCTCCATTTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.73932812659	38.7067003398679	0.0208803361684003	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1850.67267244632	1850.67267244632
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGAAGAGAGATCGC"	10.949350019067	6.6346168288025	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGAAGAGAGATCGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.84644316973	30.3102986637238	0.0154341490237911	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1954.27223247129	1954.27223247129
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGAAGCATGACGAG"	-2.21759233895	9.75608728015748	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGAAGCATGACGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.6810790849	32.6575379173257	0.0175325439679507	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.05838121855	1853.05838121855
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGAAGGTCACCACG"	5.28421034392659	-10.1388244858948	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGAAGGTCACCACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.03453229756	33.2715025672805	0.0154175023936516	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.44971773631	2152.44971773631
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGAAGGTCCAGAAG"	-2.51857862892802	9.71444890582887	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGAAGGTCCAGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1822.70456283802	38.8465522237315	0.0213125884555015	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1818.64426159249	1818.64426159249
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGAAGGTGCGGCTT"	3.97848596152608	-7.09496023571166	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGAAGGTGCGGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.73150951613	7.63821036795328	0.00299451758817306	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.38297760196	2545.38297760196
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGGAACAGGTGAGT"	-4.37384019318278	13.1538829573425	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGGAACAGGTGAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1868.14396440317	22.9482851535373	0.0122840025130873	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1866.12668282426	1866.12668282426
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGGAAGTTGCCGAC"	0.23622085627858	8.01104781711427	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGGAAGTTGCCGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1602.43558715607	5.34088531224133	0.00333297971852966	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1597.755747222	1597.755747222
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGGCTAGAGAGTGA"	-4.31349597397502	12.9012164839539	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGGCTAGAGAGTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1810.88718685742	4.09221253120059	0.00225978324928243	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1806.34075563099	1806.34075563099
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGGCTTCGCTACGG"	-0.923136274248916	10.5075464018616	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGGCTTCGCTACGG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1611.20613695964	41.3045359545203	0.0256357861399797	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1606.82407790322	1606.82407790322
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGGCTTCGGCACTG"	4.03564014014546	-7.33022787487181	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGGCTTCGGCACTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.3686731065	0.921032718130889	0.00038322573163126	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.4892222874	2397.4892222874
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTGCCAACTTGGT"	4.10988440093343	-6.88304331218871	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTGCCAACTTGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.31573469753	35.9414934229119	0.0148806604894713	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2406.9798918745	2406.9798918745
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTGCCAGAGATGC"	6.79346623000447	-1.46105196392211	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTGCCAGAGATGC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1737.94291856862	44.1580735013509	0.0254082415651025	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1731.15668087605	1731.15668087605
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTGCTCCTCACGT"	5.03068365630452	-7.87176849758299	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTGCTCCTCACGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.90042524155	25.8727216676016	0.010287771797214	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2506.91505044622	2506.91505044622
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTGCTCTACCCAC"	3.79730524596516	-6.45447828685912	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTGCTCTACCCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.19141734947	20.5578156907118	0.00805181137262846	1643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2550.73712840608	2550.73712840608
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTTAAGCAAGTGC"	3.84983195838277	-6.79390575802001	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTTAAGCAAGTGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2134.63520026475	31.1517417771739	0.0145934732891645	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2131.69805448996	2131.69805448996
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTTAGTGACACAG"	10.7995401817257	7.25451514804689	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTTAGTGACACAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1928.84042172886	34.5646119472829	0.0179198919505751	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1924.06643284686	1924.06643284686
"healthy-4003"	"2020-08-26-Control4003-c2:CGAGTTAGTGTGACCC"	6.77900089797322	-1.69920649444731	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGAGTTAGTGTGACCC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2795.82799197348	27.8557418799745	0.00996332462510045	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2783.86598645008	2783.86598645008
"healthy-4003"	"2020-08-26-Control4003-c2:CGATCGGGTCAGATTC"	-2.40385041657146	9.28957269275514	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATCGGGTCAGATTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1555.12958199534	36.2045540669663	0.0232807313847849	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1550.62099738064	1550.62099738064
"healthy-4003"	"2020-08-26-Control4003-c2:CGATCGGTCCCGAATA"	3.53740849074666	-7.50366451656493	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATCGGTCCCGAATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1815.0011522818	10.7642159443484	0.00593069372480328	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1805.20499799993	1805.20499799993
"healthy-4003"	"2020-08-26-Control4003-c2:CGATCGGTCGAGAACG"	11.082481999963	6.14763352954713	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATCGGTCGAGAACG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1719.66556370151	34.9279696447273	0.0203109083428677	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1717.89137701668	1717.89137701668
"healthy-4003"	"2020-08-26-Control4003-c2:CGATCGGTCTCAATCT"	9.30050434645955	6.71511123264161	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATCGGTCTCAATCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1443.91911172993	12.2310821169166	0.00847075297885819	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1441.74613778159	1441.74613778159
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGCGAGTTGGGAC"	4.03612365302388	-6.8281984559265	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGCGAGTTGGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.26573390582	25.2542567810801	0.0101944076630255	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2473.44027882586	2473.44027882586
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGCGGTCTCAGAT"	-3.5728419822758	9.95131967151491	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGCGGTCTCAGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2521.99281500721	31.8836765621593	0.0126422551136682	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2514.05069276518	2514.05069276518
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGCGGTTATGACC"	5.11650576171224	-8.5586614838806	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGCGGTTATGACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.48738126848	1.22834552341441	0.000486187080339856	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2523.92090153881	2523.92090153881
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGCGTCACTTGTT"	0.665833016007584	8.56173226917116	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGCGTCACTTGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1661.18518375727	11.7974624094344	0.00710183459664077	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1646.46000295999	1646.46000295999
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGGCCAACAGCCC"	5.64692177352254	-10.0231580964294	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGGCCAACAGCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.98153995662	4.38212123347891	0.00166368714700676	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2627.58671471056	2627.58671471056
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGGCCACTCCCTA"	5.31330885466878	-10.2983598939148	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGGCCACTCCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2100.18316901206	0	0	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2092.27813353437	2092.27813353437
"healthy-4003"	"2020-08-26-Control4003-c2:CGATGGCGTACTCCCT"	5.29203333434407	-10.3016405335632	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGATGGCGTACTCCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.93844737256	9.86382960193774	0.00475150388703577	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2074.29459806501	2074.29459806501
"healthy-4003"	"2020-08-26-Control4003-c2:CGCAGGTAGTTAACGA"	-3.15357885780986	12.0553970106873	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCAGGTAGTTAACGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1868.03323790048	37.3877480537672	0.0200144982943601	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1862.12124618112	1862.12124618112
"healthy-4003"	"2020-08-26-Control4003-c2:CGCATAACATGTTACG"	-3.98985181275066	13.0509347685608	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCATAACATGTTACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2292.29415270705	40.52799737936	0.0176801032849554	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2280.03204813432	2280.03204813432
"healthy-4003"	"2020-08-26-Control4003-c2:CGCATAAGTATGTGTC"	4.28843750533406	-7.26724817669066	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCATAAGTATGTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.11951270492	0	0	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.931492341	2408.931492341
"healthy-4003"	"2020-08-26-Control4003-c2:CGCATAATCCACCTGT"	5.47202219542806	-9.90029051220091	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCATAATCCACCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.06444412984	23.0974943236017	0.00890741237684609	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2589.12348886119	2589.12348886119
"healthy-4003"	"2020-08-26-Control4003-c2:CGCATGGCAATAGTCC"	3.9977134662563	-7.3538651696411	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCATGGCAATAGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2529.21417090399	30.1954173888024	0.0119386557833534	1564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2525.37241307005	2525.37241307005
"healthy-4003"	"2020-08-26-Control4003-c2:CGCATGGCAATGCTCA"	4.88901676711385	-8.24722006237181	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCATGGCAATGCTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.53931675454	5.9917433551332	0.00253829424174605	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.81334926794	2351.81334926794
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCAGAAGTTTCAGC"	3.81706990775411	-7.87102749263915	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCAGAAGTTTCAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.36570879414	34.6707570684385	0.0196728504733341	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1758.87105416106	1758.87105416106
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCAGACAAGAAACT"	-4.18039021912273	11.6192035445007	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCAGACAAGAAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2017.48078448222	36.614649572907	0.0181486980468585	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2009.51488945359	2009.51488945359
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCAGACATGGTGGA"	4.05079688605611	-7.46705677425536	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCAGACATGGTGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2020.46561626319	34.4997500831071	0.017075148324926	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2016.86541165704	2016.86541165704
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCATTGTAACCCTA"	-3.51641784134563	9.92790601337282	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCATTGTAACCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2272.69542945342	40.8143406688984	0.0179585615124479	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2266.02281266922	2266.02281266922
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCATTTCATGCAGT"	-0.604016403586227	8.3886098631653	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCATTTCATGCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1908.03997575044	35.7929312843992	0.018759004915671	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1906.3728312644	1906.3728312644
"healthy-4003"	"2020-08-26-Control4003-c2:CGCCATTTCTCATGCC"	-3.80798302117046	10.3812980421814	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCCATTTCTCATGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2331.95363928289	32.7418234772494	0.0140405121807302	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2316.18571019121	2316.18571019121
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAAGGTACAAT"	5.46980537947957	-9.8048362961975	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAAGGTACAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2600.41747926383	38.4563103909228	0.0147885140357577	1719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2593.42421500321	2593.42421500321
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAGTAGCGTCC"	-0.36735306206401	8.64629170978395	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAGTAGCGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.00002391554	28.6886023555999	0.0170157781427392	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1680.850687219	1680.850687219
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAGTCACATTG"	-0.0201435041731179	8.56629846179811	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAGTCACATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1589.95998001343	41.5407578993407	0.0261269204392111	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1587.93645813756	1587.93645813756
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAGTCACGTGC"	-4.06641135636027	13.002417541388	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAGTCACGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1494.09243006954	33.8704737952246	0.0226695973512483	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1486.83133572833	1486.83133572833
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAGTCACTTCC"	5.6324597793514	-9.84193041240843	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAGTCACTTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2881.56568717866	36.5352731360255	0.0126789659172397	2212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2874.05008034859	2874.05008034859
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGAGTGCCTGCA"	0.351889629929703	8.29481694782106	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGAGTGCCTGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1396.54159563934	21.8930515138275	0.0156766197170123	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1389.80862962477	1389.80862962477
"healthy-4003"	"2020-08-26-Control4003-c2:CGCGTGATCTGGTGCG"	3.55008568343465	-6.63603975689086	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGCGTGATCTGGTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.0985310476	43.6414290048131	0.0182745512538249	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2383.11371048164	2383.11371048164
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAACCCAACATCGT"	3.83941998061482	-7.65823652660521	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAACCCAACATCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.32446745214	12.4725564517192	0.00562251223151526	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2213.64240455482	2213.64240455482
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAACCCAGCACACC"	4.38574232634847	-7.36602642452391	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAACCCAGCACACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.77836125734	14.7795387600221	0.00677718516589683	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.697046321	2173.697046321
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAACCTCCTTATCA"	3.92724480208699	-6.95077707683715	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAACCTCCTTATCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.61925656896	32.5263505817522	0.0146145170544108	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2220.72940111543	2220.72940111543
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTAGATAGTGT"	-2.14339623871501	9.65661141956178	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTAGATAGTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1947.46037175006	35.6769699116378	0.0183197411506644	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.5832823755	1945.5832823755
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTAGGTAGACC"	5.56540789183919	-10.0639658204285	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTAGGTAGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.82290182349	34.0396294226687	0.0146607346305073	1380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2319.25183661945	2319.25183661945
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTCAACGAGGT"	2.80569924887959	-7.2679596177307	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTCAACGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1519.0370643087	30.9148343544362	0.0203515997606715	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1519.0370643087	1519.0370643087
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTCAAGCCTGC"	-0.327385793358642	8.85159776294557	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTCAAGCCTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1646.58331347928	36.6305180562478	0.0222463799774859	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1642.91207558777	1642.91207558777
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTGTCCAGCCA"	-4.10265384140666	-5.27805235302123	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTGTCCAGCCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3003.11207727117	47.1125732616919	0.0156879170838344	2770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2996.00160655349	2996.00160655349
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTTCAACACGT"	3.79881729659383	-6.88515236293944	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTTCAACACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.41469338239	36.8214242314519	0.0152254385206176	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2414.11175283352	2414.11175283352
"healthy-4003"	"2020-08-26-Control4003-c2:CGGAATTTCCGCGAGT"	4.20782675322835	-7.37753775036009	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGAATTTCCGCGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.11686528044	27.0831206492032	0.0114559144883857	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.02702429247	2360.02702429247
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACAGAGCTTTC"	9.90353645858113	7.49702403629152	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACAGAGCTTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2027.2771306824	22.4511680940104	0.0110745431664062	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2019.80616126564	2019.80616126564
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACAGCGGGTAT"	4.16289200362508	-7.60390760814818	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACAGCGGGTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.48376719895	12.1923662908837	0.00540565463968078	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2249.64193274116	2249.64193274116
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACAGTACTGTC"	4.72832407531087	-7.6266718140808	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACAGTACTGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2632.91847209353	2.89721201523624	0.00110038045079784	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2623.96531735019	2623.96531735019
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACAGTTACGAA"	-4.23090634766276	12.9945430525574	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACAGTTACGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2089.08486309504	25.4234778932466	0.0121696721575882	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2078.1614079737	2078.1614079737
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACCAGGCTACC"	-4.14971290054973	13.1079187163147	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACCAGGCTACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1960.39178862248	41.2472968176826	0.0210403333951251	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1954.56598666305	1954.56598666305
"healthy-4003"	"2020-08-26-Control4003-c2:CGGACACTCTATACGG"	5.26199783858601	-10.0576000443664	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGACACTCTATACGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.00320363808	31.5584125474652	0.0146238951333633	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2156.49527549531	2156.49527549531
"healthy-4003"	"2020-08-26-Control4003-c2:CGGCAGTCAGCTTCGG"	5.56021036681477	-9.95756533062132	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGCAGTCAGCTTCGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.80596687705	20.9437727366732	0.00923525779655409	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.99594848871	2264.99594848871
"healthy-4003"	"2020-08-26-Control4003-c2:CGGCAGTCAGGAGGAG"	-1.74429140511211	9.2054986723694	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGCAGTCAGGAGGAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2133.64437679036	35.7728596505165	0.0167660834390451	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2120.6690000501	2120.6690000501
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGACTAGAAATTCG"	5.54380096968953	-9.90863420879515	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGACTAGAAATTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.32299875145	44.0832698910015	0.0194086309676053	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2271.32299875145	2271.32299875145
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGACTAGTCTAGAA"	-3.58932099762614	11.3256759413513	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGACTAGTCTAGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.55079816295	33.7913591658005	0.0194141757893336	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1736.10539407649	1736.10539407649
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGACTCAAACTAAG"	3.95037617263142	-7.64035417949828	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGACTCAAACTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1840.08344528265	6.58452882181518	0.0035783859904265	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1836.28334764222	1836.28334764222
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGCATCAAGACGGT"	3.88027467307393	-7.69044258510741	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGCATCAAGACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.67725291404	48.5862910665139	0.0206602717300212	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.00620175572	2341.00620175572
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGCATCACAGAGAC"	-1.77686903896983	9.22243592822877	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGCATCACAGAGAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1889.91160622325	48.9500778596768	0.0259007234510281	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1878.96090323531	1878.96090323531
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTCAAGGTACAAT"	3.33774723586385	-5.36841919338378	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTCAAGGTACAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2580.84006944959	0	0	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2572.13885161646	2572.13885161646
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTCAAGTCAACAA"	4.73302378234212	-6.91372826015624	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTCAAGTCAACAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3006.46113223698	26.1930786802932	0.00871226253332737	2788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3002.98891830516	3002.98891830516
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTCACAGGCATTT"	4.45062460479085	-7.83900072490843	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTCACAGGCATTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.16425022097	36.3281529786026	0.0169428032273454	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.57997497861	2142.57997497861
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTCAGTATCTCGA"	-2.51464281502422	9.59165761554567	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTCAGTATCTCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1615.74381551842	38.3953877915985	0.0237632893425491	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1607.36079291687	1607.36079291687
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTCATCGTGCACG"	-3.45748601380046	9.76471612537233	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTCATCGTGCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1921.73847969956	26.2495628115345	0.0136592793914593	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1919.85456017197	1919.85456017197
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTGTAGTGAGGCT"	-1.77902529659923	8.87221334064332	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTGTAGTGAGGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.18169782746	7.67542162835751	0.00390968479221839	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.30355508721	1957.30355508721
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTGTAGTGCGTCC"	5.57927336272542	-10.0536756745544	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTGTAGTGCGTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2652.38958358245	40.7612505265128	0.0153677464196111	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2644.20243634938	2644.20243634938
"healthy-4003"	"2020-08-26-Control4003-c2:CGGGTGTGTGCACAAG"	5.07526459273641	-7.65551712429198	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGGTGTGTGCACAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.98267387657	48.2329140161326	0.0204899188729805	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2348.96443273979	2348.96443273979
"healthy-4003"	"2020-08-26-Control4003-c2:CGGTCAGAGCGCTGAA"	4.41221108016316	-8.13412859356078	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGTCAGAGCGCTGAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1744.18220854691	1.67772146049819	0.000961895753939556	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1742.29166081669	1742.29166081669
"healthy-4003"	"2020-08-26-Control4003-c2:CGGTCAGCAACTGGTT"	10.9968172508175	5.29945323551027	"2020-08-26-Control4003-c2"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGTCAGCAACTGGTT"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1868.56434152553	22.8283372166384	0.0122170463758294	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1861.22347982408	1861.22347982408
"healthy-4003"	"2020-08-26-Control4003-c2:CGGTCAGCAATCGAAA"	-3.56356487694438	10.8360080488953	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGTCAGCAATCGAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1444.82225379443	48.6160882402116	0.0336484907486264	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1440.14762851004	1440.14762851004
"healthy-4003"	"2020-08-26-Control4003-c2:CGGTCAGGTACGAGCA"	4.62008919295613	-7.11301376735839	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGTCAGGTACGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.28851102036	33.6920604474458	0.0141367947236154	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2380.29139989673	2380.29139989673
"healthy-4003"	"2020-08-26-Control4003-c2:CGGTCAGGTCGTCATA"	-1.6544670862263	8.42145059192506	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGGTCAGGTCGTCATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2775.21388055269	36.9855903332967	0.0133271134857292	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2763.37610905225	2763.37610905225
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAAGTAGCATGGGT"	-3.82951078835185	11.1831807860169	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAAGTAGCATGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.05563847688	43.2000639778391	0.0248125694682747	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1738.95475512417	1738.95475512417
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAAGTCATAGGAGC"	5.42301621016805	-9.77549650585326	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAAGTCATAGGAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.83518977532	32.2180159938477	0.0130393221398054	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.63163751024	2467.63163751024
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAAGTGTATCGATC"	5.6228367286617	-10.2119903794494	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAAGTGTATCGATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.27842589265	47.0260150245057	0.0218189977032916	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.42039396412	2152.42039396412
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAAGTTCATTTACC"	4.15541901168172	-7.78580858623656	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAAGTTCATTTACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.70658574583	18.5953242057207	0.00824002744671169	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2253.42319772906	2253.42319772906
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAAGTTCTCGCGTT"	3.60149206694905	-8.06900885021361	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAAGTTCTCGCGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1701.46013087495	23.2838136170713	0.0136846072350211	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1701.46013087495	1701.46013087495
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAATGAGAAACTGT"	-2.30370841446574	9.38578126514284	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAATGAGAAACTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1779.18151058145	29.8774639263391	0.0167928138577468	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.37786648785	1775.37786648785
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAATGAGTTAGAAC"	-2.97939119759257	9.99590776050416	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAATGAGTTAGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.99369280701	0	0	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1861.30147075261	1861.30147075261
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAATGTCTCTGGTC"	9.72051968154256	7.218066192511	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAATGTCTCTGGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1970.19196050024	33.0143273803507	0.0167569089927502	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1961.41667855696	1961.41667855696
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAGTATCACGATAC"	4.42062296447102	-7.884641670343	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAGTATCACGATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.29654853308	35.5230389840311	0.0162480423837588	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2186.29654853308	2186.29654853308
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAGTATCCGGTAGC"	-3.69845948639568	2.87375662410585	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAGTATCCGGTAGC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2395.00319261072	0	0	2467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2392.5237215642	2392.5237215642
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAGTATCGCGTGCA"	3.76881923255269	-6.73849823391112	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAGTATCGCGTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.84732127054	29.5925470931865	0.0123515997160843	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.71203189273	2391.71203189273
"healthy-4003"	"2020-08-26-Control4003-c2:CGTAGTATCGTGCACG"	4.05112566527669	-7.92779495632323	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTAGTATCGTGCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2066.29262735081	24.0899826320935	0.0116585532529239	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2064.11872488778	2064.11872488778
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATAGACAGCGT"	-0.486280838877517	8.86301324451295	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATAGACAGCGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1702.34759621506	29.572130911776	0.0173713823061316	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1695.58144540782	1695.58144540782
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATAGAGAATCT"	-3.95639167252238	12.1104717024597	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATAGAGAATCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1973.66657235376	28.7756131456825	0.0145797742885037	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1968.18727057569	1968.18727057569
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATCACATGAAA"	4.08175005492513	-7.05375482952269	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATCACATGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1972.83763976142	33.6851729883011	0.0170744780560729	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1971.28558559997	1971.28558559997
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATCACTCTCGT"	-3.75005302849467	12.6549672850403	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATCACTCTCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1575.72833853755	17.3069855626958	0.0109834830912278	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1571.18513739001	1571.18513739001
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATGTCTTTATC"	4.81909193572347	-7.68720343029173	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATGTCTTTATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.96316044292	23.2356142004968	0.00961753663339676	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2409.95275092592	2409.95275092592
"healthy-4003"	"2020-08-26-Control4003-c2:CGTCCATTCTCCACTG"	0.52770166572873	8.99977395618287	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTCCATTCTCCACTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.0951273463	30.0133923681851	0.0179926143756154	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.61704720333	1664.61704720333
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGAATAGCGCCTAC"	5.35846151885335	-9.96775629436644	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGAATAGCGCCTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1931.65735628092	14.4674204688863	0.00748964117359868	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1927.85884316549	1927.85884316549
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGAATCAAGTATCC"	-2.24421463432963	9.27972695911256	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGAATCAAGTATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.21247284446	31.8014577512369	0.0157260714085621	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2015.59705456527	2015.59705456527
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGAATGTCCTTGTC"	5.49951471862142	-9.756711982843	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGAATGTCCTTGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.08092483762	14.120672634789	0.00619577500776768	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2277.51023354135	2277.51023354135
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGATAAGACCGTTT"	4.77622761306111	-7.36896755611571	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGATAAGACCGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.90227650827	36.5942290998077	0.0164475669274059	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.66939723437	2221.66939723437
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGATAAGGGCGAGA"	4.58906712111775	-7.58751728450926	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGATAAGGGCGAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.56191374048	30.9098684947869	0.0136013317427781	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.56191374048	2272.56191374048
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGATAAGTACCGGA"	-1.4106869501179	8.83482167804567	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGATAAGTACCGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1832.47654889674	16.8401770140478	0.00918984585324521	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1828.66070528568	1828.66070528568
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGCTTCACACCGCA"	4.71007742461507	-7.04902794277342	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGCTTCACACCGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2975.84296719198	38.463827642175	0.0129253552913344	2382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2966.5851703819	2966.5851703819
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGCTTGTAGTCGGA"	0.555945296853226	7.94906947696535	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGCTTGTAGTCGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1618.33315976668	28.690926710957	0.0177286898793407	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1616.6060290692	1616.6060290692
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGCTTGTGTAGCAG"	3.96830119666402	-6.98045875942381	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGCTTGTGTAGCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1893.3114111083	33.3865437841707	0.0176339420912416	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1889.72059802184	1889.72059802184
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGTCTCAATAACCC"	4.7053185897762	-7.03498890316161	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGTCTCAATAACCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.57363354654	33.769655299174	0.0143117615907654	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2356.71041580595	2356.71041580595
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGTCTCAGTTTCAG"	0.093425409018439	9.12005040729371	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGTCTCAGTTTCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1525.44091595546	39.4013063574514	0.0258294542550489	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1523.28561941112	1523.28561941112
"healthy-4003"	"2020-08-26-Control4003-c2:CGTGTCTTCGTCCATC"	4.58749355849568	-7.23324396526488	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTGTCTTCGTCCATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.0114513266	33.2063593526968	0.0145513552674738	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2279.18225054335	2279.18225054335
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGAAGAGTCAAT"	4.83128466185872	-7.51371672069701	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGAAGAGTCAAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.99693561802	12.726543605335	0.00552128439247698	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2303.57185444944	2303.57185444944
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGACACAAAGCG"	0.122464959591073	8.76357266986696	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGACACAAAGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1648.06051877153	19.6808764902236	0.011941840888764	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1641.27401765683	1641.27401765683
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGACACTCTAGA"	-5.83012614670451	3.54429385745851	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGACACTCTAGA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2353.17436696781	28.0441677032011	0.0119175901696301	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2341.5489876749	2341.5489876749
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGACATCTAGAC"	3.76785649833028	-7.52940418636473	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGACATCTAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.54671094851	29.6396836318937	0.0127179101335543	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.98502905775	2328.98502905775
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGACATGATGCT"	-3.7355207008427	10.2457971342835	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGACATGATGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.8906689562	32.8222631134883	0.0165945790779273	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1968.65397121683	1968.65397121683
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTAGATCTTCTTCC"	-3.29966173592265	9.90125749194948	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTAGATCTTCTTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1860.56900417378	43.2525448924407	0.0232469447762556	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.3340472704	1855.3340472704
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTCTGCATCCAACA"	-1.27023516121562	9.74551198566285	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTCTGCATCCAACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2170.58399855222	44.5768334740729	0.0205367926345194	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2168.7882270004	2168.7882270004
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTGGGCAACTGCTA"	5.42095722731893	-9.43405725872191	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTGGGCAACTGCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2554.45903501263	33.8526334572663	0.0132523688942614	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2550.3920370652	2550.3920370652
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTGGGCACAGTATC"	-0.107038180262405	8.66249749744264	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTGGGCACAGTATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1654.52529494744	37.2043241533462	0.0224864039655121	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.88196097319	1650.88196097319
"healthy-4003"	"2020-08-26-Control4003-c2:CGTTGGGCACTAGGCC"	0.382779707282227	8.52770516956178	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CGTTGGGCACTAGGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1565.60955665659	34.728590486008	0.0221821528479758	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1554.07283375084	1554.07283375084
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACCCAGATTGTGA"	4.43095221099202	-7.20997669613036	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACCCAGATTGTGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.16480656401	5.22152019164122	0.00202058327641414	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2581.40730102868	2581.40730102868
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACCCAGCAACTTC"	-4.40230880203899	12.6888742216858	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACCCAGCAACTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1981.44151015198	32.8391726833083	0.0165733747451316	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1975.45900431132	1975.45900431132
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACCCAGGCCTTCG"	0.0893344442242801	8.08402535999147	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACCCAGGCCTTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1664.64970186208	34.8625162527	0.0209428543517009	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1653.85076040898	1653.85076040898
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACCCTCGCTTTAT"	5.58391871032063	-9.89130690014037	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACCCTCGCTTTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.27490339546	33.1252927293355	0.0124846817368771	1781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2641.84338714073	2641.84338714073
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACTTAGGGTAATT"	4.4344331222469	-8.09634401714476	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACTTAGGGTAATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.95446179848	27.5485894785268	0.0124207191594855	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2211.47972510439	2211.47972510439
"healthy-4003"	"2020-08-26-Control4003-c2:CTAACTTCAAAGCTCT"	10.3526970344478	7.18599650943605	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAACTTCAAAGCTCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1893.75571118383	30.526611455805	0.016119614201307	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1889.06470023216	1889.06470023216
"healthy-4003"	"2020-08-26-Control4003-c2:CTAAGTGAGGGATCAC"	-0.0916492146557153	8.49344251239625	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAAGTGAGGGATCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1833.67641622674	30.104672359244	0.0164176580408839	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.68904753592	1827.68904753592
"healthy-4003"	"2020-08-26-Control4003-c2:CTAAGTGAGGTCGAGT"	-3.52684507790263	12.2994556196961	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAAGTGAGGTCGAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1730.19335815332	31.4451764752623	0.0181743712788405	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1727.96409245921	1727.96409245921
"healthy-4003"	"2020-08-26-Control4003-c2:CTAAGTGCACAACATC"	4.29875196990315	-7.30858662044676	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAAGTGCACAACATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.89687821313	14.4897102907089	0.00632214757498416	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.30304771895	2290.30304771895
"healthy-4003"	"2020-08-26-Control4003-c2:CTAAGTGTCAGACCGC"	3.48889531668965	-7.38948824321898	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAAGTGTCAGACCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.51975621095	30.3761029087273	0.0147778209462317	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2052.11642453177	2052.11642453177
"healthy-4003"	"2020-08-26-Control4003-c2:CTAAGTGTCTCAAAGC"	3.90909184989278	-7.52397587215575	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAAGTGTCTCAAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.54333464703	28.9323036479935	0.0155755739897671	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1853.87124771248	1853.87124771248
"healthy-4003"	"2020-08-26-Control4003-c2:CTACAGACAGACGGAT"	4.43241324004476	-7.29254057323607	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACAGACAGACGGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.53081231288	26.9089763336564	0.0122395265888259	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2195.65034532554	2195.65034532554
"healthy-4003"	"2020-08-26-Control4003-c2:CTACAGAGTGCAAGAC"	4.32882704314534	-7.73079969799193	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACAGAGTGCAAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1886.35267353505	40.3034542213962	0.0213658107451705	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1884.60117400329	1884.60117400329
"healthy-4003"	"2020-08-26-Control4003-c2:CTACATTAGATCCCAT"	-3.35213623467143	10.5582828291687	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACATTAGATCCCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1840.94824907274	31.0779966946169	0.0168815156592644	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1831.98197530899	1831.98197530899
"healthy-4003"	"2020-08-26-Control4003-c2:CTACATTAGCAAATGT"	4.73214258727376	-7.09635355388793	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACATTAGCAAATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.96197909212	17.693203827838	0.00639907671846091	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2760.74361459534	2760.74361459534
"healthy-4003"	"2020-08-26-Control4003-c2:CTACATTCAGGCTTGC"	3.85622276839558	-6.51156666195067	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACATTCAGGCTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.18148900981	18.4762625955051	0.00737816435294028	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2500.55816375506	2500.55816375506
"healthy-4003"	"2020-08-26-Control4003-c2:CTACATTGTCCTACAA"	-1.3343257707661	9.05249593341676	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACATTGTCCTACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2108.88364209507	40.7119577521471	0.0193049805781137	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2097.67942015816	2097.67942015816
"healthy-4003"	"2020-08-26-Control4003-c2:CTACCCAAGGGCAGTT"	3.84321393546407	-7.73450996791991	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACCCAAGGGCAGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.55369740112	4.61690592237631	0.00193698422964429	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2377.42764576345	2377.42764576345
"healthy-4003"	"2020-08-26-Control4003-c2:CTACCCATCATGCTAG"	-4.28911338272746	12.8126296767029	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACCCATCATGCTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1845.73031783007	42.6056820912948	0.0230833733832709	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1843.65986759635	1843.65986759635
"healthy-4003"	"2020-08-26-Control4003-c2:CTACCTGAGACGCCAA"	-2.47439299050029	10.1960191496643	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACCTGAGACGCCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1714.21941378139	43.0874637041008	0.0251353259435176	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1714.21941378139	1714.21941378139
"healthy-4003"	"2020-08-26-Control4003-c2:CTACCTGTCGTGAGAG"	5.61869444426839	-9.9137001267639	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACCTGTCGTGAGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.50607177437	38.6970417070979	0.0155066910655053	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2491.48332880078	2491.48332880078
"healthy-4003"	"2020-08-26-Control4003-c2:CTACCTGTCTGGCTGG"	0.48026548799817	9.00221536243287	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACCTGTCTGGCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1437.92555569977	34.4718261497129	0.0239733037729739	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1431.39890389746	1431.39890389746
"healthy-4003"	"2020-08-26-Control4003-c2:CTACGGGCAACTTGGT"	-0.438718120486099	8.36546704852907	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACGGGCAACTTGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2011.41031611624	40.6306196673412	0.0202000652685293	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2000.6014142267	2000.6014142267
"healthy-4003"	"2020-08-26-Control4003-c2:CTACTATAGCGTACAG"	5.13930286940877	-8.55984213268431	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTACTATAGCGTACAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.66122542717	29.8997953126452	0.0127522880441705	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.86028313451	2341.86028313451
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGACAAGGTGGTTG"	-4.66779551926311	-5.22960808193358	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGACAAGGTGGTTG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2367.69083813048	34.4651586527859	0.0145564438134159	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2362.19733019677	2362.19733019677
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGACAGTACCACGC"	-4.18226466599162	3.6012232073578	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGACAGTACCACGC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2974.59433849915	33.5181284128924	0.0112681342726566	4009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2965.4774357757	2965.4774357757
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTAAGCCACCGT"	-3.4537230533665	10.1048097380432	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTAAGCCACCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1870.43840931838	34.4280501350495	0.0184064067351973	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1862.79511059119	1862.79511059119
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTAAGGGTTTCT"	-4.35549388352092	12.9022483595642	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTAAGGGTTTCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1729.15254974431	47.0660987181896	0.027219170873703	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1724.8164355419	1724.8164355419
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTAAGTCCGCGT"	5.3183876472408	-9.09728434002074	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTAAGTCCGCGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.85389042228	38.7218209080692	0.0138546852272906	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2788.77394084965	2788.77394084965
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTACAAGTGGGT"	-3.48468718949016	12.6464528807434	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTACAAGTGGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1667.72134625954	15.2889809698472	0.00916758726158788	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1665.25626504593	1665.25626504593
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTACAATGAACA"	-0.159843067557174	8.67205998981325	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTACAATGAACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1792.02341999085	17.955833201292	0.0100198652545421	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.58060187495	1785.58060187495
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTACAGACCAAG"	-4.18213448944743	13.051128364447	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTACAGACCAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2038.01195846919	30.0211898139527	0.0147306249549695	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2030.2483751253	2030.2483751253
"healthy-4003"	"2020-08-26-Control4003-c2:CTAGGTATCGAGATGG"	4.27768625792806	-7.14944031154784	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTAGGTATCGAGATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.64079574452	37.6985940004419	0.018032076135306	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2089.08747234181	2089.08747234181
"healthy-4003"	"2020-08-26-Control4003-c2:CTATAGGTCAAGGACG"	2.60391869124715	-4.39278414165648	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATAGGTCAAGGACG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2512.87588375598	30.3745513218041	0.0120875652944719	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2509.43298324087	2509.43298324087
"healthy-4003"	"2020-08-26-Control4003-c2:CTATAGGTCTCATAGG"	-7.47861752930339	0.243213749769606	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATAGGTCTCATAGG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2744.88550610306	31.1493787225069	0.0113481522829453	2619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2740.76699077417	2740.76699077417
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCCGAGCATTGTC"	-2.75917301598247	9.74743554675905	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCCGAGCATTGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.82217126408	41.779901652921	0.021394626847091	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.23377917197	1945.23377917197
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCCGCACCAGTAT"	5.12274899062459	-8.01428415691527	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCCGCACCAGTAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2889.97205389879	32.4599350091256	0.0112319200337369	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2886.02049502699	2886.02049502699
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCCGGTCCCGTGA"	4.28412642058675	-7.47732689296874	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCCGGTCCCGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2585.37269318162	23.9296691597421	0.00925579094373961	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2576.33479031103	2576.33479031103
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCTAAGGCTTTCA"	-0.0583453354543031	8.51864049518434	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCTAAGGCTTTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.09630342106	33.2979484517902	0.0177107674703688	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1871.71486562552	1871.71486562552
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCTAAGGTCGTAG"	-7.22083173218425	2.20665214145509	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCTAAGGTCGTAG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2718.55941150372	9.94171672543585	0.00365697975308797	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2702.32126588631	2702.32126588631
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCTACAGCATCTA"	4.06838907775227	-6.81153347408446	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCTACAGCATCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.4631142574	19.4211615288203	0.00866063811945989	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2239.59156776915	2239.59156776915
"healthy-4003"	"2020-08-26-Control4003-c2:CTATCTAGTACAGAAT"	4.04552306708638	-6.56095077907714	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTATCTAGTACAGAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.74273911229	28.6505783347566	0.0117770686863549	1467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2426.05375054526	2426.05375054526
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAACCCAGTGGTGA"	-3.71524582329448	11.138346649054	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAACCCAGTGGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.2971231769	15.5946373535011	0.0078196158296909	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1988.54981000983	1988.54981000983
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAACCCAGTTAAAG"	4.14423288878743	-7.02246048366698	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAACCCAGTTAAAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3114.97496790837	36.4379091595414	0.0116976571352702	2678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3109.36128832113	3109.36128832113
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAACCGTGAGGAAA"	-0.493541638285476	8.78289029682008	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAACCGTGAGGAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.19698253902	30.9888078360778	0.0184435564151825	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1670.55900642752	1670.55900642752
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAACCTCCAGCAAT"	5.5839487510616	-10.1120853654114	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAACCTCCAGCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.24279796351	7.31280514699875	0.00305688250090002	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2383.96207127328	2383.96207127328
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAAGAAGGGCCTCT"	3.77096929129903	-6.79680731212767	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAAGAAGGGCCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.03604307882	22.7487599636089	0.00991215803874311	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2289.59077857087	2289.59077857087
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAAGACACGATAGG"	-0.765128652483779	8.30980680072633	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAAGACACGATAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.12654780605	36.5261007780314	0.0191323622941637	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1907.72748999267	1907.72748999267
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAAGAGTGGTTTAC"	3.73732389983479	-7.46716263210448	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAAGAGTGGTTTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.06037824493	7.4615049547656	0.00371577719255984	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2006.40989421529	2006.40989421529
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAATTCAATAGTGA"	-2.78675685349162	10.0834665068421	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAATTCAATAGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.11330200551	37.4001691439664	0.0192872531508528	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1937.3141813611	1937.3141813611
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAATTCACTGAATC"	5.48414148864095	-9.91238405620726	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAATTCACTGAATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2383.53353676201	29.1130676591102	0.0122142471293522	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2378.47738989806	2378.47738989806
"healthy-4003"	"2020-08-26-Control4003-c2:CTCACTGCAGATTAAG"	-4.21126113358195	12.1092309721741	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCACTGCAGATTAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1849.73471832468	34.0974321969627	0.018433687738664	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1837.71852572274	1837.71852572274
"healthy-4003"	"2020-08-26-Control4003-c2:CTCACTGGTGTCATGT"	4.79783691939656	-7.59341766750487	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCACTGGTGTCATGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.82659307212	4.71395049407042	0.00174343669307371	1935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2702.85253722962	2702.85253722962
"healthy-4003"	"2020-08-26-Control4003-c2:CTCACTGTCGCAACAT"	4.79197849807088	-7.38579800045165	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCACTGTCGCAACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.9314965998	9.83317527605651	0.0040416983749025	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2427.23557333386	2427.23557333386
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGAAAGGAAGTGA"	3.5570875602657	-6.87210323726805	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGAAAGGAAGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2026.61878751602	3.46951402989311	0.00171197170936406	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2023.66442632757	2023.66442632757
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGAAAGGACACTG"	-4.03682837906535	10.5935287245545	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGAAAGGACACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2629.04764873704	27.6088061472196	0.0105014476099292	1566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2623.31508930089	2623.31508930089
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGAAAGGATATGT"	5.10520519789998	-8.61837580120238	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGAAAGGATATGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.35684996195	33.0844373321233	0.0126259281565424	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2615.7703737703	2615.7703737703
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGAAGTTACACTG"	-1.84988878193553	8.81342504108278	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGAAGTTACACTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2396.42639416992	29.615098836551	0.0123580256454357	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2380.61600182883	2380.61600182883
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGAATCCTCAGAA"	2.92633618888203	-4.87402346050414	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGAATCCTCAGAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2453.14660842348	25.1335223724981	0.010245422057612	1690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2445.58770557271	2445.58770557271
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGGGCACGCTGCA"	-3.87670741501506	12.9887084730896	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGGGCACGCTGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1567.28980488091	17.2941722924445	0.0110344444521915	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1559.63595933581	1559.63595933581
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGGGGTCATATGC"	-0.996802191168624	8.58091447437135	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGGGGTCATATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.00237347834	33.61828694688	0.0168935913820637	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1982.94959765808	1982.94959765808
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGGGGTTCGGCGT"	9.83405174788777	7.10562131488649	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGGGGTTCGGCGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1592.86913084944	10.9971645846112	0.00690399755486923	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1587.09878423804	1587.09878423804
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGTCCAATCTCTT"	-4.37101493302043	12.7273654707703	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGTCCAATCTCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2132.58298002819	37.0103601241769	0.0173547104477443	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2125.18665583813	2125.18665583813
"healthy-4003"	"2020-08-26-Control4003-c2:CTCAGTCGTTAATCGC"	3.54805030402486	-7.04630901729735	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCAGTCGTTAATCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.80714258186	5.07819141065699	0.00274080949600647	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1849.11326695545	1849.11326695545
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATCGCACTTGGCG"	4.2527252632076	-7.1645546189514	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATCGCACTTGGCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2541.75695555531	5.2023036588727	0.00204673528973824	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2535.00594701323	2535.00594701323
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATCGGTTAACCTG"	-4.04626498642619	12.7406530150208	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATCGGTTAACCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1631.90505108733	43.148499808241	0.026440570043883	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1629.6129664574	1629.6129664574
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATGCCACATGACT"	-1.49766943875011	8.67264554584352	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATGCCACATGACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.54451222602	33.3290626177681	0.0202172658187823	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.75055591728	1639.75055591728
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATGCTCTGTTGGA"	4.89252676543538	-8.05172159588011	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATGCTCTGTTGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.97244545214	28.6829279768824	0.011674094282162	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2448.81901781125	2448.81901781125
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATTAAGCCTAACT"	8.73517574843709	5.89833161914674	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATTAAGCCTAACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2054.57636015224	40.088737455825	0.019511923836627	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2039.55586392306	2039.55586392306
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATTACACCGTACG"	3.37056793746297	-6.9460396996704	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATTACACCGTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.16078610074	35.1100581612417	0.0187137789156182	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1872.15795545274	1872.15795545274
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATTACACCTAAAC"	-1.3120051425999	8.489306426886	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATTACACCTAAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.74775947152	31.818048203353	0.0161124619844451	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1974.74775947152	1974.74775947152
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATTAGTACCGCGT"	5.32507814940755	-10.0569563142029	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATTAGTACCGCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.78119270118	0	0	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2201.49886948717	2201.49886948717
"healthy-4003"	"2020-08-26-Control4003-c2:CTCATTATCTTACCAT"	3.10277738150899	-5.25863268291625	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCATTATCTTACCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2855.80109107111	31.2803236057041	0.0109532571100643	2401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2849.1533603641	2849.1533603641
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCAACAGATGCTAA"	-3.34969721260722	10.7905015715393	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCAACAGATGCTAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.35526028268	28.0883783947344	0.0134435626763321	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2076.24362256167	2076.24362256167
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCAACCAAGAGTAT"	-0.715199987322646	8.76984498584596	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCAACCAAGAGTAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2078.48772528029	34.4535726275234	0.0165762694715347	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2067.0691142956	2067.0691142956
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCAACGTGTGCTTA"	-4.26637731018718	11.8330678709778	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCAACGTGTGCTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2822.1189019169	33.1096635820451	0.0117322000712145	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2807.93552515746	2807.93552515746
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCAACTCAGGAACG"	-1.60389421406444	8.98893640125123	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCAACTCAGGAACG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1991.81973139787	37.4259588868468	0.0187898323813577	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1984.56799455068	1984.56799455068
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCACACAACTCGTA"	5.1348692375118	-10.177405380365	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCACACAACTCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.1951317213	37.4254886528064	0.0180957241794	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2060.70920647418	2060.70920647418
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCACATCGTCCATC"	5.52610840377156	-9.80774500286254	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCACATCGTCCATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2732.59722898325	36.9966230405696	0.0135389960321139	1793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2724.20524614169	2724.20524614169
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCATGAGGCGAAGG"	-4.00596747818645	11.2587013014588	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCATGAGGCGAAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1748.75453465284	15.2820694125987	0.0087388304703567	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1748.75453465284	1748.75453465284
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCATGAGTGGAATT"	10.350530286401	6.86793754184572	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCATGAGTGGAATT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.77213714636	26.0707908362087	0.0150718064399038	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1728.07255539845	1728.07255539845
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCATGGTTCCGCGA"	5.41984619674031	-9.85260775005492	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCATGGTTCCGCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.79658963049	38.102589933397	0.0174239296485438	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.91853038654	2183.91853038654
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCATGTCCATGATG"	4.69434227523152	-8.16064169323119	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCATGTCCATGATG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.47810306023	11.2906023372244	0.0047831845262986	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.12199871256	2359.12199871256
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCCAAGTGCCCACA"	-3.47518239441569	11.7810992964539	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCCAAGTGCCCACA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1856.8261981607	39.4258213163562	0.0212329087964236	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.29347046857	1848.29347046857
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCCAATCAGACCGC"	-2.56151614609416	9.87264726245729	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCCAATCAGACCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1732.39956797292	32.9590747237081	0.0190250998285998	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1724.6993334814	1724.6993334814
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCCTCTCGCGAAGA"	4.60121931609456	-7.28065159237059	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCCTCTCGCGAAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.33197138593	28.2274085185167	0.0120355705984924	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.61135365742	2342.61135365742
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCCTCTCGGAATGG"	-3.746321062476	10.9491109617981	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCCTCTCGGAATGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1507.97368327732	36.2574148325102	0.0240437981342691	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.5768513416	1505.5768513416
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCGATCAAATAGCA"	4.63185514983479	-7.96561338817748	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCGATCAAATAGCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.78570699504	1.24245482915641	0.00055078584162655	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2254.27556935515	2254.27556935515
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCGATGTCCCGGTA"	-4.19049344483073	12.6450338133606	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCGATGTCCCGGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2119.41977448259	42.9859078513086	0.0202819226133732	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2109.88317683626	2109.88317683626
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTCCAGCAGCGAT"	3.50052275237386	-6.94820597088011	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTCCAGCAGCGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.72298113877	15.2074222805893	0.006420093190162	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.12199952598	2365.12199952598
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTCCTCAAGTTGC"	4.14911665496175	-7.80104496395262	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTCCTCAAGTTGC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.96963195469	21.928789540762	0.00967317304636938	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2262.57878715546	2262.57878715546
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTCCTCAGTCATG"	4.92743601378743	-7.56618168270262	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTCCTCAGTCATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2658.34236617929	12.3324926345465	0.00463916641868497	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2652.82540903545	2652.82540903545
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTCCTCGTGTGGC"	-1.72410295429881	8.84327218616334	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTCCTCGTGTGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2107.3354617442	36.5548905143363	0.0173464980673179	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2094.30072130783	2094.30072130783
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTTTGTGGCAACA"	-3.07788954201396	10.5200633772644	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTTTGTGGCAACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2158.38713958439	27.2503460813721	0.0126253282284749	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2153.39461268422	2153.39461268422
"healthy-4003"	"2020-08-26-Control4003-c2:CTCCTTTTCGTCAAAC"	3.05620398101155	-5.04291393673094	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCCTTTTCGTCAAAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2875.32107933775	15.4517004394873	0.00537390434429194	2264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2867.04787489144	2867.04787489144
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCAGAGACTTGTC"	-0.443681160837966	8.22428414905397	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCAGAGACTTGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1867.62596854493	19.0682626945008	0.0102098937451362	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.59794187776	1855.59794187776
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCAGAGCCGAACA"	-0.718629757792312	8.9649448164734	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCAGAGCCGAACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.19051567108	36.3427423606093	0.019166187184386	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1879.6807412772	1879.6807412772
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGAAGAAGCCTG"	-5.96459470215495	-4.3992433778015	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGAAGAAGCCTG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3281.04957157555	36.1490619538677	0.0110175299596309	3819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3276.21874896345	3276.21874896345
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGACAAAGGCAC"	5.51811852034871	-9.9992656937805	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGACAAAGGCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.15406810802	25.2427007072206	0.0100242876426486	1500	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.34534356631	2511.34534356631
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGACAGACACCC"	11.1503788429195	4.78079793536989	"2020-08-26-Control4003-c2"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGACAGACACCC"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1759.69783890021	44.2784231569803	0.0251625149375951	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1749.90659055036	1749.90659055036
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGACATCTAACG"	10.4752756553585	7.16433522785035	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGACATCTAACG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1986.68717426647	36.2772101924803	0.0182601522083489	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1973.04074066527	1973.04074066527
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGAGTGATTAGA"	-3.93564687195476	12.6593570479187	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGAGTGATTAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1803.20535202108	32.5948782884337	0.0180760767218778	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1803.20535202108	1803.20535202108
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGAGTTATCCAG"	4.2594071823055	-7.24218037044676	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGAGTTATCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.82093624594	32.1850476512036	0.0147312061676347	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2180.78258162557	2180.78258162557
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGATCCAGCAAT"	4.32070650634114	-7.50274803554686	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGATCCAGCAAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.67295143123	30.3089189482934	0.0129987865277972	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.68736631166	2327.68736631166
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTCGATCGCTGTTC"	4.94999613341634	-7.57790281688841	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTCGATCGCTGTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.24629814782	21.7365978122961	0.00862137024386091	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.35779197533	2515.35779197533
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTGGTAGACTAAGT"	5.56934656676595	-10.2136020890442	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTGGTAGACTAAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2592.31223140519	42.7057152494986	0.0164739859389351	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2587.13833319925	2587.13833319925
"healthy-4003"	"2020-08-26-Control4003-c2:CTCTGGTTCCATGCAA"	-4.26504884186442	12.5376453169617	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTCTGGTTCCATGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1704.44209514482	22.8826020051037	0.0134252739182433	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1702.16971882253	1702.16971882253
"healthy-4003"	"2020-08-26-Control4003-c2:CTGAGCGAGGCATCTT"	-3.83858762207683	12.5650462874207	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGAGCGAGGCATCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1869.5270782207	33.0274846204165	0.0176662242580889	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1869.5270782207	1869.5270782207
"healthy-4003"	"2020-08-26-Control4003-c2:CTGAGCGCATGGCCCA"	-3.43432603302653	10.4190168150696	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGAGCGCATGGCCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1798.00864641217	19.3786335330393	0.0107778311142765	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1791.04325009978	1791.04325009978
"healthy-4003"	"2020-08-26-Control4003-c2:CTGAGCGGTCCACAGC"	-0.129427815706092	8.5174350508484	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGAGCGGTCCACAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1773.17643532883	0	0	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1773.17643532883	1773.17643532883
"healthy-4003"	"2020-08-26-Control4003-c2:CTGAGCGGTTAGGGTG"	4.30097212371175	-6.80294229900511	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGAGCGGTTAGGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.08321572503	28.7055502268691	0.0108812148365001	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2628.0526530973	2628.0526530973
"healthy-4003"	"2020-08-26-Control4003-c2:CTGATCCAGTAATACG"	4.00139584121053	-7.4728985062805	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGATCCAGTAATACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2038.1933807624	5.26563248533236	0.00258348031891003	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.61951122685	2036.61951122685
"healthy-4003"	"2020-08-26-Control4003-c2:CTGATCCTCCTCAGGG"	2.45212521132771	-4.02471592342528	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGATCCTCCTCAGGG"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2255.44419392636	6.88493069827037	0.00305258304187293	1716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2249.84638981452	2249.84638981452
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCAGGTCCGCAACG"	-4.09616170349773	12.5177049406799	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCAGGTCCGCAACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1576.6925045849	45.5079992301999	0.0288629514619155	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1572.31924396353	1572.31924396353
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCATCAGTGCAGCA"	4.19354071196858	-7.32262327587279	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCATCAGTGCAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2578.8314357375	31.4500481120663	0.0121954648435842	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2577.57631985665	2577.57631985665
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCATCCAATAGTGA"	4.55133308944051	-7.89977266704711	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCATCCAATAGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2610.44613324472	25.2276903572334	0.00966412983434214	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2606.93801162601	2606.93801162601
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCATCCATATACCG"	-2.08766112747844	9.01320836627809	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCATCCATATACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2120.77307924621	25.8425118276656	0.012185420533936	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2101.53572458265	2101.53572458265
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCATCGTTTGAACC"	5.24894871291463	-8.81000807201537	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCATCGTTTGAACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2889.29767798522	30.9246730005403	0.0107031799582883	2177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2886.4089405183	2886.4089405183
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCCATCAAGCCCAC"	-0.970014910132247	8.63621995532838	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCCATCAAGCCCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1827.94091846577	39.2246249020584	0.0214583658070199	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1823.73157175497	1823.73157175497
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCCATGTGGCTCTG"	4.5681606727535	-7.30176021968993	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCCATGTGGCTCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.73038715504	12.5068634187617	0.00474152456205015	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2633.6243476286	2633.6243476286
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCCTACATTGAGGG"	4.27956738051717	-7.65068485653075	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCCTACATTGAGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2081.04774201859	39.4688179765683	0.0189658397448797	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2081.04774201859	2081.04774201859
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCCTATCATGGTAC"	2.64374556121175	-4.3806247941223	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCCTATCATGGTAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2612.85704899316	17.1561890653155	0.00656606494102938	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2608.03190173383	2608.03190173383
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCGAGAGAATCTAG"	2.737405915826	-4.59530784999999	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCGAGAGAATCTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2563.16655126791	31.6354398679592	0.0123423270533513	2003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2557.89399468257	2557.89399468257
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCGAGAGATCCCAT"	4.26161541518514	-7.30292847072753	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCGAGAGATCCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.98343633266	40.6847776608376	0.0183928943556154	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2206.23564194163	2206.23564194163
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCGAGAGATGACAT"	5.23839296874349	-9.48425486004027	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCGAGAGATGACAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2687.33588239633	30.1817708367656	0.0112311122083675	1842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2681.92916428981	2681.92916428981
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCGAGCAGACACCC"	3.32819737967793	-6.59771206295165	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCGAGCAGACACCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2317.85243430831	23.660030700804	0.0102077381418221	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2314.04264888808	2314.04264888808
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCGAGCAGGTCCCA"	5.59170546111409	-10.1125087968078	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCGAGCAGGTCCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.91561746446	7.05678378845474	0.00313925653330993	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.83229577807	2238.83229577807
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCTCACACGACTAT"	10.1249071556026	6.12868354404298	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCTCACACGACTAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1701.2537269796	37.0464245916036	0.0217759549937184	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1697.61249027471	1697.61249027471
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCTCACATCTCCCA"	0.0138897496158302	8.37935445392457	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCTCACATCTCCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1379.88702481059	4.62600029384763	0.00335244857779761	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1379.88702481059	1379.88702481059
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCTCAGTTGTTTGG"	4.13704886016194	-6.82212879573973	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCTCAGTTGTTTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.29412479013	32.5055172045831	0.0138658015906998	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.13746961257	2341.13746961257
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCTCATCGACGACC"	5.62017454680745	-10.1866541138855	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCTCATCGACGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.79762214688	11.8700638278877	0.0047088523583176	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2516.67480256576	2516.67480256576
"healthy-4003"	"2020-08-26-Control4003-c2:CTGCTCATCGGCATAT"	-1.48629675331767	8.83485410297243	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGCTCATCGGCATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.4378207765	29.9466336507002	0.0143805655813213	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2079.60244255998	2079.60244255998
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGACGCACGATTCA"	5.58628382262532	-9.86270048534545	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGACGCACGATTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.89576065357	20.0622295218315	0.00867032554490042	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.09102435194	2311.09102435194
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGACGTCCGTCCTA"	3.58958067473714	-5.98226883327635	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGACGTCCGTCCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2987.22777830685	21.9099555378244	0.00733454465606333	3054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2979.36857139727	2979.36857139727
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGACGTCCTGCTAC"	-0.565065185458022	8.98072240436403	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGACGTCCTGCTAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1724.968262537	35.0803200620962	0.0203367915943577	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1709.14318099295	1709.14318099295
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGCAGAGTGTACAA"	4.34277929839436	-7.44371941005858	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGCAGAGTGTACAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.93724455122	33.2954801034312	0.0146036827035496	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.47707208517	2278.47707208517
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGCAGCAAGGAGTC"	4.28921236571614	-7.46738150036009	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGCAGCAAGGAGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1964.61053331699	17.4580290703152	0.00888625443783997	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1964.61053331699	1964.61053331699
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGCAGGTCCAGAAG"	-0.560599545866805	8.26654622638551	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGCAGGTCCAGAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.94695740843	36.3720362106747	0.01826871181843	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1982.97623722925	1982.97623722925
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGTCTAGCCTGAGA"	-4.04586873474773	11.9573430784973	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGTCTAGCCTGAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.14463309246	42.3906113766947	0.0217148927687506	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1944.71138133669	1944.71138133669
"healthy-4003"	"2020-08-26-Control4003-c2:CTGGTCTCAATGTTGC"	4.96784414824788	-7.89709761058959	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGGTCTCAATGTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.75959776959	27.5241326172582	0.0101988086082234	1918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2694.56922854663	2694.56922854663
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTACCAGAATCCCT"	3.04091801223103	-6.31511976635131	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTACCAGAATCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.45615391572	30.8693046624772	0.0117086357065447	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2632.58147102945	2632.58147102945
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTACCGTAGTACGG"	5.5872651534969	-9.72445967113646	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTACCGTAGTACGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.08097530802	25.4480286544946	0.0111317267101905	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2279.29056896132	2279.29056896132
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTACCGTCAGTCGC"	-3.00674162331279	-5.76470377361449	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTACCGTCAGTCGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2783.13319484007	33.5828447472099	0.0120665603821882	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2777.13019747209	2777.13019747209
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTACCTCAGCAATC"	3.41894402083699	-6.51540853893431	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTACCTCAGCAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.71446071747	32.9044773227878	0.0143705592497666	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.08930566364	2281.08930566364
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTACCTCGCACTCT"	3.63383450087849	-6.99333193218382	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTACCTCGCACTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1987.37408498815	12.5428438440345	0.0063112646676729	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1985.57971124109	1985.57971124109
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTAGAAGCCTCATA"	4.24561276015584	-7.31554939663085	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTAGAAGCCTCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.00389617908	27.6099397707105	0.0109563083662583	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2517.52127317212	2517.52127317212
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTAGACACCCTTGT"	5.56570877608601	-10.1442709199158	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTAGACACCCTTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.64110040438	22.0285972941493	0.0100926337775221	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2177.49492209597	2177.49492209597
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTAGAGTCTTAGTG"	-3.62536750260051	12.9716682204041	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTAGAGTCTTAGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1594.48380565328	37.9088460725978	0.0237749959818916	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1589.69210145607	1589.69210145607
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTAGATCTCGCGTT"	-3.60223994675334	10.5670108565125	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTAGATCTCGCGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1488.42299574153	11.2788045606847	0.00757768765529292	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1480.91433863717	1480.91433863717
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTATTTCACTTGTT"	5.06115831908528	-7.78822376644286	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTATTTCACTTGTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.08049829181	0	0	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.32629900901	2391.32629900901
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGATCCACCGTGAC"	-3.36233101311381	10.4530286558899	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGATCCACCGTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1737.5537671502	32.7540799104497	0.0188506856764326	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1726.62487599154	1726.62487599154
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGATCGTGAGACCA"	3.95098819312398	-7.62960436260375	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGATCGTGAGACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.08271866313	32.1785965492636	0.0139175801494981	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2307.51925227823	2307.51925227823
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGATCTCACGAACT"	5.10880150374715	-9.34501554882201	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGATCTCACGAACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.33776395514	4.97177210977819	0.00232289136486142	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2138.70802066444	2138.70802066444
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGGAGAGTAGGGTC"	-0.87313417616542	8.5666293867859	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGGAGAGTAGGGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1585.30030133245	31.3733949749842	0.0197901905075112	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1576.54766203463	1576.54766203463
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGGAGCAATAGAGT"	5.64766039428059	-9.71636297619017	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGGAGCAATAGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.66963760717	38.0911378174808	0.0137380729751683	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2768.92778668351	2768.92778668351
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGTTGCATGTGTCA"	-3.29446278038676	10.27756116474	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGTTGCATGTGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.54909759076	31.2644912311051	0.0171919973304679	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1814.693292065	1814.693292065
"healthy-4003"	"2020-08-26-Control4003-c3:ATGGTTGGTGTGTGGA"	-4.0439055961674	10.9009399184021	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGGTTGGTGTGTGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1906.63533763476	28.1857696693538	0.0147829892339661	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1888.25029571321	1888.25029571321
"healthy-4003"	"2020-08-26-Control4003-c3:ATGTCCCAGAATCCCT"	4.14136614379231	-6.81007912075194	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGTCCCAGAATCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2659.10853465336	23.7717826554211	0.00893975644304414	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2650.82075564044	2650.82075564044
"healthy-4003"	"2020-08-26-Control4003-c3:ATGTCCCTCAAGAGGC"	5.34575619277303	-9.73452570354613	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGTCCCTCAAGAGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.98606229172	9.89882843705267	0.00454077602067166	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.56399452167	2173.56399452167
"healthy-4003"	"2020-08-26-Control4003-c3:ATGTCCCTCCGATTAG"	3.4468113380367	-6.82817318355712	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATGTCCCTCCGATTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.8214034014	38.3358710952057	0.0161903558436189	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.09871972002	2365.09871972002
"healthy-4003"	"2020-08-26-Control4003-c3:ATTACCTGTGTGACCC"	-3.16554151001628	9.58825681293336	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTACCTGTGTGACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.92355656186	22.4685353360786	0.010684428003086	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2095.72259328194	2095.72259328194
"healthy-4003"	"2020-08-26-Control4003-c3:ATTACCTTCCAAGGGA"	-8.22191081467326	-0.64910145914229	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTACCTTCCAAGGGA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3114.50441646357	3.69487044343917	0.00118634297768458	4603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3104.58355447031	3104.58355447031
"healthy-4003"	"2020-08-26-Control4003-c3:ATTACTCAGTACCCTA"	4.2109018760616	-6.81492521679076	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTACTCAGTACCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.82681058736	22.6519229975089	0.0092576732033075	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2442.98957640698	2442.98957640698
"healthy-4003"	"2020-08-26-Control4003-c3:ATTACTCCAGCAGTCC"	5.45888104018514	-10.121590637323	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTACTCCAGCAGTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.769575812	26.2337177965642	0.0118663283969469	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2206.61582618521	2206.61582618521
"healthy-4003"	"2020-08-26-Control4003-c3:ATTATCCAGAATAACC"	3.99407114562337	-7.36676409160765	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTATCCAGAATAACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1910.4758869772	8.45773697447232	0.00442703152242049	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1906.95911088874	1906.95911088874
"healthy-4003"	"2020-08-26-Control4003-c3:ATTATCCGTTGCCAAT"	4.92810978469197	-7.87377502834471	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTATCCGTTGCCAAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.0982785634	8.37631924343814	0.00342295988551615	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.22641067925	2439.22641067925
"healthy-4003"	"2020-08-26-Control4003-c3:ATTATCCTCGTTATCT"	-3.40339503708537	-5.44544222271117	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTATCCTCGTTATCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2426.61716753278	34.8006999473358	0.0143412403130399	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2422.43299116685	2422.43299116685
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCACTAGCTGGAGT"	-4.18439135971721	12.7309293516907	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCACTAGCTGGAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1866.49319101756	35.7378226748189	0.0191470415465783	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1862.17856344475	1862.17856344475
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCACTGTGCCTACG"	-3.54784594002422	11.6538858183655	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCACTGTGCCTACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1504.46528328781	42.5911319863514	0.028309813765376	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1502.21034646558	1502.21034646558
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCACTTCTACCAGA"	3.7143210369045	-7.12573959743651	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCACTTCTACCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.44100893083	0	0	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2427.21307091389	2427.21307091389
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGCATCACGGC"	0.315140743821305	9.13890550220338	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGCATCACGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1792.09350702349	26.709066938789	0.0149038355610977	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.09350702349	1792.09350702349
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGGTACCTAAC"	4.06720842894856	-7.54838611995848	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGGTACCTAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1858.2321256194	2.04749728421493	0.00110185226914665	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1856.31027139509	1856.31027139509
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGGTACGTGTT"	2.39404811438863	-6.64457752620848	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGGTACGTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.61010606789	36.5273918136114	0.0172574966494277	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2112.16351529835	2112.16351529835
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGGTTGCATTG"	2.54487504538838	-4.24352791225585	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGGTTGCATTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2217.09346515984	5.19282876042034	0.00234217855134311	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2213.32562582627	2213.32562582627
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGGTTGCTCAA"	-3.44877109947856	10.3817863234314	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGGTTGCTCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1713.61729432294	31.6888156729569	0.0184923528596141	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1711.67225668417	1711.67225668417
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGTCATATGGC"	5.296234746545	-9.127561592218	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGTCATATGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2727.53038032872	47.1405844104991	0.0172832481538914	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2721.458906489	2721.458906489
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGTCCTCAGGG"	-0.188568006188232	7.90710017764894	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGTCCTCAGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1575.62681517232	33.7493990083726	0.021419665293448	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1567.18530203001	1567.18530203001
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCAGGTCTTTGGAG"	4.05582298812215	-7.7211861840454	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCAGGTCTTTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1631.02636149142	40.9980613084257	0.0251363572511096	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1628.70490031485	1628.70490031485
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCATGTGGGCTCT"	1.03566994246785	9.0144643553528	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCATGTGGGCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1551.95914159109	38.7989257770044	0.024999966002473	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1547.90718225072	1547.90718225072
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCATTCATTCCTA"	5.55104269561116	-9.76958753978881	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCATTCATTCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.25506702435	1.60246251132187	0.000711492465832931	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2240.81350218515	2240.81350218515
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCCGCAATACAGA"	-2.27057800713237	9.6246013411316	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCCGCAATACAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1696.69357559428	24.4244835696366	0.0143953415755003	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1686.31053302383	1686.31053302383
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCCGTCCGTGGCA"	-3.79753838005717	-5.68488123333129	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCCGTCCGTGGCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1578.57006586937	38.9085482878919	0.0246479704190157	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1576.46287341398	1576.46287341398
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTAAGCGTCAGA"	-3.50188312950786	10.8343982466492	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTAAGCGTCAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1687.85545244496	33.3088542570284	0.0197344234713811	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1681.05924793757	1681.05924793757
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTAAGTTAACGA"	5.19256939467732	-10.1613149872986	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTAAGTTAACGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2604.16778608456	30.0863779920707	0.0115531641827528	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2593.97469022089	2593.97469022089
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTACAGGTTTAC"	5.48426785048787	-10.1538315049377	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTACAGGTTTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.26404794284	33.0306805538573	0.0141140828031317	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.63918693287	2331.63918693287
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTACATAGATCC"	-1.05121944370921	8.8081655272278	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTACATAGATCC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1965.69999083479	30.2683220025624	0.0153982409033375	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1958.30488221086	1958.30488221086
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTAGTCTCGGGT"	4.71970142897908	-8.3544550172058	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTAGTCTCGGGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.45513339793	28.8143305823444	0.0148111000288233	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1945.45513339793	1945.45513339793
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCCTATCTCGACCT"	4.64335741576497	-7.82673551952513	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCCTATCTCGACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.08153296512	12.3075711243338	0.00534627942064304	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.68645025161	2300.68645025161
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCGTTAGGTGCGAT"	4.05580057677571	-7.45233347332152	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCGTTAGGTGCGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.52375385028	15.6476822992818	0.00726608298204527	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.40560992361	2150.40560992361
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCGTTGTGAATAAC"	4.28843750533406	-7.55469992077025	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCGTTGTGAATAAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2786.177247531	33.7867433428081	0.0121265592032052	2242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2773.41699078664	2773.41699078664
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCGTTTCTGTTGGA"	4.52711405333821	-7.72697880184325	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCGTTTCTGTTGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.18029264072	0.187394631122004	8.66692901419124e-05	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2162.18029264072	2162.18029264072
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCTACCAAACTCTG"	0.223474477499169	8.41565415942994	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCTACCAAACTCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1625.59644597127	38.4719825885697	0.0236663796134122	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1620.11793723733	1620.11793723733
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCTTGAGGCTAAAT"	5.49012865599934	-10.1342687836853	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCTTGAGGCTAAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.57227502328	35.1769739602871	0.0143020696393051	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.09783804723	2452.09783804723
"healthy-4003"	"2020-08-26-Control4003-c3:ATTCTTGGTTAGAGAT"	5.52056183394734	-9.98118593609007	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTCTTGGTTAGAGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2503.12964574237	31.2281011049688	0.0124756227301632	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.41794984337	2495.41794984337
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGGGTGTCGGCCTA"	2.65955438193623	-4.19447567379149	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGGGTGTCGGCCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2218.41899243296	14.2181689730082	0.00640914499087252	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2215.9876463935	2215.9876463935
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGTTCAGCCTCATA"	3.82749476012532	-6.895863079187	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGTTCAGCCTCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.17100910443	21.8433610348557	0.0100191044388892	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.26108046994	2171.26108046994
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGTTCCAATGTGGG"	-0.2415967983311	8.4797038801941	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGTTCCAATGTGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1617.78226031818	27.7658054319598	0.0171628816269124	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1614.11367182438	1614.11367182438
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGTTCTCCCTCTAG"	-3.97379193726237	12.9971971281799	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGTTCTCCCTCTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2549.9282059571	35.3738167096488	0.0138724755571585	1360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2535.11560517911	2535.11560517911
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGTTCTCCTACCAC"	5.26042570647542	-9.93845941936644	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGTTCTCCTACCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.61797200916	40.1619251078732	0.0172693561845741	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2324.26132065029	2324.26132065029
"healthy-4003"	"2020-08-26-Control4003-c3:ATTGTTCTCGGTCGAC"	0.112606131553096	8.41729924762575	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTGTTCTCGGTCGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1693.78847196114	29.0686613623875	0.0171619194743547	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1683.27030982466	1683.27030982466
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTACCCAAATCCCA"	4.94751514968221	-7.82765915310057	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTACCCAAATCCCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3064.32148850081	26.6336556453177	0.00869153440501045	2606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3053.75031356016	3053.75031356016
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTACCTCTTTGGAG"	3.94482793387715	-6.76431562816771	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTACCTCTTTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.85504543812	4.78250203111835	0.00199366028398139	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2394.85557770725	2394.85557770725
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTCACCAAATGCGG"	-3.04891334000285	9.26769445026246	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTCACCAAATGCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.74396076132	38.8175186020769	0.0200530232246264	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.01133462125	1932.01133462125
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTCACTCTGCTCTG"	10.2605387168819	7.00646874988405	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTCACTCTGCTCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2047.81949738461	36.6516245824729	0.017897878513845	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2040.74805437345	2040.74805437345
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTCTGTCGAAGCAG"	1.70317472991292	-7.10755636608275	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTCTGTCGAAGCAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1760.10689161908	31.5267203235572	0.0179118214204346	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1752.06574355941	1752.06574355941
"healthy-4003"	"2020-08-26-Control4003-c3:ATTTCTGTCTAGATCG"	-4.17927728119548	11.9310302504334	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.ATTTCTGTCTAGATCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1772.55215608307	23.3062936724267	0.0131484388724156	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1772.55215608307	1772.55215608307
"healthy-4003"	"2020-08-26-Control4003-c3:CAAAGAATCCATCCGT"	-0.974394421011764	8.35789964282838	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAAGAATCCATCCGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1909.34768508502	20.7508713760582	0.0108680422838412	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1900.30472454367	1900.30472454367
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAACAGCATCCTA"	-4.09338937225993	10.5015935667786	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAACAGCATCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2193.51191006333	34.2434249780827	0.0156112327546442	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2182.48628847143	2182.48628847143
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAACAGCCTCAAT"	4.35700382766072	-6.8530254594055	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAACAGCCTCAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.39222602314	26.2261643291715	0.0102270487576088	1663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2558.33941587325	2558.33941587325
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAACAGGGTCTTT"	-3.2292038005894	10.7285966643128	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAACAGGGTCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.8741926894	30.1714120401179	0.0161096843332506	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1870.94031017217	1870.94031017217
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAACTCCTAACAG"	5.54830040511434	-10.0548639527527	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAACTCCTAACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.93498254235	28.9284671778988	0.0121398474527555	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2377.74219245419	2377.74219245419
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAGTAGTCGCCCA"	3.28648366507832	-7.57436897670897	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAGTAGTCGCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.41370770079	23.1578465250583	0.0125488644786923	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1841.7722476922	1841.7722476922
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAGTCACTAGGTT"	4.63518347319905	-8.81201746380004	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAGTCACTAGGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1761.27207155988	19.9546214711561	0.0113296643905125	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1759.14756365768	1759.14756365768
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAGTTCACAACCA"	2.87085594710652	-4.76925375377806	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAGTTCACAACCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2763.79547182691	34.1145247874603	0.0123433608366505	2196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2759.28939784926	2759.28939784926
"healthy-4003"	"2020-08-26-Control4003-c3:CAACAGTTCGGACTGC"	-3.45949087563213	10.5121021040711	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACAGTTCGGACTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1744.62013282956	28.223376624146	0.0161773764345887	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1740.50038061942	1740.50038061942
"healthy-4003"	"2020-08-26-Control4003-c3:CAACCAATCGACCTAA"	5.66101564940755	-9.73433687603148	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACCAATCGACCTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2761.6380784513	39.0848514001314	0.0141527782750048	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2753.40208186279	2753.40208186279
"healthy-4003"	"2020-08-26-Control4003-c3:CAACCTCCACAAAGTA"	-4.24630580368693	12.8466071852478	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACCTCCACAAAGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2561.95004332913	18.9727946824654	0.00740560680793416	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2551.08088411006	2551.08088411006
"healthy-4003"	"2020-08-26-Control4003-c3:CAACCTCCACGGTGAA"	2.89713587340657	-6.09334280407103	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACCTCCACGGTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.21677447327	31.9762696888284	0.0134738090648822	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.81816296496	2371.81816296496
"healthy-4003"	"2020-08-26-Control4003-c3:CAACGATAGGTTACAA"	10.2026211219722	7.45140025699464	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACGATAGGTTACAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1571.77733418257	26.5065042959983	0.0168640326587885	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1567.20002990712	1567.20002990712
"healthy-4003"	"2020-08-26-Control4003-c3:CAACGGCCAACACACT"	-3.74958763542827	10.464892364386	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACGGCCAACACACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2231.39657059588	32.4681500266079	0.0145505960054145	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2223.38376874308	2223.38376874308
"healthy-4003"	"2020-08-26-Control4003-c3:CAACGGCTCTTCACAT"	-2.09856043282207	9.34132287586061	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAACGGCTCTTCACAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.27762094079	29.6291334856017	0.0156744877881246	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1884.5872749589	1884.5872749589
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGACTGTCTGCCTT"	-2.27470384064372	8.95478055560914	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGACTGTCTGCCTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2110.05779275049	23.88303486884	0.0113186638540872	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2099.60079529816	2099.60079529816
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGACTGTTTGGAGG"	-3.54358611527141	11.2193422087464	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGACTGTTTGGAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.48462932042	35.6604612758189	0.0213218469399679	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.22184610886	1664.22184610886
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGAGGAGCCTTTCC"	-3.57518468323405	-5.39516069805297	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGAGGAGCCTTTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1728.06754708331	33.3192712634606	0.0192812319863874	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1721.05916829186	1721.05916829186
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGAGGAGCTGTTAC"	-0.257727543742019	8.30090329730836	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGAGGAGCTGTTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1553.27147556811	6.6594632287973	0.00428737882176173	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1553.27147556811	1553.27147556811
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGCTAGTGCAATAA"	2.68622054633443	-4.43183185970458	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGCTAGTGCAATAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2361.24655899387	37.516244145599	0.0158883213625877	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2354.12452217103	2354.12452217103
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGCTATCTTAGGAC"	5.57024254378621	-10.0094137421814	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGCTATCTTAGGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.05988713314	41.7333707724909	0.0176756934459484	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.06217744071	2351.06217744071
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGCTATCTTGCGCT"	3.61216725882832	-6.7083401910034	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGCTATCTTGCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.62505152903	37.420594219704	0.0191740694199361	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1951.62505152903	1951.62505152903
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGGGAAGAGAGGTA"	3.92955126342122	-7.98233129894408	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGGGAAGAGAGGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1654.64552085903	45.4688361836345	0.0274795027759353	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1652.49697999093	1652.49697999093
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGGGAGTGATATAG"	1.45512451705281	-6.53895857250365	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGGGAGTGATATAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2218.39407176292	46.5294219310333	0.0209743717418327	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2211.41210782747	2211.41210782747
"healthy-4003"	"2020-08-26-Control4003-c3:CAAGGGATCCACATAG"	4.28677572783772	-7.03607466137084	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAAGGGATCCACATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.95857750194	6.75026521649816	0.00276428325962986	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2437.75237609762	2437.75237609762
"healthy-4003"	"2020-08-26-Control4003-c3:CAATACGCACGCGGTT"	3.80024375495259	-6.453649067041	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATACGCACGCGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.05312766689	26.0128579386594	0.0104719410583185	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2481.33140549775	2481.33140549775
"healthy-4003"	"2020-08-26-Control4003-c3:CAATACGGTCAGCGTC"	-0.898649076849777	8.64254090869752	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATACGGTCAGCGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.449972352	29.9166727729352	0.0170713419754764	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1746.1387736906	1746.1387736906
"healthy-4003"	"2020-08-26-Control4003-c3:CAATACGTCATCGACA"	5.04748215255086	-8.17123892223509	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATACGTCATCGACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.84580905699	32.848321227938	0.0140087340076099	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.63025860961	2343.63025860961
"healthy-4003"	"2020-08-26-Control4003-c3:CAATCGAAGGAGAGGC"	-4.10190806809123	13.1025142439636	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATCGAAGGAGAGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1875.34060660689	40.5933778165001	0.0216458693815343	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1873.27751667525	1873.27751667525
"healthy-4003"	"2020-08-26-Control4003-c3:CAATCGAAGGGCCAAT"	-2.26189504090007	9.33660981738893	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATCGAAGGGCCAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1551.11381543181	34.0917974677051	0.0219789142025109	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1541.57042147519	1541.57042147519
"healthy-4003"	"2020-08-26-Control4003-c3:CAATCGATCTCGGGAC"	-6.99652419510539	3.77166459644166	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATCGATCTCGGGAC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2048.5764119124	37.8571376318618	0.0184797293436183	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2030.93981456553	2030.93981456553
"healthy-4003"	"2020-08-26-Control4003-c3:CAATGACGTACTGCCG"	6.74708761748616	-1.63990869438323	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATGACGTACTGCCG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2600.97277130803	23.1824703356624	0.00891300000960947	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2585.96678749782	2585.96678749782
"healthy-4003"	"2020-08-26-Control4003-c3:CAATGACGTGAGATAT"	-4.10431991043742	12.9770574339661	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATGACGTGAGATAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1847.78871072275	37.7862956291539	0.0204494677394008	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1843.45807739709	1843.45807739709
"healthy-4003"	"2020-08-26-Control4003-c3:CAATGACTCATGGATC"	-1.51745472374614	8.65564725482789	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATGACTCATGGATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1652.35291722936	30.3805842054212	0.018386256282564	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.37698789375	1650.37698789375
"healthy-4003"	"2020-08-26-Control4003-c3:CAATGACTCCTGTAAG"	-0.468321542174178	8.49246976459352	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATGACTCCTGTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1638.67883239879	37.3019767042097	0.0227634457507485	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1636.76651869247	1636.76651869247
"healthy-4003"	"2020-08-26-Control4003-c3:CAATTTCAGGGAGTTC"	-2.78470716896709	11.9148244627747	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATTTCAGGGAGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1628.13345560198	33.7575722238196	0.0207339098079882	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1613.34180884237	1613.34180884237
"healthy-4003"	"2020-08-26-Control4003-c3:CAATTTCGTCATAAAG"	5.41035475310628	-9.82987978374632	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATTTCGTCATAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.84322415989	3.53075825160554	0.0014792585519932	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2382.60274814701	2382.60274814701
"healthy-4003"	"2020-08-26-Control4003-c3:CAATTTCTCGTGGCTG"	3.59765996512715	-6.75392916118773	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAATTTCTCGTGGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.57697343763	30.1036110856003	0.0134657009994651	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.57697343763	2235.57697343763
"healthy-4003"	"2020-08-26-Control4003-c3:CACAACAAGGGTCTTT"	0.0096760290557563	8.0458569296631	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAACAAGGGTCTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1402.94049587317	37.807962554009	0.0269490849150219	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1402.94049587317	1402.94049587317
"healthy-4003"	"2020-08-26-Control4003-c3:CACAACACAAATAAGC"	4.42641510543172	-7.44806291973265	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAACACAAATAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.52575487253	2.73763645707683	0.00119155855000577	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.21490896459	2290.21490896459
"healthy-4003"	"2020-08-26-Control4003-c3:CACAACACAGTAGATA"	4.68928350982015	-7.60036709224852	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAACACAGTAGATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.59140268323	20.6202627623619	0.0093363864123125	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2201.49845140204	2201.49845140204
"healthy-4003"	"2020-08-26-Control4003-c3:CACAACAGTACTCGCG"	5.09189428862874	-8.77794363414916	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAACAGTACTCGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.49066583602	27.9809267852059	0.0120270960877253	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.19117433861	2325.19117433861
"healthy-4003"	"2020-08-26-Control4003-c3:CACACAAAGTGCGACA"	-5.56303677979167	-5.5046973458496	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACACAAAGTGCGACA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2403.44025588786	4.8543970849677	0.00201977023272186	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2401.97583292298	2401.97583292298
"healthy-4003"	"2020-08-26-Control4003-c3:CACACAACATGAAGCG"	3.80659260329549	-6.69869377529296	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACACAACATGAAGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2389.6186209861	26.2832164937151	0.0109989168409096	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2384.84865779483	2384.84865779483
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATAGCACTAAA"	5.61375774916951	-9.88165666973265	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATAGCACTAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.29802037573	41.4371304854532	0.015664446941811	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2633.75582340285	2633.75582340285
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATCAGTATACC"	5.40109409865682	-9.55621912395629	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATCAGTATACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2571.33612808582	38.5825854454586	0.0150048782125504	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2564.04937045547	2564.04937045547
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATGTATGGGAC"	-7.24092421951945	1.26255128467409	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATGTATGGGAC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2649.3176566186	28.7280571258766	0.0108435683633887	2708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2643.40703310921	2643.40703310921
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATGTCCCTCAT"	5.298507352441	-9.61625196849974	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATGTCCCTCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.70639262019	37.4653818373584	0.0151576991301311	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.77433628036	2467.77433628036
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATGTGCCGTTG"	9.84248127517049	6.76936671817628	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATGTGCCGTTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1651.39028602815	34.4522361989534	0.0208625644043337	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1643.72624656312	1643.72624656312
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATTCCATTGTT"	4.57225193557088	-7.36613371288451	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATTCCATTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.18333474611	2.52656449136707	0.00119505458672555	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.18333474611	2114.18333474611
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGATTCCGGGACT"	14.443339963525	1.94352600658265	"2020-08-26-Control4003-c3"	"Control4003"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGATTCCGGGACT"	"Plasmablast"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1321.31633570897	10.9803931734225	0.0083101925531942	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1310.52455236187	1310.52455236187
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGGCCATAGTCAC"	5.43267120894734	-9.6307411423889	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGGCCATAGTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.37860556964	19.4670907277757	0.0081610066772301	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2380.92191787037	2380.92191787037
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGGCGTCCAAGAG"	4.52756609496419	-7.77311184322508	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGGCGTCCAAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.56168894273	2.24670362171878	0.00108506963773004	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2067.44762083795	2067.44762083795
"healthy-4003"	"2020-08-26-Control4003-c3:CACAGGCTCGGTAGAG"	-5.49007783356364	-5.49419691478881	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACAGGCTCGGTAGAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2595.62386013012	15.8639527963046	0.00611180727684839	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2591.78914042569	2591.78914042569
"healthy-4003"	"2020-08-26-Control4003-c3:CACCAAACAGGAGGAG"	4.35511745986287	-6.69185974514159	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACCAAACAGGAGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.75957420238	2.13665752109731	0.000996687103726307	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.15012592797	2142.15012592797
"healthy-4003"	"2020-08-26-Control4003-c3:CACGAATAGTGACACG"	6.85757555541341	-1.66730441963347	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGAATAGTGACACG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2938.7538985492	11.5787781570986	0.00394002987552473	2185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2923.29018745661	2923.29018745661
"healthy-4003"	"2020-08-26-Control4003-c3:CACGAATGTCAAGCGA"	-0.377288292080718	8.4034213789734	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGAATGTCAAGCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1596.24559957373	33.0750415774879	0.0207205216956091	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1590.22785736733	1590.22785736733
"healthy-4003"	"2020-08-26-Control4003-c3:CACGAATGTGATTAGA"	1.96893109855	-6.26512720501097	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGAATGTGATTAGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2086.83060007321	37.3845039217149	0.0179144890440093	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2085.22560633369	2085.22560633369
"healthy-4003"	"2020-08-26-Control4003-c3:CACGGGTGTATTGGCT"	4.27862896498982	-7.94159986889037	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGGGTGTATTGGCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.16191717502	24.1849769336529	0.0110224212462821	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2186.08262448752	2186.08262448752
"healthy-4003"	"2020-08-26-Control4003-c3:CACGGGTGTTTGATCG"	5.34856762465779	-9.3478632203308	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGGGTGTTTGATCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.13875786595	4.9306428798855	0.00205175122066778	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.88847328497	2396.88847328497
"healthy-4003"	"2020-08-26-Control4003-c3:CACGGGTTCCATCGTC"	4.18992867049519	-7.21900179302367	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGGGTTCCATCGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.51341714877	38.2866889630537	0.016577816209581	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.69551188889	2301.69551188889
"healthy-4003"	"2020-08-26-Control4003-c3:CACGGGTTCGGTAGGA"	0.239127342670602	8.51314256275026	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGGGTTCGGTAGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1471.2231185928	11.2354620990137	0.00763681725567239	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1469.25883967705	1469.25883967705
"healthy-4003"	"2020-08-26-Control4003-c3:CACGTGGAGTCCCTAA"	3.55018152770345	-7.39850284969481	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGTGGAGTCCCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.76705959146	39.8459962522301	0.0186216513959411	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2136.37734055889	2136.37734055889
"healthy-4003"	"2020-08-26-Control4003-c3:CACGTGGCATCACAGT"	3.96429051932637	-6.79349186336669	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGTGGCATCACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.59091335104	28.1625075605427	0.0117904273197759	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2383.64264745182	2383.64264745182
"healthy-4003"	"2020-08-26-Control4003-c3:CACGTGGTCTTCGACC"	-2.3973277610844	9.05086991870729	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGTGGTCTTCGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.78858073988	43.0270630092352	0.0212396611464363	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2024.08712040661	2024.08712040661
"healthy-4003"	"2020-08-26-Control4003-c3:CACGTTCCACTGCTTC"	3.9532102542812	-6.9894099465576	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGTTCCACTGCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.9640204499	32.4166403650853	0.013318455035787	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.54923011687	2432.54923011687
"healthy-4003"	"2020-08-26-Control4003-c3:CACGTTCTCTGTCAGA"	5.48648132857625	-10.1042080155578	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACGTTCTCTGTCAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.10441628123	39.3495916364077	0.0167651644994786	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2344.22828046585	2344.22828046585
"healthy-4003"	"2020-08-26-Control4003-c3:CACTAAGAGGCTATCT"	4.02346529540364	-6.96850922023924	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTAAGAGGCTATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1803.07761670049	37.0082901986442	0.0205250677263505	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1803.07761670049	1803.07761670049
"healthy-4003"	"2020-08-26-Control4003-c3:CACTAAGGTGGAATGC"	4.06856503066365	-7.55527069484862	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTAAGGTGGAATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.23386660766	34.9030003423223	0.0164463497126798	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2122.23386660766	2122.23386660766
"healthy-4003"	"2020-08-26-Control4003-c3:CACTAAGGTGTCCGGT"	5.36663879927937	-9.85357191478881	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTAAGGTGTCCGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.34645084863	22.6564275989642	0.0104825524802229	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2156.20297924186	2156.20297924186
"healthy-4003"	"2020-08-26-Control4003-c3:CACTGAAGTATGCGGA"	5.36937775191609	-10.2100076905456	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTGAAGTATGCGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2038.6094805661	6.27845062219417	0.00307977112931443	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2035.59507897066	2035.59507897066
"healthy-4003"	"2020-08-26-Control4003-c3:CACTGGGTCATACGGT"	4.16219868239705	-6.8846211663452	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTGGGTCATACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.51160309041	41.3343683151136	0.0182531051104813	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.52785519654	2259.52785519654
"healthy-4003"	"2020-08-26-Control4003-c3:CACTGTCCAGAAACCG"	3.16386022147481	-7.77229120647582	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTGTCCAGAAACCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1998.95985029147	36.7035777682059	0.0183613381543677	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1995.69823506736	1995.69823506736
"healthy-4003"	"2020-08-26-Control4003-c3:CACTGTCCATCGCTCT"	-1.89783606949504	9.33967683399049	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTGTCCATCGCTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1710.00073284287	31.8357674423614	0.0186173998822998	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1703.65653220963	1703.65653220963
"healthy-4003"	"2020-08-26-Control4003-c3:CACTGTCGTGAATTGA"	9.65195622023885	6.12926814639894	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTGTCGTGAATTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1519.38867834053	41.67197702838	0.0274268050186435	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1517.46328841854	1517.46328841854
"healthy-4003"	"2020-08-26-Control4003-c3:CACTTCGCACGTAACT"	-3.11275682869609	9.92044255817262	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTTCGCACGTAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2129.51561727808	29.8796650440807	0.0140312025897573	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2123.1712916907	2123.1712916907
"healthy-4003"	"2020-08-26-Control4003-c3:CACTTCGGTACCACGC"	5.53899445113484	-10.1070404282776	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTTCGGTACCACGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.79191269541	0.546525767428239	0.000225669994421595	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2413.52352616889	2413.52352616889
"healthy-4003"	"2020-08-26-Control4003-c3:CACTTCGGTTGCTAGT"	3.786060710519	-8.11305048381957	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CACTTCGGTTGCTAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1551.83204031176	35.5899991395853	0.0229341824469839	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1549.64934279638	1549.64934279638
"healthy-4003"	"2020-08-26-Control4003-c3:CAGAGCCCAGCGACAA"	4.51940645751302	-7.13090994274291	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGAGCCCAGCGACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.52937168709	37.1558768981586	0.0149729748606191	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2480.17007110248	2480.17007110248
"healthy-4003"	"2020-08-26-Control4003-c3:CAGAGCCCATCAACCA"	-1.68105504933055	8.87287995899049	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGAGCCCATCAACCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1597.57624948631	24.6947687640399	0.0154576464015288	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1593.46934897871	1593.46934897871
"healthy-4003"	"2020-08-26-Control4003-c3:CAGAGCCTCAATGTCG"	4.18374313887898	-6.96955301677855	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGAGCCTCAATGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.71968801955	20.8541764514084	0.0099130015135432	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.44356758204	2100.44356758204
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATACAGACCGTTT"	4.6848427253658	-7.53258993541869	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATACAGACCGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2934.96382376205	18.0897317267793	0.00616352800682629	2298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2928.43480728535	2928.43480728535
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATACCAACGATTC"	5.18931164321248	-10.2719288102356	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATACCAACGATTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1997.69260190116	48.2978871510776	0.0241768363686753	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1993.14543654851	1993.14543654851
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATACCACAGTGTT"	-0.582493225962478	8.39778993213502	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATACCACAGTGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1779.78115207007	31.1179305792309	0.0174841331154887	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1776.03002343764	1776.03002343764
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATACCACTGTCGG"	-0.226297418505508	8.48323438251344	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATACCACTGTCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1994.46675515626	48.2195866246612	0.0241766810602383	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1986.10774912647	1986.10774912647
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATCAAGCTAGATA"	10.4478270011837	7.45663545215455	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATCAAGCTAGATA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.64098561083	31.1611974110862	0.0155058528534213	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2004.82897895306	2004.82897895306
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATCACACAGTGTT"	-3.60303507271464	-5.55987074291381	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATCACACAGTGTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2272.91512551544	39.0462576058757	0.0171789334179476	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2271.57157569726	2271.57157569726
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATCAGTGCTGATT"	6.79511227187459	-1.73601188575896	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATCAGTGCTGATT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2843.53472956195	29.1124104718056	0.0102381061743847	2083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2835.77763832857	2835.77763832857
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATCATCGTTTACT"	4.10863508757893	-7.05744316494139	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATCATCGTTTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.48121209262	25.5823883649459	0.0112179781307959	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2277.76390575161	2277.76390575161
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATCATCTTCTGTA"	5.61321796950643	-9.88644888317259	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATCATCTTCTGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.506431182	19.1009222847421	0.00791745963362413	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.76771424053	2408.76771424053
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATTGAGGGCGAAG"	-4.25723872605022	13.0066337355408	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATTGAGGGCGAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2007.2681689215	34.953059135658	0.0174132483525797	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2003.23992827159	2003.23992827159
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATTGTCCTTTGAT"	4.85728373107259	-7.38418962871703	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATTGTCCTTTGAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.78659962586	0	0	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2627.98523512796	2627.98523512796
"healthy-4003"	"2020-08-26-Control4003-c3:CAGATTGTCTATACTC"	-6.8855484527653	3.57448384845582	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGATTGTCTATACTC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2111.61719929398	32.7222353410892	0.0154962913505487	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2088.44160833034	2088.44160833034
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCAATTCACCTGTC"	0.793442805379075	-7.03690292751464	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCAATTCACCTGTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2218.71741467571	36.9751709771268	0.0166651105420431	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2215.5972066222	2215.5972066222
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCAATTCACCTTGC"	4.70169701155965	-7.53593208706053	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCAATTCACCTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.65514257663	29.1170365014428	0.0117565970331866	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2475.1990948656	2475.1990948656
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCACGAGCGAATGC"	3.82413568076436	-7.62297871029051	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCACGAGCGAATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.91968393804	43.2849654353885	0.0219173294931554	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1973.34205410699	1973.34205410699
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCAGCAGCTGTTAC"	3.95144142684285	-6.50993349468382	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCAGCAGCTGTTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.03650766721	37.0937397901507	0.0156050357958338	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.801769652	2371.801769652
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCAGCTCCGAACGC"	4.84994711455647	-7.96561815654906	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCAGCTCCGAACGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.09170105856	5.13046203663003	0.00263088245226882	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1948.09676466328	1948.09676466328
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCCAGCAAGGCGTA"	3.47015966948811	-7.20402195369872	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCCAGCAAGGCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.02903013564	29.5239961258207	0.0134015465624631	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2203.02903013564	2203.02903013564
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCCAGGTACTCGTA"	3.83737053450887	-7.57557537471923	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCCAGGTACTCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.61901992467	8.27097972710183	0.0049009756523549	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1685.87056085912	1685.87056085912
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCCAGGTCTCTCCA"	3.95297851142232	-6.94398977672728	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCCAGGTCTCTCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.70842006308	42.2108200111586	0.0165033745363819	1653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2555.24588575451	2555.24588575451
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCCAGTCGTCTACC"	-3.53057728233989	10.3552770384583	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCCAGTCGTCTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1861.34538724339	12.7170695935777	0.00683219228453421	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1859.46829143138	1859.46829143138
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCGTGAGTGGTCAG"	-3.61710367623027	-5.00357391750487	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCGTGAGTGGTCAG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2954.64974252855	21.0486735251614	0.00712391496771737	2689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2947.30815175789	2947.30815175789
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCGTGGTCCTATAG"	10.3365560966427	6.1504540213379	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCGTGGTCCTATAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1729.47600529814	38.7343499850974	0.0223965813150557	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1720.19085037218	1720.19085037218
"healthy-4003"	"2020-08-26-Control4003-c3:CAGCGTGTCGGATACT"	4.3223782974178	-6.99708034908446	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGCGTGTCGGATACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.59736312657	1.20981083729694	0.000544322987765577	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.27169441529	2221.27169441529
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGCCAAGGTAACTA"	4.85711063918416	-8.20336058056029	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGCCAAGGTAACTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.267185779	36.2344975734757	0.0158279897595901	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2289.267185779	2289.267185779
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGCCACACTCCGAG"	3.55078544196431	-7.11919453060301	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGCCACACTCCGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.41345625179	22.0135173764905	0.00945429915695782	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.95086874734	2321.95086874734
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGCCAGTAAGGCCA"	3.35679139670674	-6.44307901775511	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGCCAGTAAGGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.84173210156	7.17104973870655	0.00312894631346593	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2289.1454694442	2289.1454694442
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTAGCGACCCT"	3.54417838630025	-7.03545143520506	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTAGCGACCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2167.17965809885	34.2453968708465	0.0158018264627346	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2165.52224107547	2165.52224107547
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTAGGCCCAAA"	3.82763351973836	-7.03290941631468	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTAGGCCCAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.16488820888	14.786596969228	0.00653648062804814	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.38332260307	2259.38332260307
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTAGGTCCAGA"	4.00635470923726	-6.661008857843	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTAGGTCCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.73358074638	20.8291119324971	0.00889094351303111	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.37241065456	2341.37241065456
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTAGTCGAAAT"	-4.11838660660441	-4.14227249538573	"2020-08-26-Control4003-c3"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTAGTCGAAAT"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3064.5221690185	24.8047070691759	0.00809415161683113	2799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3057.01600975218	3057.01600975218
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTGTGTGTGTT"	10.8243013816768	6.09928462589113	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTGTGTGTGTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1862.07204458047	29.2453366579258	0.0157058029752629	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1851.60142630941	1851.60142630941
"healthy-4003"	"2020-08-26-Control4003-c3:CAGGGCTTCGACCATA"	5.39861645278279	-10.132480644342	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGGGCTTCGACCATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.17980970619	32.0988793303595	0.0154159977830584	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.50992027543	2080.50992027543
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTGCGCATGTCTAG"	10.1634527641231	7.11934421146242	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTGCGCATGTCTAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1823.50128492544	32.1122323407622	0.0176102054910673	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1816.78082481967	1816.78082481967
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTTAGAGTCCGCCA"	-3.65708694878276	10.6459398039612	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTTAGAGTCCGCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.93409019089	25.3711521896999	0.0124311472436266	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2035.70759211125	2035.70759211125
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTTAGCAGCTTTCC"	2.82831968840901	-4.73128845607909	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTTAGCAGCTTTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2786.10197024184	29.374567385217	0.0105432492058671	2097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2782.15264612209	2782.15264612209
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTTAGTCTCAACGA"	3.47412433203999	-6.92711594020995	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTTAGTCTCAACGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.86054709786	27.9898228583174	0.0112234915825143	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.46384603056	2489.46384603056
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTTAGTCTGAATGC"	5.51563133773152	-9.52089598095091	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTTAGTCTGAATGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.99551866014	33.6045426518808	0.0123682731241502	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2712.45839570017	2712.45839570017
"healthy-4003"	"2020-08-26-Control4003-c3:CAGTTCCCACATGACT"	4.80405630645101	-7.72114326870116	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CAGTTCCCACATGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.0719852197	32.2646849231172	0.0136710596647812	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.65822874717	2355.65822874717
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCAGAACCGCA"	-3.36903534355815	9.76966950977174	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCAGAACCGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2050.06847923233	33.6674113481405	0.0164225788988023	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2045.08954676774	2045.08954676774
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCAGATGAACT"	4.8904353576595	-7.49963524257811	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCAGATGAACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2639.80731909876	34.405988628578	0.0130335227043481	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2634.78712284675	2634.78712284675
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCAGTGAGGTC"	4.11595453795735	-6.92833330547484	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCAGTGAGGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.48536370078	32.4912420392058	0.0137704783166124	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2358.33944719465	2358.33944719465
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCCACGACCTG"	-1.97918854180034	8.86169526660768	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCCACGACCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2048.75398830614	24.0541878189277	0.0117408863905691	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.9473602982	2046.9473602982
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCGTTGGAGAC"	3.97026695784871	-7.58220817958983	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCGTTGGAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.51519910487	14.6042930692149	0.00706369320793282	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2067.51519910487	2067.51519910487
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCTCAAGTAAG"	9.63609375533406	6.76246163928834	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCTCAAGTAAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1734.03498251489	37.44227234605	0.0215925703481178	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1729.16594665531	1729.16594665531
"healthy-4003"	"2020-08-26-Control4003-c3:CATAAGCTCTATCACT"	4.60455908355061	-7.31761124050292	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAAGCTCTATCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3112.55150839088	30.9721341894839	0.00995072181327395	2577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3103.95604524954	3103.95604524954
"healthy-4003"	"2020-08-26-Control4003-c3:CATACAGCAGTCAGCC"	-7.19711623612102	3.44284532153932	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACAGCAGTCAGCC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2390.40832261841	35.08734294775	0.0146783888826642	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2376.8347949746	2376.8347949746
"healthy-4003"	"2020-08-26-Control4003-c3:CATACAGGTAGTCGTT"	-4.3370283645695	3.44210407817689	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACAGGTAGTCGTT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2625.60595095445	31.4998870228506	0.0119971875488018	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2616.95410003576	2616.95410003576
"healthy-4003"	"2020-08-26-Control4003-c3:CATACCCCAACAAGTA"	6.81352104720418	-1.6760349503723	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACCCCAACAAGTA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2426.7339009757	23.6635529812379	0.00975119396969053	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2414.31657139619	2414.31657139619
"healthy-4003"	"2020-08-26-Control4003-c3:CATACCCGTGTGCCTG"	5.40071501311604	-9.91058161174925	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACCCGTGTGCCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.7335368533	20.5439484740698	0.0117411868958149	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1740.63973694355	1740.63973694355
"healthy-4003"	"2020-08-26-Control4003-c3:CATACCCGTTGGTACT"	-4.10031257095988	13.0736789473328	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACCCGTTGGTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2257.4990392221	12.4014493823895	0.00549344613969927	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2248.91641608923	2248.91641608923
"healthy-4003"	"2020-08-26-Control4003-c3:CATACCCTCATAGAGA"	-3.68061170998271	12.3312768706116	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACCCTCATAGAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1564.65950579755	40.9368827009792	0.0261634448576801	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1562.44590307841	1562.44590307841
"healthy-4003"	"2020-08-26-Control4003-c3:CATACCCTCTCTGACC"	-3.96193442764934	12.4742469557556	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACCCTCTCTGACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1909.11669226427	44.4294602798813	0.0232722601294667	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1907.00459542959	1907.00459542959
"healthy-4003"	"2020-08-26-Control4003-c3:CATACTTGTTTGGGTT"	-4.15216384354289	10.8865318068298	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATACTTGTTTGGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.70862536327	34.3556023661221	0.0179242697150229	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.6674232177	1912.6674232177
"healthy-4003"	"2020-08-26-Control4003-c3:CATAGACAGGCCCGTT"	11.3480040031368	4.57615134799806	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATAGACAGGCCCGTT"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.05200455958	34.9498614893342	0.0180242001798567	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1937.10980720998	1937.10980720998
"healthy-4003"	"2020-08-26-Control4003-c3:CATCAAGTCGTTAGAC"	-2.64089045944865	9.73634717548219	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCAAGTCGTTAGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.32302073677	37.0201073481492	0.0193183022630057	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1910.75618202456	1910.75618202456
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCACCACAGAGCA"	10.6664968925411	7.73452041232911	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCACCACAGAGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2181.83947131316	27.2090756661182	0.0124707046617606	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2172.52889759572	2172.52889759572
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCACCAGCGATTT"	5.61819328841512	-9.87790491497191	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCACCAGCGATTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.52977565308	13.1813577435827	0.00481681502640947	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2728.69614286841	2728.69614286841
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCACGTTTGGAGG"	-3.87080750885661	12.6601667174133	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCACGTTTGGAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1571.06306524778	31.094610437496	0.0197920829057183	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1571.06306524778	1571.06306524778
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCACTCTCGTGAA"	-4.48046002808269	12.9047431715759	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"IFN+ NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCACTCTCGTGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1876.23263013487	37.3036786670001	0.0198822246601258	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1872.34185805617	1872.34185805617
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCCAAGAGCCTGA"	-1.52205095711406	9.21982572162477	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCCAAGAGCCTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1806.97113156473	38.6935599478015	0.0214134909362361	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1797.34839928124	1797.34839928124
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCCAAGGCCGCTT"	4.61964478072469	-7.11676790630492	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCCAAGGCCGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.85199513448	1.22627006826682	0.000563581562996442	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.03590151116	2173.03590151116
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCCAAGGTCCCGT"	2.73671783980672	-6.74092771923216	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCCAAGGTCCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.31338885895	16.3168138180108	0.00826873922314277	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1966.86041633981	1966.86041633981
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCCAAGTACCCTA"	5.52186502990071	-10.1196413270203	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCCAAGTACCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.73734993039	38.4428882146533	0.0156479438942639	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.08156742351	2450.08156742351
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCCAGTTAAGAAC"	4.67570318755452	-7.40204765712889	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCCAGTTAAGAAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.16375119336	31.7764693355523	0.0127199305171139	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2492.10327553231	2492.10327553231
"healthy-4003"	"2020-08-26-Control4003-c3:CATCCGTCAAACACCT"	4.10573210295979	-7.09968902980956	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCCGTCAAACACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.6987077898	32.2130418612518	0.0143251924989601	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.64058193973	2242.64058193973
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGCTGTCGAAGCA"	4.54277386245076	-7.73346378719481	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGCTGTCGAAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.06613183626	7.98547734318392	0.00318518815350718	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.30707447884	2501.30707447884
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGCTTCCTCGCAT"	4.04378380355184	-6.84150459682616	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGCTTCCTCGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2834.37243026056	28.3665800979804	0.0100080637939922	2037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2830.09338548901	2830.09338548901
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGGGAGCCAAGCA"	3.95166363295857	-7.62226107036742	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGGGAGCCAAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.33587029394	31.9183741267197	0.0131387242567071	1442	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.2994827926	2425.2994827926
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGGGAGCGGATCA"	5.40759100493733	-10.2085571519104	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGGGAGCGGATCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1939.22428124604	23.354399292213	0.0120431656709696	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1934.01118567193	1934.01118567193
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGGGCAAACACCT"	10.3767115074093	7.65632245624391	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGGGCAAACACCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2016.14946285267	17.4788863229116	0.00866943976374676	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2013.5907773069	2013.5907773069
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGGGGTGATTAGA"	-3.89214477959331	11.1037320860657	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGGGGTGATTAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1785.78130244761	39.5020984089862	0.0221203449464077	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1779.57329310418	1779.57329310418
"healthy-4003"	"2020-08-26-Control4003-c3:CATCGTCGTCGCTCGA"	0.16452313688342	8.3020391234192	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATCGTCGTCGCTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1879.92671370494	37.7478439123716	0.0200794231164355	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.61365128421	1876.61365128421
"healthy-4003"	"2020-08-26-Control4003-c3:CATGAGTAGTTGAATG"	-1.47895441475566	8.73929975116578	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGAGTAGTTGAATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.10651942028	27.2919556775801	0.0157202080473111	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1732.28976125057	1732.28976125057
"healthy-4003"	"2020-08-26-Control4003-c3:CATGAGTCAATTCTCT"	2.68935670432393	-7.08432581340941	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGAGTCAATTCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.99652394714	33.9865312387114	0.0169678433448986	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1999.99901511316	1999.99901511316
"healthy-4003"	"2020-08-26-Control4003-c3:CATGAGTCACCTCTAC"	10.2860609489376	7.8908104666504	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGAGTCACCTCTAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2428.35597320394	37.9662058030271	0.0156345306132918	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2420.11396385687	2420.11396385687
"healthy-4003"	"2020-08-26-Control4003-c3:CATGAGTCAGTTTGGT"	5.0148569541866	-9.44221975719603	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGAGTCAGTTTGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.85392371515	42.1190497582765	0.0172700174244613	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2436.310846603	2436.310846603
"healthy-4003"	"2020-08-26-Control4003-c3:CATGAGTTCATCCTAT"	-3.76231775704082	12.2627496489319	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGAGTTCATCCTAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2007.21607081022	42.1947050581809	0.0210215061904864	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1991.7589495207	1991.7589495207
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCAACACATTCTT"	9.82229580458943	6.76509139621583	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCAACACATTCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1813.93990824034	12.9030420448572	0.00711326873963214	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1810.57135024939	1810.57135024939
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCAATCAGGAAGC"	-3.96621213379558	12.6289996870789	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCAATCAGGAAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1648.76912051763	18.1467365477294	0.0110062326628438	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1646.54249264727	1646.54249264727
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCAATCGGCGATC"	4.05394758757893	-7.35593845760497	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCAATCGGCGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2029.09996929315	38.4474883022652	0.018948050310039	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2029.09996929315	2029.09996929315
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCCTCAAGCGAGT"	6.73450293120686	-1.76903333580168	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCCTCAAGCGAGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2382.80078124467	28.2866965315393	0.0118711965994755	1474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2372.70131054064	2372.70131054064
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCCTGTTACCTGA"	6.77509464797322	-1.63302650367888	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCCTGTTACCTGA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2309.97077252692	15.6319231640599	0.00676715192675787	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2300.68895196072	2300.68895196072
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGCAAAGCGTG"	-3.29636130753215	-5.55428221141966	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGCAAAGCGTG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2108.88208297305	29.0984214681096	0.0137980315272476	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2107.54694873489	2107.54694873489
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGCACGCTGAC"	3.96324338492696	-6.73942949688109	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGCACGCTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.16830106458	27.4491203855074	0.0115372755988826	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2377.86325437488	2377.86325437488
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGGTCACATTG"	3.94138588485066	-8.2624140015808	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGGTCACATTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.49661786943	26.7670267507805	0.0151869946752791	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1758.69174156651	1758.69174156651
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGGTCCTCCAT"	4.09057344970052	-7.02552893078002	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGGTCCTCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.16158410338	22.9629742234162	0.0101464139302778	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.95872969838	2259.95872969838
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGGTCTACATG"	5.19047703322713	-8.88249685680541	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGGTCTACATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.39937122783	32.1782025746527	0.0130572191140516	1577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.02847618204	2462.02847618204
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCGGTCATGCCAA"	0.124396164982957	8.37929818713991	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCGGTCATGCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1714.13713080302	29.470012762296	0.0171923309009065	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1705.26245882183	1705.26245882183
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCTCAGTGACACG"	5.57065643843953	-9.70059111034545	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCTCAGTGACACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.7320319191	3.73420912988104	0.00146627485070234	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.58869928788	2545.58869928788
"healthy-4003"	"2020-08-26-Control4003-c3:CATGCTCGTGTTAAAG"	5.49849428710286	-10.0375814667908	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGCTCGTGTTAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.09624711258	40.5897854545395	0.0193644664506474	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2093.4651154684	2093.4651154684
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGATCACACAGAG"	2.38804473456685	-4.32310058986815	"2020-08-26-Control4003-c3"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGATCACACAGAG"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2663.39869466818	34.898261940835	0.0131029057011619	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2659.87681121437	2659.87681121437
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGATCACTGTTCC"	3.23100413855855	-7.4466819993225	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGATCACTGTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.25567249943	36.000591539847	0.0171819563656887	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2093.73700221103	2093.73700221103
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGATGTACAAACA"	-3.95521579209026	13.0469827421936	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGATGTACAAACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1991.71182776125	17.5326251263148	0.00880279209167625	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1985.51668033123	1985.51668033123
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGATTCGACACCG"	0.197691013186616	8.84968278491823	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGATTCGACACCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1519.04623641465	37.9378154037797	0.0249747601451046	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1515.38286481223	1515.38286481223
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGTAAGTGTTGAA"	-2.0677858394688	9.12406537616578	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGTAAGTGTTGAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2059.13438497486	27.1094213756867	0.0131654454286711	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2048.07133364058	2048.07133364058
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGTACACCAGCTG"	-2.83561048927959	12.0288018950256	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGTACACCAGCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1719.87696629166	42.3779600237911	0.0246401113884123	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1717.75970713906	1717.75970713906
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGTATCTCATAGG"	4.80486359175984	-8.1805744401184	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGTATCTCATAGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.99006858637	32.2303242443629	0.0147778409028948	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.27051394012	2173.27051394012
"healthy-4003"	"2020-08-26-Control4003-c3:CATGGTATCTGCGGCA"	-3.70306954804118	11.6484269865784	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATGGTATCTGCGGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1640.14389174468	21.3683607542407	0.0130283451725143	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1638.03317814118	1638.03317814118
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCATAGGCGAACT"	0.0192095163160979	8.49409768665162	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCATAGGCGAACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.84549246604	35.4304132404322	0.0187577085482916	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.31829803964	1881.31829803964
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCATCACGGTAGA"	3.88122119483296	-7.63264038479003	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCATCACGGTAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1772.55438627479	43.5342577854902	0.0245601816917911	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1760.68840446997	1760.68840446997
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCATGTAGTTCCA"	5.50610603865926	-10.0493898621765	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCATGTAGTTCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1992.81513818389	35.8049405148612	0.0179670155193076	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.1607069794	1984.1607069794
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCCGAGTGGCCTC"	3.43981828269307	-7.24965383922728	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCCGAGTGGCCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1966.83700428416	0	0	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1963.01486840014	1963.01486840014
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCCGTCAGTGCGC"	-3.8398588699406	10.5440425642761	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCCGTCAGTGCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2038.0628099042	29.5227327080269	0.0144856834463382	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2034.06698620657	2034.06698620657
"healthy-4003"	"2020-08-26-Control4003-c3:CATTCCGTCTACTGAG"	-1.62232599678691	9.08228013599244	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTCCGTCTACTGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1944.33787253011	43.8989379746048	0.0225778341279133	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.88877995271	1932.88877995271
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGAGCATGTGGTT"	-3.33163056793864	10.9791326292786	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGAGCATGTGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1449.91653926219	37.1951085173465	0.0256532755576909	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1447.53118161791	1447.53118161791
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGAGGTTCTCGCT"	2.51437487181966	-3.9898195496765	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGAGGTTCTCGCT"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2587.83704946924	37.3677179488241	0.0144397491938251	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2580.1527112849	2580.1527112849
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGAGGTTGGCTAT"	4.02568783339803	-6.9993992081848	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGAGGTTGGCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.57886044033	5.26264659138707	0.00249110065897856	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2112.57886044033	2112.57886044033
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGAGTCAGACCTA"	-1.06354878369029	9.68885991657106	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGAGTCAGACCTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1928.39612268302	26.5787477751458	0.0137828257703434	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1928.39612268302	1928.39612268302
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGCCAGCTCTATG"	-3.19130216065105	10.4202575453552	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGCCAGCTCTATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1909.09004901891	46.0812310245422	0.0241377985539359	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1909.09004901891	1909.09004901891
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGCCCAAGCTCTA"	-3.07519517365153	10.2231321104797	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGCCCAAGCTCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1509.30748322427	25.7209491444082	0.0170415567604962	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1497.93418374698	1497.93418374698
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGCCGTAAGGTCG"	4.67690720137898	-7.24606802379759	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGCCGTAAGGTCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2776.51627100136	33.4525856435877	0.0120484025226054	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2766.58808879305	2766.58808879305
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGCCGTCAGTCCG"	-0.328176001936752	8.27741048419801	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGCCGTCAGTCCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1528.6898251814	29.1906286217802	0.0190951938980273	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1522.72404626338	1522.72404626338
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGTTAGGCCCGTT"	4.61344446715657	-7.75297071849974	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGTTAGGCCCGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.57932295176	27.23862917421	0.0105104362166255	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2590.15326991065	2590.15326991065
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGTTAGGTTCACT"	-0.376649717718917	8.11168954456178	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGTTAGGTTCACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2154.74143084467	28.8961228715038	0.0134104827882649	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2141.96501748979	2141.96501748979
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGTTCACGGGCTT"	-3.01756153526958	10.2137040861878	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGTTCACGGGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.76866562724	32.0322688347991	0.0168257149164945	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1896.14035056635	1896.14035056635
"healthy-4003"	"2020-08-26-Control4003-c3:CATTGTTGTTCCGCTT"	-4.04465804520305	12.9568786391052	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTGTTGTTCCGCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.15565417299	39.9936383722367	0.0203928934896816	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1953.01929216532	1953.01929216532
"healthy-4003"	"2020-08-26-Control4003-c3:CATTTCAAGCTGGAGT"	5.25441660460774	-10.1459236375061	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTTCAAGCTGGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.94795900759	32.8869104152442	0.0168137962279581	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1954.22970853792	1954.22970853792
"healthy-4003"	"2020-08-26-Control4003-c3:CATTTCAGTTCGAAGG"	-2.64036140862163	9.753222442511	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTTCAGTTCGAAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2081.72324546173	33.7289182905088	0.0162024026796259	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2074.28605727847	2074.28605727847
"healthy-4003"	"2020-08-26-Control4003-c3:CATTTCATCTCCGCAT"	3.64225592192952	-5.77404978191527	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CATTTCATCTCCGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2827.63293146158	33.5678083028704	0.0118713457922275	2223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2820.96575641921	2820.96575641921
"healthy-4003"	"2020-08-26-Control4003-c3:CCAAGCGAGTCAGAGC"	4.6168552833492	-7.8164968720642	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAAGCGAGTCAGAGC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.85466720279	14.0068156105565	0.00600158005011693	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.25430983644	2328.25430983644
"healthy-4003"	"2020-08-26-Control4003-c3:CCAAGCGGTCGTGGAA"	3.60252799567525	-7.39286854183348	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAAGCGGTCGTGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.60346131985	20.8750456244863	0.0113723067450944	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1835.60346131985	1835.60346131985
"healthy-4003"	"2020-08-26-Control4003-c3:CCAAGCGTCATGCCGG"	-3.33842096749004	11.6168451079163	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAAGCGTCATGCCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1607.70955450009	33.2417156748214	0.0206764434420232	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1605.32509094506	1605.32509094506
"healthy-4003"	"2020-08-26-Control4003-c3:CCAAGCGTCTCAGTCC"	-4.02390084686931	13.137032485846	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAAGCGTCTCAGTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1975.4957457757	37.6079097733548	0.0190372010943449	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1971.45359057133	1971.45359057133
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATGAGTAGCTTAC"	-2.77887449684795	9.73296926105348	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATGAGTAGCTTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1802.8957900155	44.9211006143788	0.0249160827060296	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1796.90666384646	1796.90666384646
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATTTAGCTATCCA"	2.65975775298421	-4.32950069820555	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATTTAGCTATCCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2510.44496953592	2.69167330697909	0.0010721897271768	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2503.31758016661	2503.31758016661
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATTTCAAATGCGG"	3.91008486327474	-6.84122660076293	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATTTCAAATGCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2066.29949381064	28.7465299561084	0.0139120829493572	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2064.43552418496	2064.43552418496
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATTTCACACACGC"	4.94206251677815	-7.80025103008422	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATTTCACACACGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3038.34316323512	36.8225977009834	0.012119301778202	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3034.29471625509	3034.29471625509
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATTTGTCTTGAAC"	0.185145561664742	8.77222440326539	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATTTGTCTTGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1469.10481127909	33.254361732668	0.022635799350296	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1460.30257281537	1460.30257281537
"healthy-4003"	"2020-08-26-Control4003-c3:CCAATTTTCCTGTTGC"	-1.63885317269023	9.41742608630983	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCAATTTTCCTGTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2018.48068345097	41.3354150423725	0.0204784793737545	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2012.90894725799	2012.90894725799
"healthy-4003"	"2020-08-26-Control4003-c3:CCACAAAAGGTAGGCT"	4.23804869231526	-7.22489740764769	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACAAAAGGTAGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.68431659776	32.942947123324	0.0155341117324689	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2118.09331521665	2118.09331521665
"healthy-4003"	"2020-08-26-Control4003-c3:CCACACTCATACAGAA"	-4.06260095062907	13.0981035002503	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACACTCATACAGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1718.45066313402	35.8054195068822	0.0208358728446601	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1716.19107396874	1716.19107396874
"healthy-4003"	"2020-08-26-Control4003-c3:CCACACTCATAGACTC"	4.36963190612142	-7.29162743007811	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACACTCATAGACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2786.43104782293	38.2274870332906	0.0137191577244153	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2779.61817921673	2779.61817921673
"healthy-4003"	"2020-08-26-Control4003-c3:CCACACTGTTTACTTC"	-2.71526751938518	10.5139150389465	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACACTGTTTACTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.75478674491	35.3726131869959	0.0178761984172807	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1974.67004301084	1974.67004301084
"healthy-4003"	"2020-08-26-Control4003-c3:CCACACTTCACAAGAA"	3.63040604171101	-7.65699293529662	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACACTTCACAAGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1846.22853200644	14.3398393195817	0.00776709874806095	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1842.10813339039	1842.10813339039
"healthy-4003"	"2020-08-26-Control4003-c3:CCACCATTCCAACACA"	4.38322319564168	-7.13981392299803	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACCATTCCAACACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.30262774224	31.5436568554475	0.0121074828388682	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2601.89883415149	2601.89883415149
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGAGAGATGAAGG"	4.36460461196248	-7.61648132717284	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGAGAGATGAAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.66016927134	35.4390588112821	0.0156142577162376	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.94904452288	2264.94904452288
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGAGCAAGCGCAA"	4.46890129622762	-6.99882271206053	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGAGCAAGCGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.96107427978	29.2880418994185	0.0130635818058648	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2239.07706115299	2239.07706115299
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGAGCAGGTTCAT"	-2.17431936684306	10.2567081221375	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGAGCAGGTTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1658.23395464105	36.8664271287784	0.0222323436482512	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1656.13822241218	1656.13822241218
"healthy-4003"	"2020-08-26-Control4003-c3:CCACGAGGTCATGGCC"	-0.419373790652114	8.39320275867311	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCACGAGGTCATGGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1670.6606406469	34.1410876113954	0.0204356808203584	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.51906685462	1664.51906685462
"healthy-4003"	"2020-08-26-Control4003-c2:GCATTAGGTATGACAA"	-3.09171758118327	9.55750367725221	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATTAGGTATGACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1733.55475035775	40.6896189271883	0.0234717818510153	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.55475035775	1733.55475035775
"healthy-4003"	"2020-08-26-Control4003-c2:GCATTAGGTTCCATTT"	5.63964953002278	-9.82540037548216	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATTAGGTTCCATTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2756.05245549181	43.328048147826	0.015721053516775	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2748.47478764492	2748.47478764492
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAACGAGGTCACTT"	-3.49097023430522	10.521099067572	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAACGAGGTCACTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1690.18241640525	39.2664697703903	0.0232320898556642	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1683.99219503374	1683.99219503374
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAACGCAGAGCGTA"	3.50990166243855	-6.60512258922728	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAACGCAGAGCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2858.87142478775	30.9059174400843	0.0108105307472437	2163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2853.97783474304	2853.97783474304
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAACGCAGCGGTCT"	-3.68180547180827	10.0399904021057	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAACGCAGCGGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2195.90868827957	31.4629094196942	0.0143279680014129	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2189.45967554384	2189.45967554384
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAACGGTAACGTTC"	3.21172155913655	-7.39241793071898	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAACGGTAACGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.61493240079	16.3450178766839	0.0079014308659728	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.70745091547	2062.70745091547
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAACGTCATGCCGG"	3.6650022464687	-6.80536987697753	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAACGTCATGCCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.61031365284	31.6795669072181	0.0131362711163867	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.77899725451	2407.77899725451
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGCAAGTAGGATT"	10.8370491462642	6.00694129550783	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGCAAGTAGGATT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.72485729307	36.2908990230338	0.0196196201180659	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1844.26016302321	1844.26016302321
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGCAGTCGTATTG"	-0.734318534762222	9.03648469531862	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGCAGTCGTATTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1766.61001742296	36.0015176615368	0.0203788710051887	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1766.61001742296	1766.61001742296
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGGTAGAGTATAC"	4.49979986724202	-7.6715412369934	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGGTAGAGTATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.10140158402	13.8836783906776	0.00568746483930103	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.76675433166	2439.76675433166
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGGTCAGCAGTGA"	5.51142277297322	-10.1429682007995	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGGTCAGCAGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.38275204057	31.5375093905549	0.0131385335791739	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2393.52380207315	2393.52380207315
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGGTGTACGTGTT"	3.85544099387471	-6.76192858135375	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGGTGTACGTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.41340668352	22.6580508191719	0.00942352540382181	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2401.55974509058	2401.55974509058
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGGTGTCCCTAAA"	5.32640184935872	-9.58537962352904	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGGTGTCCCTAAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.52075721861	4.96266168172914	0.00200469402943119	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2469.14971133343	2469.14971133343
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGGTGTTGAGAGC"	-1.68370125714	10.0429715880188	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGGTGTTGAGAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1829.2548415211	26.7896460309214	0.0146451141868482	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.29135242781	1825.29135242781
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGTGAGAGATTCA"	4.30940975722615	-6.57955887233885	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGTGAGAGATTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2836.90670777619	32.0431222995244	0.0112950920140206	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2829.33394154326	2829.33394154326
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGTGAGCTGAAGC"	3.88126625594441	-7.0519647828308	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGTGAGCTGAAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.18721232285	29.3451908005637	0.013313384015888	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.68576292471	2202.68576292471
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGTGCAAGGTACG"	4.51247467574422	-6.92275860225829	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGTGCAAGGTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2373.45651587495	37.6882026275282	0.0158790364919051	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2366.86141218548	2366.86141218548
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGTGGTACCGGCT"	3.92707886275594	-6.60495951091918	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGTGGTACCGGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.58066372995	41.3967684133256	0.0187351243124315	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.31882503728	2205.31882503728
"healthy-4003"	"2020-08-26-Control4003-c2:GCCAGTGTCCAAACCA"	4.09191050109212	-7.53449394619139	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCAGTGTCCAAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.68511863215	21.1362645299706	0.0100329490833895	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2103.48948047333	2103.48948047333
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATGGTCATCACTT"	-3.66502819481547	10.7216081389221	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATGGTCATCACTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.05143561711	25.2107062736117	0.015086732662003	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1671.05143561711	1671.05143561711
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATTCAGTCGAAAT"	5.00413622435872	-7.7314663163391	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATTCAGTCGAAAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.85607523767	29.267477636545	0.0108604974883357	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2691.48248156592	2691.48248156592
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATTCGTACGATGG"	2.89521517333333	-6.2393369904724	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATTCGTACGATGG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2189.98959285376	0.428671891331099	0.000195741519836403	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2188.49471091747	2188.49471091747
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATTCTCATTTGGG"	-3.93871198120769	12.6724042662415	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATTCTCATTTGGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1983.03882669419	41.4820289465213	0.0209184149034912	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1979.06523056666	1979.06523056666
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATTCTCCCGAAAT"	4.79917873915975	-7.36591484462889	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATTCTCCCGAAAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3078.86267262267	33.0079184988709	0.0107208154466837	2732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3068.87712414982	3068.87712414982
"healthy-4003"	"2020-08-26-Control4003-c2:GCCATTCTCTTCGGTC"	5.56526007232015	-9.73340418255004	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCATTCTCTTCGGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2766.46252173534	21.8995535924769	0.00791608540524881	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2765.25339741798	2765.25339741798
"healthy-4003"	"2020-08-26-Control4003-c2:GCCCAGACAACAGCCC"	5.07905592498128	-8.2094183198181	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCCAGACAACAGCCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.85088001974	9.56752513615777	0.00400172391181452	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2386.69120584676	2386.69120584676
"healthy-4003"	"2020-08-26-Control4003-c2:GCCCAGATCGCCCAGA"	-1.76743684235271	8.9957875975403	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCCAGATCGCCCAGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2078.34068427705	33.7083965062296	0.0162188984516535	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2069.51587320434	2069.51587320434
"healthy-4003"	"2020-08-26-Control4003-c2:GCCCGAACATGCACTA"	4.4120098548824	-7.17082025921019	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCCGAACATGCACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2684.59272833959	40.11485298645	0.0149426214870443	1928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2680.37379821623	2680.37379821623
"healthy-4003"	"2020-08-26-Control4003-c2:GCCCGAATCCATTGGA"	10.233885427087	6.16095254505006	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCCGAATCCATTGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1721.98432685723	47.0380788217822	0.0273162061280958	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1715.10613376626	1715.10613376626
"healthy-4003"	"2020-08-26-Control4003-c2:GCCGATGGTTTACTTC"	5.5438343482906	-9.60108091747435	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCGATGGTTTACTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.60236414581	29.4327693840699	0.0118033130731941	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2488.6789127603	2488.6789127603
"healthy-4003"	"2020-08-26-Control4003-c2:GCCTGTTAGCGCCATC"	-1.17315206947978	8.74401757800905	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCTGTTAGCGCCATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.96215519011	47.1680853622727	0.0249044497710875	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1890.11259283217	1890.11259283217
"healthy-4003"	"2020-08-26-Control4003-c2:GCCTGTTCACTCTCGT"	4.72912754592244	-7.02520754253539	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCTGTTCACTCTCGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.72780395111	21.1360156608169	0.0075251206724569	1811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2802.51739237367	2802.51739237367
"healthy-4003"	"2020-08-26-Control4003-c2:GCCTGTTCAGCTGCCA"	-0.741274456412155	8.58283612811891	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCCTGTTCAGCTGCCA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1697.10575970524	29.2109342856235	0.017212206203753	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.17053977052	1693.17053977052
"healthy-4003"	"2020-08-26-Control4003-c2:GCGAGAATCGTGGAAG"	-0.00333975154216889	8.31984422290651	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGAGAATCGTGGAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1568.78560868757	12.7346841083494	0.0081175426634638	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1565.4230636677	1565.4230636677
"healthy-4003"	"2020-08-26-Control4003-c2:GCGAGAATCTCATTTG"	5.03669752654378	-8.02394487774047	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGAGAATCTCATTTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.73079347438	26.0531052612417	0.0100099116384078	1830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2598.48098531592	2598.48098531592
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGAGGATGCGT"	6.74524225768392	-1.80146267330321	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGAGGATGCGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2933.98695290971	14.5917956485821	0.00497336759937227	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2923.67722809643	2923.67722809643
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGAGTACCGGA"	5.07143177565877	-7.96084406292113	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGAGTACCGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2668.14804390046	30.0457317674614	0.0112608938009072	1752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2662.41657286157	2662.41657286157
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGCAGAAGCGT"	4.44970573958699	-7.79116203701171	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGCAGAAGCGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.08659010524	24.1005713638914	0.0110802813430638	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.68105984128	2171.68105984128
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGCATTGGCAT"	5.2806621986324	-10.1924686661926	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGCATTGGCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.07039965186	10.8625060211742	0.00537197222363988	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2020.17236267404	2020.17236267404
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGGTAGCTTGT"	4.16775049743001	-7.54299833690795	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGGTAGCTTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.00096817992	26.5204546025338	0.0129368010133575	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2046.68342239443	2046.68342239443
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGGTGGACAGT"	-5.66554770889934	3.61409709537355	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGGTGGACAGT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2001.50770183037	39.8230599390744	0.0198965309514704	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1991.77883294999	1991.77883294999
"healthy-4003"	"2020-08-26-Control4003-c2:GCGATCGTCTCCTGTG"	4.85008062896077	-8.53348829662474	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGATCGTCTCCTGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.1529140646	25.286614195764	0.0123460577685004	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.64098063946	2044.64098063946
"healthy-4003"	"2020-08-26-Control4003-c2:GCGGATCGTATCGCAT"	2.89581241187398	-4.82007982647093	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGGATCGTATCGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2515.05586883505	13.4075436655159	0.00533091285631206	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2509.09053911427	2509.09053911427
"healthy-4003"	"2020-08-26-Control4003-c2:GCGGATCTCTACGCAA"	5.2095385986263	-10.0234737626282	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGGATCTCTACGCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.52253612022	32.5819594839719	0.0125822266574239	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2583.576561924	2583.576561924
"healthy-4003"	"2020-08-26-Control4003-c2:GCGTGCACATTGACCA"	0.293265481560868	8.57528779590455	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGTGCACATTGACCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1616.26057879749	30.4669535092052	0.0188502732225721	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1616.26057879749	1616.26057879749
"healthy-4003"	"2020-08-26-Control4003-c2:GCGTTTCCAATGAAAC"	-4.40527043762858	12.9987287291321	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGTTTCCAATGAAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2145.27881989521	30.2311767922312	0.0140919569577011	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2143.37347651959	2143.37347651959
"healthy-4003"	"2020-08-26-Control4003-c2:GCGTTTCTCGGCATCG"	3.76041163977925	-6.92942573940428	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGTTTCTCGGCATCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.32767641092	27.9484405447292	0.0129852163548509	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.32767641092	2152.32767641092
"healthy-4003"	"2020-08-26-Control4003-c2:GCGTTTCTCGTCCTCA"	4.34664835509602	-6.70020391857298	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCGTTTCTCGTCCTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.61094020093	24.6648354902537	0.00989121241514375	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.84515057075	2489.84515057075
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAAAGTCATGCT"	4.38031353530232	-7.04895546352538	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAAAGTCATGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.56844664969	35.4483752731281	0.0164145643673031	1223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.01962537943	2154.01962537943
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAACAGCCTATA"	-3.36758766594585	10.7641582258972	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAACAGCCTATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.67888021127	24.0812838375978	0.0128318616954259	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1874.79037269065	1874.79037269065
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAAGTTAAACAG"	4.0370098548824	-7.25690987026366	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAAGTTAAACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2683.63285549509	32.2742591221155	0.0120263317897713	1800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2680.21923403396	2680.21923403396
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAAGTTCGTAAC"	5.52823175963704	-10.1236849061218	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAAGTTCGTAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.05570079994	42.8835763719884	0.018799881281702	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2269.55224819257	2269.55224819257
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAATCAGATGCT"	0.267547045915765	8.62497994983522	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAATCAGATGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1376.32110337703	30.867747042219	0.0224277219658116	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1371.92957173494	1371.92957173494
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAATCGAAATCC"	-3.97272620621379	11.0311555632385	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAATCGAAATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.47438171056	33.0571176999296	0.0169830736076162	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1942.61808709918	1942.61808709918
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACAATCGACATAC"	-4.18080697479899	12.6801414259705	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACAATCGACATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1758.11284023701	29.8788529225832	0.0169948436976066	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1751.5783591034	1751.5783591034
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACCTAGCCACCGT"	-0.553900579840499	8.63656327808229	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACCTAGCCACCGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1654.08269281717	29.9394093508399	0.018100309906422	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.21899011296	1650.21899011296
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACCTAGGACACTG"	4.03664102134053	-7.06713297283324	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACCTAGGACACTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.92220561259	39.4627780581358	0.0171732437076196	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2296.43026458681	2296.43026458681
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACCTCATACTGTG"	-1.65020046654399	8.61923692310182	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACCTCATACTGTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2185.10265022576	19.0992398021065	0.00874066021572633	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2172.77557948081	2172.77557948081
"healthy-4003"	"2020-08-26-Control4003-c2:GCTACCTGTGTACGCC"	4.17758001860921	-7.38703873073729	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTACCTGTGTACGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.84983766319	5.77470798637617	0.00290062458610861	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1987.54564845961	1987.54564845961
"healthy-4003"	"2020-08-26-Control4003-c2:GCTCAAAGTCTGTGTA"	3.50672235068623	-7.47774841701659	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTCAAAGTCTGTGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.01127720811	34.7482228087689	0.0161618793246011	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2147.96010347125	2147.96010347125
"healthy-4003"	"2020-08-26-Control4003-c2:GCTCAAAGTCTTCCGT"	3.03447975692098	-4.98744394695433	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTCAAAGTCTTCCGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2787.11911475817	32.9721391438295	0.0118301865784055	2601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2777.02857087332	2777.02857087332
"healthy-4003"	"2020-08-26-Control4003-c2:GCTCAAAGTTGCATAC"	3.83056129988973	-6.55910446560057	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTCAAAGTTGCATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.21487348466	38.1680177492928	0.0170224621202228	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2236.18163467436	2236.18163467436
"healthy-4003"	"2020-08-26-Control4003-c2:GCTCAAATCCTTCTTC"	5.29145445403401	-9.6566314927307	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTCAAATCCTTCTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2345.80042331464	21.1735784609081	0.00902616362861322	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.34831650616	2341.34831650616
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGAATCACCCATAA"	-0.494104782969314	8.61884400928346	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGAATCACCCATAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2088.57137654022	28.568097000673	0.0136782957583173	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2079.3617270966	2079.3617270966
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGAATTCCGGTTCT"	-0.433522890240508	8.35855577075807	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGAATTCCGGTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.01366971302	19.2568544358916	0.0104826952316038	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1830.08944881133	1830.08944881133
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGAATTCCTTCACG"	3.6001247363979	-6.53543999111327	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGAATTCCTTCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.31159431223	17.2756488527421	0.0068247816237084	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2525.15361794519	2525.15361794519
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGCAGCAGCCATTA"	3.92702426490132	-6.58454468166503	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGCAGCAGCCATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.51475954343	35.8144966495451	0.0145734614656796	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.44996243904	2452.44996243904
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGCAGGTATCGTGT"	3.85460438308064	-7.57710459148558	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGCAGGTATCGTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.54922926372	30.4615816405078	0.0136320924334905	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.58177459164	2231.58177459164
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGCAGTCATTGCCC"	-2.50726638260539	9.62634656513063	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGCAGTCATTGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2119.02422013496	33.9990044319035	0.0160446511695549	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2108.77427492137	2108.77427492137
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGGGTAGGATGTTA"	-7.05914721909221	3.33267328822938	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGGGTAGGATGTTA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2497.2361464018	27.2944925303544	0.0109298804479033	2189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2489.44631167626	2489.44631167626
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGGGTCATCATTTC"	3.21238293227498	-7.93888237392577	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGGGTCATCATTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1800.81370866469	28.365984083481	0.0157517593002523	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1800.81370866469	1800.81370866469
"healthy-4003"	"2020-08-26-Control4003-c2:GCTGGGTGTAGTCGTT"	3.86000098761861	-7.4428110352722	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTGGGTGTAGTCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.13722042545	21.3403419767245	0.0115657208257952	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1840.18841210033	1840.18841210033
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTCACAGAGTGTTA"	4.98569454726521	-8.30577757274779	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTCACAGAGTGTTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.22125184768	15.3312447067193	0.00630598498391207	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2428.6517552107	2428.6517552107
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTCACTCGAACCTA"	-0.20859075608905	8.08826730335084	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTCACTCGAACCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1915.20988940777	4.75902502226217	0.00248485821245094	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1905.25173052096	1905.25173052096
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTGGGAGCACTTTG"	-3.49972162666972	10.3118028410706	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTGGGAGCACTTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.84445569618	44.3557659408987	0.0255381337087664	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1736.84445569618	1736.84445569618
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTGGGAGGAAAGAC"	3.51472415503804	-7.16625406658324	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTGGGAGGAAAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.57326271496	27.9974636685651	0.0128867753962773	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.48002686314	2169.48002686314
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTGGGTCCGACGGT"	-3.61379394951518	10.8080634840759	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTGGGTCCGACGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1909.5170141341	29.8525944862775	0.0156335839195518	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1902.18133495692	1902.18133495692
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTTCGCATCCGTTC"	3.50893177565877	-6.5809011689392	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTTCGCATCCGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.31189149018	34.475265250088	0.0156186651206837	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.31189149018	2207.31189149018
"healthy-4003"	"2020-08-26-Control4003-c2:GCTTTCGGTAGCACGA"	4.06222261962239	-6.92564585125121	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCTTTCGGTAGCACGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.44620366633	14.752769443296	0.00580258863374248	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2542.44620366633	2542.44620366633
"healthy-4003"	"2020-08-26-Control4003-c2:GGAACCCCAACCAACT"	3.70125164565389	-7.3410215607849	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAACCCCAACCAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2010.2888032262	24.3412438006844	0.0121083317788074	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2005.08471607317	2005.08471607317
"healthy-4003"	"2020-08-26-Control4003-c2:GGAACCCCACGCGGTT"	5.60905565795247	-9.4962778321472	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAACCCCACGCGGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2717.56899290907	33.1958506785747	0.0122152743003737	1746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2708.99865338001	2708.99865338001
"healthy-4003"	"2020-08-26-Control4003-c2:GGAACCCGTGTACGCC"	-5.31544623795207	-5.23687126552733	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAACCCGTGTACGCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2674.74703204585	41.285225802703	0.0154351889386433	1965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2673.72428678322	2673.72428678322
"healthy-4003"	"2020-08-26-Control4003-c2:GGAACCCTCACAAGAA"	3.73820890960042	-7.00178434765013	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAACCCTCACAAGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.95377143283	31.4956347912657	0.0141112397552242	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2228.94681278318	2228.94681278318
"healthy-4003"	"2020-08-26-Control4003-c2:GGAACCCTCTCTGCTG"	-4.8613260788029	3.18067023837892	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAACCCTCTCTGCTG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2999.81363922458	26.7136371377925	0.00890509889964286	2896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2993.1678020682	2993.1678020682
"healthy-4003"	"2020-08-26-Control4003-c2:GGAAGTGTCCACTTTA"	-0.851195434958297	8.18552301013795	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAAGTGTCCACTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2292.23144820668	38.3060098156825	0.0167112312526953	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2290.82984957815	2290.82984957815
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATCTAGGAGATAG"	-0.381930033594924	8.38149926746217	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATCTAGGAGATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1735.22483119581	33.9196543339149	0.0195476999430325	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.23772314339	1730.23772314339
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATCTCAACAACAA"	-2.44030461731609	10.0817079314026	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATCTCAACAACAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2123.45070344104	37.3122873432983	0.0175715345229507	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2112.81661011203	2112.81661011203
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATCTCAAGCACAG"	5.09223951873128	-7.8973074189392	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATCTCAAGCACAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2706.94784360828	36.3601572824928	0.013432160271705	1838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2700.25777750123	2700.25777750123
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATCTCAGACGCTC"	4.24254049834554	-7.30045320903929	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATCTCAGACGCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.74188997156	27.7255573588439	0.0112306424059436	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.52010909927	2467.52010909927
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATCTGTTACAGCT"	-3.24291477623637	10.5686416395935	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATCTGTTACAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1802.71243921037	33.7938373929402	0.018746105400894	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1796.97247713636	1796.97247713636
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATGGAGTCTAACC"	5.35245575484578	-9.3376560441223	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATGGAGTCTAACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.75209228719	20.5597480903864	0.00804450015024231	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2546.95290120287	2546.95290120287
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATGGGTTTGAAAG"	-3.35703144493755	9.99192426288453	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATGGGTTTGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.39512159394	23.334097641203	0.0112054131318471	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2076.77221082886	2076.77221082886
"healthy-4003"	"2020-08-26-Control4003-c2:GGAATGGTCCTTGACC"	5.58572639998738	-10.166114830133	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAATGGTCCTTGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.35816574087	36.9053420900834	0.0154586532593573	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2374.65763993768	2374.65763993768
"healthy-4003"	"2020-08-26-Control4003-c2:GGACGTCAGACCGTTT"	-0.700678150088149	8.69172952258912	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGACGTCAGACCGTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1996.88902884555	33.7896501215904	0.0169211456588176	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1990.58323408513	1990.58323408513
"healthy-4003"	"2020-08-26-Control4003-c2:GGACGTCAGGTATTGA"	5.48092951354329	-9.6205682984558	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGACGTCAGGTATTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.06146154494	0	0	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2282.28563107437	2282.28563107437
"healthy-4003"	"2020-08-26-Control4003-c2:GGACGTCCAGGTTACT"	4.34028019484822	-6.73526146328124	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGACGTCCAGGTTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2627.56351437222	23.0247696056431	0.00876278327039573	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2622.66631807423	2622.66631807423
"healthy-4003"	"2020-08-26-Control4003-c2:GGACGTCTCCGCCTAT"	3.40729989585225	-6.57597925579222	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGACGTCTCCGCCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1736.05055781139	24.776899179908	0.0142719917161536	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1732.27751946104	1732.27751946104
"healthy-4003"	"2020-08-26-Control4003-c2:GGACGTCTCTCTCGAC"	5.24934496459309	-8.84345438396605	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGACGTCTCTCTCGAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.98008699538	3.00334512076777	0.00120423781105087	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2488.96136507646	2488.96136507646
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGAACCAAATAGCA"	5.55378832396809	-10.0541677705017	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGAACCAAATAGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.34083288617	16.0512741993091	0.00731485007194491	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2188.02114480696	2188.02114480696
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGAACTCCGTGGCA"	-1.50773582878764	8.95717046344606	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGAACTCCGTGGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1808.69181341397	35.2028505012478	0.0194631557682573	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1804.8582812688	1804.8582812688
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGAACTCTCATGGA"	-2.38854513588603	10.112543083075	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGAACTCTCATGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.29523644675	35.4207819585849	0.0189082752517808	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.2043681994	1864.2043681994
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGATGCAAATGGCG"	5.58425249633138	-10.0083704224792	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGATGCAAATGGCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.53651681755	0	0	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.77897537946	2354.77897537946
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGATGCAGGATCTT"	-3.88644609871562	12.8744802244934	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGATGCAGGATCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1536.0488082967	40.1932647642345	0.0261666586029933	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1529.26325138231	1529.26325138231
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGATGGTACCTAAC"	3.27406086501424	-6.21663620388182	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGATGGTACCTAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.22612244658	0	0	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2405.99554980516	2405.99554980516
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGATGGTGCCCTTT"	5.49283852156941	-10.1157207719055	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGATGGTGCCCTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.55089510305	2.12308924181249	0.000856930626938417	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2476.26678044977	2476.26678044977
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGATGTCGTAGGAG"	-4.08476052704509	10.7540340193543	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGATGTCGTAGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2423.68894463885	35.4415900208822	0.0146229944644003	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2415.24873679104	2415.24873679104
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGCAAAGCAGCACA"	5.19976915892903	-8.75639536296996	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGCAAAGCAGCACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2861.13224408149	30.7588595397552	0.0107505899468236	2183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2855.29667796082	2855.29667796082
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGCAATCATTCATC"	-3.20456085625346	-5.62833454525145	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGCAATCATTCATC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2997.6524501095	32.8340351629254	0.0109532494875202	2821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2992.55097027055	2992.55097027055
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGGATCAGATCCAT"	3.85379685935323	-6.68148186123046	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGGATCAGATCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.98893199223	0.944058901278312	0.000406923881515084	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2314.02723901146	2314.02723901146
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGGATTCATTATCC"	5.08598532256429	-8.53286077892455	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGGATTCATTATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.58695266739	8.01829700887505	0.00311561146226845	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.24979225067	2568.24979225067
"healthy-4003"	"2020-08-26-Control4003-c2:GGAGGTATCGCTCTCA"	5.10096182402913	-8.48911764537963	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGAGGTATCGCTCTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2762.75269551271	30.7210821616903	0.0111197365625913	2051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2753.73105317583	2753.73105317583
"healthy-4003"	"2020-08-26-Control4003-c2:GGATCTAAGTGCAGCA"	-3.70339808884318	12.8079766997131	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATCTAAGTGCAGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1677.61416834365	23.8225023530088	0.0142002272051203	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1675.17767502248	1675.17767502248
"healthy-4003"	"2020-08-26-Control4003-c2:GGATCTACATCCCACT"	3.6855739551479	-6.83137276088866	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATCTACATCCCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.40866255798	36.5569338364549	0.0153767984495864	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.03951446741	2376.03951446741
"healthy-4003"	"2020-08-26-Control4003-c2:GGATCTACATGAATAG"	4.00424303588216	-7.2078428498474	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATCTACATGAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.44401017405	33.1122862307545	0.0137427083140075	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2401.98051826903	2401.98051826903
"healthy-4003"	"2020-08-26-Control4003-c2:GGATCTATCACGATAC"	-4.30308280411418	12.7608670958313	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATCTATCACGATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2118.49263281844	29.8469733809429	0.0140887784637865	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2118.49263281844	2118.49263281844
"healthy-4003"	"2020-08-26-Control4003-c2:GGATCTATCGGCATTA"	-0.230855206877548	8.85876462543336	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATCTATCGGCATTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.55697910434	9.95721752118917	0.00582444319955098	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1704.94219437996	1704.94219437996
"healthy-4003"	"2020-08-26-Control4003-c2:GGATGTTAGAGTACCG"	-4.30458007279094	13.0125303038391	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATGTTAGAGTACCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1900.29330899312	37.8667055698903	0.0199267688786181	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1898.1387167654	1898.1387167654
"healthy-4003"	"2020-08-26-Control4003-c2:GGATGTTCACGGAAGT"	-2.69153366509135	10.6217527159485	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATGTTCACGGAAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1489.3339537906	50.1815020660344	0.0336939219966847	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1487.11481237948	1487.11481237948
"healthy-4003"	"2020-08-26-Control4003-c2:GGATGTTGTTCAAGTC"	-3.49167404595073	10.5360536345276	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGATGTTGTTCAAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.29915159843	5.48587573110732	0.00281861898084987	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1942.66390578517	1942.66390578517
"healthy-4003"	"2020-08-26-Control4003-c2:GGCACGTCAAATCAAG"	-1.27644787254985	8.86040303790895	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCACGTCAAATCAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.06749698078	22.619903590418	0.0125036261102304	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.06749698078	1809.06749698078
"healthy-4003"	"2020-08-26-Control4003-c2:GGCAGTCCAAAGAACT"	-1.74934945526775	9.10570142352907	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCAGTCCAAAGAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1742.53630813466	35.3471343172481	0.02028487679266	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1735.08766109121	1735.08766109121
"healthy-4003"	"2020-08-26-Control4003-c2:GGCAGTCCAATGGCCC"	3.90697183188741	-6.93491127407225	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCAGTCCAATGGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.10055713107	33.8311733201807	0.0149755057221288	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.0643340067	2256.0643340067
"healthy-4003"	"2020-08-26-Control4003-c2:GGCAGTCGTGCTCTTC"	-3.71064410629924	11.1895036467346	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCAGTCGTGCTCTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.0746150743	33.0594919659152	0.0189661943786072	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1732.28436790745	1732.28436790745
"healthy-4003"	"2020-08-26-Control4003-c2:GGCGTCAGTCGCCTAG"	5.7241641479427	-10.1812486878601	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCGTCAGTCGCCTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.45734207583	14.9275311945906	0.0061443890930128	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2419.25887476121	2419.25887476121
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTGTGAGCAAATCA"	0.0364151290500581	8.3779611357483	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTGTGAGCAAATCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.52138843992	27.3222735833216	0.0163947932338863	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1663.03788045953	1663.03788045953
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTGTGCACCGTGAC"	4.36944212493245	-7.09439661419066	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTGTGCACCGTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.59601838402	31.2776855024154	0.0119764639255995	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2604.26572189586	2604.26572189586
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTGTGCAGCAGTGA"	4.85558285292928	-8.13317396557006	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTGTGCAGCAGTGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.26747859513	30.2465387652151	0.0124406463013657	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2426.9296301453	2426.9296301453
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTGTGTCAAGATAG"	5.51300491866414	-10.1844005814758	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTGTGTCAAGATAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.49452823469	32.9505379252422	0.0132464765454686	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2477.7928897932	2477.7928897932
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTGTGTCGAATGCT"	4.93066086348836	-7.68886139309081	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTGTGTCGAATGCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2725.40279436412	37.7476343341089	0.0138502956011374	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2722.21281216403	2722.21281216403
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTGGGTGGAGAAA"	4.69366659697835	-7.57078602230223	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTGGGTGGAGAAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2915.31481092953	20.8108281458808	0.00713844970287974	2006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2909.75668710431	2909.75668710431
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTGGTCATAAGGA"	5.28370394286458	-10.334779762384	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTGGTCATAAGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2025.58848173102	26.1522611669598	0.0129109448453274	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2023.88388201837	2023.88388201837
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTGGTCGACGAGA"	3.64382185515706	-6.96480514919432	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTGGTCGACGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.744906117	25.2327167919478	0.0121618405798004	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2070.07132200505	2070.07132200505
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTTCAGCCTGAAG"	2.72698821601216	-7.29714443599852	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTTCAGCCTGAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1939.93241772563	35.8878390423684	0.0184995305581022	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1936.68675014937	1936.68675014937
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTTCCAAATGATG"	3.27578272399251	-6.72378208553465	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTTCCAAATGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.61709237272	19.6953617450812	0.00915374850613493	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.12639689126	2150.12639689126
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTTCGTTGTTGCA"	-4.93780503693278	-5.1963420144287	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTTCGTTGTTGCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2302.08802251142	34.4228848961342	0.0149528969177213	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2293.50037643735	2293.50037643735
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTTCTCATCCTGC"	5.42126574096028	-10.1363678208557	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTTCTCATCCTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.76347999273	37.347613912282	0.0153582427812402	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2430.46934274571	2430.46934274571
"healthy-4003"	"2020-08-26-Control4003-c2:GGCTTTCTCGTCGCTT"	5.59916843947713	-10.1282625428406	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGCTTTCTCGTCGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2470.52929140845	34.9290349221829	0.0141382800210678	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.08504899592	2462.08504899592
"healthy-4003"	"2020-08-26-Control4003-c2:GGGAAGTAGATGGTCG"	0.447762926190537	8.50726125324098	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGAAGTAGATGGTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1331.00295493089	17.9973359981046	0.0135216348930187	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1328.71347228696	1328.71347228696
"healthy-4003"	"2020-08-26-Control4003-c2:GGGAAGTCAAATGGAT"	-3.09961734238322	10.5801372298035	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGAAGTCAAATGGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1566.03603326146	38.6111381308476	0.024655331876646	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1563.87198873989	1563.87198873989
"healthy-4003"	"2020-08-26-Control4003-c2:GGGAAGTCACCATAAC"	3.1109959083492	-7.50419666683348	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGAAGTCACCATAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.25969614462	22.7367608981349	0.00995802664783463	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2279.36963398987	2279.36963398987
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACAACAAGTCCAT"	-1.62839696827586	8.83653066242067	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACAACAAGTCCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.55729239197	39.5875942264531	0.0211183698610453	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1868.71476216472	1868.71476216472
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACAAGTGACTGTT"	5.32831539687459	-10.2268800965515	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACAAGTGACTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.89810211469	36.8871151181405	0.0160525460568484	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2293.76764913623	2293.76764913623
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACAATCGGTATGT"	2.62366761740987	-4.34953787243041	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACAATCGGTATGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2086.21766791152	0	0	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2085.06051273553	2085.06051273553
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACAATCTCATTAC"	4.24352421340291	-6.59571173107298	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACAATCTCATTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3157.66230725439	2.91762694108592	0.000923983205671797	3081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3149.22450219708	3149.22450219708
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACAATCTTTGATC"	4.18959869918172	-6.66034843837889	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACAATCTTTGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.70469242284	32.8519200495737	0.012627074911788	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2595.77639763637	2595.77639763637
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACCTCAAAGGCTG"	10.6729561286861	6.63054273212282	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACCTCAAAGGCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1955.1703142045	39.281057261603	0.0200908621495643	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1946.24135683532	1946.24135683532
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCAGCAACCAG"	-2.43293962898906	9.34127328479616	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCAGCAACCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2308.55676511843	35.5663238296633	0.0154063024860637	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2303.9854031855	2303.9854031855
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCCAAGTTGGG"	3.78507198867146	-6.96702005779418	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCCAAGTTGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1811.47202097585	2.19819171483937	0.0012134836692952	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1809.579600902	1809.579600902
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCGTATCGTGT"	4.12254061278645	-7.56377079403075	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCGTATCGTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.4901438451	21.0157550119362	0.0102341640523216	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2053.4901438451	2053.4901438451
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCGTCAATGGG"	4.8288537460262	-7.70438864147338	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCGTCAATGGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.43581327222	30.1596501480581	0.0129084008970993	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.2907085268	2332.2907085268
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCTCACTGGGC"	-0.451217214495498	8.13589761340944	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCTCACTGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2612.40036934229	33.7107079025332	0.0129041123627694	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2606.75207900961	2606.75207900961
"healthy-4003"	"2020-08-26-Control4003-c2:GGGACTCTCTGGTCAA"	10.3899370628292	7.32695338809816	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGACTCTCTGGTCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2154.0566529112	27.5885625689427	0.0128077237577093	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2145.26259023396	2145.26259023396
"healthy-4003"	"2020-08-26-Control4003-c2:GGGAGTAAGGTGAGCT"	2.67527594146077	-4.36981680309447	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGAGTAAGGTGAGCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2410.67051950671	20.3240838368887	0.00843088413469609	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2406.33646290506	2406.33646290506
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATCCAGTGCACCC"	5.58100285109822	-9.72248365795287	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATCCAGTGCACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2947.01807088567	36.2167144298348	0.0122892746358188	2188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2938.03185245481	2938.03185245481
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATCCCAGCAGTGA"	5.50395311888997	-9.87859251415404	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATCCCAGCAGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.5218478521	0	0	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.20979758032	2224.20979758032
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATCCGTCACTCTC"	5.25761522826497	-10.2556705704895	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATCCGTCACTCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2518.92012131818	42.6730719390138	0.0169410183268069	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2516.31529163281	2516.31529163281
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATGAGTCTTCCGT"	-3.61357365074809	13.1628303297791	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATGAGTCTTCCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1577.03299462687	36.0942672799969	0.0228874521985109	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1570.14018610831	1570.14018610831
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATGAGTGTTTGCA"	4.38730110701863	-6.96796610271605	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATGAGTGTTTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2382.82280508061	34.3729129599588	0.0144252912498023	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2379.55157675738	2379.55157675738
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATGATCACCGGTG"	2.75039186057393	-7.69918873226317	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATGATCACCGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1862.55077536493	34.7227657558962	0.0186425874747458	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1862.55077536493	1862.55077536493
"healthy-4003"	"2020-08-26-Control4003-c2:GGGATGATCCGCGGAT"	4.25973095473592	-7.05986978923949	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGATGATCCGCGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2719.62163374377	32.804752878204	0.0120622488331385	1784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2708.51128737063	2708.51128737063
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCCATAGCAGTACG"	2.83963503417317	-4.71229078685912	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCCATAGCAGTACG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2692.41919686113	43.4053916107597	0.0161213349174461	2374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2685.66360387359	2685.66360387359
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCCATAGTGTTCCA"	4.93981184539143	-7.69813158428343	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCCATAGTGTTCCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.64568685926	32.1268649499183	0.0133436847146007	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2405.00318052829	2405.00318052829
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCCATTCAATCCGA"	5.58912291106526	-10.0887689820495	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCCATTCAATCCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.84413521367	36.4189648200926	0.0131673959340009	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2758.40996061322	2758.40996061322
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCCATTCGAACCAT"	-0.865160385996658	8.56242845142213	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCCATTCGAACCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1459.70368479823	12.6499826038423	0.0086661304863328	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1448.18550732003	1448.18550732003
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCGTTAGAACGTGC"	5.54468359526936	-9.54092695629271	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCGTTAGAACGTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.90655101901	0	0	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.22192776146	2371.22192776146
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCGTTAGGATATGT"	-0.0639610764687837	8.18741319263307	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCGTTAGGATATGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1987.76223793003	25.1030924982117	0.0126288204993536	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1979.36437589727	1979.36437589727
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCGTTGTTTATGCG"	-4.01430879059489	13.0232200392517	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCGTTGTTTATGCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1682.89450441058	34.4993947714942	0.020500034126368	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1675.99190717083	1675.99190717083
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCTACTCAAAGGTA"	-5.48300729218181	-5.35003473674925	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCTACTCAAAGGTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2612.54849217841	6.92986600641121	0.00265253105431659	2199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2608.34253326212	2608.34253326212
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCTCAAGCAAGCCA"	-3.83209238472636	10.4543704756531	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCTCAAGCAAGCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1535.52374487213	39.6933895147588	0.0258500655866212	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1530.62376778506	1530.62376778506
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCTCAAGTTAACAG"	4.45614208754842	-6.76907637035521	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCTCAAGTTAACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2570.92213886237	24.5719254282329	0.00955763111484427	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2563.63028763965	2563.63028763965
"healthy-4003"	"2020-08-26-Control4003-c2:GGGCTCATCAAAGAAC"	-0.271517614752609	8.56854341113893	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGCTCATCAAAGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1986.002020066	22.4661992111038	0.0113122740984711	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1978.0986924286	1978.0986924286
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTAGACAAAGGAGA"	-4.37376914444621	12.8609161146912	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTAGACAAAGGAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1792.81700025089	25.5507694199935	0.0142517442753041	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1790.62131605097	1790.62131605097
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTAGACAATCGCGC"	3.63159980353658	-7.55427362835082	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTAGACAATCGCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1731.11484796042	38.9344201074457	0.0224909515121529	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1731.11484796042	1731.11484796042
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTAGAGTGCCTGAC"	-4.14361224594768	12.921076751593	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTAGAGTGCCTGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1614.73306004542	32.230313951515	0.0199601499151869	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1612.37039422307	1612.37039422307
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTATTCAACGACTT"	6.67033781585042	-1.56001844322356	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTATTCAACGACTT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2251.60945626696	1.01741728188326	0.000451862235278618	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2248.22415348493	2248.22415348493
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTCACAGGCGACAT"	4.07175030288045	-7.42546369945677	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTCACAGGCGACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.91110000714	37.5279191411482	0.0155272236289689	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2411.37080333912	2411.37080333912
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTCACTCGGTTGTA"	-1.56860504570659	-6.34801819240721	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	51	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTCACTCGGTTGTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.38035708285	39.0534650949849	0.0164895241502034	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2346.93944074439	2346.93944074439
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTCTGAGCTATCCA"	-7.56159148636516	0.0790516839357986	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTCTGAGCTATCCA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2837.33809061479	35.8403809545734	0.0126316920331505	2613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2829.07497765778	2829.07497765778
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTCTGGTATCGTTG"	-1.3044515651768	8.79814050281373	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTCTGGTATCGTTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1911.41998984936	31.8943853789762	0.0166862257109123	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1897.47814125604	1897.47814125604
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTCTGTCAACTGAC"	-3.85506520691569	12.1514959105286	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTCTGTCAACTGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2056.36272814751	36.2585700535077	0.0176323804926048	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2052.83303768069	2052.83303768069
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGAACACTCTAGA"	5.07143892821614	-8.34335329448851	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGAACACTCTAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.90398905788	35.239985299661	0.0155522852997461	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2261.66472257367	2261.66472257367
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGAAGTTAAACCC"	5.54748262938802	-9.8147821656433	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGAAGTTAAACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2800.66470234403	33.0078034681973	0.011785703386975	1915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2792.77092799022	2792.77092799022
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGAATCCCGAGTG"	-3.03060350838359	9.47968003833619	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGAATCCCGAGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2001.95810893436	34.2459299752701	0.0171062170693967	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1998.50139919359	1998.50139919359
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGAATCTTTACAC"	6.71300139006917	-1.57311870968016	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGAATCTTTACAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2427.56783247036	1.40452089934732	0.000578571226954363	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2418.99427819926	2418.99427819926
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGTCAGCCAAGCA"	4.99397053298299	-8.61034014141234	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGTCAGCCAAGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2005.71850923579	33.7067350535363	0.0168053168469683	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2002.49531684385	2002.49531684385
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGTCAGCTGCCTG"	5.4385162788326	-9.76058676159056	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGTCAGCTGCCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.70956881724	31.8077498247929	0.0127500813009962	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2493.47498402638	2493.47498402638
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTGTCGTGAATTGA"	5.4306751686031	-9.86076071178588	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTGTCGTGAATTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.12389845262	17.5999354481034	0.00779405215992079	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2250.94579806915	2250.94579806915
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTATGTCGCAACC"	5.48874392089192	-10.1872139207092	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTATGTCGCAACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.42821126739	1.15158235361183	0.000493092593493547	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.19464242741	2331.19464242741
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTATGTGACTATC"	-3.23655281487163	10.8557376631531	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTATGTGACTATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.06977680355	33.0394553832649	0.0171716513515187	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.59238432922	1916.59238432922
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTATGTTCGGTAT"	4.06678833541219	-7.54218056118163	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTATGTTCGGTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.92087083722	28.0767971837986	0.0126135648178896	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.44633770917	2224.44633770917
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTATTCATTGCCC"	5.57093824920003	-9.85465052044066	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTATTCATTGCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.94652818067	34.1242128190899	0.0137213295229365	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2482.12084901064	2482.12084901064
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTATTCGCAGAGA"	-0.932221691042739	8.84443757617799	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTATTCGCAGAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1598.52546689324	43.8142264586096	0.0274091513498144	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1590.29880406447	1590.29880406447
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTTACACAGTCAT"	-0.772168199450332	10.0029725798401	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTTACACAGTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.18221193664	35.4195282748845	0.0211942946866571	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1666.75911741953	1666.75911741953
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTTACATACTTTC"	-4.16117129746135	12.8561115034851	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTTACATACTTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2110.9032497899	33.364408769339	0.0158057498716058	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2101.18116413742	2101.18116413742
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTTAGTCCAAGAG"	4.29800571975057	-7.71185114299925	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTTAGTCCAAGAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.92305199075	29.7010661625313	0.0128524686864607	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2306.54157244378	2306.54157244378
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTTAGTTAAGGGC"	-2.24999509277995	9.83496759021608	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTTAGTTAAGGGC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1832.0452647902	34.1588065027053	0.0186451760549798	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.97392415762	1825.97392415762
"healthy-4003"	"2020-08-26-Control4003-c2:GGGTTTATCCTGTTGC"	3.38703741607015	-6.90745499050292	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGGTTTATCCTGTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.2366951789	26.9772019891222	0.0113960729166052	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2362.00601150732	2362.00601150732
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTAGAGTCTGG"	-0.387656013399917	8.68169782245485	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTAGAGTCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.09755970635	33.1657438633862	0.0196119636463465	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.65251696619	1685.65251696619
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTAGCAACAAT"	3.9535924392635	-7.19592573558959	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTAGCAACAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.85631040061	29.2752161176165	0.012028325580485	1436	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2431.14746832564	2431.14746832564
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTAGTGGAAAG"	-3.76123605194743	10.1879548796448	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTAGTGGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1765.33496593249	35.8630844509087	0.0203151725553484	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1755.62600083018	1755.62600083018
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTCACATACTG"	-3.3998912376469	11.0470981367859	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTCACATACTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2274.0902917649	6.92638859422179	0.00304578433816112	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2269.89722541548	2269.89722541548
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTGTAAGTTAG"	6.7164441543514	-1.22159697925719	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTGTAAGTTAG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1594.44899114847	51.1613707243624	0.0320871793380553	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1585.24503472558	1585.24503472558
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTGTCGTATTG"	5.26665319976155	-10.2553882828918	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTGTCGTATTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.58058459076	40.2984148700167	0.0199835380633672	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2009.92151954042	2009.92151954042
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAACTTCCCTGTTG"	5.31297840651814	-10.1856661072937	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAACTTCCCTGTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.81839287297	30.7461755169351	0.014059775433177	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2176.44885376205	2176.44885376205
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCAGATACAGT"	2.98275866088216	-5.06638529216918	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCAGATACAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2558.13204864379	27.6407570288651	0.0108050548225292	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2555.46146098578	2555.46146098578
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCAGTGGATAT"	5.07106890258138	-7.61763431942137	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCAGTGGATAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.02164180633	29.3071016015297	0.0112243809596518	1747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2604.13273835591	2604.13273835591
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCAGTTCCTGA"	-2.98436603966411	9.37966249072877	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCAGTTCCTGA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1994.89477113485	26.3031834788321	0.0131852485952774	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1987.109007094	1987.109007094
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCCAGCCGGTT"	3.17471565779988	-6.41486694729003	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCCAGCCGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.19185947352	23.52215331088	0.0099704283127398	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2356.14803770902	2356.14803770902
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCCATTGTACG"	-4.1166447204655	13.1134795912537	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCCATTGTACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1858.25121968135	37.9525430959492	0.0204237956063106	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1858.25121968135	1858.25121968135
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCGTCAGCGTC"	-2.77635536614116	10.6329774626526	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCGTCAGCGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1505.90610790051	39.500126130503	0.02623013873393	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.90610790051	1505.90610790051
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAATCTCCGTACGG"	3.731053729623	-6.94617941295775	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAATCTCCGTACGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.53367742587	32.628277612763	0.0133039060434061	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2444.95768169552	2444.95768169552
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAGAGGTATCGGTT"	-4.13697991791423	13.0337342985901	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAGAGGTATCGGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2201.44632741798	37.8294599369792	0.0171839119881467	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2188.21962294985	2188.21962294985
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAGAGTCACTGATG"	5.43714394149129	-9.95970823681029	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAGAGTCACTGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.42695314905	32.3177041307323	0.0146736780915818	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2197.83187303459	2197.83187303459
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAGAGTCGGCATAT"	-7.08692059937175	3.55438158595888	"2020-08-26-Control4003-c2"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAGAGTCGGCATAT"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2038.1206334877	35.075439705879	0.0172096975662608	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2024.74763925116	2024.74763925116
"healthy-4003"	"2020-08-26-Control4003-c2:GGTAGAGTCTAAGGAA"	2.72785200652425	-4.6011681786743	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTAGAGTCTAAGGAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2441.4596259317	28.9241201107814	0.0118470605876775	1717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2437.2997355774	2437.2997355774
"healthy-4003"	"2020-08-26-Control4003-c2:GGTCACGAGCCATATC"	-2.88845954361613	9.83371636951295	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTCACGAGCCATATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.06048092317	39.5080937127359	0.0196747528712745	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2004.60324929817	2004.60324929817
"healthy-4003"	"2020-08-26-Control4003-c2:GGTCTGGGTCGAATGG"	-2.08004770699199	9.93576047504274	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTCTGGGTCGAATGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1407.9903262639	35.5998909659142	0.0252841871864123	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1407.9903262639	1407.9903262639
"healthy-4003"	"2020-08-26-Control4003-c2:GGTCTGGGTGGACCAA"	3.86422433432881	-6.73457672512206	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTCTGGGTGGACCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.11743901958	42.6918331511098	0.0213020616057284	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2000.69468960772	2000.69468960772
"healthy-4003"	"2020-08-26-Control4003-c2:GGTCTGGTCACTAGCA"	-1.2974068922108	8.39831063831178	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTCTGGTCACTAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.53537945816	38.9266767532369	0.0222624473090728	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1744.56584552208	1744.56584552208
"healthy-4003"	"2020-08-26-Control4003-c2:GGTCTGGTCATTATCC"	5.58852448043172	-9.83623983776244	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTCTGGTCATTATCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.3967559634	13.3289820075349	0.00504809816079006	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2636.74605815396	2636.74605815396
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGAAGAGGCGAACT"	-2.60821590843852	-5.75473406231078	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGAAGAGGCGAACT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1842.69000595645	35.982226723147	0.0195270102984415	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1840.75318118647	1840.75318118647
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGAAGGTATGAGGC"	-3.12018952789958	9.98764321887819	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGAAGGTATGAGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1679.89950185205	39.0176147368788	0.0232261600731846	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1677.86408612058	1677.86408612058
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGAAGTCATGAGTC"	-2.826159576804	10.0408086546692	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGAAGTCATGAGTC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1967.69873663952	36.7725158930706	0.0186880822802537	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1960.7582949242	1960.7582949242
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGATTAGCGCCCAT"	4.67216934737508	-7.18240978634032	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGATTAGCGCCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.99505674576	33.2783894395684	0.0149431806499819	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.40460836711	2224.40460836711
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGATTAGGGATCTG"	-0.597755233675796	7.94229123676149	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGATTAGGGATCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1800.48049235	34.7395591721894	0.0192946045901598	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1794.59884363909	1794.59884363909
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGATTCAGTTTCGA"	3.7808698612148	-6.88579275524291	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGATTCAGTTTCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.97602323197	26.0430471033358	0.011432537848395	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2275.05268541831	2275.05268541831
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGGCTCAGAAGCTG"	-3.76260123673137	10.7638082274231	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGGCTCAGAAGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1637.33656239495	24.2220552428507	0.0147935713396767	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1633.03795265279	1633.03795265279
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGGCTGTTATGTGC"	4.66205610808675	-7.87071945583495	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGGCTGTTATGTGC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.02862547796	31.8733144704126	0.0138397387326429	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.22806365345	2300.22806365345
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGGCTTCTGTTGGA"	4.70071425017659	-7.39928629314574	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGGCTTCTGTTGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.09690042627	31.7387625233572	0.0125000201914424	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2534.49568130081	2534.49568130081
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTCGAGCGTGTCC"	5.36337484893147	-10.0821647874084	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTCGAGCGTGTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.0962559228	47.0584346658651	0.0201699499308709	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.97618068101	2328.97618068101
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTAAGATGGCAC"	-0.609398047358352	8.31433961475221	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTAAGATGGCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1747.95358683493	37.4675219715896	0.0214350782845631	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1744.26023927419	1744.26023927419
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTAAGCGCTGCT"	5.2444187599117	-9.89684202587279	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTAAGCGCTGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.91201930906	30.0092728181997	0.0133202151530991	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2245.72988270313	2245.72988270313
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTACACTAGAGG"	3.99869646605794	-8.0741586915222	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTACACTAGAGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.6497684783	27.2853631107436	0.0111475765291808	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2441.28950352684	2441.28950352684
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTAGTAGTCACT"	9.77540649947469	5.5810975798401	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTAGTAGTCACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1599.97520006421	31.0595030901322	0.0194124903241536	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1599.97520006421	1599.97520006421
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTAGTCGGCACT"	3.85236348685567	-7.6969876519409	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTAGTCGGCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1953.90274053985	35.9658324768673	0.0184071764324002	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1952.22134584988	1952.22134584988
"healthy-4003"	"2020-08-26-Control4003-c2:GGTGTTAGTCGGTGTC"	3.0717622238094	-6.49327423488768	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTGTTAGTCGGTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.75239846078	15.481136593498	0.00706336016986686	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2188.79652122591	2188.79652122591
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTAACAGGCTGTAG"	4.89461054381673	-8.61337377941283	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTAACAGGCTGTAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.386339337	20.8082636525634	0.00890617416401613	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.25475967318	2332.25475967318
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTAACAGTGCACCC"	-3.24458084526713	10.2810125120911	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTAACAGTGCACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1938.02219134235	37.7359098288968	0.0194713507396732	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1924.4796156527	1924.4796156527
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTAACTCATACGGT"	-0.49045161429103	8.67191693866578	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTAACTCATACGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.69596302367	26.7953068328269	0.0154466877216462	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.09268530673	1733.09268530673
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTAACTCATGGGAG"	3.50597371634786	-6.60552980816039	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTAACTCATGGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.81436693686	21.6408326976875	0.0101228773799922	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2135.01824239317	2135.01824239317
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTCTCAGAGTGAAG"	3.55967654761617	-7.13828422939452	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTCTCAGAGTGAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.77161680771	14.3189922762694	0.00641023109458822	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2230.93180420555	2230.93180420555
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTCTCAGCGTTGTT"	-3.65324674072917	12.7626857527527	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTCTCAGCGTTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1527.43876693038	24.8428837672966	0.0162644056869279	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1518.09828537036	1518.09828537036
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTCTCTCAATCTTC"	14.2739235359127	1.98704562270967	"2020-08-26-Control4003-c2"	"Control4003"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTCTCTCAATCTTC"	"Plasmablast"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1407.43262784966	3.03852582273916	0.00215891387098334	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1392.47784436672	1392.47784436672
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTCTCTCGTGGGTC"	-3.32472763481792	9.91472528064577	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTCTCTCGTGGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2097.31836471798	38.2588816428211	0.0182418092963038	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2085.15043459691	2085.15043459691
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTGTAAGCGCCATC"	-1.0083888572758	10.5369043120178	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTGTAAGCGCCATC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1738.15091129132	40.5894933657477	0.0233521112016636	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1734.41438502413	1734.41438502413
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTGTACACATTACG"	3.91334213790242	-7.26491739666136	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTGTACACATTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.81331057178	40.9386478313436	0.0182858694103834	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.78322009135	2231.78322009135
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTGTATCGAGCACC"	-3.87405119362529	11.4226226576599	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTGTATCGAGCACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.29749861744	34.6013966754438	0.0186199447080928	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1856.23103593786	1856.23103593786
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTGTATCGCGAAGA"	-0.868098120123702	9.34252736652223	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTGTATCGCGAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1624.63551507243	2.98312766512831	0.00183618272372638	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1614.6333959316	1614.6333959316
"healthy-4003"	"2020-08-26-Control4003-c2:GGTTGTATCGGTCTGG"	3.95908393439595	-6.50168754970702	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GGTTGTATCGGTCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.11303966817	35.1474236297944	0.0148544989358258	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.91886238932	2361.91886238932
"healthy-4003"	"2020-08-26-Control4003-c2:GTAACACAGAGAATCT"	-1.03009078922923	8.42022130573121	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAACACAGAGAATCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2276.43783173919	28.9914819134852	0.0127354595452913	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2260.82708538499	2260.82708538499
"healthy-4003"	"2020-08-26-Control4003-c2:GTAACACCACTAGGTT"	4.13660969313924	-7.41200401699217	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAACACCACTAGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.35504302168	28.5840625003145	0.0141340476287517	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2020.89323760085	2020.89323760085
"healthy-4003"	"2020-08-26-Control4003-c2:GTAACACTCTAGACAC"	3.92401256141011	-7.69762613689574	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAACACTCTAGACAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.06210998013	33.0878101102317	0.0157256812682893	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2104.06210998013	2104.06210998013
"healthy-4003"	"2020-08-26-Control4003-c2:GTAACCACAAGTACCT"	3.93001451072041	-7.31650116359862	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAACCACAAGTACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.936688357	34.1119220880216	0.0174759367409271	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1948.31095551744	1948.31095551744
"healthy-4003"	"2020-08-26-Control4003-c2:GTAACCACAGCAGATG"	-2.87748585167583	9.72248551929323	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAACCACAGCAGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1692.71175728973	34.4481224775692	0.0203508496524685	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1690.59142070061	1690.59142070061
"healthy-4003"	"2020-08-26-Control4003-c2:GTAAGTCTCCCATTTA"	2.67033161696736	-4.39664127742919	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAAGTCTCCCATTTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2384.80609333383	20.0653976800985	0.00841384871339717	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2380.23564319547	2380.23564319547
"healthy-4003"	"2020-08-26-Control4003-c2:GTAAGTCTCTCCATAT"	-2.89472208443339	10.8326205977234	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAAGTCTCTCCATAT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1897.93422214451	35.3720859829228	0.0186371506294645	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1892.45549409313	1892.45549409313
"healthy-4003"	"2020-08-26-Control4003-c2:GTAATCGCACCCAACG"	4.97765841063802	-7.4772143593994	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAATCGCACCCAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.36736606132	30.0344031605262	0.01302238472608	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.14865932448	2300.14865932448
"healthy-4003"	"2020-08-26-Control4003-c2:GTAATCGGTCCGTTTC"	-0.0223361951416314	7.96327445590822	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAATCGGTCCGTTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1596.98372735726	33.3607475592727	0.0208898481479703	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1585.42160365053	1585.42160365053
"healthy-4003"	"2020-08-26-Control4003-c2:GTAATCGTCGTCTACC"	4.08449282225911	-7.41917517101439	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAATCGTCGTCTACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2110.06108068042	22.1932753761776	0.0105178355164112	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.90774552104	2100.90774552104
"healthy-4003"	"2020-08-26-Control4003-c2:GTAATGCAGGTTAAAC"	-4.29889188233073	12.989324546698	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAATGCAGGTTAAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1955.76690046595	14.7959782834105	0.00756530764473285	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1951.64792679298	1951.64792679298
"healthy-4003"	"2020-08-26-Control4003-c2:GTAATGCAGTTAGTGA"	9.60172810134236	6.80422828281251	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAATGCAGTTAGTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.67248545412	32.8149179645003	0.0177409342586635	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1841.1338610537	1841.1338610537
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAACCACCATTCC"	-3.79778657379802	10.7332725294861	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAACCACCATTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.63237522413	44.3106298696458	0.0229039017629963	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1927.29155095274	1927.29155095274
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAACCATAGCACT"	3.85310115393941	-7.73281719600829	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAACCATAGCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1664.53589226903	12.84865884077	0.00771906385464311	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1660.23359275926	1660.23359275926
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAACGTCCTGGTG"	4.18934883651082	-6.68806221401366	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAACGTCCTGGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.29787692634	37.9937609411214	0.0158750656604083	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.97851838263	2391.97851838263
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAACTCACCTCAC"	9.83933319625203	7.21658608997194	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAACTCACCTCAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2168.69512520233	7.0168867374044	0.00323553396503796	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2154.42390569632	2154.42390569632
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAGTAGATTACCC"	-0.807504217058975	8.46226403796998	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAGTAGATTACCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.13040277904	26.6906863018218	0.0147533236193597	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.97343568977	1800.97343568977
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAGTCAGTAGAAT"	2.82866420325581	-6.39726545726927	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAGTCAGTAGAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2061.23428953907	29.3702288341014	0.0142488551559411	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2061.23428953907	2061.23428953907
"healthy-4003"	"2020-08-26-Control4003-c2:GTACAGTGTGGAGAAA"	2.69973673400227	-6.04561426555785	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTACAGTGTGGAGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2641.83604158903	35.5087209601466	0.0134409253266106	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2635.68007370604	2635.68007370604
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAAAGTTCGGTCG"	3.40678562697713	-6.15324880993041	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAAAGTTCGGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.77647573643	41.2726823832324	0.0164185967931541	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.3344178669	2510.3344178669
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGAGCAAGTCG"	5.43207659301106	-9.58164694225463	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGAGCAAGTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.36956346747	37.9107951432025	0.0134992187767462	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2803.72696932345	2803.72696932345
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGCACCTCGTT"	4.03389515456502	-6.6697077981201	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGCACCTCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.42411824823	36.7246238588133	0.0145534884894053	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.92661290048	2511.92661290048
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGCAGTTCTAG"	5.56081451949422	-10.1051597825256	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGCAGTTCTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.30947360487	36.1025901934374	0.0163337263964925	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2208.79082449226	2208.79082449226
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGGTAGCCAGA"	-3.64664040032085	10.5736140974793	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGGTAGCCAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.77485790071	40.8755433051532	0.0207408487789895	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1963.09764329989	1963.09764329989
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGGTGCAGATG"	5.58615221556966	-10.130681060907	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGGTGCAGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.52780836896	16.0541216369135	0.00639471970132988	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2503.50142917394	2503.50142917394
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGAGGGTTAGAAAC"	0.571554024785203	8.91717908466188	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGAGGGTTAGAAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1882.37897139683	39.5276945749846	0.0209987973599454	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.43403392164	1864.43403392164
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCCACGTACTA"	-4.26015315476115	12.7857246168884	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCCACGTACTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1802.23645462895	43.0492010290724	0.0238865443646436	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1793.75599388797	1793.75599388797
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCCAGGACTAG"	-3.09815535965617	10.0977639921936	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCCAGGACTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1491.98168046623	40.4114700535656	0.0270857682655577	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1487.19196143577	1487.19196143577
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCCATATGCGT"	4.24552549895589	-6.98330213939818	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCCATATGCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1893.75834493416	34.5156756327467	0.0182260190298708	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1887.85741291782	1887.85741291782
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCTCAAGCCGC"	2.80408610877339	-4.78370716488036	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCTCAAGCCGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2090.34343802873	21.7696011639276	0.0104143657773562	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2088.95141113875	2088.95141113875
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCTCCCATACC"	5.41536488112752	-9.34495451366576	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCTCCCATACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.85416289283	34.8996485178351	0.014683125730928	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.8355822602	2368.8355822602
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGATCTCGACACTA"	3.6141218143398	-6.79522135173949	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGATCTCGACACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.32406268998	49.491824283888	0.0215902389585401	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2286.65919667637	2286.65919667637
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGCTAAGCTGTCCG"	-4.25367818298991	12.8035783537659	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGCTAAGCTGTCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1603.77774271054	29.675586600177	0.0185035530858673	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1597.04299708932	1597.04299708932
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGCTAGTCGAACAG"	5.37094082412068	-10.0509491196838	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGCTAGTCGAACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.02679406265	30.5043215867121	0.0129748932099577	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2342.2536650526	2342.2536650526
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGCTATCACTGCTC"	-3.59018931809123	10.3738126524719	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGCTATCACTGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.07279775952	48.1586327694921	0.0276603211717881	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1741.07279775952	1741.07279775952
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGAGAGACAGTCG"	3.65969552573506	-6.80489256298216	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGAGAGACAGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.79415425672	29.6384557301051	0.0133579114012196	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2215.78235573244	2215.78235573244
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGAGCAAATGAAC"	-0.886978248984176	8.5297231444153	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGAGCAAATGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.25747106405	35.4142595811996	0.019412972205367	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.57903837609	1816.57903837609
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGAGCAACCTATG"	-4.38953051987346	13.117459274176	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGAGCAACCTATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.99051030047	33.5874129641526	0.0174753271590825	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1919.93851710082	1919.93851710082
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGAGGTACCAGAG"	-3.84465680542644	10.2572412260803	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGAGGTACCAGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1895.13100139961	35.1334722561423	0.0185388093119659	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1889.46693716106	1889.46693716106
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGAGTCACTCCGT"	-4.42628322067912	12.7540797957214	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGAGTCACTCCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2149.61980684476	37.6657391013903	0.0175220469133454	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2145.82292059647	2145.82292059647
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGTTCACAAGTTC"	3.74984635886495	-7.0741873017517	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGTTCACAAGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.86865396543	15.8584262148986	0.00758098563446451	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2084.18619095612	2084.18619095612
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGGTTCATGGGATG"	4.75391449508016	-7.10646345531615	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGGTTCATGGGATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.90824963425	26.1518780869124	0.0111716800908359	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.64788368375	2336.64788368375
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGTACCAATGGCAG"	4.1732984977657	-7.13470604335936	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGTACCAATGGCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.04680146314	35.9733019798212	0.0167704042425945	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2141.45287552236	2141.45287552236
"healthy-4003"	"2020-08-26-Control4003-c2:GTAGTACTCCGATTAG"	5.37425531920735	-10.0443420640198	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTAGTACTCCGATTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.27785069629	0	0	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2265.56703520839	2265.56703520839
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTGGCAGACCCGT"	5.54490913924519	-10.0776682130066	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTGGCAGACCCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.73313806672	13.8530595744643	0.00658498900064625	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2098.93408325869	2098.93408325869
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTGGCAGCGCGTT"	4.76640381392781	-7.5345726243225	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTGGCAGCGCGTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.96336372164	0	0	1480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2422.23143392077	2422.23143392077
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTGGGTACGGATG"	2.64544691619222	-4.29437878048094	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTGGGTACGGATG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2400.20548083792	36.4781732606515	0.0151979376565363	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2397.99075793262	2397.99075793262
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTGGGTCAAGCCC"	3.35324253615682	-6.8933840028015	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTGGGTCAAGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.0570499011	36.2181385767579	0.017345377885376	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2084.93275430893	2084.93275430893
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTGGGTTGGGATG"	5.491706986993	-9.93450167095336	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTGGGTTGGGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.50727634616	35.6599114901548	0.0168246232924613	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2109.85953558878	2109.85953558878
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTTCAGATGATTG"	-0.837276260287124	8.1500558623108	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTTCAGATGATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.27913282464	5.22263431723854	0.00298730003646529	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1744.45470907094	1744.45470907094
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTTCAGGTAAACT"	5.49958481368367	-9.64910128032836	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTTCAGGTAAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.15292771428	14.4780391080941	0.00625900645592006	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.79241463283	2308.79241463283
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTTCCAGCTCCTT"	3.11510481414143	-6.06567957317504	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTTCCAGCTCCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.3306558935	35.6770158815272	0.0139290941602702	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2554.04487809719	2554.04487809719
"healthy-4003"	"2020-08-26-Control4003-c2:GTATTTCCATTCGGGC"	-4.20519957962688	12.8460607298645	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTATTTCCATTCGGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2166.49731276943	38.7353406728769	0.017879247042943	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2161.01038756223	2161.01038756223
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAAACAGCTTGTGT"	3.38400401648824	-7.64670326625975	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAAACAGCTTGTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1897.03395380932	34.0214003043439	0.0179339965086168	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1895.37263040241	1895.37263040241
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAAACCACAAATAG"	-4.32302842560466	13.1381683119568	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAAACCACAAATAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1944.19097543154	30.6677571406233	0.0157740456200894	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1936.02951864023	1936.02951864023
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAAACCACTCACTC"	-2.66537938538249	9.49820706928102	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAAACCACTCACTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2190.6118300127	35.3197251003984	0.0161232239397674	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2180.87522520672	2180.87522520672
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAAACCATAATCGC"	3.67507090148274	-5.74793722545775	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAAACCATAATCGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.36187046651	41.6960194102233	0.0172200693827684	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2416.58434990067	2416.58434990067
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACGGCAACTGGTT"	2.73664965209309	-4.43312408840331	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACGGCAACTGGTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2525.97608884053	27.8654716971169	0.0110315659044531	1940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2522.2934937423	2522.2934937423
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACGGCATCTCCCA"	4.55083813247029	-7.38667108928832	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACGGCATCTCCCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.85191096493	21.2629740431886	0.00927359239447795	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.02082701184	2283.02082701184
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACGGGTACAGCGA"	5.45965447005574	-9.96323969280394	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACGGGTACAGCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.82769739603	33.283878429302	0.0133948436200151	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2483.60937601324	2483.60937601324
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACGGGTCTGATCA"	-3.10005031052287	9.41963574970094	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACGGGTCTGATCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1952.68154208916	40.513092950986	0.0207474143006654	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.44363122424	1945.44363122424
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACGGTCATATGGC"	-0.832843641669113	8.24923608386842	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACGGTCATATGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2137.40220256823	36.4238550770485	0.0170411797242853	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2132.68348902668	2132.68348902668
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACTCCAGCAGATG"	5.51680388030354	-10.2138147584167	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACTCCAGCAGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.23848799621	32.4177177502859	0.0154794775934538	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2089.78495275909	2089.78495275909
"healthy-4003"	"2020-08-26-Control4003-c2:GTCACTCTCTGTGCTC"	3.44655837592427	-6.29668238079222	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCACTCTCTGTGCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2621.19897834483	28.3063047619721	0.0107989912234157	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2615.48519458361	2615.48519458361
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAGCGCACGCCAGT"	-1.13020120087321	8.57324311817018	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAGCGCACGCCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1970.19193226311	34.8407305676846	0.017683927132756	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1962.24243279434	1962.24243279434
"healthy-4003"	"2020-08-26-Control4003-c2:GTCAGCGCACTCTAGA"	-1.21914909306224	9.00082299793092	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCAGCGCACTCTAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1732.09656953012	41.5797138448545	0.0240054247414936	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1726.11216774765	1726.11216774765
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATCCAGAGCAGAA"	3.31203593787495	-6.78038647091063	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATCCAGAGCAGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.24180489209	33.4595234008263	0.0144456089731897	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2313.14207637271	2313.14207637271
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATCCGTCGTTGGC"	4.45956196364705	-7.46096708690795	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATCCGTCGTTGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.27443077213	24.9702001887021	0.0123843261649357	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2011.13307839186	2011.13307839186
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATCCTCCTGTTAT"	3.83524241027181	-6.6961298218933	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATCCTCCTGTTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.3700015431	36.8747638663469	0.0152477759163478	1455	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2417.06140666958	2417.06140666958
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATCCTCTGCTTAT"	-1.50881801071818	9.13623426044313	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATCCTCTGCTTAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2050.04928664117	25.1432770589203	0.0122647183278776	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2042.8467353893	2042.8467353893
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATTTCAGAGTAAT"	-4.02872310105022	13.076500869635	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATTTCAGAGTAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1803.89860950619	27.152562213479	0.0150521554096169	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1801.69390900295	1801.69390900295
"healthy-4003"	"2020-08-26-Control4003-c2:GTCATTTTCGCCAACG"	4.24161352690999	-7.13801338588866	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCATTTTCGCCAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.63284007751	8.4053150947704	0.00378509897857632	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2218.997449273	2218.997449273
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCACTAGCGACTGA"	0.551126529544038	8.46134755695192	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCACTAGCGACTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1707.21904419392	34.4505916862025	0.0201793623398038	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1701.05059750073	1701.05059750073
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCACTCAGATTAAG"	2.77083077010457	-6.99612476741942	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCACTCAGATTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1791.62096273254	42.0191799054813	0.0234531637994426	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1791.62096273254	1791.62096273254
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCACTTCTTCTAAC"	5.24673428115193	-10.0480966798035	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCACTTCTTCTAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.14506352383	5.10994556956434	0.00257798768798483	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1978.36785006849	1978.36785006849
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCCATTCAAATAGG"	-2.05137668076213	8.31004140460817	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCCATTCAAATAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2453.23450159509	33.2896746092965	0.0135697074974494	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2444.9331759994	2444.9331759994
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCTCAGTAGACGTG"	-3.74275861206706	10.2373647459778	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCTCAGTAGACGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.37775854597	35.7983008036653	0.0176139994905655	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2026.9369262237	2026.9369262237
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCTCAGTTCGGCCA"	2.54182924804036	-3.97900583660277	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCTCAGTTCGGCCA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2851.54600116505	30.449075906565	0.0106780938810471	2853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2842.335061331	2842.335061331
"healthy-4003"	"2020-08-26-Control4003-c2:GTCCTCATCCACTTCG"	2.81371440467183	-6.92710115825804	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCCTCATCCACTTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1587.14597645848	35.7746613898971	0.0225402464048858	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1587.14597645848	1587.14597645848
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGAATCACGTGTGC"	3.16783775862996	-7.06276180660399	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGAATCACGTGTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.98352898798	36.7291333577206	0.0191798690702739	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1902.78361576468	1902.78361576468
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGAATGTCGTATTG"	4.26236404952351	-7.11964514171752	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGAATGTCGTATTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.8295193725	33.7392111002448	0.0164997672327219	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2042.94443552855	2042.94443552855
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGAATTCCATGATG"	5.56553616103475	-10.1195583573547	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGAATTCCATGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.54823013782	37.4698538830713	0.0158398181891596	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2356.18290388089	2356.18290388089
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGCGAAGATGCTAA"	5.32580008086507	-10.1189003220764	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGCGAAGATGCTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1785.23979410781	33.3227449969823	0.0186656969595704	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1783.31305754781	1783.31305754781
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGCGACACACAGCC"	4.11523546752278	-7.56254436885985	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGCGACACACAGCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.78152919757	14.5836119695497	0.0062116563181814	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2344.95559089287	2344.95559089287
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGCGAGTACAGTCT"	-0.392056385905105	8.3623475798401	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGCGAGTACAGTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1452.19946231273	31.0266865044692	0.0213653064263342	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1452.19946231273	1452.19946231273
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTAACACTCACTC"	-3.26837287369426	-5.71462299739989	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTAACACTCACTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2027.61948285798	0	0	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2024.65076276631	2024.65076276631
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTAAGTTCCGGTG"	-4.1335633796757	12.1450414427551	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTAAGTTCCGGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1620.40674473677	27.1254255790016	0.0167398868630407	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1615.58351671961	1615.58351671961
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTTCAGCAAATGT"	-1.17210815373119	9.07634732807008	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTTCAGCAAATGT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1565.39050828999	36.0513059299868	0.0230302315869851	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1561.16222186118	1561.16222186118
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTTCAGCTGGCTC"	0.667578836053055	8.49331090534059	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTTCAGCTGGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1582.49308170981	31.5043317593587	0.0199080375917472	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1578.61225123359	1578.61225123359
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTTCCAGCTATTG"	10.2690187889034	7.01005790317384	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTTCCAGCTATTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1587.49878969244	39.8723893963216	0.0251164849102319	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1581.95089497129	1581.95089497129
"healthy-4003"	"2020-08-26-Control4003-c2:GTCGTTCCATGTGGTT"	-1.7948502105778	9.25703904712526	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCGTTCCATGTGGTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1616.05365854479	34.1572872830502	0.021136233380894	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1613.9802791803	1613.9802791803
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTACCCATCCGGCA"	5.32148756560628	-9.17476465618285	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTACCCATCCGGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.68927611788	4.11910982585269	0.00168354431682817	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2444.04320956123	2444.04320956123
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTACCGTATCGTAC"	-0.128533149988014	8.11710546100465	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTACCGTATCGTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1469.50206691619	46.9629951369491	0.0319584410217964	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1465.10834662875	1465.10834662875
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTAGACACGAAGAC"	6.88604178008382	-1.6261116496292	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTAGACACGAAGAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2329.56027003837	30.1756525281024	0.0129533684602225	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2323.96324471258	2323.96324471258
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTAGACACTGGCCA"	3.3591853576595	-6.93005325710448	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTAGACACTGGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.07839308828	29.1635815729588	0.0116047241714255	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2507.56831071302	2507.56831071302
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTAGATCCGTTGAA"	5.54477037963216	-10.0849704972473	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTAGATCCGTTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.74526786618	38.2620695874062	0.0141829808926586	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2691.40101448612	2691.40101448612
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTCACGTCGCGTTG"	3.529060502618	-7.00871851360472	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTCACGTCGCGTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.40377105496	20.124470225011	0.00986782044371765	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2039.40377105496	2039.40377105496
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTGTCAGCGACATG"	-5.45869050446208	-2.91605212604674	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTGTCAGCGACATG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2859.48968000675	31.3990389216988	0.0109806442531468	1946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2856.1411620246	2856.1411620246
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTGTCGTGCTTATG"	-0.334700832993346	8.4064321287903	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTGTCGTGCTTATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2003.14758574443	20.848930672302	0.0104080851659035	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2001.56724114144	2001.56724114144
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTGTCGTTTCGTTT"	-3.17388639870341	10.1256456145081	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTGTCGTTTCGTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2072.00869214733	24.8020580698215	0.011970055031052	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2062.7215315758	2062.7215315758
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTGTCTCATTCATC"	5.39160837706868	-10.2416839829651	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTGTCTCATTCATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2072.71666074675	18.5129561915713	0.00893173511950325	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2070.97708577495	2070.97708577495
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTGTCTCTAGTGAC"	3.79921378669087	-7.85659458553465	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTGTCTCTAGTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2000.20364015849	24.0537390871633	0.0120256450914455	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2000.20364015849	2000.20364015849
"healthy-4003"	"2020-08-26-Control4003-c2:GTCTTTAGTACTCGAT"	4.47108377990071	-7.44760754024657	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTCTTTAGTACTCGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.0481206141	25.2589564496651	0.0126354919569948	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1996.08382482675	1996.08382482675
"healthy-4003"	"2020-08-26-Control4003-c2:GTGACGCAGTCAGCGA"	0.462356676428956	8.23088643634645	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGACGCAGTCAGCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1685.64985659354	25.2724658449868	0.0149927137869895	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1682.39096507745	1682.39096507745
"healthy-4003"	"2020-08-26-Control4003-c2:GTGACGCCAATACGAA"	5.33979906615559	-9.42440225994261	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGACGCCAATACGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.89525333407	7.74100862756893	0.00315973044848924	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2442.45631902247	2442.45631902247
"healthy-4003"	"2020-08-26-Control4003-c2:GTGACGCCAGCAGGAT"	3.62978543814961	-7.34840109264525	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGACGCCAGCAGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.09135539975	10.8718478710408	0.00476607297875431	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2276.42425906252	2276.42425906252
"healthy-4003"	"2020-08-26-Control4003-c2:GTGACGCTCATCGCAA"	5.43136133727376	-9.5282831422058	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGACGCTCATCGCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.89280799151	17.3434280418645	0.00695157242279546	1514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2493.05013549396	2493.05013549396
"healthy-4003"	"2020-08-26-Control4003-c2:GTGAGCCCAAAGGGTC"	4.63260664519612	1.72172210300294	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGAGCCCAAAGGGTC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2245.99553910816	36.0811458475405	0.0160646560597656	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2235.68850587007	2235.68850587007
"healthy-4003"	"2020-08-26-Control4003-c2:GTGAGCCCAAGACGAC"	-3.56803427162822	10.3676757582459	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGAGCCCAAGACGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1954.05430338545	35.193636301378	0.0180105722959715	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.21795572826	1950.21795572826
"healthy-4003"	"2020-08-26-Control4003-c2:GTGAGGACAATAAGGT"	-4.23347077789958	12.8839807280335	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGAGGACAATAAGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1973.53851632861	23.4001637638765	0.0118569582353062	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1969.26220712693	1969.26220712693
"healthy-4003"	"2020-08-26-Control4003-c2:GTGAGTTCACGACCTG"	5.42785086211507	-10.1410274735657	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGAGTTCACGACCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2600.73586898541	42.8058853522548	0.0164591436841889	1648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2592.22783114673	2592.22783114673
"healthy-4003"	"2020-08-26-Control4003-c2:GTGATGTAGCGTTACT"	-3.72543201866801	10.2331580885681	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGATGTAGCGTTACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.41133187339	29.8004228528787	0.0148674188670777	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1995.07048117036	1995.07048117036
"healthy-4003"	"2020-08-26-Control4003-c2:GTGATGTCAACTTGCA"	2.68945636328999	-4.36859848415526	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGATGTCAACTTGCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2615.64943994882	27.338590510298	0.0104519321636744	2226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2610.06073303068	2610.06073303068
"healthy-4003"	"2020-08-26-Control4003-c2:GTGATGTGTCATAACC"	4.37208904799764	-7.55525114452513	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGATGTGTCATAACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.6576638648	0.567542076130183	0.000270302195399568	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2093.49609042065	2093.49609042065
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCAGCAGCCTGAAG"	4.35319962081258	-7.10788824474486	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCAGCAGCCTGAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.96182473939	26.5494782352916	0.011283429232105	1404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2346.39777615218	2346.39777615218
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCAGCGTAAGTCAA"	-3.99733958664592	13.1225023039612	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCAGCGTAAGTCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2103.89009514718	43.9482824582891	0.0208890581117616	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2094.51996377537	2094.51996377537
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCAGCTCAGACCTA"	-0.949215154082137	8.20039842212526	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCAGCTCAGACCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2744.26955500774	34.7003449481967	0.0126446561653813	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2738.2758281471	2738.2758281471
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCAGCTCGCATTAG"	-1.00703630867656	9.34139440143434	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCAGCTCGCATTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1836.58237750037	40.0775661093636	0.0218218178505612	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.81838049854	1821.81838049854
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGAGAAAGCGA"	5.54837765273396	-9.99322798168334	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGAGAAAGCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.00930503696	10.5658096465702	0.00492806146957841	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.99576641508	2140.99576641508
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGAGCGATGGT"	3.63781776007954	-6.76210262691649	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGAGCGATGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1948.56064361921	43.6880649078683	0.0224206852637253	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1946.92545852386	1946.92545852386
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGCATAACGGG"	0.72600563344304	8.88468263233034	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGCATAACGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1657.04589102366	46.4936090043716	0.0280581299867619	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1651.03500973804	1651.03500973804
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGCATCTCCCA"	-7.48852096024211	-0.670227252599321	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGCATCTCCCA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2944.35475976917	31.6797229773004	0.0107594789222288	2653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2933.61801553891	2933.61801553891
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGGTCAGGTAG"	2.4581376510555	-4.37524940883788	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGGTCAGGTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2236.76083134264	48.6537002420054	0.0217518563273483	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2231.36306006591	2231.36306006591
"healthy-4003"	"2020-08-26-Control4003-c2:GTGCGTGTCCTACGAA"	5.40766968306844	-10.1837997666565	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GTGCGTGTCCTACGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.52991910832	35.2636608477377	0.0158379460994892	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2222.02808766941	2222.02808766941
"healthy-4003"	"2020-08-26-Control4003-c1:AAACCCACATATCTGG"	-0.884071092039901	8.29036614978639	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAACCCACATATCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2153.3276394955	30.2335896440102	0.0140404038333403	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2146.17963106916	2146.17963106916
"healthy-4003"	"2020-08-26-Control4003-c1:AAACCCATCTTCTGTA"	-0.889364759356338	8.58605382526246	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAACCCATCTTCTGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1877.04042907872	43.1216680745766	0.0229732228494094	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1869.94344604446	1869.94344604446
"healthy-4003"	"2020-08-26-Control4003-c1:AAACGAACAGAAACCG"	-0.128160010010558	8.65110299671022	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAACGAACAGAAACCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.34549766243	17.1720864889303	0.00858027087726097	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1992.78314047392	1992.78314047392
"healthy-4003"	"2020-08-26-Control4003-c1:AAACGAAGTGACAACG"	-1.47988114777263	8.81148145282594	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAACGAAGTGACAACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2022.85912888283	35.2743081688786	0.0174378470874339	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2012.64480576457	2012.64480576457
"healthy-4003"	"2020-08-26-Control4003-c1:AAACGCTTCAATCGGT"	5.65265669402425	-10.1538000336853	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAACGCTTCAATCGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.10011204602	8.59962708360236	0.00372423310654231	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2307.75779385816	2307.75779385816
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGAACGTAACACCT"	-2.16770825806316	9.59576890552369	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGAACGTAACACCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1774.37382691873	39.9963891180784	0.0225411288823696	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1764.65792459387	1764.65792459387
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGGATAGGTGCAGT"	-0.297155241400558	8.12517926776735	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGGATAGGTGCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1806.71541348149	30.3519817316215	0.0167995366094398	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1795.70286820056	1795.70286820056
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGGATGTACGTACT"	2.63145174559895	-4.35498192226561	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGGATGTACGTACT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2379.86344149241	14.7108676742668	0.0061813915108682	1855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2375.35657078493	2375.35657078493
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGGGCCAGATTAAG"	5.52639975127522	-10.0326395264831	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGGGCCAGATTAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.7438981106	35.7521455708384	0.0158634464194493	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2248.56256866378	2248.56256866378
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGGGCTCACTCTTA"	-3.16009126129802	9.87145898425905	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGGGCTCACTCTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.01511233097	30.818724648839	0.0172459227883302	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1777.24307747671	1777.24307747671
"healthy-4003"	"2020-08-26-Control4003-c1:AAAGTCCGTCGAGTGA"	10.0338818031246	6.27332542026369	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAAGTCCGTCGAGTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1695.1079145784	38.2195915036691	0.0225469960791109	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1685.1145462172	1685.1145462172
"healthy-4003"	"2020-08-26-Control4003-c1:AAATGGACAACAGCTT"	0.102857579558533	8.24637982929078	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAATGGACAACAGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1846.18942276785	34.9238185209402	0.0189167038280295	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.89455967774	1837.89455967774
"healthy-4003"	"2020-08-26-Control4003-c1:AACAAAGCACGTCGGT"	3.91471662101094	-6.96687414562377	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAAAGCACGTCGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.19523441184	3.77030894688486	0.00158669998671977	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2373.33385181905	2373.33385181905
"healthy-4003"	"2020-08-26-Control4003-c1:AACAAAGGTCTTACAG"	5.26958765563313	-9.31058599865111	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAAAGGTCTTACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.47145861692	29.5970816184605	0.0105385018343879	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2803.46086941456	2803.46086941456
"healthy-4003"	"2020-08-26-Control4003-c1:AACAACCAGGAAAGTG"	-4.25798116150554	13.0929174193176	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAACCAGGAAAGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2229.06399800482	31.7359860738911	0.014237359762796	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2223.99733923188	2223.99733923188
"healthy-4003"	"2020-08-26-Control4003-c1:AACAACCAGGTGCATG"	5.58877052840535	-10.0966940156189	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAACCAGGTGCATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.09816693678	3.70233438130679	0.00156276106789356	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2363.73286835284	2363.73286835284
"healthy-4003"	"2020-08-26-Control4003-c1:AACAACCTCCCGATCT"	-4.22785935822185	13.1014270552429	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAACCTCCCGATCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2358.16150347911	34.6414959428553	0.0146900438717819	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2346.09879463622	2346.09879463622
"healthy-4003"	"2020-08-26-Control4003-c1:AACAAGATCCCGTTGT"	0.0903467173570811	8.44068429553834	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAAGATCCCGTTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1583.22828623291	29.6656089953273	0.0187374172463232	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1577.35959544833	1577.35959544833
"healthy-4003"	"2020-08-26-Control4003-c1:AACAGGGCAGTGACCC"	-3.58485207977946	12.2882013090881	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAGGGCAGTGACCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1822.73593673157	8.30959028346819	0.00455885579255572	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1813.89563496989	1813.89563496989
"healthy-4003"	"2020-08-26-Control4003-c1:AACAGGGGTCAAAGAT"	0.282825593918008	8.55937287891237	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAGGGGTCAAAGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1535.60289352109	33.9028464613183	0.0220778735207903	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1530.78862135695	1530.78862135695
"healthy-4003"	"2020-08-26-Control4003-c1:AACAGGGTCCAAGCAT"	-0.97453878346141	8.39898870075075	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACAGGGTCCAAGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2125.91738108275	26.8814711818479	0.0126446452816322	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2113.95642623789	2113.95642623789
"healthy-4003"	"2020-08-26-Control4003-c1:AACCATGAGCTGTCCG"	3.10783900794331	-3.72369005596312	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCATGAGCTGTCCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2566.54309095729	30.7157363111953	0.0119677461950342	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2562.63904134564	2562.63904134564
"healthy-4003"	"2020-08-26-Control4003-c1:AACCCAAGTCAGTCCG"	-2.85449872437175	9.85375306690065	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCCAAGTCAGTCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1616.72192225937	40.0499937686481	0.0247723453348602	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1614.08128813136	1614.08128813136
"healthy-4003"	"2020-08-26-Control4003-c1:AACCCAAGTTATGTGC"	-0.872286955744582	8.3212680586609	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCCAAGTTATGTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1864.29032918393	29.8523284375069	0.0160127035849477	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1859.57234711489	1859.57234711489
"healthy-4003"	"2020-08-26-Control4003-c1:AACCCAATCTGTGCAA"	-3.85479388657268	12.5322608717713	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCCAATCTGTGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1867.48930107608	46.1592583521013	0.0247172812853618	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1861.42844128804	1861.42844128804
"healthy-4003"	"2020-08-26-Control4003-c1:AACCTGACAAGTTTGC"	2.43541945990865	-3.98679687893065	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCTGACAAGTTTGC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2560.57056910086	26.9997940781111	0.0105444444312238	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2556.51279302389	2556.51279302389
"healthy-4003"	"2020-08-26-Control4003-c1:AACCTGACACGAAAGC"	0.175179858773392	8.8862323530945	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCTGACACGAAAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1580.11624740278	38.3303879938804	0.0242579544744784	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1575.5570777119	1575.5570777119
"healthy-4003"	"2020-08-26-Control4003-c1:AACCTTTAGCTGTGCC"	4.97844328460042	-7.6973972550598	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCTTTAGCTGTGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.61140238549	33.6034782617251	0.0143078068290029	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2339.81712097756	2339.81712097756
"healthy-4003"	"2020-08-26-Control4003-c1:AACCTTTTCCTCCACA"	0.402133275836152	8.77637956226198	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCTTTTCCTCCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.30422938699	31.649706658137	0.0182177111658242	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1731.96504888687	1731.96504888687
"healthy-4003"	"2020-08-26-Control4003-c1:AACCTTTTCTTCGGTC"	-7.04743848267253	3.40590427005617	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACCTTTTCTTCGGTC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2792.07530106998	35.7846270353486	0.0128164978292796	2352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2774.98029093858	2774.98029093858
"healthy-4003"	"2020-08-26-Control4003-c1:AACGAAAAGTTACGTC"	5.37219967421834	-9.43226435100707	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACGAAAAGTTACGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.16255064117	36.053711340232	0.0132884450036773	1774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2709.59072057151	2709.59072057151
"healthy-4003"	"2020-08-26-Control4003-c1:AACGAAACAAGAAACT"	-3.97074637833293	12.4820127257141	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACGAAACAAGAAACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2001.90348066037	24.6977277803145	0.0123371221534454	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2001.90348066037	2001.90348066037
"healthy-4003"	"2020-08-26-Control4003-c1:AACGAAATCCATTGCC"	5.00233139571492	-7.79049827968749	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACGAAATCCATTGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.91291607392	33.0824179253372	0.0133941637010927	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.72796080867	2467.72796080867
"healthy-4003"	"2020-08-26-Control4003-c1:AACGGGAGTCTGGTTA"	-1.57243118706401	10.3969449766907	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACGGGAGTCTGGTTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1729.18637342983	33.7428650169743	0.0195137236422037	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1723.51081909101	1723.51081909101
"healthy-4003"	"2020-08-26-Control4003-c1:AACTTCTCAGTGCCTG"	4.81083454665486	-7.97487738048705	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AACTTCTCAGTGCCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.26152184433	30.026893771745	0.0115877511855204	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2583.76431675739	2583.76431675739
"healthy-4003"	"2020-08-26-Control4003-c1:AAGAACATCTACTCAT"	-3.1974016231602	10.4325065382752	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGAACATCTACTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1688.935359275	32.5983615935803	0.0193011303923281	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1678.51578268377	1678.51578268377
"healthy-4003"	"2020-08-26-Control4003-c1:AAGACAATCTCATTTG"	0.0400851844692647	8.30955789172975	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGACAATCTCATTTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.54684612147	45.1663735954332	0.026972296236469	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1666.22635234171	1666.22635234171
"healthy-4003"	"2020-08-26-Control4003-c1:AAGACTCCAAGTACCT"	4.7999173599178	-7.91126730358275	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGACTCCAAGTACCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2533.56938114134	12.6875770219601	0.00500778747817222	1598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2525.48789877849	2525.48789877849
"healthy-4003"	"2020-08-26-Control4003-c1:AAGATAGCACTTGAAC"	-4.08936295929607	12.3265170820984	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGATAGCACTTGAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1882.33253900986	30.2002781819154	0.0160440716802363	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1878.21990460936	1878.21990460936
"healthy-4003"	"2020-08-26-Control4003-c1:AAGATAGGTGGTCTAT"	3.88003220137898	-7.06040146267089	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGATAGGTGGTCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.78014500411	36.8952147011209	0.0154906046968736	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.36887991497	2375.36887991497
"healthy-4003"	"2020-08-26-Control4003-c1:AAGCGAGGTATCGCAT"	-0.494646946818191	8.48591897571412	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGCGAGGTATCGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.72990121122	31.2682461581705	0.0171640406941672	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1817.33706354689	1817.33706354689
"healthy-4003"	"2020-08-26-Control4003-c1:AAGGTAACATCTAACG"	-1.63272414627727	9.58437154376832	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGGTAACATCTAACG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1606.47126864526	36.8726745887984	0.022952588887502	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1604.67601949737	1604.67601949737
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTACCAGGTGCCTC"	-1.24897942963298	8.94442269885866	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTACCAGGTGCCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2282.32714444775	22.5319662380853	0.00987236483292906	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2263.17454493955	2263.17454493955
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTACCGTGGGAGAG"	-4.48022017899211	12.592372871283	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTACCGTGGGAGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1700.79375340358	34.7875228392148	0.0204536986154842	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1698.60341641804	1698.60341641804
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTACCGTTCCCAAA"	11.0233017402584	5.56363389575807	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTACCGTTCCCAAA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.80159748476	12.1480668426036	0.00752294700570379	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1614.80159748476	1614.80159748476
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTACCTCTGACGCG"	-1.31020996990855	8.56202123248903	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTACCTCTGACGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1877.0807656056	34.8828524354115	0.018583565009339	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1867.88612294644	1867.88612294644
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTCGTTCATGGTAC"	0.21564326164071	8.32522771442262	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTCGTTCATGGTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1402.38964633825	19.573251743258	0.0139570709141823	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1398.50180180752	1398.50180180752
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTGAATCTCTGCCA"	0.195981417864007	8.61529061878053	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTGAATCTCTGCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1604.84632626336	37.0444432328667	0.0230828601010783	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1595.29202217283	1595.29202217283
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTTCGCACTCGATA"	-2.96424899521526	13.2278184660706	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTTCGCACTCGATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1827.94735439271	27.6142976649883	0.0151067248182114	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1817.46539498624	1817.46539498624
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTTCGGTCTATGAC"	0.214409400790375	8.50824067676393	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTTCGGTCTATGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1566.28187331133	35.1532350894603	0.0224437476347355	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1564.46452830282	1564.46452830282
"healthy-4003"	"2020-08-26-Control4003-c1:AAGTTCGGTTGCTCCT"	-4.09712396088298	13.114402747992	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AAGTTCGGTTGCTCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2149.37042066493	36.7782693923578	0.0171111824368459	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2132.20503587469	2132.20503587469
"healthy-4003"	"2020-08-26-Control4003-c1:AATCGACAGTACCCTA"	5.55788101729695	-9.9355154267517	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATCGACAGTACCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.31815419799	13.8092841075001	0.00540836796417077	1461	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.64448553189	2545.64448553189
"healthy-4003"	"2020-08-26-Control4003-c1:AATCGACTCACCTTGC"	5.59299482878987	-9.94569303905638	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATCGACTCACCTTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1961.72118200555	13.2089757316508	0.00673336040453348	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1958.39430644039	1958.39430644039
"healthy-4003"	"2020-08-26-Control4003-c1:AATGAAGCAGAGGTTG"	4.23887123641316	-6.75499584591063	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGAAGCAGAGGTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.42008449366	35.7295794980996	0.0152663104093253	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2334.97097153352	2334.97097153352
"healthy-4003"	"2020-08-26-Control4003-c1:AATGAAGGTTTCCATT"	2.99652924117391	-5.05615427410277	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGAAGGTTTCCATT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2567.26761083944	27.4428996767186	0.0106895360502544	1986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2567.26761083944	2567.26761083944
"healthy-4003"	"2020-08-26-Control4003-c1:AATGACCTCCATGCAA"	-3.68051801148112	10.2476005324158	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGACCTCCATGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.84197114814	6.23685963121337	0.00324019307802873	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1919.21938046827	1919.21938046827
"healthy-4003"	"2020-08-26-Control4003-c1:AATGCCAGTAGTGATA"	2.71348084983174	-7.61106064235839	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGCCAGTAGTGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1911.90990986076	28.5837693803503	0.0149503746138499	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1910.07095283347	1910.07095283347
"healthy-4003"	"2020-08-26-Control4003-c1:AATGCCAGTGAATGAT"	-3.52993855896648	12.8196820982727	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGCCAGTGAATGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2111.80966992481	6.63529264484901	0.00314199368406398	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2109.87725986764	2109.87725986764
"healthy-4003"	"2020-08-26-Control4003-c1:AATGGAAAGGAGCAAA"	4.98816217955892	-7.62085392391356	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGGAAAGGAGCAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.8078538118	1.62534187199439	0.000661566540286263	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2453.14952700784	2453.14952700784
"healthy-4003"	"2020-08-26-Control4003-c1:AATGGAATCGACGCGT"	10.9043966728145	5.65892169559327	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATGGAATCGACGCGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1832.13026983697	31.9040724649915	0.0174136484671641	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1820.49439259786	1820.49439259786
"healthy-4003"	"2020-08-26-Control4003-c1:AATTCCTAGGGCCTCT"	-0.776415507227737	8.73330972278444	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATTCCTAGGGCCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2647.89420882249	30.305473563308	0.0114451224910472	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2637.80225829448	2637.80225829448
"healthy-4003"	"2020-08-26-Control4003-c1:AATTCCTTCGTGGTAT"	-4.33466277542766	13.0364274748596	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AATTCCTTCGTGGTAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2097.2889568987	31.4476246936233	0.0149944167636898	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2081.63249494403	2081.63249494403
"healthy-4003"	"2020-08-26-Control4003-c1:ACAACCACACAGTACT"	9.76236404952351	7.44692609393922	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAACCACACAGTACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1868.34603416995	17.5436958415439	0.0093899607035792	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1863.58735082446	1863.58735082446
"healthy-4003"	"2020-08-26-Control4003-c1:ACAAGCTAGAATCTAG"	-3.53996334496196	10.0673322447571	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAAGCTAGAATCTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1887.27038949481	44.6068968311921	0.0236356682537327	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.45891786877	1882.45891786877
"healthy-4003"	"2020-08-26-Control4003-c1:ACAAGCTAGCCTCACG"	-0.419935624033767	8.45315549457399	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAAGCTAGCCTCACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1787.55076261948	15.1223490059038	0.00845981514043467	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1784.4553319559	1784.4553319559
"healthy-4003"	"2020-08-26-Control4003-c1:ACAAGCTAGCGTGCTC"	5.45604481276814	-9.57632925426634	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAAGCTAGCGTGCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2507.40367078792	39.2938482664648	0.0156711297523614	1462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2496.97790820931	2496.97790820931
"healthy-4003"	"2020-08-26-Control4003-c1:ACAAGCTCATTCACAG"	5.75107588347737	-1.87823774730834	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAAGCTCATTCACAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2968.15574586354	36.5126555921193	0.0123014621597953	2512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2956.79651319371	2956.79651319371
"healthy-4003"	"2020-08-26-Control4003-c1:ACAAGCTGTGTTGATC"	2.97106208381001	-6.56374123012694	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAAGCTGTGTTGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.34097047194	29.5128186961496	0.0136548647804078	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.8827054419	2154.8827054419
"healthy-4003"	"2020-08-26-Control4003-c1:ACACCAAAGAATCCCT"	-1.27305303040202	9.0555095442566	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACACCAAAGAATCCCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2018.5536614872	33.798058173095	0.0167437006099673	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2007.12346197607	2007.12346197607
"healthy-4003"	"2020-08-26-Control4003-c1:ACACCAATCATTCGTT"	2.68295301970784	-4.43690969860228	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACACCAATCATTCGTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2850.1374640865	31.4224040354682	0.0110248731618773	2469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2846.19398949934	2846.19398949934
"healthy-4003"	"2020-08-26-Control4003-c1:ACACGCGAGTCTGCAT"	3.27854051169698	-6.66781904613646	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACACGCGAGTCTGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.36489647876	33.3452298072176	0.0141451286803439	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.59900552975	2354.59900552975
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGAAAAGAGATGCC"	3.26595940169637	-6.84016230022582	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGAAAAGAGATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.29176192207	19.1361216707181	0.00908521887454741	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.80928371572	2100.80928371572
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGAAACAGTTACCA"	-3.65842185440715	11.0732831724915	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGAAACAGTTACCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.06517459598	38.9601045214637	0.0215837660987416	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1799.16586574906	1799.16586574906
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGAAATCCGCAAAT"	2.93314208564107	-4.80749514019164	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGAAATCCGCAAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2491.65291673589	35.1587682190007	0.0141106202966099	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2485.5024972177	2485.5024972177
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGCCGAGTAAGACT"	0.157666375010651	8.53720281207887	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGCCGAGTAAGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1548.44249786275	12.8861850134677	0.00832203006004675	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1537.95315442085	1537.95315442085
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGCCGCAGTAGAAT"	-1.56838295880015	8.71688363635866	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGCCGCAGTAGAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2202.08118608663	35.5491775281588	0.0161434454609433	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2189.33273171146	2189.33273171146
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGGGAGTGCCTTTC"	2.99157371100728	-4.98246385967406	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGGGAGTGCCTTTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2666.97350028113	35.8207059085391	0.0134312192846173	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2664.99285514185	2664.99285514185
"healthy-4003"	"2020-08-26-Control4003-c1:ACAGGGATCGTTGTGA"	-2.97065768662151	10.9087142714295	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACAGGGATCGTTGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1603.25476849659	37.2157535411437	0.0232126261355467	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1596.65837719802	1596.65837719802
"healthy-4003"	"2020-08-26-Control4003-c1:ACATCCCGTTTCCAAG"	-4.61429009857829	-4.11232283031615	"2020-08-26-Control4003-c1"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACATCCCGTTTCCAAG"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3444.72983118457	37.3582663842632	0.0108450497470266	3756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3433.14762045895	3433.14762045895
"healthy-4003"	"2020-08-26-Control4003-c1:ACATCGACAGCCCAGT"	-3.18767295303996	-5.60652496730956	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACATCGACAGCCCAGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2748.69961271953	35.335286338814	0.0128552738812568	1916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2744.24195268125	2744.24195268125
"healthy-4003"	"2020-08-26-Control4003-c1:ACATTTCCAGACAAGC"	2.71102537688557	-4.3715481988159	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACATTTCCAGACAAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2796.33648553193	31.183941429053	0.0111517128179662	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2783.79354394345	2783.79354394345
"healthy-4003"	"2020-08-26-Control4003-c1:ACCAACACACACAGCC"	10.1574093299801	6.16269252384035	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCAACACACACAGCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.65212661944	35.0649703881391	0.0187347690788421	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1862.70087257831	1862.70087257831
"healthy-4003"	"2020-08-26-Control4003-c1:ACCACAATCAGTGTCA"	4.82093872603719	-7.78065206920775	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCACAATCAGTGTCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.71879669303	17.1079854419308	0.00696092061669152	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.90551744162	2450.90551744162
"healthy-4003"	"2020-08-26-Control4003-c1:ACCATTTAGGACATCG"	4.46781744536702	-7.5727167359558	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCATTTAGGACATCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.46132606496	34.1458103890014	0.0155175689681689	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2194.64661456337	2194.64661456337
"healthy-4003"	"2020-08-26-Control4003-c1:ACCCTCACAGGAATAT"	-1.0546375316685	8.18458554828493	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCCTCACAGGAATAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2557.3470792255	32.1033536693868	0.0125533815609845	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2543.45807857634	2543.45807857634
"healthy-4003"	"2020-08-26-Control4003-c1:ACCCTCAGTTAAGGGC"	2.72792090949361	-4.58339741146239	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCCTCAGTTAAGGGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2579.03176836601	36.9868379489355	0.0143413657802165	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2572.32706603364	2572.32706603364
"healthy-4003"	"2020-08-26-Control4003-c1:ACCCTCATCCTCTCGA"	2.77632560309712	-6.30603554165038	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCCTCATCCTCTCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.67063898585	19.9560454031351	0.00842144265739636	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2364.68451512551	2364.68451512551
"healthy-4003"	"2020-08-26-Control4003-c1:ACCCTTGAGTACTGGG"	3.29607190665547	-3.58697750484618	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCCTTGAGTACTGGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2384.62205095895	26.658880851537	0.011179499426677	1599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2380.24119858293	2380.24119858293
"healthy-4003"	"2020-08-26-Control4003-c1:ACCCTTGGTCCACAGC"	4.31994976577107	-6.7411942712036	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCCTTGGTCCACAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.8280734278	4.24757666044047	0.00175677365447189	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2416.47671735788	2416.47671735788
"healthy-4003"	"2020-08-26-Control4003-c1:ACCGTTCAGCATGAAT"	0.291536440222901	8.58033940875856	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCGTTCAGCATGAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1638.70069443596	35.1497186704386	0.0214497490541048	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1621.67604153701	1621.67604153701
"healthy-4003"	"2020-08-26-Control4003-c1:ACCGTTCAGTCCGCCA"	-2.61848817291911	9.00137517536012	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCGTTCAGTCCGCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.48065312378	36.6541964924705	0.018043094053644	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2022.14875625408	2022.14875625408
"healthy-4003"	"2020-08-26-Control4003-c1:ACCTACCTCGTTCCTG"	0.150167529552621	8.35916898334352	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCTACCTCGTTCCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.50363768546	25.356977108073	0.0139132655670722	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.67411534989	1816.67411534989
"healthy-4003"	"2020-08-26-Control4003-c1:ACCTGAAAGCACCTGC"	2.79794039305989	-4.63059427654418	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCTGAAAGCACCTGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2436.30659865393	15.0312200631043	0.00616967506118037	1859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2428.74187452049	2428.74187452049
"healthy-4003"	"2020-08-26-Control4003-c1:ACCTGAACATTGAAAG"	5.65677895125691	-9.93095495617064	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACCTGAACATTGAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.24391645597	24.8653158900608	0.00955533635137678	1548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2597.72845312473	2597.72845312473
"healthy-4003"	"2020-08-26-Control4003-c1:ACGATGTAGTCACTGT"	5.393722196191	-9.88430025493773	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGATGTAGTCACTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.45334568819	50.6956364181784	0.0197840231914791	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.0039317906	2556.0039317906
"healthy-4003"	"2020-08-26-Control4003-c1:ACGATGTCAATAAGGT"	-3.9381836456364	12.8977498778137	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGATGTCAATAAGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1695.27791630235	34.0543741272823	0.0200877825398445	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1686.27903827313	1686.27903827313
"healthy-4003"	"2020-08-26-Control4003-c1:ACGATGTCATTGAGCT"	-3.58079276505168	11.4380264052185	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGATGTCATTGAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1632.29004351582	18.6675226917942	0.0114364005134687	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1627.78210049666	1627.78210049666
"healthy-4003"	"2020-08-26-Control4003-c1:ACGGAAGCAGAGAGGG"	-8.33224044266399	2.24197051608888	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGGAAGCAGAGAGGG"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2126.81621667393	25.7021689733063	0.0120848095720754	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2122.3813241633	2122.3813241633
"healthy-4003"	"2020-08-26-Control4003-c1:ACGGAAGTCCTTTAGT"	-4.17753634873088	13.2009162672791	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGGAAGTCCTTTAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2299.01227320633	43.1714278259171	0.0187782502638439	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2291.98321943929	2291.98321943929
"healthy-4003"	"2020-08-26-Control4003-c1:ACGGGTCCAGAGTAAT"	10.6465612846309	6.22934243762819	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGGGTCCAGAGTAAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1441.46935883669	38.7618709342623	0.0268905271531712	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1432.81249238403	1432.81249238403
"healthy-4003"	"2020-08-26-Control4003-c1:ACGGTCGAGAACCGCA"	4.03349389609639	-6.90912916576537	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGGTCGAGAACCGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.65691118059	28.1725773627547	0.0122135967538993	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.10320436021	2301.10320436021
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTAACTCGTTATCT"	-2.01293883743938	8.81466672504274	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTAACTCGTTATCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1853.58228172241	19.5960158693034	0.0105719697811818	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.58228172241	1853.58228172241
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTACAGTTTCCATT"	-3.20244822922404	9.72368524158327	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTACAGTTTCCATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1925.32791819005	29.2351945904182	0.0151845274325537	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1919.75372116165	1919.75372116165
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTAGTGTAGATTAG"	-2.58855019035991	10.6298751601013	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTAGTGTAGATTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1561.73531290145	35.5577012632864	0.0227680714968441	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1555.32819575539	1555.32819575539
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTAGTGTATGTCCA"	-3.87377319756206	10.8614234694275	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTAGTGTATGTCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1877.5486722721	37.5166923812874	0.0199817415843003	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1873.64998699487	1873.64998699487
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTCCTTCGGCATAT"	-3.6408625644749	10.3152036436829	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTCCTTCGGCATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1826.77093253335	27.6462127168089	0.0151339241414737	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1822.83364247132	1822.83364247132
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTCCTTCTCACGAA"	-0.838580052286941	8.75465390765993	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTCCTTCTCACGAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1771.55472793029	34.569611920608	0.019513713787999	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1762.9514458297	1762.9514458297
"healthy-4003"	"2020-08-26-Control4003-c1:ACGTTCCCAACGAGGT"	3.33598866042439	-6.43927910244139	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACGTTCCCAACGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.49735626644	19.390382354908	0.00907153512871571	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2133.09282551608	2133.09282551608
"healthy-4003"	"2020-08-26-Control4003-c1:ACTACGATCTGGGCAC"	0.96666451272313	8.7558908232483	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTACGATCTGGGCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.26983475171	37.6183316314957	0.0208380658156124	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.0861639903	1801.0861639903
"healthy-4003"	"2020-08-26-Control4003-c1:ACTATCTAGGTGAGCT"	5.60385527190511	-9.84932711040648	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTATCTAGGTGAGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.12799443707	23.7380669314209	0.0105169343475097	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2254.07014696305	2254.07014696305
"healthy-4003"	"2020-08-26-Control4003-c1:ACTATGGAGTGGCCTC"	-8.09113154831584	0.0500600634138062	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTATGGAGTGGCCTC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2872.51134041688	9.90796335629219	0.00344923385223409	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2853.24970984215	2853.24970984215
"healthy-4003"	"2020-08-26-Control4003-c1:ACTATGGTCACTGTCC"	-2.34821973267253	9.60033319080202	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTATGGTCACTGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1827.28347035613	29.7458777097308	0.0162787428400113	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.944914154	1821.944914154
"healthy-4003"	"2020-08-26-Control4003-c1:ACTCCCATCTTGCAAG"	-3.35739551010783	-5.67780353939208	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTCCCATCTTGCAAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2491.84339512494	36.7480232573858	0.0147473245426578	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2487.83681465377	2487.83681465377
"healthy-4003"	"2020-08-26-Control4003-c1:ACTCTCGCATGACGAG"	-0.331488589674789	8.33963010394899	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTCTCGCATGACGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1672.0770915211	35.2552506603986	0.0210847040720633	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1668.30612310824	1668.30612310824
"healthy-4003"	"2020-08-26-Control4003-c1:ACTGATGAGTGCTAGG"	5.61692585524861	-9.92361071026	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTGATGAGTGCTAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.81106483772	24.9130419730818	0.0112789375106251	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2198.43253228332	2198.43253228332
"healthy-4003"	"2020-08-26-Control4003-c1:ACTGATGTCCTTGGAA"	6.81703629073445	-1.60609247600707	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTGATGTCCTTGGAA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2759.03217515477	27.4211940975807	0.00993870036910406	1960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2748.12676715195	2748.12676715195
"healthy-4003"	"2020-08-26-Control4003-c1:ACTGTCCTCGACGTCG"	-0.132771979004699	8.01338956439821	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTGTCCTCGACGTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1750.20276801109	35.5115618216187	0.0202899700941358	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1737.32970695161	1737.32970695161
"healthy-4003"	"2020-08-26-Control4003-c1:ACTGTGACACTAAACC"	0.532154222100419	8.79699704730836	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTGTGACACTAAACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1782.50281717124	27.8743250211002	0.01563774528297	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1772.80913771935	1772.80913771935
"healthy-4003"	"2020-08-26-Control4003-c1:ACTGTGATCAGTAGGG"	-3.58033667030986	11.0710420378479	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTGTGATCAGTAGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1890.49991309158	41.8337167492	0.0221283886127179	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.14507726455	1881.14507726455
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTATCTCAAGTAAG"	10.129845281213	7.46226642215577	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTATCTCAAGTAAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.77718902074	37.7140705856512	0.0193526847492516	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1943.64965967312	1943.64965967312
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTCGCAGAAACTCA"	-0.25893814387973	7.89470813358156	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTCGCAGAAACTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1770.71626494033	9.0835483575395	0.00512987232194742	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1759.72711270954	1759.72711270954
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTTCAAGCTTTGTG"	5.05963100966756	-7.94126417553099	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTTCAAGCTTTGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2635.5908385302	3.18739578991396	0.00120936669809169	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2632.14903704657	2632.14903704657
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTTCACAGACGGAT"	-3.95379672470744	10.7528810271057	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTTCACAGACGGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1821.03322883736	34.1217138914555	0.018737556982	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1814.46937286268	1814.46937286268
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTTCACATCGATAC"	-1.5114303630894	8.65558431232301	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTTCACATCGATAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.8318796079	40.1303951886375	0.0223464098417718	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.84432426506	1785.84432426506
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTTGTAGTATAACG"	-0.273297707468826	8.53489492023317	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTTGTAGTATAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.88048871682	26.7947740223901	0.0163994699780237	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1632.0080326225	1632.0080326225
"healthy-4003"	"2020-08-26-Control4003-c1:ACTTTGTTCAAGGTGG"	10.9931723075802	5.14696977222291	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ACTTTGTTCAAGGTGG"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1565.12132911489	28.4238286192919	0.0181607828674638	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1563.590107807	1563.590107807
"healthy-4003"	"2020-08-26-Control4003-c1:AGAAATGTCACTGAAC"	-2.4646044773167	10.9765233763489	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAAATGTCACTGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1453.33711989855	35.0887774589332	0.0241435913103097	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1451.0012269432	1451.0012269432
"healthy-4003"	"2020-08-26-Control4003-c1:AGAACCTCAATGCAAA"	-2.37676320496257	9.43733403766481	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAACCTCAATGCAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.21490829207	43.307648653626	0.0227549965402961	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1895.79838659388	1895.79838659388
"healthy-4003"	"2020-08-26-Control4003-c1:AGAACCTGTTGGGAAC"	2.58538236197774	-6.04472067272338	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAACCTGTTGGGAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.27226184453	18.1160793241973	0.00772121787347699	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.69588501039	2336.69588501039
"healthy-4003"	"2020-08-26-Control4003-c1:AGAACCTTCCACTAGA"	-4.30851970139201	3.57189271533815	"2020-08-26-Control4003-c1"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAACCTTCCACTAGA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2809.15942817375	31.4265559686585	0.0111871742320759	2638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2795.28593848877	2795.28593848877
"healthy-4003"	"2020-08-26-Control4003-c1:AGAAGCGAGTGACCTT"	-3.77828369560893	11.390899635199	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAAGCGAGTGACCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1811.34929411444	42.9446015988356	0.0237086252432781	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.38368646741	1807.38368646741
"healthy-4003"	"2020-08-26-Control4003-c1:AGAAGCGCATTAAGCC"	4.7780348258907	-8.13085558330687	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAAGCGCATTAAGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.48424363132	30.5838298521348	0.0126825750294269	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2406.54553073015	2406.54553073015
"healthy-4003"	"2020-08-26-Control4003-c1:AGAAGTATCATTACTC"	-0.315792809159118	8.51635739887086	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAAGTATCATTACTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1622.20038622558	27.9218637478996	0.0172123394772863	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1615.90540071321	1615.90540071321
"healthy-4003"	"2020-08-26-Control4003-c1:AGACAAACACGCAGTC"	10.0920082527095	5.93583104694215	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACAAACACGCAGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.15530184275	39.1523511017784	0.0208018706338663	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1872.81058860809	1872.81058860809
"healthy-4003"	"2020-08-26-Control4003-c1:AGACAAATCGGCTTCT"	-4.85903106156047	2.72813961589662	"2020-08-26-Control4003-c1"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACAAATCGGCTTCT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3093.67033847091	27.5581647285204	0.00890791898083794	3311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3073.21786231387	3073.21786231387
"healthy-4003"	"2020-08-26-Control4003-c1:AGACACTCAACGATTC"	-2.62118611756023	9.15729043567506	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACACTCAACGATTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1761.26369240443	29.593045653591	0.0168021664110905	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1759.37286778977	1759.37286778977
"healthy-4003"	"2020-08-26-Control4003-c1:AGACACTGTCTTCGAA"	10.0079666572506	6.7483076819214	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACACTGTCTTCGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1661.43588788254	29.457326243251	0.0177300408990163	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1657.51759555059	1657.51759555059
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCATAGTCGCGAA"	-3.51464257660564	-5.1258115998474	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCATAGTCGCGAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2533.66761352014	30.4282593500375	0.0120095703113015	2133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2526.15465165844	2526.15465165844
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCATGTTATTCCT"	-4.08334432068523	13.084053970221	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCATGTTATTCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2211.14949740428	35.0364636086989	0.0158453617224114	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2200.40158440521	2200.40158440521
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCATTCTTCGTGC"	-1.82923422280009	9.68159768665162	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCATTCTTCGTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2099.94506124072	37.3730900571301	0.0177971751485007	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2088.73546124269	2088.73546124269
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCCGGTCCCAAAT"	2.71053995665852	-4.08678009426268	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCCGGTCCCAAAT"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2726.03434936075	29.8085103174323	0.0109347522801473	2347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2713.56352397341	2713.56352397341
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCCGTCCCGAAAT"	-0.327421377331573	8.08471200549928	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCCGTCCCGAAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1630.24319460912	41.1566189529398	0.025245692844501	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1626.65588319599	1626.65588319599
"healthy-4003"	"2020-08-26-Control4003-c1:AGACCCGTCGCACTCT"	-3.61259804192241	10.7232274779114	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGACCCGTCGCACTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1735.24924943122	13.716775822449	0.00790478706557294	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1728.66206278152	1728.66206278152
"healthy-4003"	"2020-08-26-Control4003-c1:AGAGAATTCCTTGACC"	-4.25731597366984	13.110137916449	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAGAATTCCTTGACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1842.97178378149	36.7609512211423	0.0199465621474218	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1838.69682648188	1838.69682648188
"healthy-4003"	"2020-08-26-Control4003-c1:AGAGCAGCATTCTCTA"	0.120765869587105	8.14150045001832	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGAGCAGCATTCTCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1504.1879129244	38.1549231277852	0.0253657955897315	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1500.0864039595	1500.0864039595
"healthy-4003"	"2020-08-26-Control4003-c1:AGATAGACAAAGCGTG"	0.325469394295853	8.23245523059694	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATAGACAAAGCGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.02940817583	33.23180495745	0.0184720743343191	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1791.27928020779	1791.27928020779
"healthy-4003"	"2020-08-26-Control4003-c1:AGATAGACAGTGTGGA"	0.424877514212769	8.48795602405397	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATAGACAGTGTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.71064015353	39.6605901544288	0.0221603365731941	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1780.56027661097	1780.56027661097
"healthy-4003"	"2020-08-26-Control4003-c1:AGATCCAAGGATTCAA"	-3.92856274071391	10.3682012327942	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATCCAAGGATTCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2095.12430923233	34.5349908231226	0.0164835044254613	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2084.66892397732	2084.66892397732
"healthy-4003"	"2020-08-26-Control4003-c1:AGATCCAGTACATACC"	-4.04548011246379	12.6990861662659	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATCCAGTACATACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2232.82937597513	38.3511398391893	0.0171760279812874	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2225.78574344957	2225.78574344957
"healthy-4003"	"2020-08-26-Control4003-c1:AGATGAAAGTCGAGGT"	2.6503766971523	-4.27626087581786	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATGAAAGTCGAGGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2137.33305634349	31.5464032089162	0.0147597039756102	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2134.10014604322	2134.10014604322
"healthy-4003"	"2020-08-26-Control4003-c1:AGATGAACAAATGGCG"	4.42093576964681	-7.287473701593	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATGAACAAATGGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2608.68326100515	37.8700440171389	0.0145169191611814	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2604.02036237165	2604.02036237165
"healthy-4003"	"2020-08-26-Control4003-c1:AGATGAAGTGGCATCC"	-0.113101224333602	8.76138780200807	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATGAAGTGGCATCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2113.70295559648	35.2145662801299	0.0166601301223012	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2100.05744272909	2100.05744272909
"healthy-4003"	"2020-08-26-Control4003-c1:AGATGAATCCTACTGC"	-3.27643046799358	10.479935623053	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGATGAATCCTACTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.76178430069	28.682936981454	0.0165820156519702	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1723.56490372312	1723.56490372312
"healthy-4003"	"2020-08-26-Control4003-c1:AGCATCAGTACTCGAT"	-2.31516156616862	9.97090146625368	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCATCAGTACTCGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1604.00823541107	29.2940930088699	0.0182630564869653	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1599.75479312254	1599.75479312254
"healthy-4003"	"2020-08-26-Control4003-c1:AGCCAATTCGCAGTTA"	2.59142913398091	-4.39668371593627	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCCAATTCGCAGTTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2465.42546974097	34.5294289174545	0.014005464509573	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2462.52562821669	2462.52562821669
"healthy-4003"	"2020-08-26-Control4003-c1:AGCCACGAGTGACCTT"	-4.04368291321452	12.9514941939148	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCCACGAGTGACCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1993.40826864311	38.4432245969567	0.0192851736403826	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1983.89173808121	1983.89173808121
"healthy-4003"	"2020-08-26-Control4003-c1:AGCCAGCGTGGTCTTA"	-0.58035252514537	8.17800328815309	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCCAGCGTGGTCTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.31987164839	32.0552819897466	0.0182306316993935	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1754.1956333372	1754.1956333372
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGATTAGCACACCC"	-3.97442040863689	12.893359161261	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGATTAGCACACCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1918.86279631439	31.6046026444289	0.0164704859071387	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1905.48807310042	1905.48807310042
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGATTGTACAGTCT"	-4.16359935227092	13.1419524916443	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGATTGTACAGTCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1760.50485948386	32.8182731344691	0.018641398776991	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1760.50485948386	1760.50485948386
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGATTTCATGAAAG"	-5.81199918213542	-4.89591505443724	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGATTTCATGAAAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2845.30092570584	0	0	2488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2843.03112248599	2843.03112248599
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGCCAAGACTCATC"	-3.14043341103252	10.5688314207825	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGCCAAGACTCATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1722.6973886338	40.184253230583	0.0233263563848851	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1709.82337297717	1709.82337297717
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGCCATCTATCCAT"	6.80559982833211	-1.64388742363127	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGCCATCTATCCAT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2426.95398259644	19.1620377336376	0.00789550929727041	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2418.97317527369	2418.97317527369
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGTATAGGCCGCTT"	-3.72997222366984	10.1990508803162	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGTATAGGCCGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1863.77003981682	22.5193675443783	0.0120826963967033	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1863.77003981682	1863.77003981682
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGTATGTCGTTTCC"	-5.82536635819133	-5.31152250682982	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGTATGTCGTTTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3005.80998949026	37.3876497133968	0.0124384607956331	3751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2998.19365493267	2998.19365493267
"healthy-4003"	"2020-08-26-Control4003-c1:AGCGTATTCCGCAGTG"	-3.73658285561259	10.646644569281	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCGTATTCCGCAGTG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2109.07483708443	32.1334313529922	0.0152357947608029	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2103.64844721372	2103.64844721372
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTACAAGACATGCG"	5.63964571532552	-10.1658277741638	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTACAAGACATGCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.70892137179	21.1222342566282	0.00871483950501501	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2416.89225230334	2416.89225230334
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTCAAGTTGTAGCT"	3.57113399085347	-6.53950073635253	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTCAAGTTGTAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.61326362602	35.5783905596948	0.015193965251376	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.75277098161	2336.75277098161
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTCAATCCACTAGA"	-0.904667894274551	8.35948655689088	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTCAATCCACTAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1630.99540110636	20.6485974368527	0.0126601199628436	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1627.14771376511	1627.14771376511
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTTCCAGGCACGAT"	-3.80073199692424	10.6809530028137	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTTCCAGGCACGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2163.73680357754	40.4323380456073	0.0186863476088017	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2153.16978537435	2153.16978537435
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTTCCAGTATGCAA"	-0.527464846999008	8.28403852069703	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTTCCAGTATGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1796.83076221276	31.0735899338634	0.0172935540660474	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1793.48096522364	1793.48096522364
"healthy-4003"	"2020-08-26-Control4003-c1:AGCTTCCCAGAACTTC"	-3.66546879234965	12.8926944502625	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGCTTCCCAGAACTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1857.47189070487	35.6397877545961	0.019187255501924	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1844.33736248854	1844.33736248854
"healthy-4003"	"2020-08-26-Control4003-c1:AGGAAATCATAATGAG"	-4.11681256714519	12.7223481901917	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGAAATCATAATGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2126.07434948652	36.1325079108108	0.0169949408963696	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2117.89541267683	2117.89541267683
"healthy-4003"	"2020-08-26-Control4003-c1:AGGACGAAGTCTAGCT"	-5.61606393280681	-5.51892282879027	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGACGAAGTCTAGCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2726.5340805462	33.7048799575962	0.0123618040200122	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2726.5340805462	2726.5340805462
"healthy-4003"	"2020-08-26-Control4003-c1:AGGACGAGTCATCACA"	-3.75358162346538	12.6977920302185	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGACGAGTCATCACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1589.41608392367	32.2707543573067	0.0203035282477087	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1589.41608392367	1589.41608392367
"healthy-4003"	"2020-08-26-Control4003-c1:AGGACGAGTCGGCCTA"	2.95909990844075	-4.95977451717528	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGACGAGTCGGCCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2662.15405664757	31.2253719168188	0.0117293632345758	2351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2651.97411229883	2651.97411229883
"healthy-4003"	"2020-08-26-Control4003-c1:AGGACGATCGTTCTGC"	3.42926206168477	-6.40695240413817	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGACGATCGTTCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.85914509951	27.9551451151226	0.0113414777354322	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2463.49133175839	2463.49133175839
"healthy-4003"	"2020-08-26-Control4003-c1:AGGAGGTGTACGACAG"	3.04049386557881	-5.01194336330565	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGAGGTGTACGACAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2603.6300118344	34.5171668984542	0.0132573240981099	2029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2587.58133277959	2587.58133277959
"healthy-4003"	"2020-08-26-Control4003-c1:AGGAGGTGTAGTGATA"	-2.70181308212932	9.92555520618287	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGAGGTGTAGTGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.61621267837	37.4239700466262	0.0204099253638038	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.68772434589	1827.68772434589
"healthy-4003"	"2020-08-26-Control4003-c1:AGGAGGTTCTCCTGCA"	5.53158678588216	-10.0126304856506	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGAGGTTCTCCTGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.15186250933	21.3827265294478	0.00902166939919597	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2362.82866068994	2362.82866068994
"healthy-4003"	"2020-08-26-Control4003-c1:AGGATCTTCATATGGC"	-3.37381158295329	-5.53902151500853	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGATCTTCATATGGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2447.00626122636	5.47644674264389	0.00223801909681231	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2442.12070229651	2442.12070229651
"healthy-4003"	"2020-08-26-Control4003-c1:AGGCATTGTCAATCTG"	4.33390678939168	-7.27325060283812	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGCATTGTCAATCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.41812483948	6.59418094712235	0.00315750034377296	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.06421537138	2080.06421537138
"healthy-4003"	"2020-08-26-Control4003-c1:AGGCTGCGTTCCGCGA"	-4.43536553803142	12.7154931792053	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGCTGCGTTCCGCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2021.0905426042	34.4778054570464	0.0170590108311631	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2015.58931573926	2015.58931573926
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGAGTAGGTACAGC"	-3.12842021408733	9.58428094470827	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGAGTAGGTACAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1813.47893992156	35.5672266761995	0.0196127045609573	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.47893992156	1813.47893992156
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGCCTGTGCGGCTT"	5.48028578337972	-10.0616417161194	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGCCTGTGCGGCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.90205431835	20.14777908777	0.00868475419049104	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2316.87871231966	2316.87871231966
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGCCTGTTAGAAAC"	3.13927235183064	-7.5226040116516	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGCCTGTTAGAAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.79021270703	40.1068970312667	0.0202991677827557	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1975.79021270703	1975.79021270703
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGCTCAGGGAGGGT"	3.54671086844746	-6.67289926921996	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGCTCAGGGAGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.31834208618	17.9265450939573	0.00836782505278865	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.82523563534	2140.82523563534
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGCTCGTGAATTGA"	2.58940305289571	-4.21296265041503	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGCTCGTGAATTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2466.43468472002	34.326529643844	0.0139174695589965	1792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2460.4757224654	2460.4757224654
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGCTCGTTGTGCAT"	3.40009893950765	-6.51791193401488	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGCTCGTTGTGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2081.9994232815	1.23752478510771	0.000594392472576774	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2075.06608270649	2075.06608270649
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGTCCGTTCAACGT"	6.7923752265865	-1.65796556389006	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGTCCGTTCAACGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2500.26951493813	25.9504607858236	0.010379065389063	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2492.77100274449	2492.77100274449
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGTCCTCTGGCCAG"	-3.40673790398296	10.4595565565857	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGTCCTCTGGCCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2136.70341207864	30.8223517165452	0.0144251895430637	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2129.65443292586	2129.65443292586
"healthy-4003"	"2020-08-26-Control4003-c1:AGGGTGAGTCACGCTG"	-4.19105611267741	12.9108190306458	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGGTGAGTCACGCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2075.37780032072	39.44267788442	0.0190050591648058	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2067.68414144612	2067.68414144612
"healthy-4003"	"2020-08-26-Control4003-c1:AGGTAGGGTAGGCAGT"	-3.27751145783122	9.88573548877565	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGTAGGGTAGGCAGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1967.73435901908	40.1768850803448	0.0204178398858538	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.0241897092	1964.0241897092
"healthy-4003"	"2020-08-26-Control4003-c1:AGGTCATCACCGGTCA"	3.57787432250325	-5.59535887157591	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGTCATCACCGGTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.60835606067	26.5455354869709	0.0100111071932236	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2642.09921997421	2642.09921997421
"healthy-4003"	"2020-08-26-Control4003-c1:AGGTCATGTGCCGTTG"	-4.32944951477702	13.0372810133728	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGTCATGTGCCGTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1766.73662502177	27.9554534957123	0.0158232150167645	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1766.73662502177	1766.73662502177
"healthy-4003"	"2020-08-26-Control4003-c1:AGGTTACGTGTGGTCC"	-3.45960698548015	12.3660564192566	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGTTACGTGTGGTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1487.16766620774	36.4185044502402	0.0244884993654461	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1482.23401222422	1482.23401222422
"healthy-4003"	"2020-08-26-Control4003-c1:AGGTTGTGTGCCGTAC"	4.73674215850179	-7.66190626537474	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGGTTGTGTGCCGTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.29708186122	31.9229174857135	0.014804508040311	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2153.30892804243	2153.30892804243
"healthy-4003"	"2020-08-26-Control4003-c1:AGTAACCCAACCGACC"	-0.343394617468673	8.50636766040651	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTAACCCAACCGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.87732258239	25.0485503974386	0.0130063063226952	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1922.5643389899	1922.5643389899
"healthy-4003"	"2020-08-26-Control4003-c1:AGTACCACAAAGCTCT"	-4.3665431541508	-4.6319790116516	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTACCACAAAGCTCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2612.57884952217	33.9974900763991	0.0130130005770417	1969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2606.94838060215	2606.94838060215
"healthy-4003"	"2020-08-26-Control4003-c1:AGTACCATCACCGCTT"	10.5712114768917	7.06476686084596	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTACCATCACCGCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2161.28766079854	31.3222378839763	0.0144923965708496	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2152.97260527428	2152.97260527428
"healthy-4003"	"2020-08-26-Control4003-c1:AGTACCATCATGACAC"	-1.79610429230388	9.52673909747926	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTACCATCATGACAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.84822079772	35.6444965932026	0.0205817670192739	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1720.42901683276	1720.42901683276
"healthy-4003"	"2020-08-26-Control4003-c1:AGTACTGAGACCAGCA"	-3.94941935959514	13.0301685103211	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTACTGAGACCAGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1828.83804936494	12.6973936011001	0.00694287479720214	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1817.99181279663	1817.99181279663
"healthy-4003"	"2020-08-26-Control4003-c1:AGTAGCTTCGGAGTAG"	0.728946586220902	8.37952134692994	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTAGCTTCGGAGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1638.08955212648	31.144924332896	0.019012955849981	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1634.41735756433	1634.41735756433
"healthy-4003"	"2020-08-26-Control4003-c1:AGTAGTCTCCCGAAAT"	-1.97054109993632	9.48775479877321	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTAGTCTCCCGAAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1586.33968214951	43.6676311298539	0.0275272891558028	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1584.13122994931	1584.13122994931
"healthy-4003"	"2020-08-26-Control4003-c1:AGTAGTCTCGTGCATA"	5.45097460326497	-10.0804958573547	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTAGTCTCGTGCATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.22461927572	33.9037622857939	0.0145558148429396	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.17135257785	2323.17135257785
"healthy-4003"	"2020-08-26-Control4003-c1:AGTCAACTCAAACCCA"	-0.697282592684585	9.39052388751832	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTCAACTCAAACCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1807.5013425435	44.1581304284104	0.0244304827825309	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1790.74102713227	1790.74102713227
"healthy-4003"	"2020-08-26-Control4003-c1:AGTCATGAGTTACGGG"	-4.44347081604655	-1.19271054184111	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTCATGAGTTACGGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2561.7751839836	3.26383541081306	0.00127405223971986	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2553.57554669618	2553.57554669618
"healthy-4003"	"2020-08-26-Control4003-c1:AGTCATGCAACCGGAA"	5.40460791167561	-10.2307749024597	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTCATGCAACCGGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.0477099987	14.5541080938795	0.00673474631149549	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2161.0477099987	2161.0477099987
"healthy-4003"	"2020-08-26-Control4003-c1:AGTCATGCACCTCAGG"	6.71777309951131	-1.66782047664794	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTCATGCACCTCAGG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2372.58100783015	32.8346799367383	0.0138392239625855	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2366.71260277599	2366.71260277599
"healthy-4003"	"2020-08-26-Control4003-c1:AGTCTCCGTCCAGCGT"	-3.872382025153	12.5812635191712	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTCTCCGTCCAGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1790.84194261214	10.1404364442479	0.00566238493915158	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1784.57389912421	1784.57389912421
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGACTGTGGCTAGA"	5.50363506850545	-9.83683874523314	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGACTGTGGCTAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.04289913609	35.0676794701149	0.0144666084427024	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2420.00546954177	2420.00546954177
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGATCGTCTCCTGT"	5.54161610183064	-9.82040693676146	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGATCGTCTCCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.76840152763	39.2117501705371	0.0174602822552246	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2245.76840152763	2245.76840152763
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGCCGGTAATCAGA"	-3.99323878708537	12.7877111204895	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGCCGGTAATCAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2047.07303578314	29.6520806896279	0.0144851112643785	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2041.65109733733	2041.65109733733
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGCCGGTTAAGGAT"	-1.10525319996532	9.23448941791383	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGCCGGTTAAGGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1506.19375868667	36.027629365569	0.0239196512120615	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1501.84274657575	1501.84274657575
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGCCGTCGACGCGT"	-6.08953748169597	3.40970561588136	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGCCGTCGACGCGT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2422.4379924331	36.3622195726712	0.0150105883767737	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2399.72332915415	2399.72332915415
"healthy-4003"	"2020-08-26-Control4003-c1:AGTGTTGAGGTCGCCT"	-3.73097262802776	10.0956306227478	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTGTTGAGGTCGCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1826.20797847589	34.5422568940831	0.0189147442685643	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.23819974405	1815.23819974405
"healthy-4003"	"2020-08-26-Control4003-c1:AGTTCGAGTATGATCC"	-3.73275933685954	10.914976096991	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTTCGAGTATGATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2330.04773102128	41.2651038938158	0.0177099822224367	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2313.24709868258	2313.24709868258
"healthy-4003"	"2020-08-26-Control4003-c1:AGTTCGATCTATACGG"	-2.57055387917216	10.3839950331482	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.AGTTCGATCTATACGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1640.38883386653	16.4737108246262	0.0100425645947591	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1625.59523578425	1625.59523578425
"healthy-4003"	"2020-08-26-Control4003-c1:ATACCGAAGGAGTACC"	-2.8486217063969	10.2562303313049	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACCGAAGGAGTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1712.20211576336	32.8338935333439	0.0191764121951837	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1702.93406861985	1702.93406861985
"healthy-4003"	"2020-08-26-Control4003-c1:ATACCGAAGTGCCTCG"	2.56860270079915	-4.20307829296263	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACCGAAGTGCCTCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2362.72635224666	38.3767638787373	0.0162425766497444	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2359.16740779218	2359.16740779218
"healthy-4003"	"2020-08-26-Control4003-c1:ATACCGACACAAATAG"	-3.41993675652202	10.4385471113953	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACCGACACAAATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2120.8323244525	38.9460168954128	0.0183635530477247	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2106.52822604571	2106.52822604571
"healthy-4003"	"2020-08-26-Control4003-c1:ATACTTCCAACACAAA"	5.2972227531368	-8.81289675151976	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACTTCCAACACAAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.66283953864	26.5035608204709	0.0099091221624938	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2670.86025362893	2670.86025362893
"healthy-4003"	"2020-08-26-Control4003-c1:ATACTTCGTGACGCCT"	-3.71014223519023	12.8320207365784	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACTTCGTGACGCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1960.10979472327	29.0915406472747	0.0148417913759682	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1948.35665562382	1948.35665562382
"healthy-4003"	"2020-08-26-Control4003-c1:ATACTTCTCCGAGTGC"	-3.4993933242863	12.296754814032	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATACTTCTCCGAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2057.45483286851	42.8539743855657	0.0208286343403314	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2045.90738516707	2045.90738516707
"healthy-4003"	"2020-08-26-Control4003-c1:ATAGACCGTGTTGAGG"	-3.78529057923015	10.1480684050354	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATAGACCGTGTTGAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1620.2975522674	33.4018995425737	0.0206146701239115	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1618.12324554894	1618.12324554894
"healthy-4003"	"2020-08-26-Control4003-c1:ATAGACCGTTACACAC"	2.71480335769002	-6.35073616420897	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATAGACCGTTACACAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.30362549588	9.10020597958495	0.00431636405190194	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2105.83902140946	2105.83902140946
"healthy-4003"	"2020-08-26-Control4003-c1:ATAGAGATCGAGTCCG"	-3.19757423821147	10.2669172056946	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATAGAGATCGAGTCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1746.74413930438	43.2991220892353	0.0247884742332547	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1742.46660379198	1742.46660379198
"healthy-4003"	"2020-08-26-Control4003-c1:ATAGGCTCACTAACCA"	0.2260435867006	8.1484803923401	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATAGGCTCACTAACCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1845.88804857217	29.9372919135239	0.0162183681381333	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1839.51933829618	1839.51933829618
"healthy-4003"	"2020-08-26-Control4003-c1:ATATCCTTCGGTTCAA"	3.97511305388753	-6.82147552883299	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATATCCTTCGGTTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2575.01100391872	24.3491756445415	0.00945595013282906	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2567.81807716066	2567.81807716066
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACAGAGTGTAGAT"	-4.25656066361125	12.837547279242	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACAGAGTGTAGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1596.73547336829	31.8163905615578	0.0199258994944489	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1596.73547336829	1596.73547336829
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACAGCAGTTAGAA"	5.18792357024495	-8.50330068981322	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACAGCAGTTAGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.12376463986	3.38822148216312	0.00139139600679156	1567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.08248587063	2429.08248587063
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACAGTCCAGCAAT"	-3.21283374252971	9.90753934467164	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACAGTCCAGCAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.21294381698	38.2492659567067	0.0183255216340114	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2072.69464005238	2072.69464005238
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACTTCAAATCGGG"	0.0629841630229771	7.93919036472169	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACTTCAAATCGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1945.81847495335	24.2752179914574	0.012475582025728	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1936.17864417468	1936.17864417468
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACTTCAGCTCTGG"	2.89219202575032	-4.90725042736205	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACTTCAGCTCTGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2764.41585363947	33.5718045894137	0.0121442671315949	2369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2753.49235030488	2753.49235030488
"healthy-4003"	"2020-08-26-Control4003-c1:ATCACTTTCCGCATAA"	-4.06104312363322	10.6248550184998	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCACTTTCCGCATAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.72482612932	29.3789814855267	0.0161803050014772	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.8551333488	1809.8551333488
"healthy-4003"	"2020-08-26-Control4003-c1:ATCAGGTAGATACAGT"	-4.1838096183842	12.563075996283	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCAGGTAGATACAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1898.53236250601	34.4089952807748	0.0181239972308694	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1879.51697177815	1879.51697177815
"healthy-4003"	"2020-08-26-Control4003-c1:ATCATTCCACAGCATT"	-4.03022275391276	-4.7477746239868	"2020-08-26-Control4003-c1"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCATTCCACAGCATT"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3068.95302927518	36.850652558765	0.0120075648624275	3042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3059.18484089522	3059.18484089522
"healthy-4003"	"2020-08-26-Control4003-c1:ATCATTCCACAGCTTA"	-4.09253583374675	13.1068067320618	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCATTCCACAGCTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.71278515255	34.9408929018172	0.0181821618567436	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1917.67589829564	1917.67589829564
"healthy-4003"	"2020-08-26-Control4003-c1:ATCATTCGTTGGTACT"	4.18702997741048	-7.91195156490477	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCATTCGTTGGTACT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.80988176302	4.43405617804147	0.00182862013693938	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.32519696536	2423.32519696536
"healthy-4003"	"2020-08-26-Control4003-c1:ATCCATTGTCTTACTT"	4.99535383757893	-8.07184412395629	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCCATTGTCTTACTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.48088878052	20.6121867332316	0.00812309043365348	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2537.48088878052	2537.48088878052
"healthy-4003"	"2020-08-26-Control4003-c1:ATCCCTGAGCAGGGAG"	5.48559011992757	-9.52027704631957	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCCCTGAGCAGGGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.96451781955	0.548704743481163	0.000231231752249441	1324	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2371.53580868626	2371.53580868626
"healthy-4003"	"2020-08-26-Control4003-c1:ATCCGTCTCGCCAACG"	5.45292248305623	-9.38545324718627	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCCGTCTCGCCAACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2773.06723461446	35.5665969420132	0.0128257247058627	1821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2771.8871797849	2771.8871797849
"healthy-4003"	"2020-08-26-Control4003-c1:ATCCTATTCAAGTCGT"	-3.70350466194804	12.7370013960632	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCCTATTCAAGTCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1884.42053405966	38.5492747616534	0.0204568322542133	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1876.04290322282	1876.04290322282
"healthy-4003"	"2020-08-26-Control4003-c1:ATCCTATTCATGGAGG"	-5.85376677933391	-4.65883304989012	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCCTATTCATGGAGG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3246.00576593227	37.9111656600564	0.0116793278859651	3650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3237.87244684119	3237.87244684119
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGCCTGTACGAGTG"	-1.10113571110423	8.70202539050905	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGCCTGTACGAGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.21655179885	39.7062371317453	0.019538388808318	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2022.13366743503	2022.13366743503
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGCCTGTTGCCTAA"	-3.53389416161235	10.8924245604309	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGCCTGTTGCCTAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1851.33048384718	31.3848052883294	0.0169525676599404	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.33048384718	1851.33048384718
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGGATTCCTCACGT"	4.68002523955647	-7.34635879909667	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGGATTCCTCACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.40820908591	7.84308804403801	0.00330596059059328	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.25876813973	2368.25876813973
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGGATTCCTCTCTT"	-4.209944109351	12.0763034590515	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGGATTCCTCTCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.12924673859	38.2185494269054	0.0188814768071188	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2016.64938264037	2016.64938264037
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGTCCTCAGTGTTG"	-3.90364394608195	12.8509835966858	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGTCCTCAGTGTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1696.55290157811	38.6332395617673	0.0227716091410007	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1696.55290157811	1696.55290157811
"healthy-4003"	"2020-08-26-Control4003-c1:ATCGTGAGTTTAGACC"	5.52240767058675	-10.2039966813293	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCGTGAGTTTAGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.76718921816	32.2777327688874	0.0154308438029147	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2085.93632528013	2085.93632528013
"healthy-4003"	"2020-08-26-Control4003-c1:ATCTTCAGTATCGTAC"	-3.56688294830974	12.4792260893616	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATCTTCAGTATCGTAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1577.51947424866	42.5203978649654	0.0269539606699416	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1570.9987220113	1570.9987220113
"healthy-4003"	"2020-08-26-Control4003-c1:ATGACCACAACTCCAA"	5.53010620650594	-9.95585443889769	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGACCACAACTCCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.05094816649	0.484430033696558	0.000193690589970465	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2498.2479032033	2498.2479032033
"healthy-4003"	"2020-08-26-Control4003-c1:ATGACCACACTGGACC"	2.63204254683797	-4.34258844768675	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGACCACACTGGACC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2460.67713087781	26.0690119096548	0.0105942431790533	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2457.72885805906	2457.72885805906
"healthy-4003"	"2020-08-26-Control4003-c1:ATGACCAGTTCTCTCG"	5.71017326888387	-9.82031443035277	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGACCAGTTCTCTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2791.17607891972	23.5450588373541	0.00843553332775296	2031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2789.15664093064	2789.15664093064
"healthy-4003"	"2020-08-26-Control4003-c1:ATGACCATCCACGTGG"	-3.94029865685161	12.1793861159119	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGACCATCCACGTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2411.03375162093	46.2435193039842	0.0191799551843249	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2403.15226117235	2403.15226117235
"healthy-4003"	"2020-08-26-Control4003-c1:ATGAGGGCACCAGACC"	5.39558424529378	-9.40765287792357	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGAGGGCACCAGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.77022109364	27.8337363913605	0.011584019207085	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.55403609281	2397.55403609281
"healthy-4003"	"2020-08-26-Control4003-c1:ATGAGTCAGTACAACA"	-4.22411046448405	12.9657554396423	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGAGTCAGTACAACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2248.15330614994	34.7033233518171	0.0154363687106588	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2239.22281375091	2239.22281375091
"healthy-4003"	"2020-08-26-Control4003-c1:ATGAGTCAGTCGCGAA"	-7.12171016159709	2.70010993564454	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGAGTCAGTCGCGAA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2123.95669297076	38.5666188392143	0.0181579120548224	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2119.26328010016	2119.26328010016
"healthy-4003"	"2020-08-26-Control4003-c1:ATGAGTCGTTGTCCCT"	-3.54743204537089	10.2905349501404	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGAGTCGTTGTCCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.14595736485	39.7816820816206	0.0229137889662237	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1736.14595736485	1736.14595736485
"healthy-4003"	"2020-08-26-Control4003-c1:ATGATCGGTATCGCAT"	-4.04207978668864	12.978938079718	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGATCGGTATCGCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2217.16952442793	12.1866765552571	0.00549650192328055	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2205.80031860002	2205.80031860002
"healthy-4003"	"2020-08-26-Control4003-c1:ATGATCGTCCATAGGT"	-2.03734407845195	9.79213998401491	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGATCGTCCATAGGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1640.27165333162	34.6274185902653	0.0211107827901141	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1632.06895051018	1632.06895051018
"healthy-4003"	"2020-08-26-Control4003-c1:ATGCCTCGTGTCCATA"	0.237074484198731	8.3689565428528	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGCCTCGTGTCCATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1527.61396235413	12.9529703593113	0.00847921705255304	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1518.50908463064	1518.50908463064
"healthy-4003"	"2020-08-26-Control4003-c1:ATGCCTCTCCCGAGTG"	-4.42997489395793	12.7676534422669	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGCCTCTCCCGAGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1674.90913934993	37.4410689824319	0.0223540896056987	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1672.53278052981	1672.53278052981
"healthy-4003"	"2020-08-26-Control4003-c1:ATGGAGGGTCGCACAC"	2.77176322516744	-4.63688089763793	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGGAGGGTCGCACAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2114.34070064747	3.89869705812667	0.00184393038308953	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2113.09809185961	2113.09809185961
"healthy-4003"	"2020-08-26-Control4003-c1:ATGGAGGTCATGAGGG"	5.43658079680745	-9.83012297069701	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGGAGGTCATGAGGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.7960547912	23.4999596910515	0.0114589452403858	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.19025670572	2049.19025670572
"healthy-4003"	"2020-08-26-Control4003-c1:ATGGATCGTTGTCAGT"	-4.54204402390178	10.1928043135437	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGGATCGTTGTCAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2443.1926728003	41.0692049832769	0.016809646427191	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2440.15633805176	2440.15633805176
"healthy-4003"	"2020-08-26-Control4003-c1:ATGTCCCAGCAACAAT"	10.4825836616451	7.71960256183473	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGTCCCAGCAACAAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2370.74745756456	35.1351448427341	0.014820281565894	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2361.59324862485	2361.59324862485
"healthy-4003"	"2020-08-26-Control4003-c1:ATGTCCCAGTATAGAC"	-0.858909766108352	8.58753488147584	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGTCCCAGTATAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1911.72215801931	39.0224557615116	0.0204122003805939	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1897.48726269682	1897.48726269682
"healthy-4003"	"2020-08-26-Control4003-c1:ATGTCCCCAATCTGCA"	2.67077984389607	-4.44932224666747	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGTCCCCAATCTGCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2343.64877436311	31.3503594577903	0.0133767311043908	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2342.56792106157	2342.56792106157
"healthy-4003"	"2020-08-26-Control4003-c1:ATGTCCCTCTCTAAGG"	5.70536913451497	-9.81401541149291	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGTCCCTCTCTAAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2332.05472391319	32.1517514455814	0.0137868769184073	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.53354665029	2327.53354665029
"healthy-4003"	"2020-08-26-Control4003-c1:ATGTCTTTCACAATGC"	5.28157867965047	-10.0856018296448	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATGTCTTTCACAATGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.84884196209	33.6581429521697	0.0147633221697289	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.44868408823	2278.44868408823
"healthy-4003"	"2020-08-26-Control4003-c1:ATTACCTGTCAACACT"	5.66374744948689	-9.91280558025511	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTACCTGTCAACACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.21862673803	34.1703153146105	0.0141070318498158	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2414.19802783052	2414.19802783052
"healthy-4003"	"2020-08-26-Control4003-c1:ATTACCTTCCTATTGT"	-2.37984500351604	9.77925202930299	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTACCTTCCTATTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2252.43335719558	36.7700244730354	0.0163245781969845	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2232.79544155577	2232.79544155577
"healthy-4003"	"2020-08-26-Control4003-c1:ATTACTCAGAGGTCAC"	-0.163111905485946	8.30045697772828	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTACTCAGAGGTCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1571.07760394928	35.1071485936771	0.0223459035412553	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1569.43993098613	1569.43993098613
"healthy-4003"	"2020-08-26-Control4003-c1:ATTATCCCACAAAGTA"	3.19172372397725	-5.23732759868773	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTATCCCACAAAGTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2526.72798526583	25.8409634434955	0.0102270460430179	1769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2522.47077778148	2522.47077778148
"healthy-4003"	"2020-08-26-Control4003-c1:ATTATCCTCATCACAG"	3.45765413817708	-6.6555385819641	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTATCCTCATCACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.10819770348	3.78100088760865	0.00157337938059633	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.45778094029	2397.45778094029
"healthy-4003"	"2020-08-26-Control4003-c1:ATTATCCTCCGCAGTG"	0.231993411749047	9.11844441974489	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTATCCTCCGCAGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.23436878308	35.0065202549318	0.019434739233064	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1779.72155599441	1779.72155599441
"healthy-4003"	"2020-08-26-Control4003-c1:ATTATCCTCGGCTTCT"	-0.637290696532089	8.70039079273073	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTATCCTCGGCTTCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2051.39831688137	31.8830068654313	0.015542084929611	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.2408934813	2041.2408934813
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCACTTCACCCTGT"	5.63246168670003	-9.79671385204466	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCACTTCACCCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2837.77103174547	33.5399604552781	0.0118191214442866	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2831.22319952482	2831.22319952482
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCACTTCGTGGGAA"	-3.51842461052592	10.4792775877747	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCACTTCGTGGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2154.6910973576	30.6007361493695	0.0142019132983361	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2145.92473380082	2145.92473380082
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCATCGTGCCTGCA"	-3.57923922959026	10.4700393446716	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCATCGTGCCTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1800.6783681884	25.7094113043504	0.0142776254541314	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1796.74389162683	1796.74389162683
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCCATGTAATCAAG"	-3.14696250382121	-5.6664290658203	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCCATGTAATCAAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2490.25300217752	35.2414834518645	0.0141517682825997	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2476.9842939969	2476.9842939969
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCCCGCAACGCCCA"	2.69650377806966	-4.38100721752318	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCCCGCAACGCCCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2314.1053001489	10.6759562315832	0.00461342715514987	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2310.88576350344	2310.88576350344
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCCTAAGAAACTAC"	5.40073551711385	-10.139916442987	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCCTAAGAAACTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.55651131581	32.1034890034475	0.0151391810744657	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2117.45779282217	2117.45779282217
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCCTAAGATTGATG"	10.4160086112911	6.06870267474977	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCCTAAGATTGATG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1371.2408850442	32.1440875592695	0.0234416052714424	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1369.08606740428	1369.08606740428
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCCTACAACAGAGC"	2.77856268462483	-4.59841110622557	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCCTACAACAGAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2659.17437113311	33.5789415482211	0.0126275816707396	2062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2658.22765498667	2658.22765498667
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCTACCATACATCG"	-0.134606475860435	8.47559354389039	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCTACCATACATCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1826.06344332874	31.2181726402565	0.0170958861009499	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.18604878565	1821.18604878565
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCTTGCATAGAATG"	10.8172012763912	6.0663909682068	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCTTGCATAGAATG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.28636431282	28.6870058022753	0.0172264701237214	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1655.91442297274	1655.91442297274
"healthy-4003"	"2020-08-26-Control4003-c1:ATTCTTGGTATGCTTG"	4.87146629866902	-7.51817848598631	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTCTTGGTATGCTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.81710207714	38.3939091705733	0.0159256830961973	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2404.86550422353	2404.86550422353
"healthy-4003"	"2020-08-26-Control4003-c1:ATTGGGTGTTCCTACC"	-0.819725851446945	8.76876924121705	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTGGGTGTTCCTACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1854.81968126516	32.6688178496023	0.0176129346585967	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.61317450355	1848.61317450355
"healthy-4003"	"2020-08-26-Control4003-c1:ATTGTTCTCGGTGTTA"	5.3451358276302	-9.37340357219847	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTGTTCTCGGTGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2561.96346293312	7.56432288313052	0.0029525490868907	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2558.25514173918	2558.25514173918
"healthy-4003"	"2020-08-26-Control4003-c1:ATTTACCAGGTCCAGA"	-3.58062467995341	10.8856458433899	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTTACCAGGTCCAGA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2310.63471624703	33.9677564179265	0.0147006171850033	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2306.56528815276	2306.56528815276
"healthy-4003"	"2020-08-26-Control4003-c1:ATTTACCGTGTTCGAT"	-3.96127782288249	10.732021308783	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTTACCGTGTTCGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.89131269645	37.4247101890746	0.0179246448134035	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2079.36448681234	2079.36448681234
"healthy-4003"	"2020-08-26-Control4003-c1:ATTTCACTCCAGTTCC"	-3.50882087174113	9.75597379291383	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTTCACTCCAGTTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1599.74698873871	28.8507784877396	0.0180345884010611	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1594.77250423752	1594.77250423752
"healthy-4003"	"2020-08-26-Control4003-c1:ATTTCTGTCGATTGGT"	10.4479690986568	7.54109571063844	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.ATTTCTGTCGATTGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1824.21855058344	32.1190843827368	0.0176070374750132	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1820.26738985391	1820.26738985391
"healthy-4003"	"2020-08-26-Control4003-c1:CAACAACAGCTCCCTT"	-3.65282736244853	10.9972800978455	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAACAACAGCTCCCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1790.17681754739	27.6155057029305	0.0154261330122489	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1788.2077049263	1788.2077049263
"healthy-4003"	"2020-08-26-Control4003-c1:CAACAACCATCGAAGG"	4.01047076758687	-6.91778852855834	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAACAACCATCGAAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.93794595373	30.5396117504449	0.0123246071598821	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.37273870358	2471.37273870358
"healthy-4003"	"2020-08-26-Control4003-c1:CAACCTCTCACATCAG"	-1.96630869332011	9.55033872211305	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAACCTCTCACATCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2097.56306424008	28.3355398565107	0.0135087904338058	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2087.80786574914	2087.80786574914
"healthy-4003"	"2020-08-26-Control4003-c1:CAACGATGTCGGTGTC"	-3.35038648071941	11.9799966582092	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAACGATGTCGGTGTC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1791.85193406949	38.1132600017125	0.0212703177517314	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.75896020896	1785.75896020896
"healthy-4003"	"2020-08-26-Control4003-c1:CAACGATGTTACCTGA"	-2.73246059837993	9.67668340289918	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAACGATGTTACCTGA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2311.3970787578	29.9106165309745	0.0129404924864962	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2306.473897716	2306.473897716
"healthy-4003"	"2020-08-26-Control4003-c1:CAAGACTAGTCCCGAC"	-2.27227745476421	9.3478851088318	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAAGACTAGTCCCGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1810.28702140465	33.5404445413475	0.01852769430746	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1808.39263256234	1808.39263256234
"healthy-4003"	"2020-08-26-Control4003-c1:CAAGACTCAGAGGAAA"	6.81843723830525	-1.67425479805144	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAAGACTCAGAGGAAA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2566.6891586646	24.6717558397761	0.00961228817151056	1656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2554.36249366649	2554.36249366649
"healthy-4003"	"2020-08-26-Control4003-c1:CAAGAGGAGGTTCCAT"	5.32654966887776	-10.1596508256164	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAAGAGGAGGTTCCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.90417298815	38.707226116691	0.0188824563736886	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.90417298815	2049.90417298815
"healthy-4003"	"2020-08-26-Control4003-c1:CAAGCTACAAACTAGA"	3.53851403769795	-6.79086162960204	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAAGCTACAAACTAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2409.30305974722	29.6013744865078	0.0122862810333265	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.97889956655	2400.97889956655
"healthy-4003"	"2020-08-26-Control4003-c1:CAAGGGACAGGCCTGT"	0.73548980531041	9.13866326892702	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAAGGGACAGGCCTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1614.81770911889	34.6823477808813	0.0214775621948098	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1611.08224856322	1611.08224856322
"healthy-4003"	"2020-08-26-Control4003-c1:CAATCGACAATCGCCG"	-3.93045149269755	12.4380302199158	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAATCGACAATCGCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1919.26376541759	40.6021183713348	0.0211550486717497	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1913.45550151384	1913.45550151384
"healthy-4003"	"2020-08-26-Control4003-c1:CAATCGACAGACAATA"	5.60059227523152	-9.48711683666381	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAATCGACAGACAATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2787.80032365491	32.2168734574829	0.0115563776874971	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2783.418500799	2783.418500799
"healthy-4003"	"2020-08-26-Control4003-c1:CAATTTCTCACCTCAC"	-4.247879366309	13.0143584975037	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAATTTCTCACCTCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2467.45360202919	37.076359893602	0.0150261629491679	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2460.85009128164	2460.85009128164
"healthy-4003"	"2020-08-26-Control4003-c1:CACAACATCATGCAGT"	-2.37478313866313	9.95222661578981	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACAACATCATGCAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1543.95376182645	43.2488803157638	0.0280117717156255	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1535.01929213094	1535.01929213094
"healthy-4003"	"2020-08-26-Control4003-c1:CACAGGCCAGTCGTTA"	-2.31756816330608	9.60491941058961	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACAGGCCAGTCGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1699.33808139817	19.0591230410625	0.0112156158034081	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1695.31446433963	1695.31446433963
"healthy-4003"	"2020-08-26-Control4003-c1:CACAGGCTCGATCCAA"	2.64351954039876	-4.38907482540282	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACAGGCTCGATCCAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2381.78805925237	25.916835136996	0.0108812516026851	1711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2376.64369156669	2376.64369156669
"healthy-4003"	"2020-08-26-Control4003-c1:CACCAAAAGTAAGAGG"	5.55859531935994	-9.86279203807982	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACCAAAAGTAAGAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.0150783595	39.3775538507332	0.0157572293947833	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2494.27344427255	2494.27344427255
"healthy-4003"	"2020-08-26-Control4003-c1:CACCAAACATCAACCA"	5.51533855971639	-10.1569252244202	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACCAAACATCAACCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.13409294479	38.0188271829147	0.0152188896866214	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2491.66895366545	2491.66895366545
"healthy-4003"	"2020-08-26-Control4003-c1:CACCGTTCAGGACATG"	-3.40873346749004	9.59467218005983	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACCGTTCAGGACATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2524.48496556807	33.7966778583009	0.0133875536274766	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2521.48743302792	2521.48743302792
"healthy-4003"	"2020-08-26-Control4003-c1:CACCGTTTCCTGGTCT"	2.66492285308186	-4.41412212764891	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACCGTTTCCTGGTCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1867.70056913119	31.7663178332384	0.0170082498009921	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1865.85092211614	1865.85092211614
"healthy-4003"	"2020-08-26-Control4003-c1:CACCGTTTCTGAATGC"	5.69217791137044	-10.0017938843933	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACCGTTTCTGAATGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.95383346724	38.6460369673293	0.0145836642432235	1723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2640.15036210093	2640.15036210093
"healthy-4003"	"2020-08-26-Control4003-c1:CACGAATCAGACCATT"	-3.72122440758403	-4.60384943401488	"2020-08-26-Control4003-c1"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGAATCAGACCATT"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2936.71031145842	36.8808667876253	0.0125585648144197	2767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2932.38103575876	2932.38103575876
"healthy-4003"	"2020-08-26-Control4003-c1:CACGAATTCATGCCCT"	-4.25383744660075	12.8880471953186	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGAATTCATGCCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2599.2727268862	37.8826950044241	0.0145743440511553	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2587.50296309586	2587.50296309586
"healthy-4003"	"2020-08-26-Control4003-c1:CACGTTCAGGACGCAT"	2.00394942340199	-6.25743725216063	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGTTCAGGACGCAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2483.22875001542	34.6593081589561	0.01395735618748	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2476.83995068813	2476.83995068813
"healthy-4003"	"2020-08-26-Control4003-c1:CACGTTCGTTTCTATC"	-4.04582486572917	12.5684432753357	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGTTCGTTTCTATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1685.05510118236	40.7228034688902	0.0241670456000614	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1680.73945298162	1680.73945298162
"healthy-4003"	"2020-08-26-Control4003-c1:CACGTTCTCTGCACCT"	5.08465017852132	-8.30228521740111	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGTTCTCTGCACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.88780166539	31.3894849410869	0.0119858074565569	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2616.7137330836	2616.7137330836
"healthy-4003"	"2020-08-26-Control4003-c1:CACGTTCTCTGGACCG"	-4.06494174423869	13.0724839934143	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACGTTCTCTGGACCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1961.36410990552	24.7228295539647	0.0126049158486721	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1948.95019949147	1948.95019949147
"healthy-4003"	"2020-08-26-Control4003-c1:CACTGAAGTGCGGCTT"	-4.33558164063151	12.8490867384705	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTGAAGTGCGGCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1926.05211789759	40.6430462445933	0.0211017375214944	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1914.02642287644	1914.02642287644
"healthy-4003"	"2020-08-26-Control4003-c1:CACTGGGGTAACATAG"	2.66080488738362	-4.54091360485228	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTGGGGTAACATAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2434.00427976647	28.6742096069685	0.0117806734545757	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2427.58907009088	2427.58907009088
"healthy-4003"	"2020-08-26-Control4003-c1:CACTGTCCACTCCGGA"	-0.861856440932113	8.49677274310914	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTGTCCACTCCGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2116.74788816474	35.9409942487906	0.0169793457453037	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2106.54298885513	2106.54298885513
"healthy-4003"	"2020-08-26-Control4003-c1:CACTGTCCACTTCCTG"	-2.46798835220988	9.47710321033327	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTGTCCACTTCCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2057.32195074581	36.9926540254293	0.0179809747385522	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2038.68447094482	2038.68447094482
"healthy-4003"	"2020-08-26-Control4003-c1:CACTGTCGTTAGGAGC"	-2.34865436974223	9.29636952960817	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTGTCGTTAGGAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.53403895524	25.5802012519305	0.0126351055402018	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2022.81613931143	2022.81613931143
"healthy-4003"	"2020-08-26-Control4003-c1:CACTTCGAGTCAGGGT"	-3.54859314385112	12.3550929793152	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTTCGAGTCAGGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1956.45142940537	31.7989830198704	0.0162533976269143	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1951.2422685332	1951.2422685332
"healthy-4003"	"2020-08-26-Control4003-c1:CACTTCGAGTTCCATG"	0.890935977070969	9.29908845508424	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTTCGAGTTCCATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1725.17454462901	37.2314846587413	0.0215812856586912	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.44176566163	1717.44176566163
"healthy-4003"	"2020-08-26-Control4003-c1:CACTTCGGTGTGTGGA"	10.1815382438595	5.96241662586061	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTTCGGTGTGTGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1534.20128831485	27.6141562328825	0.0179990438303005	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1521.20402299385	1521.20402299385
"healthy-4003"	"2020-08-26-Control4003-c1:CACTTCGTCTCGGCTT"	-2.17686090889629	9.29901502216188	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CACTTCGTCTCGGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.99325594182	27.1956898378706	0.0162557079900245	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1670.95747607733	1670.95747607733
"healthy-4003"	"2020-08-26-Control4003-c1:CAGAGCCGTGAATATG"	10.3929172950679	6.00798604572145	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGAGCCGTGAATATG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1509.64907118815	37.1182272571762	0.0245873216269811	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1498.84281558215	1498.84281558215
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATACTCCGTGGGT"	-3.78684745255168	10.496256805304	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATACTCCGTGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2078.82003439079	35.3391022779057	0.0169995967391482	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2071.848902862	2071.848902862
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATTGCAAATGATG"	5.45637812194173	-10.282385849115	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATTGCAAATGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2102.26821900413	40.7069103576984	0.0193633286132165	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2098.05601721025	2098.05601721025
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATTGCAACTCGAT"	9.73057522353474	6.22407338703004	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATTGCAACTCGAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1579.02848932441	3.86838323408765	0.00244985018335088	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1575.98473426623	1575.98473426623
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATTGGTGAATAAC"	5.56712784346883	-9.99484827434691	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATTGGTGAATAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.78016841658	32.721713098064	0.0138312568238175	1367	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.29916082885	2360.29916082885
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATTGGTGAGTAGC"	4.95823254164998	-8.03724768078002	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATTGGTGAGTAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2588.36054683952	29.9547391325266	0.011572861890938	1768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2581.6460228213	2581.6460228213
"healthy-4003"	"2020-08-26-Control4003-c1:CAGATTGTCACCTTGC"	-1.25084994259532	8.49231336200563	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGATTGTCACCTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2255.02714713489	31.1838705623927	0.0138286009558746	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2238.85998572947	2238.85998572947
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCAATCATGACGTT"	0.145913233130616	8.30965898120729	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCAATCATGACGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1649.62173364971	25.4132238362976	0.0154054855836993	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1646.16607937326	1646.16607937326
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCACGAGTGTTCCA"	-3.85183153572734	12.9978370436463	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCACGAGTGTTCCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1990.6668270012	39.0202448441235	0.0196015949604709	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1974.96302521747	1974.96302521747
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCACGGTTTGATCG"	-0.0337533456390679	8.34405706012575	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCACGGTTTGATCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1481.6305952408	24.2414162945701	0.016361309203817	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1476.37319613599	1476.37319613599
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCACGTCCATTTCA"	-1.31208548966106	8.71020314777223	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCACGTCCATTTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.65354567416	31.4421936190962	0.0162689239825073	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1924.73170894421	1924.73170894421
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCAGCTCCATTGTT"	-4.1096285385197	12.6997575529846	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCAGCTCCATTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1934.18774079957	34.5275113854368	0.0178511685588305	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1928.17003658012	1928.17003658012
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCCAGAGACAACTA"	1.95364429530446	-5.37405826961669	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCCAGAGACAACTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2699.94890629386	49.1008925765172	0.0181858599109257	2219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2694.4007169143	2694.4007169143
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCCAGAGCCTTTGA"	-0.0705804032390893	7.97166631305543	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCCAGAGCCTTTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1869.30570476382	30.3649062711847	0.0162439488596228	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1858.44726388837	1858.44726388837
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCCAGGTGGTTTGT"	9.30369724807088	5.52877376163331	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCCAGGTGGTTTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1495.95575532141	35.4947033541055	0.0237271077221661	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1493.88153200779	1493.88153200779
"healthy-4003"	"2020-08-26-Control4003-c1:CAGCGTGGTGACTGTT"	-3.74568138542827	10.4439916380676	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGCGTGGTGACTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.78620229691	35.7106932311207	0.0175933274108921	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2024.30794632783	2024.30794632783
"healthy-4003"	"2020-08-26-Control4003-c1:CAGGCCAAGAATCGTA"	-3.75730500641521	12.7812347182068	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGGCCAAGAATCGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1782.60666611174	31.8387667478201	0.0178607919251573	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1776.22966920615	1776.22966920615
"healthy-4003"	"2020-08-26-Control4003-c1:CAGGGCTTCATCGCCT"	9.85546745833699	7.00031564319459	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGGGCTTCATCGCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1935.94705654147	34.7811664273572	0.0179659698388101	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1929.20924917881	1929.20924917881
"healthy-4003"	"2020-08-26-Control4003-c1:CAGGGCTTCTTACACT"	-2.53151927414592	9.69540021503297	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGGGCTTCTTACACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1898.53311898478	31.0052993138	0.0163311869588979	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1894.94745022586	1894.94745022586
"healthy-4003"	"2020-08-26-Control4003-c1:CAGGTATAGGACAGTC"	-0.0889939171379388	8.4728383787903	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGGTATAGGACAGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2204.83835070215	32.2010585565732	0.0146047253515518	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2193.34931673448	2193.34931673448
"healthy-4003"	"2020-08-26-Control4003-c1:CAGGTATTCATGACAC"	9.9672438102657	6.07848260486452	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGGTATTCATGACAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1733.03146676417	36.5020397352959	0.0210625371987334	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1724.49187612334	1724.49187612334
"healthy-4003"	"2020-08-26-Control4003-c1:CAGTTAGAGCCAGACA"	0.329374839633149	8.17791841113893	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGTTAGAGCCAGACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1679.24099371728	32.1961749304265	0.0191730520222442	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1675.71000564548	1675.71000564548
"healthy-4003"	"2020-08-26-Control4003-c1:CAGTTAGCACTGTCGG"	-1.90271494808849	9.33458707416383	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGTTAGCACTGTCGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1902.68585649451	31.2035636583348	0.0163997454187335	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1883.29879454543	1883.29879454543
"healthy-4003"	"2020-08-26-Control4003-c1:CAGTTCCCAAAGCTAA"	-4.3285325569218	12.8693313368591	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CAGTTCCCAAAGCTAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1932.48056114713	40.3098197619963	0.020859107497603	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1928.3632156921	1928.3632156921
"healthy-4003"	"2020-08-26-Control4003-c1:CATAAGCAGCGTGAAC"	0.487597008317155	8.29824731433717	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATAAGCAGCGTGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1634.16029739249	36.2851132651117	0.0222041334151915	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1634.16029739249	1634.16029739249
"healthy-4003"	"2020-08-26-Control4003-c1:CATACCCGTGTCGCTG"	5.60349812087361	-9.74234297191771	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATACCCGTGTCGCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.96610990542	35.2892708884578	0.0134848024033957	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2608.16531182818	2608.16531182818
"healthy-4003"	"2020-08-26-Control4003-c1:CATACCCTCGCTGTTC"	8.98651184615437	6.70041558826295	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATACCCTCGCTGTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.37236459014	32.6118276673182	0.0189013272361443	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1716.08564472978	1716.08564472978
"healthy-4003"	"2020-08-26-Control4003-c1:CATAGACCAACACGTT"	-2.75065908852275	9.29725453937379	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATAGACCAACACGTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2249.4995841632	36.1398013092701	0.0160657070415569	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2242.03688682111	2242.03688682111
"healthy-4003"	"2020-08-26-Control4003-c1:CATCAAGGTTAGGCTT"	9.62215771254842	6.38589522922365	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCAAGGTTAGGCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1554.74218357696	36.1264330534094	0.0232362853693814	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1545.27190431506	1545.27190431506
"healthy-4003"	"2020-08-26-Control4003-c1:CATCCACAGTTGCTCA"	-4.07082877579387	13.1968545683655	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCCACAGTTGCTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2361.27447858217	34.9736501370226	0.0148113446591023	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2352.84586015534	2352.84586015534
"healthy-4003"	"2020-08-26-Control4003-c1:CATCCCACATCAGCGC"	4.08219589766805	-6.90200092708739	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCCCACATCAGCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2748.12508406754	30.8205085818794	0.0112151039851001	2095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2742.34352345895	2742.34352345895
"healthy-4003"	"2020-08-26-Control4003-c1:CATCCCACATTCTCCG"	3.64685239371602	-6.68214847957762	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCCCACATTCTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.60592125037	33.7147784593224	0.0136851345292314	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2451.62224473285	2451.62224473285
"healthy-4003"	"2020-08-26-Control4003-c1:CATCCCAGTTTGTTGG"	2.71727885779683	-4.63100292598876	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCCCAGTTTGTTGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2703.99648095737	30.1631751085619	0.011155034897783	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2697.41892361214	2697.41892361214
"healthy-4003"	"2020-08-26-Control4003-c1:CATCGGGCAACGATCT"	4.15184845504109	-6.96442844783934	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATCGGGCAACGATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.6348761308	41.9166373776171	0.0190995950321892	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2193.05196455967	2193.05196455967
"healthy-4003"	"2020-08-26-Control4003-c1:CATGCCTGTGGTGATG"	-3.0867796939915	9.60951039874879	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATGCCTGTGGTGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.34929864557	34.9676104932775	0.0177739715653703	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.85994168876	1957.85994168876
"healthy-4003"	"2020-08-26-Control4003-c1:CATGCGGCATGCTGCG"	-2.70813832703288	10.182310081366	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATGCGGCATGCTGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1621.67102063977	39.3535913016216	0.0242673087209119	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1619.52587563853	1619.52587563853
"healthy-4003"	"2020-08-26-Control4003-c1:CATGCGGGTTCAGCGC"	-0.615537802607375	8.6969594725403	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATGCGGGTTCAGCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1486.14148147837	18.0098849503393	0.0121185534316852	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1482.10915428879	1482.10915428879
"healthy-4003"	"2020-08-26-Control4003-c1:CATGGTATCTCCAATT"	-3.43391809883769	10.2034339674744	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATGGTATCTCCAATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2000.4012337799	35.168259807032	0.0175806029376312	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1996.62094697792	1996.62094697792
"healthy-4003"	"2020-08-26-Control4003-c1:CATTCCGAGACGACGT"	2.26135100898091	-4.41511537944945	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTCCGAGACGACGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2902.73907559705	31.5513859664184	0.0108695219049024	2496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2894.34890077543	2894.34890077543
"healthy-4003"	"2020-08-26-Control4003-c1:CATTCCGAGCAGCCCT"	-1.6099935573643	8.70471284473268	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTCCGAGCAGCCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1914.80173230435	34.4045845551289	0.0179677007674967	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.4891391897	1911.4891391897
"healthy-4003"	"2020-08-26-Control4003-c1:CATTCTAAGAGGCGTT"	0.242021520703477	8.45580384815065	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTCTAAGAGGCGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1754.02234788935	26.796427035753	0.0152771297743142	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1747.45136370964	1747.45136370964
"healthy-4003"	"2020-08-26-Control4003-c1:CATTCTATCTCTCTTC"	6.75271620330159	-1.6161930791107	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTCTATCTCTCTTC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2345.39658277862	27.7765127416446	0.0118429919040546	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2330.11943688635	2330.11943688635
"healthy-4003"	"2020-08-26-Control4003-c1:CATTTCAAGCAATAAC"	3.81313552436177	-6.33140327846678	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTTCAAGCAATAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.35051843618	35.9512592040122	0.0136522878182438	1655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2627.0430512761	2627.0430512761
"healthy-4003"	"2020-08-26-Control4003-c1:CATTTCACAACACGAG"	-2.83850107613261	11.7221221693787	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTTCACAACACGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1358.71858716791	29.9219200312586	0.0220221614054955	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1358.71858716791	1358.71858716791
"healthy-4003"	"2020-08-26-Control4003-c1:CATTTCACAGGACTAG"	-0.0175006118720353	8.35431096637575	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTTCACAGGACTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.87259279248	35.6485178570239	0.0190138348568679	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.36748931148	1864.36748931148
"healthy-4003"	"2020-08-26-Control4003-c1:CATTTCACATCGGCCA"	-3.54370150986369	10.2743558653626	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CATTTCACATCGGCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.30030111962	32.7547107537414	0.0189410195166997	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1727.25451803543	1727.25451803543
"healthy-4003"	"2020-08-26-Control4003-c1:CCAATTTTCATAGCAC"	-4.26354299011882	12.4263973006043	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCAATTTTCATAGCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1911.34507851636	14.9412982979982	0.00781716418763903	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1911.34507851636	1911.34507851636
"healthy-4003"	"2020-08-26-Control4003-c1:CCAATTTTCGACATAC"	-2.68057499352153	10.1549606093201	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCAATTTTCGACATAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1781.58390665854	38.8294396607557	0.0217948980767246	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1773.33749275509	1773.33749275509
"healthy-4003"	"2020-08-26-Control4003-c1:CCACAAACACAACGTT"	9.73356594619099	6.54824683750001	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACAAACACAACGTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1612.56517130845	35.3448993265887	0.0219184315495972	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1612.56517130845	1612.56517130845
"healthy-4003"	"2020-08-26-Control4003-c1:CCACACTCACGCGCAT"	10.644831319421	6.42038772189943	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACACTCACGCGCAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2018.18915419828	34.2020066732973	0.016946878642247	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2001.4958637087	2001.4958637087
"healthy-4003"	"2020-08-26-Control4003-c1:CCACACTGTCGCATCG"	5.40451492842976	-9.99301721965941	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACACTGTCGCATCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.35034564354	28.835893189224	0.0123159241174128	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2335.53426921067	2335.53426921067
"healthy-4003"	"2020-08-26-Control4003-c1:CCACCATCATGAGATA"	4.56765141066853	-7.47186996853026	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACCATCATGAGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.42213403283	4.7229502322035	0.00197578083174603	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.86504259438	2388.86504259438
"healthy-4003"	"2020-08-26-Control4003-c1:CCACCATTCCGAGGCT"	-3.7034526866978	13.0592469939026	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACCATTCCGAGGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1883.01341724519	28.6112177925019	0.015194378080619	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1883.01341724519	1883.01341724519
"healthy-4003"	"2020-08-26-Control4003-c1:CCACCATTCGCAGTGC"	-3.9363194507664	12.441286064032	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACCATTCGCAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2126.52196918306	13.0615109077799	0.00614219420117145	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2116.30748775312	2116.30748775312
"healthy-4003"	"2020-08-26-Control4003-c1:CCACGAGGTGGTTTAC"	3.09871520575826	-6.19637873088988	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACGAGGTGGTTTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.77269900343	29.0882976720528	0.0119176593887377	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2435.27222148845	2435.27222148845
"healthy-4003"	"2020-08-26-Control4003-c1:CCACGTTGTCTGTGTA"	-3.72318873825725	10.602795577887	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACGTTGTCTGTGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2049.64404825123	38.1505510273594	0.0186132568042289	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2042.31884056201	2042.31884056201
"healthy-4003"	"2020-08-26-Control4003-c1:CCACGTTTCCTTCTTC"	-3.60616980019267	10.5187625654968	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACGTTTCCTTCTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2313.4817913614	31.2244160579595	0.0134967200410015	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2304.75056744188	2304.75056744188
"healthy-4003"	"2020-08-26-Control4003-c1:CCACTTGAGTCCCAGC"	10.3592754798824	7.11372945392457	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACTTGAGTCCCAGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1943.59988330924	33.7900138533223	0.0173852726291536	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1936.96034442054	1936.96034442054
"healthy-4003"	"2020-08-26-Control4003-c1:CCACTTGCACGCACCA"	9.69127621230428	5.3823261030945	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACTTGCACGCACCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1380.8670981034	34.0295307281796	0.0246435958789363	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1376.33070286487	1376.33070286487
"healthy-4003"	"2020-08-26-Control4003-c1:CCACTTGTCTTTGCGC"	-4.06067500534709	13.1942014464172	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCACTTGTCTTTGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2435.34854488301	34.549687201292	0.0141867525590476	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2426.86053000074	2426.86053000074
"healthy-4003"	"2020-08-26-Control4003-c1:CCATAAGGTCGAATTC"	-3.82092605057414	10.2231664427551	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCATAAGGTCGAATTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1929.25113525281	37.6125910963215	0.0194959538491565	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1923.42734556791	1923.42734556791
"healthy-4003"	"2020-08-26-Control4003-c1:CCCAACTCAATACGCT"	-3.25027380409892	9.83441636646119	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCAACTCAATACGCT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2180.70083187036	33.2199534652825	0.0152336134236213	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2173.95504315203	2173.95504315203
"healthy-4003"	"2020-08-26-Control4003-c1:CCCATTGTCAACGTGT"	-0.123774091631728	8.69385621631471	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCATTGTCAACGTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.25138682551	35.6441495271899	0.0212896043017611	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1668.69032959963	1668.69032959963
"healthy-4003"	"2020-08-26-Control4003-c1:CCCATTGTCAAGAAAC"	-3.24986300888713	9.65755746448366	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCATTGTCAAGAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2008.7001350343	31.0008580965745	0.0154332931809382	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2003.40096662444	2003.40096662444
"healthy-4003"	"2020-08-26-Control4003-c1:CCCATTGTCTCAGTCC"	-6.93672023239787	3.30741856181947	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCATTGTCTCAGTCC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2389.44365956489	34.5611343542566	0.0144640925999276	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2377.69117722059	2377.69117722059
"healthy-4003"	"2020-08-26-Control4003-c1:CCCGAAGGTAGTACGG"	4.92085947570149	-7.96212389385375	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCGAAGGTAGTACGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.76036419548	4.45008022836398	0.00184592392278237	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2409.49375605738	2409.49375605738
"healthy-4003"	"2020-08-26-Control4003-c1:CCCGAAGTCTCACTCG"	-1.68412588062938	9.47901341998903	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCGAAGTCTCACTCG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2101.14928220762	21.4429323846326	0.0102053350355492	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2098.03530288838	2098.03530288838
"healthy-4003"	"2020-08-26-Control4003-c1:CCCGGAAAGCAGGCAT"	-4.32394776764567	10.9677943953308	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCGGAAAGCAGGCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.96168932583	42.0000482170459	0.0204284196709998	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2048.80380051693	2048.80380051693
"healthy-4003"	"2020-08-26-Control4003-c1:CCCGGAAGTACGTGTT"	-4.04286227646525	12.5435027846131	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCGGAAGTACGTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1737.67162976591	31.9616062579285	0.0183933521791077	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1730.84712594912	1730.84712594912
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTCAATCCTCACCA"	10.465650220483	6.46740481937257	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTCAATCCTCACCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1906.74252904597	32.3310254428084	0.016956156875037	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1898.47991402552	1898.47991402552
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTCTCAGCTACGTT"	4.55457033690755	-7.2500849000183	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTCTCAGCTACGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2546.5526522947	20.2432168530901	0.00794926303010027	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2536.08994734389	2536.08994734389
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTCTCGTCTTGCGG"	-4.32014785233195	13.0766858824524	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTCTCGTCTTGCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2001.3184122785	37.8761483531557	0.0189255983059855	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1997.3430549565	1997.3430549565
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTTAGAGTCTAGCT"	0.21747707304303	8.30339715564577	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTTAGAGTCTAGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2102.5872232369	29.3940784549633	0.0139799567552359	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2072.21651118754	2072.21651118754
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTTAGCACCATAAC"	-7.39975343170817	0.815723873022474	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTTAGCACCATAAC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2158.14237918818	10.7825781517333	0.00499623113642267	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2155.0043130231	2155.0043130231
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTTAGCACCTCAGG"	9.67078842696492	6.5578779944214	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTTAGCACCTCAGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1752.51763528312	33.1451189872848	0.0189128590320464	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1745.74726333613	1745.74726333613
"healthy-4003"	"2020-08-26-Control4003-c1:CCCTTAGTCCGCATAA"	-5.40689883652385	-5.56003143703612	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCCTTAGTCCGCATAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2952.67015046596	35.2804436631208	0.0119486572713018	2201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2944.57029109249	2944.57029109249
"healthy-4003"	"2020-08-26-Control4003-c1:CCGAACGTCTACGCAA"	-4.12313447418864	13.2316188582214	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGAACGTCTACGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1978.50927642659	37.1580751612829	0.018780844549991	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1962.59465642159	1962.59465642159
"healthy-4003"	"2020-08-26-Control4003-c1:CCGCAAGGTGAATATG"	4.73533596572225	-8.32784845745238	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGCAAGGTGAATATG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.3637093394	37.1187058383974	0.0146173254748346	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2533.92304605912	2533.92304605912
"healthy-4003"	"2020-08-26-Control4003-c1:CCGCAAGTCATGAGGG"	3.4556802707607	-7.60413601314696	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGCAAGTCATGAGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.65407773389	15.7999875982666	0.00770861179450103	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.37193959235	2044.37193959235
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGACATCCGTAGGC"	5.58362545546834	-9.97945883190306	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGACATCCGTAGGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.92458574829	19.0609069156371	0.00796885780981845	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2384.69799702376	2384.69799702376
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGGTACACTGTGAT"	5.49386181411092	-9.34432794963988	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGGTACACTGTGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.52132195479	31.4914873325195	0.0128247663952068	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2449.76264548909	2449.76264548909
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGTAGTCGACGTCG"	-3.03085837784465	-5.78207733547362	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGTAGTCGACGTCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2432.35406701665	32.9328523016593	0.0135394977023442	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2428.67479201156	2428.67479201156
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGTGACACGGCACT"	4.99324287947957	-8.15333368694457	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGTGACACGGCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.17545135811	36.4282432011173	0.0136477514741798	1835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2663.6443800593	2663.6443800593
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGTGACAGAAATTG"	0.210759271948975	8.59078881824342	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGTGACAGAAATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1714.5559834679	45.1836176106529	0.0263529555443641	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1707.25665720663	1707.25665720663
"healthy-4003"	"2020-08-26-Control4003-c1:CCGGTGACATTGTGCA"	-3.49799929085429	12.4964561232361	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGGTGACATTGTGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1808.00587114359	32.856358603979	0.0181727057021097	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1803.57618052136	1803.57618052136
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTGAGAGCCTCACG"	5.49004854735677	-9.65078451549681	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTGAGAGCCTCACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.74529643529	0	0	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.7807735639	2311.7807735639
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTGAGCATAACAGA"	-1.41029046002086	8.69405171954957	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTGAGCATAACAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.54146315238	33.3650809075048	0.0164235293803611	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2026.15359920854	2026.15359920854
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTGAGCATATCGGT"	0.466047843068284	7.8013591536316	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTGAGCATATCGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1537.94114599043	17.3054263541104	0.0112523332893638	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1532.94806262708	1532.94806262708
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTGAGGTTCTGAGT"	-3.44914803925212	12.1743364104065	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTGAGGTTCTGAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1530.68222821195	36.96527338647	0.0241495411034141	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1530.68222821195	1530.68222821195
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTTCAAGACATACA"	2.64176549491231	-4.34867241298827	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTTCAAGACATACA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2483.61925557531	31.8851421536443	0.0128381764161586	1807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2480.55796891244	2480.55796891244
"healthy-4003"	"2020-08-26-Control4003-c1:CCGTTCACATCTCGTC"	-3.20349274101909	10.2962312468323	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCGTTCACATCTCGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2252.74751899129	37.1802971631606	0.0165044226437807	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2237.83686339409	2237.83686339409
"healthy-4003"	"2020-08-26-Control4003-c1:CCTAAGAGTTCTATCT"	-4.09707627716716	13.074683166388	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTAAGAGTTCTATCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2138.06004836727	41.313505319457	0.0193228928958314	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2125.35087693572	2125.35087693572
"healthy-4003"	"2020-08-26-Control4003-c1:CCTACGTAGGACTTCT"	10.7193008857662	6.48115060413209	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTACGTAGGACTTCT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.44138091993	29.9737696018073	0.0139449113932006	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2135.83747048465	2135.83747048465
"healthy-4003"	"2020-08-26-Control4003-c1:CCTATCGAGGAGGGTG"	10.0411220985347	6.86487577045289	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTATCGAGGAGGGTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1864.64403858259	36.474932947631	0.0195613383535431	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1859.53908414595	1859.53908414595
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCAACCATGAATAG"	-2.12041221085246	8.47031495654909	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCAACCATGAATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2555.24615847419	34.3506967357124	0.0134432045311142	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2547.71475171063	2547.71475171063
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCAACGTTTCGTTT"	5.5834719139034	-10.1918487778869	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCAACGTTTCGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.6591687706	41.009585447364	0.0170471303581719	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2399.3029254918	2399.3029254918
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCAGTCACACAGCC"	-3.38801465454753	9.70885179126588	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCAGTCACACAGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2128.0203272514	31.2968152901189	0.0147070095568789	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2124.76028403382	2124.76028403382
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCAGTTCCAAATGC"	5.55441631850545	-10.0347280732361	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCAGTTCCAAATGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.96635090001	2.72249840288843	0.00111260148791465	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2442.8426717346	2442.8426717346
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCTAGAGTGGTGGT"	-7.56937060776408	0.240854493621267	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCTAGAGTGGTGGT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3060.3164522706	38.2014842809774	0.0124828542658175	3572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3052.65690690124	3052.65690690124
"healthy-4003"	"2020-08-26-Control4003-c1:CCTCTCCGTACTCGTA"	-2.89779744568523	10.636749244574	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTCTCCGTACTCGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1603.09554496796	34.3365270495435	0.0214188899453462	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1598.93591013101	1598.93591013101
"healthy-4003"	"2020-08-26-Control4003-c1:CCTGCATCACTCCGAG"	3.7182899909908	-7.05027820980223	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTGCATCACTCCGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.6629549182	40.6131968407563	0.0181093626894272	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2230.60251600159	2230.60251600159
"healthy-4003"	"2020-08-26-Control4003-c1:CCTTTGGCAGGTAGTG"	-0.834426979452926	9.1194972761902	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CCTTTGGCAGGTAGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1574.09407036851	33.3446397439004	0.0211833843806387	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1569.11823052947	1569.11823052947
"healthy-4003"	"2020-08-26-Control4003-c1:CGAAGGACACTAGGCC"	-0.293896595866042	8.51700685108034	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAAGGACACTAGGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.58432045427	36.2605276259066	0.0193535605683948	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1863.14933651211	1863.14933651211
"healthy-4003"	"2020-08-26-Control4003-c1:CGAAGTTCAAGCTGTT"	3.52125777777974	-6.58670332348021	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAAGTTCAAGCTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.44889768982	30.9508818536404	0.0127451238043691	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2420.46603801239	2420.46603801239
"healthy-4003"	"2020-08-26-Control4003-c1:CGAATTGAGTACGTCT"	2.99683131751363	-4.99385168468627	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAATTGAGTACGTCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2534.14822865632	30.9195893078387	0.0122011762998699	2018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2529.71638968427	2529.71638968427
"healthy-4003"	"2020-08-26-Control4003-c1:CGAATTGCAGTTGTCA"	-3.72373280945476	10.8412656554016	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAATTGCAGTTGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.43558726484	23.9694833149947	0.0132031582299801	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.47267405213	1813.47267405213
"healthy-4003"	"2020-08-26-Control4003-c1:CGAATTGGTGCCCACA"	4.99882998046224	-7.90244724666747	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAATTGGTGCCCACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.22484516103	32.8087285302106	0.0127698938424964	1589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2566.11549591746	2566.11549591746
"healthy-4003"	"2020-08-26-Control4003-c1:CGAATTGGTTGAATCC"	-3.22349367561992	10.5232763060364	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAATTGGTTGAATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1476.30543039345	38.3026880495348	0.0259449618357949	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1474.02850106489	1474.02850106489
"healthy-4003"	"2020-08-26-Control4003-c1:CGACAGCCAGAGTCTT"	-0.102554063231307	8.73762796008912	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGACAGCCAGAGTCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1421.33840479928	30.0442632678341	0.0211380084900168	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1417.0464630744	1417.0464630744
"healthy-4003"	"2020-08-26-Control4003-c1:CGACAGCCAGGCACAA"	5.33811106261556	-9.98681929027709	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGACAGCCAGGCACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.00738067148	5.14696932729527	0.00230494953659649	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2227.13570515256	2227.13570515256
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGGAAGTCTTTCAT"	-1.76655373993571	9.56370256030885	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGGAAGTCTTTCAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1803.85975815679	13.6655751549655	0.00757574145837658	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1802.17018294235	1802.17018294235
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGGCTCACCCTTAC"	0.398287017911118	8.1075401076111	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGGCTCACCCTTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.35400130086	16.3829961138075	0.00958432021766094	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1700.31469100553	1700.31469100553
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGTGCGTTACCCAA"	6.792009015649	-1.72126545822295	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGTGCGTTACCCAA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2696.34983102629	25.6428431489888	0.00951020629961381	1992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2683.78341760821	2683.78341760821
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGTGCTCTCCGAAA"	5.44359602507893	-9.5513429871765	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGTGCTCTCCGAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.38165717923	20.8387478594273	0.00913827200539945	1318	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2274.54080585812	2274.54080585812
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGTTACATGCCATA"	-2.3175245327061	8.35626981342164	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGTTACATGCCATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2290.23084689914	40.0405720597135	0.0174832035442743	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2276.7150425071	2276.7150425071
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGTTAGTGTGAGCA"	-3.58600840988811	10.6778440245422	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGTTAGTGTGAGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1664.33762362553	43.0083245686708	0.0258411057697434	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1657.99834609681	1657.99834609681
"healthy-4003"	"2020-08-26-Control4003-c1:CGAGTTAGTGTTTACG"	-0.134185220033485	8.1786899336609	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGAGTTAGTGTTTACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.69105255566	34.0313577765257	0.0173038656642602	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.28729545369	1957.28729545369
"healthy-4003"	"2020-08-26-Control4003-c1:CGATGGCGTCACTCTC"	-1.49834845486339	8.4864406355652	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGATGGCGTCACTCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.27479084195	33.4574395790535	0.0176624002709673	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1884.22413599165	1884.22413599165
"healthy-4003"	"2020-08-26-Control4003-c1:CGATGGCGTTGCGAAG"	-3.95029197159465	10.3096284636292	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGATGGCGTTGCGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.58498556739	28.1100810148771	0.0134267685375375	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2090.13436280884	2090.13436280884
"healthy-4003"	"2020-08-26-Control4003-c1:CGATGGCTCCGTATAG"	-1.40888307514842	8.65346906268922	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGATGGCTCCGTATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1805.30498333366	0	0	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.38630379242	1792.38630379242
"healthy-4003"	"2020-08-26-Control4003-c1:CGCAGGTCAATCGTCA"	10.4086996513302	5.85299346530763	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCAGGTCAATCGTCA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1670.11868214281	33.4330821144187	0.0200183869996132	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1664.32758578391	1664.32758578391
"healthy-4003"	"2020-08-26-Control4003-c1:CGCATAACAATCGCGC"	-4.29703221741374	12.9317302473816	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCATAACAATCGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2547.98840443361	37.1367345809427	0.0145749229142186	1560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2538.52742111907	2538.52742111907
"healthy-4003"	"2020-08-26-Control4003-c1:CGCCAGAAGAGCCTGA"	0.783263702958268	8.72965810382692	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCCAGAAGAGCCTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1483.93484211122	5.05105932596037	0.00340382824273748	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1481.81694696662	1481.81694696662
"healthy-4003"	"2020-08-26-Control4003-c1:CGCCAGACAAATACAG"	3.89426459845845	-6.9970388642517	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCCAGACAAATACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.09398865485	10.477960909478	0.00473667075775993	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2209.09266226968	2209.09266226968
"healthy-4003"	"2020-08-26-Control4003-c1:CGCCAGAGTTAAACAG"	-3.50984940949138	10.1628608473572	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCCAGAGTTAAACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1927.29806343473	33.2609289789104	0.0172578023139994	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1923.56427553176	1923.56427553176
"healthy-4003"	"2020-08-26-Control4003-c1:CGCCAGAGTTCAAAGA"	4.75041975554768	-8.11651327526244	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCCAGAGTTCAAAGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.50018511025	30.210488637536	0.0122981829273423	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.50371875567	2452.50371875567
"healthy-4003"	"2020-08-26-Control4003-c1:CGCCATTAGCTAAGTA"	3.28557838973348	-7.00122549450072	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCCATTAGCTAAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.12034593275	39.4777147933717	0.0197179529560097	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1998.41091181275	1998.41091181275
"healthy-4003"	"2020-08-26-Control4003-c1:CGCGTGACAGAGACTG"	0.32895733889882	8.3972482451233	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCGTGACAGAGACTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1784.25869989043	23.3355519401173	0.0130785697957086	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.99071079411	1775.99071079411
"healthy-4003"	"2020-08-26-Control4003-c1:CGCGTGATCTATACGG"	0.191418190568131	8.77334783161012	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGCGTGATCTATACGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.07188055076	29.1002217548793	0.0160857189079849	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.60635452497	1807.60635452497
"healthy-4003"	"2020-08-26-Control4003-c1:CGGACACAGCATGATA"	-3.79289207878764	11.8323116072449	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGACACAGCATGATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2162.07153324382	29.1044273613414	0.0134613618993795	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2155.32808032692	2155.32808032692
"healthy-4003"	"2020-08-26-Control4003-c1:CGGACACAGGTGCAGT"	-4.47169766846355	3.68026754939882	"2020-08-26-Control4003-c1"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGACACAGGTGCAGT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2154.26892229718	14.1984959522071	0.00659086514466665	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2149.06572407833	2149.06572407833
"healthy-4003"	"2020-08-26-Control4003-c1:CGGAGAAAGATTAGAC"	3.29916920241658	-6.29056217586669	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGAGAAAGATTAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2537.41011216417	28.6823966976865	0.0113038079891717	1626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2532.54677776807	2532.54677776807
"healthy-4003"	"2020-08-26-Control4003-c1:CGGCAGTAGGGACCAT"	9.62825932082478	6.2529463537964	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGCAGTAGGGACCAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1778.93506702596	34.0779975858181	0.0191564032985139	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1769.67638910038	1769.67638910038
"healthy-4003"	"2020-08-26-Control4003-c1:CGGCAGTCACGGGCTT"	0.569855053990525	8.60029981220094	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGCAGTCACGGGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1530.85671638495	30.280724994542	0.0197802476681479	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1529.0619839102	1529.0619839102
"healthy-4003"	"2020-08-26-Control4003-c1:CGGGACTAGTATGAGT"	5.63989367064778	-9.98576929485472	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGGACTAGTATGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.01807903679	8.19358569847674	0.00339839247565912	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.60650992252	2407.60650992252
"healthy-4003"	"2020-08-26-Control4003-c1:CGGGACTTCTTCCGTG"	5.53854860839192	-10.1287937394348	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGGACTTCTTCCGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.82871693249	19.8945692053286	0.00837726487955979	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.23923937972	2372.23923937972
"healthy-4003"	"2020-08-26-Control4003-c1:CGGGCATGTTCTCGCT"	-4.34063373032268	13.0260295637879	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGGCATGTTCTCGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2082.30086434671	31.5248315422196	0.015139422012443	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2059.03457244282	2059.03457244282
"healthy-4003"	"2020-08-26-Control4003-c1:CGGGTCAAGCGACAGT"	-3.70621548119243	11.4456434019837	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGGTCAAGCGACAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1723.93206866154	30.7221260761924	0.017820960950071	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1723.93206866154	1723.93206866154
"healthy-4003"	"2020-08-26-Control4003-c1:CGGGTCAGTCGGCTAC"	-3.3594106239384	10.3215827711853	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGGTCAGTCGGCTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.55976882661	38.2971820332874	0.0192394032236785	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1973.85895918261	1973.85895918261
"healthy-4003"	"2020-08-26-Control4003-c1:CGGTCAGTCCAGCACG"	0.0660774261573374	8.85410783374635	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGTCAGTCCAGCACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1600.90775746742	40.2727503082002	0.0251561966142948	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1582.38619338449	1582.38619338449
"healthy-4003"	"2020-08-26-Control4003-c1:CGGTCAGTCTGGGCAC"	-3.56960497322734	10.5985383757385	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGGTCAGTCTGGGCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1870.34604945094	37.6299599393197	0.0201192500983262	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1858.36081208067	1858.36081208067
"healthy-4003"	"2020-08-26-Control4003-c1:CGTAATGCATGCTGCG"	5.74702801284139	-9.7521543732849	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTAATGCATGCTGCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2649.55766116545	29.7973785091077	0.0112461709914254	1795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2637.44351816811	2637.44351816811
"healthy-4003"	"2020-08-26-Control4003-c1:CGTAATGTCCACCTGT"	10.1361948448116	6.9927358397278	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTAATGTCCACCTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1752.2727272838	40.2275039693998	0.0229573304104073	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1750.46518180355	1750.46518180355
"healthy-4003"	"2020-08-26-Control4003-c1:CGTAGTACACAGCATT"	-0.512343804270583	8.40709016406862	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTAGTACACAGCATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.89711219224	34.3715746265601	0.0190013983630636	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.64311705145	1801.64311705145
"healthy-4003"	"2020-08-26-Control4003-c1:CGTAGTACAGATTAAG"	0.446944077580613	9.09803388202516	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTAGTACAGATTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1502.26238755788	39.3849068921895	0.0262170624908041	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1500.28336942922	1500.28336942922
"healthy-4003"	"2020-08-26-Control4003-c1:CGTCAAATCGTGGGTC"	-1.20269487324412	8.48278043353883	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTCAAATCGTGGGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1995.80885328101	25.4933285253261	0.0127734319263172	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1991.25106743395	1991.25106743395
"healthy-4003"	"2020-08-26-Control4003-c1:CGTCCATAGAGGCTGT"	3.58848228034322	-5.63455107128295	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTCCATAGAGGCTGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2792.35293170006	13.1853645796044	0.00472195488969826	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2791.65115023893	2791.65115023893
"healthy-4003"	"2020-08-26-Control4003-c1:CGTCCATCAACCGATT"	3.81350435790364	-7.37246181881102	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTCCATCAACCGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.23843193441	36.3670193279875	0.0165814253473172	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2191.66219977441	2191.66219977441
"healthy-4003"	"2020-08-26-Control4003-c1:CGTCCATTCTTGGAAC"	5.42100729522054	-9.93541529094847	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTCCATTCTTGGAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2015.7786456321	10.9310082528106	0.00542272251791958	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2014.10356222172	2014.10356222172
"healthy-4003"	"2020-08-26-Control4003-c1:CGTGAATAGCGCGTTC"	3.2047778564388	-5.36110212719115	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTGAATAGCGCGTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.13437245271	27.6138269408763	0.0117399019649042	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.6746018747	2343.6746018747
"healthy-4003"	"2020-08-26-Control4003-c1:CGTGAATCAGAGTGTG"	5.34361090239827	-9.8807640305725	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTGAATCAGAGTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.59308020861	40.6391330174012	0.0192914015522052	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2103.66502583116	2103.66502583116
"healthy-4003"	"2020-08-26-Control4003-c1:CGTGATACACACACTA"	0.641989012330216	8.59088513934938	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTGATACACACACTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1531.77372218109	30.8588931069649	0.0201458561797397	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1515.41452074893	1515.41452074893
"healthy-4003"	"2020-08-26-Control4003-c1:CGTGCTTGTGCATTAC"	5.67474188384358	-9.86662008678588	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTGCTTGTGCATTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.42007493563	19.8440344018412	0.00826345819665603	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.39305566026	2396.39305566026
"healthy-4003"	"2020-08-26-Control4003-c1:CGTTGGGAGGAAGAAC"	-2.84263620796855	10.8138570555481	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CGTTGGGAGGAAGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1398.11918788586	37.705645593014	0.0269688349317557	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1395.62341280787	1395.62341280787
"healthy-4003"	"2020-08-26-Control4003-c1:CTAACCCGTCACTCTC"	5.62306704100911	-9.89591600811156	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTAACCCGTCACTCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.53499753099	24.9769000641377	0.0101263108324592	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2456.492786375	2456.492786375
"healthy-4003"	"2020-08-26-Control4003-c1:CTAACTTCAGGACTAG"	-3.45232019844707	-5.53142406856688	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTAACTTCAGGACTAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2615.36300347804	32.7397010830276	0.0125182244451301	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2610.45773631454	2610.45773631454
"healthy-4003"	"2020-08-26-Control4003-c1:CTAAGTGAGCTTGTTG"	5.43986954268758	-10.0434341660705	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTAAGTGAGCTTGTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2078.2975596511	10.0958068260123	0.004857729240517	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2076.68498586916	2076.68498586916
"healthy-4003"	"2020-08-26-Control4003-c1:CTACAGATCTATTTCG"	-4.11709104004558	13.0572662123474	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACAGATCTATTTCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2137.33932790902	39.2002093339696	0.018340657855353	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2131.94156348651	2131.94156348651
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCCAAGCGGATCA"	-0.239330987364608	8.61013791644899	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCCAAGCGGATCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1993.0395794083	31.3318838086745	0.0157206530830544	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1981.90368388859	1981.90368388859
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCCACAGCACAGA"	-0.397206733853179	8.46345422351686	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCCACAGCACAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2147.56307700511	32.9272414452266	0.0153323745401441	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2133.64175476307	2133.64175476307
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCCAGTCCGGCAT"	-3.53859291496928	9.84204194629518	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCCAGTCCGGCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1884.32079979647	34.5790186785764	0.0183509191653095	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.7569026118	1876.7569026118
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCTGAGAGAGTGA"	-2.87192473831828	10.179136253241	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCTGAGAGAGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1642.7911431381	32.7390449371512	0.0199289149286575	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1640.68203572997	1640.68203572997
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCTGCATCCGGCA"	-4.25164161148723	12.4238433607849	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCTGCATCCGGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2092.93558254328	37.7562867358584	0.0180398704340331	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2089.40182916642	2089.40182916642
"healthy-4003"	"2020-08-26-Control4003-c1:CTACCTGGTCTTCTAT"	-3.61336050453838	10.5457629927429	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACCTGGTCTTCTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.67658934905	37.1958444348238	0.0198517954732766	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1866.48813204856	1866.48813204856
"healthy-4003"	"2020-08-26-Control4003-c1:CTACGGGAGGAAGTCC"	-3.13752851906474	10.1448955305847	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACGGGAGGAAGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1668.8576489254	33.336348259799	0.0199755493113895	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.36698987963	1660.36698987963
"healthy-4003"	"2020-08-26-Control4003-c1:CTACGGGAGGCTATCT"	3.69815840300862	-6.37200167095336	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACGGGAGGCTATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.06790171658	15.66871347457	0.00672746099975092	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.57535358357	2327.57535358357
"healthy-4003"	"2020-08-26-Control4003-c1:CTACGGGAGTGCTACT"	-4.0188549560612	12.4604863890442	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACGGGAGTGCTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1703.08958339712	43.1460986007236	0.025334015909287	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1698.70528165637	1698.70528165637
"healthy-4003"	"2020-08-26-Control4003-c1:CTACTATTCAAATGAG"	5.45288242873494	-9.75766088878783	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTACTATTCAAATGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.82193788592	43.167733738824	0.0174993310525765	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2465.42764486687	2465.42764486687
"healthy-4003"	"2020-08-26-Control4003-c1:CTAGGTAAGCCATTCA"	4.11478724059407	-7.22141697322997	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTAGGTAAGCCATTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.40542305396	4.32424129583649	0.00197507563026161	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2187.77387823879	2187.77387823879
"healthy-4003"	"2020-08-26-Control4003-c1:CTAGGTAAGCCATTTG"	-3.86996136131938	10.921417213324	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTAGGTAAGCCATTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.10523365481	35.025908035199	0.0177516674923212	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.62162678759	1964.62162678759
"healthy-4003"	"2020-08-26-Control4003-c1:CTATAGGCACTAGGCC"	5.61662354049031	-10.076273941156	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTATAGGCACTAGGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.69265641161	40.3613404272666	0.0177749024348588	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.08802939157	2264.08802939157
"healthy-4003"	"2020-08-26-Control4003-c1:CTATAGGCATAATCGC"	2.56440343436543	-4.47993328487548	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTATAGGCATAATCGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2265.88297550485	27.8529609468012	0.0122923210280069	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2263.71130355902	2263.71130355902
"healthy-4003"	"2020-08-26-Control4003-c1:CTATCTAAGTGCCGAA"	5.55874027785603	-10.1491022340027	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTATCTAAGTGCCGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.78082744087	11.288466333069	0.00505352458683319	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2230.64748772381	2230.64748772381
"healthy-4003"	"2020-08-26-Control4003-c1:CTATCTATCCAATCCC"	-0.741574804217178	8.40616605365602	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTATCTATCCAATCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2193.56105180794	22.1368826587011	0.0100917558872846	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2180.78215383528	2180.78215383528
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAACCAGGCGTTGA"	-3.16725430908855	10.5030021437439	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAACCAGGCGTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1764.7209749983	39.4183120269317	0.022336852446019	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.24152381506	1756.24152381506
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAACCCAAGTTCGT"	5.44522013243977	-10.1763439408508	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAACCCAAGTTCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.06917712581	11.6706614520676	0.00506963976931339	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2299.03741629983	2299.03741629983
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAACCCAGCAGTGA"	2.51479162749593	-4.02345707332762	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAACCCAGCAGTGA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2230.96344972343	38.3828033466527	0.0172045863644296	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2226.06317272402	2226.06317272402
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAACCTCGTGGCGT"	3.04599537429158	-5.01566030895384	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAACCTCGTGGCGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2515.94425593711	0	0	1806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2512.92322794589	2512.92322794589
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAACCTCTGACAGT"	-3.43364701691325	9.96599195087282	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAACCTCTGACAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2666.10561247761	40.8790447143505	0.0153328677315081	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2659.40466074098	2659.40466074098
"healthy-4003"	"2020-08-26-Control4003-c1:CTCACTGGTAGTAAGT"	10.068472524255	6.96215102756349	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCACTGGTAGTAAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1895.82993322418	31.6335167835568	0.0166858409761252	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1886.6775225446	1886.6775225446
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAGAAGTCATCCCT"	-3.6065345806187	10.5208492049011	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAGAAGTCATCCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1701.1401187466	33.0802904270399	0.0194459527833683	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.00190311771	1693.00190311771
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAGAATCTTGGATG"	-3.55414448204692	10.7034806975159	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAGAATCTTGGATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1860.34982755296	33.1889733294654	0.0178401786792547	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1843.0486984646	1843.0486984646
"healthy-4003"	"2020-08-26-Control4003-c1:CTCAGTCCAAGAGCTG"	9.53875126418416	6.19164702976076	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCAGTCCAAGAGCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1683.02250173389	35.9206689478678	0.0213429522842752	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1674.15445414465	1674.15445414465
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCAACCAAATAAGC"	-3.35640917244609	9.84570310199586	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCAACCAAATAAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2073.1790956392	33.250719830469	0.0160385178011923	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2065.92237139661	2065.92237139661
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCAACCATCGGTTA"	-3.40012488785442	10.3504237898621	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCAACCATCGGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1766.26605532396	33.4727666333226	0.018951146421247	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.10315283049	1756.10315283049
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCACAGTGCGACAA"	-0.51230756464656	8.68151662433473	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCACAGTGCGACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1953.15586125815	29.5405350190822	0.0151245149478513	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.43091224922	1945.43091224922
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCCAACACGTGAGA"	-0.827108959585983	8.59596059406129	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCCAACACGTGAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1931.42318529081	36.3813180246406	0.0188365337548553	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1925.16812873905	1925.16812873905
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCCTCGTCCAAAGG"	1.05970658835713	8.79611585224	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCCTCGTCCAAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1380.58984702737	23.807669538141	0.0172445636837057	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1380.58984702737	1380.58984702737
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCCTCTCATTCTTG"	5.56484331664388	-9.96263983165892	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCCTCTCATTCTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2603.55048837392	30.2606062726008	0.0116228229134517	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2597.12553080684	2597.12553080684
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCTCCAGATGCTTC"	5.10959543761556	-8.01486971294554	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCTCCAGATGCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2779.87364780149	32.0076655162071	0.0115140720663764	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2771.82626824911	2771.82626824911
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCTCCAGTCGCTAT"	5.39652695235555	-9.78024485027465	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCTCCAGTCGCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.62211778678	28.4668054906256	0.011616154642534	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2438.61666462759	2438.61666462759
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCTCCTCACACCCT"	11.2767149406368	5.85578963840333	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCTCCTCACACCCT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2546.54711271337	32.2775117695164	0.0126750106480946	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2529.50888988579	2529.50888988579
"healthy-4003"	"2020-08-26-Control4003-c1:CTCCTTTTCCCGTAAA"	5.58571829375569	-9.85835840618285	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCCTTTTCCCGTAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2609.115195759	7.89319890320027	0.00302523971192621	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2605.59023163594	2605.59023163594
"healthy-4003"	"2020-08-26-Control4003-c1:CTCGAGGAGTCATAGA"	-1.2862996858662	8.74234006488649	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCGAGGAGTCATAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.56713623417	11.6850266824052	0.00672493536435672	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.64327347992	1733.64327347992
"healthy-4003"	"2020-08-26-Control4003-c1:CTCGAGGGTTAACAGA"	-3.98246512833293	9.79951856220094	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCGAGGGTTAACAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2299.75866331074	34.4637744193894	0.0149858221948277	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2291.07233562131	2291.07233562131
"healthy-4003"	"2020-08-26-Control4003-c1:CTCGAGGTCCATTTGT"	-3.57754288139995	12.6168927916321	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCGAGGTCCATTTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1841.15824187227	26.017597241747	0.0141311032642636	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1841.15824187227	1841.15824187227
"healthy-4003"	"2020-08-26-Control4003-c1:CTCTCGAGTCTCTCAC"	5.50846018370931	-9.93162729656371	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCTCGAGTCTCTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.05093273619	32.7357974397373	0.0152753240437179	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2138.0370945975	2138.0370945975
"healthy-4003"	"2020-08-26-Control4003-c1:CTCTCGAGTGAATGAT"	-7.03987966004069	3.35495231235353	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCTCGAGTGAATGAT"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2097.83958648387	39.16898459205	0.0186711056671879	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2083.78071309398	2083.78071309398
"healthy-4003"	"2020-08-26-Control4003-c1:CTCTGGTCACTTCAAG"	0.494644065468949	8.0451450117859	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTCTGGTCACTTCAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1588.72042767982	31.8550735904171	0.0200507735882382	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1584.76464620484	1584.76464620484
"healthy-4003"	"2020-08-26-Control4003-c1:CTGAATGGTACCTAAC"	-0.911519328982192	8.19050977313844	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGAATGGTACCTAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2035.96752762633	32.9039503293471	0.016161333559042	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2030.04728499815	2030.04728499815
"healthy-4003"	"2020-08-26-Control4003-c1:CTGAATGGTCCGCAGT"	-0.65335581722911	8.45963380420534	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGAATGGTCCGCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.18081208787	37.0582294055273	0.0205972791375664	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1788.97248724362	1788.97248724362
"healthy-4003"	"2020-08-26-Control4003-c1:CTGATCCCATAGGCGA"	0.327946026890916	8.48923776233522	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGATCCCATAGGCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1884.01295203034	34.0761439811843	0.0180870009117834	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.143209614	1881.143209614
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCAGGAGATCCTAC"	10.0070511299068	6.38706777179567	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCAGGAGATCCTAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1584.74268269224	33.7360542771681	0.0212880328431967	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1584.74268269224	1584.74268269224
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCAGGAGATGGGCT"	1.59920360621755	-6.61715700542601	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCAGGAGATGGGCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2105.50729762028	36.8172512570253	0.0174861665398346	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2103.8244339478	2103.8244339478
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCAGGAGCATTTCG"	-3.10321412506755	10.4439983137879	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCAGGAGCATTTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1566.59104773634	40.0765800637664	0.0255820305635445	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1564.43886952565	1564.43886952565
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCATCCATGGAAGC"	9.5774904685909	5.61354682529298	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCATCCATGGAAGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1594.16594315562	33.7225320010947	0.0211537149854937	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1588.60510887268	1588.60510887268
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCCTAAGTCGAATA"	5.09114803847615	-10.3393659821716	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCCTAAGTCGAATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1859.92735372587	0	0	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1859.92735372587	1859.92735372587
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCCTACAATCGCAT"	3.29092397269551	-5.41313412105712	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCCTACAATCGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2491.57477946004	26.5543079049712	0.0106576403501427	1685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2490.46497450199	2490.46497450199
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCCTACATCTAACG"	-4.06790147247966	12.8155584105286	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCCTACATCTAACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1953.423044612	5.85061808887389	0.00299505941890635	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1949.54082654408	1949.54082654408
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCGAGAGACTAGAT"	9.38884510573689	5.71092078769533	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCGAGAGACTAGAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1469.40970236467	39.0664001648492	0.0265864585635859	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1459.62437349956	1459.62437349956
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCGAGAGGGAGGAC"	5.13451494750325	-8.44988539135131	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCGAGAGGGAGGAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.81587003773	29.484322448697	0.0121594067463103	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2415.27347565398	2415.27347565398
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCGAGCAGTGCGCT"	4.89260735091512	-8.50317385112914	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCGAGCAGTGCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.80432905302	4.67139595786451	0.00225801729639787	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2067.15993926519	2067.15993926519
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCGAGTCAAAGAAC"	5.52078642424886	-10.0039072266785	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCGAGTCAAAGAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2523.86415429983	22.0308564290626	0.00872901831563685	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2517.12084002104	2517.12084002104
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCGAGTCGTTCGCT"	-1.45225463333781	8.55590627277223	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCGAGTCGTTCGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1809.72038864252	32.5461158699143	0.0179840576887832	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.83500199696	1807.83500199696
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCTCAAGGTGCTTT"	-0.374027709395248	8.52848622882692	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCTCAAGGTGCTTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2371.21248235605	21.8286576944867	0.00920569449465683	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2358.01376742789	2358.01376742789
"healthy-4003"	"2020-08-26-Control4003-c1:CTGCTCAGTCATCTAG"	3.40002789077107	-7.09104969417723	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGCTCAGTCATCTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.11695570549	36.9412379907341	0.0162442120217489	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2269.79488818931	2269.79488818931
"healthy-4003"	"2020-08-26-Control4003-c1:CTGGACGCACTCAGAT"	2.17569150504414	-6.49751331722411	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGGACGCACTCAGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2462.98027991612	38.0776586123408	0.0154599932946429	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2460.59648025485	2460.59648025485
"healthy-4003"	"2020-08-26-Control4003-c1:CTGGACGGTTGGGACA"	0.14521069553439	8.97120282733766	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGGACGGTTGGGACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1461.55217723124	29.5635322467648	0.020227490135022	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1457.71075121767	1457.71075121767
"healthy-4003"	"2020-08-26-Control4003-c1:CTGGCAGAGCTCATAC"	4.12929930266683	-7.05263664638671	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGGCAGAGCTCATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2063.68318097531	35.8753023974576	0.0173841133795076	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.04213068512	2062.04213068512
"healthy-4003"	"2020-08-26-Control4003-c1:CTGGCAGTCAGTGCGC"	10.6180950599605	6.74130580509035	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGGCAGTCAGTGCGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1734.23118267661	34.6702103422296	0.0199916889331443	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1724.82273820975	1724.82273820975
"healthy-4003"	"2020-08-26-Control4003-c1:CTGGTCTCAGAGTAAT"	5.31897415694539	-10.2601862183777	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGGTCTCAGAGTAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.11794102939	25.0899112031577	0.0120675747671801	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2076.01256800282	2076.01256800282
"healthy-4003"	"2020-08-26-Control4003-c1:CTGTCGTCACGCGGTT"	-3.79292641106303	12.8351077803406	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGTCGTCACGCGGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2061.93936089598	38.931135419988	0.0188808343049774	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2054.35177070269	2054.35177070269
"healthy-4003"	"2020-08-26-Control4003-c1:CTGTGAAGTAGGATAT"	5.56017221984212	-9.95499231731566	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGTGAAGTAGGATAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.54894921616	38.0530908819197	0.01752347829675	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2162.47928053639	2162.47928053639
"healthy-4003"	"2020-08-26-Control4003-c1:CTGTGGGAGTCATTGC"	3.5468496280605	-5.63218929683837	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGTGGGAGTCATTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.6742977636	37.9304338839945	0.0150896374752055	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2512.6049385183	2512.6049385183
"healthy-4003"	"2020-08-26-Control4003-c1:CTGTGGGGTTACTCAG"	4.11854757842366	-7.53031256115111	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTGTGGGGTTACTCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.1894005973	33.9627217822214	0.0162408635834328	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2087.86874800134	2087.86874800134
"healthy-4003"	"2020-08-26-Control4003-c1:CTTACCGCAGTAGATA"	0.280541350215119	8.56791780078737	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTACCGCAGTAGATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1608.87844150292	29.9448233307761	0.0186122348079967	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1600.23074140155	1600.23074140155
"healthy-4003"	"2020-08-26-Control4003-c1:CTTACCGGTCCCGCAA"	-0.693566362292129	8.62585351550905	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTACCGGTCCCGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.38847115052	36.4921155304419	0.0200683825867818	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1812.80922392088	1812.80922392088
"healthy-4003"	"2020-08-26-Control4003-c1:CTTAGGAAGGACAGCT"	10.5157848792965	5.58623359287111	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTAGGAAGGACAGCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1487.43088450123	34.1471222014016	0.0229571152227701	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1482.19710078165	1482.19710078165
"healthy-4003"	"2020-08-26-Control4003-c1:CTTAGGACAAGAGATT"	4.89362301406209	-7.99677946483763	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTAGGACAAGAGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.01705446805	1.7204803359224	0.000729630149477662	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.25539143131	2355.25539143131
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCAATCAAATGATG"	5.40681137618367	-9.7849102250305	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCAATCAAATGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.08594891111	31.7424468801191	0.0138911391474115	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.08594891111	2285.08594891111
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCAATTCGCTGCGA"	-7.10633454743083	3.28387305820314	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCAATTCGCTGCGA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2227.77721014854	36.6644914656974	0.0164578806617977	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2210.02421322314	2210.02421322314
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCGGTCAGGTTACT"	-4.21713719788249	13.0674648054871	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCGGTCAGGTTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1687.10058146622	21.9598668574695	0.013016335302537	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1684.8728577009	1684.8728577009
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCTAAAGTATGTAG"	-0.404176155955154	8.75336835468141	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCTAAAGTATGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1820.46697702384	32.962405028787	0.0181065657574712	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.65179598029	1815.65179598029
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCTAACAGGCTTGC"	-0.00305092978532914	8.93553922260133	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCTAACAGGCTTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1873.61059513799	43.421415891509	0.0231752617134998	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1862.96840856714	1862.96840856714
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCTAAGTAGAGGAA"	-3.53111896935161	10.2896728285584	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCTAAGTAGAGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1683.14997450715	32.8000943915341	0.0194873272663289	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1676.11611751948	1676.11611751948
"healthy-4003"	"2020-08-26-Control4003-c1:CTTCTCTTCACAATGC"	-4.3395451110905	12.8925437697205	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTCTCTTCACAATGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2246.83917739657	35.5873562241888	0.0158388533466041	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2237.56966954822	2237.56966954822
"healthy-4003"	"2020-08-26-Control4003-c1:CTTTCGGAGGGATCTG"	-4.12367520752605	12.8926753767761	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.CTTTCGGAGGGATCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1828.15952703104	38.9221839134197	0.0212903651666711	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1819.65155026311	1819.65155026311
"healthy-4003"	"2020-08-26-Control4003-c1:GAAACCTCACCTATCC"	0.819159169762772	8.25626657092897	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAACCTCACCTATCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.83995582495	18.2054850922999	0.00972598380307382	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1863.95910921134	1863.95910921134
"healthy-4003"	"2020-08-26-Control4003-c1:GAAACCTTCCGTGCGA"	-3.50668964806255	12.4708223112854	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAACCTTCCGTGCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1578.45325896668	8.50116235831647	0.00538575489012685	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1578.45325896668	1578.45325896668
"healthy-4003"	"2020-08-26-Control4003-c1:GAAATGAGTAGAAACT"	4.14286150512044	-7.06269028103026	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAATGAGTAGAAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.38138974396	1.36779186997046	0.000547471204991099	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.63582270754	2495.63582270754
"healthy-4003"	"2020-08-26-Control4003-c1:GAACACTGTCGAGTGA"	-4.31646571579631	13.1891622313294	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAACACTGTCGAGTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2133.53355547467	28.9271729319457	0.0135583398056798	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2125.29773570355	2125.29773570355
"healthy-4003"	"2020-08-26-Control4003-c1:GAACTGTAGAAGTCTA"	-4.06645713272746	12.6428680189881	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAACTGTAGAAGTCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1910.7288557422	40.4387868828086	0.0211640635254344	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1904.95276016747	1904.95276016747
"healthy-4003"	"2020-08-26-Control4003-c1:GAACTGTAGATTAGAC"	2.54833640631978	-4.04085447704466	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAACTGTAGATTAGAC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2630.53921162137	35.6150455522617	0.013539066589435	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2623.52859871943	2623.52859871943
"healthy-4003"	"2020-08-26-Control4003-c1:GAACTGTTCTTTGCGC"	-2.32480583611186	9.93685338580934	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAACTGTTCTTTGCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1679.97170610138	38.3665545119258	0.0228376194507233	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1677.95463280067	1677.95463280067
"healthy-4003"	"2020-08-26-Control4003-c1:GAAGCCCAGGAGCAAA"	-1.13096104088481	9.00823018634645	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAGCCCAGGAGCAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2105.46713551773	44.5042472367435	0.0211374694413361	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2101.8754845075	2101.8754845075
"healthy-4003"	"2020-08-26-Control4003-c1:GAAGCCCGTGTCCGGT"	2.58087935027425	-4.30691149151	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAGCCCGTGTCCGGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1757.61187390455	37.0752542199751	0.0210941077324495	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1755.76011395139	1755.76011395139
"healthy-4003"	"2020-08-26-Control4003-c1:GAAGCGAAGCACAAAT"	-0.77996532145198	8.40335843646852	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAGCGAAGCACAAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1558.82145609655	41.5219552306523	0.0266367614252806	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1552.96675737075	1552.96675737075
"healthy-4003"	"2020-08-26-Control4003-c1:GAAGCGAGTCTTGAAC"	5.04089226302449	-8.14110758220824	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAGCGAGTCTTGAAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2666.34871923351	0.576406013239197	0.000216178029933344	1799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2661.73670851696	2661.73670851696
"healthy-4003"	"2020-08-26-Control4003-c1:GAAGTAAGTCCGTTTC"	-4.28095565262492	12.5584878691467	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAAGTAAGTCCGTTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2078.2227950198	33.09883767488	0.0159265107447561	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2076.24838444332	2076.24838444332
"healthy-4003"	"2020-08-26-Control4003-c1:GAATAGACAAGAGCTG"	-0.21285260739978	8.10171315753785	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAATAGACAAGAGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.12032966549	35.9461559736035	0.0207287552995458	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.14361102194	1729.14361102194
"healthy-4003"	"2020-08-26-Control4003-c1:GACACGCGTTAAACAG"	-4.14251361313518	12.9661397703919	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACACGCGTTAAACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1992.37380720809	32.8897527343676	0.0165078222848432	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1990.43497539716	1990.43497539716
"healthy-4003"	"2020-08-26-Control4003-c1:GACATCAAGGACTGGT"	-2.88820085945781	10.6023597487244	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACATCAAGGACTGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1831.30082363972	33.4539597226109	0.0182678669122864	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.61641905556	1827.61641905556
"healthy-4003"	"2020-08-26-Control4003-c1:GACATCAGTGTTCCAA"	-3.88190207901652	12.774556136969	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACATCAGTGTTCCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1663.87784740373	37.0534398416027	0.0222693269817973	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1661.74094994297	1661.74094994297
"healthy-4003"	"2020-08-26-Control4003-c1:GACCAATCAAGTGCAG"	4.71326126632039	-7.17498400127562	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACCAATCAAGTGCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2590.8921115284	13.2618461570437	0.00511864083341564	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2587.14552344007	2587.14552344007
"healthy-4003"	"2020-08-26-Control4003-c1:GACCCTTAGGCTCCCA"	9.79616131362264	5.96723935687868	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACCCTTAGGCTCCCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1817.39507150315	17.4853578552816	0.00962110997738076	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1806.47211050692	1806.47211050692
"healthy-4003"	"2020-08-26-Control4003-c1:GACCGTGCAGTAACAA"	5.61095394667928	-10.1219835511413	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACCGTGCAGTAACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.02435418891	18.4194995472944	0.0079086762292398	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.24069060415	2321.24069060415
"healthy-4003"	"2020-08-26-Control4003-c1:GACGCTGAGTCACGCC"	-3.72237978401836	12.8668308028015	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACGCTGAGTCACGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1620.90922360001	28.4863938131122	0.0175743301341975	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1618.6751026469	1618.6751026469
"healthy-4003"	"2020-08-26-Control4003-c1:GACGCTGGTTGGGTTT"	5.51056017455403	-9.75588800823363	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACGCTGGTTGGGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.64646401148	43.0512024186049	0.0168455234418573	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2549.08616585852	2549.08616585852
"healthy-4003"	"2020-08-26-Control4003-c1:GACGTTACACAGGATG"	4.39130177077596	-7.45576670086058	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACGTTACACAGGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.99323739652	36.737443526394	0.0156130680456363	1365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.61711617078	2351.61711617078
"healthy-4003"	"2020-08-26-Control4003-c1:GACGTTAGTCTACGTA"	-3.25042663040813	10.262671447638	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACGTTAGTCTACGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1910.77673106015	27.7176646855087	0.0145059672514068	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1906.89043805909	1906.89043805909
"healthy-4003"	"2020-08-26-Control4003-c1:GACGTTATCCAATGCA"	-4.3627384704655	12.3974952467713	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACGTTATCCAATGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2025.52490442271	36.5573599727855	0.0180483389233886	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2017.81622096928	2017.81622096928
"healthy-4003"	"2020-08-26-Control4003-c1:GACTATGTCTTACACT"	-0.0496339378064454	8.53520867908327	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTATGTCTTACACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1976.36539449844	37.5605300975957	0.0190048511283146	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1970.13762648251	1970.13762648251
"healthy-4003"	"2020-08-26-Control4003-c1:GACTCAACAACAGAGC"	5.64620747145955	-9.76371862804564	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTCAACAACAGAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2573.32104985319	38.9052270040543	0.0151186836971912	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.75049141338	2568.75049141338
"healthy-4003"	"2020-08-26-Control4003-c1:GACTCTCAGAAGCGCT"	4.24328865584676	-6.752064251062	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTCTCAGAAGCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.22114743455	32.8225101670365	0.0135004214658429	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.69340833803	2425.69340833803
"healthy-4003"	"2020-08-26-Control4003-c1:GACTCTCCAAATGAAC"	3.40845646437947	-5.57791712200316	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTCTCCAAATGAAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2998.70342557791	29.7301253886835	0.00991432668369128	3005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2989.60961441661	2989.60961441661
"healthy-4003"	"2020-08-26-Control4003-c1:GACTCTCGTTACTCAG"	-4.02833590927775	12.767681098822	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTCTCGTTACTCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2301.31573476134	29.9435890381669	0.0130115084105451	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2294.29930821233	2294.29930821233
"healthy-4003"	"2020-08-26-Control4003-c1:GACTGATAGCCTTGAT"	-3.63222728195842	10.4623508223328	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GACTGATAGCCTTGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.84608884729	39.9923018858633	0.0190999243444298	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2081.32762163033	2081.32762163033
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAAATCAGAGAAAG"	-4.3607648414677	13.1738595732483	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAAATCAGAGAAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.72228307191	33.4971515417559	0.0173585348708479	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1929.72228307191	1929.72228307191
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAAATCATTGTCGA"	0.372937460511369	8.38039491260377	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAAATCATTGTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1798.44106054672	31.1841919873623	0.0173395685137896	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.74865791993	1792.74865791993
"healthy-4003"	"2020-08-26-Control4003-c1:GAGACTTGTGGAATGC"	-3.80995998802837	12.6328315504822	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGACTTGTGGAATGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1747.44311028724	30.767250473816	0.0176070112341217	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1745.16259683146	1745.16259683146
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTAGCGCCTAC"	10.2490374046261	7.00226495349733	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTAGCGCCTAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1705.59145139491	38.8761881304958	0.022793376513878	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1692.40737636203	1692.40737636203
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTCAACGTTAC"	4.73033918914143	-7.76598837291869	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTCAACGTTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.75154355792	22.7275651415315	0.00986545845409658	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.32584379211	2301.32584379211
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTGTCGTGTTA"	5.30445494231526	-10.0582914582458	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTGTCGTGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.89726105485	38.1340355908664	0.0160233957216977	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2376.09611296963	2376.09611296963
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTGTGAGAACC"	-1.57050476494487	8.78758618915407	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTGTGAGAACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1466.01939094156	33.2257798666349	0.0226639429682409	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1463.90434940074	1463.90434940074
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTTCCTACACC"	-0.0129276094144166	8.21097085559694	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTTCCTACACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.61305281982	28.7278183205056	0.0169324515526738	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1687.86289430111	1687.86289430111
"healthy-4003"	"2020-08-26-Control4003-c1:GAGAGGTTCGCTGATA"	6.803718705743	-1.65438964283141	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGAGGTTCGCTGATA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2337.32834721471	22.1853966980087	0.0094917758236433	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2331.11177473043	2331.11177473043
"healthy-4003"	"2020-08-26-Control4003-c1:GAGATGGCAGGAAGTC"	-7.27632127228435	2.99205110156862	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGATGGCAGGAAGTC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2293.01276897483	30.0303835410911	0.013096474623871	1900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2278.57735971493	2278.57735971493
"healthy-4003"	"2020-08-26-Control4003-c1:GAGCTGCCAACCACGC"	-0.0336361256545365	8.68188569629518	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGCTGCCAACCACGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1948.99329558792	31.4418455682795	0.0161323518348969	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1942.16969259565	1942.16969259565
"healthy-4003"	"2020-08-26-Control4003-c1:GAGGCAAAGCTGTTAC"	10.0102383094722	7.48351380908815	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGGCAAAGCTGTTAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1766.51389294402	32.8511534312977	0.018596600662194	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1762.90811630256	1762.90811630256
"healthy-4003"	"2020-08-26-Control4003-c1:GAGGCCTGTAACACCT"	-4.06445537033732	10.6019973524841	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGGCCTGTAACACCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1923.37266523636	27.9478607341064	0.0145306529718576	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1917.76090081534	1917.76090081534
"healthy-4003"	"2020-08-26-Control4003-c1:GAGGCCTGTAGGCAAC"	5.25943626937215	-10.2037134400574	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGGCCTGTAGGCAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2466.08278533185	28.9840864649145	0.0117530873810525	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2461.36251629783	2461.36251629783
"healthy-4003"	"2020-08-26-Control4003-c1:GAGGGTAGTCGTGGTC"	-3.704093794257	12.5052680739197	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGGGTAGTCGTGGTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1752.15843803424	31.2477250636999	0.017833846748903	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1742.63412889088	1742.63412889088
"healthy-4003"	"2020-08-26-Control4003-c1:GAGGGTATCCAACTAG"	-3.5569580596989	10.4528951414856	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGGGTATCCAACTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1494.1424109275	38.2870799294014	0.0256247862649414	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1489.57284287127	1489.57284287127
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTCTACAATCGTCA"	4.19644465026204	-6.87771418010863	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTCTACAATCGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.71303463925	37.5087158368879	0.0148979313054485	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2509.91152935025	2509.91152935025
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTCTATCTAAACGC"	-1.13463781300243	8.55720803821412	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTCTATCTAAACGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1933.78943972757	37.1055872081829	0.0191880183260337	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.27882674744	1912.27882674744
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTGAGGTTATCTTC"	-4.51351437988933	12.9379482039246	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTGAGGTTATCTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1949.85058602297	3.30153977505876	0.00169322705992195	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1945.55172923906	1945.55172923906
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTTGTCAGCAGTAG"	-3.01885781708415	10.3767270811829	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTTGTCAGCAGTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.28982120138	35.8718278269783	0.0214507242537707	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1668.09458992417	1668.09458992417
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTTGTTCCTGTAAG"	2.67647757109944	-4.56040337001952	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTTGTTCCTGTAAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2147.97994077776	18.1479447589758	0.00844884275427851	1328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2145.52153660251	2145.52153660251
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTTTGCAAACTGCT"	4.85961355742757	-7.97098734295043	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTTTGCAAACTGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.21524500929	30.4806481508206	0.0117858125728863	1668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2579.04266060609	2579.04266060609
"healthy-4003"	"2020-08-26-Control4003-c1:GAGTTTGCAAGTGTCT"	-2.43168912354167	8.96417901599733	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GAGTTTGCAAGTGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1808.24511201661	30.3587448444189	0.0167890650679332	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1797.77095531587	1797.77095531587
"healthy-4003"	"2020-08-26-Control4003-c1:GATAGAAAGATGAATC"	-3.7157612842625	12.5276708372864	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATAGAAAGATGAATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1534.92985064155	34.1616417939015	0.0222561583381958	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1532.97048662882	1532.97048662882
"healthy-4003"	"2020-08-26-Control4003-c1:GATAGCTGTAGATTGA"	-3.95914683762248	12.4996757277283	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATAGCTGTAGATTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1792.45103467444	46.5514413866768	0.0259708301572276	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1790.30158409188	1790.30158409188
"healthy-4003"	"2020-08-26-Control4003-c1:GATCACAAGACGCTCC"	-0.291039804846603	8.25221250140993	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCACAAGACGCTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2242.75630155872	31.9149228909619	0.014230223260896	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2235.77636206529	2235.77636206529
"healthy-4003"	"2020-08-26-Control4003-c1:GATCCCTCAATTGAGA"	10.4059587913448	6.34796283328859	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCCCTCAATTGAGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1731.62499317264	27.0831258994199	0.0156402951021161	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1725.9860865976	1725.9860865976
"healthy-4003"	"2020-08-26-Control4003-c1:GATCCCTCACAGACGA"	6.78896488723103	-1.70346739208373	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCCCTCACAGACGA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2541.78126773719	23.4083195959635	0.00920941541787454	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2532.31133933192	2532.31133933192
"healthy-4003"	"2020-08-26-Control4003-c1:GATCCCTCATTCACCC"	5.11929049071614	-8.21721460735472	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCCCTCATTCACCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2682.12327125594	26.3339595637068	0.00981832559521981	1782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2677.47043492538	2677.47043492538
"healthy-4003"	"2020-08-26-Control4003-c1:GATCGTACAGCTGTGC"	2.82471885260884	-4.6833591691223	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCGTACAGCTGTGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2605.71433390281	29.8472046621812	0.0114545191212409	2123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2603.09901426154	2603.09901426154
"healthy-4003"	"2020-08-26-Control4003-c1:GATCGTATCACTCACC"	-3.83924112740214	12.4981488951477	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCGTATCACTCACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2207.09365091137	37.1623296850836	0.0168376768560493	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2200.55070173514	2200.55070173514
"healthy-4003"	"2020-08-26-Control4003-c1:GATCGTATCACTGGGC"	-3.79667053642924	10.3495597609314	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATCGTATCACTGGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.79737461769	37.5495291326306	0.0184809418506587	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2028.25855633576	2028.25855633576
"healthy-4003"	"2020-08-26-Control4003-c1:GATGACTCATTCCTCG"	-3.16000781479533	9.42263696277467	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATGACTCATTCCTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2134.52352685125	44.0519642009448	0.0206378442995792	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2131.27099703526	2131.27099703526
"healthy-4003"	"2020-08-26-Control4003-c1:GATGAGGCAAACTCTG"	-2.17153821411784	9.33793160999147	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATGAGGCAAACTCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2054.94666736219	35.7244586995863	0.017384615993681	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2051.49930630636	2051.49930630636
"healthy-4003"	"2020-08-26-Control4003-c1:GATGAGGGTAGTCTGT"	-2.51188502731975	-5.82223560726317	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATGAGGGTAGTCTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2075.94737545372	29.1450634395803	0.0140394037846024	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2074.30688676513	2074.30688676513
"healthy-4003"	"2020-08-26-Control4003-c1:GATGAGGTCCGGCTTT"	-3.9532941383427	11.2087106474671	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATGAGGTCCGGCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1869.16409638129	34.279860396989	0.0183396741160153	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1867.1979879275	1867.1979879275
"healthy-4003"	"2020-08-26-Control4003-c1:GATGTTGTCTCTGACC"	-1.32234738293346	8.58157918536989	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATGTTGTCTCTGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2073.26100021945	40.4016558336604	0.0194870090304038	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2068.0896813398	2068.0896813398
"healthy-4003"	"2020-08-26-Control4003-c1:GATTCGAGTCAAGGCA"	5.36066116866414	-9.8543796769348	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATTCGAGTCAAGGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.39933380714	38.4769709535088	0.0183889233435663	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2083.97493578189	2083.97493578189
"healthy-4003"	"2020-08-26-Control4003-c1:GATTGGTTCGAGATAA"	10.3212429481441	7.58174226367799	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATTGGTTCGAGATAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2031.90379280269	22.5532050078704	0.0110995437322167	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2026.94330716609	2026.94330716609
"healthy-4003"	"2020-08-26-Control4003-c1:GATTGGTTCGGTTGTA"	-3.73316441002544	11.5414132841858	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GATTGGTTCGGTTGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1825.62272886501	19.697286796653	0.0107893523044046	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1823.6337024958	1823.6337024958
"healthy-4003"	"2020-08-26-Control4003-c1:GCAACCGAGGATGGCT"	-0.116873885423499	8.61178491199342	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAACCGAGGATGGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.91306075879	32.7775054340081	0.0176042083407751	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.18924146179	1855.18924146179
"healthy-4003"	"2020-08-26-Control4003-c1:GCACATACAACCACAT"	4.10102238234822	-7.20424606716307	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACATACAACCACAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.3047069275	34.2807520204768	0.0148768311401776	1171	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.97123618389	2300.97123618389
"healthy-4003"	"2020-08-26-Control4003-c1:GCACGGTCAAGTATAG"	-4.33117232742961	11.7808389433655	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACGGTCAAGTATAG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2045.21435861786	22.9900960687141	0.0112409224841599	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2037.17811648	2037.17811648
"healthy-4003"	"2020-08-26-Control4003-c1:GCACGTGAGCAGCGAT"	-2.1434465450352	9.33127877796022	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACGTGAGCAGCGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1681.05507422313	21.7312494900979	0.0129271490406944	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1674.89684939354	1674.89684939354
"healthy-4003"	"2020-08-26-Control4003-c1:GCACGTGAGTAGTCCT"	0.572498162358445	8.58165166461793	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACGTGAGTAGTCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1376.40614398523	41.8847113770853	0.0304304885299428	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1366.82479874857	1366.82479874857
"healthy-4003"	"2020-08-26-Control4003-c1:GCACTAACAGACAAGC"	-0.299585829407531	8.84539506519166	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACTAACAGACAAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1814.37245935667	44.4716211781647	0.0245107452710858	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1806.77313429072	1806.77313429072
"healthy-4003"	"2020-08-26-Control4003-c1:GCACTAAGTGAGCCAA"	4.24822821196858	-6.78777363216551	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACTAAGTGAGCCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.46767956393	34.8360101617654	0.0134529619491647	1961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2585.60714585508	2585.60714585508
"healthy-4003"	"2020-08-26-Control4003-c1:GCACTAAGTGGTCCCA"	3.44249715384786	-6.84909012233885	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCACTAAGTGGTCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1953.73122186501	34.6219478709618	0.017720936986364	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1949.62735112136	1949.62735112136
"healthy-4003"	"2020-08-26-Control4003-c1:GCAGCCAAGCCTCACG"	-0.16067304733451	8.64900300586549	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAGCCAAGCCTCACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2288.62900269866	19.1061095333095	0.00834827729211697	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2278.7867382692	2278.7867382692
"healthy-4003"	"2020-08-26-Control4003-c1:GCAGCTGCAGTTGTTG"	0.526259114115876	8.8667421110901	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAGCTGCAGTTGTTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1564.74121171573	37.4949326457293	0.023962385834151	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1549.79528258291	1549.79528258291
"healthy-4003"	"2020-08-26-Control4003-c1:GCAGCTGGTCAAGCCC"	-3.86968408051189	11.2645921477112	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAGCTGGTCAAGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1830.70013747655	21.9039022183506	0.0119647678884993	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1824.83857322929	1824.83857322929
"healthy-4003"	"2020-08-26-Control4003-c1:GCAGCTGTCTCTATAC"	-2.96219716492351	-5.74827387249144	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAGCTGTCTCTATAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2065.35607740828	9.76283861067607	0.00472695179173512	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2063.65380722944	2063.65380722944
"healthy-4003"	"2020-08-26-Control4003-c1:GCAGGCTTCCGAGTGC"	-3.70624480667766	12.5968932875427	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCAGGCTTCCGAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1964.87142912799	45.4604574703311	0.0231366066992518	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1960.87522657421	1960.87522657421
"healthy-4003"	"2020-08-26-Control4003-c1:GCATCGGTCAGCTGTA"	2.69210090216939	-4.57982399379881	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATCGGTCAGCTGTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2358.75447992403	33.9650453026419	0.0143995679040473	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2353.37839491131	2353.37839491131
"healthy-4003"	"2020-08-26-Control4003-c1:GCATCTCCAGAGGCTA"	-3.88877306404765	12.6660003432068	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATCTCCAGAGGCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1445.91173733056	35.3092800178425	0.0244200798058604	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1440.83674700012	1440.83674700012
"healthy-4003"	"2020-08-26-Control4003-c1:GCATCTCGTACTCCCT"	3.15876116332356	-5.13638546383055	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATCTCGTACTCCCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2893.20161971361	34.5943251373816	0.0119571083126955	2410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2888.53528225323	2888.53528225323
"healthy-4003"	"2020-08-26-Control4003-c1:GCATGATAGGTGGGTT"	-4.24057136002238	13.2838945158753	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATGATAGGTGGGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1909.86255611824	30.1954100560444	0.0158102529207212	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1899.20986322231	1899.20986322231
"healthy-4003"	"2020-08-26-Control4003-c1:GCATTAGAGTAACAGT"	-4.20551572266276	11.6802825697693	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATTAGAGTAACAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.01432745913	33.6864339653611	0.0169960597653933	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1972.1769114585	1972.1769114585
"healthy-4003"	"2020-08-26-Control4003-c1:GCATTAGGTAGCTTAC"	5.48496498641316	-9.5824823609558	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATTAGGTAGCTTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.06759401044	11.4126836777689	0.00490221319481056	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2322.30146280645	2322.30146280645
"healthy-4003"	"2020-08-26-Control4003-c1:GCATTAGGTCCTGTTC"	-7.02565083923991	3.3189339407715	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCATTAGGTCCTGTTC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2826.37422651323	29.9245855277344	0.0105876232690711	2328	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2795.82826843342	2795.82826843342
"healthy-4003"	"2020-08-26-Control4003-c1:GCCAACGAGAGAACCC"	5.37295593795125	-9.48091509258422	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCAACGAGAGAACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.7155354185	18.8924231453108	0.00756388102544483	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.3051455748	2495.3051455748
"healthy-4003"	"2020-08-26-Control4003-c1:GCCAGCATCTGAATCG"	-4.31147180023845	12.7730169066223	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCAGCATCTGAATCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2528.97790267257	38.0356252108968	0.0150399199497558	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2523.0792594581	2523.0792594581
"healthy-4003"	"2020-08-26-Control4003-c1:GCCAGGTAGCCTCTTC"	9.34439053115193	6.2181768187317	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCAGGTAGCCTCTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1659.20450057011	29.6717053253338	0.0178830911531029	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1652.20963568977	1652.20963568977
"healthy-4003"	"2020-08-26-Control4003-c1:GCCAGTGCAGGATCTT"	2.74607648429219	-4.64838459407958	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCAGTGCAGGATCTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2402.28171659858	31.8125200225732	0.0132426267089178	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2400.0849438184	2400.0849438184
"healthy-4003"	"2020-08-26-Control4003-c1:GCCAGTGGTGACACAG"	10.7123772102291	6.10929772937623	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCAGTGGTGACACAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1831.34894952233	32.1259903167344	0.0175422550274287	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1820.98933041146	1820.98933041146
"healthy-4003"	"2020-08-26-Control4003-c1:GCCATGGAGCCTGAGA"	-3.313224653632	9.67999074542848	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCATGGAGCCTGAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2164.43473884473	31.8293739631727	0.0147056288609384	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2154.02510711736	2154.02510711736
"healthy-4003"	"2020-08-26-Control4003-c1:GCCATGGCAGTTACCA"	5.44185747680013	-10.0320263138977	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCATGGCAGTTACCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.28607112801	18.8368026191426	0.00819245715253754	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.76708844469	2290.76708844469
"healthy-4003"	"2020-08-26-Control4003-c1:GCCATTCCAAGCTACT"	-3.46448383751567	10.7059373625549	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCATTCCAAGCTACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.78783787867	31.0181483104095	0.0149789117663472	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2063.63941103677	2063.63941103677
"healthy-4003"	"2020-08-26-Control4003-c1:GCCCGAACACTATCGA"	-0.141303549439269	8.35103509509889	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCCGAACACTATCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1813.14414591658	33.1373427303443	0.018276176665255	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1803.29872736264	1803.29872736264
"healthy-4003"	"2020-08-26-Control4003-c1:GCCGATGCATTAAAGG"	4.9366680580074	-7.57582809841307	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCGATGCATTAAAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.43305095276	30.7817938387686	0.0127279908892421	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2415.55740165924	2415.55740165924
"healthy-4003"	"2020-08-26-Control4003-c1:GCCGTGACAAGAGAGA"	5.19006743010823	-8.65857412731322	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCGTGACAAGAGAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.64541357081	3.24945931901329	0.0013221839493485	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.70657934851	2450.70657934851
"healthy-4003"	"2020-08-26-Control4003-c1:GCCGTGATCCACTTCG"	-0.149303565651733	8.27807900989381	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCGTGATCCACTTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.85083578898	30.9371625902798	0.0163355856784736	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1888.75769478065	1888.75769478065
"healthy-4003"	"2020-08-26-Control4003-c1:GCCTGTTTCTTCGGAA"	-0.359196136624175	8.42746446216432	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCCTGTTTCTTCGGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.0518120539	38.0689761522042	0.0195020316146983	1076	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1944.63651317714	1944.63651317714
"healthy-4003"	"2020-08-26-Control4003-c1:GCGAGAACAGATTTCG"	-3.16274271431621	10.3626413115296	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGAGAACAGATTTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1718.50733736686	33.6109050887982	0.0195581970224798	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1716.56220608163	1716.56220608163
"healthy-4003"	"2020-08-26-Control4003-c1:GCGAGAATCATGGCCG"	-2.46496878090556	10.1098556288513	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGAGAATCATGGCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1705.39188532197	37.7127456539107	0.0221138296590351	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1697.80905976148	1697.80905976148
"healthy-4003"	"2020-08-26-Control4003-c1:GCGATCGCACAGTGTT"	-1.98126779022868	10.0375747450623	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGATCGCACAGTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1607.098935607	38.3407520932841	0.0238571199593277	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1602.64511435355	1602.64511435355
"healthy-4003"	"2020-08-26-Control4003-c1:GCGATCGCATAGAATG"	4.3050443130428	-8.02276422893675	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGATCGCATAGAATG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.92194502135	33.92036295253	0.0150762398791609	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2245.71904985085	2245.71904985085
"healthy-4003"	"2020-08-26-Control4003-c1:GCGATCGCATCAGCAT"	2.92145909842793	-4.89653303539427	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGATCGCATCAGCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2410.9398276555	38.6088176669204	0.0160140113096332	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2407.16919727859	2407.16919727859
"healthy-4003"	"2020-08-26-Control4003-c1:GCGGAAATCAATCTTC"	4.49236788329427	-7.70310785686644	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGGAAATCAATCTTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.21216626641	29.8371556533594	0.0122725429180375	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.90123742951	2423.90123742951
"healthy-4003"	"2020-08-26-Control4003-c1:GCGGATCCAGGCTTGC"	-3.07371840897258	10.1553916701111	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGGATCCAGGCTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1756.01506218885	25.4928283468264	0.0145174314820796	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1743.91022815978	1743.91022815978
"healthy-4003"	"2020-08-26-Control4003-c1:GCGGATCTCCAATCTT"	-0.646998683840591	8.62400147998659	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGGATCTCCAATCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1665.61569674161	42.0776399152179	0.0252625140346198	802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.4886288383	1660.4886288383
"healthy-4003"	"2020-08-26-Control4003-c1:GCGGATCTCGTTGCCT"	-3.02677879753764	10.4240693815979	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGGATCTCGTTGCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1745.18105869596	33.0255739591616	0.0189238668358223	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.18105869596	1745.18105869596
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTGCAAGGCTCACC"	-3.78283224526103	10.9108485945496	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTGCAAGGCTCACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1655.36931226073	36.5746535211481	0.0220945581449727	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1653.43381243599	1653.43381243599
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTGCAAGGTACTGG"	-3.28171406212505	10.3467502363953	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTGCAAGGTACTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1626.07988743615	30.7517466576533	0.0189115841695452	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1623.96203579847	1623.96203579847
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTGCAGTTTGAACC"	9.90655579146687	6.11913249576417	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTGCAGTTTGAACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1521.39368822801	33.3613678855193	0.021928162410333	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1519.17930413626	1519.17930413626
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTGCATCAGAACCT"	3.61722483214681	-6.38702061092528	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTGCATCAGAACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.3573067013	28.9125080327499	0.0116565899415522	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2476.26301070777	2476.26301070777
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTTTCGTATACAGA"	5.38471617278401	-10.105700515863	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTTTCGTATACAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.84802782081	40.4519994799814	0.0182887788723153	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2208.77528667997	2208.77528667997
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTTTCGTCCTGGTG"	-3.78851709786113	10.1600456007752	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTTTCGTCCTGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1634.42141608306	32.0958544736394	0.0196374412118009	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1631.64828982165	1631.64828982165
"healthy-4003"	"2020-08-26-Control4003-c1:GCGTTTCTCGCTTGAA"	5.47959770736043	-9.42183973705443	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCGTTTCTCGCTTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2725.86186513445	24.3224717421879	0.00892285557580454	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2720.28646532101	2720.28646532101
"healthy-4003"	"2020-08-26-Control4003-c1:GCTACAAAGGGAGTGG"	5.40212978896443	-9.85206987774047	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTACAAAGGGAGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.16076148516	16.8826508382388	0.0075028642962807	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2247.26498247893	2247.26498247893
"healthy-4003"	"2020-08-26-Control4003-c1:GCTACAATCGGCTGAC"	-3.69318685951884	10.9243421324524	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTACAATCGGCTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1788.23288895729	35.3684474688671	0.0197784347258541	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.43164973386	1774.43164973386
"healthy-4003"	"2020-08-26-Control4003-c1:GCTCAAAAGAAGCGAA"	10.0832878547603	5.77053878391115	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTCAAAAGAAGCGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1630.81496887844	30.9679496675559	0.0189892478659632	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1629.00296499674	1629.00296499674
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGAATCACGGCCAT"	-1.17203233662303	8.83309075916139	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGAATCACGGCCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1893.4343376466	33.0685217308297	0.0174648368170673	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1888.54156875243	1888.54156875243
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGAATTCCCGTAAA"	-0.299468795687515	8.56598184192506	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGAATTCCCGTAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2028.07770307411	41.9378691265898	0.0206786303419348	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2018.55485852082	2018.55485852082
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGCAGAGTCACTCA"	-2.0168071788853	9.28296849811403	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGCAGAGTCACTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.8960494116	35.1759097807397	0.018179741382715	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1929.57095624476	1929.57095624476
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGCAGGTCCGAAGA"	0.352591295807999	8.58238408649293	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGCAGGTCCGAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1675.0091648617	1.33156176581977	0.00079495789859139	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1668.87742161667	1668.87742161667
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGCAGTCTTACGGA"	4.34360470351521	-7.22352125560912	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGCAGTCTTACGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.19820313192	31.3179871639003	0.0122422051292033	1600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2555.69113926999	2555.69113926999
"healthy-4003"	"2020-08-26-Control4003-c1:GCTGGGTGTTGGCCTG"	10.967751165002	5.91168496692506	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTGGGTGTTGGCCTG"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1890.70394277709	35.6709534201001	0.0188664933800827	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1883.88078721856	1883.88078721856
"healthy-4003"	"2020-08-26-Control4003-c1:GCTTCACTCCGTCAAA"	-0.633123258978683	8.26316545093385	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTTCACTCCGTCAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1839.04052781782	34.2380002993783	0.0186173169005713	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1835.9104460107	1835.9104460107
"healthy-4003"	"2020-08-26-Control4003-c1:GCTTGGGCACGCTGCA"	-3.1104019683903	10.8309993513855	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTTGGGCACGCTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1636.20056757249	37.7752024914634	0.0230871466738994	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1630.03757530589	1630.03757530589
"healthy-4003"	"2020-08-26-Control4003-c1:GCTTTCGAGGTCTACT"	10.8055616813595	5.85048387134401	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GCTTTCGAGGTCTACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1669.53490592245	24.1129676779401	0.0144429251478376	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1665.52559725812	1665.52559725812
"healthy-4003"	"2020-08-26-Control4003-c1:GGAACCCAGGTACATA"	-4.3047960800236	13.0461616286072	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAACCCAGGTACATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2017.81525411283	35.4321974395201	0.0175596836069606	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2015.87576121819	2015.87576121819
"healthy-4003"	"2020-08-26-Control4003-c1:GGAACCCTCATCGGGC"	-0.378999124199706	8.551318145636	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAACCCTCATCGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.70921182874	35.7760022379717	0.0207793522809649	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1711.27695147191	1711.27695147191
"healthy-4003"	"2020-08-26-Control4003-c1:GGAAGTGAGCGATCGA"	-0.877878467470962	8.22635076129762	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAAGTGAGCGATCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.65735436031	29.6798384553113	0.0151376977671832	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1948.64503671256	1948.64503671256
"healthy-4003"	"2020-08-26-Control4003-c1:GGAAGTGTCGCCGTGA"	-2.53977928581889	10.6268853911194	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAAGTGTCGCCGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1774.50226244175	36.0927320716264	0.0203396371115143	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1768.01530730749	1768.01530730749
"healthy-4003"	"2020-08-26-Control4003-c1:GGAATCTGTCAGTTTG"	-3.36365471306499	12.1242847212586	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAATCTGTCAGTTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1799.90443355912	34.879303331551	0.019378419587856	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1793.9115053625	1793.9115053625
"healthy-4003"	"2020-08-26-Control4003-c1:GGAATCTTCGTTAGAC"	5.54487623748128	-9.87952139293822	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAATCTTCGTTAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.4640806509	18.8731283586414	0.0078852774567266	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2390.55201496109	2390.55201496109
"healthy-4003"	"2020-08-26-Control4003-c1:GGAATGGTCATTGCCC"	2.99455060538594	-4.93630793010863	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAATGGTCATTGCCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2363.2368417047	23.987790044015	0.0101503961095628	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2361.17163052316	2361.17163052316
"healthy-4003"	"2020-08-26-Control4003-c1:GGACGTCAGACGCTCC"	5.02241196212117	-8.7302570573059	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGACGTCAGACGCTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.93161510499	30.5513353777005	0.012394394712812	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.77449375612	2457.77449375612
"healthy-4003"	"2020-08-26-Control4003-c1:GGAGCAAGTCAAATCC"	0.899279673665208	9.07208821857301	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAGCAAGTCAAATCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1740.46912146339	25.0888725700272	0.0144150058513721	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1726.42682070795	1726.42682070795
"healthy-4003"	"2020-08-26-Control4003-c1:GGAGGATCAGACGATG"	5.31209101256673	-10.2499132386413	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAGGATCAGACGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.82472602134	34.4147549474317	0.0136738782767107	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2512.81344932208	2512.81344932208
"healthy-4003"	"2020-08-26-Control4003-c1:GGAGGTAAGAGATTCA"	-4.14946685257609	12.993758178595	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAGGTAAGAGATTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1660.2014306048	20.3872413228552	0.0122799805776751	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1653.69602200257	1653.69602200257
"healthy-4003"	"2020-08-26-Control4003-c1:GGAGGTAGTGTCTCCT"	5.42388453063313	-10.1926126710144	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGAGGTAGTGTCTCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.34416256702	2.05111636357659	0.000909447168915461	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.44564825817	2252.44564825817
"healthy-4003"	"2020-08-26-Control4003-c1:GGATCTATCCACGGGT"	-3.91250238838847	10.5129356154236	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGATCTATCCACGGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1916.66294121701	40.5039937871976	0.0211325595732962	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.72874186233	1912.72874186233
"healthy-4003"	"2020-08-26-Control4003-c1:GGATGTTAGACGCCCT"	6.79018892821614	-1.70610299026641	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGATGTTAGACGCCCT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2407.31670877785	2.01173960314873	0.000835677165290832	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2399.88850969469	2399.88850969469
"healthy-4003"	"2020-08-26-Control4003-c1:GGCACGTAGACTCGAG"	6.78042330321614	-1.57349851047667	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGCACGTAGACTCGAG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2607.26739489759	43.462095586098	0.0166695965558243	1647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2594.21731501518	2594.21731501518
"healthy-4003"	"2020-08-26-Control4003-c1:GGCACGTCATAGACTC"	9.83489956435506	6.71839664066163	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGCACGTCATAGACTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1764.78301542518	34.9503906328111	0.0198043557351388	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1757.0553462931	1757.0553462931
"healthy-4003"	"2020-08-26-Control4003-c1:GGCGTCACATATCTCT"	-3.81787167015727	12.9605922468933	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGCGTCACATATCTCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1722.71306444046	34.6214564835886	0.0200970534201143	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1713.82571110287	1713.82571110287
"healthy-4003"	"2020-08-26-Control4003-c1:GGCGTCATCAAACCCA"	-4.28479466858562	13.0657863386902	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGCGTCATCAAACCCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2044.5313879444	37.2522925122815	0.0182204551771325	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2034.57766753711	2034.57766753711
"healthy-4003"	"2020-08-26-Control4003-c1:GGCTTGGTCCCATTTA"	-3.39027533951457	10.6886520155701	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGCTTGGTCCCATTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1684.20911897348	32.9475435473304	0.0195626203279387	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1679.95848068838	1679.95848068838
"healthy-4003"	"2020-08-26-Control4003-c1:GGGAAGTTCCTGTTGC"	-3.17427573624309	10.2637147673401	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGAAGTTCCTGTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1857.1427579554	32.5333562477889	0.0175179619921121	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.18365871408	1855.18365871408
"healthy-4003"	"2020-08-26-Control4003-c1:GGGACAACATTGTCGA"	-2.16376147690471	8.91794869983522	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGACAACATTGTCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1817.27225325691	43.8101493762776	0.0241076422631564	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1814.37835670005	1814.37835670005
"healthy-4003"	"2020-08-26-Control4003-c1:GGGACCTAGAAACTCA"	-2.2647594017094	8.95175454700319	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGACCTAGAAACTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1879.59297693471	15.4693152509588	0.00823014101499067	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1877.48293414269	1877.48293414269
"healthy-4003"	"2020-08-26-Control4003-c1:GGGACCTCAAGTCCCG"	-3.81674251976665	12.96421716297	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGACCTCAAGTCCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1946.45480955337	37.1504375217306	0.0190862060292348	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1935.73843859236	1935.73843859236
"healthy-4003"	"2020-08-26-Control4003-c1:GGGACCTTCGGATTAC"	-0.314524660736877	8.56862638080446	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGACCTTCGGATTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.33310883845	33.9759719926476	0.0179166686666451	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1889.63835663167	1889.63835663167
"healthy-4003"	"2020-08-26-Control4003-c1:GGGAGATAGACCATGG"	-7.518706659705	0.0568394212047531	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGAGATAGACCATGG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3137.01144204316	36.2517158445316	0.0115561312141471	3393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3131.04051938089	3131.04051938089
"healthy-4003"	"2020-08-26-Control4003-c1:GGGATCCAGCAGCACA"	4.21126570281331	-7.02268936550292	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGATCCAGCAGCACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2307.78008433599	40.0947362111017	0.0173737248549998	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2306.72068586661	2306.72068586661
"healthy-4003"	"2020-08-26-Control4003-c1:GGGATCCTCTCGTCAC"	-4.18995557251628	13.1885814436707	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGATCCTCTCGTCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2037.30416350875	32.2499285450248	0.0158297072782113	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2033.26087233393	2033.26087233393
"healthy-4003"	"2020-08-26-Control4003-c1:GGGATGAAGCTCGCAC"	2.92000593718831	-5.03552915966185	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGATGAAGCTCGCAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2563.58492485785	6.26303054241249	0.0024430751178488	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2560.38625685697	2560.38625685697
"healthy-4003"	"2020-08-26-Control4003-c1:GGGCGTTAGACTGGGT"	-0.0353676554864228	8.54991433704225	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGCGTTAGACTGGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1932.80605254071	35.039555563838	0.0181288523583512	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1926.72578341596	1926.72578341596
"healthy-4003"	"2020-08-26-Control4003-c1:GGGCGTTAGTAGTCAA"	2.66798080977742	-4.32946016704711	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGCGTTAGTAGTCAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2136.87333031709	28.0295524420218	0.0131170865602326	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2135.75452616206	2135.75452616206
"healthy-4003"	"2020-08-26-Control4003-c1:GGGCGTTCACCGGCTA"	-3.8268235725468	10.2375316389832	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGCGTTCACCGGCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1946.57230122852	35.3884333702224	0.0181798710214298	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1937.43001397634	1937.43001397634
"healthy-4003"	"2020-08-26-Control4003-c1:GGGCGTTGTTCCCACT"	10.0913177925045	7.82937524402467	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGCGTTGTTCCCACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1637.94235276824	45.2637574156141	0.0276345240961107	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1633.97860914117	1633.97860914117
"healthy-4003"	"2020-08-26-Control4003-c1:GGGCTACAGTAGACCG"	3.4199193912441	-6.07149460231932	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGCTACAGTAGACCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.93782952234	21.5659579133828	0.00926397502540169	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.3726858778	2321.3726858778
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTAGATCGATGCTA"	-6.60179505768474	-3.08066990291747	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTAGATCGATGCTA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3135.19923108752	29.495654231398	0.0094079042693458	3225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3124.09246482485	3124.09246482485
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTATTCATTGTAGC"	-0.526599983603317	8.26933667743532	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTATTCATTGTAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1916.76751233654	24.3786984749797	0.0127186517499256	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1910.80641876184	1910.80641876184
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCACAGATGGCGT"	-4.15711341324504	11.6994018324646	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCACAGATGGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1964.3214952935	5.61031874233165	0.00285611024253104	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1959.79771483189	1959.79771483189
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCACAGTGCGACA"	10.361456533044	5.93996713245241	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCACAGTGCGACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1878.61301514845	35.5567225270233	0.018927113908137	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1867.91878787311	1867.91878787311
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCACCACCTCAGG"	-3.79590640488322	10.7667503126892	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCACCACCTCAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.38367587253	30.1414581518167	0.01670457262214	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.5129895304	1800.5129895304
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCACGTGTGTTTG"	-4.32595096054729	12.6606597670349	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCACGTGTGTTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2124.26186102902	38.0773081646992	0.0179249596592833	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2118.53532220422	2118.53532220422
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCTGGTTCCAAAC"	-4.01044784012492	11.4698858031067	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCTGGTTCCAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1832.01982488256	34.5040933951114	0.0188339083051807	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1820.38015649789	1820.38015649789
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCTGGTTTGGGAG"	-3.47026095810588	10.4660033949646	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCTGGTTTGGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1676.66112851714	29.7826677621846	0.0177630811949011	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1672.2178868848	1672.2178868848
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTCTGTCCTCGATC"	-3.46852598610576	10.9455489882263	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTCTGTCCTCGATC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2396.82815978763	37.6810016902692	0.0157211945029918	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2392.88965469113	2392.88965469113
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTGTCAGCGTGAAC"	-2.66765580597575	9.87189004505006	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTGTCAGCGTGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.32541620081	36.5422518728914	0.0199105028189144	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1833.41410543512	1833.41410543512
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTGTCGTTGCGGAA"	3.24475969847981	-5.43360664760741	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTGTCGTTGCGGAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2409.00140378546	26.7765709486614	0.0111152160005325	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2407.94258392887	2407.94258392887
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTGTCTCCGACAGC"	-2.26589856568034	11.2733516463074	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTGTCTCCGACAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1384.42043589365	43.9676988769805	0.03175892072743	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1379.6875401147	1379.6875401147
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTTATTCACCTACC"	5.1072961288387	-8.51462938701781	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTTATTCACCTACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.37500689953	31.7969084114582	0.0129816415705603	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2447.98281269086	2447.98281269086
"healthy-4003"	"2020-08-26-Control4003-c1:GGGTTTATCGCAATGT"	-3.28112183037456	-5.45264294063719	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGGTTTATCGCAATGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2544.02438905747	42.0352591362199	0.0165231352800801	1631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2537.71723278584	2537.71723278584
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCACGAGAGTCACG"	-1.06270299378093	8.57346627796022	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCACGAGAGTCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1834.69950128688	19.9372024597017	0.0108667400005927	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1826.49045999162	1826.49045999162
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCACGGTGGCGTAA"	-0.0481297773426354	8.11062429035035	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCACGGTGGCGTAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1756.43685013596	31.2513968249746	0.0177924966801713	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1753.19302571905	1753.19302571905
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCTGGAGTCGCGAA"	5.61212267455403	-10.089327835199	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCTGGAGTCGCGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.51991477858	30.1025109762754	0.0117564057215616	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2555.69689163856	2555.69689163856
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCTGGCACCAGCTG"	-2.53969345513042	9.90083024585573	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCTGGCACCAGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1485.11947436959	28.1294653656316	0.0189408770480045	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1482.66586152042	1482.66586152042
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCTGGGTGAGTAAT"	2.59147109565083	-6.21737482463988	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCTGGGTGAGTAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.5302206489	26.209548962148	0.0114776448873534	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2280.71488148115	2280.71488148115
"healthy-4003"	"2020-08-26-Control4003-c1:GGTCTGGTCCCTGGTT"	4.70491900023763	-7.80971863186034	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTCTGGTCCCTGGTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2440.63718482672	36.5205747482956	0.0149635410684315	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2437.18512785361	2437.18512785361
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGAAGCATGACCCG"	4.80168547210042	-8.10031320964965	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGAAGCATGACCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.16590247562	33.8665123437193	0.0137491803981541	1625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2459.6980142552	2459.6980142552
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGAAGGTTTACTGG"	-1.21585045281108	8.66405389392702	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGAAGGTTTACTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1607.97835597767	41.1202969033892	0.0255726681584515	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1597.93048255828	1597.93048255828
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGATTAGACATAGT"	5.04064907607381	-7.54560615932616	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGATTAGACATAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.74552786373	19.9473256532412	0.00759682362268749	1632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2621.92176092448	2621.92176092448
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGATTAGTCTAGCT"	5.58048119124715	-9.79528334057006	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGATTAGTCTAGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.07557783461	5.20697350091191	0.0019472050618436	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2667.87391048931	2667.87391048931
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGATTTCCATACAG"	-3.84027514877971	12.7967595824036	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGATTTCCATACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2161.59991566291	25.1845429729266	0.0116508808084419	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2156.2434088537	2156.2434088537
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGTCGGTCATCACA"	-3.47661457482036	11.7224321135315	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGTCGGTCATCACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1736.97495332405	29.4853273912932	0.0169751022229003	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1732.92511683671	1732.92511683671
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGTTAAGGACCCAA"	-4.25636945191081	12.8903693922791	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGTTAAGGACCCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1798.68642790201	33.8539713637825	0.0188214970873327	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1794.74477797088	1794.74477797088
"healthy-4003"	"2020-08-26-Control4003-c1:GGTGTTAGTAACACGG"	6.83948483046834	-1.68047978794249	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTGTTAGTAACACGG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2713.36796070904	28.6199897016519	0.0105477731424871	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2686.02749118909	2686.02749118909
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTAACAGGATATAC"	4.37034763869588	-7.37976887142333	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTAACAGGATATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.35640174538	20.7042925415949	0.0087753984630209	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.20702634613	2354.20702634613
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTAACAGGGAGGTG"	2.68409003791158	-4.41318752681883	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTAACAGGGAGGTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2383.54041413068	37.1792025612721	0.0155983101192064	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2379.583210097	2379.583210097
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTAACAGTGCACAG"	-4.3212288421696	12.4178170927796	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTAACAGTGCACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1753.30500228786	4.79301253590557	0.00273370151208787	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1749.07999164071	1749.07999164071
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTAACCATAAGCGG"	-0.652367751032668	8.79283425891725	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTAACCATAAGCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1709.59205447272	31.2842773685419	0.0182992646033271	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1708.02887576222	1708.02887576222
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTCTCTCAAGCGTT"	-0.0476791960304559	8.50953385913698	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTCTCTCAAGCGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1888.18357780185	35.87494692983	0.0189997134556134	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1878.60689178586	1878.60689178586
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTGTAAGTCCCGGT"	-3.40002379837688	10.9423608549866	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTGTAAGTCCCGGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1696.43328873575	39.3425335886053	0.023191323731878	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1692.21956220914	1692.21956220914
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTGTAGTGTCGCTG"	-3.3984104198521	10.7968635329041	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTGTAGTGTCGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2042.67740771324	38.1300528046106	0.0186667031517702	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2034.96681200281	2034.96681200281
"healthy-4003"	"2020-08-26-Control4003-c1:GGTTGTAGTTGCTGAT"	-4.06600270691569	12.3883981474671	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GGTTGTAGTTGCTGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1937.86168365155	34.4919865685578	0.0177989930135591	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1928.08690677662	1928.08690677662
"healthy-4003"	"2020-08-26-Control4003-c1:GTAACCAGTCAGCTTA"	-2.89483795586284	9.68043038928834	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAACCAGTCAGCTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2007.33486285529	12.4982526725624	0.00622629183791713	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2003.80398509738	2003.80398509738
"healthy-4003"	"2020-08-26-Control4003-c1:GTAAGTCTCCACTTTA"	9.99497189101521	6.0936593779358	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAAGTCTCCACTTTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.67722426243	17.9932681732384	0.0111435696886463	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1611.11911208237	1611.11911208237
"healthy-4003"	"2020-08-26-Control4003-c1:GTAATCGGTGGGAGAG"	-4.13900027695354	13.1576633223328	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAATCGGTGGGAGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1736.92337242789	35.6005522260122	0.0204963286182565	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1732.38438177492	1732.38438177492
"healthy-4003"	"2020-08-26-Control4003-c1:GTAATCGTCGCCACTT"	-3.06546602669414	10.756622291449	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAATCGTCGCCACTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1634.95880379882	32.1397229576107	0.0196578182171527	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1628.52036750206	1628.52036750206
"healthy-4003"	"2020-08-26-Control4003-c1:GTAATCGTCTGGACTA"	4.08690037307088	-7.02549173748168	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAATCGTCTGGACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2430.93051911895	30.7513778015087	0.0126500439069127	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2428.01478447941	2428.01478447941
"healthy-4003"	"2020-08-26-Control4003-c1:GTACAGTCAAAGGCGT"	6.74367441710774	-1.64491894161376	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTACAGTCAAAGGCGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2457.53253682513	31.8662815339623	0.0129667790991407	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2454.61716110563	2454.61716110563
"healthy-4003"	"2020-08-26-Control4003-c1:GTACAGTCAGCGATTT"	5.64377798613851	-9.88467981731566	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTACAGTCAGCGATTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.60217351909	42.4370140854303	0.0172325902014401	1425	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.80051634511	2452.80051634511
"healthy-4003"	"2020-08-26-Control4003-c1:GTACAGTCAGTCAGAG"	-3.09352956238444	11.161446548346	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTACAGTCAGTCAGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1472.71341023695	40.9307654734562	0.0277927566822868	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1472.71341023695	1472.71341023695
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGAAACAGGTGTTT"	0.160634649067563	8.30265710437623	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGAAACAGGTGTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1994.23121735746	37.3085497549202	0.0187082367531872	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1991.51330417081	1991.51330417081
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGAAAGTTACCTTT"	-1.53874025765117	9.27732560718385	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGAAAGTTACCTTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2018.58541294005	34.0481331993565	0.0168673235133338	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2001.3140559468	2001.3140559468
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGAGGGTGAGAACC"	10.6180216270382	6.26792857730714	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGAGGGTGAGAACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1451.14613840477	32.8936105447149	0.0226673314797051	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1445.17914439514	1445.17914439514
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGCTACAAAGTGTA"	2.76481284674947	-4.85478832637938	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGCTACAAAGTGTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2792.63869216511	34.1505681038681	0.0122287814029359	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2787.84447199668	2787.84447199668
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGCTACAACTTCTT"	0.10022727873866	8.08658406818239	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGCTACAACTTCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1641.03702861232	21.6456205441931	0.0131902084881636	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.24579203503	1639.24579203503
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGGTTCAGCTCATA"	4.15698732909505	-7.00142385875853	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGGTTCAGCTCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2398.0004843899	33.9480401855317	0.0141568112294059	1662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.92728867046	2396.92728867046
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGGTTTCGCAACAT"	-0.0244808596676171	8.37968537891237	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGGTTTCGCAACAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1896.19651264391	38.0595688327894	0.0200715319214052	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1894.47477957312	1894.47477957312
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGTACAGGCCACTC"	5.45826401290242	-10.0732956162659	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGTACAGGCCACTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.33650611103	15.9196534040377	0.00680811053602983	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2336.92081971665	2336.92081971665
"healthy-4003"	"2020-08-26-Control4003-c1:GTAGTACAGGTCGTCC"	-2.34371862831767	9.47742173755494	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTAGTACAGGTCGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.13135744361	19.8638325735092	0.0126269382906388	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1570.95766534989	1570.95766534989
"healthy-4003"	"2020-08-26-Control4003-c1:GTATTGGTCACTTGGA"	-4.19525704804118	12.9166955717835	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTATTGGTCACTTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1876.73208391512	26.5701896701938	0.0141576892609865	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1871.2189756328	1871.2189756328
"healthy-4003"	"2020-08-26-Control4003-c1:GTATTTCAGGTGCTGA"	-0.168400372297126	8.12757203662721	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTATTTCAGGTGCTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1416.37297707161	43.1692087235562	0.0304787011771502	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1414.68214961625	1414.68214961625
"healthy-4003"	"2020-08-26-Control4003-c1:GTATTTCCATATCTCT"	-1.61414108696635	9.19608972156373	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTATTTCCATATCTCT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2242.41628783366	33.4764658662769	0.014928747194669	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2233.17783629923	2233.17783629923
"healthy-4003"	"2020-08-26-Control4003-c1:GTATTTCTCCTCATAT"	-4.0261734527653	12.3810329207214	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTATTTCTCCTCATAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2063.87626886167	38.8498243930889	0.0188237177679825	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2052.64317393572	2052.64317393572
"healthy-4003"	"2020-08-26-Control4003-c1:GTCAAACAGAAACTAC"	4.07596315917317	-7.19574549114379	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCAAACAGAAACTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2228.23213041701	36.8552075443836	0.016540111347145	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.38582678229	2221.38582678229
"healthy-4003"	"2020-08-26-Control4003-c1:GTCAAGTCAAAGGCTG"	3.93722929534261	-7.28351404583129	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCAAGTCAAAGGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.7041817657	32.9958914325624	0.0154786446050089	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2125.84998703577	2125.84998703577
"healthy-4003"	"2020-08-26-Control4003-c1:GTCACGGAGCAGATAT"	-0.0923396748607934	8.65641591632692	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCACGGAGCAGATAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1635.14852733289	15.6702344978087	0.00958337070661625	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1626.9252251581	1626.9252251581
"healthy-4003"	"2020-08-26-Control4003-c1:GTCATCCAGTCTCCTC"	0.0923837805980861	8.32640550220338	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCATCCAGTCTCCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2115.78755695421	32.3815644245566	0.0153047333689643	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2103.09591245896	2103.09591245896
"healthy-4003"	"2020-08-26-Control4003-c1:GTCATCCTCCATAGAC"	10.2459274726803	6.77308032596437	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCATCCTCCATAGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1825.08454377163	2.453395582495	0.00134426407306312	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1819.04023980317	1819.04023980317
"healthy-4003"	"2020-08-26-Control4003-c1:GTCATGAAGCTCGGCT"	2.55276288565938	-4.36049988186034	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCATGAAGCTCGGCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2250.14706906165	34.6708670017717	0.0154082670766183	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2248.03635558662	2248.03635558662
"healthy-4003"	"2020-08-26-Control4003-c1:GTCCACTAGGGACACT"	4.26586117324178	-7.33037474071654	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCCACTAGGGACACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2446.91659293762	31.9384721275572	0.0130525381289003	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.64838479735	2445.64838479735
"healthy-4003"	"2020-08-26-Control4003-c1:GTCCACTTCCACGGGT"	-4.12260995331462	13.0012426146301	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCCACTTCCACGGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2006.37699160244	38.0097514068385	0.0189444713361077	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2000.42301717147	2000.42301717147
"healthy-4003"	"2020-08-26-Control4003-c1:GTCCTCAGTATGAAAC"	-1.79773829403575	9.0977105864319	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCCTCAGTATGAAAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2065.45907686089	22.9181178700082	0.0110958954000868	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.04635440929	2059.04635440929
"healthy-4003"	"2020-08-26-Control4003-c1:GTCGAATGTTCCCACT"	-0.26859493079837	8.51415155017702	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCGAATGTTCCCACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1612.38700015076	28.897955534579	0.0179224686950943	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1608.65748643486	1608.65748643486
"healthy-4003"	"2020-08-26-Control4003-c1:GTCGAATGTTTGTGGT"	6.84427465972249	-1.63572337543639	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCGAATGTTTGTGGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2366.55531066554	22.3138752858654	0.00942884165238044	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2360.37478125061	2360.37478125061
"healthy-4003"	"2020-08-26-Control4003-c1:GTCGTAAAGAAGGATG"	5.5469500022823	-10.1157121888367	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCGTAAAGAAGGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.30285913913	2.77496192504079	0.00114040959374146	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.98156481722	2423.98156481722
"healthy-4003"	"2020-08-26-Control4003-c1:GTCTAGACACACCAGC"	-2.86420832100566	9.51607034290162	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCTAGACACACCAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.36479670007	25.1277306597753	0.0135141477908859	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1857.3042844888	1857.3042844888
"healthy-4003"	"2020-08-26-Control4003-c1:GTCTCACGTTTACGAC"	-0.299957345158416	8.12301824176637	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCTCACGTTTACGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1753.62664239356	33.9421143504685	0.0193553824570891	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1747.53730330471	1747.53730330471
"healthy-4003"	"2020-08-26-Control4003-c1:GTCTTTACATCATCTT"	-0.672738711268264	8.4577312239441	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCTTTACATCATCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1615.12106695749	27.6889699373415	0.0171435878732614	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1613.13610263971	1613.13610263971
"healthy-4003"	"2020-08-26-Control4003-c1:GTCTTTATCTCCCTAG"	2.74981822547261	-4.46029713070067	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTCTTTATCTCCCTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2574.89107203145	34.2040942423172	0.0132837053240206	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2570.96739417739	2570.96739417739
"healthy-4003"	"2020-08-26-Control4003-c1:GTGAGCCTCCCTTTGG"	4.51752056655232	-8.28398134624632	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGAGCCTCCCTTTGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2589.96072736914	14.5222412903742	0.0056071279911359	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.0708708549	2586.0708708549
"healthy-4003"	"2020-08-26-Control4003-c1:GTGAGGAGTTGTATGC"	-0.610648016363937	8.42117116535035	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGAGGAGTTGTATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2451.96077303346	28.826076364824	0.0117563366762844	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2439.14383984604	2439.14383984604
"healthy-4003"	"2020-08-26-Control4003-c1:GTGAGTTTCTCGGTCT"	10.6514908271724	6.61365220630494	"2020-08-26-Control4003-c1"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGAGTTTCTCGGTCT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2128.50578849219	30.8610557614408	0.0144989296849892	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2120.92868851177	2120.92868851177
"healthy-4003"	"2020-08-26-Control4003-c1:GTGATGTAGACCATGG"	-3.67526660385783	11.2027625807556	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGATGTAGACCATGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1723.07557590731	8.60971609162266	0.00499671413837382	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1723.07557590731	1723.07557590731
"healthy-4003"	"2020-08-26-Control4003-c1:GTGATGTTCCGTGGTG"	0.143720177083653	8.52457234943239	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGATGTTCCGTGGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1955.52227920163	29.0575238172645	0.0148592138920185	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1944.01385757326	1944.01385757326
"healthy-4003"	"2020-08-26-Control4003-c1:GTGCGTGAGCGTTACT"	-4.07812486115153	12.9936675795349	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGCGTGAGCGTTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1753.14357936873	30.3888851068001	0.0173339397094575	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1753.14357936873	1753.14357936873
"healthy-4003"	"2020-08-26-Control4003-c1:GTGCGTGTCTAGCCTC"	-3.17147837105449	10.0969667204651	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGCGTGTCTAGCCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1635.1082485573	33.9516627416771	0.0207641682265585	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1630.78905350001	1630.78905350001
"healthy-4003"	"2020-08-26-Control4003-c1:GTGCTGGTCTCGTTTA"	-0.275397459894973	8.3987827070984	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGCTGGTCTCGTTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2289.15186410735	4.35739417289132	0.0019034972040138	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2276.37597573159	2276.37597573159
"healthy-4003"	"2020-08-26-Control4003-c1:GTGGAAGAGGAGTCTG"	0.0108031454378783	8.71069142902223	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGGAAGAGGAGTCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.61630857706	34.6000725845273	0.0183689599771331	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.44737731425	1876.44737731425
"healthy-4003"	"2020-08-26-Control4003-c1:GTGGCGTGTGACTCTA"	10.165749211877	7.26221463764039	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGGCGTGTGACTCTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1945.39168468033	22.0176363678818	0.0113178423354369	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1937.87144857771	1937.87144857771
"healthy-4003"	"2020-08-26-Control4003-c1:GTGGGAAGTTCGGGTC"	-4.06526980820354	10.5922212370667	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGGGAAGTTCGGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1914.08924217771	33.7634810403736	0.0176394497687893	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1910.11358103123	1910.11358103123
"healthy-4003"	"2020-08-26-Control4003-c1:GTGGGAAGTTTGACAC"	-4.06108842316325	13.1751746901306	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGGGAAGTTTGACAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.25446923668	29.8755559315891	0.0155500254703161	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1912.75307180472	1912.75307180472
"healthy-4003"	"2020-08-26-Control4003-c1:GTGGTTACACCCTTAC"	5.41669477996175	-10.0082073441711	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGGTTACACCCTTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.69782273562	28.7105292355123	0.01488596549292	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1926.85580493063	1926.85580493063
"healthy-4003"	"2020-08-26-Control4003-c1:GTGTAACAGCTACTGT"	-3.92734728279765	10.2273359068665	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGTAACAGCTACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.04643376858	39.7370977269493	0.0201706401665542	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1968.0821430983	1968.0821430983
"healthy-4003"	"2020-08-26-Control4003-c1:GTGTAACAGGGCAAGG"	-0.625140528113204	8.63116738880006	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTGTAACAGGGCAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1495.17227125347	8.03569221207798	0.00537442565420324	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1495.17227125347	1495.17227125347
"healthy-4003"	"2020-08-26-Control4003-c1:GTTACAGAGGAGAGGC"	10.8626753288204	5.95189855182496	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTACAGAGGAGAGGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1611.54653015743	40.1237893695293	0.0248976921352743	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1611.54653015743	1611.54653015743
"healthy-4003"	"2020-08-26-Control4003-c1:GTTACAGTCGGCATTA"	3.27077736434285	-6.97609903728636	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTACAGTCGGCATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.51426229722	3.69430415557447	0.00150817825902751	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2443.60873235261	2443.60873235261
"healthy-4003"	"2020-08-26-Control4003-c1:GTTACGAAGTAACGTA"	2.32017030295674	-4.17759992992552	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTACGAAGTAACGTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1462.36205594966	38.8066341615216	0.0265369536932633	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1457.89727410282	1457.89727410282
"healthy-4003"	"2020-08-26-Control4003-c1:GTTACGATCATTCGGA"	-0.427179763943511	8.39278504932252	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTACGATCATTCGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1950.81571097594	27.4631012880191	0.0140777527746483	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1941.72798705777	1941.72798705777
"healthy-4003"	"2020-08-26-Control4003-c1:GTTACGATCGCACGGT"	5.17236151274983	-10.1407518616882	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTACGATCGCACGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2018.09370437576	39.671220745809	0.0196577694384514	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2016.5062147935	2016.5062147935
"healthy-4003"	"2020-08-26-Control4003-c1:GTTAGACCAACTAGAA"	4.76449503478352	-6.95072319423827	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTAGACCAACTAGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.99561241231	29.6994235804729	0.0111109137039211	1885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2665.41416079536	2665.41416079536
"healthy-4003"	"2020-08-26-Control4003-c1:GTTAGTGTCGTAGTGT"	-2.35294399681743	10.1982812651428	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTAGTGTCGTAGTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1759.11263569207	40.3874114333999	0.0229589684105195	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1753.13802909813	1753.13802909813
"healthy-4003"	"2020-08-26-Control4003-c1:GTTATGGGTCCGGACT"	5.45070328292195	-9.99088289653929	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTATGGGTCCGGACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.04381165005	0.714272022118577	0.000330368893668927	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2153.8913383065	2153.8913383065
"healthy-4003"	"2020-08-26-Control4003-c1:GTTATGGGTTCGGTCG"	4.3211485343868	-8.00617792522582	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTATGGGTTCGGTCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2254.71460605748	17.9148117738456	0.00794548974212344	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2248.64679922564	2248.64679922564
"healthy-4003"	"2020-08-26-Control4003-c1:GTTCGCTCACTTCCTG"	-3.93533215943034	11.9680509337219	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTCGCTCACTTCCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2010.47842758015	39.3766153418254	0.0195856940326487	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2005.54645065497	2005.54645065497
"healthy-4003"	"2020-08-26-Control4003-c1:GTTCGCTCATCCTCAC"	4.81170143660848	-8.18774511730345	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTCGCTCATCCTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.70680024893	23.8220889797686	0.0110404661917088	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.73801495987	2154.73801495987
"healthy-4003"	"2020-08-26-Control4003-c1:GTTCTATGTATTGGCT"	3.43181242522542	-5.52592279827269	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTCTATGTATTGGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2738.08732221419	6.58477711179318	0.00240488207164566	1921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2731.58377389114	2731.58377389114
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGAACAGTATGCAA"	-2.54561052742656	10.4553069838318	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGAACAGTATGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1561.4290419274	38.783639760291	0.0248385541186151	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1555.04762161784	1555.04762161784
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGAACCAGCTGTGC"	-1.07169816914256	8.84339616382448	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGAACCAGCTGTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1394.65112125938	39.6002998773406	0.0283944129637104	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1388.35349582384	1388.35349582384
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGAACGTATTGGCT"	5.64440645751302	-9.71847345745238	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGAACGTATTGGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.6460055723	5.2661940788476	0.00209337643976246	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2509.02425023247	2509.02425023247
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGCGGAGGCATGCA"	10.7100197273189	7.32611034000245	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGCGGAGGCATGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2373.54095104076	33.5556299012604	0.0141373713761065	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2363.05974657953	2363.05974657953
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGCGGCAGAAATCA"	-0.0343366888469041	8.66337964618532	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGCGGCAGAAATCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1880.90598335815	33.9769104809689	0.0180641195155895	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1879.0526173751	1879.0526173751
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGCGGGTGTACGCC"	-1.37324259701427	8.36981866443483	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGCGGGTGTACGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.16485271371	36.656821857745	0.0202281938107625	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1808.54427860866	1808.54427860866
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGCGGTCAACTGAC"	-3.06003222885783	9.96945951068727	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGCGGTCAACTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1958.11591516787	35.4733778819046	0.0181160765852125	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.93276169969	1950.93276169969
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGTCCCACAGCTGC"	6.79973759230916	-1.5734468928543	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGTCCCACAGCTGC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2552.70614238582	26.719536593606	0.0104671415757371	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2543.31521098418	2543.31521098418
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGTGAAGGCGAACT"	-2.41675458374675	9.99373052203981	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGTGAAGGCGAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1810.41136731221	33.387271789531	0.0184418151544743	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1806.46516987339	1806.46516987339
"healthy-4003"	"2020-08-26-Control4003-c1:GTTGTGAGTCTACATG"	-0.456787983805496	8.03851173007814	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTGTGAGTCTACATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1781.23358918306	37.4922621754698	0.0210484814586643	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.52166155458	1775.52166155458
"healthy-4003"	"2020-08-26-Control4003-c1:GTTTGGACACGGTCTG"	9.24593319472615	6.5626501807007	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTTGGACACGGTCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1576.92424620801	35.2438427101592	0.0223497373414793	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1571.31239820873	1571.31239820873
"healthy-4003"	"2020-08-26-Control4003-c1:GTTTGGACATCGCTAA"	-0.528844694525558	8.2749337919983	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTTGGACATCGCTAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2004.5113046103	12.4824704705194	0.00622718886234771	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1998.58257308913	1998.58257308913
"healthy-4003"	"2020-08-26-Control4003-c1:GTTTGGAGTATTTCGG"	-3.55809817734416	11.3271989592346	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.GTTTGGAGTATTTCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.35907508589	36.5459259578022	0.0195814012671277	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.70665669107	1848.70665669107
"healthy-4003"	"2020-08-26-Control4003-c1:TAACCAGTCGGTCGAC"	5.62082066115682	-9.99071028148802	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAACCAGTCGGTCGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.1228949004	0.762526920211221	0.000317570967246493	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.31848908471	2397.31848908471
"healthy-4003"	"2020-08-26-Control4003-c1:TAACGACGTGACTATC"	3.57359947737996	-6.53554060375365	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAACGACGTGACTATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.67043148419	13.7081390891657	0.00626322670237284	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2187.23679385217	2187.23679385217
"healthy-4003"	"2020-08-26-Control4003-c1:TAACGACGTTGTGCAT"	-0.185083593160468	8.12465188587037	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAACGACGTTGTGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1453.54612774395	23.3342778569732	0.0160533452716704	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1451.43624453857	1451.43624453857
"healthy-4003"	"2020-08-26-Control4003-c1:TAAGCCACACAATGCT"	3.88440646704976	-6.61150410091551	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAAGCCACACAATGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.52273731939	43.8794661405133	0.018999365293733	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2304.81490320052	2304.81490320052
"healthy-4003"	"2020-08-26-Control4003-c1:TAAGCGTAGACGCATG"	-4.1640924018925	12.7746515044006	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAAGCGTAGACGCATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2603.40998190082	34.8371294228601	0.0133813458752373	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2592.85325545138	2592.85325545138
"healthy-4003"	"2020-08-26-Control4003-c1:TAAGCGTGTCCTCATC"	0.205234159796876	8.35912892902223	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAAGCGTGTCCTCATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.97171236277	36.9639685138194	0.0217823127189038	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1691.49683530267	1691.49683530267
"healthy-4003"	"2020-08-26-Control4003-c1:TAAGCGTGTCGGAAAC"	-3.42934189263042	10.7775335081848	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAAGCGTGTCGGAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1821.85425053895	38.2992156129539	0.0210221073401585	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.39099257907	1815.39099257907
"healthy-4003"	"2020-08-26-Control4003-c1:TAAGTCGAGTGCCAGA"	5.27336945113484	-10.16055967724	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAAGTCGAGTGCCAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.0493065763	45.3081276739984	0.0228592333821713	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1978.73444567644	1978.73444567644
"healthy-4003"	"2020-08-26-Control4003-c1:TAATCTCTCTGGTTGA"	0.128515829413575	8.42590138995973	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAATCTCTCTGGTTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1611.3607440414	26.1567724050359	0.0162327228721192	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1604.65555770202	1604.65555770202
"healthy-4003"	"2020-08-26-Control4003-c1:TAATTCCTCAGCATTG"	0.153076392679852	9.08796689594118	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAATTCCTCAGCATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1740.96470279306	34.2296203924594	0.0196612948772277	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1737.10689546389	1737.10689546389
"healthy-4003"	"2020-08-26-Control4003-c1:TACAACGGTTTCACTT"	2.64960064467732	-4.27745821392211	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACAACGGTTTCACTT"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2395.06489490044	30.3907190282216	0.0126888916842835	1933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2390.13110450019	2390.13110450019
"healthy-4003"	"2020-08-26-Control4003-c1:TACACCCCATCCGAAT"	5.57688059386556	-10.0761690369812	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACACCCCATCCGAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.01757589778	34.8255931226565	0.0147564973576133	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2353.52467075288	2353.52467075288
"healthy-4003"	"2020-08-26-Control4003-c1:TACACCCTCCCAATAG"	-3.8060658973759	12.392870880011	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACACCCTCCCAATAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1983.50259749223	20.4678952041036	0.0103190664988195	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1978.04290368505	1978.04290368505
"healthy-4003"	"2020-08-26-Control4003-c1:TACAGGTCAGAGGAAA"	-2.01887426796611	9.38226602161256	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACAGGTCAGAGGAAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.10974361607	33.2498633124635	0.0172806480621919	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1918.64592900087	1918.64592900087
"healthy-4003"	"2020-08-26-Control4003-c1:TACCCACCAAGCTACT"	0.0509626844082072	8.34608266437379	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCCACCAAGCTACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1545.0101503956	39.7748000348755	0.0257440380082236	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1538.8832377335	1538.8832377335
"healthy-4003"	"2020-08-26-Control4003-c1:TACCCGTGTCTTACAG"	-4.12319693985637	9.98737237537233	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCCGTGTCTTACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2089.57791370561	26.7094782108905	0.0127822360849539	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2081.91203462609	2081.91203462609
"healthy-4003"	"2020-08-26-Control4003-c1:TACCGAAGTGCCCACA"	-3.00727448883708	9.78054139697877	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCGAAGTGCCCACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.87556025593	29.0047337467689	0.0155949862273461	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.52682767483	1851.52682767483
"healthy-4003"	"2020-08-26-Control4003-c1:TACCGGGCAGCGAACA"	5.22065414962117	-9.39017488872679	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCGGGCAGCGAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1986.13802374421	15.0480424455362	0.0075765340906006	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1982.70109545162	1982.70109545162
"healthy-4003"	"2020-08-26-Control4003-c1:TACCGGGGTGCCGAAA"	-4.18962655487712	13.1963615187439	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCGGGGTGCCGAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1973.4954998063	32.0440685566001	0.0162372138977491	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1965.62421390633	1965.62421390633
"healthy-4003"	"2020-08-26-Control4003-c1:TACCGGGTCATGCATG"	5.15910210189168	-8.67185022747191	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCGGGTCATGCATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.51961452719	6.75147530889145	0.00282191011847804	1501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.84337958562	2388.84337958562
"healthy-4003"	"2020-08-26-Control4003-c1:TACCTCGGTGCATTTG"	-2.2402802509373	9.73812291705934	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCTCGGTGCATTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1639.82991629481	24.0600835531019	0.0146723043127946	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.82991629481	1639.82991629481
"healthy-4003"	"2020-08-26-Control4003-c1:TACCTGCAGCAATAGT"	-0.43429128351863	8.30997464740602	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCTGCAGCAATAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.62556099256	34.4647719291349	0.020373759254922	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.15666784606	1685.15666784606
"healthy-4003"	"2020-08-26-Control4003-c1:TACCTGCTCGCCGAAC"	6.67654099044148	-1.56292250072631	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACCTGCTCGCCGAAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2640.36469656163	20.4536653941614	0.00774653040195427	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2635.09536163854	2635.09536163854
"healthy-4003"	"2020-08-26-Control4003-c1:TACGCTCGTCCCTCAT"	-3.97720561447795	12.7470168837341	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACGCTCGTCCCTCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1711.48916728156	41.818916834208	0.0244342281760572	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1705.0244383139	1705.0244383139
"healthy-4003"	"2020-08-26-Control4003-c1:TACGCTCGTTTACCTT"	0.339616079896134	8.55759141528932	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACGCTCGTTTACCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1416.87462879683	32.5941811986914	0.0230042803620314	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1406.38016484689	1406.38016484689
"healthy-4003"	"2020-08-26-Control4003-c1:TACGGGCCACTTGTGA"	-0.635638157755691	8.45226190173952	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACGGGCCACTTGTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1486.22320416755	41.1640636632448	0.0276970939141683	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1486.22320416755	1486.22320416755
"healthy-4003"	"2020-08-26-Control4003-c1:TACGGTACAGGACAGT"	-2.89308844032939	9.56646249378053	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACGGTACAGGACAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1543.27274410457	28.2770757740332	0.0183227986641078	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1535.87845359971	1535.87845359971
"healthy-4003"	"2020-08-26-Control4003-c1:TACGTCCTCGGCTGAC"	-0.230817030102569	8.52144525134889	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACGTCCTCGGCTGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.55761405934	31.9243179214806	0.0166919509701579	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1897.86290032928	1897.86290032928
"healthy-4003"	"2020-08-26-Control4003-c1:TACTTACTCCCATAGA"	-2.58669124069865	9.88574788654176	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACTTACTCCCATAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1708.96973123182	42.8772243397742	0.0250895165409796	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1705.1708008699	1705.1708008699
"healthy-4003"	"2020-08-26-Control4003-c1:TACTTGTAGAACAAGG"	10.2641035514766	6.69012925708619	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TACTTGTAGAACAAGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1709.12660388325	41.6570790628458	0.0243733138131477	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1694.475615567	1694.475615567
"healthy-4003"	"2020-08-26-Control4003-c1:TAGACCACACAAGCTT"	-4.35231719437297	13.0365924605164	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGACCACACAAGCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2026.43332483252	40.8182546314573	0.0201429053358224	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2022.783038947	2022.783038947
"healthy-4003"	"2020-08-26-Control4003-c1:TAGACCATCTTGGCTC"	2.59747995909993	-4.34372856533202	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGACCATCTTGGCTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2613.85217193181	34.2597119819846	0.0131069814696768	2009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2607.2123851152	2607.2123851152
"healthy-4003"	"2020-08-26-Control4003-c1:TAGAGTCAGCTCGACC"	10.4958750205928	7.33177373493043	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGAGTCAGCTCGACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2090.04968921487	31.4089198794673	0.015027834046982	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2088.70066681802	2088.70066681802
"healthy-4003"	"2020-08-26-Control4003-c1:TAGAGTCCAGACCAGA"	0.0344048580968797	10.3082017668518	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGAGTCCAGACCAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.22805719088	22.1308345329695	0.0125870102245598	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.33068889074	1756.33068889074
"healthy-4003"	"2020-08-26-Control4003-c1:TAGAGTCGTTAATGAG"	-7.75509677353557	-0.330702149030291	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGAGTCGTTAATGAG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2435.96146684224	30.7260170720122	0.0126135070239196	2491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2430.16071341051	2430.16071341051
"healthy-4003"	"2020-08-26-Control4003-c1:TAGAGTCTCACCTTAT"	-3.07167182388957	10.2771835097107	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGAGTCTCACCTTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1578.05483636621	26.1809343258863	0.0165906366005463	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1575.95594738239	1575.95594738239
"healthy-4003"	"2020-08-26-Control4003-c1:TAGATCGAGCCTTTGA"	-3.05290112915691	10.3757838972839	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGATCGAGCCTTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1617.19890207632	10.4120740016805	0.00643833852985708	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1617.19890207632	1617.19890207632
"healthy-4003"	"2020-08-26-Control4003-c1:TAGATCGGTGGTCCGT"	-4.39621529999431	12.572015739325	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGATCGGTGGTCCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1916.5931302391	35.6652024454604	0.0186086456654528	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1910.24048756236	1910.24048756236
"healthy-4003"	"2020-08-26-Control4003-c1:TAGCACAAGTTCGGTT"	5.52995743331258	-9.98848535930785	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGCACAAGTTCGGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2471.44768178885	0	0	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.66051354117	2462.66051354117
"healthy-4003"	"2020-08-26-Control4003-c1:TAGGAGGTCCCAACTC"	-3.5227259201115	10.5068015822205	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGGAGGTCCCAACTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.60419690603	32.4469306902966	0.0180601441019531	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1784.78422984174	1784.78422984174
"healthy-4003"	"2020-08-26-Control4003-c1:TAGGGTTTCCACACCT"	-3.94309053841289	12.2821359404358	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGGGTTTCCACACCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1643.97203301756	19.0633283917754	0.0115958957992637	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1641.9106753625	1641.9106753625
"healthy-4003"	"2020-08-26-Control4003-c1:TAGGTTGTCGTTCATT"	-3.06338701668437	10.6976470717224	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGGTTGTCGTTCATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1565.9790208708	36.9523989056468	0.023596994859547	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1556.79873328485	1556.79873328485
"healthy-4003"	"2020-08-26-Control4003-c1:TAGTGCAAGGTAGTAT"	-3.01361809197124	10.3452939757141	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGTGCAAGGTAGTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1723.94032301717	37.4449991680393	0.0217205889717253	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.93068300379	1717.93068300379
"healthy-4003"	"2020-08-26-Control4003-c1:TAGTGCAGTAGAGATT"	0.0399079928988635	8.74377343738405	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TAGTGCAGTAGAGATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1475.41269362451	43.2452255223536	0.0293105960855719	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1475.41269362451	1475.41269362451
"healthy-4003"	"2020-08-26-Control4003-c1:TATACCTAGGCATGGT"	0.155777287750882	8.42469785297243	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATACCTAGGCATGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1801.93721245606	33.4166429350819	0.018544843129986	850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.13423633251	1800.13423633251
"healthy-4003"	"2020-08-26-Control4003-c1:TATACCTCATTCTTCA"	5.15784992751424	-8.39877798473509	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATACCTCATTCTTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.22587232026	8.71201431880383	0.00360562910057652	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2413.83315424518	2413.83315424518
"healthy-4003"	"2020-08-26-Control4003-c1:TATATCCGTGGCAGAT"	-2.63219581070598	-5.78935673153075	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATATCCGTGGCAGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2295.07969133878	33.0419648141809	0.0143968703739898	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2290.8335671095	2290.8335671095
"healthy-4003"	"2020-08-26-Control4003-c1:TATCAGGTCCTTTAGT"	-0.432776252657729	8.40171334827272	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCAGGTCCTTTAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2099.8565083796	32.3985317001521	0.0154289264865785	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2097.17721065337	2097.17721065337
"healthy-4003"	"2020-08-26-Control4003-c1:TATCCTAAGAGAGCCT"	3.12708510932271	-5.16319277202757	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCCTAAGAGAGCCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2882.18095724967	29.6198905147192	0.0102769017469965	2672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2873.52632309901	2873.52632309901
"healthy-4003"	"2020-08-26-Control4003-c1:TATCCTACATGACACT"	-3.59637723389323	10.2874459990296	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCCTACATGACACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.93120600488	39.4977652763513	0.0190816801842342	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2063.3478253913	2063.3478253913
"healthy-4003"	"2020-08-26-Control4003-c1:TATCCTATCAGCAATC"	-3.92161236229594	12.5246953734192	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCCTATCAGCAATC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2092.60880088983	29.4623778857603	0.0140792573715795	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2088.83229716158	2088.83229716158
"healthy-4003"	"2020-08-26-Control4003-c1:TATCGCCAGTAGATCA"	-0.157883043319541	8.25155255878297	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCGCCAGTAGATCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1962.70500183909	30.929980865959	0.0157588536417735	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1946.04063819636	1946.04063819636
"healthy-4003"	"2020-08-26-Control4003-c1:TATCTGTAGCGACTAG"	4.84858955916707	-8.28409292614134	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCTGTAGCGACTAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2325.89940136361	22.224719028244	0.00955532256262426	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2324.48405928474	2324.48405928474
"healthy-4003"	"2020-08-26-Control4003-c1:TATCTGTCAATGAACA"	-0.31526098671611	8.437548614386	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATCTGTCAATGAACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1850.90490917978	26.2684375181729	0.01419221343457	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1844.5952753814	1844.5952753814
"healthy-4003"	"2020-08-26-Control4003-c1:TATGTTCAGGCATGCA"	5.47237982329671	-10.0740490189758	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATGTTCAGGCATGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2764.49405730159	34.0995666041192	0.0123348308577677	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2756.24005290518	2756.24005290518
"healthy-4003"	"2020-08-26-Control4003-c1:TATGTTCCACCTTCGT"	6.7737041908199	-1.70169641887816	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATGTTCCACCTTCGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2154.76298656552	15.1603698655701	0.00703574822850204	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2146.14091861587	2146.14091861587
"healthy-4003"	"2020-08-26-Control4003-c1:TATGTTCGTACTTGTG"	5.39858879622762	-10.1348304978577	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATGTTCGTACTTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.07360576726	33.7202149267594	0.0161954960830183	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2077.38997858047	2077.38997858047
"healthy-4003"	"2020-08-26-Control4003-c1:TATGTTCTCCTTACCG"	5.62731184539143	-9.94557955181273	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATGTTCTCCTTACCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2757.48235148931	27.9323728671139	0.0101296651461895	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2749.58038182476	2749.58038182476
"healthy-4003"	"2020-08-26-Control4003-c1:TATTCCATCGTTCTAT"	-4.50560079041179	12.9224262007507	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATTCCATCGTTCTAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2430.34056893319	31.0229177686004	0.0127648438104368	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2430.34056893319	2430.34056893319
"healthy-4003"	"2020-08-26-Control4003-c1:TATTGCTAGTCCCTAA"	-4.2853721183842	12.7930392988953	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATTGCTAGTCCCTAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2182.11766979648	47.0367567097105	0.0215555546617692	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2173.553781432	2173.553781432
"healthy-4003"	"2020-08-26-Control4003-c1:TATTGGGCATGCCATA"	-1.11749194088634	8.50975797260133	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATTGGGCATGCCATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.24601956254	33.7634847390816	0.01996367432564	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1689.06714225594	1689.06714225594
"healthy-4003"	"2020-08-26-Control4003-c1:TATTTCGAGGTCGTAG"	0.658530076115769	9.14816377246705	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATTTCGAGGTCGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1654.47141316648	19.3298240931022	0.0116833835503431	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1647.01464487756	1647.01464487756
"healthy-4003"	"2020-08-26-Control4003-c1:TATTTCGCAATACCCA"	0.249206681817216	8.16817185962526	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TATTTCGCAATACCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2010.0949894996	26.241414188437	0.0130548129941708	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2004.41292305902	2004.41292305902
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGACAGTAGTCCT"	0.0919041345709979	8.58302781665651	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGACAGTAGTCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2015.03586552493	32.959788613569	0.0163569240515641	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2007.57216622537	2007.57216622537
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGCATCCTAAGTG"	5.51531519469563	-10.0318413010803	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGCATCCTAAGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.9325543933	32.3259169093926	0.0154378978642694	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2087.41372227352	2087.41372227352
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGCATCGTTCATT"	-3.14776549759563	10.8497037657532	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGCATCGTTCATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1754.82972701962	38.8388628280163	0.0221325535064759	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1746.63775868346	1746.63775868346
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGCATCTGGCTGG"	-0.535057286650497	8.44474599445192	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGCATCTGGCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1960.45445609794	28.7810005328296	0.0146807799810432	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1941.32869989249	1941.32869989249
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGTGAGGTCATTC"	-3.75048289719279	12.6252116926941	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGTGAGGTCATTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1835.02585021201	32.1763659986372	0.0175345573442029	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1835.02585021201	1835.02585021201
"healthy-4003"	"2020-08-26-Control4003-c1:TCAAGTGCAGTGACCC"	5.61218561705892	-9.77220632946166	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAAGTGCAGTGACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2843.50445473416	35.1656573041928	0.0123670132626821	2310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2831.82835475521	2831.82835475521
"healthy-4003"	"2020-08-26-Control4003-c1:TCACAAGCACCGGAAA"	4.52687468108479	-7.43975212490233	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACAAGCACCGGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.03714842824	32.4122402785575	0.0145213713406973	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2228.01093823053	2228.01093823053
"healthy-4003"	"2020-08-26-Control4003-c1:TCACAAGTCTACGCAA"	-0.193401942879516	8.82321641528932	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACAAGTCTACGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1885.68967989447	26.9060122947129	0.0142685260367011	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1875.02799781488	1875.02799781488
"healthy-4003"	"2020-08-26-Control4003-c1:TCACACCCACGGTCTG"	5.60611023482625	-9.93835928356322	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACACCCACGGTCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.41874346136	21.1807478038739	0.00915164892425505	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.48965335906	2308.48965335906
"healthy-4003"	"2020-08-26-Control4003-c1:TCACGCTGTACTAGCT"	-0.640741626650649	8.29459760272828	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACGCTGTACTAGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1783.77216056792	25.5951974738951	0.0143489163244627	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1781.96645693486	1781.96645693486
"healthy-4003"	"2020-08-26-Control4003-c1:TCACTATCACTGTCCT"	-4.43376336517985	12.1292981871399	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACTATCACTGTCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2794.12889000827	35.1003757093271	0.0125621891799069	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2790.18536209956	2790.18536209956
"healthy-4003"	"2020-08-26-Control4003-c1:TCACTATTCGATTGAC"	-5.51325927200969	-5.53612615978392	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACTATTCGATTGAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3074.65873889335	37.1821390607618	0.0120930946223139	2540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3067.71137068435	3067.71137068435
"healthy-4003"	"2020-08-26-Control4003-c1:TCACTCGAGAGTATAC"	4.80562986907308	-7.96079256450804	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCACTCGAGAGTATAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.58349661483	33.8894665560264	0.01389719343343	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.63550312209	2433.63550312209
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGCAACAATGAACA"	5.6521712737972	-9.95176317608031	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGCAACAATGAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2479.54028538235	18.7174551848746	0.00754876026625567	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2475.60070253971	2475.60070253971
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGCAACAGCTAACT"	5.60975756224934	-9.84504129802855	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGCAACAGCTAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2558.74757130806	19.1863732164694	0.00749834545291279	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2557.42905628089	2557.42905628089
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGCAAGTAACCCTA"	-4.08335433426555	13.1709422835144	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGCAAGTAACCCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2325.25953162072	33.2728381718807	0.0143093008412223	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2320.12896122641	2320.12896122641
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGCAAGTTCCTAAG"	5.56691183623616	-9.77450754558715	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGCAAGTTCCTAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2728.5634181059	40.7034911563305	0.0149175536424167	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2722.4732321824	2722.4732321824
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGGGCAGGTCGTCC"	5.43199600753133	-9.89956476604613	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGGGCAGGTCGTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.22415798635	22.1830671297986	0.0097327272756695	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2273.95217433403	2273.95217433403
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGGGCGTGATAGTA"	-3.0299268764561	10.4636440047058	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGGGCGTGATAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.32312817119	37.0471130990605	0.0186887357427135	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1980.50856598189	1980.50856598189
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGGGCTCGATACGT"	-3.90011463585551	-5.71712686931761	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGGGCTCGATACGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2691.28982131212	33.7627983481198	0.0125452108802087	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2687.70021553699	2687.70021553699
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGGTATCGTTCTAT"	5.56577648696248	-9.59996702587279	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGGTATCGTTCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.04200784185	16.5890580928605	0.00763051405309703	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.7369175938	2169.7369175938
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGTCCTCCTCTTTC"	-3.86673627319987	12.4489402540955	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGTCCTCCTCTTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2187.7640758345	40.7019002578425	0.0186043370523475	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2180.26811179628	2180.26811179628
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGTGACAGCTCATA"	4.57102837142293	-7.98849871074828	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGTGACAGCTCATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.5115203475	34.6093918127095	0.0137365483480448	1553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.7992642759	2511.7992642759
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGTGACAGTGCGCT"	5.41039814528768	-9.86945440685423	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGTGACAGTGCGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.72805142504	13.9159601503703	0.00616370077945695	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.63805467249	2252.63805467249
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGTGATCCATTTAC"	-1.30847213688548	9.06023881519166	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGTGATCCATTTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.03955968594	25.3359663786621	0.0139820161448645	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1808.54542281363	1808.54542281363
"healthy-4003"	"2020-08-26-Control4003-c1:TCAGTTTAGCACTCGC"	-1.01291881027873	9.21934125507203	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCAGTTTAGCACTCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1867.731376445	34.7925529522675	0.0186282424716186	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1861.58059802827	1861.58059802827
"healthy-4003"	"2020-08-26-Control4003-c1:TCATACTGTAGGCAAC"	0.354815174906892	8.24468801105348	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATACTGTAGGCAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.10127275755	32.7393674739449	0.0174693694251497	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1868.27892541094	1868.27892541094
"healthy-4003"	"2020-08-26-Control4003-c1:TCATACTGTGTTCATG"	-3.53074202957805	-5.45986463939818	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATACTGTGTTCATG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2863.38532208128	34.1572525457637	0.0119289752176756	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2857.5436897854	2857.5436897854
"healthy-4003"	"2020-08-26-Control4003-c1:TCATATCAGTCACTGT"	-3.8049467605656	10.8440322645935	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATATCAGTCACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2087.84228173546	28.9292966398379	0.0138560737527508	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2080.21786203912	2080.21786203912
"healthy-4003"	"2020-08-26-Control4003-c1:TCATCATAGCCAAGCA"	4.63130869445149	-7.57656195079955	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATCATAGCCAAGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.2520319954	19.1793357447006	0.00797725674740632	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.68536893452	2400.68536893452
"healthy-4003"	"2020-08-26-Control4003-c1:TCATCCGCACAAATGA"	2.48163952407185	-4.34286692058715	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATCCGCACAAATGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2185.81127134402	3.49429306249876	0.00159862523737018	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2182.05269771294	2182.05269771294
"healthy-4003"	"2020-08-26-Control4003-c1:TCATCCGGTCCCTCAT"	5.42986454543416	-9.86370375072631	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATCCGGTCCCTCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2045.34412721068	30.5881934894903	0.0149550352346843	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2041.91781980101	2041.91781980101
"healthy-4003"	"2020-08-26-Control4003-c1:TCATCCGGTTTAGAGA"	3.66432275351827	-6.67096569454344	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATCCGGTTTAGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2442.07357145929	39.4774755269528	0.0161655553658699	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2437.22516332178	2437.22516332178
"healthy-4003"	"2020-08-26-Control4003-c1:TCATGAGAGGCACCAA"	0.878597457974595	8.50430772388307	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATGAGAGGCACCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1511.94016017509	21.4340897157901	0.0141765463213226	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1507.19905077894	1507.19905077894
"healthy-4003"	"2020-08-26-Control4003-c1:TCATGAGAGTGGAATT"	-3.95570741120036	12.262668586615	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATGAGAGTGGAATT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1664.47452467491	17.1105805059381	0.0102798692634122	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1662.14068600783	1662.14068600783
"healthy-4003"	"2020-08-26-Control4003-c1:TCATGAGGTACAGTAA"	-0.637920836836654	8.85181996906129	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATGAGGTACAGTAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1580.05634355587	37.1842064442251	0.023533468661341	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1578.03462192256	1578.03462192256
"healthy-4003"	"2020-08-26-Control4003-c1:TCATGCCTCGCATAGT"	1.85672058638875	-6.29739620601805	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATGCCTCGCATAGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2637.1696114522	33.8047460488635	0.0128185710551429	1695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2632.18787436917	2632.18787436917
"healthy-4003"	"2020-08-26-Control4003-c1:TCATTACCACCTGATA"	5.62222828444783	-9.7721214524475	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATTACCACCTGATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2767.62805660583	29.8036503228222	0.0107686617252222	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2764.22487211668	2764.22487211668
"healthy-4003"	"2020-08-26-Control4003-c1:TCATTACCAGTTGCGC"	-3.19626889649089	10.4244460829529	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATTACCAGTTGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1834.36675735417	22.8579433564736	0.0124609450453862	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1834.36675735417	1834.36675735417
"healthy-4003"	"2020-08-26-Control4003-c1:TCATTACTCCGATTAG"	10.6437078910762	7.65038297260133	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATTACTCCGATTAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2341.82284315202	36.4483726900026	0.0155641033208747	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2331.51966622054	2331.51966622054
"healthy-4003"	"2020-08-26-Control4003-c1:TCATTTGGTCCAACGC"	-2.71259293976482	9.8092002638611	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATTTGGTCCAACGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1819.43846165007	23.9421803067194	0.0131591042024065	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.83570438985	1813.83570438985
"healthy-4003"	"2020-08-26-Control4003-c1:TCATTTGTCCGATCGG"	-2.9597958129948	8.90293786609498	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCATTTGTCCGATCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2419.12176850107	34.3130094544948	0.0141840770073165	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2411.43330763941	2411.43330763941
"healthy-4003"	"2020-08-26-Control4003-c1:TCCACCACAAGTTCGT"	4.95424332198445	-7.76685144817504	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCACCACAAGTTCGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2379.9744203576	27.3454012282186	0.0114897878709595	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2379.9744203576	2379.9744203576
"healthy-4003"	"2020-08-26-Control4003-c1:TCCACCAGTAGTCCTA"	-7.3954647583073	1.22679672324983	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCACCAGTAGTCCTA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2917.6107157793	25.2547502760448	0.00865596981100311	2821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2904.85395593046	2904.85395593046
"healthy-4003"	"2020-08-26-Control4003-c1:TCCACCAGTGACTCTA"	-4.3297909301823	13.0285157927307	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCACCAGTGACTCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2357.81660744138	38.0296629161766	0.0161291861276035	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2346.91766281093	2346.91766281093
"healthy-4003"	"2020-08-26-Control4003-c1:TCCATCGTCAACCGAT"	-5.65815148773845	-4.29227259075316	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCATCGTCAACCGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3065.70351979302	37.9221256754167	0.0123697955234683	3267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3057.92080293679	3057.92080293679
"healthy-4003"	"2020-08-26-Control4003-c1:TCCATGCGTTGCTGAT"	-4.13175378266032	11.6381721266541	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCATGCGTTGCTGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2447.81157685275	30.7686137671878	0.0125698456769079	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2435.02903916124	2435.02903916124
"healthy-4003"	"2020-08-26-Control4003-c1:TCCATGCTCCTCACGT"	-2.55204997482951	9.54666898334352	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCATGCTCCTCACGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1903.54606759617	37.2221728055909	0.0195541224030347	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1900.03282564536	1900.03282564536
"healthy-4003"	"2020-08-26-Control4003-c1:TCCATGCTCTGGCCGA"	-0.242241690785247	8.51840779865114	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCATGCTCTGGCCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2308.6025135524	23.9639680574522	0.010380291937124	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2300.54267059984	2300.54267059984
"healthy-4003"	"2020-08-26-Control4003-c1:TCCCACATCACCCTGT"	-1.36082051220592	8.55722901904909	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCCACATCACCCTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1963.17688465449	37.6205681844452	0.019163106737102	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.79104229155	1957.79104229155
"healthy-4003"	"2020-08-26-Control4003-c1:TCCCAGTCAAGCTCTA"	-2.38523612442668	8.91594121539918	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCCAGTCAAGCTCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1625.38936264268	13.7522375350991	0.00846088811159663	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1623.03487908998	1623.03487908998
"healthy-4003"	"2020-08-26-Control4003-c1:TCCCATGAGCTAAACA"	-0.544129828841049	8.5278634794983	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCCATGAGCTAAACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1929.31515719238	32.9402171948454	0.0170735284341939	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.56860110625	1912.56860110625
"healthy-4003"	"2020-08-26-Control4003-c1:TCCGAAAAGAGAGAAC"	5.3656403022701	-10.0629444352356	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCGAAAAGAGAGAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.25721424757	36.2299835613917	0.0168413071767728	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.70876197711	2144.70876197711
"healthy-4003"	"2020-08-26-Control4003-c1:TCCGAAAGTGGTTCTA"	5.40689768370931	-10.2497883073059	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCGAAAGTGGTTCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.48550543309	25.0964853643884	0.0118632272827842	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2108.41320634549	2108.41320634549
"healthy-4003"	"2020-08-26-Control4003-c1:TCCGATCTCTACACAG"	-0.575836877257186	8.80668828571168	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCGATCTCTACACAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.13736565378	25.6478739418249	0.0137807527886666	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.28489424941	1851.28489424941
"healthy-4003"	"2020-08-26-Control4003-c1:TCCGGGACACAGCCTG"	4.89355959472005	-7.72041752254637	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCGGGACACAGCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2898.36461688471	34.3236330462679	0.011842413768893	2084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2889.49070015939	2889.49070015939
"healthy-4003"	"2020-08-26-Control4003-c1:TCCGTGTTCTGACAGT"	-0.341374496847945	8.46013829791871	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCGTGTTCTGACAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.4613233601	32.1133779158761	0.0192473013705845	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1663.0660916528	1663.0660916528
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTCCCCACTTCCTG"	5.15289511260335	-8.18415167247923	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTCCCCACTTCCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.03866866625	4.93576294759458	0.00198140759903871	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2487.85520437859	2487.85520437859
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTCCCGTTATGGTC"	2.51185454901997	-4.29525473034056	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTCCCGTTATGGTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2342.57432266596	31.817774705807	0.013582397108151	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2338.30129728441	2338.30129728441
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTCGAAGAGAACCC"	-3.8933290046757	11.3266772993836	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTCGAAGAGAACCC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2096.391076751	35.6327865305743	0.0169972038737153	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2085.9866690615	2085.9866690615
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTCTTAGATACATG"	0.0250647338921249	9.22902295673219	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTCTTAGATACATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1938.56181598858	38.8698989758246	0.0200508947691218	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1931.26841425898	1931.26841425898
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTCTTTCGGAAGGT"	-3.9729507965153	13.1432323225769	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTCTTTCGGAAGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1594.0663454201	38.7058256369028	0.0242811886394241	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1591.72864934582	1591.72864934582
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTTCTCAAGGGTCA"	-0.739557961851913	9.17343328082887	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTTCTCAAGGGTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1684.22473270645	45.2416045104828	0.0268619760961366	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.62975641197	1660.62975641197
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTTCTTCACCCTTG"	6.77070250090901	-1.72848203098448	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTTCTTCACCCTTG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2639.02818107221	16.5848895839435	0.00628446854144815	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2626.78028780668	2626.78028780668
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTTTCGTAGGAGGG"	5.55180992659871	-9.87707807933959	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTTTCGTAGGAGGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2401.2015349328	32.4728251170933	0.0135235733630339	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2395.42167052016	2395.42167052016
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTTTCGTCTAATCG"	-3.99419055405315	13.0578632124695	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTTTCGTCTAATCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1611.35538498111	26.3352233003598	0.0163435226926483	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1606.66581479629	1606.66581479629
"healthy-4003"	"2020-08-26-Control4003-c1:TCCTTTCGTTTCACAG"	3.89429606971089	-7.00545837795409	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCCTTTCGTTTCACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.40024799959	39.0907166516971	0.0167240149328948	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.18837655636	2333.18837655636
"healthy-4003"	"2020-08-26-Control4003-c1:TCGAACACAGTATACC"	-4.02857623520549	13.0230026015076	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGAACACAGTATACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1665.5436772738	35.5040626100937	0.0213168006906956	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1659.30496642726	1659.30496642726
"healthy-4003"	"2020-08-26-Control4003-c1:TCGAAGTCAGCAGAAC"	-3.29619846764262	-5.5404467812744	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGAAGTCAGCAGAAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2538.67360808219	33.4275087199154	0.0131673124947983	2035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2534.18561678243	2534.18561678243
"healthy-4003"	"2020-08-26-Control4003-c1:TCGAAGTTCGTAGAGG"	10.8643804984981	7.25353429401246	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGAAGTTCGTAGAGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2012.01884698577	30.0588413625246	0.0149396420453795	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2007.16725753626	2007.16725753626
"healthy-4003"	"2020-08-26-Control4003-c1:TCGACCTTCCGCGATG"	0.365212519734544	8.06583402240602	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGACCTTCCGCGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1865.02580834255	28.1687831674905	0.0151036961748664	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1854.260153865	1854.260153865
"healthy-4003"	"2020-08-26-Control4003-c1:TCGACCTTCTTAATCC"	-1.65140471878703	8.92698571765748	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGACCTTCTTAATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1712.44669611603	29.2103167869794	0.0170576502341537	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1708.38964810832	1708.38964810832
"healthy-4003"	"2020-08-26-Control4003-c1:TCGACGGAGCATATGA"	-3.97633729401286	13.2417258986267	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"IFN+ NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGACGGAGCATATGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1891.04557455219	40.3482941266016	0.0213365001190711	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1876.18579290874	1876.18579290874
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCAGGAGGGTAATT"	3.00910272177998	-7.16300108348998	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCAGGAGGGTAATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2197.23229027508	34.4220832763301	0.0156661102372661	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2190.43144827025	2190.43144827025
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCTCAAGCATGTTC"	0.972532649605912	8.78714177692262	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCTCAAGCATGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.90700476759	33.2974203562687	0.0197974205838271	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1676.46693772447	1676.46693772447
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCTCAAGTGATGGC"	10.6048628288204	6.50647351825563	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCTCAAGTGATGGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.24583936416	26.7830731889928	0.0148362470113357	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1800.2519534188	1800.2519534188
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCTCATCAAGCTGT"	4.27084936675374	-7.02016737377318	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCTCATCAAGCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.21996023653	29.1828330285528	0.0130384115712509	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.47420681672	2235.47420681672
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCTTGCAACGATCT"	-3.18925223770793	9.73721025073854	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCTTGCAACGATCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1837.67659209366	42.1124857126181	0.0229161572247266	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.81767713595	1825.81767713595
"healthy-4003"	"2020-08-26-Control4003-c1:TCGCTTGCATAAGCGG"	-4.08323655548747	12.9986448057922	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGCTTGCATAAGCGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1678.63986663948	36.8835627559101	0.0219722904769017	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1674.17039984974	1674.17039984974
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGATATCAGTCATG"	-4.4488128227299	12.9082765349182	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGATATCAGTCATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2216.46283710178	31.8649564487778	0.0143764902868591	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2208.71175714096	2208.71175714096
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGATATCGTGGACC"	4.87694801863973	-8.10477259075316	"2020-08-26-Control4003-c1"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGATATCGTGGACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2709.03533635472	37.6360195801275	0.0138927754374628	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2701.74496825665	2701.74496825665
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGACTCCGTAGTA"	-1.09427664700206	8.64315412128297	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGACTCCGTAGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1689.56081351445	19.2284984992189	0.0113807673245106	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1684.28926972297	1684.28926972297
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGCAGTCAGACGA"	3.81683744963948	-7.00595095073851	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGCAGTCAGACGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.19984349962	9.12414780668066	0.00421984481874386	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2155.93049721882	2155.93049721882
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGCATCAAACCTG"	2.77348293837849	-4.58697035228881	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGCATCAAACCTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2841.09437759265	34.3820348855033	0.0121016869966271	2331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2835.86032567945	2835.86032567945
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGCATCAATCTTC"	10.7084700065548	6.1072902449402	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGCATCAATCTTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1784.23622416356	31.844831257048	0.0178478784511712	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1776.23340754937	1776.23340754937
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGTGGTAGAATAC"	-7.106193403632	3.71404717052308	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGTGGTAGAATAC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2182.3607168687	35.8636463553584	0.0164334182145729	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2166.80802051394	2166.80802051394
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGTGTCACGTCCT"	-4.29756246033366	12.8772048720154	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGTGTCACGTCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.94788012777	35.1064779872013	0.0178481994067483	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1957.65684872255	1957.65684872255
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGGTGTCGACATTG"	-3.38437471810039	12.3875636824402	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGGTGTCGACATTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1711.41290559244	37.6016501527056	0.0219711152287291	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1702.69661421454	1702.69661421454
"healthy-4003"	"2020-08-26-Control4003-c1:TCGGTCTCACCAGTAT"	6.71897806701009	-1.6076892844406	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGGTCTCACCAGTAT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2495.16495214825	13.9899702255133	0.00560683181024502	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2485.19493041417	2485.19493041417
"healthy-4003"	"2020-08-26-Control4003-c1:TCGTAGAAGCACCTGC"	0.152056207030457	7.88487908923952	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGTAGAAGCACCTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2014.23258555171	28.6722564780872	0.0142348290280657	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2005.86436313553	2005.86436313553
"healthy-4003"	"2020-08-26-Control4003-c1:TCGTCCAAGCTGCCTG"	-5.52318797531779	-5.535680317041	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGTCCAAGCTGCCTG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2260.36479576594	2.0989738194731	0.000928599588617221	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2254.03217631858	2254.03217631858
"healthy-4003"	"2020-08-26-Control4003-c1:TCGTCCAGTGTGCTTA"	-2.98712978783305	9.80632016742555	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGTCCAGTGTGCTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.47582679677	4.93173870685393	0.00255335253925124	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1923.30725928272	1923.30725928272
"healthy-4003"	"2020-08-26-Control4003-c1:TCGTGGGAGATGATTG"	-2.44261990013774	9.72660253131715	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGTGGGAGATGATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1572.14830596341	23.7847304420186	0.0151288083648339	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1572.14830596341	1572.14830596341
"healthy-4003"	"2020-08-26-Control4003-c1:TCGTGGGTCATGAGTC"	2.72431506690328	-4.40969135677489	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCGTGGGTCATGAGTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2171.66061461399	27.1325963403551	0.0124939395031474	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2169.20962848314	2169.20962848314
"healthy-4003"	"2020-08-26-Control4003-c1:TCTAACTGTTGCCTAA"	-0.423858235508758	8.61541936481325	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTAACTGTTGCCTAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1719.25677735904	35.4622121762028	0.0206264780474947	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1713.58010433178	1713.58010433178
"healthy-4003"	"2020-08-26-Control4003-c1:TCTACATCAAGTGATA"	-3.45265207710918	-5.34791471874388	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTACATCAAGTGATA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2521.51001651525	33.6187066069656	0.0133327674237943	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2516.85457218836	2516.85457218836
"healthy-4003"	"2020-08-26-Control4003-c1:TCTACATTCACCTCTG"	-3.90897379341777	10.9088754423889	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTACATTCACCTCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2260.32737656523	38.0123905330122	0.0168172057406903	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2256.98333274679	2256.98333274679
"healthy-4003"	"2020-08-26-Control4003-c1:TCTACATTCCATCCGT"	3.82344235953633	-6.68299534237059	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTACATTCCATCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.45042713606	38.1909260085435	0.015021306060061	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2539.93458472976	2539.93458472976
"healthy-4003"	"2020-08-26-Control4003-c1:TCTACCGCAAACTAGA"	-0.208342770964462	8.374316192511	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTACCGCAAACTAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.66854374219	40.2982306046549	0.0241499312465502	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.785147386	1660.785147386
"healthy-4003"	"2020-08-26-Control4003-c1:TCTACCGTCACGAACT"	-2.05624471131023	9.05767438495485	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTACCGTCACGAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1877.85088774786	36.8574836727344	0.0196274815605504	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.29460683527	1872.29460683527
"healthy-4003"	"2020-08-26-Control4003-c1:TCTATCAAGTAAGCAT"	-0.630199472338516	8.36641690814821	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTATCAAGTAAGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1871.68716487537	30.5095499877837	0.0163005605639312	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.41532584368	1864.41532584368
"healthy-4003"	"2020-08-26-Control4003-c1:TCTCACGCAGAGTAAT"	-3.7352868122166	12.5565852888855	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTCACGCAGAGTAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1789.83012871528	27.8150950339905	0.0155406340455091	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1789.83012871528	1789.83012871528
"healthy-4003"	"2020-08-26-Control4003-c1:TCTCACGGTGAACCGA"	5.57209600982015	-9.99947264110716	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTCACGGTGAACCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2611.17215935056	27.0381164919444	0.0103547812407241	1760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2602.18198307559	2602.18198307559
"healthy-4003"	"2020-08-26-Control4003-c1:TCTCACGTCTAGTGAC"	-3.6571925682133	10.9242152937683	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTCACGTCTAGTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.25284845076	33.0191687063103	0.0174773687563244	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1877.14626606246	1877.14626606246
"healthy-4003"	"2020-08-26-Control4003-c1:TCTCCGAAGAGCCGAT"	-3.20147452774699	10.6117315062317	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTCCGAAGAGCCGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1444.74419624966	33.350168014297	0.0230837874973777	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1442.34909672146	1442.34909672146
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAAGGAAAGTG"	0.224478473036927	8.23359296405641	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAAGGAAAGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1486.88988153709	33.9891736624734	0.0228592406771486	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1484.94345087285	1484.94345087285
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAAGGACCCAA"	-2.50613842430766	9.2729282149109	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAAGGACCCAA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2152.62275570634	28.1782899466238	0.0130902127982837	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2140.61900362264	2140.61900362264
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCACATCCGATA"	10.2239281135494	6.02167508685914	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCACATCCGATA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1640.71762740435	45.0236049549161	0.0274414099068006	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1634.55061857611	1634.55061857611
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAGTCGTATTG"	-0.821744362742263	8.93251130664674	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAGTCGTATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1792.83895570827	34.7884497973914	0.0194041130613698	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1780.09136572897	1780.09136572897
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAGTCTTCTAT"	3.2990218597347	-6.70359947597655	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAGTCTTCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.27244805399	25.2835408100846	0.0105117159723592	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.42129215354	2397.42129215354
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAGTGTGCTTA"	10.4185997444088	6.71952626788942	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAGTGTGCTTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1912.68727268969	35.8048824183974	0.0187196741096349	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1897.5212001833	1897.5212001833
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCAGTGTGGTCC"	4.94778456267659	-7.59821464931639	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCAGTGTGGTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2334.16204383605	34.0458639520803	0.0145859041971773	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2330.19317705413	2330.19317705413
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCATCCACTTTA"	2.97888459739034	-6.54334547435912	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCATCCACTTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.96110989916	30.7157309221705	0.0132511847549965	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2317.96110989916	2317.96110989916
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGCCATCTACAGGT"	3.10062708434407	-6.16831638729247	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGCCATCTACAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.37003551293	34.1911656538064	0.0136145471078789	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2504.45699719944	2504.45699719944
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGGCTGTACCGCGT"	-4.12723718109782	12.7437667616638	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGGCTGTACCGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.78386175044	41.4759689317598	0.0209180484730918	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1976.80325770516	1976.80325770516
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGGCTGTTCTATCT"	10.5038277107174	6.71912286365358	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGGCTGTTCTATCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1644.5636692692	32.9062272793385	0.02000909292491	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1634.46766347877	1634.46766347877
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGGCTTCCCAAGCG"	4.66084875640218	-6.97245838558348	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGGCTTCCCAAGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2419.80338713421	16.7594191923172	0.00692594252963893	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2417.03208125784	2417.03208125784
"healthy-4003"	"2020-08-26-Control4003-c1:TCTGTCGCAACCGATT"	0.12170666930024	9.26023671710817	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTGTCGCAACCGATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1792.11087790839	30.199953537415	0.016851609969949	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1788.23309207703	1788.23309207703
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTAGTGTCCGGACT"	-4.66471038284953	9.08846948230592	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTAGTGTCCGGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	3174.14998236229	41.5566025791598	0.0130921987965522	3033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	3157.36206546496	3157.36206546496
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTAGTGTTATGTCG"	-7.75586591187175	0.189025021437086	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTAGTGTTATGTCG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2793.33664526549	30.1701957514324	0.0108007732625313	3467	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2788.02074597233	2788.02074597233
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTAGTTCCGTTGAA"	5.32911934432332	-10.0554657212463	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTAGTTCCGTTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.06905398	25.5697098457801	0.0127908086991156	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1994.23674475602	1994.23674475602
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTCCTTCGGACAAG"	5.28807892379109	-9.99356462871703	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTCCTTCGGACAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.26086843918	23.5933136819126	0.0107719194648835	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2185.8849472264	2185.8849472264
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTGCGTCATAGACC"	5.37747349318807	-9.77610113536986	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTGCGTCATAGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2701.72597141621	34.1036572455108	0.0126229149833557	2136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2696.34486275342	2696.34486275342
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTTGAAGATGCAGC"	2.88275947150533	-4.91597607052001	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTTGAAGATGCAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2647.73481386064	29.1842571305914	0.0110223489821619	2337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2643.96480292717	2643.96480292717
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTTGAAGCTCGAAG"	3.61696543273274	-6.38768150722655	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTTGAAGCTCGAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2069.30529286965	12.3448962976756	0.00596572015749114	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2066.27284313806	2066.27284313806
"healthy-4003"	"2020-08-26-Control4003-c1:TCTTTGAGTAACTGCT"	-0.268598149449188	8.85444829547731	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TCTTTGAGTAACTGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2147.77434983973	27.4294484322128	0.0127711034607801	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2132.32876277361	2132.32876277361
"healthy-4003"	"2020-08-26-Control4003-c1:TGAACGTAGTTAGTAG"	-7.04266772690471	3.32486221874086	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAACGTAGTTAGTAG"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2021.10418021335	25.0712893235066	0.0124047486363914	1463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2011.73830281453	2011.73830281453
"healthy-4003"	"2020-08-26-Control4003-c1:TGAATCGAGAACAGGA"	10.0617329078609	7.52372548663942	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAATCGAGAACAGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1913.43840284407	30.8549398377789	0.0161253896607893	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1899.13558413974	1899.13558413974
"healthy-4003"	"2020-08-26-Control4003-c1:TGAATGCGTAACAGTA"	-0.442961315543014	7.87727878177492	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAATGCGTAACAGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2306.51836621549	24.8789911683891	0.0107863832921523	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2297.54788311767	2297.54788311767
"healthy-4003"	"2020-08-26-Control4003-c1:TGACAGTCAGCTCCTT"	-0.118496159941512	8.14093492114869	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACAGTCAGCTCCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1983.49293553428	30.7028809792617	0.0154791985538338	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1967.29214629304	1967.29214629304
"healthy-4003"	"2020-08-26-Control4003-c1:TGACAGTCAGGCATGA"	-0.211562375456649	8.34235856616823	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACAGTCAGGCATGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.6642800126	25.478447300241	0.0145702337443854	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1733.84416791416	1733.84416791416
"healthy-4003"	"2020-08-26-Control4003-c1:TGACAGTTCCATTCAT"	-4.01635060730632	11.2554054030213	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACAGTTCCATTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2032.22372247703	22.6847486560578	0.0111625252698103	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2026.87511883887	2026.87511883887
"healthy-4003"	"2020-08-26-Control4003-c1:TGACCCTAGCAGAAAG"	-4.39558730545695	13.0079812773499	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACCCTAGCAGAAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1866.26644061583	40.0481983027232	0.0214589929021647	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1866.26644061583	1866.26644061583
"healthy-4003"	"2020-08-26-Control4003-c1:TGACTCCAGTAACCTC"	-2.98267612877544	9.98698422992555	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACTCCAGTAACCTC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2035.6658682053	38.0240466443382	0.0186789233136091	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2030.56955542208	2030.56955542208
"healthy-4003"	"2020-08-26-Control4003-c1:TGACTCCCATATACCG"	-3.48681149902995	9.34286687457887	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACTCCCATATACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2249.67689754051	43.292575941683	0.0192439083092391	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2246.37763375059	2246.37763375059
"healthy-4003"	"2020-08-26-Control4003-c1:TGACTCCTCTATCGTT"	-4.03020558777507	11.1804456480774	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGACTCCTCTATCGTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2521.58718308244	33.5525819346961	0.0133061359765006	1557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2514.82066019267	2514.82066019267
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGACTAGAGGTGCT"	-3.58058200302776	11.2242889174256	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGACTAGAGGTGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.29649079861	37.3835623857613	0.0203581298407334	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1832.04438850414	1832.04438850414
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGACTCATCGCCTT"	10.3490091758663	6.31750867450563	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGACTCATCGCCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1875.76928407827	33.3159437197477	0.0177612161594376	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1872.46836466198	1872.46836466198
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGACTTCACCTCGT"	-4.14712844315227	10.3571462401184	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGACTTCACCTCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.29142023432	34.5683097783526	0.0164431579017241	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2095.13730591101	2095.13730591101
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGCATCACTCCCTA"	2.72116198119466	-4.40445806896361	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGCATCACTCCCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2665.39322002104	19.6386874323196	0.00736802633277673	2370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2662.39035738594	2662.39035738594
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGCGCTCTTAGCTT"	8.78826584395711	6.15724561298219	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGCGCTCTTAGCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1722.66249699455	26.4842882849331	0.0153740435698455	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1712.52831244307	1712.52831244307
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGAGAGATGCCGA"	-3.67524609986003	10.4554986723694	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGAGAGATGCCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2319.31255853038	33.1851996937237	0.0143082050634656	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2314.28848016963	2314.28848016963
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGAGCACCCTGAG"	2.85895599898641	-4.7108946076599	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGAGCACCCTGAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2390.71610426469	35.7126838103843	0.0149380697050051	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2386.35587424818	2386.35587424818
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGAGCACGATAGG"	2.68460454520528	-5.01818039333495	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGAGCACGATAGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2403.25665324912	0	0	1692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2398.58863229065	2398.58863229065
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGAGGTAAGACCG"	-1.28433809700664	8.57748887622682	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGAGGTAAGACCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1938.77189642881	36.1526375770387	0.0186471846655253	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1933.49207963352	1933.49207963352
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGAGTCTCTAGGA"	4.68734945830647	-7.70372249996337	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGAGTCTCTAGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2309.04160529194	16.1109641456973	0.00697733817735184	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2305.89579952451	2305.89579952451
"healthy-4003"	"2020-08-26-Control4003-c1:TGAGGTTAGTGCTCAT"	-0.528647105128127	8.23960492694703	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGAGGTTAGTGCTCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2047.66886517349	42.1657976664473	0.0205920978648444	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2042.591224636	2042.591224636
"healthy-4003"	"2020-08-26-Control4003-c1:TGATCAGTCAGCTGAT"	-3.36740026894267	10.1553983458313	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATCAGTCAGCTGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.93998911149	34.5504639394198	0.0172412667680427	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1993.04890066277	1993.04890066277
"healthy-4003"	"2020-08-26-Control4003-c1:TGATCTTTCTCGCAGG"	-0.697867373854476	8.24412629688112	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATCTTTCTCGCAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2120.92427515235	30.6111123489574	0.0144329114940978	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2112.59807012597	2112.59807012597
"healthy-4003"	"2020-08-26-Control4003-c1:TGATGCAAGGACTGGT"	-1.40107820454295	9.10915753925172	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATGCAAGGACTGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2119.8501703022	22.3692189011631	0.0105522641243906	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2106.76940336568	2106.76940336568
"healthy-4003"	"2020-08-26-Control4003-c1:TGATGCACACTTGGGC"	-3.73722777786906	12.571678138617	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATGCACACTTGGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1683.307540447	32.8997072335203	0.0195446800082555	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1683.307540447	1683.307540447
"healthy-4003"	"2020-08-26-Control4003-c1:TGATGCACAGCTACAT"	4.99131836470906	-7.60758640682372	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATGCACAGCTACAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2698.46880728579	5.9876727252228	0.00221891493022126	1955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2695.3569107784	2695.3569107784
"healthy-4003"	"2020-08-26-Control4003-c1:TGATGGTCAAATAAGC"	5.38694824752156	-9.52647974407347	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATGGTCAAATAAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.87870382539	26.3646815676377	0.00956670608580899	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2745.88598573485	2745.88598573485
"healthy-4003"	"2020-08-26-Control4003-c1:TGATTCTGTCTTACTT"	4.32451929625813	-7.17473652279051	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATTCTGTCTTACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.29974994557	6.90901560369697	0.00298535900712924	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2312.9142105766	2312.9142105766
"healthy-4003"	"2020-08-26-Control4003-c1:TGATTTCTCGCCAGTG"	-7.26935086670573	-0.189245440718256	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGATTTCTCGCCAGTG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1840.20961695752	41.9726690971817	0.0228086347937777	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1837.22419560966	1837.22419560966
"healthy-4003"	"2020-08-26-Control4003-c1:TGCACGGTCTGGGCGT"	-3.32057557526286	10.2594537504944	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCACGGTCTGGGCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.40291734987	32.2255967230353	0.0180292850650682	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.40471783793	1785.40471783793
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGATGTCATGACT"	5.40654577788655	-9.95266153728636	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGATGTCATGACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.24673358977	5.14313395453347	0.00195315307484389	1710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2628.52241259737	2628.52241259737
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGGCGTAAGTAGT"	-5.3691066307133	3.80293438518373	"2020-08-26-Control4003-c1"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGGCGTAAGTAGT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2242.66603298931	33.4413848299051	0.0149114421576761	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2233.78411328375	2233.78411328375
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGTAAGGAAAGGT"	5.20937695082967	-10.2221822968689	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGTAAGGAAAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.83213852743	7.53207958419444	0.00304224162332523	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.14258073034	2462.14258073034
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGTACAATAGTAG"	3.71331038054768	-6.66336443340453	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGTACAATAGTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.94392155434	14.6638079877904	0.00638405136938106	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2295.73876559194	2295.73876559194
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGTAGTCTACATG"	-4.13948569718059	12.6530771025452	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGTAGTCTACATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2009.155835195	34.0962006695714	0.0169704111907587	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1999.9343474509	1999.9343474509
"healthy-4003"	"2020-08-26-Control4003-c1:TGCAGTATCTTAAGGC"	4.25005354461018	-8.1109886399475	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCAGTATCTTAAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2142.76725956419	23.9119658875937	0.0111593855006246	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2138.57133448691	2138.57133448691
"healthy-4003"	"2020-08-26-Control4003-c1:TGCATCCAGATGCTTC"	5.59977926787679	-10.0300417176453	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCATCCAGATGCTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.17575974647	17.1265970380106	0.00649675841024264	1640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2630.59797490863	2630.59797490863
"healthy-4003"	"2020-08-26-Control4003-c1:TGCATCCAGCAACAAT"	-3.34940395775493	10.2346267470154	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCATCCAGCAACAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1520.62716004703	19.6363308303111	0.0129133106038326	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1520.62716004703	1520.62716004703
"healthy-4003"	"2020-08-26-Control4003-c1:TGCATGACAACCGGAA"	2.89413609084432	-6.35896208202513	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCATGACAACCGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2404.83671994853	14.0544652781587	0.00584424928377653	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.89700979753	2396.89700979753
"healthy-4003"	"2020-08-26-Control4003-c1:TGCATGATCCACCTCA"	-2.61164365235026	10.3280648955139	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCATGATCCACCTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1800.77567175204	38.6143292165607	0.021443164644151	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1798.96015709488	1798.96015709488
"healthy-4003"	"2020-08-26-Control4003-c1:TGCATGATCCATAAGC"	-3.21084533158	10.243553138617	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCATGATCCATAAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.59368646922	36.4208597001994	0.019553840413386	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.11673187771	1855.11673187771
"healthy-4003"	"2020-08-26-Control4003-c1:TGCCGAGAGACGTCCC"	0.0662505813757002	8.37235353076784	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCCGAGAGACGTCCC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1942.59540401538	39.1533530928408	0.0201551764262955	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1931.01665723942	1931.01665723942
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGACGGTGACCGTC"	-3.31559048119243	10.0205983885559	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGACGGTGACCGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1737.22738005733	32.3612957272924	0.0186281289938133	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1735.07840702171	1735.07840702171
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGATACACCAATTG"	0.548792024224442	8.26960275256959	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGATACACCAATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1717.32677944118	24.5593565288132	0.0143009221208353	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1706.42926394886	1706.42926394886
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGGCAAGCGGTATG"	5.49533190306966	-9.78019335186156	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGGCAAGCGGTATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.51986395846	31.987791895642	0.0133811027374913	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2387.71356395601	2387.71356395601
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGGCATCACCTCTG"	5.62918772277181	-9.92376043712767	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGGCATCACCTCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.97707615745	34.9535606803836	0.0135322767681632	1767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2576.41586669786	2576.41586669786
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGGGTGTCAGCTTA"	4.88740553435628	-7.99592497265013	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGGGTGTCAGCTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.53290320892	34.4283032954848	0.0159277257562788	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2158.50373938594	2158.50373938594
"healthy-4003"	"2020-08-26-Control4003-c1:TGCGGGTTCTGACAGT"	5.68140806731526	-9.88773443615111	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCGGGTTCTGACAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.56387375308	37.3765848384217	0.0162185067917221	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2294.61018589318	2294.61018589318
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCCAAGAATCGAT"	0.616729279130143	8.92361829364625	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCCAAGAATCGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.14217945679	39.898436985825	0.0239178875021417	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1661.17838872888	1661.17838872888
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCCAAGAGCAACC"	2.72059120711629	-4.44580032741698	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCCAAGAGCAACC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2483.35487842847	1.36374254024948	0.000549153305512455	2005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2480.75719615454	2480.75719615454
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCCACAATGAACA"	5.45702375945393	-9.98932268535765	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCCACAATGAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.65538974158	36.4630819798494	0.0153810132580359	1346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2366.44571761835	2366.44571761835
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCGTAGCACCGTC"	10.7753282981807	6.12345550144044	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCGTAGCACCGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1835.62797504557	33.5967200104269	0.018302575721855	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1827.48605938054	1827.48605938054
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCGTAGTGTAGAT"	-7.15211139145549	3.38733885372011	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCGTAGTGTAGAT"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2167.76228292369	37.0995065701264	0.0171141950675929	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2159.12818989721	2159.12818989721
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCGTCAAGCTACT"	-0.11343046549018	8.10680577838746	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCGTCAAGCTACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1661.42914181893	27.1669152316678	0.0163515340786219	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1658.19511996119	1658.19511996119
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTCGTCACCAGTAT"	5.32569040831868	-10.3200025788513	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTCGTCACCAGTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1925.74628008109	11.5389603886017	0.00599194219298495	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1923.74084249061	1923.74084249061
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTTCGGTAATTGGA"	0.857904632657212	8.78426835620729	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTTCGGTAATTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1600.03491271076	29.8653265145185	0.0186654217837791	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.8978061783	1592.8978061783
"healthy-4003"	"2020-08-26-Control4003-c1:TGCTTGCAGGAAGAAC"	-4.34703717652019	12.9596309431824	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGCTTGCAGGAAGAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1886.48081038054	6.44336596938485	0.00341554811155758	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1880.14260798488	1880.14260798488
"healthy-4003"	"2020-08-26-Control4003-c1:TGGAACTAGTAAATGC"	-0.713902751833755	8.66921613300172	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGAACTAGTAAATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1965.9794923825	37.2123936591194	0.0189281698020273	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1954.37562245561	1954.37562245561
"healthy-4003"	"2020-08-26-Control4003-c1:TGGAACTGTTCTCAGA"	-0.0937493545120538	8.80202672565309	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGAACTGTTCTCAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2065.28361239277	29.7545344376973	0.0144069968207537	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.5913822861	2059.5913822861
"healthy-4003"	"2020-08-26-Control4003-c1:TGGAGAGAGGCGTTGA"	-3.0757626098698	11.129705406073	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGAGAGAGGCGTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1463.70896209775	41.0896228242767	0.0280722629213038	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1461.41569216315	1461.41569216315
"healthy-4003"	"2020-08-26-Control4003-c1:TGGAGGACACCGCTGA"	5.48519672927205	-9.75772669231566	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGAGGACACCGCTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.05075791079	38.9971350999849	0.0147825567734219	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2631.96994722352	2631.96994722352
"healthy-4003"	"2020-08-26-Control4003-c1:TGGATCAAGCCGGAAT"	-2.7672303718632	9.56607053363649	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGATCAAGCCGGAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.30016626465	39.7382382723936	0.0196597412574449	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2010.81742963282	2010.81742963282
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGAAGTCGCGAAGA"	-1.41892526570018	9.61635491931764	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGAAGTCGCGAAGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1792.49330914667	17.3156714114668	0.00966010379124373	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1786.78912955823	1786.78912955823
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGATTCACCTGCGA"	-0.516531268984634	8.72739217365114	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGATTCACCTGCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1952.30737909432	33.3483500444423	0.017081505915279	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1942.97376583266	1942.97376583266
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGATTCAGATTTCG"	-4.25554261627849	12.9992275007996	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGATTCAGATTTCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1958.85479285955	35.5194720483797	0.0181327744036239	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1952.80790030263	1952.80790030263
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGCGTGTTAAACCC"	-4.02113233032878	12.8339633711609	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGCGTGTTAAACCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1734.48545797467	35.349272569827	0.0203802645950711	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1732.28283341072	1732.28283341072
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGCTGGTCGGATTT"	-0.429860870272475	8.38912866199342	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGCTGGTCGGATTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.65957398782	31.4275480249683	0.0185231902184721	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.00167272129	1693.00167272129
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGCTGTCATCGACA"	4.98319353637044	-8.05361940776976	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGCTGTCATCGACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.09956478833	28.4059697321757	0.0121699905868205	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.57437853218	2331.57437853218
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGCTGTCTCCGTGT"	-3.64818201485332	11.6278705366882	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGCTGTCTCCGTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2017.20175052074	44.301412183513	0.0219618152582292	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2012.04725210045	2012.04725210045
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGTTACAAAGGCAC"	-2.85673699799235	10.7218694456848	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGTTACAAAGGCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1754.59038362735	39.3504883952074	0.022427165201861	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1741.08816281131	1741.08816281131
"healthy-4003"	"2020-08-26-Control4003-c1:TGGGTTACAATCACGT"	-4.34500394287761	12.7541455992493	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGGTTACAATCACGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2135.50550157479	21.144994703071	0.00990163438468222	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2124.38398126578	2124.38398126578
"healthy-4003"	"2020-08-26-Control4003-c1:TGGTTAGAGATGTAGT"	-4.15564713898357	3.51713965022889	"2020-08-26-Control4003-c1"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGTTAGAGATGTAGT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2800.09086013991	34.2889629826474	0.0122456608357823	2847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2796.07645167196	2796.07645167196
"healthy-4003"	"2020-08-26-Control4003-c1:TGGTTAGAGCATAGGC"	-1.68509374085124	9.63918397510377	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGGTTAGAGCATAGGC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1881.49048379893	36.176834106996	0.0192277529004298	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1877.72189045091	1877.72189045091
"healthy-4003"	"2020-08-26-Control4003-c1:TGTAACGCATATCTGG"	-0.273206810385543	8.50392434680787	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTAACGCATATCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1703.76584806402	36.8452226689825	0.0216257549186406	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1703.76584806402	1703.76584806402
"healthy-4003"	"2020-08-26-Control4003-c1:TGTAACGTCAGCGTCG"	5.45805897292439	-10.1796741715637	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTAACGTCAGCGTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.28685956626	28.2723922792402	0.0135320777756242	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2087.68197123131	2087.68197123131
"healthy-4003"	"2020-08-26-Control4003-c1:TGTAAGCGTGCATTAC"	6.82535471495931	-1.7242892018524	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTAAGCGTGCATTAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2273.89810566177	0	0	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2262.00067992697	2262.00067992697
"healthy-4003"	"2020-08-26-Control4003-c1:TGTACAGGTAACGTTC"	3.42198671874349	-6.75628330623778	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTACAGGTAACGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2020.13589205147	32.9501809190112	0.0163108734658191	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2014.47311884863	2014.47311884863
"healthy-4003"	"2020-08-26-Control4003-c1:TGTAGACGTTACGTAC"	1.07294525679891	9.24010751331178	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTAGACGTTACGTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1502.68397591316	25.3675050579089	0.0168814637438943	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1497.96908602092	1497.96908602092
"healthy-4003"	"2020-08-26-Control4003-c1:TGTCCACGTGTACAGG"	-5.28386197510417	-5.19133188640746	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTCCACGTGTACAGG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3117.36597985652	37.5809778166895	0.0120553627836855	2644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3113.13731600403	3113.13731600403
"healthy-4003"	"2020-08-26-Control4003-c1:TGTCCTGGTGACCGAA"	0.170173314481419	8.45478246295778	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTCCTGGTGACCGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1662.04848027477	29.9389030963865	0.0180132549992988	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1658.26946565258	1658.26946565258
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGAGTAGTAGCCAG"	3.89509524878804	-7.1456074944702	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGAGTAGTAGCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.44250989777	33.4060591172541	0.0154197764143903	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2163.2547684149	2163.2547684149
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGAGTAGTGCACCC"	3.39522399482076	-7.13678314602049	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGAGTAGTGCACCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.16510804967	24.7269174181026	0.0115375699824661	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2139.76060825031	2139.76060825031
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGATGCAACGCCCA"	-3.73769364777263	12.7498121031555	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGATGCAACGCCCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1884.44315172245	42.6247116978799	0.0226192611111242	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1876.11711017531	1876.11711017531
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGATGGTTCAGCTA"	-3.208319525153	9.7480258711609	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGATGGTTCAGCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1940.0609378359	32.2791130135537	0.0166381954216141	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.65016463685	1932.65016463685
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGCGGGTACGGCAA"	-3.78920517388042	12.8769464262756	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGCGGGTACGGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1706.8434699187	35.9157567910046	0.0210422088633092	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1704.69695989204	1704.69695989204
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGGCGGTCGCACGT"	-0.0109429759090722	8.53841493213502	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGGCGGTCGCACGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1883.23927460191	20.2253931737749	0.0107396831865936	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.4988370044	1881.4988370044
"healthy-4003"	"2020-08-26-Control4003-c1:TGTGTGATCGTTCTCG"	6.82087292250935	-1.70187928592833	"2020-08-26-Control4003-c1"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTGTGATCGTTCTCG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2357.94118289776	12.2230193571641	0.00518376770625925	1370	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2355.1856818951	2355.1856818951
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTACTAGAATACAC"	10.2652727561886	7.28349635684816	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTACTAGAATACAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2040.48545741988	34.0836296206104	0.0167036866137277	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2035.2101837804	2035.2101837804
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTACTGTCATGACT"	-3.33972249451335	10.338068939093	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTACTGTCATGACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.99391055759	42.5541039517839	0.023641248841004	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.3753772451	1792.3753772451
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTACTTCCGACGGT"	1.66289522227589	-6.42976524746092	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTACTTCCGACGGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2148.28658613523	8.9324915890226	0.00415796088225461	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2141.92532102518	2141.92532102518
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTCCGTCCTCTCGA"	2.81977858123128	-4.84032251751097	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTCCGTCCTCTCGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2589.41703305097	31.9555778754695	0.0123408386782016	2067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2584.07384816783	2584.07384816783
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTCCGTCGTTAGAC"	5.42182840880696	-10.2043104401794	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTCCGTCGTTAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.83407671789	39.3503091817352	0.0195594207480228	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1999.76947608862	1999.76947608862
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTCTAGTGCTCTTC"	-0.619359175593215	8.43578813159791	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTCTAGTGCTCTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1615.17393162807	5.07867843238011	0.00314435388841429	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1611.84609696069	1611.84609696069
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTCTAGTGGCAGAT"	5.45730080184285	-9.68527319347533	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTCTAGTGGCAGAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.49022552303	31.8359107410858	0.0135906269295009	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2339.83214633281	2339.83214633281
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTGAGCAAGTGACG"	-7.44030175629314	0.0386609763833656	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTGAGCAAGTGACG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2586.75929158453	32.5796182210363	0.0125947622289508	2582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2581.39535684744	2581.39535684744
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTGGAGTCGTCAGC"	-2.51093707504924	9.35409162128297	"2020-08-26-Control4003-c1"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTGGAGTCGTCAGC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1545.94302726944	32.4909180036735	0.0210168922337723	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1539.07703902478	1539.07703902478
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTTGTCAATCCTTT"	-2.96844301644023	9.97341821277467	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTTGTCAATCCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1644.89973675618	33.3384491758143	0.0202677697800349	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1638.74326042046	1638.74326042046
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTTGTCACGACAAG"	5.26614393767659	-10.1689787141052	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTTGTCACGACAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.00471216318	19.6402872564498	0.00981521289633434	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1994.43728737257	1994.43728737257
"healthy-4003"	"2020-08-26-Control4003-c1:TGTTTGTTCCTGGCTT"	-2.53381357613261	9.66983316028444	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TGTTTGTTCCTGGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1902.39794920729	40.5917742019056	0.0213371625105146	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1891.38667899134	1891.38667899134
"healthy-4003"	"2020-08-26-Control4003-c1:TTAATCCAGACAGCGT"	-0.868075589567977	8.98024556720582	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAATCCAGACAGCGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1647.46241828919	37.0310030734232	0.0224776011047816	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1643.63850784672	1643.63850784672
"healthy-4003"	"2020-08-26-Control4003-c1:TTAATCCTCCTGATAG"	4.89832510527913	-7.82427551662596	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAATCCTCCTGATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2603.09827925611	41.349678423042	0.0158847934219597	1738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2599.60769858132	2599.60769858132
"healthy-4003"	"2020-08-26-Control4003-c1:TTACAGGCAGTAGAAT"	3.25006093558614	-5.3528509370056	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACAGGCAGTAGAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2512.70306987245	39.8522969690378	0.015860328841426	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2510.67174596196	2510.67174596196
"healthy-4003"	"2020-08-26-Control4003-c1:TTACAGGTCTTTCAGT"	-3.49112759056743	10.3235931166443	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACAGGTCTTTCAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1536.94977393657	36.155194992845	0.0235239925246492	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1532.31936554433	1532.31936554433
"healthy-4003"	"2020-08-26-Control4003-c1:TTACCATTCTACTGAG"	3.81045999106709	-6.70370294963988	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACCATTCTACTGAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2502.05057735383	21.3259819905079	0.00852340163845218	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2495.87107394681	2495.87107394681
"healthy-4003"	"2020-08-26-Control4003-c1:TTACCGCAGCACTCTA"	11.1030746894771	6.03134820545045	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACCGCAGCACTCTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2320.35727008365	30.2712296293905	0.0130459347875765	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2301.10548339361	2301.10548339361
"healthy-4003"	"2020-08-26-Control4003-c1:TTACGCCAGGATCATA"	5.40553774413411	-9.78235723888548	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACGCCAGGATCATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.48034914379	32.238567633572	0.0126105282383138	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2551.77088384624	2551.77088384624
"healthy-4003"	"2020-08-26-Control4003-c1:TTACGCCCATTGCTGA"	5.04653563079183	-7.83278849041136	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACGCCCATTGCTGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2944.05446202688	20.8132828156576	0.00706959843444213	2504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2940.69253774898	2940.69253774898
"healthy-4003"	"2020-08-26-Control4003-c1:TTACGCCTCAGCTTGA"	-3.48276076737102	10.8911561735901	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACGCCTCAGCTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1844.18796950427	38.8508639165964	0.0210666507747797	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.21691258091	1840.21691258091
"healthy-4003"	"2020-08-26-Control4003-c1:TTACTGTTCCTAAACG"	10.4264494377071	6.70278737628785	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTACTGTTCCTAAACG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2003.36084874056	31.9989457188571	0.0159726320592587	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1996.49513703587	1996.49513703587
"healthy-4003"	"2020-08-26-Control4003-c1:TTAGGCACATGCTGCG"	-4.04892859879191	12.6995343931946	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAGGCACATGCTGCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2210.80956363701	36.7731046161085	0.0166333207621976	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2203.1329904306	2203.1329904306
"healthy-4003"	"2020-08-26-Control4003-c1:TTAGGGTGTACGTACT"	2.59305300292317	-4.20348312770995	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAGGGTGTACGTACT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2090.46051213352	33.6717539440457	0.0161073379519044	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2084.72715448243	2084.72715448243
"healthy-4003"	"2020-08-26-Control4003-c1:TTAGTCTCAATCCTAG"	-1.68873665753062	9.05046079242555	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAGTCTCAATCCTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2212.96580724811	36.1960536578982	0.0163563546889634	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2205.88003177827	2205.88003177827
"healthy-4003"	"2020-08-26-Control4003-c1:TTAGTCTCACTTGACA"	-3.78417382660564	10.438395477179	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAGTCTCACTTGACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1982.16595434025	28.1229714814841	0.0141880004647969	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1973.67762304815	1973.67762304815
"healthy-4003"	"2020-08-26-Control4003-c1:TTAGTCTGTAGTTCCA"	-3.60711107674297	13.2418937453064	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTAGTCTGTAGTTCCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1694.01747747606	36.675590154381	0.0216500659774919	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1687.34651739919	1687.34651739919
"healthy-4003"	"2020-08-26-Control4003-c1:TTATTGCGTGTCCGGT"	10.6013332801754	6.86785266483156	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTATTGCGTGTCCGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1836.18486257066	29.1104079805826	0.0158537457605592	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1829.12140412538	1829.12140412538
"healthy-4003"	"2020-08-26-Control4003-c1:TTCAATCAGAGGATCC"	10.3652702766353	7.68257711017457	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCAATCAGAGGATCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2110.96165541823	30.2065725955023	0.0143093895230028	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2105.33157581273	2105.33157581273
"healthy-4003"	"2020-08-26-Control4003-c1:TTCAATCCAAATAAGC"	-4.04950557175334	13.0205592879089	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCAATCCAAATAAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1881.96420416577	37.964581974709	0.0201728502012279	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1877.90291353241	1877.90291353241
"healthy-4003"	"2020-08-26-Control4003-c1:TTCAATCTCAGACAAA"	5.00989927825276	-7.67992117321166	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCAATCTCAGACAAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.68636580795	37.3616248130246	0.0145733991923969	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2560.00931442863	2560.00931442863
"healthy-4003"	"2020-08-26-Control4003-c1:TTCAATCTCCACGGAC"	-2.19803009453471	8.66470525348512	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCAATCTCCACGGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2102.01376219309	31.2096177294755	0.0148474849645673	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2094.51373873552	2094.51373873552
"healthy-4003"	"2020-08-26-Control4003-c1:TTCAATCTCTATCGCC"	4.9149018722469	-7.75694420253905	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCAATCTCTATCGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.88908135464	35.4375222140932	0.0135315093970161	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2614.06759291438	2614.06759291438
"healthy-4003"	"2020-08-26-Control4003-c1:TTCACGCCATTAAGCC"	-3.56464038315471	12.4734849699768	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCACGCCATTAAGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1694.99838761579	38.8387767010919	0.0229137543639337	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1692.77587915469	1692.77587915469
"healthy-4003"	"2020-08-26-Control4003-c1:TTCACGCGTAGAATGT"	-7.70877108994182	-1.07421305095824	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCACGCGTAGAATGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2979.94303910652	32.357823964668	0.0108585377438523	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2973.57490742349	2973.57490742349
"healthy-4003"	"2020-08-26-Control4003-c1:TTCACGCGTCTTACAG"	-5.68797336044963	-4.56191112911376	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCACGCGTCTTACAG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2934.12460349161	40.2384661540701	0.0137139595592451	3057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2930.29735369491	2930.29735369491
"healthy-4003"	"2020-08-26-Control4003-c1:TTCACGCTCGGTTAGT"	5.37109436568562	-10.2246895066467	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCACGCTCGGTTAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.36768175421	8.32710064804448	0.00387781781331549	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.39858056659	2144.39858056659
"healthy-4003"	"2020-08-26-Control4003-c1:TTCATTGAGGAGAATG"	-4.10443292084392	12.9945134886536	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCATTGAGGAGAATG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1902.89559854517	39.3459620397083	0.0206768895097501	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1898.82951411916	1898.82951411916
"healthy-4003"	"2020-08-26-Control4003-c1:TTCATTGTCAAGAAAC"	-1.81753657284434	8.86855981433717	"2020-08-26-Control4003-c1"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCATTGTCAAGAAAC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1904.48488732653	29.2719815742609	0.0153700256531583	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1891.82293050565	1891.82293050565
"healthy-4003"	"2020-08-26-Control4003-c1:TTCATTGTCGCATTGA"	2.68307246741597	-4.26062014019164	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCATTGTCGCATTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2753.07771140733	36.0791173773764	0.013105012338694	2317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2751.68118973472	2751.68118973472
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCAATAGGCTTCCG"	-6.95802436295207	3.37537095630494	"2020-08-26-Control4003-c1"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCAATAGGCTTCCG"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2098.92533742255	29.9192014514808	0.0142545334595947	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2083.02604777045	2083.02604777045
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCAATTCCTTGGAA"	-3.77793655815776	10.368643737677	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCAATTCCTTGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.59380863461	36.8781393550171	0.0185635026117209	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1978.55939679986	1978.55939679986
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCACGTCCTGGTCT"	2.76404084739034	-4.71395924007567	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCACGTCCTGGTCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2769.48356496359	36.2258088199388	0.0130803480035871	2311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2765.22949508239	2765.22949508239
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCGGTAGTATCCTG"	-4.11969027939494	11.0469941862854	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCGGTAGTATCCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2110.98583856651	33.7465034139563	0.0159861344389085	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2104.32413557657	2104.32413557657
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCGGTGTGACACAG"	0.303659220307511	9.25632855975953	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCGGTGTGACACAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1529.90742918724	33.7695635240444	0.022072945643505	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1527.98300086029	1527.98300086029
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCGTGGTATGATCC"	-8.6049111885136	0.343345380667128	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCGTGGTATGATCC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2471.4136267428	3.70340946527233	0.00149849844040605	1833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2458.46473239982	2458.46473239982
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCGTGGTCTGTGGC"	-0.469106296927291	8.12818048084108	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCGTGGTCTGTGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.79296307583	25.7901178010008	0.015344018191155	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1676.79165439796	1676.79165439796
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCGTGGTTCTCTAT"	5.56444134291951	-9.77814676677855	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCGTGGTTCTCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.03037590852	30.5146499714475	0.0114414332311655	1658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2660.61124274525	2660.61124274525
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCTAATCACCTTAT"	0.163341735571068	7.89706704700319	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCTAATCACCTTAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2063.93550779008	24.9497421924121	0.0120884311056437	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.31942509747	2059.31942509747
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCTAATCGGTGTAT"	-0.44258032265361	8.56483266437379	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCTAATCGGTGTAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1791.44421257119	35.0944654547253	0.0195900409337088	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.51177219427	1783.51177219427
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCTCTGTTACGGAG"	-0.690502147108871	8.54421231830446	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCTCTGTTACGGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1572.10208546115	6.70153632634829	0.00426278699603819	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1570.29761220175	1570.29761220175
"healthy-4003"	"2020-08-26-Control4003-c1:TTCCTCTTCCTCACCA"	2.50475205954854	-3.97332765972289	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCCTCTTCCTCACCA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2828.36634192086	0.456103453488357	0.000161260387923651	2775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2812.0998562933	2812.0998562933
"healthy-4003"	"2020-08-26-Control4003-c1:TTCGATTTCAGATTGC"	3.76973690566365	-6.51498367702635	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCGATTTCAGATTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.24150737452	25.698938457581	0.0118688554464035	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2165.24150737452	2165.24150737452
"healthy-4003"	"2020-08-26-Control4003-c1:TTCGGTCGTGAAAGTT"	5.53092207488362	-9.66673090374144	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCGGTCGTGAAAGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2521.80246788156	40.9465193218372	0.0162370050165881	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2514.41925851743	2514.41925851743
"healthy-4003"	"2020-08-26-Control4003-c1:TTCGGTCTCCTTCACG"	-3.6668475669926	11.5143136748108	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCGGTCTCCTTCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2132.06012403641	36.2616730618959	0.0170078097953661	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2125.09733827956	2125.09733827956
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTAACAGACTCTTG"	-3.89570508423503	10.4288787611756	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTAACAGACTCTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2359.00005294938	38.7286992560647	0.0164174219528497	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2351.08706905007	2351.08706905007
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTAGTAGCACTCTA"	-0.974305729300338	8.82219312274782	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTAGTAGCACTCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2195.44289480141	31.8314618947911	0.014498879460798	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2188.01452929419	2188.01452929419
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTAGTAGTATTCCG"	3.81049789962117	-6.55232384121092	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTAGTAGTATTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2528.73860745527	34.9264701230962	0.013811815116092	1556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2522.29735134154	2522.29735134154
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTAGTTCAACACCA"	-3.66870437088664	10.9120759733948	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTAGTTCAACACCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.52417152323	35.1604960566113	0.0167948842124086	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2091.75421917655	2091.75421917655
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTCTCGTCGAGTTT"	-0.727025072008926	8.81244084918825	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTCTCGTCGAGTTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1491.1967876963	36.3823479769648	0.0243980863405497	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1491.1967876963	1491.1967876963
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTCTCTCCTCCACA"	-1.61362753334697	9.30689237201539	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTCTCTCCTCCACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2433.72689567666	39.4694979398629	0.0162177185985731	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2416.95388048107	2416.95388048107
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTTCCCAAAGACTA"	2.48024477538411	-4.07897331630858	"2020-08-26-Control4003-c1"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTTCCCAAAGACTA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2132.81221544035	23.4160720072861	0.010978965629401	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2131.54142292006	2131.54142292006
"healthy-4003"	"2020-08-26-Control4003-c1:TTCTTGAAGGCTCCCA"	-0.449483732611495	9.96182153308717	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTCTTGAAGGCTCCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1901.68484776042	12.0355937246575	0.00632891077553237	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1887.01680712552	1887.01680712552
"healthy-4003"	"2020-08-26-Control4003-c1:TTGAACGCACGTCGGT"	-3.31056938591655	10.40500257099	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGAACGCACGTCGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1667.00708609359	37.7061387650177	0.0226190632778755	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1658.67202629137	1658.67202629137
"healthy-4003"	"2020-08-26-Control4003-c1:TTGAACGCATCGATAC"	-4.21914420548137	12.7047700651917	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGAACGCATCGATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2284.99624922308	31.9194444582467	0.0139691452312447	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2272.6358936262	2272.6358936262
"healthy-4003"	"2020-08-26-Control4003-c1:TTGACCCTCAGTGCGC"	5.01965155181233	-8.25574591076048	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGACCCTCAGTGCGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.34056127475	32.7764910899004	0.013626549029103	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2405.34056127475	2405.34056127475
"healthy-4003"	"2020-08-26-Control4003-c1:TTGACCCTCGGCCAAC"	-0.569694797427017	8.85925862872926	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGACCCTCGGCCAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1739.7456435472	33.000595742852	0.0189686324924869	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1734.21376324874	1734.21376324874
"healthy-4003"	"2020-08-26-Control4003-c1:TTGATGGGTGCTCCGA"	-2.08624253693278	8.8796405562195	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGATGGGTGCTCCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.82077149368	29.5745751724379	0.0169888685019894	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1732.87581300203	1732.87581300203
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCATTGTACGTGAG"	-0.261713663966018	8.99148271167604	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCATTGTACGTGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1545.77447053969	26.7797972272464	0.0173245177337523	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1540.41676295414	1540.41676295414
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCATTGTATGCAAA"	5.41752161559407	-9.78204729473265	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCATTGTATGCAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2284.83551554851	14.7736861678298	0.00646597361923585	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2280.2243217019	2280.2243217019
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCCTGCACCCTCTA"	5.58218826827351	-9.97408010875853	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCCTGCACCCTCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2785.68651270875	33.5847373356058	0.0120561797540344	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2773.14628998166	2773.14628998166
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCCTGTCCTTCTTC"	-4.1874340576237	12.5858831175598	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCCTGTCCTTCTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1834.73767269235	16.1519234548534	0.0088033966355264	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1834.73767269235	1834.73767269235
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCGTCCATGTCGTA"	5.46717848357503	-9.80472090160521	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCGTCCATGTCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.63789825832	31.2011336640277	0.0123782688840736	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.54111283363	2515.54111283363
"healthy-4003"	"2020-08-26-Control4003-c1:TTGCGTCTCGCTCATC"	4.62889351424519	-7.1242828599182	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGCGTCTCGCTCATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.14397385761	4.20006037296629	0.00190293901200541	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.97362498327	2202.97362498327
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGATCAACAGCCC"	5.5535909133846	-9.96529390728148	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGATCAACAGCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.5475742535	8.42342746305404	0.00397416296070672	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2113.38562616316	2113.38562616316
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGATTCCTTCTTC"	3.55569042739217	-6.88646175777587	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGATTCCTTCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.7018308617	0.341502151263163	0.000143566607143634	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2373.18905280089	2373.18905280089
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGCGCAGGTCAAG"	5.53707565841023	-9.99556162273558	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGCGCAGGTCAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.28564387685	32.4295532572959	0.0146853978547643	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2201.91787931572	2201.91787931572
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGCGTCAAAGGTA"	-3.82903299751933	11.8157033690247	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGCGTCAAAGGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1601.70111697572	30.1998422201435	0.0188548549414549	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.26323745857	1592.26323745857
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGTAAGTCCCGGT"	0.123577949672383	8.36739347064821	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGTAAGTCCCGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1537.39873164037	41.3286653533386	0.0268822033625862	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1531.5002223387	1531.5002223387
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGTACAATACGCT"	-2.60858879509624	9.83572957599489	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ TRM"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGTACAATACGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1715.95123397201	42.1984801790845	0.0245918877784221	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1711.81277118609	1711.81277118609
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGTACACACACTA"	-2.63149843636211	9.96382901752321	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGTACACACACTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.68600277899	39.4905594377644	0.0256318025649185	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1538.42505724414	1538.42505724414
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGGTATCTAGTTCT"	-0.156333233148414	8.50002095783082	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGGTATCTAGTTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.84027017358	48.9183748523713	0.0268953660497647	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.1871213885	1807.1871213885
"healthy-4003"	"2020-08-26-Control4003-c1:TTGGTTTGTGTCTTGA"	5.37283052977864	-9.98919489299925	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGGTTTGTGTCTTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.71872268347	41.1484941745554	0.0178772904651799	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2298.77367991911	2298.77367991911
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTGGAAGTTGCATC"	-1.89465210858043	9.31049535358278	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTGGAAGTTGCATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1663.77058112835	38.8400133777371	0.0233445727543736	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1659.68149150806	1659.68149150806
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTGGAGTTTCTATC"	-2.6712785762852	10.4647454985413	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTGGAGTTTCTATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1801.12918524294	31.1115388311175	0.0172733522314898	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.00311047933	1787.00311047933
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTTCATCTCAATCT"	-4.11898217621501	12.7710704573425	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTTCATCTCAATCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1769.56734303644	40.8665421879166	0.0230940870087446	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1767.51290462506	1767.51290462506
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTTGTCAAATACGA"	2.03050376948659	-6.29000666057738	"2020-08-26-Control4003-c1"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTTGTCAAATACGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2040.93392646837	9.41719472181899	0.00461415952750342	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2040.93392646837	2040.93392646837
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTTGTGTGACACAG"	3.29826130446736	-7.38554623043212	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTTGTGTGACACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.93261410073	22.791883950261	0.0112834872763356	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2016.22078328241	2016.22078328241
"healthy-4003"	"2020-08-26-Control4003-c1:TTGTTGTTCGCAGATT"	-0.456816534430343	8.57894418323366	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTGTTGTTCGCAGATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1919.73789415421	34.1984204507017	0.0178141091837793	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1918.18537722059	1918.18537722059
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACCAAGACGCCAA"	1.1268525319988	9.26372239673463	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACCAAGACGCCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1593.24003097633	40.4805997336837	0.0254077219669639	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1578.21839242133	1578.21839242133
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACCACAGACGCTC"	-1.94349501553233	9.30769631946412	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACCACAGACGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1853.04808543072	40.9635995615772	0.0221060639945863	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.04808543072	1853.04808543072
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACCAGTGGCTTAT"	-2.16533384743388	10.1329107054505	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACCAGTGGCTTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.2542034403	32.4379595300108	0.0210601337477656	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1540.2542034403	1540.2542034403
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACCATCTTAGCAG"	3.41160335120503	-6.79526808178099	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACCATCTTAGCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.00217003895	2.99647736807207	0.00128383658187519	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.18780968221	2331.18780968221
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACGTCACCAGTTA"	5.57068028029744	-9.60618879711302	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACGTCACCAGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2484.17319932902	32.8858388190627	0.0132381425046954	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.743433198	2471.743433198
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACTGTCGTAGCTA"	-2.88841829720195	10.551149345282	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACTGTCGTAGCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1566.99474643865	33.8289502316173	0.021588426067478	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1562.44305443068	1562.44305443068
"healthy-4003"	"2020-08-26-Control4003-c1:TTTACTGTCTGCCTGT"	5.59235062178914	-9.96963884746703	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTACTGTCTGCCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.01360014498	31.0348068586009	0.0134698887439935	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2298.23924326852	2298.23924326852
"healthy-4003"	"2020-08-26-Control4003-c1:TTTAGTCAGAAATCCA"	5.32947506484334	-9.5212383500305	"2020-08-26-Control4003-c1"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTAGTCAGAAATCCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2844.1823327808	32.3159766778061	0.01136213255576	2153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2831.52999853555	2831.52999853555
"healthy-4003"	"2020-08-26-Control4003-c1:TTTAGTCTCATTATCC"	-4.06275210800822	12.9139804610047	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTAGTCTCATTATCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1875.80476959619	17.2128112184209	0.00917622745043254	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1865.33914248269	1865.33914248269
"healthy-4003"	"2020-08-26-Control4003-c1:TTTATGCTCATTGTTC"	-1.56174490872081	9.29058835590211	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTATGCTCATTGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1889.35535514116	34.5254311989512	0.018273656729002	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1880.44994956019	1880.44994956019
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCACACAACGGTAG"	2.72111596640889	-4.77094080364379	"2020-08-26-Control4003-c1"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCACACAACGGTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2560.09259932142	31.5780722666072	0.0123347383118006	1985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2556.39447163446	2556.39447163446
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCACACATATGCGT"	-3.33455882492717	10.7027349242005	"2020-08-26-Control4003-c1"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCACACATATGCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1669.03453176758	30.2417762795432	0.0181193232997498	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1660.87472282	1660.87472282
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCACAGTGATTCAC"	1.89547862586324	-6.40251686489256	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCACAGTGATTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.75890287411	28.1078837506705	0.0121010767479529	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.22561962243	2318.22561962243
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCAGTAGCGAATGC"	-7.80376277390178	-0.363434307929598	"2020-08-26-Control4003-c1"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCAGTAGCGAATGC"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2969.9012399255	33.4985805058692	0.0112793584027425	3221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2961.76781003125	2961.76781003125
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCATGGTGATACTC"	-3.97587333145793	11.9044313200745	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCATGGTGATACTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1744.37834430153	34.3609202422767	0.0196980892101337	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1738.35504925471	1738.35504925471
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCATGTCTGTCCCA"	10.3141981559688	7.26432464206544	"2020-08-26-Control4003-c1"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCATGTCTGTCCCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1848.77531365224	26.9798471435785	0.0145933618565471	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1848.77531365224	1848.77531365224
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCCTCTCTCGCGTT"	-3.86038790169414	12.0307521590027	"2020-08-26-Control4003-c1"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCCTCTCTCGCGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.88568845369	35.8476568407536	0.0185750156370538	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1919.83336041099	1919.83336041099
"healthy-4003"	"2020-08-26-Control4003-c1:TTTCGATGTTCCCAAA"	3.51808085021321	-7.04362442409667	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTCGATGTTCCCAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.89329376953	23.017203261143	0.0110346983375872	1026	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.46108639286	2082.46108639286
"healthy-4003"	"2020-08-26-Control4003-c1:TTTGACTTCATTCGTT"	5.61820282515828	-9.79084684765013	"2020-08-26-Control4003-c1"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTGACTTCATTCGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.01812054296	1.31133860221595	0.000510443500468107	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2565.47623818574	2565.47623818574
"healthy-4003"	"2020-08-26-Control4003-c1:TTTGATCAGAGGTGCT"	0.032806052907747	8.51205918872682	"2020-08-26-Control4003-c1"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTGATCAGAGGTGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.37247358783	24.950718379003	0.014085529018336	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1761.96883001861	1761.96883001861
"healthy-4003"	"2020-08-26-Control4003-c1:TTTGATCGTGGACTGA"	3.46197738227193	-6.53736021434935	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTGATCGTGGACTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.98843253618	40.8791006901301	0.0163713616600977	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2492.86090130768	2492.86090130768
"healthy-4003"	"2020-08-26-Control4003-c1:TTTGGTTTCCCAATAG"	5.02882494506184	-8.19864180004271	"2020-08-26-Control4003-c1"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTGGTTTCCCAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2956.01365910662	31.6993844482959	0.0107236934953393	2187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2943.46524075073	2943.46524075073
"healthy-4003"	"2020-08-26-Control4003-c1:TTTGTTGCAAGACCTT"	-7.82776389542277	0.363793856743254	"2020-08-26-Control4003-c1"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613774"	"2020-08-26"	"2020.08.26.Control4003.c1.TTTGTTGCAAGACCTT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2945.15501109103	32.6481135512468	0.0110853633945577	2776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2937.79820364423	2937.79820364423
"healthy-4003"	"2020-08-26-Control4003-c2:AAACCCAGTCAAAGAT"	0.827206273644608	8.23216912830202	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACCCAGTCAAAGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1632.10949396717	36.940993437013	0.0226338940944584	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1621.73632241683	1621.73632241683
"healthy-4003"	"2020-08-26-Control4003-c2:AAACGAATCCTCGATC"	5.53102125701253	-9.48692896282347	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACGAATCCTCGATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.12596071287	26.01608506078	0.0098765531522795	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2625.97109851111	2625.97109851111
"healthy-4003"	"2020-08-26-Control4003-c2:AAACGCTCAACCTAAC"	5.20932497557942	-8.60169699108275	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACGCTCAACCTAAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.12702192178	30.9171813910471	0.012440885764921	1618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2481.65297767638	2481.65297767638
"healthy-4003"	"2020-08-26-Control4003-c2:AAACGCTGTGAGCTCC"	3.21199168738667	-5.49072410976561	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACGCTGTGAGCTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2474.29323507456	32.6226650289384	0.0131846397858156	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2472.3442440598	2472.3442440598
"healthy-4003"	"2020-08-26-Control4003-c2:AAACGCTGTGTGATGG"	-3.21859703484233	10.0403241881165	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACGCTGTGTGATGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.80632880995	32.8933821644296	0.0170891905705478	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1912.35263375358	1912.35263375358
"healthy-4003"	"2020-08-26-Control4003-c2:AAACGCTTCGTTGTGA"	-2.12494860115703	10.0387325056824	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAACGCTTCGTTGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1593.46553256016	37.8704844781172	0.0237661146126406	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1584.05329957071	1584.05329957071
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGAACCACGCGGTT"	4.22665037688558	-7.28565742885741	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGAACCACGCGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1884.73686350099	40.0274636507798	0.0212376934021585	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1882.7479122073	1882.7479122073
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGAACGTCTGCATA"	3.64407958564107	-7.01534511959227	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGAACGTCTGCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.449646987	3.47554940399515	0.00179666056927793	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1932.82975892259	1932.82975892259
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGAACGTTCTTAGG"	-2.94155774536784	10.4766587981018	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGAACGTTCTTAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1436.77584174664	25.4434209968921	0.017708692099083	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1434.37860854716	1434.37860854716
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGAACTCATCTCTA"	-2.36573491516765	9.70661828601686	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGAACTCATCTCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2056.38248239905	40.3860124276095	0.0196393486004091	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.53364663659	2046.53364663659
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGAACTCGAGAAGC"	10.5903412300045	6.25329873645631	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGAACTCGAGAAGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1779.92582740122	36.4686730503798	0.0204888723389255	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1769.92083119696	1769.92083119696
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGGGCAGCGAGTCA"	3.43092193183247	-6.77994205867919	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGGGCAGCGAGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.03427963996	0	0	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.90900635261	1984.90900635261
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGGGCCACCGTACG"	3.73164548453633	-6.66985466396483	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGGGCCACCGTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2645.79593853349	1.95536001550866	0.000739044151905561	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2643.38733566258	2643.38733566258
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGGGCCACGTATAC"	0.277830575674218	8.44046876514284	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGGGCCACGTATAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.74193012766	39.2685372617757	0.0189269502348948	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2059.04626847165	2059.04626847165
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGGGCTCACCACAA"	-4.17156348648723	13.0950994261536	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGGGCTCACCACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2014.60892008357	39.0500797698534	0.0193834542181187	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2012.62576204701	2012.62576204701
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGGTAAGGAAGTAG"	-1.82697103443797	8.62929246509401	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGGTAAGGAAGTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.62175742838	38.0754213955506	0.0211105356423726	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.77011504608	1801.77011504608
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGTCCAGCACTAGG"	-3.59318695488628	10.6935968169006	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGTCCAGCACTAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1863.7128288279	35.8166287057201	0.0192178903056891	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1857.95446804293	1857.95446804293
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGTGAAGGTGCATG"	4.0475079017574	-7.00558807766112	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGTGAAGGTGCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2416.0115632417	11.564337135706	0.00478654047507516	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2413.15187664871	2413.15187664871
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGTGACAATACCTG"	4.98364080962483	-8.02529146587523	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGTGACAATACCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.80919259387	33.2470412926371	0.0152243343444979	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.80919259387	2183.80919259387
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGTGACAGTGTGCC"	5.48090757903401	-9.56531813060912	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGTGACAGTGTGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.56325389966	27.0493784173822	0.0104053549675334	1697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2593.73841439099	2593.73841439099
"healthy-4003"	"2020-08-26-Control4003-c2:AAAGTGATCATCCCGT"	3.52364840087239	-6.40887024318846	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAAGTGATCATCCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2618.84582105705	24.4484641622154	0.00933558744300082	1819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2607.41882167707	2607.41882167707
"healthy-4003"	"2020-08-26-Control4003-c2:AAATGGAGTTGCATAC"	4.50279392775838	-8.31173899089965	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAATGGAGTTGCATAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.67064733155	25.2516057399506	0.00944807986916097	1748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2670.31093061342	2670.31093061342
"healthy-4003"	"2020-08-26-Control4003-c2:AAATGGAGTTGCGGCT"	5.37648977813069	-10.2426204911438	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAATGGAGTTGCGGCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.02498384596	34.0585014500066	0.0159373436003131	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2135.39834325976	2135.39834325976
"healthy-4003"	"2020-08-26-Control4003-c2:AAATGGATCGAAATCC"	-2.61629162254985	11.2522201308045	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAATGGATCGAAATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1468.30821391105	39.9842732099922	0.0272315259365663	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1463.37543641418	1463.37543641418
"healthy-4003"	"2020-08-26-Control4003-c2:AACAAAGGTACTCGCG"	10.2799097495968	6.81737992847291	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAAAGGTACTCGCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.6200185514	34.9672781122019	0.0209935505834117	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1661.77225417012	1661.77225417012
"healthy-4003"	"2020-08-26-Control4003-c2:AACAAAGTCGTACACA"	5.44314064559285	-10.1187534562317	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAAAGTCGTACACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2570.03640126916	38.3340888443141	0.0149157766113288	1659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2562.91409854321	2562.91409854321
"healthy-4003"	"2020-08-26-Control4003-c2:AACAACCAGGTTCAGG"	-0.513518254191238	8.28622624957887	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAACCAGGTTCAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2136.15141944321	36.5732610179806	0.0171210995087199	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2122.35537771594	2122.35537771594
"healthy-4003"	"2020-08-26-Control4003-c2:AACAACCAGTGCTCAT"	-0.511410872370559	8.30406091296998	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAACCAGTGCTCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1804.4664085025	36.4423392550065	0.0201956318406888	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1800.27966588373	1800.27966588373
"healthy-4003"	"2020-08-26-Control4003-c2:AACAACCCATTCTCCG"	4.77869524535481	-7.78827049648436	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAACCCATTCTCCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2531.93111961183	13.2594783174791	0.0052369032533207	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2528.53234060095	2528.53234060095
"healthy-4003"	"2020-08-26-Control4003-c2:AACAACCGTACGACTT"	3.64100040969197	-6.9921560517517	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAACCGTACGACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2823.54912326958	29.6571648822563	0.0105035059024984	1984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2816.9942706631	2816.9942706631
"healthy-4003"	"2020-08-26-Control4003-c2:AACAAGAAGCGATTCT"	-4.89276156845744	8.75686643207399	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAAGAAGCGATTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2778.21639948276	2.20244355305413	0.000792754500140513	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2773.97412268466	2773.97412268466
"healthy-4003"	"2020-08-26-Control4003-c2:AACAAGATCGCGTGCA"	3.78998603400533	-7.40977432644042	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAAGATCGCGTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.93264136364	32.5523373044933	0.0147768191787939	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2201.48892404277	2201.48892404277
"healthy-4003"	"2020-08-26-Control4003-c2:AACACACAGACTGAGC"	2.68378104743306	-4.44891168987425	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACACACAGACTGAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2512.30201704003	0.892727326150269	0.000355342359356169	2072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2507.58115018572	2507.58115018572
"healthy-4003"	"2020-08-26-Control4003-c2:AACACACGTAACACGG"	-3.96894679489787	13.2254781492981	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACACACGTAACACGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2093.73834253889	39.2813536911193	0.0187613480123243	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2084.16187177004	2084.16187177004
"healthy-4003"	"2020-08-26-Control4003-c2:AACACACGTGGAACCA"	0.0268000970477283	8.70065400684205	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACACACGTGGAACCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1499.71456173405	48.8207778937319	0.0325533799160305	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1489.9530312311	1489.9530312311
"healthy-4003"	"2020-08-26-Control4003-c2:AACACACTCGTCTACC"	5.09368719634358	-8.20027925884398	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACACACTCGTCTACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.58814538188	28.4124341001215	0.0110357200824861	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.7623252184	2568.7623252184
"healthy-4003"	"2020-08-26-Control4003-c2:AACAGGGGTCTGCATA"	4.41099896010701	-6.72789575969847	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACAGGGGTCTGCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2755.56460852058	31.2347270256566	0.0113351459548706	1877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2752.22197559596	2752.22197559596
"healthy-4003"	"2020-08-26-Control4003-c2:AACCAACAGAAGCCAC"	0.309753467410249	8.20798013294069	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCAACAGAAGCCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2076.4908830249	37.4410869025985	0.0180309421094384	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2065.823532156	2065.823532156
"healthy-4003"	"2020-08-26-Control4003-c2:AACCAACCATTGGCAT"	-5.29181228104289	-5.58168795025023	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCAACCATTGGCAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2530.44804634633	38.8528876724952	0.0153541534783116	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2527.33962425589	2527.33962425589
"healthy-4003"	"2020-08-26-Control4003-c2:AACCAACCATTGTCGA"	3.11580004271809	-6.72822239315184	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCAACCATTGTCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.45464063131	46.0762720601176	0.0210638754304957	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2178.65699507048	2178.65699507048
"healthy-4003"	"2020-08-26-Control4003-c2:AACCAACGTTTCGTAG"	2.62308587607686	-4.33076813137206	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCAACGTTTCGTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2662.72518170275	32.2998556887546	0.0121303752676796	2210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2655.11789274348	2655.11789274348
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACAAGGTTGCCC"	-4.09204564514812	13.1356715925964	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACAAGGTTGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1749.47173764454	42.2818165992621	0.0241683336114876	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1747.34549928711	1747.34549928711
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACACACCGTGAC"	-3.70327148857768	10.9189519652161	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACACACCGTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1522.96170329322	40.7529390080068	0.0267590044581447	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1520.73945617863	1520.73945617863
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACACACTTGAAC"	-3.66412244263347	12.4339456328186	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACACACTTGAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1886.00557953821	32.4322705223568	0.0171962749602777	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1872.52887917665	1872.52887917665
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACACAGTAGAGC"	3.74437679824178	-6.73704197322997	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACACAGTAGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.92406021439	3.13291814815469	0.00127099986515698	1562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2457.58760775383	2457.58760775383
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACAGTTGGTGTT"	5.59995617446248	-9.81153585827025	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACAGTTGGTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2669.34303437069	24.0783482112735	0.00902032743684066	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2656.38090950375	2656.38090950375
"healthy-4003"	"2020-08-26-Control4003-c2:AACCACATCTAGAGCT"	-2.04277215424235	8.9999379881653	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCACATCTAGAGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2149.54899670236	38.9054940615921	0.0180993753207195	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2146.29635788379	2146.29635788379
"healthy-4003"	"2020-08-26-Control4003-c2:AACCATGAGGTTCAGG"	-4.11112485352214	12.5682677992615	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCATGAGGTTCAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1682.22024735913	47.4011032421919	0.0281777034348538	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1679.9943616776	1679.9943616776
"healthy-4003"	"2020-08-26-Control4003-c2:AACCATGCACCGTCTT"	-0.770430843264419	8.89507005298463	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCATGCACCGTCTT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2270.62375270285	28.7033775571163	0.0126411861599479	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2255.08828899071	2255.08828899071
"healthy-4003"	"2020-08-26-Control4003-c2:AACCATGGTGGCTACC"	5.44043125685994	-9.68442442333373	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCATGGTGGCTACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2703.76979536674	31.6093388312053	0.0116908395401754	1645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2701.13600557141	2701.13600557141
"healthy-4003"	"2020-08-26-Control4003-c2:AACCATGGTTGTGCAT"	4.79486860808675	-7.36402799999388	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCATGGTTGTGCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2700.94705771306	33.0998495000904	0.0122549049621567	1952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2695.79401442254	2695.79401442254
"healthy-4003"	"2020-08-26-Control4003-c2:AACCATGTCTGCTGAA"	4.04859103736226	-7.02518274700316	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCATGTCTGCTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2811.5243312337	32.6281749497206	0.0116051547508406	2022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2806.23623069006	2806.23623069006
"healthy-4003"	"2020-08-26-Control4003-c2:AACCCAAGTTGACGGA"	9.81124081191365	6.11654422366945	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCCAAGTTGACGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1556.2026513424	24.4870236276298	0.0157351123945889	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1548.1560938797	1548.1560938797
"healthy-4003"	"2020-08-26-Control4003-c2:AACCTGACAGTCGTTA"	-3.32868609848674	10.2929668196472	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCTGACAGTCGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1909.58254785019	26.1426555002241	0.0136902463471168	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1900.59195035865	1900.59195035865
"healthy-4003"	"2020-08-26-Control4003-c2:AACCTGATCAAATGCC"	4.32606424865071	-7.08157017147215	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCTGATCAAATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2690.57222762482	25.6897434486741	0.00954805939974799	1776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2685.87948182388	2685.87948182388
"healthy-4003"	"2020-08-26-Control4003-c2:AACCTGATCACGGTCG"	-4.0965441268986	12.6506805189881	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCTGATCACGGTCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1755.39119616878	35.4494486135446	0.0201946145627907	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1749.05236971086	1749.05236971086
"healthy-4003"	"2020-08-26-Control4003-c2:AACCTTTGTCTGTTAG"	-3.11676965180095	11.2821864851746	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCTTTGTCTGTTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1494.56063559909	44.452393861639	0.0297427838006856	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1484.62770091392	1484.62770091392
"healthy-4003"	"2020-08-26-Control4003-c2:AACCTTTGTTCAAACC"	5.04873671111409	-7.71000196849974	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACCTTTGTTCAAACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2807.3638915736	41.2413894497906	0.0146904323923158	2080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2802.28693187325	2802.28693187325
"healthy-4003"	"2020-08-26-Control4003-c2:AACGAAAGTCCTCATC"	-0.20689700070079	8.26962754810182	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGAAAGTCCTCATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1990.27508603862	32.5359217699236	0.0163474496556565	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1987.33174106253	1987.33174106253
"healthy-4003"	"2020-08-26-Control4003-c2:AACGAAAGTCTTTCTA"	5.28910841521565	-9.18580534374388	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGAAAGTCTTTCTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3061.7936251338	34.9009722594831	0.0113988650224451	2355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3055.91403262143	3055.91403262143
"healthy-4003"	"2020-08-26-Control4003-c2:AACGGGAAGTGGATTA"	-2.3738194507664	9.0908221968445	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGGGAAGTGGATTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.72708700028	33.1146434926603	0.0160693978846388	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2054.21753525294	2054.21753525294
"healthy-4003"	"2020-08-26-Control4003-c2:AACGGGAGTCCGTACG"	-3.57618365708049	11.0227889784607	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGGGAGTCCGTACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1508.18334099884	18.2834535509557	0.012122832187529	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.79696634133	1505.79696634133
"healthy-4003"	"2020-08-26-Control4003-c2:AACGGGAGTCGCGTCA"	5.30917133864705	-9.22927477276	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGGGAGTCGCGTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2689.43994319459	0	0	1764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2683.59278068323	2683.59278068323
"healthy-4003"	"2020-08-26-Control4003-c2:AACGTCAAGCCTCTTC"	2.62444724616353	-6.07766153728636	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGTCAAGCCTCTTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2525.33354320993	37.7484528722366	0.0149479077620198	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2520.76658936132	2520.76658936132
"healthy-4003"	"2020-08-26-Control4003-c2:AACGTCAAGGCATGCA"	4.39018930968587	-7.96473505413207	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGTCAAGGCATGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.93186972548	31.6165816092236	0.0155140522992471	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2037.93186972548	2037.93186972548
"healthy-4003"	"2020-08-26-Control4003-c2:AACGTCACAATGTTGC"	-2.53087053719218	9.81546495044557	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGTCACAATGTTGC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2228.75503745162	32.3376333066441	0.0145092810843938	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2219.3902928257	2219.3902928257
"healthy-4003"	"2020-08-26-Control4003-c2:AACGTCAGTTCCTAAG"	0.369157333939713	8.42667577350465	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGTCAGTTCCTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1749.42655016876	35.5746554864388	0.020335038063191	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1743.43911868189	1743.43911868189
"healthy-4003"	"2020-08-26-Control4003-c2:AACGTCAGTTCGGTCG"	2.86627854880635	-7.53993179714354	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACGTCAGTTCGGTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.52222107348	19.764507255535	0.00963406930352086	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2046.42069264743	2046.42069264743
"healthy-4003"	"2020-08-26-Control4003-c2:AACTTCTAGGCACGAT"	-1.9872330230778	9.89949605548707	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AACTTCTAGGCACGAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.94612269981	29.2491719680388	0.0158022816598118	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1843.52346822436	1843.52346822436
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACAAGATTAGTG"	4.27898134764974	-7.46963074123534	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACAAGATTAGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.10953838525	6.00472509642213	0.00274550725102476	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2181.6480580371	2181.6480580371
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACACACTACCGG"	-1.14294157448466	9.08036134326784	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACACACTACCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1436.46874901055	40.1207109246278	0.0279300966013101	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1426.88352040997	1426.88352040997
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACACACTGCACG"	3.7890862422878	-6.78107025539549	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACACACTGCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.23741567532	8.10524429960187	0.00323531983391562	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.17819162976	2501.17819162976
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACACAGGCGAAT"	-3.1768470806187	9.65851113880006	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACACAGGCGAAT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1888.03211287862	32.0472612212282	0.0169738962608887	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1882.12944269827	1882.12944269827
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACAGTAAGCGGT"	5.48990692672078	-9.86216738140257	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACAGTAAGCGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.90524450883	36.5468325423349	0.0138755304954602	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2625.67896953752	2625.67896953752
"healthy-4003"	"2020-08-26-Control4003-c2:AAGAACATCTGACCCT"	5.4631892639095	-10.1373338929382	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGAACATCTGACCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.34165308077	8.87106039547352	0.00377116155038764	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2340.50756589803	2340.50756589803
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACAAGTTTACTTC"	0.303140153258485	8.56868646228639	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACAAGTTTACTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1872.20314291177	38.7460881318662	0.0206954508534826	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1860.18412826493	1860.18412826493
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACTCAGAATAGTC"	3.47411145743672	-5.65149977123412	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACTCAGAATAGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2979.0500270747	30.4542830148468	0.0102228169174962	2685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2972.17637923327	2972.17637923327
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACTCAGCGACCCT"	2.94794382628743	-5.1258206597534	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACTCAGCGACCCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2557.44555888224	29.4635452284409	0.0115206930314162	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2551.39664337872	2551.39664337872
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACTCAGTTCGCAT"	4.70997585830037	-7.3291487923828	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACTCAGTTCGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.57526466818	32.208295776696	0.0143047830921355	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2246.62568947997	2246.62568947997
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACTCCACCTTCCA"	4.17890324172322	-7.2809834710327	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACTCCACCTTCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.7548102087	10.26946589786	0.00395016709173263	1623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2594.654437597	2594.654437597
"healthy-4003"	"2020-08-26-Control4003-c2:AAGACTCGTACCCAGC"	5.01164640960042	-7.69211199199828	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGACTCGTACCCAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2641.86146700547	26.3748526304165	0.00998343514972884	1744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2638.35570126011	2638.35570126011
"healthy-4003"	"2020-08-26-Control4003-c2:AAGATAGAGACTCTTG"	-2.96379957619365	11.8652820357117	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGATAGAGACTCTTG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1802.69057220883	32.5855023820457	0.0180760374988364	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1798.89677205382	1798.89677205382
"healthy-4003"	"2020-08-26-Control4003-c2:AAGATAGAGCAATAGT"	-2.00780711594279	9.59118459308473	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGATAGAGCAATAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1586.4342867258	35.3095846415705	0.0222571996438914	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1579.52784268555	1579.52784268555
"healthy-4003"	"2020-08-26-Control4003-c2:AAGATAGCATGACCCG"	-3.92250523987468	10.737072921637	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGATAGCATGACCCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2188.05293908443	38.4560734764164	0.0175754767124181	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2176.08192778106	2176.08192778106
"healthy-4003"	"2020-08-26-Control4003-c2:AAGATAGTCTGCCTCA"	5.58134474334065	-9.59558203136595	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGATAGTCTGCCTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.78283897442	42.5265085787452	0.016146550865714	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2625.93105621014	2625.93105621014
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCAGAGAGGGC"	2.63178720053975	-4.14378311550292	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCAGAGAGGGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2421.03491897217	28.877885204148	0.0119279094150397	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2416.75245998826	2416.75245998826
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCCAGGACATG"	-2.90605411949809	10.0397853621277	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCCAGGACATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.57176906761	42.4148618547097	0.0225422503419723	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1879.68291116738	1879.68291116738
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCCATCCCGTT"	5.59323801574056	-9.82058145916136	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCCATCCCGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3028.37066236049	37.4399566169813	0.0123630693832565	2336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3017.28101297849	3017.28101297849
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCCATGCCATA"	-1.03263626518901	8.6449985274109	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCCATGCCATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2059.23078158262	31.5668031343887	0.015329414952766	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.50708073632	2046.50708073632
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCGTCATGGCC"	3.34906162795369	-6.85506727611693	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCGTCATGGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1986.90747998697	31.2410403156519	0.0157234499493942	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1986.90747998697	1986.90747998697
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCATCGTGCCAAGA"	-3.68542752686198	10.0158843764099	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCATCGTGCCAAGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.88156749191	25.3200826716128	0.013680012333757	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1838.51033739591	1838.51033739591
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCCATAGTTCCATG"	4.07976259764974	-7.2475247613159	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCCATAGTTCCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.8388808768	21.303608903727	0.00898947564563756	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.43429443574	2368.43429443574
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGAGTCCATGAGT"	0.0274662590468347	8.86371705615846	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGAGTCCATGAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.06736431471	39.5790840123217	0.0235440202174505	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1673.07240278165	1673.07240278165
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGAGTCCTTGAAG"	-0.441789547831374	7.73153398120729	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGAGTCCTTGAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2776.05892871427	34.589764928786	0.0124600254594762	2122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2768.20962806858	2768.20962806858
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGAGTCTAGATCG"	5.50812115248982	-9.92214205181273	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGAGTCTAGATCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.68213516137	30.8179045687791	0.0123732788434613	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2487.99688397079	2487.99688397079
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGTTAGATGCTGG"	-0.413222352892715	8.55352494800416	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGTTAGATGCTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2032.90236177913	35.3754736949367	0.0174014622443437	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2031.4062944515	2031.4062944515
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGTTAGGATCACG"	5.36650480803792	-10.1338806382385	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGTTAGGATCACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2064.37343058122	22.1293221068776	0.0107196313317437	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.83911744713	2062.83911744713
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGTTAGTCTAGCT"	-1.6182943386143	3.55316684329835	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGTTAGTCTAGCT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2617.4687207488	22.3551497190005	0.00854075142972677	3576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2614.45600621642	2614.45600621642
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGTTCACCGGTCA"	5.42157282409017	-9.60026552593382	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGTTCACCGGTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.64518537699	34.6175581577473	0.0134299159380558	1670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2575.3368506833	2575.3368506833
"healthy-4003"	"2020-08-26-Control4003-c2:AAGCGTTTCGCCATAA"	-2.41361532631572	9.67758653247682	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGCGTTTCGCCATAA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2017.81610752817	40.4807046343036	0.0200616421304578	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2016.24901296493	2016.24901296493
"healthy-4003"	"2020-08-26-Control4003-c2:AAGGAATAGCGACTTT"	-3.52900658074077	10.4835052260193	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGGAATAGCGACTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1774.78905660734	39.8544823263692	0.022455898168853	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1762.8798874516	1762.8798874516
"healthy-4003"	"2020-08-26-Control4003-c2:AAGGAATTCTCCAATT"	4.67983879622762	-7.50255157863768	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGGAATTCTCCAATT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2742.94337994681	15.5280303504198	0.00566108307737687	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2739.0645840678	2739.0645840678
"healthy-4003"	"2020-08-26-Control4003-c2:AAGGTAAGTCATCACA"	0.400355835526627	8.60884187305299	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGGTAAGTCATCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1849.0093124963	29.2570605000328	0.0158231006746708	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1843.9909714685	1843.9909714685
"healthy-4003"	"2020-08-26-Control4003-c2:AAGGTAATCCATCGTC"	5.01273216780965	-8.40050890361937	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGGTAATCCATCGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2499.10824543246	0.39368312279442	0.000157529440156881	1422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2494.75030600422	2494.75030600422
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTACCAGCGCATCC"	-3.75560794296916	10.1377315291199	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTACCAGCGCATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2093.54664743072	32.8685759828064	0.0156999491858201	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2086.20968463128	2086.20968463128
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTACCCAAGTTCGT"	4.14847673949544	-6.99918320095214	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTACCCAAGTTCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.01534730696	28.5148953068539	0.0123333503560295	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.02862230475	2308.02862230475
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTACCGTGTGGACA"	-2.5437220138615	9.70516297901002	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTACCGTGTGGACA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1968.40621926854	37.6484943644	0.0191263845825432	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1963.34896377423	1963.34896377423
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTACCTCTGCTTTA"	-4.0247667831486	13.1346721419129	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTACCTCTGCTTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1875.76846077476	34.4158149487302	0.0183475816277001	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1869.86716160266	1869.86716160266
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTCGTAGAATTCAG"	-0.788017253310043	8.53794572437135	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTCGTAGAATTCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1793.10371581168	1.25938257548922	0.000702347869999889	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1786.15309020683	1786.15309020683
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTCGTCAGCATTGT"	-3.46075187149699	10.5681981810364	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTCGTCAGCATTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.94245661876	44.5496324894759	0.0231674288204186	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1921.1702031725	1921.1702031725
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTCGTGTCAGTCGC"	3.75363053855245	-7.7423420182434	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTCGTGTCAGTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.54892238129	9.19686403576337	0.00456069472636599	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2011.29512544043	2011.29512544043
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTCGTTCCGATTAG"	-0.99111113968547	8.33686063373414	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTCGTTCCGATTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1831.26643999218	40.9057164150862	0.0223373920483471	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.53281827474	1821.53281827474
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTGAAGTCACTTCC"	3.25163354453389	-6.50624945079955	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTGAAGTCACTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.26488519535	2.48720624150738	0.0012746635581762	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1949.62573553581	1949.62573553581
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTTCGAGCCGGAAT"	10.6123091178829	6.28016612613527	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTTCGAGCCGGAAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1658.16601965222	34.1592388509273	0.0206006144415454	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1656.4344822231	1656.4344822231
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTTCGTCACACCGG"	0.50694908675496	8.82416913593141	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTTCGTCACACCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1685.93627283657	31.5358020264183	0.0187052159292828	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1674.80236577993	1674.80236577993
"healthy-4003"	"2020-08-26-Control4003-c2:AAGTTCGTCGGCCTTT"	-4.84251962128337	-4.68905355846556	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AAGTTCGTCGGCCTTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3029.90909733245	34.9251536803222	0.0115267991739655	2641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3025.27590859271	3025.27590859271
"healthy-4003"	"2020-08-26-Control4003-c2:AATAGAGAGCATAGGC"	-2.77111182633098	10.1624727019104	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATAGAGAGCATAGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1604.39770172279	36.8837530911163	0.0229891585181847	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.69985557996	1592.69985557996
"healthy-4003"	"2020-08-26-Control4003-c2:AATAGAGCAGTCGGTC"	-0.588634471327621	8.48134038532106	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATAGAGCAGTCGGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1705.1499801504	42.7196710802502	0.0250533217473821	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1698.92950744607	1698.92950744607
"healthy-4003"	"2020-08-26-Control4003-c2:AATAGAGTCCGGCAGT"	9.63604225692097	6.8023586043152	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATAGAGTCCGGCAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1981.89717170658	42.9243777435296	0.0216582264490383	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1970.19852765246	1970.19852765246
"healthy-4003"	"2020-08-26-Control4003-c2:AATAGAGTCTCGAGTA"	4.62395395812337	-7.46012213146361	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATAGAGTCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2593.05694185144	26.1166974893808	0.0100717793997742	1627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2590.82276316177	2590.82276316177
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGAGACGTCGA"	-0.11951162937339	8.25965497577516	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGAGACGTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1885.16057735233	39.8876211050775	0.0211587392523871	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.5979534725	1876.5979534725
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGCAGCGGATA"	5.62896837767903	-9.87262346660765	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGCAGCGGATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.70823329012	27.5870815415261	0.0122953069976809	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.8751760978	2235.8751760978
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGGTCTAATCG"	-0.145841653377372	8.62780282581178	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGGTCTAATCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.3659564973	29.6678318391446	0.0181636158884848	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1625.72447480588	1625.72447480588
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGGTTACGGAG"	4.25406469878499	-7.67012455379637	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGGTTACGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.82421055606	28.2293477576028	0.0139210034137337	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2026.0751272558	2026.0751272558
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGTCACGGTCG"	5.24858536300008	-8.58978464519652	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGTCACGGTCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.4127021181	5.07056977184234	0.00194542091040369	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2600.64221723155	2600.64221723155
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGTCGAGTCCG"	2.50841393050496	-4.02988102352294	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGTCGAGTCCG"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2326.79671548385	22.8181747848784	0.00980669030217944	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2321.4765904804	2321.4765904804
"healthy-4003"	"2020-08-26-Control4003-c2:AATCACGTCGGACGTC"	4.91268934783284	-7.96985437786254	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCACGTCGGACGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.88944466689	21.2155921783134	0.00901299431304248	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2350.9228386138	2350.9228386138
"healthy-4003"	"2020-08-26-Control4003-c2:AATCGACCAAAGACGC"	4.25339569625203	-7.81940414821776	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCGACCAAAGACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.55342238213	37.5368220975798	0.0162177384780115	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2313.17760569328	2313.17760569328
"healthy-4003"	"2020-08-26-Control4003-c2:AATCGACGTGCTGATT"	-2.41159449043925	9.26181027973024	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCGACGTGCTGATT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2093.11830417621	26.5048093347677	0.0126628338598373	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2080.10337237521	2080.10337237521
"healthy-4003"	"2020-08-26-Control4003-c2:AATCGACGTTCCTACC"	5.44179405745809	-9.72338964855345	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCGACGTTCCTACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.21983943763	27.1481925076095	0.0105339063793384	1718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2571.41346034789	2571.41346034789
"healthy-4003"	"2020-08-26-Control4003-c2:AATCGTGTCCAAGAGG"	-1.66190908375438	9.43443772876588	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATCGTGTCCAAGAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1523.13199563206	37.3707494393085	0.0245354634703216	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1511.95234354148	1511.95234354148
"healthy-4003"	"2020-08-26-Control4003-c2:AATGAAGAGCACGTCC"	2.90840234336202	-6.52470447933348	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGAAGAGCACGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.0993059077	23.6836630611946	0.0115411875989689	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.20954558483	2047.20954558483
"healthy-4003"	"2020-08-26-Control4003-c2:AATGAAGGTCCCTGTT"	3.56745280799214	-6.30430366909178	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGAAGGTCCCTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2808.52932187578	29.8898681757006	0.0106425337784038	1976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2798.70397528618	2798.70397528618
"healthy-4003"	"2020-08-26-Control4003-c2:AATGACCCAGGTTCAT"	-5.71626410904582	-5.38463356411131	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGACCCAGGTTCAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2511.39139376482	24.7136110607469	0.00984060514108032	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2505.90272768753	2505.90272768753
"healthy-4003"	"2020-08-26-Control4003-c2:AATGCCAAGTCTGGAG"	2.68761982497517	-6.95302441036376	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGCCAAGTCTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2031.98800289461	39.8824269615128	0.0196272945040519	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2031.98800289461	2031.98800289461
"healthy-4003"	"2020-08-26-Control4003-c2:AATGCCACAGAGCTAG"	0.2646417665178	8.7889137038025	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGCCACAGAGCTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1551.38677537998	43.0414458550919	0.0277438524925867	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1551.38677537998	1551.38677537998
"healthy-4003"	"2020-08-26-Control4003-c2:AATGCCACAGCAGTGA"	3.32054366645162	-5.72285129940184	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGCCACAGCAGTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2661.89043072649	35.2436503147218	0.0132400830281745	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2654.23409544243	2654.23409544243
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAACAAGGACAC"	-4.23625407639201	13.1356267699036	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAACAAGGACAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2175.11596892023	38.3159715086018	0.01761559937773	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2164.07804965703	2164.07804965703
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAACACGGTGAA"	3.43381442603413	-6.6821818581787	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAACACGGTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.14381827994	33.0161681513666	0.0142732881070566	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.71177459041	2311.71177459041
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAACAGCAAGAC"	0.103755251585883	8.47587487781373	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAACAGCAAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1896.98202693056	33.8795273813413	0.0178596986689223	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1894.07031676585	1894.07031676585
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAACATCGCCTT"	-3.82402382317241	12.7490596541199	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAACATCGCCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2004.82875417248	14.8024401911842	0.00738339379878564	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2000.74728335965	2000.74728335965
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAAGTCGCCTAG"	-8.57853064957317	0.00916613945690533	"2020-08-26-Control4003-c2"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAAGTCGCCTAG"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2897.93840029466	33.2342127924019	0.0114682260979125	2724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2869.50878394421	2869.50878394421
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGAATCCAAGCAT"	4.01460208472554	-7.61532881176146	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGAATCCAAGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.2612057388	1.46679710582422	0.000680881734265454	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.9919965339	2144.9919965339
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGCTAGCGTGTCC"	3.76087560233418	-6.98903658306273	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGCTAGCGTGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2111.32111053198	31.1985336591613	0.0147767828889374	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2109.84898734919	2109.84898734919
"healthy-4003"	"2020-08-26-Control4003-c2:AATGGCTGTGGCCTCA"	-3.86208067360576	13.0337171324524	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATGGCTGTGGCCTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2131.54141500638	46.1366495109057	0.0216447352071588	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2127.74842651557	2127.74842651557
"healthy-4003"	"2020-08-26-Control4003-c2:AATTCCTAGAAGTATC"	4.65120663222615	-7.40151169216307	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTCCTAGAAGTATC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2908.91134505971	19.7428261625644	0.00678701542282964	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2902.86634551529	2902.86634551529
"healthy-4003"	"2020-08-26-Control4003-c2:AATTCCTCAGTGGTGA"	-3.93147597733195	12.8760318526062	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTCCTCAGTGGTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1561.98353788533	48.0962118935438	0.0307917533872721	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1554.79678741789	1554.79678741789
"healthy-4003"	"2020-08-26-Control4003-c2:AATTCCTCATGGATCT"	-3.93337355080302	12.3821048506531	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTCCTCATGGATCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1922.42141176464	37.777290670664	0.019650889466523	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1907.22294622693	1907.22294622693
"healthy-4003"	"2020-08-26-Control4003-c2:AATTCCTGTTGAATCC"	5.37435736235921	-9.99975302135619	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTCCTGTTGAATCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2485.47353008152	45.0634039416167	0.0181307116717267	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.30494002035	2471.30494002035
"healthy-4003"	"2020-08-26-Control4003-c2:AATTCCTTCTGCTAGA"	3.49175037917439	-7.25928499614867	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTCCTTCTGCTAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2228.34704789675	5.40124347040001	0.00242387893550874	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2222.86959076715	2222.86959076715
"healthy-4003"	"2020-08-26-Control4003-c2:AATTTCCCATAGCTGT"	10.0429655509884	7.74271009052125	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.AATTTCCCATAGCTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2256.68613358141	31.4780910401956	0.0139488121860523	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2242.25145783537	2242.25145783537
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAAGAAGGACAAGA"	0.498295356600922	8.37693688953248	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAAGAAGGACAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1738.99936775581	30.266522193768	0.0174045619308229	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1731.2033619065	1731.2033619065
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAAGAAGGTCTTTG"	5.02733768996541	-8.56592562114867	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAAGAAGGTCTTTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2841.83232192076	16.4189225206141	0.00577758314379253	2618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2836.93680051137	2836.93680051137
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAAGAAGTACAACA"	2.62009849128072	-4.4457578889099	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAAGAAGTACAACA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2696.67407512223	18.5975988769185	0.00689649485211724	2346	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2692.7664895342	2692.7664895342
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAAGAGTCGTGGAA"	-2.68342457237895	10.0804157027039	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAAGAGTCGTGGAA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1864.79548859304	42.4150375482228	0.0227451416563778	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.67223243213	1855.67223243213
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAAGATCAGCTCTC"	-2.09847078743632	9.22520158374635	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAAGATCAGCTCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1690.3424486496	14.3742435872382	0.00850374644423185	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1690.3424486496	1690.3424486496
"healthy-4003"	"2020-08-26-Control4003-c2:ACAACCAGTTCCGTTC"	3.25369014319722	-6.28665211116942	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAACCAGTTCCGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.41742963477	34.4187035751726	0.0136559536410444	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.66514751919	2510.66514751919
"healthy-4003"	"2020-08-26-Control4003-c2:ACAACCATCGAACGCC"	-3.63855276528056	10.8808994063172	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAACCATCGAACGCC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1693.95242835847	17.3266871302998	0.0102285559146961	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1689.84635221453	1689.84635221453
"healthy-4003"	"2020-08-26-Control4003-c2:ACAACCATCTCGAGTA"	-3.85686645928081	10.6873626478943	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAACCATCTCGAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.52921395843	18.2521736502986	0.00941062063873084	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1929.7555732733	1929.7555732733
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAGCTCATGACACT"	3.30486144599263	-5.41653730785521	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAGCTCATGACACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.51133042163	0	0	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.79247905207	2202.79247905207
"healthy-4003"	"2020-08-26-Control4003-c2:ACAAGCTGTCATTGCA"	4.81316771086995	-7.68642952358397	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAAGCTGTCATTGCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.37199519782	23.2247444877555	0.0099277688778999	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.8974919913	2333.8974919913
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTAGTAGTCTC"	5.09880652007405	-8.15284349834593	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTAGTAGTCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2542.7646095797	17.6238741551092	0.0069309892424617	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2538.97896855264	2538.97896855264
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTCAATTGCCA"	-0.0868891877239526	8.01955506885377	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTCAATTGCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2023.46863397205	30.9079723147217	0.0152747474291458	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2020.53091755135	2020.53091755135
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTGTAAGTCAA"	4.5069748359615	-7.65236618435057	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTGTAAGTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2998.96071619492	28.0643019450027	0.00935800919080081	2354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2990.66791358877	2990.66791358877
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTGTGGACCAA"	3.39237560805623	-6.78460361873778	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTGTGGACCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1921.71783033108	30.109048812464	0.0156677782436336	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1919.94983963706	1919.94983963706
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTTCGCGTTTC"	5.19389214095418	-8.56938936626586	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTTCGCGTTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3171.2806700245	33.8029542914528	0.0106590862836469	2962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3162.11377524051	3162.11377524051
"healthy-4003"	"2020-08-26-Control4003-c2:ACACAGTTCGGCTATA"	-0.170079375535804	8.62535474384157	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACAGTTCGGCTATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1695.40405873818	29.3231633457177	0.0172956783927613	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1687.94681393418	1687.94681393418
"healthy-4003"	"2020-08-26-Control4003-c2:ACACCAATCGGTGTTA"	4.67570032653157	-7.81580641185912	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACCAATCGGTGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.42083437575	32.0620725577197	0.0126257421076886	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2532.92040428049	2532.92040428049
"healthy-4003"	"2020-08-26-Control4003-c2:ACACGCGGTCACGCTG"	11.5222650962764	4.26690433109132	"2020-08-26-Control4003-c2"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACGCGGTCACGCTG"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2010.96230408254	21.1324576962979	0.0105086294523751	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2003.18815064404	2003.18815064404
"healthy-4003"	"2020-08-26-Control4003-c2:ACACGCGGTGGCTGAA"	4.15065588530843	-7.31909038936766	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACGCGGTGGCTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.77490172016	8.64182428809169	0.00358764294742541	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2406.01412374746	2406.01412374746
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAAGAGAGCCT"	3.99233641204182	-6.87035372173461	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAAGAGAGCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3096.78989041823	35.3663036924188	0.0114203110136227	3124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3088.30107088408	3088.30107088408
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAAGGTTGCCC"	-3.27773199501689	9.76894471729127	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAAGGTTGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2158.84267785139	36.8602775121698	0.0170740915446675	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2151.99455082396	2151.99455082396
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAAGTGCAGGT"	3.97837009009663	-7.3135295144287	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAAGTGCAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1906.52747553529	17.6031067354712	0.00923307267341048	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1904.85095154058	1904.85095154058
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAAGTTCATGC"	-3.90417609635051	11.2235498198303	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAAGTTCATGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1749.07913155351	28.4185277646982	0.0162477084381295	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.01181931109	1745.01181931109
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAGTATATGGA"	4.94656767424886	-8.31934358989867	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAGTATATGGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.06431990978	22.2449685541256	0.00953465721638821	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.06431990978	2333.06431990978
"healthy-4003"	"2020-08-26-Control4003-c2:ACACTGAGTTAGGCCC"	4.11575760421101	-7.80323507702025	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACACTGAGTTAGGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2148.15210213077	15.9317812627956	0.0074165052125465	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2145.33930507362	2145.33930507362
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGAAAAGCCTTCTC"	6.80814470824544	-1.72491362011107	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGAAAAGCCTTCTC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2766.50923180459	25.8038887884873	0.00932723754970282	1797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2759.11585223884	2759.11585223884
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGAAAAGTCGCGAA"	4.37990917739217	-6.9111161462036	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGAAAAGTCGCGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.85242268651	6.29263699421272	0.00262209331487493	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2394.79065037705	2394.79065037705
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGAAAGTCTAGTGT"	-3.16823039475139	10.8690185316834	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGAAAGTCTAGTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1911.0816045431	32.6772116041231	0.0170988049523587	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1909.09836857476	1909.09836857476
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGCCGTCACTCTTA"	-4.11522851410564	11.4836969145569	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGCCGTCACTCTTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2218.41400388495	33.4024179468768	0.0150568910439537	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2218.41400388495	2218.41400388495
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGCCGTCTGACCCT"	5.50483097609822	-10.1034918061462	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGCCGTCTGACCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.67546264714	37.442650682006	0.0160101952066597	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2329.66844150351	2329.66844150351
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGGGAAGGGTGGGA"	2.46156801757161	-4.23953583156737	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGGGAAGGGTGGGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1788.34790939596	20.5468994138979	0.0114893188880892	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1785.47285696575	1785.47285696575
"healthy-4003"	"2020-08-26-Control4003-c2:ACAGGGAGTCCTGTTC"	-3.93797622147258	12.8837709196839	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACAGGGAGTCCTGTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1808.48244947114	38.2307970881957	0.0211397114190275	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1804.02100800538	1804.02100800538
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCCCTCCTGTAAG"	-4.31129393997844	12.6280803450379	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCCCTCCTGTAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2318.7865852595	7.79740319364681	0.00336270842828522	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2308.41018563177	2308.41018563177
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCCCTCGTAGTCA"	-4.05432734909709	10.7326335676941	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCCCTCGTAGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2039.16539862047	35.1799338793907	0.0172521237871094	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2035.30299092651	2035.30299092651
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCCCTCGTGGAAG"	5.08259214934651	-9.45966055309447	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCCCTCGTGGAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2490.28984275244	23.1108064211689	0.00928036810190143	1526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2486.47429536828	2486.47429536828
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCGAAGACTTGTC"	4.30490221556966	-7.10759308254393	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCGAAGACTTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2796.08635900365	29.1278378590203	0.0104173598806153	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2787.95772244626	2787.95772244626
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCGACAATGCTCA"	4.12478079375569	-7.55358984386595	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCGACAATGCTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.12370995078	31.7106860470521	0.0127550716483372	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2475.91139495311	2475.91139495311
"healthy-4003"	"2020-08-26-Control4003-c2:ACATCGAGTCCAGCAC"	-0.409037153155166	8.6360988386902	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATCGAGTCCAGCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1989.28356231501	35.6982166336941	0.0179452629629889	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1984.30717374608	1984.30717374608
"healthy-4003"	"2020-08-26-Control4003-c2:ACATGCAAGGGCGAGA"	4.6884671646053	-7.48318197643431	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATGCAAGGGCGAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2397.86825972549	23.5368133944224	0.00981572415371851	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.64604396341	2396.64604396341
"healthy-4003"	"2020-08-26-Control4003-c2:ACATGCAAGTAACGAT"	3.45357813414876	-6.60000517284545	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATGCAAGTAACGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.1515874365	37.8112467350414	0.0153134570301119	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2466.04044959023	2466.04044959023
"healthy-4003"	"2020-08-26-Control4003-c2:ACATGCAAGTCTAGAA"	-3.85952220383342	13.0727529295715	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATGCAAGTCTAGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2143.06606691359	36.5635984274748	0.0170613491538938	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2139.55738233986	2139.55738233986
"healthy-4003"	"2020-08-26-Control4003-c2:ACATGCAGTAGGTACG"	4.12621750411336	-7.08876087581786	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATGCAGTAGGTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.73047805699	30.6155341134917	0.0127738744067341	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2391.25466564362	2391.25466564362
"healthy-4003"	"2020-08-26-Control4003-c2:ACATGCATCGCTTACC"	-3.92927871170695	10.9067487486633	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATGCATCGCTTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2166.83378978597	30.9040407808817	0.0142623033324278	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2158.03746633934	2158.03746633934
"healthy-4003"	"2020-08-26-Control4003-c2:ACATTTCGTCCACTTC"	-1.02109513703044	8.90304277026979	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATTTCGTCCACTTC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2106.79411498118	20.3335878137516	0.00965143564298081	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2096.56273744526	2096.56273744526
"healthy-4003"	"2020-08-26-Control4003-c2:ACATTTCGTCTACAGT"	4.59795965728108	-7.17601110851439	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATTTCGTCTACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.39206193149	12.0783637676516	0.0049493538173911	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.56401937775	2429.56401937775
"healthy-4003"	"2020-08-26-Control4003-c2:ACATTTCGTGCGAACA"	5.45917667922322	-9.54508592998656	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATTTCGTGCGAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2772.83866375715	34.7310957788106	0.0125254657736742	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2768.15808271327	2768.15808271327
"healthy-4003"	"2020-08-26-Control4003-c2:ACATTTCTCTCATGGA"	-3.59140739861186	11.9244394072327	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACATTTCTCTCATGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1988.79172903432	32.4142864719613	0.0162984821380469	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1984.9592532075	1984.9592532075
"healthy-4003"	"2020-08-26-Control4003-c2:ACCAAACTCGAAGCCC"	-2.73441491547282	10.0338430174622	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCAAACTCGAAGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.27253161968	39.0543075162651	0.01972168319899	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1976.62353860995	1976.62353860995
"healthy-4003"	"2020-08-26-Control4003-c2:ACCAAACTCGCGGACT"	4.50887932357137	-7.41754581844481	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCAAACTCGCGGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.3071715567	32.1032523256126	0.0122004958876086	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2624.13963391018	2624.13963391018
"healthy-4003"	"2020-08-26-Control4003-c2:ACCAACACAGCGGATA"	-2.14136133614238	9.07200143421022	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCAACACAGCGGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2023.36126048133	42.9633292983077	0.0212336423244988	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2011.43168381448	2011.43168381448
"healthy-4003"	"2020-08-26-Control4003-c2:ACCAACACATGACGAG"	4.6857668357784	-7.12807133114012	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCAACACATGACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2702.40462555212	29.4903322543753	0.0109126264718224	1724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2697.51947703705	2697.51947703705
"healthy-4003"	"2020-08-26-Control4003-c2:ACCACAAAGCGAGTCA"	9.11798061904256	5.99222753131715	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCACAAAGCGAGTCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1514.34785743882	35.9430720343398	0.0237350169300794	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1508.52289371955	1508.52289371955
"healthy-4003"	"2020-08-26-Control4003-c2:ACCACAATCTTCGTGC"	3.72230162200276	-7.47220232402953	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCACAATCTTCGTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.75536658914	27.7710658991046	0.0138043950871569	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2011.75536658914	2011.75536658914
"healthy-4003"	"2020-08-26-Control4003-c2:ACCATTTAGTGATAAC"	-4.24756894531901	12.871253944281	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCATTTAGTGATAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2096.37584628959	41.0418792432002	0.0195775386917574	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2093.02914378158	2093.02914378158
"healthy-4003"	"2020-08-26-Control4003-c2:ACCATTTCACTGCGAC"	2.81842078742329	-4.67803003704222	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCATTTCACTGCGAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2793.91729230519	29.8677265634463	0.0106902686939609	2405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2785.81937215611	2785.81937215611
"healthy-4003"	"2020-08-26-Control4003-c2:ACCATTTTCTATCGCC"	-7.69178138199504	0.101269475463308	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCATTTTCTATCGCC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2980.310473891	35.8148656069535	0.0120171592593153	3359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2972.93497562043	2972.93497562043
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCAAAGTCAATCTG"	-3.16341195526775	10.4347705611023	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCAAAGTCAATCTG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1985.31008915472	37.5825314114729	0.0189303079739419	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1983.54541740501	1983.54541740501
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCAAAGTCCCTCAT"	-2.61368833008464	9.24168584430543	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCAAAGTCCCTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1698.59714706681	45.0226913946731	0.0265058089096757	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1696.54352707073	1696.54352707073
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCAAAGTTCTCACC"	0.373050500720185	8.78434369647828	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCAAAGTTCTCACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1736.1415888847	27.6879048159406	0.0159479532045121	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1734.49624513406	1734.49624513406
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCAAATCTCGCAGG"	3.99443282660787	-6.69838478481444	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCAAATCTCGCAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2274.44356380504	49.1676839732431	0.0216174561355076	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2269.29144881813	2269.29144881813
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTCAAGAGAGCAA"	4.76319660720174	-7.46225359356078	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTCAAGAGAGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.80972666534	20.2445032595761	0.00870802587728949	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.38308737214	2323.38308737214
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTCAAGCACAAAT"	-1.12409685078319	9.78868959033815	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTCAAGCACAAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1634.00273259836	21.9487181919773	0.0134324856097853	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1628.35723394273	1628.35723394273
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTCAGTAGCACGA"	4.71179022368733	-6.87675955211791	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTCAGTAGCACGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.64525701215	21.5353259676949	0.00898936347301845	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.84302608224	2388.84302608224
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTCATCGAACGGA"	-0.185624296695548	8.22818753803102	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTCATCGAACGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1997.06988952935	32.0420107857993	0.016044511488454	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1987.35937459473	1987.35937459473
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTTGAGTCTACCA"	5.48048033294026	-9.99623968517455	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTTGAGTCTACCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2231.72639117691	40.0685816796051	0.0179540744053641	1152	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2225.16672760205	2225.16672760205
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTTGTCACTCGAA"	10.644584317773	6.18951509082643	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTTGTCACTCGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1638.38314652313	30.7760869488248	0.0187844259837119	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1636.41923314756	1636.41923314756
"healthy-4003"	"2020-08-26-Control4003-c2:ACCCTTGTCGGCTTGG"	-1.48420331898387	9.11732385242311	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCCTTGTCGGCTTGG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1652.61124692349	47.8725790031109	0.028967840496203	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1641.53178771172	1641.53178771172
"healthy-4003"	"2020-08-26-Control4003-c2:ACCGTTCAGAACCGCA"	-0.050707439810592	8.59577653491823	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCGTTCAGAACCGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1667.91740142322	26.6084653468336	0.0159531073446016	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1663.23362287872	1663.23362287872
"healthy-4003"	"2020-08-26-Control4003-c2:ACCGTTCGTCGAATGG"	-3.26196895065959	-5.49388649379881	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCGTTCGTCGAATGG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2408.16804571779	35.0026940384003	0.0145349881627415	1421	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2402.92390796701	2402.92390796701
"healthy-4003"	"2020-08-26-Control4003-c2:ACCGTTCGTTATCTGG"	5.447433133691	-9.68373873150023	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCGTTCGTTATCTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.00441417864	39.3582228584498	0.0161502468479176	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.13425903778	2433.13425903778
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTACCCACTCCGAG"	2.73763026770894	-4.60575535213622	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTACCCACTCCGAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2449.63831292626	27.9383241274934	0.0114050813052965	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2447.58377121892	2447.58377121892
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTACCCAGTAGAAT"	5.05502094802205	-8.08527567302855	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTACCCAGTAGAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.07411617931	18.2253043933941	0.00743867472132432	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.06870433333	2445.06870433333
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTACCTCCCTCGTA"	3.96078838881795	-6.88935615932616	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTACCTCCCTCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2540.38804985891	36.3717018112624	0.0143173802967946	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2535.32955118577	2535.32955118577
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGAAGTATCAGCT"	4.54350056227986	-7.37259533321532	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGAAGTATCAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2900.15518149341	22.1043080193502	0.0076217673317632	2128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2894.15388831227	2894.15388831227
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGAAGTCGAATGG"	-1.96532879296001	9.92573735797731	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGAAGTCGAATGG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1784.35413135696	38.1198423726279	0.0213633839285247	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1776.97340958456	1776.97340958456
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGAATCGACGCTG"	-4.17869792404826	11.0667876967224	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGAATCGACGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1836.69575730546	38.0041455601499	0.0206915845528517	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1828.88525299557	1828.88525299557
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGAATCGAGTACT"	4.2911282974178	-6.81584169780882	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGAATCGAGTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.07562335431	13.9995694157903	0.00565165200601864	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2477.07562335431	2477.07562335431
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGTCGTAGGAGTC"	3.3547498184139	-7.13993694698485	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGTCGTAGGAGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.87542311064	35.3748377795026	0.0174442854705738	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2024.37114495351	2024.37114495351
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGTCGTATGAAAC"	-3.26854954186137	10.894597984198	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGTCGTATGAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1598.48315125797	41.8120285361489	0.0261573157672909	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1591.88533506493	1591.88533506493
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGTCGTCTGTGGC"	-3.9096032184666	10.5274448164734	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGTCGTCTGTGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.38990140812	30.6260314848751	0.0171153483434631	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.3861464863	1785.3861464863
"healthy-4003"	"2020-08-26-Control4003-c2:ACCTGTCGTGAATTAG"	10.563740392297	6.50598905170289	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACCTGTCGTGAATTAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1713.64575043183	35.9530282851728	0.0209804320852854	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1706.23415822698	1706.23415822698
"healthy-4003"	"2020-08-26-Control4003-c2:ACGATGTAGTAAACTG"	-2.76462326470073	9.45338628375856	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGATGTAGTAAACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.93243102994	12.2154292265536	0.00609877249841737	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1997.3354331526	1997.3354331526
"healthy-4003"	"2020-08-26-Control4003-c2:ACGATGTGTTGCATAC"	-4.24698052826579	12.5601653822693	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGATGTGTTGCATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1734.09391173801	36.8685006689726	0.0212609596397354	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1729.60128466486	1729.60128466486
"healthy-4003"	"2020-08-26-Control4003-c2:ACGATGTTCAAGGTGG"	3.85030784186665	-5.95619919216307	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGATGTTCAAGGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.97560784717	26.5129815447117	0.010804093349555	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.5744883621	2450.5744883621
"healthy-4003"	"2020-08-26-Control4003-c2:ACGATGTTCATGGAGG"	4.43724121627156	-7.42682793056639	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGATGTTCATGGAGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2640.31412020345	39.1651932735934	0.0148335355153028	1741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2635.60579337553	2635.60579337553
"healthy-4003"	"2020-08-26-Control4003-c2:ACGATGTTCGATTCCC"	5.33861412581746	-10.2616749039856	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGATGTTCGATTCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.60415134066	22.4555766049496	0.0114417248071192	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1958.37742719806	1958.37742719806
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGAGCGAGGAG"	-1.72921476784404	8.94580648029176	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGAGCGAGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1559.60375758024	21.3451004824836	0.013686233043963	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1559.60375758024	1559.60375758024
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGAGCGTGAGT"	-0.654836396605331	8.33561227405397	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGAGCGTGAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1796.55351392687	29.3357792299236	0.0163289203480513	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.87237613798	1792.87237613798
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGCAGAACGCA"	-0.659725288779098	8.53355596149293	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGCAGAACGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.23817109359	28.529125748523	0.0152054926650887	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1869.42295612283	1869.42295612283
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGCAGGTGAGT"	5.53692307051961	-10.1932888261047	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGCAGGTGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.07851707111	39.0677992247218	0.0177655317540708	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.07851707111	2199.07851707111
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGGTAGTATAG"	5.66329683837239	-9.75131037151488	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGGTAGTATAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2624.2720839304	12.9828858101215	0.00494723313547462	1609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2608.90708460744	2608.90708460744
"healthy-4003"	"2020-08-26-Control4003-c2:ACGCACGGTTGAGTCT"	3.14150466498677	-6.34722902691039	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGCACGGTTGAGTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.91825406063	36.2113759010956	0.0173432919754741	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.88634218404	2082.88634218404
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGAAGCACCATAAC"	-0.0489159551566422	7.88018796527711	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGAAGCACCATAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1655.26343339568	22.0240270016221	0.0133054512999427	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.54159991553	1650.54159991553
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGAAGCAGTCCCGA"	10.5642754035885	7.14948461139528	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGAAGCAGTCCCGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.9362665467	39.9166493628871	0.0211991505352935	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1873.76839562246	1873.76839562246
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGAAGCATAACGGG"	4.83308519896809	-8.14854147350463	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGAAGCATAACGGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.08199260502	31.6356265681305	0.0136120957301815	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2320.0382771086	2320.0382771086
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGGTCAGTCGGCAA"	-2.75178275528606	10.2743863829407	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGGTCAGTCGGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2025.98279563501	36.4230186209126	0.0179779506022392	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2024.15178559219	2024.15178559219
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGGTCAGTTCCGTA"	5.62113489684407	-10.0833587876526	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGGTCAGTTCCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.16742954602	0.24482577425542	0.000100537552894694	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.64026328078	2432.64026328078
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGGTCTCTGGAGAG"	3.48333134230916	-7.53013136303099	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGGTCTCTGGAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.99635694334	29.0117638046918	0.0172586714330813	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1678.98895921524	1678.98895921524
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGGTCTCTGTAACG"	4.57741703566853	-7.88054516231688	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGGTCTCTGTAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.73798045547	0	0	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1945.46253931179	1945.46253931179
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTCGCAACGGCTC"	-0.142027671367484	8.49151704395143	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTCGCAACGGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1594.28973547043	46.537325166134	0.0291900048847784	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.69100351342	1592.69100351342
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTCGCACGAGGAT"	-4.39179025116618	12.9686736830506	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTCGCACGAGGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2047.66265106932	28.2542732870651	0.0137983047511807	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2039.41003487983	2039.41003487983
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTCGCACGCAAAG"	-3.40056786957439	10.9393796690735	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTCGCACGCAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1860.28472652	35.6514927040133	0.0191645355121019	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1855.8811984121	1855.8811984121
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTCGTCTTGTGCC"	-2.07998643341716	9.03424642169801	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTCGTCTTGTGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.88797694663	49.0259928026795	0.0272383578481635	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.15841159308	1787.15841159308
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTTAAGTGGCAGT"	0.212230612605256	7.99294421756593	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTTAAGTGGCAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1705.67049175436	32.664763437064	0.0191506880109457	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1696.13827488718	1696.13827488718
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTTACAGGACAGT"	2.35986151274983	-6.89782049572142	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTTACAGGACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.66189469311	31.2144034098163	0.0146500969898429	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2120.96963394632	2120.96963394632
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTTACAGGCGAAT"	5.12693132933919	-8.41733648693236	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTTACAGGCGAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.90668078875	24.9674274134711	0.0112470617028821	1305	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2218.61656902754	2218.61656902754
"healthy-4003"	"2020-08-26-Control4003-c2:ACGGTTAGTGTCCTAA"	5.20077337798421	-10.2338524094787	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGGTTAGTGTCCTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1735.11633831711	30.1271169616781	0.0173631682766	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1733.18502528739	1733.18502528739
"healthy-4003"	"2020-08-26-Control4003-c2:ACGTAACCAAAGGCAC"	5.45796503600423	-10.1734285584656	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.ACGTAACCAAAGGCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.03048197709	39.8105824798322	0.0172040008936349	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2306.11899691255	2306.11899691255
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCTGGTCTATGCCC"	-3.1978477043217	9.86661241138307	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCTGGTCTATGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.44851636337	31.3921716679554	0.0163122948735865	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1914.4994503716	1914.4994503716
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCTGGTCTGCTTAT"	5.55260386046712	-10.0129919282165	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCTGGTCTGCTTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.64690071	14.7498823391699	0.00577600698634917	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2547.42832090113	2547.42832090113
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGAAGAGTACTGTC"	5.23300327834432	-9.84290792858275	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGAAGAGTACTGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.54546566964	32.3320086546365	0.0150273415879564	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2151.54546566964	2151.54546566964
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGAAGCACTTCAAG"	4.25003637847249	-6.91283800518187	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGAAGCACTTCAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.89145343793	2.83098987320449	0.00120166396846224	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.45813215881	2354.45813215881
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGAAGGTGTTACAC"	3.53014554557149	-7.3381033173767	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGAAGGTGTTACAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1873.15779604032	9.57045461130739	0.00510926235447886	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1871.21483331057	1871.21483331057
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGATTAGTTGCCCG"	10.7569786506588	6.53558108890382	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGATTAGTTGCCCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1944.70867068062	32.1182226889775	0.0165156988155643	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1930.91761661414	1930.91761661414
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGATTCACTCTAGA"	4.85413517531697	-7.50991012966307	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGATTCACTCTAGA"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2739.01776314714	32.893514507261	0.0120092373805806	2463	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2732.35202783378	2732.35202783378
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGATTTCCTTGACC"	-4.71505437317546	2.9540383585724	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGATTTCCTTGACC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2958.31164851008	31.1282396523371	0.0105222989836161	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2946.46611172073	2946.46611172073
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGATTTCGCATTAG"	-4.00280652466472	10.711495376471	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGATTTCGCATTAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2152.68472860559	2.22281087799488	0.00103257613549139	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2152.68472860559	2152.68472860559
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGATTTCTTCGATT"	3.95689048346822	-6.81158115780028	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGATTTCTTCGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2462.28116242822	28.6472660107785	0.0116344414471853	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2458.10012875262	2458.10012875262
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGGCTCATCGATCA"	-2.17345223847087	8.61670873248903	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGGCTCATCGATCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1910.19365748558	32.1054086637024	0.0168074103575254	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1908.34547278989	1908.34547278989
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGGCTGTAACATGA"	-3.85536084595378	10.6649436720642	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGGCTGTAACATGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.1634984613	23.1100519690637	0.012437039037846	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.95663805808	1853.95663805808
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGGCTGTTCGGCTG"	-3.40737162056621	10.4408664473328	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGGCTGTTCGGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1766.87953259324	36.0301118545464	0.0203919459079732	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1762.83330472027	1762.83330472027
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTGAAAGTAAGGGA"	-7.16968284073527	3.35202000224916	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTGAAAGTAAGGGA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2377.4394115844	0	0	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2366.09378877991	2366.09378877991
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTGAACAAGTGGGT"	3.69369544562642	-7.23258211528929	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTGAACAAGTGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.48866842083	1.30959313790487	0.000705034254135312	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1855.56260543482	1855.56260543482
"healthy-4003"	"2020-08-26-Control4003-c2:CTGTGAACATGACTCA"	-0.560131530196029	8.625123954657	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTGTGAACATGACTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1378.66043948364	39.1299581172033	0.0283825929841425	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1372.02512095514	1372.02512095514
"healthy-4003"	"2020-08-26-Control4003-c2:CTTACCGCAAGGAGTC"	4.17337288436238	-7.50464584743651	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTACCGCAAGGAGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.92181539699	34.6672406102583	0.0147587886420984	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.61262617987	2347.61262617987
"healthy-4003"	"2020-08-26-Control4003-c2:CTTAGGACATGTAACC"	5.58617319640462	-10.0584230653015	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTAGGACATGTAACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2463.2517398059	39.9463434027084	0.01621691472178	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.08367328521	2445.08367328521
"healthy-4003"	"2020-08-26-Control4003-c2:CTTAGGAGTACTCGCG"	4.47127451476399	-7.52009727871092	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTAGGAGTACTCGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.04538444505	27.628288763702	0.0112262410674446	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2458.55353908019	2458.55353908019
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCAATCAATCTCGA"	4.91202749785726	-7.69636537944945	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCAATCAATCTCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.48637407287	21.425973321148	0.00810213035363428	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2640.22794708515	2640.22794708515
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCAATCAGCTGAAG"	4.87520994719808	-7.89909412777098	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCAATCAGCTGAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2752.91550430812	0.493639470387373	0.000179315155011064	2001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2747.76936619513	2747.76936619513
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCAATGTGTCCCTT"	10.5105053382808	6.37986085498659	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCAATGTGTCCCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1827.21646934218	39.6093530189241	0.0216774277615744	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1819.57599994713	1819.57599994713
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCGAAGCAGCAGT"	5.03558506545369	-7.58621694957884	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCGAAGCAGCAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2778.1947070334	38.0633932452858	0.0137007651583681	2020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2767.93928525736	2767.93928525736
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCGACAGTCAGAG"	4.20326723632161	-7.185254119989	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCGACAGTCAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2822.82519474107	28.4032362175477	0.0100619890563762	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2818.4827526822	2818.4827526822
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCGAGTATCGAGG"	3.82775034484212	-6.46779539501341	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCGAGTATCGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.61275454309	9.9606062740104	0.00455318531733958	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2186.14902567445	2186.14902567445
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCGAGTTGAATCC"	2.50186552581136	-3.98236372387084	"2020-08-26-Control4003-c2"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCGAGTTGAATCC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2344.85730446976	32.7047573467649	0.0139474403343962	1706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2336.19338352585	2336.19338352585
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCGATCTGGAGAG"	10.4611937004024	6.1072115668091	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCGATCTGGAGAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1717.00847186354	36.3959916126843	0.021197327916025	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1711.08243564654	1711.08243564654
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTCACCATTCC"	0.107750357210082	7.91555688464967	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTCACCATTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1525.26220579979	5.38905329516639	0.00353319794765423	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1523.24407031614	1523.24407031614
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTCATGGAGAC"	3.96418895301167	-7.2671313515869	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTCATGGAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2612.40752183111	30.2556855994037	0.0115815336415035	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2608.77819036543	2608.77819036543
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTGTAAGGAGA"	4.68495382842366	-7.71719791805419	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTGTAAGGAGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.63122319792	34.1119132897685	0.0133373071850119	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2553.8046053138	2553.8046053138
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTGTGCGTTTA"	5.50765671309773	-10.0320692292419	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTGTGCGTTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2560.30224888392	38.0718166151456	0.0148700477186792	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2555.40314114717	2555.40314114717
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTGTGTATCCA"	10.3176113563472	6.58557221973268	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTGTGTATCCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1884.87022952215	44.8815027010925	0.0238114550265197	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1881.65002458303	1881.65002458303
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCCTTTCTGGGAGA"	4.93213238295857	-8.39421560680541	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCCTTTCTGGGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2550.13977537983	6.11644872426014	0.00239847587309175	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2547.69741389529	2547.69741389529
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCGGTAGAGTCCGA"	3.40957345542256	-7.16213228618773	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCGGTAGAGTCCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.27691270014	36.8779414339863	0.0165129282554571	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2229.51355281653	2229.51355281653
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCGGTCAATTGCTG"	-1.34008751335796	8.84389875018922	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCGGTCAATTGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1821.43541632757	38.915798985993	0.021365456407154	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1819.52205763692	1819.52205763692
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTAAAGACCCTTA"	3.47897471961324	-8.47180464183959	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTAAAGACCCTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.78132651933	28.74875198953	0.0170032348587103	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1690.78132651933	1690.78132651933
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTAACAGTGTGGA"	0.0952662016147792	8.41199872577516	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTAACAGTGTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1679.42560211937	31.7129878752553	0.0188832347412322	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1677.50772400713	1677.50772400713
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTAATCCATATGG"	5.30418886718099	-9.36716940319213	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTAATCCATATGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.11224901617	35.4086899382185	0.0133109758625089	1755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2658.96637891763	2658.96637891763
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTCTCAGTATTCG"	5.38472284850423	-9.66745855724486	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTCTCAGTATTCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.540087092	38.7092401534463	0.0169588435148854	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2280.59647155928	2280.59647155928
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTCTGTACGTTCA"	5.60650076445882	-9.82365133678588	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTCTGTACGTTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2812.12185030102	39.7569072869545	0.0141376901156324	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2803.49282813602	2803.49282813602
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTCTGTGCATCTA"	3.45326222953145	-6.6522541276184	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTCTGTGCATCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.50224555469	30.5321769762492	0.013768724265085	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.31917760507	2214.31917760507
"healthy-4003"	"2020-08-26-Control4003-c2:CTTCTCTGTGCATGAG"	4.92787231978719	-7.60847046291503	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTCTCTGTGCATGAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.66542611535	24.9301727857293	0.0108407825341106	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2299.66542611535	2299.66542611535
"healthy-4003"	"2020-08-26-Control4003-c2:CTTGAGACATGGTGGA"	10.8296982246334	6.22297761524049	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTGAGACATGGTGGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1695.65960452195	40.0275246241594	0.0236058726158333	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1681.94019918633	1681.94019918633
"healthy-4003"	"2020-08-26-Control4003-c2:CTTGAGAGTATAGGGC"	-0.0716229257291139	8.60375688159791	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTGAGAGTATAGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.67699422977	26.3656938896542	0.0146828711256967	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.42530034747	1792.42530034747
"healthy-4003"	"2020-08-26-Control4003-c2:CTTGATTGTCGCATTA"	4.44810785826985	-7.09684851085814	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTGATTGTCGCATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.32306380491	19.8927357545159	0.00863278941524327	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.40025674714	2301.40025674714
"healthy-4003"	"2020-08-26-Control4003-c2:CTTGATTTCAGTCCGG"	3.64521541175191	-7.20361473476561	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTGATTTCAGTCCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.26233921381	29.677994582482	0.0140039267594836	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.37770345479	2114.37770345479
"healthy-4003"	"2020-08-26-Control4003-c2:CTTGATTTCTCGTCAC"	-3.03601251068767	10.8896522291931	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTGATTTCTCGTCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.57391407075	26.1086322356131	0.0146056238738443	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1777.58366020223	1777.58366020223
"healthy-4003"	"2020-08-26-Control4003-c2:CTTTCAATCACCTACC"	10.9265600639278	6.32804725253908	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTTCAATCACCTACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1932.12285995202	29.8976170343549	0.0154739730345602	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1928.38174956706	1928.38174956706
"healthy-4003"	"2020-08-26-Control4003-c2:CTTTCAATCTCCCAAC"	9.62209381636922	7.31505153262941	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTTCAATCTCCCAAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1834.79438015123	31.8341519529696	0.0173502558637365	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1823.98510671619	1823.98510671619
"healthy-4003"	"2020-08-26-Control4003-c2:CTTTCGGAGCTCTGTA"	4.30106319960896	-6.97537138378295	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTTCGGAGCTCTGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.34529268324	33.6672683035972	0.015498120127124	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.08987235565	2169.08987235565
"healthy-4003"	"2020-08-26-Control4003-c2:CTTTCGGTCGACCTAA"	-4.06211219254191	13.1510076292786	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTTCGGTCGACCTAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2019.66163452571	38.0503976997431	0.0188399863864714	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2009.87400729927	2009.87400729927
"healthy-4003"	"2020-08-26-Control4003-c2:CTTTCGGTCGGCCCAA"	3.67792739447896	-7.16254188930663	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.CTTTCGGTCGGCCCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1877.12500928136	10.3049918377054	0.00548977387587549	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1875.10860311928	1875.10860311928
"healthy-4003"	"2020-08-26-Control4003-c2:GAAACCTCATACCATG"	10.4692655998165	7.25179002368776	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAACCTCATACCATG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1909.98555838849	24.3964501605017	0.0127731071333784	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1905.57538897271	1905.57538897271
"healthy-4003"	"2020-08-26-Control4003-c2:GAAACCTTCCCGAAAT"	2.96310271796529	-7.01962616359862	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAACCTTCCCGAAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2071.53261381844	8.31461682940008	0.00401375135198755	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2068.02745548797	2068.02745548797
"healthy-4003"	"2020-08-26-Control4003-c2:GAAATGAGTATCGAGG"	3.07956113395039	-5.14120104229125	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAATGAGTATCGAGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2448.02560886018	28.5212176350237	0.0116507023177357	1847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2446.11847361978	2446.11847361978
"healthy-4003"	"2020-08-26-Control4003-c2:GAACGTTCAAATGGTA"	4.89731134948079	-8.06268694317015	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAACGTTCAAATGGTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.20245910675	31.8765014874074	0.0131873527462764	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2414.51043844144	2414.51043844144
"healthy-4003"	"2020-08-26-Control4003-c2:GAACGTTCACTGCGTG"	4.76251282271687	-7.49774029171141	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAACGTTCACTGCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.39022280546	26.4750144740194	0.0118171442655499	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2238.97004685479	2238.97004685479
"healthy-4003"	"2020-08-26-Control4003-c2:GAACGTTTCGTACACA"	0.214987491338891	8.15509126270143	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAACGTTTCGTACACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1511.71462004295	21.291688646605	0.0140844630092947	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1505.52028076846	1505.52028076846
"healthy-4003"	"2020-08-26-Control4003-c2:GAACTGTCAGGGTTGA"	-3.75601563873943	-4.62927153026732	"2020-08-26-Control4003-c2"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAACTGTCAGGGTTGA"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3110.16592139563	38.664766749753	0.0124317376393871	3213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3101.59548575095	3101.59548575095
"healthy-4003"	"2020-08-26-Control4003-c2:GAACTGTCATAGAGGC"	-4.06859813156779	12.8702344664368	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAACTGTCATAGAGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1806.34173134223	43.8352768077004	0.0242674329265083	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1802.48388727965	1802.48388727965
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGAATAGACTCTAC"	6.72767128524129	-1.67327704345854	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGAATAGACTCTAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2645.25532057637	0.406743591666178	0.000153763452813906	1694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2636.71181693285	2636.71181693285
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGAATCAACCACGC"	4.9680310684139	-7.79049398815306	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGAATCAACCACGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2674.60893331042	26.5818343749893	0.00993858729922373	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2668.36750914174	2668.36750914174
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGAATCAGAAGTGC"	5.38533558425252	-9.94499399578246	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGAATCAGAAGTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2138.22759919967	40.0384543962609	0.0187250666913322	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2133.94467781912	2133.94467781912
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGAATTCCGCACTT"	5.08782829818074	-9.02594854747923	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGAATTCCGCACTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.78338350619	29.7656719849513	0.0125711127936351	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.30016249224	2365.30016249224
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCCCAGGTCGAGT"	5.14823116835896	-8.30861380016478	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCCCAGGTCGAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.16692633755	25.1087073001464	0.0102310511280572	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2446.72285796812	2446.72285796812
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCCCGTGGGATTG"	-3.88789806786235	10.7052869566712	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCCCGTGGGATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1611.20536163359	48.47341716014	0.0300851885888668	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1603.11853317578	1603.11853317578
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCCCTCCTCTGCA"	-3.94680176201518	10.7902698286804	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCCCTCCTCTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1853.35674838382	38.9777550437788	0.0210308970886305	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1843.39033814612	1843.39033814612
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCGACAGAAATCA"	5.08543886718099	-8.24559881603392	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCGACAGAAATCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2510.26197092229	3.99533110859917	0.00159159926528754	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.12257183334	2505.12257183334
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCGAGTGTGGTCC"	4.14313950118367	-6.96971371090087	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCGAGTGTGGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.99776321677	30.6088074686134	0.0125703636902637	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.46873052561	2432.46873052561
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGCGATCGTCTAAG"	-0.543588737875778	8.20179364765016	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGCGATCGTCTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1361.4328150882	33.5044586831128	0.0246097040645684	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1359.31809712597	1359.31809712597
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGGACAGACTCAAA"	-4.00199828568156	12.9204158552918	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGGACAGACTCAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1809.81546032175	41.4563494443957	0.0229063959023897	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1805.72005671679	1805.72005671679
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGGACGTTTAGAGA"	3.91660418090169	-7.14553167736205	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGGACGTTTAGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2097.11902840362	26.4073548743381	0.0125922060296406	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2094.39907591732	2094.39907591732
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGGGTAGACACACG"	-1.21141014519389	8.86669824207155	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGGGTAGACACACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2116.89976515491	25.9435729757369	0.0122554564948135	1247	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2108.57776209013	2108.57776209013
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGGGTTCACCCTGT"	6.74597658690755	-1.81700506126555	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGGGTTCACCCTGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3004.16130190576	24.6813164032312	0.00821570945194388	2365	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2993.96005897128	2993.96005897128
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGTAAAGGCCTAGA"	3.85818733748738	-6.93124248897704	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGTAAAGGCCTAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.13629209925	26.7019874612118	0.0139644791909142	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1910.25350327069	1910.25350327069
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGTAATCCCGAAAT"	-3.72881184044536	12.4006700285706	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGTAATCCCGAAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1835.07222531236	33.4828168304231	0.0182460485034718	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1835.07222531236	1835.07222531236
"healthy-4003"	"2020-08-26-Control4003-c2:GAAGTAATCGTGCTCT"	4.74011625823323	-7.13443615352782	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAAGTAATCGTGCTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.74357334689	21.4383863284612	0.00979036385328623	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2180.91059505432	2180.91059505432
"healthy-4003"	"2020-08-26-Control4003-c2:GAATAGAAGCAGGCAT"	-4.32974896851237	12.2935142287048	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATAGAAGCAGGCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2021.99740755111	33.496977730268	0.0165662812450571	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2016.3329274878	2016.3329274878
"healthy-4003"	"2020-08-26-Control4003-c2:GAATAGACAGGAATCG"	-3.62131128731425	12.6695813902649	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATAGACAGGAATCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2143.51652444916	36.4593140832116	0.0170091126741283	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2136.47337134045	2136.47337134045
"healthy-4003"	"2020-08-26-Control4003-c2:GAATAGAGTCACTTCC"	4.62755550917928	-7.77781870281371	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATAGAGTCACTTCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2239.00459063213	1.75985660889289	0.000785999553665957	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2237.36856125019	2237.36856125019
"healthy-4003"	"2020-08-26-Control4003-c2:GAATAGATCGATTCCC"	5.50247349318807	-9.93923189556273	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATAGATCGATTCCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.11179224771	1.2895217744262	0.000585318356954812	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2198.80032671501	2198.80032671501
"healthy-4003"	"2020-08-26-Control4003-c2:GAATCACAGGGTTGCA"	4.57790388640706	-8.10048105632933	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATCACAGGGTTGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.33760272642	25.2188088215144	0.0110447131389602	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2280.31905436556	2280.31905436556
"healthy-4003"	"2020-08-26-Control4003-c2:GAATCACTCTGAGCAT"	5.33749308165852	-9.21212007915648	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATCACTCTGAGCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2720.20194428269	35.4639198483671	0.0130372378870271	1988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2713.21936091216	2713.21936091216
"healthy-4003"	"2020-08-26-Control4003-c2:GAATCGTAGAATCGTA"	-3.94547758522685	11.2501172789368	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATCGTAGAATCGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1576.3329343301	19.3680783544817	0.0122867941998006	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1574.00592212129	1574.00592212129
"healthy-4003"	"2020-08-26-Control4003-c2:GAATCGTGTACTCCCT"	-2.45912466469463	10.5727729567322	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAATCGTGTACTCCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1491.25010917977	43.4803310373611	0.0291569675466957	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1488.96777126782	1488.96777126782
"healthy-4003"	"2020-08-26-Control4003-c2:GACACGCAGAATCGTA"	-4.42230210724528	12.9493522414002	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACACGCAGAATCGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2202.62696289684	35.0283615046649	0.0159029931507769	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2198.90207739714	2198.90207739714
"healthy-4003"	"2020-08-26-Control4003-c2:GACACGCCACTGAATC"	5.46413054045979	-10.0463133088318	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACACGCCACTGAATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.79133486352	22.1995284116268	0.00941938646974548	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.95572416702	2349.95572416702
"healthy-4003"	"2020-08-26-Control4003-c2:GACAGCCCACTAGTAC"	-3.92185483399089	11.0069856413635	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACAGCCCACTAGTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1972.68072526996	40.0361734274626	0.0202953133340843	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1963.41465790912	1963.41465790912
"healthy-4003"	"2020-08-26-Control4003-c2:GACAGCCCACTGGCCA"	-1.27067027512248	8.75299642169801	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACAGCCCACTGGCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1786.6907926863	39.637400456523	0.0221848126260996	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.27220092402	1783.27220092402
"healthy-4003"	"2020-08-26-Control4003-c2:GACAGCCGTAGCGTCC"	-0.535947362810928	8.50147340381471	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACAGCCGTAGCGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1911.63995289412	27.8958288461003	0.0145926165666643	1028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1907.04337368026	1907.04337368026
"healthy-4003"	"2020-08-26-Control4003-c2:GACAGCCGTTCCGGTG"	-1.01316724243816	8.91299340808717	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACAGCCGTTCCGGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1876.3517712376	39.969432809012	0.0213016735037104	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1873.23431857233	1873.23431857233
"healthy-4003"	"2020-08-26-Control4003-c2:GACATCAAGACGCTCC"	-2.03995762291606	9.16548249805299	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACATCAAGACGCTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.26200896768	30.9048801493703	0.0158546567917452	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.90000928081	1945.90000928081
"healthy-4003"	"2020-08-26-Control4003-c2:GACATCACATTACGGT"	-4.3571380180424	13.0110997923645	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACATCACATTACGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1726.41672210365	30.8692391031072	0.0178805260096722	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1724.25562859576	1724.25562859576
"healthy-4003"	"2020-08-26-Control4003-c2:GACATCAGTACAAACA"	5.46653379973714	-10.0303383103577	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACATCAGTACAAACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.54792734044	38.1421821158096	0.0160629236734463	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.30309520076	2372.30309520076
"healthy-4003"	"2020-08-26-Control4003-c2:GACATCATCATTTGTC"	4.42700447615926	-7.03954269802245	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACATCATCATTTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.78141412114	33.7515886379368	0.0160738581696912	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2096.47008062983	2096.47008062983
"healthy-4003"	"2020-08-26-Control4003-c2:GACCAATAGTGGATAT"	-3.29796204987224	12.722762084845	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCAATAGTGGATAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1890.95336195802	37.5015045697711	0.019832062135546	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1888.97628263407	1888.97628263407
"healthy-4003"	"2020-08-26-Control4003-c2:GACCAATCATTAAGCC"	-3.69590912285503	12.7393703230652	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCAATCATTAAGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1954.08884931529	35.5617735827532	0.0181986472085002	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1946.20291675802	1946.20291675802
"healthy-4003"	"2020-08-26-Control4003-c2:GACCAATGTGGTAACG"	-1.34585247460063	9.34279916370241	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCAATGTGGTAACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1602.13479915365	41.6018321968422	0.0259664993350241	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1595.42754387887	1595.42754387887
"healthy-4003"	"2020-08-26-Control4003-c2:GACCCAGCACAGAGAC"	5.46568502959554	-10.0410490266052	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCCAGCACAGAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.18969702146	44.4110391482918	0.0211966674002964	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2091.79885264579	2091.79885264579
"healthy-4003"	"2020-08-26-Control4003-c2:GACCCAGTCCACGGGT"	10.3974310356075	6.51166484439699	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCCAGTCCACGGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1849.66323197053	37.5857055758357	0.020320296649782	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1839.96546713955	1839.96546713955
"healthy-4003"	"2020-08-26-Control4003-c2:GACCCTTAGCACGTCC"	-0.114396880299407	8.73701856220094	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCCTTAGCACGTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1795.19900006058	38.0062574285961	0.0211710553689666	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1793.39529169949	1793.39529169949
"healthy-4003"	"2020-08-26-Control4003-c2:GACCCTTGTACAGGTG"	10.2103086906368	7.71418330753175	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCCTTGTACAGGTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2165.9779850625	34.1652653710606	0.0157735977035218	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2148.29009278468	2148.29009278468
"healthy-4003"	"2020-08-26-Control4003-c2:GACCCTTGTGTCATGT"	-3.55432424965556	10.2308702238831	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCCTTGTGTCATGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1956.01400545599	44.7692825086639	0.0228880173576402	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1941.1380619836	1941.1380619836
"healthy-4003"	"2020-08-26-Control4003-c2:GACCGTGAGAGAGGTA"	5.00709166106526	-7.7911701432434	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCGTGAGAGAGGTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.46554663062	15.9444694978386	0.00634867140392575	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2510.07244059345	2510.07244059345
"healthy-4003"	"2020-08-26-Control4003-c2:GACCGTGCACGGCTAC"	5.64397348937337	-10.0192852250305	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCGTGCACGGCTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.29005398968	24.3709022866097	0.00954490158629985	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2548.70634312325	2548.70634312325
"healthy-4003"	"2020-08-26-Control4003-c2:GACCGTGGTTGAAGTA"	-3.3784695667332	10.3654384382996	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCGTGGTTGAAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1683.07046746614	31.2362872744265	0.0185591084141906	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1680.93598665189	1680.93598665189
"healthy-4003"	"2020-08-26-Control4003-c2:GACCTTCAGTAATACG"	-1.62083027783092	8.88745973193971	"2020-08-26-Control4003-c2"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCTTCAGTAATACG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2011.52317834496	40.3212325727909	0.0200451245140344	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2008.28743654301	2008.28743654301
"healthy-4003"	"2020-08-26-Control4003-c2:GACCTTCAGTTCTACG"	0.423220862715882	8.63175199115602	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCTTCAGTTCTACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1878.3090863053	26.9440393917798	0.0143448379120498	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1872.34416176525	1872.34416176525
"healthy-4003"	"2020-08-26-Control4003-c2:GACCTTCGTGTTATCG"	-2.22120438042338	9.20298860156862	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCTTCGTGTTATCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1652.16242862093	33.0464081802548	0.02000191240751	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1652.16242862093	1652.16242862093
"healthy-4003"	"2020-08-26-Control4003-c2:GACCTTCTCCTGTTAT"	5.48272814330403	-9.5910969010559	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCTTCTCCTGTTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3074.48169422369	35.4492259276953	0.0115301470144698	2333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3057.66502196252	3057.66502196252
"healthy-4003"	"2020-08-26-Control4003-c2:GACCTTCTCTAAGCCA"	-2.45016751709636	9.38668725574342	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACCTTCTCTAAGCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2161.03206410367	45.2131031912828	0.0209219955327391	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2158.01546292116	2158.01546292116
"healthy-4003"	"2020-08-26-Control4003-c2:GACGCTGAGTTTCTTC"	-1.9835675758427	9.04281232440797	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACGCTGAGTTTCTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2069.12396182351	37.3061043802138	0.0180299030258855	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2063.06419682309	2063.06419682309
"healthy-4003"	"2020-08-26-Control4003-c2:GACGCTGGTGGTTTGT"	3.25972332534139	-6.5928788415161	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACGCTGGTGGTTTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.00199247312	29.6301542411273	0.0134804947141055	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2194.78056454173	2194.78056454173
"healthy-4003"	"2020-08-26-Control4003-c2:GACGTTAAGCCTGGAA"	-1.79959414425548	9.29620168292848	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACGTTAAGCCTGGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.14108066682	37.6537100325842	0.0210692431839432	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1779.13071457453	1779.13071457453
"healthy-4003"	"2020-08-26-Control4003-c2:GACGTTACAGACACCC"	11.0181137519771	6.44389674747316	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACGTTACAGACACCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1874.75423726518	32.4753926087685	0.0173224799086959	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1868.82186020115	1868.82186020115
"healthy-4003"	"2020-08-26-Control4003-c2:GACGTTAGTATGTCCA"	-2.70303950730022	10.194291091803	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACGTTAGTATGTCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1751.25992748792	24.0035961005332	0.0137064725365839	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1743.039478786	1743.039478786
"healthy-4003"	"2020-08-26-Control4003-c2:GACTATGCAGAGAAAG"	-0.638966898352462	8.55985639179078	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTATGCAGAGAAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2266.7994380663	1.00966081491692	0.0004454125045038	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2250.06700062408	2250.06700062408
"healthy-4003"	"2020-08-26-Control4003-c2:GACTATGGTGTGATGG"	-4.22321734848674	3.55900428378908	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTATGGTGTGATGG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2461.60964924976	12.1008747256968	0.00491583819123592	1871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2455.793125673	2455.793125673
"healthy-4003"	"2020-08-26-Control4003-c2:GACTATGTCACCTTAT"	3.86480559882466	-7.10585310375365	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTATGTCACCTTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1777.26140880419	40.0541937449165	0.0225370300319898	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1775.3045897875	1775.3045897875
"healthy-4003"	"2020-08-26-Control4003-c2:GACTATGTCTGTACAG"	-1.0222626728123	8.2683419951233	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTATGTCTGTACAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1993.3005102124	40.7820769827033	0.0204595728410052	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1993.3005102124	1993.3005102124
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAAAGCATGGGT"	4.09329857405965	-8.45332910930785	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAAAGCATGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2065.53628172714	39.9107028157802	0.0193221988734122	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2065.53628172714	2065.53628172714
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAAAGGCGCTTC"	-3.46167097511943	-5.58613922512206	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAAAGGCGCTTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2684.95076846362	31.2614092325867	0.0116431964413541	1810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2682.64258998375	2682.64258998375
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAAAGGGAGGGT"	3.67243804511372	-7.04032614147338	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAAAGGGAGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.93825057058	41.5074776301721	0.020467821255649	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2020.41407332776	2020.41407332776
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAACACTGTCCT"	4.13275875624959	-6.53659727489623	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAACACTGTCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2815.08724084548	23.7247468112419	0.0084277128136592	2039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2812.11473060727	2812.11473060727
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAACATAGCTGT"	4.53373207625691	-6.90224697506102	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAACATAGCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2784.96238549091	37.4989693744902	0.0134648028173925	2012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2776.70893632651	2776.70893632651
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAATCAGTGGGA"	4.60685219344441	-7.31317903911742	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAATCAGTGGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.60767619168	24.4818069909815	0.00929239188521986	1757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2630.01562660733	2630.01562660733
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCAATCTTGCAGA"	-3.78665314140971	12.9799270399841	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCAATCTTGCAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2033.34879845176	35.1561880808668	0.0172897970616923	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2027.20543966489	2027.20543966489
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCTCAGTTGTCAC"	-0.038991997868377	8.05063150012819	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCTCAGTTGTCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2074.29692820477	39.6674489943437	0.0191233224399915	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2061.13003595732	2061.13003595732
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCTCCAGAAGCTG"	3.21005453643147	-3.62467553531798	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCTCCAGAAGCTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2265.68190396389	36.2663019172009	0.016006793298632	1386	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2258.06943538811	2258.06943538811
"healthy-4003"	"2020-08-26-Control4003-c2:GACTCTCGTGAATGTA"	-0.418384711176711	8.31942079151002	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTCTCGTGAATGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1673.52806144404	19.4013985812237	0.0115931121970448	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1671.77802636627	1671.77802636627
"healthy-4003"	"2020-08-26-Control4003-c2:GACTGATAGGTGATCG"	-1.88337347927745	8.68393228137819	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTGATAGGTGATCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1649.33419870436	31.8020395325026	0.0192817438439613	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1647.34744811323	1647.34744811323
"healthy-4003"	"2020-08-26-Control4003-c2:GACTGATAGTAGATCA"	5.06702580031697	-8.17244341289672	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTGATAGTAGATCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2673.12002052867	35.807852916188	0.0133955275637441	1825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2667.50966096664	2667.50966096664
"healthy-4003"	"2020-08-26-Control4003-c2:GACTGATAGTTGGCTT"	4.91150440749471	-7.82734157955321	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTGATAGTTGGCTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2657.74066444921	11.128443358798	0.00418718180733569	1766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2651.94409637025	2651.94409637025
"healthy-4003"	"2020-08-26-Control4003-c2:GACTGATGTGTCGCTG"	4.12363495406453	-8.18539621746215	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTGATGTGTCGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.05386679679	28.5116729236975	0.0117522835390883	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2421.52593282266	2421.52593282266
"healthy-4003"	"2020-08-26-Control4003-c2:GACTGATTCGAGTCCG"	1.78350200232808	-6.46734192287596	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTGATTCGAGTCCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2145.37458593227	41.395045110078	0.0192950197981812	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2142.62770731959	2142.62770731959
"healthy-4003"	"2020-08-26-Control4003-c2:GACTTCCCAACGATTC"	11.0003820854122	6.03994319522706	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTTCCCAACGATTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1638.17780293812	13.6078547616489	0.00830670195704207	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1638.17780293812	1638.17780293812
"healthy-4003"	"2020-08-26-Control4003-c2:GACTTCCGTGGATTTC"	5.27857269820516	-10.0806265107361	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTTCCGTGGATTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2227.31545755636	40.5611970286311	0.0182108003116594	1222	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2215.57621632808	2215.57621632808
"healthy-4003"	"2020-08-26-Control4003-c2:GACTTCCTCAGCAGAG"	0.0593110212007582	8.33219716632692	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GACTTCCTCAGCAGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.45538073473	33.1237793000174	0.017823284671447	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1851.78980395143	1851.78980395143
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAAATAGGCGAACT"	-3.97206483307536	12.7750253447327	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAAATAGGCGAACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2203.66070886001	37.0263482433176	0.0168022001274742	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2196.35955043379	2196.35955043379
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAAATCACGTATAC"	4.06821837004964	-6.63794233715209	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAAATCACGTATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.17592947294	40.2141400910422	0.017991487632262	1212	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.21603028765	2232.21603028765
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTCACCAGTAT"	5.50530972060506	-10.203923248407	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTCACCAGTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.41086359349	40.4761409398254	0.016021202854651	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2521.37448665525	2521.37448665525
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTCATTCGATG"	5.51836218413655	-9.9183502427307	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTCATTCGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2794.01216241664	8.82132887486836	0.00315722636913595	1888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2790.59443738506	2790.59443738506
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTGTAGCTCGC"	4.6593300300533	-7.17923452770384	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTGTAGCTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.67951736532	35.756953837427	0.0135050158461053	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2645.29520539444	2645.29520539444
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTGTCAGGAGT"	-5.666655878455	-5.40581896221312	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTGTCAGGAGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2974.00735170868	33.7485983576293	0.0113478530368257	2292	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2964.31859418077	2964.31859418077
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTGTGTCTAAC"	9.99625839766805	6.21852920139161	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTGTGTCTAAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1434.71376334869	37.5492353116649	0.0261719349677272	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1432.43321320617	1432.43321320617
"healthy-4003"	"2020-08-26-Control4003-c2:GAGACTTTCCGTGGCA"	-2.13208041611369	8.92005918109743	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGACTTTCCGTGGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2304.03654946616	33.1868828057599	0.0144038005011028	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2291.02943306215	2291.02943306215
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAGGTCAAGGGTCA"	4.88035978850667	-7.59835531627806	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAGGTCAAGGGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2962.7132993604	31.5033532459354	0.0106332776960688	2552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2952.0017368326	2952.0017368326
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAGGTGTAATCAAG"	-1.81517885151561	3.95024941051332	"2020-08-26-Control4003-c2"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAGGTGTAATCAAG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3090.61101322741	37.449082871552	0.0121170482830984	5448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3086.03424675243	3086.03424675243
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAGGTGTCAGTTTG"	4.07416739043538	-7.14013197338256	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAGGTGTCAGTTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.87191347725	5.53255583550875	0.00232668370577551	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2374.803361647	2374.803361647
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAGGTTCCTTGAAG"	-3.83281765404399	10.7610845335755	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAGGTTCCTTGAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1848.49300315194	41.2399690305767	0.0223100487587764	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1839.02706108022	1839.02706108022
"healthy-4003"	"2020-08-26-Control4003-c2:GAGAGGTTCTTCTTCC"	-2.51475797119792	8.46045873248903	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGAGGTTCTTCTTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2660.95621624655	38.1379618435113	0.0143324274223901	1846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2643.54035744737	2643.54035744737
"healthy-4003"	"2020-08-26-Control4003-c2:GAGATGGTCAAGCCCG"	5.02273287352864	-7.86925794994506	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGATGGTCAAGCCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3002.80819849679	31.7300662241626	0.0105667975197506	2741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2997.90819340946	2997.90819340946
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCCTGAGGCTATCT"	-0.593157748610336	8.3060035475525	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCCTGAGGCTATCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1927.84831203179	39.4093227418648	0.0204421284060107	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1922.72953192968	1922.72953192968
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCCTGAGGTGCTGA"	4.57531799849812	-7.14850237285765	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCCTGAGGTGCTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2926.84071843417	38.8283856154085	0.0132663131857005	2456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2916.53652226175	2916.53652226175
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCTGCAGAAGCCTG"	-2.00243912163432	9.39385221088258	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCTGCAGAAGCCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1982.17939303157	38.8565516120604	0.0196029439861307	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1972.82628740828	1972.82628740828
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCTGCCAATCAAGA"	3.63948192176167	-6.77581264888915	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCTGCCAATCAAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.28634995165	28.42761665444	0.0111424641357795	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2543.9719360704	2543.9719360704
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCTGCCACCGGTCA"	4.77040495452229	-8.23270990764769	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCTGCCACCGGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2616.74013536345	1.27051055316292	0.000485531801951918	1571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2610.88144867134	2610.88144867134
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCTGCTCACTTTGT"	-3.12180505219157	10.0600423582825	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCTGCTCACTTTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1717.09945439536	37.8984307079413	0.0220711913983378	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1706.39769453963	1706.39769453963
"healthy-4003"	"2020-08-26-Control4003-c2:GAGCTGCTCCGAAGGA"	3.70833148536031	-5.8112192383972	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGCTGCTCCGAAGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.58962260805	32.3883692902823	0.012589792404374	1936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2568.72544145912	2568.72544145912
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCAAAGATACTGA"	3.98556484755818	-7.57126238262328	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCAAAGATACTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.35386716508	32.7953128208183	0.015643977543337	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2089.6466310905	2089.6466310905
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCAAAGGCCGCTT"	-4.28633246842082	13.173593498114	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCAAAGGCCGCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2185.24567591613	30.7459941884074	0.0140698112469746	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2176.68422109158	2176.68422109158
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCAAAGTCACGAG"	4.8691107231075	-7.86364700710448	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCAAAGTCACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2581.71869502475	19.8664096074839	0.00769503263301635	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2579.16114555987	2579.16114555987
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCAACAAGAATAC"	4.65774120864217	-6.8707542649475	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCAACAAGAATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.57077094828	34.2288818084947	0.0156041839460222	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2188.71006038353	2188.71006038353
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCAACAGAATGTA"	1.76922227916066	-5.99973585521849	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCAACAGAATGTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2632.39681709044	33.6323436694415	0.0127763198356299	2025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2629.57694576541	2629.57694576541
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCCTAGCAGGCAT"	-3.44145284119304	-5.5808429948059	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCCTAGCAGGCAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2702.02296974115	33.8324891418559	0.0125211700717322	2058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2700.09678387907	2700.09678387907
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCCTTCTCCTGAC"	-3.62348709526713	10.6821765669617	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCCTTCTCCTGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1885.10824280269	39.0066848619432	0.0206920133158772	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1881.18514200609	1881.18514200609
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGCCTTCTCTAAGG"	-7.39869246903117	0.0389794458630457	"2020-08-26-Control4003-c2"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGCCTTCTCTAAGG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2829.07198502289	34.6106553373237	0.0122339253014955	3216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2819.51730109547	2819.51730109547
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGGATCAAACCGGA"	3.88503374633138	-6.38290359890135	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGGATCAAACCGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.14064959594	35.9289033958432	0.014422671558778	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2488.72661983185	2488.72661983185
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGGATCAATGTGGG"	-3.33257804337199	10.0033616789612	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGGATCAATGTGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1801.104570236	32.1499588828716	0.0178501345308667	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1799.16988736587	1799.16988736587
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGGATGTATCACCA"	5.55713715133016	-10.2531595460144	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGGATGTATCACCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.29326882373	32.5603192509744	0.0144053515975469	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2260.29326882373	2260.29326882373
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGGTAAGGGCAGAG"	3.71183933791463	-6.86818411266478	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGGTAAGGGCAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.09169173829	18.3730845283914	0.00776188121166485	1372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.51844094464	2361.51844094464
"healthy-4003"	"2020-08-26-Control4003-c2:GAGGGTACACAGGATG"	2.60675706443135	-4.33347036754759	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGGGTACACAGGATG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2164.6923989342	34.9647100137014	0.0161522764300908	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2163.06122329671	2163.06122329671
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCATAGTATCCTG"	3.45855869826619	-7.09659244930419	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCATAGTATCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.54914390998	13.9644579550146	0.00556009743582988	1602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.45861587232	2505.45861587232
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCATCAAGCCCAC"	-3.47822318497356	12.7710695036682	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCATCAAGCCCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1645.35367990213	39.3215556593962	0.0238985429939508	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1640.96017479411	1640.96017479411
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCATGTACATACC"	-2.79668913307841	-5.77792408382567	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCATGTACATACC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2373.50011407164	32.2704034125835	0.0135961246520545	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2369.04746993115	2369.04746993115
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCTAAGATGTTCC"	-3.8002430004185	10.7996425398621	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCTAAGATGTTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2652.52474102171	36.4623408025406	0.0137462773630892	1686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2643.40246453906	2643.40246453906
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCTAAGTATTGCC"	2.40967335280721	-4.37983229076537	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCTAAGTATTGCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2271.30146874412	29.1365445950318	0.0128281273956743	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2260.70858823255	2260.70858823255
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCTACATACAGAA"	-3.61552272263225	10.3892879256043	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCTACATACAGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1788.94736393542	37.3504623949068	0.0208784579959588	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.98764513628	1783.98764513628
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCTACATTGCTTT"	5.09016384658162	-8.34178926860961	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCTACATTGCTTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.3158447146	0.92920484865216	0.000395858465636157	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.35724921846	2343.35724921846
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTCTAGTTCCACGG"	2.91541041907613	-4.8572192422119	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTCTAGTTCCACGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2633.99809381492	28.307712069412	0.0107470510840093	2205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2629.04513354203	2629.04513354203
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGAGAGAGCCCAA"	6.75705160674397	-1.75980355655821	"2020-08-26-Control4003-c2"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGAGAGAGCCCAA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2828.27912606894	36.9041960421174	0.0130482863950599	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2823.78708644191	2823.78708644191
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGAGGTCGTCATA"	-4.03782926026042	13.1273908385071	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGAGGTCGTCATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.48524115131	36.0658777613066	0.0209504426173216	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1716.83315367698	1716.83315367698
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGTTGTAGTGGCA"	4.31114592131917	-6.85605480587157	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGTTGTAGTGGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2025.26507345137	30.8331778014502	0.0152242677788867	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2023.71226403922	2023.71226403922
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGTTGTGACTGAG"	10.3636909919674	5.80175349796144	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGTTGTGACTGAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1497.58281820459	3.60579945971068	0.00240774628012465	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1489.15758106834	1489.15758106834
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGTTGTGATTCAC"	5.18989719924275	-10.292992614862	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGTTGTGATTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.56593177691	27.5551417723401	0.0123534307503698	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2228.77903828434	2228.77903828434
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTGTTTCCCGTTCA"	3.77800764617268	-7.19894792949828	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTGTTTCCCGTTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.849876607	30.1964710358951	0.014058929986111	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.78657266626	2140.78657266626
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTACCACTAGGTT"	4.055840631097	-7.53444912349852	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTACCACTAGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1996.11023203621	33.7250801752845	0.0168953996798474	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1992.85019751543	1992.85019751543
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTACCAGGTATGG"	5.3835936981136	-10.2491817704407	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTACCAGGTATGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2252.09221915879	37.5245444470163	0.0166620816535802	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2244.88790522741	2244.88790522741
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTGTAGGAATGTT"	-4.22645602646525	13.0497112044129	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTGTAGGAATGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2076.66471736523	34.9110564734931	0.016811118415777	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2064.46580095466	2064.46580095466
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTGTCACAAGGTG"	-2.33840809288676	8.9000615843567	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTGTCACAAGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.37056059229	38.804066214897	0.0214936850427906	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.2440229245	1801.2440229245
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTGTCACCATATG"	4.06671824034993	-6.8811040154663	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTGTCACCATATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.47662949963	21.4443488071298	0.00852496443641993	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.47647531382	2511.47647531382
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTTGCACCGTCGA"	14.466792722314	1.99681565845338	"2020-08-26-Control4003-c2"	"Control4003"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTTGCACCGTCGA"	"Plasmablast"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1596.78265070485	22.9227502479137	0.0143555857384818	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1582.51812953779	1582.51812953779
"healthy-4003"	"2020-08-26-Control4003-c2:GAGTTTGGTAGGAAAG"	4.40181841430013	-7.42759325420531	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GAGTTTGGTAGGAAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.02015559432	31.5866561008943	0.0126954984789298	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2483.36323693138	2483.36323693138
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGAAAGAGAATCT"	-2.79339585724528	10.02964685047	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGAAAGAGAATCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.96422475344	42.9787487052005	0.0222346322579678	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1928.91974534409	1928.91974534409
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGAAAGAGCATAT"	10.5871979194576	7.75531098926393	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGAAAGAGCATAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2203.0939124887	27.8439423627469	0.012638563524191	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2197.57442512001	2197.57442512001
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGAAAGTCATACC"	4.66246094283406	-7.59959604656371	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGAAAGTCATACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.57181058196	1.81587354472605	0.000699334999065198	1762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2586.48380867361	2586.48380867361
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGAACAAGATCCT"	-4.17332921448405	13.0381297835144	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGAACAAGATCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1953.31641855114	33.5024014232071	0.0171515485688986	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1949.57070601072	1949.57070601072
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGAAGTGCCTACG"	3.24617733535115	-6.37288715755614	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGAAGTGCCTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.8560826873	7.08637809859973	0.00326582862114222	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2165.08625377074	2165.08625377074
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGCTGTCCAGGTC"	-3.4015716117924	9.66589734638063	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGCTGTCCAGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2106.98396185601	36.8021077139202	0.0174667241802361	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2103.45069435565	2103.45069435565
"healthy-4003"	"2020-08-26-Control4003-c2:GATAGCTTCGCCTCTA"	5.46051611480061	-9.36648466503295	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATAGCTTCGCCTCTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2667.47769158079	31.1439784069082	0.0116754410000152	1826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2663.10296889262	2663.10296889262
"healthy-4003"	"2020-08-26-Control4003-c2:GATCACATCATGGATC"	3.29487790641133	-6.92417051708373	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCACATCATGGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.40276682222	30.4282948487588	0.0156411285969655	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1941.72896154648	1941.72896154648
"healthy-4003"	"2020-08-26-Control4003-c2:GATCAGTAGGGTTGCA"	-4.04414449158366	11.2044276961121	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCAGTAGGGTTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1856.56280595873	33.7514652733869	0.0181795440289226	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1854.64562965549	1854.64562965549
"healthy-4003"	"2020-08-26-Control4003-c2:GATCAGTCAATCGTCA"	-0.325779209763366	8.94905374133912	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCAGTCAATCGTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1921.31778601126	33.4229876325414	0.0173958664599307	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.62935431476	1911.62935431476
"healthy-4003"	"2020-08-26-Control4003-c2:GATCAGTTCAGTGCGC"	-1.61416731301005	9.14623162830202	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCAGTTCAGTGCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1886.27079247659	30.1218365829417	0.015968988494697	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1878.41600410444	1878.41600410444
"healthy-4003"	"2020-08-26-Control4003-c2:GATCAGTTCATCGCTC"	10.6429468589718	6.13910958850709	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCAGTTCATCGCTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1991.88421738091	31.6598463785105	0.0158944210221915	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1982.33401524363	1982.33401524363
"healthy-4003"	"2020-08-26-Control4003-c2:GATCAGTTCGGCCTTT"	-4.06220469895061	12.9071531065735	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCAGTTCGGCCTTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1929.05110377801	33.8543276965334	0.0175497308652064	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1920.87049256358	1920.87049256358
"healthy-4003"	"2020-08-26-Control4003-c2:GATCATGGTACTTCCC"	-0.547078470618087	8.4545917280945	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCATGGTACTTCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1944.57554543415	36.3298336472569	0.0186826547996857	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1936.10243603963	1936.10243603963
"healthy-4003"	"2020-08-26-Control4003-c2:GATCCCTAGACAGCGT"	5.47587122496907	-9.65546228801879	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCCCTAGACAGCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.64940045713	35.9637724744026	0.014711218904305	1513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2438.41288154831	2438.41288154831
"healthy-4003"	"2020-08-26-Control4003-c2:GATCCCTAGGTCCCTG"	5.0096513229305	-8.50942709362181	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCCCTAGGTCCCTG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2434.95220679087	26.8127215347284	0.0110116007451604	1515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.71006408529	2433.71006408529
"healthy-4003"	"2020-08-26-Control4003-c2:GATCCCTTCGGACTGC"	-0.49114696207698	8.26859471881715	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCCCTTCGGACTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2001.15156460236	32.7441144680144	0.0163626359178451	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1992.00818809374	1992.00818809374
"healthy-4003"	"2020-08-26-Control4003-c2:GATCCCTTCTCGGGAC"	5.57862200316731	-9.94547178661498	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATCCCTTCTCGGGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2433.39265610768	4.02435035417309	0.00165380229289021	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2427.62620740105	2427.62620740105
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTAGAGAGCCT"	-2.42302380028422	10.1467761763367	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTAGAGAGCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.14819502305	38.2791323988662	0.0228921889296651	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1670.15650156549	1670.15650156549
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTAGTCACGCC"	-2.79478798332866	10.7488136061463	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTAGTCACGCC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1787.28590188305	37.30209509347	0.0208708047515897	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1781.56795477658	1781.56795477658
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTCACTAGGCC"	5.40007462081258	-9.41858961498412	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTCACTAGGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2600.35995905946	13.315743157412	0.00512073073230533	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2599.30429233901	2599.30429233901
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTGTCAGATTC"	-3.39635906639751	10.3751668700012	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTGTCAGATTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.65248035552	37.0054735906616	0.0198991338336435	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1857.65747074725	1857.65747074725
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTGTGGCCCAT"	3.44418158110921	-6.73778965389403	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTGTGGCCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.23006928238	20.1467759312883	0.00970821319019106	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2069.41306395793	2069.41306395793
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTGTGGTGATG"	-5.47794423523601	-5.16857912456664	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTGTGGTGATG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2660.12150497699	30.7956442144859	0.0115767810443502	2633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2651.71253298068	2651.71253298068
"healthy-4003"	"2020-08-26-Control4003-c2:GATGACTTCATACGGT"	4.42594208297078	-6.89187052166136	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGACTTCATACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.1776153128	0	0	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.45812381258	2347.45812381258
"healthy-4003"	"2020-08-26-Control4003-c2:GATGAGGAGTGTACAA"	4.35097755965535	-7.23458340084227	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGAGGAGTGTACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.86306135069	9.66150512158584	0.00407166569320958	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.01822141379	2365.01822141379
"healthy-4003"	"2020-08-26-Control4003-c2:GATGAGGTCATCACCC"	-3.39591942253764	10.2395515211853	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGAGGTCATCACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1988.77595573294	21.2603025574448	0.0106901446068668	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1979.73107852392	1979.73107852392
"healthy-4003"	"2020-08-26-Control4003-c2:GATGATCCAATTGCTG"	-3.75293837013896	10.2358073958191	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGATCCAATTGCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1907.96754023426	30.1235773738565	0.0157883070537762	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1907.96754023426	1907.96754023426
"healthy-4003"	"2020-08-26-Control4003-c2:GATGATCTCGAGCTGC"	4.45552362975423	-7.33201410686644	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGATCTCGAGCTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.11757652285	36.4847826407352	0.0171522171803855	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2121.97932527733	2121.97932527733
"healthy-4003"	"2020-08-26-Control4003-c2:GATGATCTCTAGATCG"	-3.79485927048381	10.7164964445862	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGATCTCTAGATCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1666.71676539435	33.604429697431	0.0201620517625742	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1664.64508154832	1664.64508154832
"healthy-4003"	"2020-08-26-Control4003-c2:GATGATCTCTCCTGAC"	-0.744435231119949	9.01443097675172	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGATCTCTCCTGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1496.94229903179	33.2881305209259	0.0222374172621459	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1496.94229903179	1496.94229903179
"healthy-4003"	"2020-08-26-Control4003-c2:GATGCTAAGAAATTGC"	5.52359785613362	-9.88006021892699	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGCTAAGAAATTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.00016906313	14.2737581413746	0.0060125345934611	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2357.54390209972	2357.54390209972
"healthy-4003"	"2020-08-26-Control4003-c2:GATGCTACACATGTTG"	-1.95205030861552	8.75467488849489	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGCTACACATGTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.98150134662	23.1569377905907	0.0119923146723268	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1925.52280102333	1925.52280102333
"healthy-4003"	"2020-08-26-Control4003-c2:GATGCTAGTCCAAATC"	5.14656366881673	-9.29530241405638	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGCTAGTCCAAATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2415.68052993681	18.7038947361544	0.00774270210996965	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2410.40775286587	2410.40775286587
"healthy-4003"	"2020-08-26-Control4003-c2:GATGCTAGTTACGGAG"	3.86755742606465	-7.08506586467894	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGCTAGTTACGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.87061772265	31.3894919649877	0.0137620659940495	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2279.6394389706	2279.6394389706
"healthy-4003"	"2020-08-26-Control4003-c2:GATGCTATCCCAAGTA"	2.70912851867024	-4.5378718606201	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGCTATCCCAAGTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2526.14550027839	29.0085659590119	0.0114833314058177	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2523.79822632491	2523.79822632491
"healthy-4003"	"2020-08-26-Control4003-c2:GATGGAGAGGCATTTC"	3.18738617476766	-7.20491650020751	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGGAGAGGCATTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.21821731735	31.4793177537074	0.0149529951312225	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2103.50811855336	2103.50811855336
"healthy-4003"	"2020-08-26-Control4003-c2:GATGGAGCACAGTATC"	2.52764668044392	-4.36539509212645	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGGAGCACAGTATC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2104.48188430859	25.2894524356033	0.0120169494563798	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2102.13755216025	2102.13755216025
"healthy-4003"	"2020-08-26-Control4003-c2:GATGGAGCATCCCGTT"	4.31557955321614	-6.52178766643675	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGGAGCATCCCGTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2955.66726143706	33.4476394859115	0.0113164427952723	2545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2947.74937368641	2947.74937368641
"healthy-4003"	"2020-08-26-Control4003-c2:GATGTTGGTGCCTATA"	-5.03781257095988	-5.02094795620116	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGTTGGTGCCTATA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3024.85511528992	22.0294229159124	0.00728280267195573	2306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3020.88604113416	3020.88604113416
"healthy-4003"	"2020-08-26-Control4003-c2:GATGTTGTCAGTCTTT"	5.42960037764851	-9.97861101543578	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATGTTGTCAGTCTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.00538381752	15.7456436066125	0.00772221776929927	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.74490266223	2036.74490266223
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTAGACCGCCT"	-3.86097393456157	10.6944188841614	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTAGACCGCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1992.96360482089	18.860599384017	0.00946359448732234	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1989.23883517727	1989.23883517727
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTGTCTCTCCA"	5.67836584624593	-9.71107675945433	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTGTCTCTCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2714.14823729847	34.4138745549368	0.0126794380948001	1721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2709.11383500921	2709.11383500921
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTGTGTTCCTC"	2.93592061576192	-4.86197330867919	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTGTGTTCCTC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2374.27055716593	3.95370586403288	0.00166522970690933	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2370.80263297365	2370.80263297365
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTTCAGCTTGA"	2.93916692313496	-4.83146335994872	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTTCAGCTTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2568.8142638603	6.12744925381332	0.0023853220297077	2142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2563.74220656148	2563.74220656148
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTTCTAGGAAA"	-3.93108377876933	12.7899675139221	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTTCTAGGAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2053.62244617043	38.4628140177751	0.0187292528329636	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2050.40907078702	2050.40907078702
"healthy-4003"	"2020-08-26-Control4003-c2:GATTCTTTCTATTTCG"	3.93733801421468	-6.64351513302001	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTCTTTCTATTTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2762.2492878486	27.807645926896	0.0100670298112573	2069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2755.16431818152	2755.16431818152
"healthy-4003"	"2020-08-26-Control4003-c2:GATTGGTAGAGGGTGG"	4.78273405608479	-8.35589029705199	"2020-08-26-Control4003-c2"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTGGTAGAGGGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.0492451927	39.099731783889	0.017756066023159	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.46849809525	2200.46849809525
"healthy-4003"	"2020-08-26-Control4003-c2:GATTGGTCAGAGGCTA"	4.36557497557942	-6.73795559322508	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTGGTCAGAGGCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2630.58616558405	1.50624247423072	0.00057258815314126	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2621.69029319038	2621.69029319038
"healthy-4003"	"2020-08-26-Control4003-c2:GATTGGTTCGGAATGG"	-1.93884406510051	9.01211736286012	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTGGTTCGGAATGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1894.78421649378	32.4835237134768	0.0171436533145639	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1892.90311375706	1892.90311375706
"healthy-4003"	"2020-08-26-Control4003-c2:GATTTCTCAGAGGGTT"	-0.141297886998016	8.812623954657	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTTCTCAGAGGGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1500.37110388419	21.0825152281534	0.0140515337662626	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1498.42966494517	1498.42966494517
"healthy-4003"	"2020-08-26-Control4003-c2:GATTTCTGTCCGACGT"	10.3578411537105	7.37358090961305	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTTCTGTCCGACGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.48097628857	3.59537854996562	0.00208369642979149	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1721.94992852623	1721.94992852623
"healthy-4003"	"2020-08-26-Control4003-c2:GATTTCTTCCAAAGGG"	-0.689219931990463	9.54140660846559	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GATTTCTTCCAAAGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1399.31277840294	42.6152811779049	0.0304544358027964	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1392.44210892002	1392.44210892002
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACATAGGCTAGCA"	4.10144962844197	-6.60756542598876	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACATAGGCTAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.47376079477	11.2446148478153	0.00449519600167331	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2495.97075894293	2495.97075894293
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACATAGTCTGGAG"	-4.08748565140422	13.081778503302	"2020-08-26-Control4003-c2"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACATAGTCTGGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2123.51480895756	36.699404460584	0.0172823868737699	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2117.87575212477	2117.87575212477
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACATGTACTAAGA"	-0.0130227607792199	8.62779710376588	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACATGTACTAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.71638611904	32.5861862099184	0.0186343460086387	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1742.34887086264	1742.34887086264
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACATTCCTGCCAT"	0.260189791291398	8.69114205921022	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACATTCCTGCCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1846.18907822887	20.8525934055094	0.0112949392082387	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1835.74165771444	1835.74165771444
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACCGAGAGGTTTA"	5.41260923919026	-10.2483549348083	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACCGAGAGGTTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.56957066998	48.0686690779134	0.0197685765020776	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2426.3741340274	2426.3741340274
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACCGAGGAATCGC"	5.59957565841023	-10.1567230454651	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACCGAGGAATCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2459.19966927269	11.3418948065734	0.00461202681030278	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2453.75743838502	2453.75743838502
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACCGAGGTCTACT"	3.89342464980428	-7.18366959011229	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACCGAGGTCTACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.38144997214	24.7192643176524	0.0113631861290207	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2173.77147428537	2173.77147428537
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACCGCACGCTATA"	4.35934128341023	-7.27947618877562	"2020-08-26-Control4003-c2"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACCGCACGCTATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2586.85580616915	30.8945349503011	0.0119428902363339	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2580.82536633227	2580.82536633227
"healthy-4003"	"2020-08-26-Control4003-c2:GCAACCGGTCTCGGAC"	3.78313936766927	-6.94247295772704	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAACCGGTCTCGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.95747264464	4.78728390347419	0.00206263318475167	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2309.31904197286	2309.31904197286
"healthy-4003"	"2020-08-26-Control4003-c2:GCACATACACAGCTTA"	3.91544141349141	-7.08909418499144	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACATACACAGCTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.01831609417	38.5300965267035	0.0172547158476056	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.47801359591	2231.47801359591
"healthy-4003"	"2020-08-26-Control4003-c2:GCACATACATGACAGG"	-4.59830365601237	2.93044183338014	"2020-08-26-Control4003-c2"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACATACATGACAGG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2657.96763030637	28.581506897417	0.0107531433308398	2817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2650.03781311824	2650.03781311824
"healthy-4003"	"2020-08-26-Control4003-c2:GCACATAGTCAACCAT"	3.42367782172505	-6.60052492534789	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACATAGTCAACCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.96288257881	30.432592238823	0.0141681183067214	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.95705215818	2140.95705215818
"healthy-4003"	"2020-08-26-Control4003-c2:GCACATAGTTTACGAC"	3.85157002982442	-6.94418098842772	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACATAGTTTACGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2601.58730838144	8.69014781155858	0.00334032526356576	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2597.63021986372	2597.63021986372
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGGTAGCGTCAAG"	5.58727802810018	-9.71869470989379	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGGTAGCGTCAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2661.48908299755	18.2802615692371	0.0068684337974622	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2656.17865157318	2656.17865157318
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGGTAGTGCCGAA"	4.56166185912434	-7.75956489956053	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGGTAGTGCCGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.65098578035	19.9413607490985	0.00740035012115815	1654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2683.81751418174	2683.81751418174
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGGTCAATTGCTG"	5.28795065459554	-9.90068914806517	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGGTCAATTGCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.17108502986	27.4316658618782	0.0119989558268427	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.57100262873	2281.57100262873
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGGTGTAAGCAAT"	5.37168802794759	-9.91856768047484	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGGTGTAAGCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.89224425662	20.4993847728416	0.00917242646732626	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2231.65136305995	2231.65136305995
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGTGAGATGAACT"	3.56362785872762	-6.68486645137938	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGTGAGATGAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.55608331867	31.7675097381347	0.0142932320028119	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2219.39262105939	2219.39262105939
"healthy-4003"	"2020-08-26-Control4003-c2:GCACGTGCAGAGGCTA"	-4.99791512909587	-5.49356081401976	"2020-08-26-Control4003-c2"	"Control4003"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACGTGCAGAGGCTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2043.69394000182	37.0932183426013	0.0181500848128796	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2043.69394000182	2043.69394000182
"healthy-4003"	"2020-08-26-Control4003-c2:GCACTAAAGCCTTTCC"	10.8706299262935	6.57726428592531	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACTAAAGCCTTTCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1826.07326648372	29.7992149660169	0.0163187400598653	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1812.11119660595	1812.11119660595
"healthy-4003"	"2020-08-26-Control4003-c2:GCACTAATCGTGCATA"	0.687781174748582	8.03232381427614	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCACTAATCGTGCATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1374.1799676758	0.402736124562243	0.000293073785119577	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1374.1799676758	1374.1799676758
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGCCAAGATGCAGC"	5.36961092528645	-9.98258211528929	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGCCAAGATGCAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.27699356886	3.62875868261488	0.00164399787302983	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2204.18574293973	2204.18574293973
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGCCAAGCTGAAGC"	3.03347911414449	-4.93735029613646	"2020-08-26-Control4003-c2"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGCCAAGCTGAAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2763.36487884487	14.3337399955854	0.00518706020522962	2471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2758.03132994332	2758.03132994332
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGCCACAGAGGGTT"	-3.63011298599895	11.1404514082703	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGCCACAGAGGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1780.14979930942	38.6389739642614	0.021705462079231	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.88356949306	1775.88356949306
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGCTGGTCTGTAGT"	5.4684907394344	-10.1720781556335	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGCTGGTCTGTAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.12604202889	36.6971975569947	0.0162439796958108	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.64521912603	2256.64521912603
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGCTGTCCCAGGCA"	4.30297531661336	-7.43121817028197	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGCTGTCCCAGGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.31711800132	40.6801819638881	0.0185982094818789	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2182.53446790136	2182.53446790136
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGGCTTCTCCGCAT"	5.41063084182088	-9.95627405559691	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGGCTTCTCCGCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.03368972819	19.1190568092761	0.00833425284680165	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2287.26367390411	2287.26367390411
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGTTAAGCCAAGCA"	-3.19826326790507	11.2716884382996	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGTTAAGCCAAGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2031.34334953695	36.7463407656451	0.0180896748814136	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2019.16788991424	2019.16788991424
"healthy-4003"	"2020-08-26-Control4003-c2:GCAGTTAGTTATGTGC"	0.0191896530682265	8.50412652576295	"2020-08-26-Control4003-c2"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCAGTTAGTTATGTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2128.14954812229	31.3875323169137	0.0147487437358937	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2119.82287856171	2119.82287856171
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGCAGAATGTA"	3.99381055411641	-6.71071150219115	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGCAGAATGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2213.23028001184	5.82745307966277	0.00263300802103232	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2210.45563797971	2210.45563797971
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGCAGCGGATA"	4.49392761763875	-7.40984680568846	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGCAGCGGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2312.48539470418	27.3952037210436	0.0118466494031838	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2309.04017083098	2309.04017083098
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGGTACGGATG"	3.94240727004353	-7.95811750805052	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGGTACGGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1909.76803468867	47.8847823169563	0.0250736117932577	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1906.17920662451	1906.17920662451
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGGTAGGATAT"	3.90053286132161	-7.67116930401	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGGTAGGATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.85883498461	24.9342460856928	0.0115604441427762	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.04999785996	2154.04999785996
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGTCAGCACCG"	9.89385761794392	6.02998302066652	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGTCAGCACCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1548.09771960015	37.2328604943797	0.0240507172273313	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1541.89737718384	1541.89737718384
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCGGTCCCGAGGT"	5.56700291213338	-10.1484661332336	"2020-08-26-Control4003-c2"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCGGTCCCGAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.49993190851	24.573954606859	0.010851823954858	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.32306069744	2259.32306069744
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCTCCAGAGCCCT"	10.6381422477657	7.59909293735353	"2020-08-26-Control4003-c2"	"Control4003"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCTCCAGAGCCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.20921272281	33.3112797153578	0.0188924147372832	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1755.51091534327	1755.51091534327
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCTCGTCGCAGTC"	4.62859215316121	-7.18494703685912	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCTCGTCGCAGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.30308878055	22.6946927584428	0.00950243411946117	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2384.47070524714	2384.47070524714
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCTCGTCTTCGAA"	5.05841936644856	-8.07830717479857	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCTCGTCTTCGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.22189139677	17.1689316672814	0.00723139304270369	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2369.87376012848	2369.87376012848
"healthy-4003"	"2020-08-26-Control4003-c2:GCATCTCTCCATTGCC"	-2.8698390525883	10.484987235907	"2020-08-26-Control4003-c2"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATCTCTCCATTGCC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1819.72338828581	31.8847638725238	0.0175217640646799	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.07127911054	1816.07127911054
"healthy-4003"	"2020-08-26-Control4003-c2:GCATGATAGTGCAGGT"	3.50142707404439	-6.82529213344725	"2020-08-26-Control4003-c2"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATGATAGTGCAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.90710161892	8.49213309399779	0.00441629919971076	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1922.90710161892	1922.90710161892
"healthy-4003"	"2020-08-26-Control4003-c2:GCATTAGAGCATGTTC"	-2.15788660469707	9.49632642352907	"2020-08-26-Control4003-c2"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613775"	"2020-08-26"	"2020.08.26.Control4003.c2.GCATTAGAGCATGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1704.32616431479	39.9865869522084	0.0234618160475666	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1700.49780129141	1700.49780129141
"healthy-4003"	"2020-08-26-Control4003-c3:TACCTCGTCCGAGTGC"	4.36179127272908	-6.97519352352294	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCTCGTCCGAGTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.12321782239	31.0098336847411	0.0118217220884058	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2619.42894383476	2619.42894383476
"healthy-4003"	"2020-08-26-Control4003-c3:TACCTCGTCGCCTAGG"	4.42602409896199	-6.94709064876708	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCTCGTCGCCTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.61302646713	18.7144554476886	0.00860587848040807	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.57263569327	2171.57263569327
"healthy-4003"	"2020-08-26-Control4003-c3:TACCTGCTCGTAACTG"	3.01729192313496	-5.00218536770018	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCTGCTCGTAACTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2337.01808569653	36.4131422624209	0.0155810271581909	1601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2332.76089942883	2332.76089942883
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCAGATGTTCC"	3.77593054351155	-6.79609491741332	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCAGATGTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2770.43582666757	25.2881758005055	0.00912786918111849	2077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2763.36643729796	2763.36643729796
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCCAAACTCGT"	4.50394405898396	-7.15850117122801	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCCAAACTCGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2692.3225733324	1.50377606892302	0.000558542309832414	2013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2686.36457175843	2686.36457175843
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCGTATAGGGC"	-2.12653956833537	9.68972585285035	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCGTATAGGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.25814672923	31.8132590281055	0.0194189536561258	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1635.98344334383	1635.98344334383
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCGTGATTCAC"	4.44263090667073	-7.99876596843871	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCGTGATTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2168.42074005012	4.40609039336332	0.00203193518305008	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2160.85213563472	2160.85213563472
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCTCGCATGAT"	4.41284527358357	-7.10892155086669	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCTCGCATGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.92970738079	36.7653952453823	0.0156987612094048	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.66606869505	2333.66606869505
"healthy-4003"	"2020-08-26-Control4003-c3:TACGCTCTCGGTATGT"	6.80157198485677	-1.72553219711455	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGCTCTCGGTATGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2521.54821167802	7.28266515013459	0.00288817208269366	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2515.33180814084	2515.33180814084
"healthy-4003"	"2020-08-26-Control4003-c3:TACGGGCAGGCACTCC"	4.75460924681966	-7.72870113765868	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGGGCAGGCACTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.95108057002	21.6407112657955	0.00831391393689058	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2601.81453632711	2601.81453632711
"healthy-4003"	"2020-08-26-Control4003-c3:TACGGGCGTTACACTG"	5.09864248809163	-10.2736006013122	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGGGCGTTACACTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1761.56145962419	47.200617367641	0.0267947604721727	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1759.73766093997	1759.73766093997
"healthy-4003"	"2020-08-26-Control4003-c3:TACGGTAGTATGGTTC"	-5.57667146149333	3.62033484065858	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGGTAGTATGGTTC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2943.9091008658	33.6539007875528	0.0114317051357514	2955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2929.24140816472	2929.24140816472
"healthy-4003"	"2020-08-26-Control4003-c3:TACGGTATCCGTCAAA"	10.5379349189693	6.34662292087404	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACGGTATCCGTCAAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1693.34023383251	39.4840236210449	0.0233172417640377	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1691.35758195682	1691.35758195682
"healthy-4003"	"2020-08-26-Control4003-c3:TACTGCCTCCCTTTGG"	-2.33550248566325	9.86901185596315	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTGCCTCCCTTTGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1908.58557209855	37.3161691364321	0.0195517401378036	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1904.70067644252	1904.70067644252
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTACCAGTAACGG"	5.47617878493611	-10.1784219971863	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTACCAGTAACGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2228.5015199827	0	0	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2227.16727109653	2227.16727109653
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTACTCCATCTAT"	4.40148319777791	-7.17112209713133	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTACTCCATCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2789.96667877446	32.7490017832008	0.0117381336602867	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2778.1704961147	2778.1704961147
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTACTCGCTGTTC"	5.55792011794393	-9.65066149151	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTACTCGCTGTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2605.87227871383	41.624186515378	0.0159732258773336	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2597.99419150469	2597.99419150469
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTCAAGGAACGCT"	-0.337012867361861	8.10682485187379	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTCAAGGAACGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1455.71455763117	6.76039002383918	0.00464403545901203	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1455.71455763117	1455.71455763117
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTCACACCGAATT"	10.1392446952755	7.58183381641237	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTCACACCGAATT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2119.85798481378	30.4550583176559	0.0143665559371569	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2110.30264218524	2110.30264218524
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTCAGTTCAAAGA"	-4.04780803147014	12.4063691862854	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTCAGTTCAAAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1816.3696824247	35.5131394531987	0.0195517133966868	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1810.41617960709	1810.41617960709
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTGTAGCGCGTTC"	-0.681797246367294	8.33461473071901	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTGTAGCGCGTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1615.87548243576	15.6664652960791	0.00969534191611325	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1610.12840675385	1610.12840675385
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTGTAGGCACCAA"	2.80117072638814	-4.17685797130736	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTGTAGGCACCAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2554.38559428744	23.0210562266213	0.00901236535239825	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2547.88473069449	2547.88473069449
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTGTGTATGCTAC"	-3.66594038429912	12.8829068907532	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTGTGTATGCTAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1876.67133117345	31.3350903103502	0.0166971647031859	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1858.7000249195	1858.7000249195
"healthy-4003"	"2020-08-26-Control4003-c3:TACTTGTGTTGTTGCA"	4.32188477095906	-6.98614361202391	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACTTGTGTTGTTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2335.81449129676	6.86796179269967	0.00294028563410736	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.00759766042	2332.00759766042
"healthy-4003"	"2020-08-26-Control4003-c3:TAGACCAAGTGCTAGG"	4.06466641005818	-7.52919866954955	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGACCAAGTGCTAGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.5605686493	36.4394623043562	0.0172082266943606	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.28323969707	2114.28323969707
"healthy-4003"	"2020-08-26-Control4003-c3:TAGACCAGTCCGAAGA"	-0.122013936669189	8.50447652423707	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGACCAGTCCGAAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1743.56881893739	26.0212730841712	0.0149241445485529	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1734.73208696704	1734.73208696704
"healthy-4003"	"2020-08-26-Control4003-c3:TAGACTGAGGACAAGA"	5.38013138350789	-10.2718916169372	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGACTGAGGACAAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2134.60327477623	43.4114619647887	0.0203370164740985	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2125.74952774019	2125.74952774019
"healthy-4003"	"2020-08-26-Control4003-c3:TAGACTGCAAGTCCCG"	-5.96952615204509	-4.35985758220824	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGACTGCAAGTCCCG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3549.38305558534	32.9798096527991	0.0092917020046348	5496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3541.90483204159	3541.90483204159
"healthy-4003"	"2020-08-26-Control4003-c3:TAGAGTCAGAGCAACC"	-1.14918718758281	9.0594386824402	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGAGTCAGAGCAACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1840.53913623315	32.5567316157816	0.0176886929350561	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1828.92998474101	1828.92998474101
"healthy-4003"	"2020-08-26-Control4003-c3:TAGAGTCCAGTTGTCA"	4.03704442557637	-7.55750944530638	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGAGTCCAGTTGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1790.96430043772	42.1204466484937	0.0235183061092839	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1787.04249936314	1787.04249936314
"healthy-4003"	"2020-08-26-Control4003-c3:TAGAGTCGTACAGAGC"	2.53919782218282	-3.96679594432982	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGAGTCGTACAGAGC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2642.97664992694	32.4848419126181	0.0122910060191096	2232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2633.83738050676	2633.83738050676
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTGATTCCAGCACG"	3.3523608642513	-6.65380813991698	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTGATTCCAGCACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.34561493108	34.3003072168272	0.0160031620555653	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2141.72078305443	2141.72078305443
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTGATTCCTATGGA"	5.50950493392293	-9.8482876054016	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTGATTCCTATGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2743.29465727474	17.7544021053531	0.00647192676086454	1840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2731.27803252706	2731.27803252706
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTTAGAGTTAGTAG"	-2.10283980789836	3.8954868086609	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTTAGAGTTAGTAG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2911.46523824421	32.1423822519211	0.0110399333743393	3807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2906.31907204165	2906.31907204165
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTTAGTCATCACAG"	5.6030990081722	-9.88776590740355	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTTAGTCATCACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.41020051502	28.8975367322251	0.0115340540747718	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.26758406991	2501.26758406991
"healthy-4003"	"2020-08-26-Control4003-c3:CCCTTAGTCCAAATGC"	-7.49317965927775	0.159114814642347	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCCTTAGTCCAAATGC"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3078.40492498833	33.4980912717865	0.0108816390592	3602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3066.32382087478	3066.32382087478
"healthy-4003"	"2020-08-26-Control4003-c3:CCGATCTAGCAGGCAT"	5.56595530089681	-10.038995765802	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGATCTAGCAGGCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.08622152164	21.8206997107619	0.00895727725808166	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2436.08622152164	2436.08622152164
"healthy-4003"	"2020-08-26-Control4003-c3:CCGATCTAGGAGCAAA"	11.2935720878536	5.50839994037477	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGATCTAGGAGCAAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1946.60480323159	34.9428293070704	0.0179506540048916	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1939.79399859031	1939.79399859031
"healthy-4003"	"2020-08-26-Control4003-c3:CCGATGGAGCACCAGA"	3.48967780646626	-7.73623707210692	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGATGGAGCACCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.6443734258	23.7695199825606	0.0125854927041904	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1888.6443734258	1888.6443734258
"healthy-4003"	"2020-08-26-Control4003-c3:CCGATGGCAGGCCTGT"	4.45589651641194	-8.36559965526732	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGATGGCAGGCCTGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.98904203468	28.8716498323229	0.0164511852443535	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1754.98904203468	1754.98904203468
"healthy-4003"	"2020-08-26-Control4003-c3:CCGATGGGTCAATCTG"	4.80076374587361	-7.41641046917113	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGATGGGTCAATCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.32865313835	40.6943764452862	0.0155124964600232	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2618.7217824503	2618.7217824503
"healthy-4003"	"2020-08-26-Control4003-c3:CCGCAAGTCGAGTACT"	-3.49491939964946	10.5367069014343	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGCAAGTCGAGTACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1560.80072408594	28.4738537396546	0.0182431064390555	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1554.12807269502	1554.12807269502
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGACAAGTCGTTAC"	-2.86106882515605	10.9577922591004	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGACAAGTCGTTAC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1574.55868939167	27.6405109067322	0.0175544494422187	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1572.36489436945	1572.36489436945
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGACACACGTCGTG"	3.78141727027242	-7.80997946178588	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGACACACGTCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.97163219213	40.0560929431576	0.0222537356849199	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1793.85822726511	1793.85822726511
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGGTAAGATGTAGT"	-1.27875838699992	9.69758699024049	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGGTAAGATGTAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1742.28989279785	38.2021711726744	0.0219264149614779	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1732.66422098921	1732.66422098921
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGGTAAGCTGACTT"	3.55515803870503	-6.51743080532225	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGGTAAGCTGACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2257.65429483685	2.11335015817589	0.000936082270438404	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2255.00952012315	2255.00952012315
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGGTATCAAACGAA"	-0.927582303912002	8.90291020953981	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGGTATCAAACGAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1700.60284933634	33.1281582853463	0.0194802439019049	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1688.73681464738	1688.73681464738
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGAGATCACTC"	3.55728568610494	-7.15656282817992	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGAGATCACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.69602589241	25.235878371437	0.0120879084207911	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2079.52853660964	2079.52853660964
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGCACGGCTAC"	-4.12447534027751	11.0540818938049	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGCACGGCTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.18576690675	34.0556414209513	0.0167170034143039	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2033.66017981105	2033.66017981105
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGGTTCGGCCA"	5.47925962981526	-10.1177511445251	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGGTTCGGCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.70183348186	35.8536314925632	0.016181613857412	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.68368178131	2207.68368178131
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGGTTGTGCCG"	4.79393496093099	-8.16635515606078	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGGTTGTGCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.03071628772	35.3518733596896	0.0164195861639372	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.313541112	2150.313541112
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGTCAACGTGT"	-0.0894354981487573	8.64341256702272	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGTCAACGTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1798.29427501852	25.7358588359725	0.0143112610619346	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.45844736631	1787.45844736631
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTAGTCGACACTA"	4.74360670623128	-7.57028582012328	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTAGTCGACACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2160.05661148005	36.6996995938734	0.016990156368507	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2158.50106287978	2158.50106287978
"healthy-4003"	"2020-08-26-Control4003-c3:CCGGTGACAACGAGGT"	4.69895662841145	-7.81329824840697	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGGTGACAACGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.11200527187	15.2971779975257	0.00642438405402903	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.67318642611	2375.67318642611
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTAGGAGACTGAGC"	3.53458823737447	-6.95907452022704	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTAGGAGACTGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.40948306852	31.9030849425276	0.0159562536902473	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1996.20114174432	1996.20114174432
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTAGGCAGTAGAAT"	2.68590297278706	-4.38538315212401	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTAGGCAGTAGAAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2379.75779422501	32.8180733791793	0.0137905098824844	1605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2375.24403487168	2375.24403487168
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTAGGGTTCCTAAG"	9.8301178413326	6.27249429309694	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTAGGGTTCCTAAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1600.7300210335	28.540947099641	0.0178299567851009	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1596.68341564159	1596.68341564159
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTGAGAGACGTCGA"	-0.261651257902938	8.35781762683717	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTGAGAGACGTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1772.60624993957	32.2070386161931	0.0181693134712185	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1765.20253363114	1765.20253363114
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTGAGGTTTCGCTC"	-0.0614662421053231	8.04747960651246	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTGAGGTTTCGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1592.88458362744	19.4517319882491	0.0122116393040556	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1591.10083472305	1591.10083472305
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTGAGTCTCAGGCG"	4.61724915084187	-7.34065439617308	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTGAGTCTCAGGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2480.75660356795	40.3475029787988	0.0162641925131909	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.08196408514	2471.08196408514
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTGAGTCTTGCGCT"	-1.74905012074168	8.63025949085084	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTGAGTCTTGCGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1458.29089082657	35.9874426217037	0.0246778217213615	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1455.91237595528	1455.91237595528
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTTCACACACCTTC"	4.64116587218587	-7.10841991817626	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTTCACACACCTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2798.29157145427	32.3860181360599	0.0115734966528985	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2796.05786143409	2796.05786143409
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTTCAGTACCGTGC"	-0.408265183598357	8.19123265827028	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTTCAGTACCGTGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1956.64407206165	25.4606506778761	0.0130124078474063	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.69358707001	1950.69358707001
"healthy-4003"	"2020-08-26-Control4003-c3:CCGTTCAGTCTAGATC"	-2.16543326798137	9.18809125507203	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCGTTCAGTCTAGATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1969.69692949143	24.8753133584052	0.0126290055012819	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1958.66860049218	1958.66860049218
"healthy-4003"	"2020-08-26-Control4003-c3:CCTAACCTCTTCCCAG"	5.59702839431111	-10.1646185151306	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTAACCTCTTCCCAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2487.28405044898	35.2173834857609	0.0141589713002034	1495	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2477.99880100901	2477.99880100901
"healthy-4003"	"2020-08-26-Control4003-c3:CCTAAGACAGATCACT"	5.57190432128255	-9.64647486126097	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTAAGACAGATCACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2962.76531482435	39.3856502190862	0.013293543711349	2301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2958.93155179022	2958.93155179022
"healthy-4003"	"2020-08-26-Control4003-c3:CCTAAGACATATAGCC"	4.83682169493977	-8.02780249035033	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTAAGACATATAGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.72342267135	9.76656373383559	0.00435672109907174	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2237.43780217288	2237.43780217288
"healthy-4003"	"2020-08-26-Control4003-c3:CCTAAGAGTGGCAGAT"	-6.69074998322185	3.41071102702943	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTAAGAGTGGCAGAT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2045.8825547034	7.54221585801774	0.00368653412713184	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2038.21895346217	2038.21895346217
"healthy-4003"	"2020-08-26-Control4003-c3:CCTACGTAGAGGGTGG"	-1.84808347645457	9.24278161609498	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTACGTAGAGGGTGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1499.57164761098	39.197771754636	0.026139312394365	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1497.43977759161	1497.43977759161
"healthy-4003"	"2020-08-26-Control4003-c3:CCTACGTCATACTGAC"	-4.10090718689616	13.1076946028504	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTACGTCATACTGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2105.5910819635	34.8646529732805	0.0165581310027057	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2099.87048256649	2099.87048256649
"healthy-4003"	"2020-08-26-Control4003-c3:CCTACGTGTGAACTAA"	-1.62671015682872	9.39871022785035	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTACGTGTGAACTAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1893.7614807467	32.8666246000683	0.0173552081052515	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1889.71163992837	1889.71163992837
"healthy-4003"	"2020-08-26-Control4003-c3:CCTACGTTCCATGCAA"	-2.31395016136821	8.97985074603883	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTACGTTCCATGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1986.32751617916	37.4393894892069	0.0188485479782429	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1982.87505482661	1982.87505482661
"healthy-4003"	"2020-08-26-Control4003-c3:CCTACGTTCTTAAGGC"	-3.22327003899272	10.0757083662781	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTACGTTCTTAAGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1957.15939983049	42.6852346665765	0.0218097895706775	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1951.63085915191	1951.63085915191
"healthy-4003"	"2020-08-26-Control4003-c3:CCTATCGAGATACCAA"	-3.05851016464885	10.569345451239	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTATCGAGATACCAA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2202.08583118317	27.8270443373709	0.0126366756205954	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2194.20425531705	2194.20425531705
"healthy-4003"	"2020-08-26-Control4003-c3:CCTATCGTCCCGTGTT"	-0.0884567004745782	8.42028520191041	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTATCGTCCCGTGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1352.32150057644	37.7857059923396	0.0279413630384736	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1341.79059239307	1341.79059239307
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCAACAGGTTAAAC"	-2.74266419830974	10.4309434660706	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCAACAGGTTAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.52263960843	32.0240850979303	0.0159599919112698	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1998.84885835077	1998.84885835077
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCAACCATCGGATT"	5.28165497359578	-8.96855738079222	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCAACCATCGGATT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.70268800579	29.2990035183133	0.0128860310861535	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.35690508201	2272.35690508201
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCACATCGAGTGGA"	5.14804472503011	-10.0917387238708	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCACATCGAGTGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2058.53250299973	32.3929991475978	0.0157359668115	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2053.05023450187	2053.05023450187
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCACATCTACGGGC"	-0.73409746113475	8.3140544661316	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCACATCTACGGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2080.77439399391	28.7732990112245	0.0138281685387314	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2073.49816749708	2073.49816749708
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCAGTAGACGCTCC"	-4.21283469620402	13.0606078871521	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCAGTAGACGCTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2183.09223125456	27.8237586294888	0.0127451136654448	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2171.39039523108	2171.39039523108
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCAGTGTAGCGTCC"	-3.25906072083171	10.9508971937927	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCAGTGTAGCGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1779.08672715228	34.0659258283182	0.0191479849230545	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.04839314623	1775.04839314623
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCAGTGTCTGGTTA"	-0.139476711780387	8.24372479999391	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCAGTGTCTGGTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1468.44791405806	11.7322360454084	0.00798954864731043	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1468.44791405806	1468.44791405806
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCATGAGACTTGTC"	-3.86349521103557	13.1479129561218	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCATGAGACTTGTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1903.24755301219	36.9529541009975	0.0194157370871244	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1899.06559461271	1899.06559461271
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCATGAGCACTCGC"	-0.722109774977523	8.21076200092164	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCATGAGCACTCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1450.57315260345	34.8736306735628	0.0240412767952947	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1450.57315260345	1450.57315260345
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCCAAAGATTGAGT"	6.75459446486775	-1.6225726834503	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCCAAAGATTGAGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2886.26265025466	29.1606279466997	0.0101032482072021	1990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2873.72041903713	2873.72041903713
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCCAACAGAGGCTA"	3.43602170523946	-6.36008980190428	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCCAACAGAGGCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.10221257665	29.905381995754	0.0128509103872329	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.37997114765	2323.37997114765
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCCAATCGGCATAT"	2.44703592833821	-6.2727055779663	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCCAATCGGCATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1907.47064617797	37.9238733644297	0.0198817598794605	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1901.11037284773	1901.11037284773
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCCTCAGCTGAGCA"	-2.56428370896037	9.94629190051881	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCCTCAGCTGAGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1633.60104443977	19.0459219881721	0.0116588576219378	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1631.29014310975	1631.29014310975
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCCTCTCTTTGCTA"	4.28471817550008	-7.15509989177855	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCCTCTCTTTGCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.66462223125	27.411776568625	0.0122556490124476	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2234.99801719352	2234.99801719352
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCTAGTCGCAGATT"	4.18127598342244	-7.14285423671874	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCTAGTCGCAGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.46773563996	28.5599642450092	0.0129203262207945	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.21597600357	2207.21597600357
"healthy-4003"	"2020-08-26-Control4003-c3:CCTCTCCAGTGCTCAT"	-3.84870396080669	13.0807752379212	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTCTCCAGTGCTCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1589.39794061004	4.79220676262299	0.0030151081992617	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1584.43177356315	1584.43177356315
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGCATAGTGAGGCT"	-3.80732260170634	10.3019428023132	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGCATAGTGAGGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.22054518588	41.9819476279577	0.02195455316786	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1908.51238665772	1908.51238665772
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGCATCACTGTTCC"	3.52873792228047	-6.83024694835814	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGCATCACTGTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2587.46838532492	18.2292880479089	0.00704522155760362	1661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2585.07290233076	2585.07290233076
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGCATTCGCGCTGA"	0.101810612797183	8.28826139057008	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGCATTCGCGCTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1788.15507104011	28.7973703583361	0.0161045151087404	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1782.93599607454	1782.93599607454
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGTTGAGTTCGGTT"	-2.39864669266399	8.94137189472047	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGTTGAGTTCGGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2459.86112386745	31.8441375748977	0.0129455021935676	1638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2447.92378927	2447.92378927
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGTTGGTCTGTCCT"	5.03261770781819	-8.79605390941771	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGTTGGTCTGTCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2423.85926210354	18.9072327011367	0.00780046638711525	1392	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2415.33367542393	2415.33367542393
"healthy-4003"	"2020-08-26-Control4003-c3:CCTGTTGTCTGAGATC"	-0.977905969054061	8.61514661395875	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTGTTGTCTGAGATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1597.17689864371	43.3213876334505	0.0271237254121558	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1595.10901350875	1595.10901350875
"healthy-4003"	"2020-08-26-Control4003-c3:CCTTCAGCAGTGCCTG"	3.20201720771138	-6.26304581081542	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTTCAGCAGTGCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.42527936121	29.3757541306321	0.0128986686838181	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.10970778804	2272.10970778804
"healthy-4003"	"2020-08-26-Control4003-c3:CCTTGTGAGTCACGAG"	5.5096661048824	-10.0472374192444	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTTGTGAGTCACGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2223.93575178915	34.2822565876278	0.0154151290387088	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2222.58827260443	2222.58827260443
"healthy-4003"	"2020-08-26-Control4003-c3:CCTTGTGGTAACACCT"	4.98077549514119	-8.00495150005492	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTTGTGGTAACACCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.99449886995	29.1523293735678	0.011247064523585	1727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2583.94502451142	2583.94502451142
"healthy-4003"	"2020-08-26-Control4003-c3:CCTTTGGAGGACTGGT"	4.22655024108235	-7.31978847896727	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CCTTTGGAGGACTGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.17019053221	29.3519151067602	0.0135251673969229	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2162.03950290948	2162.03950290948
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGGAAGAAGATCT"	3.87573256072347	-7.32056953823241	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGGAAGAAGATCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.31726414856	34.5220288126164	0.0153341465293975	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2248.37978554396	2248.37978554396
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGGACACAGTCCG"	4.20987095412557	-7.33661701595458	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGGACACAGTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1917.98708436908	13.1984470989309	0.00688140561867886	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1916.14181245793	1916.14181245793
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGGACATACTGTG"	-2.32106481018718	9.61238477313844	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGGACATACTGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1810.51485999905	37.6973635922166	0.0208213500066144	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1804.65450123702	1804.65450123702
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGGAGTTCGGTTA"	5.30775322493855	-9.42984106456908	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGGAGTTCGGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2474.52964870677	26.9067897354256	0.0108734966055014	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2467.70263303536	2467.70263303536
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGTTGTACATACC"	-4.23406825485881	13.0751819380554	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGTTGTACATACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2170.40404350358	33.6130370911355	0.015486995240239	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2162.73987612772	2162.73987612772
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGTTTCGGAGCAA"	-3.97788367691692	12.8588742979797	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGTTTCGGAGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1415.16046223661	36.2511961787334	0.0256163150017912	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1415.16046223661	1415.16046223661
"healthy-4003"	"2020-08-26-Control4003-c3:CGAAGTTTCTTCCCAG"	3.63950171050374	-6.77364542400511	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAAGTTTCTTCCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.68546628367	31.0018953254983	0.0124822147354618	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2478.98026719204	2478.98026719204
"healthy-4003"	"2020-08-26-Control4003-c3:CGAATTGCACTAGAGG"	3.30671777304952	-6.58441069042357	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAATTGCACTAGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.44713514488	32.4075629188693	0.0141366675034891	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2287.20399705283	2287.20399705283
"healthy-4003"	"2020-08-26-Control4003-c3:CGAATTGGTGTATCCA"	10.4368168312008	5.64878127658693	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAATTGGTGTATCCA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1596.65683093297	33.4907047965953	0.0209755184381265	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1588.13353588369	1588.13353588369
"healthy-4003"	"2020-08-26-Control4003-c3:CGAATTGTCATACAGC"	5.24950995024983	-10.0576544038025	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAATTGTCATACAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.38761953403	44.9845710819358	0.022499174568471	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1991.52118527607	1991.52118527607
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCCAACAGATA"	-5.84272513809856	-4.73402168666991	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCCAACAGATA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3465.17298039468	34.723087673709	0.0100205928737659	4325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3454.68548789524	3454.68548789524
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCCAAGTTTGC"	-1.8355749649113	9.26489160144655	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCCAAGTTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1939.34663219435	39.8248841500476	0.0205352068005431	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1935.66607322291	1935.66607322291
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCGTACGGCAA"	10.4210545020992	5.92435405338136	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCGTACGGCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1638.76238661475	13.8144733088189	0.00842982083409662	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1632.65916560873	1632.65916560873
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCGTGTTCAGT"	5.51502766188924	-10.0844660035339	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCGTGTTCAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.43288202372	44.7887142514842	0.0199465834004879	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2236.32478400922	2236.32478400922
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCGTTGTGGAG"	2.94703688201253	-7.22231438076171	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCGTTGTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.9708025608	9.85904472064441	0.00439945255394594	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.02797005434	2232.02797005434
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCGTTTATGCG"	5.18916048583333	-9.00742533123168	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCGTTTATGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.79485538625	24.6500202248454	0.0101952488524538	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2412.92962341546	2412.92962341546
"healthy-4003"	"2020-08-26-Control4003-c3:CGACAGCTCAGCCTTC"	-0.316789935261565	9.22984025562135	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGACAGCTCAGCCTTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2179.2915013791	32.3423011924735	0.0148407412097035	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2168.21462033027	2168.21462033027
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGAAGCACTGGACC"	5.46487249907796	-10.1188926926819	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGAAGCACTGGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.47159180117	33.6708476650367	0.016068386608904	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2089.81366636027	2089.81366636027
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGAAAGTAGGGTC"	-0.55974237147029	8.5499000319275	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGAAAGTAGGGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1722.88139582048	25.306242909403	0.0146883255984963	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1719.66336738012	1719.66336738012
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGAACATCATTTC"	4.21701540526692	-7.36873962795409	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGAACATCATTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.94191937598	23.1875243007681	0.0107402260767952	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2154.46906856943	2154.46906856943
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGAAGTAGAGGAA"	2.64249410209004	-4.33305313503417	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGAAGTAGAGGAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2153.94212464963	26.5110712925943	0.0123081632459863	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2150.38833675622	2150.38833675622
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGAATCTGGCCAG"	4.8379188972408	-8.16555216228636	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGAATCTGGCCAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2785.39374156333	33.3742508385885	0.0119818790214761	2047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2766.06248572539	2766.06248572539
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTAGGTGCTTT"	3.82354607161824	-6.56498911296996	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTAGGTGCTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2631.58467230793	32.9366559295698	0.0125159020251794	1869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2622.82678283459	2622.82678283459
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTCATGAGAAT"	5.21499218520467	-10.159019493219	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTCATGAGAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.44968292998	34.6377846494541	0.0169755642294085	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2034.07282762365	2034.07282762365
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTGTCCTACAA"	5.45028891143147	-10.2555074921814	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTGTCCTACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.65692987784	33.3384663247178	0.0143474132932655	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.35858960839	2318.35858960839
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTGTGGCCACT"	3.63826789435689	-7.31578590786131	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTGTGGCCACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.48787616103	37.3225964197372	0.0148371203747149	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2509.52170252802	2509.52170252802
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTGTTCTGAGT"	4.17468752440755	-7.09688856517943	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTGTTCTGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2288.06740452701	18.2401273974937	0.00797184880192124	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.27271269723	2285.27271269723
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGGCTTCGCATTGA"	4.3096887069637	-7.32869675075682	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGGCTTCGCATTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.39134911026	26.5583041598657	0.0119288570585218	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2220.18563547646	2220.18563547646
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCAGCAAGGAA"	5.44547571715657	-9.82924654400023	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCAGCAAGGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2596.02889456694	29.2918292167977	0.0112833217219195	1594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2588.22864378348	2588.22864378348
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCAGCGCCCAT"	-4.10592112961467	12.513792968634	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCAGCGCCCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.06298706278	33.3663907262003	0.0193870828534546	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1716.76048703814	1716.76048703814
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCCACCTCTAC"	-1.61773715439494	8.81816670978395	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCCACCTCTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2035.46838243549	41.7468592794597	0.0205097065813955	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2026.85062033549	2026.85062033549
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCCACGACGAA"	4.12627090987508	-7.70313551342162	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCCACGACGAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.0878954188	38.4935373573	0.0176649769099387	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2177.92070520865	2177.92070520865
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCCAGCAGTTT"	-7.1705997985905	4.08409640872804	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCCAGCAGTTT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1825.95970526325	12.9248238155266	0.00707837296643036	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1818.90393378702	1818.90393378702
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTGCTCATTGGTG"	-0.122833724052268	8.17729852283327	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTGCTCATTGGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.64599885572	4.16498347407273	0.0022751441167086	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.8917912986	1825.8917912986
"healthy-4003"	"2020-08-26-Control4003-c3:CGAGTTAAGTGGTTCT"	5.09812368926351	-7.83231642162474	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGAGTTAAGTGGTTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.84903001315	34.0172461160813	0.0132473699654793	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2563.75060557691	2563.75060557691
"healthy-4003"	"2020-08-26-Control4003-c3:CGATCGGAGTCATCGT"	5.38552774962727	-10.0557184449402	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATCGGAGTCATCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.327419017	2.51879235487834	0.001196958387804	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2101.11379308522	2101.11379308522
"healthy-4003"	"2020-08-26-Control4003-c3:CGATCGGTCCGATAAC"	-1.96786985817607	4.14498517597047	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATCGGTCCGATAAC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2880.08111324899	36.7260203290381	0.0127517312481549	3512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2874.5193560919	2874.5193560919
"healthy-4003"	"2020-08-26-Control4003-c3:CGATGCGCATCGATCA"	4.93874516066853	-7.59818746959838	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATGCGCATCGATCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.29571518241	0	0	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2315.0384674668	2315.0384674668
"healthy-4003"	"2020-08-26-Control4003-c3:CGATGCGGTGCAAGAC"	0.120573175221127	8.15551850879518	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATGCGGTGCAAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1995.81333575062	35.9365589419851	0.0180059719505128	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1986.35964439176	1986.35964439176
"healthy-4003"	"2020-08-26-Control4003-c3:CGATGCGGTTTCACTT"	10.9134270149166	6.36243484104005	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATGCGGTTTCACTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1548.72798585329	5.9320944753262	0.00383030107902249	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1546.6010924886	1546.6010924886
"healthy-4003"	"2020-08-26-Control4003-c3:CGATGGCCATATCGGT"	-4.06364856186565	12.6609124907288	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATGGCCATATCGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1833.03810247925	24.0628468232567	0.0131273031317303	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1822.69100737614	1822.69100737614
"healthy-4003"	"2020-08-26-Control4003-c3:CGATGGCGTGGATTTC"	1.84088840064351	-6.68241932308348	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGATGGCGTGGATTTC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2086.66535126623	34.3788189669915	0.0164754827342725	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2083.54836187313	2083.54836187313
"healthy-4003"	"2020-08-26-Control4003-c3:CGCAGGTCAAATGCTC"	10.9239555793697	6.26091764057008	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCAGGTCAAATGCTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.82188754683	33.5391417714067	0.0176445473356222	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1892.36383497243	1892.36383497243
"healthy-4003"	"2020-08-26-Control4003-c3:CGCATAAAGCCAGTAG"	5.48266186293904	-10.0978737107483	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCATAAAGCCAGTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.60854963942	37.7548402693057	0.0155266933384094	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.94731489437	2425.94731489437
"healthy-4003"	"2020-08-26-Control4003-c3:CGCATAAGTTGATGTC"	-0.346192191273528	8.59626290881959	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCATAAGTTGATGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1716.25326810623	16.8858449326091	0.00983878384758533	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1710.33915254012	1710.33915254012
"healthy-4003"	"2020-08-26-Control4003-c3:CGCATGGAGGACTTCT"	-3.18931827965434	9.93762776935426	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCATGGAGGACTTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2195.46241660091	37.325516688877	0.0170012095887597	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2188.85633369256	2188.85633369256
"healthy-4003"	"2020-08-26-Control4003-c3:CGCATGGTCCGAGATT"	4.44967093047444	-7.53837921535643	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCATGGTCCGAGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2230.06519540201	32.1671422198336	0.0144243057495164	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.31760631558	2224.31760631558
"healthy-4003"	"2020-08-26-Control4003-c3:CGCCAGAGTAGTCTGT"	3.87067308005635	-7.4925198785034	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCCAGAGTAGTCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1952.269005773	6.24590362515812	0.00319930481234324	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1950.64670900509	1950.64670900509
"healthy-4003"	"2020-08-26-Control4003-c3:CGCGTGAAGTGTACAA"	-2.40119562569316	10.0747184523377	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCGTGAAGTGTACAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1858.98279267222	36.6991232974821	0.0197415077977824	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1841.19061824219	1841.19061824219
"healthy-4003"	"2020-08-26-Control4003-c3:CGCGTGACATCTCAAG"	-0.0199629468029321	8.77833173358766	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCGTGACATCTCAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2128.72364980964	34.5777750499565	0.0162434306834749	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2114.01701469439	2114.01701469439
"healthy-4003"	"2020-08-26-Control4003-c3:CGCGTGAGTCATCGCG"	-3.96771989288982	12.6921386488709	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCGTGAGTCATCGCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2077.54489014255	40.473203249448	0.0194812653346185	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2071.52494847131	2071.52494847131
"healthy-4003"	"2020-08-26-Control4003-c3:CGCGTGAGTTCGGCCA"	-8.6554368537968	0.789091862085737	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCGTGAGTTCGGCCA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2727.30729830543	22.8081063536587	0.00836286632160235	2422	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2711.95138845579	2711.95138845579
"healthy-4003"	"2020-08-26-Control4003-c3:CGCGTGATCCCATGGG"	4.8423887687618	-7.36162187969359	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGCGTGATCCCATGGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.56737635957	38.2344935773138	0.0155895792897916	1525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2448.86003419034	2448.86003419034
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAACCCACAGCGCT"	-0.91046772423442	8.33956906879274	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAACCCACAGCGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1874.62650782661	30.8327470374189	0.0164474080083107	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1862.31626584169	1862.31626584169
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAACCGTCCTACAA"	4.43773188170735	-7.07193376934203	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAACCGTCCTACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.61907232238	11.7786189243322	0.00529943212987231	1151	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2219.43049618716	2219.43049618716
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAACCTCTGGACCG"	5.21027578887288	-10.0406065217224	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAACCTCTGGACCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.24397651302	37.5735961978057	0.0170537609989393	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.38942099346	2200.38942099346
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAATTAGATTGCGG"	-2.04166303101237	10.0225267180237	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAATTAGATTGCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.26030496328	21.6870159894485	0.0137498014254237	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1568.66707738157	1568.66707738157
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAATTCATAGGTAA"	4.22017683562581	-7.11079075252684	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAATTCATAGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2160.79141937483	35.7544151295545	0.016546907216014	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2159.2160629454	2159.2160629454
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAATTCATTCGGGC"	2.6286002593929	-4.39829828655394	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAATTCATTCGGGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2381.07154485702	33.6105048968304	0.0141157055819794	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2375.51388874842	2375.51388874842
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAATTTCTGCTCTG"	5.03304447707478	-7.5938406220642	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAATTTCTGCTCTG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2400.78408953976	30.5453476384731	0.0127230715046636	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.77517563848	2396.77517563848
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAATTTCTGGGCAC"	4.52087893065755	-7.44793894207152	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAATTTCTGGGCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.18661940895	33.2766261376175	0.0135757211932078	1587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2447.65172214525	2447.65172214525
"healthy-4003"	"2020-08-26-Control4003-c3:CGGACACCAAGGTTGG"	10.0485788780147	7.16743562305299	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGACACCAAGGTTGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.08624669578	22.6591441564469	0.0119253240192917	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1888.96061644613	1888.96061644613
"healthy-4003"	"2020-08-26-Control4003-c3:CGGACACCATTACTCT"	5.34799780425374	-10.0913143388	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGACACCATTACTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.45689584349	39.4991132771393	0.0167195064369784	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.13469026152	2361.13469026152
"healthy-4003"	"2020-08-26-Control4003-c3:CGGACACGTGGACCAA"	5.53474106368367	-9.94743540203246	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGACACGTGGACCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2321.96034281598	42.1372308565942	0.0181472655150914	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2319.07456109079	2319.07456109079
"healthy-4003"	"2020-08-26-Control4003-c3:CGGACACTCAGCTTCC"	4.8021351295406	-8.09697344219359	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGACACTCAGCTTCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.59025967744	1.42804968884465	0.000636502000614837	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2240.4368597627	2240.4368597627
"healthy-4003"	"2020-08-26-Control4003-c3:CGGAGAATCGAATGCT"	4.78010286864583	-7.32269575512084	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGAGAATCGAATGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.59750381652	28.9147251052777	0.0123641306629678	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2332.627309504	2332.627309504
"healthy-4003"	"2020-08-26-Control4003-c3:CGGCAGTAGCCATTGT"	3.3420635658199	-6.9264765015808	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGCAGTAGCCATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.72373428572	33.0676797544029	0.0147116299258686	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.3065689477	2242.3065689477
"healthy-4003"	"2020-08-26-Control4003-c3:CGGCAGTAGCCTGACC"	-3.96597514572795	11.4589624174866	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGCAGTAGCCTGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.87682596235	29.17140165077	0.0155425232211563	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1871.16252279522	1871.16252279522
"healthy-4003"	"2020-08-26-Control4003-c3:CGGCAGTTCTGGGTCG"	4.52431501921956	-7.78025772487792	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGCAGTTCTGGGTCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2380.71415297463	7.91859095386642	0.00332614100015845	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.67259024927	2375.67259024927
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTAGACTCATC"	5.5131856399471	-9.9585113755432	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTAGACTCATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2595.94991473078	36.6474563245997	0.014117166173601	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2593.48529773996	2593.48529773996
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTAGCAAGGAA"	-4.21480498734172	12.9575023421082	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTAGCAAGGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1794.13031744342	1.52492860035577	0.000849954200946086	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1789.7742858967	1789.7742858967
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTAGTCTGGAG"	4.04467691954915	-6.94197895443114	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTAGTCTGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2428.39450917314	28.0151320720303	0.0115364830410399	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.53420678742	2418.53420678742
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTCACCCTGTT"	4.55798639830892	-7.98237135326537	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTCACCCTGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2617.72216389443	5.40845258275178	0.00206609114494624	1595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2611.12632393628	2611.12632393628
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTGTCGCAGTC"	5.47957624968831	-10.0773449174133	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTGTCGCAGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2377.83341611392	30.122785360252	0.0126681647066267	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2372.47662852108	2372.47662852108
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGACTTCCGAGCTG"	-4.10615334931071	13.1940402754578	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGACTTCCGAGCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1821.35274573761	31.6855367067991	0.017396705158268	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1810.91383262217	1810.91383262217
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGCATAGCTGTACT"	4.82591118392293	-8.29573728954466	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGCATAGCTGTACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2811.7914195643	33.6268322778853	0.0119592200345699	2270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2802.91565574367	2802.91565574367
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGCATGTTTACACG"	3.84170236167256	-7.01322367107543	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGCATGTTTACACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.39389073863	19.9874768005361	0.00862870381434249	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2310.7681666305	2310.7681666305
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGTCAAGCCTCTGG"	5.27411093291585	-9.85294058239134	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGTCAAGCCTCTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.73063274221	32.0578220745203	0.0147614172730259	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.0873364871	2167.0873364871
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGTCACATCTAGAC"	4.7882248359615	-7.14671566402587	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGTCACATCTAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2186.39456365874	29.1748765233128	0.0133438296125705	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2185.46684371551	2185.46684371551
"healthy-4003"	"2020-08-26-Control4003-c3:CGGGTCAGTGGTCAAG"	2.58714332160298	-7.06318285381468	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGGTCAGTGGTCAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.31427535197	2.18856929067217	0.00113850753684459	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1919.14910149058	1919.14910149058
"healthy-4003"	"2020-08-26-Control4003-c3:CGGTCAGCAAAGGTTA"	-4.12944779816325	11.1609067686829	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGTCAGCAAAGGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.66889100055	37.2274063653973	0.0235964634770658	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1573.11240287907	1573.11240287907
"healthy-4003"	"2020-08-26-Control4003-c3:CGGTCAGCAAATACGA"	5.31186117705647	-9.34284212505492	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGTCAGCAAATACGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.63201372466	22.7627166604911	0.00837285684328607	1699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2716.06346795499	2716.06346795499
"healthy-4003"	"2020-08-26-Control4003-c3:CGGTCAGGTGGGAGAG"	0.0554341202018827	8.02704284274904	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGTCAGGTGGGAGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1895.5410915361	32.8917965100528	0.0173521938706156	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1887.89988447887	1887.89988447887
"healthy-4003"	"2020-08-26-Control4003-c3:CGGTCAGTCATCGCCT"	3.78667726096455	-6.54488565838011	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGTCAGTCATCGCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.13555373038	28.7732563005618	0.0118353154995457	1591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2425.21559002963	2425.21559002963
"healthy-4003"	"2020-08-26-Control4003-c3:CGGTCAGTCGCATAGT"	-1.21843383732494	9.51393125140993	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGGTCAGTCGCATAGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1886.19319057614	27.5218600062344	0.0145912201060528	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1878.35506310685	1878.35506310685
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAAGTAGCCATTGT"	4.08181395110433	-7.82057955181273	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAAGTAGCCATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.56658762152	48.3297018550427	0.0228556065048793	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.56658762152	2114.56658762152
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAAGTCACTAAACC"	0.162457068532151	8.13511369312135	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAAGTCACTAAACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.65845235707	29.8011830810671	0.0160250840918099	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1856.36767223641	1856.36767223641
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAAGTTCCAAACCA"	4.98927893218343	-7.70636703884276	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAAGTTCCAAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1935.7385000052	33.4907011002476	0.0173012527777681	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1935.7385000052	1935.7385000052
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAATGAGTAGGATT"	5.50929941710774	-1.97077991878661	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAATGAGTAGGATT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2523.0823052168	32.0632908877959	0.0127079845241279	1593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2516.79300079531	2516.79300079531
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAATGCAAGGGCAT"	4.9338399368221	-8.57178022777709	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAATGCAAGGGCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.02811039605	35.5922216976372	0.0169807940652628	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2090.7213109186	2090.7213109186
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAATGCAGCTGTGC"	2.67943443831746	-4.92679216777953	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAATGCAGCTGTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.93840371338	0.79681187371293	0.000382542216463246	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.93840371338	2082.93840371338
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAATGCATAAGATG"	4.3457051711971	-7.58579637920531	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAATGCATAAGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.13823399612	30.2124346919377	0.0120122362594502	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2508.51648446409	2508.51648446409
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAATGGTGATATAG"	2.40540804442708	-6.08093597805174	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAATGGTGATATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.88439297071	31.7039893884063	0.014217772673932	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2224.99034465016	2224.99034465016
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAGTAAGCAATAGT"	2.965672870248	-4.88482715999755	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAGTAAGCAATAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2590.21090829478	24.018405082779	0.00927276037864853	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2584.96536150594	2584.96536150594
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAGTACACCCTTAC"	4.48213114318196	-7.25938560878905	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAGTACACCCTTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.04217049193	4.36269307492051	0.00184700050211716	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2362.04217049193	2362.04217049193
"healthy-4003"	"2020-08-26-Control4003-c3:CGTAGTACATACAGAA"	9.91846050795857	6.89475390994874	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTAGTACATACAGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1879.58620457237	40.7515328712555	0.0216811193719774	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1872.35660362987	1872.35660362987
"healthy-4003"	"2020-08-26-Control4003-c3:CGTCAAAAGAGGGTAA"	-3.52824268761333	10.7816467055115	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTCAAAAGAGGGTAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.33868330113	25.5129800219664	0.0142185977816791	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.64138733427	1787.64138733427
"healthy-4003"	"2020-08-26-Control4003-c3:CGTCAAAAGGTAGTCG"	0.630071004002732	9.40249536121217	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTCAAAAGGTAGTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1321.31671773855	31.5416366701007	0.0238713672858727	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1316.79350397751	1316.79350397751
"healthy-4003"	"2020-08-26-Control4003-c3:CGTCCATAGCTACAAA"	5.5866548019344	-9.80294420635375	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTCCATAGCTACAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.22835805176	12.3058160386302	0.00549065694016443	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2236.5528300186	2236.5528300186
"healthy-4003"	"2020-08-26-Control4003-c3:CGTCCATGTACCGCGT"	-3.987776140601	12.8426379927429	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTCCATGTACCGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2120.714012836	28.0240932920427	0.0132144613193584	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2119.06076762844	2119.06076762844
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGAATAGAGTGGCT"	4.01561917838399	-7.02861978923949	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGAATAGAGTGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.68420540757	32.0062310378795	0.0147176454210192	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2166.72970729208	2166.72970729208
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGAATTCCAACTGA"	5.36018433150594	-10.0501289597717	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGAATTCCAACTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.9919659416	30.1235525570589	0.0147592705212642	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2037.45778472834	2037.45778472834
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGATAAGGTCATAA"	5.23040499266927	-10.1065788499084	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGATAAGGTCATAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.21037037069	31.5721763804569	0.0158637382512364	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1980.43189213143	1980.43189213143
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGATACAAGGACAC"	-3.63059339943584	12.6404790648255	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGATACAAGGACAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1607.34750379292	37.4664483761326	0.0233094886374735	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1604.89161320412	1604.89161320412
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGATATCGAGTACT"	-1.55541596832927	9.21904752338258	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGATATCGAGTACT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1742.08542431872	11.0084260816798	0.00631910808046905	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1740.09593400434	1740.09593400434
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGCTTTCTCGAACA"	9.43368496474568	7.13564012134401	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGCTTTCTCGAACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1665.8025925764	38.3632089585888	0.0230298650809846	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1659.79014380615	1659.79014380615
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGTCTAGTAGTCAA"	4.20592989501302	-7.47546961223754	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGTCTAGTAGTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2036.78425402856	25.348343223886	0.0124452765057219	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2035.04696607273	2035.04696607273
"healthy-4003"	"2020-08-26-Control4003-c3:CGTGTCTGTAATTGGA"	3.96059789237325	-7.062131904718	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTGTCTGTAATTGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1848.94672428869	5.08516586756782	0.00275030416007477	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1847.20768360564	1847.20768360564
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTAGAGTCACATTG"	-2.45796857300456	9.01998422229616	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTAGAGTCACATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1808.9528448039	24.8889940191731	0.013758785415919	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1804.99672144058	1804.99672144058
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTAGAGTGTTGAGG"	-1.40092037144359	8.64925859058229	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTAGAGTGTTGAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1659.08730425613	8.95088417210141	0.00539506519586962	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1649.08264745091	1649.08264745091
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTAGAGTTCTTCAT"	-4.21803794327434	12.9411439665589	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTAGAGTTCTTCAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1709.88864818231	36.1145987087953	0.0211210237270052	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1705.44402090686	1705.44402090686
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTAGATCCAGTGCG"	2.72313584861104	-4.52059700405272	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTAGATCCAGTGCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2597.92360163691	29.9046609782809	0.0115109855268409	2071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2594.30078548484	2594.30078548484
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTCTGCACAGACGA"	5.41245903548543	-9.85947229778441	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTCTGCACAGACGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.89609744292	31.9275374885832	0.0142667648980953	1188	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2233.29344819913	2233.29344819913
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTCTGGTACCAGAG"	-1.94788918915446	9.09856793964235	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTCTGGTACCAGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1975.63819458148	32.8510405454376	0.0166280651161418	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1970.04170926012	1970.04170926012
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTCTGGTACTGCGC"	5.51839508590047	-9.78933050548705	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTCTGGTACTGCGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.76307270265	30.6003583105582	0.0142741325756583	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.21616337372	2142.21616337372
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTCTGGTAGCTCGC"	-0.580880085856277	9.70075032794801	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTCTGGTAGCTCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1471.42720972715	27.4387167147126	0.0186476888107844	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1471.42720972715	1471.42720972715
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTCTGTCCCGAACG"	0.220385988324326	8.05721089923707	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTCTGTCCCGAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1859.16776528545	30.2287157578671	0.0162592727360599	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1846.02556428423	1846.02556428423
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTGGGAGAACAAGG"	5.57690443572347	-10.0315160981384	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTGGGAGAACAAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.53814362885	36.5062124755134	0.0161851452517579	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2251.24830205232	2251.24830205232
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTGGGAGACATACA"	9.89579929885213	6.35639903629152	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTGGGAGACATACA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1585.43484152269	30.600333154695	0.0193009087180813	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1583.36087549267	1583.36087549267
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTGGGAGCCACCGT"	4.68396582183186	-7.60734894191893	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTGGGAGCCACCGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.38007821453	25.9032819743723	0.0110115207207642	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.85762417352	2349.85762417352
"healthy-4003"	"2020-08-26-Control4003-c3:CGTTGGGCACACTTAG"	4.85855211791341	-8.06312372600707	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CGTTGGGCACACTTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.96279163224	23.12324958766	0.0102136173231844	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2263.96279163224	2263.96279163224
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACCCAGATTAGAC"	-0.251905183226424	8.0563812025818	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACCCAGATTAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1531.44613079787	38.8285820050383	0.0253541938068751	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1527.52796851905	1527.52796851905
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACCCAGGCCTGAA"	4.65875210341756	-7.8756633034912	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACCCAGGCCTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.5017675732	34.7675075864348	0.0154487803952831	1276	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.95623243834	2242.95623243834
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACCCAGTTCCGGC"	-4.77913318100627	2.64690206134645	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACCCAGTTCCGGC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3117.30536804435	33.0309963114598	0.0105960091847473	3191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3101.11663242284	3101.11663242284
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACCCCAAGTGGTG"	-3.86678753319438	13.08588979328	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACCCCAAGTGGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2026.28147925474	37.8452181251004	0.0186771771407691	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2016.11163879744	2016.11163879744
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACTTAGCTACTGT"	-3.60981116715129	11.1423024901184	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACTTAGCTACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2015.06561055396	28.9277792664438	0.0143557505596512	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2007.6003419902	2007.6003419902
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACTTCAGAGGACT"	-0.203977147967178	8.63057420337526	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACTTCAGAGGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1740.52086177008	31.4084282940675	0.0180454190374516	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.50678982497	1730.50678982497
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACTTCATGTTCGA"	10.2192274528438	6.0554423102173	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACTTCATGTTCGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1737.32747440362	33.0900984939009	0.0190465522369407	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1721.23007835516	1721.23007835516
"healthy-4003"	"2020-08-26-Control4003-c3:CTAACTTGTGATGGCA"	5.22897829589192	-10.2563438645569	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAACTTGTGATGGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.63881537314	25.1054655181771	0.011668066842261	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.0380104441	2146.0380104441
"healthy-4003"	"2020-08-26-Control4003-c3:CTAAGTGAGAAATGGG"	9.63482727584187	6.1362299689087	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAAGTGAGAAATGGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1996.8379341489	22.553601741323	0.0112946580969956	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1986.69086148804	1986.69086148804
"healthy-4003"	"2020-08-26-Control4003-c3:CTACAGAGTCTCACAA"	5.49070086058919	-10.1052713624206	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACAGAGTCTCACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.42685163046	34.3773471811076	0.0155593959382446	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2206.46558790924	2206.46558790924
"healthy-4003"	"2020-08-26-Control4003-c3:CTACAGATCCCTTCCC"	-1.93399653855022	8.8606328734192	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACAGATCCCTTCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1845.49283184899	45.2483439447536	0.0245182983991433	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1834.71961066089	1834.71961066089
"healthy-4003"	"2020-08-26-Control4003-c3:CTACAGATCGAACCAT"	3.358894486993	-7.35943272030028	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACAGATCGAACCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.573997632	31.6881588002543	0.0140425968009501	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2255.03630203781	2255.03630203781
"healthy-4003"	"2020-08-26-Control4003-c3:CTACATTTCGATTCCC"	-0.772519688040572	8.85120675647584	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACATTTCGATTCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1771.37560481069	20.1927347791573	0.0113994653219329	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1766.00760007678	1766.00760007678
"healthy-4003"	"2020-08-26-Control4003-c3:CTACCTGCATTAAAGG"	-1.68306336823161	3.69719979846803	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACCTGCATTAAAGG"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2720.26007277435	38.9148259592224	0.0143055534831762	2833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2714.27769361845	2714.27769361845
"healthy-4003"	"2020-08-26-Control4003-c3:CTACCTGGTGGCAGAT"	-7.05314288559611	-2.16933967983397	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACCTGGTGGCAGAT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3338.13310335513	38.8113549618425	0.0116266648932703	3256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3322.4869050601	3322.4869050601
"healthy-4003"	"2020-08-26-Control4003-c3:CTACGGGTCTTCCAGC"	-4.14418206635173	13.1062783964905	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTACGGGTCTTCCAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1989.11450809023	38.5690043341978	0.0193900372137089	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1975.47345956173	1975.47345956173
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGACAAGTTCATCG"	5.38276304778401	-9.79044630443724	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGACAAGTTCATCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.59725091025	26.8361627826154	0.012256209570714	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.24838834888	2183.24838834888
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGACACAAATGGTA"	3.49301518973653	-7.53231289302977	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGACACAAATGGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1890.15519233009	30.6326561516222	0.01620642383013	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1890.15519233009	1890.15519233009
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGACACAGGCTACC"	5.39378323134725	-10.1586723557678	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGACACAGGCTACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2100.59285752274	38.541982712778	0.0183481451794667	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.59285752274	2100.59285752274
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGACATCAGTGTGT"	-3.21347890320476	10.0974178084168	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGACATCAGTGTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2009.0234307536	36.5292932307493	0.0181826118459191	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2005.37096780018	2005.37096780018
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGGTAAGACGGAAA"	4.9798604446346	-8.32170870220336	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGGTAAGACGGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2505.69020739756	37.6131681647512	0.0150111007552752	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2501.94146498212	2501.94146498212
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGGTAAGTCGCCAC"	4.88328899916951	-8.07642176067504	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGGTAAGTCGCCAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2695.29236802017	15.1758100436767	0.00563048752103436	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2692.88170284716	2692.88170284716
"healthy-4003"	"2020-08-26-Control4003-c3:CTAGGTAGTCGGTGAA"	-4.19733748856242	13.1719016798767	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTAGGTAGTCGGTGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1950.93583840916	40.5840467918894	0.0208023482848019	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1943.32369254343	1943.32369254343
"healthy-4003"	"2020-08-26-Control4003-c3:CTATAGGAGCGCTGAA"	5.17125000533406	-9.11498930370482	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATAGGAGCGCTGAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.86700798047	29.2332125532917	0.011845538053209	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2463.6601847442	2463.6601847442
"healthy-4003"	"2020-08-26-Control4003-c3:CTATAGGGTTACCTTT"	4.03790607032124	-7.58654310619506	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATAGGGTTACCTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2066.92166281635	41.8280330838272	0.0202368739155954	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2063.81817001547	2063.81817001547
"healthy-4003"	"2020-08-26-Control4003-c3:CTATAGGTCATAAGGA"	-3.29289589348491	10.2477149733338	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATAGGTCATAAGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.20188103438	19.0631804718844	0.00999012770155685	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1900.30893942505	1900.30893942505
"healthy-4003"	"2020-08-26-Control4003-c3:CTATCCGAGGAGTCTG"	-3.39863119545634	10.5857896574768	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATCCGAGGAGTCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1533.82219012042	37.6725166059978	0.0245612019754651	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1531.46936993236	1531.46936993236
"healthy-4003"	"2020-08-26-Control4003-c3:CTATCCGCATGTCAGT"	3.2040511566097	-6.15545608913573	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATCCGCATGTCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.95187426321	34.386157715177	0.0147773394437153	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.48950782331	2325.48950782331
"healthy-4003"	"2020-08-26-Control4003-c3:CTATCCGGTTTCTATC"	4.57823576506917	-7.6567011109558	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATCCGGTTTCTATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.90475885222	47.9695762949683	0.0242772715031231	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1968.25415899865	1968.25415899865
"healthy-4003"	"2020-08-26-Control4003-c3:CTATCCGTCGGTAACT"	-3.56791911545451	10.6602992781433	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATCCGTCGGTAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1817.59709783305	28.5747362221817	0.0157211607876403	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.36025986805	1813.36025986805
"healthy-4003"	"2020-08-26-Control4003-c3:CTATCTAGTTTCAGAC"	5.45508827742879	-9.76943495189818	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTATCTAGTTTCAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.14637732032	28.5772956311699	0.0116969232365496	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2435.98647862865	2435.98647862865
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAACCAGTGATCGG"	4.81947817382161	-7.9017601243225	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAACCAGTGATCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.14517501491	3.76277794155228	0.00183358272473337	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2048.76111245744	2048.76111245744
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAACCTCCTGCCAT"	4.17694677886311	-7.53294279491576	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAACCTCCTGCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.21559732575	28.0234290899972	0.0156711691430865	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1788.21559732575	1788.21559732575
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAACCTCGTTCTGC"	5.00505556639974	-8.25102236187132	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAACCTCGTTCTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2834.60475002504	0.170090627959542	6.00050599499063e-05	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2829.91753084215	2829.91753084215
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAAGAAGAAGCTGC"	3.9654504257137	-7.11148693477782	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAAGAAGAAGCTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2374.33447594251	37.15821780938	0.0156499508329086	1311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2366.93099870129	2366.93099870129
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAAGACAACTCATG"	5.3255053955013	-10.0667238465515	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAAGACAACTCATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.35638851928	40.9403475115001	0.0158846280219014	1581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2570.74344617346	2570.74344617346
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAAGAGTTCGGTTA"	-2.76926956597026	10.2886266478333	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAAGAGTTCGGTTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1632.49625127874	39.1336531637811	0.0239716649475474	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1625.88873952947	1625.88873952947
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAATTTCAACTGGT"	-0.255312214524108	8.6271991499695	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAATTTCAACTGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1682.77307470965	33.2483309828751	0.0197580597660869	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1682.77307470965	1682.77307470965
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAATTTCGAGAGCA"	3.82776131209676	-7.80600168621215	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAATTTCGAGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.60176190807	34.580778611658	0.0155377207205349	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2222.34368469897	2222.34368469897
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAATTTCTGATTCT"	5.32064594802205	-9.58688356792601	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAATTTCTGATTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2045.41187198056	7.78137852743954	0.00380430887002963	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2043.70097492284	2043.70097492284
"healthy-4003"	"2020-08-26-Control4003-c3:CTCACTGAGGTGCTGA"	4.56409277495686	-8.56334307109984	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCACTGAGGTGCTGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.42295129427	0	0	1483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2485.49384517936	2485.49384517936
"healthy-4003"	"2020-08-26-Control4003-c3:CTCACTGGTTGCATGT"	5.09691252288167	-9.0733213654724	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCACTGGTTGCATGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.69614542534	18.0557304318871	0.00764847710997295	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.15393382231	2359.15393382231
"healthy-4003"	"2020-08-26-Control4003-c3:CTCACTGTCACCCTGT"	-1.57012472572978	8.89963243091432	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCACTGTCACCCTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1677.18174668775	41.8043373630724	0.0249253472055914	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1673.73180856054	1673.73180856054
"healthy-4003"	"2020-08-26-Control4003-c3:CTCACTGTCGCCACTT"	-0.441643546253997	8.48303792560426	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCACTGTCGCCACTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2112.92638466936	33.7265250399732	0.0159619972019285	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2108.61653016421	2108.61653016421
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAAAGTTTCAGC"	3.38308801230733	-5.46118786251219	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAAAGTTTCAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2652.3442345166	38.6902739279473	0.0145871992875008	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2646.6586172616	2646.6586172616
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAACAGGCCCTA"	5.14237989959065	-9.09873201763304	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAACAGGCCCTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2572.66939515799	6.99805399991323	0.00272015285488459	1576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2566.96051907533	2566.96051907533
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAAGTAACATGA"	4.11218657073323	-7.43852760708006	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAAGTAACATGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.0773272111	32.6820131543721	0.0146092460715767	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2232.75591232361	2232.75591232361
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAAGTCGCATTA"	-0.187308917671996	8.53559873187868	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAAGTCGCATTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1522.99233087639	35.5429295843914	0.0233375630748834	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1517.56185890447	1517.56185890447
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAAGTGGGCTTC"	5.07342543181722	-9.89830496227416	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAAGTGGGCTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.12503524827	23.170184353131	0.0127020812199847	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1820.44337765096	1820.44337765096
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAATCACCGGGT"	0.279332150786561	8.65664479816285	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAATCACCGGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1651.44197759462	35.5443432204285	0.0215232164996799	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1642.04744468297	1642.04744468297
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAATCCATTTGT"	5.58039106902425	-10.115746521112	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAATCCATTTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2341.46530825719	33.8367872215849	0.0144511161887641	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2333.09866831841	2333.09866831841
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAATCGAACGCC"	3.99712123450581	-6.87475922023924	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAATCGAACGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.08105456114	23.4414061573619	0.0110568443158954	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2116.8230660125	2116.8230660125
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGAATCTCTGACC"	0.385455359786195	8.37687299335328	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGAATCTCTGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1616.62888335899	23.5718914906182	0.0145808922092503	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1616.62888335899	1616.62888335899
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGGGCAGACGGAT"	4.00781645354573	-8.21905519878539	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGGGCAGACGGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1615.41983187858	3.96102067608176	0.00245200696309112	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1615.41983187858	1615.41983187858
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGTCCAAGTATAG"	5.3284293609554	-10.0566206208435	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGTCCAAGTATAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.95433401731	22.8360643049635	0.0100868042971704	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2257.6194115866	2257.6194115866
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGTCGTAGAATAC"	4.67330946502034	-8.02976324474486	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGTCGTAGAATAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.67176242934	36.2318481551928	0.0155657033521678	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2320.56411813783	2320.56411813783
"healthy-4003"	"2020-08-26-Control4003-c3:CTCAGTCTCTGGCTGG"	5.24557747420613	-10.2406549683777	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCAGTCTCTGGCTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1956.70238715398	26.3361300855798	0.0134594459834465	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1956.70238715398	1956.70238715398
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATCGAGCGCTTCG"	-3.76422963562663	-5.46213104641112	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATCGAGCGCTTCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2252.17354720489	3.59311005501542	0.00159539661562704	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2250.54209353491	2250.54209353491
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATCGCATAAGATG"	-0.332789222628433	9.88748643482057	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATCGCATAAGATG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1912.96430708029	36.4368045573504	0.0190472997444281	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1892.82648369463	1892.82648369463
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATCGGTAGGAAAG"	-3.25509248200114	10.7628097304138	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATCGGTAGGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1546.19634801306	39.5627775941335	0.0255871627461633	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1541.86657925018	1541.86657925018
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATGCGTACAATAG"	3.10205688056294	-6.94244816219481	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATGCGTACAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.33302469594	22.0931996091611	0.0122785494991371	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1797.4307825922	1797.4307825922
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATGCTCACAGAGG"	2.22193946418111	-6.79408504879149	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATGCTCACAGAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2006.41074983178	29.5093369445573	0.0147075253394807	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2006.41074983178	2006.41074983178
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATGCTCGACATCA"	10.5258623557979	7.27712104404298	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATGCTCGACATCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2043.42423367116	28.7373997282804	0.014063354664563	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2040.10001414891	2040.10001414891
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATTACAGTGGTGA"	2.52966298636739	-4.36994745647582	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATTACAGTGGTGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2229.28679628684	10.1585472139615	0.00455685972342449	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2229.28679628684	2229.28679628684
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATTACAGTTGTCA"	3.65349926528279	-6.78122236644896	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATTACAGTTGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.21212315063	33.6337362341438	0.0156130103775263	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.02102832724	2150.02102832724
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATTACATGTCAGT"	2.7317542034084	-4.46763517772826	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATTACATGTCAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2582.40062223249	0	0	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2579.04548748614	2579.04548748614
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATTAGTACTTCCC"	4.85647120055501	-8.13672640239867	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATTAGTACTTCCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2736.54611243974	36.1564600184935	0.0132124431794276	1823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2730.74586305894	2730.74586305894
"healthy-4003"	"2020-08-26-Control4003-c3:CTCATTATCCCTGGTT"	3.79202713546101	-7.19449474727782	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCATTATCCCTGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2059.08585839278	38.4182252198592	0.0186579034882239	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2055.64488113329	2055.64488113329
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCAACCAGCTTTCC"	4.0483693080837	-7.45415689861449	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCAACCAGCTTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.61278777561	33.1173939836669	0.0146367925447044	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2257.44454546569	2257.44454546569
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCATGAGACAGCTG"	3.78643025931661	-7.21115829860839	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCATGAGACAGCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.14353881936	35.3537778262629	0.0164348762359515	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2147.80490256513	2147.80490256513
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCATGCAGGGAGAG"	-0.83397756043132	8.23659513080446	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCATGCAGGGAGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1861.32431758463	40.3792711979111	0.0216938396046476	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1853.55212346929	1853.55212346929
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCCAAGTGGTCCGT"	4.33145060118977	-8.0111351243225	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCCAAGTGGTCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.08157314992	46.4444132235505	0.0206964014941571	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2239.58061821292	2239.58061821292
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCCAATCCATAGGT"	4.15691341933553	-6.96042730724486	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCCAATCCATAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2994.73328502029	30.8872224890241	0.0103138475280996	2522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2989.5806928604	2989.5806928604
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCGATGTCCCTCAT"	-3.00360832634624	10.4919719466004	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCGATGTCCCTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.6351914017	40.0248138603125	0.021627608750916	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1843.47376369634	1843.47376369634
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCTTTCAAGTAGTA"	-3.12578449669536	10.1206416853699	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCTTTCAAGTAGTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1832.11294530511	32.2639942821809	0.0176102648937988	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1827.16858674926	1827.16858674926
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCTTTGTCTTACTT"	4.39041771468465	-7.30341722881468	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCTTTGTCTTACTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.55328414394	20.6951180605377	0.00879687537792297	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.53431141543	2349.53431141543
"healthy-4003"	"2020-08-26-Control4003-c3:CTCCTTTGTTATAGAG"	-1.98220215264018	9.35350225055543	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCCTTTGTTATAGAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2182.26034866079	34.2052250305424	0.0156742182716803	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2168.43878495076	2168.43878495076
"healthy-4003"	"2020-08-26-Control4003-c3:CTCGAGGGTTGCATCA"	-1.92602990093883	9.03925798023073	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCGAGGGTTGCATCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.08263946293	29.4130792888375	0.0150907297070494	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1945.82901046854	1945.82901046854
"healthy-4003"	"2020-08-26-Control4003-c3:CTCGAGGTCCGCTTAC"	4.51888956603352	-7.88034536754759	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCGAGGTCCGCTTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.30663623384	30.8568835271059	0.0146358613101114	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2105.06884134328	2105.06884134328
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCAGAGTCGTTAC"	-1.00704715672191	8.65301988208619	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCAGAGTCGTTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1641.21831087061	35.4159848664985	0.0215790822171071	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.10467165134	1639.10467165134
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCAGCAGCACAGA"	4.75324310836141	-7.5731616250244	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCAGCAGCACAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.82208315544	29.3578306671069	0.0107781748480051	1736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2715.09299692092	2715.09299692092
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCGAAGCAGCACA"	-2.1693483394688	9.09627626026002	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCGAAGCAGCACA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1917.18152511631	37.2240344673221	0.0194160198080689	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1907.97631118823	1907.97631118823
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCGAAGCTCGACC"	4.95510592040364	-7.9050331345764	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCGAAGCTCGACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1996.27713814552	2.9070729282731	0.00145624716765212	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1994.55011117825	1994.55011117825
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCGACATCGATGT"	-0.187230120331603	8.41296289050905	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCGACATCGATGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2053.15721243543	21.3498054893046	0.0103985244578421	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2050.16965295632	2050.16965295632
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCGAGTCGACGCT"	-0.872686128050643	9.27187821948854	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCGAGTCGACGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1580.29791013968	27.075184200067	0.0171329620993258	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1567.50726644779	1567.50726644779
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTCGATCAGAGTGG"	6.78850903090779	-1.66637172615203	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTCGATCAGAGTGG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2272.20417332434	11.2800217651087	0.00496435219050123	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2257.80903103603	2257.80903103603
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTGGTAGACGATAT"	-2.89988933029826	9.91945741260377	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTGGTAGACGATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.05429994498	32.0250366906488	0.0160200934469515	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1990.52227759739	1990.52227759739
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTGGTAGTAGAATC"	4.74057831343953	-7.75636579906615	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTGGTAGTAGAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.37272256346	31.2973524784896	0.01500803771904	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.31626858005	2080.31626858005
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTGGTTCCGAAGGA"	4.79176582869832	-8.07787134563597	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTGGTTCCGAAGGA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.05357416428	23.967030338422	0.00960196951960318	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.59562976592	2489.59562976592
"healthy-4003"	"2020-08-26-Control4003-c3:CTCTGGTTCGCCGAAC"	-3.73111424866374	10.7895507582459	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTCTGGTTCGCCGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1999.78986808951	28.7429673482336	0.0143729937864387	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1985.894945456	1985.894945456
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAATGAGTTTCGGT"	0.520084192126435	8.89763448322145	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAATGAGTTTCGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1831.32114449146	31.2659818121872	0.0170729103992677	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1820.88284994366	1820.88284994366
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAATGCAGAGCCCT"	10.3482128578121	5.60472915256349	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAATGCAGAGCCCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1712.40642279397	34.1742569885221	0.0199568610194554	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1707.17317043785	1707.17317043785
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAATGGTGTTACTG"	0.0964929546112239	8.62244031513063	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAATGGTGTTACTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1974.23696322386	27.663569915021	0.0140122844574074	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1956.80359294776	1956.80359294776
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAGCGAGGTCATTC"	4.57946886596028	-7.9251165620056	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAGCGAGGTCATTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2043.20420543043	32.4928212536164	0.0159028750857388	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2043.20420543043	2043.20420543043
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAGCGGTCTTAGTG"	3.9204658466274	-8.08702757274779	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAGCGGTCTTAGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1570.62387086612	45.6101251000758	0.0290394956718212	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1568.3194379892	1568.3194379892
"healthy-4003"	"2020-08-26-Control4003-c3:CTGAGGCCAAATACAG"	-3.47492657128032	12.3042526015076	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGAGGCCAAATACAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2033.4613231179	39.0381216399382	0.0191978677912994	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2029.87787790931	2029.87787790931
"healthy-4003"	"2020-08-26-Control4003-c3:CTGATCCGTCCACACG"	5.64539017257039	-9.75998690044554	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGATCCGTCCACACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2774.63018158208	21.909264408948	0.00789628273864429	1943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2770.37178860853	2770.37178860853
"healthy-4003"	"2020-08-26-Control4003-c3:CTGATCCGTGCAAGAC"	3.1644672351772	-6.41463949596556	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGATCCGTGCAAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.36415623571	1.39393352423976	0.000597904673326729	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2329.96513810037	2329.96513810037
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCAGGGTTCCGCAG"	-2.46595559540446	9.19870469653932	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCAGGGTTCCGCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.18432739536	39.1101024245007	0.0208789395963412	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1869.39391043418	1869.39391043418
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCATCCACAACATC"	-2.75300345841106	9.32401464069215	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCATCCACAACATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1631.01618460814	33.3658672763533	0.0204571037315424	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1624.52634923545	1624.52634923545
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCATCTCCATACAG"	-2.19689450684245	9.30719850147096	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCATCTCCATACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1948.65062877347	37.5286956357637	0.0192588117549759	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1936.98752231074	1936.98752231074
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCATCTCGACCTAA"	5.19438328322713	-8.60479929363402	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCATCTCGACCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2532.87429636871	13.3173832666273	0.00525781452546616	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.98349229092	2529.98349229092
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCCATAGCGAGTCA"	4.66849865493123	-7.3922968140808	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCCATAGCGAGTCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2671.83775224785	12.7633118419142	0.0047769786287271	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2668.19761107757	2668.19761107757
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCCATAGTCATGAA"	9.77713074263875	5.66392324054567	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCCATAGTCATGAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1664.778044027	37.3007904826443	0.0224058640228194	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1649.00091475146	1649.00091475146
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCCTACATTAAAGG"	4.51505531844441	-7.15772821819457	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCCTACATTAAAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.4472121037	39.6675643645982	0.0169270142547776	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.4472121037	2343.4472121037
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCGAGCACTTGGCG"	-4.07157121124919	-5.02921583568724	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCGAGCACTTGGCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2749.10467987201	0.361527991241065	0.000131507539122845	2453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2745.20020027626	2745.20020027626
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCGAGGTAACGATA"	-0.152164976031143	8.28865239703981	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCGAGGTAACGATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1757.05637086926	33.2170577741605	0.0189049471177337	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1742.35197970953	1742.35197970953
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCGAGGTCGTTTCC"	4.90815748748128	-7.64018204128417	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCGAGGTCGTTTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.64957942084	31.1381753872545	0.0127843412493921	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.87057279681	2432.87057279681
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCGAGTCACCTGGG"	-2.31631360474284	9.48241136157838	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCGAGTCACCTGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1760.05644598496	36.9627456138941	0.0210008864762341	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1757.94001348281	1757.94001348281
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCAAGACAAGCC"	-1.75487313690837	9.19816682422487	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCAAGACAAGCC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2071.60529366813	43.208035140272	0.0208572720258717	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2065.46408936411	2065.46408936411
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCACACTAGAGG"	-4.06364760819133	12.3957910307678	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCACACTAGAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2200.90453249958	32.6246964900445	0.0148233128735449	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2199.30160093684	2199.30160093684
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCAGTGCCGAAA"	4.32745804366414	-7.29073192989501	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCAGTGCCGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.92008837027	18.70423016603	0.00911103665066603	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2046.18213112443	2046.18213112443
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCAGTTGCATGT"	4.01134337958638	-7.04407789623412	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCAGTTGCATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2472.58122338474	20.2391751600795	0.00818544400833634	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.27737679042	2471.27737679042
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCAGTTTAGACC"	2.89447726783101	-6.73701145565184	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCAGTTTAGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.80185353429	32.7615472302975	0.014765422688877	1289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.64249601059	2214.64249601059
"healthy-4003"	"2020-08-26-Control4003-c3:CTGCTCATCTATCGGA"	5.12320150908772	-8.27946188366088	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGCTCATCTATCGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.88800052227	12.5981102618889	0.00499748908292586	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2520.88800052227	2520.88800052227
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGACGAGCACTTTG"	5.4725190597469	-10.1269712678161	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGACGAGCACTTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.48936374599	40.8457809490166	0.0163285846987771	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2492.31233328313	2492.31233328313
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGACGTCTATCACT"	-4.11117492142375	10.4982089766297	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGACGTCTATCACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1934.04210726812	27.3749773622333	0.0141542819876353	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.06024247796	1932.06024247796
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGCAGCACAGCTGC"	10.3613983589107	6.20546529376832	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGCAGCACAGCTGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1841.14965430316	0	0	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1833.91153245674	1833.91153245674
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGCAGCAGAGATTA"	1.21257557448689	-7.00388910686644	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGCAGCAGAGATTA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1490.03285898651	27.8319987014234	0.0186787818359617	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1490.03285898651	1490.03285898651
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGCAGGTTCGTACA"	2.62789787825887	-6.17865993892821	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGCAGGTTCGTACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.15047348975	19.7257022194619	0.00966874869073769	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2031.40085743243	2031.40085743243
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGCAGTCATCACAG"	5.55427469786946	-9.77406122600707	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGCAGTCATCACAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.93668364617	18.1869801048174	0.00767727572896748	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.93668364617	2368.93668364617
"healthy-4003"	"2020-08-26-Control4003-c3:CTGGTCTTCAGACCGC"	3.5462564426357	-6.42152120983275	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGGTCTTCAGACCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.30970230323	19.7480732594072	0.00845991996688445	1415	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.20080465755	2325.20080465755
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTACCTCTAGTGTG"	3.53378715094869	-7.3576755753723	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTACCTCTAGTGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.14443470902	27.2130133012175	0.012402562416009	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2189.49454647093	2189.49454647093
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTATTTCAACTTTC"	3.73675980147664	-6.79338743602904	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTATTTCAACTTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.07660618289	9.31405412847271	0.00379224903043564	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.83218743197	2445.83218743197
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTATTTCGGATAAA"	4.25417818602864	-7.28923990642699	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTATTTCGGATAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2107.24473444924	26.8291535533855	0.012731864085259	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2103.96618060101	2103.96618060101
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTCGTAGCCGTTAT"	-1.1819135946339	8.71064469898073	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTCGTAGCCGTTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1584.39139656901	34.9382594100555	0.0220515331538118	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1574.41245383946	1574.41245383946
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTCGTAGCGTCAGA"	-0.296111593872863	8.14342591846315	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTCGTAGCGTCAGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1982.91628684147	33.9671325735513	0.0171298873275465	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1977.84884745102	1977.84884745102
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTCGTGTGCGAGTA"	5.34268679198567	-10.0802183381286	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTCGTGTGCGAGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1650.2438054313	34.5212727748687	0.0209188925062175	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1648.24963017579	1648.24963017579
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTGAACATCTTAGG"	4.27509226378743	-6.78902389919432	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTGAACATCTTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.80132256341	26.1638949918595	0.0120028805933062	1228	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2174.10474121256	2174.10474121256
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTGAAGTTCTGACA"	5.43252052840535	-9.95214273845824	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTGAAGTTCTGACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2502.41233846973	39.576860463676	0.0158154832659904	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2494.54635518524	2494.54635518524
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTGAATCACTTGGA"	-4.22201381149943	12.9458427199158	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTGAATCACTTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2105.68514822316	39.4194614183939	0.0187204917371703	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2098.18418798399	2098.18418798399
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTGAATCGTTTACT"	-3.86166201058086	12.9108695753845	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTGAATCGTTTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.77056585392	33.4974585214058	0.0194552393830665	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1721.77056585392	1721.77056585392
"healthy-4003"	"2020-08-26-Control4003-c3:CTGTGGGCATCAGCAT"	4.28084578093831	-6.95827581798705	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTGTGGGCATCAGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2196.69526833901	31.3374591580068	0.0142657288927025	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2192.37505218745	2192.37505218745
"healthy-4003"	"2020-08-26-Control4003-c3:CTTACCGGTCCTACAA"	-0.00510540503318909	8.45754525745241	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTACCGGTCCTACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.18847381846	1.83863074047362	0.000988410995096323	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1849.82219003868	1849.82219003868
"healthy-4003"	"2020-08-26-Control4003-c3:CTTACCGTCGAGTGAG"	4.04574336585347	-7.86864807521971	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTACCGTCGAGTGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.97544718773	32.1859143605131	0.0157390223950001	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.97544718773	2044.97544718773
"healthy-4003"	"2020-08-26-Control4003-c3:CTTAGGAAGCTTCATG"	5.34113325652425	-9.38539984142455	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTAGGAAGCTTCATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.60536422748	32.3947043078994	0.0133939603322787	1448	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.72021871111	2407.72021871111
"healthy-4003"	"2020-08-26-Control4003-c3:CTTAGGAAGTGCACTT"	-4.97697625580485	9.04904840076295	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTAGGAAGTGCACTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2843.34256765473	36.9810769812466	0.0130061981985342	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2835.49217594789	2835.49217594789
"healthy-4003"	"2020-08-26-Control4003-c3:CTTAGGAGTTTCGTTT"	5.44886412200276	-10.1090288392273	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTAGGAGTTTCGTTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.79054074006	6.50455798021991	0.00312300149870505	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2076.74869120699	2076.74869120699
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCAATCACCTCGTT"	-4.00349555435832	10.8852205046448	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCAATCACCTCGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1932.08728964783	28.8898341877825	0.0149526547493868	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1932.08728964783	1932.08728964783
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCAATGTGGATCAG"	5.00602640685384	-8.14976313030394	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCAATGTGGATCAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2680.25691414905	28.2827649000552	0.0105522589087452	2014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2676.36879997684	2676.36879997684
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCGAAGCGGTAGT"	4.25291695174519	-7.0323901406494	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCGAAGCGGTAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.61634398865	18.0714101561823	0.00781089319460262	1491	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.9017583702	2308.9017583702
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCGACACCTGCGA"	0.463392128317994	8.94798562610475	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCGACACCTGCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1764.57832576383	29.5226773276074	0.0167307264838062	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1757.27351039824	1757.27351039824
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCGACACGCGGTT"	-7.86119447174724	-0.758661889192186	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCGACACGCGGTT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3096.80054308223	36.6939238264659	0.0118489787495144	3676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3081.46306150729	3081.46306150729
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCGAGTGTAGGAC"	0.307710816233796	8.52655408466188	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCGAGTGTAGGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1759.61515827141	24.5868355088932	0.01397284820679	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1751.10537624905	1751.10537624905
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCTTCATGAGGGT"	4.07661833342854	-7.40082886135253	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCTTCATGAGGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2096.62835399895	37.5791125952928	0.0179235926689713	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2093.49081477019	2093.49081477019
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCTTGTGCGGCTT"	2.71367921408955	-4.42399313366088	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCTTGTGCGGCTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2644.63599880366	34.0685152468032	0.0128821188481948	2107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2636.41702864641	2636.41702864641
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCCTTTCCTGGGTG"	5.27858080443684	-9.99025061046752	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCCTTTCCTGGGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.89383910001	39.9935675532915	0.0173515876847967	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2300.2401117473	2300.2401117473
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCGGTAGAGCAGTC"	4.45052733001058	-7.94783213054808	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCGGTAGAGCAGTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1927.96442115714	13.86970240445	0.00719396180357187	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1924.37216685735	1924.37216685735
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCGGTCAACTTGGT"	0.188397203653496	8.75672433460084	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCGGTCAACTTGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1489.26442781	29.6860118688477	0.0199333384417848	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1479.74141623369	1479.74141623369
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCGGTCAGCGGATA"	4.11281313475911	-7.56018640911254	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCGGTCAGCGGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.38497114564	34.2812324989957	0.0148378875932511	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2307.7717616671	2307.7717616671
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCGGTTCGTTACCC"	5.60210003432576	-9.77566149151	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCGGTTCGTTACCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2613.16049626846	35.8015280928877	0.0137004704242283	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2610.59846133548	2610.59846133548
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCGGTTCTTGTGCC"	9.99914803084676	5.90769193256227	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCGGTTCTTGTGCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1486.59088432221	41.3004111873375	0.0277819618180746	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1479.74632711559	1479.74632711559
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCTAAAGGAATCGC"	3.05426015433614	-6.41384270107421	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCTAAAGGAATCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.07362523226	36.495039634703	0.0167096196818099	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2182.63975594331	2182.63975594331
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCTAAGTATGGTTC"	5.60921682891194	-9.8279428712097	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCTAAGTATGGTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2771.80004319362	0	0	1864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2757.55169677468	2757.55169677468
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCTCTCAGACAAAT"	-4.05228362503703	11.5730657347473	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCTCTCAGACAAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2006.23012187284	31.3708029200075	0.0156366922109227	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2002.48888342844	2002.48888342844
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCTCTCAGTTAGGG"	4.25974096831624	-7.31644394313964	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCTCTCAGTTAGGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.48725736992	32.1968307419762	0.0145786807845653	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2195.25164830713	2195.25164830713
"healthy-4003"	"2020-08-26-Control4003-c3:CTTCTCTGTTACACAC"	-3.56348095360454	11.070870376471	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTCTCTGTTACACAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2216.00621797363	36.5791699122914	0.016506799311123	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2205.11918510965	2205.11918510965
"healthy-4003"	"2020-08-26-Control4003-c3:CTTGAGAAGCTCCCTT"	4.21589340743367	-7.47596790706786	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTGAGAAGCTCCCTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2566.89123919248	34.9323656575617	0.0136088218792438	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2563.00217875915	2563.00217875915
"healthy-4003"	"2020-08-26-Control4003-c3:CTTGAGAGTACTCGTA"	-3.78220162811931	12.8616065748963	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTGAGAGTACTCGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1953.31970723123	33.1469048928608	0.0169695236115983	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1947.57142977129	1947.57142977129
"healthy-4003"	"2020-08-26-Control4003-c3:CTTGAGATCCGGTTCT"	-3.9309381050175	11.5488290556702	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTGAGATCCGGTTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1641.25896318823	39.6440970966516	0.0241546873380913	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1634.4365175908	1634.4365175908
"healthy-4003"	"2020-08-26-Control4003-c3:CTTGATTTCCTTCTGG"	4.32460941848103	-6.90721657192381	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTGATTTCCTTCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2086.53826939496	38.7507133866132	0.0185717721812263	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2083.39785010873	2083.39785010873
"healthy-4003"	"2020-08-26-Control4003-c3:CTTTCAACAATACGAA"	-1.67062995854076	3.75794408405153	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTTCAACAATACGAA"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2752.62265946557	37.5995334549287	0.0136595306027993	3289	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2747.96481601406	2747.96481601406
"healthy-4003"	"2020-08-26-Control4003-c3:CTTTCAATCGGACAAG"	4.18646015700643	-7.64133360302123	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTTCAATCGGACAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2006.63823953374	14.6134553702809	0.00728255600953589	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2006.63823953374	2006.63823953374
"healthy-4003"	"2020-08-26-Control4003-c3:CTTTCGGTCGACGATT"	-2.46829019013103	9.86779019916383	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.CTTTCGGTCGACGATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1924.45854363786	26.6034696820646	0.0138238725744516	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1918.72174831487	1918.72174831487
"healthy-4003"	"2020-08-26-Control4003-c3:GAAACCTCAATCGCAT"	-1.64947972717937	9.02357575977174	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAACCTCAATCGCAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1846.04529080143	39.4782165275286	0.0213852914249952	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1839.16724993002	1839.16724993002
"healthy-4003"	"2020-08-26-Control4003-c3:GAAACCTCACTGTCCT"	-1.21627471867259	9.02042481983034	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAACCTCACTGTCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.08299611808	38.6229887805067	0.0214681528666795	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1795.26585102876	1795.26585102876
"healthy-4003"	"2020-08-26-Control4003-c3:GAAACCTGTACCGTGC"	-4.38169513168986	12.882822013739	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAACCTGTACCGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1839.05250303484	34.6337986800162	0.0188324143127306	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1833.00117808217	1833.00117808217
"healthy-4003"	"2020-08-26-Control4003-c3:GAAATGAAGTTACGTC"	9.95535912093465	6.9907769926819	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAATGAAGTTACGTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1571.11674830476	20.0162938415357	0.0127401696042852	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1567.5611945951	1567.5611945951
"healthy-4003"	"2020-08-26-Control4003-c3:GAAATGACATCCTCAC"	4.96592297133748	-7.9836578599182	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAATGACATCCTCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.25537745622	28.0755007450858	0.0117655054904537	1555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2385.09078258263	2385.09078258263
"healthy-4003"	"2020-08-26-Control4003-c3:GAAATGAGTAAGGAGA"	3.14511241492574	-6.59520342266234	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAATGAGTAAGGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2109.61381312671	37.0328894351094	0.0175543453520633	1142	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2108.097171341	2108.097171341
"healthy-4003"	"2020-08-26-Control4003-c3:GAAATGAGTTCAACGT"	-3.82566366615947	12.9257497557434	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAATGAGTTCAACGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1725.69699221364	32.0415567330502	0.0185673133102868	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1721.45541421955	1721.45541421955
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTAGATGGCAC"	5.63484682616536	-9.813503288385	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTAGATGGCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.25981138582	29.1048054095526	0.0109777266205908	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2645.71606125273	2645.71606125273
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTAGCACACAG"	6.77731432494466	-1.73216059124144	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTAGCACACAG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2297.06918159171	4.88771989621173	0.00212780700528353	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2294.29206048601	2294.29206048601
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTCACGGCACT"	1.78922226008717	-6.90546419536742	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTCACGGCACT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1927.74918226753	30.2448304372634	0.0156891937579181	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1921.65937186091	1921.65937186091
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTGTCTTGCGG"	-1.47243569317515	8.44678685748903	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTGTCTTGCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2253.70286758726	28.6158979436268	0.012697280708642	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2243.57168829346	2243.57168829346
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTTCAGAGCAG"	-2.02481637421306	9.39834973895875	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTTCAGAGCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1949.47857918382	37.6388695341817	0.0193071470166858	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1947.59268628075	1947.59268628075
"healthy-4003"	"2020-08-26-Control4003-c3:GAACACTTCCATAGAC"	10.0308777290279	5.90352103793947	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACACTTCCATAGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1586.25037346888	34.2961275758977	0.0216208791181542	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1582.33437735759	1582.33437735759
"healthy-4003"	"2020-08-26-Control4003-c3:GAACGTTCATCGCTGG"	5.40413965758626	-9.49861338054808	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACGTTCATCGCTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.85961632113	1.74377528501201	0.000818727803301893	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2128.37951784357	2128.37951784357
"healthy-4003"	"2020-08-26-Control4003-c3:GAACTGTAGAGTGTTA"	4.95408596572225	-7.75012066280516	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACTGTAGAGTGTTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.36327835926	0	0	1205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.36327835926	2283.36327835926
"healthy-4003"	"2020-08-26-Control4003-c3:GAACTGTGTATTCTCT"	0.0810920159215152	8.21204850757448	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACTGTGTATTCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1699.09101716994	17.2540642236841	0.0101548793144837	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1695.67503748256	1695.67503748256
"healthy-4003"	"2020-08-26-Control4003-c3:GAACTGTTCCCTCTTT"	-4.12514148178752	12.9392242201599	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAACTGTTCCCTCTTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2305.92369850722	33.2590010289122	0.0144232877481779	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2302.23964644254	2302.23964644254
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGAATAGGCATGGT"	4.86647142943684	-7.84156181728514	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGAATAGGCATGGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.47132040384	32.5041736677444	0.0141048288950059	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.8948560539	2301.8948560539
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGAATAGTATGAAC"	3.50001539763753	-7.09095241939696	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGAATAGTATGAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2602.81166857141	28.9561319595842	0.0111249431947864	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2594.27516507479	2594.27516507479
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGCCCAGAGTCCGA"	4.6524940925533	-8.22594644939574	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGCCCAGAGTCCGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.01429231292	18.1016930758547	0.00917463859556461	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1971.70126554556	1971.70126554556
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGCGAGTGAGTCAG"	-0.932143370539504	8.47152993762819	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGCGAGTGAGTCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1831.94469263087	37.9496916917554	0.0207155226052461	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1830.24562940237	1830.24562940237
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGGGTAGCTCTTCC"	2.66390909728352	-4.33183815395506	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGGGTAGCTCTTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2845.30288748497	34.0690768321173	0.0119737961754335	2262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2837.96175501891	2837.96175501891
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGGGTCATTCAGCA"	-2.1315053505009	8.91674611652223	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGGGTCATTCAGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.59982125683	37.0633986268335	0.0204138589313017	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.90229063637	1807.90229063637
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGGGTTCCCATTCG"	10.0294166999752	5.58052060687868	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGGGTTCCCATTCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1503.58427201469	38.976222083477	0.0259222065626237	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1494.15985775435	1494.15985775435
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGTAAAGCATCAGG"	-4.01620564881023	3.51993916118471	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGTAAAGCATCAGG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2733.38062065099	7.83279200119786	0.00286560603452745	3120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2724.00848102722	2724.00848102722
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGTAACAGACCTGC"	5.3612925010616	-10.1005449525085	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGTAACAGACCTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2083.47805536859	13.211006340576	0.00634084256684855	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.38616592882	2080.38616592882
"healthy-4003"	"2020-08-26-Control4003-c3:GAAGTAAGTTACCGTA"	1.8769746023113	-7.27609684383544	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAAGTAAGTTACCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.55062100816	27.353483010405	0.0147653093525289	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1847.57407604931	1847.57407604931
"healthy-4003"	"2020-08-26-Control4003-c3:GAATAGACAAAGGCAC"	11.0547443824703	5.16406962955324	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATAGACAAAGGCAC"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1587.21974851586	23.0912618049577	0.0145482450218688	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1578.23032428573	1578.23032428573
"healthy-4003"	"2020-08-26-Control4003-c3:GAATAGACACATTGTG"	-3.23350153389629	10.0671071776184	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATAGACACATTGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1732.98326841994	0	0	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1731.00187206393	1731.00187206393
"healthy-4003"	"2020-08-26-Control4003-c3:GAATAGACATTCATCT"	5.20474113997762	-9.08189871227416	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATAGACATTCATCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.37304928952	32.7773542398487	0.014430634479044	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2263.54451461851	2263.54451461851
"healthy-4003"	"2020-08-26-Control4003-c3:GAATAGAGTCATACCA"	-1.89476225796397	8.78041551196901	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATAGAGTCATACCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1579.8509385545	34.5411208916032	0.0218635315830536	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1575.4808317864	1575.4808317864
"healthy-4003"	"2020-08-26-Control4003-c3:GAATCACAGTAGGGTC"	6.78094830092732	-1.73016562378081	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATCACAGTAGGGTC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2464.10559762253	24.8020031195258	0.010065316658286	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2452.6699366614	2452.6699366614
"healthy-4003"	"2020-08-26-Control4003-c3:GAATCACTCAAGTAAG"	2.42072381552998	-6.51654245769652	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAATCACTCAAGTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.1793417474	30.2122670448445	0.0141365146362225	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2137.1793417474	2137.1793417474
"healthy-4003"	"2020-08-26-Control4003-c3:GACACGCCAAAGAACT"	-2.90922222557719	-5.70918848430785	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACACGCCAAAGAACT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2340.59491178188	27.5544534539927	0.0117724144897058	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2332.92529333468	2332.92529333468
"healthy-4003"	"2020-08-26-Control4003-c3:GACACGCGTAGGTGCA"	-7.99922404709514	1.40622530067293	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_MEP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACACGCGTAGGTGCA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1712.07924896256	47.024028436253	0.0274660349190888	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1700.02920009612	1700.02920009612
"healthy-4003"	"2020-08-26-Control4003-c3:GACACGCTCACGGGAA"	4.69420065459554	-7.30932190334471	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACACGCTCACGGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.94418162141	2.0016180436701	0.000904504533053123	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2208.5835165059	2208.5835165059
"healthy-4003"	"2020-08-26-Control4003-c3:GACAGCCAGCTTGTTG"	-0.316365043551284	8.51828477466432	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACAGCCAGCTTGTTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1746.90287424122	39.0600400695759	0.0223595945976916	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1741.15268797015	1741.15268797015
"healthy-4003"	"2020-08-26-Control4003-c3:GACAGCCGTCCAGTTA"	4.01967277106587	-7.36919453060301	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACAGCCGTCCAGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.38958470228	39.3819208125624	0.0159609658145308	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2456.58948163794	2456.58948163794
"healthy-4003"	"2020-08-26-Control4003-c3:GACCAATAGGTCATAA"	-2.84561047974284	10.7171926268372	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCAATAGGTCATAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1737.48230476383	37.8507758792553	0.0217848410746263	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1727.754637794	1727.754637794
"healthy-4003"	"2020-08-26-Control4003-c3:GACCAATGTCATAACC"	10.6820455985958	6.85109851444093	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCAATGTCATAACC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2036.09653010688	37.3934534334985	0.0183652655365685	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2025.20356047628	2025.20356047628
"healthy-4003"	"2020-08-26-Control4003-c3:GACCAATGTGAATATG"	-3.823873381049	11.1072206267151	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCAATGTGAATATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1961.32716615373	31.2862826098368	0.0159515878583331	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1961.32716615373	1961.32716615373
"healthy-4003"	"2020-08-26-Control4003-c3:GACCAATTCTGCGATA"	5.30490841445271	-10.160746597406	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCAATTCTGCGATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1847.04423605171	42.4535051383415	0.0229845632874994	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1841.44290350292	1841.44290350292
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCAGCAGAGGACT"	4.65666546401326	-8.16696932232054	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCAGCAGAGGACT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.35587347956	38.9043539239371	0.0181850782313562	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2135.30435665441	2135.30435665441
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCAGTCCCTCAAC"	4.70214666899983	-7.52572157299193	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCAGTCCCTCAAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.67408121931	32.1907831493964	0.0125369428249671	1597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2559.87642876081	2559.87642876081
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCAGTCGCTGCGA"	-2.14454803887065	9.12280080402223	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCAGTCGCTGCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.6007876924	30.5516621580143	0.0165090506613858	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1847.2707338242	1847.2707338242
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTAGAGCAGTC"	-1.01299975338634	9.95767209613649	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTAGAGCAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1690.44118036952	41.7836925513264	0.0247176258106731	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.98752768368	1685.98752768368
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTCAGTTTCGA"	-3.9270113510197	12.631546951178	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTCAGTTTCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1682.72288649513	30.3898176080098	0.0180599062697171	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1673.53033445508	1673.53033445508
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTCATGGACAG"	-4.04165778580363	11.085479713324	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTCATGGACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1526.41983487589	43.6973751189943	0.0286273632722724	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1524.17213514727	1524.17213514727
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTTCAGCAATC"	3.39754929122273	-6.84290602123412	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTTCAGCAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.85930015985	2.71251230975586	0.00123641124549702	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2187.34032180179	2187.34032180179
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTTCCATCCGT"	2.65077795562093	-4.34773256694945	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTTCCATCCGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2291.00633314582	13.9387047822779	0.00608409701039039	1622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2286.85264881565	2286.85264881565
"healthy-4003"	"2020-08-26-Control4003-c3:GACCCTTTCTTCTCAA"	4.8994947868282	-7.8408823243347	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCCTTTCTTCTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2390.49276423039	9.45949152409184	0.00395713037313346	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2381.79963462673	2381.79963462673
"healthy-4003"	"2020-08-26-Control4003-c3:GACCGTGAGTCACTGT"	-3.45897517624553	10.2085094221863	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCGTGAGTCACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.92810590515	27.8482784502367	0.0141510649533753	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1964.07244022387	1964.07244022387
"healthy-4003"	"2020-08-26-Control4003-c3:GACCTTCCAACGCCCA"	4.9388333755428	-8.37271692669066	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCTTCCAACGCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2848.71392543941	23.6813310486676	0.00831299023646778	2157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2840.84569579289	2840.84569579289
"healthy-4003"	"2020-08-26-Control4003-c3:GACCTTCCACGACTAT"	4.07220711287801	-6.7257495156494	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCTTCCACGACTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.11150420479	1.03818810884058	0.000484204346091423	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2144.11150420479	2144.11150420479
"healthy-4003"	"2020-08-26-Control4003-c3:GACCTTCGTCTACGAT"	2.87481011924092	-4.85750009929808	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCTTCGTCTACGAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2264.18793737515	31.5926159948799	0.0139531774166701	1417	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2260.50346220179	2260.50346220179
"healthy-4003"	"2020-08-26-Control4003-c3:GACCTTCTCATGCAGT"	6.74920763549153	-1.65676274215849	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCTTCTCATGCAGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2353.81844878454	26.180801585496	0.0111226936805662	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2353.81844878454	2353.81844878454
"healthy-4003"	"2020-08-26-Control4003-c3:GACCTTCTCGCAGTGC"	-4.00878367844279	12.7428664931091	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACCTTCTCGCAGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1847.74466506158	27.0835383218255	0.0146576195477327	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1839.56901840737	1839.56901840737
"healthy-4003"	"2020-08-26-Control4003-c3:GACGCTGAGAATAACC"	-3.50067601624187	10.5767202147278	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGCTGAGAATAACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2046.99408482428	31.0388322355744	0.0151631274685578	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2041.4287046237	2041.4287046237
"healthy-4003"	"2020-08-26-Control4003-c3:GACGCTGGTGGTAACG"	-2.05809412422832	9.26774022662965	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGCTGGTGGTAACG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2072.35599505386	30.3361539790354	0.014638485883429	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2067.28448811983	2067.28448811983
"healthy-4003"	"2020-08-26-Control4003-c3:GACGCTGTCTCTGAGA"	4.87509407576863	-8.54945757305297	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGCTGTCTCTGAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2030.25706811477	41.6211636146856	0.0205004401995919	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2027.26200480497	2027.26200480497
"healthy-4003"	"2020-08-26-Control4003-c3:GACGTTAAGATCGCCC"	3.54590692099873	-6.61652948772582	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGTTAAGATCGCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.03260322926	8.29170691574829	0.00319030507945378	1892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2596.46562623195	2596.46562623195
"healthy-4003"	"2020-08-26-Control4003-c3:GACGTTAAGATGACCG"	-4.08831773224528	12.6790704497131	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGTTAAGATGACCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1601.11314525487	40.3046017899543	0.0251728629606238	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1601.11314525487	1601.11314525487
"healthy-4003"	"2020-08-26-Control4003-c3:GACGTTACACTCTAGA"	-1.89237723770793	9.95654389942018	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGTTACACTCTAGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1847.75385129489	8.10990330263349	0.00438906042433636	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1842.30312997195	1842.30312997195
"healthy-4003"	"2020-08-26-Control4003-c3:GACGTTATCTGGCCGA"	-1.50107584419902	8.81466195667116	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACGTTATCTGGCCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.378531331	38.8656503058659	0.0196452042368849	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1973.02746024725	1973.02746024725
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGAGAACTGAT"	-4.00786910477336	12.9009389647278	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGAGAACTGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2057.25242290174	30.38054238105	0.0147675326774915	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2051.85893743121	2051.85893743121
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGAGACACACG"	4.09420694884602	-7.45247080242308	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGAGACACACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.00776948206	35.2780432595247	0.015616609971914	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2253.85345522127	2253.85345522127
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGAGTCACTCA"	-2.79329095307048	9.9734782942566	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGAGTCACTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2020.30549681145	36.8893655993092	0.0182593007134465	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2012.61733650488	2012.61733650488
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGCAGGTTCAT"	-0.924104551703292	8.77721307361452	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGCAGGTTCAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1990.56469184146	36.3477907223908	0.0182600399129785	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1980.65974098793	1980.65974098793
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGGTTTCTTAC"	-1.6233973306721	8.80096814716188	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGGTTTCTTAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2256.64603463498	41.8638945120087	0.0185513784038268	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2243.66479439684	2243.66479439684
"healthy-4003"	"2020-08-26-Control4003-c3:GACTATGTCAGCACCG"	-3.63126860085185	12.9104079970154	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTATGTCAGCACCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2179.52774744214	19.173768496675	0.00879721238657183	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2175.65052501778	2175.65052501778
"healthy-4003"	"2020-08-26-Control4003-c3:GACTCAAGTGGCCTCA"	3.05043997344319	-4.95551969921263	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTCAAGTGGCCTCA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2650.73790685686	1.60039998296482	0.000603756402632241	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2644.64004833649	2644.64004833649
"healthy-4003"	"2020-08-26-Control4003-c3:GACTCTCCATCAGCTA"	5.04356874999349	-8.13502981578978	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTCTCCATCAGCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2693.8619061136	16.5353350594979	0.00613815245019489	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2687.93448747129	2687.93448747129
"healthy-4003"	"2020-08-26-Control4003-c3:GACTCTCGTGGCTCTG"	6.78009714659993	-1.68825616752776	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTCTCGTGGCTCTG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2683.61528091045	37.8888766685575	0.014118594769554	1836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2677.47051570876	2677.47051570876
"healthy-4003"	"2020-08-26-Control4003-c3:GACTCTCTCACCTTAT"	5.33649935302083	-9.56040956890257	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTCTCTCACCTTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.15948403676	34.0913220724375	0.0158996204929004	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2140.7839604493	2140.7839604493
"healthy-4003"	"2020-08-26-Control4003-c3:GACTCTCTCCTCCACA"	-0.274339894682723	8.60822961414186	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTCTCTCCTCCACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2383.16501087202	28.8292467330343	0.0120970417916993	1452	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2377.21454516457	2377.21454516457
"healthy-4003"	"2020-08-26-Control4003-c3:GACTGATAGCTGTACT"	5.25417151030843	-9.48305990612181	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTGATAGCTGTACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.36445779339	36.3360127878639	0.0155324291889678	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2334.35092758769	2334.35092758769
"healthy-4003"	"2020-08-26-Control4003-c3:GACTGATGTGGATCAG"	9.31838573989217	6.75780055606691	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTGATGTGGATCAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1772.93143180552	33.981075412168	0.0191666044171614	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1766.62080147009	1766.62080147009
"healthy-4003"	"2020-08-26-Control4003-c3:GACTTCCAGCCAAGGT"	6.81010498580281	-1.58693470871123	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTTCCAGCCAAGGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2833.94123618461	41.4197151024658	0.0146155871454236	2073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2820.09257570403	2820.09257570403
"healthy-4003"	"2020-08-26-Control4003-c3:GACTTCCAGTGAGTTA"	5.54790272292439	-9.75893499767455	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTTCCAGTGAGTTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2461.7943450006	34.4066820629028	0.0139762617185208	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2456.73756131027	2456.73756131027
"healthy-4003"	"2020-08-26-Control4003-c3:GACTTCCCACGTAACT"	4.17311014708821	-7.14282514965209	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTTCCCACGTAACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.1307123267	27.403502013613	0.0120713322210097	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2265.49782063759	2265.49782063759
"healthy-4003"	"2020-08-26-Control4003-c3:GACTTCCTCTACTGCC"	4.19337811049764	-7.02116491710814	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GACTTCCTCTACTGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.68807522641	23.4864389736021	0.00916476694945681	1572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2558.70545822174	2558.70545822174
"healthy-4003"	"2020-08-26-Control4003-c3:GAGAAATGTGTTCATG"	4.12657799300496	-7.25712826168212	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGAAATGTGTTCATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2387.78065196171	18.7288746369989	0.00784363279835269	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2380.32842207012	2380.32842207012
"healthy-4003"	"2020-08-26-Control4003-c3:GAGAAATGTGTTCGAT"	11.1975971656734	5.69195029819337	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGAAATGTGTTCGAT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1513.36538139564	0	0	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1508.23697757881	1508.23697757881
"healthy-4003"	"2020-08-26-Control4003-c3:GAGAAATTCGAGCCTG"	5.35408510741536	-10.1677713624206	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGAAATTCGAGCCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2083.68405948664	42.3819468135713	0.0203399102760392	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2075.55234271468	2075.55234271468
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACCCCAGGAATAT"	3.06927551802937	-6.8108644715515	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACCCCAGGAATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.49171760994	42.1506381305523	0.0176105218248436	1499	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.50470156274	2388.50470156274
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACCCCAGTGGCTC"	-2.88975582543071	9.52012250507203	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACCCCAGTGGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2335.62261855142	38.2054964102903	0.0163577352380607	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2327.25172564054	2327.25172564054
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACCCCATAATGCC"	4.18947901305501	-6.74914123928221	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACCCCATAATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2224.56363669854	17.7360836944057	0.00797283719009617	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2220.39743308664	2220.39743308664
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACTTAGACCTCAT"	5.3436709838802	-9.71637442028197	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACTTAGACCTCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.32899534189	33.9865425723987	0.0133367954587194	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2544.0568884979	2544.0568884979
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACTTTCACTGCTC"	4.34689344939534	-7.47435476696166	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACTTTCACTGCTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.60710494715	29.9880976921568	0.0127738996993843	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.73998075448	2343.73998075448
"healthy-4003"	"2020-08-26-Control4003-c3:GAGACTTTCCGTAGGC"	-0.361384699971038	8.43149945819703	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGACTTTCCGTAGGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.5214845162	33.1788002536174	0.0197431574420895	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1677.60724917661	1677.60724917661
"healthy-4003"	"2020-08-26-Control4003-c3:GAGAGGTCAGATAAAC"	4.80364241179768	-7.65663483059081	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGAGGTCAGATAAAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.37093987898	34.9125068602291	0.0130985546281278	2030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2662.49137963696	2662.49137963696
"healthy-4003"	"2020-08-26-Control4003-c3:GAGATGGCACACTTAG"	5.55635418471639	-10.0375290147034	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGATGGCACACTTAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.02331469362	29.631873192132	0.0122850691415874	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.98520643192	2407.98520643192
"healthy-4003"	"2020-08-26-Control4003-c3:GAGATGGGTAACGGTG"	-0.0819583338802636	8.68270204151002	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGATGGGTAACGGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1673.95815125175	30.3576165625673	0.0181352302862927	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1662.85698323992	1662.85698323992
"healthy-4003"	"2020-08-26-Control4003-c3:GAGATGGGTTGACGGA"	-0.217520306736785	8.87832067096559	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGATGGGTTGACGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1451.19983497799	23.3750434227633	0.0161073911802903	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1451.19983497799	1451.19983497799
"healthy-4003"	"2020-08-26-Control4003-c3:GAGATGGTCAGTCCGG"	-3.34539113465007	9.71011922443239	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGATGGTCAGTCCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1967.27260370039	34.4256845661645	0.0174991938084283	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1957.99853792294	1957.99853792294
"healthy-4003"	"2020-08-26-Control4003-c3:GAGCCTGAGTTTCAGC"	-2.84364662590678	11.6262159117493	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGCCTGAGTTTCAGC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2105.46690008974	35.4550741031329	0.0168395305106064	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2093.51084396989	2093.51084396989
"healthy-4003"	"2020-08-26-Control4003-c3:GAGCCTGCATCCGATA"	3.47764529761617	-6.94332363521727	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGCCTGCATCCGATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2497.49028806944	35.4685874133558	0.0142016918275078	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2493.92152981237	2493.92152981237
"healthy-4003"	"2020-08-26-Control4003-c3:GAGCTGCAGGGAGGCA"	5.41404690322225	-9.52556993877562	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGCTGCAGGGAGGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2489.9876828163	32.7522887160871	0.0131535946712165	1547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2487.49529092108	2487.49529092108
"healthy-4003"	"2020-08-26-Control4003-c3:GAGCTGCCATGGATCT"	4.49513210830037	-7.19669821178588	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGCTGCCATGGATCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.8838390168	2.51928182990693	0.00104366324061934	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2408.52876714168	2408.52876714168
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGCAAAGAGTCGAC"	5.41916336592976	-10.1439466706482	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGCAAAGAGTCGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2140.34279900732	40.5106097455599	0.0189271595953454	1145	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2137.34886965732	2137.34886965732
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGCCTAGAGTCAAT"	5.41614737090413	-9.80083563244017	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGCCTAGAGTCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.22056756478	22.6393378016025	0.00925104099796399	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2441.81672321007	2441.81672321007
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGGATGTCGCTTAA"	4.26473774489705	-6.73787119304808	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGGATGTCGCTTAA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2313.36687327929	20.7478425283742	0.00896867797668567	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2309.47313535185	2309.47313535185
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGGTACATGATGCT"	-4.06416879120524	12.9909543761047	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGGTACATGATGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1988.02921706204	38.5098575874365	0.0193708710399877	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1982.2206588446	1982.2206588446
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGGTAGTAGATTAG"	0.650003631680649	8.24238202655641	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGGTAGTAGATTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1540.68962726689	24.361762393737	0.0158122453494762	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1540.68962726689	1540.68962726689
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGGTAGTGCCTTCT"	5.24085487899129	-9.8065510026184	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGGTAGTGCCTTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2665.47819723698	23.4940793417249	0.00881420803444527	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2660.54870226528	2660.54870226528
"healthy-4003"	"2020-08-26-Control4003-c3:GAGGGTATCCCATAAG"	-3.27603397789653	10.7799253233704	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGGGTATCCCATAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1436.82730037394	29.6017067009533	0.0206021326942002	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1422.5154270418	1422.5154270418
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTCATCACCTCTGT"	5.47963537749593	-9.92368032848509	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTCATCACCTCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.48579696896	19.8907057804187	0.00888578601095071	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.06183687544	2235.06183687544
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTCATCATCAACCA"	4.53478254851643	-7.29926826870116	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTCATCATCAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2109.13559584177	23.9736363157542	0.0113665694908469	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2104.85014109896	2104.85014109896
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTCATGTGAAGCTG"	5.44337191161458	-9.87403776561888	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTCATGTGAAGCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.55241394824	35.2796105417568	0.0149963122320186	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.65919947845	2343.65919947845
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTCATGTTCAAGTC"	-3.98754010620769	10.7620239027771	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTCATGTTCAAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2487.59549482716	36.6234287529644	0.0147224212413638	1527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2480.92680958863	2480.92680958863
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTCTACACTCCCTA"	-1.35105774822887	8.8070668944153	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTCTACACTCCCTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2079.23706824451	32.266014987611	0.0155181991896927	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2069.65302236424	2069.65302236424
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGAGCACGCTGCA"	-4.48057685318645	12.8238973387512	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGAGCACGCTGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2156.61712212394	37.9810156172762	0.0176113855480618	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2153.29834536271	2153.29834536271
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGAGGTACTTGTG"	5.43077196654622	-9.8675689927307	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGAGGTACTTGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.51426408657	17.7293676206751	0.0082174972911158	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.56396861856	2152.56396861856
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGAGGTCACTTAG"	10.3634191947872	6.16035459125368	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGAGGTCACTTAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1511.16000802505	9.04580951000866	0.00598600377324088	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1507.00879065454	1507.00879065454
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGAGGTGCGCTCA"	4.86015667495076	-7.53810169613036	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGAGGTGCGCTCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.64813533678	31.4819116752638	0.0117792953210044	1758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2670.27284796756	2670.27284796756
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGTTCAAACTGCT"	2.50697459754292	-6.02753546154173	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGTTCAAACTGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.8988259271	31.4680704245411	0.0135004016796074	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.00317251548	2325.00317251548
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTGTTGTCACGACC"	5.61589731749837	-10.149947189447	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTGTTGTCACGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2469.05710007822	32.5837883381599	0.0131968549196889	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2466.36410228206	2466.36410228206
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTTGTGTCCCTAAA"	4.02967967566792	-8.11040689861449	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTTGTGTCCCTAAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2435.44136929351	38.775943552098	0.0159215261927436	1419	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2431.27603295211	2431.27603295211
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTTGTGTCTACGTA"	3.78942884978597	-7.36079027568968	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTTGTGTCTACGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2065.11193839078	30.3182653641503	0.0146811728703556	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2056.53222106309	2056.53222106309
"healthy-4003"	"2020-08-26-Control4003-c3:GAGTTTGCAATACCTG"	-1.83277032795604	9.02134893024293	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GAGTTTGCAATACCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.42302082304	19.0358438490273	0.0094969193884088	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2004.42302082304	2004.42302082304
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAAAGAATTCAG"	3.74123515662495	-6.98040010845336	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAAAGAATTCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2465.90596903564	26.3525413798484	0.0106867584209443	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2461.8117462403	2461.8117462403
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAAAGTGAATAC"	3.85566772994344	-7.4761419526306	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAAAGTGAATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.38316704187	19.634760534626	0.00935263311760868	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2094.34200565818	2094.34200565818
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAACAATTGGTC"	0.065862144424957	8.18828485095827	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAACAATTGGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1824.82611586528	2.68797645852541	0.00147300415922141	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1821.28806341011	1821.28806341011
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAAGTAGAGGAA"	4.126312871545	-7.27038338100585	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAAGTAGAGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.02562605064	6.08807704174146	0.0026355019498853	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.5378135641	2308.5378135641
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAAGTCTGTGCG"	3.76677026328389	-7.02832462703856	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAAGTCTGTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.33731254974	17.891067998783	0.00771387063967624	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2316.57660161524	2316.57660161524
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAAGTTCATCTT"	2.06487717208211	-7.23120214855345	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAAGTTCATCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1878.21814296918	10.7286548614845	0.00571214525940214	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1878.21814296918	1878.21814296918
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAATCACGGAGA"	11.0763060050899	4.67767379367677	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAATCACGGAGA"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1656.49269139091	45.2439693781421	0.0273131113788084	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1654.27523386254	1654.27523386254
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAATCTCGCTCA"	-4.67731891098674	3.544806218985	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAATCTCGCTCA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2562.68158322571	2.43456808286185	0.000950008030181182	2594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2553.93458892804	2553.93458892804
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGAATCTCGGCTT"	-3.5997408432072	12.7987174757752	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGAATCTCGGCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2160.78301608135	25.8525566585481	0.0119644390325839	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2152.11902463403	2152.11902463403
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGCTGTGTATCCA"	3.97638620909993	-7.09084370052489	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGCTGTGTATCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.05461045485	29.6643098744028	0.0141862913221334	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2087.51982052429	2087.51982052429
"healthy-4003"	"2020-08-26-Control4003-c3:GATAGCTTCGCGTCGA"	5.16896166381184	-9.36192991649779	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATAGCTTCGCGTCGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.41361351241	43.9000834630834	0.0203862756265753	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2145.23613975039	2145.23613975039
"healthy-4003"	"2020-08-26-Control4003-c3:GATCACAAGACAGCTG"	-0.487311224371749	8.82391831958619	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCACAAGACAGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2090.61590761301	32.3035366119653	0.0154516841158299	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2084.0962826078	2084.0962826078
"healthy-4003"	"2020-08-26-Control4003-c3:GATCACAGTGGCTACC"	-1.66682956638988	8.61257741535035	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCACAGTGGCTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.16536460176	37.074720011439	0.0194703257924203	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1902.53002229178	1902.53002229178
"healthy-4003"	"2020-08-26-Control4003-c3:GATCACATCGAGCCTG"	5.18363251265828	-9.13848879253539	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCACATCGAGCCTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2749.15724813335	26.6856700118674	0.00970685472065544	2089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2744.39017401832	2744.39017401832
"healthy-4003"	"2020-08-26-Control4003-c3:GATCAGTCAAACACGG"	-3.52980170670207	10.0441312559876	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCAGTCAAACACGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2082.94303051942	35.7715446057817	0.0171735587971705	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2072.40446126063	2072.40446126063
"healthy-4003"	"2020-08-26-Control4003-c3:GATCAGTGTTGATCGT"	4.95374168929402	-7.50255110180052	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCAGTGTTGATCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.47618727374	1.8334904627076	0.000745783291373183	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2455.90811667005	2455.90811667005
"healthy-4003"	"2020-08-26-Control4003-c3:GATCAGTTCTCTGGTC"	3.79978575286214	-7.22136976635131	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCAGTTCTCTGGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.41566849042	18.990111252267	0.00932984428991406	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2035.41566849042	2035.41566849042
"healthy-4003"	"2020-08-26-Control4003-c3:GATCATGAGCTGTTAC"	4.06625856932942	-7.44821789180907	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCATGAGCTGTTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.42565827902	36.3069105408319	0.0172526458219119	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2099.52513368132	2099.52513368132
"healthy-4003"	"2020-08-26-Control4003-c3:GATCATGAGGGACAGG"	2.52299680289571	-6.6594071618286	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCATGAGGGACAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2015.75891923519	32.2630715867374	0.0160054217192691	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2014.41048577649	2014.41048577649
"healthy-4003"	"2020-08-26-Control4003-c3:GATCATGTCAAGCTGT"	5.50624861296956	-9.80847742473754	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCATGTCAAGCTGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2716.42221934034	34.1375194277908	0.0125670888659131	1865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2708.07827101779	2708.07827101779
"healthy-4003"	"2020-08-26-Control4003-c3:GATCCCTAGACCATTC"	-0.476917068392593	8.6102609404358	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCCCTAGACCATTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1847.38580506339	36.8611069135164	0.0199531179748627	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.38144395564	1840.38144395564
"healthy-4003"	"2020-08-26-Control4003-c3:GATCCCTAGTATAGGT"	4.46103920516316	-7.25138189708861	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCCCTAGTATAGGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.52227777989	30.7570105646793	0.0120260968328215	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2551.41757781962	2551.41757781962
"healthy-4003"	"2020-08-26-Control4003-c3:GATCCCTGTGTAAATG"	11.1433960395748	5.47792098605958	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCCCTGTGTAAATG"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1854.75911252295	26.2121970770316	0.0141323996739265	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1847.32740857094	1847.32740857094
"healthy-4003"	"2020-08-26-Control4003-c3:GATCCCTGTGTAGGAC"	4.22012629088704	-7.47192909633788	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCCCTGTGTAGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.56599312522	38.7728332915004	0.0169197978185312	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2284.22805035332	2284.22805035332
"healthy-4003"	"2020-08-26-Control4003-c3:GATCCCTTCCCGAACG"	3.77996124800984	-6.77912857448729	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCCCTTCCCGAACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2655.14576291005	5.09551427242259	0.00191910905367315	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2649.94867605761	2649.94867605761
"healthy-4003"	"2020-08-26-Control4003-c3:GATCGTAGTTCTCCAC"	4.3403660255367	-7.18428184902342	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCGTAGTTCTCCAC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.45567267741	28.7050292965706	0.0122021552329189	1445	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2352.45567267741	2352.45567267741
"healthy-4003"	"2020-08-26-Control4003-c3:GATCGTATCGATTTCT"	-2.60575352135356	8.88759992206422	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATCGTATCGATTTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2262.90354944108	27.7281528962702	0.0122533516300855	1312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2255.08075387854	2255.08075387854
"healthy-4003"	"2020-08-26-Control4003-c3:GATGACTGTGTTAGCT"	-3.43732653084453	12.7267474898132	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGACTGTGTTAGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1761.53875513358	32.4400403135231	0.0184157403400774	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1759.23848961347	1759.23848961347
"healthy-4003"	"2020-08-26-Control4003-c3:GATGAGGTCCTTACCG"	3.64995374259297	-7.82268764888915	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGAGGTCCTTACCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2530.27452463054	33.3924562163194	0.0131971672999377	1580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2522.68136708763	2522.68136708763
"healthy-4003"	"2020-08-26-Control4003-c3:GATGATCAGCCATGCC"	2.51200928267781	-6.54108240520629	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGATCAGCCATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.04792854104	34.3616344114604	0.0167777491593854	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2042.90350409169	2042.90350409169
"healthy-4003"	"2020-08-26-Control4003-c3:GATGATCGTACCCACG"	-3.17185173454936	10.7190294035706	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGATCGTACCCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1843.02478422887	13.1987818404869	0.00716147821420061	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1834.59031382762	1834.59031382762
"healthy-4003"	"2020-08-26-Control4003-c3:GATGATCTCGCCATAA"	-2.11020050469096	8.83400247180787	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGATCTCGCCATAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.88383785919	28.4425514203474	0.0152680220002517	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1861.025433054	1861.025433054
"healthy-4003"	"2020-08-26-Control4003-c3:GATGCTAAGTTCCAGT"	4.27847303923909	-7.42704489147338	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGCTAAGTTCCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2306.41426670575	16.222838972504	0.00703379232720196	1345	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2301.00623491713	2301.00623491713
"healthy-4003"	"2020-08-26-Control4003-c3:GATGCTACAGACAAGC"	0.121379581361455	8.07231328571168	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGCTACAGACAAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1639.69526981973	0	0	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.69526981973	1639.69526981973
"healthy-4003"	"2020-08-26-Control4003-c3:GATGCTACAGTCGGTC"	4.38606609877889	-7.37809803402098	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGCTACAGTCGGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.86299103711	13.216928342414	0.00645086001369166	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.63343650115	2044.63343650115
"healthy-4003"	"2020-08-26-Control4003-c3:GATGCTATCGTTCCTG"	-2.06973562660869	9.71692750537721	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGCTATCGTTCCTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1750.12746320484	35.6504224658605	0.0203701862952184	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1745.79468923387	1745.79468923387
"healthy-4003"	"2020-08-26-Control4003-c3:GATGGAGAGATGTTAG"	-3.95655093613322	13.2474632033142	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGGAGAGATGTTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1912.61844966161	40.597963954463	0.0212263789265684	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1904.23455936748	1904.23455936748
"healthy-4003"	"2020-08-26-Control4003-c3:GATGGAGAGTCTTCCC"	4.36933912810628	-7.1907358399597	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGGAGAGTCTTCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.12681719978	35.9888074475391	0.0156464448735712	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2297.48140649807	2297.48140649807
"healthy-4003"	"2020-08-26-Control4003-c3:GATGGAGCATGACGAG"	4.2250358062679	-7.42409613048705	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGGAGCATGACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.23724443109	1.17081645088731	0.00053899105813092	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2170.58117413633	2170.58117413633
"healthy-4003"	"2020-08-26-Control4003-c3:GATGGAGGTCCTTTGC"	-7.01527295532878	2.74408791148988	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGGAGGTCCTTTGC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2277.54918329916	0.799439304014495	0.000351008579694627	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2272.13263906478	2272.13263906478
"healthy-4003"	"2020-08-26-Control4003-c3:GATGTTGAGCCGATTT"	-4.48778567734416	13.0312461622986	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGTTGAGCCGATTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2243.09519536734	20.1703030008091	0.00899217431452166	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2233.51390215927	2233.51390215927
"healthy-4003"	"2020-08-26-Control4003-c3:GATGTTGAGCGGTATG"	5.45235313948934	-9.87478735363158	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGTTGAGCGGTATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.09748358634	37.9989319064851	0.0165493547979215	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2291.69086524188	2291.69086524188
"healthy-4003"	"2020-08-26-Control4003-c3:GATGTTGAGTACGTCT"	-0.641865770251113	8.31515786731569	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGTTGAGTACGTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.85237267989	24.7863501798357	0.0120682238458523	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2046.59838854556	2046.59838854556
"healthy-4003"	"2020-08-26-Control4003-c3:GATGTTGCATTGCAAC"	3.18038739737813	-7.01569988643798	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGTTGCATTGCAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2453.49319587252	22.8120381029139	0.00929777924034611	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2452.20086647464	2452.20086647464
"healthy-4003"	"2020-08-26-Control4003-c3:GATGTTGTCTATCGGA"	-4.4337400001591	12.9549121626648	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATGTTGTCTATCGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.49885351181	34.8021343859144	0.0176975106411906	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1962.39944261189	1962.39944261189
"healthy-4003"	"2020-08-26-Control4003-c3:GATTCGACAGAACGCA"	9.80349411544148	6.01119563663331	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTCGACAGAACGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1370.09379810466	33.9905482351786	0.0248089205879189	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1370.09379810466	1370.09379810466
"healthy-4003"	"2020-08-26-Control4003-c3:GATTCGAGTTGCCATA"	5.01711477813069	-8.69411947643431	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTCGAGTTGCCATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2476.7725572877	30.8208299792415	0.0124439484314188	1470	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2470.23870858232	2470.23870858232
"healthy-4003"	"2020-08-26-Control4003-c3:GATTCTTGTAATACCC"	10.5428768592769	6.10421416843263	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTCTTGTAATACCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1649.78777009698	45.4949288184012	0.0275762311025781	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1645.59704997779	1645.59704997779
"healthy-4003"	"2020-08-26-Control4003-c3:GATTCTTGTGTCTTGA"	-2.94006357613261	10.6570300825867	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTCTTGTGTCTTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1877.3449748677	38.9335027850456	0.0207385980234076	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.16573638266	1864.16573638266
"healthy-4003"	"2020-08-26-Control4003-c3:GATTCTTTCATAGCAC"	-4.02582297745402	11.4422101744446	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTCTTTCATAGCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2200.0892033328	41.342177083112	0.018791136750494	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2193.30464261725	2193.30464261725
"healthy-4003"	"2020-08-26-Control4003-c3:GATTGGTAGTTTGTCG"	-3.21961865845378	11.2260102995667	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTGGTAGTTTGTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1466.10699659488	33.0123668495014	0.0225170242868867	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1461.23667371875	1461.23667371875
"healthy-4003"	"2020-08-26-Control4003-c3:GATTGGTCACGGAAGT"	-3.48130379143413	12.7195358046326	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTGGTCACGGAAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1643.63326595079	36.0518072352548	0.021934216094367	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1641.43008561503	1641.43008561503
"healthy-4003"	"2020-08-26-Control4003-c3:GATTGGTCAGGAATAT"	-1.72462807121928	8.82594773853151	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTGGTCAGGAATAT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1817.62987633207	30.5707546358337	0.0168190207664966	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1815.79674749584	1815.79674749584
"healthy-4003"	"2020-08-26-Control4003-c3:GATTGGTGTACTCGTA"	5.3986460166866	-9.55019953167113	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTGGTGTACTCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2656.91289987481	36.061650354436	0.0135727634715219	1803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2650.21490608048	2650.21490608048
"healthy-4003"	"2020-08-26-Control4003-c3:GATTGGTTCCAAGGGA"	5.15135349807088	-9.85613634502562	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTGGTTCCAAGGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.04872531623	36.0940855856923	0.0159422742020055	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.80224129842	2259.80224129842
"healthy-4003"	"2020-08-26-Control4003-c3:GATTTCTAGACCAGAC"	5.45497097548787	-10.0509205094543	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTTCTAGACCAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2527.6468141741	18.0724171695949	0.00714989810611652	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.94031620509	2515.94031620509
"healthy-4003"	"2020-08-26-Control4003-c3:GATTTCTCACGGTGCT"	14.2756267982418	2.15707228267518	"2020-08-26-Control4003-c3"	"Control4003"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTTCTCACGGTGCT"	"Plasmablast"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1173.30993915322	3.26940226000665	0.00278647793810235	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1159.92315107877	1159.92315107877
"healthy-4003"	"2020-08-26-Control4003-c3:GATTTCTTCGGCCTTT"	6.77630343016927	-1.67995514785918	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTTCTTCGGCCTTT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2747.41578581462	28.7129819281674	0.0104509052020511	1664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2732.11758607736	2732.11758607736
"healthy-4003"	"2020-08-26-Control4003-c3:GATTTCTTCGTTCTAT"	5.59418167647664	-9.76031114971312	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GATTTCTTCGTTCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2439.59263247426	20.4226019254239	0.00837131644585722	1551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2436.04508389712	2436.04508389712
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACATAGAATCGAT"	-0.0314450663631738	8.2028827437195	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACATAGAATCGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1736.95917742508	18.6673511026875	0.0107471444034514	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1732.1701638096	1732.1701638096
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACATCATTGCCGG"	5.00667681273763	-8.68598749553832	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACATCATTGCCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.67471469385	27.3224892443262	0.0123593439879327	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.37013431093	2207.37013431093
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACATGTTAGGCCC"	-3.6952796978062	12.2199992903504	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACATGTTAGGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.7877577222	33.095287052691	0.0172210937028329	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1912.17181437631	1912.17181437631
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACATGTTGCGTAT"	4.7373591857845	-7.71704008495482	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACATGTTGCGTAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2562.60442306237	14.3261914255196	0.00559048103429069	1565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2554.64964134733	2554.64964134733
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACCGAGCTACAAA"	-4.18311057511027	12.9599113234314	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACCGAGCTACAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2068.06245701529	39.9610832202791	0.0193229576238004	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2062.29281114667	2062.29281114667
"healthy-4003"	"2020-08-26-Control4003-c3:GCAACCGGTGGCCACT"	-2.70854602280315	9.60794446552125	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAACCGGTGGCCACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2143.04706570855	31.8027727558118	0.0148399786755486	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2137.60771990372	2137.60771990372
"healthy-4003"	"2020-08-26-Control4003-c3:GCACATAGTAGGTTTC"	3.74718155440633	-6.45441439067992	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACATAGTAGGTTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.61415883957	29.6777671657678	0.0121599586146295	1408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2434.93092372228	2434.93092372228
"healthy-4003"	"2020-08-26-Control4003-c3:GCACATAGTGACTGTT"	-2.65051231804546	9.96757028186647	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACATAGTGACTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.70312639535	26.913132960521	0.0136358566800639	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1968.36319040953	1968.36319040953
"healthy-4003"	"2020-08-26-Control4003-c3:GCACATAGTTTGCCGG"	5.55039562758748	-10.1298275223938	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACATAGTTTGCCGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.48059960869	26.6886515477252	0.0120846212334643	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2202.33814504962	2202.33814504962
"healthy-4003"	"2020-08-26-Control4003-c3:GCACGGTCATGAATAG"	4.10444130477254	-6.80848553096923	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACGGTCATGAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.9932864366	38.8585079192796	0.0152986656015122	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2532.37822299681	2532.37822299681
"healthy-4003"	"2020-08-26-Control4003-c3:GCACGGTTCGTTCTCG"	-2.5568736595219	9.77079198444215	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACGGTTCGTTCTCG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1930.5490372016	38.4929601627474	0.0199388668306216	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1928.72369568051	1928.72369568051
"healthy-4003"	"2020-08-26-Control4003-c3:GCACGTGAGATCCTAC"	4.44876970824544	-7.05510523235472	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACGTGAGATCCTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2548.98775939706	16.9093033584379	0.00663373266352508	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2540.97553576558	2540.97553576558
"healthy-4003"	"2020-08-26-Control4003-c3:GCACGTGCATCTCGTC"	4.03299417075459	-7.63865282451781	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACGTGCATCTCGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.58054489687	38.3105303539011	0.0191114946473114	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2002.88023126139	2002.88023126139
"healthy-4003"	"2020-08-26-Control4003-c3:GCACGTGTCTGTGCAA"	0.0535224143764048	8.29782579028932	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACGTGTCTGTGCAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1565.82118976493	30.3974706781364	0.0194131174599187	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1558.10837076666	1558.10837076666
"healthy-4003"	"2020-08-26-Control4003-c3:GCACTAAAGCAGTAAT"	-3.83990035477336	10.780264831427	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACTAAAGCAGTAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2040.95134797432	38.4930432022689	0.018860343359225	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2027.77926046684	2027.77926046684
"healthy-4003"	"2020-08-26-Control4003-c3:GCACTAAGTTCCTAGA"	5.11329092559163	-10.3846941224304	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCACTAAGTTCCTAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2176.11413207368	33.6795792836703	0.0154769360610585	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2157.81619522822	2157.81619522822
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCCAGTGCATTTG"	10.2786823707515	5.81937024677125	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCCAGTGCATTTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1401.00603461438	12.5008610858566	0.00892277461838152	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1396.86767803903	1396.86767803903
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCCAGTGTATCCA"	0.173348006873769	8.28601739490358	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCCAGTGTATCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1573.72094199258	34.1428537316709	0.0216956213904358	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1571.8362092478	1571.8362092478
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGAGAAGCTGC"	5.5772086578304	-10.1323366395203	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGAGAAGCTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.95343868788	11.1022484787274	0.00496533080100386	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2234.37516571222	2234.37516571222
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGAGACTACGG"	2.76473822173421	-6.58940222179564	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGAGACTACGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.22389370707	25.1861719137362	0.0118846205861142	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2111.75881421544	2111.75881421544
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGAGTTGGAGC"	3.59655417975728	-7.02792074596556	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGAGTTGGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2000.18981182885	4.41187724893421	0.00220572928771209	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1998.54188302993	1998.54188302993
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGGTCCTTTGC"	5.03666748580281	-8.01144697582396	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGGTCCTTTGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.47472640248	17.1057215957662	0.00794700229737692	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2152.47472640248	2152.47472640248
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGTCACCGACG"	4.67081656035726	-6.91684868251952	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGTCACCGACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.31607068033	38.5211661026966	0.0153146423830058	1563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.44423982507	2511.44423982507
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGCTGTCAGACAAA"	5.42803206023518	-10.1506090394226	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGCTGTCAGACAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.53717895896	3.89081725071421	0.00170684526956963	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.17306120144	2278.17306120144
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGGCTAGCTGGTGA"	5.36902107772176	-9.34653665935668	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGGCTAGCTGGTGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.79160162094	19.927368406709	0.00864231112330376	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2303.09272595268	2303.09272595268
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGGCTGTCTGTGAT"	-2.45305571976359	4.09428260410158	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGGCTGTCTGTGAT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3380.66754814184	39.4010440581202	0.011654811807738	5982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3371.79385846419	3371.79385846419
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGTTACAGGGATAC"	4.50880064544026	-8.28976061260375	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGTTACAGGGATAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1941.00104110511	20.1191302481695	0.0103653371750459	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1937.13188358283	1937.13188358283
"healthy-4003"	"2020-08-26-Control4003-c3:GCAGTTATCCTGTTGC"	3.37005271491353	-7.11616947567137	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCAGTTATCCTGTTGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.52449566024	18.3324882098571	0.00783264103573746	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2337.71685346043	2337.71685346043
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCGGCAATGCAAA"	3.55239548262898	-6.38707115566405	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCGGCAATGCAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.98120954147	27.4850975461831	0.0125332116055522	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2189.84722745079	2189.84722745079
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCGGCAGACCTAT"	3.22864927825276	-6.53457453167113	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCGGCAGACCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1987.96019269991	4.67416612130907	0.0023512372825539	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.63534169395	1984.63534169395
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCGGGTTAAGGAT"	-3.00134501877483	-5.63890745556029	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCGGGTTAAGGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2257.6196977671	32.8750932243017	0.0145618384074239	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2254.64024276289	2254.64024276289
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCGGTCAGTCACA"	5.44779266890828	-9.76444246685179	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCGGTCAGTCACA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2417.96442691199	37.7766785623217	0.0156233392608537	1420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2412.42688798315	2412.42688798315
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCTCAGTATTCCG"	4.43448319014851	-7.21669771587523	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCTCAGTATTCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2286.9488415952	35.2230610542318	0.0154017704347348	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.95261271006	2283.95261271006
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCTCTCATCTCTA"	-4.14582333985026	12.4847697981629	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCTCTCATCTCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1621.49398284685	48.9246792344733	0.0301725937635467	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1616.75546437594	1616.75546437594
"healthy-4003"	"2020-08-26-Control4003-c3:GCATCTCTCGCATAGT"	-4.24666819992717	12.8675069578919	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATCTCTCGCATAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1877.01090775437	38.1739132259416	0.0203376086245617	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1869.1703074122	1869.1703074122
"healthy-4003"	"2020-08-26-Control4003-c3:GCATGATAGCACTAGG"	-1.38917384567912	8.73405644977418	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATGATAGCACTAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1525.1556760689	6.97071646284062	0.00457049504664842	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1519.09055424762	1519.09055424762
"healthy-4003"	"2020-08-26-Control4003-c3:GCATGATCATTACGGT"	-3.63812718811687	10.6892919310364	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATGATCATTACGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1807.95793020079	39.689789908321	0.021952828240817	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1797.68273365876	1797.68273365876
"healthy-4003"	"2020-08-26-Control4003-c3:GCATGATGTTTCGCTC"	-0.466781298548538	8.39594266498414	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATGATGTTTCGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2009.47837017401	42.5002114341368	0.0211498725564568	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2003.86588803774	2003.86588803774
"healthy-4003"	"2020-08-26-Control4003-c3:GCATTAGGTTGGAGAC"	-4.03553471985515	12.8513364561829	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCATTAGGTTGGAGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1720.66923004071	36.6747532720836	0.0213142378743043	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1708.81290987663	1708.81290987663
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAACGAGCATCAGG"	3.55495800551717	-6.88669397747191	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAACGAGCATCAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1987.50284718839	32.3986431571452	0.0163011807520063	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1987.50284718839	1987.50284718839
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAACGAGCGTATGG"	5.03482260283772	-8.39248754894408	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAACGAGCGTATGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.91638370493	28.8057243558451	0.011606242879482	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.25300282459	2471.25300282459
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAACGAGCTCCACG"	4.94436468657796	-7.49611761486205	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAACGAGCTCCACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3126.16828405179	26.4794008861561	0.00847024167612514	2945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3119.19344482772	3119.19344482772
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAACGAGGTGAGCT"	3.09821762618367	-7.26530458843382	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAACGAGGTGAGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.68327563623	25.0994097140259	0.0148721090481647	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1687.68327563623	1687.68327563623
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCAAGAGTCACG"	10.2264219718868	7.66059777820436	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCAAGAGTCACG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2139.26952101366	27.2517280369311	0.0127388006837111	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2133.27501688546	2133.27501688546
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCAAGAGTCTTC"	4.88111319121663	-7.68924620067748	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCAAGAGTCTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.1445226881	16.2292758069751	0.00722861073885075	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.37772840499	2242.37772840499
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCAAGTTGTAAG"	5.04801191863362	-8.61157419597777	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCAAGTTGTAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.41978628835	31.7808876571291	0.0154996980958024	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.18742594942	2047.18742594942
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCACAATAGTCC"	-2.94963870468791	10.8971662291321	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCACAATAGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.88355840984	42.2055912857169	0.0229892528272728	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1832.1952763861	1832.1952763861
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCACAGTCAGAG"	3.12959112700765	-7.00991346752318	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCACAGTCAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.63062204302	38.8736575192019	0.0165094504230446	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2352.06544437907	2352.06544437907
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCAGTCAACACT"	4.86662687835042	-7.54409792339476	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCAGTCAACACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.61417937025	11.857166109078	0.00500172748997385	1310	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2366.10893857386	2366.10893857386
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGCATCGTGAGAG"	3.45600785788838	-7.27593519603881	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGCATCGTGAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.33861340269	36.6785957991051	0.0170889139160371	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.33861340269	2146.33861340269
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGGTCACTGTTCC"	-2.17371259155925	9.37366769397584	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGGTCACTGTTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.01648577128	11.8426229342926	0.00645368748788924	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1832.91381522844	1832.91381522844
"healthy-4003"	"2020-08-26-Control4003-c3:GCCAGGTGTCGGCACT"	-6.24354825440105	3.55510208690492	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCAGGTGTCGGCACT"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2565.05532073823	34.3274885429908	0.0133827478360627	2217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2548.88558993383	2548.88558993383
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATGGAGCACTAGG"	4.13754190978352	-6.52577450191649	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATGGAGCACTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.89676404703	25.5175367149448	0.0119862724890595	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2124.30370129283	2124.30370129283
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATGGCATTCTCTA"	-3.38780317726787	10.2684335478577	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATGGCATTCTCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2090.1430490061	33.0277065619355	0.0158016488764445	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2079.1878365115	2079.1878365115
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATGGGTTGCCAAT"	5.46823467788045	-10.0217228165832	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATGGGTTGCCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.96716388287	4.3463963046292	0.00204347127611253	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2123.73105709821	2123.73105709821
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATGGTCCACACAA"	0.431110908358735	9.85599229419557	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATGGTCCACACAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1737.52602551819	46.9644831881123	0.0270295135142542	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.09744452816	1729.09744452816
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATGGTCGTGTTCC"	2.62766494330708	-4.35970070278319	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATGGTCGTGTTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2243.1858468742	34.8674884118445	0.0155437359148958	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2243.1858468742	2243.1858468742
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATTCGTGTCCGGT"	3.77064051207845	-7.60995867168578	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATTCGTGTCCGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.91394572722	35.1897246988929	0.0163072882348114	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2145.03931788135	2145.03931788135
"healthy-4003"	"2020-08-26-Control4003-c3:GCCATTCTCCTATTGT"	4.12348284301106	-7.20556976711424	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCATTCTCCTATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.958429373	29.5863868951928	0.0118537178131709	1682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2483.87485558741	2483.87485558741
"healthy-4003"	"2020-08-26-Control4003-c3:GCCCAGAAGGTAGCCA"	3.89225258406941	-7.88615515148314	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCCAGAAGGTAGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.69433763451	29.9877252682788	0.0126174093123499	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.32728840268	2375.32728840268
"healthy-4003"	"2020-08-26-Control4003-c3:GCCCAGATCGCGTGCA"	5.01977505263631	-7.83244850551756	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCCAGATCGCGTGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2672.88227181147	7.48120384155911	0.00279892755489337	1722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2664.30329352022	2664.30329352022
"healthy-4003"	"2020-08-26-Control4003-c3:GCCCGAAAGTTGTACC"	-3.9116030735081	11.2296714552673	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCCGAAAGTTGTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1844.05689024423	28.11315321117	0.0152452743512954	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1844.05689024423	1844.05689024423
"healthy-4003"	"2020-08-26-Control4003-c3:GCCCGAAGTGTCGATT"	-3.70334611359294	10.3079805144104	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCCGAAGTGTCGATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.69443810806	35.0331134777007	0.01777703980904	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1966.9269794976	1966.9269794976
"healthy-4003"	"2020-08-26-Control4003-c3:GCCCGAATCCAGCAAT"	-3.54420218887981	-4.97888758098754	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCCGAATCCAGCAAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3149.58442121762	36.1320873714088	0.0114720174280771	3420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	3140.17670458638	3140.17670458638
"healthy-4003"	"2020-08-26-Control4003-c3:GCCGATGTCATTTCCA"	-3.08593259277995	10.0892019041809	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCGATGTCATTTCCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.33596083528	29.6972324676031	0.0171231140553071	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.21559528112	1730.21559528112
"healthy-4003"	"2020-08-26-Control4003-c3:GCCGTGAGTGTCATTG"	3.77023400840108	-7.92853500759276	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCGTGAGTGTCATTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1684.35391139227	5.41934801229892	0.00321746396386455	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1680.33493372619	1680.33493372619
"healthy-4003"	"2020-08-26-Control4003-c3:GCCTGTTCAACACAGG"	-3.91461453858073	12.9051389464172	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCCTGTTCAACACAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1856.76372341357	39.5134089949513	0.0212807954489265	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1841.8657926139	1841.8657926139
"healthy-4003"	"2020-08-26-Control4003-c3:GCGAGAAAGTATAGAC"	0.786836524575394	8.39683339679567	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGAGAAAGTATAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1419.09876292851	39.9216041424736	0.0281316601672527	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1410.92809209925	1410.92809209925
"healthy-4003"	"2020-08-26-Control4003-c3:GCGAGAACATAAGCAA"	-4.25706801834758	12.9622993239197	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGAGAACATAAGCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2164.4589665913	40.9087967667716	0.0189002413065824	1074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2157.31110930203	2157.31110930203
"healthy-4003"	"2020-08-26-Control4003-c3:GCGAGAAGTTCGTTCC"	-2.75212917748149	10.2537622221741	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGAGAAGTTCGTTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1811.02640282175	43.3561760601049	0.0239401126303581	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.26855843201	1807.26855843201
"healthy-4003"	"2020-08-26-Control4003-c3:GCGATCGCAAGCCCAC"	0.0498549166018188	8.24298284137575	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGATCGCAAGCCCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1629.06686173005	37.5248448386645	0.0230345639704521	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1627.1416648029	1627.1416648029
"healthy-4003"	"2020-08-26-Control4003-c3:GCGATCGCACGCCAGT"	-4.54917226257976	11.4920224913391	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGATCGCACGCCAGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	2540.46505950506	35.8293473975547	0.0141034600194561	1451	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2528.52904253937	2528.52904253937
"healthy-4003"	"2020-08-26-Control4003-c3:GCGGAAACAGGTTACT"	5.07167114791219	-10.2460899583069	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGGAAACAGGTTACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1997.75966020182	33.4976733660003	0.0167676192653806	909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1993.88166092777	1993.88166092777
"healthy-4003"	"2020-08-26-Control4003-c3:GCGGAAACATGCTGCG"	4.23434652861897	-7.36281492626341	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGGAAACATGCTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2031.94635477838	31.7089829634821	0.0156052264317483	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2024.88562470246	2024.88562470246
"healthy-4003"	"2020-08-26-Control4003-c3:GCGGAAATCACCACAA"	2.69303645667378	-4.41859486019286	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGGAAATCACCACAA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2381.53022826746	27.0844099234174	0.0113726920624144	1849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2374.17287444643	2374.17287444643
"healthy-4003"	"2020-08-26-Control4003-c3:GCGGATCAGCGCCTAC"	0.231401716440362	8.69897554004518	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGGATCAGCGCCTAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1419.92485532847	34.3008451619107	0.0241568031105251	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1412.55906803221	1412.55906803221
"healthy-4003"	"2020-08-26-Control4003-c3:GCGGATCGTCGAGTGA"	5.43256201323811	-10.0111150971619	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGGATCGTCGAGTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2410.32361674498	35.0856014534045	0.0145563862087473	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.4893961508	2400.4893961508
"healthy-4003"	"2020-08-26-Control4003-c3:GCGTGCAAGCTAAACA"	-3.96551213684734	12.9860353239807	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGTGCAAGCTAAACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1619.05251600785	48.4676097202629	0.0299357860483556	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1611.86976556088	1611.86976556088
"healthy-4003"	"2020-08-26-Control4003-c3:GCGTGCAAGTTTCGAC"	-3.44856391373332	10.6322602995667	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGTGCAAGTTTCGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1872.88117093912	41.8106979530096	0.0223242662704781	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1863.12194426194	1863.12194426194
"healthy-4003"	"2020-08-26-Control4003-c3:GCGTTTCTCTTCCCGA"	-2.06197653237041	9.59869000995485	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCGTTTCTCTTCCCGA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1719.2515780406	18.136502289831	0.0105490682815024	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1715.19365195998	1715.19365195998
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACAAAGCCTAGGA"	4.52522625502889	-7.33324959194335	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACAAAGCCTAGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2082.14052755678	9.18894601775762	0.00441322086388669	1011	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2082.14052755678	2082.14052755678
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACAAAGTAGTCCT"	3.41774525222127	-6.75230362331542	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACAAAGTAGTCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.29865603661	2.35615058007547	0.00107424977149858	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2189.56158475257	2189.56158475257
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACAAGTACTCAAC"	-3.89133129540141	10.380045867804	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACAAGTACTCAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1976.10017793866	4.16930905342749	0.00210986725266967	919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1968.47334623551	1968.47334623551
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACAAGTCGGCTAC"	3.43511476096455	-6.62749817287596	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACAAGTCGGCTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.96371651026	27.8864309907749	0.0114243529316539	1506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2436.33806864412	2436.33806864412
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACAATCGAGATGG"	-3.74262271347697	12.9277362593445	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACAATCGAGATGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1822.4810140573	38.3178086654682	0.0210250797511263	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1818.55917463559	1818.55917463559
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACCTAGACCAGAC"	10.5204445320064	6.32147357547609	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACCTAGACCAGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1676.87916441837	26.2686031123485	0.0156651735376889	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1668.80622025543	1668.80622025543
"healthy-4003"	"2020-08-26-Control4003-c3:GCTACCTAGGATTTCC"	-3.81369386139568	12.7320403822693	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTACCTAGGATTTCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1666.28835086969	32.4976091283366	0.0195029924510815	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1664.07001084049	1664.07001084049
"healthy-4003"	"2020-08-26-Control4003-c3:GCTCAAATCACTAGCA"	-3.78249583664592	13.0536412962708	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTCAAATCACTAGCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2263.03353634503	37.9781417483501	0.0167819615301361	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2261.23178976403	2261.23178976403
"healthy-4003"	"2020-08-26-Control4003-c3:GCTCAAATCGCTGATA"	4.63579954680745	-7.31088735973509	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTCAAATCGCTGATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2862.61066598075	27.0931914422857	0.00946450446938559	2111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2854.51728818351	2854.51728818351
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGAATGTGAGTCAG"	-0.653764168650466	8.90559575641481	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGAATGTGAGTCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1878.26532451222	37.4724511915657	0.0199505632684228	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1870.5392833801	1870.5392833801
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGAATGTTGGGCCT"	5.34710468825643	-9.17174723064574	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGAATGTTGGGCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2956.07846562252	36.979544085602	0.0125096625531604	2272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2947.53002700448	2947.53002700448
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGCAGAGGACAGCT"	-4.06294427338298	12.8475084074768	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGCAGAGGACAGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2010.46204658083	31.2608368247018	0.0155490808084971	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2004.81507663986	2004.81507663986
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGCAGAGTACAACA"	4.46506418761556	-7.34354021465453	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGCAGAGTACAACA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2534.82596515258	36.1252523546566	0.014251571055089	1509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2529.4955376656	2529.4955376656
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGCAGAGTATGACA"	4.48118557509725	-7.42513658916625	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGCAGAGTATGACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.42674712204	32.5854472007472	0.0132599871955121	1712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2456.35568831914	2456.35568831914
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGCAGAGTCCCAGC"	3.0102764564449	-5.08889439022215	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGCAGAGTCCCAGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2389.83475613859	41.288836734364	0.0172768584222438	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2383.38419521681	2383.38419521681
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGGGTGTGCGGTAA"	4.28966679152791	-7.68721439754637	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGGGTGTGCGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2164.83968121812	26.7836879294278	0.0123721346027605	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2163.16193136353	2163.16193136353
"healthy-4003"	"2020-08-26-Control4003-c3:GCTGGGTTCCGCACGA"	5.51225723800008	-10.137288116571	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTGGGTTCCGCACGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2810.9796597801	18.2998349159723	0.00651012711966897	1971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2796.19556052223	2796.19556052223
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTCACGTTCCCACT"	5.55678667601888	-10.027484916803	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTCACGTTCCCACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.30973769013	23.4096416787928	0.0107122762851626	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2185.30973769013	2185.30973769013
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTCACTCCACGTAA"	4.21097006377522	-7.05996563350829	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTCACTCCACGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2846.7347516212	30.710067466179	0.0107878218891626	2161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2841.78919277438	2841.78919277438
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTGGGCAGAGCGTA"	5.29073347625081	-10.1013794175354	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTGGGCAGAGCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.99012703936	30.1097868537794	0.0149651762447194	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2010.37021944295	2010.37021944295
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTGGGGTACAGTTC"	5.57847036895101	-10.1348657838074	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTGGGGTACAGTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2155.32628726926	4.57974996806775	0.002124852276483	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.49763810781	2150.49763810781
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTGGGTCACCTCGT"	4.26709522780721	-8.1838703385559	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTGGGTCACCTCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1810.04924521706	0	0	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1810.04924521706	1810.04924521706
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTTCGCAGCGAGTA"	3.92032494124715	-6.84175589000853	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTTCGCAGCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.14679461724	35.083621442146	0.0151082702968952	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2320.69487728664	2320.69487728664
"healthy-4003"	"2020-08-26-Control4003-c3:GCTTTCGTCTGACAGT"	3.84314312514607	-6.60323288356932	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GCTTTCGTCTGACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2620.57922148657	38.9365098570845	0.0148579785483444	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2619.38244881384	2619.38244881384
"healthy-4003"	"2020-08-26-Control4003-c3:GGAACCCAGCGTATAA"	4.95884337004964	-7.73515655910643	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAACCCAGCGTATAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.83954339288	26.8977774220934	0.0115498628913292	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2327.44912538152	2327.44912538152
"healthy-4003"	"2020-08-26-Control4003-c3:GGAACCCCATAGGTAA"	3.74032702025716	-6.9158654442993	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAACCCCATAGGTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.2923792915	26.3080330475936	0.012615992514456	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2079.80548640202	2079.80548640202
"healthy-4003"	"2020-08-26-Control4003-c3:GGAACCCCATCCGAGC"	5.35391869124715	-9.26704027568968	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAACCCCATCCGAGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.57141470339	20.2214493952576	0.00859912196109431	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2344.54612438298	2344.54612438298
"healthy-4003"	"2020-08-26-Control4003-c3:GGAAGTGAGAAGTCTA"	4.78197016295735	-7.81274845516356	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAAGTGAGAAGTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.07199978234	45.3929331252862	0.0208984477171267	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2169.39017908453	2169.39017908453
"healthy-4003"	"2020-08-26-Control4003-c3:GGAAGTGCACCCTAAA"	2.31884493407552	-6.6688590279785	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAAGTGCACCCTAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.86527148887	5.18122328502388	0.00276057283585078	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1873.66424242175	1873.66424242175
"healthy-4003"	"2020-08-26-Control4003-c3:GGAAGTGCATGACGGA"	0.0281753680551469	8.41536805713502	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAAGTGCATGACGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1783.19612054925	30.4672757824325	0.0170857683186571	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1775.58258000279	1775.58258000279
"healthy-4003"	"2020-08-26-Control4003-c3:GGAAGTGTCTCTATAC"	-5.57501683655437	3.58714888179628	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAAGTGTCTCTATAC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2408.8437949195	36.6596470914983	0.0152187730764516	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2403.39845891113	2403.39845891113
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATCTCAAAGCTCT"	-0.257144103676635	8.32608316028444	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATCTCAAAGCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1758.73836126574	33.2901484611029	0.0189284257364719	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1741.02136555452	1741.02136555452
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATCTCAAATTGCC"	0.725497921078843	8.30831143939821	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATCTCAAATTGCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1675.06270242841	32.7175604770697	0.019532140754873	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1672.21362058272	1672.21362058272
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATCTCAGCTGAGA"	4.07352175292317	-7.26865007793578	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATCTCAGCTGAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.83465976148	11.0752911978226	0.00478035458903347	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2311.39356177334	2311.39356177334
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATCTTCGATTCCC"	3.63609494742696	-7.04765942012938	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATCTTCGATTCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2038.50533827929	7.03330546269188	0.003450226659023	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2035.12253434785	2035.12253434785
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATGGCACGTCGGT"	9.54148735579793	6.71516797626344	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATGGCACGTCGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1642.33043564999	22.5955047126232	0.0137581964153764	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1638.80111525162	1638.80111525162
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATGGCAGGTATGG"	3.61516918715779	-7.23171379482421	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATGGCAGGTATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.1341725551	10.8232869478048	0.00451133040895246	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2395.16493066707	2395.16493066707
"healthy-4003"	"2020-08-26-Control4003-c3:GGAATGGCATCCCGTT"	5.04246725615804	-7.67314436351927	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAATGGCATCCCGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.92040986903	7.64262763681981	0.00289721691686644	1731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2629.7959504212	2629.7959504212
"healthy-4003"	"2020-08-26-Control4003-c3:GGACGTCCATTCTGTT"	-7.28461966934856	0.400074667576231	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGACGTCCATTCTGTT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2456.83794282449	27.8386478541867	0.0113310883754027	2360	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2452.51127030741	2452.51127030741
"healthy-4003"	"2020-08-26-Control4003-c3:GGACGTCGTTCTTGTT"	-1.99025950852092	9.15751836383668	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGACGTCGTTCTTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1541.18940867357	41.8849999968596	0.0271770619244704	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1539.01538835779	1539.01538835779
"healthy-4003"	"2020-08-26-Control4003-c3:GGACGTCTCCTAAACG"	-1.08486602726634	9.44564912402955	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGACGTCTCCTAAACG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1870.26845775209	43.4283400058565	0.023220377708799	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1865.24062924102	1865.24062924102
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGAACAGACCTCCG"	-3.85414038124736	13.1192407377991	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGAACAGACCTCCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2185.78630261466	29.5221081251847	0.0135064018334592	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2171.85652460575	2171.85652460575
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGAACGTTTCTATC"	5.04270233687703	-8.0067405930725	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGAACGTTTCTATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2552.51934008237	25.209323907902	0.00987625187086281	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2552.51934008237	2552.51934008237
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGATGAGAGAAGGT"	4.26559271392171	-8.05157282268675	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGATGAGAGAAGGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2494.5926400262	8.32278614960129	0.00333633075639711	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.83144214332	2489.83144214332
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGATGTCCCTCTAG"	-4.32414279404338	12.8173408278259	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGATGTCCCTCTAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1840.16583564639	30.7616328857417	0.0167167720918675	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1833.63770462147	1833.63770462147
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGCAACAGTGCCTG"	0.509726186364335	8.54270074451295	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGCAACAGTGCCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1501.00788531721	31.1384399580351	0.0207450209040405	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1495.36068159477	1495.36068159477
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGCAAGTAGCTTGT"	0.116077442734879	8.14477059924928	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGCAAGTAGCTTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1427.57124100606	16.9745431170979	0.0118905050967091	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1423.19729511749	1423.19729511749
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGCAAGTCCTCCAT"	-3.09115324440654	9.54041764819948	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGCAAGTCCTCCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2147.17842576178	34.852153969413	0.0162316058839163	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2138.35773827262	2138.35773827262
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGCAATCGTAGAGG"	0.101159346371335	8.35138223255006	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGCAATCGTAGAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1664.7029652345	25.5136014157323	0.0153262185197935	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1661.22830326429	1661.22830326429
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGGATCAGACCTGC"	-3.84446726265605	12.8824262388977	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGGATCAGACCTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1611.32886954557	40.9164414962419	0.0253929798376797	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1609.07918258338	1609.07918258338
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGGTACAACCCTAA"	4.79901852187459	-7.29008772289427	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGGTACAACCCTAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.01164272384	5.70603459309379	0.00261144356465791	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2180.28193535419	2180.28193535419
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGGTACAGGGATAC"	-3.97274861756023	12.9360379942688	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGGTACAGGGATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2106.25757487123	42.4098524281967	0.0201351690952563	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2101.14834257917	2101.14834257917
"healthy-4003"	"2020-08-26-Control4003-c3:GGAGGTACATTGGATC"	-3.69570265236552	10.6726541289124	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGAGGTACATTGGATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1902.01317595144	38.6662483486944	0.0203291169785679	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1888.53157082608	1888.53157082608
"healthy-4003"	"2020-08-26-Control4003-c3:GGATCTAAGAAGTCTA"	4.55517353591268	-6.96616604244383	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGATCTAAGAAGTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2569.35879358728	32.273583975241	0.0125609486910862	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2561.08493906335	2561.08493906335
"healthy-4003"	"2020-08-26-Control4003-c3:GGATCTACAAATTGGA"	-0.191888729960281	8.38697812640993	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGATCTACAAATTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1488.67381646171	27.6056792105486	0.018543806511061	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1474.17179728801	1474.17179728801
"healthy-4003"	"2020-08-26-Control4003-c3:GGATCTACAGCCGTTG"	-2.79063544693645	12.0926561125549	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGATCTACAGCCGTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1646.43705047712	44.9496170318503	0.0273011452328677	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1636.05101411836	1636.05101411836
"healthy-4003"	"2020-08-26-Control4003-c3:GGATGTTCACGATAGG"	3.96548022803609	-7.15383341228636	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGATGTTCACGATAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.42695890019	28.1007739871336	0.0120893340526516	1297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2321.50149961985	2321.50149961985
"healthy-4003"	"2020-08-26-Control4003-c3:GGCACGTAGGACGCAT"	4.52421249923055	-7.30428078090819	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCACGTAGGACGCAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2830.08494892916	36.3434153661688	0.0128418107661116	2218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2817.9336379453	2817.9336379453
"healthy-4003"	"2020-08-26-Control4003-c3:GGCACGTGTAAGGTCG"	0.772233327000779	8.58559224689332	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCACGTGTAAGGTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1498.40742940962	8.53597712275197	0.00569669967941576	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1495.11674989037	1495.11674989037
"healthy-4003"	"2020-08-26-Control4003-c3:GGCACGTGTTCCATTT"	4.64717258986775	-7.45003273403319	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCACGTGTTCCATTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.80854918462	14.9756500268359	0.00657747443552032	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2276.80854918462	2276.80854918462
"healthy-4003"	"2020-08-26-Control4003-c3:GGCAGTCGTTGCGGCT"	1.38200892981831	-7.16130402004393	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCAGTCGTTGCGGCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1980.64993101099	31.7822038969686	0.0160463509474115	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1978.98545720788	1978.98545720788
"healthy-4003"	"2020-08-26-Control4003-c3:GGCGTCAGTGCCTGCA"	4.72294392165486	-8.33207991039427	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCGTCAGTGCCTGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.6831082232	6.81905814709103	0.00313998765347959	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2170.0446056675	2170.0446056675
"healthy-4003"	"2020-08-26-Control4003-c3:GGCGTCATCATACGGT"	5.57148518142049	-9.77404882824095	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCGTCATCATACGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.06108429682	33.131731261363	0.0147379141486835	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2241.65173743991	2241.65173743991
"healthy-4003"	"2020-08-26-Control4003-c3:GGCGTCATCCAAATGC"	-1.71700618687328	10.8844156035217	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCGTCATCCAAATGC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1907.10823262379	36.4944052992159	0.0191359906453799	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1899.49815136889	1899.49815136889
"healthy-4003"	"2020-08-26-Control4003-c3:GGCTTGGCAGCTTTCC"	5.55741037902181	-9.87458898937377	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCTTGGCAGCTTTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.70242315421	25.1418787064042	0.00990343668367665	1549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2531.64060201069	2531.64060201069
"healthy-4003"	"2020-08-26-Control4003-c3:GGCTTGGTCGCCACTT"	2.55902542647664	-4.3443927994934	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCTTGGTCGCCACTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2550.81509096853	27.1215505359361	0.0106325035601221	1997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2543.62271366652	2543.62271366652
"healthy-4003"	"2020-08-26-Control4003-c3:GGCTTTCAGGTAAAGG"	-0.0248914090102494	8.67682836139528	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCTTTCAGGTAAAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1678.69085529878	27.0096823050502	0.0160897298152273	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1673.91279714018	1673.91279714018
"healthy-4003"	"2020-08-26-Control4003-c3:GGCTTTCCAAGTGCTT"	4.66768660125081	-7.02671482479247	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCTTTCCAAGTGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2900.424430085	32.0806470653084	0.011060673304413	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2894.81969172209	2894.81969172209
"healthy-4003"	"2020-08-26-Control4003-c3:GGCTTTCGTAAGTTAG"	3.34891380843465	-7.31208612835082	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGCTTTCGTAAGTTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2418.1774181606	26.0281035964361	0.0107635210720951	1492	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2413.11628190575	2413.11628190575
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAAGTGTAGTCGGA"	4.87969793853108	-8.20863726055297	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAAGTGTAGTCGGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2281.12357868744	17.7421306357695	0.0077778033603854	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2279.84935422103	2279.84935422103
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAAGTTCTGTGCGG"	3.32627787169759	-7.51913788234862	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAAGTTCTGTGCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.60740725124	31.0214432334051	0.016390849530944	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1887.65425728163	1887.65425728163
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACAAAGCAGAAAG"	3.47407331046407	-5.79810287868651	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACAAAGCAGAAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2594.59089016374	33.7293182868184	0.0129998599835868	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2590.48540109918	2590.48540109918
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACAACAAATCAAG"	5.1590162712032	-8.72983457958373	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACAACAAATCAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.35629541428	29.9428361940793	0.0127288694541938	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.03980831979	2351.03980831979
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACAACAAGTATAG"	4.05208291587178	-7.06169083034667	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACAACAAGTATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2272.54781256798	22.3277241192493	0.00982497441671822	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.86388752921	2264.86388752921
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACCTCATGTTCGA"	-0.312466512352782	8.3191346892151	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACCTCATGTTCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1650.92283613249	35.756123897773	0.0216582647687741	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1649.30220018849	1649.30220018849
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACCTTCTGAGTCA"	-2.55882249298747	9.95120713794557	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACCTTCTGAGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1950.55917126056	33.2005096583802	0.0170210215345193	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1946.60162218205	1946.60162218205
"healthy-4003"	"2020-08-26-Control4003-c3:GGGACTCTCTTGCGCT"	0.162255277007264	8.42450425708619	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGACTCTCTTGCGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1706.64289082507	14.6538856291743	0.00858638072906394	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1702.88087519971	1702.88087519971
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGATAGATAGGGA"	5.54893555220906	-9.69784262096556	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGATAGATAGGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.72434813245	40.539727032516	0.0154571055327957	1791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2619.38820278441	2619.38820278441
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGATCACGCTGCA"	3.16220297393147	-6.44298937236937	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGATCACGCTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.04927838378	24.5731797188893	0.0110092460578122	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2229.11278960047	2229.11278960047
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGATCATGGAGAC"	5.44603933867757	-9.62456896221312	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGATCATGGAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.03204725536	30.4060002708446	0.0129055970636163	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.3348782742	2349.3348782742
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGATTCCTACCAC"	-3.41934452477153	10.2821626433167	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGATTCCTACCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1837.60086138397	28.4012359394678	0.0154556065663126	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1835.59423463929	1835.59423463929
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGATTCGGAAGGT"	5.58876480635945	-10.2195949784485	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGATTCGGAAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.13833274329	34.3100236677003	0.0149165044463999	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2298.54269719448	2298.54269719448
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGTAAGAATTTGG"	5.45444979247395	-9.56355383312377	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGTAAGAATTTGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.92714853783	5.04572781770171	0.00205702310429783	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2448.8889442554	2448.8889442554
"healthy-4003"	"2020-08-26-Control4003-c3:GGGAGTACACCTATCC"	3.50000443038289	-7.30123855983885	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGAGTACACCTATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2295.43630764215	13.4370954592901	0.00585383067025394	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2292.69061986278	2292.69061986278
"healthy-4003"	"2020-08-26-Control4003-c3:GGGATCCAGGCTTAGG"	4.15816702422444	-7.3636627427307	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGATCCAGGCTTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2405.19742538989	32.4758962218354	0.0135023827478823	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.11644172319	2400.11644172319
"healthy-4003"	"2020-08-26-Control4003-c3:GGGATCCCAATACCCA"	5.30257000502889	-9.98246004497679	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGATCCCAATACCCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.53363839549	28.8138868949389	0.0130999982868905	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2192.69777483229	2192.69777483229
"healthy-4003"	"2020-08-26-Control4003-c3:GGGATCCCAGCATTGT"	4.60526718673055	-7.38358786022338	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGATCCCAGCATTGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.14247563657	18.573566977288	0.00770322250342521	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.28018391718	2407.28018391718
"healthy-4003"	"2020-08-26-Control4003-c3:GGGATCCGTTAATCGC"	0.19587462124173	8.399950958136	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGATCCGTTAATCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1670.82957493404	23.02557440746	0.0137809234124726	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1661.97691305068	1661.97691305068
"healthy-4003"	"2020-08-26-Control4003-c3:GGGATGACACGAAAGC"	6.81826176223103	-1.57545032417449	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGATGACACGAAAGC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2377.84627438198	27.6619038941974	0.0116331758668406	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2370.90243185745	2370.90243185745
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCCATCAAAGGTTA"	3.92353453215901	-7.07975628292235	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCCATCAAAGGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.9315318126	22.9251890683882	0.0114401059639257	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1998.27618118627	1998.27618118627
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTCAAGCGATG"	3.91292156752889	-6.78048565303954	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTCAAGCGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.57416338446	29.5347032665712	0.0122470640608961	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2400.26887658369	2400.26887658369
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTCACGAAGAC"	0.128817183046979	8.50887105548707	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTCACGAAGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1706.60283409658	37.5583488581013	0.0220076681625714	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1704.66069894835	1704.66069894835
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTCAGCCGTCA"	5.26299681243245	-9.99005319988402	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTCAGCCGTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2148.35692369633	4.01476013022651	0.00186875843857406	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2146.82674595606	2146.82674595606
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTGTAGACAGC"	1.74878301200215	-5.952663444635	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTGTAGACAGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2355.62479005046	36.2468552606835	0.0153873636471227	1352	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2351.42246061806	2351.42246061806
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTTCCCGAGAC"	5.5200592475826	-10.0950165024963	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTTCCCGAGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.93786265312	21.4009308263101	0.0091851938068171	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.50855125197	2328.50855125197
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCGTTTCTGGACTA"	2.55720486220662	-4.29727795040282	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCGTTTCTGGACTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2414.97503810093	25.4494045147909	0.0105381646241791	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2408.08668657179	2408.08668657179
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCTACTCAACGTGT"	6.7687484222347	-1.71049919044646	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCTACTCAACGTGT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2880.5202818595	20.6039549360329	0.00715285883102069	2204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2866.76263905461	2866.76263905461
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCTCAAGATGCAGC"	-1.09024606171306	8.64642427051393	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCTCAAGATGCAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.97554602985	42.4234354887842	0.0232715329512652	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1817.35000600003	1817.35000600003
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCTCATCCTCAGAA"	-3.09423146668132	10.4974088438782	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCTCATCCTCAGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1838.40882353267	32.5130193950987	0.0176854130479107	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1832.63033563889	1832.63033563889
"healthy-4003"	"2020-08-26-Control4003-c3:GGGCTCATCTTGGAAC"	-0.88035754385646	8.58563802326051	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGCTCATCTTGGAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1493.55034915336	28.2204355232269	0.0188948672130297	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1493.55034915336	1493.55034915336
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTAGAAGTTCTCTT"	-4.35718951645549	12.9595746763977	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTAGAAGTTCTCTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2046.16552231616	33.8916992549102	0.0165635178998356	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2044.15002327527	2044.15002327527
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTAGACAACAGCTT"	-2.58729181709941	9.95076654041139	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTAGACAACAGCTT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1870.82320837101	35.541770402108	0.0189979310942242	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.16956790766	1864.16956790766
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTAGACACTAACCA"	3.55519451674764	-7.08848287975463	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTAGACACTAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1849.1234015585	33.148025539691	0.0179263458089129	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1849.1234015585	1849.1234015585
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTAGACATATGGCT"	4.30384220656697	-7.14378645336302	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTAGACATATGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.73317412428	23.8116734757769	0.00996832703364052	1439	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2386.21835685088	2386.21835685088
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTCACCACCGTGCA"	10.7556196647579	5.83519933307496	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTCACCACCGTGCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1833.33116011985	34.5698845493463	0.0188563230153609	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1825.75758029335	1825.75758029335
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTCTGCAACTTGGT"	-4.70252690735515	-5.67007591640624	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTCTGCAACTTGGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2264.46328757453	42.542879845988	0.0187871802026677	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2259.33524705495	2259.33524705495
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTCTGCACCATATG"	-1.75915942612346	9.06795499408571	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTCTGCACCATATG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1624.70534193141	40.1391624931316	0.0247055028731642	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1620.85602249024	1620.85602249024
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGAAAGCTATCTG"	10.0560518699581	7.62384603107301	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGAAAGCTATCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1793.93851682773	29.0374569043967	0.016186428147908	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1792.29794038255	1792.29794038255
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGAACAACTCGTA"	5.34812511977498	-9.32121851360472	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGAACAACTCGTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2633.23906457519	35.0160533067461	0.0132977114679085	1696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2624.59465846051	2624.59465846051
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGAACATCCTGTC"	4.49432434615437	-7.78410293972167	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGAACATCCTGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.31020566078	15.964505427995	0.00772235602778935	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2064.20896260903	2064.20896260903
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGAAGTGGGTATG"	4.80427517470662	-7.40805723583373	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGAAGTGGGTATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2699.35553175773	7.97285622787969	0.00295361471806125	1947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2697.26980835553	2697.26980835553
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGAATCCTAACAG"	3.66012897071187	-7.09526445781859	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGAATCCTAACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1983.46198092746	24.9742841658543	0.0125912593263705	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1981.84192107756	1981.84192107756
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTGTCAGGTACATA"	-4.37839255753215	12.9586219557556	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTGTCAGGTACATA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1933.781895615	40.9776483834795	0.021190418876296	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1929.78261755835	1929.78261755835
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTATCACGCGTCA"	-4.08579431000407	12.9822253950867	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTATCACGCGTCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1728.07779306649	0	0	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1728.07779306649	1728.07779306649
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTATCATGTGCTA"	5.45160831984822	-1.97918155109557	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTATCATGTGCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2681.97836575295	29.0285327118166	0.0108235521518336	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2677.11206957389	2677.11206957389
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTATGTTCAGGTT"	5.4060284095699	-10.2303886643616	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTATGTTCAGGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1996.01868579222	38.9293982107864	0.019503523933863	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1990.82281892876	1990.82281892876
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTATTCAAGCCAT"	5.36407246169393	-10.2693815461365	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTATTCAAGCCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2064.426815489	18.3253461224305	0.00887672354618671	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2059.92737972966	2059.92737972966
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTATTCGCAATTG"	-3.29783449593242	10.6020860441956	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTATTCGCAATTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2024.96892292457	35.7861671293017	0.0176724525123167	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2019.4808477205	2019.4808477205
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTTAAGCAGATAT"	-2.55455027046855	11.0312404402527	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTTAAGCAGATAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1625.3163980144	41.0226048269076	0.025239765547818	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1620.7665050033	1620.7665050033
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTTAAGCTGACTT"	-0.545948604971725	8.46015737140504	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTTAAGCTGACTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1703.34554291186	29.0973449073166	0.0170824675171749	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1699.81895154228	1699.81895154228
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTTACACAATTCG"	4.08834232863728	-7.63086655056151	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTTACACAATTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.80830609126	38.4601511884801	0.0189011176499272	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2029.97449995583	2029.97449995583
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTTACATCCCGTT"	5.30478109893147	-10.2532739869324	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTTACATCCCGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2058.91503756475	6.5212380393289	0.00316731769905479	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2055.69905307893	2055.69905307893
"healthy-4003"	"2020-08-26-Control4003-c3:GGGTTTAGTCGGCTAC"	6.78906740722005	-1.7362178794113	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGGTTTAGTCGGCTAC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2497.08050706997	12.5320853859647	0.00501869497218156	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2484.81250400637	2484.81250400637
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAACTAGTGGCCTC"	5.53213419493977	-10.0622396699158	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAACTAGTGGCCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.3686529147	28.9345272798983	0.0131558332622196	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2196.51399403654	2196.51399403654
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAACTGTCACGACC"	-2.88195190849956	9.60477540576784	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAACTGTCACGACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.51552344604	39.9872374135199	0.0253482370342505	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1575.36949057402	1575.36949057402
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAACTGTTCTCTCG"	-1.29259608212169	8.70338246906129	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAACTGTTCTCTCG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1772.04835745487	33.6223148678568	0.0189737005349828	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1764.46065528647	1764.46065528647
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAACTTCCTACAAG"	3.5171386199886	-5.89375212108763	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAACTTCCTACAAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2932.27161315874	34.9872469460016	0.0119317892616067	2830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2923.92948743455	2923.92948743455
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAACTTCTGAACGT"	5.53666748580281	-10.1440916291443	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAACTTCTGAACGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2496.41542530566	33.602829540624	0.0134604317855109	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2492.33386830125	2492.33386830125
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAGAGCATCCTGTC"	4.06970133361165	-6.84966041958006	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAGAGCATCCTGTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1993.9195741656	30.0314142561117	0.0150614972866591	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.09616699178	1984.09616699178
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAGAGGTATCCCAA"	4.36042704161946	-7.68013718044432	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAGAGGTATCCCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.24213808813	1.58973889464201	0.000773504428106387	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2051.95374946608	2051.95374946608
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAGAGGTGAAGCGT"	-4.1541465324467	12.9111108549866	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAGAGGTGAAGCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1710.92023726673	26.8490445676796	0.0156927505928459	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1704.23574838649	1704.23574838649
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAGAGGTTTGGGAG"	2.68641891059224	-4.42705252086791	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAGAGGTTTGGGAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2248.09432330822	11.9063710497008	0.00529620618061068	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2241.10091876008	2241.10091876008
"healthy-4003"	"2020-08-26-Control4003-c3:GGTAGAGTCGGAATGG"	3.92096557196919	-6.74807503139647	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTAGAGTCGGAATGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.21592442323	27.2140426207076	0.011851691442103	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.42733308095	2290.42733308095
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCACGCACGTCGGT"	-3.48269067230876	10.2178964384827	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCACGCACGTCGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1708.99174049067	37.2010622665028	0.0217678420469264	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1704.75255738847	1704.75255738847
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCACGCATCCCGTT"	-2.33094368401225	9.60273168170778	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCACGCATCCCGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2138.96612051976	39.6188591015369	0.0185224341430474	1149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2124.70757587869	2124.70757587869
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCACGGTATGAGAT"	5.23809971389119	-8.82506658947142	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCACGGTATGAGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2582.08688521271	3.43005471864666	0.00132840406660603	1651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2575.97617658008	2575.97617658008
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCACGGTCATTCCC"	-0.386440227658111	8.74093339526979	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCACGGTCATTCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1766.22146032869	19.2910001483226	0.0109221864763961	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1763.14777665503	1763.14777665503
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCACGGTGCTCGTG"	5.44039167937581	-9.46763803875121	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCACGGTGCTCGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.17575640877	35.8808870033669	0.0149930012065684	1504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.3351289235	2388.3351289235
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCTGGAGCTAGTTC"	-2.88780174675639	10.1003703841004	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCTGGAGCTAGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1897.42365460784	30.9944906956128	0.016335039684123	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1891.85004280564	1891.85004280564
"healthy-4003"	"2020-08-26-Control4003-c3:GGTCTGGTCACTACGA"	9.54119076308553	6.75469110095827	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTCTGGTCACTACGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.3594533479	32.1843597323513	0.0177680689897665	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1807.67659776668	1807.67659776668
"healthy-4003"	"2020-08-26-Control4003-c3:TATTCCAGTCATACCA"	9.98167767104451	7.59419725025026	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTCCAGTCATACCA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1963.96780410761	31.0120136805416	0.015790489852064	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1958.37271530531	1958.37271530531
"healthy-4003"	"2020-08-26-Control4003-c3:TATTCCATCGCTACGG"	-4.00536714020427	12.8243541487488	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTCCATCGCTACGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1970.70563374542	12.9922090256906	0.00659266853619244	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1958.07608971243	1958.07608971243
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGCTAGAGTTCGG"	-3.70794496956523	10.5187845000061	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGCTAGAGTTCGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1792.2650232807	37.5362217477009	0.020943454935583	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1792.2650232807	1792.2650232807
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGCTAGGGACCAT"	5.06629480895345	-7.88966801082762	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGCTAGGGACCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2475.79475592462	6.53365281874562	0.00263901230225586	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2473.39151247885	2473.39151247885
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGCTAGGTATTGA"	5.61243023452107	-9.75269987499388	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGCTAGGTATTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.01469528718	39.3867909521767	0.0167459799596905	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.97939040779	2343.97939040779
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGCTGTCGTACAT"	4.6568042236263	-7.10180570995482	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGCTGTCGTACAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.01149315949	4.45387959659733	0.00178798034807468	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2484.20141766686	2484.20141766686
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGCTTCGACGCTG"	-0.0678082582658112	8.42135236347047	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGCTTCGACGCTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1697.44538263096	31.0441913723433	0.0182887718744896	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1692.4702140235	1692.4702140235
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGGGGTCCCTCAT"	-2.759828667075	9.07338426196901	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGGGGTCCCTCAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2236.89224026139	13.6907611480099	0.00612043839287051	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2230.72283014631	2230.72283014631
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGGGGTGACTGAG"	-3.86809049072917	11.6105518111023	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGGGGTGACTGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2232.32593114929	33.850974719815	0.0151639929669174	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2221.34012885685	2221.34012885685
"healthy-4003"	"2020-08-26-Control4003-c3:TATTGGGGTTCTCCAC"	4.90025867995564	-7.52529909526976	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTGGGGTTCTCCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2697.5128561683	33.6679284776105	0.0124811002848877	1839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2692.89688670495	2692.89688670495
"healthy-4003"	"2020-08-26-Control4003-c3:TATTTCGAGCTCGAAG"	4.6747576194698	-7.03221371090087	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTTCGAGCTCGAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2211.66998316968	39.192974713522	0.0177209868614088	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2211.66998316968	2211.66998316968
"healthy-4003"	"2020-08-26-Control4003-c3:TATTTCGGTTGCACGC"	5.42465891417806	-9.94914534008177	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATTTCGGTTGCACGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2515.48238090509	34.6478842222133	0.0137738528741937	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2506.19964503358	2506.19964503358
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGACAGTAAACGT"	2.23257484015767	-6.58013489162596	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGACAGTAAACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.40549254522	31.8544938033595	0.0188777943085342	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1685.84226792975	1685.84226792975
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGCAGTACGGCAA"	10.7915741401607	6.30134914005128	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGCAGTACGGCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1882.97984203817	25.5508459617904	0.0135693677602697	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1868.70482486	1868.70482486
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTCGAGCCATTTG"	5.53596701201741	-10.0812168351379	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTCGAGCCATTTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.81842490316	33.7799892812022	0.0145929326109521	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2310.22733088618	2310.22733088618
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTCGAGGCTAAAT"	5.32669891890828	-9.35832312023314	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTCGAGGCTAAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2134.55392803643	29.9902874508795	0.0140499085345047	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2131.07109988808	2131.07109988808
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTCGAGGTGTGAC"	3.87179865416829	-7.13364794170531	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTCGAGGTGTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.22577261576	4.31547309703194	0.00189505720026826	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2277.22577261576	2277.22577261576
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTCGTCCGTCCTA"	3.95874037322347	-7.63581135189208	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTCGTCCGTCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.00286845248	29.8172550674308	0.0131992993385869	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.09872008508	2256.09872008508
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTTACACTACAGT"	4.2470141845638	-7.11406042492064	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTTACACTACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.59091165664	28.2736232062633	0.0126981669862413	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2219.45287856997	2219.45287856997
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTTACAGAATCGG"	3.06296004828755	-6.61685850536498	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTTACAGAATCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.26488200942	32.0588742159829	0.0144587480170295	1303	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2211.83914312504	2211.83914312504
"healthy-4003"	"2020-08-26-Control4003-c3:GGTGTTATCTTCTCAA"	4.09656920012776	-6.90119745647582	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTGTTATCTTCTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.70540498255	32.4962734307658	0.0143173970328611	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2266.51470775638	2266.51470775638
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTAACCATTGTACG"	5.39181532439534	-10.0890817872253	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTAACCATTGTACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2120.22805350937	25.5167483895047	0.0120349074465219	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2112.82353883496	2112.82353883496
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTAACGTTTGATCG"	-1.40615139427837	9.18540284717409	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTAACGTTTGATCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.13546830831	12.8947502061741	0.00720725201337973	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1787.38740714573	1787.38740714573
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTAACTCAGTCAGT"	11.062387128442	5.95145175540773	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTAACTCAGTCAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.10764206867	41.4062944816178	0.0256527466957226	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1608.56747968135	1608.56747968135
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTAACTCTGTGCTC"	5.18961920317952	-9.56048586284789	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTAACTCTGTGCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.31979030535	28.510621916678	0.0139258273434781	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2045.67395549667	2045.67395549667
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTCTCAGGACACTG"	5.20084776458089	-9.86902716076048	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTCTCAGGACACTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1925.81265265462	15.456808509679	0.00802612262847721	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1918.41595123575	1918.41595123575
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTCTCAGTTGGCTT"	-1.29398141327556	8.45437905872194	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTCTCAGTTGGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1734.56343845017	14.1436281277397	0.00815399876085071	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1730.78216217663	1730.78216217663
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTCTCCACCAGTTA"	4.14785208281819	-7.21394445812377	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTCTCCACCAGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.52477812921	21.3901244858622	0.00926571145716549	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2303.44005526003	2303.44005526003
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTCTCCACCCAACG"	5.12435307082478	-10.2028427354065	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTCTCCACCCAACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1855.5075094103	42.8844995372267	0.02311200537844	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1851.64148460137	1851.64148460137
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTGTAGTTATTCCT"	-4.111639837653	12.0649986037048	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTGTAGTTATTCCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2325.92637798131	32.4507425284369	0.0139517496493595	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2314.13501811752	2314.13501811752
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTGTATCGACATCA"	5.45187677916829	-9.62937071239623	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTGTATCGACATCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.63613910073	41.8976455694205	0.0159753939727936	1827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2616.24283088461	2616.24283088461
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTGTATCTCATAGG"	-1.40784798088725	8.7103175886902	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTGTATCTCATAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1725.12813835388	38.1279055037288	0.0221014918579384	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1721.23739418027	1721.23739418027
"healthy-4003"	"2020-08-26-Control4003-c3:GGTTGTATCTGGCCAG"	3.72974934157674	-7.4809403649536	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GGTTGTATCTGGCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.47097795845	24.6918637690241	0.0118969930349556	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2070.95469402982	2070.95469402982
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACACCACTCACTC"	4.63563026961629	-7.94673635875853	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACACCACTCACTC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.2753437586	31.5817707256051	0.0139293936277056	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2259.51701287879	2259.51701287879
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCACAGACTCTA"	4.25417055663411	-7.16245558178099	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCACAGACTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.74168219326	30.2614784778355	0.0124905922493728	1357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2416.8418071546	2416.8418071546
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCACAGAGGGTT"	-0.317353735596496	8.94871995532838	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCACAGAGGGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1608.93285564612	36.3407103880986	0.022586840874416	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1595.95800690172	1595.95800690172
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCACAGATCATC"	-2.17442236366923	3.69723126972047	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCACAGATCATC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3211.65931759982	39.2020386183228	0.0122061634630724	5184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3204.58808036738	3204.58808036738
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCACAGATTCGT"	4.24311890181844	-6.93515970623168	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCACAGATTCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.37656238326	39.2954066147551	0.0165917055754059	1394	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2368.37656238326	2368.37656238326
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCAGTGGCTTAT"	-0.834314028651077	8.65738771045534	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCAGTGGCTTAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1762.55534478689	39.4735546347255	0.0223956398030146	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.45917111787	1756.45917111787
"healthy-4003"	"2020-08-26-Control4003-c3:GTAACCAGTTTCGACA"	-0.343559126288253	8.4245395430359	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAACCAGTTTCGACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1691.31009067581	27.9078464236063	0.0165007272039955	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1691.31009067581	1691.31009067581
"healthy-4003"	"2020-08-26-Control4003-c3:GTAAGTCGTCCCTGTT"	5.27020706710164	-10.1910152665344	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAAGTCGTCCCTGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1662.99585399548	15.8450157456073	0.00952799473765273	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1658.64987024938	1658.64987024938
"healthy-4003"	"2020-08-26-Control4003-c3:GTAAGTCGTGGACTAG"	5.08533205565755	-7.95931246196898	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAAGTCGTGGACTAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2901.86257487655	0	0	2198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2894.01885850041	2894.01885850041
"healthy-4003"	"2020-08-26-Control4003-c3:GTAATGCAGCCTATCA"	-3.69266972962077	12.9938354262146	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAATGCAGCCTATCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1854.20491888782	36.9417197992923	0.0199232131373324	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1849.98872542645	1849.98872542645
"healthy-4003"	"2020-08-26-Control4003-c3:GTAATGCAGTGCTCAT"	4.98990168151204	-8.5854645005432	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAATGCAGTGCTCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.93698304737	32.8546192964998	0.0139100321186854	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.70476886567	2360.70476886567
"healthy-4003"	"2020-08-26-Control4003-c3:GTAATGCTCCATAGAC"	-4.18680224838908	11.4995298155579	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAATGCTCCATAGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2217.13363818914	33.8021462227548	0.0152458767665277	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2205.05016975479	2205.05016975479
"healthy-4003"	"2020-08-26-Control4003-c3:GTAATGCTCTCGAGTA"	4.24141563948934	-7.51452066814574	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAATGCTCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.93049762429	26.030439822634	0.0112348816027606	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2308.38836077734	2308.38836077734
"healthy-4003"	"2020-08-26-Control4003-c3:GTACAACAGCCACCGT"	4.30016436156575	-7.35189392482909	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTACAACAGCCACCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.94354961632	30.9305025250777	0.0158948611490689	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1940.31503351741	1940.31503351741
"healthy-4003"	"2020-08-26-Control4003-c3:GTACAACAGGGCAGTT"	-0.436807433993179	8.25713250720827	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTACAACAGGGCAGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1799.38153185816	1.11294237957043	0.000618513839264056	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1793.42721587721	1793.42721587721
"healthy-4003"	"2020-08-26-Control4003-c3:GTACAGTAGTATGATG"	3.73942913588826	-6.47824766552123	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTACAGTAGTATGATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2547.35561962275	28.0367302302876	0.011006209739353	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2540.62021392561	2540.62021392561
"healthy-4003"	"2020-08-26-Control4003-c3:GTACAGTAGTCGAGGT"	10.5725275474483	7.65625140750734	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTACAGTAGTCGAGGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2129.92486506658	21.6654396143587	0.01017192670488	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2128.28524140168	2128.28524140168
"healthy-4003"	"2020-08-26-Control4003-c3:GTACAGTCAGGTTACT"	-0.531754176050979	8.77389524066774	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTACAGTCAGGTTACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1946.61085281531	33.0045292674479	0.0169548675944731	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1939.01028882052	1939.01028882052
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAAAGCTCGACC"	4.66808857497518	-7.86351921474608	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAAAGCTCGACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.79610673908	37.3928355141906	0.0144664545945036	1703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2578.84621515421	2578.84621515421
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAAAGTAGTGCG"	4.12721457061116	-6.83307316219481	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAAAGTAGTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.4719222697	8.54902563768028	0.003614088823966	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.24169169728	2361.24169169728
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAACAAGCGCAA"	3.4223584133083	-6.58777143871459	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAACAAGCGCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.6142782811	22.3452664729453	0.00878484865560889	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2537.55398441314	2537.55398441314
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAATCCGTATGA"	5.24763979491536	-9.8982553712097	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAATCCGTATGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.44123489703	27.1553414946691	0.0133150889714359	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2030.4233553487	2030.4233553487
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAATCCTTATGT"	2.6968113380367	-4.29165365612181	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAATCCTTATGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2586.38828508633	26.9463426969224	0.0104185217866555	2044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2584.5567421315	2584.5567421315
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAATCGTGCACG"	10.0864225822384	5.91244218433229	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAATCGTGCACG"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1353.64635639965	37.4792920765722	0.027687654090288	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1349.49066580824	1349.49066580824
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAAATCTTCACGC"	3.72610296782796	-7.42128517543944	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAAATCTTCACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.06381663295	37.5275808662002	0.0166858675101457	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2247.57778718524	2247.57778718524
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAGGAGCACGATG"	4.17818893966023	-7.77989342128905	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAGGAGCACGATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.36983513457	39.2355404188627	0.0187248760390516	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2092.43772700254	2092.43772700254
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAGGCATTCGGGC"	4.57405962523763	-7.3267221680847	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAGGCATTCGGGC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.45752398727	36.1034529138644	0.0149716312871928	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2404.23997865258	2404.23997865258
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGAGGGTCGTTTCC"	4.84712042388265	-7.59046127712401	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGAGGGTCGTTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.99940511832	28.2748113778719	0.0124230310931922	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2270.27963293293	2270.27963293293
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGCTAAGTTCCAGT"	3.9126464324886	-6.97506906902465	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGCTAAGTTCCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.56639495041	31.6329191217094	0.0133835542717526	1459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.38939862672	2355.38939862672
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGCTATCGATTTCT"	4.6633788543636	-7.27153112804564	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGCTATCGATTTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.02604178108	24.6528171858682	0.011584828710665	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2124.97996399007	2124.97996399007
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGCTATCGCGCCAA"	4.68820633467976	-7.47827865993651	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGCTATCGCGCCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2344.21441612353	37.2305549391583	0.0158818897636181	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2341.45710568139	2341.45710568139
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGGAGAGTAACAGT"	4.90318693694417	-8.25055982982787	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGGAGAGTAACAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.11174556196	21.2326001268453	0.00969918514661971	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2181.6382545124	2181.6382545124
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGGAGGTGCACAAG"	4.41439547118489	-6.75377132808837	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGGAGGTGCACAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.02756061791	35.0353360381167	0.0143703609442533	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2429.92702252223	2429.92702252223
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGGAGGTGGCCCAT"	2.98498787459676	-4.8700833550659	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGGAGGTGGCCCAT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2442.90321164189	29.7999209270414	0.0121985679927993	1734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2440.32800709915	2440.32800709915
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGTACGTAAGGCTG"	2.77460350570027	-4.68715383922728	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGTACGTAAGGCTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2348.18549797076	29.8035125366263	0.0126921457280022	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2347.01336775956	2347.01336775956
"healthy-4003"	"2020-08-26-Control4003-c3:GTAGTACGTGAGTAGC"	4.29012264785115	-7.6980977288452	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTAGTACGTGAGTAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2007.19932874206	1.04993088008381	0.00052308251853682	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2004.19393059371	2004.19393059371
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTGGGTAAGGAGA"	-4.12627873840983	12.5510501631531	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTGGGTAAGGAGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1724.60162893151	30.7892879589652	0.0178529855489241	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1724.60162893151	1724.60162893151
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTGGGTGTCCCTT"	5.37492241439168	-10.1793661347595	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTGGGTGTCCCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1879.83848072129	37.7281102186161	0.0200698680261827	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1875.84883537485	1875.84883537485
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTTCAGGTACTGG"	-0.309576998383361	8.42439267719118	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTTCAGGTACTGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1779.28982120842	26.2322073621083	0.0147430772937781	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.01443275342	1774.01443275342
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTTCCAGTTCACA"	-4.01822219315227	13.0674581297669	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTTCCAGTTCACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1752.09341293193	49.1393770137111	0.0280460942613111	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1747.98133713361	1747.98133713361
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTTCTCCCAAGCG"	-3.55813012543376	-5.49395801937255	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTTCTCCCAAGCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2138.64844481506	23.8519325462571	0.0111528066261118	1167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2132.67160479358	2132.67160479358
"healthy-4003"	"2020-08-26-Control4003-c3:GTATTTCTCGCGGTAC"	4.5094276863033	-8.16064741527709	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTATTTCTCGCGGTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.24635611182	32.2658141595697	0.0136589539342874	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.48959688655	2354.48959688655
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAACGTTATTCCT"	-3.16152010384257	10.4365377196106	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAACGTTATTCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1992.67945450801	34.9210769792392	0.0175246836114247	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1992.67945450801	1992.67945450801
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTAGGTACAGC"	0.55144308981244	8.67461869800416	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTAGGTACAGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1604.16491332047	21.6350023044764	0.0134867694242819	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1592.58687447156	1592.58687447156
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTCAGTCGTTA"	4.28903307494466	-7.06986858760985	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTCAGTCGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1939.28107264187	17.7972676525328	0.00917725022102528	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1937.29572982032	1937.29572982032
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTCAGTTTCAG"	-1.59150669995006	8.62059209430543	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTCAGTTTCAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2389.63750192879	32.5798244918001	0.0136337936048892	1493	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2381.7826057335	2381.7826057335
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTGTAGTGATA"	2.61831464347188	-4.46720793163451	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTGTAGTGATA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2066.63472977008	28.7533842044698	0.0139131428453584	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2063.98988497769	2063.98988497769
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTGTTGCTAGT"	4.84562220153157	-7.78206112301024	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTGTTGCTAGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.27189104797	26.1036428505287	0.0110642791742556	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2356.4713775337	2356.4713775337
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAAGTTCAAGCCTA"	-2.95933685723003	10.3153686293396	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAAGTTCAAGCCTA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1457.15243104126	20.7726778851421	0.0142556656686208	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1457.15243104126	1457.15243104126
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGCAACGACTT"	-4.10720429840739	12.3821487196716	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGCAACGACTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2068.83570949789	31.6186189405387	0.0152832913678838	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2067.10033534978	2067.10033534978
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGCAGAGTGAC"	5.42815460738484	-10.1373501054016	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGCAGAGTGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.36084934528	31.8635225153142	0.0128308064950427	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2476.65219452106	2476.65219452106
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGGTATTGGCT"	4.59353651580159	-6.78054907238158	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGGTATTGGCT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2264.64146845154	28.6693250968413	0.0126595425793577	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2263.27385657824	2263.27385657824
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGGTGACTAAA"	5.50702633437459	-9.89489939129027	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGGTGACTAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.6255675547	22.1942116324622	0.00938196303627372	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2361.10361176882	2361.10361176882
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGGTTGCTCCT"	5.31997408446614	-9.32710173046263	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGGTTGCTCCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.99523088617	5.13996283211278	0.00208518165378558	1544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2461.35183289545	2461.35183289545
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGTCGAGGCAA"	5.16081585463826	-9.5683803788391	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGTCGAGGCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2648.13879927512	23.3164448183749	0.00880484241413531	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2641.05882587293	2641.05882587293
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACGGTCTGCTTAT"	3.79522337493245	-6.78196241771849	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACGGTCTGCTTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2198.75310189517	29.5251862950051	0.0134281499225886	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2194.58375999439	2194.58375999439
"healthy-4003"	"2020-08-26-Control4003-c3:GTCACTCGTTATCTTC"	3.39769663390462	-7.22334959423216	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCACTCGTTATCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1924.42913882502	21.8618205659183	0.0113601587737682	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1920.81252867464	1920.81252867464
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAGCGTCAACTCTT"	5.57117714461629	-10.1892442933288	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAGCGTCAACTCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.8954490104	26.9276586722488	0.0125601547802522	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.36432170339	2142.36432170339
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAGCGTCCAAAGGG"	-0.840564648539382	8.26164910877077	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAGCGTCCAAAGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1649.13473742453	30.4272161677725	0.0184504124964894	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1645.4757331903	1645.4757331903
"healthy-4003"	"2020-08-26-Control4003-c3:GTCAGCGTCTTGGTCC"	2.5751871066982	-4.54799082195433	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCAGCGTCTTGGTCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2359.58864747634	33.9206782536981	0.0143756744591806	1634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2357.44110027877	2357.44110027877
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATCCAGCTGGCTC"	4.66910423812215	-7.407093547937	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATCCAGCTGGCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2348.65946109281	32.2239469527951	0.0137201444000748	1400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.44893501851	2343.44893501851
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATCCGTATCGCAT"	3.99889077719991	-6.57741119777831	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATCCGTATCGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2626.01763283891	28.0583748276798	0.0106847625380743	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2623.70454941204	2623.70454941204
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATCCGTTGATCGT"	4.43761410292928	-7.45916798031005	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATCCGTTGATCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.2144214651	25.2609020849573	0.0105773174543768	1369	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2385.38819104289	2385.38819104289
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATCCGTTGATGTC"	6.75083651122395	-1.66564669525298	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATCCGTTGATGTC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2513.22230709231	31.9408771218206	0.0127091332237835	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2502.55423603265	2502.55423603265
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATCCTCTCATGCC"	4.01937117156331	-7.82990028774413	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATCCTCTCATGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.42124604339	31.6127884574635	0.0139053809374227	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2267.90571599325	2267.90571599325
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGACACTATCGA"	4.51787199553792	-6.82704594051512	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGACACTATCGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2257.80002360143	48.3076347805032	0.0213958872688146	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2252.01913320709	2252.01913320709
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGACAGCGACCT"	-7.19910321655925	0.0156713494094982	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGACAGCGACCT"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2723.81332857594	29.4870727059955	0.0108256584240345	2662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2715.65928894702	2715.65928894702
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGACATAATGAG"	-3.85465918007548	12.8189391859802	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGACATAATGAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1730.69803631119	41.280862554134	0.0238521461791915	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1724.20230164343	1724.20230164343
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGAGTCCGGTGT"	3.27023806151692	-6.85389664089354	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGAGTCCGGTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.14759970786	18.1335900401042	0.00888401703174214	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.41250455338	2036.41250455338
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGATCACCACAA"	4.04421844062154	-7.05041744625243	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGATCACCACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.86959404694	0	0	1688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2579.15945660961	2579.15945660961
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATGATCCAACCAA"	4.32062782821004	-7.32979347622069	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATGATCCAACCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2440.96981168415	32.0291846727565	0.013121499708617	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2435.52121619475	2435.52121619475
"healthy-4003"	"2020-08-26-Control4003-c3:GTCATTTTCCACGTCT"	-4.31728921356853	12.9138288267883	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCATTTTCCACGTCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2282.1635936866	37.1081489737594	0.0162600740264264	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2272.09646970214	2272.09646970214
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCCATCACCGCTAG"	4.65784372863118	-7.72634889995726	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCCATCACCGCTAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2322.40539471932	29.443689782834	0.0126781008388041	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.33389791042	2318.33389791042
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCTCAAGTCACGCC"	4.1768180328304	-7.64190676128539	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCTCAAGTCACGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2498.3003183017	0.468508964917722	0.000187531083227098	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2496.85321420266	2496.85321420266
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCTCACAACGCATT"	5.38680758055989	-10.168203376886	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCTCACAACGCATT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.60517009173	41.8666247010403	0.01847107085675	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2252.77775282756	2252.77775282756
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCTCACATTGACTG"	2.78820862349812	-4.69614317333373	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCTCACATTGACTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2370.62349668958	1.60136599560827	0.000675504143886396	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2366.26152131879	2366.26152131879
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCTCAGTCAACGCC"	-3.93343959274943	11.3554668196472	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCTCAGTCAACGCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1931.0686875816	28.0674151967364	0.0145346539857611	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1926.94117306883	1926.94117306883
"healthy-4003"	"2020-08-26-Control4003-c3:GTCCTCATCCCGAACG"	-0.146888489753562	8.32873437488405	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCCTCATCCCGAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1961.24160009568	34.8241305561817	0.0177561655608788	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1947.88690379538	1947.88690379538
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGAATCAACACGAG"	2.19827260550801	-6.62819197094115	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGAATCAACACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1695.59751602122	18.9961989441009	0.0112032476838467	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1695.59751602122	1695.59751602122
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGCGAAGTCTGTAC"	5.24140896376912	-9.84092905437621	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGCGAAGTCTGTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.22614626887	26.6316879868046	0.0143394965875896	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1857.22614626887	1857.22614626887
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGCGACAGGATCTT"	10.4626289802486	5.8272175558838	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGCGACAGGATCTT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1574.34881953481	29.4633581614698	0.0187146315961769	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1568.24806832805	1568.24806832805
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGCGATCATTCCTA"	5.26093163070027	-10.1537342301575	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGCGATCATTCCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1915.33284330965	22.4147478019921	0.0117027950939639	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1908.46082284297	1908.46082284297
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGTAAAGAAGCTCG"	-0.717284063727218	8.70390508258668	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGTAAAGAAGCTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1492.14700853623	23.5508019060038	0.0157831646421399	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1481.42611644295	1481.42611644295
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGTAATCCAGTGCG"	-1.9420008462971	9.21453092182008	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGTAATCCAGTGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1436.32436811661	2.20652535103461	0.00153623053400392	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1433.93995979766	1433.93995979766
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGTTCCAACTTGGT"	-3.26921854439433	12.4103545912537	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGTTCCAACTTGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1685.90055827124	42.1922408197924	0.0250265299532597	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1676.34420291556	1676.34420291556
"healthy-4003"	"2020-08-26-Control4003-c3:GTCGTTCGTACAGTTC"	4.03157367286031	-7.2112550965515	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCGTTCGTACAGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.15637549681	24.619650220076	0.0120028148580885	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2049.63124524358	2049.63124524358
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTACCAGAGTCAGC"	-3.87115440788921	12.7890453108582	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTACCAGAGTCAGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2443.3043239624	36.0345190975116	0.0147482729613776	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2427.63533363276	2427.63533363276
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTACCAGCGAGTAC"	4.55734266814534	-7.80186226284178	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTACCAGCGAGTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.49288447674	35.9606653752873	0.0155036756594318	1344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2318.10826854567	2318.10826854567
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTACCAGTATCTGC"	-1.56592224064525	9.24780366504518	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTACCAGTATCTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.12558837434	48.8708219053123	0.027239353934857	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1788.48558889814	1788.48558889814
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTACCTCTGCTGAA"	5.32916082915608	-9.70457270061644	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTACCTCTGCTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2421.44052847492	28.0482919860699	0.0115833082234464	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2410.85558254319	2410.85558254319
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTAGAAGAAGGGAT"	3.76907815512959	-8.1297874680725	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTAGAAGAAGGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.24509499288	38.7882917873144	0.0182684005152238	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2120.17355350743	2120.17355350743
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTAGACAAACTGCT"	-3.64228735390361	10.2668876417908	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTAGACAAACTGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2281.82843393588	23.0490834395259	0.010101146561562	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2267.8881023906	2267.8881023906
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTAGACAAGTTCGT"	4.16067614135091	-7.07481148159178	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTAGACAAGTTCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.90578882857	4.75496249120363	0.00207467624296807	1390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2290.5933234628	2290.5933234628
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTAGACACTATCGA"	0.0786676230723083	8.13659570300905	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTAGACACTATCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.84363247664	0	0	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1683.27931507541	1683.27931507541
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTAGATCGTGCACG"	3.71011652526204	-4.52866461193236	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTAGATCGTGCACG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1813.7318966541	2.36787859125163	0.00130552844972281	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1809.78897074434	1809.78897074434
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTCACAGATTCGCT"	4.24346556243245	-7.53892471706542	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTCACAGATTCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.75414180385	31.4152565059715	0.013223277591392	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2373.13238905883	2373.13238905883
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTGTCAGATGCTGG"	2.47329821166341	-7.28362657940062	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTGTCAGATGCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1850.14269188194	26.7886352320427	0.0144792265751101	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1847.16941753884	1847.16941753884
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTGTCAGCGATGAC"	-3.69703731957133	12.7044543989929	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTGTCAGCGATGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2270.15936624448	29.3076781289388	0.0129099650732549	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2266.78320287269	2266.78320287269
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTGTCAGCTGAGCA"	3.87693132933919	-6.35474827205809	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTGTCAGCTGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.83454679085	23.5360628346641	0.0108870786941593	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2155.95882072149	2155.95882072149
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTGTCCAGAGTGAC"	0.50621928748433	8.70993707263795	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTGTCCAGAGTGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1532.11173014626	46.385725947088	0.0302756809665963	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1524.22269419802	1524.22269419802
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTTTACAAGTATCC"	-3.85156403008159	12.5951766737732	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTTTACAAGTATCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1941.21595262396	38.6281890531911	0.0198989653886664	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1935.24196712835	1935.24196712835
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTTTAGTCAACCAT"	4.79383196410481	-8.01089193737181	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTTTAGTCAACCAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2393.1658244782	5.2553720541037	0.00219599160256668	1642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.11045117962	2389.11045117962
"healthy-4003"	"2020-08-26-Control4003-c3:GTCTTTATCACTCCGT"	3.41958488997762	-6.45937588131102	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTCTTTATCACTCCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.83558413653	29.0234390051751	0.0133389853612	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.112346723	2171.112346723
"healthy-4003"	"2020-08-26-Control4003-c3:GTGACGCCATGTGGCC"	5.00607456740682	-8.15341665661009	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGACGCCATGTGGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.57571585452	17.8514534933376	0.00948750206697387	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1879.79145150892	1879.79145150892
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGCCAGTTTCAGC"	5.4232837158138	-9.98617746746215	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGCCAGTTTCAGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.45356292513	9.52736473971913	0.00439767780060577	1139	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2166.45356292513	2166.45356292513
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGCCTCGGTCTGG"	1.81019856509511	-7.34912302410277	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGCCTCGGTCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1607.98254655394	27.7661417868011	0.0172676885369848	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1606.18743162386	1606.18743162386
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGAAGGCTAAAT"	-4.27164731445964	13.0321168669495	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGAAGGCTAAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2187.82810582541	33.0225687247647	0.0150937674842175	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2182.54118788049	2182.54118788049
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGAAGTATAACG"	4.64013161238973	-8.31349279796752	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGAAGTATAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.93877001877	27.7602130148845	0.0113588005376547	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2440.13400062242	2440.13400062242
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGACACTCATAG"	-3.08294020119365	10.52622888172	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGACACTCATAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1708.86148144564	33.6272322800622	0.0196781498355354	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1708.86148144564	1708.86148144564
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGACATAAGATG"	5.24011292037312	-10.2982111207214	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGACATAAGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2007.90065070136	21.2310696382718	0.0105737650071759	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2006.11530940619	2006.11530940619
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGAGTTCGGTTA"	3.78724350508992	-7.37823440944823	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGAGTTCGGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.31727662246	40.1616185383125	0.0193520378742641	956	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2071.6202006325	2071.6202006325
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGGATCACCTACC"	3.99884833869283	-7.01421120083006	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGGATCACCTACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1932.4463660332	31.1234832768769	0.0161057423501824	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1932.4463660332	1932.4463660332
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGTTAGAGAGCCT"	2.85112824019734	-4.81926205074462	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGTTAGAGAGCCT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2386.84877201285	18.2449824531381	0.00764396247766966	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2383.32091237859	2383.32091237859
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGTTAGTATGAGT"	2.82817353782002	-4.62330105220946	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGTTAGTATGAGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2518.70427233493	33.563642598715	0.0133257575997996	1941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2513.99244665586	2513.99244665586
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGTTCACTTGAGT"	10.0763641792232	7.33633086765138	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGTTCACTTGAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1787.26434974248	31.8483675353542	0.0178196177526526	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1783.62718243931	1783.62718243931
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGTTCATGCCGAC"	3.35098328170125	-7.09811832821044	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGTTCATGCCGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.79088148316	22.3664828866919	0.0117669350713844	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1898.85161061436	1898.85161061436
"healthy-4003"	"2020-08-26-Control4003-c3:GTGAGTTTCTCGTTTA"	-1.59119794789012	9.18970964038698	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGAGTTTCTCGTTTA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1945.32860242548	36.5137724705744	0.0187699766636075	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1934.50102397394	1934.50102397394
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCACGAGAGCTGCA"	-3.09566936913188	10.2524156340393	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCACGAGAGCTGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1941.8615031595	37.3252618255649	0.0192213820423521	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1938.19265617482	1938.19265617482
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCACGCAAGAGGCT"	-3.80345426026042	12.6515083082947	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCACGCAAGAGGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1686.45019152413	29.5450444602992	0.0175190732633484	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1686.45019152413	1686.45019152413
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCACGGTACGACTT"	4.93974222716634	-8.08759882366332	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCACGGTACGACTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2357.65295685968	4.51002495256668	0.00191292994986586	1524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2356.49168995997	2356.49168995997
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCACGTCCGATGCG"	-5.85464129868205	-5.20352461254271	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCACGTCCGATGCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2774.21663950359	33.4582195284246	0.0120604206073869	2408	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2769.40499717543	2769.40499717543
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCAGCAGCGCCATC"	5.46299709853475	-9.6979551545349	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCAGCAGCGCCATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2318.84685655604	43.1811285109142	0.0186218112631409	1338	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2310.44938008349	2310.44938008349
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCAGCAGGGCAACT"	-3.0632303756779	9.37688157642213	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCAGCAGGGCAACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2003.58026271181	34.5424899329411	0.0172403824173175	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1997.67450772948	1997.67450772948
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCAGCAGTGCGACA"	-4.47495828095134	12.9417371519837	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCAGCAGTGCGACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1966.88796576443	37.7793081207223	0.0192076563476453	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1960.99850827495	1960.99850827495
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCAGCCACACGTGC"	2.87993325766866	-4.79969503795775	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCAGCCACACGTGC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2575.91409325449	31.6206180478357	0.0122754940200219	1999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2566.74497259837	2566.74497259837
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCAGCCATCAGCTA"	5.51938166198079	-9.71815302288207	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCAGCCATCAGCTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.98064114391	23.724942348077	0.0095704427676084	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2469.81923528587	2469.81923528587
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCGTGCAGAGTAAT"	-4.01917682114299	13.0012111433777	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCGTGCAGAGTAAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1946.93246980411	29.3120852133486	0.0150555222987769	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1936.3734349475	1936.3734349475
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCGTGTCGGTCGGT"	3.33226575431172	-7.01127674495848	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCGTGTCGGTCGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1869.08079658617	27.880639196508	0.0149167651004875	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1866.97866757201	1866.97866757201
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCTGGCATAGTCAC"	-2.21251450005229	3.49192020976869	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCTGGCATAGTCAC"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3127.84656069415	24.244660296029	0.00775123070316098	4525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3123.56543013209	3123.56543013209
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCTGGGTGCATGTT"	0.546311964362305	8.81415078723756	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCTGGGTGCATGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1808.6624503605	24.2245321107264	0.0133936169824822	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1806.86473033175	1806.86473033175
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCTGGGTTATGTCG"	-2.65561829033549	9.88314149463502	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCTGGGTTATGTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1812.39945192312	33.6718567184948	0.0185786067650627	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1801.34437866924	1801.34437866924
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCTTCAGCGTTAGG"	-4.35111270371135	12.995262122992	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCTTCAGCGTTAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1900.25771965977	24.1886916067069	0.0127291637110348	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1894.10564378339	1894.10564378339
"healthy-4003"	"2020-08-26-Control4003-c3:GTGCTTCCAGAACCGA"	-0.277956436306793	8.47097585285035	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGCTTCCAGAACCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1812.60032976647	3.97862906642808	0.0021949841898907	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1809.22260106052	1809.22260106052
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGAAGAGGCCTTGC"	5.29436316069905	-10.1289644471374	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGAAGAGGCCTTGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.24944713514	24.9309339260284	0.0106942369280413	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2326.68892525837	2326.68892525837
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGAAGCAGAGGCAT"	2.78673257407491	-6.73569300090941	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGAAGCAGAGGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2368.72809174138	28.4513602656124	0.0120112394347028	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2362.14094068083	2362.14094068083
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGAGACAACCGATT"	4.21379723128621	-7.14388897335204	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGAGACAACCGATT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2333.92022414125	23.1790051896762	0.00993136138498682	1523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2330.39667747719	2330.39667747719
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGAGACACTCCTGT"	2.6450694995815	-4.39942982113036	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGAGACACTCCTGT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2455.68497085057	38.2601528787993	0.0155802366072824	1920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2452.99146274689	2452.99146274689
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGAGACATGGCCCA"	-1.61625991287883	8.94171426380006	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGAGACATGGCCCA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1904.56390305933	29.9001073527247	0.0156991883048375	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1901.16287112485	1901.16287112485
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGCGTAGTACGAGC"	3.90937246856038	-7.07827045833739	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGCGTAGTACGAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.54119303223	31.1231774588162	0.0142862469428439	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.60349788315	2171.60349788315
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGCGTCATTCGGGC"	-3.79383860054668	9.3398399122986	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGCGTCATTCGGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2352.02774119377	27.461421947075	0.0116756369264323	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2348.93398146297	2348.93398146297
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGCGTTCACTAGCA"	0.02925538000409	8.21281240070192	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGCGTTCACTAGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.36743292504	0	0	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1655.4794419651	1655.4794419651
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGGAACAGCTGAAG"	5.48334374007527	-9.62255575573119	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGGAACAGCTGAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.6684268068	7.11721400506729	0.00351004824604168	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2019.37032494703	2019.37032494703
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGGAAGTGCACATT"	4.86256422576253	-8.39009001171263	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGGAAGTGCACATT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.49218322594	30.0529292610121	0.0125613489865158	1584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.02963057109	2389.02963057109
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGTTAGTATGAAAC"	-3.29356847229655	10.5785560377869	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGTTAGTATGAAAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1919.47549754357	32.6077887397771	0.0169878640188461	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1911.62361582886	1911.62361582886
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGTTATCAAGCCCG"	-0.535004476935226	8.35230348193971	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGTTATCAAGCCCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1777.82658509626	29.8859600406426	0.0168103910084258	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1773.85451318682	1773.85451318682
"healthy-4003"	"2020-08-26-Control4003-c3:GTGGTTATCGTTGTGA"	-3.79067669335063	10.4251575239929	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGGTTATCGTTGTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.03060496499	29.531433728686	0.0153327956744606	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1916.17862561234	1916.17862561234
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTAACAGACGGTTG"	-3.61783442917522	11.1957826384339	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTAACAGACGGTTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1633.24856321047	32.5000961442546	0.0198990508097367	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1627.07068506813	1627.07068506813
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTCCTTCCGGACGT"	1.91101576861684	-6.69086601650389	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTCCTTCCGGACGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.44158337198	36.9204878500305	0.0200063162024179	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1838.04840048167	1838.04840048167
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATAGATGACAT"	-5.68984113159831	-5.39247419750365	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATAGATGACAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2782.74213233642	38.2915218311848	0.0137603557966167	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2775.74775091285	2775.74775091285
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATAGGCTAGCA"	4.96533741530721	-8.6217193833557	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATAGGCTAGCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.15269004679	5.39577324683589	0.00228716575641777	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2357.59366836334	2357.59366836334
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATCACCGCTGA"	-0.565129320055801	9.11553762042848	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATCACCGCTGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1510.42612949515	37.6815281352052	0.0249476140536577	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1503.69354349652	1503.69354349652
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATGTAACTTCG"	-4.05016169968303	13.0623168715271	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATGTAACTTCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1982.51548463143	38.225685894347	0.0192814059666493	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1974.14088803004	1974.14088803004
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATGTGGTTTGT"	10.749040265649	6.03426740253297	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATGTGGTTTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1585.04146633052	44.1643184576807	0.0278631943679834	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1572.46813809161	1572.46813809161
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATGTTAAGCAA"	4.56907524642293	-7.07096483623656	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATGTTAAGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.81515868498	43.1548708940959	0.0177022735872127	1423	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2433.76284994531	2433.76284994531
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATGTTCGGACC"	5.52793802794759	-9.99084570324095	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATGTTCGGACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.70154706753	18.4914142739436	0.00833809864920498	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.70481780893	2214.70481780893
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATTCAGCTTCC"	4.30276217040364	-7.25791408931883	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATTCAGCTTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.02600983757	33.005642612041	0.0127778978943059	1689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2575.9977781917	2575.9977781917
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGATTCGTCCTTG"	4.73580231246297	-7.61542084133299	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGATTCGTCCTTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.55852784883	3.78600059561085	0.00171813026418991	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2200.50224456055	2200.50224456055
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGGCAGATGCGAC"	3.40186132964436	-6.57459499752196	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGGCAGATGCGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2543.85029337676	33.9100910961217	0.0133302227668078	1633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2541.42040128193	2541.42040128193
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGGCGTCAGGCAA"	4.10213770446126	-6.77966263210448	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGGCGTCAGGCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2330.24751968824	35.6880139145641	0.0153151172195384	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2328.71045209526	2328.71045209526
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGGCTCACCTCGT"	-1.1450654071873	8.6961517103943	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGGCTCACCTCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1708.49613100256	33.8916896297871	0.0198371474273689	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1704.3901377584	1704.3901377584
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTGGCTCACGAGGA"	0.489407678216141	8.29239175403444	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTGGCTCACGAGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1643.28596545468	34.8888694257708	0.0212311613189719	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1639.88838591679	1639.88838591679
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTTAGAGTGCAGGT"	-3.96296010437663	12.7817229994568	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTTAGAGTGCAGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2058.18117090348	41.6636069823554	0.0202429249530382	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2052.66982127992	2052.66982127992
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTTCCAGACCGCCT"	0.49193706092183	9.0616187819275	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTTCCAGACCGCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1486.53466796437	44.2209637670797	0.0297476841408851	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1481.88830390596	1481.88830390596
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTTCCCACATATCG"	1.93723990496938	-6.34559395229491	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTTCCCACATATCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1982.04117321189	26.0777936987798	0.0131570393447079	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1977.16289727443	1977.16289727443
"healthy-4003"	"2020-08-26-Control4003-c3:GTGTTCCCAGTAACGG"	4.42236771163289	-8.16473963176879	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTGTTCCCAGTAACGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.1186404761	27.8726822587189	0.0132467255992809	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2097.91453243095	2097.91453243095
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACAGAGCGGGTTA"	-8.06897006455119	-1.18138244068297	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACAGAGCGGGTTA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2554.09168563873	31.0974720126989	0.0121755503874646	2535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2548.59538764655	2548.59538764655
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACAGCACTCCACT"	-1.99834690514262	8.80425450885621	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACAGCACTCCACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1859.69017734824	16.2796841112591	0.00875397650079142	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1859.69017734824	1859.69017734824
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACAGGTTGTCATG"	5.36829294738118	-10.0645179978577	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACAGGTTGTCATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2350.610663699	33.8197040631723	0.0143876247076802	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2343.33471184074	2343.33471184074
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACCCAGGTTGCCC"	-1.1332051557606	8.94189260089723	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACCCAGGTTGCCC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1838.89965741149	24.158587928766	0.0131375237530756	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1835.08626832817	1835.08626832817
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACCCCACATGACT"	10.5074268775875	7.03900477969972	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACCCCACATGACT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1768.03028447395	42.9220349432145	0.024276753243503	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1764.79424355947	1764.79424355947
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACCCGTATCATGC"	4.97167934951131	-7.95004656231078	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACCCGTATCATGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3095.67316506276	3.03512419448454	0.000980440774154856	2797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3085.66643275128	3085.66643275128
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACCCGTGTAACGG"	10.7590490775997	6.85050532901613	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACCCGTGTAACGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1752.30952636634	21.4820189586134	0.0122592604990052	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1750.16270078134	1750.16270078134
"healthy-4003"	"2020-08-26-Control4003-c3:GTTACGACACATTACG"	-4.22035298767741	10.2020044096741	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTACGACACATTACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2236.44560596772	34.2949096276303	0.0153345601324342	1112	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2232.91393510473	2232.91393510473
"healthy-4003"	"2020-08-26-Control4003-c3:GTTAGACAGAGGCCAT"	3.45670189437215	-7.07546141063841	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTAGACAGAGGCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1858.05338747387	26.1183885358052	0.0140568557996682	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1855.12106235607	1855.12106235607
"healthy-4003"	"2020-08-26-Control4003-c3:GTTAGACCACCGGAAA"	3.67434300956075	-7.63434221660765	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTAGACCACCGGAAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1979.25485453142	6.09204981366699	0.00307795117931352	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1977.53740360664	1977.53740360664
"healthy-4003"	"2020-08-26-Control4003-c3:GTTAGACGTGAGTTTC"	3.85646643218343	-7.61318161403807	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTAGACGTGAGTTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.51698709746	17.98082042832	0.00919491906588273	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1951.76017509349	1951.76017509349
"healthy-4003"	"2020-08-26-Control4003-c3:GTTATGGTCAACTGGT"	4.68596233901326	-7.47375490581664	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTATGGTCAACTGGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.0924544366	31.1301307451394	0.0130738857649714	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.63657686367	2375.63657686367
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCATTCATCTCAAG"	-3.8212083381718	12.2129449614319	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCATTCATCTCAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1736.582074845	35.7407206457073	0.0205810719593529	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1734.3294067133	1734.3294067133
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCATTGTTTGGCTA"	8.58828129348103	6.09630773151246	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCATTGTTTGGCTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1440.98121667126	22.1061673000637	0.0153410516697297	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1440.98121667126	1440.98121667126
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCCGTTCGAGCTGC"	-1.32452080670055	9.20829961383668	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCCGTTCGAGCTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1976.54658096651	41.3533375087321	0.0209220151485176	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1967.53986790648	1967.53986790648
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCGCTGTTGCATAC"	3.8023108440334	-7.51657106792601	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCGCTGTTGCATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.71874713781	33.2356918062388	0.0138325352669055	1497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.59191531646	2397.59191531646
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCGCTTCTCGCAGG"	-3.82912598076518	12.8396997221741	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCGCTTCTCGCAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1887.27487071903	43.7148960303312	0.0231629725529469	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1873.31254921492	1873.31254921492
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCGCTTCTGCAGCG"	3.8820706802303	-7.01409914409789	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCGCTTCTGCAGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2513.45572807778	31.1947787833901	0.0124111112978493	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2509.51319710254	2509.51319710254
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCTATAGACTGAGC"	1.04726131734197	-6.45378305828246	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCTATAGACTGAGC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2034.43516474963	27.1727168254578	0.0133563936055941	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2031.14545133916	2031.14545133916
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCTATAGTCCCTAA"	6.74334396895711	-1.65438129818114	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCTATAGTCCCTAA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2753.69989606428	21.1740790691907	0.00768931977644106	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2748.40903520813	2748.40903520813
"healthy-4003"	"2020-08-26-Control4003-c3:GTTCTATGTAATGTGA"	6.76882566985433	-1.62453141128691	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTCTATGTAATGTGA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2509.45608049802	27.5330289256472	0.0109717118142124	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2497.97895910134	2497.97895910134
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGAACTCAAGCCGC"	-3.17883596840556	9.962375617865	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGAACTCAAGCCGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2243.71169683245	34.2425186829354	0.0152615501943842	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2237.08406180439	2237.08406180439
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGAACTCCACACAA"	4.57203354415242	-6.82109405910643	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGAACTCCACACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2349.95688694216	23.1024299762837	0.00983100162588318	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2346.07508946514	2346.07508946514
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGCGGCAATTTCGG"	5.17805494841878	-8.77988531505736	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGCGGCAATTTCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2911.25876586747	34.786612309448	0.0119489935821911	2329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2905.82058846091	2905.82058846091
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGCGGTCATGTCTT"	0.489643772214097	8.07892510974733	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGCGGTCATGTCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1396.65251562645	5.44230542699668	0.00389667821172798	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1391.74050231247	1391.74050231247
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGCGGTCCCATGGG"	5.44369425353352	-10.1574678651062	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGCGGTCCCATGGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2102.46627896833	31.0632000999994	0.0147746484263434	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2096.39129939907	2096.39129939907
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGCTCCAGGATCTT"	-1.86054728451427	9.50199887836305	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGCTCCAGGATCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1662.42765910946	25.3529920136096	0.0152505836116747	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1662.42765910946	1662.42765910946
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGCTCGTCGACTTA"	-0.451920728117782	8.91103837573854	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGCTCGTCGACTTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1791.51976271572	7.54127848196048	0.00420943080780134	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.80213102788	1785.80213102788
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGTAGGTGACCGAA"	-2.7642859024113	10.3292732008728	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGTAGGTGACCGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1740.28638669898	33.6918366143423	0.0193599380376984	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1727.51276079241	1727.51276079241
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGTAGTCACTTGGA"	-0.322146515280563	8.43738362872926	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGTAGTCACTTGGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.91270554319	33.4083050831711	0.0181773078680021	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.58793893245	1825.58793893245
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGTAGTCGTGACTA"	3.43547834929768	-6.93253900921019	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGTAGTCGTGACTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2137.08904507652	26.6917992081455	0.012489792725127	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2130.2231021116	2130.2231021116
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGTGAAGGCATCGA"	3.9522942501003	-7.45692827617797	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGTGAAGGCATCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.5372797299	36.2421834673334	0.0167358852727088	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2164.05020432239	2164.05020432239
"healthy-4003"	"2020-08-26-Control4003-c3:GTTGTGATCACTGTCC"	4.91905417022054	-7.90896036541136	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTGTGATCACTGTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2551.90411545081	37.0201305187431	0.0145068657927233	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2549.23219943487	2549.23219943487
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTACTAGCCGTTGC"	9.19083180007283	6.30361220920411	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTACTAGCCGTTGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1584.40103726811	40.1363768936973	0.0253322081654921	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1571.22415433456	1571.22415433456
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTACTGTATACCTG"	5.03558077391927	-7.86007406627806	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTACTGTATACCTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2694.97891070947	13.8321536175892	0.00513256469749065	1698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2681.83562519872	2681.83562519872
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTACTGTCTCAAGT"	4.52570929107015	-7.82087709819945	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTACTGTCTCAAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2381.54724676779	27.9394630845476	0.011731643418986	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2378.71228849065	2378.71228849065
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTGGAAGCAAGTCG"	9.87631763991658	6.93679378116456	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTGGAAGCAAGTCG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.90127812849	47.5832010909517	0.0269761135053078	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1750.40659201506	1750.40659201506
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTGGAGTTCAAGTC"	-3.62152824822124	10.8498973616394	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTGGAGTTCAAGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1590.99285478684	29.0780499081094	0.0182766690753022	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1590.99285478684	1590.99285478684
"healthy-4003"	"2020-08-26-Control4003-c3:GTTTGGATCTGTCTCG"	3.60733165320699	-6.76232483303221	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.GTTTGGATCTGTCTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.97331414171	36.3023479115034	0.0175971000994779	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2062.97331414171	2062.97331414171
"healthy-4003"	"2020-08-26-Control4003-c3:TAACACGAGACATAGT"	0.455838223069352	9.83981511676637	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACACGAGACATAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2012.90794953913	25.5402709329072	0.0126882458478813	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2002.2624679242	2002.2624679242
"healthy-4003"	"2020-08-26-Control4003-c3:TAACACGAGAGGGTGG"	-4.15747056427653	12.9489345320496	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACACGAGAGGGTGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1979.01090546006	6.1696119229755	0.00311752295348835	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1975.03952759179	1975.03952759179
"healthy-4003"	"2020-08-26-Control4003-c3:TAACACGAGGATACGC"	4.3535553413326	-8.29734327709349	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACACGAGGATACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.52295560951	7.65320130492727	0.0040439146496178	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1892.52295560951	1892.52295560951
"healthy-4003"	"2020-08-26-Control4003-c3:TAACACGCACCCTCTA"	4.10654081878011	-7.88562347805174	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACACGCACCCTCTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2708.2433750511	21.3617925481477	0.00788769308731149	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2700.57373176348	2700.57373176348
"healthy-4003"	"2020-08-26-Control4003-c3:TAACACGGTCTCAAGT"	3.52519907531087	-6.87621977245482	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACACGGTCTCAAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2514.83460236105	34.6639375155816	0.0137837842230409	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2512.94643046008	2512.94643046008
"healthy-4003"	"2020-08-26-Control4003-c3:TAACCAGAGTAGAGTT"	3.38117374953572	-6.37790539180907	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACCAGAGTAGAGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.44163360363	36.3229203413303	0.0154470856610907	1487	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2344.22882407809	2344.22882407809
"healthy-4003"	"2020-08-26-Control4003-c3:TAACGACAGAGAGCGG"	4.82867064055745	-7.8690715066162	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACGACAGAGAGCGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2300.07434070499	0	0	1389	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2296.19736145601	2296.19736145601
"healthy-4003"	"2020-08-26-Control4003-c3:TAACTTCAGCAACAAT"	5.52974428710286	-9.74789049541625	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACTTCAGCAACAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.81233658264	42.2373864534093	0.0172834001290266	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2441.1040395055	2441.1040395055
"healthy-4003"	"2020-08-26-Control4003-c3:TAACTTCCAGAGAAAG"	4.65447487410848	-7.31809189235839	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACTTCCAGAGAAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.15510216756	25.2723868724099	0.0106807820202736	1520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.31231603229	2355.31231603229
"healthy-4003"	"2020-08-26-Control4003-c3:TAACTTCTCTTCGATT"	4.33385910567586	-6.97613098537596	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAACTTCTCTTCGATT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.10324034053	25.975442221212	0.00993285535366841	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2609.33573460271	2609.33573460271
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCACGTGAGATCG"	2.58785309371297	-4.41905691539916	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCACGTGAGATCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2259.66991116046	27.4306476716015	0.0121392277412388	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2254.56219730154	2254.56219730154
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCCATCGGTTGTA"	-6.56481872025188	4.28286979282228	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCCATCGGTTGTA"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1623.92305120382	2.85987063785235	0.00176108753166126	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1618.43997197495	1618.43997197495
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCGTAGGCAATGC"	3.92624821242635	-7.53530647670897	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCGTAGGCAATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.77189482992	5.41223012177958	0.00255804046504487	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.03601145024	2114.03601145024
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCGTGTCGGTGAA"	-4.39297566834148	13.112130142096	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCGTGTCGGTGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1931.52021797681	31.1110559629867	0.0161070309662998	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1927.38792260877	1927.38792260877
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCGTGTGAACTAA"	5.25868143615071	-10.2427854768005	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCGTGTGAACTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.20652898071	42.3758621277397	0.0201962302292166	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2098.20652898071	2098.20652898071
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGCGTTCCCTCGTA"	4.06650032576863	-7.24454166805419	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGCGTTCCCTCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.54686131465	18.4012224401139	0.00806170631235829	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.35913705976	2278.35913705976
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGTCGAGTTGGGAC"	3.48872127112691	-7.81539013302001	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGTCGAGTTGGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.12898966393	34.0505133695468	0.0193125480717308	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1760.97650438071	1760.97650438071
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGTCGCAGGTACGA"	5.23505987700765	-9.43604662334593	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGTCGCAGGTACGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.45245476906	34.2601186150614	0.0145265250294885	1460	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.69649597116	2354.69649597116
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGTCGCATAACAGA"	3.99498667296712	-7.07011845028075	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGTCGCATAACAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.94869486227	34.4220782899227	0.0173415455920946	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1984.94869486227	1984.94869486227
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGTCGGTTGAATCC"	3.95296325263326	-8.26329138195189	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGTCGGTTGAATCC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.90630440995	36.5907816258741	0.015951297381035	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2287.98292198176	2287.98292198176
"healthy-4003"	"2020-08-26-Control4003-c3:TAAGTCGTCTACTATC"	-1.1705404323643	8.58683965289918	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAAGTCGTCTACTATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1595.9982994187	37.5152746818691	0.0235058362502849	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1589.61124577042	1589.61124577042
"healthy-4003"	"2020-08-26-Control4003-c3:TAATCTCCAACCACAT"	4.32118238982503	-7.52886202251586	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATCTCCAACCACAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.35427033978	37.0649150943759	0.0141720437321711	1669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2607.87052371706	2607.87052371706
"healthy-4003"	"2020-08-26-Control4003-c3:TAATCTCCATTGCTGA"	4.41527857360188	-6.98113825237425	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATCTCCATTGCTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2164.29890477293	21.9352861191745	0.0101350539293813	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2157.75673562801	2157.75673562801
"healthy-4003"	"2020-08-26-Control4003-c3:TAATCTCGTGGGCTCT"	5.57230248030965	-10.0707216492859	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATCTCGTGGGCTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.5665891807	24.5432325871401	0.010852314808927	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2256.32366783423	2256.32366783423
"healthy-4003"	"2020-08-26-Control4003-c3:TAATCTCGTTCTGAGT"	5.41639914092366	-10.0908928147522	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATCTCGTTCTGAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.25392255262	30.0522124501078	0.0131908968322708	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.4539268311	2272.4539268311
"healthy-4003"	"2020-08-26-Control4003-c3:TAATCTCTCCTCTAGC"	4.00836386260335	-7.963987373468	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATCTCTCCTCTAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.82005649725	26.1638201797177	0.0111819796172212	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2335.56376585754	2335.56376585754
"healthy-4003"	"2020-08-26-Control4003-c3:TAATTCCAGTGAATAC"	-0.198039690882522	9.82648274982301	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATTCCAGTGAATAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.2812665518	27.4150473663976	0.0163060446290608	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1669.07870459653	1669.07870459653
"healthy-4003"	"2020-08-26-Control4003-c3:TAATTCCGTAATCAGA"	2.79445709761922	-4.29422857677611	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATTCCGTAATCAGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2146.27855467893	45.2028824243414	0.0210610511509786	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2135.12343146942	2135.12343146942
"healthy-4003"	"2020-08-26-Control4003-c3:TAATTCCTCACGAACT"	-0.586083809763748	8.62489888751832	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATTCCTCACGAACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1951.89482532609	34.7329838105156	0.0177944955639262	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.67928809284	1950.67928809284
"healthy-4003"	"2020-08-26-Control4003-c3:TAATTCCTCGCATGAT"	-3.30165610733684	-5.70211412822875	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATTCCTCGCATGAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2504.81389618628	39.5852451388041	0.0158036671702736	1533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2498.12116140197	2498.12116140197
"healthy-4003"	"2020-08-26-Control4003-c3:TAATTCCTCGCTACAA"	5.32307591018025	-9.70081045543822	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAATTCCTCGCTACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.22791879013	32.5141863712778	0.0150165190874898	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2160.57896244237	2160.57896244237
"healthy-4003"	"2020-08-26-Control4003-c3:TACAACGCACACGTGC"	-3.88188825073894	12.8232011565003	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAACGCACACGTGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1761.84952723814	37.3089883163884	0.0211760356032639	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1757.53756829612	1757.53756829612
"healthy-4003"	"2020-08-26-Control4003-c3:TACAACGGTCGCTTGG"	-4.41743884506877	3.60043642604677	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAACGGTCGCTTGG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2622.03639043298	40.3208069521289	0.0153776687078972	2085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2607.40917705326	2607.40917705326
"healthy-4003"	"2020-08-26-Control4003-c3:TACAGGTAGCGAAACC"	4.30099978026692	-7.24223139202269	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAGGTAGCGAAACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1969.25929071384	5.18809006310962	0.00263453882765686	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1969.25929071384	1969.25929071384
"healthy-4003"	"2020-08-26-Control4003-c3:TACAGGTCATCCGGCA"	-2.53413782540019	3.42281839931337	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAGGTCATCCGGCA"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2975.8182244128	26.0114830343106	0.00874095158801014	4231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2970.46053736331	2970.46053736331
"healthy-4003"	"2020-08-26-Control4003-c3:TACAGGTGTAGACACG"	4.37720026549642	-7.72238924419554	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAGGTGTAGACACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.19765763738	36.097725194539	0.0157825123132677	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.53488297805	2285.53488297805
"healthy-4003"	"2020-08-26-Control4003-c3:TACAGGTTCAGAATAG"	4.51615824279134	-8.72210218822631	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACAGGTTCAGAATAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1547.43309168417	25.0461385782685	0.0161856035733404	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1547.43309168417	1547.43309168417
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCCAACCCGCA"	-3.36333928528484	10.9876012572083	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCCAACCCGCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1624.40211308531	47.2611783467163	0.0290945068133104	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1618.18306848271	1618.18306848271
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCCAACTTCTT"	5.63002552565877	-10.0971527329651	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCCAACTTCTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2707.93983089969	26.5229068780493	0.00979449638260141	1745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2696.26534521039	2696.26534521039
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCGTAGATTGA"	5.37200130996053	-10.1639442673889	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCGTAGATTGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1986.28580597863	23.2560032523217	0.0117082864823995	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1973.13683075133	1973.13683075133
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCGTCACAATC"	2.21694650229756	-6.10475304042967	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCGTCACAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.97680409772	30.4758806015894	0.0127408763117522	1453	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2386.77173302496	2386.77173302496
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCGTTGAATCC"	-2.41128001633342	9.89311883533327	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCGTTGAATCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1994.85499135319	36.966515839796	0.0185309288143897	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1991.14327404767	1991.14327404767
"healthy-4003"	"2020-08-26-Control4003-c3:TACATTCTCACTGATG"	5.03301586684529	-7.94111826336058	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACATTCTCACTGATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.7413012446	12.2168758544139	0.00476339498587455	1715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2561.27811647694	2561.27811647694
"healthy-4003"	"2020-08-26-Control4003-c3:TACCCACGTGCTTATG"	4.36519589003865	-7.55677082454833	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCCACGTGCTTATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2111.29941877008	22.4587088329524	0.0106373869254582	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2106.46708662789	2106.46708662789
"healthy-4003"	"2020-08-26-Control4003-c3:TACCCACGTGTTTCTT"	5.31206240233724	-9.47659399425658	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCCACGTGTTTCTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.4318019948	9.21236522183534	0.00394123379940898	1290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2335.93798923333	2335.93798923333
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGAACAGCGTTGC"	-7.17299304428752	3.35228726947633	"2020-08-26-Control4003-c3"	"Control4003"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGAACAGCGTTGC"	"HSC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2004.01477876933	35.596260781589	0.0177624741886628	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1994.00482539672	1994.00482539672
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGAACAGTAGATA"	-0.918891291052657	8.44287965381471	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGAACAGTAGATA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1809.46646128731	37.4711638968872	0.0207084047693424	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1807.60417610297	1807.60417610297
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGAACATGGAACG"	-4.26592812958415	12.8016414412293	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGAACATGGAACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1956.56416001152	39.2029004571708	0.0200366035821386	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1946.53578859011	1946.53578859011
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGAAGTCCTCCAT"	4.07083715972249	-6.7695842019287	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGAAGTCCTCCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2363.96076700592	29.8351457292005	0.0126208294763658	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.58512644051	2359.58512644051
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGGGAGCGGCTCT"	0.802420993416947	8.95959947192994	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGGGAGCGGCTCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1536.58494538154	37.4909133477975	0.0243988550457185	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1531.78414468214	1531.78414468214
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGGGCACATACGT"	-0.801678935915786	8.22623250568239	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGGGCACATACGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2094.43363623331	33.2385854270189	0.0158699635319055	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2086.48020266902	2086.48020266902
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGGGCACGGGTAA"	10.2061182456905	6.78134391391603	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGGGCACGGGTAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1657.44558115206	24.4653186590385	0.0147608578750641	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1653.83895112376	1653.83895112376
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGGGCAGTAGAAT"	10.4529434638912	6.24955413425294	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGGGCAGTAGAAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1840.60673674621	40.2369391932975	0.0218606932105593	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1835.71889309299	1835.71889309299
"healthy-4003"	"2020-08-26-Control4003-c3:TACCGGGTCGTCTAAG"	0.00978020679895279	7.9258184202942	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCGGGTCGTCTAAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1792.23834869276	26.3198353774419	0.0146854548652189	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1778.25256251395	1778.25256251395
"healthy-4003"	"2020-08-26-Control4003-c3:TACCTCGTCAGTGATC"	5.11837973174397	-10.0057277909485	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TACCTCGTCAGTGATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1704.46612522136	0	0	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1704.46612522136	1704.46612522136
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCTTCAGCGATTT"	5.43522419509236	-9.4545002213684	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCTTCAGCGATTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2557.82425042145	19.1225288524105	0.00747609177966773	1691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2554.39349824699	2554.39349824699
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCTTTCAAGGTGG"	4.6484805541927	-7.82184555446776	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCTTTCAAGGTGG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2365.82733513345	30.1657225276637	0.012750601905596	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.02678382987	2360.02678382987
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGCAAGTTGTACC"	-7.15763030472453	-1.82447745716246	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGCAAGTTGTACC"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3123.537876402	29.8236043493595	0.00954802071544376	3860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3114.07258894694	3114.07258894694
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGCAGTTGGACCC"	2.67102016982381	-4.40546944057616	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGCAGTTGGACCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2774.22737144989	31.1261321323445	0.0112197480468507	2241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2767.98076408712	2767.98076408712
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGCATCTTAGCTT"	2.5902439552242	-7.10318138515624	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGCATCTTAGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1839.13463541967	14.0555981826545	0.00764250637879328	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1837.50650640757	1837.50650640757
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGGTAGCTGAGTG"	5.36774982985799	-10.2471008530823	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGGTAGCTGAGTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.04253941814	46.5458451902014	0.0226937492985426	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2047.83755593868	2047.83755593868
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGGTCAAGCTACT"	-3.14081416550334	10.0695457228455	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGGTCAAGCTACT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1928.87880947206	33.3914832967912	0.0173113433217355	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1923.27186116337	1923.27186116337
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGGTCACCCAACG"	-0.522531072527725	9.13380525195924	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGGTCACCCAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2098.5513485661	24.7013403956424	0.0117706628491699	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2092.5549716935	2092.5549716935
"healthy-4003"	"2020-08-26-Control4003-c3:TGATGGTCATGTTACG"	3.65290870246236	-6.9799752465454	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATGGTCATGTTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.75818321735	21.8386689866628	0.00889284178544461	1578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.88696543487	2450.88696543487
"healthy-4003"	"2020-08-26-Control4003-c3:TGATTCTCAGTCAGAG"	-1.85108850422557	8.86896703327028	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATTCTCAGTCAGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1684.97422316336	28.2950394826362	0.0167925651880391	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1684.97422316336	1684.97422316336
"healthy-4003"	"2020-08-26-Control4003-c3:TGATTCTTCCGCATAA"	5.40530695494954	-9.57486345684203	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATTCTTCCGCATAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2653.02356258281	6.73932107592409	0.00254024169667123	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2649.05513426682	2649.05513426682
"healthy-4003"	"2020-08-26-Control4003-c3:TGATTTCAGATGAATC"	4.59196962889974	-7.86816074764403	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATTTCAGATGAATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.62139996287	22.1373965207418	0.00951482545509771	1313	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.74040902115	2323.74040902115
"healthy-4003"	"2020-08-26-Control4003-c3:TGATTTCGTCTACGTA"	-0.524917642504531	8.37244794452516	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATTTCGTCTACGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1740.78899715252	33.7444652833242	0.0193845809793843	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1729.36750337437	1729.36750337437
"healthy-4003"	"2020-08-26-Control4003-c3:TGATTTCTCATTCCTA"	4.43120064315144	-6.76742651378783	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATTTCTCATTCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2724.99334766195	7.9848421825519	0.00293022446803509	1890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2722.7415121591	2722.7415121591
"healthy-4003"	"2020-08-26-Control4003-c3:TGCACGGAGTACAACA"	-9.46601043167766	4.95192000949708	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_MEP"	1	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCACGGAGTACAACA"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1908.5769375348	31.5856168608292	0.0165493023831811	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1893.10789586799	1893.10789586799
"healthy-4003"	"2020-08-26-Control4003-c3:TGCACGGCAGCCGTCA"	5.43851913985555	-9.60036756908568	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCACGGCAGCCGTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.14246934946	47.066802622905	0.0222523084401879	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2108.40436296122	2108.40436296122
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGATGTGTGTACT"	-2.83228884163554	12.154945350531	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGATGTGTGTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1868.05928770231	20.0590818668931	0.0107379257173179	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1850.81684829621	1850.81684829621
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGATGTTTACGAC"	0.400559415190858	7.91498849475709	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGATGTTTACGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1540.98039791475	0.822886707033432	0.000534002060082632	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1535.61137821366	1535.61137821366
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGGCCAGAACTAA"	-4.37088904801066	13.1037788161072	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGGCCAGAACTAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2227.74689718991	35.0664776834487	0.0157407817412659	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2218.83223997083	2218.83223997083
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGGCGTAACGTTC"	-7.45961413803752	0.72663769805757	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGGCGTAACGTTC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2778.93118526631	21.4920592035316	0.00773392997908004	3315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2769.32042939582	2769.32042939582
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGTAAGGGATCAC"	2.70011415061299	-4.46138622677001	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGTAAGGGATCAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2646.67330585725	37.4664814928395	0.0141560658090758	2137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2639.59392533493	2639.59392533493
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGTAGTCCGATCG"	-2.88079176369365	9.71482560718385	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGTAGTCCGATCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1970.39651635721	38.7327685326273	0.0196573472451296	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1954.72181445559	1954.72181445559
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGTATCTTCCACG"	-3.58568487587627	10.7238387831482	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGTATCTTCCACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1758.06494918593	42.83842318297	0.0243668035147428	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.22810146949	1756.22810146949
"healthy-4003"	"2020-08-26-Control4003-c3:TGCAGTATCTTTCCAA"	9.91918053206746	7.28139159763185	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCAGTATCTTTCCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2231.68241740312	31.0970315388984	0.0139343444642469	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2222.50943456708	2222.50943456708
"healthy-4003"	"2020-08-26-Control4003-c3:TGCATCCCATCACCAA"	4.43471445617024	-6.8322062722412	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCATCCCATCACCAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2660.50648485414	35.0129154914514	0.0131602443710529	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2654.71113426352	2654.71113426352
"healthy-4003"	"2020-08-26-Control4003-c3:TGCATCCTCACTGCTC"	5.45793690261189	-9.68567945873412	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCATCCTCACTGCTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2634.0552968572	40.1386601109538	0.0152383513583959	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2624.75202168935	2624.75202168935
"healthy-4003"	"2020-08-26-Control4003-c3:TGCATGAAGAGTCGAC"	-0.214921037585098	8.29873178088991	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCATGAAGAGTCGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1844.90465368928	32.8856299301491	0.0178251108339866	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1831.81714820582	1831.81714820582
"healthy-4003"	"2020-08-26-Control4003-c3:TGCATGAGTTACGGAG"	9.95279469069783	6.48877570712892	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCATGAGTTACGGAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1720.5856214893	38.5004194904526	0.022376346175163	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1712.71110664111	1712.71110664111
"healthy-4003"	"2020-08-26-Control4003-c3:TGCCGAGTCCACAAGT"	-2.1459826034611	9.40057656848756	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCCGAGTCCACAAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.78755232031	39.7289039010796	0.0198765015596379	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1984.45946862757	1984.45946862757
"healthy-4003"	"2020-08-26-Control4003-c3:TGCCGAGTCTACTTCA"	5.63435473021809	-9.94539930736693	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCCGAGTCTACTTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2615.10647932888	31.6149938601936	0.0120893715457074	1749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2608.06834248694	2608.06834248694
"healthy-4003"	"2020-08-26-Control4003-c3:TAGAGTCGTCATCAGT"	4.83200468596761	-7.94300749218138	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGAGTCGTCATCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2486.99100482764	30.29082454876	0.0121797081251845	1449	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2485.60902757207	2485.60902757207
"healthy-4003"	"2020-08-26-Control4003-c3:TAGAGTCGTGGCTTGC"	-1.97969899597819	9.63738629901735	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGAGTCGTGGCTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1570.70657384188	31.5562888782007	0.0200905053838384	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1568.51406074532	1568.51406074532
"healthy-4003"	"2020-08-26-Control4003-c3:TAGATCGCAAGAGTGC"	10.7757612663204	5.839488483313	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGATCGCAAGAGTGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1697.2800146318	39.3690627308492	0.0231953846103524	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1684.52918981815	1684.52918981815
"healthy-4003"	"2020-08-26-Control4003-c3:TAGATCGCACTAACCA"	-4.82510505142863	-5.14602520382079	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGATCGCACTAACCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2695.71893678801	27.0851511145045	0.0100474685045529	1904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2693.50455954408	2693.50455954408
"healthy-4003"	"2020-08-26-Control4003-c3:TAGATCGTCGGCATAT"	3.75699748572652	-7.01914694225463	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGATCGTCGGCATAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.29760839771	30.4250425476977	0.0152866799514427	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1981.76398525069	1981.76398525069
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGGTTCATAGAGGC"	1.86084916171376	-6.81079962169798	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGGTTCATAGAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.4535672148	36.6723274283798	0.0192966184815158	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1894.55418497492	1894.55418497492
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGGTTTCTTTACAC"	2.5418504672939	-7.43661692058715	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGGTTTCTTTACAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.76283569369	32.9302621463625	0.0143003272572977	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2297.44619389239	2297.44619389239
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTACCAAGCTACT"	-4.27357659760173	12.9864148863587	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTACCAAGCTACT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1750.62380333756	48.378290654455	0.0276348868113309	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1739.77237901666	1739.77237901666
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTACCACGACAAG"	4.66746820983235	-8.69463255321654	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTACCACGACAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.8078790958	18.9280053279497	0.00989540326281859	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1911.08938515815	1911.08938515815
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTACCACGATAGG"	4.71038975295369	-7.25614216243895	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTACCACGATAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2751.02928377616	33.155075902943	0.0120518803992639	1910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2738.81724477282	2738.81724477282
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTACCACGTCGTG"	3.85261454161946	-7.15724041378173	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTACCACGTCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1689.02216629192	1.44923918583319	0.000858034438360774	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1689.02216629192	1689.02216629192
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTACGTCTACGTA"	-3.93791113320048	12.4422530897888	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTACGTCTACGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.53203453962	34.8112646046648	0.020221096039014	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1708.15097760426	1708.15097760426
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTTGCAGACATCT"	-0.763792018324691	8.63316438281862	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTTGCAGACATCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1528.92582240702	31.2260445112836	0.0204235182986993	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1522.41059876009	1522.41059876009
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTTGGTAGTACGG"	-0.410145859152633	8.67379186237184	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTTGGTAGTACGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1751.33264323922	34.7583362840617	0.019846792908384	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1746.12096692941	1746.12096692941
"healthy-4003"	"2020-08-26-Control4003-c3:TAGGTTGTCCATTTGT"	10.9615255790645	6.1220083006653	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGGTTGTCCATTTGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1622.04930907796	40.2889431042985	0.0248382973802444	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1622.04930907796	1622.04930907796
"healthy-4003"	"2020-08-26-Control4003-c3:TAGTGCAGTACGGATG"	5.1013032394344	-8.63971426403197	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGTGCAGTACGGATG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2370.4948485661	2.61727641788724	0.00110410550753587	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2370.4948485661	2370.4948485661
"healthy-4003"	"2020-08-26-Control4003-c3:TAGTGCAGTCCTGGTG"	14.3362461524898	2.07117316806642	"2020-08-26-Control4003-c3"	"Control4003"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGTGCAGTCCTGGTG"	"Plasma cell"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1252.88574841187	22.021189511009	0.0175763748122465	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1241.81432014246	1241.81432014246
"healthy-4003"	"2020-08-26-Control4003-c3:TAGTGCATCCGGCTTT"	10.5106960731441	5.47950122440187	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGTGCATCCGGCTTT"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1601.69798576944	23.448715041693	0.0146399104263271	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1597.71970965923	1597.71970965923
"healthy-4003"	"2020-08-26-Control4003-c3:TAGTGCATCGAAGGAC"	11.1229187446529	5.33364341342775	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TAGTGCATCGAAGGAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1440.53226157011	27.0207050806818	0.0187574452870848	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1438.54932930939	1438.54932930939
"healthy-4003"	"2020-08-26-Control4003-c3:TATACCTAGTTAACAG"	2.69971193847005	-6.54219534313353	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATACCTAGTTAACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.98371526143	34.006053240187	0.0151678413222648	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2240.46026563759	2240.46026563759
"healthy-4003"	"2020-08-26-Control4003-c3:TATACCTGTAGGTAGC"	2.99108733710591	-6.42996599590453	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATACCTGTAGGTAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.24274246983	16.2823184971504	0.00910520597145671	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1788.24274246983	1788.24274246983
"healthy-4003"	"2020-08-26-Control4003-c3:TATACCTGTCTCGACG"	5.57587923583333	-10.2298097840515	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATACCTGTCTCGACG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.16357390564	21.7648231840331	0.00887938423030389	1489	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2447.24851529394	2447.24851529394
"healthy-4003"	"2020-08-26-Control4003-c3:TATACCTTCGCTATTT"	4.27811159667317	-7.29452946102294	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATACCTTCGCTATTT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.79886244982	27.4056267851935	0.0107187261335585	1615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2551.78554698219	2551.78554698219
"healthy-4003"	"2020-08-26-Control4003-c3:TATATCCAGAGGATGA"	-1.58067129078563	8.87393472278444	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATATCCAGAGGATGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1782.52558817027	11.7619903979681	0.00659849736577506	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1778.68548953263	1778.68548953263
"healthy-4003"	"2020-08-26-Control4003-c3:TATATCCGTGAGGCAT"	0.03290369649176	8.46742723071901	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATATCCGTGAGGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1977.42785602255	24.0994127349968	0.0121872525774321	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1971.31240454381	1971.31240454381
"healthy-4003"	"2020-08-26-Control4003-c3:TATCAGGTCGTCAAAC"	-4.01485381546672	12.7300367125305	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCAGGTCGTCAAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2006.57327017258	30.3099395524377	0.0151053240880812	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2002.13143131153	2002.13143131153
"healthy-4003"	"2020-08-26-Control4003-c3:TATCCTAAGAGGGCGA"	-2.29635653916057	10.4007138975891	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCCTAAGAGGGCGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1639.99213574366	35.1535657592549	0.0214352038604834	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1635.67845242535	1635.67845242535
"healthy-4003"	"2020-08-26-Control4003-c3:TATCGCCTCGGAAGGT"	-2.87288747254069	9.4274863966736	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCGCCTCGGAAGGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1728.2855572862	32.5080806349562	0.0188094383465203	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1728.2855572862	1728.2855572862
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTGTGTACGAGCA"	3.28537168082539	-6.62212946331175	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTGTGTACGAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2133.35824611339	26.7486867547052	0.0125383004956794	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2126.14328695885	2126.14328695885
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTGTGTCACTACA"	-4.06221566620524	12.8729247816834	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTGTGTCACTACA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2220.83083024145	30.281123683831	0.0136350429179421	1119	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2213.92142182821	2213.92142182821
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTGTTCTAGAGCT"	5.18972887572591	-8.76429560100707	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTGTTCTAGAGCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2718.57588431168	13.6972292572564	0.00503838400697225	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2707.0850912909	2707.0850912909
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTTGAGACTCTAC"	4.38726439055745	-7.34583189403685	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTTGAGACTCTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2424.54676896073	15.6753547683733	0.00646527217748515	1393	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2421.72341156408	2421.72341156408
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTTGCACCTGCAG"	-3.88758049431499	12.5403480299744	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTTGCACCTGCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1842.21189977364	33.3225881308355	0.0180883578783363	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1835.79198035124	1835.79198035124
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTTGTCATTGCCC"	-0.318609784275848	8.1171254881653	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTTGTCATTGCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1818.22477863143	7.71706482464974	0.00424428536853313	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1816.79366005727	1816.79366005727
"healthy-4003"	"2020-08-26-Control4003-c3:TATCTTGTCCGTAATG"	3.66894521292989	-6.66375257885131	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATCTTGTCCGTAATG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1970.3974810162	2.96668256552253	0.00150562645055378	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1970.3974810162	1970.3974810162
"healthy-4003"	"2020-08-26-Control4003-c3:TATGTTCCACGTATAC"	-3.87282309952434	10.154664970282	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATGTTCCACGTATAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2261.23506622777	29.2952881700747	0.0129554368794332	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2249.2758161891	2249.2758161891
"healthy-4003"	"2020-08-26-Control4003-c3:TATGTTCGTCCAAGAG"	4.50616898116414	-7.84196808254393	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATGTTCGTCCAAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.29119636733	33.0265877629935	0.0157023372797998	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2096.05036933749	2096.05036933749
"healthy-4003"	"2020-08-26-Control4003-c3:TATGTTCGTGATCATC"	5.45169653472249	-10.1073923341003	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATGTTCGTGATCATC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2329.98334351838	28.6115564248561	0.0122797257347133	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2329.98334351838	2329.98334351838
"healthy-4003"	"2020-08-26-Control4003-c3:TATGTTCTCGAGCACC"	0.54437612470929	7.89525172794191	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TATGTTCTCGAGCACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1730.74109234288	34.3504709525382	0.0198472614445402	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1727.31388034669	1727.31388034669
"healthy-4003"	"2020-08-26-Control4003-c3:TGGCGTGTCGTGAGAG"	4.71845402297322	-7.7811055413452	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGCGTGTCGTGAGAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.44485017247	39.1563152616473	0.0170955066910687	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2285.05607325063	2285.05607325063
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGAAGCAGTCCCGA"	0.130492297082585	8.45867154682008	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGAAGCAGTCCCGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1658.15215565117	41.7195440937752	0.0251602628574165	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.48081430723	1650.48081430723
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGAAGTCAACCTCC"	-0.901524285704452	9.07709500873414	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGAAGTCAACCTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1866.89862934757	35.6902346742892	0.0191173929388775	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1865.26932136143	1865.26932136143
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGAGACAGATACTC"	-4.10447965088542	11.3825979002747	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGAGACAGATACTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2051.32370009954	40.8951036303492	0.0199359582441156	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2042.14556242095	2042.14556242095
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGAGATCACGAGGA"	-2.95668659630473	10.4980840452942	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGAGATCACGAGGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.26967674846	43.059253757637	0.0272998678617873	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1572.92521011015	1572.92521011015
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGATTCATGAATAG"	4.78149475631062	-7.34505703365477	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGATTCATGAATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2677.85995221608	11.5653076768865	0.00431886203283915	1851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2673.45493081114	2673.45493081114
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGATTTCTACCCAC"	5.14575686034505	-8.97057154094847	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGATTTCTACCCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2520.91603037621	24.3653485636555	0.00966527574503118	1529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2515.62586275526	2515.62586275526
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCGTAGCCGATTT"	3.5024377304012	-6.58442833339842	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCGTAGCCGATTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.96369305348	24.8423558516608	0.0115871159255872	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2137.82783070613	2137.82783070613
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCGTTCACCCTGT"	3.83392896231953	-6.66267206585082	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCGTTCACCCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.11546548232	31.1279278174418	0.012741079272443	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2438.11915426407	2438.11915426407
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGAGCGTTGTT"	-0.765167216688949	9.15382192218629	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGAGCGTTGTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1613.61172461297	39.7749179364324	0.0246496212996795	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1602.77372368462	1602.77372368462
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGAGGCTAACG"	0.342186172574204	8.38071534717409	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGAGGCTAACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1534.86364454499	25.0114632597298	0.016295560422336	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1532.62993052324	1532.62993052324
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGCAGCTTTGA"	-4.05187545242961	12.7181195982727	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGCAGCTTTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1808.98491515754	34.941670539878	0.0193156229480416	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1804.83822949964	1804.83822949964
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGGTTTCTATC"	10.6310221153194	7.33978221500245	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGGTTTCTATC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2149.66493013103	34.3836253970813	0.0159948766503743	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2143.94256567462	2143.94256567462
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGTCAGCGCAC"	-3.49960766258891	9.66890809619752	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGTCAGCGCAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.33859758083	0.802110549243346	0.000448773696449574	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1783.58000598201	1783.58000598201
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGCAGTCGGTACC"	5.65039410170857	-9.9120493165222	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGCAGTCGGTACC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.47468711398	38.6700731128603	0.0158258537797803	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.29392006238	2439.29392006238
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGTGAGTAGAATC"	3.89482345160787	-6.69176819240721	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGTGAGTAGAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.15869857613	20.8992569303173	0.00872198362434689	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2387.15632701599	2387.15632701599
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGTGCACTGTGAT"	3.04077376899068	-6.8821649781433	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGTGCACTGTGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2115.42365712377	6.37354380095092	0.00301289237240388	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2114.10665452885	2114.10665452885
"healthy-4003"	"2020-08-26-Control4003-c3:TCAAGTGCAGTTAAAG"	5.47175802764241	-9.68957617199095	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAAGTGCAGTTAAAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2556.56942082922	13.5521211438737	0.00530090090003424	1579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.56942082922	2556.56942082922
"healthy-4003"	"2020-08-26-Control4003-c3:TCAATCTAGGTATTGA"	-1.43252191963847	8.97339818561403	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAATCTAGGTATTGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1606.73456362175	36.2941420339063	0.0225887603687913	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1600.09797327551	1600.09797327551
"healthy-4003"	"2020-08-26-Control4003-c3:TCAATCTTCGATACAC"	0.417569478123826	8.43474576557008	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAATCTTCGATACAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1503.31664362107	24.4139251225257	0.0162400417943351	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1503.31664362107	1503.31664362107
"healthy-4003"	"2020-08-26-Control4003-c3:TCACAAGGTCAATGGG"	-2.34294066849406	9.99229142749635	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACAAGGTCAATGGG"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1924.11486122086	2.15103813337066	0.00111793644793421	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1920.47504033324	1920.47504033324
"healthy-4003"	"2020-08-26-Control4003-c3:TCACAAGGTGGGCTCT"	-3.28766379776652	9.73039434039918	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACAAGGTGGGCTCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1998.70266911269	24.7919938560887	0.0124040430021014	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1988.32267710505	1988.32267710505
"healthy-4003"	"2020-08-26-Control4003-c3:TCACAAGGTGGTCTAT"	2.06522883948628	-6.93305780803832	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACAAGGTGGTCTAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1981.77942512693	26.8366165563959	0.0135416768466435	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1976.02285435299	1976.02285435299
"healthy-4003"	"2020-08-26-Control4003-c3:TCACAAGGTTGCCATA"	-2.27307067337688	9.12259290302125	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACAAGGTTGCCATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1680.84730367814	32.2813625643978	0.0192054105651105	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1678.84554571471	1678.84554571471
"healthy-4003"	"2020-08-26-Control4003-c3:TCACAAGTCACCCTCA"	-3.3824442428654	-5.78375151073607	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACAAGTCACCCTCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2592.93577093048	34.8609172277843	0.0134445741458819	1649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2586.59436043856	2586.59436043856
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCAGACCTTTG"	4.00008287009541	-7.12820722973021	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCAGACCTTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.30252601077	22.6720811326699	0.0105094583904255	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2157.30252601077	2157.30252601077
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCAGCCGATCC"	-4.40285239639934	12.6412000426087	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCAGCCGATCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2448.43358183536	25.0741336387426	0.0102408878169147	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2433.77954579588	2433.77954579588
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCAGGCTCCCA"	-0.37685532394107	8.53044698322145	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCAGGCTCCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2164.87052073699	23.0924527218518	0.0106668978586259	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2164.87052073699	2164.87052073699
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCCAAGCGAGT"	3.44855465468709	-6.83728506481322	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCCAAGCGAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.41588968307	37.7963211245391	0.0156609232938723	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2409.67808408887	2409.67808408887
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCCAGCAGTGA"	4.06856646117513	-7.46377470409545	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCCAGCAGTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1738.23985468123	17.8034963496848	0.0102422552916034	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1736.18722648446	1736.18722648446
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCCATGTCGTA"	-4.27391276779826	13.2066211470398	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCCATGTCGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2237.55313603159	42.2490695214412	0.0188818173035086	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2228.21374689754	2228.21374689754
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCGTACATACC"	2.51661576804463	-4.01998379146727	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCGTACATACC"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2454.06594933412	21.951784609925	0.00894506711031191	2184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2448.83293623164	2448.83293623164
"healthy-4003"	"2020-08-26-Control4003-c3:TCACACCGTCCATCTC"	-3.76259456101115	11.1180200346741	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACACCGTCCATCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1795.83012695719	41.1300674836619	0.0229030947116093	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1793.70104200563	1793.70104200563
"healthy-4003"	"2020-08-26-Control4003-c3:TCACATTAGTAATCCC"	4.75695385512654	-8.38522722637328	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACATTAGTAATCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2636.41569287033	18.4936805723416	0.00701470584565027	1665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2627.56898470441	2627.56898470441
"healthy-4003"	"2020-08-26-Control4003-c3:TCACATTTCGTTCTCG"	-0.31131867590602	8.64809892261354	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACATTTCGTTCTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2261.05605954016	24.5173162339698	0.0108433031240083	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2256.95181731213	2256.95181731213
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGCTAGACTCCGC"	-1.14347372475322	8.77220628345338	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGCTAGACTCCGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2085.97393235323	0	0	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2083.09452529033	2083.09452529033
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGCTCACAACCGC"	-3.52794108811076	-4.5217175713745	"2020-08-26-Control4003-c3"	"Control4003"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGCTCACAACCGC"	"DC precursor"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2692.42119566151	23.5196490872565	0.00873550138631925	2094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2688.64587304662	2688.64587304662
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGCTGTTCTCCAC"	-4.1426399749821	13.1658601530823	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGCTGTTCTCCAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2349.92628490762	33.2622236962562	0.014154581745769	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2346.43569310595	2346.43569310595
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGCTTCAGAGTTC"	4.13267054137532	-7.36332609569701	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGCTTCAGAGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.61633377235	31.8443221112258	0.0144574983954137	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.73505255323	2199.73505255323
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGGGCAACACGAG"	3.46861710128133	-6.56618883526	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGGGCAACACGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2413.07767444614	29.0703199537725	0.0120469888978791	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2404.14942992963	2404.14942992963
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGGGCAACCTAAC"	10.4893585639888	7.60050246799318	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGGGCAACCTAAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2316.73869314274	37.9851031474068	0.0163959376427899	1660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2305.81741380518	2305.81741380518
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGGGCAAGCGCTC"	-0.105602900416213	8.22689817035524	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGGGCAAGCGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1696.80441277375	39.3454599755137	0.0231879759855151	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1692.65596445525	1692.65596445525
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGGGCACCTTCGT"	-3.9360867542332	10.6599349745545	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGGGCACCTTCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1984.2952569808	42.1480399837031	0.0212408107288596	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1980.00244930837	1980.00244930837
"healthy-4003"	"2020-08-26-Control4003-c3:TCACGGGCATAAGATG"	5.45605005797688	-9.42520620739134	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACGGGCATAAGATG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2567.44496108572	10.7373358829854	0.00418210946903602	1541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2560.82230276183	2560.82230276183
"healthy-4003"	"2020-08-26-Control4003-c3:TCACTATGTAGCCCTG"	10.1054331260616	6.43445680225221	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACTATGTAGCCCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1676.78795576428	26.2232531544698	0.0156389799105619	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1671.01922841793	1671.01922841793
"healthy-4003"	"2020-08-26-Control4003-c3:TCACTATGTCCGACGT"	-2.75661335411723	8.89850423419801	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACTATGTCCGACGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1908.10778012347	35.1732466196477	0.0184335743431494	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1902.33500928357	1902.33500928357
"healthy-4003"	"2020-08-26-Control4003-c3:TCACTATGTCTAATCG"	5.13551916655843	-8.85776998912963	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCACTATGTCTAATCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2625.916144565	20.2081388204862	0.00769565275810963	1608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2619.42394367081	2619.42394367081
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCAACACACAGAG"	2.70370902594869	-4.41301777279051	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCAACACACAGAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2332.97867480629	14.9500224425494	0.00640812648825039	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2327.03053550034	2327.03053550034
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCAACACCTGCGA"	3.90755858001057	-7.77063562786254	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCAACACCTGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1985.44760731895	26.9285131641984	0.0135629432199228	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1983.80872942755	1983.80872942755
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCAACACTACTTT"	4.12626661834065	-6.98944904720458	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCAACACTACTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.27483480154	37.2486632722102	0.0155249672659077	1472	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2396.68452768072	2396.68452768072
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCAATCACCCTGT"	-0.164125422865707	8.45453832233278	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCAATCACCCTGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2316.71020572974	29.5330706184316	0.0127478484557066	1388	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2305.67842166962	2305.67842166962
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCAATCCCGATCT"	-0.469152550131637	8.29667279804078	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCAATCCCGATCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1924.41083779768	27.3198849612572	0.0141964929861455	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1917.80239719162	1917.80239719162
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCCTAGGCGATAC"	4.0215331512386	-6.57115080272826	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCCTAGGCGATAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2467.83170786208	17.9967757748369	0.00729254580752095	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2462.49704974464	2462.49704974464
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCCTGTGGGAGAG"	4.58105911788289	-7.7056250802246	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCCTGTGGGAGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.76397584594	33.8437099888095	0.0147289757975902	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2294.84163193761	2294.84163193761
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCCTTCAGCTAGT"	-4.13736615601237	13.094552017096	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCCTTCAGCTAGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1938.07648039184	40.560003569818	0.0209279685193938	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1929.88774709555	1929.88774709555
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGCCTTCATTTACC"	-1.2221408886021	8.62649915302125	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGCCTTCATTTACC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.93301961682	31.0809672920951	0.0188491387596311	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1648.93301961682	1648.93301961682
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGGCAGAAACTCA"	5.37184586104695	-9.90475561535033	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGGCAGAAACTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2305.26894886968	30.4876740059774	0.0132252134923025	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2302.40459437703	2302.40459437703
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGGCAGTATTGCC"	5.47681154784505	-10.1410446397034	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGGCAGTATTGCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2449.08834810233	33.6539166020608	0.0137414057063876	1469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2437.05341013222	2437.05341013222
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGGCTCACAACCA"	4.31553568419759	-7.52575638210448	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGGCTCACAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3030.49692785481	22.9098653317968	0.00755977183847995	2494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3025.32841600011	3025.32841600011
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGGCTCGAGCCAC"	-0.824364523321945	8.78942678058473	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGGCTCGAGCCAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1825.56328456108	39.4573250825864	0.0216137810265357	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.56328456108	1825.56328456108
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGTAAGATGCTAA"	-2.51202259483989	9.19025037372438	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGTAAGATGCTAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2004.72938768148	1.06358795293735	0.000530539413186045	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2001.18594851853	2001.18594851853
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGTAGTTCTCCCA"	4.39817347106282	-7.38055899059447	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGTAGTTCTCCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.66029544103	31.5174958947251	0.0164783552886257	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1912.66029544103	1912.66029544103
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGTATCAATCGGT"	3.93432774123494	-7.97549250042113	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGTATCAATCGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1776.60585712822	44.2903804287682	0.0249297728311901	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1774.81060740412	1774.81060740412
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGGTATCCAAATGC"	4.86240448531453	-7.50925638591918	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGGTATCCAAATGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2432.98853978005	16.6457822904861	0.0068417018898046	1387	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2427.54305070564	2427.54305070564
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTCCAGGTCGACA"	6.73673214492146	-1.58659150516661	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTCCAGGTCGACA"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1900.2725168506	25.3781718943778	0.0133550170669405	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	1896.20036199929	1896.20036199929
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTCCCATGTGGCC"	-3.99778304520305	12.6680917509827	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTCCCATGTGGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2086.13735135072	38.533080610116	0.0184710180205377	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2082.34879287888	2082.34879287888
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTCCCATTCACCC"	-3.41084728661235	10.9938497313294	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTCCCATTCACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1463.04242539346	33.5744102111904	0.022948350388514	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1460.78363706348	1460.78363706348
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTCCTCTAGTGAC"	4.46716942366902	-7.03152372753295	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTCCTCTAGTGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2452.23462941992	27.5437419793626	0.011232098939031	1488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2448.35872325756	2448.35872325756
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTGAAGCACGTCC"	3.95489825782124	-7.26166059887084	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTGAAGCACGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1775.58095251418	40.2563281928668	0.0226722009694151	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1773.44393390947	1773.44393390947
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTGAAGGTGCTTT"	4.58463158187215	-8.32999613201293	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTGAAGGTGCTTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2536.61766764787	13.1429667972755	0.00518129592997062	1624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2530.46921914562	2530.46921914562
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTGACATGTAACC"	-4.07048592987712	13.039168334845	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTGACATGTAACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1877.02905992905	40.9689633081471	0.0218264938901349	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1873.09705781298	1873.09705781298
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTGATCCTGTAGA"	9.03227295455281	5.98337838733522	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTGATCCTGTAGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1661.31402030193	7.78003952484921	0.00468306378551795	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1651.52644835835	1651.52644835835
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTTTAGACCACGA"	0.320052852004212	8.25476739490358	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTTTAGACCACGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1511.60022250196	20.661567276234	0.0136686717616616	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1509.82543808158	1509.82543808158
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTTTAGGTAGACC"	3.69845737990682	-7.91679241573485	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTTTAGGTAGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1937.62830351299	36.3946208215264	0.0187830765867435	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1928.37806080183	1928.37806080183
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTTTGTCGTATGT"	3.9155863719875	-7.4771995774475	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTTTGTCGTATGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.78242491865	32.437063905905	0.0154331216786915	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2100.12911918383	2100.12911918383
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTTTGTTGACTAC"	2.65248431739156	-4.31122591411742	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTTTGTTGACTAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2043.69423574107	19.5615290443313	0.00957165152312428	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2041.24521637797	2041.24521637797
"healthy-4003"	"2020-08-26-Control4003-c3:TCAGTTTTCGAAACAA"	-3.64627061310466	12.9029969939026	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCAGTTTTCGAAACAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1473.39593682324	36.2323855349677	0.0245910719783086	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1471.06708380334	1471.06708380334
"healthy-4003"	"2020-08-26-Control4003-c3:TCATATCAGATACAGT"	-3.82485304299052	11.0771569975647	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATATCAGATACAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2021.43984295027	6.87664542729472	0.00340185509416809	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2014.41320936743	2014.41320936743
"healthy-4003"	"2020-08-26-Control4003-c3:TCATATCAGCTTTCCC"	5.15926947173421	-10.2830276719299	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATATCAGCTTTCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2574.76711423732	12.9875449448272	0.00504416297420135	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2562.87596638136	2562.87596638136
"healthy-4003"	"2020-08-26-Control4003-c3:TCATATCCAGAAATCA"	4.55116190490071	-8.41921331798705	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATATCCAGAAATCA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.69626684837	35.8387278866649	0.0188555786170353	928	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1895.56249936543	1895.56249936543
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGGTATCAGCT"	4.77150167998616	-8.07730772411498	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGGTATCAGCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.60526270304	33.0894754857811	0.0140173691928025	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.60526270304	2360.60526270304
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGGTTTAAGGA"	2.81517376479451	-4.74602272426756	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGGTTTAAGGA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2438.21354634714	33.7146518433685	0.0138276041874506	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2431.92630509786	2431.92630509786
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGGTTTGCAGT"	-7.09622941437419	2.91182468021242	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_MEP"	47	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGGTTTGCAGT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1424.21927737305	37.1959303564722	0.0261167159772472	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1424.21927737305	1424.21927737305
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGGTTTGGGAG"	3.51792301711385	-6.51142074978026	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGGTTTGGGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.50223588838	27.4534684366013	0.0134082727507692	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2044.16547955075	2044.16547955075
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGTCGGCGATC"	-3.7067690891331	-5.32114889537963	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGTCGGCGATC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2797.92783189771	36.123073437526	0.0129106523140825	2197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2789.24949167468	2789.24949167468
"healthy-4003"	"2020-08-26-Control4003-c3:TCATCCGTCTTCGTAT"	5.19881834563558	-9.02655222332152	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATCCGTCTTCGTAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2825.05290428387	38.4791922656972	0.0136206979371423	2007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2819.77499388675	2819.77499388675
"healthy-4003"	"2020-08-26-Control4003-c3:TCATGAGTCCTGCTAC"	5.51242174681966	-9.77556326305541	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATGAGTCCTGCTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.80304864568	17.0544969512103	0.00810650833602943	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2097.67155384974	2097.67155384974
"healthy-4003"	"2020-08-26-Control4003-c3:TCATGCCAGTAGTCTC"	5.2104193168575	-9.1951589814392	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATGCCAGTAGTCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.42661354713	0	0	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2339.42661354713	2339.42661354713
"healthy-4003"	"2020-08-26-Control4003-c3:TCATGCCGTCTCCTGT"	-2.73260674896892	9.65278527820436	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATGCCGTCTCCTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2143.01180958691	40.9552020344575	0.0191110482225257	1015	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2132.861841188	2132.861841188
"healthy-4003"	"2020-08-26-Control4003-c3:TCATGTTAGTGTTGAA"	-2.00529060784038	9.62878129566041	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATGTTAGTGTTGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1653.78263219893	34.6669579684301	0.0209622215722121	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1646.25395596165	1646.25395596165
"healthy-4003"	"2020-08-26-Control4003-c3:TCATGTTTCATTCATC"	3.41597094115559	-5.82553532039794	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATGTTTCATTCATC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	3054.3256132033	33.3113634855335	0.010906290849127	2567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	3045.86036790907	3045.86036790907
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTACAGCAGCCCT"	5.28109373626058	-8.96822740947875	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTACAGCAGCCCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2939.63468191449	19.5088508864276	0.00663648820258241	2266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2936.30443161653	2936.30443161653
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTACCAATCGCCG"	3.63779058036153	-7.83155157482298	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTACCAATCGCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1825.71631624104	37.6413045542877	0.0206172800338375	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1822.06825172097	1822.06825172097
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTACCATGACTTG"	-0.136434133083183	8.73572824085084	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTACCATGACTTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2198.26649946784	33.5877414352125	0.0152791945122866	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2194.03340689545	2194.03340689545
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTACTCTAACGGT"	3.54754294928853	-6.42913677608641	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTACTCTAACGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.34393459078	32.7183139015304	0.0131486300775022	1430	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2483.61219266371	2483.61219266371
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTCACAGATTCGT"	10.1747089820797	5.43141219699708	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTCACAGATTCGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1466.44009932009	29.069612575777	0.0198232526437697	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1464.51552926111	1464.51552926111
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTCACATGATAGA"	5.06284966048543	-7.90444853222045	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTCACATGATAGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2651.57992218241	36.9017090887822	0.0139168760406097	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2648.10314108001	2648.10314108001
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTCAGTGAGCGAT"	11.1914068656856	4.78925654971925	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTCAGTGAGCGAT"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1511.13338332842	21.633580873698	0.0143161292791031	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1501.39094806487	1501.39094806487
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTCATCGAGCCTG"	-4.1479357284611	13.1019897230896	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTCATCGAGCCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2330.9073773504	38.1708801788542	0.0163759746739675	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2327.9663954554	2327.9663954554
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTCATCTGAATGC"	6.65493645247762	-1.55532088195952	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTCATCTGAATGC"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2479.06236933043	0	0	1616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2469.29970796321	2469.29970796321
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTGTAGGATTCAA"	4.15843071517293	-6.70173838054808	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTGTAGGATTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.56859978506	18.8685426249463	0.00787314939644898	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2392.24178207576	2392.24178207576
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTGTGTAATGCTC"	3.9038802581722	-7.03862287914427	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTGTGTAATGCTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.54849238066	33.7549779942279	0.0144465129246411	1259	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.88136122977	2331.88136122977
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTGTGTTCAGTAC"	4.24502148207967	-7.5687670937744	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTGTGTTCAGTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2538.5251029268	29.5322325739367	0.0116336184896842	1585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2533.56512295341	2533.56512295341
"healthy-4003"	"2020-08-26-Control4003-c3:TCATTTGTCCGTTGAA"	4.15825333175008	-7.04059555446776	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCATTTGTCCGTTGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.97909588425	9.38887205770232	0.00428524036369827	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2183.18854164681	2183.18854164681
"healthy-4003"	"2020-08-26-Control4003-c3:TCCACCACAAGCTCTA"	4.39275373992268	-7.51999809658202	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCACCACAAGCTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2266.51418061006	29.7526235629947	0.013127040553078	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.8609795492	2264.8609795492
"healthy-4003"	"2020-08-26-Control4003-c3:TCCACCACAGAGGAAA"	5.32232060012166	-9.29336359417113	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCACCACAGAGGAAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2700.19470244768	36.5988825341424	0.0135541642611794	1808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2691.63502570556	2691.63502570556
"healthy-4003"	"2020-08-26-Control4003-c3:TCCACGTAGGAATTAC"	4.7121602493221	-8.37455656444701	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCACGTAGGAATTAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.74900630974	35.0250702045719	0.0164533583342871	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2125.81743350355	2125.81743350355
"healthy-4003"	"2020-08-26-Control4003-c3:TCCACGTTCACTTATC"	-0.706178228289443	8.57853601062623	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCACGTTCACTTATC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2100.78934308855	21.1175915812565	0.0100522175870379	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2087.41012768404	2087.41012768404
"healthy-4003"	"2020-08-26-Control4003-c3:TCCAGAACAACCACAT"	-3.21922884407695	-5.28102400219115	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCAGAACAACCACAT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2722.63161280532	35.0034134577235	0.01285646331773	2302	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2717.34827222186	2717.34827222186
"healthy-4003"	"2020-08-26-Control4003-c3:TCCATCGAGTCACTCA"	5.53783096846883	-9.87537100231322	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCATCGAGTCACTCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.02563376552	42.5747831270921	0.0170912665650632	1603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2487.4229761172	2487.4229761172
"healthy-4003"	"2020-08-26-Control4003-c3:TCCATCGGTGACTCTA"	-3.70160041275676	13.3328761824402	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCATCGGTGACTCTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1938.13193222166	39.8432413763648	0.0205575485930377	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1927.72262440097	1927.72262440097
"healthy-4003"	"2020-08-26-Control4003-c3:TCCATGCGTATTCTCT"	5.49126019057576	-10.0069141617981	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCATGCGTATTCTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2583.93547956725	36.3028126584101	0.0140494269092547	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2580.31914401751	2580.31914401751
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCACACAAATGCTC"	4.97139563140218	-7.98598005687865	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCACACAAATGCTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2679.99234993834	33.3192551908969	0.0124325933958966	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2675.31098483863	2675.31098483863
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCACAGTAACGATA"	-2.02475104752238	9.19175527179567	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCACAGTAACGATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2160.66131849414	29.879597173999	0.0138289128972899	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2152.12709583721	2152.12709583721
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCAGTAGTCTGTAC"	5.46628870543782	-10.1369247666565	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCAGTAGTCTGTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.02530612725	25.4627005334464	0.012475445775712	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2038.05866257729	2038.05866257729
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCAGTCACTCAAGT"	-3.56302462044414	10.986132598761	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCAGTCACTCAAGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1850.9804888757	18.9933458793628	0.010261235055427	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1841.1349690262	1841.1349690262
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCAGTCATGGGTCC"	3.75281824645345	-7.72231962597045	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCAGTCATGGGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1720.88062928005	6.00060032483437	0.00348693582967738	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1719.17216891015	1719.17216891015
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCATGTCCACCCTA"	3.74276365813557	-7.07012321865233	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCATGTCCACCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.08167672366	36.7957981069779	0.0163096037198501	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2249.75415233527	2249.75415233527
"healthy-4003"	"2020-08-26-Control4003-c3:TCCCATGTCCGTATGA"	4.51641144332234	-6.70774366771849	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCCATGTCCGTATGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2432.95865578996	0	0	1466	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2430.31918496025	2430.31918496025
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGAAAAGCGTCGAA"	5.12069716033284	-10.2516889802185	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGAAAAGCGTCGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1392.04732280893	30.1682426569588	0.0216718513535043	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1392.04732280893	1392.04732280893
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGAAACAAGCTGTT"	2.6321972804958	-4.35810043728026	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGAAACAAGCTGTT"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2350.56075827155	33.8888745161243	0.0144173573888147	1824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2348.76248725157	2348.76248725157
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGAAACATCCTTGC"	-1.52239749851878	9.14644620502321	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGAAACATCCTTGC"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2254.80773354613	36.151428272631	0.0160330425227768	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2253.18018851942	2253.18018851942
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGAAAGTGTGACCC"	-3.17350492897685	10.9198322066101	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGAAAGTGTGACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1829.6088687539	31.0028308430429	0.0169450593361837	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1823.29571241917	1823.29571241917
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGATCAGCTACTGT"	-3.22986517372783	10.0952319868836	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGATCAGCTACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1508.5969629705	39.5652586950425	0.0262265268101406	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1506.16791910317	1506.16791910317
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGATCAGCTGACTT"	-0.60872725668605	8.35918233478395	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGATCAGCTGACTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1822.87738042964	23.6225192025568	0.0129589183870333	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1819.78949280685	1819.78949280685
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGATCGTGAGTAGC"	3.19389977034871	-7.03521540081175	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGATCGTGAGTAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1872.984333868	37.9911440093997	0.0202837489467636	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1872.984333868	1872.984333868
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGATCTCTGCGGGT"	4.78683485564534	-8.03373911296996	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGATCTCTGCGGGT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2431.93016065494	25.4317196870023	0.0104574218858955	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.75032166721	2423.75032166721
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGAAGGTTCATC"	5.15996374663655	-9.51163580333861	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGAAGGTTCATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1966.04643648381	23.9400252679296	0.0121767343963377	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1964.21740190658	1964.21740190658
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGAAGTAAGACT"	0.0230923025751531	8.34946439349977	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGAAGTAAGACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1870.69437375115	44.1719415512884	0.0236125912233937	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1864.11584882563	1864.11584882563
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGAAGTCTGGTT"	3.98796810683553	-7.130970501062	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGAAGTCTGGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.35467540591	28.7449029300155	0.0129402581443969	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2221.35467540591	2221.35467540591
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGACAAGAGGTC"	-3.66758356514629	11.8789424666199	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGACAAGAGGTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1562.73170878295	42.9668785869244	0.0274947250033001	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1558.61282138467	1558.61282138467
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGAGTTTACCAG"	4.89869894561116	-7.71048309719237	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGAGTTTACCAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2174.94241709669	39.2334906608638	0.0180388640878301	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2171.99714237425	2171.99714237425
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGGGATCCTCTGCA"	5.43387951430623	-9.73324682628783	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGGGATCCTCTGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.71120882166	33.0679428542933	0.0138608322465929	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2378.00922708841	2378.00922708841
"healthy-4003"	"2020-08-26-Control4003-c3:TCCGTGTGTTAGGGAC"	5.32660355147664	-9.59666063701781	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCGTGTGTTAGGGAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.66810175073	24.5898940813472	0.0129784705081726	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1894.66810175073	1894.66810175073
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCCCAGTGAGGTC"	3.45083083686177	-7.93817284023436	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCCCAGTGAGGTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1735.98666559677	2.35354295436515	0.00135573792184405	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1732.62601456877	1732.62601456877
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCCCAGTGCCGAA"	-3.87025795403178	11.1417789229187	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCCCAGTGCCGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1788.78118438883	25.6990040384429	0.0143667678655863	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1782.3567295571	1782.3567295571
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCGACACGGCGTT"	4.52004732665364	-7.83333494579466	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCGACACGGCGTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.23466386509	12.4941005135623	0.00588169505285684	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2120.6908281813	2120.6908281813
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCGAGTCACGACC"	-0.284561793238479	8.45020673358766	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCGAGTCACGACC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1780.31816699752	28.0401351468248	0.0157500696598036	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.27799092036	1774.27799092036
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCGAGTTTACTTC"	5.14460577544515	-8.21781542217406	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCGAGTTTACTTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.9816376803	13.2323921867149	0.00562128097131401	1358	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2351.2397098053	2351.2397098053
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCTTAGACGGATC"	3.78033580359761	-7.68443491375121	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCTTAGACGGATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1937.49752333874	5.09010617741308	0.00262715493367016	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1933.1297719811	1933.1297719811
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCTTAGCATCTTG"	10.4925915199215	6.7029032477173	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCTTAGCATCTTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2009.95891900321	40.4907387356102	0.0201450578679939	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2006.49784884044	2006.49784884044
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCTTCATCAGTGT"	-4.28755603256877	13.0860395201477	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCTTCATCAGTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2321.79990569672	32.3852779960381	0.0139483501212048	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2314.49539092593	2314.49539092593
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTCTTTCCGTTGGG"	-2.96282182160075	10.5163144835266	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTCTTTCCGTTGGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1535.28804466509	25.414761424009	0.0165537415029849	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1530.43733591354	1530.43733591354
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTGCAAGTCCCAAT"	4.3837329345638	-6.99100925838622	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTGCAAGTCCCAAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2395.34914970204	33.5938721313873	0.014024624399982	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2392.625544926	2392.625544926
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTTCTCAGCTATAC"	-3.20528040352519	9.92492005908815	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTTCTCAGCTATAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2413.21817662713	36.1382117650759	0.0149751117056415	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2408.26428966682	2408.26428966682
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTTTCCAAGCAGGT"	5.35675730284993	-10.1683912507263	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTTTCCAAGCAGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.79810133371	9.79683994819108	0.00416037363994915	1336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2350.52464678195	2350.52464678195
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTTTCCAGCTCATA"	2.460301776498	-6.07604744350585	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTTTCCAGCTCATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2638.44738968564	27.8360426569986	0.0105501602062701	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2633.40680043451	2633.40680043451
"healthy-4003"	"2020-08-26-Control4003-c3:TCCTTTCTCGAGTGAG"	5.25755800780599	-10.0809736481872	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCCTTTCTCGAGTGAG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.18394755002	41.5660236176607	0.0173034307635157	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2397.0227606917	2397.0227606917
"healthy-4003"	"2020-08-26-Control4003-c3:TCGAACAAGTGTTCAC"	3.93917264518086	-6.78469850933226	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGAACAAGTGTTCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2361.48167920025	38.6901827750507	0.0163838589627143	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2354.74405590479	2354.74405590479
"healthy-4003"	"2020-08-26-Control4003-c3:TCGAACACATCTGCGG"	0.0749581633949697	8.20236108386842	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGAACACATCTGCGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1720.45360132577	4.83898551354977	0.00281262192123105	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1713.34731062908	1713.34731062908
"healthy-4003"	"2020-08-26-Control4003-c3:TCGAACATCTCGAGTA"	4.19124760207478	-7.12604763424071	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGAACATCTCGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2511.94092698594	35.5116632205249	0.0141371410605325	1516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2507.87410034323	2507.87410034323
"healthy-4003"	"2020-08-26-Control4003-c3:TCGAAGTGTAGGCAGT"	4.83654369887654	-8.12226774608763	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGAAGTGTAGGCAGT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.48491379441	46.1631838999728	0.0190325586596849	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2423.15871383564	2423.15871383564
"healthy-4003"	"2020-08-26-Control4003-c3:TCGACCTAGTAAGGGA"	4.14704718169515	-7.52402212536009	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGACCTAGTAAGGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.9402073502	35.6738717426709	0.0156194420623906	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2276.34920531275	2276.34920531275
"healthy-4003"	"2020-08-26-Control4003-c3:TCGACCTGTCGGTGAA"	-1.67148909989055	8.90617559039918	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGACCTGTCGGTGAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1583.64538809264	36.9860202693404	0.0233549887793294	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1576.83200640281	1576.83200640281
"healthy-4003"	"2020-08-26-Control4003-c3:TCGACGGAGAGAGGTA"	-4.06605754318889	13.0069913634094	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGACGGAGAGAGGTA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1487.12939444207	34.9808093698021	0.0235223710193194	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1484.65511214773	1484.65511214773
"healthy-4003"	"2020-08-26-Control4003-c3:TCGACGGAGTGTGTTC"	-2.78296480599101	10.9333467253479	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGACGGAGTGTGTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1582.32535691594	36.8361460050966	0.0232797545992012	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1582.32535691594	1582.32535691594
"healthy-4003"	"2020-08-26-Control4003-c3:TCGACGGCACCTGCGA"	3.59541930732076	-6.90001251613768	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGACGGCACCTGCGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.50393760747	34.3840532687429	0.0155689345548517	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2207.04016386387	2207.04016386387
"healthy-4003"	"2020-08-26-Control4003-c3:TCGATTTCAGGCCCTA"	3.93018474158589	-7.46193125164183	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGATTTCAGGCCCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2235.33402520829	26.3559151675946	0.0117905936519437	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2229.01412755657	2229.01412755657
"healthy-4003"	"2020-08-26-Control4003-c3:TCGATTTGTAGGAAAG"	-4.38983331146892	13.113067603949	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGATTTGTAGGAAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1799.34003781064	40.7723215191643	0.0226595977760681	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1797.27374688357	1797.27374688357
"healthy-4003"	"2020-08-26-Control4003-c3:TCGATTTGTCAAGCCC"	-3.01261268082317	9.97775266254274	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGATTTGTCAAGCCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1956.08406257862	31.503905041912	0.0161055987544737	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1950.47531740323	1950.47531740323
"healthy-4003"	"2020-08-26-Control4003-c3:TCGATTTTCAACTTTC"	-3.64130769196208	12.5525903471741	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGATTTTCAACTTTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2527.62673321681	34.4901669976018	0.0136452770277942	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2523.09539292628	2523.09539292628
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCACTAGTTTGGCT"	3.43990602073018	-7.92778923427733	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCACTAGTTTGGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1861.00362873424	41.1349143554591	0.0221036185638375	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1859.0971024	1859.0971024
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCACTCAGTCACGC"	4.98481001433675	-8.53860285198363	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCACTCAGTCACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2508.0075149194	3.0042269758625	0.00119785405665304	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2505.55892124325	2505.55892124325
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCACTTCGAGATAA"	5.41943039473836	-9.57861902630004	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCACTTCGAGATAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.10121790441	40.1263901439132	0.0175600055829088	1183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.54040286637	2278.54040286637
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCAGGAGTTGCCTA"	-0.570501725107986	8.24802491748659	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCAGGAGTTGCCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2265.76129706518	30.8107694967425	0.0135984181284461	1180	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2262.4287749937	2262.4287749937
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCAGGCAACACGTT"	4.51646484908406	-7.59301998531493	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCAGGCAACACGTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2301.76066715718	23.566894447192	0.0102386380927686	1333	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2298.98610866148	2298.98610866148
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCAGGCATTGTAGC"	3.31639327582662	-6.6970219842163	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCAGGCATTGTAGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.57864815333	22.0168305148449	0.0099283200319318	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2214.42089102451	2214.42089102451
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCAGGGTAACTTCG"	-1.97665272179301	9.42156407916871	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCAGGGTAACTTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.03055998764	32.4026662539295	0.0187403664248486	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1720.53490784695	1720.53490784695
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCTCAAGTACAGCG"	-2.69215641441997	9.62153337085573	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCTCAAGTACAGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1856.154131885	39.8842967841427	0.0214875996012457	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1848.42156880518	1848.42156880518
"healthy-4003"	"2020-08-26-Control4003-c3:TCGCTTGTCCAAGCTA"	10.9109980064327	5.32202193820802	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGCTTGTCCAAGCTA"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1876.74273032634	41.7247943217258	0.0222325594486093	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1872.08762192958	1872.08762192958
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGATAAGTACAGCG"	-0.707343916327316	8.27589509570924	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGATAAGTACAGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1830.48642324227	40.201120988601	0.021961988069485	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1825.34931450527	1825.34931450527
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGATATCTGCTTAT"	10.2349678474361	7.27448604190675	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGATATCTGCTTAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1765.76585694535	30.6393597789368	0.0173518814277793	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1747.06259011144	1747.06259011144
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGACAGTGAGTTA"	4.07347645339314	-6.83436729824217	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGACAGTGAGTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2353.51280832607	20.3628541113449	0.00865211102285351	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2347.82640692775	2347.82640692775
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGACGTCATTGCA"	2.24105062064473	-6.55246593868407	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGACGTCATTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.84822654109	41.5323348906828	0.0203306023184133	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2042.84822654109	2042.84822654109
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGACTCGAGTGGA"	3.73137607154195	-7.80296375667723	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGACTCGAGTGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.16246982095	47.1661971607208	0.0209054967413157	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2250.50229244985	2250.50229244985
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGACTCGATCCAA"	5.49438585814778	-10.0926542512146	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGACTCGATCCAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2168.91980603999	31.5064885600119	0.0145263501547051	1135	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.3843516685	2167.3843516685
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCAAGGGATCAC"	2.67651381072347	-4.38586714183959	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCAAGGGATCAC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2290.0940550416	33.7187092573493	0.0147237224528478	1629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2289.06766613211	2289.06766613211
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCACAGATCATC"	3.74885692176167	-7.21326258098754	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCACAGATCATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.71968363363	33.8417978979009	0.0146202575357964	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2306.68420130434	2306.68420130434
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCAGTAGGCAGT"	4.21988453444783	-7.64133217250975	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCAGTAGGCAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2109.92200764445	22.899201601792	0.0108531033463919	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2106.80635239375	2106.80635239375
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCAGTATCGCAT"	-0.0338499498670876	8.56945321643678	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCAGTATCGCAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1685.56988388062	44.4098498058624	0.0263470831026118	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1678.55121729943	1678.55121729943
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCAGTATCGCGC"	5.39758553084676	-10.0673532716003	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCAGTATCGCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.14853638698	32.0787583936733	0.0146201398226649	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2191.17288751507	2191.17288751507
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGCATCAAGAGTA"	3.1127196746761	-6.66704847728881	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGCATCAAGAGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.26776958256	34.8956022013619	0.0153234514919423	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2271.44669160359	2271.44669160359
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGTGAGTAACGAT"	3.76579393920247	-7.0053715935913	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGTGAGTAACGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.32875545191	33.1447429589731	0.0160326425449095	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2063.97593955317	2063.97593955317
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGTGCAAATGATG"	3.19752015647237	-3.67578294193419	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGTGCAAATGATG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2453.00943516164	31.5932386525992	0.0128793791820525	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2439.90389524809	2439.90389524809
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGGTGGTTGGGCCT"	0.735556383698624	8.22371099078981	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGGTGGTTGGGCCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1530.75506443004	37.2804307730043	0.0243542756377457	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1527.44007319475	1527.44007319475
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGTCTAGAAACTGT"	-3.61094532433208	12.9340877302918	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGTCTAGAAACTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2028.49869630524	17.9014484124242	0.0088249740781349	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2013.72241642775	2013.72241642775
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGTCTAGGAGCAAA"	-3.95841775360759	11.8306255110535	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGTCTAGGAGCAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2036.57724488337	34.7669215669311	0.0170712511171763	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2034.7905124825	2034.7905124825
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGTCTAGGATGCGT"	-3.19393883171733	10.5246143111023	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGTCTAGGATGCGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.67417084073	36.3716490246535	0.0188779449971981	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1924.75442622752	1924.75442622752
"healthy-4003"	"2020-08-26-Control4003-c3:TCGGTCTGTAGGACTG"	-1.79601643505748	9.99373242938844	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGGTCTGTAGGACTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1826.61509617194	39.7373617732081	0.0217546443454268	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1822.43675895091	1822.43675895091
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGAAGTCGGGAT"	-3.64805159989055	12.55565831745	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGAAGTCGGGAT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1615.43084871338	31.6093644015974	0.0195671417484523	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1610.70373938779	1610.70373938779
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGACAATCCTTT"	-3.66325817528422	10.4112148054871	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGACAATCCTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1726.44848247789	30.176843271087	0.0174791449483483	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1722.31980973355	1722.31980973355
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGACATTGAAGA"	5.45711531218831	-9.64879705822142	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGACATTGAAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2637.58348261811	32.9453604251151	0.0124907365557252	1772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2633.10206965023	2633.10206965023
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGAGTGACTAAA"	-0.833594481379348	9.07213780963746	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGAGTGACTAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1643.21390751551	42.4191689164315	0.0258147577271714	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1637.70447439411	1637.70447439411
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGAGTTTACCAG"	-3.78698406639751	12.4553794630798	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGAGTTTACCAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1781.68052494566	38.4236864705326	0.0215659799456496	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1779.56912055106	1779.56912055106
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTAGATCCTTCTGG"	4.01629962500874	-7.21575739299925	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTAGATCCTTCTGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2212.44968686057	42.2496339732758	0.0190963140197901	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2209.95741186949	2209.95741186949
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTCCAAGACCAGCA"	4.38881029662434	-7.78496792232665	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTCCAAGACCAGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1941.51356233393	6.28301046531455	0.00323614039438469	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1936.10431220764	1936.10431220764
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTCCAAGGTCATCT"	10.5394855934078	6.62091205203859	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTCCAAGGTCATCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1706.14501750621	38.1257366879009	0.0223461290199279	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1704.39142418947	1704.39142418947
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTCCAGTCTCACAA"	5.38291134414021	-9.35109426891478	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTCCAGTCTCACAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2372.56045824688	44.3590493550868	0.0186966992562391	1540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2365.51584997721	2365.51584997721
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTGCTAGCGTACAG"	3.7971486049587	-7.2045617333618	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTGCTAGCGTACAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1904.91977357431	27.5583280620599	0.0144669231976896	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1900.9544483681	1900.9544483681
"healthy-4003"	"2020-08-26-Control4003-c3:TCGTGCTGTGTGTGTT"	-5.56307397309001	3.80035970294801	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	54	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCGTGCTGTGTGTGTT"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2113.48113428166	33.9448242330076	0.016061096397979	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2110.44381234076	2110.44381234076
"healthy-4003"	"2020-08-26-Control4003-c3:TCTAACTCATCCTCAC"	5.40008511123006	-9.47562220012816	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTAACTCATCCTCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2426.7135720295	27.8268977703598	0.011466906556709	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2418.61713663516	2418.61713663516
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACATAGCTTCGTA"	3.71895827826802	-8.01475622570189	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACATAGCTTCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.70381959632	5.0876230733877	0.00308770484894192	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1647.70381959632	1647.70381959632
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACATCACCCATAA"	4.80436815795247	-7.24857332622679	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACATCACCCATAA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.40258882171	13.2934769928139	0.00543833370722367	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2439.00812766928	2439.00812766928
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACATGTAGGACCA"	4.05112971839253	-6.89263250744017	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACATGTAGGACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.74755540363	31.7412730208028	0.0139231525637859	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2272.73619533483	2272.73619533483
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACCGAGATAGTCA"	-0.0485089746421159	8.84306809985963	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACCGAGATAGTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1685.32527129191	43.2634049462265	0.0256706557975378	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1681.20256337985	1681.20256337985
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACCGGTAATTGGA"	-4.1515043777531	12.8127307661804	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACCGGTAATTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1536.3462797819	35.7178140783936	0.0232485439958655	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1531.71522826658	1531.71522826658
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACCGTCTACTATC"	5.04415144500081	-7.5944075814453	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACCGTCTACTATC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2564.62675827922	19.4792087059585	0.00759533863673341	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2557.65943111975	2557.65943111975
"healthy-4003"	"2020-08-26-Control4003-c3:TCTACCGTCTTAGCTT"	-3.57462845268901	9.90285298908082	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTACCGTCTTAGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2080.58029670648	32.232327321685	0.0154919891208757	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2061.54469387283	2061.54469387283
"healthy-4003"	"2020-08-26-Control4003-c3:TCTATACCAGCCTACG"	-0.565386692911941	9.23121831500856	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTATACCAGCCTACG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1720.65978406905	26.8426697838338	0.0156002191905455	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1717.31398714636	1717.31398714636
"healthy-4003"	"2020-08-26-Control4003-c3:TCTATCACAATTCGTG"	4.41215767440144	-7.06007435238036	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTATCACAATTCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2241.17214180894	23.3246299580395	0.0104073353058963	1190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2230.22783844624	2230.22783844624
"healthy-4003"	"2020-08-26-Control4003-c3:TCTATCATCAGCAGAG"	-1.68374512615855	9.1034946211609	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTATCATCAGCAGAG"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1851.93881435394	41.159147548097	0.0222248960003874	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1846.61906823216	1846.61906823216
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCACGAGAGGTCGT"	-3.35325513306316	11.875407195929	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCACGAGAGGTCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1683.74337420781	23.831429157448	0.0141538369341233	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1681.61899619546	1681.61899619546
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCACGAGTTGTAAG"	4.60691275176351	-6.89685728466185	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCACGAGTTGTAAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.52702331661	16.3282378334446	0.00696737766238192	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2337.83356037276	2337.83356037276
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCACGTCTGGCCTT"	4.02500953254048	-7.42054941570433	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCACGTCTGGCCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.459291543	7.2961746582962	0.00331424464050948	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.70726011807	2199.70726011807
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCACGTCTTGAACG"	4.91606154021565	-7.81526043331298	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCACGTCTTGAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.75585680532	35.579705465523	0.0156273696888377	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2275.59987817423	2275.59987817423
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCAGCGTTCAATCG"	5.26892580565755	-10.1196546784607	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCAGCGTTCAATCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.10441236325	29.0517480295993	0.013722397374426	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2111.02708362754	2111.02708362754
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCCGACATTAGGAA"	1.9773608642513	-6.41830017482909	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCCGACATTAGGAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.48243012791	38.7405297275559	0.0167672903383261	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2307.61930736445	2307.61930736445
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCCGAGTACCGGAA"	-3.98344121399577	12.7633561857971	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCCGAGTACCGGAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1720.2341939467	32.6884606520796	0.0190023316401374	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1717.93384281512	1717.93384281512
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCCGATCCACAGGC"	-4.17119203034099	12.7905587919983	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCCGATCCACAGGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1842.79231974312	32.3482674127895	0.0175539408680077	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1842.79231974312	1842.79231974312
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCCGATCCCGAGGT"	4.29050602492635	-6.73693087017211	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCCGATCCCGAGGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2790.48408890383	2.80969639827006	0.00100688493779363	1914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2784.65159045262	2784.65159045262
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCTGGAGACTTCAC"	5.42323698577229	-10.1757803193298	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCTGGAGACTTCAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1948.9306924184	1.86287289968092	0.000955843584857967	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1947.15984744334	1947.15984744334
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCTGGGTATCAGCT"	10.1914860206539	7.27163980090944	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCTGGGTATCAGCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1738.61968656569	27.8374867566943	0.0160112570746751	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1735.31301045284	1735.31301045284
"healthy-4003"	"2020-08-26-Control4003-c3:TCTCTGGGTCGATTAC"	5.66271366652791	-9.99107458507689	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTCTGGGTCGATTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.23917066059	11.7138910173143	0.00550920666825782	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2122.80851885595	2122.80851885595
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGCCACAGTCCGTG"	4.34516253051106	-7.37193443691405	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGCCACAGTCCGTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.99577044209	43.0712659109942	0.019551224967786	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2199.96875364409	2199.96875364409
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGCCAGTGGAAATT"	-0.157732586294967	8.52432057941285	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGCCAGTGGAAATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1304.44866887946	43.3683451434093	0.0332464942301359	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1302.68855507541	1302.68855507541
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGGCTCAGCGGTCT"	4.64623608168904	-7.91076424038085	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGGCTCAGCGGTCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.82269156485	0	0	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2255.76867375176	2255.76867375176
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGGCTGTAGGACCA"	-4.38144002381023	12.773052192572	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGGCTGTAGGACCA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2358.78860634573	39.5439181185229	0.0167645027672848	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2346.19316292653	2346.19316292653
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGGCTTCATTACTC"	5.14149584349934	-8.8561697236267	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGGCTTCATTACTC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.47339635843	7.63468872607439	0.00327883871811227	1256	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2325.40843603495	2325.40843603495
"healthy-4003"	"2020-08-26-Control4003-c3:TCTGTCGTCAGGAAAT"	-1.6822466653889	9.25544641101686	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTGTCGTCAGGAAAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1633.49718169276	5.62095897338302	0.00344105826222371	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1631.29838291288	1631.29838291288
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTAGTAGTTGGCTT"	-3.51771603050883	10.3982200392517	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTAGTAGTTGGCTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1738.32100747794	43.5914907440889	0.0250767784296262	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1731.87366814782	1731.87366814782
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTAGTCACTATCCC"	3.97322096404378	-6.97990705883177	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTAGTCACTATCCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2407.26049784967	18.6594390054932	0.00775131691072119	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2404.96502564988	2404.96502564988
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTAGTTCGCCAGAC"	-3.80736504021342	12.6138229140076	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTAGTTCGCCAGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1610.89639175244	22.7758789676949	0.0141386367765824	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1606.30293794861	1606.30293794861
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTCCTCACCATTCC"	-1.66928718510326	8.95489022815553	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTCCTCACCATTCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2343.65788273938	35.0482779376756	0.0149545196830135	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2330.70365916671	2330.70365916671
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTCCTGTCTTGTCC"	-3.37367544594463	-5.62941696560057	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTCCTGTCTTGTCC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1765.24898178705	39.1716292214131	0.0221904273139745	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1761.19037370174	1761.19037370174
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTCCTTCTTCTAAC"	-4.24100623551066	12.8539743193421	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTCCTTCTTCTAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2144.07869772771	41.0553887368597	0.0191482657704543	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2125.85877266394	2125.85877266394
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTGCGAGTCATGGG"	4.31656708297078	-7.9394626847473	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTGCGAGTCATGGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1760.32493522211	23.0814725494102	0.0131120522623841	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1760.32493522211	1760.32493522211
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTGCGAGTGGAATT"	3.18084849891011	-5.49187805568846	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTGCGAGTGGAATT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2599.95371102041	21.2402275143429	0.00816946371941624	1732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2592.16171795477	2592.16171795477
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTTGACAAACTGCT"	3.96877660331075	-6.83801891719969	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTTGACAAACTGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.19570644648	18.0476805924836	0.00791844269513038	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.16983277301	2278.16983277301
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTTGAGTGCCCTTT"	-1.89425812187846	4.16812703693239	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTTGAGTGCCCTTT"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2699.41427222945	28.00886348451	0.010375904051725	3700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	2697.61064203103	2697.61064203103
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTTGATCAATCCAG"	3.92849101599995	-6.52139189159545	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTTGATCAATCCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2539.47714349111	23.8662015535759	0.00939807692884614	1735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2536.11792698801	2536.11792698801
"healthy-4003"	"2020-08-26-Control4003-c3:TCTTTGATCTGTAACG"	4.87887014922444	-7.70273210918578	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TCTTTGATCTGTAACG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2713.69102814746	7.32146356727347	0.0026979724262388	1934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2709.40170315009	2709.40170315009
"healthy-4003"	"2020-08-26-Control4003-c3:TGAACGTCAACCAGAG"	-0.954663614661056	8.56379220569459	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAACGTCAACCAGAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1704.22154052475	31.7946681748694	0.0186564172666656	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1704.22154052475	1704.22154052475
"healthy-4003"	"2020-08-26-Control4003-c3:TGAACGTGTACGTGAG"	4.25547613677327	-7.11971285259398	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAACGTGTACGTGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2259.36489213273	33.3856114068586	0.0147765469504769	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2257.85813844091	2257.85813844091
"healthy-4003"	"2020-08-26-Control4003-c3:TGAACGTGTCGAACAG"	-3.33510551872905	10.3360204466614	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAACGTGTCGAACAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.487421638	32.976760055472	0.0183562432212325	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1794.56600682978	1794.56600682978
"healthy-4003"	"2020-08-26-Control4003-c3:TGAACGTTCTCTAAGG"	-3.38515363159831	10.8261718519959	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAACGTTCTCTAAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1977.92203089804	35.5077682176701	0.0179520565841255	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1970.046996622	1970.046996622
"healthy-4003"	"2020-08-26-Control4003-c3:TGAACGTTCTGAGCAT"	3.9551223712856	-6.84670021450194	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAACGTTCTGAGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2735.51629486092	24.1717086260821	0.00883625101100378	2060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2730.64212152033	2730.64212152033
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATCGCAACCCTCT"	5.40079130706136	-10.1220054856506	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATCGCAACCCTCT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.82659061516	37.4429079196889	0.0165396537327156	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2254.2790855933	2254.2790855933
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATCGCACGAAGAC"	-3.68935022774394	10.6174754866394	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATCGCACGAAGAC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1717.33732107125	42.7397703616463	0.0248872308528099	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1715.17645001284	1715.17645001284
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATCGCAGTCGGTC"	-4.15796075287517	12.1315212019714	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATCGCAGTCGGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.18552760834	39.0836178430339	0.021495945957971	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.9046370077	1813.9046370077
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATCGGTGTCCGTG"	-1.74192998829539	8.88633439624635	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATCGGTGTCCGTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1712.95727916634	29.909407425823	0.0174606849742215	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1711.12543984508	1711.12543984508
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATGCAGACGCAGT"	10.5545383888179	6.53987786853639	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATGCAGACGCAGT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1939.2007663198	28.9528920579581	0.014930322100122	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1930.14512193993	1930.14512193993
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATGCAGTGAGCCA"	4.34111084517781	-6.99694158947142	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATGCAGTGAGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.09071226966	1.68862601202438	0.00074189750123822	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2274.58733010381	2274.58733010381
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATGCCAGCAGACA"	-3.88357148590739	11.1017808684143	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATGCCAGCAGACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1935.81912632345	34.7428676159019	0.0179473728425684	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1930.04358596524	1930.04358596524
"healthy-4003"	"2020-08-26-Control4003-c3:TGAATGCCATAAGCGG"	5.4080077606136	-9.71944048320922	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAATGCCATAAGCGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.94434275049	27.4939174794766	0.0121228360684252	1287	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2264.30225895637	2264.30225895637
"healthy-4003"	"2020-08-26-Control4003-c3:TGACAGTGTCACCCTT"	2.54356350478474	-5.89487650310668	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACAGTGTCACCCTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2346.51822473535	27.8715301536754	0.0118778238582907	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2344.96990182122	2344.96990182122
"healthy-4003"	"2020-08-26-Control4003-c3:TGACAGTGTCGAATTC"	5.66557850417439	-9.87583162700804	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACAGTGTCGAATTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.28899353424	36.8694205711691	0.0157676919632771	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2334.26647399252	2334.26647399252
"healthy-4003"	"2020-08-26-Control4003-c3:TGACAGTTCGTTCTAT"	-2.69314680519755	10.1459617384705	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACAGTTCGTTCTAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1713.92596939395	33.3212051971133	0.01944144950957	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1708.36748595679	1708.36748595679
"healthy-4003"	"2020-08-26-Control4003-c3:TGACCCTAGCACTAAA"	5.18962540206258	-9.15985491192015	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACCCTAGCACTAAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2623.99885513638	32.5293915814881	0.0123968772005418	1644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2616.32977816002	2616.32977816002
"healthy-4003"	"2020-08-26-Control4003-c3:TGACCCTCAAGAATGT"	-3.94262252274211	10.9671392210755	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACCCTCAAGAATGT"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1910.20331805698	48.7031885939984	0.0254963375540245	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1904.73307107656	1904.73307107656
"healthy-4003"	"2020-08-26-Control4003-c3:TGACCCTTCAGCATTG"	-0.656821171671707	8.44230268085328	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACCCTTCAGCATTG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1823.35603840505	18.3548332436526	0.010066510794956	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1818.5230479368	1818.5230479368
"healthy-4003"	"2020-08-26-Control4003-c3:TGACGCGAGTATGGCG"	-1.0628105205601	8.65993115985719	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACGCGAGTATGGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1648.00869129306	32.0291354513998	0.0194350525095041	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1646.08581244805	1646.08581244805
"healthy-4003"	"2020-08-26-Control4003-c3:TGACGCGCAAATGGAT"	3.9797121482784	-7.07871200954589	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACGCGCAAATGGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2443.29212384988	10.3007394395682	0.00421592626563923	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2443.29212384988	2443.29212384988
"healthy-4003"	"2020-08-26-Control4003-c3:TGACGCGGTGATACTC"	3.73062815245931	-7.25404455578002	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACGCGGTGATACTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.0059694152	1.41439288072403	0.000624454372228083	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2258.13011232793	2258.13011232793
"healthy-4003"	"2020-08-26-Control4003-c3:TGACGCGTCATCTGTT"	-4.00940165939982	13.1624297865662	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACGCGTCATCTGTT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2100.05957209233	25.8267946471862	0.012298124772458	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2094.12356661291	2094.12356661291
"healthy-4003"	"2020-08-26-Control4003-c3:TGACTCCAGAAGTCCG"	4.43923344191853	-6.86925222789916	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACTCCAGAAGTCCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2654.92291526482	38.15655433654	0.0143720008280293	1917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2645.76423415629	2645.76423415629
"healthy-4003"	"2020-08-26-Control4003-c3:TGACTCCAGCGAATGC"	-0.0521922734683335	8.65802381122438	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACTCCAGCGAATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1589.46577594528	35.6107819836195	0.0224042458306102	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1581.43228036702	1581.43228036702
"healthy-4003"	"2020-08-26-Control4003-c3:TGACTCCCAAGTGATA"	5.42460121688191	-9.73221399700316	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACTCCCAAGTGATA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2359.90213191356	17.2005211601368	0.00728865868102314	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2355.57844920942	2355.57844920942
"healthy-4003"	"2020-08-26-Control4003-c3:TGACTCCCAGCGTGCT"	-3.83072624626811	10.8526677855286	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACTCCCAGCGTGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2037.26355444229	30.1878433479358	0.0148178389988427	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2031.56475284983	2031.56475284983
"healthy-4003"	"2020-08-26-Control4003-c3:TGACTCCGTACTCCGG"	4.52740921553914	-7.0939512482849	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGACTCCGTACTCCGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.43398084543	11.5440139778925	0.00513653085086395	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2243.3084389599	2243.3084389599
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGACTAGCTACAAA"	-3.47689543190654	12.4493350752625	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGACTAGCTACAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1752.44832006409	24.6835184133214	0.0140851619592518	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1748.40802789298	1748.40802789298
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGACTGTAGCGCTC"	-0.289380322129089	8.89720246875612	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGACTGTAGCGCTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1402.7673014248	35.3011336643229	0.0251653525345703	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1396.18713084742	1396.18713084742
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGCATAGAACAAGG"	-3.28695617142375	10.8911657103333	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGCATAGAACAAGG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.74001955556	37.2927131989098	0.0207211668317067	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1791.6261145996	1791.6261145996
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGCATGTCCTGTTC"	4.28705706176106	-7.38973572170409	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGCATGTCCTGTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.12380701377	34.0729605297154	0.0154798019180673	1159	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2198.00627371636	2198.00627371636
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGCGCCAGCTTCCT"	-2.80656633797343	9.86107347095338	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGCGCCAGCTTCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1879.99269007864	36.4000615825398	0.0193618101680051	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1876.43999349535	1876.43999349535
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGCGCCAGTTCCAA"	-3.71220455589946	10.4394826658997	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGCGCCAGTTCCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.42218940452	38.668930563623	0.0200313334439816	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1918.21800580833	1918.21800580833
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGAGAGCAACTCT"	4.3163911300594	-7.10020830547484	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGAGAGCAACTCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.08284367899	9.7759792424102	0.00398031331376699	1519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2450.98278424866	2450.98278424866
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGAGTCATTGCGA"	-4.07255349579509	12.7506160506043	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGAGTCATTGCGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1621.47747900591	22.3735875778853	0.013798272173106	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1614.52655475852	1614.52655475852
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGGAAGCAACCAG"	-3.27440391007121	10.6301650770935	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGGAAGCAACCAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1818.37523096783	31.7469980918085	0.017458991714769	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1812.44743216883	1812.44743216883
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGGAAGGACGCAT"	3.22813334044759	-7.73244430935057	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGGAAGGACGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.6798767932	36.4328780501791	0.0161659508190755	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2250.46261439491	2250.46261439491
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGTTAGTGTAGTA"	-0.0409185466473878	8.79024407947389	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGTTAGTGTAGTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1540.7126876959	40.3988167336701	0.0262208632772964	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1536.63396895113	1536.63396895113
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGTTGTTAAGAAC"	0.0754218186134517	8.75216100299684	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGTTGTTAAGAAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1688.82608199979	32.7256557269174	0.0193777536217145	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1686.9033622845	1686.9033622845
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGGTTTCACGATAC"	8.39679493483846	6.09282920444337	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGGTTTCACGATAC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1422.44843673711	47.4299273352562	0.0333438640799195	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1412.62878370962	1412.62878370962
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGTCACAGCTGTCG"	-4.69532809677775	2.91880366885988	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGTCACAGCTGTCG"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2537.07749179054	41.039516485737	0.0161759018471183	1964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2530.13131523563	2530.13131523563
"healthy-4003"	"2020-08-26-Control4003-c3:TGAGTCATCCTATTGT"	4.39076914367024	-7.2561040154663	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGAGTCATCCTATTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2828.17231947719	10.7490963167361	0.00380072184523861	2103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2823.25918396117	2823.25918396117
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCAGCATGCTGCG"	2.64703549918477	-6.70626404201659	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCAGCATGCTGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.76029004702	30.7273650477833	0.015327201561371	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2001.65274564963	2001.65274564963
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCAGTCATTCTTG"	4.18545498427693	-6.66486027156981	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCAGTCATTCTTG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.23166264446	36.7550202428027	0.0147301033379199	1620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.18168672115	2489.18168672115
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCTTAGACGCTCC"	5.41034855422322	-9.6357631913391	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCTTAGACGCTCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.20618018779	29.8864386277653	0.0127057053414337	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2348.49980495832	2348.49980495832
"healthy-4003"	"2020-08-26-Control4003-c3:TGATCTTAGCACTCCG"	5.30880751189534	-10.0628004304138	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGATCTTAGCACTCCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.37917235332	20.1112803325237	0.00957051473485443	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2094.86558062967	2094.86558062967
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGAGTCAACTCCCT"	4.0542651611263	-6.47187569057616	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGAGTCAACTCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2378.1869273105	31.8400895547868	0.0133883880989939	1542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2374.56773612022	2374.56773612022
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGAGTGTTAAAGTG"	-3.72328291359599	11.1140937575134	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGAGTGTTAAAGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1617.41894057697	31.9460208170959	0.0197512345228875	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1608.3433898581	1608.3433898581
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGATGGTGTGTACT"	-1.30158160153087	9.21716973865358	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGATGGTGTGTACT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1842.13948093774	16.9745901831067	0.00921460636328464	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1829.01673478525	1829.01673478525
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGCGGCACATGAAA"	-0.276646415621597	7.71941611850587	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGCGGCACATGAAA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1842.72140024949	23.8024083908296	0.0129169870104113	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.85420087339	1837.85420087339
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGCGGCACTTCTCG"	5.28908028182332	-9.62404730236205	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGCGGCACTTCTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1963.36735542583	19.6653459787402	0.0100161316853896	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1960.13126665118	1960.13126665118
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGCGGGTTCAGTAC"	5.340987821191	-10.1409397355286	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGCGGGTTCAGTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.13592405144	41.0577238935332	0.0212279413163112	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1927.0571338933	1927.0571338933
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGGCGAGAGGCCAT"	4.70856012877767	-7.21673443233641	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGGCGAGAGGCCAT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2289.51466303512	17.5681380344663	0.0076733022583821	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2283.68725818282	2283.68725818282
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGGCGCATGGTGGA"	-4.41003165665324	12.8061513670715	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGGCGCATGGTGGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1718.91609470462	38.4065985967584	0.0223434981585638	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1712.48027324301	1712.48027324301
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGGCGGTCCCAAAT"	-3.43950543823894	10.6694965132507	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGGCGGTCCCAAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1627.92612569323	31.2805778647296	0.0192149860924488	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1619.32909430439	1619.32909430439
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGTGAAGCATTTGC"	-3.77337322655376	11.8321418532166	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGTGAAGCATTTGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1753.75474198042	43.9942582178747	0.025085752964633	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1747.8111957686	1747.8111957686
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGTGAAGCCTATCA"	5.55533947524373	-10.0700636140076	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGTGAAGCCTATCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.45155620348	34.0681242113798	0.0148286583538141	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2294.72322811508	2294.72322811508
"healthy-4003"	"2020-08-26-Control4003-c3:TGTGTGACACGTCGGT"	5.6487041908199	-9.31899835979613	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTGTGACACGTCGGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.76699961543	10.2165466045214	0.00433682389055844	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2353.57594854623	2353.57594854623
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTACTGTAAGCAAT"	6.80466379699056	-1.67529752170714	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTACTGTAAGCAAT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2662.93185481867	27.4389951115699	0.0103040545562283	1700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2647.20997250798	2647.20997250798
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTACTTCCAGTTCC"	10.9712025123531	6.18839643085328	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTACTTCCAGTTCC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1883.0200145788	30.7712458102341	0.0163414332147272	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1877.8974705681	1877.8974705681
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCATCAGCGTTTA"	4.05291475829427	-7.78561451351317	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCATCAGCGTTTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2021.87082632365	34.4569654473552	0.017042120099239	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2014.85254674948	2014.85254674948
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCATGTTAAGAAC"	4.01529326018636	-7.71148874675902	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCATGTTAAGAAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2015.51401274542	29.3485187759535	0.0145613072349602	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2009.0098263106	2009.0098263106
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCCGCAACCTAAC"	5.54075254973714	-10.0990505448547	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCCGCAACCTAAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2275.26536238977	30.61662690123	0.0134562883992892	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2268.05897272817	2268.05897272817
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCCGCAATTGAGA"	8.79474606093709	6.37201688373414	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCCGCAATTGAGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1405.8179401734	23.5866478323759	0.0167778822266749	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1399.71289306709	1399.71289306709
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCCGCATGTAACC"	-3.86832151833232	12.6861696013245	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCCGCATGTAACC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1742.23423270978	35.7296956805257	0.0205079747658004	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1740.17925048779	1740.17925048779
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCTAAGGATTTGA"	4.03375114974324	-7.07450725948485	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCTAAGGATTTGA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2276.33109878501	29.0840713256487	0.0127767315313543	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2271.08623060126	2271.08623060126
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTCTAAGTTTGTCG"	-0.777274469763595	8.60713956439821	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTCTAAGTTTGTCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1632.04633776748	21.3629349460389	0.0130896620100026	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1632.04633776748	1632.04633776748
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTGAGCAAACAGGC"	4.10214628753011	-7.06568291103514	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTGAGCAAACAGGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.70433112758	14.1442151343224	0.00666329970072141	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2115.65488800455	2115.65488800455
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTGAGCAGGTCTCG"	2.53060545501057	-4.40846350109252	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTGAGCAGGTCTCG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2535.9298648264	28.209428773604	0.0111238994283208	1876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2529.93037465014	2529.93037465014
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTGGACACAGACGA"	-0.788496415049392	8.935839630011	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTGGACACAGACGA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1790.79870921215	27.6358150779436	0.0154321169296027	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1784.92406703722	1784.92406703722
"healthy-4003"	"2020-08-26-Control4003-c3:TGTTGGACATAATCGC"	5.55425657805745	-9.93583300029906	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTTGGACATAATCGC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2386.13666040604	37.4300265469381	0.0156864555027492	1381	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2377.7018836704	2377.7018836704
"healthy-4003"	"2020-08-26-Control4003-c3:TTAATCCAGAGAGCAA"	-2.35827074471172	9.85517976367799	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAATCCAGAGAGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1856.67025264161	44.3075694245984	0.0238639948916934	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1847.21302375607	1847.21302375607
"healthy-4003"	"2020-08-26-Control4003-c3:TTAATCCCAATCTGCA"	-1.54525075379069	9.24949357593385	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAATCCCAATCTGCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2176.67590888654	0.769434452979876	0.000353490590785044	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2173.42861037516	2173.42861037516
"healthy-4003"	"2020-08-26-Control4003-c3:TTAATCCGTGTGACCC"	-3.69089971008952	10.8078756102356	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAATCCGTGTGACCC"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1817.09554921285	35.838763684917	0.0197231035541538	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1813.25843447334	1813.25843447334
"healthy-4003"	"2020-08-26-Control4003-c3:TTAATCCGTTATCTTC"	4.20993294295613	-7.3558354607788	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAATCCGTTATCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.39279131732	34.5485288181742	0.0145811741070446	1435	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2364.32793320291	2364.32793320291
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGACGGTCATAGTC"	0.0888400572234809	8.57083890521852	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGACGGTCATAGTC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1658.65133530197	42.5305686933853	0.0256416570427939	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1650.98954430705	1650.98954430705
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATAAGAGAGCCT"	4.53520073470418	-6.85969498073729	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATAAGAGAGCCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.56847235074	0.324415217752285	0.000125520070844639	1583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2575.58118975184	2575.58118975184
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATAAGTACTCGT"	3.94418873366658	-8.13413526928099	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATAAGTACTCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1963.63841915287	28.6849611829726	0.0146080667923311	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1960.19740044602	1960.19740044602
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATAAGTGCCTCG"	3.98946561393086	-7.38710310375365	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATAAGTGCCTCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2464.00317160654	22.3614298144299	0.00907524392505151	1473	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2458.73883304146	2458.73883304146
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATAGTGAGGCAT"	6.81102861937825	-1.71713104164275	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATAGTGAGGCAT"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2720.45628551245	25.1474356429552	0.00924383007985673	2028	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2713.36003816245	2713.36003816245
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATATCGACGCGT"	4.06055178222005	-7.31153490459593	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATATCGACGCGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.48796878831	26.2000741674694	0.0125630425874343	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2083.99800919572	2083.99800919572
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGATATCTTAGCTT"	-0.128030742437202	8.4056825407776	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGATATCTTAGCTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1789.33509565319	32.1496234182483	0.0179673575376401	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1785.5916971845	1785.5916971845
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGCACAACTGTGT"	-4.10388312760051	12.9822845228943	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGCACAACTGTGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1684.53485009568	32.3343547690429	0.0191948268492079	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1684.53485009568	1684.53485009568
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGCACAGCTGTCG"	-1.94725153866466	9.47708699786989	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGCACAGCTGTCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.08001296819	37.847911182891	0.0240597495810001	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1569.16392157918	1569.16392157918
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGCACATGACGTT"	-0.00813545557911995	8.26005551898805	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGCACATGACGTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1618.53797271875	23.7191912312492	0.0146547017314686	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1613.46646165857	1613.46646165857
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGCACATGTTACG"	4.85363449630086	-7.53377106105956	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGCACATGTTACG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2451.78013843316	35.1567410326643	0.0143392714875044	1582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.78825168742	2445.78825168742
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGCATCGTCTCAC"	-7.75805840912517	0.613615907076277	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGCATCGTCTCAC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2531.65806349022	17.9406991061292	0.00708654117428309	2628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2521.85633295407	2521.85633295407
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGGTAGCCTCTTC"	2.828874250024	-6.7307133904663	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGGTAGCCTCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.29794512181	31.7177101277356	0.0151375656152289	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2095.29794512181	2095.29794512181
"healthy-4003"	"2020-08-26-Control4003-c3:TGCGGGTCATGACCCG"	3.57498492774312	-6.92510797893675	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCGGGTCATGACCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2072.89945103069	0.473944523637074	0.000228638452965684	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2067.13496415621	2067.13496415621
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTCCACAGGCTATT"	-1.6335520547932	9.1033839949402	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTCCACAGGCTATT"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	2036.17666665026	30.7377005700804	0.015095792557454	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2028.44512849579	2028.44512849579
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTCCATCAGTGCGC"	5.0499664741451	-7.72780706798705	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTCCATCAGTGCGC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2647.73237591486	21.0299911807243	0.00794264230479783	1770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2645.48613513414	2645.48613513414
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTCGTGTAATGCTC"	-3.56361637535747	11.4498290785584	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTCGTGTAATGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1578.91867606215	40.2836636927512	0.025513450631428	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1574.46401813386	1574.46401813386
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTCGTGTTGGTACT"	0.0440117168122947	7.74136350238649	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTCGTGTTGGTACT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1350.53661612387	31.2780594268909	0.023159727069571	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1350.53661612387	1350.53661612387
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTGAACATTAAGCC"	4.29409279403035	-7.36264183437499	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTGAACATTAAGCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.15756255267	0	0	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2244.1908238977	2244.1908238977
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTGAATCGTACACA"	-0.810735742480117	8.9620322951111	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTGAATCGTACACA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1420.26650856803	22.307001576237	0.0157062082656077	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1415.50556598363	1415.50556598363
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTCGAGATACATG"	-3.09021053734477	10.3596420058045	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTCGAGATACATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1593.67989117086	37.3918560052539	0.0234625888250258	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1591.59364629141	1591.59364629141
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTCGAGGTTATAG"	0.988341708748978	8.57560536945192	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTCGAGGTTATAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1402.86561877069	35.4797232701758	0.0252908922960605	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1396.06603913017	1396.06603913017
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTCGGTACTCGCG"	5.55809654769246	-9.61543180858763	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTCGGTACTCGCG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2481.00363997263	0	0	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2471.45779579059	2471.45779579059
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTCGGTTTCGGCG"	-0.240580747753936	8.52242467487184	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTCGGTTTCGGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1853.75189709289	33.1795373339621	0.01789858577407	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1850.83290414933	1850.83290414933
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTGCGTAGCGATG"	0.360115815966767	8.14803693378297	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTGCGTAGCGATG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1380.22320760288	24.6161631618432	0.0178349146907881	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1377.94847686782	1377.94847686782
"healthy-4003"	"2020-08-26-Control4003-c3:TGCTTGCGTTGCCGCA"	4.27781023558919	-6.98246052181395	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGCTTGCGTTGCCGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2352.33718963082	41.792794381106	0.0177664981726812	1343	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2349.55585202718	2349.55585202718
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAACTCAGAAACCG"	4.74195923384969	-7.55322792446288	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAACTCAGAAACCG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.90709447752	31.921146292965	0.0143924632246531	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2216.28093138444	2216.28093138444
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGAGCACGCGTCA"	-3.05226026001628	9.98110768878785	"2020-08-26-Control4003-c3"	"Control4003"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGAGCACGCGTCA"	"gd T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1568.24594904229	39.4905792924898	0.025181368596301	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1568.24594904229	1568.24594904229
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGAGGTAAGATCA"	4.50915970382039	-7.03065874492797	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGAGGTAAGATCA"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2462.7946610634	35.1696011790281	0.0142803627663551	1673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2457.81524876586	2457.81524876586
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGGACATGGAATA"	5.44502892073934	-9.58969690715941	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGGACATGGAATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.31019127728	17.4109456562047	0.00829760334224289	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2096.54196501792	2096.54196501792
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGGACATTGAAAG"	-3.41280804100688	10.6839704283508	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGGACATTGAAAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1688.10285991357	24.2894006127855	0.014388578557369	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1685.95222370743	1685.95222370743
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGGACATTGTGCA"	4.37962736663167	-7.72062399303588	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGGACATTGTGCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.7581509701	28.6603526289654	0.0133256975527621	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2150.7581509701	2150.7581509701
"healthy-4003"	"2020-08-26-Control4003-c3:TGGAGGAGTTAGAGAT"	-0.667089919478256	8.61834428394166	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGAGGAGTTAGAGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1680.85765990255	31.9261773685046	0.0189939803530749	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1673.14308513356	1673.14308513356
"healthy-4003"	"2020-08-26-Control4003-c3:TGGATCAAGTAGGCCA"	4.97150530394856	-8.37992098247679	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGATCAAGTAGGCCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.88177587222	28.4855125271061	0.0129017381448574	1296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2205.25068085632	2205.25068085632
"healthy-4003"	"2020-08-26-Control4003-c3:TGGATGTCAGGCATGA"	5.15296854552571	-9.19518759166869	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGATGTCAGGCATGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.66988270062	2.81867936152066	0.00132539581457808	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2122.61873426905	2122.61873426905
"healthy-4003"	"2020-08-26-Control4003-c3:TGGCGTGCATGGCCAC"	4.10185064849202	-7.01300432598265	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGCGTGCATGGCCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2263.33567442565	36.6760886987246	0.0162044406904123	1317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2253.86344197884	2253.86344197884
"healthy-4003"	"2020-08-26-Control4003-c3:TGGCGTGGTGACGCCT"	5.46737207946126	-9.91644289409789	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGCGTGGTGACGCCT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.86216111536	6.63688745475287	0.00296572665201374	1177	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2233.2592463168	2233.2592463168
"healthy-4003"	"2020-08-26-Control4003-c3:TGGCGTGGTTAGGGAC"	-1.61303899708446	9.28222653949586	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGCGTGGTTAGGGAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2170.48843184909	32.4852481241439	0.0149667916435145	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2166.6800112398	2166.6800112398
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACGCCAGTCGCAC"	4.90029778060262	-7.5744290581909	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACGCCAGTCGCAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.91730345103	29.0122099312371	0.0125870936401053	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2299.53656899573	2299.53656899573
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACGCGTGGTTTGT"	1.36540200290028	-7.13040449535521	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACGCGTGGTTTGT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1625.49930712516	19.5760404755797	0.0120430937065127	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1623.50216692522	1623.50216692522
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACGCTCGTTCCTG"	10.3522335487301	6.40381906116334	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACGCTCGTTCCTG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1609.31912049665	28.1667700580093	0.0175022900674396	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1603.43745131413	1603.43745131413
"healthy-4003"	"2020-08-26-Control4003-c3:TTCAGGAAGCCACCGT"	5.42953075942342	-10.1363220444885	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCAGGAAGCCACCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.25453425536	34.7503833515681	0.0164207011912183	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2109.32993809788	2109.32993809788
"healthy-4003"	"2020-08-26-Control4003-c3:TTCAGGAGTTGCCAAT"	5.39496721801106	-10.0567903748718	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCAGGAGTTGCCAAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.70519749321	31.9462513201862	0.0147169921355874	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2162.20583536118	2162.20583536118
"healthy-4003"	"2020-08-26-Control4003-c3:TTCAGGATCGTTAGAC"	3.44941391524617	-7.72972109234007	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCAGGATCGTTAGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1913.83515868485	0	0	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1908.28061852109	1908.28061852109
"healthy-4003"	"2020-08-26-Control4003-c3:TTCATGTCACTAACCA"	2.56870283660237	-6.40084125911864	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCATGTCACTAACCA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.78292108902	30.4471188242944	0.0142958789474778	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2129.78292108902	2129.78292108902
"healthy-4003"	"2020-08-26-Control4003-c3:TTCATGTGTAGTCCTA"	4.78232540664021	-8.21947195446166	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCATGTGTAGTCCTA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2606.19214067422	40.3295749076908	0.0154745209603992	1679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2600.2526608738	2600.2526608738
"healthy-4003"	"2020-08-26-Control4003-c3:TTCATGTTCCGTGTGG"	6.70717253264729	-1.66942562973174	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCATGTTCCGTGTGG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2649.46191797497	20.5212197023428	0.00774542919946082	1675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2631.69184855447	2631.69184855447
"healthy-4003"	"2020-08-26-Control4003-c3:TTCATTGTCGTTCGCT"	-1.73239574852641	9.11576936328737	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCATTGTCGTTCGCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1852.42287075153	37.3287635318866	0.0201513186439672	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1846.88775404301	1846.88775404301
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCACGGTCCTTAAG"	3.79772605475728	-6.78924181377562	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCACGGTCCTTAAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2491.83409737318	32.6110715489697	0.0130871760617399	1485	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2489.12313301512	2489.12313301512
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCACGGTTTAGACC"	5.01779903945271	-7.99800589000853	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCACGGTTTAGACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.40217547995	23.3554987936029	0.0104153924969343	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2239.58713644943	2239.58713644943
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCACGTCTCGCCTA"	11.106516500085	5.63359258258668	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCACGTCTCGCCTA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1950.92522227584	34.8607239359847	0.017868816056065	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1943.65207923406	1943.65207923406
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGGTGTCATCTAG"	0.300427828996819	8.73634812915651	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGGTGTCATCTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1664.55849127566	31.3083665215151	0.0188088112767497	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1658.3441083057	1658.3441083057
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGTCGGTTAGT"	5.65740742263143	-10.1369781724182	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGTCGGTTAGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2622.70870541176	12.1692021476984	0.00463993661308562	1573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2613.43817980154	2613.43817980154
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGTCTTAGCCC"	5.30616774138753	-9.85380175029906	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGTCTTAGCCC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.57303580924	33.4999042760255	0.0173523112851223	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1926.74788340422	1926.74788340422
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGCTGTCTTGGTCC"	4.40338100966756	-7.82116081630858	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGCTGTCTTGGTCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2364.47529280619	37.3628753268827	0.0158017617864553	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2360.38205902514	2360.38205902514
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTAAGGTCGTGA"	9.72774281081502	6.98517987811891	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTAAGGTCGTGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1472.79812547138	24.4204994321641	0.016581022890933	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1472.79812547138	1472.79812547138
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTAAGTATTAGG"	-4.14966855469401	13.0206622847351	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTAAGTATTAGG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2095.35702713571	38.9279963292914	0.0185782164209527	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2091.52933412329	2091.52933412329
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTACAAAGACGC"	-2.42151580277141	8.84658334338991	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTACAAAGACGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2055.70308940023	19.0558713205315	0.00926975856522706	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2045.61740443863	2045.61740443863
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTACAAAGGATT"	0.215914343565148	8.27958867633668	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTACAAAGGATT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1496.39742724256	18.8771474809153	0.0126150627749344	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1487.18378465566	1487.18378465566
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTACAGGTGTTT"	3.48041286048238	-6.75946857845458	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTACAGGTGTTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.23439989406	37.2825428494406	0.0171711275628554	1096	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2167.94606410086	2167.94606410086
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTAGTGTTATCG"	-4.3298319381779	12.5949792631897	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTAGTGTTATCG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1925.27521937043	29.1591593694021	0.0151454498951777	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1921.18634530865	1921.18634530865
"healthy-4003"	"2020-08-26-Control4003-c3:TGGGTTATCACGAACT"	5.44317736205403	-9.45873453533324	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGGTTATCACGAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2524.87006263302	1.07893077236157	0.000427321305887886	1531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2518.41002476719	2518.41002476719
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTACAAGTCAATCC"	4.12170710143392	-6.97998859798583	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTACAAGTCAATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.39538178652	33.6413670665847	0.0148108811598114	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2265.73243109451	2265.73243109451
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTACACAGTGCGCT"	4.09239687499349	-7.49509289180907	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTACACAGTGCGCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2340.42551841694	38.5635241720919	0.0164771422412862	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2331.27449376772	2331.27449376772
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTACAGTCCGGCAT"	2.63316835936849	-6.18521883403929	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTACAGTCCGGCAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2360.74741111748	21.2327107181776	0.00899406290490304	1427	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2359.42905767401	2359.42905767401
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTACAGTGCCTGAC"	5.39559521254842	-9.71978189861449	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTACAGTGCCTGAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2473.72654132274	8.48891525669585	0.00343163042272113	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2466.60053519213	2466.60053519213
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTACATCTCCGAAA"	5.40468086776082	-9.76848223125609	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTACATCTCCGAAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.86838517979	15.2907852868179	0.00693815719198248	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2197.96075164321	2197.96075164321
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTAGTGTAGATTAG"	-0.852383891970474	8.77527616107789	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTAGTGTAGATTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1416.91367782417	29.919909269479	0.0211162541076068	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1409.89849918743	1409.89849918743
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTAGTTCTCTGCCA"	0.358047654002351	8.70784852588502	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTAGTTCTCTGCCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1424.96589628958	12.4156320185188	0.00871293274516072	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1418.49070844278	1418.49070844278
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTGATAGACCATAA"	3.1334499317104	-6.44432594692381	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTGATAGACCATAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.53982346735	23.7280746135818	0.011069574893738	1213	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2143.53982346735	2143.53982346735
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTGATAGTCACTGT"	-1.94371114197429	9.55895230853883	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTGATAGTCACTGT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1687.54378533996	34.0964208011617	0.0202047621503895	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1687.54378533996	1687.54378533996
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTGATGTCCGAAGA"	4.62642445144002	-7.20060541546019	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTGATGTCCGAAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2279.43252176406	37.8637134828577	0.0166110262626045	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2277.81981072877	2277.81981072877
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTTAGAGCATGAAT"	4.82730879363362	-7.71827080166014	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTTAGAGCATGAAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2095.09807981082	32.2061952464074	0.015372165893692	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2090.14389010369	2090.14389010369
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTTAGAGCGCTGCT"	-0.0146887404030145	8.57756421649782	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTTAGAGCGCTGCT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1868.70772365197	3.99729100881588	0.00213906699170916	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1867.21507452273	1867.21507452273
"healthy-4003"	"2020-08-26-Control4003-c3:TGGTTAGTCGCGGTAC"	3.79592146453206	-8.14457991039427	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGGTTAGTCGCGGTAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1490.5950054485	46.3858367356688	0.0311190072193433	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1488.52247195298	1488.52247195298
"healthy-4003"	"2020-08-26-Control4003-c3:TGTAACGTCGCACTCT"	4.64520468291585	-7.75019934093627	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTAACGTCGCACTCT"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.76706871017	0	0	1530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2497.99177512309	2497.99177512309
"healthy-4003"	"2020-08-26-Control4003-c3:TGTACAGAGAATCGCG"	-5.14227757874187	-2.78609516536864	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTACAGAGAATCGCG"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3055.47903855704	0	0	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3050.09961409545	3050.09961409545
"healthy-4003"	"2020-08-26-Control4003-c3:TGTACAGAGCATGCGA"	5.20828356322591	-8.69208242809447	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTACAGAGCATGCGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2392.25545609637	3.85094656119512	0.00160975557663854	1334	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2389.33830468151	2389.33830468151
"healthy-4003"	"2020-08-26-Control4003-c3:TGTACAGAGGACAACC"	2.60251583632771	-4.30080177700194	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTACAGAGGACAACC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2184.39984347713	20.8751075175917	0.00955644983217118	1366	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2184.39984347713	2184.39984347713
"healthy-4003"	"2020-08-26-Control4003-c3:TGTAGACAGATAGGGA"	2.13054170188252	-6.40748646175536	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTAGACAGATAGGGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.80806308838	34.9570048734845	0.0167113826026052	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2090.38752035973	2090.38752035973
"healthy-4003"	"2020-08-26-Control4003-c3:TGTAGACTCTGCCTCA"	-1.67466054382976	3.91009113872377	"2020-08-26-Control4003-c3"	"Control4003"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTAGACTCTGCCTCA"	"Ery"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3008.42573958504	32.5356173450133	0.0108148314638144	4865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	25	TRUE	"Ery_healthy-4003"	3002.60992013966	3002.60992013966
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCAGAGTAGCACGA"	-3.82141075554546	11.3379430540833	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCAGAGTAGCACGA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1771.39615840679	33.3160047404898	0.0188077661692879	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1767.07396922778	1767.07396922778
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCACCAGCTACAT"	-0.68710176172908	8.75284574115602	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCACCAGCTACAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1460.09345372207	29.3157294786099	0.0200779815866431	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1442.77649098691	1442.77649098691
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCCAGTTATCCAG"	10.5586763816768	6.5441012152466	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCCAGTTATCCAG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1563.16115680475	37.0143315768741	0.0236791526041594	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1550.4637095966	1550.4637095966
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCCATCGAGGCAA"	-3.9469133419102	11.1371707686218	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCCATCGAGGCAA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.42498515112	34.5079309097198	0.0191346638722698	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1797.10809893887	1797.10809893887
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCCATCGCAACAT"	9.38069214400594	6.20971772754518	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCCATCGCAACAT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1565.55501403533	29.3739466074564	0.0187626409446596	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1558.99186090338	1558.99186090338
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCTGAGTCGTCTA"	4.20603098449056	-6.93400003826293	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCTGAGTCGTCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2292.51872989737	2.83374804047706	0.00123608501144238	1243	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2288.8786696054	2288.8786696054
"healthy-4003"	"2020-08-26-Control4003-c3:TGTCCTGGTGTTATCG"	3.61860169944112	-6.73151447689208	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TGTCCTGGTGTTATCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2455.60366916033	0	0	1414	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.71930097976	2445.71930097976
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTCCCACTTGTGA"	-4.36316523972209	12.7408780821594	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTCCCACTTGTGA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2092.98301428121	34.4297316753502	0.0164500769669047	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2085.37120628827	2085.37120628827
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTCCTCATCGCTC"	10.2494989829952	6.16633412921754	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTCCTCATCGCTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1728.88359857163	38.0237364067881	0.0219932310296671	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1722.34499383043	1722.34499383043
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTGAGTCACAGTT"	5.55082192000691	-10.0404205552307	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTGAGTCACAGTT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.09549709069	9.77631528615299	0.0040886343929166	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2375.8421938451	2375.8421938451
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTGAGTGATATAG"	3.34953369674031	-7.14918901836547	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTGAGTGATATAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2061.60486655282	31.4036200885853	0.0152326086332415	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2055.46696632966	2055.46696632966
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAACGCATCAGCGC"	-4.3514383834904	12.6527395018372	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAACGCATCAGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2289.73330238417	34.0065776193327	0.0148517635586308	1146	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2271.92289911348	2271.92289911348
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAACGGTAGATTGA"	4.47130837020223	-7.38506796276244	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAACGGTAGATTGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.89925464946	1.15531789083774	0.000542173867824548	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2125.18568013083	2125.18568013083
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAACGTCGTACCTC"	9.95134892043416	6.34522340381471	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAACGTCGTACCTC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1394.6400458599	45.6938193461019	0.032763880172341	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1390.2826454041	1390.2826454041
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAACGTCTTCACGC"	4.21299709853475	-7.80818560039672	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAACGTCTTCACGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2450.75507506237	34.9238763543911	0.0142502515693056	1505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2445.72046325268	2445.72046325268
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCAGCAACCAG"	4.91848244246785	-7.92506697094115	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCAGCAACCAG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2411.07326269617	1.6363487634798	0.000678680647658944	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2407.18238938802	2407.18238938802
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCCACAGCCTG"	5.55529083785359	-9.66489317333373	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCCACAGCCTG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2765.23578584415	34.6600892480937	0.0125342256257229	1895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2761.81627342436	2761.81627342436
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCCACTACTTT"	-3.79959688606914	11.4854478606018	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCCACTACTTT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1985.43139719151	37.7999168521924	0.0190386416300569	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1981.75398205722	1981.75398205722
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCCAGTAGGAC"	3.67526068267171	-6.47289469158324	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCCAGTAGGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2327.82576310799	15.361008340182	0.00659886516578148	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2323.78110063892	2323.78110063892
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCTCAGTGCGC"	-4.02073703232463	12.9717559584412	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCTCAGTGCGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2217.28410186436	44.6985997808064	0.0201591666774783	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2210.38523517946	2210.38523517946
"healthy-4003"	"2020-08-26-Control4003-c3:TTGACCCTCTCTTAAC"	5.40445007857625	-9.58873560344847	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGACCCTCTCTTAAC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2723.33194278332	23.8711655231798	0.008765426332415	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2719.87635799377	2719.87635799377
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGAGGACAGCT"	-4.43719897690471	12.9479093321594	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGAGGACAGCT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2470.08324433339	17.1161198684804	0.00692936965090001	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2460.2480235452	2460.2480235452
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGGTAATACCC"	-1.23532364788707	8.61931035602418	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGGTAATACCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1848.68815730784	28.6761504662095	0.0155116212287362	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1840.83468553316	1840.83468553316
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGGTAGACTGG"	9.35397591170613	6.44070336902467	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGGTAGACTGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1582.45768834764	39.4450129302651	0.0249264250290651	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1568.28137415568	1568.28137415568
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGGTGCCAAGA"	9.29849876937215	5.80155131900636	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGGTGCCAAGA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1457.40985577641	35.6763140337369	0.024479259483758	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1451.07644997153	1451.07644997153
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGGTGCGGTAA"	5.61576189574544	-9.62400247966918	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGGTGCGGTAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2184.66473673063	34.592629796288	0.015834296775466	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2176.51281277175	2176.51281277175
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGGTTGATGTC"	-3.62685046616252	10.5862779387268	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGGTTGATGTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1917.88597891475	32.2926998768418	0.016837653662349	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1913.70854409152	1913.70854409152
"healthy-4003"	"2020-08-26-Control4003-c3:TTGAGTGTCAGCTCTC"	-3.93554363671001	12.1214780577454	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGAGTGTCAGCTCTC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1844.66381437895	31.4231453513017	0.0170346190489355	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1836.20434631429	1836.20434631429
"healthy-4003"	"2020-08-26-Control4003-c3:TTGATGGCACTGCACG"	-4.31608424606975	12.8300485380921	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGATGGCACTGCACG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2033.96982726213	34.0815812179772	0.0167561881996319	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2031.98402935037	2031.98402935037
"healthy-4003"	"2020-08-26-Control4003-c3:TTGATGGGTATCATGC"	-0.274189780384856	8.1459922560486	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGATGGGTATCATGC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1476.32553017477	27.1779771231178	0.0184092035039863	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1467.96607736965	1467.96607736965
"healthy-4003"	"2020-08-26-Control4003-c3:TTGATGGGTGTGTGGA"	5.42335714873616	-10.2106285325256	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGATGGGTGTGTGGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.85430718592	33.6658586394361	0.0155439165634266	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2160.55419104035	2160.55419104035
"healthy-4003"	"2020-08-26-Control4003-c3:TTGATGGTCTGTAACG"	2.66927852210347	-4.7786493531433	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGATGGTCTGTAACG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2384.0239315565	11.8189406906915	0.00495755958413349	1775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2381.07147787051	2381.07147787051
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCATTCACCATTCC"	5.5250731903011	-9.55044462597045	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCATTCACCATTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2555.01807487153	0	0	1646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2545.4090876417	2545.4090876417
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCATTCACCGGTCA"	-0.825941483408767	8.52581498706666	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCATTCACCGGTCA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1741.98679121224	23.7795993752178	0.0136508494181346	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1736.24007492844	1736.24007492844
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCATTGTTTATGCG"	3.9731785255367	-7.03907301342162	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCATTGTTTATGCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.29850576382	32.7723610809547	0.0143719609507778	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2278.6993724167	2278.6993724167
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCCTGCACACACGC"	-4.32001576843913	13.0282583006653	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCCTGCACACACGC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2040.75000125694	31.469452417206	0.0154205328422507	966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2033.11711880572	2033.11711880572
"healthy-4003"	"2020-08-26-Control4003-c3:TTACAGGAGCTAGCCC"	-3.99124608460124	13.1984739073547	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACAGGAGCTAGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2009.08844183066	46.782797021629	0.0232855836744554	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2007.31368598539	2007.31368598539
"healthy-4003"	"2020-08-26-Control4003-c3:TTACAGGGTCCACATA"	-2.78186235848125	10.5906514891419	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACAGGGTCCACATA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1922.17035849827	38.0465147877115	0.0197935186231027	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1908.67472623589	1908.67472623589
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATAGACTCCGC"	-4.53298602524455	3.46856830203859	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATAGACTCCGC"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2723.80193746468	22.8147906258825	0.00837608282455316	3406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2714.94493658217	2714.94493658217
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATAGGTGGTTG"	-3.20736108246501	12.1485929259094	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATAGGTGGTTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1725.11847186607	45.0827683878379	0.0261331433887388	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1709.90816007427	1709.90816007427
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATAGTGTTGAA"	5.53535761412923	-9.95390894329222	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATAGTGTTGAA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2517.54487300329	37.4303146297333	0.0148677844955673	1569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2511.28638009047	2511.28638009047
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATCAGTCAACT"	5.36083092269246	-10.0443163148132	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATCAGTCAACT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.019729532	14.9984683720765	0.00742858930633285	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2015.57702572449	2015.57702572449
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATGTCAACCTA"	2.17385735091512	-6.37763883983763	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATGTCAACCTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1964.39687271173	24.9883335474207	0.012720613586055	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1964.39687271173	1964.39687271173
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATGTCCTACAA"	4.34731878814046	-7.30205728923949	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATGTCCTACAA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2189.52877786049	20.5247390537403	0.00937404397753394	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2181.6762555497	2181.6762555497
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCATGTTCTCGTC"	5.49877514418904	-9.92236902630004	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCATGTTCTCGTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2553.2590120003	27.7239452990403	0.0108582580806482	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2550.4018284518	2550.4018284518
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCGCAGTAACCGG"	2.61890854415242	-4.33570196544798	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCGCAGTAACCGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2339.7146970839	29.7227006631834	0.0127035577030944	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2336.29805798733	2336.29805798733
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCGCCAGAGAATT"	-2.00839171829875	9.12418553912965	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCGCCAGAGAATT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2279.78978808752	39.2919724386388	0.0172349102728459	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2275.42777368819	2275.42777368819
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCGCCATTCTGTT"	4.27058329161946	-6.65755512630614	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCGCCATTCTGTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2433.82911749513	7.10535515146729	0.00291941414472847	1676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2431.650532497	2431.650532497
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCGCGTACCATAC"	0.182676230638665	8.21593568408815	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCGCGTACCATAC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1540.45308874972	10.2452255073129	0.00665078708474546	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1537.12772165236	1537.12772165236
"healthy-4003"	"2020-08-26-Control4003-c3:TTACCGCTCAGCAGAG"	4.5843411880428	-7.31062223827513	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACCGCTCAGCAGAG"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2670.67897914992	36.3942857178762	0.0136273531944526	1796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2665.99148616458	2665.99148616458
"healthy-4003"	"2020-08-26-Control4003-c3:TTACGCCCAGCACACC"	3.30462231215779	-5.46938803112181	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACGCCCAGCACACC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.60870186325	0	0	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2315.36226055007	2315.36226055007
"healthy-4003"	"2020-08-26-Control4003-c3:TTACGCCCAGGGCTTC"	-3.47746191445048	10.1602945097717	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACGCCCAGGGCTTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1715.81972906018	38.1402031325416	0.0222285607786037	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1709.24987339958	1709.24987339958
"healthy-4003"	"2020-08-26-Control4003-c3:TTACGTTCAGCACAAG"	-4.27278600159343	13.0400027998718	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACGTTCAGCACAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1998.21209080575	32.9719676955387	0.0165007347554599	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1994.30294852174	1994.30294852174
"healthy-4003"	"2020-08-26-Control4003-c3:TTACGTTCATGACCCG"	5.49796309050862	-9.8826303712097	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACGTTCATGACCCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2591.82077960785	24.9586073434608	0.00962975817611783	1535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2580.93108284736	2580.93108284736
"healthy-4003"	"2020-08-26-Control4003-c3:TTACGTTTCGCCAGTG"	4.75894226607625	-7.29825260555419	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACGTTTCGCCAGTG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.36371775249	14.8616379270999	0.00691122055511285	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2142.02177514225	2142.02177514225
"healthy-4003"	"2020-08-26-Control4003-c3:TTACTGTAGGGCTTCC"	4.62395968016927	-7.71908571636351	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACTGTAGGGCTTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2099.48728836704	31.1325192065926	0.0148286295321212	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2096.49735534352	2096.49735534352
"healthy-4003"	"2020-08-26-Control4003-c3:TTACTGTAGGTACCTT"	5.27770485457723	-9.3964300385681	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACTGTAGGTACCTT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.3008960097	37.7485146334755	0.0185105173578544	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2036.23380597954	2036.23380597954
"healthy-4003"	"2020-08-26-Control4003-c3:TTACTGTTCCAGTTCC"	4.85743107375447	-8.31493475353392	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACTGTTCCAGTTCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2488.39959680835	9.27615490070275	0.00372775936493498	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2481.95187322285	2481.95187322285
"healthy-4003"	"2020-08-26-Control4003-c3:TTACTGTTCCCGAATA"	4.49075426635091	-7.82323362743529	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTACTGTTCCCGAATA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2376.59244144759	7.8167473950997	0.00328905674308148	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2367.71763213543	2367.71763213543
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGCAAGATTAGTG"	11.0530353980953	4.90776584232179	"2020-08-26-Control4003-c3"	"Control4003"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGCAAGATTAGTG"	"Pro-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1597.60861435786	34.0019562085118	0.0212830325919208	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1590.95378543646	1590.95378543646
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGCATCGTTACCC"	-2.2162369293278	9.58656117999879	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGCATCGTTACCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1750.07949367652	34.6752239435474	0.0198135136540013	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1747.89654689749	1747.89654689749
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGGTAGAGTCTTC"	5.60913767394368	-10.1954260102478	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGGTAGAGTCTTC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.83053542908	12.2023396066911	0.00577535178618244	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2109.63328601613	2109.63328601613
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGGTGTAACGGTG"	-1.35393748703654	9.36837480151979	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGGTGTAACGGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.52841700102	33.3501443597162	0.0204661324170669	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1625.59852547633	1625.59852547633
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGGTGTTTCTATC"	1.80873002585713	-6.87458803569945	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGGTGTTTCTATC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1921.85774291418	28.0799740448002	0.014610849397324	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	1920.15405491786	1920.15405491786
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGGTTCATCAGTG"	-3.63233266297038	10.8579997786316	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGGTTCATCAGTG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1700.04282710642	33.0616932778252	0.0194475649381718	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1693.59351837339	1693.59351837339
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGGGTTCTGAGATC"	4.864265580743	-7.81974413311156	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGGGTTCTGAGATC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2444.06762202048	31.3717698462078	0.0128358845571847	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2440.16409966905	2440.16409966905
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGTCTGTAACACGG"	5.45629324492757	-9.98094274913939	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGTCTGTAACACGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2504.01280500022	41.4224243102057	0.016542417126418	1471	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2492.97650611141	2492.97650611141
"healthy-4003"	"2020-08-26-Control4003-c3:TTAGTCTGTTAATCGC"	3.87054004248921	-7.73426201259764	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTAGTCTGTTAATCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.32688321055	31.7393530754174	0.0169699496704739	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1866.57353207298	1866.57353207298
"healthy-4003"	"2020-08-26-Control4003-c3:TTATTGCAGTACAGAT"	4.15750231322591	-7.46399547969969	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTATTGCAGTACAGAT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.60893139386	31.904556069415	0.0150025496453189	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2126.60893139386	2126.60893139386
"healthy-4003"	"2020-08-26-Control4003-c3:TTATTGCCAAACGTGG"	5.03639425811116	-8.30999948894652	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTATTGCCAAACGTGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2742.16974787123	21.38870390993	0.00779991972653562	2239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2737.76085046433	2737.76085046433
"healthy-4003"	"2020-08-26-Control4003-c3:TTATTGCGTTCAGCGC"	-7.49065480652507	0.499983228090681	"2020-08-26-Control4003-c3"	"Control4003"	"MPP"	"MPP_GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTATTGCGTTCAGCGC"	"MPP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2625.06234225994	29.5087824432601	0.0112411739592652	2663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	2620.48759570907	2620.48759570907
"healthy-4003"	"2020-08-26-Control4003-c3:TTCAATCCAACACGTT"	-4.56416545334514	-5.22043898021849	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCAATCCAACACGTT"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2768.54924835637	34.2519444930356	0.012371802493082	1857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2761.50385701105	2761.50385701105
"healthy-4003"	"2020-08-26-Control4003-c3:TTCAATCTCATCTCTA"	-1.09454057636912	8.8434734114441	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCAATCTCATCTCTA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2444.39720356067	29.0193648168707	0.0118717877661614	1518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2436.44092476772	2436.44092476772
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACCGCAGAGTCAG"	2.14733328399007	-6.95611526882323	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACCGCAGAGTCAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1552.38302768787	44.4762072363271	0.0286502792436286	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1550.37107087968	1550.37107087968
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACCGCAGCGAACA"	5.29541410979573	-9.46479990398558	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACCGCAGCGAACA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.22586419521	35.2164715623507	0.0172695296684308	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2034.40808561243	2034.40808561243
"healthy-4003"	"2020-08-26-Control4003-c3:TTCACGCCAAGAAATC"	10.2390400367672	7.24897096240846	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCACGCCAAGAAATC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2045.16225207945	40.3686932692732	0.0197386262279326	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2036.75928050666	2036.75928050666
"healthy-4003"	"2020-08-26-Control4003-c3:TTTAGTCGTAGGAGGG"	4.9883848625118	-8.40229322826537	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTAGTCGTAGGAGGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.22293246631	39.2865220635376	0.0177347938610396	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2209.55597655944	2209.55597655944
"healthy-4003"	"2020-08-26-Control4003-c3:TTTATGCGTGAAGCTG"	-4.35018096390422	12.7758083113464	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTATGCGTGAAGCTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1868.95937861334	35.9660303495279	0.0192438801833203	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1864.62081195518	1864.62081195518
"healthy-4003"	"2020-08-26-Control4003-c3:TTTATGCTCTCTCGAC"	4.12999929961507	-7.25805904781493	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTATGCTCTCTCGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2952.20956772442	31.2425170318941	0.010582757190905	2149	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2940.60574669425	2940.60574669425
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCACACAAATTAGG"	4.10954107817952	-7.21552421962889	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCACACAAATTAGG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1944.25587147953	6.18415120756159	0.00318072908935366	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1942.34971316063	1942.34971316063
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCACAGTCTGCATA"	5.02700342711751	-8.51556017315062	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCACAGTCTGCATA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2247.9711491012	34.2913519275077	0.015254355884958	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2244.73681019043	2244.73681019043
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCAGTCAAGGCGTA"	4.10004248198811	-7.42388870632323	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCAGTCAAGGCGTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1933.77488782213	33.2201849252957	0.0171789307713625	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1930.02102894885	1930.02102894885
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCAGTGTGCCAAGA"	5.34804739531819	-10.2177486649719	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCAGTGTGCCAAGA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.36688404546	23.3895475538727	0.0107273448909092	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2178.92955295873	2178.92955295873
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCAGTTCCCGTTCA"	-0.0218166214531243	8.18004224384157	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCAGTTCCCGTTCA"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1950.05026999572	26.6651904552578	0.0136741041323598	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1941.67773580903	1941.67773580903
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCAGTTCGCTCTAC"	5.33326496657674	-9.43120863353881	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCAGTTCGCTCTAC"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.74730500964	36.5699897319588	0.0146529216553907	1444	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2487.47165081389	2487.47165081389
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCAGTTCTAAGAAG"	2.97138013419453	-4.96807815944823	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCAGTTCTAAGAAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2440.74808253937	13.5962769170951	0.0055705367605777	1788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2436.73685699378	2436.73685699378
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCCTCCACTAACCA"	4.69715227660481	-7.34738638317259	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCCTCCACTAACCA"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2739.53605844558	36.0752254844643	0.0131683703790829	1994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2734.40658795877	2734.40658795877
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCGATAGGACTATA"	4.66237845000569	-7.49198343670043	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCGATAGGACTATA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2871.11465660305	30.245350082465	0.0105343581500328	2406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2864.49548412222	2864.49548412222
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCGATAGTTCATCG"	3.32331289824788	-7.14809992229613	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCGATAGTTCATCG"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2012.81405578696	31.9435059844498	0.0158700729918943	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2003.68678940651	2003.68678940651
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGGTTCGACGACC"	1.54711331900899	-7.04269363796385	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGGTTCGACGACC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1665.56864025636	31.4086224995796	0.0188575971835933	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1663.91468261352	1663.91468261352
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGTGAGTGGATTA"	3.40229548987691	-6.32310106670531	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGTGAGTGGATTA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.75726553253	22.7876626636806	0.0101787107582028	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2234.05078834945	2234.05078834945
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGTGGTCCAAATC"	4.15757669982259	-8.2412958375183	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGTGGTCCAAATC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.38252836171	3.06173564370411	0.00152828309140137	958	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2001.63400342454	2001.63400342454
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGTGTCCGAGGCT"	10.8422724204952	6.256640411261	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGTGTCCGAGGCT"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1806.14365601919	35.2750146253104	0.0195305697349998	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1798.78458559371	1798.78458559371
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCGTGTCCGTAGGC"	-3.78179774704631	11.1709213026795	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCGTGTCCGTAGGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1796.80700025469	29.7205750247591	0.0165407720587388	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1790.72323790819	1790.72323790819
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTAAGTCACATTG"	11.1439072090084	5.95673177326051	"2020-08-26-Control4003-c3"	"Control4003"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTAAGTCACATTG"	"Pre-B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2062.97747640524	34.8400319567703	0.016888227019075	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2054.87968674982	2054.87968674982
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTCTAGTAATACG"	-2.47049627724345	9.17183396900026	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTCTAGTAATACG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1928.65056943683	29.0937163516589	0.0150850116722566	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1924.21865860703	1924.21865860703
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTCTTCACCTCGT"	-4.29936299744304	12.4954776533875	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTCTTCACCTCGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2245.63521939313	32.7395834131115	0.0145792082037078	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2241.87461413524	2241.87461413524
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTCTTCCACCCTA"	2.75901689109151	-4.54452707683715	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTCTTCCACCCTA"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2918.87543465335	35.6417664939864	0.012210787096579	2349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2909.79031217122	2909.79031217122
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTCTTCTAGTGTG"	-4.35948214951213	13.0987062224182	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTCTTCTAGTGTG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2224.49439456466	35.5975728253166	0.0160025455277819	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2222.92282812892	2222.92282812892
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTTCAGTATGGAT"	-1.76930985871013	8.95729253375856	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTTCAGTATGGAT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1651.21451510438	27.2423557682271	0.0164983746927062	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1647.6065372003	1647.6065372003
"healthy-4003"	"2020-08-26-Control4003-c3:TTCCTTCGTAGCTCGC"	3.52055801925008	-6.82534553920897	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCCTTCGTAGCTCGC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.44679194668	33.4601049284402	0.0145197993051403	1255	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2299.87377175582	2299.87377175582
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGATTAGTACTCGT"	5.2997576194698	-10.2379913560119	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGATTAGTACTCGT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.09219217724	38.8354156553865	0.0190174644436503	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2038.66474879494	2038.66474879494
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGATTGTGCAATGG"	0.470704008906525	8.48079869830934	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGATTGTGCAATGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1658.92015834549	47.5701270798565	0.028675356580934	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1654.49514656643	1654.49514656643
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGCTGCAAGAATAC"	-4.08361325684245	12.8284196623596	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGCTGCAAGAATAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2115.0956400667	1.81051965422046	0.000855998953391707	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2107.84612603191	2107.84612603191
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGCTGCAATGGCCC"	-4.0759051841801	12.8498706587586	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGCTGCAATGGCCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1885.08172288912	15.1978845977775	0.00806218871746573	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1874.28439543659	1874.28439543659
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGCTGCATAATGCC"	2.62026729163472	-4.35897877132567	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGCTGCATAATGCC"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2539.90491268979	27.4932854227158	0.0108245333458566	2019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2535.42646267782	2535.42646267782
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGCTGTCCCTCTAG"	2.69920720633809	-4.52915146267089	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGCTGTCCCTCTAG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2493.35838823634	26.2489276396426	0.0105275389865673	1751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2493.35838823634	2493.35838823634
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGGTCAGCACCAGA"	3.34457125243489	-7.32432510769042	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGGTCAGCACCAGA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.74211873974	2.74108641543265	0.00155501271926967	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1762.74211873974	1762.74211873974
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGGTCAGCAGCCCT"	3.60162677344624	-6.41515734111937	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGGTCAGCAGCCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.49785412177	27.9609193523661	0.0112632199483845	1512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2475.97054898299	2475.97054898299
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGGTCAGTAACCGG"	0.297162090509576	8.93352315509645	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGGTCAGTAACCGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1468.38466533207	19.0841057386405	0.0129966664656803	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1464.06771140555	1464.06771140555
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGGTCCATCAGCTA"	4.94482531127278	-8.1259222260681	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGGTCCATCAGCTA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.24801431611	0.680720042220851	0.000284671451119023	1494	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2388.80748482701	2388.80748482701
"healthy-4003"	"2020-08-26-Control4003-c3:TTCGGTCTCTCCGAGG"	0.416664053767365	8.46045968616334	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCGGTCTCTCCGAGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1412.46985929358	38.7041443495508	0.0274017488549511	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1408.39520794358	1408.39520794358
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTAACAGGAAGTAG"	6.77631439742391	-1.59599699890288	"2020-08-26-Control4003-c3"	"Control4003"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTAACAGGAAGTAG"	"pDC"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2518.58372408528	17.3227530108727	0.00687797385697954	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2508.11811467641	2508.11811467641
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTAACAGGTCGTCC"	-3.58606515350993	10.4393644102844	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTAACAGGTCGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1632.73386378767	42.4761159997545	0.0260153335101515	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1630.52658261988	1630.52658261988
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTAACTCTACTGAG"	3.88950266417806	-6.97726442730101	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTAACTCTACTGAG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2333.82659057526	27.3576905118017	0.0117222464695024	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2330.9565997516	2330.9565997516
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTAGTTCTCAGAAC"	-4.17950377884563	13.1786699065003	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTAGTTCTCAGAAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1921.53928492986	35.797447938029	0.0186295686061582	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1917.48564931723	1917.48564931723
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTCTCAGACTCTTG"	2.74210180815999	-4.4623971215454	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTCTCAGACTCTTG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2328.15916424782	28.1961260203975	0.012110909964142	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2323.41679241587	2323.41679241587
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTCTCAGGAGCTGT"	3.53520383414571	-7.22152998363646	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTCTCAGGAGCTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1834.46694736658	8.4640754009918	0.00461391545546359	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1822.97325694225	1822.97325694225
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTCTCCACTGAATC"	-3.11492929878886	11.1726026304993	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTCTCCACTGAATC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1555.35065659746	38.6944324040969	0.0248782692442785	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1551.02219394673	1551.02219394673
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTGTAAGATCACTC"	-1.29633698883708	8.73866460407106	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTGTAAGATCACTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1797.47410312641	34.6941403629469	0.0193016079077869	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1791.25494312879	1791.25494312879
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTGTAAGGCTTAAA"	-3.83705840531047	12.4042348631653	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTGTAAGGCTTAAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2056.1022407027	37.9660890706197	0.0184650783988467	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2040.63847861413	2040.63847861413
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTGTAAGTCGAGGT"	-0.455744783312637	8.42284963214723	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTGTAAGTCGAGGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1397.1795995647	25.0452990499372	0.0179256117522329	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1390.50762890255	1390.50762890255
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTGTAGTACAAACA"	-1.59753404083903	9.48864839160768	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTGTAGTACAAACA"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1990.89092021673	26.5333376237014	0.0133273688449054	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1987.32437960655	1987.32437960655
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTCCAGGATTCAA"	3.97555794295613	-7.10029938137206	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTCCAGGATTCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.47969183543	21.2561910461763	0.0104070513558325	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2037.25440731958	2037.25440731958
"healthy-4003"	"2020-08-26-Control4003-c3:TTCTTCCAGGGACAGG"	5.54090418395345	-10.1447592011658	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTCTTCCAGGGACAGG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.99984585706	23.6980427599437	0.0104350701754452	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2266.68337636253	2266.68337636253
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGGTACATTATGCG"	-3.20517096939738	10.1286039122376	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGGTACATTATGCG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1926.33832969863	35.631317094031	0.018496915388485	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1917.15869783454	1917.15869783454
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGTTTAGACCAAAT"	-3.04888115349467	10.5558776625427	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGTTTAGACCAAAT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1606.89186034873	40.4498421764224	0.0251727220571296	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1602.67969115491	1602.67969115491
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGTTTCAGCGACAA"	3.81340255317037	-6.92388155376586	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGTTTCAGCGACAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1965.46194184267	30.315832379266	0.0154242785036296	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1957.40487167671	1957.40487167671
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGTTTGTGCGGCTT"	3.35745205458943	-7.18897106563719	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGTTTGTGCGGCTT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1872.19958023834	0	0	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1870.43883774677	1870.43883774677
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGGAAGAGTGAAG"	-4.433182100684	12.7593145140442	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGGAAGAGTGAAG"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1779.69151349636	38.6196140407253	0.0217001731748744	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1774.95596824408	1774.95596824408
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGGAAGGTTGAGC"	-2.94723401489909	10.1204108961853	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGGAAGGTTGAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1764.81344423192	10.6670709944972	0.00604430515268409	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1756.4144746891	1756.4144746891
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGGACATCGAGCC"	4.57714809951131	-6.91693832790526	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGGACATCGAGCC"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2438.48912668638	35.322917681254	0.0144855752255306	1667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2436.32510904075	2436.32510904075
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGGATCGAGATGG"	3.999528546899	-6.95500566875609	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGGATCGAGATGG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.85780054545	4.68733009608301	0.00221428671064973	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2110.95263181261	2110.95263181261
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGGATCTGGGATT"	5.34478201445882	-9.99833013927611	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGGATCTGGGATT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2057.52147140201	22.5341389855584	0.0109520796252996	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2054.1155343643	2054.1155343643
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGTTAGAAGGCTC"	-3.7809833091801	9.63230607593385	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGTTAGAAGGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2074.37806476895	34.2983983479232	0.0165343043924558	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2065.87587367085	2065.87587367085
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGTTGTACTTCCC"	0.0929844724828422	7.72309253299562	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGTTGTACTTCCC"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1786.10175279816	35.0827371955562	0.0196420708621973	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1774.39890267608	1774.39890267608
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGTTGTGACGTCC"	-3.16604814949687	11.1952514418396	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGTTGTGACGTCC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1433.63396115158	36.1059012981053	0.0251848814108051	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1426.19988818468	1426.19988818468
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGTTGTTCCATTT"	0.70642383870427	8.43421170795289	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGTTGTTCCATTT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1656.07289637213	24.4916885916309	0.0147890160181254	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1643.60063347535	1643.60063347535
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTGTTTCCTAAACG"	3.74191941794698	-7.47911217128905	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTGTTTCCTAAACG"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2078.96675939168	30.5049201687037	0.0146731158787886	1181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2076.2218105067	2076.2218105067
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTCACACTACCGG"	2.62273706969563	-4.36426355755004	"2020-08-26-Control4003-c3"	"Control4003"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTCACACTACCGG"	"cDC2"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2259.2569991493	0.936489160930343	0.000414512010489717	1652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2258.25995752167	2258.25995752167
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTCATCGAGCCAC"	3.6340991455013	-7.73904755031737	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTCATCGAGCCAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1850.52325011627	12.6858699091391	0.00685528804263446	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1848.75468076798	1848.75468076798
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTGTAGTAACAGT"	4.80325903472249	-7.78382542049559	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTGTAGTAACAGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2436.13971942388	31.7652989355431	0.0130391942146304	1431	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2432.00218741809	2432.00218741809
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTGTCACTGCTTC"	4.09677185592	-7.26802017604979	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTGTCACTGCTTC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.60056278855	29.0734073905518	0.0129641487980368	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2242.60056278855	2242.60056278855
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTGTGTGAGTAGC"	-3.47630987587627	10.3620538481506	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTGTGTGAGTAGC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.11287957338	35.2476908689382	0.0232487246456587	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1513.76276284667	1513.76276284667
"healthy-4003"	"2020-08-26-Control4003-c3:TTGTTTGTCCGCTGTT"	-8.79954085770305	4.74631021106569	"2020-08-26-Control4003-c3"	"Control4003"	"MEP"	"MEP"	1	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGTTTGTCCGCTGTT"	"MEP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1383.85987622229	0	0	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	1378.71673213384	1378.71673213384
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACCACACTTGAAC"	4.35442556914632	-6.36382391369017	"2020-08-26-Control4003-c3"	"Control4003"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACCACACTTGAAC"	"Granulocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2681.69910391536	21.0228787954816	0.00783938763479749	2045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	168	TRUE	"Gran_healthy-4003"	2681.69910391536	2681.69910391536
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACCAGTTGCTCCT"	-2.4271002811497	9.24252603137819	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACCAGTTGCTCCT"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2060.99701130182	33.0570812153148	0.0160393639748339	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2055.91831903134	2055.91831903134
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACCATCAACCGAT"	5.02247252044026	-7.51328852092894	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACCATCAACCGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2519.37546263503	0	0	1740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2518.28664211501	2518.28664211501
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACCATCCATAGAC"	-4.1436747116154	12.9803142317566	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACCATCCATAGAC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1912.45919352423	33.3707636305652	0.0174491376043796	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1912.45919352423	1912.45919352423
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACCATCCGACATA"	10.7256561714107	6.77909228885499	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACCATCCGACATA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1899.96674669508	32.1365395611058	0.0169142642191007	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1898.26126477536	1898.26126477536
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACGTCATTATGCG"	-0.0513386529987634	8.25889108264772	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACGTCATTATGCG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1851.23852359561	28.4332498607046	0.0153590417973149	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1837.25828505063	1837.25828505063
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACGTGTTTCGTAG"	-1.25360820713695	8.38887021625368	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACGTGTTTCGTAG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1564.24775552251	30.0926748742329	0.0192377932255245	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1560.16699916608	1560.16699916608
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACTGAGATGGTCG"	5.50054945525472	-9.71829035198363	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACTGAGATGGTCG"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2563.10945241459	18.1090472313498	0.00706526489311257	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2556.03856933318	2556.03856933318
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACTGGTCGTTGGC"	10.3210102516109	7.63899276340333	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACTGGTCGTTGGC"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2248.47916044412	37.0257931343781	0.0164670386035798	1325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	2237.22496444652	2237.22496444652
"healthy-4003"	"2020-08-26-Control4003-c3:TTTACTGTCTGACCCT"	4.59669699248616	-8.32839968120726	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTACTGTCTGACCCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2084.01189157073	27.9969656670482	0.0134341679048418	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2080.78435418099	2080.78435418099
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCGTCAGAGCGACT"	3.75733270224873	-7.43590452587279	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCGTCAGAGCGACT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.01363659382	31.9702741616652	0.0170416000918372	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1874.32280223544	1874.32280223544
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCTGCAGCAGGGAG"	-3.24256525459941	11.2128200300964	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCTGCAGCAGGGAG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1389.44862461556	46.9488368991218	0.0337895450521691	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1379.99611686084	1379.99611686084
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCTGCAGCATCCCG"	4.09392227706258	-7.89759876644286	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCTGCAGCATCCCG"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2493.093052734	42.2034230528318	0.0169281379235124	1666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2488.47073126212	2488.47073126212
"healthy-4003"	"2020-08-26-Control4003-c3:TTGCTGCCAGTGGCTC"	-2.15349326553996	9.03612039172975	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGCTGCCAGTGGCTC"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2070.28020655748	38.2633356166949	0.0184822013442907	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2063.72124440193	2063.72124440193
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGATGAGAGCCATG"	-2.21048865738567	9.16534612262575	"2020-08-26-Control4003-c3"	"Control4003"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGATGAGAGCCATG"	"CD8+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1596.71620510651	40.2464261504087	0.0252057479104272	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1582.0656339694	1582.0656339694
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGATGAGATTGACA"	-1.86636541310008	9.11215303027955	"2020-08-26-Control4003-c3"	"Control4003"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGATGAGATTGACA"	"MAIT"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1791.75838025308	38.6842820269076	0.0215901220015188	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1786.39430438941	1786.39430438941
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGATGTCGTGGTAT"	5.501472611993	-9.80434992229613	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGATGTCGTGGTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2116.41143672178	26.2793488754737	0.0124169376613175	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2111.53959706851	2111.53959706851
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGGATTCATACGAC"	3.47721328315083	-6.94431784069213	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGGATTCATACGAC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2191.95793336223	33.5437602146427	0.015303103998529	1191	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2184.28000079215	2184.28000079215
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGGCGGTACGGGAT"	5.19242920455281	-8.62622930919798	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGGCGGTACGGGAT"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2483.09213761157	29.7936345548237	0.0119986021072426	1536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2482.24451826623	2482.24451826623
"healthy-4003"	"2020-08-26-Control4003-c3:TTGGGTAAGGATTACA"	-5.47039161148723	-3.312620185968	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTGGGTAAGGATTACA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3012.7348980961	31.659553920391	0.0105085760915765	2772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3005.24312870266	3005.24312870266
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGATCAGGCTAGCA"	5.43526472625081	-9.90081694042357	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGATCAGGCTAGCA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.807495596	25.5897055977955	0.0112640290374084	1348	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2271.807495596	2271.807495596
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGATCCATAGATCC"	2.14942206916158	-6.59757950222167	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGATCCATAGATCC"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.85018583131	29.2057001498094	0.016642845289938	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	1750.93517082932	1750.93517082932
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGATCTCTAACGGT"	-4.28921494904216	12.4813260802063	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGATCTCTAACGGT"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1953.42544137119	43.7297483692625	0.0223861875877724	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	1947.65574479851	1947.65574479851
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGGAGAGATTGTGA"	4.85363211211507	-7.96772196209105	"2020-08-26-Control4003-c3"	"Control4003"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGGAGAGATTGTGA"	"HLA-II+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.99427366651	34.4029807219231	0.0167738063258567	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2048.04921419523	2048.04921419523
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCGATTCATTTGGG"	-1.54143128815349	8.71454999530641	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCGATTCATTTGGG"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2572.70473925369	38.9499474987668	0.0151396881672732	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	2557.99489887655	2557.99489887655
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCGATTCCCTCGTA"	5.46270145949666	-9.5948114625183	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCGATTCCCTCGTA"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	3011.85312842855	34.7284402753223	0.0115305889080461	2530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	3005.91436294545	3005.91436294545
"healthy-4003"	"2020-08-26-Control4003-c3:TTTCGATTCTCTTCAA"	-4.26699243012126	13.0463704832825	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTCGATTCTCTTCAA"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2167.29670193302	37.2125085963319	0.017170011177123	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2161.52571730689	2161.52571730689
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTAGTCACGCC"	-4.22522244873698	12.8250312575134	"2020-08-26-Control4003-c3"	"Control4003"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTAGTCACGCC"	"NK"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2025.27387140048	34.8606133040521	0.0172127897349241	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	645	TRUE	"NK_healthy-4003"	2017.35883530031	2017.35883530031
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTCAGATCCTA"	-6.28640160980876	-3.33740713512572	"2020-08-26-Control4003-c3"	"Control4003"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTCAGATCCTA"	"GMP"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3143.0174592352	27.6239990966633	0.00878900593297534	4209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	135	TRUE	"HSPC_healthy-4003"	3129.38320208269	3129.38320208269
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTGTAGCGAGT"	0.478658665984315	8.83704278552858	"2020-08-26-Control4003-c3"	"Control4003"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTGTAGCGAGT"	"CD4+ T"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1721.1751963095	0	0	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2108	TRUE	"T_healthy-4003"	1719.45965330188	1719.45965330188
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTGTGGACCAA"	3.84935059127156	-6.75704338466796	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTGTGGACCAA"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2501.506974185	32.4252373257721	0.0129622814009289	1558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2496.41514806375	2496.41514806375
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTTCAGAACCT"	4.35378470000569	-7.09346010601195	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTTCAGAACCT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.27647320401	3.4882150473781	0.00155843797186719	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2235.32907750819	2235.32907750819
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGACTTCGTCTACC"	4.57275261458699	-7.64645340358885	"2020-08-26-Control4003-c3"	"Control4003"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGACTTCGTCTACC"	"CD11c+"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2478.12104555019	40.6300091139579	0.0163954901181743	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2469.13830939947	2469.13830939947
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGGAGTCGAGGCAA"	9.95064415511433	6.47529122913209	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGGAGTCGAGGCAA"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1658.05538418336	33.6780290361014	0.020311763622232	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1646.3616433136	1646.3616433136
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGGTTCAGACCTAT"	5.56520285186116	-10.1380329362121	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGGTTCAGACCTAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2522.92978229846	26.1694752110016	0.0103726530142113	1503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2521.59146479331	2521.59146479331
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGTTGAGCGCCCAT"	5.59312405165975	-10.0071449509827	"2020-08-26-Control4003-c3"	"Control4003"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGTTGAGCGCCCAT"	"CD16+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.14137755473	22.404783932996	0.00996591413542029	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2239.67825701252	2239.67825701252
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGTTGCAAGTTGGG"	10.2829739051754	6.04731986606447	"2020-08-26-Control4003-c3"	"Control4003"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGTTGCAAGTTGGG"	"B"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1593.16045008659	31.7416072645919	0.0199236726362788	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	365	TRUE	"B_healthy-4003"	1587.94328014488	1587.94328014488
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGTTGTCTTACTGT"	2.58763899382893	-6.65020229732665	"2020-08-26-Control4003-c3"	"Control4003"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGTTGTCTTACTGT"	"CD14+ monocyte"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.92904002021	30.7329428476568	0.0134561723718811	1438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	2986	TRUE	"Mono_healthy-4003"	2281.46965847334	2281.46965847334
"healthy-4003"	"2020-08-26-Control4003-c3:TTTGTTGTCTTTCGAT"	2.51513065871541	-4.10236885463866	"2020-08-26-Control4003-c3"	"Control4003"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613776"	"2020-08-26"	"2020.08.26.Control4003.c3.TTTGTTGTCTTTCGAT"	"cDC1"	"4003"	"M"	42	"CITE-Seq + scTCR-seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2285.28751803141	20.8016134534039	0.00910240540381666	1687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	351	TRUE	"DC_healthy-4003"	2278.99611319868	2278.99611319868
"healthy-5"	"2019-08-29-count-2:TAGTGCACAAATGCTC"	5.41188492354695	-9.98900988018187	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGTGCACAAATGCTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.02159309434	43.2332246984647	0.020508909794896	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2108.02159309434	2108.02159309434
"healthy-5"	"2019-08-29-count-2:GCCCGAAAGGTATCTC"	4.60637869414632	-8.09109594738158	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCCGAAAGGTATCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.75394786711	37.1335962865689	0.0164180530431203	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2256.85211813905	2256.85211813905
"healthy-5"	"2019-08-29-count-1:CTGCCATGTTAACCTG"	4.09121145781819	-8.00705530559691	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCCATGTTAACCTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.64455136467	41.1800257199918	0.0207493204219747	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.64455136467	1984.64455136467
"healthy-5"	"2019-08-29-count-1:CTACGGGGTTACGCCG"	2.60894312438313	-7.22907402431639	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACGGGGTTACGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.47838415953	43.8338656977303	0.0212736353046528	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2057.02336405138	2057.02336405138
"healthy-5"	"2019-08-29-count-2:GAGTGAGAGTCCTGCG"	4.06462921675984	-8.10317137157591	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTGAGAGTCCTGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1960.78346231143	39.6722482890073	0.0202328554129279	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1958.88730469996	1958.88730469996
"healthy-5"	"2019-08-29-count-1:AATCGTGTCGTTCTGC"	4.84442486342732	-8.84336473858031	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCGTGTCGTTCTGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.21265599821	41.6121865975034	0.0201296109893492	998	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2063.63700395953	2063.63700395953
"healthy-5"	"2019-08-29-count-1:CTACGGGGTCAGTCTA"	3.36211289939229	-7.77490332042845	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACGGGGTCAGTCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1519.06480622696	49.130308166564	0.032342470160041	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1519.06480622696	1519.06480622696
"healthy-5"	"2019-08-29-count-1:CTACGGGCAGCTATAC"	4.08724321898763	-8.20744039928588	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACGGGCAGCTATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1826.30965995626	46.3834528680055	0.0253973649075023	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.20669523121	1820.20669523121
"healthy-5"	"2019-08-29-count-2:GAGAGGTTCGCACGAC"	3.34667529639546	-7.7249384156433	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGAGGTTCGCACGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1688.73732575642	46.7002951750937	0.027653972268408	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.64743366763	1682.64743366763
"healthy-5"	"2019-08-29-count-2:GATTGGTGTGATTAGA"	-1.37806425514873	9.64911744678346	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTGGTGTGATTAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1479.25374798461	44.4420930996961	0.0300435899927552	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1476.73628788775	1476.73628788775
"healthy-5"	"2019-08-29-count-2:CCCTGATAGATGGTAT"	1.72531833228413	-6.754345916864	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTGATAGATGGTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1818.16394664839	42.0383170782321	0.0231213016602412	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1813.7353389503	1813.7353389503
"healthy-5"	"2019-08-29-count-1:AGCTACACAGAAGTTA"	-5.65112338486369	-5.55309441005858	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTACACAGAAGTTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2282.96864733245	52.3967384871856	0.0229511423857743	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2276.40145574439	2276.40145574439
"healthy-5"	"2019-08-29-count-1:AACGGGAGTACAAACA"	14.372819562524	2.11657188022462	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGGGAGTACAAACA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1263.86802524695	31.6806675481991	0.0250664364596207	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1252.45195541926	1252.45195541926
"healthy-5"	"2019-08-29-count-1:ACCATTTCATATAGCC"	3.01529063758199	-7.13936426555785	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCATTTCATATAGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1765.47301623289	41.5969922129249	0.0235613865691832	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1765.47301623289	1765.47301623289
"healthy-5"	"2019-08-29-count-1:CGTGATATCAAGAATG"	3.56427206572835	-7.36225654995116	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGATATCAAGAATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1842.87967644921	42.6130507349639	0.023123078125789	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1838.93930215387	1838.93930215387
"healthy-5"	"2019-08-29-count-2:GGAACCCTCATATGGC"	-1.2856744331425	10.7979097136292	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAACCCTCATATGGC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1399.96927949772	44.7348715481335	0.031954180854728	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1395.3347284429	1395.3347284429
"healthy-5"	"2019-08-29-count-2:GGAACCCTCGTAATGC"	-3.29680524292644	12.6477212675842	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAACCCTCGTAATGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1454.3493979411	35.993340975464	0.0247487577788523	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1451.85539050238	1451.85539050238
"healthy-5"	"2019-08-29-count-2:AGATGAAGTTATAGAG"	-8.6034873527592	2.34435389125673	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATGAAGTTATAGAG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2421.36032090096	39.058894662731	0.0161309716383713	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2413.46919478281	2413.46919478281
"healthy-5"	"2019-08-29-count-1:GAGGGATTCGAAGCCC"	3.568291802972	-7.72805550014647	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGGATTCGAAGCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1821.4483597027	49.6483197137918	0.0272576048886149	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1815.03114641215	1815.03114641215
"healthy-5"	"2019-08-29-count-2:TCTTGCGAGGTACCTT"	4.64791407164876	-7.98469068920287	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTGCGAGGTACCTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1948.10248356042	43.501913795367	0.0223304031294398	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1944.32665690994	1944.32665690994
"healthy-5"	"2019-08-29-count-2:CAGGCCAAGGGTTTCT"	-7.04381499710734	3.58338902080385	"2019-08-29-count-2"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGCCAAGGGTTTCT"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2196.60498500817	43.3528699609881	0.0197363068266126	1539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2185.76850324101	2185.76850324101
"healthy-5"	"2019-08-29-count-1:GCCAGCACACGCGCAT"	0.504721661179703	8.83039472186891	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGCACACGCGCAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1567.74730556873	36.9471741849215	0.0235670468408288	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1556.30016639695	1556.30016639695
"healthy-5"	"2019-08-29-count-2:ATCGGCGAGGACTGGT"	4.60390820082967	-7.35794832622679	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGGCGAGGACTGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.83960083031	42.796941099552	0.0225860495425568	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.58563207203	1890.58563207203
"healthy-5"	"2019-08-29-count-1:AATGGAAAGATTACCC"	11.1103340583736	4.94902656162111	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGGAAAGATTACCC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1511.57731150091	37.1518875302872	0.0245782251742039	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1504.01787321612	1504.01787321612
"healthy-5"	"2019-08-29-count-1:AACCATGTCATCACTT"	3.21976675566975	-8.39784910595091	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCATGTCATCACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1911.89101337039	45.8153050333589	0.023963345563612	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1909.93697944628	1909.93697944628
"healthy-5"	"2019-08-29-count-1:GCGTTTCCACTGGATT"	3.09579910811726	-5.4279790154663	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGTTTCCACTGGATT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2429.6273028563	40.73163461357	0.0167645607890912	1510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2425.80957058763	2425.80957058763
"healthy-5"	"2019-08-29-count-1:CTGCCATCATCAGCGC"	-1.79668662968333	9.67669198596803	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCCATCATCAGCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1414.54185575605	43.6811969887607	0.0308801021412079	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1412.19884898082	1412.19884898082
"healthy-5"	"2019-08-29-count-2:TCTATCAAGGATTTCC"	6.78444256362264	-1.41984763061675	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATCAAGGATTTCC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2198.00420676546	32.1651754797017	0.0146338097901256	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2190.89006345903	2190.89006345903
"healthy-5"	"2019-08-29-count-1:ATGGGAGTCTTTCCGG"	3.57262768325154	-7.37540628826293	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGAGTCTTTCCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.33600704043	43.3007964658879	0.021843318343662	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1977.38679229673	1977.38679229673
"healthy-5"	"2019-08-29-count-1:CCCTTAGTCCTACCAC"	9.13260712203328	6.22638223255006	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTTAGTCCTACCAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1513.371372492	38.1536593454846	0.0252110354662377	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1508.72051162096	1508.72051162096
"healthy-5"	"2019-08-29-count-1:TACTTACCAAATGAAC"	-3.21022258225139	10.5694408186707	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTTACCAAATGAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1721.61155470341	38.0267209684908	0.0220878634698998	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1714.47173536613	1714.47173536613
"healthy-5"	"2019-08-29-count-1:GAATCGTTCGCACTCT"	3.10697474059407	-7.03685524379881	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATCGTTCGCACTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1772.71265944436	46.1671716766714	0.0260432346047227	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1770.49444829914	1770.49444829914
"healthy-5"	"2019-08-29-count-1:CGTAATGGTCCACGCA"	3.04819621619527	-5.20593979274901	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAATGGTCCACGCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2337.86007790398	41.2492087233659	0.0176440023563549	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2334.11787445446	2334.11787445446
"healthy-5"	"2019-08-29-count-1:CTCTCGACAATTTCTC"	2.29158844527547	-7.05012323772582	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCGACAATTTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1807.76350020603	49.6516726579302	0.027465801058751	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1803.35963184631	1803.35963184631
"healthy-5"	"2019-08-29-count-1:AATCGTGTCAACCTCC"	-3.07248125496562	12.5373573073181	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCGTGTCAACCTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1410.44336210219	39.7742560118915	0.0281998250199923	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1407.81620902645	1407.81620902645
"healthy-5"	"2019-08-29-count-2:CAACGATTCCACCTGT"	-0.366819958121139	9.7220363386902	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACGATTCCACCTGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1561.63816802199	41.3484968484545	0.0264776423214781	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1559.52816587224	1559.52816587224
"healthy-5"	"2019-08-29-count-1:CTGGACGTCAAGCCTA"	11.0976721244747	4.64112804019777	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGACGTCAAGCCTA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1673.57952424774	34.6323452949422	0.0206935761301867	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1673.57952424774	1673.57952424774
"healthy-5"	"2019-08-29-count-2:AGCGTATGTATGCAAA"	-2.91319094124492	12.7700986632141	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCGTATGTATGCAAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1428.4547021049	42.6160087783721	0.0298336438079383	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1425.82602202237	1425.82602202237
"healthy-5"	"2019-08-29-count-2:GCGTTTCAGCGATCGA"	-3.97010074082072	-4.68392565166625	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGTTTCAGCGATCGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2522.96671415488	47.2777140917888	0.0187389369136506	1614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2519.36671667218	2519.36671667218
"healthy-5"	"2019-08-29-count-1:CGAGGAAGTACTGGGA"	-3.43019471588786	11.7634153136047	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGAAGTACTGGGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1578.1848998123	39.2126889984216	0.024846701424583	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1575.80571106182	1575.80571106182
"healthy-5"	"2019-08-29-count-1:GCGTTTCCAAGTGGCA"	-3.41750846329387	12.5883455046448	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGTTTCCAAGTGGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1570.59236267863	37.8198732726221	0.0240800058444959	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1570.59236267863	1570.59236267863
"healthy-5"	"2019-08-29-count-1:AAGCCATTCAAGCTTG"	3.51984228667561	-7.20756199276122	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCCATTCAAGCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1803.96036613636	39.4649395876203	0.021876832955119	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1799.77552247537	1799.77552247537
"healthy-5"	"2019-08-29-count-1:GGGAAGTTCTGCGATA"	9.65037979659383	5.83983848178712	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAAGTTCTGCGATA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1429.69373155656	27.930910878069	0.0195362896692983	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1427.31221476171	1427.31221476171
"healthy-5"	"2019-08-29-count-1:TCATCCGTCGAACACT"	10.0395914512569	6.12206027591554	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCCGTCGAACACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1502.83860214605	36.636502775341	0.0243782018395217	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1500.49817302391	1500.49817302391
"healthy-5"	"2019-08-29-count-1:ACCATTTGTCAAACGG"	9.59926857528035	5.2992315062317	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCATTTGTCAAACGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1487.52019631583	39.9135912820023	0.026832302096373	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1485.28145021304	1485.28145021304
"healthy-5"	"2019-08-29-count-2:GTCACGGTCTGGCCTT"	6.8219276863033	-1.36519696628722	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCACGGTCTGGCCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2292.12922533105	19.6375863774489	0.00856739932479705	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2278.49781454346	2278.49781454346
"healthy-5"	"2019-08-29-count-2:GCCAGGTAGGATGGCT"	14.1173635917598	1.92382226074067	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGGTAGGATGGCT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1108.41598609248	40.5098217600859	0.0365474896323861	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1094.78653550507	1094.78653550507
"healthy-5"	"2019-08-29-count-1:AACCATGTCAGCTGTA"	2.43241633948628	-7.32755663311156	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCATGTCAGCTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1805.96605022745	51.3707395531719	0.0284450195211045	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1799.74221951168	1799.74221951168
"healthy-5"	"2019-08-29-count-2:GAGCTGCGTCCTCCAT"	5.37498678740804	-9.45861818706664	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCTGCGTCCTCCAT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.92683400202	38.9971268970082	0.0182833870695122	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2131.18884693365	2131.18884693365
"healthy-5"	"2019-08-29-count-1:CGATGGCCACGCAAAG"	-3.57187257233318	12.3045654066834	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATGGCCACGCAAAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1628.04894421511	37.709285765603	0.0231622555940926	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1625.18424133139	1625.18424133139
"healthy-5"	"2019-08-29-count-2:GAAACCTGTTTCCATT"	9.65100540694539	5.63464400852052	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAACCTGTTTCCATT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1393.62726358984	43.7220480848531	0.0313728420985606	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1388.85325541675	1388.85325541675
"healthy-5"	"2019-08-29-count-2:GACACGCGTACAGGTG"	10.3295399146969	7.33839938724367	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACACGCGTACAGGTG"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1241.83128744676	26.012471037324	0.0209468639583131	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1235.98677393059	1235.98677393059
"healthy-5"	"2019-08-29-count-2:GGTGTTACAAGTGACG"	5.14155592498128	-9.97461130535277	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTTACAAGTGACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.99445862788	50.7337901184866	0.0247241360254019	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2048.36846021495	2048.36846021495
"healthy-5"	"2019-08-29-count-1:CTAGGTAGTAGTCTTG"	2.10878409919087	-6.23146440899047	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGGTAGTAGTCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.7526878381	45.8772852138589	0.0224037235972541	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2042.45745903839	2042.45745903839
"healthy-5"	"2019-08-29-count-2:GACCTTCTCCCGGTAG"	2.87264456328694	-7.48604967510375	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCTTCTCCCGGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1654.76878917041	40.4921581283372	0.0244699793671098	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1652.45711494444	1652.45711494444
"healthy-5"	"2019-08-29-count-1:CCGAACGCATTCTGTT"	5.53934921798055	-9.95790769970091	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGAACGCATTCTGTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2441.46233589989	38.3229650256376	0.0156967258769988	1356	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2438.46652359838	2438.46652359838
"healthy-5"	"2019-08-29-count-1:CTTCCGAGTTTGAACC"	-3.14162049713786	12.4028520354065	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGAGTTTGAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1446.0639007585	45.2984494659415	0.0313253442273065	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1446.0639007585	1446.0639007585
"healthy-5"	"2019-08-29-count-1:TACAGGTCACAATGTC"	-2.68789515915568	3.72457406604616	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACAGGTCACAATGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3091.52026466027	47.7394123676255	0.0154420506031752	3772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3085.38720999492	3085.38720999492
"healthy-5"	"2019-08-29-count-1:TCCTTTCTCGTCGGGT"	-3.099432806403	-5.9184894791809	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTTTCTCGTCGGGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1996.79119723038	50.9947357100409	0.0255383416056583	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1994.81411098199	1994.81411098199
"healthy-5"	"2019-08-29-count-2:GTGATGTTCCGCAACG"	-3.20768270912822	3.56854126537172	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGATGTTCCGCAACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3042.82105240518	46.2933814075382	0.0152139677655201	3163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3030.67028420423	3030.67028420423
"healthy-5"	"2019-08-29-count-2:TCGGGCATCCGTGCGA"	-3.26486645165141	3.6544184454712	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGGCATCCGTGCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2955.26494406739	46.2911106221433	0.015663946041478	3158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2948.48074060983	2948.48074060983
"healthy-5"	"2019-08-29-count-2:CAATTTCTCTAGTCAG"	-2.76746592941936	10.4866876372131	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCTCTAGTCAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1578.91556174846	38.0683439095908	0.0241104368288287	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1576.55471328266	1576.55471328266
"healthy-5"	"2019-08-29-count-2:CCCTCAAGTACAGAAT"	3.74683370169942	-7.6842570534912	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTCAAGTACAGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1840.03779539703	44.0933208361216	0.0239632690950283	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1840.03779539703	1840.03779539703
"healthy-5"	"2019-08-29-count-1:GGAATCTGTGCAACAG"	2.80399622496907	-6.55595972454222	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAATCTGTGCAACAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2094.31424501708	42.7248048613216	0.0204003792472763	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2092.5903344959	2092.5903344959
"healthy-5"	"2019-08-29-count-1:GCCAGCACAGTGGTGA"	10.6985088783199	6.19392345035402	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGCACAGTGGTGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1646.11541420483	41.6649707041551	0.025311087147727	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1639.98015972373	1639.98015972373
"healthy-5"	"2019-08-29-count-1:CCTCAGTGTAGCTCGC"	-3.22652516785319	12.8128242262634	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCAGTGTAGCTCGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1539.25484007626	40.7850041081756	0.0264965898084524	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1539.25484007626	1539.25484007626
"healthy-5"	"2019-08-29-count-1:CGAGGCTCAAGTGTCT"	3.6354669528896	-7.69590141689452	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGCTCAAGTGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1693.50831103583	50.2563591592166	0.0296758857525048	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1689.23906786145	1689.23906786145
"healthy-5"	"2019-08-29-count-1:CGTAATGGTGACACAG"	-3.07510624352153	10.9284515150818	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAATGGTGACACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1518.61665346679	35.9342922750758	0.0236625169314737	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1513.86582960865	1513.86582960865
"healthy-5"	"2019-08-29-count-1:CTCTCGATCAGTGATC"	14.2997566657955	2.04381046378938	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCGATCAGTGATC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1217.80075337977	23.6044622876362	0.0193828606380203	1126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1208.0022711566	1208.0022711566
"healthy-5"	"2019-08-29-count-2:TCACTCGCAGGCTATT"	4.48713316497151	-8.3164158097473	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACTCGCAGGCTATT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.44895993254	36.3326073713671	0.0158973610911178	1291	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2281.13015668192	2281.13015668192
"healthy-5"	"2019-08-29-count-2:ATCACTTGTTTGGCTA"	3.97190513190572	-8.40376951610716	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACTTGTTTGGCTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.22750728351	37.5584775758814	0.0166835548403556	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2247.90369205331	2247.90369205331
"healthy-5"	"2019-08-29-count-1:GTTAGTGGTCCATACA"	-3.48819408837016	-5.48901607906493	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTAGTGGTCCATACA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2127.86792701423	46.0276797215762	0.0216308912490453	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2127.86792701423	2127.86792701423
"healthy-5"	"2019-08-29-count-1:GACGCTGGTCAACCAT"	4.58618750151936	-8.73069765484007	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGCTGGTCAACCAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2000.71381073335	41.4150448536929	0.0207001344377746	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1996.84674399937	1996.84674399937
"healthy-5"	"2019-08-29-count-1:TAAGCGTCAGCTGTCG"	2.9387158351833	-7.1122355691162	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGCGTCAGCTGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.52509312703	35.7889662074973	0.0203864737380359	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1755.52509312703	1755.52509312703
"healthy-5"	"2019-08-29-count-1:CGGGTCATCGGCTCTT"	3.94862904128377	-8.14866545116576	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGGTCATCGGCTCTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2113.33564473885	44.2203711469283	0.0209244429568086	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2111.57630241999	2111.57630241999
"healthy-5"	"2019-08-29-count-2:GATTGGTTCTGTCGTC"	-3.51667056503947	-4.52779915249022	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTGGTTCTGTCGTC"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2749.68526819384	42.4404052107401	0.0154346410848023	1861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2744.61700384332	2744.61700384332
"healthy-5"	"2019-08-29-count-1:AAGCATCTCCTTATGT"	4.4258996444637	-7.89513113414916	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCATCTCCTTATGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.53062526704	45.2605252430827	0.0239786971597769	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.03043321919	1881.03043321919
"healthy-5"	"2019-08-29-count-1:TCGAACAGTTTGACAC"	2.50005807456319	-4.57728292858275	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGAACAGTTTGACAC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2527.59741529429	41.6156212223593	0.0164644974593448	1590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2525.12573834697	2525.12573834697
"healthy-5"	"2019-08-29-count-1:AAGCATCCACTTGAGT"	-3.66472635689433	12.1800241240296	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCATCCACTTGAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1591.41831020787	32.8310941712875	0.0206300844728871	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1586.47785897323	1586.47785897323
"healthy-5"	"2019-08-29-count-1:ATCGTGATCGTTCCCA"	3.22955264624898	-8.64928724682006	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTGATCGTTCCCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1828.09409491847	44.2916052048674	0.0242282961954662	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1826.01916819286	1826.01916819286
"healthy-5"	"2019-08-29-count-1:GATCGTATCCAGTGCG"	2.60742344435994	-8.07911875164183	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCGTATCCAGTGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1554.68835742353	46.7962480074938	0.0301000826204461	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1554.68835742353	1554.68835742353
"healthy-5"	"2019-08-29-count-2:CAGCCAGGTAGCTGTT"	-2.15014753761943	10.0728130110535	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCCAGGTAGCTGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1449.48985712483	44.644204823041	0.0307999428927334	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1444.57692448108	1444.57692448108
"healthy-5"	"2019-08-29-count-2:GAATCGTAGCAGATAT"	10.428655286401	6.07618758762208	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAATCGTAGCAGATAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1863.30293295693	37.0082155691738	0.0198616204131898	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1861.55960629219	1861.55960629219
"healthy-5"	"2019-08-29-count-1:CTAGGTACACTTCTCG"	-5.53249297562297	-5.53973820125731	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGGTACACTTCTCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2461.48301433607	48.1884265092915	0.0195769892494218	1382	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2454.32758877418	2454.32758877418
"healthy-5"	"2019-08-29-count-1:GATCCCTTCACCGGTG"	8.52052082595174	6.73653409564821	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCCCTTCACCGGTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1542.77846299926	35.8594650863402	0.0232434312160588	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1542.77846299926	1542.77846299926
"healthy-5"	"2019-08-29-count-2:TCACTATGTGCATTTG"	-2.77785335007365	9.9009217985901	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACTATGTGCATTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1713.90160362922	28.1605683390814	0.0164306797306513	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1709.3051805076	1709.3051805076
"healthy-5"	"2019-08-29-count-1:ATGGATCTCTAACGGT"	4.2834173637325	-7.43289425289305	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGATCTCTAACGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1983.28899796176	40.3540886152747	0.0203470541392338	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1981.30247676571	1981.30247676571
"healthy-5"	"2019-08-29-count-2:GATTGGTCAGTTGGTT"	2.00519599494283	-7.1548266640869	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTGGTCAGTTGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1637.79332439868	51.0254257838607	0.0311549845903754	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1633.36086972096	1633.36086972096
"healthy-5"	"2019-08-29-count-1:CGGGCATAGATAACGT"	6.77983297881429	-1.58359875595244	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGGCATAGATAACGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2345.96686033483	30.694260568984	0.0130838423542791	1286	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2339.91046224879	2339.91046224879
"healthy-5"	"2019-08-29-count-1:GTGGTTAAGGATACGC"	-2.36736498299297	13.0783195265564	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGTTAAGGATACGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1396.04267324746	41.1795346969543	0.029497332342401	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1396.04267324746	1396.04267324746
"healthy-5"	"2019-08-29-count-1:GCGAGAAGTTCGTGCG"	3.78638186034505	-8.19488146221312	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGAGAAGTTCGTGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1676.21298861103	43.8456430167811	0.0261575607125639	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1671.73228992494	1671.73228992494
"healthy-5"	"2019-08-29-count-1:CTCAGAATCGGCTCTT"	-0.920089642435867	9.4672641524109	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGAATCGGCTCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1443.90363584981	38.6135379650267	0.0267424618972585	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1439.18404917311	1439.18404917311
"healthy-5"	"2019-08-29-count-1:CGCAGGTTCGGCATAT"	2.32128681716267	-6.96514465725096	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCAGGTTCGGCATAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1732.91353271772	40.8543349581269	0.0235755184472795	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1728.66023075812	1728.66023075812
"healthy-5"	"2019-08-29-count-2:CTTAGGATCCACCCTA"	5.02175249633138	-10.3579931489197	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTAGGATCCACCCTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.48159815979	44.6628684914529	0.0220287417316095	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2023.85169276489	2023.85169276489
"healthy-5"	"2019-08-29-count-2:AGATGAAGTTAAGACA"	-3.4424286884373	10.9357814558777	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATGAAGTTAAGACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1535.69794414445	43.9963360047956	0.028649081788871	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1535.69794414445	1535.69794414445
"healthy-5"	"2019-08-29-count-1:TCCACGTTCGGCTTCT"	-2.85268459740337	10.232958770636	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTTCGGCTTCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1680.65244511248	37.7441601783769	0.0224580402022685	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1676.30980217903	1676.30980217903
"healthy-5"	"2019-08-29-count-1:ACGGTTAAGTGCCAGA"	-4.0362790626591	13.2351808317932	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGTTAAGTGCCAGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1544.27975740837	36.8187630681086	0.0238420291993584	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1536.94179153177	1536.94179153177
"healthy-5"	"2019-08-29-count-2:TCACATTTCCAGTGTA"	0.496156116097611	8.81877706134645	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACATTTCCAGTGTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1403.14802795595	36.179111167052	0.0257842440328668	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1391.18858401322	1391.18858401322
"healthy-5"	"2019-08-29-count-2:TCAGCAATCGAGCTGC"	-3.36538372460063	12.675302482489	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGCAATCGAGCTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1486.57248263111	37.6274979862749	0.0253115797755635	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1486.57248263111	1486.57248263111
"healthy-5"	"2019-08-29-count-1:GAGACTTCACTGCGTG"	4.96626438674275	-8.98347475444945	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACTTCACTGCGTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.52878798969	44.6800369637852	0.0224463153878368	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.13012610458	1985.13012610458
"healthy-5"	"2019-08-29-count-1:GGGCCATTCATGGAGG"	4.05477442321126	-8.28847601329955	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCCATTCATGGAGG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.55106004984	45.1547269701754	0.0257357725279837	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1754.55106004984	1754.55106004984
"healthy-5"	"2019-08-29-count-1:CTAGGTAGTTGTTGCA"	3.27700676497762	-7.98051359569701	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGGTAGTTGTTGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1607.54740660541	48.1594700043376	0.0299583513409623	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1603.04279052305	1603.04279052305
"healthy-5"	"2019-08-29-count-1:CGCCAGATCTTTACAC"	3.78398313102071	-8.51734449779662	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCCAGATCTTTACAC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2024.29076560554	43.4125801139264	0.0214458223351822	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2018.77858781701	2018.77858781701
"healthy-5"	"2019-08-29-count-1:AACACACTCCCATACC"	-3.72171364250835	9.83547875964967	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACACACTCCCATACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1829.48392184032	40.7552644288895	0.0222769186120493	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1825.34506940934	1825.34506940934
"healthy-5"	"2019-08-29-count-2:GTGTCCTCACCCTAAA"	-5.61762366715129	-5.59063627636107	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTCCTCACCCTAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2536.13121087172	46.1239049859692	0.0181867187266369	1586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2534.86471022101	2534.86471022101
"healthy-5"	"2019-08-29-count-2:GAAGCGAAGGTGCATG"	-2.36737189713176	3.96893045986024	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGCGAAGGTGCATG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3035.39468096006	47.4418560484239	0.0156295510254431	2802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3030.93441799525	3030.93441799525
"healthy-5"	"2019-08-29-count-1:TACCTGCAGTTTGCTG"	-2.73754034462627	12.4480733641419	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTGCAGTTTGCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1517.28809565151	44.2412077687819	0.029158080061114	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1517.28809565151	1517.28809565151
"healthy-5"	"2019-08-29-count-2:GACCCTTTCGGTTCAA"	-3.64599261704143	-5.57680179989012	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCCTTTCGGTTCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2036.30222639998	50.6562428828015	0.024876583753659	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2029.06500484431	2029.06500484431
"healthy-5"	"2019-08-29-count-1:TCAGTCCAGTCCTGTA"	3.72228040274922	-7.09488537227782	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTCCAGTCCTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.43677534196	44.7485059985407	0.0233986851620437	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1908.56271299325	1908.56271299325
"healthy-5"	"2019-08-29-count-2:TATCTGTCATCGATCA"	4.40257324752156	-7.57452299511107	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTGTCATCGATCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.97683438064	41.5364778893966	0.0191679381294671	1077	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2163.51929085745	2163.51929085745
"healthy-5"	"2019-08-29-count-1:ACACCAACATGGTACT"	-2.85133109512981	9.69281575763551	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACCAACATGGTACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1719.11111469754	39.4254302184141	0.0229336137038184	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1716.9090525621	1716.9090525621
"healthy-5"	"2019-08-29-count-1:GAGACTTGTGAGACCA"	2.40553607520406	-6.579710029718	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACTTGTGAGACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.47790861657	47.7562942100342	0.0257241381588115	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.38774573544	1852.38774573544
"healthy-5"	"2019-08-29-count-1:CGGAATTGTCCTACAA"	11.0980545478756	6.2377629050049	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAATTGTCCTACAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1584.43604806043	41.1633227408124	0.0259797943824884	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1582.24719603429	1582.24719603429
"healthy-5"	"2019-08-29-count-2:TATCTTGCACCGGAAA"	3.67403854903523	-7.28099253093871	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTTGCACCGGAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.23100255609	49.6821279113454	0.0272345595715298	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.0151826209	1820.0151826209
"healthy-5"	"2019-08-29-count-1:CTCATTATCCTGTAGA"	3.19531406935994	-7.65005876934203	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCATTATCCTGTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1994.29093937102	40.3651349479253	0.0202403441499143	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1990.35342720254	1990.35342720254
"healthy-5"	"2019-08-29-count-1:GAAGTAATCAAGGTGG"	3.52736534652058	-7.70202877437743	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGTAATCAAGGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.12775859473	48.9766125208863	0.0264577160023069	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1851.12775859473	1851.12775859473
"healthy-5"	"2019-08-29-count-2:GAAGGGTGTGTTACTG"	-3.45142159882243	11.945285774115	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGGTGTGTTACTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1927.60631822458	40.2724532841519	0.0208924679813484	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1927.60631822458	1927.60631822458
"healthy-5"	"2019-08-29-count-2:ATCACTTAGCTTAAGA"	2.76384605941121	-7.13248875057372	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACTTAGCTTAAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1420.71069042108	43.9456266330732	0.030932143278269	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1418.91452232621	1418.91452232621
"healthy-5"	"2019-08-29-count-1:GAGTCTATCTCCTGCA"	2.01335002955739	-6.99688961422118	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTCTATCTCCTGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1758.90750780896	44.8935555517136	0.0255235453555126	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1754.37732387493	1754.37732387493
"healthy-5"	"2019-08-29-count-2:GATCCCTCAAATAAGC"	-1.79926059666331	9.30710599506227	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATCCCTCAAATAAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.49925234032	25.9313868985104	0.0159137151252247	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1627.04029219253	1627.04029219253
"healthy-5"	"2019-08-29-count-2:GCGTGCAGTGTATCCA"	-3.71663580361064	-4.49273111736449	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGTGCAGTGTATCCA"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2487.75060482575	41.6460383951982	0.0167404394614207	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2485.10610910196	2485.10610910196
"healthy-5"	"2019-08-29-count-1:GGTGTTAAGTCACTCA"	3.48533715781514	-6.99040748989256	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGTTAAGTCACTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.61601856913	41.3868805143053	0.0196741611344339	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2098.6134841244	2098.6134841244
"healthy-5"	"2019-08-29-count-1:AGGCATTTCAAGCCGC"	9.22848095473592	7.07351110065309	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGCATTTCAAGCCGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1551.91539492517	35.0388890785012	0.0225778345862666	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1551.91539492517	1551.91539492517
"healthy-5"	"2019-08-29-count-1:ACAGCCGGTATCAAGA"	3.72664799269978	-8.21738245403441	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGCCGGTATCAAGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1935.742461819	41.6037475870289	0.0214923980889143	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1933.7360530417	1933.7360530417
"healthy-5"	"2019-08-29-count-1:CTCTGGTAGTTGGACG"	2.3699447112972	-7.48453190242919	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTGGTAGTTGGACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1670.83506121522	49.8196629417896	0.0298172237932061	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1666.38834529337	1666.38834529337
"healthy-5"	"2019-08-29-count-2:AGTCTCCAGGTATTGA"	10.7605816322262	5.50344560230104	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTCTCCAGGTATTGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1414.25040216107	39.5950450420384	0.0279971955330784	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1406.92442920875	1406.92442920875
"healthy-5"	"2019-08-29-count-2:GTAGATCTCTTGTTAC"	2.83408011969869	-8.21252443706664	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGATCTCTTGTTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1580.43082709245	47.5755731032487	0.0301029138939123	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.73323159049	1575.73323159049
"healthy-5"	"2019-08-29-count-1:GTCTTTACAGCACACC"	-3.96293864670451	10.7921657332214	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTTTACAGCACACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1610.78117459691	35.8988861605032	0.0222866313107284	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1608.43750765127	1608.43750765127
"healthy-5"	"2019-08-29-count-1:CATTCTAGTTGCACGC"	8.68237080153767	6.06533811176149	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTCTAGTTGCACGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1689.55739344396	40.8719813790752	0.0241909399098676	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1683.42187919995	1683.42187919995
"healthy-5"	"2019-08-29-count-2:GATAGCTTCCTCAGGG"	-2.57205853882487	10.3631934889588	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATAGCTTCCTCAGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1650.03974581514	38.5320121974852	0.0233521721493138	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1641.33198402316	1641.33198402316
"healthy-5"	"2019-08-29-count-1:CCTATCGAGCTCAGAG"	-2.45107160034831	3.95607946002809	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTATCGAGCTCAGAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2848.12472460657	49.3686495193601	0.017333738615039	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2842.08629550216	2842.08629550216
"healthy-5"	"2019-08-29-count-2:GCCAGGTCAGAAATCA"	-3.22609100762065	-5.68674566661986	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGGTCAGAAATCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2164.26185634458	50.6888107045067	0.0234208307815948	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2161.07569141748	2161.07569141748
"healthy-5"	"2019-08-29-count-2:AGGATAATCACCATGA"	5.56546988066976	-9.85586359417113	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGATAATCACCATGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.56985485552	42.3310418382394	0.019158046415784	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2199.77602675126	2199.77602675126
"healthy-5"	"2019-08-29-count-1:ACACTGACAACAGCCC"	2.40292658385579	-7.4484524956909	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACTGACAACAGCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1481.14438832353	49.0195291367675	0.0330957126956754	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1481.14438832353	1481.14438832353
"healthy-5"	"2019-08-29-count-2:GATCACAGTAGAAACT"	3.35612716254537	-7.00243284618529	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATCACAGTAGAAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2399.06088115264	50.2292875373458	0.0209370624697165	1374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2393.22645795497	2393.22645795497
"healthy-5"	"2019-08-29-count-1:GTAGAGGGTCGGCTAC"	-5.76850638809856	-5.63197185909423	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGAGGGTCGGCTAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2908.07820541385	52.0037819426394	0.0178825252518402	2132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2891.51430458484	2891.51430458484
"healthy-5"	"2019-08-29-count-1:GAGGCCTTCAATGTCG"	-1.21629867973979	9.58973977649537	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGCCTTCAATGTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1505.98728978278	39.5279586310722	0.0262472060018339	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1505.98728978278	1505.98728978278
"healthy-5"	"2019-08-29-count-1:AGCGCCATCTTTCAGT"	10.1567493873531	5.18899343097535	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCCATCTTTCAGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1399.94900862535	31.3250225500059	0.0223758310888515	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1392.44623958853	1392.44623958853
"healthy-5"	"2019-08-29-count-1:GTAATGCAGCACGATG"	-3.14266691628154	-5.68004753505858	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATGCAGCACGATG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2167.4526617206	46.4212802799898	0.0214174367449109	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2167.4526617206	2167.4526617206
"healthy-5"	"2019-08-29-count-2:GCAGGCTGTGACATCT"	3.76722039756123	-7.60626604473265	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGGCTGTGACATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1898.74110501863	43.2764822475209	0.0227921974897659	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1896.65616340492	1896.65616340492
"healthy-5"	"2019-08-29-count-1:AGTACTGCAACTTCTT"	6.80624641951863	-1.68477942859801	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTACTGCAACTTCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2801.47235675235	37.2188748425103	0.0132854692471986	1841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2796.48162243347	2796.48162243347
"healthy-5"	"2019-08-29-count-1:GAGTTACCAAAGCTCT"	10.975210805505	4.43318555438844	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTTACCAAAGCTCT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1524.15142716992	38.7448869409593	0.0254206283249045	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1524.15142716992	1524.15142716992
"healthy-5"	"2019-08-29-count-2:CAACAGTCACCCTGTT"	-5.49163232269939	-5.53381540691527	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACAGTCACCCTGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2319.88986024668	38.6856399234534	0.016675636454284	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2314.92871941294	2314.92871941294
"healthy-5"	"2019-08-29-count-2:GTGCGTGGTACGTTCA"	-8.11254630509074	4.20544526660768	"2019-08-29-count-2"	"Control5"	"HSC"	"HSC"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCGTGGTACGTTCA"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1899.51941036951	44.1820309398634	0.02325958381824	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1893.79892935377	1893.79892935377
"healthy-5"	"2019-08-29-count-1:AGATGAAAGTATGTAG"	11.0484348731929	4.43261478031007	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAAAGTATGTAG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1443.04896877729	32.3531028788565	0.0224199618854719	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1429.99360684894	1429.99360684894
"healthy-5"	"2019-08-29-count-1:GAATAGAAGGGCAGTT"	-3.59754310074504	11.4015712507996	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATAGAAGGGCAGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1534.53449063625	46.2540434987747	0.0301420683477741	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1529.99573548851	1529.99573548851
"healthy-5"	"2019-08-29-count-1:GTTGCGGCATGACTAC"	-5.47056470337566	-2.91208841716918	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCGGCATGACTAC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2915.52934297466	42.4085986366584	0.0145457629294136	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2913.09786654204	2913.09786654204
"healthy-5"	"2019-08-29-count-1:GCATTAGGTTAGGACG"	-2.992823223502	10.6089963682922	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATTAGGTTAGGACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1467.35465670307	31.4755263002623	0.0214505240137263	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1467.35465670307	1467.35465670307
"healthy-5"	"2019-08-29-count-1:CTCTGGTAGCACGATG"	0.848314364522141	9.03952882373659	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTGGTAGCACGATG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1675.72916187379	41.1772500989341	0.0245727358786846	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1673.64918476946	1673.64918476946
"healthy-5"	"2019-08-29-count-2:CCTGTTGAGGATGGCT"	3.60669793662373	-8.75583174144896	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGTTGAGGATGGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.77747718874	47.773670330091	0.0274912472725657	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1733.42361741541	1733.42361741541
"healthy-5"	"2019-08-29-count-1:GTTTGGAGTAACCCGC"	-3.82365355911906	-5.49237921154173	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTTGGAGTAACCCGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2383.31623322212	45.3108665130496	0.0190116887895282	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2380.39045748264	2380.39045748264
"healthy-5"	"2019-08-29-count-2:TATCGCCAGTCTTCCC"	3.71278061446492	-7.34595062648924	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCGCCAGTCTTCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.04982614934	46.0925139807827	0.0224726446881679	985	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2045.60701845146	2045.60701845146
"healthy-5"	"2019-08-29-count-1:TATATCCAGGGTACAC"	4.92113842543904	-9.50603773510131	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATATCCAGGGTACAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2203.41902768702	43.3520353638053	0.0196748937987129	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2198.48908046485	2198.48908046485
"healthy-5"	"2019-08-29-count-1:TCCCACAAGCGTACAG"	-4.69095883789714	-4.94294073497923	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCACAAGCGTACAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2660.33728607846	45.9482026730773	0.017271570380765	1705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2654.11231537179	2654.11231537179
"healthy-5"	"2019-08-29-count-2:GGAGAACGTCACCCTT"	-2.61837397041972	12.0804738768372	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGAACGTCACCCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1474.22027424838	44.147033606452	0.0299460225704466	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1474.22027424838	1474.22027424838
"healthy-5"	"2019-08-29-count-1:AAGCGTTCACTAGAGG"	4.01522626456563	-8.35031893169554	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCGTTCACTAGAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.2882783379	43.7087021123636	0.0202515588631301	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2154.86337772549	2154.86337772549
"healthy-5"	"2019-08-29-count-2:GAATCACGTTCAGCGC"	-7.26693473282512	0.0563245430118366	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAATCACGTTCAGCGC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2278.33049235271	48.8995735077573	0.0214628973592243	1552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2268.37179673812	2268.37179673812
"healthy-5"	"2019-08-29-count-2:GTGATGTAGGCATCTT"	5.47572578963582	-10.0152693024841	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGATGTAGGCATCTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.52801876791	36.3723621782288	0.0171363401833171	1071	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2122.52801876791	2122.52801876791
"healthy-5"	"2019-08-29-count-2:GTCTCACTCTTCCTAA"	-3.43072114411052	-5.29815008556517	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACTCTTCCTAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2192.67837702429	51.4448349559329	0.0234620979962183	1236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2189.75682911314	2189.75682911314
"healthy-5"	"2019-08-29-count-1:CAATCGAGTAACACGG"	3.50724615630452	-8.23390295421752	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATCGAGTAACACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1750.30894207385	47.0340064527227	0.0268718312076922	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.15455801851	1748.15455801851
"healthy-5"	"2019-08-29-count-1:GCAACATTCCCGAGAC"	4.86962666091268	-7.93897964870604	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAACATTCCCGAGAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2454.84041831579	36.9286684802392	0.015043205336164	1412	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2451.99503068528	2451.99503068528
"healthy-5"	"2019-08-29-count-2:TACTTGTGTCAGTCCG"	3.10342897948567	-7.756223701593	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTGTGTCAGTCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.1295048331	50.9089439820086	0.0265963947859669	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1914.1295048331	1914.1295048331
"healthy-5"	"2019-08-29-count-2:GTAAGTCGTTGACGGA"	14.3056522804195	2.0521464117798	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAAGTCGTTGACGGA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1300.48262597596	37.4788448183279	0.0288191814867204	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1287.24242175008	1287.24242175008
"healthy-5"	"2019-08-29-count-1:GCATCTCCAGCTCGGT"	3.64207615432088	-7.23135664379271	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATCTCCAGCTCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.02849813667	42.0840532800425	0.0178169117405828	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2350.73686058538	2350.73686058538
"healthy-5"	"2019-08-29-count-1:CCGCAAGGTATCGTAC"	3.81691755828206	-8.24260713970336	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGCAAGGTATCGTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.18665437662	44.5501692950252	0.0256450100988208	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1734.91358464083	1734.91358464083
"healthy-5"	"2019-08-29-count-2:TCACTCGGTGGTCAAG"	-3.3533185524052	12.7074575194153	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACTCGGTGGTCAAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1626.27427194172	34.1387850201988	0.0209920218312488	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1623.76561386791	1623.76561386791
"healthy-5"	"2019-08-29-count-1:GTGGTTAAGACTGTTC"	6.52010788497273	-0.378413551208101	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGTTAAGACTGTTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1540.07709287579	50.1479312194625	0.0325619616390899	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1530.12106226073	1530.12106226073
"healthy-5"	"2019-08-29-count-1:TCATTCATCTACGCGG"	3.9988337951595	-7.86728432094725	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTCATCTACGCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.68931730484	45.0299502657907	0.0246376393621389	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1823.52497547221	1823.52497547221
"healthy-5"	"2019-08-29-count-1:TACCGAAGTACTAACC"	4.06496347960774	-8.10916044628295	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCGAAGTACTAACC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.28922824431	42.6977553137143	0.0198382981029664	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2143.79905548118	2143.79905548118
"healthy-5"	"2019-08-29-count-1:GCAGTTACAGCGTTGC"	-3.4506438774174	12.225975013617	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGTTACAGCGTTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1672.43149058306	33.400840724496	0.0199714253842777	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1670.16805926599	1670.16805926599
"healthy-5"	"2019-08-29-count-1:CCTCATGCATGAAAGT"	-2.03666649285014	9.99731156909791	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCATGCATGAAAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1784.84583230331	38.5606908558455	0.0216044938772576	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1780.69923246151	1780.69923246151
"healthy-5"	"2019-08-29-count-2:CCACGTTAGAATTCAG"	-3.79493484917338	12.7595023878845	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACGTTAGAATTCAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1648.15341314953	42.0027927532612	0.0254847591359813	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1643.23591351314	1643.23591351314
"healthy-5"	"2019-08-29-count-2:AGGATAATCTTGGCTC"	0.823411603539628	8.69015500629274	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGATAATCTTGGCTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1678.4588636687	39.6890700418259	0.0236461380739921	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1673.21018130539	1673.21018130539
"healthy-5"	"2019-08-29-count-1:GGAGATGTCTTTACAC"	-3.22442017021831	10.3751525648865	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGATGTCTTTACAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2053.9294595186	42.9746799812045	0.0209231528288595	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2052.19512045469	2052.19512045469
"healthy-5"	"2019-08-29-count-1:CTTCTAACACGGATCC"	1.86437787589375	-6.81238891994628	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTAACACGGATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.14635914134	46.7924387797611	0.0253597437124372	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1836.88122604201	1836.88122604201
"healthy-5"	"2019-08-29-count-1:ATGAGTCTCTTCCTAA"	3.40505709227864	-7.97477915203246	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAGTCTCTTCCTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1917.44717477748	42.1971257590111	0.0220069300026	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1913.66759601447	1913.66759601447
"healthy-5"	"2019-08-29-count-1:CTTACCGTCACTTGTT"	-3.90473614159282	12.5858821638855	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTACCGTCACTTGTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1683.1643752571	35.3226751655276	0.0209858738010256	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1680.83844527031	1680.83844527031
"healthy-5"	"2019-08-29-count-2:GTATTTCAGATAGCTA"	-3.26223431053813	12.1563987501892	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTATTTCAGATAGCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1513.36922302139	43.7606670858779	0.0289160546020034	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1510.96226383617	1510.96226383617
"healthy-5"	"2019-08-29-count-1:CTACATTTCGTGGGTC"	3.06834973868672	-7.1270585290161	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACATTTCGTGGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1983.76367660999	44.6005539795994	0.0224827959627814	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1978.35358424947	1978.35358424947
"healthy-5"	"2019-08-29-count-1:CGAATTGTCCTGCTAC"	-2.8261424106663	10.9512157210144	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAATTGTCCTGCTAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1655.96824394849	44.1780986758888	0.0266781074077547	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1649.24936252535	1649.24936252535
"healthy-5"	"2019-08-29-count-1:ATTTACCCAATACGCT"	-1.50121567669566	9.71968362415162	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTACCCAATACGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1634.26156293228	40.5356911831085	0.0248036740889733	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1634.26156293228	1634.26156293228
"healthy-5"	"2019-08-29-count-1:CCTCCTCCAAATCAGA"	3.77653374251668	-7.77718593990477	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCCTCCAAATCAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2018.42398387678	38.8953959406769	0.0192701812163223	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2008.94723654635	2008.94723654635
"healthy-5"	"2019-08-29-count-1:GCTGGGTTCCATCGTC"	3.33892478522603	-7.98608305370482	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTTCCATCGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1580.33097938667	46.0128925571552	0.0291159846622845	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.32930696527	1575.32930696527
"healthy-5"	"2019-08-29-count-2:GCCTGTTAGATACGAT"	3.11172546920125	-8.5213079682556	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCTGTTAGATACGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1747.03415294731	45.8559796664335	0.0262479011008874	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1747.03415294731	1747.03415294731
"healthy-5"	"2019-08-29-count-2:TCGGATATCAAATGCC"	6.80547918853108	-1.50491156494292	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGATATCAAATGCC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2199.10783340761	37.3092018704853	0.0169656081906057	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2193.6935683252	2193.6935683252
"healthy-5"	"2019-08-29-count-1:AGCTTCCCAGCCATTA"	-3.08132634583171	13.5753621825012	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTTCCCAGCCATTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1786.9856536072	34.7048655051518	0.01942089766367	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1782.4753282212	1782.4753282212
"healthy-5"	"2019-08-29-count-2:GCCGTGAGTTGTGGAG"	3.13316216048543	-7.69921257412108	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCGTGAGTTGTGGAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1478.6669630997	39.9825128627225	0.0270395659472285	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1476.15826239361	1476.15826239361
"healthy-5"	"2019-08-29-count-1:ATTATCCTCCGTATAG"	0.441759397357148	8.68026635730592	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTATCCTCCGTATAG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1594.53381552455	39.463239074902	0.0247490763072465	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1594.53381552455	1594.53381552455
"healthy-5"	"2019-08-29-count-1:GGATCTACAACCACGC"	9.26122726973836	6.29055783832399	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGATCTACAACCACGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1650.03782354825	44.6342739973983	0.0270504550625492	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1645.64797597169	1645.64797597169
"healthy-5"	"2019-08-29-count-1:CGGTCAGTCGTTGTAG"	-2.25639758530315	3.53883740985719	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGTCAGTCGTTGTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2964.10422697726	42.5428174521048	0.0143526725763923	3384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2952.17962699049	2952.17962699049
"healthy-5"	"2019-08-29-count-1:CCACGTTCAATTGTGC"	-3.23304090920146	12.4172248610291	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACGTTCAATTGTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1509.79495635341	36.727512420381	0.0243261591687181	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1509.79495635341	1509.79495635341
"healthy-5"	"2019-08-29-count-1:GGAGATGGTCAAATCC"	4.69019951400105	-8.1515045396057	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGATGGTCAAATCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2482.88531708463	34.3361356368113	0.0138291267021259	1443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2480.08796686233	2480.08796686233
"healthy-5"	"2019-08-29-count-1:CGGTCAGTCCACAGCG"	6.66253199157063	-1.32660033619078	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGTCAGTCCACAGCG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2247.32114352244	37.8000550295724	0.0168200504580866	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2241.99064844653	2241.99064844653
"healthy-5"	"2019-08-29-count-1:GAGATGGCACATATGC"	4.46056236800496	-7.78822472011717	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGATGGCACATATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.1826931325	45.7350650807135	0.022177988998269	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2053.95197875014	2053.95197875014
"healthy-5"	"2019-08-29-count-2:CGTTGGGTCGGTGTAT"	3.45369233664815	-8.30920126354369	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTTGGGTCGGTGTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1648.86668205928	50.3262391530874	0.0305217151275291	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1646.49705550838	1646.49705550838
"healthy-5"	"2019-08-29-count-1:GCCAGCACACCCAAGC"	2.60455669936482	-7.10044052517089	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGCACACCCAAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1709.63916272151	48.3081423522777	0.0282563381827179	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1705.40982297034	1705.40982297034
"healthy-5"	"2019-08-29-count-1:AGGTTGTAGTCTTCGA"	-2.53473244133647	3.61566994273988	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTTGTAGTCTTCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3225.03384994022	43.3725185330063	0.0134487017969781	3574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3216.20921022349	3216.20921022349
"healthy-5"	"2019-08-29-count-2:GGTAGAGGTGGCTTGC"	-1.2928331893986	9.23512837970582	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTAGAGGTGGCTTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1394.73306806535	31.98924774191	0.0229357491224344	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1384.50063976932	1384.50063976932
"healthy-5"	"2019-08-29-count-2:GTAATCGGTATCACCA"	6.81356443938558	-1.48051776802214	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATCGGTATCACCA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1987.00348374888	28.8575453687553	0.0145231478478889	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1983.06017457582	1983.06017457582
"healthy-5"	"2019-08-29-count-2:CTACGGGGTCGGCACT"	5.0636064010555	-10.1337633362976	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACGGGGTCGGCACT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.12786932728	35.4880246294139	0.0163831623847927	1059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2160.75743427643	2160.75743427643
"healthy-5"	"2019-08-29-count-1:TACGCTCTCGACATAC"	2.70189752158467	-7.92461016094359	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGCTCTCGACATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1739.40807448509	42.7772062169763	0.0245929674838605	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1737.28446436848	1737.28446436848
"healthy-5"	"2019-08-29-count-1:AATCGTGCATGGCCAC"	2.70119251784627	-4.86101105129393	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCGTGCATGGCCAC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2392.13785058631	42.5563769324337	0.0177901022393017	1397	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2387.9886046414	2387.9886046414
"healthy-5"	"2019-08-29-count-1:GAATCACTCCTAACAG"	4.10825171050374	-7.38960459148558	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATCACTCCTAACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2249.6129408546	33.6967025957789	0.0149788890274511	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2244.84977198081	2244.84977198081
"healthy-5"	"2019-08-29-count-2:GTCTTTAGTGCGAGTA"	-3.78691730919536	12.7266101607117	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTTTAGTGCGAGTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1504.34975845128	43.4460803174696	0.0288803053102472	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1499.11184035458	1499.11184035458
"healthy-5"	"2019-08-29-count-2:CATACAGCAGTTTCGA"	2.35028304633443	-7.32860710537108	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATACAGCAGTTTCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1672.74465504306	46.7217721934212	0.0279312039961165	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1670.62537054098	1670.62537054098
"healthy-5"	"2019-08-29-count-1:TCACAAGTCGCGTGCA"	3.07472838935201	-8.25020220195922	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACAAGTCGCGTGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1688.12589865671	46.8287029219844	0.0277400536057455	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1688.12589865671	1688.12589865671
"healthy-5"	"2019-08-29-count-1:AATCGTGTCGAAGGAC"	2.46703209456746	-7.04512789165648	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCGTGTCGAAGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1797.7317129033	49.2198205243778	0.0273788464491673	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1797.7317129033	1797.7317129033
"healthy-5"	"2019-08-29-count-1:GTCAAACTCCGCCTAT"	-3.76188884201701	-5.52369167720946	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAACTCCGCCTAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2356.46756248386	45.8237088325177	0.0194459323616646	1226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2354.81193631256	2354.81193631256
"healthy-5"	"2019-08-29-count-1:GAGGGATGTGAAAGTT"	3.68114461478536	-7.22272016918334	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGGATGTGAAAGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1774.69922637337	37.8372466831295	0.0213203714301778	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1770.65629823841	1770.65629823841
"healthy-5"	"2019-08-29-count-2:TAAGCACCACTCCGAG"	6.82694830474202	-1.61499216472777	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCACCACTCCGAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1971.59294059342	36.653237010184	0.0185906716622509	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1957.9086470248	1957.9086470248
"healthy-5"	"2019-08-29-count-2:GGAAGTGCACTCTGCT"	-2.16842232170756	4.20470473850099	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAAGTGCACTCTGCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3234.32296124779	45.2739409763515	0.0139979654223786	4220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3223.61648819031	3223.61648819031
"healthy-5"	"2019-08-29-count-2:TAGTGCAAGGACAACC"	-3.99746022644694	12.3472203978333	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGTGCAAGGACAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1629.67343344438	34.7002644644894	0.0212927717617321	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1627.35396471509	1627.35396471509
"healthy-5"	"2019-08-29-count-1:GCTACCTCAAGCTACT"	3.94667543944661	-8.24576666271361	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTACCTCAAGCTACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2078.8631258382	45.8568938568166	0.0220586402668175	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2074.69070429295	2074.69070429295
"healthy-5"	"2019-08-29-count-1:CCGATCTGTACTCGAT"	-1.62809107723888	11.3657407530579	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATCTGTACTCGAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1429.94971803094	44.4824991202356	0.0311077365583795	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1429.94971803094	1429.94971803094
"healthy-5"	"2019-08-29-count-1:GGCAGTCGTTGGGTAG"	-2.99811182442363	12.7987746962341	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCAGTCGTTGGGTAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1459.50092262114	42.4739422320918	0.029101689196477	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1452.60127092817	1452.60127092817
"healthy-5"	"2019-08-29-count-1:GGTCTGGCAACTACGT"	3.26353849944417	-7.92993881618651	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTCTGGCAACTACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1516.01327337404	48.8577471925279	0.0322277832593048	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1516.01327337404	1516.01327337404
"healthy-5"	"2019-08-29-count-2:GTAATGCGTGCGTGCT"	-3.38469896736797	12.382146812323	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCGTGCGTGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1477.4319384653	40.0952459146189	0.0271384724201024	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1472.30886340745	1472.30886340745
"healthy-5"	"2019-08-29-count-1:GCGGAAATCACACCCT"	-4.03537116470988	13.0517596968445	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGGAAATCACACCCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1688.01288821483	48.3288813686696	0.0286306352908122	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1688.01288821483	1688.01288821483
"healthy-5"	"2019-08-29-count-1:ATGATCGCATCATCCC"	5.21331038054768	-9.78576280986937	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGATCGCATCATCCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2644.5690358031	44.9918322150978	0.0170129165115308	1702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2635.71557351538	2635.71557351538
"healthy-5"	"2019-08-29-count-1:GCCGTGACAAGAAACT"	3.06642665442769	-7.30946495449217	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCGTGACAAGAAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1860.96814676307	47.0789061300159	0.0252980719803851	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1859.1178646268	1859.1178646268
"healthy-5"	"2019-08-29-count-2:TCGCTCAGTGGCAGAT"	2.15646495398824	-7.20387651836547	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTCAGTGGCAGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1484.87158908773	50.7496910877462	0.0341778315786388	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1480.02957795685	1480.02957795685
"healthy-5"	"2019-08-29-count-1:ACCAAACTCTGGCCAG"	2.4106580215389	-6.6217980614868	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCAAACTCTGGCCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.09999871766	41.4043297774726	0.0183115871924967	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2256.21796083562	2256.21796083562
"healthy-5"	"2019-08-29-count-1:GACTTCCAGAAGCGCT"	-1.66316817227061	9.45651719653932	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTTCCAGAAGCGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1418.22907759185	40.9385248013153	0.0288659465865901	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1415.68601718018	1415.68601718018
"healthy-5"	"2019-08-29-count-2:GGTTAACGTCATGACT"	14.1059662300045	1.85645077312318	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTAACGTCATGACT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1137.86079435829	22.2404038822653	0.019545803838692	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1134.57960768399	1134.57960768399
"healthy-5"	"2019-08-29-count-2:GGTAATCGTACAGAAT"	4.18361296233479	-8.03927423870238	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTAATCGTACAGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1907.97392564221	43.3797394747506	0.0227360232190538	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1907.97392564221	1907.97392564221
"healthy-5"	"2019-08-29-count-1:TCCACCACATCGTCCT"	-3.63873205605205	-5.58276274120482	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACCACATCGTCCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2190.91385083687	46.4972994111411	0.0212227876478942	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2189.02638086786	2189.02638086786
"healthy-5"	"2019-08-29-count-2:GTCATTTAGGGAACAA"	1.65050651606862	-5.90638592159423	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCATTTAGGGAACAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2112.60265149936	44.763110848179	0.0211886086654344	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2109.15498253996	2109.15498253996
"healthy-5"	"2019-08-29-count-2:CCTATCGAGCCTCTGG"	4.04487266120259	-8.5920734635559	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTATCGAGCCTCTGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1924.39449568512	43.9208036588717	0.0228231808796747	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1915.05831300758	1915.05831300758
"healthy-5"	"2019-08-29-count-2:TACTTACCAAAGGGTC"	-3.32917128029521	10.8674335249695	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTACCAAAGGGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1657.17126378834	40.5053328320107	0.0244424542695813	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1650.31470413184	1650.31470413184
"healthy-5"	"2019-08-29-count-1:ACCCTTGCAAGAGGTC"	-2.47790799561198	3.52619168842164	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCCTTGCAAGAGGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2916.93207760937	42.1898411338558	0.0144637722138642	2851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2911.60573653458	2911.60573653458
"healthy-5"	"2019-08-29-count-2:GCGTGCACATTGCCTC"	-3.43511662903484	-5.5664592019287	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGTGCACATTGCCTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1899.18498016789	53.2051836342782	0.0280147453722885	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1897.24224656855	1897.24224656855
"healthy-5"	"2019-08-29-count-2:AGGGTGAAGGTCCTGC"	3.05308737334554	-6.71104051983031	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTGAAGGTCCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.22178792536	42.122118691034	0.0196170320774047	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2142.05156747844	2142.05156747844
"healthy-5"	"2019-08-29-count-1:CTTTCAAGTCCTACAA"	-2.41719112816508	9.96237180316774	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTTCAAGTCCTACAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1744.3532275575	33.7144543924037	0.0193277679427416	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1733.63543411248	1733.63543411248
"healthy-5"	"2019-08-29-count-2:GTCAAGTTCCCGGTAG"	5.00992455062215	-10.3673143616882	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCAAGTTCCCGGTAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1913.78254814364	50.5334037932284	0.0264049872553419	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1913.78254814364	1913.78254814364
"healthy-5"	"2019-08-29-count-1:GACATCAGTATCCTCC"	4.13046087798421	-7.54982187664183	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCAGTATCCTCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.79774971645	48.3372818708228	0.0247148673107077	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1951.92782798215	1951.92782798215
"healthy-5"	"2019-08-29-count-2:TCCCAGTAGTTGTCAC"	3.106297870248	-7.88199427044066	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCAGTAGTTGTCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1792.57553001678	42.9428908651577	0.0239559729261481	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1788.22400421937	1788.22400421937
"healthy-5"	"2019-08-29-count-1:GCGTTTCCAGGTCTCG"	4.29191937026326	-8.55184461986693	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGTTTCCAGGTCTCG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1939.40152299789	41.9447049194204	0.0216276539035522	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1935.51665510516	1935.51665510516
"healthy-5"	"2019-08-29-count-1:ACGTTCCAGGAAGTGA"	-2.24724111977275	4.26843020999757	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTTCCAGGAAGTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2934.97515753969	45.170199755836	0.0153903175772366	2903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2930.22183455444	2930.22183455444
"healthy-5"	"2019-08-29-count-1:GATGATCTCGACCTAA"	3.07864441451375	-7.20203306591185	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGATCTCGACCTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1657.61381302207	48.8817181098765	0.0294892077550669	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1655.45756529271	1655.45756529271
"healthy-5"	"2019-08-29-count-2:TAAGTCGGTCATAGTC"	4.28373779830281	-7.67218878185423	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGTCGGTCATAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.81937964501	42.216631004852	0.0212912136315766	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1975.7651470452	1975.7651470452
"healthy-5"	"2019-08-29-count-2:GTGTTAGGTGCCAAGA"	-2.21799788895305	4.19787261569826	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTTAGGTGCCAAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3130.81132664937	47.8131016663768	0.0152717927328911	3656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3123.88920402008	3123.88920402008
"healthy-5"	"2019-08-29-count-2:TATTGCTGTTTCCCAC"	-1.52129612389262	9.28363702380983	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTGCTGTTTCCCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1710.72732202266	48.6176201610695	0.0284192691232563	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1699.99121458682	1699.99121458682
"healthy-5"	"2019-08-29-count-1:GCTACAAAGCTTGTTG"	3.50556530532185	-8.11108972942504	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTACAAAGCTTGTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1723.95104828031	44.9995212902964	0.0261025516560836	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1721.71892129373	1721.71892129373
"healthy-5"	"2019-08-29-count-1:CCATAAGAGCACCCAC"	2.34338297423665	-7.13179352199706	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATAAGAGCACCCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1929.82055612219	47.2034044526961	0.0244599967095114	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1924.16820259647	1924.16820259647
"healthy-5"	"2019-08-29-count-2:GTTGCTCTCCATCACC"	8.37892689284627	6.01099250400392	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGCTCTCCATCACC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1556.19893530031	48.0295344577251	0.0308633641678058	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1551.78996582609	1551.78996582609
"healthy-5"	"2019-08-29-count-2:GTGCACGCACTTGAGT"	4.03553905066792	-8.20740511333617	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCACGCACTTGAGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1976.46794896601	42.1862643988167	0.0213442694180224	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1970.90476034257	1970.90476034257
"healthy-5"	"2019-08-29-count-2:CAAGGGAGTTAGCTAC"	3.36594810065572	-6.64255049144896	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAGGGAGTTAGCTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1998.57790206616	39.7653318189183	0.0198968135181562	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1992.71773361121	1992.71773361121
"healthy-5"	"2019-08-29-count-2:CATCCACTCGGTCAGC"	-3.01058493080791	12.7583732374939	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCACTCGGTCAGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1524.04215763841	45.0528504277431	0.0295614200709218	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1524.04215763841	1524.04215763841
"healthy-5"	"2019-08-29-count-1:GTCAAGTAGATTAGTG"	-2.74319539490398	12.4274787672791	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAGTAGATTAGTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1568.27999273864	35.5422609078117	0.0226632113349514	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1566.13678280139	1566.13678280139
"healthy-5"	"2019-08-29-count-2:CTGTCGTTCGACCATA"	9.65128769454305	5.51648662174074	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTCGTTCGACCATA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1435.84474987885	42.833822073098	0.0298317921047608	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1431.11709044926	1431.11709044926
"healthy-5"	"2019-08-29-count-1:AATCACGCACACTTAG"	4.56502546843831	-8.28556444561156	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCACGCACACTTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2314.57331697645	41.4728796051674	0.0179181533378013	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2311.60856352735	2311.60856352735
"healthy-5"	"2019-08-29-count-2:CAGTTAGTCCATAGAC"	3.57712497290913	-7.67091848766478	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTTAGTCCATAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1572.94085721765	44.2154221677151	0.0281100347573952	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1568.22098724915	1568.22098724915
"healthy-5"	"2019-08-29-count-1:CCTTGTGTCTGTCAGA"	5.14318861541097	-10.0705890885559	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTGTGTCTGTCAGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.69246503468	40.9567510338944	0.0186193077827581	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2191.41009094775	2191.41009094775
"healthy-5"	"2019-08-29-count-2:GCACGTGAGGATACCG"	4.56669535216634	-8.04911329662474	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACGTGAGGATACCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.4766464172	39.0720992154983	0.0173539882270927	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2245.45202638862	2245.45202638862
"healthy-5"	"2019-08-29-count-2:TCCGAAAAGGTCGTCC"	-3.43388448181804	11.7261485823425	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGAAAAGGTCGTCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.12467247082	45.368721569749	0.026027238490888	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1734.74047836447	1734.74047836447
"healthy-5"	"2019-08-29-count-2:GTGCGTGGTACCTATG"	-2.91388330879863	11.0422887572083	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCGTGGTACCTATG"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1849.81597908287	38.3138409053144	0.0207122445359729	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1844.53785169485	1844.53785169485
"healthy-5"	"2019-08-29-count-1:CCGATCTTCCACTTCG"	3.42179193076436	-7.52332403576048	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATCTTCCACTTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.31343591539	45.3263711882189	0.026089921513982	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1730.7219026093	1730.7219026093
"healthy-5"	"2019-08-29-count-2:AGGGCTCTCGACCAAT"	10.7357918220455	7.2195162543091	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGCTCTCGACCAAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2278.28545892302	38.2470841990634	0.0167876611112391	1232	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2268.77445681341	2268.77445681341
"healthy-5"	"2019-08-29-count-1:GCTGGGTTCGTGGACC"	3.61898459967915	-7.86694910442504	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTTCGTGGACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1822.31704195108	49.9841122037143	0.0274288782100169	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1818.20161053108	1818.20161053108
"healthy-5"	"2019-08-29-count-2:GAAGCGAAGCGATGCA"	-3.19637880745586	10.8497943648132	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGCGAAGCGATGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1665.42080773748	29.209144217557	0.017538596901067	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1656.35091806724	1656.35091806724
"healthy-5"	"2019-08-29-count-1:ACGGAAGTCCCATAAG"	-3.34643087807353	10.9341115721497	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGAAGTCCCATAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1696.10933156678	35.1434007565278	0.0207200090834144	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1687.33645126538	1687.33645126538
"healthy-5"	"2019-08-29-count-1:CAATACGCAACCCTCT"	-3.5572272342747	12.3024472960266	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATACGCAACCCTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1689.97965716041	42.450188060454	0.0251187568327188	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1683.03637605171	1683.03637605171
"healthy-5"	"2019-08-29-count-2:TCAGTTTCAGAGGTAC"	3.49452342566792	-8.28360273754271	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGTTTCAGAGGTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1408.72802195818	49.8979930103083	0.0354206008772002	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1408.72802195818	1408.72802195818
"healthy-5"	"2019-08-29-count-1:AATTTCCAGATGAAGG"	-2.51579056206401	12.1732225188049	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATTTCCAGATGAAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1391.35007926362	46.5747372944158	0.0334744921415218	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1388.85661112358	1388.85661112358
"healthy-5"	"2019-08-29-count-2:GAACGTTAGAAAGTCT"	5.38796438750569	-9.6101055375305	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAACGTTAGAAAGTCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.30735253897	40.445984267672	0.0190396103555029	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2116.22878109672	2116.22878109672
"healthy-5"	"2019-08-29-count-1:ACATCGAGTCGCTTAA"	3.65586342391316	-10.6056537858215	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCGAGTCGCTTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.26592022231	36.5599129498933	0.017945577249878	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2035.58979879225	2035.58979879225
"healthy-5"	"2019-08-29-count-1:CATCGTCTCGTGGCTG"	2.66272201117818	-7.05240776455077	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCGTCTCGTGGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1978.68333816695	45.0675635592003	0.0227765416981531	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1976.97022265504	1976.97022265504
"healthy-5"	"2019-08-29-count-2:AGCCAATTCCGCACTT"	2.45527400550191	-7.45367958461913	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAATTCCGCACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1759.35590053231	40.1343811421501	0.0228119740468697	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1759.35590053231	1759.35590053231
"healthy-5"	"2019-08-29-count-1:CACAGATAGGTTCACT"	3.86644067344014	-7.90910150921019	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAGATAGGTTCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.20789900838	45.0425921889434	0.0239434419835715	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1877.36072704131	1877.36072704131
"healthy-5"	"2019-08-29-count-1:GACATCATCCTGTTGC"	3.02093114432637	-7.98895456707152	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCATCCTGTTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1448.92565011821	39.1963337117322	0.0270519979465713	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1440.88365130187	1440.88365130187
"healthy-5"	"2019-08-29-count-2:AGGGAGTCATCGGATT"	2.19914044913594	-6.68508579647215	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGAGTCATCGGATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.93235284287	45.7346533348834	0.0243667030756927	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1876.93235284287	1876.93235284287
"healthy-5"	"2019-08-29-count-1:AAGAACAAGGAAAGGT"	-5.61556420746501	-5.49691250240477	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACAAGGAAAGGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2529.32936371154	46.8407443210545	0.0185190370985613	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2524.90476142303	2524.90476142303
"healthy-5"	"2019-08-29-count-1:GTGGGAACAATGGCAG"	3.99206556853597	-8.30230905925902	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGGAACAATGGCAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.85746427622	45.1631400179418	0.0243092599332083	801	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1855.79776842975	1855.79776842975
"healthy-5"	"2019-08-29-count-1:GTAGGTTTCCGCGAGT"	-3.90982971611674	12.9489402540955	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGTTTCCGCGAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.1970918244	34.2328265437798	0.0212864621617645	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1608.1970918244	1608.1970918244
"healthy-5"	"2019-08-29-count-2:GCAGCCATCCGATGCG"	-3.7674552005833	12.9698991545471	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGCCATCCGATGCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1589.26451673482	43.3537835251146	0.0272791489828176	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1584.46484461375	1584.46484461375
"healthy-5"	"2019-08-29-count-1:CCGCAAGTCGATACGT"	3.08374609526936	-7.59162094509276	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGCAAGTCGATACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.14622679632	45.7732156420118	0.0263496618395952	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.90560980962	1732.90560980962
"healthy-5"	"2019-08-29-count-1:GACCTTCCACTCCGAG"	-2.15634212914165	9.05455873096315	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACCTTCCACTCCGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1594.59100790297	42.8126719669537	0.0268486851830779	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1592.24156364055	1592.24156364055
"healthy-5"	"2019-08-29-count-1:CTGTAGAAGATTCGCT"	-2.46029148522075	4.18541953647462	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTAGAAGATTCGCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3254.77116635783	46.6472382427956	0.0143319563368859	4155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3247.3271431189	3247.3271431189
"healthy-5"	"2019-08-29-count-1:CGCCAGAGTTCTCCCA"	4.38428415831868	-8.05534841930541	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCCAGAGTTCTCCCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1953.64758329141	39.2299938860032	0.0200803841089447	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1947.94640572758	1947.94640572758
"healthy-5"	"2019-08-29-count-1:ACAACCAAGGTAACTA"	-2.47037420693095	9.94362065875856	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAACCAAGGTAACTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1784.17825454238	39.0408571347026	0.021881702142321	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1784.17825454238	1784.17825454238
"healthy-5"	"2019-08-29-count-1:GATTGGTCACTAAACC"	-4.1431454223698	13.165594077948	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTGGTCACTAAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1713.80550224657	39.0518791802795	0.0227866459344935	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1706.98945057104	1706.98945057104
"healthy-5"	"2019-08-29-count-1:CTCAAGAGTACGAGTG"	-3.16999540749248	3.05545065486757	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAAGAGTACGAGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3122.91397784631	46.0828079603924	0.0147563488098936	3514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3118.05017703372	3118.05017703372
"healthy-5"	"2019-08-29-count-1:TCACTATAGTTCACTG"	5.16020836409871	-9.26439859783324	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACTATAGTTCACTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.63700927027	43.7541620442398	0.0202787409820329	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2154.32248232266	2154.32248232266
"healthy-5"	"2019-08-29-count-1:AGGTCATGTGGACAGT"	-7.91050277176555	-0.776400529500566	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTCATGTGGACAGT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3089.59440867696	43.1846714821034	0.0139774565104149	3056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3086.20497608093	3086.20497608093
"healthy-5"	"2019-08-29-count-2:CTGTCGTTCGGTGAAG"	4.23659863051717	-7.9737119904724	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTCGTTCGGTGAAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.34312691418	46.4740254709341	0.0215522404068598	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2147.09809037493	2147.09809037493
"healthy-5"	"2019-08-29-count-1:TAGGAGGTCCCGTTCA"	6.83063044127767	-1.55126717006835	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGAGGTCCCGTTCA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2096.86057380702	36.7546424026955	0.0175284150323664	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2090.18387685802	2090.18387685802
"healthy-5"	"2019-08-29-count-1:GTCTACCTCCCGAATA"	2.62898506697957	-7.15698006069335	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTACCTCCCGAATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1704.60596047608	47.1068278997737	0.0276350247459051	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1702.40796674727	1702.40796674727
"healthy-5"	"2019-08-29-count-1:CTTCTCTTCAGACTGT"	-0.78727231445964	9.25099370563356	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTCTTCAGACTGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1465.68119795148	50.0566653061426	0.0341524919444315	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1463.3431042302	1463.3431042302
"healthy-5"	"2019-08-29-count-1:TACCTCGCAAGGTCGA"	-3.28144965592082	12.4125795134339	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTCGCAAGGTCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1531.11785070553	45.7670912056796	0.029891292289872	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1526.1161951404	1526.1161951404
"healthy-5"	"2019-08-29-count-2:GTGGAAGTCTAGACCA"	-3.27347598496135	3.69233915889589	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAAGTCTAGACCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2920.0429452677	47.5320863805016	0.0162778723708613	3161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2914.58857938607	2914.58857938607
"healthy-5"	"2019-08-29-count-1:CATACAGAGTTGGACG"	4.96544231948201	-8.95203211223754	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACAGAGTTGGACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.34989908305	42.3004381898667	0.0214249957464542	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1970.67891262402	1970.67891262402
"healthy-5"	"2019-08-29-count-1:GTATTGGCACAAATGA"	-3.84212432327922	12.7579021223816	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTATTGGCACAAATGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1752.33899360331	41.2267126876556	0.023526676538129	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1745.38711524452	1745.38711524452
"healthy-5"	"2019-08-29-count-2:TGCGATATCGCCTAGG"	2.59492744979207	-8.33137895977172	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCGATATCGCCTAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1829.30370965474	51.4147690967626	0.0281061962676863	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1821.34285797841	1821.34285797841
"healthy-5"	"2019-08-29-count-1:GTGAGCCCAGCACGAA"	11.1585060554439	4.16716430270997	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGAGCCCAGCACGAA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1564.63476605021	36.6179880080716	0.0234035372360481	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1557.46313900469	1557.46313900469
"healthy-5"	"2019-08-29-count-2:GGGATCCGTTCGAGCC"	-3.77282391014751	13.1092262038025	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATCCGTTCGAGCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1467.36054274267	38.8834440319223	0.0264989025527732	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1459.59225434729	1459.59225434729
"healthy-5"	"2019-08-29-count-2:GCAACATAGGAGTACC"	2.01367654380147	-6.77928783809813	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAACATAGGAGTACC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1881.49455043212	45.9397490006413	0.0244166261284628	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1879.65964720721	1879.65964720721
"healthy-5"	"2019-08-29-count-1:GATGAGGTCAACTCTT"	1.92399646815602	-6.93356373226317	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGAGGTCAACTCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1952.01562730162	47.6330588896257	0.0244019864510366	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1948.18807382089	1948.18807382089
"healthy-5"	"2019-08-29-count-1:ACACCAACAATCAAGA"	-2.20724735680278	9.26319692218629	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACCAACAATCAAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1544.44124483553	42.7938949543981	0.0277083347116616	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1544.44124483553	1544.44124483553
"healthy-5"	"2019-08-29-count-1:CTACCCATCTTGCGCT"	4.64779581603352	-8.14377024089965	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACCCATCTTGCGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2394.42870604221	41.3231890635013	0.0172580578236573	1403	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2389.87336497049	2389.87336497049
"healthy-5"	"2019-08-29-count-1:TATTCCATCGAGGCAA"	-3.12078462067302	11.6007900007996	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTCCATCGAGGCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1657.40918270879	46.3305190850239	0.0279535793383885	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1650.58833583526	1650.58833583526
"healthy-5"	"2019-08-29-count-2:GCCATTCGTCAGACTT"	-7.56357131424602	-0.640029572602831	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATTCGTCAGACTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2489.52118175698	42.2461847373601	0.0169696024468226	1818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2482.1588970396	2482.1588970396
"healthy-5"	"2019-08-29-count-1:CGAGGAATCTGAATGC"	-3.30115542832072	12.3297948607239	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGAATCTGAATGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1524.2582214501	41.9410225080447	0.0275156938095069	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1524.2582214501	1524.2582214501
"healthy-5"	"2019-08-29-count-1:GCGAGAACAACGACTT"	3.21113194999043	-6.79257013713988	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGAGAACAACGACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2157.30979905392	41.9629229137286	0.0194515052646269	1125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2155.69016722646	2155.69016722646
"healthy-5"	"2019-08-29-count-1:GAGGCAATCGCTGCGA"	2.97569026526753	-7.08961775219115	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGCAATCGCTGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.13466615863	48.1685999395855	0.0305418433651629	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1577.13466615863	1577.13466615863
"healthy-5"	"2019-08-29-count-2:GGTAGAGCAGCCTACG"	-5.00640473786052	-4.5054559937683	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTAGAGCAGCCTACG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2518.63795754679	47.8361707744792	0.0189928729657806	1450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2509.92518733997	2509.92518733997
"healthy-5"	"2019-08-29-count-1:AAGATAGCAATAGTAG"	2.53506316718404	-8.11538412487181	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGATAGCAATAGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1981.46262566828	48.5108898685089	0.0244823643101256	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1973.71002043203	1973.71002043203
"healthy-5"	"2019-08-29-count-1:ATCACAGCACTACCCT"	2.72148718413655	-6.86538221752318	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACAGCACTACCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1905.63543341447	44.6810589732992	0.02344680319742	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1898.4576827717	1898.4576827717
"healthy-5"	"2019-08-29-count-1:AGGAATAAGTCCCGGT"	3.62513174590413	-7.6574073067871	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAATAAGTCCCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1727.62552186512	45.6261222368669	0.026409729226279	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1723.44435510061	1723.44435510061
"healthy-5"	"2019-08-29-count-1:CTCAGAACAATTCTCT"	3.84249844130818	-7.13771345531615	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGAACAATTCTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.92570336316	44.3831228099022	0.022092963784375	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2007.00474592094	2007.00474592094
"healthy-5"	"2019-08-29-count-1:ATTCACTTCAAGGTGG"	1.79680528220479	-7.46890833294066	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCACTTCAAGGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1705.37387929455	45.5092652222112	0.0266857993867225	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1699.2887610562	1699.2887610562
"healthy-5"	"2019-08-29-count-1:AACCATGCAGTTCACA"	-1.09639189663585	9.53082845294801	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCATGCAGTTCACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1651.55123671941	40.3910038679833	0.0244564037554261	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1644.86258736741	1644.86258736741
"healthy-5"	"2019-08-29-count-2:AGATGAAGTCCAGCCA"	-6.46334681931193	3.45305368984071	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATGAAGTCCAGCCA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2632.78177568507	45.6751748821161	0.0173486368311825	1852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2621.35215969569	2621.35215969569
"healthy-5"	"2019-08-29-count-1:AGGACGAGTACCTAGT"	-7.67603288117107	-0.0467630109754429	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGACGAGTACCTAGT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2337.6490117997	50.1136836538959	0.0214376424351723	1517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2335.21041481177	2335.21041481177
"healthy-5"	"2019-08-29-count-2:TCACATTAGTGCAAAT"	2.11533250388448	-6.40947391903075	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACATTAGTGCAAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.58623248603	48.9415378165713	0.0238438400501668	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2047.25423172794	2047.25423172794
"healthy-5"	"2019-08-29-count-1:CTCAGAAGTCGTGGAA"	0.274154623120469	8.55314538562623	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGAAGTCGTGGAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1403.32732201886	44.785518084368	0.0319138075498583	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1403.32732201886	1403.32732201886
"healthy-5"	"2019-08-29-count-2:GTAATGCCACAAGCAG"	-3.01647530022319	3.44822738254396	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCCACAAGCAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3099.96657934833	47.9038093360092	0.0154530083179411	3262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3095.62739559789	3095.62739559789
"healthy-5"	"2019-08-29-count-1:CTATAGGTCTCATGGA"	-5.57648454132732	-5.37433292781981	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATAGGTCTCATGGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2515.62140257438	43.875354086475	0.0174411594851176	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2514.18937257119	2514.18937257119
"healthy-5"	"2019-08-29-count-1:CCTTTGGAGAAATCCA"	3.73914064940755	-7.8150902024475	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTTGGAGAAATCCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.57022944625	41.0744667436342	0.0198564526158872	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2059.24256875264	2059.24256875264
"healthy-5"	"2019-08-29-count-1:CATCGGGCACTTGAGT"	2.90021361884419	-7.18922617351683	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCGGGCACTTGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1725.66853799382	43.2880441662965	0.025084796537243	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1719.5188773666	1719.5188773666
"healthy-5"	"2019-08-29-count-2:GAGGCCTAGTCCCGGT"	2.41164578971211	-4.31478454982909	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	45	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGCCTAGTCCCGGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1940.01769551388	28.049016756559	0.0144581241817639	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1933.47924573798	1933.47924573798
"healthy-5"	"2019-08-29-count-1:CACTAAGTCCCTCGAT"	-2.13501677933391	12.4668397673401	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTAAGTCCCTCGAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1737.45244290569	40.8696776748916	0.0235227604886508	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1737.45244290569	1737.45244290569
"healthy-5"	"2019-08-29-count-2:TCCTGCAAGTCGCTAT"	2.55770458754842	-6.5787883034912	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTGCAAGTCGCTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.95364795768	44.2507450585715	0.0223946270725067	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1972.40427838434	1972.40427838434
"healthy-5"	"2019-08-29-count-1:ATCGGATTCTCAGAAC"	-3.17448530617412	10.4842805632385	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGGATTCTCAGAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1605.71825232461	43.1496685139522	0.026872502975839	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1601.13690237781	1601.13690237781
"healthy-5"	"2019-08-29-count-1:CTGCCTATCACTACGA"	4.88927378234212	-8.21340658580931	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCCTATCACTACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2302.81790413899	50.3915738239681	0.0218825699302564	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2297.9291915114	2297.9291915114
"healthy-5"	"2019-08-29-count-2:CTCATTAAGCAGCCCT"	2.11874498900716	-7.07831432735594	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATTAAGCAGCCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1734.41795945656	50.4248538068268	0.0290730694593512	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.17153308109	1732.17153308109
"healthy-5"	"2019-08-29-count-2:GGTCTGGTCTACTATC"	-3.46947870674785	10.6293601759705	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTCTGGTCTACTATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1582.51968013411	42.7965858078878	0.0270433198051988	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1577.7700211195	1577.7700211195
"healthy-5"	"2019-08-29-count-1:TCAGGTATCATCACAG"	-2.87075887146648	12.739496208075	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGGTATCATCACAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1539.77280013304	43.8641924845145	0.0284874446936097	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1539.77280013304	1539.77280013304
"healthy-5"	"2019-08-29-count-1:AGATGAAAGGTCGTAG"	-3.4584940475529	-5.63361170208129	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAAAGGTCGTAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2053.47540487571	48.9167074034304	0.0238214235667416	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2047.91302169685	2047.91302169685
"healthy-5"	"2019-08-29-count-1:CCTCACAAGGTCATTC"	0.7273192006046	8.44225881183473	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCACAAGGTCATTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1449.61953627132	40.864652704127	0.0281899158238707	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1445.11936998457	1445.11936998457
"healthy-5"	"2019-08-29-count-2:TCCTCCCAGTGTTCAC"	5.4068714576656	-9.82080366527709	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCCCAGTGTTCAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.00888409537	37.9912483113298	0.01646061614976	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2301.02168396175	2301.02168396175
"healthy-5"	"2019-08-29-count-1:AGCTTCCTCAACACCA"	3.46726455268208	-7.43425657665404	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTTCCTCAACACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1867.88774903526	48.1352658424951	0.0257698921508299	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1863.56336579732	1863.56336579732
"healthy-5"	"2019-08-29-count-1:AACCTGATCTTGTTAC"	0.446849335997742	8.29179952228395	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCTGATCTTGTTAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1451.52325063746	40.7243158022631	0.0280562614373407	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1446.97464512878	1446.97464512878
"healthy-5"	"2019-08-29-count-2:GTGGAGATCTGTAAGC"	2.70060076293294	-7.7318153611389	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAGATCTGTAAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1633.18217828013	49.3487592202482	0.0302163223898368	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1631.29602022651	1631.29602022651
"healthy-5"	"2019-08-29-count-1:GATGTTGTCCAACTAG"	3.68451847609822	-7.069456123468	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGTTGTCCAACTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1633.65892751075	40.1633730220236	0.0245849193767891	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1631.39958131246	1631.39958131246
"healthy-5"	"2019-08-29-count-2:ATAGACCTCACCTCGT"	-3.7747953933781	11.803400970343	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGACCTCACCTCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1726.37177761004	34.020302517168	0.0197062434397909	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1721.72164752845	1721.72164752845
"healthy-5"	"2019-08-29-count-2:GTTGCGGAGCAGGTCA"	3.26362170752828	-5.74464609539183	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGCGGAGCAGGTCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2325.86550619835	43.7015125108803	0.0187893549280547	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2324.32364524404	2324.32364524404
"healthy-5"	"2019-08-29-count-2:GATCCCTAGGGACACT"	-2.58988938751872	3.44063613498536	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATCCCTAGGGACACT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3056.92083882446	51.5533896586474	0.0168644830457803	3094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3052.96776824236	3052.96776824236
"healthy-5"	"2019-08-29-count-1:GATGATCGTCGACTGC"	3.02217449721639	-8.30702021038207	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGATCGTCGACTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1570.53589468793	49.1106368278499	0.0312699868840681	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1570.53589468793	1570.53589468793
"healthy-5"	"2019-08-29-count-1:GTAGAGGAGGCTCACC"	-7.16329751434978	3.60571739757387	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGAGGAGGCTCACC"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2377.29595131678	37.9405345729931	0.0159595335835144	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2370.66154489478	2370.66154489478
"healthy-5"	"2019-08-29-count-1:GGTGTCGAGCAATAAC"	2.22004761275594	-8.51469328319701	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGTCGAGCAATAAC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2429.55175606703	51.9373931355564	0.021377356134052	1416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2413.78168140041	2413.78168140041
"healthy-5"	"2019-08-29-count-2:GCCAGCACATGGGATG"	11.1021992164547	4.29453084552614	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGCACATGGGATG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1558.97161872038	31.612277063447	0.0202776475747485	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1551.64329476599	1551.64329476599
"healthy-5"	"2019-08-29-count-1:CTTCAATCAAGCAGGT"	-1.81427596035655	3.39607403362123	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCAATCAAGCAGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3104.34052358217	46.2457662546229	0.0148971306154451	3354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3097.4295876629	3097.4295876629
"healthy-5"	"2019-08-29-count-2:TCACTCGAGCGCTGCT"	-2.42661915245708	9.2534141310486	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACTCGAGCGCTGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2002.89676749642	41.9894568635938	0.0209643639877055	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1999.39752703953	1999.39752703953
"healthy-5"	"2019-08-29-count-2:GTAGAAATCATGTCAG"	-5.54329047623332	-5.53393127834471	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGAAATCATGTCAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2222.17117069949	48.7848578181051	0.0219536903643425	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2220.41693898187	2220.41693898187
"healthy-5"	"2019-08-29-count-1:GTCTGTCTCCATTTGT"	3.16614331778828	-8.88653566753539	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTGTCTCCATTTGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1764.02746070175	42.2546807990771	0.0239535277882056	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.02746070175	1764.02746070175
"healthy-5"	"2019-08-29-count-2:AGTGTTGAGTTACTCG"	2.77159514006917	-7.21707394039305	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGTTGAGTTACTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1538.40152481595	43.7684475958477	0.0284506007630771	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1536.09211747192	1536.09211747192
"healthy-5"	"2019-08-29-count-1:GCACGTGGTCTGCAAT"	6.70720400389974	-1.49196281349333	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACGTGGTCTGCAAT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2187.72143698775	41.1437639238205	0.0188066740254055	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2184.03664294016	2184.03664294016
"healthy-5"	"2019-08-29-count-1:CTTCCGACAACAGAGC"	10.0804840522701	6.03740356052247	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGACAACAGAGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1395.83439575962	50.9873502469585	0.0365282231200579	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1395.83439575962	1395.83439575962
"healthy-5"	"2019-08-29-count-1:AATGGAATCACATACG"	2.13726462897603	-6.8343920937744	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGGAATCACATACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.76675440578	48.8671207730832	0.0246210899414795	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.76675440578	1984.76675440578
"healthy-5"	"2019-08-29-count-1:ATGGGAGCAGGACAGT"	-3.43000398102458	10.0483417280945	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGAGCAGGACAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1873.42358509026	35.5596939137552	0.0189811285588368	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1866.91206314342	1866.91206314342
"healthy-5"	"2019-08-29-count-1:ATTCCTATCTCAATCT"	-3.28410993042644	12.7495021590027	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCTATCTCAATCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1592.24657508409	40.4740337166702	0.0254194509506373	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1584.92527300371	1584.92527300371
"healthy-5"	"2019-08-29-count-2:GAAACCTGTCATACCA"	1.84113087233846	-7.36459305202635	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAACCTGTCATACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1781.43801870724	50.7539682740987	0.0284904485820562	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1781.43801870724	1781.43801870724
"healthy-5"	"2019-08-29-count-1:GGAATGGCATACCAGT"	3.66466989096944	-8.25241663372191	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAATGGCATACCAGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2059.40594838344	43.1937321396189	0.0209738794692345	997	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2057.61202468593	2057.61202468593
"healthy-5"	"2019-08-29-count-1:CACTAAGGTACCTGTA"	-2.84407911720927	3.5011107691559	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTAAGGTACCTGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3067.44371802017	44.2461738658865	0.014424445216698	3357	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3060.41277791465	3060.41277791465
"healthy-5"	"2019-08-29-count-1:CTGGACGGTGTCCGTG"	3.52388705787007	-8.13921358501586	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGACGGTGTCCGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1712.53115859238	45.1236806829179	0.0263491151425282	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1712.53115859238	1712.53115859238
"healthy-5"	"2019-08-29-count-1:CGATGGCTCTTCGCTG"	-3.56326446953471	11.3966512450012	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATGGCTCTTCGCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1607.72610213111	41.8175752392453	0.0260103852166201	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1600.87964246084	1600.87964246084
"healthy-5"	"2019-08-29-count-1:CTCAGTCAGTGTAGTA"	-1.69072852554973	3.41689727390138	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGTCAGTGTAGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2483.84818661588	37.7389539798339	0.0151937442003054	2395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2479.92261905239	2479.92261905239
"healthy-5"	"2019-08-29-count-2:GGGACAACAGCGTAGA"	3.90075935897176	-7.64259865200194	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACAACAGCGTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1830.30721355584	45.7087805778447	0.0249732833041966	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1826.28219508444	1826.28219508444
"healthy-5"	"2019-08-29-count-2:CTCAACCGTCGCTCGA"	3.83548297461812	-7.36490299617919	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAACCGTCGCTCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.1671402472	37.8537162655426	0.0208886451060905	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1803.08360136438	1803.08360136438
"healthy-5"	"2019-08-29-count-2:GAGTGAGGTGATGGCA"	-3.50252018395122	13.208825088385	"2019-08-29-count-2"	"Control5"	"NK"	"IFN+ NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTGAGGTGATGGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.75061484316	36.8774098869861	0.0229230121478967	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1606.27419552731	1606.27419552731
"healthy-5"	"2019-08-29-count-1:CTTCCTTGTCCTCATC"	4.28566374358479	-6.88728668605956	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCTTGTCCTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.07648071015	33.582851265368	0.0187920615753517	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1787.07648071015	1787.07648071015
"healthy-5"	"2019-08-29-count-1:CGCAGGTGTAGTGGCA"	3.87933077391927	-7.57719185268553	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCAGGTGTAGTGGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1864.01996193809	47.4247919231453	0.0254422124717141	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1861.99496768823	1861.99496768823
"healthy-5"	"2019-08-29-count-2:CATTCTAGTCTCCCTA"	-7.2470682663029	-0.492690168973528	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCTAGTCTCCCTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2260.89341155082	52.1534927860108	0.0230676477358731	1273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2253.60799978399	2253.60799978399
"healthy-5"	"2019-08-29-count-1:CGCAGGTTCGTTAGTG"	-0.730010251433212	8.88931081378785	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCAGGTTCGTTAGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1440.54263690275	44.3195490474895	0.0307658710767347	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1435.59938880443	1435.59938880443
"healthy-5"	"2019-08-29-count-1:AAGACAAGTCGATTTG"	-3.13008079949077	11.016577697638	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGACAAGTCGATTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1658.88043838995	37.5716035516942	0.02264877123282	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1652.43395851188	1652.43395851188
"healthy-5"	"2019-08-29-count-1:GGAGAACTCGTCCTCA"	-3.00222359123881	10.1378755339417	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGAACTCGTCCTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1589.247047222	37.2590729137876	0.0234444814473095	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1584.49908937385	1584.49908937385
"healthy-5"	"2019-08-29-count-1:GCTGGGTTCAGCGCAC"	-4.10127959671672	12.2606801756653	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTTCAGCGCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1824.81936746064	39.9603552509982	0.0218982524865492	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1820.38756166802	1820.38756166802
"healthy-5"	"2019-08-29-count-2:GAGGGATGTGCCTAAT"	3.34465255317037	-7.68783428585204	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGGATGTGCCTAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1712.93632566984	43.5745419677177	0.0254385065660149	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1706.26579864553	1706.26579864553
"healthy-5"	"2019-08-29-count-2:GTGTCCTTCGCCGAGT"	3.94678725776021	-8.42059137737425	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTCCTTCGCCGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1537.13853105811	45.6244358123609	0.0296814079476329	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1532.24946713516	1532.24946713516
"healthy-5"	"2019-08-29-count-1:CTCCACATCGACATAC"	-2.04158840599712	9.81831739032594	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCACATCGACATAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1656.6637421956	40.3052022151352	0.0243291388521113	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1656.6637421956	1656.6637421956
"healthy-5"	"2019-08-29-count-1:CTATCTACATCCGGTG"	-3.52528486672099	12.4303378828797	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATCTACATCCGGTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1605.44714200786	40.0647008423711	0.0249554780061235	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1595.75330560173	1595.75330560173
"healthy-5"	"2019-08-29-count-1:ATATCCTAGGCATGGT"	-3.53584490242656	12.4607658156189	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATATCCTAGGCATGGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1514.43779893451	48.5675126945362	0.0320696648807275	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1512.03037395624	1512.03037395624
"healthy-5"	"2019-08-29-count-2:CAAGAGGCACGGGCTT"	6.84518923339192	-1.52290930664214	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAGAGGCACGGGCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1979.0489831004	37.0177882150512	0.0187048367833012	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1974.98384754114	1974.98384754114
"healthy-5"	"2019-08-29-count-1:ATTCTTGCAGGAGACT"	-3.99947534027751	-5.36837580120238	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCTTGCAGGAGACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2235.926696936	47.6726800494392	0.0213212177817669	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2235.926696936	2235.926696936
"healthy-5"	"2019-08-29-count-1:CGGTCAGTCAAGTTGC"	-2.87411175194438	3.24815223300783	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGTCAGTCAAGTTGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2999.7988304559	46.6541290786815	0.0155524192505906	3226	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2995.79290215998	2995.79290215998
"healthy-5"	"2019-08-29-count-2:GCACTAATCAAACCTG"	-3.86467299881633	-5.39257957851561	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACTAATCAAACCTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2289.61562964065	51.5885256592763	0.0225315223181687	1230	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2283.34369278995	2283.34369278995
"healthy-5"	"2019-08-29-count-2:GCCATTCGTATCAAGA"	4.22655643996541	-8.15963556682738	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATTCGTATCAAGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.96047981207	42.9912337674971	0.0234162087039574	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1830.04504376883	1830.04504376883
"healthy-5"	"2019-08-29-count-1:GGTTGTATCCATCAGA"	2.65811743315999	-6.90202286159667	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTGTATCCATCAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.2662540703	42.4335567127218	0.0211821851571173	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1999.7167539599	1999.7167539599
"healthy-5"	"2019-08-29-count-2:GAGTTACGTGATCGTT"	3.38392748412434	-8.30958464061888	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTACGTGATCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1750.69785211542	42.0695129892171	0.02403013914616	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.49858391187	1748.49858391187
"healthy-5"	"2019-08-29-count-1:CGTAAGTAGGAAGTAG"	3.18901409682576	-7.5297799340454	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAAGTAGGAAGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1632.75432512724	47.6631695843421	0.0291918807690972	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1630.51074019193	1630.51074019193
"healthy-5"	"2019-08-29-count-2:GATGCTACACACCGCA"	4.60073008117024	-8.36487677013548	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGCTACACACCGCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.81682702722	40.5212515031193	0.0170557136569414	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2373.01419143022	2373.01419143022
"healthy-5"	"2019-08-29-count-1:ACATCGATCAGATGCT"	2.36623611029927	-7.12753631984862	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCGATCAGATGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1735.03784649634	51.5236588846718	0.0296959855882778	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1726.69550363618	1726.69550363618
"healthy-5"	"2019-08-29-count-1:AAGAACAAGGCGCTTC"	-5.54821477356608	-5.55620100414427	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACAAGGCGCTTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2355.34205105379	52.1001702355361	0.0221200017263846	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2347.22807143907	2347.22807143907
"healthy-5"	"2019-08-29-count-2:GTAGTACAGTCTCTGA"	3.00822391089742	-6.91799356853636	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGTACAGTCTCTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.94087830895	45.4807922614588	0.019215009837488	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2359.2632410376	2359.2632410376
"healthy-5"	"2019-08-29-count-1:GACCTTCCAAGTATCC"	-3.49581656876262	12.5466813811096	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACCTTCCAAGTATCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1742.46105079512	38.0300753115105	0.0218254952064245	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1735.90802270749	1735.90802270749
"healthy-5"	"2019-08-29-count-1:CAGATCAGTTCTCCCA"	-3.93009219589885	3.658247209433	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATCAGTTCTCCCA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2914.54106769671	45.7429111569416	0.0156947217741869	2939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2907.85054729904	2907.85054729904
"healthy-5"	"2019-08-29-count-2:TACTTGTGTCTTGAGT"	3.24847163733785	-7.74278261577757	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTGTGTCTTGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1630.19049111317	50.0778252133474	0.0307190021573196	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1630.19049111317	1630.19049111317
"healthy-5"	"2019-08-29-count-2:AGCGTATGTATGAGGC"	-2.75788937035258	11.6628083952698	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCGTATGTATGAGGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1491.3136168182	44.7486772583667	0.0300062151607256	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1489.39121261317	1489.39121261317
"healthy-5"	"2019-08-29-count-1:AGGGCTCTCCTATTGT"	9.13189949569051	5.6758184202942	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCTCTCCTATTGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1563.14476864538	45.3206718013485	0.0289932658256749	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1560.87917547329	1560.87917547329
"healthy-5"	"2019-08-29-count-1:CGTAATGCAATCCAGT"	10.4601942497188	6.15859696948854	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAATGCAATCCAGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1404.83414136441	39.8456262628956	0.0283632245897702	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1402.41433223936	1402.41433223936
"healthy-5"	"2019-08-29-count-1:CTGTAGAGTTCGGGTC"	3.75553788718526	-8.19389250194701	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTAGAGTTCGGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1898.04469380038	42.6423521697608	0.0224664636765638	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1893.9726833463	1893.9726833463
"healthy-5"	"2019-08-29-count-1:GGGTTATCAAAGGCGT"	-4.11896548691447	3.58176539028016	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTTATCAAAGGCGT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2690.44092816706	43.4995046378158	0.0161681693816081	2024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2685.38061188578	2685.38061188578
"healthy-5"	"2019-08-29-count-1:TAACACGCAAGAGATT"	-2.87155232849773	3.79213926875917	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACACGCAAGAGATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3092.18360617792	48.5144185523613	0.0156893718909296	3645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3085.0323245883	3085.0323245883
"healthy-5"	"2019-08-29-count-1:CTACTATAGGATTCAA"	-3.85688767853435	12.4435214766297	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACTATAGGATTCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1601.40745726779	40.8735889816127	0.0255235410551593	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1601.40745726779	1601.40745726779
"healthy-5"	"2019-08-29-count-1:CGGGTCATCAGCTGTA"	-3.282946686179	3.05099937999574	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGGTCATCAGCTGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2959.14746596528	44.359184651477	0.0149905285767862	3153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2953.58518293545	2953.58518293545
"healthy-5"	"2019-08-29-count-2:GTAGATCGTGGGATTG"	2.56929387625996	-4.53834202205809	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGATCGTGGGATTG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2245.61430587715	37.3408795250675	0.0166283584083608	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2242.85253710127	2242.85253710127
"healthy-5"	"2019-08-29-count-1:TACCTCGCAAGTCCAT"	3.73604430732076	-8.21737768566283	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTCGCAAGTCCAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1746.09913290774	48.0517829805107	0.0275195045200504	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.09913290774	1746.09913290774
"healthy-5"	"2019-08-29-count-1:TACCTCGAGGATTTAG"	3.1477288204128	-6.26660253917845	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTCGAGGATTTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.43092502659	49.8891465655395	0.0273450454501654	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1822.3918422096	1822.3918422096
"healthy-5"	"2019-08-29-count-2:TCAATCTGTGTCTTCC"	1.95296706733052	-6.66572620784911	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAATCTGTGTCTTCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2088.49284030778	48.9414483409542	0.023433859765467	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2085.02265048654	2085.02265048654
"healthy-5"	"2019-08-29-count-1:CGTAGTAGTCGTGCCA"	3.18916239318196	-7.30402090465697	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAGTAGTCGTGCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1760.37958550566	53.0692292555369	0.0301464693708619	784	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1756.56268342899	1756.56268342899
"healthy-5"	"2019-08-29-count-2:GCCGATGCACACAGCC"	-3.57011924210246	12.6395272978577	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCGATGCACACAGCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1433.79824579421	52.1733315165392	0.0363881959470801	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1426.4787083585	1426.4787083585
"healthy-5"	"2019-08-29-count-1:AGGGTGACAGAGGCTA"	4.15371622618977	-8.28863527691039	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGTGACAGAGGCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1498.74531748005	45.5561149876405	0.0303961683524973	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1493.90968366521	1493.90968366521
"healthy-5"	"2019-08-29-count-2:GATGTTGAGTTGAATG"	14.1202684837276	2.32700417125551	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGTTGAGTTGAATG"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1156.97751561667	43.5947311307128	0.037679842989409	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1138.4943588822	1138.4943588822
"healthy-5"	"2019-08-29-count-1:CTCAATTCAAATAGCA"	-2.44575891915019	10.4607095488342	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAATTCAAATAGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1454.53450592887	44.6972034425506	0.0307295586734856	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1452.05549056367	1452.05549056367
"healthy-5"	"2019-08-29-count-2:CTACCTGAGACTCCGC"	5.52798094329183	-10.1037826768127	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACCTGAGACTCCGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2369.31104276741	41.7603869715734	0.0176255401750866	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2361.34231601656	2361.34231601656
"healthy-5"	"2019-08-29-count-2:CTGTGGGTCGTGTGGC"	-2.26230917397197	10.213011718634	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTGGGTCGTGTGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1485.50385529776	40.1755544320906	0.0270450691116097	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1485.50385529776	1485.50385529776
"healthy-5"	"2019-08-29-count-1:CCTCACACAAGAGTTA"	9.87454189833943	5.83295390689699	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCACACAAGAGTTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1682.86788654515	40.4549198519571	0.0240392725866373	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1676.7663724968	1676.7663724968
"healthy-5"	"2019-08-29-count-1:TAACCAGGTCGAAGCA"	-3.64138565483745	-4.94824840938719	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACCAGGTCGAAGCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2921.73393626971	41.4088774581086	0.0141727064686037	2437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2918.32425439467	2918.32425439467
"healthy-5"	"2019-08-29-count-1:GGAGGTAGTTCCAAAC"	4.92101587828938	-9.16768362438353	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTAGTTCCAAAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.17542402998	40.018429155244	0.0179119458234212	1261	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2231.30725537805	2231.30725537805
"healthy-5"	"2019-08-29-count-1:GGAGGTAGTTCGGACC"	-2.85076175156291	3.3581926592621	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTAGTTCGGACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2952.9939037752	49.1318962692346	0.0166379944795764	3196	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2949.0185777541	2949.0185777541
"healthy-5"	"2019-08-29-count-2:TCAAGACGTAGAATGT"	4.06798519667928	-8.02616884624632	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGACGTAGAATGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.3565727366	44.3705037048323	0.0213900080092289	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.84270004756	2070.84270004756
"healthy-5"	"2019-08-29-count-1:ATACTTCTCTTGAACG"	-0.512597302824813	9.90680978381959	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATACTTCTCTTGAACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1549.39348988511	42.4783463045691	0.0274161125510596	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1544.70480835768	1544.70480835768
"healthy-5"	"2019-08-29-count-2:CTCGAGGTCGTAGGAG"	2.84471621093099	-7.65569212352904	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCGAGGTCGTAGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1612.82800736366	47.9554257939153	0.0297337506386087	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1612.82800736366	1612.82800736366
"healthy-5"	"2019-08-29-count-1:GTGCACGGTATAATGG"	4.10088219222371	-7.6726751557556	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCACGGTATAATGG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1829.64035149084	43.1384671080617	0.0235775665271655	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1829.64035149084	1829.64035149084
"healthy-5"	"2019-08-29-count-2:AGCTTCCGTTATCTTC"	3.76649798926656	-7.50779440319213	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTTCCGTTATCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1867.89035273371	44.4522277788583	0.0237980927059242	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1865.77302485912	1865.77302485912
"healthy-5"	"2019-08-29-count-1:CGAGGAATCAGCCCAG"	3.78931560096089	-7.48381616985472	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGAATCAGCCCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.71778243345	43.7641288977042	0.020491531820201	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2126.54620560533	2126.54620560533
"healthy-5"	"2019-08-29-count-2:CGGAATTAGAGGTCAC"	2.30208196219746	-6.909694694635	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAATTAGAGGTCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1422.01696507566	49.7315204376906	0.0349725225922635	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1412.04688340727	1412.04688340727
"healthy-5"	"2019-08-29-count-1:GTCGTAACATCGATAC"	3.43099226531331	-7.32554771816405	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCGTAACATCGATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1826.59411598247	40.7456059841012	0.0223068746513428	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1824.6080032521	1824.6080032521
"healthy-5"	"2019-08-29-count-1:CAGCAGCAGGGTAATT"	3.75947680053059	-8.19408609783324	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCAGCAGGGTAATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.30799349799	48.8032532887652	0.0231480663353144	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2103.25481663485	2103.25481663485
"healthy-5"	"2019-08-29-count-2:CTACGGGCATCGTGGC"	3.96969165381734	-8.38416674053343	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACGGGCATCGTGGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1932.36139178179	40.8410503954261	0.0211353065576245	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1928.70948504583	1928.70948504583
"healthy-5"	"2019-08-29-count-1:CTCCTCCCATTGCCTC"	9.24462189254109	5.26820418918458	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCTCCCATTGCCTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1564.47466138263	44.1767664267304	0.0282374445027371	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1558.21472246452	1558.21472246452
"healthy-5"	"2019-08-29-count-2:GCCTGTTGTCTGTGGC"	2.22805060920064	-6.65745117580565	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCTGTTGTCTGTGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1797.16514917494	42.6282833643292	0.0237197362656956	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1797.16514917494	1797.16514917494
"healthy-5"	"2019-08-29-count-1:CCTCTAGTCCGCAACG"	-1.77579842034038	10.9975785979065	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTAGTCCGCAACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.44551098592	36.3977040811281	0.0230738265300708	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1577.44551098592	1577.44551098592
"healthy-5"	"2019-08-29-count-2:GATAGCTGTATTCTCT"	-3.08676753464397	-5.76665403759154	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATAGCTGTATTCTCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1931.40470518509	47.160883907385	0.0244179191345946	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1922.95928350566	1922.95928350566
"healthy-5"	"2019-08-29-count-1:CTCCTCCGTTTATGCG"	3.03899731215779	-7.3335376015869	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCTCCGTTTATGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1960.85949579105	38.6129340688479	0.0196918413337263	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1960.85949579105	1960.85949579105
"healthy-5"	"2019-08-29-count-1:CAGCAGCTCCCGTTCA"	3.93064179000203	-8.26595213329466	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCAGCTCCCGTTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.78323456463	45.6743129351226	0.0218769420977016	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2080.74463012183	2080.74463012183
"healthy-5"	"2019-08-29-count-1:AAGCATCCAATTTCCT"	2.82243718680684	-6.91999008571776	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCATCCAATTTCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.68610174253	43.1767652834054	0.0206420864236924	1046	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2090.25487823666	2090.25487823666
"healthy-5"	"2019-08-29-count-1:CTCCTTTCAGTTCACA"	-2.53430209580119	10.4232463606629	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCTTTCAGTTCACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1647.08944264857	41.5622895118952	0.0252337781031865	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1640.40516801904	1640.40516801904
"healthy-5"	"2019-08-29-count-1:AGGTCATAGGCATTTC"	9.63382973250691	7.96075294101564	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTCATAGGCATTTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2438.3823100157	41.9803562361316	0.0172164783445551	1373	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2433.81558521276	2433.81558521276
"healthy-5"	"2019-08-29-count-1:GTAATGCTCGTAGGGA"	-4.39426408234294	-5.31409790432128	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATGCTCGTAGGGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2249.35956523556	51.6509167452361	0.0229624989901635	1163	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2244.35178651568	2244.35178651568
"healthy-5"	"2019-08-29-count-1:GCATTAGAGCCTCTGG"	3.20302166518514	-7.67454912578734	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATTAGAGCCTCTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1699.09269609018	45.30420724094	0.0266637643403391	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1697.06455056345	1697.06455056345
"healthy-5"	"2019-08-29-count-1:CGTGCTTCATCTAGAC"	-2.36517367783244	4.21727035129396	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGCTTCATCTAGAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3095.56062176171	48.1667795361812	0.0155599535662684	3469	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3090.80601251789	3090.80601251789
"healthy-5"	"2019-08-29-count-2:GTCAGCGAGACGAGCT"	4.14389767226521	-7.48391392147215	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCAGCGAGACGAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.94653142783	43.8377994259879	0.0245185181186485	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1785.87857867451	1785.87857867451
"healthy-5"	"2019-08-29-count-1:TATCTTGTCTGATGGT"	-3.74768243256267	11.4562253721985	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTTGTCTGATGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1576.5788598306	41.6890861965324	0.0264427535207543	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1571.5849137262	1571.5849137262
"healthy-5"	"2019-08-29-count-2:CACCAAAAGAGCCGTA"	6.67882742461507	-1.47828116333159	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACCAAAAGAGCCGTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2126.33971955445	42.889237684837	0.0201704540861532	1086	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2126.33971955445	2126.33971955445
"healthy-5"	"2019-08-29-count-1:CGGAGAATCCCGAAAT"	-3.86281953278239	12.7316722639832	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAGAATCCCGAAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1838.29684302413	48.6440887605518	0.026461498285842	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1829.57741613975	1829.57741613975
"healthy-5"	"2019-08-29-count-1:CGTGCTTTCGTAATGC"	3.19590916213338	-7.28767778789672	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGCTTTCGTAATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1780.49215447526	43.080145109588	0.0241956388301439	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1778.23934784208	1778.23934784208
"healthy-5"	"2019-08-29-count-1:AAGCCATAGGACAGTC"	-2.42830691757854	9.31713769519655	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCCATAGGACAGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1552.36070693033	41.3958422176268	0.0266663811012608	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1552.36070693033	1552.36070693033
"healthy-5"	"2019-08-29-count-1:GTCTAGAAGGAACTCG"	3.16731895980183	-8.13094904338988	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTAGAAGGAACTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1608.69834390004	44.3433231059033	0.0275647222949207	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1606.35504364573	1606.35504364573
"healthy-5"	"2019-08-29-count-1:TCCAGAAGTTGTTGAC"	-3.59236560288127	12.2118177183899	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCAGAAGTTGTTGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1609.51968166489	38.6716524391059	0.0240268279286302	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1607.17404530942	1607.17404530942
"healthy-5"	"2019-08-29-count-2:ATATCCTGTTGTAGCT"	-2.74304471436198	11.6868304976257	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATATCCTGTTGTAGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1663.61091014314	43.0224504899854	0.025860885034881	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1655.10579206215	1655.10579206215
"healthy-5"	"2019-08-29-count-2:CAACAGTTCAGCCCAG"	0.115689237683457	8.76308629596559	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACAGTTCAGCCCAG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1542.28377306652	37.7439606434546	0.0244727729764078	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1537.86819294965	1537.86819294965
"healthy-5"	"2019-08-29-count-2:GTAACCATCAGCAGAG"	-3.47957382622417	3.47115252101747	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAACCATCAGCAGAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2968.49920046666	45.3087169017992	0.0152631730184318	2837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2960.52602525287	2960.52602525287
"healthy-5"	"2019-08-29-count-2:GGGATCCGTCAGCTTA"	4.11459126052205	-8.34364035045775	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATCCGTCAGCTTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1886.76669590059	49.9402386905488	0.0264686878346194	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1884.73854062877	1884.73854062877
"healthy-5"	"2019-08-29-count-2:GTTCATTAGGAGTCTG"	-2.32401833954509	4.15906999194948	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCATTAGGAGTCTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3107.93505589463	45.0867666469747	0.0145069848102075	3589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3101.31394938186	3101.31394938186
"healthy-5"	"2019-08-29-count-1:CGTTAGAGTGTTGCCG"	2.92202438887898	-7.97219278728636	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTTAGAGTGTTGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1679.5074971393	42.7290416240997	0.0254414116619782	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1679.5074971393	1679.5074971393
"healthy-5"	"2019-08-29-count-2:GTCATCCCAGCTACAT"	-2.16291675987895	9.83227441394655	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCATCCCAGCTACAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1680.84842324485	45.9376969915372	0.0273300651957987	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1674.50682450706	1674.50682450706
"healthy-5"	"2019-08-29-count-1:CCTCCTCCACAGCTGC"	4.53018917617146	-8.16440584575804	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCCTCCACAGCTGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2153.4250330663	35.6613884303517	0.0165603110778242	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2141.64148156238	2141.64148156238
"healthy-5"	"2019-08-29-count-1:AAGACTCCATCCTATT"	-7.61768994751628	0.908674753549971	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGACTCCATCCTATT"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2772.5058382532	45.8276223707935	0.0165293150111694	2482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2765.22483730174	2765.22483730174
"healthy-5"	"2019-08-29-count-1:AAGCGAGTCGCTGACG"	5.58164896544759	-9.88516046917113	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCGAGTCGCTGACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.90272248894	44.1731056784929	0.0204798784933239	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2155.13423562073	2155.13423562073
"healthy-5"	"2019-08-29-count-1:GCCAGCAAGTAAACTG"	2.88516416129414	-7.14134361660155	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGCAAGTAAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1936.96726002756	43.8950833011132	0.02266175800023	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1933.31044064236	1933.31044064236
"healthy-5"	"2019-08-29-count-2:AGGACTTTCGACACCG"	3.30061854895894	-7.84956362163695	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACTTTCGACACCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1656.73901112532	50.8651223834953	0.0307019524752699	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1654.60712731504	1654.60712731504
"healthy-5"	"2019-08-29-count-1:CATTCATTCAAGGACG"	4.72962297972981	-8.70091059124144	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTCATTCAAGGACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2320.1192885094	49.3560329036203	0.0212730583069847	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2309.12725854788	2309.12725854788
"healthy-5"	"2019-08-29-count-1:CTAGGTAAGAAACACT"	1.55758049067799	-7.28071978008422	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	45	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGGTAAGAAACACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.88496667887	48.4855834766617	0.0307282118155382	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.48435060191	1575.48435060191
"healthy-5"	"2019-08-29-count-1:ATCGTAGGTGGCAGAT"	3.74124016341512	-8.67344667827757	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTAGGTGGCAGAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1747.87327024128	46.965151341246	0.0268698836127649	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1743.24542577407	1743.24542577407
"healthy-5"	"2019-08-29-count-1:ATCGTAGTCAAAGACA"	2.6016432243282	-4.44337513363036	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTAGTCAAAGACA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2366.2888065681	36.9219471447904	0.0156033139498045	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2358.76837782925	2358.76837782925
"healthy-5"	"2019-08-29-count-2:TCATGAGTCATGCGGC"	-1.89158640328105	9.37838742816774	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGAGTCATGCGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.21131961373	34.9296105185064	0.01833371981308	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1899.13922124648	1899.13922124648
"healthy-5"	"2019-08-29-count-1:ATCGTCCAGTGATTCC"	5.24704994735066	-10.3628759614197	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTCCAGTGATTCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.0862395751	46.1002046573912	0.0225199133119863	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2042.03333535275	2042.03333535275
"healthy-5"	"2019-08-29-count-2:CCACCATGTAGCTCGC"	-3.42923436585124	11.8785180815491	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACCATGTAGCTCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1597.97626512844	38.2903988934326	0.0239618070236825	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1593.23216792877	1593.23216792877
"healthy-5"	"2019-08-29-count-2:CTAACCCCAACACAGG"	3.41523565825765	-8.25216963207396	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACCCCAACACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1694.73796315111	49.0266425676251	0.028928745111998	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1692.55665022067	1692.55665022067
"healthy-5"	"2019-08-29-count-1:GTAGAGGTCTACTCAT"	3.91742744025533	-8.26992323314818	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGAGGTCTACTCAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.56306677824	41.4688506230259	0.0216370915947658	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1916.56306677824	1916.56306677824
"healthy-5"	"2019-08-29-count-1:TACACCCCAGGTTCCG"	-7.26114926758464	-1.34689488327178	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACACCCCAGGTTCCG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3341.30204211562	44.3920488510672	0.0132858533264952	3586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3321.19805560259	3321.19805560259
"healthy-5"	"2019-08-29-count-1:GTAGATCCAGGACTTT"	-2.90985427323039	12.1930427321228	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGATCCAGGACTTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1460.96068326483	42.2686244812946	0.0289320752881838	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1449.22977708745	1449.22977708745
"healthy-5"	"2019-08-29-count-2:TCATGCCCACCCTGTT"	-4.1927321952885	-5.33715488826903	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGCCCACCCTGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1807.49539089588	39.5997945966485	0.0219086559202903	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1807.49539089588	1807.49539089588
"healthy-5"	"2019-08-29-count-1:CATTCTAGTAGTCACT"	2.66486587104146	-6.98032905971678	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTCTAGTAGTCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1906.42626937977	42.3642710706048	0.0222218250718857	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1900.42432261749	1900.42432261749
"healthy-5"	"2019-08-29-count-1:GTTAGTGGTACTGCCG"	-3.74164328995402	-4.54005052959593	"2019-08-29-count-1"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTAGTGGTACTGCCG"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2614.52218216884	33.1539949863346	0.0126807090077286	1938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2606.50034299595	2606.50034299595
"healthy-5"	"2019-08-29-count-1:GCACGTGTCATCGCAA"	-4.67836795273479	-5.21454670345458	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACGTGTCATCGCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2316.50636527592	45.772023977684	0.0197590754179655	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2316.50636527592	2316.50636527592
"healthy-5"	"2019-08-29-count-1:GAGTGAGTCTTCCAGC"	1.68445088443105	-6.05373146450194	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTGAGTCTTCCAGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2121.99400074174	49.0942339120052	0.0231358966589181	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2120.22576909802	2120.22576909802
"healthy-5"	"2019-08-29-count-1:ACCGTTCCATGATGCT"	-5.35496221008952	-5.65109922802123	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCGTTCCATGATGCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2240.29832346193	50.0271707534563	0.0223305843822395	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2233.58052278507	2233.58052278507
"healthy-5"	"2019-08-29-count-2:CAGCGTGCACCTTCCA"	3.26607932624165	-7.90816070949706	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCGTGCACCTTCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1854.80143219405	41.4666811301232	0.0223563991327482	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1843.29005144368	1843.29005144368
"healthy-5"	"2019-08-29-count-1:AGGTCATCAGCGGATA"	-0.146177853376228	9.76865289295045	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTCATCAGCGGATA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1555.97874022818	41.4771149112231	0.0266566077279054	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1555.97874022818	1555.97874022818
"healthy-5"	"2019-08-29-count-1:CTCTCGATCCTCTCGA"	8.72862400588338	5.87150762164918	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCGATCCTCTCGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1438.4915965687	49.0173659959939	0.0340755316978684	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1436.16111230783	1436.16111230783
"healthy-5"	"2019-08-29-count-2:GTTGTAGTCTAGACCA"	-3.46967611733134	12.5195111998352	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGTAGTCTAGACCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1514.20584420348	36.6181139345399	0.0241830488732541	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1509.28232026848	1509.28232026848
"healthy-5"	"2019-08-29-count-1:GTAGCTATCCAATCCC"	3.95148100432698	-7.51013853466185	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGCTATCCAATCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2172.77131991401	45.5089005869802	0.0209450944836575	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2166.6823058306	2166.6823058306
"healthy-5"	"2019-08-29-count-1:CCATAAGCAAGGTCTT"	-4.08153901520427	13.0785741575989	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATAAGCAAGGTCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1478.91167046422	44.6129779829487	0.0301660869096698	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1476.37891488806	1476.37891488806
"healthy-5"	"2019-08-29-count-1:CTAACCCCACAATGTC"	-3.57884488526042	-5.60603144085082	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAACCCCACAATGTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2374.834621222	44.911473098886	0.0189114107978501	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2368.84520956311	2368.84520956311
"healthy-5"	"2019-08-29-count-2:TCATGTTAGTGCAACG"	5.24599899825398	-9.1003046265808	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGTTAGTGCAACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.20897929637	38.4243383416298	0.0159291084111784	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2412.20897929637	2412.20897929637
"healthy-5"	"2019-08-29-count-1:CAGTGCGCAAGACCGA"	-3.76615367355998	13.0416202315125	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTGCGCAAGACCGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1666.73265565583	37.9011000669834	0.0227397596959363	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1664.33857295631	1664.33857295631
"healthy-5"	"2019-08-29-count-1:AGGGAGTTCGAATCCA"	-3.3035458129948	3.60127303684083	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGAGTTCGAATCCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3035.4806486977	49.0142907069349	0.0161471267253716	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3031.0700267066	3031.0700267066
"healthy-5"	"2019-08-29-count-2:GTCATCCCAGAGATTA"	4.75119413909261	-8.06889727031859	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCATCCCAGAGATTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2362.83689568839	38.2159013760823	0.0161737365138563	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2353.02548148937	2353.02548148937
"healthy-5"	"2019-08-29-count-2:TCCGATCAGAGTAACT"	-3.08762536469157	12.3009814986023	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGATCAGAGTAACT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1505.05860517374	40.6152883336635	0.0269858517097245	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1502.46864090547	1502.46864090547
"healthy-5"	"2019-08-29-count-2:CCTACGTTCGCTTTAT"	-4.67406068268474	-4.8826155892578	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTACGTTCGCTTTAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2711.97906377523	48.5692667172504	0.017909159906876	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2703.79713497391	2703.79713497391
"healthy-5"	"2019-08-29-count-1:CTATCTACAGATCACT"	-3.40692148628886	12.1848459013733	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATCTACAGATCACT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1626.95689610767	37.1962594046365	0.0228624737960943	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1624.59751812146	1624.59751812146
"healthy-5"	"2019-08-29-count-1:CAGATACAGTGGAATT"	9.96534027633015	6.48111960971681	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATACAGTGGAATT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1494.91640304185	36.6288472906162	0.024502271308338	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1490.33659120764	1490.33659120764
"healthy-5"	"2019-08-29-count-2:CTTACCGCAAATCAGA"	-3.02155838432963	11.6942510374817	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTACCGCAAATCAGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1633.3360011818	37.5241219395311	0.0229739146828213	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1630.91016528724	1630.91016528724
"healthy-5"	"2019-08-29-count-1:CAGTTAGCAAATGGCG"	3.18149509009663	-6.75022938167723	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGCAAATGGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1546.51930557207	50.19889429679	0.032459274265717	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1541.7857344894	1541.7857344894
"healthy-5"	"2019-08-29-count-1:CTGAGCGAGTTGGGAC"	5.39153542098348	-9.49798395549925	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGAGCGAGTTGGGAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.23166569481	37.2370761494136	0.0168095629572603	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2208.87415660761	2208.87415660761
"healthy-5"	"2019-08-29-count-2:TCGACGGCAAATTGGA"	6.82705988463704	-1.12507035648497	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGACGGCAAATTGGA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2042.55382457272	37.3049698237135	0.0182638858153553	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2032.68961358803	2032.68961358803
"healthy-5"	"2019-08-29-count-1:CATTGTTGTCACTCAA"	-4.03865704956706	-5.41203358089598	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGTTGTCACTCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2280.14624455706	50.4798529192055	0.022138866329169	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2278.35744112231	2278.35744112231
"healthy-5"	"2019-08-29-count-2:GAGTTACGTCAACCAT"	-3.44879112663921	12.3468522795471	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTACGTCAACCAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1551.4481053809	38.1399617750903	0.0245834595709707	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1549.04741642264	1549.04741642264
"healthy-5"	"2019-08-29-count-1:CCATCACTCACCATCC"	3.12383546408955	-7.43495943462523	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATCACTCACCATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1818.59175181672	38.0429548929803	0.0209189087407751	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1814.7360600508	1814.7360600508
"healthy-5"	"2019-08-29-count-2:CAGGTATGTACCAATC"	11.0259176689083	4.65873859012452	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGTATGTACCAATC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1531.37542039947	35.3730589882545	0.0230988812521407	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1531.37542039947	1531.37542039947
"healthy-5"	"2019-08-29-count-2:GCTGAATGTCGACGCT"	4.10895933684651	-7.89793398296507	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTGAATGTCGACGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.20321343785	42.1756921684576	0.0196421521281774	1111	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2145.60181833633	2145.60181833633
"healthy-5"	"2019-08-29-count-2:CCGATCTAGTCGAGGT"	-3.30620418015178	-5.62828590786131	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGATCTAGTCGAGGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1946.90714542589	48.6159960648376	0.0249708858376	934	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1943.29562439516	1943.29562439516
"healthy-5"	"2019-08-29-count-2:GCTGCAGGTACCGGAA"	-2.92431984368022	10.4231529005798	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTGCAGGTACCGGAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1495.6250585141	37.2769438104589	0.0249239898718289	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1493.2709920001	1493.2709920001
"healthy-5"	"2019-08-29-count-1:ATGAGGGAGGGAGATA"	-2.48718557778056	3.51165840709535	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAGGGAGGGAGATA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3002.48563484457	41.5561136926171	0.0138405703628848	3068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2987.73983935988	2987.73983935988
"healthy-5"	"2019-08-29-count-1:CAGTTCCTCCTCAGAA"	-3.2186304134434	9.70033547962037	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTCCTCCTCAGAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1799.34662125484	42.0964207820406	0.0233953926857534	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1795.0652692761	1795.0652692761
"healthy-5"	"2019-08-29-count-2:ATCCGTCTCAGTAGGG"	-2.70815740051921	9.90879151904909	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCGTCTCAGTAGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1500.74438437376	43.9641122736315	0.0292948704199064	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1493.48558389525	1493.48558389525
"healthy-5"	"2019-08-29-count-1:GTGGGAAGTTCTAACG"	3.89555539664571	-7.55240251934203	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGGAAGTTCTAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1944.40110421064	43.2256804025753	0.0222308454304871	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1944.40110421064	1944.40110421064
"healthy-5"	"2019-08-29-count-1:CTGATCCAGTTAGTAG"	9.90718426284139	6.46174762332765	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGATCCAGTTAGTAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1494.70494378967	42.3912603897385	0.0283609554955107	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1489.69093772906	1489.69093772906
"healthy-5"	"2019-08-29-count-2:GAGTTGTGTGTCATTG"	-3.38057337227519	10.7200498350891	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTGTGTGTCATTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1644.60877446125	45.6874848420579	0.0277801538891974	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1637.50162011504	1637.50162011504
"healthy-5"	"2019-08-29-count-2:ATACCTTCAACCAATC"	-3.13325343552287	10.6589832075867	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCTTCAACCAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1718.36199668986	35.4410317159856	0.020624892650243	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1709.7492603609	1709.7492603609
"healthy-5"	"2019-08-29-count-1:AAGGTAACACGCTGCA"	4.9835020500118	-7.80308058178099	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGGTAACACGCTGCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.7003707362	44.5337061297538	0.0205631890410654	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2163.83183559459	2163.83183559459
"healthy-5"	"2019-08-29-count-1:ATAGGCTAGCTCGAAG"	4.10605635222737	-8.2396860352722	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATAGGCTAGCTCGAAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.98591411257	46.6781325148533	0.0254101744364236	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1832.86614824045	1832.86614824045
"healthy-5"	"2019-08-29-count-1:CTCAAGATCGGTAACT"	-2.57256207886394	11.3219823607239	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAAGATCGGTAACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1432.77653632864	43.510435585308	0.030367914662254	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1432.77653632864	1432.77653632864
"healthy-5"	"2019-08-29-count-2:GACCCAGTCAAGTGGG"	-2.8921471637791	11.2482270964417	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCCAGTCAAGTGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1434.1441349883	36.6828900187707	0.0255782449781939	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1429.19082235439	1429.19082235439
"healthy-5"	"2019-08-29-count-1:GTATTGGCACAGCTGC"	-5.13188395920451	-5.69756700908812	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTATTGGCACAGCTGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2124.41773042757	43.5205704727288	0.0204858817780483	1030	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2122.67104306518	2122.67104306518
"healthy-5"	"2019-08-29-count-1:CTGCAGGAGCTGACTT"	-5.42946944657024	-5.68361380016478	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCAGGAGCTGACTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1577.54286455409	45.7720983744743	0.0290148048607302	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1577.54286455409	1577.54286455409
"healthy-5"	"2019-08-29-count-1:ACGCACGCAGGCTATT"	4.6643496948177	-8.02635576641234	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGCACGCAGGCTATT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.7206590257	44.1792151378945	0.0209110536923836	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2105.58896721164	2105.58896721164
"healthy-5"	"2019-08-29-count-2:ATCGATGCAAATCGTC"	3.50007404860799	-7.57267000591429	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGATGCAAATCGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.53411914497	44.5669986787952	0.0227089038830122	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1958.79346555672	1958.79346555672
"healthy-5"	"2019-08-29-count-1:CCTCCAAGTGAGTTGG"	-3.45893273773845	10.678873992804	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCCAAGTGAGTTGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1465.43833247818	37.6915458320735	0.0257203220338408	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1462.92660624671	1462.92660624671
"healthy-5"	"2019-08-29-count-1:CACGGGTCAGTAGGAC"	-1.22011230412181	9.96363256061403	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGGGTCAGTAGGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1468.01988195242	38.6881764893225	0.0263539867306622	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1468.01988195242	1468.01988195242
"healthy-5"	"2019-08-29-count-1:ACCAAACAGTGCTCAT"	-1.27154550972636	9.93762300098268	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCAAACAGTGCTCAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2051.66238237823	38.4218205072395	0.0187271652671732	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2046.79745748542	2046.79745748542
"healthy-5"	"2019-08-29-count-2:TCTGTCGCAGGTACGA"	3.73032083091084	-8.06264212047728	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGTCGCAGGTACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1588.34127492023	41.1973029230964	0.0259373118193163	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1583.58267045875	1583.58267045875
"healthy-5"	"2019-08-29-count-2:TCTACATGTTCGAAGG"	4.14189638671224	-7.35251142894896	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACATGTTCGAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.85610993514	47.5859509297711	0.0242927240487035	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1954.97429668613	1954.97429668613
"healthy-5"	"2019-08-29-count-2:TCTACATGTTGGACCC"	5.42828144606893	-9.98813536083373	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACATGTTGGACCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.8108573173	40.0753663904999	0.0172233021280917	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2325.36658964093	2325.36658964093
"healthy-5"	"2019-08-29-count-1:GGGATCCTCTCAATCT"	6.86145271834676	-1.62258579647215	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGATCCTCTCAATCT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2385.86303112528	36.6377173648286	0.0153561696069152	1295	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2381.20467042105	2381.20467042105
"healthy-5"	"2019-08-29-count-1:ACGGAAGCAGTAACCT"	2.82663335379903	-7.90078165447386	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGAAGCAGTAACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1530.9541940116	51.4874132027412	0.033630929915563	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1526.14117275164	1526.14117275164
"healthy-5"	"2019-08-29-count-2:TATCTGTCAAAGTGTA"	4.83136286315267	-9.11345674907836	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTGTCAAAGTGTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1693.20475418555	46.0651407093985	0.0272058890665921	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1688.78103896532	1688.78103896532
"healthy-5"	"2019-08-29-count-1:CTGCAGGTCGGTCATA"	2.8922389942104	-7.11779453670653	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCAGGTCGGTCATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1607.47446189204	49.9678280615917	0.0310846792569123	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1605.31191306017	1605.31191306017
"healthy-5"	"2019-08-29-count-1:GATCATGTCCCGTTCA"	9.60162891921346	5.95137927615968	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCATGTCCCGTTCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1570.94536420492	38.0790420025442	0.0242395711971923	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1568.55142405285	1568.55142405285
"healthy-5"	"2019-08-29-count-1:GTTGCGGTCTTGGTGA"	1.78552379187886	-7.19242384349974	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCGGTCTTGGTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1461.81376825758	46.7370253331485	0.0319719422186431	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1459.36354120909	1459.36354120909
"healthy-5"	"2019-08-29-count-2:GAAGGACCATCATCTT"	3.90401448783223	-8.2392730942932	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGACCATCATCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2233.69768156335	40.8597434367674	0.0182924232648036	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2226.69632183265	2226.69632183265
"healthy-5"	"2019-08-29-count-2:ATAGAGAGTTCATCTT"	-3.06200466576274	12.4710883864197	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGAGAGTTCATCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1405.64538992319	42.6907764923947	0.0303709433392212	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1405.64538992319	1405.64538992319
"healthy-5"	"2019-08-29-count-2:ATCGGATTCAGCAATC"	-2.10950146141704	9.19146249378053	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGGATTCAGCAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1444.95856589155	44.2663414040393	0.0306350247328556	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1440.27823365062	1440.27823365062
"healthy-5"	"2019-08-29-count-2:GCTTTCGGTGCTCTCT"	4.44559397277181	-8.92557527935179	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTTTCGGTGCTCTCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.96439397958	40.326019588273	0.0180432492333662	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2230.3125641106	2230.3125641106
"healthy-5"	"2019-08-29-count-2:TCTACCGTCGAGAAAT"	3.90220012244527	-8.3751840821472	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACCGTCGAGAAAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.15354679297	40.2033859235837	0.0191157635565356	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2100.06452680125	2100.06452680125
"healthy-5"	"2019-08-29-count-1:CTACGGGAGCGAATGC"	4.00479306754414	-7.48915483867797	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACGGGAGCGAATGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2167.034799134	41.9004938387812	0.0193354042378672	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2165.57040665762	2165.57040665762
"healthy-5"	"2019-08-29-count-2:GACCTTCGTTACGATC"	-3.8487859767979	10.8805255659851	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCTTCGTTACGATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1930.90189464351	34.5680577827445	0.0179025448567011	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1924.4175428667	1924.4175428667
"healthy-5"	"2019-08-29-count-1:GTCAAACCAGAGCGTA"	-2.52150664749797	12.1037740477356	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAACCAGAGCGTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1417.16601975088	45.2971491269323	0.0319631916766499	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1412.34296379137	1412.34296379137
"healthy-5"	"2019-08-29-count-1:ATGCCTCAGCGTATAA"	-5.65900168839152	-5.44461157238158	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCAGCGTATAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2288.12005021671	46.0771486026257	0.0201375572921804	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2288.12005021671	2288.12005021671
"healthy-5"	"2019-08-29-count-1:TCCTCGAGTGTTAAAG"	-5.63082299652751	-5.49605705654296	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCGAGTGTTAAAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2142.33602777408	43.008830592213	0.0200756697523777	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2140.38252356696	2140.38252356696
"healthy-5"	"2019-08-29-count-2:ATCGGCGGTTCTGACA"	-3.87066255036052	12.2964935072693	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGGCGGTTCTGACA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1640.57170624563	45.0480929205007	0.0274587771744468	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1638.28497348714	1638.28497348714
"healthy-5"	"2019-08-29-count-1:ATGCCTCCAGCGGATA"	-3.65018544617351	12.7499599226746	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCCAGCGGATA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1678.70586456182	38.9213284551361	0.0231853174977115	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1673.9927287598	1673.9927287598
"healthy-5"	"2019-08-29-count-1:GCGAGAATCATGAGAA"	2.69923438605611	-6.66845610057982	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGAGAATCATGAGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1848.31372308974	43.7903457402165	0.0236920524871796	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1848.31372308974	1848.31372308974
"healthy-5"	"2019-08-29-count-1:GTCAAACTCTATCGTT"	2.43607654151265	-4.51274492656859	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAACTCTATCGTT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2377.77764585852	36.6226211270047	0.0154020377770781	1376	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2373.62684451088	2373.62684451088
"healthy-5"	"2019-08-29-count-1:GGGCGTTGTCTACAAC"	-3.79578266564067	12.335121131781	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCGTTGTCTACAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1686.00744267716	40.4113378201279	0.0239686592106379	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1678.60142158235	1678.60142158235
"healthy-5"	"2019-08-29-count-2:GCGATCGCAGCTTTCC"	4.10732950743977	-8.19041063701781	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGATCGCAGCTTTCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.31534551308	39.8344364272523	0.0210952246519126	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1886.3174772205	1886.3174772205
"healthy-5"	"2019-08-29-count-2:GCGATCGTCGCATAGT"	-3.75537190857585	-5.51003267681273	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGATCGTCGCATAGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1547.94824578507	47.1640259976412	0.0304687357126213	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1545.53700568216	1545.53700568216
"healthy-5"	"2019-08-29-count-2:TCATCATGTTACACAC"	-3.2649806541508	10.6930150755676	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATCATGTTACACAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.09317663087	41.902249986532	0.0250747538033828	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1666.72147121936	1666.72147121936
"healthy-5"	"2019-08-29-count-2:GGAATCTTCTGAACGT"	-3.62492547455485	-5.49598076259764	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAATCTTCTGAACGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2300.80776998438	50.9929311140096	0.0221630558533605	1322	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2297.921072187	2297.921072187
"healthy-5"	"2019-08-29-count-2:TCTATCATCGGTCGGT"	3.10049523886983	-7.31862738048705	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATCATCGGTCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1746.18878996576	44.2454813750735	0.0253383148656802	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1743.92995231575	1743.92995231575
"healthy-5"	"2019-08-29-count-2:GCGGAAAGTAGGAAAG"	-1.83995542946513	9.53488061511842	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGGAAAGTAGGAAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1510.12588585363	40.5865985920642	0.026876301487357	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1505.73548182462	1505.73548182462
"healthy-5"	"2019-08-29-count-2:CGTTCTGCACTACAGT"	3.85504664954488	-7.45148565685423	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTTCTGCACTACAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.60091577781	42.4789367895136	0.0223502664009448	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1896.64119697169	1896.64119697169
"healthy-5"	"2019-08-29-count-1:GTCACGGAGGCGTTGA"	3.37695922431294	-7.84571220791014	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCACGGAGGCGTTGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.38097392157	43.514571338509	0.0257424639828725	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1690.38097392157	1690.38097392157
"healthy-5"	"2019-08-29-count-1:ACGTAACAGGACAAGA"	-2.31669555130656	10.5009050139221	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTAACAGGACAAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1522.49015760616	45.7582218567092	0.0300548556114516	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1515.64649407219	1515.64649407219
"healthy-5"	"2019-08-29-count-2:GATTTCTGTACGACTT"	4.16866077956502	-7.98282816326293	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTTCTGTACGACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1679.41890657976	47.7555051621594	0.0284357315349132	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1679.41890657976	1679.41890657976
"healthy-5"	"2019-08-29-count-2:AGGACTTGTCACTAGT"	4.88497509536092	-9.00458815014037	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACTTGTCACTAGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2161.89249003441	36.1599465252649	0.0167260613984969	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2158.77267708471	2158.77267708471
"healthy-5"	"2019-08-29-count-2:GATTTCTTCGGTAACT"	-2.7693751854008	10.281166053656	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTTCTTCGGTAACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1875.79536421181	37.8112849443921	0.0201574679550826	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1873.67627451087	1873.67627451087
"healthy-5"	"2019-08-29-count-1:CCCTCTCCATTAGGCT"	14.2433783012325	1.85886261546937	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCTCCATTAGGCT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1538.68611172803	29.8087145143826	0.0193728365305811	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1521.63213801468	1521.63213801468
"healthy-5"	"2019-08-29-count-2:TAAGCCATCACAGTGT"	-0.243539224297363	8.86316583240358	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCCATCACAGTGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1468.32937963882	32.3919237204618	0.0220603933760622	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1468.32937963882	1468.32937963882
"healthy-5"	"2019-08-29-count-1:TCACATTTCCAATCTT"	5.12427582320516	-10.015916847345	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACATTTCCAATCTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.50257209974	41.8461307523806	0.0202399413268357	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2057.55798074055	2057.55798074055
"healthy-5"	"2019-08-29-count-2:TCATGAGCAACTGAAA"	-2.05357513848003	10.7545442351135	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGAGCAACTGAAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1431.00472112708	30.7614353425451	0.0214963898360285	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1431.00472112708	1431.00472112708
"healthy-5"	"2019-08-29-count-2:GTGAGTTGTATTAAGG"	-3.34415803375896	12.385995841864	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGAGTTGTATTAAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1439.83582593627	41.824015465515	0.0290477669135079	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1434.67009971428	1434.67009971428
"healthy-5"	"2019-08-29-count-1:CTCTCAGTCAGGACGA"	3.50573386725728	-7.57838871395262	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCAGTCAGGACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1658.05447873184	39.8727173650305	0.0240478934054851	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1653.35424682892	1653.35424682892
"healthy-5"	"2019-08-29-count-1:CGATCGGGTCCCTGAG"	4.10523380812947	-8.64020159160765	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATCGGGTCCCTGAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1897.04084237572	40.5418571919663	0.0213711040302087	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1895.22114576918	1895.22114576918
"healthy-5"	"2019-08-29-count-2:GCGTGCACAACGATTC"	2.35874857482259	-7.42178347026976	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGTGCACAACGATTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1527.16883647077	46.3393817047631	0.0303433258969923	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1524.7866530313	1524.7866530313
"healthy-5"	"2019-08-29-count-1:ACCCTCATCCACTTCG"	-2.06318674507793	9.7291860350403	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCCTCATCCACTTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1702.2807436288	37.1134829198568	0.0218022103925942	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1695.69717201914	1695.69717201914
"healthy-5"	"2019-08-29-count-1:CTGCTCAAGTGATAAC"	-2.97309241715129	11.5460471876892	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCTCAAGTGATAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1460.24376519361	43.6326595291177	0.0298803943349368	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1450.742327679	1450.742327679
"healthy-5"	"2019-08-29-count-1:GTCAGCGCACTAGAGG"	5.18937458571736	-10.1913061372009	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAGCGCACTAGAGG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1606.96509078315	43.4129669037216	0.0270155009294972	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1602.22899356452	1602.22899356452
"healthy-5"	"2019-08-29-count-1:CATCCCATCAATCTTC"	-1.64846668663676	10.1385707625183	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCCCATCAATCTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.04499963768	37.8460040348727	0.0217125800210204	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1734.31197218656	1734.31197218656
"healthy-5"	"2019-08-29-count-2:CATCCACAGCCTCAAT"	2.47220673140828	-9.2607746354309	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCACAGCCTCAAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1883.13918820168	47.9192026849022	0.0254464476046845	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.11427436363	1881.11427436363
"healthy-5"	"2019-08-29-count-1:GTTACGAGTCCTTTGC"	3.60705794867818	-7.66839315807494	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTACGAGTCCTTTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.56439097083	46.6911846729701	0.0249610143860042	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1862.34623957524	1862.34623957524
"healthy-5"	"2019-08-29-count-2:CTGTATTCATGAGAAT"	-2.1597662967747	10.5300512083801	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTCATGAGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1451.56729846618	37.3317706405461	0.0257182499771063	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1446.78824205837	1446.78824205837
"healthy-5"	"2019-08-29-count-1:ACGTCCTTCTCATGCC"	5.25459398803059	-9.58412840282591	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTCCTTCTCATGCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2069.96295946919	47.0588090844976	0.0227341309994093	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2068.19169448255	2068.19169448255
"healthy-5"	"2019-08-29-count-2:TAAGTCGAGCTTTCTT"	6.74030985411946	-1.61593320285948	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGTCGAGCTTTCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2298.28587691321	36.5521832216665	0.0159041064424758	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2287.96752668789	2287.96752668789
"healthy-5"	"2019-08-29-count-1:AGTTCCCGTTGCCAAT"	-5.13245854798015	-5.21391394054564	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTCCCGTTGCCAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2128.71598514316	44.0890812229224	0.0207115846034093	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2128.71598514316	2128.71598514316
"healthy-5"	"2019-08-29-count-1:GCACGTGGTTCACCGG"	2.28615512427632	-7.46587135708006	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACGTGGTTCACCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1549.92894466606	46.3216303500089	0.0298862928584052	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1549.92894466606	1549.92894466606
"healthy-5"	"2019-08-29-count-2:GGTGTCGAGCGTGAGT"	5.09363522109334	-10.2008152238098	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTCGAGCGTGAGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1632.80269715881	41.6594183411599	0.025514055319513	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1628.08319188527	1628.08319188527
"healthy-5"	"2019-08-29-count-2:TAAGTCGTCTGTAACG"	3.42970718917195	-7.98069002544554	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGTCGTCTGTAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1847.56063026948	40.9210666613495	0.0221487002867023	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1847.56063026948	1847.56063026948
"healthy-5"	"2019-08-29-count-2:AGGTTACCAATAGAGT"	2.49750175055806	-4.48847629940184	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTTACCAATAGAGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2232.67006705331	43.8070857921347	0.0196209401642365	1242	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2222.71542762953	2222.71542762953
"healthy-5"	"2019-08-29-count-2:ACCCTTGTCATTGTGG"	3.75755037841145	-8.14019777691039	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCCTTGTCATTGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1632.71921354054	51.3311758862582	0.0314390713728095	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1630.53756503141	1630.53756503141
"healthy-5"	"2019-08-29-count-2:TCTGCCACAGCCGGTT"	4.49603809890096	-7.98229315197142	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGCCACAGCCGGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2425.16564275107	42.6009977352484	0.0175662218630652	1375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2423.73494915552	2423.73494915552
"healthy-5"	"2019-08-29-count-2:TCTGCCACAGGATGAC"	4.40109123763387	-7.41215326702269	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGCCACAGGATGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2150.36419025431	41.6631197571162	0.0193749133034944	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2146.84778072113	2146.84778072113
"healthy-5"	"2019-08-29-count-2:GTGCACGGTTGAGGAC"	-3.23423991623576	12.3613071211609	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCACGGTTGAGGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1457.42193163457	36.4197828923881	0.0249891826806405	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1454.85373869099	1454.85373869099
"healthy-5"	"2019-08-29-count-2:CTCAACCCAATCTAGC"	-2.24903593483623	10.4916982420715	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAACCCAATCTAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1578.7823097175	43.7299059158224	0.0276985026033433	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1574.21454320375	1574.21454320375
"healthy-5"	"2019-08-29-count-2:GGAGCAACAGAGGGTT"	-7.22854361954387	0.272538057807363	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGCAACAGAGGGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2436.63134329258	52.3494747351823	0.0214843640090599	1522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2430.03461101519	2430.03461101519
"healthy-5"	"2019-08-29-count-1:ATGGGTTCACTTCCTG"	-3.25901303711589	-5.68223955547484	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGTTCACTTCCTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2184.0524402706	51.7999557554329	0.0237173589792629	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2180.6727576638	2180.6727576638
"healthy-5"	"2019-08-29-count-2:GGAGCAACATCAGCTA"	-2.52535233917888	10.2616615065369	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGCAACATCAGCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1660.77174366166	38.8835486899744	0.0234129397000965	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1656.47075440111	1656.47075440111
"healthy-5"	"2019-08-29-count-1:GCTACCTCAACAGTGG"	5.09489359435384	-9.94476129924925	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTACCTCAACAGTGG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.60152443451	38.8393279381764	0.0179928196559349	1072	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2149.78894818457	2149.78894818457
"healthy-5"	"2019-08-29-count-1:CCGATCTGTAACACGG"	2.77940668639485	-8.21041967785033	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATCTGTAACACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1683.62884921379	40.9855086610688	0.0243435533194907	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1681.44480942426	1681.44480942426
"healthy-5"	"2019-08-29-count-2:TATTTCGGTAGCACGA"	-2.36109075966533	3.49989030444948	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTTCGGTAGCACGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3037.83356924361	46.011385687673	0.0151461179945843	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3030.02077417719	3030.02077417719
"healthy-5"	"2019-08-29-count-1:GATGGAGTCGAACCTA"	2.85078110274617	-7.77054455196532	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGGAGTCGAACCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1533.95746014926	45.8221750860603	0.0298718682078716	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1533.95746014926	1533.95746014926
"healthy-5"	"2019-08-29-count-1:ATACCTTCATCCTATT"	-2.53135261955913	3.47187492931215	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATACCTTCATCCTATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2950.18362264025	45.7927764647767	0.0155220089059388	2817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2942.49007298296	2942.49007298296
"healthy-5"	"2019-08-29-count-1:CTCTGGTTCGTGGCGT"	-3.85152826729472	12.298219657782	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTGGTTCGTGGCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1613.0059317992	38.8747698985	0.0241008226517417	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1610.6215211037	1610.6215211037
"healthy-5"	"2019-08-29-count-1:CCGATCTTCCCACAGG"	4.2480956512386	-7.18427517330321	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATCTTCCCACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.07932181373	38.455678705035	0.0195994516009103	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1962.07932181373	1962.07932181373
"healthy-5"	"2019-08-29-count-2:AGCGATTGTTGGGTTT"	3.57028808173482	-8.17540266430052	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCGATTGTTGGGTTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1753.02339404148	50.612581842597	0.0288715952192247	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1742.847313942	1742.847313942
"healthy-5"	"2019-08-29-count-1:AACGTCATCCATTTCA"	3.19834079322163	-7.87624313747557	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGTCATCCATTTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1477.77745705395	48.5343181892861	0.0328427788349422	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1477.77745705395	1477.77745705395
"healthy-5"	"2019-08-29-count-2:GGGACTCCAGGACATG"	-0.125235627323943	8.35810277545778	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACTCCAGGACATG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1715.02592256602	35.978673841581	0.0209785014722983	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1715.02592256602	1715.02592256602
"healthy-5"	"2019-08-29-count-1:CATTGTTAGGGTACGT"	3.87682785567586	-7.78656437313231	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGTTAGGGTACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.96956605573	46.9834821034685	0.0255766252047113	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1836.96956605573	1836.96956605573
"healthy-5"	"2019-08-29-count-2:ACCTACCAGACCATAA"	10.1559940772945	6.40346953952638	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTACCAGACCATAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1465.82563840373	42.5892623856532	0.029054794287834	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1458.66195746151	1458.66195746151
"healthy-5"	"2019-08-29-count-1:GCTCAAACAAGCTGTT"	2.0829140144283	-6.97764637386473	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTCAAACAAGCTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1599.08416539043	48.8662380839639	0.0305588906085084	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1596.72661301148	1596.72661301148
"healthy-5"	"2019-08-29-count-1:GTTCCGTCAAATTGCC"	3.94287337836568	-7.33503773128661	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTCCGTCAAATTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1683.18633365103	29.1381243235291	0.0173112885608601	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1676.35604031682	1676.35604031682
"healthy-5"	"2019-08-29-count-1:CAAGACTTCAGCGCGT"	-3.3650885623997	12.1099099882874	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGACTTCAGCGCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1786.91848553072	36.6282179955218	0.0204979792263121	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1784.71690402597	1784.71690402597
"healthy-5"	"2019-08-29-count-2:GACAGCCGTGGTCTCG"	-2.94014416161235	11.9319219359192	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACAGCCGTGGTCTCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1486.38107326038	43.6266008056537	0.0293508855773833	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1486.38107326038	1486.38107326038
"healthy-5"	"2019-08-29-count-2:GTCGTAAAGGTAATCA"	-3.3816388649052	3.6900686987671	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCGTAAAGGTAATCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2628.17174411487	47.6917661616556	0.0181463659170864	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2623.41446678102	2623.41446678102
"healthy-5"	"2019-08-29-count-2:CTTACCGGTTCGCGTG"	-2.95186338844951	11.1566142805847	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTACCGGTTCGCGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1498.30354308671	40.1996412942654	0.0268301049408511	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1491.10781275055	1491.10781275055
"healthy-5"	"2019-08-29-count-2:TCTTCCTAGAGCATTA"	-3.90339456024821	-5.39767649089965	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTCCTAGAGCATTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2326.34225233397	43.9827681658264	0.0189064047311609	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2326.34225233397	2326.34225233397
"healthy-5"	"2019-08-29-count-1:CTCAACCTCGTGACTA"	2.77352966842	-7.27846863186034	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAACCTCGTGACTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1775.12986587421	48.108546577478	0.0271014236774083	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1773.04832038601	1773.04832038601
"healthy-5"	"2019-08-29-count-1:ACAAAGAGTCAGCTTA"	3.47524442252461	-7.6500339738098	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAAAGAGTCAGCTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.61283240086	47.5360946655131	0.0227161441091685	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2083.26353880304	2083.26353880304
"healthy-5"	"2019-08-29-count-2:AGTAGCTGTAACGTTC"	3.81277718123738	-8.13230612194213	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAGCTGTAACGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1935.59233504735	45.9379735743877	0.0237332896718998	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1933.64937447422	1933.64937447422
"healthy-5"	"2019-08-29-count-2:CTTAGGAAGTACCCTA"	3.48807444152181	-8.2075348130432	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTAGGAAGTACCCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1905.09669948555	45.0662346950591	0.023655615332927	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1905.09669948555	1905.09669948555
"healthy-5"	"2019-08-29-count-2:TCTTCCTCATAGATCC"	0.727834363549393	9.08686921680299	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTCCTCATAGATCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1530.92577795728	37.03571313173	0.0241917104440862	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1526.55417721344	1526.55417721344
"healthy-5"	"2019-08-29-count-2:GGTTGTACAGAGGCAT"	-0.930543939501602	9.83783052051393	"2019-08-29-count-2"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTGTACAGAGGCAT"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1469.97436433142	45.3335161490204	0.0308396644519982	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1465.26534055081	1465.26534055081
"healthy-5"	"2019-08-29-count-1:GCTGCAGAGCGCCTTG"	-2.15712676468547	10.2536020048889	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGCAGAGCGCCTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1609.9123308095	37.652740713492	0.0233880690227147	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1605.18993587667	1605.18993587667
"healthy-5"	"2019-08-29-count-2:TCTTCCTTCAGTCAGT"	-3.08652458611186	10.6906394728455	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTCCTTCAGTCAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1483.79408697735	41.4596777678859	0.0279416653104096	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1481.28983623848	1481.28983623848
"healthy-5"	"2019-08-29-count-2:GGTTGTATCATTACTC"	-1.5383212369984	10.6800470122131	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTGTATCATTACTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1418.90432664618	41.3180178874117	0.0291196644562174	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1416.38036295571	1416.38036295571
"healthy-5"	"2019-08-29-count-2:TCAAGTGTCTATCGCC"	2.93790449675862	-7.7870984307495	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGTGTCTATCGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1713.16982870271	48.0548925673346	0.028050279524082	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1702.80701482717	1702.80701482717
"healthy-5"	"2019-08-29-count-1:GAGCTGCAGTTGGAAT"	4.42109932479207	-8.22544767772826	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCTGCAGTTGGAAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1811.55753026659	41.144704416591	0.0227123366104393	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1807.68569951959	1807.68569951959
"healthy-5"	"2019-08-29-count-1:GTCCCATTCTCGGCTT"	3.61691536483113	-7.61771299755248	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCCCATTCTCGGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1752.93243346407	47.7299817688271	0.027228648895785	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1750.71471889885	1750.71471889885
"healthy-5"	"2019-08-29-count-2:TGAGGTTTCTACTGCC"	5.36716808852498	-9.70413591777953	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGGTTTCTACTGCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.01459736253	44.0338885919092	0.0219728382467183	968	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2000.95918480755	2000.95918480755
"healthy-5"	"2019-08-29-count-1:AGATCGTAGTCTTGGT"	-2.36133132401164	9.8770599135193	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCGTAGTCTTGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1414.02663036283	43.6681024933489	0.0308820934172534	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1404.29277664318	1404.29277664318
"healthy-5"	"2019-08-29-count-2:TATCCTATCGCCAATA"	-3.00680385056193	12.6660270460877	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCCTATCGCCAATA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1457.93286002652	39.6055624841507	0.0271655599308121	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1455.38448702871	1455.38448702871
"healthy-5"	"2019-08-29-count-2:GCAGGCTAGGACTGGT"	-2.61948523941692	3.42427871311036	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGGCTAGGACTGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3159.91887481887	51.1539108678415	0.016188362073306	3488	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3155.83571270365	3155.83571270365
"healthy-5"	"2019-08-29-count-2:CATGAGTAGATTGACA"	-3.61455164375957	12.9141702421936	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGAGTAGATTGACA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1654.60611357803	41.5233547684427	0.0250956130451192	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1649.76294876082	1649.76294876082
"healthy-5"	"2019-08-29-count-1:CTGCAGGAGTGACCTT"	2.9465671974117	-8.43435194408568	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCAGGAGTGACCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1684.05302296404	48.4133699385565	0.0287481268572803	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1677.4389064645	1677.4389064645
"healthy-5"	"2019-08-29-count-2:ATCGATGGTACGGTTT"	-1.6102731031483	9.68671605670778	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGATGGTACGGTTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1505.96995414696	39.1822552997136	0.0260179528760306	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1505.96995414696	1505.96995414696
"healthy-5"	"2019-08-29-count-1:CATACAGCATCAGCAT"	-5.66679416123088	-5.44485142147215	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACAGCATCAGCAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2583.63138599891	47.052734542964	0.0182118605610498	1607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2581.04776852227	2581.04776852227
"healthy-5"	"2019-08-29-count-2:GATGTTGCAGCTACCG"	-2.05101643028911	4.1941346892151	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGTTGCAGCTACCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3124.31590998928	44.9715313835204	0.0143940410250238	4106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3119.76249992527	3119.76249992527
"healthy-5"	"2019-08-29-count-1:CTCAATTCAGCATTGT"	3.89239801940266	-7.77444126522215	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAATTCAGCATTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1971.17269237701	46.9096341078171	0.0237978307477714	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1967.39373123117	1967.39373123117
"healthy-5"	"2019-08-29-count-2:TCAATTCGTAGACGTG"	3.1557318168575	-7.9761066666809	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAATTCGTAGACGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1494.03087097261	42.3792237272574	0.028365694813032	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1494.03087097261	1494.03087097261
"healthy-5"	"2019-08-29-count-1:GTTGCGGAGTGACCTT"	-1.72036967697795	3.93759248340455	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCGGAGTGACCTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2851.04329325933	43.8785869169932	0.0153903614935398	3377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2845.79223571453	2845.79223571453
"healthy-5"	"2019-08-29-count-1:GACTATGAGTGGAATT"	2.18079437789266	-6.70801451122435	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTATGAGTGGAATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.04333202412	53.5236320216828	0.0291675030707009	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1835.04333202412	1835.04333202412
"healthy-5"	"2019-08-29-count-2:CCGGACACAGTTCTAG"	2.59617271003072	-4.42723038112792	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGGACACAGTTCTAG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2340.52358032392	40.7064551785351	0.0173920295102951	1407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2332.68334776888	2332.68334776888
"healthy-5"	"2019-08-29-count-1:GCTTCACAGCCTGAGA"	4.34123673018758	-7.57717182552489	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTCACAGCCTGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2180.79017787278	43.7156729668824	0.0200457950565076	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2177.2737782626	2177.2737782626
"healthy-5"	"2019-08-29-count-2:CTTCCTTGTGAATTAG"	-2.85037599030193	3.44920990550844	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCCTTGTGAATTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3029.20392528367	48.2652336438236	0.0159333061868074	2954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3025.69057139712	3025.69057139712
"healthy-5"	"2019-08-29-count-2:TGAACGTGTGGCGTAA"	-3.38062582436259	12.0268611677918	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAACGTGTGGCGTAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1485.50378641551	39.6632552117097	0.0267002047214005	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1480.37097757364	1480.37097757364
"healthy-5"	"2019-08-29-count-1:CGTCCATCAGGTCAAG"	-2.02058468285258	4.24592874133912	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTCCATCAGGTCAAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3019.59623168389	42.0435919780637	0.0139235807545759	3743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3012.08755128155	3012.08755128155
"healthy-5"	"2019-08-29-count-1:CTGTGAATCGATTTCT"	3.25032462653462	-7.27257015621337	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGAATCGATTTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1976.43153080692	46.4915006838409	0.0235229503067378	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1974.5441891727	1974.5441891727
"healthy-5"	"2019-08-29-count-2:TCCACGTTCAGAGCGA"	2.49471296843831	-4.81360676204833	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCACGTTCAGAGCGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2212.10660086324	44.8700711520448	0.0202838647714965	1200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2209.38630185751	2209.38630185751
"healthy-5"	"2019-08-29-count-2:GGCAGTCAGAGGGTGG"	2.77939309653584	-7.35926916515502	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCAGTCAGAGGGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1480.39310862017	45.2060569487478	0.0305365221477442	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1477.91735637068	1477.91735637068
"healthy-5"	"2019-08-29-count-1:CTACCTGTCGCGCTGA"	3.30669679221455	-7.46313812648924	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACCTGTCGCGCTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1884.46458469238	43.1634624622637	0.0229048944792505	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1882.70402662417	1882.70402662417
"healthy-5"	"2019-08-29-count-2:CTTCGGTTCCTACTGC"	2.11615290221516	-6.96436073696288	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCGGTTCCTACTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1618.31527672717	48.7051559626051	0.0300962097207072	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1615.89720054268	1615.89720054268
"healthy-5"	"2019-08-29-count-1:CCGTAGGAGTCAGCCC"	-2.69212661209758	9.45548532092897	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTAGGAGTCAGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.3225313584	44.0523081162495	0.0254002974185809	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1730.33156911165	1730.33156911165
"healthy-5"	"2019-08-29-count-1:CCGTAGGCATGGTGGA"	3.10902275618855	-7.9820881119934	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTAGGCATGGTGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1606.31935298868	46.4463482052912	0.0289147659952388	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1606.31935298868	1606.31935298868
"healthy-5"	"2019-08-29-count-2:TCCTCGATCATTCATC"	3.28815474089925	-7.1884541741577	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCGATCATTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1904.27330173806	46.7215925884247	0.0245351297766876	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1900.39220802468	1900.39220802468
"healthy-5"	"2019-08-29-count-2:CACAGGCAGGGAGGAC"	-2.42112408104594	4.15417811954347	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAGGCAGGGAGGAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3396.30858820535	45.2602731152047	0.0133263135371103	4996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3394.08390458631	3394.08390458631
"healthy-5"	"2019-08-29-count-1:GGTAGAGAGTAACAGT"	3.17095365104024	-7.3327584496704	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAGAGAGTAACAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1855.18148900088	43.1474569599206	0.0232578091231159	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1848.75675604984	1848.75675604984
"healthy-5"	"2019-08-29-count-1:GTCGTTCCATAGCACT"	5.26777090606038	-10.2178192368713	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCGTTCCATAGCACT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1645.00197068358	41.8468448649511	0.0254387809928044	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1642.86520508542	1642.86520508542
"healthy-5"	"2019-08-29-count-1:GCTTGGGTCGCCGTGA"	3.01659049567525	-7.85506393825682	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTGGGTCGCCGTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.91417891572	48.2711650645304	0.0281478604923836	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1710.79237645255	1710.79237645255
"healthy-5"	"2019-08-29-count-2:GTGGTTACAGGTGTTT"	-1.89349279823955	12.3624067076477	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGTTACAGGTGTTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1553.28596778787	44.7575216533906	0.028814733784747	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1548.47452206846	1548.47452206846
"healthy-5"	"2019-08-29-count-2:GTAATGCAGCGTACAG"	-3.10655937615092	10.701895690802	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCAGCGTACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1576.55441333467	40.0058616313663	0.0253755032449195	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1574.27061436404	1574.27061436404
"healthy-5"	"2019-08-29-count-1:ATTCACTTCGTCTAAG"	1.1990473466808	8.89526650989381	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCACTTCGTCTAAG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1599.10594178288	39.4213905144937	0.0246521443542021	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1594.93914480612	1594.93914480612
"healthy-5"	"2019-08-29-count-1:CACTAAGCACTGCTTC"	3.22453321990315	-7.82078697597655	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTAAGCACTGCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.0168510109	51.7225789024569	0.0285442041411488	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1807.9390354702	1807.9390354702
"healthy-5"	"2019-08-29-count-1:CGGACACTCTAGTCAG"	2.95326127585713	-7.56313230907591	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGACACTCTAGTCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1910.27071470198	48.7471556254773	0.0255184541386232	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1910.27071470198	1910.27071470198
"healthy-5"	"2019-08-29-count-1:CTCAGAAGTCATCACA"	-3.14553819122966	11.2723626860413	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGAAGTCATCACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1545.33756543875	43.9921680667121	0.0284676753161191	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1536.16813611267	1536.16813611267
"healthy-5"	"2019-08-29-count-1:GTCTACCAGGCGATAC"	-1.09619865837749	9.78349778735963	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTACCAGGCGATAC"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1445.48130990831	41.5038672238862	0.0287128356066526	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1440.51798633472	1440.51798633472
"healthy-5"	"2019-08-29-count-1:CCCTCAAGTCCACACG"	-3.23815093460734	12.9285163649353	"2019-08-29-count-1"	"Control5"	"NK"	"IFN+ NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCAAGTCCACACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1578.93429639067	42.412757044103	0.0268616351808023	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1578.93429639067	1578.93429639067
"healthy-5"	"2019-08-29-count-2:GTTCGCTAGTAAACAC"	3.72692336615865	-8.19923021709593	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCGCTAGTAAACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1646.43734724185	46.8492862151686	0.0284549462472117	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1641.93976289027	1641.93976289027
"healthy-5"	"2019-08-29-count-1:TCATACTTCTGGGAGA"	-2.42501268807109	10.379648185614	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATACTTCTGGGAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1586.44491087657	39.0715121543589	0.0246283447263041	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1572.63589888424	1572.63589888424
"healthy-5"	"2019-08-29-count-1:CTCAGGGGTCCCTCAT"	-2.17367086830791	8.81741616809694	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGGGGTCCCTCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1912.98240744731	39.0262018606778	0.0204007113231922	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1908.92345253575	1908.92345253575
"healthy-5"	"2019-08-29-count-2:AGTGACTCATACTGAC"	0.193550829857033	9.52057645404664	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGACTCATACTGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1459.71415847335	41.6916711686902	0.0285615309865143	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1454.83441880491	1454.83441880491
"healthy-5"	"2019-08-29-count-1:GTTGTCCTCTTGGAAC"	4.48609938201253	-0.148068793770395	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTCCTCTTGGAAC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2607.96052831887	45.5117763749675	0.0174510986193127	2101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2597.63603565725	2597.63603565725
"healthy-5"	"2019-08-29-count-1:TCGGGACAGTCTCGTA"	-3.32091412964519	10.589744544867	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGACAGTCTCGTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1550.41234182044	39.1723165184511	0.0252657409011956	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1548.14427421769	1548.14427421769
"healthy-5"	"2019-08-29-count-1:GACTGATCAATGGCAG"	9.30977692183797	6.68611619556276	"2019-08-29-count-1"	"Control5"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTGATCAATGGCAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1498.69706043454	40.3859384975899	0.026947366191457	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1496.38441983339	1496.38441983339
"healthy-5"	"2019-08-29-count-2:TCTCACGGTCAGTTTG"	3.64345373687093	-7.59510042583617	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCACGGTCAGTTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1944.95190473934	41.9510320889553	0.0215691873854216	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1943.21788430235	1943.21788430235
"healthy-5"	"2019-08-29-count-1:CTCGAGGTCGGTTGTA"	4.70776810225789	-7.88901045238646	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCGAGGTCGGTTGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2317.50802852921	42.1500585153205	0.0181876645070657	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2312.77165700759	2312.77165700759
"healthy-5"	"2019-08-29-count-1:CAGGCCAAGACCAGAC"	1.47365417060201	-6.84101202404173	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGCCAAGACCAGAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1735.38084850427	45.1063442450421	0.0259921874117255	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1733.243536317	1733.243536317
"healthy-5"	"2019-08-29-count-1:ACAGAAACATGATAGA"	2.97856511649434	-7.9240703812805	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGAAACATGATAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1635.05370890448	45.4040389864604	0.0277691422240081	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1632.80361958168	1632.80361958168
"healthy-5"	"2019-08-29-count-1:CGGCAGTTCCCTCGTA"	2.93985762175862	-8.80734732067259	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGCAGTTCCCTCGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.73113762595	40.5558639603477	0.0218897729609678	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1841.73643192669	1841.73643192669
"healthy-5"	"2019-08-29-count-2:GAGGGATGTTATAGCC"	-7.28654466095622	3.97477457607118	"2019-08-29-count-2"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGGATGTTATAGCC"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1983.68070780626	43.103287878341	0.0217289444358254	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1971.6009180445	1971.6009180445
"healthy-5"	"2019-08-29-count-2:GCAACATGTAGGTTTC"	2.29969324645345	-4.09258749401244	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAACATGTAGGTTTC"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2164.57740445323	36.9737721840716	0.0170812889887905	1168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2161.51193354541	2161.51193354541
"healthy-5"	"2019-08-29-count-1:GGCTGTGGTGCAATAA"	3.54438819464986	-7.18870451366576	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTGTGGTGCAATAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.17958644004	48.1581816772876	0.0273132595497671	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1757.05144564395	1757.05144564395
"healthy-5"	"2019-08-29-count-1:GCGTGCAAGGTGCATG"	2.46293987807576	-4.46040108120116	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGTGCAAGGTGCATG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2314.49257505303	42.3941878307769	0.0183168389856708	1413	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2310.6680315643	2310.6680315643
"healthy-5"	"2019-08-29-count-1:GACATCACAGCAGTTT"	4.49238552626912	-7.80360367214354	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCACAGCAGTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.38950674026	45.7518003644476	0.0208494436488677	1128	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2191.06406904643	2191.06406904643
"healthy-5"	"2019-08-29-count-2:CTTTCAACAACTGCCG"	9.91285767134969	6.05707643115846	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTTCAACAACTGCCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1481.32587446185	45.3537281823109	0.0306169823697891	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1476.54858965262	1476.54858965262
"healthy-5"	"2019-08-29-count-2:TACGCTCAGATCCAAA"	4.52068676528279	-7.87851622020873	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACGCTCAGATCCAAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.6330744086	38.9292745283048	0.0182969869177868	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2123.00088196822	2123.00088196822
"healthy-5"	"2019-08-29-count-2:TGACGCGGTACCTAAC"	4.26457752761189	-8.51291658794554	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACGCGGTACCTAAC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.59546444552	41.6926677922288	0.0225171580903144	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1849.67623155896	1849.67623155896
"healthy-5"	"2019-08-29-count-2:GCCAGCAGTGCGACAA"	1.77213646945302	-6.8915324441162	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGCAGTGCGACAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1918.05592353035	49.4392286641071	0.025775697182546	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1914.76607992271	1914.76607992271
"healthy-5"	"2019-08-29-count-1:ATTCCCGGTATACCTG"	10.836463590234	5.47294995868532	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCCGGTATACCTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1610.38342902888	44.1129939498925	0.0273928513885008	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1608.07699307573	1608.07699307573
"healthy-5"	"2019-08-29-count-1:CCTAAGAGTCGATTCA"	3.55292906340901	-7.5874495736328	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTAAGAGTCGATTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1706.55584692892	44.270913554184	0.0259416728927172	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1701.78496465052	1701.78496465052
"healthy-5"	"2019-08-29-count-1:CTCATGCGTAGCTCGC"	3.71897186812703	-8.20088674938353	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCATGCGTAGCTCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.72539176246	37.5745185492406	0.0182957851619077	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2048.61277545538	2048.61277545538
"healthy-5"	"2019-08-29-count-1:CCTAAGATCTCTCGAC"	-1.86568091335948	9.76101491535035	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTAAGATCTCTCGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1520.71501890546	38.2418166382474	0.0251472604418492	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1520.71501890546	1520.71501890546
"healthy-5"	"2019-08-29-count-1:GTTTGGACAGCTTCGG"	-1.66666005078014	3.73212168300477	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTTGGACAGCTTCGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2629.48806294664	46.5638378931678	0.0177083283051636	2718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2624.45891673563	2624.45891673563
"healthy-5"	"2019-08-29-count-2:GGGAAGTGTAGTCGGA"	-3.61805067482646	-5.42563345348509	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAAGTGTAGTCGGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2273.59422222411	49.712904504775	0.0218653372791139	1240	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2270.53349451338	2270.53349451338
"healthy-5"	"2019-08-29-count-2:CTTTCGGGTACTCCGG"	1.7644200521404	-7.30775930797728	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTTCGGGTACTCCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.48079773697	50.4118007033694	0.0274502193355302	772	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1834.29385530823	1834.29385530823
"healthy-5"	"2019-08-29-count-1:GATGCTAAGGCGATAC"	3.43045320090596	-8.39804937755736	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGCTAAGGCGATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1705.13844751348	45.6035252492701	0.0267447639314987	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1702.88209981088	1702.88209981088
"healthy-5"	"2019-08-29-count-1:GTCTTTACAAGTCGTT"	3.03578962859456	-8.24969484722289	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTTTACAAGTCGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1488.71345682804	46.3436777035343	0.031130018668789	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1486.28667525815	1486.28667525815
"healthy-5"	"2019-08-29-count-2:TACGGGCCAATTGAGA"	4.06347717818562	-7.50589229976805	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACGGGCCAATTGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.46221419043	47.0759999895027	0.0235208037682312	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1999.48149439846	1999.48149439846
"healthy-5"	"2019-08-29-count-2:CTCCATGGTCACAATC"	-2.97009120407756	11.0670881041321	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCATGGTCACAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1526.59128307038	34.7353007588499	0.0227535039300028	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1519.50849874363	1519.50849874363
"healthy-5"	"2019-08-29-count-2:CTCCATGGTCCTATAG"	9.06433643874471	6.03843305194703	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCATGGTCCTATAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.74427970174	37.8618043910845	0.021939405992195	790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1725.74427970174	1725.74427970174
"healthy-5"	"2019-08-29-count-1:CTCCAACAGTCAATCC"	0.597534795373124	8.17589852893678	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCAACAGTCAATCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1582.35134580425	36.8451693924152	0.0232850747655466	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1576.18700351257	1576.18700351257
"healthy-5"	"2019-08-29-count-1:TAACACGAGGCGTTAG"	-1.67782924595531	3.8474287756714	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACACGAGGCGTTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2825.0632552899	43.8052212995344	0.0155059258292747	3239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2821.32715064917	2821.32715064917
"healthy-5"	"2019-08-29-count-1:CTTCCGAGTTGAGAGC"	3.25508775290791	-7.88830187236937	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGAGTTGAGAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.86775732843	47.3063026470819	0.0277803736922585	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1698.25200914477	1698.25200914477
"healthy-5"	"2019-08-29-count-2:ACGTAGTAGCAGCAGT"	3.81472625312154	-7.97661402141722	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAGTAGCAGCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1890.8896727551	44.208966193572	0.02337998183107	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1885.16889279398	1885.16889279398
"healthy-5"	"2019-08-29-count-1:GGTTAACGTAGTGTGG"	4.38781561431233	-8.15169908916625	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTAACGTAGTGTGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2110.62717524838	43.0921180354084	0.0204167360966237	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2105.30250428355	2105.30250428355
"healthy-5"	"2019-08-29-count-1:CACTTCGAGGGTCAAC"	-4.74131284180339	-5.13567259227904	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTTCGAGGGTCAAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2127.08378464824	48.5816746520808	0.0228395679581163	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2119.8524516561	2119.8524516561
"healthy-5"	"2019-08-29-count-1:ATTCGTTGTAGCGTCC"	-5.3271258873051	-5.30553390895995	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCGTTGTAGCGTCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2064.75577912105	48.4217604565242	0.0234515679511196	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2059.09530595709	2059.09530595709
"healthy-5"	"2019-08-29-count-1:TAACACGTCAGCCCAG"	-1.00452564182933	10.0516423949036	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACACGTCAGCCCAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1527.86860706255	40.2439408993856	0.0263399226303614	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1523.33343309653	1523.33343309653
"healthy-5"	"2019-08-29-count-1:CTCCAACTCTTAAGGC"	2.67967786368672	-8.45086004650267	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCAACTCTTAAGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1909.63404601603	46.1390001839903	0.0241611738543559	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1905.83561004818	1905.83561004818
"healthy-5"	"2019-08-29-count-2:TACTGCCAGGCTTAGG"	-3.21139083328899	13.0962447890076	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTGCCAGGCTTAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1646.26946490373	36.9909183295207	0.0224695404477322	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1643.8332292072	1643.8332292072
"healthy-5"	"2019-08-29-count-1:TAACCAGAGAGTGTGC"	-7.29117665711101	3.01728389346925	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACCAGAGAGTGTGC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2313.91994888451	42.3642372119839	0.0183084281858613	1507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2301.6939386193	2301.6939386193
"healthy-5"	"2019-08-29-count-2:CCTAAGACAGACTGCC"	-3.26215157929118	11.5080709227356	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAAGACAGACTGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.78082367156	47.1730660905605	0.0253240024221324	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1855.74289807732	1855.74289807732
"healthy-5"	"2019-08-29-count-1:CGGTCAGAGTGCAACG"	-3.4047101539677	3.72201225841371	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGTCAGAGTGCAACG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2973.88723777753	46.1409875539911	0.0155153789854095	3186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2970.96221992799	2970.96221992799
"healthy-5"	"2019-08-29-count-1:ACATCCCTCAAGAATG"	3.39736570891682	-8.39483930980834	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCCCTCAAGAATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2080.62030744524	48.7331146488204	0.0234223969046322	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2075.01323418323	2075.01323418323
"healthy-5"	"2019-08-29-count-2:GCCATGGTCACCTGTC"	-3.71125231209453	10.1162309416565	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATGGTCACCTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1713.23332444498	39.0642650688251	0.0228014856537304	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1713.23332444498	1713.23332444498
"healthy-5"	"2019-08-29-count-1:ATGGTTGCAACAGCTT"	1.93381835994069	-6.69866325771483	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGTTGCAACAGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1896.15289974	39.3499907963716	0.0207525410011857	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1894.41660382339	1894.41660382339
"healthy-5"	"2019-08-29-count-2:GAACACTCACGAGGAT"	2.41803540763203	-6.99108030712279	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAACACTCACGAGGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1866.93197751066	43.1180655324873	0.0230956810702767	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1864.91484338928	1864.91484338928
"healthy-5"	"2019-08-29-count-2:ACCGTTCTCTAGCAAC"	1.78738333758656	-6.74527456676634	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCGTTCTCTAGCAAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2108.25571214499	48.9737305237963	0.023229502114793	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2108.25571214499	2108.25571214499
"healthy-5"	"2019-08-29-count-2:CCTACGTTCCTCACGT"	-2.57535992088969	3.42374870860902	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTACGTTCCTCACGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3102.10449332292	46.8901025353255	0.0151155780329945	3248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3091.13904108371	3091.13904108371
"healthy-5"	"2019-08-29-count-2:TGAGCGCAGCGACTTT"	-4.3476165336674	-3.61753489887389	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGCGCAGCGACTTT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2774.64463115914	41.0210491709335	0.0147842533455524	2010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2769.35708446256	2769.35708446256
"healthy-5"	"2019-08-29-count-1:CTCCATGAGCATTGTC"	3.72647347029988	-8.44052412426146	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCATGAGCATTGTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1833.47339787943	39.9764430380851	0.0218036667913051	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1827.08900672995	1827.08900672995
"healthy-5"	"2019-08-29-count-2:GCCATTCCAAAGGGTC"	2.38370384749715	-4.25632193004759	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATTCCAAAGGGTC"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2488.97951264382	30.243650985008	0.0121510244786558	1612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2473.2929554232	2473.2929554232
"healthy-5"	"2019-08-29-count-2:GGGACTCGTTCGGTCG"	-2.67627082291301	10.1150493391785	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACTCGTTCGGTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1577.92656444369	41.9239902107532	0.0265690375936688	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1571.39136017549	1571.39136017549
"healthy-5"	"2019-08-29-count-1:ACTTTGTGTTACCGTA"	-3.77266154709514	12.4174089201721	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTTGTGTTACCGTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1546.70745647402	42.7860935161828	0.0276626929915505	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1539.54704801442	1539.54704801442
"healthy-5"	"2019-08-29-count-1:TAACGACAGAAATTGC"	-2.31747804108318	3.4206378229889	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACGACAGAAATTGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2881.50595979806	48.4111914592762	0.0168006563702089	3167	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2875.13534544626	2875.13534544626
"healthy-5"	"2019-08-29-count-2:TGAGCGCCACGGTGTC"	4.30682816085164	-7.64612677013548	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGCGCCACGGTGTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.59404996827	39.0844999200473	0.0180063609409685	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2165.69919679447	2165.69919679447
"healthy-5"	"2019-08-29-count-1:CGTAAGTAGCGAGAAA"	11.3739954429561	3.51241324031679	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTAAGTAGCGAGAAA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1487.70704022586	36.8797743391191	0.0247896752128834	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1485.15263470307	1485.15263470307
"healthy-5"	"2019-08-29-count-2:GTTACGAGTTTAGACC"	-3.56463275376018	12.763343788031	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTACGAGTTTAGACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1537.03825933415	36.9780670514159	0.0240580003957968	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1532.00103955113	1532.00103955113
"healthy-5"	"2019-08-29-count-1:GGAGATGTCGTTCAGA"	5.13119043883626	-10.2429876557556	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGATGTCGTTCAGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2193.23322189497	38.5451899473554	0.017574596975169	1127	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2193.23322189497	2193.23322189497
"healthy-5"	"2019-08-29-count-1:ATTGGGTGTCAGTCGC"	-2.68572364273723	10.8419112929138	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTGGGTGTCAGTCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1535.00652845466	37.7101327667246	0.0245667572532663	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1535.00652845466	1535.00652845466
"healthy-5"	"2019-08-29-count-1:TAACGACTCTGGCTGG"	3.52982558783833	-7.34744932567748	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACGACTCTGGCTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1819.86908769622	43.1927836562014	0.0237340058953797	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1817.82705183028	1817.82705183028
"healthy-5"	"2019-08-29-count-2:CCTCAACAGCTGACAG"	2.57772054251973	-6.42507221614989	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCAACAGCTGACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.80690653669	43.1212456111691	0.0222871054809062	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1929.2650027404	1929.2650027404
"healthy-5"	"2019-08-29-count-1:ACATGCACACAAAGTA"	14.3335710960323	1.91232142532197	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATGCACACAAAGTA"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1663.84941355637	33.6253248688947	0.0202093558437015	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1649.08578338559	1649.08578338559
"healthy-5"	"2019-08-29-count-2:CATTGCCTCCCGTTCA"	-1.2096577686375	10.2658900984558	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTGCCTCCCGTTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1645.04806914118	37.7155558398813	0.0229267196183339	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1640.56018924755	1640.56018924755
"healthy-5"	"2019-08-29-count-1:CTCCCAACATAGACTC"	10.5292231040889	6.6563248404297	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCCAACATAGACTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2101.63463277402	42.1514396435825	0.0200565022036896	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2096.65128258662	2096.65128258662
"healthy-5"	"2019-08-29-count-1:CATTTCATCAAGATAG"	3.84772457656209	-8.98849489605101	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTTCATCAAGATAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2021.31998525027	39.7480669016242	0.0196644109748427	972	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2021.31998525027	2021.31998525027
"healthy-5"	"2019-08-29-count-1:ATAGAGACATGACTTG"	-3.3063477081364	3.37402651393739	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATAGAGACATGACTTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3177.18770681004	45.9379009039749	0.0144586675837599	3504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3168.67250421552	3168.67250421552
"healthy-5"	"2019-08-29-count-1:GTCCCATTCCACTGAA"	2.92723383483235	-7.32954933559569	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCCCATTCCACTGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1534.08571535132	43.1462303125647	0.0281250453483846	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1531.49636842543	1531.49636842543
"healthy-5"	"2019-08-29-count-1:GATTGGTGTCATCGCG"	1.93310250815694	-6.58857681667479	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTGGTGTCATCGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1954.10296622423	49.6954719921586	0.0254313477084484	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1948.13831451168	1948.13831451168
"healthy-5"	"2019-08-29-count-2:GTGGAAGAGGACAACC"	-3.24854431572612	11.5941400297913	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAAGAGGACAACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1427.50246546105	42.5966718956133	0.0298399988275015	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1424.98821099398	1424.98821099398
"healthy-5"	"2019-08-29-count-1:GAAGTAAGTCCTGGGT"	10.9858147102291	4.34020803058473	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGTAAGTCCTGGGT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1413.1720606993	44.8700240234679	0.0317512815822755	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1410.60791536322	1410.60791536322
"healthy-5"	"2019-08-29-count-1:ACAAGCTAGATCGCCC"	-5.361555437476	-5.56581499492797	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAAGCTAGATCGCCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2068.89093279109	48.0874026001191	0.0232430824834471	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2067.00814869934	2067.00814869934
"healthy-5"	"2019-08-29-count-2:GAGTTTGAGGACGCAT"	-3.65652881088908	12.4361276396546	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTTGAGGACGCAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1451.25241131671	44.1485690808775	0.0304210134202787	536	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1443.86390837975	1443.86390837975
"healthy-5"	"2019-08-29-count-2:TGAGGTTTCAAGGAGC"	2.54763712462727	-4.26997616207274	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGGTTTCAAGGAGC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2459.79751937848	44.1514677198189	0.0179492284921788	1637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2458.64105705522	2458.64105705522
"healthy-5"	"2019-08-29-count-1:TAAGCACAGGACTTCT"	-3.81933699074443	12.5586595305237	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGCACAGGACTTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1764.89684231087	42.6684701865532	0.024176183652006	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1758.22593670201	1758.22593670201
"healthy-5"	"2019-08-29-count-2:ACTATGGAGCACCAGA"	11.4902578788692	3.60196564281312	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATGGAGCACCAGA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1517.05221364525	41.0812117465338	0.0270796294135597	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1507.08937630385	1507.08937630385
"healthy-5"	"2019-08-29-count-2:GGGAGTAGTCTCAAGT"	2.08087148246114	-6.9126301041809	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGTAGTCTCAAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1970.61272598001	49.3862492776536	0.0250613672725031	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1968.79819379065	1968.79819379065
"healthy-5"	"2019-08-29-count-1:ATTTACCAGAGAGCAA"	-3.61114297333415	-5.59781935131224	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTACCAGAGAGCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2327.6690487558	50.0672469427889	0.0215096072053504	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2322.86000876017	2322.86000876017
"healthy-5"	"2019-08-29-count-2:CTCAGAATCTATCCAT"	3.90548457679097	-7.74492123043212	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAGAATCTATCCAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.33911798106	44.8771675598008	0.0197406393110659	1175	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2273.33911798106	2273.33911798106
"healthy-5"	"2019-08-29-count-1:GACTATGAGGCTATCT"	-2.54889545860942	10.1404790648255	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTATGAGGCTATCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.34136440324	33.7864254179735	0.0188294301676594	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1791.82291815313	1791.82291815313
"healthy-5"	"2019-08-29-count-1:GGAGGTACAACCGCCA"	6.78433098372762	-1.70203735744628	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTACAACCGCCA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2208.44841877148	34.4527509370142	0.0156004327038707	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2198.60278073737	2198.60278073737
"healthy-5"	"2019-08-29-count-2:GAAGCCCCATCCGAAT"	3.77151312407796	-7.40247490322264	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGCCCCATCCGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2323.66247419196	45.818657905601	0.0197182931748872	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2318.93637110967	2318.93637110967
"healthy-5"	"2019-08-29-count-2:CCAAGCGAGGGTAATT"	-2.28480229798015	4.13374612415162	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAAGCGAGGGTAATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2925.9474298893	44.1500080393154	0.0150891323570314	2877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2920.66107546084	2920.66107546084
"healthy-5"	"2019-08-29-count-2:GCCGTGACAGAACCGA"	-2.34158978882487	3.98664853656618	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCGTGACAGAACCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2716.51375797925	49.0766375408822	0.0180660368079229	2438	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2709.42060476893	2709.42060476893
"healthy-5"	"2019-08-29-count-1:CGTCCATAGAAAGCGA"	3.84424175795857	-7.91649439251097	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTCCATAGAAAGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.80498215274	39.4667137493045	0.0188763247104322	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2081.79417188132	2081.79417188132
"healthy-5"	"2019-08-29-count-1:CCTCCTCGTAACGCGA"	11.9659906822139	-2.88070847904357	"2019-08-29-count-1"	"Control5"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCCTCGTAACGCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2073.52745891057	50.7659787119719	0.0244829064085046	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2067.3432892613	2067.3432892613
"healthy-5"	"2019-08-29-count-2:GAAGCGACAACCCGCA"	-2.71671472016032	12.1263475188049	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGCGACAACCCGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1419.84342759529	38.9660354896729	0.0274438960890691	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1419.84342759529	1419.84342759529
"healthy-5"	"2019-08-29-count-1:ACACCAAGTTTATGCG"	-0.690705279738265	8.96449849689332	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACCAAGTTTATGCG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1549.37915905882	43.0352712510647	0.027775816525896	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1542.43357746553	1542.43357746553
"healthy-5"	"2019-08-29-count-1:CGTCCATTCTCATTGT"	-4.03685985031779	-5.33351566707762	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTCCATTCTCATTGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2163.54875283285	49.0713860087576	0.0226809707636612	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2161.70378041692	2161.70378041692
"healthy-5"	"2019-08-29-count-1:CATGCGGTCATGACAC"	-2.37835536423381	9.78014371478883	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCGGTCATGACAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1474.7695339099	39.739854070141	0.0269464842854346	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1472.30823247531	1472.30823247531
"healthy-5"	"2019-08-29-count-1:CCTCCTCGTATCATGC"	2.61864819106404	-7.97386362468871	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCCTCGTATCATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1420.20577160284	48.3687940816884	0.0340575957715616	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1415.13880501813	1415.13880501813
"healthy-5"	"2019-08-29-count-1:CTCCGATTCACACCGG"	3.74801172789876	-8.01297380840453	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCGATTCACACCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1559.29209178145	46.87837972168	0.0300638860215874	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1559.29209178145	1559.29209178145
"healthy-5"	"2019-08-29-count-2:TAGAGTCTCCCATTTA"	-5.48937449875529	-3.11347582256468	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGAGTCTCCCATTTA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2779.30788920177	30.7527905054016	0.011064909585902	1812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2765.5786634164	2765.5786634164
"healthy-5"	"2019-08-29-count-2:GGGATGACAGGGCTTC"	-2.90777883949931	11.8714780577454	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATGACAGGGCTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1651.46241797709	36.5631921506817	0.0221398875037488	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1649.19711545287	1649.19711545287
"healthy-5"	"2019-08-29-count-1:CCTCTAGAGTGTAGAT"	3.13312115248982	-5.36351540004881	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTAGAGTGTAGAT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2360.3282055414	42.6756387587782	0.018080383337617	1405	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2356.27164889297	2356.27164889297
"healthy-5"	"2019-08-29-count-1:ACCACAAAGAGATGCC"	-0.577316562563735	8.7749452360901	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCACAAAGAGATGCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1376.27302363371	41.303052946803	0.0300107989022065	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1373.85990795037	1373.85990795037
"healthy-5"	"2019-08-29-count-1:CGTGAATTCGCTAATG"	2.28916134414021	-6.95504715358885	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGAATTCGCTAATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1684.60417166986	51.7194638773777	0.0307012559669201	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.46784602951	1682.46784602951
"healthy-5"	"2019-08-29-count-2:ATAGGCTCACCAGGTC"	3.89268889006917	-7.76652243053588	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGGCTCACCAGGTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1987.09297393635	46.0624665165644	0.0231808310535749	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.13601371616	1985.13601371616
"healthy-5"	"2019-08-29-count-2:ATAGGCTGTCCTTGTC"	-3.18252883377727	-5.67439749157103	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGGCTGTCCTTGTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2283.33988637892	44.7612726139197	0.0196034207964129	1241	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2275.60308501313	2275.60308501313
"healthy-5"	"2019-08-29-count-1:ATTTCTGTCCTGCTAC"	4.46213831481282	-7.64441444790038	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCTGTCCTGCTAC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2219.63841366703	39.1533281394299	0.0176395073622578	1137	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2216.32153393777	2216.32153393777
"healthy-5"	"2019-08-29-count-2:TCGCTTGTCGCTCTAC"	0.025452564551872	9.11653325641481	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTTGTCGCTCTAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1395.87829540188	35.9010780453775	0.0257193468539758	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1393.38944060161	1393.38944060161
"healthy-5"	"2019-08-29-count-1:CCACAAAAGACCACGA"	3.3266130882198	-8.13406088268431	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACAAAAGACCACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1719.40393588762	50.2349873334962	0.0292165129350847	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1715.22330995404	1715.22330995404
"healthy-5"	"2019-08-29-count-2:TGATGCATCCTAACAG"	-4.89372239533122	2.49521753871766	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGCATCCTAACAG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2455.35448629256	17.1765882546593	0.00699556351253984	1402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2451.12444999438	2451.12444999438
"healthy-5"	"2019-08-29-count-2:GTCACTCCAGGTTACT"	-3.73911414566692	12.5332984694275	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCACTCCAGGTTACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1525.28268860505	40.965321973551	0.0268575276436239	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1525.28268860505	1525.28268860505
"healthy-5"	"2019-08-29-count-2:TCATCATCACTGTGTA"	4.15287460860555	-7.45970489895018	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATCATCACTGTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2225.05856445832	37.60035910593	0.0168985930107793	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2223.33173995935	2223.33173995935
"healthy-5"	"2019-08-29-count-1:GGCAGTCAGCGCATCC"	-3.85912523689922	12.5565910109314	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCAGTCAGCGCATCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1777.00122061278	37.559055727295	0.0211362014227222	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1768.09042895568	1768.09042895568
"healthy-5"	"2019-08-29-count-2:CAGCAATCAAGAGATT"	-2.89001427117046	3.39268443668214	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAATCAAGAGATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3276.57400621543	44.1249562334719	0.0134667967669187	3885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3269.34114278477	3269.34114278477
"healthy-5"	"2019-08-29-count-2:TCGGATAGTGTACAGG"	2.42284884032552	-7.44148256694945	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGATAGTGTACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1533.13530337729	44.2454632749182	0.0288594641173883	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1525.86157540091	1525.86157540091
"healthy-5"	"2019-08-29-count-2:CCACAAAAGGCTTAGG"	1.83455373820607	-6.61285784160765	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACAAAAGGCTTAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.92918545894	47.4519782886077	0.0247541634028839	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1912.55214164767	1912.55214164767
"healthy-5"	"2019-08-29-count-2:CTCTGGTCATTGCTGA"	3.4232620197231	-6.46438076412352	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTGGTCATTGCTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1968.38457096265	44.3792415568476	0.0225460218554464	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1962.87427863826	1962.87427863826
"healthy-5"	"2019-08-29-count-1:CCGTTCACACTTACAG"	-0.939982931048232	9.76565454089967	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTTCACACTTACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1649.60278120485	41.6498410110724	0.025248406153057	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1645.03252862606	1645.03252862606
"healthy-5"	"2019-08-29-count-2:GCGGAAAGTAGCTAAA"	2.01527156409566	-6.79956486141356	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGGAAAGTAGCTAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1530.00256994057	48.4687978424259	0.0316788996271481	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1522.97404029912	1522.97404029912
"healthy-5"	"2019-08-29-count-1:CAACAACTCTCTCGCA"	8.1278473335201	6.21183345401613	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACAACTCTCTCGCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1495.01250654277	41.8602410986063	0.0279999270343286	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1490.23228737767	1490.23228737767
"healthy-5"	"2019-08-29-count-2:GAATAGAAGTAAAGCT"	-2.72811685028728	12.104598022345	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAATAGAAGTAAAGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1497.60515438269	40.9951934181832	0.0273738330148051	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1497.60515438269	1497.60515438269
"healthy-5"	"2019-08-29-count-1:CTCAGTCCAACGGGTA"	2.92771496352498	-8.51563360607298	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGTCCAACGGGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1846.47561250033	38.8616612311207	0.0210463983212309	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1846.47561250033	1846.47561250033
"healthy-5"	"2019-08-29-count-1:CTCAGTCTCCACGTGG"	1.44294180449788	-7.0871415368286	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGTCTCCACGTGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1709.28287619856	45.0389900316436	0.026349640927668	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1709.28287619856	1709.28287619856
"healthy-5"	"2019-08-29-count-1:GTTGTGACAGTGTACT"	6.90861095961873	-1.19169249450835	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTGACAGTGTACT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1966.88256840867	32.5198621645634	0.0165337080550132	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1966.88256840867	1966.88256840867
"healthy-5"	"2019-08-29-count-1:ACCCAAAGTACCTTCC"	4.01392998275105	-8.39438440715941	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCCAAAGTACCTTCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2181.57693763737	39.3885863022705	0.0180550984119442	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2176.13508714124	2176.13508714124
"healthy-5"	"2019-08-29-count-1:GCCAACGCAAGGAGTC"	4.03483905371968	-8.22628405010375	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAACGCAAGGAGTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2388.03134777916	46.6534236074483	0.0195363530930344	1379	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2382.29266452313	2382.29266452313
"healthy-5"	"2019-08-29-count-1:GTACAGTTCTTGAGCA"	-3.07089434090312	12.3843726881775	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTACAGTTCTTGAGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1454.49662567323	39.8332346336182	0.0273862681635173	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1447.05274030324	1447.05274030324
"healthy-5"	"2019-08-29-count-1:CAGGCCACAGCTGAAG"	-1.65369031849559	9.86786840045778	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGCCACAGCTGAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1571.77395797609	43.254295430372	0.0275194121972023	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1571.77395797609	1571.77395797609
"healthy-5"	"2019-08-29-count-1:CCTGTTGCATCTAGAC"	1.81106831607167	-7.4586653939453	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTGTTGCATCTAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1738.1215227773	43.189577358219	0.0248484221570466	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1738.1215227773	1738.1215227773
"healthy-5"	"2019-08-29-count-2:TCGGGACTCTTACTGT"	-1.21192822876628	8.73592660510866	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGGACTCTTACTGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.582486423	44.2921363856672	0.0264654636057612	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1669.45077168333	1669.45077168333
"healthy-5"	"2019-08-29-count-2:CCCTAACGTTTAGACC"	-2.80084977570232	9.64694497669069	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTAACGTTTAGACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1733.37904684862	38.4750826506716	0.0221965776733147	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1726.88185229538	1726.88185229538
"healthy-5"	"2019-08-29-count-2:AGTGCCGCAAATGGCG"	3.18689908561055	-7.65712168132933	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGCCGCAAATGGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1563.11973851598	44.5313545527974	0.0284887673384992	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1558.74196823282	1558.74196823282
"healthy-5"	"2019-08-29-count-2:GGCTTTCTCTGTACAG"	2.03949667987172	-7.48761513149413	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTTTCTCTGTACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1441.01045782001	42.6138528182771	0.0295722023299847	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1438.45959397116	1438.45959397116
"healthy-5"	"2019-08-29-count-2:CCTGCATCATATCGGT"	-4.0629976791447	12.1096429594788	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGCATCATATCGGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1689.09378355528	42.370532803647	0.0250847722110868	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1686.7900452069	1686.7900452069
"healthy-5"	"2019-08-29-count-2:TAGGGTTTCCGTGTCT"	-2.9732805294102	11.9863643416199	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGGGTTTCCGTGTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1641.02367146022	36.0019716301976	0.021938727793099	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1641.02367146022	1641.02367146022
"healthy-5"	"2019-08-29-count-2:CCACCATCAAATGAGT"	11.48579945144	3.91972706401674	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACCATCAAATGAGT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1597.71989945262	46.1092243039877	0.0288593916366597	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1590.58663535706	1590.58663535706
"healthy-5"	"2019-08-29-count-1:GGCTTGGCAGCACAAG"	-1.04544995251353	9.34844110095827	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTTGGCAGCACAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1644.99843881096	34.3322507851808	0.0208706889776728	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1644.99843881096	1644.99843881096
"healthy-5"	"2019-08-29-count-2:CCTGTTGAGAACTCCT"	4.12170185622518	-7.14687921917113	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGTTGAGAACTCCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2010.43343326565	44.1605003946678	0.0219656615652952	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2005.00070242739	2005.00070242739
"healthy-5"	"2019-08-29-count-2:CTGAGGCCAGCTACCG"	-3.61432753029521	12.6047782667908	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAGGCCAGCTACCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1612.42528993574	48.3612873444805	0.029992885652648	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1610.15029354601	1610.15029354601
"healthy-5"	"2019-08-29-count-2:TCGGGCATCGCCGAAC"	3.37671722945516	-8.28787233745726	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGGCATCGCCGAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1582.17563387706	39.2747849656306	0.0248232775961725	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1579.7896100902	1579.7896100902
"healthy-5"	"2019-08-29-count-2:CTGAGGCTCAAGCCCG"	-7.60969195786174	0.483563966396727	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAGGCTCAAGCCCG"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2691.09800366202	43.685988002832	0.0162335180448221	2036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2686.71177160159	2686.71177160159
"healthy-5"	"2019-08-29-count-1:TACACCCCAGGTTCAT"	-4.14012751999553	12.3436717757019	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACACCCCAGGTTCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1717.43637742221	39.8251215288984	0.0231887026806047	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1717.43637742221	1717.43637742221
"healthy-5"	"2019-08-29-count-2:GCGTTTCGTAGCGTTT"	6.80781807479207	-1.48370208656462	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGTTTCGTAGCGTTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2099.05725945225	38.6561340830002	0.018415950260017	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2097.15558231258	2097.15558231258
"healthy-5"	"2019-08-29-count-2:TGACTCCGTCGACTGC"	3.19128455695454	-8.13165571605834	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACTCCGTCGACTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1596.91305819051	42.4465461359275	0.0265803738771004	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1589.49025957441	1589.49025957441
"healthy-5"	"2019-08-29-count-1:ACCGTTCGTGAGTTTC"	2.98186482962911	-5.02924015438231	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCGTTCGTGAGTTTC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2431.48748140112	43.332588188271	0.0178214317448598	1468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2428.84372109874	2428.84372109874
"healthy-5"	"2019-08-29-count-1:ACCGTTCCATAAGCGG"	3.64457573470418	-8.2705755463806	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCGTTCCATAAGCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.10991035647	45.5083728183952	0.0259290729029912	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1755.10991035647	1755.10991035647
"healthy-5"	"2019-08-29-count-1:AAGGAATGTATAATGG"	-3.41149626198466	-5.66163399135741	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGGAATGTATAATGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1845.51792288198	50.6874110104951	0.0274651415638062	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1845.51792288198	1845.51792288198
"healthy-5"	"2019-08-29-count-1:ATCGTGAGTTACCGTA"	2.97083940085713	-4.94143917476805	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTGAGTTACCGTA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2303.00902709487	39.6589396039859	0.0172204881254911	1401	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2295.20713803639	2295.20713803639
"healthy-5"	"2019-08-29-count-2:CTGATCCTCGCCTTTG"	-3.97513757172282	-4.56525375759276	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGATCCTCGCCTTTG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2874.21232588986	46.5665441009332	0.016201497600396	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2865.45228172719	2865.45228172719
"healthy-5"	"2019-08-29-count-1:GGGAAGTGTTATGTGC"	-4.46791348877605	-5.32093050396117	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAAGTGTTATGTGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1814.764100493	51.3908822908025	0.0283182162777198	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1810.51118873402	1810.51118873402
"healthy-5"	"2019-08-29-count-2:CCTTCAGCAGTGCGCT"	3.47771658477132	-7.97034742748412	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTTCAGCAGTGCGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1384.03481039398	50.1180270374072	0.0362115364881182	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1379.21951751155	1379.21951751155
"healthy-5"	"2019-08-29-count-1:GTGGAAGTCTCCCAAC"	-1.8490094942158	4.1102289923462	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGAAGTCTCCCAAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3002.03050350787	44.3871867315508	0.0147857214241109	3853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2996.85207430698	2996.85207430698
"healthy-5"	"2019-08-29-count-1:GGGAAGTTCCTTCTTC"	4.20405640181844	-7.99885752117308	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAAGTTCCTTCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2704.44535840104	40.4294386483535	0.0149492532813667	1820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2702.10251757039	2702.10251757039
"healthy-5"	"2019-08-29-count-1:GTGGAGAAGGCCCACT"	-3.78903446617778	-4.70305302059325	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGAGAAGGCCCACT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2433.73649121749	48.6329830778324	0.0199828466447916	1398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2429.448918836	2429.448918836
"healthy-5"	"2019-08-29-count-2:CCTTCAGGTTGTATGC"	-6.19918427887614	4.04387662494508	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTTCAGGTTGTATGC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2006.3058207391	39.7546262935624	0.0198148387362587	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1999.8721384183	1999.8721384183
"healthy-5"	"2019-08-29-count-1:GGGACAAAGGTATCTC"	-0.674339036375839	9.10569665515748	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACAAAGGTATCTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1486.12064556829	44.2846090771914	0.0297987981051545	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1486.12064556829	1486.12064556829
"healthy-5"	"2019-08-29-count-2:CAGGCCACACCTGAAT"	-0.454711536795455	8.38385865772096	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGCCACACCTGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1521.84466740648	41.1343588928924	0.027029275571858	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1512.90527658081	1512.90527658081
"healthy-5"	"2019-08-29-count-2:GATGAGGCATCTAGAC"	5.24373592910115	-10.0764112702576	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGAGGCATCTAGAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1926.69407937107	43.9736147451084	0.0228233507415265	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1926.69407937107	1926.69407937107
"healthy-5"	"2019-08-29-count-2:GCTACCTGTCTACACA"	3.44988574561421	-6.81454040920409	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTACCTGTCTACACA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2296.03290043027	40.3446459651934	0.0175714581257233	1300	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2287.22611032575	2287.22611032575
"healthy-5"	"2019-08-29-count-1:CTCTGGTTCGATCCCT"	14.4318033653194	1.95010349834291	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTGGTTCGATCCCT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1782.74159751936	30.1143579939006	0.0168921609479489	1342	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1768.37531287704	1768.37531287704
"healthy-5"	"2019-08-29-count-2:GAACACTGTTCCTACC"	2.85134424743001	-8.14506246959838	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAACACTGTTCCTACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1719.15891145327	40.8813124697578	0.0237798333809637	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1719.15891145327	1719.15891145327
"healthy-5"	"2019-08-29-count-1:GAGTTACTCTCACTCG"	3.14920105513875	-7.96628096019896	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTTACTCTCACTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1468.37918311793	46.1366905602164	0.0314201475277323	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1465.90671294907	1465.90671294907
"healthy-5"	"2019-08-29-count-2:GAGACCCGTCTGTCAA"	5.38977541503255	-10.1327724686828	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACCCGTCTGTCAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2200.30170237148	41.4019545261025	0.0188164897938676	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2192.72312538018	2192.72312538018
"healthy-5"	"2019-08-29-count-1:TATTTCGGTTCGGTAT"	2.97901763495747	-7.85922291195067	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTTCGGTTCGGTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1583.9997803262	50.5810846906799	0.0319325073897823	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1581.79002192281	1581.79002192281
"healthy-5"	"2019-08-29-count-1:CAGTTAGCAACTCGAT"	2.54037012633626	-7.36106588756713	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGCAACTCGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1840.66613593229	44.4676519912209	0.0241584560736748	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1838.72767502879	1838.72767502879
"healthy-5"	"2019-08-29-count-2:GTCGCGAAGTGGAAAG"	-3.24717913094218	3.66318414295045	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCGCGAAGTGGAAAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2515.93244458432	50.8066445118994	0.0201939621317192	1802	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2510.71487410372	2510.71487410372
"healthy-5"	"2019-08-29-count-1:GGGACCTAGTAGACCG"	10.4175249534542	6.63319299304811	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACCTAGTAGACCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1805.51599862768	40.2537376026233	0.0222948661951592	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1797.66699539135	1797.66699539135
"healthy-5"	"2019-08-29-count-1:ATGACCACACACAGCC"	-3.53097258034404	3.72072765910951	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGACCACACACAGCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3148.77533784494	49.6196820337525	0.0157584065898181	3654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3137.82351193435	3137.82351193435
"healthy-5"	"2019-08-29-count-1:CTACAGAAGAATAGTC"	6.81566729125325	-1.556307934877	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACAGAAGAATAGTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2166.82307524128	36.7201589397227	0.0169465423177819	1037	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2158.07645111738	2158.07645111738
"healthy-5"	"2019-08-29-count-2:GATGCTAAGGTCACCC"	-3.52593789520915	-5.29519750988158	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGCTAAGGTCACCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2622.96343846304	47.2281629300816	0.018005650493457	1765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2614.89200864358	2614.89200864358
"healthy-5"	"2019-08-29-count-1:GCCATTCGTCTCGACG"	3.43089332160298	-7.58063223278197	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCATTCGTCTCGACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.39768818271	46.867233804121	0.0229696563937315	973	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2040.39768818271	2040.39768818271
"healthy-5"	"2019-08-29-count-1:CAAGAGGAGCCTCAGC"	-7.47527490082439	0.0533237720834984	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGAGGAGCCTCAGC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2975.5156671825	50.0590686319188	0.0168236615871425	2400	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2970.03714523467	2970.03714523467
"healthy-5"	"2019-08-29-count-1:GTAGGTTCAGTCAGTT"	-2.02025995674785	3.43223235690919	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGTTCAGTCAGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2645.94267652449	50.1345569526541	0.0189477109226368	2273	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2639.5708963559	2639.5708963559
"healthy-5"	"2019-08-29-count-1:CTGAGGCCACCAATTG"	-1.79155240479167	9.92393109882203	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGAGGCCACCAATTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1531.66554862362	43.9726471748383	0.0287090397863639	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1531.66554862362	1531.66554862362
"healthy-5"	"2019-08-29-count-2:CTGCCATCACTGAGGA"	5.03708805617635	-8.90660669719847	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCATCACTGAGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.66414050873	41.4167172270023	0.0192845410256707	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2140.79810160243	2140.79810160243
"healthy-5"	"2019-08-29-count-1:AAGTGAATCTGTCCGT"	-1.09957919541057	10.0453004606995	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGTGAATCTGTCCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1410.15740329538	41.3079980442615	0.0292931824119275	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1407.70686357002	1407.70686357002
"healthy-5"	"2019-08-29-count-2:TCGTGGGGTGCAGATG"	3.25983347472493	-7.70920183574828	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGTGGGGTGCAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1496.72447996662	43.8637909352576	0.0293065233597542	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1494.26909758032	1494.26909758032
"healthy-5"	"2019-08-29-count-2:TCGTGGGTCCATCGTC"	-3.32789383354838	3.49194381320802	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGTGGGTCCATCGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2833.4772185918	45.6511916925093	0.0161113671191602	2383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2831.81532863192	2831.81532863192
"healthy-5"	"2019-08-29-count-2:CCATAAGGTTGTGGCC"	3.30727519568745	-7.75538780605467	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCATAAGGTTGTGGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1648.9871585027	47.1320545992517	0.0285824267073421	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1646.74589050101	1646.74589050101
"healthy-5"	"2019-08-29-count-2:GACCAATAGTGTCATC"	9.25050987777058	6.22708652103273	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCAATAGTGTCATC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.64570058386	42.0376250957879	0.0238356406175408	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1761.61932941064	1761.61932941064
"healthy-5"	"2019-08-29-count-1:GGGACTCTCGCTCTCA"	11.4278036552364	3.60428092563478	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACTCTCGCTCTCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.39137107135	35.7058159076902	0.0221171994272956	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1604.89846243339	1604.89846243339
"healthy-5"	"2019-08-29-count-2:CTACATTCAAACCACT"	2.92459287223164	-7.385937713739	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACATTCAAACCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1986.46274655911	44.8865255365233	0.0225962080659576	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1982.66673026965	1982.66673026965
"healthy-5"	"2019-08-29-count-2:TACTTGTTCGTAACAC"	5.41728128966634	-10.0656490555969	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTGTTCGTAACAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2310.33335254694	39.0032562014318	0.0168820902656468	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2298.97939985798	2298.97939985798
"healthy-5"	"2019-08-29-count-1:ACATTTCAGCGTACAG"	1.38243212279622	-6.76501037990721	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATTTCAGCGTACAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1783.29047344567	53.484998567517	0.0299923088043944	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1783.29047344567	1783.29047344567
"healthy-5"	"2019-08-29-count-2:GCCCGAATCCGGGACT"	10.2836729484493	6.02704713428346	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCCGAATCCGGGACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1560.76331533427	39.8370521560716	0.0255240828411832	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1558.4538287264	1558.4538287264
"healthy-5"	"2019-08-29-count-2:ATACCTTCAGTCTGGC"	2.47615685042683	-4.37267734920653	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCTTCAGTCTGGC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2571.70698046182	38.6145864636579	0.01501515793091	1678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2568.00828016279	2568.00828016279
"healthy-5"	"2019-08-29-count-2:GTGGAAGCATCCGATA"	-7.28866181793864	-0.354446642753206	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAAGCATCCGATA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1707.21331631181	47.1917523586829	0.0276425634147665	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1701.13605570718	1701.13605570718
"healthy-5"	"2019-08-29-count-2:TAGACCATCATGCGGC"	5.43631519851033	-10.1481580964294	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGACCATCATGCGGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2065.17821582897	39.7408000135184	0.019243278719927	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2058.70540955968	2058.70540955968
"healthy-5"	"2019-08-29-count-1:CTACATTGTTGGGATG"	-0.927983979613143	10.0069474943909	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACATTGTTGGGATG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1483.61571347757	43.9594890123424	0.029629969953137	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1478.8301102898	1478.8301102898
"healthy-5"	"2019-08-29-count-1:AATCACGAGGGTTTCT"	3.48555078086202	-7.66315176403197	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCACGAGGGTTTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1546.0295071197	48.0138269731701	0.0310562164254039	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1546.0295071197	1546.0295071197
"healthy-5"	"2019-08-29-count-2:GACCCAGCAGCTACTA"	-0.166547666222411	7.91639087283937	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCCAGCAGCTACTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1655.44541445248	43.9871588411839	0.026571192536561	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1651.05464633777	1651.05464633777
"healthy-5"	"2019-08-29-count-1:AAACGAAGTTGCGGCT"	-3.15946469727214	-5.65524961864623	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGAAGTTGCGGCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1912.77515306882	49.8698493832875	0.0260719872397324	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1906.78610643355	1906.78610643355
"healthy-5"	"2019-08-29-count-1:AAACGAATCCGGACTG"	4.90517868575398	-7.40074636852416	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGAATCCGGACTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2183.93415177976	40.7273317569835	0.0186486079370998	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2177.71158155259	2177.71158155259
"healthy-5"	"2019-08-29-count-1:AAACGAATCTCGTCGT"	3.06354012069051	-7.81822540676268	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGAATCTCGTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1614.17758321706	45.3530488415744	0.028096691041382	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1609.53299228976	1609.53299228976
"healthy-5"	"2019-08-29-count-1:TACCTCGCAGAAACCG"	4.30287184295003	-8.74566938793334	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTCGCAGAAACCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.32579490325	39.6461785698816	0.0172500255002144	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2292.00549953936	2292.00549953936
"healthy-5"	"2019-08-29-count-2:AGAAATGTCGTCCTCA"	2.56657900389974	-7.05612518703612	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAAATGTCGTCCTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1752.94387370643	41.9195438523168	0.0239137969452963	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.11116000795	1746.11116000795
"healthy-5"	"2019-08-29-count-1:TACCTCGTCAGTCATG"	-0.748180012137252	10.1617498167786	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCTCGTCAGTCATG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1615.07709621331	38.6935339928583	0.0239577008946376	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1610.67149168855	1610.67149168855
"healthy-5"	"2019-08-29-count-2:TATCGCCTCCTAAGTG"	-3.76415715637859	12.5130691298279	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCGCCTCCTAAGTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.59200678172	42.7149877573392	0.0265542708015803	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1606.47040000527	1606.47040000527
"healthy-5"	"2019-08-29-count-1:AATCACGTCATACGGT"	-3.1923500103062	12.7371968992981	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCACGTCATACGGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1609.15070180065	45.5588201036763	0.0283123389578712	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1604.40902093729	1604.40902093729
"healthy-5"	"2019-08-29-count-2:GACCCTTTCGGTTGTA"	2.88639869269673	-8.362669014093	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCCTTTCGGTTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1642.65865694181	44.6398487655881	0.0271753651173614	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1640.46187764957	1640.46187764957
"healthy-5"	"2019-08-29-count-2:ATCGCCTCACATATGC"	4.29523052748982	-8.18984987651976	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGCCTCACATATGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2190.45278118622	43.6212919101116	0.0199142808668484	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2186.89601733934	2186.89601733934
"healthy-5"	"2019-08-29-count-2:GACCGTGCACCAACAT"	5.25203527983968	-9.85496237194213	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCGTGCACCAACAT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.03134994179	42.5419181450126	0.0188152712460655	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2258.0861324397	2258.0861324397
"healthy-5"	"2019-08-29-count-2:CGACAGCCAGCTACTA"	-3.67295513573344	10.1828431853089	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGACAGCCAGCTACTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1817.6790655328	33.0720881286858	0.0181946795536162	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1815.53652081857	1815.53652081857
"healthy-5"	"2019-08-29-count-1:ATTATCCTCCCAGGCA"	3.85846747931783	-7.11405041134032	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTATCCTCCCAGGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1878.5826505572	45.8587920472346	0.0244113784579202	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1870.26250643187	1870.26250643187
"healthy-5"	"2019-08-29-count-2:GTCTCACCACGTACAT"	3.18153371390645	-7.43452360546263	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACCACGTACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.5287456211	45.0483210442988	0.0230363890815581	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1955.5287456211	1955.5287456211
"healthy-5"	"2019-08-29-count-2:TCAGTTTTCCATTCGC"	-2.59889040413554	11.2104110487732	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGTTTTCCATTCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.00528291981	39.7725371821524	0.0237731091397031	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.78266373064	1670.78266373064
"healthy-5"	"2019-08-29-count-1:AGATGCTAGCATCCTA"	5.40173878249471	-9.87129595195922	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGCTAGCATCCTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.66178166205	40.861213094157	0.0180111524002584	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2256.91577684201	2256.91577684201
"healthy-5"	"2019-08-29-count-1:GAATCACAGTTGGACG"	-4.08613238754924	-5.24583818828734	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATCACAGTTGGACG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2585.30194287512	51.3351596447122	0.0198565431732985	1737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2581.99767247967	2581.99767247967
"healthy-5"	"2019-08-29-count-2:TCTACCGTCAAATGAG"	10.7336975532467	4.65802857959596	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACCGTCAAATGAG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1566.29074448219	42.6879838230031	0.02725418890036	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1561.62956531437	1561.62956531437
"healthy-5"	"2019-08-29-count-2:GACCTTCAGCCTAACT"	3.54329099234883	-7.85586693203124	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCTTCAGCCTAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1746.4033863587	49.6761619196838	0.0284448382932078	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1742.08219733689	1742.08219733689
"healthy-5"	"2019-08-29-count-1:TACGCTCAGCTGTACT"	10.2651945548946	6.3457345732483	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGCTCAGCTGTACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1432.04736089615	43.184873959885	0.0301560375299743	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1429.77615021284	1429.77615021284
"healthy-5"	"2019-08-29-count-1:CGAGGAAAGTGGACGT"	-3.32823906365092	10.5924405821594	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGAAAGTGGACGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1459.02335952	44.2035262089065	0.0302966542108338	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1454.3604285313	1454.3604285313
"healthy-5"	"2019-08-29-count-1:AAAGAACGTACGACTT"	9.81905235823933	6.03979537570802	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGAACGTACGACTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1500.54645370909	41.2149200879336	0.0274666072390212	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1498.26285938448	1498.26285938448
"healthy-5"	"2019-08-29-count-1:CCCTAACTCCCGTTCA"	9.8349424796993	6.7660455473694	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTAACTCCCGTTCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1515.00785097717	36.8900741674431	0.0243497577544891	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1508.08736173811	1508.08736173811
"healthy-5"	"2019-08-29-count-1:GGGCGTTAGGAACTAT"	3.04937996444051	-7.17855312740477	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCGTTAGGAACTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1617.70529617501	47.7293968969962	0.0295043831591886	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1613.0454593097	1613.0454593097
"healthy-5"	"2019-08-29-count-2:AGAAGCGGTGTCCCTT"	2.86814298209493	-10.8477430573669	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAAGCGGTGTCCCTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.03510611527	44.9606368443257	0.0216465464218449	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2073.65906925251	2073.65906925251
"healthy-5"	"2019-08-29-count-2:CAACGATTCGAGCCAC"	-3.35643372955974	11.9955444105896	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACGATTCGAGCCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.89929345336	45.5524858319929	0.0263020407734924	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1731.89929345336	1731.89929345336
"healthy-5"	"2019-08-29-count-2:GACGCTGGTACGTGAG"	6.79011120375935	-1.66568889534148	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACGCTGGTACGTGAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2182.8178024846	29.1646547342602	0.0133610119456894	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2175.27648473824	2175.27648473824
"healthy-5"	"2019-08-29-count-2:GACGCTGGTCACCGAC"	-3.02340040627177	12.8259744414124	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACGCTGGTCACCGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1622.52602984627	39.5896868250198	0.0244000318619054	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1615.44465076328	1615.44465076328
"healthy-5"	"2019-08-29-count-1:ATGCCTCGTCGAATTC"	2.84536137160603	-7.60519697582396	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCGTCGAATTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1989.98384368287	51.7912835555127	0.0260259819294123	936	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1978.74309961867	1978.74309961867
"healthy-5"	"2019-08-29-count-2:TCTATACTCTTGGTCC"	-2.46029458466228	12.5359382399353	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATACTCTTGGTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1621.12081650172	34.502928899275	0.0212833790967722	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1613.39763482281	1613.39763482281
"healthy-5"	"2019-08-29-count-1:CGAGGCTTCACATCAG"	2.36165847358052	-7.13519337093505	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGGCTTCACATCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1924.91121019436	54.5428563984567	0.0283352583275514	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1920.90546019801	1920.90546019801
"healthy-5"	"2019-08-29-count-1:AGCATCATCGACATCA"	-3.19945202294047	12.0541810759339	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCATCATCGACATCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1725.38064573891	42.582212922636	0.0246798948555493	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1716.73262563549	1716.73262563549
"healthy-5"	"2019-08-29-count-2:TAAGCACTCCGTAGGC"	3.24739374694173	-6.99850323116454	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCACTCCGTAGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1890.44749728161	37.7657506552555	0.0199771486431447	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1888.37204014696	1888.37204014696
"healthy-5"	"2019-08-29-count-1:CTACTATAGTATGCAA"	3.7832325893337	-7.83995296871337	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACTATAGTATGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.74189433756	40.3841579637401	0.0213138043152095	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.72549115301	1890.72549115301
"healthy-5"	"2019-08-29-count-1:CTGCCTATCAATGTCG"	3.69002523001973	-8.34974005138548	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCCTATCAATGTCG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1823.59349680698	48.0191479197846	0.0263321557155493	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1819.66132013374	1819.66132013374
"healthy-5"	"2019-08-29-count-2:GAAGTAATCTTTGCTA"	1.7361738878185	-6.12270214473876	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGTAATCTTTGCTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2265.19768902651	46.4970539207561	0.0205267090576711	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2261.83781360265	2261.83781360265
"healthy-5"	"2019-08-29-count-2:ATCGTCCAGCCATCCG"	2.38123120841328	-4.21179201519164	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGTCCAGCCATCCG"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2520.78545102952	38.7071253435625	0.0153551843643631	1725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2515.28125055412	2515.28125055412
"healthy-5"	"2019-08-29-count-1:CCCTCTCAGCATTTCG"	0.992601295083207	8.91686914050905	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCTCAGCATTTCG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1518.7286937336	44.6231999953826	0.0293819430550707	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1514.18832961142	1514.18832961142
"healthy-5"	"2019-08-29-count-1:CCCTCTCAGTATCTGC"	3.00740541991536	-8.349241279718	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCTCAGTATCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.82828030084	37.6401142992289	0.017243735862741	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2173.30530539378	2173.30530539378
"healthy-5"	"2019-08-29-count-2:TAAGCCACACCTGTCT"	2.96210183677022	-7.68293287670287	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCCACACCTGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1713.65486466483	45.5508313377029	0.0265811000084968	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1713.65486466483	1713.65486466483
"healthy-5"	"2019-08-29-count-2:CCACAAAGTCCAAAGG"	-5.50763259354289	-5.63929464733275	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACAAAGTCCAAAGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2244.96247404399	42.458066767822	0.0189125953144953	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2244.96247404399	2244.96247404399
"healthy-5"	"2019-08-29-count-1:CGAGTTAGTGCTGTCG"	-2.95541058006938	10.6719608076843	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGTTAGTGCTGTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1426.08734146723	36.9640617203848	0.0259199143317227	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1423.57876229468	1423.57876229468
"healthy-5"	"2019-08-29-count-1:GCGGATCAGATGCAGC"	-0.451463143259841	8.56774423206178	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGGATCAGATGCAGC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1449.24770203792	40.6576026256631	0.0280542812443247	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1442.25310156812	1442.25310156812
"healthy-5"	"2019-08-29-count-1:CACAACACATTGTACG"	-3.89971218529399	-5.47439196026	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAACACATTGTACG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2204.94857863184	44.4190973003269	0.0201451851216815	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2204.94857863184	2204.94857863184
"healthy-5"	"2019-08-29-count-1:ATGGAGGCACATTGTG"	-2.56762705269511	4.08874604785768	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGAGGCACATTGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3214.40572233436	47.7662227099892	0.0148600478085575	4236	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3210.28985933767	3210.28985933767
"healthy-5"	"2019-08-29-count-2:AGGTCATGTTGTCAGT"	3.142515082925	-7.39866783535155	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCATGTTGTCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1921.12428281331	44.324211922621	0.0230720169013284	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1919.0791893461	1919.0791893461
"healthy-5"	"2019-08-29-count-2:GTGAGTTGTAGCTTTG"	3.35673107680623	-7.6889047852722	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGAGTTGTAGCTTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1753.21917473283	48.9181801848645	0.0279019194461634	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1753.21917473283	1753.21917473283
"healthy-5"	"2019-08-29-count-1:AGCCACGGTGTCCACG"	2.54201235350911	-6.32987739956053	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCACGGTGTCCACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1838.17234138612	49.5538301883638	0.0269582068409301	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1834.24159254857	1834.24159254857
"healthy-5"	"2019-08-29-count-1:ACCCTCATCGTAGAGG"	-3.13355408135112	3.32243464076845	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCCTCATCGTAGAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2996.77224084527	47.9057429709771	0.0159857804066768	2964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2990.00271245382	2990.00271245382
"healthy-5"	"2019-08-29-count-1:TACAACGAGCTAGTTC"	4.5954085784847	-8.69570352947386	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACAACGAGCTAGTTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.68707912561	37.3016806537936	0.0171921937558048	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2163.7309446503	2163.7309446503
"healthy-5"	"2019-08-29-count-1:ACGTAGTAGCGGGTAT"	-3.46007428589519	12.6788654097351	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTAGTAGCGGGTAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1623.23403558548	40.4883424140962	0.0249430097733828	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1620.78678559671	1620.78678559671
"healthy-5"	"2019-08-29-count-2:ATCGTGATCCACCCTA"	-3.95296416702922	12.3735732802185	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGTGATCCACCCTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1553.8541004525	33.8787915028814	0.0218030711461363	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1553.8541004525	1553.8541004525
"healthy-5"	"2019-08-29-count-1:CGATCGGGTCGTATTG"	0.314841647713822	8.43171880328981	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATCGGGTCGTATTG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1701.86458747261	46.3961285087738	0.0272619389640603	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1693.28877285019	1693.28877285019
"healthy-5"	"2019-08-29-count-1:TACTGCCCACACCGCA"	9.37318100508992	5.51690194690553	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTGCCCACACCGCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1612.78575999876	45.5360768664775	0.0282344239364517	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1599.20303513454	1599.20303513454
"healthy-5"	"2019-08-29-count-1:AAAGTGAGTCACAATC"	1.16734077510182	-6.41073038494261	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGTGAGTCACAATC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2051.48753077361	49.6194032103782	0.0241870362193559	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2042.36130115646	2042.36130115646
"healthy-5"	"2019-08-29-count-2:GGTGGCTAGCAGTAAT"	-5.07397113266643	-4.40778734600218	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGGCTAGCAGTAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2989.44695392132	44.0306230614569	0.0147286851849641	2420	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2987.67996959595	2987.67996959595
"healthy-5"	"2019-08-29-count-2:GACTATGTCTTGATTC"	10.3517786460811	7.35050485217897	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACTATGTCTTGATTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2096.44626370822	41.0338995082027	0.0195730747878181	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2089.40619454266	2089.40619454266
"healthy-5"	"2019-08-29-count-1:GACATCATCTTGAGCA"	3.04209532317464	-7.54367544567259	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCATCTTGAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1802.87708315168	44.8146454624356	0.024857293867252	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1800.73229333978	1800.73229333978
"healthy-5"	"2019-08-29-count-1:CCCTTAGGTCTAACTG"	3.63177933272664	-8.16371824657591	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTTAGGTCTAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1660.36207486792	43.6325702289753	0.02627894896506	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1660.36207486792	1660.36207486792
"healthy-5"	"2019-08-29-count-2:TCCCAGTTCACAAGAA"	-3.65535912934001	3.50469062412111	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCAGTTCACAAGAA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1710.9555896065	19.1379588237431	0.0111855380350022	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1709.0540839295	1709.0540839295
"healthy-5"	"2019-08-29-count-1:ACGTTCCCAAGACTGG"	-3.94868026199992	-5.26694109356078	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTTCCCAAGACTGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2458.67802691546	52.7725417251924	0.0214637871032663	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2453.94522969917	2453.94522969917
"healthy-5"	"2019-08-29-count-2:GACTCAATCTAGCAAC"	9.77223267134969	6.39155385578004	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACTCAATCTAGCAAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.79394636197	38.9492488286195	0.0267914506908546	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1448.98357360241	1448.98357360241
"healthy-5"	"2019-08-29-count-2:TGCTTGCCAAGGCCTC"	-2.85292277756389	13.2169322737488	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTTGCCAAGGCCTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1586.3750669796	38.714187155935	0.0244041828201734	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1581.66121451928	1581.66121451928
"healthy-5"	"2019-08-29-count-1:GGGTATTTCATTTGGG"	2.71620311316792	-7.62802174007567	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTATTTCATTTGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1598.53333830216	55.5832312500816	0.0347713932004182	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1596.05721201827	1596.05721201827
"healthy-5"	"2019-08-29-count-2:TCTGCCAAGATTAGAC"	11.1426321464473	4.18524930560914	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGCCAAGATTAGAC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1437.74826482101	40.2587225245222	0.0280012318634474	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1430.09595971734	1430.09595971734
"healthy-5"	"2019-08-29-count-1:CCGAACGCAGTATGAA"	1.3049746948177	-6.57150127803954	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGAACGCAGTATGAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1819.01946263772	48.6870566938484	0.0267655501735251	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1816.93040346162	1816.93040346162
"healthy-5"	"2019-08-29-count-1:CGATGGCAGAGTCAGC"	6.8269473510677	-1.44796945964964	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATGGCAGAGTCAGC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1970.30924398942	28.9702244551879	0.0147033896042278	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1962.90423283898	1962.90423283898
"healthy-5"	"2019-08-29-count-2:GGTGTCGCATAGCACT"	3.77034844931905	-8.30233004009398	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTCGCATAGCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1761.25437488934	47.648080981794	0.0270534919095873	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1761.25437488934	1761.25437488934
"healthy-5"	"2019-08-29-count-2:GACTGATGTGATGTAA"	4.051610370248	-7.23891355907591	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACTGATGTGATGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1908.29206165365	43.5799098710604	0.0228371278939848	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1906.29539886175	1906.29539886175
"healthy-5"	"2019-08-29-count-1:ACTACGACAGGATCTT"	-4.50255093994792	-5.21807720577391	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTACGACAGGATCTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2002.30116266518	53.698229448985	0.0268182581373071	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1994.33909087401	1994.33909087401
"healthy-5"	"2019-08-29-count-1:GTTATGGAGGAACGTC"	-0.899479309946853	9.36089322650758	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTATGGAGGAACGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1430.02626654388	40.6721193693579	0.0284415190971669	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1427.57870140941	1427.57870140941
"healthy-5"	"2019-08-29-count-2:TGGAACTCATTAGGAA"	-5.77171788635905	-4.57373955166014	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTCATTAGGAA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2765.36069231972	47.3037824374487	0.017105827304491	2200	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2762.25476466624	2762.25476466624
"healthy-5"	"2019-08-29-count-2:ATCTTCATCGCCTATC"	-4.12848124924357	12.939161277655	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTTCATCGCCTATC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1533.10292138581	37.4612943111618	0.0244349507059184	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1530.62964321017	1530.62964321017
"healthy-5"	"2019-08-29-count-2:GACTTCCTCCACTGGG"	3.77148546752278	-8.10794641887816	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACTTCCTCCACTGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1731.11672352542	43.4118175096376	0.0250773485806488	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1721.97826367784	1721.97826367784
"healthy-5"	"2019-08-29-count-2:TGGAACTTCAGAACCT"	-2.59141693535503	10.449906326178	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTTCAGAACCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1527.47579094671	40.1196003361628	0.0262652937440647	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1525.17848948037	1525.17848948037
"healthy-5"	"2019-08-29-count-1:GTTATGGCAGGATCTT"	-4.14844642105754	-5.3227954140869	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTATGGCAGGATCTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2659.61876726345	48.7090104068121	0.0183142828612726	1742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2652.33635867684	2652.33635867684
"healthy-5"	"2019-08-29-count-2:CTGTGAAAGTTTCGGT"	3.84616341170613	-8.61643316661986	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTGAAAGTTTCGGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1757.90653813596	39.7245749707631	0.0225976604039973	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1753.47312751947	1753.47312751947
"healthy-5"	"2019-08-29-count-2:GGTGTTATCCTTTAGT"	4.04316916045491	-8.29014971172484	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTTATCCTTTAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1981.44875844119	45.9610257686319	0.023195667096024	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1975.92680620609	1975.92680620609
"healthy-5"	"2019-08-29-count-1:ATGGTTGAGGTCGACA"	2.83600964125935	-7.37840559398802	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGTTGAGGTCGACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1829.80317214412	48.1119350432502	0.0262935029164223	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1829.80317214412	1829.80317214412
"healthy-5"	"2019-08-29-count-1:ACTTTGTAGACTGAGC"	-3.41006765785869	12.5007953413757	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTTGTAGACTGAGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1426.99507157568	43.1416131350458	0.0302324892316614	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1419.04428594124	1419.04428594124
"healthy-5"	"2019-08-29-count-1:GTCATTTAGCAATAGT"	11.6603638130123	-2.44987275516661	"2019-08-29-count-1"	"Control5"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCATTTAGCAATAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1596.48016755377	35.8307391419003	0.0224435855014738	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	1592.81594467317	1592.81594467317
"healthy-5"	"2019-08-29-count-2:TGGAGGACAATCTCTT"	3.20944680747334	-5.50691082393798	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAGGACAATCTCTT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2296.99552820813	39.9692019800738	0.0174006442281816	1257	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2295.50376115039	2295.50376115039
"healthy-5"	"2019-08-29-count-2:TGGAGGACAGCGGTCT"	2.30390443381612	-7.11881735241088	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAGGACAGCGGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1758.79023938403	51.4015797984883	0.0292255316452577	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1758.79023938403	1758.79023938403
"healthy-5"	"2019-08-29-count-1:AACAACCCACCATATG"	5.39122643050496	-9.8487177125183	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAACCCACCATATG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.66084390969	43.3755040926811	0.0184054927567436	1263	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2355.04785604462	2355.04785604462
"healthy-5"	"2019-08-29-count-1:CACCAAAAGGGTAATT"	-7.90917573395427	-0.921353541966997	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCAAAAGGGTAATT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1865.71935758621	48.3036151303548	0.0258900755539398	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1861.85124073616	1861.85124073616
"healthy-5"	"2019-08-29-count-1:GACCGTGAGGTACAGC"	-4.61405024948772	-5.15075685894164	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACCGTGAGGTACAGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2284.20715986564	41.2749674242462	0.0180697128305447	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2282.62438821111	2282.62438821111
"healthy-5"	"2019-08-29-count-2:GGAGGATGTAAGCGGT"	6.82293572005574	-1.49727919017943	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGGATGTAAGCGGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2075.93704637954	37.5694240842054	0.0180975738882481	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2070.60252787238	2070.60252787238
"healthy-5"	"2019-08-29-count-1:GCTGAATCAGCAGATG"	3.42531599578206	-6.92083265697631	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGAATCAGCAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1732.40728024414	42.4257067873491	0.0244894530698175	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.40728024414	1732.40728024414
"healthy-5"	"2019-08-29-count-2:CTTAGGAAGAGTGTTA"	3.2593854862148	-7.94402697002562	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTAGGAAGAGTGTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1475.53378836536	51.574944857794	0.0349534150044306	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1468.16808600544	1468.16808600544
"healthy-5"	"2019-08-29-count-2:GCAGCCACACACCTTC"	5.31730284270589	-10.3467922440735	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGCCACACACCTTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.04400331545	45.2625482740366	0.0201073582779242	1216	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2247.89578631092	2247.89578631092
"healthy-5"	"2019-08-29-count-2:TACAACGGTAGTACGG"	-2.66010699692424	9.21637055957643	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACAACGGTAGTACGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1515.93151983806	43.9271260082787	0.0289769857235842	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1515.93151983806	1515.93151983806
"healthy-5"	"2019-08-29-count-1:GCTGAATCAGCTGAGA"	-2.27378282967265	3.38624093616334	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGAATCAGCTGAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3011.11472118392	44.7987033399652	0.0148777803199578	3509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3006.4902764186	3006.4902764186
"healthy-5"	"2019-08-29-count-2:GCAGCCAGTCGAGTTT"	3.66183628615682	-8.09309389507445	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGCCAGTCGAGTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1706.13696859785	37.1534202892224	0.0217763409228253	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1706.13696859785	1706.13696859785
"healthy-5"	"2019-08-29-count-2:TACAACGGTTGCTTGA"	-0.583210210234481	8.56305883014528	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACAACGGTTGCTTGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1626.00926482645	37.188873273954	0.0228712554586356	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1623.71552036499	1623.71552036499
"healthy-5"	"2019-08-29-count-1:GGGTGTCTCACAAGGG"	2.34797944602315	-6.92182876979979	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTGTCTCACAAGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1579.28806755973	49.4593393509028	0.0313174906889064	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1577.01127866646	1577.01127866646
"healthy-5"	"2019-08-29-count-2:TCAAGCATCTCCCTAG"	3.18063129958455	-7.35032131588133	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGCATCTCCCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2030.79485529754	46.1199649318789	0.0227103022304642	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2026.90022880633	2026.90022880633
"healthy-5"	"2019-08-29-count-2:CTTAGGACAGCAGATG"	-3.31562290611919	12.2898425825867	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTAGGACAGCAGATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1515.34104183905	34.2034113779074	0.022571428103338	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1508.21308403048	1508.21308403048
"healthy-5"	"2019-08-29-count-2:GAGACTTTCCGTTGGG"	9.59516586837117	5.55918452823488	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACTTTCCGTTGGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1434.00335596538	41.2309663733992	0.0287523499871045	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1434.00335596538	1434.00335596538
"healthy-5"	"2019-08-29-count-2:GGTTGTAGTAAGTAGT"	-2.68182621422465	9.92976281726686	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTGTAGTAAGTAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1798.6111848947	42.2359813441394	0.0234825523708795	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1794.87489856953	1794.87489856953
"healthy-5"	"2019-08-29-count-1:GACGCTGCACGCTGAC"	3.34673704680745	-7.09537794506224	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGCTGCACGCTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2061.52933622478	44.9260415616531	0.0217925793110104	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2055.9607292836	2055.9607292836
"healthy-5"	"2019-08-29-count-1:GATTCTTTCCACTTTA"	-8.04464278641399	-0.12224473869475	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTCTTTCCACTTTA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2942.14280949069	43.0091372148247	0.0146183037329415	2854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2930.71101202365	2930.71101202365
"healthy-5"	"2019-08-29-count-2:TACACCCAGCGCCTAC"	5.31643404540364	-9.59725572979125	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACACCCAGCGCCTAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2541.61834084845	41.414944325217	0.016294714143191	1484	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2536.07813445129	2536.07813445129
"healthy-5"	"2019-08-29-count-2:ACCTGTCCAGTCTACA"	-3.5601147216862	12.9204301604065	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTGTCCAGTCTACA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1761.28539426771	36.1564273881496	0.0205284319655546	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1759.07146154657	1759.07146154657
"healthy-5"	"2019-08-29-count-1:CCGGACAGTCAACCTA"	-3.0737124485081	9.80024621570436	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGGACAGTCAACCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1766.97182880642	33.0455752965252	0.0187018121951878	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1762.68956127695	1762.68956127695
"healthy-5"	"2019-08-29-count-2:TCAAGTGTCTGGGAGA"	-2.25984988632854	4.23402783954469	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGTGTCTGGGAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3133.6263443246	46.842460267337	0.0149483234822093	3767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3130.66098492607	3130.66098492607
"healthy-5"	"2019-08-29-count-1:GCTGGGTAGTATAGGT"	2.38284959372823	-4.26850941097411	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTAGTATAGGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2270.86658442274	43.583188062222	0.0191923155508939	1271	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2269.51153361912	2269.51153361912
"healthy-5"	"2019-08-29-count-2:TCCTAATAGCTCGGCT"	10.3671213584835	5.79503915393678	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTAATAGCTCGGCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1798.39299607114	39.8460909632596	0.0221564980792904	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1792.75413723944	1792.75413723944
"healthy-5"	"2019-08-29-count-1:AGCTCAACAAGTATAG"	-3.37214742127116	2.98751161182252	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTCAACAAGTATAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3203.97886702035	47.4069395415556	0.0147962709834111	3418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3196.12154299116	3196.12154299116
"healthy-5"	"2019-08-29-count-1:CGCCATTGTGAGACCA"	2.79960288581197	-6.86707117473754	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCCATTGTGAGACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.60640033485	50.2809828697874	0.0270821983920334	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1854.62061642411	1854.62061642411
"healthy-5"	"2019-08-29-count-2:GAGATGGCATTGCTTT"	-3.91782341423686	3.72475311839906	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGATGGCATTGCTTT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2760.00266247315	43.4974942085201	0.0157599464666977	2603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2751.89675978829	2751.89675978829
"healthy-5"	"2019-08-29-count-1:CTCAATTAGGCCCAAA"	-3.80258713188823	-5.45159866726073	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAATTAGGCCCAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2373.76787031877	46.9059903333896	0.0197601420593374	1364	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2370.94465262146	2370.94465262146
"healthy-5"	"2019-08-29-count-2:TATCGCCAGTTCATGC"	4.69881500777547	-8.25434210216673	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCGCCAGTTCATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.76186129573	42.0800172022751	0.0196199018462838	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2143.1930807888	2143.1930807888
"healthy-5"	"2019-08-29-count-2:CGCGTGACAGGGCTTC"	-2.07659349861797	4.09485290134279	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCGTGACAGGGCTTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2913.61517665792	44.4805914151843	0.0152664606402161	2841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2911.57684413259	2911.57684413259
"healthy-5"	"2019-08-29-count-2:TCCTAATTCAACACGT"	3.34007062491719	-7.62672474300536	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTAATTCAACACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1750.72857547053	44.8351585771736	0.0256094286717881	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1744.02884368564	1744.02884368564
"healthy-5"	"2019-08-29-count-2:CGCGTGAGTTACGATC"	3.40591349181477	-8.54371931469115	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCGTGAGTTACGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1838.24599314054	35.2338493711111	0.0191671025002023	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1836.02020903049	1836.02020903049
"healthy-5"	"2019-08-29-count-1:CACGGGTCAGCTACAT"	3.21591963347737	-7.31326105510863	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGGGTCAGCTACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.96008340034	40.7655914765848	0.0242513738899271	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1680.96008340034	1680.96008340034
"healthy-5"	"2019-08-29-count-2:TGGGAAGTCCTGTACC"	-2.47601876679118	4.13505218112794	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGAAGTCCTGTACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3308.28929006633	44.6923928034766	0.0135092154539425	4480	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3303.15703024809	3303.15703024809
"healthy-5"	"2019-08-29-count-2:TCTTTGATCAAATGCC"	-3.37772784653361	10.9601287611756	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTTGATCAAATGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.55867296076	33.1902724922592	0.0215443092657235	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1540.55867296076	1540.55867296076
"healthy-5"	"2019-08-29-count-1:CGCGTGATCCGACATA"	4.36053623732869	-7.70589783107909	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCGTGATCCGACATA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2045.35929876607	41.0080603735374	0.0200493186689873	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2045.35929876607	2045.35929876607
"healthy-5"	"2019-08-29-count-2:TCAATTCTCCCTCTTT"	10.8217016654903	6.22280356967775	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAATTCTCCCTCTTT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1851.21035405649	37.9123602639714	0.0204797689149131	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1851.21035405649	1851.21035405649
"healthy-5"	"2019-08-29-count-1:GGTAACTGTTCTCTCG"	-0.636209587485153	8.8874883421692	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAACTGTTCTCTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1447.41327850651	42.0307642974895	0.0290385371763745	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1447.41327850651	1447.41327850651
"healthy-5"	"2019-08-29-count-2:CACACAATCAACTTTC"	3.9847682910854	-8.28906538402709	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACACAATCAACTTTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2098.88383655789	41.0660365424789	0.0195656547671671	1022	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2095.43807747537	2095.43807747537
"healthy-5"	"2019-08-29-count-2:GTTCATTCATCGAACT"	3.7573160129482	-8.06568434154662	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCATTCATCGAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1674.94391620983	49.8358216917036	0.0297537256080044	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1674.94391620983	1674.94391620983
"healthy-5"	"2019-08-29-count-2:GTAAGTCTCATTTGCT"	4.10722460326497	-8.16473677074584	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAAGTCTCATTTGCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2027.74262992347	45.9805399876093	0.0226757278310733	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2024.05417009477	2024.05417009477
"healthy-5"	"2019-08-29-count-1:GGTAATCCATGCAGGA"	3.76635064658467	-7.75614263927611	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAATCCATGCAGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.66163361283	38.0985180504492	0.0175434871900682	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2168.01710194549	2168.01710194549
"healthy-5"	"2019-08-29-count-2:GGCACGTTCTGCGTCT"	6.92161764678304	-0.958975457307421	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCACGTTCTGCGTCT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1730.57809521963	48.4504646645606	0.0279966935894978	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1721.70711672763	1721.70711672763
"healthy-5"	"2019-08-29-count-1:CGGAACCGTAGACAGC"	2.48529948767964	-7.20568182384642	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAACCGTAGACAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.59841254981	48.5580905466734	0.0267892160836475	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1810.65290908686	1810.65290908686
"healthy-5"	"2019-08-29-count-2:GTGGCGTGTCATCGGC"	-4.1934064430302	-4.46027376567992	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGCGTGTCATCGGC"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2693.80977790576	46.3379206251106	0.0172016305698968	2000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2685.79232397907	2685.79232397907
"healthy-5"	"2019-08-29-count-1:CGGAACCTCGACGTCG"	6.69965805587117	-1.5296110144821	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAACCTCGACGTCG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2219.94059599256	39.1321368544505	0.0176275603613412	1184	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2210.54735035077	2210.54735035077
"healthy-5"	"2019-08-29-count-2:GTAATCGCACCGTACG"	9.01656117019002	6.60716483676759	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATCGCACCGTACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.29390571705	39.4607975625302	0.0271526615554481	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1448.36860546811	1448.36860546811
"healthy-5"	"2019-08-29-count-2:AGATCCATCTTCTTCC"	-3.77855763855632	11.0033015974793	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATCCATCTTCTTCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1978.74503754894	31.4384638490555	0.0158880822200308	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1974.41273690216	1974.41273690216
"healthy-5"	"2019-08-29-count-2:GAGCTGCCAGGGTCTC"	-2.27144608917888	10.1150483855042	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCTGCCAGGGTCTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1419.759013411	43.8027629238694	0.0308522520442623	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1419.759013411	1419.759013411
"healthy-5"	"2019-08-29-count-1:TAGATCGCAATTGGTC"	3.4969023662502	-7.64415075695189	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGATCGCAATTGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1847.81066649419	47.046749980833	0.0254608065825779	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.8368530936	1845.8368530936
"healthy-5"	"2019-08-29-count-1:AGGAATAGTGAGTAGC"	-2.65374312821086	3.38737843120424	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAATAGTGAGTAGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2711.88891632592	49.4427152642301	0.0182318364762578	2527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2702.45791047161	2702.45791047161
"healthy-5"	"2019-08-29-count-2:TGGGATTGTAACCCGC"	-5.61644254151042	-5.49367525493773	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGATTGTAACCCGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2262.63347103025	48.0475342138141	0.0212352264867436	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2257.30599170269	2257.30599170269
"healthy-5"	"2019-08-29-count-1:GGTAGAGGTACGATCT"	3.5043920474941	-6.9252066842285	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAGAGGTACGATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1832.74646627997	43.449611357111	0.0237073769648581	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1830.69675481918	1830.69675481918
"healthy-5"	"2019-08-29-count-2:TGGGATTTCCTCATAT"	3.70955481108968	-8.12297537243041	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGATTTCCTCATAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1883.83330580756	44.2083019865871	0.023467204794766	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.7849136779	1881.7849136779
"healthy-5"	"2019-08-29-count-2:TGACAGTAGCAAATCA"	-3.91413150253947	-4.51908876812132	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACAGTAGCAAATCA"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2714.57336170325	44.432216200749	0.0163680292555697	1949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2708.20592422019	2708.20592422019
"healthy-5"	"2019-08-29-count-2:TACCGAATCAAGTCTG"	-6.49329696121867	3.51145312869874	"2019-08-29-count-2"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCGAATCAAGTCTG"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2415.69147542705	39.6975462564787	0.0164332021122279	1657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2411.04250951014	2411.04250951014
"healthy-5"	"2019-08-29-count-1:CCGTGAGGTATCGAAA"	-3.48653064194377	11.7382869490418	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTGAGGTATCGAAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1434.32101055989	37.1691377252404	0.0259140997388941	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1426.5698067624	1426.5698067624
"healthy-5"	"2019-08-29-count-1:AACCCAAAGAATCGCG"	-1.90879295292552	13.0067777403626	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCCAAAGAATCGCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1414.45031640258	43.0104770130291	0.0304079093583287	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1414.45031640258	1414.45031640258
"healthy-5"	"2019-08-29-count-2:AGTGACTAGAGAAGGT"	3.29907788810078	-8.25461485302123	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGACTAGAGAAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1445.9740794941	48.7562967296209	0.0337186519599847	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1440.91132860733	1440.91132860733
"healthy-5"	"2019-08-29-count-1:GTTGTCCAGCGTCGAA"	3.15613307532613	-7.21856262600096	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTCCAGCGTCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1498.10022979884	44.3960983095137	0.0296349319133841	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1498.10022979884	1498.10022979884
"healthy-5"	"2019-08-29-count-1:GACTCTCGTAGAATAC"	1.01875509795491	9.79112050617067	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTCTCGTAGAATAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1637.26379560594	31.5655004191122	0.0192794224753684	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1626.26061746978	1626.26061746978
"healthy-5"	"2019-08-29-count-2:GTAATGCCAGTCGCAC"	-2.16944203797038	4.19711253726808	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCCAGTCGCAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3162.67104483647	47.1467203405213	0.0149072475993023	3692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3155.51974430016	3155.51974430016
"healthy-5"	"2019-08-29-count-2:TGGGCTGGTCCCTGTT"	-3.56091008606609	2.9943055876526	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGCTGGTCCCTGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3154.49901905442	44.7792951370086	0.0141953745639241	3703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3147.05235686988	3147.05235686988
"healthy-5"	"2019-08-29-count-1:GACTCTCTCCTTATGT"	-0.509702543646652	8.90080640399782	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTCTCTCCTTATGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1652.33774698673	41.5720602566816	0.0251595415843365	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1643.89895078509	1643.89895078509
"healthy-5"	"2019-08-29-count-1:CGGAGAAGTTGTTGCA"	-1.42475686493571	10.2727231749329	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAGAAGTTGTTGCA"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1457.44446675219	42.4341733647817	0.0291154650024802	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1457.44446675219	1457.44446675219
"healthy-5"	"2019-08-29-count-1:TAGGAGGGTGGACCTC"	3.98166384276692	-8.01720907604369	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGAGGGTGGACCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.95321756108	43.0485097589453	0.0210510975944414	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2043.17731641467	2043.17731641467
"healthy-5"	"2019-08-29-count-2:TGGGTTAAGACCATGG"	-0.147514234215575	8.14753530109254	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGTTAAGACCATGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1605.30991865941	37.6346814620952	0.0234438727529471	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1597.06955411965	1597.06955411965
"healthy-5"	"2019-08-29-count-1:TACGGTAAGAGCAGCT"	-0.93678311529811	9.0840968855652	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGTAAGAGCAGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1481.40950716749	38.7132554265373	0.0261327170098688	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1478.43287703299	1478.43287703299
"healthy-5"	"2019-08-29-count-2:TGGGTTACAGGTCCGT"	6.81498302993123	-1.44882943546446	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGTTACAGGTCCGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2076.85547679724	39.2647834657267	0.0189058814657039	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2069.41738608783	2069.41738608783
"healthy-5"	"2019-08-29-count-2:GAGGCCTTCCCGTAAA"	-2.70217023316081	11.8915471800598	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGCCTTCCCGTAAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1711.5519172203	38.6477882640765	0.0225805526991222	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1707.19144169205	1707.19144169205
"healthy-5"	"2019-08-29-count-1:GACTGATGTAATTGGA"	-2.0870078605717	3.63852188670961	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTGATGTAATTGGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3111.01667197888	43.2936874244119	0.0139162505345474	3297	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3105.1765402305	3105.1765402305
"healthy-5"	"2019-08-29-count-2:GAGGGATCACTCATAG"	3.78540601310078	-8.51234152233275	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGGATCACTCATAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.88673733843	37.2539729428797	0.0177832874106651	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2089.92894801459	2089.92894801459
"healthy-5"	"2019-08-29-count-1:GACTGATTCAGGGTAG"	3.49082293090169	-8.24431421672972	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTGATTCAGGGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1685.43796625746	52.4173087277013	0.0311001115301174	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1683.31538540973	1683.31538540973
"healthy-5"	"2019-08-29-count-1:ACAGAAAGTAGCGCCT"	-3.8928624195164	12.2865895994934	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGAAAGTAGCGCCT"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1598.33038667485	41.6655638185868	0.0260681797492866	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1593.66362814039	1593.66362814039
"healthy-5"	"2019-08-29-count-1:TAGGGTTGTGATTGGG"	3.52338041838948	-8.1346063843933	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGGTTGTGATTGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1479.0288124648	49.2410353198665	0.0332928168166017	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1476.62445021819	1476.62445021819
"healthy-5"	"2019-08-29-count-1:CCTAACCCAGTAGTTC"	-0.675953368574935	11.9519586333069	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTAACCCAGTAGTTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1693.55406093868	51.5805817511618	0.0304570033758312	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1679.7825746298	1679.7825746298
"healthy-5"	"2019-08-29-count-1:CACACAACAGGTTTAC"	-2.99375710907634	10.252263999823	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACACAACAGGTTTAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1866.26934105144	39.6728911992052	0.0212578593703167	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1862.05247402382	1862.05247402382
"healthy-5"	"2019-08-29-count-2:TGCTGAACATAGTCGT"	-3.35457096520122	11.3097276457581	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTGAACATAGTCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1421.47326866949	34.4230592562411	0.024216466123532	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1421.47326866949	1421.47326866949
"healthy-5"	"2019-08-29-count-1:AGGATCTCATCGAACT"	-2.61676416817363	13.0991687544617	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGATCTCATCGAACT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1774.58652550249	37.7499300914309	0.0212725215417387	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1772.44024667527	1772.44024667527
"healthy-5"	"2019-08-29-count-2:GTAGAAACAATTTCTC"	3.50750245627705	-8.20438291942748	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGAAACAATTTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.26435416809	45.5976108783114	0.0276808095573339	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1644.94046656857	1644.94046656857
"healthy-5"	"2019-08-29-count-1:AGGCATTAGCTGACTT"	-2.23948488655742	9.60404775226442	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGCATTAGCTGACTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1409.59777213296	32.6162521328019	0.0231386944400799	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1399.4140796895	1399.4140796895
"healthy-5"	"2019-08-29-count-2:GAGGGTAAGGCTATCT"	3.27961673316304	-8.33283808147582	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGGGTAAGGCTATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1529.53966459445	50.3157045825973	0.0328959789322877	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1529.53966459445	1529.53966459445
"healthy-5"	"2019-08-29-count-1:AACCTTTTCATTTGTC"	-1.08423731747325	10.6437320479187	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCTTTTCATTTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1609.79859607953	32.7351067384053	0.020334908241396	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1609.79859607953	1609.79859607953
"healthy-5"	"2019-08-29-count-1:TAGGTACAGGGCCTCT"	-1.14282045784648	9.71819303119508	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTACAGGGCCTCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1583.08321108803	37.2704830851161	0.0235429716038114	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1580.81646085341	1580.81646085341
"healthy-5"	"2019-08-29-count-2:AGCCACGAGGTTGTTC"	-1.340279797942	9.63361356342164	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCACGAGGTTGTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1492.0713000793	36.6535337941759	0.0245655377140676	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1489.73472532345	1489.73472532345
"healthy-5"	"2019-08-29-count-1:TAGGTACCACTCACTC"	4.58162226256673	-8.22980024730834	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTACCACTCACTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.27219231314	42.5458899576504	0.0190168590589158	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2233.82304485024	2233.82304485024
"healthy-5"	"2019-08-29-count-1:GGTGTCGGTCGAATGG"	-3.75518641892131	-4.88693525707396	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGTCGGTCGAATGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2242.42889077514	47.9001574593313	0.02136083675	1166	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2235.79228755942	2235.79228755942
"healthy-5"	"2019-08-29-count-1:CACTGTCCAATCCTTT"	4.75440039214436	-9.07581236278685	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGTCCAATCCTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.72048164702	37.6340033760104	0.0161400149255572	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2331.72048164702	2331.72048164702
"healthy-5"	"2019-08-29-count-1:AACGAAAAGGAACGAA"	-3.07194815102275	-5.63580849086913	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGAAAAGGAACGAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1941.38099782775	41.7518777461803	0.0215062771258693	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1936.34867050873	1936.34867050873
"healthy-5"	"2019-08-29-count-1:TAGGTACGTCGTAATC"	14.4782721000606	2.05908582294313	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTACGTCGTAATC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1576.40302323688	31.7669422349305	0.0201515359756811	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1567.84861901055	1567.84861901055
"healthy-5"	"2019-08-29-count-2:CTCCATGCACTGTTCC"	2.82319225844685	-8.39407064830931	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCATGCACTGTTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1666.47397455995	47.6926579732042	0.0286189035660146	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1664.1013510884	1664.1013510884
"healthy-5"	"2019-08-29-count-1:CCTACGTTCATTGTGG"	0.868926902383012	9.2957086333069	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTACGTTCATTGTGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1563.08790153767	40.0620293056308	0.0256300552683059	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1556.56231052138	1556.56231052138
"healthy-5"	"2019-08-29-count-1:CCTACGTTCCTAGCTC"	6.7997747856075	-1.62870492851409	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTACGTTCCTAGCTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2215.27855106562	37.9017261187307	0.0171092371659079	1093	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2210.06160653168	2210.06160653168
"healthy-5"	"2019-08-29-count-1:ATTCCTATCATTACCT"	0.753033776848954	8.59881970966188	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCTATCATTACCT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1432.72616971623	33.815948824422	0.0236025205228992	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1421.92144956896	1421.92144956896
"healthy-5"	"2019-08-29-count-1:GGTTAACAGACTCCGC"	0.53121187266652	8.40380857074586	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTAACAGACTCCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1617.14786112406	41.6270139515686	0.0257410067145215	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1611.41873180875	1611.41873180875
"healthy-5"	"2019-08-29-count-2:TCAGCAAAGGAACGAA"	-3.10363803330119	12.420009590033	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGCAAAGGAACGAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1392.32031504194	37.8003931676433	0.0271492075201851	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1392.32031504194	1392.32031504194
"healthy-5"	"2019-08-29-count-1:GGTTAACAGAGTTGTA"	3.25489415702168	-8.3224029771057	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTAACAGAGTTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1608.96507074277	42.9389092121589	0.026687284884523	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1604.58992312716	1604.58992312716
"healthy-5"	"2019-08-29-count-1:AACGGGAAGTCTGGTT"	3.01699294623677	-6.71493723308715	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGGGAAGTCTGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.73529740209	40.1338043255926	0.0196952981953834	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2031.9376372318	2031.9376372318
"healthy-5"	"2019-08-29-count-1:GAGACTTGTGCCGTTG"	-2.46616301956828	10.149236656073	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACTTGTGCCGTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1574.22861573919	45.3818042372131	0.0288279629676936	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1574.22861573919	1574.22861573919
"healthy-5"	"2019-08-29-count-1:AACGGGAGTTAACCTG"	10.0060211616451	7.78622052753297	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGGGAGTTAACCTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1811.44994809002	35.9390955306478	0.0198399605622787	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1804.11622633348	1804.11622633348
"healthy-5"	"2019-08-29-count-2:CCTAACCGTTCTTGTT"	-1.64770052853282	10.4415893324646	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAACCGTTCTTGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1468.64865087848	42.7146699245504	0.0290843353847773	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1463.9349116486	1463.9349116486
"healthy-5"	"2019-08-29-count-1:GGTTCTCAGCTTTCTT"	3.46279968795125	-7.29191639339598	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTCTCAGCTTTCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1942.07149820696	42.3082226682613	0.0217851004493515	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1938.55507895698	1938.55507895698
"healthy-5"	"2019-08-29-count-2:TACTGCCAGGATACGC"	4.0762959915096	-7.13620664989623	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTGCCAGGATACGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2016.06097345055	41.6524327770234	0.0206603040907706	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2008.71477477005	2008.71477477005
"healthy-5"	"2019-08-29-count-2:TGGTTAGAGAGTGACC"	-3.40215311470683	3.72210404956666	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGAGAGTGACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3052.58212465791	46.4600142408642	0.0152199064082742	3125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3046.23043801502	3046.23043801502
"healthy-5"	"2019-08-29-count-2:GCCATGGAGGACGCTA"	5.16157116469685	-10.2136850587097	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATGGAGGACGCTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1915.43832063361	38.4508148132413	0.0200741597362018	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1909.25633574128	1909.25633574128
"healthy-5"	"2019-08-29-count-1:CCTCAACGTCCGGTCA"	-0.948235611349899	9.78492734515993	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCAACGTCCGGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1453.99618144589	40.3050685102268	0.0277202024493258	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1448.95415813329	1448.95415813329
"healthy-5"	"2019-08-29-count-1:CGGTCAGAGAGGGCGA"	2.60630526122395	-7.25998690044554	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGTCAGAGAGGGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1677.95730941448	49.9929893579135	0.0297939578542427	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1673.68034416711	1673.68034416711
"healthy-5"	"2019-08-29-count-2:GAGTGTTAGGACGGAG"	-4.82592616501506	3.18839809978334	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTGTTAGGACGGAG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2785.71518857019	45.021491662666	0.0161615558716805	2016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2776.53839311582	2776.53839311582
"healthy-5"	"2019-08-29-count-1:GAGAGGTGTGAGCGAT"	-1.70648060265239	10.4682178267273	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGAGGTGTGAGCGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1423.62915034736	39.7980220251145	0.0279553295290448	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1418.78784652364	1418.78784652364
"healthy-5"	"2019-08-29-count-2:GGTTAACCATACCAGT"	1.99327983435933	-7.22427799617919	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTAACCATACCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1527.38038254485	48.3927762919141	0.0316835130560499	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1525.01146184937	1525.01146184937
"healthy-5"	"2019-08-29-count-2:TGGTTAGAGTTACGAA"	3.94551553305928	-7.72875931179198	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGAGTTACGAA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1874.19085901128	41.3170903900004	0.0220452950089603	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1872.27804030376	1872.27804030376
"healthy-5"	"2019-08-29-count-2:TGGTTAGCAAATACGA"	-5.29620824280437	-5.65417578136595	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGCAAATACGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2676.60679557671	54.6367926110245	0.0204127078737586	1790	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2668.3352989454	2668.3352989454
"healthy-5"	"2019-08-29-count-1:GAGATGGAGCCTGAGA"	-6.76973519745524	3.34333298290101	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGATGGAGCCTGAGA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2208.05108726487	41.0808990592932	0.0186050491749176	1301	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2195.4792373023	2195.4792373023
"healthy-5"	"2019-08-29-count-1:AACGTCATCGAGTGGA"	2.5622784095699	-7.0387902489868	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGTCATCGAGTGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1940.5138801895	50.0990431711592	0.0258174103687766	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1936.57656860482	1936.57656860482
"healthy-5"	"2019-08-29-count-2:TGGTTAGGTGCCTGCA"	-2.96768484535869	12.4781226881775	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGGTGCCTGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1507.35576185881	40.3601423286247	0.026775458952606	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1507.35576185881	1507.35576185881
"healthy-5"	"2019-08-29-count-1:AACTTCTCAATTCACG"	-3.35951624336894	10.8835239180359	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACTTCTCAATTCACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1835.27508885277	33.6457344651198	0.0183328018069225	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1826.86304554774	1826.86304554774
"healthy-5"	"2019-08-29-count-2:TCAGGGCCACACGGTC"	2.44055237349812	-4.47661974346312	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGGCCACACGGTC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2390.95247547201	41.9937589971262	0.0175636109157026	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2384.17534410842	2384.17534410842
"healthy-5"	"2019-08-29-count-1:TATACCTTCGATACAC"	4.02511419829671	-8.19021131908568	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATACCTTCGATACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.67454725248	44.1570181418292	0.0207341625032786	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2121.02163968464	2121.02163968464
"healthy-5"	"2019-08-29-count-2:TGTAACGCACGGTCTG"	3.6220461326534	-8.08980753338011	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTAACGCACGGTCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.60111736907	46.0607947289643	0.0272452172518639	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1684.25973434997	1684.25973434997
"healthy-5"	"2019-08-29-count-1:TATATCCAGAGGATCC"	-3.05426130715068	-5.54384806072386	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATATCCAGAGGATCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1980.48647898136	50.5195373260245	0.0255086504564317	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1976.64574947899	1976.64574947899
"healthy-5"	"2019-08-29-count-2:TGTAACGCAGCCGTTG"	-2.8318182033604	9.24576280200807	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTAACGCAGCCGTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1537.03018630771	38.1769646616437	0.0248381359076319	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1534.72830429192	1534.72830429192
"healthy-5"	"2019-08-29-count-2:AGCGCCATCTTTGCAT"	11.1504084068233	3.93522856319276	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCGCCATCTTTGCAT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1640.1387930629	33.2575088611851	0.0202772527555901	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1632.89533119926	1632.89533119926
"healthy-5"	"2019-08-29-count-1:TATATCCCATCTCCCA"	-3.6894875568455	12.5365247496399	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATATCCCATCTCCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.38380433396	40.7943731166733	0.0253635811345206	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1601.10655758116	1601.10655758116
"healthy-5"	"2019-08-29-count-1:TATATCCCATGGCTGC"	-2.66401014748271	12.355891204718	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATATCCCATGGCTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1414.39727615771	39.3576070924714	0.0278264160684673	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1411.82435969974	1411.82435969974
"healthy-5"	"2019-08-29-count-2:TACTTCAGTTTCAGAC"	3.10468997535054	-7.55399801647338	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTCAGTTTCAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1416.80619422667	47.9047135939149	0.0338117618267913	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1409.24787929493	1409.24787929493
"healthy-5"	"2019-08-29-count-2:TCAGGTACACTGTGAT"	-1.50454245033916	8.84913346851198	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGTACACTGTGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1662.1159312148	41.6099594065619	0.0250343304128914	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1653.86460970803	1653.86460970803
"healthy-5"	"2019-08-29-count-1:TATATCCTCACCCATC"	-3.23319635811504	3.05726907337037	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATATCCTCACCCATC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3177.77815067156	47.8472899227876	0.0150568377193594	3459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3169.65622309078	3169.65622309078
"healthy-5"	"2019-08-29-count-1:CCTCATGAGAGCATTA"	-3.62978635254558	11.3270663985047	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCATGAGAGCATTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1505.67207857344	42.382768784671	0.0281487379541678	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1503.17857842062	1503.17857842062
"healthy-5"	"2019-08-29-count-1:TAACTTCAGGGAGGGT"	-5.30356822434123	-4.32035114681395	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACTTCAGGGAGGGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2898.50694994732	42.9618828248591	0.0148220734215041	2099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2898.50694994732	2898.50694994732
"healthy-5"	"2019-08-29-count-1:GTAACACCAGTCCGTG"	-3.79412231865581	10.7812785872254	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACACCAGTCCGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1744.64320532585	34.0208576145491	0.0195001806161249	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1744.64320532585	1744.64320532585
"healthy-5"	"2019-08-29-count-2:TCAGGTAGTTGCCGAC"	6.81183256682698	-1.52555050766142	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGTAGTTGCCGAC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2274.75368542566	30.9119383973925	0.0135891365273723	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2271.40048238	2271.40048238
"healthy-5"	"2019-08-29-count-1:GTAACACTCCGTGACG"	2.47851266440694	-7.04945423519286	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACACTCCGTGACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1703.56562824287	51.0842698223755	0.0299866755794235	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1701.42196006413	1701.42196006413
"healthy-5"	"2019-08-29-count-1:AAGAACAGTTGAGGAC"	6.82675852355306	-1.38945796405943	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACAGTTGAGGAC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2224.92100674989	37.2704790514245	0.0167513718187543	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2218.4126445286	2218.4126445286
"healthy-5"	"2019-08-29-count-2:GAGTTGTGTTTGACAC"	2.80862392958943	-7.46444322979125	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTGTGTTTGACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1456.96781116808	48.3945774566245	0.0332159551403032	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1454.55406177639	1454.55406177639
"healthy-5"	"2019-08-29-count-2:GCAGCTGGTCGAGCTC"	5.47311939772908	-10.0857649079529	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGCTGGTCGAGCTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2127.39907599664	37.5173899891408	0.0176353324641569	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2123.82485386483	2123.82485386483
"healthy-5"	"2019-08-29-count-1:TAAGCACAGACGGTCA"	-2.81152496758159	3.71223590457765	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGCACAGACGGTCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3100.61767357643	51.0747037442013	0.0164724287613599	3000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3089.27831892797	3089.27831892797
"healthy-5"	"2019-08-29-count-1:CTTCTCTAGTATGCAA"	5.51814999160115	-9.91536714946898	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTCTAGTATGCAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2207.21230724378	37.7341612438382	0.0170958457960748	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2205.81494004524	2205.81494004524
"healthy-5"	"2019-08-29-count-1:CTCCCTCAGTAGTGCG"	-2.0146189731663	10.4200324782166	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCCTCAGTAGTGCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1548.11817373412	42.3021710861874	0.0273248979334394	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1543.58714485403	1543.58714485403
"healthy-5"	"2019-08-29-count-2:AGCTACAGTCGAACGA"	3.96258439597432	-8.75723745739134	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACAGTCGAACGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2026.2505727814	45.0122505664227	0.0222145529141715	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2026.2505727814	2026.2505727814
"healthy-5"	"2019-08-29-count-2:CGTGAATAGTCGCGAA"	-3.24473843994792	12.6261434325012	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGAATAGTCGCGAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1626.17080425918	42.1771609052545	0.0259364888330219	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1626.17080425918	1626.17080425918
"healthy-5"	"2019-08-29-count-2:AGCTACAGTTCTCCCA"	5.36488260802571	-10.0775470963684	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACAGTTCTCCCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2351.47363399037	40.4944649439766	0.0172208883649097	1304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2349.96457570944	2349.96457570944
"healthy-5"	"2019-08-29-count-1:GAGCTGCTCCACTTTA"	-3.77017698708232	12.8145189055237	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCTGCTCCACTTTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1614.06746058903	42.1362960376347	0.0261056598106858	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1611.67944434792	1611.67944434792
"healthy-5"	"2019-08-29-count-2:AGCTACATCAGAGTTC"	4.52320923384969	-8.10016729747923	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACATCAGAGTTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.40513661446	39.282323188615	0.0187737654153221	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2087.29824865626	2087.29824865626
"healthy-5"	"2019-08-29-count-1:GTAACCATCAGTCAGT"	-4.03051648560222	12.6114482649597	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACCATCAGTCAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1693.08798152546	36.9463568347361	0.0218218764989683	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1690.82038646412	1690.82038646412
"healthy-5"	"2019-08-29-count-2:TGAGTCAAGAAACCAT"	-1.97953830185588	10.7031097182068	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGTCAAGAAACCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.82418541271	35.1081430636902	0.0194416174881755	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1801.96393131765	1801.96393131765
"healthy-5"	"2019-08-29-count-2:GTATTTCCAGGTGACA"	1.71196546134297	-6.36559965526732	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTATTTCCAGGTGACA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2132.32230127389	49.6783281150779	0.0232977576069992	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2132.32230127389	2132.32230127389
"healthy-5"	"2019-08-29-count-1:AGGGTGATCGATTCCC"	-3.51811705055888	10.9998903044495	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGTGATCGATTCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1679.55829838001	40.3511407990174	0.0240248527472594	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1679.55829838001	1679.55829838001
"healthy-5"	"2019-08-29-count-1:TATCGCCGTCAGCTTA"	2.99809636649434	-7.57279398357543	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCGCCGTCAGCTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1422.91796462965	48.7621464935955	0.0342691200095199	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1417.98018386208	1417.98018386208
"healthy-5"	"2019-08-29-count-2:TGAGTCAGTCTCGGGT"	3.3999294238979	-7.24777939235839	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGTCAGTCTCGGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1629.21445982807	45.2073377700635	0.0277479355141706	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1619.9902820518	1619.9902820518
"healthy-5"	"2019-08-29-count-1:TAAGCGTAGGGTCAAC"	2.47817291793172	-7.79102470791014	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGCGTAGGGTCAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1483.15504122717	44.0299868197607	0.0296867054325824	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1483.15504122717	1483.15504122717
"healthy-5"	"2019-08-29-count-2:ACTATGGTCTCCGAGG"	3.6462832885677	-8.09745027935179	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATGGTCTCCGAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1630.06985982824	35.4750812166257	0.0217629207746738	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1630.06985982824	1630.06985982824
"healthy-5"	"2019-08-29-count-2:ACTATTCAGTTGAAAC"	-2.83580098572429	11.7295522459778	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATTCAGTTGAAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1461.56090117533	37.9741568987658	0.0259819189663793	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1459.14663374756	1459.14663374756
"healthy-5"	"2019-08-29-count-2:CGTGATACATAAGATG"	3.04658212241475	-6.3616047135559	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGATACATAAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1833.96453708628	53.2441588174009	0.0290322728388155	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1826.73187711401	1826.73187711401
"healthy-5"	"2019-08-29-count-2:AGCTTCCAGCTGTACT"	-4.95051227036174	-2.78410293972167	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTTCCAGCTGTACT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2472.94142900335	40.5351252444508	0.0163914619121357	1424	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2467.18930956152	2467.18930956152
"healthy-5"	"2019-08-29-count-2:GATAGAATCATTCGGA"	10.0896622138912	6.42188689792482	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATAGAATCATTCGGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1445.67035828572	40.8986736133617	0.0282904559666419	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1443.3363233299	1443.3363233299
"healthy-5"	"2019-08-29-count-1:TATCTGTCACTTGTGA"	-1.83485958996471	3.90785262668458	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTGTCACTTGTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3272.61395183174	42.8573294701934	0.0130957485670454	4407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3267.23211626836	3267.23211626836
"healthy-5"	"2019-08-29-count-1:AAGACTCTCGCTGATA"	-3.1603504222935	12.3602370985779	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGACTCTCGCTGATA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1497.39242374678	35.847562002828	0.0239399915709003	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1497.39242374678	1497.39242374678
"healthy-5"	"2019-08-29-count-1:CGTCCATTCACGGACC"	-2.77079639855083	3.42911646449891	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTCCATTCACGGACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2999.56541782367	48.1399826652894	0.0160489857561491	3404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2994.08861639413	2994.08861639413
"healthy-5"	"2019-08-29-count-1:AAGATAGAGACTAGAT"	3.40092553672139	-7.33183100139769	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGATAGAGACTAGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.94528777497	46.3854376310429	0.0270477652912326	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1710.40228569815	1710.40228569815
"healthy-5"	"2019-08-29-count-1:GTAATCGTCCGAGCTG"	3.68899669226949	-7.96615984356078	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATCGTCCGAGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1562.87611725682	44.8921220254779	0.0287240437868313	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1557.9067243222	1557.9067243222
"healthy-5"	"2019-08-29-count-2:AGCTTCCTCCGGGACT"	2.34187497672383	-6.77846434032591	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTTCCTCCGGGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.57397222509	50.8085755114922	0.0253716348140879	906	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2000.58743603387	2000.58743603387
"healthy-5"	"2019-08-29-count-1:TATCTGTTCCATCAGA"	3.68497242507283	-8.26834108745726	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTGTTCCATCAGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.0937642655	37.9672260087451	0.0195194836908452	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1943.09781355313	1943.09781355313
"healthy-5"	"2019-08-29-count-2:TGATGCAAGTTCTACG"	11.847935338586	-3.41934134876402	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGCAAGTTCTACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2645.80688396529	41.1717389844761	0.0155611277731547	2627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2642.54755112061	2642.54755112061
"healthy-5"	"2019-08-29-count-1:TATCTTGAGAAGAACG"	-2.54958448830302	-5.85097362911376	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTTGAGAAGAACG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1766.85268441442	52.3286749506732	0.0296168862363396	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1764.59858888228	1764.59858888228
"healthy-5"	"2019-08-29-count-1:CGTGATACAATCCTTT"	3.63554753836934	-8.53928282177123	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGATACAATCCTTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1716.75229140846	47.8346393259024	0.0278634486555179	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1716.75229140846	1716.75229140846
"healthy-5"	"2019-08-29-count-1:AAGATAGGTGACAGGT"	3.24121489104573	-8.10514070903929	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGATAGGTGACAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.99975109352	46.4942921096554	0.0251865104976929	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1837.76901225244	1837.76901225244
"healthy-5"	"2019-08-29-count-2:GATAGCTTCATCTGTT"	-0.876857976347762	9.53449914539186	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATAGCTTCATCTGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1521.52077664464	42.1378458365585	0.0276945582889008	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1510.29517375903	1510.29517375903
"healthy-5"	"2019-08-29-count-2:AGGAATAAGCATTGTC"	2.53404774245564	-7.4480829468933	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGAATAAGCATTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.56612851733	42.4543939659724	0.0247177638526329	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1715.43334780649	1715.43334780649
"healthy-5"	"2019-08-29-count-1:TATCTTGGTATCTCGA"	3.97487868842427	-7.69502308284911	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTTGGTATCTCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.65645944013	47.0055133861483	0.0253172918162376	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1856.65645944013	1856.65645944013
"healthy-5"	"2019-08-29-count-2:AGGAATACACGTACAT"	-2.46118674698527	4.18503329837648	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGAATACACGTACAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3227.61631392426	43.8820600621975	0.0135958105902755	3569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3218.16388493064	3218.16388493064
"healthy-5"	"2019-08-29-count-2:TGATGGTTCCCTTTGG"	3.57003130492513	-8.44011213695677	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGGTTCCCTTTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1449.24867375248	49.5643319128518	0.0342000188170031	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1446.76687525143	1446.76687525143
"healthy-5"	"2019-08-29-count-1:CGTGCTTCAGCCGTCA"	3.35844554480855	-7.95458986675414	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTGCTTCAGCCGTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1550.24363208813	49.496565009468	0.0319282492022223	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1542.66164603225	1542.66164603225
"healthy-5"	"2019-08-29-count-1:AAGCATCGTTTCGTAG"	4.88269724425618	-9.95982553875121	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCATCGTTTCGTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1836.59609209497	43.3739807054785	0.0236165049529223	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1832.65598969851	1832.65598969851
"healthy-5"	"2019-08-29-count-2:GATCACACATCCCGTT"	-1.80588887158092	8.97947499835817	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATCACACATCCCGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1759.22238826098	45.0583605201165	0.0256126575132195	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1751.01932745026	1751.01932745026
"healthy-5"	"2019-08-29-count-2:GAAGTAAGTGGACTGA"	2.36729492720906	-7.01641275798949	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGTAAGTGGACTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1795.8514350099	51.0083168636157	0.0284034168245852	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1791.77855053616	1791.77855053616
"healthy-5"	"2019-08-29-count-2:AGGACGAAGTTAACAG"	-3.16582022133525	-5.70341017162474	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACGAAGTTAACAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1572.14873688091	51.4394751085007	0.0327192166375777	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1569.69907417199	1569.69907417199
"healthy-5"	"2019-08-29-count-2:TGTGCGGCAATTCTTC"	0.355369200080079	7.94617936694948	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGCGGCAATTCTTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1408.8351737919	41.2918011571691	0.0293091781957938	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1403.80232783223	1403.80232783223
"healthy-5"	"2019-08-29-count-2:AGGACGACATACAGAA"	4.17887129363362	-7.47652103817137	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACGACATACAGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.36974132255	46.7351485415395	0.0228604188356385	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2038.73095216267	2038.73095216267
"healthy-5"	"2019-08-29-count-2:TGTGCGGTCGCAGATT"	2.14205493506734	-7.58333828365477	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGCGGTCGCAGATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1596.66908993996	52.375584533343	0.0328030302981016	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1594.33797707618	1594.33797707618
"healthy-5"	"2019-08-29-count-2:GAATAGACAATGCTCA"	2.00180413302724	-6.78696062481078	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAATAGACAATGCTCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1884.38089813788	44.9448467293964	0.0238512536259576	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1878.91150917013	1878.91150917013
"healthy-5"	"2019-08-29-count-2:TCATCCGAGATTAGAC"	2.58625616607015	-7.32682135021361	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATCCGAGATTAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1873.16063879707	41.6885694229702	0.0222557364058976	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1871.21504917048	1871.21504917048
"healthy-5"	"2019-08-29-count-1:GTACAGTTCAGCGTCG"	3.7499860721523	-7.12279655849608	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTACAGTTCAGCGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1933.51494450455	38.6945672736352	0.0200125514331364	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1928.07536777396	1928.07536777396
"healthy-5"	"2019-08-29-count-1:CGTTAGAAGCGGCTCT"	-2.88198981705363	10.4900130995545	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTTAGAAGCGGCTCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1440.18098244962	34.5014335325851	0.0239563179579703	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1437.92057171814	1437.92057171814
"healthy-5"	"2019-08-29-count-1:GAGTCATCAGTAGAAT"	3.81250443038289	-7.6723580590454	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTCATCAGTAGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1940.43305312615	49.015817201165	0.0252602464806491	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1936.4908573817	1936.4908573817
"healthy-5"	"2019-08-29-count-2:CCTCTCCTCGGTGTTA"	-2.55129323425944	3.44112489307252	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCTCCTCGGTGTTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3396.93514735257	44.9602560405296	0.0132355355902422	3619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3386.80533326843	3386.80533326843
"healthy-5"	"2019-08-29-count-2:TGTGGCGCATCGGAAG"	-3.11741791191753	9.83703897083131	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGGCGCATCGGAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.50252982977	31.245416696812	0.0180140508067627	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1734.50252982977	1734.50252982977
"healthy-5"	"2019-08-29-count-1:GAACACTTCCGATAAC"	4.29533590850179	-7.35606672680052	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAACACTTCCGATAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1946.72835761533	47.5822162900232	0.0244421447419144	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1944.81176022542	1944.81176022542
"healthy-5"	"2019-08-29-count-2:CGTTGGGGTCCAATCA"	-3.72343812409099	10.1022119292053	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTTGGGGTCCAATCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1668.72662909638	42.7615963380532	0.0256252855275694	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1666.58821851766	1666.58821851766
"healthy-5"	"2019-08-29-count-2:GCCAACGTCAGTGTCA"	-8.36161742630656	-0.14954193746718	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	16	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAACGTCAGTGTCA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1540.7837796868	47.384627698008	0.030753586793106	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1540.7837796868	1540.7837796868
"healthy-5"	"2019-08-29-count-1:CGTTCTGAGAGTCTTC"	3.0500246482784	-7.2067442170349	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTTCTGAGAGTCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.969705603	44.1943828006936	0.0228398318964488	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1933.00338813705	1933.00338813705
"healthy-5"	"2019-08-29-count-2:GTCATCCTCACTGAAC"	-1.25581751290019	10.101270652655	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCATCCTCACTGAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1513.69557949006	43.9246532231696	0.0290181551814844	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1511.29187324606	1511.29187324606
"healthy-5"	"2019-08-29-count-1:AAGCGTTAGGGCAGTT"	-2.97810206833537	3.53477237308351	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCGTTAGGGCAGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2963.49094369789	44.5921469199518	0.0150471682779327	3017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2955.22002270175	2955.22002270175
"healthy-5"	"2019-08-29-count-1:CAGGCCATCTTTGCAT"	0.44594176587407	8.3168964155945	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGCCATCTTTGCAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1785.96274182512	41.3741745164632	0.0231663144742773	808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1782.07847852656	1782.07847852656
"healthy-5"	"2019-08-29-count-1:TATTCCAGTAGGAGTC"	1.01212843236272	8.93420980060426	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTCCAGTAGGAGTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1686.43482259591	41.4578826805525	0.0245831514654902	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1679.45914557146	1679.45914557146
"healthy-5"	"2019-08-29-count-2:TGTGTGAAGCTGAGCA"	2.69775166091267	-4.96361114895018	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGTGAAGCTGAGCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2239.03230118599	36.3932201240856	0.0162539951320973	1265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2230.53720414097	2230.53720414097
"healthy-5"	"2019-08-29-count-2:TGTGTGAAGCTTCGTA"	3.31924285468404	-8.07002069866332	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGTGAAGCTTCGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1711.39806237507	46.2105425193047	0.0270016330713698	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1709.2381310493	1709.2381310493
"healthy-5"	"2019-08-29-count-2:TGTGTGAAGGTTATAG"	3.25989284095113	-7.72176363384398	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTGTGAAGGTTATAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.57185421172	44.5730719503403	0.0205257182090898	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2156.30383719248	2156.30383719248
"healthy-5"	"2019-08-29-count-1:CCTTCAGCATGTCTAG"	3.36247791823689	-7.86992504512938	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTCAGCATGTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1575.54388525862	46.3307855956128	0.029406217134985	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.54388525862	1575.54388525862
"healthy-5"	"2019-08-29-count-1:CCTTCAGCAGGCTCTG"	-2.88379083100017	11.0496253737244	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTCAGCAGGCTCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1744.33778306649	39.2309548918655	0.0224904575665951	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1737.3535198325	1737.3535198325
"healthy-5"	"2019-08-29-count-1:AGGTTGTTCAAGTGGG"	-4.82141242447551	8.66344735706178	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"Treg"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTTGTTCAAGTGGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	3479.35485221617	49.2327393114303	0.0141499621057828	4459	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	3469.72765520007	3469.72765520007
"healthy-5"	"2019-08-29-count-1:GGCTTTCAGCGTATAA"	-3.7285557788914	10.7990970381531	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTTTCAGCGTATAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.57178923727	39.5244150140033	0.0236309229106557	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.2795631839	1670.2795631839
"healthy-5"	"2019-08-29-count-2:CCTGTTGCAGCTCCTT"	6.79792275008504	-1.5933134785858	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGTTGCAGCTCCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2411.28740847945	34.9799706498193	0.0145067612126244	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2399.65428649362	2399.65428649362
"healthy-5"	"2019-08-29-count-1:CCTTGTGAGAAGCTGC"	3.28305353698079	-6.98007347499999	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTGTGAGAAGCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.03392187414	37.7037974844343	0.0188139517364927	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2002.162479279	2002.162479279
"healthy-5"	"2019-08-29-count-1:TATTGCTGTAGGGTAC"	2.35194458541219	-6.33218052303465	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTGTAGGGTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.67673575995	46.7938389404184	0.0226859779475712	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2057.0566127762	2057.0566127762
"healthy-5"	"2019-08-29-count-1:GCCAGGTAGGCCTAGA"	2.32841171798055	-6.80151369487914	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGGTAGGCCTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1839.54046057958	46.4913153625687	0.0252733312253	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1837.60895028744	1837.60895028744
"healthy-5"	"2019-08-29-count-1:GGGAAGTGTCCTACGG"	-3.00922117653545	12.5508832701477	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAAGTGTCCTACGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1421.68355824779	41.5111962774222	0.0291986188041622	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1421.68355824779	1421.68355824779
"healthy-5"	"2019-08-29-count-2:TCATGCCGTACCATAC"	14.1363064247066	1.90606031501619	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGCCGTACCATAC"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1234.93705511223	33.7953112209044	0.0273660192485139	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1226.92597758919	1226.92597758919
"healthy-5"	"2019-08-29-count-2:TGTTACTCACAGTATC"	10.9963489967281	4.26231095874635	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTACTCACAGTATC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1511.787174631	38.1995765592925	0.0252678268477944	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1506.74276196615	1506.74276196615
"healthy-5"	"2019-08-29-count-1:GAGTGTTAGAGTTGAT"	10.2037102180416	7.46774718845216	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTGTTAGAGTTGAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1871.68531406076	38.2009267029168	0.0204099088751394	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1862.62724697127	1862.62724697127
"healthy-5"	"2019-08-29-count-2:GACACGCGTAAGCGGT"	3.5020121532375	-7.60158588802489	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACACGCGTAAGCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1653.24004333641	40.4963193258902	0.0244951236749411	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1653.24004333641	1653.24004333641
"healthy-5"	"2019-08-29-count-2:TGCAGGCTCCGCAGTG"	-5.64912066879924	-5.56553223049315	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCAGGCTCCGCAGTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2329.13721165929	53.3632106869924	0.022911149424716	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2327.48675873823	2327.48675873823
"healthy-5"	"2019-08-29-count-1:TATTGCTTCTAGGCCG"	2.87660564956014	-7.66285946285399	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTTCTAGGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1524.81152231765	46.0563127375644	0.0302045938553513	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1522.47464748793	1522.47464748793
"healthy-5"	"2019-08-29-count-1:CAACGGCCAAGTACCT"	-3.79741082611735	-7.19512369548949	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	40	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGGCCAAGTACCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2305.07319823456	53.3823102494047	0.0231586182557195	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2301.74877367396	2301.74877367396
"healthy-5"	"2019-08-29-count-2:GATGACTGTGAGTAGC"	11.1150089698726	4.37061593616334	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGACTGTGAGTAGC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1530.99248438376	37.6187926102956	0.024571507041354	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1530.99248438376	1530.99248438376
"healthy-5"	"2019-08-29-count-1:AAGGTAATCGTCCTTG"	4.18298782882039	-7.49927999889525	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGGTAATCGTCCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.64362724817	44.8613038317705	0.0226270133549094	931	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1977.1728686999	1977.1728686999
"healthy-5"	"2019-08-29-count-2:TATACCTAGGATTCCT"	4.15090384063069	-7.68963148510131	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATACCTAGGATTCCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.8150832079	39.2383939003351	0.0188120194432519	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2083.93887384556	2083.93887384556
"healthy-5"	"2019-08-29-count-2:AGGCATTAGATGAATC"	-3.30796704712566	10.3011770018372	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCATTAGATGAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1631.17136156592	31.1676716421933	0.0191075397573634	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1621.64047349071	1621.64047349071
"healthy-5"	"2019-08-29-count-1:GTAGGAGCAGCGCTTG"	6.81030954894368	-1.42367782509001	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGAGCAGCGCTTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1831.04769337925	45.1373313116329	0.0246510953673363	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1824.40162511624	1824.40162511624
"healthy-5"	"2019-08-29-count-2:TGTTCCGTCGAACGCC"	-3.28193316879924	11.0363149412903	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTCCGTCGAACGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1451.25016684095	39.5674037344521	0.0272643577506568	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1448.72085539249	1448.72085539249
"healthy-5"	"2019-08-29-count-2:AGGCATTTCTTCCGTG"	-1.98823628845866	10.8662309416565	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCATTTCTTCCGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1374.47830815886	37.3051750349021	0.0271413341436237	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1369.66388366939	1369.66388366939
"healthy-5"	"2019-08-29-count-1:ACCTGAACATGAAGCG"	0.531726797192734	8.28796956622926	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCTGAACATGAAGCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1795.24506244071	42.0233444353713	0.0234081381503642	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1791.47687347499	1791.47687347499
"healthy-5"	"2019-08-29-count-2:CACTAAGGTTGCAAGG"	-4.79205069962199	-4.67453005230101	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACTAAGGTTGCAAGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2577.2538423835	50.7856555009622	0.0197053370008732	1606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2573.4745353434	2573.4745353434
"healthy-5"	"2019-08-29-count-2:CTAAGTGCATGAATCC"	2.65179028090779	-8.19549372112425	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAAGTGCATGAATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1738.56814516343	46.7178736475347	0.0268714653362887	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1738.56814516343	1738.56814516343
"healthy-5"	"2019-08-29-count-1:CTAACTTTCTGCACCT"	4.02818073806111	-8.33578493511351	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAACTTTCTGCACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1878.5671602085	46.3879911932875	0.0246932833575878	825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1870.44706913979	1870.44706913979
"healthy-5"	"2019-08-29-count-2:AGGCCACGTTCTCGCT"	3.59620680388753	-8.4291620484558	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCCACGTTCTCGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.75943213851	44.0460743417839	0.0229794483351738	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1912.72286581205	1912.72286581205
"healthy-5"	"2019-08-29-count-2:TCATTACTCAGCTTGA"	-3.04188738289531	-5.69758942043456	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTACTCAGCTTGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2313.25866440624	41.9267238031613	0.0181245290240479	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2310.26023012302	2310.26023012302
"healthy-5"	"2019-08-29-count-1:ACCTGTCAGGTCACCC"	3.37393059310262	-7.50068142330321	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCTGTCAGGTCACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2034.28727073026	37.3402759173854	0.0183554586683232	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2032.43769831894	2032.43769831894
"healthy-5"	"2019-08-29-count-2:GTTGTGATCCGCGAGT"	3.44586410102193	-7.98180487072142	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGTGATCCGCGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1724.7942188355	46.1943401016114	0.026782522574084	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1720.41381548382	1720.41381548382
"healthy-5"	"2019-08-29-count-2:GACAGCCGTAACTAAG"	3.15877570685689	-7.94071009075316	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACAGCCGTAACTAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.70615740938	48.8185311932663	0.0263498509993234	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1850.7742971696	1850.7742971696
"healthy-5"	"2019-08-29-count-1:AGTAGCTTCTCCAAGA"	-5.38543973389323	-4.10673286831053	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTAGCTTCTCCAAGA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2453.83749272954	39.2238037193566	0.0159846786250404	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2450.89668357306	2450.89668357306
"healthy-5"	"2019-08-29-count-1:AAGTGAACAATGACCT"	-3.11424622955974	11.9270934828552	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGTGAACAATGACCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1443.39094163866	46.5240905928486	0.0322324945035545	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1440.96511774993	1440.96511774993
"healthy-5"	"2019-08-29-count-1:GTAGGTTCAGGCCCTA"	-3.32090316239055	11.0847625502381	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGTTCAGGCCCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1570.14232103534	34.9037585843272	0.0222296782379013	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1565.43642320817	1565.43642320817
"healthy-5"	"2019-08-29-count-2:TCATTCATCAGTGTTG"	-3.46301207962688	10.9790143736633	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTCATCAGTGTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1532.82051014362	29.058822848381	0.018957746622048	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1530.68804486332	1530.68804486332
"healthy-5"	"2019-08-29-count-1:TCAAGACGTAGCGATG"	-2.10841737213786	9.69773767078248	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGACGTAGCGATG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1634.86532369035	41.653316327436	0.0254781331060424	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1634.86532369035	1634.86532369035
"healthy-5"	"2019-08-29-count-1:TACCGAAAGTATCTGC"	-0.464457551867324	10.3784894713196	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCGAAAGTATCTGC"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1514.05922052537	38.8422212564222	0.025654360628605	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1511.81531452775	1511.81531452775
"healthy-5"	"2019-08-29-count-1:CAGTTCCCATTGACTG"	3.35927691039388	-7.22211077129515	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTCCCATTGACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1927.87362844559	42.0285004389128	0.0218004436695364	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1925.88896753904	1925.88896753904
"healthy-5"	"2019-08-29-count-1:GATAGCTTCATCCTAT"	0.306169678538483	7.83870074832765	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATAGCTTCATCCTAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1573.79334431312	32.2389672165914	0.0204848796273579	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1562.23205552965	1562.23205552965
"healthy-5"	"2019-08-29-count-1:GTAGGTTTCGTAACTG"	-3.72713790360149	12.695587135199	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGTTTCGTAACTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1614.94171962274	39.9952160525956	0.0247657333801115	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1612.52333036929	1612.52333036929
"healthy-5"	"2019-08-29-count-1:GTAGTACAGCGATTCT"	3.49319614943807	-8.43629267131957	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGTACAGCGATTCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1902.2595170208	44.9567728155893	0.0236333541314057	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1902.2595170208	1902.2595170208
"healthy-5"	"2019-08-29-count-1:CAGTTCCTCGGACAAG"	-0.866240422159988	9.29124543750612	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTCCTCGGACAAG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1425.52913465018	41.5015516205843	0.0291130855286019	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1420.71940164531	1420.71940164531
"healthy-5"	"2019-08-29-count-1:CTACATTCAGGTCAAG"	-5.76053128662761	-5.32656242763671	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACATTCAGGTCAAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2509.09763522417	22.2254898432282	0.00885796133686226	1550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2504.16218095046	2504.16218095046
"healthy-5"	"2019-08-29-count-2:GTCGTTCCACAGACGA"	4.70347656783406	-8.01584722911986	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCGTTCCACAGACGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1954.4266281686	35.9570430460258	0.0183977451636133	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1952.56477376782	1952.56477376782
"healthy-5"	"2019-08-29-count-2:GATGGAGCAACCGCTG"	10.6983066993648	5.90138766849367	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGGAGCAACCGCTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1572.35358053919	38.9143626442164	0.0247491169453577	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1567.79874459808	1567.79874459808
"healthy-5"	"2019-08-29-count-2:GAACTGTTCTACGCGG"	3.22614206847493	-6.6706228486267	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAACTGTTCTACGCGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1977.08758879875	44.8472699200746	0.0226835018206367	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1971.58102373078	1971.58102373078
"healthy-5"	"2019-08-29-count-1:GGGAGATCAGCCTACG"	-1.82218299332317	9.88784120166627	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAGATCAGCCTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1480.32136832622	36.6048800592517	0.0247276576846555	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1475.60620111101	1475.60620111101
"healthy-5"	"2019-08-29-count-2:ACTTTGTGTTGTGGCC"	2.88437809523885	-7.73704531109007	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTTTGTGTTGTGGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1648.5639367582	44.9487031030707	0.0272653684220822	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1648.5639367582	1648.5639367582
"healthy-5"	"2019-08-29-count-1:AAACGAACACGATTCA"	2.0803653198177	-7.08859112178954	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGAACACGATTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.23969175203	52.5789912271057	0.0274960254480084	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1912.23969175203	1912.23969175203
"healthy-5"	"2019-08-29-count-1:GTGTAACTCTACACAG"	4.39656939086263	-7.60300972377928	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTAACTCTACACAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.36209189953	43.8423833469061	0.0214980868385515	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2032.98647603456	2032.98647603456
"healthy-5"	"2019-08-29-count-1:TCAAGTGGTGGGTTGA"	-1.87818799439128	3.58183524692384	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGTGGTGGGTTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2726.97962047055	38.5808120291991	0.014147818245353	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2722.9647918501	2722.9647918501
"healthy-5"	"2019-08-29-count-2:TGTTTGTGTAGAGATT"	3.87232031401936	-8.10007765209349	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTTGTGTAGAGATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1735.30740005903	39.2979948886636	0.022646128799616	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1735.30740005903	1735.30740005903
"healthy-5"	"2019-08-29-count-1:CATACAGCACCTTCGT"	-0.914762358099777	9.99886415088502	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACAGCACCTTCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1456.52116733107	44.0894888601215	0.030270407220316	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1451.73487572028	1451.73487572028
"healthy-5"	"2019-08-29-count-1:AATCACGCAGGAAGTC"	3.21356381949727	-7.9067387810913	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCACGCAGGAAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.14211763774	42.7241964250138	0.023079911595083	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1851.14211763774	1851.14211763774
"healthy-5"	"2019-08-29-count-1:CATACAGCAGACCCGT"	2.85200156745259	-7.05622484600218	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACAGCAGACCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1993.15122158022	45.7881754619683	0.0229727553866516	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1989.61368561933	1989.61368561933
"healthy-5"	"2019-08-29-count-2:TTAATCCCAGTGCCTG"	2.65660442885701	-6.31913616573485	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTAATCCCAGTGCCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2083.94904820538	45.1031075482452	0.021643095154887	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2080.45885136429	2080.45885136429
"healthy-5"	"2019-08-29-count-1:TCAATCTCACCTAAAC"	3.524346490472	-8.16750624096068	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATCTCACCTAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.15125103756	42.3787642490349	0.019591216392616	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2156.49613765935	2156.49613765935
"healthy-5"	"2019-08-29-count-1:AAACGCTCATCCCACT"	3.24296536025349	-8.34098436748656	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGCTCATCCCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.98152903064	43.3518307922909	0.022961999429385	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1885.8652225028	1885.8652225028
"healthy-5"	"2019-08-29-count-1:TCAATCTGTCTACACA"	-1.47643933716472	9.27307984912721	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATCTGTCTACACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.40658650445	39.267478619208	0.0238214764128535	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1644.247033993	1644.247033993
"healthy-5"	"2019-08-29-count-2:AGAACAACAGGATTCT"	-3.35681758347209	12.5298032530579	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAACAACAGGATTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1554.35763673412	38.0805611158382	0.0244992273437468	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1552.06494728535	1552.06494728535
"healthy-5"	"2019-08-29-count-2:TCCACGTCAAGTCCAT"	3.78369893607442	-7.81578733837279	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCACGTCAAGTCCAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.59903564355	48.6107206505556	0.0244078852121195	941	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1988.01768959753	1988.01768959753
"healthy-5"	"2019-08-29-count-1:CATACCCGTAAGTTGA"	-2.66508446160014	11.4608297117981	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACCCGTAAGTTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1709.38378477698	50.5142311387721	0.0295511350865906	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1707.11645053495	1707.11645053495
"healthy-5"	"2019-08-29-count-2:GTCTCACCACCCATAA"	-2.88339863243755	11.902166343573	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACCACCCATAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1436.382211028	42.3085416013143	0.0294549328698763	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1436.382211028	1436.382211028
"healthy-5"	"2019-08-29-count-1:CAATACGTCACACCCT"	4.32530750808064	-7.67851211940917	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATACGTCACACCCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.08499725057	40.4584432767555	0.0186523088436086	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2167.34602318807	2167.34602318807
"healthy-5"	"2019-08-29-count-1:GAATCACCAGCGCTTG"	-3.04465923729594	12.2292079695496	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATCACCAGCGCTTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1454.6611857318	40.8138155056189	0.0280572657784132	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1449.80296403001	1449.80296403001
"healthy-5"	"2019-08-29-count-1:GTATTTCTCAACCCGG"	10.454097409814	6.05742642963258	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTATTTCTCAACCCGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1517.24860823573	40.6473393614214	0.0267901642095994	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1510.11684095454	1510.11684095454
"healthy-5"	"2019-08-29-count-1:CTACCTGCAATGCAGG"	2.14433731612508	-7.12738897716673	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACCTGCAATGCAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1697.83728549783	51.9646443800896	0.030606374841658	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1693.53123697021	1693.53123697021
"healthy-5"	"2019-08-29-count-1:AGATGAATCTGCGGGT"	2.50741853293721	-6.33928253566893	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAATCTGCGGGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2277.23401322542	46.9974162359461	0.0206379388165646	1221	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2270.91621880667	2270.91621880667
"healthy-5"	"2019-08-29-count-1:CATACTTCACACCTTC"	1.90612949904744	-6.92655851757201	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACTTCACACCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1549.94637669072	46.0792866186166	0.0297296005278583	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1549.94637669072	1549.94637669072
"healthy-5"	"2019-08-29-count-2:AGGGTGAAGCGACTAG"	-3.73699317398723	12.7716254957947	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTGAAGCGACTAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1683.54748573325	44.6463480713943	0.0265192092588639	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1678.75546094165	1678.75546094165
"healthy-5"	"2019-08-29-count-2:TTACAGGCAGGTCAAG"	3.3510283428127	-7.60991337215575	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACAGGCAGGTCAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1652.4019024112	45.660050252585	0.0276325330937693	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1647.65263342289	1647.65263342289
"healthy-5"	"2019-08-29-count-1:TCAATTCTCGACCAAT"	3.89735807952229	-7.31083443081053	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATTCTCGACCAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2218.03726530113	44.3076820591204	0.0199760764853989	1099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2218.03726530113	2218.03726530113
"healthy-5"	"2019-08-29-count-2:TTACAGGGTGGAGGTT"	3.51331843909566	-7.83106567775878	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACAGGGTGGAGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1959.01147885556	41.6804455997769	0.0212762641003647	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1956.89770525059	1956.89770525059
"healthy-5"	"2019-08-29-count-1:GGGCGTTAGAAGAACG"	6.84617914733235	-1.55144717609557	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCGTTAGAAGAACG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2264.26971312836	31.6292135002181	0.0139688365378162	1187	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2256.21829103481	2256.21829103481
"healthy-5"	"2019-08-29-count-2:TTACAGGTCAGCGGAA"	2.63775910910909	-7.16718485271605	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACAGGTCAGCGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1802.07546671392	48.334951306808	0.0268218241686331	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1800.09071552466	1800.09071552466
"healthy-5"	"2019-08-29-count-2:AGGGTTTAGCGCATCC"	4.55321373519246	-8.11567213451537	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTTTAGCGCATCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2111.34192478194	44.8390129953502	0.0212372105479699	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2106.01745421634	2106.01745421634
"healthy-5"	"2019-08-29-count-1:CATAGACAGAGATCGC"	-1.87182603302653	3.398490644339	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATAGACAGAGATCGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2763.2726486596	46.2521271416272	0.0167381699247315	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2756.56086544631	2756.56086544631
"healthy-5"	"2019-08-29-count-1:GTCAAACGTATGAGAT"	-3.50224552574809	12.6769017943176	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAACGTATGAGAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1595.36444499367	35.3138624767819	0.0221352949086953	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1587.70307777295	1587.70307777295
"healthy-5"	"2019-08-29-count-2:TTACCATCAATCCAGT"	10.3842779594356	7.07671163165895	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACCATCAATCCAGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1577.3281936602	43.9146423856227	0.0278411573204169	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1572.75728003124	1572.75728003124
"healthy-5"	"2019-08-29-count-2:GATTGGTGTAGAGCTG"	4.20448364791219	-7.17276670848998	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTGGTGTAGAGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2086.99037918273	37.5332351444458	0.0179843834062828	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2081.17931318406	2081.17931318406
"healthy-5"	"2019-08-29-count-2:TCCATCGCAGCGACCT"	10.7663542228634	6.3386077650818	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCATCGCAGCGACCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1938.90932043187	43.2158772997665	0.0222887562839404	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1928.03541226101	1928.03541226101
"healthy-5"	"2019-08-29-count-1:TCACACCCAAGTTGGG"	3.76562561568562	-8.35335256969603	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACACCCAAGTTGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1609.92534440856	50.0382077226047	0.031081073353117	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1607.65606247709	1607.65606247709
"healthy-5"	"2019-08-29-count-1:TCACACCCAGCGGTCT"	3.06785811957662	-8.69749739086302	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACACCCAGCGGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1562.21540807685	44.6267818105064	0.0285663433991115	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1557.3667251639	1557.3667251639
"healthy-5"	"2019-08-29-count-1:AATGAAGGTATTGGCT"	2.45964874800984	-6.68420269405516	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGAAGGTATTGGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.02381406782	42.8064161824316	0.0232010101203269	832	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.02381406782	1845.02381406782
"healthy-5"	"2019-08-29-count-2:ATCGTAGTCTAGGCCG"	2.83043517646138	-7.51087763225707	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGTAGTCTAGGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.68469980661	39.4987201677829	0.0223955677407158	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1763.68469980661	1763.68469980661
"healthy-5"	"2019-08-29-count-1:ACGGTTATCTATCGTT"	-2.23064003410991	4.14646718585817	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGTTATCTATCGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2998.95766690113	51.4440634095008	0.0171539811906244	3265	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2996.08986494822	2996.08986494822
"healthy-5"	"2019-08-29-count-1:GTGTTCCCATCTGGGC"	5.56952776488606	-9.81794550335082	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTTCCCATCTGGGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2256.412796387	40.2847802452363	0.0178534620570052	1150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2251.41553572798	2251.41553572798
"healthy-5"	"2019-08-29-count-1:AATGACCAGAGTATAC"	-2.57005868378337	4.01200459087221	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGACCAGAGTATAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3339.22546536688	47.6095475756816	0.0142576618648453	4176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3332.36726182074	3332.36726182074
"healthy-5"	"2019-08-29-count-1:CTACTATCATAGGTTC"	-2.92053494873698	12.8343047865662	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACTATCATAGGTTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1735.26473103948	39.3353191226779	0.0226681948979132	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1725.77336702894	1725.77336702894
"healthy-5"	"2019-08-29-count-1:GTCACGGAGTGGACGT"	-3.96626267853435	3.70046446407167	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCACGGAGTGGACGT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2665.10785909432	43.7316859634948	0.0164089741487446	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2656.21966989756	2656.21966989756
"healthy-5"	"2019-08-29-count-1:AATGACCAGCTGTCCG"	-7.24040875855144	-1.15238191997679	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGACCAGCTGTCCG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3415.91083913573	45.1839046819035	0.0132274836228851	3502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3403.85240266322	3403.85240266322
"healthy-5"	"2019-08-29-count-2:GATTTCTGTCAACCAT"	5.06771006163899	-8.89354612743529	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATTTCTGTCAACCAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2342.89873943838	35.3574890937632	0.015091343257216	1284	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2336.78873268561	2336.78873268561
"healthy-5"	"2019-08-29-count-2:GTGAGGATCTGCGTCT"	3.57066764411275	-8.32254888927611	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGAGGATCTGCGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1486.60687368804	44.9250468340845	0.0302198567955175	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1481.658945749	1481.658945749
"healthy-5"	"2019-08-29-count-1:CTACTATTCGGTAACT"	2.42331304129903	-6.47324182903441	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACTATTCGGTAACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2254.94179463375	43.2782926226958	0.0191926428991153	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2254.94179463375	2254.94179463375
"healthy-5"	"2019-08-29-count-2:AGGTCATGTACTGACT"	3.15867223319356	-8.00388624584349	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCATGTACTGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1587.24502197208	47.7202105779289	0.0300648040581905	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1582.59285316909	1582.59285316909
"healthy-5"	"2019-08-29-count-2:AGGTCATGTACTGCCG"	-4.79428992691691	-4.47523262416991	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCATGTACTGCCG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2829.403254763	41.9929979272779	0.014841644737839	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2826.19478861814	2826.19478861814
"healthy-5"	"2019-08-29-count-2:GGAATGGTCCACTGAA"	-0.447993378073531	8.67681405628053	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAATGGTCCACTGAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1694.74722209375	43.5464972212344	0.025694980734316	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1686.02974222401	1686.02974222401
"healthy-5"	"2019-08-29-count-2:TCCCACAGTATGAAAC"	-2.56597171250041	3.78164026820985	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCACAGTATGAAAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3343.15953888688	46.8388528269395	0.0140103552588862	4195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3330.5600486873	3330.5600486873
"healthy-5"	"2019-08-29-count-2:AGGTCTAAGCAGGTCA"	-2.97663102570232	11.9979333647522	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCTAAGCAGGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.6564004169	36.2824341916675	0.0220072746404239	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1643.99559507336	1643.99559507336
"healthy-5"	"2019-08-29-count-1:GGGTAGACAATTCTCT"	3.43197955664937	-7.64707996761473	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTAGACAATTCTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1748.05347767447	39.7425141197036	0.0227352965039578	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.05347767447	1748.05347767447
"healthy-5"	"2019-08-29-count-2:CATCAAGGTGCCCAGT"	-3.56136212769206	12.956739402655	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCAAGGTGCCCAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1580.83359502431	37.436694799497	0.0236816164062614	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1575.96105367484	1575.96105367484
"healthy-5"	"2019-08-29-count-2:CATCAAGTCCACCTCA"	-4.20101151886638	12.2199935683045	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCAAGTCCACCTCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1768.58008014713	32.1332850016681	0.0181689737221257	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1764.32467618873	1764.32467618873
"healthy-5"	"2019-08-29-count-2:GCAACATTCTTACACT"	-3.92767725411113	13.0342969664368	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAACATTCTTACACT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2026.28152777937	38.9862981429805	0.0192403166137067	921	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2024.36549593738	2024.36549593738
"healthy-5"	"2019-08-29-count-1:GATGATCGTACCTAAC"	1.58076407489125	-7.16933109676512	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGATCGTACCTAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1559.38779078223	49.7491179032796	0.0319029802576074	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1552.00442103864	1552.00442103864
"healthy-5"	"2019-08-29-count-2:CTATCCGGTTGGGTAG"	2.7087582546169	-6.57416679775389	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTATCCGGTTGGGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.54904648609	48.4841830141289	0.0265732418141924	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1816.99960567497	1816.99960567497
"healthy-5"	"2019-08-29-count-1:TCACGGGAGCGCACAA"	3.54313244399373	-7.04837753688964	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACGGGAGCGCACAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2029.12290805734	46.7575081206354	0.0230432113968889	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2020.20848089968	2020.20848089968
"healthy-5"	"2019-08-29-count-1:TCACGGGAGCTGGAGT"	4.02963461455647	-7.30441286480101	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACGGGAGCTGGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.65040332118	42.1711964207909	0.020065752303118	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2096.69234036644	2096.69234036644
"healthy-5"	"2019-08-29-count-1:AATGCCATCCATCTGC"	3.37821092185323	-7.66720058834227	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGCCATCCATCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1581.29764927576	52.6037396036088	0.0332661846602387	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1576.69831530355	1576.69831530355
"healthy-5"	"2019-08-29-count-2:TTACGTTGTCTACTGA"	10.1296869712764	5.79222962940065	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACGTTGTCTACTGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1509.42102593192	39.0956789860864	0.0259011093090801	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1504.69441326034	1504.69441326034
"healthy-5"	"2019-08-29-count-1:GTTAGACAGACTCATC"	-1.0876056951588	10.49999425495	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTAGACAGACTCATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1402.15140562239	40.2015614167563	0.0286713412371552	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1402.15140562239	1402.15140562239
"healthy-5"	"2019-08-29-count-2:GGTGGCTCAATTGAGA"	4.37778439101521	-8.48858263408812	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGGCTCAATTGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1740.46704237933	50.2808981717135	0.0288893135850342	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1738.20374582062	1738.20374582062
"healthy-5"	"2019-08-29-count-2:TTACGTTTCATTTGGG"	6.82569660720174	-1.49468960678252	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACGTTTCATTTGGG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2129.79098120411	33.7735872999065	0.0158577004025118	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2118.71111407909	2118.71111407909
"healthy-5"	"2019-08-29-count-2:TTACTGTAGATCGCTT"	-2.34429369393047	11.0937099226746	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACTGTAGATCGCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1495.89130504814	43.2293283319771	0.0288987095426601	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1486.13185170301	1486.13185170301
"healthy-5"	"2019-08-29-count-1:AATGGAACATACACCA"	-4.17847524109538	12.7924165495667	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGGAACATACACCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1999.35417261708	39.7687706050242	0.0198908083168518	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1995.20589638441	1995.20589638441
"healthy-5"	"2019-08-29-count-1:AGCGATTGTATAGGGC"	-2.45997105065044	10.1320218809876	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGATTGTATAGGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1421.37964506725	44.9707919415438	0.0316388321006357	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1421.37964506725	1421.37964506725
"healthy-5"	"2019-08-29-count-1:CTAGGTATCGTTCTCG"	0.546431382268113	8.83244798267213	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGGTATCGTTCTCG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1411.52733213423	40.4224844005128	0.0286374082033495	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1409.14588725721	1409.14588725721
"healthy-5"	"2019-08-29-count-1:AGTTCGATCCCGAGAC"	3.01001729544942	-8.65478517925414	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTCGATCCCGAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1438.48453472736	46.6103805768095	0.0324024203608443	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1433.59341013962	1433.59341013962
"healthy-5"	"2019-08-29-count-2:TTACTGTTCCGTTGAA"	4.62895407256429	-8.20634653484496	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACTGTTCCGTTGAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.73078429189	39.1144570276877	0.0182289676384523	1101	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2141.01435758031	2141.01435758031
"healthy-5"	"2019-08-29-count-2:AGGTTACCACAGCCAC"	4.04887952384297	-7.59768822109374	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTTACCACAGCCAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.46872184511	43.5418698416707	0.0222667176187744	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1953.66452084644	1953.66452084644
"healthy-5"	"2019-08-29-count-1:GTCATCCTCCGTCACT"	5.49959101256673	-10.133140586969	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCATCCTCCGTCACT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2269.13037239988	42.1165042916763	0.0185606366227133	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2260.84247018459	2260.84247018459
"healthy-5"	"2019-08-29-count-2:GTGCACGCATGTGGTT"	4.12955727156941	-7.50300409710082	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCACGCATGTGGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2261.94234769961	42.7025183696106	0.0188786944163449	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2255.55484986531	2255.55484986531
"healthy-5"	"2019-08-29-count-2:TTAGGCATCCTCTTTC"	3.47109260138814	-7.42524053966673	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTAGGCATCCTCTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1913.97504594643	46.9965721502733	0.0245544330631721	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1901.67346305938	1901.67346305938
"healthy-5"	"2019-08-29-count-2:TTAGGGTAGAGTCACG"	4.7474647956783	-8.47312261974486	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTAGGGTAGAGTCACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.9063320767	42.4335117385946	0.0221827441454113	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1909.11686498934	1909.11686498934
"healthy-5"	"2019-08-29-count-1:CTATAGGTCTTGGGCG"	4.22911133345906	-7.5596175423828	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATAGGTCTTGGGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.11110610616	42.1912481381592	0.0201571947208517	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2087.5054595342	2087.5054595342
"healthy-5"	"2019-08-29-count-2:AGGTTGTCATCATCCC"	3.44338788565938	-7.05631067669066	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTTGTCATCATCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1882.34489207899	50.0094048064747	0.0265676099087457	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1878.51856048904	1878.51856048904
"healthy-5"	"2019-08-29-count-1:CTATCCGCAGGCACTC"	6.72239555892293	-1.19200196182402	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATCCGCAGGCACTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2013.4961047429	44.2406063448978	0.0219720347313743	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2003.02993157618	2003.02993157618
"healthy-5"	"2019-08-29-count-2:GGTGTTAGTTTGTTGG"	-1.97589955750163	4.13365886295167	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTTAGTTTGTTGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3080.84500208903	47.8969368585106	0.0155466882709235	3692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3075.91075347595	3075.91075347595
"healthy-5"	"2019-08-29-count-1:TACTTACTCATCTACT"	2.99047054824178	-7.89110090648802	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTTACTCATCTACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1824.79944041503	46.4971058720045	0.0254806664459681	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1818.76069267972	1818.76069267972
"healthy-5"	"2019-08-29-count-2:AGGTTGTTCTTCACGC"	3.93441738662068	-7.07538320934447	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTTGTTCTTCACGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1903.82505975942	48.1171795186562	0.0252739500785522	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1898.10786617719	1898.10786617719
"healthy-5"	"2019-08-29-count-2:GCACGTGAGTGCGCTC"	4.37577023085896	-7.86663057720336	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACGTGAGTGCGCTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2229.69996160603	45.4609380940982	0.0203888141350431	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2226.35517094272	2226.35517094272
"healthy-5"	"2019-08-29-count-2:CATCCCATCCACTAGA"	3.96195354041402	-7.86871292507323	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCCATCCACTAGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.7830928642	45.2376066169171	0.0203517863538477	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2221.26269459881	2221.26269459881
"healthy-5"	"2019-08-29-count-1:CCGATGGAGGACGGAG"	2.76156963881795	-6.31009056484374	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATGGAGGACGGAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1894.34516252104	49.4536278885279	0.0261059224406147	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1888.46194782123	1888.46194782123
"healthy-5"	"2019-08-29-count-1:CTATCTAAGTTAGAAC"	3.79317798194234	-7.56693508541258	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATCTAAGTTAGAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2061.07801912935	38.4703202875512	0.0186651450990691	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2059.23393080818	2059.23393080818
"healthy-5"	"2019-08-29-count-2:AGTAACCGTTGCCTAA"	3.46121134337727	-7.7117548218933	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAACCGTTGCCTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1903.88121597634	39.9280374434179	0.0209719162668151	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1901.95088386901	1901.95088386901
"healthy-5"	"2019-08-29-count-2:GCACTAAAGTACAGAT"	9.85351242598836	5.57691762531129	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACTAAAGTACAGAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1435.32771652294	44.3472404257104	0.0308969442415149	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1431.35231062664	1431.35231062664
"healthy-5"	"2019-08-29-count-2:CTCAAGAGTTAATGAG"	2.32493676719014	-7.02151968395384	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAAGAGTTAATGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.64060405556	42.8985642484008	0.0214317016558733	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2001.64060405556	2001.64060405556
"healthy-5"	"2019-08-29-count-1:GTCATTTAGGACCCAA"	-5.65159736099895	-5.4825535050598	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCATTTAGGACCCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2267.90161749837	43.9706141929164	0.0193882370618081	1176	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2262.96817241519	2262.96817241519
"healthy-5"	"2019-08-29-count-1:TCAGCAATCAGGGTAG"	3.46135630187337	-7.85560896312865	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCAATCAGGGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1629.30432374808	45.6777262788929	0.0280351102081501	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1622.50120646238	1622.50120646238
"healthy-5"	"2019-08-29-count-1:AATTCCTTCGTAGAGG"	3.81845583495442	-8.40709593212279	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATTCCTTCGTAGAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1890.96268109434	41.7450489669236	0.0220760829308195	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.96268109434	1890.96268109434
"healthy-5"	"2019-08-29-count-2:TTATTGCAGCACTGGA"	-3.58984408798869	10.8627919920715	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTATTGCAGCACTGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1670.5490807087	42.5545978849185	0.0254734197135145	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1665.91965321397	1665.91965321397
"healthy-5"	"2019-08-29-count-2:GTGCTGGTCTAACACG"	4.18418659743611	-8.26020910656127	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTGGTCTAACACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1839.9116238496	48.5176707617414	0.0263695658709026	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1832.01154257473	1832.01154257473
"healthy-5"	"2019-08-29-count-2:TACAACGAGGTGTGAC"	-2.46809897843059	11.4363860853943	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACAACGAGGTGTGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1423.7912240853	40.368778980934	0.0283530185451652	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1421.30253607885	1421.30253607885
"healthy-5"	"2019-08-29-count-1:GTCCACTCATAGAATG"	3.87174310263936	-7.75023653423461	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCCACTCATAGAATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.89993446506	41.0526992615681	0.0221559181356549	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1848.96425266687	1848.96425266687
"healthy-5"	"2019-08-29-count-1:CCGCAAGAGCTCATAC"	-2.99078665199931	3.46327040279237	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGCAAGAGCTCATAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2839.0086523237	48.5145210029809	0.0170885428486709	2690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2834.68561487431	2834.68561487431
"healthy-5"	"2019-08-29-count-1:TCAGCCTAGTGGATTA"	0.417544831603211	8.46733472431032	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCCTAGTGGATTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1558.56593022763	39.3155691002572	0.0252254770476825	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1556.13737124952	1556.13737124952
"healthy-5"	"2019-08-29-count-2:CTCAATTGTTGTGCCG"	6.85914816436116	-1.37271752273711	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAATTGTTGTGCCG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2156.61604431776	36.416640618354	0.0168860102447556	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2156.61604431776	2156.61604431776
"healthy-5"	"2019-08-29-count-2:ACCTGAAGTGACGTCC"	3.881435294717	-8.41119768535765	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTGAAGTGACGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.69119759138	44.5780456886111	0.0254776647159094	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1745.22557971547	1745.22557971547
"healthy-5"	"2019-08-29-count-1:TCAGCCTCACACCGCA"	6.79627337035481	-1.53446581279906	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCCTCACACCGCA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2422.04568796686	40.0282011391291	0.016526608617664	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2414.41416801575	2414.41416801575
"healthy-5"	"2019-08-29-count-2:TTCAATCGTCGTACAT"	2.48401631888692	-7.0770473710266	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCAATCGTCGTACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1850.12683440945	51.1494145990524	0.0276464367997662	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1848.28041778364	1848.28041778364
"healthy-5"	"2019-08-29-count-2:GAGACTTTCCATGAGT"	0.774489243596238	8.7088298567566	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACTTTCCATGAGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1517.50095914495	34.5048944186806	0.0227379720656801	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1515.20883794108	1515.20883794108
"healthy-5"	"2019-08-29-count-2:GCAGCCATCCGTGACG"	8.75048985060994	5.85706565463869	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGCCATCCGTGACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1384.09786010022	33.0409531570597	0.0238718331337261	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1379.12238777941	1379.12238777941
"healthy-5"	"2019-08-29-count-1:GATTCTTGTGGCCTCA"	-3.70537791672404	3.60895178401796	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTCTTGTGGCCTCA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3012.43823057338	47.8657974491656	0.0158893871958513	2681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3005.40382307038	3005.40382307038
"healthy-5"	"2019-08-29-count-2:TGGATGTGTCATGACT"	3.44506730613057	-7.49191143428954	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATGTGTCATGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1513.58117125067	46.1231527505726	0.0304728637133224	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1511.21062868143	1511.21062868143
"healthy-5"	"2019-08-29-count-2:CAATTTCTCTAGGCCG"	1.92688288268391	-7.28920652782591	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCTCTAGGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1558.24098123073	48.5304761944129	0.0311443972909009	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1555.91040414618	1555.91040414618
"healthy-5"	"2019-08-29-count-2:TGGATGTTCCCAAGCG"	3.18931116637532	-7.4699335328308	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATGTTCCCAAGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1726.27176818899	46.9762336652326	0.0272125365952748	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1719.80413831438	1719.80413831438
"healthy-5"	"2019-08-29-count-2:AGTAGTCCATGGGCAA"	-2.88736830177959	12.1976117857727	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAGTCCATGGGCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1642.47007489486	40.7596918766382	0.0248160940644518	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1640.11230697177	1640.11230697177
"healthy-5"	"2019-08-29-count-1:AACAGGGAGCGGTAAC"	4.80754150924031	-9.23281958019408	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAGGGAGCGGTAAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1891.95535751589	44.5641106666669	0.0235545254752622	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1885.78391609952	1885.78391609952
"healthy-5"	"2019-08-29-count-2:TTCACCGGTATCGCAT"	-0.678832988173324	8.86950490558473	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCACCGGTATCGCAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1599.39971737106	44.3030692236966	0.0276998105867605	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1595.16957078604	1595.16957078604
"healthy-5"	"2019-08-29-count-1:GCTGGGTAGTGTAGTA"	3.58973564681355	-7.96574022686156	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTAGTGTAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1846.56121518672	40.3120480440752	0.0218308755282716	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1846.56121518672	1846.56121518672
"healthy-5"	"2019-08-29-count-2:TTCACGCAGGAGACCT"	2.61687602576558	-4.37925197994383	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCACGCAGGAGACCT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2739.76532895403	40.0841169405582	0.0146304928078863	1815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2730.61405830708	2730.61405830708
"healthy-5"	"2019-08-29-count-2:GCAGGCTAGAAGTCTA"	2.38602318343465	-4.34451582348021	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAGGCTAGAAGTCTA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2369.80661504237	38.5247623224372	0.0162565004578436	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2364.77000233591	2364.77000233591
"healthy-5"	"2019-08-29-count-1:TCAGGGCTCACTGGGC"	-5.42595515671428	3.67575309360353	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGGGCTCACTGGGC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2807.9016126468	43.9837203973494	0.0156642669384307	2168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2793.6360102575	2793.6360102575
"healthy-5"	"2019-08-29-count-2:GTAACCAGTAATGTGA"	-2.27082381668742	10.7807702788147	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAACCAGTAATGTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1570.78304676053	38.7726114280753	0.0246836197449655	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1568.52524098228	1568.52524098228
"healthy-5"	"2019-08-29-count-1:CTCAATTAGGGTCAAC"	-3.2906907600468	12.5152253874573	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAATTAGGGTCAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1643.82197731972	37.7723837706425	0.0229783907818479	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1634.09341385308	1634.09341385308
"healthy-5"	"2019-08-29-count-2:TCTTTGACAGGAACCA"	5.2748233276302	-9.74990084087523	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTTGACAGGAACCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2516.88689341954	41.0155326283164	0.0162961366025436	1475	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2507.79452044886	2507.79452044886
"healthy-5"	"2019-08-29-count-1:TCAGGTAGTACCCGCA"	3.19896807250325	-7.47793104564818	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGGTAGTACCCGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2334.3997915576	53.6721266221439	0.0229918314833004	1316	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2322.13146530045	2322.13146530045
"healthy-5"	"2019-08-29-count-1:GTCGAATGTTCTCACC"	3.80717696723287	-8.22032549297484	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCGAATGTTCTCACC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.33765479424	44.3103399161159	0.0202484017121582	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2182.97486582861	2182.97486582861
"healthy-5"	"2019-08-29-count-1:ACACAGTTCACTCACC"	3.77515043792073	-8.44041254436644	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACAGTTCACTCACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.16449740719	40.8037765354697	0.0197104030073818	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2058.77760685241	2058.77760685241
"healthy-5"	"2019-08-29-count-1:ACACCAAAGTCACGAG"	3.17830552634541	-7.67925550853881	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACCAAAGTCACGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1818.62061021198	50.8267915029072	0.0279479904810837	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1812.70251612769	1812.70251612769
"healthy-5"	"2019-08-29-count-1:GATTTCTTCCAGCTCT"	4.03669514235799	-8.77773573314818	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTTCTTCCAGCTCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2205.99206059066	41.5861987502521	0.0188514725384449	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2199.28178065978	2199.28178065978
"healthy-5"	"2019-08-29-count-2:TTCAGGAAGTGGGAAA"	-3.61091075363811	12.645161605719	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCAGGAAGTGGGAAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1640.58018612088	44.8432976186959	0.0273338042224727	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1631.83584041688	1631.83584041688
"healthy-5"	"2019-08-29-count-2:AGTCAACTCGTTGTGA"	4.25695528563802	-7.61500360881957	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTCAACTCGTTGTGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1766.79004314585	43.1767919604422	0.0244379869175422	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.46462941543	1764.46462941543
"healthy-5"	"2019-08-29-count-2:GCATCGGAGGATACGC"	6.76506056365315	-1.38759782230528	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATCGGAGGATACGC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1711.799762631	45.9625627470886	0.0268504317797341	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1697.70658770364	1697.70658770364
"healthy-5"	"2019-08-29-count-1:ACACCAAGTACTCCGG"	-3.18264756622966	10.8715953596863	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACCAAGTACTCCGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1585.11910596012	43.7154995905532	0.0275786844194742	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1579.11293265138	1579.11293265138
"healthy-5"	"2019-08-29-count-1:GCAACATAGAAGGGAT"	-4.02288136902507	-4.48537924205931	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAACATAGAAGGGAT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2818.1967666625	45.6935905722448	0.0162137687164968	2154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2812.3129679052	2812.3129679052
"healthy-5"	"2019-08-29-count-1:TCAGTCCGTAAGCTCT"	-6.28517566147502	3.0759649046692	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_MEP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTCCGTAAGCTCT"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2171.90411300327	43.1381878706025	0.0198619209809183	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2163.33872460632	2163.33872460632
"healthy-5"	"2019-08-29-count-1:ACACGCGAGAAGGTAG"	-4.9250262779301	-5.13680269634398	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACGCGAGAAGGTAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2218.54815621631	43.502327590213	0.0196084666759749	1098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2218.54815621631	2218.54815621631
"healthy-5"	"2019-08-29-count-1:ATATCCTTCATCTATC"	3.12449850615804	-7.86212637340697	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATATCCTTCATCTATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1789.31387838201	51.5460797826544	0.028807734856036	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1789.31387838201	1789.31387838201
"healthy-5"	"2019-08-29-count-1:TCAGTCCGTTGACGGA"	-3.05562529984172	10.6892299422058	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTCCGTTGACGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1412.45143368469	42.9171488907438	0.0303848669534675	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1405.63599005928	1405.63599005928
"healthy-5"	"2019-08-29-count-2:TTCATGTAGTTGAATG"	5.21006216582601	-10.2056999436584	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATGTAGTTGAATG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1605.01690901741	42.6743797036928	0.0265881184577787	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1600.48915421917	1600.48915421917
"healthy-5"	"2019-08-29-count-2:GCATCGGTCATTGCCC"	2.78762211379353	-7.50325491344603	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATCGGTCATTGCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1639.84392884649	47.4285239724343	0.0289225841179878	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1637.49677274539	1637.49677274539
"healthy-5"	"2019-08-29-count-1:TCAGTGAAGGAGGGTG"	-2.28258881989177	4.18384978854982	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTGAAGGAGGGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2912.06918732696	46.4197830162183	0.0159404808162638	2680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2904.68891629666	2904.68891629666
"healthy-5"	"2019-08-29-count-1:GCAACATTCGTTGTAG"	2.47079124030415	-7.30867531215819	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAACATTCGTTGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1970.11941411272	40.918629141471	0.0207696187593276	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1968.28353271978	1968.28353271978
"healthy-5"	"2019-08-29-count-2:GAGCTGCGTTGTCTAG"	4.01736750182454	-6.99435379421385	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCTGCGTTGTCTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1951.11986688634	41.0382067624591	0.0210331550915676	872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1947.24188402055	1947.24188402055
"healthy-5"	"2019-08-29-count-1:CTCAGAACAACACACT"	5.6262923675472	-9.94755461132201	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGAACAACACACT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2568.84262693774	38.430870559638	0.0149603833869148	1477	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2557.14758023533	2557.14758023533
"healthy-5"	"2019-08-29-count-1:TCAGTGAGTTATGGTC"	-5.82259498062785	-3.92570164119872	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTGAGTTATGGTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2969.89207419489	45.9502539814639	0.0154720282197192	2826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2962.79133311308	2962.79133311308
"healthy-5"	"2019-08-29-count-2:TTCATGTGTTAACAGA"	-8.09127841416057	0.0797651999625339	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATGTGTTAACAGA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2257.565380374	41.8254594615386	0.0185267987475116	1220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2252.89915532436	2252.89915532436
"healthy-5"	"2019-08-29-count-2:TTCATGTTCGCTACGG"	4.11047615584676	-6.5491891137329	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATGTTCGCTACGG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2214.60125784767	44.0292169237468	0.0198813293218021	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2212.95004655852	2212.95004655852
"healthy-5"	"2019-08-29-count-2:TGGGCGTAGCGTACAG"	3.6592079597408	-7.12442734157714	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGCGTAGCGTACAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.97537004544	42.6925198676502	0.0221322265336361	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1923.32556896174	1923.32556896174
"healthy-5"	"2019-08-29-count-1:TAGCACATCTACTTCA"	3.55045404013936	-7.64820625698241	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGCACATCTACTTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.42007996229	39.8850291293227	0.0180932071395416	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2199.42626232672	2199.42626232672
"healthy-5"	"2019-08-29-count-2:TGGGCGTTCACCGGGT"	-1.79992459240611	9.0959491499695	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGCGTTCACCGGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2083.43249886994	35.7340328728747	0.017151519375961	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2075.2122230474	2075.2122230474
"healthy-5"	"2019-08-29-count-1:TAGGAGGAGCTTACGT"	3.19324364241902	-8.37298014080199	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGAGGAGCTTACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2024.19564613661	44.9148237687374	0.0221889736075967	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2018.62874251088	2018.62874251088
"healthy-5"	"2019-08-29-count-1:TCATACTGTCGAAGCA"	-3.48866544190105	11.3011169203552	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATACTGTCGAAGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1699.79782661729	38.2333873820159	0.022492902851925	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1695.18634129745	1695.18634129745
"healthy-5"	"2019-08-29-count-1:CTCAGGGGTGAGGAAA"	4.29860939559285	-7.6000375977722	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAGGGGTGAGGAAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.84602622072	44.9213804757921	0.0223284386033148	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2010.06087776949	2010.06087776949
"healthy-5"	"2019-08-29-count-1:ACAGAAAAGCATAGGC"	4.92302145537679	-10.3848142853943	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGAAAAGCATAGGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.67485228309	47.4992603131129	0.0218923403491223	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2157.86013798094	2157.86013798094
"healthy-5"	"2019-08-29-count-2:TTCATTGTCAATCCGA"	-1.87560127201732	9.73626420581666	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATTGTCAATCCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1771.31908150774	36.8445208810179	0.0208006119652119	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1766.96166889831	1766.96166889831
"healthy-5"	"2019-08-29-count-1:TCATACTGTTTCGGCG"	11.2457024055416	3.95006654346315	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATACTGTTTCGGCG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1497.20515277934	39.3926017072651	0.0263107575031642	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1492.04987673411	1492.04987673411
"healthy-5"	"2019-08-29-count-1:TCATACTTCACGATCA"	-3.51543889465984	3.41014335239259	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATACTTCACGATCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3195.49018470966	48.252050914377	0.0151000466674133	3468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3187.19599181483	3187.19599181483
"healthy-5"	"2019-08-29-count-2:TTCATTGTCGGCGATC"	2.54798330840413	-7.35023786937865	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATTGTCGGCGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1530.73200048086	46.1233101685501	0.0301315384757495	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1523.72187118405	1523.72187118405
"healthy-5"	"2019-08-29-count-1:CATGGATTCTTTCCAA"	9.61510052260701	6.35451934421388	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGGATTCTTTCCAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1426.33779404679	43.1898308904709	0.0302802260942223	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1419.14732231163	1419.14732231163
"healthy-5"	"2019-08-29-count-2:GCATGATGTGATAGTA"	9.56057323989217	5.39061496341554	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATGATGTGATAGTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1445.19631111356	44.4510184056315	0.0307577718430383	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1442.83309489276	1442.83309489276
"healthy-5"	"2019-08-29-count-2:TTCCAATAGGTCATAA"	0.547412355511826	8.74324891651002	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCAATAGGTCATAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1495.79563131241	39.022438724138	0.0260880817588027	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1493.66825389021	1493.66825389021
"healthy-5"	"2019-08-29-count-2:GCATTAGAGATCCCGC"	-6.93857989731486	3.13552448833314	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATTAGAGATCCCGC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2167.41490737234	38.534975929424	0.017779233592216	1329	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2162.07046271698	2162.07046271698
"healthy-5"	"2019-08-29-count-2:CTCATTACATGGCCAC"	-2.64208636704143	12.0462598570618	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATTACATGGCCAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1507.00963270219	42.0683576602724	0.027915121939095	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1504.58900230116	1504.58900230116
"healthy-5"	"2019-08-29-count-1:GTCTAGACAAGGCGTA"	11.3397556739742	3.72032020175783	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTAGACAAGGCGTA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1629.39024451985	28.6304700491659	0.0175712786703241	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1626.93051174035	1626.93051174035
"healthy-5"	"2019-08-29-count-2:GCATTAGGTTTGTTCT"	2.74278916892354	-7.43122341549071	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATTAGGTTTGTTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1662.93932310107	40.5028505615348	0.0243561806488554	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1660.63037888853	1660.63037888853
"healthy-5"	"2019-08-29-count-2:CTCATTAGTGACACGA"	5.50961174544637	-9.87558844005736	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATTAGTGACACGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2158.67529524666	41.5949695849582	0.0192687476789812	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2150.20094756734	2150.20094756734
"healthy-5"	"2019-08-29-count-1:AGGATAAGTTGTATGC"	-2.27834902229961	10.0704927214417	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGATAAGTTGTATGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1460.67673647553	36.517014875945	0.0250000660406606	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1458.18024810989	1458.18024810989
"healthy-5"	"2019-08-29-count-2:TTCCAATTCTCTGGTC"	2.72969808158223	-7.84910728847655	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCAATTCTCTGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1543.75782995942	46.1862364351693	0.0299180580910048	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1538.91926420745	1538.91926420745
"healthy-5"	"2019-08-29-count-2:GTACAGTGTTGTAGCT"	3.03354610976521	-6.80090429699095	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTACAGTGTTGTAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1793.91015322614	48.835903955974	0.0272231604621604	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1787.61647325193	1787.61647325193
"healthy-5"	"2019-08-29-count-1:CTAGACACAAAGGCTG"	-3.4584210914677	12.7074126967224	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAGACACAAAGGCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1637.89076533002	43.5688384499303	0.0266005764072744	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1637.89076533002	1637.89076533002
"healthy-5"	"2019-08-29-count-2:TCCTTTCAGATGCCGA"	2.61134781417195	-8.00719644939574	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTTTCAGATGCCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1552.93574026527	46.8999343905422	0.0302008210478373	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1550.59124744066	1550.59124744066
"healthy-5"	"2019-08-29-count-2:CTCCAACAGACCACGA"	4.19300283965413	-7.27976229107054	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCAACAGACCACGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2354.91931180701	45.7750656860598	0.019438061192396	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2350.28708537319	2350.28708537319
"healthy-5"	"2019-08-29-count-1:TCATCATCAGGCTATT"	-1.95238075676616	10.9600982435974	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCATCAGGCTATT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1461.36941831024	43.3058677814518	0.0296337580620277	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1449.74160303323	1449.74160303323
"healthy-5"	"2019-08-29-count-1:TCATCATCATCTTAGG"	0.216220368712586	8.21053121173707	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCATCATCTTAGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1596.36637070884	36.1629987820639	0.0226533203440049	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1583.89438038857	1583.89438038857
"healthy-5"	"2019-08-29-count-1:CTCATCGTCCTACGGG"	8.91070141372029	6.07929179752199	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCATCGTCCTACGGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1489.84480453445	37.0919604240487	0.0248965263436545	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1485.15801567407	1485.15801567407
"healthy-5"	"2019-08-29-count-2:TTCCGGTCATATCGGT"	3.23620094832723	-8.34397795116576	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCGGTCATATCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1949.0251989459	46.8922644785128	0.0240593423337337	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1943.14032938358	1943.14032938358
"healthy-5"	"2019-08-29-count-1:TCATCATGTTATCCAG"	-0.986733893782455	10.3204917677673	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCATGTTATCCAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1496.26834017443	39.4369426450685	0.0263568649995436	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1496.26834017443	1496.26834017443
"healthy-5"	"2019-08-29-count-1:TCATCATTCACCTCAC"	0.703778346150559	8.85826585376588	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCATTCACCTCAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1681.97791589538	32.4018373360276	0.0192641276855165	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1678.11553880494	1678.11553880494
"healthy-5"	"2019-08-29-count-2:TCCTTTCGTATGACAA"	-3.3919759792393	11.216284728888	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTTTCGTATGACAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1569.99109163079	40.3475881614287	0.0256992465603856	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1569.99109163079	1569.99109163079
"healthy-5"	"2019-08-29-count-2:AGTGCCGTCGCGTTTC"	5.23228802260701	-10.0680904618469	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGCCGTCGCGTTTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2076.1047667235	36.330660092704	0.0174994348430888	1016	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.93669018807	2070.93669018807
"healthy-5"	"2019-08-29-count-1:CTCATGCGTTTCGCTC"	-2.25434027138408	3.6396286257538	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCATGCGTTTCGCTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3028.46447577282	46.4022777365404	0.0153220478918443	3411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3023.50128193359	3023.50128193359
"healthy-5"	"2019-08-29-count-1:ACAGCCGGTAGACGTG"	-3.83528719368632	12.7824268111023	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGCCGGTAGACGTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1557.25653403779	45.1714827003312	0.0290070914541014	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1557.25653403779	1557.25653403779
"healthy-5"	"2019-08-29-count-2:CTCCACAGTGAAGCTG"	-3.57656488838847	10.7414521940979	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCACAGTGAAGCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1742.89143675711	34.4185030850867	0.0197479328655875	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1738.52212172376	1738.52212172376
"healthy-5"	"2019-08-29-count-2:TTCCGTGCACGCTGTG"	2.92594279822652	-7.28242733394774	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCGTGCACGCTGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2048.89204838789	50.6262842012893	0.0247091027763631	994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2047.06134061041	2047.06134061041
"healthy-5"	"2019-08-29-count-2:TTCCGTGCATGGGCAA"	-3.1313525241917	12.1653222807678	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCGTGCATGGGCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1619.60586068402	42.8407953574703	0.0264513709152527	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1614.82571611294	1614.82571611294
"healthy-5"	"2019-08-29-count-2:TTCCGTGGTCCATCTC"	10.0309435325557	7.40188977802125	"2019-08-29-count-2"	"Control5"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCGTGGTCCATCTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1614.33398411438	39.0628816912401	0.024197521749299	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1607.77232970431	1607.77232970431
"healthy-5"	"2019-08-29-count-2:AGCCAGCCAACCACAT"	-3.9356292289799	11.993308997992	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAGCCAACCACAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2081.51887439963	36.4841203038166	0.0175276432765183	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2072.78698152872	2072.78698152872
"healthy-5"	"2019-08-29-count-2:TGGTGATCATCATCTT"	9.2759481864864	5.30638644779054	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTGATCATCATCTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1454.57745343902	37.7916128039546	0.0259811622369128	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1445.48428328296	1445.48428328296
"healthy-5"	"2019-08-29-count-1:CTCATTAGTTGCATAC"	3.3591956096584	-7.80389311229857	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCATTAGTTGCATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1713.56772805023	44.3935087899123	0.0259070639947363	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1711.33357068206	1711.33357068206
"healthy-5"	"2019-08-29-count-1:ACAGGGAAGGTGCGAT"	-5.39938912811931	-5.55020811473998	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGGGAAGGTGCGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2375.12323818372	47.3010649306165	0.0199152044703112	1264	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2368.06783380584	2368.06783380584
"healthy-5"	"2019-08-29-count-1:CTCCAACCAATAGAGT"	2.68765725669209	-7.21858789837035	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCAACCAATAGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1651.46055230996	42.1894458231281	0.025546747552714	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1645.04559902364	1645.04559902364
"healthy-5"	"2019-08-29-count-2:GTGTTCCGTCCCGCAA"	4.19803728637044	-7.32630493557128	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTTCCGTCCCGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2113.85787453171	46.6959106939419	0.0220903738404298	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2109.31407764689	2109.31407764689
"healthy-5"	"2019-08-29-count-2:AGCCAGCGTAGTCGTT"	3.34832205352132	-7.60517122661742	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAGCGTAGTCGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1724.77767414979	53.2354571223492	0.0308651125998549	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1720.65974513895	1720.65974513895
"healthy-5"	"2019-08-29-count-2:AGTTAGCAGATCCAAA"	3.73476042327229	-7.78638365184935	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTTAGCAGATCCAAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.63502910115	44.8173776152727	0.021015024607451	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2127.72259357609	2127.72259357609
"healthy-5"	"2019-08-29-count-1:TAACACGGTAGATTAG"	10.9620968299801	4.64260766589967	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACACGGTAGATTAG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1561.80880378824	42.5577147012836	0.0272489914245956	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1556.88289607458	1556.88289607458
"healthy-5"	"2019-08-29-count-1:TAACACGGTCAAAGCG"	-3.91925392571147	12.7141160734924	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACACGGTCAAAGCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1459.25101846222	43.0797676046962	0.0295218348725871	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1454.10819441276	1454.10819441276
"healthy-5"	"2019-08-29-count-2:TGGTGATGTTTCACAG"	2.51714648780171	-4.3008432618347	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTGATGTTTCACAG"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2440.41859336795	36.6986681051118	0.0150378579334069	1630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2435.83461190885	2435.83461190885
"healthy-5"	"2019-08-29-count-2:TACTGCCAGCCTATCA"	11.3891846137935	3.58172223651735	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTGCCAGCCTATCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1678.35728380401	39.3987246878877	0.0234745754483158	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1663.17062912191	1663.17062912191
"healthy-5"	"2019-08-29-count-2:AGCCAGCTCTCGGTAA"	2.63764657553975	-7.45734932338866	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAGCTCTCGGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1608.85398370988	42.0896483554643	0.0261612606126065	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1608.85398370988	1608.85398370988
"healthy-5"	"2019-08-29-count-2:GTTACAGAGTCCGCGT"	10.6112762885982	6.77587363803712	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTACAGAGTCCGCGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1469.78255054613	36.5403734294421	0.0248610744602083	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1455.25977340443	1455.25977340443
"healthy-5"	"2019-08-29-count-2:TTCCTAAGTAAGTTAG"	-2.73385820809062	3.44490668857423	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTAAGTAAGTTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2979.20452068774	45.4746823295766	0.0152640350851371	3150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2974.97699770655	2974.97699770655
"healthy-5"	"2019-08-29-count-1:GTGACGCAGTATGACA"	-2.94753084603007	12.1352758177551	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGACGCAGTATGACA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1442.11496928047	32.0659589894787	0.022235369351639	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1434.07922624564	1434.07922624564
"healthy-5"	"2019-08-29-count-1:GTGACGCCAACTCGAT"	3.99698891219441	-8.81358244335326	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGACGCCAACTCGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2457.40658059228	41.4492034856635	0.0168670515546815	1440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2454.65604449853	2454.65604449853
"healthy-5"	"2019-08-29-count-1:CTCCACAGTTCCGCAG"	-2.70703802529033	3.80872724140016	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCACAGTTCCGCAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3327.18631857019	46.3521609590788	0.0139313391319179	4402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3317.82028722964	3317.82028722964
"healthy-5"	"2019-08-29-count-1:TCATGGAGTCGGCACT"	3.43308891829793	-8.01465990459593	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGGAGTCGGCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1931.37761360984	47.0415379313271	0.0243564684605638	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1921.53770713084	1921.53770713084
"healthy-5"	"2019-08-29-count-1:ACATCCCTCATTACGG"	2.05171718177144	-6.4869594804016	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCCCTCATTACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.07410556722	42.3883989604149	0.0241656830950752	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1754.07410556722	1754.07410556722
"healthy-5"	"2019-08-29-count-2:TTCCTCTCAAGTCCCG"	3.30819167670552	-7.5135593644348	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTCTCAAGTCCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1807.82766608978	44.7078097610581	0.0247301280977508	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1807.82766608978	1807.82766608978
"healthy-5"	"2019-08-29-count-1:ACATCCCTCCGCTGTT"	13.8647858100826	1.88351211631624	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCCCTCCGCTGTT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1327.78517188158	55.4358874611269	0.0417506450855824	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1307.82988454063	1307.82988454063
"healthy-5"	"2019-08-29-count-2:TTCCTCTCAGCAAGAC"	3.32281746444051	-7.64975168621215	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTCTCAGCAAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.32491279597	45.1706924587661	0.0252586608482369	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1786.20251351431	1786.20251351431
"healthy-5"	"2019-08-29-count-1:GTGAGCCCAACCTAAC"	10.9712244468624	4.52393720233766	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGAGCCCAACCTAAC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1645.17866018512	36.6612823992186	0.0222840736306982	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1630.41477010537	1630.41477010537
"healthy-5"	"2019-08-29-count-2:TCGACCTTCGACACCG"	-2.02128658714946	3.77416536891786	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGACCTTCGACACCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3252.06163476301	47.5972629240582	0.014636027317338	3929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3247.14162384628	3247.14162384628
"healthy-5"	"2019-08-29-count-2:CTCCGATAGTTAGTAG"	3.41590728339497	-7.87917187130126	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCGATAGTTAGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1703.54663600835	38.2618806637012	0.0224601310319007	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1701.20829179402	1701.20829179402
"healthy-5"	"2019-08-29-count-1:TCATGTTGTTAAGGAT"	1.18522109565083	-6.87222864544066	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGTTGTTAAGGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1529.68952900915	48.2702695106931	0.0315555990907253	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1527.25779159899	1527.25779159899
"healthy-5"	"2019-08-29-count-2:TTCCTTCCAAGTGCTT"	4.69936956939046	-7.74972488796385	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTTCCAAGTGCTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2283.42811102686	36.8548881069875	0.0161401569548051	1144	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2279.93022086938	2279.93022086938
"healthy-5"	"2019-08-29-count-2:AGTTCGATCCTATGGA"	2.9383176761562	-6.89169742977294	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTTCGATCCTATGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1968.13197942358	40.7249009366296	0.0206921595514936	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1966.26429317683	1966.26429317683
"healthy-5"	"2019-08-29-count-2:TTCCTTCGTACCTAGT"	-0.216246793896514	9.09556291187135	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTTCGTACCTAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1739.63681753746	39.2070943514622	0.0225375170013714	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1737.55495350133	1737.55495350133
"healthy-5"	"2019-08-29-count-1:GTGAGGACAGGCACAA"	-4.05110392990764	12.7099017866882	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGAGGACAGGCACAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1774.06534808698	39.606876894852	0.0223254892710469	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1767.42874255687	1767.42874255687
"healthy-5"	"2019-08-29-count-1:GTGAGGAGTAAGTAGT"	2.78937377509419	-9.29269697582396	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGAGGAGTAAGTAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1866.68696968449	46.9934799135877	0.0251748047084352	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1864.60315009569	1864.60315009569
"healthy-5"	"2019-08-29-count-2:TGTAAGCAGTCCCGGT"	3.6015325981075	-7.71985008632811	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTAAGCAGTCCCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.39276126843	47.3072961252537	0.0228053708094926	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2068.93537613032	2068.93537613032
"healthy-5"	"2019-08-29-count-1:ACATCGATCGAACCAT"	5.48197140273396	-10.0393228760925	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCGATCGAACCAT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.47759120705	39.6384968889886	0.0169578082964721	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2331.29975272314	2331.29975272314
"healthy-5"	"2019-08-29-count-2:ATACCGACACCTCGTT"	4.06654800948445	-7.32515575802001	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCGACACCTCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2044.6954808049	42.3650394774361	0.0207194860433491	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2042.66575993057	2042.66575993057
"healthy-5"	"2019-08-29-count-2:TCAGGTACATACAGGG"	10.0480247932369	5.80918738925783	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGTACATACAGGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1594.07363346725	36.2401652693062	0.0227343107046321	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1594.07363346725	1594.07363346725
"healthy-5"	"2019-08-29-count-1:GAGCCTGGTCATAGTC"	10.1665121513302	6.84111163699952	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCCTGGTCATAGTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1465.26483829496	44.4075034332326	0.0303068102588928	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1460.59205999933	1460.59205999933
"healthy-5"	"2019-08-29-count-1:ATCCGTCCAGCTACCG"	-1.73859308186229	9.7464275130066	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCGTCCAGCTACCG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1637.48115867613	42.2110723197038	0.0257780506945379	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1635.30479672091	1635.30479672091
"healthy-5"	"2019-08-29-count-1:GTGAGTTAGGTGCTTT"	4.1797305541927	-8.20587637340697	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGAGTTAGGTGCTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1997.70353506579	42.0618480288825	0.0210551001640478	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1991.93738467111	1991.93738467111
"healthy-5"	"2019-08-29-count-2:TTCGATTCACTCTAGA"	-3.07153950157817	9.85784051502077	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGATTCACTCTAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1582.87704653438	44.0459739568807	0.0278265289482318	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1576.37408365775	1576.37408365775
"healthy-5"	"2019-08-29-count-2:TTCGATTGTAGCGATG"	-3.53462467613872	12.1762904890808	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGATTGTAGCGATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1545.56599112469	36.3252091897219	0.0235028522873284	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1540.49601079648	1540.49601079648
"healthy-5"	"2019-08-29-count-1:ACATGCAGTCCTCAGG"	-1.03099081936534	9.98028848255006	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATGCAGTCCTCAGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1717.56404339753	28.7161521575182	0.0167191158128313	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1715.46733107603	1715.46733107603
"healthy-5"	"2019-08-29-count-2:GTATTGGAGCTCATAC"	4.59944929656331	-7.96362020885619	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTATTGGAGCTCATAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.6826126461	39.5620043209141	0.0185852057445688	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2128.6826126461	2128.6826126461
"healthy-5"	"2019-08-29-count-2:AGCTACACAAACTAGA"	1.75969399985616	-6.85836269771727	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACACAAACTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1751.11555557514	49.2817697045135	0.0281430711683258	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.93573994743	1748.93573994743
"healthy-5"	"2019-08-29-count-2:GAGTTGTTCGATAACC"	-4.05743012848552	12.3711471327576	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTGTTCGATAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1463.17126755027	35.7240376773214	0.0244154860538867	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1453.34471281245	1453.34471281245
"healthy-5"	"2019-08-29-count-1:CCTCATGTCGCGTGCA"	3.00942697104756	-7.11476614391478	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCATGTCGCGTGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1909.75443094424	42.7396933063733	0.0223796801378498	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1909.75443094424	1909.75443094424
"healthy-5"	"2019-08-29-count-2:ATACCTTGTGAATTGA"	6.89972891387288	-1.28591313278349	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCTTGTGAATTGA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2170.95890899057	42.7117382196344	0.0196741347994901	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2162.21345525207	2162.21345525207
"healthy-5"	"2019-08-29-count-1:CTCCCTCCAAGTACCT"	-3.28152642670329	-5.66630270397338	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCCTCCAAGTACCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1959.31034841167	52.2811168210147	0.026683428106934	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1955.5333090637	1955.5333090637
"healthy-5"	"2019-08-29-count-1:CCAAGCGAGTCCTGCG"	-3.26958809319194	-5.66069939052733	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCAAGCGAGTCCTGCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1871.74027981951	49.0949816616845	0.0262295908203774	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1863.2442180352	1863.2442180352
"healthy-5"	"2019-08-29-count-2:GTTATGGGTGACTAAA"	1.46638204631154	-6.34351637279662	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTATGGGTGACTAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1885.56532793855	48.9918041437233	0.0259825546311276	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1883.41243050802	1883.41243050802
"healthy-5"	"2019-08-29-count-2:ATACCTTTCGTTATCT"	2.46546687659566	-7.71607782756957	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCTTTCGTTATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.71627329085	45.8755287111125	0.0254904227916033	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1789.27770645813	1789.27770645813
"healthy-5"	"2019-08-29-count-1:TCATTTGAGTGTGTTC"	2.87943901595418	-7.97201063549193	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTTGAGTGTGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1504.92421320751	45.7672932316798	0.0304116930474088	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1504.92421320751	1504.92421320751
"healthy-5"	"2019-08-29-count-2:TGTAGACTCCGCACTT"	5.27619137343709	-10.2545576325622	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTAGACTCCGCACTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.30874780233	39.8234603358708	0.0189157340354194	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2100.64511745957	2100.64511745957
"healthy-5"	"2019-08-29-count-1:GCATCGGTCATTACTC"	-3.84063253822978	12.1803321608338	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATCGGTCATTACTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2067.84023042674	41.0485045230593	0.0198509072021431	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2064.12218535995	2064.12218535995
"healthy-5"	"2019-08-29-count-2:TTCGCTGTCTCCGAGG"	2.85225500640218	-7.37254049694213	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGCTGTCTCCGAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1580.854080482	44.3636942237666	0.0280631177611536	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1573.92604265709	1573.92604265709
"healthy-5"	"2019-08-29-count-2:GTTCATTAGCTGTACT"	3.9928204017574	-8.11650469219359	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCATTAGCTGTACT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1891.25661486107	46.2694739341108	0.0244649370003709	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1889.32602364556	1889.32602364556
"healthy-5"	"2019-08-29-count-1:CTCCGATAGACGCCAA"	-6.92987571182902	3.37263200366823	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCGATAGACGCCAA"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2538.42287341474	42.7991824928497	0.0168605408267833	1771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2527.0076737168	2527.0076737168
"healthy-5"	"2019-08-29-count-1:CCAAGCGTCCGTTGGG"	-3.94325385513957	-5.05784227764281	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCAAGCGTCCGTTGGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2497.43987763388	47.3193779786028	0.0189471540045377	1693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2496.29003124965	2496.29003124965
"healthy-5"	"2019-08-29-count-2:AGCTCAATCAAAGGTA"	-2.71380172196086	10.2528800734314	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTCAATCAAAGGTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1494.70031936675	36.6849467993983	0.0245433457958585	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1489.49380984911	1489.49380984911
"healthy-5"	"2019-08-29-count-1:TCCACCAAGCACCGAA"	3.11739458617513	-7.76423695003661	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACCAAGCACCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1512.14815464497	52.3863057432952	0.0346436330212596	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1512.14815464497	1512.14815464497
"healthy-5"	"2019-08-29-count-2:TTCGGTCCATTGTACG"	4.12383904036824	-7.52361729061278	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGGTCCATTGTACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2029.08418909989	40.1438240389835	0.0197842081933483	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2025.30674101373	2025.30674101373
"healthy-5"	"2019-08-29-count-2:TTCGGTCGTACTGGGA"	-1.78498933735545	10.0215396651062	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGGTCGTACTGGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1441.19870311712	41.9684434010106	0.0291205114952147	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1436.55064973306	1436.55064973306
"healthy-5"	"2019-08-29-count-1:CTCCGATCAGCAGGAT"	-5.61367497864421	-4.82672598278197	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCGATCAGCAGGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2596.01405531837	48.3313984655002	0.0186175411363761	1610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2593.40678824561	2593.40678824561
"healthy-5"	"2019-08-29-count-2:GCCTGTTCAGGCTATT"	4.31730236586873	-9.2319317094055	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCTGTTCAGGCTATT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1867.83198481211	39.5089955109011	0.0211523283850799	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1867.83198481211	1867.83198481211
"healthy-5"	"2019-08-29-count-1:TCCACCATCTACTGAG"	3.94131984290425	-8.3248558274475	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACCATCTACTGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.64626291994	47.7514374840633	0.0270754053621869	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1761.43788077902	1761.43788077902
"healthy-5"	"2019-08-29-count-1:ACCAACACAGCCATTA"	4.50182451781575	-8.68126299297484	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCAACACAGCCATTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2236.25159544799	36.6861750208893	0.0164052090988179	1262	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2235.41092611597	2235.41092611597
"healthy-5"	"2019-08-29-count-1:GTGCAGCAGCTGAAAT"	-4.75060687485393	-5.04170753872069	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCAGCAGCTGAAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2409.39017991136	48.1989714633722	0.0200046351418039	1306	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2403.37335228669	2403.37335228669
"healthy-5"	"2019-08-29-count-1:CTCCGATTCTGTAACG"	3.59842576560323	-7.86179830944213	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCGATTCTGTAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1628.05241915675	45.8845906631105	0.028183730525628	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1625.68204898399	1625.68204898399
"healthy-5"	"2019-08-29-count-2:ATAGGCTAGATGTTAG"	3.20678319510762	-7.92957546627196	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGGCTAGATGTTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1475.97507294005	40.7893796772867	0.0276355477982679	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1471.02777842953	1471.02777842953
"healthy-5"	"2019-08-29-count-1:GAGGCCTGTGGATCGA"	2.05672087249104	-7.06407930767211	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGCCTGTGGATCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1658.10423968998	50.4813434059792	0.0304452170120607	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1653.55759963914	1653.55759963914
"healthy-5"	"2019-08-29-count-2:TCGCTTGCATGGCTAT"	9.94315018233601	7.62320897662965	"2019-08-29-count-2"	"Control5"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTTGCATGGCTAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1812.68073957848	45.4832988310312	0.0250917317307668	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1806.66086831485	1806.66086831485
"healthy-5"	"2019-08-29-count-1:TCCACGTCAAAGGCAC"	0.653041382401627	8.48143861377565	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTCAAAGGCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1549.47346012798	38.6475807013209	0.0249423960434461	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1545.30991846495	1545.30991846495
"healthy-5"	"2019-08-29-count-1:TCCACGTCACAGTCGC"	5.18903698500935	-9.39926626598509	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTCACAGTCGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2287.28065301099	34.2041818517666	0.0149540817418886	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2282.60720079405	2282.60720079405
"healthy-5"	"2019-08-29-count-1:GTGCAGCTCTGGTCAA"	-3.544261555106	11.0084657439026	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCAGCTCTGGTCAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1695.51989296633	42.7123459759896	0.0251912974617266	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1686.85033798089	1686.85033798089
"healthy-5"	"2019-08-29-count-2:TTCTAACTCTTTCCGG"	-8.1178973716801	0.187790117505468	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAACTCTTTCCGG"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2899.24421169751	43.8933082488321	0.0151395691579677	2808	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2882.49435234866	2882.49435234866
"healthy-5"	"2019-08-29-count-1:ACCACAACATCTCGTC"	-2.19460974159892	10.6952657469544	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCACAACATCTCGTC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1532.35822813352	41.117304293996	0.0268326971716521	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1527.41628398369	1527.41628398369
"healthy-5"	"2019-08-29-count-1:ACCACAATCATGCAGT"	-2.11572823944743	10.280303932074	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCACAATCATGCAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1745.57892905197	43.7162272368171	0.0250439705184568	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1741.4910325857	1741.4910325857
"healthy-5"	"2019-08-29-count-2:TTCTAGTCACAAAGTA"	2.72476782378499	-7.19493439113768	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAGTCACAAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1651.70033297958	48.613905957754	0.0294326428269571	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1649.40352468824	1649.40352468824
"healthy-5"	"2019-08-29-count-1:AAGCATCCAGCCTATA"	-3.64026866379436	12.7529134520325	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGCATCCAGCCTATA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1534.5548961634	43.637527649976	0.028436602534765	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1529.60947673435	1529.60947673435
"healthy-5"	"2019-08-29-count-2:ATATCCTAGCGAGTAC"	9.60311760482137	5.48859975421754	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATATCCTAGCGAGTAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1435.99208850786	37.9762571247923	0.0264460072090324	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1431.32839160116	1431.32839160116
"healthy-5"	"2019-08-29-count-1:TCCAGAAAGCTCTGTA"	-3.29894075813945	-4.74699880993041	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCAGAAAGCTCTGTA"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2517.49780170701	47.6110787759337	0.0189120636942168	1636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2514.01214947856	2514.01214947856
"healthy-5"	"2019-08-29-count-1:ATCGGATGTCTTTCAT"	4.66225161132161	-8.19022085582884	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGGATGTCTTTCAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.94284814895	40.2157842556425	0.0172678278849162	1327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2324.64372809038	2324.64372809038
"healthy-5"	"2019-08-29-count-1:TATCTTGTCCGCTAGG"	-3.08661327782329	3.7333934077057	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTTGTCCGCTAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2979.33334884828	50.3218971936593	0.0168903211898434	2966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2974.15871278913	2974.15871278913
"healthy-5"	"2019-08-29-count-2:TTCTAGTGTTCCCACT"	-3.54652486267741	10.9583472975525	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAGTGTTCCCACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1726.25948584537	37.3400356371605	0.0216306041723934	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1721.57954806431	1721.57954806431
"healthy-5"	"2019-08-29-count-1:ACCATTTGTAGGATAT"	-3.0196262401646	11.3913192518982	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCATTTGTAGGATAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1462.4205582228	46.556309643586	0.0318351033714703	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1452.34992995107	1452.34992995107
"healthy-5"	"2019-08-29-count-2:ATATCCTCAGACTGCC"	0.855695505707902	9.11559388721315	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATATCCTCAGACTGCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1403.05981667372	44.3185155147587	0.0315870463882475	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1400.58110944337	1400.58110944337
"healthy-5"	"2019-08-29-count-1:GTGCTGGAGTTGGACG"	-3.84901199761088	12.8205909498963	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTGGAGTTGGACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1479.37385767586	41.6993569132555	0.028187166277743	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1476.77754401695	1476.77754401695
"healthy-5"	"2019-08-29-count-1:TCCAGAAGTGGACTGA"	2.59680285033528	-4.06873323833617	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCAGAAGTGGACTGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2268.38994821766	43.8417678521656	0.0193272624429558	1314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2264.26667854302	2264.26667854302
"healthy-5"	"2019-08-29-count-1:GCATTAGTCTTTCCGG"	10.3859764533931	6.57438323581544	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATTAGTCTTTCCGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1606.01494452228	34.8099122381478	0.0216747125279722	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1606.01494452228	1606.01494452228
"healthy-5"	"2019-08-29-count-1:CTCGAGGGTCACTAGT"	-2.4614921611851	9.28288362109987	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCGAGGGTCACTAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1405.35166818799	37.9118528756434	0.0269767729557155	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1405.35166818799	1405.35166818799
"healthy-5"	"2019-08-29-count-2:ATATCCTTCTGTCGCT"	-3.95823560181316	12.3969697722229	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATATCCTTCTGTCGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1837.17334306824	40.2334401971238	0.0218996429209725	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1832.80984485628	1832.80984485628
"healthy-5"	"2019-08-29-count-2:GCGGATCCAAGGATGC"	4.58810963210408	-9.3894777528015	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGGATCCAAGGATGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1712.64943592565	49.2903589928891	0.0287801799708348	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1706.81827852626	1706.81827852626
"healthy-5"	"2019-08-29-count-2:GCGGATCCAAGCTCTA"	2.68249120292012	-4.59322883999022	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCGGATCCAAGCTCTA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1891.47209501411	44.7024051231521	0.0236336582712412	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1891.47209501411	1891.47209501411
"healthy-5"	"2019-08-29-count-2:TTCTCTCGTAATGATG"	-3.54812250557597	12.7653264769348	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTCTCGTAATGATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1414.01165595427	40.4080185993146	0.0285768638675362	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1408.71077237983	1408.71077237983
"healthy-5"	"2019-08-29-count-1:CGTTAGAGTGGACCAA"	3.74347319182698	-8.69439413463744	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTTAGAGTGGACCAA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.40561603581	44.0381860998745	0.02146732257903	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2045.96062907406	2045.96062907406
"healthy-5"	"2019-08-29-count-1:TCCATCGGTGAACGGT"	3.18087400969807	-8.11582281505736	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCATCGGTGAACGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1511.6428573235	50.8361136045765	0.0336297117790021	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1506.72813115385	1506.72813115385
"healthy-5"	"2019-08-29-count-2:CAGCAGCAGGGTTTCT"	10.0387922721798	6.17210147464601	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAGCAGGGTTTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1457.28673316307	41.5138447291543	0.0284870806715214	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1452.48385187474	1452.48385187474
"healthy-5"	"2019-08-29-count-2:GTTGAACGTGTTAACC"	-3.82039795342143	12.7802886732849	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGAACGTGTTAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1524.82145129388	41.3496985741912	0.0271177314164252	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1522.37135033004	1522.37135033004
"healthy-5"	"2019-08-29-count-1:CTCTCAGGTCACTACA"	3.41540898856465	-8.11548902904662	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCAGGTCACTACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1528.02272498376	41.9335275250302	0.0274429999236273	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1528.02272498376	1528.02272498376
"healthy-5"	"2019-08-29-count-2:TTCTGTACACTTGAGT"	2.44693030890767	-7.14202787792357	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTGTACACTTGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1779.18869863755	50.7949946067535	0.0285495263350373	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1772.55021880141	1772.55021880141
"healthy-5"	"2019-08-29-count-2:ATCACGACAGAAGTGC"	1.94048084792439	-6.83999683773192	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACGACAGAAGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.2975795257	53.8137725164863	0.0320263346041815	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1677.98516335893	1677.98516335893
"healthy-5"	"2019-08-29-count-2:TTCTGTATCATGGATC"	1.84217633780782	-7.03801205074462	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTGTATCATGGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1801.59792957442	49.9817147044371	0.0277429907550149	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1800.44800998046	1800.44800998046
"healthy-5"	"2019-08-29-count-2:ATCACGAGTGCAACGA"	0.917934020131272	9.24222180927125	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACGAGTGCAACGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1752.27801388174	46.6266369918738	0.0266091548387256	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1744.58785836661	1744.58785836661
"healthy-5"	"2019-08-29-count-1:GTGCTTCTCTCCCAAC"	-5.60056529465373	-5.46486236965331	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTTCTCTCCCAAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2195.38131404112	47.1549294594754	0.0214791522355976	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2191.68009339765	2191.68009339765
"healthy-5"	"2019-08-29-count-2:AGGAGGTTCCGCGAGT"	3.92110862311665	-7.50675060665282	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGAGGTTCCGCGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.84327231227	44.4120838539343	0.0230013924438046	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1930.84327231227	1930.84327231227
"healthy-5"	"2019-08-29-count-2:AGGAGGTTCGGTCGGT"	-1.9290762943333	11.0127820738587	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGAGGTTCGGTCGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1424.34978298154	34.4567800771876	0.0241912348279088	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1419.35103934206	1419.35103934206
"healthy-5"	"2019-08-29-count-2:TTCTTCCGTTACGATC"	14.4257208305294	2.07140491092531	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTTCCGTTACGATC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1484.69091499794	31.3289107546943	0.0211013015828535	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1469.49627958198	1469.49627958198
"healthy-5"	"2019-08-29-count-2:TTCTTCCTCCTACCAC"	-2.83646450462993	10.4820708998474	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTTCCTCCTACCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1791.13528887288	34.6912151907975	0.0193682830137459	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1791.13528887288	1791.13528887288
"healthy-5"	"2019-08-29-count-1:TATTGCTAGCAACAAT"	4.38378490981404	-8.21932508861693	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTAGCAACAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2009.76580290819	45.0060603632152	0.0223936840292984	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1999.80728340753	1999.80728340753
"healthy-5"	"2019-08-29-count-2:TCGGGTGAGGAACGTC"	4.45164455947225	-9.0954799882141	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGGTGAGGAACGTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1760.54386865523	44.3577237990493	0.0251954663492319	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.54386865523	1760.54386865523
"healthy-5"	"2019-08-29-count-1:ACCGTTCAGTAAACAC"	11.084112783044	4.18405435169069	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCGTTCAGTAAACAC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1925.68234083203	46.8334601674406	0.0243204495229494	858	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1917.5192547077	1917.5192547077
"healthy-5"	"2019-08-29-count-1:GCCAGGTAGCTTCTAG"	2.08813848075215	-7.7888484231201	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGGTAGCTTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1463.28779344713	49.8865370390144	0.0340920885572992	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1456.03278072527	1456.03278072527
"healthy-5"	"2019-08-29-count-1:CCTTGTGAGGTAAACT"	3.11149658736531	-5.18385078823241	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTGTGAGGTAAACT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2469.96082993631	45.5507758359446	0.0184419021078643	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2467.32824863062	2467.32824863062
"healthy-5"	"2019-08-29-count-1:CTCTCGAGTTATTCTC"	-3.70228825035747	12.2887134321961	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCGAGTTATTCTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1719.39085681128	38.9583733445638	0.0226582415453893	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1712.11669456358	1712.11669456358
"healthy-5"	"2019-08-29-count-1:TCCCAGTCACCATATG"	-5.62080130997356	-5.40724422847899	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCAGTCACCATATG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2781.91287448727	43.4664660568554	0.0156246683551751	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2773.75887397354	2773.75887397354
"healthy-5"	"2019-08-29-count-2:ATCACTTTCCCAGGAC"	-3.07669244232829	13.0861310728821	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACTTTCCCAGGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1616.77713093399	40.3621374411217	0.0249645647930492	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1614.44891088421	1614.44891088421
"healthy-5"	"2019-08-29-count-2:ATCAGGTAGACTCCGC"	-3.66796741905864	11.9759778746399	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCAGGTAGACTCCGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1520.89407562693	44.2681808839214	0.0291066824398495	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1518.53757714061	1518.53757714061
"healthy-5"	"2019-08-29-count-1:ACCTACCAGTTCCTGA"	-2.4313739341801	10.6643037565979	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCTACCAGTTCCTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1739.21399575167	40.052225137159	0.0230289229703724	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1735.04591632093	1735.04591632093
"healthy-5"	"2019-08-29-count-1:TCCCATGAGACGAGCT"	4.65472521361653	-7.9292464486328	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCATGAGACGAGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.59126300768	35.3480506973017	0.0161954513868029	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2179.46899102862	2179.46899102862
"healthy-5"	"2019-08-29-count-2:ATCAGGTGTATGTCCA"	3.87727942046468	-8.11051180278929	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCAGGTGTATGTCCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1849.45939807631	44.8185465441233	0.0242333227702867	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.6331994941	1845.6331994941
"healthy-5"	"2019-08-29-count-2:ATCAGGTGTTCACGAT"	14.4463955360347	2.00894222343294	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCAGGTGTTCACGAT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1705.42969601099	26.2367644835948	0.0153842545048692	1432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1693.46658064801	1693.46658064801
"healthy-5"	"2019-08-29-count-2:TGTTCCGCAACCAATC"	-7.27163682404216	2.8750269182953	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTCCGCAACCAATC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2298.37944967519	42.0562241859292	0.0182982075443951	1575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2284.47246512638	2284.47246512638
"healthy-5"	"2019-08-29-count-1:TATTGGGCATCCTCAC"	0.912726421921891	9.03649900043336	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGGGCATCCTCAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1568.61648646818	36.0153312686046	0.0229599341708405	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1564.39313222287	1564.39313222287
"healthy-5"	"2019-08-29-count-1:TATTGGGGTTGTTTGG"	2.60053505477254	-6.44900944149169	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGGGGTTGTTTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1676.85836528412	52.1178538164947	0.0310806534979262	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1670.15005073924	1670.15005073924
"healthy-5"	"2019-08-29-count-2:ATCATTCAGTAATACG"	-3.88166938248332	11.8487939604553	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCATTCAGTAATACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1566.47062912944	40.0304963024438	0.0255545782717231	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1559.33214351015	1559.33214351015
"healthy-5"	"2019-08-29-count-1:GCCATGGCAATGCAAA"	11.239744802087	4.06453273380128	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCATGGCAATGCAAA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1540.34211821023	31.5316614212043	0.0204705571888418	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1535.6659830814	1535.6659830814
"healthy-5"	"2019-08-29-count-2:ATCCACCAGCGGGTTA"	2.18210019645039	-8.09082796489867	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCACCAGCGGGTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.78068155173	42.7933620991505	0.0208770443024933	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2044.01118052907	2044.01118052907
"healthy-5"	"2019-08-29-count-1:CAGTGCGTCCTTCTTC"	6.82436241683309	-1.3855669728485	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTGCGTCCTTCTTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2112.40076554493	38.9106915874047	0.0184201275733618	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2108.71163034966	2108.71163034966
"healthy-5"	"2019-08-29-count-1:TCCCATGTCTCATTGT"	-1.71803079071696	3.43336818302003	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCATGTCTCATTGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2489.95278304189	39.2238925472792	0.015752866003893	2608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2489.35516617037	2489.35516617037
"healthy-5"	"2019-08-29-count-2:TATATCCCAACACGTT"	-0.741781334311324	9.16800210559694	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATATCCCAACACGTT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1755.41382820405	41.2181767220017	0.0234806038665947	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1746.85711373642	1746.85711373642
"healthy-5"	"2019-08-29-count-2:GTTGTGAAGTGCCAGA"	-7.95464358750041	-0.352712684032045	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGTGAAGTGCCAGA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2479.48508795145	54.2611439827762	0.0218840372327493	1709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2472.54767965989	2472.54767965989
"healthy-5"	"2019-08-29-count-2:TTGATGGAGCCAGACA"	-2.30487690392192	10.1177520521912	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGATGGAGCCAGACA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1484.81671883433	37.1703660515719	0.0250336392229965	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1477.81901138925	1477.81901138925
"healthy-5"	"2019-08-29-count-2:TCATTCACAAACCACT"	2.57618012008016	-8.07324793255004	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTCACAAACCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1568.64283326694	44.6416338204052	0.0284587624879732	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1566.24954144122	1566.24954144122
"healthy-5"	"2019-08-29-count-2:AGGCTGCCAACGACAG"	-3.2078779739445	11.9709338911804	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCTGCCAACGACAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1479.2324526326	38.4629924953056	0.0260019934168242	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1476.78373703835	1476.78373703835
"healthy-5"	"2019-08-29-count-2:TTGATGGCATGACTCA"	11.3252798515255	4.25394628131715	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGATGGCATGACTCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1796.29424344799	31.1119633157471	0.0173200818458493	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1789.50069340401	1789.50069340401
"healthy-5"	"2019-08-29-count-1:GCCATTCTCCGTCACT"	1.06588317927663	-6.87477781688841	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCATTCTCCGTCACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1919.31027325889	51.3939166478744	0.0267772841962703	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1917.27289652244	1917.27289652244
"healthy-5"	"2019-08-29-count-1:CCATCACGTTTGATCG"	-7.96512637558635	0.182869441154875	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATCACGTTTGATCG"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2732.82456816831	42.7661973964637	0.0156490825992273	2320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2720.45401160984	2720.45401160984
"healthy-5"	"2019-08-29-count-1:ATGACCATCACCTGGG"	10.3779522376949	7.2919039496216	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGACCATCACCTGGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1932.77650284389	39.6031764434118	0.0204903031391056	911	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1929.1312906614	1929.1312906614
"healthy-5"	"2019-08-29-count-2:TGTTGAGAGTCACTGT"	10.4423538642818	7.08645436847535	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTGAGAGTCACTGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.53977001364	39.691299232995	0.0214949603997437	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1837.35961099127	1837.35961099127
"healthy-5"	"2019-08-29-count-2:GATGCTACACGTACAT"	-1.7060915035313	10.2065992125305	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGCTACACGTACAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1437.61518349276	40.5839710923545	0.0282300657076768	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1437.61518349276	1437.61518349276
"healthy-5"	"2019-08-29-count-2:TTGCATTCACACGTGC"	11.3824688392574	3.56615207279054	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGCATTCACACGTGC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1486.80927474635	45.8454373567115	0.0308347803147331	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1484.36607951338	1484.36607951338
"healthy-5"	"2019-08-29-count-2:ATCCGTCCAAGGCGTA"	5.17362227019612	-8.97765638744506	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCGTCCAAGGCGTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.73028587391	41.7102522504881	0.0201039395503493	946	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2072.7920431335	2072.7920431335
"healthy-5"	"2019-08-29-count-2:ATCCGTCCAGTAACCT"	5.35658325728719	-9.91366770183715	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCGTCCAGTAACCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1704.68179328594	44.2901490143933	0.0259814759498426	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1695.76108225728	1695.76108225728
"healthy-5"	"2019-08-29-count-1:TCCGATCCAGAGGAAA"	-3.83455095711406	-5.44486715709838	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGATCCAGAGGAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2320.5210837329	44.3557583197069	0.0191145681160346	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2317.44360208148	2317.44360208148
"healthy-5"	"2019-08-29-count-2:GATGGAGAGACTACGG"	-2.67373333397563	4.09423301303712	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGGAGAGACTACGG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1505.79577439122	22.0650406461282	0.0146534085308141	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1505.79577439122	1505.79577439122
"healthy-5"	"2019-08-29-count-1:CTACATTAGGAAAGGT"	2.76220025595967	-4.91820862209471	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACATTAGGAAAGGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2185.88383517826	44.9859350265135	0.0205802038985502	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2185.88383517826	2185.88383517826
"healthy-5"	"2019-08-29-count-2:TCATTTGCATAAGCAA"	-1.77284501019176	10.3066377409729	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTTGCATAAGCAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1455.94058715014	32.1791621853806	0.0221019748122883	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1453.55898377911	1453.55898377911
"healthy-5"	"2019-08-29-count-1:GTAGTACTCACTGCTC"	4.30734695967976	-7.62213423168334	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGTACTCACTGCTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1921.14048947158	45.1283081956618	0.0234903737873302	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1921.14048947158	1921.14048947158
"healthy-5"	"2019-08-29-count-2:GATGGAGAGTATTGCC"	3.13405837592427	-8.14940550243529	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATGGAGAGTATTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1581.84230419434	44.0112673632255	0.0278227907083578	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1579.46085537955	1579.46085537955
"healthy-5"	"2019-08-29-count-2:TGTTGGATCTACACTT"	2.53363074836079	-7.23997595226439	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTGGATCTACACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1641.21271914729	41.2054312870179	0.0251066975086731	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1636.6947119954	1636.6947119954
"healthy-5"	"2019-08-29-count-2:AGGGCTCAGCCATTTG"	3.54912271079366	-7.19368507778319	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGCTCAGCCATTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1688.7815605013	47.2172601830855	0.0279593650756522	709	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.42925421613	1682.42925421613
"healthy-5"	"2019-08-29-count-2:TATCCTATCCGAGATT"	-3.10703239861186	10.2183065184387	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCCTATCCGAGATT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1646.03250729372	36.5090356950084	0.0221800210708072	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1641.48621387968	1641.48621387968
"healthy-5"	"2019-08-29-count-1:TCAAGTGCAAGTCGTT"	-4.09413848343547	12.2776860960755	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGTGCAAGTCGTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1544.8887196595	32.7724784495275	0.0212134880865404	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1542.55850709088	1542.55850709088
"healthy-5"	"2019-08-29-count-1:ACGATGTGTGTGTTTG"	11.2325388389522	4.71682212436525	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGATGTGTGTGTTTG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1490.74666247221	40.3160253921022	0.027044182896404	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1482.59964115149	1482.59964115149
"healthy-5"	"2019-08-29-count-1:CTGATCCTCCTTCAGC"	3.43594827231709	-8.56383516704711	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGATCCTCCTTCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1965.4169501974	39.3496010616776	0.0200209940479681	881	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1959.5567286876	1959.5567286876
"healthy-5"	"2019-08-29-count-2:TCTACATCACATCATG"	3.79877867278401	-7.89969780361327	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACATCACATCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1923.96927993935	44.974012298818	0.0233756395009778	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1921.90551286226	1921.90551286226
"healthy-5"	"2019-08-29-count-1:TCCGTGTGTGTAACGG"	-2.17982731285747	9.51585004413453	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGTGTGTGTAACGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1862.38349538842	42.350259004361	0.0227398165357605	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1853.44428149368	1853.44428149368
"healthy-5"	"2019-08-29-count-2:TAACCAGGTACGTGTT"	-2.79413757744487	10.5598535307678	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACCAGGTACGTGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1447.54891147231	37.6885432044097	0.0260361103557298	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1440.0051529501	1440.0051529501
"healthy-5"	"2019-08-29-count-2:TTGCCTGTCTCCAAGA"	4.33410229262654	-8.73292448436888	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGCCTGTCTCCAAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1854.99252707688	46.2126660773339	0.0249125888125039	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1850.63094702701	1850.63094702701
"healthy-5"	"2019-08-29-count-1:ACGCACGTCTTCGGTC"	2.75098838385884	-4.49796488201293	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGCACGTCTTCGGTC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2417.45243001791	44.521660497421	0.018416767976316	1561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2416.2407705415	2416.2407705415
"healthy-5"	"2019-08-29-count-2:ATCGATGTCAGCTTCC"	-2.58113179627116	3.59086797321168	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGATGTCAGCTTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2960.2061816178	46.9016902362275	0.0158440619871265	3325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2954.67100318063	2954.67100318063
"healthy-5"	"2019-08-29-count-1:TCCTAATAGCTGACTT"	11.0393434959346	5.64606330478517	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTAATAGCTGACTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1725.64697078855	43.8092840871201	0.0253871648307656	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1721.49298289444	1721.49298289444
"healthy-5"	"2019-08-29-count-2:ATCGATGTCTCCGATC"	-3.87746868553813	12.7013406523499	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGATGTCTCCGATC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1648.99540796906	41.6483179287889	0.0252567822369402	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1644.3566941894	1644.3566941894
"healthy-5"	"2019-08-29-count-2:TCTACATTCCATTTGT"	3.0375608402187	-8.00114824688109	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACATTCCATTTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1655.61386307612	48.4461926982706	0.0292617703793914	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1653.35396032625	1653.35396032625
"healthy-5"	"2019-08-29-count-1:TCCTAATGTTCCAGGC"	-0.361960898072082	9.35812757099	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTAATGTTCCAGGC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1583.15520181181	40.5467507788672	0.0256113555591166	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1583.15520181181	1583.15520181181
"healthy-5"	"2019-08-29-count-1:CTGCAGGTCAGCCTTC"	3.40090789374654	-6.50771763240965	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCAGGTCAGCCTTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2008.47909877412	44.8139898546942	0.0223124004038909	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2001.25775394606	2001.25775394606
"healthy-5"	"2019-08-29-count-1:TCCTAATTCGTTAGAC"	1.68926026400868	-6.96723034298094	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTAATTCGTTAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1750.32598649503	45.605513334394	0.0260554397788023	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.25511779897	1748.25511779897
"healthy-5"	"2019-08-29-count-2:AGGGTCCGTAACGCGA"	10.2838245826656	6.27553794467775	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTCCGTAACGCGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1487.19174313221	38.7834578677721	0.0260783171012563	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1484.77323412518	1484.77323412518
"healthy-5"	"2019-08-29-count-1:TCAATTCAGCCTTTCC"	5.44292368468587	-9.61124708568724	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATTCAGCCTTTCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.02743101255	40.9577544043269	0.0168064396334306	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2431.08444806748	2431.08444806748
"healthy-5"	"2019-08-29-count-2:TCCACGTGTACCTAGT"	-3.18212829056438	11.0533065565857	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCACGTGTACCTAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1517.04902504462	33.0636202627732	0.021794694645284	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1509.99591221598	1509.99591221598
"healthy-5"	"2019-08-29-count-2:GCTTGGGCAGGACTAG"	3.81621756133382	-8.35087587749632	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTTGGGCAGGACTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.77140972019	40.3370425851729	0.0197655858922011	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2039.17966775334	2039.17966775334
"healthy-5"	"2019-08-29-count-1:TCCTCCCTCTCCATAT"	-4.81923375549968	-5.05217506801756	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCCCTCTCCATAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2804.72986345722	44.7043393554548	0.015938910886894	1798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2798.52647560722	2798.52647560722
"healthy-5"	"2019-08-29-count-1:CTGCATCGTACGGCAA"	3.41572894629781	-7.36519672786864	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCATCGTACGGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.36367157571	45.1168750021305	0.0215523349405267	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2088.17787895776	2088.17787895776
"healthy-5"	"2019-08-29-count-2:TTGCTGCTCAGACCTA"	9.01497425612752	6.91601989353029	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGCTGCTCAGACCTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1602.43635136263	45.4567061374737	0.0283672459744311	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1598.25160235427	1598.25160235427
"healthy-5"	"2019-08-29-count-1:TCCTCGAAGAAACCAT"	4.75702824172322	-8.23164846813353	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCGAAGAAACCAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2408.09080330048	36.4522981709525	0.0151374267618944	1323	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2400.45529860525	2400.45529860525
"healthy-5"	"2019-08-29-count-2:TCTACCGTCGAATCCA"	-2.48987470093425	9.69227120960084	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTACCGTCGAATCCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1421.12246715562	35.9465602871515	0.0252944845486108	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1418.59880582709	1418.59880582709
"healthy-5"	"2019-08-29-count-1:ACGGGTCTCATTTCCA"	-3.36651978913005	13.2679233320984	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGGTCTCATTTCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1738.99374882192	43.8389423956168	0.0252093731937309	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1729.68990341586	1729.68990341586
"healthy-5"	"2019-08-29-count-1:ATGCATGGTGACTCGC"	5.4580737548763	-9.83158018505248	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCATGGTGACTCGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2232.36425011529	40.3670547643396	0.0180826470242277	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2230.73448910369	2230.73448910369
"healthy-5"	"2019-08-29-count-1:CTGCCATAGGATACAT"	3.65483870086018	-8.14701845562132	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCCATAGGATACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1669.81444667206	51.2867058947682	0.030714014959556	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1665.31951966783	1665.31951966783
"healthy-5"	"2019-08-29-count-1:ACGGTCGCAGTCGAGA"	-2.42952356758769	3.98390147769777	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGTCGCAGTCGAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3092.91190011571	48.878868186537	0.0158035113074861	3724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3086.74232659425	3086.74232659425
"healthy-5"	"2019-08-29-count-2:ATCGGCGGTAACCCTA"	10.7757173973018	4.89780137622682	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGGCGGTAACCCTA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1441.01744097787	41.9000663734607	0.0290767239742965	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1426.1132455444	1426.1132455444
"healthy-5"	"2019-08-29-count-2:TAACTTCTCTGCGGGT"	5.05197634276692	-9.89071848308715	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACTTCTCTGCGGGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2050.86263923945	40.8105318552006	0.0198992029375185	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2047.78248552583	2047.78248552583
"healthy-5"	"2019-08-29-count-2:TTGGGATAGGCCCAAA"	-2.39107571068462	13.1046247252258	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGATAGGCCCAAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1496.00288851761	39.3216491672451	0.0262844740936356	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1493.58586986335	1493.58586986335
"healthy-5"	"2019-08-29-count-1:GTGTTAGCAACACAGG"	3.12667741355245	-6.7014575234619	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTTAGCAACACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.92618725185	42.8772729379244	0.0189812633896142	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2249.66794078298	2249.66794078298
"healthy-5"	"2019-08-29-count-1:GTGTTAGCACATATGC"	10.9940792518551	4.23300454700319	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTTAGCACATATGC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1441.08152437918	39.4264721644195	0.0273589463867456	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1427.87180441901	1427.87180441901
"healthy-5"	"2019-08-29-count-2:TTGGGATCATCAGTCA"	4.24068369445149	-7.7795882455078	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGATCATCAGTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.61708346025	45.883346359716	0.022353583008462	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2052.61708346025	2052.61708346025
"healthy-5"	"2019-08-29-count-2:ATCGTAGGTCATATGC"	3.34777249869649	-7.42912485515746	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGTAGGTCATATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1656.22379565162	38.964973502752	0.0235263939601966	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1649.32183694416	1649.32183694416
"healthy-5"	"2019-08-29-count-1:TCCTCTTGTATGGTAA"	2.97365035590474	-7.52761175548705	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCTTGTATGGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1770.58653011033	45.0089262625627	0.0254203482841124	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1759.51615405376	1759.51615405376
"healthy-5"	"2019-08-29-count-2:TTACCGCAGCTCCACG"	-0.840899269015151	9.88874337756959	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACCGCAGCTCCACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1491.02815697047	27.2267545144166	0.0182603892402254	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1486.26625833445	1486.26625833445
"healthy-5"	"2019-08-29-count-1:GCGGAAAAGACGCAGT"	3.87794127044026	-8.15713503276976	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGGAAAAGACGCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2138.09630999274	41.8103522932226	0.0195549433848303	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2134.61524093524	2134.61524093524
"healthy-5"	"2019-08-29-count-1:GGGCTACCATCAGTCA"	3.58151115950887	-7.95819666301879	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCTACCATCAGTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1424.10990984483	42.1228569312488	0.0295783749835984	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1424.10990984483	1424.10990984483
"healthy-5"	"2019-08-29-count-2:ATCGTCCAGACCATGG"	10.9162870841915	5.45155093753663	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGTCCAGACCATGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1669.53655027528	39.1277424569723	0.0234362898197831	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1663.20686497954	1663.20686497954
"healthy-5"	"2019-08-29-count-1:TCCTCTTTCATAGCAC"	1.05531789836232	9.01220986926881	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCTTTCATAGCAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1569.21206083405	38.8890519476144	0.0247825344440346	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1562.91873999114	1562.91873999114
"healthy-5"	"2019-08-29-count-2:TTGGGCGCACTACCGG"	4.87649502333943	-7.79112961208495	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGCGCACTACCGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2526.09725414765	39.9569204319914	0.0158176492874078	1486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2524.71141129908	2524.71141129908
"healthy-5"	"2019-08-29-count-2:TTGGGCGCAGGGTCTC"	4.39433207091634	-7.89733889019164	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGCGCAGGGTCTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.50333166147	42.4055303039626	0.0223127892477255	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1896.76850237562	1896.76850237562
"healthy-5"	"2019-08-29-count-2:TTGGGCGGTATACCTG"	-3.06780324402507	11.9372424849304	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGCGGTATACCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1811.7673330809	51.6420773847678	0.0285037026785061	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1807.57473886538	1807.57473886538
"healthy-5"	"2019-08-29-count-2:GGAATGGAGGTTCAGG"	4.08087791976277	-7.58456423198851	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAATGGAGGTTCAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1542.51549520969	42.8378941327629	0.0277714514154293	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1542.51549520969	1542.51549520969
"healthy-5"	"2019-08-29-count-1:GTTACAGCACTTACAG"	4.27917446669881	-7.43429186260375	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTACAGCACTTACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.33292440884	40.2559603244247	0.0199057038722702	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2017.34956708985	2017.34956708985
"healthy-5"	"2019-08-29-count-1:TCCTGCACAAATACGA"	2.34451331672017	-7.15052559291991	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTGCACAAATACGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1932.56541387912	42.8902600668297	0.0221934325010706	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1930.66958058185	1930.66958058185
"healthy-5"	"2019-08-29-count-1:ACGTAACTCCTACGGG"	3.98050965842549	-7.61040069973143	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTAACTCCTACGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.9366498922	44.4480475449573	0.0178081633389522	1465	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2493.11273685477	2493.11273685477
"healthy-5"	"2019-08-29-count-1:CTGCGAGCAGGTAGTG"	-2.5792432827061	3.71473786914674	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCGAGCAGGTAGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3123.3437777275	48.8985920825739	0.0156558469263834	3799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3119.43174333759	3119.43174333759
"healthy-5"	"2019-08-29-count-1:TCACATTGTTAAGGGC"	14.2082163291866	2.02320025050966	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACATTGTTAAGGGC"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1351.7395021192	31.917100418984	0.0236118722349577	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1342.48279158763	1342.48279158763
"healthy-5"	"2019-08-29-count-2:TTACGCCGTACCACGC"	3.35650124129598	-7.93968822872313	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACGCCGTACCACGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2001.45908458054	36.3720019064074	0.0181727431685321	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1999.62464414322	1999.62464414322
"healthy-5"	"2019-08-29-count-2:TCTCAGCCAGTTACCA"	3.32195868071858	-6.96069910442504	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCAGCCAGTTACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1807.68536718041	43.7958039323616	0.0242275590252043	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1805.62378023336	1805.62378023336
"healthy-5"	"2019-08-29-count-2:TTGGGTACATCGCCTT"	-3.42910514298137	-5.56594231044921	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGTACATCGCCTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2283.00774702066	47.1862232393437	0.0206684463952967	1251	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2277.13684289277	2277.13684289277
"healthy-5"	"2019-08-29-count-1:TCCTGCAGTCCTTAAG"	3.00854196128194	-8.15165903484496	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTGCAGTCCTTAAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1742.63292773972	50.7664767580566	0.029132054117618	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1740.46348385958	1740.46348385958
"healthy-5"	"2019-08-29-count-1:ACGTCCTTCAGAGTGG"	-5.61736331406291	-5.45431282436522	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTCCTTCAGAGTGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2163.57437957761	38.3867685394214	0.0177422920615817	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2159.98435866255	2159.98435866255
"healthy-5"	"2019-08-29-count-1:CTGCTCACAAAGCGTG"	3.9301389652187	-8.29978849804076	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCTCACAAAGCGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1766.82362787874	43.6113052281647	0.0246834514436083	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.75087233058	1764.75087233058
"healthy-5"	"2019-08-29-count-2:ATCTCTAAGATGCTTC"	0.451231827109498	8.85800740802614	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTCTAAGATGCTTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1456.49587220377	34.5734185685103	0.0237373955040453	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1449.33927659947	1449.33927659947
"healthy-5"	"2019-08-29-count-1:TCCTTCTAGATGAACT"	-1.93433819237407	3.71115706050722	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTTCTAGATGAACT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3036.66879900105	43.642074340645	0.0143716938623671	4069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3030.54947491797	3030.54947491797
"healthy-5"	"2019-08-29-count-2:GGAGAACCATTCCTCG"	14.1904303031856	1.77351627433626	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGAACCATTCCTCG"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1739.60591752843	32.2287142831153	0.0185264455348052	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1725.18545385054	1725.18545385054
"healthy-5"	"2019-08-29-count-1:CCCTTAGCAGGCACTC"	9.64181675490681	5.58013579929201	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTTAGCAGGCACTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1555.95342390028	42.2570479992596	0.0271582987962036	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1549.03892450976	1549.03892450976
"healthy-5"	"2019-08-29-count-2:AGGTGTTCAAATAGCA"	4.21569742736165	-7.322620891687	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTGTTCAAATAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1801.21826087449	45.3431904775439	0.02517362357604	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1799.24285957242	1799.24285957242
"healthy-5"	"2019-08-29-count-2:TTGTGGAGTACGGTTT"	3.00446857985799	-7.83689215099486	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTGGAGTACGGTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1743.62361277117	45.6898605042903	0.0262039698072651	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1741.47502375291	1741.47502375291
"healthy-5"	"2019-08-29-count-1:GCGTTTCGTACTGTTG"	3.08838905867879	-7.73523952877196	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGTTTCGTACTGTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1590.96430804369	44.3897376342619	0.0279011524079036	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1588.56730165568	1588.56730165568
"healthy-5"	"2019-08-29-count-2:CTGTATTTCTGTGCAA"	3.65241946753804	-8.38232614910277	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTTCTGTGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1612.3826568843	44.2523801220109	0.0274453337320821	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1612.3826568843	1612.3826568843
"healthy-5"	"2019-08-29-count-2:TCTCTGGTCGCTATTT"	4.48934998092	-7.96017744457396	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCTGGTCGCTATTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.47924138511	43.4843364016563	0.0204201738887918	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2124.45342028278	2124.45342028278
"healthy-5"	"2019-08-29-count-1:CTGCTCATCTAAGAAG"	3.71765102919881	-8.41178133403929	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCTCATCTAAGAAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2130.28890193094	39.2399191560272	0.0184199988651583	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2126.8398964263	2126.8398964263
"healthy-5"	"2019-08-29-count-2:ACCCTTGGTATTTCTC"	4.561540265649	-7.94537928020629	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCCTTGGTATTTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1970.33486411216	39.9132084802868	0.0202570685862943	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1968.5480431578	1968.5480431578
"healthy-5"	"2019-08-29-count-2:ATCTCTATCTTAGGAC"	-3.37645421448405	12.8551349409851	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTCTATCTTAGGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1563.13253315524	40.1558234155504	0.0256893274011094	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1563.13253315524	1563.13253315524
"healthy-5"	"2019-08-29-count-1:ACGTTCCTCATAAGGA"	4.42925896224324	-8.9768800965515	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTTCCTCATAAGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2026.86924721562	40.9874156877804	0.0202220324493483	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2023.32070162142	2023.32070162142
"healthy-5"	"2019-08-29-count-2:TTGTGTTTCCCATACC"	2.19633998450581	-7.04365303432616	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTGTTTCCCATACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1831.08657750841	46.4064309165557	0.0253436574144417	795	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1831.08657750841	1831.08657750841
"healthy-5"	"2019-08-29-count-2:ATCTTCACACTAGGCC"	10.0717903572017	6.65615699375001	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTTCACACTAGGCC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1781.64983849844	39.5669214111919	0.0222080234601758	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1769.25593902351	1769.25593902351
"healthy-5"	"2019-08-29-count-1:TCGAACAAGGTCGACA"	-2.6477087539738	3.34040567958681	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGAACAAGGTCGACA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3182.28382013416	45.9754104872202	0.0144473004564633	3527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3175.63721249632	3175.63721249632
"healthy-5"	"2019-08-29-count-2:TCTGCCAGTCTTCATT"	-0.330289940268356	8.58612535083619	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGCCAGTCTTCATT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1668.65178221617	39.3813948142727	0.0236007267867292	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1666.55725953827	1666.55725953827
"healthy-5"	"2019-08-29-count-1:GTTATGGAGTTGCCCG"	1.93326713618581	-7.69598629390868	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTATGGAGTTGCCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1692.76376849045	53.8233029436548	0.0317961099744311	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1690.44067123313	1690.44067123313
"healthy-5"	"2019-08-29-count-2:TCTGGCTAGGCGAACT"	3.71078266677205	-7.48800852214965	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGGCTAGGCGAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1860.35306473676	43.9984189791103	0.0236505746210793	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1856.26022672967	1856.26022672967
"healthy-5"	"2019-08-29-count-2:ATCTTCATCTAGTGAC"	-3.23207364502605	10.5196447142395	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTTCATCTAGTGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1724.58765751723	38.1297816831208	0.0221095063025173	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1719.85224512263	1719.85224512263
"healthy-5"	"2019-08-29-count-1:TCGAAGTAGCAAGTCG"	4.42480578002278	-7.58172895824584	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGAAGTAGCAAGTCG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2078.39046728592	42.0084545490257	0.020212012713801	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.88516027129	2070.88516027129
"healthy-5"	"2019-08-29-count-2:GGAGCAAGTCTCGACG"	0.0408096398109615	8.59184262836305	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGCAAGTCTCGACG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1748.16619596687	46.0453121536447	0.0263392074848913	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1737.90171838687	1737.90171838687
"healthy-5"	"2019-08-29-count-1:CCGATCTTCCACACAA"	5.24913992461507	-9.88594438945922	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGATCTTCCACACAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.17251908017	43.4478358328213	0.0191638860594732	1234	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2264.14215258627	2264.14215258627
"healthy-5"	"2019-08-29-count-2:CTGTGAAGTAGTTCCA"	2.94964613494222	-7.85860826885375	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTGAAGTAGTTCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1512.58315282895	48.0867536340109	0.031791147180289	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1507.94386763155	1507.94386763155
"healthy-5"	"2019-08-29-count-2:TCTGGCTTCCCAGGCA"	-3.52514491501506	11.5691623457703	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTGGCTTCCCAGGCA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1734.19237233533	42.7912880900178	0.0246750526485095	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1732.02859587728	1732.02859587728
"healthy-5"	"2019-08-29-count-2:ACCGTTCGTTGGTAGG"	-2.86686215820964	3.6644453772339	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCGTTCGTTGGTAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3164.79417539791	48.4729795921456	0.0153163134490574	3566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3159.3555240886	3159.3555240886
"healthy-5"	"2019-08-29-count-1:CTGGCAGCACCGAATT"	2.85521044310872	-7.45371248638304	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGCAGCACCGAATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1556.26017324891	45.7228621662978	0.0293799603384085	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1554.0009820616	1554.0009820616
"healthy-5"	"2019-08-29-count-1:CTGGCAGCAGAGGCTA"	2.77850164946858	-7.27570917522582	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGCAGCAGAGGCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1847.22418737819	47.6903805408936	0.025817321398645	842	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.31662387671	1845.31662387671
"healthy-5"	"2019-08-29-count-2:ACCGTTCTCTCAGGCG"	4.93646492537801	1.98661456191865	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	30	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCGTTCTCTCAGGCG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1911.53821993276	39.5069652190453	0.020667630292234	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1896.34829253894	1896.34829253894
"healthy-5"	"2019-08-29-count-1:CTGGCAGTCACCTCAC"	-3.43952689591106	12.6145066984924	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGCAGTCACCTCAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1832.434312898	32.9104621781775	0.0179599683036547	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1830.20903659007	1830.20903659007
"healthy-5"	"2019-08-29-count-1:GTTCATTTCAATCTTC"	1.2858063178951	-6.64914944088133	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTCATTTCAATCTTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2064.92016773158	50.1467769100349	0.0242850923215708	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2061.20261188735	2061.20261188735
"healthy-5"	"2019-08-29-count-1:CTGGCAGTCGTTCTCG"	5.37684406813924	-9.80252554332884	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGCAGTCGTTCTCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2152.12526135496	43.3742343704696	0.0201541402581565	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2148.41984432641	2148.41984432641
"healthy-5"	"2019-08-29-count-1:CTGGCAGTCTAGAGCT"	2.48902668532674	-7.26395037090453	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGGCAGTCTAGAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1458.9860790875	45.8091647446263	0.0313979450532365	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1454.20621331913	1454.20621331913
"healthy-5"	"2019-08-29-count-2:ACCTACCTCACTTATC"	6.74847235259358	-1.36798288738402	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTACCTCACTTATC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1916.03484164309	49.3310073776804	0.0257464041391735	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1909.44922702798	1909.44922702798
"healthy-5"	"2019-08-29-count-1:AATTTCCCACGTGTGC"	2.80761088904683	-7.36653330242308	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATTTCCCACGTGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1646.84774362917	44.8683724132302	0.0272450034235426	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1644.64548540851	1644.64548540851
"healthy-5"	"2019-08-29-count-2:TCTTAGTGTTGGTGTT"	2.76403965529744	-7.61569359218749	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTAGTGTTGGTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1595.3519180981	40.9271195320953	0.0256539758205114	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1588.17673255225	1588.17673255225
"healthy-5"	"2019-08-29-count-1:CTATCTATCTTGGTGA"	9.18926205214803	5.34981725299684	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTATCTATCTTGGTGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1407.99978777657	45.2637310557478	0.0321475411066827	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1407.99978777657	1407.99978777657
"healthy-5"	"2019-08-29-count-2:TACAACGCAAGTCGTT"	9.32882465895955	5.63503596866456	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACAACGCAAGTCGTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1430.88666457155	37.8974279778698	0.0264852758196732	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1430.88666457155	1430.88666457155
"healthy-5"	"2019-08-29-count-1:CCGCAAGAGCACTGGA"	1.85606851157491	-7.45428898250731	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGCAAGAGCACTGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1723.84166189167	49.0145740880375	0.0284333388451994	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1713.13191324263	1713.13191324263
"healthy-5"	"2019-08-29-count-1:GATTCGAGTGGATGAC"	4.29769148406331	-7.39763309871825	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTCGAGTGGATGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2285.33275073081	47.3382437748591	0.020713939254457	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2285.33275073081	2285.33275073081
"healthy-5"	"2019-08-29-count-1:CTCAACCGTTCTTAGG"	-1.58072314682658	9.47661588275758	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAACCGTTCTTAGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2019.45566162387	36.231828136676	0.0179413833268028	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2016.19344087313	2016.19344087313
"healthy-5"	"2019-08-29-count-2:GGAGGTAGTTTGGAGG"	4.31999887999837	-7.45292284404906	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGGTAGTTTGGAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.64168433464	42.5205041093005	0.0201936086398938	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2096.88296134834	2096.88296134834
"healthy-5"	"2019-08-29-count-1:TCGACGGCAGGTACGA"	3.30709995803182	-8.32252314006957	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGACGGCAGGTACGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1868.40167643985	43.5571997492701	0.0233125458505616	870	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1861.07749705138	1861.07749705138
"healthy-5"	"2019-08-29-count-1:TCGACGGGTGGTACAG"	3.00071634826009	-6.89921286022338	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGACGGGTGGTACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.38781513954	41.0882354659155	0.0206640953807254	980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.91890712016	1984.91890712016
"healthy-5"	"2019-08-29-count-1:TCGATTTAGGGCTTCC"	-2.89924488487895	3.46199128711549	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGATTTAGGGCTTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2654.51859411752	43.6872345510357	0.0164576863947563	2568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2648.18776097969	2648.18776097969
"healthy-5"	"2019-08-29-count-1:GTTCTATAGGTATAGT"	3.94778194007222	-8.17394735729369	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTCTATAGGTATAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.64918772868	45.076715477416	0.0238798161069614	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.64918772868	1887.64918772868
"healthy-5"	"2019-08-29-count-1:CTCAAGAAGACCTTTG"	-2.94740758362468	3.44035933101503	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCAAGAAGACCTTTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3315.58877428225	48.0238118725564	0.0144842485428406	3384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3303.84150867847	3303.84150867847
"healthy-5"	"2019-08-29-count-2:AGTAGTCCAGGCACTC"	3.73537149009053	-8.12048056041869	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAGTCCAGGCACTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1823.01422491546	46.4825412627043	0.0254976294904445	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.96549538264	1820.96549538264
"healthy-5"	"2019-08-29-count-1:CTGTAGAGTCTACACA"	-3.08489189568217	10.7981796034607	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTAGAGTCTACACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1633.50862346411	33.6052551978098	0.0205724381953641	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1631.15763110517	1631.15763110517
"healthy-5"	"2019-08-29-count-2:CATCGTCCAACATACC"	3.98568429526631	-8.21525862133177	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGTCCAACATACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1900.55312942282	45.838066952761	0.0241182770653097	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1894.66248691429	1894.66248691429
"healthy-5"	"2019-08-29-count-2:TCTTGCGCAGCGTATT"	6.75888790664021	-1.52619960224303	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTGCGCAGCGTATT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2096.25145547093	37.2305597241506	0.0177605409059986	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2088.66018659651	2088.66018659651
"healthy-5"	"2019-08-29-count-2:CTTCAATCACGCTGAC"	14.1574999290401	1.88653025710908	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCAATCACGCTGAC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1302.54141693758	33.0312420992606	0.0253590724024122	900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1287.20669968589	1287.20669968589
"healthy-5"	"2019-08-29-count-2:ACCTGTCTCCGAGTGC"	8.7590033012325	6.29950711810914	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTGTCTCCGAGTGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1575.12304855786	41.0148880378878	0.026039164416672	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1568.38810660023	1568.38810660023
"healthy-5"	"2019-08-29-count-2:TACACCCTCGGTGAAG"	4.18134512481038	-8.08754446422728	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACACCCTCGGTGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.75865218318	41.3504462825282	0.019627519383712	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2101.58531144744	2101.58531144744
"healthy-5"	"2019-08-29-count-2:TACAGGTAGACGCCCT"	3.33757533606831	-7.69278099453124	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACAGGTAGACGCCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1906.84869419422	45.1219178610355	0.0236630824450928	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1898.75504959431	1898.75504959431
"healthy-5"	"2019-08-29-count-2:ACGATCAAGTCTAACC"	-3.37775359574016	3.27970550144044	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGATCAAGTCTAACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3034.97249812311	44.6253817925432	0.0147037186729502	3339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3027.08893250587	3027.08893250587
"healthy-5"	"2019-08-29-count-2:TCCTAATGTCGTATTG"	4.06409897383992	-8.81079008495482	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTAATGTCGTATTG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1932.91538919254	40.4407236867904	0.0209221386062243	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1931.02101057257	1931.02101057257
"healthy-5"	"2019-08-29-count-2:TTTACTGAGGGCATGT"	3.07023658332173	-7.79432442104491	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTACTGAGGGCATGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1591.6111783273	41.0988524447016	0.025822168758512	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1589.24656064221	1589.24656064221
"healthy-5"	"2019-08-29-count-1:ACACAGTAGCTAGATA"	-2.90090356293376	12.4088897475037	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACAGTAGCTAGATA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1380.75487661795	48.7116652585659	0.0352790101150185	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1378.26253830489	1378.26253830489
"healthy-5"	"2019-08-29-count-2:TACATTCAGAGTGTGC"	3.58789934691731	-7.77813579952391	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACATTCAGAGTGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1724.98328034486	38.6419823266766	0.0224013663013309	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1722.86018329886	1722.86018329886
"healthy-5"	"2019-08-29-count-1:CTGTATTTCATCGTAG"	4.02942170676534	-7.78384449398192	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTATTTCATCGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1728.4155140128	42.4982549066667	0.0245879851008743	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1721.98031428276	1721.98031428276
"healthy-5"	"2019-08-29-count-2:CTTCCGAGTTGCGGAA"	-3.58782945099528	12.394769645575	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCCGAGTTGCGGAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1448.94970015005	37.9032285181904	0.0261591058090321	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1448.94970015005	1448.94970015005
"healthy-5"	"2019-08-29-count-1:CTGTCGTAGTATCTGC"	3.63028468665425	-7.7415170899597	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTCGTAGTATCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1912.7602956592	47.7779115019629	0.0249785148773684	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1910.93666508129	1910.93666508129
"healthy-5"	"2019-08-29-count-2:ACGATGTCACAGAGAC"	-2.89433942261394	9.89436242664186	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGATGTCACAGAGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1804.93312867516	39.2385759684719	0.0217396286571977	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1800.81205909076	1800.81205909076
"healthy-5"	"2019-08-29-count-1:CCGGTAGCATGTGCCG"	2.87993564185445	-7.37300064479979	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGGTAGCATGTGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1677.35785028446	40.4212393211898	0.024098160875054	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1666.27227882299	1666.27227882299
"healthy-5"	"2019-08-29-count-1:GCTTCACCACTGGCCA"	3.38922705230061	-7.36138346111449	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTCACCACTGGCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1957.81141605516	42.9532752933581	0.0219394344833813	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1954.15570740373	1954.15570740373
"healthy-5"	"2019-08-29-count-1:CCGGTAGGTGTACATC"	-3.19129047814067	-5.65412380611571	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGGTAGGTGTACATC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1916.65592655266	45.3183568952009	0.023644492612042	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1908.96553587096	1908.96553587096
"healthy-5"	"2019-08-29-count-1:GCTTCACCAGCAATTC"	5.41508116301839	-10.0143718949524	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTCACCAGCAATTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.92390253112	40.3768476606828	0.0171166384881507	1269	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2354.21817760622	2354.21817760622
"healthy-5"	"2019-08-29-count-2:TGAACGTTCACCTTAT"	-3.0530038875645	3.74593088710634	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAACGTTCACCTTAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3081.61967899874	46.5365083181968	0.0151013146220941	3027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3076.15866713507	3076.15866713507
"healthy-5"	"2019-08-29-count-2:TACCCACTCGTTCCCA"	3.76655020293538	-7.91211607372435	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCCACTCGTTCCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1730.7514756771	47.8035178297853	0.0276200936423202	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1728.63765122219	1728.63765122219
"healthy-5"	"2019-08-29-count-1:TCGCAGGGTTCACGAT"	3.40022339400594	-7.85015013134154	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGCAGGGTTCACGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1743.93352074041	47.6692046796306	0.0273343015159156	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1743.93352074041	1743.93352074041
"healthy-5"	"2019-08-29-count-1:TCGCAGGTCCGAGATT"	3.16145481643025	-8.12271597301634	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGCAGGTCCGAGATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1766.88791119536	41.9965815345123	0.0237686733088236	732	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1762.5599305565	1762.5599305565
"healthy-5"	"2019-08-29-count-2:AGTCACATCCCAGGAC"	-2.37592730942424	4.12377593601076	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTCACATCCCAGGAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3131.43445867644	47.0532577132585	0.0150261033191627	3980	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3125.13894126011	3125.13894126011
"healthy-5"	"2019-08-29-count-1:CTGTGGGAGACCATGG"	-1.77998397770579	9.6910362013611	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGGGAGACCATGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1483.06647331545	34.6669375454073	0.0233751744572231	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1483.06647331545	1483.06647331545
"healthy-5"	"2019-08-29-count-1:GCTTGGGCAACCTATG"	-0.724002460867721	8.42301366412965	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTGGGCAACCTATG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1749.69455449502	27.991906053002	0.0159981672121513	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1742.73195799356	1742.73195799356
"healthy-5"	"2019-08-29-count-2:CTTCGGTTCGGAATGG"	-1.42274127426799	13.4689330824646	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCGGTTCGGAATGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1464.35236311389	42.8679864740519	0.0292743656198258	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1461.94912728103	1461.94912728103
"healthy-5"	"2019-08-29-count-1:GTTGCTCCAGGACAGT"	3.30938949164693	-7.0755653611389	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCTCCAGGACAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.96418277221	47.4557218834008	0.0233087213836857	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2032.4095173665	2032.4095173665
"healthy-5"	"2019-08-29-count-1:CATGCTCTCATTGTGG"	9.47604050216023	5.58421275699464	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCTCTCATTGTGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1405.98279709456	41.4770860833761	0.0295004221737904	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1403.49916231776	1403.49916231776
"healthy-5"	"2019-08-29-count-2:TGAATGCCATGACTCA"	3.01876844939534	-7.93754913723143	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAATGCCATGACTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1549.85048314441	50.5923993645725	0.0326434065187554	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1549.85048314441	1549.85048314441
"healthy-5"	"2019-08-29-count-1:TCGCTCAGTCACTAGT"	10.0622431236202	6.16292474353639	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGCTCAGTCACTAGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1660.70835626662	37.3318993719675	0.0224795035390151	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1658.57469001829	1658.57469001829
"healthy-5"	"2019-08-29-count-1:ATTCACTTCAACTGGT"	-4.10680804672893	12.1381339796814	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCACTTCAACTGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2161.77214218668	40.0885888019804	0.0185443174234959	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2155.88292535118	2155.88292535118
"healthy-5"	"2019-08-29-count-1:CTGTGGGCATCCCGTT"	1.90385224398915	-7.46527721798094	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGGGCATCCCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1646.58565377029	46.1793239882803	0.0280455036654429	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1646.58565377029	1646.58565377029
"healthy-5"	"2019-08-29-count-1:GTTGCTCTCAGCGCAC"	2.70695747908894	-6.69669058239134	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCTCTCAGCGCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1516.99011640707	48.4806864858139	0.0319584722151245	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1516.99011640707	1516.99011640707
"healthy-5"	"2019-08-29-count-1:TCAGTTTGTCAGACTT"	5.32837976989095	-9.52627279674681	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTTTGTCAGACTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.42769479964	39.22428037409	0.0174064960968617	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2253.42769479964	2253.42769479964
"healthy-5"	"2019-08-29-count-2:ACGGGTCAGTGAGGCT"	-1.45651040497478	9.78263280475465	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGGGTCAGTGAGGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1548.44535951485	33.8103758477755	0.0218350461254692	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1548.44535951485	1548.44535951485
"healthy-5"	"2019-08-29-count-1:TCATACTCAAGTATAG"	4.71540894088094	-8.21919920360716	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATACTCAAGTATAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2162.00268616244	37.0576424972065	0.0171404238923421	1130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2154.01694221512	2154.01694221512
"healthy-5"	"2019-08-29-count-1:GTCTACCAGTAAATGC"	-3.41940961304362	10.8676538237366	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTACCAGTAAATGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1705.02759767145	47.4027330930737	0.0278017394896198	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1693.84205757229	1693.84205757229
"healthy-5"	"2019-08-29-count-2:ACGGGTCTCGGTCAGC"	2.7764536338741	-7.85812952434691	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGGGTCTCGGTCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1502.46366318975	52.0699349735464	0.0346563689021278	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1497.49750817503	1497.49750817503
"healthy-5"	"2019-08-29-count-2:GGCTGTGAGTAGGGTC"	4.72659983214681	-8.71141245281371	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTGTGAGTAGGGTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.73483831776	41.2388026333432	0.0219153101667661	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1877.99746591923	1877.99746591923
"healthy-5"	"2019-08-29-count-2:CTTGAGAGTGGAATGC"	3.37135424193684	-7.79463770305785	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTGAGAGTGGAATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1751.08102344942	41.8638364750996	0.0239074239937983	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.7639337055	1746.7639337055
"healthy-5"	"2019-08-29-count-2:TGACAGTGTCAGCTTA"	1.89657618579213	-7.35841658031615	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACAGTGTCAGCTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1400.59042231619	46.2431611775191	0.0330169051856329	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1400.59042231619	1400.59042231619
"healthy-5"	"2019-08-29-count-1:GGAACCCCACAAATGA"	-1.6926294368809	10.5499610670838	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAACCCCACAAATGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1478.52972937034	36.802081690405	0.0248909987803072	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1471.82129741959	1471.82129741959
"healthy-5"	"2019-08-29-count-1:CTTACCGGTGAGAGGG"	-3.27213821831401	12.1876230009827	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTACCGGTGAGAGGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1534.18574747873	42.5175155223402	0.0277134079704581	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1529.34712305134	1529.34712305134
"healthy-5"	"2019-08-29-count-2:CTTGATTAGATAACGT"	-2.45884356918986	10.3701810606751	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTGATTAGATAACGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1599.22080660743	42.2297848043747	0.0264064753471789	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1596.92406126907	1596.92406126907
"healthy-5"	"2019-08-29-count-1:CCGTTCAGTAACGCGA"	-3.91169939461406	12.3236760863098	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTTCAGTAACGCGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1729.46086746532	41.9023023843896	0.0242285345523898	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1714.06018577475	1714.06018577475
"healthy-5"	"2019-08-29-count-2:TGACAGTTCCGTGTGG"	4.99303211745564	-8.98779203807982	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACAGTTCCGTGTGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2169.92299037745	35.8309792723277	0.0165125580175982	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2164.31380287127	2164.31380287127
"healthy-5"	"2019-08-29-count-2:CTTGATTGTACCCAGC"	3.79038371619527	-7.80409719860228	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTGATTGTACCCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.75367177491	33.544926748523	0.0164617182209786	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2034.32160319303	2034.32160319303
"healthy-5"	"2019-08-29-count-1:GTTGTGAAGGCTTTCA"	4.93396582183186	-7.8145790330139	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTGAAGGCTTTCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2000.02089374167	44.7326433885611	0.0223660880386477	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1994.45162915803	1994.45162915803
"healthy-5"	"2019-08-29-count-2:CTTGATTGTCTGTAGT"	4.41426004943196	-10.3567486039368	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTGATTGTCTGTAGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1722.03847778696	36.7495103916935	0.021340702235017	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1717.96486295051	1717.96486295051
"healthy-5"	"2019-08-29-count-1:GTTGTGAAGTTCTACG"	3.98153533515279	-8.39456274425658	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTGAAGTTCTACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1682.64992117088	50.7617189511345	0.0301677243212966	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.64992117088	1682.64992117088
"healthy-5"	"2019-08-29-count-2:CATGGTACACAGGATG"	4.8502422767574	-9.48772909557494	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGTACACAGGATG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2227.35459932054	41.7156543982472	0.0187287890356446	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2224.09356731615	2224.09356731615
"healthy-5"	"2019-08-29-count-2:TGACCCTTCTGGGCCA"	-2.13208899918254	9.87697312915651	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACCCTTCTGGGCCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1660.75197279192	40.8291741644809	0.0245847512653213	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1655.87914350592	1655.87914350592
"healthy-5"	"2019-08-29-count-2:AGTGATCTCGCCGATG"	-0.0399472889607728	8.81674478137819	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGATCTCGCCGATG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1723.72628403001	36.1837512847788	0.0209915875971808	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1723.72628403001	1723.72628403001
"healthy-5"	"2019-08-29-count-1:AGGATCTAGTAAGACT"	2.73901619490926	-7.74534370815428	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGATCTAGTAAGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1491.79742398775	50.1691604581128	0.0336300087742508	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1491.79742398775	1491.79742398775
"healthy-5"	"2019-08-29-count-2:CTTTCAAAGCCTAGGA"	5.15029587325398	-10.1295032731262	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTTCAAAGCCTAGGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1841.08460145053	42.4296487948868	0.023046007098999	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1839.11948272828	1839.11948272828
"healthy-5"	"2019-08-29-count-2:GGCTTTCGTTTAAGGA"	5.4504243331844	-9.6303920975891	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTTTCGTTTAAGGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.23074435465	45.4800822073307	0.0236600534773985	907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1916.83550889594	1916.83550889594
"healthy-5"	"2019-08-29-count-1:TCGGGCAAGTGTAGTA"	3.24228324469869	-7.69126369869383	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGCAAGTGTAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1610.40980885259	42.2949809670562	0.0262634894140338	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1608.02589423232	1608.02589423232
"healthy-5"	"2019-08-29-count-1:CTTAGGATCCGATAAC"	5.16001858290975	-10.1364126435486	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTAGGATCCGATAAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2188.08848721046	41.401396821239	0.01892126258295	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2186.41242736217	2186.41242736217
"healthy-5"	"2019-08-29-count-2:ACGTAACCAAACCGGA"	-2.33013854447063	4.12372825229494	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAACCAAACCGGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3200.16310274056	45.3207324729858	0.0141620070658817	4568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3190.56227987535	3190.56227987535
"healthy-5"	"2019-08-29-count-2:CTTTCAAGTCACGCTG"	-5.4131420654362	-4.52345945751341	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTTCAAGTCACGCTG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2797.37124951861	42.7279530759511	0.015274323378888	1908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2793.04873020314	2793.04873020314
"healthy-5"	"2019-08-29-count-1:TCGGGCAGTCGCAACC"	2.5968779521877	-4.3774452439514	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGCAGTCGCAACC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2538.34015212307	42.5027015939597	0.0167442891995426	1635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2531.05927259251	2531.05927259251
"healthy-5"	"2019-08-29-count-2:ACGTAACCATAAGATG"	3.59846081313435	-7.68966677105101	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAACCATAAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1675.89536633001	51.9203281596087	0.0309806502259789	699	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1671.82131703161	1671.82131703161
"healthy-5"	"2019-08-29-count-1:GGAATCTGTCTAGATC"	3.28572549399678	-7.23543884670409	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAATCTGTCTAGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1825.51501144208	37.4738155437496	0.0205278046517661	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1825.51501144208	1825.51501144208
"healthy-5"	"2019-08-29-count-2:GGGAAGTCAGGCTATT"	10.4898258644039	6.38877818668214	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAAGTCAGGCTATT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1775.68680389787	41.477286701029	0.0233584473399142	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1768.81122719347	1768.81122719347
"healthy-5"	"2019-08-29-count-2:ACGTAACTCGGAATGG"	-3.57639465752299	-5.45198299801024	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAACTCGGAATGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2382.35864687599	43.3571882499451	0.0181992699994184	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2379.50553166853	2379.50553166853
"healthy-5"	"2019-08-29-count-1:GTTTGGACATCCAATG"	4.70745720443074	-8.12125208294066	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTTGGACATCCAATG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.45243369632	45.2752740453245	0.0212614629605674	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2126.03102499044	2126.03102499044
"healthy-5"	"2019-08-29-count-1:CTTCAATGTTTGACAC"	-2.55217776718791	3.61033580386964	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCAATGTTTGACAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3251.90406649122	48.6092248587189	0.0149479270805082	3747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3245.15057397473	3245.15057397473
"healthy-5"	"2019-08-29-count-2:TGACTCCGTGGGTATG"	2.52225412902181	-6.92192032253417	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACTCCGTGGGTATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1639.04376798284	48.1659395527356	0.029386609737709	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1629.94910590261	1629.94910590261
"healthy-5"	"2019-08-29-count-2:AGTGTTGGTCGAGCAA"	6.78057350692098	-1.5100707045761	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGTTGGTCGAGCAA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2017.81759439018	32.9962253893132	0.0163524321926062	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2009.99727912638	2009.99727912638
"healthy-5"	"2019-08-29-count-2:GGGAAGTTCATTTGTC"	3.6100341278011	-6.9724970093933	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAAGTTCATTTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.2427133329	46.8993347422012	0.0262411671298645	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1783.56590920459	1783.56590920459
"healthy-5"	"2019-08-29-count-1:CTTCCGACAACTCGAT"	-2.3339413208073	8.67854402149049	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"Treg"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGACAACTCGAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2327.57567813656	39.2212219198202	0.0168506752705117	1153	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2320.41700986106	2320.41700986106
"healthy-5"	"2019-08-29-count-2:ACGTACATCGCCAACG"	3.1336358982021	-6.50744202053221	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTACATCGCCAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2170.78263184697	48.2608368905325	0.022231998811171	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2169.11260721398	2169.11260721398
"healthy-5"	"2019-08-29-count-1:TCGGGTGTCGCAGATT"	3.87285937842671	-7.89370586788329	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGTGTCGCAGATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1666.00596674488	49.5950729801058	0.0297688447521031	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1661.46877394213	1661.46877394213
"healthy-5"	"2019-08-29-count-2:TTTGGTTAGCGTGCCT"	0.741015394299668	9.64737317645875	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGGTTAGCGTGCCT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1585.8474591299	37.1034937445016	0.0233966347336199	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1581.25436390942	1581.25436390942
"healthy-5"	"2019-08-29-count-2:AGCCAGCGTTCAAGTC"	3.76662387427632	-7.48986818706664	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAGCGTTCAAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.81833323255	38.2789804795264	0.0192277616900241	910	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.4382809958	1985.4382809958
"healthy-5"	"2019-08-29-count-1:TAGGTTGTCTCACTCG"	10.308969159692	6.02326772296754	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTTGTCTCACTCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1468.59365621062	34.811565078165	0.0237040143343588	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1463.83647207268	1463.83647207268
"healthy-5"	"2019-08-29-count-1:TCGGTCTCATCTATCT"	2.50404872474019	-6.9252763024536	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGTCTCATCTATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.82998431133	41.9745900113443	0.022234306245886	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.68470853994	1881.68470853994
"healthy-5"	"2019-08-29-count-1:ACAGGGATCCGCAGTG"	3.52332081374471	-7.938099407312	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGGGATCCGCAGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1603.61125169596	49.0743691105839	0.0306024100658333	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1603.61125169596	1603.61125169596
"healthy-5"	"2019-08-29-count-2:ACGTAGTGTCTTCAAG"	4.43956436690633	-8.26463510906371	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAGTGTCTTCAAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1952.31965890148	43.4266541883487	0.0222436187590221	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1950.45540201855	1950.45540201855
"healthy-5"	"2019-08-29-count-2:ACGTAGTGTTATAGAG"	-3.23372517052348	10.553232169989	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTAGTGTTATAGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1428.74538848486	39.2797313326107	0.0274924641221525	501	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1426.11443886292	1426.11443886292
"healthy-5"	"2019-08-29-count-2:GGGACCTCAATGTTGC"	4.30439104613606	-7.27053263103636	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACCTCAATGTTGC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2417.48751311519	41.4044492806407	0.0171270581775567	1458	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2414.25271728517	2414.25271728517
"healthy-5"	"2019-08-29-count-2:TGAGCATAGCTAGTTC"	3.47294368323628	-8.6655893555847	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGCATAGCTAGTTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1820.69774000876	40.9096197960473	0.0224691989763498	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.69774000876	1820.69774000876
"healthy-5"	"2019-08-29-count-1:AGGGAGTGTCCTGAAT"	-1.75176392021831	10.1721257933411	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGAGTGTCCTGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1487.33081012829	42.1308269924392	0.0283264669201635	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1487.33081012829	1487.33081012829
"healthy-5"	"2019-08-29-count-1:TAACCAGCAGTCTGGC"	3.31122030791585	-8.07062628185423	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACCAGCAGTCTGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1853.11123392853	46.3797011489698	0.0250280179083726	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1849.26253417939	1849.26253417939
"healthy-5"	"2019-08-29-count-2:GAACACTAGTGGAAAG"	3.96916474875752	-7.21773483669432	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAACACTAGTGGAAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2204.4715742436	45.5739260108421	0.0206734015277468	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2202.71959222642	2202.71959222642
"healthy-5"	"2019-08-29-count-2:TGAGCATTCGTTAGTG"	3.04194082793538	-9.05560209667357	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGCATTCGTTAGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1560.3800047344	49.0274830492365	0.0314202200108182	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1560.3800047344	1560.3800047344
"healthy-5"	"2019-08-29-count-1:ATTCTACTCCGGTTCT"	3.4814895587856	-7.2380957833496	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCTACTCCGGTTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1813.70150964545	40.5781259818583	0.0223731004060259	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1813.70150964545	1813.70150964545
"healthy-5"	"2019-08-29-count-2:TTTGTTGGTCTCCTGT"	-3.51359019699748	12.7552814253601	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGTTGGTCTCCTGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1518.14404996244	44.5111216536483	0.0293194322730768	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1518.14404996244	1518.14404996244
"healthy-5"	"2019-08-29-count-2:ACGTTCCAGGGTAATT"	2.88770808753316	-6.89600374614867	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTTCCAGGGTAATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.46382216179	41.9050250940137	0.0198182748055584	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2111.00895712839	2111.00895712839
"healthy-5"	"2019-08-29-count-1:CCTCACACATAGGCGA"	1.9518252807552	-6.66438105022582	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCACACATAGGCGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1844.8446118295	47.1956185755634	0.0255824356549793	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1840.51235550512	1840.51235550512
"healthy-5"	"2019-08-29-count-1:GGAGATGCAGTTACCA"	1.31195809420888	-7.27773048793944	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGATGCAGTTACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1682.75612027328	48.3480788504857	0.0287314829926953	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1680.33101851585	1680.33101851585
"healthy-5"	"2019-08-29-count-2:TACTTACAGCTAATCC"	-4.22325215759929	9.62909600818483	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTACAGCTAATCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2403.86845769274	38.8223955700306	0.0161499667112787	1278	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2397.23591950745	2397.23591950745
"healthy-5"	"2019-08-29-count-1:CTTCGGTTCGCTCATC"	2.68582858619038	-7.98550226604613	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCGGTTCGCTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1551.47964081326	44.7426027346928	0.0288386657212205	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1549.09788358862	1549.09788358862
"healthy-5"	"2019-08-29-count-1:CTTCTAAAGTACCATC"	10.5959106880123	6.08784577930299	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTAAAGTACCATC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1550.82384315969	39.4318432136545	0.0254263844263028	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1550.82384315969	1550.82384315969
"healthy-5"	"2019-08-29-count-1:TCGTGCTAGGAGATAG"	-2.54490981522258	3.37757084453431	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGTGCTAGGAGATAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2525.1562004407	45.269007889112	0.017927210950836	1733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2524.0158198439	2524.0158198439
"healthy-5"	"2019-08-29-count-2:ACTACGACAGAGTGAC"	4.27848352965657	-10.3589878312317	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTACGACAGAGTGAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2338.28251488987	40.5714541973726	0.017350963341264	1332	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2332.53911024743	2332.53911024743
"healthy-5"	"2019-08-29-count-2:GGGAGATGTGAATAAC"	-3.64141402664836	11.1699380644592	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGATGTGAATAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1658.13300643796	34.1888362720021	0.0206188744444858	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1651.27445490057	1651.27445490057
"healthy-5"	"2019-08-29-count-2:ACTACGACAGTGACCC"	-3.63785777512248	13.2609176405701	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTACGACAGTGACCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1811.01763558606	42.560266162728	0.0235007463905536	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1808.75804266498	1808.75804266498
"healthy-5"	"2019-08-29-count-1:GGAGCAAAGCGGGTTA"	3.89427675780599	-8.22339632427367	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGCAAAGCGGGTTA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.37067445526	42.0856804218771	0.0196996152985522	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2132.92892523309	2132.92892523309
"healthy-5"	"2019-08-29-count-1:AGAACAAAGGTACTGG"	9.85666908797566	5.70722196185914	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACAAAGGTACTGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1441.35541143179	46.410050584562	0.0321988943299279	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1431.83701989663	1431.83701989663
"healthy-5"	"2019-08-29-count-1:CCTCATGCACCGGCTA"	-2.89510975304301	-5.860715889093	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCATGCACCGGCTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2246.97944933668	47.264777971605	0.0210348065201744	1140	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2238.41796044319	2238.41796044319
"healthy-5"	"2019-08-29-count-2:ACTATCTCAGCGGATA"	3.44160737571065	-8.09834291851195	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATCTCAGCGGATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1585.80560879837	45.8078902904773	0.0288861951530035	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1583.50018034126	1583.50018034126
"healthy-5"	"2019-08-29-count-2:ACTATCTCATTCCTAT"	-2.22439990463908	9.82474134052125	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATCTCATTCCTAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1624.9315454154	45.0394604750228	0.0277177586970341	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1622.52070789739	1622.52070789739
"healthy-5"	"2019-08-29-count-1:CTCCCAATCACGGAGA"	3.21021022376363	-7.07410385524901	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCCAATCACGGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1584.64247046863	46.9425119970839	0.0296234089846157	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1584.64247046863	1584.64247046863
"healthy-5"	"2019-08-29-count-1:TCATTGTCAGGATGAC"	-3.2122884792393	10.601535774115	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTGTCAGGATGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1638.77374468045	26.5405755542349	0.0161953873378721	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1638.77374468045	1638.77374468045
"healthy-5"	"2019-08-29-count-2:TCGCACTTCGCCGTGA"	-3.04058037224467	3.56703088367311	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCACTTCGCCGTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2747.26368297127	44.8511458505784	0.0163257521032965	2959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2744.94524934996	2744.94524934996
"healthy-5"	"2019-08-29-count-1:CCTCATGTCATTGCTT"	-4.45824943009074	-4.6392131081787	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCATGTCATTGCTT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2506.13373605746	41.9746831857481	0.0167487802353999	1537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2503.54245248848	2503.54245248848
"healthy-5"	"2019-08-29-count-1:TCTAACTGTACTCCCT"	-2.85797391358073	11.7438344725403	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTAACTGTACTCCCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1660.20956838275	34.6446547032726	0.0208676394613366	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1655.62707312498	1655.62707312498
"healthy-5"	"2019-08-29-count-1:CTTCTCTGTTTCGATG"	6.81882776793782	-1.46478238022002	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTCTGTTTCGATG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2344.31941739772	34.6727184549093	0.0147900999316029	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2335.92509680414	2335.92509680414
"healthy-5"	"2019-08-29-count-1:TCTAACTTCTTCCAGC"	2.89965643462483	-7.53085186397704	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTAACTTCTTCCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1961.86312376661	40.5842691367727	0.0206865956371382	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1955.98984263595	1955.98984263595
"healthy-5"	"2019-08-29-count-1:TCTACATAGGAGCTGT"	3.27460350570027	-8.37964632427367	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACATAGGAGCTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1587.8349920359	44.2300734806392	0.0278555855630365	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1587.8349920359	1587.8349920359
"healthy-5"	"2019-08-29-count-2:TAGACTGCACCCTGAG"	3.71689881858174	-8.01640703594359	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGACTGCACCCTGAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1957.07641917611	40.6422969551758	0.0207668420900424	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1957.07641917611	1957.07641917611
"healthy-5"	"2019-08-29-count-1:TCTACATGTCGAAACG"	-2.2622152370518	4.22497031772462	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACATGTCGAAACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3211.44419187471	43.7286015871479	0.0136164912028631	4097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3205.34997822627	3205.34997822627
"healthy-5"	"2019-08-29-count-1:GGAGGTAAGGAGGTTC"	3.98366536673848	-8.19297220623168	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTAAGGAGGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1604.17766476689	54.6685133136799	0.0340788395913891	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1604.17766476689	1604.17766476689
"healthy-5"	"2019-08-29-count-1:CTTGAGAGTCTGTGAT"	-2.33901081505473	11.070340133551	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTGAGAGTCTGTGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1441.12076423132	39.8186289253889	0.0276303207293163	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1438.7327761307	1438.7327761307
"healthy-5"	"2019-08-29-count-1:GGAGGTACAACTGTGT"	2.70946397361104	-4.53414347088011	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTACAACTGTGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2318.40546095428	39.2952641903169	0.0169492631259342	1409	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2317.14054979223	2317.14054979223
"healthy-5"	"2019-08-29-count-2:TGAGTCACACAGTCAT"	-3.80725107613261	12.4223270186218	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGTCACACAGTCAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1580.81443822296	44.5655783801692	0.0281915304558242	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1578.56530520907	1578.56530520907
"healthy-5"	"2019-08-29-count-1:TCTACCGAGGGAGGGT"	3.14009179648702	-7.53252603923949	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACCGAGGGAGGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.54824519457	46.806399319096	0.0296703441315819	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1564.38701276081	1564.38701276081
"healthy-5"	"2019-08-29-count-1:TCTACCGAGTGACACG"	-3.12660799446757	3.63100788677064	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACCGAGTGACACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2973.31091117898	42.9532859831271	0.014446281356461	2960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2967.96560317321	2967.96560317321
"healthy-5"	"2019-08-29-count-2:CTCGAGGGTTTCGCTC"	-3.91952882233318	-5.41307451641234	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCGAGGGTTTCGCTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2403.81474181736	50.0464937626599	0.0208196134635663	1307	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2402.20836631716	2402.20836631716
"healthy-5"	"2019-08-29-count-1:TCTACCGCATCACGGC"	-1.3582058948582	10.0314445265564	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACCGCATCACGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1603.41995183161	39.8144300376384	0.0248309433795918	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1601.11253922424	1601.11253922424
"healthy-5"	"2019-08-29-count-1:ATTTCACAGTCCCAGC"	3.69671310958211	-8.37392904674681	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCACAGTCCCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1783.2802554312	47.3147440830047	0.0265324218887646	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1783.2802554312	1783.2802554312
"healthy-5"	"2019-08-29-count-1:GGATCTAAGTAACCGG"	2.6832124191219	-8.40393736278685	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGATCTAAGTAACCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1596.96333142811	50.9555511837089	0.0319077778311547	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1594.67156451984	1594.67156451984
"healthy-5"	"2019-08-29-count-1:ATTTCACGTACTGTTG"	-0.758072893053848	10.0340108641419	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCACGTACTGTTG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1498.86118033819	42.5405969914614	0.028381945939692	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1494.34491672994	1494.34491672994
"healthy-5"	"2019-08-29-count-2:GAAGGACAGCTTTCCC"	-7.22009931030925	4.1209244498047	"2019-08-29-count-2"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGACAGCTTTCCC"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2104.93673556337	46.1959322566316	0.0219464706355023	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2096.36490398496	2096.36490398496
"healthy-5"	"2019-08-29-count-2:ACTATTCGTTGTGCCG"	5.23720039901082	-10.0939989320007	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATTCGTTGTGCCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1998.00661420803	41.9880020367565	0.0210149464662307	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1996.1843439157	1996.1843439157
"healthy-5"	"2019-08-29-count-1:CTTTCAACAGCTCCTT"	0.573363860219163	8.29413793170778	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTTCAACAGCTCCTT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1604.07015786393	40.7219941513286	0.0253866665068792	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1595.50222781786	1595.50222781786
"healthy-5"	"2019-08-29-count-1:TAAGTCGGTATCGTTG"	-2.82280812683757	12.4157762297424	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGTCGGTATCGTTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1452.20566388319	44.5255000461936	0.0306606021127425	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1446.95016361598	1446.95016361598
"healthy-5"	"2019-08-29-count-2:TGATCTTCACGACCTG"	-3.12482963028606	10.9921540983948	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATCTTCACGACCTG"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1925.29096412855	36.9165986013085	0.0191745555810148	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1920.03585103276	1920.03585103276
"healthy-5"	"2019-08-29-count-1:TCTATACAGTCCCTAA"	-2.27828989449199	10.2669496306214	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATACAGTCCCTAA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1910.84952827604	40.6540152833511	0.021275361917183	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1908.765912769	1908.765912769
"healthy-5"	"2019-08-29-count-2:ACTCCCAGTCATATGC"	3.10746469077412	-6.83739378368529	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTCCCAGTCATATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1768.11468191416	51.7224578826312	0.0292528863719612	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1763.95859441136	1763.95859441136
"healthy-5"	"2019-08-29-count-1:TAAGTCGGTTGAGTCT"	4.06229462203328	-8.00451853191527	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAAGTCGGTTGAGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1622.57916924079	44.8423471338004	0.0276364617418219	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1622.57916924079	1622.57916924079
"healthy-5"	"2019-08-29-count-1:TCCACGTAGATGGTCG"	-3.5386041206425	12.5245389708313	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTAGATGGTCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1452.46145368502	46.5787682751959	0.032068849852794	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1444.71232703416	1444.71232703416
"healthy-5"	"2019-08-29-count-1:CTTTCGGCAAAGGGTC"	-3.30481825295146	3.42468760097352	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTTCGGCAAAGGGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3033.30169859476	47.238263046735	0.0155732161652826	3223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3026.51436072109	3026.51436072109
"healthy-5"	"2019-08-29-count-2:ACTCCCAGTTGCTTGA"	2.85180606421773	-6.48650648510131	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTCCCAGTTGCTTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2015.74514492954	46.7750704466558	0.0232048533339222	959	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2011.46761300031	2011.46761300031
"healthy-5"	"2019-08-29-count-1:GGATGTTTCGGCTGTG"	2.6271923976833	-4.65706016933592	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGATGTTTCGGCTGTG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2209.98296804866	38.1424721325847	0.0172591701764395	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2205.75317777889	2205.75317777889
"healthy-5"	"2019-08-29-count-2:GAAGGGTGTGGCTCTG"	4.37988724288289	-7.78410627758177	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGGTGTGGCTCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.66041237682	48.4222358390649	0.0261507107433968	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1849.60163077411	1849.60163077411
"healthy-5"	"2019-08-29-count-1:TAATCTCCAATAAGGT"	4.00349487838094	-8.27029802715453	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAATCTCCAATAAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.8430281573	41.120992199258	0.0214524567714803	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1914.81058537235	1914.81058537235
"healthy-5"	"2019-08-29-count-2:GAAGGGTTCACCGGGT"	2.04409923133199	-7.10676386272582	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGGTTCACCGGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1758.37401305069	50.5461930326935	0.028745985016577	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1756.2901907746	1756.2901907746
"healthy-5"	"2019-08-29-count-2:ACTCCCATCGACCAAT"	-5.41542897644694	-5.67766191875609	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTCCCATCGACCAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2219.13940945008	49.5957667204365	0.0223490991639532	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2212.92046629079	2212.92046629079
"healthy-5"	"2019-08-29-count-1:GAAACCTCATAATGAG"	-2.37117753449138	10.2859124907288	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAACCTCATAATGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1622.35021140882	37.3438960317198	0.0230183937901367	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1617.73585515877	1617.73585515877
"healthy-5"	"2019-08-29-count-1:CCTCTCCCAACGATTC"	-4.05739007416423	13.1800136336121	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTCCCAACGATTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1888.85106900998	29.0362524888774	0.0153724414620452	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1881.96408860517	1881.96408860517
"healthy-5"	"2019-08-29-count-2:TCGGATACAAGAGTGC"	-2.31004677239116	9.2671909102234	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGATACAAGAGTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1430.61600240221	35.3033232970021	0.0246770085317952	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1430.61600240221	1430.61600240221
"healthy-5"	"2019-08-29-count-1:GAAATGAAGGTAAAGG"	3.66203703460042	-8.18031790172728	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAATGAAGGTAAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1709.80782805541	47.1313262878879	0.0275652769361169	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1709.80782805541	1709.80782805541
"healthy-5"	"2019-08-29-count-2:GAAGTAAAGATCCCGC"	-2.96184645119365	3.61557695949403	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGTAAAGATCCCGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2905.51729569743	43.8201461862838	0.0150817020608254	3220	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2898.14552035134	2898.14552035134
"healthy-5"	"2019-08-29-count-2:TGATGGTTCCTGCCAT"	-2.53189073029216	10.7495355376038	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGGTTCCTGCCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1563.85216669207	35.4432318361562	0.0226640552035857	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1559.18251807455	1559.18251807455
"healthy-5"	"2019-08-29-count-1:CTCCTTTTCAGAGTGG"	-2.57103238526042	3.51097605312196	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCTTTTCAGAGTGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2991.15396999547	43.8906715500344	0.0146734912312458	3252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2987.68868793405	2987.68868793405
"healthy-5"	"2019-08-29-count-2:GGGCCATTCCATTGTT"	-3.57341251793559	12.759962058905	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCCATTCCATTGTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1695.56530226656	36.1067050052881	0.0212947887981797	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1688.58578999585	1688.58578999585
"healthy-5"	"2019-08-29-count-1:CCTCTCCGTGCCTACG"	4.07360949096028	-7.8787207833496	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTCCGTGCCTACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.8201320431	40.5044421338034	0.0174601649387923	1280	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2319.8201320431	2319.8201320431
"healthy-5"	"2019-08-29-count-1:CCTCTCCTCACGATCA"	3.27113189276997	-6.31524088298949	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTCCTCACGATCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2265.5443861185	38.663508419186	0.0170658799077547	1254	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2260.04472288016	2260.04472288016
"healthy-5"	"2019-08-29-count-2:TAGCACATCGGAGTGA"	-4.03627572479899	-5.38997366344603	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGCACATCGGAGTGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2453.90933953651	43.8221021785399	0.0178580770986499	1399	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2448.15403300439	2448.15403300439
"healthy-5"	"2019-08-29-count-1:TAATTCCGTCCGGTCA"	-1.02036366882976	9.14664743030397	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAATTCCGTCCGGTCA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1439.96192407792	44.1037030504841	0.0306283814266311	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1437.37737634041	1437.37737634041
"healthy-5"	"2019-08-29-count-2:TGATTCTTCCTAAGTG"	-2.43349156799968	3.93771884525148	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATTCTTCCTAAGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3317.47776138107	42.6539209302747	0.0128573343962727	4099	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3310.51656167726	3310.51656167726
"healthy-5"	"2019-08-29-count-2:ACTGATGGTTTGCAGT"	-3.14771233025249	10.2693443068298	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTGATGGTTTGCAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1546.06265959666	37.2774961792166	0.0241112453934705	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1543.7872592339	1543.7872592339
"healthy-5"	"2019-08-29-count-2:ACTGATGTCTGGAGAG"	-2.33881817284282	3.54610583865968	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTGATGTCTGGAGAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2671.95976998219	41.8838085998665	0.0156753140786044	2314	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2667.48739885897	2667.48739885897
"healthy-5"	"2019-08-29-count-2:TGATTTCAGAAACCCG"	-3.5916636985844	11.0314330824646	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATTTCAGAAACCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1646.21068911549	37.7132671949447	0.0229091375996399	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1643.86706153829	1643.86706153829
"healthy-5"	"2019-08-29-count-1:CAACAGTCAGTTGCGC"	-2.16377649727519	9.28051755512086	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACAGTCAGTTGCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1628.28494169542	42.8848554028838	0.0263374390468973	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1626.17023416058	1626.17023416058
"healthy-5"	"2019-08-29-count-1:CAACAGTGTATCGTAC"	3.57733192023579	-8.09002306377562	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACAGTGTATCGTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1898.71917793765	38.6360481551432	0.0203484794402872	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1892.71136680741	1892.71136680741
"healthy-5"	"2019-08-29-count-1:TAATTCCTCACCCTCA"	10.9578710990841	5.96821782672731	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAATTCCTCACCCTCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1664.82963029016	42.2230141322941	0.0253617627678426	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1662.64917908344	1662.64917908344
"healthy-5"	"2019-08-29-count-2:ACTGCAACAAGTATCC"	-1.49316749993022	9.30193040454713	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTGCAACAAGTATCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1477.68439129245	47.9816603427478	0.032470844671223	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1475.36723891317	1475.36723891317
"healthy-5"	"2019-08-29-count-1:CTCTCAGAGGGAGGGT"	3.65656318244283	-8.35595705425414	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCTCAGAGGGAGGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1649.12453608296	50.2777785472253	0.0304875571535952	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1649.12453608296	1649.12453608296
"healthy-5"	"2019-08-29-count-2:GAATCACAGGTGCATG"	-4.30921254578288	-4.49618008052977	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAATCACAGGTGCATG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2146.36805819453	29.3554665308126	0.0136768092586626	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2144.50801142552	2144.50801142552
"healthy-5"	"2019-08-29-count-1:AGACAGGTCGACATAC"	-3.73321400108989	3.61417601192323	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAGGTCGACATAC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2874.69110480425	45.5159880400031	0.0158333491775641	2679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2869.44346404616	2869.44346404616
"healthy-5"	"2019-08-29-count-1:TCTCCGACAGCAATTC"	1.71258964118306	-6.19988253032836	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCCGACAGCAATTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2260.77505843628	45.8803057912609	0.020294060490474	1141	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2255.62590427254	2255.62590427254
"healthy-5"	"2019-08-29-count-1:CCTGTTGTCCAAGCCG"	-3.74096975746806	12.6093759306702	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTGTTGTCCAAGCCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1687.27697278043	37.2877130435613	0.0220993432880884	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1682.42296566243	1682.42296566243
"healthy-5"	"2019-08-29-count-1:TACAACGGTAATACCC"	3.09001245078389	-7.98701383983763	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACAACGGTAATACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.90419706154	48.1604580335592	0.0282813666891319	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1702.90419706154	1702.90419706154
"healthy-5"	"2019-08-29-count-1:CAACCTCCAGCCTTCT"	1.26783158358876	8.9731464155945	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACCTCCAGCCTTCT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1484.01338873654	38.720398298278	0.0260916771992494	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1481.91057963396	1481.91057963396
"healthy-5"	"2019-08-29-count-2:TAGGGTTTCGCGTTTC"	-2.75207410278972	10.3867788084778	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGGGTTTCGCGTTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1508.67886309034	40.7450037198185	0.0270070753403129	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1504.13049286852	1504.13049286852
"healthy-5"	"2019-08-29-count-2:ATCACGATCCGCGAGT"	-1.63420532169994	3.85541436755983	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACGATCCGCGAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2842.10293926323	44.1707599275276	0.0155415763860327	3195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2835.42725782197	2835.42725782197
"healthy-5"	"2019-08-29-count-2:ATCACGATCTGTGTGA"	-3.96147523346599	10.6708345183167	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCACGATCTGTGTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2204.32617212818	37.0232051921161	0.0167957018612957	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2199.08599317213	2199.08599317213
"healthy-5"	"2019-08-29-count-2:GGGCTCATCTGTGCAA"	-1.99249277535136	10.8800964125427	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCTCATCTGTGCAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1386.76131985336	39.4123971096519	0.0284204617949825	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1384.30422345959	1384.30422345959
"healthy-5"	"2019-08-29-count-1:AGACCCGAGGATGCGT"	3.67713465270345	-7.04531910335692	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACCCGAGGATGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1931.27354751248	42.1565655597977	0.0218283762101419	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1925.46212644996	1925.46212644996
"healthy-5"	"2019-08-29-count-1:ACCGTTCAGGCAGTCA"	5.35122742232625	-9.987256073114	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCGTTCAGGCAGTCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.80710423644	39.9580816550818	0.0190930552434552	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2091.27516635574	2091.27516635574
"healthy-5"	"2019-08-29-count-1:GAACTGTTCCGATGCG"	-3.41641388359721	12.4811935194763	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAACTGTTCCGATGCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1525.54895062113	40.4670285473891	0.0265262078485996	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1518.32531838881	1518.32531838881
"healthy-5"	"2019-08-29-count-1:GGCTTTCGTCGTCAGC"	3.77141322669331	-8.17325594341429	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTTTCGTCGTCAGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1703.83908752676	43.501325621992	0.0255313579436291	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1696.99028864646	1696.99028864646
"healthy-5"	"2019-08-29-count-2:TGCAGGCCAAACTGCT"	14.0618168312008	1.73202726924745	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCAGGCCAAACTGCT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1152.22936919196	32.6397960060744	0.028327516099476	854	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1145.56034831359	1145.56034831359
"healthy-5"	"2019-08-29-count-1:TATTGCTCACCTGAAT"	-2.25575743141826	10.3084392317566	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTCACCTGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.59342479047	42.4175568378153	0.0253451980687161	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1673.59342479047	1673.59342479047
"healthy-5"	"2019-08-29-count-2:TTCTTGATCCTCCACA"	-0.0360148501699746	8.90696618640748	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTTGATCCTCCACA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1567.85884034449	50.2216721109281	0.0320320113128891	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1560.84915215495	1560.84915215495
"healthy-5"	"2019-08-29-count-1:GAAGAATGTGTTAACC"	-2.36333690109904	4.15408465946046	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGAATGTGTTAACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3309.77717315857	43.2786310889311	0.0130759953993005	4311	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3301.65685598384	3301.65685598384
"healthy-5"	"2019-08-29-count-2:TAGGTTGTCAGGAACG"	2.97954954680745	-7.96756555950316	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGGTTGTCAGGAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1864.40589130873	40.3025565579396	0.0216168360901547	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1858.36936096873	1858.36936096873
"healthy-5"	"2019-08-29-count-2:GACACGCAGGTCGCCT"	-3.90333733978923	13.0784396895203	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACACGCAGGTCGCCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1721.79125434004	36.5487034969795	0.0212271397039873	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1721.79125434004	1721.79125434004
"healthy-5"	"2019-08-29-count-1:GGGAAGTGTGAGCTCC"	4.17189421233479	-7.20263674175414	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGAAGTGTGAGCTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.56017244562	39.2396681104193	0.0171235600017178	1197	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2291.56017244562	2291.56017244562
"healthy-5"	"2019-08-29-count-1:AGACTCATCATTTCGT"	4.51297583159749	-8.20691015636595	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACTCATCATTTCGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2584.86333134355	38.2445533140005	0.0147955804278913	1650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2582.3867731146	2582.3867731146
"healthy-5"	"2019-08-29-count-1:TCTGCCACACAGAGAC"	-0.417924235493499	10.437735534552	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGCCACACAGAGAC"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1618.24922905438	43.0282175765405	0.0265893638655919	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1604.51793262256	1604.51793262256
"healthy-5"	"2019-08-29-count-1:TACAGGTCATTCGATG"	4.59018339690511	-7.69672062313231	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACAGGTCATTCGATG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2437.54622296485	42.5901174946687	0.017472537379359	1426	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2432.12550610054	2432.12550610054
"healthy-5"	"2019-08-29-count-1:CCTTGTGTCATTTGTC"	-2.26834140244182	3.39876768672792	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTGTGTCATTTGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3141.83844337029	47.6008120075721	0.0151506237082356	2900	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3134.29780226369	3134.29780226369
"healthy-5"	"2019-08-29-count-2:GACACGCGTTCACGAT"	3.91755427893941	-7.41934063350829	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACACGCGTTCACGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2143.85706729653	42.2407364778775	0.0197031495813032	1062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2136.81443964333	2136.81443964333
"healthy-5"	"2019-08-29-count-2:TCGGTCTTCCTAACAG"	0.299750243395013	8.7543153532776	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGTCTTCCTAACAG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1487.70734151937	40.6161928690328	0.027301198115721	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1481.00268085822	1481.00268085822
"healthy-5"	"2019-08-29-count-2:GCTACCTCAGGCAATG"	5.35223927077596	-9.94166853344115	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTACCTCAGGCAATG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2559.65107134217	38.8879074612837	0.0151926596154735	1588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2553.17019199067	2553.17019199067
"healthy-5"	"2019-08-29-count-1:GGGACAAGTATAGGGC"	-3.79528985443767	12.6508693465027	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACAAGTATAGGGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1552.31924510363	41.7998418038382	0.0269273488270435	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1550.15684558715	1550.15684558715
"healthy-5"	"2019-08-29-count-2:TTGACCCTCTCTGCTG"	4.09077372130696	-7.08853247081908	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGACCCTCTCTGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2343.47691864211	41.8600318053292	0.0178623614648547	1267	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2341.91093541452	2341.91093541452
"healthy-5"	"2019-08-29-count-2:TCGTAGAGTTTACGAC"	-3.3072694343632	-5.31760313427123	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGTAGAGTTTACGAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2113.4762360768	51.1428636426244	0.0241984569164401	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2110.24143901227	2110.24143901227
"healthy-5"	"2019-08-29-count-1:ATCTTCACAGGATTCT"	5.18814720687215	-10.1697006455627	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCTTCACAGGATTCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1663.73814896471	46.6736877060321	0.0280535057365101	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1654.67349702137	1654.67349702137
"healthy-5"	"2019-08-29-count-1:CCATAAGTCTGGAAGG"	4.19678368148152	-7.92888786708983	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATAAGTCTGGAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1653.79758087634	42.2276729608382	0.0255337614766989	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1653.79758087634	1653.79758087634
"healthy-5"	"2019-08-29-count-2:TGCATCCTCCTGTAAG"	-0.438015679747421	10.4305724867615	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATCCTCCTGTAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1460.6735840662	39.4245269984822	0.0269906483067442	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1458.19300272175	1458.19300272175
"healthy-5"	"2019-08-29-count-2:TCATTACCAGTCGCAC"	3.87107266959493	-8.13779833233031	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTACCAGTCGCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.91951700701	44.1442051988802	0.0214822063995851	976	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2051.34431265893	2051.34431265893
"healthy-5"	"2019-08-29-count-1:AAGTCGTCACGTCATA"	-2.95338569107707	3.82370445812074	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGTCGTCACGTCATA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3281.33295876042	46.5728195048297	0.0141932623388586	3810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3273.99596215368	3273.99596215368
"healthy-5"	"2019-08-29-count-2:TGCATGAAGCATGTTC"	5.23706593093221	-9.77757837688597	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATGAAGCATGTTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2384.31267075174	34.6264017782405	0.0145225926964198	1385	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2377.41990048066	2377.41990048066
"healthy-5"	"2019-08-29-count-2:TGCATGACAGTTTCGA"	-4.33479199829753	-4.41957285320433	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATGACAGTTTCGA"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2360.44750412137	36.0053092836407	0.0152535945920318	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2355.7076782691	2355.7076782691
"healthy-5"	"2019-08-29-count-2:TTGATGGCACACCGAC"	10.9385620551998	5.74966952884523	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGATGGCACACCGAC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1900.16506755197	47.9545583404267	0.0252370486960945	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1894.75402781887	1894.75402781887
"healthy-5"	"2019-08-29-count-2:GGGTGAATCTCGAACA"	14.334845204919	1.93764207446901	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTGAATCTCGAACA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1570.57000101924	33.316448973527	0.0212129665993276	1121	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1556.35214328572	1556.35214328572
"healthy-5"	"2019-08-29-count-1:CGAAGGACAACGAGGT"	4.7700945335323	-7.7926964989868	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAAGGACAACGAGGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1967.34590931196	42.1708498121283	0.0214354016812817	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1961.8641141068	1961.8641141068
"healthy-5"	"2019-08-29-count-2:TATATCCGTAGTTACC"	0.783689876168412	9.33091924274293	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATATCCGTAGTTACC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1370.62045264992	45.7695525288633	0.033393309169124	503	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1370.62045264992	1370.62045264992
"healthy-5"	"2019-08-29-count-1:TCTTAGTAGCGTTAGG"	-3.81657586517985	12.5941457518372	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTAGTAGCGTTAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1869.83725815754	38.4531679115783	0.0205649811200514	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1862.91999749461	1862.91999749461
"healthy-5"	"2019-08-29-count-1:GTGGCGTTCGTGTGGC"	-3.27214847031291	11.2325143584046	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGCGTTCGTGTGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1412.06381241916	44.4342154249239	0.0314675689824519	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1412.06381241916	1412.06381241916
"healthy-5"	"2019-08-29-count-2:ATCCCTGTCCGCAAAT"	3.64075984534566	-7.57107593929442	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCCTGTCCGCAAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2052.31542968688	40.7684086892684	0.0198645920113208	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2050.45765954629	2050.45765954629
"healthy-5"	"2019-08-29-count-1:TCTTAGTTCCAGCACG"	2.20321478423421	-6.96217777645262	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTAGTTCCAGCACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.63118237693	50.0822169923612	0.0256748776728432	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1950.63118237693	1950.63118237693
"healthy-5"	"2019-08-29-count-1:GGGACTCTCAATCCAG"	-5.21140990677531	-5.10668899929198	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACTCTCAATCCAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2677.44180531234	51.341884377486	0.0191757237358504	1726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2672.47897356214	2672.47897356214
"healthy-5"	"2019-08-29-count-1:CGAAGGAGTCATACCA"	4.2723032432491	-8.9106130830017	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAAGGAGTCATACCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.84332737351	45.4445718254342	0.02212660100201	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2049.18239036902	2049.18239036902
"healthy-5"	"2019-08-29-count-1:CGAAGGAGTCATTCCC"	3.65884365615193	-7.31656029140624	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAAGGAGTCATTCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.98607040505	42.1538936884566	0.0194797435459306	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2162.29995560829	2162.29995560829
"healthy-5"	"2019-08-29-count-1:AAACCCAAGCCATTGT"	2.66168489035909	-4.5023198357788	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACCCAAGCCATTGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2565.36416522748	43.4027507775105	0.0169187483655608	1592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2560.14048532705	2560.14048532705
"healthy-5"	"2019-08-29-count-2:ACTTTGTCATATGGCT"	-3.4573372406071	11.7631721266541	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTTTGTCATATGGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1504.82075081365	38.4382309064755	0.0255433950426933	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1500.21086873899	1500.21086873899
"healthy-5"	"2019-08-29-count-2:GGGTTATTCCTTGGAA"	-3.41046200218852	12.6579723128113	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTTATTCCTTGGAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1569.56999157514	29.9602765478776	0.0190882067755456	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1569.56999157514	1569.56999157514
"healthy-5"	"2019-08-29-count-2:TGTTGGATCATTCACT"	10.1970306831295	6.60164926135866	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTGGATCATTCACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1550.23694985523	37.4115447813437	0.0241327913031859	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1547.92841881171	1547.92841881171
"healthy-5"	"2019-08-29-count-1:AGATCCACACGGGTAA"	0.813764174550217	8.67067048633424	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCCACACGGGTAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1466.67979268353	38.4298950121871	0.0262019666486802	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1459.882069666	1459.882069666
"healthy-5"	"2019-08-29-count-1:TCCGGGACAGAGGGTT"	1.99387635764424	-6.48502352153929	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGGGACAGAGGGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1977.96472734565	48.7765660246747	0.0246599776782323	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1977.96472734565	1977.96472734565
"healthy-5"	"2019-08-29-count-1:GAAGTAAAGTAAACTG"	4.05451740798299	-6.13049223339232	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGTAAAGTAAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1677.9319614632	48.3251070081869	0.0288003972259079	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1673.77287857088	1673.77287857088
"healthy-5"	"2019-08-29-count-2:AGGGCTCAGTGAGTGC"	5.31171478804891	-9.70116140758666	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGCTCAGTGAGTGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.50334053636	47.7647925331021	0.0244884443622473	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1944.97729075848	1944.97729075848
"healthy-5"	"2019-08-29-count-1:ACGATGTGTGGGCTCT"	3.0130111175472	-5.26719047939452	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGATGTGTGGGCTCT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2368.53525764091	39.5331689806509	0.0166909776213449	1321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2361.27779744054	2361.27779744054
"healthy-5"	"2019-08-29-count-1:GAAGTAAGTAGATTGA"	3.00217928466145	-7.65609552776488	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGTAAGTAGATTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1862.90377112829	46.7774699175357	0.0251099765014724	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1862.90377112829	1862.90377112829
"healthy-5"	"2019-08-29-count-2:CAACAACAGCACAAAT"	3.19858398017232	-7.97722437297972	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACAACAGCACAAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.60303633322	42.8999422856018	0.0249766339358515	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1713.41676797888	1713.41676797888
"healthy-5"	"2019-08-29-count-2:CAACAACCAGTATACC"	-3.50359998169597	11.3017301329407	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACAACCAGTATACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1606.78531109398	29.6374410986069	0.0184451780172351	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1604.54397896703	1604.54397896703
"healthy-5"	"2019-08-29-count-2:AGAAATGCACACACTA"	3.69617261466328	-8.36863424694213	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAAATGCACACACTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1626.34114391788	50.5299901986106	0.0310697361298277	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1623.94019346728	1623.94019346728
"healthy-5"	"2019-08-29-count-2:GGGTTTATCCCTGGTT"	2.63086213645284	-7.03679134761962	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTTTATCCCTGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.53658581124	40.0031114932441	0.0238037730514111	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1676.68252774068	1676.68252774068
"healthy-5"	"2019-08-29-count-1:TCTTGCGTCGCTGATA"	-5.51301036301311	-5.58436825191649	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTGCGTCGCTGATA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2105.60712583909	51.6641874324505	0.0245364801431617	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2101.81418661446	2101.81418661446
"healthy-5"	"2019-08-29-count-1:AGATGAAAGCAAGGAA"	-4.08783898773845	9.23207089984743	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAAAGCAAGGAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2322.77368885801	38.7504264224226	0.0166828247660555	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2319.58944454749	2319.58944454749
"healthy-5"	"2019-08-29-count-1:AAACGCTAGGTGGTTG"	5.42928232726399	-9.94933607494506	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGCTAGGTGGTTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.74043047535	40.8930038089812	0.0183645131014447	1178	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2223.53618107838	2223.53618107838
"healthy-5"	"2019-08-29-count-2:AGAACAAAGTGTCATC"	3.502369304269	-8.04223825847777	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAACAAAGTGTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1685.97571131093	46.6547123822538	0.0276722328022018	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1684.20270331465	1684.20270331465
"healthy-5"	"2019-08-29-count-1:TCTTTGACATTCATCT"	-2.20096502724345	9.25332448566285	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTTGACATTCATCT"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1734.80553874963	35.1573760112663	0.0202658887269902	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1730.43319681307	1730.43319681307
"healthy-5"	"2019-08-29-count-1:GAATAGAAGCTGTTAC"	-2.96617756310161	13.349486328009	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATAGAAGCTGTTAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1596.66228875164	37.9230623979469	0.0237514611982207	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1594.26985281626	1594.26985281626
"healthy-5"	"2019-08-29-count-2:CAACCAAAGACATCAA"	-2.92226729813274	3.37734363162843	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACCAAAGACATCAA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3091.72683591193	48.9788007412061	0.0158418913897222	3572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3083.68651341444	3083.68651341444
"healthy-5"	"2019-08-29-count-1:AGATGAACAATAGAGT"	3.19505514678304	-7.80672123348387	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAACAATAGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1592.89932015424	48.3292748187549	0.0303404453798594	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1588.49617831767	1588.49617831767
"healthy-5"	"2019-08-29-count-1:CGACAGCGTTCTTAGG"	2.07958116111104	-7.67312529003295	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGACAGCGTTCTTAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1451.93768179813	47.1118233195626	0.0324475519233151	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1451.93768179813	1451.93768179813
"healthy-5"	"2019-08-29-count-1:TGAACGTAGGGTGAAA"	-4.27359900894816	-5.32258465206298	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAACGTAGGGTGAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2263.59810475105	49.8941042006024	0.0220419446790842	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2258.86819156577	2258.86819156577
"healthy-5"	"2019-08-29-count-1:CGAGAAGTCAAGTCGT"	-1.76881204071696	9.39997193897096	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGAAGTCAAGTCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1477.00285665114	41.4152979953107	0.0280400933612364	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1469.54786772003	1469.54786772003
"healthy-5"	"2019-08-29-count-1:CGAGAAGTCCGTGGTG"	-3.49440966072734	10.4367007979187	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGAAGTCCGTGGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1611.14938935037	39.1634454722826	0.0243077679395537	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1611.14938935037	1611.14938935037
"healthy-5"	"2019-08-29-count-1:AAACGCTTCCTAACAG"	10.2416187721187	6.0786127814087	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGCTTCCTAACAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1448.03125429147	43.411644414487	0.0299797703163034	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1441.01469628361	1441.01469628361
"healthy-5"	"2019-08-29-count-2:TGCGGCAGTGCACATT"	2.90028037604634	-7.98001387035521	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCGGCAGTGCACATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1604.52425399462	45.6865603833973	0.028473586653275	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1599.8548785055	1599.8548785055
"healthy-5"	"2019-08-29-count-1:AGATGAATCGGAACTT"	3.74825181540791	-8.09971907055052	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAATCGGAACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1707.59018634069	36.5040011012325	0.0213774952522182	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1707.59018634069	1707.59018634069
"healthy-5"	"2019-08-29-count-1:TGAACGTTCTAAGAAG"	-5.85856662216838	-4.8454914323059	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAACGTTCTAAGAAG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2719.62713535422	47.6727032357893	0.0175291320696358	1837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2715.03450080114	2715.03450080114
"healthy-5"	"2019-08-29-count-2:CAACCTCCAACAAGTA"	8.46329273757283	6.89842174136964	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACCTCCAACAAGTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1442.387265817	41.1820205434926	0.0285512923744277	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1439.93883289504	1439.93883289504
"healthy-5"	"2019-08-29-count-1:TGAATCGAGGGACACT"	3.81122221526448	-7.52932312404784	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAATCGAGGGACACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2009.97678084107	42.4919509361757	0.0211405183090698	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2006.39346633577	2006.39346633577
"healthy-5"	"2019-08-29-count-1:TGAATCGCATGATGCT"	5.55874886092488	-9.63946821605834	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAATCGCATGATGCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.89913005472	43.3339695974939	0.0198243226330435	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2179.24048012826	2179.24048012826
"healthy-5"	"2019-08-29-count-2:TGCGGGTCAGTTCTAG"	3.48967327651326	-8.01098635112914	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCGGGTCAGTTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.10402558782	36.7726354927855	0.0233165567370102	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1574.69783971786	1574.69783971786
"healthy-5"	"2019-08-29-count-2:AGAAGCGCAGAACTTC"	-7.95327601853068	1.15200862968294	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAAGCGCAGAACTTC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2590.22509207786	42.5278070850123	0.0164185758276694	2065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2580.70328747436	2580.70328747436
"healthy-5"	"2019-08-29-count-2:AGAAGCGGTATTTCCT"	2.60177769240682	-7.02904989635619	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAAGCGGTATTTCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.56850630605	40.2959995356495	0.0217045583821871	789	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.34957481266	1852.34957481266
"healthy-5"	"2019-08-29-count-2:CAACGATGTCTTACTT"	-3.06959591332133	10.90722081745	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACGATGTCTTACTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.66640643568	36.6897325420744	0.022513645981278	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1629.66640643568	1629.66640643568
"healthy-5"	"2019-08-29-count-1:TACGGGCAGCCTATCA"	-2.04467330399211	9.90727994525758	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGGCAGCCTATCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1697.87595718921	36.3883758012138	0.0214317045053479	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1692.26835576829	1692.26835576829
"healthy-5"	"2019-08-29-count-1:TGAATGCAGAACAGGA"	4.52878059920613	-8.62283041393431	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAATGCAGAACAGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2118.26610718166	40.4664858901112	0.0191035893710029	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2113.96060311618	2113.96060311618
"healthy-5"	"2019-08-29-count-1:GAATCGTAGTCGCCAC"	-3.68439469757732	10.7905740507874	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAATCGTAGTCGCCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1543.35620119475	41.0450407390956	0.0265946647360613	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1539.04612075104	1539.04612075104
"healthy-5"	"2019-08-29-count-1:AGCATCACATTCGATG"	4.43660320815389	-7.39792539989623	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCATCACATTCGATG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.59398972501	42.3658640281666	0.0179623386698726	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2351.9286528108	2351.9286528108
"healthy-5"	"2019-08-29-count-1:TGAATGCTCGTGGACC"	6.80274643477742	-1.6619798175064	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAATGCTCGTGGACC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2241.46694098199	33.4096367387968	0.014905255182644	1087	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2237.8818995799	2237.8818995799
"healthy-5"	"2019-08-29-count-2:CAACGGCCAATTGTGC"	4.2183333831722	-8.24093916332396	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACGGCCAATTGTGC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1993.40920059717	45.4255150063095	0.0227878525857618	935	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.15716947839	1984.15716947839
"healthy-5"	"2019-08-29-count-2:GGTCACGGTGTCTTGA"	2.89181341704671	-9.50194265758666	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTCACGGTGTCTTGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1663.9542795276	46.8435055447382	0.0281519186681242	670	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1659.47356361917	1659.47356361917
"healthy-5"	"2019-08-29-count-1:TGACAGTGTCCTCATC"	5.47182621535603	-9.96109106456908	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACAGTGTCCTCATC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2402.43298812025	39.4134036836047	0.0164056204183423	1362	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2399.46664801172	2399.46664801172
"healthy-5"	"2019-08-29-count-1:GACACGCCAAGCGAGT"	4.52612270888631	-7.41627123272093	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACACGCCAAGCGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2118.41090139136	42.0536040637496	0.0198514858642999	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2116.63073832818	2116.63073832818
"healthy-5"	"2019-08-29-count-2:TGCTCCAGTTGAAGTA"	0.184434552758378	8.20711705768434	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCCAGTTGAAGTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1615.94651359346	29.0060096568673	0.0179498575063386	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1613.87851815276	1613.87851815276
"healthy-5"	"2019-08-29-count-2:TAAGCACTCTTAGCCC"	-2.16365871849712	4.1714992293152	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCACTCTTAGCCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2943.42284457999	41.6263128757474	0.0141421450718159	2626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2933.37687552692	2933.37687552692
"healthy-5"	"2019-08-29-count-2:TTGGGCGAGTCACAGG"	4.03404202040975	-7.72963764583739	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGCGAGTCACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1971.95016295467	40.272861620936	0.020422859754525	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1967.96368142634	1967.96368142634
"healthy-5"	"2019-08-29-count-2:CGAGGCTTCAGCCTCT"	2.42004575309102	-6.87690546428832	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGGCTTCAGCCTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1586.91028250479	46.9579212260653	0.029590785152609	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1584.57265844036	1584.57265844036
"healthy-5"	"2019-08-29-count-2:GACGTTACATTCACAG"	-3.18946848335918	3.32588408077089	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACGTTACATTCACAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3082.02999780579	47.3405745087802	0.015360192646562	3375	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3075.81438277575	3075.81438277575
"healthy-5"	"2019-08-29-count-1:TGACCCTGTAGTCACT"	2.71596850928609	-7.20050098812255	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACCCTGTAGTCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1933.5783199106	48.7502890965815	0.0252124719203696	917	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1929.9214427865	1929.9214427865
"healthy-5"	"2019-08-29-count-1:TGACCCTGTCTCTCCA"	4.6594201522762	-8.44484999096068	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACCCTGTCTCTCCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2063.93015371451	40.8830132752563	0.0198083317895608	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2056.87856691875	2056.87856691875
"healthy-5"	"2019-08-29-count-1:AAAGGTAGTCGTTGCG"	1.73635115203206	-6.3171687356201	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGGTAGTCGTTGCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1922.88263264305	48.4390087741133	0.0251908296178913	883	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1920.94738328154	1920.94738328154
"healthy-5"	"2019-08-29-count-1:AGCCACGAGCCACTCG"	5.61783852156941	-10.1088819733826	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCACGAGCCACTCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2346.31738619266	39.6867087954827	0.0169144673389144	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2338.42034357462	2338.42034357462
"healthy-5"	"2019-08-29-count-2:CAAGACTCATCCGGTG"	3.94444455680196	-8.18241979992064	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAGACTCATCCGGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1837.04650986741	49.5052353855455	0.0269482754626167	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1830.98146307435	1830.98146307435
"healthy-5"	"2019-08-29-count-1:GGGCTCAGTTACAGCT"	4.99973978576009	-8.16162016307982	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCTCAGTTACAGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2182.23555542542	46.2156380458422	0.02117811614376	1193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2177.74020616399	2177.74020616399
"healthy-5"	"2019-08-29-count-2:TCTCAGCAGGAAAGAC"	-1.8601031107014	9.41815278613893	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCAGCAGGAAAGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1407.74297016375	45.6146263056832	0.0324026667313971	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1407.74297016375	1407.74297016375
"healthy-5"	"2019-08-29-count-2:TGCTGAAAGCAGATAT"	6.73887838897054	-1.55544593250426	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTGAAAGCAGATAT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2237.96395668491	34.9943396547766	0.0156366859931978	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2229.63389126238	2229.63389126238
"healthy-5"	"2019-08-29-count-2:GGTGAAGTCTAGACCA"	-3.49460802498515	12.364231086615	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGAAGTCTAGACCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1474.02482342587	39.1914899930324	0.0265880800446393	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1474.02482342587	1474.02482342587
"healthy-5"	"2019-08-29-count-2:CAAGAGGAGGATAATC"	3.02535309371297	-7.26094534313353	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAGAGGAGGATAATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1794.30765378494	41.7434494311371	0.0232643768436717	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1794.30765378494	1794.30765378494
"healthy-5"	"2019-08-29-count-1:TGACGCGTCTCCCTAG"	-2.42965445938762	3.70974538410035	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACGCGTCTCCCTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2912.40116304336	45.6931122753236	0.0156891546587544	3205	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2905.7223558915	2905.7223558915
"healthy-5"	"2019-08-29-count-2:GGTGATTCACTTCATT"	1.98127998885457	-6.92725231563719	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGATTCACTTCATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1606.33111712385	47.2793766979239	0.0294331450059798	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1606.33111712385	1606.33111712385
"healthy-5"	"2019-08-29-count-1:TACGTCCGTTAGGGTG"	-7.08824525299724	-0.170269571897112	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGTCCGTTAGGGTG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2526.13134120496	44.810210104611	0.0177386699470807	1925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2520.66290394918	2520.66290394918
"healthy-5"	"2019-08-29-count-2:GGTGATTGTCGAAACG"	6.78121532973592	-1.67573978817137	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGATTGTCGAAACG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2374.13884938463	29.7653715155806	0.0125373339151144	1203	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2365.47259226354	2365.47259226354
"healthy-5"	"2019-08-29-count-1:TGACTCCCAAGGCGTA"	4.79724564132039	-8.24644091045531	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACTCCCAAGGCGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2210.56777730797	43.5639035858731	0.0197071105591367	1195	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2207.5619285842	2207.5619285842
"healthy-5"	"2019-08-29-count-1:AGCCACGTCATCAGTG"	5.41083588179891	-10.0203209153381	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCACGTCATCAGTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2226.61435994458	42.8750162851459	0.0192556991711008	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2216.77342642141	2216.77342642141
"healthy-5"	"2019-08-29-count-1:AGCCAGCAGAACGTGC"	-4.49912820282634	11.5422830351624	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAGCAGAACGTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1864.88478617215	43.7160308072804	0.0234416791489901	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1858.17115000892	1858.17115000892
"healthy-5"	"2019-08-29-count-2:GGTGGCTAGGCACGAT"	3.55058660086934	-7.87816574489745	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGGCTAGGCACGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1575.85482105682	46.0937177113642	0.0292499772792853	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1571.30467319363	1571.30467319363
"healthy-5"	"2019-08-29-count-1:TCCTTCTGTCCACGCA"	4.40575613555257	-8.82151987468871	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTTCTGTCCACGCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2175.49933265577	37.1035889276448	0.0170552058420308	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2172.10715248289	2172.10715248289
"healthy-5"	"2019-08-29-count-1:CTGCTCACATGCCGCA"	4.2636681991512	-8.26023008739623	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGCTCACATGCCGCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2131.34491601457	42.4948511626477	0.0199380451485578	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2129.6137550396	2129.6137550396
"healthy-5"	"2019-08-29-count-1:CGATGCGCAGTTTGGT"	3.09141649779622	-7.47840740596923	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATGCGCAGTTTGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1574.3891945494	45.5411153307469	0.0289262118213286	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1560.60557971058	1560.60557971058
"healthy-5"	"2019-08-29-count-1:TGACTCCTCTCCGAAA"	3.59167279776875	-7.4937749139038	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACTCCTCTCCGAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1898.63076084895	47.9772322323058	0.0252693852968301	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1898.63076084895	1898.63076084895
"healthy-5"	"2019-08-29-count-1:AGCCAGCTCCGCTGTT"	5.11578478392903	-8.05924990093382	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAGCTCCGCTGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2267.80443060607	39.9831788514177	0.0176307878720972	1169	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2262.88694310783	2262.88694310783
"healthy-5"	"2019-08-29-count-1:AGCCAGCTCGACGTCG"	4.00142135199849	-7.67618276989134	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAGCTCGACGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.78224776094	48.4868583417081	0.02420975040892	938	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2002.78224776094	2002.78224776094
"healthy-5"	"2019-08-29-count-1:CGATGCGTCCAGTTCC"	-3.41820559921916	3.76344750011293	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATGCGTCCAGTTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2784.45415611914	46.3907003140758	0.0166606084040304	3034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2776.35476904185	2776.35476904185
"healthy-5"	"2019-08-29-count-2:GGTGTCGAGTAGGTTA"	2.79659785804097	-7.26173546230467	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGTCGAGTAGGTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1534.15465993653	44.8599928275752	0.0292408542626537	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1534.15465993653	1534.15465993653
"healthy-5"	"2019-08-29-count-1:AGCGATTCATGAAAGT"	-3.69650993767436	13.1158685454163	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGATTCATGAAAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1698.24785568822	32.6087515703781	0.0192014089469664	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1698.24785568822	1698.24785568822
"healthy-5"	"2019-08-29-count-1:TGAGACTGTCGTTATG"	3.79288138922994	-9.27951147472533	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	45	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGACTGTCGTTATG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1876.46812015436	42.8834607286823	0.022853284992209	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1870.6159730317	1870.6159730317
"healthy-5"	"2019-08-29-count-2:TGGAACTCAATCTCGA"	-3.92757401886638	11.8482198485169	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTCAATCTCGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2053.1045392648	42.0110929937983	0.0204622279043044	1043	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2044.53241561859	2044.53241561859
"healthy-5"	"2019-08-29-count-1:CACAGGCTCCCAACTC"	0.445647110312623	8.43839070880739	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAGGCTCCCAACTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1669.98647007627	38.605221687615	0.0231170865030133	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1665.98433047968	1665.98433047968
"healthy-5"	"2019-08-29-count-1:AAATGGATCGGACCAC"	3.76609124717061	-7.82744266903075	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAATGGATCGGACCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1586.5069467454	44.8375062653367	0.028261777458534	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1584.11979353383	1584.11979353383
"healthy-5"	"2019-08-29-count-2:CAATACGAGAGCATTA"	4.36961473998372	-9.05881788646849	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATACGAGAGCATTA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1904.36325578546	42.4775383637882	0.0223053759490167	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1900.72271535849	1900.72271535849
"healthy-5"	"2019-08-29-count-2:CAATACGCATATGGCT"	3.47755779799764	-8.26605131542357	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATACGCATATGGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1657.39748948985	49.4796689320036	0.0298538336432701	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1655.06875573992	1655.06875573992
"healthy-5"	"2019-08-29-count-1:TGAGCATGTATCGAGG"	-3.2461019558018	10.1626472243103	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGCATGTATCGAGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1664.86784647083	22.2849290780009	0.0133854042080519	663	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1662.57864678633	1662.57864678633
"healthy-5"	"2019-08-29-count-1:AGCGCCATCTATACTC"	-3.62249288979228	12.5962505110535	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCCATCTATACTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1715.27113673268	40.9389939321908	0.0238673601248681	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1710.56546011433	1710.56546011433
"healthy-5"	"2019-08-29-count-1:AGCGCCATCTCCACTG"	3.64905347403828	-8.15575125133666	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCCATCTCCACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1693.88792288524	40.0631104590942	0.0236515709911042	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1691.62956672311	1691.62956672311
"healthy-5"	"2019-08-29-count-1:AGCGCTGAGGCATGCA"	11.1161800819332	3.98035953128663	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCTGAGGCATGCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1479.2735758108	33.361030329443	0.0225523059932695	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1471.76429785186	1471.76429785186
"healthy-5"	"2019-08-29-count-1:TACTTACTCCCGGTAG"	2.73905458030049	-7.04623844539794	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTTACTCCCGGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1881.85084938067	46.0953927118635	0.0244947110059406	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1879.90446935056	1879.90446935056
"healthy-5"	"2019-08-29-count-1:CGCAGGTTCTGGGCGT"	-3.46384940567668	12.5938062437805	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCAGGTTCTGGGCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1400.26184442641	44.79209842821	0.0319883731792735	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1388.13027189154	1388.13027189154
"healthy-5"	"2019-08-29-count-1:AGCGCTGCATGTCGTA"	6.79638447341268	-1.58671476757201	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCTGCATGTCGTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2200.34940676653	33.6133129000769	0.0152763523814486	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2196.75569961754	2196.75569961754
"healthy-5"	"2019-08-29-count-2:TGGAGAGCAGAAGCGT"	2.5920201736385	-7.0165906182495	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAGAGCAGAAGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1574.92425302885	46.6450513184919	0.0296173299946238	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1574.92425302885	1574.92425302885
"healthy-5"	"2019-08-29-count-1:GGGTCTGAGTCATGGG"	-3.75627813759502	13.0494756468567	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTCTGAGTCATGGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1584.01132659129	44.371211289267	0.0280119280363679	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1579.27633204491	1579.27633204491
"healthy-5"	"2019-08-29-count-1:AGCGCTGGTTAAGAAC"	-1.94997344437297	9.97648999774782	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCTGGTTAAGAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1507.33341921132	48.2589679358515	0.0320161202032539	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1500.48442143387	1500.48442143387
"healthy-5"	"2019-08-29-count-1:TGAGCGCGTGTCCGGT"	3.66740526732747	-7.39173033153685	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGCGCGTGTCCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1674.64432967817	45.532670446398	0.0271894572712932	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1666.32085843615	1666.32085843615
"healthy-5"	"2019-08-29-count-1:TGAGCGCGTTCCTTGC"	5.27737917479817	-9.35284140026244	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGCGCGTTCCTTGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.89266704495	43.1064955291182	0.0206163119745599	1014	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2090.89266704495	2090.89266704495
"healthy-5"	"2019-08-29-count-2:CAATCGATCGTAGTGT"	1.98429383811299	-7.34365656292113	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATCGATCGTAGTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1429.57066695573	47.4501510697659	0.0331918891220752	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1424.69949938294	1424.69949938294
"healthy-5"	"2019-08-29-count-2:GAGACCCTCACGGGAA"	3.85278882560078	-7.57265665447386	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACCCTCACGGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2136.32045555011	41.3776607616539	0.0193686582245448	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2126.9431958308	2126.9431958308
"healthy-5"	"2019-08-29-count-2:ACCTACCTCGCCTTGT"	10.2696062522823	5.75784204089967	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTACCTCGCCTTGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1603.39980085514	38.7807895973152	0.0241865999837547	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1596.75395399363	1596.75395399363
"healthy-5"	"2019-08-29-count-2:TTATTGCCATCAGCGC"	-2.39317856255229	9.91669747913209	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTATTGCCATCAGCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1565.60966438959	42.3284939600113	0.0270364286340265	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1558.94920577052	1558.94920577052
"healthy-5"	"2019-08-29-count-2:TTGTTGTTCGGCTTCT"	10.2224461036617	6.46176335895387	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTGTTCGGCTTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.60780562878	41.3961145118795	0.0284781867238069	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1448.52363369208	1448.52363369208
"healthy-5"	"2019-08-29-count-1:GGGTGAAGTACAAGCG"	-0.769125680357772	9.41007230365602	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTGAAGTACAAGCG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1631.16113211293	37.9759633407619	0.0232815523819952	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1624.23177672136	1624.23177672136
"healthy-5"	"2019-08-29-count-2:GAGACTTAGGCTTCCG"	11.0228401618892	4.28410384738771	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACTTAGGCTTCCG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1449.42793112947	35.8198951583619	0.0247131260472185	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1436.13510334969	1436.13510334969
"healthy-5"	"2019-08-29-count-1:GTTCGCTAGAAGCTGC"	-3.72883615914043	11.8392629393372	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTCGCTAGAAGCTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1570.42059746322	45.4425251800978	0.0289365315594456	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1568.00882922587	1568.00882922587
"healthy-5"	"2019-08-29-count-2:GGTTCTCTCCCAAGCG"	-3.61516128006633	-5.50741054927977	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTTCTCTCCCAAGCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2534.60647572836	46.0973316432839	0.018187175044614	1546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2530.59611367492	2530.59611367492
"healthy-5"	"2019-08-29-count-1:TGAGGGACAGGGATAC"	-3.84825525704082	12.3794402846131	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGGGACAGGGATAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1647.17920937035	36.1765030690462	0.021962700150201	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1638.12108288392	1638.12108288392
"healthy-5"	"2019-08-29-count-1:AGCGTATTCTACACAG"	-2.27342734757121	9.25908658588258	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGTATTCTACACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1666.14540065928	43.1647733620871	0.0259069666699	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1659.62127614813	1659.62127614813
"healthy-5"	"2019-08-29-count-2:CAATTTCCACGGATCC"	3.27541555938069	-7.92411234295043	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCCACGGATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1860.81531645012	43.8714130608461	0.0235764466645404	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1858.8780173015	1858.8780173015
"healthy-5"	"2019-08-29-count-2:TGGATGTGTAGTCTTG"	3.61438240584676	-7.41442253505858	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATGTGTAGTCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1688.85479526241	46.995899025229	0.0278270809053936	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1688.85479526241	1688.85479526241
"healthy-5"	"2019-08-29-count-2:CAATTTCGTAGAGGAA"	5.0460373359615	-5.09114696895751	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCGTAGAGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1766.87779126756	47.590898914739	0.0269350258121686	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.72845177878	1764.72845177878
"healthy-5"	"2019-08-29-count-2:TCTTCCTTCGTAACTG"	4.50993790206258	-7.90570499813231	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTTCCTTCGTAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.75160448591	45.3538837901188	0.0204503893485547	1120	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2214.26108892034	2214.26108892034
"healthy-5"	"2019-08-29-count-1:TGAGGTTAGCCGATTT"	3.32527365264241	-8.35845377361449	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGGTTAGCCGATTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1760.01354547189	45.2918623563799	0.0257338146475664	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.01354547189	1760.01354547189
"healthy-5"	"2019-08-29-count-1:TGAGGTTAGCGATGAC"	3.67534365233724	-7.93240835582884	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGGTTAGCGATGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.71245118128	42.8982772062147	0.0217348161230577	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1973.71245118128	1973.71245118128
"healthy-5"	"2019-08-29-count-2:CAATTTCTCTCTAGGA"	3.91581811484639	-7.78566362774047	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCTCTCTAGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.95857374846	47.6279288400207	0.0241281298774054	875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1971.98960289405	1971.98960289405
"healthy-5"	"2019-08-29-count-1:CGCCATTCAAGTTGGG"	-0.0404399586027444	9.21228311145631	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCCATTCAAGTTGGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1550.08820597669	31.2606871229422	0.0201670375933512	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1548.5808627011	1548.5808627011
"healthy-5"	"2019-08-29-count-2:ACCTGTCTCCATCAGA"	-5.55824504318889	-5.47638466274413	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCTGTCTCCATCAGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2350.94103180228	48.1324908349362	0.0204737125192956	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2347.61476314552	2347.61476314552
"healthy-5"	"2019-08-29-count-1:GACGCTGTCGCACTCT"	3.21143021163289	-7.39123442089232	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGCTGTCGCACTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2011.10760763809	45.6765224614927	0.0227121225577465	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2007.45348210653	2007.45348210653
"healthy-5"	"2019-08-29-count-1:GGGTTTAAGTAAACGT"	-3.46773634377177	-5.56388571178588	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTTTAAGTAAACGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1895.14867976601	43.7166469780523	0.0230676608356923	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1893.23624687889	1893.23624687889
"healthy-5"	"2019-08-29-count-2:GTAACACGTGGTCAAG"	3.3780788379604	-7.9115257493225	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAACACGTGGTCAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1515.26436580971	44.3160721182018	0.0292464292820089	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1515.26436580971	1515.26436580971
"healthy-5"	"2019-08-29-count-2:CACAACACAGGAATAT"	-1.35233185711558	9.08312223041383	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAACACAGGAATAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.29284123226	44.6016560941215	0.0257174884389369	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1730.13135661215	1730.13135661215
"healthy-5"	"2019-08-29-count-1:GACGTTATCTCCGAGG"	-2.48740373078044	10.3797149428162	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGTTATCTCCGAGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1377.48428509532	38.4519452142285	0.0279146162539107	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1372.63626471525	1372.63626471525
"healthy-5"	"2019-08-29-count-1:TAGACTGCAACGGCTC"	-3.48134789887126	12.4572257765564	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGACTGCAACGGCTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1630.52422595787	39.6047909113262	0.0242896059321411	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1625.75007997502	1625.75007997502
"healthy-5"	"2019-08-29-count-2:CACAACATCCAAACCA"	3.58810557898824	-7.71949245845946	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAACATCCAAACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1969.37505941926	41.3416974114308	0.0209922925618962	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1960.00219009756	1960.00219009756
"healthy-5"	"2019-08-29-count-2:GAGCCTGCAATTGCGT"	1.36656071719472	-7.11119081890257	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCCTGCAATTGCGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1594.15139857997	47.335268917968	0.0296930824513488	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1587.19910124391	1587.19910124391
"healthy-5"	"2019-08-29-count-2:CACAACATCGCATAGT"	-3.50219760361369	11.2542962797913	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAACATCGCATAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1801.39461573046	31.3674939504328	0.0174128942523309	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1799.15668602144	1799.15668602144
"healthy-5"	"2019-08-29-count-2:GAGCCTGCATGCGTGC"	1.48020484027211	-6.97057249462279	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCCTGCATGCGTGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1665.01962130143	51.2621817075774	0.0307877343015989	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1665.01962130143	1665.01962130143
"healthy-5"	"2019-08-29-count-1:GACTATGAGTCACTAC"	-4.92967830124553	-4.39090874111327	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTATGAGTCACTAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2972.61884839389	41.0589349477098	0.0138123779205309	2416	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2969.91280285418	2969.91280285418
"healthy-5"	"2019-08-29-count-2:CACACAAGTAATTGGA"	11.2040382820064	4.03088996494142	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACACAAGTAATTGGA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1424.51172633647	38.4044895122528	0.0269597566676553	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1424.51172633647	1424.51172633647
"healthy-5"	"2019-08-29-count-1:TGAGTCAGTGATGAAT"	4.3323790031368	-8.34666635906371	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGTCAGTGATGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1980.91876044544	37.0061877684172	0.0186813253058877	916	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1980.91876044544	1980.91876044544
"healthy-5"	"2019-08-29-count-1:TGAGTCATCAAGCTGT"	-3.66354952278789	12.7989206084046	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGTCATCAAGCTGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1742.11975313445	42.2963013525921	0.0242786417388884	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1739.85138743554	1739.85138743554
"healthy-5"	"2019-08-29-count-2:CACACAATCCAGTGCG"	11.1410709815914	4.0466487177643	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACACAATCCAGTGCG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1446.0462795614	39.8314389984602	0.0275450651624659	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1438.44650187631	1438.44650187631
"healthy-5"	"2019-08-29-count-2:GTAAGTCTCGACCTAA"	-3.0711432498997	12.5301999815735	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAAGTCTCGACCTAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1613.23722826033	41.5717862708152	0.0257691711687344	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1608.30310273443	1608.30310273443
"healthy-5"	"2019-08-29-count-2:TCACAAGTCAGTGGGA"	-3.39575252953227	10.1216916807922	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACAAGTCAGTGGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1606.6523513247	38.5087070920418	0.0239682885101378	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1604.34087336366	1604.34087336366
"healthy-5"	"2019-08-29-count-2:GTAATCGAGAATCGTA"	3.52588572081868	-7.32966997539672	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATCGAGAATCGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1784.1108564173	48.5397306353035	0.0272066785876617	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1782.30776253222	1782.30776253222
"healthy-5"	"2019-08-29-count-2:ACGCACGCAGATTCGT"	3.27266993102376	-7.98808863079222	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGCACGCAGATTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1685.78071987433	48.238213313049	0.0286147615430344	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1683.50951145221	1683.50951145221
"healthy-5"	"2019-08-29-count-1:GACTATGTCTCTATGT"	3.74469389495198	-7.70916893398436	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTATGTCTCTATGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1695.47184052675	45.5738652630743	0.0268797535728552	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1695.47184052675	1695.47184052675
"healthy-5"	"2019-08-29-count-2:TCACACCGTCGAGATG"	-3.66480551186259	-4.61154796993407	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACACCGTCGAGATG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2812.68143053509	40.5214683140792	0.0144067038215453	1977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2811.61521620462	2811.61521620462
"healthy-5"	"2019-08-29-count-2:CACAGATGTTCGTAAC"	4.78753532943074	-8.29576017772826	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAGATGTTCGTAAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2178.88436765671	41.4715070523293	0.0190333675654987	1235	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2174.62339829126	2174.62339829126
"healthy-5"	"2019-08-29-count-1:GACTCAAAGTTACGGG"	14.154991765588	2.07409188831178	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTCAAAGTTACGGG"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1106.90179787522	40.3409895291371	0.0364449579958896	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1094.80231103753	1094.80231103753
"healthy-5"	"2019-08-29-count-1:TGATCAGCAGCTAACT"	-3.12875495377238	10.2654065855774	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCAGCAGCTAACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1707.19655869067	46.9346194921746	0.0274922177257498	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1704.98533352953	1704.98533352953
"healthy-5"	"2019-08-29-count-1:AACCATGCAATGTTGC"	4.15127481993977	-7.29887154018553	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCATGCAATGTTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.21281858737	44.0731321581364	0.020280173106463	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2158.64304825549	2158.64304825549
"healthy-5"	"2019-08-29-count-2:CACAGGCAGACCCTTA"	4.31019939956014	-8.24154760753783	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAGGCAGACCCTTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2199.27311172444	41.7831572812136	0.018998621434721	1079	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2192.91840859622	2192.91840859622
"healthy-5"	"2019-08-29-count-1:TGATCAGTCTTCGGTC"	-4.1470140022343	3.69538185680238	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCAGTCTTCGGTC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2645.89850248115	43.1325189248764	0.01630165287309	1981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2640.7310798312	2640.7310798312
"healthy-5"	"2019-08-29-count-2:TGGGATTGTCTCAAGT"	-0.29374916377719	10.1252708205017	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGATTGTCTCAAGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1476.73273591914	37.0592281946969	0.0250954199722746	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1474.45715223281	1474.45715223281
"healthy-5"	"2019-08-29-count-1:TAGATCGTCTTCGGTC"	-0.379007081419784	8.77763364398805	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGATCGTCTTCGGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1575.05053421715	41.3001500253495	0.0262214761546537	617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1568.11861192048	1568.11861192048
"healthy-5"	"2019-08-29-count-1:TGATCTTAGATGTTCC"	10.8582588630611	6.10344741428224	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCTTAGATGTTCC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.48803964716	30.1803443156344	0.0207640816383743	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1448.7266160083	1448.7266160083
"healthy-5"	"2019-08-29-count-1:TGATCTTAGCTGCGAA"	2.78632130202596	-8.13382341777953	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCTTAGCTGCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1475.79671264271	51.3938252658733	0.034824461137227	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1473.49969513331	1473.49969513331
"healthy-5"	"2019-08-29-count-2:CTTCTCTCACTCCTTG"	3.20657314833943	-7.95405676281127	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCTCTCACTCCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1576.63415001318	44.6881985628555	0.0283440508772959	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1574.22700667504	1574.22700667504
"healthy-5"	"2019-08-29-count-2:GTAATGCAGTACTGTC"	3.49854077872578	-8.08575346386107	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCAGTACTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1455.71837341161	44.0487997536084	0.0302591494056477	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1453.22856845217	1453.22856845217
"healthy-5"	"2019-08-29-count-1:TGATCTTCACCAGACC"	3.39381279525105	-7.17720129406127	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCTTCACCAGACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.2351721447	42.2818664789466	0.0212446584558061	923	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1986.49001952226	1986.49001952226
"healthy-5"	"2019-08-29-count-1:AGGACGATCAAAGGAT"	-3.33470402184184	-5.56519224559935	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGACGATCAAAGGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2321.56994782194	49.6300074095504	0.0213777781953598	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2321.56994782194	2321.56994782194
"healthy-5"	"2019-08-29-count-2:TTCATTGGTGACACGA"	3.34467138823811	-8.18566992199095	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATTGGTGACACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1435.2886262966	48.4439822048635	0.033752083948342	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1432.87090403757	1432.87090403757
"healthy-5"	"2019-08-29-count-2:TCACATTTCGTAGCCG"	4.00548615035359	-7.7103367081848	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACATTTCGTAGCCG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2105.65816011417	38.2317914902055	0.0181566942889403	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.99769475334	2099.99769475334
"healthy-5"	"2019-08-29-count-2:GTAATGCCACGACCTG"	-1.95765982094463	9.74069497669069	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATGCCACGACCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1567.37609007389	40.2423196404502	0.0256749607801872	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1567.37609007389	1567.37609007389
"healthy-5"	"2019-08-29-count-2:TGGGCTGCAGCAGGAT"	3.4731773334438	-6.82529261028441	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGCTGCAGCAGGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1980.6774164334	43.8963024748867	0.0221622673690755	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1974.90960264366	1974.90960264366
"healthy-5"	"2019-08-29-count-1:AGGACTTTCGAGCTGC"	1.95800032195393	-7.07662823116454	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGACTTTCGAGCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.57012047758	49.8630295841604	0.0264025301700479	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1888.57012047758	1888.57012047758
"healthy-5"	"2019-08-29-count-1:AGGAGGTAGATGTTAG"	2.81177463111226	-7.54657986080321	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAGGTAGATGTTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1777.13518938008	44.4953358077368	0.0250376764095579	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1768.34647712477	1768.34647712477
"healthy-5"	"2019-08-29-count-1:AGGAGGTCAGGCTCTG"	3.1488217311794	-7.05584432994994	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAGGTCAGGCTCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.97814209247	40.9962317611745	0.0202652865634871	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2022.97814209247	2022.97814209247
"healthy-5"	"2019-08-29-count-1:TGATGCACAAGTATAG"	-5.61450133743938	-5.48805477535399	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGCACAAGTATAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2433.89095364062	48.3343114303343	0.0198588648180953	1410	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2428.10104083465	2428.10104083465
"healthy-5"	"2019-08-29-count-1:AGGAGGTGTTGCGAAG"	1.77478184279744	-6.72217657482298	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAGGTGTTGCGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1794.53710786872	52.8679376095151	0.0294604872630936	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1790.18390865614	1790.18390865614
"healthy-5"	"2019-08-29-count-1:TGATGCACACTGCTTC"	-3.44450221481975	10.1911420592102	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGCACACTGCTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1791.14102009066	37.6873226038863	0.0210409577923567	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1784.5961392167	1784.5961392167
"healthy-5"	"2019-08-29-count-2:CACCAAAGTATACCTG"	3.91694941100423	-7.88195469295653	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACCAAAGTATACCTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2248.23966094647	43.2772295211647	0.0192493844285914	1219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2242.12287730242	2242.12287730242
"healthy-5"	"2019-08-29-count-2:GTACAACAGCATGCAG"	4.81114449080769	-8.50356485759886	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTACAACAGCATGCAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2057.7896230279	45.0065529346601	0.021871309112948	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2052.82298703721	2052.82298703721
"healthy-5"	"2019-08-29-count-1:AGGAGGTTCTGGGCCA"	3.67514910277669	-7.25652363216551	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGAGGTTCTGGGCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1815.59539934387	45.8880854761334	0.0252744006140997	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1811.61616623525	1811.61616623525
"healthy-5"	"2019-08-29-count-2:TGGGTTATCCTACTGC"	2.47312798079793	-6.83634760296019	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGTTATCCTACTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1838.86438492433	45.464985014902	0.0247244904994844	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1835.03568802741	1835.03568802741
"healthy-5"	"2019-08-29-count-1:GACTGATGTTACCTTT"	-3.10503635826762	12.5731372603211	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTGATGTTACCTTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1602.26664713899	43.2242197867586	0.0269769203920831	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1599.84155466067	1599.84155466067
"healthy-5"	"2019-08-29-count-1:TGATGGTAGAATCTAG"	3.93777789649312	-7.90882017528685	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGGTAGAATCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1980.56955156305	45.5478866146612	0.0229973678928443	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1976.63636140215	1976.63636140215
"healthy-5"	"2019-08-29-count-2:ACGGTTAGTGCAATAA"	3.4218930202419	-8.00928785717162	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGGTTAGTGCAATAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1557.85171426496	41.4573520355141	0.0266118730402238	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1557.85171426496	1557.85171426496
"healthy-5"	"2019-08-29-count-2:TGGTACAGTCCTACGG"	-5.5206483406132	-5.60872795498046	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTACAGTCCTACGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2165.70062278804	50.0062434996393	0.0230900997919385	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2160.45838360977	2160.45838360977
"healthy-5"	"2019-08-29-count-1:AACCTTTAGTCACAGG"	-2.74178181114848	12.205539680365	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCTTTAGTCACAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1469.94756502137	48.4701375456607	0.0329740588705666	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1462.89990465989	1462.89990465989
"healthy-5"	"2019-08-29-count-1:TAGGGTTTCCTTCTTC"	4.51635469970052	-7.57648899471434	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGGTTTCCTTCTTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2456.6203324142	40.2378179951499	0.0163793393159809	1384	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2449.25642962365	2449.25642962365
"healthy-5"	"2019-08-29-count-1:TGATGGTGTTGGACTT"	3.5789872604305	-8.23905947124632	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGGTGTTGGACTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1438.02604031408	46.5192568781336	0.0323493842072382	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1435.50559624719	1435.50559624719
"healthy-5"	"2019-08-29-count-2:CACGAATGTTTGGGAG"	3.04876484450642	-8.02925875103148	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGAATGTTTGGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1471.61918343491	47.4845972174502	0.0322669055635821	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1469.05676413648	1469.05676413648
"healthy-5"	"2019-08-29-count-1:TGATGGTTCACCTGTC"	3.44738688048665	-7.11939384853514	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGGTTCACCTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.18512301517	43.8654144449812	0.021219877192711	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2059.95541225997	2059.95541225997
"healthy-5"	"2019-08-29-count-1:GACTTCCTCCCTCAAC"	11.0259834724361	-2.54481985485228	"2019-08-29-count-1"	"Control5"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACTTCCTCCCTCAAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1581.19843256396	43.9072251353559	0.027768320680763	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	1577.02560194053	1577.02560194053
"healthy-5"	"2019-08-29-count-2:CACGAATTCCTGGGAC"	4.14274992522542	-7.6356673470703	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGAATTCCTGGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1846.31901973156	48.1692524740983	0.0260893442353758	817	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1844.31215732639	1844.31215732639
"healthy-5"	"2019-08-29-count-1:GAGAAATCAATGGGTG"	-1.1557357114857	9.69703576648561	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGAAATCAATGGGTG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1582.2069692544	39.5037498219052	0.0249674983042964	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1579.98137892633	1579.98137892633
"healthy-5"	"2019-08-29-count-2:CACGGGTCAGAACGCA"	-2.88704834404643	3.85006330097047	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGGGTCAGAACGCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2941.61548047335	43.3699122134401	0.0147435694778372	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2935.07273840173	2935.07273840173
"healthy-5"	"2019-08-29-count-1:TAGGTACCATGGTGGA"	-1.46798108044322	3.73568866336671	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTACCATGGTGGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2851.78641185534	43.8002758462897	0.0153588907164312	3825	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2847.53548253081	2847.53548253081
"healthy-5"	"2019-08-29-count-1:TGATTCTGTATCAGGG"	9.58155026015584	6.88042209232179	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATTCTGTATCAGGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1699.05498656629	34.1505316097995	0.0200997212449351	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1699.05498656629	1699.05498656629
"healthy-5"	"2019-08-29-count-1:AGGCCACCACATCCCT"	-2.3005395931309	3.35921380603639	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGCCACCACATCCCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2982.70038735649	47.4110030111832	0.0158953286800632	3067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2976.99293376484	2976.99293376484
"healthy-5"	"2019-08-29-count-2:CACGGGTTCAGTCTTT"	10.2628590064937	5.98959443652955	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGGGTTCAGTCTTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1396.69709603658	35.5247925380111	0.025434858165611	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1389.58108579226	1389.58108579226
"healthy-5"	"2019-08-29-count-2:TGGTGATCACGAAAGC"	5.42833437499349	-9.93842699443968	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTGATCACGAAAGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.57075495782	39.8748776243833	0.0185847413944487	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2140.68072442338	2140.68072442338
"healthy-5"	"2019-08-29-count-1:CTTCCGACAAAGTGTA"	-2.86193237724956	3.52789709651796	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGACAAAGTGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2776.65287514871	46.505150379115	0.0167486367472651	2744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2768.9997180614	2768.9997180614
"healthy-5"	"2019-08-29-count-1:GAGACCCCATCTTTCA"	-2.53907165947612	9.86228463733522	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACCCCATCTTTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.80310690542	46.3043627635543	0.0284110163782142	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1623.05377094008	1623.05377094008
"healthy-5"	"2019-08-29-count-1:GAGACCCGTACGGTTT"	9.99574532088582	5.66754291141359	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACCCGTACGGTTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1527.87019196559	37.6405027044936	0.0246359297422182	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1527.87019196559	1527.87019196559
"healthy-5"	"2019-08-29-count-2:AGCCAGCCAGGACTTT"	14.3873411613399	1.96398506248323	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCCAGCCAGGACTTT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1366.28743450584	37.3363608509485	0.0273268712776037	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1355.52194205812	1355.52194205812
"healthy-5"	"2019-08-29-count-2:GAGTCTATCCTTTAGT"	-1.38342378559764	8.97716138446657	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTCTATCCTTTAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1549.18498949543	34.0909288530331	0.0220057185450373	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1546.752733576	1546.752733576
"healthy-5"	"2019-08-29-count-1:GAGACTTAGCTCTATG"	2.55932392653767	-7.33735277568968	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGACTTAGCTCTATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1795.83217791271	42.0869724273543	0.023435916198067	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.71707568326	1793.71707568326
"healthy-5"	"2019-08-29-count-2:CACGTTCAGCATGCAG"	-2.76704798165019	3.44510266864625	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGTTCAGCATGCAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3053.6009253055	49.9258735322373	0.0163498357360638	3148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3040.56445570201	3040.56445570201
"healthy-5"	"2019-08-29-count-2:GTAGATCCATTCTGTT"	14.339637418359	2.0510180958542	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGATCCATTCTGTT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1137.130221134	18.239675400697	0.0160400937919911	1248	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1128.20873618346	1128.20873618346
"healthy-5"	"2019-08-29-count-2:TTTGGTTCAACACACT"	-4.25810752335246	-5.24899437343749	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGGTTCAACACACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2699.0144920412	46.913699138305	0.0173817885293477	1814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2691.98530576434	2691.98530576434
"healthy-5"	"2019-08-29-count-2:CACGTTCGTATGTGTC"	-2.65336118164714	10.5388631590637	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACGTTCGTATGTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1420.69971830108	43.1836579395785	0.0303960487802581	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1413.70809175413	1413.70809175413
"healthy-5"	"2019-08-29-count-2:GAAATGAAGTTAGAAC"	-3.1835540336674	12.38778016651	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAATGAAGTTAGAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1514.63194820935	48.6137864378694	0.0320961052586685	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1512.22335585448	1512.22335585448
"healthy-5"	"2019-08-29-count-1:CGGGTGTAGGACGCAT"	2.20122661170308	-7.27735998546752	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGGTGTAGGACGCAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1770.75295846793	48.6817221508014	0.0274921026775645	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.36195864047	1764.36195864047
"healthy-5"	"2019-08-29-count-2:GTAGATCTCTGGAGAG"	1.86770548400227	-6.15883114254149	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGATCTCTGGAGAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1905.49414521861	44.8663469806861	0.0235457805489813	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1903.56257299735	1903.56257299735
"healthy-5"	"2019-08-29-count-1:AGGCTGCTCGCAGAGA"	1.93406762656514	-6.74599459087523	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGCTGCTCGCAGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1689.25590630843	47.6532776704372	0.0282096261984218	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1687.12276003783	1687.12276003783
"healthy-5"	"2019-08-29-count-1:AACGGGATCCTAACAG"	3.0795701938564	-8.00441839611205	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGGGATCCTAACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1938.68908444954	45.688295339022	0.0235665923460824	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1932.61365826679	1932.61365826679
"healthy-5"	"2019-08-29-count-1:ACATCCCAGTGCTAGG"	2.99203481253926	-7.59682609951171	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCCCAGTGCTAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1751.77889717146	43.4439268947929	0.0247998916786475	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1749.67445050171	1749.67445050171
"healthy-5"	"2019-08-29-count-2:GCCATGGAGGACTTCT"	9.71894421157185	5.75652692401735	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCATGGAGGACTTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1466.01634585049	44.1379119713924	0.030107380518862	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1458.739132895	1458.739132895
"healthy-5"	"2019-08-29-count-2:TGGTTAGAGGCCACCT"	9.06051792678181	6.44987866962282	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGAGGCCACCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1450.08046653172	32.2817256182507	0.0222620236347723	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1450.08046653172	1450.08046653172
"healthy-5"	"2019-08-29-count-2:TGGTTAGAGTCGAAGC"	-2.61350021782573	10.4316282042297	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTTAGAGTCGAAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1408.81801748295	50.150561912541	0.0355976153698986	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1408.81801748295	1408.81801748295
"healthy-5"	"2019-08-29-count-1:TATACCTAGTCTACCA"	-5.64702783051189	-5.43960239803465	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATACCTAGTCTACCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2832.65987030289	38.4547271662641	0.0135754834420527	1978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2830.57144782787	2830.57144782787
"healthy-5"	"2019-08-29-count-1:TGCAGATGTGTTCATG"	-3.32334838333781	10.0406045683655	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGATGTGTTCATG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1646.86122656969	36.8185379211517	0.0223567944445705	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1644.72971881595	1644.72971881595
"healthy-5"	"2019-08-29-count-2:GTAGCTATCTGTCCCA"	5.00898136672322	-10.1020469895569	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGCTATCTGTCCCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2270.47720933989	38.1247837634966	0.0167915289379103	1162	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2267.12180377387	2267.12180377387
"healthy-5"	"2019-08-29-count-1:GAGAGGTTCTATTGTC"	-3.56418786469157	11.9852819212708	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGAGGTTCTATTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1722.93796737334	41.1413699984022	0.0238786136108679	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1714.30366849159	1714.30366849159
"healthy-5"	"2019-08-29-count-1:AGGGCCTAGCCTGACC"	-3.55044064942058	3.22087810123292	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCCTAGCCTGACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3025.67132242263	45.5435316001919	0.0150523724314264	3122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3016.07797995893	3016.07797995893
"healthy-5"	"2019-08-29-count-2:GTAGGAGCAACTTCTT"	2.43114962157552	-8.76129152691039	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGGAGCAACTTCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.35334048118	42.3168203614905	0.0235177935369682	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.11750895205	1793.11750895205
"healthy-5"	"2019-08-29-count-1:AGGGCCTCAGTTAGGG"	14.4251476722652	2.01184425437776	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCCTCAGTTAGGG"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1556.06672730134	43.2420239950202	0.0277893121395984	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1546.27294583327	1546.27294583327
"healthy-5"	"2019-08-29-count-2:GTAGGAGTCATCACAG"	9.69823326644246	6.55650994861452	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGGAGTCATCACAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1508.48597824066	41.7571036083934	0.0276814661924101	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1506.15876305553	1506.15876305553
"healthy-5"	"2019-08-29-count-1:TGCAGGCTCCGGTTCT"	-3.12163958969768	3.63417480075685	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGGCTCCGGTTCT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1983.95327770901	41.5592968543574	0.020947719546273	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1978.55377971098	1978.55377971098
"healthy-5"	"2019-08-29-count-1:AGGGCCTGTCGTCATA"	1.89034678515736	-6.8094315758911	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCCTGTCGTCATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1678.10904207178	54.4513959780733	0.0324480678030601	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1675.92785003385	1675.92785003385
"healthy-5"	"2019-08-29-count-1:AGGGCCTTCCATCACC"	-3.37195573273357	11.6181087263855	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCCTTCCATCACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.52060609176	37.8560704544875	0.0226341429316959	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1665.64412507874	1665.64412507874
"healthy-5"	"2019-08-29-count-2:GTAGGTTGTCAAGCGA"	0.683872063725632	8.75792596423952	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGGTTGTCAAGCGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1800.32091639626	42.6534746811368	0.0236921508230417	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1789.43650978629	1789.43650978629
"healthy-5"	"2019-08-29-count-2:GTAGGTTTCTCCGTGT"	-3.86468491974528	12.1314096220764	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGGTTTCTCCGTGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1607.81719181136	34.3232306351636	0.0213477196350258	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1605.36028000188	1605.36028000188
"healthy-5"	"2019-08-29-count-1:AGGGCTCAGACTCAAA"	-2.8882785839146	10.4785775908264	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCTCAGACTCAAA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1557.33027948189	46.3103153863209	0.0297369902816814	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1557.33027948189	1557.33027948189
"healthy-5"	"2019-08-29-count-1:TGCAGTACACTACAGT"	-4.06264100495036	12.4077014693054	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGTACACTACAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1526.19477079205	43.9896387681412	0.0288230831411589	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1523.86068748746	1523.86068748746
"healthy-5"	"2019-08-29-count-1:AAGAACACAAGGTACG"	-3.27425370636638	3.71152851665346	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACACAAGGTACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2984.46010073146	45.7129880216945	0.0153170042415681	2989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2976.52066283217	2976.52066283217
"healthy-5"	"2019-08-29-count-1:TGCAGTACAGAGTAAT"	-3.82086739960368	12.1574353941712	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGTACAGAGTAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1653.33455209822	36.8009346744214	0.0222586134353255	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1646.60545055554	1646.60545055554
"healthy-5"	"2019-08-29-count-1:AAGAACACACCACATA"	-2.80558381500896	10.8413657912048	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACACACCACATA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2029.60127525295	44.0526310109763	0.0217050666789151	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2027.58857709036	2027.58857709036
"healthy-5"	"2019-08-29-count-1:AGGGCTCCATTAGGCT"	6.84738125380818	-1.45024492656859	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCTCCATTAGGCT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2261.80659855509	34.1923551723836	0.0151172762490951	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2248.84089165373	2248.84089165373
"healthy-5"	"2019-08-29-count-1:AAGAACAGTATATGGA"	11.038814206689	5.32159469211427	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACAGTATATGGA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1968.46210122298	45.4955244671234	0.0231122176235233	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1961.23272839266	1961.23272839266
"healthy-5"	"2019-08-29-count-1:TATCAGGAGACGGTCA"	0.317328174679917	8.08611581409303	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCAGGAGACGGTCA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1457.61095439046	29.8205242570062	0.0204584935144621	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1457.61095439046	1457.61095439046
"healthy-5"	"2019-08-29-count-1:TGCAGTATCGAGATAA"	2.18752851065938	-6.47993519222411	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGTATCGAGATAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.29456346067	45.5106752521201	0.0240251311121207	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.69879666341	1890.69879666341
"healthy-5"	"2019-08-29-count-2:AGCGTATGTCGATGCC"	-3.12017474594768	11.9728250273499	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCGTATGTCGATGCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1468.63669042964	42.1921819409933	0.0287288082995192	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1466.46740747694	1466.46740747694
"healthy-5"	"2019-08-29-count-1:GAGCCTGTCAAATGCC"	4.43855824050252	-8.25194075023802	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCCTGTCAAATGCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2206.73266244159	40.4122636638614	0.0183131669511558	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2204.18203801796	2204.18203801796
"healthy-5"	"2019-08-29-count-2:GTAGTACTCCGTGCGA"	-7.55313859406169	-0.724289917108141	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGTACTCCGTGCGA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2786.10348997889	49.7484246181599	0.0178559141098297	2486	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2777.31696664068	2777.31696664068
"healthy-5"	"2019-08-29-count-2:TGAGGTTAGCTAAACA"	-1.25698802891429	9.6173410185608	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGGTTAGCTAAACA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1427.6895623579	45.2284666214792	0.0316794825807806	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1425.19321785661	1425.19321785661
"healthy-5"	"2019-08-29-count-1:TAACTTCTCGTCACCT"	3.17075767096822	-7.88910391246947	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAACTTCTCGTCACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1610.52699496729	47.0040294785067	0.0291854961918606	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1608.21247625381	1608.21247625381
"healthy-5"	"2019-08-29-count-2:CACTGTCGTCTTACAG"	-2.96724853935893	12.0160207518372	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACTGTCGTCTTACAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1439.39792522399	41.9983884706603	0.0291777469834303	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1434.43424103318	1434.43424103318
"healthy-5"	"2019-08-29-count-2:AGCTACAGTCAGTCCG"	3.90624203261678	-7.74053099071654	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACAGTCAGTCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.52640736296	40.4974634548246	0.0208156842803878	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1945.52640736296	1945.52640736296
"healthy-5"	"2019-08-29-count-1:AGGGTCCTCCGGGACT"	-2.87074814263042	3.41358659351198	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGTCCTCCGGGACT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3148.41461253217	49.8416448645854	0.0158307119609317	3468	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3140.39407799002	3140.39407799002
"healthy-5"	"2019-08-29-count-1:TATCCTACATCGTTCC"	-2.76537547531779	13.4181022414002	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCCTACATCGTTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1824.68171911348	39.0977227691279	0.0214271466412912	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1817.89067083063	1817.89067083063
"healthy-5"	"2019-08-29-count-2:CACTTCGAGCCAAGCA"	3.61121286925618	-8.06807043468627	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACTTCGAGCCAAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1769.47954660884	45.404800071711	0.0256599745155168	721	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1769.47954660884	1769.47954660884
"healthy-5"	"2019-08-29-count-1:TATCCTAGTTTCGACA"	2.84069051322286	-7.77847721492919	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCCTAGTTTCGACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1670.72802684254	51.7751379264804	0.0309895668802112	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1670.72802684254	1670.72802684254
"healthy-5"	"2019-08-29-count-2:CACTTCGGTGAGACCA"	-3.76791844788249	13.2079572447571	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACTTCGGTGAGACCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1622.80357990961	41.9760271688542	0.0258663634271699	633	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1622.80357990961	1622.80357990961
"healthy-5"	"2019-08-29-count-2:AGCTACATCATCTGTT"	-3.15190849724467	10.4354905852112	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGCTACATCATCTGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1929.34289721888	49.6994794530554	0.0257597960034458	885	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1929.34289721888	1929.34289721888
"healthy-5"	"2019-08-29-count-1:AGGGTGAGTCGTGGTC"	5.32373013076131	-9.68182184612425	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGTGAGTCGTGGTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.17391590279	37.3877939249265	0.0176093883053518	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2123.17391590279	2123.17391590279
"healthy-5"	"2019-08-29-count-2:GAGTTTGGTAGAGTTA"	4.02664556083028	-7.74720146572264	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTTGGTAGAGTTA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1973.24294585642	40.2471268829695	0.0203964377359026	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1973.24294585642	1973.24294585642
"healthy-5"	"2019-08-29-count-1:TATCGCCCAGTTTCAG"	-2.99505434456523	10.1967353590759	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCGCCCAGTTTCAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1980.61413371445	41.6181572072214	0.0210127538215485	904	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1978.64297542069	1978.64297542069
"healthy-5"	"2019-08-29-count-1:TGCATGAAGTGCAGGT"	-2.91642365875896	10.5295591124329	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCATGAAGTGCAGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1519.64946116129	51.0059037242069	0.0335642561181373	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1515.07643342561	1515.07643342561
"healthy-5"	"2019-08-29-count-1:TATCGCCTCACATCAG"	-4.21790347519572	12.1264819868836	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCGCCTCACATCAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1754.18985158922	36.7906666461214	0.0209730244493153	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1751.99523837258	1751.99523837258
"healthy-5"	"2019-08-29-count-2:GAGTTTGTCTGGTTGA"	3.11660399016682	-8.48816111004027	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGTTTGTCTGGTTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1470.83968350663	46.4063318973171	0.0315509109644635	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1465.79816042568	1465.79816042568
"healthy-5"	"2019-08-29-count-2:GTATTTCTCATAGCAC"	-3.73233280602153	12.7821674116882	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTATTTCTCATAGCAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1510.49822061965	33.3401274773619	0.0220722719313663	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1508.01635187847	1508.01635187847
"healthy-5"	"2019-08-29-count-2:TGTCAGATCTTTGATC"	3.30712284621541	-8.08137991344603	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTCAGATCTTTGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1500.89065685149	42.2364306352652	0.0281409111599557	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1498.38028473614	1498.38028473614
"healthy-5"	"2019-08-29-count-2:CAGATACCATTGACAC"	10.4170528846676	5.60443828189699	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGATACCATTGACAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1445.83922330037	42.7970206348066	0.0296001242358852	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1440.95310788709	1440.95310788709
"healthy-5"	"2019-08-29-count-1:TATCTGTCATGGCCCA"	-5.57345614853557	-5.39795925533446	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTGTCATGGCCCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2327.49588067804	46.6246014785359	0.0200320876464681	1143	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2327.49588067804	2327.49588067804
"healthy-5"	"2019-08-29-count-1:TATCTGTGTCACATTG"	-2.97966227951701	12.2530956038269	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTGTGTCACATTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1493.60672740763	40.3849360741395	0.0270385338610742	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1491.12548068969	1491.12548068969
"healthy-5"	"2019-08-29-count-1:CAGCACGGTAGTTACC"	10.0724779563839	5.43803498828737	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCACGGTAGTTACC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1642.76279145977	49.4324144533557	0.030091023920398	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1640.59368926236	1640.59368926236
"healthy-5"	"2019-08-29-count-1:AGGTAGGCAATTGCAC"	3.73525800284688	-7.69842245494994	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTAGGCAATTGCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1792.99990673955	43.8000302146474	0.0244283505258485	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1786.96742152651	1786.96742152651
"healthy-5"	"2019-08-29-count-2:CAGATCAAGCCGTTAT"	4.00266542014424	-7.4094653359619	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGATCAAGCCGTTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.28954009749	42.3735534138638	0.01990032478717	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2127.63161960031	2127.63161960031
"healthy-5"	"2019-08-29-count-2:CAGATCAAGGTACAGC"	-2.93709884110149	10.8664569624695	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGATCAAGGTACAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1489.07591852978	37.0029185948849	0.0248495849905486	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1484.17602314234	1484.17602314234
"healthy-5"	"2019-08-29-count-2:TGTCCCAGTACTGAGG"	-5.49246058884318	-5.61652901088866	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTCCCAGTACTGAGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2123.8322980596	47.0341794705576	0.0221459008385594	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2118.65437424722	2118.65437424722
"healthy-5"	"2019-08-29-count-2:GTCAAGTTCGTTCCCA"	-2.8146952194279	10.8770169981751	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCAAGTTCGTTCCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1414.38422001362	44.968590849978	0.0317937588765978	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1414.38422001362	1414.38422001362
"healthy-5"	"2019-08-29-count-1:TATCTGTTCTTTCGAT"	3.14972080764119	-7.66887524044188	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATCTGTTCTTTCGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.6235042339	47.4966095096641	0.026931263614734	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1759.3357694742	1759.3357694742
"healthy-5"	"2019-08-29-count-1:AGGTAGGGTACCCGAC"	3.28230442580525	-7.1093902817932	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTAGGGTACCCGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1802.96418568857	48.7365052446651	0.0270313218817778	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1800.92073698987	1800.92073698987
"healthy-5"	"2019-08-29-count-1:TGCCGAGTCTTAGCCC"	-2.05980358544047	9.29372975910035	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCCGAGTCTTAGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1418.10361906523	33.7799182456566	0.0238204865931611	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1410.42664608958	1410.42664608958
"healthy-5"	"2019-08-29-count-1:AGGTAGGGTCTCGCGA"	5.36682714995686	-10.0334396592346	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTAGGGTCTCGCGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2123.22254589832	38.1280819289806	0.0179576474461601	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2116.43613488636	2116.43613488636
"healthy-5"	"2019-08-29-count-1:AGGTAGGGTTGTGCCG"	-3.27582726898845	11.4494056471619	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTAGGGTTGTGCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1528.19574079259	39.2893150944125	0.0257096090805981	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1525.74649226459	1525.74649226459
"healthy-5"	"2019-08-29-count-2:TGTCCTGGTATGAGAT"	-3.48997888985332	12.493493057135	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTCCTGGTATGAGAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1443.33371097116	39.10192664842	0.0270913970561319	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1440.77383080329	1440.77383080329
"healthy-5"	"2019-08-29-count-2:GTCACGGGTACTGCGC"	-2.41541681709941	10.3805827864441	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCACGGGTACTGCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1581.69466236198	44.7844856540004	0.0283142421351557	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1579.58584999198	1579.58584999198
"healthy-5"	"2019-08-29-count-1:GAGGGATCAAATACAG"	-3.18079457703288	11.1357536085877	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGGATCAAATACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.37233630679	37.0163133463238	0.024411097762756	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1513.97030199285	1513.97030199285
"healthy-5"	"2019-08-29-count-2:CAGATTGCACTAGAGG"	-3.25571332398112	3.63924143398134	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGATTGCACTAGAGG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2052.01370246193	37.2937706861435	0.0181742308257492	1066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2048.87010355465	2048.87010355465
"healthy-5"	"2019-08-29-count-1:GAGGGATGTCGAACGA"	2.48160996016805	-6.63324596798094	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGGATGTCGAACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1774.45980868891	52.5005642855488	0.0295867869356476	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1768.70253203026	1768.70253203026
"healthy-5"	"2019-08-29-count-2:CAGATTGGTCGAACAG"	5.25248970565144	-9.27268888866576	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGATTGGTCGAACAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.71048542188	37.5308666229064	0.0162351068006066	1225	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2304.09468379676	2304.09468379676
"healthy-5"	"2019-08-29-count-2:CAGCAATAGACATGCG"	-3.74844227257426	12.9607152708801	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAATAGACATGCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1609.1039557326	38.6766546633152	0.0240361441692599	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1603.93688806346	1603.93688806346
"healthy-5"	"2019-08-29-count-1:TGCGATATCTCTTAAC"	3.84162249144856	-8.19607450878295	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGATATCTCTTAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1880.19703843611	45.0624714152142	0.0239668877750684	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1880.19703843611	1880.19703843611
"healthy-5"	"2019-08-29-count-2:GTCACTCTCAGTCCGG"	4.87612976607625	-9.55791761791381	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCACTCTCAGTCCGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1665.59775795041	34.5984889056737	0.0207724156330809	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1663.32566906747	1663.32566906747
"healthy-5"	"2019-08-29-count-1:TGCGATATCTTGGAAC"	-3.10608349266704	12.6060456999573	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGATATCTTGGAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1548.25914347813	36.8702486281911	0.0238140034783601	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1545.80739798253	1545.80739798253
"healthy-5"	"2019-08-29-count-2:CAGCAATGTTGTAGCT"	-3.04165540161784	10.6967906721863	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAATGTTGTAGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1495.23208597845	34.8938969386294	0.023336776454871	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1488.07184767928	1488.07184767928
"healthy-5"	"2019-08-29-count-2:CAGCAATTCTGAATGC"	-3.31269321861919	3.66844961726991	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAATTCTGAATGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3209.93209909529	45.0807154036538	0.0140441336489204	3634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3200.82496919021	3200.82496919021
"healthy-5"	"2019-08-29-count-2:GTCAGCGGTCTGCCTT"	-3.63464341583903	2.87973902309266	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCAGCGGTCTGCCTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3072.34771541401	45.5008585152515	0.0148098010804484	3114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3066.64419607673	3066.64419607673
"healthy-5"	"2019-08-29-count-1:TGCGGCACACCTGCTT"	3.1232611137325	-6.3629474869934	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGCACACCTGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.02630052778	40.5572922042356	0.0197741453602029	1001	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2045.78274532239	2045.78274532239
"healthy-5"	"2019-08-29-count-2:CAGCACGGTATCACCA"	6.81729807433431	-1.44922783291014	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCACGGTATCACCA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2169.10408146161	44.9431964333564	0.0207197048852872	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2162.51752465588	2162.51752465588
"healthy-5"	"2019-08-29-count-1:AGGTCTATCGAAATCC"	14.3130394416744	1.96303114974824	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTCTATCGAAATCC"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1214.3587616116	39.2828537424099	0.0323486394500723	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1208.3190909405	1208.3190909405
"healthy-5"	"2019-08-29-count-1:TGCGGCATCAGGGTAG"	-3.26956377449687	10.0353688963684	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGCATCAGGGTAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1613.41886972012	37.4752867241765	0.0232272520344809	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1613.41886972012	1613.41886972012
"healthy-5"	"2019-08-29-count-1:TAATTCCTCATTTACC"	3.20053114470784	-7.91716291820677	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAATTCCTCATTTACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1705.07387198514	51.3790104473176	0.0301330114146313	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1702.84609613368	1702.84609613368
"healthy-5"	"2019-08-29-count-2:AGGACTTGTTACAGCT"	3.28935470160787	-7.84871246730956	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACTTGTTACAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1793.40802972019	31.8379961027474	0.017752789981494	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.40802972019	1793.40802972019
"healthy-5"	"2019-08-29-count-1:TGCGGGTAGGTGGGTT"	3.9736303287441	-7.8295150033203	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTAGGTGGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.00419601187	43.1985134074602	0.0220625234079929	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1954.00225294858	1954.00225294858
"healthy-5"	"2019-08-29-count-1:CGTTCTGAGACATCAA"	-3.7814761203831	3.58161470973817	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGTTCTGAGACATCAA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2974.85917534108	45.6116408119398	0.0153323697437578	3082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2964.95323972155	2964.95323972155
"healthy-5"	"2019-08-29-count-2:AGGACTTTCCGTATGA"	3.63291348990743	-7.09626533901366	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGACTTTCCGTATGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1841.07211373732	39.9548679145496	0.0217019570371105	781	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1838.97300947731	1838.97300947731
"healthy-5"	"2019-08-29-count-1:TATTCCAAGTGCCTCG"	-3.92032585564311	-4.48359348690184	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTCCAAGTGCCTCG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2726.64783496026	39.2519396756698	0.0143956763218166	1886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2723.41778354293	2723.41778354293
"healthy-5"	"2019-08-29-count-1:TATTCCACACTCGATA"	3.20711054381673	-8.25468161022338	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTCCACACTCGATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1743.60122210228	40.5363697163517	0.0232486472265009	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1743.60122210228	1743.60122210228
"healthy-5"	"2019-08-29-count-1:TGCGGGTGTATGGAAT"	-3.04358706894572	13.0351400145325	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTGTATGGAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1407.45400968564	42.557177860765	0.030236993584089	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1402.34798140022	1402.34798140022
"healthy-5"	"2019-08-29-count-1:TGCGGGTGTTAACCTG"	-3.83809767189677	12.6498136290344	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTGTTAACCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1516.63517010081	42.1477686538278	0.0277903146944867	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1511.89157450537	1511.89157450537
"healthy-5"	"2019-08-29-count-2:GGGCTCATCTCATGCC"	3.26636113700215	-6.84957601940306	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCTCATCTCATGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.72192992487	42.0160836713975	0.0194184303862264	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2160.33794307744	2160.33794307744
"healthy-5"	"2019-08-29-count-1:AGGTTGTGTTGAAGTA"	2.4138466316158	-6.56359293377074	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTTGTGTTGAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1734.67970250407	47.7939709138658	0.027552043668277	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1730.71592676119	1730.71592676119
"healthy-5"	"2019-08-29-count-1:TGCGGGTTCATCACTT"	-4.85187135163005	-5.11772444164427	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTTCATCACTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2834.59263524332	52.309889970684	0.0184541120019504	2126	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2832.57002856483	2832.57002856483
"healthy-5"	"2019-08-29-count-2:ACTGTCCTCCATTGGA"	-2.90672741356547	10.7938985594544	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTGTCCTCCATTGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1602.41870852564	51.7311598329062	0.0322831726549818	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1595.79299816634	1595.79299816634
"healthy-5"	"2019-08-29-count-1:GAGTGAGCAACAGATA"	-3.48751221123393	11.0142879256043	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGTGAGCAACAGATA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1533.82057842352	36.9764143000918	0.0241073922336448	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1529.25164040841	1529.25164040841
"healthy-5"	"2019-08-29-count-2:CTAACCCGTATGCAAA"	-2.40113530579265	4.18652818286744	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACCCGTATGCAAA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3319.58429848099	47.4765745764534	0.0143019638326938	4527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3313.7261063266	3313.7261063266
"healthy-5"	"2019-08-29-count-1:AGTAACCAGTCCCGGT"	3.63931860503499	-7.8610673180786	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTAACCAGTCCCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2040.37486717468	49.1417134428273	0.0240846494599663	949	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2036.57540163717	2036.57540163717
"healthy-5"	"2019-08-29-count-2:TGTTACTAGCATCCCG"	-3.05085192146953	3.57351086223451	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTACTAGCATCCCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2860.65284727227	47.0677171610354	0.0164534879532538	2804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2854.4994779597	2854.4994779597
"healthy-5"	"2019-08-29-count-1:CCTTGTGAGCCTAGGA"	4.00901546058003	-7.67558195507201	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTGTGAGCCTAGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1944.52204943844	45.4126262063771	0.0233541328160777	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1938.659919179	1938.659919179
"healthy-5"	"2019-08-29-count-2:TGTTACTAGGCCTGCT"	-3.43142781677898	3.58903739536134	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTACTAGGCCTGCT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3088.88328097999	46.9160615915671	0.0151886806084438	3158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3084.99247120256	3084.99247120256
"healthy-5"	"2019-08-29-count-1:TATTGCTGTCATCACA"	-2.42893681946452	4.1553163298401	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTGTCATCACA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3397.95150154934	46.0225825533693	0.0135442140749757	4443	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3389.17730213716	3389.17730213716
"healthy-5"	"2019-08-29-count-1:TGCTCCATCCCTTTGG"	3.57088436660115	-8.4071369401184	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTCCATCCCTTTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.0714331439	48.286555356187	0.0270199357790859	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1782.99082373796	1782.99082373796
"healthy-5"	"2019-08-29-count-1:TATTGCTGTTATTCCT"	-2.35018668595012	9.71037671649782	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTGTTATTCCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1678.86484873911	41.4581855343059	0.0246941768811483	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1674.19012764427	1674.19012764427
"healthy-5"	"2019-08-29-count-1:TATTGCTGTTCACGAT"	9.22699703749959	6.23694512927858	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTGCTGTTCACGAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1648.27474056124	37.9392579657154	0.0230175571050717	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1646.08640313635	1646.08640313635
"healthy-5"	"2019-08-29-count-2:GATCGTATCTTCACAT"	3.43839563903157	-8.03262808239134	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GATCGTATCTTCACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1685.33302498943	45.7841699453225	0.0271662450485771	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1680.90407100842	1680.90407100842
"healthy-5"	"2019-08-29-count-2:CAGCGTGTCCGTGGGT"	-2.55324564400371	4.06481454456178	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCGTGTCCGTGGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3029.38429335159	44.6873517333885	0.0147512984177878	2986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3023.9293532191	3023.9293532191
"healthy-5"	"2019-08-29-count-1:TGCTCGTTCCCTCTTT"	-5.92399535599406	-4.4083576432434	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTCGTTCCCTCTTT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3354.01220099793	39.7418058185452	0.0118490343615091	3164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3343.46808985856	3343.46808985856
"healthy-5"	"2019-08-29-count-1:TGCTGAAAGCGTGCTC"	10.5872818427974	4.97980067813722	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTGAAAGCGTGCTC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1560.21451112825	30.4225576352191	0.0194989582638988	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1557.79249748836	1557.79249748836
"healthy-5"	"2019-08-29-count-1:TGCTGAAAGGTAGGCT"	11.4762331443721	3.72936484897462	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTGAAAGGTAGGCT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1492.87633287027	28.6194071340669	0.0191706483008153	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1485.09526364322	1485.09526364322
"healthy-5"	"2019-08-29-count-2:TCATGGATCTAGTTCT"	3.64983048018758	-7.88587334072264	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGGATCTAGTTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.00469474305	39.3521070333532	0.0207771961403147	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1894.00469474305	1894.00469474305
"healthy-5"	"2019-08-29-count-2:TGCATCCAGTGATTCC"	2.72206201133077	-7.41500713741454	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATCCAGTGATTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.80519587218	47.7540421595614	0.0265328949316761	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1797.64472151487	1797.64472151487
"healthy-5"	"2019-08-29-count-1:CCTTTGGAGGCGACAT"	5.98958887633626	-1.60306003009947	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTTGGAGGCGACAT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2218.72945866463	47.3352281572236	0.0213343848536237	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2215.8515317705	2215.8515317705
"healthy-5"	"2019-08-29-count-1:TGCTGAAGTTCTAAGC"	3.58043589171712	-7.46669723903807	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTGAAGTTCTAAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1780.80980380164	45.7581054672761	0.025695110937503	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1780.80980380164	1780.80980380164
"healthy-5"	"2019-08-29-count-2:AGGCATTAGCGTTAGG"	-3.47609124603923	11.2356214293274	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCATTAGCGTTAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2038.83769725518	40.3362190685089	0.0197839284229501	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2033.38735735961	2033.38735735961
"healthy-5"	"2019-08-29-count-1:AAGTACCTCTAGAACC"	14.2839800315792	1.94445500457612	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGTACCTCTAGAACC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1450.7263913748	35.1170880320221	0.024206554896091	964	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1439.44737593255	1439.44737593255
"healthy-5"	"2019-08-29-count-1:GTAGGAGCATGGAATA"	3.24166574057881	-7.9707765809265	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAGGAGCATGGAATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.82007531968	42.9625266369477	0.026072340834064	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1645.60908530443	1645.60908530443
"healthy-5"	"2019-08-29-count-1:TGCTTCGAGACTCCGC"	4.1335469680721	-8.14719679271849	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTCGAGACTCCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.32105980631	44.1361830319677	0.0221642727146474	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1987.72512474392	1987.72512474392
"healthy-5"	"2019-08-29-count-1:AGTAGCTAGCTGAAAT"	2.65753354605977	-7.24203302776488	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTAGCTAGCTGAAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1731.12502869158	43.0054462547104	0.0248424842469147	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1724.98470520094	1724.98470520094
"healthy-5"	"2019-08-29-count-1:GTGGCGTAGCGAATGC"	14.28840126571	2.13722846591798	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGCGTAGCGAATGC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1364.49329144579	31.2821872750614	0.0229258637409023	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1353.90145834717	1353.90145834717
"healthy-5"	"2019-08-29-count-1:TATTTCGCAGTAGATA"	-0.623420040041763	8.93529698932496	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATTTCGCAGTAGATA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1519.21026326821	42.1913157814084	0.02777187384888	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1514.54424121342	1514.54424121342
"healthy-5"	"2019-08-29-count-1:AGTAGCTGTAGCGCTC"	9.25129379805867	5.73878285968629	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTAGCTGTAGCGCTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1418.80853165434	42.9736979220252	0.0302885815550584	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1411.51536860966	1411.51536860966
"healthy-5"	"2019-08-29-count-1:TGCTTCGCAACTTGGT"	3.01888694342915	-6.67317821895751	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTCGCAACTTGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1871.64852955978	45.3744765334447	0.0242430540867184	826	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1871.64852955978	1871.64852955978
"healthy-5"	"2019-08-29-count-2:TATATCCCATTCGGGC"	4.05581488189046	-7.72381975567015	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATATCCCATTCGGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1693.37667137923	48.3868131382701	0.0285741583406011	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1691.14359518463	1691.14359518463
"healthy-5"	"2019-08-29-count-1:TGCTTCGCATGGACAG"	5.02316774901692	-10.2712431184021	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTCGCATGGACAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1945.90505268164	48.154593351197	0.0247466305125399	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1939.97820651625	1939.97820651625
"healthy-5"	"2019-08-29-count-1:TCAAGACCACGCCACA"	-1.54022989693339	9.42225358569948	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGACCACGCCACA"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1598.21825485799	41.3918242199815	0.0258987307235201	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1587.0337733621	1587.0337733621
"healthy-5"	"2019-08-29-count-1:TGCTTGCAGAATTTGG"	-2.28215132179912	4.21401546085206	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTGCAGAATTTGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3183.06147274057	45.7222930524059	0.0143642507202475	4078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3176.11490752307	3176.11490752307
"healthy-5"	"2019-08-29-count-2:TGTTCTATCCTTGGAA"	-3.63148627701457	11.918957687262	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTCTATCCTTGGAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.81498496671	36.3390715496698	0.0210074903186072	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1729.81498496671	1729.81498496671
"healthy-5"	"2019-08-29-count-2:CAGGTATCAATTGCGT"	-3.70588527146037	12.9822606810364	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGTATCAATTGCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1560.00373812383	33.4745703108344	0.0214580064731725	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1557.50961863983	1557.50961863983
"healthy-5"	"2019-08-29-count-1:TGCTTGCAGTGATCGG"	3.85277094420735	-7.65422632610472	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTGCAGTGATCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1754.78904036928	41.4380510688843	0.0236142636610974	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1754.78904036928	1754.78904036928
"healthy-5"	"2019-08-29-count-1:TGCTTGCCACATGAAA"	-2.54776583138164	10.8446664580139	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTTGCCACATGAAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1522.37302935115	42.9828034845708	0.0282340810404993	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1522.37302935115	1522.37302935115
"healthy-5"	"2019-08-29-count-2:CAGGTATGTGACCGTC"	3.07938804206197	-7.73124506389769	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGTATGTGACCGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1544.19159173506	51.1076183558832	0.0330966821924334	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1541.73158980799	1541.73158980799
"healthy-5"	"2019-08-29-count-2:TGTTGAGCAAGGAGTC"	5.52214207228963	-4.8137998810974	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTGAGCAAGGAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1644.37424082073	45.7977611220133	0.027851178877112	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1633.80620626916	1633.80620626916
"healthy-5"	"2019-08-29-count-1:TCAAGACTCCGTATGA"	-1.93872592869456	9.93189904773561	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGACTCCGTATGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1440.15526595683	39.8061845621246	0.0276402034579777	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1435.33441286074	1435.33441286074
"healthy-5"	"2019-08-29-count-2:TCATTGTCACATGTTG"	-2.82208452645	9.95819280231325	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTGTCACATGTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1815.36468989431	43.9859888697611	0.0242298360845181	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1810.92124746272	1810.92124746272
"healthy-5"	"2019-08-29-count-1:AGTCAACAGCCTCTCT"	-3.42976961556132	3.71054599368898	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCAACAGCCTCTCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3099.00892969522	48.2865721343469	0.0155812949332468	3183	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3093.26068512658	3093.26068512658
"healthy-5"	"2019-08-29-count-2:AGGGCCTCAAAGTGTA"	-2.58162961426433	3.71043012225953	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGCCTCAAAGTGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2964.40564007615	46.2969874536647	0.015617628986995	3462	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2962.38899913394	2962.38899913394
"healthy-5"	"2019-08-29-count-1:CTACATTAGATGGGCT"	5.39915861663167	-9.73846819317015	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACATTAGATGGGCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2242.40754471231	45.4956241143414	0.0202887402076495	1133	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2240.70575610814	2240.70575610814
"healthy-5"	"2019-08-29-count-2:CAGTGCGCACAAATGA"	5.29182686385457	-9.58022596752318	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTGCGCACAAATGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.97752803306	47.2184212690365	0.0212410699944485	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2218.27914118167	2218.27914118167
"healthy-5"	"2019-08-29-count-2:TCATTTGAGTTCTACG"	-1.61765966835673	10.3381538161072	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTTGAGTTCTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1571.11118372241	42.4906158940227	0.0270449452172764	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1559.73262351912	1559.73262351912
"healthy-5"	"2019-08-29-count-2:ATCCTATTCCACAGGC"	-3.24356780472453	11.3289890059265	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCTATTCCACAGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1535.53390713825	41.9368510757904	0.0273109248065693	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1530.86125970024	1530.86125970024
"healthy-5"	"2019-08-29-count-2:CAGTGCGCATGATAGA"	2.98556961592976	-7.85871746456298	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTGCGCATGATAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1421.43870361264	46.1920087647617	0.032496658946575	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1418.85977873023	1418.85977873023
"healthy-5"	"2019-08-29-count-2:CAGTGCGGTAGGTAGC"	-3.01512632790263	11.7712783583435	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTGCGGTAGGTAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1394.70318199568	42.2802462848347	0.0303148704546124	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1394.70318199568	1394.70318199568
"healthy-5"	"2019-08-29-count-1:GATCACAGTAGTAAGT"	-3.11329303208049	-5.74177172100218	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCACAGTAGTAAGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1944.30435319101	50.0107645795526	0.0257216749514933	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1942.27132956372	1942.27132956372
"healthy-5"	"2019-08-29-count-1:TCTTCCTTCCCTCGTA"	9.42211403426472	5.55497930133668	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTCCTTCCCTCGTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1666.73664588891	38.3060366415343	0.0229826569998434	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1662.39127670337	1662.39127670337
"healthy-5"	"2019-08-29-count-1:AAACGAAGTCTGTGGC"	-1.45401988449748	10.4675655134949	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACGAAGTCTGTGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1521.70528586496	45.2231131036847	0.029718706719205	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1516.99837427288	1516.99837427288
"healthy-5"	"2019-08-29-count-1:TGGAACTTCATCCTGC"	-7.53397593918498	-0.00308356499346355	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGAACTTCATCCTGC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3028.10939846659	42.1605221133992	0.0139230511733654	2578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3021.09878942672	3021.09878942672
"healthy-5"	"2019-08-29-count-2:TGTTTGTCACATTCGA"	-4.90348229828532	3.13204548442689	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTTTGTCACATTCGA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2961.47183809932	44.5892954455016	0.0150564644484748	2404	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2947.25100840741	2947.25100840741
"healthy-5"	"2019-08-29-count-2:CAGTTAGGTCTCAGGC"	10.1477877098018	7.14954278552858	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTTAGGTCTCAGGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1922.71957944703	45.7537704038832	0.0237963824225693	1000	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1919.50723076918	1919.50723076918
"healthy-5"	"2019-08-29-count-1:AGTCACAGTCTACATG"	3.93590058860127	-7.85139849102172	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCACAGTCTACATG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1866.42936193731	46.0586805749628	0.0246774303460137	869	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1864.57166776311	1864.57166776311
"healthy-5"	"2019-08-29-count-1:TGGAGAGAGGCTAAAT"	-5.16143451157268	-4.34473516857298	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGAGAGAGGCTAAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2828.17072854439	42.8283785815638	0.0151434912147637	2125	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2824.23260869485	2824.23260869485
"healthy-5"	"2019-08-29-count-1:TCAAGTGTCGCACTCT"	-3.86579142037089	12.8298339613709	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAAGTGTCGCACTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1484.9976074039	40.2796046597946	0.0271243566043263	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1484.9976074039	1484.9976074039
"healthy-5"	"2019-08-29-count-1:GATCAGTCATCCTTGC"	-1.91807017746623	9.54763505542604	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCAGTCATCCTTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1669.1501395298	37.52346468072	0.0224805808609226	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1664.75774131821	1664.75774131821
"healthy-5"	"2019-08-29-count-2:AGGGCTCTCCCTCGTA"	4.5343300300533	-8.86778166210326	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGCTCTCCCTCGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.49419118723	48.4175433129777	0.0219930370503803	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2198.59669161256	2198.59669161256
"healthy-5"	"2019-08-29-count-2:GTCTAGAAGGGTAGCT"	-2.52153621140178	4.18615481937257	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTAGAAGGGTAGCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3220.21674915402	45.6224181959597	0.0141674991933214	3986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3211.13123958552	3211.13123958552
"healthy-5"	"2019-08-29-count-2:GTCTAGAAGTTGCGCC"	-7.79152284088786	0.0372797076585664	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTAGAAGTTGCGCC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2934.81550863558	44.5098011161406	0.0151661325848839	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2923.77125699305	2923.77125699305
"healthy-5"	"2019-08-29-count-1:CTACCCACACCAATTG"	9.23880257186238	6.71765372836915	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACCCACACCAATTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1629.93970139496	39.0216667200953	0.0239405584677146	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1618.85853932617	1618.85853932617
"healthy-5"	"2019-08-29-count-1:TCAATCTTCCTTTGAT"	2.70657887038533	-6.40085174953612	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATCTTCCTTTGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1641.09772175377	44.4608190947355	0.0270921216362559	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1636.68767300631	1636.68767300631
"healthy-5"	"2019-08-29-count-1:GATCATGAGTGCACCC"	3.48874296721761	-6.82916691219481	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCATGAGTGCACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2355.14086460251	44.6676862025203	0.0189660359063317	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2350.47422832219	2350.47422832219
"healthy-5"	"2019-08-29-count-1:CTACCCAGTGACTGAG"	2.8069085079128	-6.61286165630492	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACCCAGTGACTGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.1142706354	44.05740225948	0.0232847470912446	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1892.1142706354	1892.1142706354
"healthy-5"	"2019-08-29-count-1:GATCATGCAGCTGTTA"	5.13858189162557	-10.157422088739	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCATGCAGCTGTTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.54990879919	39.9969084155286	0.0205054524547653	887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1946.73651644075	1946.73651644075
"healthy-5"	"2019-08-29-count-1:GATCATGGTTTGGGAG"	3.79326381263081	-8.03462698375853	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCATGGTTTGGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1756.35710117168	43.2391971595067	0.0246186821180393	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1754.22864412946	1754.22864412946
"healthy-5"	"2019-08-29-count-1:TGGATCACACAAGTGG"	9.55797638472859	6.66915891254274	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGATCACACAAGTGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1456.23810469114	41.5605599349192	0.0285396734236219	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1451.5525198421	1451.5525198421
"healthy-5"	"2019-08-29-count-1:TGGATCACACCAGCCA"	4.45208944854085	-8.13605883037718	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGATCACACCAGCCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.93436956438	43.266954048406	0.0217210741023903	945	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1982.89569278291	1982.89569278291
"healthy-5"	"2019-08-29-count-2:GTCTCACGTCTTGAAC"	11.23886169967	3.79008576953737	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACGTCTTGAAC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1437.0890498033	36.1319728048587	0.0251424731193967	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1431.86531118779	1431.86531118779
"healthy-5"	"2019-08-29-count-2:GTCTCACTCACGATCA"	2.61059560355489	-7.08573152935179	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACTCACGATCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1395.88278871794	41.2664508392372	0.0295629770441819	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1393.31425873874	1393.31425873874
"healthy-5"	"2019-08-29-count-2:AGGGTCCTCGTAATGC"	3.81134023246114	-8.30449392711791	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTCCTCGTAATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.99857011477	44.3080751452389	0.0260176819421832	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1696.25532041692	1696.25532041692
"healthy-5"	"2019-08-29-count-1:AGTCTCCGTCACAATC"	8.99169506606404	6.22076366031495	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCTCCGTCACAATC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1479.84802698696	42.1001885000732	0.0284489945807415	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1468.0203936991	1468.0203936991
"healthy-5"	"2019-08-29-count-1:TGGATGTAGACTGAGC"	-2.45044122162517	9.27097318256227	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGATGTAGACTGAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1767.86425888037	35.2593087751806	0.0199445792277689	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1761.76526714329	1761.76526714329
"healthy-5"	"2019-08-29-count-1:AGTCTCCTCAGTCCGG"	2.47487225112264	-7.0784859887329	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCTCCTCAGTCCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1780.0370616434	53.2753895745458	0.0299293709791413	786	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1780.0370616434	1780.0370616434
"healthy-5"	"2019-08-29-count-1:AATCGTGCAGTGTGCC"	-3.17138038101848	10.3314265974793	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATCGTGCAGTGTGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1449.50848620654	41.1195833241541	0.0283679493534853	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1447.04638799927	1447.04638799927
"healthy-5"	"2019-08-29-count-1:AGTGACTCAATTTCTC"	3.10585441169087	-7.63571264660033	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGACTCAATTTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.78408856458	45.86547805331	0.0267470863295117	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1707.99297681803	1707.99297681803
"healthy-5"	"2019-08-29-count-2:AGGGTGATCCTCACCA"	2.20610513266866	-8.93592169201048	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGGTGATCCTCACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1662.62907373921	49.7883161098369	0.0299455343926257	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1660.73858899986	1660.73858899986
"healthy-5"	"2019-08-29-count-1:TGGCGTGCAACTGAAA"	3.44789638099019	-7.37946035778197	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGCGTGCAACTGAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.85689208652	44.1205525248547	0.0220068338538303	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2001.67955184806	2001.67955184806
"healthy-5"	"2019-08-29-count-1:CTACGGGCAGGACAGT"	11.3354956108028	3.92196867549745	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTACGGGCAGGACAGT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1484.14948002664	25.6425457943811	0.0172776031925846	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1474.24735501772	1474.24735501772
"healthy-5"	"2019-08-29-count-2:CATACAGGTATCGATC"	-1.09017179432567	9.9153432616028	"2019-08-29-count-2"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATACAGGTATCGATC"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1572.65345746369	39.4857292596016	0.0251077114746452	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1564.67879173138	1564.67879173138
"healthy-5"	"2019-08-29-count-2:CATACAGTCATGACAC"	0.829113205044907	8.19279477680055	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATACAGTCATGACAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1617.48221746587	43.1099550463138	0.0266525063341066	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1608.82160190966	1608.82160190966
"healthy-5"	"2019-08-29-count-2:GTGACGCCAAGACCTT"	3.78077306327168	-7.79840376293334	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGACGCCAAGACCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1985.08595901118	45.0999836574555	0.0227194109417412	912	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.08595901118	1985.08595901118
"healthy-5"	"2019-08-29-count-2:TTACCATGTCACTCGG"	3.48632254180257	-7.77205517208251	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACCATGTCACTCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1763.53274226892	47.7833647200248	0.0270952523731133	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1752.54681916539	1752.54681916539
"healthy-5"	"2019-08-29-count-1:GATCGTATCGCATTAG"	3.4202684360439	-7.69592907344969	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCGTATCGCATTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1872.53969080914	45.9016667634104	0.0245130541097241	855	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1865.00304695012	1865.00304695012
"healthy-5"	"2019-08-29-count-2:GTGACGCTCGAGTGGA"	-2.28727970543559	12.1344442137512	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGACGCTCGAGTGGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1573.20634316988	46.7403651042532	0.0297102572127157	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1570.79276812537	1570.79276812537
"healthy-5"	"2019-08-29-count-2:TCCATCGGTCATAGTC"	6.75663055953328	-0.711467825528704	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCATCGGTCATAGTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2073.59167956262	36.7020035835353	0.0176997255270993	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2066.66365461788	2066.66365461788
"healthy-5"	"2019-08-29-count-1:GATCGTATCTGCCTCA"	4.78747620162312	-7.84395601665648	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATCGTATCTGCCTCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2192.46893368561	44.2593836227413	0.0201870060472601	1070	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2188.85439944941	2188.85439944941
"healthy-5"	"2019-08-29-count-1:AGTGCCGGTACCTGTA"	-3.58536611023601	11.597216583136	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGCCGGTACCTGTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1518.77612681442	39.3316748108391	0.0258969535512359	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1513.81838344643	1513.81838344643
"healthy-5"	"2019-08-29-count-1:CGAGTGCAGTTGCTGT"	3.75488438185994	-8.1816034547058	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGTGCAGTTGCTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1522.12480375823	46.9236225033235	0.0308277103082914	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1519.75290638037	1519.75290638037
"healthy-5"	"2019-08-29-count-1:GATGACTGTAACGATA"	-2.37588367882426	10.6869039305481	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGACTGTAACGATA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1651.27319302091	44.7043521229138	0.0270726566093705	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1649.205827431	1649.205827431
"healthy-5"	"2019-08-29-count-1:TGGGAGAAGACGTCCC"	4.39407171782796	-8.02073290264281	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGAGAAGACGTCCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2062.60302159645	39.1741987794208	0.0189926022454385	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2058.85383928829	2058.85383928829
"healthy-5"	"2019-08-29-count-2:CATACTTAGAGTCTTC"	2.91787876662557	-7.46547558223876	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATACTTAGAGTCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1685.70011115552	40.1369873195147	0.0238102774354102	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1683.29466535766	1683.29466535766
"healthy-5"	"2019-08-29-count-2:TTACCGCCATACAGCT"	5.48219790038411	-9.68551828777465	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACCGCCATACAGCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2391.70607418362	42.1261844018497	0.0176134454214776	1309	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2390.15301156601	2390.15301156601
"healthy-5"	"2019-08-29-count-1:GATGACTTCGGCGATC"	3.55006327208821	-6.72636845028075	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGACTTCGGCGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.0878303667	40.1127847477121	0.0188669462167956	1069	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2124.40874913887	2124.40874913887
"healthy-5"	"2019-08-29-count-1:TCACATTCACACGCCA"	-3.96722159805949	13.0343160399231	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACATTCACACGCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1896.88427155297	42.3307622225826	0.022315943496082	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1892.42124434592	1892.42124434592
"healthy-5"	"2019-08-29-count-1:AATGACCGTAGTCTGT"	-5.6934531730717	-3.25062587177428	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	43	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGACCGTAGTCTGT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2558.29133664222	41.3438092498238	0.0161607119008142	1464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2549.44834706757	2549.44834706757
"healthy-5"	"2019-08-29-count-1:TCACATTCACCTGATA"	3.32076420363728	-8.13097383892211	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACATTCACCTGATA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1979.0130026933	41.846411169674	0.0211450915748021	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1973.08692870686	1973.08692870686
"healthy-5"	"2019-08-29-count-1:TCACATTCACTTGGCG"	-2.59596715393718	10.7058295973572	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACATTCACTTGGCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1674.70458461371	39.5369744191201	0.0236083275715399	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.41566584789	1670.41566584789
"healthy-5"	"2019-08-29-count-1:AGTGTTGGTGTCCAAT"	-5.67490754547771	-5.2196893922058	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGTTGGTGTCCAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2688.63447427806	47.7456378018405	0.017758322396971	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2682.98973070133	2682.98973070133
"healthy-5"	"2019-08-29-count-2:GTGAGTTAGAAGCGAA"	4.07345833358113	-8.37458422100218	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGAGTTAGAAGCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1499.68645865186	50.7825302135162	0.0338620982543025	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1494.91024318332	1494.91024318332
"healthy-5"	"2019-08-29-count-2:GTGAGTTAGTCGAAAT"	4.27025761184041	-8.11180593883666	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGAGTTAGTCGAAAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2003.95774431056	46.8338684673663	0.023370686632656	984	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2002.21839676346	2002.21839676346
"healthy-5"	"2019-08-29-count-2:CATCAAGCAAGAGTAT"	-3.39375148239787	11.8219594725403	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCAAGCAAGAGTAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1427.80368408968	42.4378447450427	0.0297224648023651	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1422.74071148307	1422.74071148307
"healthy-5"	"2019-08-29-count-1:AGTTAGCAGTTACTCG"	6.85280479964559	-1.47738256370696	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTAGCAGTTACTCG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2339.23255785551	39.4371403375195	0.0168590079704061	1319	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2333.33499982835	2333.33499982835
"healthy-5"	"2019-08-29-count-2:CATCAAGCACGACTAT"	2.94721998748128	-7.12697651302489	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCAAGCACGACTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1571.19463130145	45.8674071631599	0.0291926959584676	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1568.74109014648	1568.74109014648
"healthy-5"	"2019-08-29-count-2:AGGTCTAAGCATATGA"	2.79577602919881	-7.18973734295043	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCTAAGCATATGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1578.08830736222	50.0459091351899	0.0317129966059008	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.98162104146	1575.98162104146
"healthy-5"	"2019-08-29-count-2:AGGTCTAAGCTGTGCC"	-0.100122908980209	8.294069267157	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"Treg"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCTAAGCTGTGCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1674.20196710752	37.8830326032161	0.022627516480981	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1674.20196710752	1674.20196710752
"healthy-5"	"2019-08-29-count-2:GCAACATTCGACGCGT"	2.65303530272786	-4.42672445690306	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCAACATTCGACGCGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2395.42387708547	36.2935336751723	0.0151511947519413	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2391.54871732427	2391.54871732427
"healthy-5"	"2019-08-29-count-1:TGGGATTGTACTCGAT"	-3.29113970223125	11.0170535811218	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGATTGTACTCGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1730.8227283101	28.3617018498391	0.0163862545747421	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1724.17416734438	1724.17416734438
"healthy-5"	"2019-08-29-count-1:AATGCCACAGACGGAT"	1.03894360837285	9.52144048297731	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGCCACAGACGGAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1676.52727901137	36.6781946423512	0.0218774815665271	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1676.52727901137	1676.52727901137
"healthy-5"	"2019-08-29-count-2:AGGTCTACATCACAGT"	-2.77775083008464	11.4039430388245	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTCTACATCACAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1468.32550553679	37.8007020357113	0.0257440886868557	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1463.30539074832	1463.30539074832
"healthy-5"	"2019-08-29-count-1:TGGGATTGTCGCCACA"	6.82337631758992	-0.795496605989061	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGATTGTCGCCACA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1691.12240724142	10.9590153831702	0.00648032060615094	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1688.82336460502	1688.82336460502
"healthy-5"	"2019-08-29-count-1:AGTTCCCAGTCGGCAA"	6.85588469085042	-1.5429258576599	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTCCCAGTCGGCAA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2054.14385190891	38.1423936180323	0.0185685114421693	993	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2052.34970940634	2052.34970940634
"healthy-5"	"2019-08-29-count-1:AATGCCATCCAGTTCC"	3.88411607322041	-8.26599790966185	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGCCATCCAGTTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1927.52014508483	40.2138173377228	0.0208629816089175	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1923.40514083954	1923.40514083954
"healthy-5"	"2019-08-29-count-1:AGTTCCCGTATGTCTG"	3.82325377044026	-7.52115299617919	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTCCCGTATGTCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1961.47911655134	42.7639631114328	0.0218018956972737	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1959.56556100872	1959.56556100872
"healthy-5"	"2019-08-29-count-2:CATCCACCAATCAGCT"	10.2572418647701	5.99340627277223	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCACCAATCAGCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.91258141151	35.3515998283701	0.0200415826730377	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1763.91258141151	1763.91258141151
"healthy-5"	"2019-08-29-count-1:TGGGATTTCCTGGTCT"	-0.758091251284438	9.67593572223512	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGATTTCCTGGTCT"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1643.13861402559	32.9601275210478	0.0200592495603871	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1643.13861402559	1643.13861402559
"healthy-5"	"2019-08-29-count-2:CATCCACCATCCGATA"	0.455100526183289	8.80087468707887	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCACCATCCGATA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1842.16727162214	30.8584639001945	0.016751173672205	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1837.25479544266	1837.25479544266
"healthy-5"	"2019-08-29-count-1:TGGGCGTAGAGACAAG"	-3.41653309288676	11.5596647032532	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCGTAGAGACAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1519.2911607583	31.0415149422948	0.0204315773987663	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1516.87333714974	1516.87333714974
"healthy-5"	"2019-08-29-count-2:TTACTGTAGTATGGAT"	-3.13659964028056	9.40417764270631	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACTGTAGTATGGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2161.89378916121	36.8554506774758	0.0170477619493857	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2154.27278961467	2154.27278961467
"healthy-5"	"2019-08-29-count-2:GCACATACACATAACC"	3.05421175536458	-6.63217451488646	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACATACACATAACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2458.08373677119	43.9580845296391	0.0178830704064541	1482	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2455.37090134751	2455.37090134751
"healthy-5"	"2019-08-29-count-2:TCCCATGGTCAACATC"	-3.67702351036723	10.4049005278381	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCATGGTCAACATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1689.64734302112	37.4355027177187	0.0221558083539394	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1685.24162888689	1685.24162888689
"healthy-5"	"2019-08-29-count-1:AGTTCGACATACTTTC"	4.64203466948811	-7.73150303280028	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTTCGACATACTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.34144846262	41.8461116856097	0.0193432764464193	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2163.34144846262	2163.34144846262
"healthy-5"	"2019-08-29-count-1:TGGGCGTGTGTTGATC"	3.53056802329366	-6.98897507106932	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCGTGTGTTGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.41597281913	44.3657287140215	0.0238985924295018	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.60975229029	1852.60975229029
"healthy-5"	"2019-08-29-count-1:AATGGAATCTTAGCAG"	5.52278532561604	-10.1111726990906	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGGAATCTTAGCAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2337.91244985077	40.5151192487878	0.0173296135410776	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2326.0542699351	2326.0542699351
"healthy-5"	"2019-08-29-count-1:TCACTATAGTTACGTC"	-2.09086404267009	9.53989408099977	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACTATAGTTACGTC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1538.50292970942	48.7252534627206	0.0316705626760967	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1538.50292970942	1538.50292970942
"healthy-5"	"2019-08-29-count-1:TGGGCGTTCAGAGTGG"	3.19481362876241	-6.9293046227661	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCGTTCAGAGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.44126159117	47.5903201986361	0.0251475811506149	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.39801567044	1890.39801567044
"healthy-5"	"2019-08-29-count-1:GATGGAGAGGGACAGG"	3.47316350516621	-7.9936094514099	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGGAGAGGGACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.39198516492	50.3079444602376	0.0256360323730174	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1957.08529842731	1957.08529842731
"healthy-5"	"2019-08-29-count-1:TGGGCGTTCTTCACAT"	-2.77310882034953	12.2390479811463	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCGTTCTTCACAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1689.78519959586	43.3119988619532	0.0256316594986819	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1685.32600336283	1685.32600336283
"healthy-5"	"2019-08-29-count-2:CATCCCAGTCTACAGT"	4.3871509033138	-8.08825971996459	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCCAGTCTACAGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2093.14260062514	44.8180522666338	0.0214118485062835	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2085.60246897006	2085.60246897006
"healthy-5"	"2019-08-29-count-1:TCACTATGTGAGAACC"	-3.90619383278545	11.3650693663391	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACTATGTGAGAACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1928.61109820677	41.7536422582963	0.0216495914065407	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1926.39400392134	1926.39400392134
"healthy-5"	"2019-08-29-count-2:GTGCGTGCACACAGAG"	4.28612198409383	-7.16059257900389	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCGTGCACACAGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2117.85460235334	43.4196120607082	0.0205016963924061	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2108.87760494996	2108.87760494996
"healthy-5"	"2019-08-29-count-1:TGGGCTGCACCGGCTA"	-3.4285036129063	3.65550897205202	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCTGCACCGGCTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3316.20793619889	47.0221574278008	0.0141794960787949	3483	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3306.51540614275	3306.51540614275
"healthy-5"	"2019-08-29-count-2:CATCCCATCATCACTT"	3.36661853370015	-7.95531656658324	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCCATCATCACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1819.21908186525	44.6118976095391	0.0245225536903441	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1813.23934400487	1813.23934400487
"healthy-5"	"2019-08-29-count-2:GCACGTGGTATCAGCT"	0.965479274361771	-6.63139202510985	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCACGTGGTATCAGCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1925.30786110163	49.3998240201479	0.0256581427927491	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1921.372916659	1921.372916659
"healthy-5"	"2019-08-29-count-1:TGGGCTGCAGAAACCG"	-0.354260514408904	11.4211663969788	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCTGCAGAAACCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.45901708992	36.8872034572717	0.0239455922215674	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1540.45901708992	1540.45901708992
"healthy-5"	"2019-08-29-count-1:AATTCCTAGTTTGCTG"	4.1444374519283	-8.43166067516478	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATTCCTAGTTTGCTG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2020.98022218151	48.0335033687538	0.0237674287167962	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2019.17305641902	2019.17305641902
"healthy-5"	"2019-08-29-count-1:ATACCTTTCCGCCTAT"	-2.51074777069743	3.46203301036683	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATACCTTTCCGCCTAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2996.76687260881	49.152131007972	0.0164017199526712	2970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2986.85643191913	2986.85643191913
"healthy-5"	"2019-08-29-count-1:GATGTTGCAAACCATC"	-3.59265838089641	3.68534967983095	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGTTGCAAACCATC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2988.55606709979	47.6282581951064	0.0159368795919317	3105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2982.80657378129	2982.80657378129
"healthy-5"	"2019-08-29-count-1:TCAGCAAGTCACTCTC"	4.06643976744954	-7.42753031170043	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCAAGTCACTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1977.82228836176	46.550825242568	0.0235364044163575	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1975.85652950503	1975.85652950503
"healthy-5"	"2019-08-29-count-2:AGTAACCTCTTTCCAA"	1.96962716159169	-6.77898981487425	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAACCTCTTTCCAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1720.10088060076	47.3347244715448	0.0275185746402344	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1715.6533052934	1715.6533052934
"healthy-5"	"2019-08-29-count-2:GTGCTGGCACAAATAG"	3.36775102195088	-7.94542219555052	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTGGCACAAATAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.25521919254	40.4004063261374	0.0192267964201237	987	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.40803990871	2099.40803990871
"healthy-5"	"2019-08-29-count-2:CATCCGTTCCTATTGT"	-3.39407549324687	3.35247085178224	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCGTTCCTATTGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3162.84928247132	42.8840870528127	0.0135586881393554	3219	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3151.13290682191	3151.13290682191
"healthy-5"	"2019-08-29-count-2:GTGCTGGGTTGAATCC"	-5.69752250137981	-3.68962218677672	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTGGGTTGAATCC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2911.47584979174	47.7977037823149	0.0164170016336333	2398	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2906.2485282502	2906.2485282502
"healthy-5"	"2019-08-29-count-2:TTATTGCAGTAACAGT"	5.11570467528645	-9.70121481334838	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTATTGCAGTAACAGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2221.80899688683	45.7068150387682	0.0205718921396088	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2215.85105224968	2215.85105224968
"healthy-5"	"2019-08-29-count-2:CTTACCGCAGGACAGT"	2.99353875693623	-7.70979740535887	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTACCGCAGGACAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.26421243276	48.0476278833085	0.0280281344817452	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1714.26421243276	1714.26421243276
"healthy-5"	"2019-08-29-count-2:CATCCGTTCTCTGACC"	5.52458252486531	-9.89056017315062	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCCGTTCTCTGACC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.47496645241	41.6642508036783	0.0176060391064002	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2356.48862738093	2356.48862738093
"healthy-5"	"2019-08-29-count-1:TGGGTTAGTATGTCCA"	4.39655890044515	-8.031370185968	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGTTAGTATGTCCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.80468523088	39.6884853207	0.0182744266050245	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2170.04328578342	2170.04328578342
"healthy-5"	"2019-08-29-count-1:AATTTCCGTGTGACCC"	3.56151666220967	-8.23281099712523	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATTTCCGTGTGACCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2004.45343377301	41.782194993412	0.0208446822906556	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2004.45343377301	2004.45343377301
"healthy-5"	"2019-08-29-count-2:GAGACTTGTATGAAGT"	-1.70956037464793	10.2396783598694	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGACTTGTATGAAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1550.10543445059	39.0265773342156	0.0251767244129739	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1545.44141125503	1545.44141125503
"healthy-5"	"2019-08-29-count-1:TGGGTTATCGCAGTTA"	-3.38995657387431	10.0567035445007	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGTTATCGCAGTTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1751.71713615765	38.7110687628034	0.0220989267980304	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1749.48824551171	1749.48824551171
"healthy-5"	"2019-08-29-count-2:GTGCTTCAGGTAGTCG"	3.5156361061031	-8.05578043377074	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTTCAGGTAGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1566.22190122574	47.3402556484314	0.0302257653346453	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1566.22190122574	1566.22190122574
"healthy-5"	"2019-08-29-count-2:CATCGCTTCATTGTTC"	0.283776198595208	8.57935998523561	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGCTTCATTGTTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1699.81267844502	42.6229134616894	0.0250750650363901	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1693.75213660126	1693.75213660126
"healthy-5"	"2019-08-29-count-2:AGTAGCTTCTCTATGT"	5.1927510696346	-9.97306253826293	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTAGCTTCTCTATGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.67240301826	45.1025771058533	0.0228405365046449	905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1968.872590634	1968.872590634
"healthy-5"	"2019-08-29-count-2:TTCAATCTCAGTCATG"	2.81243958052937	-6.66653873836669	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCAATCTCAGTCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1843.6899341083	44.5194117319409	0.0241469082779761	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1843.6899341083	1843.6899341083
"healthy-5"	"2019-08-29-count-1:GATTCGATCGCAATTG"	2.61135019835774	-6.75818922435912	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTCGATCGCAATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.10300443513	39.0839120148168	0.0222687283401898	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.41363235756	1746.41363235756
"healthy-5"	"2019-08-29-count-1:TCAGCCTGTGAAAGTT"	-3.04749737206157	10.50447938526	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCCTGTGAAAGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1611.92358443558	32.2702942047654	0.020019741950773	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1607.16673459039	1607.16673459039
"healthy-5"	"2019-08-29-count-1:TCAGCCTTCATTCCTA"	-0.421140442520934	9.05332849109498	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCCTTCATTCCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1710.42914222409	41.5061197060316	0.0242664946950451	734	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1708.33773274732	1708.33773274732
"healthy-5"	"2019-08-29-count-1:TAGACCAGTGAATAAC"	-7.90860162201579	-0.150017135497652	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGACCAGTGAATAAC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2841.7218021756	45.5174205266564	0.0160175498149779	2875	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2836.30957905953	2836.30957905953
"healthy-5"	"2019-08-29-count-1:TGGTACAAGTTCTACG"	-0.996915320784408	9.4323577650818	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGTACAAGTTCTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1454.47520281336	43.6133032315038	0.0299855942178618	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1449.7950791565	1449.7950791565
"healthy-5"	"2019-08-29-count-1:TGGTACACAACGGGTA"	-3.48014531555827	12.745373702887	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGTACACAACGGGTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1604.31692760657	34.5703637615784	0.0215483382159115	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1599.4413376704	1599.4413376704
"healthy-5"	"2019-08-29-count-2:TCCGTGTTCCTTCTAA"	3.17431416091267	-8.34160616314086	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGTGTTCCTTCTAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1486.49346365759	40.6921884125891	0.0273746164429571	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1486.49346365759	1486.49346365759
"healthy-5"	"2019-08-29-count-1:GATTGGTCATTGCTTT"	-2.31966052475627	11.5147161253723	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTGGTCATTGCTTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1580.07817772315	30.8691183410465	0.0195364500163708	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1572.98919364083	1572.98919364083
"healthy-5"	"2019-08-29-count-2:CATCGTCGTAAGGTCG"	3.69563259658162	-6.71147110378417	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGTCGTAAGGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.46107535408	37.4715703654639	0.0187127584284444	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1995.15323223101	1995.15323223101
"healthy-5"	"2019-08-29-count-1:ATAGGCTAGAGTGACC"	3.30667271193807	-6.92154838955077	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATAGGCTAGAGTGACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1788.16052284611	45.7412942315767	0.0255800827985918	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1786.23854325436	1786.23854325436
"healthy-5"	"2019-08-29-count-2:CATCGTCTCAAGCCCG"	3.75480188903157	-8.18570234691771	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGTCTCAAGCCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1675.78072336752	46.4051374960478	0.0276916525228883	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1668.93791997865	1668.93791997865
"healthy-5"	"2019-08-29-count-1:ACAAGCTTCCGATCTC"	-5.80653939667399	-4.98347618496092	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAAGCTTCCGATCTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2941.62900151956	47.0406425102092	0.015991358014865	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2939.74074548705	2939.74074548705
"healthy-5"	"2019-08-29-count-1:GATTGGTGTGGTGATG"	6.89266790923421	-1.13103427803191	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTGGTGTGGTGATG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2114.10575250008	38.00737127132	0.0179779896187188	986	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2106.58816380068	2106.58816380068
"healthy-5"	"2019-08-29-count-1:TGGTAGTCAAGAGGCT"	-2.75269828262981	13.6997518309387	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGTAGTCAAGAGGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1692.80801941663	33.5006362123454	0.019789979624441	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1688.08621118033	1688.08621118033
"healthy-5"	"2019-08-29-count-2:CATGAGTCAGTAACCT"	2.39848293837849	-7.35325815593871	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGAGTCAGTAACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1616.37786964835	49.9399326540528	0.0308961992067594	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1609.95118200468	1609.95118200468
"healthy-5"	"2019-08-29-count-2:TTCACGCTCGAACCTA"	-3.82575378838237	-5.22714903270873	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCACGCTCGAACCTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2719.38841848256	43.3956442453612	0.0159578690379127	1872	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2716.03223479464	2716.03223479464
"healthy-5"	"2019-08-29-count-2:GTGGAGACATGGTGGA"	-4.13286529007609	12.2439832457337	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAGACATGGTGGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1481.00256132885	40.0532550377507	0.0270446899172223	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1473.20812733729	1473.20812733729
"healthy-5"	"2019-08-29-count-2:TCCTCCCGTTCTCCTG"	0.840460737317246	8.72163865650026	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCCCGTTCTCCTG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1518.34384257669	34.5408619333635	0.0227490381063793	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1516.01005909013	1516.01005909013
"healthy-5"	"2019-08-29-count-1:TCAGGTATCATAAGGA"	-3.44848189774211	12.2677068480286	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGGTATCATAAGGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1582.48781652599	43.3356403619996	0.0273845017379872	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1582.48781652599	1582.48781652599
"healthy-5"	"2019-08-29-count-2:GTGGAGATCACGATCA"	2.90292634543721	-6.96492912685546	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGAGATCACGATCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1833.33562049899	46.7146226225263	0.0254806714603689	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1831.23807015491	1831.23807015491
"healthy-5"	"2019-08-29-count-1:ATATCCTAGATTGAGT"	-3.15946493569072	3.52253720844118	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATATCCTAGATTGAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3089.40203272358	46.8021527498339	0.0151492593887412	3130	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3083.64732747471	3083.64732747471
"healthy-5"	"2019-08-29-count-2:TTCAGGAGTGTGTGTT"	2.67777456816975	-4.63149406826171	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCAGGAGTGTGTGTT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2146.48675199057	43.6276619288599	0.0203251484726851	1089	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2146.48675199057	2146.48675199057
"healthy-5"	"2019-08-29-count-2:GTGGCGTCAAGGGTCA"	1.91550638255422	-6.39262010967406	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGCGTCAAGGGTCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1763.23172427661	45.3494297992221	0.0257194951604147	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1758.9601754549	1758.9601754549
"healthy-5"	"2019-08-29-count-1:GTCGTAAAGATAACGT"	-3.9265001815861	-5.42135956203612	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCGTAAAGATAACGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2065.75759859627	46.6452353959844	0.0225802075847045	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2062.51214715297	2062.51214715297
"healthy-5"	"2019-08-29-count-1:ATATCCTCACGCCACA"	5.27569260176961	-10.167808555719	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATATCCTCACGCCACA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2250.40629921947	41.2985635378581	0.0183516032425709	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2237.54691860539	2237.54691860539
"healthy-5"	"2019-08-29-count-1:ATATCCTGTTCCTTGC"	2.88083257254903	-9.71507933056029	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATATCCTGTTCCTTGC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2102.30361662918	46.6078463272832	0.0221698930442854	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2095.91759001136	2095.91759001136
"healthy-5"	"2019-08-29-count-2:CATGCAATCTTCGATT"	6.82830586013143	-1.28909530555876	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGCAATCTTCGATT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2245.90778661024	47.5360747758442	0.0211656395953775	1148	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2238.00630369711	2238.00630369711
"healthy-5"	"2019-08-29-count-2:CATGCCTAGAACGTGC"	3.50789846953694	-7.93898060238036	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGCCTAGAACGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.58036116931	44.4898757145751	0.0229971711734344	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1928.9794031992	1928.9794031992
"healthy-5"	"2019-08-29-count-1:TGGTTAGAGATCCCGC"	2.32898535308186	-7.67477180874022	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGTTAGAGATCCCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1576.45097931672	49.8744950361086	0.0316372000718511	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1576.45097931672	1576.45097931672
"healthy-5"	"2019-08-29-count-2:GTGGGAACAATAGTAG"	5.39552511748616	-9.90630342876586	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGGAACAATAGTAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2156.11918943139	44.0964442736571	0.0204517656026642	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2148.34358002205	2148.34358002205
"healthy-5"	"2019-08-29-count-1:ATCACAGCAATGGGTG"	-2.69192061844524	12.1133641966614	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACAGCAATGGGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1627.66698781378	45.8473098036182	0.0281674999535369	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1627.66698781378	1627.66698781378
"healthy-5"	"2019-08-29-count-1:TGGTTAGAGTTTCAGC"	6.78392281112019	-1.60808577453765	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGTTAGAGTTTCAGC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2222.86245983496	36.5112662433672	0.0164253375560078	1109	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2208.89369947911	2208.89369947911
"healthy-5"	"2019-08-29-count-2:CATGCCTGTACGCTAT"	-2.04397044602092	9.12490079486696	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGCCTGTACGCTAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1611.20526881554	38.9617681865856	0.0241817532133742	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1608.79919262129	1608.79919262129
"healthy-5"	"2019-08-29-count-1:GCAACATTCTGTACAG"	-3.11892209473308	9.82906339252321	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAACATTCTGTACAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1710.80666771734	28.655375616953	0.0167496282061998	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1710.80666771734	1710.80666771734
"healthy-5"	"2019-08-29-count-1:ATCACAGGTACCTATG"	3.44742931899373	-7.94572641765746	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACAGGTACCTATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1868.05570252199	50.1150514072846	0.0268273860033328	867	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1866.12835923729	1866.12835923729
"healthy-5"	"2019-08-29-count-2:GTGGTTAAGCCATTGT"	3.29296578940694	-7.9478798142639	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGGTTAAGCCATTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1463.95778984632	50.2580916799567	0.0343302874089236	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1463.95778984632	1463.95778984632
"healthy-5"	"2019-08-29-count-2:AGTCTCCCACTGGACC"	-7.4380501312321	0.608397460821547	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTCTCCCACTGGACC"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2496.19766209278	43.5680977538577	0.0174537851771445	1853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2491.9714362534	2491.9714362534
"healthy-5"	"2019-08-29-count-1:TGATCTTAGGAATCGC"	3.41030492362325	-8.25123503124388	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATCTTAGGAATCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1430.48552635191	45.0190801874129	0.0314711888782424	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1430.48552635191	1430.48552635191
"healthy-5"	"2019-08-29-count-2:CATGCTCCAGAGTTCT"	3.62403931197469	-8.79247667705687	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGCTCCAGAGTTCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.6633250053	46.2777205675455	0.0224576814688671	969	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2060.6633250053	2060.6633250053
"healthy-5"	"2019-08-29-count-2:GCATCTCGTAATACCC"	11.0560041862423	3.86363408649293	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATCTCGTAATACCC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1570.32094317872	37.9255089194869	0.0241514380128665	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1560.70374894821	1560.70374894821
"healthy-5"	"2019-08-29-count-1:ATCACGAGTCTACGAT"	4.99068607863728	-10.1995716325012	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACGAGTCTACGAT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1462.01966894392	48.4984957726623	0.0331722594455208	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1456.76685348901	1456.76685348901
"healthy-5"	"2019-08-29-count-2:AGATGCTGTCGAGCAA"	-3.99071679535564	11.903293586615	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATGCTGTCGAGCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1572.17191194036	44.3467141997962	0.0282072932756214	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1569.68466780089	1569.68466780089
"healthy-5"	"2019-08-29-count-1:GCAACCGGTGATACTC"	12.010231633752	-3.25666096126708	"2019-08-29-count-1"	"Control5"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAACCGGTGATACTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2369.94507299238	32.9289610120272	0.0138943983923011	2509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2365.08182184884	2365.08182184884
"healthy-5"	"2019-08-29-count-1:ACACTGACACGACGTC"	2.23260774192159	-6.50771429454955	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACACTGACACGACGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1793.6372498467	45.1136979943709	0.0251520746450971	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.6372498467	1793.6372498467
"healthy-5"	"2019-08-29-count-1:ATCACTTCAACAAGTA"	3.59984292563741	-7.8845196000305	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACTTCAACAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1869.71272011921	42.2006786973441	0.0225706752931827	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1863.65418657212	1863.65418657212
"healthy-5"	"2019-08-29-count-1:ATCACTTCACTTTATC"	-2.88283501091655	11.0693797835144	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCACTTCACTTTATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1590.63371228328	26.7174580853776	0.0167967382302151	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1588.40326206155	1588.40326206155
"healthy-5"	"2019-08-29-count-2:CATGGATAGCACTCTA"	1.92697395858113	-6.93289043819579	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGATAGCACTCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1631.87385716842	51.7293132591696	0.0316993332737916	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1624.8913137164	1624.8913137164
"healthy-5"	"2019-08-29-count-1:GCACATACAACAGTGG"	6.85070671614949	-1.49435999309691	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACATACAACAGTGG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2255.13542194556	32.0927398078056	0.0142309590348762	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2250.25928431212	2250.25928431212
"healthy-5"	"2019-08-29-count-2:GCATGATGTCTTACAG"	3.35463633117024	-5.47647955333861	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCATGATGTCTTACAG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2450.68032150986	42.7659125423252	0.0174506287772275	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2442.88450998454	2442.88450998454
"healthy-5"	"2019-08-29-count-2:CATGGATGTACAGTTC"	-4.7066572708195	-5.19047405635985	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGATGTACAGTTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2293.85341429677	53.0544207195063	0.0231289499097183	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2286.85088095412	2286.85088095412
"healthy-5"	"2019-08-29-count-2:CATGGATTCGAACACT"	10.1211344200069	6.93091867053834	"2019-08-29-count-2"	"Control5"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGATTCGAACACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1948.08112950895	43.3635951505673	0.0222596453985968	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1943.07837371711	1943.07837371711
"healthy-5"	"2019-08-29-count-1:TCATATCCAGCTGGTC"	2.89426006850545	-8.19247534191283	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATATCCAGCTGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1497.3340790332	43.7842846435966	0.0292414934360322	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1494.8827133493	1494.8827133493
"healthy-5"	"2019-08-29-count-2:AGTGATCAGTGAACAT"	-2.09284196320232	11.0640029677185	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGATCAGTGAACAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1417.7159796229	36.4453576547462	0.0257070937892937	528	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1412.84131652517	1412.84131652517
"healthy-5"	"2019-08-29-count-1:ATCAGGTGTACCGCGT"	4.20652212676351	-8.16142465984496	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCAGGTGTACCGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.53102275412	37.3612227866663	0.0184999499218959	948	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2019.53102275412	2019.53102275412
"healthy-5"	"2019-08-29-count-2:TGGTACACAGTTGTCA"	9.59472908553426	6.43169210040895	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGTACACAGTTGTCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1556.28345901842	36.9902149506909	0.0237683018066782	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1547.09886696915	1547.09886696915
"healthy-5"	"2019-08-29-count-1:TCATCATAGCAAATCA"	4.19965376433675	-8.50665476238402	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCATAGCAAATCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2076.64086261217	44.1348928380052	0.0212530214697253	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2071.30087754993	2071.30087754993
"healthy-5"	"2019-08-29-count-2:CATGGTAGTGTAGGAC"	3.22717132148091	-7.99523451244506	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGTAGTGTAGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1639.29109339446	47.4271500213769	0.0289314998492244	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1632.53785893403	1632.53785893403
"healthy-5"	"2019-08-29-count-2:GTGTGATTCGCATAGT"	-3.72901068154033	3.59380791271058	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTGATTCGCATAGT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2837.02787936492	47.8851056291756	0.0168786165188813	2418	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2830.24743911206	2830.24743911206
"healthy-5"	"2019-08-29-count-2:CATGGTATCATTTACC"	11.0943762260372	3.92863056743471	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGGTATCATTTACC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1575.50438685036	37.647995180293	0.0238958364664134	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1570.40042809079	1570.40042809079
"healthy-5"	"2019-08-29-count-1:GCACGGTTCACGGAGA"	3.47008552131001	-7.53015234386595	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACGGTTCACGGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1767.0582815357	46.8708872723828	0.0265248111859948	724	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.81941714812	1764.81941714812
"healthy-5"	"2019-08-29-count-2:GCCAGCAAGTTGCGCC"	4.65698113021199	-8.45609667217406	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGCAAGTTGCGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2339.9968941678	36.850424375727	0.0157480655070837	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2331.04599869958	2331.04599869958
"healthy-5"	"2019-08-29-count-1:TGTCAGAAGGTCCCGT"	3.9891172843868	-7.70039942180785	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTCAGAAGGTCCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.57263155677	43.4439858302052	0.0226912184547839	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1910.58228197701	1910.58228197701
"healthy-5"	"2019-08-29-count-1:ATCATTCTCATCTGTT"	3.88063444670979	-8.13945677196654	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCATTCTCATCTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.89493732662	38.9867940763539	0.0189818833319194	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2050.05212199065	2050.05212199065
"healthy-5"	"2019-08-29-count-2:CATTCATTCCAATCTT"	-3.24774752083476	12.07297132099	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCATTCCAATCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1617.0169066868	42.3439529188936	0.0261864627041251	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1612.33179777928	1612.33179777928
"healthy-5"	"2019-08-29-count-1:ATCATTCTCCCATGGG"	-2.56933222237285	11.082715965155	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCATTCTCCCATGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1669.34648489151	40.2117618286157	0.0240883256966448	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1667.13740195791	1667.13740195791
"healthy-5"	"2019-08-29-count-1:ATCATTCTCCGTAGTA"	3.92347015914266	-8.1387453309265	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCATTCTCCGTAGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2074.4541872717	41.3321488749339	0.0199243488376543	979	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2072.64927205172	2072.64927205172
"healthy-5"	"2019-08-29-count-2:TTCCGGTTCTGGGCCA"	-3.87691078606303	11.1488036879334	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCGGTTCTGGGCCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1744.24038280638	37.3791281988452	0.0214300325616268	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1739.89701025522	1739.89701025522
"healthy-5"	"2019-08-29-count-1:ACAGCCGGTACCGTGC"	-3.24381695213969	11.2080669173035	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGCCGGTACCGTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1426.81945439517	32.1813687809699	0.0225546187233701	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1419.45912928835	1419.45912928835
"healthy-5"	"2019-08-29-count-1:TCATCCGCAGTGCCTG"	4.77066053923909	-7.48635151302489	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATCCGCAGTGCCTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1984.44328948956	26.8392070833523	0.0135248042740773	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.44328948956	1984.44328948956
"healthy-5"	"2019-08-29-count-2:GTGTTAGGTAGTCACT"	-4.57163749161418	-4.46907427227172	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTTAGGTAGTCACT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2864.14400297634	43.5455527055039	0.0152036883132456	2190	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2859.24695336396	2859.24695336396
"healthy-5"	"2019-08-29-count-1:ATCCACCCATCGGAAG"	2.89373626288716	-7.16359665310057	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCACCCATCGGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.15536818585	49.0540235242069	0.0290233811917893	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1685.84211791675	1685.84211791675
"healthy-5"	"2019-08-29-count-1:AACGAAAGTCCACATA"	-4.91293321076091	-5.11471083080443	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACGAAAGTCCACATA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1958.38255613544	52.3841622940246	0.0267486871397571	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1952.58075435554	1952.58075435554
"healthy-5"	"2019-08-29-count-2:CATTCCGCAGGACATG"	3.3307601409847	-7.9063873521057	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCCGCAGGACATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1600.03751626189	40.9719437655462	0.0256068644323212	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1593.00229357719	1593.00229357719
"healthy-5"	"2019-08-29-count-2:CATTCCGGTCAACATC"	0.21542558547799	8.60591886127321	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCCGGTCAACATC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1642.75247997824	40.5102591210448	0.0246599896300759	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1636.08461442083	1636.08461442083
"healthy-5"	"2019-08-29-count-1:ATCCACCTCGGCCCAA"	0.766494591801804	8.6263742216858	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCACCTCGGCCCAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1496.11472818235	37.2799001602915	0.0249178084127167	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1487.02034679447	1487.02034679447
"healthy-5"	"2019-08-29-count-1:ACAGGGAAGTCGAAAT"	-3.30045423927959	10.3226985701355	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGGGAAGTCGAAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1627.00954777285	39.2011649994926	0.0240939981287471	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1622.60881547469	1622.60881547469
"healthy-5"	"2019-08-29-count-2:AGTGTTGTCTCTAGGA"	14.2104937034542	1.88074741447297	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTGTTGTCTCTAGGA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1124.46683085174	35.4208645817235	0.0315001417648697	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1113.89015838029	1113.89015838029
"healthy-5"	"2019-08-29-count-2:TTCCTAAAGTGTTGTC"	5.10805525359456	-9.01125051891478	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTAAAGTGTTGTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2028.19392338243	41.3734987656112	0.0203991828831695	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2024.71509817068	2024.71509817068
"healthy-5"	"2019-08-29-count-2:CATTCCGTCTCCTACG"	2.26909484443013	-7.24712612545165	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCCGTCTCCTACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1580.16684697899	48.9082665384666	0.0309513306344649	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1580.16684697899	1580.16684697899
"healthy-5"	"2019-08-29-count-2:GTAGATCGTCACCGAC"	2.8578368621761	-7.08105709468993	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAGATCGTCACCGAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2322.15437029026	45.3571248039271	0.0195323469379245	1258	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2317.51784030023	2317.51784030023
"healthy-5"	"2019-08-29-count-1:ACAGGGAGTCTACGAT"	1.76115955886189	-6.86897232448729	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGGGAGTCTACGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1755.99234322476	45.8571628596321	0.0261146713062647	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1751.71157669736	1751.71157669736
"healthy-5"	"2019-08-29-count-1:TGCACGGGTACCCAGC"	-2.57318792763408	10.3301791914734	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCACGGGTACCCAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1465.26241861075	33.3025497815404	0.0227280447232895	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1465.26241861075	1465.26241861075
"healthy-5"	"2019-08-29-count-1:GCACTAATCATTTCCA"	-3.06027470055278	10.3155288466248	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCACTAATCATTTCCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1711.4115735178	43.0105726392281	0.0251316359575739	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1711.4115735178	1711.4115735178
"healthy-5"	"2019-08-29-count-2:GCCAGTGCAGGTCAGA"	6.77758230742757	-1.5736202231613	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCAGTGCAGGTCAGA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2513.48766866575	36.7567819142915	0.0146238162902161	1481	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2505.21051924795	2505.21051924795
"healthy-5"	"2019-08-29-count-1:ATCCATTCATGGCACC"	2.10919751700703	-6.72525312816771	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCATTCATGGCACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.49822623009	46.7151260686821	0.0219681001810661	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2123.00839775141	2123.00839775141
"healthy-5"	"2019-08-29-count-1:TGTCCTGAGCCAAGGT"	-2.0717798275059	3.61788914287416	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTCCTGAGCCAAGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2589.32848842785	42.8555961784232	0.0165508533853284	2238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2581.35668920336	2581.35668920336
"healthy-5"	"2019-08-29-count-1:TGTCCTGAGGGAGTGG"	3.6599940257961	-8.20960237896117	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTCCTGAGGGAGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1650.73413433828	42.2867087733418	0.0256169106179494	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1650.73413433828	1650.73413433828
"healthy-5"	"2019-08-29-count-1:ATCCATTGTTCTGAGT"	3.03744353827779	-8.3025522462097	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCATTGTTCTGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1732.24567655358	44.7331207317971	0.0258237739237985	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1725.78026939133	1725.78026939133
"healthy-5"	"2019-08-29-count-2:CATTCTATCACGGACC"	3.46716894683186	-7.82129480755004	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCTATCACGGACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.27844740995	43.745711270407	0.023836007736125	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1835.27844740995	1835.27844740995
"healthy-5"	"2019-08-29-count-2:AGTTCCCCATTGAAGA"	2.13002981719319	-6.67238571560057	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGTTCCCCATTGAAGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2064.29868808886	45.9005568491681	0.0222354241244338	1023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2054.05561723561	2054.05561723561
"healthy-5"	"2019-08-29-count-1:GCAGCCACATCGAAGG"	-3.20549807968791	3.50669453227846	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGCCACATCGAAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3137.74286159455	48.0357691467348	0.0153090202943921	3395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3131.21900215903	3131.21900215903
"healthy-5"	"2019-08-29-count-1:TGTCCTGCACAAACGG"	2.10368909415547	-7.20944883739623	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTCCTGCACAAACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.70744261932	49.1573999741426	0.0292480408711301	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1678.55642107056	1678.55642107056
"healthy-5"	"2019-08-29-count-1:GCAGCCAGTGTGGACA"	-3.13178167763408	11.5634546049866	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGCCAGTGTGGACA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1552.67175396828	41.3214447128313	0.0266131232227436	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1550.26256343457	1550.26256343457
"healthy-5"	"2019-08-29-count-1:TCATGTTAGGTTTACC"	6.81172670897786	-1.55392208015593	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGTTAGGTTTACC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2319.60494326248	33.6547516990065	0.0145088290990067	1283	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2310.57030380359	2310.57030380359
"healthy-5"	"2019-08-29-count-1:GCAGCCATCGGCTGAC"	3.14126600798909	-7.72214081203612	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGCCATCGGCTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1893.23220785791	47.4484370333457	0.0250621328099161	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.35448489594	1887.35448489594
"healthy-5"	"2019-08-29-count-1:TCATGTTCAGTGTGGA"	5.3530670600826	-9.95919611370238	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGTTCAGTGTGGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2240.66357487607	37.8063625593067	0.0168728420380546	1186	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2239.1112879582	2239.1112879582
"healthy-5"	"2019-08-29-count-1:TCATGTTCATTCTCTA"	-5.54426036301311	-5.51753237163695	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGTTCATTCTCTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2360.0153505621	44.0548266910766	0.0186671780251699	1406	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2350.56470182503	2350.56470182503
"healthy-5"	"2019-08-29-count-1:TCATGTTGTCTGATCA"	-5.24972711029704	-5.1758113137451	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATGTTGTCTGATCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2483.14404550348	43.6940708532914	0.0175962691058593	1454	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2481.76160293136	2481.76160293136
"healthy-5"	"2019-08-29-count-1:ATCCCTGTCGTGCAGC"	-2.43199978295024	4.1805267103943	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCCTGTCGTGCAGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3000.55988486609	47.2316370722504	0.0157409413191426	3266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2996.52479487383	2996.52479487383
"healthy-5"	"2019-08-29-count-1:ATCCGTCAGACGAGCT"	-3.94414172592815	12.2597665556702	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCGTCAGACGAGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1632.68113457815	36.2924294869302	0.0222287308392936	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1630.28685806725	1630.28685806725
"healthy-5"	"2019-08-29-count-1:ATCCGTCAGCTGGCTC"	3.26477422293965	-9.77482893383177	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCGTCAGCTGGCTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2277.76350923475	40.1494700416785	0.0176267070215588	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2274.66852564011	2274.66852564011
"healthy-5"	"2019-08-29-count-2:GTTACGACATGTGCCG"	3.346048493951	-7.81272270595702	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTACGACATGTGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1649.87926892738	53.0347854506149	0.0321446462474153	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1649.87926892738	1649.87926892738
"healthy-5"	"2019-08-29-count-2:TTCCTTCTCTGGTGCG"	-3.23404131355937	11.3715677031311	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTTCTCTGGTGCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1482.17078672885	36.1399139136232	0.024383096898964	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1477.38674060514	1477.38674060514
"healthy-5"	"2019-08-29-count-1:TGTGAGTGTACTGTTG"	3.48577012595479	-8.51382257854613	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGAGTGTACTGTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1581.56888273808	47.0550637180695	0.0297521430976851	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1576.87132847179	1576.87132847179
"healthy-5"	"2019-08-29-count-1:ATCCGTCAGTCATGCT"	2.9395886856014	-6.34821417247923	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCGTCAGTCATGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2132.56406726071	44.6733884146661	0.0209482046051959	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2125.54873987913	2125.54873987913
"healthy-5"	"2019-08-29-count-1:TCATTCAGTGATGTAA"	2.49420775946919	-7.17160561000975	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTCAGTGATGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1706.16683733367	39.0623407797663	0.0228947954707708	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1699.51653705576	1699.51653705576
"healthy-5"	"2019-08-29-count-2:GCCCAGATCTAACGGT"	3.19068016585652	-7.62336876308592	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCCAGATCTAACGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1493.17105266121	45.690990192298	0.030599970519697	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1490.61738711219	1490.61738711219
"healthy-5"	"2019-08-29-count-1:CTCCATGTCATCTACT"	-4.76506696167644	-4.45826961910399	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCATGTCATCTACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2719.79464472303	39.3595435854135	0.0144715130099176	1809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2716.26495788096	2716.26495788096
"healthy-5"	"2019-08-29-count-2:TTCGATTCACGTAGTT"	3.21946992453877	-7.45323755657347	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGATTCACGTAGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1751.36310522278	39.8832346125445	0.022772681743499	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1747.12604565122	1747.12604565122
"healthy-5"	"2019-08-29-count-1:TGTGATGCATCAGTCA"	4.01757802542989	-7.1967983475891	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGATGCATCAGTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2245.60600915471	42.2685495361279	0.0188227807388343	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2234.68384380717	2234.68384380717
"healthy-5"	"2019-08-29-count-1:TGTGATGTCTATCGTT"	10.2978273826534	7.48980138385621	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGATGTCTATCGTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1484.76892281252	41.4355070643379	0.0279070409056306	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1484.76892281252	1484.76892281252
"healthy-5"	"2019-08-29-count-1:TGTGATGTCTGGGATT"	-2.11150298538859	3.96654841983644	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGATGTCTGGGATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2969.52110218058	43.4518675753811	0.0146326178801941	2939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2959.5080362188	2959.5080362188
"healthy-5"	"2019-08-29-count-2:CATTGTTAGGACTTCT"	0.457122226327103	8.62756059253541	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTGTTAGGACTTCT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1532.96395108793	39.0117155868768	0.0254485538027104	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1524.34610449314	1524.34610449314
"healthy-5"	"2019-08-29-count-1:AAGAACAGTTGGACTT"	-1.23598180237468	9.63297650897828	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGAACAGTTGGACTT"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1546.42893479125	40.1725529308255	0.0259776262762752	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1544.14089171031	1544.14089171031
"healthy-5"	"2019-08-29-count-2:CACTGTCGTCGACTGC"	-2.72286806526836	12.6276254423889	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACTGTCGTCGACTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1412.33453410697	43.4212267076987	0.0307442929837825	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1409.79350078615	1409.79350078615
"healthy-5"	"2019-08-29-count-2:TTCGATTTCTAGTGAC"	3.68935169753377	-7.75462057506713	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGATTTCTAGTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1977.16086568128	43.534109127284	0.0220184962604362	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1977.16086568128	1977.16086568128
"healthy-5"	"2019-08-29-count-1:TCATTGTGTGCAATAA"	11.2657238441402	4.01083943927614	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTGTGTGCAATAA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1447.63543809529	35.7505716002124	0.0246958389242327	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1445.14697878096	1445.14697878096
"healthy-5"	"2019-08-29-count-1:TGTGGCGAGATCGACG"	-3.42536650124248	12.4579534300598	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGGCGAGATCGACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1533.30600447941	40.4727030057962	0.0263957115458747	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1528.65083278823	1528.65083278823
"healthy-5"	"2019-08-29-count-2:TTCGCTGAGTAAACGT"	4.28891434249226	-7.49252321636351	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGCTGAGTAAACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1773.37267929341	42.823274952507	0.0241479275352147	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1771.30011755053	1771.30011755053
"healthy-5"	"2019-08-29-count-1:TCATTGTGTGTGGTCC"	-1.47524843636211	12.4689788588318	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTGTGTGTGGTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1602.04309172754	37.632531191648	0.0234903364247634	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1602.04309172754	1602.04309172754
"healthy-5"	"2019-08-29-count-2:GCCGATGCAAGGTCAG"	-2.30543480339702	4.21351525867311	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCCGATGCAAGGTCAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3164.29669518723	43.3990549706496	0.0137152293704499	3513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3156.92595491883	3156.92595491883
"healthy-5"	"2019-08-29-count-1:TGTGGCGCATACTGAC"	-3.26251278343852	3.69821450794069	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGGCGCATACTGAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3073.38690190451	49.0403974022977	0.0159564672355142	3304	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3069.483701663	3069.483701663
"healthy-5"	"2019-08-29-count-2:GTTATGGTCCGCGGAT"	4.04872574385945	-7.76895286953124	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTATGGTCCGCGGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2030.52010871876	41.5556281670653	0.0204655092991354	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2028.72285780964	2028.72285780964
"healthy-5"	"2019-08-29-count-1:CCAAGCGCAACTCCCT"	4.53480782088582	-7.5668082467285	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCAAGCGCAACTCCCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1923.56689344542	49.9272924930674	0.0259555790147955	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1921.66993768292	1921.66993768292
"healthy-5"	"2019-08-29-count-2:ATACTTCCATTGCTTT"	2.24019016799275	-8.68030931865843	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACTTCCATTGCTTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1862.46980612168	49.1157038163095	0.0263712752039647	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1856.29208093869	1856.29208093869
"healthy-5"	"2019-08-29-count-2:GTTATGGTCGGTCTGG"	1.81050087985341	-7.50973703777465	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTATGGTCGGTCTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1373.69051830976	48.7034576127369	0.0354544615134009	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1368.82604164082	1368.82604164082
"healthy-5"	"2019-08-29-count-1:TCATTTGGTACGATCT"	-2.3509763282841	10.3446054228577	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTTGGTACGATCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1609.08019843957	39.4858792315988	0.0245394103226743	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1602.60551170726	1602.60551170726
"healthy-5"	"2019-08-29-count-2:CATTTCATCTATGTGG"	3.34886660155599	-7.74454309856566	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTTCATCTATGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1764.12116350441	44.6590551654315	0.0253151858780021	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1757.39101036234	1757.39101036234
"healthy-5"	"2019-08-29-count-1:TCATTTGGTCTCTCTG"	10.4540049034053	6.46930024707643	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCATTTGGTCTCTCTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1555.48840200317	45.8414484671797	0.0294707748435442	597	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1555.48840200317	1555.48840200317
"healthy-5"	"2019-08-29-count-1:ACCAAACTCCAACACA"	-3.12252293053325	11.9704990156922	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCAAACTCCAACACA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1697.82569282907	42.1534759329612	0.0248279173244937	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1693.70721459457	1693.70721459457
"healthy-5"	"2019-08-29-count-2:CCAAGCGCACGCTGTG"	3.03103913840596	-7.11523439800414	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAAGCGCACGCTGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.73322522913	41.7674960071497	0.0216329710709738	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1927.41806028843	1927.41806028843
"healthy-5"	"2019-08-29-count-2:CCAAGCGCACTTCATT"	3.12560429152791	-8.07735636150511	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAAGCGCACTTCATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.0906296201	49.2067353912522	0.0279252012150254	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1762.0906296201	1762.0906296201
"healthy-5"	"2019-08-29-count-1:GCATCTCAGGAATTAC"	-3.25793061676677	13.0694522627625	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATCTCAGGAATTAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1657.66699248886	36.2518087959657	0.0218691745448441	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1655.26543156276	1655.26543156276
"healthy-5"	"2019-08-29-count-2:GTTCATTCAGTCAGTT"	-1.64971874180492	10.2340965040955	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCATTCAGTCAGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1418.70080117619	35.8520915200657	0.0252710730059095	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1411.19108281635	1411.19108281635
"healthy-5"	"2019-08-29-count-2:TTCGGTCGTTGGACCC"	3.30821408805196	-7.41010715877684	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCGGTCGTTGGACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.64137422284	50.5193764185541	0.027006446620236	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1868.48398363825	1868.48398363825
"healthy-5"	"2019-08-29-count-1:TCCACCAGTACATTGC"	-3.66487966004069	12.3716468580994	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACCAGTACATTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1602.99861896971	43.1026927544624	0.0268887896997476	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1600.68809998286	1600.68809998286
"healthy-5"	"2019-08-29-count-2:TCGCTCATCGCCAACG"	9.23279346999471	6.17607543552247	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTCATCGCCAACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1448.62282030637	42.1877361256043	0.0291226505162207	538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1441.54227195058	1441.54227195058
"healthy-5"	"2019-08-29-count-2:CCAATGAAGCGATGCA"	-3.43739376488383	-5.69018080150756	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAATGAAGCGATGCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2345.02404506781	47.1212712609889	0.0200941527060659	1350	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2342.15415258653	2342.15415258653
"healthy-5"	"2019-08-29-count-2:TTCTAACAGCCTGCCA"	-2.64937363091167	4.0981874235901	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAACAGCCTGCCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3375.65250395671	48.5084218924204	0.0143700875121364	4349	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3370.46013774904	3370.46013774904
"healthy-5"	"2019-08-29-count-1:TGTTACTTCTCAACGA"	5.46889271315877	-10.0042190781799	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTACTTCTCAACGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2060.37881371117	42.5976009903021	0.0206746452190386	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2058.52247280526	2058.52247280526
"healthy-5"	"2019-08-29-count-1:ATCGCCTCAAGAATGT"	-2.23347602310832	10.9140558012756	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGCCTCAAGAATGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1448.57500372384	41.8049004157039	0.0288593274826891	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1448.57500372384	1448.57500372384
"healthy-5"	"2019-08-29-count-1:ACCACAAAGATTAGAC"	10.0313717323238	6.06436345661012	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCACAAAGATTAGAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1509.50426102506	40.5427549413182	0.0268583242777909	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1502.78981976346	1502.78981976346
"healthy-5"	"2019-08-29-count-1:TCCACGTAGTCTAGAA"	3.86762442168538	-8.19049646770629	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTAGTCTAGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1899.45822129586	39.5309070548484	0.0208116749353294	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1891.51678997208	1891.51678997208
"healthy-5"	"2019-08-29-count-1:ATCGCCTCATGTGTCA"	5.407234330743	-9.58254721080931	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGCCTCATGTGTCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1954.32260119275	40.1726425300476	0.0205557887451794	868	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1952.33522775835	1952.33522775835
"healthy-5"	"2019-08-29-count-2:CCAATTTCAAATTGCC"	3.65269078788106	-8.40421392833861	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAATTTCAAATTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.3259937116	46.9107443428772	0.0262463280386032	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1783.23958092619	1783.23958092619
"healthy-5"	"2019-08-29-count-2:TTCTAACTCTTACCGC"	-2.13923941078838	10.0211276778015	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAACTCTTACCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1733.15009769903	44.0500690159712	0.0254161881734612	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1730.98360178872	1730.98360178872
"healthy-5"	"2019-08-29-count-1:ATCGCCTGTATGCAAA"	3.81300034102742	-8.25680925762328	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGCCTGTATGCAAA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1896.64000828307	43.6184531905382	0.0229977502320136	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1892.8961283489	1892.8961283489
"healthy-5"	"2019-08-29-count-1:ATCGCCTGTCCAAAGG"	3.2975021797115	-7.38256599819335	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGCCTGTCCAAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1966.91405853033	40.3288054688398	0.0205035930746122	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1961.17670877956	1961.17670877956
"healthy-5"	"2019-08-29-count-1:TGTTCCGCACACAGAG"	-2.047266582877	9.66941354358522	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTCCGCACACAGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1431.19677856066	39.7704661556271	0.0277882585758919	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1431.19677856066	1431.19677856066
"healthy-5"	"2019-08-29-count-2:CCAATTTCAGTGGTGA"	4.17331041869466	-8.92972948467406	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCAATTTCAGTGGTGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1936.09621687213	35.4369977431372	0.0183033247182248	890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1934.23388559387	1934.23388559387
"healthy-5"	"2019-08-29-count-1:TCCACGTTCTCAAAGC"	-3.81079564514812	12.6593065031799	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCACGTTCTCAAAGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1764.78122933549	45.3081750796983	0.0256735363718474	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1762.4950880801	1762.4950880801
"healthy-5"	"2019-08-29-count-2:TTCTAGTGTAGGCTGA"	-1.6831992668217	3.63719222629396	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTAGTGTAGGCTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2640.00864908525	43.0955696719119	0.0163240259409166	2563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2635.93257720396	2635.93257720396
"healthy-5"	"2019-08-29-count-2:GTTCCGTTCTCCCAAC"	3.4104401069576	-7.86559011852416	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCCGTTCTCCCAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.47581372919	39.5174355894598	0.0188046111838583	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.83434540487	2099.83434540487
"healthy-5"	"2019-08-29-count-1:ACCATTTAGGATATGT"	5.38530172881429	-9.95453455364379	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCATTTAGGATATGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.26263984249	49.8193860171936	0.0249188801032758	989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1995.82920488934	1995.82920488934
"healthy-5"	"2019-08-29-count-1:TGTTCTAAGCGAGAAA"	5.37277950820271	-9.57416918193968	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTCTAAGCGAGAAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2059.26599623063	40.7685895673602	0.0197976316036805	1052	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2056.05384228682	2056.05384228682
"healthy-5"	"2019-08-29-count-1:TGTTCTAAGGCGTCCT"	-6.9699891609257	4.18365571582643	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTCTAAGGCGTCCT"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2328.95002415765	36.7735422544802	0.0157897515502853	1479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2317.46352190025	2317.46352190025
"healthy-5"	"2019-08-29-count-1:TGTTCTACACTGAGTT"	4.03838028487508	-8.46031954204711	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTCTACACTGAGTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1606.90678677887	50.7328865488714	0.0315717669290378	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1602.30860106045	1602.30860106045
"healthy-5"	"2019-08-29-count-1:TGTTCTACAGACCCGT"	2.72809710082356	-8.0789480439392	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTCTACAGACCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1539.54874259684	46.7367798349742	0.0303574538056785	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1539.54874259684	1539.54874259684
"healthy-5"	"2019-08-29-count-1:GCATTAGTCGGATAAA"	-3.21264968338664	10.525418258551	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATTAGTCGGATAAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.42211961083	33.4685686986292	0.022070746836124	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1511.47133496604	1511.47133496604
"healthy-5"	"2019-08-29-count-1:ATCGGATTCGCACTCT"	-3.45436177673991	11.7542466887268	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGGATTCGCACTCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1615.86861362612	34.0567930583756	0.0210764617687262	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1615.86861362612	1615.86861362612
"healthy-5"	"2019-08-29-count-1:ACCATTTTCCTGTAAG"	2.05548300322835	-6.86276676571044	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCATTTTCCTGTAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.12596300878	49.0325086614996	0.0246255182105139	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1987.05697677414	1987.05697677414
"healthy-5"	"2019-08-29-count-2:TTCTCTCAGGGAGTGG"	1.35873093184773	-6.84319450771483	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTCTCAGGGAGTGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1927.92418171543	48.7846446332307	0.0253042340025131	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1924.00927105876	1924.00927105876
"healthy-5"	"2019-08-29-count-2:CCACAAACAGTCAGTT"	5.37963356551473	-10.0618725053039	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACAAACAGTCAGTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2215.86767497123	43.6991906314872	0.0197210289788873	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2210.71206482992	2210.71206482992
"healthy-5"	"2019-08-29-count-2:CTGAATGCACAACGCC"	-0.619127432734329	10.681652999762	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAATGCACAACGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1485.29952501508	34.6130954007884	0.0233037813705872	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1485.29952501508	1485.29952501508
"healthy-5"	"2019-08-29-count-1:ATCGGCGCAACGCCCA"	3.45030822333638	-7.22923900997313	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGGCGCAACGCCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1885.61928890073	46.9171071913089	0.0248815375762625	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1879.59152900491	1879.59152900491
"healthy-5"	"2019-08-29-count-2:CCACAAATCTGGAGAG"	6.81164993819539	-1.51758506214293	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACAAATCTGGAGAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2200.1533534203	33.959668770744	0.0154351371543948	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2196.84432141724	2196.84432141724
"healthy-5"	"2019-08-29-count-1:TCCATCGGTCCTGGGT"	-1.38651416721995	9.51010606372682	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCATCGGTCCTGGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1492.24710644593	42.1800556273179	0.0282661332999852	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1492.24710644593	1492.24710644593
"healthy-5"	"2019-08-29-count-2:GTTGAACAGGAGATAG"	9.23863281783406	6.72407052600709	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGAACAGGAGATAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1458.76311455815	48.5685615896868	0.0332943444380947	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1454.08976100931	1454.08976100931
"healthy-5"	"2019-08-29-count-1:TGCGGGTAGCATGCGA"	4.65741409835164	-7.93737461483153	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTAGCATGCGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.23222506294	42.8083585770271	0.0184818940492307	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2312.95562872908	2312.95562872908
"healthy-5"	"2019-08-29-count-2:CCACACTGTGCCTGAC"	4.08547367629353	-7.99737074291381	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACACTGTGCCTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1893.13118165998	44.6060888096888	0.0235620696768495	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1893.13118165998	1893.13118165998
"healthy-5"	"2019-08-29-count-1:GCCAACGGTATCCTCC"	0.182775695889634	8.63262364948121	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAACGGTATCCTCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1928.07681595313	37.3339743348468	0.0193633230927011	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1921.93283442023	1921.93283442023
"healthy-5"	"2019-08-29-count-1:TGTTGAGTCGAAGGAC"	-4.16387830200847	-5.29368736660155	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTGAGTCGAAGGAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2195.70984004072	50.4553297135472	0.0229790516002841	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2193.92389076772	2193.92389076772
"healthy-5"	"2019-08-29-count-1:ACCCTCAGTTTACTGG"	11.1768003898555	4.62896106326906	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCCTCAGTTTACTGG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1852.22756377365	43.1381241655454	0.0232898618988575	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1842.82526916951	1842.82526916951
"healthy-5"	"2019-08-29-count-1:ATCGTAGCACGCTGAC"	0.0821530233020007	7.97556350314943	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTAGCACGCTGAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1760.86250370875	36.3974485083751	0.0206702388356356	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1751.28273176829	1751.28273176829
"healthy-5"	"2019-08-29-count-1:TGTTGGAAGAGGGCGA"	3.66334762152974	-8.18619062816771	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTGGAAGAGGGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1451.37878647274	50.5338236790493	0.0348178050761379	534	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1448.88894736203	1448.88894736203
"healthy-5"	"2019-08-29-count-1:TGTTGGACAATTGTGC"	-3.58139572563823	12.8184146651062	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTGGACAATTGTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1542.29199077606	39.097139566058	0.0253500243792259	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1542.29199077606	1542.29199077606
"healthy-5"	"2019-08-29-count-2:TTCTGTATCGTTGTAG"	-2.45836434784587	10.459879852179	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCTGTATCGTTGTAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1449.28386398567	42.744645034595	0.0294936320597975	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1444.44998459699	1444.44998459699
"healthy-5"	"2019-08-29-count-2:CAGCCAGAGAAGTCAT"	-2.43488750878032	10.1839580305847	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCCAGAGAAGTCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1526.45657229359	39.2872568538695	0.0257375529490748	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1524.19110935014	1524.19110935014
"healthy-5"	"2019-08-29-count-1:ATCGTCCCACTGGCCA"	-3.15024290505107	10.6812705763611	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTCCCACTGGCCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1672.54523270396	27.6208906532408	0.0165142861987576	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1672.54523270396	1672.54523270396
"healthy-5"	"2019-08-29-count-1:ATCGTCCGTCACCACG"	-2.364649395377	12.3879270323547	"2019-08-29-count-1"	"Control5"	"NK"	"IFN+ NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTCCGTCACCACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1593.8314418978	47.7526229553641	0.0299608990637707	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1591.43078691668	1591.43078691668
"healthy-5"	"2019-08-29-count-1:GCCAGCAGTAAGATCA"	4.95162787017171	-8.97838308727416	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCAGCAGTAAGATCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2179.01586801532	37.5966006403681	0.0172539361425631	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2177.23701963205	2177.23701963205
"healthy-5"	"2019-08-29-count-1:TCCCACACACAGTGAG"	-1.95250711861308	3.46204350078431	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCACACACAGTGAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2858.84844574185	47.9610673106139	0.0167763588105029	3181	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2852.08926754161	2852.08926754161
"healthy-5"	"2019-08-29-count-1:TCCCACAGTCTGATAC"	-3.19286356392558	11.0435361632141	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCCACAGTCTGATAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1572.97336376913	39.4436102725889	0.0250758284794313	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1570.73340203584	1570.73340203584
"healthy-5"	"2019-08-29-count-1:TGCTCCAGTCTTGTCC"	2.33925952491109	-6.77142479335936	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTCCAGTCTTGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1582.57504035522	44.3638519168564	0.0280327003684443	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1582.57504035522	1582.57504035522
"healthy-5"	"2019-08-29-count-2:CCACGAGGTGGGACAT"	-3.91320429268535	-5.19696571743163	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACGAGGTGGGACAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2472.71640054405	51.7359442789414	0.0209227165183838	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2465.43570081769	2465.43570081769
"healthy-5"	"2019-08-29-count-1:ATCGTGACATACTTTC"	3.40409602698628	-8.18760397350463	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTGACATACTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1533.00053324564	46.351531792307	0.0302358223543291	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1525.45471902748	1525.45471902748
"healthy-5"	"2019-08-29-count-2:GTTGCTCTCATGAGTC"	-3.37237916413005	3.58227870548097	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGCTCTCATGAGTC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1503.14600908109	6.35467264181365	0.00422758175414936	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1496.92661050009	1496.92661050009
"healthy-5"	"2019-08-29-count-1:TGTTTGTAGGTTGACG"	-2.77394328537639	3.91071817958681	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTTGTAGGTTGACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3319.43610977622	44.3852374851849	0.0133713185063162	4497	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3314.90125184327	3314.90125184327
"healthy-5"	"2019-08-29-count-2:CCACGTTAGATGATTG"	1.83582963523213	-6.64985277568968	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACGTTAGATGATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1931.5316156799	49.8392705410013	0.025802979426489	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1927.53782639247	1927.53782639247
"healthy-5"	"2019-08-29-count-2:CCACGTTAGTAGAATC"	-3.22682342949565	11.8648547896179	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACGTTAGTAGAATC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1586.25596189013	43.7873758616235	0.0276042309145668	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1581.53363033285	1581.53363033285
"healthy-5"	"2019-08-29-count-2:CCACGTTCAGCTACCG"	4.9594837623531	-10.3898687592712	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACGTTCAGCTACCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2146.65472094466	37.4813276493469	0.0174603429623059	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2141.77334009281	2141.77334009281
"healthy-5"	"2019-08-29-count-1:ATCTCTACAAATCCCA"	-3.74879584732707	12.5256147154602	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCTCTACAAATCCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1836.56610748819	35.7111825445119	0.0194445396759242	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1819.62564032503	1819.62564032503
"healthy-5"	"2019-08-29-count-2:GTTGTCCAGGACAAGA"	-3.37587891045268	3.70536563480226	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTGTCCAGGACAAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3032.81664280742	44.9754988132945	0.0148296135607003	3004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3029.28909823134	3029.28909823134
"healthy-5"	"2019-08-29-count-2:CAGGCCAAGTGATAGT"	-4.04165444794353	10.1788196333679	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGCCAAGTGATAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1734.59039721645	40.2296651937576	0.0231926022756239	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1732.21621947289	1732.21621947289
"healthy-5"	"2019-08-29-count-2:CAGGCCAAGTGGCCTC"	2.47692455825154	-6.94351818477782	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGGCCAAGTGGCCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1474.8332308156	49.2788238373682	0.0334131499126287	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1474.8332308156	1474.8332308156
"healthy-5"	"2019-08-29-count-2:CTGCATCAGATGCTAA"	3.23125614699666	-8.84903337871703	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCATCAGATGCTAA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1960.25255284786	43.6047142626952	0.0222444369218376	873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1960.25255284786	1960.25255284786
"healthy-5"	"2019-08-29-count-1:GCCATGGAGAGCAGAA"	3.38938870009724	-7.95573904430541	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCATGGAGAGCAGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1448.23030715156	45.6939192927659	0.0315515557623143	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1445.67548214174	1445.67548214174
"healthy-5"	"2019-08-29-count-1:GCCATGGAGCGTTACT"	-2.08231482926067	4.22884366596071	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCATGGAGCGTTACT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3010.02279425655	43.8862745998928	0.0145800472619784	3774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3006.13956259596	3006.13956259596
"healthy-5"	"2019-08-29-count-2:GCTACCTGTCGGTACC"	1.88052036341969	-6.65573074733885	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTACCTGTCGGTACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1664.4776695205	46.7391929715228	0.0280803965276309	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1659.8745108586	1659.8745108586
"healthy-5"	"2019-08-29-count-2:CCACTTGAGGATAATC"	-3.37013469162639	11.0753068693909	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACTTGAGGATAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1490.30928429978	39.3257136821457	0.0263876190643359	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1487.86916174049	1487.86916174049
"healthy-5"	"2019-08-29-count-2:TTGAGTGCACGACCTG"	6.83371319350545	-1.4991687766281	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGAGTGCACGACCTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2177.58848384279	34.9377123459717	0.016044221672369	1097	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2167.56904185704	2167.56904185704
"healthy-5"	"2019-08-29-count-1:TTAATCCGTACGTTCA"	2.91476478156392	-5.28210976040038	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAATCCGTACGTTCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2478.82867514933	39.7443521692966	0.0160335212222371	1496	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2476.1751679109	2476.1751679109
"healthy-5"	"2019-08-29-count-1:CCTTTGGGTAAGTTAG"	4.26550163802449	-8.26236059581908	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTTGGGTAAGTTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.02337614205	38.5461645049371	0.0181136001310373	1123	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2123.64171530209	2123.64171530209
"healthy-5"	"2019-08-29-count-1:CTGAATGAGTAAAGCT"	2.63834561881368	-7.63446047222289	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGAATGAGTAAAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.02518206583	47.3830452459863	0.0287688650798615	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1644.83337589175	1644.83337589175
"healthy-5"	"2019-08-29-count-2:CCACTTGGTTACGTAC"	-5.39614377442058	-4.16847565090331	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACTTGGTTACGTAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	3301.1648349641	42.5195335966016	0.0128801607075958	2708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	3292.1077127706	3292.1077127706
"healthy-5"	"2019-08-29-count-1:ATGAAAGCAGGCTTGC"	11.4774242835933	3.53036687457887	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAAAGCAGGCTTGC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1693.84769865761	31.2194179746457	0.0184310655552961	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1691.49983467675	1691.49983467675
"healthy-5"	"2019-08-29-count-1:GTGGCGTCAACACAGG"	2.28237881240193	-6.67392876064452	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGCGTCAACACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1585.89666671618	47.9450192970133	0.0302321206061238	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1581.27284700832	1581.27284700832
"healthy-5"	"2019-08-29-count-2:AGGCTGCAGATGTAGT"	1.9106728034908	-6.94306280529173	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGCTGCAGATGTAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1879.28015860336	54.5084978429173	0.0290049876775301	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1879.28015860336	1879.28015860336
"healthy-5"	"2019-08-29-count-2:TTGATGGCAGGGTTGA"	3.1200987296993	-5.37090303814086	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGATGGCAGGGTTGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2155.208461523	42.1533089835704	0.0195588082248816	1157	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2149.1502106454	2149.1502106454
"healthy-5"	"2019-08-29-count-1:TTACAGGCACATGACT"	3.22328438338582	-7.89540245449217	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACAGGCACATGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1697.64378899907	47.3138333974382	0.0278702951137556	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1693.08993448035	1693.08993448035
"healthy-5"	"2019-08-29-count-1:TCCGAAAGTCTTGCGG"	-5.59112201157268	-5.60895159160765	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGAAAGTCTTGCGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2235.26860649984	52.8608394470668	0.0236485401769411	1253	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2230.87643462746	2230.87643462746
"healthy-5"	"2019-08-29-count-2:GCTGAATCAGCGTATT"	5.44694199141805	-9.91486933147582	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTGAATCAGCGTATT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.24808976671	42.8761122430663	0.0204050689929843	988	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.40537924817	2099.40537924817
"healthy-5"	"2019-08-29-count-2:ATCCCTGAGGCTTTCA"	-3.25684485855754	11.7373103865418	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCCTGAGGCTTTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1518.22350635349	45.4087583259623	0.0299091392907137	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1513.24311919967	1513.24311919967
"healthy-5"	"2019-08-29-count-2:TCGTGCTCACTTCAGA"	-7.75763211670573	-0.746145211812578	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGTGCTCACTTCAGA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2657.76467842505	42.1184350144769	0.0158473153610558	1804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2647.27733679043	2647.27733679043
"healthy-5"	"2019-08-29-count-1:TTACCATGTATTTCGG"	-2.90564570847209	11.3218087919983	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACCATGTATTTCGG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1912.34401269331	44.068824947059	0.0230444023954629	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1908.77077054746	1908.77077054746
"healthy-5"	"2019-08-29-count-1:ATGACCATCGAAGCAG"	3.76749958571736	-8.17072584545287	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGACCATCGAAGCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.46908343459	44.4786868765158	0.0240104880962707	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1850.44044738594	1850.44044738594
"healthy-5"	"2019-08-29-count-1:TTACCATTCTTTCTAG"	3.74265875396077	-8.46568109905394	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACCATTCTTTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.54671016095	40.0697047487949	0.0215713039836952	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1857.54671016095	1857.54671016095
"healthy-5"	"2019-08-29-count-1:TTACCGCAGGAACATT"	-7.87704358521159	0.190493963006414	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACCGCAGGAACATT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2900.82361663904	46.7559742054269	0.016118172072661	2631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2888.88827797053	2888.88827797053
"healthy-5"	"2019-08-29-count-1:ATGACCATCTTGGAAC"	1.92250599440877	-7.35785534298094	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGACCATCTTGGAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1820.81120373752	46.3464600850475	0.0254537428097508	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1818.74436182354	1818.74436182354
"healthy-5"	"2019-08-29-count-1:TTACCGCCAAATCGGG"	-2.13833318176921	10.5029563673767	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACCGCCAAATCGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1751.0589733065	39.1258019045385	0.0223440800686786	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1751.0589733065	1751.0589733065
"healthy-5"	"2019-08-29-count-1:TCCGATCCAGCTGTCG"	2.53343262252156	-7.17032625591429	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGATCCAGCTGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.69384155379	47.5149729926544	0.0271561640466537	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1747.55701553165	1747.55701553165
"healthy-5"	"2019-08-29-count-1:ACGATGTAGAAACTAC"	-2.20388040962871	4.15171334827272	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGATGTAGAAACTAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3210.16910651489	44.9447718500696	0.0140007489819948	4150	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3204.26012935381	3204.26012935381
"healthy-5"	"2019-08-29-count-1:AGTCAACGTCCAGCAC"	-1.7104985517567	3.64505050266115	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCAACGTCCAGCAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3059.19289109773	46.3578512324079	0.0151536215213201	3686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3053.70877717239	3053.70877717239
"healthy-5"	"2019-08-29-count-1:AAACCCATCCACGTGG"	-2.43095837059672	10.6445140608582	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACCCATCCACGTGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1477.3621981011	38.2106439322066	0.0258641002059751	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1472.53372897425	1472.53372897425
"healthy-5"	"2019-08-29-count-2:GTTTGGAGTCCCACGA"	3.30100740966145	-8.09422304546507	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTTGGAGTCCCACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1537.87123423051	44.9974658399273	0.029259579630828	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1533.09461699723	1533.09461699723
"healthy-5"	"2019-08-29-count-1:GTGGTTAGTCGGTGTC"	3.33166422423665	-7.96654703533324	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGTTAGTCGGTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1492.31125916782	43.9609075334692	0.0294582696896516	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1482.09711363807	1482.09711363807
"healthy-5"	"2019-08-29-count-1:AGTCAACTCTTTGCAT"	2.96713485297505	-5.38024809276732	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCAACTCTTTGCAT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2193.49196487491	38.1057999089643	0.0173722085693336	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2187.69287350226	2187.69287350226
"healthy-5"	"2019-08-29-count-2:GTCGTTCTCTAGACAC"	-5.59380851212199	-5.50470306789549	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCGTTCTCTAGACAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1800.32982697374	46.7566517984095	0.0259711587831685	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1798.14021856688	1798.14021856688
"healthy-5"	"2019-08-29-count-1:ATGAGTCCATGAGATA"	-2.20171580734904	4.19611690128175	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAGTCCATGAGATA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3197.03854041171	46.7670867903883	0.0146282524277501	3886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3190.85376562423	3190.85376562423
"healthy-5"	"2019-08-29-count-1:TTACGCCGTCTCACAA"	-3.1888292831486	12.2543449171814	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACGCCGTCTCACAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1493.1178643468	35.8408059129724	0.0240040031458948	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1490.57806282155	1490.57806282155
"healthy-5"	"2019-08-29-count-1:ATGAGTCGTACGAGCA"	2.66823496398274	-8.30634500896605	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAGTCGTACGAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1622.96324019119	44.7919877708835	0.0275988923603759	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1622.96324019119	1622.96324019119
"healthy-5"	"2019-08-29-count-1:TCCGTGTCATCAGTCA"	4.34956516799275	-8.88634779369506	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCGTGTCATCAGTCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1766.4986865942	46.357593557594	0.0262426425275023	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1758.4366215127	1758.4366215127
"healthy-5"	"2019-08-29-count-2:CCATCACTCACTGGGC"	4.06890072402303	-10.3248777619568	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCATCACTCACTGGGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2280.93339003546	45.1792929605985	0.0198073705957262	1285	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2275.04991518244	2275.04991518244
"healthy-5"	"2019-08-29-count-2:CCATCACTCGGAGTGA"	-3.6872230571812	12.3524856337341	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCATCACTCGGAGTGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1452.31105284661	41.248093611515	0.0284016936527933	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1447.35162311428	1447.35162311428
"healthy-5"	"2019-08-29-count-2:GCTTCACCAGTTGTTG"	2.43559803542439	-4.45800688182982	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTTCACCAGTTGTTG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2318.6369653912	35.5012158682203	0.0153112438032016	1347	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2314.50185782501	2314.50185782501
"healthy-5"	"2019-08-29-count-1:TTACGTTGTACTTCCC"	11.0878435569698	4.70399568164674	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACGTTGTACTTCCC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1426.44509205283	45.8482475697062	0.0321416140201547	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1423.91224295653	1423.91224295653
"healthy-5"	"2019-08-29-count-1:TTACGTTGTCTTCATT"	5.33401693877522	-9.9246340028015	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACGTTGTCTTCATT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2299.72357308681	37.6915907817283	0.0163896179622739	1218	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2296.75873587968	2296.75873587968
"healthy-5"	"2019-08-29-count-1:TTACGTTTCCTCTCGA"	-3.16905436936076	10.4415616759094	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACGTTTCCTCTCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1652.26520393442	48.4623516803716	0.0293308553402757	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1650.11295976641	1650.11295976641
"healthy-5"	"2019-08-29-count-1:TTACTGTAGCCACCGT"	-3.17354522171672	-5.63240435039672	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACTGTAGCCACCGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2122.18541079153	50.7160259396166	0.0238980183737578	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2118.53198872047	2118.53198872047
"healthy-5"	"2019-08-29-count-2:TAACGACAGATTTGCC"	-2.18358669701274	3.402885175589	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACGACAGATTTGCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2889.69301354026	42.0868031882143	0.0145644547676891	3058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2882.71114446604	2882.71114446604
"healthy-5"	"2019-08-29-count-2:TAACGACAGGGTATAT"	3.64367808875386	-8.11997606670531	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACGACAGGGTATAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1669.21277625954	42.997398060939	0.0257590875605984	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1666.9930369875	1666.9930369875
"healthy-5"	"2019-08-29-count-1:GCCGTGAGTGTTTACG"	-3.70846162262614	2.96227381313173	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCGTGAGTGTTTACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2617.60589579102	46.811277211679	0.0178832410512787	2244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2613.29824263851	2613.29824263851
"healthy-5"	"2019-08-29-count-2:TTGCGTCTCGATTGAC"	3.9141751724178	-8.07519819652709	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGCGTCTCGATTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1986.54705989236	40.1567576815624	0.0202143500611248	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1980.6117646133	1980.6117646133
"healthy-5"	"2019-08-29-count-2:GCTTGGGCAATGACCT"	10.7486139732296	5.97203490817872	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTTGGGCAATGACCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1548.75951899658	42.6284741276141	0.0275242693295809	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1546.47260212129	1546.47260212129
"healthy-5"	"2019-08-29-count-1:TCCTCCCAGAGCATTA"	-0.559378544718582	9.82881352985231	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCCCAGAGCATTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1604.63700790033	42.4361011801935	0.0264459195265109	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1600.13828312418	1600.13828312418
"healthy-5"	"2019-08-29-count-1:GCCTGTTCACTGGACC"	2.62361516532246	-4.42285253917845	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCTGTTCACTGGACC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2684.63199765406	42.0920474503812	0.0156788891316065	1778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2683.44018769337	2683.44018769337
"healthy-5"	"2019-08-29-count-1:TCCTCCCCAGGTCAGA"	3.68366398391072	-8.34474661266478	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCCCCAGGTCAGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2010.64374005169	47.4018366753185	0.0235754528418345	937	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2004.94288845992	2004.94288845992
"healthy-5"	"2019-08-29-count-1:ATGCATGCAGCGCTTG"	4.23070206221883	-8.25981714641722	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCATGCAGCGCTTG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.7694743133	47.6954119529815	0.0254950770834493	807	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1866.65110359111	1866.65110359111
"healthy-5"	"2019-08-29-count-2:CCCATTGAGATGCTGG"	-2.74879513207133	3.30707571590272	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCATTGAGATGCTGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2946.16320315784	45.853623688901	0.0155638437272425	3407	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2941.06276601713	2941.06276601713
"healthy-5"	"2019-08-29-count-2:TTGGATGAGTCCGCGT"	-3.64159236374553	11.9666356810364	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGATGAGTCCGCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1544.04538511245	40.2866072361005	0.0260915952500753	605	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1541.74292840962	1541.74292840962
"healthy-5"	"2019-08-29-count-1:TTAGGCACAAGTTGGG"	5.40236296233479	-9.82713129436644	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGCACAAGTTGGG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2030.51864465607	42.4948702474609	0.02092808670302	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2024.48482252229	2024.48482252229
"healthy-5"	"2019-08-29-count-2:TTGGATGCAGGTTCCG"	-3.74527178230937	10.5484504469666	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGATGCAGGTTCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.77817327278	43.9402310625737	0.0262835295765068	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1667.12743090249	1667.12743090249
"healthy-5"	"2019-08-29-count-1:TTAGGCAGTGCCCAGT"	-1.66479883614238	9.06645295703737	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGCAGTGCCCAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1432.64286076518	37.1578471826317	0.025936573726955	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1428.12588151307	1428.12588151307
"healthy-5"	"2019-08-29-count-2:TAACTTCGTCCACGCA"	8.62843288955037	6.39626929843751	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACTTCGTCCACGCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1410.68712072959	40.7076938581106	0.0288566424545345	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1408.16231725392	1408.16231725392
"healthy-5"	"2019-08-29-count-2:CCCATTGGTGCAATGG"	9.9107424217159	5.66656968677369	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCATTGGTGCAATGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1405.05290260375	35.2391249188905	0.0250802833498922	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1397.60736255429	1397.60736255429
"healthy-5"	"2019-08-29-count-1:TTAGGCATCACACGAT"	11.1574226814205	3.83776137912599	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGCATCACACGAT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1446.74878577638	42.3439912572278	0.0292683786387312	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1441.56397388216	1441.56397388216
"healthy-5"	"2019-08-29-count-1:TCCTCGAGTCTACGTA"	3.38938250121419	-8.17337038433226	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCGAGTCTACGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1604.03413490535	41.7162244777744	0.0260070677861454	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1604.03413490535	1604.03413490535
"healthy-5"	"2019-08-29-count-2:CCCATTGTCGTGCACG"	9.0484262901241	6.24362609470216	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCATTGTCGTGCACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1566.91006941995	40.7795773557758	0.0260254740534484	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1562.56109681553	1562.56109681553
"healthy-5"	"2019-08-29-count-2:TTGGGATAGGTTACCT"	4.19681944426839	-7.86897184765013	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGATAGGTTACCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.00033581482	37.6378753555428	0.0178717328366335	1017	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2102.45049178645	2102.45049178645
"healthy-5"	"2019-08-29-count-1:TTAGGGTAGCGATGAC"	2.84729733046834	-8.16982462322386	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGGTAGCGATGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1947.0835899187	45.5643291957021	0.0234013215619596	892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1943.31973359544	1943.31973359544
"healthy-5"	"2019-08-29-count-1:ATGCCTCGTCAAAGTA"	-5.50770936432536	-5.45704605495604	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCGTCAAAGTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2176.15169473959	51.8358305429993	0.0238199527488373	1138	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2171.16674298026	2171.16674298026
"healthy-5"	"2019-08-29-count-1:TTAGGGTAGTATGGCG"	-1.99490533295329	3.85148212993471	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGGTAGTATGGCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3028.92643161421	47.3632094542244	0.0156369626412429	3380	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3026.79625307679	3026.79625307679
"healthy-5"	"2019-08-29-count-1:ATGCCTCGTCTGCCTT"	10.5440317588741	7.76306436145631	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCGTCTGCCTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2403.04138708718	46.4929935408408	0.0193475625474752	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2388.9724117341	2388.9724117341
"healthy-5"	"2019-08-29-count-1:GCGAGAATCATTATCC"	3.77481236037557	-7.83274605190428	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGAGAATCATTATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1878.61061688271	40.3004285859507	0.0214522521185489	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1876.49243318377	1876.49243318377
"healthy-5"	"2019-08-29-count-2:CCCGAAGTCTAAGGAA"	3.10139503058736	-7.8317704430786	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCGAAGTCTAAGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1610.40522429818	52.3903067566473	0.0325323750607423	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1610.40522429818	1610.40522429818
"healthy-5"	"2019-08-29-count-1:TCCTCTTGTGTGTGTT"	3.15605749663655	-7.71439554607543	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCTTGTGTGTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.76313078869	45.3290744361634	0.0275094603035977	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1643.32188018408	1643.32188018408
"healthy-5"	"2019-08-29-count-1:ACGGTTATCAGAGTTC"	2.44570555266682	-3.92610361492308	"2019-08-29-count-1"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGGTTATCAGAGTTC"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2222.2110817609	53.4299550269492	0.0240436002976868	1298	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2215.16631369681	2215.16631369681
"healthy-5"	"2019-08-29-count-1:TTAGGGTTCTCGGGAC"	0.637320776551408	8.55210683429567	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGGGTTCTCGGGAC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1669.46240210977	50.2730104217049	0.0301132929727394	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1664.33280238917	1664.33280238917
"healthy-5"	"2019-08-29-count-2:CCCGGAAAGGCTCAAG"	-0.404607663781005	9.60457036578981	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCGGAAAGGCTCAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1406.19860573623	43.7974208130016	0.031145970870929	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1406.19860573623	1406.19860573623
"healthy-5"	"2019-08-29-count-1:ATGCGATCAGGAGACT"	14.1807629066402	2.09467194164125	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCGATCAGGAGACT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1788.39386480164	37.9613303578726	0.0212264932826098	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1773.25193595325	1773.25193595325
"healthy-5"	"2019-08-29-count-2:CCCGGAAGTGAGATTA"	5.4390512901241	-9.8458404771057	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCGGAAGTGAGATTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2057.09706748276	44.6964067295303	0.0217279035763852	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2057.09706748276	2057.09706748276
"healthy-5"	"2019-08-29-count-1:ATGCGATCATGTACGT"	0.287948061793488	8.59783361041871	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCGATCATGTACGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1444.94443319603	43.4800758917875	0.0300911750603552	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1442.64477046492	1442.64477046492
"healthy-5"	"2019-08-29-count-1:ATGCGATGTTGCAACT"	-6.59088311615642	3.54450128162233	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCGATGTTGCAACT"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2245.29449683848	41.2199642326913	0.0183583776162689	1396	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2236.15072588445	2236.15072588445
"healthy-5"	"2019-08-29-count-2:TTGGGCGTCATGCCAA"	11.018683095544	4.63059232318727	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGGGCGTCATGCCAA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1439.83883229412	46.2053904648089	0.0320906683640343	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1430.04703689276	1430.04703689276
"healthy-5"	"2019-08-29-count-1:TTAGTCTGTTGCTGAT"	2.90660466727559	-8.23198320781859	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAGTCTGTTGCTGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1455.06529852879	44.6218713830482	0.0306665765640656	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1450.14850692424	1450.14850692424
"healthy-5"	"2019-08-29-count-2:CCCTAACGTAAGCTCT"	14.1580168205196	2.09479639613954	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTAACGTAAGCTCT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1201.91242828324	36.6472491026143	0.0304907813915857	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1184.61012837255	1184.61012837255
"healthy-5"	"2019-08-29-count-1:GCGGATCAGTGAACAT"	-2.40557442131694	4.16480872714845	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCGGATCAGTGAACAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3159.51893716211	44.4083358854807	0.0140554105763228	4336	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3156.51843583589	3156.51843583589
"healthy-5"	"2019-08-29-count-1:GTTACAGTCTCATAGG"	-3.644514421851	12.9365319975647	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTACAGTCTCATAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1587.1334065088	43.3185471033239	0.0272935765359582	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1584.64233187211	1584.64233187211
"healthy-5"	"2019-08-29-count-1:TTATTGCAGGTAAGAG"	3.26804318007771	-7.44831182872923	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTATTGCAGGTAAGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1426.68850346404	46.7190958022879	0.0327465285441444	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1424.21956683911	1424.21956683911
"healthy-5"	"2019-08-29-count-2:TAAGCCATCATGCCAA"	3.71457137641255	-6.90543939983519	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCCATCATGCCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1915.25073409355	41.1302039195507	0.0214751015036246	824	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1911.14716060134	1911.14716060134
"healthy-5"	"2019-08-29-count-1:TTATTGCCAAATTGGA"	-1.85971007767375	3.40110228145448	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTATTGCCAAATTGGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2511.52265387621	47.9086413340548	0.0190755362131072	1794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2499.43267499165	2499.43267499165
"healthy-5"	"2019-08-29-count-1:TTATTGCGTAGGATAT"	-3.30695996704753	12.3861732252869	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTATTGCGTAGGATAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1530.39090284314	41.4862608732659	0.0271082772357005	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1530.39090284314	1530.39090284314
"healthy-5"	"2019-08-29-count-1:ATGGAGGTCTACCAGA"	2.74696960028951	-4.51247312938841	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGAGGTCTACCAGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2459.48427643344	38.703093127015	0.0157362636947366	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2457.00843849855	2457.00843849855
"healthy-5"	"2019-08-29-count-2:CCCTCAAAGAAACACT"	3.79003061827962	-8.31420614635619	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTCAAAGAAACACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1537.06321199247	47.9287835808206	0.0311820510743285	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1532.47559714574	1532.47559714574
"healthy-5"	"2019-08-29-count-1:ACGTAGTGTCCCAAAT"	-2.24918280068095	12.1301069029602	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTAGTGTCCCAAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1450.90434344139	41.6619592669172	0.0287144769090011	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1448.37543615681	1448.37543615681
"healthy-5"	"2019-08-29-count-1:TCCTGCAGTGACTATC"	9.54557289656941	5.60586927020875	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTGCAGTGACTATC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1509.18604968615	41.8864914295068	0.0277543590057816	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1509.18604968615	1509.18604968615
"healthy-5"	"2019-08-29-count-2:ATCTCTAAGAGAGTTT"	3.54684986647908	-7.58188440715941	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTCTAAGAGAGTTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1509.62745928972	40.1871377047483	0.026620566191646	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1509.62745928972	1509.62745928972
"healthy-5"	"2019-08-29-count-2:TAAGCGTGTTTGGAAA"	3.81990780410115	-8.18687918102416	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCGTGTTTGGAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1647.33790821038	47.2313510031882	0.0286713192040235	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1647.33790821038	1647.33790821038
"healthy-5"	"2019-08-29-count-1:TTCAATCCAGTTGCGC"	-3.74593911591228	12.971839881781	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCAATCCAGTTGCGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1681.36611094392	32.2021727253005	0.0191523859769139	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1676.67263171392	1676.67263171392
"healthy-5"	"2019-08-29-count-1:TCCTTCTAGCGCAATG"	-2.6217351955479	12.9917821654114	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTTCTAGCGCAATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1505.94841416029	38.048674986533	0.0252655898626839	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1500.81432830684	1500.81432830684
"healthy-5"	"2019-08-29-count-2:CCCTCAATCTACTGCC"	3.59539570388142	-8.12380220806273	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTCAATCTACTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1948.7671628849	45.8000597987876	0.0235020687289222	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1943.16174791235	1943.16174791235
"healthy-5"	"2019-08-29-count-1:TTCAATCGTGCATGAG"	3.35672416266744	-8.09089472210082	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCAATCGTGCATGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1616.72640937052	48.3245403251813	0.0298903636664145	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1616.72640937052	1616.72640937052
"healthy-5"	"2019-08-29-count-2:CCCTCTCCACTTCCTG"	11.2889057594234	4.03178618038026	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTCTCCACTTCCTG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1435.74866977609	35.8496318891698	0.0249692948660441	507	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1416.93401203321	1416.93401203321
"healthy-5"	"2019-08-29-count-1:TCCTTTCAGTCGAATA"	-7.10230336609538	3.44919488513795	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTTTCAGTCGAATA"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2116.86734537575	41.111419524235	0.0194208766147023	1331	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2106.62736922633	2106.62736922633
"healthy-5"	"2019-08-29-count-1:ACGTTCCCACCTCGTT"	2.56954946097676	-7.45087816631468	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGTTCCCACCTCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1779.67136684887	46.4700241208538	0.0261115759833428	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1777.43356839817	1777.43356839817
"healthy-5"	"2019-08-29-count-2:ATCTCTATCCGATCTC"	-0.852224628359634	8.96886727893678	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTCTATCCGATCTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1554.49955510837	35.6738593517868	0.0229487742434895	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1549.77289134306	1549.77289134306
"healthy-5"	"2019-08-29-count-1:ATGGGAGAGTCTGCAT"	-2.92855868759807	3.35305450046388	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGAGAGTCTGCAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3021.72914895849	49.1124789773365	0.0162531042844341	3325	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3015.91776889326	3015.91776889326
"healthy-5"	"2019-08-29-count-1:TTCACCGAGTCAGGGT"	1.80089499530141	-7.12302257930907	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACCGAGTCAGGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1736.43948289776	51.4548261498105	0.0296323751311754	704	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.09800809578	1732.09800809578
"healthy-5"	"2019-08-29-count-2:CCCTCTCTCCTTCTTC"	3.87852563437764	-7.8501973382202	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTCTCTCCTTCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1962.9246086171	46.9086016263645	0.0238973017203203	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1962.9246086171	1962.9246086171
"healthy-5"	"2019-08-29-count-1:ATGGGAGGTACTCGAT"	11.1854444938595	4.03390643680421	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGAGGTACTCGAT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1440.51255126793	46.3741490068258	0.0321928114864445	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1432.70024254112	1432.70024254112
"healthy-5"	"2019-08-29-count-1:TTCACCGCATTCTTCA"	-1.85557923737224	9.81835362994996	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACCGCATTCTTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.52704161289	47.2691267910233	0.0264143126601875	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1772.5173932797	1772.5173932797
"healthy-5"	"2019-08-29-count-1:TTCACCGGTTCTCCCA"	3.0402168231899	-7.20676996624144	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACCGGTTCTCCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.33668257392	41.1312872954328	0.0206654922534219	913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.52469956638	1984.52469956638
"healthy-5"	"2019-08-29-count-2:TAATCTCCAGTGAGCA"	-1.37031040611919	9.98410508716432	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATCTCCAGTGAGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1446.44951935435	38.9656549187487	0.0269388280734068	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1446.44951935435	1446.44951935435
"healthy-5"	"2019-08-29-count-1:ATGGGTTAGGTAATCA"	3.93699993666951	-6.46376278316649	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGGTTAGGTAATCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2078.987061213	52.4983224897232	0.0252518755259077	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2078.987061213	2078.987061213
"healthy-5"	"2019-08-29-count-2:ATCTTCAGTATCAGGG"	-7.36677298966106	0.015937092992939	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCTTCAGTATCAGGG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2392.5796235868	48.0940871430655	0.0201013528113919	1628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2384.48384363241	2384.48384363241
"healthy-5"	"2019-08-29-count-1:TTCACCGTCTTGAGCA"	5.7165056663448	-1.78525545513304	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACCGTCTTGAGCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2286.77434371268	39.330614806939	0.0171991674277245	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2279.17050948109	2279.17050948109
"healthy-5"	"2019-08-29-count-2:TTGTTCAGTGACGCCT"	-3.28280888024028	11.4852809675964	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTCAGTGACGCCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1497.27490749359	26.2661208052508	0.017542617373599	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1487.45008257397	1487.45008257397
"healthy-5"	"2019-08-29-count-1:TTCACGCAGCTCTTCC"	9.53528656539265	6.37486503208009	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACGCAGCTCTTCC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1562.6848146333	44.3385807303193	0.0283733356305275	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1562.6848146333	1562.6848146333
"healthy-5"	"2019-08-29-count-2:TAATCTCTCATGCATG"	-2.06914458695109	10.4579400786194	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATCTCTCATGCATG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1631.29092408738	35.6145381787442	0.0218321193680818	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1629.20570001979	1629.20570001979
"healthy-5"	"2019-08-29-count-2:TAATCTCTCTCTGCTG"	-1.67419848862346	9.68447873676149	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATCTCTCTCTGCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1557.86016059418	38.1856747583964	0.0245116190299341	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1555.42976574991	1555.42976574991
"healthy-5"	"2019-08-29-count-2:CTGTGAACACAACCGC"	6.80166878279988	-1.54188182270201	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTGAACACAACCGC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2374.11398936553	41.9758001165668	0.0176806169815732	1299	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2360.26825896555	2360.26825896555
"healthy-5"	"2019-08-29-count-1:GCTACCTGTCACCCTT"	9.52086224135701	7.07357404315797	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTACCTGTCACCCTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1635.52638132326	35.4463260502489	0.021672732678008	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1631.07351553818	1631.07351553818
"healthy-5"	"2019-08-29-count-2:CCCTTAGCAACTTGGT"	10.9369503456051	5.9506945380005	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTTAGCAACTTGGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1430.86330927562	36.7405364287963	0.0256771811749065	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1430.86330927562	1430.86330927562
"healthy-5"	"2019-08-29-count-1:GCTACCTGTGATACTC"	8.629167218774	6.04983041370241	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTACCTGTGATACTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1409.90035329957	41.2443595662537	0.0292533862196218	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1407.46177208416	1407.46177208416
"healthy-5"	"2019-08-29-count-1:ATGGTTGAGCCTTTCC"	1.70502533492391	-6.52649643337401	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGTTGAGCCTTTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2063.64947746956	48.1757092307858	0.0233449089861223	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2061.93917855401	2061.93917855401
"healthy-5"	"2019-08-29-count-1:TTCACGCTCGAAGCCC"	3.87427105483357	-8.52361490642699	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCACGCTCGAAGCCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1778.82203642471	48.3895240579882	0.0272031282877782	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1776.56633166577	1776.56633166577
"healthy-5"	"2019-08-29-count-1:TTCAGGAAGGATATAC"	3.57336296614949	-7.47657587444457	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCAGGAAGGATATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2296.00901500255	44.1193579184679	0.0192156727740108	1185	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2287.56170936953	2287.56170936953
"healthy-5"	"2019-08-29-count-2:CCCTTAGGTCGTCAGC"	-3.94752154770549	-4.64891340648802	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCTTAGGTCGTCAGC"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2632.91377836962	46.9416995840966	0.0178288024354388	1785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2629.50026664677	2629.50026664677
"healthy-5"	"2019-08-29-count-2:GGAGGATAGTCACACT"	3.18065251883809	-7.10843899166258	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGGATAGTCACACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.49314630997	42.8390092619759	0.0249427541262772	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1715.25380392264	1715.25380392264
"healthy-5"	"2019-08-29-count-1:ATGGTTGGTGACAGGT"	3.98398770865743	-7.5230283967224	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGTTGGTGACAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2171.97600647438	37.8455552239241	0.017424481260894	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2168.86155976103	2168.86155976103
"healthy-5"	"2019-08-29-count-1:ATGGTTGGTGCATTAC"	9.34383740004842	5.83888290012208	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGGTTGGTGCATTAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1461.51540970737	30.4874126587979	0.0208601376737466	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1456.76609416731	1456.76609416731
"healthy-5"	"2019-08-29-count-2:TAATTCCTCATAGACC"	-4.26377950134929	-4.54905607616576	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATTCCTCATAGACC"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	3083.63477367037	42.0694132809278	0.0136428002564174	2574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	3075.43181581373	3075.43181581373
"healthy-5"	"2019-08-29-count-1:GCTCAAAGTGACAACG"	2.59087695655171	-6.97008469020995	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTCAAAGTGACAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1790.15501472877	44.9826317916291	0.0251277858182827	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1785.93137246788	1785.93137246788
"healthy-5"	"2019-08-29-count-1:TCAGCAATCTATCGCC"	4.43432058867757	-8.15272905742797	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCAATCTATCGCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.08242947358	38.6828230880378	0.0186057188207936	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2079.08242947358	2079.08242947358
"healthy-5"	"2019-08-29-count-2:TAATTCCTCTTGGATG"	2.63992347297017	-7.15459253704222	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATTCCTCTTGGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1946.95198158424	45.3557828758128	0.0232957891642025	876	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1939.17516870377	1939.17516870377
"healthy-5"	"2019-08-29-count-2:CCGAACGAGACGCATG"	3.55126871642415	-7.59822180187377	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGAACGAGACGCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.92215598411	45.3397931505797	0.0213371548801898	1147	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2120.21642308598	2120.21642308598
"healthy-5"	"2019-08-29-count-1:GCTGAATAGAGGGTGG"	-1.03429387036021	9.10490987384645	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGAATAGAGGGTGG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1426.79348098888	41.1945673999214	0.028872130374026	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1421.95025555719	1421.95025555719
"healthy-5"	"2019-08-29-count-1:ATGTCCCCAGTAGTTC"	3.47257771071736	-7.61700632488402	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGTCCCCAGTAGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.64032215894	40.8910404519171	0.0238065210302704	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1715.36239717482	1715.36239717482
"healthy-5"	"2019-08-29-count-2:CATCGCTCAACCGCCA"	-1.49666271629985	9.64055059039918	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGCTCAACCGCCA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1657.06778043879	42.3208505012702	0.0255396013372873	695	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1657.06778043879	1657.06778043879
"healthy-5"	"2019-08-29-count-1:ATGTCCCTCACGATAC"	-3.75985179367717	2.91086719119874	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGTCCCTCACGATAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2953.41507253853	50.5013446586839	0.0170993048448408	2696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2944.94345519818	2944.94345519818
"healthy-5"	"2019-08-29-count-2:CCGATCTAGAGATTCA"	-3.76955781403239	12.6171989210877	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGATCTAGAGATTCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1445.89985897882	38.1697750371077	0.0263986297530075	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1443.33720064916	1443.33720064916
"healthy-5"	"2019-08-29-count-1:ATGTCTTAGCTCTTCC"	-3.29388294640239	10.6797208555969	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGTCTTAGCTCTTCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1645.59904888348	37.0051715952499	0.0224873559694613	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1639.25837271359	1639.25837271359
"healthy-5"	"2019-08-29-count-1:TTCATTGAGCCTCACG"	-3.68475852432902	12.7212905653748	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCATTGAGCCTCACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1514.62201777136	37.7159863096474	0.0249012531622532	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1512.0284002351	1512.0284002351
"healthy-5"	"2019-08-29-count-1:TTCATTGCACAGACGA"	2.13975991782491	-6.86857416546019	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCATTGCACAGACGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2009.95006703038	49.4456533981149	0.024600438692076	939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2006.17559545301	2006.17559545301
"healthy-5"	"2019-08-29-count-2:TTTACCAAGATCGCCC"	3.26254381713216	-7.64864303981932	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTACCAAGATCGCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1686.5819636988	42.7710152186492	0.0253595829548949	682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.32632749929	1682.32632749929
"healthy-5"	"2019-08-29-count-1:ATGTCTTAGTTCATGC"	-0.561967114836532	9.40821454608766	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGTCTTAGTTCATGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.42075974148	43.4070517744199	0.0286246752397533	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1506.41857484485	1506.41857484485
"healthy-5"	"2019-08-29-count-1:GCTGCAGAGGGTACAC"	3.58176531371419	-7.93219997799071	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGCAGAGGGTACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1646.46594872293	46.368650364682	0.0281625322410387	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1641.62886550805	1641.62886550805
"healthy-5"	"2019-08-29-count-1:ACTATTCTCCGTCAAA"	0.467107643454713	8.50892922962037	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATTCTCCGTCAAA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1925.18717453072	41.0838930522453	0.0213402071215542	927	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1923.36877169104	1923.36877169104
"healthy-5"	"2019-08-29-count-2:CCGATGGAGCTTAGTC"	3.31566156920735	-7.92783739483031	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGATGGAGCTTAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1493.74410888209	50.9623323541597	0.0341171771330364	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1491.35038962555	1491.35038962555
"healthy-5"	"2019-08-29-count-1:CCGGACAGTATGCTAC"	4.04575719413106	-7.92625191127928	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGGACAGTATGCTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1848.48069448708	38.6495708006503	0.0209088311908904	806	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1844.43565932047	1844.43565932047
"healthy-5"	"2019-08-29-count-1:GCTGCAGTCCTCGCAT"	-0.0476090413635552	8.43122098529664	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGCAGTCCTCGCAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1666.5003132782	41.633415325765	0.0249825427538427	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1662.31081120331	1662.31081120331
"healthy-5"	"2019-08-29-count-1:GCTGGGTAGCCGAACA"	-4.99299989166911	-5.13426258480223	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTAGCCGAACA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2510.24826401099	48.8999176398893	0.019480112123155	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2507.5447486528	2507.5447486528
"healthy-5"	"2019-08-29-count-1:GCTGGGTAGCCTCAGC"	3.24068893966023	-7.08160355007323	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTAGCCTCAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.0631699147	40.8051983745084	0.0221158814721747	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.0631699147	1845.0631699147
"healthy-5"	"2019-08-29-count-2:GGATGTTAGGTTGACG"	-2.22309122505839	12.4227056273255	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGATGTTAGGTTGACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1634.48746875151	44.727645308374	0.027364936203848	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1627.24733359449	1627.24733359449
"healthy-5"	"2019-08-29-count-2:TACACCCTCGCAGTGC"	3.65767707404439	-8.08854105388793	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACACCCTCGCAGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.56649284606	46.5553022701546	0.0225169552859556	978	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2060.16354112814	2060.16354112814
"healthy-5"	"2019-08-29-count-1:TCGATTTTCTGTTGGA"	5.22772469100301	-9.48515131389769	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGATTTTCTGTTGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2356.47268946226	40.0410743533485	0.0169919534957504	1260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2350.25757622745	2350.25757622745
"healthy-5"	"2019-08-29-count-1:ATTACCTTCTTGGGCG"	11.9003130393917	-2.11744620716246	"2019-08-29-count-1"	"Control5"	"Ery"	"Erythrocytes"	34	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTACCTTCTTGGGCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	1473.21861015068	42.1016684183771	0.02857801831194	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	1468.70920973976	1468.70920973976
"healthy-5"	"2019-08-29-count-1:TTCCACGCAATAGTCC"	-2.44953976097758	4.18289659107057	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCACGCAATAGTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3450.07966096524	45.8778104759911	0.0132976090364116	4892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3442.60253139422	3442.60253139422
"healthy-5"	"2019-08-29-count-2:ACGATCACATCGATGT"	4.75291981276814	-7.97771360790404	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGATCACATCGATGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2209.03811391745	41.9808213107029	0.0190041181481723	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2202.33032293053	2202.33032293053
"healthy-5"	"2019-08-29-count-2:TTTAGTCGTACGATTC"	2.09024204787557	-4.0745215645996	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	45	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTAGTCGTACGATTC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1665.24723237877	39.7588091638432	0.0238756194220174	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1665.24723237877	1665.24723237877
"healthy-5"	"2019-08-29-count-1:GCTGGGTTCAACCGAT"	-5.51092324677165	-5.52514364635619	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTGGGTTCAACCGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2222.80120590771	53.3971843993494	0.024022474100442	1154	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2216.2531588327	2216.2531588327
"healthy-5"	"2019-08-29-count-1:ATTATCCAGGTGCCTC"	3.56918468055074	-7.92095901882323	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTATCCAGGTGCCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1935.45001825239	39.9287029038338	0.0206301906674332	856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1933.44727735986	1933.44727735986
"healthy-5"	"2019-08-29-count-2:TACATTCTCCAATGCA"	11.2147346931392	3.69220564449159	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACATTCTCCAATGCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1592.55734689175	41.3665464126907	0.0259749179478072	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1578.02333581374	1578.02333581374
"healthy-5"	"2019-08-29-count-1:TTCCGGTAGTAATCCC"	-3.14806137505229	10.7360296019348	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCGGTAGTAATCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1712.27536075964	47.2095783277746	0.0275712536719739	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1704.08064988081	1704.08064988081
"healthy-5"	"2019-08-29-count-2:TACATTCTCTTCGGTC"	-1.96177921715434	3.94498560512391	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACATTCTCTTCGGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3218.9428471986	45.0044867826525	0.0139811388145084	3889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3216.1183687413	3216.1183687413
"healthy-5"	"2019-08-29-count-2:TACCCACAGTGCGTCC"	2.15821399268453	-7.32679273998412	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCCACAGTGCGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1560.01696245971	44.9043075620575	0.0287844995552201	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1560.01696245971	1560.01696245971
"healthy-5"	"2019-08-29-count-2:ACGATGTTCTAGTCAG"	4.06783260878865	-7.41267349636229	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGATGTTCTAGTCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.60661722034	46.9076144192181	0.0220264221757745	1006	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2129.60661722034	2129.60661722034
"healthy-5"	"2019-08-29-count-2:TACCCACTCGTAACTG"	-3.85525880280193	12.56467053974	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCCACTCGTAACTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1651.40978710374	27.1307551814566	0.0164288448532443	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1646.63658161688	1646.63658161688
"healthy-5"	"2019-08-29-count-1:TTCCGGTTCAGACCTA"	-2.35327229920085	3.9600255259308	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCGGTTCAGACCTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3322.10401112557	47.5451738560858	0.0143117655849604	4098	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3314.51033002978	3314.51033002978
"healthy-5"	"2019-08-29-count-2:CCGGACATCTACCACC"	4.01838411864583	-7.40146829998168	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGGACATCTACCACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.85415339042	45.3353731785182	0.0227947198145397	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1984.83849587208	1984.83849587208
"healthy-5"	"2019-08-29-count-2:TTTCACAAGCTTTGTG"	3.58405007895772	-8.26578428661498	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCACAAGCTTTGTG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1885.32760563527	44.8413795513965	0.0237843966307845	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.37779709383	1881.37779709383
"healthy-5"	"2019-08-29-count-1:GCTTCACTCAAACCCA"	-3.77035365524943	12.8973645933899	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTCACTCAAACCCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1628.88854423766	42.5106634826408	0.0260979571825379	649	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1628.88854423766	1628.88854423766
"healthy-5"	"2019-08-29-count-1:TTCCGTGAGTCCGTCG"	2.99720897254292	-6.73670246517333	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCGTGAGTCCGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2104.53736627997	45.9760762164007	0.0218461676913197	1048	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2104.53736627997	2104.53736627997
"healthy-5"	"2019-08-29-count-1:GTTGCTCCACATAGCT"	2.71636118468587	-6.94143917476805	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGCTCCACATAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2047.73194667776	46.801172296049	0.0228551263127868	1018	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2045.96983663789	2045.96983663789
"healthy-5"	"2019-08-29-count-1:TTCCGTGCAGATACCT"	4.46761288222615	-8.00340273296507	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCGTGCAGATACCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2298.11219922803	44.1948140124429	0.0192309209390597	1179	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2293.03390741934	2293.03390741934
"healthy-5"	"2019-08-29-count-2:CTTCGGTTCTGGCCGA"	-3.42039595070537	10.7214755781922	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCGGTTCTGGCCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1601.68686313746	35.4955132932837	0.02216133135022	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1601.68686313746	1601.68686313746
"healthy-5"	"2019-08-29-count-2:CTTCTAAAGCTCTGTA"	5.4318057495052	-9.74193289196166	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCTAAAGCTCTGTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.33072458739	37.9864214573154	0.0189144252947281	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2000.13043135198	2000.13043135198
"healthy-5"	"2019-08-29-count-1:TTCCGTGTCTCTGACC"	-4.00139699402507	13.1374349364075	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCGTGTCTCTGACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1592.70836448938	29.6415302430649	0.0186107707499658	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1592.70836448938	1592.70836448938
"healthy-5"	"2019-08-29-count-1:GCTTGGGTCCAAACCA"	-3.38268313828166	11.8337516554627	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTGGGTCCAAACCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1496.86881733357	41.6160320038846	0.0278020568816556	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1489.48763951028	1489.48763951028
"healthy-5"	"2019-08-29-count-2:CTTCTCTAGTGGTTGG"	-2.93607340279277	9.76488015735475	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTTCTCTAGTGGTTGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1508.26720469638	30.4817538434437	0.020209783616942	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1505.88822786084	1505.88822786084
"healthy-5"	"2019-08-29-count-2:TTTCAGTTCACATACG"	9.3956695991451	5.73883626544801	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCAGTTCACATACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1519.5764037086	39.0441170148193	0.0256940795602842	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1517.15957591256	1517.15957591256
"healthy-5"	"2019-08-29-count-1:GCTTTCGCAAACACCT"	-3.25178251686748	11.8394355543884	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTTCGCAAACACCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1701.49565899336	39.0129297121776	0.0229286096064791	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1696.9820848565	1696.9820848565
"healthy-5"	"2019-08-29-count-1:ATTCACTTCGATACTG"	-3.89824328842815	3.69897148692933	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCACTTCGATACTG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3075.42924570671	43.3168502388025	0.0140848144366426	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3065.91140006759	3065.91140006759
"healthy-5"	"2019-08-29-count-2:CCGGTAGTCATGCATG"	2.59633674201314	-7.40322973644408	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGGTAGTCATGCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1386.06595470462	43.7616493847896	0.0315725591818	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1386.06595470462	1386.06595470462
"healthy-5"	"2019-08-29-count-2:TTCATTGGTCTAACTG"	3.21205653724019	-7.63031246578368	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCATTGGTCTAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.55307646371	42.9404404094768	0.0243626367812028	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.44493090162	1760.44493090162
"healthy-5"	"2019-08-29-count-1:GCTTTCGGTAGTCCTA"	-1.13814650002177	10.4925870665344	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCTTTCGGTAGTCCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1428.54405790484	37.005722355267	0.0259045019651274	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1426.04241537392	1426.04241537392
"healthy-5"	"2019-08-29-count-1:ATTCAGGAGTCTAACC"	-3.09424267235454	11.9357108839783	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCAGGAGTCTAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1475.55464692916	48.7398436581229	0.033031540891798	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1468.21464379625	1468.21464379625
"healthy-5"	"2019-08-29-count-2:ACGGGTCTCTTAGCTT"	9.95855392989461	5.77837321842042	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGGGTCTCTTAGCTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1468.27966859173	40.9626772657745	0.0278984161818864	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1465.96631093907	1465.96631093907
"healthy-5"	"2019-08-29-count-2:TTTCATGCATAGAGGC"	2.84052242812459	-8.06255533611449	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCATGCATAGAGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1880.22830297439	46.2330638882567	0.0245890692184131	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1876.09669030153	1876.09669030153
"healthy-5"	"2019-08-29-count-1:CCGTTCAAGTCTGCGC"	-4.78789029541667	2.5503792532715	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCGTTCAAGTCTGCGC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2856.66067359787	41.6879507732954	0.0145932455886652	2450	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2853.26122678628	2853.26122678628
"healthy-5"	"2019-08-29-count-1:ATTCAGGGTAATCAGA"	-3.62106404724773	11.726891494635	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCAGGGTAATCAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1395.17143069232	39.3358945574301	0.0281943090949838	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1389.95197930928	1389.95197930928
"healthy-5"	"2019-08-29-count-1:ATTCAGGGTTGCTTGA"	9.54213490065877	7.15226218784181	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCAGGGTTGCTTGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1611.03356237781	42.9138937736781	0.0266374920894505	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1611.03356237781	1611.03356237781
"healthy-5"	"2019-08-29-count-2:GGCTGTGTCCCAAGCG"	10.656887670129	6.27974793994752	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTGTGTCCCAAGCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1539.45375904289	35.817206872719	0.0232661790991288	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1532.51492297205	1532.51492297205
"healthy-5"	"2019-08-29-count-1:TCGGATATCTACCAGA"	-0.918023268610793	10.2359285124573	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGATATCTACCAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1445.72774484725	39.7748904220045	0.0275120198555827	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1438.55161624713	1438.55161624713
"healthy-5"	"2019-08-29-count-1:CTTACCGTCCGGGACT"	-2.60002193871196	11.3197936781677	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTACCGTCCGGGACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1580.27387467846	41.7210859654314	0.0264011742736179	642	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1578.08018755633	1578.08018755633
"healthy-5"	"2019-08-29-count-2:GGCTTGGAGGCATCGA"	3.90017714080159	-8.17187120830687	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTTGGAGGCATCGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1696.02866748867	48.069505879849	0.0283423899615012	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1693.883734074	1693.883734074
"healthy-5"	"2019-08-29-count-2:TACCTCGCATCCGTTC"	6.79002775725667	-1.61138417637023	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCTCGCATCCGTTC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2550.5789531359	30.7548980835157	0.0120580066912663	1351	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2545.62203020662	2545.62203020662
"healthy-5"	"2019-08-29-count-1:CTTACCGTCTTCCGTG"	6.78736795958821	-1.67640390312346	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTACCGTCTTCCGTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2427.18884187121	38.5771149082241	0.0158937426881394	1266	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2413.91436190054	2413.91436190054
"healthy-5"	"2019-08-29-count-1:GGAAGTGAGATACCAA"	3.79013933715169	-7.66466333782347	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAAGTGAGATACCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.09106814014	45.2148969372045	0.0265643230162829	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1699.81009540164	1699.81009540164
"healthy-5"	"2019-08-29-count-2:ACGGTTACATCCGTGG"	2.55538620528523	-4.18822433864745	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGGTTACATCCGTGG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2480.67515485696	39.748828410426	0.0160233911855009	1433	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2472.32638748866	2472.32638748866
"healthy-5"	"2019-08-29-count-2:CCGTAGGCAGACACAG"	3.06409229811971	-8.35404207622679	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGTAGGCAGACACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1480.47479266212	45.3137016919253	0.0306075469278639	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1475.63408482314	1475.63408482314
"healthy-5"	"2019-08-29-count-1:CATGGTATCTTAATCC"	2.81402220305745	-7.41936256801756	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGGTATCTTAATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1662.58032040779	52.0479941906565	0.0313055517088585	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1662.58032040779	1662.58032040779
"healthy-5"	"2019-08-29-count-1:TTCCTTCCATGACGTT"	-2.68268261376079	10.4986285933289	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCTTCCATGACGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1648.95028237916	31.8710014910629	0.019328054842914	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1644.4512921563	1644.4512921563
"healthy-5"	"2019-08-29-count-2:TGACGCGCAATAGGAT"	-1.45607183399852	10.2863378294739	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGACGCGCAATAGGAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1860.67477578019	35.3053319546539	0.018974477654135	932	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1859.02668524778	1859.02668524778
"healthy-5"	"2019-08-29-count-1:CTTAGGAGTCCCGGTA"	-4.09247765961345	11.3164319762024	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTAGGAGTCCCGGTA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1832.06659806056	30.3789712155639	0.0165818050761491	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1827.56799732268	1827.56799732268
"healthy-5"	"2019-08-29-count-1:GGAAGTGGTTCCTAAG"	-3.40904484215434	3.64178965175477	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAAGTGGTTCCTAAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3083.59047841453	45.0888767182784	0.0146222000080443	3440	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3074.94599968067	3074.94599968067
"healthy-5"	"2019-08-29-count-1:GGAAGTGTCTCTATGT"	-4.86034665527995	2.90610573375551	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAAGTGTCTCTATGT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3106.40453038203	45.5278456255736	0.0146561225945594	3074	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3091.98386420786	3091.98386420786
"healthy-5"	"2019-08-29-count-2:CCGTGAGCATGGCCCA"	2.48857965049092	-7.5447397462097	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGTGAGCATGGCCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1421.1322315427	44.5420102715696	0.0313426219481473	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1416.19241505549	1416.19241505549
"healthy-5"	"2019-08-29-count-1:TTCGATTCATGCACTA"	3.39921512183492	-6.69089033519896	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCGATTCATGCACTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2264.21732375088	40.0807645178886	0.0177018186803249	1164	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2256.12121928973	2256.12121928973
"healthy-5"	"2019-08-29-count-2:TACGCTCCAATCTCGA"	4.95597614821736	-9.28454878246459	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACGCTCCAATCTCGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2201.94457173116	41.9637475647398	0.0190575857828011	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2201.0194198226	2201.0194198226
"healthy-5"	"2019-08-29-count-2:GGGAAGTCAGAGAATT"	6.78324427184407	-1.43811573898467	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAAGTCAGAGAATT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2239.8910624108	38.4009170870865	0.0171441003232342	1092	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2238.09588193047	2238.09588193047
"healthy-5"	"2019-08-29-count-1:TTCGCTGAGATGCTAA"	-2.87152085724528	10.5146941908631	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCGCTGAGATGCTAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1566.88581938271	41.4867902772208	0.0264772262050114	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1566.88581938271	1566.88581938271
"healthy-5"	"2019-08-29-count-2:TTTGATCGTCTGGTTA"	-2.26789865914043	8.96118447864381	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGATCGTCTGGTTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1420.98976036001	33.7173897936623	0.0237281018725427	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1415.77035388928	1415.77035388928
"healthy-5"	"2019-08-29-count-1:ATTCCTACACGACTAT"	0.413757790892762	8.29760072315065	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCTACACGACTAT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1858.25629659263	35.2456617558741	0.0189670616590951	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1850.31543564934	1850.31543564934
"healthy-5"	"2019-08-29-count-2:CCGTTCACAGCATCTA"	14.3481527763302	1.93556616390077	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGTTCACAGCATCTA"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1667.04941756063	31.7617545376254	0.0190526772650219	1441	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1644.44858496367	1644.44858496367
"healthy-5"	"2019-08-29-count-1:ATCCACCGTCCGTACG"	0.487971325486344	9.06873796069948	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCACCGTCCGTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1539.43906124425	44.2293430978646	0.0287308177448196	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1537.20838457189	1537.20838457189
"healthy-5"	"2019-08-29-count-1:ATTCCTAGTAGACACG"	-2.52537641945537	3.90748498523561	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCTAGTAGACACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3237.92793965435	46.3469963435016	0.014313782519956	4327	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3234.34124708887	3234.34124708887
"healthy-5"	"2019-08-29-count-1:ATTCCTAGTGTCTTAG"	-3.41412697258647	12.9844217070374	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCCTAGTGTCTTAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1416.39512049376	40.347138602538	0.0284857932781305	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1413.80486235277	1413.80486235277
"healthy-5"	"2019-08-29-count-1:TTCGCTGTCGCCATAA"	-5.52637372437175	-4.48220827495726	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCGCTGTCGCCATAA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3076.46647943542	41.2822821475111	0.0134187329598621	2845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3073.0407126485	3073.0407126485
"healthy-5"	"2019-08-29-count-2:CCTAACCAGATACCAA"	8.39191975173299	5.89160821521608	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAACCAGATACCAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1553.85295242927	36.5784245853271	0.0235404672804727	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1549.29764964886	1549.29764964886
"healthy-5"	"2019-08-29-count-2:TACGGTACAAGTGCTT"	5.29289736327474	-9.20239546215209	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACGGTACAAGTGCTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2237.86920950798	41.0596725836511	0.0183476641124521	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2231.46033951067	2231.46033951067
"healthy-5"	"2019-08-29-count-2:CCTAACCAGTAGGCCA"	-3.29574165764506	3.61691114986268	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAACCAGTAGGCCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3005.3155481594	51.2229307330821	0.0170441106473673	3059	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3001.29659312983	3001.29659312983
"healthy-5"	"2019-08-29-count-1:ACTTCGCGTACCGTCG"	5.2287093597347	-10.0077667466369	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCGCGTACCGTCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.78605995894	42.9594897674397	0.0193704390802398	1091	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2205.54906336215	2205.54906336215
"healthy-5"	"2019-08-29-count-1:ATTCGTTCACTACTTT"	3.71597685393636	-7.98164560711058	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCGTTCACTACTTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1975.76984831344	44.0996234820597	0.022320222934723	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1964.11551129547	1964.11551129547
"healthy-5"	"2019-08-29-count-2:CCTAACCGTCGGAAAC"	2.44552721556966	-7.35201551830443	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAACCGTCGGAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2021.66647609684	46.2756690103362	0.0228898631685673	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2019.78243508689	2019.78243508689
"healthy-5"	"2019-08-29-count-1:TTCGGTCGTGTTCGAT"	-5.52251325073894	-5.44099190151366	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCGGTCGTGTTCGAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2557.73890218464	43.5015430878991	0.0170078122715118	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2555.07112008199	2555.07112008199
"healthy-5"	"2019-08-29-count-1:TTCGGTCTCATGTCTT"	4.06025328215901	-8.77164366161498	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCGGTCTCATGTCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1983.38827123508	44.2129167411631	0.0222916094555864	899	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1979.54667358825	1979.54667358825
"healthy-5"	"2019-08-29-count-2:TTTGGTTGTTGGTGTT"	2.63310732421224	-7.17606880581053	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGGTTGTTGGTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1614.91285223005	45.5933452139769	0.0282326969848662	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1607.72940600577	1607.72940600577
"healthy-5"	"2019-08-29-count-1:ATTCGTTTCATTCGGA"	4.45088543471639	-7.65354587947997	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCGTTTCATTCGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1889.69461775177	40.3690641935878	0.0213627449717861	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.91808777629	1881.91808777629
"healthy-5"	"2019-08-29-count-1:TTCTAACAGGATGCGT"	-3.7458647293156	10.4419879683289	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAACAGGATGCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2098.45402106023	36.5279665636663	0.017407084547514	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2091.0472515239	2091.0472515239
"healthy-5"	"2019-08-29-count-1:ATCCATTGTTATAGAG"	3.36943044242207	-8.08710100567015	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCATTGTTATAGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1674.9618895095	44.8815266994706	0.0267955509797383	675	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1663.67910701633	1663.67910701633
"healthy-5"	"2019-08-29-count-2:TACTGCCCAAGATTGA"	-3.35235438767131	13.2469901808533	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTGCCCAAGATTGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1584.32480008523	33.4297884140666	0.0211003377667686	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1579.35314810343	1579.35314810343
"healthy-5"	"2019-08-29-count-2:ACGTCCTAGTTGTCAC"	-3.0081766647404	10.5855264433655	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACGTCCTAGTTGTCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1794.71710086955	42.032575688287	0.0234201678180489	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1786.76335662667	1786.76335662667
"healthy-5"	"2019-08-29-count-1:GGAGAACCAACCGTAT"	3.62745871123616	-7.77678873455199	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGAACCAACCGTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1860.23780568139	40.6948235562776	0.0218761404762288	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1858.27654924373	1858.27654924373
"healthy-5"	"2019-08-29-count-1:GGAGAACCATCTGTTT"	2.66422738608662	-4.53184893047484	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGAACCATCTGTTT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2367.45270226329	38.8890979381866	0.0164265574982801	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2363.78891391192	2363.78891391192
"healthy-5"	"2019-08-29-count-2:TTTGTTGGTCACTTCC"	-3.34911880913432	11.1502771147522	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGTTGGTCACTTCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1531.8505333305	24.0878790067969	0.0157246927704009	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1524.40258576447	1524.40258576447
"healthy-5"	"2019-08-29-count-1:TTCTAGTAGCTCGCAC"	3.75017108496968	-8.08034899151	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTAGCTCGCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1681.83061895263	43.1982473159591	0.0256852544062143	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1675.22515788468	1675.22515788468
"healthy-5"	"2019-08-29-count-1:TTCTAGTCAAACTAAG"	-2.68603406372722	10.2995280989441	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTCAAACTAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1497.0178622962	37.8907946333844	0.0253108500490873	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1489.64652442416	1489.64652442416
"healthy-5"	"2019-08-29-count-2:TACTGCCTCTTTCTAG"	3.75835599479024	-7.87094213878783	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTGCCTCTTTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2045.11213556977	42.8442008234812	0.0209495607005162	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2043.39559771124	2043.39559771124
"healthy-5"	"2019-08-29-count-1:CCTCACAGTTAAACCC"	2.58947791632954	-6.26651050960692	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCACAGTTAAACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2290.26481510991	39.8303766678457	0.017391166473443	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2290.26481510991	2290.26481510991
"healthy-5"	"2019-08-29-count-1:TTCTAGTGTTGTGTAC"	2.3708242374355	-7.33880903637084	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTGTTGTGTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1728.88373369709	42.2684499903403	0.0244484051567495	713	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1722.46973935928	1722.46973935928
"healthy-5"	"2019-08-29-count-1:TTCTAGTTCAAGGAGC"	3.13087453421895	-7.96596147930297	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTTCAAGGAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1568.02290054892	47.1942588305079	0.030097939777529	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1565.6309251674	1565.6309251674
"healthy-5"	"2019-08-29-count-1:TTCTAGTTCCCTTGTG"	-1.33947084370311	10.1087217100891	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTTCCCTTGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1492.73159428465	38.2059927563566	0.0255946835336233	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1485.33690064181	1485.33690064181
"healthy-5"	"2019-08-29-count-1:TTCTAGTTCGAGCACC"	3.46281780776326	-8.83981134807738	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAGTTCGAGCACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1804.09228964788	47.2689313044889	0.0262009496829648	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.48769731385	1793.48769731385
"healthy-5"	"2019-08-29-count-2:CCTATCGCACCATATG"	10.0484568077022	6.25651691043702	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTATCGCACCATATG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1516.29593284716	42.021121083332	0.0277130078456576	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1509.33898434	1509.33898434
"healthy-5"	"2019-08-29-count-2:GGGAGATCAAGTACCT"	-3.26579270783122	3.6291568049225	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGATCAAGTACCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2866.41034516448	53.014391705114	0.0184950461801629	2654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2858.88650939571	2858.88650939571
"healthy-5"	"2019-08-29-count-1:ATTCTTGTCTACGCAA"	-1.53438852253612	9.89921948993532	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTCTTGTCTACGCAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1530.96250031208	42.3116299723935	0.0276372739134815	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1526.28508901402	1526.28508901402
"healthy-5"	"2019-08-29-count-1:ATTGGGTGTACGAAAT"	3.84880127486531	-7.36268427288207	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTGGGTGTACGAAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1760.79331972516	47.74938786917	0.0271181105324861	749	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.79331972516	1760.79331972516
"healthy-5"	"2019-08-29-count-2:CCTATCGGTGGTCTCG"	-4.82490144196208	-4.35336019909056	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTATCGGTGGTCTCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2848.43354930897	46.625559449194	0.0163688422573542	2206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2842.69849956853	2842.69849956853
"healthy-5"	"2019-08-29-count-2:TACTTGTCATATGGCT"	3.10220279273335	-7.50957491314086	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACTTGTCATATGGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1737.64067422999	45.0093626334715	0.0259025719764627	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1733.33438624913	1733.33438624913
"healthy-5"	"2019-08-29-count-1:TTCTCTCCACCTCTAC"	-2.81199727478679	10.6410007246765	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTCTCCACCTCTAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1829.75154762552	30.2636534648342	0.0165397610971323	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1823.76583437667	1823.76583437667
"healthy-5"	"2019-08-29-count-1:TTCTCTCGTACGGTTT"	4.39493670043294	-8.18183519756468	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTCTCGTACGGTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2119.37983803701	37.3924287506339	0.0176430992121106	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2110.39416507565	2110.39416507565
"healthy-5"	"2019-08-29-count-2:CCTCAACCAGGTGACA"	-1.86950407448466	9.4040841826233	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCAACCAGGTGACA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1681.52465280235	35.5823272875733	0.0211607526706632	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.13909965034	1670.13909965034
"healthy-5"	"2019-08-29-count-1:GGAGCAACACCCAATA"	-6.80822596970256	3.48423860156862	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGCAACACCCAATA"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2139.01229046397	42.8758898225115	0.0200447141017649	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2122.49895632266	2122.49895632266
"healthy-5"	"2019-08-29-count-1:GGAGCAACAGTCTCTC"	5.32935299453084	-10.2573051682678	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGCAACAGTCTCTC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2056.05184628246	40.5674853054313	0.0197307696198329	1044	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2049.58266271678	2049.58266271678
"healthy-5"	"2019-08-29-count-2:CCTCAACTCAGTGCGC"	-2.79829059067424	3.94623086536256	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCAACTCAGTGCGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3346.37076435332	46.1243464727288	0.0137833939275531	4223	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3341.35191584541	3341.35191584541
"healthy-5"	"2019-08-29-count-1:ATCCGTCTCTAGGCCG"	-1.51322112503703	8.94013879382936	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCGTCTCTAGGCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1968.9076077718	39.7342323436691	0.0201808516493245	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1963.43114308792	1963.43114308792
"healthy-5"	"2019-08-29-count-2:CCTCACAAGCGTGCCT"	-2.59605107727702	10.4959134825501	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCACAAGCGTGCCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1453.96936679123	38.1307385683402	0.0262252695546751	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1453.96936679123	1453.96936679123
"healthy-5"	"2019-08-29-count-2:GGGAGTAAGTTGAATG"	-2.24790392342265	10.3683738478455	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGTAAGTTGAATG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1429.95308949603	39.7366990607147	0.027788813040517	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1427.53494320545	1427.53494320545
"healthy-5"	"2019-08-29-count-1:ATTGTTCGTCTCACGG"	4.61005844649617	-8.71929743206175	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTGTTCGTCTCACGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1968.86065193085	43.2438175149238	0.0219638791970955	884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1966.90114055833	1966.90114055833
"healthy-5"	"2019-08-29-count-1:ATTGTTCGTCTCCTGT"	-2.3570924800938	10.8346223601135	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTGTTCGTCTCCTGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1475.67556139163	35.9914066687746	0.0243897829647819	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1475.67556139163	1475.67556139163
"healthy-5"	"2019-08-29-count-2:CCTCACACAGGCGTTC"	9.79952683028523	5.93514058673707	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCACACAGGCGTTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1504.63393962393	45.1479094191682	0.0300059092316185	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1502.26451380573	1502.26451380573
"healthy-5"	"2019-08-29-count-1:GGAGGATCACTATCGA"	-2.28721867027934	4.09747598255006	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGATCACTATCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3146.34219819947	47.811400144231	0.0151958678148841	3260	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3137.61683386819	3137.61683386819
"healthy-5"	"2019-08-29-count-1:AGAACCTGTCTACGTA"	-3.70118818703349	11.388777709845	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACCTGTCTACGTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1576.48621109403	40.2636177624301	0.0255401014478194	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1576.48621109403	1576.48621109403
"healthy-5"	"2019-08-29-count-1:TTCTGTATCTCTCGAC"	-3.64774904671367	3.69239876354066	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTGTATCTCTCGAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2984.16832012728	43.9152474030728	0.0147160758684013	2799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2976.68423744578	2976.68423744578
"healthy-5"	"2019-08-29-count-1:ATTTACCAGACTCTTG"	3.04374732550923	-8.13892271434935	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTACCAGACTCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1843.25462427793	46.8707762930972	0.0254282700153041	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1839.1583630884	1839.1583630884
"healthy-5"	"2019-08-29-count-2:CCTCAGTCACATATGC"	2.47673477706258	-7.72455599224242	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCAGTCACATATGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1579.44519578429	43.7945113571096	0.027727781548864	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1577.04330982619	1577.04330982619
"healthy-5"	"2019-08-29-count-1:TTCTTCCAGTAAGCAT"	-1.00935135307963	10.3231458433899	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCAGTAAGCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1473.39381956405	40.425106172123	0.0274367284804304	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1466.49337424505	1466.49337424505
"healthy-5"	"2019-08-29-count-1:TTCTTCCCAAATGGTA"	3.04417266425435	-5.14806463634642	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCCAAATGGTA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2326.72920296108	37.8375452237288	0.016262118159507	1353	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2322.59819709862	2322.59819709862
"healthy-5"	"2019-08-29-count-1:ATTTACCGTAAGGTCG"	-0.572294454008895	8.71482656085817	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTACCGTAAGGTCG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1620.90223386077	35.2678479398998	0.021758158637302	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1620.90223386077	1620.90223386077
"healthy-5"	"2019-08-29-count-1:GGAGGTAGTAGCTCGC"	3.9214092689449	-8.06109144603881	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGGTAGTAGCTCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1863.96137203045	43.545437967897	0.0233617705931653	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1858.23444895427	1858.23444895427
"healthy-5"	"2019-08-29-count-1:TTCTTCCCAGTGTACT"	0.361566771834534	-4.50526192104491	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	21	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCCAGTGTACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2396.72768297197	38.3248475042996	0.0159904889389755	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2391.36800612276	2391.36800612276
"healthy-5"	"2019-08-29-count-2:CCTCATGCACGGGTAA"	-3.38201079788859	12.5772418745789	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCATGCACGGGTAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1415.44179062124	48.0819749585529	0.0339695883484191	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1412.95273367431	1412.95273367431
"healthy-5"	"2019-08-29-count-2:TGATCAGCAGATTTCG"	-5.33009992066081	-5.26522781765135	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATCAGCAGATTTCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1924.15288552319	48.4328173513325	0.0251709818464676	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1918.16011066686	1918.16011066686
"healthy-5"	"2019-08-29-count-2:ACTATTCGTCCATACA"	3.24456038054768	-7.87803413784178	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTATTCGTCCATACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1734.83623479283	46.5005801958215	0.0268040171534545	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.66628462999	1732.66628462999
"healthy-5"	"2019-08-29-count-2:TGATCAGTCAGTGTGT"	3.15975274619405	-8.12021448528441	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATCAGTCAGTGTGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1571.27862363481	49.372142033957	0.0314216341337002	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1566.37679913323	1566.37679913323
"healthy-5"	"2019-08-29-count-2:GGGATGAAGGACGGAG"	3.41623677787129	-7.5072870484558	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATGAAGGACGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1774.16057672341	42.7410655435564	0.0240908664662656	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1770.08629847408	1770.08629847408
"healthy-5"	"2019-08-29-count-1:TTCTTCCTCACAATGC"	-3.14963732186015	12.1418256529602	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCTCACAATGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1764.18026879337	39.8296213655741	0.0225768432342892	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1759.66633771293	1759.66633771293
"healthy-5"	"2019-08-29-count-2:GGGATGACAAAGCAAT"	3.80049409446065	-8.41632082378539	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATGACAAAGCAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.16798068581	39.1553897671541	0.0223851512259	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.98790069808	1746.98790069808
"healthy-5"	"2019-08-29-count-1:ATTTCTGAGCATAGGC"	3.91925897177998	-8.65979578411254	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCTGAGCATAGGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1902.13707909342	45.1501425639574	0.0237365345853394	844	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1896.24184585767	1896.24184585767
"healthy-5"	"2019-08-29-count-2:CCTCCAACAGCCTATA"	3.09802617606465	-7.45666506206664	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCCAACAGCCTATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1679.4210365122	44.2355889045666	0.0263397849275691	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1677.15558534408	1677.15558534408
"healthy-5"	"2019-08-29-count-1:TCTATACCAGCGATTT"	-3.47478566590007	12.7279548414978	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATACCAGCGATTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1744.27416547014	44.28772656302	0.0253903471367891	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1733.18471429845	1733.18471429845
"healthy-5"	"2019-08-29-count-2:TGATCTTTCTATGCCC"	-3.06613812866862	10.0881452330383	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATCTTTCTATGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2165.93957702098	41.65971024884	0.0192340131233663	1156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2156.3117778701	2156.3117778701
"healthy-5"	"2019-08-29-count-2:GAAGGGTCATTGGATC"	4.16869368132893	-8.30240251934203	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAAGGGTCATTGGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1780.72106621416	47.71789058785	0.0267969484346579	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1776.39588860898	1776.39588860898
"healthy-5"	"2019-08-29-count-1:ATTTCTGCATGAGTAA"	2.72852267798726	-7.44783022319945	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCTGCATGAGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1740.32191346471	48.0733287445045	0.0276232393401275	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1736.04241432436	1736.04241432436
"healthy-5"	"2019-08-29-count-2:TAGATCGGTCTTGCTC"	3.84532393988912	-8.03160955822142	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGATCGGTCTTGCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1831.42321097669	44.6179951248005	0.0243624711412312	792	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1827.41702213716	1827.41702213716
"healthy-5"	"2019-08-29-count-2:TGATGCACACCTCGTT"	-1.95442614975627	10.8731899031433	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGCACACCTCGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1701.59930476252	34.9948463795827	0.02056585606355	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1699.32695415501	1699.32695415501
"healthy-5"	"2019-08-29-count-2:CCTCCTCAGTGATTCC"	-1.49585698071178	10.4077777632507	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCCTCAGTGATTCC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1552.83115020292	39.3144600830425	0.0253179233800822	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1550.53182179766	1550.53182179766
"healthy-5"	"2019-08-29-count-1:TTCTTGATCACGAGGA"	-1.3741047185963	3.63526389682619	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTGATCACGAGGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2518.25085118376	42.4665553351557	0.0168635127494123	2464	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2513.58217070891	2513.58217070891
"healthy-5"	"2019-08-29-count-2:ACTCCCATCGAAGCCC"	5.20457949218099	-10.3171301118103	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTCCCATCGAAGCCC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2133.83395437655	48.5816930772988	0.0227673259100862	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2128.54324260755	2128.54324260755
"healthy-5"	"2019-08-29-count-1:TTGAACGAGAAAGCGA"	2.2273289161617	-7.09288360988768	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAACGAGAAAGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1818.28381772163	48.1276834150929	0.026468740988631	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1818.28381772163	1818.28381772163
"healthy-5"	"2019-08-29-count-1:CCTCTCCAGTCACGCC"	-3.80563340607341	11.1445264586243	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTCCAGTCACGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.75799753896	33.9129322264625	0.0208085692953636	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1627.34743570434	1627.34743570434
"healthy-5"	"2019-08-29-count-2:TGATGGTGTTGTAAAG"	-2.64480028572734	-5.82514240657958	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGATGGTGTTGTAAAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1907.09653790637	52.040235274434	0.0272876774930147	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1900.98564439225	1900.98564439225
"healthy-5"	"2019-08-29-count-1:CAAAGAAGTAAGCTCT"	-4.27564940872844	12.8373222121033	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAAGAAGTAAGCTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1719.39022789638	44.2586741240098	0.0257409129154811	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1715.49842385443	1715.49842385443
"healthy-5"	"2019-08-29-count-2:CCTCCTCGTTGTCTAG"	3.14666451987569	-7.76728155529173	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCCTCGTTGTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1733.33994629979	39.2113540264842	0.0226218487090139	725	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1726.90829745654	1726.90829745654
"healthy-5"	"2019-08-29-count-1:TTGAACGCAAACAGGC"	-2.51119504395183	9.60636422717897	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAACGCAAACAGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1569.88787186945	42.6243878998801	0.0271512307749231	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1565.09688051385	1565.09688051385
"healthy-5"	"2019-08-29-count-1:CCTCTCCGTCTTTCTA"	-3.4210835498875	11.8634719618591	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTCTCCGTCTTTCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1793.28358322422	43.6390679391934	0.0243347278408321	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1791.14960199931	1791.14960199931
"healthy-5"	"2019-08-29-count-2:TAGCACATCAATCGGT"	-2.78492508354838	3.36296556079713	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGCACATCAATCGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3274.80574027317	46.7144556248594	0.0142648020462315	3884	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3269.34470843016	3269.34470843016
"healthy-5"	"2019-08-29-count-1:TCTCACGGTACGAGTG"	-2.51241670075114	3.5215866335663	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCACGGTACGAGTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3082.22807989621	46.1130405882771	0.0149609436397808	3170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3078.92355728712	3078.92355728712
"healthy-5"	"2019-08-29-count-1:GAAATGAGTGTACATC"	11.1054235893184	4.50568387592164	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAATGAGTGTACATC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1521.24501451958	42.1118719497383	0.0276825044932275	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1513.8437730659	1513.8437730659
"healthy-5"	"2019-08-29-count-1:TTGACCCGTCACCGAC"	4.35283150252644	-7.67642977153929	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGACCCGTCACCGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2029.4749594435	41.3475941651265	0.0203735424143712	943	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2025.74588143279	2025.74588143279
"healthy-5"	"2019-08-29-count-1:TAATTCCGTCGGATTT"	-3.80402002754863	12.8677072294983	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAATTCCGTCGGATTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1550.82447924145	48.0568543478004	0.0309879389905595	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1548.38964050065	1548.38964050065
"healthy-5"	"2019-08-29-count-1:GAACACTAGTAAACAC"	7.97820677336995	6.35854957187501	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAACACTAGTAAACAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1635.45530558834	33.8855827459479	0.020719357251868	659	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1635.45530558834	1635.45530558834
"healthy-5"	"2019-08-29-count-1:GGCGTCACACAATGCT"	-3.22773514214213	10.5780009993347	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCGTCACACAATGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1693.34645135622	40.5696182637756	0.0239582503812395	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1688.75833976404	1688.75833976404
"healthy-5"	"2019-08-29-count-1:GGCGTCACAGTTACCA"	4.12462009963338	-8.05858614360961	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCGTCACAGTTACCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1868.59802412656	46.917822196874	0.0251085688794971	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1868.59802412656	1868.59802412656
"healthy-5"	"2019-08-29-count-2:ACTGCAAAGGCCCGTT"	-2.79756389084514	9.95279119098512	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTGCAAAGGCCCGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1480.52904806215	39.7367281112643	0.026839546419758	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1473.41686020754	1473.41686020754
"healthy-5"	"2019-08-29-count-1:TTGAGTGCAGATACCT"	3.08204688605611	-7.43200113689574	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAGTGCAGATACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.48244672984	44.6035537168697	0.0264320104800537	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1682.9183805812	1682.9183805812
"healthy-5"	"2019-08-29-count-1:CAACAGTCATCCGATA"	2.33368792113606	-6.46856644069823	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACAGTCATCCGATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2068.85230101701	43.6661957206669	0.0211064829032027	974	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2065.12125348413	2065.12125348413
"healthy-5"	"2019-08-29-count-1:TTGAGTGCATCATTTC"	-3.93539057198222	12.8570384749207	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAGTGCATCATTTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1505.48376025819	39.8849800129249	0.0264931320189629	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1497.92029674165	1497.92029674165
"healthy-5"	"2019-08-29-count-1:AGACAGGTCCGCAGTG"	-3.32173500481303	11.7488288649353	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAGGTCCGCAGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1430.97622795363	37.9388649246384	0.0265125752500396	520	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1420.73920295707	1420.73920295707
"healthy-5"	"2019-08-29-count-1:TCTCCGAAGCTGAAAT"	-4.349930147559	-5.48445942318114	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	62	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCCGAAGCTGAAAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2258.5443975886	52.2133754618114	0.0231181532307085	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2253.16787434483	2253.16787434483
"healthy-5"	"2019-08-29-count-1:CAACCAAAGAGCATTA"	4.71111931380574	-7.91403820430907	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACCAAAGAGCATTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.0145664976	43.7273641667502	0.0206065334598162	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2116.90227590002	2116.90227590002
"healthy-5"	"2019-08-29-count-2:CCTGCATCAACTACGT"	6.701921125024	-1.48983802711638	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGCATCAACTACGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2588.05173802593	39.030100782569	0.0150808811930243	1457	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2585.00821783476	2585.00821783476
"healthy-5"	"2019-08-29-count-2:CCTGCATCACGTAACT"	9.78305973586385	5.85915515506593	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGCATCACGTAACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1528.869643958	43.9763821574362	0.028763984118089	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1528.869643958	1528.869643958
"healthy-5"	"2019-08-29-count-1:TTGAGTGTCATTCGTT"	3.10944404181783	-7.39769174968871	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAGTGTCATTCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1736.49646822639	45.6403020544679	0.0262829800633478	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.03674335265	1732.03674335265
"healthy-5"	"2019-08-29-count-1:CAACCAACATTGACAC"	-1.76759908619578	9.6563100584778	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACCAACATTGACAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1558.68338276438	46.7172791431412	0.0299722699681872	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1556.26834462591	1556.26834462591
"healthy-5"	"2019-08-29-count-2:TGCACGGAGTTATGGA"	0.649725516408127	8.88026139819948	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCACGGAGTTATGGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1689.81474571586	32.387561627977	0.0191663386238571	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1685.69005629825	1685.69005629825
"healthy-5"	"2019-08-29-count-1:CCTTCAGAGCATTTGC"	-3.40003977242168	3.6778423556122	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCTTCAGAGCATTTGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2990.15091025154	47.8717982696511	0.0160098268303201	2994	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2981.50444336427	2981.50444336427
"healthy-5"	"2019-08-29-count-2:CCTGCATTCCCAGGAC"	-2.94633660736735	12.521948791388	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGCATTCCCAGGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1553.51170446977	36.582978364804	0.0235485695148271	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1541.33543615383	1541.33543615383
"healthy-5"	"2019-08-29-count-1:TGTTGGACATGAAGGC"	3.36794437941853	-7.61023523723754	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTGGACATGAAGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1701.15557439964	50.9927197818411	0.0299753417907338	726	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1697.19716609017	1697.19716609017
"healthy-5"	"2019-08-29-count-1:GGCTTGGGTATGAAGT"	-2.03901849213298	3.47799561107484	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTTGGGTATGAAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2661.56823587497	50.1839225668921	0.0188550200932175	2390	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2654.44453082122	2654.44453082122
"healthy-5"	"2019-08-29-count-1:TTGCATTAGCCGATAG"	2.92011227187459	-6.21733715450438	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCATTAGCCGATAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1990.68492538738	42.4456976113432	0.0213221575499113	996	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.60493216544	1985.60493216544
"healthy-5"	"2019-08-29-count-1:TTGCATTCAAGTGATA"	-2.08394871178325	3.85102531993715	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCATTCAAGTGATA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2955.37530962895	44.9315277950914	0.0152033238041542	2848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2951.22685158318	2951.22685158318
"healthy-5"	"2019-08-29-count-2:TAGGTACGTCCACTCT"	2.98652567443196	-7.59889128124388	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGGTACGTCCACTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1770.99221480596	48.4945422637012	0.0273826964671409	748	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1764.59182450121	1764.59182450121
"healthy-5"	"2019-08-29-count-2:CCTGTTGCACTGATTG"	3.67704929885213	-8.27559854900511	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGTTGCACTGATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1609.42620660754	45.3892686119705	0.0282021433636558	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1609.42620660754	1609.42620660754
"healthy-5"	"2019-08-29-count-1:TTGCATTTCGGTTAGT"	3.29637255248372	-9.02314379131468	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCATTTCGGTTAGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1802.86648556617	44.8415401559237	0.0248723577230633	797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1798.98608330805	1798.98608330805
"healthy-5"	"2019-08-29-count-1:CAACGATAGGTTACCT"	-2.28673444214519	11.1162366637024	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGATAGGTTACCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1471.68034187389	38.9041867946186	0.0264352153709426	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1471.68034187389	1471.68034187389
"healthy-5"	"2019-08-29-count-1:ATCGTGAAGCCTGTGC"	-4.70272050324138	-5.20350601589354	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTGAAGCCTGTGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1760.99306891103	51.9370737095364	0.0294930596982153	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1760.99306891103	1760.99306891103
"healthy-5"	"2019-08-29-count-1:TTGCCTGAGTCTAGAA"	-6.9080904525822	3.00429651820985	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGAGTCTAGAA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2437.9394376042	35.6408926115636	0.0146192690687134	1677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2425.23679685822	2425.23679685822
"healthy-5"	"2019-08-29-count-2:ACTTAGGAGGGTCTTT"	3.52361597594563	-6.61764242565306	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTTAGGAGGGTCTTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1515.81964301743	43.0473230361167	0.0283987103837931	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1511.0710585573	1511.0710585573
"healthy-5"	"2019-08-29-count-2:GGGTATTTCTAGGAAA"	-2.72457204285319	12.6041135557922	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTATTTCTAGGAAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1612.25815325171	48.6656421801312	0.0301847703991938	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1612.25815325171	1612.25815325171
"healthy-5"	"2019-08-29-count-1:CAACGATGTTGACTAC"	9.64914097365681	5.77109429920045	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGATGTTGACTAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1362.5560919384	43.9900415475009	0.0322849399065251	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1352.86234150701	1352.86234150701
"healthy-5"	"2019-08-29-count-1:TTGCCTGCAGAGGAAA"	3.54097570952718	-7.60590603267821	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGCAGAGGAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1916.03418794787	45.8713429334547	0.0239407747638284	805	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1913.85733273468	1913.85733273468
"healthy-5"	"2019-08-29-count-1:CAACGGCAGCCAACCC"	0.196005364030045	8.17747876727907	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGGCAGCCAACCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1961.55115463534	36.7962390814204	0.0187587455950191	1088	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1950.8787452215	1950.8787452215
"healthy-5"	"2019-08-29-count-1:TTGCCTGGTGTCCATA"	-2.68858991089519	10.4347314604553	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGGTGTCCATA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1688.92534596574	37.0028656087828	0.0219091185392947	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1684.45113228233	1684.45113228233
"healthy-5"	"2019-08-29-count-1:TTGCCTGTCCACAAGT"	8.70098270949666	6.1417197951111	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGTCCACAAGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1397.32967554912	27.9668316494731	0.0200144834385506	512	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1394.8958288219	1394.8958288219
"healthy-5"	"2019-08-29-count-2:GGGTCTGAGATGTTAG"	-3.72399197045024	-5.01150228893431	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTCTGAGATGTTAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2947.23562590031	43.4157189104923	0.0147309969141778	2615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2941.58704889226	2941.58704889226
"healthy-5"	"2019-08-29-count-1:CAACGGCCAACATACC"	3.48414053496663	-8.55325415050658	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGGCCAACATACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1807.97529660951	50.5476570524782	0.0279581569213198	755	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1805.78183527071	1805.78183527071
"healthy-5"	"2019-08-29-count-1:GAAGCCCTCGACCATA"	-0.35092599216159	8.44999215686647	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGCCCTCGACCATA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2076.64794931115	39.1820786373269	0.0188679446847618	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2062.61919162592	2062.61919162592
"healthy-5"	"2019-08-29-count-2:GCTACCTCAAGTGGCA"	4.11520304259602	-7.07816460048827	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GCTACCTCAAGTGGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2477.66690872419	44.5061159731794	0.0179629133425754	1574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2473.06062375537	2473.06062375537
"healthy-5"	"2019-08-29-count-1:TTGCGTCAGGAGTCTG"	3.10435213622395	-5.17731192028197	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCGTCAGGAGTCTG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2669.47781041773	41.2347034222219	0.0154467301662153	1954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2663.6570155969	2663.6570155969
"healthy-5"	"2019-08-29-count-2:GACACGCTCATCGCAA"	-2.53431044045146	10.6709871062073	"2019-08-29-count-2"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACACGCTCATCGCAA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1593.51705387903	44.2282780062898	0.0277551331494237	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1582.54603109415	1582.54603109415
"healthy-5"	"2019-08-29-count-2:TATACCTTCGCCAACG"	3.48523559150044	-8.11203386699828	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATACCTTCGCCAACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1705.42403056635	41.0500296978038	0.0240702775157751	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1703.23400693923	1703.23400693923
"healthy-5"	"2019-08-29-count-2:TTGAGTGAGCCATCCG"	3.03967275199239	-7.03198149120482	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGAGTGAGCCATCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1818.52733147804	49.2417400612429	0.0270778113745592	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1814.62538231537	1814.62538231537
"healthy-5"	"2019-08-29-count-1:GGGACAATCGCGTTTC"	2.34365000304524	-6.94607164776	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGACAATCGCGTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1799.86273515491	52.8619080531232	0.0293699663983394	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.62520266541	1793.62520266541
"healthy-5"	"2019-08-29-count-1:CAAGACTCAATGAGCG"	-0.888255516917068	8.93287179553834	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGACTCAATGAGCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1904.89328438899	39.1256547970834	0.0205395520671559	882	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1903.00542222769	1903.00542222769
"healthy-5"	"2019-08-29-count-1:TTGCGTCCAGCAGTCC"	4.0213016467983	-8.03544046795043	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCGTCCAGCAGTCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.02091707765	36.0859247928535	0.0175769883748772	1019	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2047.98952838015	2047.98952838015
"healthy-5"	"2019-08-29-count-1:CTAACTTGTGTTCGTA"	3.26724781569783	-7.99884035503539	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTAACTTGTGTTCGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1784.20965159117	43.8891127870886	0.0245986298459646	771	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1780.36983882776	1780.36983882776
"healthy-5"	"2019-08-29-count-1:CAAGACTCACTTGAGT"	3.70335759696309	-7.61062529003295	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGACTCACTTGAGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2228.64159200963	44.688337515269	0.020051827837859	1100	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2214.6055871053	2214.6055871053
"healthy-5"	"2019-08-29-count-1:CAAGACTCAGACCGCT"	4.55403818663899	-8.41083528911742	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGACTCAGACCGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2276.90906011234	42.5037110908062	0.0186672853279038	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2273.71035400975	2273.71035400975
"healthy-5"	"2019-08-29-count-2:TGCATGAGTACTGCCG"	-3.73994574967082	10.4157943495545	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATGAGTACTGCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1746.76610451547	31.0629108391	0.0177830968661466	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1739.90213737551	1739.90213737551
"healthy-5"	"2019-08-29-count-1:TTACAGGAGAACTTCC"	-3.46786914292033	2.92898986423341	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACAGGAGAACTTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3295.1545734378	47.1351110089264	0.0143043702377066	3561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3290.37695269673	3290.37695269673
"healthy-5"	"2019-08-29-count-2:GGGTGAATCGTCAAAC"	3.47919501838033	-7.68086817180785	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTGAATCGTCAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2090.43993489219	41.3406245589228	0.0197760403773834	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2081.4477644829	2081.4477644829
"healthy-5"	"2019-08-29-count-1:TTGCTGCGTACATTGC"	2.73074092444722	-4.62254526531371	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCTGCGTACATTGC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2344.0511450547	44.4047854645915	0.0189436077614063	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2342.77763975807	2342.77763975807
"healthy-5"	"2019-08-29-count-2:TGCATGATCTCCTACG"	5.29017176207845	-9.95727636730345	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCATGATCTCCTACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2164.21680093729	45.4458405891366	0.0209987467842661	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2157.32225684577	2157.32225684577
"healthy-5"	"2019-08-29-count-2:CCTTTGGGTACGGATG"	3.18158235129659	-8.09755136882933	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTTTGGGTACGGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1433.34249201035	41.4231920315156	0.0288997167546586	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1430.74334330917	1430.74334330917
"healthy-5"	"2019-08-29-count-2:CCTTTGGGTTAACAGA"	1.8476480441982	-6.76051809703978	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTTTGGGTTAACAGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1706.70671625736	54.0155074259057	0.0316489686900373	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1697.82855525595	1697.82855525595
"healthy-5"	"2019-08-29-count-1:CGAAGGACAGTCACGC"	2.70513166961018	-7.18720867550048	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAAGGACAGTCACGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.46722256083	51.3729092710662	0.027465281749622	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1865.07265549162	1865.07265549162
"healthy-5"	"2019-08-29-count-1:TACCGAAAGTAGCTCT"	5.1661716895992	-9.65649320995482	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCGAAAGTAGCTCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2268.76828155395	39.5144628958134	0.0174167028061361	1165	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2265.45291146246	2265.45291146246
"healthy-5"	"2019-08-29-count-2:TATCAGGAGCATCCTA"	4.04936947402303	-8.33740427410277	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCAGGAGCATCCTA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2043.6689093938	35.1964948067707	0.0172222098427924	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2043.6689093938	2043.6689093938
"healthy-5"	"2019-08-29-count-2:TATCAGGCACCCGTAG"	3.46336021003072	-8.12803366100463	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCAGGCACCCGTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1789.73647732094	44.2005854167621	0.0246967003113922	766	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1779.33744876038	1779.33744876038
"healthy-5"	"2019-08-29-count-2:CGAAGGACAGTTAAAG"	4.56168808516805	-8.2006235352722	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAAGGACAGTTAAAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2246.01084273152	39.4121133001181	0.0175476059822518	1210	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2243.0078254326	2243.0078254326
"healthy-5"	"2019-08-29-count-1:TACCGAACAACGATCT"	-4.18077359619792	12.4013204344544	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACCGAACAACGATCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1815.26603923676	40.48206703384	0.022300900341231	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1804.47138360657	1804.47138360657
"healthy-5"	"2019-08-29-count-2:GGGTTATGTCCTCCAT"	3.93909396704976	-7.69591047680052	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTTATGTCCTCCAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2251.20022570493	44.5715571650951	0.0197990194990933	1217	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2240.32301480652	2240.32301480652
"healthy-5"	"2019-08-29-count-2:GACCAATCAGACACCC"	2.80964555320088	-5.11391165172728	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCAATCAGACACCC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2322.91513620214	38.1714834192194	0.0164325776797976	1337	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2319.2006119635	2319.2006119635
"healthy-5"	"2019-08-29-count-2:CAGTGCGCAGCTGTTA"	2.98892678794209	-7.23888685619506	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTGCGCAGCTGTTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1575.14934313479	50.7551284630102	0.0322224230256158	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1570.46761768689	1570.46761768689
"healthy-5"	"2019-08-29-count-2:CGAAGGATCTCTAAGG"	3.6859778362209	-7.24667742168578	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAAGGATCTCTAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1606.67679031177	44.2815806721764	0.0275609761335904	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1606.67679031177	1606.67679031177
"healthy-5"	"2019-08-29-count-2:CGAAGGATCTGAGGTT"	3.45102300223653	-8.28773882305297	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAAGGATCTGAGGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1702.65034987195	49.5031914160014	0.0290741968365522	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1691.82205410833	1691.82205410833
"healthy-5"	"2019-08-29-count-2:GACCAATTCACTGTCC"	-2.45535145226176	10.1611337431702	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACCAATTCACTGTCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1789.47025675962	39.8571476938739	0.0222731546072452	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1787.33872801104	1787.33872801104
"healthy-5"	"2019-08-29-count-2:TATCCTAGTAGATTAG"	5.32658733901326	-9.83248999035033	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCCTAGTAGATTAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2042.12048544887	42.3293830989787	0.0207281516446246	944	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2038.27913837302	2038.27913837302
"healthy-5"	"2019-08-29-count-1:TTGGGATCAGTTAAAG"	-3.02611051026042	11.5929708250794	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGATCAGTTAAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1480.87806379919	43.6573202090921	0.0294806988342371	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1478.33476381021	1478.33476381021
"healthy-5"	"2019-08-29-count-1:CAAGCTATCAATCTCT"	10.6611086326534	7.41978976810304	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGCTATCAATCTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	2296.99743857567	44.4798873499453	0.0193643608838879	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	2287.82965284582	2287.82965284582
"healthy-5"	"2019-08-29-count-1:TTGGGATCATTGAGGG"	4.62043013152425	-8.12688543712767	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGATCATTGAGGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2243.6572448287	38.9667075009889	0.0173674956773373	1274	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2242.59274216244	2242.59274216244
"healthy-5"	"2019-08-29-count-1:CAAGGGACACAGTCGC"	-4.05750832977946	-5.36095764553221	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGGGACACAGTCGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2317.4942129534	49.1698615397795	0.0212168217141382	1231	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2317.4942129534	2317.4942129534
"healthy-5"	"2019-08-29-count-2:CAACAACGTTCAAACC"	-0.6202748817509	9.78948400104371	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACAACGTTCAAACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1440.71416778315	44.8612207299726	0.0311381825299888	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1440.71416778315	1440.71416778315
"healthy-5"	"2019-08-29-count-1:TTGGGCGCAAGTCGTT"	-3.22012744370158	13.3905458220276	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGCGCAAGTCGTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1453.77203316373	49.9662136253848	0.0343700473564945	552	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1453.77203316373	1453.77203316373
"healthy-5"	"2019-08-29-count-1:CAAGGGAGTATTAAGG"	4.84009089049642	-8.72814180767211	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGGGAGTATTAAGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2002.98548089911	47.3668591139432	0.0236481290381999	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1990.50109634551	1990.50109634551
"healthy-5"	"2019-08-29-count-2:CGAATTGCACATCCCT"	-2.78339372101482	3.47072885120241	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAATTGCACATCCCT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1460.74513955262	36.8583008176513	0.0252325336019532	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1456.07655023025	1456.07655023025
"healthy-5"	"2019-08-29-count-1:TTGGGCGGTCGAATTC"	3.51997294005696	-7.63789369976195	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGCGGTCGAATTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1658.56216503667	49.6916754482924	0.0299606951706834	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1658.56216503667	1658.56216503667
"healthy-5"	"2019-08-29-count-2:CGAATTGTCCCAAGTA"	5.41424812850301	-10.2042341462341	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAATTGTCCCAAGTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.09816827558	43.640066969949	0.0194987277986886	1199	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2231.67942076662	2231.67942076662
"healthy-5"	"2019-08-29-count-2:CGACAGCAGCGCTGCT"	5.21477760848348	-9.39723112499388	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGACAGCAGCGCTGCT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2316.72170042226	41.652224428845	0.0179789503509434	1252	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2313.64291919327	2313.64291919327
"healthy-5"	"2019-08-29-count-2:CGACAGCAGCGGACAT"	-2.38751445236858	4.1913122900757	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGACAGCAGCGGACAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3122.94676390811	45.2850238254138	0.0145007351226005	3865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3113.45781425975	3113.45781425975
"healthy-5"	"2019-08-29-count-2:TATCTGTAGTCCGCGT"	2.58505787429158	-7.15299084102782	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTGTAGTCCGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1544.09814980638	47.6864628342223	0.0308830515988907	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1544.09814980638	1544.09814980638
"healthy-5"	"2019-08-29-count-1:CAATACGGTCTGTGAT"	2.82533611831014	-4.89299490368041	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATACGGTCTGTGAT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2377.94636711413	37.3124217409858	0.0156910274583981	1437	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2375.30029425205	2375.30029425205
"healthy-5"	"2019-08-29-count-1:TTGGGTACACATTACG"	0.835104187100571	8.43758199298707	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGTACACATTACG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1566.60750714096	33.7433839923666	0.0215391435560958	661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1558.16873631635	1558.16873631635
"healthy-5"	"2019-08-29-count-1:AGATGAAGTGGCTCTG"	-2.56035671654399	12.6383332976135	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGAAGTGGCTCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1606.9679344057	41.8129889443977	0.0260198029152717	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1602.19407876157	1602.19407876157
"healthy-5"	"2019-08-29-count-1:TTGGGTACAGCTTCGG"	2.29555453833882	-6.58811857616576	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGTACAGCTTCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1632.52260340813	46.4557452016084	0.0284564177577849	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1632.52260340813	1632.52260340813
"healthy-5"	"2019-08-29-count-1:GGGATGATCTGGGCCA"	-1.21754024449046	8.77066896045534	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGATGATCTGGGCCA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1465.31806531065	41.0408464203778	0.0280081488053428	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1462.97114742724	1462.97114742724
"healthy-5"	"2019-08-29-count-2:GGTAATCTCCGATCGG"	1.75701298293416	-6.9918513528076	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTAATCTCCGATCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1594.03829089297	53.7662403139701	0.0337295789073239	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1594.03829089297	1594.03829089297
"healthy-5"	"2019-08-29-count-2:TATCTGTTCAAATGAG"	3.9839526611263	-7.48581554805907	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTGTTCAAATGAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2124.70491784318	40.7496175839012	0.0191789538592807	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2121.76058601687	2121.76058601687
"healthy-5"	"2019-08-29-count-1:CAATCGAAGTCCGCGT"	2.30374517020528	-6.97387220775756	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATCGAAGTCCGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1421.75360385345	51.1773194380942	0.0359959132858082	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1419.27138616491	1419.27138616491
"healthy-5"	"2019-08-29-count-1:TTGGGTAGTGCGGTAA"	3.95499338683431	-7.62304403698119	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGTAGTGCGGTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.88615339885	41.7115745514711	0.0200933825215687	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.83114967571	2070.83114967571
"healthy-5"	"2019-08-29-count-1:TTGGGTAGTGCTTCAA"	-4.4911654991215	3.5729040869507	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGTAGTGCTTCAA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2624.97792666845	43.3998972088792	0.0165334332026026	2102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2621.22912603874	2621.22912603874
"healthy-5"	"2019-08-29-count-2:CGAGAAGCACCTGAAT"	-4.22464118424113	12.3385524519714	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGAAGCACCTGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1635.78294833807	44.0255740206281	0.0269140683153332	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1633.36272248177	1633.36272248177
"healthy-5"	"2019-08-29-count-1:TTGGGTATCAGAGCGA"	-5.22914872589763	-5.16410019313964	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGTATCAGAGCGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1716.80130646812	48.6632967813092	0.0283453283719952	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1712.43853977198	1712.43853977198
"healthy-5"	"2019-08-29-count-2:CGAGAAGGTCAAAGTA"	6.80906548079793	-1.46603443538817	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGAAGGTCAAAGTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1998.12519937512	35.9616709589243	0.0179977065351915	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1992.52458664442	1992.52458664442
"healthy-5"	"2019-08-29-count-2:CGAGAAGGTGAATTAG"	9.10843147811238	6.42809627139894	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGAAGGTGAATTAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1516.57604817714	39.6950553485309	0.0261741278297535	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1511.94284779435	1511.94284779435
"healthy-5"	"2019-08-29-count-2:CGAGAAGGTGCATGTT"	3.08108605918233	-7.53800775921019	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGAAGGTGCATGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1665.91727790392	47.7284915468459	0.0286499769105574	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1657.56061404312	1657.56061404312
"healthy-5"	"2019-08-29-count-1:AGATGCTTCGATCCCT"	-3.61837516251262	-5.33612301265868	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATGCTTCGATCCCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2024.85279443429	41.0799504426136	0.0202878700888924	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2021.97558381669	2021.97558381669
"healthy-5"	"2019-08-29-count-2:TATCTTGCAGTCAGAG"	5.61426605758016	-9.78718569194945	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTTGCAGTCAGAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2094.35291342885	40.5343298713938	0.0193541067560727	1047	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2090.94165224301	2090.94165224301
"healthy-5"	"2019-08-29-count-1:TTGGTTTCAAACGTGG"	3.6583649116451	-7.55465223705443	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGTTTCAAACGTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2121.99430973066	46.3281490791615	0.0218323625406148	1021	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2120.16732403679	2120.16732403679
"healthy-5"	"2019-08-29-count-2:GACGCTGGTGAGTTGG"	14.0660397010738	2.3193526037964	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GACGCTGGTGAGTTGG"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1151.82689393644	38.0518246297926	0.0330360619552371	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1142.01046422053	1142.01046422053
"healthy-5"	"2019-08-29-count-2:CGAGGAAAGATAACGT"	11.0645567375118	5.00399491870729	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGGAAAGATAACGT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1415.30174328452	30.4614690366731	0.0215229502692342	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1412.69555876618	1412.69555876618
"healthy-5"	"2019-08-29-count-2:TATCTTGGTCAGACTT"	-2.47954855385478	10.5717525252136	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTTGGTCAGACTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1642.51962661737	41.1344575520343	0.0250435105221525	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1640.20839890589	1640.20839890589
"healthy-5"	"2019-08-29-count-1:CAATGACTCCGTAGTA"	10.2623669105465	5.39549300754396	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATGACTCCGTAGTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1426.53447948652	42.2439545425164	0.0296129922900441	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1421.76031410276	1421.76031410276
"healthy-5"	"2019-08-29-count-1:GGGCGTTTCCAATGCA"	-3.42438040199931	12.1045417555603	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGCGTTTCCAATGCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1594.25423656194	40.8788760937346	0.0256413783675376	618	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1587.12955489549	1587.12955489549
"healthy-5"	"2019-08-29-count-2:TGCTCCAGTAGAATGT"	-2.09891424599345	10.212149597052	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCCAGTAGAATGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1568.79546224903	42.4625331968378	0.0270669658464994	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1564.2815369933	1564.2815369933
"healthy-5"	"2019-08-29-count-2:CAACGGCGTATTTCTC"	3.22988476332967	-8.02621462261351	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAACGGCGTATTTCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1410.75279794235	53.2369507197386	0.0377365551196406	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1410.75279794235	1410.75279794235
"healthy-5"	"2019-08-29-count-2:CGAGGAATCGTTGTGA"	4.25618519362752	-8.0977411500183	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGGAATCGTTGTGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2129.97662149133	37.8785584424746	0.0177835559603248	1031	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2128.39330109326	2128.39330109326
"healthy-5"	"2019-08-29-count-1:TGACCCTAGGTGCGAT"	10.4486071067745	5.4132394560608	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACCCTAGGTGCGAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1436.45564588686	34.6238465866166	0.0241036656340614	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1434.01035950331	1434.01035950331
"healthy-5"	"2019-08-29-count-1:TGACCCTAGTGAGGTC"	-2.33757887306865	9.99628636920778	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACCCTAGTGAGGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.62894001793	38.9343521834259	0.024741761665226	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1573.62894001793	1573.62894001793
"healthy-5"	"2019-08-29-count-1:AGCCAATGTGGGATTG"	3.85675110396687	-7.8730302087036	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAATGTGGGATTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2091.44838662625	39.9234357122106	0.0190888935952236	1056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2090.02205451281	2090.02205451281
"healthy-5"	"2019-08-29-count-1:TTGTGGATCTGGCCAG"	2.55780424651448	-6.7965502968994	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTGGATCTGGCCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1813.65499315881	52.6868701750314	0.0290501062075029	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1809.38145101907	1809.38145101907
"healthy-5"	"2019-08-29-count-2:TGCTCGTAGTCCTGTA"	2.92401327666585	-7.23569729244383	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCGTAGTCCTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.10055755318	43.8941092685869	0.0259713003894478	688	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1687.87754714559	1687.87754714559
"healthy-5"	"2019-08-29-count-2:TATGTTCGTTTACCAG"	1.64142515239064	-7.14276125347289	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATGTTCGTTTACCAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1803.91229032823	44.7250541713641	0.0247933640738299	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1803.91229032823	1803.91229032823
"healthy-5"	"2019-08-29-count-1:TTGTGTTAGTATGTAG"	5.06547751006429	-9.73822023784789	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTGTTAGTATGTAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2053.69442194212	44.3232619578079	0.0215822088643025	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2051.94979788396	2051.94979788396
"healthy-5"	"2019-08-29-count-1:CAATTTCTCTATTTCG"	-3.83616576615031	-5.15893413936766	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATTTCTCTATTTCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2654.37476629375	53.0997741672319	0.0200046258883684	1902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2647.71010577561	2647.71010577561
"healthy-5"	"2019-08-29-count-1:CACAACACAACAAGTA"	-0.298311899334747	8.49599454486696	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAACACAACAAGTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	2081.18457933205	37.4337957723775	0.0179867735635403	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2077.07293250488	2077.07293250488
"healthy-5"	"2019-08-29-count-1:TTGTGTTGTCCGGTCA"	-2.15377197685893	9.88324830615846	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTGTTGTCCGGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1400.7366711023	39.7421253689913	0.0283723030808613	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1400.7366711023	1400.7366711023
"healthy-5"	"2019-08-29-count-1:TGACGCGAGGTCACTT"	10.0181690650875	5.85362527454225	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGACGCGAGGTCACTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1468.59740874789	45.6405293971672	0.0310776317085292	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1466.28770338251	1466.28770338251
"healthy-5"	"2019-08-29-count-1:TTGTGTTTCATTTACC"	-5.09995923462566	-5.17717363750609	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTGTTTCATTTACC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2076.94857011352	51.0564627910468	0.0245824396067045	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2075.33766082178	2075.33766082178
"healthy-5"	"2019-08-29-count-2:CGAGTTACACCCATAA"	4.30046333846394	-8.25482656871947	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGTTACACCCATAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.90354925092	43.5876953249249	0.0209767654233221	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2074.15293660875	2074.15293660875
"healthy-5"	"2019-08-29-count-1:GACAGCCTCATCTCTA"	2.79478897628133	-6.47019913112792	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACAGCCTCATCTCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2159.27556000753	41.646722846459	0.0192873589725221	1060	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2157.47352127078	2157.47352127078
"healthy-5"	"2019-08-29-count-2:TATTCCAGTCGCTCGA"	4.20873465117757	-8.19665625011595	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTCCAGTCGCTCGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1551.27818652263	43.1665123755695	0.0278264161454705	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1551.27818652263	1551.27818652263
"healthy-5"	"2019-08-29-count-1:TTGTTCAAGATGCTGG"	3.57607831534688	-8.12833883678588	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTTCAAGATGCTGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2020.77876722493	41.8311990665452	0.0207005337471902	947	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2017.12202165058	2017.12202165058
"healthy-5"	"2019-08-29-count-1:GGGTAGACAAAGGAGA"	3.04194559630696	-7.07038738643798	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTAGACAAAGGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1509.32716603273	41.3559393786716	0.027400248474541	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1509.32716603273	1509.32716603273
"healthy-5"	"2019-08-29-count-1:CACACAACATGACAGG"	8.86894859847371	5.78004262531129	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACACAACATGACAGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1489.70137221862	36.5015133410773	0.024502570798277	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1487.40861814393	1487.40861814393
"healthy-5"	"2019-08-29-count-1:AGCCACGGTTTGGAGG"	-3.79296598854716	13.0530671843323	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCACGGTTTGGAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1766.77218781823	43.6654643949607	0.0247148244103179	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1762.35226528706	1762.35226528706
"healthy-5"	"2019-08-29-count-2:CGATCGGAGCCTCACG"	2.8707672553951	-7.36006023800048	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGATCGGAGCCTCACG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1708.72899376369	50.0022204135936	0.0292628149906075	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1708.72899376369	1708.72899376369
"healthy-5"	"2019-08-29-count-2:TATTGCTCAAGTCGTT"	3.40986408767049	-8.20970442211302	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTGCTCAAGTCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1811.7093139304	46.4031126827015	0.0256128907247447	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1809.99644182699	1809.99644182699
"healthy-5"	"2019-08-29-count-2:CGATCGGCAATCGAAA"	4.3870231109554	-7.27529766475829	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGATCGGCAATCGAAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2347.42378134844	39.7147420582256	0.016918437298702	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2342.87127384916	2342.87127384916
"healthy-5"	"2019-08-29-count-1:GACATCAGTAGACAGC"	-3.62609372559245	12.5228633650574	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCAGTAGACAGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1520.64541785885	33.294623454386	0.0218950605205957	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1518.12683330328	1518.12683330328
"healthy-5"	"2019-08-29-count-1:TTGTTCAGTCTAGATC"	-2.43014703217204	11.6863126524719	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTTCAGTCTAGATC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1562.08691328979	42.1253385899205	0.0269673462030379	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1557.89554414599	1557.89554414599
"healthy-5"	"2019-08-29-count-1:CACAGATGTTGCTCGG"	-2.63716254654582	12.5976981886658	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAGATGTTGCTCGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1498.37854036376	43.0768658799317	0.0287489874684631	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1498.37854036376	1498.37854036376
"healthy-5"	"2019-08-29-count-1:GACATCATCTATCGCC"	2.70230998572652	-6.90799715435179	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACATCATCTATCGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1728.04442635532	46.5950416696888	0.0269640299514545	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1721.8201857208	1721.8201857208
"healthy-5"	"2019-08-29-count-1:GACCAATAGTCATCCA"	4.1696216064388	-7.78971865093382	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACCAATAGTCATCCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2303.25354669299	45.1852342317759	0.0196180026713311	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2295.23207583763	2295.23207583763
"healthy-5"	"2019-08-29-count-1:AGCCAGCCACGCCAGT"	-3.46223578873332	11.9298934706482	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAGCCACGCCAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1604.94508482405	42.1223366944765	0.0262453445247283	648	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1600.53499271183	1600.53499271183
"healthy-5"	"2019-08-29-count-2:CGATGCGCATAGAGGC"	2.35324873503987	-6.24120476162108	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGATGCGCATAGAGGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2207.25317217694	41.7914952593868	0.0189337117219631	1110	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2204.24335330654	2204.24335330654
"healthy-5"	"2019-08-29-count-2:CGATGCGGTGACGTCC"	4.0490206676418	-8.12028505718382	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGATGCGGTGACGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1444.71722369924	48.6080710384869	0.0336453876517264	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1439.90599020042	1439.90599020042
"healthy-5"	"2019-08-29-count-1:GGGTATTGTTATAGAG"	-4.5779918235844	-4.31145861065062	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTATTGTTATAGAG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2936.22263426274	47.2686303317928	0.0160984490005001	2371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2933.57531249026	2933.57531249026
"healthy-5"	"2019-08-29-count-1:AGCCAGCTCTGTGCGG"	9.16411747512166	6.27829740131227	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCCAGCTCTGTGCGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1636.07930913976	40.5143299718691	0.0247630599235261	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1627.59869527818	1627.59869527818
"healthy-5"	"2019-08-29-count-1:TACTGCCTCGGTGAAG"	4.05401148375813	-8.24372389232787	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTGCCTCGGTGAAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.15501376593	43.3987122283145	0.0211272819906375	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2050.47154491382	2050.47154491382
"healthy-5"	"2019-08-29-count-1:GGGTATTTCCCTTGTG"	-0.793024997145492	10.4819555052551	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTATTTCCCTTGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1481.71543498366	46.9217975695903	0.0316672125171644	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1476.95805682007	1476.95805682007
"healthy-5"	"2019-08-29-count-2:TATTGGGAGGAACATT"	-5.59526000443156	-4.55045225536498	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTGGGAGGAACATT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2896.10161156024	48.1705154389412	0.016632881680208	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2892.16963701408	2892.16963701408
"healthy-5"	"2019-08-29-count-1:TGAGACTTCTACTGCC"	-4.94628034058269	8.77497289264528	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGACTTCTACTGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	3452.05855812066	43.2852016335785	0.0125389534693014	3209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	3444.4055047345	3444.4055047345
"healthy-5"	"2019-08-29-count-2:CAAGGGATCAACTACG"	-3.17645702782329	9.77966592395631	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAGGGATCAACTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1803.10986332518	37.7654988384276	0.0209446465834216	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1796.89739874983	1796.89739874983
"healthy-5"	"2019-08-29-count-2:CGCAGGTAGAAGTCCG"	3.65884866294209	-7.5575857392517	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCAGGTAGAAGTCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.37204970357	39.7778713004183	0.021767801092761	764	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1823.07825315495	1823.07825315495
"healthy-5"	"2019-08-29-count-2:CGCAGGTAGAGCATCG"	3.76484932479207	-8.42201139843138	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCAGGTAGAGCATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1789.56265708548	41.4923437994904	0.0231857452071925	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1785.43662542669	1785.43662542669
"healthy-5"	"2019-08-29-count-1:TTGTTTGAGTTTGGCT"	2.79985322532002	-6.68867351925048	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTTTGAGTTTGGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.46093769743	49.214473256355	0.0281312215642432	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1747.28521227716	1747.28521227716
"healthy-5"	"2019-08-29-count-1:CACAGGCTCCGATAAC"	-5.38394151154216	-5.35067703640135	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAGGCTCCGATAAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1984.78380640279	51.1062410579285	0.025749021577596	894	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1975.2625795702	1975.2625795702
"healthy-5"	"2019-08-29-count-1:TTGTTTGCACAATTCG"	2.26044430312459	-7.3211994401184	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGTTTGCACAATTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1956.55314915308	44.4475969627178	0.0227172959661011	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1954.61526864619	1954.61526864619
"healthy-5"	"2019-08-29-count-2:CGCAGGTGTCCAGCGT"	0.822481234639329	9.04644296253053	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCAGGTGTCCAGCGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1385.00619307555	49.9683413935688	0.036078063508589	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1380.17471408056	1380.17471408056
"healthy-5"	"2019-08-29-count-1:CACATGAAGCAGTAAT"	4.4205810028011	-8.39225485241088	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACATGAAGCAGTAAT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2340.75433024454	38.2652544135817	0.0163474030226761	1377	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2337.03834874637	2337.03834874637
"healthy-5"	"2019-08-29-count-2:TATTTCGCATGACTAC"	1.46710385855977	-7.04411413585814	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTTCGCATGACTAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1635.58693081662	48.5241281960443	0.0296677157794462	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1633.14630224375	1633.14630224375
"healthy-5"	"2019-08-29-count-1:TTTACCACACCTTCGT"	-0.677445868880111	9.09007451618043	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACCACACCTTCGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1675.65571330129	37.5137816469583	0.0223875234925501	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1673.43060436306	1673.43060436306
"healthy-5"	"2019-08-29-count-1:TTTACCACAGGTTACT"	3.16879286345784	-7.23679354107054	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACCACAGGTTACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1750.35095124678	51.0408358136621	0.0291603439740503	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1746.12958088013	1746.12958088013
"healthy-5"	"2019-08-29-count-1:TGAGCGCAGTGCCAGA"	3.98856701430623	-8.19814493572386	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGCGCAGTGCCAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1814.58384995736	45.6755035427767	0.0251713380695248	776	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1812.61012709733	1812.61012709733
"healthy-5"	"2019-08-29-count-1:TTTACCATCACCATCC"	-3.19393191757854	-5.67368318950804	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACCATCACCATCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1890.34556570825	42.9689484024893	0.0227307372693999	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1890.34556570825	1890.34556570825
"healthy-5"	"2019-08-29-count-1:AGCGCTGGTATGTCAC"	3.10572351989095	-6.63707735454711	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGCTGGTATGTCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1897.49441789935	44.8493284756567	0.0236360792698973	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1895.6326796704	1895.6326796704
"healthy-5"	"2019-08-29-count-1:TTTACGTCAATTGTGC"	3.19542874869649	-7.87027790462645	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACGTCAATTGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1637.24789229109	46.3410389693966	0.0283042288144583	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1635.02827469804	1635.02827469804
"healthy-5"	"2019-08-29-count-2:TCAAGACAGGTAATCA"	2.01081957396809	-6.86590769207152	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGACAGGTAATCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1541.45973400865	29.9277103220968	0.0194151748902763	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1528.75869430056	1528.75869430056
"healthy-5"	"2019-08-29-count-2:CGCATAATCTTTCCAA"	-3.41994128647502	12.1206512221131	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCATAATCTTTCCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1489.37069557838	43.8277599608608	0.0294270325654828	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1482.11395315533	1482.11395315533
"healthy-5"	"2019-08-29-count-2:TCAAGACAGTAAACTG"	4.47939552840535	-8.01875784313353	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGACAGTAAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1888.98802721809	41.402088600357	0.021917602443108	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1888.98802721809	1888.98802721809
"healthy-5"	"2019-08-29-count-1:GGGTCTGAGTGGACTG"	-2.31235299530681	10.3920650252136	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTCTGAGTGGACTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1408.16995678645	40.7882592935416	0.0289654377988743	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1408.16995678645	1408.16995678645
"healthy-5"	"2019-08-29-count-1:CACCAAAAGCTCATAC"	10.3914991813595	5.98284576022951	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCAAAAGCTCATAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1713.81772824678	36.9951785153162	0.0215864137157467	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1711.59830720605	1711.59830720605
"healthy-5"	"2019-08-29-count-1:AGCGTATAGGGATGTC"	3.5986348586971	-8.1188068619934	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCGTATAGGGATGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1752.93352900673	48.577703368358	0.0277122335584988	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1748.72345569341	1748.72345569341
"healthy-5"	"2019-08-29-count-1:TCGACCTCATCCGTTC"	-3.47406874123271	12.2756232985291	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGACCTCATCCGTTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1476.61867661461	47.6346489490202	0.0322592756704327	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1471.82152968192	1471.82152968192
"healthy-5"	"2019-08-29-count-1:GGGTCTGTCCCTAGGG"	4.11992325362508	-7.92194082653197	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTCTGTCCCTAGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.13089818036	41.2989046084796	0.0198826682731737	963	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2077.13089818036	2077.13089818036
"healthy-5"	"2019-08-29-count-1:TTTACTGGTAGAAACT"	4.05700935897176	-7.59528019344481	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACTGGTAGAAACT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2054.94557733885	44.629586559233	0.0217181355318559	1007	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2051.50978581281	2051.50978581281
"healthy-5"	"2019-08-29-count-1:CACCAAAGTAACCAGG"	3.25191654738728	-6.67027857219847	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCAAAGTAACCAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1874.80025605748	48.9424597651504	0.0261054262218161	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1866.59109295285	1866.59109295285
"healthy-5"	"2019-08-29-count-2:CAATGACCATTACGGT"	-1.49079630795177	9.75034616077272	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATGACCATTACGGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.85802743569	37.9035294438748	0.0226444111881711	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1669.60979592728	1669.60979592728
"healthy-5"	"2019-08-29-count-2:CCGAACGGTAGTAAGT"	2.97516049918477	-7.85751202022704	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGAACGGTAGTAAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1835.69566330254	45.6790630921786	0.0248837887485113	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1828.10489215705	1828.10489215705
"healthy-5"	"2019-08-29-count-2:CGCCAGACACAAATCC"	4.12683071669881	-6.86106254970702	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCCAGACACAAATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.31002396079	44.7126569718919	0.0207839207152353	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2149.5085195829	2149.5085195829
"healthy-5"	"2019-08-29-count-1:TTTAGTCGTTCCAAAC"	2.10121907767598	-7.02913668071898	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTAGTCGTTCCAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1677.16668151278	45.3577581463759	0.0270442757099514	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1674.82348232989	1674.82348232989
"healthy-5"	"2019-08-29-count-2:TCAAGCATCATTTGTC"	-1.75608013096507	10.0797595747742	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGCATCATTTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1537.88495648055	43.6007669073199	0.0283511238754168	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1535.41899254818	1535.41899254818
"healthy-5"	"2019-08-29-count-1:CACCGTTAGTTACGAA"	9.69702496108357	5.97033927524415	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCGTTAGTTACGAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1516.17831694899	42.0002978932341	0.0277014236542779	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1509.35165567231	1509.35165567231
"healthy-5"	"2019-08-29-count-1:GGGTGTCTCGCTAAAC"	-3.86633072319682	12.8445529707703	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTGTCTCGCTAAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1669.90386757991	43.0104141352424	0.0257562216426116	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1667.52464588403	1667.52464588403
"healthy-5"	"2019-08-29-count-1:CACCGTTGTCGTACAT"	-3.10831675949748	10.1255283125672	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCGTTGTCGTACAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1511.25377134617	35.4913650733095	0.023484715635611	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1509.01937903759	1509.01937903759
"healthy-5"	"2019-08-29-count-2:CAATTTCCAGAGGCAT"	-3.8397573036259	12.346990562323	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAATTTCCAGAGGCAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1539.70497539884	24.7102304725018	0.0160486787191818	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1539.70497539884	1539.70497539884
"healthy-5"	"2019-08-29-count-2:TCAAGTGCACCCTCTA"	9.9515491920406	6.08890912616578	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGTGCACCCTCTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1464.54356058093	41.7522959328425	0.0285087429671814	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1459.74518365265	1459.74518365265
"healthy-5"	"2019-08-29-count-1:AGCTACAAGGGCAGGA"	-2.89106545868571	10.6109647520813	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTACAAGGGCAGGA"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1471.54360171168	41.1783332247065	0.0279830874034643	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1471.54360171168	1471.54360171168
"healthy-5"	"2019-08-29-count-1:GGGTTATAGCTCGACC"	-1.96309981766399	9.86171815479127	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGGTTATAGCTCGACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1383.10106408217	40.1248505537287	0.0290107871331556	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1380.67304662641	1380.67304662641
"healthy-5"	"2019-08-29-count-2:TCAAGTGTCCGTGGTG"	-4.21754966202434	-4.50854685222777	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAAGTGTCCGTGGTG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1912.72570091372	43.1734741174591	0.0225717017849631	820	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1910.66126798422	1910.66126798422
"healthy-5"	"2019-08-29-count-1:TTTATGCTCGAGTGAG"	-3.34069905701335	-5.6569452515808	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTATGCTCGAGTGAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2129.79823315493	51.7069541919032	0.0242778650986616	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2124.72434271648	2124.72434271648
"healthy-5"	"2019-08-29-count-2:GTAACACAGAGTATAC"	11.4449640708858	4.02035782420961	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAACACAGAGTATAC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1557.79316610643	46.4859842316479	0.0298409219163772	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1550.59286631012	1550.59286631012
"healthy-5"	"2019-08-29-count-2:CGCCATTCACAGTACT"	3.41133822974507	-7.8985805741516	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCCATTCACAGTACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1411.32525613647	46.613462029019	0.033028149837426	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1411.32525613647	1411.32525613647
"healthy-5"	"2019-08-29-count-2:GAGATGGAGCCATCCG"	6.85316528853719	-1.5567414990631	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGATGGAGCCATCCG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2180.31081549006	35.7410615888176	0.0163926451838401	1103	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2168.62485286555	2168.62485286555
"healthy-5"	"2019-08-29-count-1:TTTCACATCCATCTAT"	2.49980988082234	-4.0614953271118	"2019-08-29-count-1"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCACATCCATCTAT"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2395.07662053602	38.6075356855065	0.0161195409593477	1456	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2383.23638658783	2383.23638658783
"healthy-5"	"2019-08-29-count-1:TTTCAGTAGGCAGTCA"	-2.8316002887791	11.0462159880432	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCAGTAGGCAGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1454.15358870568	37.9029759641082	0.0260653181744338	548	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1444.46833418487	1444.46833418487
"healthy-5"	"2019-08-29-count-2:CACAACAGTGAACCGA"	-4.72090802612956	3.28242156589357	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CACAACAGTGAACCGA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2440.04159160963	42.5642587758705	0.017444071003639	1860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2431.02212961363	2431.02212961363
"healthy-5"	"2019-08-29-count-1:GACGTTATCCCTGGTT"	-5.40527806702312	-5.63990738308104	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGTTATCCCTGGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2379.77871085618	40.1300148317187	0.0168629186607359	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2376.48945659315	2376.48945659315
"healthy-5"	"2019-08-29-count-1:GACGTTATCGAGGCAA"	3.77440275725667	-7.82933046734007	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GACGTTATCGAGGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.3041456618	39.7476744110874	0.0196546471490716	957	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2020.4809476685	2020.4809476685
"healthy-5"	"2019-08-29-count-1:TTTCAGTGTTACACTG"	-3.10877809944804	11.2920655974182	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCAGTGTTACACTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1556.21135061102	40.4157277128927	0.0259705904966085	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1553.90101561101	1553.90101561101
"healthy-5"	"2019-08-29-count-1:AGCTCAATCTTCCCGA"	-1.09729884091075	9.4488315352234	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTCAATCTTCCCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1675.10510866764	35.8854738895274	0.0214228192033097	655	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1672.74016886161	1672.74016886161
"healthy-5"	"2019-08-29-count-1:TTTCAGTTCGCTCCTA"	3.60082044181172	-8.10038664257201	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCAGTTCGCTCCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1794.30122388452	46.0471129044166	0.0256629780392882	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1792.27865416139	1792.27865416139
"healthy-5"	"2019-08-29-count-2:CGGAACCCAATGACCT"	-3.17131982269939	10.1391238936218	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAACCCAATGACCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.88728573217	34.7709952665871	0.0225655669876367	589	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1534.00384200118	1534.00384200118
"healthy-5"	"2019-08-29-count-1:GGTAACTCATTCGGGC"	-2.23285923424419	9.78190229022828	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAACTCATTCGGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1532.17944337988	35.7959691795457	0.0233627786446359	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1527.28708937205	1527.28708937205
"healthy-5"	"2019-08-29-count-1:CGGAACCAGATAGCAT"	-3.10513434830363	3.51811645114747	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAACCAGATAGCAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3145.43997291579	48.3267002071721	0.0153640510145784	3720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3139.86199021679	3139.86199021679
"healthy-5"	"2019-08-29-count-2:CGGAACCTCGCGTTTC"	3.29176392134969	-7.1193213692871	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAACCTCGCGTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2495.87537808226	44.5054573752712	0.0178316023973391	1508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2491.75514161538	2491.75514161538
"healthy-5"	"2019-08-29-count-1:TGAGTCATCTCTTAAC"	2.93111767348592	-5.23246862804564	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGAGTCATCTCTTAAC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2559.70702441203	40.1513329914031	0.0156859096015592	1639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2554.77120691738	2554.77120691738
"healthy-5"	"2019-08-29-count-1:AGCTTCCTCCCGTGAG"	-3.137443403632	11.7983350523743	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGCTTCCTCCCGTGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1613.43842426866	36.4891228592564	0.0226157517450945	635	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1604.79013259346	1604.79013259346
"healthy-5"	"2019-08-29-count-2:CGGAATTAGACGCTCC"	3.51429714736287	-6.94021513378295	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAATTAGACGCTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1935.46638545308	41.7348502136919	0.0215632007496333	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1931.74246934881	1931.74246934881
"healthy-5"	"2019-08-29-count-1:TTTCATGGTGGCAGAT"	-3.20061979714091	10.5142278441223	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCATGGTGGCAGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1417.55617654775	34.6544868632941	0.0244466409420824	517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1415.03063743871	1415.03063743871
"healthy-5"	"2019-08-29-count-2:TCACACCAGACTTAAG"	-2.25541220131572	10.495861984137	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACACCAGACTTAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1730.63424938203	46.8681067373833	0.0270814626222258	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1726.55993857195	1726.55993857195
"healthy-5"	"2019-08-29-count-1:CACGTTCAGCTCTTCC"	-2.75606904450114	9.92706391895143	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGTTCAGCTCTTCC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1906.16949952649	41.0590192089091	0.0215400672495853	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1904.27248163089	1904.27248163089
"healthy-5"	"2019-08-29-count-1:CACGTTCAGGTTATAG"	6.68791307982747	-0.614754282590471	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGTTCAGGTTATAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1446.88291425722	24.5753416020814	0.0169850243996401	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1441.73038875834	1441.73038875834
"healthy-5"	"2019-08-29-count-1:CACGTTCCAAATACGA"	3.55039443549458	-7.30354931270751	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGTTCCAAATACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1556.4672851301	41.056592398719	0.0263780631889652	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1556.4672851301	1556.4672851301
"healthy-5"	"2019-08-29-count-2:GTAATCGGTCTTGAGT"	4.18484558638875	-7.94493963634642	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTAATCGGTCTTGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.92058458837	45.7102112254774	0.0211237933365159	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2154.99487539588	2154.99487539588
"healthy-5"	"2019-08-29-count-1:CACGTTCTCCCATTCG"	5.28420271453206	-10.2591552964416	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGTTCTCCCATTCG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2185.11296230331	48.1818520697714	0.0220500509131497	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2177.01022513132	2177.01022513132
"healthy-5"	"2019-08-29-count-2:CGGACACTCAGAGTTC"	-3.11424193802531	10.8914298781189	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGACACTCAGAGTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1532.52101037587	39.7013844547983	0.0259059315898455	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1530.22836690507	1530.22836690507
"healthy-5"	"2019-08-29-count-2:CGGACACTCGAGCTGC"	14.2335716682369	1.90506980502931	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGACACTCGAGCTGC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1308.02271649196	45.2447635436076	0.0345901970762033	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1298.14516418728	1298.14516418728
"healthy-5"	"2019-08-29-count-2:CGGACACTCGTCACCT"	-2.58231339874919	4.01007220828859	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGACACTCGTCACCT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3266.07638274409	42.7455550913567	0.0130877389509926	4474	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3260.30875807138	3260.30875807138
"healthy-5"	"2019-08-29-count-2:CGGACACTCTGCACCT"	4.85335316237752	-7.69955542003783	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGACACTCTGCACCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2101.32599993625	36.7044064108618	0.0174672594409318	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.78898440798	2099.78898440798
"healthy-5"	"2019-08-29-count-1:CACTAAGCACAGACGA"	2.08613075789754	-7.09023620998534	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTAAGCACAGACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1974.47763362635	52.585636320155	0.0266326827028045	951	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1970.81093104436	1970.81093104436
"healthy-5"	"2019-08-29-count-1:GGTAGAGGTCTGTGGC"	3.86148156699483	-8.59048368847045	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTAGAGGTCTGTGGC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1864.92366491541	35.3293162800718	0.0189441085148513	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1861.45156011163	1861.45156011163
"healthy-5"	"2019-08-29-count-2:CGGAGAATCGTCGGGT"	6.96715893325154	-1.07176616108092	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAGAATCGTCGGGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1592.48014484055	38.5302486025482	0.024195120251503	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1585.48489687916	1585.48489687916
"healthy-5"	"2019-08-29-count-1:TTTCGATAGAGGGCGA"	3.05125011977498	-7.28888800060423	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCGATAGAGGGCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1542.2122343577	43.7690235317142	0.0283806745638631	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1542.2122343577	1542.2122343577
"healthy-5"	"2019-08-29-count-1:TTTCGATCACGGATCC"	6.81405415114705	-1.37804605877074	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCGATCACGGATCC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2100.29431863024	39.0363445323504	0.0185861306132604	983	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2090.92454197789	2090.92454197789
"healthy-5"	"2019-08-29-count-1:AGGACTTAGATTGGGC"	-3.1499539417332	11.3556556471619	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGACTTAGATTGGGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1478.66959302323	40.6546960956495	0.0274941043539879	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1473.70159852518	1473.70159852518
"healthy-5"	"2019-08-29-count-1:CACTAAGGTCTCAGGC"	-5.11500440064128	-5.07593204891356	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTAAGGTCTCAGGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2132.59352904941	50.8060537329052	0.0238235993126884	999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2128.85238731163	2128.85238731163
"healthy-5"	"2019-08-29-count-1:AGGACTTTCAAAGAAC"	1.98782410201375	-6.90285684978636	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGACTTTCAAAGAAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2118.47134295181	42.6333700806727	0.0201245913580633	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2118.47134295181	2118.47134295181
"healthy-5"	"2019-08-29-count-1:GGTCACGGTTGTGTTG"	-2.97174129906352	3.63110396945802	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTCACGGTTGTGTTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3092.37243330745	47.1998122384029	0.015263301318438	3161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3086.27976934701	3086.27976934701
"healthy-5"	"2019-08-29-count-1:TTTCGATGTCGTATTG"	4.70307936248128	-9.45256235515746	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCGATGTCGTATTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1644.01322773866	42.0177477140581	0.0255580350602492	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1641.7270718297	1641.7270718297
"healthy-5"	"2019-08-29-count-1:TTTCGATGTGGCCACT"	10.287315984338	7.13469455325929	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCGATGTGGCCACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1625.57915406635	41.4013610764298	0.0254686835598655	666	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1617.03175359035	1617.03175359035
"healthy-5"	"2019-08-29-count-1:CACTGAACATAACGGG"	3.571620841592	-6.86604311382445	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGAACATAACGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.86457519321	43.0796176214456	0.0207526146629465	1082	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2074.2567439367	2074.2567439367
"healthy-5"	"2019-08-29-count-1:CACTGAAGTACATACC"	3.14816846427266	-6.47457840358885	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGAAGTACATACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2367.379441976	45.1917798525502	0.0190893690513886	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2364.33019654138	2364.33019654138
"healthy-5"	"2019-08-29-count-2:CGGGACTAGTTGCGAG"	-2.75396070900615	10.4357518919739	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGACTAGTTGCGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1728.32254203997	41.4783164944729	0.0239991757820362	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1726.12782646939	1726.12782646939
"healthy-5"	"2019-08-29-count-1:TTTGACTCAAGTCCCG"	10.074123998254	5.3627776869568	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTGACTCAAGTCCCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1528.63778314529	46.0881461056778	0.0301498148311158	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1526.3491141618	1526.3491141618
"healthy-5"	"2019-08-29-count-1:TGATGCATCCCTCTTT"	4.05029358443562	-6.8821215859619	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGCATCCCTCTTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2577.49320228494	45.9592616582432	0.0178309923834136	1671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2576.26719267231	2576.26719267231
"healthy-5"	"2019-08-29-count-1:GGTGATTCATGAAGGC"	-1.68731627884563	10.4885825880798	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGATTCATGAAGGC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1368.4569867515	42.4177142528467	0.030996746454954	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1366.04525432406	1366.04525432406
"healthy-5"	"2019-08-29-count-1:TTTGACTGTCAAACGG"	3.3919161754543	-7.53948976909789	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTGACTGTCAAACGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1669.85753559004	48.407008050039	0.0289887053346347	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1667.54163161113	1667.54163161113
"healthy-5"	"2019-08-29-count-1:CACTGGGAGTTTCGAC"	-3.61850295487102	-5.00989582454833	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGGGAGTTTCGAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2428.90918875339	47.1062648106598	0.0193940000016372	1611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2424.27909767961	2424.27909767961
"healthy-5"	"2019-08-29-count-1:TGATGGTAGGTCACCC"	4.95671810683553	-9.35374643718871	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGATGGTAGGTCACCC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.99915960102	38.8693188669925	0.0174850803245327	1209	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2221.50220206801	2221.50220206801
"healthy-5"	"2019-08-29-count-2:GTACAGTTCAAGCCTA"	3.19236030158345	-6.37824346935423	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTACAGTTCAAGCCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2141.29468488846	44.3551211943893	0.0207141602262463	1102	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2136.45964214794	2136.45964214794
"healthy-5"	"2019-08-29-count-2:CGGGACTTCTTCTCAA"	3.06058325347249	-7.28683235561522	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGACTTCTTCTCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1792.43863906003	43.924002523186	0.0245051638399293	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1790.23394489687	1790.23394489687
"healthy-5"	"2019-08-29-count-2:TCACGGGTCTGACCCT"	3.15436186370198	-7.71759273922118	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACGGGTCTGACCCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.51730727798	46.0226266745654	0.0261118721980906	728	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.41612536025	1760.41612536025
"healthy-5"	"2019-08-29-count-1:CACTGGGTCCCTCATG"	3.0858539539272	-7.68684914028319	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGGGTCCCTCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1849.27985578993	51.5466549648809	0.0278739071339003	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1845.46064615408	1845.46064615408
"healthy-5"	"2019-08-29-count-1:CACTGGGTCGATACAC"	3.7546931701595	-7.9094333878723	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGGGTCGATACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1764.16330307091	49.4332679273771	0.0280208004788036	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1761.96587133205	1761.96587133205
"healthy-5"	"2019-08-29-count-2:CGGGCATGTATTCCTT"	-3.11640534821208	12.1465320357117	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGCATGTATTCCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1629.08515800285	36.3688376608331	0.0223247001436185	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1622.11010438233	1622.11010438233
"healthy-5"	"2019-08-29-count-1:TAGGTACAGTTAGTGA"	2.3986607986385	-4.35900976574095	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGGTACAGTTAGTGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2306.51556225515	41.3022871160189	0.0179067888341652	1391	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2303.85120602058	2303.85120602058
"healthy-5"	"2019-08-29-count-1:GGTGTCGCAATGAAAC"	2.51264514502828	-7.15188600933226	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGTCGCAATGAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1558.04478623669	49.9496571511464	0.032059192131309	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1551.08096448093	1551.08096448093
"healthy-5"	"2019-08-29-count-2:CGGGTCAAGACGGATC"	-2.98755321922954	11.0064182051453	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGTCAAGACGGATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1725.87343621054	37.7657402690506	0.0218821029843138	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1719.11312882218	1719.11312882218
"healthy-5"	"2019-08-29-count-1:CACTGTCCAAATGGCG"	3.4713782268459	-6.57882740413817	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGTCCAAATGGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1925.13472387205	41.3947528967784	0.0215022628720345	864	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1923.20207548626	1923.20207548626
"healthy-5"	"2019-08-29-count-1:TTTGGAGCAACCACAT"	2.30833091315572	-7.18216659938964	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTGGAGCAACCACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1814.0876973516	46.7097207839809	0.025748325647196	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1811.99605248515	1811.99605248515
"healthy-5"	"2019-08-29-count-2:CGGGTCAGTAAGAACT"	4.2544375854427	-7.38940098201903	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGTCAGTAAGAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2202.31870577873	37.0833538974026	0.0168383230819856	1057	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2200.51052599672	2200.51052599672
"healthy-5"	"2019-08-29-count-2:CGGGTCAGTCTGATAC"	-3.59911380234416	10.9942331084046	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGTCAGTCTGATAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1881.34624305293	42.2085040451114	0.0224352663423709	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1873.85967394194	1873.85967394194
"healthy-5"	"2019-08-29-count-1:CACTGTCCATATTCGG"	-5.45784650269206	-5.64422132885131	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGTCCATATTCGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2332.16739806732	47.7381734061817	0.0204694454805185	1229	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2327.30425075868	2327.30425075868
"healthy-5"	"2019-08-29-count-1:GGTGTTAGTGGTCCGT"	3.33796586570088	-8.43362905895384	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTGTTAGTGGTCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1416.57390930921	45.9766861172249	0.0324562564756295	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1416.57390930921	1416.57390930921
"healthy-5"	"2019-08-29-count-2:CGGGTCATCCCTCTCC"	3.41439404067342	-7.25990536129149	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGGTCATCCCTCTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1711.77087848187	53.9684996593753	0.0315278758026533	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1707.33341883241	1707.33341883241
"healthy-5"	"2019-08-29-count-1:CACTGTCTCCATTGCC"	1.75625302371327	-6.56050732052001	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGTCTCCATTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.85491194163	51.9451501268746	0.0261181194339425	967	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1987.05658848922	1987.05658848922
"healthy-5"	"2019-08-29-count-2:TCACTCGTCGACACCG"	3.93845643576924	-8.15658094799193	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCACTCGTCGACACCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1999.18451739637	41.7804064092407	0.0208987244777452	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1995.5768144347	1995.5768144347
"healthy-5"	"2019-08-29-count-1:GGTTAACAGAATGTTG"	2.31184472617452	-7.05440905010375	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	51	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTAACAGAATGTTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1806.21665082764	48.5327815133921	0.0268698561111999	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1803.9965481425	1803.9965481425
"healthy-5"	"2019-08-29-count-1:CACTGTCTCTCGCAGG"	6.80508484420125	-1.41122414981993	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACTGTCTCTCGCAGG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1760.92783587345	19.8329778633041	0.011262799905407	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1753.76719847762	1753.76719847762
"healthy-5"	"2019-08-29-count-2:TCAGCAAGTCTGCCTT"	-2.81182823601421	11.7531842955383	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGCAAGTCTGCCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1491.77634444183	41.6598816562935	0.0279263589421518	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1484.52389510879	1484.52389510879
"healthy-5"	"2019-08-29-count-1:GGTTAACGTAATTAGG"	-2.96451507034953	10.3085422285828	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTAACGTAATTAGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1634.36256551671	34.4016151030744	0.021048949498056	645	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1627.54243766872	1627.54243766872
"healthy-5"	"2019-08-29-count-1:TTTGGTTTCTAAGGAA"	6.81908049163167	-1.52656223690184	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTGGTTTCTAAGGAA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2011.13166010129	31.832723351751	0.0158282642470796	971	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2009.37744336658	2009.37744336658
"healthy-5"	"2019-08-29-count-2:CGGTCAGAGTATGTAG"	6.82470192488973	-1.59488954460295	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGTCAGAGTATGTAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2145.46716162447	33.8552342293351	0.0157798892636983	1035	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2136.77055226198	2136.77055226198
"healthy-5"	"2019-08-29-count-1:TTTGTTGAGGTGGTTG"	-4.84269700470622	-5.15107729351195	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTGTTGAGGTGGTTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1958.03738305695	46.9805748743897	0.0239937068009611	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1950.16657081486	1950.16657081486
"healthy-5"	"2019-08-29-count-2:CGGTCAGGTCTCACGG"	-3.92285118523296	12.6272229918274	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGTCAGGTCTCACGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1584.18498304359	41.5460125416001	0.0262254806012493	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1579.3476325293	1579.3476325293
"healthy-5"	"2019-08-29-count-1:AGGCTGCTCTCTCGCA"	-3.20730672302898	12.0451440581116	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGCTGCTCTCTCGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.32748015979	44.2616804956762	0.0291900536492367	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1513.93571321217	1513.93571321217
"healthy-5"	"2019-08-29-count-1:TATACCTAGGTTCATC"	2.05045666274373	-6.97676708614501	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TATACCTAGGTTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1618.52299825401	48.0591200824303	0.0296931956693074	624	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1613.57010529533	1613.57010529533
"healthy-5"	"2019-08-29-count-1:AGGGAGTCACACGGAA"	-3.12711725655254	12.395743347052	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGAGTCACACGGAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1512.6739390177	38.5203384997421	0.0254650638886239	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1510.14418479827	1510.14418479827
"healthy-5"	"2019-08-29-count-1:TGCAGATGTAGTACGG"	1.91575576838796	-7.18129064953002	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGATGTAGTACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1777.73389513995	49.9099321186511	0.0280750298203219	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1773.56289144312	1773.56289144312
"healthy-5"	"2019-08-29-count-1:TGCAGATGTGGGTATG"	-3.07745585861858	12.3985566862854	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGATGTGGGTATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1509.08625439718	37.0950445283629	0.0245811294220428	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1509.08625439718	1509.08625439718
"healthy-5"	"2019-08-29-count-2:CGTAAGTTCCCGTTGT"	3.13663806495015	-7.74883987819823	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTAAGTTCCCGTTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1863.2045402899	46.2681443921116	0.0248325631414105	831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1857.39434962783	1857.39434962783
"healthy-5"	"2019-08-29-count-1:CAGAGCCTCTTGGTCC"	-3.62816296044047	12.2857064970764	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGAGCCTCTTGGTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1492.36029331471	40.2786919613733	0.026989924713093	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1490.01580674902	1490.01580674902
"healthy-5"	"2019-08-29-count-1:CAGATACAGCCACTCG"	4.24660315093343	-8.22065641796263	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATACAGCCACTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1840.70937526229	48.9840807100909	0.0266115234530769	796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1836.61162546808	1836.61162546808
"healthy-5"	"2019-08-29-count-2:AAACCCAAGCAGAAAG"	3.69129957732503	-7.34255697643431	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAACCCAAGCAGAAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.11549889245	46.0003702143381	0.0251764982795135	754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1827.11549889245	1827.11549889245
"healthy-5"	"2019-08-29-count-1:CAGATACAGGGCATGT"	2.77412380751912	-4.787952922937	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATACAGGGCATGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2412.72246184973	44.44205880588	0.0184198802425904	1446	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2408.91506477708	2408.91506477708
"healthy-5"	"2019-08-29-count-2:CGTAATGGTGCGCTCA"	3.75318660315816	-7.89605429088744	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTAATGGTGCGCTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.63635792998	45.407453058954	0.0237159671970539	819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1910.38719876505	1910.38719876505
"healthy-5"	"2019-08-29-count-1:AGGGCCTCATTGTACG"	5.02631201323811	-8.64639856731566	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGCCTCATTGTACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1740.74042751297	46.2190786413277	0.026551390380105	707	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1736.30241759754	1736.30241759754
"healthy-5"	"2019-08-29-count-1:CAGATACCACTGCATA"	5.11217846450154	-9.59361746227416	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATACCACTGCATA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.51090705552	38.9389895746337	0.0184675305422114	970	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2100.78230442932	2100.78230442932
"healthy-5"	"2019-08-29-count-2:TCAGGGCCAGACCAAG"	8.81511368331258	6.38193891132203	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGGCCAGACCAAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1450.970739532	49.4897752567202	0.0341080449855817	540	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1450.970739532	1450.970739532
"healthy-5"	"2019-08-29-count-2:TCAGGGCCAGTCGCTG"	-2.36154447022136	12.695361114386	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGGGCCAGTCGCTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1501.36629685252	41.4397716839882	0.0276013733429763	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1494.24970943464	1494.24970943464
"healthy-5"	"2019-08-29-count-2:CGTAATGTCATTCTTG"	-2.71076307717021	11.6840677031311	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTAATGTCATTCTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1495.98055215802	42.5154929119308	0.0284198165882574	560	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1493.52373758885	1493.52373758885
"healthy-5"	"2019-08-29-count-1:CAGATACTCCTGGTCT"	2.13754858550374	-6.54283382808837	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATACTCCTGGTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.74931868633	42.0667613758932	0.020246312198283	1009	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2076.22536951304	2076.22536951304
"healthy-5"	"2019-08-29-count-1:GGTTGTATCTTAGCTT"	-2.64809236946757	10.9790487059387	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGTTGTATCTTAGCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1637.38346656602	41.2851683858445	0.0252141109452078	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1630.33953288776	1630.33953288776
"healthy-5"	"2019-08-29-count-1:GTAACACCAACACGAG"	9.58800949630086	5.86544559085695	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACACCAACACGAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1481.09917853152	40.0903044581375	0.0270679405128604	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1478.7152317062	1478.7152317062
"healthy-5"	"2019-08-29-count-1:TGCAGTACAGACACCC"	-3.31016598168071	3.66550300205079	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGTACAGACACCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3022.85948978319	43.436782643465	0.0143694348977432	3395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3017.20728608517	3017.20728608517
"healthy-5"	"2019-08-29-count-1:GTAACACCACTCTAGA"	8.98471321639363	7.62884042346803	"2019-08-29-count-1"	"Control5"	"B"	"Atypical memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACACCACTCTAGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1540.91807687021	43.4919387109318	0.028224692385509	621	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1530.08483564542	1530.08483564542
"healthy-5"	"2019-08-29-count-2:AAACGAAGTATATGGA"	10.2198873954708	4.69021079624025	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAACGAAGTATATGGA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1477.10425504254	29.3851108665262	0.0198937283987987	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1464.44597840399	1464.44597840399
"healthy-5"	"2019-08-29-count-2:AAACGAAGTGACTATC"	-5.04569707337077	-5.51139786159667	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAACGAAGTGACTATC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1818.3287234933	48.7463024470915	0.0268083002909628	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1816.04186616847	1816.04186616847
"healthy-5"	"2019-08-29-count-1:TGCAGTAGTCAGGTAG"	3.7498754459316	-8.36455538189086	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCAGTAGTCAGGTAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1805.49056158289	52.4057428913438	0.0290257639704298	765	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1799.23416547085	1799.23416547085
"healthy-5"	"2019-08-29-count-2:AAACGAATCCACCTCA"	-3.85802302780803	13.1501188048157	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAACGAATCCACCTCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1677.44999963637	24.6902406314673	0.0147189130148854	651	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1675.03652662273	1675.03652662273
"healthy-5"	"2019-08-29-count-1:CAGATTGAGCCTCAAT"	9.63273300704305	6.2777995833191	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATTGAGCCTCAAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1508.80822369481	42.9723148352294	0.0284809654138798	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1504.29903813421	1504.29903813421
"healthy-5"	"2019-08-29-count-1:CAGATTGCAAGAGAGA"	-4.18150792542155	2.85002491557924	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATTGCAAGAGAGA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2759.04938588473	45.9388287079454	0.0166502379199763	2525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2751.35996020213	2751.35996020213
"healthy-5"	"2019-08-29-count-1:CAGATTGCAGGAACCA"	3.5938159423763	-7.35873844539794	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATTGCAGGAACCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1859.80736039547	43.4733602133581	0.0233751952697476	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1855.91930118852	1855.91930118852
"healthy-5"	"2019-08-29-count-1:GTAACCAAGAGTGTTA"	5.21376957473103	-9.76311399852904	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACCAAGAGTGTTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2055.3705959847	46.4450809886013	0.0225969375446622	1004	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2051.86977190806	2051.86977190806
"healthy-5"	"2019-08-29-count-2:GGGAGTAAGAGCCGTA"	3.8575824695522	-7.57996275341185	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGTAAGAGCCGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1814.75314939051	44.5205851879	0.0245325846123217	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1812.55510529353	1812.55510529353
"healthy-5"	"2019-08-29-count-2:AAACGCTTCAGTCTTT"	9.7217546897823	5.93706843936769	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAACGCTTCAGTCTTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1539.73815048367	34.6536985377319	0.0225062284303642	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1539.73815048367	1539.73815048367
"healthy-5"	"2019-08-29-count-1:GAGCTGCCAGAGTCTT"	5.30732168731038	-9.93167402660521	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCTGCCAGAGTCTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.43624916195	32.7097050918286	0.0147312065834694	1114	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2217.04837480931	2217.04837480931
"healthy-5"	"2019-08-29-count-1:CAGATTGTCTCGGTCT"	-1.71744273129161	10.1182574995789	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGATTGTCTCGGTCT"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1515.50365784816	43.0132144422439	0.0283821251235497	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1502.16600388958	1502.16600388958
"healthy-5"	"2019-08-29-count-2:AAAGAACAGTCTGTAC"	3.9671479659969	-8.00220968639525	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGAACAGTCTGTAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1997.49098853858	46.3438792540085	0.0232010454715067	953	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1992.16993502791	1992.16993502791
"healthy-5"	"2019-08-29-count-2:AAAGAACAGTGCAACG"	5.51640667495076	-9.87521936809691	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGAACAGTGCAACG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2304.32893156159	41.0174788896488	0.0178001839615198	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2301.46316733172	2301.46316733172
"healthy-5"	"2019-08-29-count-1:GTAACCAGTGCAGTGA"	-1.93419347229655	4.18618152225343	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAACCAGTGCAGTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2895.79956022063	49.680112308543	0.0171559223196919	3517	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2888.07683348516	2888.07683348516
"healthy-5"	"2019-08-29-count-2:TCAGTGACAGAATCGG"	4.25986256179158	-7.97269728099974	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGTGACAGAATCGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.81922382102	41.8486533860435	0.020832463613347	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2006.95371385667	2006.95371385667
"healthy-5"	"2019-08-29-count-1:TGCATCCTCGAGTCTA"	4.43614592131917	-7.94082024013671	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCATCCTCGAGTCTA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.86744094303	43.3100524824026	0.020126728839497	1067	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2148.71483039526	2148.71483039526
"healthy-5"	"2019-08-29-count-2:TCAGTGAGTCCACAGC"	1.73556651648824	-6.68035795604857	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGTGAGTCCACAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1834.84208266716	48.0246991354778	0.0261737506399833	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1832.810726444	1832.810726444
"healthy-5"	"2019-08-29-count-1:AGGGTGATCCTATTTG"	-3.31325016441997	3.71753904903261	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGGTGATCCTATTTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2814.29833003481	47.3150612899525	0.0168123829606108	3049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2803.7188599563	2803.7188599563
"healthy-5"	"2019-08-29-count-1:CAGCAATGTACGCGTC"	-1.65909169140514	10.1764306792053	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCAATGTACGCGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1513.83008260177	45.0376689053583	0.0297508085107897	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1503.9044839496	1503.9044839496
"healthy-5"	"2019-08-29-count-1:TGCATGACACGGCTAC"	4.5588718849117	-8.80830957805785	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCATGACACGGCTAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2071.48758653554	41.9663890889301	0.0202590589302622	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2064.81201945119	2064.81201945119
"healthy-5"	"2019-08-29-count-1:AAGACTCCACATACTG"	6.75898994979207	-1.37876048004302	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAGACTCCACATACTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2243.20232019275	23.3052261504865	0.0103892662470516	1081	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2237.75102462405	2237.75102462405
"healthy-5"	"2019-08-29-count-2:CGTGATACAACCGACC"	-1.92642591419871	9.53731725299684	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGATACAACCGACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1465.92373105621	38.1121076779645	0.0259986975246689	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1461.12521096692	1461.12521096692
"healthy-5"	"2019-08-29-count-2:AAAGGATTCACGGACC"	-2.89650927010234	-5.69333841716918	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGGATTCACGGACC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2381.22229922936	47.6866738074384	0.0200261327230437	1330	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2377.6902900643	2377.6902900643
"healthy-5"	"2019-08-29-count-2:AAAGGATTCGTCTACC"	4.75866808471028	-8.4999103776184	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGGATTCGTCTACC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.63402139955	42.4365910072257	0.0219352035257429	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1930.9006280884	1930.9006280884
"healthy-5"	"2019-08-29-count-2:CGTGATACATGGAACG"	6.61942591246907	-0.476929031964861	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGATACATGGAACG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1939.22194069377	39.4898092988925	0.0203637389151882	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1939.22194069377	1939.22194069377
"healthy-5"	"2019-08-29-count-1:GTAATCGAGGACTTCT"	14.1101499992305	1.96496853912202	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATCGAGGACTTCT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1129.17859929416	40.1479164636831	0.0355549746415484	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1117.68089542765	1117.68089542765
"healthy-5"	"2019-08-29-count-2:TCAGTTTGTGTTTACG"	-0.987547020346481	9.23650357807008	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCAGTTTGTGTTTACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1407.71014696503	39.9432719406461	0.0283746423415092	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1405.76920592435	1405.76920592435
"healthy-5"	"2019-08-29-count-2:AAAGGGCCAGCTATTG"	-4.24911008301433	13.2418727644714	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGGGCCAGCTATTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2277.08854809805	42.9877395323915	0.0188783785190511	1132	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2271.74740217395	2271.74740217395
"healthy-5"	"2019-08-29-count-2:TGTCCACGTATCGAGG"	-3.67820225182231	12.1853656538757	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGTCCACGTATCGAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1511.39499393089	43.3854914673011	0.0287055942632591	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1509.00173768016	1509.00173768016
"healthy-5"	"2019-08-29-count-1:CAGCACGTCTGTGCGG"	3.4793812232906	-7.94820406353148	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCACGTCTGTGCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1698.91367193723	42.6687949808802	0.0251153402822559	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1692.02423695723	1692.02423695723
"healthy-5"	"2019-08-29-count-2:CGTGCTTAGAAGCCTG"	2.88735904273335	-7.46684696590575	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGCTTAGAAGCCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1581.27088974424	42.6401807391228	0.0269657659643753	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1578.91919613808	1578.91919613808
"healthy-5"	"2019-08-29-count-2:TCATACTAGGAGTACC"	-3.26225433769878	3.6255779036316	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATACTAGGAGTACC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1706.62342889904	17.9284529403586	0.0105052190405733	779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1703.00896841771	1703.00896841771
"healthy-5"	"2019-08-29-count-2:TCATACTCAGCTCCTT"	2.53237428244893	-7.31973841106566	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATACTCAGCTCCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2145.77012631709	48.2958484797757	0.0225074661481418	1040	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2145.77012631709	2145.77012631709
"healthy-5"	"2019-08-29-count-2:CGTGCTTTCCCATACC"	-3.2688458961552	10.3548698195252	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGCTTTCCCATACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1500.71630311152	36.151359583391	0.0240894028461184	533	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1498.12546785469	1498.12546785469
"healthy-5"	"2019-08-29-count-1:GTAATGCAGAGCACTG"	9.5936094718868	5.6647648581299	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATGCAGAGCACTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1419.49720076199	38.3613195739612	0.0270245827560413	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1412.38249012335	1412.38249012335
"healthy-5"	"2019-08-29-count-1:GTAATGCAGATCCTAC"	-2.86713324013408	11.3746652373108	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTAATGCAGATCCTAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1627.20292430152	39.7657038188121	0.0244380729808986	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1627.20292430152	1627.20292430152
"healthy-5"	"2019-08-29-count-2:AAAGGTAGTACGCTAT"	3.34854592856709	-7.6183014146057	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGGTAGTACGCTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1779.1287339024	47.1240537832732	0.0264871523264703	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1776.93209149809	1776.93209149809
"healthy-5"	"2019-08-29-count-1:CAGCCAGAGGTAGGCT"	1.34670855578725	-6.4621038666931	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCCAGAGGTAGGCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1922.52632597116	48.3986413811386	0.0251745012421041	861	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1918.55886360273	1918.55886360273
"healthy-5"	"2019-08-29-count-2:CGTGTCTGTCACAGTT"	-2.60313759270366	3.49926421726076	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGTCTGTCACAGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2777.58613143058	47.228469585014	0.0170034221623541	2402	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2773.4567607106	2773.4567607106
"healthy-5"	"2019-08-29-count-2:CGTGTCTGTCCTGTTC"	-2.04407391968425	4.06528995120851	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTGTCTGTCCTGTTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2814.83594059682	43.8582350480988	0.015581098143432	2840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2809.96059473054	2809.96059473054
"healthy-5"	"2019-08-29-count-2:TCATATCTCGGAATGG"	4.859542508691	-8.66218187725218	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATATCTCGGAATGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2063.65547685432	39.121880331069	0.018957563784195	1085	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2060.51580416045	2060.51580416045
"healthy-5"	"2019-08-29-count-2:AAAGTCCCACCTCTAC"	-0.177867318422157	9.21459386432496	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGTCCCACCTCTAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.02793855809	44.8043470097619	0.0267803937861174	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1668.69917702153	1668.69917702153
"healthy-5"	"2019-08-29-count-1:GTACAACAGGACATCG"	9.9386097389156	5.10692880237428	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTACAACAGGACATCG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1400.1669862486	42.9131753595642	0.0306486124733874	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1400.1669862486	1400.1669862486
"healthy-5"	"2019-08-29-count-1:CAGCCAGGTCATGGCC"	-1.62162123146709	10.0048074492249	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCCAGGTCATGGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1530.6157581529	47.7830536620822	0.0312181900699528	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1526.09009010453	1526.09009010453
"healthy-5"	"2019-08-29-count-2:TCATCATGTCCACGCA"	3.92498459395711	-7.00516512310179	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATCATGTCCACGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2278.34860550984	40.5983208240636	0.0178191874263152	1211	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2275.17389287409	2275.17389287409
"healthy-5"	"2019-08-29-count-2:AAAGTCCTCACTCCGT"	-4.18135486069377	12.2446784743103	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGTCCTCACTCCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1973.21991164211	31.0099101552278	0.0157153847740273	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1969.12710394833	1969.12710394833
"healthy-5"	"2019-08-29-count-1:CAGCGTGAGCAAGTCG"	-1.4270148080891	9.41758916461793	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCGTGAGCAAGTCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1876.80595962855	37.7665096227345	0.0201227566595159	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1873.38341614153	1873.38341614153
"healthy-5"	"2019-08-29-count-1:CAGCGTGAGGAAGTAG"	3.74229754981343	-8.32274153148802	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGCGTGAGGAAGTAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2331.36630366304	46.2630908109232	0.0198437674672722	1281	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2326.78003861856	2326.78003861856
"healthy-5"	"2019-08-29-count-2:CGTTCTGAGTCTCCTC"	3.08720316466634	-6.91703083431395	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGTTCTGAGTCTCCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1849.66263439663	40.4846269787153	0.0218875735638795	811	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1847.62425596687	1847.62425596687
"healthy-5"	"2019-08-29-count-2:AAAGTGACACCATAAC"	4.51223578032796	-7.90994598781737	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGTGACACCATAAC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2220.58171102424	44.5437139077054	0.0200594797690015	1172	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2218.98224380504	2218.98224380504
"healthy-5"	"2019-08-29-count-1:GAGGGTACATTCCTAT"	5.37076296386067	-10.2206650010315	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGGGTACATTCCTAT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2073.10269737307	38.6142854636659	0.0186263254167755	1013	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2071.35254831236	2071.35254831236
"healthy-5"	"2019-08-29-count-1:GTACAGTGTTTACTTC"	-2.38010297241862	10.0467681654724	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTACAGTGTTTACTTC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1666.02105742608	43.2376025145229	0.0259526146574178	703	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1657.71364703648	1657.71364703648
"healthy-5"	"2019-08-29-count-2:AAAGTGAGTTCCAAAC"	3.89976896819417	-8.03134634411009	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGTGAGTTCCAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.04861938498	41.113167301034	0.021323719167491	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1922.3012778013	1922.3012778013
"healthy-5"	"2019-08-29-count-2:AAAGTGATCAGAGCAG"	2.55087818679158	-4.40945246135863	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAAGTGATCAGAGCAG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2352.36890284236	39.3644648775662	0.0167339675465027	1383	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2348.32299164361	2348.32299164361
"healthy-5"	"2019-08-29-count-2:AAATGGACACTCAAGT"	-1.66305373135265	9.57074830615846	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAATGGACACTCAAGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1477.00158509603	44.7477565707275	0.030296349727897	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1474.72790520559	1474.72790520559
"healthy-5"	"2019-08-29-count-1:CAGGCCACACACGGTC"	-6.74447904053386	0.386489785555281	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGCCACACACGGTC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2060.47782036526	54.2534923362685	0.0263305393535617	1244	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2059.13948806553	2059.13948806553
"healthy-5"	"2019-08-29-count-2:TCATCCGTCATCCCGT"	0.512136359780472	9.11406037891237	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATCCGTCATCCCGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1486.36171314161	39.7070001250416	0.0267142242523968	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1481.73297297673	1481.73297297673
"healthy-5"	"2019-08-29-count-1:CAGGCCAGTAGTAAGT"	4.11354031142537	-8.44333841716918	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGCCAGTAGTAAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1880.05243277372	39.9820110575081	0.0212664340422256	833	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1874.0981679368	1874.0981679368
"healthy-5"	"2019-08-29-count-2:AAATGGATCAGTCTTT"	4.5008040862972	-8.79650976574095	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAATGGATCAGTCTTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1937.92724125302	47.2754206702015	0.0243948377750417	901	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1932.2628933808	1932.2628933808
"healthy-5"	"2019-08-29-count-1:AGGTTACCACACTGGC"	3.31758966025655	-7.71110536968382	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGGTTACCACACTGGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2308.75231620165	42.7951521994285	0.0185360516583411	1239	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2302.4525575958	2302.4525575958
"healthy-5"	"2019-08-29-count-2:CAGCAGCCACCAGCTG"	4.08648171004598	-7.83275749599608	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCAGCCACCAGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1969.46898413382	35.6510758913945	0.0181018722196704	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1961.48491922553	1961.48491922553
"healthy-5"	"2019-08-29-count-2:AACAAAGCATACCATG"	2.33672632750813	-7.29309227382811	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAAAGCATACCATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1660.04267837031	50.9535336643906	0.0306941106564879	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1657.72443683507	1657.72443683507
"healthy-5"	"2019-08-29-count-2:AACAAAGGTCGCTTGG"	3.592372794717	-7.32972958004149	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAAAGGTCGCTTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1797.15580324154	44.7805944660858	0.02491748037945	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1790.46021500286	1790.46021500286
"healthy-5"	"2019-08-29-count-1:CAGGGCTAGGATTTCC"	-3.68247447434123	12.7308397063049	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGGCTAGGATTTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1586.38819755155	39.1798026675178	0.0246974874926505	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1576.89075798633	1576.89075798633
"healthy-5"	"2019-08-29-count-2:AACAAAGGTTGTGTAC"	-3.95890412750896	12.8049888380798	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAAAGGTTGTGTAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1501.77999710332	39.1230789079793	0.0260511386377772	561	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1491.90950574569	1491.90950574569
"healthy-5"	"2019-08-29-count-1:CAGGGCTCACCCTGAG"	3.80689205703084	-8.45831873333129	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGGCTCACCCTGAG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1914.21402706369	42.3693105729452	0.0221340508291738	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1901.56413286578	1901.56413286578
"healthy-5"	"2019-08-29-count-2:AACAACCCAAACGGCA"	-3.77195392075236	10.8417014845642	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAACCCAAACGGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1706.06832412668	43.2313528025252	0.0253397546810764	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1701.67837558851	1701.67837558851
"healthy-5"	"2019-08-29-count-2:CTAACCCCACAGAGCA"	-1.55753217163737	9.18535993182985	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACCCCACAGAGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1490.98630008821	43.5724741659493	0.0292239265802585	553	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1483.43827871096	1483.43827871096
"healthy-5"	"2019-08-29-count-1:TGCGGGTTCATTGCCC"	-2.49753866615947	10.4967698820862	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCGGGTTCATTGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1575.30646553066	50.1120540662736	0.0318109873620006	609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1575.30646553066	1575.30646553066
"healthy-5"	"2019-08-29-count-2:TCATGCCCAAGGTCGA"	3.30429853972737	-6.33433916484984	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGCCCAAGGTCGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1718.90539470989	36.5140175342086	0.0212425987181052	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1716.74085434045	1716.74085434045
"healthy-5"	"2019-08-29-count-2:CTAACCCGTAGAGGAA"	3.33036746558492	-8.05753424083861	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACCCGTAGAGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1457.87971993168	49.0163413201043	0.0336216634678211	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1457.87971993168	1457.87971993168
"healthy-5"	"2019-08-29-count-2:AACAACCTCTTTACAC"	11.135738034814	5.28553578937379	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAACCTCTTTACAC"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1575.48517299003	40.0810272528944	0.025440434438889	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1566.3387131881	1566.3387131881
"healthy-5"	"2019-08-29-count-2:GTCCACTGTGTCATTG"	3.86297502097432	-8.37260820781859	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCCACTGTGTCATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1623.41328084724	46.9149414501244	0.028898951366001	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1616.47870342404	1616.47870342404
"healthy-5"	"2019-08-29-count-1:CAGGGCTTCAGGACAG"	3.75035395201985	-7.8345723382202	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGGCTTCAGGACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1615.73281257024	47.4499327175231	0.029367437702798	615	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1610.90289502674	1610.90289502674
"healthy-5"	"2019-08-29-count-1:AGTAACCCAGGACATG"	5.15660538253133	-10.261446975824	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTAACCCAGGACATG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.94983827558	45.7701781936935	0.0214989462742658	1094	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2122.29333861517	2122.29333861517
"healthy-5"	"2019-08-29-count-1:TGCTCCATCAGTCAGT"	-5.20935044708903	-5.38839247142943	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGCTCCATCAGTCAGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1845.11141522835	49.5563543999332	0.0268581907796609	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1841.39445404717	1841.39445404717
"healthy-5"	"2019-08-29-count-2:AACAAGAGTTCGAAGG"	3.17043056067769	-7.92352249538573	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAAGAGTTCGAAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.88506935737	49.9084329107353	0.0291030774029876	701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1708.286516875	1708.286516875
"healthy-5"	"2019-08-29-count-2:CTAACTTAGCCTTTGA"	5.33034529265706	-9.84642698681029	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACTTAGCCTTTGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.72467944698	45.933448913463	0.0214669902883649	1075	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2134.60595278648	2134.60595278648
"healthy-5"	"2019-08-29-count-2:CAGCGTGGTTAGGCTT"	2.84929170188252	-7.39336731350096	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGCGTGGTTAGGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1554.9273405053	48.611791758407	0.0312630632262275	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1554.9273405053	1554.9273405053
"healthy-5"	"2019-08-29-count-1:CAGGTATCACATTCGA"	9.6180645423824	5.90366218173829	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGGTATCACATTCGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1462.5750900041	42.9932765322904	0.029395602882974	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1455.25214278188	1455.25214278188
"healthy-5"	"2019-08-29-count-2:TCATGGAAGATGGTCG"	4.16978754576985	-8.24139120494994	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGGAAGATGGTCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2111.79691129936	43.2952208074879	0.02050160248641	1008	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2104.41963291658	2104.41963291658
"healthy-5"	"2019-08-29-count-2:TCATGGAAGCGATTCT"	6.8275257545406	-1.44169773971709	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGGAAGCGATTCT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2130.86708464158	33.3557098251118	0.0156535853716669	1049	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2123.22441338801	2123.22441338801
"healthy-5"	"2019-08-29-count-2:AACACACCAGGCGTTC"	3.1414700942928	-8.11464693462523	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACACACCAGGCGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1557.84307117215	51.4585020596326	0.0330318907031595	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1555.46565025322	1555.46565025322
"healthy-5"	"2019-08-29-count-2:CTAACTTGTCGATTAC"	-3.54332361641582	11.1688403853211	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAACTTGTCGATTAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1644.66428183805	32.3817073451711	0.0196889466760851	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1642.38596914689	1642.38596914689
"healthy-5"	"2019-08-29-count-1:AGTACCATCCAAGCAT"	14.241284986108	2.03641853416292	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTACCATCCAAGCAT"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1212.47574988343	40.3038347027765	0.0332409408655403	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1203.94774823213	1203.94774823213
"healthy-5"	"2019-08-29-count-2:TATACCTAGGACATCG"	3.64090909537618	-8.21925833141478	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATACCTAGGACATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1726.54300044229	44.5751221785159	0.0258175569140746	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1724.39043742878	1724.39043742878
"healthy-5"	"2019-08-29-count-2:AACACACGTATGCGTT"	-1.9919413131779	4.1249904402527	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACACACGTATGCGTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3076.66643469457	47.2989158108374	0.0153734299166991	3679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3068.67037623351	3068.67037623351
"healthy-5"	"2019-08-29-count-1:CAGTGCGCAGCAATTC"	-3.31972346726115	12.4440946348938	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTGCGCAGCAATTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1569.29946768475	43.7186233244508	0.0278586874109826	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1562.09984741552	1562.09984741552
"healthy-5"	"2019-08-29-count-2:TCATGTTGTTCGCGTG"	3.49231829222981	-7.84893085872801	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGTTGTTCGCGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.99360294766	44.2726696793543	0.0280563049157195	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1575.61030782221	1575.61030782221
"healthy-5"	"2019-08-29-count-2:AACACACGTGATACCT"	3.40815081176106	-7.06676247036131	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACACACGTGATACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2021.21101223109	44.600692008223	0.0220663214965325	975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2019.41762867945	2019.41762867945
"healthy-5"	"2019-08-29-count-2:TCATGTTTCTATCGCC"	-3.59073553505595	12.1714906462464	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATGTTTCTATCGCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1539.40599647825	48.147004690051	0.031276352567288	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1536.96742614733	1536.96742614733
"healthy-5"	"2019-08-29-count-2:TCATTACAGCTGACTT"	-3.30483065071757	11.8971042403015	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTACAGCTGACTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2307.29904245918	44.0046441131646	0.0190719292572771	1194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2302.12284508546	2302.12284508546
"healthy-5"	"2019-08-29-count-2:AACAGGGAGCATCTTG"	-0.579592387110549	10.4033860930237	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAGGGAGCATCTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1483.0878699782	39.598766674746	0.0267002161344142	565	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1480.77695958794	1480.77695958794
"healthy-5"	"2019-08-29-count-2:AACAGGGAGGATTCAA"	5.36328043517415	-10.1039877167908	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACAGGGAGGATTCAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2029.18432278774	40.5229349691771	0.0199700611295408	995	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2025.67053266253	2025.67053266253
"healthy-5"	"2019-08-29-count-1:CAGTTAGAGAGGTCAC"	3.09379329261128	-5.19887831127318	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGAGAGGTCAC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2388.31507013233	41.1858142757988	0.0172447156536666	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2385.43983451409	2385.43983451409
"healthy-5"	"2019-08-29-count-2:AACCAACAGATACATG"	3.35818018493001	-9.12363245403441	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCAACAGATACATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1826.71870573333	45.434840116363	0.0248723790771735	798	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.60232672301	1820.60232672301
"healthy-5"	"2019-08-29-count-2:CTAAGTGTCACTCGAA"	3.88978614386861	-7.65938570415648	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAAGTGTCACTCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2077.64731679122	41.9176732663196	0.0201755480478075	965	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2073.84827559708	2073.84827559708
"healthy-5"	"2019-08-29-count-1:CAGTTAGCAGTAACCT"	1.28707243975942	9.39986322009889	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGCAGTAACCT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1518.92703607421	37.5490285489535	0.0247207585731057	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1510.2256228519	1510.2256228519
"healthy-5"	"2019-08-29-count-2:TCATTCACAATGCAGG"	-2.60812364044841	10.2753219374451	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTCACAATGCAGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1661.41700947615	38.4833843456731	0.0231629892592752	667	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1656.24541607016	1656.24541607016
"healthy-5"	"2019-08-29-count-2:CTACAGAAGAGAGCCT"	-2.34443078461345	11.9219016798767	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACAGAAGAGAGCCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1453.23708427895	44.2024704870701	0.0304165582926903	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1453.23708427895	1453.23708427895
"healthy-5"	"2019-08-29-count-1:CAGTTAGTCCGAGTGC"	-2.35509334030803	10.6996135481629	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGTCCGAGTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1615.70303063803	43.2639011959584	0.0267771368720363	636	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1615.70303063803	1615.70303063803
"healthy-5"	"2019-08-29-count-2:CTACAGAAGGTGATCG"	3.78965582427327	-7.67280247127684	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACAGAAGGTGATCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2273.4640654858	42.0089172124478	0.0184779332342212	1192	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2268.70863949232	2268.70863949232
"healthy-5"	"2019-08-29-count-1:CAGTTAGTCTTCCCGA"	6.85901608046834	-1.62697663223418	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTAGTCTTCCCGA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2383.1184989869	27.8649094301523	0.0116926243667691	1214	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2374.54161697006	2374.54161697006
"healthy-5"	"2019-08-29-count-2:TCATTCATCCATATGG"	1.3563240962917	-6.93890859996947	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTCATCCATATGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1864.10859749492	50.4063144750414	0.0270404388149809	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1858.26746024539	1858.26746024539
"healthy-5"	"2019-08-29-count-2:GTCGTAACATAGTCGT"	3.53686418113057	-6.99114324962767	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCGTAACATAGTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1801.0435456713	39.8127701000404	0.0221053900644035	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1794.73727031421	1794.73727031421
"healthy-5"	"2019-08-29-count-1:CAGTTCCGTATGCGTT"	3.57654895362203	-8.4158039323059	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAGTTCCGTATGCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1569.13439404245	43.531249771911	0.0277422061087863	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1569.13439404245	1569.13439404245
"healthy-5"	"2019-08-29-count-2:AACCACAGTGGACCAA"	3.73277487334554	-8.107297920343	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCACAGTGGACCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1577.65773665309	42.4156048896981	0.0268851753484125	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1572.79442171534	1572.79442171534
"healthy-5"	"2019-08-29-count-2:CTACATTAGGTGAGAA"	4.70414080199544	-8.87106707012328	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACATTAGGTGAGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1779.81434236158	37.966567192467	0.0213317570764659	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1779.81434236158	1779.81434236158
"healthy-5"	"2019-08-29-count-2:AACCACAGTTGGACTT"	2.58314480361287	-6.16557552730712	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCACAGTTGGACTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2145.46193268443	45.6348512397049	0.0212704082717543	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2145.46193268443	2145.46193268443
"healthy-5"	"2019-08-29-count-2:AACCACATCACAAGGG"	-2.78966556015666	-5.8125996819702	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCACATCACAAGGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2007.19023608116	49.7158314190659	0.0247688687028147	918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2003.30801543942	2003.30801543942
"healthy-5"	"2019-08-29-count-1:CATAAGCAGGCGTTAG"	3.91041531142537	-7.54663422023924	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATAAGCAGGCGTTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1895.57916058097	43.5248369103983	0.0229612341259641	853	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.93140072369	1887.93140072369
"healthy-5"	"2019-08-29-count-1:CATAAGCCAACACACT"	2.33834566649739	-7.28807213222655	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATAAGCCAACACACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1517.2661194034	49.0081909516022	0.0323003264390247	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1512.27910224329	1512.27910224329
"healthy-5"	"2019-08-29-count-2:AACCATGAGTCGAAGC"	-3.26185212555583	-4.81342365657958	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCATGAGTCGAAGC"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2719.68904571388	46.587417693492	0.0171296853833021	2033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2713.71886026639	2713.71886026639
"healthy-5"	"2019-08-29-count-1:AATAGAGTCTTGGCTC"	2.33419622954671	-4.28593113338622	"2019-08-29-count-1"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATAGAGTCTTGGCTC"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2590.72295795289	40.6097785569952	0.0156750757283148	1701	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2587.20685028315	2587.20685028315
"healthy-5"	"2019-08-29-count-1:GTATTGGAGAGAAGGT"	2.61525382575337	-7.35559608852538	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTATTGGAGAGAAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1519.51735466081	38.0818179550112	0.0250617854664199	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1514.51390855027	1514.51390855027
"healthy-5"	"2019-08-29-count-2:TCATTTGTCGCACGAC"	3.03800954398457	-7.85632755672606	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCATTTGTCGCACGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1516.20623697706	48.6427153127868	0.0320818593978141	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1513.8025051201	1513.8025051201
"healthy-5"	"2019-08-29-count-2:TCCACCAAGTCTCTGA"	-1.86086998406108	9.68056485736696	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCACCAAGTCTCTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1641.74105549022	44.2675804658391	0.0269638018235592	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1637.62732915579	1637.62732915579
"healthy-5"	"2019-08-29-count-2:CTACCCAAGGCCACTC"	4.69953121718709	-8.97160627758177	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACCCAAGGCCACTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2106.22152590853	45.6914035786459	0.0216935412617325	1083	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2099.56696575698	2099.56696575698
"healthy-5"	"2019-08-29-count-2:TCCACCAGTGGTCTTA"	0.868721385567826	8.83761022174684	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCACCAGTGGTCTTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1508.58205976497	34.2582773286155	0.0227089253162355	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1499.89532035909	1499.89532035909
"healthy-5"	"2019-08-29-count-2:CTACCCAGTTCTCTCG"	4.19086327132527	-8.16048433696898	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACCCAGTTCTCTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1714.14886889261	44.7376096784218	0.0260990223721489	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1714.14886889261	1714.14886889261
"healthy-5"	"2019-08-29-count-2:AACCCAATCATGCGGC"	3.05603541907613	-8.35929777538451	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCCAATCATGCGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1549.75340385699	51.7016573057383	0.0333612155179427	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1547.22557976903	1547.22557976903
"healthy-5"	"2019-08-29-count-2:AACCCAATCTAGAGCT"	2.2750994163448	-7.00922729885253	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCCAATCTAGAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1567.07565227353	43.2476416517979	0.027597673149381	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1567.07565227353	1567.07565227353
"healthy-5"	"2019-08-29-count-1:CATACAGGTTGCTAGT"	-2.37794290009196	3.78946826541749	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACAGGTTGCTAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2874.53480183077	42.0742102431149	0.0146368762751866	2850	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2868.68824850538	2868.68824850538
"healthy-5"	"2019-08-29-count-2:CAGTTCCTCGGAGATG"	3.72360815581624	-7.79014828121337	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAGTTCCTCGGAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1901.34620962653	46.6186390977814	0.0245187535346014	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1901.34620962653	1901.34620962653
"healthy-5"	"2019-08-29-count-1:TCAATCTTCGGAGATG"	3.6297787624294	-7.08801700985106	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAATCTTCGGAGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1889.70412497677	44.4154731849511	0.0235039298469527	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1886.02638949001	1886.02638949001
"healthy-5"	"2019-08-29-count-1:AGTCATGAGCCTCTGG"	3.57657708701436	-8.24025633251341	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTCATGAGCCTCTGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1675.8464469649	44.8068536258395	0.0267368491349482	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1669.38676320371	1669.38676320371
"healthy-5"	"2019-08-29-count-1:GTATTTCGTCCCGCAA"	2.84735908088033	-8.60440637981566	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTATTTCGTCCCGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1597.85613776775	47.505087767537	0.029730516186459	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1597.85613776775	1597.85613776775
"healthy-5"	"2019-08-29-count-2:AACCTGAGTATCACGT"	3.52422346648518	-7.34142591869506	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCTGAGTATCACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1782.51416010346	39.4199811035727	0.0221148207323551	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1782.51416010346	1782.51416010346
"healthy-5"	"2019-08-29-count-1:CATACCCTCGATACAC"	3.22559656676595	-7.61230232631835	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACCCTCGATACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1940.89378834251	44.3043899047082	0.0228267977211383	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1939.12325610202	1939.12325610202
"healthy-5"	"2019-08-29-count-2:CTACGGGCAGAGGAAA"	-2.94010267677959	3.41021440112916	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACGGGCAGAGGAAA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3103.49851618877	35.041776962843	0.011291056457754	3582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3098.48544960887	3098.48544960887
"healthy-5"	"2019-08-29-count-2:GTCTCACTCCGCAGTG"	2.73097672042195	-6.69665720379027	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTCTCACTCCGCAGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1713.7362245401	43.758002485248	0.0255336859072294	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1709.22302949746	1709.22302949746
"healthy-5"	"2019-08-29-count-2:CTACGGGCATCCGGCA"	5.48423351821248	-10.0329923859802	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACGGGCATCCGGCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2422.60749256837	41.772694122766	0.0172428650744739	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2418.36339914079	2418.36339914079
"healthy-5"	"2019-08-29-count-2:AACCTTTAGGGTTGCA"	-2.63505540314372	10.7843694456848	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCTTTAGGGTTGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1545.44944285464	39.8631510131726	0.0257938887599845	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1545.44944285464	1545.44944285464
"healthy-5"	"2019-08-29-count-1:CATACTTCACGTACAT"	-2.27956543389018	4.07696912372438	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACTTCACGTACAT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3539.13399777181	45.2540332816893	0.0127867532877197	4890	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3531.19637497804	3531.19637497804
"healthy-5"	"2019-08-29-count-2:AACCTTTGTCCAGAAG"	3.38099588927571	-7.42707397854003	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCTTTGTCCAGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1868.43435225837	48.3384372943082	0.0258710921450795	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1862.62995826283	1862.62995826283
"healthy-5"	"2019-08-29-count-2:TCCAGAAGTGGACTGA"	-3.28047881546672	3.07164332950441	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCAGAAGTGGACTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3101.53455812209	50.3775888080525	0.0162427946115019	3374	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3096.78723656856	3096.78723656856
"healthy-5"	"2019-08-29-count-1:CATACTTTCCACCTCA"	5.24597849425618	-9.85647871410521	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATACTTTCCACCTCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2238.17384036047	41.4896950918978	0.0185372978379623	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2233.34296076137	2233.34296076137
"healthy-5"	"2019-08-29-count-2:CTACGGGTCCTGCCAT"	3.87216605719869	-8.22731783306273	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACGGGTCCTGCCAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.00188744613	47.6326796569289	0.0271410988202661	729	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1755.00188744613	1755.00188744613
"healthy-5"	"2019-08-29-count-1:AGTGACTGTCCACATA"	3.36060442504231	-6.72170307552489	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGACTGTCCACATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2173.44127113919	40.7754273969773	0.0187607679758493	1158	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2170.31120362707	2170.31120362707
"healthy-5"	"2019-08-29-count-2:AACCTTTTCTTACCAT"	-3.09988651695903	-5.68780949031981	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACCTTTTCTTACCAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1823.71545527472	49.5418188099905	0.0271653226750375	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1814.88631306382	1814.88631306382
"healthy-5"	"2019-08-29-count-2:AACGAAATCCTCTGCA"	4.29502358016316	-8.48729612743529	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACGAAATCCTCTGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1796.48942905919	47.9166161533671	0.0266723618732679	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1790.18751820909	1790.18751820909
"healthy-5"	"2019-08-29-count-1:CATAGACAGTCAGCCC"	-2.2653697532719	9.95536038959352	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATAGACAGTCAGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1682.89858458911	38.0053425092872	0.0225832636959323	683	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1673.94427291435	1673.94427291435
"healthy-5"	"2019-08-29-count-2:AACGGGAAGAGATGCC"	-1.82715318623241	4.08491084659425	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACGGGAAGAGATGCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3320.30334843086	35.1405767837339	0.0105835440609187	5541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3316.82802965303	3316.82802965303
"healthy-5"	"2019-08-29-count-2:AACGGGAAGGGCAGTT"	4.63033403930013	-8.08007051860961	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACGGGAAGGGCAGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.86406465917	38.6741037148742	0.0166206974882046	1249	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2325.29937656568	2325.29937656568
"healthy-5"	"2019-08-29-count-1:CATCAAGAGGGAGAAT"	-3.56055579605754	12.3459615477356	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCAAGAGGGAGAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1765.60856121258	33.2546064626297	0.0188346427363215	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1765.60856121258	1765.60856121258
"healthy-5"	"2019-08-29-count-2:CTACTATTCTCCTACG"	9.50300659713094	6.53161380374757	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTACTATTCTCCTACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1509.91523584511	35.3480108593048	0.0234105928731292	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1507.60965773195	1507.60965773195
"healthy-5"	"2019-08-29-count-2:AGGTAGGAGAATCGCG"	-2.97200832787212	-5.95732738887938	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGGTAGGAGAATCGCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2085.34286206287	50.500472025578	0.0242168676164943	1115	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2082.16321872535	2082.16321872535
"healthy-5"	"2019-08-29-count-1:CATCAAGCAGTGAGCA"	-4.88196835938151	3.2085926302704	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCAAGCAGTGAGCA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3227.90955018981	43.9193722548026	0.0136061347357828	3538	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3219.55562725754	3219.55562725754
"healthy-5"	"2019-08-29-count-1:GTCAAGTGTCGATTTG"	-3.16409311714824	11.9901494749817	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCAAGTGTCGATTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1409.17182088038	46.3304414977237	0.0328777802757783	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1404.12459216762	1404.12459216762
"healthy-5"	"2019-08-29-count-2:CTAGACACACTTTATC"	10.5090490775997	5.79226586902467	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAGACACACTTTATC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1530.72067624617	43.776320021653	0.0285985031109705	587	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1526.01964059072	1526.01964059072
"healthy-5"	"2019-08-29-count-2:AACGTCAAGAAGCTCG"	3.64431728896443	-7.35659506237181	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACGTCAAGAAGCTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2019.3561796254	41.0813671088907	0.0203437944842952	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2013.60994196498	2013.60994196498
"healthy-5"	"2019-08-29-count-2:TCCATGCCAAAGGCGT"	-3.12718663635905	11.1137904890808	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCATGCCAAAGGCGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1486.92609977883	38.3409488461211	0.0257853761877097	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1486.92609977883	1486.92609977883
"healthy-5"	"2019-08-29-count-2:TCCATGCCACCGGTCA"	14.39364685592	1.97530124271242	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCATGCCACCGGTCA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1986.65562642519	40.4394876626548	0.0203555599293382	2156	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1964.10652142758	1964.10652142758
"healthy-5"	"2019-08-29-count-1:CATCCACAGCTAATCC"	9.7065130668575	6.69378993594972	"2019-08-29-count-1"	"Control5"	"B"	"Atypical memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCCACAGCTAATCC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1846.88735650835	38.1667505005253	0.0206654457652912	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1846.88735650835	1846.88735650835
"healthy-5"	"2019-08-29-count-2:AACGTCACACTTGTCC"	0.703383286564988	8.7423524626526	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACGTCACACTTGTCC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1641.24014549844	38.1806956354631	0.0232633205690126	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1635.23440897184	1635.23440897184
"healthy-5"	"2019-08-29-count-2:TCCATGCTCCTGGCTT"	3.46363749083821	-6.57664825832518	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCATGCTCCTGGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1890.83107391964	50.3628112863075	0.0266352779901733	880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.04529569985	1887.04529569985
"healthy-5"	"2019-08-29-count-2:TTACGCCAGAGCTTTC"	3.08306135711018	-7.92559959804686	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTACGCCAGAGCTTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1528.26991842834	49.3282009268276	0.0322771523092964	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1523.46392550409	1523.46392550409
"healthy-5"	"2019-08-29-count-1:AGTGTTGGTCAACCTA"	-3.13061461868938	12.3752689131531	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGTTGGTCAACCTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1407.70753393858	40.6945927244877	0.0289084143853586	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1400.10446813938	1400.10446813938
"healthy-5"	"2019-08-29-count-1:AGTGTTGGTGCTGTCG"	3.77943481978719	-7.55566360866698	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGTGTTGGTGCTGTCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1928.69735522825	47.3437893642684	0.0245470287165223	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1928.69735522825	1928.69735522825
"healthy-5"	"2019-08-29-count-1:CATCCACTCCTAGCTC"	4.00469674643819	-7.31290724193724	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCCACTCCTAGCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2151.18793234656	39.4062245324597	0.0183183551469046	1039	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2143.94176882858	2143.94176882858
"healthy-5"	"2019-08-29-count-2:CTAGGTACACTACCGG"	3.6366626220638	-7.74990274822386	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTAGGTACACTACCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1736.3448060151	46.1387912322541	0.0265723668895825	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1734.19894609463	1734.19894609463
"healthy-5"	"2019-08-29-count-2:AACTTCTGTGTCCGGT"	-1.85839460316356	3.55314586246339	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACTTCTGTGTCCGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2794.91004411284	42.7853371808189	0.0153083056361479	3117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2787.44659114745	2787.44659114745
"healthy-5"	"2019-08-29-count-1:GTCACTCAGTCACGCC"	4.26919617232625	-8.62943460857543	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCACTCAGTCACGCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1873.44454076987	48.2735087193303	0.0257672472650259	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1867.51467117375	1867.51467117375
"healthy-5"	"2019-08-29-count-2:CTATAGGAGAACAAGG"	-3.55577049675639	13.0885715254578	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTATAGGAGAACAAGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1531.59445747334	38.741035925496	0.0252945782981003	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1523.7791840406	1523.7791840406
"healthy-5"	"2019-08-29-count-1:GTCACTCGTGCCTACG"	4.46427692946736	-8.46877195751341	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCACTCGTGCCTACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2366.69846114608	36.9226524894089	0.0156009111830533	1354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2362.41266936134	2362.41266936134
"healthy-5"	"2019-08-29-count-2:CATCAAGCATGGCCAC"	-1.17506144467052	11.1560926207337	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCAAGCATGGCCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.38852549756	45.6153476084055	0.0272918875010382	678	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1666.87643640048	1666.87643640048
"healthy-5"	"2019-08-29-count-1:TGGGATTCATCCGGCA"	-2.88484607163127	3.39169571483461	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGATTCATCCGGCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3021.35592045531	47.0622560237948	0.0155765349276369	3354	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3011.74692835735	3011.74692835735
"healthy-5"	"2019-08-29-count-2:TCCCACATCCCGAACG"	8.25662865218465	6.15769431674806	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCACATCCCGAACG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1583.65157745664	37.5454607811036	0.0237081573469601	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1581.42327754376	1581.42327754376
"healthy-5"	"2019-08-29-count-2:CTATCCGCATCTAACG"	-3.42173157158549	10.5171165236267	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTATCCGCATCTAACG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1729.22415662897	39.0667507077249	0.0225920685632124	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1726.99205999159	1726.99205999159
"healthy-5"	"2019-08-29-count-2:AAGAACATCATCTATC"	-1.18002698841746	8.79686925494996	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGAACATCATCTATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1588.70543026315	42.3559228667772	0.0266606521636686	657	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1580.05872004796	1580.05872004796
"healthy-5"	"2019-08-29-count-2:CTATCCGTCCCGTTGT"	3.33838977393453	-8.10704424297484	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTATCCGTCCCGTTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1459.80485094005	42.5501290330183	0.0291478200018433	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1457.24461613918	1457.24461613918
"healthy-5"	"2019-08-29-count-2:TCCCAGTCAAGGTCGA"	4.08818211135213	-7.92496015941771	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCAGTCAAGGTCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2014.42730359194	32.7576224949789	0.016261506402623	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2012.56931969379	2012.56931969379
"healthy-5"	"2019-08-29-count-1:CATCCCATCTCTTAAC"	10.1155029731685	5.81184146488038	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCCCATCTCTTAAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1662.62709238732	37.3934517776578	0.0224905824937361	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1656.62537628769	1656.62537628769
"healthy-5"	"2019-08-29-count-2:AAGACAACAGCAGTTT"	-1.59150288525279	9.37911031329957	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGACAACAGCAGTTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1539.21662603578	45.3665032363104	0.0294737611775614	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1536.94319237768	1536.94319237768
"healthy-5"	"2019-08-29-count-1:CATCCGTGTGTCCACG"	-2.90710149231609	3.48681805217592	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCCGTGTGTCCACG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2758.22167589156	48.4413984642157	0.0175625472338287	2559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2751.50989413516	2751.50989413516
"healthy-5"	"2019-08-29-count-2:AAGACTCAGAGTCACG"	4.2421142059261	-8.41511919414672	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGACTCAGAGTCACG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1966.88258437633	37.9414625359166	0.0192901512460884	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1961.14680272284	1961.14680272284
"healthy-5"	"2019-08-29-count-2:AAGACTCAGGCACTCC"	6.78076090392415	-1.54278399860533	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGACTCAGGCACTCC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2349.33305854822	36.4998096545315	0.015536243157063	1238	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2346.07804077546	2346.07804077546
"healthy-5"	"2019-08-29-count-2:AAGACTCAGGCGAACT"	3.40025796469991	-7.9154000512329	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGACTCAGGCGAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1701.96955769491	42.3775775310011	0.0248991395524112	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1695.48258828241	1695.48258828241
"healthy-5"	"2019-08-29-count-1:AATGGAAGTGACTCTA"	4.64773525771443	-8.90530111705931	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AATGGAAGTGACTCTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1833.69040053729	44.8889428633174	0.0244801100830133	785	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1829.5755743112	1829.5755743112
"healthy-5"	"2019-08-29-count-2:CTATCTAGTTGCATGT"	6.81861366805379	-1.50724162971648	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTATCTAGTTGCATGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2109.5054193958	34.9175820144808	0.0165524969471194	955	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2097.67156635421	2097.67156635421
"healthy-5"	"2019-08-29-count-2:TCCCATGGTCGGCTAC"	3.10880984839742	-7.90328266536864	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCCATGGTCGGCTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1411.87650287617	48.3189121482441	0.0342231859867435	526	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1409.42785142593	1409.42785142593
"healthy-5"	"2019-08-29-count-1:TCACTATAGCCGCACT"	-3.35154734078105	9.85143468463746	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCACTATAGCCGCACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2151.15646836231	44.0679160243762	0.0204856860356259	1033	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2151.15646836231	2151.15646836231
"healthy-5"	"2019-08-29-count-1:GATGGAGAGAAGATCT"	-3.53169832649882	-5.07244732296141	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGGAGAGAAGATCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2672.87975805239	41.7999030698691	0.0156385273014776	1989	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2667.48856740551	2667.48856740551
"healthy-5"	"2019-08-29-count-2:AAGACTCTCATAGCAC"	14.1773630577022	2.1450190314087	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGACTCTCATAGCAC"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1347.57175652427	35.2575145723505	0.0261637381472647	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1334.85417246459	1334.85417246459
"healthy-5"	"2019-08-29-count-2:AAGATAGAGAAGTATC"	3.38390698012654	-7.61191131984862	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGATAGAGAAGTATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1839.00868230516	47.7287662874163	0.0259535296090007	852	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1835.27648717234	1835.27648717234
"healthy-5"	"2019-08-29-count-2:AAGATAGAGGCATGGT"	4.16609587249104	-7.28124620830687	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGATAGAGGCATGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1894.71542686984	49.2746500141493	0.0260063592217398	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1890.76990923625	1890.76990923625
"healthy-5"	"2019-08-29-count-2:AAGATAGCAGATCACT"	4.87066998061482	-9.51397039806517	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGATAGCAGATCACT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2051.34810252757	45.9064113155328	0.0223786549240323	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2044.25032504823	2044.25032504823
"healthy-5"	"2019-08-29-count-2:AAGATAGCAGTTTCAG"	-3.75075517121013	12.9889230498108	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGATAGCAGTTTCAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1677.09836970541	39.1080575906633	0.0233188811682721	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1672.20792003426	1672.20792003426
"healthy-5"	"2019-08-29-count-2:CTCAACCGTTCTCGCT"	-4.26309571686442	13.0349654921326	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAACCGTTCTCGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1730.45653990018	41.5942242112264	0.0240365610185308	691	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1725.83690900518	1725.83690900518
"healthy-5"	"2019-08-29-count-2:CTCAACCTCTGATGGT"	3.3631726699764	-7.82740404522093	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAACCTCTGATGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.31840298264	38.7267448763845	0.0221381909721834	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1742.58038328956	1742.58038328956
"healthy-5"	"2019-08-29-count-1:TGGGCTGCACTGCGAC"	-5.32845006409343	3.69455144489137	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGCTGCACTGCGAC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2413.61686631162	38.1086098522651	0.0157890054482843	1498	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2404.47198080744	2404.47198080744
"healthy-5"	"2019-08-29-count-1:CATCGGGTCCTGTACC"	-3.79697595062907	11.8003434904846	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCGGGTCCTGTACC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1405.10601093157	40.4624980048738	0.0287967581734616	510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1405.10601093157	1405.10601093157
"healthy-5"	"2019-08-29-count-1:GATGTTGAGGTAGCCA"	4.06478323516194	-7.53703548824462	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATGTTGAGGTAGCCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2139.30717065909	41.2792969728504	0.0192956381107875	1113	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2137.72235033651	2137.72235033651
"healthy-5"	"2019-08-29-count-1:ATACCTTTCATTTCCA"	3.33066048201863	-7.32516481792601	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATACCTTTCATTTCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1917.25784807413	45.895809798444	0.0239382563198507	862	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1917.25784807413	1917.25784807413
"healthy-5"	"2019-08-29-count-2:CTCAAGACATCTAACG"	-3.84045491638835	12.2541036375794	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAAGACATCTAACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1687.63464351931	32.7328812501315	0.0193957154031112	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1683.11263959217	1683.11263959217
"healthy-5"	"2019-08-29-count-2:AAGCATCGTCGTCATA"	4.41460194167439	-8.71616079723509	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGCATCGTCGTCATA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1798.75777269852	43.6490847945283	0.024266238321264	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1792.69314845971	1792.69314845971
"healthy-5"	"2019-08-29-count-1:CATCGTCGTATCAGGG"	3.31975998458211	-8.03117563640746	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATCGTCGTATCAGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1446.89041037673	49.6765859172731	0.0343333438116704	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1446.89041037673	1446.89041037673
"healthy-5"	"2019-08-29-count-2:AAGCATCTCTTCCTAA"	-4.15343509140666	11.0289497145447	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGCATCTCTTCCTAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1808.27954415588	42.3588295661456	0.0234249343266884	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1803.97150576012	1803.97150576012
"healthy-5"	"2019-08-29-count-2:CTCAAGATCCTATGGA"	-4.29661117020305	-4.50611355220946	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAAGATCCTATGGA"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2726.42405852252	46.809091237412	0.017168675977272	1896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2719.89149874467	2719.89149874467
"healthy-5"	"2019-08-29-count-1:GTCATTTAGGGTAATT"	11.2779337364132	4.06879756534425	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCATTTAGGGTAATT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1569.26738045799	31.1222250753325	0.0198323277874096	586	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1566.80766430736	1566.80766430736
"healthy-5"	"2019-08-29-count-2:AAGCGAGAGTGCACTT"	-2.75764785233195	3.46269152248231	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGCGAGAGTGCACTT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3077.89477180949	48.0286458926651	0.0156043820381907	3796	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3071.82180827699	3071.82180827699
"healthy-5"	"2019-08-29-count-2:GTGCTGGTCACTTATC"	4.39657225188558	-8.04196169292601	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTGGTCACTTATC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1896.30109284444	41.6190036944275	0.0219474659649113	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1892.43258167536	1892.43258167536
"healthy-5"	"2019-08-29-count-1:TGGGTTACACTCTCGT"	3.08726324614827	-6.75677444851073	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGGGTTACACTCTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1869.20124312639	41.2061811899744	0.0220448072894783	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1862.87888482293	1862.87888482293
"healthy-5"	"2019-08-29-count-1:GTCATTTTCGGACTGC"	3.92378534850423	-8.21385195171507	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCATTTTCGGACTGC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.92462459165	42.0981771810854	0.0212303466601787	925	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1981.11013458947	1981.11013458947
"healthy-5"	"2019-08-29-count-1:GTCCACTCAAATTGGA"	3.82598485526387	-8.0206918946472	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCCACTCAAATTGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1663.84826924934	47.6476038148763	0.0286369885376465	686	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1661.73149714388	1661.73149714388
"healthy-5"	"2019-08-29-count-2:TCCGATCTCGAGAAAT"	-3.41849003258403	12.089404083136	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGATCTCGAGAAAT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1434.61840037796	40.7370961833263	0.0283957714278542	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1432.066132168	1432.066132168
"healthy-5"	"2019-08-29-count-2:AAGCGTTTCGGTCACG"	3.67146887358968	-5.83890011226805	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGCGTTTCGGTCACG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2412.61790467259	40.9609904525447	0.0169778191454247	1447	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2408.77169081203	2408.77169081203
"healthy-5"	"2019-08-29-count-2:CTCAATTTCACATTGG"	11.0831495719845	4.1258768805298	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAATTTCACATTGG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1442.7908034027	42.4885957465568	0.0294488956031262	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1440.18437673813	1440.18437673813
"healthy-5"	"2019-08-29-count-2:CTCAATTTCCCTGTTG"	2.93235959586446	-6.72610380565795	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAATTTCCCTGTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2313.48128701523	50.0388068069426	0.0216292247911375	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2310.39029990637	2310.39029990637
"healthy-5"	"2019-08-29-count-1:TCAGCCTCACCCTAGG"	-2.02790151062663	4.20823762500612	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGCCTCACCCTAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3205.44971251978	42.9409330927639	0.0133962273452758	4246	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3198.913614208	3198.913614208
"healthy-5"	"2019-08-29-count-1:ATAGAGAAGCTTAGTC"	3.83972277221028	-8.24370958721312	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATAGAGAAGCTTAGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1785.06195620742	45.2718142105116	0.0253614806214889	736	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1782.83631498359	1782.83631498359
"healthy-5"	"2019-08-29-count-1:CATGAGTTCCATTTCA"	-3.69742188873943	13.2370595701965	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGAGTTCCATTTCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1763.30724957672	39.9568851739075	0.022660194463273	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1763.30724957672	1763.30724957672
"healthy-5"	"2019-08-29-count-2:GTGCTTCCATCAGTCA"	2.76260890540425	-8.10576059734496	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGCTTCCATCAGTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1598.94471897848	43.1183456641132	0.0269667519785552	631	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1594.3446944432	1594.3446944432
"healthy-5"	"2019-08-29-count-1:ATAGAGACACACTTAG"	-3.87670741501506	-5.14489080822142	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATAGAGACACACTTAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2450.84979718394	51.2473655563774	0.0209100392913761	1359	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2441.79149196602	2441.79149196602
"healthy-5"	"2019-08-29-count-2:TCCGGGATCCCTCTAG"	5.50097097930257	-10.0003156892029	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGGGATCCCTCTAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2291.91213619702	37.2289911367134	0.0162436380298975	1204	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2291.91213619702	2291.91213619702
"healthy-5"	"2019-08-29-count-2:AAGGAATGTCGCTTAA"	2.90344085273091	-7.27344849025878	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGGAATGTCGCTTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1559.43598161223	44.1124671555325	0.0282874498701297	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1559.43598161223	1559.43598161223
"healthy-5"	"2019-08-29-count-2:AAGGAATGTGCAACGA"	11.2338253456051	4.19828651035158	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGGAATGTGCAACGA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1701.82993159817	39.4465202472416	0.0231788849842345	681	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1699.57063804428	1699.57063804428
"healthy-5"	"2019-08-29-count-2:AAGGTAAAGATGAATC"	-2.11591253700908	12.0360173949036	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGGTAAAGATGAATC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1503.82651654894	39.2710408141076	0.0261140765786129	571	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1496.65750681007	1496.65750681007
"healthy-5"	"2019-08-29-count-2:TCCGTGTTCGGTGCAC"	-7.15387950363811	-0.648542307969652	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCGTGTTCGGTGCAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1984.98670336859	49.9580117233223	0.0251679326811318	929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1976.05949172835	1976.05949172835
"healthy-5"	"2019-08-29-count-1:CATGCAATCGGACAAG"	2.85845245894734	-5.12777902996215	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCAATCGGACAAG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2364.21787244012	40.5933270410965	0.0171698757184337	1355	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2359.97364947255	2359.97364947255
"healthy-5"	"2019-08-29-count-2:AAGGTAACAATTGCTG"	10.5462862449581	6.24423835361329	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGGTAACAATTGCTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1613.37713361917	46.5870487064341	0.0288754859205973	647	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1609.06708925168	1609.06708925168
"healthy-5"	"2019-08-29-count-2:CTCAGAAAGCACCCAC"	2.79740943488423	-7.27218248760375	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAGAAAGCACCCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1591.46167579727	46.5175122509201	0.0292294266072203	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1584.25179402725	1584.25179402725
"healthy-5"	"2019-08-29-count-2:CATCGTCTCCAACCGG"	3.42617787894551	-8.18968489086302	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATCGTCTCCAACCGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1576.89815149185	42.6603890135731	0.0270533572337653	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1576.89815149185	1576.89815149185
"healthy-5"	"2019-08-29-count-1:CATGCCTGTACTAAGA"	-2.55798039856609	11.134609199408	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCCTGTACTAAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1414.65697340884	32.5250756608981	0.0229914928299005	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1412.22733622607	1412.22733622607
"healthy-5"	"2019-08-29-count-2:TTCACGCGTAGGGAGG"	6.86446203765218	-1.43102791225585	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCACGCGTAGGGAGG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1936.76657343358	37.0588059676862	0.0191343688372248	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1923.34345038696	1923.34345038696
"healthy-5"	"2019-08-29-count-1:CATGCCTGTTCAAGTC"	-2.55082450333293	10.2673043974671	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCCTGTTCAAGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1575.67116057693	40.4192253757629	0.0256520690275016	608	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1570.99257209337	1570.99257209337
"healthy-5"	"2019-08-29-count-2:AAGTACCCAGGTGTTT"	-1.22656355324443	8.85714051807252	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTACCCAGGTGTTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1512.7979238071	40.8196543389699	0.0269828862775296	588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1510.44846027439	1510.44846027439
"healthy-5"	"2019-08-29-count-2:CTCAGGGAGGGAGGAC"	3.23143972930257	-7.80976107036742	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAGGGAGGGAGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1734.73984813712	44.9515126441133	0.0259125382358543	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1732.51586204715	1732.51586204715
"healthy-5"	"2019-08-29-count-1:GATTTCTCAAACACCT"	-2.39482031288798	9.81850335681764	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GATTTCTCAAACACCT"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1976.01669691203	36.5607972319684	0.0185022714074749	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1967.8288966695	1967.8288966695
"healthy-5"	"2019-08-29-count-2:CTCAGGGCAAGCACCC"	2.07921733435933	-7.20577051555785	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAGGGCAAGCACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1795.43913927591	41.9842870428227	0.0233838541916574	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1795.43913927591	1795.43913927591
"healthy-5"	"2019-08-29-count-2:AAGTACCGTACCTAGT"	3.01462616500203	-8.45982077037963	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTACCGTACCTAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1842.1333402027	44.0924485082673	0.023935535797542	813	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1832.06547155159	1832.06547155159
"healthy-5"	"2019-08-29-count-2:AAGTACCGTCTTGCTC"	9.26383747634236	6.16000936115114	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTACCGTCTTGCTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1506.28326161981	39.2938773704096	0.026086645434906	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1499.04972898471	1499.04972898471
"healthy-5"	"2019-08-29-count-2:TCCTCCCGTTCTCTAT"	9.31057228621785	6.93985745990602	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCCCGTTCTCTAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1542.14543712007	39.444008345851	0.0255773595644209	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1537.41180743225	1537.41180743225
"healthy-5"	"2019-08-29-count-2:AAGTACCGTTTGACAC"	-2.97555051270183	-5.73760511791381	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTACCGTTTGACAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2099.95310475748	47.4172019309529	0.0225801242054065	1024	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2091.4326306205	2091.4326306205
"healthy-5"	"2019-08-29-count-2:TCCTCCCTCTACTGCC"	3.50262965735738	-8.447874092218	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCCCTCTACTGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1934.34956860809	40.2832712602535	0.0208252282389891	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1934.34956860809	1934.34956860809
"healthy-5"	"2019-08-29-count-1:TCAGTCCCAGACGATG"	-3.97194562378581	13.040349937323	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTCCCAGACGATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1547.80498357738	39.6230403558829	0.0255995043150098	579	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1545.33942000411	1545.33942000411
"healthy-5"	"2019-08-29-count-2:AAGTGAAAGGCTAACG"	4.48071827468221	-9.21527578746947	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTGAAAGGCTAACG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2128.00061931059	38.8877104959516	0.0182742947267328	1050	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2121.13399859943	2121.13399859943
"healthy-5"	"2019-08-29-count-2:AAGTGAAAGGGCCCTT"	3.64945640143697	-8.98260309612425	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTGAAAGGGCCCTT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1642.22742742353	41.6132186478097	0.0253394980213527	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1639.9936957452	1639.9936957452
"healthy-5"	"2019-08-29-count-1:CATGCGGTCCTGGGAC"	1.99775602397267	-7.44577124035033	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCGGTCCTGGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1545.72582501373	49.5755087123951	0.0320726405098102	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1543.37024369337	1543.37024369337
"healthy-5"	"2019-08-29-count-2:TCCTCGACACATGACT"	2.9324070411617	-7.98621370708617	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCGACACATGACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1442.44641262079	40.3892111211576	0.0280004933062117	514	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1442.44641262079	1442.44641262079
"healthy-5"	"2019-08-29-count-2:TCCTCGATCAGTGGGA"	4.53305258330647	-7.34583761608275	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCGATCAGTGGGA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1809.41910124719	46.3028428775454	0.0255898939309472	735	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1807.23457650367	1807.23457650367
"healthy-5"	"2019-08-29-count-2:AAGTGAATCGGCTTGG"	-3.93330345574077	12.7810029753479	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTGAATCGGCTTGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1565.10432960691	36.3396436027712	0.0232186716983259	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1565.10432960691	1565.10432960691
"healthy-5"	"2019-08-29-count-1:CATGCTCCATACTGTG"	-3.77791843834575	12.4502296217713	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGCTCCATACTGTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1710.0406801589	38.8082950626827	0.0226943695041667	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1705.60101197073	1705.60101197073
"healthy-5"	"2019-08-29-count-2:AAGTTCGAGCGATCGA"	3.97337998923604	-8.35798170482787	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTTCGAGCGATCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1832.14145933687	35.4421447322553	0.0193446551583867	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1830.15979969866	1830.15979969866
"healthy-5"	"2019-08-29-count-2:AAGTTCGAGGTTCATC"	-3.70667753639873	11.8925094374451	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTTCGAGGTTCATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.27274610028	35.4180570611188	0.0225123438697522	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1568.54741973623	1568.54741973623
"healthy-5"	"2019-08-29-count-2:CTCAGTCGTACTTCCC"	-5.40578828278239	-5.22641518032225	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCAGTCGTACTTCCC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1909.02853089958	50.1530566075374	0.0262715071020463	837	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1905.03425784099	1905.03425784099
"healthy-5"	"2019-08-29-count-2:AAGTTCGCAATTGGTC"	-2.41646490517314	9.71503827655641	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTTCGCAATTGGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1579.35050718123	35.0375589573195	0.0221847897588315	626	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1579.35050718123	1579.35050718123
"healthy-5"	"2019-08-29-count-2:AAGTTCGTCAGCTGTA"	6.8601209121639	-1.45833065426024	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AAGTTCGTCAGCTGTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2141.87407761054	35.482189855031	0.016565955125903	1106	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2137.03292752063	2137.03292752063
"healthy-5"	"2019-08-29-count-2:CATGCTCAGGCCCACT"	-4.47320352020915	-5.46865560924681	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATGCTCAGGCCCACT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2467.04913147357	44.3317544089843	0.0179695466310008	1395	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2462.68662630666	2462.68662630666
"healthy-5"	"2019-08-29-count-1:TCAGTTTCAGGTCAGA"	10.4521156745845	6.74991223895875	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCAGTTTCAGGTCAGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1792.6182057868	41.1071448892119	0.0229313440845981	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1788.66353541332	1788.66353541332
"healthy-5"	"2019-08-29-count-2:AATAGAGAGGCGAAGG"	2.920755525201	-10.2540960541931	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATAGAGAGGCGAAGG"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1787.73396237254	47.4063931024	0.0265175882430997	763	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1785.68056273908	1785.68056273908
"healthy-5"	"2019-08-29-count-2:AATAGAGCACAGCATT"	-3.00127277794536	12.0432595976624	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATAGAGCACAGCATT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1409.91712243967	35.9005220884169	0.0254628598497308	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1407.46322108784	1407.46322108784
"healthy-5"	"2019-08-29-count-2:CTCATGCCAACGGGTA"	-3.92024884644206	-5.26053335582884	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATGCCAACGGGTA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2328.49177541122	40.6444911796612	0.0174552865545266	1335	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2325.60207860506	2325.60207860506
"healthy-5"	"2019-08-29-count-2:TCCTCTTTCGATAACC"	-2.66351638260539	3.32985684955446	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTCTTTCGATAACC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3341.73822974825	46.96713724353	0.0140547026770162	3730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3330.68165894803	3330.68165894803
"healthy-5"	"2019-08-29-count-1:CATGGATGTGGACCTC"	-2.1425772708958	3.46736023509828	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGGATGTGGACCTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3279.47818052329	46.4674861775147	0.0141691707093779	3831	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3274.81101383349	3274.81101383349
"healthy-5"	"2019-08-29-count-2:TCCTGCAAGAAATTGC"	-4.12738309326823	13.0421294935974	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTGCAAGAAATTGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1764.22877269987	38.4842625344709	0.0218136463535717	708	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1764.22877269987	1764.22877269987
"healthy-5"	"2019-08-29-count-2:AATCACGAGGACAAGA"	4.28439249572102	-7.06715490734252	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATCACGAGGACAAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1858.97454703337	45.3737911136319	0.0244079679229828	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1855.00929678213	1855.00929678213
"healthy-5"	"2019-08-29-count-2:CTCATGCTCCCTTTGG"	9.4270883994991	6.16626212680665	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATGCTCCCTTTGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1549.32990332903	39.0909786924507	0.0252308940842465	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1549.32990332903	1549.32990332903
"healthy-5"	"2019-08-29-count-2:AATCACGTCCCATAAG"	-2.31985769692119	9.91342637622682	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATCACGTCCCATAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1509.74340612559	35.103620372801	0.0232513818112221	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1499.65618003354	1499.65618003354
"healthy-5"	"2019-08-29-count-1:GTCTAGAAGGAGAGTA"	3.29345979270284	-7.21696379100951	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTAGAAGGAGAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1773.94305675272	48.9004508648313	0.027565964239205	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1773.94305675272	1773.94305675272
"healthy-5"	"2019-08-29-count-1:GTCTAGAAGGTGATCG"	2.47603168067281	-7.45635034954222	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTAGAAGGTGATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1444.49038703089	49.5872348699559	0.0343285322735038	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1441.97847425136	1441.97847425136
"healthy-5"	"2019-08-29-count-2:AATCGACAGCCTCTCT"	10.1259829002315	5.59120843494264	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATCGACAGCCTCTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1417.46066007969	38.0249506825923	0.0268261065393198	529	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1417.46066007969	1417.46066007969
"healthy-5"	"2019-08-29-count-2:AATCGACAGGGCTGAT"	4.1006928878719	-7.7718510857788	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATCGACAGGGCTGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1955.2722687883	44.3190621652562	0.0226664403074265	874	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1953.28567365616	1953.28567365616
"healthy-5"	"2019-08-29-count-1:CATGGTACATGGGATG"	2.38234533843343	-7.59006359493407	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGGTACATGGGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1660.01248879166	47.6009833803633	0.0286750754598313	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1660.01248879166	1660.01248879166
"healthy-5"	"2019-08-29-count-2:AATCGACGTCCTACGG"	6.82370867308919	-1.65742995655211	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATCGACGTCCTACGG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2682.20375946791	37.1873064446093	0.0138644598917371	1680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2679.53244379049	2679.53244379049
"healthy-5"	"2019-08-29-count-1:GTCTAGATCAGGAAAT"	6.68356718596761	-0.881095134374224	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTAGATCAGGAAAT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1894.24993231111	40.271221102778	0.0212597189081825	924	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1887.46970490228	1887.46970490228
"healthy-5"	"2019-08-29-count-1:ACAGAAAGTAACCAGG"	-3.15200052681621	3.70442006671754	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACAGAAAGTAACCAGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2890.59359398321	46.1384688129764	0.0159615896572295	2887	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2885.97329680907	2885.97329680907
"healthy-5"	"2019-08-29-count-1:CATGGTATCCGATAGT"	2.44264282759969	-6.4282174340454	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATGGTATCCGATAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2070.03427095675	43.9666928892997	0.0212395966125618	1003	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.03427095675	2070.03427095675
"healthy-5"	"2019-08-29-count-2:CTCATTATCATCGGGC"	2.50506391105	-7.223020576593	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCATTATCATCGGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1561.34002120383	48.4037436640755	0.0310014109718107	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1559.08509011086	1559.08509011086
"healthy-5"	"2019-08-29-count-1:GTCTCACCACAACGCC"	-2.29326162758525	11.0882444151672	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTCACCACAACGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1611.38202163134	39.7307877333116	0.0246563429403839	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1606.98401570541	1606.98401570541
"healthy-5"	"2019-08-29-count-2:CTCCAACAGCCGCACT"	-0.92352662506755	9.06252858722535	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCAACAGCCGCACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1606.71901247623	40.0104698778967	0.0249019707660232	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1600.06215340947	1600.06215340947
"healthy-5"	"2019-08-29-count-2:CTCCAACAGCGATGGT"	4.38188900527303	-7.37626030361327	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCAACAGCGATGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2008.23279940762	39.78754623654	0.0198122181095122	898	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2008.23279940762	2008.23279940762
"healthy-5"	"2019-08-29-count-1:GTCTCACCATGTGCTA"	-1.43205450001414	10.1012277373108	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTCACCATGTGCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1478.33887965863	41.7694954963783	0.0282543441636491	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1470.83263577888	1470.83263577888
"healthy-5"	"2019-08-29-count-2:CTCCAACCAATCAGCT"	4.2687164741451	-8.11350443279418	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCAACCAATCAGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2282.60465937795	43.5190401069088	0.0190655179503438	1268	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2282.60465937795	2282.60465937795
"healthy-5"	"2019-08-29-count-2:TCCTTTCGTACTTCCC"	-1.87149165096934	4.12218186939088	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCCTTTCGTACTTCCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3370.82595743683	43.1140925781518	0.0127903644752207	4168	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3364.63814811068	3364.63814811068
"healthy-5"	"2019-08-29-count-2:AATGAAGAGTACTCGT"	4.23724617537801	-7.89551784908446	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGAAGAGTACTCGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1837.4419988647	44.8330791146514	0.0243997248034781	821	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1833.61255762105	1833.61255762105
"healthy-5"	"2019-08-29-count-2:GTGTGGCTCCCTAGGG"	-5.38933787766154	-5.45392038738402	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTGTGGCTCCCTAGGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2207.95012550124	48.0966662471456	0.0217834024834356	1095	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2206.21184449454	2206.21184449454
"healthy-5"	"2019-08-29-count-2:CATTCCGAGGAATTAC"	5.43272223052327	-10.0767603150574	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCCGAGGAATTAC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2319.54495796711	41.592788219548	0.0179314430085462	1275	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2318.03848898348	2318.03848898348
"healthy-5"	"2019-08-29-count-1:ATCCACCAGTTAACGA"	2.93860592421834	-7.37582018291625	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCACCAGTTAACGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1599.47766951817	44.6524339356104	0.0279168848597064	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1599.47766951817	1599.47766951817
"healthy-5"	"2019-08-29-count-2:AATGAAGTCCGGTAGC"	-2.57554517212566	3.42831561649171	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGAAGTCCGGTAGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3056.54938496127	44.1475550398317	0.0144435929146262	3290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3047.30628462696	3047.30628462696
"healthy-5"	"2019-08-29-count-2:AATGAAGTCGCTTGCT"	-7.62131772461589	0.628785646799482	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGAAGTCGCTTGCT"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2617.04637201975	42.3941320203352	0.0161992284407314	2023	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2601.99682976024	2601.99682976024
"healthy-5"	"2019-08-29-count-1:CATTCTAGTAAGAACT"	9.81164516982381	6.34199569309083	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTCTAGTAAGAACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1539.43950589632	37.8243765188106	0.0245702259646688	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1534.94723062449	1534.94723062449
"healthy-5"	"2019-08-29-count-2:CTCCATGCACGACAGA"	-0.148957054049331	9.11797044360963	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCATGCACGACAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1520.82808790173	41.415188839956	0.0272319989152069	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1520.82808790173	1520.82808790173
"healthy-5"	"2019-08-29-count-2:AATGAAGTCTTCCTAA"	-4.24532018128093	12.2306804426941	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGAAGTCTTCCTAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1695.69114444004	34.8184621243199	0.0205334929291135	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1693.4562372082	1693.4562372082
"healthy-5"	"2019-08-29-count-2:AATGACCAGGCTAGCA"	-2.47521338883098	3.36150047862855	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGACCAGGCTAGCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3040.45051036175	46.7330270512663	0.0153704284585465	3321	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3032.39277620037	3032.39277620037
"healthy-5"	"2019-08-29-count-2:AATGACCGTATGTGTC"	-1.42240701142009	9.94713494861452	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGACCGTATGTGTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1460.15810387456	44.0888892204532	0.0301945995460782	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1457.9069955972	1457.9069955972
"healthy-5"	"2019-08-29-count-2:CTCCATGGTTGGACCC"	11.1570450263912	4.01621315563051	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCATGGTTGGACCC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1561.19794146154	41.5766134446316	0.0266312248693519	582	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1548.75471741933	1548.75471741933
"healthy-5"	"2019-08-29-count-2:AATGACCTCCCGTGAG"	3.67695416983907	-7.70264580166014	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGACCTCCCGTGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1901.18994089596	44.4875341569754	0.0233998367022761	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1896.9763011312	1896.9763011312
"healthy-5"	"2019-08-29-count-2:CATTCCGTCTAGCATG"	-2.05624542656596	10.7335872420105	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCCGTCTAGCATG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1421.87164323848	38.2875611450645	0.0269275791012049	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1419.34688020737	1419.34688020737
"healthy-5"	"2019-08-29-count-1:GTCTTTAGTTGGACCC"	-7.0727723640507	3.73798010433046	"2019-08-29-count-1"	"Control5"	"HSC"	"HSC"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTCTTTAGTTGGACCC"	"HSC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1939.8114996651	43.5680039608087	0.0224599163209057	1051	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1933.71904372979	1933.71904372979
"healthy-5"	"2019-08-29-count-2:CATTCTAAGCCTAGGA"	5.29366507109944	-10.0395899049011	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTCTAAGCCTAGGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.69086609526	48.4657335146814	0.0239610186247802	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2005.35254404694	2005.35254404694
"healthy-5"	"2019-08-29-count-2:TTCCTAACATACTGTG"	-1.76787171784099	9.43157193744508	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTCCTAACATACTGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1637.20540226098	35.0864938610945	0.0214307220173107	630	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1637.20540226098	1637.20540226098
"healthy-5"	"2019-08-29-count-2:CTCCCAAGTACGTGAG"	2.29322876509969	-4.61694338237914	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCCAAGTACGTGAG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2145.08126946323	39.428383524916	0.018380834370337	1198	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2142.25778214666	2142.25778214666
"healthy-5"	"2019-08-29-count-1:CTCCAACTCGTTACCC"	4.83525480803792	-7.27452375805052	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTCCAACTCGTTACCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2358.46360341621	44.4764836381789	0.0188582446528983	1224	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2355.12473280286	2355.12473280286
"healthy-5"	"2019-08-29-count-1:ACATCCCAGGGTACGT"	3.2341648536617	-5.45119573986205	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACATCCCAGGGTACGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2179.72293623367	47.6557807288218	0.0218632285492054	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2175.37845373562	2175.37845373562
"healthy-5"	"2019-08-29-count-2:TCGACCTAGTCATCGT"	6.85450663146321	-1.486803197023	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGACCTAGTCATCGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2133.33386866693	30.8206152121381	0.0144471597553538	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2119.99296598133	2119.99296598133
"healthy-5"	"2019-08-29-count-1:CATTGCCGTACGGCAA"	7.92339720305745	6.06691024387208	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGCCGTACGGCAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1532.90499658193	38.5088898723002	0.0251215110904899	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1532.90499658193	1532.90499658193
"healthy-5"	"2019-08-29-count-1:CATTGCCGTAGTCACT"	3.24965776976888	-8.02918913280638	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGCCGTAGTCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1710.38692536401	42.2774052190738	0.0247180357801649	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1710.38692536401	1710.38692536401
"healthy-5"	"2019-08-29-count-2:CTCCCTCGTCGTTATG"	4.07188477095906	-8.06939985668334	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCCTCGTCGTTATG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2324.97594623399	46.2109805841429	0.0198758962039998	1237	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2320.10205400476	2320.10205400476
"healthy-5"	"2019-08-29-count-1:CATTGCCGTTGGTGTT"	2.69470848616902	-7.28363373195799	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGCCGTTGGTGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1857.40363378765	44.9018785500939	0.0241745400586566	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1853.25649245483	1853.25649245483
"healthy-5"	"2019-08-29-count-1:GCAGCCACAACCCTCT"	1.92211606082265	-6.33915665065917	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGCCACAACCCTCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1867.29489192523	48.7236034262123	0.0260931487773616	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1867.29489192523	1867.29489192523
"healthy-5"	"2019-08-29-count-2:CTCCCTCTCCCAAGCG"	3.48262657698933	-7.76829149639281	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCCTCTCCCAAGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.48308088216	42.626410861339	0.0217650135849724	895	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1956.55312566641	1956.55312566641
"healthy-5"	"2019-08-29-count-1:GTGACGCGTTTGACAC"	3.68262757834737	-7.07271244442137	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGACGCGTTTGACAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2056.87871525135	40.7767688692414	0.0198245859451458	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2051.61669912717	2051.61669912717
"healthy-5"	"2019-08-29-count-1:CATTGTTAGCTAAACA"	2.02776946601216	-7.01684667980345	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGTTAGCTAAACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1523.48208873598	50.3107184358534	0.0330235050400861	559	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1523.48208873598	1523.48208873598
"healthy-5"	"2019-08-29-count-2:CTCCGATAGATGAAGG"	4.38731112059895	-8.85105993663939	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCGATAGATGAAGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2149.71604204261	46.3152897288329	0.0215448407245569	1134	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2143.68097170761	2143.68097170761
"healthy-5"	"2019-08-29-count-2:CTCCGATAGCCTATCA"	3.32166280326192	-7.05827906047972	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCGATAGCCTATCA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2231.86203211012	40.2598547889971	0.0180386843854023	1174	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2230.29796317034	2230.29796317034
"healthy-5"	"2019-08-29-count-2:AATGGAAGTGTTGACT"	11.0261255699093	4.29449508273927	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGGAAGTGTTGACT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1452.75110400497	37.1536852896987	0.0255747080055714	530	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1450.23889307599	1450.23889307599
"healthy-5"	"2019-08-29-count-2:CATTGAGAGTGGATAT"	3.25620092925374	-8.94943430339965	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CATTGAGAGTGGATAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1569.32500639694	43.3779151393714	0.0276411291240199	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1566.91349867615	1566.91349867615
"healthy-5"	"2019-08-29-count-2:AATGGAATCTCTGACC"	-2.88773785057719	10.9409761198792	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGGAATCTCTGACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1490.76407308662	39.0034336254079	0.026163384488232	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1483.73877098308	1483.73877098308
"healthy-5"	"2019-08-29-count-2:AATGGAATCTTAGCAG"	-2.61795411530193	3.82348654353944	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATGGAATCTTAGCAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3224.26889244106	44.9394206443385	0.0139378637897397	3999	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3218.86041205772	3218.86041205772
"healthy-5"	"2019-08-29-count-2:CTCCGATCAGTGGGTA"	4.51646389540975	-8.17314913189086	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCGATCAGTGGGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1940.47588438812	49.5763839251651	0.0255485699791614	930	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1940.47588438812	1940.47588438812
"healthy-5"	"2019-08-29-count-2:CTCCTCCAGAGATTCA"	3.36394943770711	-7.1765814057556	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTCCAGAGATTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.65054115595	53.1681649767904	0.0302840250553413	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1753.61912881183	1753.61912881183
"healthy-5"	"2019-08-29-count-2:CTCCTCCAGCGCTGCT"	-3.92371783676799	12.3219632872376	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTCCAGCGCTGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1942.72980899604	40.4824502950473	0.0208379210055812	823	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1934.07268545697	1934.07268545697
"healthy-5"	"2019-08-29-count-1:CATTGTTTCAAGTTGC"	9.43658890303914	6.63894174182741	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CATTGTTTCAAGTTGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1526.33534614895	41.8692944281322	0.0274312552177811	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1517.11139436499	1517.11139436499
"healthy-5"	"2019-08-29-count-2:CTCCTCCCACGCACCA"	-5.8722485107487	-4.6298489800659	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTCCCACGCACCA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3241.98731690265	38.7894732241187	0.0119647208432566	2915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3234.59838531965	3234.59838531965
"healthy-5"	"2019-08-29-count-2:GTTACGATCCTTTAGT"	-5.35146985474284	-5.52726747905882	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTACGATCCTTTAGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1484.66705548176	51.0113926246578	0.0343588095636061	543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1484.66705548176	1484.66705548176
"healthy-5"	"2019-08-29-count-2:CTCCTCCCAGTTCTAG"	3.10563745078389	-6.86307718670043	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTCCCAGTTCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1819.79500830693	50.2447404094801	0.0276101100289455	791	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1815.69422771826	1815.69422771826
"healthy-5"	"2019-08-29-count-2:ATACCGACACTGGAAG"	5.36936153945271	-10.101064705011	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACCGACACTGGAAG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2067.70559095144	47.2966793596278	0.0228739911361678	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2062.67773087054	2062.67773087054
"healthy-5"	"2019-08-29-count-2:TCGACGGTCAATCCAG"	14.2698017555172	2.1430499323639	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGACGGTCAATCCAG"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1194.64097124968	37.3078809351843	0.0312293666742047	914	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1181.64374286069	1181.64374286069
"healthy-5"	"2019-08-29-count-1:GCAGGCTTCTGGGCAC"	10.5670324760372	6.3645391234192	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCAGGCTTCTGGGCAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1763.69138972129	42.5192620307463	0.0241081077327623	745	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1761.56946896925	1761.56946896925
"healthy-5"	"2019-08-29-count-2:AATTTCCCAACGGGTA"	-2.68109999123271	4.01363966548768	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATTTCCCAACGGGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3340.18065207678	45.3096021178956	0.0135650154400254	4588	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3332.06832575049	3332.06832575049
"healthy-5"	"2019-08-29-count-2:AATTTCCCAATGAGCG"	-8.15213332596477	-0.686733626481615	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATTTCCCAATGAGCG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2981.6101181992	48.0987012723141	0.0161317876467914	2804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2973.61961412929	2973.61961412929
"healthy-5"	"2019-08-29-count-2:CTCCTTTAGGGACACT"	4.27318348464314	-8.30008795177611	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTTTAGGGACACT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2108.90894931013	43.5466384394116	0.0206488945165967	1078	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2104.05807552238	2104.05807552238
"healthy-5"	"2019-08-29-count-1:GAGCTGCAGTGGTGAC"	6.7942005592281	-1.5742465487686	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAGCTGCAGTGGTGAC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2169.54606349279	30.3317211248763	0.0139806762507935	1080	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2166.09707920156	2166.09707920156
"healthy-5"	"2019-08-29-count-2:AATTTCCTCCTAAACG"	-2.6588970226353	3.58039782131044	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AATTTCCTCCTAAACG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	1461.64783349772	25.0557287930598	0.0171421105815218	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	1457.28184972256	1457.28184972256
"healthy-5"	"2019-08-29-count-1:GCATCGGAGGTACTGG"	3.88905562934224	-8.38125326549681	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATCGGAGGTACTGG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1739.06982161726	41.0305399869038	0.0235933827824965	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1737.01422185961	1737.01422185961
"healthy-5"	"2019-08-29-count-1:CCAAGCGAGCAAGGAA"	3.00463857230489	-6.88433267986449	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCAAGCGAGCAAGGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1844.32069202535	46.5174128036818	0.0252219763107459	840	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1838.49379372797	1838.49379372797
"healthy-5"	"2019-08-29-count-2:TCGCACTTCTCCACTG"	-3.48216972771342	12.4157352217468	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCACTTCTCCACTG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1726.21517416064	37.345447202399	0.0216342943576301	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1719.37185668948	1719.37185668948
"healthy-5"	"2019-08-29-count-1:GTGATGTAGAACAGGA"	4.62212194976155	-7.84457447445067	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGATGTAGAACAGGA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2195.32448043888	41.0846849592171	0.0187146298077101	1105	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2188.61661630832	2188.61661630832
"healthy-5"	"2019-08-29-count-1:TGTGGCGAGTCTGGAG"	3.05252184447591	-9.05411436473998	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTGGCGAGTCTGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1834.78357022608	46.0996140818952	0.0251253689154274	803	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1828.75473181747	1828.75473181747
"healthy-5"	"2019-08-29-count-2:ACAAAGACAATGAAAC"	2.61618818816487	-7.24474861538085	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAAAGACAATGAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1768.7187789469	49.5044974740125	0.0279889025113916	737	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.50797641873	1760.50797641873
"healthy-5"	"2019-08-29-count-2:TCGCAGGGTCTTACTT"	4.06214012679402	-7.87617638027342	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCAGGGTCTTACTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2208.46643468497	47.4258086545381	0.0214745435609499	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2203.51842849728	2203.51842849728
"healthy-5"	"2019-08-29-count-2:CTCGAGGCACTCTGCT"	1.8888861137325	-6.99476148998412	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCGAGGCACTCTGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1547.54203475562	46.4678169911902	0.0300268528722247	575	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1545.10191787782	1545.10191787782
"healthy-5"	"2019-08-29-count-2:ATACTTCCACAGAGAC"	2.90565552291219	-7.49659111416014	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATACTTCCACAGAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1798.28215888319	51.901951198592	0.028861961924165	768	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1785.59490341218	1785.59490341218
"healthy-5"	"2019-08-29-count-2:ACAAAGATCCTAGAGT"	2.58236660537068	-7.53862621700438	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAAAGATCCTAGAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1454.34077982864	45.015572804549	0.0309525617578111	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1451.75460958694	1451.75460958694
"healthy-5"	"2019-08-29-count-1:ATCCTATGTGGGATTG"	3.74071135100667	-6.31697561657103	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCCTATGTGGGATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1749.01895856165	45.2469214976578	0.0258698862446109	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1740.68954712674	1740.68954712674
"healthy-5"	"2019-08-29-count-2:CTCGAGGGTAACGGTG"	5.4657117324764	-9.46233370220336	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCGAGGGTAACGGTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2447.17629442362	37.364501772153	0.0152684143996064	1371	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2444.21094330645	2444.21094330645
"healthy-5"	"2019-08-29-count-1:GCATCGGTCCCGAATA"	3.0181573825771	-7.26317408001097	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATCGGTCCCGAATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1806.0261465832	42.5908341498913	0.0235826232252885	762	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1806.0261465832	1806.0261465832
"healthy-5"	"2019-08-29-count-2:TCGCTCACAATTTCGG"	5.45533432540242	-10.1245422593323	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTCACAATTTCGG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2187.66802683542	42.6914853901828	0.0195146086455989	1108	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2179.19036080262	2179.19036080262
"healthy-5"	"2019-08-29-count-1:TGTTACTAGAGGTCGT"	2.21454181250874	-6.9946122399536	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTACTAGAGGTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1562.16713479183	48.379494168446	0.0309694738104274	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1557.62219500923	1557.62219500923
"healthy-5"	"2019-08-29-count-2:ACAACCAAGTAACCGG"	-4.32275662842448	12.4408712157044	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAACCAAGTAACCGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1839.61362794793	38.0229830964519	0.0206690049034188	777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1839.61362794793	1839.61362794793
"healthy-5"	"2019-08-29-count-2:ACAACCAAGTGCTAGG"	-3.4766984981602	-5.44344713604125	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAACCAAGTGCTAGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2673.17017174661	43.8933993336862	0.0164199794676771	1754	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2673.17017174661	2673.17017174661
"healthy-5"	"2019-08-29-count-1:GTGCACGCAGACAAGC"	6.85420145568196	-1.46652724659117	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCACGCAGACAAGC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2225.66219214198	31.8977609318977	0.0143318069761518	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2218.47275723802	2218.47275723802
"healthy-5"	"2019-08-29-count-2:ACAACCACAGAGACTG"	6.79131569442098	-1.57660415088805	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAACCACAGAGACTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2444.1013816479	31.5404402539133	0.0129047184747498	1339	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2434.86003369275	2434.86003369275
"healthy-5"	"2019-08-29-count-2:ACAACCACAGGCACTC"	4.01240791854207	-7.9771995774475	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAACCACAGGCACTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2412.34697998485	40.0479861137149	0.0166012544820424	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2407.54144948163	2407.54144948163
"healthy-5"	"2019-08-29-count-1:ATCGATGCATGCACTA"	-3.64533935013469	12.4297113188538	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGATGCATGCACTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1544.13585690281	33.9912899307268	0.0220131472103145	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1541.59084242639	1541.59084242639
"healthy-5"	"2019-08-29-count-1:ATCGATGGTAAGGTCG"	-0.819587807089645	10.0757417448792	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGATGGTAAGGTCG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1451.82541696199	43.8269518055193	0.0301874807352727	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1447.02399057206	1447.02399057206
"healthy-5"	"2019-08-29-count-2:ATAGACCTCTTCACGC"	-2.90719089928325	3.45961353862611	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATAGACCTCTTCACGC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3084.75237641634	42.986786002661	0.0139352469038699	3432	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3079.03143227633	3079.03143227633
"healthy-5"	"2019-08-29-count-2:CTCTCAGCAATCTCGA"	-4.22758374634441	-5.1368732682434	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCAGCAATCTCGA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2743.7685878134	47.0308648217009	0.0171409735611783	1856	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2736.14077280123	2736.14077280123
"healthy-5"	"2019-08-29-count-2:ACAACCATCGACACCG"	3.91146840628926	-8.1781912080017	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAACCATCGACACCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1884.06368919295	37.3411111434194	0.0198194526849645	800	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.97872011802	1881.97872011802
"healthy-5"	"2019-08-29-count-2:GTTCATTTCACGATAC"	-4.23072181168254	13.0869321593079	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTCATTTCACGATAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1853.92526297408	41.2571317377584	0.0222539346983025	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1849.53444812324	1849.53444812324
"healthy-5"	"2019-08-29-count-2:ACAAGCTTCCATAGAC"	2.37823428687398	-7.34531261837157	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAAGCTTCCATAGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.67342633983	53.9977110498185	0.0306339848567095	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1753.96476110388	1753.96476110388
"healthy-5"	"2019-08-29-count-2:TCGCTTGAGGGTTAAT"	2.34153785285298	-7.35854675686034	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGCTTGAGGGTTAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1637.03441400936	44.2618044440661	0.0270377971686384	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1632.38168650018	1632.38168650018
"healthy-5"	"2019-08-29-count-2:ACAAGCTTCCCTTGTG"	-3.86326299133952	11.3357276686463	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAAGCTTCCCTTGTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1692.76690841578	38.7725812308594	0.0229048553809135	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1692.76690841578	1692.76690841578
"healthy-5"	"2019-08-29-count-1:GCATGATGTAACCCGC"	3.20615377005879	-7.58001377498778	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATGATGTAACCCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1828.89172189618	47.6568739931848	0.0260577886720241	788	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1828.89172189618	1828.89172189618
"healthy-5"	"2019-08-29-count-2:ACAAGCTTCGGCTTGG"	-3.40853820267375	-5.632848285791	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAAGCTTCGGCTTGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1803.53234837921	42.6671660708974	0.0236575551912009	739	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1801.29120914504	1801.29120914504
"healthy-5"	"2019-08-29-count-1:CCAATTTGTGGCTGAA"	-7.64121423187907	0.372661776188291	"2019-08-29-count-1"	"Control5"	"MPP"	"MPP_GMP"	42	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCAATTTGTGGCTGAA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2814.64454539802	52.5145187281849	0.0186576023654734	1966	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2811.20707577965	2811.20707577965
"healthy-5"	"2019-08-29-count-2:CTCTCGAAGGAGATAG"	2.02950932559316	-6.86212017452391	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCGAAGGAGATAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1459.78981820777	45.2674476294992	0.0310095652571927	515	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1457.26464329402	1457.26464329402
"healthy-5"	"2019-08-29-count-1:GCATGATTCACAACCA"	-1.40115759792979	9.59937760913698	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATGATTCACAACCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1558.59077896516	44.6180159244231	0.0286271525063479	590	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1558.59077896516	1558.59077896516
"healthy-5"	"2019-08-29-count-2:CTCTCGAGTAACCCGC"	4.72005953368489	-8.63352873241576	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCGAGTAACCCGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2135.76721113169	44.3924892577734	0.0207852658409579	991	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2133.85058292333	2133.85058292333
"healthy-5"	"2019-08-29-count-2:ACACAGTGTAGAATGT"	-1.98227892342265	3.85388515079347	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACACAGTGTAGAATGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2845.28607410636	41.7149712517147	0.0146610815802824	2661	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2838.8409894728	2838.8409894728
"healthy-5"	"2019-08-29-count-2:CTCTCGAGTGATCATC"	-4.90042243424113	3.7021388777527	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCGAGTGATCATC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2444.21291843586	39.4018246795243	0.0161204551298825	1613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2433.27102812616	2433.27102812616
"healthy-5"	"2019-08-29-count-1:CCACAAAGTCCCGTGA"	-2.45587621155437	4.18628690326539	"2019-08-29-count-1"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACAAAGTCCCGTGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3074.12101120029	46.3939269677122	0.0150917699071312	3929	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3070.6004404259	3070.6004404259
"healthy-5"	"2019-08-29-count-2:CTCTCGATCTAGGCAT"	-2.90402231636699	11.0871591337952	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCGATCTAGGCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1556.60869636458	30.1355679850308	0.0193597582073205	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1549.27143624759	1549.27143624759
"healthy-5"	"2019-08-29-count-2:CTCTCGATCTCAATCT"	3.41258801993672	-8.47493364727172	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTCGATCTCAATCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1588.83325012049	47.4882018300466	0.0298887260991329	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1588.83325012049	1588.83325012049
"healthy-5"	"2019-08-29-count-1:GCATTAGCAATCCAGT"	6.81152071532552	-1.43860723888548	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCATTAGCAATCCAGT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2258.23858257625	36.1408024434206	0.0160039788188325	1116	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2254.69905163031	2254.69905163031
"healthy-5"	"2019-08-29-count-2:TCGGATACAGTATGAA"	3.23340572890584	-7.69776775753173	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGATACAGTATGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1712.36952470274	45.9667178620379	0.0268439242808981	706	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1703.87583631469	1703.87583631469
"healthy-5"	"2019-08-29-count-2:CTCTGGTAGGTCGTAG"	-4.07117591324504	-4.4042654267517	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCTGGTAGGTCGTAG"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2645.8843390642	43.8972900380356	0.0165907819136045	1873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2641.70016592412	2641.70016592412
"healthy-5"	"2019-08-29-count-1:GTGCTGGAGGGTAATT"	3.28402342376057	-7.81036665355834	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTGGAGGGTAATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1423.80964935458	45.2177067684754	0.0317582527896006	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1418.76758296642	1418.76758296642
"healthy-5"	"2019-08-29-count-2:ACACGCGAGATCCCGC"	-5.65752253952678	3.12351844394533	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACACGCGAGATCCCGC"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2521.84443934103	45.3654485027497	0.0179889955918946	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2515.64444041647	2515.64444041647
"healthy-5"	"2019-08-29-count-2:TCGGGACAGAAGTATC"	1.91226639327351	-6.97877981578978	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCGGGACAGAAGTATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1573.68047624376	44.0899435108668	0.0280170874433835	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1571.32013478136	1571.32013478136
"healthy-5"	"2019-08-29-count-1:CCACACTTCGGTTGTA"	4.77211203154866	-7.58586313640746	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACACTTCGGTTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2264.9231263976	47.4256000536097	0.0209391654404806	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2260.18376242715	2260.18376242715
"healthy-5"	"2019-08-29-count-1:ATCGGATTCGGCTGAC"	3.48164643821065	-7.24909450924071	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGGATTCGGCTGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1879.23887692012	42.1699216686704	0.0224398942500501	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1875.44885908687	1875.44885908687
"healthy-5"	"2019-08-29-count-2:ACACTGAAGAAGCTGC"	4.26109947737996	-7.10924389278563	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACACTGAAGAAGCTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.73196794415	42.9160257174861	0.0210194219374931	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2040.11636298991	2040.11636298991
"healthy-5"	"2019-08-29-count-2:ACACTGAAGGTATCTC"	1.46238066729848	-7.46562483226927	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACACTGAAGGTATCTC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1946.41318283249	43.6175332426786	0.0224091850730299	871	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1938.69943681874	1938.69943681874
"healthy-5"	"2019-08-29-count-2:ACACTGAAGTTGCCTA"	-1.91790745678599	9.89369008624879	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACACTGAAGTTGCCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1483.53642679136	36.956028149903	0.0249107655750879	562	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1483.53642679136	1483.53642679136
"healthy-5"	"2019-08-29-count-2:CCACACTAGTGGTGGT"	-3.9349938434666	-4.48017885601195	"2019-08-29-count-2"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACACTAGTGGTGGT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2729.70239683389	41.4887846287529	0.0151990138840317	1919	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2725.36451984398	2725.36451984398
"healthy-5"	"2019-08-29-count-1:CCACCATTCTGTAAGC"	8.92582287368123	6.74248836124269	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACCATTCTGTAAGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1576.65855875621	43.5018657042232	0.0275911772162902	637	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1574.48823369075	1574.48823369075
"healthy-5"	"2019-08-29-count-1:GTGCTTCAGAGGTATT"	2.68930830535237	-7.48896982586058	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTTCAGAGGTATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1920.53707348477	51.3998784741625	0.0267632836584084	891	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1918.62133653301	1918.62133653301
"healthy-5"	"2019-08-29-count-1:ATCGTAGCAACCTATG"	-7.2616904777592	-1.30837871944579	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATCGTAGCAACCTATG"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2588.96341143106	7.14646683950229	0.00276035837661841	1429	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2581.37481517534	2581.37481517534
"healthy-5"	"2019-08-29-count-2:CTGAATGTCTTCGATT"	6.80493034896199	-1.64262583171996	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAATGTCTTCGATT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2245.82370566235	35.7700351441794	0.0159273566549294	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2234.14274104255	2234.14274104255
"healthy-5"	"2019-08-29-count-1:CCACGAGCAACCAACT"	-3.90591679039653	3.75890967929689	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACGAGCAACCAACT"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2852.32131386902	41.390899819725	0.014511303343865	2779	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2843.65033998988	2843.65033998988
"healthy-5"	"2019-08-29-count-2:CTGAGCGCAGTGGGTA"	4.66560520705525	-9.94219591533812	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAGCGCAGTGGGTA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2154.55553446692	38.3647583228208	0.0178063446075494	1107	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2152.94984120498	2152.94984120498
"healthy-5"	"2019-08-29-count-1:GTGCTTCGTTGCTCGG"	4.88706507262532	-10.4025516740051	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTTCGTTGCTCGG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1865.67623076005	41.6635232472158	0.0223315935317687	866	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1861.9745758021	1861.9745758021
"healthy-5"	"2019-08-29-count-1:GTGCTTCGTTGGAGAC"	-3.30360660973247	10.2532529600891	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGCTTCGTTGGAGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1453.69008962578	40.2925138629416	0.0277174028704524	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1444.11145329038	1444.11145329038
"healthy-5"	"2019-08-29-count-2:CTGAGGCAGCCTTTCC"	-2.61514935913737	3.45892903888551	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGAGGCAGCCTTTCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3155.59263091082	45.235614916891	0.014335061653327	3272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3143.37518101327	3143.37518101327
"healthy-5"	"2019-08-29-count-2:CCACCATGTAGAGTTA"	-3.75810180130656	12.1793012388977	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCACCATGTAGAGTTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1840.59456428182	30.7115852728043	0.0166856872604031	727	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1835.8686107194	1835.8686107194
"healthy-5"	"2019-08-29-count-1:CCACGTTAGAGGGCGA"	-5.30480990830119	3.63027427280275	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACGTTAGAGGGCGA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2533.51744589989	42.9252338019987	0.0169429398923093	1907	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2526.16342348339	2526.16342348339
"healthy-5"	"2019-08-29-count-2:ACAGAAAGTGGCTAGA"	-2.95986066284831	3.43256971919862	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGAAAGTGGCTAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3049.15223550312	49.6690428903135	0.0162894598413247	3344	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3041.68048103517	3041.68048103517
"healthy-5"	"2019-08-29-count-1:CCACGTTAGTCCCGAC"	3.49348606643025	-8.05809881603392	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACGTTAGTCCCGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1625.02906642434	46.24569028122	0.028458377291046	658	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1622.82455669679	1622.82455669679
"healthy-5"	"2019-08-29-count-2:ACAGCCGCAGTCAACT"	-1.85804305496867	9.18970391834108	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGCCGCAGTCAACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1787.1172450666	36.8057796734431	0.0205950559623589	757	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1782.8835848124	1782.8835848124
"healthy-5"	"2019-08-29-count-2:ACAGCCGCATACTGTG"	2.28824414786641	-7.26662161266478	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGCCGCATACTGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1854.87636923449	47.5181882382328	0.025617981352495	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.95164371125	1852.95164371125
"healthy-5"	"2019-08-29-count-1:TGTTGGATCACTTGGA"	-1.04495618763621	8.59750459277955	"2019-08-29-count-1"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TGTTGGATCACTTGGA"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1418.24939971755	45.3766389253293	0.0319948232901536	519	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1418.24939971755	1418.24939971755
"healthy-5"	"2019-08-29-count-1:CCACTTGAGAGCAGAA"	3.92605008658711	-7.06807997142943	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACTTGAGAGCAGAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1980.04633250804	46.4615717816847	0.0234648912093051	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1978.18546935264	1978.18546935264
"healthy-5"	"2019-08-29-count-1:CCACTTGAGTTGTACC"	11.4803997474605	3.72170255267946	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACTTGAGTTGTACC"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1506.5546126219	37.9512456671415	0.02519075335815	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1498.22040592463	1498.22040592463
"healthy-5"	"2019-08-29-count-1:CCACTTGCACATTGTG"	6.7760931449825	-1.63013031398924	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACTTGCACATTGTG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2423.72493978208	32.3369786106809	0.0133418516597797	1361	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2413.36095534874	2413.36095534874
"healthy-5"	"2019-08-29-count-2:CTGATCCGTCTGTGCG"	2.59860696372334	-4.73114778911742	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGATCCGTCTGTGCG"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2206.82400827735	40.163948830555	0.0181998875668872	1227	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2206.82400827735	2206.82400827735
"healthy-5"	"2019-08-29-count-1:CCACTTGCACCATAAC"	-2.29542026940044	10.7408942946228	"2019-08-29-count-1"	"Control5"	"gd T"	"gd T"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACTTGCACCATAAC"	"gd T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"gd_T"	1718.70318138708	44.6407480095933	0.0259735063581868	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1716.5118018585	1716.5118018585
"healthy-5"	"2019-08-29-count-1:CCACTTGTCCGCGGAT"	4.96298136290852	-9.21304705059203	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCACTTGTCCGCGGAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1958.72572764928	39.5831166984116	0.0202086061053154	888	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1954.92188290737	1954.92188290737
"healthy-5"	"2019-08-29-count-2:ACAGGGACAGCCCACA"	4.10383190688435	-8.15865518963011	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGGGACAGCCCACA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.17540448185	42.7421929553863	0.0204784863138981	1027	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2085.44361989539	2085.44361989539
"healthy-5"	"2019-08-29-count-2:ACAGGGACAGCTACCG"	-2.74123201790507	12.291326499823	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGGGACAGCTACCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1619.20703275489	43.2329166976724	0.0267000549176944	652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1614.77549847347	1614.77549847347
"healthy-5"	"2019-08-29-count-1:GTGGAAGTCGGAGTAG"	3.32713784751241	-8.13333418285521	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGAAGTCGGAGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1867.2558988508	47.578508985325	0.0254804437970217	851	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1863.52991296058	1863.52991296058
"healthy-5"	"2019-08-29-count-2:CTGCAGGCAAATAAGC"	-3.20815906944926	10.5630826720032	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCAGGCAAATAAGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1516.67761278569	37.8763775863972	0.0249732555337382	569	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1501.91425586034	1501.91425586034
"healthy-5"	"2019-08-29-count-2:ACAGGGATCCTATTTG"	-3.24456439438518	10.9089994200501	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACAGGGATCCTATTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1699.33480287571	35.6102794569061	0.0209554229082135	674	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1694.71293622726	1694.71293622726
"healthy-5"	"2019-08-29-count-1:CCATAAGAGTGCCGAA"	3.58041061934773	-7.46761324321898	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATAAGAGTGCCGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2088.18610842162	46.7534513873851	0.0223895040766861	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2084.78322429324	2084.78322429324
"healthy-5"	"2019-08-29-count-2:CTGCAGGCATTAGGCT"	4.06884588774983	-8.15944006359252	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCAGGCATTAGGCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1930.30099701407	38.034114570097	0.0197037221805982	849	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1928.28640947011	1928.28640947011
"healthy-5"	"2019-08-29-count-2:AACACACGTAATGTGA"	3.11387052115743	-8.15217020427855	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AACACACGTAATGTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.70478151371	46.3270804372306	0.0250186103636669	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1851.70478151371	1851.70478151371
"healthy-5"	"2019-08-29-count-2:TTGACCCGTGACTATC"	3.4573573070461	-7.5468468896118	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGACCCGTGACTATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2126.0650708586	48.3313075220274	0.0227327508383876	1124	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2122.8540918145	2122.8540918145
"healthy-5"	"2019-08-29-count-1:ACCTACCTCTAGATCG"	11.0116526084835	4.93950412357179	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACCTACCTCTAGATCG"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1472.23630623165	40.0656536861833	0.0272141459333629	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1472.23630623165	1472.23630623165
"healthy-5"	"2019-08-29-count-2:ACATCCCAGCTAATGA"	-8.33119140091594	1.89052555644838	"2019-08-29-count-2"	"Control5"	"MEP"	"MEP"	65	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCCCAGCTAATGA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2762.2455208746	41.868006293786	0.0151572356538855	2193	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2758.47597259594	2758.47597259594
"healthy-5"	"2019-08-29-count-1:GTGGAGAGTAAGGAGA"	2.39851488646809	-7.16210558330687	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGAGAGTAAGGAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1483.83480041749	50.7262258366515	0.0341858984722417	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1483.83480041749	1483.83480041749
"healthy-5"	"2019-08-29-count-1:CCATAAGTCAGCTGTA"	3.64825119551961	-7.04994919216307	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATAAGTCAGCTGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2085.98189778041	43.3315926624616	0.0207727558463324	1042	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2080.82122250062	2080.82122250062
"healthy-5"	"2019-08-29-count-1:TTAATCCCAATGTCAC"	-1.01638994637187	9.58430764758912	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAATCCCAATGTCAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1490.54894743078	42.0491425010982	0.02821050766134	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1488.26244313255	1488.26244313255
"healthy-5"	"2019-08-29-count-2:ACATCCCCAAGAATGT"	5.36747994002644	-10.0304403535095	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCCCCAAGAATGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2385.27677061177	42.5324031700075	0.0178312234848533	1411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2380.54357498461	2380.54357498461
"healthy-5"	"2019-08-29-count-1:CCATCACAGCCTGAAG"	3.50585379180257	-8.29984953319701	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATCACAGCCTGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1729.77730711061	50.852972869388	0.0293985663127538	720	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1729.77730711061	1729.77730711061
"healthy-5"	"2019-08-29-count-1:GTGGCGTAGACTCATC"	3.90830864486043	-6.45641758358153	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGCGTAGACTCATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2035.48662154288	44.9598313240941	0.0220880013890806	982	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2031.9176036169	2031.9176036169
"healthy-5"	"2019-08-29-count-2:ACATCCCCATACACCA"	-1.5510119003361	9.25190064990846	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCCCCATACACCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1375.33766962333	48.520818617641	0.0352792042923755	511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1370.52513803908	1370.52513803908
"healthy-5"	"2019-08-29-count-2:ATCCACCTCACTGATG"	2.68943776664082	-6.80600025570067	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCCACCTCACTGATG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1897.7470020718	45.5480954297225	0.0240011420805812	834	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1895.69289841248	1895.69289841248
"healthy-5"	"2019-08-29-count-1:TTAATCCTCTCCCTAG"	-3.54031620445903	2.87549684131471	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTAATCCTCTCCCTAG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3075.32786659293	46.3715630488638	0.0150785753781231	3161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3068.01503074538	3068.01503074538
"healthy-5"	"2019-08-29-count-2:CTGCATCTCTGGAGAG"	-1.12897799435313	9.02700421893922	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCATCTCTGGAGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1434.39447091456	37.9819342038551	0.0264794203923821	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1434.39447091456	1434.39447091456
"healthy-5"	"2019-08-29-count-2:ACATCCCGTGCCCAGT"	5.24552549895589	-9.95999910747679	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCCCGTGCCCAGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2297.86414265592	42.624431735978	0.0185495873949762	1245	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2288.99350513495	2288.99350513495
"healthy-5"	"2019-08-29-count-1:CCATCACCATTACTCT"	-3.54425082626994	12.3982171782288	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATCACCATTACTCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1639.24098710312	42.9262509416435	0.026186662778304	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1636.95529488965	1636.95529488965
"healthy-5"	"2019-08-29-count-2:CCATAAGAGAAGGTAG"	3.49039282378499	-6.03558542644652	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCATAAGAGAAGGTAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2122.14541043214	42.3544713879408	0.0199583266913439	1131	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2120.58767215387	2120.58767215387
"healthy-5"	"2019-08-29-count-1:ATGACCACATACAGGG"	-1.53186235848125	8.91934201801149	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGACCACATACAGGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1905.13910836295	40.085969005344	0.0210409669453424	860	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1901.29872121504	1901.29872121504
"healthy-5"	"2019-08-29-count-2:GTTTACTAGTGCAGGT"	5.09942497786824	-9.643750213739	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTTACTAGTGCAGGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.57783133836	42.5258927392488	0.0204492912447909	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2073.13862589293	2073.13862589293
"healthy-5"	"2019-08-29-count-1:CCATCACGTTAGGGTG"	-5.44882808151897	-5.35438015377196	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCATCACGTTAGGGTG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2238.84763200959	50.3784265708976	0.022501945130441	1206	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2235.6764967951	2235.6764967951
"healthy-5"	"2019-08-29-count-2:CTGCCATCACTCTGCT"	-3.70083699646648	13.3279018172058	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCATCACTCTGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1643.18855268453	40.8697181316066	0.0248722023195916	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1636.01438890576	1636.01438890576
"healthy-5"	"2019-08-29-count-2:ACATCGACACCATATG"	-3.67482219162639	13.0164317854675	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCGACACCATATG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1821.81980402181	43.1936400785563	0.0237090627641674	758	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1820.0245609285	1820.0245609285
"healthy-5"	"2019-08-29-count-2:CTGCCATCAGTGAGCA"	2.84297670897786	-7.53919317638548	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCATCAGTGAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1789.59339794965	44.3762435532158	0.0247968301649178	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1789.59339794965	1789.59339794965
"healthy-5"	"2019-08-29-count-2:CTGCCATCATGACGAG"	3.63710822638814	-7.91834833538207	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCATCATGACGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1864.31088317232	45.5105443251055	0.024411456659881	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1858.14390657606	1858.14390657606
"healthy-5"	"2019-08-29-count-2:ACATCGAGTGTTCCTC"	3.34423961219136	-7.02976467525633	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATCGAGTGTTCCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1849.1239981215	42.8460307782878	0.0231709884365865	836	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1847.4534792042	1847.4534792042
"healthy-5"	"2019-08-29-count-1:GTGGGAAGTATGAGGC"	-3.88024602356609	10.1391029127869	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGGGAAGTATGAGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1540.95609287276	41.2491819838011	0.0267685641236549	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1540.95609287276	1540.95609287276
"healthy-5"	"2019-08-29-count-2:CTGCCTACAATCAGCT"	2.03976227816884	-6.70474674617919	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCTACAATCAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1895.89914678347	45.5269366177253	0.0240133747066478	809	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1891.67070921959	1891.67070921959
"healthy-5"	"2019-08-29-count-2:CTGCCTACACATTCTT"	5.51779903945271	-10.0131607285705	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCTACACATTCTT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2293.84172333214	39.7724353358081	0.0173387879953779	1201	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2283.5601881766	2283.5601881766
"healthy-5"	"2019-08-29-count-2:TCTAACTAGCCGGAAT"	3.77198471602742	-7.89997913753661	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTAACTAGCCGGAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.69231901289	48.6944613938414	0.0283487682018773	693	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1717.69231901289	1717.69231901289
"healthy-5"	"2019-08-29-count-2:GTTTGGAGTCCATACA"	8.6503025489742	6.47738978946535	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GTTTGGAGTCCATACA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1418.69599287513	39.5728911838439	0.0278938485641631	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1418.69599287513	1418.69599287513
"healthy-5"	"2019-08-29-count-2:CTGCCTAGTTCGTTCC"	-3.67450890961345	13.0043277510437	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGCCTAGTTCGTTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1590.03938581456	43.4335209961723	0.0273160032283867	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1590.03938581456	1590.03938581456
"healthy-5"	"2019-08-29-count-2:ACATGCATCGGAAACG"	-3.18744073334392	12.1190337904724	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACATGCATCGGAAACG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1423.62583165088	44.5985387409276	0.0313274301079588	521	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1423.62583165088	1423.62583165088
"healthy-5"	"2019-08-29-count-2:TTGCCTGCAGTCCCGA"	2.40074362334554	-7.53883984005126	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGCCTGCAGTCCCGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1478.24861640865	50.9067962174695	0.0344372358292111	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1475.85112139997	1475.85112139997
"healthy-5"	"2019-08-29-count-1:ACGATGTGTGGGACAT"	6.45963825759236	-1.62672128593596	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACGATGTGTGGGACAT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2367.57884123231	43.4652179427044	0.0183585092017806	1378	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2357.73680907674	2357.73680907674
"healthy-5"	"2019-08-29-count-1:GTGTAACTCGTGTCAA"	4.68236078795735	-9.01166059887084	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTAACTCGTGTCAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1783.43821498806	46.4147069417691	0.0260254078620155	775	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1781.40251315766	1781.40251315766
"healthy-5"	"2019-08-29-count-1:CCCAACTTCGACGACC"	6.83953728255574	-1.49518194114836	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCAACTTCGACGACC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2316.5096613413	32.9043947613574	0.0142042985231087	1208	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2309.95531379116	2309.95531379116
"healthy-5"	"2019-08-29-count-1:CCCAACTTCTAGGCAT"	1.82721521434132	-6.75894834911498	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCAACTTCTAGGCAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.59510261654	45.8461183474208	0.0217013275713072	1010	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2112.59510261654	2112.59510261654
"healthy-5"	"2019-08-29-count-1:GCCGATGCAGTTCCAA"	2.597992559045	-4.82384397899779	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GCCGATGCAGTTCCAA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2440.6311721913	41.1676853226343	0.0168676389090254	1511	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2439.372929604	2439.372929604
"healthy-5"	"2019-08-29-count-1:CCCATTGGTACTGAGG"	-3.88180075112041	3.64823386752931	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCATTGGTACTGAGG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2707.89876530359	42.326762084821	0.0156308509856998	2411	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2697.48544643116	2697.48544643116
"healthy-5"	"2019-08-29-count-1:ATGAGTCTCCGGCAGT"	2.96405734595601	-7.85379888927611	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGAGTCTCCGGCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1631.3615777162	45.9381291795743	0.0281593791389182	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1626.79806641134	1626.79806641134
"healthy-5"	"2019-08-29-count-2:ACCAAACCACGGCGTT"	3.42214574393575	-7.46698763286742	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCAAACCACGGCGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1801.57606750327	45.7167272866804	0.0253759628090738	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1795.00224309638	1795.00224309638
"healthy-5"	"2019-08-29-count-2:CCATCACTCGTCAACA"	2.62627234038655	-7.81756260311278	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCATCACTCGTCAACA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1827.06944440101	47.7516174665485	0.0261356335485122	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1822.95054403379	1822.95054403379
"healthy-5"	"2019-08-29-count-1:CCCGAAGCACCCTAAA"	10.8873888450557	5.68657443607179	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCGAAGCACCCTAAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1642.34351953699	42.0241977406889	0.0255879462735886	654	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1637.8880416419	1637.8880416419
"healthy-5"	"2019-08-29-count-2:ACCAAACGTCCCACGA"	-3.48052583161052	11.5501994856629	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCAAACGTCCCACGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1584.00538326337	38.0227974155721	0.0240042097188063	619	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1584.00538326337	1584.00538326337
"healthy-5"	"2019-08-29-count-1:CCCGAAGGTCATTCCC"	3.68243970450703	-7.59978582775267	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCGAAGGTCATTCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2028.25181668518	44.8806743577622	0.0221277624348991	954	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2022.78608022728	2022.78608022728
"healthy-5"	"2019-08-29-count-2:ACCAAACTCCAAGCTA"	4.68660845336263	-7.99870779430541	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCAAACTCCAAGCTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2163.19520984157	47.6343389191109	0.0220203607618934	1041	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2161.33900012429	2161.33900012429
"healthy-5"	"2019-08-29-count-1:GTGTGATCATCGAGCC"	-2.02853522720988	3.44495604122011	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-6"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTGTGATCATCGAGCC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2790.66351381803	46.9056468400567	0.0168080625298616	2873	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2787.54229328538	2787.54229328538
"healthy-5"	"2019-08-29-count-2:TAACGACGTAGCGCTC"	3.59053005751912	-8.03215696727904	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACGACGTAGCGCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1705.74719761066	47.0709191506941	0.0275954837953883	689	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1703.5478509787	1703.5478509787
"healthy-5"	"2019-08-29-count-2:ATCGCCTGTATGAAAC"	1.90466084060017	-7.12787344371947	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATCGCCTGTATGAAAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1726.32601918625	47.0722674619042	0.0272673104261575	690	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1724.04198522985	1724.04198522985
"healthy-5"	"2019-08-29-count-1:TTACTGTTCTCTATAC"	9.94787468489949	7.01200721347658	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTACTGTTCTCTATAC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1633.28395399824	44.9579903861412	0.0275261324132188	676	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1631.15152136407	1631.15152136407
"healthy-5"	"2019-08-29-count-2:TAACGACTCCTACGAA"	-1.65361545506175	9.589479423407	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACGACTCCTACGAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1651.86762383396	46.2641065969688	0.0280071513778994	702	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1649.77213036945	1649.77213036945
"healthy-5"	"2019-08-29-count-2:TAACGACTCGAAGCCC"	3.60665645179097	-6.05921652233275	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAACGACTCGAAGCCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1830.3318675386	47.4254059841704	0.0259108235098082	774	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1821.81295546124	1821.81295546124
"healthy-5"	"2019-08-29-count-2:ACCAACAGTATCGTGT"	5.42580236968343	-9.39501669323119	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCAACAGTATCGTGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2217.2243510026	39.7877452948841	0.0179448440916196	1161	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2214.05022203489	2214.05022203489
"healthy-5"	"2019-08-29-count-1:CCCTAACAGCGAACTG"	5.32322563704793	-9.75226595317992	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTAACAGCGAACTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2468.67421345384	35.4225421994823	0.0143488120086626	1434	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2457.55565912966	2457.55565912966
"healthy-5"	"2019-08-29-count-2:CTGGCAGAGTATTAGG"	3.19214310225789	-7.90240385448607	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGGCAGAGTATTAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1556.4265256069	43.899322023487	0.0282052003748582	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1551.52138004597	1551.52138004597
"healthy-5"	"2019-08-29-count-2:CTGGCAGCAATCGCCG"	3.09613861617391	-7.07581999218138	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGGCAGCAATCGCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1873.41726750693	47.4937010077088	0.0253513735735508	877	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1869.65783576864	1869.65783576864
"healthy-5"	"2019-08-29-count-1:CCCTAACCACGGCACT"	4.3111683326656	-7.56717779552611	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTAACCACGGCACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2038.93691754367	38.1775270296154	0.0187242315841769	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2037.07752615922	2037.07752615922
"healthy-5"	"2019-08-29-count-2:CTGGCAGCAGATTCGT"	-3.76727447930034	12.5536165007385	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGGCAGCAGATTCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1508.17749556053	45.8032152126819	0.0303699102708456	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1505.68063738389	1505.68063738389
"healthy-5"	"2019-08-29-count-1:CCCTAACTCAATGTCG"	-3.20550761643108	13.0311813124451	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTAACTCAATGTCG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1408.45548273066	42.1059601245483	0.029895130262062	504	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1408.45548273066	1408.45548273066
"healthy-5"	"2019-08-29-count-2:CTGGCAGGTATCGGTT"	4.00078334388081	-8.28641512310179	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGGCAGGTATCGGTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1882.07289910695	43.3194627713411	0.0230168888739093	787	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1882.07289910695	1882.07289910695
"healthy-5"	"2019-08-29-count-2:CCCATTGGTTCGTTCC"	3.40382709082906	-6.70607092296752	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCCATTGGTTCGTTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1826.83098215857	41.0255060506529	0.0224571985319504	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1822.71639971249	1822.71639971249
"healthy-5"	"2019-08-29-count-1:CCCTAACTCGATACTG"	3.71635403212849	-7.4208064309326	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTAACTCGATACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1977.31167735906	40.0162590867779	0.0202377093833909	857	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1969.17804726834	1969.17804726834
"healthy-5"	"2019-08-29-count-1:ATGCCTCCAGCACAGA"	3.46598424491231	-7.59766819393309	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCCAGCACAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1883.21622301467	38.927693427643	0.0206708570964449	814	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1881.16854830556	1881.16854830556
"healthy-5"	"2019-08-29-count-2:ACCACAAAGTAGATCA"	-1.20606849613841	9.88570401752321	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAAAGTAGATCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1388.74092865502	39.3054084942183	0.0283029092634903	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1383.797714876	1383.797714876
"healthy-5"	"2019-08-29-count-1:CCCTCAACAACGTATC"	0.320765008299988	8.0077070959839	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCAACAACGTATC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1837.27854946264	37.2348285916255	0.0202662947338691	865	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1835.43484489367	1835.43484489367
"healthy-5"	"2019-08-29-count-2:TCTATACTCCTACGAA"	3.61025037345235	-7.93861343776854	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATACTCCTACGAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1907.8067356859	45.1042239863995	0.0236419251188898	845	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1901.76061119574	1901.76061119574
"healthy-5"	"2019-08-29-count-2:ACCACAAGTACAGTCT"	-5.29372725907024	-4.62343790447386	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAAGTACAGTCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2771.64347027159	41.1406495324179	0.0148434132938413	1816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2769.28556828623	2769.28556828623
"healthy-5"	"2019-08-29-count-2:ACCACAAGTCCCGGTA"	2.2393442588741	-6.87626697933348	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAAGTCCCGGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1845.51586848737	49.8781279151015	0.027026658923276	810	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1841.46617771032	1841.46617771032
"healthy-5"	"2019-08-29-count-2:ACCACAAGTCGGAAAC"	-4.37075028839763	-4.69075491344603	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAAGTCGGAAAC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2492.8513987959	45.720791120999	0.0183407607621871	1543	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2489.0646010537	2489.0646010537
"healthy-5"	"2019-08-29-count-2:TCTATCAAGGTGCGAT"	3.50276460227315	-7.24285604869994	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATCAAGGTGCGAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2039.83927155209	43.8802021772591	0.0215115978936277	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2038.0876784471	2038.0876784471
"healthy-5"	"2019-08-29-count-1:TCCTCTTGTCGCACAC"	-3.55097303810771	3.71155569637147	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCCTCTTGTCGCACAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3050.37814409125	42.8629195946424	0.0140516741105264	3290	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3040.71705803243	3040.71705803243
"healthy-5"	"2019-08-29-count-1:ATGCCTCTCGTTCGCT"	-2.91489921036418	10.2053966292175	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATGCCTCTCGTTCGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1629.01398684442	40.0174444351001	0.0245654394365381	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1621.71322208288	1621.71322208288
"healthy-5"	"2019-08-29-count-2:ACCACAATCGGTTCAA"	3.81274356421773	-8.36469652568968	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAATCGGTTCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1856.15024782678	41.1855919352298	0.022188716664209	822	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.1721626391	1852.1721626391
"healthy-5"	"2019-08-29-count-2:TCTATCAGTGGACTAG"	3.00745524939839	-8.30178263103636	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTATCAGTGGACTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1556.95933864652	36.2137683560126	0.023259289730388	572	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1556.95933864652	1556.95933864652
"healthy-5"	"2019-08-29-count-2:ACCACAATCTTCTCAA"	-2.15257583084758	9.82572362506715	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCACAATCTTCTCAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1658.16943823833	44.8974612315109	0.0270765219742626	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1652.07956589638	1652.07956589638
"healthy-5"	"2019-08-29-count-2:ACCATTTAGCGATGCA"	-2.59240160408672	10.2411203154358	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCATTTAGCGATGCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1552.02115693466	42.7272652159917	0.0275300791004555	592	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1537.52685140621	1537.52685140621
"healthy-5"	"2019-08-29-count-1:CCCTCTCAGCCATCCG"	-0.863091747195083	9.64378068530885	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCTCAGCCATCCG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1560.58502154889	39.4352863309319	0.0252695532677818	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1553.74780575846	1553.74780575846
"healthy-5"	"2019-08-29-count-2:CTGTACCGTGAATTAG"	1.96522523936574	-7.46551849758299	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTACCGTGAATTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1508.87535223883	43.2244549958064	0.0286468030189976	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1503.90826768082	1503.90826768082
"healthy-5"	"2019-08-29-count-2:CTGTACCGTGCAATGG"	2.01864983615224	-7.05412819301756	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTACCGTGCAATGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1732.75076471186	51.8897237629582	0.0299464440124411	705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1730.53844898473	1730.53844898473
"healthy-5"	"2019-08-29-count-2:TAAGCCAGTAGGATAT"	-7.65027556839641	0.192275814059652	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCCAGTAGGATAT"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2791.97938413101	38.1570159910958	0.0136666539187115	2372	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2778.79698275362	2778.79698275362
"healthy-5"	"2019-08-29-count-2:CTGTACCGTGTTAACC"	-3.87530932846721	12.6638393172058	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTACCGTGTTAACC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.95064016041	36.1141677912636	0.0224457897525452	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1604.08222226462	1604.08222226462
"healthy-5"	"2019-08-29-count-2:ACCCAAACAAATGCGG"	1.69940366324727	-6.11976244365843	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCCAAACAAATGCGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1991.68996508086	48.7614849086272	0.0244824675343723	942	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1989.86219920462	1989.86219920462
"healthy-5"	"2019-08-29-count-2:TCTCAGCAGAGTGGCT"	-3.27876267853435	12.3031739958557	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCAGCAGAGTGGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1411.25825481257	42.9820055354106	0.0304565131072477	506	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1408.67137934193	1408.67137934193
"healthy-5"	"2019-08-29-count-1:TTATTGCAGGATGCGT"	14.0625282722408	2.22936413371889	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTATTGCAGGATGCGT"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1128.35406400245	41.6162432921698	0.036882255862624	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1123.59631347574	1123.59631347574
"healthy-5"	"2019-08-29-count-1:CCCTCTCTCAAGCTGT"	-1.93882105770763	10.596918083075	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTCTCTCAAGCTGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1543.67710982652	43.2371320618084	0.0280091813155586	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1532.63200464773	1532.63200464773
"healthy-5"	"2019-08-29-count-2:CTGTAGAGTAGTTAGA"	2.82367243346516	-7.9950800172058	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTAGAGTAGTTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1715.54883220556	45.9486417985353	0.0267836396935799	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1713.59601651989	1713.59601651989
"healthy-5"	"2019-08-29-count-2:CTGTAGAGTGATAGTA"	-2.49375997009929	3.39460632884828	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTAGAGTGATAGTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2877.06642030243	47.6332419936432	0.0165561843332891	2905	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2872.29585530789	2872.29585530789
"healthy-5"	"2019-08-29-count-1:GTTACGAAGCTCGTGC"	3.74566735801045	-8.16609957134398	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTACGAAGCTCGTGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1535.06181629891	43.0503329999444	0.0280446901504856	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1535.06181629891	1535.06181629891
"healthy-5"	"2019-08-29-count-1:CCCTGATCAGAGAGGG"	-3.87174830856975	-5.12933065807494	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CCCTGATCAGAGAGGG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1933.02776055317	43.8543296312002	0.0226868597162053	1038	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1930.06811876972	1930.06811876972
"healthy-5"	"2019-08-29-count-2:TAAGCGTCATTCACCC"	-0.149080465466338	10.6528243788513	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGCGTCATTCACCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1466.58749015354	37.3979584441767	0.0254999846209389	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1463.99138389628	1463.99138389628
"healthy-5"	"2019-08-29-count-2:CTGTATTCAACTCGTA"	14.1707378822262	2.08766219699708	"2019-08-29-count-2"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTCAACTCGTA"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1231.01204591091	41.7439826050818	0.0339102957958407	753	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1214.33133765266	1214.33133765266
"healthy-5"	"2019-08-29-count-2:CTGTATTCACCATTCC"	-3.02005038681682	12.0819482573303	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTCACCATTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1640.55875047855	42.4937159149555	0.0259019775442727	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1640.55875047855	1640.55875047855
"healthy-5"	"2019-08-29-count-2:ACCCTCAAGCTGTTCA"	3.24765076217	-8.59509470379027	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACCCTCAAGCTGTTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1457.73039847939	49.0288459557107	0.0336336856299727	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1457.73039847939	1457.73039847939
"healthy-5"	"2019-08-29-count-2:TAAGTCGAGCTGGCTC"	3.96582355078999	-8.07356169140013	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAAGTCGAGCTGGCTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1820.04405659945	41.3972491753965	0.0227451907140878	773	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1820.04405659945	1820.04405659945
"healthy-5"	"2019-08-29-count-2:TCTCCGAGTTACCTTT"	0.499117513268632	8.18830201709596	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TCTCCGAGTTACCTTT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1537.7794504179	40.6913522122429	0.0264611106626407	623	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1524.74317690126	1524.74317690126
"healthy-5"	"2019-08-29-count-2:CTGTATTTCCATCCGT"	10.5099712806637	6.27679584110109	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTTCCATCCGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1432.50461263349	42.0783808883397	0.0293739932962474	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1427.76476973861	1427.76476973861
"healthy-5"	"2019-08-29-count-2:CTGTATTTCCATCTAT"	4.10017170485799	-7.63690235531005	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTGTATTTCCATCTAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2049.29056466783	41.6849219842902	0.0203411476649466	962	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2043.74620617635	2043.74620617635
"healthy-5"	"2019-08-29-count-1:TTCAATCTCTCTGGTC"	-2.90752540054973	3.38319633090822	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCAATCTCTCTGGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3380.69288468863	46.3661790560583	0.0137149929430306	3780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3372.10612438857	3372.10612438857
"healthy-5"	"2019-08-29-count-2:TATTGCTTCGCTTACC"	9.19844116744344	6.27745816791383	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTGCTTCGCTTACC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1542.77050212148	38.2887554148387	0.0248181796075226	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1538.33153604185	1538.33153604185
"healthy-5"	"2019-08-29-count-1:TACTGCCTCGAACCAT"	3.2831105190212	-7.93549015438231	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTGCCTCGAACCAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1830.96738386981	51.2631741310926	0.0279978630874058	804	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1822.7623278723	1822.7623278723
"healthy-5"	"2019-08-29-count-2:TGCTTGCTCGGCGATC"	4.08857550200765	-8.2962742081848	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTTGCTCGGCGATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1672.3891740345	46.5904222305872	0.0278586007096611	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1672.3891740345	1672.3891740345
"healthy-5"	"2019-08-29-count-2:TGGAACTCAACTGTGT"	2.72716702994649	-7.48847439205321	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTCAACTGTGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1715.6296324495	50.5011219217007	0.0294359114382965	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1707.46554486693	1707.46554486693
"healthy-5"	"2019-08-29-count-2:AGACCATCAGGTGTGA"	2.032074590295	-4.07604315197142	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	45	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCATCAGGTGTGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	1571.86678009468	33.3927471664235	0.0212440059102286	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1566.85547026291	1566.85547026291
"healthy-5"	"2019-08-29-count-1:TACTTACCAACCACGC"	-0.834764103323776	10.6035671004089	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTTACCAACCACGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1657.12806791705	44.0532196240555	0.026584076678774	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1657.12806791705	1657.12806791705
"healthy-5"	"2019-08-29-count-2:TGGAACTCATTACGGT"	5.31327595290486	-9.63338949596556	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTCATTACGGT"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2092.26890626096	45.9170644763591	0.0219460626399195	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2090.50288201377	2090.50288201377
"healthy-5"	"2019-08-29-count-2:AGACCATGTTCGGCGT"	-3.04200087013896	11.5488433607849	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCATGTTCGGCGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1525.90155039118	40.0933652251732	0.0262751979083413	583	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1523.50764767667	1523.50764767667
"healthy-5"	"2019-08-29-count-2:AGACCATTCCGTGGGT"	0.403290738433045	8.31767842853395	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCATTCCGTGGGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1571.03062019328	38.3241304423337	0.0243942606526782	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1564.85497325214	1564.85497325214
"healthy-5"	"2019-08-29-count-2:TGGAACTTCACTTCTA"	-3.8799012703007	12.9391679533753	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTTCACTTCTA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1554.12690697235	37.8432602572261	0.0243501737776035	591	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1549.2793521894	1549.2793521894
"healthy-5"	"2019-08-29-count-2:AGACCATTCTCTATAC"	-3.43376241150554	12.6355371245178	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCATTCTCTATAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1635.23239653361	38.7932114507297	0.0237233628277939	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1630.64086069144	1630.64086069144
"healthy-5"	"2019-08-29-count-1:CGCAGGTAGTTGTCAC"	1.98361255702321	-7.39916708385619	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCAGGTAGTTGTCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1473.85568105191	48.2910088786675	0.0327650865003292	535	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1471.35862658394	1471.35862658394
"healthy-5"	"2019-08-29-count-1:AACAAAGAGGATAATC"	3.40026535567586	-7.33730366146239	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAAAGAGGATAATC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2113.31581613903	40.1252099787365	0.0189868497989308	1025	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2111.52740293962	2111.52740293962
"healthy-5"	"2019-08-29-count-1:GTTATGGTCATGCCGG"	9.1739317375118	6.91895721042482	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTATGGTCATGCCGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1430.56585344554	41.6332624255572	0.0291026535585782	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1428.24604153606	1428.24604153606
"healthy-5"	"2019-08-29-count-2:TTGTTCATCTATCGCC"	3.69909705695454	-8.60626127636107	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTCATCTATCGCC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1794.58892239421	35.675493082751	0.0198794791595812	741	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1792.51852367998	1792.51852367998
"healthy-5"	"2019-08-29-count-1:ACTACGATCATTCTTG"	9.18231072005574	6.26291177356569	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTACGATCATTCTTG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.17786066414	38.894698836708	0.0267652707143034	545	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1453.17786066414	1453.17786066414
"healthy-5"	"2019-08-29-count-2:GGAGCAATCGTTCGCT"	-2.4350520175999	9.58086297595827	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGCAATCGTTCGCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1707.63122254222	25.7785664818134	0.0150960969450042	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1705.37406833801	1705.37406833801
"healthy-5"	"2019-08-29-count-1:TCGAAGTTCCACGTGG"	-2.55885515633281	10.4244727858338	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGAAGTTCCACGTGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1548.78326602951	40.0451784129419	0.0258558955867353	612	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1544.29172865047	1544.29172865047
"healthy-5"	"2019-08-29-count-2:TTGTTGTGTCGCATTA"	-3.61939487877544	3.67432210529176	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTGTGTCGCATTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2958.23726845236	46.4420928103653	0.0156992453937483	2819	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2950.42512111915	2950.42512111915
"healthy-5"	"2019-08-29-count-2:TTGTTGTGTGGACCAA"	3.38310279425923	-8.11277677929076	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTGTGTGGACCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1426.66493304016	46.6704720274565	0.0327129874342701	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1421.85379886448	1421.85379886448
"healthy-5"	"2019-08-29-count-2:ATGAAAGTCTCAGGCG"	-1.12360701981242	9.03769776904909	"2019-08-29-count-2"	"Control5"	"MAIT"	"MAIT"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGAAAGTCTCAGGCG"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1363.0236494142	42.5732191114065	0.0312343950376089	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1363.0236494142	1363.0236494142
"healthy-5"	"2019-08-29-count-1:ACTATCTCAGCTCCTT"	3.24849762496297	-7.27850868618163	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATCTCAGCTCCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1946.44373402814	44.3233244303925	0.0227714388325348	889	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1942.50678756655	1942.50678756655
"healthy-5"	"2019-08-29-count-2:ATGAAAGTCTTAAGGC"	-0.641685048968154	9.33108327472535	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGAAAGTCTTAAGGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1479.94636939941	45.7391121460417	0.0309059254387735	555	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1477.54038826352	1477.54038826352
"healthy-5"	"2019-08-29-count-2:TTGTTGTGTTTGTGGT"	2.75383271750752	-5.01924898540648	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTGTGTTTGTGGT"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2161.03313526181	43.8215606473344	0.0202780604944428	1084	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2161.03313526181	2161.03313526181
"healthy-5"	"2019-08-29-count-2:TAATTCCTCGTAACTG"	3.28049697455708	-8.36302187359007	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAATTCCTCGTAACTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1738.83574815716	35.4771789760384	0.0204028350657258	710	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1730.01208187752	1730.01208187752
"healthy-5"	"2019-08-29-count-2:ATGACCACAACAAGTA"	3.27760281142537	-7.92310621654662	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGACCACAACAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1828.48122567252	47.7507325708652	0.0261149701186035	759	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1826.29699894115	1826.29699894115
"healthy-5"	"2019-08-29-count-2:GGAGGTAAGGCATCTT"	2.88514675673787	-7.65870478069457	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGGTAAGGCATCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1484.75372198029	43.9944979652436	0.0296308386461331	539	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1482.2482303614	1482.2482303614
"healthy-5"	"2019-08-29-count-1:ACTATGGGTCACAGTT"	-5.03824792328532	-5.0908241502014	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATGGGTCACAGTT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2893.19787856541	48.7141039535566	0.0168374601386447	2312	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2885.61626877743	2885.61626877743
"healthy-5"	"2019-08-29-count-2:GGAGGTACAGCCGTCA"	4.63788761672322	-8.1171503297058	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGAGGTACAGCCGTCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2336.72014083085	38.8784814524248	0.0166380563821396	1250	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2325.72992081202	2325.72992081202
"healthy-5"	"2019-08-29-count-1:TCGACGGAGACTCGAG"	3.62604536589925	-7.83139231121215	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGACGGAGACTCGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1644.98239476096	45.3253810365462	0.0275537180099321	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1638.27876374719	1638.27876374719
"healthy-5"	"2019-08-29-count-1:CTGTACCAGTTAGTGA"	-4.09147916260417	13.1184243925842	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTACCAGTTAGTGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1657.44908445582	42.3106563474906	0.0255275753230044	664	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1652.85429986004	1652.85429986004
"healthy-5"	"2019-08-29-count-1:ACTATGGTCACGATAC"	-3.72112713280376	12.5142545470032	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATGGTCACGATAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1612.73605147257	37.0139151266788	0.022951006206429	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1605.47461776408	1605.47461776408
"healthy-5"	"2019-08-29-count-2:ATGACCAGTCGCTTAA"	3.43525018271748	-7.75812771236571	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGACCAGTCGCTTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1698.08177678653	52.0835725425852	0.0306720048790282	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1691.3941247228	1691.3941247228
"healthy-5"	"2019-08-29-count-2:TTGTTTGTCTCCATAT"	-5.31071219864543	-5.15200378811034	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTGTTTGTCTCCATAT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2224.91350853621	50.2446471589028	0.0225827417408055	1129	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2217.90127166045	2217.90127166045
"healthy-5"	"2019-08-29-count-1:ACTATTCAGGCTGTAG"	2.85793103751485	-7.63372709667357	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATTCAGGCTGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1525.31770474467	46.5061741842499	0.0304895000166768	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1517.76345921815	1517.76345921815
"healthy-5"	"2019-08-29-count-1:ACTATTCCACGGCGTT"	11.1071831184322	5.35161588275758	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATTCCACGGCGTT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1497.7550342196	45.7382033384155	0.0305378398292262	577	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1493.18827593034	1493.18827593034
"healthy-5"	"2019-08-29-count-1:GTTCTATGTAATACCC"	-4.05927691879924	12.337490058783	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTCTATGTAATACCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1656.00083895454	38.7103649087593	0.0233758123777267	662	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1649.21107908376	1649.21107908376
"healthy-5"	"2019-08-29-count-2:TACACCCAGCCTTGAT"	4.30946411666219	-8.06370642101439	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACACCCAGCCTTGAT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2166.86052322257	38.3705551320799	0.0177079026180305	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2166.86052322257	2166.86052322257
"healthy-5"	"2019-08-29-count-1:ACTATTCGTTTACCAG"	3.53466167029683	-8.07844736492308	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTATTCGTTTACCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1757.06658720201	41.1995381709615	0.0234479094139332	712	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1752.56528388919	1752.56528388919
"healthy-5"	"2019-08-29-count-2:ATGAGTCGTCGTAATC"	-5.3266490501469	-4.3339472047058	"2019-08-29-count-2"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGAGTCGTCGTAATC"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2815.12997329341	43.6134624821543	0.0154925218003811	1975	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2809.86026651783	2809.86026651783
"healthy-5"	"2019-08-29-count-2:GGATCTATCCTCTAGC"	3.05295981940572	-9.36123564159545	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGATCTATCCTCTAGC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1755.99116059737	41.9722689808247	0.0239023236122362	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1753.89539225786	1753.89539225786
"healthy-5"	"2019-08-29-count-2:ATGAGTCGTGCCAAGA"	2.93413629111592	-5.05262472545775	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGAGTCGTGCCAAGA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2175.0916076032	40.6226861623578	0.0186763104691122	1182	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2175.0916076032	2175.0916076032
"healthy-5"	"2019-08-29-count-2:TTTACCATCGTGTGGC"	3.4761241870815	-8.14979650890502	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTACCATCGTGTGGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1610.37261837592	48.9546321685003	0.0303995681557673	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1607.95805285647	1607.95805285647
"healthy-5"	"2019-08-29-count-1:ATTACCTCAGATGCGA"	9.9352203803951	6.27076385104982	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTACCTCAGATGCGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1628.4611069521	44.7815713075333	0.027499318906884	684	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1628.4611069521	1628.4611069521
"healthy-5"	"2019-08-29-count-2:ATGATCGAGCTATCCA"	10.8316160636837	4.38056180560914	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGATCGAGCTATCCA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1491.72513216754	31.8442138019265	0.0213472395920926	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1489.20716123519	1489.20716123519
"healthy-5"	"2019-08-29-count-1:TTCCACGAGGAGTATT"	3.66842641410176	-8.09458353435668	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCACGAGGAGTATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1882.37715566997	42.9045025500492	0.0227927237752621	839	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1878.43790281836	1878.43790281836
"healthy-5"	"2019-08-29-count-2:ATGATCGCAGGTCAGA"	-3.31296692314799	11.3141774901184	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGATCGCAGGTCAGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1461.66335164972	41.1230465278076	0.0281344171907941	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1456.57901609113	1456.57901609113
"healthy-5"	"2019-08-29-count-2:GGATGTTAGTGTAGTA"	4.12813105162923	-7.7491984597412	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGATGTTAGTGTAGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1861.83550222633	45.9544566910339	0.0246823398931231	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1857.97299356454	1857.97299356454
"healthy-5"	"2019-08-29-count-1:TCGCACTCAACCAGAG"	-1.05904100361522	9.96645066821901	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGCACTCAACCAGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1465.80864343152	44.7483358152569	0.0305280883802808	541	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1463.33790090225	1463.33790090225
"healthy-5"	"2019-08-29-count-1:ACTCCCACATGAGATA"	6.8226338821346	-1.5675178996292	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTCCCACATGAGATA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2274.73668838181	38.4404827096169	0.0168988713752898	1136	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2264.53066667214	2264.53066667214
"healthy-5"	"2019-08-29-count-1:CTGTATTGTGCGGCTT"	-3.97574696961101	12.7894000777039	"2019-08-29-count-1"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTATTGTGCGGCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1850.12191627385	49.4028725204118	0.0267024957035854	841	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1846.25170150091	1846.25170150091
"healthy-5"	"2019-08-29-count-2:TTTAGTCCAATTGCTG"	3.16075195845906	-8.57107355510863	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTAGTCCAATTGCTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1446.382630083	42.430514334654	0.0293356083322288	513	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1446.382630083	1446.382630083
"healthy-5"	"2019-08-29-count-2:ATGCATGAGCGAATGC"	14.3007961708004	2.15688750827638	"2019-08-29-count-2"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCATGAGCGAATGC"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1308.93312759851	26.6033026791997	0.0203244169761434	1215	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1295.81816432663	1295.81816432663
"healthy-5"	"2019-08-29-count-2:TTTAGTCTCTTGATTC"	-3.29065857353862	9.75931546771852	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTAGTCTCTTGATTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1715.47319996636	37.707632255753	0.0219808926519472	679	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1715.47319996636	1715.47319996636
"healthy-5"	"2019-08-29-count-1:ACTCTCGCAATAACGA"	10.9181105094845	4.70734260166017	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTCTCGCAATAACGA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1594.72824203585	37.7511786500804	0.0236724839097893	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1592.35293971195	1592.35293971195
"healthy-5"	"2019-08-29-count-2:GGCACGTCATAGGAGC"	-5.02436767044719	-5.09248831188353	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCACGTCATAGGAGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	1861.27772524206	51.3499065414691	0.0275885247242139	799	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	1861.27772524206	1861.27772524206
"healthy-5"	"2019-08-29-count-2:TACCCACCAATTGCGT"	3.85944284972493	-7.55200292980345	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACCCACCAATTGCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2258.63279250286	44.0958259032777	0.0195232381508168	1207	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2255.53575952692	2255.53575952692
"healthy-5"	"2019-08-29-count-2:ATGCATGGTGGAACCA"	4.19997896727864	-8.37947752391966	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCATGGTGGAACCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1797.64267836084	43.9753375072904	0.0244627800822959	761	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1793.41876878434	1793.41876878434
"healthy-5"	"2019-08-29-count-1:CTGTGAACAAGTGGAC"	-3.59300384941753	12.5672635802063	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGAACAAGTGGAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1400.59351906753	37.6968595246662	0.0269149178626525	502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1393.05767205908	1393.05767205908
"healthy-5"	"2019-08-29-count-1:CTGTGAACATACCACA"	5.84837879714314	-1.80570890819701	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGAACATACCACA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2410.29983480579	42.0671613583319	0.0174530822891258	1502	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2402.82647525166	2402.82647525166
"healthy-5"	"2019-08-29-count-1:ACTCTCGTCGCTACAA"	-2.91995821419414	11.9751567610535	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ NK-like"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTCTCGTCGCTACAA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1595.10189274005	44.6422075379584	0.0279870569655412	632	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1592.85315372849	1592.85315372849
"healthy-5"	"2019-08-29-count-1:ACTGATGAGACTTCAC"	6.80575384673421	-1.48553886329802	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTGATGAGACTTCAC"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2353.21856034493	30.8356833391129	0.01310362065757	1233	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2345.05214341497	2345.05214341497
"healthy-5"	"2019-08-29-count-2:ATGCCTCAGTGTACAA"	3.88578929480855	-7.95608236705931	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCCTCAGTGTACAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1925.71879121707	38.1077155528267	0.0197888267625733	879	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1916.21855272614	1916.21855272614
"healthy-5"	"2019-08-29-count-2:ATGCCTCAGTTGCCCG"	2.12926449355428	-6.9394831887451	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCCTCAGTTGCCCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1674.49639543107	52.6621376205372	0.0314495377620567	697	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1668.06286404792	1668.06286404792
"healthy-5"	"2019-08-29-count-1:ACTGATGCATTCTCTA"	14.2723337608272	1.97451362693635	"2019-08-29-count-1"	"Control5"	"Plasma cell"	"Plasma cell"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTGATGCATTCTCTA"	"Plasma cell"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1385.80975291858	29.9904821486909	0.021641125042979	1065	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1364.88367459053	1364.88367459053
"healthy-5"	"2019-08-29-count-1:CTGTGGGAGGACATCG"	3.19320787963216	-8.01926329052123	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGGGAGGACATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1678.78395846438	45.7993111316324	0.0272812418183492	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1676.62072490353	1676.62072490353
"healthy-5"	"2019-08-29-count-2:TTTCACATCCATTTCA"	1.98960723456685	-6.67014696514281	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCACATCCATTTCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1922.22494860521	55.0884534025769	0.0286586923359567	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1920.1876415775	1920.1876415775
"healthy-5"	"2019-08-29-count-2:TTTCACATCCCGTAAA"	-2.86643610420879	3.64742920482484	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCACATCCCGTAAA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3282.37721248363	48.0091751488964	0.0146263430559738	3317	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3276.20279790396	3276.20279790396
"healthy-5"	"2019-08-29-count-1:ACTGCAAAGGAACTCG"	4.53690924224202	-7.79838898098143	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTGCAAAGGAACTCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2294.16155795505	41.096688625585	0.0179135983179046	1326	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2291.36285193325	2291.36285193325
"healthy-5"	"2019-08-29-count-2:ATGCCTCGTGGTCTGC"	4.65045418319051	-8.20363905346068	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCCTCGTGGTCTGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2081.47965078319	41.7692597877231	0.0200670997537769	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2079.75184305474	2079.75184305474
"healthy-5"	"2019-08-29-count-1:TTCCTAAAGCCGCTTG"	3.89355578002278	-8.04229738628539	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCTAAAGCCGCTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.6729428481	43.9272639739965	0.0232705904592346	812	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.6729428481	1887.6729428481
"healthy-5"	"2019-08-29-count-2:CCGGTAGGTACTAGCT"	4.64079870757405	-7.90591719066771	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGGTAGGTACTAGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.7569612469	45.5062303291544	0.0195577927076526	1282	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2322.13011556576	2322.13011556576
"healthy-5"	"2019-08-29-count-2:ATGCCTCTCTCGGCTT"	-3.76804910126384	12.3532409437927	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCCTCTCTCGGCTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1749.47662914392	40.3116394463723	0.0230421137240903	698	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1744.8729858097	1744.8729858097
"healthy-5"	"2019-08-29-count-1:ACTGCAAGTCAAAGTA"	3.37117662009541	-7.96645834362181	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTGCAAGTCAAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2114.32708758487	43.8552965679725	0.02074196411023	1012	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2107.07758438581	2107.07758438581
"healthy-5"	"2019-08-29-count-2:ATGCGATAGGCCCGTT"	-1.10244880142863	9.31422231281129	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCGATAGGCCCGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1553.21586595106	48.6917563241289	0.0313489949410954	602	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1548.48832415102	1548.48832415102
"healthy-5"	"2019-08-29-count-1:CTGTGGGGTGAGTAAT"	3.6270030933315	-8.3582916489807	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTGTGGGGTGAGTAAT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1783.6454729499	48.8693559482225	0.027398581550738	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1783.6454729499	1783.6454729499
"healthy-5"	"2019-08-29-count-1:TTCCTAAGTGCGACAA"	3.98784842070882	-7.51236393367919	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCCTAAGTGCGACAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1680.24464079674	48.2717603802754	0.0287290071982528	719	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1678.21274856259	1678.21274856259
"healthy-5"	"2019-08-29-count-1:ACTGTCCAGATACCAA"	-3.80383406105693	3.73493502223817	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	39	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTGTCCAGATACCAA"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2916.03806508305	46.5021080890197	0.0159470168259602	2777	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2907.25703678045	2907.25703678045
"healthy-5"	"2019-08-29-count-2:GGCTGTGAGCAGAAAG"	-3.6503246826237	11.9175920256409	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTGTGAGCAGAAAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1504.09033260276	39.5772726217666	0.026313095539468	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1499.14059541787	1499.14059541787
"healthy-5"	"2019-08-29-count-2:TTTCATGCACAACGAG"	9.0061375099117	6.11391875827638	"2019-08-29-count-2"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCATGCACAACGAG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1413.91352006401	37.8748924414435	0.0267872765229155	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1411.47030983989	1411.47030983989
"healthy-5"	"2019-08-29-count-1:TCGGATAAGGTTCCGC"	-1.39285073700603	10.2279920347962	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGATAAGGTTCCGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1533.53821536962	36.0328711523439	0.0234965589974939	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1533.53821536962	1533.53821536962
"healthy-5"	"2019-08-29-count-2:ATGCGATTCTTACGTT"	3.79233803328816	-7.68656732952269	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGCGATTCTTACGTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2133.0325690448	43.7991660114506	0.0205337539834493	1053	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2129.49828312621	2129.49828312621
"healthy-5"	"2019-08-29-count-1:TCGGATAAGTCGCCAC"	1.31712605532948	-6.7920336953369	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	56	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGATAAGTCGCCAC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2041.86990782866	48.4427095781398	0.0237246797126533	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2036.136887267	2036.136887267
"healthy-5"	"2019-08-29-count-2:CCGGTGACATATGAAG"	6.80926670607869	-1.65091302311095	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCGGTGACATATGAAG"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2188.59246253751	34.5367637950462	0.0157803539883361	1073	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2177.97135711326	2177.97135711326
"healthy-5"	"2019-08-29-count-2:ATGGAGGGTCCAACGC"	4.32398905333821	-6.904248260614	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGGAGGGTCCAACGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2147.48460453906	44.891693607947	0.0209043145236344	1054	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2136.83318690834	2136.83318690834
"healthy-5"	"2019-08-29-count-2:ATGGAGGTCTCGACCT"	-2.87633524361308	12.5522956618103	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGGAGGTCTCGACCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1485.03762371457	35.452455366742	0.0238731024726928	546	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1482.50622415241	1482.50622415241
"healthy-5"	"2019-08-29-count-1:TCGGGACCAGGTTTAC"	-1.80023870888408	3.38628528201906	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGACCAGGTTTAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2734.36859602111	44.0455273402635	0.0161081162957898	2829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2730.68445821233	2730.68445821233
"healthy-5"	"2019-08-29-count-2:TTTCCTCTCCTCTGCA"	3.87471546706502	-8.13454916393431	"2019-08-29-count-2"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTCCTCTCCTCTGCA"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1972.76980608432	41.9791874618014	0.0212793136494341	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1970.82598903875	1970.82598903875
"healthy-5"	"2019-08-29-count-1:TCGGGACCATGGATCT"	-2.38862715187724	10.1629972227844	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGACCATGGATCT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1475.22391869843	38.6063632459272	0.026169832766804	568	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1470.58102430031	1470.58102430031
"healthy-5"	"2019-08-29-count-1:ACTTAGGCAATCGCGC"	3.61745776709859	-7.88224651729735	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTAGGCAATCGCGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2038.80225846823	39.9514420880698	0.0195955453365476	961	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2036.98262247417	2036.98262247417
"healthy-5"	"2019-08-29-count-1:GTTGTGAGTAAGATTG"	-2.56369672241862	9.15052697742311	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GTTGTGAGTAAGATTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1976.36285638745	39.9140347936875	0.0201957017481322	886	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1974.3897030526	1974.3897030526
"healthy-5"	"2019-08-29-count-1:ACTTAGGGTCAAGCCC"	-2.04491744461711	9.19066331470338	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTAGGGTCAAGCCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.44854606238	37.0640155680705	0.0235559120511597	599	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1573.44854606238	1573.44854606238
"healthy-5"	"2019-08-29-count-2:GGCTTTCGTCTCCTGT"	9.55842651900594	6.37568996036378	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGCTTTCGTCTCCTGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1438.90314716427	47.1062028068985	0.0327375771605847	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1433.96585525155	1433.96585525155
"healthy-5"	"2019-08-29-count-1:TCGGGCAAGGCTAACG"	-5.32655463638957	-5.56554224407347	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGCAAGGCTAACG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2833.99621209093	45.6839710435856	0.0161199830997233	2170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2829.20105307763	2829.20105307763
"healthy-5"	"2019-08-29-count-2:TTTGACTTCAGCTTCC"	-3.41815338555034	12.9466218718323	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGACTTCAGCTTCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1870.0025307598	30.9643301062167	0.016558442888115	769	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1860.95350968351	1860.95350968351
"healthy-5"	"2019-08-29-count-2:GGGAAGTAGAGGTATT"	-2.86192570152934	3.39891026103822	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAAGTAGAGGTATT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3155.67447538883	43.3506022889969	0.0137373492187135	3479	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3150.74984664329	3150.74984664329
"healthy-5"	"2019-08-29-count-1:CTTCAATAGGGTACGT"	3.12548937377278	-7.35692884838256	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCAATAGGGTACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1860.26041957072	45.9025549492891	0.0246753381765127	846	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1852.47622498383	1852.47622498383
"healthy-5"	"2019-08-29-count-1:TCGGGCAGTAGCCAGA"	2.97832216796224	-7.66615011608275	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGCAGTAGCCAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1470.49692717097	45.0711007526613	0.0306502515713323	544	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1465.54289099447	1465.54289099447
"healthy-5"	"2019-08-29-count-1:TCGGGCAGTATGGGAC"	3.04522814330403	-7.58336117183837	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGGGCAGTATGGGAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1862.33285731797	46.8523723313229	0.0251578938465367	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1862.33285731797	1862.33285731797
"healthy-5"	"2019-08-29-count-1:ACTTCCGAGCGCGTTC"	3.02210511740987	-7.865842842218	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCCGAGCGCGTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1540.56815561525	45.9475636595898	0.0298250768666837	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1535.66235026237	1535.66235026237
"healthy-5"	"2019-08-29-count-2:ATGGGAGCATTCTTCA"	5.72939886626546	-1.67297663604888	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGGGAGCATTCTTCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2457.72701344557	46.0495178840653	0.018736628450654	1476	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2450.46771866588	2450.46771866588
"healthy-5"	"2019-08-29-count-1:ACTTCCGAGGATTCAA"	-4.18697915497478	13.1193523176941	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCCGAGGATTCAA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	2502.74703031886	41.7948185456344	0.0166995777197305	1363	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	2496.23611716145	2496.23611716145
"healthy-5"	"2019-08-29-count-1:ACTTCCGAGTGATTCC"	2.82856263694112	-7.93755962764891	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCCGAGTGATTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1773.57388969772	42.3373850624345	0.0238712270790422	742	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1769.31449235538	1769.31449235538
"healthy-5"	"2019-08-29-count-2:TACGGGCAGGCTAGCA"	2.65392388877217	-6.96816399013671	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TACGGGCAGGCTAGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1991.61681140585	40.3883589265115	0.0202791815650532	926	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1983.96741325363	1983.96741325363
"healthy-5"	"2019-08-29-count-1:ACTTCCGGTAGGCTGA"	3.90337791022603	-7.75250866329344	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCCGGTAGGCTGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1852.49923064369	47.6853304917245	0.0257410797818012	835	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1850.55297331807	1850.55297331807
"healthy-5"	"2019-08-29-count-2:ATGGGTTCACTAACCA"	-3.87273345413859	11.3863601454529	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGGGTTCACTAACCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1620.12979475095	38.6042016420973	0.0238278450079561	628	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1615.39916234485	1615.39916234485
"healthy-5"	"2019-08-29-count-1:ACTTCCGGTCACAGAG"	-3.2836962741917	11.1208715208801	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCCGGTCACAGAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1601.41815398858	35.3472266516237	0.0220724528216356	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1599.04325240971	1599.04325240971
"healthy-5"	"2019-08-29-count-2:TTTGGAGCAATGTTGC"	-2.57966933670695	11.0015020140442	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGGAGCAATGTTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1492.62560653069	50.7408142593712	0.0339943345721556	563	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1490.19891158643	1490.19891158643
"healthy-5"	"2019-08-29-count-2:TTTGGAGTCAATCCGA"	-7.68263183060344	0.586195445898451	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGGAGTCAATCCGA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2410.264337473	43.8313605710708	0.018185291915751	1617	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2400.9982285914	2400.9982285914
"healthy-5"	"2019-08-29-count-1:CTTCCGAGTCGCTTAA"	3.33848871764485	-8.0364618531433	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCCGAGTCGCTTAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.29903859699	44.1663013493183	0.0222131080345356	893	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1988.29903859699	1988.29903859699
"healthy-5"	"2019-08-29-count-1:ACTTCGCCACGGCGTT"	10.7787872749263	5.52611110294191	"2019-08-29-count-1"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCGCCACGGCGTT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1447.56281149083	45.4613559005951	0.0314054461331283	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1445.32757561393	1445.32757561393
"healthy-5"	"2019-08-29-count-1:ACTTCGCCAGCTGGTC"	9.47172035750691	5.72748372638551	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCGCCAGCTGGTC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1528.14469461385	38.9152833795054	0.0254657059090461	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1523.56915716904	1523.56915716904
"healthy-5"	"2019-08-29-count-1:ACTTCGCCAGTACTAC"	-2.95773110809978	3.38153526866762	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCGCCAGTACTAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3160.5751421078	43.4231945055826	0.0137390166514515	3609	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3150.76521796279	3150.76521796279
"healthy-5"	"2019-08-29-count-2:ATGGTTGTCCTGTAGA"	3.17208160933797	-7.78499224102172	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGGTTGTCCTGTAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1511.01976279706	48.2619245908822	0.0319399691381563	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1511.01976279706	1511.01976279706
"healthy-5"	"2019-08-29-count-1:ACTTCGCGTCTGTCAA"	6.88906492766683	-0.978685402032457	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTCGCGTCTGTCAA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1532.76646942525	40.1899110402947	0.0262205051075816	554	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1530.22931421715	1530.22931421715
"healthy-5"	"2019-08-29-count-2:GGGACAAGTTAGAAAC"	-1.4743277830189	10.736150718573	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACAAGTTAGAAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1410.29733685797	33.3900207968304	0.0236758731114254	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1410.29733685797	1410.29733685797
"healthy-5"	"2019-08-29-count-2:CCTAACCTCACCTCGT"	-0.983092646033126	8.78197190845338	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTAACCTCACCTCGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1685.42197671476	38.5355407098599	0.0228640312291249	714	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1675.03282845057	1675.03282845057
"healthy-5"	"2019-08-29-count-2:ATGTCCCAGATTGACA"	9.00396027144734	6.93174693668214	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGTCCCAGATTGACA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.46463373181	39.0726688396561	0.0231409459570962	730	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1686.44250514344	1686.44250514344
"healthy-5"	"2019-08-29-count-2:TGAGCATCATAGTCGT"	2.31090797957723	-7.78216745769652	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGAGCATCATAGTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1723.0190068443	49.6854683482021	0.0288362857001798	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1721.02181655976	1721.02181655976
"healthy-5"	"2019-08-29-count-2:TTTGTTGAGGACAAGA"	-3.70438895645793	12.7685603865418	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGTTGAGGACAAGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1448.21173050081	39.7033628942102	0.0274154407522168	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1438.19726042252	1438.19726042252
"healthy-5"	"2019-08-29-count-2:TTTGTTGCAATAACCC"	-0.947615603834945	8.98444173419801	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGTTGCAATAACCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1671.73170021104	36.2066110275413	0.0216581470716686	696	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1667.45154922868	1667.45154922868
"healthy-5"	"2019-08-29-count-2:ATGTCTTAGACGGTTG"	4.59512009200398	-8.20204451000365	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGTCTTAGACGGTTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1994.58189211047	44.129926991236	0.0221249010460744	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1992.64526046564	1992.64526046564
"healthy-5"	"2019-08-29-count-2:TTTGTTGCACTTGTCC"	3.29719962653462	-8.11734678661498	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TTTGTTGCACTTGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.57199334428	43.5982474947598	0.0257890510823583	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1690.57199334428	1690.57199334428
"healthy-5"	"2019-08-29-count-1:TTCTAACTCTGGTCAA"	10.4791132408077	5.6508693465027	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTAACTCTGGTCAA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1488.89639342128	41.7058849298264	0.0280112740645385	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1481.81140699949	1481.81140699949
"healthy-5"	"2019-08-29-count-2:ATGTCTTCATATAGCC"	3.67195524749104	-8.34880640422972	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGTCTTCATATAGCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1628.53928621884	43.7732996992612	0.0268788724163324	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1628.53928621884	1628.53928621884
"healthy-5"	"2019-08-29-count-2:ATGTCTTCATCGCCTT"	-2.91877685013469	10.3102922209534	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGTCTTCATCGCCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1622.33263886085	38.2271417603322	0.0235630726058584	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1617.69792296663	1617.69792296663
"healthy-5"	"2019-08-29-count-1:GGAGATGAGTGCCAGA"	-1.74661205235179	3.58959267223207	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGAGATGAGTGCCAGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2764.57612050566	42.7607459970698	0.0154673787709808	3062	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2760.24284861064	2760.24284861064
"healthy-5"	"2019-08-29-count-2:CCTATCGAGATAGCTA"	4.4109431701595	-8.14605715191039	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTATCGAGATAGCTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2165.056749521	39.3266982875385	0.0181642805881367	1122	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2161.85342422999	2161.85342422999
"healthy-5"	"2019-08-29-count-1:TCGTCCAAGGCATTTC"	3.42071427878682	-7.53297665035399	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGTCCAAGGCATTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1664.18819038757	45.738086576226	0.0274837225984485	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1661.85530807803	1661.85530807803
"healthy-5"	"2019-08-29-count-1:ACTTTGTGTGCATTAC"	-3.00603805008586	3.47959563815919	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ACTTTGTGTGCATTAC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2999.49141986901	45.8496234783382	0.015285799177362	3294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2991.57443167545	2991.57443167545
"healthy-5"	"2019-08-29-count-2:ATGTCTTTCTGGACCG"	2.96027483519856	-7.80364468013915	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATGTCTTTCTGGACCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1640.78982237189	40.130996162558	0.0244583404988126	641	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1633.88550378372	1633.88550378372
"healthy-5"	"2019-08-29-count-2:GGGACTCTCGGACGTC"	-2.373926739127	4.17225692355958	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGACTCTCGGACGTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3084.47420197541	49.130368842062	0.0159282800324922	3296	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3076.75040752343	3076.75040752343
"healthy-5"	"2019-08-29-count-1:AGAAATGAGCGACCCT"	-4.75057588043864	-5.10852005397948	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes (cycling)"	38	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAATGAGCGACCCT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2637.01444286302	48.5291484161322	0.0184030650827395	1880	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2635.1821574497	2635.1821574497
"healthy-5"	"2019-08-29-count-2:ATTACCTGTAGCTAAA"	2.65712585028951	-7.29985620891722	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTACCTGTAGCTAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1512.96204349025	48.0229383314506	0.0317410066816128	573	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1508.26920248732	1508.26920248732
"healthy-5"	"2019-08-29-count-2:ATTACCTGTCAATCTG"	-2.42606864395793	10.1623391875061	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTACCTGTCAATCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1731.93550379965	40.55026760416	0.0234132665536319	680	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1729.58779228651	1729.58779228651
"healthy-5"	"2019-08-29-count-2:ATTACCTGTGAGTAGC"	2.54013194617574	-8.20666506206664	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTACCTGTGAGTAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1496.61274066071	50.1513333825204	0.0335098933879048	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1494.06328900121	1494.06328900121
"healthy-5"	"2019-08-29-count-2:ATTACTCAGAGCCTGA"	-1.98416219177898	9.2977666624817	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTACTCAGAGCCTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1670.19197620555	28.1008929063691	0.0168249478543242	669	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.19197620555	1670.19197620555
"healthy-5"	"2019-08-29-count-2:GGGAGATGTGCGTTTA"	-6.97975573960002	0.919054008367933	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	27	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGATGTGCGTTTA"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2465.96732328267	43.3307125903658	0.0175714869297961	2056	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2450.34949657625	2450.34949657625
"healthy-5"	"2019-08-29-count-1:TCGTGCTGTGTTCATG"	3.91147770461385	-8.34489729320677	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCGTGCTGTGTTCATG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1481.94631345757	39.6571035303292	0.0267601485763705	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1479.50863781144	1479.50863781144
"healthy-5"	"2019-08-29-count-1:AGAAATGTCCACCCTA"	6.81098379668538	-1.58501424705657	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAATGTCCACCCTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2364.41245585539	32.214378327999	0.0136246864409046	1340	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2357.19452894582	2357.19452894582
"healthy-5"	"2019-08-29-count-2:ATTACTCCAATCAAGA"	10.48104919967	6.09626290881959	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTACTCCAATCAAGA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1621.43943391126	39.4688960655282	0.0243418873625891	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1616.94693051887	1616.94693051887
"healthy-5"	"2019-08-29-count-1:CTTCTAAGTAAGTAGT"	-2.83186231079753	3.98779318416444	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTAAGTAAGTAGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3217.69723712958	47.0420665969409	0.0146197927058252	3652	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3210.32966464478	3210.32966464478
"healthy-5"	"2019-08-29-count-1:CTTCTAAGTAGACAGC"	2.78361644324605	-7.66412832653197	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CTTCTAAGTAGACAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1555.71276499455	50.1616893649035	0.0322435416701613	611	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1553.37932742842	1553.37932742842
"healthy-5"	"2019-08-29-count-2:GGGAGATTCGGTGAAG"	3.5528162914211	-8.36187937175902	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGATTCGGTGAAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1621.85266491534	44.8790706213034	0.0276714843414251	660	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1619.66465428201	1619.66465428201
"healthy-5"	"2019-08-29-count-2:CTCCTTTCAACCGCTG"	-2.74567780914958	10.1706266173157	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CTCCTTTCAACCGCTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1546.47552917494	34.6899279918152	0.0224316048572217	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1541.90944414599	1541.90944414599
"healthy-5"	"2019-08-29-count-1:AGAACAAGTGTCATTG"	2.72856273230855	-7.32515909588011	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACAAGTGTCATTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1741.74514760731	49.9138883048485	0.0286574005235018	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1735.00871184869	1735.00871184869
"healthy-5"	"2019-08-29-count-1:TCTAACTAGGAAAGGT"	4.18128265914266	-8.17766954815062	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTAACTAGGAAAGGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1687.99675790086	40.7436044058559	0.0241372527613877	672	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1687.99675790086	1687.99675790086
"healthy-5"	"2019-08-29-count-1:AGAACAATCATTACCT"	1.85542907294576	-7.12951090252074	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACAATCATTACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1875.49960904601	47.1251561140903	0.0251267213742908	794	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1873.34371442848	1873.34371442848
"healthy-5"	"2019-08-29-count-1:TCTAACTCATCCTATT"	-3.29671249809917	10.3398599394592	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTAACTCATCCTATT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1944.58179845752	27.1393810374921	0.0139564100924011	847	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1942.51583065031	1942.51583065031
"healthy-5"	"2019-08-29-count-2:ATTATCCGTCACAATC"	-1.90215049210246	10.4434699782166	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	5	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTATCCGTCACAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1568.49269210553	30.4422358105806	0.0194085926978182	593	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1563.71714891469	1563.71714891469
"healthy-5"	"2019-08-29-count-1:TCTAACTGTTGTGGAG"	4.0795542198116	-6.85792782222899	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTAACTGTTGTGGAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1786.16261708974	47.4716310184021	0.0265774406900025	751	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1783.97949314103	1783.97949314103
"healthy-5"	"2019-08-29-count-1:AGAACCTCAAGGCCTC"	-3.39152155342754	12.6765327223572	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACCTCAAGGCCTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1793.52695518098	37.5020399234166	0.0209096606076	740	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1786.79594134691	1786.79594134691
"healthy-5"	"2019-08-29-count-2:ATTATCCTCAGCTGTA"	-1.49889193001445	8.82209680164186	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTATCCTCAGCTGTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1805.34338477343	36.2981875882809	0.0201059742398183	778	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1799.15778713116	1799.15778713116
"healthy-5"	"2019-08-29-count-1:TCTACATCAGTAGTTC"	3.60626639899556	-8.59560110485228	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTACATCAGTAGTTC"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1833.51829984526	48.8358129862346	0.0266350289442739	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1831.56053420266	1831.56053420266
"healthy-5"	"2019-08-29-count-2:ATTATCCTCGGACTGC"	10.5260530906612	7.08626363361207	"2019-08-29-count-2"	"Control5"	"B"	"Memory"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTATCCTCGGACTGC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1892.66138233674	40.8082535139912	0.0215613072126024	933	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1889.23363312485	1889.23363312485
"healthy-5"	"2019-08-29-count-2:GGGAGTAGTGCTATTG"	0.725404460995835	4.64517114246217	"2019-08-29-count-2"	"Control5"	"Ery"	"Erythrocytes"	25	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGAGTAGTGCTATTG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2152.10167767992	51.2369531135427	0.0238078682085221	1036	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2144.87221336258	2144.87221336258
"healthy-5"	"2019-08-29-count-1:AGAACCTTCTGTACAG"	-3.60924134674724	-5.63438560878905	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAACCTTCTGTACAG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2159.73700421664	48.3514339918454	0.0223876490042282	1045	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2157.89671127124	2157.89671127124
"healthy-5"	"2019-08-29-count-1:AGAAGCGAGAGGATCC"	2.26319493827168	-6.67261936580809	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGCGAGAGGATCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2253.86179890528	50.4397453260626	0.022379253843586	1277	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2252.4304860089	2252.4304860089
"healthy-5"	"2019-08-29-count-2:GGGATCCCAACCACAT"	-2.66629872742351	10.0492963560852	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGATCCCAACCACAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1578.3632921765	35.6526228536366	0.0225883502425307	610	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1575.9951973976	1575.9951973976
"healthy-5"	"2019-08-29-count-1:AGAAGCGAGCCTGTCG"	4.27298702773396	-8.33422758495482	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGCGAGCCTGTCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2262.1541444305	44.384561994162	0.0196204852367989	1272	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2254.76876683794	2254.76876683794
"healthy-5"	"2019-08-29-count-1:AGAAGCGAGCTACTAC"	4.2341329055721	-7.61406567012938	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGCGAGCTACTAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.36144998351	45.4872061364584	0.0258103728590319	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.19631749475	1760.19631749475
"healthy-5"	"2019-08-29-count-1:AGAAGCGCATCCTATT"	4.30635323104207	-7.27234365856322	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGCGCATCCTATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2234.3182440397	43.1384821779526	0.0193072237104224	1160	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2229.46519062886	2229.46519062886
"healthy-5"	"2019-08-29-count-1:TTCTTCCGTATCGTGT"	3.79163493689839	-8.26192285930785	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCGTATCGTGT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2112.77357218714	41.4804755310272	0.0196331855325541	1058	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2112.77357218714	2112.77357218714
"healthy-5"	"2019-08-29-count-1:ATTTCACCATCCGGCA"	2.47026767310445	-7.65003445064696	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.ATTTCACCATCCGGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1717.23759272108	48.1914676450301	0.0280633663328249	700	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1714.98525254107	1714.98525254107
"healthy-5"	"2019-08-29-count-1:TTCTTCCGTCCCGCAA"	3.61010231551473	-7.03230907833251	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTCTTCCGTCCCGCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2260.79656446957	45.3186840863741	0.0200454498200314	1173	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2257.54715024087	2257.54715024087
"healthy-5"	"2019-08-29-count-2:ATTCATCGTCGTACAT"	3.32832612571065	-7.81975319301756	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCATCGTCGTACAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1638.59651375543	50.2833001333713	0.0306868101520179	644	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1636.24918170766	1636.24918170766
"healthy-5"	"2019-08-29-count-2:ATTCATCTCTCCTGCA"	-2.8973322910374	3.43115780437318	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-1"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCATCTCTCCTGCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3339.38948567814	46.8604733936256	0.0140326468639251	3510	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3331.08633652318	3331.08633652318
"healthy-5"	"2019-08-29-count-2:ATTCATCTCTGTCCGT"	1.80535437640492	-7.06518509304198	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCATCTCTGTCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1632.26633594908	52.7610220224552	0.0323237824982634	646	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1632.26633594908	1632.26633594908
"healthy-5"	"2019-08-29-count-1:TCTATACAGGGCAGAG"	-0.113792012364227	8.59591672504274	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATACAGGGCAGAG"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1591.35662997172	34.4975922956744	0.0216781025987163	653	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1587.08595457488	1587.08595457488
"healthy-5"	"2019-08-29-count-1:AGAAGTAGTACCAGAG"	4.87436737593953	-9.0347938767639	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGTAGTACCAGAG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1885.61619245805	46.2134540923532	0.0245084096526082	843	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1883.672454346	1883.672454346
"healthy-5"	"2019-08-29-count-1:AGAAGTAGTAGTGTGG"	-3.6483191055363	12.5869760283264	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGTAGTAGTGTGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1552.89346039197	45.2164613077332	0.0291175553642425	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1543.0749269569	1543.0749269569
"healthy-5"	"2019-08-29-count-1:AGAAGTAGTGGCACTC"	4.96245731887166	-9.43349363720091	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGTAGTGGCACTC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2138.05970675561	36.0751504802624	0.016872845209269	1117	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2138.05970675561	2138.05970675561
"healthy-5"	"2019-08-29-count-1:AGAAGTAGTTCCGCTT"	2.9443003135616	-7.86751797115477	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGTAGTTCCGCTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1569.97090470358	43.8432628353488	0.0279261626467062	594	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1567.56403172448	1567.56403172448
"healthy-5"	"2019-08-29-count-1:TCTATACTCTCCCTAG"	4.03891982611958	-8.42993738567504	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATACTCTCCCTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1648.98610324085	44.7322840602589	0.0271271443539421	616	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1648.98610324085	1648.98610324085
"healthy-5"	"2019-08-29-count-1:AGAAGTATCGCAATTG"	4.8206807571346	-8.163037323114	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAAGTATCGCAATTG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2311.76114770666	43.1592327936796	0.0186694169665819	1270	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2298.06107832816	2298.06107832816
"healthy-5"	"2019-08-29-count-1:TCTATCAGTCTTACAG"	2.50183834609334	-6.99168064510497	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATCAGTCTTACAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1696.30679778666	44.7927104409086	0.0264060195357079	692	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1696.30679778666	1696.30679778666
"healthy-5"	"2019-08-29-count-1:AGACAAAAGCAGGTCA"	-3.69614301148112	12.3095397719177	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAAAAGCAGGTCA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1529.51138307929	45.6480544769645	0.029844860902613	585	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1529.51138307929	1529.51138307929
"healthy-5"	"2019-08-29-count-1:TCTATCATCGAGTACT"	9.03396572646443	7.07279298389284	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTATCATCGAGTACT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1449.52721124348	42.4464436834293	0.0292829574734347	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1449.52721124348	1449.52721124348
"healthy-5"	"2019-08-29-count-1:AGACAAAAGTTGGCTT"	-2.68304810944255	10.9553661116394	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAAAAGTTGGCTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1476.94696150819	39.3068831640293	0.0266136050842957	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1476.94696150819	1476.94696150819
"healthy-5"	"2019-08-29-count-2:GGGCCATCAGTAGAAT"	-1.22638283196147	9.33963868701784	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCCATCAGTAGAAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1704.61396293169	41.8788663823013	0.0245679475194933	752	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1702.6426811921	1702.6426811921
"healthy-5"	"2019-08-29-count-2:GGGCCATCATCCGAGC"	3.43678226050679	-7.97133161937865	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCCATCATCCGAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2037.99403765043	44.2301474070977	0.0217027854792401	896	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2025.62272889035	2025.62272889035
"healthy-5"	"2019-08-29-count-1:TCTCACGCAAGGCCTC"	0.875501175492448	8.79909989917604	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCACGCAAGGCCTC"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1699.20149160862	28.0061785363046	0.0164819644254146	743	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1697.23757100978	1697.23757100978
"healthy-5"	"2019-08-29-count-2:GGGCCATTCCAATGCA"	4.43565573272054	-8.50920870220336	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCCATTCCAATGCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2326.94591186049	41.7669849119405	0.0179492719186352	1288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2319.45427068541	2319.45427068541
"healthy-5"	"2019-08-29-count-1:AGACAAATCGTGGGTC"	2.999843497842	-7.64471867000731	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAAATCGTGGGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1508.42333237186	47.039262471722	0.0311843906562736	558	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1505.93617875048	1505.93617875048
"healthy-5"	"2019-08-29-count-2:ATTCCTACAACCTAAC"	-2.57701955261882	9.21380994403688	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCCTACAACCTAAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1743.34478362853	41.5829837651049	0.0238524152856073	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1738.9776942258	1738.9776942258
"healthy-5"	"2019-08-29-count-1:TCTCACGGTCAACCTA"	0.461536069482011	9.26990983569948	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ Naive"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCACGGTCAACCTA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1966.78286037075	36.5247308339838	0.0185707998426927	940	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1958.58819046167	1958.58819046167
"healthy-5"	"2019-08-29-count-1:GAACACTAGAAACCAT"	-3.26695809784587	10.2890462645325	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAACACTAGAAACCAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1840.79725707307	32.4302709287122	0.0176175137180927	783	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1836.55105484816	1836.55105484816
"healthy-5"	"2019-08-29-count-1:GAACACTAGCATACTC"	3.26322450217549	-7.82925894176634	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAACACTAGCATACTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1981.05827303328	47.4146475993812	0.0239339994410072	908	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1979.13574760069	1979.13574760069
"healthy-5"	"2019-08-29-count-2:TAGCACATCGTGCATA"	-2.41653595390971	4.03349206531373	"2019-08-29-count-2"	"Control5"	"Ery"	"Heat shock proteins"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGCACATCGTGCATA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3346.81728611123	45.0263299690506	0.0134534771754355	3939	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3337.21734459487	3337.21734459487
"healthy-5"	"2019-08-29-count-1:TCTCACGTCAGTGTCA"	-1.7312128347462	9.30179879749147	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCACGTCAGTGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	2162.55970303568	45.8016969144186	0.02117939072393	1155	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	2154.67764233079	2154.67764233079
"healthy-5"	"2019-08-29-count-1:AGACAGGAGGCGTTAG"	-2.78132400932963	10.1560382612976	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAGGAGGCGTTAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1590.73475217636	38.5962968548869	0.0242631883172738	634	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1586.2905689425	1586.2905689425
"healthy-5"	"2019-08-29-count-2:CCTCTCCGTGAATGAT"	-0.333603571087676	9.83292577350465	"2019-08-29-count-2"	"Control5"	"MAIT"	"MAIT"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTCTCCGTGAATGAT"	"MAIT"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"MAIT"	1558.4464256166	41.3047779914589	0.0265038164370114	603	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1556.15573519393	1556.15573519393
"healthy-5"	"2019-08-29-count-1:TTGAGTGAGGTACAGC"	3.67315425452535	-7.94948198711547	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGAGTGAGGTACAGC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2117.99846859939	44.203366232471	0.0208703485332084	1118	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2108.71686056583	2108.71686056583
"healthy-5"	"2019-08-29-count-1:AGACAGGAGTGCACTT"	3.68755807456319	-7.86564257061156	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAGGAGTGCACTT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1982.37197534137	44.9154788408849	0.022657442397081	903	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1980.45131717637	1980.45131717637
"healthy-5"	"2019-08-29-count-1:AGACAGGCAACTACGT"	1.93816973742787	-6.53616335308226	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGACAGGCAACTACGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1988.90286923978	45.443461512326	0.0228485071921565	920	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1985.01159845778	1985.01159845778
"healthy-5"	"2019-08-29-count-1:GGCTGTGAGTAGATCA"	3.34104218062703	-5.47462561046752	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GGCTGTGAGTAGATCA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2453.81470398865	43.0164617430941	0.0175304441990552	1428	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2452.40807556079	2452.40807556079
"healthy-5"	"2019-08-29-count-1:TCTCCGAAGCCTATCA"	-1.56309745732005	3.63153145397035	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCCGAAGCCTATCA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2689.73660546291	41.5256350096178	0.015438550721018	2705	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2685.31843053561	2685.31843053561
"healthy-5"	"2019-08-29-count-2:GGGCTACTCTCGCGTT"	-2.51884828034099	12.3704557188782	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCTACTCTCGCGTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1495.00648501213	47.4628270686802	0.031747572699188	574	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1492.65768612188	1492.65768612188
"healthy-5"	"2019-08-29-count-1:TCTCCGACACAGAAGC"	4.32161583480184	-8.54468252575072	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCCGACACAGAAGC"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1786.40597622707	44.1430570480614	0.0247105404009521	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1786.40597622707	1786.40597622707
"healthy-5"	"2019-08-29-count-2:GGGCTCACAGCTGTCG"	-1.73569033566173	3.79460570895997	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGCTCACAGCTGTCG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2776.88144874179	44.4054506174393	0.0159911222128548	2918	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2771.33310711255	2771.33310711255
"healthy-5"	"2019-08-29-count-1:CAACCAATCTGGCCGA"	1.02427103099172	8.84155938709108	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	4	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACCAATCTGGCCGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1460.44571085673	36.4165644542076	0.0249352401006709	566	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1455.84309536473	1455.84309536473
"healthy-5"	"2019-08-29-count-2:ATTCTTGAGGGACAGG"	3.16231169280354	-8.15578749096068	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCTTGAGGGACAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1743.81116811953	42.7034356789228	0.0244885664569822	731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1741.68960204163	1741.68960204163
"healthy-5"	"2019-08-29-count-2:ATTCTTGGTCTGCAAT"	6.86441816863362	-1.34042193805846	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCTTGGTCTGCAAT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2143.62157488518	34.6052718206966	0.0161433679461592	1055	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2138.41846477632	2138.41846477632
"healthy-5"	"2019-08-29-count-1:TCTCTGGGTGACCGAA"	10.8997608619625	4.6860780485901	"2019-08-29-count-1"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTCTGGGTGACCGAA"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1407.80164660807	43.8414570336403	0.0311417855912238	508	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1405.25176773266	1405.25176773266
"healthy-5"	"2019-08-29-count-2:ATTCTTGTCGCCACTT"	-3.49108825150188	12.1487636336121	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTCTTGTCGCCACTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1573.22109364676	39.8621662653465	0.0253379302034052	606	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1563.84487146693	1563.84487146693
"healthy-5"	"2019-08-29-count-2:GGGTAGATCCCTGTTG"	-3.42616234245952	11.0578908690247	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTAGATCCCTGTTG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1539.4772172121	35.5738988909744	0.0231077787272465	581	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1534.73757986384	1534.73757986384
"healthy-5"	"2019-08-29-count-2:TGCAGGCCAAGGGTCA"	-4.76537785950358	8.7293433913025	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	78	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCAGGCCAAGGGTCA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1837.17357309928	33.2600341845046	0.0181039149874094	738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1825.80266958317	1825.80266958317
"healthy-5"	"2019-08-29-count-2:CCTGTTGGTATACGGG"	3.66640939292256	-8.19553949749144	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTGTTGGTATACGGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1764.94184993721	51.6025530119349	0.0292375372105153	744	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1762.81377300045	1762.81377300045
"healthy-5"	"2019-08-29-count-1:GAAGAATGTGCCCAGT"	-4.31998382034953	-4.40207245266112	"2019-08-29-count-1"	"Control5"	"DC precursor"	"DC precursor"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGAATGTGCCCAGT"	"DC precursor"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2754.73813640283	45.1402408942914	0.0163863999622251	2288	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2750.44075471498	2750.44075471498
"healthy-5"	"2019-08-29-count-1:TCTGCCAAGCACGTCC"	3.2132064300472	-6.28414299404296	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGCCAAGCACGTCC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1994.23701452793	44.5398288678511	0.0223342704720555	952	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1990.55136064024	1990.55136064024
"healthy-5"	"2019-08-29-count-2:GGGTCACCAAACTCGT"	11.2234369712764	4.31664035404054	"2019-08-29-count-2"	"Control5"	"Pre-B"	"Pre-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTCACCAAACTCGT"	"Pre-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1579.45749138151	41.9905046000709	0.0265853970931139	604	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1579.45749138151	1579.45749138151
"healthy-5"	"2019-08-29-count-2:TAGTGCAAGAATTCAG"	11.214317937463	3.89601538265077	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TAGTGCAAGAATTCAG"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1511.31638931692	34.3286274779996	0.0227143884104342	556	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1498.78179260207	1498.78179260207
"healthy-5"	"2019-08-29-count-2:ATTGGGTGTCCTTGTC"	2.90371813353841	-7.14817240154418	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTGGGTGTCCTTGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1767.74085866363	51.9286392838184	0.0293757080000262	793	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1763.86600736717	1763.86600736717
"healthy-5"	"2019-08-29-count-2:ATTGGGTGTGTAACGG"	-2.43147764626201	3.93379900539247	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTGGGTGTGTAACGG"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3057.47920987003	44.5210443619107	0.0145613563677521	3731	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3051.84063126755	3051.84063126755
"healthy-5"	"2019-08-29-count-2:ATTGGGTGTTAGAAGT"	-3.85173330727275	11.0118512877258	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTGGGTGTTAGAAGT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1561.97575715445	39.0153256629237	0.0249781889918704	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1561.97575715445	1561.97575715445
"healthy-5"	"2019-08-29-count-1:TTGCCTGTCCACCTGT"	0.0889222185010135	8.51599881732789	"2019-08-29-count-1"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGTCCACCTGT"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1770.52281446183	34.9043211655747	0.0197141323909933	815	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1764.82922711418	1764.82922711418
"healthy-5"	"2019-08-29-count-1:TCTGCCACACTAGGTT"	-3.10346947136577	11.5914125212464	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGCCACACTAGGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1517.20877254801	44.7546845273973	0.0294980396483182	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1514.79002537971	1514.79002537971
"healthy-5"	"2019-08-29-count-1:TTGCCTGTCTTAGCAG"	3.36084093627278	-7.12651159679564	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCCTGTCTTAGCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1843.44602157847	42.5409347460792	0.0230768540267065	816	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1835.48896067505	1835.48896067505
"healthy-5"	"2019-08-29-count-2:GGGTCTGGTACAGAGC"	2.39937152442281	-4.20531179821166	"2019-08-29-count-2"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTCTGGTACAGAGC"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2315.31574277547	47.7443150441757	0.0206210816788826	1293	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2310.94582500165	2310.94582500165
"healthy-5"	"2019-08-29-count-2:GGGTCTGGTCATAACC"	-3.29135523262675	-5.41366627132567	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTCTGGTCATAACC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2148.83234767904	43.410791206791	0.0202020372848906	1294	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2143.47590127912	2143.47590127912
"healthy-5"	"2019-08-29-count-1:TTGCGTCAGGGCAATC"	-3.41046200218852	-5.57485201275023	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCGTCAGGGCAATC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2047.58156503244	44.5441062986657	0.0217544966507647	960	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2047.58156503244	2047.58156503244
"healthy-5"	"2019-08-29-count-1:CAACGGCTCAAAGGTA"	4.25744309005086	-7.7600422135559	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAACGGCTCAAAGGTA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2144.18384317597	46.7777091682989	0.0218160906851213	1034	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2142.36836411361	2142.36836411361
"healthy-5"	"2019-08-29-count-1:TTGCGTCAGTCTGCGC"	5.14261068877522	-9.69653036510619	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGCGTCAGTCTGCGC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2109.27910003596	42.546571778983	0.0201711436757031	1061	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2104.23529231064	2104.23529231064
"healthy-5"	"2019-08-29-count-1:TCTGCCATCTATCGTT"	-2.77490387383159	9.77716634357301	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGCCATCTATCGTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1753.90129937803	40.8975115016018	0.0233180233780002	711	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1749.43214080876	1749.43214080876
"healthy-5"	"2019-08-29-count-1:GAAGCGAAGTTTAGGA"	3.16016950187032	-8.22169973766478	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGCGAAGTTTAGGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1709.58201673174	49.0477845196913	0.0286899277365222	718	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1703.16377151222	1703.16377151222
"healthy-5"	"2019-08-29-count-2:CCTTTGGAGAGCCGTA"	6.78951849517171	-1.54378642952117	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CCTTTGGAGAGCCGTA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	1984.40432764609	35.8202383607219	0.0180508769617591	902	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	1982.54695431047	1982.54695431047
"healthy-5"	"2019-08-29-count-2:GGGTGAAGTCCTTTGC"	-1.95976005020793	10.0433225401672	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGGTGAAGTCCTTTGC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1557.70328496006	45.0412592378469	0.0289151725317199	607	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1553.05413599325	1553.05413599325
"healthy-5"	"2019-08-29-count-1:TCTGGCTGTCCAGCCA"	10.0104834037716	6.44880817020265	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGGCTGTCCAGCCA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1453.79514494932	42.7839609777777	0.0294291538435901	549	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1453.79514494932	1453.79514494932
"healthy-5"	"2019-08-29-count-1:GAAGCGACAGTATACC"	-3.51362095299419	-5.17167951976927	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.GAAGCGACAGTATACC"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2636.95966130722	44.8619364977239	0.0170127503867407	1909	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2629.67406719449	2629.67406719449
"healthy-5"	"2019-08-29-count-1:CAAGACTCATCGATGT"	10.7690264182979	6.46165988529054	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAAGACTCATCGATGT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1497.32528764912	44.1068365255922	0.0294570838343633	564	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1492.61422879237	1492.61422879237
"healthy-5"	"2019-08-29-count-2:ACTTCGCGTTCCACGG"	3.28475250777547	-7.90738251125487	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ACTTCGCGTTCCACGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1690.56650559042	44.7210573843508	0.026453296712354	694	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1688.40641750053	1688.40641750053
"healthy-5"	"2019-08-29-count-1:TCTGTCGAGGTTACCT"	4.51443686065022	-7.99387743389281	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGTCGAGGTTACCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1892.82908663458	43.0283591904242	0.02273230028757	828	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1888.91368970702	1888.91368970702
"healthy-5"	"2019-08-29-count-1:TCTGTCGCAATGAGCG"	4.52286638793294	-7.76422455227049	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTGTCGCAATGAGCG"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2255.18961161266	41.3588275996607	0.0183394014351128	1279	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2253.81821908903	2253.81821908903
"healthy-5"	"2019-08-29-count-2:TATATCCGTAGCTGCC"	10.4672132926876	6.04609391773073	"2019-08-29-count-2"	"Control5"	"B"	"Activated NFkB"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATATCCGTAGCTGCC"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1442.20709837794	39.9127053715568	0.0276747392357498	542	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1435.02963228489	1435.02963228489
"healthy-5"	"2019-08-29-count-2:ATTTCACCAGCAAGAC"	-2.17623529854472	9.55461022937623	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTTCACCAGCAAGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1810.02966224968	40.2394996344328	0.0222314034259634	838	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1806.22972010672	1806.22972010672
"healthy-5"	"2019-08-29-count-1:AGAGCCCCAGGAATCG"	3.21676458892171	-7.35812714016112	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAGCCCCAGGAATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1905.08471799123	40.1192832834797	0.0210590546995634	827	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1898.94106172406	1898.94106172406
"healthy-5"	"2019-08-29-count-2:ATTTCACCATGCAGGA"	5.43731798705403	-9.92469599163207	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTTCACCATGCAGGA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2222.30365018672	37.4663695428299	0.0168592485278427	1170	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2210.91022354498	2210.91022354498
"healthy-5"	"2019-08-29-count-2:TATATCCTCGCCTTTG"	2.36323132094685	-6.59084560787352	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATATCCTCGCCTTTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1791.85432179737	48.6059902385797	0.0271260836594261	782	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1791.85432179737	1791.85432179737
"healthy-5"	"2019-08-29-count-1:TCTTAGTGTCATAACC"	-0.642320374876815	9.5239047774109	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTAGTGTCATAACC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1447.33805470444	41.2537439436809	0.0285031847325436	525	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1442.56551811029	1442.56551811029
"healthy-5"	"2019-08-29-count-1:TCTTAGTGTCTTTATC"	-1.30257318440135	9.72693822467653	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTAGTGTCTTTATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1416.86739408093	40.3627158769935	0.0284872924915992	524	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1414.39902684705	1414.39902684705
"healthy-5"	"2019-08-29-count-1:AGAGCCCTCACCGGTG"	4.9882194000179	-4.89374926006468	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	14	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGAGCCCTCACCGGTG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1970.47903118803	46.9878648571787	0.0238459096054674	897	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1966.56136718313	1966.56136718313
"healthy-5"	"2019-08-29-count-2:CGAAGGACAGATACTC"	-2.69406257095988	3.52080676639406	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-4"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAAGGACAGATACTC"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3145.9218181431	48.3519448716576	0.0153697223474541	3738	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3144.10652968416	3144.10652968416
"healthy-5"	"2019-08-29-count-1:TTGGATGTCGGTGAAG"	-2.70417223396953	10.9110402830872	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGATGTCGGTGAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1530.15700324639	32.4747625994407	0.0212231571861855	576	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1522.87947579497	1522.87947579497
"healthy-5"	"2019-08-29-count-1:TCTTCCTAGCCTCTCT"	3.32189359244649	-7.61859514629515	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTCCTAGCCTCTCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1618.52705436276	49.710527705636	0.030713436375154	640	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1613.89128587467	1613.89128587467
"healthy-5"	"2019-08-29-count-1:TTGGGATAGGATATGT"	3.81578864631001	-7.44346001064452	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTGGGATAGGATATGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1887.54981085849	45.1471125293954	0.0239183688131979	830	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1887.54981085849	1887.54981085849
"healthy-5"	"2019-08-29-count-2:ATTTCTGGTCCAGCGT"	2.51888718184773	-4.02244379436644	"2019-08-29-count-2"	"Control5"	"cDC1"	"cDC1"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.ATTTCTGGTCCAGCGT"	"cDC1"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2272.62888259128	40.8753659411369	0.0179859396552816	1315	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2269.8454733701	2269.8454733701
"healthy-5"	"2019-08-29-count-1:AAACCCATCACCTCGT"	-3.62377343598064	-5.40311148082884	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAACCCATCACCTCGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2479.05246327434	45.3977814827573	0.0183125537499903	1570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2472.82633828692	2472.82633828692
"healthy-5"	"2019-08-29-count-1:TCTTCCTGTAGCGATG"	-7.32968602600749	-1.05812516128691	"2019-08-29-count-1"	"Control5"	"MEP"	"MEP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTCCTGTAGCGATG"	"MEP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	3446.78360977008	43.9800170785424	0.0127597267649408	3682	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	3432.71447240902	3432.71447240902
"healthy-5"	"2019-08-29-count-1:TCTTCCTGTCGGTAAG"	-2.61120114746745	10.8370818861756	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTCCTGTCGGTAAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1381.65340679658	39.570050139662	0.0286396356314907	509	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1376.78454921838	1376.78454921838
"healthy-5"	"2019-08-29-count-1:AGATCCACACCTGTCT"	9.81901993331258	6.86052033984987	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCCACACCTGTCT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1539.78865044118	33.3668700658835	0.0216697727031065	567	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1537.30160337372	1537.30160337372
"healthy-5"	"2019-08-29-count-2:CAAAGAAAGTCGCCCA"	3.53278507766072	-8.25487997448119	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CAAAGAAAGTCGCCCA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1748.13372101582	48.8288482808538	0.0279319869491906	750	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1741.97590283165	1741.97590283165
"healthy-5"	"2019-08-29-count-1:AGATCCAGTCTTCATT"	4.08156837996785	-8.3569374314514	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCCAGTCTTCATT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1870.12114223337	41.9937829124042	0.0224551137164588	818	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1868.05881621364	1868.05881621364
"healthy-5"	"2019-08-29-count-1:AGATCCAGTGTCCGGT"	-2.0194083255833	3.71945808017579	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-5"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCCAGTGTCCGGT"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	2867.28344731741	40.4051055759122	0.0140917723407201	2892	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	2864.16261486014	2864.16261486014
"healthy-5"	"2019-08-29-count-1:TCTTCCTTCCGTGGCA"	4.74472727355306	-7.81917335903319	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TCTTCCTTCCGTGGCA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2375.797384515	33.1612415486262	0.0139579417692623	1308	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2371.33659619989	2371.33659619989
"healthy-5"	"2019-08-29-count-1:AGATCGTAGGCCCAAA"	-4.05753407898601	-5.68542053615721	"2019-08-29-count-1"	"Control5"	"Granulocyte"	"Granulocytes"	63	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AGATCGTAGGCCCAAA"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2018.66929144082	49.1154526753047	0.0243306087250422	915	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2009.04954757507	2009.04954757507
"healthy-5"	"2019-08-29-count-2:TGGCGTGGTTGCAACT"	2.92694725570027	-7.43370153820189	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGCGTGGTTGCAACT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1414.76902659602	51.8210848376697	0.036628653768561	516	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1412.2627440421	1412.2627440421
"healthy-5"	"2019-08-29-count-2:TGGCGTGTCCACACCT"	4.12489904937093	-7.83036281978758	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGCGTGTCCACACCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2041.3480418729	44.8208102935722	0.0219564764920978	950	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2037.54169227437	2037.54169227437
"healthy-5"	"2019-08-29-count-1:AACCAACAGTCTAGCT"	2.85629834708516	-7.0094785920349	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCAACAGTCTAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1978.54036998689	47.6546624656966	0.0240857670576681	922	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1972.85166355186	1972.85166355186
"healthy-5"	"2019-08-29-count-1:CACGAATTCTGCTTAT"	9.98334374007527	6.22942016208497	"2019-08-29-count-1"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGAATTCTGCTTAT"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1601.29389666966	44.1596026301732	0.0275774501620318	639	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1592.42471480667	1592.42471480667
"healthy-5"	"2019-08-29-count-2:AGATAGAAGGAACGTC"	3.14742102202718	-7.72839119350585	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATAGAAGGAACGTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1573.50305780773	48.4468072804248	0.0307891408536077	614	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1573.50305780773	1573.50305780773
"healthy-5"	"2019-08-29-count-1:TTTCAGTGTTCATCTT"	6.86297144469563	-1.48249115860137	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTCAGTGTTCATCTT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2055.19220027118	32.3883913920171	0.0157593004623818	977	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2051.57623884143	2051.57623884143
"healthy-5"	"2019-08-29-count-1:TAGACTGCAAGTAGTA"	3.07238878783528	-7.32190563594969	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGACTGCAAGTAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1851.87491730661	47.4576060920432	0.0256267880992016	878	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1851.87491730661	1851.87491730661
"healthy-5"	"2019-08-29-count-2:GAGCCTGCACTCCTGT"	1.99426676806752	-6.96938421642455	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGCCTGCACTCCTGT"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2184.39200858137	42.0505636142009	0.0192504657813275	1068	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2180.83866865789	2180.83866865789
"healthy-5"	"2019-08-29-count-1:AACCACAAGCTACAAA"	4.01218261298482	-7.8858008614746	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCACAAGCTACAAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1758.23853406605	44.0846720654047	0.0250732032151836	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1756.15310445753	1756.15310445753
"healthy-5"	"2019-08-29-count-2:AGATAGAGTAGGCTGA"	-4.10887179794963	12.1251134642395	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATAGAGTAGGCTGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1654.14788728491	42.0039765515031	0.025393120454573	656	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1649.54772316549	1649.54772316549
"healthy-5"	"2019-08-29-count-2:AGATAGAGTCGAACGA"	6.81318678435628	-1.53963436996611	"2019-08-29-count-2"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATAGAGTCGAACGA"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2161.8329452589	37.5985179720569	0.0173919627113251	1029	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2149.16870556583	2149.16870556583
"healthy-5"	"2019-08-29-count-1:CGCGTGATCGATAACC"	4.11199154433553	-8.39509489452513	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCGTGATCGATAACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1812.79457052789	44.0057115671331	0.0242750680538052	760	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1810.67904502835	1810.67904502835
"healthy-5"	"2019-08-29-count-2:CGGAACCTCATTTACC"	4.59981312331502	-9.97455885326537	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	61	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGGAACCTCATTTACC"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1841.63108184322	53.456567280231	0.0290267512355017	829	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1833.64613231523	1833.64613231523
"healthy-5"	"2019-08-29-count-1:TAGAGTCAGCTCCGAC"	-2.87683401528056	10.5911760100159	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGAGTCAGCTCCGAC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1518.89347841172	39.8007521067494	0.0262037810237808	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1516.51356322007	1516.51356322007
"healthy-5"	"2019-08-29-count-2:TGGGAGACAATAGTAG"	2.97023644027058	-7.8089604607788	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGAGACAATAGTAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1531.66396564947	48.5625692606943	0.0317057594549482	596	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1522.35161732517	1522.35161732517
"healthy-5"	"2019-08-29-count-2:TGGGAGACATTGAAGA"	-3.71900854530986	13.0069951781067	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGGAGACATTGAAGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1637.16584105782	33.0220399179545	0.020170247319977	625	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1634.73562771074	1634.73562771074
"healthy-5"	"2019-08-29-count-1:CGGAACCAGTGAGTTA"	-5.53453002396281	-4.51017954265746	"2019-08-29-count-1"	"Control5"	"GMP"	"GMP"	57	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGGAACCAGTGAGTTA"	"GMP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2790.98197499341	44.3725526436255	0.015898545042997	2194	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2788.38660915165	2788.38660915165
"healthy-5"	"2019-08-29-count-2:AGATCCACAACGAGGT"	2.9016179042751	-6.9294471970764	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGATCCACAACGAGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1677.39171107103	40.2750949079604	0.0240105484259513	671	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1675.09852445117	1675.09852445117
"healthy-5"	"2019-08-29-count-1:AACCACATCCGTATAG"	-3.75187263909038	10.7273082503113	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCACATCCGTATAG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1784.0270749132	34.8212264713571	0.0195183284833563	747	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1784.0270749132	1784.0270749132
"healthy-5"	"2019-08-29-count-1:CACGTTCAGCGTATAA"	2.29378165778462	-4.3404636613098	"2019-08-29-count-1"	"Control5"	"cDC2"	"cDC2"	36	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACGTTCAGCGTATAA"	"cDC2"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"cDC"	2409.21014628108	40.2251899787656	0.0166964222863075	1490	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2402.93399042055	2402.93399042055
"healthy-5"	"2019-08-29-count-1:AACCACATCTGTAAGC"	3.67164053496663	-8.30222418224486	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACCACATCTGTAAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1950.73253389504	41.9982890050033	0.0215294963688051	863	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1946.68668809978	1946.68668809978
"healthy-5"	"2019-08-29-count-2:AGACACTTCACTTCTA"	-1.15938959541972	9.40529153430787	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACACTTCACTTCTA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1636.61370956449	43.7539547290442	0.0267344422653573	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1623.52260689066	1623.52260689066
"healthy-5"	"2019-08-29-count-1:AAAGTGAGTCACCTTC"	3.49183764037434	-8.03321745311888	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGTGAGTCACCTTC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1722.71171616939	43.4216776813825	0.0252054230976815	717	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1720.56618523235	1720.56618523235
"healthy-5"	"2019-08-29-count-2:AGACACTTCTAACGGT"	1.96712853488271	-7.51990940487059	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACACTTCTAACGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1432.25142638344	46.1022944389197	0.0321886880960084	518	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1432.25142638344	1432.25142638344
"healthy-5"	"2019-08-29-count-2:GGTGGCTAGGCTCACC"	3.0875686603481	-7.761838935968	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GGTGGCTAGGCTCACC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1762.19092509351	42.7410754450293	0.0242545088823229	733	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1760.04851654969	1760.04851654969
"healthy-5"	"2019-08-29-count-2:AGACAGGAGCTGACCC"	-3.23602757874187	11.87459657276	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACAGGAGCTGACCC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1591.03901492878	42.7640704348514	0.0268780778055061	600	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1583.77505587274	1583.77505587274
"healthy-5"	"2019-08-29-count-1:TACTGCCGTGCAATAA"	4.24529757079427	-8.25834753429564	"2019-08-29-count-1"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTGCCGTGCAATAA"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2244.31985597306	38.2666918092584	0.01705046261896	1202	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2244.31985597306	2244.31985597306
"healthy-5"	"2019-08-29-count-1:AAATGGAAGCCTAACT"	6.82023300704305	-1.4950400820938	"2019-08-29-count-1"	"Control5"	"pDC"	"pDC"	32	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAATGGAAGCCTAACT"	"pDC"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"DC"	"pDC"	2093.55717121889	31.1103172789496	0.0148600275677386	981	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	212	TRUE	"DC_healthy-5"	2070.10346515174	2070.10346515174
"healthy-5"	"2019-08-29-count-2:TATTGCTTCCCAGCGA"	-0.329865525395232	8.84044263446657	"2019-08-29-count-2"	"Control5"	"CD4+ T"	"CD4+ TCM"	18	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATTGCTTCCCAGCGA"	"CD4+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD4_T"	1541.9714206986	40.8183170225947	0.0264715133333027	595	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1537.27988443255	1537.27988443255
"healthy-5"	"2019-08-29-count-1:TACGGGCCACCACTGG"	-2.54583702507671	10.6687307127747	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGGCCACCACTGG"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1546.62047927535	40.545466099842	0.0262155238748934	627	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1542.21151077323	1542.21151077323
"healthy-5"	"2019-08-29-count-2:TGCGGGTTCTGGTGCG"	4.395280500024	-7.35018923198851	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCGGGTTCTGGTGCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2125.17734462059	40.137029107953	0.0188864375058161	1090	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2125.17734462059	2125.17734462059
"healthy-5"	"2019-08-29-count-2:TGCTCCAAGATGAACT"	-8.07631335678752	0.086030927765645	"2019-08-29-count-2"	"Control5"	"MPP"	"MPP_GMP"	37	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCCAAGATGAACT"	"MPP"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"HSPC"	"HSPC"	2609.20419220244	44.9437418434048	0.0172250765109601	2066	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	113	TRUE	"HSPC_healthy-5"	2603.56786680633	2603.56786680633
"healthy-5"	"2019-08-29-count-1:TACGGGCGTGGGCTTC"	-3.35388646546062	12.1041602858338	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGGCGTGGGCTTC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1511.11026154691	30.8201678788339	0.0203957107982866	570	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1501.48414950638	1501.48414950638
"healthy-5"	"2019-08-29-count-2:TGCTCCACATTCACCC"	-4.08637843552287	10.6890401610169	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCCACATTCACCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1840.82298316695	37.9312726512357	0.0206056057524764	770	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1838.63376637064	1838.63376637064
"healthy-5"	"2019-08-29-count-2:TATCTTGTCCTGGGTG"	5.4192234474117	-10.1577100983826	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TATCTTGTCCTGGGTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2087.9688642682	37.004432456628	0.0177226936138233	990	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2086.10694165397	2086.10694165397
"healthy-5"	"2019-08-29-count-2:AGACAAAAGCCGGAAT"	11.1841303306514	3.8493978747162	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACAAAAGCCGGAAT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1477.4922046261	33.5111032608206	0.0226810694201267	532	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1469.86057177094	1469.86057177094
"healthy-5"	"2019-08-29-count-1:AAAGGGCCAGGCATTT"	3.9252847629482	-7.52030804073485	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGGGCCAGGCATTT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1615.8341743531	39.3132609594496	0.0243300095909833	629	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1615.8341743531	1615.8341743531
"healthy-5"	"2019-08-29-count-1:TACGGGCTCAGCATTG"	5.46794333037679	-9.50732614910277	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGGCTCAGCATTG"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2194.2337700199	37.9928546370178	0.0173148618693774	1064	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2184.76102092878	2184.76102092878
"healthy-5"	"2019-08-29-count-1:CAATTTCCACGCCAGT"	2.85965957221333	-7.83586122905882	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CAATTTCCACGCCAGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2103.0612026426	35.8160120428328	0.0170304183244065	1005	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2097.54013599962	2097.54013599962
"healthy-5"	"2019-08-29-count-1:CGAGTGCGTGAACCGA"	-2.8514600795811	3.88468000972597	"2019-08-29-count-1"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGAGTGCGTGAACCGA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3125.19640882768	37.3949502522645	0.0119656320308815	3797	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3119.62753441291	3119.62753441291
"healthy-5"	"2019-08-29-count-2:CGAGGCTTCGTGACTA"	-2.7858136695927	4.00263474071351	"2019-08-29-count-2"	"Control5"	"Ery"	"Ery-2"	53	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGAGGCTTCGTGACTA"	"Ery"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Ery"	"Ery"	3163.52548891988	48.0036303383046	0.0151740931142914	3913	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	241	TRUE	"Ery_healthy-5"	3156.91872038077	3156.91872038077
"healthy-5"	"2019-08-29-count-2:AGACAAACACATACGT"	-2.11030826988872	13.6786412962708	"2019-08-29-count-2"	"Control5"	"NK"	"Activated NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACAAACACATACGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1642.53238345214	40.9305542284035	0.0249191764136662	622	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1640.07288250921	1640.07288250921
"healthy-5"	"2019-08-29-count-1:AAAGGTAAGGGTTAAT"	2.54562153395955	-7.4845500222412	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGGTAAGGGTTAAT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1409.94827767723	51.1676464153146	0.0362904421569343	505	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1402.17035762356	1402.17035762356
"healthy-5"	"2019-08-29-count-1:TACGGTAAGATCCAAA"	5.34660591658894	-9.32762052929076	"2019-08-29-count-1"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGTAAGATCCAAA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2271.70012984888	40.0293760840037	0.0176208891120971	1189	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2271.70012984888	2271.70012984888
"healthy-5"	"2019-08-29-count-1:AAAGGTACATCCGTGG"	9.20138706740681	6.41028592670289	"2019-08-29-count-1"	"Control5"	"B"	"Memory"	0	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGGTACATCCGTGG"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1746.12757219106	48.0151682223833	0.027498087188517	756	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1742.04792357588	1742.04792357588
"healthy-5"	"2019-08-29-count-2:TGCTCGTTCCATCCGT"	2.40343060073201	-8.85203268444213	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	13	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGCTCGTTCCATCCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1648.842489977	47.1751626365849	0.0286110789377116	650	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1648.842489977	1648.842489977
"healthy-5"	"2019-08-29-count-1:TACGGTATCGCCACTT"	-2.95238933983501	11.1451492079529	"2019-08-29-count-1"	"Control5"	"NK"	"Activated NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGGTATCGCCACTT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1608.79684198995	45.8712109226155	0.0285127430172455	638	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1599.98130248382	1599.98130248382
"healthy-5"	"2019-08-29-count-1:CACAACAGTACTCAAC"	-2.69267497482951	13.5896100767883	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	22	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACAACAGTACTCAAC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1503.42266089248	44.7055757674332	0.0297358666530238	557	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1495.78953196783	1495.78953196783
"healthy-5"	"2019-08-29-count-1:AAAGTCCTCAGTCCGG"	14.1198021369869	2.15588638866273	"2019-08-29-count-1"	"Control5"	"Plasmablast"	"Plasmablast"	69	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGTCCTCAGTCCGG"	"Plasmablast"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"Plasma"	1305.86015683862	48.3488780330357	0.0370245449176461	601	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1293.70799228406	1293.70799228406
"healthy-5"	"2019-08-29-count-1:TACGTCCCATGTGGCC"	-3.49067435684856	10.9264354475769	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGTCCCATGTGGCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1736.02627220313	36.5117497217825	0.0210317956049403	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1731.76109062256	1731.76109062256
"healthy-5"	"2019-08-29-count-1:AAAGTGAAGCTAAGTA"	3.39234723624532	-8.00677778637084	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGTGAAGCTAAGTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1813.66130791541	42.3328471031182	0.0233410984280052	767	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1809.49973843592	1809.49973843592
"healthy-5"	"2019-08-29-count-1:CACACAACATTGTAGC"	3.22832932051961	-7.24065020000609	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACACAACATTGTAGC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2075.88863195268	48.9106101236135	0.0235612881012821	1032	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2070.69747798287	2070.69747798287
"healthy-5"	"2019-08-29-count-1:AAAGTGACAGCTATAC"	3.18927540358846	-8.68917372142943	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AAAGTGACAGCTATAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1662.80129424174	43.401922952276	0.0261016894216863	687	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1656.34112611465	1656.34112611465
"healthy-5"	"2019-08-29-count-1:TACGTCCTCTAGTCAG"	2.69448866423909	-7.20944597637328	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACGTCCTCTAGTCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1779.68910602064	42.0916602165984	0.023651131017324	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1775.36931168969	1775.36931168969
"healthy-5"	"2019-08-29-count-1:CGATCGGGTGGGTTGA"	-1.97570500794109	9.37411496723024	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGATCGGGTGGGTTGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1467.552529127	38.3886409859459	0.0261582738771076	550	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1465.16338219358	1465.16338219358
"healthy-5"	"2019-08-29-count-1:TACTGCCCAAGCTACT"	-1.57268903675731	9.63471982562868	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TACTGCCCAAGCTACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1439.71678301298	37.7796764811573	0.0262410474941422	537	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1434.88107021031	1434.88107021031
"healthy-5"	"2019-08-29-count-2:TGGATCACATAGCACT"	-1.21269700947459	9.55967328632203	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ TRM"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATCACATAGCACT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1461.9301495871	41.3914988477868	0.0283129114338857	547	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1457.06614842075	1457.06614842075
"healthy-5"	"2019-08-29-count-1:AACAAGACATCCGTTC"	-1.03509817543681	9.31876752460328	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ GZMK+"	15	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAAGACATCCGTTC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1680.80726820541	36.6745828488993	0.0218196241429017	746	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1670.96925835168	1670.96925835168
"healthy-5"	"2019-08-29-count-2:TGGATCATCACGACTA"	3.00698914107625	-7.53213550960692	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATCATCACGACTA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2079.1802609837	46.879503917167	0.0225471089721616	1063	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2072.50976422415	2072.50976422415
"healthy-5"	"2019-08-29-count-1:AACAAGAGTGTCCGGT"	3.60366096076314	-7.43815948879393	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAAGAGTGTCCGGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1660.90374646335	42.8783795985441	0.0258162941048495	677	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1656.56376777077	1656.56376777077
"healthy-5"	"2019-08-29-count-1:CGCCAGACAACCAATC"	-3.24052486839946	10.7792091139588	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCCAGACAACCAATC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1673.09660017829	38.5227700190427	0.0230248331237644	673	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1665.73151980257	1665.73151980257
"healthy-5"	"2019-08-29-count-2:AGAGAGCTCGCGAAGA"	-2.71633491936381	11.2482042082581	"2019-08-29-count-2"	"Control5"	"NK"	"CD56bright NK"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGAGCTCGCGAAGA"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1492.4222716703	40.8870094125322	0.0273964079662066	584	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1490.17139089277	1490.17139089277
"healthy-5"	"2019-08-29-count-1:TAGACCACATTACTCT"	3.70025863227193	-8.17792894756468	"2019-08-29-count-1"	"Control5"	"CD11c+"	"CD11c+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGACCACATTACTCT"	"CD11c+"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1807.8223270512	47.4115118465043	0.0262257585477655	780	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1803.60544787502	1803.60544787502
"healthy-5"	"2019-08-29-count-2:AGAGCAGAGTCTAGCT"	3.47176422652547	-8.60614969646605	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+ IFN+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGCAGAGTCTAGCT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1516.32024672342	44.0936790324475	0.0290793973949293	578	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1513.95430929194	1513.95430929194
"healthy-5"	"2019-08-29-count-2:AGAGCAGAGTGCCTCG"	2.2605000930721	-7.18804266369017	"2019-08-29-count-2"	"Control5"	"Granulocyte"	"Granulocytes"	29	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGCAGAGTGCCTCG"	"Granulocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Gran"	"Gran"	2069.69825627743	44.0684264238596	0.021292198652726	1020	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	254	TRUE	"Gran_healthy-5"	2066.20317011812	2066.20317011812
"healthy-5"	"2019-08-29-count-1:AACACACTCAGAGTGG"	-3.85270319405254	12.4307937392029	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACACACTCAGAGTGG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1759.76558484286	41.7267766552906	0.0237115539789447	723	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1755.36400707678	1755.36400707678
"healthy-5"	"2019-08-29-count-2:AGAGCAGCAGCCCAGT"	-3.3232036632603	12.8682555922302	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGCAGCAGCCCAGT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1760.51625066514	38.4524414235362	0.0218415714191837	685	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1758.13669795316	1758.13669795316
"healthy-5"	"2019-08-29-count-2:AGAGCAGCATCGATCA"	5.35430683669393	-9.69017412578734	"2019-08-29-count-2"	"Control5"	"CD16+ monocyte"	"CD16+"	50	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGCAGCATCGATCA"	"CD16+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2328.32909471081	41.8160727751459	0.0179596917249104	1320	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2322.53957937809	2322.53957937809
"healthy-5"	"2019-08-29-count-2:TGGATGTTCGGTTCAA"	3.18298615989034	-7.96384622966918	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGATGTTCGGTTCAA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1599.72738070623	39.6792199662966	0.0248037387150174	613	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1599.72738070623	1599.72738070623
"healthy-5"	"2019-08-29-count-2:AGAGCCCGTAGTCTGT"	4.98969330367391	-9.04444601452025	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGAGCCCGTAGTCTGT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2089.79827757872	38.823583681449	0.0185776704373738	1002	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2088.00321154398	2088.00321154398
"healthy-5"	"2019-08-29-count-2:GAGATGGAGAGGGCGA"	-3.06945310059245	11.8667745360169	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ NK-like"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.GAGATGGAGAGGGCGA"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1441.12773913609	48.6530702542728	0.033760414800869	527	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1438.62420927792	1438.62420927792
"healthy-5"	"2019-08-29-count-1:TAGACCATCGGTCATA"	3.85545553740804	-8.10277368938597	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TAGACCATCGGTCATA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1971.54348674013	35.4842455943674	0.0179982058894573	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1969.8027004889	1969.8027004889
"healthy-5"	"2019-08-29-count-1:AACAGGGTCCATACTT"	-3.11389241638835	10.7211665877136	"2019-08-29-count-1"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAGGGTCCATACTT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1674.09894459125	35.8675824652486	0.0214250075129257	668	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1671.83842976082	1671.83842976082
"healthy-5"	"2019-08-29-count-2:TGGAGGACAGTGACCC"	-3.88674579086955	11.0766486891541	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAGGACAGTGACCC"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1623.0042509615	36.0984885683025	0.022241770806772	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1620.59317563928	1620.59317563928
"healthy-5"	"2019-08-29-count-2:AGACTCACACCTTCGT"	3.18327798423116	-7.99858095562132	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACTCACACCTTCGT"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1919.25174502054	50.6427260468582	0.0263867031400387	859	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1917.27502937485	1917.27502937485
"healthy-5"	"2019-08-29-count-2:TGGAGGAGTGAGATCG"	3.19795860823933	-7.00604965603026	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAGGAGTGAGATCG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1761.00383696325	41.7440662034884	0.0237046991762799	722	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1758.79420135775	1758.79420135775
"healthy-5"	"2019-08-29-count-1:TTTACTGCAAAGGGCT"	-3.582755903632	12.7951040037903	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	26	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.TTTACTGCAAAGGGCT"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1437.4225957374	41.3904905909431	0.028794935263773	523	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1437.4225957374	1437.4225957374
"healthy-5"	"2019-08-29-count-2:AGACCCGCATATGGCT"	4.50575031813924	-8.68599512493285	"2019-08-29-count-2"	"Control5"	"HLA-II+ monocyte"	"HLA-II+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCCGCATATGGCT"	"HLA-II+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	2022.66263667598	43.3231341912123	0.021418863138941	992	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	2017.63388629028	2017.63388629028
"healthy-5"	"2019-08-29-count-2:AGACCCGGTATGTCAC"	3.26546349105183	-8.09073355114134	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCCGGTATGTCAC"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1703.57282134127	48.6162891827424	0.0285378403398485	716	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1701.43054528136	1701.43054528136
"healthy-5"	"2019-08-29-count-2:TGGAACTTCTTCCAGC"	-2.37325153771098	13.3101482161316	"2019-08-29-count-2"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.TGGAACTTCTTCCAGC"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1604.51933629103	34.4543443635411	0.021473312028252	620	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1597.27825525169	1597.27825525169
"healthy-5"	"2019-08-29-count-1:AACAAAGGTCTTCAAG"	-2.60785541954692	13.0868654021057	"2019-08-29-count-1"	"Control5"	"NK"	"CD56dim NK"	6	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAAAGGTCTTCAAG"	"NK"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"NK"	"NK"	1679.80265774925	40.2432555816113	0.0239571329381826	643	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	344	TRUE	"NK_healthy-5"	1677.42997224498	1677.42997224498
"healthy-5"	"2019-08-29-count-2:AGACCCGGTTATCCAG"	1.88527884063069	-6.67146398937377	"2019-08-29-count-2"	"Control5"	"CD14+ monocyte"	"CD14+"	3	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACCCGGTTATCCAG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1878.68634471643	52.2609472642719	0.027817813980098	848	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1874.75360983035	1874.75360983035
"healthy-5"	"2019-08-29-count-1:CGCATAACAATGCAGG"	2.81513013419453	-7.76106645977172	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCATAACAATGCAGG"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1656.22721675978	42.697878085218	0.0257802055497866	665	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1647.33343084203	1647.33343084203
"healthy-5"	"2019-08-29-count-2:AGACTCAAGTGAGTTA"	10.8144508796627	5.75494048679201	"2019-08-29-count-2"	"Control5"	"B"	"Naive B"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACTCAAGTGAGTTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1464.04813034484	50.1817193255163	0.034276003831716	551	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1461.66655621566	1461.66655621566
"healthy-5"	"2019-08-29-count-2:AGACTCACAAATGGAT"	-2.83388410034831	10.8867110976013	"2019-08-29-count-2"	"Control5"	"CD8+ T"	"CD8+ Cytotoxic"	9	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.AGACTCACAAATGGAT"	"CD8+ T"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"T"	"CD8_T"	1479.35585182453	41.9113602445081	0.0283308172221157	580	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	710	TRUE	"T_healthy-5"	1474.83837520727	1474.83837520727
"healthy-5"	"2019-08-29-count-1:CACCAAACAACCGATT"	11.2850843864376	3.96413204753724	"2019-08-29-count-1"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CACCAAACAACCGATT"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1602.29681515123	40.1549730724988	0.0250608830353999	598	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1589.79141770748	1589.79141770748
"healthy-5"	"2019-08-29-count-1:AACAACCTCCGTCCTA"	10.5094429450924	6.26269528949586	"2019-08-29-count-1"	"Control5"	"B"	"Activated AP-1"	2	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.AACAACCTCCGTCCTA"	"B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1688.28767326146	42.1020542139256	0.0249377252945242	715	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1686.21098340626	1686.21098340626
"healthy-5"	"2019-08-29-count-1:CGCATGGCAGGTCAGA"	3.03343166884724	-7.80034639751586	"2019-08-29-count-1"	"Control5"	"CD14+ monocyte"	"CD14+"	8	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613751"	"2019-08-29-count-1_metadata.csv"	"2019.08.29.count.1.CGCATGGCAGGTCAGA"	"CD14+ monocyte"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"Mono"	"Mono"	1444.18328909711	51.6136483611743	0.0357389873922738	522	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	1687	TRUE	"Mono_healthy-5"	1434.30082798471	1434.30082798471
"healthy-5"	"2019-08-29-count-2:CGCATGGTCCGTGCGA"	11.0910393196041	4.28348586643068	"2019-08-29-count-2"	"Control5"	"Pro-B"	"Pro-B"	48	"Control"	"Control"	"Control"	"control_39to53yrs"	"control_39to53yrs"	"male"	"Control"	NA	"GSM5613752"	"2019-08-29-count-2_metadata.csv"	"2019.08.29.count.2.CGCATGGTCCGTGCGA"	"Pro-B"	"5"	"M"	47	"CITE-Seq"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"healthy"	"control"	"B"	"B"	1432.37635982164	41.4839842255882	0.0289616509942638	531	30000	1100	500	TRUE	TRUE	TRUE	TRUE	5	313	TRUE	"B_healthy-5"	1425.01976544781	1425.01976544781